data_1exe_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1exe _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.546 ' HA ' ' CB ' ' A' ' 5' ' ' GLU . 1.2 mtp . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -174.12 -167.55 0.35 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.884 -1.135 . . . . 0.0 111.736 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.438 ' O ' HG13 ' A' ' 7' ' ' ILE . 0.4 OUTLIER -53.02 -11.56 0.25 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.574 -0.704 . . . . 0.0 110.847 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.684 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 19.6 m -116.47 -42.48 3.0 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.026 -1.046 . . . . 0.0 109.538 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.546 ' CB ' ' HA ' ' A' ' 1' ' ' MET . 0.4 OUTLIER -62.13 -54.31 42.95 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.164 -0.96 . . . . 0.0 108.612 179.073 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.504 HD11 HG11 ' B' ' 42' ' ' VAL . 9.9 mt -57.93 -29.32 65.04 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.318 -0.864 . . . . 0.0 108.974 177.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.684 ' HB ' ' O ' ' A' ' 4' ' ' THR . 0.6 OUTLIER -55.17 -58.62 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.85 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.508 ' HE2' ' HA ' ' A' ' 5' ' ' GLU . 0.0 OUTLIER -61.06 -28.19 68.89 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.625 -0.83 . . . . 0.0 108.761 178.235 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.478 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . . . -61.16 -32.59 72.32 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.361 -0.837 . . . . 0.0 109.064 179.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.814 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.7 OUTLIER -97.52 -34.84 4.97 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.446 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 178.465 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.523 ' HA ' ' OG1' ' A' ' 14' ' ' THR . . . -61.22 -26.89 68.04 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 177.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.413 ' CG ' ' N ' ' A' ' 13' ' ' ASP . 11.0 pt20 -91.56 -39.85 11.68 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.435 ' HB3' ' CB ' ' B' ' 27' ' ' SER . 43.8 m-20 -66.21 -22.89 66.36 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 176.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.814 ' OG1' ' O ' ' A' ' 10' ' ' ILE . 16.8 p -93.0 -76.12 0.48 Allowed 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 58.63 14.52 22.06 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.805 HD11 ' HB ' ' A' ' 14' ' ' THR . 1.7 mp -80.79 -50.89 9.26 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.365 -1.079 . . . . 0.0 108.465 179.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.501 HG22 ' O ' ' A' ' 17' ' ' THR . 0.5 OUTLIER -150.7 0.74 0.42 Allowed 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 120.266 -0.573 . . . . 0.0 110.619 -179.655 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.593 ' O ' ' C ' ' A' ' 19' ' ' VAL . 9.1 mt-30 55.64 29.66 14.03 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 -176.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.744 ' HB ' ' HB ' ' B' ' 19' ' ' VAL . 0.7 OUTLIER -4.98 -95.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.714 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 1.092 ' O ' ' N ' ' A' ' 22' ' ' SER . 0.1 OUTLIER -132.45 24.42 4.43 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 178.292 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.664 ' O ' HG12 ' A' ' 7' ' ' ILE . 13.4 m -4.29 -40.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 CA-C-O 122.417 1.104 . . . . 0.0 110.898 -178.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 1.092 ' N ' ' O ' ' A' ' 20' ' ' SER . 8.6 t -79.92 -40.77 27.45 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.335 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.862 ' N ' ' O ' ' A' ' 20' ' ' SER . 1.7 ttpt -84.73 -27.71 26.79 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.412 -0.805 . . . . 0.0 111.366 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.53 ' SD ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -78.45 -40.39 35.78 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 117.895 -1.522 . . . . 0.0 109.751 179.627 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.663 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 0.2 OUTLIER -78.8 -49.21 13.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.585 -1.322 . . . . 0.0 109.837 178.842 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.44 ' CB ' ' O ' ' A' ' 22' ' ' SER . . . -55.04 -34.23 63.34 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.585 ' O ' ' N ' ' A' ' 31' ' ' ILE . 20.7 t -85.16 -29.64 24.59 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.744 -0.783 . . . . 0.0 108.99 178.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.697 ' HA ' ' CG1' ' A' ' 31' ' ' ILE . 0.2 OUTLIER -59.81 -39.27 84.45 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.442 -0.786 . . . . 0.0 109.101 179.165 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.541 ' HG3' ' CD2' ' A' ' 28' ' ' PHE . 4.5 mt-10 -79.21 -31.96 43.86 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.972 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 24.7 tttm -69.74 -25.86 64.04 Favored 'General case' 0 C--O 1.188 -2.179 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 176.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.697 ' CG1' ' HA ' ' A' ' 28' ' ' PHE . 1.9 pp -97.59 -31.33 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.957 -1.09 . . . . 0.0 109.157 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.642 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 2.0 mm -63.68 -56.16 18.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 177.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.432 ' HA ' ' HB3' ' B' ' 85' ' ' LEU . 0.4 OUTLIER -68.82 -36.98 78.89 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.39 -0.823 . . . . 0.0 108.882 179.313 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.972 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 59.4 mm-40 -74.98 -32.84 61.78 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.554 -0.716 . . . . 0.0 111.652 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.552 ' N ' ' O ' ' A' ' 31' ' ' ILE . 24.2 m -67.66 -58.14 5.18 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 118.221 -1.391 . . . . 0.0 108.988 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.761 ' O ' ' HG3' ' A' ' 52' ' ' PRO . 0.7 OUTLIER -51.29 -35.65 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 178.447 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.666 ' O ' ' HB2' ' B' ' 92' ' ' LEU . . . -73.32 -27.9 61.78 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.082 178.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.562 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -75.78 -25.77 56.71 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 177.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 35' ' ' THR . . . 108.97 27.58 4.8 Favored Glycine 0 C--N 1.295 -1.706 0 C-N-CA 120.075 -1.059 . . . . 0.0 111.403 177.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.49 ' HB2' HG22 ' A' ' 35' ' ' THR . 0.2 OUTLIER -108.46 151.65 25.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.123 -1.222 . . . . 0.0 109.651 179.011 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -76.69 81.61 3.32 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.374 -0.829 . . . . 0.0 110.421 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.491 ' CG2' ' CG2' ' A' ' 35' ' ' THR . 60.7 t -68.29 140.63 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.448 -0.782 . . . . 0.0 109.8 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.508 ' HG2' ' HA ' ' B' ' 2' ' ' ASN . 4.2 pt20 -158.85 174.17 15.4 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.372 -0.83 . . . . 0.0 109.76 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.63 ' CD1' ' HB2' ' A' ' 48' ' ' LEU . 27.9 mt -127.5 115.22 18.53 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.441 -0.787 . . . . 0.0 109.244 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.523 ' CG2' ' HE3' ' B' ' 3' ' ' LYS . 0.0 OUTLIER 33.2 -95.54 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.89 -0.507 . . . . 0.0 111.566 -179.599 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.406 ' H ' HG23 ' A' ' 45' ' ' THR . . . -139.73 25.06 2.72 Favored Glycine 0 N--CA 1.487 2.083 0 C-N-CA 119.417 -1.373 . . . . 0.0 111.089 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.754 ' CD1' ' HG3' ' B' ' 29' ' ' GLU . 13.3 p90 -122.07 -31.83 3.81 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.616 -1.52 . . . . 0.0 110.538 178.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.63 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 8.3 mt -122.09 148.97 44.21 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 119.886 -1.759 . . . . 0.0 111.548 177.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.468 ' N ' ' HB2' ' A' ' 80' ' ' LYS . 1.0 OUTLIER -149.25 77.12 1.35 Allowed 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.289 0.566 . . . . 0.0 110.483 -179.815 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.416 ' N ' ' O ' ' A' ' 42' ' ' VAL . 43.5 mm -69.63 126.28 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.394 -0.816 . . . . 0.0 109.962 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -140.67 126.33 11.38 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.335 -0.853 . . . . 0.0 108.766 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.761 ' HG3' ' O ' ' A' ' 36' ' ' VAL . 55.2 Cg_endo -86.83 140.37 5.9 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.317 1.167 . . . . 0.0 110.885 -178.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.576 HG21 ' O ' ' A' ' 76' ' ' GLY . 18.4 m -137.28 117.07 15.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-O 122.204 1.002 . . . . 0.0 110.837 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.72 0.771 . . . . 0.0 111.765 -178.862 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.421 ' HB ' ' CD1' ' B' ' 94' ' ' TYR . 8.0 p . . . . . 0 N--CA 1.498 1.974 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.576 ' O ' HG21 ' A' ' 53' ' ' VAL . . . -117.93 82.92 0.34 Allowed Glycine 0 N--CA 1.493 2.445 0 C-N-CA 118.556 -1.783 . . . . 0.0 110.285 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.566 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 97.3 t -70.69 74.45 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.146 -1.208 . . . . 0.0 109.165 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.461 ' N ' ' O ' ' A' ' 51' ' ' LYS . 0.4 OUTLIER -58.87 -166.41 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.445 0.641 . . . . 0.0 110.587 -179.68 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.411 HG13 ' HG3' ' B' ' 81' ' ' PRO . 7.9 p -172.21 178.74 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.541 -0.724 . . . . 0.0 109.061 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.468 ' HB2' ' N ' ' A' ' 49' ' ' ASN . 0.4 OUTLIER -122.04 177.96 1.4 Allowed Pre-proline 0 C--N 1.309 -1.192 0 O-C-N 120.905 -1.122 . . . . 0.0 110.619 179.425 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.419 ' CD ' ' CB ' ' A' ' 80' ' ' LYS . 56.4 Cg_endo -106.32 74.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.302 -1.919 0 C-N-CA 123.739 2.96 . . . . 0.0 109.874 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.718 ' CA ' ' O ' ' A' ' 47' ' ' PHE . . . -56.53 93.83 0.03 OUTLIER Glycine 0 N--CA 1.486 2.032 0 C-N-CA 119.198 -1.477 . . . . 0.0 110.71 -178.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' A' ' 81' ' ' PRO . 2.9 pt-20 -62.2 -28.14 69.47 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.668 -0.901 . . . . 0.0 108.995 178.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.433 ' O ' ' HB1' ' A' ' 88' ' ' ALA . 71.1 m -53.24 -27.66 23.38 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.443 ' CD2' HG11 ' B' ' 36' ' ' VAL . 4.4 tt -85.74 -30.91 22.72 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.432 ' HA ' ' HB2' ' A' ' 89' ' ' ALA . 3.0 tttt -79.9 -40.31 28.53 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.629 0.728 . . . . 0.0 109.139 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.417 ' O ' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -67.73 -37.08 81.71 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 178.256 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.609 ' O ' ' HB3' ' B' ' 37' ' ' ALA . . . -64.12 -36.71 84.94 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 176.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.432 ' HB2' ' HA ' ' A' ' 86' ' ' LYS . . . -57.49 -39.34 76.23 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.583 ' HA ' ' HB2' ' A' ' 94' ' ' TYR . 6.3 mm-40 -56.44 -29.07 61.19 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 176.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -70.42 -42.44 64.68 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.577 ' O ' ' HG2' ' A' ' 93' ' ' LYS . 0.4 OUTLIER -61.36 -48.94 79.0 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.27 -1.723 . . . . 0.0 110.791 -178.943 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.577 ' HG2' ' O ' ' A' ' 92' ' ' LEU . 0.0 OUTLIER 157.06 44.02 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.42 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.577 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.622 ' CD1' ' O ' ' B' ' 75' ' ' VAL . 87.5 t80 -42.48 -54.55 3.83 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.717 -0.615 . . . . 0.0 111.053 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 . . . . . 0 N--CA 1.496 1.854 0 O-C-N 121.087 -1.008 . . . . 0.0 110.557 179.881 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.51 ' HG2' ' HB3' ' B' ' 5' ' ' GLU . 5.3 mtp . . . . . 0 N--CA 1.492 1.653 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 2' ' ' ASN . . . . . 0.508 ' HA ' ' HG2' ' A' ' 43' ' ' GLN . 23.2 p30 -176.47 -174.02 0.56 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.237 -0.914 . . . . 0.0 111.225 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.523 ' HE3' ' CG2' ' A' ' 45' ' ' THR . 0.0 OUTLIER -49.53 -16.37 0.21 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.493 -0.754 . . . . 0.0 110.728 -179.641 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.561 ' O ' HG13 ' B' ' 7' ' ' ILE . 3.2 m -105.87 -57.53 2.03 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 122.113 0.958 . . . . 0.0 108.716 178.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.51 ' HB3' ' HG2' ' B' ' 1' ' ' MET . 0.4 OUTLIER -50.35 -46.01 55.48 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.838 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' B' ' 2' ' ' ASN . 6.2 mt -58.02 -31.6 67.14 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.795 -0.762 . . . . 0.0 109.914 178.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' ILE . . . . . 0.584 HG13 ' N ' ' B' ' 8' ' ' LYS . 0.8 OUTLIER -60.9 -40.39 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 178.827 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . 0.804 ' HA ' ' HB2' ' B' ' 11' ' ' ALA . 0.0 OUTLIER -70.43 -31.45 68.64 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 177.865 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . 0.432 ' O ' ' HB2' ' B' ' 13' ' ' ASP . . . -58.53 -37.95 76.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.6 -0.687 . . . . 0.0 109.152 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . 0.736 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.3 mp -92.89 -30.41 4.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.804 ' HB2' ' HA ' ' B' ' 8' ' ' LYS . . . -67.6 -12.97 61.63 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 118.576 -1.25 . . . . 0.0 108.455 178.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.444 ' CG ' ' N ' ' B' ' 13' ' ' ASP . 17.0 pt20 -112.93 -42.0 3.65 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.432 -0.793 . . . . 0.0 109.338 178.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.444 ' N ' ' CG ' ' B' ' 12' ' ' GLN . 0.9 OUTLIER -70.9 -27.43 63.79 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 176.906 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.736 ' OG1' ' O ' ' B' ' 10' ' ' ILE . 0.1 OUTLIER -113.54 -85.76 0.58 Allowed 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 178.143 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . 0.571 ' O ' ' C ' ' B' ' 16' ' ' LEU . . . 80.19 -28.26 2.64 Favored Glycine 0 N--CA 1.499 2.885 0 O-C-N 121.031 -1.043 . . . . 0.0 111.062 177.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' LEU . . . . . 0.945 HD12 ' HB2' ' A' ' 20' ' ' SER . 5.1 mp -13.93 -66.0 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.519 0 CA-C-O 121.918 0.866 . . . . 0.0 112.062 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' THR . . . . . 0.573 ' O ' HG23 ' B' ' 17' ' ' THR . 0.6 OUTLIER -139.64 7.62 2.33 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.549 -179.579 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . 0.618 ' O ' ' C ' ' B' ' 19' ' ' VAL . 11.4 mt-30 58.95 25.83 14.23 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 -175.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.744 ' HB ' ' HB ' ' A' ' 19' ' ' VAL . 2.4 p -4.94 -96.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.393 -179.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' SER . . . . . 0.961 ' O ' ' N ' ' B' ' 23' ' ' LYS . 0.6 OUTLIER -132.01 23.07 4.54 Favored 'General case' 0 C--N 1.279 -2.462 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 178.045 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . 0.616 ' C ' ' O ' ' B' ' 20' ' ' SER . 30.4 m -24.42 -40.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 122.449 1.119 . . . . 0.0 109.054 -178.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.693 ' N ' ' O ' ' B' ' 20' ' ' SER . 3.2 m -81.95 -36.24 28.19 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.088 177.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . 0.961 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.8 OUTLIER -85.19 -37.92 19.58 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.675 -0.641 . . . . 0.0 111.44 179.656 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' MET . . . . . 0.54 ' HG2' HG21 ' A' ' 14' ' ' THR . 0.0 OUTLIER -68.14 -38.11 81.82 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 117.637 -1.625 . . . . 0.0 108.374 179.156 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . 0.497 ' HA ' ' HB3' ' B' ' 28' ' ' PHE . 8.8 mt -71.68 -35.5 70.31 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 118.47 -1.292 . . . . 0.0 108.976 178.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . 0.456 ' HA ' ' CE ' ' B' ' 3' ' ' LYS . . . -62.96 -37.15 85.95 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 177.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' SER . . . . . 0.53 ' O ' ' N ' ' B' ' 31' ' ' ILE . 1.2 p -80.86 -26.59 36.86 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . 0.65 ' O ' HG13 ' B' ' 31' ' ' ILE . 1.8 t80 -55.36 -48.84 73.63 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . 0.754 ' HG3' ' CD1' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -69.16 -33.91 74.15 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.869 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . 1.21 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 24.1 tttp -64.88 -22.61 67.02 Favored 'General case' 0 C--O 1.191 -1.99 0 C-N-CA 119.012 -1.075 . . . . 0.0 108.374 178.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.65 HG13 ' O ' ' B' ' 28' ' ' PHE . 0.7 OUTLIER -104.53 -27.04 3.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 120.271 -1.518 . . . . 0.0 109.345 178.265 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.59 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.2 mm -70.99 -61.88 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 177.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' THR . . . . . 0.428 ' OG1' ' N ' ' A' ' 85' ' ' LEU . 0.6 OUTLIER -66.73 -37.79 85.37 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.408 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 1.21 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 18.2 mm-40 -76.25 -35.0 59.17 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 121.065 -1.022 . . . . 0.0 111.901 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' THR . . . . . 0.563 ' CB ' ' O ' ' B' ' 31' ' ' ILE . 4.5 m -61.82 -52.8 62.71 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 120.339 -1.476 . . . . 0.0 108.912 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.443 HG11 ' CD2' ' A' ' 85' ' ' LEU . 1.0 OUTLIER -53.35 -38.32 31.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 C-N-CA 118.194 -1.402 . . . . 0.0 107.259 178.71 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . 0.609 ' HB3' ' O ' ' A' ' 88' ' ' ALA . . . -83.37 -2.36 55.59 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.832 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . 0.578 ' HB2' ' O ' ' B' ' 34' ' ' GLU . 0.0 OUTLIER -100.95 -23.83 14.46 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 177.546 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.05 43.97 1.45 Allowed Glycine 0 C--N 1.301 -1.375 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . 0.468 ' CB ' HG22 ' B' ' 35' ' ' THR . 0.1 OUTLIER -138.16 137.92 38.1 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.105 -1.232 . . . . 0.0 110.103 179.366 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 5.7 mttp -90.79 84.17 5.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.461 -0.775 . . . . 0.0 110.916 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . 0.54 ' HB ' ' CG2' ' B' ' 50' ' ' ILE . 3.5 t -63.54 146.39 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.399 -0.813 . . . . 0.0 109.278 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -138.61 114.1 9.68 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 120.88 -1.138 . . . . 0.0 110.501 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.627 HD12 ' CB ' ' B' ' 48' ' ' LEU . 17.1 mt -85.75 110.99 19.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.187 -0.946 . . . . 0.0 108.784 178.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' THR . . . . . 0.534 HG22 ' HG2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 33.07 -89.83 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.407 0 O-C-N 121.739 -0.601 . . . . 0.0 110.997 -179.441 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -148.31 22.01 1.38 Allowed Glycine 0 N--CA 1.485 1.917 0 C-N-CA 119.818 -1.182 . . . . 0.0 110.176 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . 0.541 ' HB2' ' CG ' ' B' ' 85' ' ' LEU . 14.4 p90 -118.14 -34.91 3.97 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.832 -1.393 . . . . 0.0 112.111 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . 0.627 ' CB ' HD12 ' B' ' 44' ' ' LEU . 0.0 OUTLIER -115.76 92.06 3.79 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.805 -1.185 . . . . 0.0 110.692 179.428 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' ASN . . . . . 0.63 ' O ' ' HB ' ' B' ' 79' ' ' VAL . 1.1 t-20 -79.96 60.82 3.65 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.88 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' ILE . . . . . 0.631 ' HA ' ' HB ' ' B' ' 79' ' ' VAL . 32.2 mm -56.34 116.92 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.314 -0.867 . . . . 0.0 111.62 -177.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . 0.534 ' HG3' ' O ' ' B' ' 51' ' ' LYS . 6.9 ptmt -169.97 126.17 0.73 Allowed Pre-proline 0 N--CA 1.488 1.435 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' PRO . . . . . 0.468 ' HB2' HG12 ' B' ' 75' ' ' VAL . 54.8 Cg_endo -79.32 144.76 18.42 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.433 1.228 . . . . 0.0 112.158 -177.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.414 HG22 ' OG ' ' B' ' 78' ' ' SER . 30.0 m -150.31 122.17 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . 0.59 ' HB2' ' N ' ' B' ' 75' ' ' VAL . . . . . . . . 0 C--N 1.299 -1.61 0 C-N-CA 118.96 -1.096 . . . . 0.0 111.535 -177.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . 0.622 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 84.3 t . . . . . 0 N--CA 1.526 3.335 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -143.57 -142.65 3.98 Favored Glycine 0 N--CA 1.491 2.305 0 O-C-N 120.285 -1.509 . . . . 0.0 110.559 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.416 ' CG2' ' CD2' ' A' ' 85' ' ' LEU . 11.3 t -141.57 83.55 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-O 121.982 0.896 . . . . 0.0 109.734 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 78' ' ' SER . . . . . 0.463 ' CB ' ' HG3' ' B' ' 51' ' ' LYS . 0.1 OUTLIER -58.44 -45.04 89.31 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.586 0.707 . . . . 0.0 110.947 179.343 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . 0.631 ' HB ' ' HA ' ' B' ' 50' ' ' ILE 0.284 7.5 p -46.9 172.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-O 122.438 1.113 . . . . 0.0 113.791 -174.52 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 80' ' ' LYS . . . . . 0.627 ' HB2' ' HD2' ' B' ' 81' ' ' PRO . 0.3 OUTLIER 178.15 175.74 0.32 Allowed Pre-proline 0 N--CA 1.48 1.03 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -179.625 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 81' ' ' PRO . . . . . 0.627 ' HD2' ' HB2' ' B' ' 80' ' ' LYS . 47.1 Cg_endo -72.84 137.99 27.97 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.374 1.197 . . . . 0.0 109.583 177.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -101.67 -161.02 26.87 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . 0.413 ' HA ' ' HB2' ' B' ' 86' ' ' LYS . 0.4 OUTLIER -91.11 -10.64 41.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.418 -1.048 . . . . 0.0 110.417 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -54.93 -36.69 65.52 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.252 -0.905 . . . . 0.0 109.977 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . 0.541 ' CG ' ' HB2' ' B' ' 47' ' ' PHE . 0.0 OUTLIER -85.4 -33.42 21.97 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 119.629 -0.828 . . . . 0.0 108.852 179.198 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 86' ' ' LYS . . . . . 0.413 ' HB2' ' HA ' ' B' ' 83' ' ' GLU . 8.6 mttt -69.38 -34.09 74.01 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.653 -0.819 . . . . 0.0 109.264 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . 0.5 ' O ' ' HG3' ' B' ' 90' ' ' GLU . 35.8 tptt -73.15 -38.17 66.32 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 177.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.703 ' O ' ' HG ' ' B' ' 92' ' ' LEU . . . -67.71 -34.23 76.46 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 177.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . 0.663 ' HA ' ' HA ' ' A' ' 37' ' ' ALA . . . -72.16 -45.21 61.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.79 -0.569 . . . . 0.0 110.45 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . 0.519 ' HA ' ' HB2' ' B' ' 94' ' ' TYR . 0.6 OUTLIER -56.82 -19.31 16.63 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.622 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . 0.425 ' N ' ' HG3' ' B' ' 90' ' ' GLU . . . -93.93 -24.58 19.68 Favored Glycine 0 CA--C 1.547 2.089 0 CA-C-O 118.467 -1.185 . . . . 0.0 113.57 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 92' ' ' LEU . . . . . 0.703 ' HG ' ' O ' ' B' ' 88' ' ' ALA . 0.1 OUTLIER -113.03 -71.67 0.74 Allowed 'General case' 0 N--CA 1.507 2.381 0 CA-C-N 122.27 3.035 . . . . 0.0 113.171 -177.924 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 93' ' ' LYS . . . . . 0.459 ' O ' ' CD2' ' B' ' 97' ' ' PHE . 0.0 OUTLIER -113.0 36.58 3.44 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.803 -1.186 . . . . 0.0 112.459 -177.462 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . 0.519 ' HB2' ' HA ' ' B' ' 90' ' ' GLU . 6.2 t80 -71.24 -53.63 13.72 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 119.241 -0.984 . . . . 0.0 109.371 178.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -71.72 -31.53 66.81 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.41 -34.84 69.32 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 97' ' ' PHE . . . . . 0.472 ' CE2' ' HG2' ' A' ' 52' ' ' PRO . 7.4 m-85 . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.488 ' HB2' ' HA ' ' B' ' 42' ' ' VAL . 2.3 mtp . . . . . 0 N--CA 1.494 1.768 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' B' ' 43' ' ' GLN . 49.9 p-10 -166.93 -158.3 0.29 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.005 -1.059 . . . . 0.0 111.794 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.429 ' CD ' ' HA ' ' A' ' 26' ' ' ALA . 2.1 mmtp -56.02 -8.04 0.41 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.472 -0.768 . . . . 0.0 111.352 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.738 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 33.8 m -123.82 -41.95 2.21 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 120.854 -1.154 . . . . 0.0 109.885 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.487 ' CB ' ' HA ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -61.9 -54.94 34.96 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.015 -1.053 . . . . 0.0 108.2 179.0 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.474 ' HA ' ' HB2' ' A' ' 9' ' ' ALA . 6.9 mt -56.38 -29.24 61.2 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.592 -0.843 . . . . 0.0 109.179 177.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.738 ' HB ' ' O ' ' A' ' 4' ' ' THR . 0.8 OUTLIER -55.94 -59.73 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.47 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.454 ' HA ' ' CB ' ' A' ' 11' ' ' ALA . 0.1 OUTLIER -60.96 -28.56 69.07 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.224 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.474 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . . . -59.61 -33.96 72.16 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.554 -0.858 . . . . 0.0 108.991 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.772 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.6 OUTLIER -95.44 -36.14 6.48 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.422 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 178.318 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.479 ' HA ' ' OG1' ' A' ' 14' ' ' THR . . . -57.98 -23.98 56.19 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.719 -0.793 . . . . 0.0 108.89 178.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -93.13 -44.2 8.49 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -62.46 -31.39 72.11 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 177.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.772 ' OG1' ' O ' ' A' ' 10' ' ' ILE . 28.2 p -83.25 -75.44 0.32 Allowed 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 177.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 59.02 18.8 42.32 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.001 -1.239 . . . . 0.0 110.001 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.611 HD13 ' HB ' ' A' ' 14' ' ' THR . 3.5 mp -87.41 -53.66 4.7 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.326 -1.102 . . . . 0.0 109.112 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.521 HG22 ' O ' ' A' ' 17' ' ' THR . 0.5 OUTLIER -149.89 4.99 0.57 Allowed 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 120.021 -0.671 . . . . 0.0 110.596 -178.991 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.556 ' O ' ' C ' ' A' ' 19' ' ' VAL . 16.8 mt-30 56.48 26.68 11.16 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 -176.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.905 ' HB ' ' HB ' ' B' ' 19' ' ' VAL . 1.7 p -3.24 -94.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.9 -179.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.947 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -131.69 25.13 4.72 Favored 'General case' 0 C--N 1.28 -2.453 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 179.729 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.632 ' HA ' ' CE ' ' A' ' 24' ' ' MET . 5.6 m -17.27 -39.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-O 122.464 1.125 . . . . 0.0 110.12 -178.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.871 ' N ' ' O ' ' A' ' 20' ' ' SER . 16.3 p -80.85 -37.27 30.25 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.038 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.947 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.5 OUTLIER -88.7 -28.83 20.3 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.442 -0.786 . . . . 0.0 111.186 179.878 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.755 ' N ' ' OG ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -76.83 -38.55 53.61 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 117.875 -1.53 . . . . 0.0 109.288 179.744 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.691 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 0.3 OUTLIER -80.21 -48.35 13.25 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 118.172 -1.411 . . . . 0.0 109.365 178.827 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 22' ' ' SER . . . -54.55 -34.33 61.66 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 119.054 -1.058 . . . . 0.0 108.217 178.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.615 ' O ' ' N ' ' A' ' 31' ' ' ILE . 25.1 p -87.21 -31.02 20.55 Favored 'General case' 0 C--O 1.203 -1.364 0 C-N-CA 119.696 -0.802 . . . . 0.0 109.381 178.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.709 ' O ' HG13 ' A' ' 31' ' ' ILE . 0.1 OUTLIER -56.57 -38.23 71.67 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.2 -0.938 . . . . 0.0 108.927 179.079 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.57 ' HG3' ' CE2' ' A' ' 28' ' ' PHE . 1.0 OUTLIER -82.15 -33.93 29.35 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 178.146 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.991 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 20.1 tttt -68.45 -21.47 64.64 Favored 'General case' 0 C--O 1.189 -2.097 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 176.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.709 HG13 ' O ' ' A' ' 28' ' ' PHE . 1.3 pp -102.31 -30.49 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.878 -1.139 . . . . 0.0 109.448 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.673 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 2.1 mm -65.87 -56.4 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 177.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.512 ' O ' ' CB ' ' B' ' 88' ' ' ALA . 0.4 OUTLIER -64.95 -49.43 70.37 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 178.559 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.991 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 15.4 mm-40 -62.52 -32.04 72.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.46 -0.775 . . . . 0.0 111.044 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.618 ' N ' ' O ' ' A' ' 31' ' ' ILE . 1.2 m -56.25 -53.11 61.09 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 178.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.422 ' CG1' ' HB3' ' A' ' 52' ' ' PRO . 13.4 t -54.89 -34.38 30.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 C-N-CA 117.91 -1.516 . . . . 0.0 106.975 177.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.67 ' CB ' ' O ' ' B' ' 88' ' ' ALA . . . -79.29 -3.58 46.7 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -108.53 -18.51 13.71 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.34 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 35' ' ' THR . . . 95.77 43.85 3.26 Favored Glycine 0 C--N 1.303 -1.266 0 C-N-CA 120.209 -0.996 . . . . 0.0 110.657 178.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.499 ' CB ' HG21 ' A' ' 35' ' ' THR . 0.2 OUTLIER -125.71 127.05 45.62 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.125 -1.22 . . . . 0.0 110.222 179.236 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.1 mtmt -77.64 87.66 3.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.566 -0.708 . . . . 0.0 110.065 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.538 ' HB ' ' HB ' ' A' ' 50' ' ' ILE . 93.0 t -60.04 123.29 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.571 -0.706 . . . . 0.0 110.238 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -121.86 94.8 4.42 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.517 -0.739 . . . . 0.0 109.357 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 46' ' ' GLY . 12.1 mt -72.52 104.28 3.79 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.336 -0.852 . . . . 0.0 110.411 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.541 HG23 ' HG3' ' B' ' 29' ' ' GLU . 0.1 OUTLIER 31.24 -90.28 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 O-C-N 122.108 -0.37 . . . . 0.0 111.508 179.504 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -148.74 19.67 1.28 Allowed Glycine 0 N--CA 1.486 2.022 0 C-N-CA 119.746 -1.216 . . . . 0.0 110.272 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.673 ' CD1' ' HG3' ' B' ' 29' ' ' GLU . 6.1 p90 -120.7 -22.03 6.47 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.879 -1.365 . . . . 0.0 111.853 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.523 ' HG ' ' CE2' ' A' ' 47' ' ' PHE . 4.6 mt -129.08 102.71 6.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.229 -1.545 . . . . 0.0 110.632 177.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.734 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 1.3 m120 -99.67 89.71 4.22 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.853 -0.53 . . . . 0.0 111.696 -178.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.612 ' HA ' ' HA ' ' A' ' 79' ' ' VAL . 0.9 OUTLIER -90.19 148.17 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.242 0 O-C-N 121.39 -0.818 . . . . 0.0 110.777 179.376 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -164.64 110.22 0.86 Allowed Pre-proline 0 N--CA 1.504 2.262 0 O-C-N 120.881 -1.137 . . . . 0.0 111.367 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.687 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 55.8 Cg_endo -78.53 141.43 17.66 Favored 'Trans proline' 0 N--CA 1.489 1.253 0 O-C-N 123.635 1.334 . . . . 0.0 112.264 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.702 ' O ' ' N ' ' A' ' 76' ' ' GLY . 33.9 m -151.39 115.66 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 CA-C-O 121.355 0.597 . . . . 0.0 110.38 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.407 ' N ' HG21 ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.504 2.255 0 CA-C-O 121.599 0.714 . . . . 0.0 112.513 -178.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.537 ' HB ' ' HB2' ' B' ' 94' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.498 1.926 0 CA-C-O 121.269 0.557 . . . . 0.0 110.061 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.768 ' O ' ' N ' ' A' ' 78' ' ' SER . . . -99.31 53.93 1.01 Allowed Glycine 0 N--CA 1.484 1.862 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.687 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 4.5 p -50.91 69.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.922 -0.752 . . . . 0.0 109.971 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.768 ' N ' ' O ' ' A' ' 76' ' ' GLY . 1.0 OUTLIER -70.39 175.78 4.47 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 118.815 -1.154 . . . . 0.0 109.329 -179.771 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.734 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 0.7 OUTLIER 176.46 175.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 179.644 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.518 ' N ' ' CG2' ' A' ' 79' ' ' VAL . 0.4 OUTLIER -176.1 174.5 0.76 Allowed Pre-proline 0 C--N 1.299 -1.622 0 O-C-N 121.159 -0.963 . . . . 0.0 109.865 178.521 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.432 ' CG ' HG11 ' B' ' 77' ' ' VAL . 54.2 Cg_endo -88.11 169.56 6.25 Favored 'Trans proline' 0 C--N 1.293 -2.368 0 O-C-N 124.529 1.805 . . . . 0.0 108.255 176.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.562 ' CA ' ' HA ' ' A' ' 47' ' ' PHE . . . -150.15 133.64 4.46 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 107.307 -2.317 . . . . 0.0 107.307 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.879 ' O ' ' N ' ' A' ' 85' ' ' LEU . 8.6 tt0 51.09 32.63 7.99 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.142 -1.211 . . . . 0.0 107.901 -177.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.584 ' C ' ' O ' ' A' ' 83' ' ' GLU . 1.6 t 8.94 45.83 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 122.45 1.119 . . . . 0.0 110.204 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.879 ' N ' ' O ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER 19.2 27.6 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 104.026 -2.583 . . . . 0.0 104.026 -171.353 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.565 ' HB2' ' CB ' ' A' ' 84' ' ' SER 0.339 7.9 tttt -66.16 -45.71 79.96 Favored 'General case' 0 CA--C 1.475 -1.914 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 178.497 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.03 -34.42 76.19 Favored 'General case' 0 C--N 1.281 -2.403 0 CA-C-N 112.445 -2.161 . . . . 0.0 106.118 177.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.642 ' C ' ' HB3' ' B' ' 37' ' ' ALA . . . -81.59 -30.02 33.12 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 117.764 -1.574 . . . . 0.0 107.585 178.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.696 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . -73.25 -27.66 61.7 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.497 ' N ' ' O ' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -67.07 -30.02 69.96 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 174.468 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -56.99 -50.05 66.98 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 177.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.76 ' HB3' ' O ' ' B' ' 37' ' ' ALA . 0.6 OUTLIER -80.52 17.72 1.05 Allowed 'General case' 0 N--CA 1.502 2.154 0 O-C-N 120.62 -1.518 . . . . 0.0 110.506 179.317 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.477 ' CB ' ' O ' ' A' ' 92' ' ' LEU . 0.0 OUTLIER 71.72 67.09 0.15 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.305 -0.872 . . . . 0.0 109.387 -179.393 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.497 ' CD1' ' N ' ' B' ' 75' ' ' VAL . 0.0 OUTLIER -45.64 -36.26 4.68 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.706 -0.621 . . . . 0.0 109.923 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 . . . . . 0 N--CA 1.492 1.645 0 O-C-N 121.47 -0.769 . . . . 0.0 109.764 179.748 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.515 ' HA ' ' CB ' ' B' ' 5' ' ' GLU . 11.6 mtp . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 120.879 0.371 . . . . 0.0 110.169 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -174.83 -166.71 0.25 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.086 -1.009 . . . . 0.0 111.303 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.468 ' O ' HG13 ' B' ' 7' ' ' ILE . 0.0 OUTLIER -52.04 -11.48 0.17 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.408 -0.807 . . . . 0.0 111.471 -179.267 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.547 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 59.6 m -115.59 -44.01 2.99 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.93 -1.106 . . . . 0.0 109.376 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.538 ' HA ' ' HE2' ' B' ' 8' ' ' LYS . 0.0 OUTLIER -62.07 -51.47 67.8 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.893 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.443 ' HA ' ' HB2' ' B' ' 9' ' ' ALA . 6.2 mt -62.99 -30.76 71.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.374 -0.829 . . . . 0.0 108.869 178.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' ILE . . . . . 0.664 HG12 ' O ' ' B' ' 21' ' ' VAL . 0.6 OUTLIER -53.17 -54.38 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.369 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . 0.538 ' HE2' ' HA ' ' B' ' 5' ' ' GLU . 14.1 mtmt -59.44 -36.5 76.04 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.714 -0.846 . . . . 0.0 108.714 178.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . 0.443 ' HB2' ' HA ' ' B' ' 6' ' ' LEU . . . -52.71 -34.63 53.19 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.819 -0.753 . . . . 0.0 109.243 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . 0.846 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.2 mp -97.15 -35.74 5.66 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.425 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.471 ' HA ' ' OG1' ' B' ' 14' ' ' THR . . . -60.09 -25.91 65.78 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.71 -0.796 . . . . 0.0 108.878 178.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.441 ' CG ' ' N ' ' B' ' 13' ' ' ASP . 16.6 pt20 -92.77 -41.2 10.25 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.441 ' N ' ' CG ' ' B' ' 12' ' ' GLN . 1.3 m-20 -65.13 -22.49 66.94 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 176.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.846 ' OG1' ' O ' ' B' ' 10' ' ' ILE . 24.5 p -96.33 -78.38 0.47 Allowed 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 61.87 12.42 35.47 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' LEU . . . . . 0.708 HD13 ' HB3' ' A' ' 20' ' ' SER . 3.7 mp -78.19 -54.57 6.1 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.433 -1.039 . . . . 0.0 108.652 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' THR . . . . . 0.551 HG21 ' O ' ' B' ' 17' ' ' THR . 0.5 OUTLIER -151.01 6.21 0.5 Allowed 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.3 -179.13 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . 0.555 ' O ' ' C ' ' B' ' 19' ' ' VAL . 16.4 mt-30 56.92 25.8 10.97 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 -176.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.905 ' HB ' ' HB ' ' A' ' 19' ' ' VAL . 2.3 p -0.28 -94.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.118 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' SER . . . . . 0.94 ' O ' ' N ' ' B' ' 23' ' ' LYS . 0.0 OUTLIER -130.17 24.12 5.23 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . 0.664 ' O ' HG12 ' B' ' 7' ' ' ILE . 15.5 m -22.7 -40.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-O 122.446 1.117 . . . . 0.0 109.259 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.76 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.3 OUTLIER -76.32 -36.57 58.22 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.092 178.167 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . 0.94 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.0 OUTLIER -95.1 -28.29 15.15 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 118.786 -1.166 . . . . 0.0 111.13 179.125 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' MET . . . . . 0.755 ' N ' ' OG ' ' B' ' 20' ' ' SER . 0.0 OUTLIER -70.41 -35.14 73.25 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 116.761 -1.976 . . . . 0.0 108.241 179.123 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . 0.592 HD12 HG13 ' B' ' 7' ' ' ILE . 0.3 OUTLIER -83.12 -41.75 18.17 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 118.2 -1.4 . . . . 0.0 109.24 178.315 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . 0.408 ' CB ' ' O ' ' B' ' 22' ' ' SER . . . -64.3 -34.88 79.16 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 177.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' SER . . . . . 0.599 ' CB ' ' O ' ' B' ' 23' ' ' LYS . 7.3 t -84.7 -28.24 26.48 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 119.447 -0.901 . . . . 0.0 108.575 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . 0.634 ' O ' HG13 ' B' ' 31' ' ' ILE . 0.7 OUTLIER -51.05 -44.44 61.11 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.996 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . 0.723 ' O ' ' HB ' ' B' ' 33' ' ' THR . 1.4 tt0 -70.79 -38.63 73.39 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 176.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . 1.256 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 6.9 ttpt -60.96 -19.9 61.55 Favored 'General case' 0 C--O 1.192 -1.931 0 C-N-CA 119.302 -0.959 . . . . 0.0 108.636 178.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.634 HG13 ' O ' ' B' ' 28' ' ' PHE . 0.8 OUTLIER -108.48 -28.67 2.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 120.111 -1.618 . . . . 0.0 109.366 178.276 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.624 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.2 mm -73.53 -59.78 3.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 176.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' THR . . . . . 0.723 ' HB ' ' O ' ' B' ' 29' ' ' GLU . 0.9 OUTLIER -66.67 -38.98 87.94 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 114.748 -1.114 . . . . 0.0 108.658 179.159 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 1.256 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 75.6 mm-40 -77.52 -39.54 45.82 Favored 'General case' 0 C--O 1.205 -1.262 0 O-C-N 121.029 -1.044 . . . . 0.0 112.788 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' THR . . . . . 0.441 ' CB ' ' O ' ' B' ' 31' ' ' ILE . 98.1 m -63.13 -51.19 67.48 Favored 'General case' 0 N--CA 1.504 2.268 0 CA-C-N 121.206 1.821 . . . . 0.0 110.13 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.495 HG21 ' HA ' ' B' ' 51' ' ' LYS . 0.9 OUTLIER -53.97 -41.46 49.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 178.042 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . 0.76 ' O ' ' HB3' ' A' ' 92' ' ' LEU . . . -86.38 3.14 44.91 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.291 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . 0.75 ' HB2' ' O ' ' B' ' 34' ' ' GLU . 0.0 OUTLIER -102.71 -36.33 8.34 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.468 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 141.16 33.2 0.13 Allowed Glycine 0 C--N 1.302 -1.36 0 C-N-CA 119.056 -1.545 . . . . 0.0 111.56 178.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . 0.432 ' HB3' ' CG2' ' B' ' 35' ' ' THR . 0.2 OUTLIER -146.93 158.87 44.04 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.79 -1.418 . . . . 0.0 110.605 179.271 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 33.3 mtpt -101.34 91.46 4.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.455 -0.778 . . . . 0.0 110.007 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . 0.608 ' HB ' ' HB ' ' B' ' 50' ' ' ILE . 91.5 t -70.78 148.97 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.471 -0.768 . . . . 0.0 110.471 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' GLN . . . . . 0.417 ' O ' ' HA ' ' A' ' 2' ' ' ASN . 20.5 mt-30 -146.73 165.41 29.72 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.13 -0.981 . . . . 0.0 110.39 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.551 HD13 ' CB ' ' B' ' 48' ' ' LEU . 19.0 mt -122.81 117.42 25.61 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.388 -0.82 . . . . 0.0 109.58 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' THR . . . . . 0.555 HG21 ' HG2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 29.04 -92.47 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.809 -0.557 . . . . 0.0 111.136 179.817 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -148.61 23.11 1.34 Allowed Glycine 0 N--CA 1.485 1.966 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . 0.606 ' HA ' ' H ' ' B' ' 83' ' ' GLU . 0.9 OUTLIER -116.57 -32.83 5.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.135 -1.215 . . . . 0.0 111.252 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . 0.561 ' HB2' ' CE1' ' B' ' 47' ' ' PHE . 0.1 OUTLIER -118.24 162.85 17.58 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.692 -1.255 . . . . 0.0 112.768 179.856 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' ASN . . . . . 0.619 ' O ' ' HB ' ' B' ' 79' ' ' VAL . 0.2 OUTLIER -142.1 142.22 32.78 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 178.971 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' ILE . . . . . 0.646 ' N ' HG11 ' B' ' 79' ' ' VAL . 33.6 mm -138.06 101.91 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.227 -0.921 . . . . 0.0 110.431 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . 0.561 ' N ' ' CG1' ' B' ' 79' ' ' VAL . 0.0 OUTLIER -157.43 133.5 6.07 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.065 -1.022 . . . . 0.0 109.064 -179.798 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' PRO . . . . . 0.487 ' HG3' ' CG1' ' B' ' 36' ' ' VAL . 57.9 Cg_endo -93.96 159.61 2.21 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.153 1.081 . . . . 0.0 112.009 -178.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.478 ' O ' ' N ' ' B' ' 76' ' ' GLY . 28.0 m -137.95 116.83 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-O 121.935 0.874 . . . . 0.0 110.441 177.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . 0.468 ' HA ' ' HA ' ' B' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.495 1.789 0 CA-C-O 121.55 0.69 . . . . 0.0 111.991 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . 0.592 HG13 ' CB ' ' A' ' 89' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.496 1.839 0 CA-C-O 121.191 0.519 . . . . 0.0 109.829 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 76' ' ' GLY . . . . . 0.51 ' O ' ' N ' ' B' ' 78' ' ' SER . . . -129.67 107.28 0.78 Allowed Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' B' ' 52' ' ' PRO . 8.6 p -58.41 86.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.194 -1.18 . . . . 0.0 108.875 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 78' ' ' SER . . . . . 0.51 ' N ' ' O ' ' B' ' 76' ' ' GLY . 0.5 OUTLIER -58.16 -47.32 83.74 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 -178.258 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . 0.646 HG11 ' N ' ' B' ' 50' ' ' ILE . 17.7 m -48.08 178.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 -173.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 80' ' ' LYS . . . . . 0.791 ' HB2' ' HD2' ' B' ' 81' ' ' PRO . 0.0 OUTLIER 179.4 -179.7 0.24 Allowed Pre-proline 0 C--N 1.308 -1.228 0 CA-C-N 113.64 -1.618 . . . . 0.0 107.162 -177.391 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 81' ' ' PRO . . . . . 0.791 ' HD2' ' HB2' ' B' ' 80' ' ' LYS . 39.2 Cg_endo -63.64 153.16 76.82 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 122.989 0.994 . . . . 0.0 111.691 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . 0.536 ' C ' ' H ' ' B' ' 84' ' ' SER . . . -117.16 -79.53 0.73 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 107.351 -2.3 . . . . 0.0 107.351 178.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . 0.918 ' O ' ' N ' ' B' ' 85' ' ' LEU . 16.9 tt0 -75.71 41.32 0.2 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.523 -0.986 . . . . 0.0 108.707 177.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 84' ' ' SER . . . . . 0.603 ' C ' ' O ' ' B' ' 83' ' ' GLU . 0.3 OUTLIER 7.8 44.72 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 122.741 1.258 . . . . 0.0 110.453 178.209 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . 0.918 ' N ' ' O ' ' B' ' 83' ' ' GLU . 0.2 OUTLIER 19.08 28.61 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 104.08 -2.563 . . . . 0.0 104.08 -171.577 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 86' ' ' LYS . . . . . 0.46 ' HB2' ' CB ' ' B' ' 84' ' ' SER 0.355 2.7 tttt -58.05 -41.8 84.08 Favored 'General case' 0 CA--C 1.482 -1.658 0 N-CA-C 103.794 -2.669 . . . . 0.0 103.794 176.765 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . 0.41 ' O ' ' HG2' ' B' ' 90' ' ' GLU 0.264 0.0 OUTLIER -66.05 -35.92 81.83 Favored 'General case' 0 C--N 1.285 -2.228 0 CA-C-N 111.588 -2.551 . . . . 0.0 105.532 176.236 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.67 ' O ' ' CB ' ' A' ' 37' ' ' ALA . . . -74.52 -27.3 60.48 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 118.54 -1.264 . . . . 0.0 108.409 178.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . 0.692 ' N ' ' O ' ' B' ' 85' ' ' LEU . . . -62.01 -50.0 73.81 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.114 -0.991 . . . . 0.0 109.264 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . 0.433 ' HG2' ' N ' ' B' ' 91' ' ' GLY . 2.7 pt-20 -57.62 -26.69 61.93 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 176.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . 0.433 ' N ' ' HG2' ' B' ' 90' ' ' GLU . . . -65.66 -37.53 93.64 Favored Glycine 0 N--CA 1.487 2.055 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.286 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 92' ' ' LEU . . . . . 0.67 ' HB3' ' HA ' ' A' ' 37' ' ' ALA . 1.1 pp -85.4 22.11 1.6 Allowed 'General case' 0 N--CA 1.504 2.258 0 CA-C-N 119.931 1.865 . . . . 0.0 111.239 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 93' ' ' LYS . . . . . 0.447 ' O ' ' N ' ' B' ' 96' ' ' ASP . 4.0 mmtt 53.65 39.02 29.63 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 -177.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . 0.537 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -36.16 -36.81 0.1 Allowed 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.943 -178.643 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . 0.51 ' N ' ' CD1' ' B' ' 94' ' ' TYR . 7.0 pt-20 -60.01 -42.3 94.01 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.332 -0.855 . . . . 0.0 109.609 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 96' ' ' ASP . . . . . 0.447 ' N ' ' O ' ' B' ' 93' ' ' LYS . 0.3 OUTLIER -61.09 -35.08 76.02 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.085 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.461 ' HA ' ' CB ' ' A' ' 5' ' ' GLU . 6.3 mtp . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 120.837 0.351 . . . . 0.0 110.069 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . 0.506 ' HA ' ' O ' ' B' ' 43' ' ' GLN . 1.6 t-20 -176.93 -165.31 0.12 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.946 -1.096 . . . . 0.0 111.626 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.523 ' CD ' ' HB ' ' B' ' 45' ' ' THR . 0.4 OUTLIER -51.07 -12.93 0.13 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.511 -0.743 . . . . 0.0 110.802 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.622 ' O ' HG13 ' A' ' 7' ' ' ILE . 74.8 m -112.61 -60.6 1.85 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.172 -0.955 . . . . 0.0 109.938 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.497 ' HA ' ' CE ' ' A' ' 8' ' ' LYS . 4.6 mt-10 -50.17 -41.6 49.61 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.98 -1.075 . . . . 0.0 108.879 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.469 ' HB2' ' O ' ' A' ' 2' ' ' ASN . 10.1 mt -60.62 -34.51 74.36 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.303 -0.959 . . . . 0.0 109.772 177.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.622 HG13 ' O ' ' A' ' 4' ' ' THR . 1.0 OUTLIER -57.59 -39.74 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 179.089 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.618 ' HA ' ' HB2' ' A' ' 11' ' ' ALA . 1.0 OUTLIER -66.97 -36.66 82.69 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.397 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 13' ' ' ASP . . . -52.39 -39.0 60.33 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 120.214 -0.594 . . . . 0.0 109.447 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.708 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.3 mp -93.93 -29.99 4.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.618 ' HB2' ' HA ' ' A' ' 8' ' ' LYS . . . -63.92 -15.15 58.43 Favored 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 118.496 -1.282 . . . . 0.0 108.858 178.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -115.16 -42.78 3.14 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.405 -0.81 . . . . 0.0 109.352 178.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 9' ' ' ALA . 1.0 OUTLIER -67.12 -26.15 66.54 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 177.071 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.708 ' OG1' ' O ' ' A' ' 10' ' ' ILE 0.257 0.2 OUTLIER -112.54 -82.8 0.59 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 178.891 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 16' ' ' LEU . . . 71.15 -11.17 2.89 Favored Glycine 0 N--CA 1.501 2.967 0 O-C-N 121.0 -1.063 . . . . 0.0 111.739 177.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.784 HD13 ' HB3' ' B' ' 20' ' ' SER . 4.4 mp -35.73 -64.11 0.32 Allowed 'General case' 0 N--CA 1.511 2.59 0 O-C-N 121.518 -0.989 . . . . 0.0 110.532 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.491 HG22 ' O ' ' A' ' 17' ' ' THR . 0.5 OUTLIER -135.22 3.64 3.14 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.167 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.613 ' O ' ' C ' ' A' ' 19' ' ' VAL . 28.2 mt-30 56.44 29.04 14.57 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 -176.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.672 HG22 ' CD1' ' B' ' 16' ' ' LEU . 1.5 p -9.68 -94.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.904 -178.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.968 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -133.9 25.13 3.97 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 177.627 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.661 ' C ' ' O ' ' A' ' 20' ' ' SER . 27.0 m -19.17 -39.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 122.474 1.13 . . . . 0.0 109.347 -178.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.852 ' N ' ' O ' ' A' ' 20' ' ' SER . 3.1 m -81.5 -38.7 25.89 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.661 177.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.968 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.1 OUTLIER -86.45 -35.79 19.45 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.547 -0.72 . . . . 0.0 111.186 179.492 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.567 ' SD ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -68.17 -38.21 81.81 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 117.567 -1.653 . . . . 0.0 108.15 178.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.607 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 8.4 mt -72.42 -47.27 50.49 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 118.404 -1.319 . . . . 0.0 107.832 176.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.497 ' HA ' ' HE2' ' A' ' 3' ' ' LYS . . . -55.31 -34.0 63.78 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 177.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.547 ' HA ' ' HB3' ' A' ' 30' ' ' LYS . 54.9 p -83.16 -32.25 26.72 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.819 ' O ' HG13 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -56.57 -47.13 80.17 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.013 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.655 ' O ' ' HB ' ' A' ' 33' ' ' THR . 0.3 OUTLIER -71.02 -35.68 72.11 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 177.733 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.872 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 70.9 tttt -65.04 -21.44 66.83 Favored 'General case' 0 C--O 1.192 -1.962 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.819 HG13 ' O ' ' A' ' 28' ' ' PHE . 1.3 pp -105.06 -29.48 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.761 -1.212 . . . . 0.0 109.062 178.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.616 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.2 mm -71.43 -49.34 47.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 176.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.655 ' HB ' ' O ' ' A' ' 29' ' ' GLU . 0.3 OUTLIER -69.07 -43.37 74.71 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 177.968 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.872 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 57.7 mm-40 -68.31 -41.62 80.59 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 121.616 -0.677 . . . . 0.0 110.905 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.526 ' HA ' ' HB2' ' A' ' 38' ' ' LYS . 3.8 m -52.58 -50.37 63.14 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.588 -1.32 . . . . 0.0 108.537 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.424 HG12 ' HB3' ' B' ' 85' ' ' LEU . 1.1 t -54.01 -36.89 32.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 177.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.624 ' HB3' ' O ' ' B' ' 88' ' ' ALA . . . -81.33 -6.24 58.68 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.537 0.684 . . . . 0.0 109.7 178.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.597 ' HG2' ' O ' ' A' ' 34' ' ' GLU . 2.4 mmpt? -97.58 -25.05 15.27 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 177.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.79 41.07 1.76 Allowed Glycine 0 C--N 1.303 -1.295 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 178.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.454 ' CB ' HG22 ' A' ' 35' ' ' THR . 0.2 OUTLIER -136.76 147.64 46.8 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.176 -1.191 . . . . 0.0 110.593 179.707 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.5 mtmt -100.51 102.94 14.25 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.564 ' HB ' ' CG1' ' A' ' 50' ' ' ILE . 2.0 t -74.77 152.42 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 C-N-CA 119.622 -0.831 . . . . 0.0 110.019 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.474 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 6.1 mt-30 -140.26 94.16 2.71 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.403 -0.81 . . . . 0.0 110.221 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.592 HD12 ' CB ' ' A' ' 48' ' ' LEU . 22.1 mt -58.84 112.77 1.77 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.954 -1.091 . . . . 0.0 109.078 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.561 HG22 ' HG2' ' B' ' 29' ' ' GLU . 0.1 OUTLIER 35.99 -88.48 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.869 -0.519 . . . . 0.0 110.606 -179.157 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -149.52 29.12 1.19 Allowed Glycine 0 N--CA 1.484 1.898 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.543 ' CE2' ' HG2' ' B' ' 29' ' ' GLU . 3.9 p90 -128.03 -28.64 2.62 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.991 -1.3 . . . . 0.0 112.717 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.592 ' CB ' HD12 ' A' ' 44' ' ' LEU . 0.6 OUTLIER -123.78 100.84 6.97 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.36 -1.462 . . . . 0.0 111.297 179.28 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.474 ' HA ' ' HA ' ' A' ' 43' ' ' GLN . 44.6 t-20 -109.45 87.35 2.48 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.863 -0.523 . . . . 0.0 110.623 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.564 ' CG1' ' HB ' ' A' ' 42' ' ' VAL . 1.1 pt -79.39 147.62 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.159 -0.963 . . . . 0.0 110.505 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.406 ' HG3' ' HB3' ' A' ' 78' ' ' SER . 8.4 ptmt -157.15 122.71 2.42 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.053 -1.029 . . . . 0.0 110.079 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.556 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 55.3 Cg_endo -80.65 140.87 13.42 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 O-C-N 123.459 1.241 . . . . 0.0 112.025 -178.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.706 ' O ' ' N ' ' A' ' 76' ' ' GLY . 31.5 m -142.21 114.75 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 121.441 0.639 . . . . 0.0 109.64 178.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.618 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.497 1.914 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -177.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.618 ' HA ' ' HB3' ' A' ' 54' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.281 0.562 . . . . 0.0 109.888 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.706 ' N ' ' O ' ' A' ' 53' ' ' VAL . . . -115.37 61.2 0.38 Allowed Glycine 0 N--CA 1.484 1.873 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.556 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 2.3 p -43.47 83.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.998 -0.707 . . . . 0.0 110.787 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.617 ' N ' ' O ' ' A' ' 76' ' ' GLY . 1.3 t -81.68 175.97 10.02 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.985 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.464 ' HA ' ' HA ' ' A' ' 50' ' ' ILE . 3.3 p 176.25 176.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.447 ' N ' ' CG2' ' A' ' 79' ' ' VAL . 0.0 OUTLIER -176.09 171.43 1.1 Allowed Pre-proline 0 N--CA 1.485 1.286 0 O-C-N 120.799 -1.188 . . . . 0.0 110.868 177.3 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.502 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 55.6 Cg_endo -97.03 136.51 0.44 Allowed 'Trans proline' 0 C--N 1.302 -1.878 0 C-N-CA 122.843 2.362 . . . . 0.0 110.706 178.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' A' ' 47' ' ' PHE . . . -91.64 -158.74 34.85 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 178.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -89.33 -16.53 30.87 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.117 -1.226 . . . . 0.0 110.394 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.416 ' HB3' ' OG1' ' B' ' 33' ' ' THR . 0.2 OUTLIER -53.59 -33.42 54.81 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.304 -0.872 . . . . 0.0 109.975 -179.857 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.545 ' HG ' ' OG1' ' B' ' 33' ' ' THR . 0.0 OUTLIER -86.0 -30.94 22.32 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.326 -0.859 . . . . 0.0 108.77 178.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.4 ' HA ' ' CG1' ' B' ' 75' ' ' VAL . 0.6 OUTLIER -72.94 -33.12 65.72 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.415 -0.803 . . . . 0.0 109.838 -179.88 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -78.63 -34.92 46.22 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.75 ' C ' ' HB1' ' B' ' 37' ' ' ALA . . . -68.53 -31.26 70.37 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 177.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.713 ' N ' ' HB3' ' B' ' 37' ' ' ALA . . . -69.94 -35.73 74.74 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -178.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -59.55 -24.79 64.01 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 174.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -64.43 -54.41 29.53 Favored Glycine 0 N--CA 1.483 1.797 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 178.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.644 ' HB3' ' O ' ' B' ' 37' ' ' ALA . 2.1 pp -67.11 -42.19 84.96 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 119.76 1.78 . . . . 0.0 109.502 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.629 ' O ' ' CG ' ' A' ' 93' ' ' LYS . 2.6 tttp 156.8 80.88 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 1.059 ' O ' ' C ' ' A' ' 95' ' ' GLU . 9.1 t80 -61.79 -62.85 1.51 Allowed 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 115.297 -2.561 . . . . 0.0 105.96 177.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 1.059 ' C ' ' O ' ' A' ' 94' ' ' TYR . 2.3 mp0 . . . . . 0 CA--C 1.486 -1.501 0 N-CA-C 101.561 -3.496 . . . . 0.0 101.561 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.471 ' HA ' ' CB ' ' B' ' 5' ' ' GLU . 5.9 mtp . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 120.863 0.363 . . . . 0.0 110.133 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 2' ' ' ASN . . . . . 0.58 ' H ' ' HB2' ' B' ' 5' ' ' GLU . 2.0 t-20 -172.53 -159.42 0.13 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.055 -1.028 . . . . 0.0 111.396 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.467 ' HG2' ' OE1' ' B' ' 29' ' ' GLU . 1.4 mttt -58.36 -7.56 0.92 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.407 -0.808 . . . . 0.0 110.291 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.65 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 90.0 m -116.82 -48.3 2.67 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.042 -1.036 . . . . 0.0 110.304 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.58 ' HB2' ' H ' ' B' ' 2' ' ' ASN . 3.0 mt-10 -61.64 -52.89 62.49 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.117 -0.989 . . . . 0.0 108.904 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.503 ' HA ' ' HB2' ' B' ' 9' ' ' ALA . 0.9 OUTLIER -60.23 -27.79 67.49 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.196 -1.002 . . . . 0.0 108.928 178.355 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' ILE . . . . . 0.65 ' HB ' ' O ' ' B' ' 4' ' ' THR . 0.4 OUTLIER -56.26 -58.01 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 178.158 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . 0.512 ' HE2' ' HA ' ' B' ' 5' ' ' GLU . 0.1 OUTLIER -55.35 -31.85 62.08 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.94 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . 0.503 ' HB2' ' HA ' ' B' ' 6' ' ' LEU . . . -57.57 -37.22 72.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.27 -0.894 . . . . 0.0 108.958 178.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . 0.934 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.2 mp -92.57 -25.96 4.95 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.209 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 177.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.4 ' CB ' ' HA ' ' B' ' 8' ' ' LYS . . . -75.99 -2.23 29.51 Favored 'General case' 0 C--N 1.287 -2.121 0 O-C-N 120.703 -1.248 . . . . 0.0 108.152 177.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.4 ' N ' ' O ' ' B' ' 8' ' ' LYS . 55.7 tp60 -125.3 -41.62 2.04 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.531 -0.731 . . . . 0.0 109.898 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' B' ' 9' ' ' ALA . 1.0 OUTLIER -72.18 -23.78 61.32 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 177.838 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.934 ' OG1' ' O ' ' B' ' 10' ' ' ILE 0.284 0.2 OUTLIER -103.8 -62.13 1.34 Allowed 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 179.609 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 52.12 24.07 14.01 Favored Glycine 0 N--CA 1.5 2.912 0 O-C-N 121.369 -0.832 . . . . 0.0 111.569 177.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' LEU . . . . . 0.824 HD12 ' HB2' ' A' ' 20' ' ' SER . 4.5 mp -69.76 -69.97 0.31 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.343 -1.092 . . . . 0.0 109.904 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' THR . . . . . 0.529 HG22 ' O ' ' B' ' 17' ' ' THR . 0.6 OUTLIER -137.81 5.74 2.64 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.736 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . 0.669 ' O ' ' C ' ' B' ' 19' ' ' VAL . 33.2 mt-30 57.42 27.53 14.04 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 -176.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.669 ' C ' ' O ' ' B' ' 18' ' ' GLN . 1.5 p -0.41 -96.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.947 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' SER . . . . . 1.091 ' O ' ' N ' ' B' ' 22' ' ' SER . 14.9 p -133.53 23.08 4.01 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 175.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . 0.649 ' HA ' ' HE1' ' B' ' 24' ' ' MET . 28.1 m -3.87 -39.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-O 122.302 1.048 . . . . 0.0 110.981 -177.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 1.091 ' N ' ' O ' ' B' ' 20' ' ' SER . 2.4 t -73.0 -44.01 61.5 Favored 'General case' 0 C--N 1.281 -2.387 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.93 177.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . 0.813 ' N ' ' O ' ' B' ' 20' ' ' SER . 5.1 mtpt -88.37 -29.32 20.37 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.659 -0.651 . . . . 0.0 109.693 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' MET . . . . . 0.649 ' HE1' ' HA ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -62.77 -41.44 99.24 Favored 'General case' 0 C--N 1.314 -0.958 0 O-C-N 120.899 -1.126 . . . . 0.0 109.443 179.796 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . 0.568 ' N ' ' HE3' ' B' ' 24' ' ' MET . 1.2 mt -84.51 -45.38 12.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.891 -1.13 . . . . 0.0 108.406 177.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . 0.499 ' O ' ' CB ' ' B' ' 30' ' ' LYS . . . -53.31 -34.68 58.38 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 178.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' SER . . . . . 0.577 ' O ' ' CG1' ' B' ' 31' ' ' ILE . 58.4 m -78.55 -40.28 35.34 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 177.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . 0.691 ' HA ' ' CG1' ' B' ' 31' ' ' ILE . 0.1 OUTLIER -63.82 -36.63 84.53 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.636 -0.665 . . . . 0.0 109.394 179.42 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . 0.575 ' HG3' ' CE2' ' B' ' 28' ' ' PHE . 0.9 OUTLIER -82.07 -31.97 30.57 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 178.721 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . 0.822 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 16.6 tttp -72.22 -28.42 63.16 Favored 'General case' 0 C--O 1.191 -1.989 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 176.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.691 ' CG1' ' HA ' ' B' ' 28' ' ' PHE . 1.6 pp -94.67 -30.48 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.03 -1.044 . . . . 0.0 109.884 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.647 HG13 ' CE1' ' B' ' 28' ' ' PHE . 3.6 mm -62.91 -61.88 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 177.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' THR . . . . . 0.786 ' O ' ' HB2' ' B' ' 37' ' ' ALA . 0.4 OUTLIER -58.42 -40.18 81.79 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.813 179.213 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.84 ' O ' ' N ' ' B' ' 38' ' ' LYS . 40.9 mm-40 -73.29 -48.42 34.74 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.855 -0.528 . . . . 0.0 112.296 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' THR . . . . . 0.48 ' CG2' ' CB ' ' B' ' 40' ' ' ASP . 92.9 m -52.16 -59.16 4.7 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.477 -1.389 . . . . 0.0 110.504 -178.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.668 ' O ' ' HG3' ' B' ' 52' ' ' PRO . 0.9 OUTLIER -51.38 -45.32 33.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 178.408 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . 0.786 ' HB2' ' O ' ' B' ' 33' ' ' THR . . . -83.52 1.88 39.71 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.993 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . 0.84 ' N ' ' O ' ' B' ' 34' ' ' GLU . 0.5 OUTLIER -107.53 -37.85 6.07 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.188 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 145.28 41.92 0.05 OUTLIER Glycine 0 C--N 1.301 -1.405 0 C-N-CA 119.008 -1.568 . . . . 0.0 111.273 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . 0.48 ' CB ' ' CG2' ' B' ' 35' ' ' THR . 0.6 OUTLIER -161.75 127.11 3.54 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.93 -1.335 . . . . 0.0 110.604 179.236 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.83 86.53 0.23 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.675 -0.641 . . . . 0.0 109.421 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 9.4 p -61.8 125.93 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 C-N-CA 119.919 -0.712 . . . . 0.0 109.66 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' GLN . . . . . 0.506 ' O ' ' HA ' ' A' ' 2' ' ' ASN . 5.4 mt-30 -131.11 172.25 12.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.899 . . . . 0.0 110.29 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.622 ' HB3' ' HE1' ' B' ' 47' ' ' PHE . 29.3 mt -136.48 120.21 17.31 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.503 -0.748 . . . . 0.0 109.625 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' THR . . . . . 0.532 ' CG2' ' HG2' ' A' ' 29' ' ' GLU . 0.1 OUTLIER 34.43 -92.72 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.375 0 O-C-N 121.646 -0.659 . . . . 0.0 110.821 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -159.24 30.37 0.42 Allowed Glycine 0 N--CA 1.486 2.032 0 N-CA-C 108.256 -1.937 . . . . 0.0 108.256 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . 0.653 ' CE1' ' HG2' ' A' ' 29' ' ' GLU . 0.1 OUTLIER -124.65 -26.76 3.78 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.546 -0.973 . . . . 0.0 110.981 -179.447 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . 0.587 ' HB3' HD13 ' B' ' 44' ' ' LEU . 9.7 mt -130.56 90.29 2.9 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.835 -1.165 . . . . 0.0 110.415 177.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -98.26 88.83 4.28 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.705 -0.622 . . . . 0.0 110.481 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' ILE . . . . . 0.505 HD12 ' HB ' ' B' ' 79' ' ' VAL . 0.8 OUTLIER -81.73 147.32 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.383 -0.823 . . . . 0.0 110.906 -179.835 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' B' ' 78' ' ' SER . 3.3 ptmt -164.31 131.04 2.34 Favored Pre-proline 0 N--CA 1.502 2.154 0 O-C-N 121.258 -0.901 . . . . 0.0 110.391 179.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' PRO . . . . . 0.668 ' HG3' ' O ' ' B' ' 36' ' ' VAL . 50.8 Cg_endo -84.28 146.86 11.27 Favored 'Trans proline' 0 C--N 1.318 -1.039 0 O-C-N 123.195 1.103 . . . . 0.0 112.241 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.52 HG23 ' O ' ' B' ' 76' ' ' GLY . 23.1 m -146.4 117.39 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-O 121.765 0.793 . . . . 0.0 110.284 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 121.755 0.788 . . . . 0.0 111.783 -178.69 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . 0.533 ' CG1' ' CB ' ' A' ' 89' ' ' ALA . 11.9 p . . . . . 0 N--CA 1.497 1.889 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 76' ' ' GLY . . . . . 0.56 ' O ' ' N ' ' B' ' 78' ' ' SER . . . -119.23 71.31 0.32 Allowed Glycine 0 N--CA 1.488 2.161 0 C-N-CA 119.005 -1.569 . . . . 0.0 109.826 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.661 ' HA ' ' HA ' ' B' ' 52' ' ' PRO . 3.1 p -59.07 77.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.377 -1.072 . . . . 0.0 109.726 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 78' ' ' SER . . . . . 0.56 ' N ' ' O ' ' B' ' 76' ' ' GLY . 0.2 OUTLIER -71.11 177.35 3.83 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 122.174 0.988 . . . . 0.0 111.286 -179.298 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . 0.505 ' HB ' HD12 ' B' ' 50' ' ' ILE . 1.6 p 176.56 176.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 80' ' ' LYS . . . . . 0.488 ' N ' ' CG2' ' B' ' 79' ' ' VAL . 16.1 ptmt -176.33 174.05 0.78 Allowed Pre-proline 0 N--CA 1.486 1.326 0 O-C-N 120.764 -1.21 . . . . 0.0 110.349 178.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 81' ' ' PRO . . . . . 0.414 ' CD ' ' HB2' ' B' ' 80' ' ' LYS . 52.8 Cg_endo -96.01 136.56 0.6 Allowed 'Trans proline' 0 C--N 1.302 -1.877 0 C-N-CA 122.294 1.996 . . . . 0.0 109.842 178.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' B' ' 47' ' ' PHE . . . -97.35 -168.3 32.86 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 107.793 -2.123 . . . . 0.0 107.793 178.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . 0.585 ' HA ' ' HB2' ' B' ' 86' ' ' LYS . 0.9 OUTLIER -76.97 -18.28 58.33 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.886 -1.361 . . . . 0.0 110.283 179.776 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 84' ' ' SER . . . . . 0.463 ' CB ' ' HB3' ' B' ' 47' ' ' PHE . 0.2 OUTLIER -50.94 -42.19 59.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.167 -0.958 . . . . 0.0 108.815 179.368 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . 0.506 ' HG ' ' HD2' ' B' ' 47' ' ' PHE . 1.0 OUTLIER -73.72 -31.41 63.37 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 177.942 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 86' ' ' LYS . . . . . 0.585 ' HB2' ' HA ' ' B' ' 83' ' ' GLU . 29.4 mtmm -73.29 -38.24 65.97 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.392 0.615 . . . . 0.0 110.196 -179.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 13.8 ttpt -74.54 -37.12 63.12 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 177.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.624 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -68.92 -34.73 75.86 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 176.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . 0.497 ' CB ' ' CG1' ' A' ' 75' ' ' VAL . . . -55.95 -44.36 78.36 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -54.07 -33.51 57.67 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 176.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . 0.43 ' C ' ' H ' ' B' ' 93' ' ' LYS . . . -61.79 -38.47 96.0 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 178.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 92' ' ' LEU . . . . . 0.593 ' HB3' ' HA ' ' A' ' 37' ' ' ALA . 0.4 OUTLIER -72.27 13.8 0.29 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.69 -1.477 . . . . 0.0 110.762 179.697 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 93' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' B' ' 92' ' ' LEU . 72.8 mmtt 62.17 39.84 12.37 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 -177.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . 0.401 ' C ' ' O ' ' B' ' 93' ' ' LYS . 0.0 OUTLIER -38.09 -37.23 0.25 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.565 -179.214 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -60.12 -42.53 94.97 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.46 -0.775 . . . . 0.0 109.811 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 96' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' B' ' 93' ' ' LYS . 3.4 m-20 -60.57 -36.68 79.08 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.458 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.544 ' HB3' ' HG ' ' A' ' 6' ' ' LEU . 7.3 mtp . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . 0.426 ' O ' ' N ' ' A' ' 4' ' ' THR . 50.4 p-10 -171.16 -162.78 0.26 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.798 -1.189 . . . . 0.0 112.43 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.529 ' HE2' ' HA ' ' A' ' 26' ' ' ALA . 9.8 tttm -46.79 -15.34 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.776 -0.578 . . . . 0.0 111.068 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.632 ' O ' ' CG1' ' A' ' 7' ' ' ILE . 58.6 m -117.26 -58.06 2.09 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.126 -0.984 . . . . 0.0 110.304 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.57 ' HA ' ' HE3' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -46.64 -44.86 18.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.115 -0.991 . . . . 0.0 109.489 179.698 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.544 ' HG ' ' HB3' ' A' ' 1' ' ' MET . 1.3 mt -63.74 -33.28 75.3 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.15 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.676 HG13 ' N ' ' A' ' 8' ' ' LYS . 0.9 OUTLIER -56.68 -42.61 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.764 -1.21 . . . . 0.0 108.097 179.699 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.676 ' N ' HG13 ' A' ' 7' ' ' ILE . 6.7 mtmt -66.56 -34.14 77.23 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 177.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.71 -39.51 65.26 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.546 -0.862 . . . . 0.0 109.362 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.723 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.3 mp -91.01 -31.58 5.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 178.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.623 ' HB3' ' O ' ' A' ' 7' ' ' ILE . . . -65.3 -13.47 58.53 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 118.956 -1.098 . . . . 0.0 108.364 177.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.426 ' HB3' ' O ' ' A' ' 8' ' ' LYS . 1.1 tp60 -113.44 -45.12 3.15 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.457 ' HB3' ' HB2' ' B' ' 27' ' ' SER . 1.8 m-20 -62.34 -33.8 75.41 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 177.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.723 ' OG1' ' O ' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -102.16 -71.14 0.73 Allowed 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 178.494 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 46.37 27.37 2.8 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.57 ' CD2' ' HB3' ' B' ' 20' ' ' SER . 0.1 OUTLIER -87.28 -25.83 23.75 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.449 -1.03 . . . . 0.0 108.946 178.868 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.509 HG23 ' CG2' ' B' ' 17' ' ' THR . 0.5 OUTLIER -153.8 -8.32 0.16 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.907 -0.496 . . . . 0.0 110.228 -179.449 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.515 ' O ' ' C ' ' A' ' 19' ' ' VAL . 4.5 mt-30 57.06 36.82 28.19 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 -177.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.653 ' HB ' ' HB ' ' B' ' 19' ' ' VAL . 0.6 OUTLIER -23.93 -93.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.614 -178.712 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.945 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -135.18 22.92 3.49 Favored 'General case' 0 C--N 1.281 -2.39 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 178.709 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.68 ' C ' ' O ' ' A' ' 20' ' ' SER . 31.3 m -21.7 -40.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-O 122.385 1.088 . . . . 0.0 108.697 -177.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.811 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.2 OUTLIER -82.16 -39.04 23.8 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 114.891 -1.049 . . . . 0.0 109.601 177.614 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.945 ' N ' ' O ' ' A' ' 20' ' ' SER . 1.2 mtpt -85.33 -32.76 22.29 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.576 -0.703 . . . . 0.0 111.836 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.549 ' N ' ' HB3' ' A' ' 20' ' ' SER . 0.0 OUTLIER -77.01 -34.95 57.37 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.252 -1.53 . . . . 0.0 108.976 179.715 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.617 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 2.2 mt -77.74 -43.57 30.49 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 118.551 -1.26 . . . . 0.0 107.863 177.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.529 ' HA ' ' HE2' ' A' ' 3' ' ' LYS . . . -59.3 -34.08 71.88 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 177.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.616 ' O ' ' N ' ' A' ' 31' ' ' ILE . 85.6 p -81.75 -26.64 34.33 Favored 'General case' 0 C--O 1.204 -1.294 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.738 ' HA ' ' CG1' ' A' ' 31' ' ' ILE . 0.3 OUTLIER -64.86 -30.23 71.22 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.67 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.753 ' O ' ' HB ' ' A' ' 33' ' ' THR . 4.5 mt-10 -90.64 -21.55 21.62 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 177.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.785 ' O ' ' CG ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -83.36 -19.06 36.81 Favored 'General case' 0 C--O 1.192 -1.944 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 175.52 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.738 ' CG1' ' HA ' ' A' ' 28' ' ' PHE . 2.1 pp -104.67 -33.34 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.059 -1.025 . . . . 0.0 109.048 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.694 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 2.6 mm -64.14 -46.46 93.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 176.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.753 ' HB ' ' O ' ' A' ' 29' ' ' GLU 0.324 16.4 m -67.56 -54.26 21.42 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 113.762 -1.563 . . . . 0.0 108.197 178.504 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.785 ' CG ' ' O ' ' A' ' 30' ' ' LYS . 57.2 mm-40 -63.2 -32.43 73.82 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.054 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.651 ' N ' ' O ' ' A' ' 31' ' ' ILE . 1.5 m -58.26 -51.79 68.29 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.026 -1.046 . . . . 0.0 108.417 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.502 HG11 ' CG2' ' A' ' 77' ' ' VAL . 0.9 OUTLIER -52.39 -41.61 35.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 C-N-CA 117.982 -1.487 . . . . 0.0 107.218 177.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.847 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -72.51 -7.99 52.84 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.463 -0.895 . . . . 0.0 109.343 177.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.521 ' N ' ' O ' ' A' ' 35' ' ' THR . 0.0 OUTLIER -101.52 -23.69 14.26 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.301 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 35' ' ' THR . . . 102.61 41.48 2.33 Favored Glycine 0 C--N 1.301 -1.383 0 C-N-CA 119.967 -1.111 . . . . 0.0 110.648 178.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.481 ' CB ' HG21 ' A' ' 35' ' ' THR . 0.1 OUTLIER -128.86 133.97 48.14 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.011 -1.288 . . . . 0.0 110.809 179.648 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -85.27 91.83 8.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.56 -0.713 . . . . 0.0 109.55 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.427 ' CG1' ' CD1' ' A' ' 32' ' ' ILE . 82.0 t -67.43 149.63 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-O 121.437 0.637 . . . . 0.0 111.153 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.4 ' O ' ' HA ' ' B' ' 2' ' ' ASN . 4.2 pt20 -158.2 147.62 19.56 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.566 -0.709 . . . . 0.0 109.885 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.675 HD13 ' HB2' ' A' ' 48' ' ' LEU . 35.7 mt -99.47 118.7 36.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.3 -0.875 . . . . 0.0 109.736 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.478 HG21 ' HG3' ' B' ' 29' ' ' GLU . 0.0 OUTLIER 27.36 -95.18 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.953 -0.467 . . . . 0.0 112.235 -179.627 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -129.82 4.45 6.11 Favored Glycine 0 N--CA 1.486 1.976 0 C-N-CA 119.556 -1.307 . . . . 0.0 111.241 -178.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.614 ' O ' ' N ' ' A' ' 82' ' ' GLY . 26.8 p90 -100.24 -64.67 1.02 Allowed 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 119.554 1.677 . . . . 0.0 110.765 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.675 ' HB2' HD13 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -88.17 142.31 27.86 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.241 -1.537 . . . . 0.0 114.673 -178.843 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.619 ' HB2' ' HG2' ' A' ' 81' ' ' PRO . 0.1 OUTLIER -145.25 92.31 2.24 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.567 177.021 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.51 ' HA ' ' HA ' ' A' ' 79' ' ' VAL . 46.6 mm -85.71 160.17 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.172 -0.955 . . . . 0.0 110.655 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 5.0 ptmt -167.32 128.04 1.18 Allowed Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 120.976 -1.077 . . . . 0.0 110.478 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 52.4 Cg_endo -77.62 148.65 26.14 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 O-C-N 123.55 1.289 . . . . 0.0 111.216 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.582 ' O ' ' N ' ' A' ' 76' ' ' GLY . 32.9 m -140.59 114.86 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-O 121.717 0.77 . . . . 0.0 111.085 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.702 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.498 1.927 0 CA-C-O 122.0 0.905 . . . . 0.0 111.861 -178.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.702 ' HA ' ' HA ' ' A' ' 54' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.495 1.791 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 53' ' ' VAL . . . -118.51 99.52 0.79 Allowed Glycine 0 N--CA 1.486 2.014 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.537 ' O ' ' CG1' ' A' ' 77' ' ' VAL . 1.4 t -58.53 86.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-O 122.09 0.948 . . . . 0.0 108.82 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 76' ' ' GLY . 0.2 OUTLIER -79.58 -152.77 0.07 Allowed 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 121.726 0.774 . . . . 0.0 110.272 -179.129 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.51 ' HA ' ' HA ' ' A' ' 50' ' ' ILE . 5.4 p 179.98 178.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.882 ' CB ' ' HD3' ' A' ' 81' ' ' PRO . 16.3 mttt -148.45 -70.19 0.02 OUTLIER Pre-proline 0 C--N 1.302 -1.462 0 C-N-CA 117.856 -1.537 . . . . 0.0 112.464 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.882 ' HD3' ' CB ' ' A' ' 80' ' ' LYS . 57.0 Cg_endo -102.23 -172.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.297 -2.16 0 C-N-CA 121.375 1.383 . . . . 0.0 112.834 -177.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.666 ' O ' ' C ' ' A' ' 83' ' ' GLU . . . 177.31 24.08 0.03 OUTLIER Glycine 0 C--N 1.29 -2.024 0 N-CA-C 107.23 -2.348 . . . . 0.0 107.23 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.898 ' O ' ' N ' ' A' ' 85' ' ' LEU . 44.3 tt0 32.6 48.38 0.12 Allowed 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 -176.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 1.325 ' O ' ' N ' ' A' ' 86' ' ' LYS . 0.2 OUTLIER 13.21 41.21 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.334 0 CA-C-N 114.007 -1.452 . . . . 0.0 109.686 -176.685 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 1.069 ' C ' ' O ' ' A' ' 84' ' ' SER . 4.7 mt 20.23 32.43 0.0 OUTLIER 'General case' 0 C--O 1.198 -1.642 0 N-CA-C 102.236 -3.246 . . . . 0.0 102.236 -173.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 1.325 ' N ' ' O ' ' A' ' 84' ' ' SER 0.349 3.2 tttt -57.77 -41.59 82.32 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 103.288 -2.856 . . . . 0.0 103.288 176.496 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.304 11.8 tttp -70.35 -32.77 70.61 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 111.44 -2.618 . . . . 0.0 105.438 174.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.778 ' HB3' ' O ' ' B' ' 33' ' ' THR . . . -77.41 -16.33 58.89 Favored 'General case' 0 C--O 1.2 -1.508 0 CA-C-O 122.201 1.001 . . . . 0.0 109.172 178.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.693 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . -89.96 -24.12 21.36 Favored 'General case' 0 C--N 1.282 -2.337 0 O-C-N 120.443 -1.41 . . . . 0.0 108.787 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -71.85 -34.64 69.43 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.421 ' HA3' ' CB ' ' B' ' 37' ' ' ALA . . . -77.34 -32.44 47.63 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 178.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.814 ' HG ' ' O ' ' B' ' 36' ' ' VAL 0.26 2.5 mt -51.33 -7.83 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.104 -1.233 . . . . 0.0 112.021 179.573 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.419 ' H ' ' C ' ' A' ' 91' ' ' GLY . 0.2 OUTLIER 62.56 36.7 13.67 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 -175.313 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.501 ' CD1' ' N ' ' B' ' 75' ' ' VAL . 63.9 t80 -34.18 -45.08 0.2 Allowed 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.697 -178.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 . . . . . 0 N--CA 1.494 1.752 0 O-C-N 121.272 -0.893 . . . . 0.0 109.737 179.857 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.436 ' HB3' ' HG ' ' B' ' 6' ' ' LEU . 2.1 mtp . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 120.886 0.374 . . . . 0.0 110.113 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 2' ' ' ASN . . . . . 0.409 ' N ' ' HB2' ' B' ' 5' ' ' GLU . 41.7 t30 -177.82 178.06 1.02 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.299 -0.876 . . . . 0.0 110.693 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.517 ' O ' HG13 ' B' ' 7' ' ' ILE . 0.0 OUTLIER -49.45 -19.62 0.57 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.437 -0.789 . . . . 0.0 110.096 179.553 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.533 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 81.4 m -103.64 -41.43 5.95 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.158 -0.964 . . . . 0.0 108.941 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.409 ' HB2' ' N ' ' B' ' 2' ' ' ASN . 0.0 OUTLIER -65.22 -49.93 67.82 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.692 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.464 ' HA ' ' HB1' ' B' ' 9' ' ' ALA . 9.4 mt -60.54 -33.48 72.73 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' ILE . . . . . 0.681 HG12 ' O ' ' B' ' 21' ' ' VAL . 0.6 OUTLIER -53.24 -55.71 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.333 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . 0.488 ' O ' ' N ' ' B' ' 12' ' ' GLN . 0.0 OUTLIER -58.15 -31.62 67.41 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.13 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . 0.464 ' HB1' ' HA ' ' B' ' 6' ' ' LEU . . . -56.1 -37.16 69.0 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.173 -0.954 . . . . 0.0 109.021 178.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . 0.69 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.5 mp -92.86 -33.38 5.36 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.417 ' CB ' ' HA ' ' B' ' 8' ' ' LYS . . . -67.46 -13.94 62.48 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.488 ' N ' ' O ' ' B' ' 8' ' ' LYS . 3.9 tp-100 -108.47 -43.33 4.34 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.44 -21.74 66.69 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 177.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.69 ' OG1' ' O ' ' B' ' 10' ' ' ILE . 0.2 OUTLIER -121.96 -80.82 0.63 Allowed 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.97 179.786 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . 0.505 ' O ' ' C ' ' B' ' 16' ' ' LEU . . . 70.43 -18.8 0.71 Allowed Glycine 0 N--CA 1.498 2.778 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' LEU . . . . . 0.716 ' N ' HD11 ' B' ' 16' ' ' LEU . 0.0 OUTLIER -27.83 -64.65 0.08 Allowed 'General case' 0 N--CA 1.515 2.805 0 CA-C-O 122.078 0.942 . . . . 0.0 111.068 -179.722 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' THR . . . . . 0.535 HG21 ' O ' ' B' ' 17' ' ' THR . 0.4 OUTLIER -130.11 -0.56 4.65 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.597 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . 0.641 ' O ' ' C ' ' B' ' 19' ' ' VAL . 2.4 mt-30 58.09 29.55 17.99 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 -176.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.653 ' HB ' ' HB ' ' A' ' 19' ' ' VAL . 0.4 OUTLIER 5.33 -99.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.616 -179.221 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' SER . . . . . 0.997 ' O ' ' N ' ' B' ' 22' ' ' SER . 1.7 p -136.07 23.17 3.28 Favored 'General case' 0 C--N 1.273 -2.721 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 177.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . 0.681 ' O ' HG12 ' B' ' 7' ' ' ILE . 35.1 m -5.0 -42.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-O 122.406 1.098 . . . . 0.0 111.037 -177.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.997 ' N ' ' O ' ' B' ' 20' ' ' SER . 14.0 p -76.74 -37.58 55.7 Favored 'General case' 0 C--N 1.28 -2.423 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.741 179.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . 0.868 ' N ' ' O ' ' B' ' 20' ' ' SER . 1.6 mtmt -88.78 -31.07 18.56 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.358 -0.839 . . . . 0.0 111.329 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' MET . . . . . 0.623 ' SD ' ' HA ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -72.09 -36.98 69.66 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.234 -1.541 . . . . 0.0 108.754 179.773 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . 0.626 ' HA ' ' HB3' ' B' ' 28' ' ' PHE . 0.3 OUTLIER -80.06 -35.89 36.43 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 118.168 -1.413 . . . . 0.0 108.149 177.742 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . 0.456 ' HA ' ' HE2' ' B' ' 3' ' ' LYS . . . -66.07 -34.37 77.92 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 176.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' SER . . . . . 0.572 ' O ' ' N ' ' B' ' 31' ' ' ILE . 83.7 p -81.97 -27.38 33.24 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . 0.837 ' O ' HG13 ' B' ' 31' ' ' ILE . 0.5 OUTLIER -59.04 -50.73 72.96 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 178.26 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . 0.587 ' HG3' ' CD1' ' A' ' 47' ' ' PHE . 1.2 tt0 -65.21 -31.49 72.69 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 176.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . 1.268 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 9.3 ttmt -69.88 -22.48 63.24 Favored 'General case' 0 C--O 1.186 -2.278 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.837 HG13 ' O ' ' B' ' 28' ' ' PHE . 0.9 OUTLIER -100.76 -29.37 3.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 O-C-N 119.945 -1.722 . . . . 0.0 108.055 177.824 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.586 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.4 mm -65.3 -60.93 2.0 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 176.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' THR . . . . . 0.778 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 0.4 OUTLIER -76.56 -27.76 56.0 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 119.279 -0.968 . . . . 0.0 108.95 179.587 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 1.268 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 79.1 mm-40 -80.19 -27.37 38.9 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.101 -1.624 . . . . 0.0 110.204 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' THR . . . . . 0.565 ' CB ' ' O ' ' B' ' 31' ' ' ILE . 3.7 m -72.15 -48.76 41.14 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.656 -1.277 . . . . 0.0 108.575 178.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.814 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 4.5 t -51.1 -48.54 30.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 C-N-CA 116.867 -1.933 . . . . 0.0 106.047 177.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . 0.768 ' CA ' ' O ' ' A' ' 88' ' ' ALA . . . -70.24 5.96 1.5 Allowed 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 121.58 0.705 . . . . 0.0 111.044 177.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . 0.493 ' N ' ' O ' ' B' ' 35' ' ' THR . 0.0 OUTLIER -108.57 -35.1 6.54 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 177.438 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 121.17 32.24 1.08 Allowed Glycine 0 C--N 1.302 -1.326 0 C-N-CA 119.727 -1.225 . . . . 0.0 111.487 177.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . 0.503 ' HB2' HG21 ' B' ' 35' ' ' THR . 0.3 OUTLIER -125.26 146.63 49.45 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.798 -1.413 . . . . 0.0 110.371 179.123 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 2.8 mtmm -88.6 91.6 8.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.512 -0.743 . . . . 0.0 110.179 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 78.2 t -64.35 153.3 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.564 -0.71 . . . . 0.0 110.367 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' GLN . . . . . 0.409 ' O ' ' HA ' ' A' ' 2' ' ' ASN . 0.2 OUTLIER -165.83 164.14 18.69 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.44 -0.787 . . . . 0.0 110.043 179.821 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.555 ' HB3' ' HG2' ' A' ' 29' ' ' GLU . 15.4 mt -125.46 117.92 24.7 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.394 -0.816 . . . . 0.0 109.718 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' THR . . . . . 0.54 HG23 ' HG2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 30.34 -93.28 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.875 -0.516 . . . . 0.0 111.124 -179.812 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . 0.551 ' O ' ' HA3' ' B' ' 82' ' ' GLY . . . -144.54 24.34 2.0 Favored Glycine 0 N--CA 1.483 1.775 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . 0.643 ' O ' ' HA ' ' B' ' 81' ' ' PRO . 8.8 p90 -120.7 -22.09 6.45 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.111 -1.229 . . . . 0.0 111.4 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . 0.527 ' HB2' ' HB2' ' B' ' 44' ' ' LEU . 0.9 OUTLIER -128.22 115.45 18.37 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.388 -1.445 . . . . 0.0 110.624 177.828 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' ASN . . . . . 0.595 ' O ' ' HA ' ' B' ' 79' ' ' VAL . 1.2 m120 -113.78 94.75 4.98 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.717 -0.614 . . . . 0.0 111.408 -178.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' ILE . . . . . 0.527 ' HA ' ' HA ' ' B' ' 79' ' ' VAL . 1.3 mp -93.45 141.48 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 O-C-N 121.246 -0.909 . . . . 0.0 109.839 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . 0.416 ' HG3' ' CB ' ' B' ' 78' ' ' SER . 0.0 OUTLIER -161.29 113.42 1.26 Allowed Pre-proline 0 N--CA 1.5 2.025 0 C-N-CA 118.769 -1.172 . . . . 0.0 111.318 179.723 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' PRO . . . . . 0.663 ' HA ' ' HA ' ' B' ' 77' ' ' VAL . 55.7 Cg_endo -83.06 141.91 10.7 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 O-C-N 123.571 1.301 . . . . 0.0 111.724 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.618 ' O ' ' N ' ' B' ' 76' ' ' GLY . 33.4 m -149.24 114.73 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.581 0.705 . . . . 0.0 110.718 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . 0.602 ' HA ' ' HA ' ' B' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.501 2.09 0 O-C-N 121.448 -0.783 . . . . 0.0 111.46 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . 0.602 ' HA ' ' HA ' ' B' ' 54' ' ' ALA . 1.4 p . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 76' ' ' GLY . . . . . 0.626 ' O ' ' N ' ' B' ' 78' ' ' SER . . . -113.14 50.22 0.79 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.856 -1.698 . . . . 0.0 108.856 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.663 ' HA ' ' HA ' ' B' ' 52' ' ' PRO . 7.1 p -45.69 81.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-O 121.695 0.76 . . . . 0.0 111.534 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 78' ' ' SER . . . . . 0.626 ' N ' ' O ' ' B' ' 76' ' ' GLY . 0.6 OUTLIER -77.48 178.81 6.92 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 119.28 -0.968 . . . . 0.0 108.737 178.408 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' B' ' 49' ' ' ASN . 0.2 OUTLIER 179.48 172.8 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.517 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 80' ' ' LYS . . . . . 0.521 ' N ' ' CG2' ' B' ' 79' ' ' VAL . 0.2 OUTLIER 176.46 172.56 0.33 Allowed Pre-proline 0 N--CA 1.487 1.417 0 O-C-N 121.149 -0.97 . . . . 0.0 110.892 178.404 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 81' ' ' PRO . . . . . 0.643 ' HA ' ' O ' ' B' ' 47' ' ' PHE . 54.6 Cg_endo -88.95 165.78 5.83 Favored 'Trans proline' 0 C--N 1.298 -2.079 0 O-C-N 124.617 1.851 . . . . 0.0 107.475 174.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . 0.551 ' HA3' ' O ' ' B' ' 46' ' ' GLY . . . -126.79 -99.33 1.08 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 107.711 -2.156 . . . . 0.0 107.711 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . 0.911 ' O ' ' N ' ' B' ' 85' ' ' LEU . 0.4 OUTLIER -79.43 45.24 0.65 Allowed 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.121 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 84' ' ' SER . . . . . 1.334 ' O ' ' N ' ' B' ' 86' ' ' LYS . 0.1 OUTLIER 8.45 43.16 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 122.148 0.975 . . . . 0.0 111.164 179.165 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . 1.004 ' C ' ' O ' ' B' ' 84' ' ' SER . 0.4 OUTLIER 20.55 30.05 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 102.786 -3.042 . . . . 0.0 102.786 -172.647 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 86' ' ' LYS . . . . . 1.334 ' N ' ' O ' ' B' ' 84' ' ' SER 0.336 7.7 tttt -56.38 -37.17 69.73 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 103.82 -2.659 . . . . 0.0 103.82 177.08 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . 0.29 0.0 OUTLIER -70.59 -34.79 72.56 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 111.905 -2.407 . . . . 0.0 105.796 175.377 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.637 ' N ' ' O ' ' B' ' 85' ' ' LEU . . . -75.3 -27.77 59.45 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 118.586 -1.246 . . . . 0.0 107.859 178.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . 0.704 ' N ' ' O ' ' B' ' 85' ' ' LEU . . . -62.42 -48.33 80.16 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -57.24 -28.98 63.41 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 176.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -69.68 -33.94 72.07 Favored Glycine 0 N--CA 1.489 2.184 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.189 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 92' ' ' LEU . . . . . 0.847 ' HB3' ' HA ' ' A' ' 37' ' ' ALA . 0.7 OUTLIER -85.75 16.95 3.62 Favored 'General case' 0 N--CA 1.506 2.335 0 CA-C-N 119.689 1.745 . . . . 0.0 111.556 -179.155 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 93' ' ' LYS . . . . . 0.411 ' HB2' ' O ' ' B' ' 92' ' ' LEU . 8.7 mmtp 54.92 40.22 31.9 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -178.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . 0.484 ' CD2' ' N ' ' A' ' 75' ' ' VAL . 2.6 p90 -41.77 -30.7 0.26 Allowed 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.651 -178.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -58.22 -42.51 86.44 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.246 -0.909 . . . . 0.0 108.871 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.72 -33.68 76.19 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 177.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.488 1.428 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.458 ' HG2' ' HB3' ' A' ' 5' ' ' GLU . 4.0 mtp . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 120.932 0.396 . . . . 0.0 110.134 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . 0.462 ' O ' ' HB2' ' A' ' 6' ' ' LEU . 4.0 t30 -176.08 -174.79 0.66 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.18 -0.95 . . . . 0.0 111.052 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.542 ' O ' ' CG2' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -51.84 -15.3 0.48 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.453 -0.779 . . . . 0.0 110.275 179.619 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.63 ' O ' HG13 ' A' ' 7' ' ' ILE . 38.7 m -106.89 -58.48 1.93 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 122.004 0.907 . . . . 0.0 109.161 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.458 ' HB3' ' HG2' ' A' ' 1' ' ' MET . 2.6 mt-10 -50.46 -45.05 55.81 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.056 -1.028 . . . . 0.0 108.571 179.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.462 ' HB2' ' O ' ' A' ' 2' ' ' ASN . 2.4 mt -58.26 -36.31 73.06 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.364 -0.934 . . . . 0.0 109.954 178.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.63 HG13 ' O ' ' A' ' 4' ' ' THR . 0.9 OUTLIER -55.8 -42.81 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.295 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.575 ' N ' HG13 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -64.64 -33.76 76.69 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 177.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.23 -38.11 70.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.473 -0.767 . . . . 0.0 109.019 178.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.722 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.4 mp -91.52 -32.41 5.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 178.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.58 ' HB3' ' O ' ' A' ' 7' ' ' ILE . . . -65.3 -14.11 60.0 Favored 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 118.689 -1.205 . . . . 0.0 108.227 178.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.402 ' N ' ' O ' ' A' ' 8' ' ' LYS . 6.4 tp-100 -110.75 -46.07 3.41 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -66.63 -27.78 67.96 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 177.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.762 ' CG2' ' HB2' ' B' ' 20' ' ' SER . 0.2 OUTLIER -111.55 -82.26 0.58 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 178.848 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.516 ' O ' ' C ' ' A' ' 16' ' ' LEU . . . 69.0 -21.35 0.37 Allowed Glycine 0 N--CA 1.498 2.831 0 O-C-N 121.004 -1.06 . . . . 0.0 110.825 178.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.68 ' N ' HD11 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -30.2 -63.77 0.13 Allowed 'General case' 0 N--CA 1.518 2.925 0 CA-C-O 122.052 0.929 . . . . 0.0 110.497 -179.57 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.501 HG21 ' CG2' ' B' ' 17' ' ' THR . 0.5 OUTLIER -129.31 -4.89 4.87 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.774 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.626 ' O ' ' C ' ' A' ' 19' ' ' VAL . 22.1 mt-30 56.41 31.78 19.41 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -177.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.671 ' HB ' ' HB ' ' B' ' 19' ' ' VAL . 1.6 p -6.46 -98.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.538 -178.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.92 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -133.48 23.28 4.03 Favored 'General case' 0 C--N 1.279 -2.493 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 177.15 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.598 ' C ' ' O ' ' A' ' 20' ' ' SER . 30.4 m -20.6 -37.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-O 122.254 1.026 . . . . 0.0 109.858 -178.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.825 ' N ' ' O ' ' A' ' 20' ' ' SER . 11.2 t -75.46 -42.76 52.41 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.931 177.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.92 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -93.8 -22.91 18.38 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.52 -0.738 . . . . 0.0 109.888 178.739 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.79 ' N ' ' OG ' ' A' ' 20' ' ' SER 0.26 2.0 tmm? -68.02 -33.01 73.79 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 179.201 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.558 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 7.3 mt -84.41 -41.55 16.56 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 176.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.435 ' HA ' ' HE2' ' A' ' 3' ' ' LYS . . . -59.19 -34.1 71.74 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 177.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.45 ' O ' HG13 ' A' ' 31' ' ' ILE . 10.2 t -80.17 -36.32 35.23 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 178.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.623 ' O ' ' CG1' ' A' ' 32' ' ' ILE . 0.2 OUTLIER -52.1 -44.87 64.63 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.694 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.626 ' HG3' ' CD2' ' B' ' 47' ' ' PHE . 0.9 OUTLIER -69.53 -36.72 76.66 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.247 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 1.137 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 16.5 ttpt -62.53 -23.82 67.17 Favored 'General case' 0 C--O 1.191 -1.981 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.576 HG13 ' O ' ' A' ' 28' ' ' PHE . 0.5 OUTLIER -104.15 -27.96 3.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 O-C-N 120.499 -1.376 . . . . 0.0 109.379 178.225 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.623 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.3 mm -73.81 -57.55 6.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 177.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.56 ' HA ' HD21 ' B' ' 85' ' ' LEU . 0.6 OUTLIER -68.35 -36.33 79.08 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.568 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 1.137 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 68.2 mm-40 -75.55 -37.79 59.75 Favored 'General case' 0 N--CA 1.483 1.185 0 O-C-N 121.17 -0.956 . . . . 0.0 111.702 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.485 ' O ' ' N ' ' A' ' 38' ' ' LYS . 14.0 m -62.18 -53.97 47.63 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 120.281 -1.512 . . . . 0.0 109.499 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.735 HG12 ' HB3' ' A' ' 52' ' ' PRO . 2.1 t -54.76 -32.89 26.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 177.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.649 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -90.38 10.5 24.79 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.333 177.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.667 ' HB2' ' O ' ' A' ' 34' ' ' GLU . 1.9 ttmt -114.23 -35.35 5.03 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 178.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 127.95 38.58 0.38 Allowed Glycine 0 C--N 1.301 -1.404 0 C-N-CA 119.732 -1.223 . . . . 0.0 110.835 178.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.415 ' CB ' ' CG2' ' A' ' 35' ' ' THR . 0.3 OUTLIER -145.92 135.8 23.49 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.083 -1.245 . . . . 0.0 110.281 179.431 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 51' ' ' LYS . 0.1 OUTLIER -75.02 76.49 2.21 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.391 -0.818 . . . . 0.0 110.459 -179.634 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.0 p -60.56 136.46 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.412 -0.805 . . . . 0.0 110.056 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' B' ' 1' ' ' MET . 6.9 pt20 -144.75 175.15 10.39 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.239 -0.913 . . . . 0.0 110.737 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.662 ' HB2' ' HB2' ' A' ' 48' ' ' LEU . 27.6 mt -125.26 115.01 19.7 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.665 -0.647 . . . . 0.0 109.276 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.56 HG21 ' HG3' ' B' ' 29' ' ' GLU . 0.0 OUTLIER 32.26 -93.88 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.859 -0.526 . . . . 0.0 111.552 -179.767 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -145.05 21.87 1.94 Allowed Glycine 0 N--CA 1.489 2.188 0 C-N-CA 119.504 -1.331 . . . . 0.0 111.013 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.651 ' CD2' ' HG3' ' B' ' 29' ' ' GLU . 8.5 p90 -119.76 -22.15 6.96 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.768 -1.431 . . . . 0.0 111.216 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.662 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 6.8 mt -128.72 108.47 10.51 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.453 -1.404 . . . . 0.0 110.653 178.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.574 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 1.1 t-20 -109.68 91.13 3.52 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.673 -0.642 . . . . 0.0 111.095 -179.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.518 ' CD1' HG22 ' A' ' 79' ' ' VAL . 11.1 mm -93.52 138.11 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.29 -0.881 . . . . 0.0 110.138 179.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 21.0 ptmt -160.93 128.39 2.7 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 120.804 -1.185 . . . . 0.0 111.295 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.735 ' HB3' HG12 ' A' ' 36' ' ' VAL . 55.7 Cg_endo -78.69 141.91 17.66 Favored 'Trans proline' 0 C--N 1.314 -1.274 0 O-C-N 123.513 1.27 . . . . 0.0 110.631 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.518 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 34.5 m -145.66 113.04 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 C-N-CA 119.465 -0.894 . . . . 0.0 111.928 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.783 ' HA ' ' CA ' ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.495 1.798 0 C-N-CA 119.259 -0.976 . . . . 0.0 109.379 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.957 ' HB ' ' CD2' ' B' ' 94' ' ' TYR . 1.1 t . . . . . 0 N--CA 1.515 2.796 0 CA-C-O 122.236 1.017 . . . . 0.0 108.761 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 53' ' ' VAL . . . -138.28 99.22 0.27 Allowed Glycine 0 C--N 1.289 -2.068 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -178.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.597 HG23 ' CD2' ' B' ' 85' ' ' LEU . 1.5 p -59.93 82.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.838 -0.801 . . . . 0.0 109.368 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.486 ' N ' ' O ' ' A' ' 76' ' ' GLY . 0.1 OUTLIER -62.67 177.1 0.57 Allowed 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.554 -0.858 . . . . 0.0 110.535 -179.462 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.574 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 0.2 OUTLIER 177.42 174.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.761 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.532 ' N ' ' CG2' ' A' ' 79' ' ' VAL . 0.5 OUTLIER 177.71 170.26 0.45 Allowed Pre-proline 0 N--CA 1.485 1.323 0 O-C-N 120.822 -1.174 . . . . 0.0 110.997 177.227 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.423 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 56.1 Cg_endo -103.83 136.06 0.1 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 123.359 2.706 . . . . 0.0 109.223 176.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.537 ' HA3' ' HA ' ' A' ' 47' ' ' PHE . . . -97.46 161.25 21.33 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 108.295 -1.922 . . . . 0.0 108.295 178.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.71 -23.95 54.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.015 -1.285 . . . . 0.0 110.584 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.5 t -51.82 -31.18 26.39 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.117 -0.989 . . . . 0.0 108.654 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.502 ' CD2' ' CG1' ' B' ' 36' ' ' VAL . 0.5 OUTLIER -82.96 -31.22 27.72 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.597 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.414 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 5.0 mttt -81.27 -31.8 33.53 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.581 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.403 ' O ' ' HG3' ' A' ' 90' ' ' GLU . 1.1 tmtt? -69.63 -40.2 76.68 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 178.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.653 ' O ' ' HB2' ' B' ' 37' ' ' ALA . . . -62.0 -38.4 88.49 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 176.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.459 ' HA ' HD23 ' A' ' 92' ' ' LEU . . . -53.57 -43.04 68.17 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 120.0 -0.68 . . . . 0.0 109.5 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.509 ' HG3' ' N ' ' A' ' 91' ' ' GLY . 0.3 OUTLIER -54.16 -30.96 51.25 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 177.517 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.509 ' N ' ' HG3' ' A' ' 90' ' ' GLU . . . -64.1 -43.3 97.44 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 178.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.536 ' O ' ' CD1' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -71.59 8.91 0.96 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.745 -1.444 . . . . 0.0 110.831 179.804 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 17.2 mmtm 65.69 50.34 1.61 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 -177.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.584 ' CD1' ' N ' ' B' ' 75' ' ' VAL . 0.0 OUTLIER -34.64 -38.57 0.08 Allowed 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.063 -179.005 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.421 ' HG2' ' CE2' ' A' ' 94' ' ' TYR . 24.8 mt-10 . . . . . 0 N--CA 1.495 1.777 0 O-C-N 121.333 -0.855 . . . . 0.0 109.828 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.453 ' O ' ' HG2' ' A' ' 43' ' ' GLN . 5.3 mtp . . . . . 0 N--CA 1.493 1.687 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 22.6 p30 -176.73 -172.7 0.45 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.249 -0.907 . . . . 0.0 111.099 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.505 ' O ' HG13 ' B' ' 7' ' ' ILE . 0.0 OUTLIER -51.5 -11.15 0.12 Allowed 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.381 -0.825 . . . . 0.0 111.244 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.608 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 45.7 m -114.48 -43.28 3.19 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.812 -1.18 . . . . 0.0 108.995 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.435 ' CB ' ' HA ' ' B' ' 1' ' ' MET . 0.0 OUTLIER -64.19 -50.41 68.22 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.708 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.455 ' HA ' ' HB3' ' B' ' 9' ' ' ALA . 0.7 OUTLIER -62.08 -28.93 69.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.375 -0.828 . . . . 0.0 108.898 178.176 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' ILE . . . . . 0.658 HG12 ' O ' ' B' ' 21' ' ' VAL . 0.5 OUTLIER -55.52 -59.32 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.144 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . 0.469 ' O ' ' HB3' ' B' ' 12' ' ' GLN . 0.1 OUTLIER -57.86 -30.3 65.7 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.375 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . 0.455 ' HB3' ' HA ' ' B' ' 6' ' ' LEU . . . -58.98 -36.57 75.1 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.466 -0.894 . . . . 0.0 108.97 178.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . 0.914 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.1 mp -89.03 -35.16 7.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 177.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.449 ' CB ' ' HA ' ' B' ' 8' ' ' LYS . . . -65.57 -9.46 26.78 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 118.839 -1.144 . . . . 0.0 108.42 177.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.469 ' HB3' ' O ' ' B' ' 8' ' ' LYS . 0.4 OUTLIER -118.46 -43.15 2.72 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.547 -0.721 . . . . 0.0 109.448 178.846 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' B' ' 9' ' ' ALA . 1.7 m-20 -66.1 -38.32 87.93 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 177.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.914 ' OG1' ' O ' ' B' ' 10' ' ' ILE 0.251 0.1 OUTLIER -89.13 -77.95 0.36 Allowed 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 177.549 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.84 6.52 78.49 Favored Glycine 0 N--CA 1.5 2.936 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 177.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' LEU . . . . . 0.825 HD12 ' HB3' ' A' ' 20' ' ' SER . 5.2 mp -55.48 -71.4 0.09 Allowed 'General case' 0 C--N 1.294 -1.817 0 O-C-N 121.63 -0.924 . . . . 0.0 110.569 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' THR . . . . . 0.604 HG21 ' O ' ' B' ' 17' ' ' THR . 0.5 OUTLIER -139.57 8.37 2.39 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.581 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . 0.613 ' O ' ' C ' ' B' ' 19' ' ' VAL . 11.2 mt-30 58.69 23.86 11.53 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 -175.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.671 ' HB ' ' HB ' ' A' ' 19' ' ' VAL . 0.2 OUTLIER 5.49 -94.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.125 -179.194 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' SER . . . . . 0.978 ' O ' ' N ' ' B' ' 23' ' ' LYS . 0.4 OUTLIER -135.72 23.19 3.37 Favored 'General case' 0 C--N 1.275 -2.654 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 178.153 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . 0.658 ' O ' HG12 ' B' ' 7' ' ' ILE . 18.3 m -15.0 -40.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-O 122.245 1.022 . . . . 0.0 109.885 -177.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.914 ' N ' ' O ' ' B' ' 20' ' ' SER . 7.7 t -74.93 -42.21 58.16 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.173 177.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . 0.978 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.2 OUTLIER -92.89 -25.9 17.86 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.661 -0.649 . . . . 0.0 109.827 178.599 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' MET . . . . . 0.561 ' HE2' ' HA ' ' B' ' 21' ' ' VAL . 2.2 tmm? -64.12 -41.06 97.39 Favored 'General case' 0 C--N 1.316 -0.85 0 O-C-N 120.779 -1.201 . . . . 0.0 108.321 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . 0.666 ' HA ' ' HB3' ' B' ' 28' ' ' PHE . 2.5 mt -81.28 -42.63 20.34 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 118.952 -1.099 . . . . 0.0 108.547 177.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . 0.445 ' HB2' ' HA ' ' B' ' 23' ' ' LYS . . . -58.01 -34.02 69.58 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' SER . . . . . 0.53 ' O ' HG13 ' B' ' 31' ' ' ILE . 73.8 m -82.02 -37.12 27.0 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 177.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . 0.666 ' HB3' ' HA ' ' B' ' 25' ' ' LEU . 0.8 OUTLIER -52.81 -48.3 67.03 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.318 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . 0.651 ' HG3' ' CD2' ' A' ' 47' ' ' PHE . 1.7 tt0 -67.16 -34.93 78.59 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . 1.245 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 13.8 ttpt -65.41 -20.84 66.55 Favored 'General case' 0 C--O 1.193 -1.92 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.584 HG13 ' O ' ' B' ' 28' ' ' PHE . 0.7 OUTLIER -106.47 -25.33 3.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 O-C-N 120.057 -1.652 . . . . 0.0 108.968 177.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.59 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.2 mm -76.53 -58.96 3.61 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 176.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' THR . . . . . 0.487 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 0.6 OUTLIER -70.35 -34.19 72.35 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.257 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 1.245 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 77.9 mm-40 -78.83 -37.29 40.91 Favored 'General case' 0 C--O 1.208 -1.093 0 O-C-N 121.126 -0.984 . . . . 0.0 111.614 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' THR . . . . . 0.512 ' CB ' ' O ' ' B' ' 31' ' ' ILE . 26.1 m -61.55 -47.15 86.86 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 120.073 -1.642 . . . . 0.0 108.459 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.502 ' CG1' ' CD2' ' A' ' 85' ' ' LEU . 1.7 t -52.66 -44.46 46.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 177.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . 0.653 ' HB2' ' O ' ' A' ' 88' ' ' ALA . . . -84.85 -1.28 56.29 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.815 178.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . 0.657 ' HB2' ' O ' ' B' ' 34' ' ' GLU . 3.0 ttmt -94.16 -29.84 14.93 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 177.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.1 31.88 0.56 Allowed Glycine 0 C--N 1.303 -1.254 0 C-N-CA 119.665 -1.255 . . . . 0.0 111.395 177.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . 0.464 ' CB ' ' CG2' ' B' ' 35' ' ' THR . 0.2 OUTLIER -146.84 146.38 30.19 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.758 -1.436 . . . . 0.0 110.934 179.453 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.39 96.75 9.72 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.609 0.719 . . . . 0.0 109.341 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 74.5 t -58.35 129.95 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.567 -0.708 . . . . 0.0 110.124 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.69 109.05 13.23 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.517 -0.74 . . . . 0.0 109.955 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.577 HD12 ' HB3' ' B' ' 48' ' ' LEU . 23.4 mt -77.06 106.32 8.69 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.214 -0.929 . . . . 0.0 109.93 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' THR . . . . . 0.62 HG23 ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 32.42 -93.25 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.246 0 O-C-N 122.018 -0.426 . . . . 0.0 111.425 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -148.28 29.39 1.35 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . 0.629 ' CE1' ' HG ' ' B' ' 48' ' ' LEU . 3.2 p90 -130.18 -24.66 2.57 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.075 -1.25 . . . . 0.0 111.152 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . 0.629 ' HG ' ' CE1' ' B' ' 47' ' ' PHE . 6.5 mt -134.49 94.09 3.15 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.727 -1.233 . . . . 0.0 110.196 178.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -98.03 72.43 2.19 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.386 -0.821 . . . . 0.0 111.365 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' ILE . . . . . 0.418 HD12 HG23 ' B' ' 79' ' ' VAL . 2.8 mm -61.06 125.28 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.146 -0.971 . . . . 0.0 108.752 178.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' B' ' 51' ' ' LYS . 2.2 ptmt -145.5 113.68 4.74 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 120.821 -1.175 . . . . 0.0 110.489 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' PRO . . . . . 0.545 ' HA ' ' HA ' ' B' ' 77' ' ' VAL . 55.8 Cg_endo -79.87 138.37 13.14 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.742 1.39 . . . . 0.0 110.759 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.598 ' CG2' ' HA3' ' B' ' 76' ' ' GLY . 17.0 m -122.08 -156.75 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . 0.48 ' HA ' ' HA ' ' B' ' 75' ' ' VAL . . . . . . . . 0 C--N 1.293 -1.857 0 O-C-N 121.01 -1.056 . . . . 0.0 111.964 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . 0.584 ' N ' ' CD1' ' A' ' 94' ' ' TYR . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.779 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 76' ' ' GLY . . . . . 0.598 ' HA3' ' CG2' ' B' ' 53' ' ' VAL . . . -117.59 90.25 0.5 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.545 ' HA ' ' HA ' ' B' ' 52' ' ' PRO . 65.2 t -66.35 78.79 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 O-C-N 121.628 -0.925 . . . . 0.0 110.027 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 78' ' ' SER . . . . . 0.464 ' O ' ' HB ' ' B' ' 79' ' ' VAL . 0.4 OUTLIER -75.73 174.37 9.9 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 118.75 -1.18 . . . . 0.0 110.368 -179.831 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . 0.464 ' HB ' ' O ' ' B' ' 78' ' ' SER . 7.2 p 175.09 177.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 80' ' ' LYS . . . . . 0.426 ' HB3' ' O ' ' B' ' 79' ' ' VAL . 0.3 OUTLIER -177.5 172.5 0.77 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 120.743 -1.223 . . . . 0.0 110.933 177.207 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 81' ' ' PRO . . . . . 0.411 ' HB3' HG22 ' A' ' 77' ' ' VAL . 56.7 Cg_endo -96.44 100.33 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.559 2.173 . . . . 0.0 110.352 178.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' B' ' 46' ' ' GLY . . . -61.81 172.93 7.95 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 108.623 -1.791 . . . . 0.0 108.623 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -68.1 -26.45 65.82 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.978 -1.307 . . . . 0.0 110.558 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -50.14 -33.83 20.26 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.21 -0.931 . . . . 0.0 108.658 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . 0.597 ' CD2' HG23 ' A' ' 77' ' ' VAL . 0.5 OUTLIER -82.57 -31.78 28.83 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 178.522 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -76.15 -39.24 55.43 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.586 -0.696 . . . . 0.0 109.695 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 31.7 tttt -65.61 -39.95 92.08 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 178.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.608 ' O ' ' HB1' ' A' ' 37' ' ' ALA . . . -64.06 -35.45 80.79 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 176.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . 0.436 ' HA ' ' HA ' ' A' ' 37' ' ' ALA . . . -53.65 -41.87 67.22 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . 0.467 ' HA ' ' HB2' ' B' ' 94' ' ' TYR . 0.9 OUTLIER -55.19 -33.39 62.99 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 176.868 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . 0.475 ' C ' ' H ' ' B' ' 93' ' ' LYS . . . -70.06 -25.51 75.51 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 178.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 92' ' ' LEU . . . . . 0.649 ' HB3' ' HA ' ' A' ' 37' ' ' ALA . 0.4 OUTLIER -73.76 20.18 0.1 Allowed 'General case' 0 N--CA 1.502 2.157 0 O-C-N 120.671 -1.488 . . . . 0.0 110.6 179.788 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 93' ' ' LYS . . . . . 0.731 ' O ' ' C ' ' B' ' 94' ' ' TYR . 0.0 OUTLIER 72.0 29.93 2.29 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 -177.437 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . 0.957 ' CD2' ' HB ' ' A' ' 75' ' ' VAL . 15.0 t80 -22.2 -66.5 0.03 OUTLIER 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . 0.747 ' O ' ' N ' ' B' ' 97' ' ' PHE . 8.2 mt-10 4.85 36.47 0.0 OUTLIER 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 101.563 -3.495 . . . . 0.0 101.563 177.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 96' ' ' ASP . . . . . 0.973 ' O ' ' C ' ' B' ' 97' ' ' PHE . 0.0 OUTLIER 17.87 40.61 0.0 OUTLIER 'General case' 0 CA--C 1.476 -1.881 0 CA-C-N 112.689 -2.051 . . . . 0.0 107.531 -173.741 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 97' ' ' PHE . . . . . 0.973 ' C ' ' O ' ' B' ' 96' ' ' ASP . 42.2 p90 . . . . . 0 CA--C 1.504 -0.793 1 N-CA-C 99.96 -4.089 . . . . 0.0 99.96 -167.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.495 ' HG2' ' HB3' ' A' ' 5' ' ' GLU . 6.5 mtp . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 120.89 0.376 . . . . 0.0 110.109 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . 0.488 ' O ' ' HB2' ' A' ' 6' ' ' LEU . 26.5 p30 -177.85 -173.02 0.37 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.219 -0.926 . . . . 0.0 110.995 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.55 ' HE2' ' HA ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -48.57 -15.36 0.08 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.533 -0.729 . . . . 0.0 110.923 -179.724 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.624 ' O ' HG13 ' A' ' 7' ' ' ILE . 60.7 m -107.07 -60.47 1.67 Allowed 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 122.059 0.933 . . . . 0.0 109.461 179.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.495 ' HB3' ' HG2' ' A' ' 1' ' ' MET . 8.9 mt-10 -50.57 -44.21 56.67 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.014 -1.054 . . . . 0.0 108.469 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' A' ' 2' ' ' ASN . 4.7 mt -56.64 -34.37 67.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.365 -0.834 . . . . 0.0 109.955 178.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.624 HG13 ' O ' ' A' ' 4' ' ' THR . 0.9 OUTLIER -60.12 -41.52 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 179.301 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.745 ' HA ' ' HB2' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -70.63 -29.92 66.43 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 177.571 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.48 -37.52 83.95 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.517 -0.74 . . . . 0.0 109.159 178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.686 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.1 mp -93.64 -30.04 4.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 178.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.745 ' HB2' ' HA ' ' A' ' 8' ' ' LYS . . . -62.69 -13.88 37.43 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 118.473 -1.291 . . . . 0.0 108.335 178.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -116.21 -46.56 2.79 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 121.631 -0.668 . . . . 0.0 109.865 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.17 -29.97 71.05 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 177.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.74 ' CG2' ' HB2' ' B' ' 20' ' ' SER 0.271 0.2 OUTLIER -105.09 -74.43 0.65 Allowed 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 179.016 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 57.48 11.51 7.41 Favored Glycine 0 N--CA 1.497 2.747 0 O-C-N 121.402 -0.811 . . . . 0.0 111.811 177.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.619 HD13 HG23 ' A' ' 14' ' ' THR . 2.4 mp -54.37 -62.3 1.74 Allowed 'General case' 0 N--CA 1.505 2.296 0 O-C-N 121.011 -1.288 . . . . 0.0 109.334 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.484 ' O ' HG21 ' A' ' 17' ' ' THR . 0.6 OUTLIER -135.89 4.61 3.03 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.384 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.597 ' O ' ' C ' ' A' ' 19' ' ' VAL . 24.5 mt-30 56.97 28.89 15.43 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 -176.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.68 ' HB ' ' HB ' ' B' ' 19' ' ' VAL . 1.5 p -10.7 -97.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.979 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.921 ' O ' ' N ' ' A' ' 22' ' ' SER . 0.3 OUTLIER -133.55 24.76 4.07 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 177.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.642 ' HA ' ' SD ' ' A' ' 24' ' ' MET . 32.5 m -16.01 -38.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 CA-C-O 122.551 1.167 . . . . 0.0 110.117 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.921 ' N ' ' O ' ' A' ' 20' ' ' SER . 98.0 p -79.22 -38.08 36.56 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.392 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.914 ' N ' ' O ' ' A' ' 20' ' ' SER . 14.1 ttpt -92.08 -25.24 18.85 Favored 'General case' 0 C--N 1.308 -1.225 0 O-C-N 121.226 -0.921 . . . . 0.0 110.897 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.642 ' SD ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -74.91 -35.67 62.2 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 117.399 -1.72 . . . . 0.0 107.418 178.541 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.593 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 8.2 mt -77.48 -37.87 50.4 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 118.68 -1.208 . . . . 0.0 108.494 177.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.55 ' HA ' ' HE2' ' A' ' 3' ' ' LYS . . . -64.48 -35.53 81.23 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 177.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.486 ' O ' HG13 ' A' ' 31' ' ' ILE . 82.7 p -80.93 -28.82 35.62 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.624 ' O ' ' CG1' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -54.78 -41.41 70.51 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.686 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.624 ' HG3' ' CD1' ' B' ' 47' ' ' PHE . 0.7 OUTLIER -72.39 -36.44 68.69 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 176.201 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 1.111 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 22.9 ttpt -60.71 -23.59 65.01 Favored 'General case' 0 C--O 1.191 -2.02 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.602 ' CG1' ' HA ' ' A' ' 28' ' ' PHE . 0.7 OUTLIER -104.17 -27.23 3.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 120.682 -1.261 . . . . 0.0 109.404 178.127 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.624 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.2 mm -70.89 -58.5 5.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 177.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.531 ' O ' ' CB ' ' B' ' 88' ' ' ALA . 0.5 OUTLIER -67.71 -42.84 81.36 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.342 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 1.111 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 34.0 mm-40 -69.09 -34.62 75.38 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.24 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.54 ' CB ' ' O ' ' A' ' 31' ' ' ILE . 1.2 m -57.88 -50.35 73.62 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.44 -1.413 . . . . 0.0 107.812 178.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.508 ' HA ' ' HG3' ' A' ' 52' ' ' PRO . 2.1 t -53.1 -40.52 38.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 C-N-CA 118.607 -1.237 . . . . 0.0 107.853 178.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.717 ' HB3' ' CB ' ' B' ' 88' ' ' ALA . . . -77.71 -9.34 58.94 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.481 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -102.1 2.19 37.19 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 177.495 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.415 ' HA2' ' HG2' ' A' ' 52' ' ' PRO . . . 66.26 50.92 47.66 Favored Glycine 0 C--N 1.302 -1.359 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.538 ' CB ' HG22 ' A' ' 35' ' ' THR . 0.2 OUTLIER -127.9 157.78 39.58 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.284 -1.127 . . . . 0.0 110.081 179.591 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.05 92.93 4.29 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.45 -0.781 . . . . 0.0 111.001 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.526 ' HA ' ' HB3' ' B' ' 1' ' ' MET . 2.3 t -87.4 92.17 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.557 -0.714 . . . . 0.0 109.303 179.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -89.19 148.37 23.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.137 -0.977 . . . . 0.0 110.617 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.63 ' HB2' ' HB2' ' A' ' 48' ' ' LEU . 19.2 mt -118.45 117.31 28.68 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.543 -0.723 . . . . 0.0 109.725 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.501 ' C ' ' O ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER 29.91 -88.59 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.429 0 O-C-N 121.82 -0.55 . . . . 0.0 111.137 179.506 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -152.38 21.28 0.84 Allowed Glycine 0 N--CA 1.486 2.009 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.572 ' CE2' ' HG2' ' B' ' 29' ' ' GLU . 8.8 p90 -118.54 -23.54 7.1 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.916 -1.343 . . . . 0.0 111.25 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.63 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -129.27 94.11 3.72 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.8 -1.188 . . . . 0.0 110.792 178.543 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.646 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 0.6 OUTLIER -96.02 83.37 3.64 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.64 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.587 ' CB ' ' HB ' ' A' ' 79' ' ' VAL . 0.7 OUTLIER -94.26 144.72 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.022 -1.048 . . . . 0.0 113.093 -177.629 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.571 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 9.7 ptmt -177.01 112.43 0.24 Allowed Pre-proline 0 N--CA 1.494 1.746 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 177.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.531 ' CB ' HG23 ' A' ' 75' ' ' VAL . 55.5 Cg_endo -69.58 132.06 22.8 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 O-C-N 123.313 1.165 . . . . 0.0 113.379 -175.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.562 ' CG2' ' HA3' ' A' ' 76' ' ' GLY . 19.1 m -125.37 -141.16 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.272 177.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.292 -1.896 0 O-C-N 120.576 -1.328 . . . . 0.0 111.189 179.726 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.54 ' CG2' ' O ' ' A' ' 53' ' ' VAL . 8.7 p . . . . . 0 N--CA 1.494 1.742 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.562 ' HA3' ' CG2' ' A' ' 53' ' ' VAL . . . -91.6 55.85 3.07 Favored Glycine 0 N--CA 1.484 1.84 0 N-CA-C 107.449 -2.261 . . . . 0.0 107.449 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.529 ' C ' ' O ' ' A' ' 76' ' ' GLY . 19.2 t -26.0 93.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-O 122.932 1.348 . . . . 0.0 110.986 -178.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.556 ' CB ' ' CG ' ' A' ' 51' ' ' LYS . 45.7 t -57.31 -41.63 80.28 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 114.199 -1.364 . . . . 0.0 113.329 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.646 ' HA ' ' O ' ' A' ' 49' ' ' ASN 0.255 7.5 p -44.38 167.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 CA-C-O 122.423 1.106 . . . . 0.0 113.568 -172.238 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.468 ' HB3' ' O ' ' A' ' 79' ' ' VAL . 0.5 OUTLIER 174.61 176.07 0.21 Allowed Pre-proline 0 N--CA 1.485 1.301 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.382 -179.518 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -78.96 130.76 9.65 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 123.751 1.395 . . . . 0.0 109.344 176.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.422 ' CA ' ' HA ' ' A' ' 47' ' ' PHE . . . -104.39 -174.93 25.15 Favored Glycine 0 N--CA 1.498 2.821 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.4 ' HG2' ' N ' ' A' ' 84' ' ' SER . 2.2 pm0 -80.93 -24.27 38.29 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.32 -1.106 . . . . 0.0 110.707 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.416 ' HB2' ' HA3' ' A' ' 46' ' ' GLY . 22.0 t -51.07 -32.13 21.05 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.15 -0.969 . . . . 0.0 108.518 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.603 HD13 ' O ' ' B' ' 33' ' ' THR . 0.6 OUTLIER -84.22 -35.1 23.71 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.592 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -71.34 -31.12 67.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.244 -0.91 . . . . 0.0 109.182 178.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.45 -37.18 65.9 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.728 ' C ' ' HB3' ' B' ' 37' ' ' ALA . . . -65.24 -33.77 76.78 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 176.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.604 ' N ' ' CB ' ' B' ' 37' ' ' ALA . . . -62.38 -35.07 78.01 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.1 -26.37 66.16 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 175.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.545 ' C ' ' H ' ' A' ' 93' ' ' LYS . . . -59.83 -50.18 70.48 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 178.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.61 ' O ' ' HB3' ' A' ' 93' ' ' LYS . 1.3 pp -74.91 27.76 0.09 Allowed 'General case' 0 N--CA 1.505 2.311 0 O-C-N 120.454 -1.615 . . . . 0.0 109.473 178.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.61 ' HB3' ' O ' ' A' ' 92' ' ' LEU . 4.1 ttpt 68.99 93.39 0.08 Allowed 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -177.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 1.126 ' O ' ' C ' ' A' ' 95' ' ' GLU . 24.8 t80 -58.95 -60.74 3.38 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 115.301 -2.56 . . . . 0.0 106.181 177.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 1.126 ' C ' ' O ' ' A' ' 94' ' ' TYR . 38.5 mm-40 . . . . . 0 CA--C 1.484 -1.596 0 N-CA-C 101.366 -3.568 . . . . 0.0 101.366 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.57 ' HA ' ' HB2' ' B' ' 5' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 120.823 0.344 . . . . 0.0 110.246 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 2' ' ' ASN . . . . . 0.517 ' C ' ' H ' ' B' ' 4' ' ' THR . 40.7 p-10 -176.37 -135.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.131 -1.027 . . . . 0.0 111.374 178.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.5 ' O ' HD23 ' B' ' 25' ' ' LEU . 4.9 mttp -61.5 9.16 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.006 -1.058 . . . . 0.0 111.289 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.534 ' O ' HG21 ' B' ' 7' ' ' ILE . 52.9 m -127.8 -66.39 0.87 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.518 -1.364 . . . . 0.0 110.591 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.57 ' HB2' ' HA ' ' B' ' 1' ' ' MET . 19.7 mp0 -53.59 -42.44 67.64 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.955 -1.09 . . . . 0.0 109.797 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.444 ' HB2' ' O ' ' B' ' 2' ' ' ASN . 18.0 mt -57.59 -33.08 67.82 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 118.804 -1.158 . . . . 0.0 109.636 179.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' ILE . . . . . 0.66 HG13 ' N ' ' B' ' 8' ' ' LYS . 0.8 OUTLIER -61.83 -41.47 90.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 178.111 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . 0.757 ' HA ' ' HB1' ' B' ' 11' ' ' ALA . 0.0 OUTLIER -70.39 -29.86 66.61 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 177.875 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' B' ' 13' ' ' ASP . . . -59.17 -39.46 82.56 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.508 -0.745 . . . . 0.0 109.257 178.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . 0.87 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.1 mp -92.64 -29.81 4.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 178.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.757 ' HB1' ' HA ' ' B' ' 8' ' ' LYS . . . -62.87 -15.59 55.42 Favored 'General case' 0 C--N 1.294 -1.809 0 C-N-CA 118.403 -1.319 . . . . 0.0 108.42 178.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.428 ' HB3' ' O ' ' B' ' 8' ' ' LYS . 15.3 tp60 -114.74 -45.31 3.0 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.567 -0.708 . . . . 0.0 109.4 178.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' B' ' 9' ' ' ALA . 3.0 m-20 -62.63 -27.75 69.43 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 177.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.87 ' OG1' ' O ' ' B' ' 10' ' ' ILE 0.258 0.2 OUTLIER -106.66 -82.52 0.54 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 178.412 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.95 4.17 82.35 Favored Glycine 0 N--CA 1.5 2.931 0 O-C-N 121.038 -1.039 . . . . 0.0 110.681 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' LEU . . . . . 0.83 HD12 ' HB3' ' A' ' 20' ' ' SER . 5.4 mp -50.95 -71.02 0.07 Allowed 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.632 -0.923 . . . . 0.0 110.838 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' THR . . . . . 0.551 ' O ' HG23 ' B' ' 17' ' ' THR . 0.6 OUTLIER -136.96 7.82 2.96 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -179.638 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . 0.614 ' O ' ' C ' ' B' ' 19' ' ' VAL . 30.6 mt-30 58.34 26.78 14.43 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 -175.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.68 ' HB ' ' HB ' ' A' ' 19' ' ' VAL . 1.4 p -6.44 -92.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.857 -179.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' SER . . . . . 0.937 ' O ' ' N ' ' B' ' 23' ' ' LYS . 0.5 OUTLIER -134.51 25.11 3.76 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 177.531 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . 0.689 ' C ' ' O ' ' B' ' 20' ' ' SER . 35.3 m -15.56 -41.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 122.66 1.219 . . . . 0.0 109.26 -177.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.925 ' N ' ' O ' ' B' ' 20' ' ' SER . 48.0 t -79.74 -41.68 26.14 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 114.537 -1.21 . . . . 0.0 110.288 177.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . 0.937 ' N ' ' O ' ' B' ' 20' ' ' SER . 1.5 mtpt -85.04 -34.95 22.19 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 121.461 -0.774 . . . . 0.0 111.662 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' MET . . . . . 0.65 ' CE ' ' HA ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -69.23 -30.64 68.83 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 117.667 -1.613 . . . . 0.0 108.058 179.261 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . 0.819 ' HG ' ' N ' ' B' ' 26' ' ' ALA . 0.3 OUTLIER -72.84 -43.23 62.9 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 118.403 -1.319 . . . . 0.0 108.043 177.488 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . 0.819 ' N ' ' HG ' ' B' ' 25' ' ' LEU . . . -63.98 -26.69 68.69 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' SER . . . . . 0.605 ' O ' ' CG1' ' B' ' 31' ' ' ILE . 1.4 t -83.4 -35.83 24.75 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 177.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . 0.668 ' HA ' ' CG1' ' B' ' 31' ' ' ILE . 0.6 OUTLIER -64.85 -48.48 74.18 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.467 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . 0.601 ' HG3' ' CD2' ' B' ' 28' ' ' PHE . 6.4 mt-10 -72.35 -30.21 64.51 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 120.492 -1.38 . . . . 0.0 107.536 178.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . 1.128 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 14.3 tttt -73.19 -25.32 60.73 Favored 'General case' 0 C--O 1.187 -2.203 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 177.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.668 ' CG1' ' HA ' ' B' ' 28' ' ' PHE . 1.9 pp -100.28 -29.89 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.266 -1.521 . . . . 0.0 109.465 178.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.602 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.5 mm -65.79 -64.59 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 177.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' THR . . . . . 0.603 ' O ' HD13 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -62.72 -38.5 90.73 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.034 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 1.128 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 76.7 mm-40 -74.38 -42.74 58.78 Favored 'General case' 0 C--O 1.202 -1.404 0 O-C-N 121.036 -1.04 . . . . 0.0 112.111 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' THR . . . . . 0.546 ' N ' ' O ' ' B' ' 31' ' ' ILE . 67.5 m -57.19 -56.55 20.29 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 120.222 -1.548 . . . . 0.0 110.494 -178.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.604 ' O ' ' HG3' ' B' ' 52' ' ' PRO . 1.3 t -51.63 -44.39 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 117.667 -1.613 . . . . 0.0 106.974 178.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . 0.728 ' HB3' ' C ' ' A' ' 88' ' ' ALA . . . -85.97 6.08 30.29 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.705 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . 0.785 ' N ' ' O ' ' B' ' 34' ' ' GLU . 0.1 OUTLIER -105.64 -36.43 7.09 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 178.156 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 142.68 37.57 0.08 OUTLIER Glycine 0 C--N 1.301 -1.388 0 C-N-CA 119.252 -1.451 . . . . 0.0 111.4 178.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . 0.433 ' CB ' ' CG2' ' B' ' 35' ' ' THR . 0.4 OUTLIER -155.53 145.0 21.07 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.821 -1.4 . . . . 0.0 110.988 179.461 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.15 92.79 5.72 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.557 0.694 . . . . 0.0 109.519 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 11.3 p -68.25 154.81 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.668 -0.645 . . . . 0.0 110.447 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' GLN . . . . . 0.462 ' HG3' ' HA ' ' A' ' 2' ' ' ASN . 0.4 OUTLIER -164.1 176.3 9.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.189 -0.945 . . . . 0.0 111.386 179.937 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.684 ' N ' ' O ' ' B' ' 48' ' ' LEU . 18.1 mt -134.28 118.8 17.96 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' THR . . . . . 0.529 HG21 ' HG3' ' A' ' 29' ' ' GLU . 0.1 OUTLIER 27.21 -95.11 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.416 0 O-C-N 121.826 -0.546 . . . . 0.0 112.374 -179.812 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -137.66 14.97 3.62 Favored Glycine 0 N--CA 1.49 2.247 0 C-N-CA 119.322 -1.418 . . . . 0.0 111.686 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . 0.711 ' O ' ' N ' ' B' ' 82' ' ' GLY . 20.4 p90 -110.9 -33.48 6.5 Favored 'General case' 0 C--O 1.195 -1.803 0 CA-C-N 119.447 1.623 . . . . 0.0 109.342 178.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . 0.684 ' O ' ' N ' ' B' ' 44' ' ' LEU . 1.2 mm? -127.37 128.57 46.08 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 119.931 -1.731 . . . . 0.0 115.095 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' ASN . . . . . 0.696 ' N ' ' HG2' ' B' ' 81' ' ' PRO . 0.5 OUTLIER -143.93 91.86 2.27 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.621 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' ILE . . . . . 0.454 ' CD1' ' CG1' ' B' ' 79' ' ' VAL . 24.9 mm -83.79 148.07 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.457 -0.777 . . . . 0.0 110.688 -178.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' B' ' 78' ' ' SER . 0.0 OUTLIER -149.9 129.88 6.68 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.177 -0.952 . . . . 0.0 109.399 179.149 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' PRO . . . . . 0.604 ' HG3' ' O ' ' B' ' 36' ' ' VAL . 54.9 Cg_endo -81.77 151.64 16.84 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 O-C-N 123.388 1.204 . . . . 0.0 111.387 -178.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.584 HG21 ' O ' ' B' ' 53' ' ' VAL . 20.1 m -138.8 117.48 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-O 122.364 1.078 . . . . 0.0 111.134 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . 0.485 ' HA ' ' HE1' ' A' ' 94' ' ' TYR . . . . . . . . 0 N--CA 1.493 1.697 0 O-C-N 121.598 -0.689 . . . . 0.0 110.991 -179.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . 0.593 ' N ' ' CE1' ' A' ' 94' ' ' TYR . 9.4 p . . . . . 0 N--CA 1.496 1.862 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 76' ' ' GLY . . . . . 0.487 ' HA3' HG21 ' B' ' 53' ' ' VAL . . . -114.79 98.96 0.89 Allowed Glycine 0 N--CA 1.484 1.847 0 C-N-CA 118.938 -1.601 . . . . 0.0 109.24 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.545 ' HA ' ' HA ' ' B' ' 52' ' ' PRO . 67.9 t -68.84 66.07 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.701 -0.882 . . . . 0.0 109.078 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 78' ' ' SER . . . . . 0.451 ' N ' ' O ' ' B' ' 76' ' ' GLY . 37.6 t -65.89 -176.19 0.36 Allowed 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.603 0.716 . . . . 0.0 109.648 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . 0.454 ' CG1' ' CD1' ' B' ' 50' ' ' ILE . 17.7 m -152.68 -153.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 80' ' ' LYS . . . . . 0.721 ' HB3' ' HD3' ' B' ' 81' ' ' PRO . 13.0 ttmt -164.99 -57.58 0.01 OUTLIER Pre-proline 0 C--N 1.294 -1.808 0 O-C-N 121.452 -0.78 . . . . 0.0 109.985 178.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 81' ' ' PRO . . . . . 0.721 ' HD3' ' HB3' ' B' ' 80' ' ' LYS . 44.3 Cg_endo -95.95 164.84 1.33 Allowed 'Trans proline' 0 C--N 1.296 -2.213 0 C-N-CA 121.825 1.683 . . . . 0.0 112.842 -179.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . 0.711 ' N ' ' O ' ' B' ' 47' ' ' PHE . . . 177.05 -25.39 0.06 OUTLIER Glycine 0 C--N 1.287 -2.141 0 N-CA-C 105.774 -2.93 . . . . 0.0 105.774 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . 0.908 ' O ' ' N ' ' B' ' 85' ' ' LEU . 22.5 tt0 30.76 49.84 0.09 Allowed 'General case' 0 C--O 1.205 -1.268 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 84' ' ' SER . . . . . 1.3 ' O ' ' N ' ' B' ' 86' ' ' LYS . 1.2 m 12.67 43.93 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.941 1.353 . . . . 0.0 109.093 -178.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . 1.116 ' O ' ' N ' ' B' ' 88' ' ' ALA . 0.3 OUTLIER 23.05 26.4 0.0 OUTLIER 'General case' 0 C--O 1.187 -2.225 0 N-CA-C 102.785 -3.043 . . . . 0.0 102.785 -170.182 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 86' ' ' LYS . . . . . 1.3 ' N ' ' O ' ' B' ' 84' ' ' SER 0.324 21.8 tttt -37.33 -40.83 0.37 Allowed 'General case' 0 CA--C 1.486 -1.497 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 176.624 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . 0.426 ' N ' ' C ' ' B' ' 85' ' ' LEU 0.307 0.0 OUTLIER -61.06 -39.71 90.9 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-N 111.865 -2.425 . . . . 0.0 106.711 175.355 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 1.116 ' N ' ' O ' ' B' ' 85' ' ' LEU . . . -90.03 -21.62 22.27 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.433 -0.907 . . . . 0.0 108.966 178.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . 0.711 ' N ' ' O ' ' B' ' 85' ' ' LEU . . . -71.83 -36.74 70.3 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 178.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -66.51 -31.93 72.97 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 174.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -60.88 -42.18 99.53 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 92' ' ' LEU . . . . . 0.663 ' HB3' ' HA ' ' A' ' 37' ' ' ALA . 1.2 pp -85.34 21.17 1.8 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 120.443 -1.622 . . . . 0.0 110.581 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 93' ' ' LYS . . . . . 0.453 ' O ' ' N ' ' B' ' 96' ' ' ASP . 0.8 OUTLIER 55.66 45.22 25.11 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 -178.071 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . 0.486 ' CD1' ' N ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -37.29 -43.69 0.55 Allowed 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.661 -178.862 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -54.42 -41.84 69.79 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.297 -0.877 . . . . 0.0 109.535 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 96' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' B' ' 93' ' ' LYS . 0.7 OUTLIER -59.76 -34.29 72.79 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.193 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.488 ' HG2' ' HB3' ' A' ' 5' ' ' GLU . 11.2 mtp . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 120.852 0.358 . . . . 0.0 110.093 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . 0.435 ' N ' ' HB2' ' A' ' 5' ' ' GLU . 7.8 t-20 -179.17 -179.86 0.6 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.261 -0.9 . . . . 0.0 110.304 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.537 ' O ' HG13 ' A' ' 7' ' ' ILE . 0.6 OUTLIER -52.63 -20.08 2.8 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.12 -0.988 . . . . 0.0 109.931 179.668 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.444 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 16.6 m -97.69 -46.68 5.9 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.488 ' HB3' ' HG2' ' A' ' 1' ' ' MET . 0.0 OUTLIER -62.55 -47.04 85.6 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 178.657 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.428 ' HG ' ' HB3' ' A' ' 1' ' ' MET . 2.4 mt -65.69 -29.68 70.26 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.193 178.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.63 HG12 ' O ' ' A' ' 21' ' ' VAL . 0.3 OUTLIER -56.34 -58.76 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 178.428 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.481 ' HE2' ' HA ' ' A' ' 5' ' ' GLU . 0.2 OUTLIER -62.64 -27.47 69.24 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.506 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.427 ' HB3' ' HA ' ' A' ' 6' ' ' LEU . . . -61.22 -32.19 71.97 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.202 -0.937 . . . . 0.0 108.708 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.852 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.2 tp -96.29 -37.59 7.44 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.549 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 178.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.496 ' HA ' ' OG1' ' A' ' 14' ' ' THR . . . -59.38 -24.19 63.2 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.419 ' N ' ' O ' ' A' ' 8' ' ' LYS . 39.3 tp60 -92.5 -45.15 8.27 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.409 ' CB ' ' HB3' ' B' ' 27' ' ' SER . 3.3 m-20 -63.81 -32.12 73.52 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 177.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.852 ' OG1' ' O ' ' A' ' 10' ' ' ILE . 27.7 p -82.5 -74.01 0.37 Allowed 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 58.87 14.79 24.99 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.735 HD11 ' HB ' ' A' ' 14' ' ' THR . 2.9 mp -77.0 -47.31 21.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.542 -0.976 . . . . 0.0 108.615 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.613 ' HB ' HG23 ' B' ' 17' ' ' THR . 0.5 OUTLIER -160.69 5.57 0.07 Allowed 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 120.0 -0.68 . . . . 0.0 111.055 -179.158 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.552 ' O ' ' C ' ' A' ' 19' ' ' VAL . 13.7 mt-30 58.97 25.52 13.89 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 -176.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.801 ' HB ' ' HB ' ' B' ' 19' ' ' VAL . 1.9 p -5.03 -93.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.942 -178.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.965 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -130.32 25.05 5.18 Favored 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 179.695 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.68 ' HA ' ' CE ' ' A' ' 24' ' ' MET . 12.5 m -19.26 -40.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 CA-C-O 122.553 1.168 . . . . 0.0 109.548 -178.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.826 ' N ' ' O ' ' A' ' 20' ' ' SER . 29.2 t -80.06 -35.75 36.62 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.999 178.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.965 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.3 OUTLIER -90.8 -36.21 14.38 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.479 -0.763 . . . . 0.0 110.891 179.561 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.68 ' CE ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -67.61 -38.64 84.23 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 117.626 -1.63 . . . . 0.0 108.994 179.462 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.541 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 0.2 OUTLIER -78.29 -48.04 16.53 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 117.858 -1.537 . . . . 0.0 109.112 178.455 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.468 ' HA ' ' HE3' ' A' ' 3' ' ' LYS . . . -54.97 -37.24 66.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.747 -1.221 . . . . 0.0 107.831 177.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.554 ' O ' HG13 ' A' ' 31' ' ' ILE . 8.4 t -83.18 -28.82 29.06 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.13 178.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.611 ' O ' HG13 ' A' ' 31' ' ' ILE . 2.8 t80 -51.91 -49.26 63.4 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.821 ' HG3' ' CD1' ' B' ' 47' ' ' PHE . 3.3 tt0 -67.17 -35.52 79.83 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 176.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 1.287 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 32.6 tttt -66.11 -17.88 64.99 Favored 'General case' 0 C--O 1.193 -1.913 0 C-N-CA 119.527 -0.869 . . . . 0.0 108.951 178.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.611 HG13 ' O ' ' A' ' 28' ' ' PHE . 1.3 pp -109.24 -26.21 3.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 119.786 -1.821 . . . . 0.0 109.344 178.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.581 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.2 mm -76.5 -54.7 12.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 177.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.739 ' HA ' ' HG ' ' B' ' 85' ' ' LEU . 0.6 OUTLIER -79.35 -29.39 42.19 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.876 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 1.287 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 41.5 mm-40 -78.5 -29.88 46.89 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 118.851 -1.14 . . . . 0.0 110.232 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.529 HG23 ' HB2' ' A' ' 40' ' ' ASP . 7.2 m -73.73 -58.73 3.1 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 117.718 -1.593 . . . . 0.0 107.916 178.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.613 HG22 ' HA ' ' A' ' 33' ' ' THR . 24.7 m -43.22 -40.7 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.701 ' O ' ' HB2' ' B' ' 92' ' ' LEU . . . -79.01 -32.56 45.16 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.58 ' HB2' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -60.44 -27.66 67.68 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 105.129 -2.175 . . . . 0.0 105.129 176.664 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.484 ' CA ' ' CZ ' ' B' ' 97' ' ' PHE . . . 116.74 26.98 2.91 Favored Glycine 0 C--N 1.297 -1.628 0 CA-C-N 114.363 -1.29 . . . . 0.0 111.025 176.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.529 ' HB2' HG23 ' A' ' 35' ' ' THR . 0.2 OUTLIER -122.0 137.34 54.84 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.251 -1.146 . . . . 0.0 110.072 179.213 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.9 mttm -82.02 87.73 6.44 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.535 -0.728 . . . . 0.0 110.704 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.2 m -65.09 140.18 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.446 -0.784 . . . . 0.0 109.718 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.46 ' O ' ' HA ' ' B' ' 2' ' ' ASN . 9.0 mt-30 -135.29 172.22 13.32 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.168 -0.958 . . . . 0.0 110.251 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.6 HD13 ' HG ' ' A' ' 48' ' ' LEU . 11.7 mt -131.65 115.99 16.77 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.214 -0.929 . . . . 0.0 110.332 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.54 HG22 ' HG3' ' B' ' 29' ' ' GLU . 0.0 OUTLIER 26.82 -93.41 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.891 -0.506 . . . . 0.0 111.853 178.892 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.428 ' N ' ' OG1' ' A' ' 45' ' ' THR . . . -153.27 33.87 0.78 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.777 ' CD2' ' HG3' ' B' ' 29' ' ' GLU . 3.2 p90 -131.44 -15.3 3.2 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.265 -1.138 . . . . 0.0 111.154 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.6 ' HG ' HD13 ' A' ' 44' ' ' LEU . 47.6 tp -161.05 121.61 2.79 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 118.261 -1.375 . . . . 0.0 111.085 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 43' ' ' GLN . 16.2 m-20 -131.59 118.16 19.71 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.46 0.648 . . . . 0.0 111.163 -178.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.481 HD13 HG22 ' A' ' 79' ' ' VAL . 5.0 mm -94.61 151.51 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.677 -0.639 . . . . 0.0 109.564 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.458 ' O ' ' N ' ' A' ' 78' ' ' SER . 11.5 ptmt -165.52 115.1 0.83 Allowed Pre-proline 0 N--CA 1.5 2.051 0 O-C-N 120.68 -1.263 . . . . 0.0 110.851 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.648 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 43.9 Cg_endo -82.69 155.78 15.83 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 O-C-N 123.515 1.271 . . . . 0.0 112.024 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.524 ' O ' ' N ' ' A' ' 76' ' ' GLY . 33.0 m -147.62 118.42 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 CA-C-O 121.669 0.747 . . . . 0.0 110.701 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.557 ' HA ' ' CE1' ' B' ' 94' ' ' TYR . . . . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.635 -0.666 . . . . 0.0 111.428 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.542 ' CG2' ' HB2' ' A' ' 52' ' ' PRO . 7.5 p . . . . . 0 N--CA 1.496 1.859 0 CA-C-O 121.412 0.625 . . . . 0.0 111.413 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.603 ' O ' ' N ' ' A' ' 78' ' ' SER . . . -116.9 68.75 0.3 Allowed Glycine 0 N--CA 1.487 2.088 0 N-CA-C 108.749 -1.741 . . . . 0.0 108.749 179.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.648 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 6.4 p -47.08 80.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.963 -0.728 . . . . 0.0 111.622 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.603 ' N ' ' O ' ' A' ' 76' ' ' GLY . 0.2 OUTLIER -77.15 176.66 8.51 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 177.757 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.579 ' CG2' ' N ' ' A' ' 80' ' ' LYS . 0.2 OUTLIER 177.49 174.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -179.745 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.579 ' N ' ' CG2' ' A' ' 79' ' ' VAL . 6.5 ptpt -178.15 170.21 0.87 Allowed Pre-proline 0 C--N 1.299 -1.599 0 O-C-N 121.538 -0.726 . . . . 0.0 109.557 176.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.526 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 56.0 Cg_endo -100.69 176.28 0.27 Allowed 'Trans proline' 0 C--N 1.292 -2.447 0 C-N-CA 122.6 2.2 . . . . 0.0 110.943 178.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 47' ' ' PHE . . . -126.27 163.2 20.29 Favored Glycine 0 N--CA 1.485 1.958 0 N-CA-C 107.084 -2.407 . . . . 0.0 107.084 177.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -58.06 -22.5 50.58 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.751 -1.441 . . . . 0.0 110.905 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.411 ' CB ' ' HB3' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -53.54 -35.29 60.56 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.0 -1.063 . . . . 0.0 108.894 179.198 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.668 ' HG ' ' HA ' ' B' ' 33' ' ' THR . 0.5 OUTLIER -82.31 -25.65 33.77 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.742 -0.599 . . . . 0.0 109.386 178.711 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.415 ' HG2' HG22 ' B' ' 77' ' ' VAL . 20.4 mttt -84.86 -30.67 24.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.345 -0.847 . . . . 0.0 109.956 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -73.5 -38.43 65.37 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.618 ' O ' ' HB2' ' B' ' 37' ' ' ALA . . . -63.65 -37.28 86.73 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 176.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.535 ' N ' ' HB1' ' B' ' 37' ' ' ALA . . . -54.92 -44.46 74.26 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 120.106 -0.638 . . . . 0.0 109.362 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.472 ' HA ' ' CB ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -54.47 -29.37 49.72 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.247 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 88' ' ' ALA . . . -67.9 -40.86 89.07 Favored Glycine 0 N--CA 1.488 2.122 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.31 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.599 ' HG ' ' N ' ' A' ' 93' ' ' LYS . 0.3 OUTLIER -70.39 -47.63 59.96 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 119.895 1.847 . . . . 0.0 110.533 -178.948 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.645 ' O ' ' CG ' ' A' ' 93' ' ' LYS . 0.1 OUTLIER 160.35 57.0 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.175 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 1.029 ' O ' ' C ' ' A' ' 95' ' ' GLU . 17.4 t80 -53.18 -65.47 0.55 Allowed 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 178.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 1.029 ' C ' ' O ' ' A' ' 94' ' ' TYR . 1.0 OUTLIER . . . . . 0 N--CA 1.483 1.216 0 N-CA-C 103.208 -2.886 . . . . 0.0 103.208 175.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.45 ' HA ' ' HB2' ' B' ' 5' ' ' GLU . 5.5 mtp . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 120.881 0.372 . . . . 0.0 110.259 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 2' ' ' ASN . . . . . 0.502 ' C ' ' H ' ' B' ' 4' ' ' THR . 16.4 m-80 -147.45 -155.99 0.68 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.076 -1.015 . . . . 0.0 111.083 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.526 ' O ' ' CG2' ' B' ' 7' ' ' ILE . 1.0 OUTLIER -60.92 2.17 0.12 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.342 -0.849 . . . . 0.0 110.446 179.765 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.663 ' O ' HG13 ' B' ' 7' ' ' ILE . 4.5 m -116.3 -63.25 1.48 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 122.147 0.975 . . . . 0.0 108.904 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.45 ' HB2' ' HA ' ' B' ' 1' ' ' MET . 5.5 mm-40 -52.03 -48.05 64.71 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.214 -0.929 . . . . 0.0 108.515 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' B' ' 2' ' ' ASN . 7.5 mt -56.72 -32.8 65.87 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 119.122 -1.031 . . . . 0.0 110.256 178.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' ILE . . . . . 0.663 HG13 ' O ' ' B' ' 4' ' ' THR . 1.1 pp -60.72 -42.42 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.54 -1.35 . . . . 0.0 107.91 179.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . 0.787 ' HA ' ' HB2' ' B' ' 11' ' ' ALA . 0.0 OUTLIER -71.93 -27.2 62.65 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.29 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . 0.435 ' N ' ' HG2' ' B' ' 8' ' ' LYS . . . -62.54 -36.35 82.35 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . 0.958 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.0 OUTLIER -95.46 -35.24 5.79 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.382 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.787 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.787 ' HB2' ' HA ' ' B' ' 8' ' ' LYS . . . -56.32 -25.25 48.15 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -92.49 -46.82 7.45 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.419 ' OD2' ' CG2' ' A' ' 31' ' ' ILE . 87.0 m-20 -61.64 -24.97 67.08 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 177.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.958 ' OG1' ' O ' ' B' ' 10' ' ' ILE . 17.2 p -93.77 -77.93 0.44 Allowed 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 177.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 61.46 9.23 16.46 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' LEU . . . . . 0.687 HD11 ' HB ' ' B' ' 14' ' ' THR . 3.2 mp -72.75 -60.25 2.32 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.377 -1.072 . . . . 0.0 108.343 179.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' THR . . . . . 0.613 HG23 ' HB ' ' A' ' 17' ' ' THR . 0.5 OUTLIER -143.5 3.44 1.31 Allowed 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.598 179.659 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . 0.639 ' O ' ' C ' ' B' ' 19' ' ' VAL . 4.9 mt-30 59.1 25.33 13.79 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 106.565 -1.642 . . . . 0.0 106.565 -176.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.801 ' HB ' ' HB ' ' A' ' 19' ' ' VAL . 2.2 p 2.54 -97.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.481 -179.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' SER . . . . . 0.95 ' O ' ' N ' ' B' ' 23' ' ' LYS . 0.3 OUTLIER -131.55 21.77 4.7 Favored 'General case' 0 C--N 1.278 -2.525 0 N-CA-C 105.655 -1.98 . . . . 0.0 105.655 175.891 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . 0.904 ' HA ' ' HE3' ' B' ' 24' ' ' MET . 21.2 m -15.31 -39.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-O 122.426 1.108 . . . . 0.0 109.444 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.936 ' N ' ' O ' ' B' ' 20' ' ' SER . 16.5 m -77.41 -45.01 27.2 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.983 177.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . 0.95 ' N ' ' O ' ' B' ' 20' ' ' SER . 6.6 mtmt -96.76 -14.36 22.03 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 121.482 -0.761 . . . . 0.0 109.719 178.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' MET . . . . . 0.904 ' HE3' ' HA ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -71.78 -36.06 70.23 Favored 'General case' 0 C--O 1.216 -0.71 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 177.708 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . 0.504 ' HA ' ' HB3' ' B' ' 28' ' ' PHE . 3.4 mt -84.51 -36.16 22.41 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 176.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . 0.467 ' HB1' ' O ' ' B' ' 22' ' ' SER . . . -61.48 -34.21 75.09 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' SER . . . . . 0.445 ' O ' HG13 ' B' ' 31' ' ' ILE . 11.1 m -77.45 -34.76 54.41 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . 0.654 ' O ' ' CG1' ' B' ' 32' ' ' ILE . 0.1 OUTLIER -52.36 -45.53 65.77 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.745 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . 0.777 ' HG3' ' CD2' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -68.72 -35.96 77.82 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 118.455 -1.298 . . . . 0.0 107.577 177.08 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . 1.133 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 23.5 ttmt -63.92 -22.58 66.99 Favored 'General case' 0 C--O 1.191 -1.978 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.565 HG13 ' O ' ' B' ' 28' ' ' PHE . 0.4 OUTLIER -105.08 -27.99 3.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 O-C-N 120.24 -1.537 . . . . 0.0 108.935 177.963 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.654 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.1 mm -72.46 -58.75 4.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 177.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' THR . . . . . 0.668 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 0.5 OUTLIER -69.05 -36.13 77.36 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.49 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 1.133 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 22.3 mm-40 -75.19 -39.03 60.52 Favored 'General case' 0 C--O 1.206 -1.185 0 C-N-CA 119.156 -1.018 . . . . 0.0 111.832 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' THR . . . . . 0.503 ' HA ' ' CB ' ' B' ' 38' ' ' LYS . 55.4 m -62.77 -51.59 66.51 Favored 'General case' 0 N--CA 1.504 2.229 0 CA-C-N 120.546 1.521 . . . . 0.0 109.826 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.441 HG12 ' HB3' ' B' ' 52' ' ' PRO . 2.4 t -53.85 -36.77 31.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 178.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . 0.618 ' HB2' ' O ' ' A' ' 88' ' ' ALA . . . -94.66 11.65 30.47 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.581 0.705 . . . . 0.0 109.424 177.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . 0.732 ' HB2' ' O ' ' B' ' 34' ' ' GLU . 0.1 OUTLIER -106.76 -33.62 7.53 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 176.933 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 131.07 38.46 0.28 Allowed Glycine 0 C--N 1.303 -1.264 0 C-N-CA 119.837 -1.173 . . . . 0.0 111.033 177.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . 0.435 ' CB ' ' CG2' ' B' ' 35' ' ' THR . 0.2 OUTLIER -147.82 147.31 29.68 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.771 -1.429 . . . . 0.0 111.235 179.634 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -91.4 95.96 10.26 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 61.8 t -59.27 124.65 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.655 -0.653 . . . . 0.0 110.924 -178.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' GLN . . . . . 0.426 ' CG ' ' O ' ' A' ' 1' ' ' MET . 11.1 pt20 -120.68 96.79 5.26 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.454 -0.779 . . . . 0.0 109.235 178.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.602 ' HB3' ' CE1' ' B' ' 47' ' ' PHE . 10.6 mt -65.53 113.2 4.0 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.497 -0.752 . . . . 0.0 110.406 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' THR . . . . . 0.558 HG23 ' HD1' ' B' ' 47' ' ' PHE . 0.0 OUTLIER 29.4 -91.97 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.99 -0.444 . . . . 0.0 111.39 179.351 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -149.85 29.51 1.14 Allowed Glycine 0 N--CA 1.484 1.884 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . 0.821 ' CD1' ' HG3' ' A' ' 29' ' ' GLU . 3.9 p90 -132.66 -23.97 2.01 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.044 -1.268 . . . . 0.0 111.743 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . 0.559 ' HG ' ' CE2' ' B' ' 47' ' ' PHE . 7.3 mt -132.59 105.62 7.32 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.382 -1.449 . . . . 0.0 111.876 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' ASN . . . . . 0.405 ' O ' ' HA ' ' B' ' 79' ' ' VAL . 0.1 OUTLIER -110.38 88.63 2.81 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.283 -0.886 . . . . 0.0 110.603 179.561 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' ILE . . . . . 0.445 HD13 ' CD2' ' A' ' 48' ' ' LEU . 1.1 mm -76.83 148.91 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.413 -0.804 . . . . 0.0 110.303 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' B' ' 51' ' ' LYS . 0.0 OUTLIER -161.17 126.75 2.27 Favored Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 120.918 -1.114 . . . . 0.0 110.182 179.096 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' PRO . . . . . 0.441 ' HB3' HG12 ' B' ' 36' ' ' VAL . 50.1 Cg_endo -75.74 146.82 30.53 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.493 1.26 . . . . 0.0 111.334 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.451 ' O ' ' N ' ' B' ' 76' ' ' GLY . 33.3 m -146.38 123.74 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.68 -0.637 . . . . 0.0 110.56 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . 0.939 ' HA ' ' N ' ' B' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.498 1.96 0 C-N-CA 118.857 -1.137 . . . . 0.0 111.713 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . 0.939 ' N ' ' HA ' ' B' ' 54' ' ' ALA . 74.1 t . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 122.696 1.236 . . . . 0.0 112.036 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 76' ' ' GLY . . . . . 0.467 ' O ' ' CG2' ' B' ' 77' ' ' VAL . . . -109.2 -142.96 9.94 Favored Glycine 0 C--N 1.283 -2.399 0 N-CA-C 106.764 -2.534 . . . . 0.0 106.764 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.517 HG21 ' HB3' ' A' ' 85' ' ' LEU . 99.2 t -155.18 77.57 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 O-C-N 121.279 -1.13 . . . . 0.0 110.138 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 78' ' ' SER . . . . . 0.426 ' O ' ' HB ' ' B' ' 79' ' ' VAL . 0.6 OUTLIER -74.74 175.95 7.47 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 118.788 -1.165 . . . . 0.0 110.147 179.745 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . 0.445 ' CG2' ' N ' ' B' ' 80' ' ' LYS . 5.9 p 176.25 177.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 80' ' ' LYS . . . . . 0.511 ' HB2' ' HD2' ' B' ' 81' ' ' PRO . 0.1 OUTLIER -177.35 174.3 0.65 Allowed Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 120.878 -1.138 . . . . 0.0 110.604 178.053 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 81' ' ' PRO . . . . . 0.511 ' HD2' ' HB2' ' B' ' 80' ' ' LYS . 51.5 Cg_endo -90.86 144.36 3.55 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.245 1.964 . . . . 0.0 110.137 178.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . 0.419 ' CA ' ' HA ' ' B' ' 47' ' ' PHE . . . -106.24 41.45 2.17 Favored Glycine 0 N--CA 1.496 2.663 0 C-N-CA 120.002 -1.094 . . . . 0.0 110.608 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . 0.458 ' O ' ' N ' ' B' ' 87' ' ' LYS . 0.3 OUTLIER 66.46 -48.59 0.44 Allowed 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.419 -1.048 . . . . 0.0 111.604 179.669 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 4.9 t -46.1 -31.93 2.62 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.192 -0.942 . . . . 0.0 109.488 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . 0.739 ' HG ' ' HA ' ' A' ' 33' ' ' THR . 4.0 tt -86.16 -32.76 21.1 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.425 0.631 . . . . 0.0 109.436 178.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -81.95 -22.01 36.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.456 -0.777 . . . . 0.0 110.329 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' B' ' 83' ' ' GLU . 0.0 OUTLIER -90.81 -29.74 17.4 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.619 ' O ' ' HG ' ' B' ' 92' ' ' LEU . . . -70.56 -36.23 73.51 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 177.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . 0.596 ' HA ' ' CB ' ' A' ' 37' ' ' ALA . . . -73.51 -40.42 64.06 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 119.891 -0.724 . . . . 0.0 109.466 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.4 -22.28 41.97 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -101.44 -12.7 34.94 Favored Glycine 0 N--CA 1.485 1.926 0 C-N-CA 120.069 -1.062 . . . . 0.0 113.181 -178.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 92' ' ' LEU . . . . . 0.701 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 3.4 mt -94.35 -69.4 0.75 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 121.751 2.775 . . . . 0.0 111.281 -179.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 93' ' ' LYS . . . . . 0.451 ' CB ' ' CZ ' ' B' ' 97' ' ' PHE . 0.6 OUTLIER -148.4 49.31 1.03 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.0 -1.063 . . . . 0.0 111.23 -179.576 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . 0.557 ' CE1' ' HA ' ' A' ' 54' ' ' ALA . 55.3 t80 -53.85 -48.74 69.68 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.151 -0.968 . . . . 0.0 109.866 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -64.25 -38.82 92.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.455 -0.778 . . . . 0.0 109.858 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.37 -27.78 57.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.526 -0.734 . . . . 0.0 109.547 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 97' ' ' PHE . . . . . 0.484 ' CZ ' ' CA ' ' A' ' 39' ' ' GLY . 2.9 m-85 . . . . . 0 N--CA 1.493 1.684 0 O-C-N 121.493 -0.754 . . . . 0.0 109.615 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.496 ' HA ' ' HB2' ' A' ' 5' ' ' GLU . 1.5 mtp . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . 0.478 ' HA ' ' O ' ' B' ' 43' ' ' GLN . 29.4 p-10 -170.25 -151.11 0.08 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.14 -1.024 . . . . 0.0 111.743 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.45 ' O ' ' CG2' ' A' ' 7' ' ' ILE . 3.6 mttp -53.7 -3.83 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.286 -0.884 . . . . 0.0 111.407 -179.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.663 ' O ' HG13 ' A' ' 7' ' ' ILE . 72.9 m -118.25 -63.93 1.35 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.017 -1.052 . . . . 0.0 110.241 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.496 ' HB2' ' HA ' ' A' ' 1' ' ' MET . 3.9 mt-10 -50.6 -42.93 56.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.907 -1.121 . . . . 0.0 109.375 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.456 ' HB2' ' O ' ' A' ' 2' ' ' ASN . 28.0 mt -61.16 -32.76 72.49 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.201 -1.0 . . . . 0.0 109.726 178.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.663 HG13 ' O ' ' A' ' 4' ' ' THR . 1.0 OUTLIER -60.03 -42.11 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 178.769 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.589 ' N ' HG13 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -68.38 -31.22 70.44 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 177.478 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.447 ' HB1' ' HA ' ' A' ' 6' ' ' LEU . . . -56.91 -38.73 73.26 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.497 -0.752 . . . . 0.0 109.008 178.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.724 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.4 mp -93.38 -30.38 4.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 178.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.591 ' HB1' ' O ' ' A' ' 7' ' ' ILE . . . -63.19 -13.13 33.83 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 118.455 -1.298 . . . . 0.0 108.58 178.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -116.9 -45.19 2.78 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.513 -0.742 . . . . 0.0 110.155 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 9' ' ' ALA . 1.0 OUTLIER -67.22 -23.98 65.78 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 177.723 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.724 ' OG1' ' O ' ' A' ' 10' ' ' ILE 0.278 0.2 OUTLIER -111.27 -71.96 0.74 Allowed 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 179.25 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 57.31 19.22 31.85 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.421 -0.8 . . . . 0.0 111.228 177.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.676 ' CD1' ' CG2' ' A' ' 14' ' ' THR . 4.7 mp -60.92 -66.45 0.53 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.414 -1.051 . . . . 0.0 110.015 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.514 HG21 ' O ' ' A' ' 17' ' ' THR . 0.6 OUTLIER -135.14 8.59 3.46 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -179.807 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.587 ' O ' ' C ' ' A' ' 19' ' ' VAL . 22.3 mt-30 58.03 27.37 14.75 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 -175.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.613 ' CG2' ' CD1' ' B' ' 16' ' ' LEU . 0.5 OUTLIER -11.32 -95.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.626 -179.222 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.951 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -135.59 24.69 3.43 Favored 'General case' 0 C--N 1.279 -2.488 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 178.471 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.637 ' C ' ' O ' ' A' ' 20' ' ' SER . 26.8 m -18.48 -39.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-O 122.478 1.132 . . . . 0.0 109.71 -177.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.861 ' N ' ' O ' ' A' ' 20' ' ' SER . 4.9 p -84.88 -37.66 20.36 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.808 178.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.951 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.1 OUTLIER -85.56 -33.25 21.77 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.609 -0.682 . . . . 0.0 110.939 179.468 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.512 ' SD ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -74.39 -41.68 60.53 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 118.207 -1.397 . . . . 0.0 108.949 179.493 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.554 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 3.1 mt -69.49 -43.76 72.49 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 118.029 -1.469 . . . . 0.0 108.045 177.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.448 ' HA ' ' HD3' ' A' ' 3' ' ' LYS . . . -61.18 -32.33 72.07 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 177.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.547 ' O ' ' N ' ' A' ' 31' ' ' ILE . 7.2 t -75.86 -38.09 58.31 Favored 'General case' 0 C--O 1.207 -1.158 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 177.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.718 ' O ' ' CG1' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -57.3 -38.08 73.45 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.315 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.864 ' HG2' HG22 ' B' ' 45' ' ' THR . 1.4 mt-10 -77.18 -36.67 54.87 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 1.04 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 15.9 ttpt -69.14 -20.21 64.03 Favored 'General case' 0 C--O 1.19 -2.049 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 177.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.69 ' CG1' ' HA ' ' A' ' 28' ' ' PHE . 1.1 pp -105.93 -30.69 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 120.603 -1.311 . . . . 0.0 109.342 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.718 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.1 mm -67.43 -54.22 25.6 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 176.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.529 ' HB ' ' O ' ' A' ' 29' ' ' GLU . 0.3 OUTLIER -68.73 -40.2 80.0 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.955 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 1.04 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 61.3 mm-40 -73.26 -35.29 66.18 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.329 -0.857 . . . . 0.0 111.49 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.588 ' N ' ' O ' ' A' ' 31' ' ' ILE . 3.4 m -59.3 -50.66 73.12 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.598 -1.314 . . . . 0.0 108.078 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.407 ' CG2' ' HD3' ' A' ' 52' ' ' PRO . 1.1 t -54.22 -36.94 34.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 177.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.837 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -80.75 -5.04 56.58 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.639 0.733 . . . . 0.0 109.714 177.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -101.05 -24.21 14.35 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.36 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 105.86 40.68 1.96 Allowed Glycine 0 C--N 1.3 -1.433 0 C-N-CA 120.136 -1.031 . . . . 0.0 110.641 178.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.442 ' CB ' ' CG2' ' A' ' 35' ' ' THR . 0.1 OUTLIER -134.18 123.43 24.33 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.21 -1.171 . . . . 0.0 110.03 179.284 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.87 68.48 5.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.438 -0.789 . . . . 0.0 110.629 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.461 ' CG1' ' HB ' ' A' ' 50' ' ' ILE . 2.6 p -59.61 145.97 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.168 -0.958 . . . . 0.0 109.405 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -137.8 120.65 16.44 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.238 -0.914 . . . . 0.0 111.03 -178.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.67 HD12 ' HB2' ' A' ' 48' ' ' LEU . 10.1 mt -64.5 -178.81 0.42 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.28 -0.887 . . . . 0.0 109.326 178.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.747 HG21 ' HG2' ' B' ' 29' ' ' GLU . 1.4 t -36.32 -34.16 0.06 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.77 -0.581 . . . . 0.0 111.467 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 166.39 -23.37 0.13 Allowed Glycine 0 N--CA 1.488 2.155 0 C-N-CA 119.686 -1.245 . . . . 0.0 110.398 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.617 ' CD1' HD22 ' A' ' 85' ' ' LEU . 20.2 p90 -81.65 -18.83 43.22 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.885 -1.362 . . . . 0.0 111.395 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.67 ' HB2' HD12 ' A' ' 44' ' ' LEU . 2.7 mt -125.94 100.32 6.32 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 118.553 -1.259 . . . . 0.0 111.611 178.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.528 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 0.1 OUTLIER -91.81 64.48 4.79 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.056 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.683 ' HA ' ' HB ' ' A' ' 79' ' ' VAL . 27.2 mm -57.29 116.42 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 O-C-N 121.335 -0.853 . . . . 0.0 112.767 -177.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.528 ' HG2' ' O ' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -172.71 135.7 0.77 Allowed Pre-proline 0 N--CA 1.494 1.734 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.038 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.463 ' HB2' ' CG1' ' A' ' 75' ' ' VAL . 51.2 Cg_endo -90.63 156.08 4.27 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.473 1.249 . . . . 0.0 113.147 -177.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.61 ' O ' ' N ' ' A' ' 76' ' ' GLY . 27.1 m -132.14 111.94 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 CA-C-O 121.717 0.77 . . . . 0.0 110.195 177.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.692 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.498 1.973 0 CA-C-O 122.07 0.938 . . . . 0.0 112.473 -178.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.692 ' HA ' ' HA ' ' A' ' 54' ' ' ALA . 0.4 OUTLIER . . . . . 0 N--CA 1.494 1.728 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.61 ' N ' ' O ' ' A' ' 53' ' ' VAL . . . -113.32 -149.14 10.34 Favored Glycine 0 C--N 1.299 -1.487 0 N-CA-C 108.337 -1.905 . . . . 0.0 108.337 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.534 ' CG1' ' HB3' ' B' ' 81' ' ' PRO . 4.3 t -144.99 86.85 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 CA-C-O 122.021 0.915 . . . . 0.0 108.783 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.511 ' CB ' ' HG3' ' A' ' 51' ' ' LYS . 0.5 OUTLIER -56.37 -44.54 80.25 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.812 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.683 ' HB ' ' HA ' ' A' ' 50' ' ' ILE 0.267 13.2 p -47.53 173.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 CA-C-O 122.082 0.944 . . . . 0.0 113.057 -175.226 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.656 ' HB2' ' HD2' ' A' ' 81' ' ' PRO . 0.1 OUTLIER 177.94 176.4 0.3 Allowed Pre-proline 0 N--CA 1.484 1.229 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -178.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.656 ' HD2' ' HB2' ' A' ' 80' ' ' LYS . 50.7 Cg_endo -78.07 112.51 3.26 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.612 1.322 . . . . 0.0 109.693 177.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -81.04 -172.53 46.37 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.04 -23.66 52.07 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.363 -1.081 . . . . 0.0 110.62 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.26 -37.51 23.83 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.199 -0.938 . . . . 0.0 108.814 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.617 HD22 ' CD1' ' A' ' 47' ' ' PHE . 0.1 OUTLIER -79.63 -35.11 39.94 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.555 0.693 . . . . 0.0 109.152 178.486 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.435 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 0.1 OUTLIER -73.38 -31.38 63.87 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 120.036 -0.666 . . . . 0.0 110.039 -179.778 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -70.77 -40.27 72.74 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 178.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.588 ' O ' ' CB ' ' B' ' 37' ' ' ALA . . . -66.22 -35.31 80.09 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 176.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.565 ' O ' ' HG ' ' A' ' 92' ' ' LEU . . . -58.46 -43.53 88.91 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.255 178.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.527 ' HA ' ' HB2' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -58.28 -24.36 59.19 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 177.29 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -74.71 -38.27 43.3 Favored Glycine 0 N--CA 1.488 2.126 0 CA-C-O 119.399 -0.667 . . . . 0.0 112.792 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.609 ' HG ' ' H ' ' A' ' 93' ' ' LYS . 2.0 pp -57.26 -49.37 76.28 Favored 'General case' 0 N--CA 1.505 2.299 0 CA-C-N 120.774 2.287 . . . . 0.0 111.326 -178.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.609 ' H ' ' HG ' ' A' ' 92' ' ' LEU . 0.4 OUTLIER 159.05 45.95 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -179.447 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.619 ' HE1' ' O ' ' B' ' 75' ' ' VAL . 2.4 t80 -32.48 -71.75 0.05 Allowed 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.331 0.586 . . . . 0.0 112.41 -178.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 . . . . . 0 C--N 1.301 -1.539 0 O-C-N 121.397 -0.815 . . . . 0.0 110.465 -178.354 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.63 ' HA ' ' CB ' ' B' ' 5' ' ' GLU . 5.9 mtp . . . . . 0 N--CA 1.493 1.692 0 N-CA-C 110.081 -0.341 . . . . 0.0 110.081 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 2' ' ' ASN . . . . . 0.402 ' C ' ' H ' ' B' ' 4' ' ' THR . 51.7 p-10 -171.57 -158.51 0.13 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.941 -1.099 . . . . 0.0 112.063 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.522 ' HE2' ' HA ' ' B' ' 26' ' ' ALA . 0.1 OUTLIER -49.72 -12.38 0.07 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.556 -0.715 . . . . 0.0 111.038 -179.536 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.659 ' O ' HG13 ' B' ' 7' ' ' ILE . 19.7 m -114.04 -58.68 2.12 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.007 -1.058 . . . . 0.0 110.197 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.677 ' HA ' ' HE2' ' B' ' 8' ' ' LYS . 0.3 OUTLIER -49.34 -46.64 47.21 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.07 -1.019 . . . . 0.0 109.23 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.467 ' CB ' HD11 ' B' ' 25' ' ' LEU . 10.7 mt -58.79 -31.36 68.33 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.289 -0.964 . . . . 0.0 109.815 178.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' ILE . . . . . 0.659 HG13 ' O ' ' B' ' 4' ' ' THR . 0.9 OUTLIER -58.82 -41.77 83.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.517 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . 0.677 ' HE2' ' HA ' ' B' ' 5' ' ' GLU . 35.6 mtmt -63.55 -35.31 80.07 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . 0.448 ' HB1' ' HA ' ' B' ' 6' ' ' LEU . . . -53.63 -39.75 65.22 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.944 -0.702 . . . . 0.0 109.199 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . 0.678 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.5 mp -90.56 -32.23 5.37 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 178.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.538 ' HB2' ' O ' ' B' ' 7' ' ' ILE . . . -64.21 -15.87 60.82 Favored 'General case' 0 C--N 1.293 -1.871 0 O-C-N 120.805 -1.185 . . . . 0.0 108.58 178.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 -111.54 -43.41 3.67 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.514 -0.741 . . . . 0.0 109.587 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -69.66 -24.55 63.63 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.734 ' CG2' ' HB2' ' A' ' 20' ' ' SER . 0.2 OUTLIER -115.2 -82.65 0.62 Allowed 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 179.258 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . 0.515 ' O ' ' C ' ' B' ' 16' ' ' LEU . . . 67.22 -21.92 0.21 Allowed Glycine 0 N--CA 1.5 2.924 0 O-C-N 120.993 -1.067 . . . . 0.0 110.469 178.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' LEU . . . . . 0.725 ' N ' HD11 ' B' ' 16' ' ' LEU . 0.0 OUTLIER -27.44 -54.73 0.09 Allowed 'General case' 0 N--CA 1.514 2.736 0 CA-C-O 121.942 0.877 . . . . 0.0 110.76 -179.758 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' THR . . . . . 0.446 HG21 ' CG2' ' A' ' 17' ' ' THR . 0.5 OUTLIER -138.78 -3.28 1.66 Allowed 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.975 -179.433 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . 0.538 ' O ' ' C ' ' B' ' 19' ' ' VAL . 11.9 mt-30 56.78 34.94 25.51 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 -176.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.654 HG22 ' CD1' ' A' ' 16' ' ' LEU . 1.8 p -20.43 -95.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.521 -178.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' SER . . . . . 0.916 ' O ' ' N ' ' B' ' 23' ' ' LYS . 0.5 OUTLIER -133.44 24.11 4.08 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 178.495 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . 0.629 ' C ' ' O ' ' B' ' 20' ' ' SER . 30.0 m -19.0 -39.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-O 122.382 1.087 . . . . 0.0 109.585 -178.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.841 ' N ' ' O ' ' B' ' 20' ' ' SER . 28.0 t -84.34 -38.71 20.0 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.009 178.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . 0.916 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.3 OUTLIER -84.91 -32.06 23.34 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.406 -0.809 . . . . 0.0 111.276 179.831 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' MET . . . . . 0.541 ' CE ' ' HG ' ' B' ' 25' ' ' LEU . 0.0 OUTLIER -74.9 -41.07 60.44 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 118.073 -1.451 . . . . 0.0 108.462 178.812 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . 0.627 ' HA ' ' HB3' ' B' ' 28' ' ' PHE . 11.1 mt -69.01 -44.34 72.96 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 118.319 -1.353 . . . . 0.0 108.008 177.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . 0.522 ' HA ' ' HE2' ' B' ' 3' ' ' LYS . . . -57.29 -34.5 68.75 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' SER . . . . . 0.543 ' HA ' ' HB3' ' B' ' 30' ' ' LYS . 54.0 p -84.09 -26.61 28.85 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . 0.737 ' O ' HG13 ' B' ' 31' ' ' ILE . 0.4 OUTLIER -62.54 -44.51 96.17 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.0 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . 0.747 ' HG2' HG21 ' A' ' 45' ' ' THR . 0.7 OUTLIER -74.49 -32.37 62.52 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 177.918 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . 0.816 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 17.5 ttpp -69.17 -27.17 65.28 Favored 'General case' 0 C--O 1.192 -1.933 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 176.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.737 HG13 ' O ' ' B' ' 28' ' ' PHE . 2.0 pp -97.33 -30.6 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.113 -0.992 . . . . 0.0 109.246 178.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.599 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.9 mm -64.58 -53.82 37.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 177.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' THR . . . . . 0.561 ' HA ' HD21 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -68.57 -40.38 80.6 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.129 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.816 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 52.7 mm-40 -70.03 -36.11 74.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.523 -0.735 . . . . 0.0 111.058 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' THR . . . . . 0.597 ' N ' ' O ' ' B' ' 31' ' ' ILE . 3.2 m -59.02 -52.78 64.27 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.799 -1.188 . . . . 0.0 108.651 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.537 ' HB ' ' CD1' ' A' ' 85' ' ' LEU . 13.6 t -54.25 -36.85 34.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 177.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . 0.588 ' CB ' ' O ' ' A' ' 88' ' ' ALA . . . -79.14 -3.84 47.46 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . 0.485 ' N ' ' O ' ' B' ' 34' ' ' GLU . 0.0 OUTLIER -102.43 -29.43 11.62 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 177.823 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' B' ' 35' ' ' THR . . . 112.66 38.55 1.29 Allowed Glycine 0 C--N 1.302 -1.355 0 C-N-CA 120.001 -1.095 . . . . 0.0 111.03 177.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . 0.437 ' CB ' HG23 ' B' ' 35' ' ' THR . 0.1 OUTLIER -130.29 133.63 46.62 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.043 -1.269 . . . . 0.0 110.745 179.364 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.4 ' HG3' ' HD2' ' B' ' 52' ' ' PRO . 0.1 OUTLIER -82.98 88.4 6.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.581 -0.7 . . . . 0.0 109.664 179.683 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . 0.45 ' CG2' ' HB ' ' B' ' 50' ' ' ILE . 25.4 m -73.39 144.91 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.507 -0.745 . . . . 0.0 110.443 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' GLN . . . . . 0.478 ' O ' ' HA ' ' A' ' 2' ' ' ASN . 19.6 mt-30 -138.9 171.53 14.19 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.469 -0.769 . . . . 0.0 110.24 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.674 ' O ' ' N ' ' B' ' 46' ' ' GLY . 91.5 mt -136.06 -179.16 5.49 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.276 -0.89 . . . . 0.0 110.608 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' THR . . . . . 0.864 HG22 ' HG2' ' A' ' 29' ' ' GLU . 4.1 t -45.62 72.19 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . 0.674 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . 42.74 29.03 0.72 Allowed Glycine 0 N--CA 1.494 2.562 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . 0.73 ' CE2' ' HG ' ' B' ' 48' ' ' LEU . 0.7 OUTLIER -129.12 -32.83 2.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.054 -1.262 . . . . 0.0 110.476 179.606 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . 0.73 ' HG ' ' CE2' ' B' ' 47' ' ' PHE . 8.0 mt -128.29 117.99 22.46 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.685 -1.259 . . . . 0.0 110.46 178.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -118.04 69.19 0.78 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.607 -0.683 . . . . 0.0 110.856 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' ILE . . . . . 0.601 ' HA ' ' HB ' ' B' ' 79' ' ' VAL . 11.2 mm -59.86 113.46 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.164 -0.96 . . . . 0.0 109.637 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . 0.439 ' HG3' ' O ' ' B' ' 51' ' ' LYS . 1.3 ptmt -138.34 121.92 11.32 Favored Pre-proline 0 N--CA 1.498 1.952 0 O-C-N 121.017 -1.052 . . . . 0.0 110.246 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' PRO . . . . . 0.574 ' HA ' ' HA ' ' B' ' 77' ' ' VAL . 50.2 Cg_endo -76.61 135.46 16.23 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 123.482 1.254 . . . . 0.0 112.237 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.599 ' O ' ' N ' ' B' ' 76' ' ' GLY . 33.6 m -139.41 116.8 10.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . 0.545 ' HA ' ' N ' ' B' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.492 1.653 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -176.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . 0.619 ' O ' ' HE1' ' A' ' 94' ' ' TYR . 45.2 t . . . . . 0 N--CA 1.513 2.719 0 CA-C-O 122.706 1.241 . . . . 0.0 114.002 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 76' ' ' GLY . . . . . 0.599 ' N ' ' O ' ' B' ' 53' ' ' VAL . . . -142.56 68.12 0.45 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.574 ' HA ' ' HA ' ' B' ' 52' ' ' PRO . 5.3 p -36.48 95.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.827 -0.807 . . . . 0.0 112.139 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 78' ' ' SER . . . . . 0.475 ' O ' ' HB ' ' B' ' 79' ' ' VAL . 15.5 t -94.07 176.0 6.49 Favored 'General case' 0 C--N 1.293 -1.872 0 C-N-CA 119.547 -0.861 . . . . 0.0 108.846 177.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . 0.601 ' HB ' ' HA ' ' B' ' 50' ' ' ILE . 14.5 p 176.24 178.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 80' ' ' LYS . . . . . 0.533 ' HB2' ' HD2' ' B' ' 81' ' ' PRO . 0.2 OUTLIER -178.0 173.35 0.66 Allowed Pre-proline 0 C--N 1.305 -1.352 0 O-C-N 121.024 -1.047 . . . . 0.0 110.424 178.097 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 81' ' ' PRO . . . . . 0.568 ' HA ' ' O ' ' B' ' 47' ' ' PHE . 51.0 Cg_endo -88.01 103.74 0.49 Allowed 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 121.834 1.689 . . . . 0.0 109.853 178.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . 0.476 ' O ' ' HB3' ' B' ' 83' ' ' GLU . . . -71.46 37.43 0.57 Allowed Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . 0.476 ' HB3' ' O ' ' B' ' 82' ' ' GLY . 1.2 tp10 64.22 -27.93 0.09 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.303 -1.116 . . . . 0.0 112.613 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 84' ' ' SER . . . . . 0.463 ' H ' ' C ' ' B' ' 82' ' ' GLY . 1.0 OUTLIER -52.13 -36.43 51.28 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.435 -1.415 . . . . 0.0 108.945 179.602 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . 0.473 ' HB2' ' CD2' ' B' ' 47' ' ' PHE . 1.2 tt -85.79 -36.42 20.1 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 86' ' ' LYS . . . . . 0.513 ' HA ' ' HB1' ' B' ' 89' ' ' ALA . 0.2 OUTLIER -70.52 -35.39 73.15 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.094 179.323 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' B' ' 83' ' ' GLU . 0.2 OUTLIER -70.25 -38.87 75.25 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 178.487 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.61 ' O ' ' HB1' ' A' ' 37' ' ' ALA . . . -63.92 -37.49 87.61 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 176.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . 0.542 ' HB2' HG11 ' A' ' 75' ' ' VAL . . . -55.95 -42.33 76.04 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.255 178.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.66 -31.67 58.03 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 177.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -71.74 -27.76 70.3 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 179.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 92' ' ' LEU . . . . . 0.837 ' HB3' ' HA ' ' A' ' 37' ' ' ALA . 0.5 OUTLIER -71.58 9.47 0.84 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.761 -1.435 . . . . 0.0 111.675 -179.654 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 93' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' B' ' 92' ' ' LEU . 29.9 mmtp 60.76 40.35 16.22 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 -177.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . 0.595 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 1.8 p90 -41.95 -29.94 0.24 Allowed 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.768 -178.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . 0.468 ' HG3' ' CE1' ' B' ' 94' ' ' TYR . 3.8 mp0 -59.53 -47.85 83.92 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.87 -35.52 66.58 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 177.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 178.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.462 ' CG ' ' HB3' ' A' ' 5' ' ' GLU . 0.9 OUTLIER . . . . . 0 N--CA 1.496 1.826 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . 0.423 ' C ' ' H ' ' A' ' 4' ' ' THR . 2.8 t-20 -174.1 -169.2 0.45 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.945 -1.097 . . . . 0.0 111.635 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.614 ' HG2' ' HA ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -57.74 -4.87 0.32 Allowed 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.473 -0.767 . . . . 0.0 110.702 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.902 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 99.2 m -125.29 -40.31 2.13 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.323 -0.86 . . . . 0.0 108.974 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.462 ' HB3' ' CG ' ' A' ' 1' ' ' MET . 0.1 OUTLIER -61.66 -50.59 71.9 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.274 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.487 ' O ' ' HB2' ' A' ' 9' ' ' ALA . 9.1 mt -57.8 -31.25 66.39 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.902 ' HB ' ' O ' ' A' ' 4' ' ' THR . 3.5 mt -52.55 -51.65 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 178.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.537 ' CE ' ' N ' ' A' ' 8' ' ' LYS . 3.1 mmpt? -60.53 -34.24 73.82 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.489 ' HB2' HD11 ' B' ' 31' ' ' ILE . . . -55.26 -37.18 66.91 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.535 -0.866 . . . . 0.0 109.504 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.836 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.0 OUTLIER -97.12 -30.27 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.291 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.508 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -68.14 -13.62 62.36 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 118.829 -1.148 . . . . 0.0 108.542 178.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.426 ' CG ' ' N ' ' A' ' 13' ' ' ASP . 6.5 pt20 -111.14 -39.61 4.7 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.522 -0.736 . . . . 0.0 109.432 178.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.426 ' N ' ' CG ' ' A' ' 12' ' ' GLN . 0.9 OUTLIER -66.89 -36.07 81.45 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 177.408 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.836 ' OG1' ' O ' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -97.31 -67.46 0.85 Allowed 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.376 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 46.17 29.98 3.8 Favored Glycine 0 N--CA 1.497 2.759 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 178.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.558 ' CD1' ' CG2' ' B' ' 19' ' ' VAL . 0.0 OUTLIER -89.65 -26.85 20.52 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.621 -0.929 . . . . 0.0 109.687 179.333 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.498 HG21 ' O ' ' A' ' 17' ' ' THR . 0.4 OUTLIER -162.15 -3.03 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.683 -178.6 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.536 ' O ' ' C ' ' A' ' 19' ' ' VAL . 9.7 mt-30 54.27 30.45 12.45 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 -177.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.675 ' HB ' ' HB ' ' B' ' 19' ' ' VAL . 2.3 p -12.25 -93.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.526 -178.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.945 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.5 OUTLIER -128.5 23.37 5.9 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 178.688 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.719 ' HB ' ' CG2' ' A' ' 7' ' ' ILE . 15.3 m -24.59 -37.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 CA-C-O 122.233 1.016 . . . . 0.0 109.4 -178.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.735 ' N ' ' O ' ' A' ' 20' ' ' SER . 48.5 t -82.28 -36.55 26.94 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.253 177.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.945 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.3 OUTLIER -86.82 -32.43 20.3 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.637 -0.665 . . . . 0.0 111.744 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.644 ' CE ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -78.4 -36.67 45.44 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.433 -1.417 . . . . 0.0 109.873 179.631 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.727 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 0.4 OUTLIER -80.5 -45.04 18.15 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 118.535 -1.266 . . . . 0.0 109.345 178.904 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.614 ' HA ' ' HG2' ' A' ' 3' ' ' LYS . . . -57.24 -33.37 67.49 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 177.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.648 ' HA ' ' HB3' ' A' ' 30' ' ' LYS . 49.4 m -87.46 -31.15 20.16 Favored 'General case' 0 C--O 1.199 -1.586 0 C-N-CA 119.687 -0.805 . . . . 0.0 109.238 178.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.831 ' O ' HG13 ' A' ' 31' ' ' ILE . 0.1 OUTLIER -58.21 -49.71 76.1 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.04 -1.037 . . . . 0.0 109.931 179.45 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.724 ' HG2' HG23 ' B' ' 45' ' ' THR . 1.1 mt-10 -73.12 -37.4 66.68 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 1.251 ' O ' ' HB3' ' A' ' 34' ' ' GLU . 16.8 ttpt -69.06 -16.37 63.68 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 177.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 1.008 ' HA ' ' CG ' ' A' ' 34' ' ' GLU . 1.8 pp -107.39 -29.38 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.14 -0.975 . . . . 0.0 110.241 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.613 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.2 mm -63.39 -45.77 97.15 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 178.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.497 ' O ' ' CB ' ' B' ' 88' ' ' ALA . 0.5 OUTLIER -79.03 -41.32 29.15 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 177.704 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 1.251 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -59.39 -35.51 74.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.134 -0.979 . . . . 0.0 109.124 177.842 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.578 ' N ' ' O ' ' A' ' 31' ' ' ILE . 15.8 m -63.73 -48.93 75.04 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 177.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.437 ' HB ' ' HB3' ' B' ' 88' ' ' ALA . 24.5 t -55.69 -35.58 39.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 177.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.731 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -83.14 -1.24 52.39 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 177.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -106.27 -11.69 15.94 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 177.198 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 35' ' ' THR . . . 85.88 46.28 5.44 Favored Glycine 0 C--N 1.303 -1.255 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.243 177.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.511 ' CB ' ' CG2' ' A' ' 35' ' ' THR . 0.2 OUTLIER -124.6 143.15 50.87 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.031 -1.276 . . . . 0.0 109.975 178.951 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.402 ' CG ' ' HB2' ' A' ' 51' ' ' LYS . 0.3 OUTLIER -105.35 97.58 7.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.549 -0.72 . . . . 0.0 110.185 -179.317 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.552 ' HB ' ' CG1' ' A' ' 50' ' ' ILE . 3.2 t -84.83 172.62 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.472 -0.768 . . . . 0.0 110.134 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.478 ' O ' ' HG3' ' A' ' 43' ' ' GLN . 4.5 pt20 -157.32 107.21 2.21 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.602 -0.686 . . . . 0.0 109.207 179.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.805 HD11 ' HB2' ' A' ' 48' ' ' LEU . 16.1 mt -70.72 179.93 2.43 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.228 -0.92 . . . . 0.0 111.14 -178.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.667 HG21 ' HB3' ' B' ' 29' ' ' GLU . 1.8 t -31.63 -43.43 0.06 Allowed 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 121.053 0.454 . . . . 0.0 111.433 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 172.61 24.44 0.02 OUTLIER Glycine 0 N--CA 1.487 2.071 0 C-N-CA 119.347 -1.406 . . . . 0.0 111.127 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.566 ' CE2' HD11 ' A' ' 44' ' ' LEU . 49.3 p90 -127.82 -49.33 1.36 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.696 -1.473 . . . . 0.0 111.502 178.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.805 ' HB2' HD11 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -96.53 110.75 23.08 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.697 -1.252 . . . . 0.0 112.513 -179.238 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.675 ' O ' ' HB ' ' A' ' 79' ' ' VAL . 1.7 t-20 -105.82 63.33 0.67 Allowed 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.684 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.742 ' HA ' ' CB ' ' A' ' 79' ' ' VAL . 1.1 pp -57.46 130.27 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.69 0 O-C-N 121.117 -0.989 . . . . 0.0 112.67 -177.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.606 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -175.5 112.23 0.27 Allowed Pre-proline 0 N--CA 1.492 1.671 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.171 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.425 ' HG3' ' CG1' ' A' ' 36' ' ' VAL . 55.9 Cg_endo -90.77 156.89 4.15 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 120.882 1.055 . . . . 0.0 111.434 -178.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.583 ' O ' ' N ' ' A' ' 76' ' ' GLY . 32.4 m -139.81 114.92 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 121.913 0.863 . . . . 0.0 111.114 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.561 ' HA ' ' HE1' ' B' ' 94' ' ' TYR . . . . . . . . 0 N--CA 1.499 1.989 0 O-C-N 121.691 -0.631 . . . . 0.0 112.137 -178.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.54 ' N ' ' CE1' ' B' ' 94' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' A' ' 53' ' ' VAL . . . -118.95 97.99 0.72 Allowed Glycine 0 N--CA 1.488 2.165 0 C-N-CA 118.837 -1.649 . . . . 0.0 109.631 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.421 HG23 ' CG1' ' A' ' 79' ' ' VAL . 6.1 p -63.09 84.21 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-O 122.504 1.145 . . . . 0.0 108.667 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 76' ' ' GLY . 0.3 OUTLIER -56.7 -44.15 81.24 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.374 -179.397 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.742 ' CB ' ' HA ' ' A' ' 50' ' ' ILE 0.286 1.9 p -45.98 172.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-O 122.758 1.266 . . . . 0.0 113.971 -174.392 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.601 ' N ' ' CG2' ' A' ' 79' ' ' VAL . 0.0 OUTLIER 178.62 174.22 0.39 Allowed Pre-proline 0 C--N 1.309 -1.188 0 CA-C-N 114.403 -1.272 . . . . 0.0 108.204 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.487 ' HD2' ' HB2' ' A' ' 80' ' ' LYS . 39.0 Cg_endo -66.77 153.77 76.81 Favored 'Trans proline' 0 C--N 1.298 -2.095 0 O-C-N 123.464 1.244 . . . . 0.0 109.166 176.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.494 ' C ' ' H ' ' A' ' 84' ' ' SER . . . -120.0 -83.73 0.81 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 108.239 -1.945 . . . . 0.0 108.239 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.941 ' O ' ' N ' ' A' ' 85' ' ' LEU . 17.5 tt0 -76.54 43.56 0.32 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.428 -1.042 . . . . 0.0 108.791 177.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 1.343 ' O ' ' N ' ' A' ' 86' ' ' LYS . 0.5 OUTLIER 7.21 44.69 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 122.212 1.005 . . . . 0.0 110.203 178.567 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.983 ' C ' ' O ' ' A' ' 84' ' ' SER . 0.2 OUTLIER 20.07 28.65 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 104.538 -2.393 . . . . 0.0 104.538 -171.326 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 1.343 ' N ' ' O ' ' A' ' 84' ' ' SER 0.354 7.7 tttt -62.28 -42.07 99.04 Favored 'General case' 0 CA--C 1.483 -1.616 0 N-CA-C 103.496 -2.779 . . . . 0.0 103.496 176.383 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.406 ' O ' ' HG2' ' A' ' 90' ' ' GLU 0.257 24.0 tptt -67.4 -35.48 79.37 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 111.834 -2.439 . . . . 0.0 104.857 175.708 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.67 ' O ' ' CB ' ' B' ' 37' ' ' ALA . . . -71.59 -27.87 63.43 Favored 'General case' 0 C--O 1.211 -0.927 0 C-N-CA 118.326 -1.35 . . . . 0.0 108.36 178.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.671 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . -59.16 -49.92 76.03 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.977 -1.077 . . . . 0.0 109.363 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.456 ' HG2' ' N ' ' A' ' 91' ' ' GLY . 2.2 pt-20 -56.95 -27.96 61.66 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.903 -1.518 . . . . 0.0 106.903 177.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.456 ' N ' ' HG2' ' A' ' 90' ' ' GLU . . . -68.39 -32.46 75.57 Favored Glycine 0 N--CA 1.488 2.155 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.186 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.781 ' HB3' ' HA ' ' B' ' 37' ' ' ALA . 0.8 OUTLIER -84.85 22.12 1.43 Allowed 'General case' 0 N--CA 1.504 2.263 0 O-C-N 120.213 -1.757 . . . . 0.0 110.975 -179.657 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.45 ' O ' ' C ' ' A' ' 94' ' ' TYR . 2.6 mmtt 55.29 38.19 30.01 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 -177.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.625 ' CD1' ' N ' ' B' ' 75' ' ' VAL . 1.5 t80 -33.66 -41.03 0.08 Allowed 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.81 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 . . . . . 0 N--CA 1.494 1.746 0 O-C-N 121.333 -0.854 . . . . 0.0 109.629 179.727 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.469 ' CB ' HG21 ' A' ' 42' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 2' ' ' ASN . . . . . 0.422 ' N ' ' HB2' ' B' ' 5' ' ' GLU . 0.7 OUTLIER 177.67 176.64 0.4 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.016 -1.053 . . . . 0.0 111.324 -179.811 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.512 ' O ' ' CD2' ' B' ' 25' ' ' LEU . 0.9 OUTLIER -47.63 -29.05 2.67 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.174 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.518 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 16.1 m -95.71 -45.39 7.03 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.661 0.743 . . . . 0.0 109.733 179.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.61 ' HA ' ' HE2' ' B' ' 8' ' ' LYS . 0.0 OUTLIER -56.04 -49.87 72.53 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 120.945 -1.097 . . . . 0.0 108.054 179.207 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.465 ' HG ' HG13 ' A' ' 42' ' ' VAL . 7.6 mt -55.8 -35.01 65.85 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.213 -0.995 . . . . 0.0 108.662 177.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' ILE . . . . . 0.566 HG13 HD22 ' B' ' 25' ' ' LEU . 0.3 OUTLIER -50.87 -48.86 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 178.166 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . 0.61 ' HE2' ' HA ' ' B' ' 5' ' ' GLU . 39.7 mtmt -61.99 -37.75 86.0 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . 0.448 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . . . -52.58 -34.39 50.33 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 119.695 -0.802 . . . . 0.0 108.911 178.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . 0.699 ' O ' ' OG1' ' B' ' 14' ' ' THR . 0.8 OUTLIER -99.41 -36.74 5.56 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.627 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.47 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.575 ' HA ' ' OG1' ' B' ' 14' ' ' THR . . . -63.21 -25.89 68.55 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.417 ' N ' ' O ' ' B' ' 8' ' ' LYS . 9.6 mm100 -93.41 -39.21 11.04 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 177.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.446 ' OD2' ' O ' ' B' ' 9' ' ' ALA . 23.9 m-20 -68.21 -20.16 64.82 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 176.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.699 ' OG1' ' O ' ' B' ' 10' ' ' ILE . 31.0 p -93.77 -77.84 0.44 Allowed 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 177.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 61.97 11.45 31.47 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' LEU . . . . . 0.575 HD13 ' HB ' ' B' ' 14' ' ' THR . 3.4 mp -83.18 -65.14 1.05 Allowed 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 122.27 1.034 . . . . 0.0 109.151 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' THR . . . . . 0.576 HG22 ' O ' ' B' ' 17' ' ' THR . 0.5 OUTLIER -140.55 6.73 2.09 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 115.386 -0.824 . . . . 0.0 108.878 -179.724 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . 0.582 ' O ' ' C ' ' B' ' 19' ' ' VAL . 6.8 mt-30 57.38 24.5 10.17 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 -176.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.675 ' HB ' ' HB ' ' A' ' 19' ' ' VAL . 0.1 OUTLIER 17.14 -96.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.36 -178.833 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' SER . . . . . 1.024 ' O ' ' N ' ' B' ' 22' ' ' SER . 1.4 p -136.25 23.19 3.23 Favored 'General case' 0 C--N 1.272 -2.776 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 176.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . 0.685 ' HA ' ' CE ' ' B' ' 24' ' ' MET . 17.8 m -5.35 -42.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.397 1.094 . . . . 0.0 110.452 -177.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 1.024 ' N ' ' O ' ' B' ' 20' ' ' SER . 27.3 t -73.33 -40.34 64.54 Favored 'General case' 0 C--N 1.281 -2.371 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.498 178.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . 0.873 ' N ' ' O ' ' B' ' 20' ' ' SER . 13.5 ttpt -93.26 -27.42 16.84 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.254 -0.904 . . . . 0.0 111.239 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' MET . . . . . 0.685 ' CE ' ' HA ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -73.63 -25.74 60.45 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 119.905 -1.747 . . . . 0.0 108.281 179.115 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . 0.691 ' HG ' ' N ' ' B' ' 26' ' ' ALA . 0.2 OUTLIER -81.99 -46.27 14.21 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 176.946 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . 0.691 ' N ' ' HG ' ' B' ' 25' ' ' LEU . . . -64.27 -27.73 69.24 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 178.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' SER . . . . . 0.677 ' O ' ' N ' ' B' ' 31' ' ' ILE . 30.6 t -83.67 -40.07 19.41 Favored 'General case' 0 C--O 1.2 -1.549 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . 0.751 ' O ' HG13 ' B' ' 31' ' ' ILE . 0.5 OUTLIER -51.51 -46.4 63.24 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.52 0.676 . . . . 0.0 109.379 179.548 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . 0.667 ' HB3' HG21 ' A' ' 45' ' ' THR . 0.6 OUTLIER -75.31 -31.58 60.69 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 177.855 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . 1.274 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 18.0 ttpt -71.41 -18.54 62.33 Favored 'General case' 0 C--O 1.191 -2.016 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 176.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.751 HG13 ' O ' ' B' ' 28' ' ' PHE . 1.0 OUTLIER -105.82 -32.01 2.68 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.491 0 O-C-N 119.879 -1.763 . . . . 0.0 108.673 178.368 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.608 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.5 mm -67.37 -63.42 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 176.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' THR . . . . . 0.522 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 0.5 OUTLIER -64.3 -45.11 89.4 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.74 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 1.274 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 15.6 mm-40 -68.79 -27.72 66.13 Favored 'General case' 0 C--N 1.31 -1.116 0 O-C-N 121.339 -0.851 . . . . 0.0 111.165 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' THR . . . . . 0.595 ' CB ' ' O ' ' B' ' 31' ' ' ILE . 1.1 m -57.85 -51.14 70.84 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 177.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.463 ' CG2' ' CD1' ' A' ' 85' ' ' LEU . 4.3 t -54.07 -36.25 31.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 117.249 -1.78 . . . . 0.0 107.068 177.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . 0.781 ' HA ' ' HB3' ' A' ' 92' ' ' LEU . . . -81.4 1.09 34.55 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.212 177.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' B' ' 34' ' ' GLU . 0.0 OUTLIER -108.72 -25.69 10.71 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.703 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.22 40.7 1.48 Allowed Glycine 0 C--N 1.303 -1.289 0 C-N-CA 119.946 -1.121 . . . . 0.0 110.748 178.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . 0.47 ' CB ' HG21 ' B' ' 35' ' ' THR . 0.3 OUTLIER -136.77 135.83 38.39 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.086 -1.244 . . . . 0.0 110.553 179.594 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.9 93.12 9.29 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.48 -0.762 . . . . 0.0 109.006 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . 0.421 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 14.1 t -59.3 135.17 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.499 -0.75 . . . . 0.0 110.008 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' GLN . . . . . 0.45 ' HA ' ' HA ' ' B' ' 49' ' ' ASN . 11.2 mt-30 -132.0 91.95 3.04 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.501 -0.749 . . . . 0.0 109.757 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.646 HD13 ' CB ' ' B' ' 48' ' ' LEU . 7.6 mt -67.65 -179.28 1.07 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.284 -0.885 . . . . 0.0 110.979 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' THR . . . . . 0.724 HG23 ' HG2' ' A' ' 29' ' ' GLU . 3.2 t -52.53 73.38 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 O-C-N 122.109 -0.369 . . . . 0.0 111.687 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . 40.09 62.12 1.57 Allowed Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . 0.642 ' CE1' ' HG ' ' B' ' 48' ' ' LEU . 0.2 OUTLIER -163.45 -45.16 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.445 -1.032 . . . . 0.0 108.775 -179.867 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . 0.646 ' CB ' HD13 ' B' ' 44' ' ' LEU . 0.0 OUTLIER -125.02 102.17 7.39 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.785 -0.572 . . . . 0.0 109.958 178.843 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' ASN . . . . . 0.929 ' O ' ' O ' ' B' ' 79' ' ' VAL . 0.7 OUTLIER -120.24 100.58 7.26 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.11 -0.994 . . . . 0.0 110.568 -179.635 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' ILE . . . . . 0.54 ' N ' ' HD3' ' B' ' 80' ' ' LYS . 0.4 OUTLIER -90.84 140.8 15.36 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 O-C-N 121.252 -0.905 . . . . 0.0 110.921 -179.177 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . 0.489 ' O ' ' HD3' ' B' ' 51' ' ' LYS . 0.0 OUTLIER -157.3 119.37 2.11 Favored Pre-proline 0 N--CA 1.496 1.825 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.663 179.205 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' PRO . . . . . 0.597 ' HA ' ' HA ' ' B' ' 77' ' ' VAL . 57.2 Cg_endo -87.9 136.55 3.68 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.62 1.326 . . . . 0.0 110.778 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.536 ' O ' ' N ' ' B' ' 76' ' ' GLY . 30.6 m -128.41 111.7 24.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-O 122.016 0.913 . . . . 0.0 110.642 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . 0.562 ' HA ' ' HE1' ' A' ' 94' ' ' TYR . . . . . . . . 0 N--CA 1.498 1.964 0 O-C-N 121.879 -0.513 . . . . 0.0 111.534 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . 0.625 ' N ' ' CD1' ' A' ' 94' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.711 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 76' ' ' GLY . . . . . 0.611 ' O ' ' N ' ' B' ' 78' ' ' SER . . . -107.57 57.27 0.45 Allowed Glycine 0 N--CA 1.484 1.842 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.606 ' O ' ' O ' ' B' ' 78' ' ' SER . 73.5 t -45.17 87.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 122.117 -0.637 . . . . 0.0 109.944 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 78' ' ' SER . . . . . 0.611 ' N ' ' O ' ' B' ' 76' ' ' GLY . 5.7 m -57.54 -129.03 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . 0.929 ' O ' ' O ' ' B' ' 49' ' ' ASN . 1.9 m -144.34 179.74 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 119.702 -1.874 . . . . 0.0 113.2 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 80' ' ' LYS . . . . . 0.728 ' H ' ' HD2' ' B' ' 81' ' ' PRO . 3.6 mmtt -101.81 -54.8 0.13 Allowed Pre-proline 0 C--N 1.296 -1.731 0 CA-C-N 113.962 -1.472 . . . . 0.0 112.526 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 81' ' ' PRO . . . . . 0.728 ' HD2' ' H ' ' B' ' 80' ' ' LYS . 28.6 Cg_endo -53.35 114.78 1.9 Allowed 'Trans proline' 0 C--N 1.298 -2.083 0 O-C-N 123.317 1.167 . . . . 0.0 110.339 -177.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -130.85 -57.9 0.09 OUTLIER Glycine 0 N--CA 1.478 1.436 0 N-CA-C 107.072 -2.411 . . . . 0.0 107.072 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . 0.833 ' O ' ' N ' ' B' ' 85' ' ' LEU . 25.7 tt0 -82.78 56.21 3.32 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 177.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 84' ' ' SER . . . . . 1.304 ' O ' ' N ' ' B' ' 86' ' ' LYS . 1.3 m 8.9 45.2 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.983 0.897 . . . . 0.0 111.561 178.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . 0.999 ' C ' ' O ' ' B' ' 84' ' ' SER . 1.2 mt 22.08 29.36 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 103.745 -2.687 . . . . 0.0 103.745 -171.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 86' ' ' LYS . . . . . 1.304 ' N ' ' O ' ' B' ' 84' ' ' SER 0.337 8.3 tttt -59.26 -40.71 86.84 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 104.074 -2.565 . . . . 0.0 104.074 177.119 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . 0.407 ' O ' ' HG2' ' B' ' 90' ' ' GLU 0.278 6.7 tttp -63.62 -37.67 88.19 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 112.248 -2.251 . . . . 0.0 105.749 175.23 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.727 ' O ' ' CB ' ' A' ' 37' ' ' ALA . . . -78.14 -24.57 47.3 Favored 'General case' 0 C--O 1.207 -1.145 0 C-N-CA 119.023 -1.071 . . . . 0.0 108.185 178.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . 0.71 ' N ' ' O ' ' B' ' 85' ' ' LEU . . . -76.03 -37.75 58.02 Favored 'General case' 0 C--N 1.291 -1.959 0 O-C-N 120.962 -1.086 . . . . 0.0 109.036 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' B' ' 87' ' ' LYS . 3.7 pt-20 -66.98 -23.54 65.95 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 176.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . 0.464 ' HA3' ' HB3' ' A' ' 37' ' ' ALA . . . -72.39 -38.92 57.99 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 92' ' ' LEU . . . . . 0.731 ' HB3' ' HA ' ' A' ' 37' ' ' ALA . 2.2 pp -76.5 22.25 0.18 Allowed 'General case' 0 N--CA 1.503 2.218 0 CA-C-N 120.177 1.988 . . . . 0.0 110.618 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 93' ' ' LYS . . . . . 0.49 ' O ' ' N ' ' B' ' 96' ' ' ASP . 0.1 OUTLIER 54.77 49.39 18.03 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 106.457 -1.682 . . . . 0.0 106.457 -177.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . 0.561 ' HE1' ' HA ' ' A' ' 54' ' ' ALA . 28.3 t80 -27.56 -46.22 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.919 -178.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -57.35 -48.13 79.8 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.302 -0.874 . . . . 0.0 109.79 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 96' ' ' ASP . . . . . 0.49 ' N ' ' O ' ' B' ' 93' ' ' LYS . 7.8 m-20 -54.24 -33.54 58.67 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.414 -0.804 . . . . 0.0 109.008 178.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 97' ' ' PHE . . . . . 0.424 ' HB2' ' CD1' ' B' ' 92' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.443 ' HA ' ' CB ' ' A' ' 5' ' ' GLU . 5.8 mtp . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 120.972 0.415 . . . . 0.0 110.075 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . 0.402 ' N ' HD13 ' A' ' 6' ' ' LEU . 5.2 t-20 -172.62 -173.34 1.0 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.055 -1.028 . . . . 0.0 111.059 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.521 ' O ' ' CG2' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -51.53 -15.7 0.48 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.219 -0.926 . . . . 0.0 110.034 179.419 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.631 ' O ' HG13 ' A' ' 7' ' ' ILE . 18.5 m -107.82 -55.42 2.36 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 122.094 0.95 . . . . 0.0 109.261 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.664 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 0.4 OUTLIER -50.83 -47.69 60.1 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.104 -0.997 . . . . 0.0 108.832 179.37 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.42 ' HG ' ' HB3' ' A' ' 1' ' ' MET . 1.0 OUTLIER -58.38 -30.6 66.92 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.542 -0.863 . . . . 0.0 110.146 178.563 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.631 HG13 ' O ' ' A' ' 4' ' ' THR . 1.0 OUTLIER -60.47 -41.14 86.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.829 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.664 ' HE2' ' HA ' ' A' ' 5' ' ' GLU . 33.4 mtmt -65.47 -36.42 83.84 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 177.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.414 ' CB ' HD11 ' B' ' 31' ' ' ILE . . . -55.88 -38.18 69.82 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.6 -0.688 . . . . 0.0 109.176 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.597 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.4 mp -90.05 -32.09 5.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 178.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.653 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -66.41 -11.14 50.06 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 119.055 -1.058 . . . . 0.0 108.345 178.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.5 tp-100 -116.36 -43.77 2.92 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.446 ' HB3' ' HB2' ' B' ' 27' ' ' SER . 2.1 m-20 -65.13 -38.4 90.51 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 177.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.597 ' OG1' ' O ' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -98.37 -70.95 0.71 Allowed 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 178.036 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.416 ' CA ' ' O ' ' A' ' 11' ' ' ALA . . . 45.06 27.42 1.54 Allowed Glycine 0 N--CA 1.5 2.952 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 178.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.565 ' CD1' ' CG2' ' B' ' 19' ' ' VAL . 0.1 OUTLIER -84.46 -20.3 31.97 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.678 -0.895 . . . . 0.0 109.255 179.139 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.538 HG21 ' CG2' ' B' ' 17' ' ' THR . 0.4 OUTLIER -162.96 -7.75 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.819 -0.551 . . . . 0.0 110.573 -178.914 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.478 ' O ' ' C ' ' A' ' 19' ' ' VAL . 4.6 mt-30 59.73 33.83 21.91 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 -176.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.706 ' HB ' ' HB ' ' B' ' 19' ' ' VAL . 2.8 p -23.88 -98.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.228 -178.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.941 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -129.71 22.7 5.43 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 178.625 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.604 ' C ' ' O ' ' A' ' 20' ' ' SER . 28.1 m -25.42 -39.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 CA-C-O 122.31 1.053 . . . . 0.0 109.05 -178.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.695 ' N ' ' O ' ' A' ' 20' ' ' SER . 23.0 t -83.45 -34.57 25.4 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 114.922 -1.036 . . . . 0.0 109.326 177.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.941 ' N ' ' O ' ' A' ' 20' ' ' SER . 2.4 mtmt -87.35 -31.76 19.97 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.676 -0.64 . . . . 0.0 111.481 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.576 ' HG2' HG22 ' B' ' 14' ' ' THR . 0.0 OUTLIER -77.47 -35.71 53.5 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.45 -1.407 . . . . 0.0 108.869 179.186 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.575 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 13.4 mt -76.34 -41.42 48.4 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 118.462 -1.295 . . . . 0.0 108.737 178.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.438 ' HA ' ' HG2' ' A' ' 3' ' ' LYS . . . -62.59 -35.26 78.96 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 177.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.519 ' O ' ' N ' ' A' ' 31' ' ' ILE . 60.2 p -83.67 -29.02 27.95 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.635 ' O ' ' CG1' ' A' ' 32' ' ' ILE . 0.6 OUTLIER -51.55 -40.28 59.41 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.742 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.689 ' HG3' HG21 ' B' ' 45' ' ' THR . 0.2 OUTLIER -73.49 -41.55 62.97 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 175.816 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.892 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 12.5 tttt -56.63 -22.78 36.65 Favored 'General case' 0 C--O 1.192 -1.967 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 177.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.599 HG13 ' O ' ' A' ' 28' ' ' PHE . 0.5 OUTLIER -106.28 -30.72 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 120.521 -1.362 . . . . 0.0 109.307 178.168 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.635 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.5 mm -71.43 -53.41 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 176.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.603 ' HA ' ' CD2' ' B' ' 85' ' ' LEU 0.26 3.6 m -61.78 -53.86 50.19 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.73 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.892 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 62.0 mm-40 -62.14 -34.53 76.55 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.711 -0.618 . . . . 0.0 110.822 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.531 HG21 ' CB ' ' A' ' 40' ' ' ASP . 1.0 OUTLIER -55.03 -53.26 58.14 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 120.839 -1.163 . . . . 0.0 108.428 179.026 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.457 HG12 ' CG2' ' A' ' 77' ' ' VAL . 4.0 t -51.95 -42.35 33.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 C-N-CA 118.656 -1.217 . . . . 0.0 107.924 178.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.895 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -78.23 -1.93 35.33 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.341 177.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 35' ' ' THR . 0.0 OUTLIER -108.49 -8.01 15.64 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.73 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.28 49.7 4.59 Favored Glycine 0 C--N 1.305 -1.192 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.531 ' CB ' HG21 ' A' ' 35' ' ' THR . 0.1 OUTLIER -131.22 134.8 46.81 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.1 -1.236 . . . . 0.0 110.783 179.51 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -98.57 110.21 22.84 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.624 ' HB ' ' CG1' ' A' ' 50' ' ' ILE . 39.4 t -89.9 120.92 39.48 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 C-N-CA 119.116 -1.034 . . . . 0.0 111.031 -178.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -108.88 91.02 3.47 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.545 HD11 ' CZ ' ' A' ' 47' ' ' PHE . 9.8 mt -60.88 104.53 0.37 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.547 -0.721 . . . . 0.0 110.783 -178.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.594 HG21 ' HG3' ' B' ' 29' ' ' GLU . 0.1 OUTLIER 32.91 -91.43 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 120.892 0.377 . . . . 0.0 111.402 179.498 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.49 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -149.12 29.81 1.22 Allowed Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.635 ' CE2' ' HG3' ' B' ' 29' ' ' GLU . 1.8 p90 -131.33 -22.69 2.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.286 -1.126 . . . . 0.0 111.585 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.588 ' HG ' ' CE1' ' A' ' 47' ' ' PHE . 5.3 mt -133.86 119.52 19.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.235 -1.541 . . . . 0.0 110.712 178.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.625 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 0.6 OUTLIER -119.97 84.18 2.17 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.432 -0.793 . . . . 0.0 111.586 -178.656 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.627 ' HA ' ' HA ' ' A' ' 79' ' ' VAL . 1.1 pt -83.3 147.66 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.042 -1.036 . . . . 0.0 110.425 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.421 ' HG3' ' HB2' ' A' ' 78' ' ' SER . 0.4 OUTLIER -165.94 113.99 0.78 Allowed Pre-proline 0 N--CA 1.495 1.778 0 C-N-CA 119.011 -1.076 . . . . 0.0 110.72 179.427 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.562 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 47.4 Cg_endo -71.31 143.92 44.71 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 O-C-N 123.51 1.269 . . . . 0.0 111.26 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.578 ' O ' ' N ' ' A' ' 76' ' ' GLY . 25.8 m -138.23 114.88 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.726 0.774 . . . . 0.0 110.526 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.433 ' HA ' HG21 ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.499 1.997 0 CA-C-O 121.735 0.778 . . . . 0.0 112.482 -178.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.538 ' N ' ' CD1' ' B' ' 94' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.496 1.833 0 CA-C-O 121.308 0.575 . . . . 0.0 109.961 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 53' ' ' VAL . . . -108.15 85.72 0.42 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.18 -1.968 . . . . 0.0 108.18 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.728 HG22 ' HB2' ' B' ' 85' ' ' LEU . 73.4 t -60.19 80.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.781 -0.835 . . . . 0.0 110.557 -179.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.468 ' N ' ' O ' ' A' ' 76' ' ' GLY . 0.3 OUTLIER -75.43 178.48 5.88 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.27 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.627 ' HA ' ' HA ' ' A' ' 50' ' ' ILE . 6.6 p 178.64 177.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 48' ' ' LEU . 1.4 mttt -175.83 173.67 0.88 Allowed Pre-proline 0 N--CA 1.487 1.396 0 O-C-N 120.799 -1.188 . . . . 0.0 111.069 178.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.438 ' HG3' HG12 ' B' ' 79' ' ' VAL . 56.5 Cg_endo -94.96 142.69 1.32 Allowed 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 122.586 2.191 . . . . 0.0 109.407 177.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.49 ' HA3' ' O ' ' A' ' 46' ' ' GLY . . . -106.26 163.97 13.65 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.273 -1.931 . . . . 0.0 108.273 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.34 -24.79 57.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.071 -1.252 . . . . 0.0 110.624 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.416 ' HB2' ' HB3' ' A' ' 47' ' ' PHE . 3.5 m -55.29 -36.64 66.37 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.037 -1.039 . . . . 0.0 108.652 178.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.6 ' HG ' ' HA ' ' B' ' 33' ' ' THR . 0.5 OUTLIER -80.69 -30.78 36.38 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.757 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.435 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -77.32 -41.9 38.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.639 -0.663 . . . . 0.0 109.947 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.3 ttmt -64.15 -38.97 92.98 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.65 ' O ' ' HB3' ' B' ' 37' ' ' ALA . . . -66.18 -35.99 81.9 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 176.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.469 ' N ' ' HB2' ' B' ' 37' ' ' ALA . . . -56.65 -39.39 73.62 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.774 -0.77 . . . . 0.0 108.932 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.39 -33.05 65.39 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 176.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.473 ' C ' ' H ' ' A' ' 93' ' ' LYS . . . -60.21 -42.33 98.61 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 178.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.546 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 0.5 OUTLIER -65.2 6.01 0.31 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.729 -1.454 . . . . 0.0 110.822 179.649 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.546 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 3.1 mmtt 80.07 52.95 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 CA-C-O 122.052 0.929 . . . . 0.0 108.783 -179.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.646 ' CD2' ' HB ' ' B' ' 75' ' ' VAL . 4.5 t80 -42.28 -61.87 1.08 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 . . . . . 0 N--CA 1.499 2.016 0 O-C-N 120.878 -1.139 . . . . 0.0 110.305 179.011 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.438 ' HA ' ' CB ' ' B' ' 5' ' ' GLU . 9.6 mtp . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 120.869 0.366 . . . . 0.0 110.08 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 2' ' ' ASN . . . . . 0.444 ' O ' ' HB2' ' B' ' 6' ' ' LEU . 0.7 OUTLIER -172.44 -169.59 0.62 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.126 -0.984 . . . . 0.0 111.017 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.579 ' O ' ' CG2' ' B' ' 7' ' ' ILE . 0.0 OUTLIER -56.53 -10.85 1.06 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.308 -0.87 . . . . 0.0 110.098 179.61 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.664 ' O ' HG13 ' B' ' 7' ' ' ILE . 37.1 m -109.86 -56.68 2.29 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 122.162 0.982 . . . . 0.0 108.761 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.581 ' HA ' ' HE2' ' B' ' 8' ' ' LYS . 0.1 OUTLIER -49.4 -46.11 47.01 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.057 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.489 HD12 HG11 ' A' ' 42' ' ' VAL . 5.3 mt -64.45 -27.01 68.7 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.154 -1.019 . . . . 0.0 110.557 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' ILE . . . . . 0.664 HG13 ' O ' ' B' ' 4' ' ' THR . 1.2 pp -59.36 -41.68 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 120.37 -1.456 . . . . 0.0 107.306 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . 0.581 ' HE2' ' HA ' ' B' ' 5' ' ' GLU . 18.6 mtmt -67.36 -44.09 79.84 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 177.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.69 -32.11 50.52 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.646 -0.659 . . . . 0.0 109.863 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . 0.734 ' O ' ' OG1' ' B' ' 14' ' ' THR . 0.8 OUTLIER -94.4 -29.85 4.21 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.478 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 178.162 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.558 ' HB2' ' HA ' ' B' ' 8' ' ' LYS . . . -63.08 -28.53 70.14 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 177.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.436 ' HG3' ' O ' ' B' ' 8' ' ' LYS . 58.5 mt-30 -87.96 -43.85 11.45 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.428 ' HB3' ' OG ' ' A' ' 27' ' ' SER . 94.1 m-20 -64.16 -26.1 68.38 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 177.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.734 ' OG1' ' O ' ' B' ' 10' ' ' ILE . 20.6 p -87.74 -76.74 0.37 Allowed 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 177.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 61.32 10.99 25.1 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' LEU . . . . . 0.607 HD13 ' HB ' ' B' ' 14' ' ' THR . 3.1 mp -82.33 -67.16 0.81 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.525 -0.985 . . . . 0.0 109.204 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' THR . . . . . 0.538 ' CG2' HG21 ' A' ' 17' ' ' THR . 0.5 OUTLIER -137.52 6.39 2.74 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.787 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . 0.639 ' O ' ' C ' ' B' ' 19' ' ' VAL . 15.4 mt-30 57.97 25.88 12.75 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 -176.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.706 ' HB ' ' HB ' ' A' ' 19' ' ' VAL . 0.4 OUTLIER 4.17 -102.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.642 -179.099 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' SER . . . . . 0.967 ' O ' ' N ' ' B' ' 22' ' ' SER . 0.2 OUTLIER -135.2 24.09 3.52 Favored 'General case' 0 C--N 1.27 -2.853 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 177.33 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . 0.601 ' C ' ' O ' ' B' ' 20' ' ' SER . 35.2 m -12.4 -38.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-O 122.394 1.092 . . . . 0.0 110.469 -177.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.967 ' N ' ' O ' ' B' ' 20' ' ' SER . 12.1 t -80.14 -46.87 15.65 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.34 177.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . 0.939 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.1 OUTLIER -85.44 -24.1 27.59 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.855 -0.528 . . . . 0.0 110.085 178.624 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' MET . . . . . 0.536 ' HE2' ' HA ' ' B' ' 21' ' ' VAL . 3.5 tmm? -68.37 -45.1 73.71 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . 0.648 ' HA ' ' HB3' ' B' ' 28' ' ' PHE . 11.6 mt -71.0 -34.79 71.69 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 176.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . 0.456 ' HA ' ' HE3' ' B' ' 3' ' ' LYS . . . -62.29 -34.72 77.12 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 177.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' SER . . . . . 0.446 ' HB2' ' HB3' ' A' ' 13' ' ' ASP . 0.1 OUTLIER -76.38 -40.71 50.28 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 177.636 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . 0.648 ' HB3' ' HA ' ' B' ' 25' ' ' LEU . 0.1 OUTLIER -52.84 -45.94 67.57 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.163 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . 0.635 ' HG3' ' CE2' ' A' ' 47' ' ' PHE . 1.2 tt0 -68.58 -36.38 78.66 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 177.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . 1.252 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 13.4 ttmt -64.71 -22.74 67.05 Favored 'General case' 0 C--O 1.191 -1.989 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.596 HG13 ' O ' ' B' ' 28' ' ' PHE . 0.6 OUTLIER -105.83 -27.61 3.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 O-C-N 120.282 -1.511 . . . . 0.0 109.335 178.237 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.645 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.2 mm -73.18 -60.42 2.43 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 177.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' THR . . . . . 0.6 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 0.6 OUTLIER -68.75 -35.21 76.81 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.553 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 1.252 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 31.1 mm-40 -78.54 -37.78 42.06 Favored 'General case' 0 C--O 1.207 -1.184 0 O-C-N 121.115 -0.99 . . . . 0.0 111.952 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' THR . . . . . 0.514 ' CB ' ' O ' ' B' ' 31' ' ' ILE . 37.2 m -61.95 -49.99 73.92 Favored 'General case' 0 N--CA 1.504 2.246 0 CA-C-N 120.714 1.597 . . . . 0.0 109.201 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.515 HG11 ' HB3' ' B' ' 52' ' ' PRO . 2.1 t -52.83 -43.53 45.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 178.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . 0.65 ' HB3' ' O ' ' A' ' 88' ' ' ALA . . . -85.99 0.82 52.31 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.834 178.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . 0.735 ' HB2' ' O ' ' B' ' 34' ' ' GLU . 7.6 tppt? -96.05 -33.46 12.1 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 177.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 134.01 33.44 0.33 Allowed Glycine 0 C--N 1.303 -1.263 0 C-N-CA 119.581 -1.295 . . . . 0.0 111.482 177.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . 0.453 ' CB ' ' CG2' ' B' ' 35' ' ' THR . 0.1 OUTLIER -144.85 157.55 44.12 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.752 -1.44 . . . . 0.0 110.66 179.356 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -103.96 99.81 9.57 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.518 -0.739 . . . . 0.0 109.61 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 59.7 t -59.07 136.28 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.584 -0.698 . . . . 0.0 110.085 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -127.96 97.25 4.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.342 -0.849 . . . . 0.0 109.403 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.57 ' HB3' ' CE1' ' B' ' 47' ' ' PHE . 11.0 mt -69.1 101.6 1.47 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.249 -0.907 . . . . 0.0 110.442 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' THR . . . . . 0.689 HG21 ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 32.34 -95.1 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.036 0 O-C-N 122.052 -0.405 . . . . 0.0 111.451 179.277 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -144.41 30.71 1.85 Allowed Glycine 0 N--CA 1.487 2.037 0 C-N-CA 119.668 -1.253 . . . . 0.0 110.448 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . 0.623 ' O ' ' HA ' ' B' ' 81' ' ' PRO . 3.9 p90 -133.65 -18.6 2.15 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.893 -1.357 . . . . 0.0 111.686 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . 0.566 ' HG ' ' CE2' ' B' ' 47' ' ' PHE . 4.6 mt -135.47 120.25 18.43 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.337 -1.477 . . . . 0.0 111.196 178.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' ASN . . . . . 0.486 ' O ' ' HA ' ' B' ' 79' ' ' VAL . 2.6 m120 -116.95 94.56 4.64 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.506 -0.747 . . . . 0.0 111.208 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' ILE . . . . . 0.48 ' HA ' ' HA ' ' B' ' 79' ' ' VAL . 33.8 mm -90.19 141.91 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.305 -0.872 . . . . 0.0 109.739 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . 0.432 ' O ' ' N ' ' B' ' 78' ' ' SER . 2.3 pttt -162.44 128.63 2.35 Favored Pre-proline 0 N--CA 1.498 1.951 0 O-C-N 120.582 -1.324 . . . . 0.0 111.439 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' PRO . . . . . 0.515 ' HB3' HG11 ' B' ' 36' ' ' VAL . 52.5 Cg_endo -77.12 145.15 24.27 Favored 'Trans proline' 0 C--N 1.314 -1.24 0 O-C-N 123.531 1.28 . . . . 0.0 110.72 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.529 ' O ' ' N ' ' B' ' 76' ' ' GLY . 15.3 m -156.57 121.28 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-O 121.257 0.551 . . . . 0.0 109.962 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . 0.838 ' HA ' ' N ' ' B' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.12 -0.988 . . . . 0.0 111.561 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . 0.838 ' N ' ' HA ' ' B' ' 54' ' ' ALA . 0.9 OUTLIER . . . . . 0 N--CA 1.517 2.894 0 CA-C-O 121.908 0.861 . . . . 0.0 109.288 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 76' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' B' ' 53' ' ' VAL . . . -157.17 110.63 0.45 Allowed Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.535 HG22 ' CD2' ' A' ' 85' ' ' LEU . 2.7 p -67.93 89.42 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.395 -1.062 . . . . 0.0 111.31 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 78' ' ' SER . . . . . 0.432 ' N ' ' O ' ' B' ' 51' ' ' LYS . 0.3 OUTLIER -74.52 -176.38 2.72 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 177.343 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . 0.553 ' CG2' ' N ' ' B' ' 80' ' ' LYS . 0.2 OUTLIER 179.84 174.66 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.298 -0.876 . . . . 0.0 109.028 179.676 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 80' ' ' LYS . . . . . 0.553 ' N ' ' CG2' ' B' ' 79' ' ' VAL . 4.7 mttt 179.25 174.25 0.42 Allowed Pre-proline 0 C--N 1.307 -1.243 0 O-C-N 121.492 -0.755 . . . . 0.0 109.379 178.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 81' ' ' PRO . . . . . 0.623 ' HA ' ' O ' ' B' ' 47' ' ' PHE . 52.3 Cg_endo -95.68 171.57 1.22 Allowed 'Trans proline' 0 C--N 1.296 -2.206 0 C-N-CA 121.856 1.704 . . . . 0.0 109.567 177.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' B' ' 47' ' ' PHE . . . -120.5 -92.63 1.31 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 106.177 -2.769 . . . . 0.0 106.177 177.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . 0.877 ' O ' ' N ' ' B' ' 85' ' ' LEU . 29.2 tt0 -80.13 51.61 1.41 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 175.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 84' ' ' SER . . . . . 0.566 ' C ' ' O ' ' B' ' 83' ' ' GLU . 0.1 OUTLIER 8.27 44.15 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.007 179.586 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . 0.877 ' N ' ' O ' ' B' ' 83' ' ' GLU . 3.6 mp 20.18 28.93 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 103.104 -2.924 . . . . 0.0 103.104 -172.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 86' ' ' LYS . . . . . 0.556 ' HD2' ' HB2' ' B' ' 84' ' ' SER 0.349 4.0 tttp -57.94 -42.59 85.23 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 104.418 -2.438 . . . . 0.0 104.418 177.397 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . 0.417 ' O ' ' HG2' ' B' ' 90' ' ' GLU 0.282 15.8 tttt -69.2 -31.17 69.59 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 111.789 -2.459 . . . . 0.0 105.976 175.654 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 33' ' ' THR . . . -78.02 -27.04 48.8 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 118.19 -1.404 . . . . 0.0 107.917 178.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . 0.692 ' N ' ' O ' ' B' ' 85' ' ' LEU . . . -64.96 -48.7 73.1 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.294 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' B' ' 87' ' ' LYS . 4.0 pt-20 -59.24 -28.08 66.37 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 177.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . 0.411 ' N ' ' HG2' ' B' ' 90' ' ' GLU . . . -75.51 -24.49 70.34 Favored Glycine 0 N--CA 1.49 2.255 0 C-N-CA 120.462 -0.875 . . . . 0.0 111.137 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 92' ' ' LEU . . . . . 0.895 ' HB3' ' HA ' ' A' ' 37' ' ' ALA . 0.3 OUTLIER -88.05 23.92 1.96 Allowed 'General case' 0 N--CA 1.503 2.216 0 O-C-N 120.322 -1.693 . . . . 0.0 110.544 -179.738 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 93' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' B' ' 92' ' ' LEU . 1.2 mmmm 55.11 35.86 25.7 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 -177.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . 0.538 ' CD1' ' N ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -41.71 -43.62 2.92 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.794 -178.701 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . 0.443 ' HG2' ' N ' ' B' ' 96' ' ' ASP . 4.9 pm0 -53.81 -36.11 62.12 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.264 -0.897 . . . . 0.0 109.289 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 96' ' ' ASP . . . . . 0.443 ' N ' ' HG2' ' B' ' 95' ' ' GLU . 20.1 t70 -64.97 -34.35 78.23 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 177.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.491 ' HA ' ' CB ' ' A' ' 5' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . 0.435 ' C ' ' H ' ' A' ' 4' ' ' THR . 52.2 p-10 -171.66 -149.25 0.06 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.988 -1.07 . . . . 0.0 112.044 178.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.534 ' HD2' ' HB ' ' B' ' 45' ' ' THR . 3.8 tttm -51.32 -6.94 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.44 -0.788 . . . . 0.0 111.622 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.625 ' O ' HG13 ' A' ' 7' ' ' ILE . 48.7 m -118.13 -62.49 1.54 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.849 -1.157 . . . . 0.0 110.586 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.52 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 4.9 mt-10 -49.22 -42.02 39.08 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.071 -1.018 . . . . 0.0 109.167 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.464 ' CB ' HD21 ' A' ' 25' ' ' LEU . 21.0 mt -62.26 -32.51 73.22 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.111 -1.035 . . . . 0.0 109.556 178.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.625 HG13 ' O ' ' A' ' 4' ' ' THR . 1.0 OUTLIER -57.18 -43.95 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 178.292 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.592 ' N ' HG13 ' A' ' 7' ' ' ILE . 2.6 mtpt -63.56 -34.75 78.49 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.451 ' HB3' ' HA ' ' A' ' 6' ' ' LEU . . . -52.56 -40.12 62.21 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.807 -0.757 . . . . 0.0 109.155 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.748 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.5 mp -91.15 -32.1 5.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 178.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.545 ' HB3' ' O ' ' A' ' 7' ' ' ILE . . . -66.79 -13.06 61.05 Favored 'General case' 0 C--N 1.292 -1.918 0 O-C-N 120.756 -1.215 . . . . 0.0 108.923 178.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.444 ' N ' ' O ' ' A' ' 8' ' ' LYS . 11.5 pt20 -114.58 -39.98 3.68 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.45 -0.781 . . . . 0.0 109.656 179.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 9' ' ' ALA . 1.0 OUTLIER -73.95 -20.29 60.41 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 176.887 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.748 ' OG1' ' O ' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -119.14 -83.99 0.65 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 179.232 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.539 ' O ' ' C ' ' A' ' 16' ' ' LEU . . . 68.6 -21.17 0.34 Allowed Glycine 0 N--CA 1.495 2.588 0 O-C-N 120.957 -1.09 . . . . 0.0 110.843 178.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.778 HD12 HG21 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -28.77 -59.68 0.13 Allowed 'General case' 0 N--CA 1.518 2.973 0 CA-C-O 122.004 0.906 . . . . 0.0 110.266 -179.166 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.485 HG21 ' CG2' ' B' ' 17' ' ' THR . 0.6 OUTLIER -130.23 -7.28 4.3 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.564 -179.932 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.566 ' O ' ' C ' ' A' ' 19' ' ' VAL . 23.6 mt-30 57.25 36.86 27.88 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -177.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.691 ' HB ' ' HB ' ' B' ' 19' ' ' VAL . 1.0 OUTLIER -19.62 -93.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.872 -178.974 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.935 ' O ' ' N ' ' A' ' 22' ' ' SER . 0.4 OUTLIER -134.39 25.03 3.8 Favored 'General case' 0 C--N 1.278 -2.506 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 177.946 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.669 ' C ' ' O ' ' A' ' 20' ' ' SER . 27.3 m -16.34 -38.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 122.684 1.23 . . . . 0.0 109.466 -178.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.935 ' N ' ' O ' ' A' ' 20' ' ' SER . 32.2 p -84.55 -39.31 18.93 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 114.66 -1.154 . . . . 0.0 110.38 178.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.926 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.3 OUTLIER -89.69 -25.38 21.25 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 121.245 -0.91 . . . . 0.0 110.613 179.593 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.555 ' HB3' ' CG2' ' B' ' 14' ' ' THR . 0.0 OUTLIER -81.01 -35.02 32.47 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.25 -1.531 . . . . 0.0 109.361 178.9 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.626 ' C ' ' CD1' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -80.75 -40.99 24.27 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 117.875 -1.53 . . . . 0.0 107.141 177.819 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.502 ' CB ' ' O ' ' A' ' 22' ' ' SER . . . -60.55 -25.74 66.38 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 176.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.488 ' O ' ' N ' ' A' ' 31' ' ' ILE . 7.0 t -83.42 -37.9 22.62 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.729 ' HA ' ' CG1' ' A' ' 31' ' ' ILE . 0.1 OUTLIER -60.11 -33.04 71.56 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.486 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.64 ' HG3' ' CD1' ' A' ' 28' ' ' PHE . 29.6 mt-10 -80.06 -33.89 38.61 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 177.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.85 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 6.6 tttm -69.46 -28.0 65.72 Favored 'General case' 0 C--O 1.195 -1.799 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 177.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.729 ' CG1' ' HA ' ' A' ' 28' ' ' PHE . 1.1 pp -96.98 -30.3 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.217 -0.927 . . . . 0.0 109.728 179.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.708 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.6 mm -65.09 -53.98 34.68 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 177.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.46 ' HA ' ' CD2' ' B' ' 85' ' ' LEU . 0.4 OUTLIER -69.09 -37.3 78.35 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.162 -1.015 . . . . 0.0 108.464 179.591 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.85 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 15.5 mm-40 -73.17 -38.41 66.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.431 -0.793 . . . . 0.0 111.25 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.539 ' N ' ' O ' ' A' ' 31' ' ' ILE . 19.4 m -58.13 -48.49 80.08 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.697 -1.252 . . . . 0.0 108.097 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.427 ' HB ' ' CD2' ' B' ' 85' ' ' LEU . 2.8 t -55.84 -36.79 44.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 106.652 -1.611 . . . . 0.0 106.652 177.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.694 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -80.29 -4.01 51.63 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -101.81 -32.58 10.19 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.583 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.72 34.57 0.79 Allowed Glycine 0 C--N 1.302 -1.33 0 C-N-CA 119.682 -1.247 . . . . 0.0 111.472 177.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.466 ' CB ' ' CG2' ' A' ' 35' ' ' THR . 0.4 OUTLIER -135.8 144.0 45.5 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.856 -1.379 . . . . 0.0 110.552 179.262 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.45 ' HG2' ' HB2' ' A' ' 51' ' ' LYS . 49.0 mtmt -91.67 92.4 8.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.517 -0.739 . . . . 0.0 109.978 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.462 ' HA ' ' HB2' ' B' ' 1' ' ' MET . 35.4 m -63.05 147.29 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.533 -0.73 . . . . 0.0 110.413 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.457 ' O ' ' HA ' ' B' ' 2' ' ' ASN . 31.9 mt-30 -142.74 171.41 14.08 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.308 -0.87 . . . . 0.0 110.49 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.786 HD12 ' HB2' ' A' ' 48' ' ' LEU . 21.3 mt -131.47 -177.99 4.66 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.512 -0.743 . . . . 0.0 109.781 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.847 HG22 ' HG2' ' B' ' 29' ' ' GLU . 2.8 t -43.25 66.23 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.88 -0.512 . . . . 0.0 112.098 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.78 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . 46.98 23.03 1.39 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.676 ' HA ' ' HA2' ' A' ' 82' ' ' GLY . 0.7 OUTLIER -117.61 -37.83 3.4 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 121.014 -1.286 . . . . 0.0 109.522 179.39 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.786 ' HB2' HD12 ' A' ' 44' ' ' LEU . 6.9 mt -120.6 118.86 31.25 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.442 -1.411 . . . . 0.0 111.095 177.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.564 ' H ' ' HB2' ' A' ' 80' ' ' LYS . 32.6 t-20 -116.9 85.64 2.36 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.766 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.425 ' HB ' ' CG2' ' A' ' 42' ' ' VAL . 40.1 mm -86.12 126.07 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.444 -0.785 . . . . 0.0 110.473 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.45 ' HB2' ' HG2' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -147.48 130.69 8.09 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.353 -0.842 . . . . 0.0 109.441 179.307 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.488 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 53.7 Cg_endo -78.18 142.09 18.97 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 123.57 1.3 . . . . 0.0 112.467 -178.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.542 ' O ' ' N ' ' A' ' 76' ' ' GLY . 33.7 m -134.72 109.64 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 CA-C-O 121.696 0.76 . . . . 0.0 110.92 178.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.767 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.504 2.232 0 O-C-N 121.43 -0.794 . . . . 0.0 111.471 -179.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.767 ' HA ' ' HA ' ' A' ' 54' ' ' ALA . 0.8 OUTLIER . . . . . 0 N--CA 1.477 0.898 0 CA-C-O 122.043 0.925 . . . . 0.0 109.733 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.544 ' O ' ' N ' ' A' ' 78' ' ' SER . . . -114.24 86.22 0.41 Allowed Glycine 0 C--N 1.289 -2.067 0 N-CA-C 108.886 -1.685 . . . . 0.0 108.886 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.488 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 3.8 p -45.21 87.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 CA-C-O 121.766 0.793 . . . . 0.0 110.792 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.544 ' N ' ' O ' ' A' ' 76' ' ' GLY . 0.1 OUTLIER -59.37 -162.35 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.122 179.8 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.499 ' CG1' ' HD3' ' B' ' 81' ' ' PRO . 5.4 p 179.93 178.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.564 ' HB2' ' H ' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -139.76 177.69 1.92 Allowed Pre-proline 0 C--N 1.305 -1.331 0 O-C-N 120.896 -1.127 . . . . 0.0 110.455 179.051 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.421 ' CD ' ' CB ' ' A' ' 80' ' ' LYS . 56.4 Cg_endo -106.69 84.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.298 -2.095 0 C-N-CA 124.074 3.183 . . . . 0.0 108.592 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.676 ' HA2' ' HA ' ' A' ' 47' ' ' PHE . . . -55.73 100.72 0.1 Allowed Glycine 0 N--CA 1.483 1.779 0 C-N-CA 118.698 -1.715 . . . . 0.0 110.955 -177.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -57.35 -29.01 63.64 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.453 ' O ' ' HB1' ' A' ' 88' ' ' ALA . 0.3 OUTLIER -61.88 -32.76 73.15 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 177.3 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.479 ' HB3' ' O ' ' A' ' 82' ' ' GLY . 1.9 tt -81.69 -39.45 24.28 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 177.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.422 ' CD ' ' HA2' ' B' ' 76' ' ' GLY . 0.3 OUTLIER -69.78 -45.93 66.9 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.614 0.721 . . . . 0.0 109.53 179.301 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.69 -37.55 87.78 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.662 ' O ' ' HB2' ' B' ' 37' ' ' ALA . . . -66.28 -36.89 84.13 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 176.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.659 ' HB1' ' CG1' ' B' ' 75' ' ' VAL . . . -57.77 -31.6 66.68 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.647 ' HA ' ' CD1' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -65.2 -31.33 72.45 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 177.096 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.482 ' N ' ' HG3' ' A' ' 90' ' ' GLU . . . -66.01 -31.85 80.73 Favored Glycine 0 N--CA 1.484 1.869 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 178.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.553 ' HB3' ' HA ' ' B' ' 37' ' ' ALA . 1.0 OUTLIER -58.19 -43.39 87.52 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 120.723 -1.457 . . . . 0.0 111.386 -179.253 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.524 ' H ' ' HG ' ' A' ' 92' ' ' LEU . 0.0 OUTLIER 164.82 46.11 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -179.651 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.647 ' CD1' ' HA ' ' A' ' 90' ' ' GLU . 2.2 t80 -40.29 -73.29 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -178.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.197 -0.939 . . . . 0.0 110.256 -178.408 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.547 ' HA ' ' CB ' ' B' ' 5' ' ' GLU . 10.0 mtp . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 2' ' ' ASN . . . . . 0.457 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 10.2 p30 -170.86 -156.63 0.12 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.971 -1.081 . . . . 0.0 112.191 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.514 ' HE2' ' HA ' ' B' ' 26' ' ' ALA . 0.3 OUTLIER -57.07 -4.69 0.2 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.61 -0.681 . . . . 0.0 111.26 -179.282 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.636 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 93.9 m -124.08 -42.15 2.16 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.935 -1.103 . . . . 0.0 109.743 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.547 ' CB ' ' HA ' ' B' ' 1' ' ' MET . 0.0 OUTLIER -63.68 -53.49 50.54 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.134 -0.979 . . . . 0.0 108.709 179.087 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.545 ' HG ' ' HB3' ' B' ' 1' ' ' MET . 14.8 mt -60.0 -29.78 68.7 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.335 -0.946 . . . . 0.0 108.964 178.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 7' ' ' ILE . . . . . 0.636 ' HB ' ' O ' ' B' ' 4' ' ' THR . 1.1 mt -54.65 -55.73 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . 0.53 ' HE2' ' HA ' ' B' ' 5' ' ' GLU . 14.6 mtmt -56.57 -34.24 66.94 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 177.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . 0.498 ' HB3' ' HA ' ' B' ' 6' ' ' LEU . . . -53.22 -38.63 63.08 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.585 -0.846 . . . . 0.0 109.259 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . 0.793 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.4 mp -92.7 -31.15 4.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 177.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.408 ' HB2' ' HA ' ' B' ' 8' ' ' LYS . . . -68.92 -6.48 27.71 Favored 'General case' 0 C--N 1.29 -2.0 0 C-N-CA 118.38 -1.328 . . . . 0.0 108.645 178.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.42 ' CG ' ' N ' ' B' ' 13' ' ' ASP . 12.7 pt20 -122.45 -40.13 2.5 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.324 -0.86 . . . . 0.0 110.13 179.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' B' ' 9' ' ' ALA . 1.0 OUTLIER -70.76 -30.04 66.43 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 177.22 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.793 ' OG1' ' O ' ' B' ' 10' ' ' ILE 0.271 0.2 OUTLIER -101.62 -75.59 0.59 Allowed 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.286 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.91 14.37 51.93 Favored Glycine 0 N--CA 1.499 2.868 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 177.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 16' ' ' LEU . . . . . 0.697 ' CD1' ' CG2' ' B' ' 14' ' ' THR . 4.7 mp -53.02 -64.99 0.64 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.557 -0.966 . . . . 0.0 110.005 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 17' ' ' THR . . . . . 0.595 HG21 ' O ' ' B' ' 17' ' ' THR . 0.5 OUTLIER -141.92 9.47 1.94 Allowed 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.696 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . 0.638 ' O ' ' C ' ' B' ' 19' ' ' VAL . 14.6 mt-30 57.95 27.48 14.79 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -175.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.778 HG21 HD12 ' A' ' 16' ' ' LEU . 1.2 p -2.13 -96.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.988 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 20' ' ' SER . . . . . 0.971 ' O ' ' N ' ' B' ' 22' ' ' SER . 0.8 OUTLIER -134.09 23.74 3.86 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 177.496 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . 0.657 ' HA ' ' SD ' ' B' ' 24' ' ' MET . 28.6 m -9.93 -40.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 CA-C-O 122.415 1.102 . . . . 0.0 110.857 -178.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.971 ' N ' ' O ' ' B' ' 20' ' ' SER . 7.1 m -77.92 -39.68 42.1 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.264 178.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . 0.91 ' N ' ' O ' ' B' ' 20' ' ' SER . 1.3 mtmt -89.47 -25.71 21.32 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.478 -0.764 . . . . 0.0 111.113 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' MET . . . . . 0.657 ' SD ' ' HA ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -74.79 -40.59 61.05 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 117.529 -1.668 . . . . 0.0 108.795 179.225 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . 0.541 ' HA ' ' HB3' ' B' ' 28' ' ' PHE . 0.5 OUTLIER -74.15 -40.47 62.58 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 117.708 -1.597 . . . . 0.0 107.291 176.804 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . 0.514 ' HA ' ' HE2' ' B' ' 3' ' ' LYS . . . -60.15 -33.38 72.09 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 177.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' SER . . . . . 0.612 ' HA ' ' HB3' ' B' ' 30' ' ' LYS . 18.6 m -78.63 -34.1 46.81 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . 0.836 ' O ' HG13 ' B' ' 31' ' ' ILE . 0.3 OUTLIER -60.72 -49.17 78.6 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.768 -0.582 . . . . 0.0 109.689 179.413 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . 0.847 ' HG2' HG22 ' A' ' 45' ' ' THR . 0.6 OUTLIER -71.89 -33.49 68.38 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 178.043 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . 0.915 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 10.8 ttpp -68.59 -21.02 64.53 Favored 'General case' 0 C--O 1.189 -2.085 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 176.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.836 HG13 ' O ' ' B' ' 28' ' ' PHE . 1.2 pp -105.15 -28.8 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 120.557 -1.339 . . . . 0.0 109.198 178.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.628 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.6 mm -69.64 -50.97 45.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 176.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' THR . . . . . 0.707 ' HB ' ' O ' ' B' ' 29' ' ' GLU . 0.3 OUTLIER -70.33 -40.21 74.29 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.46 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.915 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 39.4 mm-40 -73.91 -33.03 63.83 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.419 -0.801 . . . . 0.0 111.163 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 35' ' ' THR . . . . . 0.559 ' N ' ' O ' ' B' ' 31' ' ' ILE . 1.6 m -59.27 -48.75 80.45 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 120.53 -1.356 . . . . 0.0 107.531 178.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.492 HG11 ' HG3' ' B' ' 52' ' ' PRO . 1.2 t -56.12 -35.1 40.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 177.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . 0.662 ' HB2' ' O ' ' A' ' 88' ' ' ALA . . . -77.59 -1.35 30.32 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.534 0.683 . . . . 0.0 109.216 176.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . 0.518 ' N ' ' O ' ' B' ' 35' ' ' THR . 0.4 OUTLIER -115.68 -5.4 12.14 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.737 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.44 48.14 8.35 Favored Glycine 0 C--N 1.301 -1.378 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . 0.48 ' CB ' HG21 ' B' ' 35' ' ' THR . 0.1 OUTLIER -128.05 117.79 22.32 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.173 -1.192 . . . . 0.0 110.07 179.273 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 12.9 mtmt -70.51 80.82 0.57 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.492 -0.755 . . . . 0.0 109.954 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . 0.636 ' HB ' ' HB ' ' B' ' 50' ' ' ILE . 2.7 t -68.29 147.4 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.314 -0.866 . . . . 0.0 109.257 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 43' ' ' GLN . . . . . 0.435 ' O ' ' HA ' ' A' ' 2' ' ' ASN . 31.0 mt-30 -143.4 113.51 7.25 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.067 -1.021 . . . . 0.0 110.705 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.526 HD11 ' CB ' ' B' ' 48' ' ' LEU . 45.9 mt -73.98 120.11 19.11 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.271 -0.893 . . . . 0.0 109.939 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 45' ' ' THR . . . . . 0.539 HG22 ' CG ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 31.68 -96.19 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.757 -0.589 . . . . 0.0 110.583 179.793 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . 0.444 ' H ' HG21 ' B' ' 45' ' ' THR . . . -138.79 7.54 3.29 Favored Glycine 0 N--CA 1.482 1.732 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . 0.603 ' CE1' ' HB2' ' B' ' 48' ' ' LEU . 37.4 p90 -105.46 -54.99 2.39 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.588 -1.536 . . . . 0.0 111.76 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . 0.603 ' HB2' ' CE1' ' B' ' 47' ' ' PHE . 0.2 OUTLIER -92.12 148.03 22.49 Favored 'General case' 0 C--N 1.292 -1.903 0 O-C-N 120.047 -1.658 . . . . 0.0 113.241 -178.849 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 49' ' ' ASN . . . . . 0.477 ' O ' ' HB ' ' B' ' 79' ' ' VAL . 1.4 m-20 -132.82 146.22 51.64 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 178.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 50' ' ' ILE . . . . . 0.842 ' HA ' HG23 ' B' ' 79' ' ' VAL . 26.8 mm -137.21 98.76 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 O-C-N 120.97 -1.081 . . . . 0.0 111.601 -178.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . 0.534 ' N ' ' CG1' ' B' ' 79' ' ' VAL . 2.5 pttt -145.56 126.29 7.34 Favored Pre-proline 0 N--CA 1.487 1.415 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 52' ' ' PRO . . . . . 0.492 ' HG3' HG11 ' B' ' 36' ' ' VAL . 55.6 Cg_endo -88.08 151.21 6.96 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.239 1.126 . . . . 0.0 111.849 -178.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.518 ' O ' ' N ' ' B' ' 76' ' ' GLY . 14.0 m -133.14 118.64 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-O 121.506 0.67 . . . . 0.0 109.838 178.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . 0.852 ' HA ' ' HA ' ' B' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 122.694 1.235 . . . . 0.0 112.899 -177.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . 0.852 ' HA ' ' HA ' ' B' ' 54' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.519 2.989 0 CA-C-O 122.064 0.935 . . . . 0.0 111.248 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 76' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' B' ' 53' ' ' VAL . . . -140.64 -144.9 4.53 Favored Glycine 0 N--CA 1.483 1.772 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 7.6 t -140.9 85.64 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.93 -50.58 72.88 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.53 0.681 . . . . 0.0 111.279 -179.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . 0.842 HG23 ' HA ' ' B' ' 50' ' ' ILE . 17.7 m -51.54 -176.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -176.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 80' ' ' LYS . . . . . 0.722 ' HB2' ' HD2' ' B' ' 81' ' ' PRO . 0.0 OUTLIER 178.87 177.26 0.3 Allowed Pre-proline 0 N--CA 1.484 1.251 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.033 -178.727 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 81' ' ' PRO . . . . . 0.722 ' HD2' ' HB2' ' B' ' 80' ' ' LYS . 45.1 Cg_endo -72.54 137.61 28.12 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 123.508 1.268 . . . . 0.0 110.926 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . 0.576 ' N ' ' O ' ' B' ' 47' ' ' PHE . . . -94.92 -154.6 31.02 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . 0.447 ' O ' ' N ' ' B' ' 87' ' ' LYS . 16.4 pt-20 -88.05 -16.73 32.81 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.369 -1.077 . . . . 0.0 110.739 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 84' ' ' SER . . . . . 0.443 ' CB ' ' HB3' ' B' ' 47' ' ' PHE . 3.4 m -53.6 -37.14 62.72 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.067 -1.021 . . . . 0.0 109.51 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . 0.475 HD13 ' CD1' ' B' ' 47' ' ' PHE . 0.5 OUTLIER -81.67 -33.26 31.37 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.717 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 86' ' ' LYS . . . . . 0.53 ' O ' ' HB2' ' B' ' 89' ' ' ALA . 7.5 mttt -74.43 -27.46 60.62 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.382 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . 0.447 ' N ' ' O ' ' B' ' 83' ' ' GLU . 1.3 ttmm -74.7 -39.16 62.11 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 177.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.592 ' O ' ' CB ' ' A' ' 37' ' ' ALA . . . -64.8 -35.19 80.3 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 176.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . 0.53 ' HB2' ' O ' ' B' ' 86' ' ' LYS . . . -54.48 -45.43 73.21 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.454 -0.898 . . . . 0.0 109.19 178.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.9 -31.85 51.36 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 177.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' B' ' 88' ' ' ALA . . . -63.38 -38.65 96.73 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 178.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 92' ' ' LEU . . . . . 0.694 ' HB3' ' HA ' ' A' ' 37' ' ' ALA . 0.7 OUTLIER -75.46 15.17 0.49 Allowed 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.523 -1.575 . . . . 0.0 110.957 -179.823 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 93' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' B' ' 92' ' ' LEU . 22.3 mmtm 57.82 44.57 19.97 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 -177.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . 0.713 ' CD1' ' C ' ' B' ' 94' ' ' TYR . 0.1 OUTLIER -36.91 -36.37 0.12 Allowed 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.314 -178.829 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . 0.519 ' N ' ' CD1' ' B' ' 94' ' ' TYR . 8.8 pt-20 -57.25 -43.52 83.05 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.327 -0.858 . . . . 0.0 109.42 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 96' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' B' ' 93' ' ' LYS . 0.9 OUTLIER -61.81 -31.58 71.83 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 177.971 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.474 ' CB ' ' HB3' ' A' ' 5' ' ' GLU . 3.5 ptm . . . . . 0 N--CA 1.496 1.857 0 CA-C-O 121.282 0.563 . . . . 0.0 110.732 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . 0.45 ' O ' ' HB2' ' A' ' 6' ' ' LEU . 16.7 p-10 -177.17 -153.99 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 119.727 -0.789 . . . . 0.0 111.248 178.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.534 ' HE2' ' HA ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -52.41 -7.98 0.07 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.401 -0.812 . . . . 0.0 111.143 -179.812 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.585 ' O ' HG13 ' A' ' 7' ' ' ILE . 87.4 m -114.54 -64.26 1.34 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.17 -0.956 . . . . 0.0 109.903 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.536 ' HA ' ' CE ' ' A' ' 8' ' ' LYS . 0.4 OUTLIER -49.11 -41.01 34.43 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.915 -1.115 . . . . 0.0 109.096 179.577 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.45 ' HB2' ' O ' ' A' ' 2' ' ' ASN . 28.2 mt -61.52 -35.05 76.62 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.335 -0.946 . . . . 0.0 109.621 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.624 HG13 ' N ' ' A' ' 8' ' ' LYS . 1.1 pp -57.2 -38.74 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 178.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.624 ' N ' HG13 ' A' ' 7' ' ' ILE . 1.3 mtmp? -65.79 -40.11 91.6 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 177.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' A' ' 13' ' ' ASP . . . -51.61 -37.34 49.59 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.768 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.3 mp -91.98 -30.85 4.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 178.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.559 ' HB1' ' O ' ' A' ' 7' ' ' ILE . . . -66.25 -9.57 33.72 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 118.575 -1.25 . . . . 0.0 108.497 178.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.435 ' CG ' ' N ' ' A' ' 13' ' ' ASP . 17.2 pt20 -119.59 -42.22 2.65 Favored 'General case' 0 N--CA 1.483 1.185 0 O-C-N 121.413 -0.805 . . . . 0.0 110.41 179.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.447 ' HB2' ' O ' ' A' ' 9' ' ' ALA . 6.6 m-20 -69.53 -33.73 73.21 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 177.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.768 ' OG1' ' O ' ' A' ' 10' ' ' ILE 0.273 0.2 OUTLIER -95.14 -71.41 0.67 Allowed 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.479 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 57.37 18.52 29.54 Favored Glycine 0 N--CA 1.5 2.91 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 177.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.687 ' CD1' ' CG2' ' A' ' 14' ' ' THR . 4.4 mp -63.82 -68.17 0.37 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.425 -1.044 . . . . 0.0 109.815 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.537 ' O ' HG23 ' A' ' 17' ' ' THR . 0.6 OUTLIER -135.07 7.48 3.42 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.592 ' O ' ' C ' ' A' ' 19' ' ' VAL . 15.0 mt-30 57.88 26.92 13.89 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 -176.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.691 ' HB ' ' HB ' ' B' ' 19' ' ' VAL . 0.3 OUTLIER -5.92 -97.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.184 -179.128 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.98 ' O ' ' N ' ' A' ' 23' ' ' LYS . 1.7 p -135.63 25.01 3.42 Favored 'General case' 0 C--N 1.275 -2.653 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 178.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.571 ' C ' ' O ' ' A' ' 20' ' ' SER . 27.4 m -19.15 -38.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 CA-C-O 122.284 1.04 . . . . 0.0 110.435 -178.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.803 ' N ' ' O ' ' A' ' 20' ' ' SER . 25.4 p -79.3 -36.26 39.92 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.16 178.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.98 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.2 OUTLIER -91.82 -32.65 15.27 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.779 -0.576 . . . . 0.0 111.642 179.811 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.635 ' N ' ' OG ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -72.8 -30.31 63.97 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 117.764 -1.574 . . . . 0.0 108.061 179.385 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.5 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 2.2 mt -82.01 -37.58 26.36 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 118.741 -1.184 . . . . 0.0 107.895 177.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.534 ' HA ' ' HE2' ' A' ' 3' ' ' LYS . . . -67.6 -34.04 76.21 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 177.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 31' ' ' ILE . 61.1 p -82.56 -30.51 29.62 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.658 ' O ' HG13 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -52.48 -45.61 66.22 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.335 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.714 ' HG3' ' CD1' ' B' ' 47' ' ' PHE . 0.5 OUTLIER -69.62 -36.58 76.27 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 176.856 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 1.108 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 13.1 tttt -62.26 -23.42 66.68 Favored 'General case' 0 C--O 1.19 -2.058 0 C-N-CA 119.275 -0.97 . . . . 0.0 108.434 178.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.658 HG13 ' O ' ' A' ' 28' ' ' PHE . 0.5 OUTLIER -103.61 -28.39 3.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 120.589 -1.319 . . . . 0.0 109.202 178.141 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.636 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.2 mm -72.56 -56.15 10.79 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 177.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.455 ' HB ' ' O ' ' A' ' 29' ' ' GLU . 0.4 OUTLIER -69.67 -36.45 76.03 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.4 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 1.108 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 44.5 mm-40 -74.31 -35.46 63.68 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.084 -1.01 . . . . 0.0 110.696 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.475 HG21 ' CB ' ' A' ' 40' ' ' ASP . 2.2 m -58.58 -51.51 69.57 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.63 -1.294 . . . . 0.0 108.248 178.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -54.11 -35.71 29.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 177.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.645 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -82.23 -4.2 56.63 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.629 0.728 . . . . 0.0 109.416 178.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -101.07 -26.39 13.71 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.087 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.84 39.23 1.6 Allowed Glycine 0 C--N 1.301 -1.4 0 C-N-CA 120.092 -1.052 . . . . 0.0 110.906 177.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.475 ' CB ' HG21 ' A' ' 35' ' ' THR . 0.1 OUTLIER -132.47 134.23 44.8 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.067 -1.255 . . . . 0.0 110.274 179.384 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.87 92.24 6.09 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.584 -0.697 . . . . 0.0 109.887 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.2 t -59.29 132.97 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.589 -0.694 . . . . 0.0 109.868 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.405 ' O ' ' HA ' ' B' ' 2' ' ' ASN . 6.4 mt-30 -129.7 89.21 2.79 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.335 -0.853 . . . . 0.0 110.178 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.514 ' O ' ' N ' ' A' ' 46' ' ' GLY . 10.7 mt -59.92 107.6 0.64 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.295 -0.878 . . . . 0.0 109.516 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.457 ' CG2' ' C ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER 34.11 -90.67 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.308 0 O-C-N 122.0 -0.438 . . . . 0.0 110.953 -179.457 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -151.01 28.32 1.01 Allowed Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.713 ' CD2' ' HG3' ' B' ' 29' ' ' GLU . 1.6 p90 -129.98 -26.3 2.42 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.17 -1.194 . . . . 0.0 111.922 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.648 ' HG ' ' CE1' ' A' ' 47' ' ' PHE . 4.6 mt -128.95 96.02 4.24 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.568 -1.332 . . . . 0.0 110.867 178.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -102.05 86.35 2.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.66 -0.65 . . . . 0.0 110.576 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.482 ' CD1' ' CG2' ' A' ' 79' ' ' VAL . 6.9 mm -73.22 131.9 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.7 ptmt -145.52 113.99 4.76 Favored Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 120.613 -1.304 . . . . 0.0 111.129 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.624 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 54.7 Cg_endo -78.48 143.81 19.63 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 O-C-N 123.638 1.336 . . . . 0.0 111.135 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.534 ' O ' ' N ' ' A' ' 76' ' ' GLY . 24.2 m -142.33 116.86 4.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-O 121.582 0.706 . . . . 0.0 110.395 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.449 ' HA ' HG21 ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.499 1.995 0 CA-C-O 121.917 0.865 . . . . 0.0 112.404 -178.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.608 ' HB ' ' HB2' ' B' ' 94' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.501 2.097 0 CA-C-O 121.202 0.525 . . . . 0.0 110.059 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.565 ' O ' ' N ' ' A' ' 78' ' ' SER . . . -101.85 77.83 0.36 Allowed Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.624 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 4.4 p -59.54 74.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.576 -0.955 . . . . 0.0 110.3 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.565 ' N ' ' O ' ' A' ' 76' ' ' GLY . 0.6 OUTLIER -67.68 177.34 2.07 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.524 -0.87 . . . . 0.0 109.824 179.585 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.51 ' CG2' ' N ' ' A' ' 80' ' ' LYS . 0.8 OUTLIER 176.62 175.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -179.82 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.51 ' N ' ' CG2' ' A' ' 79' ' ' VAL . 2.3 ptpt -177.18 172.23 0.83 Allowed Pre-proline 0 N--CA 1.486 1.362 0 O-C-N 121.161 -0.962 . . . . 0.0 110.176 177.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -98.77 133.38 0.25 Allowed 'Trans proline' 0 C--N 1.302 -1.901 0 C-N-CA 122.542 2.161 . . . . 0.0 110.489 178.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.534 ' HA3' ' HA ' ' A' ' 47' ' ' PHE . . . -92.09 177.78 40.0 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 108.382 -1.887 . . . . 0.0 108.382 178.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.89 -18.25 64.73 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.115 -1.226 . . . . 0.0 110.676 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.427 ' CB ' ' HB3' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -51.92 -39.89 59.87 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.119 -0.988 . . . . 0.0 109.401 179.8 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.516 ' HG ' ' HB2' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -75.66 -34.32 60.48 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.744 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.468 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 0.8 OUTLIER -72.94 -43.82 61.9 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.961 -179.257 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -61.46 -40.82 95.89 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 178.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.759 ' O ' ' HB2' ' B' ' 37' ' ' ALA . . . -66.68 -36.24 82.05 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 176.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.581 ' HA ' ' CB ' ' B' ' 37' ' ' ALA . . . -58.56 -34.36 70.96 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -55.98 -34.54 65.84 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 176.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.432 ' C ' ' H ' ' A' ' 93' ' ' LYS . . . -61.54 -44.54 97.85 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 178.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.556 ' CB ' ' O ' ' B' ' 37' ' ' ALA . 0.6 OUTLIER -58.07 -2.59 0.18 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.707 -1.467 . . . . 0.0 111.212 179.699 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 6.7 mmmt 68.1 58.97 0.45 Allowed 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -177.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.401 ' C ' ' O ' ' A' ' 93' ' ' LYS . 23.5 t80 -37.41 -33.97 0.08 Allowed 'General case' 0 N--CA 1.494 1.775 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.21 -179.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 . . . . . 0 N--CA 1.494 1.748 0 O-C-N 121.155 -0.966 . . . . 0.0 109.083 179.208 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.592 ' HG2' ' HB3' ' B' ' 5' ' ' GLU . 24.2 mtp . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 2' ' ' ASN . . . . . 0.553 ' O ' ' HB2' ' B' ' 6' ' ' LEU . 19.5 p-10 -175.4 -162.63 0.11 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.167 -0.958 . . . . 0.0 111.299 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.515 ' O ' ' CG2' ' B' ' 7' ' ' ILE . 0.0 OUTLIER -57.1 -3.52 0.14 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.423 -0.798 . . . . 0.0 110.885 -179.888 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.655 ' O ' HG13 ' B' ' 7' ' ' ILE . 96.8 m -117.93 -60.71 1.77 Allowed 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 122.167 0.984 . . . . 0.0 109.101 179.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.592 ' HB3' ' HG2' ' B' ' 1' ' ' MET . 0.4 OUTLIER -52.04 -44.74 64.37 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.098 -1.001 . . . . 0.0 109.013 179.27 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.553 ' HB2' ' O ' ' B' ' 2' ' ' ASN . 1.9 mt -61.18 -32.1 71.84 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.191 -1.004 . . . . 0.0 109.966 178.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 7' ' ' ILE . . . . . 0.655 HG13 ' O ' ' B' ' 4' ' ' THR . 0.9 OUTLIER -57.7 -40.79 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 179.1 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . 0.566 ' N ' HG13 ' B' ' 7' ' ' ILE . 1.0 OUTLIER -64.87 -37.79 88.81 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 177.484 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.33 -38.3 58.22 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 120.15 -0.62 . . . . 0.0 109.618 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . 0.736 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.3 mp -93.73 -29.19 4.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 178.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.562 ' HB2' ' O ' ' B' ' 7' ' ' ILE . . . -66.8 -16.25 64.14 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.815 -1.178 . . . . 0.0 108.329 178.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.431 ' CG ' ' N ' ' B' ' 13' ' ' ASP . 17.7 pt20 -108.62 -41.91 4.67 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.515 -0.741 . . . . 0.0 109.098 178.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.431 ' N ' ' CG ' ' B' ' 12' ' ' GLN . 1.1 m-20 -68.78 -22.55 64.27 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 176.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.736 ' OG1' ' O ' ' B' ' 10' ' ' ILE . 0.2 OUTLIER -120.32 -83.14 0.65 Allowed 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.363 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . 0.511 ' O ' ' C ' ' B' ' 16' ' ' LEU . . . 69.36 -21.01 0.42 Allowed Glycine 0 N--CA 1.498 2.779 0 O-C-N 120.924 -1.11 . . . . 0.0 110.65 178.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 16' ' ' LEU . . . . . 0.702 HD12 ' N ' ' B' ' 16' ' ' LEU . 0.0 OUTLIER -29.21 -59.45 0.14 Allowed 'General case' 0 N--CA 1.517 2.876 0 CA-C-O 122.008 0.908 . . . . 0.0 110.712 -179.608 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 17' ' ' THR . . . . . 0.478 HG23 ' CG2' ' A' ' 17' ' ' THR . 0.5 OUTLIER -132.7 -2.75 3.32 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -179.927 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . 0.618 ' O ' ' C ' ' B' ' 19' ' ' VAL . 8.2 mt-30 56.56 30.97 18.21 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -176.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.691 ' HB ' ' HB ' ' A' ' 19' ' ' VAL . 2.0 p -8.74 -97.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.802 -179.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 20' ' ' SER . . . . . 0.92 ' O ' ' N ' ' B' ' 23' ' ' LYS . 0.4 OUTLIER -132.94 22.08 4.17 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 177.449 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . 0.666 ' C ' ' O ' ' B' ' 20' ' ' SER . 27.9 m -18.51 -38.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-O 122.401 1.096 . . . . 0.0 109.255 -178.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.91 ' N ' ' O ' ' B' ' 20' ' ' SER . 26.5 t -79.16 -44.92 20.98 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.19 177.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . 0.92 ' N ' ' O ' ' B' ' 20' ' ' SER . 5.9 mtmt -89.69 -21.56 22.68 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.431 -0.793 . . . . 0.0 109.889 178.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' MET . . . . . 0.6 ' HA ' HG22 ' A' ' 14' ' ' THR 0.263 2.2 tmm? -68.89 -38.93 79.95 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 178.653 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . 0.568 ' N ' ' HE3' ' B' ' 24' ' ' MET . 8.3 mt -73.97 -41.38 62.03 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 176.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . 0.476 ' HA ' ' HE2' ' B' ' 3' ' ' LYS . . . -58.03 -34.51 70.13 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 177.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' SER . . . . . 0.475 ' O ' ' HB3' ' B' ' 30' ' ' LYS . 6.2 m -79.59 -33.49 41.58 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . 0.664 ' O ' HG13 ' B' ' 31' ' ' ILE . 2.8 t80 -60.74 -57.46 12.58 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 178.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . 0.713 ' HG3' ' CD2' ' A' ' 47' ' ' PHE . 2.3 tt0 -58.04 -31.85 67.41 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 118.216 -1.394 . . . . 0.0 107.637 177.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . 1.166 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 24.1 ttmm -67.42 -26.79 66.6 Favored 'General case' 0 C--O 1.191 -1.988 0 C-N-CA 119.344 -0.942 . . . . 0.0 108.487 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.664 HG13 ' O ' ' B' ' 28' ' ' PHE . 0.3 OUTLIER -98.57 -30.21 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 120.344 -1.473 . . . . 0.0 109.598 178.169 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.637 HD13 ' CG ' ' B' ' 28' ' ' PHE . 1.8 mp -67.85 -66.37 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' THR . . . . . 0.439 HG21 ' CB ' ' A' ' 88' ' ' ALA . 0.3 OUTLIER -60.78 -37.64 82.6 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.254 -179.082 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 1.166 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 62.3 mm-40 -73.13 -40.07 65.2 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 119.366 -0.934 . . . . 0.0 111.048 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 35' ' ' THR . . . . . 0.488 ' CG2' ' CB ' ' B' ' 40' ' ' ASP . 23.6 m -61.7 -49.46 76.4 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 118.316 -1.354 . . . . 0.0 109.423 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.548 ' HA ' ' HG3' ' B' ' 52' ' ' PRO . 0.6 OUTLIER -50.82 -43.26 24.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 C-N-CA 118.918 -1.113 . . . . 0.0 108.027 179.195 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . 0.759 ' HB2' ' O ' ' A' ' 88' ' ' ALA . . . -88.22 -4.01 58.78 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.69 0.757 . . . . 0.0 109.773 178.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . 0.705 ' HB2' ' O ' ' B' ' 34' ' ' GLU . 0.0 OUTLIER -88.56 -26.16 22.13 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 176.958 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 117.14 39.69 0.79 Allowed Glycine 0 C--N 1.302 -1.323 0 C-N-CA 120.194 -1.003 . . . . 0.0 110.968 177.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . 0.488 ' CB ' ' CG2' ' B' ' 35' ' ' THR . 0.3 OUTLIER -145.44 161.27 40.11 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.902 -1.351 . . . . 0.0 110.718 179.475 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -107.04 96.76 6.66 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.561 -0.712 . . . . 0.0 110.045 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 91.4 t -60.22 120.0 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.498 -0.751 . . . . 0.0 109.813 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 43' ' ' GLN . . . . . 0.415 ' O ' ' CB ' ' A' ' 2' ' ' ASN . 0.7 OUTLIER -108.96 103.02 11.98 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.277 -0.889 . . . . 0.0 110.117 -179.431 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.484 ' CB ' ' HB2' ' B' ' 48' ' ' LEU . 12.6 mt -75.75 100.26 4.65 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.001 -1.062 . . . . 0.0 109.286 179.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 45' ' ' THR . . . . . 0.568 HG23 ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 35.07 -93.88 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.913 -0.492 . . . . 0.0 111.224 -179.61 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -147.65 28.47 1.46 Allowed Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.715 -1.231 . . . . 0.0 110.17 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . 0.714 ' CD1' ' HG3' ' A' ' 29' ' ' GLU . 4.2 p90 -129.2 -23.58 2.97 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.969 -1.313 . . . . 0.0 111.594 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . 0.597 ' HG ' ' CE2' ' B' ' 47' ' ' PHE . 7.7 mt -128.73 106.03 8.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.482 -1.386 . . . . 0.0 110.711 178.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 49' ' ' ASN . . . . . 0.512 ' O ' ' HA ' ' B' ' 79' ' ' VAL . 0.6 OUTLIER -101.21 86.56 3.04 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.725 -0.609 . . . . 0.0 110.56 -179.385 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 50' ' ' ILE . . . . . 0.528 ' HA ' HG11 ' B' ' 79' ' ' VAL . 12.3 mm -84.33 128.43 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.383 -0.823 . . . . 0.0 109.836 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . 0.417 ' O ' ' N ' ' B' ' 78' ' ' SER . 0.0 OUTLIER -152.25 123.98 3.81 Favored Pre-proline 0 N--CA 1.501 2.078 0 O-C-N 120.87 -1.144 . . . . 0.0 110.972 -179.878 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 52' ' ' PRO . . . . . 0.646 ' HA ' ' HA ' ' B' ' 77' ' ' VAL . 57.1 Cg_endo -84.93 141.8 8.58 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 123.406 1.214 . . . . 0.0 111.454 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.575 ' O ' ' N ' ' B' ' 76' ' ' GLY . 30.0 m -143.79 112.31 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-O 121.9 0.857 . . . . 0.0 110.673 178.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . 0.789 ' HA ' ' HA ' ' B' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.495 1.81 0 O-C-N 121.727 -0.608 . . . . 0.0 110.952 -179.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . 0.789 ' HA ' ' HA ' ' B' ' 54' ' ' ALA . 12.2 p . . . . . 0 N--CA 1.508 2.468 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 76' ' ' GLY . . . . . 0.595 ' O ' ' N ' ' B' ' 78' ' ' SER . . . -125.9 73.62 0.43 Allowed Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.24 -1.457 . . . . 0.0 109.792 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.646 ' HA ' ' HA ' ' B' ' 52' ' ' PRO . 3.7 p -61.69 72.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.544 -0.974 . . . . 0.0 109.326 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 78' ' ' SER . . . . . 0.635 ' O ' ' CG1' ' B' ' 79' ' ' VAL . 0.1 OUTLIER -64.3 176.26 1.1 Allowed 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.454 -0.898 . . . . 0.0 109.986 -179.709 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . 0.635 ' CG1' ' O ' ' B' ' 78' ' ' SER . 16.9 m -172.37 179.0 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 80' ' ' LYS . . . . . 0.51 ' O ' ' HA ' ' B' ' 48' ' ' LEU . 0.1 OUTLIER 179.3 170.58 0.55 Allowed Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 120.833 -1.167 . . . . 0.0 111.12 176.8 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 81' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -102.27 133.37 0.13 Allowed 'Trans proline' 0 C--N 1.303 -1.832 0 C-N-CA 123.076 2.517 . . . . 0.0 110.252 177.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . 0.501 ' HA3' ' HA ' ' B' ' 47' ' ' PHE . . . -96.96 171.09 26.84 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 107.955 -2.058 . . . . 0.0 107.955 178.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . 0.447 ' HA ' ' HB2' ' B' ' 86' ' ' LYS . 3.5 pm0 -59.75 -19.15 48.41 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.99 -1.3 . . . . 0.0 110.674 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 84' ' ' SER . . . . . 0.471 ' CB ' ' HB3' ' B' ' 47' ' ' PHE . 0.4 OUTLIER -52.08 -38.03 55.9 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.101 -0.999 . . . . 0.0 109.552 179.6 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . 0.49 HD12 ' HB2' ' B' ' 47' ' ' PHE . 1.0 OUTLIER -78.46 -33.07 48.63 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.471 -0.768 . . . . 0.0 108.951 178.617 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 86' ' ' LYS . . . . . 0.53 ' O ' ' HB3' ' B' ' 89' ' ' ALA . 0.6 OUTLIER -73.71 -42.42 61.23 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.493 -179.274 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 7.3 tttp -64.5 -39.77 94.4 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 177.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.604 ' CB ' ' HB1' ' A' ' 37' ' ' ALA . . . -66.91 -34.48 77.87 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 176.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' B' ' 86' ' ' LYS . . . -57.18 -44.6 83.7 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.471 -0.768 . . . . 0.0 109.222 179.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -53.88 -31.82 51.16 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 177.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -67.14 -33.8 84.3 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 92' ' ' LEU . . . . . 0.645 ' HB3' ' HA ' ' A' ' 37' ' ' ALA . 0.4 OUTLIER -77.51 13.07 1.34 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.648 -1.501 . . . . 0.0 111.438 -179.553 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 93' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' B' ' 92' ' ' LEU . 34.9 mmtt 58.53 39.53 24.8 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -177.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . 0.608 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -42.07 -33.58 0.6 Allowed 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.449 -179.14 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . 0.481 ' N ' ' CD1' ' B' ' 94' ' ' TYR . 2.5 pp20? -61.62 -39.92 93.0 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.383 -0.823 . . . . 0.0 109.467 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.66 -34.82 76.38 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 177.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.459 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.502 ' HG2' ' HB3' ' A' ' 5' ' ' GLU . 2.7 mtp . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 120.892 0.377 . . . . 0.0 110.184 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . 0.462 ' HB3' ' O ' ' A' ' 1' ' ' MET . 39.2 p-10 179.56 -167.57 0.09 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.184 -0.947 . . . . 0.0 111.21 179.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.532 ' HD3' HG21 ' B' ' 45' ' ' THR . 0.0 OUTLIER -55.47 -11.68 0.91 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.568 -0.708 . . . . 0.0 110.326 179.794 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.708 ' O ' HG12 ' A' ' 7' ' ' ILE . 53.7 m -104.02 -55.25 2.4 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 122.113 0.959 . . . . 0.0 109.286 179.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.651 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 0.2 OUTLIER -57.13 -49.6 75.42 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.068 -1.02 . . . . 0.0 109.14 179.427 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.42 ' O ' ' CB ' ' A' ' 9' ' ' ALA . 15.7 mt -49.93 -40.81 44.7 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 119.322 -0.951 . . . . 0.0 110.396 178.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.708 HG12 ' O ' ' A' ' 4' ' ' THR . 0.7 OUTLIER -57.47 -45.33 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.238 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.651 ' HE2' ' HA ' ' A' ' 5' ' ' GLU . 28.6 mtmt -56.36 -37.17 69.67 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 177.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 13' ' ' ASP . . . -54.9 -37.56 66.49 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.736 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.5 mp -88.26 -33.81 6.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 178.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.416 ' CB ' ' HA ' ' A' ' 8' ' ' LYS . . . -65.85 -13.05 58.86 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 119.158 -1.017 . . . . 0.0 108.818 178.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -117.08 -39.65 3.2 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 121.449 -0.782 . . . . 0.0 109.652 178.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 9' ' ' ALA . 1.5 m-20 -66.97 -30.15 70.19 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 177.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.736 ' OG1' ' O ' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -104.66 -75.31 0.63 Allowed 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 114.339 -1.3 . . . . 0.0 108.19 178.983 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 51.14 15.79 1.73 Allowed Glycine 0 N--CA 1.494 2.522 0 C-N-CA 120.306 -0.95 . . . . 0.0 110.883 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.6 ' CD1' ' CG2' ' B' ' 19' ' ' VAL . 0.0 OUTLIER -73.06 -27.66 61.87 Favored 'General case' 0 N--CA 1.508 2.432 0 O-C-N 121.073 -1.251 . . . . 0.0 107.963 178.812 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.46 HG22 ' CG2' ' B' ' 17' ' ' THR . 0.4 OUTLIER -159.6 -12.39 0.06 Allowed 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.552 -179.861 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.706 ' O ' ' C ' ' A' ' 19' ' ' VAL . 21.1 mt-30 58.24 34.37 24.04 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 -177.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.706 ' C ' ' O ' ' A' ' 18' ' ' GLN . 0.2 OUTLIER 0.69 -94.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -178.875 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 1.106 ' O ' ' N ' ' A' ' 22' ' ' SER . 18.7 p -135.06 21.74 3.49 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 175.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.606 ' HA ' ' HE3' ' A' ' 24' ' ' MET . 33.9 m -4.44 -38.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 122.451 1.119 . . . . 0.0 111.061 -178.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 1.106 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.5 OUTLIER -75.24 -41.61 57.1 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-N 115.008 -0.997 . . . . 0.0 108.622 177.629 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.885 ' N ' ' O ' ' A' ' 20' ' ' SER . 2.5 mtpt -90.7 -30.8 16.88 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.549 -0.72 . . . . 0.0 109.502 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.606 ' HE3' ' HA ' ' A' ' 21' ' ' VAL . 2.0 tmm? -61.63 -29.73 70.25 Favored 'General case' 0 C--O 1.215 -0.717 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 22' ' ' SER . 1.2 pp -81.97 -44.39 16.78 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.514 ' H ' ' HG ' ' A' ' 25' ' ' LEU . . . -63.61 -23.73 67.5 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 178.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.507 ' O ' ' CG1' ' A' ' 31' ' ' ILE . 7.9 m -85.14 -40.98 16.11 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.634 ' O ' HG13 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -58.97 -45.52 90.36 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.853 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.573 ' HG3' ' CE2' ' B' ' 47' ' ' PHE . 0.8 OUTLIER -69.02 -37.37 78.6 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.046 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 1.259 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 20.2 tttt -62.37 -22.02 65.79 Favored 'General case' 0 C--O 1.193 -1.883 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.634 HG13 ' O ' ' A' ' 28' ' ' PHE . 0.6 OUTLIER -106.81 -27.72 2.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 120.144 -1.597 . . . . 0.0 109.482 178.013 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.623 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.3 mm -74.02 -59.47 3.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 177.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.493 ' O ' ' HB1' ' A' ' 37' ' ' ALA . 0.7 OUTLIER -70.51 -32.59 70.12 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.393 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 1.259 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 71.7 mm-40 -81.75 -27.31 33.9 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 121.125 -0.984 . . . . 0.0 111.676 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.592 ' HA ' ' HB2' ' A' ' 38' ' ' LYS . 3.1 m -70.57 -55.39 8.97 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 117.496 -1.682 . . . . 0.0 108.437 178.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.694 ' O ' ' HG3' ' A' ' 52' ' ' PRO . 87.1 t -55.2 -40.96 58.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.657 ' HA ' ' HA ' ' B' ' 89' ' ' ALA . . . -68.93 -22.2 64.16 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.592 ' HB2' ' HA ' ' A' ' 35' ' ' THR . 13.4 mtmt -82.32 -25.48 33.88 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 177.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 35' ' ' THR . . . 104.06 30.79 4.97 Favored Glycine 0 C--N 1.295 -1.722 0 C-N-CA 120.133 -1.032 . . . . 0.0 110.653 177.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.513 ' CB ' HG21 ' A' ' 35' ' ' THR . 0.3 OUTLIER -117.25 138.22 51.87 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.225 -1.162 . . . . 0.0 110.018 179.545 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -72.18 82.55 1.0 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.461 -0.774 . . . . 0.0 110.638 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.8 p -73.36 140.96 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.47 -0.769 . . . . 0.0 109.654 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -149.1 163.18 38.31 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.009 -1.057 . . . . 0.0 111.462 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.627 HD12 ' CE1' ' A' ' 47' ' ' PHE . 23.4 mt -106.94 109.28 21.14 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.535 HG21 ' HG3' ' B' ' 29' ' ' GLU . 0.0 OUTLIER 35.8 -95.11 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.743 -0.598 . . . . 0.0 111.378 -178.854 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -139.47 10.49 3.22 Favored Glycine 0 N--CA 1.488 2.105 0 C-N-CA 119.52 -1.324 . . . . 0.0 111.034 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.636 ' O ' ' HA ' ' A' ' 81' ' ' PRO . 23.6 p90 -105.11 -20.31 13.56 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.604 -1.527 . . . . 0.0 110.695 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.584 ' HB2' HD12 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -132.81 147.67 52.31 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.13 -0.981 . . . . 0.0 111.666 178.505 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -154.08 116.28 4.31 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.773 -0.58 . . . . 0.0 109.718 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.502 ' HA ' ' HA ' ' A' ' 79' ' ' VAL . 0.8 OUTLIER -109.54 155.1 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.212 -0.93 . . . . 0.0 110.522 -179.657 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 9.0 ptmt -162.19 126.78 2.04 Favored Pre-proline 0 N--CA 1.498 1.939 0 C-N-CA 118.803 -1.159 . . . . 0.0 110.96 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.694 ' HG3' ' O ' ' A' ' 36' ' ' VAL . 53.9 Cg_endo -87.05 144.29 7.09 Favored 'Trans proline' 0 C--N 1.316 -1.17 0 O-C-N 123.405 1.213 . . . . 0.0 110.888 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.572 ' O ' ' N ' ' A' ' 76' ' ' GLY . 25.8 m -143.85 116.59 3.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-O 121.599 0.714 . . . . 0.0 110.278 179.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' A' ' 53' ' ' VAL . . . . . . . . 0 N--CA 1.5 2.035 0 CA-C-O 121.62 0.724 . . . . 0.0 112.318 -178.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.464 HG13 ' CB ' ' B' ' 89' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.783 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.626 ' O ' ' N ' ' A' ' 78' ' ' SER . . . -110.74 64.02 0.27 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.625 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 7.5 p -54.86 75.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.531 -0.982 . . . . 0.0 110.75 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.626 ' N ' ' O ' ' A' ' 76' ' ' GLY . 29.9 t -79.78 178.72 7.98 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.294 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.56 ' CG2' ' N ' ' A' ' 80' ' ' LYS . 0.2 OUTLIER 179.27 172.96 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.463 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.56 ' N ' ' CG2' ' A' ' 79' ' ' VAL . 0.1 OUTLIER 177.28 173.8 0.33 Allowed Pre-proline 0 C--N 1.299 -1.616 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 177.814 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.636 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 52.5 Cg_endo -85.87 174.59 6.41 Favored 'Trans proline' 0 C--N 1.294 -2.294 0 O-C-N 123.648 1.341 . . . . 0.0 110.106 177.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -115.84 -68.58 0.43 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 105.289 -3.124 . . . . 0.0 105.289 177.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.863 ' O ' ' N ' ' A' ' 85' ' ' LEU . 37.8 tt0 -87.33 53.13 2.7 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 174.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 1.312 ' O ' ' N ' ' A' ' 86' ' ' LYS . 1.9 m 9.62 44.31 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 122.386 1.089 . . . . 0.0 110.854 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.983 ' C ' ' O ' ' A' ' 84' ' ' SER . 3.6 mp 21.6 29.58 0.0 OUTLIER 'General case' 0 C--O 1.195 -1.802 0 N-CA-C 103.685 -2.709 . . . . 0.0 103.685 -172.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 1.312 ' N ' ' O ' ' A' ' 84' ' ' SER 0.339 9.7 tttt -55.59 -36.66 67.14 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 104.261 -2.496 . . . . 0.0 104.261 176.732 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.292 14.0 tttt -75.99 -31.59 59.03 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 111.625 -2.534 . . . . 0.0 106.5 176.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.605 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -82.21 -20.48 37.67 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 118.53 -1.268 . . . . 0.0 108.755 179.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.725 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . -80.99 -43.94 18.87 Favored 'General case' 0 C--N 1.293 -1.888 0 O-C-N 120.941 -1.099 . . . . 0.0 108.587 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.7 -30.46 67.43 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 177.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.441 ' HA3' ' CB ' ' B' ' 37' ' ' ALA . . . -71.63 -33.83 63.37 Favored Glycine 0 N--CA 1.489 2.18 0 C-N-CA 120.279 -0.962 . . . . 0.0 110.837 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.767 ' HB3' ' HA ' ' B' ' 37' ' ' ALA . 0.4 OUTLIER -81.07 20.84 0.76 Allowed 'General case' 0 N--CA 1.504 2.241 0 O-C-N 120.371 -1.664 . . . . 0.0 110.764 -179.807 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.2 37.46 28.38 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -178.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.522 ' CD1' ' N ' ' B' ' 75' ' ' VAL . 0.0 OUTLIER -39.18 -33.94 0.16 Allowed 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.61 -179.21 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.418 ' HG2' ' CE2' ' A' ' 94' ' ' TYR . 46.1 mt-10 . . . . . 0 N--CA 1.493 1.701 0 O-C-N 121.439 -0.788 . . . . 0.0 109.305 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.436 ' O ' ' HB2' ' B' ' 2' ' ' ASN . 5.2 mtp . . . . . 0 N--CA 1.493 1.69 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 2' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' B' ' 1' ' ' MET . 12.2 t30 -177.22 178.01 1.15 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.207 -0.933 . . . . 0.0 110.816 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.564 ' NZ ' ' O ' ' B' ' 25' ' ' LEU . 1.7 mttm -44.53 -23.29 0.11 Allowed 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.49 -0.756 . . . . 0.0 110.58 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.488 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 13.4 m -102.94 -43.9 5.39 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.165 -0.96 . . . . 0.0 109.309 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.482 ' O ' ' CG ' ' B' ' 8' ' ' LYS . 0.1 OUTLIER -62.06 -46.51 88.82 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.153 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.5 ' HA ' ' HB1' ' B' ' 9' ' ' ALA . 1.6 mt -66.13 -29.23 69.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.944 -1.098 . . . . 0.0 109.154 178.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 7' ' ' ILE . . . . . 0.642 HG12 ' O ' ' B' ' 21' ' ' VAL . 0.3 OUTLIER -56.79 -59.77 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.638 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . 0.507 ' HA ' ' CB ' ' B' ' 11' ' ' ALA . 19.9 pttt -61.13 -25.87 67.29 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . 0.5 ' HB1' ' HA ' ' B' ' 6' ' ' LEU . . . -58.56 -38.29 77.53 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.018 -1.051 . . . . 0.0 108.744 178.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . 0.862 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.1 mp -90.62 -35.99 7.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 177.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.507 ' CB ' ' HA ' ' B' ' 8' ' ' LYS . . . -62.42 -12.82 23.89 Favored 'General case' 0 C--N 1.293 -1.851 0 C-N-CA 118.783 -1.167 . . . . 0.0 108.689 177.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.442 ' HB3' ' O ' ' B' ' 8' ' ' LYS . 6.9 tp-100 -113.79 -44.26 3.2 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.501 -0.749 . . . . 0.0 109.284 178.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -64.29 -33.26 75.42 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.862 ' OG1' ' O ' ' B' ' 10' ' ' ILE 0.253 0.2 OUTLIER -98.77 -69.53 0.76 Allowed 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 178.348 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 57.86 22.2 46.96 Favored Glycine 0 N--CA 1.501 2.98 0 O-C-N 121.398 -0.814 . . . . 0.0 111.585 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 16' ' ' LEU . . . . . 0.809 HD12 ' HB3' ' A' ' 20' ' ' SER . 4.9 mp -65.66 -66.17 0.58 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.348 -1.09 . . . . 0.0 109.64 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 17' ' ' THR . . . . . 0.605 HG21 ' O ' ' B' ' 17' ' ' THR . 0.5 OUTLIER -135.54 6.73 3.26 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -179.57 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . 0.652 ' O ' ' C ' ' B' ' 19' ' ' VAL . 25.1 mt-30 58.69 24.98 12.78 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 -175.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.669 ' HB ' ' HB ' ' A' ' 19' ' ' VAL . 0.2 OUTLIER 7.69 -95.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 CA-C-N 115.211 -0.904 . . . . 0.0 108.958 -179.185 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 20' ' ' SER . . . . . 1.026 ' O ' ' N ' ' B' ' 22' ' ' SER . 1.2 p -137.42 23.47 2.95 Favored 'General case' 0 C--N 1.273 -2.729 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 177.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . 0.648 ' HA ' ' SD ' ' B' ' 24' ' ' MET . 9.4 m -4.02 -43.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 122.441 1.115 . . . . 0.0 111.006 -177.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 1.026 ' N ' ' O ' ' B' ' 20' ' ' SER . 5.9 m -75.35 -38.06 60.34 Favored 'General case' 0 C--N 1.278 -2.506 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.559 178.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . 0.868 ' N ' ' O ' ' B' ' 20' ' ' SER . 6.1 mtmt -92.94 -26.99 17.33 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.36 -0.837 . . . . 0.0 111.154 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' MET . . . . . 0.648 ' SD ' ' HA ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -70.9 -37.52 72.96 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 117.157 -1.817 . . . . 0.0 108.264 179.177 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . 0.585 ' HA ' ' HB3' ' B' ' 28' ' ' PHE . 0.4 OUTLIER -80.44 -51.45 8.8 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 117.956 -1.498 . . . . 0.0 108.241 177.52 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . 0.472 ' O ' ' HB2' ' B' ' 30' ' ' LYS . . . -49.95 -34.11 19.75 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.374 -0.829 . . . . 0.0 108.859 178.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' SER . . . . . 0.49 ' O ' ' N ' ' B' ' 31' ' ' ILE . 83.1 p -81.92 -33.88 30.17 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . 0.796 ' O ' HG13 ' B' ' 31' ' ' ILE . 0.3 OUTLIER -56.02 -52.44 64.22 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.812 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . 0.791 ' O ' ' OG1' ' B' ' 33' ' ' THR . 0.2 OUTLIER -63.42 -39.01 93.34 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 176.401 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . 0.997 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 17.5 ttpt -59.96 -23.79 63.87 Favored 'General case' 0 C--O 1.189 -2.115 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.796 HG13 ' O ' ' B' ' 28' ' ' PHE . 0.6 OUTLIER -102.83 -27.16 3.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 O-C-N 120.615 -1.303 . . . . 0.0 108.582 178.047 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.589 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.2 mm -68.88 -54.33 21.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 177.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' THR . . . . . 0.791 ' OG1' ' O ' ' B' ' 29' ' ' GLU . 0.3 OUTLIER -70.73 -49.07 50.86 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.107 -1.037 . . . . 0.0 108.669 178.576 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.997 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 19.2 mm-40 -58.09 -35.68 71.77 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.551 -0.86 . . . . 0.0 109.95 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 35' ' ' THR . . . . . 0.529 ' C ' ' HB2' ' B' ' 40' ' ' ASP . 31.1 m -69.72 -42.34 74.13 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 118.302 -1.359 . . . . 0.0 107.697 177.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.601 ' O ' ' HB3' ' A' ' 92' ' ' LEU . 55.5 t -56.95 -43.03 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 177.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . 0.767 ' HA ' ' HB3' ' A' ' 92' ' ' LEU . . . -76.89 2.92 13.25 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.398 -0.921 . . . . 0.0 109.69 177.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . 0.543 ' HB2' ' O ' ' B' ' 34' ' ' GLU . 0.1 OUTLIER -119.91 4.6 10.95 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.107 -0.996 . . . . 0.0 109.311 178.001 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.73 34.46 4.07 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . 0.596 ' HB3' ' HA ' ' B' ' 36' ' ' VAL . 14.2 t0 -49.17 162.91 0.11 Allowed 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 123.086 1.422 . . . . 0.0 113.019 -179.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -179.83 56.99 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 104.381 -2.451 . . . . 0.0 104.381 178.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . 0.452 ' CG1' ' HB ' ' B' ' 50' ' ' ILE . 7.4 p -90.67 148.74 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.941 -176.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -132.26 95.9 3.76 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.632 HD11 ' HB3' ' B' ' 48' ' ' LEU . 19.2 mt -59.65 101.59 0.12 Allowed 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.245 -0.909 . . . . 0.0 109.792 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 45' ' ' THR . . . . . 0.532 HG21 ' HD3' ' A' ' 3' ' ' LYS . 0.0 OUTLIER 35.53 -93.55 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 120.921 0.391 . . . . 0.0 110.877 -179.648 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -147.17 35.4 1.25 Allowed Glycine 0 N--CA 1.485 1.95 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . 0.573 ' CE2' ' HG3' ' A' ' 29' ' ' GLU . 1.1 p90 -135.75 -25.53 1.26 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.246 -1.149 . . . . 0.0 111.773 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . 0.632 ' HB3' HD11 ' B' ' 44' ' ' LEU . 4.8 mt -136.36 113.58 10.64 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.214 -1.554 . . . . 0.0 111.374 178.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -113.69 95.95 5.6 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.414 -0.804 . . . . 0.0 110.291 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 50' ' ' ILE . . . . . 0.603 ' N ' ' CD1' ' B' ' 50' ' ' ILE . 0.3 OUTLIER -87.5 139.42 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.37 -0.831 . . . . 0.0 109.271 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . 0.407 ' HG3' ' HB3' ' B' ' 78' ' ' SER . 1.7 ptmt -158.83 111.4 1.61 Allowed Pre-proline 0 N--CA 1.5 2.042 0 C-N-CA 118.603 -1.239 . . . . 0.0 111.233 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 52' ' ' PRO . . . . . 0.619 ' HA ' ' HA ' ' B' ' 77' ' ' VAL . 44.9 Cg_endo -69.38 144.66 56.78 Favored 'Trans proline' 0 C--N 1.314 -1.251 0 O-C-N 123.47 1.248 . . . . 0.0 111.681 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.615 ' O ' ' N ' ' B' ' 76' ' ' GLY . 29.7 m -143.07 116.86 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 121.491 0.663 . . . . 0.0 110.841 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . 0.644 ' HA ' ' HA ' ' B' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.5 2.067 0 CA-C-O 121.806 0.812 . . . . 0.0 112.105 -178.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . 0.644 ' HA ' ' HA ' ' B' ' 54' ' ' ALA . 1.2 t . . . . . 0 N--CA 1.493 1.711 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 76' ' ' GLY . . . . . 0.615 ' N ' ' O ' ' B' ' 53' ' ' VAL . . . -115.32 86.9 0.42 Allowed Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.619 ' HA ' ' HA ' ' B' ' 52' ' ' PRO . 3.6 p -60.53 78.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.767 -0.843 . . . . 0.0 109.827 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 78' ' ' SER . . . . . 0.607 ' O ' ' CG2' ' B' ' 79' ' ' VAL . 2.2 t -68.05 177.66 2.12 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.551 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . 0.607 ' CG2' ' O ' ' B' ' 78' ' ' SER . 14.6 t -172.33 175.27 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 80' ' ' LYS . . . . . 0.496 ' N ' ' CG1' ' B' ' 79' ' ' VAL . 0.0 OUTLIER 179.28 172.17 0.49 Allowed Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 120.87 -1.144 . . . . 0.0 110.178 177.186 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 81' ' ' PRO . . . . . 0.425 ' CB ' HG13 ' A' ' 77' ' ' VAL . 54.0 Cg_endo -95.17 143.45 1.31 Allowed 'Trans proline' 0 C--N 1.303 -1.855 0 C-N-CA 122.35 2.033 . . . . 0.0 110.739 178.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . 0.541 ' O ' ' HB3' ' B' ' 83' ' ' GLU . . . -107.6 42.37 1.95 Allowed Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . 0.541 ' HB3' ' O ' ' B' ' 82' ' ' GLY . 1.0 OUTLIER 69.02 -40.18 0.44 Allowed 'General case' 0 N--CA 1.506 2.34 0 O-C-N 121.448 -1.031 . . . . 0.0 111.93 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 84' ' ' SER . . . . . 0.447 ' CB ' ' HB3' ' B' ' 47' ' ' PHE . 0.1 OUTLIER -48.85 -33.34 10.39 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.949 -1.094 . . . . 0.0 110.165 -179.177 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . 0.431 HD23 ' CD1' ' B' ' 47' ' ' PHE . 0.8 OUTLIER -82.61 -29.98 29.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.412 -0.805 . . . . 0.0 108.877 178.703 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 86' ' ' LYS . . . . . 0.443 ' HA ' ' HB2' ' B' ' 89' ' ' ALA . 0.3 OUTLIER -82.49 -39.5 22.37 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.53 0.681 . . . . 0.0 109.607 179.812 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . 0.465 ' O ' ' CG ' ' B' ' 90' ' ' GLU . 1.2 ttmp? -68.69 -37.05 79.26 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 178.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.565 ' O ' ' HG ' ' B' ' 92' ' ' LEU . . . -71.62 -30.66 66.02 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 177.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . 0.657 ' HA ' ' HA ' ' A' ' 37' ' ' ALA . . . -69.94 -52.79 21.55 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.623 -0.673 . . . . 0.0 110.368 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . 0.651 ' HA ' ' CB ' ' B' ' 94' ' ' TYR . 8.2 pt-20 -52.2 -23.25 5.28 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 177.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . 0.405 ' N ' ' C ' ' B' ' 89' ' ' ALA . . . -81.17 -29.66 40.41 Favored Glycine 0 CA--C 1.546 2.03 0 CA-C-O 118.604 -1.109 . . . . 0.0 112.81 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 92' ' ' LEU . . . . . 0.593 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 0.2 OUTLIER -111.64 -73.55 0.67 Allowed 'General case' 0 N--CA 1.507 2.391 0 CA-C-N 122.065 2.933 . . . . 0.0 113.54 -177.687 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -120.31 42.7 2.9 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.771 -1.205 . . . . 0.0 112.628 -177.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . 0.651 ' CB ' ' HA ' ' B' ' 90' ' ' GLU . 0.8 OUTLIER -77.19 -43.51 33.46 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.124 -0.985 . . . . 0.0 108.967 178.507 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -75.04 -35.73 61.89 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.19 -40.13 76.77 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.481 ' HA ' ' CB ' ' A' ' 5' ' ' GLU . 2.8 mtp . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . 0.502 ' H ' ' HB2' ' A' ' 5' ' ' GLU . 0.6 OUTLIER -177.12 -162.54 0.08 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.023 -1.048 . . . . 0.0 111.728 179.855 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.491 ' HE2' ' HA ' ' A' ' 26' ' ' ALA . 0.9 OUTLIER -52.22 -11.77 0.2 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.657 -0.652 . . . . 0.0 110.396 179.778 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.591 ' O ' HG13 ' A' ' 7' ' ' ILE . 73.7 m -114.38 -58.95 2.08 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.104 -0.997 . . . . 0.0 110.731 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.502 ' HB2' ' H ' ' A' ' 2' ' ' ASN . 1.6 mm-40 -49.74 -48.4 50.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.822 -1.174 . . . . 0.0 108.945 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.42 ' HB3' HD13 ' A' ' 25' ' ' LEU . 16.2 mt -55.65 -32.93 63.61 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.151 -1.02 . . . . 0.0 110.105 178.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.617 HG13 ' N ' ' A' ' 8' ' ' LYS . 1.0 OUTLIER -60.5 -40.94 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 120.599 -1.313 . . . . 0.0 107.563 178.743 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.617 ' N ' HG13 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -66.75 -31.14 71.6 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 177.343 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 13' ' ' ASP . . . -58.45 -39.01 78.69 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.815 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.4 mp -91.01 -30.61 4.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 178.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.599 ' HB1' ' HA ' ' A' ' 8' ' ' LYS . . . -66.08 -10.6 41.94 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 118.456 -1.298 . . . . 0.0 108.493 178.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.443 ' CG ' ' N ' ' A' ' 13' ' ' ASP . 6.4 pt20 -118.53 -42.52 2.75 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.48 -0.762 . . . . 0.0 110.405 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.443 ' N ' ' CG ' ' A' ' 12' ' ' GLN . 16.8 m-20 -69.85 -25.82 63.91 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 177.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.815 ' OG1' ' O ' ' A' ' 10' ' ' ILE 0.277 0.2 OUTLIER -106.53 -72.89 0.7 Allowed 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 179.025 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.65 15.68 54.3 Favored Glycine 0 N--CA 1.501 2.974 0 O-C-N 121.328 -0.857 . . . . 0.0 111.039 177.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.685 ' CD1' ' CG2' ' A' ' 14' ' ' THR . 4.4 mp -59.36 -68.87 0.23 Allowed 'General case' 0 C--N 1.294 -1.835 0 O-C-N 121.524 -0.986 . . . . 0.0 110.628 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.518 ' O ' HG23 ' A' ' 17' ' ' THR . 0.6 OUTLIER -138.11 9.64 2.77 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.302 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.558 ' O ' ' C ' ' A' ' 19' ' ' VAL . 7.7 mt-30 57.84 25.71 12.34 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -176.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.666 ' HB ' ' HB ' ' B' ' 19' ' ' VAL . 2.4 p -11.45 -95.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.089 -179.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.942 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -130.74 22.86 5.02 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 177.957 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.616 ' HA ' ' CE ' ' A' ' 24' ' ' MET . 30.5 m -25.19 -38.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-O 122.479 1.133 . . . . 0.0 109.182 -178.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.71 ' N ' ' O ' ' A' ' 20' ' ' SER . 4.9 m -84.49 -35.36 23.01 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.135 177.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.942 ' N ' ' O ' ' A' ' 20' ' ' SER . 1.2 mtmt -85.69 -34.07 21.37 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.652 -0.655 . . . . 0.0 111.543 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.616 ' CE ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -76.1 -40.24 53.41 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.44 -1.412 . . . . 0.0 109.349 179.466 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.722 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 11.6 mt -74.56 -38.29 62.74 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 117.894 -1.523 . . . . 0.0 108.724 178.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.491 ' HA ' ' HE2' ' A' ' 3' ' ' LYS . . . -64.08 -33.22 75.26 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 177.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.551 ' O ' ' N ' ' A' ' 31' ' ' ILE . 58.3 m -84.25 -30.52 25.61 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 178.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.722 ' HB3' ' HA ' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -59.24 -35.91 74.53 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.608 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.729 ' O ' ' HB ' ' A' ' 33' ' ' THR . 2.1 mt-10 -79.99 -32.92 39.76 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 177.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.739 ' O ' ' CG ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -68.6 -27.31 65.93 Favored 'General case' 0 C--O 1.194 -1.821 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 176.758 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.709 ' CG1' ' HA ' ' A' ' 28' ' ' PHE . 1.7 pp -97.11 -31.69 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.299 -0.875 . . . . 0.0 109.445 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.637 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 3.3 mm -65.42 -51.62 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 177.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.729 ' HB ' ' O ' ' A' ' 29' ' ' GLU . 0.3 OUTLIER -65.51 -43.27 90.62 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.867 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.739 ' CG ' ' O ' ' A' ' 30' ' ' LYS . 44.5 mm-40 -69.02 -36.08 77.36 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.614 -0.679 . . . . 0.0 111.451 179.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.582 ' N ' ' O ' ' A' ' 31' ' ' ILE . 2.3 m -57.59 -56.12 26.05 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.736 -1.228 . . . . 0.0 108.689 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.521 ' O ' HD21 ' B' ' 92' ' ' LEU . 0.4 OUTLIER -55.51 -29.51 24.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 106.303 -1.739 . . . . 0.0 106.303 177.414 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.638 ' HB1' ' O ' ' B' ' 88' ' ' ALA . . . -75.73 -4.1 38.53 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 177.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.467 ' N ' ' O ' ' A' ' 35' ' ' THR . 0.0 OUTLIER -115.26 -32.07 5.77 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.634 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.18 42.58 0.76 Allowed Glycine 0 C--N 1.301 -1.391 0 C-N-CA 119.804 -1.189 . . . . 0.0 110.558 178.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.475 ' CB ' HG21 ' A' ' 35' ' ' THR . 0.1 OUTLIER -125.86 117.44 23.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.218 -1.166 . . . . 0.0 110.33 179.349 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.6 mtmt -67.13 89.41 0.18 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.57 0.7 . . . . 0.0 109.626 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.415 ' CG2' ' CG2' ' A' ' 35' ' ' THR . 42.5 t -66.23 131.94 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.682 -0.637 . . . . 0.0 110.374 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.44 ' O ' ' HA ' ' B' ' 2' ' ' ASN . 0.8 OUTLIER -128.04 154.8 45.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.517 -0.739 . . . . 0.0 109.59 179.454 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 48' ' ' LEU . 73.1 mt -128.13 112.19 14.28 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.287 -0.883 . . . . 0.0 109.686 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.572 HG23 ' HG2' ' B' ' 29' ' ' GLU . 0.1 OUTLIER 32.45 -90.89 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.427 0 O-C-N 121.937 -0.477 . . . . 0.0 111.007 -179.371 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -149.94 28.99 1.14 Allowed Glycine 0 N--CA 1.482 1.752 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.587 ' CE2' ' HG2' ' B' ' 29' ' ' GLU . 5.8 p90 -129.06 -24.09 2.94 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.096 -1.238 . . . . 0.0 112.046 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 1.0 OUTLIER -131.47 107.63 9.03 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.38 -1.45 . . . . 0.0 111.524 179.143 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -111.46 95.51 5.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.608 -0.683 . . . . 0.0 109.741 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.648 ' HA ' HG23 ' A' ' 79' ' ' VAL . 0.3 OUTLIER -83.44 142.42 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.369 -0.832 . . . . 0.0 109.969 -179.351 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.483 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 13.0 ptmt -157.48 128.09 3.54 Favored Pre-proline 0 N--CA 1.494 1.743 0 C-N-CA 118.564 -1.255 . . . . 0.0 110.51 178.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.501 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 54.8 Cg_endo -85.28 143.74 9.01 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.475 1.25 . . . . 0.0 111.891 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.828 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 32.6 m -133.13 -149.37 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.96 ' HA ' ' CA ' ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.496 1.849 0 C-N-CA 118.542 -1.263 . . . . 0.0 113.238 177.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.96 ' CA ' ' HA ' ' A' ' 54' ' ' ALA . 0.9 OUTLIER . . . . . 0 N--CA 1.513 2.704 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.454 ' CA ' HG22 ' A' ' 53' ' ' VAL . . . -145.11 111.18 0.58 Allowed Glycine 0 N--CA 1.491 2.321 0 C-N-CA 119.1 -1.524 . . . . 0.0 110.805 -178.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.585 HG21 ' CD2' ' B' ' 85' ' ' LEU . 4.9 p -76.96 81.69 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 O-C-N 121.603 -0.939 . . . . 0.0 110.08 179.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.625 ' O ' ' CG2' ' A' ' 79' ' ' VAL . 2.7 t -67.05 178.14 1.52 Allowed 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.347 -0.941 . . . . 0.0 109.607 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.648 HG23 ' HA ' ' A' ' 50' ' ' ILE . 3.4 t -176.41 174.96 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.527 ' N ' ' CG1' ' A' ' 79' ' ' VAL . 0.0 OUTLIER 179.32 170.59 0.55 Allowed Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 120.993 -1.067 . . . . 0.0 110.558 176.357 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.569 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 54.7 Cg_endo -95.09 144.53 1.41 Allowed 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 122.637 2.225 . . . . 0.0 110.551 178.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 46' ' ' GLY . . . -106.07 -171.68 23.32 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.79 -26.21 54.21 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.959 -1.318 . . . . 0.0 110.401 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.409 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 1.7 t -53.64 -27.56 27.91 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.675 ' CD2' HG23 ' B' ' 77' ' ' VAL . 1.3 mt -84.97 -29.07 25.38 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 178.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.25 -29.2 26.67 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.306 -0.871 . . . . 0.0 109.706 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.83 -38.06 58.44 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 178.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.68 ' C ' ' HB2' ' B' ' 37' ' ' ALA . . . -65.61 -33.31 75.61 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 177.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.732 ' N ' ' CB ' ' B' ' 37' ' ' ALA . . . -72.63 -26.86 61.82 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.77 -34.57 62.79 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 175.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -63.6 -50.08 64.47 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 107.864 -2.094 . . . . 0.0 107.864 176.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' B' ' 37' ' ' ALA . 3.4 mt -49.67 -12.56 0.07 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.073 -1.251 . . . . 0.0 111.484 178.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.524 ' CB ' ' O ' ' A' ' 92' ' ' LEU . 0.0 OUTLIER 73.54 61.14 0.09 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -177.589 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.528 ' CD1' ' N ' ' B' ' 75' ' ' VAL . 50.8 t80 -37.46 -39.99 0.34 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.189 -178.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 . . . . . 0 N--CA 1.495 1.791 0 O-C-N 121.293 -0.879 . . . . 0.0 109.697 179.83 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.468 ' HB3' ' HG ' ' B' ' 6' ' ' LEU . 1.5 mtp . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.059 0.457 . . . . 0.0 110.329 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 2' ' ' ASN . . . . . 0.509 ' O ' ' HB2' ' B' ' 6' ' ' LEU . 12.4 t-20 -173.54 -161.06 0.13 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.306 -0.871 . . . . 0.0 110.892 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.464 ' HE2' ' HB2' ' B' ' 29' ' ' GLU . 0.7 OUTLIER -55.77 -2.21 0.05 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.335 -0.853 . . . . 0.0 110.895 179.903 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.635 ' O ' ' CG1' ' B' ' 7' ' ' ILE . 54.4 m -122.77 -60.14 1.55 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.966 -1.084 . . . . 0.0 109.969 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.463 ' HB2' ' CA ' ' B' ' 1' ' ' MET . 5.4 mt-10 -51.74 -47.62 63.99 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.822 -1.174 . . . . 0.0 109.108 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.509 ' HB2' ' O ' ' B' ' 2' ' ' ASN . 5.2 mt -60.43 -33.3 72.33 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.265 178.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 7' ' ' ILE . . . . . 0.663 HG13 ' N ' ' B' ' 8' ' ' LYS . 0.9 OUTLIER -58.4 -42.65 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 120.582 -1.324 . . . . 0.0 108.397 179.812 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . 0.663 ' N ' HG13 ' B' ' 7' ' ' ILE . 0.1 OUTLIER -67.14 -32.2 73.15 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.213 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.33 -30.78 71.4 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 178.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . 0.819 HG22 HG23 ' B' ' 14' ' ' THR . 1.2 mp -96.65 -32.59 4.25 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.5 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 178.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.568 ' HB1' ' HA ' ' B' ' 8' ' ' LYS . . . -63.79 -29.58 70.77 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.403 ' CG ' ' N ' ' B' ' 13' ' ' ASP . 6.5 pt20 -89.56 -38.16 14.17 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.116 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.466 ' HB2' ' HA ' ' B' ' 10' ' ' ILE . 66.0 m-20 -67.96 -23.03 65.01 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 176.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.819 HG23 HG22 ' B' ' 10' ' ' ILE . 18.4 p -92.31 -76.46 0.46 Allowed 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 61.05 12.37 29.62 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 16' ' ' LEU . . . . . 0.69 HD11 ' HB ' ' B' ' 14' ' ' THR . 3.3 mp -79.78 -61.66 1.92 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.481 -1.011 . . . . 0.0 109.016 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 17' ' ' THR . . . . . 0.462 ' O ' HG23 ' B' ' 17' ' ' THR . 0.6 OUTLIER -141.55 5.93 1.84 Allowed 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.889 -179.794 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . 0.575 ' O ' ' C ' ' B' ' 19' ' ' VAL . 6.7 mt-30 54.53 29.69 11.74 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 -176.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.666 ' HB ' ' HB ' ' A' ' 19' ' ' VAL . 1.4 p -12.07 -95.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.743 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 20' ' ' SER . . . . . 0.945 ' O ' ' N ' ' B' ' 23' ' ' LYS . 0.5 OUTLIER -132.97 24.39 4.25 Favored 'General case' 0 C--N 1.283 -2.311 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 178.601 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . 0.649 ' C ' ' O ' ' B' ' 20' ' ' SER . 17.1 m -19.28 -39.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 CA-C-O 122.398 1.094 . . . . 0.0 109.433 -177.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.848 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.6 OUTLIER -82.43 -37.54 25.31 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.875 178.221 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . 0.945 ' N ' ' O ' ' B' ' 20' ' ' SER . 1.9 mtmt -89.63 -28.75 19.29 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.46 -0.775 . . . . 0.0 111.377 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' MET . . . . . 0.524 ' CE ' ' HA ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -77.81 -36.36 50.33 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 118.002 -1.479 . . . . 0.0 108.549 179.078 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . 0.614 ' HA ' ' HB3' ' B' ' 28' ' ' PHE . 0.8 OUTLIER -75.18 -42.63 55.39 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 177.281 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . 0.445 ' HA ' ' HE2' ' B' ' 3' ' ' LYS . . . -60.3 -32.48 71.25 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 177.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' SER . . . . . 0.545 ' O ' ' N ' ' B' ' 31' ' ' ILE . 12.1 m -79.88 -35.66 37.73 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . 0.708 ' CE1' ' HG3' ' B' ' 29' ' ' GLU . 0.0 OUTLIER -59.25 -40.08 84.84 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 178.849 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . 0.708 ' HG3' ' CE1' ' B' ' 28' ' ' PHE . 1.3 mt-10 -76.03 -34.05 59.66 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . 0.751 ' O ' ' CG ' ' B' ' 34' ' ' GLU . 30.0 tttp -70.08 -29.89 66.99 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 177.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.706 ' CG1' ' HA ' ' B' ' 28' ' ' PHE . 2.0 pp -93.02 -35.23 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.311 -0.868 . . . . 0.0 109.232 179.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.68 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.3 mm -60.52 -60.05 3.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 33' ' ' THR . . . . . 0.647 ' HA ' HD21 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -58.29 -39.53 79.55 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.116 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.842 ' O ' ' N ' ' B' ' 38' ' ' LYS . 7.0 mm-40 -68.66 -54.7 14.76 Favored 'General case' 0 C--O 1.199 -1.586 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.109 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 35' ' ' THR . . . . . 0.497 ' HA ' ' HB2' ' B' ' 38' ' ' LYS . 50.2 m -47.02 -63.85 0.93 Allowed 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.87 -1.144 . . . . 0.0 112.124 -178.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.815 ' O ' ' HG3' ' B' ' 52' ' ' PRO . 0.9 OUTLIER -49.61 -44.02 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 C-N-CA 118.058 -1.457 . . . . 0.0 107.841 179.126 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . 0.732 ' CB ' ' N ' ' A' ' 89' ' ' ALA . . . -93.63 15.27 16.63 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.793 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . 0.842 ' N ' ' O ' ' B' ' 34' ' ' GLU . 4.7 mmtt -121.95 -28.08 4.5 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 144.16 41.11 0.06 OUTLIER Glycine 0 N--CA 1.477 1.384 0 C-N-CA 119.026 -1.559 . . . . 0.0 112.06 178.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . 0.502 ' O ' ' HA ' ' B' ' 36' ' ' VAL . 0.4 OUTLIER -172.92 147.3 1.65 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.59 -1.535 . . . . 0.0 111.421 179.069 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 2.2 mttt -102.81 114.7 29.18 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . 0.449 ' HB ' ' CG1' ' B' ' 50' ' ' ILE . 7.5 t -87.92 154.95 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 C-N-CA 119.858 -0.737 . . . . 0.0 111.107 -178.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 43' ' ' GLN . . . . . 0.401 ' HA ' ' HA ' ' B' ' 49' ' ' ASN . 14.6 mt-30 -142.04 121.12 12.92 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.552 -0.717 . . . . 0.0 109.89 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.577 HD12 ' CB ' ' B' ' 48' ' ' LEU . 20.5 mt -87.09 102.56 14.54 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.199 -0.938 . . . . 0.0 109.934 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 45' ' ' THR . . . . . 0.629 HG23 ' HG2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 37.56 28.09 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.435 0 O-C-N 121.819 -0.55 . . . . 0.0 111.753 -179.659 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . 90.64 -11.5 71.44 Favored Glycine 0 N--CA 1.486 2.028 0 C-N-CA 119.903 -1.142 . . . . 0.0 111.902 178.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . 0.618 ' CE2' ' HG2' ' A' ' 29' ' ' GLU . 0.8 OUTLIER -87.76 -35.3 17.96 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 120.028 1.914 . . . . 0.0 111.776 -179.561 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . 0.577 ' CB ' HD12 ' B' ' 44' ' ' LEU . 0.4 OUTLIER -120.18 85.59 2.41 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.63 -1.294 . . . . 0.0 110.516 178.539 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 49' ' ' ASN . . . . . 0.401 ' HA ' ' HA ' ' B' ' 43' ' ' GLN . 7.6 t-20 -90.84 80.41 5.83 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.847 -0.533 . . . . 0.0 110.444 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 50' ' ' ILE . . . . . 0.471 HD13 HG23 ' B' ' 36' ' ' VAL . 2.9 pt -73.07 147.86 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.227 -0.921 . . . . 0.0 110.344 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . 0.564 ' O ' ' N ' ' B' ' 78' ' ' SER . 0.0 OUTLIER -165.14 132.52 2.35 Favored Pre-proline 0 N--CA 1.498 1.935 0 C-N-CA 119.285 -0.966 . . . . 0.0 110.549 179.456 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 52' ' ' PRO . . . . . 0.815 ' HG3' ' O ' ' B' ' 36' ' ' VAL . 54.4 Cg_endo -85.47 149.19 10.16 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 O-C-N 123.398 1.209 . . . . 0.0 111.174 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.577 ' CG2' ' HA3' ' B' ' 76' ' ' GLY . 11.8 m -144.93 120.15 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 CA-C-O 122.296 1.046 . . . . 0.0 111.619 178.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . 0.465 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . . . . . . . . 0 N--CA 1.495 1.778 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.875 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . 0.528 ' N ' ' CD1' ' A' ' 94' ' ' TYR . 7.6 p . . . . . 0 N--CA 1.509 2.496 0 CA-C-O 121.065 0.459 . . . . 0.0 111.09 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 76' ' ' GLY . . . . . 0.577 ' HA3' ' CG2' ' B' ' 53' ' ' VAL . . . -101.25 78.81 0.4 Allowed Glycine 0 N--CA 1.478 1.495 0 C-N-CA 118.693 -1.718 . . . . 0.0 109.248 -179.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.675 HG23 ' CD2' ' A' ' 85' ' ' LEU . 2.4 p -66.74 69.19 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 O-C-N 121.672 -0.899 . . . . 0.0 109.384 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 78' ' ' SER . . . . . 0.564 ' N ' ' O ' ' B' ' 51' ' ' LYS . 0.6 OUTLIER -64.37 174.12 1.79 Allowed 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 118.927 -1.109 . . . . 0.0 110.136 -179.944 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . 0.45 ' CG2' ' N ' ' B' ' 80' ' ' LYS . 3.7 p 174.06 176.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 80' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' B' ' 48' ' ' LEU . 0.0 OUTLIER 179.68 171.26 0.56 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 120.865 -1.147 . . . . 0.0 110.663 176.91 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 81' ' ' PRO . . . . . 0.493 ' HA ' ' O ' ' B' ' 47' ' ' PHE . 54.8 Cg_endo -94.9 138.84 0.97 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.493 2.128 . . . . 0.0 110.227 177.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . 0.524 ' HA3' ' HA ' ' B' ' 47' ' ' PHE . . . -92.64 -164.71 38.17 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 108.248 -1.941 . . . . 0.0 108.248 178.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . 0.566 ' O ' ' N ' ' B' ' 87' ' ' LYS . 0.0 OUTLIER -94.46 -18.17 21.75 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.138 -1.213 . . . . 0.0 110.36 179.517 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 14.5 t -61.22 -34.83 75.74 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 177.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . 0.598 ' CD1' ' HA ' ' A' ' 33' ' ' THR . 0.9 OUTLIER -86.74 -26.87 23.99 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.283 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 86' ' ' LYS . . . . . 0.417 ' CG ' HG13 ' A' ' 77' ' ' VAL . 4.4 tttp -79.32 -34.32 42.4 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 177.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . 0.566 ' N ' ' O ' ' B' ' 83' ' ' GLU . 15.7 tttt -67.14 -39.56 86.59 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 178.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.638 ' O ' ' HB1' ' A' ' 37' ' ' ALA . . . -60.45 -38.0 82.75 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 175.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . 0.417 ' CA ' HD23 ' B' ' 92' ' ' LEU . . . -55.78 -34.99 65.76 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 177.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . 0.639 ' HA ' ' HB2' ' B' ' 94' ' ' TYR . 0.0 OUTLIER -56.91 -32.53 66.03 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 177.346 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.24 -13.27 77.23 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 92' ' ' LEU . . . . . 0.624 ' HB3' ' HA ' ' A' ' 37' ' ' ALA . 0.3 OUTLIER -78.69 16.75 0.8 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.689 -1.477 . . . . 0.0 111.267 -179.883 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 93' ' ' LYS . . . . . 0.594 ' CG ' ' O ' ' B' ' 92' ' ' LEU . 0.1 OUTLIER 86.75 34.55 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -178.324 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . 0.742 ' CD2' ' HB ' ' A' ' 75' ' ' VAL . 3.6 t80 -42.09 -62.38 0.94 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.413 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -58.39 -32.62 68.77 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.53 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 96' ' ' ASP . . . . . 0.443 ' HB3' ' HG3' ' B' ' 93' ' ' LYS . 0.5 OUTLIER -64.52 -34.77 79.0 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.711 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.439 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 177.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.487 ' HG2' ' CB ' ' A' ' 5' ' ' GLU . 1.4 mtp . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.01 0.433 . . . . 0.0 110.041 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . 0.596 ' H ' ' HB2' ' A' ' 5' ' ' GLU . 47.0 p-10 -177.03 -169.68 0.26 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.295 -0.878 . . . . 0.0 110.44 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.694 ' HE3' ' HB2' ' A' ' 29' ' ' GLU . 2.5 tptm -52.0 -17.38 1.0 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.4 -0.812 . . . . 0.0 110.158 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.42 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 24.4 m -95.49 -54.58 3.33 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.128 -0.983 . . . . 0.0 109.292 178.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.596 ' HB2' ' H ' ' A' ' 2' ' ' ASN . 2.8 mt-10 -62.85 -42.24 99.67 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.446 -0.901 . . . . 0.0 108.631 179.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.433 ' HA ' ' HB2' ' A' ' 9' ' ' ALA . 23.2 mt -65.35 -31.26 72.28 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 118.899 -1.12 . . . . 0.0 108.585 177.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.603 HG13 ' CD1' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -57.91 -57.23 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 178.341 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.536 ' HA ' ' CB ' ' A' ' 11' ' ' ALA . 18.4 pttt -65.83 -24.33 66.88 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.433 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . . . -60.25 -38.46 83.56 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.089 -1.007 . . . . 0.0 108.451 178.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.818 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.2 mp -88.48 -37.83 10.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 177.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.536 ' CB ' ' HA ' ' A' ' 8' ' ' LYS . . . -61.13 -15.76 36.92 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 119.047 -1.061 . . . . 0.0 108.631 177.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.442 ' N ' ' O ' ' A' ' 8' ' ' LYS . 53.2 tp60 -111.13 -43.74 3.69 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.605 -0.684 . . . . 0.0 109.237 178.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.433 ' HB2' ' O ' ' A' ' 9' ' ' ALA . 35.5 m-20 -62.33 -30.63 71.3 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 177.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.818 ' OG1' ' O ' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -105.03 -70.59 0.77 Allowed 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.122 179.053 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 49.08 26.7 6.32 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.551 ' CD1' ' CG2' ' B' ' 19' ' ' VAL . 0.0 OUTLIER -87.41 -27.46 22.74 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.48 -1.012 . . . . 0.0 109.042 178.851 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.521 HG21 ' CG2' ' B' ' 17' ' ' THR . 0.4 OUTLIER -159.34 -7.61 0.07 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.982 -0.449 . . . . 0.0 110.169 -179.448 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.62 ' O ' ' C ' ' A' ' 19' ' ' VAL . 5.4 mt-30 58.0 31.2 20.31 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 -176.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.818 ' HB ' ' HB ' ' B' ' 19' ' ' VAL . 1.6 p -5.05 -91.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.502 -178.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.97 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -132.43 22.99 4.38 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.101 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.685 ' HA ' ' HE2' ' A' ' 24' ' ' MET . 16.0 m -19.41 -38.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 122.331 1.062 . . . . 0.0 109.389 -178.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.862 ' N ' ' O ' ' A' ' 20' ' ' SER . 5.6 t -78.88 -39.24 35.59 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.409 177.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.97 ' N ' ' O ' ' A' ' 20' ' ' SER . 3.1 mtmt -94.85 -28.36 15.27 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.603 -0.686 . . . . 0.0 109.543 178.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.685 ' HE2' ' HA ' ' A' ' 21' ' ' VAL 0.261 0.0 OUTLIER -63.09 -42.26 99.56 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.896 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.674 ' HB3' ' HG3' ' A' ' 3' ' ' LYS . 0.4 OUTLIER -86.1 -49.16 7.99 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 118.822 -1.151 . . . . 0.0 109.63 177.743 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 25' ' ' LEU . . . -46.77 -39.66 12.15 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.543 -1.348 . . . . 0.0 108.148 178.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.548 ' O ' ' N ' ' A' ' 31' ' ' ILE . 55.6 m -78.31 -30.26 48.18 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.911 ' O ' HG13 ' A' ' 31' ' ' ILE . 7.7 t80 -54.79 -47.35 74.08 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.572 -0.705 . . . . 0.0 109.455 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.694 ' HB2' ' HE3' ' A' ' 3' ' ' LYS . 21.4 tt0 -68.78 -34.28 75.3 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 117.577 -1.649 . . . . 0.0 107.177 177.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.932 ' O ' ' HB3' ' A' ' 34' ' ' GLU . 7.8 tttp -69.22 -22.5 63.87 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.375 -0.93 . . . . 0.0 108.821 178.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.911 HG13 ' O ' ' A' ' 28' ' ' PHE . 2.3 pp -95.42 -40.43 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 119.364 -0.934 . . . . 0.0 109.66 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.613 HG13 ' CE1' ' A' ' 28' ' ' PHE . 6.2 mm -50.31 -50.28 21.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 177.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.46 ' HA ' ' CD2' ' B' ' 85' ' ' LEU . 7.5 p -69.38 -39.7 77.87 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.932 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -56.76 -32.86 66.02 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.692 -179.121 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.511 HG22 ' CB ' ' A' ' 40' ' ' ASP . 2.2 m -85.28 -56.23 3.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.021 -1.072 . . . . 0.0 110.272 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 94.2 t -53.92 -39.56 40.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 118.308 -1.357 . . . . 0.0 108.101 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.666 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -77.69 -3.45 41.16 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.101 -1.04 . . . . 0.0 109.012 177.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.616 ' HB2' ' O ' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -103.04 -26.76 12.95 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.253 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.49 43.29 1.37 Allowed Glycine 0 C--N 1.3 -1.418 0 C-N-CA 120.058 -1.068 . . . . 0.0 110.507 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.511 ' CB ' HG22 ' A' ' 35' ' ' THR . 0.1 OUTLIER -129.01 140.94 51.41 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.179 -1.189 . . . . 0.0 109.979 179.241 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.453 ' O ' ' N ' ' A' ' 43' ' ' GLN . 51.3 mtpt -88.08 89.32 7.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.552 -0.717 . . . . 0.0 110.53 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.67 ' HA ' ' HB3' ' B' ' 1' ' ' MET . 27.8 m -61.63 80.31 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.608 -0.683 . . . . 0.0 109.939 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.453 ' N ' ' O ' ' A' ' 41' ' ' LYS . 1.9 tt0 -84.04 107.24 16.27 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.469 -0.769 . . . . 0.0 109.318 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.665 ' HB2' ' HB2' ' A' ' 48' ' ' LEU . 65.1 mt -61.89 114.67 3.48 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.138 -0.976 . . . . 0.0 109.179 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.587 HG21 ' HD1' ' A' ' 47' ' ' PHE . 0.0 OUTLIER 33.02 -97.5 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.853 -0.529 . . . . 0.0 111.256 -179.614 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -144.44 28.32 1.93 Allowed Glycine 0 N--CA 1.489 2.201 0 C-N-CA 119.726 -1.226 . . . . 0.0 110.39 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.687 ' CD1' ' HG3' ' B' ' 29' ' ' GLU . 3.6 p90 -126.03 -29.54 3.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.903 -1.351 . . . . 0.0 110.517 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.665 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 11.9 mt -123.63 93.12 3.84 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.23 -1.544 . . . . 0.0 110.53 177.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -86.86 86.0 7.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.911 -0.493 . . . . 0.0 110.055 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.573 ' N ' ' CD1' ' A' ' 50' ' ' ILE . 1.5 mp -82.97 137.81 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.425 -0.797 . . . . 0.0 110.069 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 13.5 ptmt -153.43 127.94 4.66 Favored Pre-proline 0 N--CA 1.494 1.732 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.472 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.551 ' HB2' ' CG1' ' A' ' 75' ' ' VAL . 41.1 Cg_endo -65.47 141.33 67.05 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 123.539 1.284 . . . . 0.0 111.894 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.58 ' C ' ' HA ' ' A' ' 75' ' ' VAL . 33.4 m -147.66 117.69 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 CA-C-O 121.326 0.584 . . . . 0.0 111.244 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.642 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.504 2.262 0 O-C-N 121.309 -0.869 . . . . 0.0 112.278 -178.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.642 ' HA ' ' HA ' ' A' ' 54' ' ' ALA . 38.2 t . . . . . 0 N--CA 1.48 1.055 0 CA-C-O 122.162 0.982 . . . . 0.0 109.975 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 78' ' ' SER . . . -126.57 105.62 0.79 Allowed Glycine 0 C--N 1.29 -1.998 0 N-CA-C 108.015 -2.034 . . . . 0.0 108.015 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.607 HG13 ' HB2' ' B' ' 85' ' ' LEU . 13.2 p -51.02 89.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.678 -0.895 . . . . 0.0 110.476 -178.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.504 ' N ' ' O ' ' A' ' 76' ' ' GLY . 0.5 OUTLIER -58.58 -171.92 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.281 -0.887 . . . . 0.0 110.729 -179.14 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.528 ' HB ' ' HG3' ' B' ' 81' ' ' PRO . 3.3 p -167.48 -164.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.447 ' CB ' ' CD ' ' A' ' 81' ' ' PRO . 2.0 mttm -160.08 178.59 1.61 Allowed Pre-proline 0 C--N 1.308 -1.211 0 O-C-N 120.914 -1.116 . . . . 0.0 111.335 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.447 ' CD ' ' CB ' ' A' ' 80' ' ' LYS . 55.5 Cg_endo -103.64 83.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 123.977 3.118 . . . . 0.0 108.862 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.651 ' CA ' ' O ' ' A' ' 47' ' ' PHE . . . -57.0 121.63 25.94 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.591 -1.29 . . . . 0.0 111.183 -178.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -62.19 -35.74 79.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.53 -0.982 . . . . 0.0 109.043 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.94 -30.85 48.35 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.558 ' HB2' ' OG1' ' B' ' 33' ' ' THR . 8.8 tt -85.26 -34.23 21.99 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.412 ' HA ' ' CG1' ' B' ' 75' ' ' VAL . 0.3 OUTLIER -75.35 -44.75 43.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.542 -0.724 . . . . 0.0 109.446 179.606 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 41.4 tptt -64.98 -38.26 90.38 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 177.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.748 ' O ' ' HB2' ' B' ' 37' ' ' ALA . . . -61.65 -36.63 81.35 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 176.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.606 ' CB ' ' CG1' ' B' ' 75' ' ' VAL . . . -56.42 -39.68 73.46 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.5 ' HA ' ' CB ' ' A' ' 94' ' ' TYR . 6.4 mm-40 -55.9 -28.89 58.81 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 176.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 88' ' ' ALA . . . -65.72 -50.84 51.56 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 178.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.599 ' HB3' ' O ' ' B' ' 37' ' ' ALA . 0.4 OUTLIER -59.85 -37.2 78.61 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.417 -1.637 . . . . 0.0 109.64 -179.745 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.596 ' CB ' ' O ' ' A' ' 92' ' ' LEU . 1.1 ttmt 143.82 65.23 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 1.095 ' O ' ' C ' ' A' ' 95' ' ' GLU . 7.7 t80 -49.11 -60.74 2.53 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 116.328 -2.149 . . . . 0.0 106.45 178.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 1.095 ' C ' ' O ' ' A' ' 94' ' ' TYR . 3.8 mm-40 . . . . . 0 CA--C 1.488 -1.417 0 N-CA-C 102.291 -3.226 . . . . 0.0 102.291 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.67 ' HB3' ' HA ' ' A' ' 42' ' ' VAL . 1.6 tpt . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 120.855 0.36 . . . . 0.0 110.401 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 2' ' ' ASN . . . . . 0.484 ' HB3' ' O ' ' B' ' 1' ' ' MET . 25.9 p30 179.6 -160.49 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.343 -0.943 . . . . 0.0 111.41 178.05 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.565 ' HE3' ' CG2' ' A' ' 45' ' ' THR . 0.1 OUTLIER -52.56 -10.45 0.15 Allowed 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.419 -0.801 . . . . 0.0 110.814 -179.705 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.478 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 4.4 m -106.43 -51.5 2.94 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.861 -1.149 . . . . 0.0 109.495 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.577 ' CB ' ' HA ' ' B' ' 1' ' ' MET . 1.3 mt-10 -65.46 -37.84 88.05 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.217 -0.927 . . . . 0.0 108.637 179.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.472 ' HA ' ' HB3' ' B' ' 9' ' ' ALA . 24.6 mt -71.88 -27.95 63.2 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 118.892 -1.123 . . . . 0.0 108.214 177.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 7' ' ' ILE . . . . . 0.651 HG12 ' O ' ' B' ' 21' ' ' VAL . 0.2 OUTLIER -57.31 -60.78 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 177.542 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . 0.517 ' HG3' ' O ' ' B' ' 5' ' ' GLU . 0.0 OUTLIER -62.8 -24.1 67.57 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.581 178.443 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . 0.472 ' HB3' ' HA ' ' B' ' 6' ' ' LEU . . . -60.83 -36.28 78.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.04 -1.038 . . . . 0.0 108.674 178.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . 0.915 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.0 OUTLIER -96.56 -35.19 5.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 178.535 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.507 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -60.34 -25.12 65.58 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -91.27 -43.25 9.92 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 178.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.473 ' HB3' ' CB ' ' A' ' 27' ' ' SER . 1.1 m-20 -64.33 -26.11 68.33 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 177.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.915 ' OG1' ' O ' ' B' ' 10' ' ' ILE . 10.7 p -91.78 -75.1 0.49 Allowed 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 177.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' B' ' 11' ' ' ALA . . . 57.75 17.78 29.24 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 178.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 16' ' ' LEU . . . . . 0.663 HD12 ' HB ' ' B' ' 14' ' ' THR . 3.8 mp -77.54 -57.13 3.98 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 122.317 1.056 . . . . 0.0 108.532 178.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 17' ' ' THR . . . . . 0.606 HG22 ' O ' ' B' ' 17' ' ' THR . 0.5 OUTLIER -142.67 5.54 1.59 Allowed 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 115.162 -0.927 . . . . 0.0 109.18 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . 0.622 ' O ' ' C ' ' B' ' 19' ' ' VAL . 3.9 mt-30 58.26 25.24 12.43 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 -176.134 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.818 ' HB ' ' HB ' ' A' ' 19' ' ' VAL . 0.2 OUTLIER 9.43 -98.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.437 -178.954 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 20' ' ' SER . . . . . 1.051 ' O ' ' N ' ' B' ' 22' ' ' SER . 1.9 p -136.6 24.14 3.15 Favored 'General case' 0 C--N 1.273 -2.733 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 177.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . 0.651 ' O ' HG12 ' B' ' 7' ' ' ILE . 21.9 m -4.35 -42.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 CA-C-O 122.528 1.156 . . . . 0.0 110.763 -177.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 1.051 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.5 OUTLIER -76.62 -38.09 55.31 Favored 'General case' 0 C--N 1.281 -2.407 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.2 178.724 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . 0.882 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.0 OUTLIER -89.19 -32.79 17.28 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.437 -0.79 . . . . 0.0 111.302 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' MET . . . . . 0.568 ' SD ' ' HA ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -68.83 -37.7 79.35 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 117.322 -1.751 . . . . 0.0 108.736 179.683 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . 0.639 ' HA ' ' HB3' ' B' ' 28' ' ' PHE . 0.3 OUTLIER -82.91 -44.39 15.43 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 118.21 -1.396 . . . . 0.0 109.669 178.234 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . 0.525 ' HA ' ' CE ' ' B' ' 3' ' ' LYS . . . -58.4 -35.36 71.9 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.957 -1.089 . . . . 0.0 108.2 178.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' SER . . . . . 0.52 ' O ' HG13 ' B' ' 31' ' ' ILE . 20.0 t -81.68 -30.99 32.43 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . 0.667 ' HA ' ' CG1' ' B' ' 31' ' ' ILE . 0.0 OUTLIER -54.51 -45.09 73.23 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 178.793 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . 0.687 ' HG3' ' CD1' ' A' ' 47' ' ' PHE . 1.5 tt0 -69.93 -34.83 73.97 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 176.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . 1.118 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 7.2 tttp -63.95 -18.27 64.08 Favored 'General case' 0 C--O 1.189 -2.112 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 177.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.667 ' CG1' ' HA ' ' B' ' 28' ' ' PHE . 1.2 pp -108.53 -26.08 3.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 120.32 -1.487 . . . . 0.0 108.617 177.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.61 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.1 mm -73.42 -57.02 7.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 176.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 33' ' ' THR . . . . . 0.558 ' OG1' ' HB2' ' A' ' 85' ' ' LEU . 0.5 OUTLIER -67.19 -40.88 86.59 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.335 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 1.118 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 76.9 mm-40 -74.72 -40.69 61.15 Favored 'General case' 0 C--O 1.207 -1.138 0 O-C-N 121.4 -0.813 . . . . 0.0 112.513 -179.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 35' ' ' THR . . . . . 0.519 ' HA ' ' CB ' ' B' ' 38' ' ' LYS . 53.3 m -59.51 -49.11 79.05 Favored 'General case' 0 N--CA 1.505 2.284 0 CA-C-N 120.797 1.635 . . . . 0.0 109.469 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.527 HG11 ' HG3' ' B' ' 52' ' ' PRO . 1.4 t -53.0 -41.77 42.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 C-N-CA 118.266 -1.374 . . . . 0.0 107.345 178.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . 0.748 ' HB2' ' O ' ' A' ' 88' ' ' ALA . . . -92.7 11.57 26.33 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.717 -0.793 . . . . 0.0 109.745 178.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . 0.693 ' HB2' ' O ' ' B' ' 34' ' ' GLU . 1.4 tppt? -104.76 -29.26 10.67 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 177.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.82 34.56 0.43 Allowed Glycine 0 C--N 1.305 -1.183 0 C-N-CA 119.835 -1.174 . . . . 0.0 111.042 177.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . 0.461 ' CB ' ' CG2' ' B' ' 35' ' ' THR . 0.1 OUTLIER -150.94 179.82 7.92 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.869 -1.371 . . . . 0.0 110.785 179.638 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 5.0 mtmp? -133.2 113.6 12.86 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 59.2 t -61.24 140.52 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.441 -0.787 . . . . 0.0 110.499 -179.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 43' ' ' GLN . . . . . 0.53 ' HA ' ' HA ' ' B' ' 49' ' ' ASN . 12.4 mt-30 -140.53 82.91 1.87 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.524 -0.735 . . . . 0.0 109.826 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.534 ' O ' ' C ' ' B' ' 45' ' ' THR . 5.6 mt -59.79 117.5 5.07 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.274 -0.891 . . . . 0.0 110.704 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 45' ' ' THR . . . . . 0.534 ' C ' ' O ' ' B' ' 44' ' ' LEU . 0.0 OUTLIER 24.38 -92.73 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.243 0 O-C-N 122.16 -0.337 . . . . 0.0 111.436 179.062 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -146.54 48.3 0.67 Allowed Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . 0.558 ' O ' ' HA ' ' B' ' 81' ' ' PRO . 16.5 p90 -151.27 -40.09 0.12 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.963 -1.316 . . . . 0.0 111.671 179.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . 0.623 ' HB3' ' HD2' ' B' ' 80' ' ' LYS . 0.0 OUTLIER -116.86 107.94 15.22 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.703 -1.248 . . . . 0.0 110.378 179.401 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 49' ' ' ASN . . . . . 0.945 ' O ' ' O ' ' B' ' 79' ' ' VAL . 0.5 OUTLIER -124.54 97.49 5.32 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.997 -1.064 . . . . 0.0 110.606 -179.495 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 50' ' ' ILE . . . . . 0.516 ' HA ' ' O ' ' B' ' 79' ' ' VAL . 0.5 OUTLIER -88.56 143.89 10.27 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 O-C-N 121.496 -0.753 . . . . 0.0 110.883 -179.211 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . 0.528 ' HG3' ' HB2' ' B' ' 78' ' ' SER . 0.0 OUTLIER -159.88 136.69 6.66 Favored Pre-proline 0 N--CA 1.495 1.792 0 C-N-CA 119.416 -0.914 . . . . 0.0 110.023 179.6 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 52' ' ' PRO . . . . . 0.527 ' HG3' HG11 ' B' ' 36' ' ' VAL . 56.6 Cg_endo -89.28 144.86 4.98 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.752 1.396 . . . . 0.0 112.58 -178.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.584 ' O ' ' N ' ' B' ' 76' ' ' GLY . 33.3 m -144.23 113.16 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-O 121.655 0.741 . . . . 0.0 109.709 177.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.822 0 CA-C-O 122.0 0.905 . . . . 0.0 112.462 -178.063 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . 0.606 ' CG1' ' CB ' ' A' ' 89' ' ' ALA . 6.1 p . . . . . 0 N--CA 1.495 1.789 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 76' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' B' ' 53' ' ' VAL . . . -118.26 45.14 1.3 Allowed Glycine 0 N--CA 1.488 2.16 0 C-N-CA 118.898 -1.62 . . . . 0.0 109.825 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.536 ' O ' ' O ' ' B' ' 78' ' ' SER . 6.5 p -28.13 91.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 122.061 -0.67 . . . . 0.0 110.828 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 78' ' ' SER . . . . . 0.536 ' O ' ' O ' ' B' ' 77' ' ' VAL . 57.7 m -57.91 -122.12 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 119.864 -0.734 . . . . 0.0 109.102 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . 0.945 ' O ' ' O ' ' B' ' 49' ' ' ASN . 4.5 m -148.41 -168.88 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 119.859 -1.776 . . . . 0.0 112.868 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 80' ' ' LYS . . . . . 0.786 ' H ' ' HD2' ' B' ' 81' ' ' PRO . 0.0 OUTLIER -114.58 -52.92 0.04 OUTLIER Pre-proline 0 C--N 1.301 -1.531 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -178.403 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 81' ' ' PRO . . . . . 0.786 ' HD2' ' H ' ' B' ' 80' ' ' LYS . 26.7 Cg_endo -49.49 130.59 25.99 Favored 'Trans proline' 0 C--N 1.298 -2.106 0 C-N-CA 120.869 1.046 . . . . 0.0 112.551 -175.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -128.04 -62.8 0.13 Allowed Glycine 0 N--CA 1.486 1.981 0 N-CA-C 105.856 -2.897 . . . . 0.0 105.856 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . 0.885 ' O ' ' N ' ' B' ' 85' ' ' LEU . 26.3 tt0 -91.03 47.6 1.42 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.514 -1.662 . . . . 0.0 106.514 175.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 84' ' ' SER . . . . . 1.286 ' O ' ' N ' ' B' ' 86' ' ' LYS . 4.5 m 8.45 43.79 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.506 1.146 . . . . 0.0 110.875 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . 1.026 ' C ' ' O ' ' B' ' 84' ' ' SER . 4.3 mp 22.01 29.66 0.0 OUTLIER 'General case' 0 C--O 1.194 -1.831 0 N-CA-C 103.599 -2.741 . . . . 0.0 103.599 -171.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 86' ' ' LYS . . . . . 1.286 ' N ' ' O ' ' B' ' 84' ' ' SER 0.319 6.5 tttm -51.85 -34.78 42.13 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 103.459 -2.793 . . . . 0.0 103.459 175.997 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . 0.456 ' O ' ' CG ' ' B' ' 90' ' ' GLU 0.286 16.8 tptp -68.01 -36.2 79.58 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 111.773 -2.467 . . . . 0.0 106.609 175.565 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.799 ' N ' ' O ' ' B' ' 85' ' ' LEU . . . -80.38 -26.2 38.7 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 118.349 -1.34 . . . . 0.0 107.764 177.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . 0.694 ' N ' ' O ' ' B' ' 85' ' ' LEU . . . -67.27 -50.11 61.74 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.53 -0.731 . . . . 0.0 109.051 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . 0.456 ' CG ' ' O ' ' B' ' 87' ' ' LYS . 6.5 pt-20 -57.03 -27.83 61.98 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 176.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . 0.423 ' N ' ' HG3' ' B' ' 90' ' ' GLU . . . -63.32 -38.25 96.13 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 178.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 92' ' ' LEU . . . . . 0.666 ' HB3' ' HA ' ' A' ' 37' ' ' ALA . 0.9 OUTLIER -85.37 23.48 1.31 Allowed 'General case' 0 N--CA 1.503 2.222 0 O-C-N 120.493 -1.592 . . . . 0.0 110.5 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 93' ' ' LYS . . . . . 0.458 ' O ' ' N ' ' B' ' 96' ' ' ASP . 0.4 OUTLIER 58.58 48.17 12.24 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 -177.659 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . 0.721 ' CD1' ' C ' ' B' ' 94' ' ' TYR . 0.0 OUTLIER -42.98 -37.11 1.77 Allowed 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.762 -178.51 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . 0.469 ' N ' ' CD1' ' B' ' 94' ' ' TYR . 8.8 pt-20 -53.85 -39.48 65.65 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.258 -0.901 . . . . 0.0 109.097 178.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 96' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' B' ' 93' ' ' LYS . 0.2 OUTLIER -65.96 -28.5 68.95 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.308 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.412 0 O-C-N 121.549 -0.719 . . . . 0.0 109.185 178.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.418 ' HA ' ' CB ' ' A' ' 5' ' ' GLU . 3.8 mtp . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 120.908 0.385 . . . . 0.0 110.064 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . 0.476 ' H ' ' HB2' ' A' ' 5' ' ' GLU . 27.3 p30 -177.82 -167.75 0.16 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.215 -0.928 . . . . 0.0 111.28 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.495 ' HD2' ' HB ' ' B' ' 45' ' ' THR . 12.7 tttt -51.31 -16.63 0.56 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.555 -0.716 . . . . 0.0 110.252 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.6 ' O ' HG12 ' A' ' 7' ' ' ILE . 41.0 m -104.69 -58.95 1.81 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.263 -0.898 . . . . 0.0 110.271 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.476 ' HB2' ' H ' ' A' ' 2' ' ' ASN . 3.5 mm-40 -54.88 -45.54 74.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.125 -0.985 . . . . 0.0 109.762 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.0 mt -52.04 -45.85 64.81 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.389 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.621 HG21 ' CD2' ' A' ' 25' ' ' LEU . 0.6 OUTLIER -56.36 -45.99 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 178.271 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.496 ' N ' ' CG1' ' A' ' 7' ' ' ILE . 0.9 OUTLIER -56.67 -39.94 74.65 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 176.828 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 13' ' ' ASP . . . -54.85 -35.71 64.3 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 178.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.768 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.5 mp -88.33 -32.45 5.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 177.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' A' ' 7' ' ' ILE . . . -67.89 -10.84 56.5 Favored 'General case' 0 C--N 1.287 -2.12 0 C-N-CA 118.999 -1.08 . . . . 0.0 108.969 178.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.454 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -120.6 -34.73 3.53 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.356 -0.84 . . . . 0.0 110.333 179.157 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 9' ' ' ALA . 0.9 OUTLIER -74.94 -36.88 62.11 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 176.823 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.768 ' OG1' ' O ' ' A' ' 10' ' ' ILE 0.268 0.2 OUTLIER -91.96 -70.28 0.7 Allowed 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 177.95 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 54.45 21.49 20.56 Favored Glycine 0 N--CA 1.5 2.908 0 O-C-N 121.534 -0.729 . . . . 0.0 111.445 177.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.89 HD13 ' HB3' ' B' ' 20' ' ' SER . 5.0 mp -64.7 -62.87 1.31 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.362 -1.081 . . . . 0.0 109.01 178.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.587 ' O ' HG23 ' A' ' 17' ' ' THR . 0.5 OUTLIER -138.82 6.45 2.44 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.866 -179.815 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.594 ' O ' ' C ' ' A' ' 19' ' ' VAL . 6.3 mt-30 57.53 26.92 13.32 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 -176.107 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.7 ' HB ' ' HB ' ' B' ' 19' ' ' VAL . 1.2 p -0.83 -95.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.802 -178.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.96 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -133.2 25.79 4.19 Favored 'General case' 0 C--N 1.277 -2.575 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 179.005 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.631 ' C ' ' O ' ' A' ' 20' ' ' SER . 31.0 m -19.1 -39.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 CA-C-O 122.483 1.135 . . . . 0.0 109.505 -178.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.854 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.6 OUTLIER -77.7 -40.47 41.25 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.362 177.522 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.96 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -85.6 -38.94 17.88 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 121.543 -0.723 . . . . 0.0 111.577 179.891 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.625 ' CE ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -66.22 -27.21 67.8 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 117.315 -1.754 . . . . 0.0 108.176 179.368 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.659 ' HG ' ' N ' ' A' ' 26' ' ' ALA . 0.4 OUTLIER -74.64 -45.1 47.07 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 118.827 -1.149 . . . . 0.0 108.838 177.933 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.659 ' N ' ' HG ' ' A' ' 25' ' ' LEU . . . -63.99 -25.27 68.05 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 178.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.496 ' O ' ' CG1' ' A' ' 31' ' ' ILE . 19.1 p -85.3 -41.03 15.9 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.675 ' O ' HG13 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -57.33 -48.23 79.52 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.087 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.564 ' N ' ' CD1' ' A' ' 28' ' ' PHE . 0.7 OUTLIER -68.6 -35.14 76.94 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.034 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 1.235 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 13.8 ttmt -64.85 -22.13 66.93 Favored 'General case' 0 C--O 1.191 -2.023 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 177.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.675 HG13 ' O ' ' A' ' 28' ' ' PHE . 0.6 OUTLIER -105.08 -28.44 2.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 120.068 -1.645 . . . . 0.0 109.17 178.076 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.591 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.2 mm -72.24 -61.15 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 176.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.497 ' OG1' ' HG ' ' B' ' 85' ' ' LEU . 0.5 OUTLIER -67.8 -35.27 78.34 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.282 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 1.235 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 27.4 mm-40 -77.8 -32.31 52.32 Favored 'General case' 0 N--CA 1.482 1.138 0 O-C-N 120.958 -1.089 . . . . 0.0 111.214 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.52 ' CB ' ' O ' ' A' ' 31' ' ' ILE . 1.8 m -59.3 -50.93 72.11 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.32 -1.488 . . . . 0.0 107.457 178.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.481 HG12 ' HB3' ' B' ' 85' ' ' LEU . 0.4 OUTLIER -53.89 -36.49 30.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 C-N-CA 117.918 -1.513 . . . . 0.0 107.006 177.868 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.592 ' HB3' ' O ' ' B' ' 88' ' ' ALA . . . -80.43 -7.86 59.31 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.677 0.751 . . . . 0.0 109.632 177.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.555 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -100.26 -8.21 23.73 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 177.566 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 80.47 47.49 6.82 Favored Glycine 0 C--N 1.302 -1.316 0 N-CA-C 110.201 -1.159 . . . . 0.0 110.201 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.493 ' CB ' HG21 ' A' ' 35' ' ' THR . 0.3 OUTLIER -130.28 119.51 22.97 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.295 -1.121 . . . . 0.0 110.314 179.594 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -76.09 81.9 2.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.479 -0.763 . . . . 0.0 109.519 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.548 ' CG1' ' HB ' ' A' ' 50' ' ' ILE . 5.9 p -63.6 144.91 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.439 -0.788 . . . . 0.0 110.253 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -128.01 98.87 5.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.502 -0.749 . . . . 0.0 109.876 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.486 ' O ' ' N ' ' A' ' 46' ' ' GLY . 8.7 mt -61.62 108.22 0.94 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.256 -0.902 . . . . 0.0 109.495 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.472 ' C ' ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER 31.12 -91.77 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.315 0 O-C-N 122.003 -0.436 . . . . 0.0 111.189 -179.669 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -149.48 32.36 1.12 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.693 ' CD2' ' HG3' ' B' ' 29' ' ' GLU . 2.1 p90 -134.92 -23.04 1.57 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.031 -1.276 . . . . 0.0 111.936 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.614 ' HG ' ' CE1' ' A' ' 47' ' ' PHE . 5.0 mt -130.82 118.23 20.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.259 -1.525 . . . . 0.0 111.166 178.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.406 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 2.1 m-20 -115.92 93.57 4.31 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.544 -0.723 . . . . 0.0 110.513 -179.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.548 ' HB ' ' CG1' ' A' ' 42' ' ' VAL . 9.5 mm -87.63 132.94 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.313 -0.867 . . . . 0.0 109.282 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 0.5 OUTLIER -149.85 126.06 5.16 Favored Pre-proline 0 N--CA 1.497 1.895 0 C-N-CA 118.57 -1.252 . . . . 0.0 111.038 179.959 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.547 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 56.1 Cg_endo -81.48 138.95 11.16 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.439 1.231 . . . . 0.0 110.51 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.595 ' O ' ' N ' ' A' ' 76' ' ' GLY . 28.6 m -140.84 115.61 6.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-O 121.546 0.689 . . . . 0.0 110.377 179.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.436 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.498 1.962 0 CA-C-O 121.824 0.821 . . . . 0.0 112.139 -178.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.61 ' HB ' ' HB2' ' B' ' 94' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.804 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.627 ' O ' ' N ' ' A' ' 78' ' ' SER . . . -113.49 70.69 0.23 Allowed Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.547 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 2.6 p -51.07 79.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.821 -0.811 . . . . 0.0 110.18 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.627 ' N ' ' O ' ' A' ' 76' ' ' GLY . 0.7 OUTLIER -73.53 178.16 4.85 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.227 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.567 ' CG2' ' O ' ' A' ' 78' ' ' SER . 41.8 t -166.5 175.99 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.486 ' N ' ' CG1' ' A' ' 79' ' ' VAL . 0.0 OUTLIER -175.33 169.15 1.56 Allowed Pre-proline 0 C--N 1.308 -1.225 0 O-C-N 120.982 -1.074 . . . . 0.0 110.045 176.662 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.444 ' HB2' HG12 ' B' ' 77' ' ' VAL . 55.8 Cg_endo -103.32 137.84 0.12 Allowed 'Trans proline' 0 C--N 1.3 -1.991 0 C-N-CA 122.962 2.442 . . . . 0.0 110.727 178.217 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.505 ' HA3' ' HA ' ' A' ' 47' ' ' PHE . . . -89.83 -148.11 18.59 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 107.437 -2.265 . . . . 0.0 107.437 177.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -101.28 -13.96 17.85 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.064 -1.256 . . . . 0.0 109.803 178.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.431 ' CB ' ' HB3' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -56.5 -32.97 65.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.3 -0.875 . . . . 0.0 108.953 179.161 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.529 ' HG ' ' OG1' ' B' ' 33' ' ' THR . 0.5 OUTLIER -82.48 -31.73 29.19 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.961 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.471 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 0.1 OUTLIER -75.53 -39.98 57.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.485 -0.759 . . . . 0.0 110.173 -179.399 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.1 ttmt -70.22 -37.61 75.06 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.58 ' O ' ' HB1' ' B' ' 37' ' ' ALA . . . -69.18 -34.03 74.29 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 176.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.471 ' HB1' ' O ' ' A' ' 86' ' ' LYS . . . -59.89 -43.52 94.75 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.46 -32.91 52.11 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -66.11 -35.78 90.99 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 178.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.552 ' HB3' ' HA ' ' B' ' 37' ' ' ALA . 0.5 OUTLIER -72.69 7.21 2.03 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.722 -1.457 . . . . 0.0 111.438 -179.715 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.414 ' CB ' ' O ' ' A' ' 92' ' ' LEU . 0.1 OUTLIER 63.75 38.42 9.23 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -177.862 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.627 ' HB2' ' HB ' ' B' ' 75' ' ' VAL . 0.4 OUTLIER -43.69 -35.75 1.94 Allowed 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.506 -179.238 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.458 ' N ' ' CG ' ' A' ' 94' ' ' TYR . 15.2 pt-20 . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.4 -0.812 . . . . 0.0 109.157 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.489 ' CB ' ' CB ' ' B' ' 5' ' ' GLU . 4.0 ptp . . . . . 0 N--CA 1.495 1.807 0 CA-C-O 121.605 0.717 . . . . 0.0 110.577 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 2' ' ' ASN . . . . . 0.433 ' HB3' ' O ' ' B' ' 1' ' ' MET . 14.1 p-10 179.72 -157.93 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.542 178.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.472 ' CE ' ' HB2' ' B' ' 29' ' ' GLU . 9.7 mttm -53.92 -11.53 0.44 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.253 -0.904 . . . . 0.0 110.761 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.422 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 15.4 m -101.04 -55.03 2.66 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.039 -1.038 . . . . 0.0 110.008 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.489 ' CB ' ' CB ' ' B' ' 1' ' ' MET . 2.5 mp0 -64.09 -50.16 69.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.195 -0.94 . . . . 0.0 109.24 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.42 ' HA ' ' HB3' ' B' ' 9' ' ' ALA . 32.5 mt -53.94 -43.28 69.69 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 7' ' ' ILE . . . . . 0.642 HG12 ' O ' ' B' ' 21' ' ' VAL . 0.3 OUTLIER -50.24 -52.4 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 177.163 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . 0.498 ' O ' ' HB3' ' B' ' 12' ' ' GLN . 0.0 OUTLIER -56.26 -39.73 73.06 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.056 177.22 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . 0.423 ' O ' ' HB2' ' B' ' 13' ' ' ASP . . . -49.61 -38.1 30.55 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.195 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . 0.714 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.4 mp -93.63 -32.0 4.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 178.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.401 ' HB1' ' O ' ' B' ' 7' ' ' ILE . . . -68.23 -8.49 39.55 Favored 'General case' 0 C--N 1.291 -1.973 0 C-N-CA 118.377 -1.329 . . . . 0.0 109.012 178.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.498 ' HB3' ' O ' ' B' ' 8' ' ' LYS . 0.9 OUTLIER -119.9 -41.84 2.64 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.364 -0.835 . . . . 0.0 109.674 179.294 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.47 ' CB ' ' HB2' ' A' ' 27' ' ' SER . 1.5 m-20 -70.28 -35.4 73.71 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 177.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.714 ' OG1' ' O ' ' B' ' 10' ' ' ILE 0.262 0.2 OUTLIER -96.72 -79.27 0.45 Allowed 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 177.592 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 52.47 5.01 0.17 Allowed Glycine 0 N--CA 1.502 3.04 0 O-C-N 121.226 -0.921 . . . . 0.0 111.793 177.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 16' ' ' LEU . . . . . 0.629 HD21 ' CG2' ' B' ' 14' ' ' THR . 0.7 OUTLIER -61.43 -23.7 66.01 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.127 -1.219 . . . . 0.0 110.052 179.524 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 17' ' ' THR . . . . . 0.485 HG21 HG22 ' A' ' 17' ' ' THR . 0.5 OUTLIER -159.82 -9.98 0.06 Allowed 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.707 -0.621 . . . . 0.0 110.482 -179.783 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . 0.645 ' O ' ' C ' ' B' ' 19' ' ' VAL . 7.3 mt-30 54.94 35.94 25.64 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 -177.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.7 ' HB ' ' HB ' ' A' ' 19' ' ' VAL . 0.2 OUTLIER -10.53 -92.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.165 -179.329 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 20' ' ' SER . . . . . 1.063 ' O ' ' N ' ' B' ' 22' ' ' SER . 4.5 p -134.96 24.9 3.61 Favored 'General case' 0 C--N 1.282 -2.368 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 176.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . 0.663 ' HA ' ' SD ' ' B' ' 24' ' ' MET . 30.7 m -4.48 -41.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 CA-C-O 122.561 1.172 . . . . 0.0 110.976 -177.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 1.063 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.6 OUTLIER -76.74 -37.3 56.21 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.766 179.13 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . 0.837 ' N ' ' O ' ' B' ' 20' ' ' SER . 1.5 mtmt -89.6 -31.47 17.55 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.318 -0.864 . . . . 0.0 110.811 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 24' ' ' MET . . . . . 0.663 ' SD ' ' HA ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -68.65 -39.69 80.59 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 117.191 -1.804 . . . . 0.0 108.759 179.285 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . 0.601 ' HA ' ' HB3' ' B' ' 28' ' ' PHE . 0.3 OUTLIER -77.02 -45.09 28.45 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 118.132 -1.427 . . . . 0.0 108.431 177.574 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . 0.41 ' CB ' ' O ' ' B' ' 22' ' ' SER . . . -55.26 -34.46 64.06 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 27' ' ' SER . . . . . 0.474 ' O ' ' N ' ' B' ' 31' ' ' ILE . 90.8 p -81.49 -35.44 30.46 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . 0.659 ' O ' HG13 ' B' ' 31' ' ' ILE . 0.7 OUTLIER -53.41 -49.17 67.83 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.633 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . 0.693 ' HG3' ' CD2' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -67.55 -34.88 77.97 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 177.184 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . 1.181 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 53.1 tttm -64.51 -21.55 66.71 Favored 'General case' 0 C--O 1.19 -2.064 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.056 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.659 HG13 ' O ' ' B' ' 28' ' ' PHE . 0.6 OUTLIER -105.61 -26.69 3.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 O-C-N 120.163 -1.586 . . . . 0.0 109.062 177.924 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.605 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.2 mm -74.87 -58.14 5.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 176.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 33' ' ' THR . . . . . 0.529 ' OG1' ' HG ' ' A' ' 85' ' ' LEU . 0.6 OUTLIER -70.15 -35.5 74.08 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.263 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 1.181 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 50.9 mm-40 -76.69 -32.84 58.15 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 119.314 -0.954 . . . . 0.0 111.033 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 35' ' ' THR . . . . . 0.506 ' CB ' ' O ' ' B' ' 31' ' ' ILE . 2.2 m -61.68 -50.79 71.07 Favored 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 118.015 -1.474 . . . . 0.0 107.942 178.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 1.2 t -54.12 -36.0 30.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 177.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . 0.58 ' HB1' ' O ' ' A' ' 88' ' ' ALA . . . -81.5 -5.44 57.96 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-O 121.655 0.74 . . . . 0.0 109.346 177.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . 0.511 ' N ' ' O ' ' B' ' 34' ' ' GLU . 0.9 OUTLIER -99.08 -25.08 14.66 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 177.833 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.32 39.5 2.09 Favored Glycine 0 C--N 1.303 -1.292 0 C-N-CA 120.183 -1.008 . . . . 0.0 110.795 177.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . 0.47 ' CB ' HG22 ' B' ' 35' ' ' THR . 0.1 OUTLIER -131.02 133.35 45.67 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.984 -1.304 . . . . 0.0 110.567 179.528 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.51 89.45 6.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.546 -0.721 . . . . 0.0 109.879 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 58.6 t -60.02 127.3 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.59 -0.694 . . . . 0.0 110.449 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 43' ' ' GLN . . . . . 0.456 ' HA ' ' HA ' ' B' ' 49' ' ' ASN . 1.9 tt0 -119.32 99.63 6.81 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 121.391 -0.818 . . . . 0.0 109.548 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.634 HD11 ' HB3' ' B' ' 48' ' ' LEU . 12.6 mt -71.98 87.72 1.05 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.156 -0.965 . . . . 0.0 110.386 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 45' ' ' THR . . . . . 0.495 ' HB ' ' HD2' ' A' ' 3' ' ' LYS . 1.8 t 36.2 29.58 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . 93.31 -26.02 17.56 Favored Glycine 0 N--CA 1.491 2.347 0 C-N-CA 119.883 -1.151 . . . . 0.0 112.453 177.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . 0.565 ' CD1' ' HG ' ' B' ' 48' ' ' LEU . 0.4 OUTLIER -81.72 -29.76 32.81 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 119.738 1.769 . . . . 0.0 111.415 -178.776 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . 0.634 ' HB3' HD11 ' B' ' 44' ' ' LEU . 4.6 mt -133.65 95.21 3.43 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.475 -1.391 . . . . 0.0 110.367 177.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 49' ' ' ASN . . . . . 0.456 ' HA ' ' HA ' ' B' ' 43' ' ' GLN . 17.3 t-20 -103.22 90.23 3.66 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.222 -0.924 . . . . 0.0 111.368 -179.326 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 50' ' ' ILE . . . . . 0.462 HD13 ' HB ' ' B' ' 79' ' ' VAL . 1.2 mm -73.44 141.84 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.495 -0.753 . . . . 0.0 109.468 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' B' ' 51' ' ' LYS . 9.6 ptmt -152.52 115.57 2.88 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 120.889 -1.132 . . . . 0.0 110.656 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 52' ' ' PRO . . . . . 0.592 ' HA ' ' HA ' ' B' ' 77' ' ' VAL . 52.7 Cg_endo -77.14 142.89 22.1 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 O-C-N 123.528 1.278 . . . . 0.0 111.194 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.628 ' O ' ' N ' ' B' ' 76' ' ' GLY . 33.2 m -143.15 116.35 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-O 121.416 0.627 . . . . 0.0 110.528 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . 0.547 ' HA ' ' HA ' ' B' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.5 2.042 0 CA-C-O 121.782 0.801 . . . . 0.0 112.213 -178.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . 0.627 ' HB ' ' HB2' ' A' ' 94' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.696 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 76' ' ' GLY . . . . . 0.628 ' N ' ' O ' ' B' ' 53' ' ' VAL . . . -114.25 75.63 0.24 Allowed Glycine 0 N--CA 1.486 1.99 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.592 ' HA ' ' HA ' ' B' ' 52' ' ' PRO . 2.8 p -51.54 82.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.79 -0.829 . . . . 0.0 110.365 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 78' ' ' SER . . . . . 0.584 ' N ' ' O ' ' B' ' 76' ' ' GLY . 0.5 OUTLIER -80.81 177.91 8.73 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.819 -0.753 . . . . 0.0 110.034 179.762 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . 0.462 ' HB ' HD13 ' B' ' 50' ' ' ILE . 7.4 p 177.97 177.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 80' ' ' LYS . . . . . 0.425 ' N ' ' CG2' ' B' ' 79' ' ' VAL . 2.7 ptpt -171.85 173.26 1.69 Allowed Pre-proline 0 C--N 1.307 -1.265 0 O-C-N 120.845 -1.159 . . . . 0.0 110.539 178.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 81' ' ' PRO . . . . . 0.448 ' CB ' ' O ' ' A' ' 77' ' ' VAL . 55.5 Cg_endo -98.9 128.6 0.19 Allowed 'Trans proline' 0 C--N 1.3 -1.989 0 C-N-CA 122.689 2.259 . . . . 0.0 110.549 178.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . 0.435 ' HA3' ' HA ' ' B' ' 47' ' ' PHE . . . -81.8 -155.33 14.68 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 107.941 -2.064 . . . . 0.0 107.941 178.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -93.84 -15.35 25.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.097 -1.237 . . . . 0.0 109.977 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.38 -36.93 66.9 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.247 -0.908 . . . . 0.0 109.144 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . 0.497 ' HG ' ' OG1' ' A' ' 33' ' ' THR . 0.3 OUTLIER -82.29 -32.26 29.64 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.487 -0.758 . . . . 0.0 109.017 179.116 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 86' ' ' LYS . . . . . 0.488 ' O ' ' HB2' ' B' ' 89' ' ' ALA . 2.2 mttp -73.39 -37.43 65.98 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.496 -0.752 . . . . 0.0 109.922 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 28.5 tptt -69.66 -37.99 76.93 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 178.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.592 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -67.85 -34.43 76.69 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 176.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . 0.488 ' HB2' ' O ' ' B' ' 86' ' ' LYS . . . -59.67 -44.6 93.54 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.073 179.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -53.52 -31.83 47.93 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 177.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -68.43 -32.68 75.72 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 178.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 92' ' ' LEU . . . . . 0.577 ' CB ' ' O ' ' A' ' 37' ' ' ALA . 0.5 OUTLIER -73.33 8.97 1.45 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.748 -1.443 . . . . 0.0 111.426 -179.728 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 61.55 38.43 15.61 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 -177.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . 0.61 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 0.2 OUTLIER -45.43 -37.7 5.36 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.609 -178.998 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . 0.448 ' N ' ' CG ' ' B' ' 94' ' ' TYR . 2.6 pp20? -57.28 -38.01 73.28 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.324 -0.86 . . . . 0.0 109.162 179.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.06 -34.84 78.43 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 177.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.481 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.582 ' CG ' ' HB3' ' A' ' 5' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 121.096 0.474 . . . . 0.0 110.25 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . 0.543 ' N ' ' HB2' ' A' ' 5' ' ' GLU . 2.0 t-20 -177.24 -178.84 0.82 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.187 -0.946 . . . . 0.0 110.931 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.467 ' HG2' HD12 ' A' ' 25' ' ' LEU . 8.4 mttt -46.67 -25.13 0.66 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.64 -0.663 . . . . 0.0 109.852 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.446 ' O ' HG21 ' A' ' 7' ' ' ILE . 8.3 m -101.63 -52.4 3.22 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.396 -0.815 . . . . 0.0 110.111 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.582 ' HB3' ' CG ' ' A' ' 1' ' ' MET . 6.7 mt-10 -53.7 -47.61 70.33 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.107 -0.996 . . . . 0.0 108.573 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.459 ' HB2' ' O ' ' A' ' 2' ' ' ASN . 4.1 mt -55.37 -37.67 67.83 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 119.177 -1.009 . . . . 0.0 108.814 177.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.589 HD12 HD22 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -50.77 -44.86 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.081 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.752 ' HA ' ' HB1' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -68.18 -32.4 72.61 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.745 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.437 ' HB1' ' HA ' ' A' ' 6' ' ' LEU . . . -53.23 -38.52 63.01 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.369 -0.832 . . . . 0.0 109.033 179.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.765 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.3 mp -102.32 -29.7 3.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.752 ' HB1' ' HA ' ' A' ' 8' ' ' LYS . . . -69.11 -11.32 60.69 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 118.554 -1.259 . . . . 0.0 108.577 178.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.418 ' CG ' ' O ' ' A' ' 8' ' ' LYS . 54.0 mm-40 -113.74 -42.49 3.42 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.484 -0.76 . . . . 0.0 109.053 178.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.429 ' HB2' ' O ' ' A' ' 9' ' ' ALA . 1.5 m-20 -65.54 -36.17 83.0 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 177.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.765 ' OG1' ' O ' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -99.69 -73.04 0.64 Allowed 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 178.144 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 46.32 22.55 0.99 Allowed Glycine 0 N--CA 1.5 2.919 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 178.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.576 ' CD1' ' CG2' ' B' ' 19' ' ' VAL . 0.0 OUTLIER -75.05 -26.25 59.27 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 121.507 -0.996 . . . . 0.0 108.8 179.323 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.559 ' O ' HG23 ' A' ' 17' ' ' THR . 0.4 OUTLIER -162.05 -2.91 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.932 -179.191 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.575 ' O ' ' C ' ' A' ' 19' ' ' VAL . 21.9 mt-30 57.92 28.16 15.73 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -176.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.701 ' HB ' ' HB ' ' B' ' 19' ' ' VAL . 1.6 p -1.76 -90.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.235 -178.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.958 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.4 OUTLIER -129.98 25.6 5.26 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 178.918 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.745 ' HA ' ' CE ' ' A' ' 24' ' ' MET . 13.5 m -22.91 -41.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 CA-C-O 122.576 1.179 . . . . 0.0 108.777 -178.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.747 ' N ' ' O ' ' A' ' 20' ' ' SER . 6.6 m -76.36 -37.74 56.83 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.731 177.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.958 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.9 OUTLIER -89.01 -38.73 14.19 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.493 -0.755 . . . . 0.0 111.717 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.745 ' CE ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -66.88 -27.75 67.77 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.075 -1.64 . . . . 0.0 109.178 179.648 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.64 ' HG ' ' N ' ' A' ' 26' ' ' ALA . 0.2 OUTLIER -82.94 -45.47 14.11 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 118.865 -1.134 . . . . 0.0 108.982 178.618 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.64 ' N ' ' HG ' ' A' ' 25' ' ' LEU . . . -66.4 -27.64 68.01 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.56 ' O ' ' N ' ' A' ' 31' ' ' ILE . 52.9 p -87.76 -31.24 19.73 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.814 ' O ' HG13 ' A' ' 31' ' ' ILE . 0.1 OUTLIER -55.66 -48.17 75.47 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.562 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.57 ' HG3' HG22 ' B' ' 45' ' ' THR . 1.0 OUTLIER -69.89 -36.37 75.37 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 177.01 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 1.193 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 35.7 tttp -65.22 -17.8 64.78 Favored 'General case' 0 C--O 1.19 -2.043 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.814 HG13 ' O ' ' A' ' 28' ' ' PHE . 1.2 pp -108.56 -30.07 2.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 120.195 -1.566 . . . . 0.0 108.916 178.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.598 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.1 mm -71.41 -58.06 6.05 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 176.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.613 ' O ' ' HB3' ' B' ' 88' ' ' ALA . 0.6 OUTLIER -69.95 -42.26 73.45 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.915 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 1.193 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 55.1 mm-40 -68.39 -34.39 75.95 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 120.728 -1.232 . . . . 0.0 111.178 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.537 ' CB ' ' O ' ' A' ' 31' ' ' ILE . 1.8 m -57.85 -49.1 77.83 Favored 'General case' 0 N--CA 1.5 2.037 0 C-N-CA 118.071 -1.451 . . . . 0.0 107.446 178.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.453 HG12 ' CG2' ' A' ' 77' ' ' VAL . 36.4 t -55.13 -35.81 36.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 C-N-CA 117.85 -1.54 . . . . 0.0 107.362 177.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.784 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -84.86 2.77 41.0 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 121.626 0.727 . . . . 0.0 109.094 177.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.513 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -110.13 -15.82 13.92 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.798 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.93 46.89 3.27 Favored Glycine 0 C--N 1.304 -1.243 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 178.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.486 ' CB ' HG23 ' A' ' 35' ' ' THR . 0.3 OUTLIER -137.25 136.68 38.31 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.052 -1.264 . . . . 0.0 110.861 179.521 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.5 mtmm -80.06 91.96 5.56 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.572 -0.705 . . . . 0.0 109.45 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.429 HG23 ' CG2' ' A' ' 35' ' ' THR . 41.1 t -59.97 124.34 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.615 -0.678 . . . . 0.0 110.163 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.416 ' O ' ' HA ' ' B' ' 2' ' ' ASN . 19.1 mt-30 -125.5 165.17 18.95 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.341 -0.849 . . . . 0.0 109.832 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.614 ' HB3' ' CE1' ' A' ' 47' ' ' PHE . 72.1 mt -134.43 108.09 7.95 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.416 -0.803 . . . . 0.0 109.084 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.508 HG22 ' HG3' ' B' ' 29' ' ' GLU . 0.0 OUTLIER 35.22 -96.05 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.871 -0.518 . . . . 0.0 111.475 -179.037 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -138.91 22.55 2.96 Favored Glycine 0 N--CA 1.488 2.12 0 C-N-CA 119.385 -1.388 . . . . 0.0 110.911 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.621 ' CD1' ' HG3' ' B' ' 29' ' ' GLU . 17.6 p90 -118.13 -56.82 2.14 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.728 -1.454 . . . . 0.0 111.101 179.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.607 ' HB2' HD13 ' A' ' 44' ' ' LEU . 0.9 OUTLIER -103.89 128.89 51.36 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.057 -1.652 . . . . 0.0 115.281 -178.162 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.547 ' CB ' ' CG ' ' A' ' 81' ' ' PRO . 19.2 t-20 -129.72 99.9 5.3 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.564 177.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.546 ' HA ' HG12 ' A' ' 79' ' ' VAL . 1.0 OUTLIER -86.82 158.07 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.162 -0.961 . . . . 0.0 110.21 -179.93 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.402 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 6.6 ptmt -166.49 123.39 0.99 Allowed Pre-proline 0 N--CA 1.496 1.833 0 C-N-CA 118.681 -1.208 . . . . 0.0 111.213 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.606 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 54.0 Cg_endo -79.96 144.31 16.88 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.609 1.32 . . . . 0.0 110.985 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.517 ' O ' ' N ' ' A' ' 76' ' ' GLY . 28.4 m -137.06 113.81 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 CA-C-O 121.849 0.833 . . . . 0.0 111.459 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.507 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.499 1.989 0 O-C-N 121.62 -0.675 . . . . 0.0 111.006 -179.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.602 HG22 HD23 ' B' ' 92' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 121.18 0.514 . . . . 0.0 109.919 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.574 ' O ' ' N ' ' A' ' 78' ' ' SER . . . -105.99 77.16 0.24 Allowed Glycine 0 N--CA 1.484 1.874 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.61 ' CG1' ' HB2' ' B' ' 85' ' ' LEU . 15.5 t -59.87 77.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.492 -1.005 . . . . 0.0 109.232 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.574 ' N ' ' O ' ' A' ' 76' ' ' GLY . 0.3 OUTLIER -97.31 -165.18 1.23 Allowed 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 122.461 1.124 . . . . 0.0 111.733 -178.671 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.546 HG12 ' HA ' ' A' ' 50' ' ' ILE . 29.9 m -152.82 -157.08 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.64 ' HB3' ' HD3' ' A' ' 81' ' ' PRO . 0.1 OUTLIER -172.06 -58.12 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.69 0 C-N-CA 118.345 -1.342 . . . . 0.0 112.824 179.421 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.64 ' HD3' ' HB3' ' A' ' 80' ' ' LYS . 55.8 Cg_endo -89.62 171.82 4.13 Favored 'Trans proline' 0 C--N 1.297 -2.151 0 O-C-N 123.595 1.313 . . . . 0.0 112.963 -176.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.65 ' O ' ' C ' ' A' ' 83' ' ' GLU . . . 176.2 -1.57 0.03 OUTLIER Glycine 0 C--N 1.301 -1.405 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 179.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.905 ' O ' ' N ' ' A' ' 85' ' ' LEU . 11.8 pt-20 31.8 45.78 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 -176.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.741 ' HB3' ' HB2' ' A' ' 86' ' ' LYS . 1.2 t 12.4 41.71 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.335 0 CA-C-O 122.873 1.321 . . . . 0.0 109.608 -177.021 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.905 ' N ' ' O ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER 18.31 27.05 0.0 OUTLIER 'General case' 0 C--O 1.189 -2.117 0 N-CA-C 101.381 -3.563 . . . . 0.0 101.381 -173.293 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.741 ' HB2' ' HB3' ' A' ' 84' ' ' SER 0.351 4.5 tttt -51.91 -44.25 63.72 Favored 'General case' 0 CA--C 1.469 -2.145 0 CA-C-N 111.808 -2.451 . . . . 0.0 105.631 178.589 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.277 23.6 tttt -62.23 -38.02 87.62 Favored 'General case' 0 C--N 1.268 -2.971 0 CA-C-N 111.409 -2.632 . . . . 0.0 106.625 177.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.659 ' O ' ' HG ' ' A' ' 92' ' ' LEU . . . -86.99 -22.34 25.6 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 118.232 -1.387 . . . . 0.0 109.39 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.793 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . -76.32 -47.13 24.66 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.494 ' HA ' ' CB ' ' A' ' 94' ' ' TYR . 4.0 mm-40 -56.86 -27.24 60.11 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 175.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.445 ' C ' ' CD2' ' A' ' 92' ' ' LEU . . . -76.95 -32.52 49.15 Favored Glycine 0 CA--C 1.548 2.147 0 CA-C-O 118.496 -1.169 . . . . 0.0 113.169 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.659 ' HG ' ' O ' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -115.21 -74.2 0.62 Allowed 'General case' 0 N--CA 1.505 2.312 0 CA-C-N 122.31 3.055 . . . . 0.0 113.44 -177.301 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -120.39 42.0 3.09 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.827 -1.171 . . . . 0.0 112.713 -177.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.494 ' CB ' ' HA ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -74.37 -55.5 5.93 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.102 -0.999 . . . . 0.0 108.923 178.371 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.432 ' N ' ' CG ' ' A' ' 94' ' ' TYR . 12.0 pt-20 . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.604 -0.685 . . . . 0.0 109.547 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.437 ' HG2' ' HB3' ' B' ' 5' ' ' GLU . 9.0 mtp . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 120.867 0.365 . . . . 0.0 110.063 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 2' ' ' ASN . . . . . 0.421 ' O ' ' HB2' ' B' ' 6' ' ' LEU . 1.0 OUTLIER -176.48 -172.97 0.49 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.237 -0.914 . . . . 0.0 110.801 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.557 ' O ' HG13 ' B' ' 7' ' ' ILE . 0.0 OUTLIER -54.24 -15.07 1.35 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.234 -0.916 . . . . 0.0 110.335 179.785 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.531 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 19.1 m -105.64 -46.65 4.11 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.106 -0.996 . . . . 0.0 108.69 178.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.437 ' HB3' ' HG2' ' B' ' 1' ' ' MET . 0.8 OUTLIER -62.01 -50.6 71.39 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.927 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.469 ' HA ' ' HB3' ' B' ' 9' ' ' ALA . 2.0 mt -64.51 -26.51 68.46 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.488 -0.885 . . . . 0.0 109.013 178.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 7' ' ' ILE . . . . . 0.723 HG12 ' O ' ' B' ' 21' ' ' VAL . 0.3 OUTLIER -56.84 -58.97 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.408 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . 0.45 ' N ' ' CG2' ' B' ' 7' ' ' ILE . 0.1 OUTLIER -62.43 -26.99 68.79 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.137 178.758 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . 0.469 ' HB3' ' HA ' ' B' ' 6' ' ' LEU . . . -59.85 -34.67 73.42 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 119.441 -0.904 . . . . 0.0 108.699 178.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . 0.862 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.0 OUTLIER -97.47 -36.82 6.3 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.498 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 178.522 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.491 ' HA ' ' OG1' ' B' ' 14' ' ' THR . . . -59.04 -28.3 66.3 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -90.8 -42.01 10.9 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.458 ' HB3' ' CB ' ' A' ' 27' ' ' SER . 82.6 m-20 -64.98 -23.13 67.13 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 106.932 -1.506 . . . . 0.0 106.932 176.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.862 ' OG1' ' O ' ' B' ' 10' ' ' ILE . 17.8 p -93.41 -75.57 0.49 Allowed 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 58.35 17.72 33.15 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 16' ' ' LEU . . . . . 0.665 HD11 ' HB ' ' B' ' 14' ' ' THR . 2.7 mp -84.32 -59.28 2.44 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.324 -1.103 . . . . 0.0 108.411 178.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 17' ' ' THR . . . . . 0.531 HG22 ' O ' ' B' ' 17' ' ' THR . 0.5 OUTLIER -140.87 3.44 1.83 Allowed 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.357 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . 0.594 ' O ' ' C ' ' B' ' 19' ' ' VAL . 16.6 mt-30 57.14 24.71 10.03 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 106.762 -1.569 . . . . 0.0 106.762 -176.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.701 ' HB ' ' HB ' ' A' ' 19' ' ' VAL . 0.1 OUTLIER 10.61 -94.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.917 -179.167 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 20' ' ' SER . . . . . 1.025 ' O ' ' N ' ' B' ' 22' ' ' SER . 0.3 OUTLIER -137.17 23.46 3.01 Favored 'General case' 0 C--N 1.276 -2.619 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 178.193 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . 0.723 ' O ' HG12 ' B' ' 7' ' ' ILE . 15.3 m -5.24 -44.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 122.503 1.144 . . . . 0.0 110.537 -177.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 1.025 ' N ' ' O ' ' B' ' 20' ' ' SER . 5.8 m -79.54 -38.59 33.87 Favored 'General case' 0 C--N 1.281 -2.393 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.355 178.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . 0.932 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.5 OUTLIER -91.12 -24.61 19.93 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.418 -0.801 . . . . 0.0 110.875 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 24' ' ' MET . . . . . 0.536 ' SD ' ' HA ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -77.07 -38.76 51.86 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 117.444 -1.703 . . . . 0.0 108.558 178.349 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . 0.623 ' HA ' ' HB3' ' B' ' 28' ' ' PHE . 0.3 OUTLIER -78.0 -36.17 49.13 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 118.234 -1.387 . . . . 0.0 108.438 177.711 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . 0.434 ' CB ' ' O ' ' B' ' 22' ' ' SER . . . -64.45 -34.61 78.6 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 176.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 27' ' ' SER . . . . . 0.591 ' O ' HG13 ' B' ' 31' ' ' ILE . 29.2 t -80.42 -32.09 37.45 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . 0.623 ' HB3' ' HA ' ' B' ' 25' ' ' LEU . 0.4 OUTLIER -52.74 -47.11 67.62 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.828 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . 0.621 ' HG3' ' CD1' ' A' ' 47' ' ' PHE . 1.7 tt0 -68.47 -35.61 77.81 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 176.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . 1.159 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 2.0 tttt -63.8 -19.39 64.97 Favored 'General case' 0 C--O 1.189 -2.096 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.095 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.615 ' CG1' ' HA ' ' B' ' 28' ' ' PHE . 1.4 pp -107.43 -28.24 2.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 120.29 -1.506 . . . . 0.0 108.714 178.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.582 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.2 mm -72.66 -58.18 5.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 176.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 33' ' ' THR . . . . . 0.66 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 0.6 OUTLIER -68.52 -38.07 80.57 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.771 179.169 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 1.159 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 78.7 mm-40 -76.95 -27.57 54.87 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 121.172 -0.955 . . . . 0.0 111.963 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 35' ' ' THR . . . . . 0.558 ' O ' ' N ' ' B' ' 38' ' ' LYS . 2.7 m -70.63 -59.75 2.65 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 117.706 -1.597 . . . . 0.0 109.462 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.573 HG12 ' HG3' ' B' ' 52' ' ' PRO . 0.9 OUTLIER -51.02 -43.86 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 178.94 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . 0.579 ' HB2' ' CB ' ' A' ' 88' ' ' ALA . . . -60.91 -27.83 68.48 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.829 177.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . 0.558 ' N ' ' O ' ' B' ' 35' ' ' THR . 0.6 OUTLIER -76.64 -32.3 57.91 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 177.574 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.5 23.7 4.99 Favored Glycine 0 C--N 1.295 -1.695 0 C-N-CA 120.087 -1.054 . . . . 0.0 110.944 177.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . 0.472 ' CB ' HG21 ' B' ' 35' ' ' THR . 0.4 OUTLIER -100.48 158.34 15.98 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.103 -1.234 . . . . 0.0 109.749 179.38 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -95.28 90.77 5.97 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.388 -0.82 . . . . 0.0 110.436 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 73.3 t -59.83 118.43 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.423 -0.798 . . . . 0.0 109.712 179.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -123.71 93.22 3.87 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.309 -0.869 . . . . 0.0 110.068 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.601 ' HB2' ' HB2' ' B' ' 48' ' ' LEU . 75.3 mt -62.33 101.18 0.21 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.173 -0.954 . . . . 0.0 109.549 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 45' ' ' THR . . . . . 0.57 HG22 ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 34.99 -94.78 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.928 -0.482 . . . . 0.0 111.31 -179.557 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . 0.418 ' H ' HG23 ' B' ' 45' ' ' THR . . . -141.0 20.45 2.68 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 119.493 -1.337 . . . . 0.0 110.908 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . 0.577 ' CZ ' HD12 ' B' ' 44' ' ' LEU . 8.8 p90 -119.84 -22.71 6.69 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.702 -1.47 . . . . 0.0 111.446 179.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . 0.601 ' HB2' ' HB2' ' B' ' 44' ' ' LEU . 0.2 OUTLIER -133.48 139.21 46.54 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.614 -1.304 . . . . 0.0 111.472 178.242 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -143.31 116.69 9.07 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.738 -0.601 . . . . 0.0 109.952 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 50' ' ' ILE . . . . . 0.453 ' CD1' HG21 ' B' ' 79' ' ' VAL . 6.4 mm -116.79 147.05 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 O-C-N 121.314 -0.866 . . . . 0.0 110.592 -179.359 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' B' ' 78' ' ' SER . 14.4 ptmt -156.81 124.85 2.83 Favored Pre-proline 0 N--CA 1.502 2.164 0 O-C-N 120.877 -1.139 . . . . 0.0 110.631 179.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 52' ' ' PRO . . . . . 0.583 ' HA ' ' HA ' ' B' ' 77' ' ' VAL . 53.6 Cg_endo -84.96 150.75 11.01 Favored 'Trans proline' 0 C--N 1.317 -1.12 0 O-C-N 123.239 1.126 . . . . 0.0 111.748 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.541 ' O ' ' N ' ' B' ' 76' ' ' GLY . 33.0 m -140.54 115.69 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 CA-C-O 121.966 0.889 . . . . 0.0 110.391 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 122.073 0.94 . . . . 0.0 112.237 -178.422 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . 0.417 ' CG2' ' HA ' ' A' ' 94' ' ' TYR . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 76' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' B' ' 53' ' ' VAL . . . -121.86 96.42 0.58 Allowed Glycine 0 N--CA 1.494 2.536 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.588 ' O ' ' CG1' ' B' ' 77' ' ' VAL . 8.1 p -67.63 74.54 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.644 -0.915 . . . . 0.0 111.5 -178.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 78' ' ' SER . . . . . 0.578 ' C ' ' CG1' ' B' ' 79' ' ' VAL . 0.1 OUTLIER -61.45 172.76 1.07 Allowed 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 117.368 -1.733 . . . . 0.0 107.463 178.209 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . 0.595 ' CG2' ' N ' ' B' ' 80' ' ' LYS . 0.2 OUTLIER 176.41 173.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.041 -1.037 . . . . 0.0 110.137 179.397 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 80' ' ' LYS . . . . . 0.595 ' N ' ' CG2' ' B' ' 79' ' ' VAL . 0.1 OUTLIER 176.08 171.14 0.34 Allowed Pre-proline 0 C--N 1.299 -1.61 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 175.955 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 81' ' ' PRO . . . . . 0.513 ' HA ' ' O ' ' B' ' 47' ' ' PHE . 54.0 Cg_endo -89.89 -169.43 0.36 Allowed 'Trans proline' 0 C--N 1.293 -2.361 0 O-C-N 123.712 1.375 . . . . 0.0 109.791 176.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -128.83 -90.96 0.65 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 106.293 -2.723 . . . . 0.0 106.293 178.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . 0.949 ' O ' ' N ' ' B' ' 85' ' ' LEU . 1.6 tt0 -77.99 56.65 1.63 Allowed 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 175.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 84' ' ' SER . . . . . 1.302 ' O ' ' N ' ' B' ' 86' ' ' LYS . 0.3 OUTLIER 8.43 43.84 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 122.396 1.093 . . . . 0.0 110.274 -179.79 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . 0.98 ' C ' ' O ' ' B' ' 84' ' ' SER . 3.7 mp 20.92 29.69 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 103.616 -2.735 . . . . 0.0 103.616 -172.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 86' ' ' LYS . . . . . 1.302 ' N ' ' O ' ' B' ' 84' ' ' SER 0.346 15.6 tttt -57.79 -42.45 84.18 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 104.161 -2.533 . . . . 0.0 104.161 177.043 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . 0.42 ' O ' ' CG ' ' B' ' 90' ' ' GLU 0.286 34.8 tttp -65.14 -34.41 78.34 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 112.055 -2.339 . . . . 0.0 105.846 175.342 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.674 ' O ' ' CB ' ' A' ' 37' ' ' ALA . . . -78.84 -25.24 44.08 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 118.419 -1.313 . . . . 0.0 108.051 178.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . 0.692 ' N ' ' O ' ' B' ' 85' ' ' LEU . . . -68.42 -49.76 57.69 Favored 'General case' 0 C--N 1.294 -1.843 0 O-C-N 121.141 -0.975 . . . . 0.0 109.291 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . 0.42 ' CG ' ' O ' ' B' ' 87' ' ' LYS . 7.0 pt-20 -58.52 -27.18 64.27 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 177.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . 0.451 ' HA3' ' HB2' ' A' ' 37' ' ' ALA . . . -75.97 -23.07 72.88 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 179.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 92' ' ' LEU . . . . . 0.784 ' HB3' ' HA ' ' A' ' 37' ' ' ALA . 0.4 OUTLIER -80.79 21.65 0.66 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.575 -1.544 . . . . 0.0 110.38 179.625 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 93' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' B' ' 92' ' ' LEU . 0.9 OUTLIER 58.18 37.85 26.28 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 -177.067 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . 0.537 ' CD1' ' N ' ' A' ' 75' ' ' VAL . 52.3 t80 -33.89 -45.94 0.21 Allowed 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 114.926 -1.033 . . . . 0.0 111.602 -178.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -56.92 -44.67 82.68 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.156 -0.965 . . . . 0.0 109.599 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 96' ' ' ASP . . . . . 0.436 ' N ' ' O ' ' B' ' 93' ' ' LYS . 0.2 OUTLIER -57.07 -33.43 67.27 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.777 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.473 ' HB3' ' HG ' ' A' ' 6' ' ' LEU . 9.6 mtp . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . 0.429 ' HA ' ' O ' ' B' ' 43' ' ' GLN . 0.6 OUTLIER -173.13 -168.76 0.49 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.99 -1.069 . . . . 0.0 112.043 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.465 ' O ' ' CG2' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -51.92 -16.5 0.73 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.604 -0.685 . . . . 0.0 109.856 179.697 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.73 ' O ' HG13 ' A' ' 7' ' ' ILE . 1.4 m -112.86 -53.92 2.67 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.822 0.82 . . . . 0.0 109.906 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.551 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 0.1 OUTLIER -48.41 -48.26 37.19 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.154 -0.966 . . . . 0.0 109.068 -179.955 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.473 ' HG ' ' HB3' ' A' ' 1' ' ' MET . 1.2 mt -61.01 -29.79 69.92 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.363 -0.935 . . . . 0.0 110.44 178.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.73 HG13 ' O ' ' A' ' 4' ' ' THR . 1.0 OUTLIER -60.82 -44.18 97.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 120.621 -1.299 . . . . 0.0 107.868 179.381 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.551 ' HE2' ' HA ' ' A' ' 5' ' ' GLU . 0.0 OUTLIER -64.6 -33.35 75.71 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 177.658 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.425 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . . . -56.19 -38.82 71.48 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 119.921 -0.712 . . . . 0.0 109.165 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.823 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.1 mp -90.98 -33.18 5.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 178.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.558 ' HB3' ' O ' ' A' ' 7' ' ' ILE . . . -62.93 -13.43 34.37 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 118.574 -1.251 . . . . 0.0 108.655 178.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.45 ' CG ' ' N ' ' A' ' 13' ' ' ASP . 8.0 pt20 -115.53 -42.24 3.16 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.486 -0.759 . . . . 0.0 110.177 179.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.45 ' N ' ' CG ' ' A' ' 12' ' ' GLN . 65.6 m-20 -69.76 -31.29 69.17 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 177.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.823 ' OG1' ' O ' ' A' ' 10' ' ' ILE 0.265 0.2 OUTLIER -99.27 -67.95 0.83 Allowed 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 178.666 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 53.06 23.82 18.05 Favored Glycine 0 N--CA 1.501 3.022 0 O-C-N 121.439 -0.788 . . . . 0.0 111.417 177.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.84 HD13 ' HB2' ' B' ' 20' ' ' SER . 4.7 mp -67.85 -69.15 0.34 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.536 -0.979 . . . . 0.0 110.028 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.453 HG22 ' O ' ' A' ' 17' ' ' THR . 0.6 OUTLIER -130.17 6.03 4.92 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.843 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.597 ' O ' ' C ' ' A' ' 19' ' ' VAL . 22.8 mt-30 56.94 28.01 14.03 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 -176.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.608 ' HB ' ' HB ' ' B' ' 19' ' ' VAL . 0.4 OUTLIER -9.24 -97.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.306 -179.412 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.97 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.9 OUTLIER -136.37 25.1 3.21 Favored 'General case' 0 C--N 1.278 -2.516 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 177.779 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.659 ' HA ' ' SD ' ' A' ' 24' ' ' MET . 27.2 m -18.23 -39.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 CA-C-O 122.24 1.019 . . . . 0.0 110.343 -177.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.806 ' N ' ' O ' ' A' ' 20' ' ' SER . 5.2 m -80.02 -37.55 33.89 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 115.032 -0.986 . . . . 0.0 108.998 178.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.97 ' N ' ' O ' ' A' ' 20' ' ' SER . 2.6 mtpt -88.0 -30.45 19.97 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.867 -0.521 . . . . 0.0 111.24 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.733 ' N ' ' OG ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -74.48 -36.76 63.3 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 117.982 -1.487 . . . . 0.0 109.14 -179.671 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.52 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 12.8 mt -77.27 -47.33 20.37 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 118.11 -1.436 . . . . 0.0 107.851 177.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 22' ' ' SER . . . -54.82 -33.57 61.78 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 177.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.572 ' HA ' ' HB3' ' A' ' 30' ' ' LYS . 89.6 p -78.38 -34.03 48.47 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.712 ' HA ' ' CG1' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -66.31 -31.15 71.77 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.381 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.685 ' O ' ' HB ' ' A' ' 33' ' ' THR . 1.6 mt-10 -86.21 -33.13 20.85 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 177.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.741 ' O ' ' CG ' ' A' ' 34' ' ' GLU . 17.6 tttm -69.26 -30.63 68.79 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 176.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.712 ' CG1' ' HA ' ' A' ' 28' ' ' PHE . 1.8 pp -91.33 -36.18 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.35 -0.844 . . . . 0.0 109.379 178.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.693 HG13 ' CE1' ' A' ' 28' ' ' PHE . 3.4 mm -58.42 -55.23 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 177.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.685 ' HB ' ' O ' ' A' ' 29' ' ' GLU . 0.3 OUTLIER -63.01 -36.88 85.04 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.559 179.862 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.741 ' CG ' ' O ' ' A' ' 30' ' ' LYS . 5.2 mm-40 -72.68 -47.05 50.53 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.758 -0.588 . . . . 0.0 111.845 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.473 ' HA ' ' CB ' ' A' ' 38' ' ' LYS . 66.5 m -56.02 -50.78 69.96 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.536 -1.352 . . . . 0.0 109.722 -179.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.501 ' CG1' ' HB3' ' A' ' 52' ' ' PRO . 2.1 t -50.08 -44.54 22.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.733 ' HB3' ' C ' ' B' ' 88' ' ' ALA . . . -84.26 -4.87 59.12 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 121.746 0.784 . . . . 0.0 110.024 178.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.635 ' N ' ' O ' ' A' ' 34' ' ' GLU . 3.1 ttmt -90.66 -26.21 19.72 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 177.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.05 37.04 0.9 Allowed Glycine 0 C--N 1.302 -1.319 0 C-N-CA 120.071 -1.062 . . . . 0.0 111.185 177.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.434 ' CB ' ' CG2' ' A' ' 35' ' ' THR . 0.3 OUTLIER -145.53 140.89 27.8 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.906 -1.35 . . . . 0.0 110.713 179.356 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -92.07 93.73 8.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.666 -0.646 . . . . 0.0 109.374 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.487 ' CG2' ' HB ' ' A' ' 50' ' ' ILE . 31.6 m -60.19 137.39 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.544 -0.723 . . . . 0.0 110.382 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.457 ' O ' ' CB ' ' B' ' 2' ' ' ASN . 3.9 mt-30 -125.7 107.92 11.02 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.413 -0.805 . . . . 0.0 110.008 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.625 HD13 ' HB3' ' A' ' 48' ' ' LEU . 24.1 mt -72.38 103.49 3.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.182 -0.949 . . . . 0.0 109.892 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.452 ' CG2' ' C ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER 33.55 -96.65 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.915 -0.491 . . . . 0.0 111.193 -179.748 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.7 28.98 2.01 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.6 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 1.5 p90 -129.43 -25.34 2.67 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.097 -1.237 . . . . 0.0 111.275 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.625 ' HB3' HD13 ' A' ' 44' ' ' LEU . 5.0 mt -134.79 95.85 3.42 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.45 -1.406 . . . . 0.0 110.6 178.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.416 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 4.5 m-20 -103.98 89.6 3.34 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.178 -0.951 . . . . 0.0 110.888 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.487 ' HB ' ' CG2' ' A' ' 42' ' ' VAL . 0.9 OUTLIER -80.31 153.46 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.393 -0.817 . . . . 0.0 110.301 179.645 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.529 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 16.0 ptmt -165.58 115.25 0.82 Allowed Pre-proline 0 N--CA 1.495 1.811 0 C-N-CA 118.969 -1.092 . . . . 0.0 110.43 178.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.553 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 55.3 Cg_endo -78.13 141.51 18.62 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.451 1.238 . . . . 0.0 111.089 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.628 ' O ' ' N ' ' A' ' 76' ' ' GLY . 23.8 m -146.39 115.32 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-O 121.57 0.7 . . . . 0.0 110.393 179.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.515 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.503 2.181 0 CA-C-O 121.086 0.47 . . . . 0.0 111.938 -178.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.55 ' CG1' ' HB1' ' B' ' 89' ' ' ALA . 4.4 p . . . . . 0 N--CA 1.506 2.359 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.628 ' N ' ' O ' ' A' ' 53' ' ' VAL . . . -123.6 61.41 0.58 Allowed Glycine 0 N--CA 1.487 2.094 0 N-CA-C 108.935 -1.666 . . . . 0.0 108.935 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.553 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 3.4 p -47.73 82.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.803 -0.821 . . . . 0.0 110.803 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.599 ' N ' ' O ' ' A' ' 76' ' ' GLY . 0.4 OUTLIER -83.73 174.84 10.13 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 118.597 -1.241 . . . . 0.0 110.093 179.952 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.476 ' HA ' ' HA ' ' A' ' 50' ' ' ILE . 2.6 p 175.15 176.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.465 ' N ' ' CG2' ' A' ' 79' ' ' VAL . 0.1 OUTLIER -177.14 173.0 0.76 Allowed Pre-proline 0 N--CA 1.485 1.324 0 O-C-N 120.934 -1.103 . . . . 0.0 110.195 177.377 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.453 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 55.0 Cg_endo -98.6 135.45 0.3 Allowed 'Trans proline' 0 C--N 1.302 -1.904 0 C-N-CA 122.505 2.137 . . . . 0.0 110.622 178.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.424 ' HA3' ' HA ' ' A' ' 47' ' ' PHE . . . -89.73 -158.28 34.17 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 107.956 -2.058 . . . . 0.0 107.956 178.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -90.17 -16.12 30.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.029 -1.277 . . . . 0.0 110.217 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.42 -36.61 61.71 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.269 -0.895 . . . . 0.0 109.267 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.451 ' CB ' ' CG2' ' B' ' 77' ' ' VAL . 0.5 OUTLIER -82.3 -33.21 29.12 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.915 -0.714 . . . . 0.0 109.158 179.07 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.403 ' HA ' ' HB2' ' A' ' 89' ' ' ALA . 2.2 mttt -70.97 -43.83 67.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.458 -0.776 . . . . 0.0 109.755 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.4 tptt -64.71 -39.06 93.0 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 177.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.634 ' O ' ' HB1' ' B' ' 37' ' ' ALA . . . -64.55 -34.9 79.31 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 176.34 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.438 ' HB3' ' CG1' ' B' ' 75' ' ' VAL . . . -54.43 -46.3 73.21 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 120.036 -0.666 . . . . 0.0 109.211 179.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -52.65 -32.58 42.85 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 177.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 88' ' ' ALA . . . -64.65 -38.42 95.64 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 178.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.565 ' HB3' ' HA ' ' B' ' 37' ' ' ALA . 0.5 OUTLIER -72.45 10.37 0.83 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.537 -1.567 . . . . 0.0 111.13 -179.85 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 22.1 mmtt 61.41 41.69 12.54 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -177.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.544 ' CD1' ' N ' ' B' ' 75' ' ' VAL . 0.0 OUTLIER -38.0 -40.27 0.46 Allowed 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.005 -178.962 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? . . . . . 0 N--CA 1.494 1.75 0 O-C-N 121.37 -0.831 . . . . 0.0 109.769 179.698 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.471 ' CB ' ' CB ' ' B' ' 5' ' ' GLU . 1.3 ptm . . . . . 0 N--CA 1.496 1.842 0 CA-C-O 121.479 0.657 . . . . 0.0 110.871 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 2' ' ' ASN . . . . . 0.457 ' CB ' ' O ' ' A' ' 43' ' ' GLN . 17.8 p30 -178.3 -152.32 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 120.106 -0.637 . . . . 0.0 110.516 178.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.569 ' O ' HD22 ' B' ' 25' ' ' LEU . 1.0 OUTLIER -59.14 -3.22 0.35 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.147 -0.971 . . . . 0.0 110.207 179.612 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.593 ' O ' HG22 ' B' ' 7' ' ' ILE . 25.1 m -109.01 -53.26 2.67 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.003 -1.061 . . . . 0.0 109.969 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.471 ' CB ' ' CB ' ' B' ' 1' ' ' MET . 1.8 mt-10 -65.88 -46.84 76.9 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.199 -0.938 . . . . 0.0 109.532 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 29.9 mt -49.05 -51.7 29.69 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.213 -0.929 . . . . 0.0 109.643 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 7' ' ' ILE . . . . . 0.593 HG22 ' O ' ' B' ' 4' ' ' THR . 0.1 OUTLIER -50.22 -51.05 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 177.414 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . 0.483 ' N ' ' CG1' ' B' ' 7' ' ' ILE . 0.1 OUTLIER -56.15 -37.38 69.42 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.489 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . 0.418 ' N ' ' O ' ' B' ' 5' ' ' GLU . . . -55.34 -36.2 66.03 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.372 -0.83 . . . . 0.0 108.825 179.063 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . 0.647 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.6 mp -89.22 -34.22 6.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 178.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.22 -12.48 60.18 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.476 ' N ' ' O ' ' B' ' 8' ' ' LYS . 8.9 tp-100 -112.61 -44.19 3.37 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' B' ' 9' ' ' ALA . 2.2 m-20 -68.89 -22.41 64.19 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 176.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.647 ' OG1' ' O ' ' B' ' 10' ' ' ILE . 0.2 OUTLIER -120.04 -83.54 0.65 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.297 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . 0.546 ' O ' ' C ' ' B' ' 16' ' ' LEU . . . 68.32 -21.84 0.3 Allowed Glycine 0 N--CA 1.497 2.713 0 O-C-N 120.906 -1.121 . . . . 0.0 110.346 178.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 16' ' ' LEU . . . . . 0.738 ' N ' HD13 ' B' ' 16' ' ' LEU . 0.0 OUTLIER -25.57 -58.3 0.07 Allowed 'General case' 0 N--CA 1.514 2.735 0 CA-C-O 122.202 1.001 . . . . 0.0 110.794 -179.819 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 17' ' ' THR . . . . . 0.474 ' O ' HG23 ' B' ' 17' ' ' THR . 0.5 OUTLIER -136.25 -0.89 2.42 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.419 -179.38 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . 0.655 ' O ' ' C ' ' B' ' 19' ' ' VAL . 4.7 mt-30 55.24 31.15 15.95 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 -176.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.656 HG21 ' CD1' ' A' ' 16' ' ' LEU . 1.2 p -4.09 -92.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.856 -178.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 20' ' ' SER . . . . . 0.934 ' O ' ' N ' ' B' ' 22' ' ' SER . 0.6 OUTLIER -133.37 25.83 4.14 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 177.803 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . 0.677 ' C ' ' O ' ' B' ' 20' ' ' SER . 30.0 m -17.26 -37.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-O 122.426 1.107 . . . . 0.0 109.374 -178.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.934 ' N ' ' O ' ' B' ' 20' ' ' SER . 12.2 t -80.14 -41.24 25.79 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.904 177.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . 0.911 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.0 OUTLIER -87.33 -36.17 17.99 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.438 -0.789 . . . . 0.0 111.483 179.963 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 24' ' ' MET . . . . . 0.534 ' SD ' ' HA ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -71.42 -30.09 65.67 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 118.023 -1.471 . . . . 0.0 108.512 179.367 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . 0.648 ' HG ' ' N ' ' B' ' 26' ' ' ALA . 0.3 OUTLIER -75.31 -41.85 55.93 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 118.662 -1.215 . . . . 0.0 107.843 177.368 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . 0.648 ' N ' ' HG ' ' B' ' 25' ' ' LEU . . . -68.42 -24.43 64.74 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 27' ' ' SER . . . . . 0.488 ' O ' ' HB3' ' B' ' 30' ' ' LYS . 4.5 t -84.55 -36.83 21.87 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . 0.614 ' CD1' ' N ' ' B' ' 29' ' ' GLU . 0.1 OUTLIER -51.89 -53.45 40.7 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.441 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . 0.614 ' N ' ' CD1' ' B' ' 28' ' ' PHE . 0.1 OUTLIER -63.87 -39.04 93.27 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 177.742 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . 1.279 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 19.3 tttm -56.08 -29.51 60.68 Favored 'General case' 0 C--O 1.191 -2.015 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.314 178.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.59 ' O ' ' CB ' ' B' ' 35' ' ' THR . 0.2 OUTLIER -104.46 -23.88 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 119.645 -1.909 . . . . 0.0 108.382 177.516 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.56 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.3 mm -73.1 -61.53 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 177.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.38 -36.29 81.04 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 1.279 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 18.4 mm-40 -78.3 -35.24 48.07 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 121.07 -1.019 . . . . 0.0 111.658 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 35' ' ' THR . . . . . 0.59 ' CB ' ' O ' ' B' ' 31' ' ' ILE . 3.0 m -56.39 -47.94 77.92 Favored 'General case' 0 N--CA 1.504 2.257 0 CA-C-N 120.49 1.496 . . . . 0.0 107.211 178.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.476 ' CG2' ' CG2' ' B' ' 50' ' ' ILE . 23.5 t -53.58 -42.32 49.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 177.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . 0.634 ' HB1' ' O ' ' A' ' 88' ' ' ALA . . . -82.89 -1.19 51.44 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.735 178.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . 0.663 ' N ' ' O ' ' B' ' 34' ' ' GLU . 0.0 OUTLIER -100.37 -18.85 16.56 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 177.905 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.99 42.43 2.26 Favored Glycine 0 C--N 1.302 -1.321 0 C-N-CA 120.272 -0.966 . . . . 0.0 110.74 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . 0.477 ' CB ' HG23 ' B' ' 35' ' ' THR . 0.4 OUTLIER -144.88 150.96 37.97 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.13 -1.218 . . . . 0.0 110.159 179.276 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 63.9 mttt -97.34 92.18 5.85 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.549 -0.719 . . . . 0.0 110.238 -179.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 66.9 t -59.38 129.62 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.536 -0.728 . . . . 0.0 109.399 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 43' ' ' GLN . . . . . 0.45 ' HA ' ' O ' ' B' ' 48' ' ' LEU . 0.8 OUTLIER -125.02 103.91 8.27 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.092 -1.005 . . . . 0.0 111.123 -179.021 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.605 HD13 ' CB ' ' B' ' 48' ' ' LEU . 19.9 mt -62.96 113.97 3.4 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.225 -0.922 . . . . 0.0 109.111 178.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 45' ' ' THR . . . . . 0.566 HG21 ' HG2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 33.12 -89.87 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.499 0 O-C-N 121.832 -0.543 . . . . 0.0 110.93 -179.252 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -146.06 15.79 1.72 Allowed Glycine 0 N--CA 1.484 1.856 0 C-N-CA 119.732 -1.223 . . . . 0.0 110.338 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . 0.592 ' O ' ' HA ' ' B' ' 81' ' ' PRO . 17.1 p90 -111.14 -37.79 5.23 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.762 -1.434 . . . . 0.0 112.113 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . 0.605 ' CB ' HD13 ' B' ' 44' ' ' LEU . 0.0 OUTLIER -114.32 117.8 32.11 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.3 -1.5 . . . . 0.0 111.272 179.703 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -113.19 74.17 0.85 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.699 -0.626 . . . . 0.0 110.569 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 50' ' ' ILE . . . . . 0.518 ' HA ' ' HB ' ' B' ' 79' ' ' VAL . 3.1 mm -59.87 134.95 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.422 -0.799 . . . . 0.0 110.144 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . 0.46 ' O ' ' HD3' ' B' ' 51' ' ' LYS . 0.0 OUTLIER -154.05 126.15 3.85 Favored Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 120.872 -1.142 . . . . 0.0 110.959 179.338 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 52' ' ' PRO . . . . . 0.537 ' HA ' ' HA ' ' B' ' 77' ' ' VAL . 55.7 Cg_endo -83.79 142.17 10.02 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 O-C-N 123.439 1.231 . . . . 0.0 110.655 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.546 HG21 ' CA ' ' B' ' 76' ' ' GLY . 27.6 m -137.88 114.78 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-O 121.762 0.791 . . . . 0.0 111.058 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . 0.498 ' HA ' ' HA ' ' B' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.494 1.753 0 O-C-N 121.561 -0.712 . . . . 0.0 110.504 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . 0.544 ' N ' ' CD1' ' A' ' 94' ' ' TYR . 1.1 t . . . . . 0 N--CA 1.493 1.675 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 76' ' ' GLY . . . . . 0.546 ' CA ' HG21 ' B' ' 53' ' ' VAL . . . -120.03 86.35 0.4 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.537 ' HA ' ' HA ' ' B' ' 52' ' ' PRO . 3.2 p -61.22 76.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.648 -0.913 . . . . 0.0 109.485 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 78' ' ' SER . . . . . 0.534 ' N ' ' O ' ' B' ' 76' ' ' GLY . 0.1 OUTLIER -77.3 177.78 7.65 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.872 0.844 . . . . 0.0 110.37 -179.884 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . 0.518 ' HB ' ' HA ' ' B' ' 50' ' ' ILE . 7.0 p 177.73 174.76 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 80' ' ' LYS . . . . . 0.602 ' HB2' ' HD2' ' B' ' 81' ' ' PRO . 0.0 OUTLIER 177.17 171.75 0.39 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 120.821 -1.174 . . . . 0.0 111.14 177.493 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 81' ' ' PRO . . . . . 0.602 ' HD2' ' HB2' ' B' ' 80' ' ' LYS . 51.1 Cg_endo -74.64 141.45 27.81 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.374 1.723 . . . . 0.0 110.475 176.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' B' ' 47' ' ' PHE . . . -110.31 -75.67 0.83 Allowed Glycine 0 N--CA 1.492 2.433 0 N-CA-C 106.501 -2.64 . . . . 0.0 106.501 178.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . 0.885 ' O ' ' N ' ' B' ' 85' ' ' LEU . 2.1 pt-20 -91.22 40.62 1.03 Allowed 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 176.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 84' ' ' SER . . . . . 0.612 ' C ' ' O ' ' B' ' 83' ' ' GLU . 1.9 t 10.52 43.83 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.665 1.222 . . . . 0.0 110.302 178.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . 0.885 ' N ' ' O ' ' B' ' 83' ' ' GLU . 0.0 OUTLIER 18.76 26.21 0.0 OUTLIER 'General case' 0 C--O 1.186 -2.287 0 N-CA-C 102.898 -3.001 . . . . 0.0 102.898 -170.669 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 86' ' ' LYS . . . . . 0.567 ' HB2' ' HB3' ' B' ' 84' ' ' SER 0.325 2.9 tttm -48.71 -38.59 21.9 Favored 'General case' 0 CA--C 1.473 -2.018 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 177.708 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . 0.27 2.9 tttt -62.54 -40.92 98.33 Favored 'General case' 0 C--N 1.275 -2.652 0 CA-C-N 111.886 -2.415 . . . . 0.0 106.137 177.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.783 ' N ' ' O ' ' B' ' 85' ' ' LEU . . . -78.65 -33.57 47.08 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 118.29 -1.364 . . . . 0.0 107.989 177.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . 0.735 ' N ' ' O ' ' B' ' 85' ' ' LEU . . . -64.73 -30.63 71.65 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -64.46 -33.92 77.01 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 175.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -64.23 -45.36 93.81 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 178.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 92' ' ' LEU . . . . . 0.508 ' O ' ' CB ' ' B' ' 93' ' ' LYS . 0.5 OUTLIER -65.49 2.32 0.94 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.499 -1.589 . . . . 0.0 111.403 -179.617 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 93' ' ' LYS . . . . . 0.508 ' CB ' ' O ' ' B' ' 92' ' ' LEU . 7.0 tptt 72.9 53.91 0.14 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -177.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . 0.416 ' CD1' ' N ' ' A' ' 75' ' ' VAL . 6.1 t80 -38.97 -43.62 0.99 Allowed 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.008 -179.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -57.16 -41.19 78.75 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.304 -0.873 . . . . 0.0 109.656 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 96' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' B' ' 93' ' ' LYS . 4.1 t70 -60.89 -31.95 71.42 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.498 ' HB3' HG23 ' B' ' 42' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 120.897 0.379 . . . . 0.0 110.291 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . 0.49 ' H ' ' HB2' ' A' ' 5' ' ' GLU . 16.1 p-10 -173.29 -161.62 0.14 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.398 -0.921 . . . . 0.0 111.459 178.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.57 ' HD2' ' HB ' ' B' ' 45' ' ' THR . 6.8 tttt -45.88 -21.75 0.15 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.956 -0.465 . . . . 0.0 110.116 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.633 ' O ' HG13 ' A' ' 7' ' ' ILE . 88.3 m -94.29 -66.36 0.92 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.501 -0.749 . . . . 0.0 110.662 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.49 ' HB2' ' H ' ' A' ' 2' ' ' ASN . 4.2 mt-10 -48.98 -41.11 33.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.888 -1.133 . . . . 0.0 109.123 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.41 ' CD1' ' CG1' ' B' ' 42' ' ' VAL . 22.5 mt -53.25 -41.88 65.92 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.763 178.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.633 HG13 ' O ' ' A' ' 4' ' ' THR . 1.2 pp -59.05 -40.34 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 178.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.571 ' N ' HG13 ' A' ' 7' ' ' ILE . 17.7 mtmt -62.31 -37.52 85.9 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 176.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 13' ' ' ASP . . . -53.87 -36.87 63.11 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.848 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.6 mp -90.91 -31.95 5.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 178.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 7' ' ' ILE . . . -67.45 -8.0 29.84 Favored 'General case' 0 C--N 1.284 -2.26 0 O-C-N 120.777 -1.202 . . . . 0.0 109.128 179.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.428 ' HB3' ' O ' ' A' ' 8' ' ' LYS . 1.5 tt0 -124.07 -38.73 2.43 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.374 -0.829 . . . . 0.0 109.961 179.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 9' ' ' ALA . 1.0 OUTLIER -73.18 -19.22 61.15 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 177.482 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.848 ' OG1' ' O ' ' A' ' 10' ' ' ILE 0.28 0.2 OUTLIER -112.1 -71.59 0.75 Allowed 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 179.516 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 57.4 18.64 30.2 Favored Glycine 0 N--CA 1.498 2.769 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 177.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.701 ' CD1' ' CG2' ' A' ' 14' ' ' THR . 4.9 mp -58.73 -62.75 1.63 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.419 -1.048 . . . . 0.0 109.384 179.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.581 ' O ' HG23 ' A' ' 17' ' ' THR . 0.5 OUTLIER -143.27 8.88 1.62 Allowed 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.242 -179.771 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.611 ' O ' ' C ' ' A' ' 19' ' ' VAL . 2.7 mt-30 58.24 26.7 14.18 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 -176.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.666 ' HB ' ' HB ' ' B' ' 19' ' ' VAL . 0.6 OUTLIER -2.26 -98.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.453 -179.306 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.967 ' O ' ' N ' ' A' ' 23' ' ' LYS . 1.1 p -134.4 25.57 3.79 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 178.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.664 ' HA ' ' CE ' ' A' ' 24' ' ' MET . 28.3 m -19.36 -39.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 CA-C-O 122.55 1.166 . . . . 0.0 109.872 -178.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.809 ' N ' ' O ' ' A' ' 20' ' ' SER . 36.7 t -76.64 -41.85 44.28 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.118 177.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.967 ' N ' ' O ' ' A' ' 20' ' ' SER . 1.2 mtpt -82.78 -37.72 24.18 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.664 -0.648 . . . . 0.0 111.999 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.683 ' N ' ' OG ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -69.27 -24.52 63.99 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 117.47 -1.692 . . . . 0.0 108.437 179.914 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.69 ' HG ' ' N ' ' A' ' 26' ' ' ALA . 0.3 OUTLIER -75.66 -47.32 26.86 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.134 -1.027 . . . . 0.0 109.241 178.609 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.69 ' N ' ' HG ' ' A' ' 25' ' ' LEU . . . -64.0 -27.93 69.46 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 178.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.577 ' O ' HG13 ' A' ' 31' ' ' ILE . 7.2 p -85.96 -34.99 20.72 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 178.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.622 ' O ' HG13 ' A' ' 31' ' ' ILE . 0.1 OUTLIER -58.31 -46.65 85.73 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 179.146 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.555 ' HG3' HG21 ' B' ' 45' ' ' THR . 2.4 tt0 -70.95 -34.35 71.38 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 177.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 1.27 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 60.6 tttt -64.37 -19.1 65.27 Favored 'General case' 0 C--O 1.193 -1.888 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 177.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.622 HG13 ' O ' ' A' ' 28' ' ' PHE . 1.7 pp -108.91 -29.2 2.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 120.116 -1.615 . . . . 0.0 109.062 178.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.584 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.1 mm -72.0 -55.05 14.68 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.0 -32.2 51.08 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 1.27 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 73.2 mm-40 -78.75 -37.13 41.96 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 120.933 -1.104 . . . . 0.0 110.606 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.751 ' C ' ' HB2' ' A' ' 40' ' ' ASP . 73.1 m -64.96 -37.45 87.68 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 177.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.572 ' HA ' ' HB3' ' A' ' 40' ' ' ASP . 1.4 t -56.75 -35.94 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 175.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.678 ' CB ' ' O ' ' B' ' 88' ' ' ALA . . . -89.46 12.67 15.8 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 176.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 34' ' ' GLU . 3.1 ttmt -130.17 17.1 5.56 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.32 40.49 10.05 Favored Glycine 0 N--CA 1.48 1.598 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.751 ' HB2' ' C ' ' A' ' 35' ' ' THR . 4.8 t70 -60.68 163.23 5.7 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 122.578 1.18 . . . . 0.0 112.8 -178.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.467 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 16.8 mtmt -157.52 57.58 0.5 Allowed 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 105.9 -1.889 . . . . 0.0 105.9 176.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.465 ' HB ' ' HB ' ' A' ' 50' ' ' ILE . 2.2 t -95.68 150.15 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-O 121.533 0.683 . . . . 0.0 111.05 -177.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.469 ' CG ' ' O ' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -137.53 99.94 4.08 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.299 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.575 HD13 ' HB2' ' A' ' 48' ' ' LEU . 11.9 mt -66.78 113.3 4.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.095 -1.003 . . . . 0.0 110.17 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.517 HG23 ' CD2' ' A' ' 47' ' ' PHE . 0.1 OUTLIER 29.99 -88.93 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.21 0 O-C-N 122.038 -0.414 . . . . 0.0 111.411 179.299 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -147.6 19.49 1.48 Allowed Glycine 0 N--CA 1.484 1.884 0 C-N-CA 119.729 -1.224 . . . . 0.0 110.274 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.517 ' CD2' HG23 ' A' ' 45' ' ' THR . 32.1 p90 -116.91 -39.2 3.29 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.759 -1.436 . . . . 0.0 111.831 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.575 ' HB2' HD13 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -115.78 108.92 16.95 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.758 -1.214 . . . . 0.0 112.238 -179.885 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.693 ' O ' ' HB ' ' A' ' 79' ' ' VAL . 0.1 OUTLIER -92.81 68.13 4.53 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.711 -0.618 . . . . 0.0 109.675 179.002 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.574 ' HA ' ' HB ' ' A' ' 79' ' ' VAL . 48.0 mm -53.07 114.3 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.49 0 O-C-N 121.186 -0.946 . . . . 0.0 112.398 -176.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.504 ' O ' ' N ' ' A' ' 78' ' ' SER . 0.6 OUTLIER -157.39 109.65 1.86 Allowed Pre-proline 0 N--CA 1.478 0.967 0 O-C-N 121.846 -0.534 . . . . 0.0 110.293 179.973 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.406 ' HB2' HG13 ' A' ' 75' ' ' VAL . 50.2 Cg_endo -76.8 149.85 30.03 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 O-C-N 123.132 1.069 . . . . 0.0 109.86 178.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.576 ' O ' ' CG2' ' A' ' 75' ' ' VAL . 1.9 t -110.95 -142.91 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.487 -0.758 . . . . 0.0 110.17 -179.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.631 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.501 2.087 0 O-C-N 121.377 -0.827 . . . . 0.0 109.703 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.631 ' HA ' ' HA ' ' A' ' 54' ' ' ALA . 0.9 OUTLIER . . . . . 0 N--CA 1.496 1.852 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.458 ' N ' ' CG1' ' A' ' 75' ' ' VAL . . . -111.94 -157.38 13.84 Favored Glycine 0 N--CA 1.475 1.283 0 C-N-CA 118.659 -1.734 . . . . 0.0 109.561 -179.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.455 ' N ' HG21 ' A' ' 53' ' ' VAL . 3.5 t -139.02 85.62 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.172 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.504 ' N ' ' O ' ' A' ' 51' ' ' LYS . 0.2 OUTLIER -55.09 -45.7 75.46 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.453 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.693 ' HB ' ' O ' ' A' ' 49' ' ' ASN 0.273 5.8 p -50.37 170.84 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-O 122.347 1.07 . . . . 0.0 112.264 -177.165 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.652 ' HB2' ' HD2' ' A' ' 81' ' ' PRO . 5.6 ptmt 174.79 177.46 0.2 Allowed Pre-proline 0 C--N 1.302 -1.499 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.652 ' HD2' ' HB2' ' A' ' 80' ' ' LYS . 36.8 Cg_endo -63.15 143.59 90.42 Favored 'Trans proline' 0 C--N 1.295 -2.249 0 N-CA-C 106.973 -1.972 . . . . 0.0 106.973 175.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.518 ' C ' ' H ' ' A' ' 84' ' ' SER . . . -120.77 -102.97 1.88 Allowed Glycine 0 N--CA 1.498 2.797 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -178.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.96 ' O ' ' N ' ' A' ' 85' ' ' LEU . 32.6 tt0 -72.38 50.51 0.23 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.629 ' HB3' ' HB2' ' A' ' 86' ' ' LYS . 2.7 t 7.86 43.54 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 122.491 1.139 . . . . 0.0 109.785 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.96 ' N ' ' O ' ' A' ' 83' ' ' GLU . 3.0 pp 18.48 27.98 0.0 OUTLIER 'General case' 0 C--O 1.196 -1.713 0 N-CA-C 103.33 -2.841 . . . . 0.0 103.33 -171.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.629 ' HB2' ' HB3' ' A' ' 84' ' ' SER 0.335 1.6 tttt -55.71 -39.85 71.62 Favored 'General case' 0 CA--C 1.473 -2.004 0 N-CA-C 104.473 -2.418 . . . . 0.0 104.473 177.134 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.255 28.7 tttt -59.11 -41.34 87.91 Favored 'General case' 0 C--N 1.28 -2.43 0 CA-C-N 112.188 -2.278 . . . . 0.0 105.79 177.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.647 ' O ' ' HB1' ' B' ' 37' ' ' ALA . . . -77.76 -32.08 52.42 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 117.65 -1.62 . . . . 0.0 107.061 177.336 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.688 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . -61.5 -34.32 75.29 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.21 -1.034 . . . . 0.0 108.21 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.425 ' HA ' ' CB ' ' A' ' 94' ' ' TYR . 3.9 mt-10 -60.23 -35.91 76.52 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 175.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -62.51 -32.88 84.7 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 178.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.548 ' O ' ' CB ' ' A' ' 93' ' ' LYS . 0.3 OUTLIER -78.73 17.37 0.71 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.481 -1.599 . . . . 0.0 110.667 -179.81 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.745 ' O ' ' C ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER 80.12 32.47 0.19 Allowed 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -178.068 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 1.11 ' O ' ' C ' ' A' ' 95' ' ' GLU . 9.5 t80 -25.53 -68.22 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 117.755 -1.578 . . . . 0.0 108.25 -177.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 1.11 ' C ' ' O ' ' A' ' 94' ' ' TYR . 62.6 mm-40 . . . . . 0 CA--C 1.489 -1.403 0 N-CA-C 101.391 -3.559 . . . . 0.0 101.391 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.55 ' O ' ' HB3' ' B' ' 2' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 120.721 0.296 . . . . 0.0 110.309 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 2' ' ' ASN . . . . . 0.55 ' HB3' ' O ' ' B' ' 1' ' ' MET . 25.4 p30 178.89 -143.94 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.577 178.079 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.424 ' HA ' HD12 ' B' ' 25' ' ' LEU . 3.1 mttp -55.05 -3.13 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.215 -0.928 . . . . 0.0 111.192 -179.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.658 ' O ' HG13 ' B' ' 7' ' ' ILE . 16.3 m -114.51 -65.03 1.23 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.898 -1.126 . . . . 0.0 110.573 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.503 ' HB2' ' HA ' ' B' ' 1' ' ' MET . 9.2 mp0 -49.02 -44.72 41.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.84 -1.163 . . . . 0.0 108.909 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.527 ' CB ' HD23 ' B' ' 25' ' ' LEU . 20.1 mt -57.01 -34.47 68.2 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.125 -1.03 . . . . 0.0 109.648 178.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 7' ' ' ILE . . . . . 0.658 HG13 ' O ' ' B' ' 4' ' ' THR . 1.1 pp -57.63 -43.43 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 178.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . 0.602 ' N ' HG13 ' B' ' 7' ' ' ILE . 0.0 OUTLIER -63.7 -32.55 74.08 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 177.926 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' B' ' 13' ' ' ASP . . . -55.18 -40.94 71.26 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.439 -0.788 . . . . 0.0 109.162 178.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . 0.505 ' O ' ' CB ' ' B' ' 14' ' ' THR . 1.1 mp -91.44 -29.79 4.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 178.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.584 ' HB2' ' O ' ' B' ' 7' ' ' ILE . . . -65.99 -15.42 62.99 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.268 -0.973 . . . . 0.0 108.399 178.02 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.453 ' HB3' ' O ' ' B' ' 8' ' ' LYS . 1.8 tp60 -112.31 -42.99 3.59 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.465 ' HB3' ' CB ' ' A' ' 27' ' ' SER . 18.8 m-20 -59.83 -39.97 86.92 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 177.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.639 ' CG2' ' HB3' ' A' ' 20' ' ' SER . 0.2 OUTLIER -98.83 -71.69 0.68 Allowed 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 113.858 -1.519 . . . . 0.0 108.504 179.387 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 47.26 27.39 3.85 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 16' ' ' LEU . . . . . 0.561 HD13 HG22 ' A' ' 19' ' ' VAL . 0.4 OUTLIER -91.6 -28.56 17.44 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.543 -0.975 . . . . 0.0 108.814 178.89 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 17' ' ' THR . . . . . 0.528 HG21 ' CG2' ' A' ' 17' ' ' THR . 0.7 OUTLIER -147.39 -13.94 0.4 Allowed 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.893 -0.504 . . . . 0.0 110.342 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . 0.446 ' O ' ' O ' ' B' ' 19' ' ' VAL . 3.1 mt-30 57.36 43.71 22.86 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -177.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.666 ' HB ' ' HB ' ' A' ' 19' ' ' VAL . 1.4 p -34.5 -94.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.96 -178.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 20' ' ' SER . . . . . 0.918 ' O ' ' N ' ' B' ' 23' ' ' LYS . 0.4 OUTLIER -134.16 25.19 3.88 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 178.845 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . 0.653 ' C ' ' O ' ' B' ' 20' ' ' SER . 31.1 m -17.28 -39.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-O 122.642 1.211 . . . . 0.0 109.574 -178.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.896 ' N ' ' O ' ' B' ' 20' ' ' SER . 38.2 p -85.67 -38.43 18.36 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.071 178.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . 0.918 ' N ' ' O ' ' B' ' 20' ' ' SER . 1.8 mtpt -86.1 -29.91 22.98 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.463 -0.773 . . . . 0.0 111.092 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 24' ' ' MET . . . . . 0.559 ' CE ' ' HA ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -80.66 -35.08 34.28 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.588 -1.32 . . . . 0.0 110.093 179.856 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . 0.619 ' C ' ' CD1' ' B' ' 25' ' ' LEU . 0.1 OUTLIER -79.81 -43.06 23.11 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 118.099 -1.441 . . . . 0.0 107.368 177.955 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' B' ' 22' ' ' SER . . . -59.75 -25.25 64.71 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 176.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 27' ' ' SER . . . . . 0.523 ' O ' ' N ' ' B' ' 31' ' ' ILE . 4.3 t -81.24 -36.81 29.52 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . 0.735 ' HA ' ' CG1' ' B' ' 31' ' ' ILE . 0.0 OUTLIER -60.96 -36.43 79.37 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.769 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . 0.649 ' O ' ' HB ' ' B' ' 33' ' ' THR . 9.2 mt-10 -77.55 -34.5 53.81 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 177.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . 1.011 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 64.0 tttt -68.42 -25.4 65.01 Favored 'General case' 0 C--O 1.192 -1.97 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 177.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.735 ' CG1' ' HA ' ' B' ' 28' ' ' PHE . 1.1 pp -100.81 -29.85 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 120.983 -1.073 . . . . 0.0 109.518 178.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.703 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.1 mm -66.02 -57.32 11.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 176.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 33' ' ' THR . . . . . 0.649 ' HB ' ' O ' ' B' ' 29' ' ' GLU . 0.5 OUTLIER -65.26 -38.48 90.46 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.474 179.172 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 1.011 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 23.9 mm-40 -75.21 -38.9 60.5 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.37 -0.831 . . . . 0.0 112.067 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 35' ' ' THR . . . . . 0.54 ' N ' ' O ' ' B' ' 31' ' ' ILE . 44.1 m -59.57 -54.59 44.79 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.334 -1.479 . . . . 0.0 109.425 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.625 ' O ' ' HG3' ' B' ' 52' ' ' PRO . 2.6 t -54.32 -36.23 32.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 177.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . 0.647 ' HB1' ' O ' ' A' ' 88' ' ' ALA . . . -88.49 4.8 45.31 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.686 0.755 . . . . 0.0 109.823 177.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . 0.73 ' N ' ' O ' ' B' ' 34' ' ' GLU . 1.2 tppp? -105.26 -32.9 8.41 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 178.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.21 35.03 0.44 Allowed Glycine 0 C--N 1.301 -1.397 0 C-N-CA 119.661 -1.256 . . . . 0.0 111.092 177.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . 0.417 ' HB2' HG21 ' B' ' 35' ' ' THR . 0.2 OUTLIER -147.14 173.05 12.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.011 -1.288 . . . . 0.0 110.543 179.523 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' B' ' 41' ' ' LYS . 0.0 OUTLIER -127.65 114.53 17.47 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.651 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . 0.697 ' HB ' ' CG1' ' B' ' 50' ' ' ILE . 38.4 t -98.96 131.02 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.572 -178.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 43' ' ' GLN . . . . . 0.443 ' HG3' ' CB ' ' A' ' 2' ' ' ASN . 0.0 OUTLIER -111.51 123.61 50.58 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.259 -0.9 . . . . 0.0 110.547 180.0 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.563 ' HB2' ' CB ' ' B' ' 48' ' ' LEU . 16.4 mt -84.04 102.69 12.68 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.267 -0.896 . . . . 0.0 109.705 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 45' ' ' THR . . . . . 0.57 ' HB ' ' HD2' ' A' ' 3' ' ' LYS . 0.1 OUTLIER 34.98 -91.97 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.975 -0.453 . . . . 0.0 111.125 -179.777 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -148.85 20.1 1.26 Allowed Glycine 0 N--CA 1.487 2.095 0 N-CA-C 110.089 -1.205 . . . . 0.0 110.089 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . 0.528 ' CE2' ' HG3' ' A' ' 29' ' ' GLU . 3.8 p90 -116.61 -33.6 4.81 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.056 -1.261 . . . . 0.0 111.079 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . 0.563 ' CB ' ' HB2' ' B' ' 44' ' ' LEU . 0.1 OUTLIER -119.58 178.9 4.39 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.626 -1.296 . . . . 0.0 111.797 179.227 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 49' ' ' ASN . . . . . 0.618 ' O ' ' HB ' ' B' ' 79' ' ' VAL . 2.0 m-80 -165.98 145.05 6.04 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 50' ' ' ILE . . . . . 0.698 ' N ' HG13 ' B' ' 79' ' ' VAL . 1.6 pp -146.59 101.61 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-O 122.131 0.967 . . . . 0.0 110.636 178.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . 0.648 ' H ' HG22 ' B' ' 79' ' ' VAL . 0.1 OUTLIER -147.94 133.14 9.17 Favored Pre-proline 0 N--CA 1.495 1.782 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.919 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 52' ' ' PRO . . . . . 0.625 ' HG3' ' O ' ' B' ' 36' ' ' VAL . 58.0 Cg_endo -95.71 153.18 1.5 Allowed 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.305 1.16 . . . . 0.0 112.49 -178.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' B' ' 76' ' ' GLY . 27.9 m -134.57 112.92 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 CA-C-O 122.017 0.913 . . . . 0.0 109.965 176.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.865 0 O-C-N 121.687 -0.633 . . . . 0.0 111.662 -178.608 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . 0.568 ' N ' ' CD1' ' A' ' 94' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 76' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' B' ' 78' ' ' SER . . . -118.02 99.3 0.8 Allowed Glycine 0 N--CA 1.486 1.968 0 C-N-CA 119.217 -1.468 . . . . 0.0 109.642 -179.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.508 HG11 ' CB ' ' A' ' 81' ' ' PRO . 2.1 t -60.71 88.08 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 179.135 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 78' ' ' SER . . . . . 0.499 ' N ' ' O ' ' B' ' 76' ' ' GLY . 0.8 OUTLIER -58.06 -48.25 80.7 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.564 -178.057 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . 0.698 HG13 ' N ' ' B' ' 50' ' ' ILE . 27.2 m -49.46 177.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 115.224 1.564 . . . . 0.0 115.224 -174.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 80' ' ' LYS . . . . . 0.639 ' HB2' ' HD2' ' B' ' 81' ' ' PRO . 0.0 OUTLIER 179.56 178.97 0.28 Allowed Pre-proline 0 N--CA 1.481 1.087 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.161 -179.051 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 81' ' ' PRO . . . . . 0.639 ' HD2' ' HB2' ' B' ' 80' ' ' LYS . 41.8 Cg_endo -70.21 130.99 19.7 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.372 1.196 . . . . 0.0 110.78 179.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -82.18 -157.99 22.03 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' B' ' 87' ' ' LYS . 11.1 pt-20 -83.73 -21.25 32.34 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.574 -0.956 . . . . 0.0 110.842 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 84' ' ' SER . . . . . 0.478 ' HB2' ' HA ' ' B' ' 47' ' ' PHE . 0.4 OUTLIER -56.28 -45.39 80.16 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.032 -1.042 . . . . 0.0 109.282 -179.682 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . 0.425 ' CD2' ' CG2' ' A' ' 36' ' ' VAL . 12.8 mt -61.6 -32.53 72.65 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 86' ' ' LYS . . . . . 0.415 ' O ' ' HB1' ' B' ' 89' ' ' ALA . 1.7 tttp -82.7 -31.32 28.62 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.642 0.734 . . . . 0.0 109.799 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' B' ' 83' ' ' GLU . 9.8 tmtt? -73.56 -38.97 65.04 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.678 ' O ' ' CB ' ' A' ' 37' ' ' ALA . . . -66.71 -34.73 78.49 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 176.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . 0.471 ' CB ' ' CG1' ' A' ' 75' ' ' VAL . . . -53.39 -46.16 69.58 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.406 -0.809 . . . . 0.0 109.448 178.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -56.5 -29.71 62.13 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 176.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . 0.495 ' C ' ' H ' ' B' ' 93' ' ' LYS . . . -64.72 -34.21 89.28 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 178.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 92' ' ' LEU . . . . . 0.588 ' HB3' ' HA ' ' A' ' 37' ' ' ALA . 1.5 pp -71.06 20.8 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 CA-C-N 119.928 1.864 . . . . 0.0 110.947 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 93' ' ' LYS . . . . . 0.495 ' H ' ' C ' ' B' ' 91' ' ' GLY . 0.2 OUTLIER 59.42 44.33 15.21 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 106.044 -1.835 . . . . 0.0 106.044 -177.656 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . 0.598 ' HA ' HG23 ' A' ' 75' ' ' VAL . 0.3 OUTLIER -35.53 -42.24 0.22 Allowed 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.044 -178.233 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -52.85 -41.39 64.23 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.206 -0.934 . . . . 0.0 109.5 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 96' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' B' ' 93' ' ' LYS . 0.4 OUTLIER -65.14 -30.4 71.32 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.141 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.625 -0.672 . . . . 0.0 109.371 178.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.426 ' HG2' ' HB3' ' A' ' 5' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.139 0.495 . . . . 0.0 110.132 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . 0.421 ' N ' ' HB2' ' A' ' 5' ' ' GLU . 4.4 p30 173.05 173.26 0.12 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.489 -0.757 . . . . 0.0 110.337 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.62 ' HD2' HD11 ' A' ' 25' ' ' LEU . 2.2 mmmp? -43.19 -26.16 0.15 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.627 -0.671 . . . . 0.0 110.555 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.514 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 5.7 m -85.83 -55.46 3.96 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.247 -0.908 . . . . 0.0 109.027 178.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.426 ' HB3' ' HG2' ' A' ' 1' ' ' MET . 1.0 OUTLIER -60.2 -48.76 80.36 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.697 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.459 ' CD1' ' CG2' ' B' ' 42' ' ' VAL . 9.5 mt -57.56 -33.24 67.94 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.575 -0.85 . . . . 0.0 108.718 177.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.591 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -54.79 -54.09 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 178.373 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.509 ' N ' HG22 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -68.74 -27.86 66.3 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.65 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.451 ' N ' ' HG2' ' A' ' 8' ' ' LYS . . . -59.49 -33.86 71.86 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.289 -0.882 . . . . 0.0 108.795 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.927 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.8 OUTLIER -95.75 -37.02 7.05 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.528 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 178.429 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.591 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -60.18 -26.93 66.72 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.418 ' CG ' ' O ' ' A' ' 8' ' ' LYS . 1.4 pp0? -92.91 -37.56 12.18 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.517 ' HB3' ' CB ' ' B' ' 27' ' ' SER . 21.8 m-20 -69.08 -29.59 67.72 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 176.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.927 ' OG1' ' O ' ' A' ' 10' ' ' ILE . 16.6 p -85.82 -75.77 0.36 Allowed 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 177.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 55.26 15.25 7.27 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.663 HD11 ' C ' ' B' ' 19' ' ' VAL . 0.7 OUTLIER -80.92 -51.53 8.47 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.251 -1.146 . . . . 0.0 107.989 178.702 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.489 HG22 ' O ' ' A' ' 17' ' ' THR . 0.5 OUTLIER -144.8 -2.21 0.84 Allowed 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.897 -179.847 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.671 ' O ' ' C ' ' A' ' 19' ' ' VAL . 6.7 mt-30 56.23 30.07 15.96 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 -176.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.783 ' HB ' ' HB ' ' B' ' 19' ' ' VAL . 0.4 OUTLIER 3.78 -97.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.868 -179.399 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 1.022 ' O ' ' N ' ' A' ' 22' ' ' SER . 6.1 p -134.98 24.14 3.58 Favored 'General case' 0 C--N 1.28 -2.456 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 176.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.728 ' HA ' ' CE ' ' A' ' 24' ' ' MET . 18.1 m -5.14 -44.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-O 122.447 1.118 . . . . 0.0 110.719 -177.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 1.022 ' N ' ' O ' ' A' ' 20' ' ' SER . 33.3 m -71.22 -41.79 69.74 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.88 178.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.89 ' N ' ' O ' ' A' ' 20' ' ' SER . 5.0 mtpt -85.87 -32.61 21.6 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.459 -0.776 . . . . 0.0 111.486 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.728 ' CE ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -65.82 -26.83 67.86 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 116.938 -1.905 . . . . 0.0 108.158 179.277 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.709 ' C ' ' CD1' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -77.88 -49.68 13.74 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 177.727 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.456 ' N ' ' CG ' ' A' ' 25' ' ' LEU . . . -57.79 -29.72 65.09 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.508 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 1.6 t -83.39 -38.92 21.33 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.606 ' O ' HG13 ' A' ' 31' ' ' ILE . 19.7 t80 -53.32 -48.09 68.73 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.565 ' HG3' ' HE3' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -66.86 -38.76 86.95 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 176.332 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 1.24 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 42.2 tttt -60.79 -19.56 59.74 Favored 'General case' 0 C--O 1.194 -1.836 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.606 HG13 ' O ' ' A' ' 28' ' ' PHE . 0.9 OUTLIER -112.74 -23.46 4.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 O-C-N 119.996 -1.69 . . . . 0.0 109.904 178.641 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.588 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.3 mm -82.46 -49.68 16.88 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 176.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.494 ' OG1' ' O ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -77.48 -38.88 48.27 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.564 178.677 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 1.24 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 64.2 mm-40 -74.16 -28.5 61.34 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.946 -1.096 . . . . 0.0 111.157 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.568 ' OG1' ' O ' ' A' ' 31' ' ' ILE . 87.8 m -78.09 -42.29 32.53 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 118.19 -1.404 . . . . 0.0 109.425 179.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.595 ' N ' ' HB2' ' A' ' 40' ' ' ASP . 3.4 p -54.42 -41.22 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 177.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.641 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -78.85 -2.71 41.04 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.806 -0.758 . . . . 0.0 110.115 178.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.497 ' HB2' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -113.66 1.25 14.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.925 -1.109 . . . . 0.0 108.982 177.697 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.33 35.77 2.82 Favored Glycine 0 N--CA 1.484 1.887 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.595 ' HB2' ' N ' ' A' ' 36' ' ' VAL . 12.4 t70 -47.15 165.22 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 122.619 1.2 . . . . 0.0 112.912 -179.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.422 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 8.2 mttt -174.21 58.39 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 178.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.581 ' CG2' ' HB ' ' A' ' 50' ' ' ILE . 12.0 m -93.39 132.63 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 CA-C-O 121.606 0.717 . . . . 0.0 111.324 -177.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.443 ' O ' ' CG ' ' A' ' 43' ' ' GLN . 1.1 tt0 -118.35 102.29 8.84 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.653 HD12 ' HB3' ' A' ' 48' ' ' LEU . 72.1 mt -70.52 104.45 2.78 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.093 -1.005 . . . . 0.0 110.166 -179.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.46 HG22 ' HD2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER 33.36 -92.48 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.141 0 O-C-N 122.09 -0.381 . . . . 0.0 111.064 179.965 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -149.49 34.7 1.06 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.631 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 1.5 p90 -133.69 -26.1 1.61 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.111 -1.229 . . . . 0.0 111.617 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.653 ' HB3' HD12 ' A' ' 44' ' ' LEU . 5.7 mt -139.72 104.9 5.01 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.603 -1.311 . . . . 0.0 110.605 178.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.447 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 1.5 t30 -106.12 76.79 1.18 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.165 -0.959 . . . . 0.0 110.716 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.585 HG12 HG21 ' A' ' 79' ' ' VAL . 1.4 mm -64.29 109.98 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.187 -0.946 . . . . 0.0 109.849 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.512 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -131.06 119.59 17.92 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.053 -1.029 . . . . 0.0 109.84 -179.913 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.649 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 54.0 Cg_endo -79.42 139.28 14.45 Favored 'Trans proline' 0 C--N 1.316 -1.146 0 O-C-N 123.39 1.205 . . . . 0.0 111.832 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.556 ' O ' ' N ' ' A' ' 76' ' ' GLY . 33.9 m -144.24 117.7 3.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.359 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.642 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.499 2.012 0 CA-C-O 121.626 0.727 . . . . 0.0 111.96 -178.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.642 ' HA ' ' HA ' ' A' ' 54' ' ' ALA . 0.4 OUTLIER . . . . . 0 N--CA 1.496 1.849 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.56 ' O ' ' N ' ' A' ' 78' ' ' SER . . . -123.76 86.45 0.38 Allowed Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.649 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 4.7 p -64.77 68.9 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.549 -0.971 . . . . 0.0 108.697 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.56 ' N ' ' O ' ' A' ' 76' ' ' GLY . 1.0 OUTLIER -65.42 174.49 2.14 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.903 0.859 . . . . 0.0 110.983 -178.517 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.585 HG21 HG12 ' A' ' 50' ' ' ILE . 4.9 p 174.79 -168.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.464 ' O ' HD21 ' A' ' 48' ' ' LEU . 7.6 pttt -172.98 172.26 1.63 Allowed Pre-proline 0 N--CA 1.485 1.279 0 O-C-N 120.678 -1.264 . . . . 0.0 111.235 177.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 80' ' ' LYS . 55.3 Cg_endo -93.3 87.3 0.16 Allowed 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 122.635 2.223 . . . . 0.0 109.472 178.254 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.582 ' HA3' ' HA ' ' A' ' 47' ' ' PHE . . . -58.73 158.05 19.98 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.48 ' O ' ' N ' ' A' ' 87' ' ' LYS . 13.7 pt-20 -55.21 -17.27 4.15 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.219 -1.165 . . . . 0.0 111.07 -179.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.481 ' CB ' ' HB3' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -55.8 -35.89 66.82 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.85 -1.156 . . . . 0.0 109.317 179.426 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.412 HD12 ' HB2' ' A' ' 47' ' ' PHE . 0.7 OUTLIER -81.74 -37.8 26.71 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.894 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.406 ' HG3' HG21 ' B' ' 77' ' ' VAL . 0.6 OUTLIER -75.0 -30.95 61.29 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.448 0.642 . . . . 0.0 110.368 -179.429 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.48 ' N ' ' O ' ' A' ' 83' ' ' GLU . 16.2 ttpt -78.1 -34.66 49.97 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.643 ' O ' ' HG ' ' A' ' 92' ' ' LEU . . . -71.59 -32.18 67.77 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 177.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.689 ' HA ' ' HA ' ' B' ' 37' ' ' ALA . . . -73.02 -54.12 9.39 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.538 -0.726 . . . . 0.0 110.484 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.578 ' HA ' ' HB3' ' A' ' 94' ' ' TYR . 19.1 pt-20 -53.86 -21.42 7.59 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 177.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.66 -28.87 34.06 Favored Glycine 0 CA--C 1.54 1.629 0 CA-C-O 119.093 -0.837 . . . . 0.0 112.335 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.655 ' HB2' ' O ' ' B' ' 37' ' ' ALA . 2.3 mt -97.88 -74.1 0.59 Allowed 'General case' 0 N--CA 1.5 2.026 0 CA-C-N 121.425 2.613 . . . . 0.0 111.816 -178.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -146.87 42.61 1.14 Allowed 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 119.244 -0.982 . . . . 0.0 111.385 -178.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.578 ' HB3' ' HA ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -60.63 -48.41 81.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.279 -0.888 . . . . 0.0 108.824 178.857 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.554 -0.716 . . . . 0.0 109.301 179.32 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.416 ' HB3' HG12 ' A' ' 42' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.126 0.489 . . . . 0.0 110.223 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 2' ' ' ASN . . . . . 0.562 ' H ' ' HB2' ' B' ' 5' ' ' GLU . 0.6 OUTLIER 178.3 178.21 0.4 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.39 -0.819 . . . . 0.0 109.834 -179.426 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.533 ' CE ' ' HB2' ' B' ' 29' ' ' GLU . 0.1 OUTLIER -51.34 -23.86 4.09 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.764 -0.774 . . . . 0.0 108.975 178.915 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.493 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 30.4 m -90.22 -53.58 4.4 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.664 0.745 . . . . 0.0 109.51 178.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.562 ' HB2' ' H ' ' B' ' 2' ' ' ASN . 8.6 mm-40 -59.19 -49.23 78.64 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.508 ' HA ' ' HB2' ' B' ' 9' ' ' ALA . 17.6 mt -54.42 -37.23 64.86 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.227 -0.989 . . . . 0.0 108.506 177.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 7' ' ' ILE . . . . . 0.58 ' O ' ' HB2' ' B' ' 11' ' ' ALA . 0.1 OUTLIER -51.7 -51.27 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 177.604 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . 0.506 ' N ' ' CG2' ' B' ' 7' ' ' ILE . 0.0 OUTLIER -64.79 -29.67 70.64 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.539 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . 0.508 ' HB2' ' HA ' ' B' ' 6' ' ' LEU . . . -53.57 -38.19 63.64 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.294 -0.879 . . . . 0.0 108.64 178.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . 0.761 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.1 mp -97.41 -33.72 4.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.056 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.58 ' HB2' ' O ' ' B' ' 7' ' ' ILE . . . -66.23 -12.3 55.33 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 118.579 -1.248 . . . . 0.0 109.197 178.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.453 ' N ' ' O ' ' B' ' 8' ' ' LYS . 23.3 mm100 -113.22 -41.67 3.66 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.345 -0.847 . . . . 0.0 109.525 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.457 ' CB ' ' OG ' ' A' ' 27' ' ' SER . 1.1 m-20 -70.67 -31.12 67.91 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 177.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.761 ' OG1' ' O ' ' B' ' 10' ' ' ILE . 0.1 OUTLIER -106.63 -84.04 0.52 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 177.752 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . 0.592 ' O ' ' C ' ' B' ' 16' ' ' LEU . . . 72.63 -19.49 1.15 Allowed Glycine 0 N--CA 1.5 2.921 0 O-C-N 121.038 -1.039 . . . . 0.0 111.18 177.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 16' ' ' LEU . . . . . 0.796 HD13 ' HB3' ' A' ' 20' ' ' SER . 4.9 mp -18.86 -61.44 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.511 0 CA-C-O 122.031 0.919 . . . . 0.0 111.575 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 17' ' ' THR . . . . . 0.622 HG21 ' O ' ' B' ' 17' ' ' THR . 0.5 OUTLIER -142.59 7.47 1.7 Allowed 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.543 -179.464 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . 0.584 ' O ' ' C ' ' B' ' 19' ' ' VAL . 29.7 mt-30 60.01 23.1 12.25 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 -175.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.783 ' HB ' ' HB ' ' A' ' 19' ' ' VAL . 1.4 p 5.04 -91.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.951 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 20' ' ' SER . . . . . 0.972 ' O ' ' N ' ' B' ' 23' ' ' LYS . 0.5 OUTLIER -132.44 24.64 4.45 Favored 'General case' 0 C--N 1.277 -2.578 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 179.236 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . 0.675 ' HA ' ' CE ' ' B' ' 24' ' ' MET . 16.7 m -22.69 -43.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 CA-C-O 122.541 1.162 . . . . 0.0 108.578 -178.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.717 ' N ' ' O ' ' B' ' 20' ' ' SER . 13.7 t -74.91 -39.06 61.65 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.614 177.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . 0.972 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.3 OUTLIER -86.25 -40.94 15.03 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.592 -0.692 . . . . 0.0 111.792 179.869 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 24' ' ' MET . . . . . 0.675 ' CE ' ' HA ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -61.84 -28.19 69.31 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 117.203 -1.799 . . . . 0.0 108.814 179.383 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . 0.685 ' C ' ' CD1' ' B' ' 25' ' ' LEU . 0.1 OUTLIER -80.57 -48.82 12.15 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 118.476 -1.29 . . . . 0.0 108.766 178.122 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . 0.45 ' N ' ' CG ' ' B' ' 25' ' ' LEU . . . -61.07 -29.25 69.63 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 27' ' ' SER . . . . . 0.535 ' O ' ' N ' ' B' ' 31' ' ' ILE . 75.3 m -83.64 -33.12 25.34 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . 0.663 ' O ' HG13 ' B' ' 31' ' ' ILE . 0.7 OUTLIER -55.43 -50.78 68.91 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.913 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . 0.609 ' HG3' ' CE2' ' A' ' 47' ' ' PHE . 3.0 tt0 -65.73 -34.66 78.71 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 176.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . 1.341 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 23.2 ttpp -66.89 -20.85 65.99 Favored 'General case' 0 C--O 1.193 -1.905 0 C-N-CA 119.414 -0.914 . . . . 0.0 108.93 178.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.663 HG13 ' O ' ' B' ' 28' ' ' PHE . 0.9 OUTLIER -108.04 -25.35 3.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 O-C-N 119.728 -1.858 . . . . 0.0 109.604 178.569 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.622 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.1 mm -76.62 -58.29 4.66 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 177.169 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 33' ' ' THR . . . . . 0.413 ' O ' HG12 ' B' ' 36' ' ' VAL . 0.7 OUTLIER -75.54 -29.12 59.3 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.328 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 1.341 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 74.3 mm-40 -81.58 -27.59 34.21 Favored 'General case' 0 C--N 1.315 -0.915 0 O-C-N 120.898 -1.126 . . . . 0.0 110.416 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 35' ' ' THR . . . . . 0.522 HG21 ' CB ' ' B' ' 40' ' ' ASP . 1.8 m -69.73 -57.08 5.56 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 117.715 -1.594 . . . . 0.0 107.485 177.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.702 ' O ' ' HG3' ' B' ' 52' ' ' PRO . 7.1 p -48.43 -40.25 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . 0.689 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . . . -71.34 -32.83 69.01 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.14 178.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . 0.514 ' HA ' HD11 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -68.86 -21.49 64.26 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 176.653 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' B' ' 35' ' ' THR . . . 99.25 30.88 6.41 Favored Glycine 0 C--N 1.298 -1.557 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 177.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . 0.522 ' CB ' HG21 ' B' ' 35' ' ' THR . 0.3 OUTLIER -118.03 151.82 36.74 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.395 -1.062 . . . . 0.0 109.905 179.528 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.416 ' CG ' ' CB ' ' B' ' 51' ' ' LYS . 0.0 OUTLIER -95.59 90.54 5.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.428 -0.795 . . . . 0.0 110.558 -179.299 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . 0.459 ' CG2' ' CD1' ' A' ' 6' ' ' LEU . 10.5 p -75.06 152.89 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.41 -0.806 . . . . 0.0 109.392 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 43' ' ' GLN . . . . . 0.43 ' CB ' ' HA ' ' B' ' 49' ' ' ASN . 18.5 pt20 -157.16 175.94 13.38 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.148 -0.97 . . . . 0.0 111.14 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.693 HD12 ' CB ' ' B' ' 48' ' ' LEU . 24.1 mt -128.51 117.49 21.4 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.625 -0.672 . . . . 0.0 109.356 179.151 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 45' ' ' THR . . . . . 0.506 ' C ' ' O ' ' B' ' 44' ' ' LEU . 0.6 OUTLIER 28.54 -103.37 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.815 -0.553 . . . . 0.0 111.313 179.893 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -133.96 57.97 0.7 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . 0.622 ' HB2' ' HG ' ' B' ' 85' ' ' LEU . 8.0 p90 -157.67 -25.39 0.09 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.081 -1.247 . . . . 0.0 110.987 178.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . 0.804 ' CD1' ' HG2' ' B' ' 80' ' ' LYS . 0.5 OUTLIER -130.78 145.65 52.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.842 -1.161 . . . . 0.0 109.965 178.003 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 49' ' ' ASN . . . . . 0.85 ' O ' ' O ' ' B' ' 79' ' ' VAL 0.265 0.4 OUTLIER -162.18 90.61 0.75 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.333 -0.854 . . . . 0.0 110.874 -177.247 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' B' B ' 50' ' ' ILE . . . . . 0.555 ' CB ' ' HD3' ' B' ' 80' ' ' LYS . 0.3 OUTLIER -83.53 146.14 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.884 -1.135 . . . . 0.0 109.809 -179.428 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . 0.416 ' CB ' ' CG ' ' B' ' 41' ' ' LYS . 1.5 ptmt -167.3 122.79 0.87 Allowed Pre-proline 0 N--CA 1.495 1.807 0 C-N-CA 119.124 -1.03 . . . . 0.0 110.689 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 52' ' ' PRO . . . . . 0.702 ' HG3' ' O ' ' B' ' 36' ' ' VAL . 55.4 Cg_endo -88.45 146.92 6.19 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.611 1.321 . . . . 0.0 110.841 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.492 HG21 ' O ' ' B' ' 76' ' ' GLY . 26.7 m -132.22 114.39 23.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-O 121.909 0.861 . . . . 0.0 110.065 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.806 0 CA-C-O 121.484 0.659 . . . . 0.0 111.58 -178.855 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . 0.523 ' N ' ' CD1' ' A' ' 94' ' ' TYR . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 76' ' ' GLY . . . . . 0.552 ' O ' ' N ' ' B' ' 78' ' ' SER . . . -114.8 54.48 0.57 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.612 ' HA ' ' HA ' ' B' ' 52' ' ' PRO . 69.9 t -37.75 87.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 122.052 -0.675 . . . . 0.0 111.59 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 78' ' ' SER . . . . . 0.552 ' N ' ' O ' ' B' ' 76' ' ' GLY . 1.8 t -59.45 -129.51 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . 0.85 ' O ' ' O ' ' B' ' 49' ' ' ASN . 17.7 m -140.15 -170.01 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 119.76 -1.838 . . . . 0.0 112.815 178.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 80' ' ' LYS . . . . . 0.804 ' HG2' ' CD1' ' B' ' 48' ' ' LEU . 0.0 OUTLIER -101.28 -54.26 0.15 Allowed Pre-proline 0 C--N 1.29 -2.004 0 CA-C-N 113.49 -1.686 . . . . 0.0 113.261 -178.489 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 81' ' ' PRO . . . . . 0.682 ' HD2' ' H ' ' B' ' 80' ' ' LYS . 30.5 Cg_endo -52.43 138.88 56.53 Favored 'Trans proline' 0 C--N 1.298 -2.115 0 C-N-CA 121.219 1.279 . . . . 0.0 113.372 -174.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -135.2 -64.41 0.06 OUTLIER Glycine 0 N--CA 1.485 1.95 0 N-CA-C 106.091 -2.803 . . . . 0.0 106.091 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . 0.924 ' O ' ' N ' ' B' ' 85' ' ' LEU . 4.0 tt0 -97.19 46.18 1.04 Allowed 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 175.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 84' ' ' SER . . . . . 1.33 ' O ' ' N ' ' B' ' 86' ' ' LYS . 0.1 OUTLIER 8.18 43.26 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 122.551 1.167 . . . . 0.0 110.489 179.393 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . 1.047 ' C ' ' O ' ' B' ' 84' ' ' SER . 0.5 OUTLIER 21.29 28.85 0.0 OUTLIER 'General case' 0 C--O 1.191 -2.004 0 N-CA-C 103.203 -2.888 . . . . 0.0 103.203 -171.161 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 86' ' ' LYS . . . . . 1.33 ' N ' ' O ' ' B' ' 84' ' ' SER 0.309 1.2 tttm -49.8 -35.99 24.78 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 176.938 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . 0.415 ' O ' ' HG2' ' B' ' 90' ' ' GLU 0.298 0.0 OUTLIER -66.49 -38.78 88.02 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 111.97 -2.377 . . . . 0.0 106.569 175.64 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.793 ' N ' ' O ' ' B' ' 85' ' ' LEU . . . -79.35 -26.33 42.11 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 118.725 -1.19 . . . . 0.0 108.285 178.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . 0.697 ' N ' ' O ' ' B' ' 85' ' ' LEU . . . -68.48 -45.01 73.54 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.448 -0.782 . . . . 0.0 108.924 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . 0.466 ' HG2' ' N ' ' B' ' 91' ' ' GLY . 3.6 pt-20 -58.58 -28.37 65.49 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 176.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . 0.466 ' N ' ' HG2' ' B' ' 90' ' ' GLU . . . -62.48 -38.84 96.99 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 110.646 -0.981 . . . . 0.0 110.646 178.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 92' ' ' LEU . . . . . 0.641 ' HB3' ' HA ' ' A' ' 37' ' ' ALA . 0.9 OUTLIER -78.82 18.99 0.54 Allowed 'General case' 0 N--CA 1.505 2.28 0 O-C-N 120.392 -1.652 . . . . 0.0 111.481 -179.557 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 93' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' B' ' 92' ' ' LEU . 6.7 mptt 54.51 39.53 31.16 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -178.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . 0.553 ' HB2' ' CB ' ' A' ' 75' ' ' VAL . 1.2 p90 -42.01 -30.42 0.28 Allowed 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.746 -178.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . 0.506 ' CG ' ' CE1' ' B' ' 94' ' ' TYR . 22.7 mt-10 -59.08 -47.37 85.51 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.188 -0.945 . . . . 0.0 108.501 178.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.97 -36.44 67.83 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.217 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.503 ' HA ' ' CB ' ' A' ' 5' ' ' GLU . 5.9 mtp . . . . . 0 N--CA 1.496 1.842 0 CA-C-O 120.743 0.306 . . . . 0.0 110.238 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -173.97 -164.24 0.19 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.049 -1.032 . . . . 0.0 111.795 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.526 ' O ' HG13 ' A' ' 7' ' ' ILE . 12.9 mttt -62.52 -3.22 1.34 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.444 -0.785 . . . . 0.0 110.321 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.662 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 87.2 m -124.36 -39.61 2.31 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.201 -0.937 . . . . 0.0 108.871 179.061 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.542 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -63.11 -55.52 24.61 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 178.343 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.543 ' HA ' ' HB3' ' A' ' 9' ' ' ALA . 0.8 OUTLIER -58.71 -29.58 66.78 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.499 -0.881 . . . . 0.0 109.201 178.198 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.662 ' HB ' ' O ' ' A' ' 4' ' ' THR . 1.7 mt -54.25 -56.09 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.49 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.542 ' HE2' ' HA ' ' A' ' 5' ' ' GLU . 12.7 mtmt -58.69 -33.28 69.97 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.23 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.543 ' HB3' ' HA ' ' A' ' 6' ' ' LEU . . . -52.34 -37.97 57.45 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.574 -0.851 . . . . 0.0 109.202 179.106 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.862 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.0 OUTLIER -96.07 -35.1 5.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 178.546 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -61.49 -13.14 18.49 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 118.616 -1.234 . . . . 0.0 108.687 178.467 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -114.75 -43.66 3.12 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.474 -0.766 . . . . 0.0 109.377 178.431 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' A' ' 9' ' ' ALA . 1.1 m-20 -63.99 -39.55 94.37 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 177.501 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.862 ' OG1' ' O ' ' A' ' 10' ' ' ILE . 0.1 OUTLIER -89.45 -78.0 0.37 Allowed 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 177.375 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.9 7.8 67.05 Favored Glycine 0 N--CA 1.5 2.924 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 177.528 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.887 HD12 ' HB3' ' B' ' 20' ' ' SER . 5.1 mp -54.75 -68.1 0.21 Allowed 'General case' 0 C--N 1.293 -1.858 0 O-C-N 121.671 -0.899 . . . . 0.0 110.676 179.821 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.596 ' O ' HG23 ' A' ' 17' ' ' THR . 0.5 OUTLIER -142.94 7.98 1.65 Allowed 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.715 -179.25 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.591 ' O ' ' C ' ' A' ' 19' ' ' VAL . 11.6 mt-30 59.4 24.61 13.23 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 -176.031 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.699 ' HB ' ' HB ' ' B' ' 19' ' ' VAL . 1.6 p -2.72 -91.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.932 -179.064 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.987 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.5 OUTLIER -131.01 24.8 4.96 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 178.21 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.634 ' C ' ' O ' ' A' ' 20' ' ' SER . 1.4 m -20.93 -40.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-O 122.265 1.031 . . . . 0.0 109.409 -178.248 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.77 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.2 OUTLIER -80.42 -34.68 35.99 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.603 177.863 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.987 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -90.13 -38.11 13.75 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.563 -0.71 . . . . 0.0 111.193 179.544 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.622 ' CE ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -66.54 -37.33 84.77 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 117.686 -1.605 . . . . 0.0 108.774 179.455 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.58 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 0.4 OUTLIER -79.89 -37.99 33.58 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 118.054 -1.458 . . . . 0.0 109.425 178.699 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.448 ' HA ' ' CE ' ' A' ' 3' ' ' LYS . . . -66.06 -34.78 78.86 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 177.447 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.608 ' O ' HG13 ' A' ' 31' ' ' ILE . 62.1 m -83.16 -30.46 27.8 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.205 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.606 ' O ' HG13 ' A' ' 31' ' ' ILE . 1.4 t80 -52.49 -49.53 64.53 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.552 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.699 ' HG3' ' CD2' ' B' ' 47' ' ' PHE . 0.2 OUTLIER -67.15 -35.99 80.87 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 177.172 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 1.158 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 9.7 ttmm -64.22 -20.79 66.27 Favored 'General case' 0 C--O 1.19 -2.061 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.413 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.608 HG13 ' O ' ' A' ' 27' ' ' SER . 1.3 pp -105.04 -27.99 3.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 O-C-N 120.297 -1.502 . . . . 0.0 108.951 178.222 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.58 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.2 mm -73.48 -58.69 4.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 177.078 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.439 ' HA ' ' CD2' ' B' ' 85' ' ' LEU . 0.4 OUTLIER -69.43 -33.42 72.94 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.305 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 1.158 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 27.2 mm-40 -76.96 -39.42 50.67 Favored 'General case' 0 N--CA 1.483 1.211 0 O-C-N 121.056 -1.027 . . . . 0.0 111.094 179.104 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.679 ' HA ' ' HB2' ' A' ' 38' ' ' LYS . 21.9 m -57.94 -52.76 64.15 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.074 -1.641 . . . . 0.0 108.488 179.295 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.534 HG11 ' HB3' ' A' ' 52' ' ' PRO . 2.4 t -54.35 -36.56 34.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 177.918 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.567 ' HB2' ' O ' ' B' ' 88' ' ' ALA . . . -87.24 -0.23 56.4 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.432 0.634 . . . . 0.0 109.724 178.668 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.679 ' HB2' ' HA ' ' A' ' 35' ' ' THR . 1.5 mmpt? -102.6 -30.6 10.85 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 177.85 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.11 41.51 0.47 Allowed Glycine 0 C--N 1.303 -1.282 0 C-N-CA 119.945 -1.121 . . . . 0.0 110.842 177.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.502 ' CB ' ' CG2' ' A' ' 35' ' ' THR . 0.4 OUTLIER -147.0 120.27 8.93 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.074 -1.25 . . . . 0.0 110.624 179.526 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.2 mtpt -63.95 86.62 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.53 -0.731 . . . . 0.0 109.608 179.723 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.534 ' HA ' ' HG2' ' B' ' 1' ' ' MET . 11.3 p -68.1 146.75 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.656 -0.653 . . . . 0.0 110.391 -179.479 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.516 ' O ' ' HA ' ' B' ' 2' ' ' ASN . 22.9 mt-30 -144.68 176.48 9.39 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.341 -0.849 . . . . 0.0 110.257 -179.805 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.665 HD11 ' CB ' ' A' ' 48' ' ' LEU . 32.4 mt -125.52 113.9 18.07 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.594 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.541 HG23 ' HG2' ' B' ' 29' ' ' GLU . 0.1 OUTLIER 36.05 -87.53 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.85 -0.531 . . . . 0.0 110.621 -179.229 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -151.59 27.09 0.95 Allowed Glycine 0 N--CA 1.484 1.87 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.34 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.584 ' CE2' ' HG2' ' B' ' 29' ' ' GLU . 4.6 p90 -125.38 -29.92 3.19 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.96 -1.318 . . . . 0.0 112.66 179.84 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.665 ' CB ' HD11 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -122.04 85.71 2.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.445 -1.409 . . . . 0.0 110.692 179.132 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -89.47 85.6 6.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.811 -0.556 . . . . 0.0 109.88 179.605 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.622 ' HA ' HG21 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -75.68 139.37 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.404 -0.81 . . . . 0.0 109.656 -179.57 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.491 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 2.2 ptmt -153.9 125.51 3.7 Favored Pre-proline 0 N--CA 1.496 1.861 0 C-N-CA 118.752 -1.179 . . . . 0.0 110.785 179.674 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.584 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 52.9 Cg_endo -80.97 144.18 14.87 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 O-C-N 123.518 1.272 . . . . 0.0 111.248 -179.768 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.568 ' O ' ' N ' ' A' ' 76' ' ' GLY . 31.6 m -137.98 114.82 11.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-O 121.772 0.796 . . . . 0.0 110.259 179.043 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.5 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.496 1.835 0 CA-C-O 121.924 0.869 . . . . 0.0 111.898 -178.513 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.66 ' HB ' ' HB2' ' B' ' 94' ' ' TYR . 1.0 OUTLIER . . . . . 0 N--CA 1.496 1.831 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 . . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 53' ' ' VAL . . . -117.74 86.92 0.42 Allowed Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.141 -1.583 . . . . 0.0 109.141 -179.86 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.584 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 5.0 p -60.75 77.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.676 -0.896 . . . . 0.0 109.834 179.868 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.628 ' O ' ' CG2' ' A' ' 79' ' ' VAL . 0.8 OUTLIER -62.69 178.02 0.48 Allowed 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.502 -0.879 . . . . 0.0 109.565 179.775 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.628 ' CG2' ' O ' ' A' ' 78' ' ' SER . 2.7 t -176.78 173.56 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.709 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.529 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 10.9 pttp 177.53 169.33 0.47 Allowed Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.081 -1.012 . . . . 0.0 110.027 176.503 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.485 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 55.1 Cg_endo -97.47 141.83 0.61 Allowed 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 122.505 2.136 . . . . 0.0 110.753 177.757 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.528 ' HA3' ' HA ' ' A' ' 47' ' ' PHE . . . -97.63 -155.09 29.87 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 108.432 -1.867 . . . . 0.0 108.432 178.424 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.567 ' HA ' ' HB2' ' A' ' 86' ' ' LYS . 4.7 pm0 -93.77 -15.37 25.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.126 -1.22 . . . . 0.0 110.347 179.358 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.35 -34.18 56.53 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.309 -0.87 . . . . 0.0 109.574 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.516 ' CG ' ' HB2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -88.17 -25.36 22.98 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 119.68 -0.808 . . . . 0.0 108.855 179.005 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.567 ' HB2' ' HA ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -76.19 -35.71 58.98 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.554 -0.858 . . . . 0.0 109.184 179.647 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.7 tttp -72.82 -39.83 66.31 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 177.166 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.787 ' O ' ' HB1' ' B' ' 37' ' ' ALA . . . -65.08 -37.0 86.11 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 176.243 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.529 ' N ' ' HB3' ' B' ' 37' ' ' ALA . . . -56.71 -38.04 71.77 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.758 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.15 -33.06 62.6 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 176.391 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.513 ' C ' ' H ' ' A' ' 93' ' ' LYS . . . -59.82 -44.44 97.04 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 177.805 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.617 ' O ' ' CD1' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -69.42 15.44 0.07 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.71 -1.465 . . . . 0.0 110.422 179.397 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.602 ' HB3' ' O ' ' A' ' 92' ' ' LEU . 0.8 OUTLIER 65.37 73.77 0.39 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 -177.086 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 1.055 ' O ' ' C ' ' A' ' 95' ' ' GLU . 47.7 t80 -47.39 -58.19 4.44 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 116.481 -2.088 . . . . 0.0 106.538 179.817 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 1.055 ' C ' ' O ' ' A' ' 94' ' ' TYR . 56.2 mm-40 . . . . . 0 CA--C 1.484 -1.588 0 N-CA-C 102.3 -3.222 . . . . 0.0 102.3 179.295 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.534 ' HG2' ' HA ' ' A' ' 42' ' ' VAL . 4.2 ptm . . . . . 0 N--CA 1.496 1.832 0 CA-C-O 121.307 0.575 . . . . 0.0 110.833 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 2' ' ' ASN . . . . . 0.516 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 16.4 p-10 -176.15 -140.81 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.706 -0.797 . . . . 0.0 111.238 178.044 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.415 ' HG3' ' HB ' ' A' ' 45' ' ' THR . 0.1 OUTLIER -57.56 -0.36 0.07 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.003 -1.061 . . . . 0.0 110.916 -179.62 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.755 ' O ' HG13 ' B' ' 7' ' ' ILE . 4.2 m -120.16 -69.47 0.84 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.957 -1.089 . . . . 0.0 110.376 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.595 ' O ' ' HG3' ' B' ' 8' ' ' LYS . 1.7 mm-40 -48.82 -36.17 16.17 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.062 -1.024 . . . . 0.0 109.331 -179.865 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.441 ' HA ' ' CB ' ' B' ' 9' ' ' ALA . 87.0 mt -69.36 -28.96 66.66 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 118.869 -1.133 . . . . 0.0 109.988 178.608 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 7' ' ' ILE . . . . . 0.755 HG13 ' O ' ' B' ' 4' ' ' THR . 1.5 pp -63.76 -45.91 95.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.521 -1.362 . . . . 0.0 107.972 178.929 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . 0.675 ' HA ' ' HB2' ' B' ' 11' ' ' ALA . 0.0 OUTLIER -74.23 -20.44 60.17 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.39 -0.924 . . . . 0.0 108.562 177.522 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . 0.441 ' CB ' ' HA ' ' B' ' 6' ' ' LEU . . . -69.15 -33.57 73.63 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.149 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . 0.873 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.0 OUTLIER -94.37 -34.5 5.63 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.4 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 178.3 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.675 ' HB2' ' HA ' ' B' ' 8' ' ' LYS . . . -56.91 -25.49 57.4 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.285 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 11.6 mm-40 -92.52 -45.03 8.32 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.441 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -62.34 -25.26 67.8 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 177.061 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.873 ' OG1' ' O ' ' B' ' 10' ' ' ILE . 14.8 p -91.42 -74.39 0.51 Allowed 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.119 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 59.15 17.24 36.9 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.575 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 16' ' ' LEU . . . . . 0.705 HD12 ' HB ' ' B' ' 14' ' ' THR . 3.4 mp -83.44 -61.53 1.82 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.358 -1.084 . . . . 0.0 108.878 179.053 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 17' ' ' THR . . . . . 0.519 ' HB ' HG22 ' A' ' 17' ' ' THR . 0.6 OUTLIER -139.84 2.84 2.0 Allowed 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.732 179.909 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . 0.623 ' O ' ' C ' ' B' ' 19' ' ' VAL . 17.6 mt-30 56.64 28.14 13.61 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 -176.836 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.699 ' HB ' ' HB ' ' A' ' 19' ' ' VAL . 1.7 p -6.16 -100.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.765 -179.377 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 20' ' ' SER . . . . . 0.899 ' O ' ' N ' ' B' ' 23' ' ' LYS . 0.5 OUTLIER -133.92 24.12 3.93 Favored 'General case' 0 C--N 1.28 -2.445 0 N-CA-C 105.434 -2.062 . . . . 0.0 105.434 177.154 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . 0.65 ' HA ' ' HE1' ' B' ' 24' ' ' MET . 16.6 m -18.43 -37.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 CA-C-O 122.212 1.006 . . . . 0.0 110.513 -177.922 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.844 ' N ' ' O ' ' B' ' 20' ' ' SER . 5.2 t -77.49 -43.13 33.25 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.146 -0.934 . . . . 0.0 108.893 178.496 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . 0.899 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.0 OUTLIER -92.3 -19.21 22.39 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.724 -0.61 . . . . 0.0 109.566 178.474 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 24' ' ' MET . . . . . 0.728 ' N ' ' OG ' ' B' ' 20' ' ' SER 0.258 3.1 tmm? -68.57 -44.86 73.54 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.3 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . 0.544 ' HA ' ' HB3' ' B' ' 28' ' ' PHE . 8.4 mt -76.83 -44.14 33.55 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 177.005 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . 0.475 ' HB3' ' HA ' ' B' ' 23' ' ' LYS . . . -54.74 -33.48 61.21 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 177.567 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 27' ' ' SER . . . . . 0.528 ' O ' ' N ' ' B' ' 31' ' ' ILE . 10.4 m -75.27 -40.97 58.24 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.465 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . 0.729 ' HA ' ' CG1' ' B' ' 31' ' ' ILE . 0.0 OUTLIER -64.39 -31.38 72.57 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.548 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . 0.592 ' HG3' ' CE2' ' B' ' 28' ' ' PHE . 1.5 mt-10 -84.4 -32.3 24.22 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 178.221 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . 0.747 ' O ' ' CG ' ' B' ' 34' ' ' GLU . 24.8 tttt -71.4 -29.02 64.43 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 176.332 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.729 ' CG1' ' HA ' ' B' ' 28' ' ' PHE . 1.3 pp -93.89 -31.29 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.224 -0.922 . . . . 0.0 109.749 178.955 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.648 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 3.4 mm -61.65 -55.22 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 177.447 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 33' ' ' THR . . . . . 0.437 ' OG1' ' HG ' ' A' ' 85' ' ' LEU . 0.4 OUTLIER -64.52 -40.32 95.4 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.429 179.46 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.793 ' O ' ' N ' ' B' ' 38' ' ' LYS . 17.8 mm-40 -68.92 -44.14 73.73 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.77 -0.581 . . . . 0.0 110.959 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 35' ' ' THR . . . . . 0.467 ' HA ' ' CB ' ' B' ' 38' ' ' LYS . 93.0 m -54.0 -52.12 61.76 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.798 -1.189 . . . . 0.0 108.998 179.876 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.577 ' HA ' ' HG3' ' B' ' 52' ' ' PRO . 0.4 OUTLIER -50.9 -37.26 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.145 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . 0.787 ' HB1' ' O ' ' A' ' 88' ' ' ALA . . . -96.32 0.77 51.21 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.774 0.797 . . . . 0.0 110.108 179.043 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . 0.793 ' N ' ' O ' ' B' ' 34' ' ' GLU . 0.0 OUTLIER -95.8 -22.84 17.24 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 176.906 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.49 44.87 0.69 Allowed Glycine 0 C--N 1.304 -1.22 0 C-N-CA 120.35 -0.928 . . . . 0.0 110.961 177.631 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . 0.417 ' CB ' HG23 ' B' ' 35' ' ' THR . 0.4 OUTLIER -155.41 166.14 34.47 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.005 -1.291 . . . . 0.0 111.399 179.6 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.422 ' HG2' ' HA ' ' B' ' 51' ' ' LYS . 11.0 mttt -121.48 112.86 19.04 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.273 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . 0.462 HG22 ' CG1' ' B' ' 50' ' ' ILE . 0.8 OUTLIER -79.47 147.15 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 C-N-CA 118.664 -1.214 . . . . 0.0 110.064 -178.602 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 43' ' ' GLN . . . . . 0.459 ' HA ' ' HA ' ' B' ' 49' ' ' ASN . 1.6 mt-30 -123.66 85.85 2.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.485 -0.759 . . . . 0.0 109.259 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.537 ' HB2' ' CB ' ' B' ' 48' ' ' LEU . 12.6 mt -58.96 90.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.473 -0.767 . . . . 0.0 110.727 -179.219 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 45' ' ' THR . . . . . 0.531 HG22 ' HD2' ' B' ' 47' ' ' PHE . 2.2 t 35.93 26.98 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 179.34 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . 97.91 -25.39 27.71 Favored Glycine 0 N--CA 1.494 2.563 0 C-N-CA 119.841 -1.171 . . . . 0.0 112.859 177.44 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . 0.699 ' CD2' ' HG3' ' A' ' 29' ' ' GLU . 1.4 p90 -86.44 -28.43 23.51 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 119.873 1.836 . . . . 0.0 112.031 -178.577 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . 0.611 ' HG ' ' CE1' ' B' ' 47' ' ' PHE . 5.5 mt -129.78 94.06 3.65 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.6 -1.313 . . . . 0.0 110.382 177.786 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 49' ' ' ASN . . . . . 0.476 ' O ' ' HA ' ' B' ' 79' ' ' VAL . 0.6 OUTLIER -105.0 95.26 5.73 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.533 -0.729 . . . . 0.0 110.156 -179.695 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 50' ' ' ILE . . . . . 0.462 ' CG1' HG22 ' B' ' 42' ' ' VAL . 2.0 pp -86.83 146.63 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.483 -0.761 . . . . 0.0 110.684 -179.765 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' B' ' 51' ' ' LYS . 2.6 ptmt -155.11 128.79 4.5 Favored Pre-proline 0 N--CA 1.496 1.848 0 C-N-CA 119.092 -1.043 . . . . 0.0 110.434 179.044 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 52' ' ' PRO . . . . . 0.577 ' HG3' ' HA ' ' B' ' 36' ' ' VAL . 57.1 Cg_endo -84.72 140.99 8.41 Favored 'Trans proline' 0 C--N 1.315 -1.205 0 O-C-N 123.352 1.185 . . . . 0.0 110.955 -179.404 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.567 HG23 ' O ' ' B' ' 76' ' ' GLY . 24.8 m -144.61 116.25 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-O 121.767 0.794 . . . . 0.0 111.281 179.18 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.87 0 O-C-N 121.807 -0.558 . . . . 0.0 111.332 -179.231 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . 0.58 ' N ' ' CD1' ' A' ' 94' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.811 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 . . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 76' ' ' GLY . . . . . 0.624 ' O ' ' N ' ' B' ' 78' ' ' SER . . . -114.42 68.8 0.25 Allowed Glycine 0 N--CA 1.487 2.098 0 C-N-CA 119.403 -1.38 . . . . 0.0 109.656 -179.382 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.574 ' HA ' ' HA ' ' B' ' 52' ' ' PRO . 2.5 p -58.09 76.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.453 -1.027 . . . . 0.0 109.428 179.521 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 78' ' ' SER . . . . . 0.624 ' N ' ' O ' ' B' ' 76' ' ' GLY . 6.5 t -76.95 177.17 7.95 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.897 0.856 . . . . 0.0 110.789 -179.446 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' B' ' 49' ' ' ASN . 4.8 p 177.23 177.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 80' ' ' LYS . . . . . 0.433 ' N ' ' CG2' ' B' ' 79' ' ' VAL . 0.1 OUTLIER -172.48 173.51 1.48 Allowed Pre-proline 0 N--CA 1.485 1.303 0 O-C-N 120.64 -1.288 . . . . 0.0 110.642 178.131 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 81' ' ' PRO . . . . . 0.403 ' CD ' ' HB2' ' B' ' 80' ' ' LYS . 53.4 Cg_endo -97.72 133.1 0.32 Allowed 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 122.503 2.136 . . . . 0.0 110.504 178.801 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . 0.504 ' HA3' ' HA ' ' B' ' 47' ' ' PHE . . . -89.76 -164.37 39.98 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 108.41 -1.876 . . . . 0.0 108.41 178.669 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -83.87 -18.25 38.14 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.039 -1.271 . . . . 0.0 110.385 179.805 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 1.1 m -52.44 -38.18 58.59 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.23 -0.918 . . . . 0.0 109.434 179.656 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . 0.451 ' CD2' ' CD1' ' B' ' 47' ' ' PHE . 0.4 OUTLIER -78.71 -33.03 47.11 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.17 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.04 -45.57 56.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.66 -0.65 . . . . 0.0 110.563 -179.32 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.74 -39.31 93.69 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 178.443 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.567 ' O ' ' HB2' ' A' ' 37' ' ' ALA . . . -66.83 -33.68 76.15 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 176.822 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . 0.438 ' HB3' ' CG1' ' A' ' 75' ' ' VAL . . . -56.44 -44.83 80.84 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.019 179.17 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -53.81 -32.86 54.18 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 177.114 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -64.71 -35.82 92.38 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 178.447 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 92' ' ' LEU . . . . . 0.524 ' HB3' ' HA ' ' A' ' 37' ' ' ALA . 0.4 OUTLIER -75.58 12.01 1.14 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.689 -1.477 . . . . 0.0 111.111 -179.768 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 93' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' B' ' 92' ' ' LEU . 0.0 OUTLIER 61.01 40.04 15.72 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -177.639 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . 0.66 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 0.1 OUTLIER -37.79 -38.49 0.29 Allowed 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.167 -179.055 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . 0.413 ' N ' ' CG ' ' B' ' 94' ' ' TYR . 14.6 pt-20 -61.74 -42.93 99.61 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.31 -0.869 . . . . 0.0 109.885 179.77 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -58.96 -33.71 70.96 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.57 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.463 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.491 ' HG2' ' HA ' ' B' ' 42' ' ' VAL . 1.5 ptm . . . . . 0 N--CA 1.496 1.841 0 CA-C-O 121.297 0.57 . . . . 0.0 110.739 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . 0.419 ' HB3' ' O ' ' A' ' 1' ' ' MET . 34.5 p-10 -175.38 -148.08 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 119.714 -0.795 . . . . 0.0 111.359 178.648 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.418 ' O ' ' CG2' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -53.83 -6.88 0.1 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.178 -0.952 . . . . 0.0 111.091 -179.521 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.627 ' O ' ' CG1' ' A' ' 7' ' ' ILE . 32.9 m -118.49 -64.1 1.33 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.953 -1.092 . . . . 0.0 110.613 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.664 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 5.0 mt-10 -48.79 -40.32 28.58 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.846 -1.159 . . . . 0.0 109.314 -179.706 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.407 ' HB2' ' O ' ' A' ' 2' ' ' ASN . 74.0 mt -62.66 -33.88 75.95 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.456 178.19 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.657 HG13 ' N ' ' A' ' 8' ' ' LYS . 0.9 OUTLIER -58.78 -38.03 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 178.771 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.752 ' HA ' ' HB1' ' A' ' 11' ' ' ALA . 31.4 mtmt -68.95 -34.29 75.1 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.17 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 13' ' ' ASP . . . -54.37 -40.4 68.09 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.286 179.163 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.852 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.4 mp -92.24 -29.23 4.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 178.247 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.752 ' HB1' ' HA ' ' A' ' 8' ' ' LYS . . . -68.07 -9.14 43.86 Favored 'General case' 0 C--N 1.289 -2.033 0 O-C-N 120.579 -1.326 . . . . 0.0 108.723 178.596 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -121.51 -41.46 2.49 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.376 -0.828 . . . . 0.0 110.102 179.202 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' A' ' 9' ' ' ALA . 62.8 m-20 -68.62 -24.5 64.57 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 177.471 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.852 ' OG1' ' O ' ' A' ' 10' ' ' ILE 0.274 0.2 OUTLIER -106.96 -81.85 0.55 Allowed 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 178.752 . . . . . . . . 4 4 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.51 6.43 66.07 Favored Glycine 0 N--CA 1.501 3.02 0 O-C-N 121.07 -1.019 . . . . 0.0 110.61 177.679 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.696 HD13 ' HB2' ' B' ' 20' ' ' SER . 5.0 mp -51.81 -70.17 0.09 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.67 -0.9 . . . . 0.0 110.514 179.812 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.475 ' O ' HG21 ' A' ' 17' ' ' THR . 0.6 OUTLIER -132.82 8.57 4.14 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.825 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.588 ' O ' ' C ' ' A' ' 19' ' ' VAL . 2.3 mt-30 57.04 26.98 12.62 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 -176.179 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.619 ' CG2' ' CD1' ' B' ' 16' ' ' LEU . 0.6 OUTLIER -10.17 -94.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.626 -179.034 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.931 ' O ' ' N ' ' A' ' 23' ' ' LYS . 2.4 m -134.57 23.29 3.69 Favored 'General case' 0 C--N 1.28 -2.425 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 178.181 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.669 ' C ' ' O ' ' A' ' 20' ' ' SER . 31.5 m -18.16 -40.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 CA-C-O 122.418 1.104 . . . . 0.0 109.279 -177.376 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.867 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.4 OUTLIER -86.43 -38.03 17.75 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.088 178.142 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.931 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.9 OUTLIER -85.21 -31.52 23.13 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.535 -0.728 . . . . 0.0 110.895 179.448 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.533 ' CE ' ' HG ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -76.46 -43.77 38.5 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 118.217 -1.393 . . . . 0.0 109.315 179.249 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.533 ' HG ' ' CE ' ' A' ' 24' ' ' MET . 7.0 mt -68.5 -48.54 64.14 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 117.743 -1.583 . . . . 0.0 108.293 177.888 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.435 ' CB ' ' O ' ' A' ' 22' ' ' SER . . . -55.76 -33.14 64.05 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 177.558 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.532 ' O ' ' CG1' ' A' ' 31' ' ' ILE . 7.5 t -73.34 -36.81 66.24 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 177.488 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.714 ' O ' ' CG1' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -64.19 -33.74 76.49 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.535 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.566 ' HG3' ' CD2' ' A' ' 28' ' ' PHE . 2.1 mt-10 -83.1 -31.44 27.27 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.175 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.767 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 6.7 tttm -72.12 -27.62 62.74 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 176.588 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.709 ' CG1' ' HA ' ' A' ' 28' ' ' PHE . 1.8 pp -95.99 -31.71 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.35 -0.844 . . . . 0.0 109.751 179.009 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.714 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 2.6 mm -63.28 -52.89 52.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.829 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.466 ' HA ' HD23 ' B' ' 85' ' ' LEU . 0.4 OUTLIER -68.34 -38.82 81.85 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.556 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.767 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 34.0 mm-40 -71.94 -34.3 68.91 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.413 -0.805 . . . . 0.0 110.832 179.169 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.594 ' N ' ' O ' ' A' ' 31' ' ' ILE . 3.2 m -59.98 -54.16 49.31 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.997 -1.064 . . . . 0.0 108.563 179.894 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.447 ' HB ' ' CD2' ' B' ' 85' ' ' LEU . 1.0 OUTLIER -54.04 -35.04 27.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 177.755 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.67 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -78.51 -7.15 57.18 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.736 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.489 ' N ' ' O ' ' A' ' 35' ' ' THR . 1.3 ttmt -102.21 -25.28 13.75 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 178.122 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 35' ' ' THR . . . 104.8 41.83 1.92 Allowed Glycine 0 C--N 1.3 -1.417 0 C-N-CA 120.218 -0.991 . . . . 0.0 110.699 178.067 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.456 ' CB ' HG22 ' A' ' 35' ' ' THR . 0.3 OUTLIER -128.67 154.27 46.45 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.116 -1.226 . . . . 0.0 110.429 179.449 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 43.1 tttt -109.01 98.38 7.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.382 -0.824 . . . . 0.0 110.0 -179.738 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.499 ' CG2' ' HB ' ' A' ' 50' ' ' ILE . 19.3 m -84.93 147.41 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.451 -0.781 . . . . 0.0 110.414 -179.602 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.431 ' O ' ' HA ' ' B' ' 2' ' ' ASN . 1.7 tt0 -136.57 107.91 6.86 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 121.296 -0.878 . . . . 0.0 110.134 -179.131 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.62 HD12 ' CB ' ' A' ' 48' ' ' LEU . 20.3 mt -66.64 99.13 0.57 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.039 -1.038 . . . . 0.0 109.875 179.51 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.547 HG22 ' HG2' ' B' ' 29' ' ' GLU . 1.7 t 37.17 26.67 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.782 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . 94.44 -0.24 65.58 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 120.06 -1.067 . . . . 0.0 112.487 177.664 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.561 ' CE1' ' HG ' ' A' ' 48' ' ' LEU . 0.8 OUTLIER -104.23 -31.38 9.62 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 120.002 1.901 . . . . 0.0 111.96 -179.919 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.62 ' CB ' HD12 ' A' ' 44' ' ' LEU . 1.0 OUTLIER -123.04 93.82 4.07 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.706 -1.246 . . . . 0.0 109.779 178.115 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 43' ' ' GLN . 6.1 t-20 -96.08 75.14 3.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.702 -0.624 . . . . 0.0 111.371 -179.114 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.515 ' HA ' ' HB ' ' A' ' 79' ' ' VAL . 2.6 mm -63.19 129.71 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.202 -0.936 . . . . 0.0 109.031 178.798 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 78' ' ' SER . 0.0 OUTLIER -144.05 127.26 8.81 Favored Pre-proline 0 N--CA 1.492 1.656 0 C-N-CA 118.712 -1.195 . . . . 0.0 109.704 179.491 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.577 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 54.3 Cg_endo -76.71 142.13 22.56 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.384 1.202 . . . . 0.0 111.162 -179.277 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.536 ' HB ' ' HA3' ' A' ' 76' ' ' GLY . 1.7 t -122.08 -142.84 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.588 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.498 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.5 2.037 0 O-C-N 121.291 -0.88 . . . . 0.0 110.158 179.693 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.539 ' N ' ' CD1' ' B' ' 94' ' ' TYR . 0.5 OUTLIER . . . . . 0 N--CA 1.497 1.923 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 . . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.618 ' O ' ' N ' ' A' ' 78' ' ' SER . . . -110.91 38.67 3.19 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 118.569 -1.777 . . . . 0.0 110.226 -178.765 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.644 HG21 ' HB3' ' B' ' 85' ' ' LEU . 3.0 p -27.78 87.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 CA-C-O 121.924 0.868 . . . . 0.0 110.58 179.781 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.618 ' N ' ' O ' ' A' ' 76' ' ' GLY . 0.1 OUTLIER -87.81 175.52 7.8 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.963 -179.168 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.515 ' HB ' ' HA ' ' A' ' 50' ' ' ILE . 7.2 p 175.57 177.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.845 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -177.15 171.71 0.89 Allowed Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.001 -1.062 . . . . 0.0 110.185 176.948 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -96.91 128.8 0.3 Allowed 'Trans proline' 0 C--N 1.302 -1.894 0 C-N-CA 122.414 2.076 . . . . 0.0 110.691 178.639 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.495 ' HA3' ' HA ' ' A' ' 47' ' ' PHE . . . -87.75 173.18 43.28 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 178.749 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -62.19 -17.92 59.52 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.086 -1.244 . . . . 0.0 110.591 -179.846 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.506 ' HB2' ' HB3' ' A' ' 47' ' ' PHE . 0.8 OUTLIER -53.74 -41.15 66.77 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.177 -0.952 . . . . 0.0 109.506 179.802 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.533 ' O ' ' HB2' ' A' ' 89' ' ' ALA . 1.0 OUTLIER -76.76 -26.79 54.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.448 -0.783 . . . . 0.0 109.116 179.111 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.552 ' HA ' ' HB2' ' A' ' 89' ' ' ALA . 0.7 OUTLIER -81.03 -41.27 22.93 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.665 -0.647 . . . . 0.0 110.63 -179.522 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.67 -40.92 98.02 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 178.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.656 ' O ' ' HB2' ' B' ' 37' ' ' ALA . . . -65.29 -37.39 87.02 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 176.3 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.552 ' HB2' ' HA ' ' A' ' 86' ' ' LYS . . . -56.66 -40.33 75.31 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.467 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -55.5 -31.75 62.3 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 177.096 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.418 ' C ' ' H ' ' A' ' 93' ' ' LYS . . . -68.56 -34.04 77.97 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 178.643 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.573 ' HB3' ' HA ' ' B' ' 37' ' ' ALA . 0.6 OUTLIER -66.27 5.84 0.49 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.648 -1.501 . . . . 0.0 111.305 -179.806 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.423 ' CB ' ' O ' ' A' ' 92' ' ' LEU . 0.4 OUTLIER 65.36 39.49 5.23 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 -177.388 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.474 ' CD1' ' N ' ' B' ' 75' ' ' VAL . 0.0 OUTLIER -43.54 -31.49 0.74 Allowed 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.154 -179.079 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 . . . . . 0 N--CA 1.494 1.741 0 O-C-N 121.279 -0.888 . . . . 0.0 108.944 179.151 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.514 ' HA ' ' CB ' ' B' ' 5' ' ' GLU . 2.5 mtp . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 2' ' ' ASN . . . . . 0.472 ' H ' ' HB2' ' B' ' 5' ' ' GLU . 17.5 p30 -173.43 -153.91 0.06 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.002 -1.061 . . . . 0.0 111.693 179.705 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.458 ' HG3' ' HB ' ' A' ' 45' ' ' THR . 0.1 OUTLIER -56.52 -0.55 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.515 -0.741 . . . . 0.0 111.562 -179.229 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.703 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 61.3 m -125.52 -45.68 1.78 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.779 -1.201 . . . . 0.0 110.363 179.738 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.514 ' CB ' ' HA ' ' B' ' 1' ' ' MET . 3.3 mt-10 -65.99 -51.45 58.23 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.051 -1.031 . . . . 0.0 108.682 179.673 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.504 ' HA ' ' HB1' ' B' ' 9' ' ' ALA . 17.9 mt -58.02 -32.62 68.12 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.161 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 7' ' ' ILE . . . . . 0.703 ' HB ' ' O ' ' B' ' 4' ' ' THR . 1.3 mt -53.63 -55.35 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 177.591 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . 0.491 ' O ' ' N ' ' B' ' 12' ' ' GLN . 0.6 OUTLIER -57.11 -31.98 65.84 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 177.829 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . 0.504 ' HB1' ' HA ' ' B' ' 6' ' ' LEU . . . -54.52 -38.42 66.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.271 -0.893 . . . . 0.0 108.971 178.677 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . 0.792 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.6 mp -90.83 -34.34 6.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 178.121 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.414 ' CB ' ' HA ' ' B' ' 8' ' ' LYS . . . -67.28 -12.62 60.6 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 119.139 -1.024 . . . . 0.0 109.011 178.686 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.491 ' N ' ' O ' ' B' ' 8' ' ' LYS . 1.1 pp0? -113.7 -36.0 5.0 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.339 -0.851 . . . . 0.0 109.416 178.496 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' B' ' 9' ' ' ALA . 56.0 m-20 -72.15 -21.54 61.44 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 176.784 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.792 ' OG1' ' O ' ' B' ' 10' ' ' ILE . 0.2 OUTLIER -117.24 -77.94 0.57 Allowed 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.462 179.648 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . 0.46 ' O ' ' C ' ' B' ' 16' ' ' LEU . . . 64.99 -13.1 0.21 Allowed Glycine 0 N--CA 1.5 2.908 0 N-CA-C 110.499 -1.041 . . . . 0.0 110.499 179.065 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 16' ' ' LEU . . . . . 0.719 ' N ' HD13 ' B' ' 16' ' ' LEU . 0.0 OUTLIER -35.05 -59.43 0.5 Allowed 'General case' 0 N--CA 1.513 2.677 0 CA-C-O 122.06 0.934 . . . . 0.0 110.678 -179.695 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 17' ' ' THR . . . . . 0.471 HG23 ' H ' ' B' ' 19' ' ' VAL . 0.5 OUTLIER -136.38 -1.17 2.36 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.543 -179.291 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . 0.627 ' O ' ' C ' ' B' ' 19' ' ' VAL . 5.1 mt-30 54.83 31.79 16.37 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 -176.815 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.627 ' C ' ' O ' ' B' ' 18' ' ' GLN . 0.9 OUTLIER -6.79 -93.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.01 -178.835 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 20' ' ' SER . . . . . 1.06 ' O ' ' N ' ' B' ' 22' ' ' SER . 0.3 OUTLIER -133.16 24.77 4.2 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 178.116 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . 0.651 ' C ' ' O ' ' B' ' 20' ' ' SER . 0.0 OUTLIER -8.85 -39.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-O 122.362 1.077 . . . . 0.0 110.288 -178.252 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 1.06 ' N ' ' O ' ' B' ' 20' ' ' SER . 5.9 m -85.05 -43.09 14.23 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.483 178.244 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . 0.885 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.2 OUTLIER -81.94 -25.3 35.0 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.286 -0.884 . . . . 0.0 111.004 179.927 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 24' ' ' MET . . . . . 0.561 ' SD ' ' HA ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -82.94 -45.92 13.57 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 118.357 -1.337 . . . . 0.0 110.063 179.399 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . 0.551 HD21 ' HE2' ' B' ' 24' ' ' MET . 0.4 OUTLIER -69.05 -48.22 63.4 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 117.53 -1.668 . . . . 0.0 108.104 178.272 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . 0.443 ' CB ' ' O ' ' B' ' 22' ' ' SER . . . -54.84 -34.09 62.48 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 177.698 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 27' ' ' SER . . . . . 0.592 ' O ' ' N ' ' B' ' 31' ' ' ILE . 3.7 t -72.55 -39.45 67.47 Favored 'General case' 0 C--O 1.204 -1.311 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.681 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . 0.695 ' HA ' ' CG1' ' B' ' 31' ' ' ILE . 0.1 OUTLIER -62.96 -37.68 88.05 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.688 0.756 . . . . 0.0 109.287 179.357 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . 0.547 ' HG2' HG22 ' A' ' 45' ' ' THR . 0.9 OUTLIER -81.9 -31.18 31.56 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 178.656 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . 0.815 ' O ' ' CG ' ' B' ' 34' ' ' GLU . 9.7 ttmt -71.99 -30.19 64.99 Favored 'General case' 0 C--O 1.19 -2.03 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 176.277 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.695 ' CG1' ' HA ' ' B' ' 28' ' ' PHE . 1.3 pp -91.19 -30.28 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.21 -0.931 . . . . 0.0 109.606 179.167 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.658 HG12 ' O ' ' B' ' 28' ' ' PHE . 5.2 mm -62.57 -51.68 69.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 177.495 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 33' ' ' THR . . . . . 0.513 ' HA ' HG23 ' B' ' 36' ' ' VAL . 0.4 OUTLIER -75.69 -25.66 56.9 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 114.904 -1.043 . . . . 0.0 108.966 179.74 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.815 ' CG ' ' O ' ' B' ' 30' ' ' LYS . 5.6 mm-40 -81.84 -35.75 29.04 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.078 -1.014 . . . . 0.0 109.394 178.674 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 35' ' ' THR . . . . . 0.519 ' N ' ' O ' ' B' ' 31' ' ' ILE . 52.0 m -62.55 -54.34 41.18 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 178.232 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.513 HG23 ' HA ' ' B' ' 33' ' ' THR . 2.2 m -50.17 -34.39 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 177.146 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . 0.656 ' HB2' ' O ' ' A' ' 88' ' ' ALA . . . -90.58 -4.13 57.08 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 121.57 0.7 . . . . 0.0 110.352 178.318 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . 0.658 ' N ' ' O ' ' B' ' 34' ' ' GLU . 0.0 OUTLIER -97.93 -24.5 15.36 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 177.731 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 111.81 43.87 0.92 Allowed Glycine 0 C--N 1.301 -1.383 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 178.089 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . 0.494 ' CB ' ' CG2' ' B' ' 35' ' ' THR . 0.1 OUTLIER -145.82 136.64 24.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.202 -1.175 . . . . 0.0 110.565 179.684 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 10.9 mtmt -89.68 88.28 7.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.477 -0.764 . . . . 0.0 109.901 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . 0.491 ' HA ' ' HG2' ' A' ' 1' ' ' MET . 7.6 p -62.1 142.19 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.486 -0.759 . . . . 0.0 110.128 -179.808 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -134.31 110.92 9.81 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.448 -0.782 . . . . 0.0 110.548 -179.361 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.595 HD12 ' CB ' ' B' ' 48' ' ' LEU . 17.0 mt -66.64 118.63 10.48 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.253 -0.904 . . . . 0.0 109.533 179.323 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 45' ' ' THR . . . . . 0.52 HG22 ' HG2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 29.06 -89.34 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.823 -0.548 . . . . 0.0 111.228 -179.975 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -149.58 26.85 1.2 Allowed Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 179.623 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . 0.565 ' CD1' ' HG ' ' B' ' 48' ' ' LEU . 7.7 p90 -125.45 -24.44 3.91 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.951 -1.323 . . . . 0.0 112.011 179.736 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . 0.595 ' CB ' HD12 ' B' ' 44' ' ' LEU . 1.6 mt -128.07 108.47 10.68 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.404 -1.435 . . . . 0.0 110.82 178.814 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -106.19 69.83 0.82 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.574 -0.704 . . . . 0.0 110.989 -179.643 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 50' ' ' ILE . . . . . 0.482 HG12 HG21 ' B' ' 79' ' ' VAL . 1.9 mm -60.1 125.6 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.302 -0.874 . . . . 0.0 109.281 179.142 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . 0.442 ' HG3' ' HB2' ' B' ' 78' ' ' SER . 9.1 ptmt -149.71 122.63 4.37 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 120.665 -1.272 . . . . 0.0 111.252 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 52' ' ' PRO . . . . . 0.657 ' HA ' ' HA ' ' B' ' 77' ' ' VAL . 55.4 Cg_endo -79.8 144.49 17.32 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 O-C-N 123.61 1.321 . . . . 0.0 110.964 179.78 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.507 ' O ' ' N ' ' B' ' 76' ' ' GLY . 32.6 m -138.92 114.3 8.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-O 121.833 0.825 . . . . 0.0 110.753 179.282 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . 0.537 ' HA ' ' HA ' ' B' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.493 1.701 0 O-C-N 121.581 -0.699 . . . . 0.0 111.173 -179.022 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . 0.537 ' HA ' ' HA ' ' B' ' 54' ' ' ALA . 8.6 p . . . . . 0 N--CA 1.493 1.716 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 76' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' B' ' 53' ' ' VAL . . . -120.24 96.72 0.63 Allowed Glycine 0 N--CA 1.49 2.244 0 C-N-CA 119.295 -1.431 . . . . 0.0 110.239 -179.143 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.657 ' HA ' ' HA ' ' B' ' 52' ' ' PRO . 6.4 p -69.39 68.61 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.575 -0.956 . . . . 0.0 109.075 179.04 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 78' ' ' SER . . . . . 0.442 ' HB2' ' HG3' ' B' ' 51' ' ' LYS . 1.6 m -65.65 177.18 1.28 Allowed 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.894 0.854 . . . . 0.0 110.732 -179.178 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . 0.482 HG21 HG12 ' B' ' 50' ' ' ILE . 7.3 p 177.24 177.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -179.84 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 80' ' ' LYS . . . . . 0.436 ' HB2' ' HD2' ' B' ' 81' ' ' PRO . 0.6 OUTLIER -177.47 172.62 0.76 Allowed Pre-proline 0 N--CA 1.487 1.423 0 O-C-N 120.852 -1.155 . . . . 0.0 110.769 177.651 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 81' ' ' PRO . . . . . 0.444 ' HA ' ' O ' ' B' ' 47' ' ' PHE . 53.4 Cg_endo -92.76 128.25 0.79 Allowed 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.441 2.094 . . . . 0.0 110.61 178.527 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.67 178.93 41.37 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 108.634 -1.787 . . . . 0.0 108.634 179.152 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . 0.41 ' HA ' ' HB2' ' B' ' 86' ' ' LYS . 4.0 pt-20 -69.61 -28.31 65.82 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.115 -1.227 . . . . 0.0 110.498 -179.828 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -48.71 -32.17 8.03 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.841 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . 0.644 ' HB3' HG21 ' A' ' 77' ' ' VAL . 0.5 OUTLIER -83.4 -38.23 22.22 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.211 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 86' ' ' LYS . . . . . 0.479 ' HA ' ' HB1' ' B' ' 89' ' ' ALA . 0.1 OUTLIER -70.12 -36.39 74.79 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.447 -0.783 . . . . 0.0 109.125 179.575 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 13.0 ttpt -64.97 -42.03 94.94 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 178.029 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.575 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -63.72 -34.86 78.82 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 176.233 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . 0.501 ' HB2' ' CG1' ' A' ' 75' ' ' VAL . . . -54.47 -43.99 72.21 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.616 -0.834 . . . . 0.0 109.275 178.743 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -53.35 -32.7 50.47 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 177.104 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' B' ' 88' ' ' ALA . . . -60.88 -42.3 99.57 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 178.138 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 92' ' ' LEU . . . . . 0.67 ' HB3' ' HA ' ' A' ' 37' ' ' ALA . 0.4 OUTLIER -75.39 17.79 0.25 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.665 -1.491 . . . . 0.0 110.502 179.682 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 93' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' B' ' 92' ' ' LEU . 0.0 OUTLIER 58.17 44.74 18.56 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -177.539 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . 0.539 ' CD1' ' N ' ' A' ' 75' ' ' VAL . 0.1 OUTLIER -36.71 -35.62 0.09 Allowed 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.68 -179.16 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . 0.431 ' HG3' ' N ' ' B' ' 96' ' ' ASP . 0.0 OUTLIER -64.77 -44.0 91.42 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.382 -0.824 . . . . 0.0 109.382 179.887 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 96' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' B' ' 93' ' ' LYS . 25.8 m-20 -56.39 -34.52 66.78 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.572 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.439 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.81 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.556 ' HB3' ' HG ' ' A' ' 6' ' ' LEU . 11.1 mtp . . . . . 0 N--CA 1.493 1.706 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . 0.492 ' HA ' ' O ' ' B' ' 43' ' ' GLN . 43.7 p-10 -168.5 -159.03 0.25 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.83 -1.169 . . . . 0.0 112.36 -179.891 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.46 ' CG ' ' HA ' ' A' ' 26' ' ' ALA . 5.6 tttm -50.92 -10.09 0.06 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.547 -0.721 . . . . 0.0 111.305 -179.388 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.67 ' O ' HG13 ' A' ' 7' ' ' ILE . 1.3 m -120.12 -57.88 1.91 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.978 -1.076 . . . . 0.0 109.558 179.208 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.529 ' CB ' ' HA ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -48.11 -40.86 24.77 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.402 -0.811 . . . . 0.0 109.154 179.576 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.556 ' HG ' ' HB3' ' A' ' 1' ' ' MET . 5.6 mt -68.83 -29.65 68.02 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.301 -0.96 . . . . 0.0 110.169 178.583 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.675 ' O ' ' HB1' ' A' ' 11' ' ' ALA . 1.2 pp -59.99 -46.8 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.667 -1.271 . . . . 0.0 108.263 179.73 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.61 ' H ' HG13 ' A' ' 7' ' ' ILE . 18.4 pttt -72.43 -24.8 61.28 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.2 -1.0 . . . . 0.0 108.678 177.514 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.452 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . . . -58.45 -39.26 79.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.264 -0.898 . . . . 0.0 109.04 178.774 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.802 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.9 OUTLIER -92.28 -32.79 5.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 177.863 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.675 ' HB1' ' O ' ' A' ' 7' ' ' ILE . . . -60.61 -14.29 19.39 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 118.856 -1.138 . . . . 0.0 108.966 178.129 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -112.87 -44.01 3.35 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.271 -0.893 . . . . 0.0 109.656 179.071 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.79 -39.03 90.54 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.569 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.802 ' OG1' ' O ' ' A' ' 10' ' ' ILE 0.251 0.2 OUTLIER -91.87 -70.07 0.71 Allowed 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 177.693 . . . . . . . . 4 4 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.448 ' HA2' ' O ' ' A' ' 11' ' ' ALA . . . 58.23 18.9 37.11 Favored Glycine 0 N--CA 1.499 2.853 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 177.236 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.709 ' CD1' HG23 ' B' ' 19' ' ' VAL . 3.3 mp -62.74 -63.83 1.1 Allowed 'General case' 0 C--N 1.293 -1.853 0 O-C-N 121.48 -1.012 . . . . 0.0 109.937 179.308 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.523 HG21 ' O ' ' A' ' 17' ' ' THR . 0.6 OUTLIER -138.13 7.63 2.67 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.445 -179.681 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.54 ' O ' ' C ' ' A' ' 19' ' ' VAL . 28.4 mt-30 58.14 26.5 13.79 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 -176.219 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.72 ' HB ' ' HB ' ' B' ' 19' ' ' VAL . 2.7 p -13.88 -96.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.121 -178.708 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.959 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -129.72 23.38 5.41 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 105.966 -1.865 . . . . 0.0 105.966 178.402 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.612 ' HA ' ' CE ' ' A' ' 24' ' ' MET . 30.0 m -24.6 -39.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 CA-C-O 122.481 1.134 . . . . 0.0 109.156 -178.868 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.706 ' N ' ' O ' ' A' ' 20' ' ' SER . 48.2 t -82.66 -35.27 27.04 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.246 177.92 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.959 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.6 OUTLIER -86.84 -36.56 18.41 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.684 -0.635 . . . . 0.0 111.347 179.521 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.613 ' HG2' HG23 ' B' ' 14' ' ' THR . 0.0 OUTLIER -70.06 -39.4 75.7 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.28 -1.513 . . . . 0.0 109.039 179.433 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.668 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 9.0 mt -77.82 -44.54 27.11 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 118.167 -1.413 . . . . 0.0 109.413 178.638 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.48 ' CB ' ' O ' ' A' ' 22' ' ' SER . . . -58.01 -32.8 68.27 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.955 -1.09 . . . . 0.0 108.121 178.025 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.58 ' O ' ' N ' ' A' ' 31' ' ' ILE . 25.8 p -85.27 -31.42 23.11 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.378 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.749 ' O ' ' CG1' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -56.13 -34.67 66.3 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.572 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.786 ' HG2' HG21 ' B' ' 45' ' ' THR . 0.8 OUTLIER -79.74 -39.31 31.38 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.378 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.81 ' O ' ' CG ' ' A' ' 34' ' ' GLU . 39.7 ttmt -65.92 -28.08 68.66 Favored 'General case' 0 C--O 1.192 -1.965 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.478 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.718 ' CG1' ' HA ' ' A' ' 28' ' ' PHE . 2.1 pp -93.2 -37.97 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.911 . . . . 0.0 108.939 179.103 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.749 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.1 mm -58.71 -53.52 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 177.651 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.706 ' OG1' ' HB2' ' B' ' 85' ' ' LEU . 0.3 OUTLIER -69.92 -27.35 64.71 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.654 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.81 ' CG ' ' O ' ' A' ' 30' ' ' LYS . 16.9 mm-40 -76.67 -45.03 31.4 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.0 -1.062 . . . . 0.0 110.685 178.973 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.467 ' CG2' ' CB ' ' A' ' 40' ' ' ASP . 96.4 m -61.58 -53.43 56.36 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 120.651 -1.281 . . . . 0.0 108.859 179.445 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.578 HG23 ' HA ' ' A' ' 33' ' ' THR . 15.7 m -50.11 -35.34 11.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 177.25 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.638 ' HA ' ' HA ' ' B' ' 89' ' ' ALA . . . -92.01 1.18 57.36 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-O 121.582 0.706 . . . . 0.0 110.32 178.484 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.595 ' N ' ' O ' ' A' ' 34' ' ' GLU . 8.8 ttmt -101.53 -32.93 10.14 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 177.784 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 132.98 35.87 0.29 Allowed Glycine 0 C--N 1.305 -1.173 0 C-N-CA 119.637 -1.268 . . . . 0.0 111.565 177.738 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.467 ' CB ' ' CG2' ' A' ' 35' ' ' THR . 0.2 OUTLIER -145.97 -174.02 4.32 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.824 -1.398 . . . . 0.0 111.39 179.467 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.402 ' HG2' ' CB ' ' A' ' 51' ' ' LYS . 0.5 OUTLIER -134.57 127.67 31.73 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.831 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.481 ' HB ' HD12 ' A' ' 50' ' ' ILE . 1.1 t -85.96 115.38 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.201 -0.937 . . . . 0.0 110.713 -178.794 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.435 ' O ' ' HA ' ' B' ' 2' ' ' ASN . 4.8 mt-30 -105.54 100.43 10.0 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.951 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.676 ' HB3' ' HE1' ' A' ' 47' ' ' PHE . 47.8 mt -71.9 115.44 11.12 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.219 -0.926 . . . . 0.0 110.704 -178.933 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.536 ' C ' ' O ' ' A' ' 44' ' ' LEU . 2.1 t 28.43 -117.17 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.717 -0.615 . . . . 0.0 110.516 178.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -127.08 32.32 3.63 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 109.071 -1.611 . . . . 0.0 109.071 179.024 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.676 ' HE1' ' HB3' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -131.08 -28.0 1.98 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.14 -1.212 . . . . 0.0 111.921 -179.836 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.576 ' HB3' HD11 ' A' ' 44' ' ' LEU . 6.3 mt -128.03 128.9 45.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 119.852 -1.78 . . . . 0.0 110.602 176.796 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.489 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 7.4 m-80 -129.81 111.47 12.64 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.533 -0.729 . . . . 0.0 110.399 -178.876 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.688 ' HA ' ' HA ' ' A' ' 79' ' ' VAL . 1.2 pp -111.9 149.18 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.581 -0.699 . . . . 0.0 110.348 179.947 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.402 ' CB ' ' HG2' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -165.58 117.68 0.87 Allowed Pre-proline 0 N--CA 1.497 1.918 0 O-C-N 120.696 -1.253 . . . . 0.0 110.933 -179.78 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.593 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 53.0 Cg_endo -82.33 149.59 15.07 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 O-C-N 123.667 1.351 . . . . 0.0 111.212 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.623 ' CG2' ' HA3' ' A' ' 76' ' ' GLY . 10.8 m -132.48 -149.95 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 O-C-N 121.521 -0.737 . . . . 0.0 110.345 179.542 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.408 ' HA ' ' HE1' ' B' ' 94' ' ' TYR . . . . . . . . 0 C--N 1.296 -1.758 0 O-C-N 121.1 -1.0 . . . . 0.0 111.266 -179.132 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.619 ' CG1' ' CB ' ' B' ' 89' ' ' ALA . 14.6 p . . . . . 0 N--CA 1.501 2.081 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.623 ' HA3' ' CG2' ' A' ' 53' ' ' VAL . . . -110.13 87.02 0.46 Allowed Glycine 0 N--CA 1.487 2.037 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 179.356 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.593 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 84.1 t -65.2 75.49 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 O-C-N 121.918 -0.754 . . . . 0.0 110.753 -179.247 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.537 ' O ' HG11 ' A' ' 79' ' ' VAL . 0.5 OUTLIER -65.83 178.77 0.99 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.323 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.688 ' HA ' ' HA ' ' A' ' 50' ' ' ILE . 0.0 OUTLIER 179.7 178.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.924 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.429 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 11.1 mttt 179.14 169.79 0.57 Allowed Pre-proline 0 C--N 1.307 -1.28 0 O-C-N 121.384 -0.822 . . . . 0.0 110.46 177.13 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 57.4 Cg_endo -109.39 161.15 0.08 OUTLIER 'Trans proline' 0 C--N 1.301 -1.959 0 C-N-CA 123.413 2.742 . . . . 0.0 110.605 177.798 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 47' ' ' PHE . . . -105.57 -150.79 19.55 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 107.604 -2.198 . . . . 0.0 107.604 177.093 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -100.46 -13.1 18.84 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.88 -1.365 . . . . 0.0 110.125 178.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.02 -38.09 75.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.335 -0.853 . . . . 0.0 109.075 179.664 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.551 ' HG ' ' HD2' ' A' ' 47' ' ' PHE . 0.5 OUTLIER -77.42 -38.16 50.23 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.692 -0.63 . . . . 0.0 109.539 179.239 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.422 ' HA ' ' HB1' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -69.14 -41.5 77.22 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.799 -0.761 . . . . 0.0 110.779 -178.923 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -64.93 -40.24 94.74 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 178.942 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.569 ' O ' ' HB3' ' B' ' 37' ' ' ALA . . . -72.79 -30.78 64.37 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 177.02 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.55 ' HA ' ' HA ' ' B' ' 37' ' ' ALA . . . -64.68 -39.08 93.05 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.304 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -56.98 -33.15 66.8 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 176.935 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -74.07 -20.79 79.66 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 178.745 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.583 ' CB ' ' O ' ' B' ' 37' ' ' ALA . 0.4 OUTLIER -76.82 16.07 0.57 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.681 -1.482 . . . . 0.0 111.268 -179.757 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.419 ' CB ' ' O ' ' A' ' 92' ' ' LEU . 0.0 OUTLIER 65.19 34.94 8.15 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -177.728 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.527 ' CD1' ' HB ' ' B' ' 75' ' ' VAL . 0.0 OUTLIER -49.31 -27.75 4.18 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.486 -179.578 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.362 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.486 ' HG2' ' HB3' ' B' ' 5' ' ' GLU . 3.0 mtp . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.193 0.52 . . . . 0.0 110.211 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 2' ' ' ASN . . . . . 0.522 ' O ' ' N ' ' B' ' 6' ' ' LEU . 23.3 t-20 -173.06 165.99 4.98 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.374 -0.829 . . . . 0.0 109.783 -179.816 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.637 ' NZ ' ' HB2' ' B' ' 29' ' ' GLU . 0.0 OUTLIER -47.36 -26.15 1.21 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.983 -1.073 . . . . 0.0 109.202 179.307 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.623 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 16.7 m -79.28 -56.19 4.53 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 177.342 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.486 ' HB3' ' HG2' ' B' ' 1' ' ' MET . 0.5 OUTLIER -57.95 -50.46 73.29 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 177.42 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' B' ' 2' ' ' ASN . 1.8 mt -61.15 -28.05 68.83 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 177.302 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 7' ' ' ILE . . . . . 0.623 ' HB ' ' O ' ' B' ' 4' ' ' THR . 0.1 OUTLIER -53.68 -54.28 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.278 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . 0.513 ' N ' ' CG2' ' B' ' 7' ' ' ILE . 0.1 OUTLIER -62.97 -32.91 74.34 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.234 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.68 -29.38 70.61 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.375 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . 0.714 ' O ' ' OG1' ' B' ' 14' ' ' THR . 0.6 OUTLIER -93.19 -35.58 6.7 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.627 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 178.109 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.567 ' HA ' ' OG1' ' B' ' 14' ' ' THR . . . -63.75 -29.11 70.36 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.849 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.469 ' N ' ' O ' ' B' ' 8' ' ' LYS . 1.1 tt0 -89.85 -39.06 13.31 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.027 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.452 ' HB2' ' HA ' ' B' ' 10' ' ' ILE . 43.2 m-20 -67.41 -25.51 65.97 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 176.755 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.714 ' OG1' ' O ' ' B' ' 10' ' ' ILE . 24.7 p -88.73 -76.35 0.4 Allowed 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.756 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 60.45 12.53 26.08 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.604 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 16' ' ' LEU . . . . . 0.652 HD13 ' HB ' ' B' ' 14' ' ' THR . 3.4 mp -82.98 -60.66 2.09 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.43 -1.041 . . . . 0.0 108.708 179.092 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 17' ' ' THR . . . . . 0.549 HG21 ' O ' ' B' ' 17' ' ' THR . 0.5 OUTLIER -146.14 3.9 0.93 Allowed 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.816 -179.665 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 18' ' ' GLN . . . . . 0.677 ' O ' ' C ' ' B' ' 19' ' ' VAL . 8.3 mt-30 57.09 28.03 14.3 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 -176.367 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.72 ' HB ' ' HB ' ' A' ' 19' ' ' VAL . 1.0 OUTLIER 5.73 -97.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.917 -179.516 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 20' ' ' SER . . . . . 1.033 ' O ' ' N ' ' B' ' 22' ' ' SER . 96.4 p -133.47 23.85 4.06 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 175.833 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . 0.661 ' C ' ' O ' ' B' ' 20' ' ' SER . 30.8 m -9.1 -41.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 CA-C-O 122.289 1.042 . . . . 0.0 109.885 -177.593 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 1.033 ' N ' ' O ' ' B' ' 20' ' ' SER . 15.3 p -67.81 -46.46 71.81 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.944 177.285 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . 0.902 ' N ' ' O ' ' B' ' 20' ' ' SER . 32.6 mtmt -91.72 -23.85 19.65 Favored 'General case' 0 C--N 1.307 -1.258 0 O-C-N 121.543 -0.723 . . . . 0.0 109.338 178.498 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 24' ' ' MET . . . . . 0.608 ' HE3' ' HA ' ' B' ' 21' ' ' VAL . 2.1 tmm? -63.46 -24.75 67.96 Favored 'General case' 0 C--O 1.216 -0.701 0 O-C-N 120.459 -1.401 . . . . 0.0 107.625 178.207 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . 0.673 ' C ' ' CD1' ' B' ' 25' ' ' LEU . 0.1 OUTLIER -89.27 -46.4 8.79 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 176.61 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . 0.418 ' N ' ' CG ' ' B' ' 25' ' ' LEU . . . -58.96 -28.19 66.06 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.25 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 27' ' ' SER . . . . . 0.489 ' O ' ' N ' ' B' ' 31' ' ' ILE . 23.8 p -86.61 -31.82 20.94 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.082 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 28' ' ' PHE . . . . . 0.871 ' O ' HG13 ' B' ' 31' ' ' ILE . 0.7 OUTLIER -57.69 -42.27 83.35 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.08 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 29' ' ' GLU . . . . . 0.669 ' O ' ' HB ' ' B' ' 33' ' ' THR . 2.3 tt0 -70.78 -43.27 69.07 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 177.35 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . 1.28 ' O ' ' HB3' ' B' ' 34' ' ' GLU . 25.5 ttpt -60.57 -21.34 62.49 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.873 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.881 ' HA ' ' HG2' ' B' ' 34' ' ' GLU . 1.3 pp -102.71 -33.7 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 119.361 -0.936 . . . . 0.0 110.209 179.58 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.668 HG13 ' CD1' ' B' ' 28' ' ' PHE . 1.0 OUTLIER -71.88 -43.76 68.33 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 176.791 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 33' ' ' THR . . . . . 0.669 ' HB ' ' O ' ' B' ' 29' ' ' GLU . 0.3 OUTLIER -77.02 -26.22 53.52 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 177.277 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 1.28 ' HB3' ' O ' ' B' ' 30' ' ' LYS . 0.0 OUTLIER -64.54 -43.94 92.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.097 -1.002 . . . . 0.0 109.961 178.3 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 35' ' ' THR . . . . . 0.577 ' N ' ' HG3' ' B' ' 34' ' ' GLU . 47.9 m -67.33 -56.08 11.23 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 118.911 -1.115 . . . . 0.0 109.255 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.623 ' CG2' ' HA ' ' B' ' 33' ' ' THR . 19.6 m -50.22 -33.92 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 118.164 -1.414 . . . . 0.0 108.217 178.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . 0.583 ' O ' ' CB ' ' A' ' 92' ' ' LEU . . . -93.3 0.5 57.0 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.242 0.544 . . . . 0.0 110.492 178.84 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . 0.731 ' HB2' ' O ' ' B' ' 34' ' ' GLU . 9.7 tppt? -103.89 -16.74 15.28 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 106.673 -1.602 . . . . 0.0 106.673 177.132 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.89 50.07 1.3 Allowed Glycine 0 C--N 1.304 -1.216 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 178.21 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . 0.462 ' CB ' HG22 ' B' ' 35' ' ' THR . 0.3 OUTLIER -148.94 141.01 23.86 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.057 -1.26 . . . . 0.0 110.775 179.43 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -90.57 92.89 9.05 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.621 -0.674 . . . . 0.0 109.24 179.866 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . 0.429 ' CG2' ' HB ' ' B' ' 50' ' ' ILE . 24.1 m -59.28 137.95 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 C-N-CA 119.814 -0.755 . . . . 0.0 110.001 -179.608 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 43' ' ' GLN . . . . . 0.492 ' O ' ' HA ' ' A' ' 2' ' ' ASN . 1.6 mt-30 -118.51 173.43 6.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.345 -0.847 . . . . 0.0 110.149 -179.318 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.656 ' O ' ' N ' ' B' ' 46' ' ' GLY . 36.1 mt -141.31 -177.67 5.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.383 -0.823 . . . . 0.0 110.794 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 45' ' ' THR . . . . . 0.786 HG21 ' HG2' ' A' ' 29' ' ' GLU . 2.4 t -51.58 69.02 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 120.878 0.371 . . . . 0.0 111.765 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . 0.656 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . 41.57 29.63 0.48 Allowed Glycine 0 N--CA 1.5 2.914 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 179.352 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . 0.663 ' C ' ' HA3' ' B' ' 82' ' ' GLY . 0.5 OUTLIER -123.72 -27.79 3.94 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.166 -1.197 . . . . 0.0 110.656 -179.755 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . 0.572 ' HB3' ' CE2' ' B' ' 47' ' ' PHE . 11.1 tp -168.73 150.0 4.7 Favored 'General case' 0 C--N 1.293 -1.854 0 C-N-CA 118.069 -1.452 . . . . 0.0 111.322 -179.839 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 49' ' ' ASN . . . . . 0.423 ' O ' ' N ' ' B' ' 80' ' ' LYS . 17.2 m-80 -148.35 -178.95 6.6 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.96 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 50' ' ' ILE . . . . . 0.72 ' HA ' ' HA ' ' B' ' 79' ' ' VAL . 0.0 OUTLIER -142.8 167.17 14.7 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 O-C-N 121.411 -0.806 . . . . 0.0 110.382 179.716 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 51' ' ' LYS . . . . . 0.452 ' O ' ' HD3' ' B' ' 51' ' ' LYS . 0.0 OUTLIER -170.88 130.13 0.79 Allowed Pre-proline 0 N--CA 1.494 1.771 0 C-N-CA 119.259 -0.977 . . . . 0.0 110.605 179.333 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 52' ' ' PRO . . . . . 0.626 ' HA ' ' HA ' ' B' ' 77' ' ' VAL . 57.7 Cg_endo -90.39 143.22 3.73 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.67 1.353 . . . . 0.0 110.741 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.518 ' CG2' ' HA3' ' B' ' 76' ' ' GLY . 16.5 m -126.6 -152.54 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 C-N-CA 119.841 -0.744 . . . . 0.0 110.229 178.945 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . 0.401 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . . . . . . . . 0 C--N 1.291 -1.969 0 O-C-N 121.292 -0.88 . . . . 0.0 110.506 -179.298 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . 0.527 ' HB ' ' CD1' ' A' ' 94' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.502 2.128 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 . . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 76' ' ' GLY . . . . . 0.518 ' HA3' ' CG2' ' B' ' 53' ' ' VAL . . . -114.89 88.2 0.47 Allowed Glycine 0 N--CA 1.491 2.303 0 C-N-CA 118.539 -1.791 . . . . 0.0 110.494 -179.178 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.626 ' HA ' ' HA ' ' B' ' 52' ' ' PRO . 5.0 p -69.62 68.58 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.354 -1.086 . . . . 0.0 108.308 178.349 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 78' ' ' SER . . . . . 0.443 ' N ' ' O ' ' B' ' 76' ' ' GLY . 0.3 OUTLIER -59.93 -153.8 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 121.895 0.855 . . . . 0.0 110.953 -179.073 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . 0.72 ' HA ' ' HA ' ' B' ' 50' ' ' ILE . 3.1 p -157.19 -169.49 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 179.805 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 80' ' ' LYS . . . . . 0.43 ' CB ' ' CD ' ' B' ' 81' ' ' PRO . 0.9 OUTLIER -140.38 175.29 3.24 Favored Pre-proline 0 C--N 1.307 -1.25 0 C-N-CA 117.651 -1.62 . . . . 0.0 113.126 -179.692 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 81' ' ' PRO . . . . . 0.43 ' CD ' ' CB ' ' B' ' 80' ' ' LYS . 58.9 Cg_endo -111.52 119.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 124.78 3.653 . . . . 0.0 111.185 -179.075 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . 0.663 ' HA3' ' C ' ' B' ' 47' ' ' PHE . . . -123.78 144.6 15.6 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 177.934 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . 0.423 ' HA ' ' HB2' ' B' ' 86' ' ' LYS . 8.0 pm0 -85.3 -23.62 28.04 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.156 -1.203 . . . . 0.0 111.59 -178.882 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 84' ' ' SER . . . . . 0.408 ' CB ' ' O ' ' B' ' 45' ' ' THR . 5.4 t -51.16 -30.96 18.29 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.051 -1.031 . . . . 0.0 108.42 179.283 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . 0.706 ' HB2' ' OG1' ' A' ' 33' ' ' THR . 0.1 OUTLIER -87.2 -40.52 14.5 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.172 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 86' ' ' LYS . . . . . 0.472 ' CG ' HG23 ' A' ' 77' ' ' VAL . 3.1 mtpp -64.24 -26.39 68.48 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.059 -1.057 . . . . 0.0 109.129 178.68 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -81.37 -36.01 30.13 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 178.343 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.6 ' O ' ' HB2' ' A' ' 37' ' ' ALA . . . -66.37 -37.98 86.52 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 176.737 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . 0.638 ' HA ' ' HA ' ' A' ' 37' ' ' ALA . . . -61.43 -35.06 76.51 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.414 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.2 -32.87 64.79 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 176.751 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . 0.408 ' C ' ' H ' ' B' ' 93' ' ' LYS . . . -66.42 -36.94 92.28 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 178.288 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 92' ' ' LEU . . . . . 0.516 ' O ' ' CB ' ' B' ' 93' ' ' LYS . 0.4 OUTLIER -69.65 7.1 0.93 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.902 -1.352 . . . . 0.0 110.658 179.553 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 93' ' ' LYS . . . . . 0.516 ' CB ' ' O ' ' B' ' 92' ' ' LEU . 6.5 tptm 72.99 43.41 0.41 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -177.76 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . 0.567 ' CD1' ' HA ' ' A' ' 75' ' ' VAL . 0.2 OUTLIER -41.31 -33.47 0.39 Allowed 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.422 -179.542 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -61.51 -43.19 99.3 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.193 -0.942 . . . . 0.0 109.323 179.299 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.3 -36.81 76.27 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 177.77 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 97' ' ' PHE . . . . . 0.403 ' HB3' ' CB ' ' A' ' 54' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.451 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.546 ' HA ' ' CB ' ' A' ' 5' ' ' GLU . 1.2 mtp . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -174.12 -167.55 0.35 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.884 -1.135 . . . . 0.0 111.736 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.438 ' O ' HG13 ' A' ' 7' ' ' ILE . 0.4 OUTLIER -53.02 -11.56 0.25 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.574 -0.704 . . . . 0.0 110.847 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.684 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 19.6 m -116.47 -42.48 3.0 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.026 -1.046 . . . . 0.0 109.538 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.546 ' CB ' ' HA ' ' A' ' 1' ' ' MET . 0.4 OUTLIER -62.13 -54.31 42.95 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.164 -0.96 . . . . 0.0 108.612 179.073 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.504 HD11 HG11 ' B' ' 42' ' ' VAL . 9.9 mt -57.93 -29.32 65.04 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.318 -0.864 . . . . 0.0 108.974 177.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.684 ' HB ' ' O ' ' A' ' 4' ' ' THR . 0.6 OUTLIER -55.17 -58.62 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.85 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.508 ' HE2' ' HA ' ' A' ' 5' ' ' GLU . 0.0 OUTLIER -61.06 -28.19 68.89 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.625 -0.83 . . . . 0.0 108.761 178.235 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.478 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . . . -61.16 -32.59 72.32 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.361 -0.837 . . . . 0.0 109.064 179.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.814 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.7 OUTLIER -97.52 -34.84 4.97 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.446 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 178.465 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.523 ' HA ' ' OG1' ' A' ' 14' ' ' THR . . . -61.22 -26.89 68.04 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 177.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.413 ' CG ' ' N ' ' A' ' 13' ' ' ASP . 11.0 pt20 -91.56 -39.85 11.68 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.435 ' HB3' ' CB ' ' B' ' 27' ' ' SER . 43.8 m-20 -66.21 -22.89 66.36 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 176.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.814 ' OG1' ' O ' ' A' ' 10' ' ' ILE . 16.8 p -93.0 -76.12 0.48 Allowed 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 58.63 14.52 22.06 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.805 HD11 ' HB ' ' A' ' 14' ' ' THR . 1.7 mp -80.79 -50.89 9.26 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.365 -1.079 . . . . 0.0 108.465 179.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.501 HG22 ' O ' ' A' ' 17' ' ' THR . 0.5 OUTLIER -150.7 0.74 0.42 Allowed 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 120.266 -0.573 . . . . 0.0 110.619 -179.655 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.593 ' O ' ' C ' ' A' ' 19' ' ' VAL . 9.1 mt-30 55.64 29.66 14.03 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 -176.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.744 ' HB ' ' HB ' ' B' ' 19' ' ' VAL . 0.7 OUTLIER -4.98 -95.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.714 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 1.092 ' O ' ' N ' ' A' ' 22' ' ' SER . 0.1 OUTLIER -132.45 24.42 4.43 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 178.292 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.664 ' O ' HG12 ' A' ' 7' ' ' ILE . 13.4 m -4.29 -40.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 CA-C-O 122.417 1.104 . . . . 0.0 110.898 -178.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 1.092 ' N ' ' O ' ' A' ' 20' ' ' SER . 8.6 t -79.92 -40.77 27.45 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.335 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.862 ' N ' ' O ' ' A' ' 20' ' ' SER . 1.7 ttpt -84.73 -27.71 26.79 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.412 -0.805 . . . . 0.0 111.366 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.53 ' SD ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -78.45 -40.39 35.78 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 117.895 -1.522 . . . . 0.0 109.751 179.627 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.663 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 0.2 OUTLIER -78.8 -49.21 13.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.585 -1.322 . . . . 0.0 109.837 178.842 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.44 ' CB ' ' O ' ' A' ' 22' ' ' SER . . . -55.04 -34.23 63.34 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.585 ' O ' ' N ' ' A' ' 31' ' ' ILE . 20.7 t -85.16 -29.64 24.59 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.744 -0.783 . . . . 0.0 108.99 178.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.697 ' HA ' ' CG1' ' A' ' 31' ' ' ILE . 0.2 OUTLIER -59.81 -39.27 84.45 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.442 -0.786 . . . . 0.0 109.101 179.165 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.541 ' HG3' ' CD2' ' A' ' 28' ' ' PHE . 4.5 mt-10 -79.21 -31.96 43.86 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.972 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 24.7 tttm -69.74 -25.86 64.04 Favored 'General case' 0 C--O 1.188 -2.179 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 176.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.697 ' CG1' ' HA ' ' A' ' 28' ' ' PHE . 1.9 pp -97.59 -31.33 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.957 -1.09 . . . . 0.0 109.157 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.642 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 2.0 mm -63.68 -56.16 18.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 177.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.432 ' HA ' ' HB3' ' B' ' 85' ' ' LEU . 0.4 OUTLIER -68.82 -36.98 78.89 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.39 -0.823 . . . . 0.0 108.882 179.313 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.972 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 59.4 mm-40 -74.98 -32.84 61.78 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.554 -0.716 . . . . 0.0 111.652 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.552 ' N ' ' O ' ' A' ' 31' ' ' ILE . 24.2 m -67.66 -58.14 5.18 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 118.221 -1.391 . . . . 0.0 108.988 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.761 ' O ' ' HG3' ' A' ' 52' ' ' PRO . 0.7 OUTLIER -51.29 -35.65 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 178.447 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.666 ' O ' ' HB2' ' B' ' 92' ' ' LEU . . . -73.32 -27.9 61.78 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.082 178.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.562 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -75.78 -25.77 56.71 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 177.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 35' ' ' THR . . . 108.97 27.58 4.8 Favored Glycine 0 C--N 1.295 -1.706 0 C-N-CA 120.075 -1.059 . . . . 0.0 111.403 177.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.49 ' HB2' HG22 ' A' ' 35' ' ' THR . 0.2 OUTLIER -108.46 151.65 25.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.123 -1.222 . . . . 0.0 109.651 179.011 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -76.69 81.61 3.32 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.374 -0.829 . . . . 0.0 110.421 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.491 ' CG2' ' CG2' ' A' ' 35' ' ' THR . 60.7 t -68.29 140.63 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.448 -0.782 . . . . 0.0 109.8 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.508 ' HG2' ' HA ' ' B' ' 2' ' ' ASN . 4.2 pt20 -158.85 174.17 15.4 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.372 -0.83 . . . . 0.0 109.76 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.63 ' CD1' ' HB2' ' A' ' 48' ' ' LEU . 27.9 mt -127.5 115.22 18.53 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.441 -0.787 . . . . 0.0 109.244 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.523 ' CG2' ' HE3' ' B' ' 3' ' ' LYS . 0.0 OUTLIER 33.2 -95.54 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.89 -0.507 . . . . 0.0 111.566 -179.599 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.406 ' H ' HG23 ' A' ' 45' ' ' THR . . . -139.73 25.06 2.72 Favored Glycine 0 N--CA 1.487 2.083 0 C-N-CA 119.417 -1.373 . . . . 0.0 111.089 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.754 ' CD1' ' HG3' ' B' ' 29' ' ' GLU . 13.3 p90 -122.07 -31.83 3.81 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.616 -1.52 . . . . 0.0 110.538 178.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.63 ' HB2' ' CD1' ' A' ' 44' ' ' LEU . 8.3 mt -122.09 148.97 44.21 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 119.886 -1.759 . . . . 0.0 111.548 177.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.468 ' N ' ' HB2' ' A' ' 80' ' ' LYS . 1.0 OUTLIER -149.25 77.12 1.35 Allowed 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.289 0.566 . . . . 0.0 110.483 -179.815 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.416 ' N ' ' O ' ' A' ' 42' ' ' VAL . 43.5 mm -69.63 126.28 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.394 -0.816 . . . . 0.0 109.962 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -140.67 126.33 11.38 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.335 -0.853 . . . . 0.0 108.766 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.761 ' HG3' ' O ' ' A' ' 36' ' ' VAL . 55.2 Cg_endo -86.83 140.37 5.9 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.317 1.167 . . . . 0.0 110.885 -178.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.576 HG21 ' O ' ' A' ' 76' ' ' GLY . 18.4 m -137.28 117.07 15.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-O 122.204 1.002 . . . . 0.0 110.837 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -43.34 115.66 0.81 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.72 0.771 . . . . 0.0 111.765 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.408 ' O ' ' HB3' ' A' ' 56' ' ' GLN . 2.7 ttt-85 -141.21 -151.18 0.35 Allowed 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 178.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.487 ' HB2' ' CB ' ' A' ' 72' ' ' ALA . 4.1 pt20 -177.43 -175.33 0.54 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.898 -1.126 . . . . 0.0 111.552 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -172.9 148.98 1.86 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.847 -0.533 . . . . 0.0 109.772 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.788 ' HG3' ' HA ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -176.17 147.3 0.71 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.741 -1.224 . . . . 0.0 112.724 -179.892 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.755 ' HB3' ' O ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER 135.26 39.16 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.225 0 C-N-CA 123.659 0.784 . . . . 0.0 109.917 176.038 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 1.082 ' O ' ' O ' ' A' ' 61' ' ' PHE . . . -146.93 72.22 0.32 Allowed Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 1.082 ' O ' ' O ' ' A' ' 60' ' ' GLY . 0.3 OUTLIER -11.71 -155.7 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.201 0 C-N-CA 123.728 0.811 . . . . 0.0 111.646 -177.435 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.551 ' CB ' ' O ' ' A' ' 61' ' ' PHE . 1.2 t30 170.57 -56.94 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 120.186 -1.572 . . . . 0.0 112.21 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 62' ' ' ASN . 38.8 Cg_endo -65.02 -13.35 39.28 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.392 1.206 . . . . 0.0 111.661 -178.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.505 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 4.7 tt0 -116.22 -111.55 0.35 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.022 -1.048 . . . . 0.0 109.376 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.424 ' O ' ' O ' ' A' ' 66' ' ' GLN . 6.7 t -96.29 7.86 45.39 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.888 -1.132 . . . . 0.0 109.955 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.721 ' O ' ' CB ' ' A' ' 67' ' ' GLU . 3.1 mp0 58.23 118.8 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.578 -0.701 . . . . 0.0 110.294 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.721 ' CB ' ' O ' ' A' ' 66' ' ' GLN . 7.0 tt0 137.17 41.81 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.308 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 1.066 ' H ' ' N ' ' A' ' 61' ' ' PHE . . . 163.06 96.67 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.624 ' HB3' ' HA ' ' A' ' 61' ' ' PHE . 2.8 pp -152.18 -148.76 0.27 Allowed 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 174.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.788 ' HA ' ' HG3' ' A' ' 58' ' ' ARG . 0.3 OUTLIER -177.19 67.75 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.459 -1.401 . . . . 0.0 110.617 179.729 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.738 ' O ' ' HD3' ' A' ' 58' ' ' ARG . 0.9 OUTLIER -115.41 -152.38 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.291 0 O-C-N 120.933 -1.104 . . . . 0.0 109.721 179.125 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.585 ' N ' ' HD3' ' A' ' 73' ' ' PRO . . . -179.94 56.33 0.07 OUTLIER Pre-proline 0 N--CA 1.5 2.031 0 O-C-N 119.894 -1.754 . . . . 0.0 112.086 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.585 ' HD3' ' N ' ' A' ' 72' ' ' ALA . 55.7 Cg_endo -103.79 96.88 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 121.133 1.222 . . . . 0.0 111.212 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.414 ' N ' ' HA ' ' A' ' 56' ' ' GLN . 1.2 t -161.89 95.87 0.99 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.561 -1.337 . . . . 0.0 111.925 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.421 ' HB ' ' CD1' ' B' ' 94' ' ' TYR . 8.0 p -62.47 170.91 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.04 -1.037 . . . . 0.0 108.287 178.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.576 ' O ' HG21 ' A' ' 53' ' ' VAL . . . -117.93 82.92 0.34 Allowed Glycine 0 N--CA 1.493 2.445 0 C-N-CA 118.556 -1.783 . . . . 0.0 110.285 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.566 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 97.3 t -70.69 74.45 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.146 -1.208 . . . . 0.0 109.165 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.461 ' N ' ' O ' ' A' ' 51' ' ' LYS . 0.4 OUTLIER -58.87 -166.41 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.445 0.641 . . . . 0.0 110.587 -179.68 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.411 HG13 ' HG3' ' B' ' 81' ' ' PRO . 7.9 p -172.21 178.74 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.541 -0.724 . . . . 0.0 109.061 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.468 ' HB2' ' N ' ' A' ' 49' ' ' ASN . 0.4 OUTLIER -122.04 177.96 1.4 Allowed Pre-proline 0 C--N 1.309 -1.192 0 O-C-N 120.905 -1.122 . . . . 0.0 110.619 179.425 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.419 ' CD ' ' CB ' ' A' ' 80' ' ' LYS . 56.4 Cg_endo -106.32 74.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.302 -1.919 0 C-N-CA 123.739 2.96 . . . . 0.0 109.874 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.718 ' CA ' ' O ' ' A' ' 47' ' ' PHE . . . -56.53 93.83 0.03 OUTLIER Glycine 0 N--CA 1.486 2.032 0 C-N-CA 119.198 -1.477 . . . . 0.0 110.71 -178.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' A' ' 81' ' ' PRO . 2.9 pt-20 -62.2 -28.14 69.47 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.668 -0.901 . . . . 0.0 108.995 178.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.433 ' O ' ' HB1' ' A' ' 88' ' ' ALA . 71.1 m -53.24 -27.66 23.38 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.443 ' CD2' HG11 ' B' ' 36' ' ' VAL . 4.4 tt -85.74 -30.91 22.72 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.432 ' HA ' ' HB2' ' A' ' 89' ' ' ALA . 3.0 tttt -79.9 -40.31 28.53 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.629 0.728 . . . . 0.0 109.139 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.417 ' O ' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -67.73 -37.08 81.71 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 178.256 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.609 ' O ' ' HB3' ' B' ' 37' ' ' ALA . . . -64.12 -36.71 84.94 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 176.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.432 ' HB2' ' HA ' ' A' ' 86' ' ' LYS . . . -57.49 -39.34 76.23 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.583 ' HA ' ' HB2' ' A' ' 94' ' ' TYR . 6.3 mm-40 -56.44 -29.07 61.19 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 176.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -70.42 -42.44 64.68 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.577 ' O ' ' HG2' ' A' ' 93' ' ' LYS . 0.4 OUTLIER -61.36 -48.94 79.0 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.27 -1.723 . . . . 0.0 110.791 -178.943 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.577 ' HG2' ' O ' ' A' ' 92' ' ' LEU . 0.0 OUTLIER 157.06 44.02 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.42 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.577 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 1.016 ' CG ' ' HB3' ' B' ' 74' ' ' SER . 87.5 t80 -42.48 -54.55 3.83 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.717 -0.615 . . . . 0.0 111.053 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.619 ' HA ' ' OG ' ' B' ' 74' ' ' SER . 5.3 mp0 -61.98 -39.5 92.37 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.087 -1.008 . . . . 0.0 110.557 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.521 ' HB2' ' CD ' ' A' ' 93' ' ' LYS . 0.6 OUTLIER -53.37 -31.1 43.14 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.279 -0.888 . . . . 0.0 109.68 179.81 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -80.75 -29.84 36.2 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.538 -0.865 . . . . 0.0 108.756 178.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.639 ' HA ' ' O ' ' B' ' 73' ' ' PRO . . . -69.69 -21.0 63.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.782 -0.574 . . . . 0.0 110.427 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 11.4 mtmt . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.215 179.929 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.51 ' HG2' ' HB3' ' B' ' 5' ' ' GLU . 5.3 mtp . . . . . 0 N--CA 1.492 1.653 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . 0.508 ' HA ' ' HG2' ' A' ' 43' ' ' GLN . 23.2 p30 -176.47 -174.02 0.56 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.237 -0.914 . . . . 0.0 111.225 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.523 ' HE3' ' CG2' ' A' ' 45' ' ' THR . 0.0 OUTLIER -49.53 -16.37 0.21 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.493 -0.754 . . . . 0.0 110.728 -179.641 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.561 ' O ' HG13 ' B' ' 7' ' ' ILE . 3.2 m -105.87 -57.53 2.03 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 122.113 0.958 . . . . 0.0 108.716 178.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.51 ' HB3' ' HG2' ' B' ' 1' ' ' MET . 0.4 OUTLIER -50.35 -46.01 55.48 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.838 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' B' ' 2' ' ' ASN . 6.2 mt -58.02 -31.6 67.14 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.795 -0.762 . . . . 0.0 109.914 178.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' ILE . . . . . 0.584 HG13 ' N ' ' B' ' 8' ' ' LYS . 0.8 OUTLIER -60.9 -40.39 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 178.827 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . 0.804 ' HA ' ' HB2' ' B' ' 11' ' ' ALA . 0.0 OUTLIER -70.43 -31.45 68.64 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 177.865 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . 0.432 ' O ' ' HB2' ' B' ' 13' ' ' ASP . . . -58.53 -37.95 76.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.6 -0.687 . . . . 0.0 109.152 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . 0.736 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.3 mp -92.89 -30.41 4.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.804 ' HB2' ' HA ' ' B' ' 8' ' ' LYS . . . -67.6 -12.97 61.63 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 118.576 -1.25 . . . . 0.0 108.455 178.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.444 ' CG ' ' N ' ' B' ' 13' ' ' ASP . 17.0 pt20 -112.93 -42.0 3.65 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.432 -0.793 . . . . 0.0 109.338 178.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.444 ' N ' ' CG ' ' B' ' 12' ' ' GLN . 0.9 OUTLIER -70.9 -27.43 63.79 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 176.906 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.736 ' OG1' ' O ' ' B' ' 10' ' ' ILE . 0.1 OUTLIER -113.54 -85.76 0.58 Allowed 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 178.143 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . 0.571 ' O ' ' C ' ' B' ' 16' ' ' LEU . . . 80.19 -28.26 2.64 Favored Glycine 0 N--CA 1.499 2.885 0 O-C-N 121.031 -1.043 . . . . 0.0 111.062 177.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' LEU . . . . . 0.945 HD12 ' HB2' ' A' ' 20' ' ' SER . 5.1 mp -13.93 -66.0 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.519 0 CA-C-O 121.918 0.866 . . . . 0.0 112.062 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' THR . . . . . 0.573 ' O ' HG23 ' B' ' 17' ' ' THR . 0.6 OUTLIER -139.64 7.62 2.33 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.549 -179.579 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . 0.618 ' O ' ' C ' ' B' ' 19' ' ' VAL . 11.4 mt-30 58.95 25.83 14.23 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 -175.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.744 ' HB ' ' HB ' ' A' ' 19' ' ' VAL . 2.4 p -4.94 -96.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.393 -179.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.961 ' O ' ' N ' ' B' ' 23' ' ' LYS . 0.6 OUTLIER -132.01 23.07 4.54 Favored 'General case' 0 C--N 1.279 -2.462 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 178.045 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.616 ' C ' ' O ' ' B' ' 20' ' ' SER . 30.4 m -24.42 -40.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 122.449 1.119 . . . . 0.0 109.054 -178.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.693 ' N ' ' O ' ' B' ' 20' ' ' SER . 3.2 m -81.95 -36.24 28.19 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.088 177.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . 0.961 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.8 OUTLIER -85.19 -37.92 19.58 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.675 -0.641 . . . . 0.0 111.44 179.656 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' MET . . . . . 0.54 ' HG2' HG21 ' A' ' 14' ' ' THR . 0.0 OUTLIER -68.14 -38.11 81.82 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 117.637 -1.625 . . . . 0.0 108.374 179.156 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.497 ' HA ' ' HB3' ' B' ' 28' ' ' PHE . 8.8 mt -71.68 -35.5 70.31 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 118.47 -1.292 . . . . 0.0 108.976 178.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . 0.456 ' HA ' ' CE ' ' B' ' 3' ' ' LYS . . . -62.96 -37.15 85.95 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 177.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' SER . . . . . 0.53 ' O ' ' N ' ' B' ' 31' ' ' ILE . 1.2 p -80.86 -26.59 36.86 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . 0.65 ' O ' HG13 ' B' ' 31' ' ' ILE . 1.8 t80 -55.36 -48.84 73.63 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . 0.754 ' HG3' ' CD1' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -69.16 -33.91 74.15 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.869 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . 1.21 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 24.1 tttp -64.88 -22.61 67.02 Favored 'General case' 0 C--O 1.191 -1.99 0 C-N-CA 119.012 -1.075 . . . . 0.0 108.374 178.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.65 HG13 ' O ' ' B' ' 28' ' ' PHE . 0.7 OUTLIER -104.53 -27.04 3.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 120.271 -1.518 . . . . 0.0 109.345 178.265 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.59 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.2 mm -70.99 -61.88 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 177.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' THR . . . . . 0.428 ' OG1' ' N ' ' A' ' 85' ' ' LEU . 0.6 OUTLIER -66.73 -37.79 85.37 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.408 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 1.21 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 18.2 mm-40 -76.25 -35.0 59.17 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 121.065 -1.022 . . . . 0.0 111.901 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' THR . . . . . 0.563 ' CB ' ' O ' ' B' ' 31' ' ' ILE . 4.5 m -61.82 -52.8 62.71 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 120.339 -1.476 . . . . 0.0 108.912 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.443 HG11 ' CD2' ' A' ' 85' ' ' LEU . 1.0 OUTLIER -53.35 -38.32 31.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 C-N-CA 118.194 -1.402 . . . . 0.0 107.259 178.71 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . 0.609 ' HB3' ' O ' ' A' ' 88' ' ' ALA . . . -83.37 -2.36 55.59 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.832 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . 0.578 ' HB2' ' O ' ' B' ' 34' ' ' GLU . 0.0 OUTLIER -100.95 -23.83 14.46 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 177.546 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.05 43.97 1.45 Allowed Glycine 0 C--N 1.301 -1.375 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . 0.468 ' CB ' HG22 ' B' ' 35' ' ' THR . 0.1 OUTLIER -138.16 137.92 38.1 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.105 -1.232 . . . . 0.0 110.103 179.366 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 5.7 mttp -90.79 84.17 5.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.461 -0.775 . . . . 0.0 110.916 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . 0.54 ' HB ' ' CG2' ' B' ' 50' ' ' ILE . 3.5 t -63.54 146.39 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.399 -0.813 . . . . 0.0 109.278 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -138.61 114.1 9.68 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 120.88 -1.138 . . . . 0.0 110.501 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.627 HD12 ' CB ' ' B' ' 48' ' ' LEU . 17.1 mt -85.75 110.99 19.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.187 -0.946 . . . . 0.0 108.784 178.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' THR . . . . . 0.534 HG22 ' HG2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 33.07 -89.83 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.407 0 O-C-N 121.739 -0.601 . . . . 0.0 110.997 -179.441 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -148.31 22.01 1.38 Allowed Glycine 0 N--CA 1.485 1.917 0 C-N-CA 119.818 -1.182 . . . . 0.0 110.176 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . 0.541 ' HB2' ' CG ' ' B' ' 85' ' ' LEU . 14.4 p90 -118.14 -34.91 3.97 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.832 -1.393 . . . . 0.0 112.111 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . 0.627 ' CB ' HD12 ' B' ' 44' ' ' LEU . 0.0 OUTLIER -115.76 92.06 3.79 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.805 -1.185 . . . . 0.0 110.692 179.428 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' ASN . . . . . 0.63 ' O ' ' HB ' ' B' ' 79' ' ' VAL . 1.1 t-20 -79.96 60.82 3.65 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.88 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' ILE . . . . . 0.631 ' HA ' ' HB ' ' B' ' 79' ' ' VAL . 32.2 mm -56.34 116.92 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.314 -0.867 . . . . 0.0 111.62 -177.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . 0.534 ' HG3' ' O ' ' B' ' 51' ' ' LYS . 6.9 ptmt -169.97 126.17 0.73 Allowed Pre-proline 0 N--CA 1.488 1.435 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . 0.468 ' HB2' HG12 ' B' ' 75' ' ' VAL . 54.8 Cg_endo -79.32 144.76 18.42 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.433 1.228 . . . . 0.0 112.158 -177.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.414 HG22 ' OG ' ' B' ' 78' ' ' SER . 30.0 m -150.31 122.17 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.738 ' HA ' ' O ' ' B' ' 74' ' ' SER . . . -64.26 148.13 50.88 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 118.96 -1.096 . . . . 0.0 111.535 -177.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . 0.494 ' O ' ' CG ' ' B' ' 56' ' ' GLN . 3.8 tpt180 -158.57 17.62 0.21 Allowed 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 119.421 -0.912 . . . . 0.0 111.681 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . 0.799 ' N ' ' HA ' ' B' ' 73' ' ' PRO . 0.0 OUTLIER -173.5 147.02 1.41 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.181 -0.949 . . . . 0.0 111.491 179.14 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.648 ' CB ' ' O ' ' B' ' 72' ' ' ALA . . . -165.81 21.8 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.259 -0.901 . . . . 0.0 110.7 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' ARG . . . . . 0.621 ' HG3' ' N ' ' B' ' 59' ' ' LYS . 0.0 OUTLIER -166.87 152.36 7.84 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.236 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . 0.621 ' N ' ' HG3' ' B' ' 58' ' ' ARG . 2.8 ptpt -174.57 36.62 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.309 -0.869 . . . . 0.0 111.07 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -102.57 104.0 2.52 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 108.421 -1.872 . . . . 0.0 108.421 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' PHE . . . . . 0.621 ' CD2' ' O ' ' B' ' 62' ' ' ASN . 42.3 p90 -52.19 158.21 1.19 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.283 -1.128 . . . . 0.0 111.277 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . 0.621 ' O ' ' CD2' ' B' ' 61' ' ' PHE . 1.2 t-20 -56.22 -171.19 0.02 OUTLIER Pre-proline 0 N--CA 1.495 1.776 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . 0.496 ' HD2' ' CB ' ' B' ' 62' ' ' ASN . 43.5 Cg_endo -72.78 60.91 3.66 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 N-CA-C 109.145 -1.137 . . . . 0.0 109.145 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -135.47 -94.05 0.27 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.427 -0.796 . . . . 0.0 111.178 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.433 ' N ' ' CE2' ' B' ' 61' ' ' PHE . 0.0 OUTLIER -174.92 -30.88 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.977 -1.077 . . . . 0.0 110.974 -179.85 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -139.66 15.04 2.53 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.073 -1.017 . . . . 0.0 111.988 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' B' ' 61' ' ' PHE . 5.7 tt0 -89.37 47.39 1.48 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.73 -1.231 . . . . 0.0 109.54 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . 0.416 ' HA ' ' CA ' ' B' ' 61' ' ' PHE . . . -47.92 152.77 0.72 Allowed 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.508 0.671 . . . . 0.0 111.506 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.492 ' O ' ' HB3' ' B' ' 70' ' ' GLU . 17.4 mt -127.48 -162.83 1.2 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.596 -0.69 . . . . 0.0 109.485 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . 0.492 ' HB3' ' O ' ' B' ' 69' ' ' LEU . 1.9 pt-20 173.96 79.87 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.422 -0.798 . . . . 0.0 109.421 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.74 ' O ' ' CB ' ' B' ' 72' ' ' ALA . 1.2 pp -111.27 88.9 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.682 -1.261 . . . . 0.0 112.484 -179.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . 0.74 ' CB ' ' O ' ' B' ' 71' ' ' ILE . . . 135.78 124.09 0.0 OUTLIER Pre-proline 0 C--N 1.283 -2.292 0 CA-C-N 114.144 -1.389 . . . . 0.0 108.522 178.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' PRO . . . . . 0.799 ' HA ' ' N ' ' B' ' 56' ' ' GLN . 48.1 Cg_endo -103.11 131.4 0.1 Allowed 'Trans proline' 0 C--N 1.296 -2.197 0 O-C-N 122.99 0.995 . . . . 0.0 111.897 179.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' SER . . . . . 1.016 ' HB3' ' CG ' ' A' ' 94' ' ' TYR . 2.7 m -111.18 155.47 22.87 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 176.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . 0.622 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 84.3 t -19.41 145.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -176.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -143.57 -142.65 3.98 Favored Glycine 0 N--CA 1.491 2.305 0 O-C-N 120.285 -1.509 . . . . 0.0 110.559 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.416 ' CG2' ' CD2' ' A' ' 85' ' ' LEU . 11.3 t -141.57 83.55 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-O 121.982 0.896 . . . . 0.0 109.734 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' SER . . . . . 0.463 ' CB ' ' HG3' ' B' ' 51' ' ' LYS . 0.1 OUTLIER -58.44 -45.04 89.31 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.586 0.707 . . . . 0.0 110.947 179.343 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . 0.631 ' HB ' ' HA ' ' B' ' 50' ' ' ILE 0.284 7.5 p -46.9 172.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-O 122.438 1.113 . . . . 0.0 113.791 -174.52 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . 0.627 ' HB2' ' HD2' ' B' ' 81' ' ' PRO . 0.3 OUTLIER 178.15 175.74 0.32 Allowed Pre-proline 0 N--CA 1.48 1.03 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -179.625 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' PRO . . . . . 0.627 ' HD2' ' HB2' ' B' ' 80' ' ' LYS . 47.1 Cg_endo -72.84 137.99 27.97 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.374 1.197 . . . . 0.0 109.583 177.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -101.67 -161.02 26.87 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . 0.413 ' HA ' ' HB2' ' B' ' 86' ' ' LYS . 0.4 OUTLIER -91.11 -10.64 41.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.418 -1.048 . . . . 0.0 110.417 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -54.93 -36.69 65.52 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.252 -0.905 . . . . 0.0 109.977 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . 0.541 ' CG ' ' HB2' ' B' ' 47' ' ' PHE . 0.0 OUTLIER -85.4 -33.42 21.97 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 119.629 -0.828 . . . . 0.0 108.852 179.198 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . 0.413 ' HB2' ' HA ' ' B' ' 83' ' ' GLU . 8.6 mttt -69.38 -34.09 74.01 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.653 -0.819 . . . . 0.0 109.264 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . 0.5 ' O ' ' HG3' ' B' ' 90' ' ' GLU . 35.8 tptt -73.15 -38.17 66.32 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 177.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.703 ' O ' ' HG ' ' B' ' 92' ' ' LEU . . . -67.71 -34.23 76.46 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 177.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . 0.663 ' HA ' ' HA ' ' A' ' 37' ' ' ALA . . . -72.16 -45.21 61.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.79 -0.569 . . . . 0.0 110.45 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.519 ' HA ' ' HB2' ' B' ' 94' ' ' TYR . 0.6 OUTLIER -56.82 -19.31 16.63 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.622 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . 0.425 ' N ' ' HG3' ' B' ' 90' ' ' GLU . . . -93.93 -24.58 19.68 Favored Glycine 0 CA--C 1.547 2.089 0 CA-C-O 118.467 -1.185 . . . . 0.0 113.57 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . 0.703 ' HG ' ' O ' ' B' ' 88' ' ' ALA . 0.1 OUTLIER -113.03 -71.67 0.74 Allowed 'General case' 0 N--CA 1.507 2.381 0 CA-C-N 122.27 3.035 . . . . 0.0 113.171 -177.924 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . 0.459 ' O ' ' CD2' ' B' ' 97' ' ' PHE . 0.0 OUTLIER -113.0 36.58 3.44 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.803 -1.186 . . . . 0.0 112.459 -177.462 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . 0.519 ' HB2' ' HA ' ' B' ' 90' ' ' GLU . 6.2 t80 -71.24 -53.63 13.72 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 119.241 -0.984 . . . . 0.0 109.371 178.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -71.72 -31.53 66.81 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.41 -34.84 69.32 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' PHE . . . . . 0.472 ' CE2' ' HG2' ' A' ' 52' ' ' PRO . 7.4 m-85 -76.99 -34.84 57.51 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.48 -45.15 92.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.669 -0.644 . . . . 0.0 110.274 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 3.9 pttt . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.294 -179.931 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.488 ' HB2' ' HA ' ' B' ' 42' ' ' VAL . 2.3 mtp . . . . . 0 N--CA 1.494 1.768 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' B' ' 43' ' ' GLN . 49.9 p-10 -166.93 -158.3 0.29 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.005 -1.059 . . . . 0.0 111.794 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.429 ' CD ' ' HA ' ' A' ' 26' ' ' ALA . 2.1 mmtp -56.02 -8.04 0.41 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.472 -0.768 . . . . 0.0 111.352 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.738 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 33.8 m -123.82 -41.95 2.21 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 120.854 -1.154 . . . . 0.0 109.885 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.487 ' CB ' ' HA ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -61.9 -54.94 34.96 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.015 -1.053 . . . . 0.0 108.2 179.0 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.474 ' HA ' ' HB2' ' A' ' 9' ' ' ALA . 6.9 mt -56.38 -29.24 61.2 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.592 -0.843 . . . . 0.0 109.179 177.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.738 ' HB ' ' O ' ' A' ' 4' ' ' THR . 0.8 OUTLIER -55.94 -59.73 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.47 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.454 ' HA ' ' CB ' ' A' ' 11' ' ' ALA . 0.1 OUTLIER -60.96 -28.56 69.07 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.224 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.474 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . . . -59.61 -33.96 72.16 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.554 -0.858 . . . . 0.0 108.991 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.772 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.6 OUTLIER -95.44 -36.14 6.48 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.422 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 178.318 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.479 ' HA ' ' OG1' ' A' ' 14' ' ' THR . . . -57.98 -23.98 56.19 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.719 -0.793 . . . . 0.0 108.89 178.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -93.13 -44.2 8.49 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -62.46 -31.39 72.11 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 177.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.772 ' OG1' ' O ' ' A' ' 10' ' ' ILE . 28.2 p -83.25 -75.44 0.32 Allowed 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 177.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 59.02 18.8 42.32 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.001 -1.239 . . . . 0.0 110.001 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.611 HD13 ' HB ' ' A' ' 14' ' ' THR . 3.5 mp -87.41 -53.66 4.7 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.326 -1.102 . . . . 0.0 109.112 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.521 HG22 ' O ' ' A' ' 17' ' ' THR . 0.5 OUTLIER -149.89 4.99 0.57 Allowed 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 120.021 -0.671 . . . . 0.0 110.596 -178.991 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.556 ' O ' ' C ' ' A' ' 19' ' ' VAL . 16.8 mt-30 56.48 26.68 11.16 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 -176.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.905 ' HB ' ' HB ' ' B' ' 19' ' ' VAL . 1.7 p -3.24 -94.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.9 -179.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.947 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -131.69 25.13 4.72 Favored 'General case' 0 C--N 1.28 -2.453 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 179.729 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.632 ' HA ' ' CE ' ' A' ' 24' ' ' MET . 5.6 m -17.27 -39.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-O 122.464 1.125 . . . . 0.0 110.12 -178.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.871 ' N ' ' O ' ' A' ' 20' ' ' SER . 16.3 p -80.85 -37.27 30.25 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.038 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.947 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.5 OUTLIER -88.7 -28.83 20.3 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.442 -0.786 . . . . 0.0 111.186 179.878 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.755 ' N ' ' OG ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -76.83 -38.55 53.61 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 117.875 -1.53 . . . . 0.0 109.288 179.744 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.691 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 0.3 OUTLIER -80.21 -48.35 13.25 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 118.172 -1.411 . . . . 0.0 109.365 178.827 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 22' ' ' SER . . . -54.55 -34.33 61.66 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 119.054 -1.058 . . . . 0.0 108.217 178.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.615 ' O ' ' N ' ' A' ' 31' ' ' ILE . 25.1 p -87.21 -31.02 20.55 Favored 'General case' 0 C--O 1.203 -1.364 0 C-N-CA 119.696 -0.802 . . . . 0.0 109.381 178.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.709 ' O ' HG13 ' A' ' 31' ' ' ILE . 0.1 OUTLIER -56.57 -38.23 71.67 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.2 -0.938 . . . . 0.0 108.927 179.079 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.57 ' HG3' ' CE2' ' A' ' 28' ' ' PHE . 1.0 OUTLIER -82.15 -33.93 29.35 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 178.146 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.991 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 20.1 tttt -68.45 -21.47 64.64 Favored 'General case' 0 C--O 1.189 -2.097 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 176.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.709 HG13 ' O ' ' A' ' 28' ' ' PHE . 1.3 pp -102.31 -30.49 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.878 -1.139 . . . . 0.0 109.448 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.673 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 2.1 mm -65.87 -56.4 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 177.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.512 ' O ' ' CB ' ' B' ' 88' ' ' ALA . 0.4 OUTLIER -64.95 -49.43 70.37 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 178.559 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.991 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 15.4 mm-40 -62.52 -32.04 72.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.46 -0.775 . . . . 0.0 111.044 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.618 ' N ' ' O ' ' A' ' 31' ' ' ILE . 1.2 m -56.25 -53.11 61.09 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 178.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.422 ' CG1' ' HB3' ' A' ' 52' ' ' PRO . 13.4 t -54.89 -34.38 30.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 C-N-CA 117.91 -1.516 . . . . 0.0 106.975 177.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.67 ' CB ' ' O ' ' B' ' 88' ' ' ALA . . . -79.29 -3.58 46.7 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -108.53 -18.51 13.71 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.34 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 35' ' ' THR . . . 95.77 43.85 3.26 Favored Glycine 0 C--N 1.303 -1.266 0 C-N-CA 120.209 -0.996 . . . . 0.0 110.657 178.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.499 ' CB ' HG21 ' A' ' 35' ' ' THR . 0.2 OUTLIER -125.71 127.05 45.62 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.125 -1.22 . . . . 0.0 110.222 179.236 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.1 mtmt -77.64 87.66 3.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.566 -0.708 . . . . 0.0 110.065 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.538 ' HB ' ' HB ' ' A' ' 50' ' ' ILE . 93.0 t -60.04 123.29 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.571 -0.706 . . . . 0.0 110.238 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -121.86 94.8 4.42 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.517 -0.739 . . . . 0.0 109.357 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 46' ' ' GLY . 12.1 mt -72.52 104.28 3.79 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.336 -0.852 . . . . 0.0 110.411 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.541 HG23 ' HG3' ' B' ' 29' ' ' GLU . 0.1 OUTLIER 31.24 -90.28 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 O-C-N 122.108 -0.37 . . . . 0.0 111.508 179.504 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -148.74 19.67 1.28 Allowed Glycine 0 N--CA 1.486 2.022 0 C-N-CA 119.746 -1.216 . . . . 0.0 110.272 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.673 ' CD1' ' HG3' ' B' ' 29' ' ' GLU . 6.1 p90 -120.7 -22.03 6.47 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.879 -1.365 . . . . 0.0 111.853 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.523 ' HG ' ' CE2' ' A' ' 47' ' ' PHE . 4.6 mt -129.08 102.71 6.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.229 -1.545 . . . . 0.0 110.632 177.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.734 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 1.3 m120 -99.67 89.71 4.22 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.853 -0.53 . . . . 0.0 111.696 -178.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.612 ' HA ' ' HA ' ' A' ' 79' ' ' VAL . 0.9 OUTLIER -90.19 148.17 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.242 0 O-C-N 121.39 -0.818 . . . . 0.0 110.777 179.376 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -164.64 110.22 0.86 Allowed Pre-proline 0 N--CA 1.504 2.262 0 O-C-N 120.881 -1.137 . . . . 0.0 111.367 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.687 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 55.8 Cg_endo -78.53 141.43 17.66 Favored 'Trans proline' 0 N--CA 1.489 1.253 0 O-C-N 123.635 1.334 . . . . 0.0 112.264 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.702 ' O ' ' N ' ' A' ' 76' ' ' GLY . 33.9 m -151.39 115.66 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 CA-C-O 121.355 0.597 . . . . 0.0 110.38 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.407 ' N ' HG21 ' A' ' 75' ' ' VAL . . . -37.09 133.35 0.64 Allowed 'General case' 0 N--CA 1.504 2.255 0 CA-C-O 121.599 0.714 . . . . 0.0 112.513 -178.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.56 ' O ' ' O ' ' A' ' 74' ' ' SER . 13.0 ttp85 -174.15 107.41 0.12 Allowed 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.482 ' O ' ' O ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -55.53 -158.21 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.144 -0.972 . . . . 0.0 111.569 -178.399 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.59 ' O ' ' N ' ' A' ' 72' ' ' ALA 0.262 . . -158.36 146.34 18.38 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.139 -0.976 . . . . 0.0 110.587 -177.41 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.915 ' HB2' ' C ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -179.45 169.58 1.4 Allowed 'General case' 0 N--CA 1.483 1.223 0 O-C-N 120.587 -1.32 . . . . 0.0 111.534 179.166 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.412 ' N ' ' CG ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -169.1 24.76 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.858 -179.781 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.582 ' O ' ' O ' ' A' ' 61' ' ' PHE . . . 47.52 -164.47 0.19 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.834 ' HB2' ' C ' ' A' ' 67' ' ' GLU . 1.1 t80 -57.67 -139.19 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.424 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 178.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.484 ' CB ' ' CD ' ' A' ' 63' ' ' PRO . 0.8 OUTLIER 177.54 -62.56 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 120.75 -1.219 . . . . 0.0 112.048 178.1 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.608 ' HD2' ' CD1' ' A' ' 61' ' ' PHE . 46.7 Cg_endo -70.91 7.25 1.38 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.207 1.109 . . . . 0.0 112.628 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.454 ' O ' ' OG1' ' A' ' 65' ' ' THR . 0.0 OUTLIER -156.38 90.22 1.17 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.493 -1.379 . . . . 0.0 111.088 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.517 ' O ' ' O ' ' A' ' 66' ' ' GLN . 25.6 p 50.37 11.37 0.07 Allowed 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.732 -0.605 . . . . 0.0 112.011 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.633 ' O ' ' HB3' ' A' ' 67' ' ' GLU . 10.2 mp0 54.41 131.64 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.286 -0.884 . . . . 0.0 111.745 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.834 ' C ' ' HB2' ' A' ' 61' ' ' PHE . 0.0 OUTLIER 139.07 76.42 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.22 0 C-N-CA 124.473 1.109 . . . . 0.0 110.317 179.843 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.672 ' N ' ' HB2' ' A' ' 61' ' ' PHE . . . -176.06 18.37 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.731 -1.23 . . . . 0.0 112.178 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.449 ' HB3' ' O ' ' A' ' 68' ' ' ALA . 0.5 OUTLIER 166.31 101.8 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 179.283 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.915 ' C ' ' HB2' ' A' ' 58' ' ' ARG . 1.5 pt-20 -135.81 56.07 1.84 Allowed 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.236 -0.986 . . . . 0.0 111.351 -177.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.685 ' N ' ' HB2' ' A' ' 58' ' ' ARG . 0.3 OUTLIER -162.47 151.39 3.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-O 122.515 1.15 . . . . 0.0 110.318 177.839 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.59 ' N ' ' O ' ' A' ' 57' ' ' ALA . . . -176.61 143.85 0.61 Allowed Pre-proline 0 C--N 1.288 -2.094 0 CA-C-N 114.944 -1.026 . . . . 0.0 108.706 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -96.51 125.16 0.27 Allowed 'Trans proline' 0 C--N 1.299 -2.059 0 C-N-CA 121.55 1.5 . . . . 0.0 110.726 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.56 ' O ' ' O ' ' A' ' 55' ' ' ARG . 0.4 OUTLIER -173.55 108.27 0.15 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.937 -1.102 . . . . 0.0 110.502 179.405 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.537 ' HB ' ' HB2' ' B' ' 94' ' ' TYR . 0.4 OUTLIER -49.31 177.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.269 -0.894 . . . . 0.0 110.061 179.613 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.768 ' O ' ' N ' ' A' ' 78' ' ' SER . . . -99.31 53.93 1.01 Allowed Glycine 0 N--CA 1.484 1.862 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.687 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 4.5 p -50.91 69.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.922 -0.752 . . . . 0.0 109.971 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.768 ' N ' ' O ' ' A' ' 76' ' ' GLY . 1.0 OUTLIER -70.39 175.78 4.47 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 118.815 -1.154 . . . . 0.0 109.329 -179.771 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.734 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 0.7 OUTLIER 176.46 175.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 179.644 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.518 ' N ' ' CG2' ' A' ' 79' ' ' VAL . 0.4 OUTLIER -176.1 174.5 0.76 Allowed Pre-proline 0 C--N 1.299 -1.622 0 O-C-N 121.159 -0.963 . . . . 0.0 109.865 178.521 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.432 ' CG ' HG11 ' B' ' 77' ' ' VAL . 54.2 Cg_endo -88.11 169.56 6.25 Favored 'Trans proline' 0 C--N 1.293 -2.368 0 O-C-N 124.529 1.805 . . . . 0.0 108.255 176.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.562 ' CA ' ' HA ' ' A' ' 47' ' ' PHE . . . -150.15 133.64 4.46 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 107.307 -2.317 . . . . 0.0 107.307 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.879 ' O ' ' N ' ' A' ' 85' ' ' LEU . 8.6 tt0 51.09 32.63 7.99 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.142 -1.211 . . . . 0.0 107.901 -177.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.584 ' C ' ' O ' ' A' ' 83' ' ' GLU . 1.6 t 8.94 45.83 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 122.45 1.119 . . . . 0.0 110.204 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.879 ' N ' ' O ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER 19.2 27.6 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 104.026 -2.583 . . . . 0.0 104.026 -171.353 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.565 ' HB2' ' CB ' ' A' ' 84' ' ' SER 0.339 7.9 tttt -66.16 -45.71 79.96 Favored 'General case' 0 CA--C 1.475 -1.914 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 178.497 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.03 -34.42 76.19 Favored 'General case' 0 C--N 1.281 -2.403 0 CA-C-N 112.445 -2.161 . . . . 0.0 106.118 177.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.642 ' C ' ' HB3' ' B' ' 37' ' ' ALA . . . -81.59 -30.02 33.12 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 117.764 -1.574 . . . . 0.0 107.585 178.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.696 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . -73.25 -27.66 61.7 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.497 ' N ' ' O ' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -67.07 -30.02 69.96 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 174.468 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -56.99 -50.05 66.98 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 177.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.76 ' HB3' ' O ' ' B' ' 37' ' ' ALA . 0.6 OUTLIER -80.52 17.72 1.05 Allowed 'General case' 0 N--CA 1.502 2.154 0 O-C-N 120.62 -1.518 . . . . 0.0 110.506 179.317 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.477 ' CB ' ' O ' ' A' ' 92' ' ' LEU . 0.0 OUTLIER 71.72 67.09 0.15 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.305 -0.872 . . . . 0.0 109.387 -179.393 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.523 ' CD2' ' HA ' ' B' ' 74' ' ' SER . 0.0 OUTLIER -45.64 -36.26 4.68 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.706 -0.621 . . . . 0.0 109.923 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -62.2 -41.11 98.06 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.47 -0.769 . . . . 0.0 109.764 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -57.69 -34.41 69.4 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.48 -25.72 61.53 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.971 -0.692 . . . . 0.0 109.196 178.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.19 -29.22 63.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.682 -0.636 . . . . 0.0 110.107 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 6.4 mttm . . . . . 0 N--CA 1.494 1.758 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.157 -179.988 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.515 ' HA ' ' CB ' ' B' ' 5' ' ' GLU . 11.6 mtp . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 120.879 0.371 . . . . 0.0 110.169 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -174.83 -166.71 0.25 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.086 -1.009 . . . . 0.0 111.303 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.468 ' O ' HG13 ' B' ' 7' ' ' ILE . 0.0 OUTLIER -52.04 -11.48 0.17 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.408 -0.807 . . . . 0.0 111.471 -179.267 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.547 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 59.6 m -115.59 -44.01 2.99 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.93 -1.106 . . . . 0.0 109.376 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.538 ' HA ' ' HE2' ' B' ' 8' ' ' LYS . 0.0 OUTLIER -62.07 -51.47 67.8 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.893 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.443 ' HA ' ' HB2' ' B' ' 9' ' ' ALA . 6.2 mt -62.99 -30.76 71.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.374 -0.829 . . . . 0.0 108.869 178.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' ILE . . . . . 0.664 HG12 ' O ' ' B' ' 21' ' ' VAL . 0.6 OUTLIER -53.17 -54.38 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.369 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . 0.538 ' HE2' ' HA ' ' B' ' 5' ' ' GLU . 14.1 mtmt -59.44 -36.5 76.04 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.714 -0.846 . . . . 0.0 108.714 178.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . 0.443 ' HB2' ' HA ' ' B' ' 6' ' ' LEU . . . -52.71 -34.63 53.19 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.819 -0.753 . . . . 0.0 109.243 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . 0.846 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.2 mp -97.15 -35.74 5.66 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.425 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.471 ' HA ' ' OG1' ' B' ' 14' ' ' THR . . . -60.09 -25.91 65.78 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.71 -0.796 . . . . 0.0 108.878 178.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.441 ' CG ' ' N ' ' B' ' 13' ' ' ASP . 16.6 pt20 -92.77 -41.2 10.25 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.441 ' N ' ' CG ' ' B' ' 12' ' ' GLN . 1.3 m-20 -65.13 -22.49 66.94 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 176.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.846 ' OG1' ' O ' ' B' ' 10' ' ' ILE . 24.5 p -96.33 -78.38 0.47 Allowed 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 61.87 12.42 35.47 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' LEU . . . . . 0.708 HD13 ' HB3' ' A' ' 20' ' ' SER . 3.7 mp -78.19 -54.57 6.1 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.433 -1.039 . . . . 0.0 108.652 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' THR . . . . . 0.551 HG21 ' O ' ' B' ' 17' ' ' THR . 0.5 OUTLIER -151.01 6.21 0.5 Allowed 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.3 -179.13 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . 0.555 ' O ' ' C ' ' B' ' 19' ' ' VAL . 16.4 mt-30 56.92 25.8 10.97 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 -176.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.905 ' HB ' ' HB ' ' A' ' 19' ' ' VAL . 2.3 p -0.28 -94.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.118 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.94 ' O ' ' N ' ' B' ' 23' ' ' LYS . 0.0 OUTLIER -130.17 24.12 5.23 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.664 ' O ' HG12 ' B' ' 7' ' ' ILE . 15.5 m -22.7 -40.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-O 122.446 1.117 . . . . 0.0 109.259 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.76 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.3 OUTLIER -76.32 -36.57 58.22 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.092 178.167 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . 0.94 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.0 OUTLIER -95.1 -28.29 15.15 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 118.786 -1.166 . . . . 0.0 111.13 179.125 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' MET . . . . . 0.755 ' N ' ' OG ' ' B' ' 20' ' ' SER . 0.0 OUTLIER -70.41 -35.14 73.25 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 116.761 -1.976 . . . . 0.0 108.241 179.123 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.592 HD12 HG13 ' B' ' 7' ' ' ILE . 0.3 OUTLIER -83.12 -41.75 18.17 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 118.2 -1.4 . . . . 0.0 109.24 178.315 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . 0.408 ' CB ' ' O ' ' B' ' 22' ' ' SER . . . -64.3 -34.88 79.16 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 177.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' SER . . . . . 0.599 ' CB ' ' O ' ' B' ' 23' ' ' LYS . 7.3 t -84.7 -28.24 26.48 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 119.447 -0.901 . . . . 0.0 108.575 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . 0.634 ' O ' HG13 ' B' ' 31' ' ' ILE . 0.7 OUTLIER -51.05 -44.44 61.11 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.996 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . 0.723 ' O ' ' HB ' ' B' ' 33' ' ' THR . 1.4 tt0 -70.79 -38.63 73.39 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 176.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . 1.256 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 6.9 ttpt -60.96 -19.9 61.55 Favored 'General case' 0 C--O 1.192 -1.931 0 C-N-CA 119.302 -0.959 . . . . 0.0 108.636 178.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.634 HG13 ' O ' ' B' ' 28' ' ' PHE . 0.8 OUTLIER -108.48 -28.67 2.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 120.111 -1.618 . . . . 0.0 109.366 178.276 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.624 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.2 mm -73.53 -59.78 3.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 176.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' THR . . . . . 0.723 ' HB ' ' O ' ' B' ' 29' ' ' GLU . 0.9 OUTLIER -66.67 -38.98 87.94 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 114.748 -1.114 . . . . 0.0 108.658 179.159 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 1.256 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 75.6 mm-40 -77.52 -39.54 45.82 Favored 'General case' 0 C--O 1.205 -1.262 0 O-C-N 121.029 -1.044 . . . . 0.0 112.788 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' THR . . . . . 0.441 ' CB ' ' O ' ' B' ' 31' ' ' ILE . 98.1 m -63.13 -51.19 67.48 Favored 'General case' 0 N--CA 1.504 2.268 0 CA-C-N 121.206 1.821 . . . . 0.0 110.13 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.495 HG21 ' HA ' ' B' ' 51' ' ' LYS . 0.9 OUTLIER -53.97 -41.46 49.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 178.042 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . 0.76 ' O ' ' HB3' ' A' ' 92' ' ' LEU . . . -86.38 3.14 44.91 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.291 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . 0.75 ' HB2' ' O ' ' B' ' 34' ' ' GLU . 0.0 OUTLIER -102.71 -36.33 8.34 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.468 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 141.16 33.2 0.13 Allowed Glycine 0 C--N 1.302 -1.36 0 C-N-CA 119.056 -1.545 . . . . 0.0 111.56 178.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . 0.432 ' HB3' ' CG2' ' B' ' 35' ' ' THR . 0.2 OUTLIER -146.93 158.87 44.04 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.79 -1.418 . . . . 0.0 110.605 179.271 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 33.3 mtpt -101.34 91.46 4.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.455 -0.778 . . . . 0.0 110.007 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . 0.608 ' HB ' ' HB ' ' B' ' 50' ' ' ILE . 91.5 t -70.78 148.97 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.471 -0.768 . . . . 0.0 110.471 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' GLN . . . . . 0.417 ' O ' ' HA ' ' A' ' 2' ' ' ASN . 20.5 mt-30 -146.73 165.41 29.72 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.13 -0.981 . . . . 0.0 110.39 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.551 HD13 ' CB ' ' B' ' 48' ' ' LEU . 19.0 mt -122.81 117.42 25.61 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.388 -0.82 . . . . 0.0 109.58 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' THR . . . . . 0.555 HG21 ' HG2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 29.04 -92.47 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.809 -0.557 . . . . 0.0 111.136 179.817 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -148.61 23.11 1.34 Allowed Glycine 0 N--CA 1.485 1.966 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . 0.606 ' HA ' ' H ' ' B' ' 83' ' ' GLU . 0.9 OUTLIER -116.57 -32.83 5.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.135 -1.215 . . . . 0.0 111.252 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . 0.561 ' HB2' ' CE1' ' B' ' 47' ' ' PHE . 0.1 OUTLIER -118.24 162.85 17.58 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.692 -1.255 . . . . 0.0 112.768 179.856 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' ASN . . . . . 0.619 ' O ' ' HB ' ' B' ' 79' ' ' VAL . 0.2 OUTLIER -142.1 142.22 32.78 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 178.971 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' ILE . . . . . 0.646 ' N ' HG11 ' B' ' 79' ' ' VAL . 33.6 mm -138.06 101.91 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.227 -0.921 . . . . 0.0 110.431 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . 0.561 ' N ' ' CG1' ' B' ' 79' ' ' VAL . 0.0 OUTLIER -157.43 133.5 6.07 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.065 -1.022 . . . . 0.0 109.064 -179.798 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . 0.487 ' HG3' ' CG1' ' B' ' 36' ' ' VAL . 57.9 Cg_endo -93.96 159.61 2.21 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.153 1.081 . . . . 0.0 112.009 -178.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.478 ' O ' ' N ' ' B' ' 76' ' ' GLY . 28.0 m -137.95 116.83 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-O 121.935 0.874 . . . . 0.0 110.441 177.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.468 ' HA ' ' HA ' ' B' ' 75' ' ' VAL . . . -46.55 112.6 0.52 Allowed 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.55 0.69 . . . . 0.0 111.991 -178.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 2.3 ttp180 -137.54 157.66 46.05 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . 0.464 ' HA ' ' HA ' ' B' ' 73' ' ' PRO . 44.9 mt-30 -87.07 -157.57 0.39 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.906 -1.121 . . . . 0.0 110.285 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.577 ' CB ' ' O ' ' B' ' 72' ' ' ALA . . . -176.46 145.82 0.59 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.164 -0.96 . . . . 0.0 111.226 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' ARG . . . . . 0.535 ' CB ' ' O ' ' B' ' 70' ' ' GLU . 0.7 OUTLIER 170.73 139.64 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.531 0.682 . . . . 0.0 110.858 178.744 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . 0.717 ' N ' ' HB2' ' B' ' 70' ' ' GLU . 0.0 OUTLIER -140.64 88.08 2.17 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.679 -0.638 . . . . 0.0 110.672 -179.852 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . 0.56 ' N ' ' HB3' ' B' ' 70' ' ' GLU . . . 140.42 70.17 0.04 OUTLIER Glycine 0 N--CA 1.498 2.771 0 C-N-CA 119.609 -1.281 . . . . 0.0 111.014 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' PHE . . . . . 0.789 ' CE1' ' HB2' ' B' ' 66' ' ' GLN . 39.6 p90 -69.22 -159.15 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.348 0 O-C-N 121.563 -0.963 . . . . 0.0 111.202 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . 0.736 ' HB2' ' H ' ' B' ' 68' ' ' ALA . 0.3 OUTLIER -134.57 -58.7 0.02 OUTLIER Pre-proline 0 N--CA 1.504 2.241 0 O-C-N 121.539 -0.726 . . . . 0.0 111.816 179.238 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . 0.69 ' HD2' ' H ' ' B' ' 62' ' ' ASN . 37.9 Cg_endo -62.78 70.5 0.13 Allowed 'Trans proline' 0 N--CA 1.492 1.422 0 O-C-N 123.613 1.323 . . . . 0.0 111.548 -178.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . 0.724 ' CB ' ' CE1' ' B' ' 61' ' ' PHE . 0.0 OUTLIER 169.94 61.08 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.199 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.52 ' CG2' ' O ' ' B' ' 64' ' ' GLN . 9.0 t 42.08 53.39 4.29 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.536 0.684 . . . . 0.0 110.705 -178.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . 0.789 ' HB2' ' CE1' ' B' ' 61' ' ' PHE . 0.0 OUTLIER -148.48 -146.41 0.2 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.441 -0.787 . . . . 0.0 110.467 -179.472 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . 0.616 ' C ' ' O ' ' B' ' 61' ' ' PHE . 11.5 pt-20 -152.43 116.91 5.0 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . 0.736 ' H ' ' HB2' ' B' ' 62' ' ' ASN . . . -73.24 119.41 17.43 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 122.479 1.133 . . . . 0.0 111.792 -176.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' B' ' 67' ' ' GLU . 0.0 OUTLIER -168.79 46.56 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 -179.699 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . 0.717 ' HB2' ' N ' ' B' ' 59' ' ' LYS . 1.1 pt-20 -125.02 107.87 11.26 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.954 -176.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.581 ' CD1' ' N ' ' B' ' 72' ' ' ALA . 0.1 OUTLIER -163.22 153.04 3.01 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 O-C-N 120.854 -1.154 . . . . 0.0 110.469 179.601 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . 0.581 ' N ' ' CD1' ' B' ' 71' ' ' ILE . . . 160.95 58.14 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.523 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.89 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' PRO . . . . . 0.56 ' HD2' HD12 ' B' ' 71' ' ' ILE . 38.0 Cg_endo -62.57 122.69 11.15 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.06 1.032 . . . . 0.0 111.387 -178.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' SER . . . . . 0.523 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 2.3 m -148.28 159.01 44.42 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . 0.592 HG13 ' CB ' ' A' ' 89' ' ' ALA . 0.5 OUTLIER -53.48 171.9 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 120.877 -1.139 . . . . 0.0 109.829 -179.631 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . 0.51 ' O ' ' N ' ' B' ' 78' ' ' SER . . . -129.67 107.28 0.78 Allowed Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' B' ' 52' ' ' PRO . 8.6 p -58.41 86.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.194 -1.18 . . . . 0.0 108.875 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' SER . . . . . 0.51 ' N ' ' O ' ' B' ' 76' ' ' GLY . 0.5 OUTLIER -58.16 -47.32 83.74 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 -178.258 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . 0.646 HG11 ' N ' ' B' ' 50' ' ' ILE . 17.7 m -48.08 178.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 -173.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . 0.791 ' HB2' ' HD2' ' B' ' 81' ' ' PRO . 0.0 OUTLIER 179.4 -179.7 0.24 Allowed Pre-proline 0 C--N 1.308 -1.228 0 CA-C-N 113.64 -1.618 . . . . 0.0 107.162 -177.391 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' PRO . . . . . 0.791 ' HD2' ' HB2' ' B' ' 80' ' ' LYS . 39.2 Cg_endo -63.64 153.16 76.82 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 122.989 0.994 . . . . 0.0 111.691 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . 0.536 ' C ' ' H ' ' B' ' 84' ' ' SER . . . -117.16 -79.53 0.73 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 107.351 -2.3 . . . . 0.0 107.351 178.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . 0.918 ' O ' ' N ' ' B' ' 85' ' ' LEU . 16.9 tt0 -75.71 41.32 0.2 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.523 -0.986 . . . . 0.0 108.707 177.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' SER . . . . . 0.603 ' C ' ' O ' ' B' ' 83' ' ' GLU . 0.3 OUTLIER 7.8 44.72 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 122.741 1.258 . . . . 0.0 110.453 178.209 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . 0.918 ' N ' ' O ' ' B' ' 83' ' ' GLU . 0.2 OUTLIER 19.08 28.61 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 104.08 -2.563 . . . . 0.0 104.08 -171.577 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . 0.46 ' HB2' ' CB ' ' B' ' 84' ' ' SER 0.355 2.7 tttt -58.05 -41.8 84.08 Favored 'General case' 0 CA--C 1.482 -1.658 0 N-CA-C 103.794 -2.669 . . . . 0.0 103.794 176.765 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . 0.41 ' O ' ' HG2' ' B' ' 90' ' ' GLU 0.264 0.0 OUTLIER -66.05 -35.92 81.83 Favored 'General case' 0 C--N 1.285 -2.228 0 CA-C-N 111.588 -2.551 . . . . 0.0 105.532 176.236 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.67 ' O ' ' CB ' ' A' ' 37' ' ' ALA . . . -74.52 -27.3 60.48 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 118.54 -1.264 . . . . 0.0 108.409 178.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . 0.692 ' N ' ' O ' ' B' ' 85' ' ' LEU . . . -62.01 -50.0 73.81 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.114 -0.991 . . . . 0.0 109.264 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.433 ' HG2' ' N ' ' B' ' 91' ' ' GLY . 2.7 pt-20 -57.62 -26.69 61.93 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 176.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . 0.433 ' N ' ' HG2' ' B' ' 90' ' ' GLU . . . -65.66 -37.53 93.64 Favored Glycine 0 N--CA 1.487 2.055 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.286 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . 0.67 ' HB3' ' HA ' ' A' ' 37' ' ' ALA . 1.1 pp -85.4 22.11 1.6 Allowed 'General case' 0 N--CA 1.504 2.258 0 CA-C-N 119.931 1.865 . . . . 0.0 111.239 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . 0.447 ' O ' ' N ' ' B' ' 96' ' ' ASP . 4.0 mmtt 53.65 39.02 29.63 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 -177.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . 0.537 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -36.16 -36.81 0.1 Allowed 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.943 -178.643 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . 0.51 ' N ' ' CD1' ' B' ' 94' ' ' TYR . 7.0 pt-20 -60.01 -42.3 94.01 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.332 -0.855 . . . . 0.0 109.609 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 96' ' ' ASP . . . . . 0.447 ' N ' ' O ' ' B' ' 93' ' ' LYS . 0.3 OUTLIER -61.09 -35.08 76.02 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.085 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.44 -26.27 59.95 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.83 -63.72 1.07 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.585 -0.697 . . . . 0.0 110.229 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.174 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.461 ' HA ' ' CB ' ' A' ' 5' ' ' GLU . 6.3 mtp . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 120.837 0.351 . . . . 0.0 110.069 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.506 ' HA ' ' O ' ' B' ' 43' ' ' GLN . 1.6 t-20 -176.93 -165.31 0.12 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.946 -1.096 . . . . 0.0 111.626 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.523 ' CD ' ' HB ' ' B' ' 45' ' ' THR . 0.4 OUTLIER -51.07 -12.93 0.13 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.511 -0.743 . . . . 0.0 110.802 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.622 ' O ' HG13 ' A' ' 7' ' ' ILE . 74.8 m -112.61 -60.6 1.85 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.172 -0.955 . . . . 0.0 109.938 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.497 ' HA ' ' CE ' ' A' ' 8' ' ' LYS . 4.6 mt-10 -50.17 -41.6 49.61 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.98 -1.075 . . . . 0.0 108.879 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.469 ' HB2' ' O ' ' A' ' 2' ' ' ASN . 10.1 mt -60.62 -34.51 74.36 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.303 -0.959 . . . . 0.0 109.772 177.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.622 HG13 ' O ' ' A' ' 4' ' ' THR . 1.0 OUTLIER -57.59 -39.74 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 179.089 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.618 ' HA ' ' HB2' ' A' ' 11' ' ' ALA . 1.0 OUTLIER -66.97 -36.66 82.69 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.397 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 13' ' ' ASP . . . -52.39 -39.0 60.33 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 120.214 -0.594 . . . . 0.0 109.447 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.708 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.3 mp -93.93 -29.99 4.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.618 ' HB2' ' HA ' ' A' ' 8' ' ' LYS . . . -63.92 -15.15 58.43 Favored 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 118.496 -1.282 . . . . 0.0 108.858 178.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -115.16 -42.78 3.14 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.405 -0.81 . . . . 0.0 109.352 178.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 9' ' ' ALA . 1.0 OUTLIER -67.12 -26.15 66.54 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 177.071 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.708 ' OG1' ' O ' ' A' ' 10' ' ' ILE 0.257 0.2 OUTLIER -112.54 -82.8 0.59 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 178.891 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 16' ' ' LEU . . . 71.15 -11.17 2.89 Favored Glycine 0 N--CA 1.501 2.967 0 O-C-N 121.0 -1.063 . . . . 0.0 111.739 177.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.784 HD13 ' HB3' ' B' ' 20' ' ' SER . 4.4 mp -35.73 -64.11 0.32 Allowed 'General case' 0 N--CA 1.511 2.59 0 O-C-N 121.518 -0.989 . . . . 0.0 110.532 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.491 HG22 ' O ' ' A' ' 17' ' ' THR . 0.5 OUTLIER -135.22 3.64 3.14 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.167 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.613 ' O ' ' C ' ' A' ' 19' ' ' VAL . 28.2 mt-30 56.44 29.04 14.57 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 -176.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.672 HG22 ' CD1' ' B' ' 16' ' ' LEU . 1.5 p -9.68 -94.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.904 -178.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.968 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -133.9 25.13 3.97 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 177.627 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.661 ' C ' ' O ' ' A' ' 20' ' ' SER . 27.0 m -19.17 -39.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 122.474 1.13 . . . . 0.0 109.347 -178.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.852 ' N ' ' O ' ' A' ' 20' ' ' SER . 3.1 m -81.5 -38.7 25.89 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.661 177.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.968 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.1 OUTLIER -86.45 -35.79 19.45 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.547 -0.72 . . . . 0.0 111.186 179.492 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.567 ' SD ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -68.17 -38.21 81.81 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 117.567 -1.653 . . . . 0.0 108.15 178.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.607 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 8.4 mt -72.42 -47.27 50.49 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 118.404 -1.319 . . . . 0.0 107.832 176.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.497 ' HA ' ' HE2' ' A' ' 3' ' ' LYS . . . -55.31 -34.0 63.78 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 177.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.547 ' HA ' ' HB3' ' A' ' 30' ' ' LYS . 54.9 p -83.16 -32.25 26.72 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.819 ' O ' HG13 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -56.57 -47.13 80.17 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.013 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.655 ' O ' ' HB ' ' A' ' 33' ' ' THR . 0.3 OUTLIER -71.02 -35.68 72.11 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 177.733 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.872 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 70.9 tttt -65.04 -21.44 66.83 Favored 'General case' 0 C--O 1.192 -1.962 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.819 HG13 ' O ' ' A' ' 28' ' ' PHE . 1.3 pp -105.06 -29.48 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.761 -1.212 . . . . 0.0 109.062 178.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.616 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.2 mm -71.43 -49.34 47.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 176.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.655 ' HB ' ' O ' ' A' ' 29' ' ' GLU . 0.3 OUTLIER -69.07 -43.37 74.71 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 177.968 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.872 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 57.7 mm-40 -68.31 -41.62 80.59 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 121.616 -0.677 . . . . 0.0 110.905 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.526 ' HA ' ' HB2' ' A' ' 38' ' ' LYS . 3.8 m -52.58 -50.37 63.14 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.588 -1.32 . . . . 0.0 108.537 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.424 HG12 ' HB3' ' B' ' 85' ' ' LEU . 1.1 t -54.01 -36.89 32.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 177.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.624 ' HB3' ' O ' ' B' ' 88' ' ' ALA . . . -81.33 -6.24 58.68 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.537 0.684 . . . . 0.0 109.7 178.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.597 ' HG2' ' O ' ' A' ' 34' ' ' GLU . 2.4 mmpt? -97.58 -25.05 15.27 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 177.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.79 41.07 1.76 Allowed Glycine 0 C--N 1.303 -1.295 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 178.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.454 ' CB ' HG22 ' A' ' 35' ' ' THR . 0.2 OUTLIER -136.76 147.64 46.8 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.176 -1.191 . . . . 0.0 110.593 179.707 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.5 mtmt -100.51 102.94 14.25 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.564 ' HB ' ' CG1' ' A' ' 50' ' ' ILE . 2.0 t -74.77 152.42 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 C-N-CA 119.622 -0.831 . . . . 0.0 110.019 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.474 ' HA ' ' HA ' ' A' ' 49' ' ' ASN . 6.1 mt-30 -140.26 94.16 2.71 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.403 -0.81 . . . . 0.0 110.221 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.592 HD12 ' CB ' ' A' ' 48' ' ' LEU . 22.1 mt -58.84 112.77 1.77 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.954 -1.091 . . . . 0.0 109.078 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.561 HG22 ' HG2' ' B' ' 29' ' ' GLU . 0.1 OUTLIER 35.99 -88.48 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.869 -0.519 . . . . 0.0 110.606 -179.157 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -149.52 29.12 1.19 Allowed Glycine 0 N--CA 1.484 1.898 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.543 ' CE2' ' HG2' ' B' ' 29' ' ' GLU . 3.9 p90 -128.03 -28.64 2.62 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.991 -1.3 . . . . 0.0 112.717 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.592 ' CB ' HD12 ' A' ' 44' ' ' LEU . 0.6 OUTLIER -123.78 100.84 6.97 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.36 -1.462 . . . . 0.0 111.297 179.28 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.474 ' HA ' ' HA ' ' A' ' 43' ' ' GLN . 44.6 t-20 -109.45 87.35 2.48 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.863 -0.523 . . . . 0.0 110.623 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.564 ' CG1' ' HB ' ' A' ' 42' ' ' VAL . 1.1 pt -79.39 147.62 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.159 -0.963 . . . . 0.0 110.505 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.406 ' HG3' ' HB3' ' A' ' 78' ' ' SER . 8.4 ptmt -157.15 122.71 2.42 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.053 -1.029 . . . . 0.0 110.079 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.556 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 55.3 Cg_endo -80.65 140.87 13.42 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 O-C-N 123.459 1.241 . . . . 0.0 112.025 -178.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.706 ' O ' ' N ' ' A' ' 76' ' ' GLY . 31.5 m -142.21 114.75 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 121.441 0.639 . . . . 0.0 109.64 178.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.618 ' HB3' ' HA ' ' A' ' 75' ' ' VAL . . . -117.0 145.06 43.9 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -177.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.612 ' O ' ' CB ' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -162.5 7.87 0.06 Allowed 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.986 175.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.825 ' O ' ' HA ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER 130.72 14.55 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.436 0 C-N-CA 124.547 1.139 . . . . 0.0 110.19 176.868 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.68 ' CB ' ' O ' ' A' ' 56' ' ' GLN . . . 152.9 179.95 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 122.27 1.033 . . . . 0.0 111.624 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.638 ' HB2' ' CG1' ' A' ' 71' ' ' ILE 0.261 0.0 OUTLIER -91.68 -143.85 0.19 Allowed 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.438 -179.868 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.413 ' HA ' ' C ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -160.98 48.58 0.22 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.341 -0.849 . . . . 0.0 109.802 179.571 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -163.41 33.93 0.3 Allowed Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.601 -1.285 . . . . 0.0 110.978 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.824 ' CD1' ' O ' ' A' ' 61' ' ' PHE . 0.1 OUTLIER -90.33 116.88 28.63 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.816 -1.402 . . . . 0.0 112.824 -179.692 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.617 ' HA ' ' O ' ' A' ' 66' ' ' GLN . 0.9 OUTLIER -117.67 -26.23 0.09 OUTLIER Pre-proline 0 N--CA 1.497 1.903 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 -178.75 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 62' ' ' ASN . 45.2 Cg_endo -75.38 -4.63 15.58 Favored 'Trans proline' 0 N--CA 1.485 1.008 0 N-CA-C 110.027 -0.797 . . . . 0.0 110.027 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.782 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -90.14 46.3 1.34 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.511 -0.743 . . . . 0.0 110.133 179.527 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.1 p 50.97 23.76 1.59 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.293 -0.88 . . . . 0.0 109.591 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.648 ' O ' ' O ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -155.21 111.05 3.12 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.648 -0.658 . . . . 0.0 109.909 -179.778 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.557 ' O ' ' CD2' ' A' ' 69' ' ' LEU . 5.6 mt-10 -29.74 152.38 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 122.335 1.064 . . . . 0.0 111.851 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.815 ' HA ' ' C ' ' A' ' 61' ' ' PHE . . . -57.88 118.69 5.61 Favored 'General case' 0 C--N 1.281 -2.395 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.118 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.613 ' H ' ' N ' ' A' ' 61' ' ' PHE . 0.4 OUTLIER 175.71 19.46 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.594 -0.692 . . . . 0.0 112.355 179.549 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.642 ' H ' ' H ' ' A' ' 61' ' ' PHE . 3.2 mt-10 162.41 85.99 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.308 0 O-C-N 121.075 -1.016 . . . . 0.0 110.598 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.638 ' CG1' ' HB2' ' A' ' 58' ' ' ARG . 0.7 OUTLIER -80.14 -174.38 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.828 -1.17 . . . . 0.0 109.017 178.909 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.67 ' O ' ' HA ' ' A' ' 57' ' ' ALA . . . -48.09 170.74 0.1 Allowed Pre-proline 0 C--N 1.283 -2.299 0 O-C-N 121.952 -0.468 . . . . 0.0 112.178 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.825 ' HA ' ' O ' ' A' ' 56' ' ' GLN . 36.7 Cg_endo -61.96 117.3 4.13 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.878 2.385 . . . . 0.0 110.015 178.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.563 ' N ' ' CZ ' ' B' ' 94' ' ' TYR . 0.5 OUTLIER 176.37 165.6 0.44 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.339 -0.851 . . . . 0.0 109.113 -179.548 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.618 ' HA ' ' HB3' ' A' ' 54' ' ' ALA . 0.3 OUTLIER -61.58 171.78 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.058 -1.026 . . . . 0.0 109.888 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.706 ' N ' ' O ' ' A' ' 53' ' ' VAL . . . -115.37 61.2 0.38 Allowed Glycine 0 N--CA 1.484 1.873 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.556 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 2.3 p -43.47 83.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.998 -0.707 . . . . 0.0 110.787 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.617 ' N ' ' O ' ' A' ' 76' ' ' GLY . 1.3 t -81.68 175.97 10.02 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.985 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.464 ' HA ' ' HA ' ' A' ' 50' ' ' ILE . 3.3 p 176.25 176.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.447 ' N ' ' CG2' ' A' ' 79' ' ' VAL . 0.0 OUTLIER -176.09 171.43 1.1 Allowed Pre-proline 0 N--CA 1.485 1.286 0 O-C-N 120.799 -1.188 . . . . 0.0 110.868 177.3 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.502 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 55.6 Cg_endo -97.03 136.51 0.44 Allowed 'Trans proline' 0 C--N 1.302 -1.878 0 C-N-CA 122.843 2.362 . . . . 0.0 110.706 178.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' A' ' 47' ' ' PHE . . . -91.64 -158.74 34.85 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 178.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -89.33 -16.53 30.87 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.117 -1.226 . . . . 0.0 110.394 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.416 ' HB3' ' OG1' ' B' ' 33' ' ' THR . 0.2 OUTLIER -53.59 -33.42 54.81 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.304 -0.872 . . . . 0.0 109.975 -179.857 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.545 ' HG ' ' OG1' ' B' ' 33' ' ' THR . 0.0 OUTLIER -86.0 -30.94 22.32 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.326 -0.859 . . . . 0.0 108.77 178.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.4 ' HA ' ' CG1' ' B' ' 75' ' ' VAL . 0.6 OUTLIER -72.94 -33.12 65.72 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.415 -0.803 . . . . 0.0 109.838 -179.88 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -78.63 -34.92 46.22 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.75 ' C ' ' HB1' ' B' ' 37' ' ' ALA . . . -68.53 -31.26 70.37 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 177.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.713 ' N ' ' HB3' ' B' ' 37' ' ' ALA . . . -69.94 -35.73 74.74 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -178.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -59.55 -24.79 64.01 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 174.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -64.43 -54.41 29.53 Favored Glycine 0 N--CA 1.483 1.797 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 178.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.644 ' HB3' ' O ' ' B' ' 37' ' ' ALA . 2.1 pp -67.11 -42.19 84.96 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 119.76 1.78 . . . . 0.0 109.502 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.629 ' O ' ' CG ' ' A' ' 93' ' ' LYS . 2.6 tttp 156.8 80.88 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.8 ' O ' ' N ' ' A' ' 97' ' ' PHE . 9.1 t80 -61.79 -62.85 1.51 Allowed 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 115.297 -2.561 . . . . 0.0 105.96 177.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.975 ' O ' ' N ' ' A' ' 98' ' ' ALA . 2.3 mp0 10.35 41.28 0.0 OUTLIER 'General case' 0 CA--C 1.486 -1.501 0 N-CA-C 101.561 -3.496 . . . . 0.0 101.561 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 1.045 ' O ' ' N ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER 19.39 44.52 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 113.027 -1.897 . . . . 0.0 108.103 -173.029 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.812 ' C ' ' O ' ' A' ' 96' ' ' ASP . 0.1 OUTLIER 27.16 28.8 0.0 OUTLIER 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 101.888 -3.375 . . . . 0.0 101.888 -170.495 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 1.045 ' N ' ' O ' ' A' ' 96' ' ' ASP 0.263 . . -70.01 -31.68 69.46 Favored 'General case' 0 C--O 1.215 -0.711 0 CA-C-N 110.186 -3.188 . . . . 0.0 109.614 -178.356 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.199 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.471 ' HA ' ' CB ' ' B' ' 5' ' ' GLU . 5.9 mtp . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 120.863 0.363 . . . . 0.0 110.133 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . 0.58 ' H ' ' HB2' ' B' ' 5' ' ' GLU . 2.0 t-20 -172.53 -159.42 0.13 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.055 -1.028 . . . . 0.0 111.396 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.467 ' HG2' ' OE1' ' B' ' 29' ' ' GLU . 1.4 mttt -58.36 -7.56 0.92 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.407 -0.808 . . . . 0.0 110.291 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.65 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 90.0 m -116.82 -48.3 2.67 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.042 -1.036 . . . . 0.0 110.304 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.58 ' HB2' ' H ' ' B' ' 2' ' ' ASN . 3.0 mt-10 -61.64 -52.89 62.49 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.117 -0.989 . . . . 0.0 108.904 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.503 ' HA ' ' HB2' ' B' ' 9' ' ' ALA . 0.9 OUTLIER -60.23 -27.79 67.49 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.196 -1.002 . . . . 0.0 108.928 178.355 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' ILE . . . . . 0.65 ' HB ' ' O ' ' B' ' 4' ' ' THR . 0.4 OUTLIER -56.26 -58.01 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 178.158 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . 0.512 ' HE2' ' HA ' ' B' ' 5' ' ' GLU . 0.1 OUTLIER -55.35 -31.85 62.08 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.94 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . 0.503 ' HB2' ' HA ' ' B' ' 6' ' ' LEU . . . -57.57 -37.22 72.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.27 -0.894 . . . . 0.0 108.958 178.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . 0.934 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.2 mp -92.57 -25.96 4.95 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.209 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 177.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.4 ' CB ' ' HA ' ' B' ' 8' ' ' LYS . . . -75.99 -2.23 29.51 Favored 'General case' 0 C--N 1.287 -2.121 0 O-C-N 120.703 -1.248 . . . . 0.0 108.152 177.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.4 ' N ' ' O ' ' B' ' 8' ' ' LYS . 55.7 tp60 -125.3 -41.62 2.04 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.531 -0.731 . . . . 0.0 109.898 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' B' ' 9' ' ' ALA . 1.0 OUTLIER -72.18 -23.78 61.32 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 177.838 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.934 ' OG1' ' O ' ' B' ' 10' ' ' ILE 0.284 0.2 OUTLIER -103.8 -62.13 1.34 Allowed 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 179.609 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 52.12 24.07 14.01 Favored Glycine 0 N--CA 1.5 2.912 0 O-C-N 121.369 -0.832 . . . . 0.0 111.569 177.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' LEU . . . . . 0.824 HD12 ' HB2' ' A' ' 20' ' ' SER . 4.5 mp -69.76 -69.97 0.31 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.343 -1.092 . . . . 0.0 109.904 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' THR . . . . . 0.529 HG22 ' O ' ' B' ' 17' ' ' THR . 0.6 OUTLIER -137.81 5.74 2.64 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.736 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . 0.669 ' O ' ' C ' ' B' ' 19' ' ' VAL . 33.2 mt-30 57.42 27.53 14.04 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 -176.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.669 ' C ' ' O ' ' B' ' 18' ' ' GLN . 1.5 p -0.41 -96.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.947 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 1.091 ' O ' ' N ' ' B' ' 22' ' ' SER . 14.9 p -133.53 23.08 4.01 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 175.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.649 ' HA ' ' HE1' ' B' ' 24' ' ' MET . 28.1 m -3.87 -39.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-O 122.302 1.048 . . . . 0.0 110.981 -177.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 1.091 ' N ' ' O ' ' B' ' 20' ' ' SER . 2.4 t -73.0 -44.01 61.5 Favored 'General case' 0 C--N 1.281 -2.387 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.93 177.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . 0.813 ' N ' ' O ' ' B' ' 20' ' ' SER . 5.1 mtpt -88.37 -29.32 20.37 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.659 -0.651 . . . . 0.0 109.693 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' MET . . . . . 0.649 ' HE1' ' HA ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -62.77 -41.44 99.24 Favored 'General case' 0 C--N 1.314 -0.958 0 O-C-N 120.899 -1.126 . . . . 0.0 109.443 179.796 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.568 ' N ' ' HE3' ' B' ' 24' ' ' MET . 1.2 mt -84.51 -45.38 12.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.891 -1.13 . . . . 0.0 108.406 177.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . 0.499 ' O ' ' CB ' ' B' ' 30' ' ' LYS . . . -53.31 -34.68 58.38 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 178.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' SER . . . . . 0.577 ' O ' ' CG1' ' B' ' 31' ' ' ILE . 58.4 m -78.55 -40.28 35.34 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 177.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . 0.691 ' HA ' ' CG1' ' B' ' 31' ' ' ILE . 0.1 OUTLIER -63.82 -36.63 84.53 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.636 -0.665 . . . . 0.0 109.394 179.42 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . 0.575 ' HG3' ' CE2' ' B' ' 28' ' ' PHE . 0.9 OUTLIER -82.07 -31.97 30.57 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 178.721 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . 0.822 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 16.6 tttp -72.22 -28.42 63.16 Favored 'General case' 0 C--O 1.191 -1.989 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 176.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.691 ' CG1' ' HA ' ' B' ' 28' ' ' PHE . 1.6 pp -94.67 -30.48 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.03 -1.044 . . . . 0.0 109.884 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.647 HG13 ' CE1' ' B' ' 28' ' ' PHE . 3.6 mm -62.91 -61.88 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 177.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' THR . . . . . 0.786 ' O ' ' HB2' ' B' ' 37' ' ' ALA . 0.4 OUTLIER -58.42 -40.18 81.79 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.813 179.213 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.84 ' O ' ' N ' ' B' ' 38' ' ' LYS . 40.9 mm-40 -73.29 -48.42 34.74 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.855 -0.528 . . . . 0.0 112.296 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' THR . . . . . 0.48 ' CG2' ' CB ' ' B' ' 40' ' ' ASP . 92.9 m -52.16 -59.16 4.7 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.477 -1.389 . . . . 0.0 110.504 -178.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.668 ' O ' ' HG3' ' B' ' 52' ' ' PRO . 0.9 OUTLIER -51.38 -45.32 33.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 178.408 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . 0.786 ' HB2' ' O ' ' B' ' 33' ' ' THR . . . -83.52 1.88 39.71 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.993 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . 0.84 ' N ' ' O ' ' B' ' 34' ' ' GLU . 0.5 OUTLIER -107.53 -37.85 6.07 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.188 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 145.28 41.92 0.05 OUTLIER Glycine 0 C--N 1.301 -1.405 0 C-N-CA 119.008 -1.568 . . . . 0.0 111.273 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . 0.48 ' CB ' ' CG2' ' B' ' 35' ' ' THR . 0.6 OUTLIER -161.75 127.11 3.54 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.93 -1.335 . . . . 0.0 110.604 179.236 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.83 86.53 0.23 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.675 -0.641 . . . . 0.0 109.421 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 9.4 p -61.8 125.93 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 C-N-CA 119.919 -0.712 . . . . 0.0 109.66 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' GLN . . . . . 0.506 ' O ' ' HA ' ' A' ' 2' ' ' ASN . 5.4 mt-30 -131.11 172.25 12.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.899 . . . . 0.0 110.29 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.622 ' HB3' ' HE1' ' B' ' 47' ' ' PHE . 29.3 mt -136.48 120.21 17.31 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.503 -0.748 . . . . 0.0 109.625 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' THR . . . . . 0.532 ' CG2' ' HG2' ' A' ' 29' ' ' GLU . 0.1 OUTLIER 34.43 -92.72 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.375 0 O-C-N 121.646 -0.659 . . . . 0.0 110.821 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -159.24 30.37 0.42 Allowed Glycine 0 N--CA 1.486 2.032 0 N-CA-C 108.256 -1.937 . . . . 0.0 108.256 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . 0.653 ' CE1' ' HG2' ' A' ' 29' ' ' GLU . 0.1 OUTLIER -124.65 -26.76 3.78 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.546 -0.973 . . . . 0.0 110.981 -179.447 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . 0.587 ' HB3' HD13 ' B' ' 44' ' ' LEU . 9.7 mt -130.56 90.29 2.9 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.835 -1.165 . . . . 0.0 110.415 177.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -98.26 88.83 4.28 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.705 -0.622 . . . . 0.0 110.481 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' ILE . . . . . 0.505 HD12 ' HB ' ' B' ' 79' ' ' VAL . 0.8 OUTLIER -81.73 147.32 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.383 -0.823 . . . . 0.0 110.906 -179.835 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' B' ' 78' ' ' SER . 3.3 ptmt -164.31 131.04 2.34 Favored Pre-proline 0 N--CA 1.502 2.154 0 O-C-N 121.258 -0.901 . . . . 0.0 110.391 179.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . 0.668 ' HG3' ' O ' ' B' ' 36' ' ' VAL . 50.8 Cg_endo -84.28 146.86 11.27 Favored 'Trans proline' 0 C--N 1.318 -1.039 0 O-C-N 123.195 1.103 . . . . 0.0 112.241 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.52 HG23 ' O ' ' B' ' 76' ' ' GLY . 23.1 m -146.4 117.39 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-O 121.765 0.793 . . . . 0.0 110.284 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.505 ' HB1' ' CB ' ' A' ' 96' ' ' ASP . . . -51.66 130.69 28.88 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.755 0.788 . . . . 0.0 111.783 -178.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.89 96.11 1.7 Allowed 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . 0.438 ' C ' ' HA ' ' B' ' 73' ' ' PRO . 61.6 mt-30 -60.71 -171.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.29 -0.881 . . . . 0.0 111.566 -178.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.547 ' CB ' ' HD3' ' B' ' 73' ' ' PRO . . . -80.7 -157.39 0.16 Allowed 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.502 0.667 . . . . 0.0 110.382 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' ARG . . . . . 0.557 ' HB3' HG12 ' B' ' 71' ' ' ILE . 0.0 OUTLIER -166.33 148.85 6.91 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.637 -0.665 . . . . 0.0 109.555 -179.806 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -164.91 165.67 20.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.329 -0.857 . . . . 0.0 110.372 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . 0.507 ' O ' ' HB3' ' B' ' 61' ' ' PHE . . . 166.46 -101.78 0.18 Allowed Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' PHE . . . . . 0.672 ' N ' ' CD1' ' B' ' 61' ' ' PHE . 0.0 OUTLIER 170.49 152.48 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.68 -0.894 . . . . 0.0 110.879 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . 0.63 ' HB3' ' HB1' ' B' ' 68' ' ' ALA . 0.0 OUTLIER -105.88 -44.91 0.14 Allowed Pre-proline 0 N--CA 1.502 2.161 0 O-C-N 120.836 -1.165 . . . . 0.0 113.404 -178.656 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . 0.555 ' HD2' ' H ' ' B' ' 62' ' ' ASN . 39.9 Cg_endo -67.54 -11.85 33.59 Favored 'Trans proline' 0 N--CA 1.488 1.177 0 O-C-N 122.843 0.918 . . . . 0.0 111.223 -177.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . 0.558 ' CB ' ' CD2' ' B' ' 61' ' ' PHE . 0.9 OUTLIER -90.84 50.4 1.8 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.333 -0.854 . . . . 0.0 109.222 178.738 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' B' ' 64' ' ' GLN . 3.2 p 53.33 28.42 7.32 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.454 -0.779 . . . . 0.0 109.701 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . 0.558 ' CB ' ' CE1' ' B' ' 61' ' ' PHE . 0.0 OUTLIER -139.91 -145.67 0.19 Allowed 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.47 -0.768 . . . . 0.0 110.126 -179.878 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . 0.54 ' N ' ' O ' ' B' ' 61' ' ' PHE . 2.8 mt-10 -140.34 117.11 10.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.13 -0.981 . . . . 0.0 108.49 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . 0.63 ' HB1' ' HB3' ' B' ' 62' ' ' ASN . . . -73.61 133.15 43.42 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.358 -0.839 . . . . 0.0 109.944 -178.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' B' ' 67' ' ' GLU . 1.4 mt -138.67 177.93 7.52 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 120.029 -0.669 . . . . 0.0 110.38 -177.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' B' ' 58' ' ' ARG . 0.6 OUTLIER 173.59 37.89 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.356 -0.84 . . . . 0.0 110.964 -179.653 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.557 HG12 ' HB3' ' B' ' 58' ' ' ARG . 2.6 pt -65.15 -153.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.957 -1.09 . . . . 0.0 110.181 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -131.39 143.45 49.32 Favored Pre-proline 0 C--N 1.303 -1.427 0 O-C-N 121.291 -0.881 . . . . 0.0 111.943 -178.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' PRO . . . . . 0.547 ' HD3' ' CB ' ' B' ' 57' ' ' ALA . 48.6 Cg_endo -74.95 123.08 7.64 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.65 1.566 . . . . 0.0 109.804 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' SER . . . . . 0.421 ' C ' ' CE1' ' A' ' 94' ' ' TYR . 4.9 p -178.57 152.28 0.63 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.214 -0.929 . . . . 0.0 110.168 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . 0.533 ' CG1' ' CB ' ' A' ' 89' ' ' ALA . 11.9 p -50.99 170.03 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.419 -0.801 . . . . 0.0 109.994 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . 0.56 ' O ' ' N ' ' B' ' 78' ' ' SER . . . -119.23 71.31 0.32 Allowed Glycine 0 N--CA 1.488 2.161 0 C-N-CA 119.005 -1.569 . . . . 0.0 109.826 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.661 ' HA ' ' HA ' ' B' ' 52' ' ' PRO . 3.1 p -59.07 77.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.377 -1.072 . . . . 0.0 109.726 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' SER . . . . . 0.56 ' N ' ' O ' ' B' ' 76' ' ' GLY . 0.2 OUTLIER -71.11 177.35 3.83 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 122.174 0.988 . . . . 0.0 111.286 -179.298 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . 0.505 ' HB ' HD12 ' B' ' 50' ' ' ILE . 1.6 p 176.56 176.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . 0.488 ' N ' ' CG2' ' B' ' 79' ' ' VAL . 16.1 ptmt -176.33 174.05 0.78 Allowed Pre-proline 0 N--CA 1.486 1.326 0 O-C-N 120.764 -1.21 . . . . 0.0 110.349 178.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' PRO . . . . . 0.414 ' CD ' ' HB2' ' B' ' 80' ' ' LYS . 52.8 Cg_endo -96.01 136.56 0.6 Allowed 'Trans proline' 0 C--N 1.302 -1.877 0 C-N-CA 122.294 1.996 . . . . 0.0 109.842 178.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' B' ' 47' ' ' PHE . . . -97.35 -168.3 32.86 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 107.793 -2.123 . . . . 0.0 107.793 178.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . 0.585 ' HA ' ' HB2' ' B' ' 86' ' ' LYS . 0.9 OUTLIER -76.97 -18.28 58.33 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.886 -1.361 . . . . 0.0 110.283 179.776 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' SER . . . . . 0.463 ' CB ' ' HB3' ' B' ' 47' ' ' PHE . 0.2 OUTLIER -50.94 -42.19 59.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.167 -0.958 . . . . 0.0 108.815 179.368 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . 0.506 ' HG ' ' HD2' ' B' ' 47' ' ' PHE . 1.0 OUTLIER -73.72 -31.41 63.37 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 177.942 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . 0.585 ' HB2' ' HA ' ' B' ' 83' ' ' GLU . 29.4 mtmm -73.29 -38.24 65.97 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.392 0.615 . . . . 0.0 110.196 -179.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 13.8 ttpt -74.54 -37.12 63.12 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 177.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.624 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -68.92 -34.73 75.86 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 176.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . 0.497 ' CB ' ' CG1' ' A' ' 75' ' ' VAL . . . -55.95 -44.36 78.36 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -54.07 -33.51 57.67 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 176.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . 0.43 ' C ' ' H ' ' B' ' 93' ' ' LYS . . . -61.79 -38.47 96.0 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 178.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . 0.593 ' HB3' ' HA ' ' A' ' 37' ' ' ALA . 0.4 OUTLIER -72.27 13.8 0.29 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.69 -1.477 . . . . 0.0 110.762 179.697 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' B' ' 92' ' ' LEU . 72.8 mmtt 62.17 39.84 12.37 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 -177.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . 0.563 ' CZ ' ' N ' ' A' ' 74' ' ' SER . 0.0 OUTLIER -38.09 -37.23 0.25 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.565 -179.214 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -60.12 -42.53 94.97 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.46 -0.775 . . . . 0.0 109.811 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 96' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' B' ' 93' ' ' LYS . 3.4 m-20 -60.57 -36.68 79.08 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -75.43 -26.34 58.24 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.1 -57.1 4.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.605 -0.684 . . . . 0.0 110.191 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 35.8 mttt . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 117.917 -1.04 . . . . 0.0 110.191 -179.995 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.544 ' HB3' ' HG ' ' A' ' 6' ' ' LEU . 7.3 mtp . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.426 ' O ' ' N ' ' A' ' 4' ' ' THR . 50.4 p-10 -171.16 -162.78 0.26 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.798 -1.189 . . . . 0.0 112.43 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.529 ' HE2' ' HA ' ' A' ' 26' ' ' ALA . 9.8 tttm -46.79 -15.34 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.776 -0.578 . . . . 0.0 111.068 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.632 ' O ' ' CG1' ' A' ' 7' ' ' ILE . 58.6 m -117.26 -58.06 2.09 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.126 -0.984 . . . . 0.0 110.304 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.57 ' HA ' ' HE3' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -46.64 -44.86 18.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.115 -0.991 . . . . 0.0 109.489 179.698 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.544 ' HG ' ' HB3' ' A' ' 1' ' ' MET . 1.3 mt -63.74 -33.28 75.3 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.15 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.676 HG13 ' N ' ' A' ' 8' ' ' LYS . 0.9 OUTLIER -56.68 -42.61 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.764 -1.21 . . . . 0.0 108.097 179.699 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.676 ' N ' HG13 ' A' ' 7' ' ' ILE . 6.7 mtmt -66.56 -34.14 77.23 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 177.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.71 -39.51 65.26 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.546 -0.862 . . . . 0.0 109.362 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.723 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.3 mp -91.01 -31.58 5.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 178.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.623 ' HB3' ' O ' ' A' ' 7' ' ' ILE . . . -65.3 -13.47 58.53 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 118.956 -1.098 . . . . 0.0 108.364 177.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.426 ' HB3' ' O ' ' A' ' 8' ' ' LYS . 1.1 tp60 -113.44 -45.12 3.15 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.457 ' HB3' ' HB2' ' B' ' 27' ' ' SER . 1.8 m-20 -62.34 -33.8 75.41 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 177.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.723 ' OG1' ' O ' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -102.16 -71.14 0.73 Allowed 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 178.494 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 46.37 27.37 2.8 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.57 ' CD2' ' HB3' ' B' ' 20' ' ' SER . 0.1 OUTLIER -87.28 -25.83 23.75 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.449 -1.03 . . . . 0.0 108.946 178.868 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.509 HG23 ' CG2' ' B' ' 17' ' ' THR . 0.5 OUTLIER -153.8 -8.32 0.16 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.907 -0.496 . . . . 0.0 110.228 -179.449 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.515 ' O ' ' C ' ' A' ' 19' ' ' VAL . 4.5 mt-30 57.06 36.82 28.19 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 -177.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.653 ' HB ' ' HB ' ' B' ' 19' ' ' VAL . 0.6 OUTLIER -23.93 -93.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.614 -178.712 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.945 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -135.18 22.92 3.49 Favored 'General case' 0 C--N 1.281 -2.39 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 178.709 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.68 ' C ' ' O ' ' A' ' 20' ' ' SER . 31.3 m -21.7 -40.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-O 122.385 1.088 . . . . 0.0 108.697 -177.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.811 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.2 OUTLIER -82.16 -39.04 23.8 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 114.891 -1.049 . . . . 0.0 109.601 177.614 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.945 ' N ' ' O ' ' A' ' 20' ' ' SER . 1.2 mtpt -85.33 -32.76 22.29 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.576 -0.703 . . . . 0.0 111.836 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.549 ' N ' ' HB3' ' A' ' 20' ' ' SER . 0.0 OUTLIER -77.01 -34.95 57.37 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.252 -1.53 . . . . 0.0 108.976 179.715 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.617 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 2.2 mt -77.74 -43.57 30.49 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 118.551 -1.26 . . . . 0.0 107.863 177.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.529 ' HA ' ' HE2' ' A' ' 3' ' ' LYS . . . -59.3 -34.08 71.88 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 177.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.616 ' O ' ' N ' ' A' ' 31' ' ' ILE . 85.6 p -81.75 -26.64 34.33 Favored 'General case' 0 C--O 1.204 -1.294 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.738 ' HA ' ' CG1' ' A' ' 31' ' ' ILE . 0.3 OUTLIER -64.86 -30.23 71.22 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.67 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.753 ' O ' ' HB ' ' A' ' 33' ' ' THR . 4.5 mt-10 -90.64 -21.55 21.62 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 177.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.785 ' O ' ' CG ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -83.36 -19.06 36.81 Favored 'General case' 0 C--O 1.192 -1.944 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 175.52 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.738 ' CG1' ' HA ' ' A' ' 28' ' ' PHE . 2.1 pp -104.67 -33.34 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.059 -1.025 . . . . 0.0 109.048 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.694 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 2.6 mm -64.14 -46.46 93.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 176.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.753 ' HB ' ' O ' ' A' ' 29' ' ' GLU 0.324 16.4 m -67.56 -54.26 21.42 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 113.762 -1.563 . . . . 0.0 108.197 178.504 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.785 ' CG ' ' O ' ' A' ' 30' ' ' LYS . 57.2 mm-40 -63.2 -32.43 73.82 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.054 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.651 ' N ' ' O ' ' A' ' 31' ' ' ILE . 1.5 m -58.26 -51.79 68.29 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.026 -1.046 . . . . 0.0 108.417 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.502 HG11 ' CG2' ' A' ' 77' ' ' VAL . 0.9 OUTLIER -52.39 -41.61 35.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 C-N-CA 117.982 -1.487 . . . . 0.0 107.218 177.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.847 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -72.51 -7.99 52.84 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.463 -0.895 . . . . 0.0 109.343 177.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.521 ' N ' ' O ' ' A' ' 35' ' ' THR . 0.0 OUTLIER -101.52 -23.69 14.26 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.301 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 35' ' ' THR . . . 102.61 41.48 2.33 Favored Glycine 0 C--N 1.301 -1.383 0 C-N-CA 119.967 -1.111 . . . . 0.0 110.648 178.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.481 ' CB ' HG21 ' A' ' 35' ' ' THR . 0.1 OUTLIER -128.86 133.97 48.14 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.011 -1.288 . . . . 0.0 110.809 179.648 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -85.27 91.83 8.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.56 -0.713 . . . . 0.0 109.55 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.427 ' CG1' ' CD1' ' A' ' 32' ' ' ILE . 82.0 t -67.43 149.63 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-O 121.437 0.637 . . . . 0.0 111.153 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.4 ' O ' ' HA ' ' B' ' 2' ' ' ASN . 4.2 pt20 -158.2 147.62 19.56 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.566 -0.709 . . . . 0.0 109.885 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.675 HD13 ' HB2' ' A' ' 48' ' ' LEU . 35.7 mt -99.47 118.7 36.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.3 -0.875 . . . . 0.0 109.736 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.478 HG21 ' HG3' ' B' ' 29' ' ' GLU . 0.0 OUTLIER 27.36 -95.18 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.953 -0.467 . . . . 0.0 112.235 -179.627 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -129.82 4.45 6.11 Favored Glycine 0 N--CA 1.486 1.976 0 C-N-CA 119.556 -1.307 . . . . 0.0 111.241 -178.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.614 ' O ' ' N ' ' A' ' 82' ' ' GLY . 26.8 p90 -100.24 -64.67 1.02 Allowed 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 119.554 1.677 . . . . 0.0 110.765 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.675 ' HB2' HD13 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -88.17 142.31 27.86 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.241 -1.537 . . . . 0.0 114.673 -178.843 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.619 ' HB2' ' HG2' ' A' ' 81' ' ' PRO . 0.1 OUTLIER -145.25 92.31 2.24 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.567 177.021 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.51 ' HA ' ' HA ' ' A' ' 79' ' ' VAL . 46.6 mm -85.71 160.17 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.172 -0.955 . . . . 0.0 110.655 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 5.0 ptmt -167.32 128.04 1.18 Allowed Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 120.976 -1.077 . . . . 0.0 110.478 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 52.4 Cg_endo -77.62 148.65 26.14 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 O-C-N 123.55 1.289 . . . . 0.0 111.216 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.582 ' O ' ' N ' ' A' ' 76' ' ' GLY . 32.9 m -140.59 114.86 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-O 121.717 0.77 . . . . 0.0 111.085 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.702 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . -54.48 141.53 30.63 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 122.0 0.905 . . . . 0.0 111.861 -178.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.06 94.13 0.09 Allowed 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -51.99 -178.07 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.451 -0.781 . . . . 0.0 111.661 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.439 ' N ' ' HA ' ' A' ' 73' ' ' PRO . . . -67.14 179.78 1.12 Allowed 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.456 0.646 . . . . 0.0 110.878 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.457 ' HB2' HG12 ' A' ' 71' ' ' ILE . 52.9 mtp85 -153.89 19.6 0.52 Allowed 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.655 -0.653 . . . . 0.0 110.593 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.59 97.98 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.868 0.842 . . . . 0.0 110.779 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 68' ' ' ALA . . . 168.47 -103.51 0.2 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 107.758 -2.137 . . . . 0.0 107.758 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.588 ' CD1' ' O ' ' A' ' 62' ' ' ASN . 51.3 p90 -178.4 162.87 1.53 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.407 -1.055 . . . . 0.0 110.443 178.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.588 ' O ' ' CD1' ' A' ' 61' ' ' PHE . 1.3 t-20 -56.59 -170.38 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.62 -0.675 . . . . 0.0 109.56 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.503 ' HD2' ' CB ' ' A' ' 62' ' ' ASN . 43.1 Cg_endo -73.2 61.63 4.1 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 N-CA-C 108.884 -1.237 . . . . 0.0 108.884 178.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.408 ' C ' ' CE1' ' A' ' 61' ' ' PHE . 32.8 mt-30 -140.0 -110.07 0.15 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.505 -0.747 . . . . 0.0 110.66 -178.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.404 ' CG2' ' O ' ' A' ' 64' ' ' GLN . 0.1 OUTLIER -171.95 21.44 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.977 -1.077 . . . . 0.0 110.743 179.754 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.438 ' HG2' ' N ' ' A' ' 67' ' ' GLU . 2.2 pm0 -173.72 -27.45 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.953 -1.092 . . . . 0.0 111.887 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.505 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 3.5 tp10 -64.93 82.25 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.927 -1.108 . . . . 0.0 109.329 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.456 ' HA ' ' HA ' ' A' ' 61' ' ' PHE . . . -92.67 160.95 14.76 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.855 0.836 . . . . 0.0 112.243 -178.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.8 mt -130.79 -146.42 0.3 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -174.4 32.16 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.717 -1.24 . . . . 0.0 110.968 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.457 HG12 ' HB2' ' A' ' 58' ' ' ARG . 1.1 pt -62.8 -158.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.143 -0.973 . . . . 0.0 109.897 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.33 148.55 48.06 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.275 -0.891 . . . . 0.0 110.773 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.439 ' HA ' ' N ' ' A' ' 57' ' ' ALA . 41.8 Cg_endo -68.21 82.81 0.48 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 124.081 1.569 . . . . 0.0 110.494 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.507 ' HA ' ' CE1' ' B' ' 94' ' ' TYR . 18.9 p -169.47 160.21 9.02 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.544 -0.722 . . . . 0.0 109.445 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.702 ' HA ' ' HA ' ' A' ' 54' ' ' ALA . 0.5 OUTLIER -52.58 168.63 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.06 -1.025 . . . . 0.0 109.003 179.836 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 53' ' ' VAL . . . -118.51 99.52 0.79 Allowed Glycine 0 N--CA 1.486 2.014 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.537 ' O ' ' CG1' ' A' ' 77' ' ' VAL . 1.4 t -58.53 86.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-O 122.09 0.948 . . . . 0.0 108.82 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 76' ' ' GLY . 0.2 OUTLIER -79.58 -152.77 0.07 Allowed 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 121.726 0.774 . . . . 0.0 110.272 -179.129 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.51 ' HA ' ' HA ' ' A' ' 50' ' ' ILE . 5.4 p 179.98 178.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.882 ' CB ' ' HD3' ' A' ' 81' ' ' PRO . 16.3 mttt -148.45 -70.19 0.02 OUTLIER Pre-proline 0 C--N 1.302 -1.462 0 C-N-CA 117.856 -1.537 . . . . 0.0 112.464 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.882 ' HD3' ' CB ' ' A' ' 80' ' ' LYS . 57.0 Cg_endo -102.23 -172.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.297 -2.16 0 C-N-CA 121.375 1.383 . . . . 0.0 112.834 -177.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.666 ' O ' ' C ' ' A' ' 83' ' ' GLU . . . 177.31 24.08 0.03 OUTLIER Glycine 0 C--N 1.29 -2.024 0 N-CA-C 107.23 -2.348 . . . . 0.0 107.23 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.898 ' O ' ' N ' ' A' ' 85' ' ' LEU . 44.3 tt0 32.6 48.38 0.12 Allowed 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 -176.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 1.325 ' O ' ' N ' ' A' ' 86' ' ' LYS . 0.2 OUTLIER 13.21 41.21 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.334 0 CA-C-N 114.007 -1.452 . . . . 0.0 109.686 -176.685 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 1.069 ' C ' ' O ' ' A' ' 84' ' ' SER . 4.7 mt 20.23 32.43 0.0 OUTLIER 'General case' 0 C--O 1.198 -1.642 0 N-CA-C 102.236 -3.246 . . . . 0.0 102.236 -173.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 1.325 ' N ' ' O ' ' A' ' 84' ' ' SER 0.349 3.2 tttt -57.77 -41.59 82.32 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 103.288 -2.856 . . . . 0.0 103.288 176.496 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.304 11.8 tttp -70.35 -32.77 70.61 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 111.44 -2.618 . . . . 0.0 105.438 174.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.778 ' HB3' ' O ' ' B' ' 33' ' ' THR . . . -77.41 -16.33 58.89 Favored 'General case' 0 C--O 1.2 -1.508 0 CA-C-O 122.201 1.001 . . . . 0.0 109.172 178.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.693 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . -89.96 -24.12 21.36 Favored 'General case' 0 C--N 1.282 -2.337 0 O-C-N 120.443 -1.41 . . . . 0.0 108.787 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -71.85 -34.64 69.43 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.421 ' HA3' ' CB ' ' B' ' 37' ' ' ALA . . . -77.34 -32.44 47.63 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 178.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.814 ' HG ' ' O ' ' B' ' 36' ' ' VAL 0.26 2.5 mt -51.33 -7.83 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.104 -1.233 . . . . 0.0 112.021 179.573 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' A' ' 96' ' ' ASP . 0.2 OUTLIER 62.56 36.7 13.67 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 -175.313 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.501 ' CD1' ' N ' ' B' ' 75' ' ' VAL . 63.9 t80 -34.18 -45.08 0.2 Allowed 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.697 -178.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -54.56 -41.34 69.69 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.272 -0.893 . . . . 0.0 109.737 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.45 ' N ' ' O ' ' A' ' 93' ' ' LYS . 6.9 t0 -63.76 -33.86 76.61 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.401 ' HB3' ' CB ' ' B' ' 54' ' ' ALA . 0.1 OUTLIER -81.75 -17.9 46.1 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.82 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.5 -32.85 54.42 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.506 -0.746 . . . . 0.0 110.25 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 118.043 -0.98 . . . . 0.0 110.211 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.436 ' HB3' ' HG ' ' B' ' 6' ' ' LEU . 2.1 mtp . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 120.886 0.374 . . . . 0.0 110.113 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . 0.409 ' N ' ' HB2' ' B' ' 5' ' ' GLU . 41.7 t30 -177.82 178.06 1.02 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.299 -0.876 . . . . 0.0 110.693 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.517 ' O ' HG13 ' B' ' 7' ' ' ILE . 0.0 OUTLIER -49.45 -19.62 0.57 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.437 -0.789 . . . . 0.0 110.096 179.553 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.533 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 81.4 m -103.64 -41.43 5.95 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.158 -0.964 . . . . 0.0 108.941 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.409 ' HB2' ' N ' ' B' ' 2' ' ' ASN . 0.0 OUTLIER -65.22 -49.93 67.82 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.692 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.464 ' HA ' ' HB1' ' B' ' 9' ' ' ALA . 9.4 mt -60.54 -33.48 72.73 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' ILE . . . . . 0.681 HG12 ' O ' ' B' ' 21' ' ' VAL . 0.6 OUTLIER -53.24 -55.71 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.333 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . 0.488 ' O ' ' N ' ' B' ' 12' ' ' GLN . 0.0 OUTLIER -58.15 -31.62 67.41 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.13 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . 0.464 ' HB1' ' HA ' ' B' ' 6' ' ' LEU . . . -56.1 -37.16 69.0 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.173 -0.954 . . . . 0.0 109.021 178.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . 0.69 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.5 mp -92.86 -33.38 5.36 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.417 ' CB ' ' HA ' ' B' ' 8' ' ' LYS . . . -67.46 -13.94 62.48 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.488 ' N ' ' O ' ' B' ' 8' ' ' LYS . 3.9 tp-100 -108.47 -43.33 4.34 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.44 -21.74 66.69 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 177.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.69 ' OG1' ' O ' ' B' ' 10' ' ' ILE . 0.2 OUTLIER -121.96 -80.82 0.63 Allowed 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.97 179.786 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . 0.505 ' O ' ' C ' ' B' ' 16' ' ' LEU . . . 70.43 -18.8 0.71 Allowed Glycine 0 N--CA 1.498 2.778 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' LEU . . . . . 0.716 ' N ' HD11 ' B' ' 16' ' ' LEU . 0.0 OUTLIER -27.83 -64.65 0.08 Allowed 'General case' 0 N--CA 1.515 2.805 0 CA-C-O 122.078 0.942 . . . . 0.0 111.068 -179.722 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' THR . . . . . 0.535 HG21 ' O ' ' B' ' 17' ' ' THR . 0.4 OUTLIER -130.11 -0.56 4.65 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.597 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . 0.641 ' O ' ' C ' ' B' ' 19' ' ' VAL . 2.4 mt-30 58.09 29.55 17.99 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 -176.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.653 ' HB ' ' HB ' ' A' ' 19' ' ' VAL . 0.4 OUTLIER 5.33 -99.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.616 -179.221 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.997 ' O ' ' N ' ' B' ' 22' ' ' SER . 1.7 p -136.07 23.17 3.28 Favored 'General case' 0 C--N 1.273 -2.721 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 177.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.681 ' O ' HG12 ' B' ' 7' ' ' ILE . 35.1 m -5.0 -42.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-O 122.406 1.098 . . . . 0.0 111.037 -177.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.997 ' N ' ' O ' ' B' ' 20' ' ' SER . 14.0 p -76.74 -37.58 55.7 Favored 'General case' 0 C--N 1.28 -2.423 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.741 179.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . 0.868 ' N ' ' O ' ' B' ' 20' ' ' SER . 1.6 mtmt -88.78 -31.07 18.56 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.358 -0.839 . . . . 0.0 111.329 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' MET . . . . . 0.623 ' SD ' ' HA ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -72.09 -36.98 69.66 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.234 -1.541 . . . . 0.0 108.754 179.773 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.626 ' HA ' ' HB3' ' B' ' 28' ' ' PHE . 0.3 OUTLIER -80.06 -35.89 36.43 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 118.168 -1.413 . . . . 0.0 108.149 177.742 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . 0.456 ' HA ' ' HE2' ' B' ' 3' ' ' LYS . . . -66.07 -34.37 77.92 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 176.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' SER . . . . . 0.572 ' O ' ' N ' ' B' ' 31' ' ' ILE . 83.7 p -81.97 -27.38 33.24 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . 0.837 ' O ' HG13 ' B' ' 31' ' ' ILE . 0.5 OUTLIER -59.04 -50.73 72.96 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 178.26 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . 0.587 ' HG3' ' CD1' ' A' ' 47' ' ' PHE . 1.2 tt0 -65.21 -31.49 72.69 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 176.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . 1.268 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 9.3 ttmt -69.88 -22.48 63.24 Favored 'General case' 0 C--O 1.186 -2.278 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.837 HG13 ' O ' ' B' ' 28' ' ' PHE . 0.9 OUTLIER -100.76 -29.37 3.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 O-C-N 119.945 -1.722 . . . . 0.0 108.055 177.824 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.586 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.4 mm -65.3 -60.93 2.0 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 176.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' THR . . . . . 0.778 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 0.4 OUTLIER -76.56 -27.76 56.0 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 119.279 -0.968 . . . . 0.0 108.95 179.587 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 1.268 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 79.1 mm-40 -80.19 -27.37 38.9 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.101 -1.624 . . . . 0.0 110.204 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' THR . . . . . 0.565 ' CB ' ' O ' ' B' ' 31' ' ' ILE . 3.7 m -72.15 -48.76 41.14 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.656 -1.277 . . . . 0.0 108.575 178.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.814 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 4.5 t -51.1 -48.54 30.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 C-N-CA 116.867 -1.933 . . . . 0.0 106.047 177.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . 0.768 ' CA ' ' O ' ' A' ' 88' ' ' ALA . . . -70.24 5.96 1.5 Allowed 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 121.58 0.705 . . . . 0.0 111.044 177.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . 0.493 ' N ' ' O ' ' B' ' 35' ' ' THR . 0.0 OUTLIER -108.57 -35.1 6.54 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 177.438 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 121.17 32.24 1.08 Allowed Glycine 0 C--N 1.302 -1.326 0 C-N-CA 119.727 -1.225 . . . . 0.0 111.487 177.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . 0.503 ' HB2' HG21 ' B' ' 35' ' ' THR . 0.3 OUTLIER -125.26 146.63 49.45 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.798 -1.413 . . . . 0.0 110.371 179.123 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 2.8 mtmm -88.6 91.6 8.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.512 -0.743 . . . . 0.0 110.179 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 78.2 t -64.35 153.3 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.564 -0.71 . . . . 0.0 110.367 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' GLN . . . . . 0.409 ' O ' ' HA ' ' A' ' 2' ' ' ASN . 0.2 OUTLIER -165.83 164.14 18.69 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.44 -0.787 . . . . 0.0 110.043 179.821 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.555 ' HB3' ' HG2' ' A' ' 29' ' ' GLU . 15.4 mt -125.46 117.92 24.7 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.394 -0.816 . . . . 0.0 109.718 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' THR . . . . . 0.54 HG23 ' HG2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 30.34 -93.28 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.875 -0.516 . . . . 0.0 111.124 -179.812 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . 0.551 ' O ' ' HA3' ' B' ' 82' ' ' GLY . . . -144.54 24.34 2.0 Favored Glycine 0 N--CA 1.483 1.775 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . 0.643 ' O ' ' HA ' ' B' ' 81' ' ' PRO . 8.8 p90 -120.7 -22.09 6.45 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.111 -1.229 . . . . 0.0 111.4 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . 0.527 ' HB2' ' HB2' ' B' ' 44' ' ' LEU . 0.9 OUTLIER -128.22 115.45 18.37 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.388 -1.445 . . . . 0.0 110.624 177.828 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' ASN . . . . . 0.595 ' O ' ' HA ' ' B' ' 79' ' ' VAL . 1.2 m120 -113.78 94.75 4.98 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.717 -0.614 . . . . 0.0 111.408 -178.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' ILE . . . . . 0.527 ' HA ' ' HA ' ' B' ' 79' ' ' VAL . 1.3 mp -93.45 141.48 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 O-C-N 121.246 -0.909 . . . . 0.0 109.839 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . 0.416 ' HG3' ' CB ' ' B' ' 78' ' ' SER . 0.0 OUTLIER -161.29 113.42 1.26 Allowed Pre-proline 0 N--CA 1.5 2.025 0 C-N-CA 118.769 -1.172 . . . . 0.0 111.318 179.723 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . 0.663 ' HA ' ' HA ' ' B' ' 77' ' ' VAL . 55.7 Cg_endo -83.06 141.91 10.7 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 O-C-N 123.571 1.301 . . . . 0.0 111.724 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.618 ' O ' ' N ' ' B' ' 76' ' ' GLY . 33.4 m -149.24 114.73 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.581 0.705 . . . . 0.0 110.718 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.602 ' HA ' ' HA ' ' B' ' 75' ' ' VAL . . . -57.36 134.05 55.68 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.448 -0.783 . . . . 0.0 111.46 -178.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . 0.443 ' C ' ' HG2' ' B' ' 56' ' ' GLN . 0.0 OUTLIER 170.45 81.5 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.382 -0.824 . . . . 0.0 110.206 179.596 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . 0.487 ' HG3' ' O ' ' B' ' 74' ' ' SER . 28.3 mm100 -148.98 -144.34 0.15 Allowed 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.436 -0.906 . . . . 0.0 111.004 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.55 ' CB ' ' HB ' ' B' ' 71' ' ' ILE . . . -56.4 -165.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 122.336 1.065 . . . . 0.0 112.729 -178.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' ARG . . . . . 0.673 ' O ' ' CB ' ' B' ' 59' ' ' LYS . 12.4 mpt_? -90.08 -142.33 0.16 Allowed 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.701 -178.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . 0.673 ' CB ' ' O ' ' B' ' 58' ' ' ARG . 0.3 OUTLIER 137.0 54.95 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.655 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.597 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -110.44 -100.55 2.6 Favored Glycine 0 N--CA 1.491 2.305 0 C-N-CA 120.032 -1.08 . . . . 0.0 110.964 -178.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' PHE . . . . . 0.95 ' CD1' ' O ' ' B' ' 67' ' ' GLU . 0.4 OUTLIER -173.48 111.9 0.2 Allowed 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.338 -1.095 . . . . 0.0 109.774 -178.256 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . 0.952 ' C ' ' HA ' ' B' ' 67' ' ' GLU . 5.2 m-20 -113.66 -75.34 0.02 OUTLIER Pre-proline 0 N--CA 1.511 2.595 0 O-C-N 121.103 -0.998 . . . . 0.0 112.181 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . 0.702 ' O ' ' N ' ' B' ' 67' ' ' GLU . 56.0 Cg_endo -79.69 -90.33 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 120.569 0.846 . . . . 0.0 112.131 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . 0.788 ' HB2' ' CB ' ' B' ' 68' ' ' ALA . 5.6 tp60 37.85 24.78 0.01 OUTLIER 'General case' 0 N--CA 1.518 2.962 0 O-C-N 121.182 -0.949 . . . . 0.0 112.835 -178.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.438 ' N ' ' O ' ' B' ' 63' ' ' PRO . 1.1 p 48.52 24.26 0.73 Allowed 'General case' 0 N--CA 1.505 2.295 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 -176.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . 0.762 ' O ' ' HB2' ' B' ' 67' ' ' GLU . 0.0 OUTLIER -170.77 -36.31 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 114.036 -1.438 . . . . 0.0 107.484 -177.206 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . 0.952 ' HA ' ' C ' ' B' ' 62' ' ' ASN . 12.2 mt-10 138.02 129.9 0.0 OUTLIER 'General case' 0 C--O 1.194 -1.832 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . 0.788 ' CB ' ' HB2' ' B' ' 64' ' ' GLN . . . -149.86 91.24 1.77 Allowed 'General case' 0 N--CA 1.51 2.545 0 O-C-N 120.286 -1.509 . . . . 0.0 111.055 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 22.8 mt -94.41 153.38 17.99 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.916 -1.115 . . . . 0.0 110.58 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . 0.483 ' C ' HG13 ' B' ' 71' ' ' ILE . 0.4 OUTLIER -159.55 142.06 13.74 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.551 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.629 HD13 ' HB2' ' B' ' 59' ' ' LYS 0.253 0.7 OUTLIER -164.55 -148.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.645 -0.659 . . . . 0.0 109.295 -176.57 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -107.11 81.94 1.05 Allowed Pre-proline 0 C--N 1.296 -1.751 0 O-C-N 121.371 -0.831 . . . . 0.0 111.179 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' PRO . . . . . 0.491 ' HD3' ' O ' ' B' ' 71' ' ' ILE . 54.3 Cg_endo -77.18 123.76 6.85 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.697 1.367 . . . . 0.0 110.338 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' SER . . . . . 0.487 ' O ' ' HG3' ' B' ' 56' ' ' GLN . 48.0 t -156.95 135.08 11.14 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.863 -1.148 . . . . 0.0 109.96 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . 0.602 ' HA ' ' HA ' ' B' ' 54' ' ' ALA . 1.4 p -60.09 -173.75 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.703 -1.248 . . . . 0.0 109.081 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . 0.626 ' O ' ' N ' ' B' ' 78' ' ' SER . . . -113.14 50.22 0.79 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.856 -1.698 . . . . 0.0 108.856 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.663 ' HA ' ' HA ' ' B' ' 52' ' ' PRO . 7.1 p -45.69 81.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-O 121.695 0.76 . . . . 0.0 111.534 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' SER . . . . . 0.626 ' N ' ' O ' ' B' ' 76' ' ' GLY . 0.6 OUTLIER -77.48 178.81 6.92 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 119.28 -0.968 . . . . 0.0 108.737 178.408 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' B' ' 49' ' ' ASN . 0.2 OUTLIER 179.48 172.8 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.517 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . 0.521 ' N ' ' CG2' ' B' ' 79' ' ' VAL . 0.2 OUTLIER 176.46 172.56 0.33 Allowed Pre-proline 0 N--CA 1.487 1.417 0 O-C-N 121.149 -0.97 . . . . 0.0 110.892 178.404 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' PRO . . . . . 0.643 ' HA ' ' O ' ' B' ' 47' ' ' PHE . 54.6 Cg_endo -88.95 165.78 5.83 Favored 'Trans proline' 0 C--N 1.298 -2.079 0 O-C-N 124.617 1.851 . . . . 0.0 107.475 174.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . 0.551 ' HA3' ' O ' ' B' ' 46' ' ' GLY . . . -126.79 -99.33 1.08 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 107.711 -2.156 . . . . 0.0 107.711 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . 0.911 ' O ' ' N ' ' B' ' 85' ' ' LEU . 0.4 OUTLIER -79.43 45.24 0.65 Allowed 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.121 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' SER . . . . . 1.334 ' O ' ' N ' ' B' ' 86' ' ' LYS . 0.1 OUTLIER 8.45 43.16 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 122.148 0.975 . . . . 0.0 111.164 179.165 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . 1.004 ' C ' ' O ' ' B' ' 84' ' ' SER . 0.4 OUTLIER 20.55 30.05 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 102.786 -3.042 . . . . 0.0 102.786 -172.647 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . 1.334 ' N ' ' O ' ' B' ' 84' ' ' SER 0.336 7.7 tttt -56.38 -37.17 69.73 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 103.82 -2.659 . . . . 0.0 103.82 177.08 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . 0.29 0.0 OUTLIER -70.59 -34.79 72.56 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 111.905 -2.407 . . . . 0.0 105.796 175.377 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.637 ' N ' ' O ' ' B' ' 85' ' ' LEU . . . -75.3 -27.77 59.45 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 118.586 -1.246 . . . . 0.0 107.859 178.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . 0.704 ' N ' ' O ' ' B' ' 85' ' ' LEU . . . -62.42 -48.33 80.16 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -57.24 -28.98 63.41 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 176.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -69.68 -33.94 72.07 Favored Glycine 0 N--CA 1.489 2.184 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.189 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . 0.847 ' HB3' ' HA ' ' A' ' 37' ' ' ALA . 0.7 OUTLIER -85.75 16.95 3.62 Favored 'General case' 0 N--CA 1.506 2.335 0 CA-C-N 119.689 1.745 . . . . 0.0 111.556 -179.155 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . 0.411 ' HB2' ' O ' ' B' ' 92' ' ' LEU . 8.7 mmtp 54.92 40.22 31.9 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -178.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . 0.507 ' CE1' ' HA ' ' A' ' 74' ' ' SER . 2.6 p90 -41.77 -30.7 0.26 Allowed 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.651 -178.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -58.22 -42.51 86.44 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.246 -0.909 . . . . 0.0 108.871 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.72 -33.68 76.19 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 177.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -76.52 -22.73 54.03 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 98' ' ' ALA . . . . . 0.406 ' N ' ' O ' ' B' ' 94' ' ' TYR . . . -68.74 -41.18 79.33 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.554 -0.716 . . . . 0.0 110.036 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 4.6 mtmp? . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.224 179.977 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.458 ' HG2' ' HB3' ' A' ' 5' ' ' GLU . 4.0 mtp . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 120.932 0.396 . . . . 0.0 110.134 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.462 ' O ' ' HB2' ' A' ' 6' ' ' LEU . 4.0 t30 -176.08 -174.79 0.66 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.18 -0.95 . . . . 0.0 111.052 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.542 ' O ' ' CG2' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -51.84 -15.3 0.48 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.453 -0.779 . . . . 0.0 110.275 179.619 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.63 ' O ' HG13 ' A' ' 7' ' ' ILE . 38.7 m -106.89 -58.48 1.93 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 122.004 0.907 . . . . 0.0 109.161 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.458 ' HB3' ' HG2' ' A' ' 1' ' ' MET . 2.6 mt-10 -50.46 -45.05 55.81 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.056 -1.028 . . . . 0.0 108.571 179.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.462 ' HB2' ' O ' ' A' ' 2' ' ' ASN . 2.4 mt -58.26 -36.31 73.06 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.364 -0.934 . . . . 0.0 109.954 178.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.63 HG13 ' O ' ' A' ' 4' ' ' THR . 0.9 OUTLIER -55.8 -42.81 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.295 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.575 ' N ' HG13 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -64.64 -33.76 76.69 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 177.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.23 -38.11 70.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.473 -0.767 . . . . 0.0 109.019 178.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.722 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.4 mp -91.52 -32.41 5.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 178.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.58 ' HB3' ' O ' ' A' ' 7' ' ' ILE . . . -65.3 -14.11 60.0 Favored 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 118.689 -1.205 . . . . 0.0 108.227 178.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.402 ' N ' ' O ' ' A' ' 8' ' ' LYS . 6.4 tp-100 -110.75 -46.07 3.41 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -66.63 -27.78 67.96 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 177.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.762 ' CG2' ' HB2' ' B' ' 20' ' ' SER . 0.2 OUTLIER -111.55 -82.26 0.58 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 178.848 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.516 ' O ' ' C ' ' A' ' 16' ' ' LEU . . . 69.0 -21.35 0.37 Allowed Glycine 0 N--CA 1.498 2.831 0 O-C-N 121.004 -1.06 . . . . 0.0 110.825 178.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.68 ' N ' HD11 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -30.2 -63.77 0.13 Allowed 'General case' 0 N--CA 1.518 2.925 0 CA-C-O 122.052 0.929 . . . . 0.0 110.497 -179.57 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.501 HG21 ' CG2' ' B' ' 17' ' ' THR . 0.5 OUTLIER -129.31 -4.89 4.87 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.774 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.626 ' O ' ' C ' ' A' ' 19' ' ' VAL . 22.1 mt-30 56.41 31.78 19.41 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -177.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.671 ' HB ' ' HB ' ' B' ' 19' ' ' VAL . 1.6 p -6.46 -98.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.538 -178.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.92 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -133.48 23.28 4.03 Favored 'General case' 0 C--N 1.279 -2.493 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 177.15 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.598 ' C ' ' O ' ' A' ' 20' ' ' SER . 30.4 m -20.6 -37.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-O 122.254 1.026 . . . . 0.0 109.858 -178.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.825 ' N ' ' O ' ' A' ' 20' ' ' SER . 11.2 t -75.46 -42.76 52.41 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.931 177.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.92 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -93.8 -22.91 18.38 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.52 -0.738 . . . . 0.0 109.888 178.739 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.79 ' N ' ' OG ' ' A' ' 20' ' ' SER 0.26 2.0 tmm? -68.02 -33.01 73.79 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 179.201 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.558 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 7.3 mt -84.41 -41.55 16.56 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 176.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.435 ' HA ' ' HE2' ' A' ' 3' ' ' LYS . . . -59.19 -34.1 71.74 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 177.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.45 ' O ' HG13 ' A' ' 31' ' ' ILE . 10.2 t -80.17 -36.32 35.23 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 178.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.623 ' O ' ' CG1' ' A' ' 32' ' ' ILE . 0.2 OUTLIER -52.1 -44.87 64.63 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.694 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.626 ' HG3' ' CD2' ' B' ' 47' ' ' PHE . 0.9 OUTLIER -69.53 -36.72 76.66 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.247 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 1.137 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 16.5 ttpt -62.53 -23.82 67.17 Favored 'General case' 0 C--O 1.191 -1.981 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.576 HG13 ' O ' ' A' ' 28' ' ' PHE . 0.5 OUTLIER -104.15 -27.96 3.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 O-C-N 120.499 -1.376 . . . . 0.0 109.379 178.225 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.623 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.3 mm -73.81 -57.55 6.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 177.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.56 ' HA ' HD21 ' B' ' 85' ' ' LEU . 0.6 OUTLIER -68.35 -36.33 79.08 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.568 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 1.137 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 68.2 mm-40 -75.55 -37.79 59.75 Favored 'General case' 0 N--CA 1.483 1.185 0 O-C-N 121.17 -0.956 . . . . 0.0 111.702 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.485 ' O ' ' N ' ' A' ' 38' ' ' LYS . 14.0 m -62.18 -53.97 47.63 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 120.281 -1.512 . . . . 0.0 109.499 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.735 HG12 ' HB3' ' A' ' 52' ' ' PRO . 2.1 t -54.76 -32.89 26.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 177.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.649 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -90.38 10.5 24.79 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.333 177.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.667 ' HB2' ' O ' ' A' ' 34' ' ' GLU . 1.9 ttmt -114.23 -35.35 5.03 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 178.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 127.95 38.58 0.38 Allowed Glycine 0 C--N 1.301 -1.404 0 C-N-CA 119.732 -1.223 . . . . 0.0 110.835 178.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.415 ' CB ' ' CG2' ' A' ' 35' ' ' THR . 0.3 OUTLIER -145.92 135.8 23.49 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.083 -1.245 . . . . 0.0 110.281 179.431 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 51' ' ' LYS . 0.1 OUTLIER -75.02 76.49 2.21 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.391 -0.818 . . . . 0.0 110.459 -179.634 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.0 p -60.56 136.46 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.412 -0.805 . . . . 0.0 110.056 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' B' ' 1' ' ' MET . 6.9 pt20 -144.75 175.15 10.39 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.239 -0.913 . . . . 0.0 110.737 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.662 ' HB2' ' HB2' ' A' ' 48' ' ' LEU . 27.6 mt -125.26 115.01 19.7 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.665 -0.647 . . . . 0.0 109.276 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.56 HG21 ' HG3' ' B' ' 29' ' ' GLU . 0.0 OUTLIER 32.26 -93.88 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.859 -0.526 . . . . 0.0 111.552 -179.767 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -145.05 21.87 1.94 Allowed Glycine 0 N--CA 1.489 2.188 0 C-N-CA 119.504 -1.331 . . . . 0.0 111.013 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.651 ' CD2' ' HG3' ' B' ' 29' ' ' GLU . 8.5 p90 -119.76 -22.15 6.96 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.768 -1.431 . . . . 0.0 111.216 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.662 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 6.8 mt -128.72 108.47 10.51 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.453 -1.404 . . . . 0.0 110.653 178.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.574 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 1.1 t-20 -109.68 91.13 3.52 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.673 -0.642 . . . . 0.0 111.095 -179.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.518 ' CD1' HG22 ' A' ' 79' ' ' VAL . 11.1 mm -93.52 138.11 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.29 -0.881 . . . . 0.0 110.138 179.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 21.0 ptmt -160.93 128.39 2.7 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 120.804 -1.185 . . . . 0.0 111.295 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.735 ' HB3' HG12 ' A' ' 36' ' ' VAL . 55.7 Cg_endo -78.69 141.91 17.66 Favored 'Trans proline' 0 C--N 1.314 -1.274 0 O-C-N 123.513 1.27 . . . . 0.0 110.631 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.518 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 34.5 m -145.66 113.04 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 C-N-CA 119.465 -0.894 . . . . 0.0 111.928 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.783 ' HA ' ' CA ' ' A' ' 75' ' ' VAL . . . -59.54 125.34 23.26 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 119.259 -0.976 . . . . 0.0 109.379 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.917 ' H ' ' N ' ' A' ' 75' ' ' VAL . 31.5 ttt-85 -179.03 84.1 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 121.593 0.711 . . . . 0.0 110.272 -178.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.81 ' C ' ' O ' ' A' ' 73' ' ' PRO . 27.1 mt-30 -159.61 28.88 0.19 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.599 ' HA ' ' HD2' ' A' ' 73' ' ' PRO . . . -100.3 146.56 26.79 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 -174.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.659 ' HB2' HG12 ' A' ' 71' ' ' ILE 0.28 2.7 ttt85 -84.5 17.67 2.58 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 113.957 -1.474 . . . . 0.0 110.593 178.12 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.405 ' N ' HD12 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -51.52 95.69 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.199 -0.938 . . . . 0.0 110.076 -179.153 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 58' ' ' ARG . . . -118.96 -104.84 2.16 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.646 ' CE1' ' CB ' ' A' ' 64' ' ' GLN . 34.4 p90 -175.43 -169.09 0.35 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.32 -1.106 . . . . 0.0 111.348 -179.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.854 ' H ' ' HD2' ' A' ' 63' ' ' PRO . 0.0 OUTLIER -139.19 -45.26 0.02 OUTLIER Pre-proline 0 N--CA 1.486 1.369 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.214 178.235 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.854 ' HD2' ' H ' ' A' ' 62' ' ' ASN . 39.5 Cg_endo -67.56 65.9 0.79 Allowed 'Trans proline' 0 N--CA 1.487 1.142 0 O-C-N 122.692 0.838 . . . . 0.0 111.258 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.646 ' CB ' ' CE1' ' A' ' 61' ' ' PHE . 0.3 OUTLIER -173.73 -104.17 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 179.041 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.539 ' O ' ' HB2' ' A' ' 66' ' ' GLN . 31.1 p -74.24 -6.93 50.79 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.236 -1.54 . . . . 0.0 108.925 177.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.539 ' HB2' ' O ' ' A' ' 65' ' ' THR . 42.7 mm-40 73.05 94.26 0.08 Allowed 'General case' 0 N--CA 1.503 2.22 0 CA-C-O 121.534 0.683 . . . . 0.0 112.141 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.59 ' H ' ' HA ' ' A' ' 62' ' ' ASN . 5.2 tt0 172.96 60.85 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.635 ' HA ' ' O ' ' A' ' 61' ' ' PHE . . . -61.24 143.5 55.51 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.26 -0.9 . . . . 0.0 110.441 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.575 ' HG ' ' C ' ' A' ' 68' ' ' ALA . 0.4 OUTLIER -137.59 157.99 45.34 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.324 -178.349 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -153.67 19.13 0.53 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.45 -0.781 . . . . 0.0 110.069 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.659 HG12 ' HB2' ' A' ' 58' ' ' ARG . 0.1 OUTLIER -47.88 175.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.882 -0.511 . . . . 0.0 110.85 179.043 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.776 ' N ' ' HD3' ' A' ' 73' ' ' PRO . . . -137.18 44.58 0.97 Allowed Pre-proline 0 N--CA 1.497 1.918 0 O-C-N 120.81 -1.182 . . . . 0.0 112.425 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.81 ' O ' ' C ' ' A' ' 56' ' ' GLN . 42.1 Cg_endo -94.76 114.3 0.18 Allowed 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 121.229 1.286 . . . . 0.0 111.532 178.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.796 ' O ' ' HB3' ' B' ' 96' ' ' ASP . 0.4 OUTLIER -165.9 128.87 2.06 Favored 'General case' 0 CA--C 1.565 1.526 0 O-C-N 120.807 -1.183 . . . . 0.0 113.197 178.32 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.957 ' HB ' ' CD2' ' B' ' 94' ' ' TYR . 1.1 t 164.36 127.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.796 0 CA-C-O 122.236 1.017 . . . . 0.0 108.761 175.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 53' ' ' VAL . . . -138.28 99.22 0.27 Allowed Glycine 0 C--N 1.289 -2.068 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -178.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.597 HG23 ' CD2' ' B' ' 85' ' ' LEU . 1.5 p -59.93 82.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.838 -0.801 . . . . 0.0 109.368 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.486 ' N ' ' O ' ' A' ' 76' ' ' GLY . 0.1 OUTLIER -62.67 177.1 0.57 Allowed 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.554 -0.858 . . . . 0.0 110.535 -179.462 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.574 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 0.2 OUTLIER 177.42 174.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.761 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.532 ' N ' ' CG2' ' A' ' 79' ' ' VAL . 0.5 OUTLIER 177.71 170.26 0.45 Allowed Pre-proline 0 N--CA 1.485 1.323 0 O-C-N 120.822 -1.174 . . . . 0.0 110.997 177.227 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.423 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 56.1 Cg_endo -103.83 136.06 0.1 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 123.359 2.706 . . . . 0.0 109.223 176.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.537 ' HA3' ' HA ' ' A' ' 47' ' ' PHE . . . -97.46 161.25 21.33 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 108.295 -1.922 . . . . 0.0 108.295 178.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.71 -23.95 54.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.015 -1.285 . . . . 0.0 110.584 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.5 t -51.82 -31.18 26.39 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.117 -0.989 . . . . 0.0 108.654 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.502 ' CD2' ' CG1' ' B' ' 36' ' ' VAL . 0.5 OUTLIER -82.96 -31.22 27.72 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.597 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.414 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 5.0 mttt -81.27 -31.8 33.53 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.581 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.403 ' O ' ' HG3' ' A' ' 90' ' ' GLU . 1.1 tmtt? -69.63 -40.2 76.68 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 178.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.653 ' O ' ' HB2' ' B' ' 37' ' ' ALA . . . -62.0 -38.4 88.49 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 176.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.459 ' HA ' HD23 ' A' ' 92' ' ' LEU . . . -53.57 -43.04 68.17 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 120.0 -0.68 . . . . 0.0 109.5 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.509 ' HG3' ' N ' ' A' ' 91' ' ' GLY . 0.3 OUTLIER -54.16 -30.96 51.25 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 177.517 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.509 ' N ' ' HG3' ' A' ' 90' ' ' GLU . . . -64.1 -43.3 97.44 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 178.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.536 ' O ' ' CD1' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -71.59 8.91 0.96 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.745 -1.444 . . . . 0.0 110.831 179.804 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 17.2 mmtm 65.69 50.34 1.61 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 -177.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.584 ' CD1' ' N ' ' B' ' 75' ' ' VAL . 0.0 OUTLIER -34.64 -38.57 0.08 Allowed 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.063 -179.005 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.421 ' HG2' ' CE2' ' A' ' 94' ' ' TYR . 24.8 mt-10 -65.93 -46.42 78.27 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.333 -0.855 . . . . 0.0 109.828 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.433 ' N ' ' O ' ' A' ' 93' ' ' LYS . 1.2 m-20 -52.2 -35.31 48.79 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.49 -0.756 . . . . 0.0 108.962 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -76.68 -28.89 56.11 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.98 -37.42 74.17 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.696 -0.628 . . . . 0.0 109.99 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.102 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.453 ' O ' ' HG2' ' A' ' 43' ' ' GLN . 5.3 mtp . . . . . 0 N--CA 1.493 1.687 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 22.6 p30 -176.73 -172.7 0.45 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.249 -0.907 . . . . 0.0 111.099 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.505 ' O ' HG13 ' B' ' 7' ' ' ILE . 0.0 OUTLIER -51.5 -11.15 0.12 Allowed 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.381 -0.825 . . . . 0.0 111.244 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.608 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 45.7 m -114.48 -43.28 3.19 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.812 -1.18 . . . . 0.0 108.995 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.435 ' CB ' ' HA ' ' B' ' 1' ' ' MET . 0.0 OUTLIER -64.19 -50.41 68.22 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.708 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.455 ' HA ' ' HB3' ' B' ' 9' ' ' ALA . 0.7 OUTLIER -62.08 -28.93 69.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.375 -0.828 . . . . 0.0 108.898 178.176 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' ILE . . . . . 0.658 HG12 ' O ' ' B' ' 21' ' ' VAL . 0.5 OUTLIER -55.52 -59.32 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.144 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . 0.469 ' O ' ' HB3' ' B' ' 12' ' ' GLN . 0.1 OUTLIER -57.86 -30.3 65.7 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.375 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . 0.455 ' HB3' ' HA ' ' B' ' 6' ' ' LEU . . . -58.98 -36.57 75.1 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.466 -0.894 . . . . 0.0 108.97 178.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . 0.914 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.1 mp -89.03 -35.16 7.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 177.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.449 ' CB ' ' HA ' ' B' ' 8' ' ' LYS . . . -65.57 -9.46 26.78 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 118.839 -1.144 . . . . 0.0 108.42 177.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.469 ' HB3' ' O ' ' B' ' 8' ' ' LYS . 0.4 OUTLIER -118.46 -43.15 2.72 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.547 -0.721 . . . . 0.0 109.448 178.846 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' B' ' 9' ' ' ALA . 1.7 m-20 -66.1 -38.32 87.93 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 177.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.914 ' OG1' ' O ' ' B' ' 10' ' ' ILE 0.251 0.1 OUTLIER -89.13 -77.95 0.36 Allowed 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 177.549 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.84 6.52 78.49 Favored Glycine 0 N--CA 1.5 2.936 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 177.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' LEU . . . . . 0.825 HD12 ' HB3' ' A' ' 20' ' ' SER . 5.2 mp -55.48 -71.4 0.09 Allowed 'General case' 0 C--N 1.294 -1.817 0 O-C-N 121.63 -0.924 . . . . 0.0 110.569 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' THR . . . . . 0.604 HG21 ' O ' ' B' ' 17' ' ' THR . 0.5 OUTLIER -139.57 8.37 2.39 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.581 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . 0.613 ' O ' ' C ' ' B' ' 19' ' ' VAL . 11.2 mt-30 58.69 23.86 11.53 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 -175.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.671 ' HB ' ' HB ' ' A' ' 19' ' ' VAL . 0.2 OUTLIER 5.49 -94.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.125 -179.194 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.978 ' O ' ' N ' ' B' ' 23' ' ' LYS . 0.4 OUTLIER -135.72 23.19 3.37 Favored 'General case' 0 C--N 1.275 -2.654 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 178.153 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.658 ' O ' HG12 ' B' ' 7' ' ' ILE . 18.3 m -15.0 -40.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-O 122.245 1.022 . . . . 0.0 109.885 -177.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.914 ' N ' ' O ' ' B' ' 20' ' ' SER . 7.7 t -74.93 -42.21 58.16 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.173 177.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . 0.978 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.2 OUTLIER -92.89 -25.9 17.86 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.661 -0.649 . . . . 0.0 109.827 178.599 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' MET . . . . . 0.561 ' HE2' ' HA ' ' B' ' 21' ' ' VAL . 2.2 tmm? -64.12 -41.06 97.39 Favored 'General case' 0 C--N 1.316 -0.85 0 O-C-N 120.779 -1.201 . . . . 0.0 108.321 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.666 ' HA ' ' HB3' ' B' ' 28' ' ' PHE . 2.5 mt -81.28 -42.63 20.34 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 118.952 -1.099 . . . . 0.0 108.547 177.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . 0.445 ' HB2' ' HA ' ' B' ' 23' ' ' LYS . . . -58.01 -34.02 69.58 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' SER . . . . . 0.53 ' O ' HG13 ' B' ' 31' ' ' ILE . 73.8 m -82.02 -37.12 27.0 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 177.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . 0.666 ' HB3' ' HA ' ' B' ' 25' ' ' LEU . 0.8 OUTLIER -52.81 -48.3 67.03 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.318 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . 0.651 ' HG3' ' CD2' ' A' ' 47' ' ' PHE . 1.7 tt0 -67.16 -34.93 78.59 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . 1.245 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 13.8 ttpt -65.41 -20.84 66.55 Favored 'General case' 0 C--O 1.193 -1.92 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.584 HG13 ' O ' ' B' ' 28' ' ' PHE . 0.7 OUTLIER -106.47 -25.33 3.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 O-C-N 120.057 -1.652 . . . . 0.0 108.968 177.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.59 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.2 mm -76.53 -58.96 3.61 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 176.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' THR . . . . . 0.487 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 0.6 OUTLIER -70.35 -34.19 72.35 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.257 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 1.245 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 77.9 mm-40 -78.83 -37.29 40.91 Favored 'General case' 0 C--O 1.208 -1.093 0 O-C-N 121.126 -0.984 . . . . 0.0 111.614 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' THR . . . . . 0.512 ' CB ' ' O ' ' B' ' 31' ' ' ILE . 26.1 m -61.55 -47.15 86.86 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 120.073 -1.642 . . . . 0.0 108.459 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.502 ' CG1' ' CD2' ' A' ' 85' ' ' LEU . 1.7 t -52.66 -44.46 46.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 177.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . 0.653 ' HB2' ' O ' ' A' ' 88' ' ' ALA . . . -84.85 -1.28 56.29 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.815 178.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . 0.657 ' HB2' ' O ' ' B' ' 34' ' ' GLU . 3.0 ttmt -94.16 -29.84 14.93 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 177.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.1 31.88 0.56 Allowed Glycine 0 C--N 1.303 -1.254 0 C-N-CA 119.665 -1.255 . . . . 0.0 111.395 177.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . 0.464 ' CB ' ' CG2' ' B' ' 35' ' ' THR . 0.2 OUTLIER -146.84 146.38 30.19 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.758 -1.436 . . . . 0.0 110.934 179.453 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.39 96.75 9.72 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.609 0.719 . . . . 0.0 109.341 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 74.5 t -58.35 129.95 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.567 -0.708 . . . . 0.0 110.124 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.69 109.05 13.23 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.517 -0.74 . . . . 0.0 109.955 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.577 HD12 ' HB3' ' B' ' 48' ' ' LEU . 23.4 mt -77.06 106.32 8.69 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.214 -0.929 . . . . 0.0 109.93 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' THR . . . . . 0.62 HG23 ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 32.42 -93.25 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.246 0 O-C-N 122.018 -0.426 . . . . 0.0 111.425 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -148.28 29.39 1.35 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . 0.629 ' CE1' ' HG ' ' B' ' 48' ' ' LEU . 3.2 p90 -130.18 -24.66 2.57 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.075 -1.25 . . . . 0.0 111.152 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . 0.629 ' HG ' ' CE1' ' B' ' 47' ' ' PHE . 6.5 mt -134.49 94.09 3.15 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.727 -1.233 . . . . 0.0 110.196 178.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -98.03 72.43 2.19 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.386 -0.821 . . . . 0.0 111.365 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' ILE . . . . . 0.418 HD12 HG23 ' B' ' 79' ' ' VAL . 2.8 mm -61.06 125.28 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.146 -0.971 . . . . 0.0 108.752 178.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' B' ' 51' ' ' LYS . 2.2 ptmt -145.5 113.68 4.74 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 120.821 -1.175 . . . . 0.0 110.489 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . 0.545 ' HA ' ' HA ' ' B' ' 77' ' ' VAL . 55.8 Cg_endo -79.87 138.37 13.14 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.742 1.39 . . . . 0.0 110.759 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.598 ' CG2' ' HA3' ' B' ' 76' ' ' GLY . 17.0 m -122.08 -156.75 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.48 ' HA ' ' HA ' ' B' ' 75' ' ' VAL . . . -151.48 141.23 21.84 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 121.01 -1.056 . . . . 0.0 111.964 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.73 141.07 0.1 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . 0.671 ' O ' ' CB ' ' B' ' 57' ' ' ALA . 18.3 mt-30 -80.38 18.12 0.96 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.845 -1.159 . . . . 0.0 110.961 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.671 ' CB ' ' O ' ' B' ' 56' ' ' GLN . . . 148.95 175.12 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.198 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' ARG . . . . . 0.601 ' HB3' ' CG1' ' B' ' 71' ' ' ILE . 0.2 OUTLIER -161.78 159.99 27.76 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.114 -0.991 . . . . 0.0 109.788 -179.085 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . 0.46 ' N ' ' HG3' ' B' ' 58' ' ' ARG . 1.3 ttmm -175.65 117.83 0.15 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.227 -0.921 . . . . 0.0 110.514 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.1 53.91 3.34 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' PHE . . . . . 0.791 ' O ' ' CB ' ' B' ' 62' ' ' ASN . 18.0 t80 -83.49 171.72 13.12 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.277 -1.131 . . . . 0.0 110.924 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . 0.791 ' CB ' ' O ' ' B' ' 61' ' ' PHE . 0.7 OUTLIER 143.07 -36.91 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.07 0 O-C-N 121.597 -0.69 . . . . 0.0 111.235 179.313 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . 0.68 ' HD2' ' N ' ' B' ' 62' ' ' ASN . 40.2 Cg_endo -68.61 -4.92 14.07 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 N-CA-C 109.387 -1.043 . . . . 0.0 109.387 178.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . 0.584 ' HB2' ' CE2' ' B' ' 61' ' ' PHE . 1.3 mm-40 -105.56 -42.69 5.14 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.455 -0.778 . . . . 0.0 110.28 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.437 ' HB ' ' CZ ' ' B' ' 61' ' ' PHE . 88.2 m -147.86 18.1 1.13 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.453 -0.78 . . . . 0.0 110.195 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . 0.554 ' O ' ' CB ' ' B' ' 67' ' ' GLU . 1.7 mp0 54.57 95.47 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.364 -0.835 . . . . 0.0 111.816 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . 0.554 ' CB ' ' O ' ' B' ' 66' ' ' GLN . 1.8 pt-20 151.79 74.92 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . 0.741 ' HA ' ' CA ' ' B' ' 61' ' ' PHE . . . -48.1 143.79 4.18 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.248 -0.907 . . . . 0.0 111.737 -178.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.694 ' HG ' ' HB3' ' B' ' 61' ' ' PHE . 0.2 OUTLIER -135.05 -156.15 0.7 Allowed 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.131 -177.594 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . 0.414 ' HA ' ' HG2' ' B' ' 58' ' ' ARG . 0.0 OUTLIER -175.77 59.36 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.283 -0.886 . . . . 0.0 110.369 -179.739 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.601 ' CG1' ' HB3' ' B' ' 58' ' ' ARG . 1.0 OUTLIER -66.09 -156.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.213 -0.929 . . . . 0.0 110.26 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . 0.627 ' CB ' ' HD2' ' B' ' 73' ' ' PRO . . . -134.41 -174.78 0.42 Allowed Pre-proline 0 C--N 1.301 -1.513 0 O-C-N 121.54 -0.725 . . . . 0.0 109.684 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' PRO . . . . . 0.627 ' HD2' ' CB ' ' B' ' 72' ' ' ALA . 38.0 Cg_endo -65.77 86.28 0.23 Allowed 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 123.638 1.336 . . . . 0.0 110.276 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' SER . . . . . 0.509 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 5.3 p -179.08 165.76 1.52 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.733 -0.605 . . . . 0.0 109.696 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . 0.584 ' N ' ' CD1' ' A' ' 94' ' ' TYR . 0.9 OUTLIER -53.86 167.47 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.186 -0.946 . . . . 0.0 108.558 179.63 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . 0.598 ' HA3' ' CG2' ' B' ' 53' ' ' VAL . . . -117.59 90.25 0.5 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.545 ' HA ' ' HA ' ' B' ' 52' ' ' PRO . 65.2 t -66.35 78.79 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 O-C-N 121.628 -0.925 . . . . 0.0 110.027 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' SER . . . . . 0.464 ' O ' ' HB ' ' B' ' 79' ' ' VAL . 0.4 OUTLIER -75.73 174.37 9.9 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 118.75 -1.18 . . . . 0.0 110.368 -179.831 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . 0.464 ' HB ' ' O ' ' B' ' 78' ' ' SER . 7.2 p 175.09 177.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . 0.426 ' HB3' ' O ' ' B' ' 79' ' ' VAL . 0.3 OUTLIER -177.5 172.5 0.77 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 120.743 -1.223 . . . . 0.0 110.933 177.207 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' PRO . . . . . 0.411 ' HB3' HG22 ' A' ' 77' ' ' VAL . 56.7 Cg_endo -96.44 100.33 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.559 2.173 . . . . 0.0 110.352 178.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' B' ' 46' ' ' GLY . . . -61.81 172.93 7.95 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 108.623 -1.791 . . . . 0.0 108.623 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -68.1 -26.45 65.82 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.978 -1.307 . . . . 0.0 110.558 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -50.14 -33.83 20.26 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.21 -0.931 . . . . 0.0 108.658 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . 0.597 ' CD2' HG23 ' A' ' 77' ' ' VAL . 0.5 OUTLIER -82.57 -31.78 28.83 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 178.522 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -76.15 -39.24 55.43 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.586 -0.696 . . . . 0.0 109.695 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 31.7 tttt -65.61 -39.95 92.08 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 178.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.608 ' O ' ' HB1' ' A' ' 37' ' ' ALA . . . -64.06 -35.45 80.79 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 176.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . 0.436 ' HA ' ' HA ' ' A' ' 37' ' ' ALA . . . -53.65 -41.87 67.22 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.467 ' HA ' ' HB2' ' B' ' 94' ' ' TYR . 0.9 OUTLIER -55.19 -33.39 62.99 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 176.868 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . 0.475 ' C ' ' H ' ' B' ' 93' ' ' LYS . . . -70.06 -25.51 75.51 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 178.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . 0.649 ' HB3' ' HA ' ' A' ' 37' ' ' ALA . 0.4 OUTLIER -73.76 20.18 0.1 Allowed 'General case' 0 N--CA 1.502 2.157 0 O-C-N 120.671 -1.488 . . . . 0.0 110.6 179.788 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . 0.731 ' O ' ' C ' ' B' ' 94' ' ' TYR . 0.0 OUTLIER 72.0 29.93 2.29 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 -177.437 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . 0.957 ' CD2' ' HB ' ' A' ' 75' ' ' VAL . 15.0 t80 -22.2 -66.5 0.03 OUTLIER 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . 0.964 ' O ' ' N ' ' B' ' 98' ' ' ALA . 8.2 mt-10 4.85 36.47 0.0 OUTLIER 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 101.563 -3.495 . . . . 0.0 101.563 177.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 96' ' ' ASP . . . . . 1.196 ' O ' ' N ' ' B' ' 98' ' ' ALA . 0.0 OUTLIER 17.87 40.61 0.0 OUTLIER 'General case' 0 CA--C 1.476 -1.881 0 CA-C-N 112.689 -2.051 . . . . 0.0 107.531 -173.741 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 97' ' ' PHE . . . . . 0.973 ' C ' ' O ' ' B' ' 96' ' ' ASP . 42.2 p90 25.66 27.91 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.793 1 N-CA-C 99.96 -4.089 . . . . 0.0 99.96 -167.871 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 98' ' ' ALA . . . . . 1.196 ' N ' ' O ' ' B' ' 96' ' ' ASP 0.297 . . -52.28 -30.11 26.43 Favored 'General case' 0 C--O 1.215 -0.728 0 CA-C-N 108.855 -3.793 . . . . 0.0 108.482 179.059 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.096 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.495 ' HG2' ' HB3' ' A' ' 5' ' ' GLU . 6.5 mtp . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 120.89 0.376 . . . . 0.0 110.109 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.488 ' O ' ' HB2' ' A' ' 6' ' ' LEU . 26.5 p30 -177.85 -173.02 0.37 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.219 -0.926 . . . . 0.0 110.995 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.55 ' HE2' ' HA ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -48.57 -15.36 0.08 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.533 -0.729 . . . . 0.0 110.923 -179.724 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.624 ' O ' HG13 ' A' ' 7' ' ' ILE . 60.7 m -107.07 -60.47 1.67 Allowed 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 122.059 0.933 . . . . 0.0 109.461 179.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.495 ' HB3' ' HG2' ' A' ' 1' ' ' MET . 8.9 mt-10 -50.57 -44.21 56.67 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.014 -1.054 . . . . 0.0 108.469 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' A' ' 2' ' ' ASN . 4.7 mt -56.64 -34.37 67.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.365 -0.834 . . . . 0.0 109.955 178.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.624 HG13 ' O ' ' A' ' 4' ' ' THR . 0.9 OUTLIER -60.12 -41.52 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 179.301 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.745 ' HA ' ' HB2' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -70.63 -29.92 66.43 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 177.571 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.48 -37.52 83.95 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.517 -0.74 . . . . 0.0 109.159 178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.686 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.1 mp -93.64 -30.04 4.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 178.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.745 ' HB2' ' HA ' ' A' ' 8' ' ' LYS . . . -62.69 -13.88 37.43 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 118.473 -1.291 . . . . 0.0 108.335 178.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -116.21 -46.56 2.79 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 121.631 -0.668 . . . . 0.0 109.865 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.17 -29.97 71.05 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 177.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.74 ' CG2' ' HB2' ' B' ' 20' ' ' SER 0.271 0.2 OUTLIER -105.09 -74.43 0.65 Allowed 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 179.016 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 57.48 11.51 7.41 Favored Glycine 0 N--CA 1.497 2.747 0 O-C-N 121.402 -0.811 . . . . 0.0 111.811 177.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.619 HD13 HG23 ' A' ' 14' ' ' THR . 2.4 mp -54.37 -62.3 1.74 Allowed 'General case' 0 N--CA 1.505 2.296 0 O-C-N 121.011 -1.288 . . . . 0.0 109.334 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.484 ' O ' HG21 ' A' ' 17' ' ' THR . 0.6 OUTLIER -135.89 4.61 3.03 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.384 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.597 ' O ' ' C ' ' A' ' 19' ' ' VAL . 24.5 mt-30 56.97 28.89 15.43 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 -176.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.68 ' HB ' ' HB ' ' B' ' 19' ' ' VAL . 1.5 p -10.7 -97.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.979 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.921 ' O ' ' N ' ' A' ' 22' ' ' SER . 0.3 OUTLIER -133.55 24.76 4.07 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 177.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.642 ' HA ' ' SD ' ' A' ' 24' ' ' MET . 32.5 m -16.01 -38.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 CA-C-O 122.551 1.167 . . . . 0.0 110.117 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.921 ' N ' ' O ' ' A' ' 20' ' ' SER . 98.0 p -79.22 -38.08 36.56 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.392 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.914 ' N ' ' O ' ' A' ' 20' ' ' SER . 14.1 ttpt -92.08 -25.24 18.85 Favored 'General case' 0 C--N 1.308 -1.225 0 O-C-N 121.226 -0.921 . . . . 0.0 110.897 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.642 ' SD ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -74.91 -35.67 62.2 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 117.399 -1.72 . . . . 0.0 107.418 178.541 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.593 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 8.2 mt -77.48 -37.87 50.4 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 118.68 -1.208 . . . . 0.0 108.494 177.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.55 ' HA ' ' HE2' ' A' ' 3' ' ' LYS . . . -64.48 -35.53 81.23 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 177.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.486 ' O ' HG13 ' A' ' 31' ' ' ILE . 82.7 p -80.93 -28.82 35.62 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.624 ' O ' ' CG1' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -54.78 -41.41 70.51 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.686 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.624 ' HG3' ' CD1' ' B' ' 47' ' ' PHE . 0.7 OUTLIER -72.39 -36.44 68.69 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 176.201 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 1.111 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 22.9 ttpt -60.71 -23.59 65.01 Favored 'General case' 0 C--O 1.191 -2.02 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.602 ' CG1' ' HA ' ' A' ' 28' ' ' PHE . 0.7 OUTLIER -104.17 -27.23 3.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 120.682 -1.261 . . . . 0.0 109.404 178.127 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.624 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.2 mm -70.89 -58.5 5.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 177.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.531 ' O ' ' CB ' ' B' ' 88' ' ' ALA . 0.5 OUTLIER -67.71 -42.84 81.36 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.342 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 1.111 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 34.0 mm-40 -69.09 -34.62 75.38 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.24 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.54 ' CB ' ' O ' ' A' ' 31' ' ' ILE . 1.2 m -57.88 -50.35 73.62 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.44 -1.413 . . . . 0.0 107.812 178.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.508 ' HA ' ' HG3' ' A' ' 52' ' ' PRO . 2.1 t -53.1 -40.52 38.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 C-N-CA 118.607 -1.237 . . . . 0.0 107.853 178.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.717 ' HB3' ' CB ' ' B' ' 88' ' ' ALA . . . -77.71 -9.34 58.94 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.481 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -102.1 2.19 37.19 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 177.495 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.415 ' HA2' ' HG2' ' A' ' 52' ' ' PRO . . . 66.26 50.92 47.66 Favored Glycine 0 C--N 1.302 -1.359 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.538 ' CB ' HG22 ' A' ' 35' ' ' THR . 0.2 OUTLIER -127.9 157.78 39.58 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.284 -1.127 . . . . 0.0 110.081 179.591 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.05 92.93 4.29 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.45 -0.781 . . . . 0.0 111.001 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.526 ' HA ' ' HB3' ' B' ' 1' ' ' MET . 2.3 t -87.4 92.17 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.557 -0.714 . . . . 0.0 109.303 179.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -89.19 148.37 23.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.137 -0.977 . . . . 0.0 110.617 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.63 ' HB2' ' HB2' ' A' ' 48' ' ' LEU . 19.2 mt -118.45 117.31 28.68 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.543 -0.723 . . . . 0.0 109.725 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.501 ' C ' ' O ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER 29.91 -88.59 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.429 0 O-C-N 121.82 -0.55 . . . . 0.0 111.137 179.506 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -152.38 21.28 0.84 Allowed Glycine 0 N--CA 1.486 2.009 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.572 ' CE2' ' HG2' ' B' ' 29' ' ' GLU . 8.8 p90 -118.54 -23.54 7.1 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.916 -1.343 . . . . 0.0 111.25 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.63 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -129.27 94.11 3.72 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.8 -1.188 . . . . 0.0 110.792 178.543 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.646 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 0.6 OUTLIER -96.02 83.37 3.64 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.64 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.587 ' CB ' ' HB ' ' A' ' 79' ' ' VAL . 0.7 OUTLIER -94.26 144.72 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.022 -1.048 . . . . 0.0 113.093 -177.629 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.571 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 9.7 ptmt -177.01 112.43 0.24 Allowed Pre-proline 0 N--CA 1.494 1.746 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 177.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.531 ' CB ' HG23 ' A' ' 75' ' ' VAL . 55.5 Cg_endo -69.58 132.06 22.8 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 O-C-N 123.313 1.165 . . . . 0.0 113.379 -175.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.562 ' CG2' ' HA3' ' A' ' 76' ' ' GLY . 19.1 m -125.37 -141.16 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.272 177.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -149.78 124.9 10.04 Favored 'General case' 0 C--N 1.292 -1.896 0 O-C-N 120.576 -1.328 . . . . 0.0 111.189 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.0 tpp180 -173.0 109.54 0.18 Allowed 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.41 ' HG2' ' OH ' ' B' ' 94' ' ' TYR . 3.6 mt-30 -64.1 -150.2 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.239 -0.913 . . . . 0.0 109.947 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.479 ' HB1' ' CG1' ' A' ' 71' ' ' ILE . . . -167.26 177.92 5.86 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.245 -0.909 . . . . 0.0 110.879 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.695 ' O ' ' CB ' ' A' ' 59' ' ' LYS . 0.8 OUTLIER -84.4 -153.55 0.15 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.499 -0.75 . . . . 0.0 112.16 -178.485 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.695 ' CB ' ' O ' ' A' ' 58' ' ' ARG . 25.1 ttpp 139.24 118.11 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.601 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.528 ' O ' ' HB3' ' A' ' 61' ' ' PHE . . . -166.02 -104.22 0.18 Allowed Glycine 0 N--CA 1.489 2.184 0 C-N-CA 119.243 -1.456 . . . . 0.0 111.181 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.644 ' HD1' ' N ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER 173.88 155.07 0.12 Allowed 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.678 -0.895 . . . . 0.0 110.319 -178.81 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.743 ' HB2' ' H ' ' A' ' 68' ' ' ALA . 0.3 OUTLIER -107.08 -55.53 0.07 OUTLIER Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 121.152 -0.968 . . . . 0.0 111.885 -179.151 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.605 ' HD2' ' H ' ' A' ' 62' ' ' ASN . 39.1 Cg_endo -66.46 67.49 0.49 Allowed 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 123.49 1.258 . . . . 0.0 109.897 -178.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.625 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 0.8 OUTLIER -177.6 40.04 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -179.311 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.4 ' OG1' ' O ' ' A' ' 64' ' ' GLN . 1.4 p 62.39 27.36 16.3 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -178.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.497 ' CB ' ' CE1' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -142.78 -149.45 0.27 Allowed 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.393 -0.817 . . . . 0.0 110.098 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.549 ' O ' ' CD1' ' A' ' 69' ' ' LEU . 13.6 pt-20 -142.05 122.73 14.26 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.743 ' H ' ' HB2' ' A' ' 62' ' ' ASN . . . -79.99 138.55 37.08 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.71 0.767 . . . . 0.0 109.696 -178.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.614 ' HB2' ' HG3' ' A' ' 58' ' ' ARG . 0.2 OUTLIER -137.7 -156.9 0.73 Allowed 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.097 -177.319 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.551 ' HB2' ' O ' ' A' ' 69' ' ' LEU . 11.2 tt0 167.51 125.38 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.505 -0.747 . . . . 0.0 110.33 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.556 ' CD1' ' O ' ' A' ' 58' ' ' ARG . 1.0 OUTLIER -158.45 -154.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 -179.712 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -141.59 93.35 7.77 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.101 -0.999 . . . . 0.0 111.789 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.42 111.67 1.53 Allowed 'Trans proline' 0 N--CA 1.488 1.204 0 O-C-N 123.476 1.25 . . . . 0.0 109.637 177.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.602 ' HA ' ' CE2' ' B' ' 94' ' ' TYR . 6.6 p 176.25 -165.6 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -179.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.54 ' CG2' ' O ' ' A' ' 53' ' ' VAL . 8.7 p -46.46 160.34 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.562 ' HA3' ' CG2' ' A' ' 53' ' ' VAL . . . -91.6 55.85 3.07 Favored Glycine 0 N--CA 1.484 1.84 0 N-CA-C 107.449 -2.261 . . . . 0.0 107.449 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.529 ' C ' ' O ' ' A' ' 76' ' ' GLY . 19.2 t -26.0 93.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-O 122.932 1.348 . . . . 0.0 110.986 -178.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.556 ' CB ' ' CG ' ' A' ' 51' ' ' LYS . 45.7 t -57.31 -41.63 80.28 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 114.199 -1.364 . . . . 0.0 113.329 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.646 ' HA ' ' O ' ' A' ' 49' ' ' ASN 0.255 7.5 p -44.38 167.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 CA-C-O 122.423 1.106 . . . . 0.0 113.568 -172.238 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.468 ' HB3' ' O ' ' A' ' 79' ' ' VAL . 0.5 OUTLIER 174.61 176.07 0.21 Allowed Pre-proline 0 N--CA 1.485 1.301 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.382 -179.518 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -78.96 130.76 9.65 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 123.751 1.395 . . . . 0.0 109.344 176.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.422 ' CA ' ' HA ' ' A' ' 47' ' ' PHE . . . -104.39 -174.93 25.15 Favored Glycine 0 N--CA 1.498 2.821 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.4 ' HG2' ' N ' ' A' ' 84' ' ' SER . 2.2 pm0 -80.93 -24.27 38.29 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.32 -1.106 . . . . 0.0 110.707 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.416 ' HB2' ' HA3' ' A' ' 46' ' ' GLY . 22.0 t -51.07 -32.13 21.05 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.15 -0.969 . . . . 0.0 108.518 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.603 HD13 ' O ' ' B' ' 33' ' ' THR . 0.6 OUTLIER -84.22 -35.1 23.71 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.592 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -71.34 -31.12 67.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.244 -0.91 . . . . 0.0 109.182 178.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.45 -37.18 65.9 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.728 ' C ' ' HB3' ' B' ' 37' ' ' ALA . . . -65.24 -33.77 76.78 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 176.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.604 ' N ' ' CB ' ' B' ' 37' ' ' ALA . . . -62.38 -35.07 78.01 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.1 -26.37 66.16 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 175.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.545 ' C ' ' H ' ' A' ' 93' ' ' LYS . . . -59.83 -50.18 70.48 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 178.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.61 ' O ' ' HB3' ' A' ' 93' ' ' LYS . 1.3 pp -74.91 27.76 0.09 Allowed 'General case' 0 N--CA 1.505 2.311 0 O-C-N 120.454 -1.615 . . . . 0.0 109.473 178.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.61 ' HB3' ' O ' ' A' ' 92' ' ' LEU . 4.1 ttpt 68.99 93.39 0.08 Allowed 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -177.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.834 ' O ' ' N ' ' A' ' 97' ' ' PHE . 24.8 t80 -58.95 -60.74 3.38 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 115.301 -2.56 . . . . 0.0 106.181 177.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.939 ' O ' ' N ' ' A' ' 98' ' ' ALA . 38.5 mm-40 10.81 41.44 0.0 OUTLIER 'General case' 0 CA--C 1.484 -1.596 0 N-CA-C 101.366 -3.568 . . . . 0.0 101.366 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 1.044 ' O ' ' N ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER 19.55 44.11 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 112.968 -1.924 . . . . 0.0 108.054 -172.87 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.834 ' N ' ' O ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER 26.26 29.67 0.0 OUTLIER 'General case' 0 C--N 1.366 1.31 0 N-CA-C 102.401 -3.185 . . . . 0.0 102.401 -170.536 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 1.044 ' N ' ' O ' ' A' ' 96' ' ' ASP 0.278 . . -73.73 -30.0 62.57 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 109.867 -3.333 . . . . 0.0 109.843 -178.404 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 29.8 mtmt . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.173 179.919 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.57 ' HA ' ' HB2' ' B' ' 5' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 120.823 0.344 . . . . 0.0 110.246 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . 0.517 ' C ' ' H ' ' B' ' 4' ' ' THR . 40.7 p-10 -176.37 -135.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.131 -1.027 . . . . 0.0 111.374 178.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.5 ' O ' HD23 ' B' ' 25' ' ' LEU . 4.9 mttp -61.5 9.16 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.006 -1.058 . . . . 0.0 111.289 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.534 ' O ' HG21 ' B' ' 7' ' ' ILE . 52.9 m -127.8 -66.39 0.87 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.518 -1.364 . . . . 0.0 110.591 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.57 ' HB2' ' HA ' ' B' ' 1' ' ' MET . 19.7 mp0 -53.59 -42.44 67.64 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.955 -1.09 . . . . 0.0 109.797 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.444 ' HB2' ' O ' ' B' ' 2' ' ' ASN . 18.0 mt -57.59 -33.08 67.82 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 118.804 -1.158 . . . . 0.0 109.636 179.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' ILE . . . . . 0.66 HG13 ' N ' ' B' ' 8' ' ' LYS . 0.8 OUTLIER -61.83 -41.47 90.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 178.111 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . 0.757 ' HA ' ' HB1' ' B' ' 11' ' ' ALA . 0.0 OUTLIER -70.39 -29.86 66.61 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 177.875 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' B' ' 13' ' ' ASP . . . -59.17 -39.46 82.56 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.508 -0.745 . . . . 0.0 109.257 178.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . 0.87 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.1 mp -92.64 -29.81 4.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 178.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.757 ' HB1' ' HA ' ' B' ' 8' ' ' LYS . . . -62.87 -15.59 55.42 Favored 'General case' 0 C--N 1.294 -1.809 0 C-N-CA 118.403 -1.319 . . . . 0.0 108.42 178.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.428 ' HB3' ' O ' ' B' ' 8' ' ' LYS . 15.3 tp60 -114.74 -45.31 3.0 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.567 -0.708 . . . . 0.0 109.4 178.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' B' ' 9' ' ' ALA . 3.0 m-20 -62.63 -27.75 69.43 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 177.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.87 ' OG1' ' O ' ' B' ' 10' ' ' ILE 0.258 0.2 OUTLIER -106.66 -82.52 0.54 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 178.412 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.95 4.17 82.35 Favored Glycine 0 N--CA 1.5 2.931 0 O-C-N 121.038 -1.039 . . . . 0.0 110.681 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' LEU . . . . . 0.83 HD12 ' HB3' ' A' ' 20' ' ' SER . 5.4 mp -50.95 -71.02 0.07 Allowed 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.632 -0.923 . . . . 0.0 110.838 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' THR . . . . . 0.551 ' O ' HG23 ' B' ' 17' ' ' THR . 0.6 OUTLIER -136.96 7.82 2.96 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -179.638 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . 0.614 ' O ' ' C ' ' B' ' 19' ' ' VAL . 30.6 mt-30 58.34 26.78 14.43 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 -175.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.68 ' HB ' ' HB ' ' A' ' 19' ' ' VAL . 1.4 p -6.44 -92.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.857 -179.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.937 ' O ' ' N ' ' B' ' 23' ' ' LYS . 0.5 OUTLIER -134.51 25.11 3.76 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 177.531 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.689 ' C ' ' O ' ' B' ' 20' ' ' SER . 35.3 m -15.56 -41.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 122.66 1.219 . . . . 0.0 109.26 -177.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.925 ' N ' ' O ' ' B' ' 20' ' ' SER . 48.0 t -79.74 -41.68 26.14 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 114.537 -1.21 . . . . 0.0 110.288 177.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . 0.937 ' N ' ' O ' ' B' ' 20' ' ' SER . 1.5 mtpt -85.04 -34.95 22.19 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 121.461 -0.774 . . . . 0.0 111.662 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' MET . . . . . 0.65 ' CE ' ' HA ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -69.23 -30.64 68.83 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 117.667 -1.613 . . . . 0.0 108.058 179.261 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.819 ' HG ' ' N ' ' B' ' 26' ' ' ALA . 0.3 OUTLIER -72.84 -43.23 62.9 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 118.403 -1.319 . . . . 0.0 108.043 177.488 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . 0.819 ' N ' ' HG ' ' B' ' 25' ' ' LEU . . . -63.98 -26.69 68.69 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' SER . . . . . 0.605 ' O ' ' CG1' ' B' ' 31' ' ' ILE . 1.4 t -83.4 -35.83 24.75 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 177.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . 0.668 ' HA ' ' CG1' ' B' ' 31' ' ' ILE . 0.6 OUTLIER -64.85 -48.48 74.18 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.467 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . 0.601 ' HG3' ' CD2' ' B' ' 28' ' ' PHE . 6.4 mt-10 -72.35 -30.21 64.51 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 120.492 -1.38 . . . . 0.0 107.536 178.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . 1.128 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 14.3 tttt -73.19 -25.32 60.73 Favored 'General case' 0 C--O 1.187 -2.203 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 177.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.668 ' CG1' ' HA ' ' B' ' 28' ' ' PHE . 1.9 pp -100.28 -29.89 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.266 -1.521 . . . . 0.0 109.465 178.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.602 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.5 mm -65.79 -64.59 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 177.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' THR . . . . . 0.603 ' O ' HD13 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -62.72 -38.5 90.73 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.034 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 1.128 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 76.7 mm-40 -74.38 -42.74 58.78 Favored 'General case' 0 C--O 1.202 -1.404 0 O-C-N 121.036 -1.04 . . . . 0.0 112.111 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' THR . . . . . 0.546 ' N ' ' O ' ' B' ' 31' ' ' ILE . 67.5 m -57.19 -56.55 20.29 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 120.222 -1.548 . . . . 0.0 110.494 -178.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.604 ' O ' ' HG3' ' B' ' 52' ' ' PRO . 1.3 t -51.63 -44.39 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 117.667 -1.613 . . . . 0.0 106.974 178.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . 0.728 ' HB3' ' C ' ' A' ' 88' ' ' ALA . . . -85.97 6.08 30.29 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.705 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . 0.785 ' N ' ' O ' ' B' ' 34' ' ' GLU . 0.1 OUTLIER -105.64 -36.43 7.09 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 178.156 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 142.68 37.57 0.08 OUTLIER Glycine 0 C--N 1.301 -1.388 0 C-N-CA 119.252 -1.451 . . . . 0.0 111.4 178.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . 0.433 ' CB ' ' CG2' ' B' ' 35' ' ' THR . 0.4 OUTLIER -155.53 145.0 21.07 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.821 -1.4 . . . . 0.0 110.988 179.461 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.15 92.79 5.72 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.557 0.694 . . . . 0.0 109.519 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 11.3 p -68.25 154.81 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.668 -0.645 . . . . 0.0 110.447 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' GLN . . . . . 0.462 ' HG3' ' HA ' ' A' ' 2' ' ' ASN . 0.4 OUTLIER -164.1 176.3 9.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.189 -0.945 . . . . 0.0 111.386 179.937 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.684 ' N ' ' O ' ' B' ' 48' ' ' LEU . 18.1 mt -134.28 118.8 17.96 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' THR . . . . . 0.529 HG21 ' HG3' ' A' ' 29' ' ' GLU . 0.1 OUTLIER 27.21 -95.11 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.416 0 O-C-N 121.826 -0.546 . . . . 0.0 112.374 -179.812 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -137.66 14.97 3.62 Favored Glycine 0 N--CA 1.49 2.247 0 C-N-CA 119.322 -1.418 . . . . 0.0 111.686 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . 0.711 ' O ' ' N ' ' B' ' 82' ' ' GLY . 20.4 p90 -110.9 -33.48 6.5 Favored 'General case' 0 C--O 1.195 -1.803 0 CA-C-N 119.447 1.623 . . . . 0.0 109.342 178.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . 0.684 ' O ' ' N ' ' B' ' 44' ' ' LEU . 1.2 mm? -127.37 128.57 46.08 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 119.931 -1.731 . . . . 0.0 115.095 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' ASN . . . . . 0.696 ' N ' ' HG2' ' B' ' 81' ' ' PRO . 0.5 OUTLIER -143.93 91.86 2.27 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.621 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' ILE . . . . . 0.454 ' CD1' ' CG1' ' B' ' 79' ' ' VAL . 24.9 mm -83.79 148.07 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.457 -0.777 . . . . 0.0 110.688 -178.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' B' ' 78' ' ' SER . 0.0 OUTLIER -149.9 129.88 6.68 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.177 -0.952 . . . . 0.0 109.399 179.149 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . 0.604 ' HG3' ' O ' ' B' ' 36' ' ' VAL . 54.9 Cg_endo -81.77 151.64 16.84 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 O-C-N 123.388 1.204 . . . . 0.0 111.387 -178.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.584 HG21 ' O ' ' B' ' 53' ' ' VAL . 20.1 m -138.8 117.48 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-O 122.364 1.078 . . . . 0.0 111.134 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.546 ' O ' ' HB3' ' B' ' 55' ' ' ARG . . . -79.46 115.17 18.93 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.598 -0.689 . . . . 0.0 110.991 -179.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . 0.546 ' HB3' ' O ' ' B' ' 54' ' ' ALA . 0.0 OUTLIER 163.87 76.88 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.632 -0.668 . . . . 0.0 109.728 179.466 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . 0.502 ' O ' ' O ' ' B' ' 72' ' ' ALA . 12.8 mt-30 -155.82 19.47 0.38 Allowed 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.095 -1.042 . . . . 0.0 111.76 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.543 ' CB ' ' HB3' ' B' ' 73' ' ' PRO . . . -119.07 57.08 0.89 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.796 -1.19 . . . . 0.0 111.464 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' ARG . . . . . 0.562 ' HB2' ' CG1' ' B' ' 71' ' ' ILE . 2.4 mtt-85 -51.62 176.21 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.512 -0.743 . . . . 0.0 109.841 178.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . 0.511 ' HB3' ' O ' ' B' ' 58' ' ' ARG . 1.5 pttt 173.83 56.18 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.43 -0.794 . . . . 0.0 109.223 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -134.25 -86.57 0.26 Allowed Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' PHE . . . . . 0.468 ' HZ ' ' N ' ' B' ' 66' ' ' GLN . 2.2 t80 -178.1 145.35 0.36 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.345 -1.091 . . . . 0.0 111.178 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . 0.448 ' HB3' ' HD2' ' B' ' 63' ' ' PRO . 1.4 t30 -66.63 -170.0 0.06 OUTLIER Pre-proline 0 C--N 1.303 -1.448 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 177.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . 0.448 ' HD2' ' HB3' ' B' ' 62' ' ' ASN . 44.4 Cg_endo -76.75 51.54 3.39 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 N-CA-C 109.368 -1.051 . . . . 0.0 109.368 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 -147.12 -159.63 1.05 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 122.198 0.999 . . . . 0.0 110.158 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.452 ' C ' ' CZ ' ' B' ' 61' ' ' PHE . 11.4 p -139.5 -2.42 1.59 Allowed 'General case' 0 C--N 1.286 -2.177 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.348 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . 0.468 ' N ' ' HZ ' ' B' ' 61' ' ' PHE . 0.1 OUTLIER -129.65 -7.69 4.59 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.016 -1.052 . . . . 0.0 111.166 179.271 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -127.47 79.14 1.87 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.971 -1.081 . . . . 0.0 109.633 179.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . 0.407 ' HB1' ' CE2' ' B' ' 61' ' ' PHE . . . -78.78 175.2 10.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.529 -0.732 . . . . 0.0 110.82 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 82.3 mt -106.15 -177.59 3.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.554 -0.716 . . . . 0.0 110.041 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . 0.559 ' O ' ' O ' ' B' ' 71' ' ' ILE . 0.9 OUTLIER -177.44 36.8 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.415 -0.803 . . . . 0.0 110.181 179.804 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.562 ' CG1' ' HB2' ' B' ' 58' ' ' ARG . 0.3 OUTLIER -51.13 -157.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 O-C-N 121.718 -0.614 . . . . 0.0 110.919 179.317 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . 0.502 ' O ' ' O ' ' B' ' 56' ' ' GLN . . . -137.84 146.64 53.51 Favored Pre-proline 0 N--CA 1.487 1.393 0 O-C-N 120.723 -1.235 . . . . 0.0 111.923 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' PRO . . . . . 0.543 ' HB3' ' CB ' ' B' ' 57' ' ' ALA . 36.6 Cg_endo -62.09 122.01 10.3 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.566 1.824 . . . . 0.0 110.844 178.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' SER . . . . . 0.516 ' N ' ' CE2' ' A' ' 94' ' ' TYR . 21.5 t -160.64 117.08 2.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.588 -0.695 . . . . 0.0 109.868 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . 0.593 ' N ' ' CE1' ' A' ' 94' ' ' TYR . 9.4 p -52.16 162.46 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.234 -0.917 . . . . 0.0 109.923 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . 0.487 ' HA3' HG21 ' B' ' 53' ' ' VAL . . . -114.79 98.96 0.89 Allowed Glycine 0 N--CA 1.484 1.847 0 C-N-CA 118.938 -1.601 . . . . 0.0 109.24 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.545 ' HA ' ' HA ' ' B' ' 52' ' ' PRO . 67.9 t -68.84 66.07 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.701 -0.882 . . . . 0.0 109.078 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' SER . . . . . 0.451 ' N ' ' O ' ' B' ' 76' ' ' GLY . 37.6 t -65.89 -176.19 0.36 Allowed 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.603 0.716 . . . . 0.0 109.648 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . 0.454 ' CG1' ' CD1' ' B' ' 50' ' ' ILE . 17.7 m -152.68 -153.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . 0.721 ' HB3' ' HD3' ' B' ' 81' ' ' PRO . 13.0 ttmt -164.99 -57.58 0.01 OUTLIER Pre-proline 0 C--N 1.294 -1.808 0 O-C-N 121.452 -0.78 . . . . 0.0 109.985 178.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' PRO . . . . . 0.721 ' HD3' ' HB3' ' B' ' 80' ' ' LYS . 44.3 Cg_endo -95.95 164.84 1.33 Allowed 'Trans proline' 0 C--N 1.296 -2.213 0 C-N-CA 121.825 1.683 . . . . 0.0 112.842 -179.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . 0.711 ' N ' ' O ' ' B' ' 47' ' ' PHE . . . 177.05 -25.39 0.06 OUTLIER Glycine 0 C--N 1.287 -2.141 0 N-CA-C 105.774 -2.93 . . . . 0.0 105.774 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . 0.908 ' O ' ' N ' ' B' ' 85' ' ' LEU . 22.5 tt0 30.76 49.84 0.09 Allowed 'General case' 0 C--O 1.205 -1.268 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' SER . . . . . 1.3 ' O ' ' N ' ' B' ' 86' ' ' LYS . 1.2 m 12.67 43.93 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.941 1.353 . . . . 0.0 109.093 -178.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . 1.116 ' O ' ' N ' ' B' ' 88' ' ' ALA . 0.3 OUTLIER 23.05 26.4 0.0 OUTLIER 'General case' 0 C--O 1.187 -2.225 0 N-CA-C 102.785 -3.043 . . . . 0.0 102.785 -170.182 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . 1.3 ' N ' ' O ' ' B' ' 84' ' ' SER 0.324 21.8 tttt -37.33 -40.83 0.37 Allowed 'General case' 0 CA--C 1.486 -1.497 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 176.624 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . 0.426 ' N ' ' C ' ' B' ' 85' ' ' LEU 0.307 0.0 OUTLIER -61.06 -39.71 90.9 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-N 111.865 -2.425 . . . . 0.0 106.711 175.355 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 1.116 ' N ' ' O ' ' B' ' 85' ' ' LEU . . . -90.03 -21.62 22.27 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.433 -0.907 . . . . 0.0 108.966 178.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . 0.711 ' N ' ' O ' ' B' ' 85' ' ' LEU . . . -71.83 -36.74 70.3 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 178.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -66.51 -31.93 72.97 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 174.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -60.88 -42.18 99.53 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . 0.663 ' HB3' ' HA ' ' A' ' 37' ' ' ALA . 1.2 pp -85.34 21.17 1.8 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 120.443 -1.622 . . . . 0.0 110.581 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . 0.453 ' O ' ' N ' ' B' ' 96' ' ' ASP . 0.8 OUTLIER 55.66 45.22 25.11 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 -178.071 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . 0.602 ' CE2' ' HA ' ' A' ' 74' ' ' SER . 0.0 OUTLIER -37.29 -43.69 0.55 Allowed 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.661 -178.862 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -54.42 -41.84 69.79 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.297 -0.877 . . . . 0.0 109.535 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 96' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' B' ' 93' ' ' LYS . 0.7 OUTLIER -59.76 -34.29 72.79 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.193 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -69.74 -27.48 64.99 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.04 -53.01 35.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.588 -0.695 . . . . 0.0 110.215 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.234 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.488 ' HG2' ' HB3' ' A' ' 5' ' ' GLU . 11.2 mtp . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 120.852 0.358 . . . . 0.0 110.093 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.435 ' N ' ' HB2' ' A' ' 5' ' ' GLU . 7.8 t-20 -179.17 -179.86 0.6 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.261 -0.9 . . . . 0.0 110.304 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.537 ' O ' HG13 ' A' ' 7' ' ' ILE . 0.6 OUTLIER -52.63 -20.08 2.8 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.12 -0.988 . . . . 0.0 109.931 179.668 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.444 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 16.6 m -97.69 -46.68 5.9 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.488 ' HB3' ' HG2' ' A' ' 1' ' ' MET . 0.0 OUTLIER -62.55 -47.04 85.6 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 178.657 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.428 ' HG ' ' HB3' ' A' ' 1' ' ' MET . 2.4 mt -65.69 -29.68 70.26 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.193 178.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.63 HG12 ' O ' ' A' ' 21' ' ' VAL . 0.3 OUTLIER -56.34 -58.76 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 178.428 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.481 ' HE2' ' HA ' ' A' ' 5' ' ' GLU . 0.2 OUTLIER -62.64 -27.47 69.24 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.506 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.427 ' HB3' ' HA ' ' A' ' 6' ' ' LEU . . . -61.22 -32.19 71.97 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.202 -0.937 . . . . 0.0 108.708 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.852 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.2 tp -96.29 -37.59 7.44 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.549 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 178.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.496 ' HA ' ' OG1' ' A' ' 14' ' ' THR . . . -59.38 -24.19 63.2 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.419 ' N ' ' O ' ' A' ' 8' ' ' LYS . 39.3 tp60 -92.5 -45.15 8.27 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.409 ' CB ' ' HB3' ' B' ' 27' ' ' SER . 3.3 m-20 -63.81 -32.12 73.52 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 177.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.852 ' OG1' ' O ' ' A' ' 10' ' ' ILE . 27.7 p -82.5 -74.01 0.37 Allowed 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 58.87 14.79 24.99 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.735 HD11 ' HB ' ' A' ' 14' ' ' THR . 2.9 mp -77.0 -47.31 21.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.542 -0.976 . . . . 0.0 108.615 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.613 ' HB ' HG23 ' B' ' 17' ' ' THR . 0.5 OUTLIER -160.69 5.57 0.07 Allowed 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 120.0 -0.68 . . . . 0.0 111.055 -179.158 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.552 ' O ' ' C ' ' A' ' 19' ' ' VAL . 13.7 mt-30 58.97 25.52 13.89 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 -176.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.801 ' HB ' ' HB ' ' B' ' 19' ' ' VAL . 1.9 p -5.03 -93.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.942 -178.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.965 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -130.32 25.05 5.18 Favored 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 179.695 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.68 ' HA ' ' CE ' ' A' ' 24' ' ' MET . 12.5 m -19.26 -40.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 CA-C-O 122.553 1.168 . . . . 0.0 109.548 -178.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.826 ' N ' ' O ' ' A' ' 20' ' ' SER . 29.2 t -80.06 -35.75 36.62 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.999 178.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.965 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.3 OUTLIER -90.8 -36.21 14.38 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.479 -0.763 . . . . 0.0 110.891 179.561 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.68 ' CE ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -67.61 -38.64 84.23 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 117.626 -1.63 . . . . 0.0 108.994 179.462 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.541 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 0.2 OUTLIER -78.29 -48.04 16.53 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 117.858 -1.537 . . . . 0.0 109.112 178.455 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.468 ' HA ' ' HE3' ' A' ' 3' ' ' LYS . . . -54.97 -37.24 66.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.747 -1.221 . . . . 0.0 107.831 177.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.554 ' O ' HG13 ' A' ' 31' ' ' ILE . 8.4 t -83.18 -28.82 29.06 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.13 178.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.611 ' O ' HG13 ' A' ' 31' ' ' ILE . 2.8 t80 -51.91 -49.26 63.4 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.821 ' HG3' ' CD1' ' B' ' 47' ' ' PHE . 3.3 tt0 -67.17 -35.52 79.83 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 176.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 1.287 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 32.6 tttt -66.11 -17.88 64.99 Favored 'General case' 0 C--O 1.193 -1.913 0 C-N-CA 119.527 -0.869 . . . . 0.0 108.951 178.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.611 HG13 ' O ' ' A' ' 28' ' ' PHE . 1.3 pp -109.24 -26.21 3.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 119.786 -1.821 . . . . 0.0 109.344 178.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.581 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.2 mm -76.5 -54.7 12.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 177.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.739 ' HA ' ' HG ' ' B' ' 85' ' ' LEU . 0.6 OUTLIER -79.35 -29.39 42.19 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.876 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 1.287 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 41.5 mm-40 -78.5 -29.88 46.89 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 118.851 -1.14 . . . . 0.0 110.232 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.529 HG23 ' HB2' ' A' ' 40' ' ' ASP . 7.2 m -73.73 -58.73 3.1 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 117.718 -1.593 . . . . 0.0 107.916 178.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.613 HG22 ' HA ' ' A' ' 33' ' ' THR . 24.7 m -43.22 -40.7 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.701 ' O ' ' HB2' ' B' ' 92' ' ' LEU . . . -79.01 -32.56 45.16 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.58 ' HB2' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -60.44 -27.66 67.68 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 105.129 -2.175 . . . . 0.0 105.129 176.664 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.484 ' CA ' ' CZ ' ' B' ' 97' ' ' PHE . . . 116.74 26.98 2.91 Favored Glycine 0 C--N 1.297 -1.628 0 CA-C-N 114.363 -1.29 . . . . 0.0 111.025 176.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.529 ' HB2' HG23 ' A' ' 35' ' ' THR . 0.2 OUTLIER -122.0 137.34 54.84 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.251 -1.146 . . . . 0.0 110.072 179.213 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.9 mttm -82.02 87.73 6.44 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.535 -0.728 . . . . 0.0 110.704 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.2 m -65.09 140.18 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.446 -0.784 . . . . 0.0 109.718 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.46 ' O ' ' HA ' ' B' ' 2' ' ' ASN . 9.0 mt-30 -135.29 172.22 13.32 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.168 -0.958 . . . . 0.0 110.251 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.6 HD13 ' HG ' ' A' ' 48' ' ' LEU . 11.7 mt -131.65 115.99 16.77 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.214 -0.929 . . . . 0.0 110.332 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.54 HG22 ' HG3' ' B' ' 29' ' ' GLU . 0.0 OUTLIER 26.82 -93.41 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.891 -0.506 . . . . 0.0 111.853 178.892 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.428 ' N ' ' OG1' ' A' ' 45' ' ' THR . . . -153.27 33.87 0.78 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.777 ' CD2' ' HG3' ' B' ' 29' ' ' GLU . 3.2 p90 -131.44 -15.3 3.2 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.265 -1.138 . . . . 0.0 111.154 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.6 ' HG ' HD13 ' A' ' 44' ' ' LEU . 47.6 tp -161.05 121.61 2.79 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 118.261 -1.375 . . . . 0.0 111.085 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 43' ' ' GLN . 16.2 m-20 -131.59 118.16 19.71 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.46 0.648 . . . . 0.0 111.163 -178.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.481 HD13 HG22 ' A' ' 79' ' ' VAL . 5.0 mm -94.61 151.51 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.677 -0.639 . . . . 0.0 109.564 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.458 ' O ' ' N ' ' A' ' 78' ' ' SER . 11.5 ptmt -165.52 115.1 0.83 Allowed Pre-proline 0 N--CA 1.5 2.051 0 O-C-N 120.68 -1.263 . . . . 0.0 110.851 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.648 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 43.9 Cg_endo -82.69 155.78 15.83 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 O-C-N 123.515 1.271 . . . . 0.0 112.024 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.524 ' O ' ' N ' ' A' ' 76' ' ' GLY . 33.0 m -147.62 118.42 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 CA-C-O 121.669 0.747 . . . . 0.0 110.701 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.557 ' HA ' ' CE1' ' B' ' 94' ' ' TYR . . . -77.47 117.99 19.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.635 -0.666 . . . . 0.0 111.428 -179.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.453 ' HB3' ' O ' ' A' ' 54' ' ' ALA . 2.7 ptp180 171.71 63.56 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.773 -0.579 . . . . 0.0 109.463 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.445 ' O ' ' HA ' ' A' ' 73' ' ' PRO . 41.3 mt-30 -150.92 72.16 1.06 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.116 -0.99 . . . . 0.0 111.751 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.879 ' HA ' HG12 ' A' ' 71' ' ' ILE . . . -145.44 65.66 1.24 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.077 -1.014 . . . . 0.0 110.339 179.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.742 ' CA ' HG23 ' A' ' 71' ' ' ILE 0.253 0.8 OUTLIER -179.48 123.45 0.08 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.286 -0.884 . . . . 0.0 112.301 -178.566 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.663 ' HB2' HG22 ' A' ' 71' ' ' ILE . 5.5 ttmt 169.1 19.57 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.163 -0.961 . . . . 0.0 110.257 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.537 ' HA3' ' HG ' ' A' ' 69' ' ' LEU . . . -86.46 5.15 85.26 Favored Glycine 0 N--CA 1.484 1.885 0 C-N-CA 119.68 -1.248 . . . . 0.0 110.107 -179.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.472 ' CZ ' ' CB ' ' A' ' 68' ' ' ALA . 1.7 m-85 -50.53 -177.75 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.08 -1.247 . . . . 0.0 109.802 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.708 ' HB3' ' CD ' ' A' ' 63' ' ' PRO . 2.4 t-20 -127.8 -82.96 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.636 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.708 ' CD ' ' HB3' ' A' ' 62' ' ' ASN . 44.2 Cg_endo -77.66 -5.26 15.31 Favored 'Trans proline' 0 C--N 1.322 -0.838 0 N-CA-C 107.103 -1.922 . . . . 0.0 107.103 174.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.594 ' CB ' ' O ' ' A' ' 63' ' ' PRO . 11.5 tt0 88.63 60.56 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.33 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 178.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.473 ' O ' ' HG3' ' A' ' 66' ' ' GLN . 0.0 OUTLIER 172.15 23.59 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.404 0 O-C-N 121.379 -0.826 . . . . 0.0 111.954 177.791 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.495 ' NE2' ' N ' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -146.21 -112.37 0.09 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.547 -1.345 . . . . 0.0 111.406 179.111 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.45 82.48 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.947 -1.096 . . . . 0.0 110.526 -179.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -76.25 64.88 2.11 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.577 -0.702 . . . . 0.0 110.359 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.845 ' O ' ' O ' ' A' ' 70' ' ' GLU . 0.4 OUTLIER -65.7 66.9 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.488 -0.758 . . . . 0.0 110.374 179.79 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.845 ' O ' ' O ' ' A' ' 69' ' ' LEU . 39.2 mt-10 -19.2 -164.71 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 115.972 1.842 . . . . 0.0 115.972 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.879 HG12 ' HA ' ' A' ' 57' ' ' ALA 0.298 0.1 OUTLIER -134.02 -163.6 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-N 114.071 -1.422 . . . . 0.0 109.729 -175.044 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.637 ' N ' HG13 ' A' ' 71' ' ' ILE . . . -88.88 120.18 70.0 Favored Pre-proline 0 C--N 1.286 -2.152 0 O-C-N 121.888 -0.507 . . . . 0.0 111.712 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.57 ' HD3' ' HB1' ' A' ' 57' ' ' ALA . 37.1 Cg_endo -62.55 124.46 14.24 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 123.876 1.461 . . . . 0.0 109.752 178.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.485 ' C ' ' CE1' ' B' ' 94' ' ' TYR . 5.3 m -148.49 140.14 23.64 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.479 -0.763 . . . . 0.0 110.132 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.542 ' CG2' ' HB2' ' A' ' 52' ' ' PRO . 7.5 p -50.09 161.47 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.46 -0.775 . . . . 0.0 111.413 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.603 ' O ' ' N ' ' A' ' 78' ' ' SER . . . -116.9 68.75 0.3 Allowed Glycine 0 N--CA 1.487 2.088 0 N-CA-C 108.749 -1.741 . . . . 0.0 108.749 179.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.648 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 6.4 p -47.08 80.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.963 -0.728 . . . . 0.0 111.622 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.603 ' N ' ' O ' ' A' ' 76' ' ' GLY . 0.2 OUTLIER -77.15 176.66 8.51 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 177.757 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.579 ' CG2' ' N ' ' A' ' 80' ' ' LYS . 0.2 OUTLIER 177.49 174.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -179.745 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.579 ' N ' ' CG2' ' A' ' 79' ' ' VAL . 6.5 ptpt -178.15 170.21 0.87 Allowed Pre-proline 0 C--N 1.299 -1.599 0 O-C-N 121.538 -0.726 . . . . 0.0 109.557 176.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.526 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 56.0 Cg_endo -100.69 176.28 0.27 Allowed 'Trans proline' 0 C--N 1.292 -2.447 0 C-N-CA 122.6 2.2 . . . . 0.0 110.943 178.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 47' ' ' PHE . . . -126.27 163.2 20.29 Favored Glycine 0 N--CA 1.485 1.958 0 N-CA-C 107.084 -2.407 . . . . 0.0 107.084 177.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -58.06 -22.5 50.58 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.751 -1.441 . . . . 0.0 110.905 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.411 ' CB ' ' HB3' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -53.54 -35.29 60.56 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.0 -1.063 . . . . 0.0 108.894 179.198 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.668 ' HG ' ' HA ' ' B' ' 33' ' ' THR . 0.5 OUTLIER -82.31 -25.65 33.77 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.742 -0.599 . . . . 0.0 109.386 178.711 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.415 ' HG2' HG22 ' B' ' 77' ' ' VAL . 20.4 mttt -84.86 -30.67 24.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.345 -0.847 . . . . 0.0 109.956 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -73.5 -38.43 65.37 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.618 ' O ' ' HB2' ' B' ' 37' ' ' ALA . . . -63.65 -37.28 86.73 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 176.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.535 ' N ' ' HB1' ' B' ' 37' ' ' ALA . . . -54.92 -44.46 74.26 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 120.106 -0.638 . . . . 0.0 109.362 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.472 ' HA ' ' CB ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -54.47 -29.37 49.72 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.247 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 88' ' ' ALA . . . -67.9 -40.86 89.07 Favored Glycine 0 N--CA 1.488 2.122 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.31 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.599 ' HG ' ' N ' ' A' ' 93' ' ' LYS . 0.3 OUTLIER -70.39 -47.63 59.96 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 119.895 1.847 . . . . 0.0 110.533 -178.948 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.645 ' O ' ' CG ' ' A' ' 93' ' ' LYS . 0.1 OUTLIER 160.35 57.0 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.175 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.927 ' CE1' ' OG ' ' B' ' 74' ' ' SER . 17.4 t80 -53.18 -65.47 0.55 Allowed 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 178.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 1.048 ' O ' ' N ' ' A' ' 98' ' ' ALA . 1.0 OUTLIER 5.41 41.97 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 103.208 -2.886 . . . . 0.0 103.208 175.833 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 1.189 ' CA ' ' HB3' ' B' ' 74' ' ' SER . 0.0 OUTLIER 17.11 42.47 0.0 OUTLIER 'General case' 0 CA--C 1.461 -2.455 0 CA-C-N 113.176 -1.829 . . . . 0.0 109.515 -172.327 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 1.06 ' C ' ' O ' ' A' ' 96' ' ' ASP 0.327 69.5 m-85 30.52 25.1 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.744 1 N-CA-C 97.542 -4.985 . . . . 0.0 97.542 -168.671 . . . . . . . . 4 3 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 1.143 ' N ' ' O ' ' A' ' 96' ' ' ASP 0.258 . . -50.87 -26.1 5.38 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 110.012 -3.267 . . . . 0.0 108.596 -178.565 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.829 0 CA-C-N 114.351 -1.295 . . . . 0.0 110.494 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.45 ' HA ' ' HB2' ' B' ' 5' ' ' GLU . 5.5 mtp . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 120.881 0.372 . . . . 0.0 110.259 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . 0.502 ' C ' ' H ' ' B' ' 4' ' ' THR . 16.4 m-80 -147.45 -155.99 0.68 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.076 -1.015 . . . . 0.0 111.083 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.526 ' O ' ' CG2' ' B' ' 7' ' ' ILE . 1.0 OUTLIER -60.92 2.17 0.12 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.342 -0.849 . . . . 0.0 110.446 179.765 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.663 ' O ' HG13 ' B' ' 7' ' ' ILE . 4.5 m -116.3 -63.25 1.48 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 122.147 0.975 . . . . 0.0 108.904 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.45 ' HB2' ' HA ' ' B' ' 1' ' ' MET . 5.5 mm-40 -52.03 -48.05 64.71 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.214 -0.929 . . . . 0.0 108.515 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' B' ' 2' ' ' ASN . 7.5 mt -56.72 -32.8 65.87 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 119.122 -1.031 . . . . 0.0 110.256 178.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' ILE . . . . . 0.663 HG13 ' O ' ' B' ' 4' ' ' THR . 1.1 pp -60.72 -42.42 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.54 -1.35 . . . . 0.0 107.91 179.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . 0.787 ' HA ' ' HB2' ' B' ' 11' ' ' ALA . 0.0 OUTLIER -71.93 -27.2 62.65 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.29 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . 0.435 ' N ' ' HG2' ' B' ' 8' ' ' LYS . . . -62.54 -36.35 82.35 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . 0.958 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.0 OUTLIER -95.46 -35.24 5.79 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.382 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.787 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.787 ' HB2' ' HA ' ' B' ' 8' ' ' LYS . . . -56.32 -25.25 48.15 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -92.49 -46.82 7.45 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.419 ' OD2' ' CG2' ' A' ' 31' ' ' ILE . 87.0 m-20 -61.64 -24.97 67.08 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 177.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.958 ' OG1' ' O ' ' B' ' 10' ' ' ILE . 17.2 p -93.77 -77.93 0.44 Allowed 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 177.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 61.46 9.23 16.46 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' LEU . . . . . 0.687 HD11 ' HB ' ' B' ' 14' ' ' THR . 3.2 mp -72.75 -60.25 2.32 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.377 -1.072 . . . . 0.0 108.343 179.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' THR . . . . . 0.613 HG23 ' HB ' ' A' ' 17' ' ' THR . 0.5 OUTLIER -143.5 3.44 1.31 Allowed 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.598 179.659 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . 0.639 ' O ' ' C ' ' B' ' 19' ' ' VAL . 4.9 mt-30 59.1 25.33 13.79 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 106.565 -1.642 . . . . 0.0 106.565 -176.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.801 ' HB ' ' HB ' ' A' ' 19' ' ' VAL . 2.2 p 2.54 -97.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.481 -179.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.95 ' O ' ' N ' ' B' ' 23' ' ' LYS . 0.3 OUTLIER -131.55 21.77 4.7 Favored 'General case' 0 C--N 1.278 -2.525 0 N-CA-C 105.655 -1.98 . . . . 0.0 105.655 175.891 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.904 ' HA ' ' HE3' ' B' ' 24' ' ' MET . 21.2 m -15.31 -39.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-O 122.426 1.108 . . . . 0.0 109.444 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.936 ' N ' ' O ' ' B' ' 20' ' ' SER . 16.5 m -77.41 -45.01 27.2 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.983 177.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . 0.95 ' N ' ' O ' ' B' ' 20' ' ' SER . 6.6 mtmt -96.76 -14.36 22.03 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 121.482 -0.761 . . . . 0.0 109.719 178.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' MET . . . . . 0.904 ' HE3' ' HA ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -71.78 -36.06 70.23 Favored 'General case' 0 C--O 1.216 -0.71 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 177.708 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.504 ' HA ' ' HB3' ' B' ' 28' ' ' PHE . 3.4 mt -84.51 -36.16 22.41 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 176.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . 0.467 ' HB1' ' O ' ' B' ' 22' ' ' SER . . . -61.48 -34.21 75.09 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' SER . . . . . 0.445 ' O ' HG13 ' B' ' 31' ' ' ILE . 11.1 m -77.45 -34.76 54.41 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . 0.654 ' O ' ' CG1' ' B' ' 32' ' ' ILE . 0.1 OUTLIER -52.36 -45.53 65.77 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.745 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . 0.777 ' HG3' ' CD2' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -68.72 -35.96 77.82 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 118.455 -1.298 . . . . 0.0 107.577 177.08 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . 1.133 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 23.5 ttmt -63.92 -22.58 66.99 Favored 'General case' 0 C--O 1.191 -1.978 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.565 HG13 ' O ' ' B' ' 28' ' ' PHE . 0.4 OUTLIER -105.08 -27.99 3.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 O-C-N 120.24 -1.537 . . . . 0.0 108.935 177.963 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.654 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.1 mm -72.46 -58.75 4.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 177.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' THR . . . . . 0.668 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 0.5 OUTLIER -69.05 -36.13 77.36 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.49 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 1.133 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 22.3 mm-40 -75.19 -39.03 60.52 Favored 'General case' 0 C--O 1.206 -1.185 0 C-N-CA 119.156 -1.018 . . . . 0.0 111.832 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' THR . . . . . 0.503 ' HA ' ' CB ' ' B' ' 38' ' ' LYS . 55.4 m -62.77 -51.59 66.51 Favored 'General case' 0 N--CA 1.504 2.229 0 CA-C-N 120.546 1.521 . . . . 0.0 109.826 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.441 HG12 ' HB3' ' B' ' 52' ' ' PRO . 2.4 t -53.85 -36.77 31.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 178.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . 0.618 ' HB2' ' O ' ' A' ' 88' ' ' ALA . . . -94.66 11.65 30.47 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.581 0.705 . . . . 0.0 109.424 177.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . 0.732 ' HB2' ' O ' ' B' ' 34' ' ' GLU . 0.1 OUTLIER -106.76 -33.62 7.53 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 176.933 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 131.07 38.46 0.28 Allowed Glycine 0 C--N 1.303 -1.264 0 C-N-CA 119.837 -1.173 . . . . 0.0 111.033 177.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . 0.435 ' CB ' ' CG2' ' B' ' 35' ' ' THR . 0.2 OUTLIER -147.82 147.31 29.68 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.771 -1.429 . . . . 0.0 111.235 179.634 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -91.4 95.96 10.26 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 61.8 t -59.27 124.65 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.655 -0.653 . . . . 0.0 110.924 -178.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' GLN . . . . . 0.426 ' CG ' ' O ' ' A' ' 1' ' ' MET . 11.1 pt20 -120.68 96.79 5.26 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.454 -0.779 . . . . 0.0 109.235 178.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.602 ' HB3' ' CE1' ' B' ' 47' ' ' PHE . 10.6 mt -65.53 113.2 4.0 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.497 -0.752 . . . . 0.0 110.406 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' THR . . . . . 0.558 HG23 ' HD1' ' B' ' 47' ' ' PHE . 0.0 OUTLIER 29.4 -91.97 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.99 -0.444 . . . . 0.0 111.39 179.351 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -149.85 29.51 1.14 Allowed Glycine 0 N--CA 1.484 1.884 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . 0.821 ' CD1' ' HG3' ' A' ' 29' ' ' GLU . 3.9 p90 -132.66 -23.97 2.01 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.044 -1.268 . . . . 0.0 111.743 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . 0.559 ' HG ' ' CE2' ' B' ' 47' ' ' PHE . 7.3 mt -132.59 105.62 7.32 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.382 -1.449 . . . . 0.0 111.876 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' ASN . . . . . 0.405 ' O ' ' HA ' ' B' ' 79' ' ' VAL . 0.1 OUTLIER -110.38 88.63 2.81 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.283 -0.886 . . . . 0.0 110.603 179.561 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' ILE . . . . . 0.445 HD13 ' CD2' ' A' ' 48' ' ' LEU . 1.1 mm -76.83 148.91 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.413 -0.804 . . . . 0.0 110.303 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' B' ' 51' ' ' LYS . 0.0 OUTLIER -161.17 126.75 2.27 Favored Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 120.918 -1.114 . . . . 0.0 110.182 179.096 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . 0.441 ' HB3' HG12 ' B' ' 36' ' ' VAL . 50.1 Cg_endo -75.74 146.82 30.53 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.493 1.26 . . . . 0.0 111.334 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.451 ' O ' ' N ' ' B' ' 76' ' ' GLY . 33.3 m -146.38 123.74 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.68 -0.637 . . . . 0.0 110.56 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 1.04 ' HA ' ' C ' ' B' ' 74' ' ' SER . . . -65.93 112.91 4.04 Favored 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 118.857 -1.137 . . . . 0.0 111.713 -178.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . 0.436 ' H ' ' C ' ' B' ' 74' ' ' SER . 0.6 OUTLIER 170.56 66.19 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.134 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.581 -179.857 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . 0.47 ' O ' ' HA ' ' B' ' 73' ' ' PRO . 3.9 mt-30 -138.49 89.06 2.35 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.281 -0.887 . . . . 0.0 111.248 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.605 ' HB1' ' CD ' ' B' ' 73' ' ' PRO . . . -138.05 -152.57 0.44 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.109 -0.994 . . . . 0.0 111.086 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' ARG . . . . . 0.736 ' O ' ' O ' ' B' ' 59' ' ' LYS . 10.2 ptt180 -155.49 -142.04 0.1 Allowed 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.333 -0.947 . . . . 0.0 112.285 -177.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . 0.736 ' O ' ' O ' ' B' ' 58' ' ' ARG . 0.0 OUTLIER -40.63 -137.36 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 CA-C-O 121.065 0.46 . . . . 0.0 111.749 179.789 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . 0.482 ' O ' ' CB ' ' B' ' 61' ' ' PHE . . . 66.27 -159.0 47.91 Favored Glycine 0 N--CA 1.485 1.904 0 O-C-N 120.865 -1.147 . . . . 0.0 110.415 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' PHE . . . . . 0.482 ' CB ' ' O ' ' B' ' 60' ' ' GLY . 19.2 t80 163.05 115.45 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.39 170.61 1.63 Allowed Pre-proline 0 C--N 1.301 -1.539 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -70.25 63.46 2.07 Favored 'Trans proline' 0 C--N 1.302 -1.888 0 N-CA-C 108.236 -1.486 . . . . 0.0 108.236 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -128.45 -110.53 0.28 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.692 -0.803 . . . . 0.0 112.115 -178.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.41 ' N ' ' HE1' ' B' ' 61' ' ' PHE . 0.8 OUTLIER -162.35 -31.04 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.203 -0.936 . . . . 0.0 109.866 -179.747 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -137.95 9.92 2.82 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.487 -0.758 . . . . 0.0 111.021 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . 0.442 ' O ' ' HA ' ' B' ' 61' ' ' PHE . 3.6 tt0 -94.28 87.9 5.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.941 -1.099 . . . . 0.0 109.835 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -84.61 137.92 33.0 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.629 -0.669 . . . . 0.0 110.913 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.585 ' N ' ' O ' ' B' ' 59' ' ' LYS . 0.8 OUTLIER -177.18 100.23 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.464 -0.773 . . . . 0.0 110.529 179.742 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' B' ' 59' ' ' LYS . 0.0 OUTLIER -84.61 14.08 4.99 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.71 -1.244 . . . . 0.0 108.937 178.799 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.643 HG21 ' HG2' ' B' ' 58' ' ' ARG 0.255 0.2 OUTLIER -159.29 176.6 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -179.329 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . 0.753 ' O ' ' OH ' ' A' ' 94' ' ' TYR 0.25 . . -91.85 98.53 1.96 Allowed Pre-proline 0 C--N 1.291 -1.955 0 O-C-N 121.519 -0.738 . . . . 0.0 110.344 179.04 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' PRO . . . . . 0.605 ' CD ' ' HB1' ' B' ' 57' ' ' ALA . 37.2 Cg_endo -67.1 135.9 38.97 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 123.555 1.292 . . . . 0.0 112.006 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' SER . . . . . 1.189 ' HB3' ' CA ' ' A' ' 96' ' ' ASP . 0.8 OUTLIER -159.8 -159.58 0.74 Allowed 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 179.868 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . 0.939 ' N ' ' HA ' ' B' ' 54' ' ' ALA . 74.1 t -20.31 113.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-O 122.696 1.236 . . . . 0.0 112.036 -176.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . 0.467 ' O ' ' CG2' ' B' ' 77' ' ' VAL . . . -109.2 -142.96 9.94 Favored Glycine 0 C--N 1.283 -2.399 0 N-CA-C 106.764 -2.534 . . . . 0.0 106.764 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.517 HG21 ' HB3' ' A' ' 85' ' ' LEU . 99.2 t -155.18 77.57 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 O-C-N 121.279 -1.13 . . . . 0.0 110.138 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' SER . . . . . 0.426 ' O ' ' HB ' ' B' ' 79' ' ' VAL . 0.6 OUTLIER -74.74 175.95 7.47 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 118.788 -1.165 . . . . 0.0 110.147 179.745 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . 0.445 ' CG2' ' N ' ' B' ' 80' ' ' LYS . 5.9 p 176.25 177.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . 0.511 ' HB2' ' HD2' ' B' ' 81' ' ' PRO . 0.1 OUTLIER -177.35 174.3 0.65 Allowed Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 120.878 -1.138 . . . . 0.0 110.604 178.053 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' PRO . . . . . 0.511 ' HD2' ' HB2' ' B' ' 80' ' ' LYS . 51.5 Cg_endo -90.86 144.36 3.55 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.245 1.964 . . . . 0.0 110.137 178.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . 0.419 ' CA ' ' HA ' ' B' ' 47' ' ' PHE . . . -106.24 41.45 2.17 Favored Glycine 0 N--CA 1.496 2.663 0 C-N-CA 120.002 -1.094 . . . . 0.0 110.608 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . 0.458 ' O ' ' N ' ' B' ' 87' ' ' LYS . 0.3 OUTLIER 66.46 -48.59 0.44 Allowed 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.419 -1.048 . . . . 0.0 111.604 179.669 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 4.9 t -46.1 -31.93 2.62 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.192 -0.942 . . . . 0.0 109.488 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . 0.739 ' HG ' ' HA ' ' A' ' 33' ' ' THR . 4.0 tt -86.16 -32.76 21.1 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.425 0.631 . . . . 0.0 109.436 178.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -81.95 -22.01 36.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.456 -0.777 . . . . 0.0 110.329 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' B' ' 83' ' ' GLU . 0.0 OUTLIER -90.81 -29.74 17.4 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.619 ' O ' ' HG ' ' B' ' 92' ' ' LEU . . . -70.56 -36.23 73.51 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 177.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . 0.596 ' HA ' ' CB ' ' A' ' 37' ' ' ALA . . . -73.51 -40.42 64.06 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 119.891 -0.724 . . . . 0.0 109.466 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.444 ' CG ' ' HA ' ' A' ' 74' ' ' SER . 0.1 OUTLIER -57.4 -22.28 41.97 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.488 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -101.44 -12.7 34.94 Favored Glycine 0 N--CA 1.485 1.926 0 C-N-CA 120.069 -1.062 . . . . 0.0 113.181 -178.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . 0.701 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 3.4 mt -94.35 -69.4 0.75 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 121.751 2.775 . . . . 0.0 111.281 -179.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . 0.451 ' CB ' ' CZ ' ' B' ' 97' ' ' PHE . 0.6 OUTLIER -148.4 49.31 1.03 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.0 -1.063 . . . . 0.0 111.23 -179.576 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . 0.56 ' CE2' ' HB2' ' A' ' 73' ' ' PRO . 55.3 t80 -53.85 -48.74 69.68 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.151 -0.968 . . . . 0.0 109.866 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -64.25 -38.82 92.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.455 -0.778 . . . . 0.0 109.858 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.37 -27.78 57.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.526 -0.734 . . . . 0.0 109.547 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 97' ' ' PHE . . . . . 0.484 ' CZ ' ' CA ' ' A' ' 39' ' ' GLY . 2.9 m-85 -89.62 -28.11 19.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.493 -0.754 . . . . 0.0 109.615 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.76 -31.71 72.71 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.432 -0.793 . . . . 0.0 110.049 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.175 179.935 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.496 ' HA ' ' HB2' ' A' ' 5' ' ' GLU . 1.5 mtp . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.478 ' HA ' ' O ' ' B' ' 43' ' ' GLN . 29.4 p-10 -170.25 -151.11 0.08 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.14 -1.024 . . . . 0.0 111.743 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.45 ' O ' ' CG2' ' A' ' 7' ' ' ILE . 3.6 mttp -53.7 -3.83 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.286 -0.884 . . . . 0.0 111.407 -179.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.663 ' O ' HG13 ' A' ' 7' ' ' ILE . 72.9 m -118.25 -63.93 1.35 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.017 -1.052 . . . . 0.0 110.241 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.496 ' HB2' ' HA ' ' A' ' 1' ' ' MET . 3.9 mt-10 -50.6 -42.93 56.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.907 -1.121 . . . . 0.0 109.375 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.456 ' HB2' ' O ' ' A' ' 2' ' ' ASN . 28.0 mt -61.16 -32.76 72.49 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.201 -1.0 . . . . 0.0 109.726 178.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.663 HG13 ' O ' ' A' ' 4' ' ' THR . 1.0 OUTLIER -60.03 -42.11 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 178.769 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.589 ' N ' HG13 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -68.38 -31.22 70.44 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 177.478 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.447 ' HB1' ' HA ' ' A' ' 6' ' ' LEU . . . -56.91 -38.73 73.26 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.497 -0.752 . . . . 0.0 109.008 178.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.724 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.4 mp -93.38 -30.38 4.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 178.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.591 ' HB1' ' O ' ' A' ' 7' ' ' ILE . . . -63.19 -13.13 33.83 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 118.455 -1.298 . . . . 0.0 108.58 178.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -116.9 -45.19 2.78 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.513 -0.742 . . . . 0.0 110.155 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 9' ' ' ALA . 1.0 OUTLIER -67.22 -23.98 65.78 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 177.723 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.724 ' OG1' ' O ' ' A' ' 10' ' ' ILE 0.278 0.2 OUTLIER -111.27 -71.96 0.74 Allowed 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 179.25 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 57.31 19.22 31.85 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.421 -0.8 . . . . 0.0 111.228 177.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.676 ' CD1' ' CG2' ' A' ' 14' ' ' THR . 4.7 mp -60.92 -66.45 0.53 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.414 -1.051 . . . . 0.0 110.015 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.514 HG21 ' O ' ' A' ' 17' ' ' THR . 0.6 OUTLIER -135.14 8.59 3.46 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -179.807 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.587 ' O ' ' C ' ' A' ' 19' ' ' VAL . 22.3 mt-30 58.03 27.37 14.75 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 -175.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.613 ' CG2' ' CD1' ' B' ' 16' ' ' LEU . 0.5 OUTLIER -11.32 -95.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.626 -179.222 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.951 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -135.59 24.69 3.43 Favored 'General case' 0 C--N 1.279 -2.488 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 178.471 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.637 ' C ' ' O ' ' A' ' 20' ' ' SER . 26.8 m -18.48 -39.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-O 122.478 1.132 . . . . 0.0 109.71 -177.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.861 ' N ' ' O ' ' A' ' 20' ' ' SER . 4.9 p -84.88 -37.66 20.36 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.808 178.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.951 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.1 OUTLIER -85.56 -33.25 21.77 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.609 -0.682 . . . . 0.0 110.939 179.468 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.512 ' SD ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -74.39 -41.68 60.53 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 118.207 -1.397 . . . . 0.0 108.949 179.493 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.554 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 3.1 mt -69.49 -43.76 72.49 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 118.029 -1.469 . . . . 0.0 108.045 177.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.448 ' HA ' ' HD3' ' A' ' 3' ' ' LYS . . . -61.18 -32.33 72.07 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 177.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.547 ' O ' ' N ' ' A' ' 31' ' ' ILE . 7.2 t -75.86 -38.09 58.31 Favored 'General case' 0 C--O 1.207 -1.158 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 177.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.718 ' O ' ' CG1' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -57.3 -38.08 73.45 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.315 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.864 ' HG2' HG22 ' B' ' 45' ' ' THR . 1.4 mt-10 -77.18 -36.67 54.87 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 1.04 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 15.9 ttpt -69.14 -20.21 64.03 Favored 'General case' 0 C--O 1.19 -2.049 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 177.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.69 ' CG1' ' HA ' ' A' ' 28' ' ' PHE . 1.1 pp -105.93 -30.69 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 120.603 -1.311 . . . . 0.0 109.342 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.718 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.1 mm -67.43 -54.22 25.6 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 176.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.529 ' HB ' ' O ' ' A' ' 29' ' ' GLU . 0.3 OUTLIER -68.73 -40.2 80.0 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.955 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 1.04 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 61.3 mm-40 -73.26 -35.29 66.18 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.329 -0.857 . . . . 0.0 111.49 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.588 ' N ' ' O ' ' A' ' 31' ' ' ILE . 3.4 m -59.3 -50.66 73.12 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.598 -1.314 . . . . 0.0 108.078 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.407 ' CG2' ' HD3' ' A' ' 52' ' ' PRO . 1.1 t -54.22 -36.94 34.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 177.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.837 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -80.75 -5.04 56.58 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.639 0.733 . . . . 0.0 109.714 177.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -101.05 -24.21 14.35 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.36 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 105.86 40.68 1.96 Allowed Glycine 0 C--N 1.3 -1.433 0 C-N-CA 120.136 -1.031 . . . . 0.0 110.641 178.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.442 ' CB ' ' CG2' ' A' ' 35' ' ' THR . 0.1 OUTLIER -134.18 123.43 24.33 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.21 -1.171 . . . . 0.0 110.03 179.284 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.87 68.48 5.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.438 -0.789 . . . . 0.0 110.629 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.461 ' CG1' ' HB ' ' A' ' 50' ' ' ILE . 2.6 p -59.61 145.97 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.168 -0.958 . . . . 0.0 109.405 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -137.8 120.65 16.44 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.238 -0.914 . . . . 0.0 111.03 -178.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.67 HD12 ' HB2' ' A' ' 48' ' ' LEU . 10.1 mt -64.5 -178.81 0.42 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.28 -0.887 . . . . 0.0 109.326 178.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.747 HG21 ' HG2' ' B' ' 29' ' ' GLU . 1.4 t -36.32 -34.16 0.06 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.77 -0.581 . . . . 0.0 111.467 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 166.39 -23.37 0.13 Allowed Glycine 0 N--CA 1.488 2.155 0 C-N-CA 119.686 -1.245 . . . . 0.0 110.398 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.617 ' CD1' HD22 ' A' ' 85' ' ' LEU . 20.2 p90 -81.65 -18.83 43.22 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.885 -1.362 . . . . 0.0 111.395 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.67 ' HB2' HD12 ' A' ' 44' ' ' LEU . 2.7 mt -125.94 100.32 6.32 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 118.553 -1.259 . . . . 0.0 111.611 178.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.528 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 0.1 OUTLIER -91.81 64.48 4.79 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.056 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.683 ' HA ' ' HB ' ' A' ' 79' ' ' VAL . 27.2 mm -57.29 116.42 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 O-C-N 121.335 -0.853 . . . . 0.0 112.767 -177.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.528 ' HG2' ' O ' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -172.71 135.7 0.77 Allowed Pre-proline 0 N--CA 1.494 1.734 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.038 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.463 ' HB2' ' CG1' ' A' ' 75' ' ' VAL . 51.2 Cg_endo -90.63 156.08 4.27 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.473 1.249 . . . . 0.0 113.147 -177.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.61 ' O ' ' N ' ' A' ' 76' ' ' GLY . 27.1 m -132.14 111.94 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 CA-C-O 121.717 0.77 . . . . 0.0 110.195 177.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.692 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . -48.7 142.31 6.29 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 122.07 0.938 . . . . 0.0 112.473 -178.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.11 86.57 0.48 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.526 ' C ' ' HA ' ' A' ' 73' ' ' PRO . 0.6 OUTLIER -55.22 -171.21 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.976 0.893 . . . . 0.0 112.354 -177.916 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.456 ' C ' ' HD3' ' A' ' 58' ' ' ARG . . . -73.7 -168.08 0.54 Allowed 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.843 0.83 . . . . 0.0 111.962 -178.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.801 ' N ' ' HD3' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -177.78 -150.92 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -177.563 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.58 ' N ' ' HG2' ' A' ' 58' ' ' ARG . 0.5 OUTLIER 171.01 81.84 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.462 -0.774 . . . . 0.0 110.514 177.691 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.734 ' N ' ' O ' ' A' ' 69' ' ' LEU . . . 38.45 48.73 2.28 Favored Glycine 0 N--CA 1.495 2.616 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.739 ' C ' ' CD1' ' A' ' 61' ' ' PHE . 0.1 OUTLIER -94.73 145.44 24.86 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.93 -1.335 . . . . 0.0 113.481 -178.611 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.804 ' H ' ' CD ' ' A' ' 63' ' ' PRO . 15.0 p30 -145.58 -9.48 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 178.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.804 ' CD ' ' H ' ' A' ' 62' ' ' ASN . 46.8 Cg_endo -74.78 -10.62 21.69 Favored 'Trans proline' 0 N--CA 1.481 0.767 0 N-CA-C 108.898 -1.231 . . . . 0.0 108.898 178.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.576 ' CB ' ' CE1' ' A' ' 61' ' ' PHE . 1.0 OUTLIER -87.76 -103.57 0.08 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.661 -0.65 . . . . 0.0 109.356 179.567 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.44 ' O ' ' CB ' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -80.54 -0.31 37.1 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.485 -1.384 . . . . 0.0 109.827 178.87 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.643 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER 75.29 110.45 0.07 Allowed 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.749 0.785 . . . . 0.0 112.428 178.807 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.596 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 7.9 mt-10 138.58 89.96 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.317 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.708 ' HA ' ' C ' ' A' ' 61' ' ' PHE . . . -41.8 102.6 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.371 0 O-C-N 120.792 -1.192 . . . . 0.0 110.422 -178.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.734 ' O ' ' N ' ' A' ' 60' ' ' GLY . 22.0 mt -96.84 137.26 36.2 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.474 -0.766 . . . . 0.0 110.987 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.622 ' HA ' ' HG2' ' A' ' 58' ' ' ARG . 1.0 OUTLIER -135.99 23.01 3.3 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.694 -0.628 . . . . 0.0 110.463 -179.645 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.693 ' N ' ' HD2' ' A' ' 58' ' ' ARG . 2.1 pp -58.37 -146.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 O-C-N 121.249 -0.907 . . . . 0.0 110.896 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.416 ' N ' ' CD1' ' A' ' 71' ' ' ILE . . . -136.82 156.58 75.92 Favored Pre-proline 0 C--N 1.302 -1.492 0 O-C-N 120.852 -1.155 . . . . 0.0 111.458 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.526 ' HA ' ' C ' ' A' ' 56' ' ' GLN . 45.7 Cg_endo -72.9 94.3 0.8 Allowed 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 121.968 1.779 . . . . 0.0 110.226 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.533 ' HA ' ' CE1' ' B' ' 94' ' ' TYR . 0.5 OUTLIER 178.22 156.06 0.4 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.571 -0.706 . . . . 0.0 109.966 -179.729 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.692 ' HA ' ' HA ' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -56.35 176.24 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.03 -1.044 . . . . 0.0 108.613 179.114 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.61 ' N ' ' O ' ' A' ' 53' ' ' VAL . . . -113.32 -149.14 10.34 Favored Glycine 0 C--N 1.299 -1.487 0 N-CA-C 108.337 -1.905 . . . . 0.0 108.337 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.534 ' CG1' ' HB3' ' B' ' 81' ' ' PRO . 4.3 t -144.99 86.85 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 CA-C-O 122.021 0.915 . . . . 0.0 108.783 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.511 ' CB ' ' HG3' ' A' ' 51' ' ' LYS . 0.5 OUTLIER -56.37 -44.54 80.25 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.812 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.683 ' HB ' ' HA ' ' A' ' 50' ' ' ILE 0.267 13.2 p -47.53 173.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 CA-C-O 122.082 0.944 . . . . 0.0 113.057 -175.226 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.656 ' HB2' ' HD2' ' A' ' 81' ' ' PRO . 0.1 OUTLIER 177.94 176.4 0.3 Allowed Pre-proline 0 N--CA 1.484 1.229 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -178.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.656 ' HD2' ' HB2' ' A' ' 80' ' ' LYS . 50.7 Cg_endo -78.07 112.51 3.26 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.612 1.322 . . . . 0.0 109.693 177.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -81.04 -172.53 46.37 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.04 -23.66 52.07 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.363 -1.081 . . . . 0.0 110.62 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.26 -37.51 23.83 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.199 -0.938 . . . . 0.0 108.814 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.617 HD22 ' CD1' ' A' ' 47' ' ' PHE . 0.1 OUTLIER -79.63 -35.11 39.94 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.555 0.693 . . . . 0.0 109.152 178.486 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.435 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 0.1 OUTLIER -73.38 -31.38 63.87 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 120.036 -0.666 . . . . 0.0 110.039 -179.778 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -70.77 -40.27 72.74 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 178.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.588 ' O ' ' CB ' ' B' ' 37' ' ' ALA . . . -66.22 -35.31 80.09 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 176.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.565 ' O ' ' HG ' ' A' ' 92' ' ' LEU . . . -58.46 -43.53 88.91 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.255 178.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.527 ' HA ' ' HB2' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -58.28 -24.36 59.19 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 177.29 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -74.71 -38.27 43.3 Favored Glycine 0 N--CA 1.488 2.126 0 CA-C-O 119.399 -0.667 . . . . 0.0 112.792 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.609 ' HG ' ' H ' ' A' ' 93' ' ' LYS . 2.0 pp -57.26 -49.37 76.28 Favored 'General case' 0 N--CA 1.505 2.299 0 CA-C-N 120.774 2.287 . . . . 0.0 111.326 -178.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.609 ' H ' ' HG ' ' A' ' 92' ' ' LEU . 0.4 OUTLIER 159.05 45.95 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -179.447 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.734 ' CD2' ' OG ' ' B' ' 74' ' ' SER . 2.4 t80 -32.48 -71.75 0.05 Allowed 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.331 0.586 . . . . 0.0 112.41 -178.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.556 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 3.0 mt-10 -46.6 -35.57 6.03 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.397 -0.815 . . . . 0.0 110.465 -178.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.436 ' CB ' ' HB3' ' A' ' 93' ' ' LYS . 0.5 OUTLIER -69.81 -30.44 67.96 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.801 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.514 ' HB3' ' HB3' ' B' ' 54' ' ' ALA . 0.5 OUTLIER -93.6 -3.49 52.52 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.325 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.672 ' HB1' ' O ' ' B' ' 73' ' ' PRO . . . -87.26 -36.07 18.13 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 121.36 0.6 . . . . 0.0 110.172 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.8 mttm . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 118.112 -0.947 . . . . 0.0 110.238 179.953 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.63 ' HA ' ' CB ' ' B' ' 5' ' ' GLU . 5.9 mtp . . . . . 0 N--CA 1.493 1.692 0 N-CA-C 110.081 -0.341 . . . . 0.0 110.081 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . 0.402 ' C ' ' H ' ' B' ' 4' ' ' THR . 51.7 p-10 -171.57 -158.51 0.13 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.941 -1.099 . . . . 0.0 112.063 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.522 ' HE2' ' HA ' ' B' ' 26' ' ' ALA . 0.1 OUTLIER -49.72 -12.38 0.07 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.556 -0.715 . . . . 0.0 111.038 -179.536 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.659 ' O ' HG13 ' B' ' 7' ' ' ILE . 19.7 m -114.04 -58.68 2.12 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.007 -1.058 . . . . 0.0 110.197 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.677 ' HA ' ' HE2' ' B' ' 8' ' ' LYS . 0.3 OUTLIER -49.34 -46.64 47.21 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.07 -1.019 . . . . 0.0 109.23 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.467 ' CB ' HD11 ' B' ' 25' ' ' LEU . 10.7 mt -58.79 -31.36 68.33 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.289 -0.964 . . . . 0.0 109.815 178.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' ILE . . . . . 0.659 HG13 ' O ' ' B' ' 4' ' ' THR . 0.9 OUTLIER -58.82 -41.77 83.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.517 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . 0.677 ' HE2' ' HA ' ' B' ' 5' ' ' GLU . 35.6 mtmt -63.55 -35.31 80.07 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . 0.448 ' HB1' ' HA ' ' B' ' 6' ' ' LEU . . . -53.63 -39.75 65.22 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.944 -0.702 . . . . 0.0 109.199 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . 0.678 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.5 mp -90.56 -32.23 5.37 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 178.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.538 ' HB2' ' O ' ' B' ' 7' ' ' ILE . . . -64.21 -15.87 60.82 Favored 'General case' 0 C--N 1.293 -1.871 0 O-C-N 120.805 -1.185 . . . . 0.0 108.58 178.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 -111.54 -43.41 3.67 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.514 -0.741 . . . . 0.0 109.587 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -69.66 -24.55 63.63 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.734 ' CG2' ' HB2' ' A' ' 20' ' ' SER . 0.2 OUTLIER -115.2 -82.65 0.62 Allowed 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 179.258 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . 0.515 ' O ' ' C ' ' B' ' 16' ' ' LEU . . . 67.22 -21.92 0.21 Allowed Glycine 0 N--CA 1.5 2.924 0 O-C-N 120.993 -1.067 . . . . 0.0 110.469 178.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' LEU . . . . . 0.725 ' N ' HD11 ' B' ' 16' ' ' LEU . 0.0 OUTLIER -27.44 -54.73 0.09 Allowed 'General case' 0 N--CA 1.514 2.736 0 CA-C-O 121.942 0.877 . . . . 0.0 110.76 -179.758 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' THR . . . . . 0.446 HG21 ' CG2' ' A' ' 17' ' ' THR . 0.5 OUTLIER -138.78 -3.28 1.66 Allowed 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.975 -179.433 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . 0.538 ' O ' ' C ' ' B' ' 19' ' ' VAL . 11.9 mt-30 56.78 34.94 25.51 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 -176.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.654 HG22 ' CD1' ' A' ' 16' ' ' LEU . 1.8 p -20.43 -95.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.521 -178.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.916 ' O ' ' N ' ' B' ' 23' ' ' LYS . 0.5 OUTLIER -133.44 24.11 4.08 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 178.495 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.629 ' C ' ' O ' ' B' ' 20' ' ' SER . 30.0 m -19.0 -39.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-O 122.382 1.087 . . . . 0.0 109.585 -178.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.841 ' N ' ' O ' ' B' ' 20' ' ' SER . 28.0 t -84.34 -38.71 20.0 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.009 178.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . 0.916 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.3 OUTLIER -84.91 -32.06 23.34 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.406 -0.809 . . . . 0.0 111.276 179.831 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' MET . . . . . 0.541 ' CE ' ' HG ' ' B' ' 25' ' ' LEU . 0.0 OUTLIER -74.9 -41.07 60.44 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 118.073 -1.451 . . . . 0.0 108.462 178.812 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.627 ' HA ' ' HB3' ' B' ' 28' ' ' PHE . 11.1 mt -69.01 -44.34 72.96 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 118.319 -1.353 . . . . 0.0 108.008 177.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . 0.522 ' HA ' ' HE2' ' B' ' 3' ' ' LYS . . . -57.29 -34.5 68.75 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' SER . . . . . 0.543 ' HA ' ' HB3' ' B' ' 30' ' ' LYS . 54.0 p -84.09 -26.61 28.85 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . 0.737 ' O ' HG13 ' B' ' 31' ' ' ILE . 0.4 OUTLIER -62.54 -44.51 96.17 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.0 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . 0.747 ' HG2' HG21 ' A' ' 45' ' ' THR . 0.7 OUTLIER -74.49 -32.37 62.52 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 177.918 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . 0.816 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 17.5 ttpp -69.17 -27.17 65.28 Favored 'General case' 0 C--O 1.192 -1.933 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 176.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.737 HG13 ' O ' ' B' ' 28' ' ' PHE . 2.0 pp -97.33 -30.6 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.113 -0.992 . . . . 0.0 109.246 178.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.599 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.9 mm -64.58 -53.82 37.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 177.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' THR . . . . . 0.561 ' HA ' HD21 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -68.57 -40.38 80.6 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.129 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.816 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 52.7 mm-40 -70.03 -36.11 74.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.523 -0.735 . . . . 0.0 111.058 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' THR . . . . . 0.597 ' N ' ' O ' ' B' ' 31' ' ' ILE . 3.2 m -59.02 -52.78 64.27 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.799 -1.188 . . . . 0.0 108.651 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.537 ' HB ' ' CD1' ' A' ' 85' ' ' LEU . 13.6 t -54.25 -36.85 34.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 177.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . 0.588 ' CB ' ' O ' ' A' ' 88' ' ' ALA . . . -79.14 -3.84 47.46 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . 0.485 ' N ' ' O ' ' B' ' 34' ' ' GLU . 0.0 OUTLIER -102.43 -29.43 11.62 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 177.823 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' B' ' 35' ' ' THR . . . 112.66 38.55 1.29 Allowed Glycine 0 C--N 1.302 -1.355 0 C-N-CA 120.001 -1.095 . . . . 0.0 111.03 177.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . 0.437 ' CB ' HG23 ' B' ' 35' ' ' THR . 0.1 OUTLIER -130.29 133.63 46.62 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.043 -1.269 . . . . 0.0 110.745 179.364 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.4 ' HG3' ' HD2' ' B' ' 52' ' ' PRO . 0.1 OUTLIER -82.98 88.4 6.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.581 -0.7 . . . . 0.0 109.664 179.683 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . 0.45 ' CG2' ' HB ' ' B' ' 50' ' ' ILE . 25.4 m -73.39 144.91 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.507 -0.745 . . . . 0.0 110.443 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' GLN . . . . . 0.478 ' O ' ' HA ' ' A' ' 2' ' ' ASN . 19.6 mt-30 -138.9 171.53 14.19 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.469 -0.769 . . . . 0.0 110.24 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.674 ' O ' ' N ' ' B' ' 46' ' ' GLY . 91.5 mt -136.06 -179.16 5.49 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.276 -0.89 . . . . 0.0 110.608 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' THR . . . . . 0.864 HG22 ' HG2' ' A' ' 29' ' ' GLU . 4.1 t -45.62 72.19 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . 0.674 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . 42.74 29.03 0.72 Allowed Glycine 0 N--CA 1.494 2.562 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . 0.73 ' CE2' ' HG ' ' B' ' 48' ' ' LEU . 0.7 OUTLIER -129.12 -32.83 2.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.054 -1.262 . . . . 0.0 110.476 179.606 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . 0.73 ' HG ' ' CE2' ' B' ' 47' ' ' PHE . 8.0 mt -128.29 117.99 22.46 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.685 -1.259 . . . . 0.0 110.46 178.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -118.04 69.19 0.78 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.607 -0.683 . . . . 0.0 110.856 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' ILE . . . . . 0.601 ' HA ' ' HB ' ' B' ' 79' ' ' VAL . 11.2 mm -59.86 113.46 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.164 -0.96 . . . . 0.0 109.637 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . 0.439 ' HG3' ' O ' ' B' ' 51' ' ' LYS . 1.3 ptmt -138.34 121.92 11.32 Favored Pre-proline 0 N--CA 1.498 1.952 0 O-C-N 121.017 -1.052 . . . . 0.0 110.246 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . 0.574 ' HA ' ' HA ' ' B' ' 77' ' ' VAL . 50.2 Cg_endo -76.61 135.46 16.23 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 123.482 1.254 . . . . 0.0 112.237 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.599 ' O ' ' N ' ' B' ' 76' ' ' GLY . 33.6 m -139.41 116.8 10.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.746 ' HA ' ' C ' ' B' ' 74' ' ' SER . . . -76.23 141.2 41.82 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -176.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . 0.611 ' CB ' ' O ' ' B' ' 54' ' ' ALA . 0.2 OUTLIER 146.79 68.37 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.604 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.225 179.746 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . 0.588 ' O ' ' HA ' ' B' ' 73' ' ' PRO . 10.2 mt-30 -154.95 103.63 2.42 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.899 -1.125 . . . . 0.0 111.835 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.523 ' CB ' ' HB3' ' B' ' 73' ' ' PRO . . . -142.41 179.97 6.63 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.076 -1.015 . . . . 0.0 111.485 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' ARG . . . . . 0.476 ' HD2' ' N ' ' B' ' 58' ' ' ARG . 2.0 mpt_? -84.64 165.4 17.96 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 121.212 0.53 . . . . 0.0 110.184 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . 0.425 ' HB3' ' O ' ' B' ' 58' ' ' ARG . 7.8 pttt -178.99 48.69 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.504 -0.747 . . . . 0.0 109.642 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -104.97 -105.2 3.0 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' PHE . . . . . 0.787 ' O ' ' N ' ' B' ' 67' ' ' GLU . 0.4 OUTLIER -173.83 177.18 2.49 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.371 -1.076 . . . . 0.0 110.011 -179.828 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . 0.571 ' CB ' ' HB2' ' B' ' 68' ' ' ALA . 1.1 t-20 -102.5 -58.62 0.09 OUTLIER Pre-proline 0 N--CA 1.499 1.999 0 O-C-N 120.99 -1.069 . . . . 0.0 111.654 -178.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . 0.504 ' HD2' ' H ' ' B' ' 62' ' ' ASN . 42.3 Cg_endo -69.32 62.15 1.51 Allowed 'Trans proline' 0 C--N 1.315 -1.234 0 O-C-N 123.345 1.181 . . . . 0.0 109.864 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . 0.749 ' HB3' ' CE1' ' B' ' 61' ' ' PHE . 0.4 OUTLIER -175.9 30.36 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -179.36 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.429 ' O ' ' NE2' ' B' ' 66' ' ' GLN . 4.1 p 50.81 44.88 27.86 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.603 -0.686 . . . . 0.0 110.752 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . 0.637 ' HB2' ' CE1' ' B' ' 61' ' ' PHE . 0.1 OUTLIER -130.65 -88.37 0.49 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.25 -0.906 . . . . 0.0 110.94 -179.707 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . 0.787 ' N ' ' O ' ' B' ' 61' ' ' PHE . 2.0 mt-10 156.54 90.92 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . 0.579 ' HA ' ' HA ' ' B' ' 61' ' ' PHE . . . -70.76 104.24 2.82 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.162 -0.961 . . . . 0.0 110.204 -178.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' B' ' 67' ' ' GLU . 0.2 OUTLIER 174.66 -169.12 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.899 -179.374 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -156.51 91.32 1.23 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.437 -0.789 . . . . 0.0 109.554 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.451 ' O ' ' HD3' ' B' ' 73' ' ' PRO . 1.0 OUTLIER -56.74 -172.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.361 -0.837 . . . . 0.0 110.189 -179.642 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -90.27 108.92 29.83 Favored Pre-proline 0 C--N 1.296 -1.722 0 O-C-N 121.681 -0.637 . . . . 0.0 110.75 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' PRO . . . . . 0.672 ' O ' ' HB1' ' A' ' 98' ' ' ALA . 45.7 Cg_endo -79.36 123.15 5.39 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 O-C-N 123.698 1.367 . . . . 0.0 111.088 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' SER . . . . . 0.746 ' C ' ' HA ' ' B' ' 54' ' ' ALA . 0.3 OUTLIER -150.21 -151.03 0.37 Allowed 'General case' 0 C--N 1.292 -1.922 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.988 179.264 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . 0.619 ' O ' ' HE1' ' A' ' 94' ' ' TYR . 45.2 t -17.34 139.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.719 0 CA-C-O 122.706 1.241 . . . . 0.0 114.002 -175.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . 0.599 ' N ' ' O ' ' B' ' 53' ' ' VAL . . . -142.56 68.12 0.45 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.574 ' HA ' ' HA ' ' B' ' 52' ' ' PRO . 5.3 p -36.48 95.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.827 -0.807 . . . . 0.0 112.139 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' SER . . . . . 0.475 ' O ' ' HB ' ' B' ' 79' ' ' VAL . 15.5 t -94.07 176.0 6.49 Favored 'General case' 0 C--N 1.293 -1.872 0 C-N-CA 119.547 -0.861 . . . . 0.0 108.846 177.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . 0.601 ' HB ' ' HA ' ' B' ' 50' ' ' ILE . 14.5 p 176.24 178.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . 0.533 ' HB2' ' HD2' ' B' ' 81' ' ' PRO . 0.2 OUTLIER -178.0 173.35 0.66 Allowed Pre-proline 0 C--N 1.305 -1.352 0 O-C-N 121.024 -1.047 . . . . 0.0 110.424 178.097 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' PRO . . . . . 0.568 ' HA ' ' O ' ' B' ' 47' ' ' PHE . 51.0 Cg_endo -88.01 103.74 0.49 Allowed 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 121.834 1.689 . . . . 0.0 109.853 178.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . 0.476 ' O ' ' HB3' ' B' ' 83' ' ' GLU . . . -71.46 37.43 0.57 Allowed Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . 0.476 ' HB3' ' O ' ' B' ' 82' ' ' GLY . 1.2 tp10 64.22 -27.93 0.09 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.303 -1.116 . . . . 0.0 112.613 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' SER . . . . . 0.463 ' H ' ' C ' ' B' ' 82' ' ' GLY . 1.0 OUTLIER -52.13 -36.43 51.28 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.435 -1.415 . . . . 0.0 108.945 179.602 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . 0.473 ' HB2' ' CD2' ' B' ' 47' ' ' PHE . 1.2 tt -85.79 -36.42 20.1 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . 0.513 ' HA ' ' HB1' ' B' ' 89' ' ' ALA . 0.2 OUTLIER -70.52 -35.39 73.15 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.094 179.323 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' B' ' 83' ' ' GLU . 0.2 OUTLIER -70.25 -38.87 75.25 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 178.487 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.61 ' O ' ' HB1' ' A' ' 37' ' ' ALA . . . -63.92 -37.49 87.61 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 176.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . 0.542 ' HB2' HG11 ' A' ' 75' ' ' VAL . . . -55.95 -42.33 76.04 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.255 178.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.66 -31.67 58.03 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 177.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -71.74 -27.76 70.3 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 179.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . 0.837 ' HB3' ' HA ' ' A' ' 37' ' ' ALA . 0.5 OUTLIER -71.58 9.47 0.84 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.761 -1.435 . . . . 0.0 111.675 -179.654 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' B' ' 92' ' ' LEU . 29.9 mmtp 60.76 40.35 16.22 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 -177.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . 0.595 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 1.8 p90 -41.95 -29.94 0.24 Allowed 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.768 -178.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . 0.468 ' HG3' ' CE1' ' B' ' 94' ' ' TYR . 3.8 mp0 -59.53 -47.85 83.92 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.87 -35.52 66.58 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 177.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.44 -30.18 64.36 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 178.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 98' ' ' ALA . . . . . 0.409 ' HA ' ' CB ' ' A' ' 54' ' ' ALA . . . -58.18 -39.19 78.28 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.332 0.587 . . . . 0.0 110.182 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.15 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.462 ' CG ' ' HB3' ' A' ' 5' ' ' GLU . 0.9 OUTLIER . . . . . 0 N--CA 1.496 1.826 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.423 ' C ' ' H ' ' A' ' 4' ' ' THR . 2.8 t-20 -174.1 -169.2 0.45 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.945 -1.097 . . . . 0.0 111.635 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.614 ' HG2' ' HA ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -57.74 -4.87 0.32 Allowed 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.473 -0.767 . . . . 0.0 110.702 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.902 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 99.2 m -125.29 -40.31 2.13 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.323 -0.86 . . . . 0.0 108.974 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.462 ' HB3' ' CG ' ' A' ' 1' ' ' MET . 0.1 OUTLIER -61.66 -50.59 71.9 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.274 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.487 ' O ' ' HB2' ' A' ' 9' ' ' ALA . 9.1 mt -57.8 -31.25 66.39 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.902 ' HB ' ' O ' ' A' ' 4' ' ' THR . 3.5 mt -52.55 -51.65 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 178.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.537 ' CE ' ' N ' ' A' ' 8' ' ' LYS . 3.1 mmpt? -60.53 -34.24 73.82 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.489 ' HB2' HD11 ' B' ' 31' ' ' ILE . . . -55.26 -37.18 66.91 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.535 -0.866 . . . . 0.0 109.504 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.836 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.0 OUTLIER -97.12 -30.27 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.291 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.508 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -68.14 -13.62 62.36 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 118.829 -1.148 . . . . 0.0 108.542 178.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.426 ' CG ' ' N ' ' A' ' 13' ' ' ASP . 6.5 pt20 -111.14 -39.61 4.7 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.522 -0.736 . . . . 0.0 109.432 178.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.426 ' N ' ' CG ' ' A' ' 12' ' ' GLN . 0.9 OUTLIER -66.89 -36.07 81.45 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 177.408 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.836 ' OG1' ' O ' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -97.31 -67.46 0.85 Allowed 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.376 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 46.17 29.98 3.8 Favored Glycine 0 N--CA 1.497 2.759 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 178.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.558 ' CD1' ' CG2' ' B' ' 19' ' ' VAL . 0.0 OUTLIER -89.65 -26.85 20.52 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.621 -0.929 . . . . 0.0 109.687 179.333 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.498 HG21 ' O ' ' A' ' 17' ' ' THR . 0.4 OUTLIER -162.15 -3.03 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.683 -178.6 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.536 ' O ' ' C ' ' A' ' 19' ' ' VAL . 9.7 mt-30 54.27 30.45 12.45 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 -177.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.675 ' HB ' ' HB ' ' B' ' 19' ' ' VAL . 2.3 p -12.25 -93.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.526 -178.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.945 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.5 OUTLIER -128.5 23.37 5.9 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 178.688 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.719 ' HB ' ' CG2' ' A' ' 7' ' ' ILE . 15.3 m -24.59 -37.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 CA-C-O 122.233 1.016 . . . . 0.0 109.4 -178.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.735 ' N ' ' O ' ' A' ' 20' ' ' SER . 48.5 t -82.28 -36.55 26.94 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.253 177.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.945 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.3 OUTLIER -86.82 -32.43 20.3 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.637 -0.665 . . . . 0.0 111.744 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.644 ' CE ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -78.4 -36.67 45.44 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.433 -1.417 . . . . 0.0 109.873 179.631 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.727 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 0.4 OUTLIER -80.5 -45.04 18.15 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 118.535 -1.266 . . . . 0.0 109.345 178.904 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.614 ' HA ' ' HG2' ' A' ' 3' ' ' LYS . . . -57.24 -33.37 67.49 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 177.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.648 ' HA ' ' HB3' ' A' ' 30' ' ' LYS . 49.4 m -87.46 -31.15 20.16 Favored 'General case' 0 C--O 1.199 -1.586 0 C-N-CA 119.687 -0.805 . . . . 0.0 109.238 178.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.831 ' O ' HG13 ' A' ' 31' ' ' ILE . 0.1 OUTLIER -58.21 -49.71 76.1 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.04 -1.037 . . . . 0.0 109.931 179.45 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.724 ' HG2' HG23 ' B' ' 45' ' ' THR . 1.1 mt-10 -73.12 -37.4 66.68 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 1.251 ' O ' ' HB3' ' A' ' 34' ' ' GLU . 16.8 ttpt -69.06 -16.37 63.68 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 177.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 1.008 ' HA ' ' CG ' ' A' ' 34' ' ' GLU . 1.8 pp -107.39 -29.38 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.14 -0.975 . . . . 0.0 110.241 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.613 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.2 mm -63.39 -45.77 97.15 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 178.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.497 ' O ' ' CB ' ' B' ' 88' ' ' ALA . 0.5 OUTLIER -79.03 -41.32 29.15 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 177.704 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 1.251 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -59.39 -35.51 74.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.134 -0.979 . . . . 0.0 109.124 177.842 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.578 ' N ' ' O ' ' A' ' 31' ' ' ILE . 15.8 m -63.73 -48.93 75.04 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 177.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.437 ' HB ' ' HB3' ' B' ' 88' ' ' ALA . 24.5 t -55.69 -35.58 39.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 177.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.731 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -83.14 -1.24 52.39 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 177.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -106.27 -11.69 15.94 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 177.198 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 35' ' ' THR . . . 85.88 46.28 5.44 Favored Glycine 0 C--N 1.303 -1.255 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.243 177.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.511 ' CB ' ' CG2' ' A' ' 35' ' ' THR . 0.2 OUTLIER -124.6 143.15 50.87 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.031 -1.276 . . . . 0.0 109.975 178.951 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.402 ' CG ' ' HB2' ' A' ' 51' ' ' LYS . 0.3 OUTLIER -105.35 97.58 7.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.549 -0.72 . . . . 0.0 110.185 -179.317 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.552 ' HB ' ' CG1' ' A' ' 50' ' ' ILE . 3.2 t -84.83 172.62 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.472 -0.768 . . . . 0.0 110.134 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.478 ' O ' ' HG3' ' A' ' 43' ' ' GLN . 4.5 pt20 -157.32 107.21 2.21 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.602 -0.686 . . . . 0.0 109.207 179.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.805 HD11 ' HB2' ' A' ' 48' ' ' LEU . 16.1 mt -70.72 179.93 2.43 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.228 -0.92 . . . . 0.0 111.14 -178.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.667 HG21 ' HB3' ' B' ' 29' ' ' GLU . 1.8 t -31.63 -43.43 0.06 Allowed 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 121.053 0.454 . . . . 0.0 111.433 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 172.61 24.44 0.02 OUTLIER Glycine 0 N--CA 1.487 2.071 0 C-N-CA 119.347 -1.406 . . . . 0.0 111.127 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.566 ' CE2' HD11 ' A' ' 44' ' ' LEU . 49.3 p90 -127.82 -49.33 1.36 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.696 -1.473 . . . . 0.0 111.502 178.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.805 ' HB2' HD11 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -96.53 110.75 23.08 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.697 -1.252 . . . . 0.0 112.513 -179.238 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.675 ' O ' ' HB ' ' A' ' 79' ' ' VAL . 1.7 t-20 -105.82 63.33 0.67 Allowed 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.684 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.742 ' HA ' ' CB ' ' A' ' 79' ' ' VAL . 1.1 pp -57.46 130.27 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.69 0 O-C-N 121.117 -0.989 . . . . 0.0 112.67 -177.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.606 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -175.5 112.23 0.27 Allowed Pre-proline 0 N--CA 1.492 1.671 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.171 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.425 ' HG3' ' CG1' ' A' ' 36' ' ' VAL . 55.9 Cg_endo -90.77 156.89 4.15 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 120.882 1.055 . . . . 0.0 111.434 -178.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.583 ' O ' ' N ' ' A' ' 76' ' ' GLY . 32.4 m -139.81 114.92 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 121.913 0.863 . . . . 0.0 111.114 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.561 ' HA ' ' HE1' ' B' ' 94' ' ' TYR . . . -56.41 106.45 0.29 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.691 -0.631 . . . . 0.0 112.137 -178.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.468 ' HB3' ' O ' ' A' ' 54' ' ' ALA . 7.9 ptm180 166.64 136.14 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.783 -0.573 . . . . 0.0 109.556 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.729 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 0.7 OUTLIER -168.6 16.96 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 118.699 -1.2 . . . . 0.0 113.809 -179.882 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.729 ' CB ' ' O ' ' A' ' 56' ' ' GLN . . . 146.19 -167.8 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.928 0 CA-C-N 119.425 1.011 . . . . 0.0 110.758 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.828 ' HA ' ' HA ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -130.2 149.42 51.91 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.717 0.77 . . . . 0.0 111.72 178.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 70' ' ' GLU . 4.1 tttt -150.14 19.65 0.87 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.834 -0.541 . . . . 0.0 110.157 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.7 ' HA3' ' N ' ' A' ' 69' ' ' LEU . . . -106.03 -120.44 4.68 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.854 ' H ' ' H ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -138.67 -149.9 0.31 Allowed 'General case' 0 C--O 1.206 -1.195 0 O-C-N 120.853 -1.381 . . . . 0.0 114.402 -179.583 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.717 ' H ' ' HD2' ' A' ' 63' ' ' PRO . 0.1 OUTLIER 164.02 -33.67 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 121.31 -0.869 . . . . 0.0 112.559 -179.752 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.717 ' HD2' ' H ' ' A' ' 62' ' ' ASN . 37.2 Cg_endo -62.98 -6.23 9.1 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 N-CA-C 110.381 -0.661 . . . . 0.0 110.381 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.55 ' CB ' ' CE2' ' A' ' 61' ' ' PHE . 0.2 OUTLIER -99.01 -72.29 0.66 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.185 -0.947 . . . . 0.0 109.491 178.486 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.1 p -109.41 5.79 23.72 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.441 -0.787 . . . . 0.0 109.998 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.525 ' O ' ' CB ' ' A' ' 67' ' ' GLU . 66.8 mm-40 63.58 92.7 0.06 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.468 -0.77 . . . . 0.0 111.482 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.601 ' H ' ' HA ' ' A' ' 62' ' ' ASN . 2.4 mt-10 155.93 95.76 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.784 ' HA ' ' O ' ' A' ' 61' ' ' PHE . . . -51.08 125.26 13.34 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.836 -1.165 . . . . 0.0 108.82 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.854 ' H ' ' H ' ' A' ' 61' ' ' PHE . 8.2 mt -95.84 54.25 1.49 Allowed 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.401 0.619 . . . . 0.0 111.688 -177.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.443 ' HB2' ' CA ' ' A' ' 60' ' ' GLY . 1.5 mt-10 174.87 50.07 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.828 ' HA ' ' HA ' ' A' ' 58' ' ' ARG . 0.6 OUTLIER -103.17 118.69 50.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-O 122.395 1.093 . . . . 0.0 113.219 -177.549 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.783 ' CB ' ' O ' ' A' ' 71' ' ' ILE . . . 136.57 80.83 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.027 0 CA-C-N 113.979 -1.464 . . . . 0.0 112.419 177.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.679 ' HD2' ' CB ' ' A' ' 56' ' ' GLN . 46.9 Cg_endo -91.18 16.86 1.49 Allowed 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.297 1.156 . . . . 0.0 113.742 178.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.785 ' N ' ' CE2' ' B' ' 94' ' ' TYR . 0.0 OUTLIER -174.23 144.28 0.94 Allowed 'General case' 0 C--N 1.288 -2.067 0 O-C-N 121.354 -0.841 . . . . 0.0 110.049 177.345 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.54 ' N ' ' CE1' ' B' ' 94' ' ' TYR . 0.4 OUTLIER -69.29 174.08 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.439 -1.413 . . . . 0.0 107.465 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' A' ' 53' ' ' VAL . . . -118.95 97.99 0.72 Allowed Glycine 0 N--CA 1.488 2.165 0 C-N-CA 118.837 -1.649 . . . . 0.0 109.631 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.421 HG23 ' CG1' ' A' ' 79' ' ' VAL . 6.1 p -63.09 84.21 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-O 122.504 1.145 . . . . 0.0 108.667 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 76' ' ' GLY . 0.3 OUTLIER -56.7 -44.15 81.24 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.374 -179.397 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.742 ' CB ' ' HA ' ' A' ' 50' ' ' ILE 0.286 1.9 p -45.98 172.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-O 122.758 1.266 . . . . 0.0 113.971 -174.392 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.601 ' N ' ' CG2' ' A' ' 79' ' ' VAL . 0.0 OUTLIER 178.62 174.22 0.39 Allowed Pre-proline 0 C--N 1.309 -1.188 0 CA-C-N 114.403 -1.272 . . . . 0.0 108.204 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.487 ' HD2' ' HB2' ' A' ' 80' ' ' LYS . 39.0 Cg_endo -66.77 153.77 76.81 Favored 'Trans proline' 0 C--N 1.298 -2.095 0 O-C-N 123.464 1.244 . . . . 0.0 109.166 176.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.494 ' C ' ' H ' ' A' ' 84' ' ' SER . . . -120.0 -83.73 0.81 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 108.239 -1.945 . . . . 0.0 108.239 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.941 ' O ' ' N ' ' A' ' 85' ' ' LEU . 17.5 tt0 -76.54 43.56 0.32 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.428 -1.042 . . . . 0.0 108.791 177.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 1.343 ' O ' ' N ' ' A' ' 86' ' ' LYS . 0.5 OUTLIER 7.21 44.69 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 122.212 1.005 . . . . 0.0 110.203 178.567 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.983 ' C ' ' O ' ' A' ' 84' ' ' SER . 0.2 OUTLIER 20.07 28.65 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 104.538 -2.393 . . . . 0.0 104.538 -171.326 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 1.343 ' N ' ' O ' ' A' ' 84' ' ' SER 0.354 7.7 tttt -62.28 -42.07 99.04 Favored 'General case' 0 CA--C 1.483 -1.616 0 N-CA-C 103.496 -2.779 . . . . 0.0 103.496 176.383 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.406 ' O ' ' HG2' ' A' ' 90' ' ' GLU 0.257 24.0 tptt -67.4 -35.48 79.37 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 111.834 -2.439 . . . . 0.0 104.857 175.708 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.67 ' O ' ' CB ' ' B' ' 37' ' ' ALA . . . -71.59 -27.87 63.43 Favored 'General case' 0 C--O 1.211 -0.927 0 C-N-CA 118.326 -1.35 . . . . 0.0 108.36 178.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.671 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . -59.16 -49.92 76.03 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.977 -1.077 . . . . 0.0 109.363 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.456 ' HG2' ' N ' ' A' ' 91' ' ' GLY . 2.2 pt-20 -56.95 -27.96 61.66 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.903 -1.518 . . . . 0.0 106.903 177.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.456 ' N ' ' HG2' ' A' ' 90' ' ' GLU . . . -68.39 -32.46 75.57 Favored Glycine 0 N--CA 1.488 2.155 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.186 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.781 ' HB3' ' HA ' ' B' ' 37' ' ' ALA . 0.8 OUTLIER -84.85 22.12 1.43 Allowed 'General case' 0 N--CA 1.504 2.263 0 O-C-N 120.213 -1.757 . . . . 0.0 110.975 -179.657 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.489 ' O ' ' N ' ' A' ' 96' ' ' ASP . 2.6 mmtt 55.29 38.19 30.01 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 -177.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.625 ' CD1' ' N ' ' B' ' 75' ' ' VAL . 1.5 t80 -33.66 -41.03 0.08 Allowed 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.81 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -54.98 -43.0 73.13 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.333 -0.854 . . . . 0.0 109.629 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 93' ' ' LYS . 11.8 m-20 -62.22 -33.58 74.84 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -77.98 -21.76 50.42 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.452 0.644 . . . . 0.0 109.306 178.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.21 -34.46 68.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.515 -0.74 . . . . 0.0 110.218 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 24.8 mttt . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 117.918 -1.039 . . . . 0.0 110.221 -179.972 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.469 ' CB ' HG21 ' A' ' 42' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . 0.422 ' N ' ' HB2' ' B' ' 5' ' ' GLU . 0.7 OUTLIER 177.67 176.64 0.4 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.016 -1.053 . . . . 0.0 111.324 -179.811 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.512 ' O ' ' CD2' ' B' ' 25' ' ' LEU . 0.9 OUTLIER -47.63 -29.05 2.67 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.174 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.518 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 16.1 m -95.71 -45.39 7.03 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.661 0.743 . . . . 0.0 109.733 179.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.61 ' HA ' ' HE2' ' B' ' 8' ' ' LYS . 0.0 OUTLIER -56.04 -49.87 72.53 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 120.945 -1.097 . . . . 0.0 108.054 179.207 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.465 ' HG ' HG13 ' A' ' 42' ' ' VAL . 7.6 mt -55.8 -35.01 65.85 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.213 -0.995 . . . . 0.0 108.662 177.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' ILE . . . . . 0.566 HG13 HD22 ' B' ' 25' ' ' LEU . 0.3 OUTLIER -50.87 -48.86 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 178.166 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . 0.61 ' HE2' ' HA ' ' B' ' 5' ' ' GLU . 39.7 mtmt -61.99 -37.75 86.0 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . 0.448 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . . . -52.58 -34.39 50.33 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 119.695 -0.802 . . . . 0.0 108.911 178.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . 0.699 ' O ' ' OG1' ' B' ' 14' ' ' THR . 0.8 OUTLIER -99.41 -36.74 5.56 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.627 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.47 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.575 ' HA ' ' OG1' ' B' ' 14' ' ' THR . . . -63.21 -25.89 68.55 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.417 ' N ' ' O ' ' B' ' 8' ' ' LYS . 9.6 mm100 -93.41 -39.21 11.04 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 177.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.446 ' OD2' ' O ' ' B' ' 9' ' ' ALA . 23.9 m-20 -68.21 -20.16 64.82 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 176.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.699 ' OG1' ' O ' ' B' ' 10' ' ' ILE . 31.0 p -93.77 -77.84 0.44 Allowed 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 177.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 61.97 11.45 31.47 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' LEU . . . . . 0.575 HD13 ' HB ' ' B' ' 14' ' ' THR . 3.4 mp -83.18 -65.14 1.05 Allowed 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 122.27 1.034 . . . . 0.0 109.151 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' THR . . . . . 0.576 HG22 ' O ' ' B' ' 17' ' ' THR . 0.5 OUTLIER -140.55 6.73 2.09 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 115.386 -0.824 . . . . 0.0 108.878 -179.724 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . 0.582 ' O ' ' C ' ' B' ' 19' ' ' VAL . 6.8 mt-30 57.38 24.5 10.17 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 -176.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.675 ' HB ' ' HB ' ' A' ' 19' ' ' VAL . 0.1 OUTLIER 17.14 -96.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.36 -178.833 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 1.024 ' O ' ' N ' ' B' ' 22' ' ' SER . 1.4 p -136.25 23.19 3.23 Favored 'General case' 0 C--N 1.272 -2.776 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 176.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.685 ' HA ' ' CE ' ' B' ' 24' ' ' MET . 17.8 m -5.35 -42.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.397 1.094 . . . . 0.0 110.452 -177.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 1.024 ' N ' ' O ' ' B' ' 20' ' ' SER . 27.3 t -73.33 -40.34 64.54 Favored 'General case' 0 C--N 1.281 -2.371 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.498 178.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . 0.873 ' N ' ' O ' ' B' ' 20' ' ' SER . 13.5 ttpt -93.26 -27.42 16.84 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.254 -0.904 . . . . 0.0 111.239 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' MET . . . . . 0.685 ' CE ' ' HA ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -73.63 -25.74 60.45 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 119.905 -1.747 . . . . 0.0 108.281 179.115 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.691 ' HG ' ' N ' ' B' ' 26' ' ' ALA . 0.2 OUTLIER -81.99 -46.27 14.21 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 176.946 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . 0.691 ' N ' ' HG ' ' B' ' 25' ' ' LEU . . . -64.27 -27.73 69.24 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 178.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' SER . . . . . 0.677 ' O ' ' N ' ' B' ' 31' ' ' ILE . 30.6 t -83.67 -40.07 19.41 Favored 'General case' 0 C--O 1.2 -1.549 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . 0.751 ' O ' HG13 ' B' ' 31' ' ' ILE . 0.5 OUTLIER -51.51 -46.4 63.24 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.52 0.676 . . . . 0.0 109.379 179.548 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . 0.667 ' HB3' HG21 ' A' ' 45' ' ' THR . 0.6 OUTLIER -75.31 -31.58 60.69 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 177.855 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . 1.274 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 18.0 ttpt -71.41 -18.54 62.33 Favored 'General case' 0 C--O 1.191 -2.016 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 176.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.751 HG13 ' O ' ' B' ' 28' ' ' PHE . 1.0 OUTLIER -105.82 -32.01 2.68 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.491 0 O-C-N 119.879 -1.763 . . . . 0.0 108.673 178.368 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.608 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.5 mm -67.37 -63.42 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 176.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' THR . . . . . 0.522 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 0.5 OUTLIER -64.3 -45.11 89.4 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.74 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 1.274 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 15.6 mm-40 -68.79 -27.72 66.13 Favored 'General case' 0 C--N 1.31 -1.116 0 O-C-N 121.339 -0.851 . . . . 0.0 111.165 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' THR . . . . . 0.595 ' CB ' ' O ' ' B' ' 31' ' ' ILE . 1.1 m -57.85 -51.14 70.84 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 177.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.463 ' CG2' ' CD1' ' A' ' 85' ' ' LEU . 4.3 t -54.07 -36.25 31.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 117.249 -1.78 . . . . 0.0 107.068 177.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . 0.781 ' HA ' ' HB3' ' A' ' 92' ' ' LEU . . . -81.4 1.09 34.55 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.212 177.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' B' ' 34' ' ' GLU . 0.0 OUTLIER -108.72 -25.69 10.71 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.703 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.22 40.7 1.48 Allowed Glycine 0 C--N 1.303 -1.289 0 C-N-CA 119.946 -1.121 . . . . 0.0 110.748 178.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . 0.47 ' CB ' HG21 ' B' ' 35' ' ' THR . 0.3 OUTLIER -136.77 135.83 38.39 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.086 -1.244 . . . . 0.0 110.553 179.594 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.9 93.12 9.29 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.48 -0.762 . . . . 0.0 109.006 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . 0.421 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 14.1 t -59.3 135.17 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.499 -0.75 . . . . 0.0 110.008 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' GLN . . . . . 0.45 ' HA ' ' HA ' ' B' ' 49' ' ' ASN . 11.2 mt-30 -132.0 91.95 3.04 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.501 -0.749 . . . . 0.0 109.757 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.646 HD13 ' CB ' ' B' ' 48' ' ' LEU . 7.6 mt -67.65 -179.28 1.07 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.284 -0.885 . . . . 0.0 110.979 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' THR . . . . . 0.724 HG23 ' HG2' ' A' ' 29' ' ' GLU . 3.2 t -52.53 73.38 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 O-C-N 122.109 -0.369 . . . . 0.0 111.687 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . 40.09 62.12 1.57 Allowed Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . 0.642 ' CE1' ' HG ' ' B' ' 48' ' ' LEU . 0.2 OUTLIER -163.45 -45.16 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.445 -1.032 . . . . 0.0 108.775 -179.867 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . 0.646 ' CB ' HD13 ' B' ' 44' ' ' LEU . 0.0 OUTLIER -125.02 102.17 7.39 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.785 -0.572 . . . . 0.0 109.958 178.843 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' ASN . . . . . 0.929 ' O ' ' O ' ' B' ' 79' ' ' VAL . 0.7 OUTLIER -120.24 100.58 7.26 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.11 -0.994 . . . . 0.0 110.568 -179.635 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' ILE . . . . . 0.54 ' N ' ' HD3' ' B' ' 80' ' ' LYS . 0.4 OUTLIER -90.84 140.8 15.36 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 O-C-N 121.252 -0.905 . . . . 0.0 110.921 -179.177 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . 0.489 ' O ' ' HD3' ' B' ' 51' ' ' LYS . 0.0 OUTLIER -157.3 119.37 2.11 Favored Pre-proline 0 N--CA 1.496 1.825 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.663 179.205 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . 0.597 ' HA ' ' HA ' ' B' ' 77' ' ' VAL . 57.2 Cg_endo -87.9 136.55 3.68 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.62 1.326 . . . . 0.0 110.778 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.536 ' O ' ' N ' ' B' ' 76' ' ' GLY . 30.6 m -128.41 111.7 24.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-O 122.016 0.913 . . . . 0.0 110.642 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.562 ' HA ' ' HE1' ' A' ' 94' ' ' TYR . . . -61.78 127.42 31.33 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.879 -0.513 . . . . 0.0 111.534 -178.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . 0.451 ' CB ' ' O ' ' B' ' 54' ' ' ALA . 3.1 mtt180 168.86 55.81 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.371 -0.83 . . . . 0.0 110.355 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . 0.766 ' O ' ' HA ' ' B' ' 73' ' ' PRO . 29.8 mt-30 -155.18 110.95 3.11 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.965 -1.084 . . . . 0.0 111.42 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.492 ' N ' ' CD1' ' B' ' 71' ' ' ILE . . . 176.5 121.66 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.233 -0.917 . . . . 0.0 110.002 178.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' ARG . . . . . 0.438 ' CD ' ' HB3' ' B' ' 69' ' ' LEU . 0.1 OUTLIER -166.98 158.72 12.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.285 -0.884 . . . . 0.0 110.583 -179.502 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . 0.404 ' CG ' ' HA ' ' B' ' 70' ' ' GLU . 1.6 mtmt -172.34 125.0 0.51 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.525 -0.734 . . . . 0.0 109.549 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.23 -112.12 0.41 Allowed Glycine 0 N--CA 1.49 2.28 0 C-N-CA 119.603 -1.284 . . . . 0.0 110.405 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' PHE . . . . . 0.622 ' C ' ' CD1' ' B' ' 61' ' ' PHE . 19.3 p90 -171.1 -179.77 2.82 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.5 -1.0 . . . . 0.0 110.042 -179.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . 0.839 ' H ' ' HD2' ' B' ' 63' ' ' PRO . 0.0 OUTLIER -135.66 -44.68 0.02 OUTLIER Pre-proline 0 C--N 1.297 -1.684 0 C-N-CA 119.667 -0.813 . . . . 0.0 112.388 178.347 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . 0.839 ' HD2' ' H ' ' B' ' 62' ' ' ASN . 41.3 Cg_endo -69.31 63.46 1.53 Allowed 'Trans proline' 0 N--CA 1.488 1.154 0 O-C-N 122.768 0.878 . . . . 0.0 110.88 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . 0.566 ' CB ' ' CE1' ' B' ' 61' ' ' PHE . 2.8 mt-30 -167.57 -106.87 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.454 ' O ' ' CB ' ' B' ' 66' ' ' GLN . 0.6 OUTLIER -75.63 -4.14 38.47 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.347 -1.471 . . . . 0.0 109.122 177.345 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . 0.504 ' O ' ' HB3' ' B' ' 67' ' ' GLU . 0.9 OUTLIER 75.57 102.22 0.07 Allowed 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 121.455 0.645 . . . . 0.0 112.048 179.141 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . 0.504 ' HB3' ' O ' ' B' ' 66' ' ' GLN . 1.5 pt-20 160.09 69.34 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . 0.602 ' HA ' ' O ' ' B' ' 61' ' ' PHE . . . -66.33 135.95 55.11 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.869 0.842 . . . . 0.0 111.121 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.438 ' HB3' ' CD ' ' B' ' 58' ' ' ARG . 0.2 OUTLIER -141.95 142.46 33.0 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -178.68 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . 0.404 ' HA ' ' CG ' ' B' ' 59' ' ' LYS . 16.4 pt-20 -172.36 19.83 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.049 -1.032 . . . . 0.0 111.864 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.492 ' CD1' ' N ' ' B' ' 57' ' ' ALA . 1.1 pt -64.8 -155.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 120.826 -1.171 . . . . 0.0 108.876 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . 0.461 ' CB ' ' HD2' ' B' ' 73' ' ' PRO . . . -156.66 169.96 9.69 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 120.825 -1.172 . . . . 0.0 112.601 -179.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' PRO . . . . . 0.766 ' HA ' ' O ' ' B' ' 56' ' ' GLN . 42.0 Cg_endo -68.32 117.87 5.25 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 125.07 2.09 . . . . 0.0 111.401 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' SER . . . . . 0.511 ' N ' ' CE2' ' A' ' 94' ' ' TYR . 1.3 m -165.55 126.96 1.95 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.57 -0.706 . . . . 0.0 109.112 179.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . 0.625 ' N ' ' CD1' ' A' ' 94' ' ' TYR . 0.3 OUTLIER -54.07 175.5 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.816 -1.177 . . . . 0.0 109.376 -179.293 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . 0.611 ' O ' ' N ' ' B' ' 78' ' ' SER . . . -107.57 57.27 0.45 Allowed Glycine 0 N--CA 1.484 1.842 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.606 ' O ' ' O ' ' B' ' 78' ' ' SER . 73.5 t -45.17 87.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 122.117 -0.637 . . . . 0.0 109.944 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' SER . . . . . 0.611 ' N ' ' O ' ' B' ' 76' ' ' GLY . 5.7 m -57.54 -129.03 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . 0.929 ' O ' ' O ' ' B' ' 49' ' ' ASN . 1.9 m -144.34 179.74 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 119.702 -1.874 . . . . 0.0 113.2 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . 0.728 ' H ' ' HD2' ' B' ' 81' ' ' PRO . 3.6 mmtt -101.81 -54.8 0.13 Allowed Pre-proline 0 C--N 1.296 -1.731 0 CA-C-N 113.962 -1.472 . . . . 0.0 112.526 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' PRO . . . . . 0.728 ' HD2' ' H ' ' B' ' 80' ' ' LYS . 28.6 Cg_endo -53.35 114.78 1.9 Allowed 'Trans proline' 0 C--N 1.298 -2.083 0 O-C-N 123.317 1.167 . . . . 0.0 110.339 -177.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -130.85 -57.9 0.09 OUTLIER Glycine 0 N--CA 1.478 1.436 0 N-CA-C 107.072 -2.411 . . . . 0.0 107.072 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . 0.833 ' O ' ' N ' ' B' ' 85' ' ' LEU . 25.7 tt0 -82.78 56.21 3.32 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 177.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' SER . . . . . 1.304 ' O ' ' N ' ' B' ' 86' ' ' LYS . 1.3 m 8.9 45.2 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.983 0.897 . . . . 0.0 111.561 178.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . 0.999 ' C ' ' O ' ' B' ' 84' ' ' SER . 1.2 mt 22.08 29.36 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 103.745 -2.687 . . . . 0.0 103.745 -171.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . 1.304 ' N ' ' O ' ' B' ' 84' ' ' SER 0.337 8.3 tttt -59.26 -40.71 86.84 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 104.074 -2.565 . . . . 0.0 104.074 177.119 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . 0.407 ' O ' ' HG2' ' B' ' 90' ' ' GLU 0.278 6.7 tttp -63.62 -37.67 88.19 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 112.248 -2.251 . . . . 0.0 105.749 175.23 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.727 ' O ' ' CB ' ' A' ' 37' ' ' ALA . . . -78.14 -24.57 47.3 Favored 'General case' 0 C--O 1.207 -1.145 0 C-N-CA 119.023 -1.071 . . . . 0.0 108.185 178.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . 0.71 ' N ' ' O ' ' B' ' 85' ' ' LEU . . . -76.03 -37.75 58.02 Favored 'General case' 0 C--N 1.291 -1.959 0 O-C-N 120.962 -1.086 . . . . 0.0 109.036 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' B' ' 87' ' ' LYS . 3.7 pt-20 -66.98 -23.54 65.95 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 176.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . 0.464 ' HA3' ' HB3' ' A' ' 37' ' ' ALA . . . -72.39 -38.92 57.99 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . 0.731 ' HB3' ' HA ' ' A' ' 37' ' ' ALA . 2.2 pp -76.5 22.25 0.18 Allowed 'General case' 0 N--CA 1.503 2.218 0 CA-C-N 120.177 1.988 . . . . 0.0 110.618 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . 0.49 ' O ' ' N ' ' B' ' 96' ' ' ASP . 0.1 OUTLIER 54.77 49.39 18.03 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 106.457 -1.682 . . . . 0.0 106.457 -177.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . 0.785 ' CE2' ' N ' ' A' ' 74' ' ' SER . 28.3 t80 -27.56 -46.22 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.919 -178.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -57.35 -48.13 79.8 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.302 -0.874 . . . . 0.0 109.79 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 96' ' ' ASP . . . . . 0.49 ' N ' ' O ' ' B' ' 93' ' ' LYS . 7.8 m-20 -54.24 -33.54 58.67 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.414 -0.804 . . . . 0.0 109.008 178.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 97' ' ' PHE . . . . . 0.424 ' HB2' ' CD1' ' B' ' 92' ' ' LEU . 0.4 OUTLIER -86.93 -22.18 25.81 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.816 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 98' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' B' ' 94' ' ' TYR . . . -66.04 -31.69 72.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.638 -0.664 . . . . 0.0 110.203 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 117.948 -1.025 . . . . 0.0 110.205 -179.753 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.443 ' HA ' ' CB ' ' A' ' 5' ' ' GLU . 5.8 mtp . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 120.972 0.415 . . . . 0.0 110.075 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.402 ' N ' HD13 ' A' ' 6' ' ' LEU . 5.2 t-20 -172.62 -173.34 1.0 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.055 -1.028 . . . . 0.0 111.059 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.521 ' O ' ' CG2' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -51.53 -15.7 0.48 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.219 -0.926 . . . . 0.0 110.034 179.419 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.631 ' O ' HG13 ' A' ' 7' ' ' ILE . 18.5 m -107.82 -55.42 2.36 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 122.094 0.95 . . . . 0.0 109.261 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.664 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 0.4 OUTLIER -50.83 -47.69 60.1 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.104 -0.997 . . . . 0.0 108.832 179.37 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.42 ' HG ' ' HB3' ' A' ' 1' ' ' MET . 1.0 OUTLIER -58.38 -30.6 66.92 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.542 -0.863 . . . . 0.0 110.146 178.563 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.631 HG13 ' O ' ' A' ' 4' ' ' THR . 1.0 OUTLIER -60.47 -41.14 86.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.829 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.664 ' HE2' ' HA ' ' A' ' 5' ' ' GLU . 33.4 mtmt -65.47 -36.42 83.84 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 177.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.414 ' CB ' HD11 ' B' ' 31' ' ' ILE . . . -55.88 -38.18 69.82 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.6 -0.688 . . . . 0.0 109.176 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.597 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.4 mp -90.05 -32.09 5.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 178.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.653 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -66.41 -11.14 50.06 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 119.055 -1.058 . . . . 0.0 108.345 178.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.5 tp-100 -116.36 -43.77 2.92 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.446 ' HB3' ' HB2' ' B' ' 27' ' ' SER . 2.1 m-20 -65.13 -38.4 90.51 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 177.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.597 ' OG1' ' O ' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -98.37 -70.95 0.71 Allowed 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 178.036 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.416 ' CA ' ' O ' ' A' ' 11' ' ' ALA . . . 45.06 27.42 1.54 Allowed Glycine 0 N--CA 1.5 2.952 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 178.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.565 ' CD1' ' CG2' ' B' ' 19' ' ' VAL . 0.1 OUTLIER -84.46 -20.3 31.97 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.678 -0.895 . . . . 0.0 109.255 179.139 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.538 HG21 ' CG2' ' B' ' 17' ' ' THR . 0.4 OUTLIER -162.96 -7.75 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.819 -0.551 . . . . 0.0 110.573 -178.914 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.478 ' O ' ' C ' ' A' ' 19' ' ' VAL . 4.6 mt-30 59.73 33.83 21.91 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 -176.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.706 ' HB ' ' HB ' ' B' ' 19' ' ' VAL . 2.8 p -23.88 -98.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.228 -178.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.941 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -129.71 22.7 5.43 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 178.625 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.604 ' C ' ' O ' ' A' ' 20' ' ' SER . 28.1 m -25.42 -39.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 CA-C-O 122.31 1.053 . . . . 0.0 109.05 -178.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.695 ' N ' ' O ' ' A' ' 20' ' ' SER . 23.0 t -83.45 -34.57 25.4 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 114.922 -1.036 . . . . 0.0 109.326 177.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.941 ' N ' ' O ' ' A' ' 20' ' ' SER . 2.4 mtmt -87.35 -31.76 19.97 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.676 -0.64 . . . . 0.0 111.481 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.576 ' HG2' HG22 ' B' ' 14' ' ' THR . 0.0 OUTLIER -77.47 -35.71 53.5 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.45 -1.407 . . . . 0.0 108.869 179.186 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.575 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 13.4 mt -76.34 -41.42 48.4 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 118.462 -1.295 . . . . 0.0 108.737 178.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.438 ' HA ' ' HG2' ' A' ' 3' ' ' LYS . . . -62.59 -35.26 78.96 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 177.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.519 ' O ' ' N ' ' A' ' 31' ' ' ILE . 60.2 p -83.67 -29.02 27.95 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.635 ' O ' ' CG1' ' A' ' 32' ' ' ILE . 0.6 OUTLIER -51.55 -40.28 59.41 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.742 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.689 ' HG3' HG21 ' B' ' 45' ' ' THR . 0.2 OUTLIER -73.49 -41.55 62.97 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 175.816 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.892 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 12.5 tttt -56.63 -22.78 36.65 Favored 'General case' 0 C--O 1.192 -1.967 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 177.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.599 HG13 ' O ' ' A' ' 28' ' ' PHE . 0.5 OUTLIER -106.28 -30.72 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 120.521 -1.362 . . . . 0.0 109.307 178.168 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.635 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.5 mm -71.43 -53.41 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 176.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.603 ' HA ' ' CD2' ' B' ' 85' ' ' LEU 0.26 3.6 m -61.78 -53.86 50.19 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.73 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.892 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 62.0 mm-40 -62.14 -34.53 76.55 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.711 -0.618 . . . . 0.0 110.822 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.531 HG21 ' CB ' ' A' ' 40' ' ' ASP . 1.0 OUTLIER -55.03 -53.26 58.14 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 120.839 -1.163 . . . . 0.0 108.428 179.026 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.457 HG12 ' CG2' ' A' ' 77' ' ' VAL . 4.0 t -51.95 -42.35 33.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 C-N-CA 118.656 -1.217 . . . . 0.0 107.924 178.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.895 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -78.23 -1.93 35.33 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.341 177.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 35' ' ' THR . 0.0 OUTLIER -108.49 -8.01 15.64 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.73 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.28 49.7 4.59 Favored Glycine 0 C--N 1.305 -1.192 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.531 ' CB ' HG21 ' A' ' 35' ' ' THR . 0.1 OUTLIER -131.22 134.8 46.81 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.1 -1.236 . . . . 0.0 110.783 179.51 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -98.57 110.21 22.84 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.624 ' HB ' ' CG1' ' A' ' 50' ' ' ILE . 39.4 t -89.9 120.92 39.48 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 C-N-CA 119.116 -1.034 . . . . 0.0 111.031 -178.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -108.88 91.02 3.47 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.545 HD11 ' CZ ' ' A' ' 47' ' ' PHE . 9.8 mt -60.88 104.53 0.37 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.547 -0.721 . . . . 0.0 110.783 -178.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.594 HG21 ' HG3' ' B' ' 29' ' ' GLU . 0.1 OUTLIER 32.91 -91.43 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 120.892 0.377 . . . . 0.0 111.402 179.498 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.49 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -149.12 29.81 1.22 Allowed Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.635 ' CE2' ' HG3' ' B' ' 29' ' ' GLU . 1.8 p90 -131.33 -22.69 2.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.286 -1.126 . . . . 0.0 111.585 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.588 ' HG ' ' CE1' ' A' ' 47' ' ' PHE . 5.3 mt -133.86 119.52 19.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.235 -1.541 . . . . 0.0 110.712 178.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.625 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 0.6 OUTLIER -119.97 84.18 2.17 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.432 -0.793 . . . . 0.0 111.586 -178.656 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.627 ' HA ' ' HA ' ' A' ' 79' ' ' VAL . 1.1 pt -83.3 147.66 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.042 -1.036 . . . . 0.0 110.425 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.421 ' HG3' ' HB2' ' A' ' 78' ' ' SER . 0.4 OUTLIER -165.94 113.99 0.78 Allowed Pre-proline 0 N--CA 1.495 1.778 0 C-N-CA 119.011 -1.076 . . . . 0.0 110.72 179.427 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.562 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 47.4 Cg_endo -71.31 143.92 44.71 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 O-C-N 123.51 1.269 . . . . 0.0 111.26 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.578 ' O ' ' N ' ' A' ' 76' ' ' GLY . 25.8 m -138.23 114.88 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.726 0.774 . . . . 0.0 110.526 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.433 ' HA ' HG21 ' A' ' 75' ' ' VAL . . . -44.49 116.42 1.04 Allowed 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.735 0.778 . . . . 0.0 112.482 -178.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -143.15 136.66 28.43 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.501 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 14.3 mp0 -95.86 -175.36 3.39 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.073 -1.017 . . . . 0.0 111.249 -179.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.459 ' CB ' HD12 ' A' ' 71' ' ' ILE . . . -173.74 -153.58 0.06 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.449 -0.782 . . . . 0.0 111.187 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.859 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -113.41 -148.43 0.43 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.59 -0.694 . . . . 0.0 111.381 -178.382 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.806 ' O ' ' N ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -144.09 -148.79 0.25 Allowed 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.754 -1.216 . . . . 0.0 108.576 178.521 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.587 ' HA2' ' C ' ' A' ' 69' ' ' LEU . . . -146.79 96.08 0.17 Allowed Glycine 0 N--CA 1.483 1.814 0 C-N-CA 118.95 -1.595 . . . . 0.0 111.423 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.807 ' CE2' ' HB2' ' A' ' 66' ' ' GLN . 6.9 p90 -167.42 159.49 12.46 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.281 -1.129 . . . . 0.0 111.349 178.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.728 ' H ' ' CD ' ' A' ' 63' ' ' PRO . 0.4 OUTLIER -139.98 -27.27 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.731 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -179.141 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.728 ' CD ' ' H ' ' A' ' 62' ' ' ASN . 42.6 Cg_endo -73.18 -11.31 25.03 Favored 'Trans proline' 0 N--CA 1.485 0.975 0 CA-C-N 118.896 0.641 . . . . 0.0 110.533 -178.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.594 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 0.9 OUTLIER -91.62 49.39 1.57 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.372 -0.83 . . . . 0.0 109.341 178.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 64' ' ' GLN . 2.7 p 56.29 48.85 16.35 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.849 -0.532 . . . . 0.0 110.371 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.807 ' HB2' ' CE2' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -153.82 -152.53 0.42 Allowed 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.371 -0.831 . . . . 0.0 110.619 -179.495 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.631 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 9.7 mp0 -131.42 130.2 42.23 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 178.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.55 ' HA ' ' C ' ' A' ' 61' ' ' PHE . . . -58.53 133.15 55.57 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-O 122.017 0.913 . . . . 0.0 111.289 -178.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.706 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 1.3 mt -142.02 -137.49 0.11 Allowed 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.832 ' O ' ' O ' ' A' ' 71' ' ' ILE . 3.2 tt0 -166.48 -128.2 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.538 -1.352 . . . . 0.0 112.551 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.832 ' O ' ' O ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -10.77 153.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -176.501 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.859 ' HA ' ' O ' ' A' ' 58' ' ' ARG . . . -137.47 -171.86 0.29 Allowed Pre-proline 0 C--N 1.298 -1.657 0 CA-C-N 114.878 -1.055 . . . . 0.0 112.686 -177.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.694 ' HD2' ' CB ' ' A' ' 72' ' ' ALA . 38.3 Cg_endo -66.06 117.76 4.94 Favored 'Trans proline' 0 C--N 1.318 -1.069 0 O-C-N 124.236 1.65 . . . . 0.0 110.963 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.507 ' HA ' ' CD2' ' B' ' 94' ' ' TYR . 0.8 OUTLIER -157.86 149.12 21.37 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.768 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.538 ' N ' ' CD1' ' B' ' 94' ' ' TYR . 0.4 OUTLIER -48.53 166.99 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.103 -0.998 . . . . 0.0 109.961 -179.364 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 53' ' ' VAL . . . -108.15 85.72 0.42 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.18 -1.968 . . . . 0.0 108.18 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.728 HG22 ' HB2' ' B' ' 85' ' ' LEU . 73.4 t -60.19 80.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.781 -0.835 . . . . 0.0 110.557 -179.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.468 ' N ' ' O ' ' A' ' 76' ' ' GLY . 0.3 OUTLIER -75.43 178.48 5.88 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.27 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.627 ' HA ' ' HA ' ' A' ' 50' ' ' ILE . 6.6 p 178.64 177.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 48' ' ' LEU . 1.4 mttt -175.83 173.67 0.88 Allowed Pre-proline 0 N--CA 1.487 1.396 0 O-C-N 120.799 -1.188 . . . . 0.0 111.069 178.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.438 ' HG3' HG12 ' B' ' 79' ' ' VAL . 56.5 Cg_endo -94.96 142.69 1.32 Allowed 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 122.586 2.191 . . . . 0.0 109.407 177.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.49 ' HA3' ' O ' ' A' ' 46' ' ' GLY . . . -106.26 163.97 13.65 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.273 -1.931 . . . . 0.0 108.273 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.34 -24.79 57.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.071 -1.252 . . . . 0.0 110.624 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.416 ' HB2' ' HB3' ' A' ' 47' ' ' PHE . 3.5 m -55.29 -36.64 66.37 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.037 -1.039 . . . . 0.0 108.652 178.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.6 ' HG ' ' HA ' ' B' ' 33' ' ' THR . 0.5 OUTLIER -80.69 -30.78 36.38 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.757 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.435 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -77.32 -41.9 38.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.639 -0.663 . . . . 0.0 109.947 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.3 ttmt -64.15 -38.97 92.98 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.65 ' O ' ' HB3' ' B' ' 37' ' ' ALA . . . -66.18 -35.99 81.9 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 176.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.469 ' N ' ' HB2' ' B' ' 37' ' ' ALA . . . -56.65 -39.39 73.62 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.774 -0.77 . . . . 0.0 108.932 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.39 -33.05 65.39 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 176.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.473 ' C ' ' H ' ' A' ' 93' ' ' LYS . . . -60.21 -42.33 98.61 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 178.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.546 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 0.5 OUTLIER -65.2 6.01 0.31 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.729 -1.454 . . . . 0.0 110.822 179.649 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.556 ' HB3' ' HB2' ' A' ' 96' ' ' ASP . 3.1 mmtt 80.07 52.95 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 CA-C-O 122.052 0.929 . . . . 0.0 108.783 -179.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.944 ' CD1' ' HB2' ' B' ' 74' ' ' SER . 4.5 t80 -42.28 -61.87 1.08 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.521 ' HA ' ' CB ' ' B' ' 74' ' ' SER . 15.2 mt-10 -51.18 -33.83 28.9 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.878 -1.139 . . . . 0.0 110.305 179.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.556 ' HB2' ' HB3' ' A' ' 93' ' ' LYS . 9.2 t0 -62.41 -26.12 68.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.277 -0.89 . . . . 0.0 109.133 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.493 ' HB3' ' HB1' ' B' ' 54' ' ' ALA . 0.5 OUTLIER -84.52 -20.81 31.0 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.232 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.592 ' HB1' ' HB3' ' B' ' 74' ' ' SER . . . -69.43 -36.6 76.81 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.633 -0.667 . . . . 0.0 109.804 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 14.8 mttm . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 118.005 -0.997 . . . . 0.0 110.221 -179.889 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.438 ' HA ' ' CB ' ' B' ' 5' ' ' GLU . 9.6 mtp . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 120.869 0.366 . . . . 0.0 110.08 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . 0.444 ' O ' ' HB2' ' B' ' 6' ' ' LEU . 0.7 OUTLIER -172.44 -169.59 0.62 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.126 -0.984 . . . . 0.0 111.017 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.579 ' O ' ' CG2' ' B' ' 7' ' ' ILE . 0.0 OUTLIER -56.53 -10.85 1.06 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.308 -0.87 . . . . 0.0 110.098 179.61 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.664 ' O ' HG13 ' B' ' 7' ' ' ILE . 37.1 m -109.86 -56.68 2.29 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 122.162 0.982 . . . . 0.0 108.761 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.581 ' HA ' ' HE2' ' B' ' 8' ' ' LYS . 0.1 OUTLIER -49.4 -46.11 47.01 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.057 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.489 HD12 HG11 ' A' ' 42' ' ' VAL . 5.3 mt -64.45 -27.01 68.7 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.154 -1.019 . . . . 0.0 110.557 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' ILE . . . . . 0.664 HG13 ' O ' ' B' ' 4' ' ' THR . 1.2 pp -59.36 -41.68 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 120.37 -1.456 . . . . 0.0 107.306 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . 0.581 ' HE2' ' HA ' ' B' ' 5' ' ' GLU . 18.6 mtmt -67.36 -44.09 79.84 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 177.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.69 -32.11 50.52 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.646 -0.659 . . . . 0.0 109.863 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . 0.734 ' O ' ' OG1' ' B' ' 14' ' ' THR . 0.8 OUTLIER -94.4 -29.85 4.21 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.478 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 178.162 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.558 ' HB2' ' HA ' ' B' ' 8' ' ' LYS . . . -63.08 -28.53 70.14 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 177.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.436 ' HG3' ' O ' ' B' ' 8' ' ' LYS . 58.5 mt-30 -87.96 -43.85 11.45 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.428 ' HB3' ' OG ' ' A' ' 27' ' ' SER . 94.1 m-20 -64.16 -26.1 68.38 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 177.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.734 ' OG1' ' O ' ' B' ' 10' ' ' ILE . 20.6 p -87.74 -76.74 0.37 Allowed 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 177.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 61.32 10.99 25.1 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' LEU . . . . . 0.607 HD13 ' HB ' ' B' ' 14' ' ' THR . 3.1 mp -82.33 -67.16 0.81 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.525 -0.985 . . . . 0.0 109.204 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' THR . . . . . 0.538 ' CG2' HG21 ' A' ' 17' ' ' THR . 0.5 OUTLIER -137.52 6.39 2.74 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.787 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . 0.639 ' O ' ' C ' ' B' ' 19' ' ' VAL . 15.4 mt-30 57.97 25.88 12.75 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 -176.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.706 ' HB ' ' HB ' ' A' ' 19' ' ' VAL . 0.4 OUTLIER 4.17 -102.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.642 -179.099 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.967 ' O ' ' N ' ' B' ' 22' ' ' SER . 0.2 OUTLIER -135.2 24.09 3.52 Favored 'General case' 0 C--N 1.27 -2.853 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 177.33 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.601 ' C ' ' O ' ' B' ' 20' ' ' SER . 35.2 m -12.4 -38.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-O 122.394 1.092 . . . . 0.0 110.469 -177.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.967 ' N ' ' O ' ' B' ' 20' ' ' SER . 12.1 t -80.14 -46.87 15.65 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.34 177.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . 0.939 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.1 OUTLIER -85.44 -24.1 27.59 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.855 -0.528 . . . . 0.0 110.085 178.624 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' MET . . . . . 0.536 ' HE2' ' HA ' ' B' ' 21' ' ' VAL . 3.5 tmm? -68.37 -45.1 73.71 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.648 ' HA ' ' HB3' ' B' ' 28' ' ' PHE . 11.6 mt -71.0 -34.79 71.69 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 176.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . 0.456 ' HA ' ' HE3' ' B' ' 3' ' ' LYS . . . -62.29 -34.72 77.12 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 177.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' SER . . . . . 0.446 ' HB2' ' HB3' ' A' ' 13' ' ' ASP . 0.1 OUTLIER -76.38 -40.71 50.28 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 177.636 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . 0.648 ' HB3' ' HA ' ' B' ' 25' ' ' LEU . 0.1 OUTLIER -52.84 -45.94 67.57 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.163 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . 0.635 ' HG3' ' CE2' ' A' ' 47' ' ' PHE . 1.2 tt0 -68.58 -36.38 78.66 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 177.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . 1.252 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 13.4 ttmt -64.71 -22.74 67.05 Favored 'General case' 0 C--O 1.191 -1.989 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.596 HG13 ' O ' ' B' ' 28' ' ' PHE . 0.6 OUTLIER -105.83 -27.61 3.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 O-C-N 120.282 -1.511 . . . . 0.0 109.335 178.237 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.645 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.2 mm -73.18 -60.42 2.43 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 177.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' THR . . . . . 0.6 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 0.6 OUTLIER -68.75 -35.21 76.81 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.553 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 1.252 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 31.1 mm-40 -78.54 -37.78 42.06 Favored 'General case' 0 C--O 1.207 -1.184 0 O-C-N 121.115 -0.99 . . . . 0.0 111.952 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' THR . . . . . 0.514 ' CB ' ' O ' ' B' ' 31' ' ' ILE . 37.2 m -61.95 -49.99 73.92 Favored 'General case' 0 N--CA 1.504 2.246 0 CA-C-N 120.714 1.597 . . . . 0.0 109.201 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.515 HG11 ' HB3' ' B' ' 52' ' ' PRO . 2.1 t -52.83 -43.53 45.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 178.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . 0.65 ' HB3' ' O ' ' A' ' 88' ' ' ALA . . . -85.99 0.82 52.31 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.834 178.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . 0.735 ' HB2' ' O ' ' B' ' 34' ' ' GLU . 7.6 tppt? -96.05 -33.46 12.1 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 177.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 134.01 33.44 0.33 Allowed Glycine 0 C--N 1.303 -1.263 0 C-N-CA 119.581 -1.295 . . . . 0.0 111.482 177.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . 0.453 ' CB ' ' CG2' ' B' ' 35' ' ' THR . 0.1 OUTLIER -144.85 157.55 44.12 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.752 -1.44 . . . . 0.0 110.66 179.356 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -103.96 99.81 9.57 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.518 -0.739 . . . . 0.0 109.61 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 59.7 t -59.07 136.28 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.584 -0.698 . . . . 0.0 110.085 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -127.96 97.25 4.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.342 -0.849 . . . . 0.0 109.403 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.57 ' HB3' ' CE1' ' B' ' 47' ' ' PHE . 11.0 mt -69.1 101.6 1.47 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.249 -0.907 . . . . 0.0 110.442 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' THR . . . . . 0.689 HG21 ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 32.34 -95.1 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.036 0 O-C-N 122.052 -0.405 . . . . 0.0 111.451 179.277 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -144.41 30.71 1.85 Allowed Glycine 0 N--CA 1.487 2.037 0 C-N-CA 119.668 -1.253 . . . . 0.0 110.448 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . 0.623 ' O ' ' HA ' ' B' ' 81' ' ' PRO . 3.9 p90 -133.65 -18.6 2.15 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.893 -1.357 . . . . 0.0 111.686 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . 0.566 ' HG ' ' CE2' ' B' ' 47' ' ' PHE . 4.6 mt -135.47 120.25 18.43 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.337 -1.477 . . . . 0.0 111.196 178.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' ASN . . . . . 0.486 ' O ' ' HA ' ' B' ' 79' ' ' VAL . 2.6 m120 -116.95 94.56 4.64 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.506 -0.747 . . . . 0.0 111.208 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' ILE . . . . . 0.48 ' HA ' ' HA ' ' B' ' 79' ' ' VAL . 33.8 mm -90.19 141.91 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.305 -0.872 . . . . 0.0 109.739 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . 0.432 ' O ' ' N ' ' B' ' 78' ' ' SER . 2.3 pttt -162.44 128.63 2.35 Favored Pre-proline 0 N--CA 1.498 1.951 0 O-C-N 120.582 -1.324 . . . . 0.0 111.439 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . 0.515 ' HB3' HG11 ' B' ' 36' ' ' VAL . 52.5 Cg_endo -77.12 145.15 24.27 Favored 'Trans proline' 0 C--N 1.314 -1.24 0 O-C-N 123.531 1.28 . . . . 0.0 110.72 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.529 ' O ' ' N ' ' B' ' 76' ' ' GLY . 15.3 m -156.57 121.28 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-O 121.257 0.551 . . . . 0.0 109.962 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.838 ' HA ' ' N ' ' B' ' 75' ' ' VAL . . . -68.04 125.02 25.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.12 -0.988 . . . . 0.0 111.561 -178.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . 0.575 ' HB2' ' O ' ' B' ' 54' ' ' ALA . 0.1 OUTLIER 172.23 39.63 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.831 -179.671 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . 0.495 ' O ' ' OH ' ' A' ' 94' ' ' TYR . 0.8 OUTLIER -122.56 96.88 5.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.235 -0.916 . . . . 0.0 110.04 -179.533 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.502 ' CB ' ' HD3' ' B' ' 73' ' ' PRO . . . -137.36 166.75 23.06 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.237 -0.985 . . . . 0.0 111.318 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' ARG . . . . . 0.574 ' N ' ' HD3' ' B' ' 58' ' ' ARG . 0.0 OUTLIER -98.3 157.33 16.24 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.752 -0.592 . . . . 0.0 110.949 -178.901 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' B' ' 58' ' ' ARG . 0.7 OUTLIER -178.88 40.06 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.586 -0.696 . . . . 0.0 109.484 179.278 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -106.78 -108.43 3.3 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' PHE . . . . . 0.804 ' O ' ' N ' ' B' ' 67' ' ' GLU . 5.9 p90 -179.34 172.45 1.2 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.291 -1.123 . . . . 0.0 110.238 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . 0.549 ' CB ' ' HB1' ' B' ' 68' ' ' ALA . 1.8 t30 -106.85 -60.07 0.05 OUTLIER Pre-proline 0 N--CA 1.499 1.986 0 O-C-N 120.95 -1.094 . . . . 0.0 112.184 -178.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . 0.523 ' HD2' ' H ' ' B' ' 62' ' ' ASN . 41.6 Cg_endo -67.89 62.82 0.94 Allowed 'Trans proline' 0 C--N 1.315 -1.2 0 O-C-N 123.322 1.17 . . . . 0.0 110.285 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . 0.766 ' HB3' ' CE1' ' B' ' 61' ' ' PHE . 0.0 OUTLIER -177.18 33.44 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.545 0.688 . . . . 0.0 109.295 -179.735 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' B' ' 64' ' ' GLN . 2.8 p 55.83 53.22 9.63 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.709 -0.62 . . . . 0.0 111.097 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . 0.707 ' HB2' ' CE1' ' B' ' 61' ' ' PHE . 0.0 OUTLIER -150.09 -100.36 0.07 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.002 -1.061 . . . . 0.0 110.935 179.858 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . 0.804 ' N ' ' O ' ' B' ' 61' ' ' PHE . 2.7 pt-20 170.39 96.41 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.137 -0.977 . . . . 0.0 108.803 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . 0.569 ' HA ' ' HA ' ' B' ' 61' ' ' PHE . . . -71.1 94.91 1.16 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.189 -0.945 . . . . 0.0 110.1 -178.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.492 ' CD2' ' O ' ' B' ' 68' ' ' ALA . 5.9 mt -142.61 155.87 45.02 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.747 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -144.15 50.78 1.31 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.387 -0.821 . . . . 0.0 110.059 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.483 HG12 ' HD3' ' B' ' 58' ' ' ARG . 3.2 pt -61.14 -153.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.441 -0.787 . . . . 0.0 110.17 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -133.84 139.99 35.13 Favored Pre-proline 0 C--N 1.301 -1.515 0 O-C-N 121.227 -0.92 . . . . 0.0 111.316 -179.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' PRO . . . . . 0.502 ' HD3' ' CB ' ' B' ' 57' ' ' ALA . 47.1 Cg_endo -80.88 132.42 8.58 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 124.046 1.551 . . . . 0.0 108.911 178.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' SER . . . . . 0.944 ' HB2' ' CD1' ' A' ' 94' ' ' TYR . 0.7 OUTLIER -153.48 19.21 0.55 Allowed 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 119.19 -1.004 . . . . 0.0 113.143 -178.945 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . 0.838 ' N ' ' HA ' ' B' ' 54' ' ' ALA . 0.9 OUTLIER 163.18 144.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.517 2.894 0 CA-C-O 121.908 0.861 . . . . 0.0 109.288 175.954 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' B' ' 53' ' ' VAL . . . -157.17 110.63 0.45 Allowed Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.535 HG22 ' CD2' ' A' ' 85' ' ' LEU . 2.7 p -67.93 89.42 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.395 -1.062 . . . . 0.0 111.31 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' SER . . . . . 0.432 ' N ' ' O ' ' B' ' 51' ' ' LYS . 0.3 OUTLIER -74.52 -176.38 2.72 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 177.343 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . 0.553 ' CG2' ' N ' ' B' ' 80' ' ' LYS . 0.2 OUTLIER 179.84 174.66 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.298 -0.876 . . . . 0.0 109.028 179.676 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . 0.553 ' N ' ' CG2' ' B' ' 79' ' ' VAL . 4.7 mttt 179.25 174.25 0.42 Allowed Pre-proline 0 C--N 1.307 -1.243 0 O-C-N 121.492 -0.755 . . . . 0.0 109.379 178.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' PRO . . . . . 0.623 ' HA ' ' O ' ' B' ' 47' ' ' PHE . 52.3 Cg_endo -95.68 171.57 1.22 Allowed 'Trans proline' 0 C--N 1.296 -2.206 0 C-N-CA 121.856 1.704 . . . . 0.0 109.567 177.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' B' ' 47' ' ' PHE . . . -120.5 -92.63 1.31 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 106.177 -2.769 . . . . 0.0 106.177 177.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . 0.877 ' O ' ' N ' ' B' ' 85' ' ' LEU . 29.2 tt0 -80.13 51.61 1.41 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 175.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' SER . . . . . 0.566 ' C ' ' O ' ' B' ' 83' ' ' GLU . 0.1 OUTLIER 8.27 44.15 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.007 179.586 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . 0.877 ' N ' ' O ' ' B' ' 83' ' ' GLU . 3.6 mp 20.18 28.93 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 103.104 -2.924 . . . . 0.0 103.104 -172.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . 0.556 ' HD2' ' HB2' ' B' ' 84' ' ' SER 0.349 4.0 tttp -57.94 -42.59 85.23 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 104.418 -2.438 . . . . 0.0 104.418 177.397 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . 0.417 ' O ' ' HG2' ' B' ' 90' ' ' GLU 0.282 15.8 tttt -69.2 -31.17 69.59 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 111.789 -2.459 . . . . 0.0 105.976 175.654 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 33' ' ' THR . . . -78.02 -27.04 48.8 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 118.19 -1.404 . . . . 0.0 107.917 178.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . 0.692 ' N ' ' O ' ' B' ' 85' ' ' LEU . . . -64.96 -48.7 73.1 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.294 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' B' ' 87' ' ' LYS . 4.0 pt-20 -59.24 -28.08 66.37 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 177.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . 0.411 ' N ' ' HG2' ' B' ' 90' ' ' GLU . . . -75.51 -24.49 70.34 Favored Glycine 0 N--CA 1.49 2.255 0 C-N-CA 120.462 -0.875 . . . . 0.0 111.137 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . 0.895 ' HB3' ' HA ' ' A' ' 37' ' ' ALA . 0.3 OUTLIER -88.05 23.92 1.96 Allowed 'General case' 0 N--CA 1.503 2.216 0 O-C-N 120.322 -1.693 . . . . 0.0 110.544 -179.738 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' B' ' 92' ' ' LEU . 1.2 mmmm 55.11 35.86 25.7 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 -177.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . 0.538 ' CD1' ' N ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -41.71 -43.62 2.92 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.794 -178.701 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . 0.443 ' HG2' ' N ' ' B' ' 96' ' ' ASP . 4.9 pm0 -53.81 -36.11 62.12 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.264 -0.897 . . . . 0.0 109.289 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 96' ' ' ASP . . . . . 0.443 ' N ' ' HG2' ' B' ' 95' ' ' GLU . 20.1 t70 -64.97 -34.35 78.23 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 177.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.91 -25.33 59.94 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.03 -30.86 65.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.591 -0.693 . . . . 0.0 110.17 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.22 179.965 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.491 ' HA ' ' CB ' ' A' ' 5' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.435 ' C ' ' H ' ' A' ' 4' ' ' THR . 52.2 p-10 -171.66 -149.25 0.06 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.988 -1.07 . . . . 0.0 112.044 178.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.534 ' HD2' ' HB ' ' B' ' 45' ' ' THR . 3.8 tttm -51.32 -6.94 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.44 -0.788 . . . . 0.0 111.622 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.625 ' O ' HG13 ' A' ' 7' ' ' ILE . 48.7 m -118.13 -62.49 1.54 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.849 -1.157 . . . . 0.0 110.586 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.52 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 4.9 mt-10 -49.22 -42.02 39.08 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.071 -1.018 . . . . 0.0 109.167 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.464 ' CB ' HD21 ' A' ' 25' ' ' LEU . 21.0 mt -62.26 -32.51 73.22 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.111 -1.035 . . . . 0.0 109.556 178.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.625 HG13 ' O ' ' A' ' 4' ' ' THR . 1.0 OUTLIER -57.18 -43.95 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 178.292 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.592 ' N ' HG13 ' A' ' 7' ' ' ILE . 2.6 mtpt -63.56 -34.75 78.49 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.451 ' HB3' ' HA ' ' A' ' 6' ' ' LEU . . . -52.56 -40.12 62.21 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.807 -0.757 . . . . 0.0 109.155 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.748 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.5 mp -91.15 -32.1 5.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 178.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.545 ' HB3' ' O ' ' A' ' 7' ' ' ILE . . . -66.79 -13.06 61.05 Favored 'General case' 0 C--N 1.292 -1.918 0 O-C-N 120.756 -1.215 . . . . 0.0 108.923 178.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.444 ' N ' ' O ' ' A' ' 8' ' ' LYS . 11.5 pt20 -114.58 -39.98 3.68 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.45 -0.781 . . . . 0.0 109.656 179.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 9' ' ' ALA . 1.0 OUTLIER -73.95 -20.29 60.41 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 176.887 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.748 ' OG1' ' O ' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -119.14 -83.99 0.65 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 179.232 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.539 ' O ' ' C ' ' A' ' 16' ' ' LEU . . . 68.6 -21.17 0.34 Allowed Glycine 0 N--CA 1.495 2.588 0 O-C-N 120.957 -1.09 . . . . 0.0 110.843 178.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.778 HD12 HG21 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -28.77 -59.68 0.13 Allowed 'General case' 0 N--CA 1.518 2.973 0 CA-C-O 122.004 0.906 . . . . 0.0 110.266 -179.166 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.485 HG21 ' CG2' ' B' ' 17' ' ' THR . 0.6 OUTLIER -130.23 -7.28 4.3 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.564 -179.932 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.566 ' O ' ' C ' ' A' ' 19' ' ' VAL . 23.6 mt-30 57.25 36.86 27.88 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -177.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.691 ' HB ' ' HB ' ' B' ' 19' ' ' VAL . 1.0 OUTLIER -19.62 -93.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.872 -178.974 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.935 ' O ' ' N ' ' A' ' 22' ' ' SER . 0.4 OUTLIER -134.39 25.03 3.8 Favored 'General case' 0 C--N 1.278 -2.506 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 177.946 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.669 ' C ' ' O ' ' A' ' 20' ' ' SER . 27.3 m -16.34 -38.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 122.684 1.23 . . . . 0.0 109.466 -178.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.935 ' N ' ' O ' ' A' ' 20' ' ' SER . 32.2 p -84.55 -39.31 18.93 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 114.66 -1.154 . . . . 0.0 110.38 178.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.926 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.3 OUTLIER -89.69 -25.38 21.25 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 121.245 -0.91 . . . . 0.0 110.613 179.593 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.555 ' HB3' ' CG2' ' B' ' 14' ' ' THR . 0.0 OUTLIER -81.01 -35.02 32.47 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.25 -1.531 . . . . 0.0 109.361 178.9 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.626 ' C ' ' CD1' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -80.75 -40.99 24.27 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 117.875 -1.53 . . . . 0.0 107.141 177.819 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.502 ' CB ' ' O ' ' A' ' 22' ' ' SER . . . -60.55 -25.74 66.38 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 176.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.488 ' O ' ' N ' ' A' ' 31' ' ' ILE . 7.0 t -83.42 -37.9 22.62 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.729 ' HA ' ' CG1' ' A' ' 31' ' ' ILE . 0.1 OUTLIER -60.11 -33.04 71.56 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.486 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.64 ' HG3' ' CD1' ' A' ' 28' ' ' PHE . 29.6 mt-10 -80.06 -33.89 38.61 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 177.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.85 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 6.6 tttm -69.46 -28.0 65.72 Favored 'General case' 0 C--O 1.195 -1.799 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 177.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.729 ' CG1' ' HA ' ' A' ' 28' ' ' PHE . 1.1 pp -96.98 -30.3 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.217 -0.927 . . . . 0.0 109.728 179.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.708 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.6 mm -65.09 -53.98 34.68 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 177.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.46 ' HA ' ' CD2' ' B' ' 85' ' ' LEU . 0.4 OUTLIER -69.09 -37.3 78.35 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.162 -1.015 . . . . 0.0 108.464 179.591 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.85 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 15.5 mm-40 -73.17 -38.41 66.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.431 -0.793 . . . . 0.0 111.25 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.539 ' N ' ' O ' ' A' ' 31' ' ' ILE . 19.4 m -58.13 -48.49 80.08 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.697 -1.252 . . . . 0.0 108.097 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.427 ' HB ' ' CD2' ' B' ' 85' ' ' LEU . 2.8 t -55.84 -36.79 44.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 106.652 -1.611 . . . . 0.0 106.652 177.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.694 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -80.29 -4.01 51.63 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -101.81 -32.58 10.19 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.583 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.72 34.57 0.79 Allowed Glycine 0 C--N 1.302 -1.33 0 C-N-CA 119.682 -1.247 . . . . 0.0 111.472 177.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.466 ' CB ' ' CG2' ' A' ' 35' ' ' THR . 0.4 OUTLIER -135.8 144.0 45.5 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.856 -1.379 . . . . 0.0 110.552 179.262 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.45 ' HG2' ' HB2' ' A' ' 51' ' ' LYS . 49.0 mtmt -91.67 92.4 8.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.517 -0.739 . . . . 0.0 109.978 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.462 ' HA ' ' HB2' ' B' ' 1' ' ' MET . 35.4 m -63.05 147.29 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.533 -0.73 . . . . 0.0 110.413 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.457 ' O ' ' HA ' ' B' ' 2' ' ' ASN . 31.9 mt-30 -142.74 171.41 14.08 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.308 -0.87 . . . . 0.0 110.49 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.786 HD12 ' HB2' ' A' ' 48' ' ' LEU . 21.3 mt -131.47 -177.99 4.66 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.512 -0.743 . . . . 0.0 109.781 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.847 HG22 ' HG2' ' B' ' 29' ' ' GLU . 2.8 t -43.25 66.23 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.88 -0.512 . . . . 0.0 112.098 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.78 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . 46.98 23.03 1.39 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.676 ' HA ' ' HA2' ' A' ' 82' ' ' GLY . 0.7 OUTLIER -117.61 -37.83 3.4 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 121.014 -1.286 . . . . 0.0 109.522 179.39 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.786 ' HB2' HD12 ' A' ' 44' ' ' LEU . 6.9 mt -120.6 118.86 31.25 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.442 -1.411 . . . . 0.0 111.095 177.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.564 ' H ' ' HB2' ' A' ' 80' ' ' LYS . 32.6 t-20 -116.9 85.64 2.36 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.766 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.425 ' HB ' ' CG2' ' A' ' 42' ' ' VAL . 40.1 mm -86.12 126.07 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.444 -0.785 . . . . 0.0 110.473 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.45 ' HB2' ' HG2' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -147.48 130.69 8.09 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.353 -0.842 . . . . 0.0 109.441 179.307 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.488 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 53.7 Cg_endo -78.18 142.09 18.97 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 123.57 1.3 . . . . 0.0 112.467 -178.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.542 ' O ' ' N ' ' A' ' 76' ' ' GLY . 33.7 m -134.72 109.64 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 CA-C-O 121.696 0.76 . . . . 0.0 110.92 178.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.767 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . -62.37 119.09 8.42 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.43 -0.794 . . . . 0.0 111.471 -179.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.486 ' O ' ' HB3' ' A' ' 56' ' ' GLN . 0.9 OUTLIER -173.83 16.44 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 118.888 -1.125 . . . . 0.0 113.696 179.098 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.631 ' N ' ' HA ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -176.34 141.73 0.43 Allowed 'General case' 0 N--CA 1.506 2.344 0 O-C-N 120.077 -1.64 . . . . 0.0 115.197 178.654 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.879 ' N ' ' O ' ' A' ' 72' ' ' ALA . . . 161.16 -177.75 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.611 ' HA ' ' HA ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -177.62 123.85 0.12 Allowed 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 122.248 1.023 . . . . 0.0 112.336 177.233 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.89 ' HB2' ' HB2' ' A' ' 70' ' ' GLU . 3.4 mmtm -62.81 -129.0 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.153 -0.93 . . . . 0.0 108.952 177.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.496 ' O ' ' O ' ' A' ' 61' ' ' PHE . . . -147.9 130.79 3.61 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 118.927 -1.606 . . . . 0.0 111.347 -178.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.816 ' HB3' ' N ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -53.23 -161.5 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.929 -0.748 . . . . 0.0 109.588 179.129 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.757 ' N ' ' CG ' ' A' ' 61' ' ' PHE 0.272 1.0 OUTLIER -45.07 179.72 0.01 OUTLIER Pre-proline 0 C--N 1.299 -1.589 0 O-C-N 121.242 -0.912 . . . . 0.0 110.724 177.509 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.405 ' HD2' ' CG ' ' A' ' 62' ' ' ASN . 45.8 Cg_endo -74.48 3.57 5.21 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 O-C-N 123.221 1.116 . . . . 0.0 109.944 178.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.532 ' CB ' ' CE1' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -78.67 -103.87 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.315 -0.866 . . . . 0.0 110.191 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.446 ' H ' ' HB3' ' A' ' 64' ' ' GLN . 77.1 p -68.03 -8.33 36.73 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.701 -1.25 . . . . 0.0 109.872 179.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 54.56 51.27 14.32 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.35 -0.844 . . . . 0.0 110.528 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.735 ' C ' ' HB3' ' A' ' 61' ' ' PHE . 0.1 OUTLIER 177.78 87.2 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.601 0 O-C-N 121.197 -0.94 . . . . 0.0 111.443 179.499 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.816 ' N ' ' HB3' ' A' ' 61' ' ' PHE . . . 173.78 18.66 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.479 ' HG ' ' HA ' ' A' ' 61' ' ' PHE . 0.8 OUTLIER -171.99 45.04 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.226 0 O-C-N 119.827 -1.796 . . . . 0.0 110.977 177.954 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.89 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -175.65 48.19 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.188 -0.945 . . . . 0.0 109.72 -179.836 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.611 ' HA ' ' HA ' ' A' ' 58' ' ' ARG . 0.7 OUTLIER -63.36 -176.86 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.241 -0.912 . . . . 0.0 111.154 -178.731 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.879 ' O ' ' N ' ' A' ' 57' ' ' ALA . . . -165.31 143.64 5.16 Favored Pre-proline 0 C--O 1.198 -1.619 0 O-C-N 121.73 -0.606 . . . . 0.0 109.495 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.631 ' HA ' ' N ' ' A' ' 56' ' ' GLN . 54.9 Cg_endo -98.45 62.04 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 121.781 1.654 . . . . 0.0 111.726 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.678 ' HA ' ' CG ' ' B' ' 94' ' ' TYR . 10.4 t -52.8 158.58 1.32 Allowed 'General case' 0 N--CA 1.505 2.309 0 O-C-N 120.83 -1.169 . . . . 0.0 112.644 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.767 ' HA ' ' HA ' ' A' ' 54' ' ' ALA . 0.8 OUTLIER -68.16 150.12 11.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-O 122.043 0.925 . . . . 0.0 109.733 179.877 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.544 ' O ' ' N ' ' A' ' 78' ' ' SER . . . -114.24 86.22 0.41 Allowed Glycine 0 C--N 1.289 -2.067 0 N-CA-C 108.886 -1.685 . . . . 0.0 108.886 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.488 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 3.8 p -45.21 87.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 CA-C-O 121.766 0.793 . . . . 0.0 110.792 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.544 ' N ' ' O ' ' A' ' 76' ' ' GLY . 0.1 OUTLIER -59.37 -162.35 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.122 179.8 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.499 ' CG1' ' HD3' ' B' ' 81' ' ' PRO . 5.4 p 179.93 178.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.564 ' HB2' ' H ' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -139.76 177.69 1.92 Allowed Pre-proline 0 C--N 1.305 -1.331 0 O-C-N 120.896 -1.127 . . . . 0.0 110.455 179.051 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.421 ' CD ' ' CB ' ' A' ' 80' ' ' LYS . 56.4 Cg_endo -106.69 84.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.298 -2.095 0 C-N-CA 124.074 3.183 . . . . 0.0 108.592 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.676 ' HA2' ' HA ' ' A' ' 47' ' ' PHE . . . -55.73 100.72 0.1 Allowed Glycine 0 N--CA 1.483 1.779 0 C-N-CA 118.698 -1.715 . . . . 0.0 110.955 -177.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -57.35 -29.01 63.64 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.453 ' O ' ' HB1' ' A' ' 88' ' ' ALA . 0.3 OUTLIER -61.88 -32.76 73.15 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 177.3 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.479 ' HB3' ' O ' ' A' ' 82' ' ' GLY . 1.9 tt -81.69 -39.45 24.28 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 177.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.422 ' CD ' ' HA2' ' B' ' 76' ' ' GLY . 0.3 OUTLIER -69.78 -45.93 66.9 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.614 0.721 . . . . 0.0 109.53 179.301 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.69 -37.55 87.78 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.662 ' O ' ' HB2' ' B' ' 37' ' ' ALA . . . -66.28 -36.89 84.13 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 176.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.659 ' HB1' ' CG1' ' B' ' 75' ' ' VAL . . . -57.77 -31.6 66.68 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.647 ' HA ' ' CD1' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -65.2 -31.33 72.45 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 177.096 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.482 ' N ' ' HG3' ' A' ' 90' ' ' GLU . . . -66.01 -31.85 80.73 Favored Glycine 0 N--CA 1.484 1.869 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 178.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.553 ' HB3' ' HA ' ' B' ' 37' ' ' ALA . 1.0 OUTLIER -58.19 -43.39 87.52 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 120.723 -1.457 . . . . 0.0 111.386 -179.253 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.524 ' H ' ' HG ' ' A' ' 92' ' ' LEU . 0.0 OUTLIER 164.82 46.11 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -179.651 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.776 ' CE1' ' C ' ' B' ' 74' ' ' SER . 2.2 t80 -40.29 -73.29 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -178.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -51.4 -41.86 61.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.197 -0.939 . . . . 0.0 110.256 -178.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -61.28 -32.22 72.05 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.453 ' CD1' ' CB ' ' B' ' 54' ' ' ALA . 0.1 OUTLIER -86.59 -20.61 27.66 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.467 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.574 ' CB ' ' HB2' ' B' ' 74' ' ' SER . . . -76.8 -34.94 57.92 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.776 -0.577 . . . . 0.0 110.386 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.182 -179.957 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.547 ' HA ' ' CB ' ' B' ' 5' ' ' GLU . 10.0 mtp . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . 0.457 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 10.2 p30 -170.86 -156.63 0.12 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.971 -1.081 . . . . 0.0 112.191 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.514 ' HE2' ' HA ' ' B' ' 26' ' ' ALA . 0.3 OUTLIER -57.07 -4.69 0.2 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.61 -0.681 . . . . 0.0 111.26 -179.282 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.636 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 93.9 m -124.08 -42.15 2.16 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.935 -1.103 . . . . 0.0 109.743 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.547 ' CB ' ' HA ' ' B' ' 1' ' ' MET . 0.0 OUTLIER -63.68 -53.49 50.54 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.134 -0.979 . . . . 0.0 108.709 179.087 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.545 ' HG ' ' HB3' ' B' ' 1' ' ' MET . 14.8 mt -60.0 -29.78 68.7 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.335 -0.946 . . . . 0.0 108.964 178.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' ILE . . . . . 0.636 ' HB ' ' O ' ' B' ' 4' ' ' THR . 1.1 mt -54.65 -55.73 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . 0.53 ' HE2' ' HA ' ' B' ' 5' ' ' GLU . 14.6 mtmt -56.57 -34.24 66.94 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 177.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . 0.498 ' HB3' ' HA ' ' B' ' 6' ' ' LEU . . . -53.22 -38.63 63.08 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.585 -0.846 . . . . 0.0 109.259 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . 0.793 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.4 mp -92.7 -31.15 4.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 177.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.408 ' HB2' ' HA ' ' B' ' 8' ' ' LYS . . . -68.92 -6.48 27.71 Favored 'General case' 0 C--N 1.29 -2.0 0 C-N-CA 118.38 -1.328 . . . . 0.0 108.645 178.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.42 ' CG ' ' N ' ' B' ' 13' ' ' ASP . 12.7 pt20 -122.45 -40.13 2.5 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.324 -0.86 . . . . 0.0 110.13 179.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' B' ' 9' ' ' ALA . 1.0 OUTLIER -70.76 -30.04 66.43 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 177.22 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.793 ' OG1' ' O ' ' B' ' 10' ' ' ILE 0.271 0.2 OUTLIER -101.62 -75.59 0.59 Allowed 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.286 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.91 14.37 51.93 Favored Glycine 0 N--CA 1.499 2.868 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 177.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' LEU . . . . . 0.697 ' CD1' ' CG2' ' B' ' 14' ' ' THR . 4.7 mp -53.02 -64.99 0.64 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.557 -0.966 . . . . 0.0 110.005 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' THR . . . . . 0.595 HG21 ' O ' ' B' ' 17' ' ' THR . 0.5 OUTLIER -141.92 9.47 1.94 Allowed 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.696 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . 0.638 ' O ' ' C ' ' B' ' 19' ' ' VAL . 14.6 mt-30 57.95 27.48 14.79 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -175.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.778 HG21 HD12 ' A' ' 16' ' ' LEU . 1.2 p -2.13 -96.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.988 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.971 ' O ' ' N ' ' B' ' 22' ' ' SER . 0.8 OUTLIER -134.09 23.74 3.86 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 177.496 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.657 ' HA ' ' SD ' ' B' ' 24' ' ' MET . 28.6 m -9.93 -40.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 CA-C-O 122.415 1.102 . . . . 0.0 110.857 -178.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.971 ' N ' ' O ' ' B' ' 20' ' ' SER . 7.1 m -77.92 -39.68 42.1 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.264 178.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . 0.91 ' N ' ' O ' ' B' ' 20' ' ' SER . 1.3 mtmt -89.47 -25.71 21.32 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.478 -0.764 . . . . 0.0 111.113 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' MET . . . . . 0.657 ' SD ' ' HA ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -74.79 -40.59 61.05 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 117.529 -1.668 . . . . 0.0 108.795 179.225 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.541 ' HA ' ' HB3' ' B' ' 28' ' ' PHE . 0.5 OUTLIER -74.15 -40.47 62.58 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 117.708 -1.597 . . . . 0.0 107.291 176.804 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . 0.514 ' HA ' ' HE2' ' B' ' 3' ' ' LYS . . . -60.15 -33.38 72.09 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 177.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' SER . . . . . 0.612 ' HA ' ' HB3' ' B' ' 30' ' ' LYS . 18.6 m -78.63 -34.1 46.81 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . 0.836 ' O ' HG13 ' B' ' 31' ' ' ILE . 0.3 OUTLIER -60.72 -49.17 78.6 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.768 -0.582 . . . . 0.0 109.689 179.413 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . 0.847 ' HG2' HG22 ' A' ' 45' ' ' THR . 0.6 OUTLIER -71.89 -33.49 68.38 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 178.043 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . 0.915 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 10.8 ttpp -68.59 -21.02 64.53 Favored 'General case' 0 C--O 1.189 -2.085 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 176.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.836 HG13 ' O ' ' B' ' 28' ' ' PHE . 1.2 pp -105.15 -28.8 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 120.557 -1.339 . . . . 0.0 109.198 178.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.628 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.6 mm -69.64 -50.97 45.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 176.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' THR . . . . . 0.707 ' HB ' ' O ' ' B' ' 29' ' ' GLU . 0.3 OUTLIER -70.33 -40.21 74.29 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.46 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.915 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 39.4 mm-40 -73.91 -33.03 63.83 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.419 -0.801 . . . . 0.0 111.163 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' THR . . . . . 0.559 ' N ' ' O ' ' B' ' 31' ' ' ILE . 1.6 m -59.27 -48.75 80.45 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 120.53 -1.356 . . . . 0.0 107.531 178.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.492 HG11 ' HG3' ' B' ' 52' ' ' PRO . 1.2 t -56.12 -35.1 40.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 177.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . 0.662 ' HB2' ' O ' ' A' ' 88' ' ' ALA . . . -77.59 -1.35 30.32 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.534 0.683 . . . . 0.0 109.216 176.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . 0.518 ' N ' ' O ' ' B' ' 35' ' ' THR . 0.4 OUTLIER -115.68 -5.4 12.14 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.737 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.44 48.14 8.35 Favored Glycine 0 C--N 1.301 -1.378 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . 0.48 ' CB ' HG21 ' B' ' 35' ' ' THR . 0.1 OUTLIER -128.05 117.79 22.32 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.173 -1.192 . . . . 0.0 110.07 179.273 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 12.9 mtmt -70.51 80.82 0.57 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.492 -0.755 . . . . 0.0 109.954 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . 0.636 ' HB ' ' HB ' ' B' ' 50' ' ' ILE . 2.7 t -68.29 147.4 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.314 -0.866 . . . . 0.0 109.257 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' GLN . . . . . 0.435 ' O ' ' HA ' ' A' ' 2' ' ' ASN . 31.0 mt-30 -143.4 113.51 7.25 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.067 -1.021 . . . . 0.0 110.705 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.526 HD11 ' CB ' ' B' ' 48' ' ' LEU . 45.9 mt -73.98 120.11 19.11 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.271 -0.893 . . . . 0.0 109.939 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' THR . . . . . 0.539 HG22 ' CG ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 31.68 -96.19 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.757 -0.589 . . . . 0.0 110.583 179.793 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . 0.444 ' H ' HG21 ' B' ' 45' ' ' THR . . . -138.79 7.54 3.29 Favored Glycine 0 N--CA 1.482 1.732 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . 0.603 ' CE1' ' HB2' ' B' ' 48' ' ' LEU . 37.4 p90 -105.46 -54.99 2.39 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.588 -1.536 . . . . 0.0 111.76 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . 0.603 ' HB2' ' CE1' ' B' ' 47' ' ' PHE . 0.2 OUTLIER -92.12 148.03 22.49 Favored 'General case' 0 C--N 1.292 -1.903 0 O-C-N 120.047 -1.658 . . . . 0.0 113.241 -178.849 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' ASN . . . . . 0.477 ' O ' ' HB ' ' B' ' 79' ' ' VAL . 1.4 m-20 -132.82 146.22 51.64 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 178.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' ILE . . . . . 0.842 ' HA ' HG23 ' B' ' 79' ' ' VAL . 26.8 mm -137.21 98.76 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 O-C-N 120.97 -1.081 . . . . 0.0 111.601 -178.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . 0.534 ' N ' ' CG1' ' B' ' 79' ' ' VAL . 2.5 pttt -145.56 126.29 7.34 Favored Pre-proline 0 N--CA 1.487 1.415 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . 0.492 ' HG3' HG11 ' B' ' 36' ' ' VAL . 55.6 Cg_endo -88.08 151.21 6.96 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.239 1.126 . . . . 0.0 111.849 -178.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.518 ' O ' ' N ' ' B' ' 76' ' ' GLY . 14.0 m -133.14 118.64 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-O 121.506 0.67 . . . . 0.0 109.838 178.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.852 ' HA ' ' HA ' ' B' ' 75' ' ' VAL . . . -67.06 147.78 52.73 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 122.694 1.235 . . . . 0.0 112.899 -177.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . 0.53 ' O ' ' HA ' ' B' ' 74' ' ' SER . 6.3 ttt180 -157.36 -138.84 0.06 Allowed 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . 0.666 ' HA ' ' CA ' ' B' ' 73' ' ' PRO . 1.4 mm-40 -142.4 -165.66 2.08 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 118.032 -1.467 . . . . 0.0 111.595 178.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.486 ' CB ' HG13 ' B' ' 71' ' ' ILE . . . -163.07 -154.2 0.28 Allowed 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.506 -0.746 . . . . 0.0 110.884 -177.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 58' ' ' ARG . . . . . 0.506 ' HG3' ' N ' ' B' ' 59' ' ' LYS . 0.1 OUTLIER -57.35 157.27 6.69 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.681 -0.637 . . . . 0.0 110.235 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . 0.506 ' N ' ' HG3' ' B' ' 58' ' ' ARG . 1.9 tpmt? -163.11 136.86 5.94 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.558 -0.714 . . . . 0.0 109.851 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . 0.454 ' HA3' HD13 ' B' ' 69' ' ' LEU . . . -167.34 -131.16 1.24 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 61' ' ' PHE . . . . . 0.833 ' CE2' ' HB2' ' B' ' 66' ' ' GLN . 30.3 p90 -172.83 -174.85 1.17 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.238 -1.154 . . . . 0.0 111.344 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . 0.803 ' H ' ' HD2' ' B' ' 63' ' ' PRO . 0.3 OUTLIER -150.68 -28.71 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.719 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 -179.696 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . 0.803 ' HD2' ' H ' ' B' ' 62' ' ' ASN . 42.5 Cg_endo -71.47 -9.79 25.78 Favored 'Trans proline' 0 N--CA 1.486 1.067 0 CA-C-N 118.903 0.644 . . . . 0.0 111.0 -178.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . 0.566 ' CB ' ' CE2' ' B' ' 61' ' ' PHE . 0.0 OUTLIER -96.92 46.4 1.04 Allowed 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.228 -0.92 . . . . 0.0 109.115 178.704 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.41 ' OG1' ' O ' ' B' ' 64' ' ' GLN . 1.7 p 60.51 48.72 7.31 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 121.046 0.45 . . . . 0.0 110.706 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . 0.833 ' HB2' ' CE2' ' B' ' 61' ' ' PHE . 0.0 OUTLIER -146.56 -155.94 0.67 Allowed 'General case' 0 N--CA 1.484 1.243 0 O-C-N 121.235 -0.916 . . . . 0.0 110.411 -179.911 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . 0.56 ' O ' ' CD1' ' B' ' 69' ' ' LEU . 3.9 mm-40 -130.1 117.15 19.53 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 178.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . 0.662 ' CB ' ' HB3' ' B' ' 62' ' ' ASN . . . -57.28 132.3 52.61 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 122.022 0.915 . . . . 0.0 111.809 -177.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.56 ' CD1' ' O ' ' B' ' 67' ' ' GLU . 0.2 OUTLIER -134.38 117.71 16.63 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.796 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . 0.452 ' CA ' ' HG2' ' B' ' 58' ' ' ARG . 1.9 pt-20 -173.66 83.96 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.169 -0.957 . . . . 0.0 110.713 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.516 ' O ' ' HD3' ' B' ' 73' ' ' PRO . 25.3 pt -64.0 -143.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.427 -0.796 . . . . 0.0 109.44 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . 0.541 ' O ' ' OH ' ' A' ' 94' ' ' TYR . . . -99.09 107.61 45.12 Favored Pre-proline 0 C--N 1.287 -2.12 0 C-N-CA 119.823 -0.751 . . . . 0.0 112.902 -177.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 73' ' ' PRO . . . . . 0.666 ' CA ' ' HA ' ' B' ' 56' ' ' GLN . 55.7 Cg_endo -101.56 88.45 0.04 OUTLIER 'Trans proline' 0 CA--C 1.556 1.597 0 C-N-CA 122.434 2.089 . . . . 0.0 113.549 178.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 74' ' ' SER . . . . . 0.776 ' C ' ' CE1' ' A' ' 94' ' ' TYR . 0.4 OUTLIER 162.85 33.65 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.15 0 O-C-N 120.138 -1.601 . . . . 0.0 114.828 177.397 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . 0.852 ' HA ' ' HA ' ' B' ' 54' ' ' ALA . 0.3 OUTLIER 176.02 142.84 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.519 2.989 0 O-C-N 120.302 -1.499 . . . . 0.0 111.248 176.275 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' B' ' 53' ' ' VAL . . . -140.64 -144.9 4.53 Favored Glycine 0 N--CA 1.483 1.772 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . . . . . . . . . 7.6 t -140.9 85.64 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.93 -50.58 72.88 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.53 0.681 . . . . 0.0 111.279 -179.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . 0.842 HG23 ' HA ' ' B' ' 50' ' ' ILE . 17.7 m -51.54 -176.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -176.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . 0.722 ' HB2' ' HD2' ' B' ' 81' ' ' PRO . 0.0 OUTLIER 178.87 177.26 0.3 Allowed Pre-proline 0 N--CA 1.484 1.251 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.033 -178.727 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 81' ' ' PRO . . . . . 0.722 ' HD2' ' HB2' ' B' ' 80' ' ' LYS . 45.1 Cg_endo -72.54 137.61 28.12 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 123.508 1.268 . . . . 0.0 110.926 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . 0.576 ' N ' ' O ' ' B' ' 47' ' ' PHE . . . -94.92 -154.6 31.02 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . 0.447 ' O ' ' N ' ' B' ' 87' ' ' LYS . 16.4 pt-20 -88.05 -16.73 32.81 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.369 -1.077 . . . . 0.0 110.739 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 84' ' ' SER . . . . . 0.443 ' CB ' ' HB3' ' B' ' 47' ' ' PHE . 3.4 m -53.6 -37.14 62.72 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.067 -1.021 . . . . 0.0 109.51 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . 0.475 HD13 ' CD1' ' B' ' 47' ' ' PHE . 0.5 OUTLIER -81.67 -33.26 31.37 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.717 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . 0.53 ' O ' ' HB2' ' B' ' 89' ' ' ALA . 7.5 mttt -74.43 -27.46 60.62 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.382 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . 0.447 ' N ' ' O ' ' B' ' 83' ' ' GLU . 1.3 ttmm -74.7 -39.16 62.11 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 177.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.592 ' O ' ' CB ' ' A' ' 37' ' ' ALA . . . -64.8 -35.19 80.3 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 176.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . 0.53 ' HB2' ' O ' ' B' ' 86' ' ' LYS . . . -54.48 -45.43 73.21 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.454 -0.898 . . . . 0.0 109.19 178.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.9 -31.85 51.36 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 177.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' B' ' 88' ' ' ALA . . . -63.38 -38.65 96.73 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 178.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . 0.694 ' HB3' ' HA ' ' A' ' 37' ' ' ALA . 0.7 OUTLIER -75.46 15.17 0.49 Allowed 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.523 -1.575 . . . . 0.0 110.957 -179.823 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' B' ' 92' ' ' LEU . 22.3 mmtm 57.82 44.57 19.97 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 -177.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . 0.713 ' CD1' ' C ' ' B' ' 94' ' ' TYR . 0.1 OUTLIER -36.91 -36.37 0.12 Allowed 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.314 -178.829 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . 0.519 ' N ' ' CD1' ' B' ' 94' ' ' TYR . 8.8 pt-20 -57.25 -43.52 83.05 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.327 -0.858 . . . . 0.0 109.42 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 96' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' B' ' 93' ' ' LYS . 0.9 OUTLIER -61.81 -31.58 71.83 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 177.971 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -80.74 -24.87 38.42 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.78 -30.52 69.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.577 -0.702 . . . . 0.0 110.037 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.378 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.474 ' CB ' ' HB3' ' A' ' 5' ' ' GLU . 3.5 ptm . . . . . 0 N--CA 1.496 1.857 0 CA-C-O 121.282 0.563 . . . . 0.0 110.732 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.45 ' O ' ' HB2' ' A' ' 6' ' ' LEU . 16.7 p-10 -177.17 -153.99 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 119.727 -0.789 . . . . 0.0 111.248 178.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.534 ' HE2' ' HA ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -52.41 -7.98 0.07 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.401 -0.812 . . . . 0.0 111.143 -179.812 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.585 ' O ' HG13 ' A' ' 7' ' ' ILE . 87.4 m -114.54 -64.26 1.34 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.17 -0.956 . . . . 0.0 109.903 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.536 ' HA ' ' CE ' ' A' ' 8' ' ' LYS . 0.4 OUTLIER -49.11 -41.01 34.43 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.915 -1.115 . . . . 0.0 109.096 179.577 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.45 ' HB2' ' O ' ' A' ' 2' ' ' ASN . 28.2 mt -61.52 -35.05 76.62 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.335 -0.946 . . . . 0.0 109.621 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.624 HG13 ' N ' ' A' ' 8' ' ' LYS . 1.1 pp -57.2 -38.74 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 178.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.624 ' N ' HG13 ' A' ' 7' ' ' ILE . 1.3 mtmp? -65.79 -40.11 91.6 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 177.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' A' ' 13' ' ' ASP . . . -51.61 -37.34 49.59 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.768 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.3 mp -91.98 -30.85 4.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 178.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.559 ' HB1' ' O ' ' A' ' 7' ' ' ILE . . . -66.25 -9.57 33.72 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 118.575 -1.25 . . . . 0.0 108.497 178.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.435 ' CG ' ' N ' ' A' ' 13' ' ' ASP . 17.2 pt20 -119.59 -42.22 2.65 Favored 'General case' 0 N--CA 1.483 1.185 0 O-C-N 121.413 -0.805 . . . . 0.0 110.41 179.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.447 ' HB2' ' O ' ' A' ' 9' ' ' ALA . 6.6 m-20 -69.53 -33.73 73.21 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 177.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.768 ' OG1' ' O ' ' A' ' 10' ' ' ILE 0.273 0.2 OUTLIER -95.14 -71.41 0.67 Allowed 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.479 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 57.37 18.52 29.54 Favored Glycine 0 N--CA 1.5 2.91 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 177.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.687 ' CD1' ' CG2' ' A' ' 14' ' ' THR . 4.4 mp -63.82 -68.17 0.37 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.425 -1.044 . . . . 0.0 109.815 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.537 ' O ' HG23 ' A' ' 17' ' ' THR . 0.6 OUTLIER -135.07 7.48 3.42 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.592 ' O ' ' C ' ' A' ' 19' ' ' VAL . 15.0 mt-30 57.88 26.92 13.89 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 -176.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.691 ' HB ' ' HB ' ' B' ' 19' ' ' VAL . 0.3 OUTLIER -5.92 -97.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.184 -179.128 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.98 ' O ' ' N ' ' A' ' 23' ' ' LYS . 1.7 p -135.63 25.01 3.42 Favored 'General case' 0 C--N 1.275 -2.653 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 178.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.571 ' C ' ' O ' ' A' ' 20' ' ' SER . 27.4 m -19.15 -38.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 CA-C-O 122.284 1.04 . . . . 0.0 110.435 -178.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.803 ' N ' ' O ' ' A' ' 20' ' ' SER . 25.4 p -79.3 -36.26 39.92 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.16 178.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.98 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.2 OUTLIER -91.82 -32.65 15.27 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.779 -0.576 . . . . 0.0 111.642 179.811 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.635 ' N ' ' OG ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -72.8 -30.31 63.97 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 117.764 -1.574 . . . . 0.0 108.061 179.385 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.5 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 2.2 mt -82.01 -37.58 26.36 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 118.741 -1.184 . . . . 0.0 107.895 177.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.534 ' HA ' ' HE2' ' A' ' 3' ' ' LYS . . . -67.6 -34.04 76.21 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 177.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 31' ' ' ILE . 61.1 p -82.56 -30.51 29.62 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.658 ' O ' HG13 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -52.48 -45.61 66.22 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.335 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.714 ' HG3' ' CD1' ' B' ' 47' ' ' PHE . 0.5 OUTLIER -69.62 -36.58 76.27 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 176.856 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 1.108 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 13.1 tttt -62.26 -23.42 66.68 Favored 'General case' 0 C--O 1.19 -2.058 0 C-N-CA 119.275 -0.97 . . . . 0.0 108.434 178.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.658 HG13 ' O ' ' A' ' 28' ' ' PHE . 0.5 OUTLIER -103.61 -28.39 3.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 120.589 -1.319 . . . . 0.0 109.202 178.141 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.636 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.2 mm -72.56 -56.15 10.79 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 177.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.455 ' HB ' ' O ' ' A' ' 29' ' ' GLU . 0.4 OUTLIER -69.67 -36.45 76.03 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.4 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 1.108 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 44.5 mm-40 -74.31 -35.46 63.68 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.084 -1.01 . . . . 0.0 110.696 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.475 HG21 ' CB ' ' A' ' 40' ' ' ASP . 2.2 m -58.58 -51.51 69.57 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.63 -1.294 . . . . 0.0 108.248 178.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -54.11 -35.71 29.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 177.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.645 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -82.23 -4.2 56.63 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.629 0.728 . . . . 0.0 109.416 178.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -101.07 -26.39 13.71 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.087 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.84 39.23 1.6 Allowed Glycine 0 C--N 1.301 -1.4 0 C-N-CA 120.092 -1.052 . . . . 0.0 110.906 177.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.475 ' CB ' HG21 ' A' ' 35' ' ' THR . 0.1 OUTLIER -132.47 134.23 44.8 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.067 -1.255 . . . . 0.0 110.274 179.384 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.87 92.24 6.09 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.584 -0.697 . . . . 0.0 109.887 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.2 t -59.29 132.97 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.589 -0.694 . . . . 0.0 109.868 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.405 ' O ' ' HA ' ' B' ' 2' ' ' ASN . 6.4 mt-30 -129.7 89.21 2.79 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.335 -0.853 . . . . 0.0 110.178 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.514 ' O ' ' N ' ' A' ' 46' ' ' GLY . 10.7 mt -59.92 107.6 0.64 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.295 -0.878 . . . . 0.0 109.516 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.457 ' CG2' ' C ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER 34.11 -90.67 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.308 0 O-C-N 122.0 -0.438 . . . . 0.0 110.953 -179.457 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -151.01 28.32 1.01 Allowed Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.713 ' CD2' ' HG3' ' B' ' 29' ' ' GLU . 1.6 p90 -129.98 -26.3 2.42 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.17 -1.194 . . . . 0.0 111.922 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.648 ' HG ' ' CE1' ' A' ' 47' ' ' PHE . 4.6 mt -128.95 96.02 4.24 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.568 -1.332 . . . . 0.0 110.867 178.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -102.05 86.35 2.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.66 -0.65 . . . . 0.0 110.576 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.482 ' CD1' ' CG2' ' A' ' 79' ' ' VAL . 6.9 mm -73.22 131.9 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.7 ptmt -145.52 113.99 4.76 Favored Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 120.613 -1.304 . . . . 0.0 111.129 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.624 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 54.7 Cg_endo -78.48 143.81 19.63 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 O-C-N 123.638 1.336 . . . . 0.0 111.135 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.534 ' O ' ' N ' ' A' ' 76' ' ' GLY . 24.2 m -142.33 116.86 4.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-O 121.582 0.706 . . . . 0.0 110.395 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.449 ' HA ' HG21 ' A' ' 75' ' ' VAL . . . -37.31 124.28 0.97 Allowed 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 121.917 0.865 . . . . 0.0 112.404 -178.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.569 ' O ' ' O ' ' A' ' 74' ' ' SER . 5.7 ttt85 -170.06 123.01 0.7 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.433 ' O ' ' O ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -61.17 -140.07 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.968 -1.082 . . . . 0.0 110.811 -178.65 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' A' ' 72' ' ' ALA . . . -167.1 132.25 2.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.693 -1.254 . . . . 0.0 110.615 -177.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.848 ' HB2' ' C ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -170.52 164.42 8.48 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 120.666 -1.272 . . . . 0.0 109.964 179.51 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -169.62 19.83 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.308 -0.957 . . . . 0.0 111.952 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.484 ' HA3' HD12 ' A' ' 69' ' ' LEU . . . -173.28 -133.67 1.71 Allowed Glycine 0 N--CA 1.49 2.262 0 C-N-CA 118.667 -1.73 . . . . 0.0 111.586 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.777 ' CE2' ' HB2' ' A' ' 66' ' ' GLN . 50.4 p90 177.61 -163.52 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.924 -0.75 . . . . 0.0 110.153 -178.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.799 ' H ' ' CD ' ' A' ' 63' ' ' PRO . 1.6 p30 -158.33 -16.07 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.588 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 178.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.799 ' CD ' ' H ' ' A' ' 62' ' ' ASN . 40.5 Cg_endo -69.02 -13.85 37.33 Favored 'Trans proline' 0 N--CA 1.483 0.867 0 N-CA-C 108.778 -1.278 . . . . 0.0 108.778 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.59 ' CB ' ' CE2' ' A' ' 61' ' ' PHE . 0.2 OUTLIER -102.02 39.73 1.43 Allowed 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.388 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 64' ' ' GLN . 3.1 p 59.23 62.92 1.7 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.858 -0.526 . . . . 0.0 110.641 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.777 ' HB2' ' CE2' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -157.21 119.47 3.86 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.227 -0.92 . . . . 0.0 111.001 -179.689 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.71 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 0.4 OUTLIER -45.38 97.37 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.947 -1.096 . . . . 0.0 109.264 178.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.744 ' HA ' ' O ' ' A' ' 61' ' ' PHE . . . -41.23 134.19 2.2 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 122.695 1.236 . . . . 0.0 113.201 -177.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.71 ' HG ' ' O ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -142.62 51.31 1.44 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 179.5 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.848 ' C ' ' HB2' ' A' ' 58' ' ' ARG . 2.0 mp0 -105.56 -138.49 0.36 Allowed 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 120.144 -0.623 . . . . 0.0 112.287 -176.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.797 ' N ' ' HB2' ' A' ' 58' ' ' ARG . 3.0 tp -26.52 145.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 123.51 1.624 . . . . 0.0 114.287 -176.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 57' ' ' ALA . . . -171.83 152.27 2.99 Favored Pre-proline 0 C--N 1.286 -2.163 0 CA-C-N 113.049 -1.887 . . . . 0.0 108.415 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.405 ' O ' ' HB3' ' A' ' 74' ' ' SER . 55.1 Cg_endo -91.47 121.01 0.63 Allowed 'Trans proline' 0 C--N 1.291 -2.455 0 C-N-CA 121.712 1.608 . . . . 0.0 111.388 -178.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.569 ' O ' ' O ' ' A' ' 55' ' ' ARG . 26.3 p -176.89 109.13 0.08 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.02 -1.05 . . . . 0.0 110.3 179.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.608 ' HB ' ' HB2' ' B' ' 94' ' ' TYR . 0.3 OUTLIER -48.66 172.48 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.052 -1.03 . . . . 0.0 110.059 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.565 ' O ' ' N ' ' A' ' 78' ' ' SER . . . -101.85 77.83 0.36 Allowed Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.624 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 4.4 p -59.54 74.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.576 -0.955 . . . . 0.0 110.3 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.565 ' N ' ' O ' ' A' ' 76' ' ' GLY . 0.6 OUTLIER -67.68 177.34 2.07 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.524 -0.87 . . . . 0.0 109.824 179.585 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.51 ' CG2' ' N ' ' A' ' 80' ' ' LYS . 0.8 OUTLIER 176.62 175.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -179.82 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.51 ' N ' ' CG2' ' A' ' 79' ' ' VAL . 2.3 ptpt -177.18 172.23 0.83 Allowed Pre-proline 0 N--CA 1.486 1.362 0 O-C-N 121.161 -0.962 . . . . 0.0 110.176 177.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -98.77 133.38 0.25 Allowed 'Trans proline' 0 C--N 1.302 -1.901 0 C-N-CA 122.542 2.161 . . . . 0.0 110.489 178.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.534 ' HA3' ' HA ' ' A' ' 47' ' ' PHE . . . -92.09 177.78 40.0 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 108.382 -1.887 . . . . 0.0 108.382 178.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.89 -18.25 64.73 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.115 -1.226 . . . . 0.0 110.676 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.427 ' CB ' ' HB3' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -51.92 -39.89 59.87 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.119 -0.988 . . . . 0.0 109.401 179.8 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.516 ' HG ' ' HB2' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -75.66 -34.32 60.48 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.744 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.468 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 0.8 OUTLIER -72.94 -43.82 61.9 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.961 -179.257 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -61.46 -40.82 95.89 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 178.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.759 ' O ' ' HB2' ' B' ' 37' ' ' ALA . . . -66.68 -36.24 82.05 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 176.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.581 ' HA ' ' CB ' ' B' ' 37' ' ' ALA . . . -58.56 -34.36 70.96 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.404 ' HB2' ' CG ' ' B' ' 59' ' ' LYS . 0.4 OUTLIER -55.98 -34.54 65.84 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 176.252 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.432 ' C ' ' H ' ' A' ' 93' ' ' LYS . . . -61.54 -44.54 97.85 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 178.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.556 ' CB ' ' O ' ' B' ' 37' ' ' ALA . 0.6 OUTLIER -58.07 -2.59 0.18 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.707 -1.467 . . . . 0.0 111.212 179.699 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 6.7 mmmt 68.1 58.97 0.45 Allowed 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -177.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.714 ' CD1' ' C ' ' B' ' 74' ' ' SER . 23.5 t80 -37.41 -33.97 0.08 Allowed 'General case' 0 N--CA 1.494 1.775 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.21 -179.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -60.77 -48.0 83.76 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.155 -0.966 . . . . 0.0 109.083 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.82 -40.82 76.71 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.406 ' HB3' ' CB ' ' B' ' 54' ' ' ALA . 0.1 OUTLIER -69.87 -27.83 65.15 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.192 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.3 -46.73 87.45 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.407 0.622 . . . . 0.0 110.155 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.1 mtmt . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.222 -179.888 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.592 ' HG2' ' HB3' ' B' ' 5' ' ' GLU . 24.2 mtp . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . 0.553 ' O ' ' HB2' ' B' ' 6' ' ' LEU . 19.5 p-10 -175.4 -162.63 0.11 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.167 -0.958 . . . . 0.0 111.299 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.515 ' O ' ' CG2' ' B' ' 7' ' ' ILE . 0.0 OUTLIER -57.1 -3.52 0.14 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.423 -0.798 . . . . 0.0 110.885 -179.888 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.655 ' O ' HG13 ' B' ' 7' ' ' ILE . 96.8 m -117.93 -60.71 1.77 Allowed 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 122.167 0.984 . . . . 0.0 109.101 179.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.592 ' HB3' ' HG2' ' B' ' 1' ' ' MET . 0.4 OUTLIER -52.04 -44.74 64.37 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.098 -1.001 . . . . 0.0 109.013 179.27 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.553 ' HB2' ' O ' ' B' ' 2' ' ' ASN . 1.9 mt -61.18 -32.1 71.84 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.191 -1.004 . . . . 0.0 109.966 178.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' ILE . . . . . 0.655 HG13 ' O ' ' B' ' 4' ' ' THR . 0.9 OUTLIER -57.7 -40.79 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 179.1 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . 0.566 ' N ' HG13 ' B' ' 7' ' ' ILE . 1.0 OUTLIER -64.87 -37.79 88.81 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 177.484 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.33 -38.3 58.22 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 120.15 -0.62 . . . . 0.0 109.618 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . 0.736 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.3 mp -93.73 -29.19 4.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 178.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.562 ' HB2' ' O ' ' B' ' 7' ' ' ILE . . . -66.8 -16.25 64.14 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.815 -1.178 . . . . 0.0 108.329 178.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.431 ' CG ' ' N ' ' B' ' 13' ' ' ASP . 17.7 pt20 -108.62 -41.91 4.67 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.515 -0.741 . . . . 0.0 109.098 178.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.431 ' N ' ' CG ' ' B' ' 12' ' ' GLN . 1.1 m-20 -68.78 -22.55 64.27 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 176.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.736 ' OG1' ' O ' ' B' ' 10' ' ' ILE . 0.2 OUTLIER -120.32 -83.14 0.65 Allowed 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.363 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . 0.511 ' O ' ' C ' ' B' ' 16' ' ' LEU . . . 69.36 -21.01 0.42 Allowed Glycine 0 N--CA 1.498 2.779 0 O-C-N 120.924 -1.11 . . . . 0.0 110.65 178.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' LEU . . . . . 0.702 HD12 ' N ' ' B' ' 16' ' ' LEU . 0.0 OUTLIER -29.21 -59.45 0.14 Allowed 'General case' 0 N--CA 1.517 2.876 0 CA-C-O 122.008 0.908 . . . . 0.0 110.712 -179.608 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' THR . . . . . 0.478 HG23 ' CG2' ' A' ' 17' ' ' THR . 0.5 OUTLIER -132.7 -2.75 3.32 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -179.927 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . 0.618 ' O ' ' C ' ' B' ' 19' ' ' VAL . 8.2 mt-30 56.56 30.97 18.21 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -176.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.691 ' HB ' ' HB ' ' A' ' 19' ' ' VAL . 2.0 p -8.74 -97.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.802 -179.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.92 ' O ' ' N ' ' B' ' 23' ' ' LYS . 0.4 OUTLIER -132.94 22.08 4.17 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 177.449 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.666 ' C ' ' O ' ' B' ' 20' ' ' SER . 27.9 m -18.51 -38.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-O 122.401 1.096 . . . . 0.0 109.255 -178.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.91 ' N ' ' O ' ' B' ' 20' ' ' SER . 26.5 t -79.16 -44.92 20.98 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.19 177.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . 0.92 ' N ' ' O ' ' B' ' 20' ' ' SER . 5.9 mtmt -89.69 -21.56 22.68 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.431 -0.793 . . . . 0.0 109.889 178.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' MET . . . . . 0.6 ' HA ' HG22 ' A' ' 14' ' ' THR 0.263 2.2 tmm? -68.89 -38.93 79.95 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 178.653 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.568 ' N ' ' HE3' ' B' ' 24' ' ' MET . 8.3 mt -73.97 -41.38 62.03 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 176.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . 0.476 ' HA ' ' HE2' ' B' ' 3' ' ' LYS . . . -58.03 -34.51 70.13 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 177.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' SER . . . . . 0.475 ' O ' ' HB3' ' B' ' 30' ' ' LYS . 6.2 m -79.59 -33.49 41.58 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . 0.664 ' O ' HG13 ' B' ' 31' ' ' ILE . 2.8 t80 -60.74 -57.46 12.58 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 178.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . 0.713 ' HG3' ' CD2' ' A' ' 47' ' ' PHE . 2.3 tt0 -58.04 -31.85 67.41 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 118.216 -1.394 . . . . 0.0 107.637 177.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . 1.166 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 24.1 ttmm -67.42 -26.79 66.6 Favored 'General case' 0 C--O 1.191 -1.988 0 C-N-CA 119.344 -0.942 . . . . 0.0 108.487 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.664 HG13 ' O ' ' B' ' 28' ' ' PHE . 0.3 OUTLIER -98.57 -30.21 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 120.344 -1.473 . . . . 0.0 109.598 178.169 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.637 HD13 ' CG ' ' B' ' 28' ' ' PHE . 1.8 mp -67.85 -66.37 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' THR . . . . . 0.439 HG21 ' CB ' ' A' ' 88' ' ' ALA . 0.3 OUTLIER -60.78 -37.64 82.6 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.254 -179.082 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 1.166 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 62.3 mm-40 -73.13 -40.07 65.2 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 119.366 -0.934 . . . . 0.0 111.048 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' THR . . . . . 0.488 ' CG2' ' CB ' ' B' ' 40' ' ' ASP . 23.6 m -61.7 -49.46 76.4 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 118.316 -1.354 . . . . 0.0 109.423 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.548 ' HA ' ' HG3' ' B' ' 52' ' ' PRO . 0.6 OUTLIER -50.82 -43.26 24.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 C-N-CA 118.918 -1.113 . . . . 0.0 108.027 179.195 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . 0.759 ' HB2' ' O ' ' A' ' 88' ' ' ALA . . . -88.22 -4.01 58.78 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.69 0.757 . . . . 0.0 109.773 178.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . 0.705 ' HB2' ' O ' ' B' ' 34' ' ' GLU . 0.0 OUTLIER -88.56 -26.16 22.13 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 176.958 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 117.14 39.69 0.79 Allowed Glycine 0 C--N 1.302 -1.323 0 C-N-CA 120.194 -1.003 . . . . 0.0 110.968 177.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . 0.488 ' CB ' ' CG2' ' B' ' 35' ' ' THR . 0.3 OUTLIER -145.44 161.27 40.11 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.902 -1.351 . . . . 0.0 110.718 179.475 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -107.04 96.76 6.66 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.561 -0.712 . . . . 0.0 110.045 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 91.4 t -60.22 120.0 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.498 -0.751 . . . . 0.0 109.813 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' GLN . . . . . 0.415 ' O ' ' CB ' ' A' ' 2' ' ' ASN . 0.7 OUTLIER -108.96 103.02 11.98 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.277 -0.889 . . . . 0.0 110.117 -179.431 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.484 ' CB ' ' HB2' ' B' ' 48' ' ' LEU . 12.6 mt -75.75 100.26 4.65 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.001 -1.062 . . . . 0.0 109.286 179.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' THR . . . . . 0.568 HG23 ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 35.07 -93.88 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.913 -0.492 . . . . 0.0 111.224 -179.61 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -147.65 28.47 1.46 Allowed Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.715 -1.231 . . . . 0.0 110.17 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . 0.714 ' CD1' ' HG3' ' A' ' 29' ' ' GLU . 4.2 p90 -129.2 -23.58 2.97 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.969 -1.313 . . . . 0.0 111.594 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . 0.597 ' HG ' ' CE2' ' B' ' 47' ' ' PHE . 7.7 mt -128.73 106.03 8.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.482 -1.386 . . . . 0.0 110.711 178.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' ASN . . . . . 0.512 ' O ' ' HA ' ' B' ' 79' ' ' VAL . 0.6 OUTLIER -101.21 86.56 3.04 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.725 -0.609 . . . . 0.0 110.56 -179.385 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' ILE . . . . . 0.528 ' HA ' HG11 ' B' ' 79' ' ' VAL . 12.3 mm -84.33 128.43 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.383 -0.823 . . . . 0.0 109.836 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . 0.417 ' O ' ' N ' ' B' ' 78' ' ' SER . 0.0 OUTLIER -152.25 123.98 3.81 Favored Pre-proline 0 N--CA 1.501 2.078 0 O-C-N 120.87 -1.144 . . . . 0.0 110.972 -179.878 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . 0.646 ' HA ' ' HA ' ' B' ' 77' ' ' VAL . 57.1 Cg_endo -84.93 141.8 8.58 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 123.406 1.214 . . . . 0.0 111.454 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.575 ' O ' ' N ' ' B' ' 76' ' ' GLY . 30.0 m -143.79 112.31 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-O 121.9 0.857 . . . . 0.0 110.673 178.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.789 ' HA ' ' HA ' ' B' ' 75' ' ' VAL . . . -54.37 118.15 3.88 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.727 -0.608 . . . . 0.0 110.952 -179.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . 0.478 ' O ' ' HG2' ' B' ' 56' ' ' GLN . 0.0 OUTLIER -174.88 40.95 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 118.585 -1.246 . . . . 0.0 110.372 179.568 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . 0.992 ' HB3' ' HG2' ' B' ' 73' ' ' PRO . 10.0 mt-30 -140.19 -157.35 0.76 Allowed 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.285 -0.966 . . . . 0.0 111.458 -179.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.708 ' CB ' ' HB3' ' B' ' 72' ' ' ALA . . . -69.84 -178.53 1.56 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.893 0.854 . . . . 0.0 111.866 -178.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 58' ' ' ARG . . . . . 0.43 ' C ' HG22 ' B' ' 71' ' ' ILE . 9.9 mpt_? -73.01 -168.95 0.53 Allowed 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 122.139 0.971 . . . . 0.0 111.775 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . 0.404 ' CG ' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -140.26 25.02 2.28 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.126 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . 0.582 ' HA2' ' N ' ' B' ' 69' ' ' LEU . . . 169.98 74.0 0.04 OUTLIER Glycine 0 N--CA 1.488 2.11 0 C-N-CA 119.476 -1.345 . . . . 0.0 111.651 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 61' ' ' PHE . . . . . 0.853 ' CE1' ' HB2' ' B' ' 66' ' ' GLN . 1.1 p90 -152.33 142.08 21.94 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-N 119.493 1.646 . . . . 0.0 113.015 178.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . 0.782 ' H ' ' HD2' ' B' ' 63' ' ' PRO . 0.0 OUTLIER -120.48 -50.4 0.04 OUTLIER Pre-proline 0 N--CA 1.507 2.404 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -178.013 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . 0.782 ' HD2' ' H ' ' B' ' 62' ' ' ASN . 35.7 Cg_endo -59.07 -10.01 9.25 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 O-C-N 123.043 1.023 . . . . 0.0 112.049 -176.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . 0.686 ' HB3' ' CE1' ' B' ' 61' ' ' PHE . 1.8 mt-30 -95.45 37.66 1.18 Allowed 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.163 -0.961 . . . . 0.0 108.568 177.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.505 ' OG1' ' O ' ' B' ' 64' ' ' GLN . 1.9 p 68.97 42.45 1.29 Allowed 'General case' 0 N--CA 1.504 2.232 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.332 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . 0.853 ' HB2' ' CE1' ' B' ' 61' ' ' PHE . 0.0 OUTLIER -155.61 -142.9 0.11 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.038 -1.038 . . . . 0.0 110.723 179.696 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . 0.522 ' C ' ' O ' ' B' ' 61' ' ' PHE . 6.5 mt-10 -129.0 116.56 19.52 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.028 -1.045 . . . . 0.0 109.246 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . 0.819 ' HA ' ' CA ' ' B' ' 61' ' ' PHE . . . -64.59 84.82 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.697 -0.627 . . . . 0.0 110.182 -179.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.842 ' O ' ' HB2' ' B' ' 70' ' ' GLU . 0.3 OUTLIER 171.72 15.08 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 179.853 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . 0.842 ' HB2' ' O ' ' B' ' 69' ' ' LEU . 2.4 mt-10 137.56 44.94 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.41 0 CA-C-N 122.004 2.184 . . . . 0.0 112.079 178.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.838 ' O ' ' O ' ' B' ' 72' ' ' ALA . 0.0 OUTLIER -53.28 176.89 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 120.432 -1.417 . . . . 0.0 110.855 179.187 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . 0.84 ' CB ' ' CD ' ' B' ' 73' ' ' PRO 0.254 . . -18.13 -139.56 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.954 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 73' ' ' PRO . . . . . 0.992 ' HG2' ' HB3' ' B' ' 56' ' ' GLN . 31.3 Cg_endo -68.88 -154.15 0.03 OUTLIER 'Trans proline' 0 C--N 1.325 -0.701 0 O-C-N 122.323 0.644 . . . . 0.0 113.618 -178.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 74' ' ' SER . . . . . 0.771 ' O ' ' HB ' ' B' ' 75' ' ' VAL . 0.4 OUTLIER 155.43 60.29 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 -176.341 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . 0.789 ' HA ' ' HA ' ' B' ' 54' ' ' ALA . 12.2 p 139.74 162.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.468 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -179.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . 0.595 ' O ' ' N ' ' B' ' 78' ' ' SER . . . -125.9 73.62 0.43 Allowed Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.24 -1.457 . . . . 0.0 109.792 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.646 ' HA ' ' HA ' ' B' ' 52' ' ' PRO . 3.7 p -61.69 72.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.544 -0.974 . . . . 0.0 109.326 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 78' ' ' SER . . . . . 0.635 ' O ' ' CG1' ' B' ' 79' ' ' VAL . 0.1 OUTLIER -64.3 176.26 1.1 Allowed 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.454 -0.898 . . . . 0.0 109.986 -179.709 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . 0.635 ' CG1' ' O ' ' B' ' 78' ' ' SER . 16.9 m -172.37 179.0 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . 0.51 ' O ' ' HA ' ' B' ' 48' ' ' LEU . 0.1 OUTLIER 179.3 170.58 0.55 Allowed Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 120.833 -1.167 . . . . 0.0 111.12 176.8 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 81' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -102.27 133.37 0.13 Allowed 'Trans proline' 0 C--N 1.303 -1.832 0 C-N-CA 123.076 2.517 . . . . 0.0 110.252 177.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . 0.501 ' HA3' ' HA ' ' B' ' 47' ' ' PHE . . . -96.96 171.09 26.84 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 107.955 -2.058 . . . . 0.0 107.955 178.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . 0.447 ' HA ' ' HB2' ' B' ' 86' ' ' LYS . 3.5 pm0 -59.75 -19.15 48.41 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.99 -1.3 . . . . 0.0 110.674 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 84' ' ' SER . . . . . 0.471 ' CB ' ' HB3' ' B' ' 47' ' ' PHE . 0.4 OUTLIER -52.08 -38.03 55.9 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.101 -0.999 . . . . 0.0 109.552 179.6 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . 0.49 HD12 ' HB2' ' B' ' 47' ' ' PHE . 1.0 OUTLIER -78.46 -33.07 48.63 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.471 -0.768 . . . . 0.0 108.951 178.617 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . 0.53 ' O ' ' HB3' ' B' ' 89' ' ' ALA . 0.6 OUTLIER -73.71 -42.42 61.23 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.493 -179.274 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 7.3 tttp -64.5 -39.77 94.4 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 177.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.604 ' CB ' ' HB1' ' A' ' 37' ' ' ALA . . . -66.91 -34.48 77.87 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 176.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' B' ' 86' ' ' LYS . . . -57.18 -44.6 83.7 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.471 -0.768 . . . . 0.0 109.222 179.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -53.88 -31.82 51.16 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 177.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -67.14 -33.8 84.3 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . 0.645 ' HB3' ' HA ' ' A' ' 37' ' ' ALA . 0.4 OUTLIER -77.51 13.07 1.34 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.648 -1.501 . . . . 0.0 111.438 -179.553 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' B' ' 92' ' ' LEU . 34.9 mmtt 58.53 39.53 24.8 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -177.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . 0.608 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -42.07 -33.58 0.6 Allowed 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.449 -179.14 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . 0.481 ' N ' ' CD1' ' B' ' 94' ' ' TYR . 2.5 pp20? -61.62 -39.92 93.0 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.383 -0.823 . . . . 0.0 109.467 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.66 -34.82 76.38 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 177.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.05 -26.33 62.14 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 178.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.67 -76.79 0.17 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.584 -0.698 . . . . 0.0 110.325 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 33.4 mtmt . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.209 -179.913 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.502 ' HG2' ' HB3' ' A' ' 5' ' ' GLU . 2.7 mtp . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 120.892 0.377 . . . . 0.0 110.184 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.462 ' HB3' ' O ' ' A' ' 1' ' ' MET . 39.2 p-10 179.56 -167.57 0.09 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.184 -0.947 . . . . 0.0 111.21 179.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.532 ' HD3' HG21 ' B' ' 45' ' ' THR . 0.0 OUTLIER -55.47 -11.68 0.91 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.568 -0.708 . . . . 0.0 110.326 179.794 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.708 ' O ' HG12 ' A' ' 7' ' ' ILE . 53.7 m -104.02 -55.25 2.4 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 122.113 0.959 . . . . 0.0 109.286 179.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.651 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 0.2 OUTLIER -57.13 -49.6 75.42 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.068 -1.02 . . . . 0.0 109.14 179.427 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.42 ' O ' ' CB ' ' A' ' 9' ' ' ALA . 15.7 mt -49.93 -40.81 44.7 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 119.322 -0.951 . . . . 0.0 110.396 178.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.708 HG12 ' O ' ' A' ' 4' ' ' THR . 0.7 OUTLIER -57.47 -45.33 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.238 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.651 ' HE2' ' HA ' ' A' ' 5' ' ' GLU . 28.6 mtmt -56.36 -37.17 69.67 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 177.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 13' ' ' ASP . . . -54.9 -37.56 66.49 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.736 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.5 mp -88.26 -33.81 6.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 178.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.416 ' CB ' ' HA ' ' A' ' 8' ' ' LYS . . . -65.85 -13.05 58.86 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 119.158 -1.017 . . . . 0.0 108.818 178.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -117.08 -39.65 3.2 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 121.449 -0.782 . . . . 0.0 109.652 178.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 9' ' ' ALA . 1.5 m-20 -66.97 -30.15 70.19 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 177.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.736 ' OG1' ' O ' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -104.66 -75.31 0.63 Allowed 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 114.339 -1.3 . . . . 0.0 108.19 178.983 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 51.14 15.79 1.73 Allowed Glycine 0 N--CA 1.494 2.522 0 C-N-CA 120.306 -0.95 . . . . 0.0 110.883 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.6 ' CD1' ' CG2' ' B' ' 19' ' ' VAL . 0.0 OUTLIER -73.06 -27.66 61.87 Favored 'General case' 0 N--CA 1.508 2.432 0 O-C-N 121.073 -1.251 . . . . 0.0 107.963 178.812 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.46 HG22 ' CG2' ' B' ' 17' ' ' THR . 0.4 OUTLIER -159.6 -12.39 0.06 Allowed 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.552 -179.861 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.706 ' O ' ' C ' ' A' ' 19' ' ' VAL . 21.1 mt-30 58.24 34.37 24.04 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 -177.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.706 ' C ' ' O ' ' A' ' 18' ' ' GLN . 0.2 OUTLIER 0.69 -94.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -178.875 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 1.106 ' O ' ' N ' ' A' ' 22' ' ' SER . 18.7 p -135.06 21.74 3.49 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 175.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.606 ' HA ' ' HE3' ' A' ' 24' ' ' MET . 33.9 m -4.44 -38.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 122.451 1.119 . . . . 0.0 111.061 -178.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 1.106 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.5 OUTLIER -75.24 -41.61 57.1 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-N 115.008 -0.997 . . . . 0.0 108.622 177.629 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.885 ' N ' ' O ' ' A' ' 20' ' ' SER . 2.5 mtpt -90.7 -30.8 16.88 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.549 -0.72 . . . . 0.0 109.502 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.606 ' HE3' ' HA ' ' A' ' 21' ' ' VAL . 2.0 tmm? -61.63 -29.73 70.25 Favored 'General case' 0 C--O 1.215 -0.717 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 22' ' ' SER . 1.2 pp -81.97 -44.39 16.78 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.514 ' H ' ' HG ' ' A' ' 25' ' ' LEU . . . -63.61 -23.73 67.5 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 178.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.507 ' O ' ' CG1' ' A' ' 31' ' ' ILE . 7.9 m -85.14 -40.98 16.11 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.634 ' O ' HG13 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -58.97 -45.52 90.36 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.853 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.573 ' HG3' ' CE2' ' B' ' 47' ' ' PHE . 0.8 OUTLIER -69.02 -37.37 78.6 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.046 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 1.259 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 20.2 tttt -62.37 -22.02 65.79 Favored 'General case' 0 C--O 1.193 -1.883 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.634 HG13 ' O ' ' A' ' 28' ' ' PHE . 0.6 OUTLIER -106.81 -27.72 2.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 120.144 -1.597 . . . . 0.0 109.482 178.013 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.623 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.3 mm -74.02 -59.47 3.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 177.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.493 ' O ' ' HB1' ' A' ' 37' ' ' ALA . 0.7 OUTLIER -70.51 -32.59 70.12 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.393 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 1.259 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 71.7 mm-40 -81.75 -27.31 33.9 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 121.125 -0.984 . . . . 0.0 111.676 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.592 ' HA ' ' HB2' ' A' ' 38' ' ' LYS . 3.1 m -70.57 -55.39 8.97 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 117.496 -1.682 . . . . 0.0 108.437 178.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.694 ' O ' ' HG3' ' A' ' 52' ' ' PRO . 87.1 t -55.2 -40.96 58.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.657 ' HA ' ' HA ' ' B' ' 89' ' ' ALA . . . -68.93 -22.2 64.16 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.592 ' HB2' ' HA ' ' A' ' 35' ' ' THR . 13.4 mtmt -82.32 -25.48 33.88 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 177.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 35' ' ' THR . . . 104.06 30.79 4.97 Favored Glycine 0 C--N 1.295 -1.722 0 C-N-CA 120.133 -1.032 . . . . 0.0 110.653 177.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.513 ' CB ' HG21 ' A' ' 35' ' ' THR . 0.3 OUTLIER -117.25 138.22 51.87 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.225 -1.162 . . . . 0.0 110.018 179.545 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -72.18 82.55 1.0 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.461 -0.774 . . . . 0.0 110.638 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.8 p -73.36 140.96 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.47 -0.769 . . . . 0.0 109.654 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -149.1 163.18 38.31 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.009 -1.057 . . . . 0.0 111.462 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.627 HD12 ' CE1' ' A' ' 47' ' ' PHE . 23.4 mt -106.94 109.28 21.14 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.535 HG21 ' HG3' ' B' ' 29' ' ' GLU . 0.0 OUTLIER 35.8 -95.11 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.743 -0.598 . . . . 0.0 111.378 -178.854 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -139.47 10.49 3.22 Favored Glycine 0 N--CA 1.488 2.105 0 C-N-CA 119.52 -1.324 . . . . 0.0 111.034 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.636 ' O ' ' HA ' ' A' ' 81' ' ' PRO . 23.6 p90 -105.11 -20.31 13.56 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.604 -1.527 . . . . 0.0 110.695 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.584 ' HB2' HD12 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -132.81 147.67 52.31 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.13 -0.981 . . . . 0.0 111.666 178.505 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -154.08 116.28 4.31 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.773 -0.58 . . . . 0.0 109.718 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.502 ' HA ' ' HA ' ' A' ' 79' ' ' VAL . 0.8 OUTLIER -109.54 155.1 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.212 -0.93 . . . . 0.0 110.522 -179.657 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 9.0 ptmt -162.19 126.78 2.04 Favored Pre-proline 0 N--CA 1.498 1.939 0 C-N-CA 118.803 -1.159 . . . . 0.0 110.96 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.694 ' HG3' ' O ' ' A' ' 36' ' ' VAL . 53.9 Cg_endo -87.05 144.29 7.09 Favored 'Trans proline' 0 C--N 1.316 -1.17 0 O-C-N 123.405 1.213 . . . . 0.0 110.888 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.572 ' O ' ' N ' ' A' ' 76' ' ' GLY . 25.8 m -143.85 116.59 3.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-O 121.599 0.714 . . . . 0.0 110.278 179.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' A' ' 53' ' ' VAL . . . -30.87 124.38 0.2 Allowed 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.62 0.724 . . . . 0.0 112.318 -178.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.68 -148.73 0.12 Allowed 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.626 ' HB2' ' CA ' ' A' ' 72' ' ' ALA . 0.1 OUTLIER -174.97 -165.46 0.19 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.713 -1.242 . . . . 0.0 111.922 179.122 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.526 ' O ' HD11 ' A' ' 71' ' ' ILE 0.273 . . -172.26 138.59 0.97 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.672 -0.642 . . . . 0.0 109.659 -177.948 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.679 ' HB2' ' H ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -179.21 -163.34 0.06 Allowed 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 117.992 -1.483 . . . . 0.0 114.663 -179.58 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.451 ' CB ' ' O ' ' A' ' 58' ' ' ARG . 4.5 mtmt 159.73 28.62 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 113.741 -1.572 . . . . 0.0 108.597 178.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.776 ' O ' ' N ' ' A' ' 69' ' ' LEU . . . -156.2 -113.31 0.42 Allowed Glycine 0 N--CA 1.493 2.441 0 C-N-CA 120.014 -1.089 . . . . 0.0 110.595 -179.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.494 ' O ' HG22 ' A' ' 71' ' ' ILE . 0.3 OUTLIER -50.04 179.1 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.197 0 O-C-N 120.932 -1.334 . . . . 0.0 111.75 -178.737 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.694 ' CB ' ' CD ' ' A' ' 63' ' ' PRO . 2.2 m120 -147.93 -78.24 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.337 -0.852 . . . . 0.0 108.877 179.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.694 ' CD ' ' CB ' ' A' ' 62' ' ' ASN . 54.2 Cg_endo -74.42 -12.21 22.76 Favored 'Trans proline' 0 C--N 1.318 -1.048 0 N-CA-C 108.454 -1.402 . . . . 0.0 108.454 177.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.401 ' CB ' ' O ' ' A' ' 63' ' ' PRO . 3.1 tt0 68.77 70.85 0.28 Allowed 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.665 0.745 . . . . 0.0 110.735 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.404 ' OG1' ' NE2' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -179.4 -22.98 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.739 -0.601 . . . . 0.0 110.787 179.28 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.491 ' NE2' ' N ' ' A' ' 66' ' ' GLN . 0.9 OUTLIER -174.6 -12.45 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.075 0 O-C-N 120.869 -1.144 . . . . 0.0 113.071 -179.77 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.459 ' O ' ' CB ' ' A' ' 68' ' ' ALA . 1.4 tt0 -85.64 -158.51 0.39 Allowed 'General case' 0 N--CA 1.483 1.181 0 O-C-N 120.365 -1.46 . . . . 0.0 109.653 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.463 ' HA ' ' HA ' ' A' ' 61' ' ' PHE . . . 167.83 72.12 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.861 -0.524 . . . . 0.0 111.53 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.776 ' N ' ' O ' ' A' ' 60' ' ' GLY . 3.6 pp -150.56 15.65 0.78 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.924 -1.11 . . . . 0.0 111.982 178.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.688 ' CB ' ' O ' ' A' ' 69' ' ' LEU . 0.6 OUTLIER 136.71 97.23 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.9 0 CA-C-N 118.473 0.578 . . . . 0.0 110.601 178.288 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.693 HG12 ' H ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -82.41 -165.41 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 177.531 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.693 ' H ' HG12 ' A' ' 71' ' ' ILE . . . 173.82 60.87 0.04 OUTLIER Pre-proline 0 N--CA 1.515 2.784 0 O-C-N 119.035 -2.29 . . . . 0.0 114.295 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.606 ' HD3' ' CD1' ' A' ' 71' ' ' ILE . 57.1 Cg_endo -108.09 84.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.302 -1.887 0 C-N-CA 121.541 1.494 . . . . 0.0 110.991 178.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.67 111.96 0.91 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.149 -1.594 . . . . 0.0 111.573 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.464 HG13 ' CB ' ' B' ' 89' ' ' ALA . 0.3 OUTLIER -55.9 -178.43 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.21 -0.931 . . . . 0.0 109.034 178.821 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.626 ' O ' ' N ' ' A' ' 78' ' ' SER . . . -110.74 64.02 0.27 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.625 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 7.5 p -54.86 75.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.531 -0.982 . . . . 0.0 110.75 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.626 ' N ' ' O ' ' A' ' 76' ' ' GLY . 29.9 t -79.78 178.72 7.98 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.294 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.56 ' CG2' ' N ' ' A' ' 80' ' ' LYS . 0.2 OUTLIER 179.27 172.96 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.463 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.56 ' N ' ' CG2' ' A' ' 79' ' ' VAL . 0.1 OUTLIER 177.28 173.8 0.33 Allowed Pre-proline 0 C--N 1.299 -1.616 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 177.814 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.636 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 52.5 Cg_endo -85.87 174.59 6.41 Favored 'Trans proline' 0 C--N 1.294 -2.294 0 O-C-N 123.648 1.341 . . . . 0.0 110.106 177.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -115.84 -68.58 0.43 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 105.289 -3.124 . . . . 0.0 105.289 177.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.863 ' O ' ' N ' ' A' ' 85' ' ' LEU . 37.8 tt0 -87.33 53.13 2.7 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 174.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 1.312 ' O ' ' N ' ' A' ' 86' ' ' LYS . 1.9 m 9.62 44.31 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 122.386 1.089 . . . . 0.0 110.854 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.983 ' C ' ' O ' ' A' ' 84' ' ' SER . 3.6 mp 21.6 29.58 0.0 OUTLIER 'General case' 0 C--O 1.195 -1.802 0 N-CA-C 103.685 -2.709 . . . . 0.0 103.685 -172.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 1.312 ' N ' ' O ' ' A' ' 84' ' ' SER 0.339 9.7 tttt -55.59 -36.66 67.14 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 104.261 -2.496 . . . . 0.0 104.261 176.732 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.292 14.0 tttt -75.99 -31.59 59.03 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 111.625 -2.534 . . . . 0.0 106.5 176.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.605 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -82.21 -20.48 37.67 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 118.53 -1.268 . . . . 0.0 108.755 179.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.725 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . -80.99 -43.94 18.87 Favored 'General case' 0 C--N 1.293 -1.888 0 O-C-N 120.941 -1.099 . . . . 0.0 108.587 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.7 -30.46 67.43 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 177.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.441 ' HA3' ' CB ' ' B' ' 37' ' ' ALA . . . -71.63 -33.83 63.37 Favored Glycine 0 N--CA 1.489 2.18 0 C-N-CA 120.279 -0.962 . . . . 0.0 110.837 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.767 ' HB3' ' HA ' ' B' ' 37' ' ' ALA . 0.4 OUTLIER -81.07 20.84 0.76 Allowed 'General case' 0 N--CA 1.504 2.241 0 O-C-N 120.371 -1.664 . . . . 0.0 110.764 -179.807 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.4 ' O ' ' N ' ' A' ' 96' ' ' ASP . 0.0 OUTLIER 57.2 37.46 28.38 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -178.397 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.522 ' CD1' ' N ' ' B' ' 75' ' ' VAL . 0.0 OUTLIER -39.18 -33.94 0.16 Allowed 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.61 -179.21 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.418 ' HG2' ' CE2' ' A' ' 94' ' ' TYR . 46.1 mt-10 -63.33 -45.9 89.14 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.439 -0.788 . . . . 0.0 109.305 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.4 ' N ' ' O ' ' A' ' 93' ' ' LYS . 60.3 m-20 -54.37 -39.68 67.42 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 178.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -71.55 -29.12 64.38 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.21 -61.9 1.77 Allowed 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.456 0.646 . . . . 0.0 110.172 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 25.8 mtmt . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.22 -179.848 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.436 ' O ' ' HB2' ' B' ' 2' ' ' ASN . 5.2 mtp . . . . . 0 N--CA 1.493 1.69 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' B' ' 1' ' ' MET . 12.2 t30 -177.22 178.01 1.15 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.207 -0.933 . . . . 0.0 110.816 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.564 ' NZ ' ' O ' ' B' ' 25' ' ' LEU . 1.7 mttm -44.53 -23.29 0.11 Allowed 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.49 -0.756 . . . . 0.0 110.58 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.488 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 13.4 m -102.94 -43.9 5.39 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.165 -0.96 . . . . 0.0 109.309 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.482 ' O ' ' CG ' ' B' ' 8' ' ' LYS . 0.1 OUTLIER -62.06 -46.51 88.82 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.153 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.5 ' HA ' ' HB1' ' B' ' 9' ' ' ALA . 1.6 mt -66.13 -29.23 69.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.944 -1.098 . . . . 0.0 109.154 178.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' ILE . . . . . 0.642 HG12 ' O ' ' B' ' 21' ' ' VAL . 0.3 OUTLIER -56.79 -59.77 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.638 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . 0.507 ' HA ' ' CB ' ' B' ' 11' ' ' ALA . 19.9 pttt -61.13 -25.87 67.29 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . 0.5 ' HB1' ' HA ' ' B' ' 6' ' ' LEU . . . -58.56 -38.29 77.53 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.018 -1.051 . . . . 0.0 108.744 178.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . 0.862 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.1 mp -90.62 -35.99 7.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 177.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.507 ' CB ' ' HA ' ' B' ' 8' ' ' LYS . . . -62.42 -12.82 23.89 Favored 'General case' 0 C--N 1.293 -1.851 0 C-N-CA 118.783 -1.167 . . . . 0.0 108.689 177.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.442 ' HB3' ' O ' ' B' ' 8' ' ' LYS . 6.9 tp-100 -113.79 -44.26 3.2 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.501 -0.749 . . . . 0.0 109.284 178.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -64.29 -33.26 75.42 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.862 ' OG1' ' O ' ' B' ' 10' ' ' ILE 0.253 0.2 OUTLIER -98.77 -69.53 0.76 Allowed 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 178.348 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 57.86 22.2 46.96 Favored Glycine 0 N--CA 1.501 2.98 0 O-C-N 121.398 -0.814 . . . . 0.0 111.585 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' LEU . . . . . 0.809 HD12 ' HB3' ' A' ' 20' ' ' SER . 4.9 mp -65.66 -66.17 0.58 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.348 -1.09 . . . . 0.0 109.64 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' THR . . . . . 0.605 HG21 ' O ' ' B' ' 17' ' ' THR . 0.5 OUTLIER -135.54 6.73 3.26 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -179.57 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . 0.652 ' O ' ' C ' ' B' ' 19' ' ' VAL . 25.1 mt-30 58.69 24.98 12.78 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 -175.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.669 ' HB ' ' HB ' ' A' ' 19' ' ' VAL . 0.2 OUTLIER 7.69 -95.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 CA-C-N 115.211 -0.904 . . . . 0.0 108.958 -179.185 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 1.026 ' O ' ' N ' ' B' ' 22' ' ' SER . 1.2 p -137.42 23.47 2.95 Favored 'General case' 0 C--N 1.273 -2.729 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 177.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.648 ' HA ' ' SD ' ' B' ' 24' ' ' MET . 9.4 m -4.02 -43.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 122.441 1.115 . . . . 0.0 111.006 -177.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 1.026 ' N ' ' O ' ' B' ' 20' ' ' SER . 5.9 m -75.35 -38.06 60.34 Favored 'General case' 0 C--N 1.278 -2.506 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.559 178.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . 0.868 ' N ' ' O ' ' B' ' 20' ' ' SER . 6.1 mtmt -92.94 -26.99 17.33 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.36 -0.837 . . . . 0.0 111.154 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' MET . . . . . 0.648 ' SD ' ' HA ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -70.9 -37.52 72.96 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 117.157 -1.817 . . . . 0.0 108.264 179.177 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.585 ' HA ' ' HB3' ' B' ' 28' ' ' PHE . 0.4 OUTLIER -80.44 -51.45 8.8 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 117.956 -1.498 . . . . 0.0 108.241 177.52 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . 0.472 ' O ' ' HB2' ' B' ' 30' ' ' LYS . . . -49.95 -34.11 19.75 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.374 -0.829 . . . . 0.0 108.859 178.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' SER . . . . . 0.49 ' O ' ' N ' ' B' ' 31' ' ' ILE . 83.1 p -81.92 -33.88 30.17 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . 0.796 ' O ' HG13 ' B' ' 31' ' ' ILE . 0.3 OUTLIER -56.02 -52.44 64.22 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.812 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . 0.791 ' O ' ' OG1' ' B' ' 33' ' ' THR . 0.2 OUTLIER -63.42 -39.01 93.34 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 176.401 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . 0.997 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 17.5 ttpt -59.96 -23.79 63.87 Favored 'General case' 0 C--O 1.189 -2.115 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.796 HG13 ' O ' ' B' ' 28' ' ' PHE . 0.6 OUTLIER -102.83 -27.16 3.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 O-C-N 120.615 -1.303 . . . . 0.0 108.582 178.047 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.589 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.2 mm -68.88 -54.33 21.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 177.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' THR . . . . . 0.791 ' OG1' ' O ' ' B' ' 29' ' ' GLU . 0.3 OUTLIER -70.73 -49.07 50.86 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.107 -1.037 . . . . 0.0 108.669 178.576 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.997 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 19.2 mm-40 -58.09 -35.68 71.77 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.551 -0.86 . . . . 0.0 109.95 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' THR . . . . . 0.529 ' C ' ' HB2' ' B' ' 40' ' ' ASP . 31.1 m -69.72 -42.34 74.13 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 118.302 -1.359 . . . . 0.0 107.697 177.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.601 ' O ' ' HB3' ' A' ' 92' ' ' LEU . 55.5 t -56.95 -43.03 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 177.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . 0.767 ' HA ' ' HB3' ' A' ' 92' ' ' LEU . . . -76.89 2.92 13.25 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.398 -0.921 . . . . 0.0 109.69 177.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . 0.543 ' HB2' ' O ' ' B' ' 34' ' ' GLU . 0.1 OUTLIER -119.91 4.6 10.95 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.107 -0.996 . . . . 0.0 109.311 178.001 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.73 34.46 4.07 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . 0.596 ' HB3' ' HA ' ' B' ' 36' ' ' VAL . 14.2 t0 -49.17 162.91 0.11 Allowed 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 123.086 1.422 . . . . 0.0 113.019 -179.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -179.83 56.99 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 104.381 -2.451 . . . . 0.0 104.381 178.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . 0.452 ' CG1' ' HB ' ' B' ' 50' ' ' ILE . 7.4 p -90.67 148.74 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.941 -176.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -132.26 95.9 3.76 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.632 HD11 ' HB3' ' B' ' 48' ' ' LEU . 19.2 mt -59.65 101.59 0.12 Allowed 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.245 -0.909 . . . . 0.0 109.792 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' THR . . . . . 0.532 HG21 ' HD3' ' A' ' 3' ' ' LYS . 0.0 OUTLIER 35.53 -93.55 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 120.921 0.391 . . . . 0.0 110.877 -179.648 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -147.17 35.4 1.25 Allowed Glycine 0 N--CA 1.485 1.95 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . 0.573 ' CE2' ' HG3' ' A' ' 29' ' ' GLU . 1.1 p90 -135.75 -25.53 1.26 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.246 -1.149 . . . . 0.0 111.773 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . 0.632 ' HB3' HD11 ' B' ' 44' ' ' LEU . 4.8 mt -136.36 113.58 10.64 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.214 -1.554 . . . . 0.0 111.374 178.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -113.69 95.95 5.6 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.414 -0.804 . . . . 0.0 110.291 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' ILE . . . . . 0.603 ' N ' ' CD1' ' B' ' 50' ' ' ILE . 0.3 OUTLIER -87.5 139.42 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.37 -0.831 . . . . 0.0 109.271 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . 0.407 ' HG3' ' HB3' ' B' ' 78' ' ' SER . 1.7 ptmt -158.83 111.4 1.61 Allowed Pre-proline 0 N--CA 1.5 2.042 0 C-N-CA 118.603 -1.239 . . . . 0.0 111.233 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . 0.619 ' HA ' ' HA ' ' B' ' 77' ' ' VAL . 44.9 Cg_endo -69.38 144.66 56.78 Favored 'Trans proline' 0 C--N 1.314 -1.251 0 O-C-N 123.47 1.248 . . . . 0.0 111.681 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.615 ' O ' ' N ' ' B' ' 76' ' ' GLY . 29.7 m -143.07 116.86 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 121.491 0.663 . . . . 0.0 110.841 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.644 ' HA ' ' HA ' ' B' ' 75' ' ' VAL . . . -46.01 145.14 1.62 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 121.806 0.812 . . . . 0.0 112.105 -178.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.27 96.33 0.19 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . 0.431 ' O ' ' CD1' ' B' ' 71' ' ' ILE . 13.5 mt-30 -59.07 -165.03 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.261 -0.899 . . . . 0.0 111.052 -178.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.415 ' CB ' ' HD3' ' B' ' 73' ' ' PRO . . . -91.53 166.39 12.87 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.662 -0.649 . . . . 0.0 110.977 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 58' ' ' ARG . . . . . 0.562 ' N ' HD12 ' B' ' 71' ' ' ILE . 47.8 mtt85 -157.25 142.14 16.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.815 -0.553 . . . . 0.0 109.535 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 2.5 pttt -170.24 66.46 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.201 -0.937 . . . . 0.0 110.457 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 154.43 -32.72 0.7 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 61' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -171.8 -164.66 0.32 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.325 -1.103 . . . . 0.0 110.349 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . 0.717 ' HB3' ' CD ' ' B' ' 63' ' ' PRO . 2.6 t-20 -170.21 -79.4 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.455 -0.778 . . . . 0.0 109.807 179.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . 0.717 ' CD ' ' HB3' ' B' ' 62' ' ' ASN . 57.0 Cg_endo -80.22 1.77 9.0 Favored 'Trans proline' 0 C--N 1.321 -0.889 0 N-CA-C 109.496 -1.002 . . . . 0.0 109.496 178.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 62.21 20.05 11.42 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.337 -0.852 . . . . 0.0 109.253 -178.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.438 ' O ' ' HB2' ' B' ' 66' ' ' GLN . 65.1 p -124.15 44.36 2.75 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.583 -0.698 . . . . 0.0 109.17 179.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . 0.438 ' HB2' ' O ' ' B' ' 65' ' ' THR . 33.6 mm-40 66.59 56.06 0.76 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.796 -0.565 . . . . 0.0 111.133 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -140.6 64.7 1.43 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.09 -1.006 . . . . 0.0 109.474 179.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.82 126.0 25.79 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.705 -0.622 . . . . 0.0 110.684 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 80.2 mt -116.76 176.44 5.12 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.404 -0.81 . . . . 0.0 110.301 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -154.45 73.63 0.92 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.367 -0.833 . . . . 0.0 110.522 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.562 HD12 ' N ' ' B' ' 58' ' ' ARG . 1.5 pp -117.69 -160.17 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.349 -0.844 . . . . 0.0 109.561 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -126.14 156.78 71.59 Favored Pre-proline 0 C--N 1.304 -1.412 0 O-C-N 121.187 -0.946 . . . . 0.0 111.098 -179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 73' ' ' PRO . . . . . 0.415 ' HD3' ' CB ' ' B' ' 57' ' ' ALA . 45.0 Cg_endo -73.38 82.17 1.67 Allowed 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 124.325 1.697 . . . . 0.0 110.379 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 74' ' ' SER . . . . . 0.489 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 9.2 p -176.42 154.58 1.32 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.45 -0.781 . . . . 0.0 109.628 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . 0.644 ' HA ' ' HA ' ' B' ' 54' ' ' ALA . 1.2 t -52.85 169.83 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.132 -0.98 . . . . 0.0 109.364 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . 0.615 ' N ' ' O ' ' B' ' 53' ' ' VAL . . . -115.32 86.9 0.42 Allowed Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.619 ' HA ' ' HA ' ' B' ' 52' ' ' PRO . 3.6 p -60.53 78.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.767 -0.843 . . . . 0.0 109.827 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 78' ' ' SER . . . . . 0.607 ' O ' ' CG2' ' B' ' 79' ' ' VAL . 2.2 t -68.05 177.66 2.12 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.551 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . 0.607 ' CG2' ' O ' ' B' ' 78' ' ' SER . 14.6 t -172.33 175.27 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . 0.496 ' N ' ' CG1' ' B' ' 79' ' ' VAL . 0.0 OUTLIER 179.28 172.17 0.49 Allowed Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 120.87 -1.144 . . . . 0.0 110.178 177.186 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 81' ' ' PRO . . . . . 0.425 ' CB ' HG13 ' A' ' 77' ' ' VAL . 54.0 Cg_endo -95.17 143.45 1.31 Allowed 'Trans proline' 0 C--N 1.303 -1.855 0 C-N-CA 122.35 2.033 . . . . 0.0 110.739 178.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . 0.541 ' O ' ' HB3' ' B' ' 83' ' ' GLU . . . -107.6 42.37 1.95 Allowed Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . 0.541 ' HB3' ' O ' ' B' ' 82' ' ' GLY . 1.0 OUTLIER 69.02 -40.18 0.44 Allowed 'General case' 0 N--CA 1.506 2.34 0 O-C-N 121.448 -1.031 . . . . 0.0 111.93 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 84' ' ' SER . . . . . 0.447 ' CB ' ' HB3' ' B' ' 47' ' ' PHE . 0.1 OUTLIER -48.85 -33.34 10.39 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.949 -1.094 . . . . 0.0 110.165 -179.177 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . 0.431 HD23 ' CD1' ' B' ' 47' ' ' PHE . 0.8 OUTLIER -82.61 -29.98 29.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.412 -0.805 . . . . 0.0 108.877 178.703 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . 0.443 ' HA ' ' HB2' ' B' ' 89' ' ' ALA . 0.3 OUTLIER -82.49 -39.5 22.37 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.53 0.681 . . . . 0.0 109.607 179.812 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . 0.465 ' O ' ' CG ' ' B' ' 90' ' ' GLU . 1.2 ttmp? -68.69 -37.05 79.26 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 178.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.565 ' O ' ' HG ' ' B' ' 92' ' ' LEU . . . -71.62 -30.66 66.02 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 177.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . 0.657 ' HA ' ' HA ' ' A' ' 37' ' ' ALA . . . -69.94 -52.79 21.55 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.623 -0.673 . . . . 0.0 110.368 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.651 ' HA ' ' CB ' ' B' ' 94' ' ' TYR . 8.2 pt-20 -52.2 -23.25 5.28 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 177.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . 0.405 ' N ' ' C ' ' B' ' 89' ' ' ALA . . . -81.17 -29.66 40.41 Favored Glycine 0 CA--C 1.546 2.03 0 CA-C-O 118.604 -1.109 . . . . 0.0 112.81 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . 0.593 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 0.2 OUTLIER -111.64 -73.55 0.67 Allowed 'General case' 0 N--CA 1.507 2.391 0 CA-C-N 122.065 2.933 . . . . 0.0 113.54 -177.687 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -120.31 42.7 2.9 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.771 -1.205 . . . . 0.0 112.628 -177.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . 0.651 ' CB ' ' HA ' ' B' ' 90' ' ' GLU . 0.8 OUTLIER -77.19 -43.51 33.46 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.124 -0.985 . . . . 0.0 108.967 178.507 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -75.04 -35.73 61.89 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.19 -40.13 76.77 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -75.25 -26.67 59.04 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.71 -37.35 82.12 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.614 -0.679 . . . . 0.0 110.179 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 36.2 mttm . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.18 -179.89 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.481 ' HA ' ' CB ' ' A' ' 5' ' ' GLU . 2.8 mtp . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.502 ' H ' ' HB2' ' A' ' 5' ' ' GLU . 0.6 OUTLIER -177.12 -162.54 0.08 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.023 -1.048 . . . . 0.0 111.728 179.855 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.491 ' HE2' ' HA ' ' A' ' 26' ' ' ALA . 0.9 OUTLIER -52.22 -11.77 0.2 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.657 -0.652 . . . . 0.0 110.396 179.778 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.591 ' O ' HG13 ' A' ' 7' ' ' ILE . 73.7 m -114.38 -58.95 2.08 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.104 -0.997 . . . . 0.0 110.731 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.502 ' HB2' ' H ' ' A' ' 2' ' ' ASN . 1.6 mm-40 -49.74 -48.4 50.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.822 -1.174 . . . . 0.0 108.945 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.42 ' HB3' HD13 ' A' ' 25' ' ' LEU . 16.2 mt -55.65 -32.93 63.61 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.151 -1.02 . . . . 0.0 110.105 178.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.617 HG13 ' N ' ' A' ' 8' ' ' LYS . 1.0 OUTLIER -60.5 -40.94 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 120.599 -1.313 . . . . 0.0 107.563 178.743 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.617 ' N ' HG13 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -66.75 -31.14 71.6 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 177.343 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 13' ' ' ASP . . . -58.45 -39.01 78.69 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.815 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.4 mp -91.01 -30.61 4.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 178.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.599 ' HB1' ' HA ' ' A' ' 8' ' ' LYS . . . -66.08 -10.6 41.94 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 118.456 -1.298 . . . . 0.0 108.493 178.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.443 ' CG ' ' N ' ' A' ' 13' ' ' ASP . 6.4 pt20 -118.53 -42.52 2.75 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.48 -0.762 . . . . 0.0 110.405 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.443 ' N ' ' CG ' ' A' ' 12' ' ' GLN . 16.8 m-20 -69.85 -25.82 63.91 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 177.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.815 ' OG1' ' O ' ' A' ' 10' ' ' ILE 0.277 0.2 OUTLIER -106.53 -72.89 0.7 Allowed 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 179.025 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.65 15.68 54.3 Favored Glycine 0 N--CA 1.501 2.974 0 O-C-N 121.328 -0.857 . . . . 0.0 111.039 177.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.685 ' CD1' ' CG2' ' A' ' 14' ' ' THR . 4.4 mp -59.36 -68.87 0.23 Allowed 'General case' 0 C--N 1.294 -1.835 0 O-C-N 121.524 -0.986 . . . . 0.0 110.628 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.518 ' O ' HG23 ' A' ' 17' ' ' THR . 0.6 OUTLIER -138.11 9.64 2.77 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.302 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.558 ' O ' ' C ' ' A' ' 19' ' ' VAL . 7.7 mt-30 57.84 25.71 12.34 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -176.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.666 ' HB ' ' HB ' ' B' ' 19' ' ' VAL . 2.4 p -11.45 -95.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.089 -179.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.942 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -130.74 22.86 5.02 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 177.957 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.616 ' HA ' ' CE ' ' A' ' 24' ' ' MET . 30.5 m -25.19 -38.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-O 122.479 1.133 . . . . 0.0 109.182 -178.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.71 ' N ' ' O ' ' A' ' 20' ' ' SER . 4.9 m -84.49 -35.36 23.01 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.135 177.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.942 ' N ' ' O ' ' A' ' 20' ' ' SER . 1.2 mtmt -85.69 -34.07 21.37 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.652 -0.655 . . . . 0.0 111.543 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.616 ' CE ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -76.1 -40.24 53.41 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.44 -1.412 . . . . 0.0 109.349 179.466 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.722 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 11.6 mt -74.56 -38.29 62.74 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 117.894 -1.523 . . . . 0.0 108.724 178.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.491 ' HA ' ' HE2' ' A' ' 3' ' ' LYS . . . -64.08 -33.22 75.26 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 177.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.551 ' O ' ' N ' ' A' ' 31' ' ' ILE . 58.3 m -84.25 -30.52 25.61 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 178.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.722 ' HB3' ' HA ' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -59.24 -35.91 74.53 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.608 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.729 ' O ' ' HB ' ' A' ' 33' ' ' THR . 2.1 mt-10 -79.99 -32.92 39.76 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 177.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.739 ' O ' ' CG ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -68.6 -27.31 65.93 Favored 'General case' 0 C--O 1.194 -1.821 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 176.758 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.709 ' CG1' ' HA ' ' A' ' 28' ' ' PHE . 1.7 pp -97.11 -31.69 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.299 -0.875 . . . . 0.0 109.445 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.637 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 3.3 mm -65.42 -51.62 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 177.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.729 ' HB ' ' O ' ' A' ' 29' ' ' GLU . 0.3 OUTLIER -65.51 -43.27 90.62 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.867 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.739 ' CG ' ' O ' ' A' ' 30' ' ' LYS . 44.5 mm-40 -69.02 -36.08 77.36 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.614 -0.679 . . . . 0.0 111.451 179.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.582 ' N ' ' O ' ' A' ' 31' ' ' ILE . 2.3 m -57.59 -56.12 26.05 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.736 -1.228 . . . . 0.0 108.689 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.521 ' O ' HD21 ' B' ' 92' ' ' LEU . 0.4 OUTLIER -55.51 -29.51 24.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 106.303 -1.739 . . . . 0.0 106.303 177.414 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.638 ' HB1' ' O ' ' B' ' 88' ' ' ALA . . . -75.73 -4.1 38.53 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 177.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.467 ' N ' ' O ' ' A' ' 35' ' ' THR . 0.0 OUTLIER -115.26 -32.07 5.77 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.634 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.18 42.58 0.76 Allowed Glycine 0 C--N 1.301 -1.391 0 C-N-CA 119.804 -1.189 . . . . 0.0 110.558 178.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.475 ' CB ' HG21 ' A' ' 35' ' ' THR . 0.1 OUTLIER -125.86 117.44 23.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.218 -1.166 . . . . 0.0 110.33 179.349 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.6 mtmt -67.13 89.41 0.18 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.57 0.7 . . . . 0.0 109.626 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.415 ' CG2' ' CG2' ' A' ' 35' ' ' THR . 42.5 t -66.23 131.94 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.682 -0.637 . . . . 0.0 110.374 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.44 ' O ' ' HA ' ' B' ' 2' ' ' ASN . 0.8 OUTLIER -128.04 154.8 45.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.517 -0.739 . . . . 0.0 109.59 179.454 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 48' ' ' LEU . 73.1 mt -128.13 112.19 14.28 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.287 -0.883 . . . . 0.0 109.686 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.572 HG23 ' HG2' ' B' ' 29' ' ' GLU . 0.1 OUTLIER 32.45 -90.89 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.427 0 O-C-N 121.937 -0.477 . . . . 0.0 111.007 -179.371 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -149.94 28.99 1.14 Allowed Glycine 0 N--CA 1.482 1.752 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.587 ' CE2' ' HG2' ' B' ' 29' ' ' GLU . 5.8 p90 -129.06 -24.09 2.94 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.096 -1.238 . . . . 0.0 112.046 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 1.0 OUTLIER -131.47 107.63 9.03 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.38 -1.45 . . . . 0.0 111.524 179.143 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -111.46 95.51 5.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.608 -0.683 . . . . 0.0 109.741 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.648 ' HA ' HG23 ' A' ' 79' ' ' VAL . 0.3 OUTLIER -83.44 142.42 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.369 -0.832 . . . . 0.0 109.969 -179.351 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.483 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 13.0 ptmt -157.48 128.09 3.54 Favored Pre-proline 0 N--CA 1.494 1.743 0 C-N-CA 118.564 -1.255 . . . . 0.0 110.51 178.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.501 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 54.8 Cg_endo -85.28 143.74 9.01 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.475 1.25 . . . . 0.0 111.891 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.828 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 32.6 m -133.13 -149.37 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.96 ' HA ' ' CA ' ' A' ' 75' ' ' VAL . . . -167.18 143.01 4.21 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 118.542 -1.263 . . . . 0.0 113.238 177.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.488 ' H ' ' N ' ' A' ' 75' ' ' VAL . 0.1 OUTLIER 168.38 101.61 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.729 -178.842 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.644 ' HB2' ' HA ' ' A' ' 74' ' ' SER . 0.2 OUTLIER -161.43 32.91 0.13 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.375 -0.828 . . . . 0.0 110.531 -179.349 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.718 ' HA ' ' CB ' ' A' ' 72' ' ' ALA . . . -130.47 163.02 27.89 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-O 123.039 1.399 . . . . 0.0 113.721 -178.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.465 ' CD ' ' HB2' ' A' ' 69' ' ' LEU . 52.4 mtt180 -43.58 165.69 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 113.782 -1.554 . . . . 0.0 111.22 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.89 37.57 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.565 -0.709 . . . . 0.0 109.527 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 141.74 -20.69 2.54 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 67' ' ' GLU . 0.4 OUTLIER -162.49 174.27 12.9 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.38 -1.071 . . . . 0.0 110.032 179.891 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.686 ' HB3' ' CD ' ' A' ' 63' ' ' PRO . 2.2 t-20 -145.93 -76.93 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.345 -0.847 . . . . 0.0 109.147 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.686 ' CD ' ' HB3' ' A' ' 62' ' ' ASN . 54.4 Cg_endo -75.25 -12.39 21.03 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 N-CA-C 107.991 -1.58 . . . . 0.0 107.991 177.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.406 ' CB ' ' O ' ' A' ' 63' ' ' PRO . 2.3 tp60 70.86 71.85 0.19 Allowed 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.66 0.743 . . . . 0.0 110.946 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.474 ' O ' ' HB3' ' A' ' 66' ' ' GLN . 0.0 OUTLIER 177.63 -24.82 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.928 -0.482 . . . . 0.0 110.364 179.134 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.545 ' NE2' ' N ' ' A' ' 66' ' ' GLN . 0.4 OUTLIER -178.59 16.14 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.113 -0.992 . . . . 0.0 112.446 -179.485 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.426 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 0.5 OUTLIER -128.5 100.27 5.71 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.431 -1.418 . . . . 0.0 110.636 -179.699 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 61' ' ' PHE . . . -107.43 99.07 8.61 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.462 -0.774 . . . . 0.0 110.522 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.465 ' HB2' ' CD ' ' A' ' 58' ' ' ARG . 1.1 mp -123.53 -152.12 0.5 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.361 -0.837 . . . . 0.0 110.062 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.445 ' CA ' ' HB2' ' A' ' 58' ' ' ARG . 9.0 tt0 -164.42 43.61 0.09 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.112 -0.992 . . . . 0.0 110.881 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.7 ' O ' ' HB3' ' A' ' 72' ' ' ALA . 2.8 pp -130.54 145.86 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 O-C-N 121.052 -1.03 . . . . 0.0 111.715 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.718 ' CB ' ' HA ' ' A' ' 57' ' ' ALA . . . 158.17 -166.14 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 122.067 -0.395 . . . . 0.0 110.116 179.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.681 ' HD2' ' CB ' ' A' ' 72' ' ' ALA . 43.4 Cg_endo -78.14 168.36 21.97 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 124.119 1.589 . . . . 0.0 111.433 178.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.803 ' OG ' ' HB3' ' A' ' 54' ' ' ALA . 0.1 OUTLIER -171.94 111.92 0.3 Allowed 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.385 179.301 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.96 ' CA ' ' HA ' ' A' ' 54' ' ' ALA . 0.9 OUTLIER -173.21 141.36 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.704 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 176.859 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.454 ' CA ' HG22 ' A' ' 53' ' ' VAL . . . -145.11 111.18 0.58 Allowed Glycine 0 N--CA 1.491 2.321 0 C-N-CA 119.1 -1.524 . . . . 0.0 110.805 -178.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.585 HG21 ' CD2' ' B' ' 85' ' ' LEU . 4.9 p -76.96 81.69 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 O-C-N 121.603 -0.939 . . . . 0.0 110.08 179.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.625 ' O ' ' CG2' ' A' ' 79' ' ' VAL . 2.7 t -67.05 178.14 1.52 Allowed 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.347 -0.941 . . . . 0.0 109.607 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.648 HG23 ' HA ' ' A' ' 50' ' ' ILE . 3.4 t -176.41 174.96 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.527 ' N ' ' CG1' ' A' ' 79' ' ' VAL . 0.0 OUTLIER 179.32 170.59 0.55 Allowed Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 120.993 -1.067 . . . . 0.0 110.558 176.357 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.569 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 54.7 Cg_endo -95.09 144.53 1.41 Allowed 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 122.637 2.225 . . . . 0.0 110.551 178.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 46' ' ' GLY . . . -106.07 -171.68 23.32 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.79 -26.21 54.21 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.959 -1.318 . . . . 0.0 110.401 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.409 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 1.7 t -53.64 -27.56 27.91 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.675 ' CD2' HG23 ' B' ' 77' ' ' VAL . 1.3 mt -84.97 -29.07 25.38 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 178.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.25 -29.2 26.67 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.306 -0.871 . . . . 0.0 109.706 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.83 -38.06 58.44 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 178.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.68 ' C ' ' HB2' ' B' ' 37' ' ' ALA . . . -65.61 -33.31 75.61 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 177.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.732 ' N ' ' CB ' ' B' ' 37' ' ' ALA . . . -72.63 -26.86 61.82 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.77 -34.57 62.79 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 175.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -63.6 -50.08 64.47 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 107.864 -2.094 . . . . 0.0 107.864 176.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' B' ' 37' ' ' ALA . 3.4 mt -49.67 -12.56 0.07 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.073 -1.251 . . . . 0.0 111.484 178.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.524 ' CB ' ' O ' ' A' ' 92' ' ' LEU . 0.0 OUTLIER 73.54 61.14 0.09 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -177.589 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.667 ' CE2' ' HA ' ' B' ' 73' ' ' PRO . 50.8 t80 -37.46 -39.99 0.34 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.189 -178.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -55.11 -43.16 73.8 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.293 -0.879 . . . . 0.0 109.697 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -62.05 -35.87 79.9 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.82 -28.01 62.3 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.47 -63.98 0.99 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.578 -0.702 . . . . 0.0 110.206 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.147 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.468 ' HB3' ' HG ' ' B' ' 6' ' ' LEU . 1.5 mtp . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.059 0.457 . . . . 0.0 110.329 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . 0.509 ' O ' ' HB2' ' B' ' 6' ' ' LEU . 12.4 t-20 -173.54 -161.06 0.13 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.306 -0.871 . . . . 0.0 110.892 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.464 ' HE2' ' HB2' ' B' ' 29' ' ' GLU . 0.7 OUTLIER -55.77 -2.21 0.05 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.335 -0.853 . . . . 0.0 110.895 179.903 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.635 ' O ' ' CG1' ' B' ' 7' ' ' ILE . 54.4 m -122.77 -60.14 1.55 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.966 -1.084 . . . . 0.0 109.969 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.463 ' HB2' ' CA ' ' B' ' 1' ' ' MET . 5.4 mt-10 -51.74 -47.62 63.99 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.822 -1.174 . . . . 0.0 109.108 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.509 ' HB2' ' O ' ' B' ' 2' ' ' ASN . 5.2 mt -60.43 -33.3 72.33 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.265 178.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' ILE . . . . . 0.663 HG13 ' N ' ' B' ' 8' ' ' LYS . 0.9 OUTLIER -58.4 -42.65 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 120.582 -1.324 . . . . 0.0 108.397 179.812 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . 0.663 ' N ' HG13 ' B' ' 7' ' ' ILE . 0.1 OUTLIER -67.14 -32.2 73.15 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.213 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.33 -30.78 71.4 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 178.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . 0.819 HG22 HG23 ' B' ' 14' ' ' THR . 1.2 mp -96.65 -32.59 4.25 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.5 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 178.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.568 ' HB1' ' HA ' ' B' ' 8' ' ' LYS . . . -63.79 -29.58 70.77 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.403 ' CG ' ' N ' ' B' ' 13' ' ' ASP . 6.5 pt20 -89.56 -38.16 14.17 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.116 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.466 ' HB2' ' HA ' ' B' ' 10' ' ' ILE . 66.0 m-20 -67.96 -23.03 65.01 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 176.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.819 HG23 HG22 ' B' ' 10' ' ' ILE . 18.4 p -92.31 -76.46 0.46 Allowed 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 61.05 12.37 29.62 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' LEU . . . . . 0.69 HD11 ' HB ' ' B' ' 14' ' ' THR . 3.3 mp -79.78 -61.66 1.92 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.481 -1.011 . . . . 0.0 109.016 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' THR . . . . . 0.462 ' O ' HG23 ' B' ' 17' ' ' THR . 0.6 OUTLIER -141.55 5.93 1.84 Allowed 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.889 -179.794 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . 0.575 ' O ' ' C ' ' B' ' 19' ' ' VAL . 6.7 mt-30 54.53 29.69 11.74 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 -176.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.666 ' HB ' ' HB ' ' A' ' 19' ' ' VAL . 1.4 p -12.07 -95.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.743 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.945 ' O ' ' N ' ' B' ' 23' ' ' LYS . 0.5 OUTLIER -132.97 24.39 4.25 Favored 'General case' 0 C--N 1.283 -2.311 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 178.601 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.649 ' C ' ' O ' ' B' ' 20' ' ' SER . 17.1 m -19.28 -39.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 CA-C-O 122.398 1.094 . . . . 0.0 109.433 -177.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.848 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.6 OUTLIER -82.43 -37.54 25.31 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.875 178.221 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . 0.945 ' N ' ' O ' ' B' ' 20' ' ' SER . 1.9 mtmt -89.63 -28.75 19.29 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.46 -0.775 . . . . 0.0 111.377 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' MET . . . . . 0.524 ' CE ' ' HA ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -77.81 -36.36 50.33 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 118.002 -1.479 . . . . 0.0 108.549 179.078 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.614 ' HA ' ' HB3' ' B' ' 28' ' ' PHE . 0.8 OUTLIER -75.18 -42.63 55.39 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 177.281 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . 0.445 ' HA ' ' HE2' ' B' ' 3' ' ' LYS . . . -60.3 -32.48 71.25 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 177.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' SER . . . . . 0.545 ' O ' ' N ' ' B' ' 31' ' ' ILE . 12.1 m -79.88 -35.66 37.73 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . 0.708 ' CE1' ' HG3' ' B' ' 29' ' ' GLU . 0.0 OUTLIER -59.25 -40.08 84.84 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 178.849 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . 0.708 ' HG3' ' CE1' ' B' ' 28' ' ' PHE . 1.3 mt-10 -76.03 -34.05 59.66 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . 0.751 ' O ' ' CG ' ' B' ' 34' ' ' GLU . 30.0 tttp -70.08 -29.89 66.99 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 177.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.706 ' CG1' ' HA ' ' B' ' 28' ' ' PHE . 2.0 pp -93.02 -35.23 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.311 -0.868 . . . . 0.0 109.232 179.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.68 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.3 mm -60.52 -60.05 3.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' THR . . . . . 0.647 ' HA ' HD21 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -58.29 -39.53 79.55 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.116 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.842 ' O ' ' N ' ' B' ' 38' ' ' LYS . 7.0 mm-40 -68.66 -54.7 14.76 Favored 'General case' 0 C--O 1.199 -1.586 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.109 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' THR . . . . . 0.497 ' HA ' ' HB2' ' B' ' 38' ' ' LYS . 50.2 m -47.02 -63.85 0.93 Allowed 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.87 -1.144 . . . . 0.0 112.124 -178.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.815 ' O ' ' HG3' ' B' ' 52' ' ' PRO . 0.9 OUTLIER -49.61 -44.02 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 C-N-CA 118.058 -1.457 . . . . 0.0 107.841 179.126 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . 0.732 ' CB ' ' N ' ' A' ' 89' ' ' ALA . . . -93.63 15.27 16.63 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.793 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . 0.842 ' N ' ' O ' ' B' ' 34' ' ' GLU . 4.7 mmtt -121.95 -28.08 4.5 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 144.16 41.11 0.06 OUTLIER Glycine 0 N--CA 1.477 1.384 0 C-N-CA 119.026 -1.559 . . . . 0.0 112.06 178.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . 0.502 ' O ' ' HA ' ' B' ' 36' ' ' VAL . 0.4 OUTLIER -172.92 147.3 1.65 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.59 -1.535 . . . . 0.0 111.421 179.069 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 2.2 mttt -102.81 114.7 29.18 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . 0.449 ' HB ' ' CG1' ' B' ' 50' ' ' ILE . 7.5 t -87.92 154.95 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 C-N-CA 119.858 -0.737 . . . . 0.0 111.107 -178.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' GLN . . . . . 0.401 ' HA ' ' HA ' ' B' ' 49' ' ' ASN . 14.6 mt-30 -142.04 121.12 12.92 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.552 -0.717 . . . . 0.0 109.89 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.577 HD12 ' CB ' ' B' ' 48' ' ' LEU . 20.5 mt -87.09 102.56 14.54 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.199 -0.938 . . . . 0.0 109.934 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' THR . . . . . 0.629 HG23 ' HG2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 37.56 28.09 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.435 0 O-C-N 121.819 -0.55 . . . . 0.0 111.753 -179.659 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . 90.64 -11.5 71.44 Favored Glycine 0 N--CA 1.486 2.028 0 C-N-CA 119.903 -1.142 . . . . 0.0 111.902 178.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . 0.618 ' CE2' ' HG2' ' A' ' 29' ' ' GLU . 0.8 OUTLIER -87.76 -35.3 17.96 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 120.028 1.914 . . . . 0.0 111.776 -179.561 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . 0.577 ' CB ' HD12 ' B' ' 44' ' ' LEU . 0.4 OUTLIER -120.18 85.59 2.41 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.63 -1.294 . . . . 0.0 110.516 178.539 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' ASN . . . . . 0.401 ' HA ' ' HA ' ' B' ' 43' ' ' GLN . 7.6 t-20 -90.84 80.41 5.83 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.847 -0.533 . . . . 0.0 110.444 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 50' ' ' ILE . . . . . 0.471 HD13 HG23 ' B' ' 36' ' ' VAL . 2.9 pt -73.07 147.86 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.227 -0.921 . . . . 0.0 110.344 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . 0.564 ' O ' ' N ' ' B' ' 78' ' ' SER . 0.0 OUTLIER -165.14 132.52 2.35 Favored Pre-proline 0 N--CA 1.498 1.935 0 C-N-CA 119.285 -0.966 . . . . 0.0 110.549 179.456 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . 0.815 ' HG3' ' O ' ' B' ' 36' ' ' VAL . 54.4 Cg_endo -85.47 149.19 10.16 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 O-C-N 123.398 1.209 . . . . 0.0 111.174 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.577 ' CG2' ' HA3' ' B' ' 76' ' ' GLY . 11.8 m -144.93 120.15 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 CA-C-O 122.296 1.046 . . . . 0.0 111.619 178.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.475 ' O ' ' HB3' ' B' ' 55' ' ' ARG . . . -70.95 108.19 4.42 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.875 -179.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . 0.475 ' HB3' ' O ' ' B' ' 54' ' ' ALA . 0.0 OUTLIER 166.0 86.39 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 179.906 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . 0.546 ' CG ' ' O ' ' B' ' 74' ' ' SER . 1.2 mt-30 -159.79 -158.73 0.67 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.053 -1.059 . . . . 0.0 112.34 -177.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.91 ' HA ' ' HA ' ' B' ' 72' ' ' ALA . . . -172.73 148.06 1.84 Allowed 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 122.692 1.235 . . . . 0.0 113.451 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 58' ' ' ARG . . . . . 0.499 ' HB3' ' HA ' ' B' ' 70' ' ' GLU . 1.0 OUTLIER -66.23 -173.33 0.19 Allowed 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.186 179.624 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 4.2 ttmt -165.81 23.7 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.403 -0.811 . . . . 0.0 110.819 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' B' ' 69' ' ' LEU . . . 128.45 58.75 0.11 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.916 -1.273 . . . . 0.0 109.916 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 61' ' ' PHE . . . . . 0.728 ' C ' ' CD1' ' B' ' 61' ' ' PHE . 0.1 OUTLIER -97.97 144.28 27.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.991 -1.299 . . . . 0.0 112.994 -179.38 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . 0.789 ' H ' ' CD ' ' B' ' 63' ' ' PRO . 9.7 p30 -144.47 -10.78 0.01 OUTLIER Pre-proline 0 C--N 1.302 -1.49 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . 0.789 ' CD ' ' H ' ' B' ' 62' ' ' ASN . 46.5 Cg_endo -74.51 -7.52 19.62 Favored 'Trans proline' 0 N--CA 1.482 0.817 0 N-CA-C 109.042 -1.176 . . . . 0.0 109.042 178.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . 0.584 ' CB ' ' CE1' ' B' ' 61' ' ' PHE . 0.0 OUTLIER -94.27 -106.25 0.13 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.63 -0.669 . . . . 0.0 109.42 179.864 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.541 ' O ' ' HB2' ' B' ' 66' ' ' GLN . 19.5 p -71.33 -6.35 39.35 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.396 -1.44 . . . . 0.0 110.065 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . 0.657 ' HA ' ' O ' ' B' ' 62' ' ' ASN . 41.7 mm-40 77.71 106.6 0.08 Allowed 'General case' 0 N--CA 1.504 2.252 0 CA-C-O 121.602 0.715 . . . . 0.0 111.968 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . 0.595 ' CB ' ' O ' ' B' ' 66' ' ' GLN . 10.9 mt-10 138.95 93.27 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . 0.707 ' HA ' ' C ' ' B' ' 61' ' ' PHE . . . -41.56 102.03 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.404 0 O-C-N 120.659 -1.275 . . . . 0.0 110.229 -179.007 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.594 ' O ' ' N ' ' B' ' 60' ' ' GLY . 22.0 mt -94.54 -141.87 0.24 Allowed 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.607 -0.683 . . . . 0.0 111.003 -178.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . 0.507 ' HB2' ' O ' ' B' ' 69' ' ' LEU . 2.4 tm-20 177.57 34.78 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.05 -1.031 . . . . 0.0 109.957 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.714 ' CG2' ' HD3' ' B' ' 73' ' ' PRO . 0.0 OUTLIER -66.11 -143.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 O-C-N 120.894 -1.128 . . . . 0.0 112.269 -178.335 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . 0.91 ' HA ' ' HA ' ' B' ' 57' ' ' ALA . . . -132.36 28.84 0.16 Allowed Pre-proline 0 N--CA 1.506 2.339 0 N-CA-C 117.138 2.273 . . . . 0.0 117.138 -174.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 73' ' ' PRO . . . . . 0.813 ' HD3' ' N ' ' B' ' 72' ' ' ALA . 58.3 Cg_endo -110.32 99.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.303 -1.849 0 C-N-CA 120.635 0.89 . . . . 0.0 114.41 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 74' ' ' SER . . . . . 0.546 ' O ' ' CG ' ' B' ' 56' ' ' GLN . 0.3 OUTLIER -150.33 90.29 1.65 Allowed 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 119.495 -0.882 . . . . 0.0 109.339 176.201 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . 0.528 ' N ' ' CD1' ' A' ' 94' ' ' TYR . 7.6 p -30.68 145.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.496 0 O-C-N 121.278 -0.889 . . . . 0.0 111.09 -179.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . 0.577 ' HA3' ' CG2' ' B' ' 53' ' ' VAL . . . -101.25 78.81 0.4 Allowed Glycine 0 N--CA 1.478 1.495 0 C-N-CA 118.693 -1.718 . . . . 0.0 109.248 -179.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.675 HG23 ' CD2' ' A' ' 85' ' ' LEU . 2.4 p -66.74 69.19 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 O-C-N 121.672 -0.899 . . . . 0.0 109.384 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 78' ' ' SER . . . . . 0.564 ' N ' ' O ' ' B' ' 51' ' ' LYS . 0.6 OUTLIER -64.37 174.12 1.79 Allowed 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 118.927 -1.109 . . . . 0.0 110.136 -179.944 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . 0.45 ' CG2' ' N ' ' B' ' 80' ' ' LYS . 3.7 p 174.06 176.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' B' ' 48' ' ' LEU . 0.0 OUTLIER 179.68 171.26 0.56 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 120.865 -1.147 . . . . 0.0 110.663 176.91 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 81' ' ' PRO . . . . . 0.493 ' HA ' ' O ' ' B' ' 47' ' ' PHE . 54.8 Cg_endo -94.9 138.84 0.97 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.493 2.128 . . . . 0.0 110.227 177.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . 0.524 ' HA3' ' HA ' ' B' ' 47' ' ' PHE . . . -92.64 -164.71 38.17 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 108.248 -1.941 . . . . 0.0 108.248 178.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . 0.566 ' O ' ' N ' ' B' ' 87' ' ' LYS . 0.0 OUTLIER -94.46 -18.17 21.75 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.138 -1.213 . . . . 0.0 110.36 179.517 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 14.5 t -61.22 -34.83 75.74 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 177.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . 0.598 ' CD1' ' HA ' ' A' ' 33' ' ' THR . 0.9 OUTLIER -86.74 -26.87 23.99 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.283 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . 0.417 ' CG ' HG13 ' A' ' 77' ' ' VAL . 4.4 tttp -79.32 -34.32 42.4 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 177.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . 0.566 ' N ' ' O ' ' B' ' 83' ' ' GLU . 15.7 tttt -67.14 -39.56 86.59 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 178.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.638 ' O ' ' HB1' ' A' ' 37' ' ' ALA . . . -60.45 -38.0 82.75 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 175.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . 0.417 ' CA ' HD23 ' B' ' 92' ' ' LEU . . . -55.78 -34.99 65.76 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 177.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.639 ' HA ' ' HB2' ' B' ' 94' ' ' TYR . 0.0 OUTLIER -56.91 -32.53 66.03 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 177.346 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.24 -13.27 77.23 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . 0.624 ' HB3' ' HA ' ' A' ' 37' ' ' ALA . 0.3 OUTLIER -78.69 16.75 0.8 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.689 -1.477 . . . . 0.0 111.267 -179.883 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . 0.594 ' CG ' ' O ' ' B' ' 92' ' ' LEU . 0.1 OUTLIER 86.75 34.55 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -178.324 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . 0.742 ' CD2' ' HB ' ' A' ' 75' ' ' VAL . 3.6 t80 -42.09 -62.38 0.94 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.413 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . 0.442 ' HA ' ' HB3' ' B' ' 98' ' ' ALA . 26.4 mt-10 -58.39 -32.62 68.77 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.53 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 96' ' ' ASP . . . . . 0.443 ' HB3' ' HG3' ' B' ' 93' ' ' LYS . 0.5 OUTLIER -64.52 -34.77 79.0 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.711 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -83.17 -12.74 56.64 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 177.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 98' ' ' ALA . . . . . 0.653 ' HA ' ' OG ' ' A' ' 74' ' ' SER . . . -92.79 -16.3 25.53 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.484 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 3.0 mttp . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.203 179.979 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.487 ' HG2' ' CB ' ' A' ' 5' ' ' GLU . 1.4 mtp . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.01 0.433 . . . . 0.0 110.041 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.596 ' H ' ' HB2' ' A' ' 5' ' ' GLU . 47.0 p-10 -177.03 -169.68 0.26 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.295 -0.878 . . . . 0.0 110.44 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.694 ' HE3' ' HB2' ' A' ' 29' ' ' GLU . 2.5 tptm -52.0 -17.38 1.0 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.4 -0.812 . . . . 0.0 110.158 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.42 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 24.4 m -95.49 -54.58 3.33 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.128 -0.983 . . . . 0.0 109.292 178.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.596 ' HB2' ' H ' ' A' ' 2' ' ' ASN . 2.8 mt-10 -62.85 -42.24 99.67 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.446 -0.901 . . . . 0.0 108.631 179.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.433 ' HA ' ' HB2' ' A' ' 9' ' ' ALA . 23.2 mt -65.35 -31.26 72.28 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 118.899 -1.12 . . . . 0.0 108.585 177.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.603 HG13 ' CD1' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -57.91 -57.23 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 178.341 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.536 ' HA ' ' CB ' ' A' ' 11' ' ' ALA . 18.4 pttt -65.83 -24.33 66.88 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.433 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . . . -60.25 -38.46 83.56 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.089 -1.007 . . . . 0.0 108.451 178.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.818 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.2 mp -88.48 -37.83 10.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 177.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.536 ' CB ' ' HA ' ' A' ' 8' ' ' LYS . . . -61.13 -15.76 36.92 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 119.047 -1.061 . . . . 0.0 108.631 177.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.442 ' N ' ' O ' ' A' ' 8' ' ' LYS . 53.2 tp60 -111.13 -43.74 3.69 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.605 -0.684 . . . . 0.0 109.237 178.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.433 ' HB2' ' O ' ' A' ' 9' ' ' ALA . 35.5 m-20 -62.33 -30.63 71.3 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 177.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.818 ' OG1' ' O ' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -105.03 -70.59 0.77 Allowed 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.122 179.053 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 49.08 26.7 6.32 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.551 ' CD1' ' CG2' ' B' ' 19' ' ' VAL . 0.0 OUTLIER -87.41 -27.46 22.74 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.48 -1.012 . . . . 0.0 109.042 178.851 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.521 HG21 ' CG2' ' B' ' 17' ' ' THR . 0.4 OUTLIER -159.34 -7.61 0.07 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.982 -0.449 . . . . 0.0 110.169 -179.448 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.62 ' O ' ' C ' ' A' ' 19' ' ' VAL . 5.4 mt-30 58.0 31.2 20.31 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 -176.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.818 ' HB ' ' HB ' ' B' ' 19' ' ' VAL . 1.6 p -5.05 -91.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.502 -178.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.97 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -132.43 22.99 4.38 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.101 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.685 ' HA ' ' HE2' ' A' ' 24' ' ' MET . 16.0 m -19.41 -38.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 122.331 1.062 . . . . 0.0 109.389 -178.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.862 ' N ' ' O ' ' A' ' 20' ' ' SER . 5.6 t -78.88 -39.24 35.59 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.409 177.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.97 ' N ' ' O ' ' A' ' 20' ' ' SER . 3.1 mtmt -94.85 -28.36 15.27 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.603 -0.686 . . . . 0.0 109.543 178.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.685 ' HE2' ' HA ' ' A' ' 21' ' ' VAL 0.261 0.0 OUTLIER -63.09 -42.26 99.56 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.896 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.674 ' HB3' ' HG3' ' A' ' 3' ' ' LYS . 0.4 OUTLIER -86.1 -49.16 7.99 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 118.822 -1.151 . . . . 0.0 109.63 177.743 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 25' ' ' LEU . . . -46.77 -39.66 12.15 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.543 -1.348 . . . . 0.0 108.148 178.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.548 ' O ' ' N ' ' A' ' 31' ' ' ILE . 55.6 m -78.31 -30.26 48.18 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.911 ' O ' HG13 ' A' ' 31' ' ' ILE . 7.7 t80 -54.79 -47.35 74.08 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.572 -0.705 . . . . 0.0 109.455 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.694 ' HB2' ' HE3' ' A' ' 3' ' ' LYS . 21.4 tt0 -68.78 -34.28 75.3 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 117.577 -1.649 . . . . 0.0 107.177 177.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.932 ' O ' ' HB3' ' A' ' 34' ' ' GLU . 7.8 tttp -69.22 -22.5 63.87 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.375 -0.93 . . . . 0.0 108.821 178.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.911 HG13 ' O ' ' A' ' 28' ' ' PHE . 2.3 pp -95.42 -40.43 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 119.364 -0.934 . . . . 0.0 109.66 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.613 HG13 ' CE1' ' A' ' 28' ' ' PHE . 6.2 mm -50.31 -50.28 21.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 177.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.46 ' HA ' ' CD2' ' B' ' 85' ' ' LEU . 7.5 p -69.38 -39.7 77.87 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.932 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -56.76 -32.86 66.02 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.692 -179.121 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.511 HG22 ' CB ' ' A' ' 40' ' ' ASP . 2.2 m -85.28 -56.23 3.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.021 -1.072 . . . . 0.0 110.272 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 94.2 t -53.92 -39.56 40.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 118.308 -1.357 . . . . 0.0 108.101 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.666 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -77.69 -3.45 41.16 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.101 -1.04 . . . . 0.0 109.012 177.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.616 ' HB2' ' O ' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -103.04 -26.76 12.95 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.253 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.49 43.29 1.37 Allowed Glycine 0 C--N 1.3 -1.418 0 C-N-CA 120.058 -1.068 . . . . 0.0 110.507 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.511 ' CB ' HG22 ' A' ' 35' ' ' THR . 0.1 OUTLIER -129.01 140.94 51.41 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.179 -1.189 . . . . 0.0 109.979 179.241 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.453 ' O ' ' N ' ' A' ' 43' ' ' GLN . 51.3 mtpt -88.08 89.32 7.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.552 -0.717 . . . . 0.0 110.53 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.67 ' HA ' ' HB3' ' B' ' 1' ' ' MET . 27.8 m -61.63 80.31 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.608 -0.683 . . . . 0.0 109.939 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.453 ' N ' ' O ' ' A' ' 41' ' ' LYS . 1.9 tt0 -84.04 107.24 16.27 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.469 -0.769 . . . . 0.0 109.318 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.665 ' HB2' ' HB2' ' A' ' 48' ' ' LEU . 65.1 mt -61.89 114.67 3.48 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.138 -0.976 . . . . 0.0 109.179 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.587 HG21 ' HD1' ' A' ' 47' ' ' PHE . 0.0 OUTLIER 33.02 -97.5 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.853 -0.529 . . . . 0.0 111.256 -179.614 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -144.44 28.32 1.93 Allowed Glycine 0 N--CA 1.489 2.201 0 C-N-CA 119.726 -1.226 . . . . 0.0 110.39 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.687 ' CD1' ' HG3' ' B' ' 29' ' ' GLU . 3.6 p90 -126.03 -29.54 3.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.903 -1.351 . . . . 0.0 110.517 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.665 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 11.9 mt -123.63 93.12 3.84 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.23 -1.544 . . . . 0.0 110.53 177.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -86.86 86.0 7.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.911 -0.493 . . . . 0.0 110.055 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.573 ' N ' ' CD1' ' A' ' 50' ' ' ILE . 1.5 mp -82.97 137.81 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.425 -0.797 . . . . 0.0 110.069 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 13.5 ptmt -153.43 127.94 4.66 Favored Pre-proline 0 N--CA 1.494 1.732 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.472 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.551 ' HB2' ' CG1' ' A' ' 75' ' ' VAL . 41.1 Cg_endo -65.47 141.33 67.05 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 123.539 1.284 . . . . 0.0 111.894 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.58 ' C ' ' HA ' ' A' ' 75' ' ' VAL . 33.4 m -147.66 117.69 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 CA-C-O 121.326 0.584 . . . . 0.0 111.244 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.642 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . -62.12 131.25 48.91 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.309 -0.869 . . . . 0.0 112.278 -178.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.512 ' H ' ' C ' ' A' ' 74' ' ' SER . 0.6 OUTLIER -176.16 106.75 0.08 Allowed 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.631 0.729 . . . . 0.0 110.358 179.548 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.628 ' HG2' ' HB2' ' A' ' 74' ' ' SER . 0.9 OUTLIER -172.18 19.11 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.561 -0.712 . . . . 0.0 110.018 179.227 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.614 ' CB ' HG21 ' A' ' 71' ' ' ILE . . . -172.07 169.16 5.67 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.181 -0.95 . . . . 0.0 110.355 -177.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.688 ' N ' HG21 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -144.66 174.68 10.76 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.33 -0.857 . . . . 0.0 110.26 178.21 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.749 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . 1.1 tttm -169.06 -139.14 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.127 -0.983 . . . . 0.0 111.006 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.09 98.94 0.24 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.541 ' HA ' ' O ' ' A' ' 67' ' ' GLU . 48.0 p90 -53.3 170.95 0.08 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.435 -1.038 . . . . 0.0 110.91 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.538 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 0.3 OUTLIER -59.12 -165.32 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.937 0 O-C-N 121.622 -0.674 . . . . 0.0 109.361 179.817 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.538 ' HD2' ' HB3' ' A' ' 62' ' ' ASN . 44.5 Cg_endo -75.99 60.23 6.08 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 N-CA-C 109.133 -1.141 . . . . 0.0 109.133 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.435 ' C ' ' CE1' ' A' ' 61' ' ' PHE . 24.1 mt-30 -139.8 -109.48 0.16 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.509 -0.744 . . . . 0.0 110.534 -179.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.449 ' HA ' ' CZ ' ' A' ' 61' ' ' PHE . 6.7 t -175.34 29.08 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.895 -1.128 . . . . 0.0 110.829 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -174.18 -26.8 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.025 -1.047 . . . . 0.0 111.918 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.541 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 9.8 mt-10 -72.29 65.02 0.59 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.905 -1.122 . . . . 0.0 110.227 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.487 ' CB ' ' HB2' ' A' ' 58' ' ' ARG . . . -64.63 133.06 51.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.697 -0.627 . . . . 0.0 110.941 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.44 ' CD1' ' O ' ' A' ' 69' ' ' LEU . 1.5 pp -174.71 56.41 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.252 -0.905 . . . . 0.0 111.053 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.564 ' CB ' ' HB3' ' A' ' 59' ' ' LYS . 1.6 tt0 -131.29 19.21 4.86 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.765 -1.21 . . . . 0.0 110.697 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.757 HG12 ' H ' ' A' ' 72' ' ' ALA 0.301 16.6 tt -111.99 -138.76 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.516 -0.74 . . . . 0.0 110.647 -178.832 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.757 ' H ' HG12 ' A' ' 71' ' ' ILE . . . -117.9 81.43 15.66 Favored Pre-proline 0 C--N 1.3 -1.557 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -176.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.545 ' HD2' ' CB ' ' B' ' 98' ' ' ALA . 45.0 Cg_endo -70.45 122.64 9.12 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 O-C-N 123.896 1.471 . . . . 0.0 111.285 177.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.842 ' HA ' ' CD1' ' B' ' 94' ' ' TYR . 14.7 t -76.6 129.51 36.51 Favored 'General case' 0 N--CA 1.51 2.571 0 CA-C-O 121.644 0.735 . . . . 0.0 112.807 -178.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.642 ' HA ' ' HA ' ' A' ' 54' ' ' ALA . 38.2 t -54.19 138.48 13.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-O 122.162 0.982 . . . . 0.0 109.975 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 78' ' ' SER . . . -126.57 105.62 0.79 Allowed Glycine 0 C--N 1.29 -1.998 0 N-CA-C 108.015 -2.034 . . . . 0.0 108.015 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.607 HG13 ' HB2' ' B' ' 85' ' ' LEU . 13.2 p -51.02 89.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.678 -0.895 . . . . 0.0 110.476 -178.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.504 ' N ' ' O ' ' A' ' 76' ' ' GLY . 0.5 OUTLIER -58.58 -171.92 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.281 -0.887 . . . . 0.0 110.729 -179.14 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.528 ' HB ' ' HG3' ' B' ' 81' ' ' PRO . 3.3 p -167.48 -164.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.447 ' CB ' ' CD ' ' A' ' 81' ' ' PRO . 2.0 mttm -160.08 178.59 1.61 Allowed Pre-proline 0 C--N 1.308 -1.211 0 O-C-N 120.914 -1.116 . . . . 0.0 111.335 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.447 ' CD ' ' CB ' ' A' ' 80' ' ' LYS . 55.5 Cg_endo -103.64 83.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 123.977 3.118 . . . . 0.0 108.862 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.651 ' CA ' ' O ' ' A' ' 47' ' ' PHE . . . -57.0 121.63 25.94 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.591 -1.29 . . . . 0.0 111.183 -178.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -62.19 -35.74 79.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.53 -0.982 . . . . 0.0 109.043 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.94 -30.85 48.35 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.558 ' HB2' ' OG1' ' B' ' 33' ' ' THR . 8.8 tt -85.26 -34.23 21.99 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.412 ' HA ' ' CG1' ' B' ' 75' ' ' VAL . 0.3 OUTLIER -75.35 -44.75 43.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.542 -0.724 . . . . 0.0 109.446 179.606 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 41.4 tptt -64.98 -38.26 90.38 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 177.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.748 ' O ' ' HB2' ' B' ' 37' ' ' ALA . . . -61.65 -36.63 81.35 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 176.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.606 ' CB ' ' CG1' ' B' ' 75' ' ' VAL . . . -56.42 -39.68 73.46 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.5 ' HA ' ' CB ' ' A' ' 94' ' ' TYR . 6.4 mm-40 -55.9 -28.89 58.81 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 176.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 88' ' ' ALA . . . -65.72 -50.84 51.56 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 178.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.599 ' HB3' ' O ' ' B' ' 37' ' ' ALA . 0.4 OUTLIER -59.85 -37.2 78.61 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.417 -1.637 . . . . 0.0 109.64 -179.745 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.596 ' CB ' ' O ' ' A' ' 92' ' ' LEU . 1.1 ttmt 143.82 65.23 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 1.345 ' O ' ' N ' ' A' ' 96' ' ' ASP . 7.7 t80 -49.11 -60.74 2.53 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 116.328 -2.149 . . . . 0.0 106.45 178.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 1.095 ' C ' ' O ' ' A' ' 94' ' ' TYR . 3.8 mm-40 10.96 41.9 0.0 OUTLIER 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 102.291 -3.226 . . . . 0.0 102.291 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 1.345 ' N ' ' O ' ' A' ' 94' ' ' TYR . 0.3 OUTLIER 21.13 43.18 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 113.533 -1.667 . . . . 0.0 107.626 -172.916 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.849 ' N ' ' O ' ' A' ' 94' ' ' TYR 0.254 1.0 OUTLIER 27.83 28.44 0.0 OUTLIER 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 101.677 -3.453 . . . . 0.0 101.677 -170.35 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 1.061 ' N ' ' O ' ' A' ' 96' ' ' ASP . . . -68.52 -30.93 69.85 Favored 'General case' 0 C--O 1.215 -0.733 0 CA-C-N 110.292 -3.14 . . . . 0.0 109.559 -178.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 26.2 mttm . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.196 179.993 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.67 ' HB3' ' HA ' ' A' ' 42' ' ' VAL . 1.6 tpt . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 120.855 0.36 . . . . 0.0 110.401 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . 0.484 ' HB3' ' O ' ' B' ' 1' ' ' MET . 25.9 p30 179.6 -160.49 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.343 -0.943 . . . . 0.0 111.41 178.05 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.565 ' HE3' ' CG2' ' A' ' 45' ' ' THR . 0.1 OUTLIER -52.56 -10.45 0.15 Allowed 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.419 -0.801 . . . . 0.0 110.814 -179.705 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.478 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 4.4 m -106.43 -51.5 2.94 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.861 -1.149 . . . . 0.0 109.495 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.577 ' CB ' ' HA ' ' B' ' 1' ' ' MET . 1.3 mt-10 -65.46 -37.84 88.05 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.217 -0.927 . . . . 0.0 108.637 179.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.472 ' HA ' ' HB3' ' B' ' 9' ' ' ALA . 24.6 mt -71.88 -27.95 63.2 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 118.892 -1.123 . . . . 0.0 108.214 177.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' ILE . . . . . 0.651 HG12 ' O ' ' B' ' 21' ' ' VAL . 0.2 OUTLIER -57.31 -60.78 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 177.542 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . 0.517 ' HG3' ' O ' ' B' ' 5' ' ' GLU . 0.0 OUTLIER -62.8 -24.1 67.57 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.581 178.443 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . 0.472 ' HB3' ' HA ' ' B' ' 6' ' ' LEU . . . -60.83 -36.28 78.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.04 -1.038 . . . . 0.0 108.674 178.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . 0.915 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.0 OUTLIER -96.56 -35.19 5.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 178.535 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.507 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -60.34 -25.12 65.58 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -91.27 -43.25 9.92 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 178.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.473 ' HB3' ' CB ' ' A' ' 27' ' ' SER . 1.1 m-20 -64.33 -26.11 68.33 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 177.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.915 ' OG1' ' O ' ' B' ' 10' ' ' ILE . 10.7 p -91.78 -75.1 0.49 Allowed 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 177.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' B' ' 11' ' ' ALA . . . 57.75 17.78 29.24 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 178.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' LEU . . . . . 0.663 HD12 ' HB ' ' B' ' 14' ' ' THR . 3.8 mp -77.54 -57.13 3.98 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 122.317 1.056 . . . . 0.0 108.532 178.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' THR . . . . . 0.606 HG22 ' O ' ' B' ' 17' ' ' THR . 0.5 OUTLIER -142.67 5.54 1.59 Allowed 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 115.162 -0.927 . . . . 0.0 109.18 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . 0.622 ' O ' ' C ' ' B' ' 19' ' ' VAL . 3.9 mt-30 58.26 25.24 12.43 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 -176.134 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.818 ' HB ' ' HB ' ' A' ' 19' ' ' VAL . 0.2 OUTLIER 9.43 -98.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.437 -178.954 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 1.051 ' O ' ' N ' ' B' ' 22' ' ' SER . 1.9 p -136.6 24.14 3.15 Favored 'General case' 0 C--N 1.273 -2.733 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 177.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.651 ' O ' HG12 ' B' ' 7' ' ' ILE . 21.9 m -4.35 -42.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 CA-C-O 122.528 1.156 . . . . 0.0 110.763 -177.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 1.051 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.5 OUTLIER -76.62 -38.09 55.31 Favored 'General case' 0 C--N 1.281 -2.407 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.2 178.724 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . 0.882 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.0 OUTLIER -89.19 -32.79 17.28 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.437 -0.79 . . . . 0.0 111.302 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' MET . . . . . 0.568 ' SD ' ' HA ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -68.83 -37.7 79.35 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 117.322 -1.751 . . . . 0.0 108.736 179.683 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.639 ' HA ' ' HB3' ' B' ' 28' ' ' PHE . 0.3 OUTLIER -82.91 -44.39 15.43 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 118.21 -1.396 . . . . 0.0 109.669 178.234 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . 0.525 ' HA ' ' CE ' ' B' ' 3' ' ' LYS . . . -58.4 -35.36 71.9 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.957 -1.089 . . . . 0.0 108.2 178.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' SER . . . . . 0.52 ' O ' HG13 ' B' ' 31' ' ' ILE . 20.0 t -81.68 -30.99 32.43 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . 0.667 ' HA ' ' CG1' ' B' ' 31' ' ' ILE . 0.0 OUTLIER -54.51 -45.09 73.23 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 178.793 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . 0.687 ' HG3' ' CD1' ' A' ' 47' ' ' PHE . 1.5 tt0 -69.93 -34.83 73.97 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 176.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . 1.118 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 7.2 tttp -63.95 -18.27 64.08 Favored 'General case' 0 C--O 1.189 -2.112 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 177.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.667 ' CG1' ' HA ' ' B' ' 28' ' ' PHE . 1.2 pp -108.53 -26.08 3.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 120.32 -1.487 . . . . 0.0 108.617 177.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.61 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.1 mm -73.42 -57.02 7.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 176.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' THR . . . . . 0.558 ' OG1' ' HB2' ' A' ' 85' ' ' LEU . 0.5 OUTLIER -67.19 -40.88 86.59 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.335 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 1.118 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 76.9 mm-40 -74.72 -40.69 61.15 Favored 'General case' 0 C--O 1.207 -1.138 0 O-C-N 121.4 -0.813 . . . . 0.0 112.513 -179.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' THR . . . . . 0.519 ' HA ' ' CB ' ' B' ' 38' ' ' LYS . 53.3 m -59.51 -49.11 79.05 Favored 'General case' 0 N--CA 1.505 2.284 0 CA-C-N 120.797 1.635 . . . . 0.0 109.469 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.527 HG11 ' HG3' ' B' ' 52' ' ' PRO . 1.4 t -53.0 -41.77 42.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 C-N-CA 118.266 -1.374 . . . . 0.0 107.345 178.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . 0.748 ' HB2' ' O ' ' A' ' 88' ' ' ALA . . . -92.7 11.57 26.33 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.717 -0.793 . . . . 0.0 109.745 178.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . 0.693 ' HB2' ' O ' ' B' ' 34' ' ' GLU . 1.4 tppt? -104.76 -29.26 10.67 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 177.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.82 34.56 0.43 Allowed Glycine 0 C--N 1.305 -1.183 0 C-N-CA 119.835 -1.174 . . . . 0.0 111.042 177.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . 0.461 ' CB ' ' CG2' ' B' ' 35' ' ' THR . 0.1 OUTLIER -150.94 179.82 7.92 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.869 -1.371 . . . . 0.0 110.785 179.638 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 5.0 mtmp? -133.2 113.6 12.86 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 59.2 t -61.24 140.52 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.441 -0.787 . . . . 0.0 110.499 -179.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' GLN . . . . . 0.53 ' HA ' ' HA ' ' B' ' 49' ' ' ASN . 12.4 mt-30 -140.53 82.91 1.87 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.524 -0.735 . . . . 0.0 109.826 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.534 ' O ' ' C ' ' B' ' 45' ' ' THR . 5.6 mt -59.79 117.5 5.07 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.274 -0.891 . . . . 0.0 110.704 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' THR . . . . . 0.534 ' C ' ' O ' ' B' ' 44' ' ' LEU . 0.0 OUTLIER 24.38 -92.73 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.243 0 O-C-N 122.16 -0.337 . . . . 0.0 111.436 179.062 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -146.54 48.3 0.67 Allowed Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . 0.558 ' O ' ' HA ' ' B' ' 81' ' ' PRO . 16.5 p90 -151.27 -40.09 0.12 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.963 -1.316 . . . . 0.0 111.671 179.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . 0.623 ' HB3' ' HD2' ' B' ' 80' ' ' LYS . 0.0 OUTLIER -116.86 107.94 15.22 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.703 -1.248 . . . . 0.0 110.378 179.401 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' ASN . . . . . 0.945 ' O ' ' O ' ' B' ' 79' ' ' VAL . 0.5 OUTLIER -124.54 97.49 5.32 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.997 -1.064 . . . . 0.0 110.606 -179.495 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 50' ' ' ILE . . . . . 0.516 ' HA ' ' O ' ' B' ' 79' ' ' VAL . 0.5 OUTLIER -88.56 143.89 10.27 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 O-C-N 121.496 -0.753 . . . . 0.0 110.883 -179.211 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . 0.528 ' HG3' ' HB2' ' B' ' 78' ' ' SER . 0.0 OUTLIER -159.88 136.69 6.66 Favored Pre-proline 0 N--CA 1.495 1.792 0 C-N-CA 119.416 -0.914 . . . . 0.0 110.023 179.6 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . 0.527 ' HG3' HG11 ' B' ' 36' ' ' VAL . 56.6 Cg_endo -89.28 144.86 4.98 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.752 1.396 . . . . 0.0 112.58 -178.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.584 ' O ' ' N ' ' B' ' 76' ' ' GLY . 33.3 m -144.23 113.16 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-O 121.655 0.741 . . . . 0.0 109.709 177.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.475 ' HB1' ' C ' ' A' ' 96' ' ' ASP . . . -45.02 120.22 2.29 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 122.0 0.905 . . . . 0.0 112.462 -178.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . 0.437 ' N ' ' OD1' ' A' ' 96' ' ' ASP . 0.4 OUTLIER -141.79 93.75 2.59 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.895 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . 0.409 ' O ' HD11 ' B' ' 71' ' ' ILE . 0.0 OUTLIER -52.81 -176.14 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.404 -0.81 . . . . 0.0 111.543 -178.513 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.493 ' CB ' ' HD3' ' B' ' 73' ' ' PRO . . . -73.63 -158.91 0.06 Allowed 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.57 0.7 . . . . 0.0 110.872 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 58' ' ' ARG . . . . . 0.419 ' HB2' HG12 ' B' ' 71' ' ' ILE . 0.0 OUTLIER -158.38 175.16 14.07 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.772 -0.58 . . . . 0.0 109.92 -179.629 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 2.9 tptt -176.82 93.35 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.232 -0.918 . . . . 0.0 110.433 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.13 52.72 1.45 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 61' ' ' PHE . . . . . 0.781 ' O ' ' CB ' ' B' ' 62' ' ' ASN . 21.3 t80 -76.62 164.37 25.97 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.266 -1.138 . . . . 0.0 111.305 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . 0.781 ' CB ' ' O ' ' B' ' 61' ' ' PHE . 2.7 t30 138.83 -36.58 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.035 0 O-C-N 121.721 -0.612 . . . . 0.0 110.45 178.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . 0.73 ' HD2' ' N ' ' B' ' 62' ' ' ASN . 38.4 Cg_endo -66.49 -17.25 53.12 Favored 'Trans proline' 0 C--N 1.316 -1.167 0 N-CA-C 108.069 -1.551 . . . . 0.0 108.069 177.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . 0.627 ' CB ' ' CZ ' ' B' ' 61' ' ' PHE . 0.9 OUTLIER -74.56 -72.87 0.26 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.704 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.439 ' O ' ' HG3' ' B' ' 66' ' ' GLN . 0.0 OUTLIER -176.24 20.05 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.854 -0.529 . . . . 0.0 110.317 178.753 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . 0.704 ' HB2' ' CE1' ' B' ' 61' ' ' PHE . 0.7 OUTLIER -138.93 -141.66 0.15 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.073 -1.017 . . . . 0.0 109.696 179.864 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . 0.588 ' O ' ' HD1' ' B' ' 61' ' ' PHE . 25.5 mt-10 -105.74 -157.27 0.61 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 177.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . 0.718 ' HA ' ' CA ' ' B' ' 61' ' ' PHE . . . -108.03 133.76 51.88 Favored 'General case' 0 C--N 1.287 -2.129 0 C-N-CA 118.406 -1.318 . . . . 0.0 110.948 179.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.529 ' HG ' ' CB ' ' B' ' 61' ' ' PHE . 0.0 OUTLIER -140.0 144.58 37.04 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.786 -178.571 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -114.85 68.02 0.7 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.412 -0.805 . . . . 0.0 110.344 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.419 HG12 ' HB2' ' B' ' 58' ' ' ARG . 1.5 pt -60.38 -159.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.89 . . . . 0.0 110.344 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.71 154.09 66.85 Favored Pre-proline 0 C--N 1.302 -1.466 0 O-C-N 121.375 -0.828 . . . . 0.0 110.97 -178.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 73' ' ' PRO . . . . . 0.493 ' HD3' ' CB ' ' B' ' 57' ' ' ALA . 44.0 Cg_endo -71.25 116.73 4.81 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.225 1.645 . . . . 0.0 110.322 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 74' ' ' SER . . . . . 0.451 ' CA ' ' CE1' ' A' ' 94' ' ' TYR . 4.5 p -179.27 171.4 1.31 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.33 -0.856 . . . . 0.0 109.676 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . 0.606 ' CG1' ' CB ' ' A' ' 89' ' ' ALA . 6.1 p -52.64 175.24 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.252 -0.905 . . . . 0.0 109.416 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' B' ' 53' ' ' VAL . . . -118.26 45.14 1.3 Allowed Glycine 0 N--CA 1.488 2.16 0 C-N-CA 118.898 -1.62 . . . . 0.0 109.825 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.536 ' O ' ' O ' ' B' ' 78' ' ' SER . 6.5 p -28.13 91.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 122.061 -0.67 . . . . 0.0 110.828 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 78' ' ' SER . . . . . 0.536 ' O ' ' O ' ' B' ' 77' ' ' VAL . 57.7 m -57.91 -122.12 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 119.864 -0.734 . . . . 0.0 109.102 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . 0.945 ' O ' ' O ' ' B' ' 49' ' ' ASN . 4.5 m -148.41 -168.88 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 119.859 -1.776 . . . . 0.0 112.868 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . 0.786 ' H ' ' HD2' ' B' ' 81' ' ' PRO . 0.0 OUTLIER -114.58 -52.92 0.04 OUTLIER Pre-proline 0 C--N 1.301 -1.531 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -178.403 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 81' ' ' PRO . . . . . 0.786 ' HD2' ' H ' ' B' ' 80' ' ' LYS . 26.7 Cg_endo -49.49 130.59 25.99 Favored 'Trans proline' 0 C--N 1.298 -2.106 0 C-N-CA 120.869 1.046 . . . . 0.0 112.551 -175.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -128.04 -62.8 0.13 Allowed Glycine 0 N--CA 1.486 1.981 0 N-CA-C 105.856 -2.897 . . . . 0.0 105.856 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . 0.885 ' O ' ' N ' ' B' ' 85' ' ' LEU . 26.3 tt0 -91.03 47.6 1.42 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.514 -1.662 . . . . 0.0 106.514 175.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 84' ' ' SER . . . . . 1.286 ' O ' ' N ' ' B' ' 86' ' ' LYS . 4.5 m 8.45 43.79 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.506 1.146 . . . . 0.0 110.875 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . 1.026 ' C ' ' O ' ' B' ' 84' ' ' SER . 4.3 mp 22.01 29.66 0.0 OUTLIER 'General case' 0 C--O 1.194 -1.831 0 N-CA-C 103.599 -2.741 . . . . 0.0 103.599 -171.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . 1.286 ' N ' ' O ' ' B' ' 84' ' ' SER 0.319 6.5 tttm -51.85 -34.78 42.13 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 103.459 -2.793 . . . . 0.0 103.459 175.997 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . 0.456 ' O ' ' CG ' ' B' ' 90' ' ' GLU 0.286 16.8 tptp -68.01 -36.2 79.58 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 111.773 -2.467 . . . . 0.0 106.609 175.565 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.799 ' N ' ' O ' ' B' ' 85' ' ' LEU . . . -80.38 -26.2 38.7 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 118.349 -1.34 . . . . 0.0 107.764 177.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . 0.694 ' N ' ' O ' ' B' ' 85' ' ' LEU . . . -67.27 -50.11 61.74 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.53 -0.731 . . . . 0.0 109.051 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.456 ' CG ' ' O ' ' B' ' 87' ' ' LYS . 6.5 pt-20 -57.03 -27.83 61.98 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 176.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . 0.423 ' N ' ' HG3' ' B' ' 90' ' ' GLU . . . -63.32 -38.25 96.13 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 178.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . 0.666 ' HB3' ' HA ' ' A' ' 37' ' ' ALA . 0.9 OUTLIER -85.37 23.48 1.31 Allowed 'General case' 0 N--CA 1.503 2.222 0 O-C-N 120.493 -1.592 . . . . 0.0 110.5 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . 0.458 ' O ' ' N ' ' B' ' 96' ' ' ASP . 0.4 OUTLIER 58.58 48.17 12.24 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 -177.659 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . 0.842 ' CD1' ' HA ' ' A' ' 74' ' ' SER . 0.0 OUTLIER -42.98 -37.11 1.77 Allowed 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.762 -178.51 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . 0.469 ' N ' ' CD1' ' B' ' 94' ' ' TYR . 8.8 pt-20 -53.85 -39.48 65.65 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.258 -0.901 . . . . 0.0 109.097 178.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 96' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' B' ' 93' ' ' LYS . 0.2 OUTLIER -65.96 -28.5 68.95 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.308 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -97.65 2.62 50.0 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.549 -0.719 . . . . 0.0 109.185 178.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 98' ' ' ALA . . . . . 0.545 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . . . -94.58 -33.88 12.85 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.59 -0.694 . . . . 0.0 110.278 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 19.8 mttt . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.261 179.937 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.418 ' HA ' ' CB ' ' A' ' 5' ' ' GLU . 3.8 mtp . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 120.908 0.385 . . . . 0.0 110.064 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.476 ' H ' ' HB2' ' A' ' 5' ' ' GLU . 27.3 p30 -177.82 -167.75 0.16 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.215 -0.928 . . . . 0.0 111.28 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.495 ' HD2' ' HB ' ' B' ' 45' ' ' THR . 12.7 tttt -51.31 -16.63 0.56 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.555 -0.716 . . . . 0.0 110.252 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.6 ' O ' HG12 ' A' ' 7' ' ' ILE . 41.0 m -104.69 -58.95 1.81 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.263 -0.898 . . . . 0.0 110.271 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.476 ' HB2' ' H ' ' A' ' 2' ' ' ASN . 3.5 mm-40 -54.88 -45.54 74.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.125 -0.985 . . . . 0.0 109.762 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.0 mt -52.04 -45.85 64.81 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.389 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.621 HG21 ' CD2' ' A' ' 25' ' ' LEU . 0.6 OUTLIER -56.36 -45.99 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 178.271 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.496 ' N ' ' CG1' ' A' ' 7' ' ' ILE . 0.9 OUTLIER -56.67 -39.94 74.65 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 176.828 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 13' ' ' ASP . . . -54.85 -35.71 64.3 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 178.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.768 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.5 mp -88.33 -32.45 5.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 177.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' A' ' 7' ' ' ILE . . . -67.89 -10.84 56.5 Favored 'General case' 0 C--N 1.287 -2.12 0 C-N-CA 118.999 -1.08 . . . . 0.0 108.969 178.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.454 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -120.6 -34.73 3.53 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.356 -0.84 . . . . 0.0 110.333 179.157 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 9' ' ' ALA . 0.9 OUTLIER -74.94 -36.88 62.11 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 176.823 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.768 ' OG1' ' O ' ' A' ' 10' ' ' ILE 0.268 0.2 OUTLIER -91.96 -70.28 0.7 Allowed 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 177.95 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 54.45 21.49 20.56 Favored Glycine 0 N--CA 1.5 2.908 0 O-C-N 121.534 -0.729 . . . . 0.0 111.445 177.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.89 HD13 ' HB3' ' B' ' 20' ' ' SER . 5.0 mp -64.7 -62.87 1.31 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.362 -1.081 . . . . 0.0 109.01 178.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.587 ' O ' HG23 ' A' ' 17' ' ' THR . 0.5 OUTLIER -138.82 6.45 2.44 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.866 -179.815 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.594 ' O ' ' C ' ' A' ' 19' ' ' VAL . 6.3 mt-30 57.53 26.92 13.32 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 -176.107 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.7 ' HB ' ' HB ' ' B' ' 19' ' ' VAL . 1.2 p -0.83 -95.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.802 -178.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.96 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -133.2 25.79 4.19 Favored 'General case' 0 C--N 1.277 -2.575 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 179.005 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.631 ' C ' ' O ' ' A' ' 20' ' ' SER . 31.0 m -19.1 -39.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 CA-C-O 122.483 1.135 . . . . 0.0 109.505 -178.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.854 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.6 OUTLIER -77.7 -40.47 41.25 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.362 177.522 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.96 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -85.6 -38.94 17.88 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 121.543 -0.723 . . . . 0.0 111.577 179.891 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.625 ' CE ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -66.22 -27.21 67.8 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 117.315 -1.754 . . . . 0.0 108.176 179.368 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.659 ' HG ' ' N ' ' A' ' 26' ' ' ALA . 0.4 OUTLIER -74.64 -45.1 47.07 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 118.827 -1.149 . . . . 0.0 108.838 177.933 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.659 ' N ' ' HG ' ' A' ' 25' ' ' LEU . . . -63.99 -25.27 68.05 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 178.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.496 ' O ' ' CG1' ' A' ' 31' ' ' ILE . 19.1 p -85.3 -41.03 15.9 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.675 ' O ' HG13 ' A' ' 31' ' ' ILE . 0.0 OUTLIER -57.33 -48.23 79.52 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.087 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.564 ' N ' ' CD1' ' A' ' 28' ' ' PHE . 0.7 OUTLIER -68.6 -35.14 76.94 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.034 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 1.235 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 13.8 ttmt -64.85 -22.13 66.93 Favored 'General case' 0 C--O 1.191 -2.023 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 177.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.675 HG13 ' O ' ' A' ' 28' ' ' PHE . 0.6 OUTLIER -105.08 -28.44 2.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 120.068 -1.645 . . . . 0.0 109.17 178.076 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.591 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.2 mm -72.24 -61.15 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 176.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.497 ' OG1' ' HG ' ' B' ' 85' ' ' LEU . 0.5 OUTLIER -67.8 -35.27 78.34 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.282 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 1.235 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 27.4 mm-40 -77.8 -32.31 52.32 Favored 'General case' 0 N--CA 1.482 1.138 0 O-C-N 120.958 -1.089 . . . . 0.0 111.214 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.52 ' CB ' ' O ' ' A' ' 31' ' ' ILE . 1.8 m -59.3 -50.93 72.11 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.32 -1.488 . . . . 0.0 107.457 178.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.481 HG12 ' HB3' ' B' ' 85' ' ' LEU . 0.4 OUTLIER -53.89 -36.49 30.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 C-N-CA 117.918 -1.513 . . . . 0.0 107.006 177.868 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.592 ' HB3' ' O ' ' B' ' 88' ' ' ALA . . . -80.43 -7.86 59.31 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.677 0.751 . . . . 0.0 109.632 177.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.555 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -100.26 -8.21 23.73 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 177.566 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 80.47 47.49 6.82 Favored Glycine 0 C--N 1.302 -1.316 0 N-CA-C 110.201 -1.159 . . . . 0.0 110.201 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.493 ' CB ' HG21 ' A' ' 35' ' ' THR . 0.3 OUTLIER -130.28 119.51 22.97 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.295 -1.121 . . . . 0.0 110.314 179.594 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -76.09 81.9 2.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.479 -0.763 . . . . 0.0 109.519 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.548 ' CG1' ' HB ' ' A' ' 50' ' ' ILE . 5.9 p -63.6 144.91 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.439 -0.788 . . . . 0.0 110.253 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -128.01 98.87 5.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.502 -0.749 . . . . 0.0 109.876 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.486 ' O ' ' N ' ' A' ' 46' ' ' GLY . 8.7 mt -61.62 108.22 0.94 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.256 -0.902 . . . . 0.0 109.495 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.472 ' C ' ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER 31.12 -91.77 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.315 0 O-C-N 122.003 -0.436 . . . . 0.0 111.189 -179.669 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -149.48 32.36 1.12 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.693 ' CD2' ' HG3' ' B' ' 29' ' ' GLU . 2.1 p90 -134.92 -23.04 1.57 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.031 -1.276 . . . . 0.0 111.936 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.614 ' HG ' ' CE1' ' A' ' 47' ' ' PHE . 5.0 mt -130.82 118.23 20.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.259 -1.525 . . . . 0.0 111.166 178.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.406 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 2.1 m-20 -115.92 93.57 4.31 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.544 -0.723 . . . . 0.0 110.513 -179.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.548 ' HB ' ' CG1' ' A' ' 42' ' ' VAL . 9.5 mm -87.63 132.94 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.313 -0.867 . . . . 0.0 109.282 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 0.5 OUTLIER -149.85 126.06 5.16 Favored Pre-proline 0 N--CA 1.497 1.895 0 C-N-CA 118.57 -1.252 . . . . 0.0 111.038 179.959 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.547 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 56.1 Cg_endo -81.48 138.95 11.16 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.439 1.231 . . . . 0.0 110.51 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.595 ' O ' ' N ' ' A' ' 76' ' ' GLY . 28.6 m -140.84 115.61 6.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-O 121.546 0.689 . . . . 0.0 110.377 179.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.436 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . -41.99 129.21 3.58 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.824 0.821 . . . . 0.0 112.139 -178.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -153.72 151.61 29.82 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -123.57 -171.97 2.42 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.12 -0.987 . . . . 0.0 110.957 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.685 ' HB3' ' HA ' ' A' ' 71' ' ' ILE . . . -165.5 156.02 13.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.525 -0.734 . . . . 0.0 109.61 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.716 ' HA ' ' HB ' ' A' ' 71' ' ' ILE . 78.1 mmt-85 -152.3 157.96 42.1 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.131 -0.98 . . . . 0.0 111.687 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.516 ' N ' HG21 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -117.48 168.63 10.21 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.385 -0.822 . . . . 0.0 110.053 179.145 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 60.61 15.45 40.38 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.131 -1.587 . . . . 0.0 109.131 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.855 ' HB3' ' HG ' ' A' ' 69' ' ' LEU . 8.7 t80 -57.99 172.03 0.46 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.316 -1.108 . . . . 0.0 111.317 -179.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.769 ' CB ' ' O ' ' A' ' 61' ' ' PHE . 1.9 t-20 145.56 -37.72 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.088 0 O-C-N 121.633 -0.667 . . . . 0.0 110.984 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.66 ' HD2' ' N ' ' A' ' 62' ' ' ASN . 40.9 Cg_endo -68.85 -5.71 16.24 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 O-C-N 122.963 0.98 . . . . 0.0 109.639 178.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.582 ' CB ' ' CE2' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -103.33 -43.53 5.41 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.28 -0.888 . . . . 0.0 110.087 179.282 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.433 ' HB ' ' CZ ' ' A' ' 61' ' ' PHE . 100.0 m -147.65 18.82 1.16 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.508 -0.745 . . . . 0.0 109.941 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.677 ' O ' ' CB ' ' A' ' 67' ' ' GLU . 0.9 OUTLIER 55.17 103.62 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.419 -0.801 . . . . 0.0 111.728 179.439 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.677 ' CB ' ' O ' ' A' ' 66' ' ' GLN . 3.0 tt0 139.89 80.88 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.729 ' HA ' ' CA ' ' A' ' 61' ' ' PHE . . . -48.08 148.75 1.64 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.086 -1.008 . . . . 0.0 110.397 -179.037 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.855 ' HG ' ' HB3' ' A' ' 61' ' ' PHE . 6.2 mt -123.53 -135.25 0.29 Allowed 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 119.689 -0.804 . . . . 0.0 112.217 -175.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 58' ' ' ARG . 0.9 OUTLIER -144.63 159.49 42.73 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 -179.369 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.716 ' HB ' ' HA ' ' A' ' 58' ' ' ARG . 0.4 OUTLIER -121.49 170.17 11.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 C-N-CA 118.371 -1.332 . . . . 0.0 113.059 -176.59 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.521 ' CB ' ' O ' ' A' ' 71' ' ' ILE . . . 159.82 72.99 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.628 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.292 -179.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.5 ' HD3' ' CD1' ' A' ' 71' ' ' ILE . 37.3 Cg_endo -60.72 118.56 5.44 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.684 1.36 . . . . 0.0 111.502 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.493 ' HA ' ' CD2' ' B' ' 94' ' ' TYR . 41.9 p -173.73 152.13 1.98 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.61 ' HB ' ' HB2' ' B' ' 94' ' ' TYR . 0.4 OUTLIER -54.79 177.47 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.822 -1.174 . . . . 0.0 109.67 -179.831 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.627 ' O ' ' N ' ' A' ' 78' ' ' SER . . . -113.49 70.69 0.23 Allowed Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.547 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 2.6 p -51.07 79.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.821 -0.811 . . . . 0.0 110.18 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.627 ' N ' ' O ' ' A' ' 76' ' ' GLY . 0.7 OUTLIER -73.53 178.16 4.85 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.227 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.567 ' CG2' ' O ' ' A' ' 78' ' ' SER . 41.8 t -166.5 175.99 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.486 ' N ' ' CG1' ' A' ' 79' ' ' VAL . 0.0 OUTLIER -175.33 169.15 1.56 Allowed Pre-proline 0 C--N 1.308 -1.225 0 O-C-N 120.982 -1.074 . . . . 0.0 110.045 176.662 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.444 ' HB2' HG12 ' B' ' 77' ' ' VAL . 55.8 Cg_endo -103.32 137.84 0.12 Allowed 'Trans proline' 0 C--N 1.3 -1.991 0 C-N-CA 122.962 2.442 . . . . 0.0 110.727 178.217 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.505 ' HA3' ' HA ' ' A' ' 47' ' ' PHE . . . -89.83 -148.11 18.59 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 107.437 -2.265 . . . . 0.0 107.437 177.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -101.28 -13.96 17.85 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.064 -1.256 . . . . 0.0 109.803 178.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.431 ' CB ' ' HB3' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -56.5 -32.97 65.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.3 -0.875 . . . . 0.0 108.953 179.161 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.529 ' HG ' ' OG1' ' B' ' 33' ' ' THR . 0.5 OUTLIER -82.48 -31.73 29.19 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.961 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.471 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 0.1 OUTLIER -75.53 -39.98 57.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.485 -0.759 . . . . 0.0 110.173 -179.399 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.1 ttmt -70.22 -37.61 75.06 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.58 ' O ' ' HB1' ' B' ' 37' ' ' ALA . . . -69.18 -34.03 74.29 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 176.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.471 ' HB1' ' O ' ' A' ' 86' ' ' LYS . . . -59.89 -43.52 94.75 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.46 -32.91 52.11 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -66.11 -35.78 90.99 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 178.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.552 ' HB3' ' HA ' ' B' ' 37' ' ' ALA . 0.5 OUTLIER -72.69 7.21 2.03 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.722 -1.457 . . . . 0.0 111.438 -179.715 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.414 ' CB ' ' O ' ' A' ' 92' ' ' LEU . 0.1 OUTLIER 63.75 38.42 9.23 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -177.862 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.627 ' HB2' ' HB ' ' B' ' 75' ' ' VAL . 0.4 OUTLIER -43.69 -35.75 1.94 Allowed 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.506 -179.238 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.458 ' N ' ' CG ' ' A' ' 94' ' ' TYR . 15.2 pt-20 -57.35 -42.06 81.27 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.4 -0.812 . . . . 0.0 109.157 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.13 -35.29 76.66 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 177.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.85 -27.25 62.75 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.5 -81.11 0.08 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.729 -0.607 . . . . 0.0 110.37 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 9.5 pttt . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.274 -179.903 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.489 ' CB ' ' CB ' ' B' ' 5' ' ' GLU . 4.0 ptp . . . . . 0 N--CA 1.495 1.807 0 CA-C-O 121.605 0.717 . . . . 0.0 110.577 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . 0.433 ' HB3' ' O ' ' B' ' 1' ' ' MET . 14.1 p-10 179.72 -157.93 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.542 178.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.472 ' CE ' ' HB2' ' B' ' 29' ' ' GLU . 9.7 mttm -53.92 -11.53 0.44 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.253 -0.904 . . . . 0.0 110.761 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.422 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 15.4 m -101.04 -55.03 2.66 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.039 -1.038 . . . . 0.0 110.008 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.489 ' CB ' ' CB ' ' B' ' 1' ' ' MET . 2.5 mp0 -64.09 -50.16 69.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.195 -0.94 . . . . 0.0 109.24 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.42 ' HA ' ' HB3' ' B' ' 9' ' ' ALA . 32.5 mt -53.94 -43.28 69.69 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' ILE . . . . . 0.642 HG12 ' O ' ' B' ' 21' ' ' VAL . 0.3 OUTLIER -50.24 -52.4 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 177.163 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . 0.498 ' O ' ' HB3' ' B' ' 12' ' ' GLN . 0.0 OUTLIER -56.26 -39.73 73.06 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.056 177.22 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . 0.423 ' O ' ' HB2' ' B' ' 13' ' ' ASP . . . -49.61 -38.1 30.55 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.195 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . 0.714 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.4 mp -93.63 -32.0 4.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 178.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.401 ' HB1' ' O ' ' B' ' 7' ' ' ILE . . . -68.23 -8.49 39.55 Favored 'General case' 0 C--N 1.291 -1.973 0 C-N-CA 118.377 -1.329 . . . . 0.0 109.012 178.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.498 ' HB3' ' O ' ' B' ' 8' ' ' LYS . 0.9 OUTLIER -119.9 -41.84 2.64 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.364 -0.835 . . . . 0.0 109.674 179.294 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.47 ' CB ' ' HB2' ' A' ' 27' ' ' SER . 1.5 m-20 -70.28 -35.4 73.71 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 177.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.714 ' OG1' ' O ' ' B' ' 10' ' ' ILE 0.262 0.2 OUTLIER -96.72 -79.27 0.45 Allowed 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 177.592 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 52.47 5.01 0.17 Allowed Glycine 0 N--CA 1.502 3.04 0 O-C-N 121.226 -0.921 . . . . 0.0 111.793 177.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 16' ' ' LEU . . . . . 0.629 HD21 ' CG2' ' B' ' 14' ' ' THR . 0.7 OUTLIER -61.43 -23.7 66.01 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.127 -1.219 . . . . 0.0 110.052 179.524 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 17' ' ' THR . . . . . 0.485 HG21 HG22 ' A' ' 17' ' ' THR . 0.5 OUTLIER -159.82 -9.98 0.06 Allowed 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.707 -0.621 . . . . 0.0 110.482 -179.783 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . 0.645 ' O ' ' C ' ' B' ' 19' ' ' VAL . 7.3 mt-30 54.94 35.94 25.64 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 -177.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.7 ' HB ' ' HB ' ' A' ' 19' ' ' VAL . 0.2 OUTLIER -10.53 -92.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.165 -179.329 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 1.063 ' O ' ' N ' ' B' ' 22' ' ' SER . 4.5 p -134.96 24.9 3.61 Favored 'General case' 0 C--N 1.282 -2.368 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 176.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.663 ' HA ' ' SD ' ' B' ' 24' ' ' MET . 30.7 m -4.48 -41.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 CA-C-O 122.561 1.172 . . . . 0.0 110.976 -177.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 1.063 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.6 OUTLIER -76.74 -37.3 56.21 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.766 179.13 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . 0.837 ' N ' ' O ' ' B' ' 20' ' ' SER . 1.5 mtmt -89.6 -31.47 17.55 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.318 -0.864 . . . . 0.0 110.811 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' MET . . . . . 0.663 ' SD ' ' HA ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -68.65 -39.69 80.59 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 117.191 -1.804 . . . . 0.0 108.759 179.285 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.601 ' HA ' ' HB3' ' B' ' 28' ' ' PHE . 0.3 OUTLIER -77.02 -45.09 28.45 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 118.132 -1.427 . . . . 0.0 108.431 177.574 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . 0.41 ' CB ' ' O ' ' B' ' 22' ' ' SER . . . -55.26 -34.46 64.06 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' SER . . . . . 0.474 ' O ' ' N ' ' B' ' 31' ' ' ILE . 90.8 p -81.49 -35.44 30.46 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . 0.659 ' O ' HG13 ' B' ' 31' ' ' ILE . 0.7 OUTLIER -53.41 -49.17 67.83 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.633 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . 0.693 ' HG3' ' CD2' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -67.55 -34.88 77.97 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 177.184 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . 1.181 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 53.1 tttm -64.51 -21.55 66.71 Favored 'General case' 0 C--O 1.19 -2.064 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.056 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.659 HG13 ' O ' ' B' ' 28' ' ' PHE . 0.6 OUTLIER -105.61 -26.69 3.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 O-C-N 120.163 -1.586 . . . . 0.0 109.062 177.924 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.605 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.2 mm -74.87 -58.14 5.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 176.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 33' ' ' THR . . . . . 0.529 ' OG1' ' HG ' ' A' ' 85' ' ' LEU . 0.6 OUTLIER -70.15 -35.5 74.08 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.263 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 1.181 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 50.9 mm-40 -76.69 -32.84 58.15 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 119.314 -0.954 . . . . 0.0 111.033 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 35' ' ' THR . . . . . 0.506 ' CB ' ' O ' ' B' ' 31' ' ' ILE . 2.2 m -61.68 -50.79 71.07 Favored 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 118.015 -1.474 . . . . 0.0 107.942 178.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . . . . . . . . . 1.2 t -54.12 -36.0 30.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 177.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . 0.58 ' HB1' ' O ' ' A' ' 88' ' ' ALA . . . -81.5 -5.44 57.96 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-O 121.655 0.74 . . . . 0.0 109.346 177.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . 0.511 ' N ' ' O ' ' B' ' 34' ' ' GLU . 0.9 OUTLIER -99.08 -25.08 14.66 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 177.833 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.32 39.5 2.09 Favored Glycine 0 C--N 1.303 -1.292 0 C-N-CA 120.183 -1.008 . . . . 0.0 110.795 177.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . 0.47 ' CB ' HG22 ' B' ' 35' ' ' THR . 0.1 OUTLIER -131.02 133.35 45.67 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.984 -1.304 . . . . 0.0 110.567 179.528 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.51 89.45 6.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.546 -0.721 . . . . 0.0 109.879 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 58.6 t -60.02 127.3 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.59 -0.694 . . . . 0.0 110.449 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 43' ' ' GLN . . . . . 0.456 ' HA ' ' HA ' ' B' ' 49' ' ' ASN . 1.9 tt0 -119.32 99.63 6.81 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 121.391 -0.818 . . . . 0.0 109.548 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.634 HD11 ' HB3' ' B' ' 48' ' ' LEU . 12.6 mt -71.98 87.72 1.05 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.156 -0.965 . . . . 0.0 110.386 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 45' ' ' THR . . . . . 0.495 ' HB ' ' HD2' ' A' ' 3' ' ' LYS . 1.8 t 36.2 29.58 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . 93.31 -26.02 17.56 Favored Glycine 0 N--CA 1.491 2.347 0 C-N-CA 119.883 -1.151 . . . . 0.0 112.453 177.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . 0.565 ' CD1' ' HG ' ' B' ' 48' ' ' LEU . 0.4 OUTLIER -81.72 -29.76 32.81 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 119.738 1.769 . . . . 0.0 111.415 -178.776 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . 0.634 ' HB3' HD11 ' B' ' 44' ' ' LEU . 4.6 mt -133.65 95.21 3.43 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.475 -1.391 . . . . 0.0 110.367 177.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 49' ' ' ASN . . . . . 0.456 ' HA ' ' HA ' ' B' ' 43' ' ' GLN . 17.3 t-20 -103.22 90.23 3.66 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.222 -0.924 . . . . 0.0 111.368 -179.326 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 50' ' ' ILE . . . . . 0.462 HD13 ' HB ' ' B' ' 79' ' ' VAL . 1.2 mm -73.44 141.84 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.495 -0.753 . . . . 0.0 109.468 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' B' ' 51' ' ' LYS . 9.6 ptmt -152.52 115.57 2.88 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 120.889 -1.132 . . . . 0.0 110.656 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . 0.592 ' HA ' ' HA ' ' B' ' 77' ' ' VAL . 52.7 Cg_endo -77.14 142.89 22.1 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 O-C-N 123.528 1.278 . . . . 0.0 111.194 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.628 ' O ' ' N ' ' B' ' 76' ' ' GLY . 33.2 m -143.15 116.35 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-O 121.416 0.627 . . . . 0.0 110.528 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.547 ' HA ' ' HA ' ' B' ' 75' ' ' VAL . . . -42.47 140.92 1.1 Allowed 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.782 0.801 . . . . 0.0 112.213 -178.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.97 83.73 0.19 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -56.81 -170.48 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.381 -0.824 . . . . 0.0 111.376 -178.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.493 ' HA ' HD11 ' B' ' 71' ' ' ILE . . . -80.53 165.49 22.07 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.733 -0.605 . . . . 0.0 110.816 -179.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 58' ' ' ARG . . . . . 0.598 ' HB2' HD12 ' B' ' 71' ' ' ILE . 21.6 mtt85 -139.13 19.02 2.61 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.565 -0.71 . . . . 0.0 110.53 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 2.9 ptmt -59.43 78.15 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.487 0.66 . . . . 0.0 110.156 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' B' ' 58' ' ' ARG . . . -148.49 -95.53 0.15 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.359 -1.497 . . . . 0.0 109.359 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 61' ' ' PHE . . . . . 0.839 ' O ' ' N ' ' B' ' 67' ' ' GLU . 4.0 p90 176.18 -178.67 0.15 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.262 -1.14 . . . . 0.0 110.244 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . 0.538 ' H ' ' HD2' ' B' ' 63' ' ' PRO . 0.6 OUTLIER -111.32 -60.57 0.04 OUTLIER Pre-proline 0 N--CA 1.5 2.047 0 O-C-N 120.997 -1.064 . . . . 0.0 112.287 -178.328 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . 0.538 ' HD2' ' H ' ' B' ' 62' ' ' ASN . 41.3 Cg_endo -67.68 64.99 0.85 Allowed 'Trans proline' 0 C--N 1.316 -1.174 0 O-C-N 123.379 1.2 . . . . 0.0 110.479 -178.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . 0.75 ' HB3' ' CE1' ' B' ' 61' ' ' PHE . 0.0 OUTLIER 179.85 38.42 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.784 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.414 ' OG1' ' O ' ' B' ' 64' ' ' GLN . 3.9 p 54.63 51.89 13.17 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.69 -0.631 . . . . 0.0 110.204 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . 0.687 ' HB2' ' CE1' ' B' ' 61' ' ' PHE . 0.0 OUTLIER -149.66 -120.51 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.26 -0.9 . . . . 0.0 110.498 -179.641 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . 0.839 ' N ' ' O ' ' B' ' 61' ' ' PHE . 0.9 OUTLIER -175.48 93.8 0.06 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.845 -1.159 . . . . 0.0 108.629 179.756 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . 0.578 ' N ' ' C ' ' B' ' 61' ' ' PHE . . . -66.13 92.48 0.18 Allowed 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.969 0.89 . . . . 0.0 109.663 -178.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.456 ' CD2' ' O ' ' B' ' 68' ' ' ALA . 13.7 mt -142.67 -155.83 0.63 Allowed 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.994 -179.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -166.49 26.7 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.218 -0.926 . . . . 0.0 110.966 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.598 HD12 ' HB2' ' B' ' 58' ' ' ARG . 0.0 OUTLIER -61.79 -160.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.15 -0.969 . . . . 0.0 109.393 179.611 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . 0.531 ' N ' HG12 ' B' ' 71' ' ' ILE . . . -127.5 145.77 55.9 Favored Pre-proline 0 C--N 1.3 -1.553 0 O-C-N 121.141 -0.974 . . . . 0.0 111.095 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 73' ' ' PRO . . . . . 0.411 ' HB3' ' HB2' ' B' ' 57' ' ' ALA . 40.8 Cg_endo -68.57 83.99 0.5 Allowed 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 124.048 1.552 . . . . 0.0 110.422 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 74' ' ' SER . . . . . 0.474 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 8.9 t -176.94 166.16 2.46 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.623 -0.673 . . . . 0.0 109.437 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . 0.627 ' HB ' ' HB2' ' A' ' 94' ' ' TYR . 0.4 OUTLIER -56.37 172.48 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.948 -1.095 . . . . 0.0 109.445 -179.994 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . 0.628 ' N ' ' O ' ' B' ' 53' ' ' VAL . . . -114.25 75.63 0.24 Allowed Glycine 0 N--CA 1.486 1.99 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.592 ' HA ' ' HA ' ' B' ' 52' ' ' PRO . 2.8 p -51.54 82.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.79 -0.829 . . . . 0.0 110.365 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 78' ' ' SER . . . . . 0.584 ' N ' ' O ' ' B' ' 76' ' ' GLY . 0.5 OUTLIER -80.81 177.91 8.73 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.819 -0.753 . . . . 0.0 110.034 179.762 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . 0.462 ' HB ' HD13 ' B' ' 50' ' ' ILE . 7.4 p 177.97 177.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . 0.425 ' N ' ' CG2' ' B' ' 79' ' ' VAL . 2.7 ptpt -171.85 173.26 1.69 Allowed Pre-proline 0 C--N 1.307 -1.265 0 O-C-N 120.845 -1.159 . . . . 0.0 110.539 178.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 81' ' ' PRO . . . . . 0.448 ' CB ' ' O ' ' A' ' 77' ' ' VAL . 55.5 Cg_endo -98.9 128.6 0.19 Allowed 'Trans proline' 0 C--N 1.3 -1.989 0 C-N-CA 122.689 2.259 . . . . 0.0 110.549 178.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . 0.435 ' HA3' ' HA ' ' B' ' 47' ' ' PHE . . . -81.8 -155.33 14.68 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 107.941 -2.064 . . . . 0.0 107.941 178.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -93.84 -15.35 25.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.097 -1.237 . . . . 0.0 109.977 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.38 -36.93 66.9 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.247 -0.908 . . . . 0.0 109.144 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . 0.497 ' HG ' ' OG1' ' A' ' 33' ' ' THR . 0.3 OUTLIER -82.29 -32.26 29.64 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.487 -0.758 . . . . 0.0 109.017 179.116 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . 0.488 ' O ' ' HB2' ' B' ' 89' ' ' ALA . 2.2 mttp -73.39 -37.43 65.98 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.496 -0.752 . . . . 0.0 109.922 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 28.5 tptt -69.66 -37.99 76.93 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 178.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.592 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -67.85 -34.43 76.69 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 176.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . 0.488 ' HB2' ' O ' ' B' ' 86' ' ' LYS . . . -59.67 -44.6 93.54 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.073 179.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -53.52 -31.83 47.93 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 177.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -68.43 -32.68 75.72 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 178.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . 0.577 ' CB ' ' O ' ' A' ' 37' ' ' ALA . 0.5 OUTLIER -73.33 8.97 1.45 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.748 -1.443 . . . . 0.0 111.426 -179.728 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 61.55 38.43 15.61 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 -177.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . 0.61 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 0.2 OUTLIER -45.43 -37.7 5.36 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.609 -178.998 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . 0.448 ' N ' ' CG ' ' B' ' 94' ' ' TYR . 2.6 pp20? -57.28 -38.01 73.28 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.324 -0.86 . . . . 0.0 109.162 179.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.06 -34.84 78.43 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 177.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.17 -27.49 64.57 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.53 -30.63 64.63 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.645 -0.659 . . . . 0.0 110.241 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 15.4 mttt . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.211 -179.948 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.582 ' CG ' ' HB3' ' A' ' 5' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 121.096 0.474 . . . . 0.0 110.25 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.543 ' N ' ' HB2' ' A' ' 5' ' ' GLU . 2.0 t-20 -177.24 -178.84 0.82 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.187 -0.946 . . . . 0.0 110.931 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.467 ' HG2' HD12 ' A' ' 25' ' ' LEU . 8.4 mttt -46.67 -25.13 0.66 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.64 -0.663 . . . . 0.0 109.852 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.446 ' O ' HG21 ' A' ' 7' ' ' ILE . 8.3 m -101.63 -52.4 3.22 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.396 -0.815 . . . . 0.0 110.111 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.582 ' HB3' ' CG ' ' A' ' 1' ' ' MET . 6.7 mt-10 -53.7 -47.61 70.33 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.107 -0.996 . . . . 0.0 108.573 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.459 ' HB2' ' O ' ' A' ' 2' ' ' ASN . 4.1 mt -55.37 -37.67 67.83 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 119.177 -1.009 . . . . 0.0 108.814 177.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.589 HD12 HD22 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -50.77 -44.86 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.081 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.752 ' HA ' ' HB1' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -68.18 -32.4 72.61 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.745 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.437 ' HB1' ' HA ' ' A' ' 6' ' ' LEU . . . -53.23 -38.52 63.01 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.369 -0.832 . . . . 0.0 109.033 179.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.765 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.3 mp -102.32 -29.7 3.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.752 ' HB1' ' HA ' ' A' ' 8' ' ' LYS . . . -69.11 -11.32 60.69 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 118.554 -1.259 . . . . 0.0 108.577 178.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.418 ' CG ' ' O ' ' A' ' 8' ' ' LYS . 54.0 mm-40 -113.74 -42.49 3.42 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.484 -0.76 . . . . 0.0 109.053 178.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.429 ' HB2' ' O ' ' A' ' 9' ' ' ALA . 1.5 m-20 -65.54 -36.17 83.0 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 177.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.765 ' OG1' ' O ' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -99.69 -73.04 0.64 Allowed 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 178.144 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 46.32 22.55 0.99 Allowed Glycine 0 N--CA 1.5 2.919 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 178.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.576 ' CD1' ' CG2' ' B' ' 19' ' ' VAL . 0.0 OUTLIER -75.05 -26.25 59.27 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 121.507 -0.996 . . . . 0.0 108.8 179.323 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.559 ' O ' HG23 ' A' ' 17' ' ' THR . 0.4 OUTLIER -162.05 -2.91 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.932 -179.191 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.575 ' O ' ' C ' ' A' ' 19' ' ' VAL . 21.9 mt-30 57.92 28.16 15.73 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -176.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.701 ' HB ' ' HB ' ' B' ' 19' ' ' VAL . 1.6 p -1.76 -90.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.235 -178.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.958 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.4 OUTLIER -129.98 25.6 5.26 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 178.918 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.745 ' HA ' ' CE ' ' A' ' 24' ' ' MET . 13.5 m -22.91 -41.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 CA-C-O 122.576 1.179 . . . . 0.0 108.777 -178.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.747 ' N ' ' O ' ' A' ' 20' ' ' SER . 6.6 m -76.36 -37.74 56.83 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.731 177.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.958 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.9 OUTLIER -89.01 -38.73 14.19 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.493 -0.755 . . . . 0.0 111.717 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.745 ' CE ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -66.88 -27.75 67.77 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.075 -1.64 . . . . 0.0 109.178 179.648 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.64 ' HG ' ' N ' ' A' ' 26' ' ' ALA . 0.2 OUTLIER -82.94 -45.47 14.11 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 118.865 -1.134 . . . . 0.0 108.982 178.618 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.64 ' N ' ' HG ' ' A' ' 25' ' ' LEU . . . -66.4 -27.64 68.01 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.56 ' O ' ' N ' ' A' ' 31' ' ' ILE . 52.9 p -87.76 -31.24 19.73 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.814 ' O ' HG13 ' A' ' 31' ' ' ILE . 0.1 OUTLIER -55.66 -48.17 75.47 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.562 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.57 ' HG3' HG22 ' B' ' 45' ' ' THR . 1.0 OUTLIER -69.89 -36.37 75.37 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 177.01 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 1.193 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 35.7 tttp -65.22 -17.8 64.78 Favored 'General case' 0 C--O 1.19 -2.043 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.814 HG13 ' O ' ' A' ' 28' ' ' PHE . 1.2 pp -108.56 -30.07 2.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 120.195 -1.566 . . . . 0.0 108.916 178.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.598 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.1 mm -71.41 -58.06 6.05 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 176.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.613 ' O ' ' HB3' ' B' ' 88' ' ' ALA . 0.6 OUTLIER -69.95 -42.26 73.45 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.915 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 1.193 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 55.1 mm-40 -68.39 -34.39 75.95 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 120.728 -1.232 . . . . 0.0 111.178 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.537 ' CB ' ' O ' ' A' ' 31' ' ' ILE . 1.8 m -57.85 -49.1 77.83 Favored 'General case' 0 N--CA 1.5 2.037 0 C-N-CA 118.071 -1.451 . . . . 0.0 107.446 178.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.453 HG12 ' CG2' ' A' ' 77' ' ' VAL . 36.4 t -55.13 -35.81 36.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 C-N-CA 117.85 -1.54 . . . . 0.0 107.362 177.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.784 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -84.86 2.77 41.0 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 121.626 0.727 . . . . 0.0 109.094 177.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.513 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -110.13 -15.82 13.92 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.798 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.93 46.89 3.27 Favored Glycine 0 C--N 1.304 -1.243 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 178.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.486 ' CB ' HG23 ' A' ' 35' ' ' THR . 0.3 OUTLIER -137.25 136.68 38.31 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.052 -1.264 . . . . 0.0 110.861 179.521 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.5 mtmm -80.06 91.96 5.56 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.572 -0.705 . . . . 0.0 109.45 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.429 HG23 ' CG2' ' A' ' 35' ' ' THR . 41.1 t -59.97 124.34 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.615 -0.678 . . . . 0.0 110.163 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.416 ' O ' ' HA ' ' B' ' 2' ' ' ASN . 19.1 mt-30 -125.5 165.17 18.95 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.341 -0.849 . . . . 0.0 109.832 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.614 ' HB3' ' CE1' ' A' ' 47' ' ' PHE . 72.1 mt -134.43 108.09 7.95 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.416 -0.803 . . . . 0.0 109.084 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.508 HG22 ' HG3' ' B' ' 29' ' ' GLU . 0.0 OUTLIER 35.22 -96.05 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.871 -0.518 . . . . 0.0 111.475 -179.037 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -138.91 22.55 2.96 Favored Glycine 0 N--CA 1.488 2.12 0 C-N-CA 119.385 -1.388 . . . . 0.0 110.911 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.621 ' CD1' ' HG3' ' B' ' 29' ' ' GLU . 17.6 p90 -118.13 -56.82 2.14 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.728 -1.454 . . . . 0.0 111.101 179.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.607 ' HB2' HD13 ' A' ' 44' ' ' LEU . 0.9 OUTLIER -103.89 128.89 51.36 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.057 -1.652 . . . . 0.0 115.281 -178.162 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.547 ' CB ' ' CG ' ' A' ' 81' ' ' PRO . 19.2 t-20 -129.72 99.9 5.3 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.564 177.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.546 ' HA ' HG12 ' A' ' 79' ' ' VAL . 1.0 OUTLIER -86.82 158.07 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.162 -0.961 . . . . 0.0 110.21 -179.93 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.402 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 6.6 ptmt -166.49 123.39 0.99 Allowed Pre-proline 0 N--CA 1.496 1.833 0 C-N-CA 118.681 -1.208 . . . . 0.0 111.213 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.606 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 54.0 Cg_endo -79.96 144.31 16.88 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.609 1.32 . . . . 0.0 110.985 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.517 ' O ' ' N ' ' A' ' 76' ' ' GLY . 28.4 m -137.06 113.81 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 CA-C-O 121.849 0.833 . . . . 0.0 111.459 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.507 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . -71.8 133.46 45.54 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.62 -0.675 . . . . 0.0 111.006 -179.064 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.4 ' O ' ' CG ' ' A' ' 56' ' ' GLN . 0.8 OUTLIER 174.77 47.32 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.413 -0.804 . . . . 0.0 110.691 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.668 ' O ' ' HA ' ' A' ' 73' ' ' PRO . 10.3 mt-30 -157.0 118.63 3.77 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.943 -1.098 . . . . 0.0 111.544 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.451 ' N ' HD12 ' A' ' 71' ' ' ILE . . . -177.08 72.61 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.252 -0.905 . . . . 0.0 109.591 178.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.487 ' HG3' ' N ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -133.15 156.07 48.12 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.476 -0.765 . . . . 0.0 110.075 -179.123 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.487 ' N ' ' HG3' ' A' ' 58' ' ' ARG . 13.8 mttt -154.98 102.72 2.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.567 -0.708 . . . . 0.0 109.749 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 119.2 -147.95 18.27 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.665 ' CG ' ' N ' ' A' ' 62' ' ' ASN . 66.4 t80 -127.76 175.01 8.64 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.103 -1.234 . . . . 0.0 110.941 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.665 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 2.3 t30 -63.33 -170.89 0.04 OUTLIER Pre-proline 0 N--CA 1.48 1.064 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 177.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.419 ' CD ' ' CB ' ' A' ' 62' ' ' ASN . 48.1 Cg_endo -79.57 51.71 3.99 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.093 1.049 . . . . 0.0 109.818 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.576 ' CB ' ' HE2' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -157.44 -117.07 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.139 0 O-C-N 121.209 -0.932 . . . . 0.0 110.084 -179.224 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.531 ' N ' ' CE2' ' A' ' 61' ' ' PHE . 4.7 t 177.64 69.53 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.117 -0.989 . . . . 0.0 109.156 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -130.56 -70.76 0.61 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.306 -0.871 . . . . 0.0 110.67 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -115.66 78.13 1.15 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.311 -0.868 . . . . 0.0 110.382 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.472 ' HA ' ' HB2' ' A' ' 61' ' ' PHE . . . -59.53 139.15 57.39 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.412 -0.805 . . . . 0.0 110.94 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.443 ' CB ' ' HD3' ' A' ' 58' ' ' ARG . 1.8 mp -112.42 -159.11 0.67 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.582 -0.699 . . . . 0.0 109.934 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.443 ' CB ' ' O ' ' A' ' 69' ' ' LEU . 2.3 mt-10 169.55 30.39 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.418 -0.801 . . . . 0.0 110.405 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.451 HD12 ' N ' ' A' ' 57' ' ' ALA . 1.0 OUTLIER -75.75 -159.95 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.11 -0.994 . . . . 0.0 110.01 -179.864 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.626 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . . . -163.97 -175.5 0.47 Allowed Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.101 -1.0 . . . . 0.0 111.018 -178.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.668 ' HA ' ' O ' ' A' ' 56' ' ' GLN . 41.3 Cg_endo -69.17 112.88 3.1 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 O-C-N 124.014 1.534 . . . . 0.0 111.37 -179.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.7 p -164.9 105.46 0.8 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.659 -0.65 . . . . 0.0 109.349 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.602 HG22 HD23 ' B' ' 92' ' ' LEU . 0.3 OUTLIER -51.13 170.45 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.372 -0.83 . . . . 0.0 109.919 -179.284 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.574 ' O ' ' N ' ' A' ' 78' ' ' SER . . . -105.99 77.16 0.24 Allowed Glycine 0 N--CA 1.484 1.874 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.61 ' CG1' ' HB2' ' B' ' 85' ' ' LEU . 15.5 t -59.87 77.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.492 -1.005 . . . . 0.0 109.232 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.574 ' N ' ' O ' ' A' ' 76' ' ' GLY . 0.3 OUTLIER -97.31 -165.18 1.23 Allowed 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 122.461 1.124 . . . . 0.0 111.733 -178.671 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.546 HG12 ' HA ' ' A' ' 50' ' ' ILE . 29.9 m -152.82 -157.08 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.64 ' HB3' ' HD3' ' A' ' 81' ' ' PRO . 0.1 OUTLIER -172.06 -58.12 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.69 0 C-N-CA 118.345 -1.342 . . . . 0.0 112.824 179.421 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.64 ' HD3' ' HB3' ' A' ' 80' ' ' LYS . 55.8 Cg_endo -89.62 171.82 4.13 Favored 'Trans proline' 0 C--N 1.297 -2.151 0 O-C-N 123.595 1.313 . . . . 0.0 112.963 -176.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.65 ' O ' ' C ' ' A' ' 83' ' ' GLU . . . 176.2 -1.57 0.03 OUTLIER Glycine 0 C--N 1.301 -1.405 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 179.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.905 ' O ' ' N ' ' A' ' 85' ' ' LEU . 11.8 pt-20 31.8 45.78 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 -176.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.741 ' HB3' ' HB2' ' A' ' 86' ' ' LYS . 1.2 t 12.4 41.71 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.335 0 CA-C-O 122.873 1.321 . . . . 0.0 109.608 -177.021 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.905 ' N ' ' O ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER 18.31 27.05 0.0 OUTLIER 'General case' 0 C--O 1.189 -2.117 0 N-CA-C 101.381 -3.563 . . . . 0.0 101.381 -173.293 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.741 ' HB2' ' HB3' ' A' ' 84' ' ' SER 0.351 4.5 tttt -51.91 -44.25 63.72 Favored 'General case' 0 CA--C 1.469 -2.145 0 CA-C-N 111.808 -2.451 . . . . 0.0 105.631 178.589 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.277 23.6 tttt -62.23 -38.02 87.62 Favored 'General case' 0 C--N 1.268 -2.971 0 CA-C-N 111.409 -2.632 . . . . 0.0 106.625 177.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.659 ' O ' ' HG ' ' A' ' 92' ' ' LEU . . . -86.99 -22.34 25.6 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 118.232 -1.387 . . . . 0.0 109.39 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.793 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . -76.32 -47.13 24.66 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.494 ' HA ' ' CB ' ' A' ' 94' ' ' TYR . 4.0 mm-40 -56.86 -27.24 60.11 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 175.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.445 ' C ' ' CD2' ' A' ' 92' ' ' LEU . . . -76.95 -32.52 49.15 Favored Glycine 0 CA--C 1.548 2.147 0 CA-C-O 118.496 -1.169 . . . . 0.0 113.169 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.659 ' HG ' ' O ' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -115.21 -74.2 0.62 Allowed 'General case' 0 N--CA 1.505 2.312 0 CA-C-N 122.31 3.055 . . . . 0.0 113.44 -177.301 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -120.39 42.0 3.09 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.827 -1.171 . . . . 0.0 112.713 -177.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.494 ' CB ' ' HA ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -74.37 -55.5 5.93 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.102 -0.999 . . . . 0.0 108.923 178.371 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.432 ' N ' ' CG ' ' A' ' 94' ' ' TYR . 12.0 pt-20 -69.22 -37.28 77.95 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.604 -0.685 . . . . 0.0 109.547 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -57.74 -34.87 69.98 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -78.23 -26.5 47.37 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 120.091 -0.644 . . . . 0.0 109.584 178.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.429 ' N ' ' CB ' ' B' ' 54' ' ' ALA . . . -71.9 -56.33 5.9 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.402 -0.811 . . . . 0.0 110.304 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.4 mttp . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.156 -179.914 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.437 ' HG2' ' HB3' ' B' ' 5' ' ' GLU . 9.0 mtp . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 120.867 0.365 . . . . 0.0 110.063 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . 0.421 ' O ' ' HB2' ' B' ' 6' ' ' LEU . 1.0 OUTLIER -176.48 -172.97 0.49 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.237 -0.914 . . . . 0.0 110.801 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.557 ' O ' HG13 ' B' ' 7' ' ' ILE . 0.0 OUTLIER -54.24 -15.07 1.35 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.234 -0.916 . . . . 0.0 110.335 179.785 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.531 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 19.1 m -105.64 -46.65 4.11 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.106 -0.996 . . . . 0.0 108.69 178.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.437 ' HB3' ' HG2' ' B' ' 1' ' ' MET . 0.8 OUTLIER -62.01 -50.6 71.39 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.927 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.469 ' HA ' ' HB3' ' B' ' 9' ' ' ALA . 2.0 mt -64.51 -26.51 68.46 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.488 -0.885 . . . . 0.0 109.013 178.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' ILE . . . . . 0.723 HG12 ' O ' ' B' ' 21' ' ' VAL . 0.3 OUTLIER -56.84 -58.97 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.408 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . 0.45 ' N ' ' CG2' ' B' ' 7' ' ' ILE . 0.1 OUTLIER -62.43 -26.99 68.79 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.137 178.758 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . 0.469 ' HB3' ' HA ' ' B' ' 6' ' ' LEU . . . -59.85 -34.67 73.42 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 119.441 -0.904 . . . . 0.0 108.699 178.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . 0.862 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.0 OUTLIER -97.47 -36.82 6.3 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.498 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 178.522 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.491 ' HA ' ' OG1' ' B' ' 14' ' ' THR . . . -59.04 -28.3 66.3 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -90.8 -42.01 10.9 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.458 ' HB3' ' CB ' ' A' ' 27' ' ' SER . 82.6 m-20 -64.98 -23.13 67.13 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 106.932 -1.506 . . . . 0.0 106.932 176.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.862 ' OG1' ' O ' ' B' ' 10' ' ' ILE . 17.8 p -93.41 -75.57 0.49 Allowed 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 58.35 17.72 33.15 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 16' ' ' LEU . . . . . 0.665 HD11 ' HB ' ' B' ' 14' ' ' THR . 2.7 mp -84.32 -59.28 2.44 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.324 -1.103 . . . . 0.0 108.411 178.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 17' ' ' THR . . . . . 0.531 HG22 ' O ' ' B' ' 17' ' ' THR . 0.5 OUTLIER -140.87 3.44 1.83 Allowed 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.357 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . 0.594 ' O ' ' C ' ' B' ' 19' ' ' VAL . 16.6 mt-30 57.14 24.71 10.03 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 106.762 -1.569 . . . . 0.0 106.762 -176.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.701 ' HB ' ' HB ' ' A' ' 19' ' ' VAL . 0.1 OUTLIER 10.61 -94.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.917 -179.167 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 1.025 ' O ' ' N ' ' B' ' 22' ' ' SER . 0.3 OUTLIER -137.17 23.46 3.01 Favored 'General case' 0 C--N 1.276 -2.619 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 178.193 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.723 ' O ' HG12 ' B' ' 7' ' ' ILE . 15.3 m -5.24 -44.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 122.503 1.144 . . . . 0.0 110.537 -177.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 1.025 ' N ' ' O ' ' B' ' 20' ' ' SER . 5.8 m -79.54 -38.59 33.87 Favored 'General case' 0 C--N 1.281 -2.393 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.355 178.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . 0.932 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.5 OUTLIER -91.12 -24.61 19.93 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.418 -0.801 . . . . 0.0 110.875 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' MET . . . . . 0.536 ' SD ' ' HA ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -77.07 -38.76 51.86 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 117.444 -1.703 . . . . 0.0 108.558 178.349 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.623 ' HA ' ' HB3' ' B' ' 28' ' ' PHE . 0.3 OUTLIER -78.0 -36.17 49.13 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 118.234 -1.387 . . . . 0.0 108.438 177.711 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . 0.434 ' CB ' ' O ' ' B' ' 22' ' ' SER . . . -64.45 -34.61 78.6 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 176.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' SER . . . . . 0.591 ' O ' HG13 ' B' ' 31' ' ' ILE . 29.2 t -80.42 -32.09 37.45 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . 0.623 ' HB3' ' HA ' ' B' ' 25' ' ' LEU . 0.4 OUTLIER -52.74 -47.11 67.62 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.828 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . 0.621 ' HG3' ' CD1' ' A' ' 47' ' ' PHE . 1.7 tt0 -68.47 -35.61 77.81 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 176.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . 1.159 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 2.0 tttt -63.8 -19.39 64.97 Favored 'General case' 0 C--O 1.189 -2.096 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.095 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.615 ' CG1' ' HA ' ' B' ' 28' ' ' PHE . 1.4 pp -107.43 -28.24 2.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 120.29 -1.506 . . . . 0.0 108.714 178.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.582 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.2 mm -72.66 -58.18 5.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 176.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 33' ' ' THR . . . . . 0.66 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 0.6 OUTLIER -68.52 -38.07 80.57 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.771 179.169 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 1.159 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 78.7 mm-40 -76.95 -27.57 54.87 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 121.172 -0.955 . . . . 0.0 111.963 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 35' ' ' THR . . . . . 0.558 ' O ' ' N ' ' B' ' 38' ' ' LYS . 2.7 m -70.63 -59.75 2.65 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 117.706 -1.597 . . . . 0.0 109.462 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.573 HG12 ' HG3' ' B' ' 52' ' ' PRO . 0.9 OUTLIER -51.02 -43.86 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 178.94 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . 0.579 ' HB2' ' CB ' ' A' ' 88' ' ' ALA . . . -60.91 -27.83 68.48 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.829 177.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . 0.558 ' N ' ' O ' ' B' ' 35' ' ' THR . 0.6 OUTLIER -76.64 -32.3 57.91 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 177.574 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.5 23.7 4.99 Favored Glycine 0 C--N 1.295 -1.695 0 C-N-CA 120.087 -1.054 . . . . 0.0 110.944 177.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . 0.472 ' CB ' HG21 ' B' ' 35' ' ' THR . 0.4 OUTLIER -100.48 158.34 15.98 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.103 -1.234 . . . . 0.0 109.749 179.38 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -95.28 90.77 5.97 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.388 -0.82 . . . . 0.0 110.436 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 73.3 t -59.83 118.43 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.423 -0.798 . . . . 0.0 109.712 179.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -123.71 93.22 3.87 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.309 -0.869 . . . . 0.0 110.068 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.601 ' HB2' ' HB2' ' B' ' 48' ' ' LEU . 75.3 mt -62.33 101.18 0.21 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.173 -0.954 . . . . 0.0 109.549 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 45' ' ' THR . . . . . 0.57 HG22 ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 34.99 -94.78 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.928 -0.482 . . . . 0.0 111.31 -179.557 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . 0.418 ' H ' HG23 ' B' ' 45' ' ' THR . . . -141.0 20.45 2.68 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 119.493 -1.337 . . . . 0.0 110.908 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . 0.577 ' CZ ' HD12 ' B' ' 44' ' ' LEU . 8.8 p90 -119.84 -22.71 6.69 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.702 -1.47 . . . . 0.0 111.446 179.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . 0.601 ' HB2' ' HB2' ' B' ' 44' ' ' LEU . 0.2 OUTLIER -133.48 139.21 46.54 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.614 -1.304 . . . . 0.0 111.472 178.242 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -143.31 116.69 9.07 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.738 -0.601 . . . . 0.0 109.952 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 50' ' ' ILE . . . . . 0.453 ' CD1' HG21 ' B' ' 79' ' ' VAL . 6.4 mm -116.79 147.05 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 O-C-N 121.314 -0.866 . . . . 0.0 110.592 -179.359 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' B' ' 78' ' ' SER . 14.4 ptmt -156.81 124.85 2.83 Favored Pre-proline 0 N--CA 1.502 2.164 0 O-C-N 120.877 -1.139 . . . . 0.0 110.631 179.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . 0.583 ' HA ' ' HA ' ' B' ' 77' ' ' VAL . 53.6 Cg_endo -84.96 150.75 11.01 Favored 'Trans proline' 0 C--N 1.317 -1.12 0 O-C-N 123.239 1.126 . . . . 0.0 111.748 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.541 ' O ' ' N ' ' B' ' 76' ' ' GLY . 33.0 m -140.54 115.69 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 CA-C-O 121.966 0.889 . . . . 0.0 110.391 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.429 ' CB ' ' N ' ' A' ' 98' ' ' ALA . . . -50.04 160.27 0.36 Allowed 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 122.073 0.94 . . . . 0.0 112.237 -178.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -175.26 59.56 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . 0.427 ' HA ' ' OH ' ' A' ' 94' ' ' TYR . 3.4 pt20 -47.38 174.07 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 122.144 0.973 . . . . 0.0 112.717 -177.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.486 ' C ' ' HG3' ' B' ' 58' ' ' ARG . . . -62.79 -172.44 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 122.263 1.03 . . . . 0.0 112.392 -178.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 58' ' ' ARG . . . . . 0.768 ' HD3' ' N ' ' B' ' 71' ' ' ILE . 0.0 OUTLIER 175.94 -152.86 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -179.008 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . 0.573 ' N ' ' HD2' ' B' ' 58' ' ' ARG . 3.9 pttt 173.59 90.11 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.236 -0.915 . . . . 0.0 110.653 177.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' B' ' 69' ' ' LEU . . . 47.11 49.63 17.99 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.944 -1.263 . . . . 0.0 109.944 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 61' ' ' PHE . . . . . 0.739 ' CE1' ' HB2' ' B' ' 66' ' ' GLN . 0.0 OUTLIER -97.36 131.31 44.16 Favored 'General case' 0 N--CA 1.483 1.217 0 O-C-N 121.157 -1.202 . . . . 0.0 112.972 -178.977 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . 0.673 ' H ' ' CD ' ' B' ' 63' ' ' PRO . 0.1 OUTLIER -132.98 -29.19 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.6 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -179.477 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . 0.673 ' CD ' ' H ' ' B' ' 62' ' ' ASN . 43.4 Cg_endo -73.86 -12.72 24.12 Favored 'Trans proline' 0 N--CA 1.483 0.885 0 O-C-N 122.289 0.626 . . . . 0.0 110.525 -178.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . 0.626 ' HB3' ' CE1' ' B' ' 61' ' ' PHE . 0.1 OUTLIER -84.76 53.65 2.78 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.301 -0.874 . . . . 0.0 109.271 178.831 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' B' ' 64' ' ' GLN . 3.1 p 55.61 42.2 29.8 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.914 -0.491 . . . . 0.0 110.342 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . 0.739 ' HB2' ' CE1' ' B' ' 61' ' ' PHE . 0.0 OUTLIER -158.5 -156.85 0.58 Allowed 'General case' 0 C--N 1.309 -1.195 0 O-C-N 121.386 -0.821 . . . . 0.0 110.569 -179.616 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . 0.611 ' O ' ' HG ' ' B' ' 69' ' ' LEU . 18.5 tt0 -126.99 139.2 53.21 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 178.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . 0.68 ' HA ' ' C ' ' B' ' 61' ' ' PHE . . . -45.03 123.47 3.89 Favored 'General case' 0 C--N 1.289 -2.043 0 O-C-N 121.621 -0.675 . . . . 0.0 110.981 -178.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.611 ' HG ' ' O ' ' B' ' 67' ' ' GLU . 1.3 mp -118.42 -145.87 0.38 Allowed 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.529 -0.732 . . . . 0.0 112.337 -178.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . 0.475 ' HB3' ' O ' ' B' ' 69' ' ' LEU . 2.1 pt-20 172.08 21.89 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.357 0 O-C-N 121.416 -0.803 . . . . 0.0 109.75 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.768 ' N ' ' HD3' ' B' ' 58' ' ' ARG . 0.9 OUTLIER -59.02 -151.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.399 -0.813 . . . . 0.0 111.188 -179.727 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . 0.439 ' O ' HD12 ' B' ' 71' ' ' ILE . . . -139.95 153.14 69.27 Favored Pre-proline 0 N--CA 1.488 1.425 0 O-C-N 121.406 -0.809 . . . . 0.0 110.495 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 73' ' ' PRO . . . . . 0.453 ' HA ' ' N ' ' B' ' 57' ' ' ALA . 42.9 Cg_endo -70.51 113.37 3.47 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 121.693 1.595 . . . . 0.0 110.845 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 74' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' B' ' 73' ' ' PRO . 0.4 OUTLIER 171.89 -168.88 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.568 -0.708 . . . . 0.0 110.197 179.762 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . 0.417 ' CG2' ' HA ' ' A' ' 94' ' ' TYR . 0.7 OUTLIER -109.01 172.84 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.309 -0.87 . . . . 0.0 109.272 179.46 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' B' ' 53' ' ' VAL . . . -121.86 96.42 0.58 Allowed Glycine 0 N--CA 1.494 2.536 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.588 ' O ' ' CG1' ' B' ' 77' ' ' VAL . 8.1 p -67.63 74.54 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.644 -0.915 . . . . 0.0 111.5 -178.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 78' ' ' SER . . . . . 0.578 ' C ' ' CG1' ' B' ' 79' ' ' VAL . 0.1 OUTLIER -61.45 172.76 1.07 Allowed 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 117.368 -1.733 . . . . 0.0 107.463 178.209 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . 0.595 ' CG2' ' N ' ' B' ' 80' ' ' LYS . 0.2 OUTLIER 176.41 173.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.041 -1.037 . . . . 0.0 110.137 179.397 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . 0.595 ' N ' ' CG2' ' B' ' 79' ' ' VAL . 0.1 OUTLIER 176.08 171.14 0.34 Allowed Pre-proline 0 C--N 1.299 -1.61 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 175.955 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 81' ' ' PRO . . . . . 0.513 ' HA ' ' O ' ' B' ' 47' ' ' PHE . 54.0 Cg_endo -89.89 -169.43 0.36 Allowed 'Trans proline' 0 C--N 1.293 -2.361 0 O-C-N 123.712 1.375 . . . . 0.0 109.791 176.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -128.83 -90.96 0.65 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 106.293 -2.723 . . . . 0.0 106.293 178.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . 0.949 ' O ' ' N ' ' B' ' 85' ' ' LEU . 1.6 tt0 -77.99 56.65 1.63 Allowed 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 175.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 84' ' ' SER . . . . . 1.302 ' O ' ' N ' ' B' ' 86' ' ' LYS . 0.3 OUTLIER 8.43 43.84 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 122.396 1.093 . . . . 0.0 110.274 -179.79 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . 0.98 ' C ' ' O ' ' B' ' 84' ' ' SER . 3.7 mp 20.92 29.69 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 103.616 -2.735 . . . . 0.0 103.616 -172.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . 1.302 ' N ' ' O ' ' B' ' 84' ' ' SER 0.346 15.6 tttt -57.79 -42.45 84.18 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 104.161 -2.533 . . . . 0.0 104.161 177.043 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . 0.42 ' O ' ' CG ' ' B' ' 90' ' ' GLU 0.286 34.8 tttp -65.14 -34.41 78.34 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 112.055 -2.339 . . . . 0.0 105.846 175.342 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.674 ' O ' ' CB ' ' A' ' 37' ' ' ALA . . . -78.84 -25.24 44.08 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 118.419 -1.313 . . . . 0.0 108.051 178.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . 0.692 ' N ' ' O ' ' B' ' 85' ' ' LEU . . . -68.42 -49.76 57.69 Favored 'General case' 0 C--N 1.294 -1.843 0 O-C-N 121.141 -0.975 . . . . 0.0 109.291 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.42 ' CG ' ' O ' ' B' ' 87' ' ' LYS . 7.0 pt-20 -58.52 -27.18 64.27 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 177.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . 0.451 ' HA3' ' HB2' ' A' ' 37' ' ' ALA . . . -75.97 -23.07 72.88 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 179.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . 0.784 ' HB3' ' HA ' ' A' ' 37' ' ' ALA . 0.4 OUTLIER -80.79 21.65 0.66 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.575 -1.544 . . . . 0.0 110.38 179.625 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' B' ' 92' ' ' LEU . 0.9 OUTLIER 58.18 37.85 26.28 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 -177.067 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . 0.537 ' CD1' ' N ' ' A' ' 75' ' ' VAL . 52.3 t80 -33.89 -45.94 0.21 Allowed 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 114.926 -1.033 . . . . 0.0 111.602 -178.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -56.92 -44.67 82.68 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.156 -0.965 . . . . 0.0 109.599 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 96' ' ' ASP . . . . . 0.436 ' N ' ' O ' ' B' ' 93' ' ' LYS . 0.2 OUTLIER -57.07 -33.43 67.27 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.777 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -85.67 -22.89 27.67 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.08 -47.26 85.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.623 -0.673 . . . . 0.0 110.172 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.177 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.473 ' HB3' ' HG ' ' A' ' 6' ' ' LEU . 9.6 mtp . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.429 ' HA ' ' O ' ' B' ' 43' ' ' GLN . 0.6 OUTLIER -173.13 -168.76 0.49 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.99 -1.069 . . . . 0.0 112.043 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.465 ' O ' ' CG2' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -51.92 -16.5 0.73 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.604 -0.685 . . . . 0.0 109.856 179.697 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.73 ' O ' HG13 ' A' ' 7' ' ' ILE . 1.4 m -112.86 -53.92 2.67 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.822 0.82 . . . . 0.0 109.906 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.551 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 0.1 OUTLIER -48.41 -48.26 37.19 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.154 -0.966 . . . . 0.0 109.068 -179.955 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.473 ' HG ' ' HB3' ' A' ' 1' ' ' MET . 1.2 mt -61.01 -29.79 69.92 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.363 -0.935 . . . . 0.0 110.44 178.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.73 HG13 ' O ' ' A' ' 4' ' ' THR . 1.0 OUTLIER -60.82 -44.18 97.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 120.621 -1.299 . . . . 0.0 107.868 179.381 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.551 ' HE2' ' HA ' ' A' ' 5' ' ' GLU . 0.0 OUTLIER -64.6 -33.35 75.71 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 177.658 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.425 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . . . -56.19 -38.82 71.48 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 119.921 -0.712 . . . . 0.0 109.165 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.823 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.1 mp -90.98 -33.18 5.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 178.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.558 ' HB3' ' O ' ' A' ' 7' ' ' ILE . . . -62.93 -13.43 34.37 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 118.574 -1.251 . . . . 0.0 108.655 178.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.45 ' CG ' ' N ' ' A' ' 13' ' ' ASP . 8.0 pt20 -115.53 -42.24 3.16 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.486 -0.759 . . . . 0.0 110.177 179.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.45 ' N ' ' CG ' ' A' ' 12' ' ' GLN . 65.6 m-20 -69.76 -31.29 69.17 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 177.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.823 ' OG1' ' O ' ' A' ' 10' ' ' ILE 0.265 0.2 OUTLIER -99.27 -67.95 0.83 Allowed 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 178.666 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 53.06 23.82 18.05 Favored Glycine 0 N--CA 1.501 3.022 0 O-C-N 121.439 -0.788 . . . . 0.0 111.417 177.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.84 HD13 ' HB2' ' B' ' 20' ' ' SER . 4.7 mp -67.85 -69.15 0.34 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.536 -0.979 . . . . 0.0 110.028 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.453 HG22 ' O ' ' A' ' 17' ' ' THR . 0.6 OUTLIER -130.17 6.03 4.92 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.843 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.597 ' O ' ' C ' ' A' ' 19' ' ' VAL . 22.8 mt-30 56.94 28.01 14.03 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 -176.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.608 ' HB ' ' HB ' ' B' ' 19' ' ' VAL . 0.4 OUTLIER -9.24 -97.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.306 -179.412 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.97 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.9 OUTLIER -136.37 25.1 3.21 Favored 'General case' 0 C--N 1.278 -2.516 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 177.779 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.659 ' HA ' ' SD ' ' A' ' 24' ' ' MET . 27.2 m -18.23 -39.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 CA-C-O 122.24 1.019 . . . . 0.0 110.343 -177.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.806 ' N ' ' O ' ' A' ' 20' ' ' SER . 5.2 m -80.02 -37.55 33.89 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 115.032 -0.986 . . . . 0.0 108.998 178.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.97 ' N ' ' O ' ' A' ' 20' ' ' SER . 2.6 mtpt -88.0 -30.45 19.97 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.867 -0.521 . . . . 0.0 111.24 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.733 ' N ' ' OG ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -74.48 -36.76 63.3 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 117.982 -1.487 . . . . 0.0 109.14 -179.671 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.52 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 12.8 mt -77.27 -47.33 20.37 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 118.11 -1.436 . . . . 0.0 107.851 177.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 22' ' ' SER . . . -54.82 -33.57 61.78 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 177.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.572 ' HA ' ' HB3' ' A' ' 30' ' ' LYS . 89.6 p -78.38 -34.03 48.47 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.712 ' HA ' ' CG1' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -66.31 -31.15 71.77 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.381 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.685 ' O ' ' HB ' ' A' ' 33' ' ' THR . 1.6 mt-10 -86.21 -33.13 20.85 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 177.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.741 ' O ' ' CG ' ' A' ' 34' ' ' GLU . 17.6 tttm -69.26 -30.63 68.79 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 176.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.712 ' CG1' ' HA ' ' A' ' 28' ' ' PHE . 1.8 pp -91.33 -36.18 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.35 -0.844 . . . . 0.0 109.379 178.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.693 HG13 ' CE1' ' A' ' 28' ' ' PHE . 3.4 mm -58.42 -55.23 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 177.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.685 ' HB ' ' O ' ' A' ' 29' ' ' GLU . 0.3 OUTLIER -63.01 -36.88 85.04 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.559 179.862 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.741 ' CG ' ' O ' ' A' ' 30' ' ' LYS . 5.2 mm-40 -72.68 -47.05 50.53 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.758 -0.588 . . . . 0.0 111.845 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.473 ' HA ' ' CB ' ' A' ' 38' ' ' LYS . 66.5 m -56.02 -50.78 69.96 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.536 -1.352 . . . . 0.0 109.722 -179.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.501 ' CG1' ' HB3' ' A' ' 52' ' ' PRO . 2.1 t -50.08 -44.54 22.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.733 ' HB3' ' C ' ' B' ' 88' ' ' ALA . . . -84.26 -4.87 59.12 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 121.746 0.784 . . . . 0.0 110.024 178.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.635 ' N ' ' O ' ' A' ' 34' ' ' GLU . 3.1 ttmt -90.66 -26.21 19.72 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 177.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.05 37.04 0.9 Allowed Glycine 0 C--N 1.302 -1.319 0 C-N-CA 120.071 -1.062 . . . . 0.0 111.185 177.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.434 ' CB ' ' CG2' ' A' ' 35' ' ' THR . 0.3 OUTLIER -145.53 140.89 27.8 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.906 -1.35 . . . . 0.0 110.713 179.356 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -92.07 93.73 8.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.666 -0.646 . . . . 0.0 109.374 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.487 ' CG2' ' HB ' ' A' ' 50' ' ' ILE . 31.6 m -60.19 137.39 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.544 -0.723 . . . . 0.0 110.382 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.457 ' O ' ' CB ' ' B' ' 2' ' ' ASN . 3.9 mt-30 -125.7 107.92 11.02 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.413 -0.805 . . . . 0.0 110.008 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.625 HD13 ' HB3' ' A' ' 48' ' ' LEU . 24.1 mt -72.38 103.49 3.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.182 -0.949 . . . . 0.0 109.892 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.452 ' CG2' ' C ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER 33.55 -96.65 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.915 -0.491 . . . . 0.0 111.193 -179.748 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.7 28.98 2.01 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.6 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 1.5 p90 -129.43 -25.34 2.67 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.097 -1.237 . . . . 0.0 111.275 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.625 ' HB3' HD13 ' A' ' 44' ' ' LEU . 5.0 mt -134.79 95.85 3.42 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.45 -1.406 . . . . 0.0 110.6 178.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.416 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 4.5 m-20 -103.98 89.6 3.34 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.178 -0.951 . . . . 0.0 110.888 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.487 ' HB ' ' CG2' ' A' ' 42' ' ' VAL . 0.9 OUTLIER -80.31 153.46 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.393 -0.817 . . . . 0.0 110.301 179.645 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.529 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 16.0 ptmt -165.58 115.25 0.82 Allowed Pre-proline 0 N--CA 1.495 1.811 0 C-N-CA 118.969 -1.092 . . . . 0.0 110.43 178.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.553 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 55.3 Cg_endo -78.13 141.51 18.62 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.451 1.238 . . . . 0.0 111.089 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.628 ' O ' ' N ' ' A' ' 76' ' ' GLY . 23.8 m -146.39 115.32 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-O 121.57 0.7 . . . . 0.0 110.393 179.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.515 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . -31.66 106.81 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 121.086 0.47 . . . . 0.0 111.938 -178.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.03 128.31 3.15 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.261 -0.899 . . . . 0.0 109.468 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -55.53 -175.83 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.214 -0.929 . . . . 0.0 110.165 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.67 ' HB2' ' N ' ' A' ' 71' ' ' ILE . . . -67.05 168.71 9.6 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.843 0.83 . . . . 0.0 111.462 -179.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.563 ' HB2' ' H ' ' A' ' 71' ' ' ILE . 1.9 mtp85 -47.31 170.43 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.259 0.552 . . . . 0.0 110.819 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.441 ' HB3' ' O ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -178.56 93.17 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.435 -0.791 . . . . 0.0 110.004 179.644 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.768 ' N ' ' HB2' ' A' ' 68' ' ' ALA . . . 172.21 -86.22 0.08 OUTLIER Glycine 0 N--CA 1.5 2.926 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.785 ' HA ' ' C ' ' A' ' 67' ' ' GLU . 0.2 OUTLIER -171.09 152.19 3.41 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.203 -1.174 . . . . 0.0 111.618 178.036 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.737 ' CB ' ' HD3' ' A' ' 63' ' ' PRO . 0.4 OUTLIER -152.95 -60.43 0.02 OUTLIER Pre-proline 0 C--N 1.307 -1.252 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.763 178.833 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.737 ' HD3' ' CB ' ' A' ' 62' ' ' ASN . 55.8 Cg_endo -102.27 -4.11 0.33 Allowed 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 121.534 1.489 . . . . 0.0 112.821 -178.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.656 ' O ' ' N ' ' A' ' 66' ' ' GLN . 5.4 mt-30 -139.57 52.67 1.72 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 120.533 -1.354 . . . . 0.0 112.397 -177.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.642 ' N ' ' CE1' ' A' ' 61' ' ' PHE . 8.8 t 33.06 18.38 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.656 ' N ' ' O ' ' A' ' 64' ' ' GLN . 0.9 OUTLIER 177.68 29.55 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.533 -1.354 . . . . 0.0 112.314 179.671 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.785 ' C ' ' HA ' ' A' ' 61' ' ' PHE . 3.0 mt-10 -156.49 89.88 1.14 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.246 -1.534 . . . . 0.0 110.208 179.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.768 ' HB2' ' N ' ' A' ' 60' ' ' GLY . . . -75.94 72.62 2.81 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.663 ' C ' ' O ' ' A' ' 68' ' ' ALA . 0.3 OUTLIER -13.78 92.97 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.323 0 CA-C-O 121.725 0.774 . . . . 0.0 110.279 -178.125 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 58' ' ' ARG . 5.9 mt-10 -44.65 102.06 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.599 -177.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.736 ' O ' ' CB ' ' A' ' 72' ' ' ALA . 2.5 pp -145.5 113.81 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 O-C-N 121.288 -0.882 . . . . 0.0 111.975 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.783 ' H ' ' HD3' ' A' ' 73' ' ' PRO . . . 136.43 49.79 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.329 0 CA-C-N 115.043 -0.981 . . . . 0.0 112.312 178.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.783 ' HD3' ' H ' ' A' ' 72' ' ' ALA . 55.6 Cg_endo -85.78 77.11 2.68 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 O-C-N 122.683 0.833 . . . . 0.0 110.683 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.9 ' O ' ' HB ' ' A' ' 75' ' ' VAL . 86.2 p -178.65 19.17 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.756 -1.215 . . . . 0.0 111.221 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.9 ' HB ' ' O ' ' A' ' 74' ' ' SER . 4.4 p 136.86 -173.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.628 ' N ' ' O ' ' A' ' 53' ' ' VAL . . . -123.6 61.41 0.58 Allowed Glycine 0 N--CA 1.487 2.094 0 N-CA-C 108.935 -1.666 . . . . 0.0 108.935 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.553 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 3.4 p -47.73 82.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.803 -0.821 . . . . 0.0 110.803 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.599 ' N ' ' O ' ' A' ' 76' ' ' GLY . 0.4 OUTLIER -83.73 174.84 10.13 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 118.597 -1.241 . . . . 0.0 110.093 179.952 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.476 ' HA ' ' HA ' ' A' ' 50' ' ' ILE . 2.6 p 175.15 176.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.465 ' N ' ' CG2' ' A' ' 79' ' ' VAL . 0.1 OUTLIER -177.14 173.0 0.76 Allowed Pre-proline 0 N--CA 1.485 1.324 0 O-C-N 120.934 -1.103 . . . . 0.0 110.195 177.377 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.453 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 55.0 Cg_endo -98.6 135.45 0.3 Allowed 'Trans proline' 0 C--N 1.302 -1.904 0 C-N-CA 122.505 2.137 . . . . 0.0 110.622 178.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.424 ' HA3' ' HA ' ' A' ' 47' ' ' PHE . . . -89.73 -158.28 34.17 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 107.956 -2.058 . . . . 0.0 107.956 178.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -90.17 -16.12 30.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.029 -1.277 . . . . 0.0 110.217 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.42 -36.61 61.71 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.269 -0.895 . . . . 0.0 109.267 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.451 ' CB ' ' CG2' ' B' ' 77' ' ' VAL . 0.5 OUTLIER -82.3 -33.21 29.12 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.915 -0.714 . . . . 0.0 109.158 179.07 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.403 ' HA ' ' HB2' ' A' ' 89' ' ' ALA . 2.2 mttt -70.97 -43.83 67.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.458 -0.776 . . . . 0.0 109.755 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.4 tptt -64.71 -39.06 93.0 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 177.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.634 ' O ' ' HB1' ' B' ' 37' ' ' ALA . . . -64.55 -34.9 79.31 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 176.34 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.438 ' HB3' ' CG1' ' B' ' 75' ' ' VAL . . . -54.43 -46.3 73.21 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 120.036 -0.666 . . . . 0.0 109.211 179.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -52.65 -32.58 42.85 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 177.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 88' ' ' ALA . . . -64.65 -38.42 95.64 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 178.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.565 ' HB3' ' HA ' ' B' ' 37' ' ' ALA . 0.5 OUTLIER -72.45 10.37 0.83 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.537 -1.567 . . . . 0.0 111.13 -179.85 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 22.1 mmtt 61.41 41.69 12.54 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -177.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.544 ' CD1' ' N ' ' B' ' 75' ' ' VAL . 0.0 OUTLIER -38.0 -40.27 0.46 Allowed 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.005 -178.962 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -60.84 -39.25 88.35 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.37 -0.831 . . . . 0.0 109.769 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 93' ' ' LYS . 0.6 OUTLIER -61.02 -35.5 77.03 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.394 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.83 -23.98 59.72 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.85 -43.53 58.34 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.502 -0.749 . . . . 0.0 110.28 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 30.2 mttt . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.17 -179.965 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.471 ' CB ' ' CB ' ' B' ' 5' ' ' GLU . 1.3 ptm . . . . . 0 N--CA 1.496 1.842 0 CA-C-O 121.479 0.657 . . . . 0.0 110.871 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . 0.457 ' CB ' ' O ' ' A' ' 43' ' ' GLN . 17.8 p30 -178.3 -152.32 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 120.106 -0.637 . . . . 0.0 110.516 178.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.569 ' O ' HD22 ' B' ' 25' ' ' LEU . 1.0 OUTLIER -59.14 -3.22 0.35 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.147 -0.971 . . . . 0.0 110.207 179.612 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.593 ' O ' HG22 ' B' ' 7' ' ' ILE . 25.1 m -109.01 -53.26 2.67 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.003 -1.061 . . . . 0.0 109.969 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.471 ' CB ' ' CB ' ' B' ' 1' ' ' MET . 1.8 mt-10 -65.88 -46.84 76.9 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.199 -0.938 . . . . 0.0 109.532 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 29.9 mt -49.05 -51.7 29.69 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.213 -0.929 . . . . 0.0 109.643 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' ILE . . . . . 0.593 HG22 ' O ' ' B' ' 4' ' ' THR . 0.1 OUTLIER -50.22 -51.05 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 177.414 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . 0.483 ' N ' ' CG1' ' B' ' 7' ' ' ILE . 0.1 OUTLIER -56.15 -37.38 69.42 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.489 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . 0.418 ' N ' ' O ' ' B' ' 5' ' ' GLU . . . -55.34 -36.2 66.03 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.372 -0.83 . . . . 0.0 108.825 179.063 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . 0.647 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.6 mp -89.22 -34.22 6.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 178.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.22 -12.48 60.18 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.476 ' N ' ' O ' ' B' ' 8' ' ' LYS . 8.9 tp-100 -112.61 -44.19 3.37 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' B' ' 9' ' ' ALA . 2.2 m-20 -68.89 -22.41 64.19 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 176.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.647 ' OG1' ' O ' ' B' ' 10' ' ' ILE . 0.2 OUTLIER -120.04 -83.54 0.65 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.297 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . 0.546 ' O ' ' C ' ' B' ' 16' ' ' LEU . . . 68.32 -21.84 0.3 Allowed Glycine 0 N--CA 1.497 2.713 0 O-C-N 120.906 -1.121 . . . . 0.0 110.346 178.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 16' ' ' LEU . . . . . 0.738 ' N ' HD13 ' B' ' 16' ' ' LEU . 0.0 OUTLIER -25.57 -58.3 0.07 Allowed 'General case' 0 N--CA 1.514 2.735 0 CA-C-O 122.202 1.001 . . . . 0.0 110.794 -179.819 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 17' ' ' THR . . . . . 0.474 ' O ' HG23 ' B' ' 17' ' ' THR . 0.5 OUTLIER -136.25 -0.89 2.42 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.419 -179.38 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . 0.655 ' O ' ' C ' ' B' ' 19' ' ' VAL . 4.7 mt-30 55.24 31.15 15.95 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 -176.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.656 HG21 ' CD1' ' A' ' 16' ' ' LEU . 1.2 p -4.09 -92.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.856 -178.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.934 ' O ' ' N ' ' B' ' 22' ' ' SER . 0.6 OUTLIER -133.37 25.83 4.14 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 177.803 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.677 ' C ' ' O ' ' B' ' 20' ' ' SER . 30.0 m -17.26 -37.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-O 122.426 1.107 . . . . 0.0 109.374 -178.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.934 ' N ' ' O ' ' B' ' 20' ' ' SER . 12.2 t -80.14 -41.24 25.79 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.904 177.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . 0.911 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.0 OUTLIER -87.33 -36.17 17.99 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.438 -0.789 . . . . 0.0 111.483 179.963 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' MET . . . . . 0.534 ' SD ' ' HA ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -71.42 -30.09 65.67 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 118.023 -1.471 . . . . 0.0 108.512 179.367 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.648 ' HG ' ' N ' ' B' ' 26' ' ' ALA . 0.3 OUTLIER -75.31 -41.85 55.93 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 118.662 -1.215 . . . . 0.0 107.843 177.368 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . 0.648 ' N ' ' HG ' ' B' ' 25' ' ' LEU . . . -68.42 -24.43 64.74 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' SER . . . . . 0.488 ' O ' ' HB3' ' B' ' 30' ' ' LYS . 4.5 t -84.55 -36.83 21.87 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . 0.614 ' CD1' ' N ' ' B' ' 29' ' ' GLU . 0.1 OUTLIER -51.89 -53.45 40.7 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.441 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . 0.614 ' N ' ' CD1' ' B' ' 28' ' ' PHE . 0.1 OUTLIER -63.87 -39.04 93.27 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 177.742 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . 1.279 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 19.3 tttm -56.08 -29.51 60.68 Favored 'General case' 0 C--O 1.191 -2.015 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.314 178.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.59 ' O ' ' CB ' ' B' ' 35' ' ' THR . 0.2 OUTLIER -104.46 -23.88 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 119.645 -1.909 . . . . 0.0 108.382 177.516 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.56 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.3 mm -73.1 -61.53 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 177.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.38 -36.29 81.04 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 1.279 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 18.4 mm-40 -78.3 -35.24 48.07 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 121.07 -1.019 . . . . 0.0 111.658 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 35' ' ' THR . . . . . 0.59 ' CB ' ' O ' ' B' ' 31' ' ' ILE . 3.0 m -56.39 -47.94 77.92 Favored 'General case' 0 N--CA 1.504 2.257 0 CA-C-N 120.49 1.496 . . . . 0.0 107.211 178.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.476 ' CG2' ' CG2' ' B' ' 50' ' ' ILE . 23.5 t -53.58 -42.32 49.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 177.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . 0.634 ' HB1' ' O ' ' A' ' 88' ' ' ALA . . . -82.89 -1.19 51.44 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.735 178.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . 0.663 ' N ' ' O ' ' B' ' 34' ' ' GLU . 0.0 OUTLIER -100.37 -18.85 16.56 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 177.905 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.99 42.43 2.26 Favored Glycine 0 C--N 1.302 -1.321 0 C-N-CA 120.272 -0.966 . . . . 0.0 110.74 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . 0.477 ' CB ' HG23 ' B' ' 35' ' ' THR . 0.4 OUTLIER -144.88 150.96 37.97 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.13 -1.218 . . . . 0.0 110.159 179.276 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 63.9 mttt -97.34 92.18 5.85 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.549 -0.719 . . . . 0.0 110.238 -179.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 66.9 t -59.38 129.62 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.536 -0.728 . . . . 0.0 109.399 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 43' ' ' GLN . . . . . 0.45 ' HA ' ' O ' ' B' ' 48' ' ' LEU . 0.8 OUTLIER -125.02 103.91 8.27 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.092 -1.005 . . . . 0.0 111.123 -179.021 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.605 HD13 ' CB ' ' B' ' 48' ' ' LEU . 19.9 mt -62.96 113.97 3.4 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.225 -0.922 . . . . 0.0 109.111 178.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 45' ' ' THR . . . . . 0.566 HG21 ' HG2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 33.12 -89.87 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.499 0 O-C-N 121.832 -0.543 . . . . 0.0 110.93 -179.252 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -146.06 15.79 1.72 Allowed Glycine 0 N--CA 1.484 1.856 0 C-N-CA 119.732 -1.223 . . . . 0.0 110.338 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . 0.592 ' O ' ' HA ' ' B' ' 81' ' ' PRO . 17.1 p90 -111.14 -37.79 5.23 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.762 -1.434 . . . . 0.0 112.113 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . 0.605 ' CB ' HD13 ' B' ' 44' ' ' LEU . 0.0 OUTLIER -114.32 117.8 32.11 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.3 -1.5 . . . . 0.0 111.272 179.703 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -113.19 74.17 0.85 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.699 -0.626 . . . . 0.0 110.569 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 50' ' ' ILE . . . . . 0.518 ' HA ' ' HB ' ' B' ' 79' ' ' VAL . 3.1 mm -59.87 134.95 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.422 -0.799 . . . . 0.0 110.144 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . 0.46 ' O ' ' HD3' ' B' ' 51' ' ' LYS . 0.0 OUTLIER -154.05 126.15 3.85 Favored Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 120.872 -1.142 . . . . 0.0 110.959 179.338 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . 0.537 ' HA ' ' HA ' ' B' ' 77' ' ' VAL . 55.7 Cg_endo -83.79 142.17 10.02 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 O-C-N 123.439 1.231 . . . . 0.0 110.655 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.546 HG21 ' CA ' ' B' ' 76' ' ' GLY . 27.6 m -137.88 114.78 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-O 121.762 0.791 . . . . 0.0 111.058 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.498 ' HA ' ' HA ' ' B' ' 75' ' ' VAL . . . -56.15 104.93 0.16 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.561 -0.712 . . . . 0.0 110.504 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 -130.1 82.59 2.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.613 -0.679 . . . . 0.0 109.332 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.68 -154.29 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.409 -0.807 . . . . 0.0 109.987 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.513 ' HB3' ' HB ' ' B' ' 71' ' ' ILE . . . -154.7 177.46 11.22 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.015 -1.053 . . . . 0.0 111.57 -179.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 58' ' ' ARG . . . . . 0.672 ' N ' HG12 ' B' ' 71' ' ' ILE . 4.8 mpt_? -57.51 -161.24 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.7 -179.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . 0.518 ' CB ' ' O ' ' B' ' 58' ' ' ARG . 0.0 OUTLIER 159.47 52.68 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.201 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -128.31 -101.47 1.06 Allowed Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.973 -1.108 . . . . 0.0 110.499 -179.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 61' ' ' PHE . . . . . 0.729 ' CZ ' ' HD2' ' B' ' 63' ' ' PRO . 0.0 OUTLIER -139.76 178.53 7.18 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.202 -1.175 . . . . 0.0 111.14 -178.864 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . 0.721 ' N ' ' HA ' ' B' ' 68' ' ' ALA . 44.5 m-80 -51.6 -114.34 0.0 OUTLIER Pre-proline 0 C--N 1.305 -1.336 0 CA-C-O 117.548 -1.215 . . . . 0.0 109.993 -178.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . 0.729 ' HD2' ' CZ ' ' B' ' 61' ' ' PHE . 37.4 Cg_endo -61.08 -128.65 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.48 0 CA-C-N 121.255 1.484 . . . . 0.0 109.303 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . 0.626 ' HB2' ' CE1' ' B' ' 61' ' ' PHE . 4.6 tt0 61.99 -66.23 0.08 Allowed 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.286 -1.509 . . . . 0.0 108.505 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.679 ' N ' ' O ' ' B' ' 63' ' ' PRO . 7.2 p -140.0 19.62 2.46 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 177.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . 0.687 ' HA ' ' O ' ' B' ' 62' ' ' ASN . 8.5 mp0 41.69 99.18 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 122.222 1.01 . . . . 0.0 111.477 -179.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . 0.634 ' O ' ' N ' ' B' ' 69' ' ' LEU . 5.7 pt-20 168.58 71.49 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 105.118 -2.178 . . . . 0.0 105.118 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . 0.842 ' O ' ' CG ' ' B' ' 69' ' ' LEU . . . -46.66 14.82 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 116.822 2.156 . . . . 0.0 116.822 -174.003 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.842 ' CG ' ' O ' ' B' ' 68' ' ' ALA . 4.4 mt 122.16 17.12 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.629 0 CA-C-N 120.775 1.625 . . . . 0.0 112.372 174.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . 0.563 ' HB2' ' O ' ' B' ' 69' ' ' LEU . 21.7 tt0 166.68 162.39 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.397 -0.815 . . . . 0.0 110.065 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.672 HG12 ' N ' ' B' ' 58' ' ' ARG . 1.0 OUTLIER -161.64 -154.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 O-C-N 121.592 -0.692 . . . . 0.0 109.366 -179.414 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -115.31 85.37 12.83 Favored Pre-proline 0 C--N 1.301 -1.503 0 O-C-N 121.229 -0.919 . . . . 0.0 112.289 -178.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 73' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -79.68 120.92 4.46 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.779 1.41 . . . . 0.0 109.827 178.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 74' ' ' SER . . . . . 0.529 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 7.5 p -177.5 158.25 1.37 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.076 -1.015 . . . . 0.0 109.849 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . 0.544 ' N ' ' CD1' ' A' ' 94' ' ' TYR . 1.1 t -60.06 170.0 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.101 -0.999 . . . . 0.0 108.884 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . 0.546 ' CA ' HG21 ' B' ' 53' ' ' VAL . . . -120.03 86.35 0.4 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.537 ' HA ' ' HA ' ' B' ' 52' ' ' PRO . 3.2 p -61.22 76.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.648 -0.913 . . . . 0.0 109.485 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 78' ' ' SER . . . . . 0.534 ' N ' ' O ' ' B' ' 76' ' ' GLY . 0.1 OUTLIER -77.3 177.78 7.65 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.872 0.844 . . . . 0.0 110.37 -179.884 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . 0.518 ' HB ' ' HA ' ' B' ' 50' ' ' ILE . 7.0 p 177.73 174.76 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . 0.602 ' HB2' ' HD2' ' B' ' 81' ' ' PRO . 0.0 OUTLIER 177.17 171.75 0.39 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 120.821 -1.174 . . . . 0.0 111.14 177.493 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 81' ' ' PRO . . . . . 0.602 ' HD2' ' HB2' ' B' ' 80' ' ' LYS . 51.1 Cg_endo -74.64 141.45 27.81 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.374 1.723 . . . . 0.0 110.475 176.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' B' ' 47' ' ' PHE . . . -110.31 -75.67 0.83 Allowed Glycine 0 N--CA 1.492 2.433 0 N-CA-C 106.501 -2.64 . . . . 0.0 106.501 178.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . 0.885 ' O ' ' N ' ' B' ' 85' ' ' LEU . 2.1 pt-20 -91.22 40.62 1.03 Allowed 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 176.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 84' ' ' SER . . . . . 0.612 ' C ' ' O ' ' B' ' 83' ' ' GLU . 1.9 t 10.52 43.83 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.665 1.222 . . . . 0.0 110.302 178.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . 0.885 ' N ' ' O ' ' B' ' 83' ' ' GLU . 0.0 OUTLIER 18.76 26.21 0.0 OUTLIER 'General case' 0 C--O 1.186 -2.287 0 N-CA-C 102.898 -3.001 . . . . 0.0 102.898 -170.669 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . 0.567 ' HB2' ' HB3' ' B' ' 84' ' ' SER 0.325 2.9 tttm -48.71 -38.59 21.9 Favored 'General case' 0 CA--C 1.473 -2.018 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 177.708 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . 0.27 2.9 tttt -62.54 -40.92 98.33 Favored 'General case' 0 C--N 1.275 -2.652 0 CA-C-N 111.886 -2.415 . . . . 0.0 106.137 177.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.783 ' N ' ' O ' ' B' ' 85' ' ' LEU . . . -78.65 -33.57 47.08 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 118.29 -1.364 . . . . 0.0 107.989 177.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . 0.735 ' N ' ' O ' ' B' ' 85' ' ' LEU . . . -64.73 -30.63 71.65 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -64.46 -33.92 77.01 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 175.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -64.23 -45.36 93.81 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 178.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . 0.508 ' O ' ' CB ' ' B' ' 93' ' ' LYS . 0.5 OUTLIER -65.49 2.32 0.94 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.499 -1.589 . . . . 0.0 111.403 -179.617 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . 0.508 ' CB ' ' O ' ' B' ' 92' ' ' LEU . 7.0 tptt 72.9 53.91 0.14 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -177.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . 0.655 ' CD2' ' HA ' ' A' ' 74' ' ' SER . 6.1 t80 -38.97 -43.62 0.99 Allowed 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.008 -179.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -57.16 -41.19 78.75 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.304 -0.873 . . . . 0.0 109.656 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 96' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' B' ' 93' ' ' LYS . 4.1 t70 -60.89 -31.95 71.42 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -82.69 -24.75 33.52 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.45 -31.76 72.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.448 -0.783 . . . . 0.0 109.939 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.22 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.498 ' HB3' HG23 ' B' ' 42' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 120.897 0.379 . . . . 0.0 110.291 . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.49 ' H ' ' HB2' ' A' ' 5' ' ' GLU . 16.1 p-10 -173.29 -161.62 0.14 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.398 -0.921 . . . . 0.0 111.459 178.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.57 ' HD2' ' HB ' ' B' ' 45' ' ' THR . 6.8 tttt -45.88 -21.75 0.15 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.956 -0.465 . . . . 0.0 110.116 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.633 ' O ' HG13 ' A' ' 7' ' ' ILE . 88.3 m -94.29 -66.36 0.92 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.501 -0.749 . . . . 0.0 110.662 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.49 ' HB2' ' H ' ' A' ' 2' ' ' ASN . 4.2 mt-10 -48.98 -41.11 33.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.888 -1.133 . . . . 0.0 109.123 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.41 ' CD1' ' CG1' ' B' ' 42' ' ' VAL . 22.5 mt -53.25 -41.88 65.92 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.763 178.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.633 HG13 ' O ' ' A' ' 4' ' ' THR . 1.2 pp -59.05 -40.34 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 178.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.571 ' N ' HG13 ' A' ' 7' ' ' ILE . 17.7 mtmt -62.31 -37.52 85.9 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 176.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 13' ' ' ASP . . . -53.87 -36.87 63.11 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.848 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.6 mp -90.91 -31.95 5.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 178.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 7' ' ' ILE . . . -67.45 -8.0 29.84 Favored 'General case' 0 C--N 1.284 -2.26 0 O-C-N 120.777 -1.202 . . . . 0.0 109.128 179.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.428 ' HB3' ' O ' ' A' ' 8' ' ' LYS . 1.5 tt0 -124.07 -38.73 2.43 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.374 -0.829 . . . . 0.0 109.961 179.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 9' ' ' ALA . 1.0 OUTLIER -73.18 -19.22 61.15 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 177.482 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.848 ' OG1' ' O ' ' A' ' 10' ' ' ILE 0.28 0.2 OUTLIER -112.1 -71.59 0.75 Allowed 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 179.516 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 57.4 18.64 30.2 Favored Glycine 0 N--CA 1.498 2.769 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 177.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.701 ' CD1' ' CG2' ' A' ' 14' ' ' THR . 4.9 mp -58.73 -62.75 1.63 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.419 -1.048 . . . . 0.0 109.384 179.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.581 ' O ' HG23 ' A' ' 17' ' ' THR . 0.5 OUTLIER -143.27 8.88 1.62 Allowed 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.242 -179.771 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.611 ' O ' ' C ' ' A' ' 19' ' ' VAL . 2.7 mt-30 58.24 26.7 14.18 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 -176.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.666 ' HB ' ' HB ' ' B' ' 19' ' ' VAL . 0.6 OUTLIER -2.26 -98.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.453 -179.306 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.967 ' O ' ' N ' ' A' ' 23' ' ' LYS . 1.1 p -134.4 25.57 3.79 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 178.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.664 ' HA ' ' CE ' ' A' ' 24' ' ' MET . 28.3 m -19.36 -39.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 CA-C-O 122.55 1.166 . . . . 0.0 109.872 -178.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.809 ' N ' ' O ' ' A' ' 20' ' ' SER . 36.7 t -76.64 -41.85 44.28 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.118 177.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.967 ' N ' ' O ' ' A' ' 20' ' ' SER . 1.2 mtpt -82.78 -37.72 24.18 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.664 -0.648 . . . . 0.0 111.999 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.683 ' N ' ' OG ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -69.27 -24.52 63.99 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 117.47 -1.692 . . . . 0.0 108.437 179.914 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.69 ' HG ' ' N ' ' A' ' 26' ' ' ALA . 0.3 OUTLIER -75.66 -47.32 26.86 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.134 -1.027 . . . . 0.0 109.241 178.609 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.69 ' N ' ' HG ' ' A' ' 25' ' ' LEU . . . -64.0 -27.93 69.46 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 178.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.577 ' O ' HG13 ' A' ' 31' ' ' ILE . 7.2 p -85.96 -34.99 20.72 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 178.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.622 ' O ' HG13 ' A' ' 31' ' ' ILE . 0.1 OUTLIER -58.31 -46.65 85.73 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 179.146 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.555 ' HG3' HG21 ' B' ' 45' ' ' THR . 2.4 tt0 -70.95 -34.35 71.38 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 177.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 1.27 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 60.6 tttt -64.37 -19.1 65.27 Favored 'General case' 0 C--O 1.193 -1.888 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 177.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.622 HG13 ' O ' ' A' ' 28' ' ' PHE . 1.7 pp -108.91 -29.2 2.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 120.116 -1.615 . . . . 0.0 109.062 178.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.584 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.1 mm -72.0 -55.05 14.68 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.0 -32.2 51.08 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 1.27 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 73.2 mm-40 -78.75 -37.13 41.96 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 120.933 -1.104 . . . . 0.0 110.606 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.751 ' C ' ' HB2' ' A' ' 40' ' ' ASP . 73.1 m -64.96 -37.45 87.68 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 177.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.572 ' HA ' ' HB3' ' A' ' 40' ' ' ASP . 1.4 t -56.75 -35.94 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 175.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.678 ' CB ' ' O ' ' B' ' 88' ' ' ALA . . . -89.46 12.67 15.8 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 176.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 34' ' ' GLU . 3.1 ttmt -130.17 17.1 5.56 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.32 40.49 10.05 Favored Glycine 0 N--CA 1.48 1.598 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.751 ' HB2' ' C ' ' A' ' 35' ' ' THR . 4.8 t70 -60.68 163.23 5.7 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 122.578 1.18 . . . . 0.0 112.8 -178.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.467 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 16.8 mtmt -157.52 57.58 0.5 Allowed 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 105.9 -1.889 . . . . 0.0 105.9 176.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.465 ' HB ' ' HB ' ' A' ' 50' ' ' ILE . 2.2 t -95.68 150.15 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-O 121.533 0.683 . . . . 0.0 111.05 -177.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.469 ' CG ' ' O ' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -137.53 99.94 4.08 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.299 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.575 HD13 ' HB2' ' A' ' 48' ' ' LEU . 11.9 mt -66.78 113.3 4.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.095 -1.003 . . . . 0.0 110.17 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.517 HG23 ' CD2' ' A' ' 47' ' ' PHE . 0.1 OUTLIER 29.99 -88.93 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.21 0 O-C-N 122.038 -0.414 . . . . 0.0 111.411 179.299 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -147.6 19.49 1.48 Allowed Glycine 0 N--CA 1.484 1.884 0 C-N-CA 119.729 -1.224 . . . . 0.0 110.274 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.517 ' CD2' HG23 ' A' ' 45' ' ' THR . 32.1 p90 -116.91 -39.2 3.29 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.759 -1.436 . . . . 0.0 111.831 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.575 ' HB2' HD13 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -115.78 108.92 16.95 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.758 -1.214 . . . . 0.0 112.238 -179.885 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.693 ' O ' ' HB ' ' A' ' 79' ' ' VAL . 0.1 OUTLIER -92.81 68.13 4.53 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.711 -0.618 . . . . 0.0 109.675 179.002 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.574 ' HA ' ' HB ' ' A' ' 79' ' ' VAL . 48.0 mm -53.07 114.3 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.49 0 O-C-N 121.186 -0.946 . . . . 0.0 112.398 -176.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.504 ' O ' ' N ' ' A' ' 78' ' ' SER . 0.6 OUTLIER -157.39 109.65 1.86 Allowed Pre-proline 0 N--CA 1.478 0.967 0 O-C-N 121.846 -0.534 . . . . 0.0 110.293 179.973 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.406 ' HB2' HG13 ' A' ' 75' ' ' VAL . 50.2 Cg_endo -76.8 149.85 30.03 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 O-C-N 123.132 1.069 . . . . 0.0 109.86 178.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.576 ' O ' ' CG2' ' A' ' 75' ' ' VAL . 1.9 t -110.95 -142.91 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.487 -0.758 . . . . 0.0 110.17 -179.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.631 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . 174.06 103.64 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.377 -0.827 . . . . 0.0 109.703 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.543 ' HB3' ' O ' ' A' ' 54' ' ' ALA . 0.1 OUTLIER 162.35 72.54 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.467 0 O-C-N 121.483 -0.76 . . . . 0.0 109.85 -179.897 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.74 ' O ' ' HA ' ' A' ' 73' ' ' PRO . 7.8 mt-30 -158.57 143.68 16.31 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.098 -1.001 . . . . 0.0 110.633 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.803 ' O ' ' O ' ' A' ' 58' ' ' ARG . . . 168.58 143.81 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 122.051 0.929 . . . . 0.0 111.619 178.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.889 ' HA ' ' H ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -22.1 -141.78 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 178.751 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.541 ' C ' ' O ' ' A' ' 58' ' ' ARG . 0.5 OUTLIER -18.07 66.78 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 122.079 0.942 . . . . 0.0 111.483 -179.003 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.874 ' N ' ' O ' ' A' ' 58' ' ' ARG . . . -167.1 -76.86 0.03 OUTLIER Glycine 0 N--CA 1.485 1.949 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.549 ' CB ' ' O ' ' A' ' 60' ' ' GLY . 2.6 t80 163.84 134.09 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.65 -0.912 . . . . 0.0 110.643 179.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.464 ' O ' ' CZ ' ' A' ' 61' ' ' PHE . 1.0 OUTLIER -71.84 179.18 1.05 Allowed Pre-proline 0 N--CA 1.489 1.477 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.608 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 62' ' ' ASN . 47.8 Cg_endo -74.68 53.43 3.19 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.272 1.143 . . . . 0.0 109.279 178.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -121.41 -113.8 0.32 Allowed 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.339 -0.851 . . . . 0.0 111.984 -178.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.539 ' N ' ' HE1' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -155.78 -28.44 0.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.345 -0.847 . . . . 0.0 109.855 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -155.67 32.15 0.36 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.258 -0.901 . . . . 0.0 110.169 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -119.74 99.01 6.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.267 -0.895 . . . . 0.0 110.262 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -106.36 138.61 42.23 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.398 -0.814 . . . . 0.0 110.428 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -151.43 -169.93 3.51 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.348 -0.845 . . . . 0.0 110.199 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.462 ' HA ' ' CB ' ' A' ' 58' ' ' ARG . 0.4 OUTLIER -102.89 77.11 1.54 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.192 -0.942 . . . . 0.0 110.639 -179.62 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.889 ' H ' ' HA ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -97.39 -162.42 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-O 122.135 0.969 . . . . 0.0 110.753 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.813 ' N ' ' CG1' ' A' ' 71' ' ' ILE 0.254 . . -120.08 171.8 5.26 Favored Pre-proline 0 C--N 1.303 -1.44 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.187 178.173 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.74 ' HA ' ' O ' ' A' ' 56' ' ' GLN . 51.0 Cg_endo -85.04 132.83 4.68 Favored 'Trans proline' 0 C--N 1.3 -1.986 0 O-C-N 124.214 1.639 . . . . 0.0 110.105 178.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.624 ' N ' ' CE2' ' B' ' 94' ' ' TYR . 28.7 t -161.43 135.81 7.05 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.332 -0.855 . . . . 0.0 109.722 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.631 ' HA ' ' HA ' ' A' ' 54' ' ' ALA . 0.9 OUTLIER -52.69 173.61 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.221 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.458 ' N ' ' CG1' ' A' ' 75' ' ' VAL . . . -111.94 -157.38 13.84 Favored Glycine 0 N--CA 1.475 1.283 0 C-N-CA 118.659 -1.734 . . . . 0.0 109.561 -179.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.455 ' N ' HG21 ' A' ' 53' ' ' VAL . 3.5 t -139.02 85.62 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.172 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.504 ' N ' ' O ' ' A' ' 51' ' ' LYS . 0.2 OUTLIER -55.09 -45.7 75.46 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.453 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.693 ' HB ' ' O ' ' A' ' 49' ' ' ASN 0.273 5.8 p -50.37 170.84 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-O 122.347 1.07 . . . . 0.0 112.264 -177.165 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.652 ' HB2' ' HD2' ' A' ' 81' ' ' PRO . 5.6 ptmt 174.79 177.46 0.2 Allowed Pre-proline 0 C--N 1.302 -1.499 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.652 ' HD2' ' HB2' ' A' ' 80' ' ' LYS . 36.8 Cg_endo -63.15 143.59 90.42 Favored 'Trans proline' 0 C--N 1.295 -2.249 0 N-CA-C 106.973 -1.972 . . . . 0.0 106.973 175.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.518 ' C ' ' H ' ' A' ' 84' ' ' SER . . . -120.77 -102.97 1.88 Allowed Glycine 0 N--CA 1.498 2.797 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -178.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.96 ' O ' ' N ' ' A' ' 85' ' ' LEU . 32.6 tt0 -72.38 50.51 0.23 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.629 ' HB3' ' HB2' ' A' ' 86' ' ' LYS . 2.7 t 7.86 43.54 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 122.491 1.139 . . . . 0.0 109.785 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.96 ' N ' ' O ' ' A' ' 83' ' ' GLU . 3.0 pp 18.48 27.98 0.0 OUTLIER 'General case' 0 C--O 1.196 -1.713 0 N-CA-C 103.33 -2.841 . . . . 0.0 103.33 -171.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.629 ' HB2' ' HB3' ' A' ' 84' ' ' SER 0.335 1.6 tttt -55.71 -39.85 71.62 Favored 'General case' 0 CA--C 1.473 -2.004 0 N-CA-C 104.473 -2.418 . . . . 0.0 104.473 177.134 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.255 28.7 tttt -59.11 -41.34 87.91 Favored 'General case' 0 C--N 1.28 -2.43 0 CA-C-N 112.188 -2.278 . . . . 0.0 105.79 177.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.647 ' O ' ' HB1' ' B' ' 37' ' ' ALA . . . -77.76 -32.08 52.42 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 117.65 -1.62 . . . . 0.0 107.061 177.336 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.688 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . -61.5 -34.32 75.29 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.21 -1.034 . . . . 0.0 108.21 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.425 ' HA ' ' CB ' ' A' ' 94' ' ' TYR . 3.9 mt-10 -60.23 -35.91 76.52 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 175.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -62.51 -32.88 84.7 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 178.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.548 ' O ' ' CB ' ' A' ' 93' ' ' LYS . 0.3 OUTLIER -78.73 17.37 0.71 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.481 -1.599 . . . . 0.0 110.667 -179.81 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.745 ' O ' ' C ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER 80.12 32.47 0.19 Allowed 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -178.068 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.8 ' O ' ' N ' ' A' ' 97' ' ' PHE . 9.5 t80 -25.53 -68.22 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 117.755 -1.578 . . . . 0.0 108.25 -177.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.968 ' O ' ' N ' ' A' ' 98' ' ' ALA . 62.6 mm-40 9.72 41.07 0.0 OUTLIER 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 101.391 -3.559 . . . . 0.0 101.391 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 1.076 ' O ' ' N ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER 18.5 43.3 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 112.708 -2.042 . . . . 0.0 107.713 -172.198 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.817 ' C ' ' O ' ' A' ' 96' ' ' ASP . 0.0 OUTLIER 26.27 28.76 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 101.859 -3.386 . . . . 0.0 101.859 -169.465 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 1.076 ' N ' ' O ' ' A' ' 96' ' ' ASP 0.275 . . -66.1 -28.48 68.85 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 109.831 -3.349 . . . . 0.0 109.073 -179.362 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 118.039 -0.982 . . . . 0.0 110.265 179.77 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.55 ' O ' ' HB3' ' B' ' 2' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 120.721 0.296 . . . . 0.0 110.309 . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . 0.55 ' HB3' ' O ' ' B' ' 1' ' ' MET . 25.4 p30 178.89 -143.94 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.577 178.079 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.424 ' HA ' HD12 ' B' ' 25' ' ' LEU . 3.1 mttp -55.05 -3.13 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.215 -0.928 . . . . 0.0 111.192 -179.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.658 ' O ' HG13 ' B' ' 7' ' ' ILE . 16.3 m -114.51 -65.03 1.23 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.898 -1.126 . . . . 0.0 110.573 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.503 ' HB2' ' HA ' ' B' ' 1' ' ' MET . 9.2 mp0 -49.02 -44.72 41.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.84 -1.163 . . . . 0.0 108.909 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.527 ' CB ' HD23 ' B' ' 25' ' ' LEU . 20.1 mt -57.01 -34.47 68.2 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.125 -1.03 . . . . 0.0 109.648 178.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' ILE . . . . . 0.658 HG13 ' O ' ' B' ' 4' ' ' THR . 1.1 pp -57.63 -43.43 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 178.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . 0.602 ' N ' HG13 ' B' ' 7' ' ' ILE . 0.0 OUTLIER -63.7 -32.55 74.08 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 177.926 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' B' ' 13' ' ' ASP . . . -55.18 -40.94 71.26 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.439 -0.788 . . . . 0.0 109.162 178.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . 0.505 ' O ' ' CB ' ' B' ' 14' ' ' THR . 1.1 mp -91.44 -29.79 4.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 178.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.584 ' HB2' ' O ' ' B' ' 7' ' ' ILE . . . -65.99 -15.42 62.99 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.268 -0.973 . . . . 0.0 108.399 178.02 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.453 ' HB3' ' O ' ' B' ' 8' ' ' LYS . 1.8 tp60 -112.31 -42.99 3.59 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.465 ' HB3' ' CB ' ' A' ' 27' ' ' SER . 18.8 m-20 -59.83 -39.97 86.92 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 177.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.639 ' CG2' ' HB3' ' A' ' 20' ' ' SER . 0.2 OUTLIER -98.83 -71.69 0.68 Allowed 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 113.858 -1.519 . . . . 0.0 108.504 179.387 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 47.26 27.39 3.85 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 16' ' ' LEU . . . . . 0.561 HD13 HG22 ' A' ' 19' ' ' VAL . 0.4 OUTLIER -91.6 -28.56 17.44 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.543 -0.975 . . . . 0.0 108.814 178.89 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 17' ' ' THR . . . . . 0.528 HG21 ' CG2' ' A' ' 17' ' ' THR . 0.7 OUTLIER -147.39 -13.94 0.4 Allowed 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.893 -0.504 . . . . 0.0 110.342 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . 0.446 ' O ' ' O ' ' B' ' 19' ' ' VAL . 3.1 mt-30 57.36 43.71 22.86 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -177.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.666 ' HB ' ' HB ' ' A' ' 19' ' ' VAL . 1.4 p -34.5 -94.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.96 -178.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.918 ' O ' ' N ' ' B' ' 23' ' ' LYS . 0.4 OUTLIER -134.16 25.19 3.88 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 178.845 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.653 ' C ' ' O ' ' B' ' 20' ' ' SER . 31.1 m -17.28 -39.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-O 122.642 1.211 . . . . 0.0 109.574 -178.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.896 ' N ' ' O ' ' B' ' 20' ' ' SER . 38.2 p -85.67 -38.43 18.36 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.071 178.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . 0.918 ' N ' ' O ' ' B' ' 20' ' ' SER . 1.8 mtpt -86.1 -29.91 22.98 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.463 -0.773 . . . . 0.0 111.092 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' MET . . . . . 0.559 ' CE ' ' HA ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -80.66 -35.08 34.28 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.588 -1.32 . . . . 0.0 110.093 179.856 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.619 ' C ' ' CD1' ' B' ' 25' ' ' LEU . 0.1 OUTLIER -79.81 -43.06 23.11 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 118.099 -1.441 . . . . 0.0 107.368 177.955 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' B' ' 22' ' ' SER . . . -59.75 -25.25 64.71 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 176.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 27' ' ' SER . . . . . 0.523 ' O ' ' N ' ' B' ' 31' ' ' ILE . 4.3 t -81.24 -36.81 29.52 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . 0.735 ' HA ' ' CG1' ' B' ' 31' ' ' ILE . 0.0 OUTLIER -60.96 -36.43 79.37 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.769 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . 0.649 ' O ' ' HB ' ' B' ' 33' ' ' THR . 9.2 mt-10 -77.55 -34.5 53.81 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 177.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . 1.011 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 64.0 tttt -68.42 -25.4 65.01 Favored 'General case' 0 C--O 1.192 -1.97 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 177.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.735 ' CG1' ' HA ' ' B' ' 28' ' ' PHE . 1.1 pp -100.81 -29.85 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 120.983 -1.073 . . . . 0.0 109.518 178.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.703 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.1 mm -66.02 -57.32 11.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 176.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 33' ' ' THR . . . . . 0.649 ' HB ' ' O ' ' B' ' 29' ' ' GLU . 0.5 OUTLIER -65.26 -38.48 90.46 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.474 179.172 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 1.011 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 23.9 mm-40 -75.21 -38.9 60.5 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.37 -0.831 . . . . 0.0 112.067 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 35' ' ' THR . . . . . 0.54 ' N ' ' O ' ' B' ' 31' ' ' ILE . 44.1 m -59.57 -54.59 44.79 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.334 -1.479 . . . . 0.0 109.425 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.625 ' O ' ' HG3' ' B' ' 52' ' ' PRO . 2.6 t -54.32 -36.23 32.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 177.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . 0.647 ' HB1' ' O ' ' A' ' 88' ' ' ALA . . . -88.49 4.8 45.31 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.686 0.755 . . . . 0.0 109.823 177.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . 0.73 ' N ' ' O ' ' B' ' 34' ' ' GLU . 1.2 tppp? -105.26 -32.9 8.41 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 178.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.21 35.03 0.44 Allowed Glycine 0 C--N 1.301 -1.397 0 C-N-CA 119.661 -1.256 . . . . 0.0 111.092 177.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . 0.417 ' HB2' HG21 ' B' ' 35' ' ' THR . 0.2 OUTLIER -147.14 173.05 12.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.011 -1.288 . . . . 0.0 110.543 179.523 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' B' ' 41' ' ' LYS . 0.0 OUTLIER -127.65 114.53 17.47 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.651 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . 0.697 ' HB ' ' CG1' ' B' ' 50' ' ' ILE . 38.4 t -98.96 131.02 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.572 -178.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 43' ' ' GLN . . . . . 0.443 ' HG3' ' CB ' ' A' ' 2' ' ' ASN . 0.0 OUTLIER -111.51 123.61 50.58 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.259 -0.9 . . . . 0.0 110.547 180.0 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.563 ' HB2' ' CB ' ' B' ' 48' ' ' LEU . 16.4 mt -84.04 102.69 12.68 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.267 -0.896 . . . . 0.0 109.705 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 45' ' ' THR . . . . . 0.57 ' HB ' ' HD2' ' A' ' 3' ' ' LYS . 0.1 OUTLIER 34.98 -91.97 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.975 -0.453 . . . . 0.0 111.125 -179.777 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -148.85 20.1 1.26 Allowed Glycine 0 N--CA 1.487 2.095 0 N-CA-C 110.089 -1.205 . . . . 0.0 110.089 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . 0.528 ' CE2' ' HG3' ' A' ' 29' ' ' GLU . 3.8 p90 -116.61 -33.6 4.81 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.056 -1.261 . . . . 0.0 111.079 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . 0.563 ' CB ' ' HB2' ' B' ' 44' ' ' LEU . 0.1 OUTLIER -119.58 178.9 4.39 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.626 -1.296 . . . . 0.0 111.797 179.227 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 49' ' ' ASN . . . . . 0.618 ' O ' ' HB ' ' B' ' 79' ' ' VAL . 2.0 m-80 -165.98 145.05 6.04 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 50' ' ' ILE . . . . . 0.698 ' N ' HG13 ' B' ' 79' ' ' VAL . 1.6 pp -146.59 101.61 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-O 122.131 0.967 . . . . 0.0 110.636 178.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . 0.648 ' H ' HG22 ' B' ' 79' ' ' VAL . 0.1 OUTLIER -147.94 133.14 9.17 Favored Pre-proline 0 N--CA 1.495 1.782 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.919 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . 0.625 ' HG3' ' O ' ' B' ' 36' ' ' VAL . 58.0 Cg_endo -95.71 153.18 1.5 Allowed 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.305 1.16 . . . . 0.0 112.49 -178.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' B' ' 76' ' ' GLY . 27.9 m -134.57 112.92 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 CA-C-O 122.017 0.913 . . . . 0.0 109.965 176.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.559 ' HB1' ' CB ' ' A' ' 96' ' ' ASP . . . -51.67 118.89 3.68 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.687 -0.633 . . . . 0.0 111.662 -178.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 5.3 ttm-85 -163.91 126.96 2.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.445 -0.784 . . . . 0.0 109.372 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -59.45 -161.29 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.285 -0.884 . . . . 0.0 110.026 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.444 ' CB ' ' O ' ' B' ' 72' ' ' ALA . . . -168.24 -162.14 0.4 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.017 -1.052 . . . . 0.0 111.743 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 58' ' ' ARG . . . . . 0.655 ' O ' ' HB3' ' B' ' 59' ' ' LYS . 0.0 OUTLIER -69.04 143.17 54.36 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.9 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . 0.655 ' HB3' ' O ' ' B' ' 58' ' ' ARG . 1.6 ttpp 139.39 126.84 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.601 0 C-N-CA 123.878 0.871 . . . . 0.0 109.371 177.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . 0.523 ' O ' ' C ' ' B' ' 61' ' ' PHE . . . 96.49 70.98 1.06 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 61' ' ' PHE . . . . . 0.658 ' CB ' ' HA ' ' B' ' 68' ' ' ALA . 0.1 OUTLIER -19.94 140.55 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.339 0 CA-C-O 121.443 0.639 . . . . 0.0 112.311 -179.501 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . 0.43 ' O ' ' N ' ' B' ' 64' ' ' GLN . 1.0 OUTLIER -49.96 169.0 0.2 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.283 -0.886 . . . . 0.0 109.064 179.478 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -69.3 62.62 1.52 Allowed 'Trans proline' 0 C--N 1.303 -1.826 0 O-C-N 123.442 1.233 . . . . 0.0 109.286 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . 0.43 ' N ' ' O ' ' B' ' 62' ' ' ASN . 36.0 tp60 -127.05 -122.45 0.24 Allowed 'General case' 0 C--N 1.312 -1.044 0 O-C-N 121.327 -0.858 . . . . 0.0 110.574 -179.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 82.2 p -149.01 10.84 0.81 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.233 -0.917 . . . . 0.0 110.329 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . 0.455 ' NE2' ' N ' ' B' ' 66' ' ' GLN . 0.0 OUTLIER -174.94 -18.42 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.1 -1.0 . . . . 0.0 112.367 -179.918 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' B' ' 61' ' ' PHE . 11.0 tt0 -66.89 76.49 0.12 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.656 -1.278 . . . . 0.0 110.203 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . 0.658 ' HA ' ' CB ' ' B' ' 61' ' ' PHE . . . -69.95 167.87 16.54 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.633 -0.667 . . . . 0.0 111.31 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.569 ' HB3' ' HG3' ' B' ' 58' ' ' ARG . 95.3 mt -125.23 -139.85 0.28 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.653 -0.654 . . . . 0.0 110.359 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . 0.907 ' O ' ' O ' ' B' ' 71' ' ' ILE . 4.1 tt0 -166.8 -129.22 0.02 OUTLIER 'General case' 0 C--O 1.204 -1.311 0 O-C-N 120.771 -1.206 . . . . 0.0 111.085 -177.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.907 ' O ' ' O ' ' B' ' 70' ' ' GLU . 0.5 OUTLIER -8.65 -150.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -177.132 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . 0.444 ' O ' ' CB ' ' B' ' 57' ' ' ALA . . . -154.62 165.67 17.61 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 120.121 -1.612 . . . . 0.0 112.862 -177.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 73' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.87 128.1 15.44 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 124.844 1.97 . . . . 0.0 109.817 178.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 74' ' ' SER . . . . . 0.527 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 69.0 m -166.18 161.95 17.27 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . 0.568 ' N ' ' CD1' ' A' ' 94' ' ' TYR . 0.4 OUTLIER -51.53 168.77 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.874 -1.141 . . . . 0.0 108.911 -179.563 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' B' ' 78' ' ' SER . . . -118.02 99.3 0.8 Allowed Glycine 0 N--CA 1.486 1.968 0 C-N-CA 119.217 -1.468 . . . . 0.0 109.642 -179.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.508 HG11 ' CB ' ' A' ' 81' ' ' PRO . 2.1 t -60.71 88.08 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 179.135 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 78' ' ' SER . . . . . 0.499 ' N ' ' O ' ' B' ' 76' ' ' GLY . 0.8 OUTLIER -58.06 -48.25 80.7 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.564 -178.057 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . 0.698 HG13 ' N ' ' B' ' 50' ' ' ILE . 27.2 m -49.46 177.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 115.224 1.564 . . . . 0.0 115.224 -174.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . 0.639 ' HB2' ' HD2' ' B' ' 81' ' ' PRO . 0.0 OUTLIER 179.56 178.97 0.28 Allowed Pre-proline 0 N--CA 1.481 1.087 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.161 -179.051 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 81' ' ' PRO . . . . . 0.639 ' HD2' ' HB2' ' B' ' 80' ' ' LYS . 41.8 Cg_endo -70.21 130.99 19.7 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.372 1.196 . . . . 0.0 110.78 179.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -82.18 -157.99 22.03 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' B' ' 87' ' ' LYS . 11.1 pt-20 -83.73 -21.25 32.34 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.574 -0.956 . . . . 0.0 110.842 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 84' ' ' SER . . . . . 0.478 ' HB2' ' HA ' ' B' ' 47' ' ' PHE . 0.4 OUTLIER -56.28 -45.39 80.16 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.032 -1.042 . . . . 0.0 109.282 -179.682 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . 0.425 ' CD2' ' CG2' ' A' ' 36' ' ' VAL . 12.8 mt -61.6 -32.53 72.65 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . 0.415 ' O ' ' HB1' ' B' ' 89' ' ' ALA . 1.7 tttp -82.7 -31.32 28.62 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.642 0.734 . . . . 0.0 109.799 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' B' ' 83' ' ' GLU . 9.8 tmtt? -73.56 -38.97 65.04 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.678 ' O ' ' CB ' ' A' ' 37' ' ' ALA . . . -66.71 -34.73 78.49 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 176.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . 0.471 ' CB ' ' CG1' ' A' ' 75' ' ' VAL . . . -53.39 -46.16 69.58 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.406 -0.809 . . . . 0.0 109.448 178.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -56.5 -29.71 62.13 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 176.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . 0.495 ' C ' ' H ' ' B' ' 93' ' ' LYS . . . -64.72 -34.21 89.28 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 178.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . 0.588 ' HB3' ' HA ' ' A' ' 37' ' ' ALA . 1.5 pp -71.06 20.8 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 CA-C-N 119.928 1.864 . . . . 0.0 110.947 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . 0.495 ' H ' ' C ' ' B' ' 91' ' ' GLY . 0.2 OUTLIER 59.42 44.33 15.21 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 106.044 -1.835 . . . . 0.0 106.044 -177.656 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . 0.624 ' CE2' ' N ' ' A' ' 74' ' ' SER . 0.3 OUTLIER -35.53 -42.24 0.22 Allowed 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.044 -178.233 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -52.85 -41.39 64.23 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.206 -0.934 . . . . 0.0 109.5 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 96' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' B' ' 93' ' ' LYS . 0.4 OUTLIER -65.14 -30.4 71.32 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.141 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -85.18 -16.41 40.46 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.625 -0.672 . . . . 0.0 109.371 178.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 98' ' ' ALA . . . . . 0.421 ' HB3' ' CE1' ' B' ' 94' ' ' TYR . . . -74.14 -39.47 63.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.521 -0.737 . . . . 0.0 110.057 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.201 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.426 ' HG2' ' HB3' ' A' ' 5' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.139 0.495 . . . . 0.0 110.132 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.421 ' N ' ' HB2' ' A' ' 5' ' ' GLU . 4.4 p30 173.05 173.26 0.12 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.489 -0.757 . . . . 0.0 110.337 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.62 ' HD2' HD11 ' A' ' 25' ' ' LEU . 2.2 mmmp? -43.19 -26.16 0.15 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.627 -0.671 . . . . 0.0 110.555 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.514 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 5.7 m -85.83 -55.46 3.96 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.247 -0.908 . . . . 0.0 109.027 178.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.426 ' HB3' ' HG2' ' A' ' 1' ' ' MET . 1.0 OUTLIER -60.2 -48.76 80.36 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.697 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.459 ' CD1' ' CG2' ' B' ' 42' ' ' VAL . 9.5 mt -57.56 -33.24 67.94 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.575 -0.85 . . . . 0.0 108.718 177.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.591 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -54.79 -54.09 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 178.373 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.509 ' N ' HG22 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -68.74 -27.86 66.3 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.65 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.451 ' N ' ' HG2' ' A' ' 8' ' ' LYS . . . -59.49 -33.86 71.86 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.289 -0.882 . . . . 0.0 108.795 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.927 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.8 OUTLIER -95.75 -37.02 7.05 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.528 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 178.429 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.591 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -60.18 -26.93 66.72 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.418 ' CG ' ' O ' ' A' ' 8' ' ' LYS . 1.4 pp0? -92.91 -37.56 12.18 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.517 ' HB3' ' CB ' ' B' ' 27' ' ' SER . 21.8 m-20 -69.08 -29.59 67.72 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 176.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.927 ' OG1' ' O ' ' A' ' 10' ' ' ILE . 16.6 p -85.82 -75.77 0.36 Allowed 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 177.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 55.26 15.25 7.27 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.663 HD11 ' C ' ' B' ' 19' ' ' VAL . 0.7 OUTLIER -80.92 -51.53 8.47 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.251 -1.146 . . . . 0.0 107.989 178.702 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.489 HG22 ' O ' ' A' ' 17' ' ' THR . 0.5 OUTLIER -144.8 -2.21 0.84 Allowed 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.897 -179.847 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.671 ' O ' ' C ' ' A' ' 19' ' ' VAL . 6.7 mt-30 56.23 30.07 15.96 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 -176.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.783 ' HB ' ' HB ' ' B' ' 19' ' ' VAL . 0.4 OUTLIER 3.78 -97.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.868 -179.399 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 1.022 ' O ' ' N ' ' A' ' 22' ' ' SER . 6.1 p -134.98 24.14 3.58 Favored 'General case' 0 C--N 1.28 -2.456 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 176.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.728 ' HA ' ' CE ' ' A' ' 24' ' ' MET . 18.1 m -5.14 -44.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-O 122.447 1.118 . . . . 0.0 110.719 -177.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 1.022 ' N ' ' O ' ' A' ' 20' ' ' SER . 33.3 m -71.22 -41.79 69.74 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.88 178.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.89 ' N ' ' O ' ' A' ' 20' ' ' SER . 5.0 mtpt -85.87 -32.61 21.6 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.459 -0.776 . . . . 0.0 111.486 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.728 ' CE ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -65.82 -26.83 67.86 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 116.938 -1.905 . . . . 0.0 108.158 179.277 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.709 ' C ' ' CD1' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -77.88 -49.68 13.74 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 177.727 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.456 ' N ' ' CG ' ' A' ' 25' ' ' LEU . . . -57.79 -29.72 65.09 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.508 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 1.6 t -83.39 -38.92 21.33 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.606 ' O ' HG13 ' A' ' 31' ' ' ILE . 19.7 t80 -53.32 -48.09 68.73 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.565 ' HG3' ' HE3' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -66.86 -38.76 86.95 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 176.332 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 1.24 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 42.2 tttt -60.79 -19.56 59.74 Favored 'General case' 0 C--O 1.194 -1.836 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.606 HG13 ' O ' ' A' ' 28' ' ' PHE . 0.9 OUTLIER -112.74 -23.46 4.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 O-C-N 119.996 -1.69 . . . . 0.0 109.904 178.641 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.588 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.3 mm -82.46 -49.68 16.88 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 176.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.494 ' OG1' ' O ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -77.48 -38.88 48.27 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.564 178.677 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 1.24 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 64.2 mm-40 -74.16 -28.5 61.34 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.946 -1.096 . . . . 0.0 111.157 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.568 ' OG1' ' O ' ' A' ' 31' ' ' ILE . 87.8 m -78.09 -42.29 32.53 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 118.19 -1.404 . . . . 0.0 109.425 179.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.595 ' N ' ' HB2' ' A' ' 40' ' ' ASP . 3.4 p -54.42 -41.22 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 177.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.641 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -78.85 -2.71 41.04 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.806 -0.758 . . . . 0.0 110.115 178.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.497 ' HB2' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -113.66 1.25 14.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.925 -1.109 . . . . 0.0 108.982 177.697 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.33 35.77 2.82 Favored Glycine 0 N--CA 1.484 1.887 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.595 ' HB2' ' N ' ' A' ' 36' ' ' VAL . 12.4 t70 -47.15 165.22 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 122.619 1.2 . . . . 0.0 112.912 -179.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.422 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 8.2 mttt -174.21 58.39 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 178.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.581 ' CG2' ' HB ' ' A' ' 50' ' ' ILE . 12.0 m -93.39 132.63 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 CA-C-O 121.606 0.717 . . . . 0.0 111.324 -177.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.443 ' O ' ' CG ' ' A' ' 43' ' ' GLN . 1.1 tt0 -118.35 102.29 8.84 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.653 HD12 ' HB3' ' A' ' 48' ' ' LEU . 72.1 mt -70.52 104.45 2.78 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.093 -1.005 . . . . 0.0 110.166 -179.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.46 HG22 ' HD2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER 33.36 -92.48 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.141 0 O-C-N 122.09 -0.381 . . . . 0.0 111.064 179.965 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -149.49 34.7 1.06 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.631 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 1.5 p90 -133.69 -26.1 1.61 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.111 -1.229 . . . . 0.0 111.617 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.653 ' HB3' HD12 ' A' ' 44' ' ' LEU . 5.7 mt -139.72 104.9 5.01 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.603 -1.311 . . . . 0.0 110.605 178.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.447 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 1.5 t30 -106.12 76.79 1.18 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.165 -0.959 . . . . 0.0 110.716 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.585 HG12 HG21 ' A' ' 79' ' ' VAL . 1.4 mm -64.29 109.98 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.187 -0.946 . . . . 0.0 109.849 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.512 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -131.06 119.59 17.92 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.053 -1.029 . . . . 0.0 109.84 -179.913 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.649 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 54.0 Cg_endo -79.42 139.28 14.45 Favored 'Trans proline' 0 C--N 1.316 -1.146 0 O-C-N 123.39 1.205 . . . . 0.0 111.832 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.556 ' O ' ' N ' ' A' ' 76' ' ' GLY . 33.9 m -144.24 117.7 3.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.359 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.642 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . -42.33 120.23 1.59 Allowed 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 121.626 0.727 . . . . 0.0 111.96 -178.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.41 78.24 1.32 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.26 -159.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.591 0.71 . . . . 0.0 111.121 -178.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.438 ' HB3' HD11 ' A' ' 71' ' ' ILE . . . -155.11 170.2 22.36 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.49 -0.756 . . . . 0.0 110.03 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.712 ' O ' HG13 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -84.34 107.48 16.65 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.553 -0.717 . . . . 0.0 112.072 -179.397 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.404 ' O ' ' O ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -54.32 -178.05 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.22 -0.925 . . . . 0.0 109.596 178.686 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.488 ' HA3' ' O ' ' A' ' 69' ' ' LEU . . . -109.6 121.95 6.26 Favored Glycine 0 N--CA 1.484 1.836 0 C-N-CA 119.181 -1.485 . . . . 0.0 111.707 -178.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.859 ' CE1' ' HB3' ' A' ' 64' ' ' GLN . 1.3 p90 -162.37 157.63 22.89 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 121.462 -1.022 . . . . 0.0 111.694 178.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.788 ' H ' ' CD ' ' A' ' 63' ' ' PRO . 3.0 p30 -142.59 -11.37 0.01 OUTLIER Pre-proline 0 C--N 1.299 -1.612 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 178.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.788 ' CD ' ' H ' ' A' ' 62' ' ' ASN . 49.9 Cg_endo -78.18 -10.77 16.37 Favored 'Trans proline' 0 N--CA 1.483 0.864 0 N-CA-C 109.798 -0.885 . . . . 0.0 109.798 178.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.859 ' HB3' ' CE1' ' A' ' 61' ' ' PHE . 41.9 tp60 -90.25 -106.4 0.09 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.325 -0.859 . . . . 0.0 109.837 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.469 ' O ' ' CB ' ' A' ' 66' ' ' GLN . 15.5 p -73.96 -1.02 18.02 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.576 -1.327 . . . . 0.0 110.091 179.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.608 ' O ' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER 75.31 104.29 0.07 Allowed 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.589 -0.694 . . . . 0.0 111.416 179.663 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.623 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 4.1 pt-20 153.29 77.65 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.56 ' HA ' ' O ' ' A' ' 61' ' ' PHE . . . -59.72 136.67 58.07 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.158 -0.964 . . . . 0.0 109.712 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.678 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 2.1 mt -142.11 -138.81 0.11 Allowed 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.582 -0.698 . . . . 0.0 110.615 -178.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.678 ' CB ' ' O ' ' A' ' 69' ' ' LEU . 2.1 tt0 143.87 139.4 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.775 0 CA-C-O 121.344 0.592 . . . . 0.0 109.871 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.712 HG13 ' O ' ' A' ' 58' ' ' ARG . 0.8 OUTLIER -164.38 -155.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -179.512 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -129.91 87.11 52.87 Favored Pre-proline 0 C--N 1.303 -1.434 0 O-C-N 121.262 -0.899 . . . . 0.0 111.566 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.589 ' HD3' HD11 ' A' ' 71' ' ' ILE . 38.0 Cg_endo -62.85 119.5 6.61 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 O-C-N 123.61 1.321 . . . . 0.0 110.739 178.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.487 ' HA ' ' CE1' ' B' ' 94' ' ' TYR . 1.0 OUTLIER -171.07 166.06 7.39 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.317 -0.864 . . . . 0.0 109.818 179.856 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.642 ' HA ' ' HA ' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -54.97 -179.66 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.047 -1.033 . . . . 0.0 109.584 179.766 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.56 ' O ' ' N ' ' A' ' 78' ' ' SER . . . -123.76 86.45 0.38 Allowed Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.649 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 4.7 p -64.77 68.9 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.549 -0.971 . . . . 0.0 108.697 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.56 ' N ' ' O ' ' A' ' 76' ' ' GLY . 1.0 OUTLIER -65.42 174.49 2.14 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.903 0.859 . . . . 0.0 110.983 -178.517 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.585 HG21 HG12 ' A' ' 50' ' ' ILE . 4.9 p 174.79 -168.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.464 ' O ' HD21 ' A' ' 48' ' ' LEU . 7.6 pttt -172.98 172.26 1.63 Allowed Pre-proline 0 N--CA 1.485 1.279 0 O-C-N 120.678 -1.264 . . . . 0.0 111.235 177.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 80' ' ' LYS . 55.3 Cg_endo -93.3 87.3 0.16 Allowed 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 122.635 2.223 . . . . 0.0 109.472 178.254 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.582 ' HA3' ' HA ' ' A' ' 47' ' ' PHE . . . -58.73 158.05 19.98 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.48 ' O ' ' N ' ' A' ' 87' ' ' LYS . 13.7 pt-20 -55.21 -17.27 4.15 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.219 -1.165 . . . . 0.0 111.07 -179.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.481 ' CB ' ' HB3' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -55.8 -35.89 66.82 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.85 -1.156 . . . . 0.0 109.317 179.426 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.412 HD12 ' HB2' ' A' ' 47' ' ' PHE . 0.7 OUTLIER -81.74 -37.8 26.71 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.894 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.406 ' HG3' HG21 ' B' ' 77' ' ' VAL . 0.6 OUTLIER -75.0 -30.95 61.29 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.448 0.642 . . . . 0.0 110.368 -179.429 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.48 ' N ' ' O ' ' A' ' 83' ' ' GLU . 16.2 ttpt -78.1 -34.66 49.97 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.643 ' O ' ' HG ' ' A' ' 92' ' ' LEU . . . -71.59 -32.18 67.77 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 177.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.689 ' HA ' ' HA ' ' B' ' 37' ' ' ALA . . . -73.02 -54.12 9.39 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.538 -0.726 . . . . 0.0 110.484 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.578 ' HA ' ' HB3' ' A' ' 94' ' ' TYR . 19.1 pt-20 -53.86 -21.42 7.59 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 177.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.66 -28.87 34.06 Favored Glycine 0 CA--C 1.54 1.629 0 CA-C-O 119.093 -0.837 . . . . 0.0 112.335 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.655 ' HB2' ' O ' ' B' ' 37' ' ' ALA . 2.3 mt -97.88 -74.1 0.59 Allowed 'General case' 0 N--CA 1.5 2.026 0 CA-C-N 121.425 2.613 . . . . 0.0 111.816 -178.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -146.87 42.61 1.14 Allowed 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 119.244 -0.982 . . . . 0.0 111.385 -178.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.578 ' HB3' ' HA ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -60.63 -48.41 81.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.279 -0.888 . . . . 0.0 108.824 178.857 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -66.07 -36.45 83.23 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.554 -0.716 . . . . 0.0 109.301 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.0 -30.47 61.88 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -79.07 -33.74 44.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.618 -0.676 . . . . 0.0 109.274 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.08 -28.42 69.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.615 -0.678 . . . . 0.0 110.148 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 18.6 mtmt . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.195 179.931 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.416 ' HB3' HG12 ' A' ' 42' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.126 0.489 . . . . 0.0 110.223 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . 0.562 ' H ' ' HB2' ' B' ' 5' ' ' GLU . 0.6 OUTLIER 178.3 178.21 0.4 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.39 -0.819 . . . . 0.0 109.834 -179.426 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.533 ' CE ' ' HB2' ' B' ' 29' ' ' GLU . 0.1 OUTLIER -51.34 -23.86 4.09 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.764 -0.774 . . . . 0.0 108.975 178.915 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.493 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 30.4 m -90.22 -53.58 4.4 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.664 0.745 . . . . 0.0 109.51 178.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.562 ' HB2' ' H ' ' B' ' 2' ' ' ASN . 8.6 mm-40 -59.19 -49.23 78.64 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.508 ' HA ' ' HB2' ' B' ' 9' ' ' ALA . 17.6 mt -54.42 -37.23 64.86 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.227 -0.989 . . . . 0.0 108.506 177.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' ILE . . . . . 0.58 ' O ' ' HB2' ' B' ' 11' ' ' ALA . 0.1 OUTLIER -51.7 -51.27 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 177.604 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . 0.506 ' N ' ' CG2' ' B' ' 7' ' ' ILE . 0.0 OUTLIER -64.79 -29.67 70.64 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.539 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . 0.508 ' HB2' ' HA ' ' B' ' 6' ' ' LEU . . . -53.57 -38.19 63.64 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.294 -0.879 . . . . 0.0 108.64 178.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . 0.761 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.1 mp -97.41 -33.72 4.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.056 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.58 ' HB2' ' O ' ' B' ' 7' ' ' ILE . . . -66.23 -12.3 55.33 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 118.579 -1.248 . . . . 0.0 109.197 178.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.453 ' N ' ' O ' ' B' ' 8' ' ' LYS . 23.3 mm100 -113.22 -41.67 3.66 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.345 -0.847 . . . . 0.0 109.525 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.457 ' CB ' ' OG ' ' A' ' 27' ' ' SER . 1.1 m-20 -70.67 -31.12 67.91 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 177.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.761 ' OG1' ' O ' ' B' ' 10' ' ' ILE . 0.1 OUTLIER -106.63 -84.04 0.52 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 177.752 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . 0.592 ' O ' ' C ' ' B' ' 16' ' ' LEU . . . 72.63 -19.49 1.15 Allowed Glycine 0 N--CA 1.5 2.921 0 O-C-N 121.038 -1.039 . . . . 0.0 111.18 177.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 16' ' ' LEU . . . . . 0.796 HD13 ' HB3' ' A' ' 20' ' ' SER . 4.9 mp -18.86 -61.44 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.511 0 CA-C-O 122.031 0.919 . . . . 0.0 111.575 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 17' ' ' THR . . . . . 0.622 HG21 ' O ' ' B' ' 17' ' ' THR . 0.5 OUTLIER -142.59 7.47 1.7 Allowed 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.543 -179.464 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . 0.584 ' O ' ' C ' ' B' ' 19' ' ' VAL . 29.7 mt-30 60.01 23.1 12.25 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 -175.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.783 ' HB ' ' HB ' ' A' ' 19' ' ' VAL . 1.4 p 5.04 -91.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.951 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.972 ' O ' ' N ' ' B' ' 23' ' ' LYS . 0.5 OUTLIER -132.44 24.64 4.45 Favored 'General case' 0 C--N 1.277 -2.578 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 179.236 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.675 ' HA ' ' CE ' ' B' ' 24' ' ' MET . 16.7 m -22.69 -43.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 CA-C-O 122.541 1.162 . . . . 0.0 108.578 -178.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.717 ' N ' ' O ' ' B' ' 20' ' ' SER . 13.7 t -74.91 -39.06 61.65 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.614 177.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . 0.972 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.3 OUTLIER -86.25 -40.94 15.03 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.592 -0.692 . . . . 0.0 111.792 179.869 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' MET . . . . . 0.675 ' CE ' ' HA ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -61.84 -28.19 69.31 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 117.203 -1.799 . . . . 0.0 108.814 179.383 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.685 ' C ' ' CD1' ' B' ' 25' ' ' LEU . 0.1 OUTLIER -80.57 -48.82 12.15 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 118.476 -1.29 . . . . 0.0 108.766 178.122 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . 0.45 ' N ' ' CG ' ' B' ' 25' ' ' LEU . . . -61.07 -29.25 69.63 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 27' ' ' SER . . . . . 0.535 ' O ' ' N ' ' B' ' 31' ' ' ILE . 75.3 m -83.64 -33.12 25.34 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . 0.663 ' O ' HG13 ' B' ' 31' ' ' ILE . 0.7 OUTLIER -55.43 -50.78 68.91 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.913 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . 0.609 ' HG3' ' CE2' ' A' ' 47' ' ' PHE . 3.0 tt0 -65.73 -34.66 78.71 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 176.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . 1.341 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 23.2 ttpp -66.89 -20.85 65.99 Favored 'General case' 0 C--O 1.193 -1.905 0 C-N-CA 119.414 -0.914 . . . . 0.0 108.93 178.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.663 HG13 ' O ' ' B' ' 28' ' ' PHE . 0.9 OUTLIER -108.04 -25.35 3.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 O-C-N 119.728 -1.858 . . . . 0.0 109.604 178.569 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.622 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.1 mm -76.62 -58.29 4.66 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 177.169 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 33' ' ' THR . . . . . 0.413 ' O ' HG12 ' B' ' 36' ' ' VAL . 0.7 OUTLIER -75.54 -29.12 59.3 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.328 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 1.341 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 74.3 mm-40 -81.58 -27.59 34.21 Favored 'General case' 0 C--N 1.315 -0.915 0 O-C-N 120.898 -1.126 . . . . 0.0 110.416 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 35' ' ' THR . . . . . 0.522 HG21 ' CB ' ' B' ' 40' ' ' ASP . 1.8 m -69.73 -57.08 5.56 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 117.715 -1.594 . . . . 0.0 107.485 177.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.702 ' O ' ' HG3' ' B' ' 52' ' ' PRO . 7.1 p -48.43 -40.25 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . 0.689 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . . . -71.34 -32.83 69.01 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.14 178.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . 0.514 ' HA ' HD11 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -68.86 -21.49 64.26 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 176.653 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' B' ' 35' ' ' THR . . . 99.25 30.88 6.41 Favored Glycine 0 C--N 1.298 -1.557 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 177.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . 0.522 ' CB ' HG21 ' B' ' 35' ' ' THR . 0.3 OUTLIER -118.03 151.82 36.74 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.395 -1.062 . . . . 0.0 109.905 179.528 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.416 ' CG ' ' CB ' ' B' ' 51' ' ' LYS . 0.0 OUTLIER -95.59 90.54 5.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.428 -0.795 . . . . 0.0 110.558 -179.299 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . 0.459 ' CG2' ' CD1' ' A' ' 6' ' ' LEU . 10.5 p -75.06 152.89 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.41 -0.806 . . . . 0.0 109.392 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 43' ' ' GLN . . . . . 0.43 ' CB ' ' HA ' ' B' ' 49' ' ' ASN . 18.5 pt20 -157.16 175.94 13.38 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.148 -0.97 . . . . 0.0 111.14 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.693 HD12 ' CB ' ' B' ' 48' ' ' LEU . 24.1 mt -128.51 117.49 21.4 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.625 -0.672 . . . . 0.0 109.356 179.151 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 45' ' ' THR . . . . . 0.506 ' C ' ' O ' ' B' ' 44' ' ' LEU . 0.6 OUTLIER 28.54 -103.37 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.815 -0.553 . . . . 0.0 111.313 179.893 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -133.96 57.97 0.7 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . 0.622 ' HB2' ' HG ' ' B' ' 85' ' ' LEU . 8.0 p90 -157.67 -25.39 0.09 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.081 -1.247 . . . . 0.0 110.987 178.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . 0.804 ' CD1' ' HG2' ' B' ' 80' ' ' LYS . 0.5 OUTLIER -130.78 145.65 52.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.842 -1.161 . . . . 0.0 109.965 178.003 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 49' ' ' ASN . . . . . 0.85 ' O ' ' O ' ' B' ' 79' ' ' VAL 0.265 0.4 OUTLIER -162.18 90.61 0.75 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.333 -0.854 . . . . 0.0 110.874 -177.247 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' B' B ' 50' ' ' ILE . . . . . 0.555 ' CB ' ' HD3' ' B' ' 80' ' ' LYS . 0.3 OUTLIER -83.53 146.14 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.884 -1.135 . . . . 0.0 109.809 -179.428 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . 0.416 ' CB ' ' CG ' ' B' ' 41' ' ' LYS . 1.5 ptmt -167.3 122.79 0.87 Allowed Pre-proline 0 N--CA 1.495 1.807 0 C-N-CA 119.124 -1.03 . . . . 0.0 110.689 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . 0.702 ' HG3' ' O ' ' B' ' 36' ' ' VAL . 55.4 Cg_endo -88.45 146.92 6.19 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.611 1.321 . . . . 0.0 110.841 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.492 HG21 ' O ' ' B' ' 76' ' ' GLY . 26.7 m -132.22 114.39 23.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-O 121.909 0.861 . . . . 0.0 110.065 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -44.26 112.9 0.46 Allowed 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.484 0.659 . . . . 0.0 111.58 -178.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 -145.79 84.35 1.67 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.33 -153.39 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.493 -0.755 . . . . 0.0 110.27 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.504 ' HB1' ' CG1' ' B' ' 71' ' ' ILE . . . -158.37 175.01 14.26 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.04 -1.037 . . . . 0.0 111.004 -179.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 58' ' ' ARG . . . . . 0.777 ' N ' HG12 ' B' ' 71' ' ' ILE . 0.0 OUTLIER -46.62 148.4 1.01 Allowed 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.902 0.858 . . . . 0.0 112.081 -179.53 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . 0.478 ' HB3' ' O ' ' B' ' 58' ' ' ARG . 0.7 OUTLIER 177.54 76.26 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.037 -1.039 . . . . 0.0 109.302 178.385 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . 0.42 ' C ' ' CD2' ' B' ' 61' ' ' PHE . . . -127.16 -101.52 1.15 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 61' ' ' PHE . . . . . 0.812 ' O ' ' N ' ' B' ' 67' ' ' GLU . 4.2 p90 174.97 177.75 0.15 Allowed 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.412 -1.052 . . . . 0.0 110.09 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . 0.533 ' CB ' ' HB3' ' B' ' 68' ' ' ALA . 0.8 OUTLIER -108.69 -61.13 0.04 OUTLIER Pre-proline 0 N--CA 1.502 2.136 0 O-C-N 120.967 -1.083 . . . . 0.0 112.219 -178.392 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . 0.504 ' HD2' ' H ' ' B' ' 62' ' ' ASN . 41.2 Cg_endo -67.54 64.23 0.81 Allowed 'Trans proline' 0 N--CA 1.489 1.213 0 O-C-N 123.402 1.211 . . . . 0.0 110.41 -178.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . 0.766 ' HB3' ' CE1' ' B' ' 61' ' ' PHE . 0.7 OUTLIER -178.74 36.77 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.766 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' B' ' 64' ' ' GLN . 6.1 p 53.58 55.13 8.99 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.795 -0.566 . . . . 0.0 110.607 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . 0.7 ' HB2' ' CE1' ' B' ' 61' ' ' PHE . 0.0 OUTLIER -151.73 -109.53 0.05 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.188 -0.945 . . . . 0.0 110.622 -179.939 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . 0.812 ' N ' ' O ' ' B' ' 61' ' ' PHE . 5.6 pt-20 176.78 97.76 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.996 -1.065 . . . . 0.0 108.434 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . 0.57 ' HA ' ' HA ' ' B' ' 61' ' ' PHE . . . -73.09 100.36 3.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.283 -0.885 . . . . 0.0 109.604 -178.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' B' ' 67' ' ' GLU . 12.6 mt -136.24 -141.68 0.17 Allowed 'General case' 0 C--N 1.291 -1.949 0 C-N-CA 120.146 -0.622 . . . . 0.0 109.563 -179.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . 0.421 ' HB3' ' O ' ' B' ' 69' ' ' LEU . 1.1 pt-20 179.06 161.82 0.75 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.012 -1.055 . . . . 0.0 109.628 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.777 HG12 ' N ' ' B' ' 58' ' ' ARG . 1.1 pp -162.89 -151.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.515 -0.741 . . . . 0.0 109.364 -178.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -126.23 90.45 50.04 Favored Pre-proline 0 C--N 1.303 -1.438 0 O-C-N 121.281 -0.887 . . . . 0.0 112.165 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 73' ' ' PRO . . . . . 0.419 ' HD3' HD13 ' B' ' 71' ' ' ILE . 46.7 Cg_endo -72.55 122.63 8.42 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.826 1.435 . . . . 0.0 109.512 178.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 74' ' ' SER . . . . . 0.497 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 1.4 m -173.62 171.41 3.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.127 -0.983 . . . . 0.0 109.547 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . 0.523 ' N ' ' CD1' ' A' ' 94' ' ' TYR . 0.5 OUTLIER -54.63 173.11 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.122 -0.986 . . . . 0.0 109.226 179.908 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . 0.552 ' O ' ' N ' ' B' ' 78' ' ' SER . . . -114.8 54.48 0.57 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.612 ' HA ' ' HA ' ' B' ' 52' ' ' PRO . 69.9 t -37.75 87.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 122.052 -0.675 . . . . 0.0 111.59 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 78' ' ' SER . . . . . 0.552 ' N ' ' O ' ' B' ' 76' ' ' GLY . 1.8 t -59.45 -129.51 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . 0.85 ' O ' ' O ' ' B' ' 49' ' ' ASN . 17.7 m -140.15 -170.01 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 119.76 -1.838 . . . . 0.0 112.815 178.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . 0.804 ' HG2' ' CD1' ' B' ' 48' ' ' LEU . 0.0 OUTLIER -101.28 -54.26 0.15 Allowed Pre-proline 0 C--N 1.29 -2.004 0 CA-C-N 113.49 -1.686 . . . . 0.0 113.261 -178.489 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 81' ' ' PRO . . . . . 0.682 ' HD2' ' H ' ' B' ' 80' ' ' LYS . 30.5 Cg_endo -52.43 138.88 56.53 Favored 'Trans proline' 0 C--N 1.298 -2.115 0 C-N-CA 121.219 1.279 . . . . 0.0 113.372 -174.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -135.2 -64.41 0.06 OUTLIER Glycine 0 N--CA 1.485 1.95 0 N-CA-C 106.091 -2.803 . . . . 0.0 106.091 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . 0.924 ' O ' ' N ' ' B' ' 85' ' ' LEU . 4.0 tt0 -97.19 46.18 1.04 Allowed 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 175.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 84' ' ' SER . . . . . 1.33 ' O ' ' N ' ' B' ' 86' ' ' LYS . 0.1 OUTLIER 8.18 43.26 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 122.551 1.167 . . . . 0.0 110.489 179.393 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . 1.047 ' C ' ' O ' ' B' ' 84' ' ' SER . 0.5 OUTLIER 21.29 28.85 0.0 OUTLIER 'General case' 0 C--O 1.191 -2.004 0 N-CA-C 103.203 -2.888 . . . . 0.0 103.203 -171.161 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . 1.33 ' N ' ' O ' ' B' ' 84' ' ' SER 0.309 1.2 tttm -49.8 -35.99 24.78 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 176.938 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . 0.415 ' O ' ' HG2' ' B' ' 90' ' ' GLU 0.298 0.0 OUTLIER -66.49 -38.78 88.02 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 111.97 -2.377 . . . . 0.0 106.569 175.64 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.793 ' N ' ' O ' ' B' ' 85' ' ' LEU . . . -79.35 -26.33 42.11 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 118.725 -1.19 . . . . 0.0 108.285 178.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . 0.697 ' N ' ' O ' ' B' ' 85' ' ' LEU . . . -68.48 -45.01 73.54 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.448 -0.782 . . . . 0.0 108.924 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.466 ' HG2' ' N ' ' B' ' 91' ' ' GLY . 3.6 pt-20 -58.58 -28.37 65.49 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 176.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . 0.466 ' N ' ' HG2' ' B' ' 90' ' ' GLU . . . -62.48 -38.84 96.99 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 110.646 -0.981 . . . . 0.0 110.646 178.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . 0.641 ' HB3' ' HA ' ' A' ' 37' ' ' ALA . 0.9 OUTLIER -78.82 18.99 0.54 Allowed 'General case' 0 N--CA 1.505 2.28 0 O-C-N 120.392 -1.652 . . . . 0.0 111.481 -179.557 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' B' ' 92' ' ' LEU . 6.7 mptt 54.51 39.53 31.16 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -178.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . 0.553 ' HB2' ' CB ' ' A' ' 75' ' ' VAL . 1.2 p90 -42.01 -30.42 0.28 Allowed 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.746 -178.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . 0.506 ' CG ' ' CE1' ' B' ' 94' ' ' TYR . 22.7 mt-10 -59.08 -47.37 85.51 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.188 -0.945 . . . . 0.0 108.501 178.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.97 -36.44 67.83 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -74.06 -28.25 61.31 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.31 -35.04 76.28 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.733 -0.604 . . . . 0.0 110.259 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 23.7 mttt . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.299 -179.877 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.503 ' HA ' ' CB ' ' A' ' 5' ' ' GLU . 5.9 mtp . . . . . 0 N--CA 1.496 1.842 0 CA-C-O 120.743 0.306 . . . . 0.0 110.238 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -173.97 -164.24 0.19 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.049 -1.032 . . . . 0.0 111.795 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.526 ' O ' HG13 ' A' ' 7' ' ' ILE . 12.9 mttt -62.52 -3.22 1.34 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.444 -0.785 . . . . 0.0 110.321 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.662 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 87.2 m -124.36 -39.61 2.31 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.201 -0.937 . . . . 0.0 108.871 179.061 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.542 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -63.11 -55.52 24.61 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 178.343 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.543 ' HA ' ' HB3' ' A' ' 9' ' ' ALA . 0.8 OUTLIER -58.71 -29.58 66.78 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.499 -0.881 . . . . 0.0 109.201 178.198 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.662 ' HB ' ' O ' ' A' ' 4' ' ' THR . 1.7 mt -54.25 -56.09 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.49 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.542 ' HE2' ' HA ' ' A' ' 5' ' ' GLU . 12.7 mtmt -58.69 -33.28 69.97 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.23 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.543 ' HB3' ' HA ' ' A' ' 6' ' ' LEU . . . -52.34 -37.97 57.45 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.574 -0.851 . . . . 0.0 109.202 179.106 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.862 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.0 OUTLIER -96.07 -35.1 5.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 178.546 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' A' ' 7' ' ' ILE . . . -61.49 -13.14 18.49 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 118.616 -1.234 . . . . 0.0 108.687 178.467 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -114.75 -43.66 3.12 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.474 -0.766 . . . . 0.0 109.377 178.431 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' A' ' 9' ' ' ALA . 1.1 m-20 -63.99 -39.55 94.37 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 177.501 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.862 ' OG1' ' O ' ' A' ' 10' ' ' ILE . 0.1 OUTLIER -89.45 -78.0 0.37 Allowed 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 177.375 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.9 7.8 67.05 Favored Glycine 0 N--CA 1.5 2.924 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 177.528 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.887 HD12 ' HB3' ' B' ' 20' ' ' SER . 5.1 mp -54.75 -68.1 0.21 Allowed 'General case' 0 C--N 1.293 -1.858 0 O-C-N 121.671 -0.899 . . . . 0.0 110.676 179.821 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.596 ' O ' HG23 ' A' ' 17' ' ' THR . 0.5 OUTLIER -142.94 7.98 1.65 Allowed 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.715 -179.25 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.591 ' O ' ' C ' ' A' ' 19' ' ' VAL . 11.6 mt-30 59.4 24.61 13.23 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 -176.031 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.699 ' HB ' ' HB ' ' B' ' 19' ' ' VAL . 1.6 p -2.72 -91.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.932 -179.064 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.987 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.5 OUTLIER -131.01 24.8 4.96 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 178.21 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.634 ' C ' ' O ' ' A' ' 20' ' ' SER . 1.4 m -20.93 -40.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-O 122.265 1.031 . . . . 0.0 109.409 -178.248 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.77 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.2 OUTLIER -80.42 -34.68 35.99 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.603 177.863 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.987 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -90.13 -38.11 13.75 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.563 -0.71 . . . . 0.0 111.193 179.544 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.622 ' CE ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -66.54 -37.33 84.77 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 117.686 -1.605 . . . . 0.0 108.774 179.455 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.58 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 0.4 OUTLIER -79.89 -37.99 33.58 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 118.054 -1.458 . . . . 0.0 109.425 178.699 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.448 ' HA ' ' CE ' ' A' ' 3' ' ' LYS . . . -66.06 -34.78 78.86 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 177.447 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.608 ' O ' HG13 ' A' ' 31' ' ' ILE . 62.1 m -83.16 -30.46 27.8 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.205 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.606 ' O ' HG13 ' A' ' 31' ' ' ILE . 1.4 t80 -52.49 -49.53 64.53 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.552 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.699 ' HG3' ' CD2' ' B' ' 47' ' ' PHE . 0.2 OUTLIER -67.15 -35.99 80.87 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 177.172 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 1.158 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 9.7 ttmm -64.22 -20.79 66.27 Favored 'General case' 0 C--O 1.19 -2.061 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.413 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.608 HG13 ' O ' ' A' ' 27' ' ' SER . 1.3 pp -105.04 -27.99 3.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 O-C-N 120.297 -1.502 . . . . 0.0 108.951 178.222 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.58 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.2 mm -73.48 -58.69 4.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 177.078 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.439 ' HA ' ' CD2' ' B' ' 85' ' ' LEU . 0.4 OUTLIER -69.43 -33.42 72.94 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.305 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 1.158 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 27.2 mm-40 -76.96 -39.42 50.67 Favored 'General case' 0 N--CA 1.483 1.211 0 O-C-N 121.056 -1.027 . . . . 0.0 111.094 179.104 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.679 ' HA ' ' HB2' ' A' ' 38' ' ' LYS . 21.9 m -57.94 -52.76 64.15 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.074 -1.641 . . . . 0.0 108.488 179.295 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.534 HG11 ' HB3' ' A' ' 52' ' ' PRO . 2.4 t -54.35 -36.56 34.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 177.918 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.567 ' HB2' ' O ' ' B' ' 88' ' ' ALA . . . -87.24 -0.23 56.4 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.432 0.634 . . . . 0.0 109.724 178.668 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.679 ' HB2' ' HA ' ' A' ' 35' ' ' THR . 1.5 mmpt? -102.6 -30.6 10.85 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 177.85 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.11 41.51 0.47 Allowed Glycine 0 C--N 1.303 -1.282 0 C-N-CA 119.945 -1.121 . . . . 0.0 110.842 177.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.502 ' CB ' ' CG2' ' A' ' 35' ' ' THR . 0.4 OUTLIER -147.0 120.27 8.93 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.074 -1.25 . . . . 0.0 110.624 179.526 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.2 mtpt -63.95 86.62 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.53 -0.731 . . . . 0.0 109.608 179.723 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.534 ' HA ' ' HG2' ' B' ' 1' ' ' MET . 11.3 p -68.1 146.75 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.656 -0.653 . . . . 0.0 110.391 -179.479 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.516 ' O ' ' HA ' ' B' ' 2' ' ' ASN . 22.9 mt-30 -144.68 176.48 9.39 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.341 -0.849 . . . . 0.0 110.257 -179.805 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.665 HD11 ' CB ' ' A' ' 48' ' ' LEU . 32.4 mt -125.52 113.9 18.07 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.594 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.541 HG23 ' HG2' ' B' ' 29' ' ' GLU . 0.1 OUTLIER 36.05 -87.53 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.85 -0.531 . . . . 0.0 110.621 -179.229 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -151.59 27.09 0.95 Allowed Glycine 0 N--CA 1.484 1.87 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.34 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.584 ' CE2' ' HG2' ' B' ' 29' ' ' GLU . 4.6 p90 -125.38 -29.92 3.19 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.96 -1.318 . . . . 0.0 112.66 179.84 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.665 ' CB ' HD11 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -122.04 85.71 2.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.445 -1.409 . . . . 0.0 110.692 179.132 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -89.47 85.6 6.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.811 -0.556 . . . . 0.0 109.88 179.605 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.622 ' HA ' HG21 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -75.68 139.37 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.404 -0.81 . . . . 0.0 109.656 -179.57 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.491 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 2.2 ptmt -153.9 125.51 3.7 Favored Pre-proline 0 N--CA 1.496 1.861 0 C-N-CA 118.752 -1.179 . . . . 0.0 110.785 179.674 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.584 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 52.9 Cg_endo -80.97 144.18 14.87 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 O-C-N 123.518 1.272 . . . . 0.0 111.248 -179.768 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.568 ' O ' ' N ' ' A' ' 76' ' ' GLY . 31.6 m -137.98 114.82 11.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-O 121.772 0.796 . . . . 0.0 110.259 179.043 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.5 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . -50.05 137.77 16.82 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.924 0.869 . . . . 0.0 111.898 -178.513 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -162.28 107.46 1.21 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.415 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.692 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 2.8 pt20 -84.32 18.5 2.18 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.143 -0.973 . . . . 0.0 112.264 -178.063 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.692 ' CB ' ' O ' ' A' ' 56' ' ' GLN . . . 150.62 161.7 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.618 -0.677 . . . . 0.0 110.593 178.348 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.575 ' HB2' HG13 ' A' ' 71' ' ' ILE . 5.6 mtt-85 -161.22 141.96 11.24 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.756 -0.59 . . . . 0.0 110.25 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.0 ptpt -163.69 28.31 0.08 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.387 -0.821 . . . . 0.0 110.174 179.724 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -109.93 -91.98 2.15 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 179.681 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.674 ' CD1' ' N ' ' A' ' 62' ' ' ASN . 32.9 t80 -175.08 161.39 2.89 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.391 -1.064 . . . . 0.0 110.584 179.405 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.674 ' N ' ' CD1' ' A' ' 61' ' ' PHE . 0.3 OUTLIER -68.11 -165.2 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.639 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.678 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.512 ' CD ' ' CB ' ' A' ' 62' ' ' ASN . 49.8 Cg_endo -84.1 50.08 2.98 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 N-CA-C 109.524 -0.991 . . . . 0.0 109.524 178.743 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.402 ' HB3' ' H ' ' A' ' 65' ' ' THR . 23.5 tp60 -151.62 -116.23 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.128 -0.983 . . . . 0.0 110.894 -178.991 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.622 ' N ' ' CE1' ' A' ' 61' ' ' PHE . 5.1 t -172.86 -16.99 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.977 -1.077 . . . . 0.0 111.43 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.483 ' N ' ' CZ ' ' A' ' 61' ' ' PHE . 1.2 mt-30 -104.47 -48.5 3.8 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.809 -1.182 . . . . 0.0 111.148 -179.809 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.5 86.33 6.35 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.153 -0.967 . . . . 0.0 110.214 -179.803 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.45 ' HA ' ' CD2' ' A' ' 61' ' ' PHE . . . -89.03 169.94 11.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.555 -0.716 . . . . 0.0 110.668 -179.769 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -162.68 -175.41 4.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.46 -0.775 . . . . 0.0 110.304 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -173.81 58.26 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.279 -0.888 . . . . 0.0 110.392 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.575 HG13 ' HB2' ' A' ' 58' ' ' ARG . 2.8 pp -54.45 -178.93 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.063 -1.023 . . . . 0.0 110.699 -179.946 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.642 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . . . -109.39 -172.09 0.23 Allowed Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.418 -0.801 . . . . 0.0 110.893 -178.254 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.642 ' HD2' ' CB ' ' A' ' 72' ' ' ALA . 39.1 Cg_endo -66.74 107.35 1.26 Allowed 'Trans proline' 0 C--N 1.315 -1.186 0 O-C-N 123.544 1.286 . . . . 0.0 111.184 -179.42 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.44 ' HA ' ' CE2' ' B' ' 94' ' ' TYR . 0.4 OUTLIER 172.27 157.84 0.1 Allowed 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.8 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.66 ' HB ' ' HB2' ' B' ' 94' ' ' TYR . 1.0 OUTLIER -58.64 169.63 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.97 -1.081 . . . . 0.0 109.14 179.735 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 53' ' ' VAL . . . -117.74 86.92 0.42 Allowed Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.141 -1.583 . . . . 0.0 109.141 -179.86 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.584 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 5.0 p -60.75 77.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.676 -0.896 . . . . 0.0 109.834 179.868 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.628 ' O ' ' CG2' ' A' ' 79' ' ' VAL . 0.8 OUTLIER -62.69 178.02 0.48 Allowed 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.502 -0.879 . . . . 0.0 109.565 179.775 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.628 ' CG2' ' O ' ' A' ' 78' ' ' SER . 2.7 t -176.78 173.56 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.709 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.529 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 10.9 pttp 177.53 169.33 0.47 Allowed Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.081 -1.012 . . . . 0.0 110.027 176.503 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.485 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 55.1 Cg_endo -97.47 141.83 0.61 Allowed 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 122.505 2.136 . . . . 0.0 110.753 177.757 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.528 ' HA3' ' HA ' ' A' ' 47' ' ' PHE . . . -97.63 -155.09 29.87 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 108.432 -1.867 . . . . 0.0 108.432 178.424 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.567 ' HA ' ' HB2' ' A' ' 86' ' ' LYS . 4.7 pm0 -93.77 -15.37 25.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.126 -1.22 . . . . 0.0 110.347 179.358 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.35 -34.18 56.53 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.309 -0.87 . . . . 0.0 109.574 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.516 ' CG ' ' HB2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -88.17 -25.36 22.98 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 119.68 -0.808 . . . . 0.0 108.855 179.005 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.567 ' HB2' ' HA ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -76.19 -35.71 58.98 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.554 -0.858 . . . . 0.0 109.184 179.647 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.7 tttp -72.82 -39.83 66.31 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 177.166 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.787 ' O ' ' HB1' ' B' ' 37' ' ' ALA . . . -65.08 -37.0 86.11 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 176.243 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.529 ' N ' ' HB3' ' B' ' 37' ' ' ALA . . . -56.71 -38.04 71.77 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.758 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.15 -33.06 62.6 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 176.391 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.513 ' C ' ' H ' ' A' ' 93' ' ' LYS . . . -59.82 -44.44 97.04 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 177.805 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.617 ' O ' ' CD1' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -69.42 15.44 0.07 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.71 -1.465 . . . . 0.0 110.422 179.397 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.602 ' HB3' ' O ' ' A' ' 92' ' ' LEU . 0.8 OUTLIER 65.37 73.77 0.39 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 -177.086 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.733 ' O ' ' N ' ' A' ' 97' ' ' PHE . 47.7 t80 -47.39 -58.19 4.44 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 116.481 -2.088 . . . . 0.0 106.538 179.817 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.928 ' O ' ' N ' ' A' ' 98' ' ' ALA . 56.2 mm-40 8.48 39.36 0.0 OUTLIER 'General case' 0 CA--C 1.484 -1.588 0 N-CA-C 102.3 -3.222 . . . . 0.0 102.3 179.295 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 1.166 ' O ' ' N ' ' A' ' 98' ' ' ALA 0.287 0.1 OUTLIER 19.95 42.17 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 113.222 -1.808 . . . . 0.0 106.741 -174.193 . . . . . . . . 4 4 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.823 ' C ' ' O ' ' A' ' 96' ' ' ASP . 5.2 p90 23.44 27.63 0.0 OUTLIER 'General case' 0 CA--C 1.487 -1.447 0 N-CA-C 102.127 -3.286 . . . . 0.0 102.127 -168.824 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 1.166 ' N ' ' O ' ' A' ' 96' ' ' ASP 0.281 . . -61.3 -26.88 68.08 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 109.427 -3.533 . . . . 0.0 108.629 179.982 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.127 179.855 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.534 ' HG2' ' HA ' ' A' ' 42' ' ' VAL . 4.2 ptm . . . . . 0 N--CA 1.496 1.832 0 CA-C-O 121.307 0.575 . . . . 0.0 110.833 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . 0.516 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 16.4 p-10 -176.15 -140.81 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.706 -0.797 . . . . 0.0 111.238 178.044 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.415 ' HG3' ' HB ' ' A' ' 45' ' ' THR . 0.1 OUTLIER -57.56 -0.36 0.07 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.003 -1.061 . . . . 0.0 110.916 -179.62 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.755 ' O ' HG13 ' B' ' 7' ' ' ILE . 4.2 m -120.16 -69.47 0.84 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.957 -1.089 . . . . 0.0 110.376 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.595 ' O ' ' HG3' ' B' ' 8' ' ' LYS . 1.7 mm-40 -48.82 -36.17 16.17 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.062 -1.024 . . . . 0.0 109.331 -179.865 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.441 ' HA ' ' CB ' ' B' ' 9' ' ' ALA . 87.0 mt -69.36 -28.96 66.66 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 118.869 -1.133 . . . . 0.0 109.988 178.608 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 7' ' ' ILE . . . . . 0.755 HG13 ' O ' ' B' ' 4' ' ' THR . 1.5 pp -63.76 -45.91 95.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.521 -1.362 . . . . 0.0 107.972 178.929 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . 0.675 ' HA ' ' HB2' ' B' ' 11' ' ' ALA . 0.0 OUTLIER -74.23 -20.44 60.17 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.39 -0.924 . . . . 0.0 108.562 177.522 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . 0.441 ' CB ' ' HA ' ' B' ' 6' ' ' LEU . . . -69.15 -33.57 73.63 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.149 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . 0.873 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.0 OUTLIER -94.37 -34.5 5.63 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.4 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 178.3 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.675 ' HB2' ' HA ' ' B' ' 8' ' ' LYS . . . -56.91 -25.49 57.4 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.285 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 11.6 mm-40 -92.52 -45.03 8.32 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.441 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -62.34 -25.26 67.8 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 177.061 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.873 ' OG1' ' O ' ' B' ' 10' ' ' ILE . 14.8 p -91.42 -74.39 0.51 Allowed 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.119 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 59.15 17.24 36.9 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.575 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 16' ' ' LEU . . . . . 0.705 HD12 ' HB ' ' B' ' 14' ' ' THR . 3.4 mp -83.44 -61.53 1.82 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.358 -1.084 . . . . 0.0 108.878 179.053 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 17' ' ' THR . . . . . 0.519 ' HB ' HG22 ' A' ' 17' ' ' THR . 0.6 OUTLIER -139.84 2.84 2.0 Allowed 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.732 179.909 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . 0.623 ' O ' ' C ' ' B' ' 19' ' ' VAL . 17.6 mt-30 56.64 28.14 13.61 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 -176.836 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.699 ' HB ' ' HB ' ' A' ' 19' ' ' VAL . 1.7 p -6.16 -100.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.765 -179.377 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.899 ' O ' ' N ' ' B' ' 23' ' ' LYS . 0.5 OUTLIER -133.92 24.12 3.93 Favored 'General case' 0 C--N 1.28 -2.445 0 N-CA-C 105.434 -2.062 . . . . 0.0 105.434 177.154 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.65 ' HA ' ' HE1' ' B' ' 24' ' ' MET . 16.6 m -18.43 -37.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 CA-C-O 122.212 1.006 . . . . 0.0 110.513 -177.922 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.844 ' N ' ' O ' ' B' ' 20' ' ' SER . 5.2 t -77.49 -43.13 33.25 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.146 -0.934 . . . . 0.0 108.893 178.496 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . 0.899 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.0 OUTLIER -92.3 -19.21 22.39 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.724 -0.61 . . . . 0.0 109.566 178.474 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 24' ' ' MET . . . . . 0.728 ' N ' ' OG ' ' B' ' 20' ' ' SER 0.258 3.1 tmm? -68.57 -44.86 73.54 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.3 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.544 ' HA ' ' HB3' ' B' ' 28' ' ' PHE . 8.4 mt -76.83 -44.14 33.55 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 177.005 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . 0.475 ' HB3' ' HA ' ' B' ' 23' ' ' LYS . . . -54.74 -33.48 61.21 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 177.567 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 27' ' ' SER . . . . . 0.528 ' O ' ' N ' ' B' ' 31' ' ' ILE . 10.4 m -75.27 -40.97 58.24 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.465 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . 0.729 ' HA ' ' CG1' ' B' ' 31' ' ' ILE . 0.0 OUTLIER -64.39 -31.38 72.57 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.548 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . 0.592 ' HG3' ' CE2' ' B' ' 28' ' ' PHE . 1.5 mt-10 -84.4 -32.3 24.22 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 178.221 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . 0.747 ' O ' ' CG ' ' B' ' 34' ' ' GLU . 24.8 tttt -71.4 -29.02 64.43 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 176.332 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.729 ' CG1' ' HA ' ' B' ' 28' ' ' PHE . 1.3 pp -93.89 -31.29 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.224 -0.922 . . . . 0.0 109.749 178.955 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.648 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 3.4 mm -61.65 -55.22 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 177.447 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 33' ' ' THR . . . . . 0.437 ' OG1' ' HG ' ' A' ' 85' ' ' LEU . 0.4 OUTLIER -64.52 -40.32 95.4 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.429 179.46 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.793 ' O ' ' N ' ' B' ' 38' ' ' LYS . 17.8 mm-40 -68.92 -44.14 73.73 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.77 -0.581 . . . . 0.0 110.959 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 35' ' ' THR . . . . . 0.467 ' HA ' ' CB ' ' B' ' 38' ' ' LYS . 93.0 m -54.0 -52.12 61.76 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.798 -1.189 . . . . 0.0 108.998 179.876 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.577 ' HA ' ' HG3' ' B' ' 52' ' ' PRO . 0.4 OUTLIER -50.9 -37.26 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.145 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . 0.787 ' HB1' ' O ' ' A' ' 88' ' ' ALA . . . -96.32 0.77 51.21 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.774 0.797 . . . . 0.0 110.108 179.043 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . 0.793 ' N ' ' O ' ' B' ' 34' ' ' GLU . 0.0 OUTLIER -95.8 -22.84 17.24 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 176.906 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.49 44.87 0.69 Allowed Glycine 0 C--N 1.304 -1.22 0 C-N-CA 120.35 -0.928 . . . . 0.0 110.961 177.631 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . 0.417 ' CB ' HG23 ' B' ' 35' ' ' THR . 0.4 OUTLIER -155.41 166.14 34.47 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.005 -1.291 . . . . 0.0 111.399 179.6 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.422 ' HG2' ' HA ' ' B' ' 51' ' ' LYS . 11.0 mttt -121.48 112.86 19.04 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.273 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . 0.462 HG22 ' CG1' ' B' ' 50' ' ' ILE . 0.8 OUTLIER -79.47 147.15 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 C-N-CA 118.664 -1.214 . . . . 0.0 110.064 -178.602 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 43' ' ' GLN . . . . . 0.459 ' HA ' ' HA ' ' B' ' 49' ' ' ASN . 1.6 mt-30 -123.66 85.85 2.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.485 -0.759 . . . . 0.0 109.259 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.537 ' HB2' ' CB ' ' B' ' 48' ' ' LEU . 12.6 mt -58.96 90.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.473 -0.767 . . . . 0.0 110.727 -179.219 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 45' ' ' THR . . . . . 0.531 HG22 ' HD2' ' B' ' 47' ' ' PHE . 2.2 t 35.93 26.98 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 179.34 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . 97.91 -25.39 27.71 Favored Glycine 0 N--CA 1.494 2.563 0 C-N-CA 119.841 -1.171 . . . . 0.0 112.859 177.44 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . 0.699 ' CD2' ' HG3' ' A' ' 29' ' ' GLU . 1.4 p90 -86.44 -28.43 23.51 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 119.873 1.836 . . . . 0.0 112.031 -178.577 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . 0.611 ' HG ' ' CE1' ' B' ' 47' ' ' PHE . 5.5 mt -129.78 94.06 3.65 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.6 -1.313 . . . . 0.0 110.382 177.786 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 49' ' ' ASN . . . . . 0.476 ' O ' ' HA ' ' B' ' 79' ' ' VAL . 0.6 OUTLIER -105.0 95.26 5.73 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.533 -0.729 . . . . 0.0 110.156 -179.695 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 50' ' ' ILE . . . . . 0.462 ' CG1' HG22 ' B' ' 42' ' ' VAL . 2.0 pp -86.83 146.63 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.483 -0.761 . . . . 0.0 110.684 -179.765 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' B' ' 51' ' ' LYS . 2.6 ptmt -155.11 128.79 4.5 Favored Pre-proline 0 N--CA 1.496 1.848 0 C-N-CA 119.092 -1.043 . . . . 0.0 110.434 179.044 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . 0.577 ' HG3' ' HA ' ' B' ' 36' ' ' VAL . 57.1 Cg_endo -84.72 140.99 8.41 Favored 'Trans proline' 0 C--N 1.315 -1.205 0 O-C-N 123.352 1.185 . . . . 0.0 110.955 -179.404 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.567 HG23 ' O ' ' B' ' 76' ' ' GLY . 24.8 m -144.61 116.25 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-O 121.767 0.794 . . . . 0.0 111.281 179.18 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.716 ' HB2' ' CA ' ' A' ' 96' ' ' ASP . . . -64.68 117.69 7.82 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.807 -0.558 . . . . 0.0 111.332 -179.231 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . 0.509 ' HB3' ' O ' ' B' ' 54' ' ' ALA . 0.7 OUTLIER 166.3 85.49 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.356 0 O-C-N 121.58 -0.7 . . . . 0.0 110.214 178.955 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . 0.692 ' O ' ' HB3' ' B' ' 73' ' ' PRO . 6.5 mt-30 -157.59 178.31 10.42 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.076 -1.015 . . . . 0.0 111.863 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.654 ' CB ' ' O ' ' B' ' 56' ' ' GLN . . . 139.18 126.78 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.599 0 C-N-CA 123.484 0.713 . . . . 0.0 109.16 179.252 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 58' ' ' ARG . . . . . 0.624 ' HB2' ' CG1' ' B' ' 71' ' ' ILE . 0.0 OUTLIER -97.89 -166.58 1.4 Allowed 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 122.002 0.906 . . . . 0.0 111.933 -178.47 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . 0.407 ' C ' ' HA ' ' B' ' 69' ' ' LEU . 6.3 ttpt 177.68 74.04 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.48 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . 0.632 ' N ' ' HA ' ' B' ' 69' ' ' LEU . . . -133.19 -99.57 0.7 Allowed Glycine 0 N--CA 1.496 2.635 0 C-N-CA 120.381 -0.914 . . . . 0.0 111.192 -178.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 61' ' ' PHE . . . . . 0.809 ' C ' ' HA ' ' B' ' 68' ' ' ALA . 24.7 p90 -149.15 161.05 42.76 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.022 -1.281 . . . . 0.0 112.683 -178.097 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . 0.628 ' H ' ' CD ' ' B' ' 63' ' ' PRO . 11.3 p30 -124.73 -23.41 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.577 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . 0.628 ' CD ' ' H ' ' B' ' 62' ' ' ASN . 41.5 Cg_endo -71.11 -31.17 15.14 Favored 'Trans proline' 0 N--CA 1.482 0.819 0 N-CA-C 107.603 -1.73 . . . . 0.0 107.603 179.256 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . 0.697 ' HB3' ' CE1' ' B' ' 61' ' ' PHE . 0.0 OUTLIER -80.17 -9.1 59.7 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.032 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' B' ' 65' ' ' THR . 1.8 p 59.16 85.28 0.1 Allowed 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 178.575 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . 0.61 ' HB2' ' CE1' ' B' ' 61' ' ' PHE . 0.0 OUTLIER 179.78 -16.06 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.871 -1.143 . . . . 0.0 113.276 177.682 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . 0.652 ' O ' ' N ' ' B' ' 61' ' ' PHE . 1.6 pt-20 170.75 65.2 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.419 0 O-C-N 120.532 -1.355 . . . . 0.0 110.297 179.887 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . 0.809 ' HA ' ' C ' ' B' ' 61' ' ' PHE . . . -39.51 158.83 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 121.816 0.817 . . . . 0.0 113.038 -178.632 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.712 ' CD1' ' H ' ' B' ' 69' ' ' LEU . 0.0 OUTLIER -73.55 22.47 0.08 Allowed 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.637 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' B' ' 69' ' ' LEU . 1.9 tp10 -178.1 33.4 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.607 -1.308 . . . . 0.0 111.937 179.376 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.624 ' CG1' ' HB2' ' B' ' 58' ' ' ARG . 1.2 pp -62.19 -161.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.794 -1.191 . . . . 0.0 108.546 178.637 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . 0.449 ' CB ' ' HD2' ' B' ' 73' ' ' PRO . . . -112.44 170.05 5.7 Favored Pre-proline 0 C--N 1.295 -1.77 0 C-N-CA 118.897 -1.121 . . . . 0.0 112.345 -178.731 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 73' ' ' PRO . . . . . 0.692 ' HB3' ' O ' ' B' ' 56' ' ' GLN . 53.5 Cg_endo -74.72 -153.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.292 -2.406 0 O-C-N 125.178 2.146 . . . . 0.0 109.61 178.916 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 74' ' ' SER . . . . . 0.458 ' CB ' ' O ' ' B' ' 73' ' ' PRO . 5.4 t 162.79 144.44 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . 0.58 ' N ' ' CD1' ' A' ' 94' ' ' TYR . 0.4 OUTLIER -53.26 173.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 120.682 -1.261 . . . . 0.0 109.714 -179.452 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . 0.624 ' O ' ' N ' ' B' ' 78' ' ' SER . . . -114.42 68.8 0.25 Allowed Glycine 0 N--CA 1.487 2.098 0 C-N-CA 119.403 -1.38 . . . . 0.0 109.656 -179.382 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.574 ' HA ' ' HA ' ' B' ' 52' ' ' PRO . 2.5 p -58.09 76.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.453 -1.027 . . . . 0.0 109.428 179.521 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 78' ' ' SER . . . . . 0.624 ' N ' ' O ' ' B' ' 76' ' ' GLY . 6.5 t -76.95 177.17 7.95 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.897 0.856 . . . . 0.0 110.789 -179.446 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' B' ' 49' ' ' ASN . 4.8 p 177.23 177.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . 0.433 ' N ' ' CG2' ' B' ' 79' ' ' VAL . 0.1 OUTLIER -172.48 173.51 1.48 Allowed Pre-proline 0 N--CA 1.485 1.303 0 O-C-N 120.64 -1.288 . . . . 0.0 110.642 178.131 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 81' ' ' PRO . . . . . 0.403 ' CD ' ' HB2' ' B' ' 80' ' ' LYS . 53.4 Cg_endo -97.72 133.1 0.32 Allowed 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 122.503 2.136 . . . . 0.0 110.504 178.801 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . 0.504 ' HA3' ' HA ' ' B' ' 47' ' ' PHE . . . -89.76 -164.37 39.98 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 108.41 -1.876 . . . . 0.0 108.41 178.669 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -83.87 -18.25 38.14 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.039 -1.271 . . . . 0.0 110.385 179.805 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 1.1 m -52.44 -38.18 58.59 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.23 -0.918 . . . . 0.0 109.434 179.656 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . 0.451 ' CD2' ' CD1' ' B' ' 47' ' ' PHE . 0.4 OUTLIER -78.71 -33.03 47.11 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.17 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.04 -45.57 56.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.66 -0.65 . . . . 0.0 110.563 -179.32 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.74 -39.31 93.69 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 178.443 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.567 ' O ' ' HB2' ' A' ' 37' ' ' ALA . . . -66.83 -33.68 76.15 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 176.822 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . 0.438 ' HB3' ' CG1' ' A' ' 75' ' ' VAL . . . -56.44 -44.83 80.84 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.019 179.17 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -53.81 -32.86 54.18 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 177.114 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -64.71 -35.82 92.38 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 178.447 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . 0.524 ' HB3' ' HA ' ' A' ' 37' ' ' ALA . 0.4 OUTLIER -75.58 12.01 1.14 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.689 -1.477 . . . . 0.0 111.111 -179.768 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' B' ' 92' ' ' LEU . 0.0 OUTLIER 61.01 40.04 15.72 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -177.639 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . 0.66 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 0.1 OUTLIER -37.79 -38.49 0.29 Allowed 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.167 -179.055 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . 0.413 ' N ' ' CG ' ' B' ' 94' ' ' TYR . 14.6 pt-20 -61.74 -42.93 99.61 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.31 -0.869 . . . . 0.0 109.885 179.77 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -58.96 -33.71 70.96 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.57 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.88 -26.81 62.49 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.463 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.75 -63.46 1.08 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.588 -0.695 . . . . 0.0 110.194 179.834 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 3.5 mtmp? . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 118.024 -0.988 . . . . 0.0 110.196 179.924 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.491 ' HG2' ' HA ' ' B' ' 42' ' ' VAL . 1.5 ptm . . . . . 0 N--CA 1.496 1.841 0 CA-C-O 121.297 0.57 . . . . 0.0 110.739 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.419 ' HB3' ' O ' ' A' ' 1' ' ' MET . 34.5 p-10 -175.38 -148.08 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 119.714 -0.795 . . . . 0.0 111.359 178.648 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.418 ' O ' ' CG2' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -53.83 -6.88 0.1 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.178 -0.952 . . . . 0.0 111.091 -179.521 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.627 ' O ' ' CG1' ' A' ' 7' ' ' ILE . 32.9 m -118.49 -64.1 1.33 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.953 -1.092 . . . . 0.0 110.613 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.664 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 5.0 mt-10 -48.79 -40.32 28.58 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.846 -1.159 . . . . 0.0 109.314 -179.706 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.407 ' HB2' ' O ' ' A' ' 2' ' ' ASN . 74.0 mt -62.66 -33.88 75.95 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.456 178.19 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.657 HG13 ' N ' ' A' ' 8' ' ' LYS . 0.9 OUTLIER -58.78 -38.03 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 178.771 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.752 ' HA ' ' HB1' ' A' ' 11' ' ' ALA . 31.4 mtmt -68.95 -34.29 75.1 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.17 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 13' ' ' ASP . . . -54.37 -40.4 68.09 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.286 179.163 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.852 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.4 mp -92.24 -29.23 4.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 178.247 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.752 ' HB1' ' HA ' ' A' ' 8' ' ' LYS . . . -68.07 -9.14 43.86 Favored 'General case' 0 C--N 1.289 -2.033 0 O-C-N 120.579 -1.326 . . . . 0.0 108.723 178.596 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -121.51 -41.46 2.49 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.376 -0.828 . . . . 0.0 110.102 179.202 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' A' ' 9' ' ' ALA . 62.8 m-20 -68.62 -24.5 64.57 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 177.471 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.852 ' OG1' ' O ' ' A' ' 10' ' ' ILE 0.274 0.2 OUTLIER -106.96 -81.85 0.55 Allowed 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 178.752 . . . . . . . . 4 4 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.51 6.43 66.07 Favored Glycine 0 N--CA 1.501 3.02 0 O-C-N 121.07 -1.019 . . . . 0.0 110.61 177.679 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.696 HD13 ' HB2' ' B' ' 20' ' ' SER . 5.0 mp -51.81 -70.17 0.09 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.67 -0.9 . . . . 0.0 110.514 179.812 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.475 ' O ' HG21 ' A' ' 17' ' ' THR . 0.6 OUTLIER -132.82 8.57 4.14 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.825 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.588 ' O ' ' C ' ' A' ' 19' ' ' VAL . 2.3 mt-30 57.04 26.98 12.62 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 -176.179 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.619 ' CG2' ' CD1' ' B' ' 16' ' ' LEU . 0.6 OUTLIER -10.17 -94.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.626 -179.034 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.931 ' O ' ' N ' ' A' ' 23' ' ' LYS . 2.4 m -134.57 23.29 3.69 Favored 'General case' 0 C--N 1.28 -2.425 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 178.181 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.669 ' C ' ' O ' ' A' ' 20' ' ' SER . 31.5 m -18.16 -40.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 CA-C-O 122.418 1.104 . . . . 0.0 109.279 -177.376 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.867 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.4 OUTLIER -86.43 -38.03 17.75 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.088 178.142 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.931 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.9 OUTLIER -85.21 -31.52 23.13 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.535 -0.728 . . . . 0.0 110.895 179.448 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.533 ' CE ' ' HG ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -76.46 -43.77 38.5 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 118.217 -1.393 . . . . 0.0 109.315 179.249 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.533 ' HG ' ' CE ' ' A' ' 24' ' ' MET . 7.0 mt -68.5 -48.54 64.14 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 117.743 -1.583 . . . . 0.0 108.293 177.888 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.435 ' CB ' ' O ' ' A' ' 22' ' ' SER . . . -55.76 -33.14 64.05 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 177.558 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.532 ' O ' ' CG1' ' A' ' 31' ' ' ILE . 7.5 t -73.34 -36.81 66.24 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 177.488 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.714 ' O ' ' CG1' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -64.19 -33.74 76.49 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.535 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.566 ' HG3' ' CD2' ' A' ' 28' ' ' PHE . 2.1 mt-10 -83.1 -31.44 27.27 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.175 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.767 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 6.7 tttm -72.12 -27.62 62.74 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 176.588 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.709 ' CG1' ' HA ' ' A' ' 28' ' ' PHE . 1.8 pp -95.99 -31.71 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.35 -0.844 . . . . 0.0 109.751 179.009 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.714 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 2.6 mm -63.28 -52.89 52.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.829 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.466 ' HA ' HD23 ' B' ' 85' ' ' LEU . 0.4 OUTLIER -68.34 -38.82 81.85 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.556 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.767 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 34.0 mm-40 -71.94 -34.3 68.91 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.413 -0.805 . . . . 0.0 110.832 179.169 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.594 ' N ' ' O ' ' A' ' 31' ' ' ILE . 3.2 m -59.98 -54.16 49.31 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.997 -1.064 . . . . 0.0 108.563 179.894 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.447 ' HB ' ' CD2' ' B' ' 85' ' ' LEU . 1.0 OUTLIER -54.04 -35.04 27.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 177.755 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.67 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -78.51 -7.15 57.18 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.736 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.489 ' N ' ' O ' ' A' ' 35' ' ' THR . 1.3 ttmt -102.21 -25.28 13.75 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 178.122 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 35' ' ' THR . . . 104.8 41.83 1.92 Allowed Glycine 0 C--N 1.3 -1.417 0 C-N-CA 120.218 -0.991 . . . . 0.0 110.699 178.067 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.456 ' CB ' HG22 ' A' ' 35' ' ' THR . 0.3 OUTLIER -128.67 154.27 46.45 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.116 -1.226 . . . . 0.0 110.429 179.449 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 43.1 tttt -109.01 98.38 7.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.382 -0.824 . . . . 0.0 110.0 -179.738 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.499 ' CG2' ' HB ' ' A' ' 50' ' ' ILE . 19.3 m -84.93 147.41 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.451 -0.781 . . . . 0.0 110.414 -179.602 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.431 ' O ' ' HA ' ' B' ' 2' ' ' ASN . 1.7 tt0 -136.57 107.91 6.86 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 121.296 -0.878 . . . . 0.0 110.134 -179.131 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.62 HD12 ' CB ' ' A' ' 48' ' ' LEU . 20.3 mt -66.64 99.13 0.57 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.039 -1.038 . . . . 0.0 109.875 179.51 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.547 HG22 ' HG2' ' B' ' 29' ' ' GLU . 1.7 t 37.17 26.67 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.782 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . 94.44 -0.24 65.58 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 120.06 -1.067 . . . . 0.0 112.487 177.664 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.561 ' CE1' ' HG ' ' A' ' 48' ' ' LEU . 0.8 OUTLIER -104.23 -31.38 9.62 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 120.002 1.901 . . . . 0.0 111.96 -179.919 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.62 ' CB ' HD12 ' A' ' 44' ' ' LEU . 1.0 OUTLIER -123.04 93.82 4.07 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.706 -1.246 . . . . 0.0 109.779 178.115 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 43' ' ' GLN . 6.1 t-20 -96.08 75.14 3.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.702 -0.624 . . . . 0.0 111.371 -179.114 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.515 ' HA ' ' HB ' ' A' ' 79' ' ' VAL . 2.6 mm -63.19 129.71 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.202 -0.936 . . . . 0.0 109.031 178.798 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 78' ' ' SER . 0.0 OUTLIER -144.05 127.26 8.81 Favored Pre-proline 0 N--CA 1.492 1.656 0 C-N-CA 118.712 -1.195 . . . . 0.0 109.704 179.491 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.577 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 54.3 Cg_endo -76.71 142.13 22.56 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.384 1.202 . . . . 0.0 111.162 -179.277 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.536 ' HB ' ' HA3' ' A' ' 76' ' ' GLY . 1.7 t -122.08 -142.84 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.588 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.498 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . 177.42 118.36 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.291 -0.88 . . . . 0.0 110.158 179.693 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.49 88.86 0.23 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.433 -0.792 . . . . 0.0 109.764 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.438 ' HA ' ' OH ' ' B' ' 94' ' ' TYR . 1.3 mt-30 -58.68 128.07 35.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.402 -0.811 . . . . 0.0 110.247 -179.752 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.592 ' CB ' HD12 ' A' ' 71' ' ' ILE . . . -56.73 -169.4 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.807 0.813 . . . . 0.0 110.269 179.645 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.665 ' CB ' HG21 ' A' ' 71' ' ' ILE 0.251 4.2 mpt_? -57.12 -135.62 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.891 0 CA-C-O 122.576 1.179 . . . . 0.0 111.471 179.701 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.662 ' CA ' ' H ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER 170.4 61.05 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 177.622 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -45.05 115.4 1.44 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 -179.108 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.803 ' O ' ' HB2' ' A' ' 62' ' ' ASN 0.26 0.6 OUTLIER -78.06 6.1 8.61 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 118.231 -1.387 . . . . 0.0 112.075 -178.208 . . . . . . . . 4 4 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.803 ' HB2' ' O ' ' A' ' 61' ' ' PHE . 6.9 t30 161.21 -156.65 0.0 OUTLIER Pre-proline 0 C--N 1.28 -2.446 0 N-CA-C 104.764 -2.31 . . . . 0.0 104.764 -177.326 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.543 ' HD2' ' HB3' ' A' ' 62' ' ' ASN . 45.0 Cg_endo -78.12 35.91 0.55 Allowed 'Trans proline' 0 C--N 1.305 -1.715 0 N-CA-C 108.644 -1.329 . . . . 0.0 108.644 177.247 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.738 ' CB ' ' HE1' ' A' ' 61' ' ' PHE . 0.1 OUTLIER -158.79 -118.29 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 O-C-N 121.259 -0.9 . . . . 0.0 110.928 -178.582 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.479 ' N ' ' CE1' ' A' ' 61' ' ' PHE . 0.2 OUTLIER -174.27 101.7 0.1 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.001 -1.062 . . . . 0.0 110.0 -179.458 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.495 ' HB2' ' CE2' ' A' ' 61' ' ' PHE . 0.8 OUTLIER -151.19 -69.67 0.17 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.439 -0.788 . . . . 0.0 109.247 179.831 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.636 ' C ' ' HB2' ' A' ' 61' ' ' PHE . 7.7 mt-10 -101.39 37.34 1.81 Allowed 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 177.777 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.609 ' N ' ' CB ' ' A' ' 61' ' ' PHE . . . -19.77 137.8 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -177.199 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.535 ' N ' ' O ' ' A' ' 59' ' ' LYS . 1.1 pp -174.5 44.28 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.662 ' H ' ' CA ' ' A' ' 59' ' ' LYS . 2.4 tm-20 -169.75 112.15 0.47 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 119.461 -2.024 . . . . 0.0 113.105 178.953 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.665 HG21 ' CB ' ' A' ' 58' ' ' ARG 0.25 0.5 OUTLIER -168.49 -157.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-O 121.686 0.755 . . . . 0.0 111.191 -179.247 . . . . . . . . 4 4 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -113.51 74.9 2.33 Favored Pre-proline 0 C--N 1.31 -1.14 0 O-C-N 121.756 -0.59 . . . . 0.0 111.327 -179.605 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.53 121.75 8.26 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.741 1.39 . . . . 0.0 109.972 178.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.524 ' N ' ' CZ ' ' B' ' 94' ' ' TYR . 11.0 p -166.41 147.07 6.24 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.2 -0.938 . . . . 0.0 109.942 -179.879 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.539 ' N ' ' CD1' ' B' ' 94' ' ' TYR . 0.5 OUTLIER -53.87 175.18 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.143 -0.973 . . . . 0.0 108.38 179.738 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.618 ' O ' ' N ' ' A' ' 78' ' ' SER . . . -110.91 38.67 3.19 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 118.569 -1.777 . . . . 0.0 110.226 -178.765 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.644 HG21 ' HB3' ' B' ' 85' ' ' LEU . 3.0 p -27.78 87.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 CA-C-O 121.924 0.868 . . . . 0.0 110.58 179.781 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.618 ' N ' ' O ' ' A' ' 76' ' ' GLY . 0.1 OUTLIER -87.81 175.52 7.8 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.963 -179.168 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.515 ' HB ' ' HA ' ' A' ' 50' ' ' ILE . 7.2 p 175.57 177.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.845 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -177.15 171.71 0.89 Allowed Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.001 -1.062 . . . . 0.0 110.185 176.948 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -96.91 128.8 0.3 Allowed 'Trans proline' 0 C--N 1.302 -1.894 0 C-N-CA 122.414 2.076 . . . . 0.0 110.691 178.639 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.495 ' HA3' ' HA ' ' A' ' 47' ' ' PHE . . . -87.75 173.18 43.28 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 178.749 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -62.19 -17.92 59.52 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.086 -1.244 . . . . 0.0 110.591 -179.846 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.506 ' HB2' ' HB3' ' A' ' 47' ' ' PHE . 0.8 OUTLIER -53.74 -41.15 66.77 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.177 -0.952 . . . . 0.0 109.506 179.802 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.533 ' O ' ' HB2' ' A' ' 89' ' ' ALA . 1.0 OUTLIER -76.76 -26.79 54.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.448 -0.783 . . . . 0.0 109.116 179.111 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.552 ' HA ' ' HB2' ' A' ' 89' ' ' ALA . 0.7 OUTLIER -81.03 -41.27 22.93 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.665 -0.647 . . . . 0.0 110.63 -179.522 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.67 -40.92 98.02 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 178.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.656 ' O ' ' HB2' ' B' ' 37' ' ' ALA . . . -65.29 -37.39 87.02 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 176.3 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.552 ' HB2' ' HA ' ' A' ' 86' ' ' LYS . . . -56.66 -40.33 75.31 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.467 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -55.5 -31.75 62.3 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 177.096 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.418 ' C ' ' H ' ' A' ' 93' ' ' LYS . . . -68.56 -34.04 77.97 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 178.643 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.573 ' HB3' ' HA ' ' B' ' 37' ' ' ALA . 0.6 OUTLIER -66.27 5.84 0.49 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.648 -1.501 . . . . 0.0 111.305 -179.806 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.423 ' CB ' ' O ' ' A' ' 92' ' ' LEU . 0.4 OUTLIER 65.36 39.49 5.23 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 -177.388 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.474 ' CD1' ' N ' ' B' ' 75' ' ' VAL . 0.0 OUTLIER -43.54 -31.49 0.74 Allowed 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.154 -179.079 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -57.91 -41.68 83.15 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.279 -0.888 . . . . 0.0 108.944 179.151 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -63.58 -36.0 82.37 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 177.515 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -71.05 -25.47 62.65 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.139 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.14 -70.39 0.44 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.662 -0.649 . . . . 0.0 110.136 179.825 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 18.1 mtmt . . . . . 0 N--CA 1.494 1.76 0 CA-C-O 118.053 -0.975 . . . . 0.0 110.31 -179.979 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.514 ' HA ' ' CB ' ' B' ' 5' ' ' GLU . 2.5 mtp . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . 0.472 ' H ' ' HB2' ' B' ' 5' ' ' GLU . 17.5 p30 -173.43 -153.91 0.06 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.002 -1.061 . . . . 0.0 111.693 179.705 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.458 ' HG3' ' HB ' ' A' ' 45' ' ' THR . 0.1 OUTLIER -56.52 -0.55 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.515 -0.741 . . . . 0.0 111.562 -179.229 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.703 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 61.3 m -125.52 -45.68 1.78 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.779 -1.201 . . . . 0.0 110.363 179.738 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.514 ' CB ' ' HA ' ' B' ' 1' ' ' MET . 3.3 mt-10 -65.99 -51.45 58.23 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.051 -1.031 . . . . 0.0 108.682 179.673 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.504 ' HA ' ' HB1' ' B' ' 9' ' ' ALA . 17.9 mt -58.02 -32.62 68.12 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.161 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 7' ' ' ILE . . . . . 0.703 ' HB ' ' O ' ' B' ' 4' ' ' THR . 1.3 mt -53.63 -55.35 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 177.591 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . 0.491 ' O ' ' N ' ' B' ' 12' ' ' GLN . 0.6 OUTLIER -57.11 -31.98 65.84 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 177.829 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . 0.504 ' HB1' ' HA ' ' B' ' 6' ' ' LEU . . . -54.52 -38.42 66.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.271 -0.893 . . . . 0.0 108.971 178.677 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . 0.792 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.6 mp -90.83 -34.34 6.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 178.121 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.414 ' CB ' ' HA ' ' B' ' 8' ' ' LYS . . . -67.28 -12.62 60.6 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 119.139 -1.024 . . . . 0.0 109.011 178.686 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.491 ' N ' ' O ' ' B' ' 8' ' ' LYS . 1.1 pp0? -113.7 -36.0 5.0 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.339 -0.851 . . . . 0.0 109.416 178.496 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' B' ' 9' ' ' ALA . 56.0 m-20 -72.15 -21.54 61.44 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 176.784 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.792 ' OG1' ' O ' ' B' ' 10' ' ' ILE . 0.2 OUTLIER -117.24 -77.94 0.57 Allowed 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.462 179.648 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . 0.46 ' O ' ' C ' ' B' ' 16' ' ' LEU . . . 64.99 -13.1 0.21 Allowed Glycine 0 N--CA 1.5 2.908 0 N-CA-C 110.499 -1.041 . . . . 0.0 110.499 179.065 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 16' ' ' LEU . . . . . 0.719 ' N ' HD13 ' B' ' 16' ' ' LEU . 0.0 OUTLIER -35.05 -59.43 0.5 Allowed 'General case' 0 N--CA 1.513 2.677 0 CA-C-O 122.06 0.934 . . . . 0.0 110.678 -179.695 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 17' ' ' THR . . . . . 0.471 HG23 ' H ' ' B' ' 19' ' ' VAL . 0.5 OUTLIER -136.38 -1.17 2.36 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.543 -179.291 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . 0.627 ' O ' ' C ' ' B' ' 19' ' ' VAL . 5.1 mt-30 54.83 31.79 16.37 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 -176.815 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.627 ' C ' ' O ' ' B' ' 18' ' ' GLN . 0.9 OUTLIER -6.79 -93.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.01 -178.835 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 1.06 ' O ' ' N ' ' B' ' 22' ' ' SER . 0.3 OUTLIER -133.16 24.77 4.2 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 178.116 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.651 ' C ' ' O ' ' B' ' 20' ' ' SER . 0.0 OUTLIER -8.85 -39.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-O 122.362 1.077 . . . . 0.0 110.288 -178.252 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 1.06 ' N ' ' O ' ' B' ' 20' ' ' SER . 5.9 m -85.05 -43.09 14.23 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.483 178.244 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . 0.885 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.2 OUTLIER -81.94 -25.3 35.0 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.286 -0.884 . . . . 0.0 111.004 179.927 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 24' ' ' MET . . . . . 0.561 ' SD ' ' HA ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -82.94 -45.92 13.57 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 118.357 -1.337 . . . . 0.0 110.063 179.399 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.551 HD21 ' HE2' ' B' ' 24' ' ' MET . 0.4 OUTLIER -69.05 -48.22 63.4 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 117.53 -1.668 . . . . 0.0 108.104 178.272 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . 0.443 ' CB ' ' O ' ' B' ' 22' ' ' SER . . . -54.84 -34.09 62.48 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 177.698 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 27' ' ' SER . . . . . 0.592 ' O ' ' N ' ' B' ' 31' ' ' ILE . 3.7 t -72.55 -39.45 67.47 Favored 'General case' 0 C--O 1.204 -1.311 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.681 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . 0.695 ' HA ' ' CG1' ' B' ' 31' ' ' ILE . 0.1 OUTLIER -62.96 -37.68 88.05 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.688 0.756 . . . . 0.0 109.287 179.357 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . 0.547 ' HG2' HG22 ' A' ' 45' ' ' THR . 0.9 OUTLIER -81.9 -31.18 31.56 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 178.656 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . 0.815 ' O ' ' CG ' ' B' ' 34' ' ' GLU . 9.7 ttmt -71.99 -30.19 64.99 Favored 'General case' 0 C--O 1.19 -2.03 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 176.277 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.695 ' CG1' ' HA ' ' B' ' 28' ' ' PHE . 1.3 pp -91.19 -30.28 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.21 -0.931 . . . . 0.0 109.606 179.167 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.658 HG12 ' O ' ' B' ' 28' ' ' PHE . 5.2 mm -62.57 -51.68 69.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 177.495 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 33' ' ' THR . . . . . 0.513 ' HA ' HG23 ' B' ' 36' ' ' VAL . 0.4 OUTLIER -75.69 -25.66 56.9 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 114.904 -1.043 . . . . 0.0 108.966 179.74 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.815 ' CG ' ' O ' ' B' ' 30' ' ' LYS . 5.6 mm-40 -81.84 -35.75 29.04 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.078 -1.014 . . . . 0.0 109.394 178.674 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 35' ' ' THR . . . . . 0.519 ' N ' ' O ' ' B' ' 31' ' ' ILE . 52.0 m -62.55 -54.34 41.18 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 178.232 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.513 HG23 ' HA ' ' B' ' 33' ' ' THR . 2.2 m -50.17 -34.39 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 177.146 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . 0.656 ' HB2' ' O ' ' A' ' 88' ' ' ALA . . . -90.58 -4.13 57.08 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 121.57 0.7 . . . . 0.0 110.352 178.318 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . 0.658 ' N ' ' O ' ' B' ' 34' ' ' GLU . 0.0 OUTLIER -97.93 -24.5 15.36 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 177.731 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 111.81 43.87 0.92 Allowed Glycine 0 C--N 1.301 -1.383 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 178.089 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . 0.494 ' CB ' ' CG2' ' B' ' 35' ' ' THR . 0.1 OUTLIER -145.82 136.64 24.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.202 -1.175 . . . . 0.0 110.565 179.684 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 10.9 mtmt -89.68 88.28 7.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.477 -0.764 . . . . 0.0 109.901 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . 0.491 ' HA ' ' HG2' ' A' ' 1' ' ' MET . 7.6 p -62.1 142.19 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.486 -0.759 . . . . 0.0 110.128 -179.808 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -134.31 110.92 9.81 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.448 -0.782 . . . . 0.0 110.548 -179.361 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.595 HD12 ' CB ' ' B' ' 48' ' ' LEU . 17.0 mt -66.64 118.63 10.48 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.253 -0.904 . . . . 0.0 109.533 179.323 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 45' ' ' THR . . . . . 0.52 HG22 ' HG2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 29.06 -89.34 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.823 -0.548 . . . . 0.0 111.228 -179.975 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -149.58 26.85 1.2 Allowed Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 179.623 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . 0.565 ' CD1' ' HG ' ' B' ' 48' ' ' LEU . 7.7 p90 -125.45 -24.44 3.91 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.951 -1.323 . . . . 0.0 112.011 179.736 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . 0.595 ' CB ' HD12 ' B' ' 44' ' ' LEU . 1.6 mt -128.07 108.47 10.68 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.404 -1.435 . . . . 0.0 110.82 178.814 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -106.19 69.83 0.82 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.574 -0.704 . . . . 0.0 110.989 -179.643 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 50' ' ' ILE . . . . . 0.482 HG12 HG21 ' B' ' 79' ' ' VAL . 1.9 mm -60.1 125.6 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.302 -0.874 . . . . 0.0 109.281 179.142 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . 0.442 ' HG3' ' HB2' ' B' ' 78' ' ' SER . 9.1 ptmt -149.71 122.63 4.37 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 120.665 -1.272 . . . . 0.0 111.252 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . 0.657 ' HA ' ' HA ' ' B' ' 77' ' ' VAL . 55.4 Cg_endo -79.8 144.49 17.32 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 O-C-N 123.61 1.321 . . . . 0.0 110.964 179.78 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.507 ' O ' ' N ' ' B' ' 76' ' ' GLY . 32.6 m -138.92 114.3 8.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-O 121.833 0.825 . . . . 0.0 110.753 179.282 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.537 ' HA ' ' HA ' ' B' ' 75' ' ' VAL . . . -56.74 94.29 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.581 -0.699 . . . . 0.0 111.173 -179.022 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 8.7 ttt-85 -108.01 69.39 0.73 Allowed 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.623 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -51.85 -175.48 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.889 0.852 . . . . 0.0 111.647 -178.496 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.416 ' N ' ' HA ' ' B' ' 73' ' ' PRO . . . -56.75 -168.59 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.306 0.574 . . . . 0.0 111.173 -179.074 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 58' ' ' ARG . . . . . 0.761 ' HD2' ' N ' ' B' ' 71' ' ' ILE . 0.0 OUTLIER -175.4 -157.15 0.06 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.445 -0.784 . . . . 0.0 110.204 -177.83 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . 0.653 ' HB3' ' O ' ' B' ' 58' ' ' ARG . 0.0 OUTLIER 150.68 88.59 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.238 0 CA-C-O 121.36 0.6 . . . . 0.0 109.51 177.921 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . 0.427 ' O ' ' HB3' ' B' ' 61' ' ' PHE . . . -118.0 -112.83 2.58 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 -179.685 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 61' ' ' PHE . . . . . 0.634 ' C ' ' CD1' ' B' ' 61' ' ' PHE . 11.9 p90 179.37 175.77 0.67 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.479 -1.012 . . . . 0.0 110.282 -179.517 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . 0.83 ' H ' ' HD2' ' B' ' 63' ' ' PRO . 0.0 OUTLIER -135.4 -44.08 0.02 OUTLIER Pre-proline 0 C--N 1.298 -1.672 0 C-N-CA 119.719 -0.792 . . . . 0.0 112.353 178.322 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . 0.83 ' HD2' ' H ' ' B' ' 62' ' ' ASN . 41.1 Cg_endo -69.67 64.17 1.75 Allowed 'Trans proline' 0 N--CA 1.486 1.055 0 O-C-N 122.62 0.8 . . . . 0.0 110.957 -179.651 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . 0.576 ' CB ' ' CE1' ' B' ' 61' ' ' PHE . 0.0 OUTLIER -168.47 -106.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 179.119 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.443 ' O ' ' CB ' ' B' ' 66' ' ' GLN . 0.5 OUTLIER -75.45 -1.9 26.24 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.358 -1.464 . . . . 0.0 109.005 177.247 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . 0.458 ' O ' ' CB ' ' B' ' 67' ' ' GLU . 0.9 OUTLIER 73.53 98.63 0.07 Allowed 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 121.533 0.682 . . . . 0.0 111.817 179.221 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . 0.544 ' H ' ' HA ' ' B' ' 62' ' ' ASN . 0.3 OUTLIER 164.48 67.81 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.922 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . 0.585 ' HA ' ' C ' ' B' ' 61' ' ' PHE . . . -64.81 138.95 58.69 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.451 -0.781 . . . . 0.0 110.554 -179.659 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.484 HD21 ' O ' ' B' ' 67' ' ' GLU . 1.4 mt -138.12 125.09 21.3 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.813 -0.554 . . . . 0.0 109.54 -178.507 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . 0.511 ' C ' ' HD2' ' B' ' 58' ' ' ARG . 3.3 tt0 -166.15 27.64 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.3 -0.875 . . . . 0.0 110.508 -179.318 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.761 ' N ' ' HD2' ' B' ' 58' ' ' ARG . 2.4 pp -61.92 -150.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.296 -0.878 . . . . 0.0 110.033 178.98 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . 0.427 ' N ' ' CD1' ' B' ' 71' ' ' ILE . . . -135.67 163.23 52.06 Favored Pre-proline 0 C--N 1.301 -1.512 0 O-C-N 121.044 -1.035 . . . . 0.0 110.986 -179.31 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 73' ' ' PRO . . . . . 0.468 ' O ' ' CB ' ' B' ' 74' ' ' SER . 44.1 Cg_endo -70.72 114.98 4.03 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 124.238 1.652 . . . . 0.0 110.278 179.887 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 74' ' ' SER . . . . . 0.471 ' N ' ' OH ' ' A' ' 94' ' ' TYR . 2.0 t 166.89 138.41 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.726 -0.609 . . . . 0.0 109.766 179.995 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . 0.537 ' HA ' ' HA ' ' B' ' 54' ' ' ALA . 8.6 p -59.02 166.34 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.175 -0.953 . . . . 0.0 109.132 179.183 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' B' ' 53' ' ' VAL . . . -120.24 96.72 0.63 Allowed Glycine 0 N--CA 1.49 2.244 0 C-N-CA 119.295 -1.431 . . . . 0.0 110.239 -179.143 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.657 ' HA ' ' HA ' ' B' ' 52' ' ' PRO . 6.4 p -69.39 68.61 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.575 -0.956 . . . . 0.0 109.075 179.04 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 78' ' ' SER . . . . . 0.442 ' HB2' ' HG3' ' B' ' 51' ' ' LYS . 1.6 m -65.65 177.18 1.28 Allowed 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.894 0.854 . . . . 0.0 110.732 -179.178 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . 0.482 HG21 HG12 ' B' ' 50' ' ' ILE . 7.3 p 177.24 177.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -179.84 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . 0.436 ' HB2' ' HD2' ' B' ' 81' ' ' PRO . 0.6 OUTLIER -177.47 172.62 0.76 Allowed Pre-proline 0 N--CA 1.487 1.423 0 O-C-N 120.852 -1.155 . . . . 0.0 110.769 177.651 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 81' ' ' PRO . . . . . 0.444 ' HA ' ' O ' ' B' ' 47' ' ' PHE . 53.4 Cg_endo -92.76 128.25 0.79 Allowed 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.441 2.094 . . . . 0.0 110.61 178.527 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.67 178.93 41.37 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 108.634 -1.787 . . . . 0.0 108.634 179.152 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . 0.41 ' HA ' ' HB2' ' B' ' 86' ' ' LYS . 4.0 pt-20 -69.61 -28.31 65.82 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.115 -1.227 . . . . 0.0 110.498 -179.828 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -48.71 -32.17 8.03 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.841 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . 0.644 ' HB3' HG21 ' A' ' 77' ' ' VAL . 0.5 OUTLIER -83.4 -38.23 22.22 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.211 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . 0.479 ' HA ' ' HB1' ' B' ' 89' ' ' ALA . 0.1 OUTLIER -70.12 -36.39 74.79 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.447 -0.783 . . . . 0.0 109.125 179.575 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 13.0 ttpt -64.97 -42.03 94.94 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 178.029 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.575 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -63.72 -34.86 78.82 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 176.233 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . 0.501 ' HB2' ' CG1' ' A' ' 75' ' ' VAL . . . -54.47 -43.99 72.21 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.616 -0.834 . . . . 0.0 109.275 178.743 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -53.35 -32.7 50.47 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 177.104 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' B' ' 88' ' ' ALA . . . -60.88 -42.3 99.57 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 178.138 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . 0.67 ' HB3' ' HA ' ' A' ' 37' ' ' ALA . 0.4 OUTLIER -75.39 17.79 0.25 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.665 -1.491 . . . . 0.0 110.502 179.682 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' B' ' 92' ' ' LEU . 0.0 OUTLIER 58.17 44.74 18.56 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -177.539 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . 0.539 ' CD1' ' N ' ' A' ' 75' ' ' VAL . 0.1 OUTLIER -36.71 -35.62 0.09 Allowed 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.68 -179.16 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . 0.431 ' HG3' ' N ' ' B' ' 96' ' ' ASP . 0.0 OUTLIER -64.77 -44.0 91.42 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.382 -0.824 . . . . 0.0 109.382 179.887 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 96' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' B' ' 93' ' ' LYS . 25.8 m-20 -56.39 -34.52 66.78 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.572 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -82.51 -25.09 33.76 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.81 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 98' ' ' ALA . . . . . 0.402 ' HB1' ' HG3' ' A' ' 56' ' ' GLN . . . -68.28 -49.11 62.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.691 -0.631 . . . . 0.0 110.32 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.258 -179.922 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.556 ' HB3' ' HG ' ' A' ' 6' ' ' LEU . 11.1 mtp . . . . . 0 N--CA 1.493 1.706 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.492 ' HA ' ' O ' ' B' ' 43' ' ' GLN . 43.7 p-10 -168.5 -159.03 0.25 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.83 -1.169 . . . . 0.0 112.36 -179.891 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.46 ' CG ' ' HA ' ' A' ' 26' ' ' ALA . 5.6 tttm -50.92 -10.09 0.06 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.547 -0.721 . . . . 0.0 111.305 -179.388 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.67 ' O ' HG13 ' A' ' 7' ' ' ILE . 1.3 m -120.12 -57.88 1.91 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.978 -1.076 . . . . 0.0 109.558 179.208 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.529 ' CB ' ' HA ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -48.11 -40.86 24.77 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.402 -0.811 . . . . 0.0 109.154 179.576 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.556 ' HG ' ' HB3' ' A' ' 1' ' ' MET . 5.6 mt -68.83 -29.65 68.02 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.301 -0.96 . . . . 0.0 110.169 178.583 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.675 ' O ' ' HB1' ' A' ' 11' ' ' ALA . 1.2 pp -59.99 -46.8 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.667 -1.271 . . . . 0.0 108.263 179.73 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.61 ' H ' HG13 ' A' ' 7' ' ' ILE . 18.4 pttt -72.43 -24.8 61.28 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.2 -1.0 . . . . 0.0 108.678 177.514 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.452 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . . . -58.45 -39.26 79.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.264 -0.898 . . . . 0.0 109.04 178.774 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.802 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.9 OUTLIER -92.28 -32.79 5.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 177.863 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.675 ' HB1' ' O ' ' A' ' 7' ' ' ILE . . . -60.61 -14.29 19.39 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 118.856 -1.138 . . . . 0.0 108.966 178.129 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -112.87 -44.01 3.35 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.271 -0.893 . . . . 0.0 109.656 179.071 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.79 -39.03 90.54 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.569 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.802 ' OG1' ' O ' ' A' ' 10' ' ' ILE 0.251 0.2 OUTLIER -91.87 -70.07 0.71 Allowed 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 177.693 . . . . . . . . 4 4 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.448 ' HA2' ' O ' ' A' ' 11' ' ' ALA . . . 58.23 18.9 37.11 Favored Glycine 0 N--CA 1.499 2.853 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 177.236 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.709 ' CD1' HG23 ' B' ' 19' ' ' VAL . 3.3 mp -62.74 -63.83 1.1 Allowed 'General case' 0 C--N 1.293 -1.853 0 O-C-N 121.48 -1.012 . . . . 0.0 109.937 179.308 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.523 HG21 ' O ' ' A' ' 17' ' ' THR . 0.6 OUTLIER -138.13 7.63 2.67 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.445 -179.681 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.54 ' O ' ' C ' ' A' ' 19' ' ' VAL . 28.4 mt-30 58.14 26.5 13.79 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 -176.219 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.72 ' HB ' ' HB ' ' B' ' 19' ' ' VAL . 2.7 p -13.88 -96.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.121 -178.708 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.959 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -129.72 23.38 5.41 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 105.966 -1.865 . . . . 0.0 105.966 178.402 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.612 ' HA ' ' CE ' ' A' ' 24' ' ' MET . 30.0 m -24.6 -39.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 CA-C-O 122.481 1.134 . . . . 0.0 109.156 -178.868 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.706 ' N ' ' O ' ' A' ' 20' ' ' SER . 48.2 t -82.66 -35.27 27.04 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.246 177.92 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.959 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.6 OUTLIER -86.84 -36.56 18.41 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.684 -0.635 . . . . 0.0 111.347 179.521 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.613 ' HG2' HG23 ' B' ' 14' ' ' THR . 0.0 OUTLIER -70.06 -39.4 75.7 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.28 -1.513 . . . . 0.0 109.039 179.433 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.668 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 9.0 mt -77.82 -44.54 27.11 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 118.167 -1.413 . . . . 0.0 109.413 178.638 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.48 ' CB ' ' O ' ' A' ' 22' ' ' SER . . . -58.01 -32.8 68.27 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.955 -1.09 . . . . 0.0 108.121 178.025 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.58 ' O ' ' N ' ' A' ' 31' ' ' ILE . 25.8 p -85.27 -31.42 23.11 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.378 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.749 ' O ' ' CG1' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -56.13 -34.67 66.3 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.572 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.786 ' HG2' HG21 ' B' ' 45' ' ' THR . 0.8 OUTLIER -79.74 -39.31 31.38 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.378 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.81 ' O ' ' CG ' ' A' ' 34' ' ' GLU . 39.7 ttmt -65.92 -28.08 68.66 Favored 'General case' 0 C--O 1.192 -1.965 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.478 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.718 ' CG1' ' HA ' ' A' ' 28' ' ' PHE . 2.1 pp -93.2 -37.97 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.911 . . . . 0.0 108.939 179.103 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.749 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.1 mm -58.71 -53.52 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 177.651 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.706 ' OG1' ' HB2' ' B' ' 85' ' ' LEU . 0.3 OUTLIER -69.92 -27.35 64.71 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.654 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.81 ' CG ' ' O ' ' A' ' 30' ' ' LYS . 16.9 mm-40 -76.67 -45.03 31.4 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.0 -1.062 . . . . 0.0 110.685 178.973 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.467 ' CG2' ' CB ' ' A' ' 40' ' ' ASP . 96.4 m -61.58 -53.43 56.36 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 120.651 -1.281 . . . . 0.0 108.859 179.445 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.578 HG23 ' HA ' ' A' ' 33' ' ' THR . 15.7 m -50.11 -35.34 11.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 177.25 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.638 ' HA ' ' HA ' ' B' ' 89' ' ' ALA . . . -92.01 1.18 57.36 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-O 121.582 0.706 . . . . 0.0 110.32 178.484 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.595 ' N ' ' O ' ' A' ' 34' ' ' GLU . 8.8 ttmt -101.53 -32.93 10.14 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 177.784 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 132.98 35.87 0.29 Allowed Glycine 0 C--N 1.305 -1.173 0 C-N-CA 119.637 -1.268 . . . . 0.0 111.565 177.738 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.467 ' CB ' ' CG2' ' A' ' 35' ' ' THR . 0.2 OUTLIER -145.97 -174.02 4.32 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.824 -1.398 . . . . 0.0 111.39 179.467 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.402 ' HG2' ' CB ' ' A' ' 51' ' ' LYS . 0.5 OUTLIER -134.57 127.67 31.73 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.831 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.481 ' HB ' HD12 ' A' ' 50' ' ' ILE . 1.1 t -85.96 115.38 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.201 -0.937 . . . . 0.0 110.713 -178.794 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.435 ' O ' ' HA ' ' B' ' 2' ' ' ASN . 4.8 mt-30 -105.54 100.43 10.0 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.951 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.676 ' HB3' ' HE1' ' A' ' 47' ' ' PHE . 47.8 mt -71.9 115.44 11.12 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.219 -0.926 . . . . 0.0 110.704 -178.933 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.536 ' C ' ' O ' ' A' ' 44' ' ' LEU . 2.1 t 28.43 -117.17 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.717 -0.615 . . . . 0.0 110.516 178.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -127.08 32.32 3.63 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 109.071 -1.611 . . . . 0.0 109.071 179.024 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.676 ' HE1' ' HB3' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -131.08 -28.0 1.98 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.14 -1.212 . . . . 0.0 111.921 -179.836 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.576 ' HB3' HD11 ' A' ' 44' ' ' LEU . 6.3 mt -128.03 128.9 45.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 119.852 -1.78 . . . . 0.0 110.602 176.796 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.489 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 7.4 m-80 -129.81 111.47 12.64 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.533 -0.729 . . . . 0.0 110.399 -178.876 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.688 ' HA ' ' HA ' ' A' ' 79' ' ' VAL . 1.2 pp -111.9 149.18 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.581 -0.699 . . . . 0.0 110.348 179.947 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.402 ' CB ' ' HG2' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -165.58 117.68 0.87 Allowed Pre-proline 0 N--CA 1.497 1.918 0 O-C-N 120.696 -1.253 . . . . 0.0 110.933 -179.78 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.593 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 53.0 Cg_endo -82.33 149.59 15.07 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 O-C-N 123.667 1.351 . . . . 0.0 111.212 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.623 ' CG2' ' HA3' ' A' ' 76' ' ' GLY . 10.8 m -132.48 -149.95 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 O-C-N 121.521 -0.737 . . . . 0.0 110.345 179.542 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.584 ' O ' ' HB2' ' A' ' 55' ' ' ARG . . . -148.68 106.26 3.66 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.1 -1.0 . . . . 0.0 111.266 -179.132 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.584 ' HB2' ' O ' ' A' ' 54' ' ' ALA . 2.9 ttt-85 168.34 89.87 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.669 -0.645 . . . . 0.0 109.535 179.519 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.622 ' HB2' ' H ' ' A' ' 74' ' ' SER . 6.8 mt-30 -153.77 19.4 0.53 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 118.585 -1.246 . . . . 0.0 112.319 179.903 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.528 ' HB1' ' HB3' ' A' ' 73' ' ' PRO . . . -131.88 -163.4 1.33 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.748 -1.22 . . . . 0.0 110.491 178.897 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.547 ' O ' ' N ' ' A' ' 60' ' ' GLY . 2.1 mtt85 -159.61 19.93 0.17 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.295 -0.878 . . . . 0.0 111.43 -178.512 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.497 ' C ' ' O ' ' A' ' 58' ' ' ARG . 2.3 ttpm? -24.23 85.05 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.304 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.548 ' N ' ' HA ' ' A' ' 69' ' ' LEU . . . -160.32 -61.19 0.01 OUTLIER Glycine 0 N--CA 1.493 2.471 0 C-N-CA 120.108 -1.044 . . . . 0.0 110.758 179.756 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.993 ' CE2' ' HB2' ' A' ' 66' ' ' GLN . 53.2 p90 177.53 175.2 0.46 Allowed 'General case' 0 N--CA 1.508 2.463 0 O-C-N 121.344 -1.092 . . . . 0.0 109.991 -178.656 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.601 ' H ' ' HD2' ' A' ' 63' ' ' PRO . 1.5 t-20 -117.08 -58.8 0.04 OUTLIER Pre-proline 0 C--N 1.304 -1.385 0 C-N-CA 119.441 -0.903 . . . . 0.0 112.719 -178.9 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.601 ' HD2' ' H ' ' A' ' 62' ' ' ASN . 39.5 Cg_endo -66.89 69.58 0.52 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.177 1.093 . . . . 0.0 110.668 -178.869 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.686 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 0.1 OUTLIER -179.69 43.57 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.611 -0.681 . . . . 0.0 109.82 179.82 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.517 ' OG1' ' O ' ' A' ' 64' ' ' GLN . 2.5 p 71.14 8.49 6.45 Favored 'General case' 0 N--CA 1.507 2.42 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 179.076 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.993 ' HB2' ' CE2' ' A' ' 61' ' ' PHE . 0.1 OUTLIER -113.74 -142.37 0.38 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.838 -1.164 . . . . 0.0 108.185 178.349 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.777 ' O ' ' CB ' ' A' ' 68' ' ' ALA . 18.9 mt-10 -144.73 12.75 1.48 Allowed 'General case' 0 N--CA 1.486 1.33 0 O-C-N 120.553 -1.342 . . . . 0.0 111.153 178.002 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.777 ' CB ' ' O ' ' A' ' 67' ' ' GLU . . . 133.86 -176.3 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.612 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 175.524 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.839 ' HG ' ' HA ' ' A' ' 61' ' ' PHE . 3.1 mp -95.24 18.97 11.34 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 114.23 -1.35 . . . . 0.0 111.114 -179.816 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.442 ' CB ' ' O ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER 172.39 56.43 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.952 -1.093 . . . . 0.0 111.655 -179.81 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.504 HD13 ' HG3' ' A' ' 58' ' ' ARG . 24.1 pt -65.81 -146.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 120.636 -1.29 . . . . 0.0 109.169 178.466 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.414 ' O ' ' O ' ' A' ' 56' ' ' GLN . . . -106.36 101.67 36.5 Favored Pre-proline 0 C--N 1.29 -2.022 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -176.702 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.528 ' HB3' ' HB1' ' A' ' 57' ' ' ALA . 48.0 Cg_endo -73.81 132.9 17.72 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 O-C-N 124.113 1.586 . . . . 0.0 108.472 176.755 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.622 ' H ' ' HB2' ' A' ' 56' ' ' GLN . 0.4 OUTLIER -156.55 137.92 13.88 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.243 -0.91 . . . . 0.0 110.994 179.963 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.619 ' CG1' ' CB ' ' B' ' 89' ' ' ALA . 14.6 p -45.22 162.26 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 121.368 -0.833 . . . . 0.0 110.125 179.28 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.623 ' HA3' ' CG2' ' A' ' 53' ' ' VAL . . . -110.13 87.02 0.46 Allowed Glycine 0 N--CA 1.487 2.037 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 179.356 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.593 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 84.1 t -65.2 75.49 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 O-C-N 121.918 -0.754 . . . . 0.0 110.753 -179.247 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.537 ' O ' HG11 ' A' ' 79' ' ' VAL . 0.5 OUTLIER -65.83 178.77 0.99 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.323 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.688 ' HA ' ' HA ' ' A' ' 50' ' ' ILE . 0.0 OUTLIER 179.7 178.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.924 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.429 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 11.1 mttt 179.14 169.79 0.57 Allowed Pre-proline 0 C--N 1.307 -1.28 0 O-C-N 121.384 -0.822 . . . . 0.0 110.46 177.13 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 57.4 Cg_endo -109.39 161.15 0.08 OUTLIER 'Trans proline' 0 C--N 1.301 -1.959 0 C-N-CA 123.413 2.742 . . . . 0.0 110.605 177.798 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 47' ' ' PHE . . . -105.57 -150.79 19.55 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 107.604 -2.198 . . . . 0.0 107.604 177.093 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -100.46 -13.1 18.84 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.88 -1.365 . . . . 0.0 110.125 178.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.02 -38.09 75.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.335 -0.853 . . . . 0.0 109.075 179.664 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.551 ' HG ' ' HD2' ' A' ' 47' ' ' PHE . 0.5 OUTLIER -77.42 -38.16 50.23 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.692 -0.63 . . . . 0.0 109.539 179.239 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.422 ' HA ' ' HB1' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -69.14 -41.5 77.22 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.799 -0.761 . . . . 0.0 110.779 -178.923 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -64.93 -40.24 94.74 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 178.942 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.569 ' O ' ' HB3' ' B' ' 37' ' ' ALA . . . -72.79 -30.78 64.37 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 177.02 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.55 ' HA ' ' HA ' ' B' ' 37' ' ' ALA . . . -64.68 -39.08 93.05 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.304 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -56.98 -33.15 66.8 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 176.935 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -74.07 -20.79 79.66 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 178.745 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.583 ' CB ' ' O ' ' B' ' 37' ' ' ALA . 0.4 OUTLIER -76.82 16.07 0.57 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.681 -1.482 . . . . 0.0 111.268 -179.757 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.419 ' CB ' ' O ' ' A' ' 92' ' ' LEU . 0.0 OUTLIER 65.19 34.94 8.15 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -177.728 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.527 ' CD1' ' HB ' ' B' ' 75' ' ' VAL . 0.0 OUTLIER -49.31 -27.75 4.18 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.486 -179.578 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -57.57 -40.59 79.31 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.362 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -61.57 -36.84 81.79 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 176.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.446 ' HB2' ' HA ' ' A' ' 94' ' ' TYR . 0.2 OUTLIER -63.22 -31.2 72.29 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.737 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.31 -29.84 67.77 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.322 0.582 . . . . 0.0 110.074 179.671 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.354 180.0 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.486 ' HG2' ' HB3' ' B' ' 5' ' ' GLU . 3.0 mtp . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.193 0.52 . . . . 0.0 110.211 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . 0.522 ' O ' ' N ' ' B' ' 6' ' ' LEU . 23.3 t-20 -173.06 165.99 4.98 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.374 -0.829 . . . . 0.0 109.783 -179.816 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.637 ' NZ ' ' HB2' ' B' ' 29' ' ' GLU . 0.0 OUTLIER -47.36 -26.15 1.21 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.983 -1.073 . . . . 0.0 109.202 179.307 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.623 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 16.7 m -79.28 -56.19 4.53 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 177.342 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.486 ' HB3' ' HG2' ' B' ' 1' ' ' MET . 0.5 OUTLIER -57.95 -50.46 73.29 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 177.42 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' B' ' 2' ' ' ASN . 1.8 mt -61.15 -28.05 68.83 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 177.302 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 7' ' ' ILE . . . . . 0.623 ' HB ' ' O ' ' B' ' 4' ' ' THR . 0.1 OUTLIER -53.68 -54.28 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.278 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . 0.513 ' N ' ' CG2' ' B' ' 7' ' ' ILE . 0.1 OUTLIER -62.97 -32.91 74.34 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.234 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.68 -29.38 70.61 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.375 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . 0.714 ' O ' ' OG1' ' B' ' 14' ' ' THR . 0.6 OUTLIER -93.19 -35.58 6.7 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.627 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 178.109 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.567 ' HA ' ' OG1' ' B' ' 14' ' ' THR . . . -63.75 -29.11 70.36 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.849 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.469 ' N ' ' O ' ' B' ' 8' ' ' LYS . 1.1 tt0 -89.85 -39.06 13.31 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.027 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.452 ' HB2' ' HA ' ' B' ' 10' ' ' ILE . 43.2 m-20 -67.41 -25.51 65.97 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 176.755 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.714 ' OG1' ' O ' ' B' ' 10' ' ' ILE . 24.7 p -88.73 -76.35 0.4 Allowed 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.756 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 60.45 12.53 26.08 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.604 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 16' ' ' LEU . . . . . 0.652 HD13 ' HB ' ' B' ' 14' ' ' THR . 3.4 mp -82.98 -60.66 2.09 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.43 -1.041 . . . . 0.0 108.708 179.092 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 17' ' ' THR . . . . . 0.549 HG21 ' O ' ' B' ' 17' ' ' THR . 0.5 OUTLIER -146.14 3.9 0.93 Allowed 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.816 -179.665 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . 0.677 ' O ' ' C ' ' B' ' 19' ' ' VAL . 8.3 mt-30 57.09 28.03 14.3 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 -176.367 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.72 ' HB ' ' HB ' ' A' ' 19' ' ' VAL . 1.0 OUTLIER 5.73 -97.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.917 -179.516 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 1.033 ' O ' ' N ' ' B' ' 22' ' ' SER . 96.4 p -133.47 23.85 4.06 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 175.833 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.661 ' C ' ' O ' ' B' ' 20' ' ' SER . 30.8 m -9.1 -41.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 CA-C-O 122.289 1.042 . . . . 0.0 109.885 -177.593 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 1.033 ' N ' ' O ' ' B' ' 20' ' ' SER . 15.3 p -67.81 -46.46 71.81 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.944 177.285 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . 0.902 ' N ' ' O ' ' B' ' 20' ' ' SER . 32.6 mtmt -91.72 -23.85 19.65 Favored 'General case' 0 C--N 1.307 -1.258 0 O-C-N 121.543 -0.723 . . . . 0.0 109.338 178.498 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 24' ' ' MET . . . . . 0.608 ' HE3' ' HA ' ' B' ' 21' ' ' VAL . 2.1 tmm? -63.46 -24.75 67.96 Favored 'General case' 0 C--O 1.216 -0.701 0 O-C-N 120.459 -1.401 . . . . 0.0 107.625 178.207 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.673 ' C ' ' CD1' ' B' ' 25' ' ' LEU . 0.1 OUTLIER -89.27 -46.4 8.79 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 176.61 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . 0.418 ' N ' ' CG ' ' B' ' 25' ' ' LEU . . . -58.96 -28.19 66.06 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.25 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 27' ' ' SER . . . . . 0.489 ' O ' ' N ' ' B' ' 31' ' ' ILE . 23.8 p -86.61 -31.82 20.94 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.082 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 28' ' ' PHE . . . . . 0.871 ' O ' HG13 ' B' ' 31' ' ' ILE . 0.7 OUTLIER -57.69 -42.27 83.35 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.08 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . 0.669 ' O ' ' HB ' ' B' ' 33' ' ' THR . 2.3 tt0 -70.78 -43.27 69.07 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 177.35 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . 1.28 ' O ' ' HB3' ' B' ' 34' ' ' GLU . 25.5 ttpt -60.57 -21.34 62.49 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.873 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.881 ' HA ' ' HG2' ' B' ' 34' ' ' GLU . 1.3 pp -102.71 -33.7 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 119.361 -0.936 . . . . 0.0 110.209 179.58 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.668 HG13 ' CD1' ' B' ' 28' ' ' PHE . 1.0 OUTLIER -71.88 -43.76 68.33 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 176.791 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 33' ' ' THR . . . . . 0.669 ' HB ' ' O ' ' B' ' 29' ' ' GLU . 0.3 OUTLIER -77.02 -26.22 53.52 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 177.277 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 1.28 ' HB3' ' O ' ' B' ' 30' ' ' LYS . 0.0 OUTLIER -64.54 -43.94 92.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.097 -1.002 . . . . 0.0 109.961 178.3 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 35' ' ' THR . . . . . 0.577 ' N ' ' HG3' ' B' ' 34' ' ' GLU . 47.9 m -67.33 -56.08 11.23 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 118.911 -1.115 . . . . 0.0 109.255 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.623 ' CG2' ' HA ' ' B' ' 33' ' ' THR . 19.6 m -50.22 -33.92 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 118.164 -1.414 . . . . 0.0 108.217 178.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . 0.583 ' O ' ' CB ' ' A' ' 92' ' ' LEU . . . -93.3 0.5 57.0 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.242 0.544 . . . . 0.0 110.492 178.84 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . 0.731 ' HB2' ' O ' ' B' ' 34' ' ' GLU . 9.7 tppt? -103.89 -16.74 15.28 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 106.673 -1.602 . . . . 0.0 106.673 177.132 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.89 50.07 1.3 Allowed Glycine 0 C--N 1.304 -1.216 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 178.21 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . 0.462 ' CB ' HG22 ' B' ' 35' ' ' THR . 0.3 OUTLIER -148.94 141.01 23.86 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.057 -1.26 . . . . 0.0 110.775 179.43 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -90.57 92.89 9.05 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.621 -0.674 . . . . 0.0 109.24 179.866 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . 0.429 ' CG2' ' HB ' ' B' ' 50' ' ' ILE . 24.1 m -59.28 137.95 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 C-N-CA 119.814 -0.755 . . . . 0.0 110.001 -179.608 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 43' ' ' GLN . . . . . 0.492 ' O ' ' HA ' ' A' ' 2' ' ' ASN . 1.6 mt-30 -118.51 173.43 6.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.345 -0.847 . . . . 0.0 110.149 -179.318 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.656 ' O ' ' N ' ' B' ' 46' ' ' GLY . 36.1 mt -141.31 -177.67 5.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.383 -0.823 . . . . 0.0 110.794 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 45' ' ' THR . . . . . 0.786 HG21 ' HG2' ' A' ' 29' ' ' GLU . 2.4 t -51.58 69.02 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 120.878 0.371 . . . . 0.0 111.765 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . 0.656 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . 41.57 29.63 0.48 Allowed Glycine 0 N--CA 1.5 2.914 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 179.352 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . 0.663 ' C ' ' HA3' ' B' ' 82' ' ' GLY . 0.5 OUTLIER -123.72 -27.79 3.94 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.166 -1.197 . . . . 0.0 110.656 -179.755 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . 0.572 ' HB3' ' CE2' ' B' ' 47' ' ' PHE . 11.1 tp -168.73 150.0 4.7 Favored 'General case' 0 C--N 1.293 -1.854 0 C-N-CA 118.069 -1.452 . . . . 0.0 111.322 -179.839 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 49' ' ' ASN . . . . . 0.423 ' O ' ' N ' ' B' ' 80' ' ' LYS . 17.2 m-80 -148.35 -178.95 6.6 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.96 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 50' ' ' ILE . . . . . 0.72 ' HA ' ' HA ' ' B' ' 79' ' ' VAL . 0.0 OUTLIER -142.8 167.17 14.7 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 O-C-N 121.411 -0.806 . . . . 0.0 110.382 179.716 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . 0.452 ' O ' ' HD3' ' B' ' 51' ' ' LYS . 0.0 OUTLIER -170.88 130.13 0.79 Allowed Pre-proline 0 N--CA 1.494 1.771 0 C-N-CA 119.259 -0.977 . . . . 0.0 110.605 179.333 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . 0.626 ' HA ' ' HA ' ' B' ' 77' ' ' VAL . 57.7 Cg_endo -90.39 143.22 3.73 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.67 1.353 . . . . 0.0 110.741 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.518 ' CG2' ' HA3' ' B' ' 76' ' ' GLY . 16.5 m -126.6 -152.54 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 C-N-CA 119.841 -0.744 . . . . 0.0 110.229 178.945 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.401 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . . . -134.88 116.23 14.53 Favored 'General case' 0 C--N 1.291 -1.969 0 O-C-N 121.292 -0.88 . . . . 0.0 110.506 -179.298 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 5.4 mtp180 -148.57 93.43 2.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.552 -0.718 . . . . 0.0 109.477 179.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.17 134.95 13.8 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.607 -0.683 . . . . 0.0 111.556 -179.168 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.759 ' O ' ' HB2' ' B' ' 72' ' ' ALA . . . -74.24 65.63 1.2 Allowed 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 122.03 0.919 . . . . 0.0 109.146 178.762 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 58' ' ' ARG . . . . . 0.642 ' HG2' ' C ' ' B' ' 71' ' ' ILE . 46.3 mtm180 -138.53 124.23 19.75 Favored 'General case' 0 C--N 1.285 -2.223 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.111 -178.452 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 59' ' ' LYS . . . . . 0.423 ' CA ' ' HG3' ' B' ' 70' ' ' GLU . 0.5 OUTLIER -160.88 19.75 0.13 Allowed 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.506 -178.763 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . 0.496 ' HA2' ' N ' ' B' ' 69' ' ' LEU . . . 91.89 66.56 1.13 Allowed Glycine 0 N--CA 1.485 1.966 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.718 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 61' ' ' PHE . . . . . 0.874 ' C ' ' HA ' ' B' ' 68' ' ' ALA . 0.0 OUTLIER -75.46 130.87 39.63 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.905 -1.35 . . . . 0.0 113.573 -178.967 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . 0.74 ' H ' ' CD ' ' B' ' 63' ' ' PRO . 7.5 p30 -136.84 -19.77 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.477 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 178.803 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . 0.74 ' CD ' ' H ' ' B' ' 62' ' ' ASN . 47.4 Cg_endo -75.69 -6.62 17.79 Favored 'Trans proline' 0 N--CA 1.484 0.924 0 CA-C-N 119.466 0.845 . . . . 0.0 110.347 179.94 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . 0.58 ' HB3' ' CE1' ' B' ' 61' ' ' PHE . 0.0 OUTLIER -88.6 -105.45 0.08 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.317 -0.864 . . . . 0.0 109.223 179.526 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.448 ' H ' ' HB3' ' B' ' 64' ' ' GLN . 0.0 OUTLIER -81.5 12.14 3.99 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.536 -1.353 . . . . 0.0 110.097 178.797 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . 0.605 ' O ' ' HB3' ' B' ' 67' ' ' GLU . 0.0 OUTLIER 69.75 109.87 0.05 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.395 -0.816 . . . . 0.0 111.887 179.125 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 67' ' ' GLU . . . . . 0.899 ' O ' ' HG ' ' B' ' 69' ' ' LEU . 4.2 pt-20 140.75 87.08 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.389 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.769 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . 0.874 ' HA ' ' C ' ' B' ' 61' ' ' PHE . . . -56.14 101.77 0.06 Allowed 'General case' 0 N--CA 1.504 2.23 0 O-C-N 120.902 -1.124 . . . . 0.0 112.137 -178.332 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.899 ' HG ' ' O ' ' B' ' 67' ' ' GLU . 1.0 OUTLIER -131.09 147.91 52.67 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.55 -0.718 . . . . 0.0 109.738 178.099 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . 0.589 ' HB3' ' HB3' ' B' ' 58' ' ' ARG . 2.3 mt-10 -80.08 108.75 13.91 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.022 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.751 ' O ' ' CB ' ' B' ' 72' ' ' ALA . 0.8 OUTLIER -155.95 119.71 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.647 -1.283 . . . . 0.0 113.516 -178.231 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . 0.759 ' HB2' ' O ' ' B' ' 57' ' ' ALA . . . 138.78 138.5 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.962 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.06 178.355 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 73' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -94.26 127.97 0.54 Allowed 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.22 1.947 . . . . 0.0 109.687 178.817 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 74' ' ' SER . . . . . 0.466 ' N ' ' CE2' ' A' ' 94' ' ' TYR . 0.3 OUTLIER -153.65 141.27 19.91 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.881 -1.137 . . . . 0.0 111.427 -179.989 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . 0.527 ' HB ' ' CD1' ' A' ' 94' ' ' TYR . 0.3 OUTLIER -100.83 172.63 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.55 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . 0.518 ' HA3' ' CG2' ' B' ' 53' ' ' VAL . . . -114.89 88.2 0.47 Allowed Glycine 0 N--CA 1.491 2.303 0 C-N-CA 118.539 -1.791 . . . . 0.0 110.494 -179.178 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.626 ' HA ' ' HA ' ' B' ' 52' ' ' PRO . 5.0 p -69.62 68.58 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.354 -1.086 . . . . 0.0 108.308 178.349 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 78' ' ' SER . . . . . 0.443 ' N ' ' O ' ' B' ' 76' ' ' GLY . 0.3 OUTLIER -59.93 -153.8 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 121.895 0.855 . . . . 0.0 110.953 -179.073 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . 0.72 ' HA ' ' HA ' ' B' ' 50' ' ' ILE . 3.1 p -157.19 -169.49 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 179.805 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 80' ' ' LYS . . . . . 0.43 ' CB ' ' CD ' ' B' ' 81' ' ' PRO . 0.9 OUTLIER -140.38 175.29 3.24 Favored Pre-proline 0 C--N 1.307 -1.25 0 C-N-CA 117.651 -1.62 . . . . 0.0 113.126 -179.692 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 81' ' ' PRO . . . . . 0.43 ' CD ' ' CB ' ' B' ' 80' ' ' LYS . 58.9 Cg_endo -111.52 119.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 124.78 3.653 . . . . 0.0 111.185 -179.075 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . 0.663 ' HA3' ' C ' ' B' ' 47' ' ' PHE . . . -123.78 144.6 15.6 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 177.934 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . 0.423 ' HA ' ' HB2' ' B' ' 86' ' ' LYS . 8.0 pm0 -85.3 -23.62 28.04 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.156 -1.203 . . . . 0.0 111.59 -178.882 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 84' ' ' SER . . . . . 0.408 ' CB ' ' O ' ' B' ' 45' ' ' THR . 5.4 t -51.16 -30.96 18.29 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.051 -1.031 . . . . 0.0 108.42 179.283 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . 0.706 ' HB2' ' OG1' ' A' ' 33' ' ' THR . 0.1 OUTLIER -87.2 -40.52 14.5 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.172 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 86' ' ' LYS . . . . . 0.472 ' CG ' HG23 ' A' ' 77' ' ' VAL . 3.1 mtpp -64.24 -26.39 68.48 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.059 -1.057 . . . . 0.0 109.129 178.68 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -81.37 -36.01 30.13 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 178.343 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.6 ' O ' ' HB2' ' A' ' 37' ' ' ALA . . . -66.37 -37.98 86.52 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 176.737 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . 0.638 ' HA ' ' HA ' ' A' ' 37' ' ' ALA . . . -61.43 -35.06 76.51 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.414 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.2 -32.87 64.79 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 176.751 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . 0.408 ' C ' ' H ' ' B' ' 93' ' ' LYS . . . -66.42 -36.94 92.28 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 178.288 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . 0.516 ' O ' ' CB ' ' B' ' 93' ' ' LYS . 0.4 OUTLIER -69.65 7.1 0.93 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.902 -1.352 . . . . 0.0 110.658 179.553 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . 0.516 ' CB ' ' O ' ' B' ' 92' ' ' LEU . 6.5 tptm 72.99 43.41 0.41 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -177.76 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . 0.567 ' CD1' ' HA ' ' A' ' 75' ' ' VAL . 0.2 OUTLIER -41.31 -33.47 0.39 Allowed 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.422 -179.542 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -61.51 -43.19 99.3 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.193 -0.942 . . . . 0.0 109.323 179.299 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.3 -36.81 76.27 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 177.77 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 97' ' ' PHE . . . . . 0.403 ' HB3' ' CB ' ' A' ' 54' ' ' ALA . 0.1 OUTLIER -63.77 -28.51 69.92 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.967 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.35 -52.17 24.62 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.372 0.606 . . . . 0.0 110.237 179.865 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 28.9 mtmt . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.255 -179.939 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.662 ' CB ' HG22 ' B' ' 42' ' ' VAL . 1.2 mtp . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.404 ' HA ' ' O ' ' B' ' 43' ' ' GLN . 3.2 t-20 -174.12 -167.55 0.35 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.884 -1.135 . . . . 0.0 111.736 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.435 ' NZ ' ' HA ' ' A' ' 26' ' ' ALA . 0.4 OUTLIER -53.02 -11.56 0.25 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.574 -0.704 . . . . 0.0 110.847 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.707 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 19.6 m -116.47 -42.48 3.0 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.026 -1.046 . . . . 0.0 109.538 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.588 ' CB ' ' HA ' ' A' ' 1' ' ' MET . 0.4 OUTLIER -62.13 -54.31 42.95 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.164 -0.96 . . . . 0.0 108.612 179.073 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.876 HD11 ' CG1' ' B' ' 42' ' ' VAL . 9.9 mt -57.93 -29.32 65.04 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.318 -0.864 . . . . 0.0 108.974 177.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.867 HG23 ' HB ' ' A' ' 21' ' ' VAL . 0.6 OUTLIER -55.17 -58.62 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.85 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.929 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -61.06 -28.19 68.89 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.625 -0.83 . . . . 0.0 108.761 178.235 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.669 ' HB3' ' O ' ' A' ' 6' ' ' LEU . . . -61.16 -32.59 72.32 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.361 -0.837 . . . . 0.0 109.064 179.095 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.814 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.7 OUTLIER -97.52 -34.84 4.97 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.446 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 178.465 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.929 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -61.22 -26.89 68.04 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 177.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.413 ' CG ' ' N ' ' A' ' 13' ' ' ASP . 11.0 pt20 -91.56 -39.85 11.68 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.446 ' HB2' ' HA ' ' A' ' 10' ' ' ILE . 43.8 m-20 -66.21 -22.89 66.36 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 176.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.948 HG22 ' HB2' ' B' ' 20' ' ' SER . 16.8 p -93.0 -76.12 0.48 Allowed 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.302 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 58.63 14.52 22.06 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.903 HD12 ' HB ' ' A' ' 14' ' ' THR . 1.7 mp -80.79 -50.89 9.26 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.365 -1.079 . . . . 0.0 108.465 179.102 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.6 HG22 ' H ' ' A' ' 19' ' ' VAL . 0.5 OUTLIER -150.7 0.74 0.42 Allowed 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 120.266 -0.573 . . . . 0.0 110.619 -179.655 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.593 ' O ' ' C ' ' A' ' 19' ' ' VAL . 9.1 mt-30 55.64 29.66 14.03 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 -176.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 1.056 HG11 HG11 ' B' ' 19' ' ' VAL . 0.7 OUTLIER -4.98 -95.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.714 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . 1.092 ' O ' ' N ' ' A' ' 22' ' ' SER . 0.1 OUTLIER -132.45 24.42 4.43 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 178.292 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.867 ' HB ' HG23 ' A' ' 7' ' ' ILE . 13.4 m -4.29 -40.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 CA-C-O 122.417 1.104 . . . . 0.0 110.898 -178.422 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . 1.092 ' N ' ' O ' ' A' ' 20' ' ' SER . 8.6 t -79.92 -40.77 27.45 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.335 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.862 ' N ' ' O ' ' A' ' 20' ' ' SER . 1.7 ttpt -84.73 -27.71 26.79 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.412 -0.805 . . . . 0.0 111.366 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.547 ' CE ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -78.45 -40.39 35.78 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 117.895 -1.522 . . . . 0.0 109.751 179.627 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.727 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 0.2 OUTLIER -78.8 -49.21 13.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.585 -1.322 . . . . 0.0 109.837 178.842 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 22' ' ' SER . . . -55.04 -34.23 63.34 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.63 ' HA ' ' HB3' ' A' ' 30' ' ' LYS . 20.7 t -85.16 -29.64 24.59 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.744 -0.783 . . . . 0.0 108.99 178.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.732 ' HA ' ' CG1' ' A' ' 31' ' ' ILE . 0.2 OUTLIER -59.81 -39.27 84.45 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.442 -0.786 . . . . 0.0 109.101 179.165 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.553 ' HB3' HG21 ' B' ' 45' ' ' THR . 4.5 mt-10 -79.21 -31.96 43.86 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.974 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 24.7 tttm -69.74 -25.86 64.04 Favored 'General case' 0 C--O 1.188 -2.179 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 176.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.732 ' CG1' ' HA ' ' A' ' 28' ' ' PHE . 1.9 pp -97.59 -31.33 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.957 -1.09 . . . . 0.0 109.157 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.666 HG21 ' CE1' ' B' ' 47' ' ' PHE . 2.0 mm -63.68 -56.16 18.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 177.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.49 ' HA ' ' HB3' ' B' ' 85' ' ' LEU . 0.4 OUTLIER -68.82 -36.98 78.89 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.39 -0.823 . . . . 0.0 108.882 179.313 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.974 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 59.4 mm-40 -74.98 -32.84 61.78 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.554 -0.716 . . . . 0.0 111.652 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.552 ' N ' ' O ' ' A' ' 31' ' ' ILE . 24.2 m -67.66 -58.14 5.18 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 118.221 -1.391 . . . . 0.0 108.988 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.788 ' O ' ' HG3' ' A' ' 52' ' ' PRO . 0.7 OUTLIER -51.29 -35.65 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 178.447 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.788 ' HB1' ' C ' ' B' ' 88' ' ' ALA . . . -73.32 -27.9 61.78 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.082 178.266 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.606 ' N ' HD12 ' B' ' 92' ' ' LEU . 0.0 OUTLIER -75.78 -25.77 56.71 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 177.982 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.413 ' HA3' ' CE ' ' B' ' 93' ' ' LYS . . . 108.97 27.58 4.8 Favored Glycine 0 C--N 1.295 -1.706 0 C-N-CA 120.075 -1.059 . . . . 0.0 111.403 177.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.527 ' HB2' HG23 ' A' ' 35' ' ' THR . 0.2 OUTLIER -108.46 151.65 25.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.123 -1.222 . . . . 0.0 109.651 179.011 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -76.69 81.61 3.32 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.374 -0.829 . . . . 0.0 110.421 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.491 ' CG2' ' CG2' ' A' ' 35' ' ' THR . 60.7 t -68.29 140.63 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.448 -0.782 . . . . 0.0 109.8 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.487 ' HG2' ' HA ' ' B' ' 2' ' ' ASN . 4.2 pt20 -158.85 174.17 15.4 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.372 -0.83 . . . . 0.0 109.76 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.929 HD22 ' CE1' ' B' ' 28' ' ' PHE . 27.9 mt -127.5 115.22 18.53 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.441 -0.787 . . . . 0.0 109.244 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.566 HG23 ' HD1' ' A' ' 47' ' ' PHE . 0.0 OUTLIER 33.2 -95.54 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.89 -0.507 . . . . 0.0 111.566 -179.599 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.468 ' H ' HG23 ' A' ' 45' ' ' THR . . . -139.73 25.06 2.72 Favored Glycine 0 N--CA 1.487 2.083 0 C-N-CA 119.417 -1.373 . . . . 0.0 111.089 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.779 ' CD1' ' HG3' ' B' ' 29' ' ' GLU . 13.3 p90 -122.07 -31.83 3.81 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.616 -1.52 . . . . 0.0 110.538 178.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.898 ' HB2' HD12 ' A' ' 44' ' ' LEU . 8.3 mt -122.09 148.97 44.21 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 119.886 -1.759 . . . . 0.0 111.548 177.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.488 ' N ' ' HB2' ' A' ' 80' ' ' LYS . 0.8 OUTLIER -149.25 77.12 1.35 Allowed 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.289 0.566 . . . . 0.0 110.483 -179.815 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.771 HG22 HG21 ' A' ' 36' ' ' VAL . 43.5 mm -69.63 126.28 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.394 -0.816 . . . . 0.0 109.962 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -140.67 126.33 11.38 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.335 -0.853 . . . . 0.0 108.766 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.788 ' HG3' ' O ' ' A' ' 36' ' ' VAL . 55.2 Cg_endo -86.83 140.37 5.9 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.317 1.167 . . . . 0.0 110.885 -178.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.595 HG22 ' O ' ' A' ' 76' ' ' GLY . 18.4 m -137.28 117.07 15.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-O 122.204 1.002 . . . . 0.0 110.837 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.691 ' HB2' ' CB ' ' B' ' 97' ' ' PHE . . . . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.72 0.771 . . . . 0.0 111.765 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.961 HG11 ' HB3' ' B' ' 89' ' ' ALA . 8.0 p . . . . . 0 N--CA 1.498 1.974 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.595 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -117.93 82.92 0.34 Allowed Glycine 0 N--CA 1.493 2.445 0 C-N-CA 118.556 -1.783 . . . . 0.0 110.285 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.667 HG11 HD13 ' B' ' 85' ' ' LEU . 97.3 t -70.69 74.45 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.146 -1.208 . . . . 0.0 109.165 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.461 ' N ' ' O ' ' A' ' 51' ' ' LYS . 0.4 OUTLIER -58.87 -166.41 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.445 0.641 . . . . 0.0 110.587 -179.68 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.728 HG11 ' HD3' ' B' ' 81' ' ' PRO . 7.9 p -172.21 178.74 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.541 -0.724 . . . . 0.0 109.061 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.592 ' N ' HG22 ' A' ' 79' ' ' VAL . 0.4 OUTLIER -122.04 177.96 1.4 Allowed Pre-proline 0 C--N 1.309 -1.192 0 O-C-N 120.905 -1.122 . . . . 0.0 110.619 179.425 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.419 ' CD ' ' CB ' ' A' ' 80' ' ' LYS . 56.4 Cg_endo -106.32 74.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.302 -1.919 0 C-N-CA 123.739 2.96 . . . . 0.0 109.874 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.718 ' CA ' ' O ' ' A' ' 47' ' ' PHE . . . -56.53 93.83 0.03 OUTLIER Glycine 0 N--CA 1.486 2.032 0 C-N-CA 119.198 -1.477 . . . . 0.0 110.71 -178.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' A' ' 81' ' ' PRO . 2.9 pt-20 -62.2 -28.14 69.47 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.668 -0.901 . . . . 0.0 108.995 178.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.442 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 71.1 m -53.24 -27.66 23.38 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.323 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.644 ' CD2' HG22 ' B' ' 77' ' ' VAL . 4.4 tt -85.74 -30.91 22.72 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.673 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 3.0 tttt -79.9 -40.31 28.53 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.629 0.728 . . . . 0.0 109.139 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -67.73 -37.08 81.71 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 178.256 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.628 ' O ' ' HB1' ' B' ' 37' ' ' ALA . . . -64.12 -36.71 84.94 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 176.331 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.818 ' HB1' ' CG1' ' B' ' 75' ' ' VAL . . . -57.49 -39.34 76.23 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.594 ' HA ' ' HB2' ' A' ' 94' ' ' TYR . 6.3 mm-40 -56.44 -29.07 61.19 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 176.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -70.42 -42.44 64.68 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.795 HD12 ' HB2' ' A' ' 93' ' ' LYS . 0.4 OUTLIER -61.36 -48.94 79.0 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.27 -1.723 . . . . 0.0 110.791 -178.943 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.795 ' HB2' HD12 ' A' ' 92' ' ' LEU . 0.0 OUTLIER 157.06 44.02 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.42 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.577 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.622 ' CD1' ' O ' ' B' ' 75' ' ' VAL . 87.5 t80 -42.48 -54.55 3.83 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.717 -0.615 . . . . 0.0 111.053 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 . . . . . 0 N--CA 1.496 1.854 0 O-C-N 121.087 -1.008 . . . . 0.0 110.557 179.881 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.521 ' HA ' ' CB ' ' B' ' 5' ' ' GLU . 5.3 mtp . . . . . 0 N--CA 1.492 1.653 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 2' ' ' ASN . . . . . 0.861 ' C ' HD12 ' B' ' 6' ' ' LEU . 23.2 p30 -176.47 -174.02 0.56 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.237 -0.914 . . . . 0.0 111.225 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.512 ' HE3' ' CG2' ' A' ' 45' ' ' THR . 0.0 OUTLIER -49.53 -16.37 0.21 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.493 -0.754 . . . . 0.0 110.728 -179.641 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 4' ' ' THR . . . . . 0.58 ' O ' HG13 ' B' ' 7' ' ' ILE . 3.2 m -105.87 -57.53 2.03 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 122.113 0.958 . . . . 0.0 108.716 178.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.521 ' CB ' ' HA ' ' B' ' 1' ' ' MET . 0.4 OUTLIER -50.35 -46.01 55.48 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.838 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.861 HD12 ' C ' ' B' ' 2' ' ' ASN . 6.2 mt -58.02 -31.6 67.14 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.795 -0.762 . . . . 0.0 109.914 178.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 7' ' ' ILE . . . . . 0.606 HG22 ' CD1' ' B' ' 25' ' ' LEU . 0.8 OUTLIER -60.9 -40.39 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 178.827 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 8' ' ' LYS . . . . . 0.852 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.0 OUTLIER -70.43 -31.45 68.64 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 177.865 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 9' ' ' ALA . . . . . 0.557 ' HB1' HD13 ' A' ' 31' ' ' ILE . . . -58.53 -37.95 76.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.6 -0.687 . . . . 0.0 109.152 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.736 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.3 mp -92.89 -30.41 4.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.852 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -67.6 -12.97 61.63 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 118.576 -1.25 . . . . 0.0 108.455 178.298 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.444 ' CG ' ' N ' ' B' ' 13' ' ' ASP . 17.0 pt20 -112.93 -42.0 3.65 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.432 -0.793 . . . . 0.0 109.338 178.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.444 ' N ' ' CG ' ' B' ' 12' ' ' GLN . 0.9 OUTLIER -70.9 -27.43 63.79 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 176.906 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 14' ' ' THR . . . . . 0.98 HG22 ' CD1' ' B' ' 16' ' ' LEU . 0.1 OUTLIER -113.54 -85.76 0.58 Allowed 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 178.143 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 15' ' ' GLY . . . . . 0.571 ' O ' ' C ' ' B' ' 16' ' ' LEU . . . 80.19 -28.26 2.64 Favored Glycine 0 N--CA 1.499 2.885 0 O-C-N 121.031 -1.043 . . . . 0.0 111.062 177.232 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 16' ' ' LEU . . . . . 0.98 ' CD1' HG22 ' B' ' 14' ' ' THR . 5.1 mp -13.93 -66.0 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.519 0 CA-C-O 121.918 0.866 . . . . 0.0 112.062 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 17' ' ' THR . . . . . 0.584 ' CG2' HG21 ' A' ' 17' ' ' THR . 0.6 OUTLIER -139.64 7.62 2.33 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.549 -179.579 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 18' ' ' GLN . . . . . 0.618 ' O ' ' C ' ' B' ' 19' ' ' VAL . 11.4 mt-30 58.95 25.83 14.23 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 -175.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 1.056 HG11 HG11 ' A' ' 19' ' ' VAL . 2.4 p -4.94 -96.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.393 -179.164 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 20' ' ' SER . . . . . 0.961 ' O ' ' N ' ' B' ' 23' ' ' LYS . 0.6 OUTLIER -132.01 23.07 4.54 Favored 'General case' 0 C--N 1.279 -2.462 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 178.045 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.616 ' C ' ' O ' ' B' ' 20' ' ' SER . 30.4 m -24.42 -40.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 122.449 1.119 . . . . 0.0 109.054 -178.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.693 ' N ' ' O ' ' B' ' 20' ' ' SER . 3.2 m -81.95 -36.24 28.19 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.088 177.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 23' ' ' LYS . . . . . 0.961 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.8 OUTLIER -85.19 -37.92 19.58 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.675 -0.641 . . . . 0.0 111.44 179.656 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 24' ' ' MET . . . . . 0.575 ' HG3' ' O ' ' B' ' 20' ' ' SER . 0.0 OUTLIER -68.14 -38.11 81.82 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 117.637 -1.625 . . . . 0.0 108.374 179.156 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.606 ' CD1' HG22 ' B' ' 7' ' ' ILE . 8.8 mt -71.68 -35.5 70.31 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 118.47 -1.292 . . . . 0.0 108.976 178.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 26' ' ' ALA . . . . . 0.475 ' HA ' ' CE ' ' B' ' 3' ' ' LYS . . . -62.96 -37.15 85.95 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 177.109 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 27' ' ' SER . . . . . 0.53 ' O ' ' N ' ' B' ' 31' ' ' ILE . 1.2 p -80.86 -26.59 36.86 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 28' ' ' PHE . . . . . 0.929 ' CE1' HD22 ' A' ' 44' ' ' LEU . 1.8 t80 -55.36 -48.84 73.63 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 29' ' ' GLU . . . . . 0.779 ' HG3' ' CD1' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -69.16 -33.91 74.15 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.869 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 1.228 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 24.1 tttp -64.88 -22.61 67.02 Favored 'General case' 0 C--O 1.191 -1.99 0 C-N-CA 119.012 -1.075 . . . . 0.0 108.374 178.086 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.662 HG13 ' O ' ' B' ' 28' ' ' PHE . 0.7 OUTLIER -104.53 -27.04 3.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 120.271 -1.518 . . . . 0.0 109.345 178.265 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.657 HD11 ' CE2' ' B' ' 28' ' ' PHE . 1.2 mm -70.99 -61.88 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 177.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 33' ' ' THR . . . . . 0.428 ' OG1' ' N ' ' A' ' 85' ' ' LEU . 0.6 OUTLIER -66.73 -37.79 85.37 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.408 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 1.228 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 18.2 mm-40 -76.25 -35.0 59.17 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 121.065 -1.022 . . . . 0.0 111.901 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 35' ' ' THR . . . . . 0.964 HG21 HG23 ' B' ' 42' ' ' VAL . 4.5 m -61.82 -52.8 62.71 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 120.339 -1.476 . . . . 0.0 108.912 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.571 HG22 ' CD ' ' B' ' 52' ' ' PRO . 1.0 OUTLIER -53.35 -38.32 31.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 C-N-CA 118.194 -1.402 . . . . 0.0 107.259 178.71 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 37' ' ' ALA . . . . . 0.628 ' HB1' ' O ' ' A' ' 88' ' ' ALA . . . -83.37 -2.36 55.59 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.832 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 38' ' ' LYS . . . . . 0.576 ' HB2' ' O ' ' B' ' 34' ' ' GLU . 0.0 OUTLIER -100.95 -23.83 14.46 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 177.546 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.05 43.97 1.45 Allowed Glycine 0 C--N 1.301 -1.375 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 40' ' ' ASP . . . . . 0.709 ' CB ' HG23 ' B' ' 35' ' ' THR . 0.1 OUTLIER -138.16 137.92 38.1 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.105 -1.232 . . . . 0.0 110.103 179.366 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 5.7 mttp -90.79 84.17 5.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.461 -0.775 . . . . 0.0 110.916 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.964 HG23 HG21 ' B' ' 35' ' ' THR . 3.5 t -63.54 146.39 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.399 -0.813 . . . . 0.0 109.278 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 43' ' ' GLN . . . . . 0.404 ' O ' ' HA ' ' A' ' 2' ' ' ASN . 1.3 tt0 -138.61 114.1 9.68 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 120.88 -1.138 . . . . 0.0 110.501 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.685 HD22 ' HE2' ' A' ' 28' ' ' PHE . 17.1 mt -85.75 110.99 19.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.187 -0.946 . . . . 0.0 108.784 178.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 45' ' ' THR . . . . . 0.553 HG21 ' HB3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 33.07 -89.83 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.407 0 O-C-N 121.739 -0.601 . . . . 0.0 110.997 -179.441 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 46' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -148.31 22.01 1.38 Allowed Glycine 0 N--CA 1.485 1.917 0 C-N-CA 119.818 -1.182 . . . . 0.0 110.176 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 47' ' ' PHE . . . . . 0.666 ' CE1' HG21 ' A' ' 32' ' ' ILE . 14.4 p90 -118.14 -34.91 3.97 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.832 -1.393 . . . . 0.0 112.111 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.633 ' HB2' HD12 ' B' ' 44' ' ' LEU . 0.0 OUTLIER -115.76 92.06 3.79 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.805 -1.185 . . . . 0.0 110.692 179.428 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 49' ' ' ASN . . . . . 0.659 ' O ' ' HB ' ' B' ' 79' ' ' VAL . 1.1 t-20 -79.96 60.82 3.65 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.88 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 50' ' ' ILE . . . . . 0.811 HD13 HG21 ' B' ' 79' ' ' VAL . 32.2 mm -56.34 116.92 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.314 -0.867 . . . . 0.0 111.62 -177.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 51' ' ' LYS . . . . . 0.552 ' O ' ' HG3' ' B' ' 51' ' ' LYS . 6.9 ptmt -169.97 126.17 0.73 Allowed Pre-proline 0 N--CA 1.488 1.435 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 52' ' ' PRO . . . . . 0.571 ' CD ' HG22 ' B' ' 36' ' ' VAL . 54.8 Cg_endo -79.32 144.76 18.42 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.433 1.228 . . . . 0.0 112.158 -177.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.5 ' O ' HG23 ' B' ' 53' ' ' VAL . 30.0 m -150.31 122.17 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.276 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 54' ' ' ALA . . . . . 0.508 ' HB2' ' N ' ' B' ' 75' ' ' VAL . . . . . . . . 0 C--N 1.299 -1.61 0 C-N-CA 118.96 -1.096 . . . . 0.0 111.535 -177.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 75' ' ' VAL . . . . . 0.818 ' CG1' ' HB1' ' A' ' 89' ' ' ALA . 84.3 t . . . . . 0 N--CA 1.526 3.335 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -143.57 -142.65 3.98 Favored Glycine 0 N--CA 1.491 2.305 0 O-C-N 120.285 -1.509 . . . . 0.0 110.559 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.644 HG22 ' CD2' ' A' ' 85' ' ' LEU . 11.3 t -141.57 83.55 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-O 121.982 0.896 . . . . 0.0 109.734 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 78' ' ' SER . . . . . 0.49 ' HB3' ' HG3' ' B' ' 51' ' ' LYS . 0.1 OUTLIER -58.44 -45.04 89.31 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.586 0.707 . . . . 0.0 110.947 179.343 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.811 HG21 HD13 ' B' ' 50' ' ' ILE 0.284 7.5 p -46.9 172.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-O 122.438 1.113 . . . . 0.0 113.791 -174.52 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 80' ' ' LYS . . . . . 0.64 ' HB2' ' HD2' ' B' ' 81' ' ' PRO . 0.3 OUTLIER 178.15 175.74 0.32 Allowed Pre-proline 0 N--CA 1.48 1.03 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -179.625 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 81' ' ' PRO . . . . . 0.728 ' HD3' HG11 ' A' ' 79' ' ' VAL . 47.1 Cg_endo -72.84 137.99 27.97 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.374 1.197 . . . . 0.0 109.583 177.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 82' ' ' GLY . . . . . 0.546 ' O ' HD12 ' B' ' 85' ' ' LEU . . . -101.67 -161.02 26.87 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 83' ' ' GLU . . . . . 0.473 ' HA ' ' HB2' ' B' ' 86' ' ' LYS . 0.4 OUTLIER -91.11 -10.64 41.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.418 -1.048 . . . . 0.0 110.417 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -54.93 -36.69 65.52 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.252 -0.905 . . . . 0.0 109.977 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.667 HD13 HG11 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -85.4 -33.42 21.97 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 119.629 -0.828 . . . . 0.0 108.852 179.198 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 86' ' ' LYS . . . . . 0.612 ' HG2' HG13 ' A' ' 75' ' ' VAL . 8.6 mttt -69.38 -34.09 74.01 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.653 -0.819 . . . . 0.0 109.264 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 87' ' ' LYS . . . . . 0.526 ' O ' ' HG3' ' B' ' 90' ' ' GLU . 35.8 tptt -73.15 -38.17 66.32 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 177.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.788 ' C ' ' HB1' ' A' ' 37' ' ' ALA . . . -67.71 -34.23 76.46 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 177.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.961 ' HB3' HG11 ' A' ' 75' ' ' VAL . . . -72.16 -45.21 61.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.79 -0.569 . . . . 0.0 110.45 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 90' ' ' GLU . . . . . 0.526 ' HG3' ' O ' ' B' ' 87' ' ' LYS . 0.6 OUTLIER -56.82 -19.31 16.63 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.622 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 91' ' ' GLY . . . . . 0.853 ' C ' HD23 ' B' ' 92' ' ' LEU . . . -93.93 -24.58 19.68 Favored Glycine 0 CA--C 1.547 2.089 0 CA-C-O 118.467 -1.185 . . . . 0.0 113.57 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 92' ' ' LEU . . . . . 0.853 HD23 ' C ' ' B' ' 91' ' ' GLY . 0.1 OUTLIER -113.03 -71.67 0.74 Allowed 'General case' 0 N--CA 1.507 2.381 0 CA-C-N 122.27 3.035 . . . . 0.0 113.171 -177.924 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 93' ' ' LYS . . . . . 0.459 ' O ' ' CD2' ' B' ' 97' ' ' PHE . 0.0 OUTLIER -113.0 36.58 3.44 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.803 -1.186 . . . . 0.0 112.459 -177.462 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 94' ' ' TYR . . . . . 0.512 ' HB2' ' HA ' ' B' ' 90' ' ' GLU . 6.2 t80 -71.24 -53.63 13.72 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 119.241 -0.984 . . . . 0.0 109.371 178.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -71.72 -31.53 66.81 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.41 -34.84 69.32 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 97' ' ' PHE . . . . . 0.691 ' CB ' ' HB2' ' A' ' 54' ' ' ALA . 7.4 m-85 . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.759 ' SD ' HG21 ' B' ' 35' ' ' THR . 2.3 mtp . . . . . 0 N--CA 1.494 1.768 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.465 ' HA ' ' O ' ' B' ' 43' ' ' GLN . 49.9 p-10 -166.93 -158.3 0.29 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.005 -1.059 . . . . 0.0 111.794 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.426 ' CD ' ' HA ' ' A' ' 26' ' ' ALA . 2.1 mmtp -56.02 -8.04 0.41 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.472 -0.768 . . . . 0.0 111.352 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.758 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 33.8 m -123.82 -41.95 2.21 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 120.854 -1.154 . . . . 0.0 109.885 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.522 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -61.9 -54.94 34.96 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.015 -1.053 . . . . 0.0 108.2 179.0 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.88 HD11 ' CG1' ' B' ' 42' ' ' VAL . 6.9 mt -56.38 -29.24 61.2 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.592 -0.843 . . . . 0.0 109.179 177.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.919 HG23 ' HB ' ' A' ' 21' ' ' VAL . 0.8 OUTLIER -55.94 -59.73 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.47 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.892 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 0.1 OUTLIER -60.96 -28.56 69.07 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.224 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.65 ' HB3' ' O ' ' A' ' 6' ' ' LEU . . . -59.61 -33.96 72.16 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.554 -0.858 . . . . 0.0 108.991 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.772 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.6 OUTLIER -95.44 -36.14 6.48 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.422 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 178.318 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.892 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -57.98 -23.98 56.19 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.719 -0.793 . . . . 0.0 108.89 178.175 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -93.13 -44.2 8.49 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.48 ' OD2' HG21 ' B' ' 31' ' ' ILE . 96.5 m-20 -62.46 -31.39 72.11 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 177.106 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.772 ' OG1' ' O ' ' A' ' 10' ' ' ILE . 28.2 p -83.25 -75.44 0.32 Allowed 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 177.342 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 59.02 18.8 42.32 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.001 -1.239 . . . . 0.0 110.001 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.975 HD22 ' O ' ' B' ' 19' ' ' VAL . 3.5 mp -87.41 -53.66 4.7 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.326 -1.102 . . . . 0.0 109.112 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.579 HG22 ' H ' ' A' ' 19' ' ' VAL . 0.5 OUTLIER -149.89 4.99 0.57 Allowed 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 120.021 -0.671 . . . . 0.0 110.596 -178.991 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.556 ' O ' ' C ' ' A' ' 19' ' ' VAL . 16.8 mt-30 56.48 26.68 11.16 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 -176.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 1.157 HG11 HG11 ' B' ' 19' ' ' VAL . 1.7 p -3.24 -94.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.9 -179.065 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.947 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -131.69 25.13 4.72 Favored 'General case' 0 C--N 1.28 -2.453 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 179.729 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.919 ' HB ' HG23 ' A' ' 7' ' ' ILE . 5.6 m -17.27 -39.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-O 122.464 1.125 . . . . 0.0 110.12 -178.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.871 ' N ' ' O ' ' A' ' 20' ' ' SER . 16.3 p -80.85 -37.27 30.25 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.038 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.947 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.5 OUTLIER -88.7 -28.83 20.3 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.442 -0.786 . . . . 0.0 111.186 179.878 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.847 ' HB3' HG23 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -76.83 -38.55 53.61 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 117.875 -1.53 . . . . 0.0 109.288 179.744 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.745 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 0.3 OUTLIER -80.21 -48.35 13.25 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 118.172 -1.411 . . . . 0.0 109.365 178.827 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 22' ' ' SER . . . -54.55 -34.33 61.66 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 119.054 -1.058 . . . . 0.0 108.217 178.202 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.615 ' O ' ' N ' ' A' ' 31' ' ' ILE . 25.1 p -87.21 -31.02 20.55 Favored 'General case' 0 C--O 1.203 -1.364 0 C-N-CA 119.696 -0.802 . . . . 0.0 109.381 178.58 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.769 ' HB2' HD11 ' B' ' 10' ' ' ILE . 0.1 OUTLIER -56.57 -38.23 71.67 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.2 -0.938 . . . . 0.0 108.927 179.079 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.634 ' HB3' HG21 ' B' ' 45' ' ' THR . 1.0 OUTLIER -82.15 -33.93 29.35 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 178.146 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.987 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 20.1 tttt -68.45 -21.47 64.64 Favored 'General case' 0 C--O 1.189 -2.097 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 176.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 1.07 HD13 ' HB1' ' B' ' 9' ' ' ALA . 1.3 pp -102.31 -30.49 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.878 -1.139 . . . . 0.0 109.448 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.719 HG21 ' CZ ' ' B' ' 47' ' ' PHE . 2.1 mm -65.87 -56.4 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 177.099 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.707 HG23 ' HB2' ' B' ' 88' ' ' ALA . 0.4 OUTLIER -64.95 -49.43 70.37 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 178.559 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.987 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 15.4 mm-40 -62.52 -32.04 72.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.46 -0.775 . . . . 0.0 111.044 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.83 HG23 ' CB ' ' A' ' 40' ' ' ASP . 1.2 m -56.25 -53.11 61.09 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 178.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.069 HG21 HD12 ' B' ' 85' ' ' LEU . 13.4 t -54.89 -34.38 30.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 C-N-CA 117.91 -1.516 . . . . 0.0 106.975 177.173 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.727 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -79.29 -3.58 46.7 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.126 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -108.53 -18.51 13.71 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.34 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 35' ' ' THR . . . 95.77 43.85 3.26 Favored Glycine 0 C--N 1.303 -1.266 0 C-N-CA 120.209 -0.996 . . . . 0.0 110.657 178.344 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.83 ' CB ' HG23 ' A' ' 35' ' ' THR . 0.2 OUTLIER -125.71 127.05 45.62 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.125 -1.22 . . . . 0.0 110.222 179.236 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.1 mtmt -77.64 87.66 3.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.566 -0.708 . . . . 0.0 110.065 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 1.129 HG13 HD11 ' B' ' 6' ' ' LEU . 93.0 t -60.04 123.29 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.571 -0.706 . . . . 0.0 110.238 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -121.86 94.8 4.42 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.517 -0.739 . . . . 0.0 109.357 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.702 HD12 ' CB ' ' A' ' 48' ' ' LEU . 12.1 mt -72.52 104.28 3.79 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.336 -0.852 . . . . 0.0 110.411 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.499 HG21 ' HG3' ' B' ' 29' ' ' GLU . 0.1 OUTLIER 31.24 -90.28 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 O-C-N 122.108 -0.37 . . . . 0.0 111.508 179.504 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -148.74 19.67 1.28 Allowed Glycine 0 N--CA 1.486 2.022 0 C-N-CA 119.746 -1.216 . . . . 0.0 110.272 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.704 ' CD1' ' HG3' ' B' ' 29' ' ' GLU . 6.1 p90 -120.7 -22.03 6.47 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.879 -1.365 . . . . 0.0 111.853 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.702 ' CB ' HD12 ' A' ' 44' ' ' LEU . 4.6 mt -129.08 102.71 6.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.229 -1.545 . . . . 0.0 110.632 177.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.77 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 1.3 m120 -99.67 89.71 4.22 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.853 -0.53 . . . . 0.0 111.696 -178.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.63 ' HA ' ' HA ' ' A' ' 79' ' ' VAL . 0.9 OUTLIER -90.19 148.17 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.242 0 O-C-N 121.39 -0.818 . . . . 0.0 110.777 179.376 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.407 ' CE ' ' HB3' ' A' ' 78' ' ' SER . 0.2 OUTLIER -164.64 110.22 0.86 Allowed Pre-proline 0 N--CA 1.504 2.262 0 O-C-N 120.881 -1.137 . . . . 0.0 111.367 179.265 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.94 ' HB3' HG13 ' A' ' 36' ' ' VAL . 55.8 Cg_endo -78.53 141.43 17.66 Favored 'Trans proline' 0 N--CA 1.489 1.253 0 O-C-N 123.635 1.334 . . . . 0.0 112.264 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.702 ' O ' ' N ' ' A' ' 76' ' ' GLY . 33.9 m -151.39 115.66 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 CA-C-O 121.355 0.597 . . . . 0.0 110.38 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.559 ' HB2' ' HB3' ' B' ' 97' ' ' PHE . . . . . . . . 0 N--CA 1.504 2.255 0 CA-C-O 121.599 0.714 . . . . 0.0 112.513 -178.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.666 ' N ' ' HB1' ' B' ' 89' ' ' ALA . 0.4 OUTLIER . . . . . 0 N--CA 1.498 1.926 0 CA-C-O 121.269 0.557 . . . . 0.0 110.061 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.768 ' O ' ' N ' ' A' ' 78' ' ' SER . . . -99.31 53.93 1.01 Allowed Glycine 0 N--CA 1.484 1.862 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 1.052 HG11 ' O ' ' B' ' 84' ' ' SER . 4.5 p -50.91 69.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.922 -0.752 . . . . 0.0 109.971 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.768 ' N ' ' O ' ' A' ' 76' ' ' GLY . 1.0 OUTLIER -70.39 175.78 4.47 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 118.815 -1.154 . . . . 0.0 109.329 -179.771 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.77 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 0.7 OUTLIER 176.46 175.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 179.644 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.65 ' O ' HD23 ' A' ' 48' ' ' LEU . 0.4 OUTLIER -176.1 174.5 0.76 Allowed Pre-proline 0 C--N 1.299 -1.622 0 O-C-N 121.159 -0.963 . . . . 0.0 109.865 178.521 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.819 ' HB2' HG11 ' B' ' 77' ' ' VAL . 54.2 Cg_endo -88.11 169.56 6.25 Favored 'Trans proline' 0 C--N 1.293 -2.368 0 O-C-N 124.529 1.805 . . . . 0.0 108.255 176.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.613 ' CA ' ' HA ' ' A' ' 47' ' ' PHE . . . -150.15 133.64 4.46 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 107.307 -2.317 . . . . 0.0 107.307 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.879 ' O ' ' N ' ' A' ' 85' ' ' LEU . 8.6 tt0 51.09 32.63 7.99 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.142 -1.211 . . . . 0.0 107.901 -177.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.904 ' C ' HD22 ' A' ' 85' ' ' LEU . 1.6 t 8.94 45.83 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 122.45 1.119 . . . . 0.0 110.204 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 1.015 HD12 ' OG1' ' B' ' 33' ' ' THR . 0.0 OUTLIER 19.2 27.6 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 104.026 -2.583 . . . . 0.0 104.026 -171.353 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.582 ' HB2' ' CB ' ' A' ' 84' ' ' SER 0.339 7.9 tttt -66.16 -45.71 79.96 Favored 'General case' 0 CA--C 1.475 -1.914 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 178.497 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.03 -34.42 76.19 Favored 'General case' 0 C--N 1.281 -2.403 0 CA-C-N 112.445 -2.161 . . . . 0.0 106.118 177.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 1.07 ' C ' ' HB1' ' B' ' 37' ' ' ALA . . . -81.59 -30.02 33.12 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 117.764 -1.574 . . . . 0.0 107.585 178.065 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.696 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . -73.25 -27.66 61.7 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.497 ' N ' ' O ' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -67.07 -30.02 69.96 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 174.468 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -56.99 -50.05 66.98 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 177.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.873 ' O ' HD12 ' A' ' 92' ' ' LEU . 0.6 OUTLIER -80.52 17.72 1.05 Allowed 'General case' 0 N--CA 1.502 2.154 0 O-C-N 120.62 -1.518 . . . . 0.0 110.506 179.317 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.477 ' CB ' ' O ' ' A' ' 92' ' ' LEU . 0.0 OUTLIER 71.72 67.09 0.15 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.305 -0.872 . . . . 0.0 109.387 -179.393 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.497 ' CD1' ' N ' ' B' ' 75' ' ' VAL . 0.0 OUTLIER -45.64 -36.26 4.68 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.706 -0.621 . . . . 0.0 109.923 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 . . . . . 0 N--CA 1.492 1.645 0 O-C-N 121.47 -0.769 . . . . 0.0 109.764 179.748 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.55 ' HA ' ' CB ' ' B' ' 5' ' ' GLU . 11.6 mtp . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 120.879 0.371 . . . . 0.0 110.169 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -174.83 -166.71 0.25 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.086 -1.009 . . . . 0.0 111.303 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.459 ' CE ' ' HB2' ' B' ' 29' ' ' GLU . 0.0 OUTLIER -52.04 -11.48 0.17 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.408 -0.807 . . . . 0.0 111.471 -179.267 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 4' ' ' THR . . . . . 0.564 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 59.6 m -115.59 -44.01 2.99 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.93 -1.106 . . . . 0.0 109.376 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.583 ' HA ' ' HE2' ' B' ' 8' ' ' LYS . 0.0 OUTLIER -62.07 -51.47 67.8 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.893 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 1.129 HD11 HG13 ' A' ' 42' ' ' VAL . 6.2 mt -62.99 -30.76 71.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.374 -0.829 . . . . 0.0 108.869 178.305 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 7' ' ' ILE . . . . . 0.821 HG23 ' HB ' ' B' ' 21' ' ' VAL . 0.6 OUTLIER -53.17 -54.38 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.369 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 8' ' ' LYS . . . . . 0.906 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 14.1 mtmt -59.44 -36.5 76.04 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.714 -0.846 . . . . 0.0 108.714 178.199 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 9' ' ' ALA . . . . . 1.07 ' HB1' HD13 ' A' ' 31' ' ' ILE . . . -52.71 -34.63 53.19 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.819 -0.753 . . . . 0.0 109.243 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.847 HG23 ' HB3' ' A' ' 24' ' ' MET . 1.2 mp -97.15 -35.74 5.66 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.425 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.906 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -60.09 -25.91 65.78 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.71 -0.796 . . . . 0.0 108.878 178.501 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.441 ' CG ' ' N ' ' B' ' 13' ' ' ASP . 16.6 pt20 -92.77 -41.2 10.25 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.35 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.448 ' OD2' HG21 ' A' ' 31' ' ' ILE . 1.3 m-20 -65.13 -22.49 66.94 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 176.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 14' ' ' THR . . . . . 0.846 ' OG1' ' O ' ' B' ' 10' ' ' ILE . 24.5 p -96.33 -78.38 0.47 Allowed 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.033 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 61.87 12.42 35.47 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 16' ' ' LEU . . . . . 0.883 HD22 ' O ' ' A' ' 19' ' ' VAL . 3.7 mp -78.19 -54.57 6.1 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.433 -1.039 . . . . 0.0 108.652 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 17' ' ' THR . . . . . 0.586 HG22 ' H ' ' B' ' 19' ' ' VAL . 0.5 OUTLIER -151.01 6.21 0.5 Allowed 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.3 -179.13 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 18' ' ' GLN . . . . . 0.555 ' O ' ' C ' ' B' ' 19' ' ' VAL . 16.4 mt-30 56.92 25.8 10.97 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 -176.354 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 1.157 HG11 HG11 ' A' ' 19' ' ' VAL . 2.3 p -0.28 -94.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.118 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 20' ' ' SER . . . . . 0.94 ' O ' ' N ' ' B' ' 23' ' ' LYS . 0.0 OUTLIER -130.17 24.12 5.23 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.821 ' HB ' HG23 ' B' ' 7' ' ' ILE . 15.5 m -22.7 -40.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-O 122.446 1.117 . . . . 0.0 109.259 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.76 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.3 OUTLIER -76.32 -36.57 58.22 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.092 178.167 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 23' ' ' LYS . . . . . 0.94 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.0 OUTLIER -95.1 -28.29 15.15 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 118.786 -1.166 . . . . 0.0 111.13 179.125 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 24' ' ' MET . . . . . 0.755 ' N ' ' OG ' ' B' ' 20' ' ' SER . 0.0 OUTLIER -70.41 -35.14 73.25 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 116.761 -1.976 . . . . 0.0 108.241 179.123 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.666 HD12 HG13 ' B' ' 7' ' ' ILE . 0.3 OUTLIER -83.12 -41.75 18.17 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 118.2 -1.4 . . . . 0.0 109.24 178.315 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 26' ' ' ALA . . . . . 0.408 ' CB ' ' O ' ' B' ' 22' ' ' SER . . . -64.3 -34.88 79.16 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 177.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 27' ' ' SER . . . . . 0.599 ' CB ' ' O ' ' B' ' 23' ' ' LYS . 7.3 t -84.7 -28.24 26.48 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 119.447 -0.901 . . . . 0.0 108.575 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 28' ' ' PHE . . . . . 0.722 ' HB2' HD11 ' A' ' 10' ' ' ILE . 0.7 OUTLIER -51.05 -44.44 61.11 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.996 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 29' ' ' GLU . . . . . 0.745 ' O ' ' HB ' ' B' ' 33' ' ' THR . 1.4 tt0 -70.79 -38.63 73.39 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 176.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 1.251 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 6.9 ttpt -60.96 -19.9 61.55 Favored 'General case' 0 C--O 1.192 -1.931 0 C-N-CA 119.302 -0.959 . . . . 0.0 108.636 178.021 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.637 HG13 ' O ' ' B' ' 28' ' ' PHE . 0.8 OUTLIER -108.48 -28.67 2.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 120.111 -1.618 . . . . 0.0 109.366 178.276 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.624 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.2 mm -73.53 -59.78 3.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 176.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 33' ' ' THR . . . . . 1.015 ' OG1' HD12 ' A' ' 85' ' ' LEU . 0.9 OUTLIER -66.67 -38.98 87.94 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 114.748 -1.114 . . . . 0.0 108.658 179.159 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 1.251 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 75.6 mm-40 -77.52 -39.54 45.82 Favored 'General case' 0 C--O 1.205 -1.262 0 O-C-N 121.029 -1.044 . . . . 0.0 112.788 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 35' ' ' THR . . . . . 0.759 HG21 ' SD ' ' A' ' 1' ' ' MET . 98.1 m -63.13 -51.19 67.48 Favored 'General case' 0 N--CA 1.504 2.268 0 CA-C-N 121.206 1.821 . . . . 0.0 110.13 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.927 ' CG2' HG22 ' B' ' 50' ' ' ILE . 0.9 OUTLIER -53.97 -41.46 49.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 178.042 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 37' ' ' ALA . . . . . 1.07 ' HB1' ' C ' ' A' ' 88' ' ' ALA . . . -86.38 3.14 44.91 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.291 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 38' ' ' LYS . . . . . 0.761 ' HB2' ' O ' ' B' ' 34' ' ' GLU . 0.0 OUTLIER -102.71 -36.33 8.34 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.468 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 141.16 33.2 0.13 Allowed Glycine 0 C--N 1.302 -1.36 0 C-N-CA 119.056 -1.545 . . . . 0.0 111.56 178.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 40' ' ' ASP . . . . . 0.459 ' HB3' ' CG2' ' B' ' 35' ' ' THR . 0.2 OUTLIER -146.93 158.87 44.04 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.79 -1.418 . . . . 0.0 110.605 179.271 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 33.3 mtpt -101.34 91.46 4.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.455 -0.778 . . . . 0.0 110.007 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.88 ' CG1' HD11 ' A' ' 6' ' ' LEU . 91.5 t -70.78 148.97 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.471 -0.768 . . . . 0.0 110.471 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 43' ' ' GLN . . . . . 0.625 ' O ' HD23 ' B' ' 44' ' ' LEU . 20.5 mt-30 -146.73 165.41 29.72 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.13 -0.981 . . . . 0.0 110.39 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.739 HD22 ' HE2' ' A' ' 28' ' ' PHE . 19.0 mt -122.81 117.42 25.61 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.388 -0.82 . . . . 0.0 109.58 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 45' ' ' THR . . . . . 0.634 HG21 ' HB3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 29.04 -92.47 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.809 -0.557 . . . . 0.0 111.136 179.817 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 46' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -148.61 23.11 1.34 Allowed Glycine 0 N--CA 1.485 1.966 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 47' ' ' PHE . . . . . 0.719 ' CZ ' HG21 ' A' ' 32' ' ' ILE . 0.9 OUTLIER -116.57 -32.83 5.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.135 -1.215 . . . . 0.0 111.252 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.595 ' CB ' HD12 ' B' ' 44' ' ' LEU . 0.1 OUTLIER -118.24 162.85 17.58 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.692 -1.255 . . . . 0.0 112.768 179.856 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 49' ' ' ASN . . . . . 0.74 ' O ' HD13 ' B' ' 50' ' ' ILE . 0.2 OUTLIER -142.1 142.22 32.78 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 178.971 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 50' ' ' ILE . . . . . 0.927 HG22 ' CG2' ' B' ' 36' ' ' VAL . 33.6 mm -138.06 101.91 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.227 -0.921 . . . . 0.0 110.431 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 51' ' ' LYS . . . . . 0.675 ' HA ' HG22 ' B' ' 36' ' ' VAL . 0.0 OUTLIER -157.43 133.5 6.07 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.065 -1.022 . . . . 0.0 109.064 -179.798 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 52' ' ' PRO . . . . . 0.76 ' CG ' HG13 ' B' ' 36' ' ' VAL . 57.9 Cg_endo -93.96 159.61 2.21 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.153 1.081 . . . . 0.0 112.009 -178.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 1.007 HG22 ' O ' ' B' ' 76' ' ' GLY . 28.0 m -137.95 116.83 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-O 121.935 0.874 . . . . 0.0 110.441 177.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 54' ' ' ALA . . . . . 0.497 ' HA ' ' HA ' ' B' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.495 1.789 0 CA-C-O 121.55 0.69 . . . . 0.0 111.991 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 75' ' ' VAL . . . . . 0.599 HG11 ' CB ' ' A' ' 89' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.496 1.839 0 CA-C-O 121.191 0.519 . . . . 0.0 109.829 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 76' ' ' GLY . . . . . 1.007 ' O ' HG22 ' B' ' 53' ' ' VAL . . . -129.67 107.28 0.78 Allowed Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.819 HG11 ' HB2' ' A' ' 81' ' ' PRO . 8.6 p -58.41 86.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.194 -1.18 . . . . 0.0 108.875 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 78' ' ' SER . . . . . 0.547 ' OG ' HG11 ' B' ' 53' ' ' VAL . 0.5 OUTLIER -58.16 -47.32 83.74 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 -178.258 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.91 HG21 ' HA ' ' B' ' 50' ' ' ILE . 17.7 m -48.08 178.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 -173.303 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 80' ' ' LYS . . . . . 0.811 ' HB2' ' HD2' ' B' ' 81' ' ' PRO . 0.0 OUTLIER 179.4 -179.7 0.24 Allowed Pre-proline 0 C--N 1.308 -1.228 0 CA-C-N 113.64 -1.618 . . . . 0.0 107.162 -177.391 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 81' ' ' PRO . . . . . 0.811 ' HD2' ' HB2' ' B' ' 80' ' ' LYS . 39.2 Cg_endo -63.64 153.16 76.82 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 122.989 0.994 . . . . 0.0 111.691 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 82' ' ' GLY . . . . . 0.521 ' C ' ' H ' ' B' ' 84' ' ' SER . . . -117.16 -79.53 0.73 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 107.351 -2.3 . . . . 0.0 107.351 178.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 83' ' ' GLU . . . . . 0.918 ' O ' ' N ' ' B' ' 85' ' ' LEU . 16.9 tt0 -75.71 41.32 0.2 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.523 -0.986 . . . . 0.0 108.707 177.015 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 84' ' ' SER . . . . . 1.052 ' O ' HG11 ' A' ' 77' ' ' VAL . 0.3 OUTLIER 7.8 44.72 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 122.741 1.258 . . . . 0.0 110.453 178.209 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 1.069 HD12 HG21 ' A' ' 36' ' ' VAL . 0.2 OUTLIER 19.08 28.61 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 104.08 -2.563 . . . . 0.0 104.08 -171.577 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 86' ' ' LYS . . . . . 0.475 ' HB2' ' CB ' ' B' ' 84' ' ' SER 0.355 2.7 tttt -58.05 -41.8 84.08 Favored 'General case' 0 CA--C 1.482 -1.658 0 N-CA-C 103.794 -2.669 . . . . 0.0 103.794 176.765 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 87' ' ' LYS . . . . . 0.407 ' O ' ' HG2' ' B' ' 90' ' ' GLU 0.264 0.0 OUTLIER -66.05 -35.92 81.83 Favored 'General case' 0 C--N 1.285 -2.228 0 CA-C-N 111.588 -2.551 . . . . 0.0 105.532 176.236 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.707 ' HB2' HG23 ' A' ' 33' ' ' THR . . . -74.52 -27.3 60.48 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 118.54 -1.264 . . . . 0.0 108.409 178.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.749 ' HA ' HD23 ' B' ' 92' ' ' LEU . . . -62.01 -50.0 73.81 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.114 -0.991 . . . . 0.0 109.264 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 90' ' ' GLU . . . . . 0.445 ' HG2' ' N ' ' B' ' 91' ' ' GLY . 2.7 pt-20 -57.62 -26.69 61.93 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 176.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 91' ' ' GLY . . . . . 0.445 ' N ' ' HG2' ' B' ' 90' ' ' GLU . . . -65.66 -37.53 93.64 Favored Glycine 0 N--CA 1.487 2.055 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.286 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 92' ' ' LEU . . . . . 0.749 HD23 ' HA ' ' B' ' 89' ' ' ALA . 1.1 pp -85.4 22.11 1.6 Allowed 'General case' 0 N--CA 1.504 2.258 0 CA-C-N 119.931 1.865 . . . . 0.0 111.239 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 93' ' ' LYS . . . . . 0.447 ' O ' ' N ' ' B' ' 96' ' ' ASP . 4.0 mmtt 53.65 39.02 29.63 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 -177.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 94' ' ' TYR . . . . . 0.583 ' HA ' HD11 ' B' ' 92' ' ' LEU . 0.0 OUTLIER -36.16 -36.81 0.1 Allowed 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.943 -178.643 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 95' ' ' GLU . . . . . 0.51 ' N ' ' CD1' ' B' ' 94' ' ' TYR . 7.0 pt-20 -60.01 -42.3 94.01 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.332 -0.855 . . . . 0.0 109.609 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 96' ' ' ASP . . . . . 0.447 ' N ' ' O ' ' B' ' 93' ' ' LYS . 0.3 OUTLIER -61.09 -35.08 76.02 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.085 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 97' ' ' PHE . . . . . 0.559 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.505 ' CE ' HD23 ' A' ' 6' ' ' LEU . 6.3 mtp . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 120.837 0.351 . . . . 0.0 110.069 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.689 ' C ' HD12 ' A' ' 6' ' ' LEU . 1.6 t-20 -176.93 -165.31 0.12 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.946 -1.096 . . . . 0.0 111.626 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.552 ' CD ' ' HB ' ' B' ' 45' ' ' THR . 0.4 OUTLIER -51.07 -12.93 0.13 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.511 -0.743 . . . . 0.0 110.802 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.644 ' O ' HG13 ' A' ' 7' ' ' ILE . 74.8 m -112.61 -60.6 1.85 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.172 -0.955 . . . . 0.0 109.938 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.545 ' HA ' ' CE ' ' A' ' 8' ' ' LYS . 4.6 mt-10 -50.17 -41.6 49.61 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.98 -1.075 . . . . 0.0 108.879 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.689 HD12 ' C ' ' A' ' 2' ' ' ASN . 10.1 mt -60.62 -34.51 74.36 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.303 -0.959 . . . . 0.0 109.772 177.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.644 HG13 ' O ' ' A' ' 4' ' ' THR . 1.0 OUTLIER -57.59 -39.74 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 179.089 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.818 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 1.0 OUTLIER -66.97 -36.66 82.69 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.397 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.691 ' HB1' HD13 ' B' ' 31' ' ' ILE . . . -52.39 -39.0 60.33 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 120.214 -0.594 . . . . 0.0 109.447 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.708 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.3 mp -93.93 -29.99 4.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.818 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -63.92 -15.15 58.43 Favored 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 118.496 -1.282 . . . . 0.0 108.858 178.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -115.16 -42.78 3.14 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.405 -0.81 . . . . 0.0 109.352 178.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 9' ' ' ALA . 1.0 OUTLIER -67.12 -26.15 66.54 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 177.071 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . 1.104 HG22 ' CD1' ' A' ' 16' ' ' LEU 0.257 0.2 OUTLIER -112.54 -82.8 0.59 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 178.891 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 16' ' ' LEU . . . 71.15 -11.17 2.89 Favored Glycine 0 N--CA 1.501 2.967 0 O-C-N 121.0 -1.063 . . . . 0.0 111.739 177.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 1.104 ' CD1' HG22 ' A' ' 14' ' ' THR . 4.4 mp -35.73 -64.11 0.32 Allowed 'General case' 0 N--CA 1.511 2.59 0 O-C-N 121.518 -0.989 . . . . 0.0 110.532 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.571 HG22 ' H ' ' A' ' 19' ' ' VAL . 0.5 OUTLIER -135.22 3.64 3.14 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.167 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.613 ' O ' ' C ' ' A' ' 19' ' ' VAL . 28.2 mt-30 56.44 29.04 14.57 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 -176.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 1.007 HG11 HG11 ' B' ' 19' ' ' VAL . 1.5 p -9.68 -94.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.904 -178.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.968 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -133.9 25.13 3.97 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 177.627 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.703 HG12 HG22 ' A' ' 10' ' ' ILE . 27.0 m -19.17 -39.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 122.474 1.13 . . . . 0.0 109.347 -178.186 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.852 ' N ' ' O ' ' A' ' 20' ' ' SER . 3.1 m -81.5 -38.7 25.89 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.661 177.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.968 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.1 OUTLIER -86.45 -35.79 19.45 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.547 -0.72 . . . . 0.0 111.186 179.492 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.578 ' HB3' HG21 ' B' ' 14' ' ' THR . 0.0 OUTLIER -68.17 -38.21 81.81 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 117.567 -1.653 . . . . 0.0 108.15 178.99 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.645 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 8.4 mt -72.42 -47.27 50.49 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 118.404 -1.319 . . . . 0.0 107.832 176.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.507 ' HA ' ' HE2' ' A' ' 3' ' ' LYS . . . -55.31 -34.0 63.78 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 177.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.634 ' HA ' ' HB3' ' A' ' 30' ' ' LYS . 54.9 p -83.16 -32.25 26.72 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.833 ' O ' HG13 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -56.57 -47.13 80.17 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.013 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.684 ' O ' ' HB ' ' A' ' 33' ' ' THR . 0.3 OUTLIER -71.02 -35.68 72.11 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 177.733 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.873 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 70.9 tttt -65.04 -21.44 66.83 Favored 'General case' 0 C--O 1.192 -1.962 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.833 HG13 ' O ' ' A' ' 28' ' ' PHE . 1.3 pp -105.06 -29.48 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.761 -1.212 . . . . 0.0 109.062 178.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.616 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.2 mm -71.43 -49.34 47.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 176.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.684 ' HB ' ' O ' ' A' ' 29' ' ' GLU . 0.3 OUTLIER -69.07 -43.37 74.71 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 177.968 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.873 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 57.7 mm-40 -68.31 -41.62 80.59 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 121.616 -0.677 . . . . 0.0 110.905 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.612 HG21 HG23 ' A' ' 42' ' ' VAL . 3.8 m -52.58 -50.37 63.14 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.588 -1.32 . . . . 0.0 108.537 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.932 HG21 HG23 ' A' ' 77' ' ' VAL . 1.1 t -54.01 -36.89 32.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 177.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.678 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -81.33 -6.24 58.68 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.537 0.684 . . . . 0.0 109.7 178.245 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.606 ' HG2' ' O ' ' A' ' 34' ' ' GLU . 2.4 mmpt? -97.58 -25.05 15.27 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 177.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.79 41.07 1.76 Allowed Glycine 0 C--N 1.303 -1.295 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 178.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.562 ' CB ' HG23 ' A' ' 35' ' ' THR . 0.2 OUTLIER -136.76 147.64 46.8 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.176 -1.191 . . . . 0.0 110.593 179.707 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.5 mtmt -100.51 102.94 14.25 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 1.12 HG13 HD11 ' B' ' 6' ' ' LEU . 2.0 t -74.77 152.42 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 C-N-CA 119.622 -0.831 . . . . 0.0 110.019 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.464 ' HA ' ' O ' ' A' ' 48' ' ' LEU . 17.7 mt-30 -140.26 94.16 2.71 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.403 -0.81 . . . . 0.0 110.221 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.642 HD12 ' CE1' ' A' ' 47' ' ' PHE . 22.1 mt -58.84 112.77 1.77 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.954 -1.091 . . . . 0.0 109.078 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.572 HG22 ' HG2' ' B' ' 29' ' ' GLU . 0.1 OUTLIER 35.99 -88.48 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.869 -0.519 . . . . 0.0 110.606 -179.157 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -149.52 29.12 1.19 Allowed Glycine 0 N--CA 1.484 1.898 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.362 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.77 ' CE1' HG21 ' B' ' 32' ' ' ILE . 3.9 p90 -128.03 -28.64 2.62 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.991 -1.3 . . . . 0.0 112.717 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.796 HD11 HD11 ' B' ' 50' ' ' ILE . 0.6 OUTLIER -123.78 100.84 6.97 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.36 -1.462 . . . . 0.0 111.297 179.28 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.431 ' HA ' ' HA ' ' A' ' 43' ' ' GLN . 44.6 t-20 -109.45 87.35 2.48 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.863 -0.523 . . . . 0.0 110.623 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.803 HG22 ' CG2' ' A' ' 79' ' ' VAL . 1.1 pt -79.39 147.62 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.159 -0.963 . . . . 0.0 110.505 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.422 ' HG3' ' HB3' ' A' ' 78' ' ' SER . 8.4 ptmt -157.15 122.71 2.42 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.053 -1.029 . . . . 0.0 110.079 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.506 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 55.3 Cg_endo -80.65 140.87 13.42 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 O-C-N 123.459 1.241 . . . . 0.0 112.025 -178.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.706 ' O ' ' N ' ' A' ' 76' ' ' GLY . 31.5 m -142.21 114.75 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 121.441 0.639 . . . . 0.0 109.64 178.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 1.012 ' HB2' HG23 ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.497 1.914 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -177.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 1.012 HG23 ' HB2' ' A' ' 54' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.281 0.562 . . . . 0.0 109.888 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.706 ' N ' ' O ' ' A' ' 53' ' ' VAL . . . -115.37 61.2 0.38 Allowed Glycine 0 N--CA 1.484 1.873 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.95 HG21 ' CB ' ' B' ' 85' ' ' LEU . 2.3 p -43.47 83.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.998 -0.707 . . . . 0.0 110.787 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.617 ' N ' ' O ' ' A' ' 76' ' ' GLY . 1.3 t -81.68 175.97 10.02 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.985 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.803 ' CG2' HG22 ' A' ' 50' ' ' ILE . 3.3 p 176.25 176.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.606 ' N ' HG22 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -176.09 171.43 1.1 Allowed Pre-proline 0 N--CA 1.485 1.286 0 O-C-N 120.799 -1.188 . . . . 0.0 110.868 177.3 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.581 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 55.6 Cg_endo -97.03 136.51 0.44 Allowed 'Trans proline' 0 C--N 1.302 -1.878 0 C-N-CA 122.843 2.362 . . . . 0.0 110.706 178.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.657 ' O ' HD12 ' A' ' 85' ' ' LEU . . . -91.64 -158.74 34.85 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 178.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -89.33 -16.53 30.87 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.117 -1.226 . . . . 0.0 110.394 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.436 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -53.59 -33.42 54.81 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.304 -0.872 . . . . 0.0 109.975 -179.857 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.825 ' CB ' HG21 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -86.0 -30.94 22.32 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.326 -0.859 . . . . 0.0 108.77 178.966 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.439 ' HA ' ' CG1' ' B' ' 75' ' ' VAL . 0.6 OUTLIER -72.94 -33.12 65.72 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.415 -0.803 . . . . 0.0 109.838 -179.88 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -78.63 -34.92 46.22 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 1.035 ' C ' ' HB1' ' B' ' 37' ' ' ALA . . . -68.53 -31.26 70.37 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 177.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 1.051 ' N ' ' HB1' ' B' ' 37' ' ' ALA . . . -69.94 -35.73 74.74 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -178.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -59.55 -24.79 64.01 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 174.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -64.43 -54.41 29.53 Favored Glycine 0 N--CA 1.483 1.797 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 178.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.879 HD23 ' C ' ' B' ' 37' ' ' ALA . 2.1 pp -67.11 -42.19 84.96 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 119.76 1.78 . . . . 0.0 109.502 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.8 ' HB3' HD12 ' A' ' 92' ' ' LEU . 2.6 tttp 156.8 80.88 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.182 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 1.059 ' O ' ' C ' ' A' ' 95' ' ' GLU . 9.1 t80 -61.79 -62.85 1.51 Allowed 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 115.297 -2.561 . . . . 0.0 105.96 177.388 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 1.059 ' C ' ' O ' ' A' ' 94' ' ' TYR . 2.3 mp0 . . . . . 0 CA--C 1.486 -1.501 0 N-CA-C 101.561 -3.496 . . . . 0.0 101.561 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.757 ' HB2' HG22 ' A' ' 42' ' ' VAL . 5.9 mtp . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 120.863 0.363 . . . . 0.0 110.133 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 2' ' ' ASN . . . . . 0.551 ' H ' ' HB2' ' B' ' 5' ' ' GLU . 2.0 t-20 -172.53 -159.42 0.13 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.055 -1.028 . . . . 0.0 111.396 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.494 ' HG2' ' OE1' ' B' ' 29' ' ' GLU . 1.4 mttt -58.36 -7.56 0.92 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.407 -0.808 . . . . 0.0 110.291 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 4' ' ' THR . . . . . 0.671 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 90.0 m -116.82 -48.3 2.67 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.042 -1.036 . . . . 0.0 110.304 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.59 ' HA ' ' HE2' ' B' ' 8' ' ' LYS . 3.0 mt-10 -61.64 -52.89 62.49 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.117 -0.989 . . . . 0.0 108.904 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 1.12 HD11 HG13 ' A' ' 42' ' ' VAL . 0.9 OUTLIER -60.23 -27.79 67.49 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.196 -1.002 . . . . 0.0 108.928 178.355 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 7' ' ' ILE . . . . . 0.808 HG23 ' HB ' ' B' ' 21' ' ' VAL . 0.4 OUTLIER -56.26 -58.01 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 178.158 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 8' ' ' LYS . . . . . 0.91 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.1 OUTLIER -55.35 -31.85 62.08 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.94 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 9' ' ' ALA . . . . . 0.768 ' HB3' ' O ' ' B' ' 6' ' ' LEU . . . -57.57 -37.22 72.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.27 -0.894 . . . . 0.0 108.958 178.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.934 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.2 mp -92.57 -25.96 4.95 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.209 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 177.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.91 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -75.99 -2.23 29.51 Favored 'General case' 0 C--N 1.287 -2.121 0 O-C-N 120.703 -1.248 . . . . 0.0 108.152 177.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.418 ' HB3' ' O ' ' B' ' 8' ' ' LYS . 55.7 tp60 -125.3 -41.62 2.04 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.531 -0.731 . . . . 0.0 109.898 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' B' ' 9' ' ' ALA . 1.0 OUTLIER -72.18 -23.78 61.32 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 177.838 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 14' ' ' THR . . . . . 1.092 HG22 ' CD1' ' B' ' 16' ' ' LEU 0.284 0.2 OUTLIER -103.8 -62.13 1.34 Allowed 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 179.609 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 52.12 24.07 14.01 Favored Glycine 0 N--CA 1.5 2.912 0 O-C-N 121.369 -0.832 . . . . 0.0 111.569 177.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 16' ' ' LEU . . . . . 1.092 ' CD1' HG22 ' B' ' 14' ' ' THR . 4.5 mp -69.76 -69.97 0.31 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.343 -1.092 . . . . 0.0 109.904 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 17' ' ' THR . . . . . 0.586 HG22 ' H ' ' B' ' 19' ' ' VAL . 0.6 OUTLIER -137.81 5.74 2.64 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.736 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 18' ' ' GLN . . . . . 0.669 ' O ' ' C ' ' B' ' 19' ' ' VAL . 33.2 mt-30 57.42 27.53 14.04 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 -176.112 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 1.007 HG11 HG11 ' A' ' 19' ' ' VAL . 1.5 p -0.41 -96.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.947 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 20' ' ' SER . . . . . 1.091 ' O ' ' N ' ' B' ' 22' ' ' SER . 14.9 p -133.53 23.08 4.01 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 175.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.808 ' HB ' HG23 ' B' ' 7' ' ' ILE . 28.1 m -3.87 -39.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-O 122.302 1.048 . . . . 0.0 110.981 -177.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 22' ' ' SER . . . . . 1.091 ' N ' ' O ' ' B' ' 20' ' ' SER . 2.4 t -73.0 -44.01 61.5 Favored 'General case' 0 C--N 1.281 -2.387 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.93 177.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 23' ' ' LYS . . . . . 0.813 ' N ' ' O ' ' B' ' 20' ' ' SER . 5.1 mtpt -88.37 -29.32 20.37 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.659 -0.651 . . . . 0.0 109.693 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 24' ' ' MET . . . . . 0.715 ' HE2' ' HA ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -62.77 -41.44 99.24 Favored 'General case' 0 C--N 1.314 -0.958 0 O-C-N 120.899 -1.126 . . . . 0.0 109.443 179.796 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.716 HD12 HG13 ' B' ' 7' ' ' ILE . 1.2 mt -84.51 -45.38 12.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.891 -1.13 . . . . 0.0 108.406 177.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 26' ' ' ALA . . . . . 0.499 ' O ' ' CB ' ' B' ' 30' ' ' LYS . . . -53.31 -34.68 58.38 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 178.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 27' ' ' SER . . . . . 0.611 ' O ' HG23 ' B' ' 31' ' ' ILE . 58.4 m -78.55 -40.28 35.34 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 177.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 28' ' ' PHE . . . . . 0.728 ' HA ' ' CG1' ' B' ' 31' ' ' ILE . 0.1 OUTLIER -63.82 -36.63 84.53 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.636 -0.665 . . . . 0.0 109.394 179.42 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 29' ' ' GLU . . . . . 0.587 ' HG3' ' CE2' ' B' ' 28' ' ' PHE . 0.9 OUTLIER -82.07 -31.97 30.57 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 178.721 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 0.82 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 16.6 tttp -72.22 -28.42 63.16 Favored 'General case' 0 C--O 1.191 -1.989 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 176.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.728 ' CG1' ' HA ' ' B' ' 28' ' ' PHE . 1.6 pp -94.67 -30.48 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.03 -1.044 . . . . 0.0 109.884 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.979 HD13 HG21 ' B' ' 42' ' ' VAL . 3.6 mm -62.91 -61.88 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 177.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 33' ' ' THR . . . . . 0.557 ' OG1' ' HG ' ' A' ' 85' ' ' LEU . 0.4 OUTLIER -58.42 -40.18 81.79 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.813 179.213 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.84 ' O ' ' N ' ' B' ' 38' ' ' LYS . 40.9 mm-40 -73.29 -48.42 34.74 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.855 -0.528 . . . . 0.0 112.296 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 35' ' ' THR . . . . . 0.667 HG22 ' O ' ' B' ' 40' ' ' ASP . 92.9 m -52.16 -59.16 4.7 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.477 -1.389 . . . . 0.0 110.504 -178.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.998 HG23 HG12 ' B' ' 42' ' ' VAL . 0.9 OUTLIER -51.38 -45.32 33.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 178.408 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 37' ' ' ALA . . . . . 1.051 ' HB1' ' N ' ' A' ' 89' ' ' ALA . . . -83.52 1.88 39.71 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.993 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 38' ' ' LYS . . . . . 0.84 ' N ' ' O ' ' B' ' 34' ' ' GLU . 0.5 OUTLIER -107.53 -37.85 6.07 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.188 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 145.28 41.92 0.05 OUTLIER Glycine 0 C--N 1.301 -1.405 0 C-N-CA 119.008 -1.568 . . . . 0.0 111.273 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 40' ' ' ASP . . . . . 0.667 ' O ' HG22 ' B' ' 35' ' ' THR . 0.6 OUTLIER -161.75 127.11 3.54 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.93 -1.335 . . . . 0.0 110.604 179.236 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.83 86.53 0.23 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.675 -0.641 . . . . 0.0 109.421 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.998 HG12 HG23 ' B' ' 36' ' ' VAL . 9.4 p -61.8 125.93 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 C-N-CA 119.919 -0.712 . . . . 0.0 109.66 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 43' ' ' GLN . . . . . 0.55 ' O ' ' HA ' ' A' ' 2' ' ' ASN . 5.4 mt-30 -131.11 172.25 12.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.899 . . . . 0.0 110.29 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.97 HD12 ' CB ' ' B' ' 48' ' ' LEU . 29.3 mt -136.48 120.21 17.31 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.503 -0.748 . . . . 0.0 109.625 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 45' ' ' THR . . . . . 0.552 ' HB ' ' CD ' ' A' ' 3' ' ' LYS . 0.1 OUTLIER 34.43 -92.72 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.375 0 O-C-N 121.646 -0.659 . . . . 0.0 110.821 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 46' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -159.24 30.37 0.42 Allowed Glycine 0 N--CA 1.486 2.032 0 N-CA-C 108.256 -1.937 . . . . 0.0 108.256 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 47' ' ' PHE . . . . . 0.673 ' CE1' ' HG2' ' A' ' 29' ' ' GLU . 0.1 OUTLIER -124.65 -26.76 3.78 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.546 -0.973 . . . . 0.0 110.981 -179.447 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.97 ' CB ' HD12 ' B' ' 44' ' ' LEU . 9.7 mt -130.56 90.29 2.9 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.835 -1.165 . . . . 0.0 110.415 177.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 49' ' ' ASN . . . . . 0.414 ' O ' ' HA ' ' B' ' 79' ' ' VAL . 0.7 OUTLIER -98.26 88.83 4.28 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.705 -0.622 . . . . 0.0 110.481 -179.842 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 50' ' ' ILE . . . . . 0.947 HG22 HG21 ' B' ' 36' ' ' VAL . 0.8 OUTLIER -81.73 147.32 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.383 -0.823 . . . . 0.0 110.906 -179.835 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 51' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' B' ' 78' ' ' SER . 3.3 ptmt -164.31 131.04 2.34 Favored Pre-proline 0 N--CA 1.502 2.154 0 O-C-N 121.258 -0.901 . . . . 0.0 110.391 179.059 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 52' ' ' PRO . . . . . 0.897 ' HD3' HG22 ' B' ' 36' ' ' VAL . 50.8 Cg_endo -84.28 146.86 11.27 Favored 'Trans proline' 0 C--N 1.318 -1.039 0 O-C-N 123.195 1.103 . . . . 0.0 112.241 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.669 HG22 ' O ' ' B' ' 76' ' ' GLY . 23.1 m -146.4 117.39 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-O 121.765 0.793 . . . . 0.0 110.284 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 121.755 0.788 . . . . 0.0 111.783 -178.69 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 75' ' ' VAL . . . . . 1.038 HG11 ' CB ' ' A' ' 89' ' ' ALA . 11.9 p . . . . . 0 N--CA 1.497 1.889 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 76' ' ' GLY . . . . . 0.669 ' O ' HG22 ' B' ' 53' ' ' VAL . . . -119.23 71.31 0.32 Allowed Glycine 0 N--CA 1.488 2.161 0 C-N-CA 119.005 -1.569 . . . . 0.0 109.826 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.894 HG23 HG11 ' B' ' 36' ' ' VAL . 3.1 p -59.07 77.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.377 -1.072 . . . . 0.0 109.726 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 78' ' ' SER . . . . . 0.56 ' N ' ' O ' ' B' ' 76' ' ' GLY . 0.2 OUTLIER -71.11 177.35 3.83 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 122.174 0.988 . . . . 0.0 111.286 -179.298 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.574 HG22 ' N ' ' B' ' 80' ' ' LYS . 1.6 p 176.56 176.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 80' ' ' LYS . . . . . 0.691 ' O ' HD23 ' B' ' 48' ' ' LEU . 16.1 ptmt -176.33 174.05 0.78 Allowed Pre-proline 0 N--CA 1.486 1.326 0 O-C-N 120.764 -1.21 . . . . 0.0 110.349 178.27 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 81' ' ' PRO . . . . . 0.471 ' HA ' ' O ' ' B' ' 47' ' ' PHE . 52.8 Cg_endo -96.01 136.56 0.6 Allowed 'Trans proline' 0 C--N 1.302 -1.877 0 C-N-CA 122.294 1.996 . . . . 0.0 109.842 178.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 82' ' ' GLY . . . . . 0.461 ' HA3' ' HA ' ' B' ' 47' ' ' PHE . . . -97.35 -168.3 32.86 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 107.793 -2.123 . . . . 0.0 107.793 178.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 83' ' ' GLU . . . . . 0.63 ' HA ' ' HB2' ' B' ' 86' ' ' LYS . 0.9 OUTLIER -76.97 -18.28 58.33 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.886 -1.361 . . . . 0.0 110.283 179.776 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 84' ' ' SER . . . . . 0.487 ' CB ' ' HB3' ' B' ' 47' ' ' PHE . 0.2 OUTLIER -50.94 -42.19 59.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.167 -0.958 . . . . 0.0 108.815 179.368 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.95 ' CB ' HG21 ' A' ' 77' ' ' VAL . 1.0 OUTLIER -73.72 -31.41 63.37 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 177.942 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 86' ' ' LYS . . . . . 0.63 ' HB2' ' HA ' ' B' ' 83' ' ' GLU . 29.4 mtmm -73.29 -38.24 65.97 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.392 0.615 . . . . 0.0 110.196 -179.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 13.8 ttpt -74.54 -37.12 63.12 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 177.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.642 ' O ' ' HB1' ' A' ' 37' ' ' ALA . . . -68.92 -34.73 75.86 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 176.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.948 ' HA ' HD23 ' B' ' 92' ' ' LEU . . . -55.95 -44.36 78.36 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -54.07 -33.51 57.67 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 176.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 91' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' B' ' 88' ' ' ALA . . . -61.79 -38.47 96.0 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 178.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 92' ' ' LEU . . . . . 0.948 HD23 ' HA ' ' B' ' 89' ' ' ALA . 0.4 OUTLIER -72.27 13.8 0.29 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.69 -1.477 . . . . 0.0 110.762 179.697 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 93' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' B' ' 92' ' ' LEU . 72.8 mmtt 62.17 39.84 12.37 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 -177.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 94' ' ' TYR . . . . . 0.511 ' HD1' ' HB1' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -38.09 -37.23 0.25 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.565 -179.214 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -60.12 -42.53 94.97 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.46 -0.775 . . . . 0.0 109.811 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 96' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' B' ' 93' ' ' LYS . 3.4 m-20 -60.57 -36.68 79.08 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.291 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 97' ' ' PHE . . . . . 0.504 ' HB3' ' HB3' ' A' ' 54' ' ' ALA . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.458 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.583 ' HE3' ' HG ' ' A' ' 6' ' ' LEU . 7.3 mtp . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.519 ' CA ' HD12 ' A' ' 6' ' ' LEU . 50.4 p-10 -171.16 -162.78 0.26 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.798 -1.189 . . . . 0.0 112.43 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.555 ' HE2' ' HA ' ' A' ' 26' ' ' ALA . 9.8 tttm -46.79 -15.34 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.776 -0.578 . . . . 0.0 111.068 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.632 ' O ' ' CG1' ' A' ' 7' ' ' ILE . 58.6 m -117.26 -58.06 2.09 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.126 -0.984 . . . . 0.0 110.304 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.599 ' HA ' ' HE3' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -46.64 -44.86 18.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.115 -0.991 . . . . 0.0 109.489 179.698 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.715 HD23 ' CD1' ' B' ' 31' ' ' ILE . 1.3 mt -63.74 -33.28 75.3 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.15 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.75 ' N ' HD12 ' A' ' 25' ' ' LEU . 0.9 OUTLIER -56.68 -42.61 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.764 -1.21 . . . . 0.0 108.097 179.699 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.908 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 6.7 mtmt -66.56 -34.14 77.23 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 177.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.865 ' CB ' HD13 ' B' ' 31' ' ' ILE . . . -53.71 -39.51 65.26 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.546 -0.862 . . . . 0.0 109.362 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.776 HG22 HG12 ' A' ' 21' ' ' VAL . 1.3 mp -91.01 -31.58 5.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 178.129 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.908 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -65.3 -13.47 58.53 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 118.956 -1.098 . . . . 0.0 108.364 177.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.445 ' HB3' ' O ' ' A' ' 8' ' ' LYS . 1.1 tp60 -113.44 -45.12 3.15 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.487 ' HB3' ' HB2' ' B' ' 27' ' ' SER . 1.8 m-20 -62.34 -33.8 75.41 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 177.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.723 ' OG1' ' O ' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -102.16 -71.14 0.73 Allowed 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 178.494 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 46.37 27.37 2.8 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 1.076 ' CD1' HG23 ' B' ' 19' ' ' VAL . 0.1 OUTLIER -87.28 -25.83 23.75 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.449 -1.03 . . . . 0.0 108.946 178.868 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.712 HG21 HG21 ' B' ' 17' ' ' THR . 0.5 OUTLIER -153.8 -8.32 0.16 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.907 -0.496 . . . . 0.0 110.228 -179.449 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.515 ' O ' ' C ' ' A' ' 19' ' ' VAL . 4.5 mt-30 57.06 36.82 28.19 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 -177.17 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 1.056 HG23 ' CD1' ' B' ' 16' ' ' LEU . 0.6 OUTLIER -23.93 -93.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.614 -178.712 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.945 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -135.18 22.92 3.49 Favored 'General case' 0 C--N 1.281 -2.39 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 178.709 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.776 HG12 HG22 ' A' ' 10' ' ' ILE . 31.3 m -21.7 -40.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-O 122.385 1.088 . . . . 0.0 108.697 -177.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.811 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.2 OUTLIER -82.16 -39.04 23.8 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 114.891 -1.049 . . . . 0.0 109.601 177.614 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.945 ' N ' ' O ' ' A' ' 20' ' ' SER . 1.2 mtpt -85.33 -32.76 22.29 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.576 -0.703 . . . . 0.0 111.836 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.82 ' HB3' HG23 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -77.01 -34.95 57.37 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.252 -1.53 . . . . 0.0 108.976 179.715 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.75 HD12 ' N ' ' A' ' 7' ' ' ILE . 2.2 mt -77.74 -43.57 30.49 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 118.551 -1.26 . . . . 0.0 107.863 177.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.555 ' HA ' ' HE2' ' A' ' 3' ' ' LYS . . . -59.3 -34.08 71.88 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 177.338 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.611 ' O ' HG23 ' A' ' 31' ' ' ILE . 85.6 p -81.75 -26.64 34.33 Favored 'General case' 0 C--O 1.204 -1.294 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.294 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.841 ' HE2' HD22 ' B' ' 44' ' ' LEU . 0.3 OUTLIER -64.86 -30.23 71.22 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.67 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.748 ' O ' ' HB ' ' A' ' 33' ' ' THR . 4.5 mt-10 -90.64 -21.55 21.62 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 177.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.785 ' O ' ' CG ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -83.36 -19.06 36.81 Favored 'General case' 0 C--O 1.192 -1.944 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 175.52 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.756 ' CG1' ' HA ' ' A' ' 28' ' ' PHE . 2.1 pp -104.67 -33.34 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.059 -1.025 . . . . 0.0 109.048 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 1.027 HD13 HG11 ' A' ' 42' ' ' VAL . 2.6 mm -64.14 -46.46 93.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 176.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.833 ' HA ' HD13 ' B' ' 85' ' ' LEU 0.324 16.4 m -67.56 -54.26 21.42 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 113.762 -1.563 . . . . 0.0 108.197 178.504 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.785 ' CG ' ' O ' ' A' ' 30' ' ' LYS . 57.2 mm-40 -63.2 -32.43 73.82 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.054 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.832 HG21 ' CG2' ' A' ' 42' ' ' VAL . 1.5 m -58.26 -51.79 68.29 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.026 -1.046 . . . . 0.0 108.417 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.138 HG21 HG22 ' A' ' 77' ' ' VAL . 0.9 OUTLIER -52.39 -41.61 35.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 C-N-CA 117.982 -1.487 . . . . 0.0 107.218 177.996 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.888 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -72.51 -7.99 52.84 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.463 -0.895 . . . . 0.0 109.343 177.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.521 ' N ' ' O ' ' A' ' 35' ' ' THR . 0.0 OUTLIER -101.52 -23.69 14.26 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.301 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 35' ' ' THR . . . 102.61 41.48 2.33 Favored Glycine 0 C--N 1.301 -1.383 0 C-N-CA 119.967 -1.111 . . . . 0.0 110.648 178.337 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.791 ' CB ' HG23 ' A' ' 35' ' ' THR . 0.1 OUTLIER -128.86 133.97 48.14 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.011 -1.288 . . . . 0.0 110.809 179.648 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -85.27 91.83 8.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.56 -0.713 . . . . 0.0 109.55 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 1.027 HG11 HD13 ' A' ' 32' ' ' ILE . 82.0 t -67.43 149.63 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-O 121.437 0.637 . . . . 0.0 111.153 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.446 ' O ' ' HA ' ' B' ' 2' ' ' ASN . 4.2 pt20 -158.2 147.62 19.56 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.566 -0.709 . . . . 0.0 109.885 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.808 HD22 ' CE1' ' B' ' 28' ' ' PHE . 35.7 mt -99.47 118.7 36.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.3 -0.875 . . . . 0.0 109.736 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.524 HG21 ' CG ' ' B' ' 29' ' ' GLU . 0.0 OUTLIER 27.36 -95.18 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.953 -0.467 . . . . 0.0 112.235 -179.627 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.501 ' H ' HG23 ' A' ' 45' ' ' THR . . . -129.82 4.45 6.11 Favored Glycine 0 N--CA 1.486 1.976 0 C-N-CA 119.556 -1.307 . . . . 0.0 111.241 -178.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.787 ' CE2' HG21 ' B' ' 32' ' ' ILE . 26.8 p90 -100.24 -64.67 1.02 Allowed 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 119.554 1.677 . . . . 0.0 110.765 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.875 HD22 ' HA2' ' A' ' 82' ' ' GLY . 0.8 OUTLIER -88.17 142.31 27.86 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.241 -1.537 . . . . 0.0 114.673 -178.843 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.661 ' HB2' ' HG2' ' A' ' 81' ' ' PRO . 0.1 OUTLIER -145.25 92.31 2.24 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.567 177.021 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.816 HD13 HG23 ' A' ' 79' ' ' VAL . 46.6 mm -85.71 160.17 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.172 -0.955 . . . . 0.0 110.655 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.413 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 5.0 ptmt -167.32 128.04 1.18 Allowed Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 120.976 -1.077 . . . . 0.0 110.478 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.501 ' HB2' HG11 ' A' ' 75' ' ' VAL . 52.4 Cg_endo -77.62 148.65 26.14 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 O-C-N 123.55 1.289 . . . . 0.0 111.216 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.894 HG22 ' O ' ' A' ' 76' ' ' GLY . 32.9 m -140.59 114.86 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-O 121.717 0.77 . . . . 0.0 111.085 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.703 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.498 1.927 0 CA-C-O 122.0 0.905 . . . . 0.0 111.861 -178.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.703 ' HA ' ' HA ' ' A' ' 54' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.495 1.791 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.894 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -118.51 99.52 0.79 Allowed Glycine 0 N--CA 1.486 2.014 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 1.138 HG22 HG21 ' A' ' 36' ' ' VAL . 1.4 t -58.53 86.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-O 122.09 0.948 . . . . 0.0 108.82 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 76' ' ' GLY . 0.2 OUTLIER -79.58 -152.77 0.07 Allowed 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 121.726 0.774 . . . . 0.0 110.272 -179.129 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.816 HG23 HD13 ' A' ' 50' ' ' ILE . 5.4 p 179.98 178.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.872 ' CB ' ' HD3' ' A' ' 81' ' ' PRO . 16.3 mttt -148.45 -70.19 0.02 OUTLIER Pre-proline 0 C--N 1.302 -1.462 0 C-N-CA 117.856 -1.537 . . . . 0.0 112.464 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.872 ' HD3' ' CB ' ' A' ' 80' ' ' LYS . 57.0 Cg_endo -102.23 -172.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.297 -2.16 0 C-N-CA 121.375 1.383 . . . . 0.0 112.834 -177.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.875 ' HA2' HD22 ' A' ' 48' ' ' LEU . . . 177.31 24.08 0.03 OUTLIER Glycine 0 C--N 1.29 -2.024 0 N-CA-C 107.23 -2.348 . . . . 0.0 107.23 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.898 ' O ' ' N ' ' A' ' 85' ' ' LEU . 44.3 tt0 32.6 48.38 0.12 Allowed 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 -176.091 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . 1.325 ' O ' ' N ' ' A' ' 86' ' ' LYS . 0.2 OUTLIER 13.21 41.21 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.334 0 CA-C-N 114.007 -1.452 . . . . 0.0 109.686 -176.685 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 1.069 ' C ' ' O ' ' A' ' 84' ' ' SER . 4.7 mt 20.23 32.43 0.0 OUTLIER 'General case' 0 C--O 1.198 -1.642 0 N-CA-C 102.236 -3.246 . . . . 0.0 102.236 -173.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 1.325 ' N ' ' O ' ' A' ' 84' ' ' SER 0.349 3.2 tttt -57.77 -41.59 82.32 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 103.288 -2.856 . . . . 0.0 103.288 176.496 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.304 11.8 tttp -70.35 -32.77 70.61 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 111.44 -2.618 . . . . 0.0 105.438 174.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.838 ' HB1' ' HB ' ' B' ' 36' ' ' VAL . . . -77.41 -16.33 58.89 Favored 'General case' 0 C--O 1.2 -1.508 0 CA-C-O 122.201 1.001 . . . . 0.0 109.172 178.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.787 ' CB ' HG12 ' B' ' 75' ' ' VAL . . . -89.96 -24.12 21.36 Favored 'General case' 0 C--N 1.282 -2.337 0 O-C-N 120.443 -1.41 . . . . 0.0 108.787 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -71.85 -34.64 69.43 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.873 ' HA3' ' HB1' ' B' ' 37' ' ' ALA . . . -77.34 -32.44 47.63 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 178.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.889 ' CD1' HG21 ' B' ' 75' ' ' VAL 0.26 2.5 mt -51.33 -7.83 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.104 -1.233 . . . . 0.0 112.021 179.573 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.431 ' H ' ' C ' ' A' ' 91' ' ' GLY . 0.2 OUTLIER 62.56 36.7 13.67 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 -175.313 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.501 ' CD1' ' N ' ' B' ' 75' ' ' VAL . 63.9 t80 -34.18 -45.08 0.2 Allowed 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.697 -178.086 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 . . . . . 0 N--CA 1.494 1.752 0 O-C-N 121.272 -0.893 . . . . 0.0 109.737 179.857 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.523 ' CE ' HD23 ' B' ' 6' ' ' LEU . 2.1 mtp . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 120.886 0.374 . . . . 0.0 110.113 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 2' ' ' ASN . . . . . 0.446 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 41.7 t30 -177.82 178.06 1.02 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.299 -0.876 . . . . 0.0 110.693 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.515 ' HE3' ' CB ' ' B' ' 29' ' ' GLU . 0.0 OUTLIER -49.45 -19.62 0.57 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.437 -0.789 . . . . 0.0 110.096 179.553 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 4' ' ' THR . . . . . 0.554 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 81.4 m -103.64 -41.43 5.95 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.158 -0.964 . . . . 0.0 108.941 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.445 ' CB ' ' HA ' ' B' ' 1' ' ' MET . 0.0 OUTLIER -65.22 -49.93 67.82 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.692 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.903 HD11 HG13 ' A' ' 42' ' ' VAL . 9.4 mt -60.54 -33.48 72.73 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 7' ' ' ILE . . . . . 0.941 HG23 ' HB ' ' B' ' 21' ' ' VAL . 0.6 OUTLIER -53.24 -55.71 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.333 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 8' ' ' LYS . . . . . 0.953 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.0 OUTLIER -58.15 -31.62 67.41 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.13 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 9' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' B' ' 6' ' ' LEU . . . -56.1 -37.16 69.0 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.173 -0.954 . . . . 0.0 109.021 178.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.82 HG23 ' HB3' ' A' ' 24' ' ' MET . 1.5 mp -92.86 -33.38 5.36 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.953 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -67.46 -13.94 62.48 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.488 ' N ' ' O ' ' B' ' 8' ' ' LYS . 3.9 tp-100 -108.47 -43.33 4.34 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.44 -21.74 66.69 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 177.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 14' ' ' THR . . . . . 0.934 HG21 ' HB2' ' A' ' 20' ' ' SER . 0.2 OUTLIER -121.96 -80.82 0.63 Allowed 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.97 179.786 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 15' ' ' GLY . . . . . 0.505 ' O ' ' C ' ' B' ' 16' ' ' LEU . . . 70.43 -18.8 0.71 Allowed Glycine 0 N--CA 1.498 2.778 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 16' ' ' LEU . . . . . 1.056 ' CD1' HG23 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -27.83 -64.65 0.08 Allowed 'General case' 0 N--CA 1.515 2.805 0 CA-C-O 122.078 0.942 . . . . 0.0 111.068 -179.722 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 17' ' ' THR . . . . . 0.712 HG21 HG21 ' A' ' 17' ' ' THR . 0.4 OUTLIER -130.11 -0.56 4.65 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.597 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 18' ' ' GLN . . . . . 0.641 ' O ' ' C ' ' B' ' 19' ' ' VAL . 2.4 mt-30 58.09 29.55 17.99 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 -176.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 1.076 HG23 ' CD1' ' A' ' 16' ' ' LEU . 0.4 OUTLIER 5.33 -99.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.616 -179.221 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 20' ' ' SER . . . . . 1.002 ' HB3' HD21 ' A' ' 16' ' ' LEU . 1.7 p -136.07 23.17 3.28 Favored 'General case' 0 C--N 1.273 -2.721 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 177.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.941 ' HB ' HG23 ' B' ' 7' ' ' ILE . 35.1 m -5.0 -42.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-O 122.406 1.098 . . . . 0.0 111.037 -177.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.997 ' N ' ' O ' ' B' ' 20' ' ' SER . 14.0 p -76.74 -37.58 55.7 Favored 'General case' 0 C--N 1.28 -2.423 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.741 179.045 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 23' ' ' LYS . . . . . 0.868 ' N ' ' O ' ' B' ' 20' ' ' SER . 1.6 mtmt -88.78 -31.07 18.56 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.358 -0.839 . . . . 0.0 111.329 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 24' ' ' MET . . . . . 0.617 ' SD ' ' HA ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -72.09 -36.98 69.66 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.234 -1.541 . . . . 0.0 108.754 179.773 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.716 HD12 HG13 ' B' ' 7' ' ' ILE . 0.3 OUTLIER -80.06 -35.89 36.43 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 118.168 -1.413 . . . . 0.0 108.149 177.742 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 26' ' ' ALA . . . . . 0.502 ' HB2' ' O ' ' B' ' 22' ' ' SER . . . -66.07 -34.37 77.92 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 176.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 27' ' ' SER . . . . . 0.572 ' O ' ' N ' ' B' ' 31' ' ' ILE . 83.7 p -81.97 -27.38 33.24 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.007 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 28' ' ' PHE . . . . . 0.863 ' O ' HG13 ' B' ' 31' ' ' ILE . 0.5 OUTLIER -59.04 -50.73 72.96 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 178.26 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 29' ' ' GLU . . . . . 0.614 ' HG3' ' CD1' ' A' ' 47' ' ' PHE . 1.2 tt0 -65.21 -31.49 72.69 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 176.173 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 1.271 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 9.3 ttmt -69.88 -22.48 63.24 Favored 'General case' 0 C--O 1.186 -2.278 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.865 HD13 ' CB ' ' A' ' 9' ' ' ALA . 0.9 OUTLIER -100.76 -29.37 3.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 O-C-N 119.945 -1.722 . . . . 0.0 108.055 177.824 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.787 HG21 ' CE2' ' A' ' 47' ' ' PHE . 1.4 mm -65.3 -60.93 2.0 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 176.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 33' ' ' THR . . . . . 0.647 ' O ' ' CB ' ' A' ' 88' ' ' ALA . 0.4 OUTLIER -76.56 -27.76 56.0 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 119.279 -0.968 . . . . 0.0 108.95 179.587 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 1.271 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 79.1 mm-40 -80.19 -27.37 38.9 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.101 -1.624 . . . . 0.0 110.204 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 35' ' ' THR . . . . . 0.645 HG23 ' HB2' ' B' ' 40' ' ' ASP . 3.7 m -72.15 -48.76 41.14 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.656 -1.277 . . . . 0.0 108.575 178.3 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.852 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 4.5 t -51.1 -48.54 30.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 C-N-CA 116.867 -1.933 . . . . 0.0 106.047 177.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 37' ' ' ALA . . . . . 0.873 ' HB1' ' HA3' ' A' ' 91' ' ' GLY . . . -70.24 5.96 1.5 Allowed 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 121.58 0.705 . . . . 0.0 111.044 177.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 38' ' ' LYS . . . . . 0.492 ' HB2' ' O ' ' B' ' 34' ' ' GLU . 0.0 OUTLIER -108.57 -35.1 6.54 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 177.438 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 39' ' ' GLY . . . . . 0.418 ' HA2' HD21 ' A' ' 92' ' ' LEU . . . 121.17 32.24 1.08 Allowed Glycine 0 C--N 1.302 -1.326 0 C-N-CA 119.727 -1.225 . . . . 0.0 111.487 177.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 40' ' ' ASP . . . . . 0.645 ' HB2' HG23 ' B' ' 35' ' ' THR . 0.3 OUTLIER -125.26 146.63 49.45 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.798 -1.413 . . . . 0.0 110.371 179.123 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 2.8 mtmm -88.6 91.6 8.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.512 -0.743 . . . . 0.0 110.179 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.516 HG13 HD11 ' A' ' 6' ' ' LEU . 78.2 t -64.35 153.3 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.564 -0.71 . . . . 0.0 110.367 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 43' ' ' GLN . . . . . 0.782 ' O ' HD23 ' B' ' 44' ' ' LEU . 0.2 OUTLIER -165.83 164.14 18.69 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.44 -0.787 . . . . 0.0 110.043 179.821 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.841 HD22 ' HE2' ' A' ' 28' ' ' PHE . 15.4 mt -125.46 117.92 24.7 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.394 -0.816 . . . . 0.0 109.718 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 45' ' ' THR . . . . . 0.536 HG21 ' HB3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 30.34 -93.28 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.875 -0.516 . . . . 0.0 111.124 -179.812 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 46' ' ' GLY . . . . . 0.549 ' O ' ' HA3' ' B' ' 82' ' ' GLY . . . -144.54 24.34 2.0 Favored Glycine 0 N--CA 1.483 1.775 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 47' ' ' PHE . . . . . 0.715 ' CE1' HD12 ' B' ' 44' ' ' LEU . 8.8 p90 -120.7 -22.09 6.45 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.111 -1.229 . . . . 0.0 111.4 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.551 ' HB2' ' HB2' ' B' ' 44' ' ' LEU . 0.9 OUTLIER -128.22 115.45 18.37 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.388 -1.445 . . . . 0.0 110.624 177.828 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 49' ' ' ASN . . . . . 0.632 ' O ' ' HA ' ' B' ' 79' ' ' VAL . 1.2 m120 -113.78 94.75 4.98 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.717 -0.614 . . . . 0.0 111.408 -178.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 50' ' ' ILE . . . . . 0.508 ' CD1' HG23 ' B' ' 79' ' ' VAL . 1.3 mp -93.45 141.48 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 O-C-N 121.246 -0.909 . . . . 0.0 109.839 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 51' ' ' LYS . . . . . 0.426 ' HG3' ' CB ' ' B' ' 78' ' ' SER . 0.0 OUTLIER -161.29 113.42 1.26 Allowed Pre-proline 0 N--CA 1.5 2.025 0 C-N-CA 118.769 -1.172 . . . . 0.0 111.318 179.723 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 52' ' ' PRO . . . . . 0.688 ' HB3' HG13 ' B' ' 36' ' ' VAL . 55.7 Cg_endo -83.06 141.91 10.7 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 O-C-N 123.571 1.301 . . . . 0.0 111.724 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.618 ' O ' ' N ' ' B' ' 76' ' ' GLY . 33.4 m -149.24 114.73 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.581 0.705 . . . . 0.0 110.718 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 54' ' ' ALA . . . . . 0.655 ' HA ' ' HA ' ' B' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.501 2.09 0 O-C-N 121.448 -0.783 . . . . 0.0 111.46 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 75' ' ' VAL . . . . . 0.889 HG21 ' CD1' ' A' ' 92' ' ' LEU . 1.4 p . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 76' ' ' GLY . . . . . 0.626 ' O ' ' N ' ' B' ' 78' ' ' SER . . . -113.14 50.22 0.79 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.856 -1.698 . . . . 0.0 108.856 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.736 HG23 HD12 ' A' ' 85' ' ' LEU . 7.1 p -45.69 81.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-O 121.695 0.76 . . . . 0.0 111.534 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 78' ' ' SER . . . . . 0.626 ' N ' ' O ' ' B' ' 76' ' ' GLY . 0.6 OUTLIER -77.48 178.81 6.92 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 119.28 -0.968 . . . . 0.0 108.737 178.408 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.632 ' HA ' ' O ' ' B' ' 49' ' ' ASN . 0.2 OUTLIER 179.48 172.8 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.517 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 80' ' ' LYS . . . . . 0.521 ' N ' ' CG2' ' B' ' 79' ' ' VAL . 0.2 OUTLIER 176.46 172.56 0.33 Allowed Pre-proline 0 N--CA 1.487 1.417 0 O-C-N 121.149 -0.97 . . . . 0.0 110.892 178.404 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 81' ' ' PRO . . . . . 0.707 ' HA ' ' O ' ' B' ' 47' ' ' PHE . 54.6 Cg_endo -88.95 165.78 5.83 Favored 'Trans proline' 0 C--N 1.298 -2.079 0 O-C-N 124.617 1.851 . . . . 0.0 107.475 174.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 82' ' ' GLY . . . . . 0.549 ' HA3' ' O ' ' B' ' 46' ' ' GLY . . . -126.79 -99.33 1.08 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 107.711 -2.156 . . . . 0.0 107.711 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 83' ' ' GLU . . . . . 0.911 ' O ' ' N ' ' B' ' 85' ' ' LEU . 0.4 OUTLIER -79.43 45.24 0.65 Allowed 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.121 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 84' ' ' SER . . . . . 1.334 ' O ' ' N ' ' B' ' 86' ' ' LYS . 0.1 OUTLIER 8.45 43.16 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 122.148 0.975 . . . . 0.0 111.164 179.165 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 1.004 ' C ' ' O ' ' B' ' 84' ' ' SER . 0.4 OUTLIER 20.55 30.05 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 102.786 -3.042 . . . . 0.0 102.786 -172.647 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 86' ' ' LYS . . . . . 1.334 ' N ' ' O ' ' B' ' 84' ' ' SER 0.336 7.7 tttt -56.38 -37.17 69.73 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 103.82 -2.659 . . . . 0.0 103.82 177.08 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . 0.29 0.0 OUTLIER -70.59 -34.79 72.56 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 111.905 -2.407 . . . . 0.0 105.796 175.377 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.648 ' HB3' ' CB ' ' B' ' 85' ' ' LEU . . . -75.3 -27.77 59.45 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 118.586 -1.246 . . . . 0.0 107.859 178.171 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.905 ' HA ' HD23 ' B' ' 92' ' ' LEU . . . -62.42 -48.33 80.16 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -57.24 -28.98 63.41 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 176.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -69.68 -33.94 72.07 Favored Glycine 0 N--CA 1.489 2.184 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.189 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 92' ' ' LEU . . . . . 0.905 HD23 ' HA ' ' B' ' 89' ' ' ALA . 0.7 OUTLIER -85.75 16.95 3.62 Favored 'General case' 0 N--CA 1.506 2.335 0 CA-C-N 119.689 1.745 . . . . 0.0 111.556 -179.155 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 93' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' B' ' 92' ' ' LEU . 8.7 mmtp 54.92 40.22 31.9 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -178.287 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 94' ' ' TYR . . . . . 0.501 ' HA ' HD11 ' B' ' 92' ' ' LEU . 2.6 p90 -41.77 -30.7 0.26 Allowed 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.651 -178.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -58.22 -42.51 86.44 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.246 -0.909 . . . . 0.0 108.871 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.72 -33.68 76.19 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 177.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.488 1.428 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.503 ' HG2' ' HB3' ' A' ' 5' ' ' GLU . 4.0 mtp . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 120.932 0.396 . . . . 0.0 110.134 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.83 ' C ' HD12 ' A' ' 6' ' ' LEU . 4.0 t30 -176.08 -174.79 0.66 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.18 -0.95 . . . . 0.0 111.052 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.542 ' O ' ' CG2' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -51.84 -15.3 0.48 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.453 -0.779 . . . . 0.0 110.275 179.619 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.652 ' O ' HG13 ' A' ' 7' ' ' ILE . 38.7 m -106.89 -58.48 1.93 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 122.004 0.907 . . . . 0.0 109.161 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.503 ' HB3' ' HG2' ' A' ' 1' ' ' MET . 2.6 mt-10 -50.46 -45.05 55.81 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.056 -1.028 . . . . 0.0 108.571 179.051 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.83 HD12 ' C ' ' A' ' 2' ' ' ASN . 2.4 mt -58.26 -36.31 73.06 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.364 -0.934 . . . . 0.0 109.954 178.129 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.652 HG13 ' O ' ' A' ' 4' ' ' THR . 0.9 OUTLIER -55.8 -42.81 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.295 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.869 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -64.64 -33.76 76.69 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 177.863 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.672 ' HB3' ' O ' ' A' ' 6' ' ' LEU . . . -56.23 -38.11 70.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.473 -0.767 . . . . 0.0 109.019 178.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.722 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.4 mp -91.52 -32.41 5.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 178.138 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.869 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -65.3 -14.11 60.0 Favored 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 118.689 -1.205 . . . . 0.0 108.227 178.008 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.402 ' N ' ' O ' ' A' ' 8' ' ' LYS . 6.4 tp-100 -110.75 -46.07 3.41 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.441 ' OD2' HG23 ' B' ' 31' ' ' ILE . 1.6 m-20 -66.63 -27.78 67.96 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 177.325 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.794 ' CG2' ' HB2' ' B' ' 20' ' ' SER . 0.2 OUTLIER -111.55 -82.26 0.58 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 178.848 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.516 ' O ' ' C ' ' A' ' 16' ' ' LEU . . . 69.0 -21.35 0.37 Allowed Glycine 0 N--CA 1.498 2.831 0 O-C-N 121.004 -1.06 . . . . 0.0 110.825 178.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 1.113 ' CD1' HG23 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -30.2 -63.77 0.13 Allowed 'General case' 0 N--CA 1.518 2.925 0 CA-C-O 122.052 0.929 . . . . 0.0 110.497 -179.57 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.683 HG22 ' H ' ' A' ' 19' ' ' VAL . 0.5 OUTLIER -129.31 -4.89 4.87 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.774 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.626 ' O ' ' C ' ' A' ' 19' ' ' VAL . 22.1 mt-30 56.41 31.78 19.41 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -177.178 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 1.024 HG11 HG11 ' B' ' 19' ' ' VAL . 1.6 p -6.46 -98.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.538 -178.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.92 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -133.48 23.28 4.03 Favored 'General case' 0 C--N 1.279 -2.493 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 177.15 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.625 HG12 HG22 ' A' ' 10' ' ' ILE . 30.4 m -20.6 -37.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-O 122.254 1.026 . . . . 0.0 109.858 -178.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.825 ' N ' ' O ' ' A' ' 20' ' ' SER . 11.2 t -75.46 -42.76 52.41 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.931 177.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.92 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -93.8 -22.91 18.38 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.52 -0.738 . . . . 0.0 109.888 178.739 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.79 ' N ' ' OG ' ' A' ' 20' ' ' SER 0.26 2.0 tmm? -68.02 -33.01 73.79 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 179.201 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.597 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 7.3 mt -84.41 -41.55 16.56 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 176.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.539 ' HB3' ' HA ' ' A' ' 23' ' ' LYS . . . -59.19 -34.1 71.74 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 177.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.487 ' O ' HG13 ' A' ' 31' ' ' ILE . 10.2 t -80.17 -36.32 35.23 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 178.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.645 ' CE1' HD22 ' B' ' 44' ' ' LEU . 0.2 OUTLIER -52.1 -44.87 64.63 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.694 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.662 ' HG3' ' CD2' ' B' ' 47' ' ' PHE . 0.9 OUTLIER -69.53 -36.72 76.66 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.247 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 1.129 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 16.5 ttpt -62.53 -23.82 67.17 Favored 'General case' 0 C--O 1.191 -1.981 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.734 HD12 HD23 ' B' ' 6' ' ' LEU . 0.5 OUTLIER -104.15 -27.96 3.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 O-C-N 120.499 -1.376 . . . . 0.0 109.379 178.225 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.623 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.3 mm -73.81 -57.55 6.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 177.26 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.565 ' HB ' ' O ' ' A' ' 29' ' ' GLU . 0.6 OUTLIER -68.35 -36.33 79.08 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.568 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 1.129 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 68.2 mm-40 -75.55 -37.79 59.75 Favored 'General case' 0 N--CA 1.483 1.185 0 O-C-N 121.17 -0.956 . . . . 0.0 111.702 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.584 HG23 ' HB2' ' A' ' 40' ' ' ASP . 14.0 m -62.18 -53.97 47.63 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 120.281 -1.512 . . . . 0.0 109.499 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.817 HG22 ' HD3' ' A' ' 52' ' ' PRO . 2.1 t -54.76 -32.89 26.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 177.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.843 ' HB1' ' O ' ' B' ' 88' ' ' ALA . . . -90.38 10.5 24.79 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.333 177.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.675 ' HB2' ' O ' ' A' ' 34' ' ' GLU . 1.9 ttmt -114.23 -35.35 5.03 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 178.201 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 127.95 38.58 0.38 Allowed Glycine 0 C--N 1.301 -1.404 0 C-N-CA 119.732 -1.223 . . . . 0.0 110.835 178.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.584 ' HB2' HG23 ' A' ' 35' ' ' THR . 0.3 OUTLIER -145.92 135.8 23.49 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.083 -1.245 . . . . 0.0 110.281 179.431 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.02 76.49 2.21 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.391 -0.818 . . . . 0.0 110.459 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.884 HG23 HD11 ' B' ' 6' ' ' LEU . 11.0 p -60.56 136.46 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.412 -0.805 . . . . 0.0 110.056 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' B' ' 1' ' ' MET . 6.9 pt20 -144.75 175.15 10.39 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.239 -0.913 . . . . 0.0 110.737 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 1.03 HD12 ' CB ' ' A' ' 48' ' ' LEU . 27.6 mt -125.26 115.01 19.7 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.665 -0.647 . . . . 0.0 109.276 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.537 HG21 ' HG3' ' B' ' 29' ' ' GLU . 0.0 OUTLIER 32.26 -93.88 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.859 -0.526 . . . . 0.0 111.552 -179.767 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.432 ' H ' HG23 ' A' ' 45' ' ' THR . . . -145.05 21.87 1.94 Allowed Glycine 0 N--CA 1.489 2.188 0 C-N-CA 119.504 -1.331 . . . . 0.0 111.013 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.684 ' CD2' ' HG3' ' B' ' 29' ' ' GLU . 8.5 p90 -119.76 -22.15 6.96 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.768 -1.431 . . . . 0.0 111.216 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.03 ' CB ' HD12 ' A' ' 44' ' ' LEU . 6.8 mt -128.72 108.47 10.51 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.453 -1.404 . . . . 0.0 110.653 178.029 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.607 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 1.1 t-20 -109.68 91.13 3.52 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.673 -0.642 . . . . 0.0 111.095 -179.037 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.762 HG22 HG21 ' A' ' 36' ' ' VAL . 11.1 mm -93.52 138.11 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.29 -0.881 . . . . 0.0 110.138 179.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 21.0 ptmt -160.93 128.39 2.7 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 120.804 -1.185 . . . . 0.0 111.295 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.817 ' HD3' HG22 ' A' ' 36' ' ' VAL . 55.7 Cg_endo -78.69 141.91 17.66 Favored 'Trans proline' 0 C--N 1.314 -1.274 0 O-C-N 123.513 1.27 . . . . 0.0 110.631 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.753 HG22 ' O ' ' A' ' 76' ' ' GLY . 34.5 m -145.66 113.04 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 C-N-CA 119.465 -0.894 . . . . 0.0 111.928 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.922 ' HB1' ' HB3' ' B' ' 96' ' ' ASP . . . . . . . . 0 N--CA 1.495 1.798 0 C-N-CA 119.259 -0.976 . . . . 0.0 109.379 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.997 ' HB ' ' CD2' ' B' ' 94' ' ' TYR . 1.1 t . . . . . 0 N--CA 1.515 2.796 0 CA-C-O 122.236 1.017 . . . . 0.0 108.761 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.753 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -138.28 99.22 0.27 Allowed Glycine 0 C--N 1.289 -2.068 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -178.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.701 ' CG2' HD13 ' B' ' 85' ' ' LEU . 1.5 p -59.93 82.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.838 -0.801 . . . . 0.0 109.368 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.632 ' C ' HG12 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -62.67 177.1 0.57 Allowed 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.554 -0.858 . . . . 0.0 110.535 -179.462 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.632 HG12 ' C ' ' A' ' 78' ' ' SER . 0.2 OUTLIER 177.42 174.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.761 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.86 ' O ' HD23 ' A' ' 48' ' ' LEU . 0.5 OUTLIER 177.71 170.26 0.45 Allowed Pre-proline 0 N--CA 1.485 1.323 0 O-C-N 120.822 -1.174 . . . . 0.0 110.997 177.227 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.502 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 56.1 Cg_endo -103.83 136.06 0.1 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 123.359 2.706 . . . . 0.0 109.223 176.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.558 ' HA3' ' HA ' ' A' ' 47' ' ' PHE . . . -97.46 161.25 21.33 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 108.295 -1.922 . . . . 0.0 108.295 178.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.451 ' HA ' ' HB2' ' A' ' 86' ' ' LYS . 0.5 OUTLIER -57.71 -23.95 54.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.015 -1.285 . . . . 0.0 110.584 -179.429 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.5 t -51.82 -31.18 26.39 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.117 -0.989 . . . . 0.0 108.654 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.89 HD13 ' CG1' ' B' ' 77' ' ' VAL . 0.5 OUTLIER -82.96 -31.22 27.72 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.597 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.718 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 5.0 mttt -81.27 -31.8 33.53 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.581 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.421 ' O ' ' HG3' ' A' ' 90' ' ' GLU . 1.1 tmtt? -69.63 -40.2 76.68 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 178.041 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.759 ' O ' ' HB1' ' B' ' 37' ' ' ALA . . . -62.0 -38.4 88.49 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 176.163 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.79 ' HA ' HD23 ' A' ' 92' ' ' LEU . . . -53.57 -43.04 68.17 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 120.0 -0.68 . . . . 0.0 109.5 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.502 ' HG3' ' N ' ' A' ' 91' ' ' GLY . 0.3 OUTLIER -54.16 -30.96 51.25 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 177.517 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.502 ' N ' ' HG3' ' A' ' 90' ' ' GLU . . . -64.1 -43.3 97.44 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 178.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.923 HD21 HG21 ' B' ' 75' ' ' VAL . 0.4 OUTLIER -71.59 8.91 0.96 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.745 -1.444 . . . . 0.0 110.831 179.804 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 17.2 mmtm 65.69 50.34 1.61 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 -177.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.584 ' CD1' ' N ' ' B' ' 75' ' ' VAL . 0.0 OUTLIER -34.64 -38.57 0.08 Allowed 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.063 -179.005 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.446 ' HG2' ' CE2' ' A' ' 94' ' ' TYR . 24.8 mt-10 . . . . . 0 N--CA 1.495 1.777 0 O-C-N 121.333 -0.855 . . . . 0.0 109.828 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.462 ' HA ' ' CB ' ' B' ' 5' ' ' GLU . 5.3 mtp . . . . . 0 N--CA 1.493 1.687 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 2' ' ' ASN . . . . . 0.434 ' N ' HD12 ' B' ' 6' ' ' LEU . 22.6 p30 -176.73 -172.7 0.45 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.249 -0.907 . . . . 0.0 111.099 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.496 ' O ' HG13 ' B' ' 7' ' ' ILE . 0.0 OUTLIER -51.5 -11.15 0.12 Allowed 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.381 -0.825 . . . . 0.0 111.244 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 4' ' ' THR . . . . . 0.629 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 45.7 m -114.48 -43.28 3.19 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.812 -1.18 . . . . 0.0 108.995 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.501 ' HA ' ' HE2' ' B' ' 8' ' ' LYS . 0.0 OUTLIER -64.19 -50.41 68.22 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.708 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.884 HD11 HG23 ' A' ' 42' ' ' VAL . 0.7 OUTLIER -62.08 -28.93 69.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.375 -0.828 . . . . 0.0 108.898 178.176 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 7' ' ' ILE . . . . . 1.006 HG13 HD12 ' B' ' 25' ' ' LEU . 0.5 OUTLIER -55.52 -59.32 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.144 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 8' ' ' LYS . . . . . 0.895 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.1 OUTLIER -57.86 -30.3 65.7 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.375 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 9' ' ' ALA . . . . . 0.675 ' HB3' ' O ' ' B' ' 6' ' ' LEU . . . -58.98 -36.57 75.1 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.466 -0.894 . . . . 0.0 108.97 178.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.914 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.1 mp -89.03 -35.16 7.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 177.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.895 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -65.57 -9.46 26.78 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 118.839 -1.144 . . . . 0.0 108.42 177.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.491 ' HB3' ' O ' ' B' ' 8' ' ' LYS . 0.4 OUTLIER -118.46 -43.15 2.72 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.547 -0.721 . . . . 0.0 109.448 178.846 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.442 ' HB3' ' OG ' ' A' ' 27' ' ' SER . 1.7 m-20 -66.1 -38.32 87.93 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 177.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 14' ' ' THR . . . . . 1.057 HG22 ' CD1' ' B' ' 16' ' ' LEU 0.251 0.1 OUTLIER -89.13 -77.95 0.36 Allowed 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 177.549 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.84 6.52 78.49 Favored Glycine 0 N--CA 1.5 2.936 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 177.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 16' ' ' LEU . . . . . 1.057 ' CD1' HG22 ' B' ' 14' ' ' THR . 5.2 mp -55.48 -71.4 0.09 Allowed 'General case' 0 C--N 1.294 -1.817 0 O-C-N 121.63 -0.924 . . . . 0.0 110.569 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 17' ' ' THR . . . . . 0.683 ' CG2' HG21 ' A' ' 17' ' ' THR . 0.5 OUTLIER -139.57 8.37 2.39 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.581 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 18' ' ' GLN . . . . . 0.613 ' O ' ' C ' ' B' ' 19' ' ' VAL . 11.2 mt-30 58.69 23.86 11.53 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 -175.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 1.113 HG23 ' CD1' ' A' ' 16' ' ' LEU . 0.2 OUTLIER 5.49 -94.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.125 -179.194 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 20' ' ' SER . . . . . 0.978 ' O ' ' N ' ' B' ' 23' ' ' LYS . 0.4 OUTLIER -135.72 23.19 3.37 Favored 'General case' 0 C--N 1.275 -2.654 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 178.153 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.977 ' HB ' HG23 ' B' ' 7' ' ' ILE . 18.3 m -15.0 -40.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-O 122.245 1.022 . . . . 0.0 109.885 -177.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.914 ' N ' ' O ' ' B' ' 20' ' ' SER . 7.7 t -74.93 -42.21 58.16 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.173 177.538 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 23' ' ' LYS . . . . . 0.978 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.2 OUTLIER -92.89 -25.9 17.86 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.661 -0.649 . . . . 0.0 109.827 178.599 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 24' ' ' MET . . . . . 0.583 ' HE2' ' HA ' ' B' ' 21' ' ' VAL . 2.2 tmm? -64.12 -41.06 97.39 Favored 'General case' 0 C--N 1.316 -0.85 0 O-C-N 120.779 -1.201 . . . . 0.0 108.321 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 1.006 HD12 HG13 ' B' ' 7' ' ' ILE . 2.5 mt -81.28 -42.63 20.34 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 118.952 -1.099 . . . . 0.0 108.547 177.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 26' ' ' ALA . . . . . 0.553 ' HB3' ' HA ' ' B' ' 23' ' ' LYS . . . -58.01 -34.02 69.58 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 27' ' ' SER . . . . . 0.566 ' O ' HG13 ' B' ' 31' ' ' ILE . 73.8 m -82.02 -37.12 27.0 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 177.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 28' ' ' PHE . . . . . 0.954 ' CE1' HD22 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -52.81 -48.3 67.03 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.318 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 29' ' ' GLU . . . . . 0.684 ' HG3' ' CD2' ' A' ' 47' ' ' PHE . 1.7 tt0 -67.16 -34.93 78.59 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.13 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 1.241 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 13.8 ttpt -65.41 -20.84 66.55 Favored 'General case' 0 C--O 1.193 -1.92 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.662 HD11 ' HA ' ' B' ' 28' ' ' PHE . 0.7 OUTLIER -106.47 -25.33 3.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 O-C-N 120.057 -1.652 . . . . 0.0 108.968 177.929 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.634 HD11 ' CE2' ' B' ' 28' ' ' PHE . 1.2 mm -76.53 -58.96 3.61 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 176.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 33' ' ' THR . . . . . 0.492 ' OG1' ' HG ' ' A' ' 85' ' ' LEU . 0.6 OUTLIER -70.35 -34.19 72.35 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.257 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 1.241 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 77.9 mm-40 -78.83 -37.29 40.91 Favored 'General case' 0 C--O 1.208 -1.093 0 O-C-N 121.126 -0.984 . . . . 0.0 111.614 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 35' ' ' THR . . . . . 0.512 ' CB ' ' O ' ' B' ' 31' ' ' ILE . 26.1 m -61.55 -47.15 86.86 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 120.073 -1.642 . . . . 0.0 108.459 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.917 HG22 ' HD3' ' B' ' 52' ' ' PRO . 1.7 t -52.66 -44.46 46.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 177.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 37' ' ' ALA . . . . . 0.759 ' HB1' ' O ' ' A' ' 88' ' ' ALA . . . -84.85 -1.28 56.29 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.815 178.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 38' ' ' LYS . . . . . 0.661 ' HB2' ' O ' ' B' ' 34' ' ' GLU . 3.0 ttmt -94.16 -29.84 14.93 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 177.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.1 31.88 0.56 Allowed Glycine 0 C--N 1.303 -1.254 0 C-N-CA 119.665 -1.255 . . . . 0.0 111.395 177.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 40' ' ' ASP . . . . . 0.464 ' CB ' ' CG2' ' B' ' 35' ' ' THR . 0.2 OUTLIER -146.84 146.38 30.19 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.758 -1.436 . . . . 0.0 110.934 179.453 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.39 96.75 9.72 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.609 0.719 . . . . 0.0 109.341 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.554 HG13 HD11 ' A' ' 6' ' ' LEU . 74.5 t -58.35 129.95 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.567 -0.708 . . . . 0.0 110.124 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 43' ' ' GLN . . . . . 0.431 ' HA ' ' HA ' ' B' ' 49' ' ' ASN . 0.0 OUTLIER -123.69 109.05 13.23 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.517 -0.74 . . . . 0.0 109.955 -179.726 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.894 HD12 ' HB3' ' B' ' 48' ' ' LEU . 23.4 mt -77.06 106.32 8.69 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.214 -0.929 . . . . 0.0 109.93 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 45' ' ' THR . . . . . 0.609 HG21 ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 32.42 -93.25 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.246 0 O-C-N 122.018 -0.426 . . . . 0.0 111.425 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 46' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -148.28 29.39 1.35 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 47' ' ' PHE . . . . . 0.733 ' HD1' HD12 ' B' ' 85' ' ' LEU . 3.2 p90 -130.18 -24.66 2.57 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.075 -1.25 . . . . 0.0 111.152 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.894 ' HB3' HD12 ' B' ' 44' ' ' LEU . 6.5 mt -134.49 94.09 3.15 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.727 -1.233 . . . . 0.0 110.196 178.093 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 49' ' ' ASN . . . . . 0.431 ' HA ' ' HA ' ' B' ' 43' ' ' GLN . 0.1 OUTLIER -98.03 72.43 2.19 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.386 -0.821 . . . . 0.0 111.365 -179.371 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 50' ' ' ILE . . . . . 0.842 HD13 ' HB ' ' B' ' 79' ' ' VAL . 2.8 mm -61.06 125.28 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.146 -0.971 . . . . 0.0 108.752 178.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 51' ' ' LYS . . . . . 0.415 ' HG3' ' CB ' ' B' ' 78' ' ' SER . 2.2 ptmt -145.5 113.68 4.74 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 120.821 -1.175 . . . . 0.0 110.489 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 52' ' ' PRO . . . . . 0.917 ' HD3' HG22 ' B' ' 36' ' ' VAL . 55.8 Cg_endo -79.87 138.37 13.14 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.742 1.39 . . . . 0.0 110.759 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.87 ' O ' HG22 ' B' ' 75' ' ' VAL . 17.0 m -122.08 -156.75 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 54' ' ' ALA . . . . . 0.5 ' HA ' ' HA ' ' B' ' 75' ' ' VAL . . . . . . . . 0 C--N 1.293 -1.857 0 O-C-N 121.01 -1.056 . . . . 0.0 111.964 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 75' ' ' VAL . . . . . 0.923 HG21 HD21 ' A' ' 92' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.779 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 76' ' ' GLY . . . . . 0.675 ' CA ' HG22 ' B' ' 53' ' ' VAL . . . -117.59 90.25 0.5 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.89 ' CG1' HD13 ' A' ' 85' ' ' LEU . 65.2 t -66.35 78.79 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 O-C-N 121.628 -0.925 . . . . 0.0 110.027 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 78' ' ' SER . . . . . 0.472 ' O ' ' HB ' ' B' ' 79' ' ' VAL . 0.4 OUTLIER -75.73 174.37 9.9 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 118.75 -1.18 . . . . 0.0 110.368 -179.831 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.842 ' HB ' HD13 ' B' ' 50' ' ' ILE . 7.2 p 175.09 177.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 80' ' ' LYS . . . . . 0.652 ' O ' HD23 ' B' ' 48' ' ' LEU . 0.3 OUTLIER -177.5 172.5 0.77 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 120.743 -1.223 . . . . 0.0 110.933 177.207 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 81' ' ' PRO . . . . . 0.419 ' HD2' ' HB2' ' B' ' 80' ' ' LYS . 56.7 Cg_endo -96.44 100.33 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.559 2.173 . . . . 0.0 110.352 178.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 82' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' B' ' 46' ' ' GLY . . . -61.81 172.93 7.95 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 108.623 -1.791 . . . . 0.0 108.623 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -68.1 -26.45 65.82 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.978 -1.307 . . . . 0.0 110.558 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -50.14 -33.83 20.26 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.21 -0.931 . . . . 0.0 108.658 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.765 HD22 HG11 ' A' ' 36' ' ' VAL . 0.5 OUTLIER -82.57 -31.78 28.83 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 178.522 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 86' ' ' LYS . . . . . 0.754 ' O ' ' HB3' ' B' ' 89' ' ' ALA . 1.2 tttt -76.15 -39.24 55.43 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.586 -0.696 . . . . 0.0 109.695 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 31.7 tttt -65.61 -39.95 92.08 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 178.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.843 ' O ' ' HB1' ' A' ' 37' ' ' ALA . . . -64.06 -35.45 80.79 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 176.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.782 ' HA ' HD23 ' B' ' 92' ' ' LEU . . . -53.65 -41.87 67.22 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 90' ' ' GLU . . . . . 0.478 ' HA ' ' HB2' ' B' ' 94' ' ' TYR . 0.9 OUTLIER -55.19 -33.39 62.99 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 176.868 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 91' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' B' ' 88' ' ' ALA . . . -70.06 -25.51 75.51 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 178.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 92' ' ' LEU . . . . . 0.89 ' O ' HD12 ' B' ' 92' ' ' LEU . 0.4 OUTLIER -73.76 20.18 0.1 Allowed 'General case' 0 N--CA 1.502 2.157 0 O-C-N 120.671 -1.488 . . . . 0.0 110.6 179.788 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 93' ' ' LYS . . . . . 0.731 ' O ' ' C ' ' B' ' 94' ' ' TYR . 0.0 OUTLIER 72.0 29.93 2.29 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 -177.437 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 94' ' ' TYR . . . . . 0.997 ' CD2' ' HB ' ' A' ' 75' ' ' VAL . 15.0 t80 -22.2 -66.5 0.03 OUTLIER 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 95' ' ' GLU . . . . . 0.747 ' O ' ' N ' ' B' ' 97' ' ' PHE . 8.2 mt-10 4.85 36.47 0.0 OUTLIER 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 101.563 -3.495 . . . . 0.0 101.563 177.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 96' ' ' ASP . . . . . 0.973 ' O ' ' C ' ' B' ' 97' ' ' PHE . 0.0 OUTLIER 17.87 40.61 0.0 OUTLIER 'General case' 0 CA--C 1.476 -1.881 0 CA-C-N 112.689 -2.051 . . . . 0.0 107.531 -173.741 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 97' ' ' PHE . . . . . 0.973 ' C ' ' O ' ' B' ' 96' ' ' ASP . 42.2 p90 . . . . . 0 CA--C 1.504 -0.793 1 N-CA-C 99.96 -4.089 . . . . 0.0 99.96 -167.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.708 ' HE1' HD13 ' B' ' 31' ' ' ILE . 6.5 mtp . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 120.89 0.376 . . . . 0.0 110.109 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.872 ' C ' HD12 ' A' ' 6' ' ' LEU . 26.5 p30 -177.85 -173.02 0.37 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.219 -0.926 . . . . 0.0 110.995 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.575 ' HE2' ' HA ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -48.57 -15.36 0.08 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.533 -0.729 . . . . 0.0 110.923 -179.724 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.646 ' O ' HG13 ' A' ' 7' ' ' ILE . 60.7 m -107.07 -60.47 1.67 Allowed 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 122.059 0.933 . . . . 0.0 109.461 179.039 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.546 ' HB3' ' HG2' ' A' ' 1' ' ' MET . 8.9 mt-10 -50.57 -44.21 56.67 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.014 -1.054 . . . . 0.0 108.469 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.872 HD12 ' C ' ' A' ' 2' ' ' ASN . 4.7 mt -56.64 -34.37 67.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.365 -0.834 . . . . 0.0 109.955 178.01 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.646 HG13 ' O ' ' A' ' 4' ' ' THR . 0.9 OUTLIER -60.12 -41.52 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 179.301 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.789 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -70.63 -29.92 66.43 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 177.571 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 6' ' ' LEU . . . -61.48 -37.52 83.95 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.517 -0.74 . . . . 0.0 109.159 178.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.686 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.1 mp -93.64 -30.04 4.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 178.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.789 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -62.69 -13.88 37.43 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 118.473 -1.291 . . . . 0.0 108.335 178.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -116.21 -46.56 2.79 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 121.631 -0.668 . . . . 0.0 109.865 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.17 -29.97 71.05 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 177.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . 1.06 HG22 ' CD1' ' A' ' 16' ' ' LEU 0.271 0.2 OUTLIER -105.09 -74.43 0.65 Allowed 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 179.016 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 57.48 11.51 7.41 Favored Glycine 0 N--CA 1.497 2.747 0 O-C-N 121.402 -0.811 . . . . 0.0 111.811 177.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 1.06 ' CD1' HG22 ' A' ' 14' ' ' THR . 2.4 mp -54.37 -62.3 1.74 Allowed 'General case' 0 N--CA 1.505 2.296 0 O-C-N 121.011 -1.288 . . . . 0.0 109.334 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.559 HG21 ' CG2' ' B' ' 17' ' ' THR . 0.6 OUTLIER -135.89 4.61 3.03 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.384 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.597 ' O ' ' C ' ' A' ' 19' ' ' VAL . 24.5 mt-30 56.97 28.89 15.43 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 -176.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 1.084 HG11 HG11 ' B' ' 19' ' ' VAL . 1.5 p -10.7 -97.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.979 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.921 ' O ' ' N ' ' A' ' 22' ' ' SER . 0.3 OUTLIER -133.55 24.76 4.07 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 177.977 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.65 ' HA ' ' SD ' ' A' ' 24' ' ' MET . 32.5 m -16.01 -38.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 CA-C-O 122.551 1.167 . . . . 0.0 110.117 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.921 ' N ' ' O ' ' A' ' 20' ' ' SER . 98.0 p -79.22 -38.08 36.56 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.392 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.914 ' N ' ' O ' ' A' ' 20' ' ' SER . 14.1 ttpt -92.08 -25.24 18.85 Favored 'General case' 0 C--N 1.308 -1.225 0 O-C-N 121.226 -0.921 . . . . 0.0 110.897 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.65 ' SD ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -74.91 -35.67 62.2 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 117.399 -1.72 . . . . 0.0 107.418 178.541 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.663 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 8.2 mt -77.48 -37.87 50.4 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 118.68 -1.208 . . . . 0.0 108.494 177.237 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.575 ' HA ' ' HE2' ' A' ' 3' ' ' LYS . . . -64.48 -35.53 81.23 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 177.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.523 ' O ' HG13 ' A' ' 31' ' ' ILE . 82.7 p -80.93 -28.82 35.62 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.096 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.69 ' CE2' HD11 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -54.78 -41.41 70.51 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.686 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.653 ' HG3' ' CD1' ' B' ' 47' ' ' PHE . 0.7 OUTLIER -72.39 -36.44 68.69 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 176.201 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 1.12 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 22.9 ttpt -60.71 -23.59 65.01 Favored 'General case' 0 C--O 1.191 -2.02 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.304 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.647 HD11 ' HA ' ' A' ' 28' ' ' PHE . 0.7 OUTLIER -104.17 -27.23 3.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 120.682 -1.261 . . . . 0.0 109.404 178.127 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.69 HD11 ' CE2' ' A' ' 28' ' ' PHE . 1.2 mm -70.89 -58.5 5.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 177.125 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.819 ' OG1' HD12 ' B' ' 85' ' ' LEU . 0.5 OUTLIER -67.71 -42.84 81.36 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.342 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 1.12 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 34.0 mm-40 -69.09 -34.62 75.38 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.24 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.9 HG23 ' CB ' ' A' ' 40' ' ' ASP . 1.2 m -57.88 -50.35 73.62 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.44 -1.413 . . . . 0.0 107.812 178.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.684 HG11 ' HB2' ' B' ' 85' ' ' LEU . 2.1 t -53.1 -40.52 38.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 C-N-CA 118.607 -1.237 . . . . 0.0 107.853 178.402 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.801 ' HB2' ' HB1' ' B' ' 88' ' ' ALA . . . -77.71 -9.34 58.94 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.481 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -102.1 2.19 37.19 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 177.495 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.464 ' HA2' ' HG2' ' A' ' 52' ' ' PRO . . . 66.26 50.92 47.66 Favored Glycine 0 C--N 1.302 -1.359 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.9 ' CB ' HG23 ' A' ' 35' ' ' THR . 0.2 OUTLIER -127.9 157.78 39.58 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.284 -1.127 . . . . 0.0 110.081 179.591 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.412 ' CG ' ' HB2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -107.05 92.93 4.29 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.45 -0.781 . . . . 0.0 111.001 -178.969 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 1.011 HG13 HD11 ' B' ' 6' ' ' LEU . 2.3 t -87.4 92.17 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.557 -0.714 . . . . 0.0 109.303 179.023 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.471 ' O ' HD23 ' A' ' 44' ' ' LEU . 0.6 OUTLIER -89.19 148.37 23.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.137 -0.977 . . . . 0.0 110.617 -179.313 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.658 ' HB2' ' HB2' ' A' ' 48' ' ' LEU . 19.2 mt -118.45 117.31 28.68 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.543 -0.723 . . . . 0.0 109.725 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.518 HG23 ' CD2' ' A' ' 47' ' ' PHE . 0.1 OUTLIER 29.91 -88.59 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.429 0 O-C-N 121.82 -0.55 . . . . 0.0 111.137 179.506 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -152.38 21.28 0.84 Allowed Glycine 0 N--CA 1.486 2.009 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.688 ' CE1' HG21 ' B' ' 32' ' ' ILE . 8.8 p90 -118.54 -23.54 7.1 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.916 -1.343 . . . . 0.0 111.25 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.658 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -129.27 94.11 3.72 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.8 -1.188 . . . . 0.0 110.792 178.543 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.651 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 0.6 OUTLIER -96.02 83.37 3.64 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.64 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.948 HG22 ' CG2' ' A' ' 79' ' ' VAL . 0.7 OUTLIER -94.26 144.72 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.022 -1.048 . . . . 0.0 113.093 -177.629 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.584 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 9.7 ptmt -177.01 112.43 0.24 Allowed Pre-proline 0 N--CA 1.494 1.746 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 177.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.665 ' CB ' HG21 ' A' ' 75' ' ' VAL . 55.5 Cg_endo -69.58 132.06 22.8 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 O-C-N 123.313 1.165 . . . . 0.0 113.379 -175.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.89 ' O ' HG23 ' A' ' 75' ' ' VAL . 19.1 m -125.37 -141.16 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.272 177.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.739 ' HB2' ' HB3' ' B' ' 97' ' ' PHE . . . . . . . . 0 C--N 1.292 -1.896 0 O-C-N 120.576 -1.328 . . . . 0.0 111.189 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.89 HG23 ' O ' ' A' ' 53' ' ' VAL . 8.7 p . . . . . 0 N--CA 1.494 1.742 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.556 ' HA3' ' CG2' ' A' ' 53' ' ' VAL . . . -91.6 55.85 3.07 Favored Glycine 0 N--CA 1.484 1.84 0 N-CA-C 107.449 -2.261 . . . . 0.0 107.449 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.895 HG21 ' HA ' ' B' ' 84' ' ' SER . 19.2 t -26.0 93.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-O 122.932 1.348 . . . . 0.0 110.986 -178.162 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.569 ' CB ' ' HG3' ' A' ' 51' ' ' LYS . 45.7 t -57.31 -41.63 80.28 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 114.199 -1.364 . . . . 0.0 113.329 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.948 ' CG2' HG22 ' A' ' 50' ' ' ILE 0.255 7.5 p -44.38 167.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 CA-C-O 122.423 1.106 . . . . 0.0 113.568 -172.238 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.632 ' O ' HD23 ' A' ' 48' ' ' LEU . 0.5 OUTLIER 174.61 176.07 0.21 Allowed Pre-proline 0 N--CA 1.485 1.301 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.382 -179.518 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -78.96 130.76 9.65 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 123.751 1.395 . . . . 0.0 109.344 176.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.458 ' CA ' ' HA ' ' A' ' 47' ' ' PHE . . . -104.39 -174.93 25.15 Favored Glycine 0 N--CA 1.498 2.821 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.43 ' HA ' ' HB2' ' A' ' 86' ' ' LYS . 2.2 pm0 -80.93 -24.27 38.29 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.32 -1.106 . . . . 0.0 110.707 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.423 ' HB2' ' HA3' ' A' ' 46' ' ' GLY . 22.0 t -51.07 -32.13 21.05 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.15 -0.969 . . . . 0.0 108.518 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.974 HD11 ' CG1' ' B' ' 36' ' ' VAL . 0.6 OUTLIER -84.22 -35.1 23.71 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.592 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.753 ' HG3' HG23 ' B' ' 77' ' ' VAL . 0.6 OUTLIER -71.34 -31.12 67.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.244 -0.91 . . . . 0.0 109.182 178.809 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.45 -37.18 65.9 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.913 ' C ' ' HB1' ' B' ' 37' ' ' ALA . . . -65.24 -33.77 76.78 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 176.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 1.002 ' CB ' HG11 ' B' ' 75' ' ' VAL . . . -62.38 -35.07 78.01 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.1 -26.37 66.16 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 175.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.519 ' C ' ' H ' ' A' ' 93' ' ' LYS . . . -59.83 -50.18 70.48 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 178.385 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.747 HD23 ' C ' ' B' ' 37' ' ' ALA . 1.3 pp -74.91 27.76 0.09 Allowed 'General case' 0 N--CA 1.505 2.311 0 O-C-N 120.454 -1.615 . . . . 0.0 109.473 178.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.613 ' HB3' ' O ' ' A' ' 92' ' ' LEU . 4.1 ttpt 68.99 93.39 0.08 Allowed 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -177.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 1.126 ' O ' ' C ' ' A' ' 95' ' ' GLU . 24.8 t80 -58.95 -60.74 3.38 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 115.301 -2.56 . . . . 0.0 106.181 177.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 1.126 ' C ' ' O ' ' A' ' 94' ' ' TYR . 38.5 mm-40 . . . . . 0 CA--C 1.484 -1.596 0 N-CA-C 101.366 -3.568 . . . . 0.0 101.366 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.595 ' HA ' ' HB2' ' B' ' 5' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 120.823 0.344 . . . . 0.0 110.246 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 2' ' ' ASN . . . . . 0.48 ' C ' ' H ' ' B' ' 4' ' ' THR . 40.7 p-10 -176.37 -135.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.131 -1.027 . . . . 0.0 111.374 178.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.83 ' HD3' HD11 ' B' ' 25' ' ' LEU . 4.9 mttp -61.5 9.16 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.006 -1.058 . . . . 0.0 111.289 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 4' ' ' THR . . . . . 0.48 ' H ' ' C ' ' B' ' 2' ' ' ASN . 52.9 m -127.8 -66.39 0.87 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.518 -1.364 . . . . 0.0 110.591 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.595 ' HB2' ' HA ' ' B' ' 1' ' ' MET . 19.7 mp0 -53.59 -42.44 67.64 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.955 -1.09 . . . . 0.0 109.797 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 1.011 HD11 HG13 ' A' ' 42' ' ' VAL . 18.0 mt -57.59 -33.08 67.82 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 118.804 -1.158 . . . . 0.0 109.636 179.039 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 7' ' ' ILE . . . . . 0.731 HG22 HD22 ' B' ' 25' ' ' LEU . 0.8 OUTLIER -61.83 -41.47 90.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 178.111 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 8' ' ' LYS . . . . . 0.839 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.0 OUTLIER -70.39 -29.86 66.61 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 177.875 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 9' ' ' ALA . . . . . 0.553 ' HB3' ' O ' ' B' ' 6' ' ' LEU . . . -59.17 -39.46 82.56 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.508 -0.745 . . . . 0.0 109.257 178.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.87 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.1 mp -92.64 -29.81 4.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 178.154 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.839 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -62.87 -15.59 55.42 Favored 'General case' 0 C--N 1.294 -1.809 0 C-N-CA 118.403 -1.319 . . . . 0.0 108.42 178.116 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.444 ' HB3' ' O ' ' B' ' 8' ' ' LYS . 15.3 tp60 -114.74 -45.31 3.0 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.567 -0.708 . . . . 0.0 109.4 178.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' B' ' 9' ' ' ALA . 3.0 m-20 -62.63 -27.75 69.43 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 177.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 14' ' ' THR . . . . . 1.1 HG22 ' CD1' ' B' ' 16' ' ' LEU 0.258 0.2 OUTLIER -106.66 -82.52 0.54 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 178.412 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.95 4.17 82.35 Favored Glycine 0 N--CA 1.5 2.931 0 O-C-N 121.038 -1.039 . . . . 0.0 110.681 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 16' ' ' LEU . . . . . 1.1 ' CD1' HG22 ' B' ' 14' ' ' THR . 5.4 mp -50.95 -71.02 0.07 Allowed 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.632 -0.923 . . . . 0.0 110.838 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 17' ' ' THR . . . . . 0.559 ' CG2' HG21 ' A' ' 17' ' ' THR . 0.6 OUTLIER -136.96 7.82 2.96 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -179.638 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 18' ' ' GLN . . . . . 0.614 ' O ' ' C ' ' B' ' 19' ' ' VAL . 30.6 mt-30 58.34 26.78 14.43 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 -175.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 1.084 HG11 HG11 ' A' ' 19' ' ' VAL . 1.4 p -6.44 -92.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.857 -179.182 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 20' ' ' SER . . . . . 0.937 ' O ' ' N ' ' B' ' 23' ' ' LYS . 0.5 OUTLIER -134.51 25.11 3.76 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 177.531 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.696 ' HA ' ' CE ' ' B' ' 24' ' ' MET . 35.3 m -15.56 -41.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 122.66 1.219 . . . . 0.0 109.26 -177.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.925 ' N ' ' O ' ' B' ' 20' ' ' SER . 48.0 t -79.74 -41.68 26.14 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 114.537 -1.21 . . . . 0.0 110.288 177.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 23' ' ' LYS . . . . . 0.937 ' N ' ' O ' ' B' ' 20' ' ' SER . 1.5 mtpt -85.04 -34.95 22.19 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 121.461 -0.774 . . . . 0.0 111.662 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 24' ' ' MET . . . . . 0.696 ' CE ' ' HA ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -69.23 -30.64 68.83 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 117.667 -1.613 . . . . 0.0 108.058 179.261 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.842 ' HG ' ' N ' ' B' ' 26' ' ' ALA . 0.3 OUTLIER -72.84 -43.23 62.9 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 118.403 -1.319 . . . . 0.0 108.043 177.488 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 26' ' ' ALA . . . . . 0.842 ' N ' ' HG ' ' B' ' 25' ' ' LEU . . . -63.98 -26.69 68.69 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 27' ' ' SER . . . . . 0.606 ' O ' HG23 ' B' ' 31' ' ' ILE . 1.4 t -83.4 -35.83 24.75 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 177.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 28' ' ' PHE . . . . . 0.711 ' HA ' ' CG1' ' B' ' 31' ' ' ILE . 0.6 OUTLIER -64.85 -48.48 74.18 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.467 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 29' ' ' GLU . . . . . 0.605 ' HG3' ' CD2' ' B' ' 28' ' ' PHE . 6.4 mt-10 -72.35 -30.21 64.51 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 120.492 -1.38 . . . . 0.0 107.536 178.305 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 1.147 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 14.3 tttt -73.19 -25.32 60.73 Favored 'General case' 0 C--O 1.187 -2.203 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 177.117 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.711 ' CG1' ' HA ' ' B' ' 28' ' ' PHE . 1.9 pp -100.28 -29.89 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.266 -1.521 . . . . 0.0 109.465 178.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.688 HG21 ' CE1' ' A' ' 47' ' ' PHE . 1.5 mm -65.79 -64.59 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 177.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 33' ' ' THR . . . . . 0.757 ' O ' HD13 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -62.72 -38.5 90.73 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.034 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 1.147 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 76.7 mm-40 -74.38 -42.74 58.78 Favored 'General case' 0 C--O 1.202 -1.404 0 O-C-N 121.036 -1.04 . . . . 0.0 112.111 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 35' ' ' THR . . . . . 0.518 ' HA ' ' HB3' ' B' ' 38' ' ' LYS . 67.5 m -57.19 -56.55 20.29 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 120.222 -1.548 . . . . 0.0 110.494 -178.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 1.013 HG23 HG12 ' B' ' 42' ' ' VAL . 1.3 t -51.63 -44.39 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 117.667 -1.613 . . . . 0.0 106.974 178.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 37' ' ' ALA . . . . . 0.913 ' HB1' ' C ' ' A' ' 88' ' ' ALA . . . -85.97 6.08 30.29 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.705 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 38' ' ' LYS . . . . . 0.785 ' N ' ' O ' ' B' ' 34' ' ' GLU . 0.1 OUTLIER -105.64 -36.43 7.09 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 178.156 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 142.68 37.57 0.08 OUTLIER Glycine 0 C--N 1.301 -1.388 0 C-N-CA 119.252 -1.451 . . . . 0.0 111.4 178.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 40' ' ' ASP . . . . . 0.456 ' HB2' HG23 ' B' ' 35' ' ' THR . 0.4 OUTLIER -155.53 145.0 21.07 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.821 -1.4 . . . . 0.0 110.988 179.461 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.15 92.79 5.72 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.557 0.694 . . . . 0.0 109.519 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 1.013 HG12 HG23 ' B' ' 36' ' ' VAL . 11.3 p -68.25 154.81 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.668 -0.645 . . . . 0.0 110.447 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 43' ' ' GLN . . . . . 0.841 ' O ' HD23 ' B' ' 44' ' ' LEU . 0.4 OUTLIER -164.1 176.3 9.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.189 -0.945 . . . . 0.0 111.386 179.937 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.841 HD23 ' O ' ' B' ' 43' ' ' GLN . 18.1 mt -134.28 118.8 17.96 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 45' ' ' THR . . . . . 0.577 HG21 ' CG ' ' A' ' 29' ' ' GLU . 0.1 OUTLIER 27.21 -95.11 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.416 0 O-C-N 121.826 -0.546 . . . . 0.0 112.374 -179.812 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 46' ' ' GLY . . . . . 0.529 ' H ' HG23 ' B' ' 45' ' ' THR . . . -137.66 14.97 3.62 Favored Glycine 0 N--CA 1.49 2.247 0 C-N-CA 119.322 -1.418 . . . . 0.0 111.686 -178.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 47' ' ' PHE . . . . . 0.909 ' CD2' HD23 ' B' ' 48' ' ' LEU . 20.4 p90 -110.9 -33.48 6.5 Favored 'General case' 0 C--O 1.195 -1.803 0 CA-C-N 119.447 1.623 . . . . 0.0 109.342 178.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.909 HD23 ' CD2' ' B' ' 47' ' ' PHE . 1.2 mm? -127.37 128.57 46.08 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 119.931 -1.731 . . . . 0.0 115.095 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 49' ' ' ASN . . . . . 0.715 ' N ' ' HG2' ' B' ' 81' ' ' PRO . 0.5 OUTLIER -143.93 91.86 2.27 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.621 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 50' ' ' ILE . . . . . 0.577 ' CD1' HG12 ' B' ' 79' ' ' VAL . 24.9 mm -83.79 148.07 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.457 -0.777 . . . . 0.0 110.688 -178.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 51' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' B' ' 78' ' ' SER . 0.0 OUTLIER -149.9 129.88 6.68 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.177 -0.952 . . . . 0.0 109.399 179.149 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 52' ' ' PRO . . . . . 0.628 ' HG3' ' O ' ' B' ' 36' ' ' VAL . 54.9 Cg_endo -81.77 151.64 16.84 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 O-C-N 123.388 1.204 . . . . 0.0 111.387 -178.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.747 HG22 ' O ' ' B' ' 76' ' ' GLY . 20.1 m -138.8 117.48 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-O 122.364 1.078 . . . . 0.0 111.134 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 54' ' ' ALA . . . . . 0.477 ' HA ' ' HE1' ' A' ' 94' ' ' TYR . . . . . . . . 0 N--CA 1.493 1.697 0 O-C-N 121.598 -0.689 . . . . 0.0 110.991 -179.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 75' ' ' VAL . . . . . 1.002 HG11 ' CB ' ' A' ' 89' ' ' ALA . 9.4 p . . . . . 0 N--CA 1.496 1.862 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 76' ' ' GLY . . . . . 0.747 ' O ' HG22 ' B' ' 53' ' ' VAL . . . -114.79 98.96 0.89 Allowed Glycine 0 N--CA 1.484 1.847 0 C-N-CA 118.938 -1.601 . . . . 0.0 109.24 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.753 HG23 ' HG3' ' A' ' 86' ' ' LYS . 67.9 t -68.84 66.07 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.701 -0.882 . . . . 0.0 109.078 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 78' ' ' SER . . . . . 0.487 ' C ' HG13 ' B' ' 79' ' ' VAL . 37.6 t -65.89 -176.19 0.36 Allowed 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.603 0.716 . . . . 0.0 109.648 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.577 HG12 ' CD1' ' B' ' 50' ' ' ILE . 17.7 m -152.68 -153.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 80' ' ' LYS . . . . . 0.719 ' HB3' ' HD3' ' B' ' 81' ' ' PRO . 13.0 ttmt -164.99 -57.58 0.01 OUTLIER Pre-proline 0 C--N 1.294 -1.808 0 O-C-N 121.452 -0.78 . . . . 0.0 109.985 178.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 81' ' ' PRO . . . . . 0.719 ' HD3' ' HB3' ' B' ' 80' ' ' LYS . 44.3 Cg_endo -95.95 164.84 1.33 Allowed 'Trans proline' 0 C--N 1.296 -2.213 0 C-N-CA 121.825 1.683 . . . . 0.0 112.842 -179.047 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 82' ' ' GLY . . . . . 0.711 ' N ' ' O ' ' B' ' 47' ' ' PHE . . . 177.05 -25.39 0.06 OUTLIER Glycine 0 C--N 1.287 -2.141 0 N-CA-C 105.774 -2.93 . . . . 0.0 105.774 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 83' ' ' GLU . . . . . 0.908 ' O ' ' N ' ' B' ' 85' ' ' LEU . 22.5 tt0 30.76 49.84 0.09 Allowed 'General case' 0 C--O 1.205 -1.268 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 84' ' ' SER . . . . . 1.3 ' O ' ' N ' ' B' ' 86' ' ' LYS . 1.2 m 12.67 43.93 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.941 1.353 . . . . 0.0 109.093 -178.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 1.116 ' O ' ' N ' ' B' ' 88' ' ' ALA . 0.3 OUTLIER 23.05 26.4 0.0 OUTLIER 'General case' 0 C--O 1.187 -2.225 0 N-CA-C 102.785 -3.043 . . . . 0.0 102.785 -170.182 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 86' ' ' LYS . . . . . 1.3 ' N ' ' O ' ' B' ' 84' ' ' SER 0.324 21.8 tttt -37.33 -40.83 0.37 Allowed 'General case' 0 CA--C 1.486 -1.497 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 176.624 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 87' ' ' LYS . . . . . 0.426 ' N ' ' C ' ' B' ' 85' ' ' LEU 0.307 0.0 OUTLIER -61.06 -39.71 90.9 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-N 111.865 -2.425 . . . . 0.0 106.711 175.355 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 1.116 ' N ' ' O ' ' B' ' 85' ' ' LEU . . . -90.03 -21.62 22.27 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.433 -0.907 . . . . 0.0 108.966 178.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.711 ' N ' ' O ' ' B' ' 85' ' ' LEU . . . -71.83 -36.74 70.3 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 178.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -66.51 -31.93 72.97 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 174.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -60.88 -42.18 99.53 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 92' ' ' LEU . . . . . 0.862 ' O ' HD12 ' B' ' 92' ' ' LEU . 1.2 pp -85.34 21.17 1.8 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 120.443 -1.622 . . . . 0.0 110.581 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 93' ' ' LYS . . . . . 0.453 ' O ' ' N ' ' B' ' 96' ' ' ASP . 0.8 OUTLIER 55.66 45.22 25.11 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 -178.071 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 94' ' ' TYR . . . . . 0.486 ' CD1' ' N ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -37.29 -43.69 0.55 Allowed 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.661 -178.862 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -54.42 -41.84 69.79 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.297 -0.877 . . . . 0.0 109.535 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 96' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' B' ' 93' ' ' LYS . 0.7 OUTLIER -59.76 -34.29 72.79 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.193 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 97' ' ' PHE . . . . . 0.739 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.272 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.5 ' HG2' ' HB3' ' A' ' 5' ' ' GLU . 11.2 mtp . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 120.852 0.358 . . . . 0.0 110.093 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.486 ' C ' HD12 ' A' ' 6' ' ' LEU . 7.8 t-20 -179.17 -179.86 0.6 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.261 -0.9 . . . . 0.0 110.304 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.529 ' O ' HG13 ' A' ' 7' ' ' ILE . 0.6 OUTLIER -52.63 -20.08 2.8 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.12 -0.988 . . . . 0.0 109.931 179.668 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.464 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 16.6 m -97.69 -46.68 5.9 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.545 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -62.55 -47.04 85.6 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 178.657 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.743 HD11 HG13 ' B' ' 42' ' ' VAL . 2.4 mt -65.69 -29.68 70.26 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.193 178.05 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.831 HG23 ' HB ' ' A' ' 21' ' ' VAL . 0.3 OUTLIER -56.34 -58.76 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 178.428 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.973 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 0.2 OUTLIER -62.64 -27.47 69.24 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.506 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 6' ' ' LEU . . . -61.22 -32.19 71.97 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.202 -0.937 . . . . 0.0 108.708 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.852 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.2 tp -96.29 -37.59 7.44 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.549 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 178.106 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.973 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -59.38 -24.19 63.2 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.428 ' HB3' ' O ' ' A' ' 8' ' ' LYS . 39.3 tp60 -92.5 -45.15 8.27 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.434 ' HB3' ' CB ' ' B' ' 27' ' ' SER . 3.3 m-20 -63.81 -32.12 73.52 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 177.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.948 HG22 ' OG ' ' B' ' 20' ' ' SER . 27.7 p -82.5 -74.01 0.37 Allowed 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 58.87 14.79 24.99 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.936 HD22 ' O ' ' B' ' 19' ' ' VAL . 2.9 mp -77.0 -47.31 21.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.542 -0.976 . . . . 0.0 108.615 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.664 ' HB ' HG21 ' B' ' 17' ' ' THR . 0.5 OUTLIER -160.69 5.57 0.07 Allowed 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 120.0 -0.68 . . . . 0.0 111.055 -179.158 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.552 ' O ' ' C ' ' A' ' 19' ' ' VAL . 13.7 mt-30 58.97 25.52 13.89 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 -176.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.982 HG11 HG11 ' B' ' 19' ' ' VAL . 1.9 p -5.03 -93.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.942 -178.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.965 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -130.32 25.05 5.18 Favored 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 179.695 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.831 ' HB ' HG23 ' A' ' 7' ' ' ILE . 12.5 m -19.26 -40.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 CA-C-O 122.553 1.168 . . . . 0.0 109.548 -178.195 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.826 ' N ' ' O ' ' A' ' 20' ' ' SER . 29.2 t -80.06 -35.75 36.62 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.999 178.217 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.965 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.3 OUTLIER -90.8 -36.21 14.38 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.479 -0.763 . . . . 0.0 110.891 179.561 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.755 ' O ' HD11 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -67.61 -38.64 84.23 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 117.626 -1.63 . . . . 0.0 108.994 179.462 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.763 HD12 HG13 ' A' ' 7' ' ' ILE . 0.2 OUTLIER -78.29 -48.04 16.53 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 117.858 -1.537 . . . . 0.0 109.112 178.455 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.478 ' HA ' ' HE3' ' A' ' 3' ' ' LYS . . . -54.97 -37.24 66.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.747 -1.221 . . . . 0.0 107.831 177.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.588 ' O ' HG13 ' A' ' 31' ' ' ILE . 8.4 t -83.18 -28.82 29.06 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.13 178.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.667 ' CE1' HD22 ' B' ' 44' ' ' LEU . 2.8 t80 -51.91 -49.26 63.4 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.534 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.847 ' HG3' ' CD1' ' B' ' 47' ' ' PHE . 3.3 tt0 -67.17 -35.52 79.83 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 176.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 1.285 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 32.6 tttt -66.11 -17.88 64.99 Favored 'General case' 0 C--O 1.193 -1.913 0 C-N-CA 119.527 -0.869 . . . . 0.0 108.951 178.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.61 HG13 ' O ' ' A' ' 28' ' ' PHE . 1.3 pp -109.24 -26.21 3.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 119.786 -1.821 . . . . 0.0 109.344 178.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.658 ' O ' HG22 ' A' ' 36' ' ' VAL . 1.2 mm -76.5 -54.7 12.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 177.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.77 ' HA ' ' HG ' ' B' ' 85' ' ' LEU . 0.6 OUTLIER -79.35 -29.39 42.19 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.876 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 1.285 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 41.5 mm-40 -78.5 -29.88 46.89 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 118.851 -1.14 . . . . 0.0 110.232 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.537 ' HA ' ' HB2' ' A' ' 38' ' ' LYS . 7.2 m -73.73 -58.73 3.1 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 117.718 -1.593 . . . . 0.0 107.916 178.035 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.658 HG22 ' O ' ' A' ' 32' ' ' ILE . 24.7 m -43.22 -40.7 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.734 ' O ' ' HB2' ' B' ' 92' ' ' LEU . . . -79.01 -32.56 45.16 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.787 ' N ' HD12 ' B' ' 92' ' ' LEU . 0.0 OUTLIER -60.44 -27.66 67.68 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 105.129 -2.175 . . . . 0.0 105.129 176.664 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.484 ' CA ' ' CZ ' ' B' ' 97' ' ' PHE . . . 116.74 26.98 2.91 Favored Glycine 0 C--N 1.297 -1.628 0 CA-C-N 114.363 -1.29 . . . . 0.0 111.025 176.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.508 ' HB2' HG23 ' A' ' 35' ' ' THR . 0.2 OUTLIER -122.0 137.34 54.84 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.251 -1.146 . . . . 0.0 110.072 179.213 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.9 mttm -82.02 87.73 6.44 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.535 -0.728 . . . . 0.0 110.704 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.466 HG22 ' CG1' ' A' ' 36' ' ' VAL . 33.2 m -65.09 140.18 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.446 -0.784 . . . . 0.0 109.718 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.5 ' O ' ' HA ' ' B' ' 2' ' ' ASN . 9.0 mt-30 -135.29 172.22 13.32 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.168 -0.958 . . . . 0.0 110.251 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.948 HD22 ' CE1' ' B' ' 28' ' ' PHE . 11.7 mt -131.65 115.99 16.77 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.214 -0.929 . . . . 0.0 110.332 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.571 HG23 ' HD2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER 26.82 -93.41 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.891 -0.506 . . . . 0.0 111.853 178.892 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.428 ' N ' ' OG1' ' A' ' 45' ' ' THR . . . -153.27 33.87 0.78 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.811 ' CD2' ' HG3' ' B' ' 29' ' ' GLU . 3.2 p90 -131.44 -15.3 3.2 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.265 -1.138 . . . . 0.0 111.154 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.89 HD12 ' O ' ' A' ' 80' ' ' LYS . 47.6 tp -161.05 121.61 2.79 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 118.261 -1.375 . . . . 0.0 111.085 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.477 ' HA ' ' HA ' ' A' ' 43' ' ' GLN . 16.2 m-20 -131.59 118.16 19.71 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.46 0.648 . . . . 0.0 111.163 -178.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.665 HD13 HG23 ' A' ' 79' ' ' VAL . 5.0 mm -94.61 151.51 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.677 -0.639 . . . . 0.0 109.564 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.458 ' O ' ' N ' ' A' ' 78' ' ' SER . 11.5 ptmt -165.52 115.1 0.83 Allowed Pre-proline 0 N--CA 1.5 2.051 0 O-C-N 120.68 -1.263 . . . . 0.0 110.851 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.645 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 43.9 Cg_endo -82.69 155.78 15.83 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 O-C-N 123.515 1.271 . . . . 0.0 112.024 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.726 HG22 ' O ' ' A' ' 76' ' ' GLY . 33.0 m -147.62 118.42 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 CA-C-O 121.669 0.747 . . . . 0.0 110.701 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.574 ' HA ' ' CE1' ' B' ' 94' ' ' TYR . . . . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.635 -0.666 . . . . 0.0 111.428 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.91 HG11 ' HB3' ' B' ' 89' ' ' ALA . 7.5 p . . . . . 0 N--CA 1.496 1.859 0 CA-C-O 121.412 0.625 . . . . 0.0 111.413 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.726 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -116.9 68.75 0.3 Allowed Glycine 0 N--CA 1.487 2.088 0 N-CA-C 108.749 -1.741 . . . . 0.0 108.749 179.269 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.894 ' CG2' HD22 ' B' ' 85' ' ' LEU . 6.4 p -47.08 80.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.963 -0.728 . . . . 0.0 111.622 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.642 ' C ' HG12 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -77.15 176.66 8.51 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 177.757 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.665 HG23 HD13 ' A' ' 50' ' ' ILE . 0.2 OUTLIER 177.49 174.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -179.745 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.89 ' O ' HD12 ' A' ' 48' ' ' LEU . 6.5 ptpt -178.15 170.21 0.87 Allowed Pre-proline 0 C--N 1.299 -1.599 0 O-C-N 121.538 -0.726 . . . . 0.0 109.557 176.395 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.573 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 56.0 Cg_endo -100.69 176.28 0.27 Allowed 'Trans proline' 0 C--N 1.292 -2.447 0 C-N-CA 122.6 2.2 . . . . 0.0 110.943 178.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 47' ' ' PHE . . . -126.27 163.2 20.29 Favored Glycine 0 N--CA 1.485 1.958 0 N-CA-C 107.084 -2.407 . . . . 0.0 107.084 177.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -58.06 -22.5 50.58 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.751 -1.441 . . . . 0.0 110.905 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.436 ' CB ' ' HB3' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -53.54 -35.29 60.56 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.0 -1.063 . . . . 0.0 108.894 179.198 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.966 HD13 ' CG1' ' B' ' 77' ' ' VAL . 0.5 OUTLIER -82.31 -25.65 33.77 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.742 -0.599 . . . . 0.0 109.386 178.711 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.572 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 20.4 mttt -84.86 -30.67 24.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.345 -0.847 . . . . 0.0 109.956 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -73.5 -38.43 65.37 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.831 ' O ' ' HB1' ' B' ' 37' ' ' ALA . . . -63.65 -37.28 86.73 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 176.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 1.002 ' HB1' ' CG1' ' B' ' 75' ' ' VAL . . . -54.92 -44.46 74.26 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 120.106 -0.638 . . . . 0.0 109.362 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.46 ' HA ' ' CB ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -54.47 -29.37 49.72 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.247 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 88' ' ' ALA . . . -67.9 -40.86 89.07 Favored Glycine 0 N--CA 1.488 2.122 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.31 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.615 ' HG ' ' N ' ' A' ' 93' ' ' LYS . 0.3 OUTLIER -70.39 -47.63 59.96 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 119.895 1.847 . . . . 0.0 110.533 -178.948 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.645 ' O ' ' CG ' ' A' ' 93' ' ' LYS . 0.1 OUTLIER 160.35 57.0 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.175 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 1.029 ' O ' ' C ' ' A' ' 95' ' ' GLU . 17.4 t80 -53.18 -65.47 0.55 Allowed 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 178.232 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 1.029 ' C ' ' O ' ' A' ' 94' ' ' TYR . 1.0 OUTLIER . . . . . 0 N--CA 1.483 1.216 0 N-CA-C 103.208 -2.886 . . . . 0.0 103.208 175.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.478 ' HA ' ' HB2' ' B' ' 5' ' ' GLU . 5.5 mtp . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 120.881 0.372 . . . . 0.0 110.259 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 2' ' ' ASN . . . . . 0.667 ' O ' HD12 ' B' ' 6' ' ' LEU . 16.4 m-80 -147.45 -155.99 0.68 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.076 -1.015 . . . . 0.0 111.083 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.526 ' O ' ' CG2' ' B' ' 7' ' ' ILE . 1.0 OUTLIER -60.92 2.17 0.12 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.342 -0.849 . . . . 0.0 110.446 179.765 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 4' ' ' THR . . . . . 0.686 ' O ' HG13 ' B' ' 7' ' ' ILE . 4.5 m -116.3 -63.25 1.48 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 122.147 0.975 . . . . 0.0 108.904 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.478 ' HB2' ' HA ' ' B' ' 1' ' ' MET . 5.5 mm-40 -52.03 -48.05 64.71 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.214 -0.929 . . . . 0.0 108.515 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.667 HD12 ' O ' ' B' ' 2' ' ' ASN . 7.5 mt -56.72 -32.8 65.87 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 119.122 -1.031 . . . . 0.0 110.256 178.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 7' ' ' ILE . . . . . 0.686 HG13 ' O ' ' B' ' 4' ' ' THR . 1.1 pp -60.72 -42.42 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.54 -1.35 . . . . 0.0 107.91 179.232 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 8' ' ' LYS . . . . . 0.822 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.0 OUTLIER -71.93 -27.2 62.65 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.29 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 9' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' B' ' 6' ' ' LEU . . . -62.54 -36.35 82.35 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.958 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.0 OUTLIER -95.46 -35.24 5.79 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.382 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.787 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.822 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -56.32 -25.25 48.15 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -92.49 -46.82 7.45 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.522 ' OD2' HG21 ' A' ' 31' ' ' ILE . 87.0 m-20 -61.64 -24.97 67.08 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 177.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 14' ' ' THR . . . . . 0.958 ' OG1' ' O ' ' B' ' 10' ' ' ILE . 17.2 p -93.77 -77.93 0.44 Allowed 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 177.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 61.46 9.23 16.46 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 16' ' ' LEU . . . . . 0.944 HD22 ' O ' ' A' ' 19' ' ' VAL . 3.2 mp -72.75 -60.25 2.32 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.377 -1.072 . . . . 0.0 108.343 179.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 17' ' ' THR . . . . . 0.664 HG21 ' HB ' ' A' ' 17' ' ' THR . 0.5 OUTLIER -143.5 3.44 1.31 Allowed 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.598 179.659 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 18' ' ' GLN . . . . . 0.639 ' O ' ' C ' ' B' ' 19' ' ' VAL . 4.9 mt-30 59.1 25.33 13.79 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 106.565 -1.642 . . . . 0.0 106.565 -176.424 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.982 HG11 HG11 ' A' ' 19' ' ' VAL . 2.2 p 2.54 -97.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.481 -179.196 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 20' ' ' SER . . . . . 0.95 ' O ' ' N ' ' B' ' 23' ' ' LYS . 0.3 OUTLIER -131.55 21.77 4.7 Favored 'General case' 0 C--N 1.278 -2.525 0 N-CA-C 105.655 -1.98 . . . . 0.0 105.655 175.891 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.959 ' HA ' ' HE2' ' B' ' 24' ' ' MET . 21.2 m -15.31 -39.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-O 122.426 1.108 . . . . 0.0 109.444 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.936 ' N ' ' O ' ' B' ' 20' ' ' SER . 16.5 m -77.41 -45.01 27.2 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.983 177.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 23' ' ' LYS . . . . . 0.95 ' N ' ' O ' ' B' ' 20' ' ' SER . 6.6 mtmt -96.76 -14.36 22.03 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 121.482 -0.761 . . . . 0.0 109.719 178.322 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 24' ' ' MET . . . . . 0.959 ' HE2' ' HA ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -71.78 -36.06 70.23 Favored 'General case' 0 C--O 1.216 -0.71 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 177.708 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.556 ' HA ' ' HB3' ' B' ' 28' ' ' PHE . 3.4 mt -84.51 -36.16 22.41 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 176.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 26' ' ' ALA . . . . . 0.734 ' HB3' ' HA ' ' B' ' 23' ' ' LYS . . . -61.48 -34.21 75.09 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 27' ' ' SER . . . . . 0.483 ' O ' HG13 ' B' ' 31' ' ' ILE . 11.1 m -77.45 -34.76 54.41 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 28' ' ' PHE . . . . . 0.948 ' CE1' HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -52.36 -45.53 65.77 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.745 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 29' ' ' GLU . . . . . 0.811 ' HG3' ' CD2' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -68.72 -35.96 77.82 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 118.455 -1.298 . . . . 0.0 107.577 177.08 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 1.158 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 23.5 ttmt -63.92 -22.58 66.99 Favored 'General case' 0 C--O 1.191 -1.978 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.64 HD11 ' HA ' ' B' ' 28' ' ' PHE . 0.4 OUTLIER -105.08 -27.99 3.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 O-C-N 120.24 -1.537 . . . . 0.0 108.935 177.963 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.654 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.1 mm -72.46 -58.75 4.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 177.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 33' ' ' THR . . . . . 0.664 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 0.5 OUTLIER -69.05 -36.13 77.36 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.49 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 1.158 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 22.3 mm-40 -75.19 -39.03 60.52 Favored 'General case' 0 C--O 1.206 -1.185 0 C-N-CA 119.156 -1.018 . . . . 0.0 111.832 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 35' ' ' THR . . . . . 0.516 ' HA ' ' CB ' ' B' ' 38' ' ' LYS . 55.4 m -62.77 -51.59 66.51 Favored 'General case' 0 N--CA 1.504 2.229 0 CA-C-N 120.546 1.521 . . . . 0.0 109.826 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.692 ' HB ' HD21 ' A' ' 85' ' ' LEU . 2.4 t -53.85 -36.77 31.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 178.283 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 37' ' ' ALA . . . . . 0.831 ' HB1' ' O ' ' A' ' 88' ' ' ALA . . . -94.66 11.65 30.47 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.581 0.705 . . . . 0.0 109.424 177.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 38' ' ' LYS . . . . . 0.741 ' HB2' ' O ' ' B' ' 34' ' ' GLU . 0.1 OUTLIER -106.76 -33.62 7.53 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 176.933 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 131.07 38.46 0.28 Allowed Glycine 0 C--N 1.303 -1.264 0 C-N-CA 119.837 -1.173 . . . . 0.0 111.033 177.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 40' ' ' ASP . . . . . 0.493 ' HB2' HG23 ' B' ' 35' ' ' THR . 0.2 OUTLIER -147.82 147.31 29.68 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.771 -1.429 . . . . 0.0 111.235 179.634 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -91.4 95.96 10.26 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.743 HG13 HD11 ' A' ' 6' ' ' LEU . 61.8 t -59.27 124.65 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.655 -0.653 . . . . 0.0 110.924 -178.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 43' ' ' GLN . . . . . 0.426 ' CG ' ' O ' ' A' ' 1' ' ' MET . 11.1 pt20 -120.68 96.79 5.26 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.454 -0.779 . . . . 0.0 109.235 178.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.736 HD12 ' HB3' ' B' ' 48' ' ' LEU . 10.6 mt -65.53 113.2 4.0 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.497 -0.752 . . . . 0.0 110.406 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 45' ' ' THR . . . . . 0.632 HG23 ' HD1' ' B' ' 47' ' ' PHE . 0.0 OUTLIER 29.4 -91.97 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.99 -0.444 . . . . 0.0 111.39 179.351 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 46' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -149.85 29.51 1.14 Allowed Glycine 0 N--CA 1.484 1.884 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 47' ' ' PHE . . . . . 0.847 ' CD1' ' HG3' ' A' ' 29' ' ' GLU . 3.9 p90 -132.66 -23.97 2.01 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.044 -1.268 . . . . 0.0 111.743 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.736 ' HB3' HD12 ' B' ' 44' ' ' LEU . 7.3 mt -132.59 105.62 7.32 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.382 -1.449 . . . . 0.0 111.876 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 49' ' ' ASN . . . . . 0.431 ' O ' ' HA ' ' B' ' 79' ' ' VAL . 0.1 OUTLIER -110.38 88.63 2.81 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.283 -0.886 . . . . 0.0 110.603 179.561 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 50' ' ' ILE . . . . . 0.609 HD11 ' CD2' ' A' ' 48' ' ' LEU . 1.1 mm -76.83 148.91 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.413 -0.804 . . . . 0.0 110.303 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 51' ' ' LYS . . . . . 0.418 ' HG3' ' CB ' ' B' ' 78' ' ' SER . 0.0 OUTLIER -161.17 126.75 2.27 Favored Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 120.918 -1.114 . . . . 0.0 110.182 179.096 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 52' ' ' PRO . . . . . 0.49 ' HB3' HG13 ' B' ' 36' ' ' VAL . 50.1 Cg_endo -75.74 146.82 30.53 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.493 1.26 . . . . 0.0 111.334 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.523 ' O ' HG23 ' B' ' 53' ' ' VAL . 33.3 m -146.38 123.74 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.68 -0.637 . . . . 0.0 110.56 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 54' ' ' ALA . . . . . 0.947 ' HA ' ' N ' ' B' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.498 1.96 0 C-N-CA 118.857 -1.137 . . . . 0.0 111.713 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 75' ' ' VAL . . . . . 1.002 ' CG1' ' HB1' ' A' ' 89' ' ' ALA . 74.1 t . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 122.696 1.236 . . . . 0.0 112.036 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 76' ' ' GLY . . . . . 0.543 ' C ' HG23 ' B' ' 77' ' ' VAL . . . -109.2 -142.96 9.94 Favored Glycine 0 C--N 1.283 -2.399 0 N-CA-C 106.764 -2.534 . . . . 0.0 106.764 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.966 ' CG1' HD13 ' A' ' 85' ' ' LEU . 99.2 t -155.18 77.57 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 O-C-N 121.279 -1.13 . . . . 0.0 110.138 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 78' ' ' SER . . . . . 0.438 ' O ' ' HB ' ' B' ' 79' ' ' VAL . 0.6 OUTLIER -74.74 175.95 7.47 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 118.788 -1.165 . . . . 0.0 110.147 179.745 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.614 HG22 ' N ' ' B' ' 80' ' ' LYS . 5.9 p 176.25 177.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 80' ' ' LYS . . . . . 0.632 ' O ' HD23 ' B' ' 48' ' ' LEU . 0.1 OUTLIER -177.35 174.3 0.65 Allowed Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 120.878 -1.138 . . . . 0.0 110.604 178.053 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 81' ' ' PRO . . . . . 0.574 ' HA ' ' O ' ' B' ' 47' ' ' PHE . 51.5 Cg_endo -90.86 144.36 3.55 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.245 1.964 . . . . 0.0 110.137 178.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 82' ' ' GLY . . . . . 0.51 ' H ' ' HA ' ' B' ' 47' ' ' PHE . . . -106.24 41.45 2.17 Favored Glycine 0 N--CA 1.496 2.663 0 C-N-CA 120.002 -1.094 . . . . 0.0 110.608 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 83' ' ' GLU . . . . . 0.458 ' O ' ' N ' ' B' ' 87' ' ' LYS . 0.3 OUTLIER 66.46 -48.59 0.44 Allowed 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.419 -1.048 . . . . 0.0 111.604 179.669 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 84' ' ' SER . . . . . 0.418 ' N ' ' O ' ' B' ' 82' ' ' GLY . 4.9 t -46.1 -31.93 2.62 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.192 -0.942 . . . . 0.0 109.488 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.894 HD22 ' CG2' ' A' ' 77' ' ' VAL . 4.0 tt -86.16 -32.76 21.1 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.425 0.631 . . . . 0.0 109.436 178.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 86' ' ' LYS . . . . . 0.649 ' HG3' HG12 ' A' ' 77' ' ' VAL . 14.8 tttt -81.95 -22.01 36.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.456 -0.777 . . . . 0.0 110.329 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 87' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' B' ' 83' ' ' GLU . 0.0 OUTLIER -90.81 -29.74 17.4 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.642 ' O ' ' HG ' ' B' ' 92' ' ' LEU . . . -70.56 -36.23 73.51 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 177.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.91 ' HB3' HG11 ' A' ' 75' ' ' VAL . . . -73.51 -40.42 64.06 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 119.891 -0.724 . . . . 0.0 109.466 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.4 -22.28 41.97 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -101.44 -12.7 34.94 Favored Glycine 0 N--CA 1.485 1.926 0 C-N-CA 120.069 -1.062 . . . . 0.0 113.181 -178.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 92' ' ' LEU . . . . . 0.787 HD12 ' N ' ' A' ' 38' ' ' LYS . 3.4 mt -94.35 -69.4 0.75 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 121.751 2.775 . . . . 0.0 111.281 -179.035 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 93' ' ' LYS . . . . . 0.455 ' HB3' ' CE1' ' B' ' 97' ' ' PHE . 0.6 OUTLIER -148.4 49.31 1.03 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.0 -1.063 . . . . 0.0 111.23 -179.576 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 94' ' ' TYR . . . . . 0.574 ' CE1' ' HA ' ' A' ' 54' ' ' ALA . 55.3 t80 -53.85 -48.74 69.68 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.151 -0.968 . . . . 0.0 109.866 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -64.25 -38.82 92.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.455 -0.778 . . . . 0.0 109.858 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.37 -27.78 57.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.526 -0.734 . . . . 0.0 109.547 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 97' ' ' PHE . . . . . 0.484 ' CZ ' ' CA ' ' A' ' 39' ' ' GLY . 2.9 m-85 . . . . . 0 N--CA 1.493 1.684 0 O-C-N 121.493 -0.754 . . . . 0.0 109.615 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.575 ' CB ' HG12 ' B' ' 42' ' ' VAL . 1.5 mtp . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.505 ' HA ' ' O ' ' B' ' 43' ' ' GLN . 29.4 p-10 -170.25 -151.11 0.08 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.14 -1.024 . . . . 0.0 111.743 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.457 ' NZ ' ' HB ' ' B' ' 45' ' ' THR . 3.6 mttp -53.7 -3.83 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.286 -0.884 . . . . 0.0 111.407 -179.328 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.687 ' O ' HG13 ' A' ' 7' ' ' ILE . 72.9 m -118.25 -63.93 1.35 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.017 -1.052 . . . . 0.0 110.241 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.532 ' HB2' ' HA ' ' A' ' 1' ' ' MET . 3.9 mt-10 -50.6 -42.93 56.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.907 -1.121 . . . . 0.0 109.375 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.636 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 28.0 mt -61.16 -32.76 72.49 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.201 -1.0 . . . . 0.0 109.726 178.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.687 HG13 ' O ' ' A' ' 4' ' ' THR . 1.0 OUTLIER -60.03 -42.11 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 178.769 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.863 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -68.38 -31.22 70.44 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 177.478 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.636 ' HB3' ' O ' ' A' ' 6' ' ' LEU . . . -56.91 -38.73 73.26 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.497 -0.752 . . . . 0.0 109.008 178.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.724 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.4 mp -93.38 -30.38 4.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 178.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.863 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -63.19 -13.13 33.83 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 118.455 -1.298 . . . . 0.0 108.58 178.227 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -116.9 -45.19 2.78 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.513 -0.742 . . . . 0.0 110.155 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 9' ' ' ALA . 1.0 OUTLIER -67.22 -23.98 65.78 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 177.723 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . 1.138 HG22 ' CD1' ' A' ' 16' ' ' LEU 0.278 0.2 OUTLIER -111.27 -71.96 0.74 Allowed 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 179.25 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 57.31 19.22 31.85 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.421 -0.8 . . . . 0.0 111.228 177.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 1.138 ' CD1' HG22 ' A' ' 14' ' ' THR . 4.7 mp -60.92 -66.45 0.53 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.414 -1.051 . . . . 0.0 110.015 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.555 HG21 HG21 ' B' ' 17' ' ' THR . 0.6 OUTLIER -135.14 8.59 3.46 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -179.807 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.587 ' O ' ' C ' ' A' ' 19' ' ' VAL . 22.3 mt-30 58.03 27.37 14.75 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 -175.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 1.105 HG23 ' CD1' ' B' ' 16' ' ' LEU . 0.5 OUTLIER -11.32 -95.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.626 -179.222 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.951 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -135.59 24.69 3.43 Favored 'General case' 0 C--N 1.279 -2.488 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 178.471 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.637 ' C ' ' O ' ' A' ' 20' ' ' SER . 26.8 m -18.48 -39.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-O 122.478 1.132 . . . . 0.0 109.71 -177.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.861 ' N ' ' O ' ' A' ' 20' ' ' SER . 4.9 p -84.88 -37.66 20.36 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.808 178.093 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.951 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.1 OUTLIER -85.56 -33.25 21.77 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.609 -0.682 . . . . 0.0 110.939 179.468 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.525 ' CE ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -74.39 -41.68 60.53 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 118.207 -1.397 . . . . 0.0 108.949 179.493 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.601 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 3.1 mt -69.49 -43.76 72.49 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 118.029 -1.469 . . . . 0.0 108.045 177.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.428 ' HA ' ' HD3' ' A' ' 3' ' ' LYS . . . -61.18 -32.33 72.07 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 177.355 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.547 ' O ' ' N ' ' A' ' 31' ' ' ILE . 7.2 t -75.86 -38.09 58.31 Favored 'General case' 0 C--O 1.207 -1.158 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 177.517 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.719 ' HA ' ' CG1' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -57.3 -38.08 73.45 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.315 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.872 ' HG2' HG22 ' B' ' 45' ' ' THR . 1.4 mt-10 -77.18 -36.67 54.87 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 1.052 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 15.9 ttpt -69.14 -20.21 64.03 Favored 'General case' 0 C--O 1.19 -2.049 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 177.208 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.821 HD13 ' HB1' ' B' ' 9' ' ' ALA . 1.1 pp -105.93 -30.69 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 120.603 -1.311 . . . . 0.0 109.342 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.718 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.1 mm -67.43 -54.22 25.6 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 176.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.743 ' HA ' HD12 ' B' ' 85' ' ' LEU . 0.3 OUTLIER -68.73 -40.2 80.0 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.955 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 1.052 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 61.3 mm-40 -73.26 -35.29 66.18 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.329 -0.857 . . . . 0.0 111.49 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.702 HG23 ' HB2' ' A' ' 40' ' ' ASP . 3.4 m -59.3 -50.66 73.12 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.598 -1.314 . . . . 0.0 108.078 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.725 HG22 ' HD3' ' A' ' 52' ' ' PRO . 1.1 t -54.22 -36.94 34.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 177.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.926 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -80.75 -5.04 56.58 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.639 0.733 . . . . 0.0 109.714 177.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -101.05 -24.21 14.35 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.36 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 105.86 40.68 1.96 Allowed Glycine 0 C--N 1.3 -1.433 0 C-N-CA 120.136 -1.031 . . . . 0.0 110.641 178.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.702 ' HB2' HG23 ' A' ' 35' ' ' THR . 0.1 OUTLIER -134.18 123.43 24.33 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.21 -1.171 . . . . 0.0 110.03 179.284 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.422 ' HB2' ' HB3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -79.87 68.48 5.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.438 -0.789 . . . . 0.0 110.629 -179.43 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 1.002 HG13 ' HB ' ' A' ' 50' ' ' ILE . 2.6 p -59.61 145.97 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.168 -0.958 . . . . 0.0 109.405 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -137.8 120.65 16.44 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.238 -0.914 . . . . 0.0 111.03 -178.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.736 HD12 ' CE1' ' A' ' 47' ' ' PHE . 10.1 mt -64.5 -178.81 0.42 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.28 -0.887 . . . . 0.0 109.326 178.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.791 HG22 ' HG2' ' B' ' 29' ' ' GLU . 1.4 t -36.32 -34.16 0.06 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.77 -0.581 . . . . 0.0 111.467 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 166.39 -23.37 0.13 Allowed Glycine 0 N--CA 1.488 2.155 0 C-N-CA 119.686 -1.245 . . . . 0.0 110.398 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.82 ' CG ' HD23 ' A' ' 85' ' ' LEU . 20.2 p90 -81.65 -18.83 43.22 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.885 -1.362 . . . . 0.0 111.395 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.707 ' HB2' HD12 ' A' ' 44' ' ' LEU . 2.7 mt -125.94 100.32 6.32 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 118.553 -1.259 . . . . 0.0 111.611 178.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.639 ' C ' HG23 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -91.81 64.48 4.79 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.056 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 1.011 HD11 HD11 ' B' ' 48' ' ' LEU . 27.2 mm -57.29 116.42 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 O-C-N 121.335 -0.853 . . . . 0.0 112.767 -177.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.552 ' HG2' ' O ' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -172.71 135.7 0.77 Allowed Pre-proline 0 N--CA 1.494 1.734 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.038 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.725 ' HD3' HG22 ' A' ' 36' ' ' VAL . 51.2 Cg_endo -90.63 156.08 4.27 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.473 1.249 . . . . 0.0 113.147 -177.243 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.61 ' O ' ' N ' ' A' ' 76' ' ' GLY . 27.1 m -132.14 111.94 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 CA-C-O 121.717 0.77 . . . . 0.0 110.195 177.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.746 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.498 1.973 0 CA-C-O 122.07 0.938 . . . . 0.0 112.473 -178.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.823 ' CG1' ' HB1' ' B' ' 89' ' ' ALA . 0.4 OUTLIER . . . . . 0 N--CA 1.494 1.728 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.61 ' N ' ' O ' ' A' ' 53' ' ' VAL . . . -113.32 -149.14 10.34 Favored Glycine 0 C--N 1.299 -1.487 0 N-CA-C 108.337 -1.905 . . . . 0.0 108.337 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.992 HG11 ' HB3' ' B' ' 81' ' ' PRO . 4.3 t -144.99 86.85 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 CA-C-O 122.021 0.915 . . . . 0.0 108.783 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.514 ' CB ' ' HG3' ' A' ' 51' ' ' LYS . 0.5 OUTLIER -56.37 -44.54 80.25 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.812 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.808 HG12 HG12 ' A' ' 77' ' ' VAL 0.267 13.2 p -47.53 173.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 CA-C-O 122.082 0.944 . . . . 0.0 113.057 -175.226 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.671 ' HB2' ' HD2' ' A' ' 81' ' ' PRO . 0.1 OUTLIER 177.94 176.4 0.3 Allowed Pre-proline 0 N--CA 1.484 1.229 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -178.954 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.671 ' HD2' ' HB2' ' A' ' 80' ' ' LYS . 50.7 Cg_endo -78.07 112.51 3.26 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.612 1.322 . . . . 0.0 109.693 177.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -81.04 -172.53 46.37 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.449 ' HA ' ' HB2' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -77.04 -23.66 52.07 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.363 -1.081 . . . . 0.0 110.62 -179.888 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.26 -37.51 23.83 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.199 -0.938 . . . . 0.0 108.814 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.896 ' CG ' HG21 ' B' ' 77' ' ' VAL . 0.1 OUTLIER -79.63 -35.11 39.94 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.555 0.693 . . . . 0.0 109.152 178.486 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.449 ' HB2' ' HA ' ' A' ' 83' ' ' GLU . 0.1 OUTLIER -73.38 -31.38 63.87 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 120.036 -0.666 . . . . 0.0 110.039 -179.778 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -70.77 -40.27 72.74 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 178.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.654 ' HB2' HG23 ' B' ' 33' ' ' THR . . . -66.22 -35.31 80.09 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 176.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.859 ' HB1' ' CG1' ' B' ' 75' ' ' VAL . . . -58.46 -43.53 88.91 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.255 178.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.572 ' HA ' ' HB2' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -58.28 -24.36 59.19 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 177.29 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -74.71 -38.27 43.3 Favored Glycine 0 N--CA 1.488 2.126 0 CA-C-O 119.399 -0.667 . . . . 0.0 112.792 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 1.094 HD21 HG21 ' B' ' 75' ' ' VAL . 2.0 pp -57.26 -49.37 76.28 Favored 'General case' 0 N--CA 1.505 2.299 0 CA-C-N 120.774 2.287 . . . . 0.0 111.326 -178.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.602 ' H ' ' HG ' ' A' ' 92' ' ' LEU . 0.4 OUTLIER 159.05 45.95 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -179.447 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.617 ' HE1' ' O ' ' B' ' 75' ' ' VAL . 2.4 t80 -32.48 -71.75 0.05 Allowed 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.331 0.586 . . . . 0.0 112.41 -178.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 . . . . . 0 C--N 1.301 -1.539 0 O-C-N 121.397 -0.815 . . . . 0.0 110.465 -178.354 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.686 ' HB3' HG23 ' A' ' 42' ' ' VAL . 5.9 mtp . . . . . 0 N--CA 1.493 1.692 0 N-CA-C 110.081 -0.341 . . . . 0.0 110.081 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -171.57 -158.51 0.13 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.941 -1.099 . . . . 0.0 112.063 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.545 ' HE2' ' HA ' ' B' ' 26' ' ' ALA . 0.1 OUTLIER -49.72 -12.38 0.07 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.556 -0.715 . . . . 0.0 111.038 -179.536 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 4' ' ' THR . . . . . 0.681 ' O ' HG13 ' B' ' 7' ' ' ILE . 19.7 m -114.04 -58.68 2.12 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.007 -1.058 . . . . 0.0 110.197 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.725 ' HA ' ' HE2' ' B' ' 8' ' ' LYS . 0.3 OUTLIER -49.34 -46.64 47.21 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.07 -1.019 . . . . 0.0 109.23 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.827 HD11 ' CG2' ' A' ' 42' ' ' VAL . 10.7 mt -58.79 -31.36 68.33 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.289 -0.964 . . . . 0.0 109.815 178.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 7' ' ' ILE . . . . . 0.683 HD13 ' CG2' ' B' ' 21' ' ' VAL . 0.9 OUTLIER -58.82 -41.77 83.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.517 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 8' ' ' LYS . . . . . 0.867 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 35.6 mtmt -63.55 -35.31 80.07 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 9' ' ' ALA . . . . . 0.821 ' HB1' HD13 ' A' ' 31' ' ' ILE . . . -53.63 -39.75 65.22 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.944 -0.702 . . . . 0.0 109.199 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.678 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.5 mp -90.56 -32.23 5.37 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 178.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.867 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -64.21 -15.87 60.82 Favored 'General case' 0 C--N 1.293 -1.871 0 O-C-N 120.805 -1.185 . . . . 0.0 108.58 178.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 -111.54 -43.41 3.67 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.514 -0.741 . . . . 0.0 109.587 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -69.66 -24.55 63.63 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 14' ' ' THR . . . . . 0.766 ' CG2' ' HB2' ' A' ' 20' ' ' SER . 0.2 OUTLIER -115.2 -82.65 0.62 Allowed 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 179.258 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 15' ' ' GLY . . . . . 0.515 ' O ' ' C ' ' B' ' 16' ' ' LEU . . . 67.22 -21.92 0.21 Allowed Glycine 0 N--CA 1.5 2.924 0 O-C-N 120.993 -1.067 . . . . 0.0 110.469 178.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 16' ' ' LEU . . . . . 1.105 ' CD1' HG23 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -27.44 -54.73 0.09 Allowed 'General case' 0 N--CA 1.514 2.736 0 CA-C-O 121.942 0.877 . . . . 0.0 110.76 -179.758 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 17' ' ' THR . . . . . 0.555 HG21 HG21 ' A' ' 17' ' ' THR . 0.5 OUTLIER -138.78 -3.28 1.66 Allowed 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.975 -179.433 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 18' ' ' GLN . . . . . 0.538 ' O ' ' C ' ' B' ' 19' ' ' VAL . 11.9 mt-30 56.78 34.94 25.51 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 -176.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 1.085 HG11 HG11 ' A' ' 19' ' ' VAL . 1.8 p -20.43 -95.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.521 -178.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 20' ' ' SER . . . . . 0.916 ' O ' ' N ' ' B' ' 23' ' ' LYS . 0.5 OUTLIER -133.44 24.11 4.08 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 178.495 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.683 ' CG2' HD13 ' B' ' 7' ' ' ILE . 30.0 m -19.0 -39.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-O 122.382 1.087 . . . . 0.0 109.585 -178.054 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.841 ' N ' ' O ' ' B' ' 20' ' ' SER . 28.0 t -84.34 -38.71 20.0 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.009 178.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 23' ' ' LYS . . . . . 0.916 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.3 OUTLIER -84.91 -32.06 23.34 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.406 -0.809 . . . . 0.0 111.276 179.831 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 24' ' ' MET . . . . . 0.637 ' HB3' HG21 ' A' ' 14' ' ' THR . 0.0 OUTLIER -74.9 -41.07 60.44 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 118.073 -1.451 . . . . 0.0 108.462 178.812 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.674 ' HA ' ' HB3' ' B' ' 28' ' ' PHE . 11.1 mt -69.01 -44.34 72.96 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 118.319 -1.353 . . . . 0.0 108.008 177.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 26' ' ' ALA . . . . . 0.545 ' HA ' ' HE2' ' B' ' 3' ' ' LYS . . . -57.29 -34.5 68.75 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.059 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 27' ' ' SER . . . . . 0.627 ' HA ' ' HB3' ' B' ' 30' ' ' LYS . 54.0 p -84.09 -26.61 28.85 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 28' ' ' PHE . . . . . 0.744 ' O ' HG13 ' B' ' 31' ' ' ILE . 0.4 OUTLIER -62.54 -44.51 96.17 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.0 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 29' ' ' GLU . . . . . 0.791 ' HG2' HG22 ' A' ' 45' ' ' THR . 0.7 OUTLIER -74.49 -32.37 62.52 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 177.918 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 0.808 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 17.5 ttpp -69.17 -27.17 65.28 Favored 'General case' 0 C--O 1.192 -1.933 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 176.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.744 HG13 ' O ' ' B' ' 28' ' ' PHE . 2.0 pp -97.33 -30.6 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.113 -0.992 . . . . 0.0 109.246 178.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.737 HG22 HD21 ' A' ' 85' ' ' LEU . 1.9 mm -64.58 -53.82 37.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 177.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 33' ' ' THR . . . . . 0.654 HG23 ' HB2' ' A' ' 88' ' ' ALA . 0.4 OUTLIER -68.57 -40.38 80.6 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.129 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.808 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 52.7 mm-40 -70.03 -36.11 74.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.523 -0.735 . . . . 0.0 111.058 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 35' ' ' THR . . . . . 0.949 HG21 HG13 ' B' ' 42' ' ' VAL . 3.2 m -59.02 -52.78 64.27 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.799 -1.188 . . . . 0.0 108.651 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.844 HG13 ' HB3' ' B' ' 52' ' ' PRO . 13.6 t -54.25 -36.85 34.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 177.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 37' ' ' ALA . . . . . 0.629 ' HB2' ' C ' ' A' ' 88' ' ' ALA . . . -79.14 -3.84 47.46 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 38' ' ' LYS . . . . . 0.485 ' N ' ' O ' ' B' ' 35' ' ' THR . 0.0 OUTLIER -102.43 -29.43 11.62 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 177.823 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 39' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' B' ' 35' ' ' THR . . . 112.66 38.55 1.29 Allowed Glycine 0 C--N 1.302 -1.355 0 C-N-CA 120.001 -1.095 . . . . 0.0 111.03 177.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 40' ' ' ASP . . . . . 0.634 ' CB ' HG23 ' B' ' 35' ' ' THR . 0.1 OUTLIER -130.29 133.63 46.62 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.043 -1.269 . . . . 0.0 110.745 179.364 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.441 ' HG3' ' HD2' ' B' ' 52' ' ' PRO . 0.1 OUTLIER -82.98 88.4 6.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.581 -0.7 . . . . 0.0 109.664 179.683 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.949 HG13 HG21 ' B' ' 35' ' ' THR . 25.4 m -73.39 144.91 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.507 -0.745 . . . . 0.0 110.443 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 43' ' ' GLN . . . . . 0.505 ' O ' ' HA ' ' A' ' 2' ' ' ASN . 19.6 mt-30 -138.9 171.53 14.19 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.469 -0.769 . . . . 0.0 110.24 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 1.001 HD12 ' CB ' ' B' ' 48' ' ' LEU . 91.5 mt -136.06 -179.16 5.49 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.276 -0.89 . . . . 0.0 110.608 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 45' ' ' THR . . . . . 0.872 HG22 ' HG2' ' A' ' 29' ' ' GLU . 4.1 t -45.62 72.19 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 46' ' ' GLY . . . . . 0.674 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . 42.74 29.03 0.72 Allowed Glycine 0 N--CA 1.494 2.562 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 47' ' ' PHE . . . . . 0.73 ' CE2' ' HG ' ' B' ' 48' ' ' LEU . 0.7 OUTLIER -129.12 -32.83 2.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.054 -1.262 . . . . 0.0 110.476 179.606 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 1.011 HD11 HD11 ' A' ' 50' ' ' ILE . 8.0 mt -128.29 117.99 22.46 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.685 -1.259 . . . . 0.0 110.46 178.059 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -118.04 69.19 0.78 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.607 -0.683 . . . . 0.0 110.856 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 50' ' ' ILE . . . . . 0.919 HD13 ' HB ' ' B' ' 79' ' ' VAL . 11.2 mm -59.86 113.46 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.164 -0.96 . . . . 0.0 109.637 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 51' ' ' LYS . . . . . 0.444 ' O ' ' HG3' ' B' ' 51' ' ' LYS . 1.3 ptmt -138.34 121.92 11.32 Favored Pre-proline 0 N--CA 1.498 1.952 0 O-C-N 121.017 -1.052 . . . . 0.0 110.246 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 52' ' ' PRO . . . . . 0.844 ' HB3' HG13 ' B' ' 36' ' ' VAL . 50.2 Cg_endo -76.61 135.46 16.23 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 123.482 1.254 . . . . 0.0 112.237 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.599 ' O ' ' N ' ' B' ' 76' ' ' GLY . 33.6 m -139.41 116.8 10.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 54' ' ' ALA . . . . . 0.514 ' HA ' ' N ' ' B' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.492 1.653 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -176.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 75' ' ' VAL . . . . . 1.094 HG21 HD21 ' A' ' 92' ' ' LEU . 45.2 t . . . . . 0 N--CA 1.513 2.719 0 CA-C-O 122.706 1.241 . . . . 0.0 114.002 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 76' ' ' GLY . . . . . 0.599 ' N ' ' O ' ' B' ' 53' ' ' VAL . . . -142.56 68.12 0.45 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.896 HG21 ' CG ' ' A' ' 85' ' ' LEU . 5.3 p -36.48 95.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.827 -0.807 . . . . 0.0 112.139 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 78' ' ' SER . . . . . 0.49 ' O ' ' HB ' ' B' ' 79' ' ' VAL . 15.5 t -94.07 176.0 6.49 Favored 'General case' 0 C--N 1.293 -1.872 0 C-N-CA 119.547 -0.861 . . . . 0.0 108.846 177.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.919 ' HB ' HD13 ' B' ' 50' ' ' ILE . 14.5 p 176.24 178.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 80' ' ' LYS . . . . . 0.587 ' N ' HG22 ' B' ' 79' ' ' VAL . 0.2 OUTLIER -178.0 173.35 0.66 Allowed Pre-proline 0 C--N 1.305 -1.352 0 O-C-N 121.024 -1.047 . . . . 0.0 110.424 178.097 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 81' ' ' PRO . . . . . 0.992 ' HB3' HG11 ' A' ' 77' ' ' VAL . 51.0 Cg_endo -88.01 103.74 0.49 Allowed 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 121.834 1.689 . . . . 0.0 109.853 178.16 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 82' ' ' GLY . . . . . 0.48 ' O ' ' HB3' ' B' ' 83' ' ' GLU . . . -71.46 37.43 0.57 Allowed Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 83' ' ' GLU . . . . . 0.48 ' HB3' ' O ' ' B' ' 82' ' ' GLY . 1.2 tp10 64.22 -27.93 0.09 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.303 -1.116 . . . . 0.0 112.613 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 84' ' ' SER . . . . . 0.446 ' HB3' ' CB ' ' B' ' 47' ' ' PHE . 1.0 OUTLIER -52.13 -36.43 51.28 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.435 -1.415 . . . . 0.0 108.945 179.602 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.743 HD12 ' HA ' ' A' ' 33' ' ' THR . 1.2 tt -85.79 -36.42 20.1 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 86' ' ' LYS . . . . . 0.66 ' O ' ' HB3' ' B' ' 89' ' ' ALA . 0.2 OUTLIER -70.52 -35.39 73.15 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.094 179.323 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 87' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' B' ' 83' ' ' GLU . 0.2 OUTLIER -70.25 -38.87 75.25 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 178.487 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.573 ' C ' ' HB2' ' A' ' 37' ' ' ALA . . . -63.92 -37.49 87.61 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 176.204 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.823 ' HB1' ' CG1' ' A' ' 75' ' ' VAL . . . -55.95 -42.33 76.04 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.255 178.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.66 -31.67 58.03 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 177.282 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -71.74 -27.76 70.3 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 179.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 92' ' ' LEU . . . . . 0.926 ' HB3' ' HA ' ' A' ' 37' ' ' ALA . 0.5 OUTLIER -71.58 9.47 0.84 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.761 -1.435 . . . . 0.0 111.675 -179.654 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 93' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' B' ' 92' ' ' LEU . 29.9 mmtp 60.76 40.35 16.22 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 -177.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 94' ' ' TYR . . . . . 0.629 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 1.8 p90 -41.95 -29.94 0.24 Allowed 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.768 -178.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 95' ' ' GLU . . . . . 0.469 ' HG3' ' CE1' ' B' ' 94' ' ' TYR . 3.8 mp0 -59.53 -47.85 83.92 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.87 -35.52 66.58 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 177.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 178.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.543 ' CE ' HD23 ' A' ' 6' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.496 1.826 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.419 ' O ' ' HB2' ' A' ' 6' ' ' LEU . 2.8 t-20 -174.1 -169.2 0.45 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.945 -1.097 . . . . 0.0 111.635 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.623 ' O ' HG13 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -57.74 -4.87 0.32 Allowed 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.473 -0.767 . . . . 0.0 110.702 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.924 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 99.2 m -125.29 -40.31 2.13 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.323 -0.86 . . . . 0.0 108.974 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.489 ' CB ' ' HA ' ' A' ' 1' ' ' MET . 0.1 OUTLIER -61.66 -50.59 71.9 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.274 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.827 HD11 ' CG1' ' B' ' 42' ' ' VAL . 9.1 mt -57.8 -31.25 66.39 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 1.062 HG23 ' HB ' ' A' ' 21' ' ' VAL . 3.5 mt -52.55 -51.65 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 178.171 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.971 ' CE ' HG22 ' A' ' 7' ' ' ILE . 3.1 mmpt? -60.53 -34.24 73.82 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.004 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.884 ' HB1' HD13 ' B' ' 31' ' ' ILE . . . -55.26 -37.18 66.91 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.535 -0.866 . . . . 0.0 109.504 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.836 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.0 OUTLIER -97.12 -30.27 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.291 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.823 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -68.14 -13.62 62.36 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 118.829 -1.148 . . . . 0.0 108.542 178.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.426 ' CG ' ' N ' ' A' ' 13' ' ' ASP . 6.5 pt20 -111.14 -39.61 4.7 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.522 -0.736 . . . . 0.0 109.432 178.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.426 ' N ' ' CG ' ' A' ' 12' ' ' GLN . 0.9 OUTLIER -66.89 -36.07 81.45 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 177.408 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.861 HG22 HD21 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -97.31 -67.46 0.85 Allowed 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.376 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 46.17 29.98 3.8 Favored Glycine 0 N--CA 1.497 2.759 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 178.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 1.069 ' CD1' HG23 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -89.65 -26.85 20.52 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.621 -0.929 . . . . 0.0 109.687 179.333 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.704 HG22 ' H ' ' A' ' 19' ' ' VAL . 0.4 OUTLIER -162.15 -3.03 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.683 -178.6 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.536 ' O ' ' C ' ' A' ' 19' ' ' VAL . 9.7 mt-30 54.27 30.45 12.45 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 -177.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.969 HG11 HG11 ' B' ' 19' ' ' VAL . 2.3 p -12.25 -93.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.526 -178.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.945 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.5 OUTLIER -128.5 23.37 5.9 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 178.688 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 1.062 ' HB ' HG23 ' A' ' 7' ' ' ILE . 15.3 m -24.59 -37.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 CA-C-O 122.233 1.016 . . . . 0.0 109.4 -178.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.735 ' N ' ' O ' ' A' ' 20' ' ' SER . 48.5 t -82.28 -36.55 26.94 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.253 177.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.945 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.3 OUTLIER -86.82 -32.43 20.3 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.637 -0.665 . . . . 0.0 111.744 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.787 ' HG2' HG22 ' B' ' 14' ' ' THR . 0.0 OUTLIER -78.4 -36.67 45.44 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.433 -1.417 . . . . 0.0 109.873 179.631 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.789 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 0.4 OUTLIER -80.5 -45.04 18.15 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 118.535 -1.266 . . . . 0.0 109.345 178.904 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.603 ' HA ' ' HG2' ' A' ' 3' ' ' LYS . . . -57.24 -33.37 67.49 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 177.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.81 ' O ' HG23 ' A' ' 31' ' ' ILE . 49.4 m -87.46 -31.15 20.16 Favored 'General case' 0 C--O 1.199 -1.586 0 C-N-CA 119.687 -0.805 . . . . 0.0 109.238 178.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.969 ' HB2' HD11 ' B' ' 10' ' ' ILE . 0.1 OUTLIER -58.21 -49.71 76.1 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.04 -1.037 . . . . 0.0 109.931 179.45 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.759 ' HG2' HG22 ' B' ' 45' ' ' THR . 1.1 mt-10 -73.12 -37.4 66.68 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 1.244 ' O ' ' HB3' ' A' ' 34' ' ' GLU . 16.8 ttpt -69.06 -16.37 63.68 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 177.177 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 1.044 ' HA ' ' CG ' ' A' ' 34' ' ' GLU . 1.8 pp -107.39 -29.38 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.14 -0.975 . . . . 0.0 110.241 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.613 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.2 mm -63.39 -45.77 97.15 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 178.141 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.853 ' O ' ' HB1' ' B' ' 88' ' ' ALA . 0.5 OUTLIER -79.03 -41.32 29.15 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 177.704 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 1.244 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -59.39 -35.51 74.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.134 -0.979 . . . . 0.0 109.124 177.842 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.764 HG23 ' HB2' ' A' ' 40' ' ' ASP . 15.8 m -63.73 -48.93 75.04 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 177.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.736 HG21 HD22 ' B' ' 85' ' ' LEU . 24.5 t -55.69 -35.58 39.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 177.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.878 ' HB2' ' O ' ' B' ' 88' ' ' ALA . . . -83.14 -1.24 52.39 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 177.207 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -106.27 -11.69 15.94 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 177.198 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 35' ' ' THR . . . 85.88 46.28 5.44 Favored Glycine 0 C--N 1.303 -1.255 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.243 177.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.764 ' HB2' HG23 ' A' ' 35' ' ' THR . 0.2 OUTLIER -124.6 143.15 50.87 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.031 -1.276 . . . . 0.0 109.975 178.951 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.419 ' CG ' ' HB2' ' A' ' 51' ' ' LYS . 0.3 OUTLIER -105.35 97.58 7.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.549 -0.72 . . . . 0.0 110.185 -179.317 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 1.006 HG22 ' HB2' ' B' ' 1' ' ' MET . 3.2 t -84.83 172.62 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.472 -0.768 . . . . 0.0 110.134 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 43' ' ' GLN . 4.5 pt20 -157.32 107.21 2.21 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.602 -0.686 . . . . 0.0 109.207 179.06 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.808 HD12 ' HB2' ' A' ' 48' ' ' LEU . 16.1 mt -70.72 179.93 2.43 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.228 -0.92 . . . . 0.0 111.14 -178.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.836 HG22 ' HG2' ' B' ' 29' ' ' GLU . 1.8 t -31.63 -43.43 0.06 Allowed 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 121.053 0.454 . . . . 0.0 111.433 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.444 ' N ' HG23 ' A' ' 45' ' ' THR . . . 172.61 24.44 0.02 OUTLIER Glycine 0 N--CA 1.487 2.071 0 C-N-CA 119.347 -1.406 . . . . 0.0 111.127 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.669 ' CZ ' HG21 ' B' ' 32' ' ' ILE . 49.3 p90 -127.82 -49.33 1.36 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.696 -1.473 . . . . 0.0 111.502 178.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.035 ' CD1' HD11 ' B' ' 48' ' ' LEU . 0.3 OUTLIER -96.53 110.75 23.08 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.697 -1.252 . . . . 0.0 112.513 -179.238 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.709 ' O ' ' HB ' ' A' ' 79' ' ' VAL . 1.7 t-20 -105.82 63.33 0.67 Allowed 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.684 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.909 HD11 HG23 ' A' ' 42' ' ' VAL . 1.1 pp -57.46 130.27 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.69 0 O-C-N 121.117 -0.989 . . . . 0.0 112.67 -177.172 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.597 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -175.5 112.23 0.27 Allowed Pre-proline 0 N--CA 1.492 1.671 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.171 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.664 ' HG3' HG13 ' A' ' 36' ' ' VAL . 55.9 Cg_endo -90.77 156.89 4.15 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 120.882 1.055 . . . . 0.0 111.434 -178.325 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.915 HG22 ' O ' ' A' ' 76' ' ' GLY . 32.4 m -139.81 114.92 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 121.913 0.863 . . . . 0.0 111.114 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.619 ' HA ' ' HE1' ' B' ' 94' ' ' TYR . . . . . . . . 0 N--CA 1.499 1.989 0 O-C-N 121.691 -0.631 . . . . 0.0 112.137 -178.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.54 ' N ' ' CE1' ' B' ' 94' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.915 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -118.95 97.99 0.72 Allowed Glycine 0 N--CA 1.488 2.165 0 C-N-CA 118.837 -1.649 . . . . 0.0 109.631 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.703 HG21 HD12 ' B' ' 85' ' ' LEU . 6.1 p -63.09 84.21 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-O 122.504 1.145 . . . . 0.0 108.667 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 76' ' ' GLY . 0.3 OUTLIER -56.7 -44.15 81.24 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.374 -179.397 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.787 ' CB ' ' HA ' ' A' ' 50' ' ' ILE 0.286 1.9 p -45.98 172.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-O 122.758 1.266 . . . . 0.0 113.971 -174.392 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.601 ' N ' ' CG2' ' A' ' 79' ' ' VAL . 0.0 OUTLIER 178.62 174.22 0.39 Allowed Pre-proline 0 C--N 1.309 -1.188 0 CA-C-N 114.403 -1.272 . . . . 0.0 108.204 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.66 ' HG3' HG12 ' B' ' 79' ' ' VAL . 39.0 Cg_endo -66.77 153.77 76.81 Favored 'Trans proline' 0 C--N 1.298 -2.095 0 O-C-N 123.464 1.244 . . . . 0.0 109.166 176.266 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.487 ' H ' ' HA ' ' A' ' 47' ' ' PHE . . . -120.0 -83.73 0.81 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 108.239 -1.945 . . . . 0.0 108.239 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.941 ' O ' ' N ' ' A' ' 85' ' ' LEU . 17.5 tt0 -76.54 43.56 0.32 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.428 -1.042 . . . . 0.0 108.791 177.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . 1.343 ' O ' ' N ' ' A' ' 86' ' ' LYS . 0.5 OUTLIER 7.21 44.69 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 122.212 1.005 . . . . 0.0 110.203 178.567 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 1.023 HD12 HG21 ' B' ' 36' ' ' VAL . 0.2 OUTLIER 20.07 28.65 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 104.538 -2.393 . . . . 0.0 104.538 -171.326 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 1.343 ' N ' ' O ' ' A' ' 84' ' ' SER 0.354 7.7 tttt -62.28 -42.07 99.04 Favored 'General case' 0 CA--C 1.483 -1.616 0 N-CA-C 103.496 -2.779 . . . . 0.0 103.496 176.383 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.257 24.0 tptt -67.4 -35.48 79.37 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 111.834 -2.439 . . . . 0.0 104.857 175.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.703 ' HB3' ' O ' ' A' ' 85' ' ' LEU . . . -71.59 -27.87 63.43 Favored 'General case' 0 C--O 1.211 -0.927 0 C-N-CA 118.326 -1.35 . . . . 0.0 108.36 178.126 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.954 ' HA ' HD23 ' A' ' 92' ' ' LEU . . . -59.16 -49.92 76.03 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.977 -1.077 . . . . 0.0 109.363 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.471 ' HG2' ' N ' ' A' ' 91' ' ' GLY . 2.2 pt-20 -56.95 -27.96 61.66 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.903 -1.518 . . . . 0.0 106.903 177.256 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.471 ' N ' ' HG2' ' A' ' 90' ' ' GLU . . . -68.39 -32.46 75.57 Favored Glycine 0 N--CA 1.488 2.155 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.186 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.954 HD23 ' HA ' ' A' ' 89' ' ' ALA . 0.8 OUTLIER -84.85 22.12 1.43 Allowed 'General case' 0 N--CA 1.504 2.263 0 O-C-N 120.213 -1.757 . . . . 0.0 110.975 -179.657 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.45 ' O ' ' C ' ' A' ' 94' ' ' TYR . 2.6 mmtt 55.29 38.19 30.01 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 -177.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.625 ' CD1' ' N ' ' B' ' 75' ' ' VAL . 1.5 t80 -33.66 -41.03 0.08 Allowed 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.81 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 . . . . . 0 N--CA 1.494 1.746 0 O-C-N 121.333 -0.854 . . . . 0.0 109.629 179.727 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 1' ' ' MET . . . . . 1.006 ' HB2' HG22 ' A' ' 42' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 2' ' ' ASN . . . . . 0.447 ' N ' ' HB2' ' B' ' 5' ' ' GLU . 0.7 OUTLIER 177.67 176.64 0.4 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.016 -1.053 . . . . 0.0 111.324 -179.811 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.95 ' O ' HD22 ' B' ' 25' ' ' LEU . 0.9 OUTLIER -47.63 -29.05 2.67 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.174 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 4' ' ' THR . . . . . 0.548 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 16.1 m -95.71 -45.39 7.03 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.661 0.743 . . . . 0.0 109.733 179.04 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.662 ' HA ' ' HE2' ' B' ' 8' ' ' LYS . 0.0 OUTLIER -56.04 -49.87 72.53 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 120.945 -1.097 . . . . 0.0 108.054 179.207 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.802 ' CD1' HG11 ' A' ' 42' ' ' VAL . 7.6 mt -55.8 -35.01 65.85 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.213 -0.995 . . . . 0.0 108.662 177.155 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 7' ' ' ILE . . . . . 0.823 ' CD1' HD23 ' B' ' 25' ' ' LEU . 0.3 OUTLIER -50.87 -48.86 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 178.166 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 8' ' ' LYS . . . . . 0.802 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 39.7 mtmt -61.99 -37.75 86.0 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 9' ' ' ALA . . . . . 0.925 ' HB1' HD13 ' A' ' 31' ' ' ILE . . . -52.58 -34.39 50.33 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 119.695 -0.802 . . . . 0.0 108.911 178.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.969 HD11 ' HB2' ' A' ' 28' ' ' PHE . 0.8 OUTLIER -99.41 -36.74 5.56 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.627 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.47 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.802 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -63.21 -25.89 68.55 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -93.41 -39.21 11.04 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 177.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.472 ' OD2' ' HB3' ' A' ' 27' ' ' SER . 23.9 m-20 -68.21 -20.16 64.82 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 176.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 14' ' ' THR . . . . . 0.859 HG22 ' HB2' ' A' ' 20' ' ' SER . 31.0 p -93.77 -77.84 0.44 Allowed 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 177.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 61.97 11.45 31.47 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 16' ' ' LEU . . . . . 0.892 HD11 ' OG ' ' A' ' 20' ' ' SER . 3.4 mp -83.18 -65.14 1.05 Allowed 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 122.27 1.034 . . . . 0.0 109.151 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 17' ' ' THR . . . . . 0.62 HG22 ' H ' ' B' ' 19' ' ' VAL . 0.5 OUTLIER -140.55 6.73 2.09 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 115.386 -0.824 . . . . 0.0 108.878 -179.724 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 18' ' ' GLN . . . . . 0.582 ' O ' ' C ' ' B' ' 19' ' ' VAL . 6.8 mt-30 57.38 24.5 10.17 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 -176.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 1.069 HG23 ' CD1' ' A' ' 16' ' ' LEU . 0.1 OUTLIER 17.14 -96.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.36 -178.833 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 20' ' ' SER . . . . . 1.024 ' O ' ' N ' ' B' ' 22' ' ' SER . 1.4 p -136.25 23.19 3.23 Favored 'General case' 0 C--N 1.272 -2.776 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 176.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.733 ' HA ' ' CE ' ' B' ' 24' ' ' MET . 17.8 m -5.35 -42.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.397 1.094 . . . . 0.0 110.452 -177.273 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 22' ' ' SER . . . . . 1.024 ' N ' ' O ' ' B' ' 20' ' ' SER . 27.3 t -73.33 -40.34 64.54 Favored 'General case' 0 C--N 1.281 -2.371 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.498 178.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 23' ' ' LYS . . . . . 0.873 ' N ' ' O ' ' B' ' 20' ' ' SER . 13.5 ttpt -93.26 -27.42 16.84 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.254 -0.904 . . . . 0.0 111.239 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 24' ' ' MET . . . . . 0.733 ' CE ' ' HA ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -73.63 -25.74 60.45 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 119.905 -1.747 . . . . 0.0 108.281 179.115 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.95 HD22 ' O ' ' B' ' 3' ' ' LYS . 0.2 OUTLIER -81.99 -46.27 14.21 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 176.946 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 26' ' ' ALA . . . . . 0.697 ' N ' ' HG ' ' B' ' 25' ' ' LEU . . . -64.27 -27.73 69.24 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 178.219 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 27' ' ' SER . . . . . 0.68 ' HA ' ' HB3' ' B' ' 30' ' ' LYS . 30.6 t -83.67 -40.07 19.41 Favored 'General case' 0 C--O 1.2 -1.549 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.135 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 28' ' ' PHE . . . . . 0.772 ' O ' HG13 ' B' ' 31' ' ' ILE . 0.5 OUTLIER -51.51 -46.4 63.24 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.52 0.676 . . . . 0.0 109.379 179.548 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 29' ' ' GLU . . . . . 0.836 ' HG2' HG22 ' A' ' 45' ' ' THR . 0.6 OUTLIER -75.31 -31.58 60.69 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 177.855 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 1.295 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 18.0 ttpt -71.41 -18.54 62.33 Favored 'General case' 0 C--O 1.191 -2.016 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 176.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.884 HD13 ' HB1' ' A' ' 9' ' ' ALA . 1.0 OUTLIER -105.82 -32.01 2.68 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.491 0 O-C-N 119.879 -1.763 . . . . 0.0 108.673 178.368 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.669 HG21 ' CZ ' ' A' ' 47' ' ' PHE . 1.5 mm -67.37 -63.42 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 176.335 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 33' ' ' THR . . . . . 0.852 ' OG1' HD22 ' A' ' 85' ' ' LEU . 0.5 OUTLIER -64.3 -45.11 89.4 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.74 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 1.295 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 15.6 mm-40 -68.79 -27.72 66.13 Favored 'General case' 0 C--N 1.31 -1.116 0 O-C-N 121.339 -0.851 . . . . 0.0 111.165 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 35' ' ' THR . . . . . 0.719 HG23 ' CB ' ' B' ' 40' ' ' ASP . 1.1 m -57.85 -51.14 70.84 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 177.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 1.023 HG21 HD12 ' A' ' 85' ' ' LEU . 4.3 t -54.07 -36.25 31.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 117.249 -1.78 . . . . 0.0 107.068 177.197 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 37' ' ' ALA . . . . . 0.843 ' HA ' ' HB3' ' A' ' 92' ' ' LEU . . . -81.4 1.09 34.55 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.212 177.37 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 38' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' B' ' 34' ' ' GLU . 0.0 OUTLIER -108.72 -25.69 10.71 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.703 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.22 40.7 1.48 Allowed Glycine 0 C--N 1.303 -1.289 0 C-N-CA 119.946 -1.121 . . . . 0.0 110.748 178.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 40' ' ' ASP . . . . . 0.719 ' CB ' HG23 ' B' ' 35' ' ' THR . 0.3 OUTLIER -136.77 135.83 38.39 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.086 -1.244 . . . . 0.0 110.553 179.594 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.9 93.12 9.29 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.48 -0.762 . . . . 0.0 109.006 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.827 ' CG1' HD11 ' A' ' 6' ' ' LEU . 14.1 t -59.3 135.17 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.499 -0.75 . . . . 0.0 110.008 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 43' ' ' GLN . . . . . 0.445 ' HA ' ' HA ' ' B' ' 49' ' ' ASN . 11.2 mt-30 -132.0 91.95 3.04 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.501 -0.749 . . . . 0.0 109.757 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.667 ' HB3' ' CE2' ' B' ' 47' ' ' PHE . 7.6 mt -67.65 -179.28 1.07 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.284 -0.885 . . . . 0.0 110.979 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 45' ' ' THR . . . . . 0.759 HG22 ' HG2' ' A' ' 29' ' ' GLU . 3.2 t -52.53 73.38 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 O-C-N 122.109 -0.369 . . . . 0.0 111.687 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 46' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . 40.09 62.12 1.57 Allowed Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 47' ' ' PHE . . . . . 0.674 ' CE1' ' HG ' ' B' ' 48' ' ' LEU . 0.2 OUTLIER -163.45 -45.16 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.445 -1.032 . . . . 0.0 108.775 -179.867 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 1.035 HD11 ' CD1' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -125.02 102.17 7.39 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.785 -0.572 . . . . 0.0 109.958 178.843 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 49' ' ' ASN . . . . . 0.929 ' O ' ' O ' ' B' ' 79' ' ' VAL . 0.7 OUTLIER -120.24 100.58 7.26 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.11 -0.994 . . . . 0.0 110.568 -179.635 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 50' ' ' ILE . . . . . 0.693 HG13 HD11 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -90.84 140.8 15.36 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 O-C-N 121.252 -0.905 . . . . 0.0 110.921 -179.177 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 51' ' ' LYS . . . . . 0.499 ' HD3' ' O ' ' B' ' 51' ' ' LYS . 0.0 OUTLIER -157.3 119.37 2.11 Favored Pre-proline 0 N--CA 1.496 1.825 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.663 179.205 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 52' ' ' PRO . . . . . 0.754 ' HB3' HG13 ' B' ' 36' ' ' VAL . 57.2 Cg_endo -87.9 136.55 3.68 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.62 1.326 . . . . 0.0 110.778 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.581 ' O ' HG23 ' B' ' 53' ' ' VAL . 30.6 m -128.41 111.7 24.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-O 122.016 0.913 . . . . 0.0 110.642 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 54' ' ' ALA . . . . . 0.59 ' HA ' ' HE1' ' A' ' 94' ' ' TYR . . . . . . . . 0 N--CA 1.498 1.964 0 O-C-N 121.879 -0.513 . . . . 0.0 111.534 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 75' ' ' VAL . . . . . 0.7 ' CG1' HG23 ' B' ' 77' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.711 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 76' ' ' GLY . . . . . 0.611 ' O ' ' N ' ' B' ' 78' ' ' SER . . . -107.57 57.27 0.45 Allowed Glycine 0 N--CA 1.484 1.842 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.85 HG11 ' C ' ' A' ' 84' ' ' SER . 73.5 t -45.17 87.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 122.117 -0.637 . . . . 0.0 109.944 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 78' ' ' SER . . . . . 0.611 ' N ' ' O ' ' B' ' 76' ' ' GLY . 5.7 m -57.54 -129.03 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.929 ' O ' ' O ' ' B' ' 49' ' ' ASN . 1.9 m -144.34 179.74 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 119.702 -1.874 . . . . 0.0 113.2 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 80' ' ' LYS . . . . . 0.893 ' CB ' HD13 ' B' ' 48' ' ' LEU . 3.6 mmtt -101.81 -54.8 0.13 Allowed Pre-proline 0 C--N 1.296 -1.731 0 CA-C-N 113.962 -1.472 . . . . 0.0 112.526 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 81' ' ' PRO . . . . . 0.804 ' HD2' ' H ' ' B' ' 80' ' ' LYS . 28.6 Cg_endo -53.35 114.78 1.9 Allowed 'Trans proline' 0 C--N 1.298 -2.083 0 O-C-N 123.317 1.167 . . . . 0.0 110.339 -177.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -130.85 -57.9 0.09 OUTLIER Glycine 0 N--CA 1.478 1.436 0 N-CA-C 107.072 -2.411 . . . . 0.0 107.072 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 83' ' ' GLU . . . . . 0.833 ' O ' ' N ' ' B' ' 85' ' ' LEU . 25.7 tt0 -82.78 56.21 3.32 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 177.014 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 84' ' ' SER . . . . . 1.304 ' O ' ' N ' ' B' ' 86' ' ' LYS . 1.3 m 8.9 45.2 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.983 0.897 . . . . 0.0 111.561 178.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.999 ' C ' ' O ' ' B' ' 84' ' ' SER . 1.2 mt 22.08 29.36 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 103.745 -2.687 . . . . 0.0 103.745 -171.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 86' ' ' LYS . . . . . 1.304 ' N ' ' O ' ' B' ' 84' ' ' SER 0.337 8.3 tttt -59.26 -40.71 86.84 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 104.074 -2.565 . . . . 0.0 104.074 177.119 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 87' ' ' LYS . . . . . 0.406 ' O ' ' HG2' ' B' ' 90' ' ' GLU 0.278 6.7 tttp -63.62 -37.67 88.19 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 112.248 -2.251 . . . . 0.0 105.749 175.23 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.878 ' O ' ' HB2' ' A' ' 37' ' ' ALA . . . -78.14 -24.57 47.3 Favored 'General case' 0 C--O 1.207 -1.145 0 C-N-CA 119.023 -1.071 . . . . 0.0 108.185 178.148 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.716 ' N ' ' O ' ' B' ' 85' ' ' LEU . . . -76.03 -37.75 58.02 Favored 'General case' 0 C--N 1.291 -1.959 0 O-C-N 120.962 -1.086 . . . . 0.0 109.036 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 90' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' B' ' 87' ' ' LYS . 3.7 pt-20 -66.98 -23.54 65.95 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 176.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 91' ' ' GLY . . . . . 0.417 ' C ' ' HB1' ' A' ' 37' ' ' ALA . . . -72.39 -38.92 57.99 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 92' ' ' LEU . . . . . 0.79 ' HB3' ' HA ' ' A' ' 37' ' ' ALA . 2.2 pp -76.5 22.25 0.18 Allowed 'General case' 0 N--CA 1.503 2.218 0 CA-C-N 120.177 1.988 . . . . 0.0 110.618 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 93' ' ' LYS . . . . . 0.49 ' O ' ' N ' ' B' ' 96' ' ' ASP . 0.1 OUTLIER 54.77 49.39 18.03 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 106.457 -1.682 . . . . 0.0 106.457 -177.927 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 94' ' ' TYR . . . . . 0.638 ' HA ' HD11 ' B' ' 92' ' ' LEU . 28.3 t80 -27.56 -46.22 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.919 -178.06 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -57.35 -48.13 79.8 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.302 -0.874 . . . . 0.0 109.79 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 96' ' ' ASP . . . . . 0.49 ' N ' ' O ' ' B' ' 93' ' ' LYS . 7.8 m-20 -54.24 -33.54 58.67 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.414 -0.804 . . . . 0.0 109.008 178.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 97' ' ' PHE . . . . . 0.541 ' CD2' ' HB2' ' A' ' 54' ' ' ALA . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.487 ' HA ' ' CB ' ' A' ' 5' ' ' GLU . 5.8 mtp . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 120.972 0.415 . . . . 0.0 110.075 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.644 ' O ' HD12 ' A' ' 6' ' ' LEU . 5.2 t-20 -172.62 -173.34 1.0 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.055 -1.028 . . . . 0.0 111.059 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.555 ' HE3' ' CB ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -51.53 -15.7 0.48 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.219 -0.926 . . . . 0.0 110.034 179.419 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.652 ' O ' HG13 ' A' ' 7' ' ' ILE . 18.5 m -107.82 -55.42 2.36 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 122.094 0.95 . . . . 0.0 109.261 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.71 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 0.4 OUTLIER -50.83 -47.69 60.1 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.104 -0.997 . . . . 0.0 108.832 179.37 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.644 HD12 ' O ' ' A' ' 2' ' ' ASN . 1.0 OUTLIER -58.38 -30.6 66.92 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.542 -0.863 . . . . 0.0 110.146 178.563 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.652 HG13 ' O ' ' A' ' 4' ' ' THR . 1.0 OUTLIER -60.47 -41.14 86.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.829 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.824 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 33.4 mtmt -65.47 -36.42 83.84 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 177.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.926 ' CB ' HD13 ' B' ' 31' ' ' ILE . . . -55.88 -38.18 69.82 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.6 -0.688 . . . . 0.0 109.176 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.729 HG22 HG12 ' A' ' 21' ' ' VAL . 1.4 mp -90.05 -32.09 5.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 178.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.824 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -66.41 -11.14 50.06 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 119.055 -1.058 . . . . 0.0 108.345 178.133 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.5 tp-100 -116.36 -43.77 2.92 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.513 ' OD2' HG23 ' B' ' 31' ' ' ILE . 2.1 m-20 -65.13 -38.4 90.51 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 177.156 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.717 HG22 HD21 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -98.37 -70.95 0.71 Allowed 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 178.036 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.416 ' CA ' ' O ' ' A' ' 11' ' ' ALA . . . 45.06 27.42 1.54 Allowed Glycine 0 N--CA 1.5 2.952 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 178.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 1.082 ' CD1' HG23 ' B' ' 19' ' ' VAL . 0.1 OUTLIER -84.46 -20.3 31.97 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.678 -0.895 . . . . 0.0 109.255 179.139 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.756 HG21 ' CG2' ' B' ' 17' ' ' THR . 0.4 OUTLIER -162.96 -7.75 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.819 -0.551 . . . . 0.0 110.573 -178.914 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.478 ' O ' ' C ' ' A' ' 19' ' ' VAL . 4.6 mt-30 59.73 33.83 21.91 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 -176.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 1.006 HG11 HG11 ' B' ' 19' ' ' VAL . 2.8 p -23.88 -98.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.228 -178.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.941 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -129.71 22.7 5.43 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 178.625 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.729 HG12 HG22 ' A' ' 10' ' ' ILE . 28.1 m -25.42 -39.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 CA-C-O 122.31 1.053 . . . . 0.0 109.05 -178.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.695 ' N ' ' O ' ' A' ' 20' ' ' SER . 23.0 t -83.45 -34.57 25.4 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 114.922 -1.036 . . . . 0.0 109.326 177.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.941 ' N ' ' O ' ' A' ' 20' ' ' SER . 2.4 mtmt -87.35 -31.76 19.97 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.676 -0.64 . . . . 0.0 111.481 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.664 ' HG2' HG22 ' B' ' 14' ' ' THR . 0.0 OUTLIER -77.47 -35.71 53.5 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.45 -1.407 . . . . 0.0 108.869 179.186 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.635 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 13.4 mt -76.34 -41.42 48.4 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 118.462 -1.295 . . . . 0.0 108.737 178.364 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.458 ' HA ' ' HE2' ' A' ' 3' ' ' LYS . . . -62.59 -35.26 78.96 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 177.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.555 ' HA ' ' CB ' ' A' ' 30' ' ' LYS . 60.2 p -83.67 -29.02 27.95 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.295 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.635 ' HB3' ' HA ' ' A' ' 25' ' ' LEU . 0.6 OUTLIER -51.55 -40.28 59.41 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.742 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.674 ' HG3' HG21 ' B' ' 45' ' ' THR . 0.2 OUTLIER -73.49 -41.55 62.97 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 175.816 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.896 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 12.5 tttt -56.63 -22.78 36.65 Favored 'General case' 0 C--O 1.192 -1.967 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 177.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.851 HD13 ' HB1' ' B' ' 9' ' ' ALA . 0.5 OUTLIER -106.28 -30.72 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 120.521 -1.362 . . . . 0.0 109.307 178.168 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.671 HG21 ' CE2' ' B' ' 47' ' ' PHE . 1.5 mm -71.43 -53.41 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 176.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.653 ' HA ' HD23 ' B' ' 85' ' ' LEU 0.26 3.6 m -61.78 -53.86 50.19 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.73 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.896 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 62.0 mm-40 -62.14 -34.53 76.55 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.711 -0.618 . . . . 0.0 110.822 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.945 HG23 ' CB ' ' A' ' 40' ' ' ASP . 1.0 OUTLIER -55.03 -53.26 58.14 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 120.839 -1.163 . . . . 0.0 108.428 179.026 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.814 HG21 HD22 ' B' ' 85' ' ' LEU . 4.0 t -51.95 -42.35 33.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 C-N-CA 118.656 -1.217 . . . . 0.0 107.924 178.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.917 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -78.23 -1.93 35.33 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.341 177.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 35' ' ' THR . 0.0 OUTLIER -108.49 -8.01 15.64 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.73 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.28 49.7 4.59 Favored Glycine 0 C--N 1.305 -1.192 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.945 ' CB ' HG23 ' A' ' 35' ' ' THR . 0.1 OUTLIER -131.22 134.8 46.81 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.1 -1.236 . . . . 0.0 110.783 179.51 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.418 ' CD ' ' HB3' ' A' ' 51' ' ' LYS . 0.8 OUTLIER -98.57 110.21 22.84 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.35 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.787 HG22 ' HB2' ' B' ' 1' ' ' MET . 39.4 t -89.9 120.92 39.48 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 C-N-CA 119.116 -1.034 . . . . 0.0 111.031 -178.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -108.88 91.02 3.47 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.741 HD12 ' HB3' ' A' ' 48' ' ' LEU . 9.8 mt -60.88 104.53 0.37 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.547 -0.721 . . . . 0.0 110.783 -178.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.592 HG21 ' HG3' ' B' ' 29' ' ' GLU . 0.1 OUTLIER 32.91 -91.43 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 120.892 0.377 . . . . 0.0 111.402 179.498 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.494 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -149.12 29.81 1.22 Allowed Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.664 ' CE2' ' HG3' ' B' ' 29' ' ' GLU . 1.8 p90 -131.33 -22.69 2.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.286 -1.126 . . . . 0.0 111.585 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.798 HD23 ' O ' ' A' ' 80' ' ' LYS . 5.3 mt -133.86 119.52 19.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.235 -1.541 . . . . 0.0 110.712 178.071 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.655 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 0.6 OUTLIER -119.97 84.18 2.17 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.432 -0.793 . . . . 0.0 111.586 -178.656 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.764 HG22 ' CG2' ' A' ' 79' ' ' VAL . 1.1 pt -83.3 147.66 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.042 -1.036 . . . . 0.0 110.425 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.428 ' HG3' ' HB2' ' A' ' 78' ' ' SER . 0.4 OUTLIER -165.94 113.99 0.78 Allowed Pre-proline 0 N--CA 1.495 1.778 0 C-N-CA 119.011 -1.076 . . . . 0.0 110.72 179.427 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.535 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 47.4 Cg_endo -71.31 143.92 44.71 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 O-C-N 123.51 1.269 . . . . 0.0 111.26 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.73 HG22 ' O ' ' A' ' 76' ' ' GLY . 25.8 m -138.23 114.88 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.726 0.774 . . . . 0.0 110.526 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.82 ' HB2' ' HB3' ' B' ' 97' ' ' PHE . . . . . . . . 0 N--CA 1.499 1.997 0 CA-C-O 121.735 0.778 . . . . 0.0 112.482 -178.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.81 HG12 ' HB2' ' B' ' 89' ' ' ALA . 0.4 OUTLIER . . . . . 0 N--CA 1.496 1.833 0 CA-C-O 121.308 0.575 . . . . 0.0 109.961 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.73 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -108.15 85.72 0.42 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.18 -1.968 . . . . 0.0 108.18 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 1.109 HG11 HD13 ' B' ' 85' ' ' LEU . 73.4 t -60.19 80.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.781 -0.835 . . . . 0.0 110.557 -179.052 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.468 ' N ' ' O ' ' A' ' 76' ' ' GLY . 0.3 OUTLIER -75.43 178.48 5.88 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.27 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.764 ' CG2' HG22 ' A' ' 50' ' ' ILE . 6.6 p 178.64 177.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.798 ' O ' HD23 ' A' ' 48' ' ' LEU . 1.4 mttt -175.83 173.67 0.88 Allowed Pre-proline 0 N--CA 1.487 1.396 0 O-C-N 120.799 -1.188 . . . . 0.0 111.069 178.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.485 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 56.5 Cg_endo -94.96 142.69 1.32 Allowed 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 122.586 2.191 . . . . 0.0 109.407 177.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.515 ' CA ' ' HA ' ' A' ' 47' ' ' PHE . . . -106.26 163.97 13.65 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.273 -1.931 . . . . 0.0 108.273 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.34 -24.79 57.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.071 -1.252 . . . . 0.0 110.624 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.457 ' HB2' ' HB3' ' A' ' 47' ' ' PHE . 3.5 m -55.29 -36.64 66.37 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.037 -1.039 . . . . 0.0 108.652 178.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.892 HD13 HG21 ' B' ' 77' ' ' VAL . 0.5 OUTLIER -80.69 -30.78 36.38 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.757 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.815 ' HG3' HG12 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -77.32 -41.9 38.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.639 -0.663 . . . . 0.0 109.947 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.3 ttmt -64.15 -38.97 92.98 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.896 ' O ' ' HB1' ' B' ' 37' ' ' ALA . . . -66.18 -35.99 81.9 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 176.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.908 ' HB1' ' CG1' ' B' ' 75' ' ' VAL . . . -56.65 -39.39 73.62 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.774 -0.77 . . . . 0.0 108.932 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.39 -33.05 65.39 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 176.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.446 ' C ' ' H ' ' A' ' 93' ' ' LYS . . . -60.21 -42.33 98.61 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 178.098 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.883 ' O ' HD12 ' A' ' 92' ' ' LEU . 0.5 OUTLIER -65.2 6.01 0.31 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.729 -1.454 . . . . 0.0 110.822 179.649 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.542 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 3.1 mmtt 80.07 52.95 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 CA-C-O 122.052 0.929 . . . . 0.0 108.783 -179.008 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.688 ' CD2' ' HB ' ' B' ' 75' ' ' VAL . 4.5 t80 -42.28 -61.87 1.08 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 . . . . . 0 N--CA 1.499 2.016 0 O-C-N 120.878 -1.139 . . . . 0.0 110.305 179.011 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.787 ' HB2' HG22 ' A' ' 42' ' ' VAL . 9.6 mtp . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 120.869 0.366 . . . . 0.0 110.08 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 2' ' ' ASN . . . . . 0.44 ' O ' ' HB2' ' B' ' 6' ' ' LEU . 0.7 OUTLIER -172.44 -169.59 0.62 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.126 -0.984 . . . . 0.0 111.017 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.584 ' HD2' ' HB ' ' A' ' 45' ' ' THR . 0.0 OUTLIER -56.53 -10.85 1.06 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.308 -0.87 . . . . 0.0 110.098 179.61 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 4' ' ' THR . . . . . 0.688 ' O ' HG13 ' B' ' 7' ' ' ILE . 37.1 m -109.86 -56.68 2.29 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 122.162 0.982 . . . . 0.0 108.761 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.628 ' HA ' ' HE2' ' B' ' 8' ' ' LYS . 0.1 OUTLIER -49.4 -46.11 47.01 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.057 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.735 HD11 ' CG1' ' A' ' 42' ' ' VAL . 5.3 mt -64.45 -27.01 68.7 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.154 -1.019 . . . . 0.0 110.557 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 7' ' ' ILE . . . . . 0.688 HG13 ' O ' ' B' ' 4' ' ' THR . 1.2 pp -59.36 -41.68 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 120.37 -1.456 . . . . 0.0 107.306 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 8' ' ' LYS . . . . . 0.767 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 18.6 mtmt -67.36 -44.09 79.84 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 177.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 9' ' ' ALA . . . . . 0.851 ' HB1' HD13 ' A' ' 31' ' ' ILE . . . -53.69 -32.11 50.52 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.646 -0.659 . . . . 0.0 109.863 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.734 ' O ' ' OG1' ' B' ' 14' ' ' THR . 0.8 OUTLIER -94.4 -29.85 4.21 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.478 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 178.162 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.767 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -63.08 -28.53 70.14 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 177.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.425 ' HG3' ' O ' ' B' ' 8' ' ' LYS . 58.5 mt-30 -87.96 -43.85 11.45 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.447 ' HB3' ' OG ' ' A' ' 27' ' ' SER . 94.1 m-20 -64.16 -26.1 68.38 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 177.252 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 14' ' ' THR . . . . . 0.827 HG22 ' HB2' ' A' ' 20' ' ' SER . 20.6 p -87.74 -76.74 0.37 Allowed 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 177.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 61.32 10.99 25.1 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 16' ' ' LEU . . . . . 0.879 HD22 ' O ' ' A' ' 19' ' ' VAL . 3.1 mp -82.33 -67.16 0.81 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.525 -0.985 . . . . 0.0 109.204 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 17' ' ' THR . . . . . 0.756 ' CG2' HG21 ' A' ' 17' ' ' THR . 0.5 OUTLIER -137.52 6.39 2.74 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.787 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 18' ' ' GLN . . . . . 0.639 ' O ' ' C ' ' B' ' 19' ' ' VAL . 15.4 mt-30 57.97 25.88 12.75 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 -176.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 1.082 HG23 ' CD1' ' A' ' 16' ' ' LEU . 0.4 OUTLIER 4.17 -102.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.642 -179.099 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 20' ' ' SER . . . . . 0.967 ' O ' ' N ' ' B' ' 22' ' ' SER . 0.2 OUTLIER -135.2 24.09 3.52 Favored 'General case' 0 C--N 1.27 -2.853 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 177.33 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.601 ' C ' ' O ' ' B' ' 20' ' ' SER . 35.2 m -12.4 -38.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-O 122.394 1.092 . . . . 0.0 110.469 -177.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.967 ' N ' ' O ' ' B' ' 20' ' ' SER . 12.1 t -80.14 -46.87 15.65 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.34 177.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 23' ' ' LYS . . . . . 0.939 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.1 OUTLIER -85.44 -24.1 27.59 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.855 -0.528 . . . . 0.0 110.085 178.624 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 24' ' ' MET . . . . . 0.599 ' CE ' HG21 ' B' ' 10' ' ' ILE . 3.5 tmm? -68.37 -45.1 73.71 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.701 ' HA ' ' HB3' ' B' ' 28' ' ' PHE . 11.6 mt -71.0 -34.79 71.69 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 176.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 26' ' ' ALA . . . . . 0.585 ' HB3' ' HA ' ' B' ' 23' ' ' LYS . . . -62.29 -34.72 77.12 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 177.16 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 27' ' ' SER . . . . . 0.466 ' HA ' ' HB3' ' B' ' 30' ' ' LYS . 0.1 OUTLIER -76.38 -40.71 50.28 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 177.636 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 28' ' ' PHE . . . . . 0.701 ' HB3' ' HA ' ' B' ' 25' ' ' LEU . 0.1 OUTLIER -52.84 -45.94 67.57 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.163 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 29' ' ' GLU . . . . . 0.664 ' HG3' ' CE2' ' A' ' 47' ' ' PHE . 1.2 tt0 -68.58 -36.38 78.66 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 177.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 1.246 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 13.4 ttmt -64.71 -22.74 67.05 Favored 'General case' 0 C--O 1.191 -1.989 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.926 HD13 ' CB ' ' A' ' 9' ' ' ALA . 0.6 OUTLIER -105.83 -27.61 3.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 O-C-N 120.282 -1.511 . . . . 0.0 109.335 178.237 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.645 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.2 mm -73.18 -60.42 2.43 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 177.044 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 33' ' ' THR . . . . . 0.598 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 0.6 OUTLIER -68.75 -35.21 76.81 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.553 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 1.246 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 31.1 mm-40 -78.54 -37.78 42.06 Favored 'General case' 0 C--O 1.207 -1.184 0 O-C-N 121.115 -0.99 . . . . 0.0 111.952 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 35' ' ' THR . . . . . 0.514 ' CB ' ' O ' ' B' ' 31' ' ' ILE . 37.2 m -61.95 -49.99 73.92 Favored 'General case' 0 N--CA 1.504 2.246 0 CA-C-N 120.714 1.597 . . . . 0.0 109.201 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.734 HG11 HD22 ' A' ' 85' ' ' LEU . 2.1 t -52.83 -43.53 45.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 178.207 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 37' ' ' ALA . . . . . 0.896 ' HB1' ' O ' ' A' ' 88' ' ' ALA . . . -85.99 0.82 52.31 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.834 178.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 38' ' ' LYS . . . . . 0.747 ' HB2' ' O ' ' B' ' 34' ' ' GLU . 7.6 tppt? -96.05 -33.46 12.1 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 177.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 134.01 33.44 0.33 Allowed Glycine 0 C--N 1.303 -1.263 0 C-N-CA 119.581 -1.295 . . . . 0.0 111.482 177.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 40' ' ' ASP . . . . . 0.453 ' CB ' ' CG2' ' B' ' 35' ' ' THR . 0.1 OUTLIER -144.85 157.55 44.12 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.752 -1.44 . . . . 0.0 110.66 179.356 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.401 ' HG3' ' HD2' ' B' ' 52' ' ' PRO . 4.5 mptp? -103.96 99.81 9.57 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.518 -0.739 . . . . 0.0 109.61 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.511 HG13 HD11 ' A' ' 6' ' ' LEU . 59.7 t -59.07 136.28 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.584 -0.698 . . . . 0.0 110.085 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -127.96 97.25 4.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.342 -0.849 . . . . 0.0 109.403 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.714 HD12 ' HB3' ' B' ' 48' ' ' LEU . 11.0 mt -69.1 101.6 1.47 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.249 -0.907 . . . . 0.0 110.442 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 45' ' ' THR . . . . . 0.674 HG21 ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 32.34 -95.1 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.036 0 O-C-N 122.052 -0.405 . . . . 0.0 111.451 179.277 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 46' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -144.41 30.71 1.85 Allowed Glycine 0 N--CA 1.487 2.037 0 C-N-CA 119.668 -1.253 . . . . 0.0 110.448 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 47' ' ' PHE . . . . . 0.702 ' O ' ' HA ' ' B' ' 81' ' ' PRO . 3.9 p90 -133.65 -18.6 2.15 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.893 -1.357 . . . . 0.0 111.686 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.714 ' HB3' HD12 ' B' ' 44' ' ' LEU . 4.6 mt -135.47 120.25 18.43 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.337 -1.477 . . . . 0.0 111.196 178.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 49' ' ' ASN . . . . . 0.53 ' O ' ' HA ' ' B' ' 79' ' ' VAL . 2.6 m120 -116.95 94.56 4.64 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.506 -0.747 . . . . 0.0 111.208 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 50' ' ' ILE . . . . . 0.647 HG22 HG21 ' B' ' 36' ' ' VAL . 33.8 mm -90.19 141.91 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.305 -0.872 . . . . 0.0 109.739 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 51' ' ' LYS . . . . . 0.432 ' O ' ' N ' ' B' ' 78' ' ' SER . 2.3 pttt -162.44 128.63 2.35 Favored Pre-proline 0 N--CA 1.498 1.951 0 O-C-N 120.582 -1.324 . . . . 0.0 111.439 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 52' ' ' PRO . . . . . 0.566 ' O ' HG13 ' B' ' 53' ' ' VAL . 52.5 Cg_endo -77.12 145.15 24.27 Favored 'Trans proline' 0 C--N 1.314 -1.24 0 O-C-N 123.531 1.28 . . . . 0.0 110.72 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.659 HG22 ' O ' ' B' ' 76' ' ' GLY . 15.3 m -156.57 121.28 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-O 121.257 0.551 . . . . 0.0 109.962 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 54' ' ' ALA . . . . . 0.832 ' HA ' ' N ' ' B' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.12 -0.988 . . . . 0.0 111.561 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 75' ' ' VAL . . . . . 0.908 ' CG1' ' HB1' ' A' ' 89' ' ' ALA . 0.9 OUTLIER . . . . . 0 N--CA 1.517 2.894 0 CA-C-O 121.908 0.861 . . . . 0.0 109.288 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 76' ' ' GLY . . . . . 0.659 ' O ' HG22 ' B' ' 53' ' ' VAL . . . -157.17 110.63 0.45 Allowed Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.892 HG21 HD13 ' A' ' 85' ' ' LEU . 2.7 p -67.93 89.42 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.395 -1.062 . . . . 0.0 111.31 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 78' ' ' SER . . . . . 0.617 ' C ' HG12 ' B' ' 79' ' ' VAL . 0.3 OUTLIER -74.52 -176.38 2.72 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 177.343 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.617 HG12 ' C ' ' B' ' 78' ' ' SER . 0.2 OUTLIER 179.84 174.66 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.298 -0.876 . . . . 0.0 109.028 179.676 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 80' ' ' LYS . . . . . 0.555 ' O ' HD23 ' B' ' 48' ' ' LEU . 4.7 mttt 179.25 174.25 0.42 Allowed Pre-proline 0 C--N 1.307 -1.243 0 O-C-N 121.492 -0.755 . . . . 0.0 109.379 178.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 81' ' ' PRO . . . . . 0.702 ' HA ' ' O ' ' B' ' 47' ' ' PHE . 52.3 Cg_endo -95.68 171.57 1.22 Allowed 'Trans proline' 0 C--N 1.296 -2.206 0 C-N-CA 121.856 1.704 . . . . 0.0 109.567 177.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 82' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' B' ' 47' ' ' PHE . . . -120.5 -92.63 1.31 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 106.177 -2.769 . . . . 0.0 106.177 177.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 83' ' ' GLU . . . . . 0.877 ' O ' ' N ' ' B' ' 85' ' ' LEU . 29.2 tt0 -80.13 51.61 1.41 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 175.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 84' ' ' SER . . . . . 0.671 ' O ' HG21 ' A' ' 77' ' ' VAL . 0.1 OUTLIER 8.27 44.15 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.007 179.586 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 1.109 HD13 HG11 ' A' ' 77' ' ' VAL . 3.6 mp 20.18 28.93 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 103.104 -2.924 . . . . 0.0 103.104 -172.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 86' ' ' LYS . . . . . 0.59 ' HD2' ' HB2' ' B' ' 84' ' ' SER 0.349 4.0 tttp -57.94 -42.59 85.23 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 104.418 -2.438 . . . . 0.0 104.418 177.397 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 87' ' ' LYS . . . . . 0.419 ' O ' ' HG2' ' B' ' 90' ' ' GLU 0.282 15.8 tttt -69.2 -31.17 69.59 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 111.789 -2.459 . . . . 0.0 105.976 175.654 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.768 ' HB3' ' HB3' ' B' ' 85' ' ' LEU . . . -78.02 -27.04 48.8 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 118.19 -1.404 . . . . 0.0 107.917 178.389 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 1.008 ' HA ' HD23 ' B' ' 92' ' ' LEU . . . -64.96 -48.7 73.1 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.294 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 90' ' ' GLU . . . . . 0.423 ' HG2' ' N ' ' B' ' 91' ' ' GLY . 4.0 pt-20 -59.24 -28.08 66.37 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 177.282 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 91' ' ' GLY . . . . . 0.423 ' N ' ' HG2' ' B' ' 90' ' ' GLU . . . -75.51 -24.49 70.34 Favored Glycine 0 N--CA 1.49 2.255 0 C-N-CA 120.462 -0.875 . . . . 0.0 111.137 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 92' ' ' LEU . . . . . 1.008 HD23 ' HA ' ' B' ' 89' ' ' ALA . 0.3 OUTLIER -88.05 23.92 1.96 Allowed 'General case' 0 N--CA 1.503 2.216 0 O-C-N 120.322 -1.693 . . . . 0.0 110.544 -179.738 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 93' ' ' LYS . . . . . 0.406 ' O ' ' N ' ' B' ' 96' ' ' ASP . 1.2 mmmm 55.11 35.86 25.7 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 -177.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 94' ' ' TYR . . . . . 0.538 ' CD1' ' N ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -41.71 -43.62 2.92 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.794 -178.701 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 95' ' ' GLU . . . . . 0.434 ' HG2' ' N ' ' B' ' 96' ' ' ASP . 4.9 pm0 -53.81 -36.11 62.12 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.264 -0.897 . . . . 0.0 109.289 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 96' ' ' ASP . . . . . 0.434 ' N ' ' HG2' ' B' ' 95' ' ' GLU . 20.1 t70 -64.97 -34.35 78.23 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 177.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 97' ' ' PHE . . . . . 0.82 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.267 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.839 ' HB3' HG22 ' B' ' 42' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.446 ' HA ' ' O ' ' B' ' 43' ' ' GLN . 52.2 p-10 -171.66 -149.25 0.06 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.988 -1.07 . . . . 0.0 112.044 178.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.895 ' HA ' HD11 ' A' ' 25' ' ' LEU . 3.8 tttm -51.32 -6.94 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.44 -0.788 . . . . 0.0 111.622 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.645 ' O ' HG13 ' A' ' 7' ' ' ILE . 48.7 m -118.13 -62.49 1.54 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.849 -1.157 . . . . 0.0 110.586 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.542 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 4.9 mt-10 -49.22 -42.02 39.08 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.071 -1.018 . . . . 0.0 109.167 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.696 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 21.0 mt -62.26 -32.51 73.22 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.111 -1.035 . . . . 0.0 109.556 178.471 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.828 HG22 HD23 ' A' ' 25' ' ' LEU . 1.0 OUTLIER -57.18 -43.95 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 178.292 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.901 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 2.6 mtpt -63.56 -34.75 78.49 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.862 ' HB1' HD13 ' B' ' 31' ' ' ILE . . . -52.56 -40.12 62.21 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.807 -0.757 . . . . 0.0 109.155 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.776 HG22 HG12 ' A' ' 21' ' ' VAL . 1.5 mp -91.15 -32.1 5.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 178.085 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.901 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -66.79 -13.06 61.05 Favored 'General case' 0 C--N 1.292 -1.918 0 O-C-N 120.756 -1.215 . . . . 0.0 108.923 178.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.444 ' N ' ' O ' ' A' ' 8' ' ' LYS . 11.5 pt20 -114.58 -39.98 3.68 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.45 -0.781 . . . . 0.0 109.656 179.046 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.426 ' HB3' ' OG ' ' B' ' 27' ' ' SER . 1.0 OUTLIER -73.95 -20.29 60.41 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 176.887 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . 1.017 HG22 HD11 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -119.14 -83.99 0.65 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 179.232 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.539 ' O ' ' C ' ' A' ' 16' ' ' LEU . . . 68.6 -21.17 0.34 Allowed Glycine 0 N--CA 1.495 2.588 0 O-C-N 120.957 -1.09 . . . . 0.0 110.843 178.349 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 1.017 HD11 HG22 ' A' ' 14' ' ' THR . 0.0 OUTLIER -28.77 -59.68 0.13 Allowed 'General case' 0 N--CA 1.518 2.973 0 CA-C-O 122.004 0.906 . . . . 0.0 110.266 -179.166 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.589 HG21 ' CG2' ' B' ' 17' ' ' THR . 0.6 OUTLIER -130.23 -7.28 4.3 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.564 -179.932 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.566 ' O ' ' C ' ' A' ' 19' ' ' VAL . 23.6 mt-30 57.25 36.86 27.88 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -177.188 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 1.062 HG11 HG11 ' B' ' 19' ' ' VAL . 1.0 OUTLIER -19.62 -93.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.872 -178.974 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.935 ' O ' ' N ' ' A' ' 22' ' ' SER . 0.4 OUTLIER -134.39 25.03 3.8 Favored 'General case' 0 C--N 1.278 -2.506 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 177.946 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.776 HG12 HG22 ' A' ' 10' ' ' ILE . 27.3 m -16.34 -38.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 122.684 1.23 . . . . 0.0 109.466 -178.006 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.935 ' N ' ' O ' ' A' ' 20' ' ' SER . 32.2 p -84.55 -39.31 18.93 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 114.66 -1.154 . . . . 0.0 110.38 178.24 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.926 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.3 OUTLIER -89.69 -25.38 21.25 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 121.245 -0.91 . . . . 0.0 110.613 179.593 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.963 ' HB3' HG21 ' B' ' 14' ' ' THR . 0.0 OUTLIER -81.01 -35.02 32.47 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.25 -1.531 . . . . 0.0 109.361 178.9 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.895 HD11 ' HA ' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -80.75 -40.99 24.27 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 117.875 -1.53 . . . . 0.0 107.141 177.819 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.502 ' CB ' ' O ' ' A' ' 22' ' ' SER . . . -60.55 -25.74 66.38 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 176.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.494 ' HA ' ' HB3' ' A' ' 30' ' ' LYS . 7.0 t -83.42 -37.9 22.62 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.238 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.756 ' HA ' ' CG1' ' A' ' 31' ' ' ILE . 0.1 OUTLIER -60.11 -33.04 71.56 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.486 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.663 ' HG3' ' CD1' ' A' ' 28' ' ' PHE . 29.6 mt-10 -80.06 -33.89 38.61 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 177.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.85 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 6.6 tttm -69.46 -28.0 65.72 Favored 'General case' 0 C--O 1.195 -1.799 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 177.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.935 HD13 ' HB1' ' B' ' 9' ' ' ALA . 1.1 pp -96.98 -30.3 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.217 -0.927 . . . . 0.0 109.728 179.106 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.747 HG21 ' CE1' ' B' ' 47' ' ' PHE . 1.6 mm -65.09 -53.98 34.68 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 177.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.629 HG23 ' HB2' ' B' ' 88' ' ' ALA . 0.4 OUTLIER -69.09 -37.3 78.35 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.162 -1.015 . . . . 0.0 108.464 179.591 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.85 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 15.5 mm-40 -73.17 -38.41 66.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.431 -0.793 . . . . 0.0 111.25 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.539 ' N ' ' O ' ' A' ' 31' ' ' ILE . 19.4 m -58.13 -48.49 80.08 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.697 -1.252 . . . . 0.0 108.097 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.776 HG13 ' HB3' ' A' ' 52' ' ' PRO . 2.8 t -55.84 -36.79 44.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 106.652 -1.611 . . . . 0.0 106.652 177.115 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.768 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -80.29 -4.01 51.63 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.505 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -101.81 -32.58 10.19 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.583 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.72 34.57 0.79 Allowed Glycine 0 C--N 1.302 -1.33 0 C-N-CA 119.682 -1.247 . . . . 0.0 111.472 177.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.53 ' HB2' HG23 ' A' ' 35' ' ' THR . 0.4 OUTLIER -135.8 144.0 45.5 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.856 -1.379 . . . . 0.0 110.552 179.262 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.454 ' HG2' ' HB2' ' A' ' 51' ' ' LYS . 49.0 mtmt -91.67 92.4 8.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.517 -0.739 . . . . 0.0 109.978 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.608 HG23 ' HB ' ' A' ' 50' ' ' ILE . 35.4 m -63.05 147.29 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.533 -0.73 . . . . 0.0 110.413 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.882 ' O ' HD23 ' A' ' 44' ' ' LEU . 31.9 mt-30 -142.74 171.41 14.08 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.308 -0.87 . . . . 0.0 110.49 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.882 HD23 ' O ' ' A' ' 43' ' ' GLN . 21.3 mt -131.47 -177.99 4.66 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.512 -0.743 . . . . 0.0 109.781 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.829 HG22 ' HG2' ' B' ' 29' ' ' GLU . 2.8 t -43.25 66.23 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.88 -0.512 . . . . 0.0 112.098 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.78 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . 46.98 23.03 1.39 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.802 ' HA ' ' HA2' ' A' ' 82' ' ' GLY . 0.7 OUTLIER -117.61 -37.83 3.4 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 121.014 -1.286 . . . . 0.0 109.522 179.39 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.832 ' HB2' HD12 ' A' ' 44' ' ' LEU . 6.9 mt -120.6 118.86 31.25 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.442 -1.411 . . . . 0.0 111.095 177.507 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.672 ' H ' ' HB2' ' A' ' 80' ' ' LYS . 32.6 t-20 -116.9 85.64 2.36 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.766 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.64 HD13 ' HA ' ' A' ' 79' ' ' VAL . 40.1 mm -86.12 126.07 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.444 -0.785 . . . . 0.0 110.473 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.598 ' HD2' HG13 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -147.48 130.69 8.09 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.353 -0.842 . . . . 0.0 109.441 179.307 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.776 ' HB3' HG13 ' A' ' 36' ' ' VAL . 53.7 Cg_endo -78.18 142.09 18.97 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 123.57 1.3 . . . . 0.0 112.467 -178.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.7 HG22 ' O ' ' A' ' 76' ' ' GLY . 33.7 m -134.72 109.64 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 CA-C-O 121.696 0.76 . . . . 0.0 110.92 178.346 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.731 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.504 2.232 0 O-C-N 121.43 -0.794 . . . . 0.0 111.471 -179.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.731 ' HA ' ' HA ' ' A' ' 54' ' ' ALA . 0.8 OUTLIER . . . . . 0 N--CA 1.477 0.898 0 CA-C-O 122.043 0.925 . . . . 0.0 109.733 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.7 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -114.24 86.22 0.41 Allowed Glycine 0 C--N 1.289 -2.067 0 N-CA-C 108.886 -1.685 . . . . 0.0 108.886 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.84 HG21 HD13 ' B' ' 85' ' ' LEU . 3.8 p -45.21 87.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 CA-C-O 121.766 0.793 . . . . 0.0 110.792 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.544 ' N ' ' O ' ' A' ' 76' ' ' GLY . 0.1 OUTLIER -59.37 -162.35 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.122 179.8 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.712 HG11 ' HD3' ' B' ' 81' ' ' PRO . 5.4 p 179.93 178.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.672 ' HB2' ' H ' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -139.76 177.69 1.92 Allowed Pre-proline 0 C--N 1.305 -1.331 0 O-C-N 120.896 -1.127 . . . . 0.0 110.455 179.051 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.435 ' HD3' ' CG ' ' A' ' 80' ' ' LYS . 56.4 Cg_endo -106.69 84.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.298 -2.095 0 C-N-CA 124.074 3.183 . . . . 0.0 108.592 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.802 ' HA2' ' HA ' ' A' ' 47' ' ' PHE . . . -55.73 100.72 0.1 Allowed Glycine 0 N--CA 1.483 1.779 0 C-N-CA 118.698 -1.715 . . . . 0.0 110.955 -177.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.414 ' HA ' ' HB2' ' A' ' 86' ' ' LYS . 6.2 pt-20 -57.35 -29.01 63.64 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.451 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 0.3 OUTLIER -61.88 -32.76 73.15 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 177.3 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.819 HD21 HG21 ' B' ' 36' ' ' VAL . 1.9 tt -81.69 -39.45 24.28 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 177.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.698 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 0.3 OUTLIER -69.78 -45.93 66.9 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.614 0.721 . . . . 0.0 109.53 179.301 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.69 -37.55 87.78 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.489 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.662 ' C ' ' HB2' ' B' ' 37' ' ' ALA . . . -66.28 -36.89 84.13 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 176.254 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 1.045 ' HB1' HG21 ' B' ' 75' ' ' VAL . . . -57.77 -31.6 66.68 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.654 ' HA ' ' CD1' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -65.2 -31.33 72.45 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 177.096 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.473 ' N ' ' HG3' ' A' ' 90' ' ' GLU . . . -66.01 -31.85 80.73 Favored Glycine 0 N--CA 1.484 1.869 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 178.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.877 HD12 ' HB2' ' A' ' 93' ' ' LYS . 1.0 OUTLIER -58.19 -43.39 87.52 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 120.723 -1.457 . . . . 0.0 111.386 -179.253 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.877 ' HB2' HD12 ' A' ' 92' ' ' LEU . 0.0 OUTLIER 164.82 46.11 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -179.651 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.654 ' CD1' ' HA ' ' A' ' 90' ' ' GLU . 2.2 t80 -40.29 -73.29 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -178.491 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.197 -0.939 . . . . 0.0 110.256 -178.408 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.713 ' CE ' HD23 ' B' ' 6' ' ' LEU . 10.0 mtp . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 2' ' ' ASN . . . . . 0.498 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 10.2 p30 -170.86 -156.63 0.12 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.971 -1.081 . . . . 0.0 112.191 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.517 ' HE3' ' HB ' ' A' ' 45' ' ' THR . 0.3 OUTLIER -57.07 -4.69 0.2 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.61 -0.681 . . . . 0.0 111.26 -179.282 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 4' ' ' THR . . . . . 0.656 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 93.9 m -124.08 -42.15 2.16 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.935 -1.103 . . . . 0.0 109.743 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.58 ' CB ' ' HA ' ' B' ' 1' ' ' MET . 0.0 OUTLIER -63.68 -53.49 50.54 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.134 -0.979 . . . . 0.0 108.709 179.087 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.764 ' O ' ' HB3' ' B' ' 9' ' ' ALA . 14.8 mt -60.0 -29.78 68.7 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.335 -0.946 . . . . 0.0 108.964 178.315 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 7' ' ' ILE . . . . . 1.042 HG23 ' HB ' ' B' ' 21' ' ' VAL . 1.1 mt -54.65 -55.73 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.29 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 8' ' ' LYS . . . . . 0.913 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 14.6 mtmt -56.57 -34.24 66.94 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 177.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 9' ' ' ALA . . . . . 0.935 ' HB1' HD13 ' A' ' 31' ' ' ILE . . . -53.22 -38.63 63.08 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.585 -0.846 . . . . 0.0 109.259 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.793 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.4 mp -92.7 -31.15 4.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 177.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.913 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -68.92 -6.48 27.71 Favored 'General case' 0 C--N 1.29 -2.0 0 C-N-CA 118.38 -1.328 . . . . 0.0 108.645 178.482 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.42 ' CG ' ' N ' ' B' ' 13' ' ' ASP . 12.7 pt20 -122.45 -40.13 2.5 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.324 -0.86 . . . . 0.0 110.13 179.071 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.433 ' HB2' ' O ' ' B' ' 9' ' ' ALA . 1.0 OUTLIER -70.76 -30.04 66.43 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 177.22 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 14' ' ' THR . . . . . 1.149 HG22 ' CD1' ' B' ' 16' ' ' LEU 0.271 0.2 OUTLIER -101.62 -75.59 0.59 Allowed 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.286 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.91 14.37 51.93 Favored Glycine 0 N--CA 1.499 2.868 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 177.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 16' ' ' LEU . . . . . 1.149 ' CD1' HG22 ' B' ' 14' ' ' THR . 4.7 mp -53.02 -64.99 0.64 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.557 -0.966 . . . . 0.0 110.005 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 17' ' ' THR . . . . . 0.589 ' CG2' HG21 ' A' ' 17' ' ' THR . 0.5 OUTLIER -141.92 9.47 1.94 Allowed 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.696 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 18' ' ' GLN . . . . . 0.638 ' O ' ' C ' ' B' ' 19' ' ' VAL . 14.6 mt-30 57.95 27.48 14.79 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -175.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 1.062 HG11 HG11 ' A' ' 19' ' ' VAL . 1.2 p -2.13 -96.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.988 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 20' ' ' SER . . . . . 0.971 ' O ' ' N ' ' B' ' 22' ' ' SER . 0.8 OUTLIER -134.09 23.74 3.86 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 177.496 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 1.042 ' HB ' HG23 ' B' ' 7' ' ' ILE . 28.6 m -9.93 -40.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 CA-C-O 122.415 1.102 . . . . 0.0 110.857 -178.177 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.971 ' N ' ' O ' ' B' ' 20' ' ' SER . 7.1 m -77.92 -39.68 42.1 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.264 178.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 23' ' ' LYS . . . . . 0.91 ' N ' ' O ' ' B' ' 20' ' ' SER . 1.3 mtmt -89.47 -25.71 21.32 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.478 -0.764 . . . . 0.0 111.113 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 24' ' ' MET . . . . . 0.67 ' SD ' ' HA ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -74.79 -40.59 61.05 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 117.529 -1.668 . . . . 0.0 108.795 179.225 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.781 HD12 HG13 ' B' ' 7' ' ' ILE . 0.5 OUTLIER -74.15 -40.47 62.58 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 117.708 -1.597 . . . . 0.0 107.291 176.804 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 26' ' ' ALA . . . . . 0.515 ' HA ' ' HE2' ' B' ' 3' ' ' LYS . . . -60.15 -33.38 72.09 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 177.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 27' ' ' SER . . . . . 0.676 ' HA ' ' HB3' ' B' ' 30' ' ' LYS . 18.6 m -78.63 -34.1 46.81 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.205 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 28' ' ' PHE . . . . . 0.864 ' O ' HG13 ' B' ' 31' ' ' ILE . 0.3 OUTLIER -60.72 -49.17 78.6 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.768 -0.582 . . . . 0.0 109.689 179.413 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 29' ' ' GLU . . . . . 0.829 ' HG2' HG22 ' A' ' 45' ' ' THR . 0.6 OUTLIER -71.89 -33.49 68.38 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 178.043 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 0.92 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 10.8 ttpp -68.59 -21.02 64.53 Favored 'General case' 0 C--O 1.189 -2.085 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 176.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.864 HG13 ' O ' ' B' ' 28' ' ' PHE . 1.2 pp -105.15 -28.8 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 120.557 -1.339 . . . . 0.0 109.198 178.653 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.645 HG21 ' HZ ' ' A' ' 47' ' ' PHE . 1.6 mm -69.64 -50.97 45.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 176.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 33' ' ' THR . . . . . 0.733 ' HB ' ' O ' ' B' ' 29' ' ' GLU . 0.3 OUTLIER -70.33 -40.21 74.29 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.46 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.92 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 39.4 mm-40 -73.91 -33.03 63.83 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.419 -0.801 . . . . 0.0 111.163 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 35' ' ' THR . . . . . 0.994 HG21 HG23 ' B' ' 42' ' ' VAL . 1.6 m -59.27 -48.75 80.45 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 120.53 -1.356 . . . . 0.0 107.531 178.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.863 ' CG1' ' HB2' ' A' ' 89' ' ' ALA . 1.2 t -56.12 -35.1 40.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 177.053 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 37' ' ' ALA . . . . . 0.662 ' HB2' ' C ' ' A' ' 88' ' ' ALA . . . -77.59 -1.35 30.32 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.534 0.683 . . . . 0.0 109.216 176.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 38' ' ' LYS . . . . . 0.427 ' H ' ' C ' ' B' ' 35' ' ' THR . 0.4 OUTLIER -115.68 -5.4 12.14 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.737 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.44 48.14 8.35 Favored Glycine 0 C--N 1.301 -1.378 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 40' ' ' ASP . . . . . 0.842 ' CB ' HG23 ' B' ' 35' ' ' THR . 0.1 OUTLIER -128.05 117.79 22.32 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.173 -1.192 . . . . 0.0 110.07 179.273 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 12.9 mtmt -70.51 80.82 0.57 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.492 -0.755 . . . . 0.0 109.954 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.994 HG23 HG21 ' B' ' 35' ' ' THR . 2.7 t -68.29 147.4 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.314 -0.866 . . . . 0.0 109.257 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 43' ' ' GLN . . . . . 0.446 ' O ' ' HA ' ' A' ' 2' ' ' ASN . 31.0 mt-30 -143.4 113.51 7.25 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.067 -1.021 . . . . 0.0 110.705 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.804 HD12 ' CB ' ' B' ' 48' ' ' LEU . 45.9 mt -73.98 120.11 19.11 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.271 -0.893 . . . . 0.0 109.939 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 45' ' ' THR . . . . . 0.547 ' HB ' ' HD2' ' A' ' 3' ' ' LYS . 0.0 OUTLIER 31.68 -96.19 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.757 -0.589 . . . . 0.0 110.583 179.793 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 46' ' ' GLY . . . . . 0.455 ' H ' HG23 ' B' ' 45' ' ' THR . . . -138.79 7.54 3.29 Favored Glycine 0 N--CA 1.482 1.732 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 47' ' ' PHE . . . . . 0.747 ' CE1' HG21 ' A' ' 32' ' ' ILE . 37.4 p90 -105.46 -54.99 2.39 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.588 -1.536 . . . . 0.0 111.76 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.804 ' CB ' HD12 ' B' ' 44' ' ' LEU . 0.2 OUTLIER -92.12 148.03 22.49 Favored 'General case' 0 C--N 1.292 -1.903 0 O-C-N 120.047 -1.658 . . . . 0.0 113.241 -178.849 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 49' ' ' ASN . . . . . 0.535 ' O ' ' HB ' ' B' ' 79' ' ' VAL . 1.4 m-20 -132.82 146.22 51.64 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 178.127 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 50' ' ' ILE . . . . . 0.917 ' HA ' HG21 ' B' ' 79' ' ' VAL . 26.8 mm -137.21 98.76 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 O-C-N 120.97 -1.081 . . . . 0.0 111.601 -178.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 51' ' ' LYS . . . . . 0.534 ' N ' ' CG1' ' B' ' 79' ' ' VAL . 2.5 pttt -145.56 126.29 7.34 Favored Pre-proline 0 N--CA 1.487 1.415 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 52' ' ' PRO . . . . . 0.765 ' CD ' HG22 ' B' ' 36' ' ' VAL . 55.6 Cg_endo -88.08 151.21 6.96 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.239 1.126 . . . . 0.0 111.849 -178.18 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.566 HG11 ' HB2' ' B' ' 78' ' ' SER . 14.0 m -133.14 118.64 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-O 121.506 0.67 . . . . 0.0 109.838 178.287 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 54' ' ' ALA . . . . . 0.881 ' HA ' ' HA ' ' B' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 122.694 1.235 . . . . 0.0 112.899 -177.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 75' ' ' VAL . . . . . 1.045 HG21 ' HB1' ' A' ' 89' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.519 2.989 0 CA-C-O 122.064 0.935 . . . . 0.0 111.248 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 76' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' B' ' 53' ' ' VAL . . . -140.64 -144.9 4.53 Favored Glycine 0 N--CA 1.483 1.772 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.467 HG23 ' HD2' ' A' ' 86' ' ' LYS . 7.6 t -140.9 85.64 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 78' ' ' SER . . . . . 0.566 ' HB2' HG11 ' B' ' 53' ' ' VAL . 0.3 OUTLIER -57.93 -50.58 72.88 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.53 0.681 . . . . 0.0 111.279 -179.139 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.917 HG21 ' HA ' ' B' ' 50' ' ' ILE . 17.7 m -51.54 -176.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -176.029 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 80' ' ' LYS . . . . . 0.739 ' HB2' ' HD2' ' B' ' 81' ' ' PRO . 0.0 OUTLIER 178.87 177.26 0.3 Allowed Pre-proline 0 N--CA 1.484 1.251 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.033 -178.727 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 81' ' ' PRO . . . . . 0.739 ' HD2' ' HB2' ' B' ' 80' ' ' LYS . 45.1 Cg_endo -72.54 137.61 28.12 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 123.508 1.268 . . . . 0.0 110.926 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 82' ' ' GLY . . . . . 0.576 ' N ' ' O ' ' B' ' 47' ' ' PHE . . . -94.92 -154.6 31.02 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 83' ' ' GLU . . . . . 0.51 ' HA ' ' HB2' ' B' ' 86' ' ' LYS . 16.4 pt-20 -88.05 -16.73 32.81 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.369 -1.077 . . . . 0.0 110.739 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 84' ' ' SER . . . . . 0.475 ' HB2' ' HB3' ' B' ' 47' ' ' PHE . 3.4 m -53.6 -37.14 62.72 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.067 -1.021 . . . . 0.0 109.51 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.84 HD13 HG21 ' A' ' 77' ' ' VAL . 0.5 OUTLIER -81.67 -33.26 31.37 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.717 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 86' ' ' LYS . . . . . 0.51 ' HB2' ' HA ' ' B' ' 83' ' ' GLU . 7.5 mttt -74.43 -27.46 60.62 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.382 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 1.3 ttmm -74.7 -39.16 62.11 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 177.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.686 ' HB1' ' HB2' ' A' ' 37' ' ' ALA . . . -64.8 -35.19 80.3 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 176.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.953 ' HA ' HD23 ' B' ' 92' ' ' LEU . . . -54.48 -45.43 73.21 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.454 -0.898 . . . . 0.0 109.19 178.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.9 -31.85 51.36 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 177.079 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 91' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' B' ' 88' ' ' ALA . . . -63.38 -38.65 96.73 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 178.663 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 92' ' ' LEU . . . . . 0.953 HD23 ' HA ' ' B' ' 89' ' ' ALA . 0.7 OUTLIER -75.46 15.17 0.49 Allowed 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.523 -1.575 . . . . 0.0 110.957 -179.823 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 93' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' B' ' 92' ' ' LEU . 22.3 mmtm 57.82 44.57 19.97 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 -177.241 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 94' ' ' TYR . . . . . 0.713 ' C ' ' CD1' ' B' ' 94' ' ' TYR . 0.1 OUTLIER -36.91 -36.37 0.12 Allowed 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.314 -178.829 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 95' ' ' GLU . . . . . 0.519 ' N ' ' CD1' ' B' ' 94' ' ' TYR . 8.8 pt-20 -57.25 -43.52 83.05 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.327 -0.858 . . . . 0.0 109.42 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 96' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' B' ' 93' ' ' LYS . 0.9 OUTLIER -61.81 -31.58 71.83 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 177.971 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.672 ' SD ' HG21 ' B' ' 35' ' ' THR . 3.5 ptm . . . . . 0 N--CA 1.496 1.857 0 CA-C-O 121.282 0.563 . . . . 0.0 110.732 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.568 ' C ' HD12 ' A' ' 6' ' ' LEU . 16.7 p-10 -177.17 -153.99 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 119.727 -0.789 . . . . 0.0 111.248 178.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.56 ' HE2' ' HA ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -52.41 -7.98 0.07 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.401 -0.812 . . . . 0.0 111.143 -179.812 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.606 ' O ' HG13 ' A' ' 7' ' ' ILE . 87.4 m -114.54 -64.26 1.34 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.17 -0.956 . . . . 0.0 109.903 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.577 ' HA ' ' CE ' ' A' ' 8' ' ' LYS . 0.4 OUTLIER -49.11 -41.01 34.43 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.915 -1.115 . . . . 0.0 109.096 179.577 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.649 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 28.2 mt -61.52 -35.05 76.62 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.335 -0.946 . . . . 0.0 109.621 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.652 ' N ' HD12 ' A' ' 25' ' ' LEU . 1.1 pp -57.2 -38.74 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 178.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.834 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 1.3 mtmp? -65.79 -40.11 91.6 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 177.294 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.857 ' CB ' HD13 ' B' ' 31' ' ' ILE . . . -51.61 -37.34 49.59 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.768 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.3 mp -91.98 -30.85 4.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 178.114 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.834 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -66.25 -9.57 33.72 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 118.575 -1.25 . . . . 0.0 108.497 178.101 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.435 ' CG ' ' N ' ' A' ' 13' ' ' ASP . 17.2 pt20 -119.59 -42.22 2.65 Favored 'General case' 0 N--CA 1.483 1.185 0 O-C-N 121.413 -0.805 . . . . 0.0 110.41 179.41 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 9' ' ' ALA . 6.6 m-20 -69.53 -33.73 73.21 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 177.458 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . 1.15 HG22 ' CD1' ' A' ' 16' ' ' LEU 0.273 0.2 OUTLIER -95.14 -71.41 0.67 Allowed 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.479 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 57.37 18.52 29.54 Favored Glycine 0 N--CA 1.5 2.91 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 177.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 1.15 ' CD1' HG22 ' A' ' 14' ' ' THR . 4.4 mp -63.82 -68.17 0.37 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.425 -1.044 . . . . 0.0 109.815 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.637 ' CG2' HG21 ' B' ' 17' ' ' THR . 0.6 OUTLIER -135.07 7.48 3.42 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.592 ' O ' ' C ' ' A' ' 19' ' ' VAL . 15.0 mt-30 57.88 26.92 13.89 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 -176.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 1.125 HG23 ' CD1' ' B' ' 16' ' ' LEU . 0.3 OUTLIER -5.92 -97.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.184 -179.128 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.98 ' O ' ' N ' ' A' ' 23' ' ' LYS . 1.7 p -135.63 25.01 3.42 Favored 'General case' 0 C--N 1.275 -2.653 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 178.211 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.571 ' C ' ' O ' ' A' ' 20' ' ' SER . 27.4 m -19.15 -38.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 CA-C-O 122.284 1.04 . . . . 0.0 110.435 -178.256 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.803 ' N ' ' O ' ' A' ' 20' ' ' SER . 25.4 p -79.3 -36.26 39.92 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.16 178.252 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.98 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.2 OUTLIER -91.82 -32.65 15.27 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.779 -0.576 . . . . 0.0 111.642 179.811 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.635 ' N ' ' OG ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -72.8 -30.31 63.97 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 117.764 -1.574 . . . . 0.0 108.061 179.385 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.652 HD12 ' N ' ' A' ' 7' ' ' ILE . 2.2 mt -82.01 -37.58 26.36 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 118.741 -1.184 . . . . 0.0 107.895 177.141 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.56 ' HA ' ' HE2' ' A' ' 3' ' ' LYS . . . -67.6 -34.04 76.21 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 177.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 31' ' ' ILE . 61.1 p -82.56 -30.51 29.62 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.19 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.66 ' O ' HG13 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -52.48 -45.61 66.22 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.335 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.747 ' HG3' ' CD1' ' B' ' 47' ' ' PHE . 0.5 OUTLIER -69.62 -36.58 76.27 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 176.856 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 1.116 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 13.1 tttt -62.26 -23.42 66.68 Favored 'General case' 0 C--O 1.19 -2.058 0 C-N-CA 119.275 -0.97 . . . . 0.0 108.434 178.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.939 HD13 ' HB1' ' B' ' 9' ' ' ALA . 0.5 OUTLIER -103.61 -28.39 3.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 120.589 -1.319 . . . . 0.0 109.202 178.141 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.636 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.2 mm -72.56 -56.15 10.79 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 177.225 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.894 ' HA ' HD23 ' B' ' 85' ' ' LEU . 0.4 OUTLIER -69.67 -36.45 76.03 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.4 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 1.116 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 44.5 mm-40 -74.31 -35.46 63.68 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.084 -1.01 . . . . 0.0 110.696 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.652 HG23 ' CB ' ' A' ' 40' ' ' ASP . 2.2 m -58.58 -51.51 69.57 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.63 -1.294 . . . . 0.0 108.248 178.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.681 HG22 ' HD3' ' A' ' 52' ' ' PRO . 0.9 OUTLIER -54.11 -35.71 29.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 177.792 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.73 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -82.23 -4.2 56.63 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.629 0.728 . . . . 0.0 109.416 178.008 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -101.07 -26.39 13.71 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.087 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.84 39.23 1.6 Allowed Glycine 0 C--N 1.301 -1.4 0 C-N-CA 120.092 -1.052 . . . . 0.0 110.906 177.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.652 ' CB ' HG23 ' A' ' 35' ' ' THR . 0.1 OUTLIER -132.47 134.23 44.8 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.067 -1.255 . . . . 0.0 110.274 179.384 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.87 92.24 6.09 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.584 -0.697 . . . . 0.0 109.887 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.532 HG13 HD11 ' B' ' 6' ' ' LEU . 58.2 t -59.29 132.97 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.589 -0.694 . . . . 0.0 109.868 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -129.7 89.21 2.79 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.335 -0.853 . . . . 0.0 110.178 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.773 HD12 ' HB3' ' A' ' 48' ' ' LEU . 10.7 mt -59.92 107.6 0.64 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.295 -0.878 . . . . 0.0 109.516 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.457 ' CG2' ' C ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER 34.11 -90.67 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.308 0 O-C-N 122.0 -0.438 . . . . 0.0 110.953 -179.457 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -151.01 28.32 1.01 Allowed Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.997 ' CE1' HG21 ' B' ' 32' ' ' ILE . 1.6 p90 -129.98 -26.3 2.42 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.17 -1.194 . . . . 0.0 111.922 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.773 ' HB3' HD12 ' A' ' 44' ' ' LEU . 4.6 mt -128.95 96.02 4.24 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.568 -1.332 . . . . 0.0 110.867 178.382 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -102.05 86.35 2.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.66 -0.65 . . . . 0.0 110.576 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.567 HD13 HG23 ' A' ' 79' ' ' VAL . 6.9 mm -73.22 131.9 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.409 ' HG3' ' CB ' ' A' ' 78' ' ' SER . 1.7 ptmt -145.52 113.99 4.76 Favored Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 120.613 -1.304 . . . . 0.0 111.129 -179.39 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.681 ' HD3' HG22 ' A' ' 36' ' ' VAL . 54.7 Cg_endo -78.48 143.81 19.63 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 O-C-N 123.638 1.336 . . . . 0.0 111.135 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.655 HG22 ' O ' ' A' ' 76' ' ' GLY . 24.2 m -142.33 116.86 4.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-O 121.582 0.706 . . . . 0.0 110.395 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.459 ' HB2' ' HB3' ' B' ' 97' ' ' PHE . . . . . . . . 0 N--CA 1.499 1.995 0 CA-C-O 121.917 0.865 . . . . 0.0 112.404 -178.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.634 ' HB ' ' HB2' ' B' ' 94' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.501 2.097 0 CA-C-O 121.202 0.525 . . . . 0.0 110.059 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.655 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -101.85 77.83 0.36 Allowed Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.889 HG21 ' CB ' ' B' ' 85' ' ' LEU . 4.4 p -59.54 74.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.576 -0.955 . . . . 0.0 110.3 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.565 ' N ' ' O ' ' A' ' 76' ' ' GLY . 0.6 OUTLIER -67.68 177.34 2.07 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.524 -0.87 . . . . 0.0 109.824 179.585 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.567 HG23 HD13 ' A' ' 50' ' ' ILE . 0.8 OUTLIER 176.62 175.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -179.82 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.689 ' O ' HD23 ' A' ' 48' ' ' LEU . 2.3 ptpt -177.18 172.23 0.83 Allowed Pre-proline 0 N--CA 1.486 1.362 0 O-C-N 121.161 -0.962 . . . . 0.0 110.176 177.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.501 ' HB2' HG13 ' B' ' 77' ' ' VAL . 55.2 Cg_endo -98.77 133.38 0.25 Allowed 'Trans proline' 0 C--N 1.302 -1.901 0 C-N-CA 122.542 2.161 . . . . 0.0 110.489 178.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.546 ' HA3' ' HA ' ' A' ' 47' ' ' PHE . . . -92.09 177.78 40.0 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 108.382 -1.887 . . . . 0.0 108.382 178.618 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.415 ' HA ' ' HB2' ' A' ' 86' ' ' LYS . 0.1 OUTLIER -67.89 -18.25 64.73 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.115 -1.226 . . . . 0.0 110.676 -179.788 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.46 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -51.92 -39.89 59.87 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.119 -0.988 . . . . 0.0 109.401 179.8 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.902 HD21 ' CD1' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -75.66 -34.32 60.48 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.744 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.632 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 0.8 OUTLIER -72.94 -43.82 61.9 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.961 -179.257 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -61.46 -40.82 95.89 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 178.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.779 ' O ' ' HB1' ' B' ' 37' ' ' ALA . . . -66.68 -36.24 82.05 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 176.22 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 1.061 ' CB ' HG11 ' B' ' 75' ' ' VAL . . . -58.56 -34.36 70.96 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -55.98 -34.54 65.84 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 176.252 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.423 ' C ' ' H ' ' A' ' 93' ' ' LYS . . . -61.54 -44.54 97.85 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 178.032 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.824 ' O ' HD12 ' A' ' 92' ' ' LEU . 0.6 OUTLIER -58.07 -2.59 0.18 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.707 -1.467 . . . . 0.0 111.212 179.699 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.512 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 6.7 mmmt 68.1 58.97 0.45 Allowed 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -177.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.401 ' C ' ' O ' ' A' ' 93' ' ' LYS . 23.5 t80 -37.41 -33.97 0.08 Allowed 'General case' 0 N--CA 1.494 1.775 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.21 -179.066 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 . . . . . 0 N--CA 1.494 1.748 0 O-C-N 121.155 -0.966 . . . . 0.0 109.083 179.208 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.633 ' HG2' ' HB3' ' B' ' 5' ' ' GLU . 24.2 mtp . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 2' ' ' ASN . . . . . 0.554 ' O ' ' HB2' ' B' ' 6' ' ' LEU . 19.5 p-10 -175.4 -162.63 0.11 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.167 -0.958 . . . . 0.0 111.299 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.515 ' O ' ' CG2' ' B' ' 7' ' ' ILE . 0.0 OUTLIER -57.1 -3.52 0.14 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.423 -0.798 . . . . 0.0 110.885 -179.888 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 4' ' ' THR . . . . . 0.678 ' O ' HG13 ' B' ' 7' ' ' ILE . 96.8 m -117.93 -60.71 1.77 Allowed 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 122.167 0.984 . . . . 0.0 109.101 179.068 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.633 ' HB3' ' HG2' ' B' ' 1' ' ' MET . 0.4 OUTLIER -52.04 -44.74 64.37 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.098 -1.001 . . . . 0.0 109.013 179.27 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.661 ' O ' ' HB3' ' B' ' 9' ' ' ALA . 1.9 mt -61.18 -32.1 71.84 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.191 -1.004 . . . . 0.0 109.966 178.451 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 7' ' ' ILE . . . . . 0.74 HG22 HD12 ' B' ' 25' ' ' LEU . 0.9 OUTLIER -57.7 -40.79 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 179.1 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 8' ' ' LYS . . . . . 0.852 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 1.0 OUTLIER -64.87 -37.79 88.81 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 177.484 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 9' ' ' ALA . . . . . 0.939 ' HB1' HD13 ' A' ' 31' ' ' ILE . . . -52.33 -38.3 58.22 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 120.15 -0.62 . . . . 0.0 109.618 179.359 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.736 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.3 mp -93.73 -29.19 4.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 178.209 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.852 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -66.8 -16.25 64.14 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.815 -1.178 . . . . 0.0 108.329 178.048 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.431 ' CG ' ' N ' ' B' ' 13' ' ' ASP . 17.7 pt20 -108.62 -41.91 4.67 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.515 -0.741 . . . . 0.0 109.098 178.647 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.431 ' N ' ' CG ' ' B' ' 12' ' ' GLN . 1.1 m-20 -68.78 -22.55 64.27 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 176.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 14' ' ' THR . . . . . 0.736 ' OG1' ' O ' ' B' ' 10' ' ' ILE . 0.2 OUTLIER -120.32 -83.14 0.65 Allowed 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.363 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 15' ' ' GLY . . . . . 0.511 ' O ' ' C ' ' B' ' 16' ' ' LEU . . . 69.36 -21.01 0.42 Allowed Glycine 0 N--CA 1.498 2.779 0 O-C-N 120.924 -1.11 . . . . 0.0 110.65 178.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 16' ' ' LEU . . . . . 1.125 ' CD1' HG23 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -29.21 -59.45 0.14 Allowed 'General case' 0 N--CA 1.517 2.876 0 CA-C-O 122.008 0.908 . . . . 0.0 110.712 -179.608 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 17' ' ' THR . . . . . 0.662 HG22 ' H ' ' B' ' 19' ' ' VAL . 0.5 OUTLIER -132.7 -2.75 3.32 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -179.927 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 18' ' ' GLN . . . . . 0.618 ' O ' ' C ' ' B' ' 19' ' ' VAL . 8.2 mt-30 56.56 30.97 18.21 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -176.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 1.109 HG11 HG11 ' A' ' 19' ' ' VAL . 2.0 p -8.74 -97.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.802 -179.059 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 20' ' ' SER . . . . . 0.92 ' O ' ' N ' ' B' ' 23' ' ' LYS . 0.4 OUTLIER -132.94 22.08 4.17 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 177.449 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.669 HG12 HG22 ' B' ' 10' ' ' ILE . 27.9 m -18.51 -38.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-O 122.401 1.096 . . . . 0.0 109.255 -178.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.91 ' N ' ' O ' ' B' ' 20' ' ' SER . 26.5 t -79.16 -44.92 20.98 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.19 177.497 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 23' ' ' LYS . . . . . 0.92 ' N ' ' O ' ' B' ' 20' ' ' SER . 5.9 mtmt -89.69 -21.56 22.68 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.431 -0.793 . . . . 0.0 109.889 178.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 24' ' ' MET . . . . . 0.621 ' HE2' ' HA ' ' B' ' 21' ' ' VAL 0.263 2.2 tmm? -68.89 -38.93 79.95 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 178.653 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.74 HD12 HG22 ' B' ' 7' ' ' ILE . 8.3 mt -73.97 -41.38 62.03 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 176.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 26' ' ' ALA . . . . . 0.553 ' HB3' ' HA ' ' B' ' 23' ' ' LYS . . . -58.03 -34.51 70.13 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 177.487 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 27' ' ' SER . . . . . 0.485 ' O ' ' HB3' ' B' ' 30' ' ' LYS . 6.2 m -79.59 -33.49 41.58 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.136 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 28' ' ' PHE . . . . . 0.673 ' O ' HG13 ' B' ' 31' ' ' ILE . 2.8 t80 -60.74 -57.46 12.58 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 178.427 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 29' ' ' GLU . . . . . 0.744 ' HG3' ' CD2' ' A' ' 47' ' ' PHE . 2.3 tt0 -58.04 -31.85 67.41 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 118.216 -1.394 . . . . 0.0 107.637 177.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 1.174 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 24.1 ttmm -67.42 -26.79 66.6 Favored 'General case' 0 C--O 1.191 -1.988 0 C-N-CA 119.344 -0.942 . . . . 0.0 108.487 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.857 HD13 ' CB ' ' A' ' 9' ' ' ALA . 0.3 OUTLIER -98.57 -30.21 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 120.344 -1.473 . . . . 0.0 109.598 178.169 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.997 HG21 ' CE1' ' A' ' 47' ' ' PHE . 1.8 mp -67.85 -66.37 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.14 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 33' ' ' THR . . . . . 0.895 ' HA ' HD23 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -60.78 -37.64 82.6 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.254 -179.082 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 1.174 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 62.3 mm-40 -73.13 -40.07 65.2 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 119.366 -0.934 . . . . 0.0 111.048 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 35' ' ' THR . . . . . 0.672 HG21 ' SD ' ' A' ' 1' ' ' MET . 23.6 m -61.7 -49.46 76.4 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 118.316 -1.354 . . . . 0.0 109.423 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.803 HG21 HG23 ' B' ' 77' ' ' VAL . 0.6 OUTLIER -50.82 -43.26 24.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 C-N-CA 118.918 -1.113 . . . . 0.0 108.027 179.195 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 37' ' ' ALA . . . . . 0.779 ' HB1' ' O ' ' A' ' 88' ' ' ALA . . . -88.22 -4.01 58.78 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.69 0.757 . . . . 0.0 109.773 178.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 38' ' ' LYS . . . . . 0.712 ' HB2' ' O ' ' B' ' 34' ' ' GLU . 0.0 OUTLIER -88.56 -26.16 22.13 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 176.958 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 117.14 39.69 0.79 Allowed Glycine 0 C--N 1.302 -1.323 0 C-N-CA 120.194 -1.003 . . . . 0.0 110.968 177.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 40' ' ' ASP . . . . . 0.636 ' HB2' HG23 ' B' ' 35' ' ' THR . 0.3 OUTLIER -145.44 161.27 40.11 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.902 -1.351 . . . . 0.0 110.718 179.475 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.409 ' HG3' ' HD2' ' B' ' 52' ' ' PRO . 3.5 mppt? -107.04 96.76 6.66 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.561 -0.712 . . . . 0.0 110.045 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.607 HG13 HD11 ' A' ' 6' ' ' LEU . 91.4 t -60.22 120.0 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.498 -0.751 . . . . 0.0 109.813 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 43' ' ' GLN . . . . . 0.421 ' O ' ' HA ' ' A' ' 2' ' ' ASN . 0.7 OUTLIER -108.96 103.02 11.98 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.277 -0.889 . . . . 0.0 110.117 -179.431 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.741 HD12 ' CB ' ' B' ' 48' ' ' LEU . 12.6 mt -75.75 100.26 4.65 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.001 -1.062 . . . . 0.0 109.286 179.298 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 45' ' ' THR . . . . . 0.552 HG21 ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 35.07 -93.88 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.913 -0.492 . . . . 0.0 111.224 -179.61 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 46' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -147.65 28.47 1.46 Allowed Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.715 -1.231 . . . . 0.0 110.17 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 47' ' ' PHE . . . . . 0.747 ' CD1' ' HG3' ' A' ' 29' ' ' GLU . 4.2 p90 -129.2 -23.58 2.97 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.969 -1.313 . . . . 0.0 111.594 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.917 HD23 ' O ' ' B' ' 80' ' ' LYS . 7.7 mt -128.73 106.03 8.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.482 -1.386 . . . . 0.0 110.711 178.154 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 49' ' ' ASN . . . . . 0.534 ' O ' ' HA ' ' B' ' 79' ' ' VAL . 0.6 OUTLIER -101.21 86.56 3.04 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.725 -0.609 . . . . 0.0 110.56 -179.385 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 50' ' ' ILE . . . . . 0.861 HG23 HG12 ' B' ' 79' ' ' VAL . 12.3 mm -84.33 128.43 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.383 -0.823 . . . . 0.0 109.836 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 51' ' ' LYS . . . . . 0.418 ' O ' ' HG3' ' B' ' 51' ' ' LYS . 0.0 OUTLIER -152.25 123.98 3.81 Favored Pre-proline 0 N--CA 1.501 2.078 0 O-C-N 120.87 -1.144 . . . . 0.0 110.972 -179.878 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 52' ' ' PRO . . . . . 0.62 ' HG3' ' HA ' ' B' ' 36' ' ' VAL . 57.1 Cg_endo -84.93 141.8 8.58 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 123.406 1.214 . . . . 0.0 111.454 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.622 HG22 ' O ' ' B' ' 76' ' ' GLY . 30.0 m -143.79 112.31 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-O 121.9 0.857 . . . . 0.0 110.673 178.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 54' ' ' ALA . . . . . 0.81 ' HA ' ' HA ' ' B' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.495 1.81 0 O-C-N 121.727 -0.608 . . . . 0.0 110.952 -179.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 75' ' ' VAL . . . . . 1.061 HG11 ' CB ' ' A' ' 89' ' ' ALA . 12.2 p . . . . . 0 N--CA 1.508 2.468 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 76' ' ' GLY . . . . . 0.622 ' O ' HG22 ' B' ' 53' ' ' VAL . . . -125.9 73.62 0.43 Allowed Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.24 -1.457 . . . . 0.0 109.792 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.893 HG21 ' CB ' ' A' ' 85' ' ' LEU . 3.7 p -61.69 72.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.544 -0.974 . . . . 0.0 109.326 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 78' ' ' SER . . . . . 0.84 ' O ' HG13 ' B' ' 79' ' ' VAL . 0.1 OUTLIER -64.3 176.26 1.1 Allowed 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.454 -0.898 . . . . 0.0 109.986 -179.709 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.861 HG12 HG23 ' B' ' 50' ' ' ILE . 16.9 m -172.37 179.0 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 80' ' ' LYS . . . . . 0.917 ' O ' HD23 ' B' ' 48' ' ' LEU . 0.1 OUTLIER 179.3 170.58 0.55 Allowed Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 120.833 -1.167 . . . . 0.0 111.12 176.8 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 81' ' ' PRO . . . . . 0.617 ' HB2' HG13 ' A' ' 77' ' ' VAL . 56.2 Cg_endo -102.27 133.37 0.13 Allowed 'Trans proline' 0 C--N 1.303 -1.832 0 C-N-CA 123.076 2.517 . . . . 0.0 110.252 177.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 82' ' ' GLY . . . . . 0.514 ' HA3' ' HA ' ' B' ' 47' ' ' PHE . . . -96.96 171.09 26.84 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 107.955 -2.058 . . . . 0.0 107.955 178.274 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 83' ' ' GLU . . . . . 0.515 ' HA ' ' HB2' ' B' ' 86' ' ' LYS . 3.5 pm0 -59.75 -19.15 48.41 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.99 -1.3 . . . . 0.0 110.674 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 84' ' ' SER . . . . . 0.498 ' CB ' ' HB3' ' B' ' 47' ' ' PHE . 0.4 OUTLIER -52.08 -38.03 55.9 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.101 -0.999 . . . . 0.0 109.552 179.6 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.894 HD23 ' HA ' ' A' ' 33' ' ' THR . 1.0 OUTLIER -78.46 -33.07 48.63 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.471 -0.768 . . . . 0.0 108.951 178.617 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 86' ' ' LYS . . . . . 0.615 ' O ' ' HB3' ' B' ' 89' ' ' ALA . 0.6 OUTLIER -73.71 -42.42 61.23 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.493 -179.274 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 7.3 tttp -64.5 -39.77 94.4 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 177.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.65 ' HB1' ' HB2' ' A' ' 37' ' ' ALA . . . -66.91 -34.48 77.87 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 176.496 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.997 ' HA ' HD23 ' B' ' 92' ' ' LEU . . . -57.18 -44.6 83.7 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.471 -0.768 . . . . 0.0 109.222 179.182 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 90' ' ' GLU . . . . . 0.41 ' HG2' ' N ' ' B' ' 91' ' ' GLY . 1.4 pt-20 -53.88 -31.82 51.16 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 177.386 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 91' ' ' GLY . . . . . 0.41 ' N ' ' HG2' ' B' ' 90' ' ' GLU . . . -67.14 -33.8 84.3 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 178.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 92' ' ' LEU . . . . . 0.997 HD23 ' HA ' ' B' ' 89' ' ' ALA . 0.4 OUTLIER -77.51 13.07 1.34 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.648 -1.501 . . . . 0.0 111.438 -179.553 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 93' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' B' ' 92' ' ' LEU . 34.9 mmtt 58.53 39.53 24.8 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -177.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 94' ' ' TYR . . . . . 0.634 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -42.07 -33.58 0.6 Allowed 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.449 -179.14 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 95' ' ' GLU . . . . . 0.481 ' N ' ' CD1' ' B' ' 94' ' ' TYR . 2.5 pp20? -61.62 -39.92 93.0 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.383 -0.823 . . . . 0.0 109.467 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.66 -34.82 76.38 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 177.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 97' ' ' PHE . . . . . 0.459 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.459 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 178.307 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.555 ' HG2' ' HB3' ' A' ' 5' ' ' GLU . 2.7 mtp . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 120.892 0.377 . . . . 0.0 110.184 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.481 ' N ' HG23 ' B' ' 42' ' ' VAL . 39.2 p-10 179.56 -167.57 0.09 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.184 -0.947 . . . . 0.0 111.21 179.373 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.871 ' HG2' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -55.47 -11.68 0.91 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.568 -0.708 . . . . 0.0 110.326 179.794 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.713 ' O ' HG12 ' A' ' 7' ' ' ILE . 53.7 m -104.02 -55.25 2.4 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 122.113 0.959 . . . . 0.0 109.286 179.15 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.693 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 0.2 OUTLIER -57.13 -49.6 75.42 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.068 -1.02 . . . . 0.0 109.14 179.427 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.918 HD11 HG21 ' B' ' 42' ' ' VAL . 15.7 mt -49.93 -40.81 44.7 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 119.322 -0.951 . . . . 0.0 110.396 178.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.713 HG12 ' O ' ' A' ' 4' ' ' THR . 0.7 OUTLIER -57.47 -45.33 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.238 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.87 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 28.6 mtmt -56.36 -37.17 69.67 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 177.172 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.878 ' CB ' HD13 ' B' ' 31' ' ' ILE . . . -54.9 -37.56 66.49 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.736 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.5 mp -88.26 -33.81 6.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 178.316 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.87 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -65.85 -13.05 58.86 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 119.158 -1.017 . . . . 0.0 108.818 178.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -117.08 -39.65 3.2 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 121.449 -0.782 . . . . 0.0 109.652 178.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.45 ' HB3' ' HB2' ' B' ' 27' ' ' SER . 1.5 m-20 -66.97 -30.15 70.19 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 177.02 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.784 HG22 HD11 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -104.66 -75.31 0.63 Allowed 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 114.339 -1.3 . . . . 0.0 108.19 178.983 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 51.14 15.79 1.73 Allowed Glycine 0 N--CA 1.494 2.522 0 C-N-CA 120.306 -0.95 . . . . 0.0 110.883 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 1.073 ' CD1' HG23 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -73.06 -27.66 61.87 Favored 'General case' 0 N--CA 1.508 2.432 0 O-C-N 121.073 -1.251 . . . . 0.0 107.963 178.812 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.759 HG21 HG21 ' B' ' 17' ' ' THR . 0.4 OUTLIER -159.6 -12.39 0.06 Allowed 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.552 -179.861 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.706 ' O ' ' C ' ' A' ' 19' ' ' VAL . 21.1 mt-30 58.24 34.37 24.04 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 -177.08 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.924 ' CG2' HD13 ' B' ' 16' ' ' LEU . 0.2 OUTLIER 0.69 -94.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -178.875 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . 1.106 ' O ' ' N ' ' A' ' 22' ' ' SER . 18.7 p -135.06 21.74 3.49 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 175.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.594 ' C ' ' O ' ' A' ' 20' ' ' SER . 33.9 m -4.44 -38.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 122.451 1.119 . . . . 0.0 111.061 -178.461 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . 1.106 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.5 OUTLIER -75.24 -41.61 57.1 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-N 115.008 -0.997 . . . . 0.0 108.622 177.629 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.885 ' N ' ' O ' ' A' ' 20' ' ' SER . 2.5 mtpt -90.7 -30.8 16.88 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.549 -0.72 . . . . 0.0 109.502 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.581 ' HE2' ' HA ' ' A' ' 21' ' ' VAL . 2.0 tmm? -61.63 -29.73 70.25 Favored 'General case' 0 C--O 1.215 -0.717 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.448 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.871 HD13 ' HG2' ' A' ' 3' ' ' LYS . 1.2 pp -81.97 -44.39 16.78 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.321 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.642 ' N ' HD12 ' A' ' 25' ' ' LEU . . . -63.61 -23.73 67.5 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 178.489 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.507 ' O ' ' CG1' ' A' ' 31' ' ' ILE . 7.9 m -85.14 -40.98 16.11 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.136 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.687 ' CE1' HD22 ' B' ' 44' ' ' LEU . 0.0 OUTLIER -58.97 -45.52 90.36 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.853 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.6 ' HG3' ' CE2' ' B' ' 47' ' ' PHE . 0.8 OUTLIER -69.02 -37.37 78.6 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.046 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 1.256 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 20.2 tttt -62.37 -22.02 65.79 Favored 'General case' 0 C--O 1.193 -1.883 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.049 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.634 HG13 ' O ' ' A' ' 28' ' ' PHE . 0.6 OUTLIER -106.81 -27.72 2.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 120.144 -1.597 . . . . 0.0 109.482 178.013 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.623 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.3 mm -74.02 -59.47 3.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 177.076 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.685 ' HA ' HD23 ' B' ' 85' ' ' LEU . 0.7 OUTLIER -70.51 -32.59 70.12 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.393 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 1.256 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 71.7 mm-40 -81.75 -27.31 33.9 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 121.125 -0.984 . . . . 0.0 111.676 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.605 ' HA ' ' HB2' ' A' ' 38' ' ' LYS . 3.1 m -70.57 -55.39 8.97 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 117.496 -1.682 . . . . 0.0 108.437 178.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.953 HG11 HG23 ' A' ' 77' ' ' VAL . 87.1 t -55.2 -40.96 58.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.54 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.782 ' HB1' ' C ' ' B' ' 88' ' ' ALA . . . -68.93 -22.2 64.16 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.651 ' N ' HD12 ' B' ' 92' ' ' LEU . 13.4 mtmt -82.32 -25.48 33.88 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 177.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 35' ' ' THR . . . 104.06 30.79 4.97 Favored Glycine 0 C--N 1.295 -1.722 0 C-N-CA 120.133 -1.032 . . . . 0.0 110.653 177.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.567 ' CB ' HG23 ' A' ' 35' ' ' THR . 0.3 OUTLIER -117.25 138.22 51.87 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.225 -1.162 . . . . 0.0 110.018 179.545 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -72.18 82.55 1.0 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.461 -0.774 . . . . 0.0 110.638 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.624 ' CG2' HD11 ' B' ' 6' ' ' LEU . 14.8 p -73.36 140.96 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.47 -0.769 . . . . 0.0 109.654 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.417 ' HG3' ' OD1' ' B' ' 2' ' ' ASN . 1.6 pt20 -149.1 163.18 38.31 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.009 -1.057 . . . . 0.0 111.462 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.641 HD12 ' HB2' ' A' ' 48' ' ' LEU . 23.4 mt -106.94 109.28 21.14 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.408 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.53 HG21 ' HG3' ' B' ' 29' ' ' GLU . 0.0 OUTLIER 35.8 -95.11 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.743 -0.598 . . . . 0.0 111.378 -178.854 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -139.47 10.49 3.22 Favored Glycine 0 N--CA 1.488 2.105 0 C-N-CA 119.52 -1.324 . . . . 0.0 111.034 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.898 ' HD1' HD11 ' A' ' 85' ' ' LEU . 23.6 p90 -105.11 -20.31 13.56 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.604 -1.527 . . . . 0.0 110.695 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.641 ' HB2' HD12 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -132.81 147.67 52.31 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.13 -0.981 . . . . 0.0 111.666 178.505 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -154.08 116.28 4.31 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.773 -0.58 . . . . 0.0 109.718 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.613 HG21 HG21 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -109.54 155.1 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.212 -0.93 . . . . 0.0 110.522 -179.657 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 9.0 ptmt -162.19 126.78 2.04 Favored Pre-proline 0 N--CA 1.498 1.939 0 C-N-CA 118.803 -1.159 . . . . 0.0 110.96 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.717 ' HG3' ' O ' ' A' ' 36' ' ' VAL . 53.9 Cg_endo -87.05 144.29 7.09 Favored 'Trans proline' 0 C--N 1.316 -1.17 0 O-C-N 123.405 1.213 . . . . 0.0 110.888 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.637 HG22 ' O ' ' A' ' 76' ' ' GLY . 25.8 m -143.85 116.59 3.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-O 121.599 0.714 . . . . 0.0 110.278 179.415 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.538 ' HB2' ' HB3' ' B' ' 97' ' ' PHE . . . . . . . . 0 N--CA 1.5 2.035 0 CA-C-O 121.62 0.724 . . . . 0.0 112.318 -178.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.565 HG11 ' HB1' ' B' ' 89' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.783 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.637 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -110.74 64.02 0.27 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.953 HG23 HG11 ' A' ' 36' ' ' VAL . 7.5 p -54.86 75.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.531 -0.982 . . . . 0.0 110.75 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.626 ' N ' ' O ' ' A' ' 76' ' ' GLY . 29.9 t -79.78 178.72 7.98 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.294 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.593 HG12 ' C ' ' A' ' 78' ' ' SER . 0.2 OUTLIER 179.27 172.96 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.463 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.56 ' N ' ' CG2' ' A' ' 79' ' ' VAL . 0.1 OUTLIER 177.28 173.8 0.33 Allowed Pre-proline 0 C--N 1.299 -1.616 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 177.814 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.668 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 52.5 Cg_endo -85.87 174.59 6.41 Favored 'Trans proline' 0 C--N 1.294 -2.294 0 O-C-N 123.648 1.341 . . . . 0.0 110.106 177.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -115.84 -68.58 0.43 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 105.289 -3.124 . . . . 0.0 105.289 177.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.863 ' O ' ' N ' ' A' ' 85' ' ' LEU . 37.8 tt0 -87.33 53.13 2.7 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 174.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' SER . . . . . 1.312 ' O ' ' N ' ' A' ' 86' ' ' LYS . 1.9 m 9.62 44.31 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 122.386 1.089 . . . . 0.0 110.854 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 1.067 HD13 HG21 ' B' ' 77' ' ' VAL . 3.6 mp 21.6 29.58 0.0 OUTLIER 'General case' 0 C--O 1.195 -1.802 0 N-CA-C 103.685 -2.709 . . . . 0.0 103.685 -172.411 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 1.312 ' N ' ' O ' ' A' ' 84' ' ' SER 0.339 9.7 tttt -55.59 -36.66 67.14 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 104.261 -2.496 . . . . 0.0 104.261 176.732 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.292 14.0 tttt -75.99 -31.59 59.03 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 111.625 -2.534 . . . . 0.0 106.5 176.462 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 1.001 ' HB3' ' HB3' ' A' ' 85' ' ' LEU . . . -82.21 -20.48 37.67 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 118.53 -1.268 . . . . 0.0 108.755 179.132 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 1.021 ' HA ' HD23 ' A' ' 92' ' ' LEU . . . -80.99 -43.94 18.87 Favored 'General case' 0 C--N 1.293 -1.888 0 O-C-N 120.941 -1.099 . . . . 0.0 108.587 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.7 -30.46 67.43 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 177.226 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.789 ' HA3' ' HB1' ' B' ' 37' ' ' ALA . . . -71.63 -33.83 63.37 Favored Glycine 0 N--CA 1.489 2.18 0 C-N-CA 120.279 -0.962 . . . . 0.0 110.837 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 1.021 HD23 ' HA ' ' A' ' 89' ' ' ALA . 0.4 OUTLIER -81.07 20.84 0.76 Allowed 'General case' 0 N--CA 1.504 2.241 0 O-C-N 120.371 -1.664 . . . . 0.0 110.764 -179.807 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.2 37.46 28.38 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -178.397 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.522 ' HB2' ' HB ' ' B' ' 75' ' ' VAL . 0.0 OUTLIER -39.18 -33.94 0.16 Allowed 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.61 -179.21 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.44 ' HG2' ' CE2' ' A' ' 94' ' ' TYR . 46.1 mt-10 . . . . . 0 N--CA 1.493 1.701 0 O-C-N 121.439 -0.788 . . . . 0.0 109.305 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.544 ' HE2' ' HG ' ' B' ' 6' ' ' LEU . 5.2 mtp . . . . . 0 N--CA 1.493 1.69 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 2' ' ' ASN . . . . . 0.443 ' N ' ' HB2' ' B' ' 5' ' ' GLU . 12.2 t30 -177.22 178.01 1.15 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.207 -0.933 . . . . 0.0 110.816 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.545 ' NZ ' ' O ' ' B' ' 25' ' ' LEU . 1.7 mttm -44.53 -23.29 0.11 Allowed 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.49 -0.756 . . . . 0.0 110.58 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 4' ' ' THR . . . . . 0.506 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 13.4 m -102.94 -43.9 5.39 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.165 -0.96 . . . . 0.0 109.309 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.482 ' O ' ' CG ' ' B' ' 8' ' ' LYS . 0.1 OUTLIER -62.06 -46.51 88.82 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.153 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.679 ' O ' ' HB3' ' B' ' 9' ' ' ALA . 1.6 mt -66.13 -29.23 69.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.944 -1.098 . . . . 0.0 109.154 178.122 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 7' ' ' ILE . . . . . 0.875 HG23 ' HB ' ' B' ' 21' ' ' VAL . 0.3 OUTLIER -56.79 -59.77 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.638 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 8' ' ' LYS . . . . . 0.953 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 19.9 pttt -61.13 -25.87 67.29 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.512 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 9' ' ' ALA . . . . . 0.679 ' HB3' ' O ' ' B' ' 6' ' ' LEU . . . -58.56 -38.29 77.53 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.018 -1.051 . . . . 0.0 108.744 178.5 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.862 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.1 mp -90.62 -35.99 7.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 177.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.953 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -62.42 -12.82 23.89 Favored 'General case' 0 C--N 1.293 -1.851 0 C-N-CA 118.783 -1.167 . . . . 0.0 108.689 177.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.465 ' HB3' ' O ' ' B' ' 8' ' ' LYS . 6.9 tp-100 -113.79 -44.26 3.2 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.501 -0.749 . . . . 0.0 109.284 178.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.547 ' OD2' HG23 ' A' ' 31' ' ' ILE . 1.7 m-20 -64.29 -33.26 75.42 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 14' ' ' THR . . . . . 1.07 HG22 HD11 ' B' ' 16' ' ' LEU 0.253 0.2 OUTLIER -98.77 -69.53 0.76 Allowed 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 178.348 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 57.86 22.2 46.96 Favored Glycine 0 N--CA 1.501 2.98 0 O-C-N 121.398 -0.814 . . . . 0.0 111.585 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 16' ' ' LEU . . . . . 1.07 HD11 HG22 ' B' ' 14' ' ' THR . 4.9 mp -65.66 -66.17 0.58 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.348 -1.09 . . . . 0.0 109.64 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 17' ' ' THR . . . . . 0.759 HG21 HG21 ' A' ' 17' ' ' THR . 0.5 OUTLIER -135.54 6.73 3.26 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -179.57 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 18' ' ' GLN . . . . . 0.652 ' O ' ' C ' ' B' ' 19' ' ' VAL . 25.1 mt-30 58.69 24.98 12.78 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 -175.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 1.073 HG23 ' CD1' ' A' ' 16' ' ' LEU . 0.2 OUTLIER 7.69 -95.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 CA-C-N 115.211 -0.904 . . . . 0.0 108.958 -179.185 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 20' ' ' SER . . . . . 1.026 ' O ' ' N ' ' B' ' 22' ' ' SER . 1.2 p -137.42 23.47 2.95 Favored 'General case' 0 C--N 1.273 -2.729 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 177.172 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.875 ' HB ' HG23 ' B' ' 7' ' ' ILE . 9.4 m -4.02 -43.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 122.441 1.115 . . . . 0.0 111.006 -177.436 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 22' ' ' SER . . . . . 1.026 ' N ' ' O ' ' B' ' 20' ' ' SER . 5.9 m -75.35 -38.06 60.34 Favored 'General case' 0 C--N 1.278 -2.506 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.559 178.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 23' ' ' LYS . . . . . 0.868 ' N ' ' O ' ' B' ' 20' ' ' SER . 6.1 mtmt -92.94 -26.99 17.33 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.36 -0.837 . . . . 0.0 111.154 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 24' ' ' MET . . . . . 0.672 ' HB3' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -70.9 -37.52 72.96 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 117.157 -1.817 . . . . 0.0 108.264 179.177 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.731 HD12 HG13 ' B' ' 7' ' ' ILE . 0.4 OUTLIER -80.44 -51.45 8.8 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 117.956 -1.498 . . . . 0.0 108.241 177.52 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 26' ' ' ALA . . . . . 0.491 ' O ' ' HB2' ' B' ' 30' ' ' LYS . . . -49.95 -34.11 19.75 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.374 -0.829 . . . . 0.0 108.859 178.445 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 27' ' ' SER . . . . . 0.507 ' HA ' ' HB3' ' B' ' 30' ' ' LYS . 83.1 p -81.92 -33.88 30.17 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.284 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 28' ' ' PHE . . . . . 0.811 ' O ' HG13 ' B' ' 31' ' ' ILE . 0.3 OUTLIER -56.02 -52.44 64.22 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.812 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 29' ' ' GLU . . . . . 0.791 ' O ' ' OG1' ' B' ' 33' ' ' THR . 0.2 OUTLIER -63.42 -39.01 93.34 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 176.401 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 0.992 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 17.5 ttpt -59.96 -23.79 63.87 Favored 'General case' 0 C--O 1.189 -2.115 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.878 HD13 ' CB ' ' A' ' 9' ' ' ALA . 0.6 OUTLIER -102.83 -27.16 3.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 O-C-N 120.615 -1.303 . . . . 0.0 108.582 178.047 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.715 HD11 ' CE2' ' B' ' 28' ' ' PHE . 1.2 mm -68.88 -54.33 21.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 177.308 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 33' ' ' THR . . . . . 0.811 ' HA ' HD23 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -70.73 -49.07 50.86 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.107 -1.037 . . . . 0.0 108.669 178.576 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.992 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 19.2 mm-40 -58.09 -35.68 71.77 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.551 -0.86 . . . . 0.0 109.95 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 35' ' ' THR . . . . . 0.831 HG22 ' CB ' ' B' ' 40' ' ' ASP . 31.1 m -69.72 -42.34 74.13 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 118.302 -1.359 . . . . 0.0 107.697 177.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.976 HG21 HD22 ' A' ' 85' ' ' LEU . 55.5 t -56.95 -43.03 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 177.111 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 37' ' ' ALA . . . . . 0.804 ' HA ' ' HB3' ' A' ' 92' ' ' LEU . . . -76.89 2.92 13.25 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.398 -0.921 . . . . 0.0 109.69 177.255 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 38' ' ' LYS . . . . . 0.546 ' HB2' ' O ' ' B' ' 34' ' ' GLU . 0.1 OUTLIER -119.91 4.6 10.95 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.107 -0.996 . . . . 0.0 109.311 178.001 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.73 34.46 4.07 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 40' ' ' ASP . . . . . 0.831 ' CB ' HG22 ' B' ' 35' ' ' THR . 14.2 t0 -49.17 162.91 0.11 Allowed 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 123.086 1.422 . . . . 0.0 113.019 -179.01 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -179.83 56.99 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 104.381 -2.451 . . . . 0.0 104.381 178.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.918 HG21 HD11 ' A' ' 6' ' ' LEU . 7.4 p -90.67 148.74 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.941 -176.377 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -132.26 95.9 3.76 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.903 HD12 ' HB3' ' B' ' 48' ' ' LEU . 19.2 mt -59.65 101.59 0.12 Allowed 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.245 -0.909 . . . . 0.0 109.792 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 45' ' ' THR . . . . . 0.534 HG22 ' HD3' ' A' ' 3' ' ' LYS . 0.0 OUTLIER 35.53 -93.55 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 120.921 0.391 . . . . 0.0 110.877 -179.648 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 46' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -147.17 35.4 1.25 Allowed Glycine 0 N--CA 1.485 1.95 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 47' ' ' PHE . . . . . 0.73 ' O ' HD11 ' B' ' 85' ' ' LEU . 1.1 p90 -135.75 -25.53 1.26 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.246 -1.149 . . . . 0.0 111.773 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.903 ' HB3' HD12 ' B' ' 44' ' ' LEU . 4.8 mt -136.36 113.58 10.64 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.214 -1.554 . . . . 0.0 111.374 178.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -113.69 95.95 5.6 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.414 -0.804 . . . . 0.0 110.291 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 50' ' ' ILE . . . . . 0.783 ' CG1' HG22 ' B' ' 79' ' ' VAL . 0.3 OUTLIER -87.5 139.42 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.37 -0.831 . . . . 0.0 109.271 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 51' ' ' LYS . . . . . 0.408 ' O ' ' HB3' ' B' ' 78' ' ' SER . 1.7 ptmt -158.83 111.4 1.61 Allowed Pre-proline 0 N--CA 1.5 2.042 0 C-N-CA 118.603 -1.239 . . . . 0.0 111.233 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 52' ' ' PRO . . . . . 0.577 ' HB3' HG13 ' B' ' 36' ' ' VAL . 44.9 Cg_endo -69.38 144.66 56.78 Favored 'Trans proline' 0 C--N 1.314 -1.251 0 O-C-N 123.47 1.248 . . . . 0.0 111.681 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.703 HG22 ' O ' ' B' ' 76' ' ' GLY . 29.7 m -143.07 116.86 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 121.491 0.663 . . . . 0.0 110.841 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 54' ' ' ALA . . . . . 0.684 ' HA ' ' HA ' ' B' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.5 2.067 0 CA-C-O 121.806 0.812 . . . . 0.0 112.105 -178.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 75' ' ' VAL . . . . . 0.897 ' HB ' ' HB1' ' A' ' 89' ' ' ALA . 1.2 t . . . . . 0 N--CA 1.493 1.711 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 76' ' ' GLY . . . . . 0.703 ' O ' HG22 ' B' ' 53' ' ' VAL . . . -115.32 86.9 0.42 Allowed Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.136 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 1.067 HG21 HD13 ' A' ' 85' ' ' LEU . 3.6 p -60.53 78.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.767 -0.843 . . . . 0.0 109.827 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 78' ' ' SER . . . . . 0.941 ' O ' HG23 ' B' ' 79' ' ' VAL . 2.2 t -68.05 177.66 2.12 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.551 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.941 HG23 ' O ' ' B' ' 78' ' ' SER . 14.6 t -172.33 175.27 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 80' ' ' LYS . . . . . 0.865 ' O ' HD23 ' B' ' 48' ' ' LEU . 0.0 OUTLIER 179.28 172.17 0.49 Allowed Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 120.87 -1.144 . . . . 0.0 110.178 177.186 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 81' ' ' PRO . . . . . 0.504 ' HA ' ' O ' ' B' ' 47' ' ' PHE . 54.0 Cg_endo -95.17 143.45 1.31 Allowed 'Trans proline' 0 C--N 1.303 -1.855 0 C-N-CA 122.35 2.033 . . . . 0.0 110.739 178.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 82' ' ' GLY . . . . . 0.557 ' O ' ' HB3' ' B' ' 83' ' ' GLU . . . -107.6 42.37 1.95 Allowed Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.215 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 83' ' ' GLU . . . . . 0.557 ' HB3' ' O ' ' B' ' 82' ' ' GLY . 1.0 OUTLIER 69.02 -40.18 0.44 Allowed 'General case' 0 N--CA 1.506 2.34 0 O-C-N 121.448 -1.031 . . . . 0.0 111.93 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 84' ' ' SER . . . . . 0.472 ' CB ' ' HB3' ' B' ' 47' ' ' PHE . 0.1 OUTLIER -48.85 -33.34 10.39 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.949 -1.094 . . . . 0.0 110.165 -179.177 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.817 ' HB2' HG21 ' A' ' 77' ' ' VAL . 0.8 OUTLIER -82.61 -29.98 29.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.412 -0.805 . . . . 0.0 108.877 178.703 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 86' ' ' LYS . . . . . 0.576 ' CD ' HG12 ' A' ' 77' ' ' VAL . 0.3 OUTLIER -82.49 -39.5 22.37 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.53 0.681 . . . . 0.0 109.607 179.812 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 87' ' ' LYS . . . . . 0.465 ' O ' ' CG ' ' B' ' 90' ' ' GLU . 1.2 ttmp? -68.69 -37.05 79.26 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 178.529 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.782 ' C ' ' HB1' ' A' ' 37' ' ' ALA . . . -71.62 -30.66 66.02 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 177.305 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.674 ' HA ' ' HA ' ' A' ' 37' ' ' ALA . . . -69.94 -52.79 21.55 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.623 -0.673 . . . . 0.0 110.368 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 90' ' ' GLU . . . . . 0.64 ' HA ' ' CB ' ' B' ' 94' ' ' TYR . 8.2 pt-20 -52.2 -23.25 5.28 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 177.455 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 91' ' ' GLY . . . . . 0.859 ' C ' HD23 ' B' ' 92' ' ' LEU . . . -81.17 -29.66 40.41 Favored Glycine 0 CA--C 1.546 2.03 0 CA-C-O 118.604 -1.109 . . . . 0.0 112.81 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 92' ' ' LEU . . . . . 0.859 HD23 ' C ' ' B' ' 91' ' ' GLY . 0.2 OUTLIER -111.64 -73.55 0.67 Allowed 'General case' 0 N--CA 1.507 2.391 0 CA-C-N 122.065 2.933 . . . . 0.0 113.54 -177.687 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -120.31 42.7 2.9 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.771 -1.205 . . . . 0.0 112.628 -177.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 94' ' ' TYR . . . . . 0.64 ' CB ' ' HA ' ' B' ' 90' ' ' GLU . 0.8 OUTLIER -77.19 -43.51 33.46 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.124 -0.985 . . . . 0.0 108.967 178.507 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -75.04 -35.73 61.89 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.19 -40.13 76.77 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 97' ' ' PHE . . . . . 0.538 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.507 ' HA ' ' CB ' ' A' ' 5' ' ' GLU . 2.8 mtp . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.466 ' H ' ' HB2' ' A' ' 5' ' ' GLU . 0.6 OUTLIER -177.12 -162.54 0.08 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.023 -1.048 . . . . 0.0 111.728 179.855 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.519 ' HE2' ' HA ' ' A' ' 26' ' ' ALA . 0.9 OUTLIER -52.22 -11.77 0.2 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.657 -0.652 . . . . 0.0 110.396 179.778 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.611 ' O ' HG13 ' A' ' 7' ' ' ILE . 73.7 m -114.38 -58.95 2.08 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.104 -0.997 . . . . 0.0 110.731 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.507 ' CB ' ' HA ' ' A' ' 1' ' ' MET . 1.6 mm-40 -49.74 -48.4 50.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.822 -1.174 . . . . 0.0 108.945 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.824 HD11 ' CG1' ' B' ' 42' ' ' VAL . 16.2 mt -55.65 -32.93 63.61 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.151 -1.02 . . . . 0.0 110.105 178.455 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.794 ' HA ' HD12 ' A' ' 25' ' ' LEU . 1.0 OUTLIER -60.5 -40.94 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 120.599 -1.313 . . . . 0.0 107.563 178.743 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.858 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -66.75 -31.14 71.6 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 177.343 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.659 ' HB3' ' O ' ' A' ' 6' ' ' LEU . . . -58.45 -39.01 78.69 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.493 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.815 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.4 mp -91.01 -30.61 4.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 178.03 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.858 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -66.08 -10.6 41.94 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 118.456 -1.298 . . . . 0.0 108.493 178.218 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.443 ' CG ' ' N ' ' A' ' 13' ' ' ASP . 6.4 pt20 -118.53 -42.52 2.75 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.48 -0.762 . . . . 0.0 110.405 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.73 ' OD2' HG21 ' B' ' 31' ' ' ILE . 16.8 m-20 -69.85 -25.82 63.91 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 177.525 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . 1.139 HG22 ' CD1' ' A' ' 16' ' ' LEU 0.277 0.2 OUTLIER -106.53 -72.89 0.7 Allowed 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 179.025 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.65 15.68 54.3 Favored Glycine 0 N--CA 1.501 2.974 0 O-C-N 121.328 -0.857 . . . . 0.0 111.039 177.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 1.139 ' CD1' HG22 ' A' ' 14' ' ' THR . 4.4 mp -59.36 -68.87 0.23 Allowed 'General case' 0 C--N 1.294 -1.835 0 O-C-N 121.524 -0.986 . . . . 0.0 110.628 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.532 ' O ' HG23 ' A' ' 17' ' ' THR . 0.6 OUTLIER -138.11 9.64 2.77 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.302 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.558 ' O ' ' C ' ' A' ' 19' ' ' VAL . 7.7 mt-30 57.84 25.71 12.34 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -176.152 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 1.026 HG11 HG11 ' B' ' 19' ' ' VAL . 2.4 p -11.45 -95.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.089 -179.045 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.976 ' HB2' HG22 ' B' ' 14' ' ' THR . 0.6 OUTLIER -130.74 22.86 5.02 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 177.957 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.652 ' HA ' ' CE ' ' A' ' 24' ' ' MET . 30.5 m -25.19 -38.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-O 122.479 1.133 . . . . 0.0 109.182 -178.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.71 ' N ' ' O ' ' A' ' 20' ' ' SER . 4.9 m -84.49 -35.36 23.01 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.135 177.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.942 ' N ' ' O ' ' A' ' 20' ' ' SER . 1.2 mtmt -85.69 -34.07 21.37 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.652 -0.655 . . . . 0.0 111.543 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.781 ' HB3' HG23 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -76.1 -40.24 53.41 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.44 -1.412 . . . . 0.0 109.349 179.466 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.794 HD12 ' HA ' ' A' ' 7' ' ' ILE . 11.6 mt -74.56 -38.29 62.74 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 117.894 -1.523 . . . . 0.0 108.724 178.751 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.519 ' HA ' ' HE2' ' A' ' 3' ' ' LYS . . . -64.08 -33.22 75.26 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 177.252 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.551 ' O ' ' N ' ' A' ' 31' ' ' ILE . 58.3 m -84.25 -30.52 25.61 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 178.231 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.865 ' HB2' HD11 ' B' ' 10' ' ' ILE . 0.1 OUTLIER -59.24 -35.91 74.53 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.608 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.753 ' O ' ' HB ' ' A' ' 33' ' ' THR . 2.1 mt-10 -79.99 -32.92 39.76 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 177.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.739 ' O ' ' CG ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -68.6 -27.31 65.93 Favored 'General case' 0 C--O 1.194 -1.821 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 176.758 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.738 ' CG1' ' HA ' ' A' ' 28' ' ' PHE . 1.7 pp -97.11 -31.69 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.299 -0.875 . . . . 0.0 109.445 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.637 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 3.3 mm -65.42 -51.62 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 177.142 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.753 ' HB ' ' O ' ' A' ' 29' ' ' GLU . 0.3 OUTLIER -65.51 -43.27 90.62 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.867 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.739 ' CG ' ' O ' ' A' ' 30' ' ' LYS . 44.5 mm-40 -69.02 -36.08 77.36 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.614 -0.679 . . . . 0.0 111.451 179.347 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.971 HG21 HG23 ' A' ' 42' ' ' VAL . 2.3 m -57.59 -56.12 26.05 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.736 -1.228 . . . . 0.0 108.689 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.019 HG21 HG23 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -55.51 -29.51 24.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 106.303 -1.739 . . . . 0.0 106.303 177.414 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 1.065 ' HB2' ' HB1' ' B' ' 88' ' ' ALA . . . -75.73 -4.1 38.53 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 177.164 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 35' ' ' THR . 0.0 OUTLIER -115.26 -32.07 5.77 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.634 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.18 42.58 0.76 Allowed Glycine 0 C--N 1.301 -1.391 0 C-N-CA 119.804 -1.189 . . . . 0.0 110.558 178.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.773 ' CB ' HG23 ' A' ' 35' ' ' THR . 0.1 OUTLIER -125.86 117.44 23.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.218 -1.166 . . . . 0.0 110.33 179.349 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.6 mtmt -67.13 89.41 0.18 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.57 0.7 . . . . 0.0 109.626 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.971 HG23 HG21 ' A' ' 35' ' ' THR . 42.5 t -66.23 131.94 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.682 -0.637 . . . . 0.0 110.374 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.503 ' O ' HD23 ' A' ' 44' ' ' LEU . 1.5 pt20 -128.04 154.8 45.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.517 -0.739 . . . . 0.0 109.59 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.983 HD12 ' CB ' ' A' ' 48' ' ' LEU . 73.1 mt -128.13 112.19 14.28 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.287 -0.883 . . . . 0.0 109.686 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.59 HG22 ' HG2' ' B' ' 29' ' ' GLU . 0.1 OUTLIER 32.45 -90.89 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.427 0 O-C-N 121.937 -0.477 . . . . 0.0 111.007 -179.371 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -149.94 28.99 1.14 Allowed Glycine 0 N--CA 1.482 1.752 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.646 ' O ' ' HA ' ' A' ' 81' ' ' PRO . 5.8 p90 -129.06 -24.09 2.94 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.096 -1.238 . . . . 0.0 112.046 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.983 ' CB ' HD12 ' A' ' 44' ' ' LEU . 1.0 OUTLIER -131.47 107.63 9.03 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.38 -1.45 . . . . 0.0 111.524 179.143 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -111.46 95.51 5.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.608 -0.683 . . . . 0.0 109.741 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.801 HD12 HG22 ' A' ' 79' ' ' VAL . 0.3 OUTLIER -83.44 142.42 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.369 -0.832 . . . . 0.0 109.969 -179.351 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 13.0 ptmt -157.48 128.09 3.54 Favored Pre-proline 0 N--CA 1.494 1.743 0 C-N-CA 118.564 -1.255 . . . . 0.0 110.51 178.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.675 ' HB3' HG22 ' A' ' 36' ' ' VAL . 54.8 Cg_endo -85.28 143.74 9.01 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.475 1.25 . . . . 0.0 111.891 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.859 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 32.6 m -133.13 -149.37 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.257 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.938 ' HA ' ' CA ' ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.496 1.849 0 C-N-CA 118.542 -1.263 . . . . 0.0 113.238 177.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.938 ' CA ' ' HA ' ' A' ' 54' ' ' ALA . 0.9 OUTLIER . . . . . 0 N--CA 1.513 2.704 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.846 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -145.11 111.18 0.58 Allowed Glycine 0 N--CA 1.491 2.321 0 C-N-CA 119.1 -1.524 . . . . 0.0 110.805 -178.142 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 1.019 HG23 HG21 ' A' ' 36' ' ' VAL . 4.9 p -76.96 81.69 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 O-C-N 121.603 -0.939 . . . . 0.0 110.08 179.248 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' SER . . . . . 1.008 ' O ' HG23 ' A' ' 79' ' ' VAL . 2.7 t -67.05 178.14 1.52 Allowed 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.347 -0.941 . . . . 0.0 109.607 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 1.008 HG23 ' O ' ' A' ' 78' ' ' SER . 3.4 t -176.41 174.96 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.607 ' O ' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER 179.32 170.59 0.55 Allowed Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 120.993 -1.067 . . . . 0.0 110.558 176.357 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.646 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 54.7 Cg_endo -95.09 144.53 1.41 Allowed 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 122.637 2.225 . . . . 0.0 110.551 178.018 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.503 ' H ' ' HA ' ' A' ' 47' ' ' PHE . . . -106.07 -171.68 23.32 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.79 -26.21 54.21 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.959 -1.318 . . . . 0.0 110.401 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.413 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 1.7 t -53.64 -27.56 27.91 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.873 HD22 HG11 ' B' ' 36' ' ' VAL . 1.3 mt -84.97 -29.07 25.38 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 178.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.506 ' HG3' HG13 ' B' ' 75' ' ' VAL . 0.4 OUTLIER -84.25 -29.2 26.67 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.306 -0.871 . . . . 0.0 109.706 179.823 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.83 -38.06 58.44 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 178.175 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.886 ' C ' ' HB1' ' B' ' 37' ' ' ALA . . . -65.61 -33.31 75.61 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 177.191 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 1.243 ' N ' ' HB1' ' B' ' 37' ' ' ALA . . . -72.63 -26.86 61.82 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.77 -34.57 62.79 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 175.217 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -63.6 -50.08 64.47 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 107.864 -2.094 . . . . 0.0 107.864 176.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.714 HD12 ' HA ' ' B' ' 37' ' ' ALA . 3.4 mt -49.67 -12.56 0.07 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.073 -1.251 . . . . 0.0 111.484 178.57 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.524 ' CB ' ' O ' ' A' ' 92' ' ' LEU . 0.0 OUTLIER 73.54 61.14 0.09 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -177.589 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.528 ' CD1' ' N ' ' B' ' 75' ' ' VAL . 50.8 t80 -37.46 -39.99 0.34 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.189 -178.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 . . . . . 0 N--CA 1.495 1.791 0 O-C-N 121.293 -0.879 . . . . 0.0 109.697 179.83 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.504 ' HB3' ' HG ' ' B' ' 6' ' ' LEU . 1.5 mtp . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.059 0.457 . . . . 0.0 110.329 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 2' ' ' ASN . . . . . 0.514 ' O ' ' HB2' ' B' ' 6' ' ' LEU . 12.4 t-20 -173.54 -161.06 0.13 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.306 -0.871 . . . . 0.0 110.892 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.511 ' HE2' ' HB2' ' B' ' 29' ' ' GLU . 0.7 OUTLIER -55.77 -2.21 0.05 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.335 -0.853 . . . . 0.0 110.895 179.903 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 4' ' ' THR . . . . . 0.635 ' O ' ' CG1' ' B' ' 7' ' ' ILE . 54.4 m -122.77 -60.14 1.55 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.966 -1.084 . . . . 0.0 109.969 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.486 ' HB2' ' CA ' ' B' ' 1' ' ' MET . 5.4 mt-10 -51.74 -47.62 63.99 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.822 -1.174 . . . . 0.0 109.108 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.724 HD11 HG13 ' A' ' 42' ' ' VAL . 5.2 mt -60.43 -33.3 72.33 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.265 178.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 7' ' ' ILE . . . . . 0.747 ' N ' HD12 ' B' ' 25' ' ' LEU . 0.9 OUTLIER -58.4 -42.65 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 120.582 -1.324 . . . . 0.0 108.397 179.812 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 8' ' ' LYS . . . . . 0.77 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.1 OUTLIER -67.14 -32.2 73.15 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.213 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 9' ' ' ALA . . . . . 0.626 ' HB3' ' O ' ' B' ' 6' ' ' LEU . . . -62.33 -30.78 71.4 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 178.519 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.865 HD11 ' HB2' ' A' ' 28' ' ' PHE . 1.2 mp -96.65 -32.59 4.25 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.5 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 178.485 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.77 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -63.79 -29.58 70.77 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.154 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.412 ' HG3' ' N ' ' B' ' 13' ' ' ASP . 6.5 pt20 -89.56 -38.16 14.17 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.116 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.481 ' HB2' ' HA ' ' B' ' 10' ' ' ILE . 66.0 m-20 -67.96 -23.03 65.01 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 176.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 14' ' ' THR . . . . . 0.976 HG22 ' HB2' ' A' ' 20' ' ' SER . 18.4 p -92.31 -76.46 0.46 Allowed 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 61.05 12.37 29.62 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 16' ' ' LEU . . . . . 0.867 HD22 ' O ' ' A' ' 19' ' ' VAL . 3.3 mp -79.78 -61.66 1.92 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.481 -1.011 . . . . 0.0 109.016 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 17' ' ' THR . . . . . 0.505 HG22 ' H ' ' B' ' 19' ' ' VAL . 0.6 OUTLIER -141.55 5.93 1.84 Allowed 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.889 -179.794 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 18' ' ' GLN . . . . . 0.575 ' O ' ' C ' ' B' ' 19' ' ' VAL . 6.7 mt-30 54.53 29.69 11.74 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 -176.55 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 1.026 HG11 HG11 ' A' ' 19' ' ' VAL . 1.4 p -12.07 -95.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.743 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 20' ' ' SER . . . . . 0.945 ' O ' ' N ' ' B' ' 23' ' ' LYS . 0.5 OUTLIER -132.97 24.39 4.25 Favored 'General case' 0 C--N 1.283 -2.311 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 178.601 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.696 HG11 ' CB ' ' B' ' 11' ' ' ALA . 17.1 m -19.28 -39.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 CA-C-O 122.398 1.094 . . . . 0.0 109.433 -177.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.848 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.6 OUTLIER -82.43 -37.54 25.31 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.875 178.221 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 23' ' ' LYS . . . . . 0.945 ' N ' ' O ' ' B' ' 20' ' ' SER . 1.9 mtmt -89.63 -28.75 19.29 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.46 -0.775 . . . . 0.0 111.377 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 24' ' ' MET . . . . . 0.744 ' HB3' HG21 ' A' ' 14' ' ' THR . 0.0 OUTLIER -77.81 -36.36 50.33 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 118.002 -1.479 . . . . 0.0 108.549 179.078 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.747 HD12 ' N ' ' B' ' 7' ' ' ILE . 0.8 OUTLIER -75.18 -42.63 55.39 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 177.281 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 26' ' ' ALA . . . . . 0.468 ' HA ' ' HE2' ' B' ' 3' ' ' LYS . . . -60.3 -32.48 71.25 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 177.151 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 27' ' ' SER . . . . . 0.562 ' HA ' ' HB3' ' B' ' 30' ' ' LYS . 12.1 m -79.88 -35.66 37.73 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 28' ' ' PHE . . . . . 0.739 ' HE1' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -59.25 -40.08 84.84 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 178.849 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 29' ' ' GLU . . . . . 0.717 ' HG3' ' CE1' ' B' ' 28' ' ' PHE . 1.3 mt-10 -76.03 -34.05 59.66 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 0.751 ' O ' ' CG ' ' B' ' 34' ' ' GLU . 30.0 tttp -70.08 -29.89 66.99 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 177.324 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.739 ' CG1' ' HA ' ' B' ' 28' ' ' PHE . 2.0 pp -93.02 -35.23 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.311 -0.868 . . . . 0.0 109.232 179.119 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.68 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.3 mm -60.52 -60.05 3.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 33' ' ' THR . . . . . 0.678 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 0.4 OUTLIER -58.29 -39.53 79.55 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.116 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.842 ' O ' ' N ' ' B' ' 38' ' ' LYS . 7.0 mm-40 -68.66 -54.7 14.76 Favored 'General case' 0 C--O 1.199 -1.586 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.109 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 35' ' ' THR . . . . . 0.556 ' HA ' ' HB2' ' B' ' 38' ' ' LYS . 50.2 m -47.02 -63.85 0.93 Allowed 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.87 -1.144 . . . . 0.0 112.124 -178.445 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 1.026 HG23 HD12 ' B' ' 50' ' ' ILE . 0.9 OUTLIER -49.61 -44.02 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 C-N-CA 118.058 -1.457 . . . . 0.0 107.841 179.126 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 37' ' ' ALA . . . . . 1.243 ' HB1' ' N ' ' A' ' 89' ' ' ALA . . . -93.63 15.27 16.63 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.793 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 38' ' ' LYS . . . . . 0.842 ' N ' ' O ' ' B' ' 34' ' ' GLU . 4.7 mmtt -121.95 -28.08 4.5 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 144.16 41.11 0.06 OUTLIER Glycine 0 N--CA 1.477 1.384 0 C-N-CA 119.026 -1.559 . . . . 0.0 112.06 178.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 40' ' ' ASP . . . . . 0.492 ' O ' ' HA ' ' B' ' 36' ' ' VAL . 0.4 OUTLIER -172.92 147.3 1.65 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.59 -1.535 . . . . 0.0 111.421 179.069 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.409 ' CG ' ' HD2' ' B' ' 52' ' ' PRO . 2.2 mttt -102.81 114.7 29.18 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.001 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.824 ' CG1' HD11 ' A' ' 6' ' ' LEU . 7.5 t -87.92 154.95 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 C-N-CA 119.858 -0.737 . . . . 0.0 111.107 -178.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 43' ' ' GLN . . . . . 0.408 ' HA ' ' O ' ' B' ' 48' ' ' LEU . 14.6 mt-30 -142.04 121.12 12.92 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.552 -0.717 . . . . 0.0 109.89 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.712 HD13 ' CZ ' ' A' ' 28' ' ' PHE . 20.5 mt -87.09 102.56 14.54 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.199 -0.938 . . . . 0.0 109.934 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 45' ' ' THR . . . . . 0.619 HG22 ' HG2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 37.56 28.09 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.435 0 O-C-N 121.819 -0.55 . . . . 0.0 111.753 -179.659 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 46' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . 90.64 -11.5 71.44 Favored Glycine 0 N--CA 1.486 2.028 0 C-N-CA 119.903 -1.142 . . . . 0.0 111.902 178.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 47' ' ' PHE . . . . . 0.627 ' CE2' ' HG2' ' A' ' 29' ' ' GLU . 0.8 OUTLIER -87.76 -35.3 17.96 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 120.028 1.914 . . . . 0.0 111.776 -179.561 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.612 ' HB2' HD12 ' B' ' 44' ' ' LEU . 0.4 OUTLIER -120.18 85.59 2.41 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.63 -1.294 . . . . 0.0 110.516 178.539 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -90.84 80.41 5.83 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.847 -0.533 . . . . 0.0 110.444 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 50' ' ' ILE . . . . . 1.026 HD12 HG23 ' B' ' 36' ' ' VAL . 2.9 pt -73.07 147.86 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.227 -0.921 . . . . 0.0 110.344 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 51' ' ' LYS . . . . . 0.564 ' O ' ' N ' ' B' ' 78' ' ' SER . 0.0 OUTLIER -165.14 132.52 2.35 Favored Pre-proline 0 N--CA 1.498 1.935 0 C-N-CA 119.285 -0.966 . . . . 0.0 110.549 179.456 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 52' ' ' PRO . . . . . 0.827 ' HG3' ' O ' ' B' ' 36' ' ' VAL . 54.4 Cg_endo -85.47 149.19 10.16 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 O-C-N 123.398 1.209 . . . . 0.0 111.174 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.602 HG22 ' HA3' ' B' ' 76' ' ' GLY . 11.8 m -144.93 120.15 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 CA-C-O 122.296 1.046 . . . . 0.0 111.619 178.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 54' ' ' ALA . . . . . 0.493 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . . . . . . . . 0 N--CA 1.495 1.778 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.875 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 75' ' ' VAL . . . . . 1.092 HG11 ' HB3' ' A' ' 89' ' ' ALA . 7.6 p . . . . . 0 N--CA 1.509 2.496 0 CA-C-O 121.065 0.459 . . . . 0.0 111.09 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 76' ' ' GLY . . . . . 0.602 ' HA3' HG22 ' B' ' 53' ' ' VAL . . . -101.25 78.81 0.4 Allowed Glycine 0 N--CA 1.478 1.495 0 C-N-CA 118.693 -1.718 . . . . 0.0 109.248 -179.309 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.867 HG21 ' HB3' ' A' ' 85' ' ' LEU . 2.4 p -66.74 69.19 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 O-C-N 121.672 -0.899 . . . . 0.0 109.384 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 78' ' ' SER . . . . . 0.564 ' N ' ' O ' ' B' ' 51' ' ' LYS . 0.6 OUTLIER -64.37 174.12 1.79 Allowed 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 118.927 -1.109 . . . . 0.0 110.136 -179.944 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.77 ' CG2' HG22 ' B' ' 50' ' ' ILE . 3.7 p 174.06 176.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 80' ' ' LYS . . . . . 0.614 ' N ' HG22 ' B' ' 79' ' ' VAL . 0.0 OUTLIER 179.68 171.26 0.56 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 120.865 -1.147 . . . . 0.0 110.663 176.91 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 81' ' ' PRO . . . . . 0.575 ' HA ' ' O ' ' B' ' 47' ' ' PHE . 54.8 Cg_endo -94.9 138.84 0.97 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.493 2.128 . . . . 0.0 110.227 177.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 82' ' ' GLY . . . . . 0.516 ' HA3' ' HA ' ' B' ' 47' ' ' PHE . . . -92.64 -164.71 38.17 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 108.248 -1.941 . . . . 0.0 108.248 178.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 83' ' ' GLU . . . . . 0.503 ' O ' ' N ' ' B' ' 87' ' ' LYS . 0.0 OUTLIER -94.46 -18.17 21.75 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.138 -1.213 . . . . 0.0 110.36 179.517 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 14.5 t -61.22 -34.83 75.74 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 177.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.859 ' CG ' HG21 ' A' ' 77' ' ' VAL . 0.9 OUTLIER -86.74 -26.87 23.99 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.283 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 86' ' ' LYS . . . . . 0.813 ' O ' ' HB3' ' B' ' 89' ' ' ALA . 4.4 tttp -79.32 -34.32 42.4 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 177.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 87' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' B' ' 83' ' ' GLU . 15.7 tttt -67.14 -39.56 86.59 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 178.09 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 1.065 ' HB1' ' HB2' ' A' ' 37' ' ' ALA . . . -60.45 -38.0 82.75 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 175.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.847 ' CA ' HD23 ' B' ' 92' ' ' LEU . . . -55.78 -34.99 65.76 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 177.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 90' ' ' GLU . . . . . 0.687 ' HA ' ' HB2' ' B' ' 94' ' ' TYR . 0.0 OUTLIER -56.91 -32.53 66.03 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 177.346 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.24 -13.27 77.23 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 92' ' ' LEU . . . . . 0.9 ' O ' HD12 ' B' ' 92' ' ' LEU . 0.3 OUTLIER -78.69 16.75 0.8 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.689 -1.477 . . . . 0.0 111.267 -179.883 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 93' ' ' LYS . . . . . 0.594 ' CG ' ' O ' ' B' ' 92' ' ' LEU . 0.1 OUTLIER 86.75 34.55 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -178.324 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 94' ' ' TYR . . . . . 0.775 ' CD2' ' HB ' ' A' ' 75' ' ' VAL . 3.6 t80 -42.09 -62.38 0.94 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.413 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -58.39 -32.62 68.77 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.53 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 96' ' ' ASP . . . . . 0.476 ' HB3' ' HG3' ' B' ' 93' ' ' LYS . 0.5 OUTLIER -64.52 -34.77 79.0 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.711 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.439 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 177.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.557 ' SD ' HG21 ' B' ' 35' ' ' THR . 1.4 mtp . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.01 0.433 . . . . 0.0 110.041 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.583 ' H ' ' HB2' ' A' ' 5' ' ' GLU . 47.0 p-10 -177.03 -169.68 0.26 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.295 -0.878 . . . . 0.0 110.44 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.795 ' O ' HD12 ' A' ' 25' ' ' LEU . 2.5 tptm -52.0 -17.38 1.0 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.4 -0.812 . . . . 0.0 110.158 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.435 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 24.4 m -95.49 -54.58 3.33 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.128 -0.983 . . . . 0.0 109.292 178.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.583 ' HB2' ' H ' ' A' ' 2' ' ' ASN . 2.8 mt-10 -62.85 -42.24 99.67 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.446 -0.901 . . . . 0.0 108.631 179.263 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.008 HD11 HG13 ' B' ' 42' ' ' VAL . 23.2 mt -65.35 -31.26 72.28 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 118.899 -1.12 . . . . 0.0 108.585 177.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.887 HG13 HD12 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -57.91 -57.23 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 178.341 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.976 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 18.4 pttt -65.83 -24.33 66.88 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 6' ' ' LEU . . . -60.25 -38.46 83.56 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.089 -1.007 . . . . 0.0 108.451 178.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.818 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.2 mp -88.48 -37.83 10.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 177.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.976 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -61.13 -15.76 36.92 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 119.047 -1.061 . . . . 0.0 108.631 177.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.451 ' HB3' ' O ' ' A' ' 8' ' ' LYS . 53.2 tp60 -111.13 -43.74 3.69 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.605 -0.684 . . . . 0.0 109.237 178.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.603 ' OD2' HG21 ' B' ' 31' ' ' ILE . 35.5 m-20 -62.33 -30.63 71.3 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 177.357 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.818 ' OG1' ' O ' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -105.03 -70.59 0.77 Allowed 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.122 179.053 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 49.08 26.7 6.32 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 1.065 ' CD1' HG23 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -87.41 -27.46 22.74 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.48 -1.012 . . . . 0.0 109.042 178.851 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.768 HG21 ' CG2' ' B' ' 17' ' ' THR . 0.4 OUTLIER -159.34 -7.61 0.07 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.982 -0.449 . . . . 0.0 110.169 -179.448 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.62 ' O ' ' C ' ' A' ' 19' ' ' VAL . 5.4 mt-30 58.0 31.2 20.31 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 -176.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.911 HG11 HG11 ' B' ' 19' ' ' VAL . 1.6 p -5.05 -91.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.502 -178.494 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.97 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -132.43 22.99 4.38 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.101 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.701 ' HA ' ' HE2' ' A' ' 24' ' ' MET . 16.0 m -19.41 -38.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 122.331 1.062 . . . . 0.0 109.389 -178.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.862 ' N ' ' O ' ' A' ' 20' ' ' SER . 5.6 t -78.88 -39.24 35.59 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.409 177.613 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.97 ' N ' ' O ' ' A' ' 20' ' ' SER . 3.1 mtmt -94.85 -28.36 15.27 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.603 -0.686 . . . . 0.0 109.543 178.445 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.701 ' HE2' ' HA ' ' A' ' 21' ' ' VAL 0.261 0.0 OUTLIER -63.09 -42.26 99.56 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.896 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.887 HD12 HG13 ' A' ' 7' ' ' ILE . 0.4 OUTLIER -86.1 -49.16 7.99 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 118.822 -1.151 . . . . 0.0 109.63 177.743 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' A' ' 22' ' ' SER . . . -46.77 -39.66 12.15 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.543 -1.348 . . . . 0.0 108.148 178.126 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.872 ' O ' HG23 ' A' ' 31' ' ' ILE . 55.6 m -78.31 -30.26 48.18 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.934 ' O ' HG13 ' A' ' 31' ' ' ILE . 7.7 t80 -54.79 -47.35 74.08 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.572 -0.705 . . . . 0.0 109.455 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.68 ' HB2' ' HE3' ' A' ' 3' ' ' LYS . 21.4 tt0 -68.78 -34.28 75.3 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 117.577 -1.649 . . . . 0.0 107.177 177.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.953 ' O ' ' HB3' ' A' ' 34' ' ' GLU . 7.8 tttp -69.22 -22.5 63.87 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.375 -0.93 . . . . 0.0 108.821 178.436 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.934 HG13 ' O ' ' A' ' 28' ' ' PHE . 2.3 pp -95.42 -40.43 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 119.364 -0.934 . . . . 0.0 109.66 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 1.054 HG21 ' CE1' ' B' ' 47' ' ' PHE . 6.2 mm -50.31 -50.28 21.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 177.705 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.694 HG22 ' HG ' ' B' ' 85' ' ' LEU . 7.5 p -69.38 -39.7 77.87 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.046 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.953 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -56.76 -32.86 66.02 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.692 -179.121 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.841 HG21 HG13 ' A' ' 42' ' ' VAL . 2.2 m -85.28 -56.23 3.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.021 -1.072 . . . . 0.0 110.272 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.754 HG13 ' HB3' ' A' ' 52' ' ' PRO . 94.2 t -53.92 -39.56 40.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 118.308 -1.357 . . . . 0.0 108.101 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.733 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -77.69 -3.45 41.16 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.101 -1.04 . . . . 0.0 109.012 177.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.619 ' HB2' ' O ' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -103.04 -26.76 12.95 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.253 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.49 43.29 1.37 Allowed Glycine 0 C--N 1.3 -1.418 0 C-N-CA 120.058 -1.068 . . . . 0.0 110.507 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.838 ' CB ' HG23 ' A' ' 35' ' ' THR . 0.1 OUTLIER -129.01 140.94 51.41 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.179 -1.189 . . . . 0.0 109.979 179.241 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.453 ' O ' ' N ' ' A' ' 43' ' ' GLN . 51.3 mtpt -88.08 89.32 7.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.552 -0.717 . . . . 0.0 110.53 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.841 HG13 HG21 ' A' ' 35' ' ' THR . 27.8 m -61.63 80.31 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.608 -0.683 . . . . 0.0 109.939 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.464 ' O ' ' HA ' ' B' ' 2' ' ' ASN . 1.9 tt0 -84.04 107.24 16.27 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.469 -0.769 . . . . 0.0 109.318 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.953 HD12 ' CB ' ' A' ' 48' ' ' LEU . 65.1 mt -61.89 114.67 3.48 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.138 -0.976 . . . . 0.0 109.179 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.588 HG23 ' HD1' ' A' ' 47' ' ' PHE . 0.0 OUTLIER 33.02 -97.5 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.853 -0.529 . . . . 0.0 111.256 -179.614 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.413 ' H ' HG23 ' A' ' 45' ' ' THR . . . -144.44 28.32 1.93 Allowed Glycine 0 N--CA 1.489 2.201 0 C-N-CA 119.726 -1.226 . . . . 0.0 110.39 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.713 ' CD1' ' HG3' ' B' ' 29' ' ' GLU . 3.6 p90 -126.03 -29.54 3.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.903 -1.351 . . . . 0.0 110.517 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.953 ' CB ' HD12 ' A' ' 44' ' ' LEU . 11.9 mt -123.63 93.12 3.84 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.23 -1.544 . . . . 0.0 110.53 177.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -86.86 86.0 7.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.911 -0.493 . . . . 0.0 110.055 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.854 ' CD1' HG23 ' A' ' 79' ' ' VAL . 1.5 mp -82.97 137.81 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.425 -0.797 . . . . 0.0 110.069 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 13.5 ptmt -153.43 127.94 4.66 Favored Pre-proline 0 N--CA 1.494 1.732 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.472 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.754 ' HB3' HG13 ' A' ' 36' ' ' VAL . 41.1 Cg_endo -65.47 141.33 67.05 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 123.539 1.284 . . . . 0.0 111.894 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.732 HG22 ' O ' ' A' ' 76' ' ' GLY . 33.4 m -147.66 117.69 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 CA-C-O 121.326 0.584 . . . . 0.0 111.244 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.582 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.504 2.262 0 O-C-N 121.309 -0.869 . . . . 0.0 112.278 -178.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 1.029 ' HB ' ' HB1' ' B' ' 89' ' ' ALA . 38.2 t . . . . . 0 N--CA 1.48 1.055 0 CA-C-O 122.162 0.982 . . . . 0.0 109.975 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.732 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -126.57 105.62 0.79 Allowed Glycine 0 C--N 1.29 -1.998 0 N-CA-C 108.015 -2.034 . . . . 0.0 108.015 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.771 HG13 ' O ' ' A' ' 77' ' ' VAL . 13.2 p -51.02 89.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.678 -0.895 . . . . 0.0 110.476 -178.686 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.504 ' N ' ' O ' ' A' ' 76' ' ' GLY . 0.5 OUTLIER -58.58 -171.92 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.281 -0.887 . . . . 0.0 110.729 -179.14 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.854 HG23 ' CD1' ' A' ' 50' ' ' ILE . 3.3 p -167.48 -164.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.693 ' H ' HG22 ' A' ' 79' ' ' VAL . 2.0 mttm -160.08 178.59 1.61 Allowed Pre-proline 0 C--N 1.308 -1.211 0 O-C-N 120.914 -1.116 . . . . 0.0 111.335 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.447 ' CD ' ' CB ' ' A' ' 80' ' ' LYS . 55.5 Cg_endo -103.64 83.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 123.977 3.118 . . . . 0.0 108.862 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.651 ' CA ' ' O ' ' A' ' 47' ' ' PHE . . . -57.0 121.63 25.94 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.591 -1.29 . . . . 0.0 111.183 -178.089 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -62.19 -35.74 79.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.53 -0.982 . . . . 0.0 109.043 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.596 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 0.3 OUTLIER -53.94 -30.85 48.35 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.586 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.987 HD21 HG11 ' B' ' 36' ' ' VAL . 8.8 tt -85.26 -34.23 21.99 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.742 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 0.3 OUTLIER -75.35 -44.75 43.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.542 -0.724 . . . . 0.0 109.446 179.606 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 41.4 tptt -64.98 -38.26 90.38 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 177.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.828 ' O ' ' HB1' ' B' ' 37' ' ' ALA . . . -61.65 -36.63 81.35 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 176.358 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.742 ' HB3' ' O ' ' A' ' 86' ' ' LYS . . . -56.42 -39.68 73.46 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.492 ' HA ' ' CB ' ' A' ' 94' ' ' TYR . 6.4 mm-40 -55.9 -28.89 58.81 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 176.558 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 88' ' ' ALA . . . -65.72 -50.84 51.56 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 178.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.624 ' HB3' ' O ' ' B' ' 37' ' ' ALA . 0.4 OUTLIER -59.85 -37.2 78.61 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.417 -1.637 . . . . 0.0 109.64 -179.745 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.596 ' CB ' ' O ' ' A' ' 92' ' ' LEU . 1.1 ttmt 143.82 65.23 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 1.095 ' O ' ' C ' ' A' ' 95' ' ' GLU . 7.7 t80 -49.11 -60.74 2.53 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 116.328 -2.149 . . . . 0.0 106.45 178.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 1.095 ' C ' ' O ' ' A' ' 94' ' ' TYR . 3.8 mm-40 . . . . . 0 CA--C 1.488 -1.417 0 N-CA-C 102.291 -3.226 . . . . 0.0 102.291 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.659 ' HG2' HG12 ' A' ' 42' ' ' VAL . 1.6 tpt . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 120.855 0.36 . . . . 0.0 110.401 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 2' ' ' ASN . . . . . 0.475 ' HB3' ' O ' ' B' ' 1' ' ' MET . 25.9 p30 179.6 -160.49 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.343 -0.943 . . . . 0.0 111.41 178.05 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.559 ' HE3' ' CG2' ' A' ' 45' ' ' THR . 0.1 OUTLIER -52.56 -10.45 0.15 Allowed 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.419 -0.801 . . . . 0.0 110.814 -179.705 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 4' ' ' THR . . . . . 0.502 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 4.4 m -106.43 -51.5 2.94 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.861 -1.149 . . . . 0.0 109.495 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.607 ' CB ' ' HA ' ' B' ' 1' ' ' MET . 1.3 mt-10 -65.46 -37.84 88.05 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.217 -0.927 . . . . 0.0 108.637 179.348 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.81 HD11 ' HB ' ' A' ' 42' ' ' VAL . 24.6 mt -71.88 -27.95 63.2 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 118.892 -1.123 . . . . 0.0 108.214 177.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 7' ' ' ILE . . . . . 0.786 HG23 ' HB ' ' B' ' 21' ' ' VAL . 0.2 OUTLIER -57.31 -60.78 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 177.542 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 8' ' ' LYS . . . . . 0.941 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.0 OUTLIER -62.8 -24.1 67.57 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.581 178.443 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 9' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' B' ' 6' ' ' LEU . . . -60.83 -36.28 78.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.04 -1.038 . . . . 0.0 108.674 178.226 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.915 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.0 OUTLIER -96.56 -35.19 5.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 178.535 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.941 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -60.34 -25.12 65.58 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.359 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -91.27 -43.25 9.92 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 178.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.482 ' HB3' ' CB ' ' A' ' 27' ' ' SER . 1.1 m-20 -64.33 -26.11 68.33 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 177.149 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 14' ' ' THR . . . . . 0.915 ' OG1' ' O ' ' B' ' 10' ' ' ILE . 10.7 p -91.78 -75.1 0.49 Allowed 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 177.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 15' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' B' ' 11' ' ' ALA . . . 57.75 17.78 29.24 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 178.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 16' ' ' LEU . . . . . 0.896 HD22 ' O ' ' A' ' 19' ' ' VAL . 3.8 mp -77.54 -57.13 3.98 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 122.317 1.056 . . . . 0.0 108.532 178.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 17' ' ' THR . . . . . 0.768 ' CG2' HG21 ' A' ' 17' ' ' THR . 0.5 OUTLIER -142.67 5.54 1.59 Allowed 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 115.162 -0.927 . . . . 0.0 109.18 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 18' ' ' GLN . . . . . 0.622 ' O ' ' C ' ' B' ' 19' ' ' VAL . 3.9 mt-30 58.26 25.24 12.43 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 -176.134 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 1.065 HG23 ' CD1' ' A' ' 16' ' ' LEU . 0.2 OUTLIER 9.43 -98.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.437 -178.954 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 20' ' ' SER . . . . . 1.051 ' O ' ' N ' ' B' ' 22' ' ' SER . 1.9 p -136.6 24.14 3.15 Favored 'General case' 0 C--N 1.273 -2.733 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 177.27 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.786 ' HB ' HG23 ' B' ' 7' ' ' ILE . 21.9 m -4.35 -42.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 CA-C-O 122.528 1.156 . . . . 0.0 110.763 -177.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 22' ' ' SER . . . . . 1.051 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.5 OUTLIER -76.62 -38.09 55.31 Favored 'General case' 0 C--N 1.281 -2.407 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.2 178.724 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 23' ' ' LYS . . . . . 0.882 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.0 OUTLIER -89.19 -32.79 17.28 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.437 -0.79 . . . . 0.0 111.302 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 24' ' ' MET . . . . . 0.594 ' HG2' HG22 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -68.83 -37.7 79.35 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 117.322 -1.751 . . . . 0.0 108.736 179.683 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.698 ' HA ' ' HB3' ' B' ' 28' ' ' PHE . 0.3 OUTLIER -82.91 -44.39 15.43 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 118.21 -1.396 . . . . 0.0 109.669 178.234 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 26' ' ' ALA . . . . . 0.541 ' HA ' ' CE ' ' B' ' 3' ' ' LYS . . . -58.4 -35.36 71.9 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.957 -1.089 . . . . 0.0 108.2 178.152 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 27' ' ' SER . . . . . 0.554 ' O ' HG13 ' B' ' 31' ' ' ILE . 20.0 t -81.68 -30.99 32.43 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.468 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 28' ' ' PHE . . . . . 0.738 ' CZ ' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -54.51 -45.09 73.23 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 178.793 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 29' ' ' GLU . . . . . 0.713 ' HG3' ' CD1' ' A' ' 47' ' ' PHE . 1.5 tt0 -69.93 -34.83 73.97 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 176.512 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 1.128 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 7.2 tttp -63.95 -18.27 64.08 Favored 'General case' 0 C--O 1.189 -2.112 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 177.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.69 ' CG1' ' HA ' ' B' ' 28' ' ' PHE . 1.2 pp -108.53 -26.08 3.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 120.32 -1.487 . . . . 0.0 108.617 177.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.624 HD11 ' CE2' ' B' ' 28' ' ' PHE . 1.1 mm -73.42 -57.02 7.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 176.641 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 33' ' ' THR . . . . . 0.561 ' OG1' ' HB2' ' A' ' 85' ' ' LEU . 0.5 OUTLIER -67.19 -40.88 86.59 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.335 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 1.128 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 76.9 mm-40 -74.72 -40.69 61.15 Favored 'General case' 0 C--O 1.207 -1.138 0 O-C-N 121.4 -0.813 . . . . 0.0 112.513 -179.08 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 35' ' ' THR . . . . . 0.557 HG21 ' SD ' ' A' ' 1' ' ' MET . 53.3 m -59.51 -49.11 79.05 Favored 'General case' 0 N--CA 1.505 2.284 0 CA-C-N 120.797 1.635 . . . . 0.0 109.469 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.987 HG11 HD21 ' A' ' 85' ' ' LEU . 1.4 t -53.0 -41.77 42.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 C-N-CA 118.266 -1.374 . . . . 0.0 107.345 178.386 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 37' ' ' ALA . . . . . 0.828 ' HB1' ' O ' ' A' ' 88' ' ' ALA . . . -92.7 11.57 26.33 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.717 -0.793 . . . . 0.0 109.745 178.209 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 38' ' ' LYS . . . . . 0.704 ' HB2' ' O ' ' B' ' 34' ' ' GLU . 1.4 tppt? -104.76 -29.26 10.67 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 177.112 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.82 34.56 0.43 Allowed Glycine 0 C--N 1.305 -1.183 0 C-N-CA 119.835 -1.174 . . . . 0.0 111.042 177.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 40' ' ' ASP . . . . . 0.49 ' HB2' HG23 ' B' ' 35' ' ' THR . 0.1 OUTLIER -150.94 179.82 7.92 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.869 -1.371 . . . . 0.0 110.785 179.638 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.409 ' O ' ' HG3' ' B' ' 43' ' ' GLN . 5.0 mtmp? -133.2 113.6 12.86 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 1.008 HG13 HD11 ' A' ' 6' ' ' LEU . 59.2 t -61.24 140.52 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.441 -0.787 . . . . 0.0 110.499 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 43' ' ' GLN . . . . . 0.5 ' HA ' ' HA ' ' B' ' 49' ' ' ASN . 43.6 mt-30 -140.53 82.91 1.87 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.524 -0.735 . . . . 0.0 109.826 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.749 HD12 ' HB3' ' B' ' 48' ' ' LEU . 5.6 mt -59.79 117.5 5.07 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.274 -0.891 . . . . 0.0 110.704 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 45' ' ' THR . . . . . 0.594 HG23 ' CD2' ' B' ' 47' ' ' PHE . 0.0 OUTLIER 24.38 -92.73 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.243 0 O-C-N 122.16 -0.337 . . . . 0.0 111.436 179.062 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 46' ' ' GLY . . . . . 0.488 ' H ' HG23 ' B' ' 45' ' ' THR . . . -146.54 48.3 0.67 Allowed Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 47' ' ' PHE . . . . . 1.054 ' CE1' HG21 ' A' ' 32' ' ' ILE . 16.5 p90 -151.27 -40.09 0.12 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.963 -1.316 . . . . 0.0 111.671 179.11 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.863 HD13 ' CB ' ' B' ' 80' ' ' LYS . 0.0 OUTLIER -116.86 107.94 15.22 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.703 -1.248 . . . . 0.0 110.378 179.401 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 49' ' ' ASN . . . . . 0.945 ' O ' ' O ' ' B' ' 79' ' ' VAL . 0.8 OUTLIER -124.54 97.49 5.32 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.997 -1.064 . . . . 0.0 110.606 -179.495 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 50' ' ' ILE . . . . . 0.508 ' H ' ' HD3' ' B' ' 80' ' ' LYS . 0.5 OUTLIER -88.56 143.89 10.27 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 O-C-N 121.496 -0.753 . . . . 0.0 110.883 -179.211 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 51' ' ' LYS . . . . . 0.55 ' HG3' ' HB2' ' B' ' 78' ' ' SER . 0.0 OUTLIER -159.88 136.69 6.66 Favored Pre-proline 0 N--CA 1.495 1.792 0 C-N-CA 119.416 -0.914 . . . . 0.0 110.023 179.6 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 52' ' ' PRO . . . . . 0.736 ' HB3' HG13 ' B' ' 36' ' ' VAL . 56.6 Cg_endo -89.28 144.86 4.98 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.752 1.396 . . . . 0.0 112.58 -178.305 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.59 HG22 ' O ' ' B' ' 76' ' ' GLY . 33.3 m -144.23 113.16 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-O 121.655 0.741 . . . . 0.0 109.709 177.226 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 54' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' B' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.495 1.822 0 CA-C-O 122.0 0.905 . . . . 0.0 112.462 -178.063 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 75' ' ' VAL . . . . . 0.715 HG11 ' CB ' ' A' ' 89' ' ' ALA . 6.1 p . . . . . 0 N--CA 1.495 1.789 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 76' ' ' GLY . . . . . 0.59 ' O ' HG22 ' B' ' 53' ' ' VAL . . . -118.26 45.14 1.3 Allowed Glycine 0 N--CA 1.488 2.16 0 C-N-CA 118.898 -1.62 . . . . 0.0 109.825 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.877 ' CG2' HD22 ' A' ' 85' ' ' LEU . 6.5 p -28.13 91.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 122.061 -0.67 . . . . 0.0 110.828 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 78' ' ' SER . . . . . 0.55 ' HB2' ' HG3' ' B' ' 51' ' ' LYS . 57.7 m -57.91 -122.12 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 119.864 -0.734 . . . . 0.0 109.102 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.945 ' O ' ' O ' ' B' ' 49' ' ' ASN . 4.5 m -148.41 -168.88 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 119.859 -1.776 . . . . 0.0 112.868 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 80' ' ' LYS . . . . . 0.888 ' H ' ' HD2' ' B' ' 81' ' ' PRO . 0.0 OUTLIER -114.58 -52.92 0.04 OUTLIER Pre-proline 0 C--N 1.301 -1.531 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -178.403 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 81' ' ' PRO . . . . . 0.888 ' HD2' ' H ' ' B' ' 80' ' ' LYS . 26.7 Cg_endo -49.49 130.59 25.99 Favored 'Trans proline' 0 C--N 1.298 -2.106 0 C-N-CA 120.869 1.046 . . . . 0.0 112.551 -175.164 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -128.04 -62.8 0.13 Allowed Glycine 0 N--CA 1.486 1.981 0 N-CA-C 105.856 -2.897 . . . . 0.0 105.856 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 83' ' ' GLU . . . . . 0.885 ' O ' ' N ' ' B' ' 85' ' ' LEU . 26.3 tt0 -91.03 47.6 1.42 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.514 -1.662 . . . . 0.0 106.514 175.322 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 84' ' ' SER . . . . . 1.286 ' O ' ' N ' ' B' ' 86' ' ' LYS . 4.5 m 8.45 43.79 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.506 1.146 . . . . 0.0 110.875 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 1.026 ' C ' ' O ' ' B' ' 84' ' ' SER . 4.3 mp 22.01 29.66 0.0 OUTLIER 'General case' 0 C--O 1.194 -1.831 0 N-CA-C 103.599 -2.741 . . . . 0.0 103.599 -171.341 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 86' ' ' LYS . . . . . 1.286 ' N ' ' O ' ' B' ' 84' ' ' SER 0.319 6.5 tttm -51.85 -34.78 42.13 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 103.459 -2.793 . . . . 0.0 103.459 175.997 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 87' ' ' LYS . . . . . 0.456 ' O ' ' CG ' ' B' ' 90' ' ' GLU 0.286 16.8 tptp -68.01 -36.2 79.58 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 111.773 -2.467 . . . . 0.0 106.609 175.565 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.919 ' HB3' ' HB3' ' B' ' 85' ' ' LEU . . . -80.38 -26.2 38.7 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 118.349 -1.34 . . . . 0.0 107.764 177.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 1.029 ' HB1' ' HB ' ' A' ' 75' ' ' VAL . . . -67.27 -50.11 61.74 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.53 -0.731 . . . . 0.0 109.051 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 90' ' ' GLU . . . . . 0.456 ' CG ' ' O ' ' B' ' 87' ' ' LYS . 6.5 pt-20 -57.03 -27.83 61.98 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 176.638 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 91' ' ' GLY . . . . . 0.44 ' N ' ' HG3' ' B' ' 90' ' ' GLU . . . -63.32 -38.25 96.13 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 178.442 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 92' ' ' LEU . . . . . 0.843 HD23 ' HA ' ' B' ' 89' ' ' ALA . 0.9 OUTLIER -85.37 23.48 1.31 Allowed 'General case' 0 N--CA 1.503 2.222 0 O-C-N 120.493 -1.592 . . . . 0.0 110.5 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 93' ' ' LYS . . . . . 0.458 ' O ' ' N ' ' B' ' 96' ' ' ASP . 0.4 OUTLIER 58.58 48.17 12.24 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 -177.659 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 94' ' ' TYR . . . . . 0.721 ' C ' ' CD1' ' B' ' 94' ' ' TYR . 0.0 OUTLIER -42.98 -37.11 1.77 Allowed 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.762 -178.51 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 95' ' ' GLU . . . . . 0.469 ' N ' ' CD1' ' B' ' 94' ' ' TYR . 8.8 pt-20 -53.85 -39.48 65.65 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.258 -0.901 . . . . 0.0 109.097 178.516 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 96' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' B' ' 93' ' ' LYS . 0.2 OUTLIER -65.96 -28.5 68.95 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.308 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.412 0 O-C-N 121.549 -0.719 . . . . 0.0 109.185 178.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.575 ' CE ' HD23 ' A' ' 6' ' ' LEU . 3.8 mtp . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 120.908 0.385 . . . . 0.0 110.064 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.805 ' C ' HD12 ' A' ' 6' ' ' LEU . 27.3 p30 -177.82 -167.75 0.16 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.215 -0.928 . . . . 0.0 111.28 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.607 ' HG2' HD13 ' A' ' 25' ' ' LEU . 12.7 tttt -51.31 -16.63 0.56 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.555 -0.716 . . . . 0.0 110.252 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.609 ' O ' HG12 ' A' ' 7' ' ' ILE . 41.0 m -104.69 -58.95 1.81 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.263 -0.898 . . . . 0.0 110.271 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.455 ' HB2' ' H ' ' A' ' 2' ' ' ASN . 3.5 mm-40 -54.88 -45.54 74.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.125 -0.985 . . . . 0.0 109.762 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.805 HD12 ' C ' ' A' ' 2' ' ' ASN . 12.0 mt -52.04 -45.85 64.81 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.389 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.72 HG21 HD22 ' A' ' 25' ' ' LEU . 0.6 OUTLIER -56.36 -45.99 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 178.271 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.866 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 0.9 OUTLIER -56.67 -39.94 74.65 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 176.828 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.913 ' CB ' HD13 ' B' ' 31' ' ' ILE . . . -54.85 -35.71 64.3 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 178.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.768 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.5 mp -88.33 -32.45 5.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 177.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.866 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -67.89 -10.84 56.5 Favored 'General case' 0 C--N 1.287 -2.12 0 C-N-CA 118.999 -1.08 . . . . 0.0 108.969 178.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.449 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -120.6 -34.73 3.53 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.356 -0.84 . . . . 0.0 110.333 179.157 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.479 ' HB3' ' HB2' ' B' ' 27' ' ' SER . 0.9 OUTLIER -74.94 -36.88 62.11 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 176.823 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . 1.113 HG22 ' CD1' ' A' ' 16' ' ' LEU 0.268 0.2 OUTLIER -91.96 -70.28 0.7 Allowed 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 177.95 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 54.45 21.49 20.56 Favored Glycine 0 N--CA 1.5 2.908 0 O-C-N 121.534 -0.729 . . . . 0.0 111.445 177.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 1.113 ' CD1' HG22 ' A' ' 14' ' ' THR . 5.0 mp -64.7 -62.87 1.31 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.362 -1.081 . . . . 0.0 109.01 178.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.675 HG21 HG21 ' B' ' 17' ' ' THR . 0.5 OUTLIER -138.82 6.45 2.44 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.866 -179.815 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.594 ' O ' ' C ' ' A' ' 19' ' ' VAL . 6.3 mt-30 57.53 26.92 13.32 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 -176.107 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 1.057 HG11 HG11 ' B' ' 19' ' ' VAL . 1.2 p -0.83 -95.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.802 -178.132 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.96 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -133.2 25.79 4.19 Favored 'General case' 0 C--N 1.277 -2.575 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 179.005 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.66 ' HA ' ' CE ' ' A' ' 24' ' ' MET . 31.0 m -19.1 -39.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 CA-C-O 122.483 1.135 . . . . 0.0 109.505 -178.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.854 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.6 OUTLIER -77.7 -40.47 41.25 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.362 177.522 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.96 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -85.6 -38.94 17.88 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 121.543 -0.723 . . . . 0.0 111.577 179.891 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.66 ' CE ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -66.22 -27.21 67.8 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 117.315 -1.754 . . . . 0.0 108.176 179.368 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.72 HD22 HG21 ' A' ' 7' ' ' ILE . 0.4 OUTLIER -74.64 -45.1 47.07 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 118.827 -1.149 . . . . 0.0 108.838 177.933 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.672 ' N ' ' HG ' ' A' ' 25' ' ' LEU . . . -63.99 -25.27 68.05 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 178.535 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.568 ' HA ' ' HB3' ' A' ' 30' ' ' LYS . 19.1 p -85.3 -41.03 15.9 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.424 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.692 ' CE1' HD22 ' B' ' 44' ' ' LEU . 0.0 OUTLIER -57.33 -48.23 79.52 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.087 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.587 ' HG3' ' CE2' ' B' ' 47' ' ' PHE . 0.7 OUTLIER -68.6 -35.14 76.94 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.034 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 1.248 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 13.8 ttmt -64.85 -22.13 66.93 Favored 'General case' 0 C--O 1.191 -2.023 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 177.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.881 HD13 ' CB ' ' B' ' 9' ' ' ALA . 0.6 OUTLIER -105.08 -28.44 2.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 120.068 -1.645 . . . . 0.0 109.17 178.076 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.651 HG21 ' CE1' ' B' ' 47' ' ' PHE . 1.2 mm -72.24 -61.15 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 176.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.819 ' HA ' HD23 ' B' ' 85' ' ' LEU . 0.5 OUTLIER -67.8 -35.27 78.34 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.282 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 1.248 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 27.4 mm-40 -77.8 -32.31 52.32 Favored 'General case' 0 N--CA 1.482 1.138 0 O-C-N 120.958 -1.089 . . . . 0.0 111.214 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.748 HG23 ' CB ' ' A' ' 40' ' ' ASP . 1.8 m -59.3 -50.93 72.11 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.32 -1.488 . . . . 0.0 107.457 178.627 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.05 HG21 HG23 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -53.89 -36.49 30.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 C-N-CA 117.918 -1.513 . . . . 0.0 107.006 177.868 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.606 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -80.43 -7.86 59.31 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.677 0.751 . . . . 0.0 109.632 177.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.555 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -100.26 -8.21 23.73 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 177.566 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 80.47 47.49 6.82 Favored Glycine 0 C--N 1.302 -1.316 0 N-CA-C 110.201 -1.159 . . . . 0.0 110.201 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.748 ' CB ' HG23 ' A' ' 35' ' ' THR . 0.3 OUTLIER -130.28 119.51 22.97 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.295 -1.121 . . . . 0.0 110.314 179.594 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -76.09 81.9 2.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.479 -0.763 . . . . 0.0 109.519 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.86 ' CG2' HD11 ' B' ' 6' ' ' LEU . 5.9 p -63.6 144.91 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.439 -0.788 . . . . 0.0 110.253 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -128.01 98.87 5.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.502 -0.749 . . . . 0.0 109.876 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.75 HD12 ' HB3' ' A' ' 48' ' ' LEU . 8.7 mt -61.62 108.22 0.94 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.256 -0.902 . . . . 0.0 109.495 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.55 HG21 ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER 31.12 -91.77 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.315 0 O-C-N 122.003 -0.436 . . . . 0.0 111.189 -179.669 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -149.48 32.36 1.12 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.738 ' CD1' HD21 ' A' ' 85' ' ' LEU . 2.1 p90 -134.92 -23.04 1.57 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.031 -1.276 . . . . 0.0 111.936 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.872 HD23 ' O ' ' A' ' 80' ' ' LYS . 5.0 mt -130.82 118.23 20.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.259 -1.525 . . . . 0.0 111.166 178.171 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.447 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 2.1 m-20 -115.92 93.57 4.31 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.544 -0.723 . . . . 0.0 110.513 -179.603 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.866 HG23 HG22 ' A' ' 79' ' ' VAL . 9.5 mm -87.63 132.94 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.313 -0.867 . . . . 0.0 109.282 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.501 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 0.5 OUTLIER -149.85 126.06 5.16 Favored Pre-proline 0 N--CA 1.497 1.895 0 C-N-CA 118.57 -1.252 . . . . 0.0 111.038 179.959 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.881 ' HB3' HG22 ' A' ' 36' ' ' VAL . 56.1 Cg_endo -81.48 138.95 11.16 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.439 1.231 . . . . 0.0 110.51 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.706 HG22 ' O ' ' A' ' 76' ' ' GLY . 28.6 m -140.84 115.61 6.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-O 121.546 0.689 . . . . 0.0 110.377 179.268 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.491 ' HB2' ' HB3' ' B' ' 97' ' ' PHE . . . . . . . . 0 N--CA 1.498 1.962 0 CA-C-O 121.824 0.821 . . . . 0.0 112.139 -178.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.683 HG12 ' CB ' ' B' ' 89' ' ' ALA . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.804 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.706 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -113.49 70.69 0.23 Allowed Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 1.05 HG23 HG21 ' A' ' 36' ' ' VAL . 2.6 p -51.07 79.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.821 -0.811 . . . . 0.0 110.18 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.774 ' O ' HG23 ' A' ' 79' ' ' VAL . 0.7 OUTLIER -73.53 178.16 4.85 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.227 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.866 HG22 HG23 ' A' ' 50' ' ' ILE . 41.8 t -166.5 175.99 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.872 ' O ' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -175.33 169.15 1.56 Allowed Pre-proline 0 C--N 1.308 -1.225 0 O-C-N 120.982 -1.074 . . . . 0.0 110.045 176.662 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.587 ' HB2' HG13 ' B' ' 77' ' ' VAL . 55.8 Cg_endo -103.32 137.84 0.12 Allowed 'Trans proline' 0 C--N 1.3 -1.991 0 C-N-CA 122.962 2.442 . . . . 0.0 110.727 178.217 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.503 ' HA3' ' HA ' ' A' ' 47' ' ' PHE . . . -89.83 -148.11 18.59 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 107.437 -2.265 . . . . 0.0 107.437 177.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.403 ' HA ' ' HB2' ' A' ' 86' ' ' LYS . 2.0 pm0 -101.28 -13.96 17.85 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.064 -1.256 . . . . 0.0 109.803 178.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.458 ' CB ' ' HB3' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -56.5 -32.97 65.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.3 -0.875 . . . . 0.0 108.953 179.161 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.893 HD23 ' HA ' ' B' ' 33' ' ' THR . 0.5 OUTLIER -82.48 -31.73 29.19 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.961 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.456 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 0.1 OUTLIER -75.53 -39.98 57.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.485 -0.759 . . . . 0.0 110.173 -179.399 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.1 ttmt -70.22 -37.61 75.06 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.641 ' O ' ' HB1' ' B' ' 37' ' ' ALA . . . -69.18 -34.03 74.29 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 176.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.967 ' HA ' HD23 ' A' ' 92' ' ' LEU . . . -59.89 -43.52 94.75 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.089 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.46 -32.91 52.11 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.25 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -66.11 -35.78 90.99 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 178.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.967 HD23 ' HA ' ' A' ' 89' ' ' ALA . 0.5 OUTLIER -72.69 7.21 2.03 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.722 -1.457 . . . . 0.0 111.438 -179.715 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.414 ' CB ' ' O ' ' A' ' 92' ' ' LEU . 0.1 OUTLIER 63.75 38.42 9.23 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -177.862 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.652 ' HB2' ' HB ' ' B' ' 75' ' ' VAL . 0.4 OUTLIER -43.69 -35.75 1.94 Allowed 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.506 -179.238 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.458 ' N ' ' CG ' ' A' ' 94' ' ' TYR . 15.2 pt-20 . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.4 -0.812 . . . . 0.0 109.157 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.661 ' HG3' HG23 ' A' ' 42' ' ' VAL . 4.0 ptp . . . . . 0 N--CA 1.495 1.807 0 CA-C-O 121.605 0.717 . . . . 0.0 110.577 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 2' ' ' ASN . . . . . 0.444 ' HB3' ' O ' ' B' ' 1' ' ' MET . 14.1 p-10 179.72 -157.93 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.542 178.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.55 ' HE2' HG21 ' A' ' 45' ' ' THR . 9.7 mttm -53.92 -11.53 0.44 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.253 -0.904 . . . . 0.0 110.761 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 4' ' ' THR . . . . . 0.438 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 15.4 m -101.04 -55.03 2.66 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.039 -1.038 . . . . 0.0 110.008 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.489 ' CB ' ' CB ' ' B' ' 1' ' ' MET . 2.5 mp0 -64.09 -50.16 69.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.195 -0.94 . . . . 0.0 109.24 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.86 HD11 ' CG2' ' A' ' 42' ' ' VAL . 32.5 mt -53.94 -43.28 69.69 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.151 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 7' ' ' ILE . . . . . 0.851 HG23 ' HB ' ' B' ' 21' ' ' VAL . 0.3 OUTLIER -50.24 -52.4 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 177.163 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 8' ' ' LYS . . . . . 0.936 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.0 OUTLIER -56.26 -39.73 73.06 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.056 177.22 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 9' ' ' ALA . . . . . 0.881 ' CB ' HD13 ' A' ' 31' ' ' ILE . . . -49.61 -38.1 30.55 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.195 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.714 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.4 mp -93.63 -32.0 4.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 178.009 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.936 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -68.23 -8.49 39.55 Favored 'General case' 0 C--N 1.291 -1.973 0 C-N-CA 118.377 -1.329 . . . . 0.0 109.012 178.381 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.515 ' HB3' ' O ' ' B' ' 8' ' ' LYS . 0.9 OUTLIER -119.9 -41.84 2.64 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.364 -0.835 . . . . 0.0 109.674 179.294 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.491 ' CB ' ' HB2' ' A' ' 27' ' ' SER . 1.5 m-20 -70.28 -35.4 73.71 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 177.315 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 14' ' ' THR . . . . . 0.901 HG22 ' CD2' ' B' ' 16' ' ' LEU 0.262 0.2 OUTLIER -96.72 -79.27 0.45 Allowed 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 177.592 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 52.47 5.01 0.17 Allowed Glycine 0 N--CA 1.502 3.04 0 O-C-N 121.226 -0.921 . . . . 0.0 111.793 177.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 16' ' ' LEU . . . . . 0.901 ' CD2' HG22 ' B' ' 14' ' ' THR . 0.7 OUTLIER -61.43 -23.7 66.01 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.127 -1.219 . . . . 0.0 110.052 179.524 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 17' ' ' THR . . . . . 0.675 HG21 HG21 ' A' ' 17' ' ' THR . 0.5 OUTLIER -159.82 -9.98 0.06 Allowed 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.707 -0.621 . . . . 0.0 110.482 -179.783 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 18' ' ' GLN . . . . . 0.645 ' O ' ' C ' ' B' ' 19' ' ' VAL . 7.3 mt-30 54.94 35.94 25.64 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 -177.431 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 1.057 HG11 HG11 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -10.53 -92.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.165 -179.329 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 20' ' ' SER . . . . . 1.063 ' O ' ' N ' ' B' ' 22' ' ' SER . 4.5 p -134.96 24.9 3.61 Favored 'General case' 0 C--N 1.282 -2.368 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 176.528 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.851 ' HB ' HG23 ' B' ' 7' ' ' ILE . 30.7 m -4.48 -41.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 CA-C-O 122.561 1.172 . . . . 0.0 110.976 -177.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 22' ' ' SER . . . . . 1.063 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.6 OUTLIER -76.74 -37.3 56.21 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.766 179.13 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 23' ' ' LYS . . . . . 0.837 ' N ' ' O ' ' B' ' 20' ' ' SER . 1.5 mtmt -89.6 -31.47 17.55 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.318 -0.864 . . . . 0.0 110.811 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 24' ' ' MET . . . . . 0.696 ' HB3' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -68.65 -39.69 80.59 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 117.191 -1.804 . . . . 0.0 108.759 179.285 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.704 HD12 HG13 ' B' ' 7' ' ' ILE . 0.3 OUTLIER -77.02 -45.09 28.45 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 118.132 -1.427 . . . . 0.0 108.431 177.574 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 26' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' B' ' 22' ' ' SER . . . -55.26 -34.46 64.06 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.013 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 27' ' ' SER . . . . . 0.484 ' O ' HG13 ' B' ' 31' ' ' ILE . 90.8 p -81.49 -35.44 30.46 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.332 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 28' ' ' PHE . . . . . 0.668 ' O ' HG13 ' B' ' 31' ' ' ILE . 0.7 OUTLIER -53.41 -49.17 67.83 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.633 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 29' ' ' GLU . . . . . 0.728 ' HG3' ' CD2' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -67.55 -34.88 77.97 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 177.184 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 1.183 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 53.1 tttm -64.51 -21.55 66.71 Favored 'General case' 0 C--O 1.19 -2.064 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.056 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.913 HD13 ' CB ' ' A' ' 9' ' ' ALA . 0.6 OUTLIER -105.61 -26.69 3.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 O-C-N 120.163 -1.586 . . . . 0.0 109.062 177.924 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.631 HD11 ' CE2' ' B' ' 28' ' ' PHE . 1.2 mm -74.87 -58.14 5.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 176.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 33' ' ' THR . . . . . 0.893 ' HA ' HD23 ' A' ' 85' ' ' LEU . 0.6 OUTLIER -70.15 -35.5 74.08 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.263 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 1.183 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 50.9 mm-40 -76.69 -32.84 58.15 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 119.314 -0.954 . . . . 0.0 111.033 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 35' ' ' THR . . . . . 0.671 HG21 ' CG2' ' B' ' 42' ' ' VAL . 2.2 m -61.68 -50.79 71.07 Favored 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 118.015 -1.474 . . . . 0.0 107.942 178.517 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.735 HG21 HG23 ' B' ' 77' ' ' VAL . 1.2 t -54.12 -36.0 30.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 177.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 37' ' ' ALA . . . . . 0.641 ' HB1' ' O ' ' A' ' 88' ' ' ALA . . . -81.5 -5.44 57.96 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-O 121.655 0.74 . . . . 0.0 109.346 177.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 38' ' ' LYS . . . . . 0.511 ' N ' ' O ' ' B' ' 34' ' ' GLU . 0.9 OUTLIER -99.08 -25.08 14.66 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 177.833 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.32 39.5 2.09 Favored Glycine 0 C--N 1.303 -1.292 0 C-N-CA 120.183 -1.008 . . . . 0.0 110.795 177.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 40' ' ' ASP . . . . . 0.613 ' CB ' HG23 ' B' ' 35' ' ' THR . 0.1 OUTLIER -131.02 133.35 45.67 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.984 -1.304 . . . . 0.0 110.567 179.528 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.51 89.45 6.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.546 -0.721 . . . . 0.0 109.879 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.671 ' CG2' HG21 ' B' ' 35' ' ' THR . 58.6 t -60.02 127.3 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.59 -0.694 . . . . 0.0 110.449 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 43' ' ' GLN . . . . . 0.458 ' HA ' ' HA ' ' B' ' 49' ' ' ASN . 1.9 tt0 -119.32 99.63 6.81 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 121.391 -0.818 . . . . 0.0 109.548 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.897 HD12 ' HB3' ' B' ' 48' ' ' LEU . 12.6 mt -71.98 87.72 1.05 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.156 -0.965 . . . . 0.0 110.386 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 45' ' ' THR . . . . . 0.508 ' HB ' ' HD2' ' A' ' 3' ' ' LYS . 1.8 t 36.2 29.58 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 46' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . 93.31 -26.02 17.56 Favored Glycine 0 N--CA 1.491 2.347 0 C-N-CA 119.883 -1.151 . . . . 0.0 112.453 177.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 47' ' ' PHE . . . . . 0.95 ' CD1' HD21 ' B' ' 85' ' ' LEU . 0.4 OUTLIER -81.72 -29.76 32.81 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 119.738 1.769 . . . . 0.0 111.415 -178.776 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.897 ' HB3' HD12 ' B' ' 44' ' ' LEU . 4.6 mt -133.65 95.21 3.43 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.475 -1.391 . . . . 0.0 110.367 177.599 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 49' ' ' ASN . . . . . 0.468 ' O ' ' HA ' ' B' ' 79' ' ' VAL . 17.3 t-20 -103.22 90.23 3.66 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.222 -0.924 . . . . 0.0 111.368 -179.326 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 50' ' ' ILE . . . . . 0.6 HD11 HD11 ' A' ' 48' ' ' LEU . 1.2 mm -73.44 141.84 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.495 -0.753 . . . . 0.0 109.468 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 51' ' ' LYS . . . . . 0.419 ' O ' ' HG3' ' B' ' 51' ' ' LYS . 9.6 ptmt -152.52 115.57 2.88 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 120.889 -1.132 . . . . 0.0 110.656 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 52' ' ' PRO . . . . . 0.545 ' HA ' ' HA ' ' B' ' 77' ' ' VAL . 52.7 Cg_endo -77.14 142.89 22.1 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 O-C-N 123.528 1.278 . . . . 0.0 111.194 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.733 HG22 ' O ' ' B' ' 76' ' ' GLY . 33.2 m -143.15 116.35 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-O 121.416 0.627 . . . . 0.0 110.528 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 54' ' ' ALA . . . . . 0.583 ' HA ' ' HA ' ' B' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.5 2.042 0 CA-C-O 121.782 0.801 . . . . 0.0 112.213 -178.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 75' ' ' VAL . . . . . 0.652 ' HB ' ' HB2' ' A' ' 94' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.696 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 76' ' ' GLY . . . . . 0.733 ' O ' HG22 ' B' ' 53' ' ' VAL . . . -114.25 75.63 0.24 Allowed Glycine 0 N--CA 1.486 1.99 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.878 HG21 ' CB ' ' A' ' 85' ' ' LEU . 2.8 p -51.54 82.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.79 -0.829 . . . . 0.0 110.365 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 78' ' ' SER . . . . . 0.584 ' N ' ' O ' ' B' ' 76' ' ' GLY . 0.5 OUTLIER -80.81 177.91 8.73 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.819 -0.753 . . . . 0.0 110.034 179.762 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.615 HG22 ' N ' ' B' ' 80' ' ' LYS . 7.4 p 177.97 177.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 80' ' ' LYS . . . . . 0.672 ' O ' HD23 ' B' ' 48' ' ' LEU . 2.7 ptpt -171.85 173.26 1.69 Allowed Pre-proline 0 C--N 1.307 -1.265 0 O-C-N 120.845 -1.159 . . . . 0.0 110.539 178.025 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 81' ' ' PRO . . . . . 0.508 ' HA ' ' O ' ' B' ' 47' ' ' PHE . 55.5 Cg_endo -98.9 128.6 0.19 Allowed 'Trans proline' 0 C--N 1.3 -1.989 0 C-N-CA 122.689 2.259 . . . . 0.0 110.549 178.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 82' ' ' GLY . . . . . 0.475 ' H ' ' HA ' ' B' ' 47' ' ' PHE . . . -81.8 -155.33 14.68 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 107.941 -2.064 . . . . 0.0 107.941 178.31 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 83' ' ' GLU . . . . . 0.446 ' HA ' ' HB2' ' B' ' 86' ' ' LYS . 3.4 pm0 -93.84 -15.35 25.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.097 -1.237 . . . . 0.0 109.977 179.07 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.38 -36.93 66.9 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.247 -0.908 . . . . 0.0 109.144 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.95 HD21 ' CD1' ' B' ' 47' ' ' PHE . 0.3 OUTLIER -82.29 -32.26 29.64 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.487 -0.758 . . . . 0.0 109.017 179.116 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 86' ' ' LYS . . . . . 0.478 ' O ' ' HB3' ' B' ' 89' ' ' ALA . 2.2 mttp -73.39 -37.43 65.98 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.496 -0.752 . . . . 0.0 109.922 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 28.5 tptt -69.66 -37.99 76.93 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 178.026 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.591 ' CB ' ' HB2' ' A' ' 37' ' ' ALA . . . -67.85 -34.43 76.69 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 176.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.985 ' HA ' HD23 ' B' ' 92' ' ' LEU . . . -59.67 -44.6 93.54 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.073 179.082 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -53.52 -31.83 47.93 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 177.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -68.43 -32.68 75.72 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 178.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 92' ' ' LEU . . . . . 0.985 HD23 ' HA ' ' B' ' 89' ' ' ALA . 0.5 OUTLIER -73.33 8.97 1.45 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.748 -1.443 . . . . 0.0 111.426 -179.728 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 61.55 38.43 15.61 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 -177.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 94' ' ' TYR . . . . . 0.629 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 0.2 OUTLIER -45.43 -37.7 5.36 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.609 -178.998 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 95' ' ' GLU . . . . . 0.448 ' N ' ' CG ' ' B' ' 94' ' ' TYR . 2.6 pp20? -57.28 -38.01 73.28 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.324 -0.86 . . . . 0.0 109.162 179.267 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.06 -34.84 78.43 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 177.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 97' ' ' PHE . . . . . 0.491 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.481 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.312 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.605 ' CG ' ' HB3' ' A' ' 5' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 121.096 0.474 . . . . 0.0 110.25 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.565 ' N ' ' HB2' ' A' ' 5' ' ' GLU . 2.0 t-20 -177.24 -178.84 0.82 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.187 -0.946 . . . . 0.0 110.931 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.818 ' O ' HD22 ' A' ' 25' ' ' LEU . 8.4 mttt -46.67 -25.13 0.66 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.64 -0.663 . . . . 0.0 109.852 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.458 ' O ' HG22 ' A' ' 7' ' ' ILE . 8.3 m -101.63 -52.4 3.22 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.396 -0.815 . . . . 0.0 110.111 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.605 ' HB3' ' CG ' ' A' ' 1' ' ' MET . 6.7 mt-10 -53.7 -47.61 70.33 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.107 -0.996 . . . . 0.0 108.573 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.641 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 4.1 mt -55.37 -37.67 67.83 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 119.177 -1.009 . . . . 0.0 108.814 177.261 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.763 ' CD1' HD23 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -50.77 -44.86 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.081 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.751 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -68.18 -32.4 72.61 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.745 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.641 ' HB3' ' O ' ' A' ' 6' ' ' LEU . . . -53.23 -38.52 63.01 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.369 -0.832 . . . . 0.0 109.033 179.061 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.765 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.3 mp -102.32 -29.7 3.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.413 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.751 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -69.11 -11.32 60.69 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 118.554 -1.259 . . . . 0.0 108.577 178.57 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.418 ' CG ' ' O ' ' A' ' 8' ' ' LYS . 54.0 mm-40 -113.74 -42.49 3.42 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.484 -0.76 . . . . 0.0 109.053 178.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.425 ' HB2' ' O ' ' A' ' 9' ' ' ALA . 1.5 m-20 -65.54 -36.17 83.0 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 177.196 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.765 ' OG1' ' O ' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -99.69 -73.04 0.64 Allowed 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 178.144 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 46.32 22.55 0.99 Allowed Glycine 0 N--CA 1.5 2.919 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 178.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 1.079 ' CD1' HG23 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -75.05 -26.25 59.27 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 121.507 -0.996 . . . . 0.0 108.8 179.323 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.729 HG22 ' H ' ' A' ' 19' ' ' VAL . 0.4 OUTLIER -162.05 -2.91 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.932 -179.191 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.575 ' O ' ' C ' ' A' ' 19' ' ' VAL . 21.9 mt-30 57.92 28.16 15.73 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -176.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 1.002 ' O ' HD22 ' B' ' 16' ' ' LEU . 1.6 p -1.76 -90.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.235 -178.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.958 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.4 OUTLIER -129.98 25.6 5.26 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 178.918 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.791 ' HA ' ' CE ' ' A' ' 24' ' ' MET . 13.5 m -22.91 -41.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 CA-C-O 122.576 1.179 . . . . 0.0 108.777 -178.397 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.747 ' N ' ' O ' ' A' ' 20' ' ' SER . 6.6 m -76.36 -37.74 56.83 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.731 177.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.958 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.9 OUTLIER -89.01 -38.73 14.19 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.493 -0.755 . . . . 0.0 111.717 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.791 ' CE ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -66.88 -27.75 67.77 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.075 -1.64 . . . . 0.0 109.178 179.648 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.818 HD22 ' O ' ' A' ' 3' ' ' LYS . 0.2 OUTLIER -82.94 -45.47 14.11 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 118.865 -1.134 . . . . 0.0 108.982 178.618 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.651 ' N ' ' HG ' ' A' ' 25' ' ' LEU . . . -66.4 -27.64 68.01 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.56 ' O ' ' N ' ' A' ' 31' ' ' ILE . 52.9 p -87.76 -31.24 19.73 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.426 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.829 ' O ' HG13 ' A' ' 31' ' ' ILE . 0.1 OUTLIER -55.66 -48.17 75.47 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.562 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.576 ' HG3' ' CE2' ' B' ' 47' ' ' PHE . 1.0 OUTLIER -69.89 -36.37 75.37 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 177.01 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 1.201 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 35.7 tttp -65.22 -17.8 64.78 Favored 'General case' 0 C--O 1.19 -2.043 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.066 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.829 HG13 ' O ' ' A' ' 28' ' ' PHE . 1.2 pp -108.56 -30.07 2.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 120.195 -1.566 . . . . 0.0 108.916 178.483 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.598 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.1 mm -71.41 -58.06 6.05 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 176.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.982 ' HA ' HD23 ' B' ' 85' ' ' LEU . 0.6 OUTLIER -69.95 -42.26 73.45 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.915 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 1.201 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 55.1 mm-40 -68.39 -34.39 75.95 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 120.728 -1.232 . . . . 0.0 111.178 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.867 HG21 HG23 ' A' ' 42' ' ' VAL . 1.8 m -57.85 -49.1 77.83 Favored 'General case' 0 N--CA 1.5 2.037 0 C-N-CA 118.071 -1.451 . . . . 0.0 107.446 178.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.912 HG13 ' HB3' ' A' ' 52' ' ' PRO . 36.4 t -55.13 -35.81 36.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 C-N-CA 117.85 -1.54 . . . . 0.0 107.362 177.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.789 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -84.86 2.77 41.0 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 121.626 0.727 . . . . 0.0 109.094 177.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.513 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -110.13 -15.82 13.92 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.798 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.93 46.89 3.27 Favored Glycine 0 C--N 1.304 -1.243 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 178.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.778 ' CB ' HG23 ' A' ' 35' ' ' THR . 0.3 OUTLIER -137.25 136.68 38.31 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.052 -1.264 . . . . 0.0 110.861 179.521 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.5 mtmm -80.06 91.96 5.56 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.572 -0.705 . . . . 0.0 109.45 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.867 HG23 HG21 ' A' ' 35' ' ' THR . 41.1 t -59.97 124.34 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.615 -0.678 . . . . 0.0 110.163 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.46 ' O ' ' HA ' ' B' ' 2' ' ' ASN . 19.1 mt-30 -125.5 165.17 18.95 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.341 -0.849 . . . . 0.0 109.832 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 1.045 HD12 ' CB ' ' A' ' 48' ' ' LEU . 72.1 mt -134.43 108.09 7.95 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.416 -0.803 . . . . 0.0 109.084 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.534 HG23 ' HD1' ' A' ' 47' ' ' PHE . 0.0 OUTLIER 35.22 -96.05 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.871 -0.518 . . . . 0.0 111.475 -179.037 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.417 ' H ' HG23 ' A' ' 45' ' ' THR . . . -138.91 22.55 2.96 Favored Glycine 0 N--CA 1.488 2.12 0 C-N-CA 119.385 -1.388 . . . . 0.0 110.911 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.936 ' CD2' HD23 ' A' ' 48' ' ' LEU . 17.6 p90 -118.13 -56.82 2.14 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.728 -1.454 . . . . 0.0 111.101 179.028 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.045 ' CB ' HD12 ' A' ' 44' ' ' LEU . 0.9 OUTLIER -103.89 128.89 51.36 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.057 -1.652 . . . . 0.0 115.281 -178.162 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.547 ' CB ' ' CG ' ' A' ' 81' ' ' PRO . 19.2 t-20 -129.72 99.9 5.3 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.564 177.003 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.881 HD11 HD11 ' B' ' 48' ' ' LEU . 1.0 OUTLIER -86.82 158.07 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.162 -0.961 . . . . 0.0 110.21 -179.93 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.6 ptmt -166.49 123.39 0.99 Allowed Pre-proline 0 N--CA 1.496 1.833 0 C-N-CA 118.681 -1.208 . . . . 0.0 111.213 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.912 ' HB3' HG13 ' A' ' 36' ' ' VAL . 54.0 Cg_endo -79.96 144.31 16.88 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.609 1.32 . . . . 0.0 110.985 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.577 ' O ' HG23 ' A' ' 53' ' ' VAL . 28.4 m -137.06 113.81 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 CA-C-O 121.849 0.833 . . . . 0.0 111.459 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.499 1.989 0 O-C-N 121.62 -0.675 . . . . 0.0 111.006 -179.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.835 HG12 ' HB2' ' B' ' 89' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 121.18 0.514 . . . . 0.0 109.919 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.574 ' O ' ' N ' ' A' ' 78' ' ' SER . . . -105.99 77.16 0.24 Allowed Glycine 0 N--CA 1.484 1.874 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.903 HG11 ' HB2' ' B' ' 85' ' ' LEU . 15.5 t -59.87 77.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.492 -1.005 . . . . 0.0 109.232 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.574 ' N ' ' O ' ' A' ' 76' ' ' GLY . 0.3 OUTLIER -97.31 -165.18 1.23 Allowed 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 122.461 1.124 . . . . 0.0 111.733 -178.671 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.611 HG12 ' CG1' ' A' ' 50' ' ' ILE . 29.9 m -152.82 -157.08 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.65 ' HB3' ' HD3' ' A' ' 81' ' ' PRO . 0.1 OUTLIER -172.06 -58.12 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.69 0 C-N-CA 118.345 -1.342 . . . . 0.0 112.824 179.421 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.65 ' HD3' ' HB3' ' A' ' 80' ' ' LYS . 55.8 Cg_endo -89.62 171.82 4.13 Favored 'Trans proline' 0 C--N 1.297 -2.151 0 O-C-N 123.595 1.313 . . . . 0.0 112.963 -176.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.65 ' O ' ' C ' ' A' ' 83' ' ' GLU . . . 176.2 -1.57 0.03 OUTLIER Glycine 0 C--N 1.301 -1.405 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 179.093 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.905 ' O ' ' N ' ' A' ' 85' ' ' LEU . 11.8 pt-20 31.8 45.78 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 -176.567 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.873 ' C ' HD22 ' A' ' 85' ' ' LEU . 1.2 t 12.4 41.71 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.335 0 CA-C-O 122.873 1.321 . . . . 0.0 109.608 -177.021 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 1.005 HD23 HG11 ' B' ' 36' ' ' VAL . 0.0 OUTLIER 18.31 27.05 0.0 OUTLIER 'General case' 0 C--O 1.189 -2.117 0 N-CA-C 101.381 -3.563 . . . . 0.0 101.381 -173.293 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.76 ' HB2' ' HB3' ' A' ' 84' ' ' SER 0.351 4.5 tttt -51.91 -44.25 63.72 Favored 'General case' 0 CA--C 1.469 -2.145 0 CA-C-N 111.808 -2.451 . . . . 0.0 105.631 178.589 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.277 23.6 tttt -62.23 -38.02 87.62 Favored 'General case' 0 C--N 1.268 -2.971 0 CA-C-N 111.409 -2.632 . . . . 0.0 106.625 177.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.826 ' O ' ' HB1' ' B' ' 37' ' ' ALA . . . -86.99 -22.34 25.6 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 118.232 -1.387 . . . . 0.0 109.39 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.793 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . -76.32 -47.13 24.66 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.474 ' HA ' ' CB ' ' A' ' 94' ' ' TYR . 4.0 mm-40 -56.86 -27.24 60.11 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 175.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.972 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -76.95 -32.52 49.15 Favored Glycine 0 CA--C 1.548 2.147 0 CA-C-O 118.496 -1.169 . . . . 0.0 113.169 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.972 HD23 ' C ' ' A' ' 91' ' ' GLY . 0.1 OUTLIER -115.21 -74.2 0.62 Allowed 'General case' 0 N--CA 1.505 2.312 0 CA-C-N 122.31 3.055 . . . . 0.0 113.44 -177.301 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -120.39 42.0 3.09 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.827 -1.171 . . . . 0.0 112.713 -177.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.495 ' HA ' HG23 ' B' ' 75' ' ' VAL . 0.0 OUTLIER -74.37 -55.5 5.93 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.102 -0.999 . . . . 0.0 108.923 178.371 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.432 ' N ' ' CG ' ' A' ' 94' ' ' TYR . 12.0 pt-20 . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.604 -0.685 . . . . 0.0 109.547 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.453 ' CB ' ' HB3' ' B' ' 5' ' ' GLU . 9.0 mtp . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 120.867 0.365 . . . . 0.0 110.063 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 2' ' ' ASN . . . . . 0.46 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 0.1 OUTLIER -176.48 -172.97 0.49 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.237 -0.914 . . . . 0.0 110.801 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.549 ' O ' HG13 ' B' ' 7' ' ' ILE . 0.0 OUTLIER -54.24 -15.07 1.35 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.234 -0.916 . . . . 0.0 110.335 179.785 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 4' ' ' THR . . . . . 0.552 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 19.1 m -105.64 -46.65 4.11 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.106 -0.996 . . . . 0.0 108.69 178.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.486 ' HA ' ' HE2' ' B' ' 8' ' ' LYS . 0.8 OUTLIER -62.01 -50.6 71.39 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.927 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.707 HD11 HG13 ' A' ' 42' ' ' VAL . 2.0 mt -64.51 -26.51 68.46 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.488 -0.885 . . . . 0.0 109.013 178.217 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 7' ' ' ILE . . . . . 0.735 HG12 ' O ' ' B' ' 21' ' ' VAL . 0.3 OUTLIER -56.84 -58.97 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.408 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 8' ' ' LYS . . . . . 0.893 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.1 OUTLIER -62.43 -26.99 68.79 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.137 178.758 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 9' ' ' ALA . . . . . 0.598 ' HB3' ' O ' ' B' ' 6' ' ' LEU . . . -59.85 -34.67 73.42 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 119.441 -0.904 . . . . 0.0 108.699 178.682 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.861 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.0 OUTLIER -97.47 -36.82 6.3 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.498 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 178.522 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.893 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -59.04 -28.3 66.3 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.437 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -90.8 -42.01 10.9 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.496 ' OD2' HG21 ' A' ' 31' ' ' ILE . 82.6 m-20 -64.98 -23.13 67.13 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 106.932 -1.506 . . . . 0.0 106.932 176.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 14' ' ' THR . . . . . 0.951 HG22 ' HB2' ' A' ' 20' ' ' SER . 17.8 p -93.41 -75.57 0.49 Allowed 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.08 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 58.35 17.72 33.15 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 16' ' ' LEU . . . . . 1.002 HD22 ' O ' ' A' ' 19' ' ' VAL . 2.7 mp -84.32 -59.28 2.44 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.324 -1.103 . . . . 0.0 108.411 178.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 17' ' ' THR . . . . . 0.716 ' CG2' HG21 ' A' ' 17' ' ' THR . 0.5 OUTLIER -140.87 3.44 1.83 Allowed 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.357 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 18' ' ' GLN . . . . . 0.594 ' O ' ' C ' ' B' ' 19' ' ' VAL . 16.6 mt-30 57.14 24.71 10.03 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 106.762 -1.569 . . . . 0.0 106.762 -176.613 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 1.079 HG23 ' CD1' ' A' ' 16' ' ' LEU . 0.1 OUTLIER 10.61 -94.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.917 -179.167 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 20' ' ' SER . . . . . 1.025 ' O ' ' N ' ' B' ' 22' ' ' SER . 0.3 OUTLIER -137.17 23.46 3.01 Favored 'General case' 0 C--N 1.276 -2.619 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 178.193 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.735 ' O ' HG12 ' B' ' 7' ' ' ILE . 15.3 m -5.24 -44.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 122.503 1.144 . . . . 0.0 110.537 -177.505 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 22' ' ' SER . . . . . 1.025 ' N ' ' O ' ' B' ' 20' ' ' SER . 5.8 m -79.54 -38.59 33.87 Favored 'General case' 0 C--N 1.281 -2.393 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.355 178.551 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 23' ' ' LYS . . . . . 0.932 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.5 OUTLIER -91.12 -24.61 19.93 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.418 -0.801 . . . . 0.0 110.875 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 24' ' ' MET . . . . . 0.653 ' HG2' HG22 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -77.07 -38.76 51.86 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 117.444 -1.703 . . . . 0.0 108.558 178.349 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.675 ' HA ' ' HB3' ' B' ' 28' ' ' PHE . 0.3 OUTLIER -78.0 -36.17 49.13 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 118.234 -1.387 . . . . 0.0 108.438 177.711 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 26' ' ' ALA . . . . . 0.49 ' HB2' ' O ' ' B' ' 22' ' ' SER . . . -64.45 -34.61 78.6 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 176.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 27' ' ' SER . . . . . 0.622 ' O ' HG13 ' B' ' 31' ' ' ILE . 29.2 t -80.42 -32.09 37.45 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 28' ' ' PHE . . . . . 0.862 ' CE1' HD22 ' A' ' 44' ' ' LEU . 0.4 OUTLIER -52.74 -47.11 67.62 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.828 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 29' ' ' GLU . . . . . 0.651 ' HG3' ' CD1' ' A' ' 47' ' ' PHE . 1.7 tt0 -68.47 -35.61 77.81 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 176.559 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 1.185 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 2.0 tttt -63.8 -19.39 64.97 Favored 'General case' 0 C--O 1.189 -2.096 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.095 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.638 ' CG1' ' HA ' ' B' ' 28' ' ' PHE . 1.4 pp -107.43 -28.24 2.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 120.29 -1.506 . . . . 0.0 108.714 178.037 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.674 HD11 ' CE2' ' B' ' 28' ' ' PHE . 1.2 mm -72.66 -58.18 5.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 176.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 33' ' ' THR . . . . . 0.982 ' OG1' HD12 ' A' ' 85' ' ' LEU . 0.6 OUTLIER -68.52 -38.07 80.57 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.771 179.169 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 1.185 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 78.7 mm-40 -76.95 -27.57 54.87 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 121.172 -0.955 . . . . 0.0 111.963 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 35' ' ' THR . . . . . 0.558 ' O ' ' N ' ' B' ' 38' ' ' LYS . 2.7 m -70.63 -59.75 2.65 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 117.706 -1.597 . . . . 0.0 109.462 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 1.005 HG11 HD23 ' A' ' 85' ' ' LEU . 0.9 OUTLIER -51.02 -43.86 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 178.94 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 37' ' ' ALA . . . . . 0.826 ' HB1' ' O ' ' A' ' 88' ' ' ALA . . . -60.91 -27.83 68.48 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.829 177.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 38' ' ' LYS . . . . . 0.795 ' N ' HD12 ' A' ' 92' ' ' LEU . 0.6 OUTLIER -76.64 -32.3 57.91 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 177.574 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.5 23.7 4.99 Favored Glycine 0 C--N 1.295 -1.695 0 C-N-CA 120.087 -1.054 . . . . 0.0 110.944 177.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 40' ' ' ASP . . . . . 0.481 ' HB3' ' CG2' ' B' ' 35' ' ' THR . 0.4 OUTLIER -100.48 158.34 15.98 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.103 -1.234 . . . . 0.0 109.749 179.38 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -95.28 90.77 5.97 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.388 -0.82 . . . . 0.0 110.436 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 73.3 t -59.83 118.43 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.423 -0.798 . . . . 0.0 109.712 179.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -123.71 93.22 3.87 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.309 -0.869 . . . . 0.0 110.068 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 1.004 HD12 ' CB ' ' B' ' 48' ' ' LEU . 75.3 mt -62.33 101.18 0.21 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.173 -0.954 . . . . 0.0 109.549 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 45' ' ' THR . . . . . 0.556 HG21 ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 34.99 -94.78 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.928 -0.482 . . . . 0.0 111.31 -179.557 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 46' ' ' GLY . . . . . 0.427 ' H ' HG23 ' B' ' 45' ' ' THR . . . -141.0 20.45 2.68 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 119.493 -1.337 . . . . 0.0 110.908 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 47' ' ' PHE . . . . . 0.576 ' CE2' ' HG3' ' A' ' 29' ' ' GLU . 8.8 p90 -119.84 -22.71 6.69 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.702 -1.47 . . . . 0.0 111.446 179.402 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 1.004 ' CB ' HD12 ' B' ' 44' ' ' LEU . 0.2 OUTLIER -133.48 139.21 46.54 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.614 -1.304 . . . . 0.0 111.472 178.242 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 49' ' ' ASN . . . . . 0.417 ' C ' HD13 ' B' ' 50' ' ' ILE . 1.3 t30 -143.31 116.69 9.07 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.738 -0.601 . . . . 0.0 109.952 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 50' ' ' ILE . . . . . 0.797 HG23 ' HB ' ' B' ' 79' ' ' VAL . 6.4 mm -116.79 147.05 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 O-C-N 121.314 -0.866 . . . . 0.0 110.592 -179.359 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 51' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' B' ' 78' ' ' SER . 14.4 ptmt -156.81 124.85 2.83 Favored Pre-proline 0 N--CA 1.502 2.164 0 O-C-N 120.877 -1.139 . . . . 0.0 110.631 179.12 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 52' ' ' PRO . . . . . 0.578 ' HA ' ' HA ' ' B' ' 77' ' ' VAL . 53.6 Cg_endo -84.96 150.75 11.01 Favored 'Trans proline' 0 C--N 1.317 -1.12 0 O-C-N 123.239 1.126 . . . . 0.0 111.748 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.852 HG22 ' O ' ' B' ' 76' ' ' GLY . 33.0 m -140.54 115.69 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 CA-C-O 121.966 0.889 . . . . 0.0 110.391 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 54' ' ' ALA . . . . . 0.422 ' HA ' ' HA ' ' B' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 122.073 0.94 . . . . 0.0 112.237 -178.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 75' ' ' VAL . . . . . 0.495 HG23 ' HA ' ' A' ' 94' ' ' TYR . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 76' ' ' GLY . . . . . 0.852 ' O ' HG22 ' B' ' 53' ' ' VAL . . . -121.86 96.42 0.58 Allowed Glycine 0 N--CA 1.494 2.536 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.832 HG13 ' O ' ' B' ' 77' ' ' VAL . 8.1 p -67.63 74.54 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.644 -0.915 . . . . 0.0 111.5 -178.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 78' ' ' SER . . . . . 0.797 ' C ' HG12 ' B' ' 79' ' ' VAL . 0.1 OUTLIER -61.45 172.76 1.07 Allowed 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 117.368 -1.733 . . . . 0.0 107.463 178.209 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.797 ' HB ' HG23 ' B' ' 50' ' ' ILE . 0.2 OUTLIER 176.41 173.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.041 -1.037 . . . . 0.0 110.137 179.397 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 80' ' ' LYS . . . . . 0.595 ' N ' ' CG2' ' B' ' 79' ' ' VAL . 0.1 OUTLIER 176.08 171.14 0.34 Allowed Pre-proline 0 C--N 1.299 -1.61 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 175.955 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 81' ' ' PRO . . . . . 0.638 ' HA ' HD23 ' B' ' 48' ' ' LEU . 54.0 Cg_endo -89.89 -169.43 0.36 Allowed 'Trans proline' 0 C--N 1.293 -2.361 0 O-C-N 123.712 1.375 . . . . 0.0 109.791 176.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -128.83 -90.96 0.65 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 106.293 -2.723 . . . . 0.0 106.293 178.174 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 83' ' ' GLU . . . . . 0.949 ' O ' ' N ' ' B' ' 85' ' ' LEU . 1.6 tt0 -77.99 56.65 1.63 Allowed 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 175.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 84' ' ' SER . . . . . 1.302 ' O ' ' N ' ' B' ' 86' ' ' LYS . 0.3 OUTLIER 8.43 43.84 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 122.396 1.093 . . . . 0.0 110.274 -179.79 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.982 HD23 ' HA ' ' A' ' 33' ' ' THR . 3.7 mp 20.92 29.69 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 103.616 -2.735 . . . . 0.0 103.616 -172.387 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 86' ' ' LYS . . . . . 1.302 ' N ' ' O ' ' B' ' 84' ' ' SER 0.346 15.6 tttt -57.79 -42.45 84.18 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 104.161 -2.533 . . . . 0.0 104.161 177.043 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 87' ' ' LYS . . . . . 0.42 ' O ' ' CG ' ' B' ' 90' ' ' GLU 0.286 34.8 tttp -65.14 -34.41 78.34 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 112.055 -2.339 . . . . 0.0 105.846 175.342 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.889 ' HB1' ' O ' ' A' ' 33' ' ' THR . . . -78.84 -25.24 44.08 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 118.419 -1.313 . . . . 0.0 108.051 178.217 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 1.069 ' HA ' HD23 ' B' ' 92' ' ' LEU . . . -68.42 -49.76 57.69 Favored 'General case' 0 C--N 1.294 -1.843 0 O-C-N 121.141 -0.975 . . . . 0.0 109.291 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 90' ' ' GLU . . . . . 0.425 ' HG3' ' N ' ' B' ' 91' ' ' GLY . 7.0 pt-20 -58.52 -27.18 64.27 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 177.375 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 91' ' ' GLY . . . . . 0.425 ' N ' ' HG3' ' B' ' 90' ' ' GLU . . . -75.97 -23.07 72.88 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 179.03 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 92' ' ' LEU . . . . . 1.069 HD23 ' HA ' ' B' ' 89' ' ' ALA . 0.4 OUTLIER -80.79 21.65 0.66 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.575 -1.544 . . . . 0.0 110.38 179.625 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 93' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' B' ' 92' ' ' LEU . 0.9 OUTLIER 58.18 37.85 26.28 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 -177.067 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 94' ' ' TYR . . . . . 0.537 ' CD1' ' N ' ' A' ' 75' ' ' VAL . 52.3 t80 -33.89 -45.94 0.21 Allowed 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 114.926 -1.033 . . . . 0.0 111.602 -178.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -56.92 -44.67 82.68 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.156 -0.965 . . . . 0.0 109.599 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 96' ' ' ASP . . . . . 0.436 ' N ' ' O ' ' B' ' 93' ' ' LYS . 0.2 OUTLIER -57.07 -33.43 67.27 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.777 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.502 ' HB3' ' HG ' ' A' ' 6' ' ' LEU . 9.6 mtp . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.445 ' HA ' ' O ' ' B' ' 43' ' ' GLN . 0.6 OUTLIER -173.13 -168.76 0.49 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.99 -1.069 . . . . 0.0 112.043 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.465 ' O ' ' CG2' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -51.92 -16.5 0.73 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.604 -0.685 . . . . 0.0 109.856 179.697 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.75 ' O ' HG13 ' A' ' 7' ' ' ILE . 1.4 m -112.86 -53.92 2.67 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.822 0.82 . . . . 0.0 109.906 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.627 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 0.1 OUTLIER -48.41 -48.26 37.19 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.154 -0.966 . . . . 0.0 109.068 -179.955 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.839 HD11 HG13 ' B' ' 42' ' ' VAL . 1.2 mt -61.01 -29.79 69.92 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.363 -0.935 . . . . 0.0 110.44 178.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.75 HG13 ' O ' ' A' ' 4' ' ' THR . 1.0 OUTLIER -60.82 -44.18 97.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 120.621 -1.299 . . . . 0.0 107.868 179.381 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.877 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -64.6 -33.35 75.71 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 177.658 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' A' ' 6' ' ' LEU . . . -56.19 -38.82 71.48 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 119.921 -0.712 . . . . 0.0 109.165 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.823 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.1 mp -90.98 -33.18 5.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 178.139 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.877 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -62.93 -13.43 34.37 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 118.574 -1.251 . . . . 0.0 108.655 178.38 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.45 ' CG ' ' N ' ' A' ' 13' ' ' ASP . 15.9 pt20 -115.53 -42.24 3.16 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.486 -0.759 . . . . 0.0 110.177 179.31 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.45 ' N ' ' CG ' ' A' ' 12' ' ' GLN . 65.6 m-20 -69.76 -31.29 69.17 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 177.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . 1.068 HG22 ' CD1' ' A' ' 16' ' ' LEU 0.265 0.2 OUTLIER -99.27 -67.95 0.83 Allowed 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 178.666 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 53.06 23.82 18.05 Favored Glycine 0 N--CA 1.501 3.022 0 O-C-N 121.439 -0.788 . . . . 0.0 111.417 177.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 1.068 ' CD1' HG22 ' A' ' 14' ' ' THR . 4.7 mp -67.85 -69.15 0.34 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.536 -0.979 . . . . 0.0 110.028 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.54 HG21 HG21 ' B' ' 17' ' ' THR . 0.6 OUTLIER -130.17 6.03 4.92 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.843 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.597 ' O ' ' C ' ' A' ' 19' ' ' VAL . 22.8 mt-30 56.94 28.01 14.03 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 -176.235 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 1.075 HG23 ' CD1' ' B' ' 16' ' ' LEU . 0.4 OUTLIER -9.24 -97.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.306 -179.412 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.97 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.9 OUTLIER -136.37 25.1 3.21 Favored 'General case' 0 C--N 1.278 -2.516 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 177.779 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.707 HG23 HD13 ' A' ' 7' ' ' ILE . 27.2 m -18.23 -39.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 CA-C-O 122.24 1.019 . . . . 0.0 110.343 -177.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.806 ' N ' ' O ' ' A' ' 20' ' ' SER . 5.2 m -80.02 -37.55 33.89 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 115.032 -0.986 . . . . 0.0 108.998 178.359 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.97 ' N ' ' O ' ' A' ' 20' ' ' SER . 2.6 mtpt -88.0 -30.45 19.97 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.867 -0.521 . . . . 0.0 111.24 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.786 ' HB3' HG23 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -74.48 -36.76 63.3 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 117.982 -1.487 . . . . 0.0 109.14 -179.671 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.576 HD12 ' CA ' ' A' ' 7' ' ' ILE . 12.8 mt -77.27 -47.33 20.37 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 118.11 -1.436 . . . . 0.0 107.851 177.223 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 22' ' ' SER . . . -54.82 -33.57 61.78 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 177.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.674 ' O ' HG23 ' A' ' 31' ' ' ILE . 89.6 p -78.38 -34.03 48.47 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.735 ' HA ' ' CG1' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -66.31 -31.15 71.77 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.381 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.71 ' O ' ' HB ' ' A' ' 33' ' ' THR . 1.6 mt-10 -86.21 -33.13 20.85 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 177.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.741 ' O ' ' CG ' ' A' ' 34' ' ' GLU . 17.6 tttm -69.26 -30.63 68.79 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 176.119 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.735 ' CG1' ' HA ' ' A' ' 28' ' ' PHE . 1.8 pp -91.33 -36.18 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.35 -0.844 . . . . 0.0 109.379 178.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.823 HG21 ' CE1' ' B' ' 47' ' ' PHE . 3.4 mm -58.42 -55.23 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 177.264 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.834 ' OG1' HD12 ' B' ' 85' ' ' LEU . 0.3 OUTLIER -63.01 -36.88 85.04 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.559 179.862 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.741 ' CG ' ' O ' ' A' ' 30' ' ' LYS . 5.2 mm-40 -72.68 -47.05 50.53 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.758 -0.588 . . . . 0.0 111.845 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.647 HG21 ' SD ' ' B' ' 1' ' ' MET . 66.5 m -56.02 -50.78 69.96 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.536 -1.352 . . . . 0.0 109.722 -179.492 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.981 HG11 HD23 ' B' ' 85' ' ' LEU . 2.1 t -50.08 -44.54 22.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.951 ' HB1' ' O ' ' B' ' 88' ' ' ALA . . . -84.26 -4.87 59.12 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 121.746 0.784 . . . . 0.0 110.024 178.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.635 ' N ' ' O ' ' A' ' 34' ' ' GLU . 3.1 ttmt -90.66 -26.21 19.72 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 177.579 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.05 37.04 0.9 Allowed Glycine 0 C--N 1.302 -1.319 0 C-N-CA 120.071 -1.062 . . . . 0.0 111.185 177.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.447 ' HB3' ' CG2' ' A' ' 35' ' ' THR . 0.3 OUTLIER -145.53 140.89 27.8 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.906 -1.35 . . . . 0.0 110.713 179.356 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -92.07 93.73 8.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.666 -0.646 . . . . 0.0 109.374 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.821 HG12 ' CG ' ' B' ' 1' ' ' MET . 31.6 m -60.19 137.39 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.544 -0.723 . . . . 0.0 110.382 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.457 ' O ' ' CB ' ' B' ' 2' ' ' ASN . 3.9 mt-30 -125.7 107.92 11.02 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.413 -0.805 . . . . 0.0 110.008 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.926 HD12 ' HB3' ' A' ' 48' ' ' LEU . 24.1 mt -72.38 103.49 3.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.182 -0.949 . . . . 0.0 109.892 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.452 ' CG2' ' C ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER 33.55 -96.65 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.915 -0.491 . . . . 0.0 111.193 -179.748 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.7 28.98 2.01 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.776 ' CD1' HD21 ' A' ' 85' ' ' LEU . 1.5 p90 -129.43 -25.34 2.67 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.097 -1.237 . . . . 0.0 111.275 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.926 ' HB3' HD12 ' A' ' 44' ' ' LEU . 5.0 mt -134.79 95.85 3.42 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.45 -1.406 . . . . 0.0 110.6 178.058 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.437 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 4.5 m-20 -103.98 89.6 3.34 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.178 -0.951 . . . . 0.0 110.888 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.614 HG12 HG23 ' A' ' 79' ' ' VAL . 0.9 OUTLIER -80.31 153.46 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.393 -0.817 . . . . 0.0 110.301 179.645 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.535 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 16.0 ptmt -165.58 115.25 0.82 Allowed Pre-proline 0 N--CA 1.495 1.811 0 C-N-CA 118.969 -1.092 . . . . 0.0 110.43 178.672 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.943 ' HB3' HG13 ' A' ' 36' ' ' VAL . 55.3 Cg_endo -78.13 141.51 18.62 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.451 1.238 . . . . 0.0 111.089 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.666 HG22 ' O ' ' A' ' 76' ' ' GLY . 23.8 m -146.39 115.32 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-O 121.57 0.7 . . . . 0.0 110.393 179.414 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.671 ' HB2' ' HB3' ' B' ' 97' ' ' PHE . . . . . . . . 0 N--CA 1.503 2.181 0 CA-C-O 121.086 0.47 . . . . 0.0 111.938 -178.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.736 HG22 ' H ' ' A' ' 76' ' ' GLY . 4.4 p . . . . . 0 N--CA 1.506 2.359 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.736 ' H ' HG22 ' A' ' 75' ' ' VAL . . . -123.6 61.41 0.58 Allowed Glycine 0 N--CA 1.487 2.094 0 N-CA-C 108.935 -1.666 . . . . 0.0 108.935 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.798 HG11 ' CB ' ' B' ' 84' ' ' SER . 3.4 p -47.73 82.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.803 -0.821 . . . . 0.0 110.803 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.599 ' N ' ' O ' ' A' ' 76' ' ' GLY . 0.4 OUTLIER -83.73 174.84 10.13 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 118.597 -1.241 . . . . 0.0 110.093 179.952 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.614 HG23 HG12 ' A' ' 50' ' ' ILE . 2.6 p 175.15 176.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.707 ' O ' HD23 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -177.14 173.0 0.76 Allowed Pre-proline 0 N--CA 1.485 1.324 0 O-C-N 120.934 -1.103 . . . . 0.0 110.195 177.377 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.564 ' HB2' HG13 ' B' ' 77' ' ' VAL . 55.0 Cg_endo -98.6 135.45 0.3 Allowed 'Trans proline' 0 C--N 1.302 -1.904 0 C-N-CA 122.505 2.137 . . . . 0.0 110.622 178.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.426 ' HA3' ' HA ' ' A' ' 47' ' ' PHE . . . -89.73 -158.28 34.17 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 107.956 -2.058 . . . . 0.0 107.956 178.3 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.445 ' HA ' ' HB2' ' A' ' 86' ' ' LYS . 3.4 pm0 -90.17 -16.12 30.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.029 -1.277 . . . . 0.0 110.217 179.397 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.412 ' CB ' ' HB3' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -53.42 -36.61 61.71 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.269 -0.895 . . . . 0.0 109.267 179.412 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.95 ' CB ' HG21 ' B' ' 77' ' ' VAL . 0.5 OUTLIER -82.3 -33.21 29.12 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.915 -0.714 . . . . 0.0 109.158 179.07 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.736 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 2.2 mttt -70.97 -43.83 67.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.458 -0.776 . . . . 0.0 109.755 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.4 tptt -64.71 -39.06 93.0 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 177.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.688 ' O ' ' HB1' ' B' ' 37' ' ' ALA . . . -64.55 -34.9 79.31 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 176.34 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.964 ' HA ' HD23 ' A' ' 92' ' ' LEU . . . -54.43 -46.3 73.21 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 120.036 -0.666 . . . . 0.0 109.211 179.242 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -52.65 -32.58 42.85 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 177.262 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 88' ' ' ALA . . . -64.65 -38.42 95.64 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 178.323 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.964 HD23 ' HA ' ' A' ' 89' ' ' ALA . 0.5 OUTLIER -72.45 10.37 0.83 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.537 -1.567 . . . . 0.0 111.13 -179.85 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 22.1 mmtt 61.41 41.69 12.54 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -177.403 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.544 ' CD1' ' N ' ' B' ' 75' ' ' VAL . 0.0 OUTLIER -38.0 -40.27 0.46 Allowed 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.005 -178.962 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? . . . . . 0 N--CA 1.494 1.75 0 O-C-N 121.37 -0.831 . . . . 0.0 109.769 179.698 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.821 ' CG ' HG12 ' A' ' 42' ' ' VAL . 1.3 ptm . . . . . 0 N--CA 1.496 1.842 0 CA-C-O 121.479 0.657 . . . . 0.0 110.871 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 2' ' ' ASN . . . . . 0.457 ' CB ' ' O ' ' A' ' 43' ' ' GLN . 17.8 p30 -178.3 -152.32 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 120.106 -0.637 . . . . 0.0 110.516 178.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.484 ' HD3' HD11 ' B' ' 25' ' ' LEU . 1.0 OUTLIER -59.14 -3.22 0.35 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.147 -0.971 . . . . 0.0 110.207 179.612 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 4' ' ' THR . . . . . 0.688 ' O ' HG23 ' B' ' 7' ' ' ILE . 25.1 m -109.01 -53.26 2.67 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.003 -1.061 . . . . 0.0 109.969 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.487 ' HB3' ' CB ' ' B' ' 1' ' ' MET . 1.8 mt-10 -65.88 -46.84 76.9 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.199 -0.938 . . . . 0.0 109.532 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.688 ' O ' ' HB3' ' B' ' 9' ' ' ALA . 29.9 mt -49.05 -51.7 29.69 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.213 -0.929 . . . . 0.0 109.643 179.151 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 7' ' ' ILE . . . . . 0.929 HG21 HD22 ' B' ' 25' ' ' LEU . 0.1 OUTLIER -50.22 -51.05 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 177.414 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 8' ' ' LYS . . . . . 0.883 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.1 OUTLIER -56.15 -37.38 69.42 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.489 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 9' ' ' ALA . . . . . 0.688 ' HB3' ' O ' ' B' ' 6' ' ' LEU . . . -55.34 -36.2 66.03 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.372 -0.83 . . . . 0.0 108.825 179.063 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.786 HG23 ' HB3' ' A' ' 24' ' ' MET . 1.6 mp -89.22 -34.22 6.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 178.335 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.883 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -67.22 -12.48 60.18 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.069 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.476 ' N ' ' O ' ' B' ' 8' ' ' LYS . 8.9 tp-100 -112.61 -44.19 3.37 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' B' ' 9' ' ' ALA . 2.2 m-20 -68.89 -22.41 64.19 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 176.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 14' ' ' THR . . . . . 0.771 HG22 HD21 ' B' ' 16' ' ' LEU . 0.2 OUTLIER -120.04 -83.54 0.65 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.297 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 15' ' ' GLY . . . . . 0.546 ' O ' ' C ' ' B' ' 16' ' ' LEU . . . 68.32 -21.84 0.3 Allowed Glycine 0 N--CA 1.497 2.713 0 O-C-N 120.906 -1.121 . . . . 0.0 110.346 178.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 16' ' ' LEU . . . . . 1.075 ' CD1' HG23 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -25.57 -58.3 0.07 Allowed 'General case' 0 N--CA 1.514 2.735 0 CA-C-O 122.202 1.001 . . . . 0.0 110.794 -179.819 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 17' ' ' THR . . . . . 0.646 HG22 ' H ' ' B' ' 19' ' ' VAL . 0.5 OUTLIER -136.25 -0.89 2.42 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.419 -179.38 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 18' ' ' GLN . . . . . 0.655 ' O ' ' C ' ' B' ' 19' ' ' VAL . 4.7 mt-30 55.24 31.15 15.95 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 -176.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 1.041 HG11 HG11 ' A' ' 19' ' ' VAL . 1.2 p -4.09 -92.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.856 -178.646 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 20' ' ' SER . . . . . 0.934 ' O ' ' N ' ' B' ' 22' ' ' SER . 0.6 OUTLIER -133.37 25.83 4.14 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 177.803 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.692 ' O ' HD23 ' B' ' 25' ' ' LEU . 30.0 m -17.26 -37.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-O 122.426 1.107 . . . . 0.0 109.374 -178.309 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.934 ' N ' ' O ' ' B' ' 20' ' ' SER . 12.2 t -80.14 -41.24 25.79 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.904 177.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 23' ' ' LYS . . . . . 0.911 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.0 OUTLIER -87.33 -36.17 17.99 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.438 -0.789 . . . . 0.0 111.483 179.963 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 24' ' ' MET . . . . . 0.769 ' HB3' HG21 ' A' ' 14' ' ' THR . 0.0 OUTLIER -71.42 -30.09 65.67 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 118.023 -1.471 . . . . 0.0 108.512 179.367 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.929 HD22 HG21 ' B' ' 7' ' ' ILE . 0.3 OUTLIER -75.31 -41.85 55.93 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 118.662 -1.215 . . . . 0.0 107.843 177.368 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 26' ' ' ALA . . . . . 0.659 ' N ' ' HG ' ' B' ' 25' ' ' LEU . . . -68.42 -24.43 64.74 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.119 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 27' ' ' SER . . . . . 0.505 ' O ' ' HB3' ' B' ' 30' ' ' LYS . 4.5 t -84.55 -36.83 21.87 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 28' ' ' PHE . . . . . 0.764 ' CE1' HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -51.89 -53.45 40.7 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.441 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 29' ' ' GLU . . . . . 0.614 ' N ' ' CD1' ' B' ' 28' ' ' PHE . 0.1 OUTLIER -63.87 -39.04 93.27 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 177.742 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 1.269 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 19.3 tttm -56.08 -29.51 60.68 Favored 'General case' 0 C--O 1.191 -2.015 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.314 178.622 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.645 HD12 ' HA ' ' B' ' 28' ' ' PHE . 0.2 OUTLIER -104.46 -23.88 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 119.645 -1.909 . . . . 0.0 108.382 177.516 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.56 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.3 mm -73.1 -61.53 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 177.367 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 33' ' ' THR . . . . . 0.798 ' HA ' HD23 ' A' ' 85' ' ' LEU . 0.7 OUTLIER -67.38 -36.29 81.04 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.916 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 1.269 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 18.4 mm-40 -78.3 -35.24 48.07 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 121.07 -1.019 . . . . 0.0 111.658 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 35' ' ' THR . . . . . 0.639 HG23 ' CB ' ' B' ' 40' ' ' ASP . 3.0 m -56.39 -47.94 77.92 Favored 'General case' 0 N--CA 1.504 2.257 0 CA-C-N 120.49 1.496 . . . . 0.0 107.211 178.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.817 HG13 ' HB3' ' B' ' 52' ' ' PRO . 23.5 t -53.58 -42.32 49.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 177.359 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 37' ' ' ALA . . . . . 0.688 ' HB1' ' O ' ' A' ' 88' ' ' ALA . . . -82.89 -1.19 51.44 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.735 178.239 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 38' ' ' LYS . . . . . 0.663 ' N ' ' O ' ' B' ' 34' ' ' GLU . 0.0 OUTLIER -100.37 -18.85 16.56 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 177.905 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.99 42.43 2.26 Favored Glycine 0 C--N 1.302 -1.321 0 C-N-CA 120.272 -0.966 . . . . 0.0 110.74 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 40' ' ' ASP . . . . . 0.639 ' CB ' HG23 ' B' ' 35' ' ' THR . 0.4 OUTLIER -144.88 150.96 37.97 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.13 -1.218 . . . . 0.0 110.159 179.276 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 63.9 mttt -97.34 92.18 5.85 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.549 -0.719 . . . . 0.0 110.238 -179.37 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.839 HG13 HD11 ' A' ' 6' ' ' LEU . 66.9 t -59.38 129.62 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.536 -0.728 . . . . 0.0 109.399 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 43' ' ' GLN . . . . . 0.504 ' HA ' ' O ' ' B' ' 48' ' ' LEU . 0.8 OUTLIER -125.02 103.91 8.27 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.092 -1.005 . . . . 0.0 111.123 -179.021 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.662 HD12 ' CE1' ' B' ' 47' ' ' PHE . 19.9 mt -62.96 113.97 3.4 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.225 -0.922 . . . . 0.0 109.111 178.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 45' ' ' THR . . . . . 0.562 HG22 ' HG2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 33.12 -89.87 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.499 0 O-C-N 121.832 -0.543 . . . . 0.0 110.93 -179.252 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 46' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -146.06 15.79 1.72 Allowed Glycine 0 N--CA 1.484 1.856 0 C-N-CA 119.732 -1.223 . . . . 0.0 110.338 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 47' ' ' PHE . . . . . 0.823 ' CE1' HG21 ' A' ' 32' ' ' ILE . 17.1 p90 -111.14 -37.79 5.23 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.762 -1.434 . . . . 0.0 112.113 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.642 ' HB2' HD12 ' B' ' 44' ' ' LEU . 0.0 OUTLIER -114.32 117.8 32.11 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.3 -1.5 . . . . 0.0 111.272 179.703 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -113.19 74.17 0.85 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.699 -0.626 . . . . 0.0 110.569 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 50' ' ' ILE . . . . . 0.924 HD13 ' HB ' ' B' ' 79' ' ' VAL . 3.1 mm -59.87 134.95 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.422 -0.799 . . . . 0.0 110.144 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 51' ' ' LYS . . . . . 0.602 ' HD3' HG13 ' B' ' 53' ' ' VAL . 0.0 OUTLIER -154.05 126.15 3.85 Favored Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 120.872 -1.142 . . . . 0.0 110.959 179.338 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 52' ' ' PRO . . . . . 0.817 ' HB3' HG13 ' B' ' 36' ' ' VAL . 55.7 Cg_endo -83.79 142.17 10.02 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 O-C-N 123.439 1.231 . . . . 0.0 110.655 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.756 HG22 ' O ' ' B' ' 76' ' ' GLY . 27.6 m -137.88 114.78 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-O 121.762 0.791 . . . . 0.0 111.058 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 54' ' ' ALA . . . . . 0.523 ' HA ' ' HA ' ' B' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.494 1.753 0 O-C-N 121.561 -0.712 . . . . 0.0 110.504 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 75' ' ' VAL . . . . . 0.554 HG21 HD21 ' A' ' 92' ' ' LEU . 1.1 t . . . . . 0 N--CA 1.493 1.675 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 76' ' ' GLY . . . . . 0.756 ' O ' HG22 ' B' ' 53' ' ' VAL . . . -120.03 86.35 0.4 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.95 HG21 ' CB ' ' A' ' 85' ' ' LEU . 3.2 p -61.22 76.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.648 -0.913 . . . . 0.0 109.485 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 78' ' ' SER . . . . . 0.534 ' N ' ' O ' ' B' ' 76' ' ' GLY . 0.1 OUTLIER -77.3 177.78 7.65 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.872 0.844 . . . . 0.0 110.37 -179.884 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.924 ' HB ' HD13 ' B' ' 50' ' ' ILE . 7.0 p 177.73 174.76 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 80' ' ' LYS . . . . . 0.614 ' HB2' ' HD2' ' B' ' 81' ' ' PRO . 0.0 OUTLIER 177.17 171.75 0.39 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 120.821 -1.174 . . . . 0.0 111.14 177.493 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 81' ' ' PRO . . . . . 0.666 ' HA ' ' O ' ' B' ' 47' ' ' PHE . 51.1 Cg_endo -74.64 141.45 27.81 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.374 1.723 . . . . 0.0 110.475 176.711 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 82' ' ' GLY . . . . . 0.52 ' H ' ' HA ' ' B' ' 47' ' ' PHE . . . -110.31 -75.67 0.83 Allowed Glycine 0 N--CA 1.492 2.433 0 N-CA-C 106.501 -2.64 . . . . 0.0 106.501 178.079 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 83' ' ' GLU . . . . . 0.885 ' O ' ' N ' ' B' ' 85' ' ' LEU . 2.1 pt-20 -91.22 40.62 1.03 Allowed 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 176.307 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 84' ' ' SER . . . . . 1.034 ' C ' HD22 ' B' ' 85' ' ' LEU . 1.9 t 10.52 43.83 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.665 1.222 . . . . 0.0 110.302 178.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 1.034 HD22 ' C ' ' B' ' 84' ' ' SER . 0.0 OUTLIER 18.76 26.21 0.0 OUTLIER 'General case' 0 C--O 1.186 -2.287 0 N-CA-C 102.898 -3.001 . . . . 0.0 102.898 -170.669 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 86' ' ' LYS . . . . . 0.583 ' HB2' ' HB3' ' B' ' 84' ' ' SER 0.325 2.9 tttm -48.71 -38.59 21.9 Favored 'General case' 0 CA--C 1.473 -2.018 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 177.708 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . 0.27 2.9 tttt -62.54 -40.92 98.33 Favored 'General case' 0 C--N 1.275 -2.652 0 CA-C-N 111.886 -2.415 . . . . 0.0 106.137 177.276 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.951 ' O ' ' HB1' ' A' ' 37' ' ' ALA . . . -78.65 -33.57 47.08 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 118.29 -1.364 . . . . 0.0 107.989 177.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.926 ' HA ' HD23 ' B' ' 92' ' ' LEU . . . -64.73 -30.63 71.65 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.258 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -64.46 -33.92 77.01 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 175.129 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -64.23 -45.36 93.81 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 178.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 92' ' ' LEU . . . . . 0.926 HD23 ' HA ' ' B' ' 89' ' ' ALA . 0.5 OUTLIER -65.49 2.32 0.94 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.499 -1.589 . . . . 0.0 111.403 -179.617 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 93' ' ' LYS . . . . . 0.508 ' CB ' ' O ' ' B' ' 92' ' ' LEU . 7.0 tptt 72.9 53.91 0.14 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -177.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 94' ' ' TYR . . . . . 0.416 ' CD1' ' N ' ' A' ' 75' ' ' VAL . 6.1 t80 -38.97 -43.62 0.99 Allowed 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.008 -179.108 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -57.16 -41.19 78.75 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.304 -0.873 . . . . 0.0 109.656 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 96' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' B' ' 93' ' ' LYS . 4.1 t70 -60.89 -31.95 71.42 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 97' ' ' PHE . . . . . 0.671 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.83 ' HB3' HG22 ' B' ' 42' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 120.897 0.379 . . . . 0.0 110.291 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.481 ' H ' ' HB2' ' A' ' 5' ' ' GLU . 16.1 p-10 -173.29 -161.62 0.14 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.398 -0.921 . . . . 0.0 111.459 178.758 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.586 ' HD2' ' HB ' ' B' ' 45' ' ' THR . 6.8 tttt -45.88 -21.75 0.15 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.956 -0.465 . . . . 0.0 110.116 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.656 ' O ' HG13 ' A' ' 7' ' ' ILE . 88.3 m -94.29 -66.36 0.92 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.501 -0.749 . . . . 0.0 110.662 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.501 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 4.2 mt-10 -48.98 -41.11 33.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.888 -1.133 . . . . 0.0 109.123 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.725 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 22.5 mt -53.25 -41.88 65.92 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.763 178.194 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.775 HG21 ' CD2' ' A' ' 25' ' ' LEU . 1.2 pp -59.05 -40.34 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 178.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.848 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 17.7 mtmt -62.31 -37.52 85.9 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 176.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.864 ' CB ' HD13 ' B' ' 31' ' ' ILE . . . -53.87 -36.87 63.11 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.848 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.6 mp -90.91 -31.95 5.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 178.166 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.848 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -67.45 -8.0 29.84 Favored 'General case' 0 C--N 1.284 -2.26 0 O-C-N 120.777 -1.202 . . . . 0.0 109.128 179.017 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.436 ' HB3' ' O ' ' A' ' 8' ' ' LYS . 1.5 tt0 -124.07 -38.73 2.43 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.374 -0.829 . . . . 0.0 109.961 179.008 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 9' ' ' ALA . 1.0 OUTLIER -73.18 -19.22 61.15 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 177.482 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . 1.146 HG22 ' CD1' ' A' ' 16' ' ' LEU 0.28 0.2 OUTLIER -112.1 -71.59 0.75 Allowed 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 179.516 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 57.4 18.64 30.2 Favored Glycine 0 N--CA 1.498 2.769 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 177.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 1.146 ' CD1' HG22 ' A' ' 14' ' ' THR . 4.9 mp -58.73 -62.75 1.63 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.419 -1.048 . . . . 0.0 109.384 179.161 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.551 ' O ' HG23 ' A' ' 17' ' ' THR . 0.5 OUTLIER -143.27 8.88 1.62 Allowed 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.242 -179.771 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.611 ' O ' ' C ' ' A' ' 19' ' ' VAL . 2.7 mt-30 58.24 26.7 14.18 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 -176.017 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 1.037 HG11 HG11 ' B' ' 19' ' ' VAL . 0.6 OUTLIER -2.26 -98.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.453 -179.306 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . 1.045 ' HB3' HD21 ' B' ' 16' ' ' LEU . 1.1 p -134.4 25.57 3.79 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 178.383 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.697 ' HA ' ' CE ' ' A' ' 24' ' ' MET . 28.3 m -19.36 -39.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 CA-C-O 122.55 1.166 . . . . 0.0 109.872 -178.195 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.809 ' N ' ' O ' ' A' ' 20' ' ' SER . 36.7 t -76.64 -41.85 44.28 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.118 177.492 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.967 ' N ' ' O ' ' A' ' 20' ' ' SER . 1.2 mtpt -82.78 -37.72 24.18 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.664 -0.648 . . . . 0.0 111.999 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.697 ' CE ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -69.27 -24.52 63.99 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 117.47 -1.692 . . . . 0.0 108.437 179.914 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.775 ' CD2' HG21 ' A' ' 7' ' ' ILE . 0.3 OUTLIER -75.66 -47.32 26.86 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.134 -1.027 . . . . 0.0 109.241 178.609 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.701 ' N ' ' HG ' ' A' ' 25' ' ' LEU . . . -64.0 -27.93 69.46 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 178.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.605 ' O ' HG13 ' A' ' 31' ' ' ILE . 7.2 p -85.96 -34.99 20.72 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 178.555 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.684 ' HE1' HD22 ' B' ' 44' ' ' LEU . 0.1 OUTLIER -58.31 -46.65 85.73 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 179.146 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.549 ' HG3' ' CE2' ' B' ' 47' ' ' PHE . 2.4 tt0 -70.95 -34.35 71.38 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 177.494 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 1.293 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 60.6 tttt -64.37 -19.1 65.27 Favored 'General case' 0 C--O 1.193 -1.888 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 177.619 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.642 HD12 HG12 ' A' ' 32' ' ' ILE . 1.7 pp -108.91 -29.2 2.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 120.116 -1.615 . . . . 0.0 109.062 178.107 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.642 HG12 HD12 ' A' ' 31' ' ' ILE . 1.1 mm -72.0 -55.05 14.68 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.62 HG23 ' HB2' ' B' ' 88' ' ' ALA . 0.7 OUTLIER -78.0 -32.2 51.08 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.791 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 1.293 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 73.2 mm-40 -78.75 -37.13 41.96 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 120.933 -1.104 . . . . 0.0 110.606 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.833 HG22 ' CB ' ' A' ' 40' ' ' ASP . 73.1 m -64.96 -37.45 87.68 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 177.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.037 HG21 HD22 ' B' ' 85' ' ' LEU . 1.4 t -56.75 -35.94 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 175.689 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.678 ' CB ' ' O ' ' B' ' 88' ' ' ALA . . . -89.46 12.67 15.8 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 176.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 34' ' ' GLU . 3.1 ttmt -130.17 17.1 5.56 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.069 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.32 40.49 10.05 Favored Glycine 0 N--CA 1.48 1.598 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.833 ' CB ' HG22 ' A' ' 35' ' ' THR . 4.8 t70 -60.68 163.23 5.7 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 122.578 1.18 . . . . 0.0 112.8 -178.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.467 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 16.8 mtmt -157.52 57.58 0.5 Allowed 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 105.9 -1.889 . . . . 0.0 105.9 176.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.771 ' CG1' HD11 ' B' ' 6' ' ' LEU . 2.2 t -95.68 150.15 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-O 121.533 0.683 . . . . 0.0 111.05 -177.547 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.469 ' O ' ' CG ' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -137.53 99.94 4.08 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.299 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.614 HD12 ' HB2' ' A' ' 48' ' ' LEU . 11.9 mt -66.78 113.3 4.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.095 -1.003 . . . . 0.0 110.17 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.562 HG23 ' CD2' ' A' ' 47' ' ' PHE . 0.1 OUTLIER 29.99 -88.93 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.21 0 O-C-N 122.038 -0.414 . . . . 0.0 111.411 179.299 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -147.6 19.49 1.48 Allowed Glycine 0 N--CA 1.484 1.884 0 C-N-CA 119.729 -1.224 . . . . 0.0 110.274 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.592 ' CE1' HG21 ' B' ' 32' ' ' ILE . 32.1 p90 -116.91 -39.2 3.29 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.759 -1.436 . . . . 0.0 111.831 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.963 HD11 HD11 ' B' ' 48' ' ' LEU . 0.1 OUTLIER -115.78 108.92 16.95 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.758 -1.214 . . . . 0.0 112.238 -179.885 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.721 ' O ' ' HB ' ' A' ' 79' ' ' VAL . 0.1 OUTLIER -92.81 68.13 4.53 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.711 -0.618 . . . . 0.0 109.675 179.002 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.836 HD13 HG21 ' A' ' 79' ' ' VAL . 48.0 mm -53.07 114.3 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.49 0 O-C-N 121.186 -0.946 . . . . 0.0 112.398 -176.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.504 ' O ' ' N ' ' A' ' 78' ' ' SER . 0.6 OUTLIER -157.39 109.65 1.86 Allowed Pre-proline 0 N--CA 1.478 0.967 0 O-C-N 121.846 -0.534 . . . . 0.0 110.293 179.973 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.569 ' HB2' HG11 ' A' ' 75' ' ' VAL . 50.2 Cg_endo -76.8 149.85 30.03 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 O-C-N 123.132 1.069 . . . . 0.0 109.86 178.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 1.046 ' O ' HG22 ' A' ' 75' ' ' VAL . 1.9 t -110.95 -142.91 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.487 -0.758 . . . . 0.0 110.17 -179.38 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.637 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.501 2.087 0 O-C-N 121.377 -0.827 . . . . 0.0 109.703 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 1.046 HG22 ' O ' ' A' ' 53' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.496 1.852 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.458 ' N ' ' CG1' ' A' ' 75' ' ' VAL . . . -111.94 -157.38 13.84 Favored Glycine 0 N--CA 1.475 1.283 0 C-N-CA 118.659 -1.734 . . . . 0.0 109.561 -179.287 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.79 HG12 ' CG1' ' A' ' 79' ' ' VAL . 3.5 t -139.02 85.62 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.172 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.504 ' N ' ' O ' ' A' ' 51' ' ' LYS . 0.2 OUTLIER -55.09 -45.7 75.46 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.453 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.836 HG21 HD13 ' A' ' 50' ' ' ILE 0.273 5.8 p -50.37 170.84 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-O 122.347 1.07 . . . . 0.0 112.264 -177.165 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.661 ' HB2' ' HD2' ' A' ' 81' ' ' PRO . 5.6 ptmt 174.79 177.46 0.2 Allowed Pre-proline 0 C--N 1.302 -1.499 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.661 ' HD2' ' HB2' ' A' ' 80' ' ' LYS . 36.8 Cg_endo -63.15 143.59 90.42 Favored 'Trans proline' 0 C--N 1.295 -2.249 0 N-CA-C 106.973 -1.972 . . . . 0.0 106.973 175.139 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.49 ' C ' ' H ' ' A' ' 84' ' ' SER . . . -120.77 -102.97 1.88 Allowed Glycine 0 N--CA 1.498 2.797 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -178.127 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.96 ' O ' ' N ' ' A' ' 85' ' ' LEU . 32.6 tt0 -72.38 50.51 0.23 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.117 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.653 ' HB3' ' HB2' ' A' ' 86' ' ' LYS . 2.7 t 7.86 43.54 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 122.491 1.139 . . . . 0.0 109.785 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 1.114 HD11 HG12 ' B' ' 36' ' ' VAL . 3.0 pp 18.48 27.98 0.0 OUTLIER 'General case' 0 C--O 1.196 -1.713 0 N-CA-C 103.33 -2.841 . . . . 0.0 103.33 -171.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.685 ' HA ' ' HB3' ' A' ' 89' ' ' ALA 0.335 1.6 tttt -55.71 -39.85 71.62 Favored 'General case' 0 CA--C 1.473 -2.004 0 N-CA-C 104.473 -2.418 . . . . 0.0 104.473 177.134 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.255 28.7 tttt -59.11 -41.34 87.91 Favored 'General case' 0 C--N 1.28 -2.43 0 CA-C-N 112.188 -2.278 . . . . 0.0 105.79 177.167 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.896 ' O ' ' HB1' ' B' ' 37' ' ' ALA . . . -77.76 -32.08 52.42 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 117.65 -1.62 . . . . 0.0 107.061 177.336 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.869 ' HA ' HD23 ' A' ' 92' ' ' LEU . . . -61.5 -34.32 75.29 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.21 -1.034 . . . . 0.0 108.21 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.412 ' HA ' ' CB ' ' A' ' 94' ' ' TYR . 3.9 mt-10 -60.23 -35.91 76.52 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 175.58 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -62.51 -32.88 84.7 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 178.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.869 HD23 ' HA ' ' A' ' 89' ' ' ALA . 0.3 OUTLIER -78.73 17.37 0.71 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.481 -1.599 . . . . 0.0 110.667 -179.81 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.745 ' O ' ' C ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER 80.12 32.47 0.19 Allowed 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -178.068 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 1.11 ' O ' ' C ' ' A' ' 95' ' ' GLU . 9.5 t80 -25.53 -68.22 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 117.755 -1.578 . . . . 0.0 108.25 -177.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 1.11 ' C ' ' O ' ' A' ' 94' ' ' TYR . 62.6 mm-40 . . . . . 0 CA--C 1.489 -1.403 0 N-CA-C 101.391 -3.559 . . . . 0.0 101.391 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.595 ' SD ' HG21 ' A' ' 35' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 120.721 0.296 . . . . 0.0 110.309 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 2' ' ' ASN . . . . . 0.543 ' HB3' ' O ' ' B' ' 1' ' ' MET . 25.4 p30 178.89 -143.94 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.577 178.079 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.782 ' HA ' HD11 ' B' ' 25' ' ' LEU . 3.1 mttp -55.05 -3.13 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.215 -0.928 . . . . 0.0 111.192 -179.388 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 4' ' ' THR . . . . . 0.677 ' O ' HG13 ' B' ' 7' ' ' ILE . 16.3 m -114.51 -65.03 1.23 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.898 -1.126 . . . . 0.0 110.573 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.539 ' HB2' ' HA ' ' B' ' 1' ' ' MET . 9.2 mp0 -49.02 -44.72 41.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.84 -1.163 . . . . 0.0 108.909 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.771 HD11 ' CG1' ' A' ' 42' ' ' VAL . 20.1 mt -57.01 -34.47 68.2 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.125 -1.03 . . . . 0.0 109.648 178.327 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 7' ' ' ILE . . . . . 0.825 HG22 HD23 ' B' ' 25' ' ' LEU . 1.1 pp -57.63 -43.43 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 178.215 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 8' ' ' LYS . . . . . 0.912 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.0 OUTLIER -63.7 -32.55 74.08 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 177.926 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 9' ' ' ALA . . . . . 0.696 ' HB3' ' O ' ' B' ' 6' ' ' LEU . . . -55.18 -40.94 71.26 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.439 -0.788 . . . . 0.0 109.162 178.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.816 HG22 HG12 ' B' ' 21' ' ' VAL . 1.1 mp -91.44 -29.79 4.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 178.22 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.912 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -65.99 -15.42 62.99 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.268 -0.973 . . . . 0.0 108.399 178.02 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.471 ' HB3' ' O ' ' B' ' 8' ' ' LYS . 1.8 tp60 -112.31 -42.99 3.59 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.583 ' OD2' HG21 ' A' ' 31' ' ' ILE . 18.8 m-20 -59.83 -39.97 86.92 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 177.118 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 14' ' ' THR . . . . . 0.785 HG21 ' CG2' ' A' ' 19' ' ' VAL . 0.2 OUTLIER -98.83 -71.69 0.68 Allowed 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 113.858 -1.519 . . . . 0.0 108.504 179.387 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 47.26 27.39 3.85 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 16' ' ' LEU . . . . . 1.045 HD21 ' HB3' ' A' ' 20' ' ' SER . 0.4 OUTLIER -91.6 -28.56 17.44 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.543 -0.975 . . . . 0.0 108.814 178.89 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 17' ' ' THR . . . . . 0.805 ' N ' HD12 ' B' ' 16' ' ' LEU . 0.7 OUTLIER -147.39 -13.94 0.4 Allowed 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.893 -0.504 . . . . 0.0 110.342 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 18' ' ' GLN . . . . . 0.446 ' O ' ' O ' ' B' ' 19' ' ' VAL . 3.1 mt-30 57.36 43.71 22.86 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -177.313 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 1.037 HG11 HG11 ' A' ' 19' ' ' VAL . 1.4 p -34.5 -94.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.96 -178.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 20' ' ' SER . . . . . 0.918 ' O ' ' N ' ' B' ' 23' ' ' LYS . 0.4 OUTLIER -134.16 25.19 3.88 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 178.845 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.816 HG12 HG22 ' B' ' 10' ' ' ILE . 31.1 m -17.28 -39.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-O 122.642 1.211 . . . . 0.0 109.574 -178.149 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.896 ' N ' ' O ' ' B' ' 20' ' ' SER . 38.2 p -85.67 -38.43 18.36 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.071 178.334 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 23' ' ' LYS . . . . . 0.918 ' N ' ' O ' ' B' ' 20' ' ' SER . 1.8 mtpt -86.1 -29.91 22.98 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.463 -0.773 . . . . 0.0 111.092 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 24' ' ' MET . . . . . 0.917 ' HB3' HG21 ' A' ' 14' ' ' THR . 0.0 OUTLIER -80.66 -35.08 34.28 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.588 -1.32 . . . . 0.0 110.093 179.856 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.893 ' C ' HD12 ' B' ' 25' ' ' LEU . 0.1 OUTLIER -79.81 -43.06 23.11 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 118.099 -1.441 . . . . 0.0 107.368 177.955 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 26' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' B' ' 22' ' ' SER . . . -59.75 -25.25 64.71 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 176.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 27' ' ' SER . . . . . 0.565 ' HA ' ' HB3' ' B' ' 30' ' ' LYS . 4.3 t -81.24 -36.81 29.52 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.154 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 28' ' ' PHE . . . . . 0.758 ' HA ' ' CG1' ' B' ' 31' ' ' ILE . 0.0 OUTLIER -60.96 -36.43 79.37 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.769 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 29' ' ' GLU . . . . . 0.674 ' O ' ' HB ' ' B' ' 33' ' ' THR . 9.2 mt-10 -77.55 -34.5 53.81 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 177.184 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 1.012 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 64.0 tttt -68.42 -25.4 65.01 Favored 'General case' 0 C--O 1.192 -1.97 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 177.332 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.864 HD13 ' CB ' ' A' ' 9' ' ' ALA . 1.1 pp -100.81 -29.85 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 120.983 -1.073 . . . . 0.0 109.518 178.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.703 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.1 mm -66.02 -57.32 11.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 176.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 33' ' ' THR . . . . . 0.98 ' O ' HD13 ' A' ' 85' ' ' LEU . 0.5 OUTLIER -65.26 -38.48 90.46 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.474 179.172 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 1.012 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 23.9 mm-40 -75.21 -38.9 60.5 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.37 -0.831 . . . . 0.0 112.067 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 35' ' ' THR . . . . . 0.512 ' N ' ' O ' ' B' ' 31' ' ' ILE . 44.1 m -59.57 -54.59 44.79 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.334 -1.479 . . . . 0.0 109.425 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 1.114 HG12 HD11 ' A' ' 85' ' ' LEU . 2.6 t -54.32 -36.23 32.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 177.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 37' ' ' ALA . . . . . 0.896 ' HB1' ' O ' ' A' ' 88' ' ' ALA . . . -88.49 4.8 45.31 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.686 0.755 . . . . 0.0 109.823 177.598 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 38' ' ' LYS . . . . . 0.73 ' N ' ' O ' ' B' ' 34' ' ' GLU . 1.2 tppp? -105.26 -32.9 8.41 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 178.263 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.21 35.03 0.44 Allowed Glycine 0 C--N 1.301 -1.397 0 C-N-CA 119.661 -1.256 . . . . 0.0 111.092 177.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 40' ' ' ASP . . . . . 0.44 ' HB3' ' CG2' ' B' ' 35' ' ' THR . 0.2 OUTLIER -147.14 173.05 12.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.011 -1.288 . . . . 0.0 110.543 179.523 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.424 ' HB3' ' HB2' ' B' ' 51' ' ' LYS . 0.0 OUTLIER -127.65 114.53 17.47 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.651 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.83 HG22 ' HB3' ' A' ' 1' ' ' MET . 38.4 t -98.96 131.02 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.572 -178.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 43' ' ' GLN . . . . . 0.454 ' HG3' ' CB ' ' A' ' 2' ' ' ASN . 0.0 OUTLIER -111.51 123.61 50.58 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.259 -0.9 . . . . 0.0 110.547 180.0 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.871 HD12 ' HB3' ' B' ' 48' ' ' LEU . 16.4 mt -84.04 102.69 12.68 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.267 -0.896 . . . . 0.0 109.705 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 45' ' ' THR . . . . . 0.586 ' HB ' ' HD2' ' A' ' 3' ' ' LYS . 0.1 OUTLIER 34.98 -91.97 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.975 -0.453 . . . . 0.0 111.125 -179.777 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 46' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -148.85 20.1 1.26 Allowed Glycine 0 N--CA 1.487 2.095 0 N-CA-C 110.089 -1.205 . . . . 0.0 110.089 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 47' ' ' PHE . . . . . 0.584 ' CZ ' HD13 ' B' ' 44' ' ' LEU . 3.8 p90 -116.61 -33.6 4.81 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.056 -1.261 . . . . 0.0 111.079 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.963 HD11 HD11 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -119.58 178.9 4.39 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.626 -1.296 . . . . 0.0 111.797 179.227 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 49' ' ' ASN . . . . . 0.675 ' O ' ' HB ' ' B' ' 79' ' ' VAL . 2.0 m-80 -165.98 145.05 6.04 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 50' ' ' ILE . . . . . 1.071 ' HA ' HG21 ' B' ' 79' ' ' VAL . 1.6 pp -146.59 101.61 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-O 122.131 0.967 . . . . 0.0 110.636 178.394 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 51' ' ' LYS . . . . . 0.535 ' N ' HG11 ' B' ' 79' ' ' VAL . 0.1 OUTLIER -147.94 133.14 9.17 Favored Pre-proline 0 N--CA 1.495 1.782 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.919 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 52' ' ' PRO . . . . . 0.836 ' CG ' HG13 ' B' ' 36' ' ' VAL . 58.0 Cg_endo -95.71 153.18 1.5 Allowed 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.305 1.16 . . . . 0.0 112.49 -178.361 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 1.003 HG22 ' O ' ' B' ' 76' ' ' GLY . 27.9 m -134.57 112.92 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 CA-C-O 122.017 0.913 . . . . 0.0 109.965 176.551 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.865 0 O-C-N 121.687 -0.633 . . . . 0.0 111.662 -178.608 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 75' ' ' VAL . . . . . 0.597 ' HB ' ' HB1' ' A' ' 89' ' ' ALA . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 76' ' ' GLY . . . . . 1.003 ' O ' HG22 ' B' ' 53' ' ' VAL . . . -118.02 99.3 0.8 Allowed Glycine 0 N--CA 1.486 1.968 0 C-N-CA 119.217 -1.468 . . . . 0.0 109.642 -179.21 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.648 ' O ' HG12 ' B' ' 77' ' ' VAL . 2.1 t -60.71 88.08 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 179.135 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 78' ' ' SER . . . . . 0.621 ' OG ' HG13 ' B' ' 53' ' ' VAL . 0.8 OUTLIER -58.06 -48.25 80.7 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.564 -178.057 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 1.071 HG21 ' HA ' ' B' ' 50' ' ' ILE . 27.2 m -49.46 177.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 115.224 1.564 . . . . 0.0 115.224 -174.584 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 80' ' ' LYS . . . . . 0.658 ' HB2' ' HD2' ' B' ' 81' ' ' PRO . 0.0 OUTLIER 179.56 178.97 0.28 Allowed Pre-proline 0 N--CA 1.481 1.087 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.161 -179.051 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 81' ' ' PRO . . . . . 0.678 ' HB2' HG11 ' A' ' 77' ' ' VAL . 41.8 Cg_endo -70.21 130.99 19.7 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.372 1.196 . . . . 0.0 110.78 179.092 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -82.18 -157.99 22.03 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 83' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' B' ' 87' ' ' LYS . 11.1 pt-20 -83.73 -21.25 32.34 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.574 -0.956 . . . . 0.0 110.842 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 84' ' ' SER . . . . . 0.513 ' HB3' ' HB3' ' B' ' 47' ' ' PHE . 0.4 OUTLIER -56.28 -45.39 80.16 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.032 -1.042 . . . . 0.0 109.282 -179.682 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 1.037 HD22 HG21 ' A' ' 36' ' ' VAL . 12.8 mt -61.6 -32.53 72.65 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.246 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 86' ' ' LYS . . . . . 0.564 ' O ' ' HB3' ' B' ' 89' ' ' ALA . 1.7 tttp -82.7 -31.32 28.62 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.642 0.734 . . . . 0.0 109.799 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 87' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' B' ' 83' ' ' GLU . 9.8 tmtt? -73.56 -38.97 65.04 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.678 ' O ' ' CB ' ' A' ' 37' ' ' ALA . . . -66.71 -34.73 78.49 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 176.665 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.914 ' HB1' ' CG1' ' A' ' 75' ' ' VAL . . . -53.39 -46.16 69.58 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.406 -0.809 . . . . 0.0 109.448 178.758 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 90' ' ' GLU . . . . . 0.408 ' HG2' ' N ' ' B' ' 91' ' ' GLY . 1.5 pt-20 -56.5 -29.71 62.13 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 176.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 91' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' B' ' 88' ' ' ALA . . . -64.72 -34.21 89.28 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 178.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 92' ' ' LEU . . . . . 1.031 HD21 HG21 ' A' ' 75' ' ' VAL . 1.5 pp -71.06 20.8 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 CA-C-N 119.928 1.864 . . . . 0.0 110.947 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 93' ' ' LYS . . . . . 0.461 ' H ' ' C ' ' B' ' 91' ' ' GLY . 0.2 OUTLIER 59.42 44.33 15.21 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 106.044 -1.835 . . . . 0.0 106.044 -177.656 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 94' ' ' TYR . . . . . 0.732 ' CD1' HG23 ' A' ' 75' ' ' VAL . 0.3 OUTLIER -35.53 -42.24 0.22 Allowed 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.044 -178.233 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -52.85 -41.39 64.23 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.206 -0.934 . . . . 0.0 109.5 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 96' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' B' ' 93' ' ' LYS . 0.4 OUTLIER -65.14 -30.4 71.32 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.141 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 97' ' ' PHE . . . . . 0.458 ' HB2' HD11 ' B' ' 92' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.625 -0.672 . . . . 0.0 109.371 178.609 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.479 ' HG2' ' HB3' ' A' ' 5' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.139 0.495 . . . . 0.0 110.132 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.443 ' N ' ' HB2' ' A' ' 5' ' ' GLU . 4.4 p30 173.05 173.26 0.12 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.489 -0.757 . . . . 0.0 110.337 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.747 ' HD2' HD13 ' A' ' 25' ' ' LEU . 2.2 mmmp? -43.19 -26.16 0.15 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.627 -0.671 . . . . 0.0 110.555 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.54 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 5.7 m -85.83 -55.46 3.96 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.247 -0.908 . . . . 0.0 109.027 178.536 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.481 ' HA ' ' CE ' ' A' ' 8' ' ' LYS . 1.0 OUTLIER -60.2 -48.76 80.36 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.697 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.795 HD11 ' CG2' ' B' ' 42' ' ' VAL . 9.5 mt -57.56 -33.24 67.94 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.575 -0.85 . . . . 0.0 108.718 177.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 1.015 ' CD1' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -54.79 -54.09 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 178.373 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.927 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -68.74 -27.86 66.3 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.65 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 6' ' ' LEU . . . -59.49 -33.86 71.86 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.289 -0.882 . . . . 0.0 108.795 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.927 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.8 OUTLIER -95.75 -37.02 7.05 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.528 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 178.429 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.927 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -60.18 -26.93 66.72 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.316 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.418 ' CG ' ' O ' ' A' ' 8' ' ' LYS . 1.4 pp0? -92.91 -37.56 12.18 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.536 ' HB3' ' CB ' ' B' ' 27' ' ' SER . 21.8 m-20 -69.08 -29.59 67.72 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 176.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . 1.016 HG22 ' HB2' ' B' ' 20' ' ' SER . 16.6 p -85.82 -75.77 0.36 Allowed 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 177.506 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 55.26 15.25 7.27 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.774 HD11 ' OG ' ' B' ' 20' ' ' SER . 0.7 OUTLIER -80.92 -51.53 8.47 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.251 -1.146 . . . . 0.0 107.989 178.702 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.685 HG22 ' H ' ' A' ' 19' ' ' VAL . 0.5 OUTLIER -144.8 -2.21 0.84 Allowed 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.897 -179.847 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.671 ' O ' ' C ' ' A' ' 19' ' ' VAL . 6.7 mt-30 56.23 30.07 15.96 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 -176.81 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.978 HG23 HD13 ' B' ' 16' ' ' LEU . 0.4 OUTLIER 3.78 -97.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.868 -179.399 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . 1.022 ' O ' ' N ' ' A' ' 22' ' ' SER . 6.1 p -134.98 24.14 3.58 Favored 'General case' 0 C--N 1.28 -2.456 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 176.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.771 ' HA ' ' CE ' ' A' ' 24' ' ' MET . 18.1 m -5.14 -44.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-O 122.447 1.118 . . . . 0.0 110.719 -177.639 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' SER . . . . . 1.022 ' N ' ' O ' ' A' ' 20' ' ' SER . 33.3 m -71.22 -41.79 69.74 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.88 178.242 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.89 ' N ' ' O ' ' A' ' 20' ' ' SER . 5.0 mtpt -85.87 -32.61 21.6 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.459 -0.776 . . . . 0.0 111.486 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.771 ' CE ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -65.82 -26.83 67.86 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 116.938 -1.905 . . . . 0.0 108.158 179.277 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 1.015 HD23 ' CD1' ' A' ' 7' ' ' ILE . 0.1 OUTLIER -77.88 -49.68 13.74 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 177.727 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.563 ' N ' HD12 ' A' ' 25' ' ' LEU . . . -57.79 -29.72 65.09 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.191 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.525 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 1.6 t -83.39 -38.92 21.33 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.118 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.65 ' CZ ' HD13 ' B' ' 44' ' ' LEU . 19.7 t80 -53.32 -48.09 68.73 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.212 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.638 ' HG3' HG21 ' B' ' 45' ' ' THR . 0.1 OUTLIER -66.86 -38.76 86.95 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 176.332 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 1.273 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 42.2 tttt -60.79 -19.56 59.74 Favored 'General case' 0 C--O 1.194 -1.836 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.479 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.717 HD13 ' HB1' ' B' ' 9' ' ' ALA . 0.9 OUTLIER -112.74 -23.46 4.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 O-C-N 119.996 -1.69 . . . . 0.0 109.904 178.641 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.649 HG21 ' CE1' ' B' ' 47' ' ' PHE . 1.3 mm -82.46 -49.68 16.88 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 176.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.494 ' OG1' ' O ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -77.48 -38.88 48.27 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.564 178.677 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 1.273 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 64.2 mm-40 -74.16 -28.5 61.34 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.946 -1.096 . . . . 0.0 111.157 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.731 HG22 ' CA ' ' A' ' 40' ' ' ASP . 87.8 m -78.09 -42.29 32.53 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 118.19 -1.404 . . . . 0.0 109.425 179.22 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.715 HG13 ' HB1' ' B' ' 88' ' ' ALA . 3.4 p -54.42 -41.22 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 177.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.698 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -78.85 -2.71 41.04 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.806 -0.758 . . . . 0.0 110.115 178.363 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -113.66 1.25 14.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.925 -1.109 . . . . 0.0 108.982 177.697 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.33 35.77 2.82 Favored Glycine 0 N--CA 1.484 1.887 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.731 ' CA ' HG22 ' A' ' 35' ' ' THR . 12.4 t70 -47.15 165.22 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 122.619 1.2 . . . . 0.0 112.912 -179.156 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.422 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 8.2 mttt -174.21 58.39 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 178.59 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.844 HG12 ' CB ' ' B' ' 1' ' ' MET . 12.0 m -93.39 132.63 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 CA-C-O 121.606 0.717 . . . . 0.0 111.324 -177.621 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.443 ' O ' ' CG ' ' A' ' 43' ' ' GLN . 1.1 tt0 -118.35 102.29 8.84 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.954 HD12 ' HB3' ' A' ' 48' ' ' LEU . 72.1 mt -70.52 104.45 2.78 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.093 -1.005 . . . . 0.0 110.166 -179.034 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.457 ' CG2' ' C ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER 33.36 -92.48 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.141 0 O-C-N 122.09 -0.381 . . . . 0.0 111.064 179.965 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -149.49 34.7 1.06 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.802 ' CD1' HD21 ' A' ' 85' ' ' LEU . 1.5 p90 -133.69 -26.1 1.61 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.111 -1.229 . . . . 0.0 111.617 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.954 ' HB3' HD12 ' A' ' 44' ' ' LEU . 5.7 mt -139.72 104.9 5.01 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.603 -1.311 . . . . 0.0 110.605 178.324 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.802 ' C ' HG23 ' A' ' 79' ' ' VAL . 1.5 t30 -106.12 76.79 1.18 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.165 -0.959 . . . . 0.0 110.716 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.888 HD13 ' HB ' ' A' ' 79' ' ' VAL . 1.4 mm -64.29 109.98 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.187 -0.946 . . . . 0.0 109.849 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.51 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -131.06 119.59 17.92 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.053 -1.029 . . . . 0.0 109.84 -179.913 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.568 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 54.0 Cg_endo -79.42 139.28 14.45 Favored 'Trans proline' 0 C--N 1.316 -1.146 0 O-C-N 123.39 1.205 . . . . 0.0 111.832 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.723 HG22 ' O ' ' A' ' 76' ' ' GLY . 33.9 m -144.24 117.7 3.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.359 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.687 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.499 2.012 0 CA-C-O 121.626 0.727 . . . . 0.0 111.96 -178.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.774 HG12 ' CB ' ' B' ' 89' ' ' ALA . 0.4 OUTLIER . . . . . 0 N--CA 1.496 1.849 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.723 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -123.76 86.45 0.38 Allowed Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.927 HG21 ' CD1' ' B' ' 85' ' ' LEU . 4.7 p -64.77 68.9 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.549 -0.971 . . . . 0.0 108.697 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.563 ' O ' ' HB ' ' A' ' 79' ' ' VAL . 1.0 OUTLIER -65.42 174.49 2.14 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.903 0.859 . . . . 0.0 110.983 -178.517 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.888 ' HB ' HD13 ' A' ' 50' ' ' ILE . 4.9 p 174.79 -168.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.846 ' O ' HD23 ' A' ' 48' ' ' LEU . 7.6 pttt -172.98 172.26 1.63 Allowed Pre-proline 0 N--CA 1.485 1.279 0 O-C-N 120.678 -1.264 . . . . 0.0 111.235 177.406 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.806 ' HB3' HG12 ' B' ' 77' ' ' VAL . 55.3 Cg_endo -93.3 87.3 0.16 Allowed 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 122.635 2.223 . . . . 0.0 109.472 178.254 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.747 ' O ' HD12 ' A' ' 85' ' ' LEU . . . -58.73 158.05 19.98 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 87' ' ' LYS . 13.7 pt-20 -55.21 -17.27 4.15 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.219 -1.165 . . . . 0.0 111.07 -179.229 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.507 ' CB ' ' HB3' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -55.8 -35.89 66.82 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.85 -1.156 . . . . 0.0 109.317 179.426 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.802 HD21 ' CD1' ' A' ' 47' ' ' PHE . 0.7 OUTLIER -81.74 -37.8 26.71 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.894 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.449 ' N ' HG21 ' B' ' 77' ' ' VAL . 0.6 OUTLIER -75.0 -30.95 61.29 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.448 0.642 . . . . 0.0 110.368 -179.429 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.431 ' HA ' ' HG2' ' A' ' 90' ' ' GLU . 16.2 ttpt -78.1 -34.66 49.97 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.659 ' O ' ' HG ' ' A' ' 92' ' ' LEU . . . -71.59 -32.18 67.77 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 177.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.702 ' HA ' ' HA ' ' B' ' 37' ' ' ALA . . . -73.02 -54.12 9.39 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.538 -0.726 . . . . 0.0 110.484 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.588 ' HA ' ' HB3' ' A' ' 94' ' ' TYR . 19.1 pt-20 -53.86 -21.42 7.59 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 177.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.706 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -83.66 -28.87 34.06 Favored Glycine 0 CA--C 1.54 1.629 0 CA-C-O 119.093 -0.837 . . . . 0.0 112.335 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.725 HD12 ' C ' ' B' ' 37' ' ' ALA . 2.3 mt -97.88 -74.1 0.59 Allowed 'General case' 0 N--CA 1.5 2.026 0 CA-C-N 121.425 2.613 . . . . 0.0 111.816 -178.332 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -146.87 42.61 1.14 Allowed 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 119.244 -0.982 . . . . 0.0 111.385 -178.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.588 ' HB3' ' HA ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -60.63 -48.41 81.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.279 -0.888 . . . . 0.0 108.824 178.857 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.554 -0.716 . . . . 0.0 109.301 179.32 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.844 ' CB ' HG12 ' A' ' 42' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.126 0.489 . . . . 0.0 110.223 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 2' ' ' ASN . . . . . 0.532 ' H ' ' HB2' ' B' ' 5' ' ' GLU . 0.6 OUTLIER 178.3 178.21 0.4 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.39 -0.819 . . . . 0.0 109.834 -179.426 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.663 ' O ' HD22 ' B' ' 25' ' ' LEU . 0.1 OUTLIER -51.34 -23.86 4.09 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.764 -0.774 . . . . 0.0 108.975 178.915 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 4' ' ' THR . . . . . 0.512 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 30.4 m -90.22 -53.58 4.4 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.664 0.745 . . . . 0.0 109.51 178.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.532 ' HB2' ' H ' ' B' ' 2' ' ' ASN . 8.6 mm-40 -59.19 -49.23 78.64 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.701 ' O ' ' HB3' ' B' ' 9' ' ' ALA . 17.6 mt -54.42 -37.23 64.86 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.227 -0.989 . . . . 0.0 108.506 177.761 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 7' ' ' ILE . . . . . 0.999 ' CD1' HD23 ' B' ' 25' ' ' LEU . 0.1 OUTLIER -51.7 -51.27 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 177.604 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 8' ' ' LYS . . . . . 0.962 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.0 OUTLIER -64.79 -29.67 70.64 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.539 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 9' ' ' ALA . . . . . 0.717 ' HB1' HD13 ' A' ' 31' ' ' ILE . . . -53.57 -38.19 63.64 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.294 -0.879 . . . . 0.0 108.64 178.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.761 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.1 mp -97.41 -33.72 4.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.056 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.962 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -66.23 -12.3 55.33 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 118.579 -1.248 . . . . 0.0 109.197 178.682 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.453 ' N ' ' O ' ' B' ' 8' ' ' LYS . 23.3 mm100 -113.22 -41.67 3.66 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.345 -0.847 . . . . 0.0 109.525 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.457 ' CB ' ' OG ' ' A' ' 27' ' ' SER . 1.1 m-20 -70.67 -31.12 67.91 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 177.133 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 14' ' ' THR . . . . . 1.049 HG22 ' CD1' ' B' ' 16' ' ' LEU . 0.1 OUTLIER -106.63 -84.04 0.52 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 177.752 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 15' ' ' GLY . . . . . 0.592 ' O ' ' C ' ' B' ' 16' ' ' LEU . . . 72.63 -19.49 1.15 Allowed Glycine 0 N--CA 1.5 2.921 0 O-C-N 121.038 -1.039 . . . . 0.0 111.18 177.239 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 16' ' ' LEU . . . . . 1.049 ' CD1' HG22 ' B' ' 14' ' ' THR . 4.9 mp -18.86 -61.44 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.511 0 CA-C-O 122.031 0.919 . . . . 0.0 111.575 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 17' ' ' THR . . . . . 0.649 ' CG2' HG21 ' A' ' 17' ' ' THR . 0.5 OUTLIER -142.59 7.47 1.7 Allowed 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.543 -179.464 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 18' ' ' GLN . . . . . 0.584 ' O ' ' C ' ' B' ' 19' ' ' VAL . 29.7 mt-30 60.01 23.1 12.25 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 -175.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.939 HG11 HG11 ' A' ' 19' ' ' VAL . 1.4 p 5.04 -91.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.951 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 20' ' ' SER . . . . . 1.016 ' HB2' HG22 ' A' ' 14' ' ' THR . 0.5 OUTLIER -132.44 24.64 4.45 Favored 'General case' 0 C--N 1.277 -2.578 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 179.236 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.719 ' HA ' ' CE ' ' B' ' 24' ' ' MET . 16.7 m -22.69 -43.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 CA-C-O 122.541 1.162 . . . . 0.0 108.578 -178.019 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.717 ' N ' ' O ' ' B' ' 20' ' ' SER . 13.7 t -74.91 -39.06 61.65 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.614 177.527 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 23' ' ' LYS . . . . . 0.972 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.3 OUTLIER -86.25 -40.94 15.03 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.592 -0.692 . . . . 0.0 111.792 179.869 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 24' ' ' MET . . . . . 0.719 ' CE ' ' HA ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -61.84 -28.19 69.31 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 117.203 -1.799 . . . . 0.0 108.814 179.383 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.999 HD23 ' CD1' ' B' ' 7' ' ' ILE . 0.1 OUTLIER -80.57 -48.82 12.15 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 118.476 -1.29 . . . . 0.0 108.766 178.122 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 26' ' ' ALA . . . . . 0.568 ' N ' HD12 ' B' ' 25' ' ' LEU . . . -61.07 -29.25 69.63 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 27' ' ' SER . . . . . 0.551 ' HA ' ' HB3' ' B' ' 30' ' ' LYS . 75.3 m -83.64 -33.12 25.34 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.406 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 28' ' ' PHE . . . . . 0.794 ' CE1' HD22 ' A' ' 44' ' ' LEU . 0.7 OUTLIER -55.43 -50.78 68.91 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.913 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 29' ' ' GLU . . . . . 0.632 ' HG3' ' CE2' ' A' ' 47' ' ' PHE . 3.0 tt0 -65.73 -34.66 78.71 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 176.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 1.333 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 23.2 ttpp -66.89 -20.85 65.99 Favored 'General case' 0 C--O 1.193 -1.905 0 C-N-CA 119.414 -0.914 . . . . 0.0 108.93 178.589 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.673 HG13 ' O ' ' B' ' 28' ' ' PHE . 0.9 OUTLIER -108.04 -25.35 3.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 O-C-N 119.728 -1.858 . . . . 0.0 109.604 178.569 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.622 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.1 mm -76.62 -58.29 4.66 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 177.169 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 33' ' ' THR . . . . . 0.527 ' HA ' HD23 ' A' ' 85' ' ' LEU . 0.7 OUTLIER -75.54 -29.12 59.3 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.328 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 1.333 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 74.3 mm-40 -81.58 -27.59 34.21 Favored 'General case' 0 C--N 1.315 -0.915 0 O-C-N 120.898 -1.126 . . . . 0.0 110.416 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 35' ' ' THR . . . . . 0.594 HG23 ' CB ' ' B' ' 40' ' ' ASP . 1.8 m -69.73 -57.08 5.56 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 117.715 -1.594 . . . . 0.0 107.485 177.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.74 ' O ' ' HG3' ' B' ' 52' ' ' PRO . 7.1 p -48.43 -40.25 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.485 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 37' ' ' ALA . . . . . 0.725 ' C ' HD12 ' A' ' 92' ' ' LEU . . . -71.34 -32.83 69.01 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.14 178.24 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 38' ' ' LYS . . . . . 0.645 ' N ' HD12 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -68.86 -21.49 64.26 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 176.653 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 39' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' B' ' 35' ' ' THR . . . 99.25 30.88 6.41 Favored Glycine 0 C--N 1.298 -1.557 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 177.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 40' ' ' ASP . . . . . 0.594 ' CB ' HG23 ' B' ' 35' ' ' THR . 0.3 OUTLIER -118.03 151.82 36.74 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.395 -1.062 . . . . 0.0 109.905 179.528 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.416 ' CG ' ' CB ' ' B' ' 51' ' ' LYS . 0.0 OUTLIER -95.59 90.54 5.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.428 -0.795 . . . . 0.0 110.558 -179.299 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.863 HG12 HG22 ' B' ' 50' ' ' ILE . 10.5 p -75.06 152.89 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.41 -0.806 . . . . 0.0 109.392 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 43' ' ' GLN . . . . . 0.607 ' O ' HD23 ' B' ' 44' ' ' LEU . 18.5 pt20 -157.16 175.94 13.38 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.148 -0.97 . . . . 0.0 111.14 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.686 HD12 ' HB2' ' B' ' 48' ' ' LEU . 24.1 mt -128.51 117.49 21.4 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.625 -0.672 . . . . 0.0 109.356 179.151 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 45' ' ' THR . . . . . 0.638 HG21 ' HG3' ' A' ' 29' ' ' GLU . 0.6 OUTLIER 28.54 -103.37 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.815 -0.553 . . . . 0.0 111.313 179.893 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 46' ' ' GLY . . . . . 0.488 ' H ' HG23 ' B' ' 45' ' ' THR . . . -133.96 57.97 0.7 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 47' ' ' PHE . . . . . 0.731 ' CD1' HD21 ' B' ' 85' ' ' LEU . 8.0 p90 -157.67 -25.39 0.09 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.081 -1.247 . . . . 0.0 110.987 178.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.949 HD13 ' HG2' ' B' ' 80' ' ' LYS . 0.5 OUTLIER -130.78 145.65 52.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.842 -1.161 . . . . 0.0 109.965 178.003 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 49' ' ' ASN . . . . . 0.85 ' O ' ' O ' ' B' ' 79' ' ' VAL 0.265 0.4 OUTLIER -162.18 90.61 0.75 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.333 -0.854 . . . . 0.0 110.874 -177.247 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' B' B ' 50' ' ' ILE . . . . . 0.863 HG22 HG12 ' B' ' 42' ' ' VAL . 0.3 OUTLIER -83.53 146.14 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.884 -1.135 . . . . 0.0 109.809 -179.428 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 51' ' ' LYS . . . . . 0.448 ' HG3' ' HB3' ' B' ' 78' ' ' SER . 1.5 ptmt -167.3 122.79 0.87 Allowed Pre-proline 0 N--CA 1.495 1.807 0 C-N-CA 119.124 -1.03 . . . . 0.0 110.689 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 52' ' ' PRO . . . . . 0.74 ' HG3' ' O ' ' B' ' 36' ' ' VAL . 55.4 Cg_endo -88.45 146.92 6.19 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.611 1.321 . . . . 0.0 110.841 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.572 ' O ' HG23 ' B' ' 53' ' ' VAL . 26.7 m -132.22 114.39 23.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-O 121.909 0.861 . . . . 0.0 110.065 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.806 0 CA-C-O 121.484 0.659 . . . . 0.0 111.58 -178.855 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 75' ' ' VAL . . . . . 0.743 HG12 HG23 ' B' ' 77' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 76' ' ' GLY . . . . . 0.57 ' O ' HG22 ' B' ' 53' ' ' VAL . . . -114.8 54.48 0.57 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.806 HG12 ' HB3' ' A' ' 81' ' ' PRO . 69.9 t -37.75 87.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 122.052 -0.675 . . . . 0.0 111.59 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 78' ' ' SER . . . . . 0.552 ' N ' ' O ' ' B' ' 76' ' ' GLY . 1.8 t -59.45 -129.51 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.56 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.85 ' O ' ' O ' ' B' ' 49' ' ' ASN . 17.7 m -140.15 -170.01 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 119.76 -1.838 . . . . 0.0 112.815 178.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 80' ' ' LYS . . . . . 0.949 ' HG2' HD13 ' B' ' 48' ' ' LEU . 0.0 OUTLIER -101.28 -54.26 0.15 Allowed Pre-proline 0 C--N 1.29 -2.004 0 CA-C-N 113.49 -1.686 . . . . 0.0 113.261 -178.489 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 81' ' ' PRO . . . . . 0.78 ' HD2' ' H ' ' B' ' 80' ' ' LYS . 30.5 Cg_endo -52.43 138.88 56.53 Favored 'Trans proline' 0 C--N 1.298 -2.115 0 C-N-CA 121.219 1.279 . . . . 0.0 113.372 -174.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -135.2 -64.41 0.06 OUTLIER Glycine 0 N--CA 1.485 1.95 0 N-CA-C 106.091 -2.803 . . . . 0.0 106.091 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 83' ' ' GLU . . . . . 0.924 ' O ' ' N ' ' B' ' 85' ' ' LEU . 4.0 tt0 -97.19 46.18 1.04 Allowed 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 175.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 84' ' ' SER . . . . . 1.33 ' O ' ' N ' ' B' ' 86' ' ' LYS . 0.1 OUTLIER 8.18 43.26 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 122.551 1.167 . . . . 0.0 110.489 179.393 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 1.047 ' C ' ' O ' ' B' ' 84' ' ' SER . 0.5 OUTLIER 21.29 28.85 0.0 OUTLIER 'General case' 0 C--O 1.191 -2.004 0 N-CA-C 103.203 -2.888 . . . . 0.0 103.203 -171.161 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 86' ' ' LYS . . . . . 1.33 ' N ' ' O ' ' B' ' 84' ' ' SER 0.309 1.2 tttm -49.8 -35.99 24.78 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 176.938 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 87' ' ' LYS . . . . . 0.411 ' O ' ' HG2' ' B' ' 90' ' ' GLU 0.298 0.0 OUTLIER -66.49 -38.78 88.02 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 111.97 -2.377 . . . . 0.0 106.569 175.64 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.793 ' N ' ' O ' ' B' ' 85' ' ' LEU . . . -79.35 -26.33 42.11 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 118.725 -1.19 . . . . 0.0 108.285 178.407 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.932 ' HA ' HD23 ' B' ' 92' ' ' LEU . . . -68.48 -45.01 73.54 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.448 -0.782 . . . . 0.0 108.924 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 90' ' ' GLU . . . . . 0.48 ' HG2' ' N ' ' B' ' 91' ' ' GLY . 3.6 pt-20 -58.58 -28.37 65.49 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 176.507 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 91' ' ' GLY . . . . . 0.48 ' N ' ' HG2' ' B' ' 90' ' ' GLU . . . -62.48 -38.84 96.99 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 110.646 -0.981 . . . . 0.0 110.646 178.587 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 92' ' ' LEU . . . . . 0.932 HD23 ' HA ' ' B' ' 89' ' ' ALA . 0.9 OUTLIER -78.82 18.99 0.54 Allowed 'General case' 0 N--CA 1.505 2.28 0 O-C-N 120.392 -1.652 . . . . 0.0 111.481 -179.557 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 93' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' B' ' 92' ' ' LEU . 6.7 mptt 54.51 39.53 31.16 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -178.253 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 94' ' ' TYR . . . . . 0.583 ' HB2' ' CB ' ' A' ' 75' ' ' VAL . 1.2 p90 -42.01 -30.42 0.28 Allowed 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.746 -178.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 95' ' ' GLU . . . . . 0.506 ' CG ' ' CE1' ' B' ' 94' ' ' TYR . 22.7 mt-10 -59.08 -47.37 85.51 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.188 -0.945 . . . . 0.0 108.501 178.518 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.97 -36.44 67.83 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.217 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.535 ' HA ' ' CB ' ' A' ' 5' ' ' GLU . 5.9 mtp . . . . . 0 N--CA 1.496 1.842 0 CA-C-O 120.743 0.306 . . . . 0.0 110.238 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -173.97 -164.24 0.19 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.049 -1.032 . . . . 0.0 111.795 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.585 ' HE3' HG21 ' B' ' 45' ' ' THR . 12.9 mttt -62.52 -3.22 1.34 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.444 -0.785 . . . . 0.0 110.321 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.678 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 87.2 m -124.36 -39.61 2.31 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.201 -0.937 . . . . 0.0 108.871 179.061 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.579 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -63.11 -55.52 24.61 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 178.343 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.762 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 0.8 OUTLIER -58.71 -29.58 66.78 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.499 -0.881 . . . . 0.0 109.201 178.198 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.958 HG23 ' HB ' ' A' ' 21' ' ' VAL . 1.7 mt -54.25 -56.09 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.49 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.916 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 12.7 mtmt -58.69 -33.28 69.97 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.23 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.87 ' HB1' HD13 ' B' ' 31' ' ' ILE . . . -52.34 -37.97 57.45 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.574 -0.851 . . . . 0.0 109.202 179.106 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.862 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.0 OUTLIER -96.07 -35.1 5.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 178.546 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.916 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -61.49 -13.14 18.49 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 118.616 -1.234 . . . . 0.0 108.687 178.467 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -114.75 -43.66 3.12 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.474 -0.766 . . . . 0.0 109.377 178.431 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 9' ' ' ALA . 1.1 m-20 -63.99 -39.55 94.37 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 177.501 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' THR . . . . . 1.062 HG22 ' CD1' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -89.45 -78.0 0.37 Allowed 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 177.375 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.9 7.8 67.05 Favored Glycine 0 N--CA 1.5 2.924 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 177.528 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 1.062 ' CD1' HG22 ' A' ' 14' ' ' THR . 5.1 mp -54.75 -68.1 0.21 Allowed 'General case' 0 C--N 1.293 -1.858 0 O-C-N 121.671 -0.899 . . . . 0.0 110.676 179.821 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.584 HG22 ' H ' ' A' ' 19' ' ' VAL . 0.5 OUTLIER -142.94 7.98 1.65 Allowed 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.715 -179.25 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.664 ' O ' HG22 ' A' ' 21' ' ' VAL . 11.6 mt-30 59.4 24.61 13.23 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 -176.031 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 1.058 HG11 HG11 ' B' ' 19' ' ' VAL . 1.6 p -2.72 -91.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.932 -179.064 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.987 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.5 OUTLIER -131.01 24.8 4.96 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 178.21 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.958 ' HB ' HG23 ' A' ' 7' ' ' ILE . 1.4 m -20.93 -40.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-O 122.265 1.031 . . . . 0.0 109.409 -178.248 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.77 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.2 OUTLIER -80.42 -34.68 35.99 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.603 177.863 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.987 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -90.13 -38.11 13.75 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.563 -0.71 . . . . 0.0 111.193 179.544 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.656 ' CE ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -66.54 -37.33 84.77 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 117.686 -1.605 . . . . 0.0 108.774 179.455 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.8 HD12 HG13 ' A' ' 7' ' ' ILE . 0.4 OUTLIER -79.89 -37.99 33.58 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 118.054 -1.458 . . . . 0.0 109.425 178.699 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.468 ' HA ' ' CE ' ' A' ' 3' ' ' LYS . . . -66.06 -34.78 78.86 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 177.447 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.64 ' O ' HG13 ' A' ' 31' ' ' ILE . 62.1 m -83.16 -30.46 27.8 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.205 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.651 ' CE1' HD22 ' B' ' 44' ' ' LEU . 1.4 t80 -52.49 -49.53 64.53 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.552 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.73 ' HG3' ' CD2' ' B' ' 47' ' ' PHE . 0.2 OUTLIER -67.15 -35.99 80.87 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 177.172 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 1.16 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 9.7 ttmm -64.22 -20.79 66.27 Favored 'General case' 0 C--O 1.19 -2.061 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.413 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.672 HD12 HG12 ' A' ' 32' ' ' ILE . 1.3 pp -105.04 -27.99 3.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 O-C-N 120.297 -1.502 . . . . 0.0 108.951 178.222 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.678 HG21 ' CE1' ' B' ' 47' ' ' PHE . 1.2 mm -73.48 -58.69 4.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 177.078 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.931 ' HA ' HD23 ' B' ' 85' ' ' LEU . 0.4 OUTLIER -69.43 -33.42 72.94 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.305 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 1.16 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 27.2 mm-40 -76.96 -39.42 50.67 Favored 'General case' 0 N--CA 1.483 1.211 0 O-C-N 121.056 -1.027 . . . . 0.0 111.094 179.104 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.779 HG21 ' SD ' ' B' ' 1' ' ' MET . 21.9 m -57.94 -52.76 64.15 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.074 -1.641 . . . . 0.0 108.488 179.295 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.83 HG13 ' HB3' ' A' ' 52' ' ' PRO . 2.4 t -54.35 -36.56 34.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 177.918 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.752 ' HB1' ' O ' ' B' ' 88' ' ' ALA . . . -87.24 -0.23 56.4 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.432 0.634 . . . . 0.0 109.724 178.668 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.697 ' HB2' ' HA ' ' A' ' 35' ' ' THR . 1.5 mmpt? -102.6 -30.6 10.85 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 177.85 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.11 41.51 0.47 Allowed Glycine 0 C--N 1.303 -1.282 0 C-N-CA 119.945 -1.121 . . . . 0.0 110.842 177.936 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.737 ' O ' HG22 ' A' ' 35' ' ' THR . 0.4 OUTLIER -147.0 120.27 8.93 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.074 -1.25 . . . . 0.0 110.624 179.526 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.2 mtpt -63.95 86.62 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.53 -0.731 . . . . 0.0 109.608 179.723 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.664 HG23 HD21 ' B' ' 6' ' ' LEU . 11.3 p -68.1 146.75 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.656 -0.653 . . . . 0.0 110.391 -179.479 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.626 ' O ' HD23 ' A' ' 44' ' ' LEU . 22.9 mt-30 -144.68 176.48 9.39 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.341 -0.849 . . . . 0.0 110.257 -179.805 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.7 HD12 ' HB2' ' A' ' 48' ' ' LEU . 32.4 mt -125.52 113.9 18.07 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.594 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.548 HG22 ' HG2' ' B' ' 29' ' ' GLU . 0.1 OUTLIER 36.05 -87.53 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.85 -0.531 . . . . 0.0 110.621 -179.229 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -151.59 27.09 0.95 Allowed Glycine 0 N--CA 1.484 1.87 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.34 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.823 ' CE1' HG21 ' B' ' 32' ' ' ILE . 4.6 p90 -125.38 -29.92 3.19 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.96 -1.318 . . . . 0.0 112.66 179.84 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.7 ' HB2' HD12 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -122.04 85.71 2.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.445 -1.409 . . . . 0.0 110.692 179.132 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -89.47 85.6 6.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.811 -0.556 . . . . 0.0 109.88 179.605 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.871 HD12 HG22 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -75.68 139.37 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.404 -0.81 . . . . 0.0 109.656 -179.57 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.499 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 2.2 ptmt -153.9 125.51 3.7 Favored Pre-proline 0 N--CA 1.496 1.861 0 C-N-CA 118.752 -1.179 . . . . 0.0 110.785 179.674 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.83 ' HB3' HG13 ' A' ' 36' ' ' VAL . 52.9 Cg_endo -80.97 144.18 14.87 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 O-C-N 123.518 1.272 . . . . 0.0 111.248 -179.768 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.768 HG22 ' O ' ' A' ' 76' ' ' GLY . 31.6 m -137.98 114.82 11.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-O 121.772 0.796 . . . . 0.0 110.259 179.043 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.547 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.496 1.835 0 CA-C-O 121.924 0.869 . . . . 0.0 111.898 -178.513 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.67 ' HB ' ' HB2' ' B' ' 94' ' ' TYR . 1.0 OUTLIER . . . . . 0 N--CA 1.496 1.831 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 . . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.768 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -117.74 86.92 0.42 Allowed Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.141 -1.583 . . . . 0.0 109.141 -179.86 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.908 HG21 ' CB ' ' B' ' 85' ' ' LEU . 5.0 p -60.75 77.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.676 -0.896 . . . . 0.0 109.834 179.868 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' SER . . . . . 1.027 ' O ' HG23 ' A' ' 79' ' ' VAL . 0.8 OUTLIER -62.69 178.02 0.48 Allowed 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.502 -0.879 . . . . 0.0 109.565 179.775 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 1.027 HG23 ' O ' ' A' ' 78' ' ' SER . 2.7 t -176.78 173.56 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.709 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.664 ' O ' HD23 ' A' ' 48' ' ' LEU . 10.9 pttp 177.53 169.33 0.47 Allowed Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.081 -1.012 . . . . 0.0 110.027 176.503 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.571 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 55.1 Cg_endo -97.47 141.83 0.61 Allowed 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 122.505 2.136 . . . . 0.0 110.753 177.757 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.603 ' H ' HD11 ' A' ' 85' ' ' LEU . . . -97.63 -155.09 29.87 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 108.432 -1.867 . . . . 0.0 108.432 178.424 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.626 ' HA ' ' HB2' ' A' ' 86' ' ' LYS . 4.7 pm0 -93.77 -15.37 25.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.126 -1.22 . . . . 0.0 110.347 179.358 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.35 -34.18 56.53 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.309 -0.87 . . . . 0.0 109.574 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.782 ' CB ' HG21 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -88.17 -25.36 22.98 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 119.68 -0.808 . . . . 0.0 108.855 179.005 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.626 ' HB2' ' HA ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -76.19 -35.71 58.98 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.554 -0.858 . . . . 0.0 109.184 179.647 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.7 tttp -72.82 -39.83 66.31 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 177.166 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.834 ' O ' ' HB1' ' B' ' 37' ' ' ALA . . . -65.08 -37.0 86.11 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 176.243 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.692 ' HA ' HD23 ' A' ' 92' ' ' LEU . . . -56.71 -38.04 71.77 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.758 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.15 -33.06 62.6 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 176.391 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.483 ' C ' ' H ' ' A' ' 93' ' ' LYS . . . -59.82 -44.44 97.04 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 177.805 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.962 ' O ' HD12 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -69.42 15.44 0.07 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.71 -1.465 . . . . 0.0 110.422 179.397 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.602 ' HB3' ' O ' ' A' ' 92' ' ' LEU . 0.8 OUTLIER 65.37 73.77 0.39 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 -177.086 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 1.055 ' O ' ' C ' ' A' ' 95' ' ' GLU . 47.7 t80 -47.39 -58.19 4.44 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 116.481 -2.088 . . . . 0.0 106.538 179.817 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 1.055 ' C ' ' O ' ' A' ' 94' ' ' TYR . 56.2 mm-40 . . . . . 0 CA--C 1.484 -1.588 0 N-CA-C 102.3 -3.222 . . . . 0.0 102.3 179.295 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.779 ' SD ' HG21 ' A' ' 35' ' ' THR . 4.2 ptm . . . . . 0 N--CA 1.496 1.832 0 CA-C-O 121.307 0.575 . . . . 0.0 110.833 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 2' ' ' ASN . . . . . 0.557 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 16.4 p-10 -176.15 -140.81 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.706 -0.797 . . . . 0.0 111.238 178.044 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.451 ' HE3' ' HB3' ' B' ' 29' ' ' GLU . 0.1 OUTLIER -57.56 -0.36 0.07 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.003 -1.061 . . . . 0.0 110.916 -179.62 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 4' ' ' THR . . . . . 0.777 ' O ' HG13 ' B' ' 7' ' ' ILE . 4.2 m -120.16 -69.47 0.84 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.957 -1.089 . . . . 0.0 110.376 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.594 ' O ' ' HG3' ' B' ' 8' ' ' LYS . 1.7 mm-40 -48.82 -36.17 16.17 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.062 -1.024 . . . . 0.0 109.331 -179.865 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.664 HD21 HG23 ' A' ' 42' ' ' VAL . 87.0 mt -69.36 -28.96 66.66 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 118.869 -1.133 . . . . 0.0 109.988 178.608 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 7' ' ' ILE . . . . . 0.874 ' HA ' HD12 ' B' ' 25' ' ' LEU . 1.5 pp -63.76 -45.91 95.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.521 -1.362 . . . . 0.0 107.972 178.929 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 8' ' ' LYS . . . . . 0.829 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.0 OUTLIER -74.23 -20.44 60.17 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.39 -0.924 . . . . 0.0 108.562 177.522 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 9' ' ' ALA . . . . . 0.536 ' HB3' ' HA ' ' B' ' 6' ' ' LEU . . . -69.15 -33.57 73.63 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.149 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.861 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.0 OUTLIER -94.37 -34.5 5.63 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.4 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 178.3 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.829 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -56.91 -25.49 57.4 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.285 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 11.6 mm-40 -92.52 -45.03 8.32 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.441 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.424 ' HB2' ' HA ' ' B' ' 10' ' ' ILE . 4.6 m-20 -62.34 -25.26 67.8 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 177.061 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 14' ' ' THR . . . . . 0.882 HG22 ' HB2' ' A' ' 20' ' ' SER . 14.8 p -91.42 -74.39 0.51 Allowed 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.119 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 59.15 17.24 36.9 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.575 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 16' ' ' LEU . . . . . 0.964 HD22 ' O ' ' A' ' 19' ' ' VAL . 3.4 mp -83.44 -61.53 1.82 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.358 -1.084 . . . . 0.0 108.878 179.053 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 17' ' ' THR . . . . . 0.561 HG22 ' H ' ' B' ' 19' ' ' VAL . 0.6 OUTLIER -139.84 2.84 2.0 Allowed 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.732 179.909 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 18' ' ' GLN . . . . . 0.623 ' O ' ' C ' ' B' ' 19' ' ' VAL . 17.6 mt-30 56.64 28.14 13.61 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 -176.836 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 1.058 HG11 HG11 ' A' ' 19' ' ' VAL . 1.7 p -6.16 -100.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.765 -179.377 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 20' ' ' SER . . . . . 0.899 ' O ' ' N ' ' B' ' 23' ' ' LYS . 0.5 OUTLIER -133.92 24.12 3.93 Favored 'General case' 0 C--N 1.28 -2.445 0 N-CA-C 105.434 -2.062 . . . . 0.0 105.434 177.154 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.635 ' HA ' ' HE2' ' B' ' 24' ' ' MET . 16.6 m -18.43 -37.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 CA-C-O 122.212 1.006 . . . . 0.0 110.513 -177.922 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.844 ' N ' ' O ' ' B' ' 20' ' ' SER . 5.2 t -77.49 -43.13 33.25 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.146 -0.934 . . . . 0.0 108.893 178.496 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 23' ' ' LYS . . . . . 0.899 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.0 OUTLIER -92.3 -19.21 22.39 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.724 -0.61 . . . . 0.0 109.566 178.474 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 24' ' ' MET . . . . . 0.728 ' N ' ' OG ' ' B' ' 20' ' ' SER 0.258 3.1 tmm? -68.57 -44.86 73.54 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.3 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.874 HD12 ' HA ' ' B' ' 7' ' ' ILE . 8.4 mt -76.83 -44.14 33.55 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 177.005 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 26' ' ' ALA . . . . . 0.604 ' HB3' ' HA ' ' B' ' 23' ' ' LYS . . . -54.74 -33.48 61.21 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 177.567 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 27' ' ' SER . . . . . 0.538 ' O ' HG23 ' B' ' 31' ' ' ILE . 10.4 m -75.27 -40.97 58.24 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.465 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 28' ' ' PHE . . . . . 0.759 ' HA ' ' CG1' ' B' ' 31' ' ' ILE . 0.0 OUTLIER -64.39 -31.38 72.57 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.548 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 29' ' ' GLU . . . . . 0.604 ' HG3' ' CE2' ' B' ' 28' ' ' PHE . 1.5 mt-10 -84.4 -32.3 24.22 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 178.221 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 0.747 ' O ' ' CG ' ' B' ' 34' ' ' GLU . 24.8 tttt -71.4 -29.02 64.43 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 176.332 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.87 HD13 ' HB1' ' A' ' 9' ' ' ALA . 1.3 pp -93.89 -31.29 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.224 -0.922 . . . . 0.0 109.749 178.955 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.823 HG21 ' CE1' ' A' ' 47' ' ' PHE . 3.4 mm -61.65 -55.22 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 177.447 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 33' ' ' THR . . . . . 0.451 ' HB ' ' O ' ' B' ' 29' ' ' GLU . 0.4 OUTLIER -64.52 -40.32 95.4 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.429 179.46 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.793 ' O ' ' N ' ' B' ' 38' ' ' LYS . 17.8 mm-40 -68.92 -44.14 73.73 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.77 -0.581 . . . . 0.0 110.959 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 35' ' ' THR . . . . . 0.483 ' HA ' ' CB ' ' B' ' 38' ' ' LYS . 93.0 m -54.0 -52.12 61.76 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.798 -1.189 . . . . 0.0 108.998 179.876 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.992 HG21 HG23 ' B' ' 77' ' ' VAL . 0.4 OUTLIER -50.9 -37.26 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.145 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 37' ' ' ALA . . . . . 0.834 ' HB1' ' O ' ' A' ' 88' ' ' ALA . . . -96.32 0.77 51.21 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.774 0.797 . . . . 0.0 110.108 179.043 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 38' ' ' LYS . . . . . 0.793 ' N ' ' O ' ' B' ' 34' ' ' GLU . 0.0 OUTLIER -95.8 -22.84 17.24 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 176.906 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.49 44.87 0.69 Allowed Glycine 0 C--N 1.304 -1.22 0 C-N-CA 120.35 -0.928 . . . . 0.0 110.961 177.631 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 40' ' ' ASP . . . . . 0.415 ' HB2' HG23 ' B' ' 35' ' ' THR . 0.4 OUTLIER -155.41 166.14 34.47 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.005 -1.291 . . . . 0.0 111.399 179.6 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.47 ' HG2' ' HD2' ' B' ' 52' ' ' PRO . 11.0 mttt -121.48 112.86 19.04 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.273 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.87 HG22 ' CG1' ' B' ' 50' ' ' ILE . 0.8 OUTLIER -79.47 147.15 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 C-N-CA 118.664 -1.214 . . . . 0.0 110.064 -178.602 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 43' ' ' GLN . . . . . 0.424 ' HA ' ' HA ' ' B' ' 49' ' ' ASN . 1.6 mt-30 -123.66 85.85 2.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.485 -0.759 . . . . 0.0 109.259 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.813 HD12 ' HB3' ' B' ' 48' ' ' LEU . 12.6 mt -58.96 90.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.473 -0.767 . . . . 0.0 110.727 -179.219 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 45' ' ' THR . . . . . 0.585 HG21 ' HE3' ' A' ' 3' ' ' LYS . 2.2 t 35.93 26.98 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 179.34 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 46' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . 97.91 -25.39 27.71 Favored Glycine 0 N--CA 1.494 2.563 0 C-N-CA 119.841 -1.171 . . . . 0.0 112.859 177.44 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 47' ' ' PHE . . . . . 0.931 ' CD1' HD21 ' B' ' 85' ' ' LEU . 1.4 p90 -86.44 -28.43 23.51 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 119.873 1.836 . . . . 0.0 112.031 -178.577 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.813 ' HB3' HD12 ' B' ' 44' ' ' LEU . 5.5 mt -129.78 94.06 3.65 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.6 -1.313 . . . . 0.0 110.382 177.786 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 49' ' ' ASN . . . . . 0.512 ' O ' ' HA ' ' B' ' 79' ' ' VAL . 0.6 OUTLIER -105.0 95.26 5.73 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.533 -0.729 . . . . 0.0 110.156 -179.695 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 50' ' ' ILE . . . . . 0.87 ' CG1' HG22 ' B' ' 42' ' ' VAL . 2.0 pp -86.83 146.63 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.483 -0.761 . . . . 0.0 110.684 -179.765 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 51' ' ' LYS . . . . . 0.451 ' O ' ' HG3' ' B' ' 51' ' ' LYS . 2.6 ptmt -155.11 128.79 4.5 Favored Pre-proline 0 N--CA 1.496 1.848 0 C-N-CA 119.092 -1.043 . . . . 0.0 110.434 179.044 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 52' ' ' PRO . . . . . 0.694 ' HB3' HG22 ' B' ' 36' ' ' VAL . 57.1 Cg_endo -84.72 140.99 8.41 Favored 'Trans proline' 0 C--N 1.315 -1.205 0 O-C-N 123.352 1.185 . . . . 0.0 110.955 -179.404 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.655 HG22 ' O ' ' B' ' 76' ' ' GLY . 24.8 m -144.61 116.25 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-O 121.767 0.794 . . . . 0.0 111.281 179.18 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 54' ' ' ALA . . . . . 0.415 ' HA ' ' HA ' ' B' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.496 1.87 0 O-C-N 121.807 -0.558 . . . . 0.0 111.332 -179.231 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 75' ' ' VAL . . . . . 0.758 HG21 HD21 ' A' ' 92' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.811 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 . . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 76' ' ' GLY . . . . . 0.655 ' O ' HG22 ' B' ' 53' ' ' VAL . . . -114.42 68.8 0.25 Allowed Glycine 0 N--CA 1.487 2.098 0 C-N-CA 119.403 -1.38 . . . . 0.0 109.656 -179.382 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.992 HG23 HG21 ' B' ' 36' ' ' VAL . 2.5 p -58.09 76.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.453 -1.027 . . . . 0.0 109.428 179.521 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 78' ' ' SER . . . . . 0.624 ' N ' ' O ' ' B' ' 76' ' ' GLY . 6.5 t -76.95 177.17 7.95 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.897 0.856 . . . . 0.0 110.789 -179.446 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.859 ' CG2' HG22 ' B' ' 50' ' ' ILE . 4.8 p 177.23 177.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 80' ' ' LYS . . . . . 0.699 ' O ' HD23 ' B' ' 48' ' ' LEU . 0.1 OUTLIER -172.48 173.51 1.48 Allowed Pre-proline 0 N--CA 1.485 1.303 0 O-C-N 120.64 -1.288 . . . . 0.0 110.642 178.131 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 81' ' ' PRO . . . . . 0.603 ' HB2' HG13 ' A' ' 77' ' ' VAL . 53.4 Cg_endo -97.72 133.1 0.32 Allowed 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 122.503 2.136 . . . . 0.0 110.504 178.801 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 82' ' ' GLY . . . . . 0.518 ' HA3' ' HA ' ' B' ' 47' ' ' PHE . . . -89.76 -164.37 39.98 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 108.41 -1.876 . . . . 0.0 108.41 178.669 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -83.87 -18.25 38.14 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.039 -1.271 . . . . 0.0 110.385 179.805 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 84' ' ' SER . . . . . 0.414 ' HB2' ' HB3' ' B' ' 47' ' ' PHE . 1.1 m -52.44 -38.18 58.59 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.23 -0.918 . . . . 0.0 109.434 179.656 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.931 HD23 ' HA ' ' A' ' 33' ' ' THR . 0.4 OUTLIER -78.71 -33.03 47.11 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.17 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 86' ' ' LYS . . . . . 0.672 ' O ' ' HB3' ' B' ' 89' ' ' ALA . 0.1 OUTLIER -73.04 -45.57 56.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.66 -0.65 . . . . 0.0 110.563 -179.32 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.74 -39.31 93.69 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 178.443 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.752 ' O ' ' HB1' ' A' ' 37' ' ' ALA . . . -66.83 -33.68 76.15 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 176.822 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.946 ' HA ' HD23 ' B' ' 92' ' ' LEU . . . -56.44 -44.83 80.84 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.019 179.17 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -53.81 -32.86 54.18 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 177.114 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -64.71 -35.82 92.38 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 178.447 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 92' ' ' LEU . . . . . 0.946 HD23 ' HA ' ' B' ' 89' ' ' ALA . 0.4 OUTLIER -75.58 12.01 1.14 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.689 -1.477 . . . . 0.0 111.111 -179.768 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 93' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' B' ' 92' ' ' LEU . 0.0 OUTLIER 61.01 40.04 15.72 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -177.639 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 94' ' ' TYR . . . . . 0.67 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 0.1 OUTLIER -37.79 -38.49 0.29 Allowed 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.167 -179.055 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 95' ' ' GLU . . . . . 0.413 ' N ' ' CG ' ' B' ' 94' ' ' TYR . 14.6 pt-20 -61.74 -42.93 99.61 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.31 -0.869 . . . . 0.0 109.885 179.77 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -58.96 -33.71 70.96 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.57 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.463 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.775 ' HG3' HG23 ' B' ' 42' ' ' VAL . 1.5 ptm . . . . . 0 N--CA 1.496 1.841 0 CA-C-O 121.297 0.57 . . . . 0.0 110.739 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.411 ' HB3' ' O ' ' A' ' 1' ' ' MET . 34.5 p-10 -175.38 -148.08 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 119.714 -0.795 . . . . 0.0 111.359 178.648 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.418 ' O ' ' CG2' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -53.83 -6.88 0.1 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.178 -0.952 . . . . 0.0 111.091 -179.521 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.627 ' O ' ' CG1' ' A' ' 7' ' ' ILE . 32.9 m -118.49 -64.1 1.33 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.953 -1.092 . . . . 0.0 110.613 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.703 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 5.0 mt-10 -48.79 -40.32 28.58 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.846 -1.159 . . . . 0.0 109.314 -179.706 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.682 HD11 ' CG2' ' B' ' 42' ' ' VAL . 74.0 mt -62.66 -33.88 75.95 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.456 178.19 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.807 ' HA ' HD12 ' A' ' 25' ' ' LEU . 0.9 OUTLIER -58.78 -38.03 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 178.771 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.841 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 31.4 mtmt -68.95 -34.29 75.1 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.17 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.67 ' HB1' HD13 ' B' ' 31' ' ' ILE . . . -54.37 -40.4 68.09 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.286 179.163 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.852 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.4 mp -92.24 -29.23 4.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 178.247 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.841 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -68.07 -9.14 43.86 Favored 'General case' 0 C--N 1.289 -2.033 0 O-C-N 120.579 -1.326 . . . . 0.0 108.723 178.596 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -121.51 -41.46 2.49 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.376 -0.828 . . . . 0.0 110.102 179.202 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.664 ' OD2' HG21 ' B' ' 31' ' ' ILE . 62.8 m-20 -68.62 -24.5 64.57 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 177.471 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' THR . . . . . 1.094 HG22 ' CD1' ' A' ' 16' ' ' LEU 0.274 0.2 OUTLIER -106.96 -81.85 0.55 Allowed 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 178.752 . . . . . . . . 4 4 . 1 . 022 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.51 6.43 66.07 Favored Glycine 0 N--CA 1.501 3.02 0 O-C-N 121.07 -1.019 . . . . 0.0 110.61 177.679 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 1.094 ' CD1' HG22 ' A' ' 14' ' ' THR . 5.0 mp -51.81 -70.17 0.09 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.67 -0.9 . . . . 0.0 110.514 179.812 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.536 ' CG2' HG21 ' B' ' 17' ' ' THR . 0.6 OUTLIER -132.82 8.57 4.14 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.825 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.588 ' O ' ' C ' ' A' ' 19' ' ' VAL . 2.3 mt-30 57.04 26.98 12.62 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 -176.179 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 1.104 HG23 ' CD1' ' B' ' 16' ' ' LEU . 0.6 OUTLIER -10.17 -94.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.626 -179.034 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.931 ' O ' ' N ' ' A' ' 23' ' ' LYS . 2.4 m -134.57 23.29 3.69 Favored 'General case' 0 C--N 1.28 -2.425 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 178.181 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.669 ' C ' ' O ' ' A' ' 20' ' ' SER . 31.5 m -18.16 -40.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 CA-C-O 122.418 1.104 . . . . 0.0 109.279 -177.376 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.867 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.4 OUTLIER -86.43 -38.03 17.75 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.088 178.142 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.931 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.9 OUTLIER -85.21 -31.52 23.13 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.535 -0.728 . . . . 0.0 110.895 179.448 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.803 ' HB3' HG23 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -76.46 -43.77 38.5 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 118.217 -1.393 . . . . 0.0 109.315 179.249 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.807 HD12 ' HA ' ' A' ' 7' ' ' ILE . 7.0 mt -68.5 -48.54 64.14 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 117.743 -1.583 . . . . 0.0 108.293 177.888 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.435 ' CB ' ' O ' ' A' ' 22' ' ' SER . . . -55.76 -33.14 64.05 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 177.558 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.532 ' O ' ' CG1' ' A' ' 31' ' ' ILE . 7.5 t -73.34 -36.81 66.24 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 177.488 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.744 ' HA ' ' CG1' ' A' ' 31' ' ' ILE . 0.1 OUTLIER -64.19 -33.74 76.49 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.535 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.567 ' HG3' ' CD2' ' A' ' 28' ' ' PHE . 2.1 mt-10 -83.1 -31.44 27.27 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.175 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.762 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 6.7 tttm -72.12 -27.62 62.74 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 176.588 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.744 ' CG1' ' HA ' ' A' ' 28' ' ' PHE . 1.8 pp -95.99 -31.71 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.35 -0.844 . . . . 0.0 109.751 179.009 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.762 HG21 ' CE1' ' B' ' 47' ' ' PHE . 2.6 mm -63.28 -52.89 52.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.829 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.583 HG23 ' HB2' ' B' ' 88' ' ' ALA . 0.4 OUTLIER -68.34 -38.82 81.85 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.556 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.762 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 34.0 mm-40 -71.94 -34.3 68.91 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.413 -0.805 . . . . 0.0 110.832 179.169 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.737 HG21 HG13 ' A' ' 42' ' ' VAL . 3.2 m -59.98 -54.16 49.31 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.997 -1.064 . . . . 0.0 108.563 179.894 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.635 HG11 HD22 ' B' ' 85' ' ' LEU . 1.0 OUTLIER -54.04 -35.04 27.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 177.755 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.737 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -78.51 -7.15 57.18 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.736 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.489 ' N ' ' O ' ' A' ' 35' ' ' THR . 1.3 ttmt -102.21 -25.28 13.75 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 178.122 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 35' ' ' THR . . . 104.8 41.83 1.92 Allowed Glycine 0 C--N 1.3 -1.417 0 C-N-CA 120.218 -0.991 . . . . 0.0 110.699 178.067 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.704 ' CB ' HG23 ' A' ' 35' ' ' THR . 0.3 OUTLIER -128.67 154.27 46.45 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.116 -1.226 . . . . 0.0 110.429 179.449 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.421 ' HE3' ' CB ' ' A' ' 51' ' ' LYS . 43.1 tttt -109.01 98.38 7.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.382 -0.824 . . . . 0.0 110.0 -179.738 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.762 HG12 ' HB2' ' B' ' 1' ' ' MET . 19.3 m -84.93 147.41 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.451 -0.781 . . . . 0.0 110.414 -179.602 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.436 ' O ' ' HA ' ' B' ' 2' ' ' ASN . 1.7 tt0 -136.57 107.91 6.86 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 121.296 -0.878 . . . . 0.0 110.134 -179.131 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.712 HD22 ' HE2' ' B' ' 28' ' ' PHE . 20.3 mt -66.64 99.13 0.57 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.039 -1.038 . . . . 0.0 109.875 179.51 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.637 HG21 ' HB3' ' B' ' 29' ' ' GLU . 1.7 t 37.17 26.67 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.782 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . 94.44 -0.24 65.58 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 120.06 -1.067 . . . . 0.0 112.487 177.664 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.881 ' CE1' HG21 ' B' ' 32' ' ' ILE . 0.8 OUTLIER -104.23 -31.38 9.62 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 120.002 1.901 . . . . 0.0 111.96 -179.919 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.832 HD13 HD13 ' B' ' 48' ' ' LEU . 1.0 OUTLIER -123.04 93.82 4.07 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.706 -1.246 . . . . 0.0 109.779 178.115 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -96.08 75.14 3.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.702 -0.624 . . . . 0.0 111.371 -179.114 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.863 HD13 ' HB ' ' A' ' 79' ' ' VAL . 2.6 mm -63.19 129.71 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.202 -0.936 . . . . 0.0 109.031 178.798 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 78' ' ' SER . 0.0 OUTLIER -144.05 127.26 8.81 Favored Pre-proline 0 N--CA 1.492 1.656 0 C-N-CA 118.712 -1.195 . . . . 0.0 109.704 179.491 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.623 ' HB3' HG13 ' A' ' 36' ' ' VAL . 54.3 Cg_endo -76.71 142.13 22.56 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.384 1.202 . . . . 0.0 111.162 -179.277 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 1.055 ' O ' HG22 ' A' ' 75' ' ' VAL . 1.7 t -122.08 -142.84 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.588 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.532 ' HB2' ' O ' ' A' ' 53' ' ' VAL . . . . . . . . 0 N--CA 1.5 2.037 0 O-C-N 121.291 -0.88 . . . . 0.0 110.158 179.693 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 1.055 HG22 ' O ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.497 1.923 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 . . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.618 ' O ' ' N ' ' A' ' 78' ' ' SER . . . -110.91 38.67 3.19 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 118.569 -1.777 . . . . 0.0 110.226 -178.765 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.734 ' CG2' HD22 ' B' ' 85' ' ' LEU . 3.0 p -27.78 87.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 CA-C-O 121.924 0.868 . . . . 0.0 110.58 179.781 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.618 ' N ' ' O ' ' A' ' 76' ' ' GLY . 0.1 OUTLIER -87.81 175.52 7.8 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.963 -179.168 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.863 ' HB ' HD13 ' A' ' 50' ' ' ILE . 7.2 p 175.57 177.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.845 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.671 ' O ' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -177.15 171.71 0.89 Allowed Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.001 -1.062 . . . . 0.0 110.185 176.948 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.603 ' HB2' HG13 ' B' ' 77' ' ' VAL . 54.7 Cg_endo -96.91 128.8 0.3 Allowed 'Trans proline' 0 C--N 1.302 -1.894 0 C-N-CA 122.414 2.076 . . . . 0.0 110.691 178.639 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.494 ' HA3' ' HA ' ' A' ' 47' ' ' PHE . . . -87.75 173.18 43.28 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 178.749 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -62.19 -17.92 59.52 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.086 -1.244 . . . . 0.0 110.591 -179.846 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.526 ' HB2' ' HB3' ' A' ' 47' ' ' PHE . 0.8 OUTLIER -53.74 -41.15 66.77 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.177 -0.952 . . . . 0.0 109.506 179.802 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.924 ' CB ' HG21 ' B' ' 77' ' ' VAL . 1.0 OUTLIER -76.76 -26.79 54.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.448 -0.783 . . . . 0.0 109.116 179.111 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.669 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 0.7 OUTLIER -81.03 -41.27 22.93 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.665 -0.647 . . . . 0.0 110.63 -179.522 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.67 -40.92 98.02 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 178.985 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.736 ' O ' ' HB1' ' B' ' 37' ' ' ALA . . . -65.29 -37.39 87.02 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 176.3 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 1.091 ' HB1' HG11 ' B' ' 75' ' ' VAL . . . -56.66 -40.33 75.31 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.467 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.412 ' HG2' ' N ' ' A' ' 91' ' ' GLY . 1.1 pt-20 -55.5 -31.75 62.3 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 177.096 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.412 ' N ' ' HG2' ' A' ' 90' ' ' GLU . . . -68.56 -34.04 77.97 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 178.643 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.835 ' O ' HD12 ' A' ' 92' ' ' LEU . 0.6 OUTLIER -66.27 5.84 0.49 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.648 -1.501 . . . . 0.0 111.305 -179.806 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.423 ' CB ' ' O ' ' A' ' 92' ' ' LEU . 0.4 OUTLIER 65.36 39.49 5.23 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 -177.388 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.525 ' HA ' HD11 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -43.54 -31.49 0.74 Allowed 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.154 -179.079 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 . . . . . 0 N--CA 1.494 1.741 0 O-C-N 121.279 -0.888 . . . . 0.0 108.944 179.151 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.762 ' HB2' HG12 ' A' ' 42' ' ' VAL . 2.5 mtp . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 2' ' ' ASN . . . . . 0.44 ' H ' ' HB2' ' B' ' 5' ' ' GLU . 17.5 p30 -173.43 -153.91 0.06 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.002 -1.061 . . . . 0.0 111.693 179.705 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.465 ' HG3' ' HB ' ' A' ' 45' ' ' THR . 0.1 OUTLIER -56.52 -0.55 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.515 -0.741 . . . . 0.0 111.562 -179.229 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 4' ' ' THR . . . . . 0.72 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 61.3 m -125.52 -45.68 1.78 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.779 -1.201 . . . . 0.0 110.363 179.738 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.54 ' CB ' ' HA ' ' B' ' 1' ' ' MET . 3.3 mt-10 -65.99 -51.45 58.23 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.051 -1.031 . . . . 0.0 108.682 179.673 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.778 ' O ' ' HB3' ' B' ' 9' ' ' ALA . 17.9 mt -58.02 -32.62 68.12 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.161 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 7' ' ' ILE . . . . . 0.845 HG23 ' HB ' ' B' ' 21' ' ' VAL . 1.3 mt -53.63 -55.35 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 177.591 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 8' ' ' LYS . . . . . 0.965 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.6 OUTLIER -57.11 -31.98 65.84 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 177.829 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 9' ' ' ALA . . . . . 0.778 ' HB3' ' O ' ' B' ' 6' ' ' LEU . . . -54.52 -38.42 66.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.271 -0.893 . . . . 0.0 108.971 178.677 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.803 HG23 ' HB3' ' A' ' 24' ' ' MET . 1.6 mp -90.83 -34.34 6.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 178.121 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.965 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -67.28 -12.62 60.6 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 119.139 -1.024 . . . . 0.0 109.011 178.686 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.491 ' N ' ' O ' ' B' ' 8' ' ' LYS . 1.1 pp0? -113.7 -36.0 5.0 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.339 -0.851 . . . . 0.0 109.416 178.496 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.435 ' OD2' HG21 ' A' ' 31' ' ' ILE . 56.0 m-20 -72.15 -21.54 61.44 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 176.784 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 14' ' ' THR . . . . . 0.837 HG21 ' HB2' ' A' ' 20' ' ' SER . 0.2 OUTLIER -117.24 -77.94 0.57 Allowed 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.462 179.648 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 15' ' ' GLY . . . . . 0.46 ' O ' ' C ' ' B' ' 16' ' ' LEU . . . 64.99 -13.1 0.21 Allowed Glycine 0 N--CA 1.5 2.908 0 N-CA-C 110.499 -1.041 . . . . 0.0 110.499 179.065 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 16' ' ' LEU . . . . . 1.104 ' CD1' HG23 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -35.05 -59.43 0.5 Allowed 'General case' 0 N--CA 1.513 2.677 0 CA-C-O 122.06 0.934 . . . . 0.0 110.678 -179.695 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 17' ' ' THR . . . . . 0.641 HG22 ' H ' ' B' ' 19' ' ' VAL . 0.5 OUTLIER -136.38 -1.17 2.36 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.543 -179.291 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 18' ' ' GLN . . . . . 0.627 ' O ' ' C ' ' B' ' 19' ' ' VAL . 5.1 mt-30 54.83 31.79 16.37 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 -176.815 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 1.005 HG11 HG11 ' A' ' 19' ' ' VAL . 0.9 OUTLIER -6.79 -93.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.01 -178.835 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 20' ' ' SER . . . . . 1.06 ' O ' ' N ' ' B' ' 22' ' ' SER . 0.3 OUTLIER -133.16 24.77 4.2 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 178.116 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.918 HG11 ' HB2' ' B' ' 11' ' ' ALA . 0.0 OUTLIER -8.85 -39.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-O 122.362 1.077 . . . . 0.0 110.288 -178.252 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 22' ' ' SER . . . . . 1.06 ' N ' ' O ' ' B' ' 20' ' ' SER . 5.9 m -85.05 -43.09 14.23 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.483 178.244 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 23' ' ' LYS . . . . . 0.885 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.2 OUTLIER -81.94 -25.3 35.0 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.286 -0.884 . . . . 0.0 111.004 179.927 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 24' ' ' MET . . . . . 0.695 ' HB3' HG21 ' A' ' 14' ' ' THR . 0.0 OUTLIER -82.94 -45.92 13.57 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 118.357 -1.337 . . . . 0.0 110.063 179.399 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.644 HD23 ' HE3' ' B' ' 24' ' ' MET . 0.4 OUTLIER -69.05 -48.22 63.4 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 117.53 -1.668 . . . . 0.0 108.104 178.272 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 26' ' ' ALA . . . . . 0.46 ' HA ' ' HE2' ' B' ' 3' ' ' LYS . . . -54.84 -34.09 62.48 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 177.698 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 27' ' ' SER . . . . . 0.737 ' O ' HG23 ' B' ' 31' ' ' ILE . 3.7 t -72.55 -39.45 67.47 Favored 'General case' 0 C--O 1.204 -1.311 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.681 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 28' ' ' PHE . . . . . 0.732 ' HA ' ' CG1' ' B' ' 31' ' ' ILE . 0.1 OUTLIER -62.96 -37.68 88.05 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.688 0.756 . . . . 0.0 109.287 179.357 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 29' ' ' GLU . . . . . 0.637 ' HB3' HG21 ' A' ' 45' ' ' THR . 0.9 OUTLIER -81.9 -31.18 31.56 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 178.656 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 0.815 ' O ' ' CG ' ' B' ' 34' ' ' GLU . 9.7 ttmt -71.99 -30.19 64.99 Favored 'General case' 0 C--O 1.19 -2.03 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 176.277 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.737 HG23 ' O ' ' B' ' 27' ' ' SER . 1.3 pp -91.19 -30.28 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.21 -0.931 . . . . 0.0 109.606 179.167 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.881 HG21 ' CE1' ' A' ' 47' ' ' PHE . 5.2 mm -62.57 -51.68 69.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 177.495 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 33' ' ' THR . . . . . 0.834 ' HA ' HD23 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -75.69 -25.66 56.9 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 114.904 -1.043 . . . . 0.0 108.966 179.74 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.815 ' CG ' ' O ' ' B' ' 30' ' ' LYS . 5.6 mm-40 -81.84 -35.75 29.04 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.078 -1.014 . . . . 0.0 109.394 178.674 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 35' ' ' THR . . . . . 0.613 HG23 ' HB2' ' B' ' 40' ' ' ASP . 52.0 m -62.55 -54.34 41.18 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 178.232 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.805 HG22 ' O ' ' B' ' 32' ' ' ILE . 2.2 m -50.17 -34.39 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 177.146 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 37' ' ' ALA . . . . . 0.736 ' HB1' ' O ' ' A' ' 88' ' ' ALA . . . -90.58 -4.13 57.08 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 121.57 0.7 . . . . 0.0 110.352 178.318 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 38' ' ' LYS . . . . . 0.658 ' N ' ' O ' ' B' ' 34' ' ' GLU . 0.0 OUTLIER -97.93 -24.5 15.36 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 177.731 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 111.81 43.87 0.92 Allowed Glycine 0 C--N 1.301 -1.383 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 178.089 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 40' ' ' ASP . . . . . 0.613 ' HB2' HG23 ' B' ' 35' ' ' THR . 0.1 OUTLIER -145.82 136.64 24.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.202 -1.175 . . . . 0.0 110.565 179.684 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 10.9 mtmt -89.68 88.28 7.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.477 -0.764 . . . . 0.0 109.901 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.775 HG23 ' HG3' ' A' ' 1' ' ' MET . 7.6 p -62.1 142.19 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.486 -0.759 . . . . 0.0 110.128 -179.808 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 43' ' ' GLN . . . . . 0.438 ' HA ' ' O ' ' B' ' 48' ' ' LEU . 6.2 mt-30 -134.31 110.92 9.81 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.448 -0.782 . . . . 0.0 110.548 -179.361 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.65 HD22 ' HE2' ' A' ' 28' ' ' PHE . 17.0 mt -66.64 118.63 10.48 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.253 -0.904 . . . . 0.0 109.533 179.323 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 45' ' ' THR . . . . . 0.547 HG21 ' HB3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 29.06 -89.34 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.823 -0.548 . . . . 0.0 111.228 -179.975 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 46' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -149.58 26.85 1.2 Allowed Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 179.623 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 47' ' ' PHE . . . . . 0.762 ' CE1' HG21 ' A' ' 32' ' ' ILE . 7.7 p90 -125.45 -24.44 3.91 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.951 -1.323 . . . . 0.0 112.011 179.736 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.832 HD13 HD13 ' A' ' 48' ' ' LEU . 1.6 mt -128.07 108.47 10.68 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.404 -1.435 . . . . 0.0 110.82 178.814 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -106.19 69.83 0.82 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.574 -0.704 . . . . 0.0 110.989 -179.643 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 50' ' ' ILE . . . . . 0.912 HD13 ' HB ' ' B' ' 79' ' ' VAL . 1.9 mm -60.1 125.6 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.302 -0.874 . . . . 0.0 109.281 179.142 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 51' ' ' LYS . . . . . 0.461 ' HG3' ' HB2' ' B' ' 78' ' ' SER . 9.1 ptmt -149.71 122.63 4.37 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 120.665 -1.272 . . . . 0.0 111.252 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 52' ' ' PRO . . . . . 0.613 ' HA ' ' HA ' ' B' ' 77' ' ' VAL . 55.4 Cg_endo -79.8 144.49 17.32 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 O-C-N 123.61 1.321 . . . . 0.0 110.964 179.78 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.705 HG22 ' O ' ' B' ' 76' ' ' GLY . 32.6 m -138.92 114.3 8.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-O 121.833 0.825 . . . . 0.0 110.753 179.282 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 54' ' ' ALA . . . . . 0.563 ' HA ' ' HA ' ' B' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.493 1.701 0 O-C-N 121.581 -0.699 . . . . 0.0 111.173 -179.022 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 75' ' ' VAL . . . . . 1.091 HG11 ' HB1' ' A' ' 89' ' ' ALA . 8.6 p . . . . . 0 N--CA 1.493 1.716 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 76' ' ' GLY . . . . . 0.705 ' O ' HG22 ' B' ' 53' ' ' VAL . . . -120.24 96.72 0.63 Allowed Glycine 0 N--CA 1.49 2.244 0 C-N-CA 119.295 -1.431 . . . . 0.0 110.239 -179.143 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.924 HG21 ' CB ' ' A' ' 85' ' ' LEU . 6.4 p -69.39 68.61 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.575 -0.956 . . . . 0.0 109.075 179.04 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 78' ' ' SER . . . . . 0.461 ' HB2' ' HG3' ' B' ' 51' ' ' LYS . 1.6 m -65.65 177.18 1.28 Allowed 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.894 0.854 . . . . 0.0 110.732 -179.178 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.912 ' HB ' HD13 ' B' ' 50' ' ' ILE . 7.3 p 177.24 177.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -179.84 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 80' ' ' LYS . . . . . 0.68 ' O ' HD23 ' B' ' 48' ' ' LEU . 0.6 OUTLIER -177.47 172.62 0.76 Allowed Pre-proline 0 N--CA 1.487 1.423 0 O-C-N 120.852 -1.155 . . . . 0.0 110.769 177.651 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 81' ' ' PRO . . . . . 0.524 ' HA ' ' O ' ' B' ' 47' ' ' PHE . 53.4 Cg_endo -92.76 128.25 0.79 Allowed 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.441 2.094 . . . . 0.0 110.61 178.527 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 82' ' ' GLY . . . . . 0.473 ' H ' ' HA ' ' B' ' 47' ' ' PHE . . . -91.67 178.93 41.37 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 108.634 -1.787 . . . . 0.0 108.634 179.152 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 83' ' ' GLU . . . . . 0.469 ' HA ' ' HB2' ' B' ' 86' ' ' LYS . 4.0 pt-20 -69.61 -28.31 65.82 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.115 -1.227 . . . . 0.0 110.498 -179.828 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -48.71 -32.17 8.03 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.841 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.734 HD22 ' CG2' ' A' ' 77' ' ' VAL . 0.5 OUTLIER -83.4 -38.23 22.22 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.211 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 86' ' ' LYS . . . . . 0.758 ' O ' ' HB3' ' B' ' 89' ' ' ALA . 0.1 OUTLIER -70.12 -36.39 74.79 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.447 -0.783 . . . . 0.0 109.125 179.575 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 13.0 ttpt -64.97 -42.03 94.94 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 178.029 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.591 ' HB1' ' HB2' ' A' ' 37' ' ' ALA . . . -63.72 -34.86 78.82 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 176.233 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.982 ' HA ' HD23 ' B' ' 92' ' ' LEU . . . -54.47 -43.99 72.21 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.616 -0.834 . . . . 0.0 109.275 178.743 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -53.35 -32.7 50.47 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 177.104 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 91' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' B' ' 88' ' ' ALA . . . -60.88 -42.3 99.57 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 178.138 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 92' ' ' LEU . . . . . 0.982 HD23 ' HA ' ' B' ' 89' ' ' ALA . 0.4 OUTLIER -75.39 17.79 0.25 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.665 -1.491 . . . . 0.0 110.502 179.682 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 93' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' B' ' 92' ' ' LEU . 0.0 OUTLIER 58.17 44.74 18.56 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -177.539 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 94' ' ' TYR . . . . . 0.693 ' HD1' HG23 ' A' ' 75' ' ' VAL . 0.1 OUTLIER -36.71 -35.62 0.09 Allowed 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.68 -179.16 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 95' ' ' GLU . . . . . 0.425 ' HG3' ' N ' ' B' ' 96' ' ' ASP . 0.0 OUTLIER -64.77 -44.0 91.42 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.382 -0.824 . . . . 0.0 109.382 179.887 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 96' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' B' ' 93' ' ' LYS . 25.8 m-20 -56.39 -34.52 66.78 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.572 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.439 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.81 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.645 ' HB2' HG12 ' B' ' 42' ' ' VAL . 11.1 mtp . . . . . 0 N--CA 1.493 1.706 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.499 ' HA ' ' O ' ' B' ' 43' ' ' GLN . 43.7 p-10 -168.5 -159.03 0.25 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.83 -1.169 . . . . 0.0 112.36 -179.891 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.507 ' HE2' ' HB2' ' A' ' 29' ' ' GLU . 5.6 tttm -50.92 -10.09 0.06 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.547 -0.721 . . . . 0.0 111.305 -179.388 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.692 ' O ' HG13 ' A' ' 7' ' ' ILE . 1.3 m -120.12 -57.88 1.91 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.978 -1.076 . . . . 0.0 109.558 179.208 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.564 ' CB ' ' HA ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -48.11 -40.86 24.77 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.402 -0.811 . . . . 0.0 109.154 179.576 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.581 ' HG ' ' HB3' ' A' ' 1' ' ' MET . 5.6 mt -68.83 -29.65 68.02 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.301 -0.96 . . . . 0.0 110.169 178.583 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.729 ' HA ' HD12 ' A' ' 25' ' ' LEU . 1.2 pp -59.99 -46.8 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.667 -1.271 . . . . 0.0 108.263 179.73 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.94 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 18.4 pttt -72.43 -24.8 61.28 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.2 -1.0 . . . . 0.0 108.678 177.514 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 6' ' ' LEU . . . -58.45 -39.26 79.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.264 -0.898 . . . . 0.0 109.04 178.774 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.802 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.9 OUTLIER -92.28 -32.79 5.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 177.863 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.94 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -60.61 -14.29 19.39 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 118.856 -1.138 . . . . 0.0 108.966 178.129 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 10.0 mm-40 -112.87 -44.01 3.35 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.271 -0.893 . . . . 0.0 109.656 179.071 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.43 ' HB3' ' HB2' ' B' ' 27' ' ' SER . 0.7 OUTLIER -65.79 -39.03 90.54 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.569 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 14' ' ' THR . . . . . 1.14 HG22 ' CD1' ' A' ' 16' ' ' LEU 0.251 0.2 OUTLIER -91.87 -70.07 0.71 Allowed 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 177.693 . . . . . . . . 4 4 . 1 . 023 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.467 ' HA2' ' O ' ' A' ' 11' ' ' ALA . . . 58.23 18.9 37.11 Favored Glycine 0 N--CA 1.499 2.853 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 177.236 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 1.14 ' CD1' HG22 ' A' ' 14' ' ' THR . 3.3 mp -62.74 -63.83 1.1 Allowed 'General case' 0 C--N 1.293 -1.853 0 O-C-N 121.48 -1.012 . . . . 0.0 109.937 179.308 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.6 HG21 ' CG2' ' B' ' 17' ' ' THR . 0.6 OUTLIER -138.13 7.63 2.67 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.445 -179.681 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.54 ' O ' ' C ' ' A' ' 19' ' ' VAL . 28.4 mt-30 58.14 26.5 13.79 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 -176.219 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.976 HG11 HG11 ' B' ' 19' ' ' VAL . 2.7 p -13.88 -96.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.121 -178.708 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.959 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -129.72 23.38 5.41 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 105.966 -1.865 . . . . 0.0 105.966 178.402 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.739 HG12 HG22 ' A' ' 10' ' ' ILE . 30.0 m -24.6 -39.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 CA-C-O 122.481 1.134 . . . . 0.0 109.156 -178.868 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.706 ' N ' ' O ' ' A' ' 20' ' ' SER . 48.2 t -82.66 -35.27 27.04 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.246 177.92 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.959 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.6 OUTLIER -86.84 -36.56 18.41 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.684 -0.635 . . . . 0.0 111.347 179.521 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.654 ' CE ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -70.06 -39.4 75.7 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.28 -1.513 . . . . 0.0 109.039 179.433 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.729 HD12 ' HA ' ' A' ' 7' ' ' ILE . 9.0 mt -77.82 -44.54 27.11 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 118.167 -1.413 . . . . 0.0 109.413 178.638 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.48 ' CB ' ' O ' ' A' ' 22' ' ' SER . . . -58.01 -32.8 68.27 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.955 -1.09 . . . . 0.0 108.121 178.025 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.58 ' O ' ' N ' ' A' ' 31' ' ' ILE . 25.8 p -85.27 -31.42 23.11 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.378 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.894 ' HB2' HD11 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -56.13 -34.67 66.3 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.572 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.781 ' HG2' HG22 ' B' ' 45' ' ' THR . 0.8 OUTLIER -79.74 -39.31 31.38 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.378 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.81 ' O ' ' CG ' ' A' ' 34' ' ' GLU . 39.7 ttmt -65.92 -28.08 68.66 Favored 'General case' 0 C--O 1.192 -1.965 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.478 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.749 ' CD1' HD23 ' B' ' 6' ' ' LEU . 2.1 pp -93.2 -37.97 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.911 . . . . 0.0 108.939 179.103 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.749 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.1 mm -58.71 -53.52 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 177.651 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.716 ' OG1' ' HB2' ' B' ' 85' ' ' LEU . 0.3 OUTLIER -69.92 -27.35 64.71 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.654 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.81 ' CG ' ' O ' ' A' ' 30' ' ' LYS . 16.9 mm-40 -76.67 -45.03 31.4 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.0 -1.062 . . . . 0.0 110.685 178.973 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.477 ' C ' ' H ' ' A' ' 38' ' ' LYS . 96.4 m -61.58 -53.43 56.36 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 120.651 -1.281 . . . . 0.0 108.859 179.445 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.952 ' CG2' HD13 ' B' ' 85' ' ' LEU . 15.7 m -50.11 -35.34 11.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 177.25 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.755 ' HB1' ' O ' ' B' ' 88' ' ' ALA . . . -92.01 1.18 57.36 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-O 121.582 0.706 . . . . 0.0 110.32 178.484 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.595 ' N ' ' O ' ' A' ' 34' ' ' GLU . 8.8 ttmt -101.53 -32.93 10.14 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 177.784 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 132.98 35.87 0.29 Allowed Glycine 0 C--N 1.305 -1.173 0 C-N-CA 119.637 -1.268 . . . . 0.0 111.565 177.738 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.467 ' CB ' ' CG2' ' A' ' 35' ' ' THR . 0.2 OUTLIER -145.97 -174.02 4.32 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.824 -1.398 . . . . 0.0 111.39 179.467 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.4 ' HG2' ' CB ' ' A' ' 51' ' ' LYS . 0.5 OUTLIER -134.57 127.67 31.73 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.831 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.693 HG22 HD11 ' B' ' 6' ' ' LEU . 1.1 t -85.96 115.38 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.201 -0.937 . . . . 0.0 110.713 -178.794 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.442 ' O ' ' HA ' ' B' ' 2' ' ' ASN . 4.8 mt-30 -105.54 100.43 10.0 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.951 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.918 HD22 ' HD2' ' B' ' 3' ' ' LYS . 47.8 mt -71.9 115.44 11.12 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.219 -0.926 . . . . 0.0 110.704 -178.933 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.536 ' C ' ' O ' ' A' ' 44' ' ' LEU . 2.1 t 28.43 -117.17 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.717 -0.615 . . . . 0.0 110.516 178.981 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -127.08 32.32 3.63 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 109.071 -1.611 . . . . 0.0 109.071 179.024 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.709 ' HE1' ' HB3' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -131.08 -28.0 1.98 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.14 -1.212 . . . . 0.0 111.921 -179.836 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.927 HD21 HD11 ' B' ' 50' ' ' ILE . 6.3 mt -128.03 128.9 45.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 119.852 -1.78 . . . . 0.0 110.602 176.796 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.514 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 7.4 m-80 -129.81 111.47 12.64 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.533 -0.729 . . . . 0.0 110.399 -178.876 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.837 HG22 HG12 ' A' ' 79' ' ' VAL . 1.2 pp -111.9 149.18 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.581 -0.699 . . . . 0.0 110.348 179.947 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.402 ' HG3' ' HB3' ' A' ' 78' ' ' SER . 0.0 OUTLIER -165.58 117.68 0.87 Allowed Pre-proline 0 N--CA 1.497 1.918 0 O-C-N 120.696 -1.253 . . . . 0.0 110.933 -179.78 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.545 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 53.0 Cg_endo -82.33 149.59 15.07 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 O-C-N 123.667 1.351 . . . . 0.0 111.212 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.772 ' O ' HG23 ' A' ' 75' ' ' VAL . 10.8 m -132.48 -149.95 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 O-C-N 121.521 -0.737 . . . . 0.0 110.345 179.542 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.805 ' HB2' ' HB3' ' B' ' 97' ' ' PHE . . . . . . . . 0 C--N 1.296 -1.758 0 O-C-N 121.1 -1.0 . . . . 0.0 111.266 -179.132 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 1.038 HG11 ' CB ' ' B' ' 89' ' ' ALA . 14.6 p . . . . . 0 N--CA 1.501 2.081 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.698 ' HA3' HG22 ' A' ' 53' ' ' VAL . . . -110.13 87.02 0.46 Allowed Glycine 0 N--CA 1.487 2.037 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 179.356 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.737 HG21 ' HG ' ' B' ' 85' ' ' LEU . 84.1 t -65.2 75.49 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 O-C-N 121.918 -0.754 . . . . 0.0 110.753 -179.247 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.856 ' O ' HG13 ' A' ' 79' ' ' VAL . 0.5 OUTLIER -65.83 178.77 0.99 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.323 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.856 HG13 ' O ' ' A' ' 78' ' ' SER . 0.0 OUTLIER 179.7 178.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.924 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.511 ' O ' HD23 ' A' ' 48' ' ' LEU . 11.1 mttt 179.14 169.79 0.57 Allowed Pre-proline 0 C--N 1.307 -1.28 0 O-C-N 121.384 -0.822 . . . . 0.0 110.46 177.13 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.591 ' HB2' HG13 ' B' ' 77' ' ' VAL . 57.4 Cg_endo -109.39 161.15 0.08 OUTLIER 'Trans proline' 0 C--N 1.301 -1.959 0 C-N-CA 123.413 2.742 . . . . 0.0 110.605 177.798 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 47' ' ' PHE . . . -105.57 -150.79 19.55 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 107.604 -2.198 . . . . 0.0 107.604 177.093 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -100.46 -13.1 18.84 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.88 -1.365 . . . . 0.0 110.125 178.885 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.411 ' HB3' ' HB2' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -58.02 -38.09 75.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.335 -0.853 . . . . 0.0 109.075 179.664 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.923 ' CB ' HG21 ' B' ' 77' ' ' VAL . 0.5 OUTLIER -77.42 -38.16 50.23 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.692 -0.63 . . . . 0.0 109.539 179.239 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.527 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -69.14 -41.5 77.22 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.799 -0.761 . . . . 0.0 110.779 -178.923 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -64.93 -40.24 94.74 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 178.942 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.661 ' O ' ' HB1' ' B' ' 37' ' ' ALA . . . -72.79 -30.78 64.37 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 177.02 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.878 ' HA ' HD23 ' A' ' 92' ' ' LEU . . . -64.68 -39.08 93.05 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.304 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -56.98 -33.15 66.8 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 176.935 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -74.07 -20.79 79.66 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 178.745 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.929 ' O ' HD12 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -76.82 16.07 0.57 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.681 -1.482 . . . . 0.0 111.268 -179.757 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.419 ' CB ' ' O ' ' A' ' 92' ' ' LEU . 0.0 OUTLIER 65.19 34.94 8.15 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -177.728 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.545 ' CD1' ' HB ' ' B' ' 75' ' ' VAL . 0.0 OUTLIER -49.31 -27.75 4.18 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.486 -179.578 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.362 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.489 ' HG2' ' HB3' ' B' ' 5' ' ' GLU . 3.0 mtp . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.193 0.52 . . . . 0.0 110.211 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 2' ' ' ASN . . . . . 0.81 ' C ' HD12 ' B' ' 6' ' ' LEU . 23.3 t-20 -173.06 165.99 4.98 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.374 -0.829 . . . . 0.0 109.783 -179.816 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.918 ' HD2' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -47.36 -26.15 1.21 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.983 -1.073 . . . . 0.0 109.202 179.307 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 4' ' ' THR . . . . . 0.655 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 16.7 m -79.28 -56.19 4.53 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 177.342 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.489 ' HB3' ' HG2' ' B' ' 1' ' ' MET . 0.5 OUTLIER -57.95 -50.46 73.29 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 177.42 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.81 HD12 ' C ' ' B' ' 2' ' ' ASN . 1.8 mt -61.15 -28.05 68.83 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 177.302 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 7' ' ' ILE . . . . . 1.025 ' CD1' HD23 ' B' ' 25' ' ' LEU . 0.1 OUTLIER -53.68 -54.28 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.278 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 8' ' ' LYS . . . . . 0.831 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.1 OUTLIER -62.97 -32.91 74.34 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.234 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 9' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' B' ' 6' ' ' LEU . . . -62.68 -29.38 70.61 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.375 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.894 HD11 ' HB2' ' A' ' 28' ' ' PHE . 0.6 OUTLIER -93.19 -35.58 6.7 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.627 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 178.109 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.831 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -63.75 -29.11 70.36 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.849 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.469 ' N ' ' O ' ' B' ' 8' ' ' LYS . 1.1 tt0 -89.85 -39.06 13.31 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.027 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.451 ' HB2' ' HA ' ' B' ' 10' ' ' ILE . 43.2 m-20 -67.41 -25.51 65.97 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 176.755 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 14' ' ' THR . . . . . 0.915 HG22 ' HB2' ' A' ' 20' ' ' SER . 24.7 p -88.73 -76.35 0.4 Allowed 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.756 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 60.45 12.53 26.08 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.604 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 16' ' ' LEU . . . . . 0.914 HD22 ' O ' ' A' ' 19' ' ' VAL . 3.4 mp -82.98 -60.66 2.09 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.43 -1.041 . . . . 0.0 108.708 179.092 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 17' ' ' THR . . . . . 0.615 HG22 ' H ' ' B' ' 19' ' ' VAL . 0.5 OUTLIER -146.14 3.9 0.93 Allowed 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.816 -179.665 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 18' ' ' GLN . . . . . 0.677 ' O ' ' C ' ' B' ' 19' ' ' VAL . 8.3 mt-30 57.09 28.03 14.3 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 -176.367 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.976 HG11 HG11 ' A' ' 19' ' ' VAL . 1.0 OUTLIER 5.73 -97.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.917 -179.516 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 20' ' ' SER . . . . . 1.033 ' O ' ' N ' ' B' ' 22' ' ' SER . 96.4 p -133.47 23.85 4.06 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 175.833 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.662 ' O ' HD11 ' B' ' 7' ' ' ILE . 30.8 m -9.1 -41.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 CA-C-O 122.289 1.042 . . . . 0.0 109.885 -177.593 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 22' ' ' SER . . . . . 1.033 ' N ' ' O ' ' B' ' 20' ' ' SER . 15.3 p -67.81 -46.46 71.81 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.944 177.285 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 23' ' ' LYS . . . . . 0.902 ' N ' ' O ' ' B' ' 20' ' ' SER . 32.6 mtmt -91.72 -23.85 19.65 Favored 'General case' 0 C--N 1.307 -1.258 0 O-C-N 121.543 -0.723 . . . . 0.0 109.338 178.498 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 24' ' ' MET . . . . . 0.609 ' HE2' ' HA ' ' B' ' 21' ' ' VAL . 2.1 tmm? -63.46 -24.75 67.96 Favored 'General case' 0 C--O 1.216 -0.701 0 O-C-N 120.459 -1.401 . . . . 0.0 107.625 178.207 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 1.025 HD23 ' CD1' ' B' ' 7' ' ' ILE . 0.1 OUTLIER -89.27 -46.4 8.79 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 176.61 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 26' ' ' ALA . . . . . 0.531 ' HB3' ' HA ' ' B' ' 23' ' ' LYS . . . -58.96 -28.19 66.06 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.25 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 27' ' ' SER . . . . . 0.774 ' O ' HG23 ' B' ' 31' ' ' ILE . 23.8 p -86.61 -31.82 20.94 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.082 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 28' ' ' PHE . . . . . 0.897 ' O ' HG13 ' B' ' 31' ' ' ILE . 0.7 OUTLIER -57.69 -42.27 83.35 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.08 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 29' ' ' GLU . . . . . 0.7 ' O ' ' HB ' ' B' ' 33' ' ' THR . 2.3 tt0 -70.78 -43.27 69.07 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 177.35 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 1.296 ' O ' ' HB3' ' B' ' 34' ' ' GLU . 25.5 ttpt -60.57 -21.34 62.49 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.873 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.919 ' HA ' ' HG2' ' B' ' 34' ' ' GLU . 1.3 pp -102.71 -33.7 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 119.361 -0.936 . . . . 0.0 110.209 179.58 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.681 HG13 ' CD1' ' B' ' 28' ' ' PHE . 1.0 OUTLIER -71.88 -43.76 68.33 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 176.791 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 33' ' ' THR . . . . . 0.7 ' HB ' ' O ' ' B' ' 29' ' ' GLU . 0.3 OUTLIER -77.02 -26.22 53.52 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 177.277 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 1.296 ' HB3' ' O ' ' B' ' 30' ' ' LYS . 0.0 OUTLIER -64.54 -43.94 92.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.097 -1.002 . . . . 0.0 109.961 178.3 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 35' ' ' THR . . . . . 0.778 HG21 HG13 ' B' ' 42' ' ' VAL . 47.9 m -67.33 -56.08 11.23 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 118.911 -1.115 . . . . 0.0 109.255 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.672 ' CG2' ' HA ' ' B' ' 33' ' ' THR . 19.6 m -50.22 -33.92 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 118.164 -1.414 . . . . 0.0 108.217 178.978 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 37' ' ' ALA . . . . . 0.661 ' HB1' ' O ' ' A' ' 88' ' ' ALA . . . -93.3 0.5 57.0 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.242 0.544 . . . . 0.0 110.492 178.84 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 38' ' ' LYS . . . . . 0.745 ' HB2' ' O ' ' B' ' 34' ' ' GLU . 9.7 tppt? -103.89 -16.74 15.28 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 106.673 -1.602 . . . . 0.0 106.673 177.132 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.89 50.07 1.3 Allowed Glycine 0 C--N 1.304 -1.216 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 178.21 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 40' ' ' ASP . . . . . 0.664 ' O ' HG22 ' B' ' 35' ' ' THR . 0.3 OUTLIER -148.94 141.01 23.86 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.057 -1.26 . . . . 0.0 110.775 179.43 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -90.57 92.89 9.05 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.621 -0.674 . . . . 0.0 109.24 179.866 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.824 HG22 HG22 ' B' ' 50' ' ' ILE . 24.1 m -59.28 137.95 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 C-N-CA 119.814 -0.755 . . . . 0.0 110.001 -179.608 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 43' ' ' GLN . . . . . 0.499 ' O ' ' HA ' ' A' ' 2' ' ' ASN . 1.6 mt-30 -118.51 173.43 6.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.345 -0.847 . . . . 0.0 110.149 -179.318 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.76 HD22 ' HE2' ' A' ' 28' ' ' PHE . 36.1 mt -141.31 -177.67 5.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.383 -0.823 . . . . 0.0 110.794 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 45' ' ' THR . . . . . 0.781 HG22 ' HG2' ' A' ' 29' ' ' GLU . 2.4 t -51.58 69.02 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 120.878 0.371 . . . . 0.0 111.765 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 46' ' ' GLY . . . . . 0.656 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . 41.57 29.63 0.48 Allowed Glycine 0 N--CA 1.5 2.914 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 179.352 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 47' ' ' PHE . . . . . 0.708 ' CE1' HD13 ' B' ' 44' ' ' LEU . 0.5 OUTLIER -123.72 -27.79 3.94 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.166 -1.197 . . . . 0.0 110.656 -179.755 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.716 HD12 ' H ' ' B' ' 49' ' ' ASN . 11.1 tp -168.73 150.0 4.7 Favored 'General case' 0 C--N 1.293 -1.854 0 C-N-CA 118.069 -1.452 . . . . 0.0 111.322 -179.839 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 49' ' ' ASN . . . . . 0.716 ' H ' HD12 ' B' ' 48' ' ' LEU . 17.2 m-80 -148.35 -178.95 6.6 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.96 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 50' ' ' ILE . . . . . 0.927 HD11 HD21 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -142.8 167.17 14.7 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 O-C-N 121.411 -0.806 . . . . 0.0 110.382 179.716 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 51' ' ' LYS . . . . . 0.462 ' HD3' ' O ' ' B' ' 51' ' ' LYS . 0.0 OUTLIER -170.88 130.13 0.79 Allowed Pre-proline 0 N--CA 1.494 1.771 0 C-N-CA 119.259 -0.977 . . . . 0.0 110.605 179.333 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 52' ' ' PRO . . . . . 0.576 ' HA ' ' HA ' ' B' ' 77' ' ' VAL . 57.7 Cg_endo -90.39 143.22 3.73 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.67 1.353 . . . . 0.0 110.741 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.65 HG22 ' CA ' ' B' ' 76' ' ' GLY . 16.5 m -126.6 -152.54 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 C-N-CA 119.841 -0.744 . . . . 0.0 110.229 178.945 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 54' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' B' ' 75' ' ' VAL . . . . . . . . 0 C--N 1.291 -1.969 0 O-C-N 121.292 -0.88 . . . . 0.0 110.506 -179.298 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 75' ' ' VAL . . . . . 0.581 HG11 ' HB1' ' A' ' 89' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.502 2.128 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 . . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 76' ' ' GLY . . . . . 0.65 ' CA ' HG22 ' B' ' 53' ' ' VAL . . . -114.89 88.2 0.47 Allowed Glycine 0 N--CA 1.491 2.303 0 C-N-CA 118.539 -1.791 . . . . 0.0 110.494 -179.178 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.923 HG21 ' CB ' ' A' ' 85' ' ' LEU . 5.0 p -69.62 68.58 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.354 -1.086 . . . . 0.0 108.308 178.349 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 78' ' ' SER . . . . . 0.479 ' N ' ' O ' ' B' ' 76' ' ' GLY . 0.3 OUTLIER -59.93 -153.8 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 121.895 0.855 . . . . 0.0 110.953 -179.073 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.764 ' HA ' ' HA ' ' B' ' 50' ' ' ILE . 3.1 p -157.19 -169.49 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 179.805 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 80' ' ' LYS . . . . . 0.512 ' H ' HG22 ' B' ' 79' ' ' VAL . 0.9 OUTLIER -140.38 175.29 3.24 Favored Pre-proline 0 C--N 1.307 -1.25 0 C-N-CA 117.651 -1.62 . . . . 0.0 113.126 -179.692 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 81' ' ' PRO . . . . . 0.43 ' CD ' ' CB ' ' B' ' 80' ' ' LYS . 58.9 Cg_endo -111.52 119.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 124.78 3.653 . . . . 0.0 111.185 -179.075 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 82' ' ' GLY . . . . . 0.667 ' HA3' ' C ' ' B' ' 47' ' ' PHE . . . -123.78 144.6 15.6 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 177.934 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 83' ' ' GLU . . . . . 0.454 ' HA ' ' HB2' ' B' ' 86' ' ' LYS . 8.0 pm0 -85.3 -23.62 28.04 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.156 -1.203 . . . . 0.0 111.59 -178.882 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 84' ' ' SER . . . . . 0.408 ' CB ' ' O ' ' B' ' 45' ' ' THR . 5.4 t -51.16 -30.96 18.29 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.051 -1.031 . . . . 0.0 108.42 179.283 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.952 HD13 ' CG2' ' A' ' 36' ' ' VAL . 0.1 OUTLIER -87.2 -40.52 14.5 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.172 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 86' ' ' LYS . . . . . 0.454 ' HB2' ' HA ' ' B' ' 83' ' ' GLU . 3.1 mtpp -64.24 -26.39 68.48 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.059 -1.057 . . . . 0.0 109.129 178.68 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -81.37 -36.01 30.13 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 178.343 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.755 ' O ' ' HB1' ' A' ' 37' ' ' ALA . . . -66.37 -37.98 86.52 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 176.737 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 1.038 ' CB ' HG11 ' A' ' 75' ' ' VAL . . . -61.43 -35.06 76.51 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.414 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 90' ' ' GLU . . . . . 0.401 ' HG2' ' N ' ' B' ' 91' ' ' GLY . 0.7 OUTLIER -56.2 -32.87 64.79 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 176.751 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 91' ' ' GLY . . . . . 0.401 ' N ' ' HG2' ' B' ' 90' ' ' GLU . . . -66.42 -36.94 92.28 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 178.288 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 92' ' ' LEU . . . . . 0.858 ' O ' HD12 ' B' ' 92' ' ' LEU . 0.4 OUTLIER -69.65 7.1 0.93 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.902 -1.352 . . . . 0.0 110.658 179.553 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 93' ' ' LYS . . . . . 0.516 ' CB ' ' O ' ' B' ' 92' ' ' LEU . 6.5 tptm 72.99 43.41 0.41 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -177.76 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 94' ' ' TYR . . . . . 0.516 ' CD1' ' CA ' ' A' ' 75' ' ' VAL . 0.2 OUTLIER -41.31 -33.47 0.39 Allowed 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.422 -179.542 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -61.51 -43.19 99.3 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.193 -0.942 . . . . 0.0 109.323 179.299 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.3 -36.81 76.27 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 177.77 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 97' ' ' PHE . . . . . 0.805 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.451 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.662 ' CB ' HG22 ' B' ' 42' ' ' VAL . 1.2 mtp . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.404 ' HA ' ' O ' ' B' ' 43' ' ' GLN . 3.2 t-20 -174.12 -167.55 0.35 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.884 -1.135 . . . . 0.0 111.736 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.435 ' NZ ' ' HA ' ' A' ' 26' ' ' ALA . 0.4 OUTLIER -53.02 -11.56 0.25 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.574 -0.704 . . . . 0.0 110.847 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.707 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 19.6 m -116.47 -42.48 3.0 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.026 -1.046 . . . . 0.0 109.538 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.588 ' CB ' ' HA ' ' A' ' 1' ' ' MET . 0.4 OUTLIER -62.13 -54.31 42.95 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.164 -0.96 . . . . 0.0 108.612 179.073 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.876 HD11 ' CG1' ' B' ' 42' ' ' VAL . 9.9 mt -57.93 -29.32 65.04 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.318 -0.864 . . . . 0.0 108.974 177.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.867 HG23 ' HB ' ' A' ' 21' ' ' VAL . 0.6 OUTLIER -55.17 -58.62 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.85 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.929 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -61.06 -28.19 68.89 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.625 -0.83 . . . . 0.0 108.761 178.235 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.669 ' HB3' ' O ' ' A' ' 6' ' ' LEU . . . -61.16 -32.59 72.32 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.361 -0.837 . . . . 0.0 109.064 179.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.814 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.7 OUTLIER -97.52 -34.84 4.97 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.446 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 178.465 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.929 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -61.22 -26.89 68.04 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 177.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.413 ' CG ' ' N ' ' A' ' 13' ' ' ASP . 11.0 pt20 -91.56 -39.85 11.68 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.446 ' HB2' ' HA ' ' A' ' 10' ' ' ILE . 43.8 m-20 -66.21 -22.89 66.36 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 176.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.948 HG22 ' HB2' ' B' ' 20' ' ' SER . 16.8 p -93.0 -76.12 0.48 Allowed 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 58.63 14.52 22.06 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.903 HD12 ' HB ' ' A' ' 14' ' ' THR . 1.7 mp -80.79 -50.89 9.26 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.365 -1.079 . . . . 0.0 108.465 179.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.6 HG22 ' H ' ' A' ' 19' ' ' VAL . 0.5 OUTLIER -150.7 0.74 0.42 Allowed 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 120.266 -0.573 . . . . 0.0 110.619 -179.655 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.593 ' O ' ' C ' ' A' ' 19' ' ' VAL . 9.1 mt-30 55.64 29.66 14.03 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 -176.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 1.056 HG11 HG11 ' B' ' 19' ' ' VAL . 0.7 OUTLIER -4.98 -95.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.714 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . 1.092 ' O ' ' N ' ' A' ' 22' ' ' SER . 0.1 OUTLIER -132.45 24.42 4.43 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 178.292 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.867 ' HB ' HG23 ' A' ' 7' ' ' ILE . 13.4 m -4.29 -40.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 CA-C-O 122.417 1.104 . . . . 0.0 110.898 -178.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . 1.092 ' N ' ' O ' ' A' ' 20' ' ' SER . 8.6 t -79.92 -40.77 27.45 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.335 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.862 ' N ' ' O ' ' A' ' 20' ' ' SER . 1.7 ttpt -84.73 -27.71 26.79 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.412 -0.805 . . . . 0.0 111.366 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.547 ' CE ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -78.45 -40.39 35.78 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 117.895 -1.522 . . . . 0.0 109.751 179.627 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.727 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 0.2 OUTLIER -78.8 -49.21 13.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.585 -1.322 . . . . 0.0 109.837 178.842 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 22' ' ' SER . . . -55.04 -34.23 63.34 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.63 ' HA ' ' HB3' ' A' ' 30' ' ' LYS . 20.7 t -85.16 -29.64 24.59 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.744 -0.783 . . . . 0.0 108.99 178.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.732 ' HA ' ' CG1' ' A' ' 31' ' ' ILE . 0.2 OUTLIER -59.81 -39.27 84.45 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.442 -0.786 . . . . 0.0 109.101 179.165 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.553 ' HB3' HG21 ' B' ' 45' ' ' THR . 4.5 mt-10 -79.21 -31.96 43.86 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.974 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 24.7 tttm -69.74 -25.86 64.04 Favored 'General case' 0 C--O 1.188 -2.179 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 176.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.732 ' CG1' ' HA ' ' A' ' 28' ' ' PHE . 1.9 pp -97.59 -31.33 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.957 -1.09 . . . . 0.0 109.157 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.666 HG21 ' CE1' ' B' ' 47' ' ' PHE . 2.0 mm -63.68 -56.16 18.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 177.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.49 ' HA ' ' HB3' ' B' ' 85' ' ' LEU . 0.4 OUTLIER -68.82 -36.98 78.89 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.39 -0.823 . . . . 0.0 108.882 179.313 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.974 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 59.4 mm-40 -74.98 -32.84 61.78 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.554 -0.716 . . . . 0.0 111.652 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.552 ' N ' ' O ' ' A' ' 31' ' ' ILE . 24.2 m -67.66 -58.14 5.18 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 118.221 -1.391 . . . . 0.0 108.988 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.788 ' O ' ' HG3' ' A' ' 52' ' ' PRO . 0.7 OUTLIER -51.29 -35.65 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 178.447 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.788 ' HB1' ' C ' ' B' ' 88' ' ' ALA . . . -73.32 -27.9 61.78 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.082 178.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.606 ' N ' HD12 ' B' ' 92' ' ' LEU . 0.0 OUTLIER -75.78 -25.77 56.71 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 177.982 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.413 ' HA3' ' CE ' ' B' ' 93' ' ' LYS . . . 108.97 27.58 4.8 Favored Glycine 0 C--N 1.295 -1.706 0 C-N-CA 120.075 -1.059 . . . . 0.0 111.403 177.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.527 ' HB2' HG23 ' A' ' 35' ' ' THR . 0.2 OUTLIER -108.46 151.65 25.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.123 -1.222 . . . . 0.0 109.651 179.011 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -76.69 81.61 3.32 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.374 -0.829 . . . . 0.0 110.421 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.491 ' CG2' ' CG2' ' A' ' 35' ' ' THR . 60.7 t -68.29 140.63 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.448 -0.782 . . . . 0.0 109.8 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.487 ' HG2' ' HA ' ' B' ' 2' ' ' ASN . 4.2 pt20 -158.85 174.17 15.4 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.372 -0.83 . . . . 0.0 109.76 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.929 HD22 ' CE1' ' B' ' 28' ' ' PHE . 27.9 mt -127.5 115.22 18.53 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.441 -0.787 . . . . 0.0 109.244 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.566 HG23 ' HD1' ' A' ' 47' ' ' PHE . 0.0 OUTLIER 33.2 -95.54 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.89 -0.507 . . . . 0.0 111.566 -179.599 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.468 ' H ' HG23 ' A' ' 45' ' ' THR . . . -139.73 25.06 2.72 Favored Glycine 0 N--CA 1.487 2.083 0 C-N-CA 119.417 -1.373 . . . . 0.0 111.089 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.779 ' CD1' ' HG3' ' B' ' 29' ' ' GLU . 13.3 p90 -122.07 -31.83 3.81 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.616 -1.52 . . . . 0.0 110.538 178.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.898 ' HB2' HD12 ' A' ' 44' ' ' LEU . 8.3 mt -122.09 148.97 44.21 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 119.886 -1.759 . . . . 0.0 111.548 177.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.488 ' N ' ' HB2' ' A' ' 80' ' ' LYS . 0.8 OUTLIER -149.25 77.12 1.35 Allowed 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.289 0.566 . . . . 0.0 110.483 -179.815 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.771 HG22 HG21 ' A' ' 36' ' ' VAL . 43.5 mm -69.63 126.28 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.394 -0.816 . . . . 0.0 109.962 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -140.67 126.33 11.38 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.335 -0.853 . . . . 0.0 108.766 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.788 ' HG3' ' O ' ' A' ' 36' ' ' VAL . 55.2 Cg_endo -86.83 140.37 5.9 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.317 1.167 . . . . 0.0 110.885 -178.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.595 HG22 ' O ' ' A' ' 76' ' ' GLY . 18.4 m -137.28 117.07 15.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-O 122.204 1.002 . . . . 0.0 110.837 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.691 ' HB2' ' CB ' ' B' ' 97' ' ' PHE . . . -43.34 115.66 0.81 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.72 0.771 . . . . 0.0 111.765 -178.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.7 ttt-85 -141.21 -151.18 0.35 Allowed 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.672 ' HB2' ' HB1' ' A' ' 72' ' ' ALA . 4.1 pt20 -177.43 -175.33 0.54 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.898 -1.126 . . . . 0.0 111.552 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.503 ' H ' ' HA ' ' A' ' 72' ' ' ALA . . . -172.9 148.98 1.86 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.847 -0.533 . . . . 0.0 109.772 -178.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 1.006 ' HB2' HD12 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -176.17 147.3 0.71 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.741 -1.224 . . . . 0.0 112.724 -179.892 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.747 ' HB3' ' O ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER 135.26 39.16 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.225 0 C-N-CA 123.659 0.784 . . . . 0.0 109.917 176.038 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 1.082 ' O ' ' O ' ' A' ' 61' ' ' PHE . . . -146.93 72.22 0.32 Allowed Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 1.152 ' N ' ' H ' ' A' ' 68' ' ' ALA . 0.3 OUTLIER -11.71 -155.7 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.201 0 C-N-CA 123.728 0.811 . . . . 0.0 111.646 -177.435 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.551 ' CB ' ' O ' ' A' ' 61' ' ' PHE . 1.2 t30 170.57 -56.94 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 120.186 -1.572 . . . . 0.0 112.21 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' A' ' 62' ' ' ASN . 38.8 Cg_endo -65.02 -13.35 39.28 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.392 1.206 . . . . 0.0 111.661 -178.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.526 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 4.7 tt0 -116.22 -111.55 0.35 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.022 -1.048 . . . . 0.0 109.376 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.424 ' O ' ' O ' ' A' ' 66' ' ' GLN . 6.7 t -96.29 7.86 45.39 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.888 -1.132 . . . . 0.0 109.955 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.721 ' O ' ' CB ' ' A' ' 67' ' ' GLU . 3.1 mp0 58.23 118.8 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.578 -0.701 . . . . 0.0 110.294 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.776 ' O ' ' HB2' ' A' ' 68' ' ' ALA . 7.0 tt0 137.17 41.81 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.308 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 1.152 ' H ' ' N ' ' A' ' 61' ' ' PHE . . . 163.06 96.67 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.694 HD13 HG13 ' A' ' 71' ' ' ILE . 2.8 pp -152.18 -148.76 0.27 Allowed 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 174.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.83 ' HA ' ' HG3' ' A' ' 58' ' ' ARG . 0.3 OUTLIER -177.19 67.75 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.459 -1.401 . . . . 0.0 110.617 179.729 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 1.006 HD12 ' HB2' ' A' ' 58' ' ' ARG . 0.9 OUTLIER -115.41 -152.38 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.291 0 O-C-N 120.933 -1.104 . . . . 0.0 109.721 179.125 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.672 ' HB1' ' HB2' ' A' ' 56' ' ' GLN . . . -179.94 56.33 0.07 OUTLIER Pre-proline 0 N--CA 1.5 2.031 0 O-C-N 119.894 -1.754 . . . . 0.0 112.086 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.577 ' HD3' ' N ' ' A' ' 72' ' ' ALA . 55.7 Cg_endo -103.79 96.88 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 121.133 1.222 . . . . 0.0 111.212 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.434 ' CB ' ' HA ' ' A' ' 56' ' ' GLN . 1.2 t -161.89 95.87 0.99 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.561 -1.337 . . . . 0.0 111.925 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.961 HG11 ' HB3' ' B' ' 89' ' ' ALA . 8.0 p -62.47 170.91 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.04 -1.037 . . . . 0.0 108.287 178.173 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.595 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -117.93 82.92 0.34 Allowed Glycine 0 N--CA 1.493 2.445 0 C-N-CA 118.556 -1.783 . . . . 0.0 110.285 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.667 HG11 HD13 ' B' ' 85' ' ' LEU . 97.3 t -70.69 74.45 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.146 -1.208 . . . . 0.0 109.165 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.461 ' N ' ' O ' ' A' ' 51' ' ' LYS . 0.4 OUTLIER -58.87 -166.41 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.445 0.641 . . . . 0.0 110.587 -179.68 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.728 HG11 ' HD3' ' B' ' 81' ' ' PRO . 7.9 p -172.21 178.74 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.541 -0.724 . . . . 0.0 109.061 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.592 ' N ' HG22 ' A' ' 79' ' ' VAL . 0.4 OUTLIER -122.04 177.96 1.4 Allowed Pre-proline 0 C--N 1.309 -1.192 0 O-C-N 120.905 -1.122 . . . . 0.0 110.619 179.425 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.419 ' CD ' ' CB ' ' A' ' 80' ' ' LYS . 56.4 Cg_endo -106.32 74.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.302 -1.919 0 C-N-CA 123.739 2.96 . . . . 0.0 109.874 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.718 ' CA ' ' O ' ' A' ' 47' ' ' PHE . . . -56.53 93.83 0.03 OUTLIER Glycine 0 N--CA 1.486 2.032 0 C-N-CA 119.198 -1.477 . . . . 0.0 110.71 -178.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' A' ' 81' ' ' PRO . 2.9 pt-20 -62.2 -28.14 69.47 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.668 -0.901 . . . . 0.0 108.995 178.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.442 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 71.1 m -53.24 -27.66 23.38 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.644 ' CD2' HG22 ' B' ' 77' ' ' VAL . 4.4 tt -85.74 -30.91 22.72 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.673 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 3.0 tttt -79.9 -40.31 28.53 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.629 0.728 . . . . 0.0 109.139 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -67.73 -37.08 81.71 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 178.256 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.628 ' O ' ' HB1' ' B' ' 37' ' ' ALA . . . -64.12 -36.71 84.94 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 176.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.818 ' HB1' ' CG1' ' B' ' 75' ' ' VAL . . . -57.49 -39.34 76.23 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.594 ' HA ' ' HB2' ' A' ' 94' ' ' TYR . 6.3 mm-40 -56.44 -29.07 61.19 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 176.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -70.42 -42.44 64.68 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.795 HD12 ' HB2' ' A' ' 93' ' ' LYS . 0.4 OUTLIER -61.36 -48.94 79.0 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.27 -1.723 . . . . 0.0 110.791 -178.943 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.795 ' HB2' HD12 ' A' ' 92' ' ' LEU . 0.0 OUTLIER 157.06 44.02 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.42 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.577 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 1.049 ' CG ' ' HB3' ' B' ' 74' ' ' SER . 87.5 t80 -42.48 -54.55 3.83 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.717 -0.615 . . . . 0.0 111.053 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.636 ' HA ' ' OG ' ' B' ' 74' ' ' SER . 5.3 mp0 -61.98 -39.5 92.37 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.087 -1.008 . . . . 0.0 110.557 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.528 ' HB2' ' CD ' ' A' ' 93' ' ' LYS . 0.6 OUTLIER -53.37 -31.1 43.14 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.279 -0.888 . . . . 0.0 109.68 179.81 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.437 ' HB3' ' HB2' ' B' ' 54' ' ' ALA . 9.2 m-85 -80.75 -29.84 36.2 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.538 -0.865 . . . . 0.0 108.756 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.946 ' HB2' ' OG ' ' B' ' 74' ' ' SER . . . -69.69 -21.0 63.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.782 -0.574 . . . . 0.0 110.427 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 11.4 mtmt . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.215 179.929 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.521 ' HA ' ' CB ' ' B' ' 5' ' ' GLU . 5.3 mtp . . . . . 0 N--CA 1.492 1.653 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 2' ' ' ASN . . . . . 0.861 ' C ' HD12 ' B' ' 6' ' ' LEU . 23.2 p30 -176.47 -174.02 0.56 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.237 -0.914 . . . . 0.0 111.225 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.512 ' HE3' ' CG2' ' A' ' 45' ' ' THR . 0.0 OUTLIER -49.53 -16.37 0.21 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.493 -0.754 . . . . 0.0 110.728 -179.641 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.58 ' O ' HG13 ' B' ' 7' ' ' ILE . 3.2 m -105.87 -57.53 2.03 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 122.113 0.958 . . . . 0.0 108.716 178.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.521 ' CB ' ' HA ' ' B' ' 1' ' ' MET . 0.4 OUTLIER -50.35 -46.01 55.48 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.838 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.861 HD12 ' C ' ' B' ' 2' ' ' ASN . 6.2 mt -58.02 -31.6 67.14 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.795 -0.762 . . . . 0.0 109.914 178.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 7' ' ' ILE . . . . . 0.606 HG22 ' CD1' ' B' ' 25' ' ' LEU . 0.8 OUTLIER -60.9 -40.39 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 178.827 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 8' ' ' LYS . . . . . 0.852 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.0 OUTLIER -70.43 -31.45 68.64 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 177.865 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 9' ' ' ALA . . . . . 0.557 ' HB1' HD13 ' A' ' 31' ' ' ILE . . . -58.53 -37.95 76.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.6 -0.687 . . . . 0.0 109.152 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.736 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.3 mp -92.89 -30.41 4.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.852 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -67.6 -12.97 61.63 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 118.576 -1.25 . . . . 0.0 108.455 178.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.444 ' CG ' ' N ' ' B' ' 13' ' ' ASP . 17.0 pt20 -112.93 -42.0 3.65 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.432 -0.793 . . . . 0.0 109.338 178.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.444 ' N ' ' CG ' ' B' ' 12' ' ' GLN . 0.9 OUTLIER -70.9 -27.43 63.79 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 176.906 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.98 HG22 ' CD1' ' B' ' 16' ' ' LEU . 0.1 OUTLIER -113.54 -85.76 0.58 Allowed 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 178.143 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 15' ' ' GLY . . . . . 0.571 ' O ' ' C ' ' B' ' 16' ' ' LEU . . . 80.19 -28.26 2.64 Favored Glycine 0 N--CA 1.499 2.885 0 O-C-N 121.031 -1.043 . . . . 0.0 111.062 177.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 16' ' ' LEU . . . . . 0.98 ' CD1' HG22 ' B' ' 14' ' ' THR . 5.1 mp -13.93 -66.0 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.519 0 CA-C-O 121.918 0.866 . . . . 0.0 112.062 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 17' ' ' THR . . . . . 0.584 ' CG2' HG21 ' A' ' 17' ' ' THR . 0.6 OUTLIER -139.64 7.62 2.33 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.549 -179.579 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 18' ' ' GLN . . . . . 0.618 ' O ' ' C ' ' B' ' 19' ' ' VAL . 11.4 mt-30 58.95 25.83 14.23 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 -175.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 1.056 HG11 HG11 ' A' ' 19' ' ' VAL . 2.4 p -4.94 -96.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.393 -179.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.961 ' O ' ' N ' ' B' ' 23' ' ' LYS . 0.6 OUTLIER -132.01 23.07 4.54 Favored 'General case' 0 C--N 1.279 -2.462 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 178.045 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.616 ' C ' ' O ' ' B' ' 20' ' ' SER . 30.4 m -24.42 -40.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 122.449 1.119 . . . . 0.0 109.054 -178.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.693 ' N ' ' O ' ' B' ' 20' ' ' SER . 3.2 m -81.95 -36.24 28.19 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.088 177.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 23' ' ' LYS . . . . . 0.961 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.8 OUTLIER -85.19 -37.92 19.58 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.675 -0.641 . . . . 0.0 111.44 179.656 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 24' ' ' MET . . . . . 0.575 ' HG3' ' O ' ' B' ' 20' ' ' SER . 0.0 OUTLIER -68.14 -38.11 81.82 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 117.637 -1.625 . . . . 0.0 108.374 179.156 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.606 ' CD1' HG22 ' B' ' 7' ' ' ILE . 8.8 mt -71.68 -35.5 70.31 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 118.47 -1.292 . . . . 0.0 108.976 178.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' ALA . . . . . 0.475 ' HA ' ' CE ' ' B' ' 3' ' ' LYS . . . -62.96 -37.15 85.95 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 177.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 27' ' ' SER . . . . . 0.53 ' O ' ' N ' ' B' ' 31' ' ' ILE . 1.2 p -80.86 -26.59 36.86 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 28' ' ' PHE . . . . . 0.929 ' CE1' HD22 ' A' ' 44' ' ' LEU . 1.8 t80 -55.36 -48.84 73.63 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' GLU . . . . . 0.779 ' HG3' ' CD1' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -69.16 -33.91 74.15 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.869 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 1.228 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 24.1 tttp -64.88 -22.61 67.02 Favored 'General case' 0 C--O 1.191 -1.99 0 C-N-CA 119.012 -1.075 . . . . 0.0 108.374 178.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.662 HG13 ' O ' ' B' ' 28' ' ' PHE . 0.7 OUTLIER -104.53 -27.04 3.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 120.271 -1.518 . . . . 0.0 109.345 178.265 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.657 HD11 ' CE2' ' B' ' 28' ' ' PHE . 1.2 mm -70.99 -61.88 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 177.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 33' ' ' THR . . . . . 0.428 ' OG1' ' N ' ' A' ' 85' ' ' LEU . 0.6 OUTLIER -66.73 -37.79 85.37 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.408 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 1.228 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 18.2 mm-40 -76.25 -35.0 59.17 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 121.065 -1.022 . . . . 0.0 111.901 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 35' ' ' THR . . . . . 0.964 HG21 HG23 ' B' ' 42' ' ' VAL . 4.5 m -61.82 -52.8 62.71 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 120.339 -1.476 . . . . 0.0 108.912 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.571 HG22 ' CD ' ' B' ' 52' ' ' PRO . 1.0 OUTLIER -53.35 -38.32 31.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 C-N-CA 118.194 -1.402 . . . . 0.0 107.259 178.71 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 0.628 ' HB1' ' O ' ' A' ' 88' ' ' ALA . . . -83.37 -2.36 55.59 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.832 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' LYS . . . . . 0.576 ' HB2' ' O ' ' B' ' 34' ' ' GLU . 0.0 OUTLIER -100.95 -23.83 14.46 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 177.546 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.05 43.97 1.45 Allowed Glycine 0 C--N 1.301 -1.375 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 40' ' ' ASP . . . . . 0.709 ' CB ' HG23 ' B' ' 35' ' ' THR . 0.1 OUTLIER -138.16 137.92 38.1 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.105 -1.232 . . . . 0.0 110.103 179.366 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 5.7 mttp -90.79 84.17 5.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.461 -0.775 . . . . 0.0 110.916 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.964 HG23 HG21 ' B' ' 35' ' ' THR . 3.5 t -63.54 146.39 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.399 -0.813 . . . . 0.0 109.278 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 43' ' ' GLN . . . . . 0.404 ' O ' ' HA ' ' A' ' 2' ' ' ASN . 1.3 tt0 -138.61 114.1 9.68 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 120.88 -1.138 . . . . 0.0 110.501 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.685 HD22 ' HE2' ' A' ' 28' ' ' PHE . 17.1 mt -85.75 110.99 19.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.187 -0.946 . . . . 0.0 108.784 178.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 45' ' ' THR . . . . . 0.553 HG21 ' HB3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 33.07 -89.83 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.407 0 O-C-N 121.739 -0.601 . . . . 0.0 110.997 -179.441 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -148.31 22.01 1.38 Allowed Glycine 0 N--CA 1.485 1.917 0 C-N-CA 119.818 -1.182 . . . . 0.0 110.176 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 47' ' ' PHE . . . . . 0.666 ' CE1' HG21 ' A' ' 32' ' ' ILE . 14.4 p90 -118.14 -34.91 3.97 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.832 -1.393 . . . . 0.0 112.111 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.633 ' HB2' HD12 ' B' ' 44' ' ' LEU . 0.0 OUTLIER -115.76 92.06 3.79 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.805 -1.185 . . . . 0.0 110.692 179.428 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 49' ' ' ASN . . . . . 0.659 ' O ' ' HB ' ' B' ' 79' ' ' VAL . 1.1 t-20 -79.96 60.82 3.65 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.88 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 50' ' ' ILE . . . . . 0.811 HD13 HG21 ' B' ' 79' ' ' VAL . 32.2 mm -56.34 116.92 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.314 -0.867 . . . . 0.0 111.62 -177.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 51' ' ' LYS . . . . . 0.552 ' O ' ' HG3' ' B' ' 51' ' ' LYS . 6.9 ptmt -169.97 126.17 0.73 Allowed Pre-proline 0 N--CA 1.488 1.435 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.571 ' CD ' HG22 ' B' ' 36' ' ' VAL . 54.8 Cg_endo -79.32 144.76 18.42 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.433 1.228 . . . . 0.0 112.158 -177.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.5 ' O ' HG23 ' B' ' 53' ' ' VAL . 30.0 m -150.31 122.17 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.75 ' HA ' ' O ' ' B' ' 74' ' ' SER . . . -64.26 148.13 50.88 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 118.96 -1.096 . . . . 0.0 111.535 -177.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 55' ' ' ARG . . . . . 0.494 ' O ' ' CG ' ' B' ' 56' ' ' GLN . 3.8 tpt180 -158.57 17.62 0.21 Allowed 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 119.421 -0.912 . . . . 0.0 111.681 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 56' ' ' GLN . . . . . 0.773 ' N ' ' HA ' ' B' ' 73' ' ' PRO . 0.0 OUTLIER -173.5 147.02 1.41 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.181 -0.949 . . . . 0.0 111.491 179.14 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.763 ' HB3' ' O ' ' B' ' 72' ' ' ALA . . . -165.81 21.8 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.259 -0.901 . . . . 0.0 110.7 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 58' ' ' ARG . . . . . 0.63 ' HG3' ' N ' ' B' ' 59' ' ' LYS . 0.0 OUTLIER -166.87 152.36 7.84 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.236 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 59' ' ' LYS . . . . . 0.63 ' N ' ' HG3' ' B' ' 58' ' ' ARG . 2.8 ptpt -174.57 36.62 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.309 -0.869 . . . . 0.0 111.07 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -102.57 104.0 2.52 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 108.421 -1.872 . . . . 0.0 108.421 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 61' ' ' PHE . . . . . 0.621 ' CD2' ' O ' ' B' ' 62' ' ' ASN . 42.3 p90 -52.19 158.21 1.19 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.283 -1.128 . . . . 0.0 111.277 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 62' ' ' ASN . . . . . 0.621 ' O ' ' CD2' ' B' ' 61' ' ' PHE . 1.2 t-20 -56.22 -171.19 0.02 OUTLIER Pre-proline 0 N--CA 1.495 1.776 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.516 ' HD2' ' CB ' ' B' ' 62' ' ' ASN . 43.5 Cg_endo -72.78 60.91 3.66 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 N-CA-C 109.145 -1.137 . . . . 0.0 109.145 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 64' ' ' GLN . . . . . 0.702 ' O ' HG23 ' B' ' 65' ' ' THR . 10.8 mt-30 -135.47 -94.05 0.27 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.427 -0.796 . . . . 0.0 111.178 -179.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.702 HG23 ' O ' ' B' ' 64' ' ' GLN . 0.0 OUTLIER -174.92 -30.88 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.977 -1.077 . . . . 0.0 110.974 -179.85 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -139.66 15.04 2.53 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.073 -1.017 . . . . 0.0 111.988 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 67' ' ' GLU . . . . . 0.44 ' O ' ' HA ' ' B' ' 61' ' ' PHE . 5.7 tt0 -89.37 47.39 1.48 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.73 -1.231 . . . . 0.0 109.54 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 68' ' ' ALA . . . . . 0.432 ' HA ' ' CA ' ' B' ' 61' ' ' PHE . . . -47.92 152.77 0.72 Allowed 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.508 0.671 . . . . 0.0 111.506 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.485 ' O ' ' HB3' ' B' ' 70' ' ' GLU . 17.4 mt -127.48 -162.83 1.2 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.596 -0.69 . . . . 0.0 109.485 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 70' ' ' GLU . . . . . 0.485 ' HB3' ' O ' ' B' ' 69' ' ' LEU . 1.9 pt-20 173.96 79.87 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.422 -0.798 . . . . 0.0 109.421 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.78 ' O ' ' HB2' ' B' ' 72' ' ' ALA . 1.2 pp -111.27 88.9 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.682 -1.261 . . . . 0.0 112.484 -179.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 72' ' ' ALA . . . . . 0.78 ' HB2' ' O ' ' B' ' 71' ' ' ILE . . . 135.78 124.09 0.0 OUTLIER Pre-proline 0 C--N 1.283 -2.292 0 CA-C-N 114.144 -1.389 . . . . 0.0 108.522 178.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 73' ' ' PRO . . . . . 0.773 ' HA ' ' N ' ' B' ' 56' ' ' GLN . 48.1 Cg_endo -103.11 131.4 0.1 Allowed 'Trans proline' 0 C--N 1.296 -2.197 0 O-C-N 122.99 0.995 . . . . 0.0 111.897 179.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 74' ' ' SER . . . . . 1.049 ' HB3' ' CG ' ' A' ' 94' ' ' TYR . 2.7 m -111.18 155.47 22.87 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 176.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 75' ' ' VAL . . . . . 0.818 ' CG1' ' HB1' ' A' ' 89' ' ' ALA . 84.3 t -19.41 145.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -176.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -143.57 -142.65 3.98 Favored Glycine 0 N--CA 1.491 2.305 0 O-C-N 120.285 -1.509 . . . . 0.0 110.559 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.644 HG22 ' CD2' ' A' ' 85' ' ' LEU . 11.3 t -141.57 83.55 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-O 121.982 0.896 . . . . 0.0 109.734 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 78' ' ' SER . . . . . 0.49 ' HB3' ' HG3' ' B' ' 51' ' ' LYS . 0.1 OUTLIER -58.44 -45.04 89.31 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.586 0.707 . . . . 0.0 110.947 179.343 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.811 HG21 HD13 ' B' ' 50' ' ' ILE 0.284 7.5 p -46.9 172.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-O 122.438 1.113 . . . . 0.0 113.791 -174.52 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 80' ' ' LYS . . . . . 0.64 ' HB2' ' HD2' ' B' ' 81' ' ' PRO . 0.3 OUTLIER 178.15 175.74 0.32 Allowed Pre-proline 0 N--CA 1.48 1.03 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -179.625 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 81' ' ' PRO . . . . . 0.728 ' HD3' HG11 ' A' ' 79' ' ' VAL . 47.1 Cg_endo -72.84 137.99 27.97 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.374 1.197 . . . . 0.0 109.583 177.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 82' ' ' GLY . . . . . 0.546 ' O ' HD12 ' B' ' 85' ' ' LEU . . . -101.67 -161.02 26.87 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 83' ' ' GLU . . . . . 0.473 ' HA ' ' HB2' ' B' ' 86' ' ' LYS . 0.4 OUTLIER -91.11 -10.64 41.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.418 -1.048 . . . . 0.0 110.417 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -54.93 -36.69 65.52 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.252 -0.905 . . . . 0.0 109.977 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.667 HD13 HG11 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -85.4 -33.42 21.97 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 119.629 -0.828 . . . . 0.0 108.852 179.198 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 86' ' ' LYS . . . . . 0.612 ' HG2' HG13 ' A' ' 75' ' ' VAL . 8.6 mttt -69.38 -34.09 74.01 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.653 -0.819 . . . . 0.0 109.264 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 87' ' ' LYS . . . . . 0.526 ' O ' ' HG3' ' B' ' 90' ' ' GLU . 35.8 tptt -73.15 -38.17 66.32 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 177.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.788 ' C ' ' HB1' ' A' ' 37' ' ' ALA . . . -67.71 -34.23 76.46 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 177.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.961 ' HB3' HG11 ' A' ' 75' ' ' VAL . . . -72.16 -45.21 61.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.79 -0.569 . . . . 0.0 110.45 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.526 ' HG3' ' O ' ' B' ' 87' ' ' LYS . 0.6 OUTLIER -56.82 -19.31 16.63 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.622 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 91' ' ' GLY . . . . . 0.853 ' C ' HD23 ' B' ' 92' ' ' LEU . . . -93.93 -24.58 19.68 Favored Glycine 0 CA--C 1.547 2.089 0 CA-C-O 118.467 -1.185 . . . . 0.0 113.57 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 92' ' ' LEU . . . . . 0.853 HD23 ' C ' ' B' ' 91' ' ' GLY . 0.1 OUTLIER -113.03 -71.67 0.74 Allowed 'General case' 0 N--CA 1.507 2.381 0 CA-C-N 122.27 3.035 . . . . 0.0 113.171 -177.924 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 93' ' ' LYS . . . . . 0.459 ' O ' ' CD2' ' B' ' 97' ' ' PHE . 0.0 OUTLIER -113.0 36.58 3.44 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.803 -1.186 . . . . 0.0 112.459 -177.462 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 94' ' ' TYR . . . . . 0.512 ' HB2' ' HA ' ' B' ' 90' ' ' GLU . 6.2 t80 -71.24 -53.63 13.72 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 119.241 -0.984 . . . . 0.0 109.371 178.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -71.72 -31.53 66.81 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.41 -34.84 69.32 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 97' ' ' PHE . . . . . 0.691 ' CB ' ' HB2' ' A' ' 54' ' ' ALA . 7.4 m-85 -76.99 -34.84 57.51 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.48 -45.15 92.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.669 -0.644 . . . . 0.0 110.274 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 3.9 pttt . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.294 -179.931 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.759 ' SD ' HG21 ' B' ' 35' ' ' THR . 2.3 mtp . . . . . 0 N--CA 1.494 1.768 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.465 ' HA ' ' O ' ' B' ' 43' ' ' GLN . 49.9 p-10 -166.93 -158.3 0.29 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.005 -1.059 . . . . 0.0 111.794 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.426 ' CD ' ' HA ' ' A' ' 26' ' ' ALA . 2.1 mmtp -56.02 -8.04 0.41 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.472 -0.768 . . . . 0.0 111.352 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.758 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 33.8 m -123.82 -41.95 2.21 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 120.854 -1.154 . . . . 0.0 109.885 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.522 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -61.9 -54.94 34.96 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.015 -1.053 . . . . 0.0 108.2 179.0 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.88 HD11 ' CG1' ' B' ' 42' ' ' VAL . 6.9 mt -56.38 -29.24 61.2 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.592 -0.843 . . . . 0.0 109.179 177.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.919 HG23 ' HB ' ' A' ' 21' ' ' VAL . 0.8 OUTLIER -55.94 -59.73 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.47 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.892 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 0.1 OUTLIER -60.96 -28.56 69.07 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.224 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.65 ' HB3' ' O ' ' A' ' 6' ' ' LEU . . . -59.61 -33.96 72.16 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.554 -0.858 . . . . 0.0 108.991 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.772 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.6 OUTLIER -95.44 -36.14 6.48 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.422 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 178.318 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.892 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -57.98 -23.98 56.19 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.719 -0.793 . . . . 0.0 108.89 178.175 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -93.13 -44.2 8.49 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.48 ' OD2' HG21 ' B' ' 31' ' ' ILE . 96.5 m-20 -62.46 -31.39 72.11 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 177.106 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.772 ' OG1' ' O ' ' A' ' 10' ' ' ILE . 28.2 p -83.25 -75.44 0.32 Allowed 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 177.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 59.02 18.8 42.32 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.001 -1.239 . . . . 0.0 110.001 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.975 HD22 ' O ' ' B' ' 19' ' ' VAL . 3.5 mp -87.41 -53.66 4.7 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.326 -1.102 . . . . 0.0 109.112 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.579 HG22 ' H ' ' A' ' 19' ' ' VAL . 0.5 OUTLIER -149.89 4.99 0.57 Allowed 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 120.021 -0.671 . . . . 0.0 110.596 -178.991 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.556 ' O ' ' C ' ' A' ' 19' ' ' VAL . 16.8 mt-30 56.48 26.68 11.16 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 -176.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 1.157 HG11 HG11 ' B' ' 19' ' ' VAL . 1.7 p -3.24 -94.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.9 -179.065 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.947 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -131.69 25.13 4.72 Favored 'General case' 0 C--N 1.28 -2.453 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 179.729 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.919 ' HB ' HG23 ' A' ' 7' ' ' ILE . 5.6 m -17.27 -39.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-O 122.464 1.125 . . . . 0.0 110.12 -178.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.871 ' N ' ' O ' ' A' ' 20' ' ' SER . 16.3 p -80.85 -37.27 30.25 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.038 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.947 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.5 OUTLIER -88.7 -28.83 20.3 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.442 -0.786 . . . . 0.0 111.186 179.878 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.847 ' HB3' HG23 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -76.83 -38.55 53.61 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 117.875 -1.53 . . . . 0.0 109.288 179.744 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.745 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 0.3 OUTLIER -80.21 -48.35 13.25 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 118.172 -1.411 . . . . 0.0 109.365 178.827 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 22' ' ' SER . . . -54.55 -34.33 61.66 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 119.054 -1.058 . . . . 0.0 108.217 178.202 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.615 ' O ' ' N ' ' A' ' 31' ' ' ILE . 25.1 p -87.21 -31.02 20.55 Favored 'General case' 0 C--O 1.203 -1.364 0 C-N-CA 119.696 -0.802 . . . . 0.0 109.381 178.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.769 ' HB2' HD11 ' B' ' 10' ' ' ILE . 0.1 OUTLIER -56.57 -38.23 71.67 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.2 -0.938 . . . . 0.0 108.927 179.079 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.634 ' HB3' HG21 ' B' ' 45' ' ' THR . 1.0 OUTLIER -82.15 -33.93 29.35 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 178.146 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.987 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 20.1 tttt -68.45 -21.47 64.64 Favored 'General case' 0 C--O 1.189 -2.097 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 176.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 1.07 HD13 ' HB1' ' B' ' 9' ' ' ALA . 1.3 pp -102.31 -30.49 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.878 -1.139 . . . . 0.0 109.448 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.719 HG21 ' CZ ' ' B' ' 47' ' ' PHE . 2.1 mm -65.87 -56.4 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 177.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.707 HG23 ' HB2' ' B' ' 88' ' ' ALA . 0.4 OUTLIER -64.95 -49.43 70.37 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 178.559 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.987 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 15.4 mm-40 -62.52 -32.04 72.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.46 -0.775 . . . . 0.0 111.044 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.83 HG23 ' CB ' ' A' ' 40' ' ' ASP . 1.2 m -56.25 -53.11 61.09 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 178.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.069 HG21 HD12 ' B' ' 85' ' ' LEU . 13.4 t -54.89 -34.38 30.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 C-N-CA 117.91 -1.516 . . . . 0.0 106.975 177.173 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.727 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -79.29 -3.58 46.7 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -108.53 -18.51 13.71 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.34 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 35' ' ' THR . . . 95.77 43.85 3.26 Favored Glycine 0 C--N 1.303 -1.266 0 C-N-CA 120.209 -0.996 . . . . 0.0 110.657 178.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.83 ' CB ' HG23 ' A' ' 35' ' ' THR . 0.2 OUTLIER -125.71 127.05 45.62 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.125 -1.22 . . . . 0.0 110.222 179.236 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.1 mtmt -77.64 87.66 3.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.566 -0.708 . . . . 0.0 110.065 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 1.129 HG13 HD11 ' B' ' 6' ' ' LEU . 93.0 t -60.04 123.29 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.571 -0.706 . . . . 0.0 110.238 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -121.86 94.8 4.42 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.517 -0.739 . . . . 0.0 109.357 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.702 HD12 ' CB ' ' A' ' 48' ' ' LEU . 12.1 mt -72.52 104.28 3.79 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.336 -0.852 . . . . 0.0 110.411 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.499 HG21 ' HG3' ' B' ' 29' ' ' GLU . 0.1 OUTLIER 31.24 -90.28 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 O-C-N 122.108 -0.37 . . . . 0.0 111.508 179.504 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -148.74 19.67 1.28 Allowed Glycine 0 N--CA 1.486 2.022 0 C-N-CA 119.746 -1.216 . . . . 0.0 110.272 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.704 ' CD1' ' HG3' ' B' ' 29' ' ' GLU . 6.1 p90 -120.7 -22.03 6.47 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.879 -1.365 . . . . 0.0 111.853 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.702 ' CB ' HD12 ' A' ' 44' ' ' LEU . 4.6 mt -129.08 102.71 6.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.229 -1.545 . . . . 0.0 110.632 177.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.77 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 1.3 m120 -99.67 89.71 4.22 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.853 -0.53 . . . . 0.0 111.696 -178.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.63 ' HA ' ' HA ' ' A' ' 79' ' ' VAL . 0.9 OUTLIER -90.19 148.17 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.242 0 O-C-N 121.39 -0.818 . . . . 0.0 110.777 179.376 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.407 ' CE ' ' HB3' ' A' ' 78' ' ' SER . 0.2 OUTLIER -164.64 110.22 0.86 Allowed Pre-proline 0 N--CA 1.504 2.262 0 O-C-N 120.881 -1.137 . . . . 0.0 111.367 179.265 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.94 ' HB3' HG13 ' A' ' 36' ' ' VAL . 55.8 Cg_endo -78.53 141.43 17.66 Favored 'Trans proline' 0 N--CA 1.489 1.253 0 O-C-N 123.635 1.334 . . . . 0.0 112.264 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.702 ' O ' ' N ' ' A' ' 76' ' ' GLY . 33.9 m -151.39 115.66 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 CA-C-O 121.355 0.597 . . . . 0.0 110.38 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.559 ' HB2' ' HB3' ' B' ' 97' ' ' PHE . . . -37.09 133.35 0.64 Allowed 'General case' 0 N--CA 1.504 2.255 0 CA-C-O 121.599 0.714 . . . . 0.0 112.513 -178.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.56 ' O ' ' O ' ' A' ' 74' ' ' SER . 13.0 ttp85 -174.15 107.41 0.12 Allowed 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.482 ' O ' ' O ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -55.53 -158.21 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.144 -0.972 . . . . 0.0 111.569 -178.399 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 1.01 ' HB3' ' HB3' ' A' ' 72' ' ' ALA 0.262 . . -158.36 146.34 18.38 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.139 -0.976 . . . . 0.0 110.587 -177.41 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.927 ' HB2' ' C ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -179.45 169.58 1.4 Allowed 'General case' 0 N--CA 1.483 1.223 0 O-C-N 120.587 -1.32 . . . . 0.0 111.534 179.166 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.432 ' H ' ' HA ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -169.1 24.76 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.858 -179.781 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.582 ' O ' ' O ' ' A' ' 61' ' ' PHE . . . 47.52 -164.47 0.19 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.861 ' HB2' ' C ' ' A' ' 67' ' ' GLU . 1.1 t80 -57.67 -139.19 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.424 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 178.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.484 ' CB ' ' CD ' ' A' ' 63' ' ' PRO . 0.8 OUTLIER 177.54 -62.56 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 120.75 -1.219 . . . . 0.0 112.048 178.1 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.615 ' HD2' ' CD1' ' A' ' 61' ' ' PHE . 46.7 Cg_endo -70.91 7.25 1.38 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.207 1.109 . . . . 0.0 112.628 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.467 ' HB2' ' CE2' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -156.38 90.22 1.17 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.493 -1.379 . . . . 0.0 111.088 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.517 ' O ' ' O ' ' A' ' 66' ' ' GLN . 25.6 p 50.37 11.37 0.07 Allowed 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.732 -0.605 . . . . 0.0 112.011 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.62 ' O ' ' HB3' ' A' ' 67' ' ' GLU . 10.2 mp0 54.41 131.64 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.286 -0.884 . . . . 0.0 111.745 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.861 ' C ' ' HB2' ' A' ' 61' ' ' PHE . 0.0 OUTLIER 139.07 76.42 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.22 0 C-N-CA 124.473 1.109 . . . . 0.0 110.317 179.843 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.757 ' HB3' ' CG ' ' A' ' 61' ' ' PHE . . . -176.06 18.37 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.731 -1.23 . . . . 0.0 112.178 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.556 HD23 ' O ' ' A' ' 68' ' ' ALA . 0.5 OUTLIER 166.31 101.8 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 179.283 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.927 ' C ' ' HB2' ' A' ' 58' ' ' ARG . 1.5 pt-20 -135.81 56.07 1.84 Allowed 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.236 -0.986 . . . . 0.0 111.351 -177.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.939 HD12 ' H ' ' A' ' 72' ' ' ALA . 0.3 OUTLIER -162.47 151.39 3.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-O 122.515 1.15 . . . . 0.0 110.318 177.839 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 1.01 ' HB3' ' HB3' ' A' ' 57' ' ' ALA . . . -176.61 143.85 0.61 Allowed Pre-proline 0 C--N 1.288 -2.094 0 CA-C-N 114.944 -1.026 . . . . 0.0 108.706 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 72' ' ' ALA . 55.2 Cg_endo -96.51 125.16 0.27 Allowed 'Trans proline' 0 C--N 1.299 -2.059 0 C-N-CA 121.55 1.5 . . . . 0.0 110.726 -179.031 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.56 ' O ' ' O ' ' A' ' 55' ' ' ARG . 0.4 OUTLIER -173.55 108.27 0.15 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.937 -1.102 . . . . 0.0 110.502 179.405 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.793 ' H ' ' HB1' ' B' ' 89' ' ' ALA . 0.4 OUTLIER -49.31 177.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.269 -0.894 . . . . 0.0 110.061 179.613 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.768 ' O ' ' N ' ' A' ' 78' ' ' SER . . . -99.31 53.93 1.01 Allowed Glycine 0 N--CA 1.484 1.862 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 1.052 HG11 ' O ' ' B' ' 84' ' ' SER . 4.5 p -50.91 69.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.922 -0.752 . . . . 0.0 109.971 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.768 ' N ' ' O ' ' A' ' 76' ' ' GLY . 1.0 OUTLIER -70.39 175.78 4.47 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 118.815 -1.154 . . . . 0.0 109.329 -179.771 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.77 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 0.7 OUTLIER 176.46 175.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 179.644 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.65 ' O ' HD23 ' A' ' 48' ' ' LEU . 0.4 OUTLIER -176.1 174.5 0.76 Allowed Pre-proline 0 C--N 1.299 -1.622 0 O-C-N 121.159 -0.963 . . . . 0.0 109.865 178.521 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.819 ' HB2' HG11 ' B' ' 77' ' ' VAL . 54.2 Cg_endo -88.11 169.56 6.25 Favored 'Trans proline' 0 C--N 1.293 -2.368 0 O-C-N 124.529 1.805 . . . . 0.0 108.255 176.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.613 ' CA ' ' HA ' ' A' ' 47' ' ' PHE . . . -150.15 133.64 4.46 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 107.307 -2.317 . . . . 0.0 107.307 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.879 ' O ' ' N ' ' A' ' 85' ' ' LEU . 8.6 tt0 51.09 32.63 7.99 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.142 -1.211 . . . . 0.0 107.901 -177.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.904 ' C ' HD22 ' A' ' 85' ' ' LEU . 1.6 t 8.94 45.83 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 122.45 1.119 . . . . 0.0 110.204 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 1.015 HD12 ' OG1' ' B' ' 33' ' ' THR . 0.0 OUTLIER 19.2 27.6 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 104.026 -2.583 . . . . 0.0 104.026 -171.353 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.582 ' HB2' ' CB ' ' A' ' 84' ' ' SER 0.339 7.9 tttt -66.16 -45.71 79.96 Favored 'General case' 0 CA--C 1.475 -1.914 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 178.497 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.03 -34.42 76.19 Favored 'General case' 0 C--N 1.281 -2.403 0 CA-C-N 112.445 -2.161 . . . . 0.0 106.118 177.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 1.07 ' C ' ' HB1' ' B' ' 37' ' ' ALA . . . -81.59 -30.02 33.12 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 117.764 -1.574 . . . . 0.0 107.585 178.065 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.696 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . -73.25 -27.66 61.7 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.497 ' N ' ' O ' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -67.07 -30.02 69.96 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 174.468 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -56.99 -50.05 66.98 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 177.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.873 ' O ' HD12 ' A' ' 92' ' ' LEU . 0.6 OUTLIER -80.52 17.72 1.05 Allowed 'General case' 0 N--CA 1.502 2.154 0 O-C-N 120.62 -1.518 . . . . 0.0 110.506 179.317 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.477 ' CB ' ' O ' ' A' ' 92' ' ' LEU . 0.0 OUTLIER 71.72 67.09 0.15 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.305 -0.872 . . . . 0.0 109.387 -179.393 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.544 ' CD2' ' HA ' ' B' ' 74' ' ' SER . 0.0 OUTLIER -45.64 -36.26 4.68 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.706 -0.621 . . . . 0.0 109.923 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.421 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 8.1 pt-20 -62.2 -41.11 98.06 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.47 -0.769 . . . . 0.0 109.764 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.402 ' HB2' ' HB3' ' A' ' 93' ' ' LYS . 4.4 m-20 -57.69 -34.41 69.4 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.673 ' HD2' HD11 ' A' ' 92' ' ' LEU . 0.1 OUTLIER -72.48 -25.72 61.53 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.971 -0.692 . . . . 0.0 109.196 178.785 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.594 ' HB2' ' HB1' ' B' ' 54' ' ' ALA . . . -72.19 -29.22 63.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.682 -0.636 . . . . 0.0 110.107 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 6.4 mttm . . . . . 0 N--CA 1.494 1.758 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.157 -179.988 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.55 ' HA ' ' CB ' ' B' ' 5' ' ' GLU . 11.6 mtp . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 120.879 0.371 . . . . 0.0 110.169 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -174.83 -166.71 0.25 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.086 -1.009 . . . . 0.0 111.303 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.459 ' CE ' ' HB2' ' B' ' 29' ' ' GLU . 0.0 OUTLIER -52.04 -11.48 0.17 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.408 -0.807 . . . . 0.0 111.471 -179.267 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.564 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 59.6 m -115.59 -44.01 2.99 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.93 -1.106 . . . . 0.0 109.376 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.583 ' HA ' ' HE2' ' B' ' 8' ' ' LYS . 0.0 OUTLIER -62.07 -51.47 67.8 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.893 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 1.129 HD11 HG13 ' A' ' 42' ' ' VAL . 6.2 mt -62.99 -30.76 71.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.374 -0.829 . . . . 0.0 108.869 178.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 7' ' ' ILE . . . . . 0.821 HG23 ' HB ' ' B' ' 21' ' ' VAL . 0.6 OUTLIER -53.17 -54.38 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.369 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 8' ' ' LYS . . . . . 0.906 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 14.1 mtmt -59.44 -36.5 76.04 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.714 -0.846 . . . . 0.0 108.714 178.199 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 9' ' ' ALA . . . . . 1.07 ' HB1' HD13 ' A' ' 31' ' ' ILE . . . -52.71 -34.63 53.19 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.819 -0.753 . . . . 0.0 109.243 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.847 HG23 ' HB3' ' A' ' 24' ' ' MET . 1.2 mp -97.15 -35.74 5.66 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.425 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.906 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -60.09 -25.91 65.78 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.71 -0.796 . . . . 0.0 108.878 178.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.441 ' CG ' ' N ' ' B' ' 13' ' ' ASP . 16.6 pt20 -92.77 -41.2 10.25 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.448 ' OD2' HG21 ' A' ' 31' ' ' ILE . 1.3 m-20 -65.13 -22.49 66.94 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 176.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.846 ' OG1' ' O ' ' B' ' 10' ' ' ILE . 24.5 p -96.33 -78.38 0.47 Allowed 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.033 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 61.87 12.42 35.47 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 16' ' ' LEU . . . . . 0.883 HD22 ' O ' ' A' ' 19' ' ' VAL . 3.7 mp -78.19 -54.57 6.1 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.433 -1.039 . . . . 0.0 108.652 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 17' ' ' THR . . . . . 0.586 HG22 ' H ' ' B' ' 19' ' ' VAL . 0.5 OUTLIER -151.01 6.21 0.5 Allowed 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.3 -179.13 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 18' ' ' GLN . . . . . 0.555 ' O ' ' C ' ' B' ' 19' ' ' VAL . 16.4 mt-30 56.92 25.8 10.97 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 -176.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 1.157 HG11 HG11 ' A' ' 19' ' ' VAL . 2.3 p -0.28 -94.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.118 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.94 ' O ' ' N ' ' B' ' 23' ' ' LYS . 0.0 OUTLIER -130.17 24.12 5.23 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.821 ' HB ' HG23 ' B' ' 7' ' ' ILE . 15.5 m -22.7 -40.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-O 122.446 1.117 . . . . 0.0 109.259 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.76 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.3 OUTLIER -76.32 -36.57 58.22 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.092 178.167 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 23' ' ' LYS . . . . . 0.94 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.0 OUTLIER -95.1 -28.29 15.15 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 118.786 -1.166 . . . . 0.0 111.13 179.125 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 24' ' ' MET . . . . . 0.755 ' N ' ' OG ' ' B' ' 20' ' ' SER . 0.0 OUTLIER -70.41 -35.14 73.25 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 116.761 -1.976 . . . . 0.0 108.241 179.123 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.666 HD12 HG13 ' B' ' 7' ' ' ILE . 0.3 OUTLIER -83.12 -41.75 18.17 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 118.2 -1.4 . . . . 0.0 109.24 178.315 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 26' ' ' ALA . . . . . 0.408 ' CB ' ' O ' ' B' ' 22' ' ' SER . . . -64.3 -34.88 79.16 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 177.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 27' ' ' SER . . . . . 0.599 ' CB ' ' O ' ' B' ' 23' ' ' LYS . 7.3 t -84.7 -28.24 26.48 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 119.447 -0.901 . . . . 0.0 108.575 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 28' ' ' PHE . . . . . 0.722 ' HB2' HD11 ' A' ' 10' ' ' ILE . 0.7 OUTLIER -51.05 -44.44 61.11 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.996 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 29' ' ' GLU . . . . . 0.745 ' O ' ' HB ' ' B' ' 33' ' ' THR . 1.4 tt0 -70.79 -38.63 73.39 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 176.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 1.251 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 6.9 ttpt -60.96 -19.9 61.55 Favored 'General case' 0 C--O 1.192 -1.931 0 C-N-CA 119.302 -0.959 . . . . 0.0 108.636 178.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.637 HG13 ' O ' ' B' ' 28' ' ' PHE . 0.8 OUTLIER -108.48 -28.67 2.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 120.111 -1.618 . . . . 0.0 109.366 178.276 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.624 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.2 mm -73.53 -59.78 3.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 176.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 33' ' ' THR . . . . . 1.015 ' OG1' HD12 ' A' ' 85' ' ' LEU . 0.9 OUTLIER -66.67 -38.98 87.94 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 114.748 -1.114 . . . . 0.0 108.658 179.159 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 1.251 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 75.6 mm-40 -77.52 -39.54 45.82 Favored 'General case' 0 C--O 1.205 -1.262 0 O-C-N 121.029 -1.044 . . . . 0.0 112.788 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 35' ' ' THR . . . . . 0.759 HG21 ' SD ' ' A' ' 1' ' ' MET . 98.1 m -63.13 -51.19 67.48 Favored 'General case' 0 N--CA 1.504 2.268 0 CA-C-N 121.206 1.821 . . . . 0.0 110.13 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.927 ' CG2' HG22 ' B' ' 50' ' ' ILE . 0.9 OUTLIER -53.97 -41.46 49.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 178.042 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 1.07 ' HB1' ' C ' ' A' ' 88' ' ' ALA . . . -86.38 3.14 44.91 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.291 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 38' ' ' LYS . . . . . 0.761 ' HB2' ' O ' ' B' ' 34' ' ' GLU . 0.0 OUTLIER -102.71 -36.33 8.34 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.468 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 141.16 33.2 0.13 Allowed Glycine 0 C--N 1.302 -1.36 0 C-N-CA 119.056 -1.545 . . . . 0.0 111.56 178.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 40' ' ' ASP . . . . . 0.459 ' HB3' ' CG2' ' B' ' 35' ' ' THR . 0.2 OUTLIER -146.93 158.87 44.04 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.79 -1.418 . . . . 0.0 110.605 179.271 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 33.3 mtpt -101.34 91.46 4.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.455 -0.778 . . . . 0.0 110.007 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.88 ' CG1' HD11 ' A' ' 6' ' ' LEU . 91.5 t -70.78 148.97 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.471 -0.768 . . . . 0.0 110.471 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 43' ' ' GLN . . . . . 0.625 ' O ' HD23 ' B' ' 44' ' ' LEU . 20.5 mt-30 -146.73 165.41 29.72 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.13 -0.981 . . . . 0.0 110.39 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.739 HD22 ' HE2' ' A' ' 28' ' ' PHE . 19.0 mt -122.81 117.42 25.61 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.388 -0.82 . . . . 0.0 109.58 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 45' ' ' THR . . . . . 0.634 HG21 ' HB3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 29.04 -92.47 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.809 -0.557 . . . . 0.0 111.136 179.817 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -148.61 23.11 1.34 Allowed Glycine 0 N--CA 1.485 1.966 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 47' ' ' PHE . . . . . 0.719 ' CZ ' HG21 ' A' ' 32' ' ' ILE . 0.9 OUTLIER -116.57 -32.83 5.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.135 -1.215 . . . . 0.0 111.252 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.595 ' CB ' HD12 ' B' ' 44' ' ' LEU . 0.1 OUTLIER -118.24 162.85 17.58 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.692 -1.255 . . . . 0.0 112.768 179.856 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 49' ' ' ASN . . . . . 0.74 ' O ' HD13 ' B' ' 50' ' ' ILE . 0.2 OUTLIER -142.1 142.22 32.78 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 178.971 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 50' ' ' ILE . . . . . 0.927 HG22 ' CG2' ' B' ' 36' ' ' VAL . 33.6 mm -138.06 101.91 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.227 -0.921 . . . . 0.0 110.431 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 51' ' ' LYS . . . . . 0.675 ' HA ' HG22 ' B' ' 36' ' ' VAL . 0.0 OUTLIER -157.43 133.5 6.07 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.065 -1.022 . . . . 0.0 109.064 -179.798 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.76 ' CG ' HG13 ' B' ' 36' ' ' VAL . 57.9 Cg_endo -93.96 159.61 2.21 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.153 1.081 . . . . 0.0 112.009 -178.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 1.007 HG22 ' O ' ' B' ' 76' ' ' GLY . 28.0 m -137.95 116.83 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-O 121.935 0.874 . . . . 0.0 110.441 177.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.594 ' HB1' ' HB2' ' A' ' 98' ' ' ALA . . . -46.55 112.6 0.52 Allowed 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.55 0.69 . . . . 0.0 111.991 -178.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 2.3 ttp180 -137.54 157.66 46.05 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 56' ' ' GLN . . . . . 0.487 ' HA ' ' HA ' ' B' ' 73' ' ' PRO . 44.9 mt-30 -87.07 -157.57 0.39 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.906 -1.121 . . . . 0.0 110.285 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.808 ' HB3' ' O ' ' B' ' 72' ' ' ALA . . . -176.46 145.82 0.59 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.164 -0.96 . . . . 0.0 111.226 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 58' ' ' ARG . . . . . 0.535 ' CB ' ' O ' ' B' ' 70' ' ' GLU . 0.7 OUTLIER 170.73 139.64 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.531 0.682 . . . . 0.0 110.858 178.744 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 59' ' ' LYS . . . . . 0.742 ' N ' ' HB2' ' B' ' 70' ' ' GLU . 0.0 OUTLIER -140.64 88.08 2.17 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.679 -0.638 . . . . 0.0 110.672 -179.852 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 60' ' ' GLY . . . . . 0.584 ' N ' ' HB3' ' B' ' 70' ' ' GLU . . . 140.42 70.17 0.04 OUTLIER Glycine 0 N--CA 1.498 2.771 0 C-N-CA 119.609 -1.281 . . . . 0.0 111.014 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 61' ' ' PHE . . . . . 0.826 ' CE1' ' HB2' ' B' ' 66' ' ' GLN . 39.6 p90 -69.22 -159.15 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.348 0 O-C-N 121.563 -0.963 . . . . 0.0 111.202 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 62' ' ' ASN . . . . . 0.892 ' HB3' ' HB2' ' B' ' 68' ' ' ALA . 0.3 OUTLIER -134.57 -58.7 0.02 OUTLIER Pre-proline 0 N--CA 1.504 2.241 0 O-C-N 121.539 -0.726 . . . . 0.0 111.816 179.238 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.792 ' HD2' ' H ' ' B' ' 62' ' ' ASN . 37.9 Cg_endo -62.78 70.5 0.13 Allowed 'Trans proline' 0 N--CA 1.492 1.422 0 O-C-N 123.613 1.323 . . . . 0.0 111.548 -178.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 64' ' ' GLN . . . . . 0.724 ' CB ' ' CE1' ' B' ' 61' ' ' PHE . 0.0 OUTLIER 169.94 61.08 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.199 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.555 HG22 ' O ' ' B' ' 64' ' ' GLN . 9.0 t 42.08 53.39 4.29 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.536 0.684 . . . . 0.0 110.705 -178.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 66' ' ' GLN . . . . . 0.826 ' HB2' ' CE1' ' B' ' 61' ' ' PHE . 1.1 tp60 -148.48 -146.41 0.2 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.441 -0.787 . . . . 0.0 110.467 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 67' ' ' GLU . . . . . 0.764 ' HG3' HD11 ' B' ' 69' ' ' LEU . 11.5 pt-20 -152.43 116.91 5.0 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 68' ' ' ALA . . . . . 0.892 ' HB2' ' HB3' ' B' ' 62' ' ' ASN . . . -73.24 119.41 17.43 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 122.479 1.133 . . . . 0.0 111.792 -176.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.764 HD11 ' HG3' ' B' ' 67' ' ' GLU . 0.0 OUTLIER -168.79 46.56 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 -179.699 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 70' ' ' GLU . . . . . 0.742 ' HB2' ' N ' ' B' ' 59' ' ' LYS . 1.1 pt-20 -125.02 107.87 11.26 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.954 -176.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 1.047 HD12 ' N ' ' B' ' 72' ' ' ALA . 0.1 OUTLIER -163.22 153.04 3.01 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 O-C-N 120.854 -1.154 . . . . 0.0 110.469 179.601 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 72' ' ' ALA . . . . . 1.047 ' N ' HD12 ' B' ' 71' ' ' ILE . . . 160.95 58.14 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.523 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.89 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 73' ' ' PRO . . . . . 0.555 ' CD ' HD12 ' B' ' 71' ' ' ILE . 38.0 Cg_endo -62.57 122.69 11.15 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.06 1.032 . . . . 0.0 111.387 -178.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 74' ' ' SER . . . . . 0.544 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 2.3 m -148.28 159.01 44.42 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 75' ' ' VAL . . . . . 0.599 HG11 ' CB ' ' A' ' 89' ' ' ALA . 0.5 OUTLIER -53.48 171.9 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 120.877 -1.139 . . . . 0.0 109.829 -179.631 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 76' ' ' GLY . . . . . 1.007 ' O ' HG22 ' B' ' 53' ' ' VAL . . . -129.67 107.28 0.78 Allowed Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.819 HG11 ' HB2' ' A' ' 81' ' ' PRO . 8.6 p -58.41 86.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.194 -1.18 . . . . 0.0 108.875 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 78' ' ' SER . . . . . 0.547 ' OG ' HG11 ' B' ' 53' ' ' VAL . 0.5 OUTLIER -58.16 -47.32 83.74 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 -178.258 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.91 HG21 ' HA ' ' B' ' 50' ' ' ILE . 17.7 m -48.08 178.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 -173.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 80' ' ' LYS . . . . . 0.811 ' HB2' ' HD2' ' B' ' 81' ' ' PRO . 0.0 OUTLIER 179.4 -179.7 0.24 Allowed Pre-proline 0 C--N 1.308 -1.228 0 CA-C-N 113.64 -1.618 . . . . 0.0 107.162 -177.391 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 81' ' ' PRO . . . . . 0.811 ' HD2' ' HB2' ' B' ' 80' ' ' LYS . 39.2 Cg_endo -63.64 153.16 76.82 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 122.989 0.994 . . . . 0.0 111.691 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 82' ' ' GLY . . . . . 0.521 ' C ' ' H ' ' B' ' 84' ' ' SER . . . -117.16 -79.53 0.73 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 107.351 -2.3 . . . . 0.0 107.351 178.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 83' ' ' GLU . . . . . 0.918 ' O ' ' N ' ' B' ' 85' ' ' LEU . 16.9 tt0 -75.71 41.32 0.2 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.523 -0.986 . . . . 0.0 108.707 177.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 84' ' ' SER . . . . . 1.052 ' O ' HG11 ' A' ' 77' ' ' VAL . 0.3 OUTLIER 7.8 44.72 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 122.741 1.258 . . . . 0.0 110.453 178.209 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 1.069 HD12 HG21 ' A' ' 36' ' ' VAL . 0.2 OUTLIER 19.08 28.61 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 104.08 -2.563 . . . . 0.0 104.08 -171.577 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 86' ' ' LYS . . . . . 0.475 ' HB2' ' CB ' ' B' ' 84' ' ' SER 0.355 2.7 tttt -58.05 -41.8 84.08 Favored 'General case' 0 CA--C 1.482 -1.658 0 N-CA-C 103.794 -2.669 . . . . 0.0 103.794 176.765 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 87' ' ' LYS . . . . . 0.407 ' O ' ' HG2' ' B' ' 90' ' ' GLU 0.264 0.0 OUTLIER -66.05 -35.92 81.83 Favored 'General case' 0 C--N 1.285 -2.228 0 CA-C-N 111.588 -2.551 . . . . 0.0 105.532 176.236 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.707 ' HB2' HG23 ' A' ' 33' ' ' THR . . . -74.52 -27.3 60.48 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 118.54 -1.264 . . . . 0.0 108.409 178.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.793 ' HB1' ' H ' ' A' ' 75' ' ' VAL . . . -62.01 -50.0 73.81 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.114 -0.991 . . . . 0.0 109.264 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.445 ' HG2' ' N ' ' B' ' 91' ' ' GLY . 2.7 pt-20 -57.62 -26.69 61.93 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 176.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 91' ' ' GLY . . . . . 0.445 ' N ' ' HG2' ' B' ' 90' ' ' GLU . . . -65.66 -37.53 93.64 Favored Glycine 0 N--CA 1.487 2.055 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.286 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 92' ' ' LEU . . . . . 0.749 HD23 ' HA ' ' B' ' 89' ' ' ALA . 1.1 pp -85.4 22.11 1.6 Allowed 'General case' 0 N--CA 1.504 2.258 0 CA-C-N 119.931 1.865 . . . . 0.0 111.239 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 93' ' ' LYS . . . . . 0.447 ' O ' ' N ' ' B' ' 96' ' ' ASP . 4.0 mmtt 53.65 39.02 29.63 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 -177.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 94' ' ' TYR . . . . . 0.583 ' HA ' HD11 ' B' ' 92' ' ' LEU . 0.0 OUTLIER -36.16 -36.81 0.1 Allowed 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.943 -178.643 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 95' ' ' GLU . . . . . 0.51 ' N ' ' CD1' ' B' ' 94' ' ' TYR . 7.0 pt-20 -60.01 -42.3 94.01 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.332 -0.855 . . . . 0.0 109.609 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 96' ' ' ASP . . . . . 0.447 ' N ' ' O ' ' B' ' 93' ' ' LYS . 0.3 OUTLIER -61.09 -35.08 76.02 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.085 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 97' ' ' PHE . . . . . 0.559 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 0.1 OUTLIER -74.44 -26.27 59.95 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.635 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.83 -63.72 1.07 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.585 -0.697 . . . . 0.0 110.229 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.174 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.505 ' CE ' HD23 ' A' ' 6' ' ' LEU . 6.3 mtp . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 120.837 0.351 . . . . 0.0 110.069 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.689 ' C ' HD12 ' A' ' 6' ' ' LEU . 1.6 t-20 -176.93 -165.31 0.12 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.946 -1.096 . . . . 0.0 111.626 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.552 ' CD ' ' HB ' ' B' ' 45' ' ' THR . 0.4 OUTLIER -51.07 -12.93 0.13 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.511 -0.743 . . . . 0.0 110.802 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.644 ' O ' HG13 ' A' ' 7' ' ' ILE . 74.8 m -112.61 -60.6 1.85 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.172 -0.955 . . . . 0.0 109.938 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.545 ' HA ' ' CE ' ' A' ' 8' ' ' LYS . 4.6 mt-10 -50.17 -41.6 49.61 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.98 -1.075 . . . . 0.0 108.879 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.689 HD12 ' C ' ' A' ' 2' ' ' ASN . 10.1 mt -60.62 -34.51 74.36 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.303 -0.959 . . . . 0.0 109.772 177.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.644 HG13 ' O ' ' A' ' 4' ' ' THR . 1.0 OUTLIER -57.59 -39.74 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 179.089 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.818 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 1.0 OUTLIER -66.97 -36.66 82.69 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.397 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.691 ' HB1' HD13 ' B' ' 31' ' ' ILE . . . -52.39 -39.0 60.33 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 120.214 -0.594 . . . . 0.0 109.447 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.708 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.3 mp -93.93 -29.99 4.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.818 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -63.92 -15.15 58.43 Favored 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 118.496 -1.282 . . . . 0.0 108.858 178.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -115.16 -42.78 3.14 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.405 -0.81 . . . . 0.0 109.352 178.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 9' ' ' ALA . 1.0 OUTLIER -67.12 -26.15 66.54 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 177.071 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . 1.104 HG22 ' CD1' ' A' ' 16' ' ' LEU 0.257 0.2 OUTLIER -112.54 -82.8 0.59 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 178.891 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 16' ' ' LEU . . . 71.15 -11.17 2.89 Favored Glycine 0 N--CA 1.501 2.967 0 O-C-N 121.0 -1.063 . . . . 0.0 111.739 177.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.104 ' CD1' HG22 ' A' ' 14' ' ' THR . 4.4 mp -35.73 -64.11 0.32 Allowed 'General case' 0 N--CA 1.511 2.59 0 O-C-N 121.518 -0.989 . . . . 0.0 110.532 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.571 HG22 ' H ' ' A' ' 19' ' ' VAL . 0.5 OUTLIER -135.22 3.64 3.14 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.167 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.613 ' O ' ' C ' ' A' ' 19' ' ' VAL . 28.2 mt-30 56.44 29.04 14.57 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 -176.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 1.007 HG11 HG11 ' B' ' 19' ' ' VAL . 1.5 p -9.68 -94.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.904 -178.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.968 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -133.9 25.13 3.97 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 177.627 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.703 HG12 HG22 ' A' ' 10' ' ' ILE . 27.0 m -19.17 -39.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 122.474 1.13 . . . . 0.0 109.347 -178.186 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.852 ' N ' ' O ' ' A' ' 20' ' ' SER . 3.1 m -81.5 -38.7 25.89 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.661 177.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.968 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.1 OUTLIER -86.45 -35.79 19.45 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.547 -0.72 . . . . 0.0 111.186 179.492 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.578 ' HB3' HG21 ' B' ' 14' ' ' THR . 0.0 OUTLIER -68.17 -38.21 81.81 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 117.567 -1.653 . . . . 0.0 108.15 178.99 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.645 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 8.4 mt -72.42 -47.27 50.49 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 118.404 -1.319 . . . . 0.0 107.832 176.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.507 ' HA ' ' HE2' ' A' ' 3' ' ' LYS . . . -55.31 -34.0 63.78 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 177.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.634 ' HA ' ' HB3' ' A' ' 30' ' ' LYS . 54.9 p -83.16 -32.25 26.72 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.833 ' O ' HG13 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -56.57 -47.13 80.17 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.013 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.684 ' O ' ' HB ' ' A' ' 33' ' ' THR . 0.3 OUTLIER -71.02 -35.68 72.11 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 177.733 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.873 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 70.9 tttt -65.04 -21.44 66.83 Favored 'General case' 0 C--O 1.192 -1.962 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.833 HG13 ' O ' ' A' ' 28' ' ' PHE . 1.3 pp -105.06 -29.48 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.761 -1.212 . . . . 0.0 109.062 178.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.616 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.2 mm -71.43 -49.34 47.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 176.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.684 ' HB ' ' O ' ' A' ' 29' ' ' GLU . 0.3 OUTLIER -69.07 -43.37 74.71 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 177.968 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.873 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 57.7 mm-40 -68.31 -41.62 80.59 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 121.616 -0.677 . . . . 0.0 110.905 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.612 HG21 HG23 ' A' ' 42' ' ' VAL . 3.8 m -52.58 -50.37 63.14 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.588 -1.32 . . . . 0.0 108.537 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.932 HG21 HG23 ' A' ' 77' ' ' VAL . 1.1 t -54.01 -36.89 32.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 177.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.678 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -81.33 -6.24 58.68 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.537 0.684 . . . . 0.0 109.7 178.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.606 ' HG2' ' O ' ' A' ' 34' ' ' GLU . 2.4 mmpt? -97.58 -25.05 15.27 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 177.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.79 41.07 1.76 Allowed Glycine 0 C--N 1.303 -1.295 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 178.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.562 ' CB ' HG23 ' A' ' 35' ' ' THR . 0.2 OUTLIER -136.76 147.64 46.8 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.176 -1.191 . . . . 0.0 110.593 179.707 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.5 mtmt -100.51 102.94 14.25 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 1.12 HG13 HD11 ' B' ' 6' ' ' LEU . 2.0 t -74.77 152.42 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 C-N-CA 119.622 -0.831 . . . . 0.0 110.019 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.464 ' HA ' ' O ' ' A' ' 48' ' ' LEU . 17.7 mt-30 -140.26 94.16 2.71 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.403 -0.81 . . . . 0.0 110.221 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.642 HD12 ' CE1' ' A' ' 47' ' ' PHE . 22.1 mt -58.84 112.77 1.77 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.954 -1.091 . . . . 0.0 109.078 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.572 HG22 ' HG2' ' B' ' 29' ' ' GLU . 0.1 OUTLIER 35.99 -88.48 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.869 -0.519 . . . . 0.0 110.606 -179.157 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -149.52 29.12 1.19 Allowed Glycine 0 N--CA 1.484 1.898 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.77 ' CE1' HG21 ' B' ' 32' ' ' ILE . 3.9 p90 -128.03 -28.64 2.62 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.991 -1.3 . . . . 0.0 112.717 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.796 HD11 HD11 ' B' ' 50' ' ' ILE . 0.6 OUTLIER -123.78 100.84 6.97 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.36 -1.462 . . . . 0.0 111.297 179.28 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.431 ' HA ' ' HA ' ' A' ' 43' ' ' GLN . 44.6 t-20 -109.45 87.35 2.48 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.863 -0.523 . . . . 0.0 110.623 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.803 HG22 ' CG2' ' A' ' 79' ' ' VAL . 1.1 pt -79.39 147.62 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.159 -0.963 . . . . 0.0 110.505 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.422 ' HG3' ' HB3' ' A' ' 78' ' ' SER . 8.4 ptmt -157.15 122.71 2.42 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.053 -1.029 . . . . 0.0 110.079 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.506 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 55.3 Cg_endo -80.65 140.87 13.42 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 O-C-N 123.459 1.241 . . . . 0.0 112.025 -178.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.706 ' O ' ' N ' ' A' ' 76' ' ' GLY . 31.5 m -142.21 114.75 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 121.441 0.639 . . . . 0.0 109.64 178.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 1.012 ' HB2' HG23 ' A' ' 75' ' ' VAL . . . -117.0 145.06 43.9 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -177.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.612 ' O ' ' CB ' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -162.5 7.87 0.06 Allowed 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.986 175.999 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.843 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 0.0 OUTLIER 130.72 14.55 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.436 0 C-N-CA 124.547 1.139 . . . . 0.0 110.19 176.868 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.893 ' HB1' ' O ' ' A' ' 71' ' ' ILE . . . 152.9 179.95 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 122.27 1.033 . . . . 0.0 111.624 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.708 ' HB3' HG23 ' A' ' 71' ' ' ILE 0.261 0.0 OUTLIER -91.68 -143.85 0.19 Allowed 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.438 -179.868 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.477 ' HA ' ' C ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -160.98 48.58 0.22 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.341 -0.849 . . . . 0.0 109.802 179.571 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -163.41 33.93 0.3 Allowed Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.601 -1.285 . . . . 0.0 110.978 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.824 ' CD1' ' O ' ' A' ' 61' ' ' PHE . 0.1 OUTLIER -90.33 116.88 28.63 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.816 -1.402 . . . . 0.0 112.824 -179.692 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.673 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 0.9 OUTLIER -117.67 -26.23 0.09 OUTLIER Pre-proline 0 N--CA 1.497 1.903 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 -178.75 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.611 ' CD ' ' H ' ' A' ' 62' ' ' ASN . 45.2 Cg_endo -75.38 -4.63 15.58 Favored 'Trans proline' 0 N--CA 1.485 1.008 0 N-CA-C 110.027 -0.797 . . . . 0.0 110.027 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.813 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -90.14 46.3 1.34 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.511 -0.743 . . . . 0.0 110.133 179.527 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.1 p 50.97 23.76 1.59 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.293 -0.88 . . . . 0.0 109.591 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.661 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 0.5 OUTLIER -155.21 111.05 3.12 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.648 -0.658 . . . . 0.0 109.909 -179.778 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.557 ' O ' ' CD2' ' A' ' 69' ' ' LEU . 5.6 mt-10 -29.74 152.38 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 122.335 1.064 . . . . 0.0 111.851 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.813 ' HA ' ' C ' ' A' ' 61' ' ' PHE . . . -57.88 118.69 5.61 Favored 'General case' 0 C--N 1.281 -2.395 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.118 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.599 ' H ' ' N ' ' A' ' 61' ' ' PHE . 0.4 OUTLIER 175.71 19.46 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.594 -0.692 . . . . 0.0 112.355 179.549 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.7 ' H ' ' H ' ' A' ' 61' ' ' PHE . 3.2 mt-10 162.41 85.99 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.308 0 O-C-N 121.075 -1.016 . . . . 0.0 110.598 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.893 ' O ' ' HB1' ' A' ' 57' ' ' ALA . 0.7 OUTLIER -80.14 -174.38 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.828 -1.17 . . . . 0.0 109.017 178.909 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.832 ' N ' HD12 ' A' ' 71' ' ' ILE . . . -48.09 170.74 0.1 Allowed Pre-proline 0 C--N 1.283 -2.299 0 O-C-N 121.952 -0.468 . . . . 0.0 112.178 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.769 ' HA ' ' O ' ' A' ' 56' ' ' GLN . 36.7 Cg_endo -61.96 117.3 4.13 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.878 2.385 . . . . 0.0 110.015 178.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.563 ' N ' ' CZ ' ' B' ' 94' ' ' TYR . 0.5 OUTLIER 176.37 165.6 0.44 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.339 -0.851 . . . . 0.0 109.113 -179.548 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 1.012 HG23 ' HB2' ' A' ' 54' ' ' ALA . 0.3 OUTLIER -61.58 171.78 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.058 -1.026 . . . . 0.0 109.888 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.706 ' N ' ' O ' ' A' ' 53' ' ' VAL . . . -115.37 61.2 0.38 Allowed Glycine 0 N--CA 1.484 1.873 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.95 HG21 ' CB ' ' B' ' 85' ' ' LEU . 2.3 p -43.47 83.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.998 -0.707 . . . . 0.0 110.787 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.617 ' N ' ' O ' ' A' ' 76' ' ' GLY . 1.3 t -81.68 175.97 10.02 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.985 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.803 ' CG2' HG22 ' A' ' 50' ' ' ILE . 3.3 p 176.25 176.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.606 ' N ' HG22 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -176.09 171.43 1.1 Allowed Pre-proline 0 N--CA 1.485 1.286 0 O-C-N 120.799 -1.188 . . . . 0.0 110.868 177.3 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.581 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 55.6 Cg_endo -97.03 136.51 0.44 Allowed 'Trans proline' 0 C--N 1.302 -1.878 0 C-N-CA 122.843 2.362 . . . . 0.0 110.706 178.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.657 ' O ' HD12 ' A' ' 85' ' ' LEU . . . -91.64 -158.74 34.85 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 178.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -89.33 -16.53 30.87 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.117 -1.226 . . . . 0.0 110.394 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.436 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -53.59 -33.42 54.81 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.304 -0.872 . . . . 0.0 109.975 -179.857 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.825 ' CB ' HG21 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -86.0 -30.94 22.32 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.326 -0.859 . . . . 0.0 108.77 178.966 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.439 ' HA ' ' CG1' ' B' ' 75' ' ' VAL . 0.6 OUTLIER -72.94 -33.12 65.72 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.415 -0.803 . . . . 0.0 109.838 -179.88 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -78.63 -34.92 46.22 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 1.035 ' C ' ' HB1' ' B' ' 37' ' ' ALA . . . -68.53 -31.26 70.37 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 177.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 1.051 ' N ' ' HB1' ' B' ' 37' ' ' ALA . . . -69.94 -35.73 74.74 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -178.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -59.55 -24.79 64.01 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 174.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -64.43 -54.41 29.53 Favored Glycine 0 N--CA 1.483 1.797 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 178.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.879 HD23 ' C ' ' B' ' 37' ' ' ALA . 2.1 pp -67.11 -42.19 84.96 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 119.76 1.78 . . . . 0.0 109.502 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.8 ' HB3' HD12 ' A' ' 92' ' ' LEU . 2.6 tttp 156.8 80.88 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.182 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.8 ' O ' ' N ' ' A' ' 97' ' ' PHE . 9.1 t80 -61.79 -62.85 1.51 Allowed 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 115.297 -2.561 . . . . 0.0 105.96 177.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.975 ' O ' ' N ' ' A' ' 98' ' ' ALA . 2.3 mp0 10.35 41.28 0.0 OUTLIER 'General case' 0 CA--C 1.486 -1.501 0 N-CA-C 101.561 -3.496 . . . . 0.0 101.561 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 1.045 ' O ' ' N ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER 19.39 44.52 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 113.027 -1.897 . . . . 0.0 108.103 -173.029 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.812 ' C ' ' O ' ' A' ' 96' ' ' ASP . 0.1 OUTLIER 27.16 28.8 0.0 OUTLIER 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 101.888 -3.375 . . . . 0.0 101.888 -170.495 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 1.045 ' N ' ' O ' ' A' ' 96' ' ' ASP 0.263 . . -70.01 -31.68 69.46 Favored 'General case' 0 C--O 1.215 -0.711 0 CA-C-N 110.186 -3.188 . . . . 0.0 109.614 -178.356 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.199 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.757 ' HB2' HG22 ' A' ' 42' ' ' VAL . 5.9 mtp . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 120.863 0.363 . . . . 0.0 110.133 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 2' ' ' ASN . . . . . 0.551 ' H ' ' HB2' ' B' ' 5' ' ' GLU . 2.0 t-20 -172.53 -159.42 0.13 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.055 -1.028 . . . . 0.0 111.396 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.494 ' HG2' ' OE1' ' B' ' 29' ' ' GLU . 1.4 mttt -58.36 -7.56 0.92 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.407 -0.808 . . . . 0.0 110.291 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.671 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 90.0 m -116.82 -48.3 2.67 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.042 -1.036 . . . . 0.0 110.304 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.59 ' HA ' ' HE2' ' B' ' 8' ' ' LYS . 3.0 mt-10 -61.64 -52.89 62.49 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.117 -0.989 . . . . 0.0 108.904 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 1.12 HD11 HG13 ' A' ' 42' ' ' VAL . 0.9 OUTLIER -60.23 -27.79 67.49 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.196 -1.002 . . . . 0.0 108.928 178.355 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 7' ' ' ILE . . . . . 0.808 HG23 ' HB ' ' B' ' 21' ' ' VAL . 0.4 OUTLIER -56.26 -58.01 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 178.158 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 8' ' ' LYS . . . . . 0.91 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.1 OUTLIER -55.35 -31.85 62.08 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.94 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 9' ' ' ALA . . . . . 0.768 ' HB3' ' O ' ' B' ' 6' ' ' LEU . . . -57.57 -37.22 72.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.27 -0.894 . . . . 0.0 108.958 178.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.934 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.2 mp -92.57 -25.96 4.95 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.209 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 177.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.91 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -75.99 -2.23 29.51 Favored 'General case' 0 C--N 1.287 -2.121 0 O-C-N 120.703 -1.248 . . . . 0.0 108.152 177.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.418 ' HB3' ' O ' ' B' ' 8' ' ' LYS . 55.7 tp60 -125.3 -41.62 2.04 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.531 -0.731 . . . . 0.0 109.898 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' B' ' 9' ' ' ALA . 1.0 OUTLIER -72.18 -23.78 61.32 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 177.838 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 14' ' ' THR . . . . . 1.092 HG22 ' CD1' ' B' ' 16' ' ' LEU 0.284 0.2 OUTLIER -103.8 -62.13 1.34 Allowed 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 179.609 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 52.12 24.07 14.01 Favored Glycine 0 N--CA 1.5 2.912 0 O-C-N 121.369 -0.832 . . . . 0.0 111.569 177.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 16' ' ' LEU . . . . . 1.092 ' CD1' HG22 ' B' ' 14' ' ' THR . 4.5 mp -69.76 -69.97 0.31 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.343 -1.092 . . . . 0.0 109.904 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 17' ' ' THR . . . . . 0.586 HG22 ' H ' ' B' ' 19' ' ' VAL . 0.6 OUTLIER -137.81 5.74 2.64 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.736 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 18' ' ' GLN . . . . . 0.669 ' O ' ' C ' ' B' ' 19' ' ' VAL . 33.2 mt-30 57.42 27.53 14.04 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 -176.112 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 1.007 HG11 HG11 ' A' ' 19' ' ' VAL . 1.5 p -0.41 -96.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.947 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 20' ' ' SER . . . . . 1.091 ' O ' ' N ' ' B' ' 22' ' ' SER . 14.9 p -133.53 23.08 4.01 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 175.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.808 ' HB ' HG23 ' B' ' 7' ' ' ILE . 28.1 m -3.87 -39.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-O 122.302 1.048 . . . . 0.0 110.981 -177.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 22' ' ' SER . . . . . 1.091 ' N ' ' O ' ' B' ' 20' ' ' SER . 2.4 t -73.0 -44.01 61.5 Favored 'General case' 0 C--N 1.281 -2.387 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.93 177.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 23' ' ' LYS . . . . . 0.813 ' N ' ' O ' ' B' ' 20' ' ' SER . 5.1 mtpt -88.37 -29.32 20.37 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.659 -0.651 . . . . 0.0 109.693 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 24' ' ' MET . . . . . 0.715 ' HE2' ' HA ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -62.77 -41.44 99.24 Favored 'General case' 0 C--N 1.314 -0.958 0 O-C-N 120.899 -1.126 . . . . 0.0 109.443 179.796 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.716 HD12 HG13 ' B' ' 7' ' ' ILE . 1.2 mt -84.51 -45.38 12.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.891 -1.13 . . . . 0.0 108.406 177.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 26' ' ' ALA . . . . . 0.499 ' O ' ' CB ' ' B' ' 30' ' ' LYS . . . -53.31 -34.68 58.38 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 178.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 27' ' ' SER . . . . . 0.611 ' O ' HG23 ' B' ' 31' ' ' ILE . 58.4 m -78.55 -40.28 35.34 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 177.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 28' ' ' PHE . . . . . 0.728 ' HA ' ' CG1' ' B' ' 31' ' ' ILE . 0.1 OUTLIER -63.82 -36.63 84.53 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.636 -0.665 . . . . 0.0 109.394 179.42 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 29' ' ' GLU . . . . . 0.587 ' HG3' ' CE2' ' B' ' 28' ' ' PHE . 0.9 OUTLIER -82.07 -31.97 30.57 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 178.721 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 0.82 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 16.6 tttp -72.22 -28.42 63.16 Favored 'General case' 0 C--O 1.191 -1.989 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 176.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.728 ' CG1' ' HA ' ' B' ' 28' ' ' PHE . 1.6 pp -94.67 -30.48 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.03 -1.044 . . . . 0.0 109.884 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.979 HD13 HG21 ' B' ' 42' ' ' VAL . 3.6 mm -62.91 -61.88 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 177.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 33' ' ' THR . . . . . 0.557 ' OG1' ' HG ' ' A' ' 85' ' ' LEU . 0.4 OUTLIER -58.42 -40.18 81.79 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.813 179.213 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.84 ' O ' ' N ' ' B' ' 38' ' ' LYS . 40.9 mm-40 -73.29 -48.42 34.74 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.855 -0.528 . . . . 0.0 112.296 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 35' ' ' THR . . . . . 0.667 HG22 ' O ' ' B' ' 40' ' ' ASP . 92.9 m -52.16 -59.16 4.7 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.477 -1.389 . . . . 0.0 110.504 -178.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.998 HG23 HG12 ' B' ' 42' ' ' VAL . 0.9 OUTLIER -51.38 -45.32 33.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 178.408 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 1.051 ' HB1' ' N ' ' A' ' 89' ' ' ALA . . . -83.52 1.88 39.71 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.993 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 38' ' ' LYS . . . . . 0.84 ' N ' ' O ' ' B' ' 34' ' ' GLU . 0.5 OUTLIER -107.53 -37.85 6.07 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.188 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 145.28 41.92 0.05 OUTLIER Glycine 0 C--N 1.301 -1.405 0 C-N-CA 119.008 -1.568 . . . . 0.0 111.273 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 40' ' ' ASP . . . . . 0.667 ' O ' HG22 ' B' ' 35' ' ' THR . 0.6 OUTLIER -161.75 127.11 3.54 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.93 -1.335 . . . . 0.0 110.604 179.236 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.83 86.53 0.23 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.675 -0.641 . . . . 0.0 109.421 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.998 HG12 HG23 ' B' ' 36' ' ' VAL . 9.4 p -61.8 125.93 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 C-N-CA 119.919 -0.712 . . . . 0.0 109.66 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 43' ' ' GLN . . . . . 0.55 ' O ' ' HA ' ' A' ' 2' ' ' ASN . 5.4 mt-30 -131.11 172.25 12.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.899 . . . . 0.0 110.29 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.97 HD12 ' CB ' ' B' ' 48' ' ' LEU . 29.3 mt -136.48 120.21 17.31 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.503 -0.748 . . . . 0.0 109.625 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 45' ' ' THR . . . . . 0.552 ' HB ' ' CD ' ' A' ' 3' ' ' LYS . 0.1 OUTLIER 34.43 -92.72 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.375 0 O-C-N 121.646 -0.659 . . . . 0.0 110.821 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -159.24 30.37 0.42 Allowed Glycine 0 N--CA 1.486 2.032 0 N-CA-C 108.256 -1.937 . . . . 0.0 108.256 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 47' ' ' PHE . . . . . 0.673 ' CE1' ' HG2' ' A' ' 29' ' ' GLU . 0.1 OUTLIER -124.65 -26.76 3.78 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.546 -0.973 . . . . 0.0 110.981 -179.447 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.97 ' CB ' HD12 ' B' ' 44' ' ' LEU . 9.7 mt -130.56 90.29 2.9 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.835 -1.165 . . . . 0.0 110.415 177.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 49' ' ' ASN . . . . . 0.414 ' O ' ' HA ' ' B' ' 79' ' ' VAL . 0.7 OUTLIER -98.26 88.83 4.28 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.705 -0.622 . . . . 0.0 110.481 -179.842 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 50' ' ' ILE . . . . . 0.947 HG22 HG21 ' B' ' 36' ' ' VAL . 0.8 OUTLIER -81.73 147.32 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.383 -0.823 . . . . 0.0 110.906 -179.835 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 51' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' B' ' 78' ' ' SER . 3.3 ptmt -164.31 131.04 2.34 Favored Pre-proline 0 N--CA 1.502 2.154 0 O-C-N 121.258 -0.901 . . . . 0.0 110.391 179.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.897 ' HD3' HG22 ' B' ' 36' ' ' VAL . 50.8 Cg_endo -84.28 146.86 11.27 Favored 'Trans proline' 0 C--N 1.318 -1.039 0 O-C-N 123.195 1.103 . . . . 0.0 112.241 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.669 HG22 ' O ' ' B' ' 76' ' ' GLY . 23.1 m -146.4 117.39 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-O 121.765 0.793 . . . . 0.0 110.284 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.88 ' HB1' ' CB ' ' A' ' 96' ' ' ASP . . . -51.66 130.69 28.88 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.755 0.788 . . . . 0.0 111.783 -178.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.89 96.11 1.7 Allowed 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 56' ' ' GLN . . . . . 0.437 ' HA ' ' HA ' ' B' ' 73' ' ' PRO . 61.6 mt-30 -60.71 -171.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.29 -0.881 . . . . 0.0 111.566 -178.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.901 ' HB2' ' HD3' ' B' ' 73' ' ' PRO . . . -80.7 -157.39 0.16 Allowed 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.502 0.667 . . . . 0.0 110.382 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 58' ' ' ARG . . . . . 0.565 ' HB3' HG12 ' B' ' 71' ' ' ILE . 0.0 OUTLIER -166.33 148.85 6.91 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.637 -0.665 . . . . 0.0 109.555 -179.806 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -164.91 165.67 20.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.329 -0.857 . . . . 0.0 110.372 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 60' ' ' GLY . . . . . 0.501 ' O ' ' HB3' ' B' ' 61' ' ' PHE . . . 166.46 -101.78 0.18 Allowed Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 61' ' ' PHE . . . . . 0.672 ' CD1' ' N ' ' B' ' 61' ' ' PHE . 0.0 OUTLIER 170.49 152.48 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.68 -0.894 . . . . 0.0 110.879 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 62' ' ' ASN . . . . . 0.649 ' H ' ' HD2' ' B' ' 63' ' ' PRO . 0.0 OUTLIER -105.88 -44.91 0.14 Allowed Pre-proline 0 N--CA 1.502 2.161 0 O-C-N 120.836 -1.165 . . . . 0.0 113.404 -178.656 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.649 ' HD2' ' H ' ' B' ' 62' ' ' ASN . 39.9 Cg_endo -67.54 -11.85 33.59 Favored 'Trans proline' 0 N--CA 1.488 1.177 0 O-C-N 122.843 0.918 . . . . 0.0 111.223 -177.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 64' ' ' GLN . . . . . 0.558 ' CB ' ' CD2' ' B' ' 61' ' ' PHE . 0.9 OUTLIER -90.84 50.4 1.8 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.333 -0.854 . . . . 0.0 109.222 178.738 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 3.2 p 53.33 28.42 7.32 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.454 -0.779 . . . . 0.0 109.701 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 66' ' ' GLN . . . . . 0.558 ' CB ' ' CE1' ' B' ' 61' ' ' PHE . 0.0 OUTLIER -139.91 -145.67 0.19 Allowed 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.47 -0.768 . . . . 0.0 110.126 -179.878 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 67' ' ' GLU . . . . . 0.69 ' HB3' HD21 ' B' ' 69' ' ' LEU . 2.8 mt-10 -140.34 117.11 10.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.13 -0.981 . . . . 0.0 108.49 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 68' ' ' ALA . . . . . 0.897 ' O ' HD23 ' B' ' 69' ' ' LEU . . . -73.61 133.15 43.42 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.358 -0.839 . . . . 0.0 109.944 -178.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.897 HD23 ' O ' ' B' ' 68' ' ' ALA . 1.4 mt -138.67 177.93 7.52 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 120.029 -0.669 . . . . 0.0 110.38 -177.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 70' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' B' ' 58' ' ' ARG . 0.6 OUTLIER 173.59 37.89 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.356 -0.84 . . . . 0.0 110.964 -179.653 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.565 HG12 ' HB3' ' B' ' 58' ' ' ARG . 2.6 pt -65.15 -153.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.957 -1.09 . . . . 0.0 110.181 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -131.39 143.45 49.32 Favored Pre-proline 0 C--N 1.303 -1.427 0 O-C-N 121.291 -0.881 . . . . 0.0 111.943 -178.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 73' ' ' PRO . . . . . 0.901 ' HD3' ' HB2' ' B' ' 57' ' ' ALA . 48.6 Cg_endo -74.95 123.08 7.64 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.65 1.566 . . . . 0.0 109.804 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 74' ' ' SER . . . . . 0.428 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 4.9 p -178.57 152.28 0.63 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.214 -0.929 . . . . 0.0 110.168 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 75' ' ' VAL . . . . . 1.038 HG11 ' CB ' ' A' ' 89' ' ' ALA . 11.9 p -50.99 170.03 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.419 -0.801 . . . . 0.0 109.994 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 76' ' ' GLY . . . . . 0.669 ' O ' HG22 ' B' ' 53' ' ' VAL . . . -119.23 71.31 0.32 Allowed Glycine 0 N--CA 1.488 2.161 0 C-N-CA 119.005 -1.569 . . . . 0.0 109.826 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.894 HG23 HG11 ' B' ' 36' ' ' VAL . 3.1 p -59.07 77.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.377 -1.072 . . . . 0.0 109.726 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 78' ' ' SER . . . . . 0.56 ' N ' ' O ' ' B' ' 76' ' ' GLY . 0.2 OUTLIER -71.11 177.35 3.83 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 122.174 0.988 . . . . 0.0 111.286 -179.298 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.574 HG22 ' N ' ' B' ' 80' ' ' LYS . 1.6 p 176.56 176.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 80' ' ' LYS . . . . . 0.691 ' O ' HD23 ' B' ' 48' ' ' LEU . 16.1 ptmt -176.33 174.05 0.78 Allowed Pre-proline 0 N--CA 1.486 1.326 0 O-C-N 120.764 -1.21 . . . . 0.0 110.349 178.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 81' ' ' PRO . . . . . 0.471 ' HA ' ' O ' ' B' ' 47' ' ' PHE . 52.8 Cg_endo -96.01 136.56 0.6 Allowed 'Trans proline' 0 C--N 1.302 -1.877 0 C-N-CA 122.294 1.996 . . . . 0.0 109.842 178.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 82' ' ' GLY . . . . . 0.461 ' HA3' ' HA ' ' B' ' 47' ' ' PHE . . . -97.35 -168.3 32.86 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 107.793 -2.123 . . . . 0.0 107.793 178.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 83' ' ' GLU . . . . . 0.63 ' HA ' ' HB2' ' B' ' 86' ' ' LYS . 0.9 OUTLIER -76.97 -18.28 58.33 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.886 -1.361 . . . . 0.0 110.283 179.776 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 84' ' ' SER . . . . . 0.487 ' CB ' ' HB3' ' B' ' 47' ' ' PHE . 0.2 OUTLIER -50.94 -42.19 59.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.167 -0.958 . . . . 0.0 108.815 179.368 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.95 ' CB ' HG21 ' A' ' 77' ' ' VAL . 1.0 OUTLIER -73.72 -31.41 63.37 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 177.942 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 86' ' ' LYS . . . . . 0.63 ' HB2' ' HA ' ' B' ' 83' ' ' GLU . 29.4 mtmm -73.29 -38.24 65.97 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.392 0.615 . . . . 0.0 110.196 -179.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 13.8 ttpt -74.54 -37.12 63.12 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 177.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.642 ' O ' ' HB1' ' A' ' 37' ' ' ALA . . . -68.92 -34.73 75.86 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 176.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.948 ' HA ' HD23 ' B' ' 92' ' ' LEU . . . -55.95 -44.36 78.36 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -54.07 -33.51 57.67 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 176.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 91' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' B' ' 88' ' ' ALA . . . -61.79 -38.47 96.0 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 178.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 92' ' ' LEU . . . . . 0.948 HD23 ' HA ' ' B' ' 89' ' ' ALA . 0.4 OUTLIER -72.27 13.8 0.29 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.69 -1.477 . . . . 0.0 110.762 179.697 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 93' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' B' ' 92' ' ' LEU . 72.8 mmtt 62.17 39.84 12.37 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 -177.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 94' ' ' TYR . . . . . 0.563 ' CZ ' ' N ' ' A' ' 74' ' ' SER . 0.0 OUTLIER -38.09 -37.23 0.25 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.565 -179.214 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -60.12 -42.53 94.97 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.46 -0.775 . . . . 0.0 109.811 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 96' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' B' ' 93' ' ' LYS . 3.4 m-20 -60.57 -36.68 79.08 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 97' ' ' PHE . . . . . 0.504 ' HB3' ' HB3' ' A' ' 54' ' ' ALA . 0.7 OUTLIER -75.43 -26.34 58.24 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.709 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 98' ' ' ALA . . . . . 0.407 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . . . -76.1 -57.1 4.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.605 -0.684 . . . . 0.0 110.191 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 35.8 mttt . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 117.917 -1.04 . . . . 0.0 110.191 -179.995 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.583 ' HE3' ' HG ' ' A' ' 6' ' ' LEU . 7.3 mtp . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.519 ' CA ' HD12 ' A' ' 6' ' ' LEU . 50.4 p-10 -171.16 -162.78 0.26 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.798 -1.189 . . . . 0.0 112.43 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.555 ' HE2' ' HA ' ' A' ' 26' ' ' ALA . 9.8 tttm -46.79 -15.34 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.776 -0.578 . . . . 0.0 111.068 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.632 ' O ' ' CG1' ' A' ' 7' ' ' ILE . 58.6 m -117.26 -58.06 2.09 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.126 -0.984 . . . . 0.0 110.304 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.599 ' HA ' ' HE3' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -46.64 -44.86 18.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.115 -0.991 . . . . 0.0 109.489 179.698 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.715 HD23 ' CD1' ' B' ' 31' ' ' ILE . 1.3 mt -63.74 -33.28 75.3 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.15 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.75 ' N ' HD12 ' A' ' 25' ' ' LEU . 0.9 OUTLIER -56.68 -42.61 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.764 -1.21 . . . . 0.0 108.097 179.699 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.908 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 6.7 mtmt -66.56 -34.14 77.23 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 177.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.865 ' CB ' HD13 ' B' ' 31' ' ' ILE . . . -53.71 -39.51 65.26 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.546 -0.862 . . . . 0.0 109.362 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.776 HG22 HG12 ' A' ' 21' ' ' VAL . 1.3 mp -91.01 -31.58 5.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 178.129 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.908 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -65.3 -13.47 58.53 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 118.956 -1.098 . . . . 0.0 108.364 177.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.445 ' HB3' ' O ' ' A' ' 8' ' ' LYS . 1.1 tp60 -113.44 -45.12 3.15 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.487 ' HB3' ' HB2' ' B' ' 27' ' ' SER . 1.8 m-20 -62.34 -33.8 75.41 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 177.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.723 ' OG1' ' O ' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -102.16 -71.14 0.73 Allowed 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 178.494 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 46.37 27.37 2.8 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.076 ' CD1' HG23 ' B' ' 19' ' ' VAL . 0.1 OUTLIER -87.28 -25.83 23.75 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.449 -1.03 . . . . 0.0 108.946 178.868 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.712 HG21 HG21 ' B' ' 17' ' ' THR . 0.5 OUTLIER -153.8 -8.32 0.16 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.907 -0.496 . . . . 0.0 110.228 -179.449 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.515 ' O ' ' C ' ' A' ' 19' ' ' VAL . 4.5 mt-30 57.06 36.82 28.19 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 -177.17 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 1.056 HG23 ' CD1' ' B' ' 16' ' ' LEU . 0.6 OUTLIER -23.93 -93.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.614 -178.712 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.945 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -135.18 22.92 3.49 Favored 'General case' 0 C--N 1.281 -2.39 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 178.709 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.776 HG12 HG22 ' A' ' 10' ' ' ILE . 31.3 m -21.7 -40.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-O 122.385 1.088 . . . . 0.0 108.697 -177.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.811 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.2 OUTLIER -82.16 -39.04 23.8 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 114.891 -1.049 . . . . 0.0 109.601 177.614 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.945 ' N ' ' O ' ' A' ' 20' ' ' SER . 1.2 mtpt -85.33 -32.76 22.29 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.576 -0.703 . . . . 0.0 111.836 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.82 ' HB3' HG23 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -77.01 -34.95 57.37 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.252 -1.53 . . . . 0.0 108.976 179.715 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.75 HD12 ' N ' ' A' ' 7' ' ' ILE . 2.2 mt -77.74 -43.57 30.49 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 118.551 -1.26 . . . . 0.0 107.863 177.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.555 ' HA ' ' HE2' ' A' ' 3' ' ' LYS . . . -59.3 -34.08 71.88 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 177.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.611 ' O ' HG23 ' A' ' 31' ' ' ILE . 85.6 p -81.75 -26.64 34.33 Favored 'General case' 0 C--O 1.204 -1.294 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.841 ' HE2' HD22 ' B' ' 44' ' ' LEU . 0.3 OUTLIER -64.86 -30.23 71.22 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.67 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.748 ' O ' ' HB ' ' A' ' 33' ' ' THR . 4.5 mt-10 -90.64 -21.55 21.62 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 177.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.785 ' O ' ' CG ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -83.36 -19.06 36.81 Favored 'General case' 0 C--O 1.192 -1.944 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 175.52 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.756 ' CG1' ' HA ' ' A' ' 28' ' ' PHE . 2.1 pp -104.67 -33.34 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.059 -1.025 . . . . 0.0 109.048 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 1.027 HD13 HG11 ' A' ' 42' ' ' VAL . 2.6 mm -64.14 -46.46 93.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 176.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.833 ' HA ' HD13 ' B' ' 85' ' ' LEU 0.324 16.4 m -67.56 -54.26 21.42 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 113.762 -1.563 . . . . 0.0 108.197 178.504 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.785 ' CG ' ' O ' ' A' ' 30' ' ' LYS . 57.2 mm-40 -63.2 -32.43 73.82 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.054 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.832 HG21 ' CG2' ' A' ' 42' ' ' VAL . 1.5 m -58.26 -51.79 68.29 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.026 -1.046 . . . . 0.0 108.417 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.138 HG21 HG22 ' A' ' 77' ' ' VAL . 0.9 OUTLIER -52.39 -41.61 35.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 C-N-CA 117.982 -1.487 . . . . 0.0 107.218 177.996 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.888 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -72.51 -7.99 52.84 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.463 -0.895 . . . . 0.0 109.343 177.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.521 ' N ' ' O ' ' A' ' 35' ' ' THR . 0.0 OUTLIER -101.52 -23.69 14.26 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.301 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 35' ' ' THR . . . 102.61 41.48 2.33 Favored Glycine 0 C--N 1.301 -1.383 0 C-N-CA 119.967 -1.111 . . . . 0.0 110.648 178.337 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.791 ' CB ' HG23 ' A' ' 35' ' ' THR . 0.1 OUTLIER -128.86 133.97 48.14 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.011 -1.288 . . . . 0.0 110.809 179.648 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -85.27 91.83 8.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.56 -0.713 . . . . 0.0 109.55 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 1.027 HG11 HD13 ' A' ' 32' ' ' ILE . 82.0 t -67.43 149.63 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-O 121.437 0.637 . . . . 0.0 111.153 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.446 ' O ' ' HA ' ' B' ' 2' ' ' ASN . 4.2 pt20 -158.2 147.62 19.56 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.566 -0.709 . . . . 0.0 109.885 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.808 HD22 ' CE1' ' B' ' 28' ' ' PHE . 35.7 mt -99.47 118.7 36.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.3 -0.875 . . . . 0.0 109.736 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.524 HG21 ' CG ' ' B' ' 29' ' ' GLU . 0.0 OUTLIER 27.36 -95.18 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.953 -0.467 . . . . 0.0 112.235 -179.627 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.501 ' H ' HG23 ' A' ' 45' ' ' THR . . . -129.82 4.45 6.11 Favored Glycine 0 N--CA 1.486 1.976 0 C-N-CA 119.556 -1.307 . . . . 0.0 111.241 -178.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.787 ' CE2' HG21 ' B' ' 32' ' ' ILE . 26.8 p90 -100.24 -64.67 1.02 Allowed 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 119.554 1.677 . . . . 0.0 110.765 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.875 HD22 ' HA2' ' A' ' 82' ' ' GLY . 0.8 OUTLIER -88.17 142.31 27.86 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.241 -1.537 . . . . 0.0 114.673 -178.843 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.661 ' HB2' ' HG2' ' A' ' 81' ' ' PRO . 0.1 OUTLIER -145.25 92.31 2.24 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.567 177.021 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.816 HD13 HG23 ' A' ' 79' ' ' VAL . 46.6 mm -85.71 160.17 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.172 -0.955 . . . . 0.0 110.655 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.413 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 5.0 ptmt -167.32 128.04 1.18 Allowed Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 120.976 -1.077 . . . . 0.0 110.478 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.501 ' HB2' HG11 ' A' ' 75' ' ' VAL . 52.4 Cg_endo -77.62 148.65 26.14 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 O-C-N 123.55 1.289 . . . . 0.0 111.216 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.894 HG22 ' O ' ' A' ' 76' ' ' GLY . 32.9 m -140.59 114.86 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-O 121.717 0.77 . . . . 0.0 111.085 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.703 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . -54.48 141.53 30.63 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 122.0 0.905 . . . . 0.0 111.861 -178.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.06 94.13 0.09 Allowed 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.498 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 7.7 mt-30 -51.99 -178.07 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.451 -0.781 . . . . 0.0 111.661 -178.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.792 ' HB2' ' HD3' ' A' ' 73' ' ' PRO . . . -67.14 179.78 1.12 Allowed 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.456 0.646 . . . . 0.0 110.878 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.485 ' HB2' HG12 ' A' ' 71' ' ' ILE . 52.9 mtp85 -153.89 19.6 0.52 Allowed 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.655 -0.653 . . . . 0.0 110.593 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.59 97.98 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.868 0.842 . . . . 0.0 110.779 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.442 ' O ' ' HB3' ' A' ' 61' ' ' PHE . . . 168.47 -103.51 0.2 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 107.758 -2.137 . . . . 0.0 107.758 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.588 ' CD1' ' O ' ' A' ' 62' ' ' ASN . 51.3 p90 -178.4 162.87 1.53 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.407 -1.055 . . . . 0.0 110.443 178.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.588 ' O ' ' CD1' ' A' ' 61' ' ' PHE . 1.3 t-20 -56.59 -170.38 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.62 -0.675 . . . . 0.0 109.56 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.522 ' HD2' ' CB ' ' A' ' 62' ' ' ASN . 43.1 Cg_endo -73.2 61.63 4.1 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 N-CA-C 108.884 -1.237 . . . . 0.0 108.884 178.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.743 ' O ' HG23 ' A' ' 65' ' ' THR . 32.8 mt-30 -140.0 -110.07 0.15 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.505 -0.747 . . . . 0.0 110.66 -178.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.743 HG23 ' O ' ' A' ' 64' ' ' GLN . 0.1 OUTLIER -171.95 21.44 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.977 -1.077 . . . . 0.0 110.743 179.754 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.438 ' HG2' ' N ' ' A' ' 67' ' ' GLU . 2.2 pm0 -173.72 -27.45 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.953 -1.092 . . . . 0.0 111.887 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.528 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 3.5 tp10 -64.93 82.25 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.927 -1.108 . . . . 0.0 109.329 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' A' ' 61' ' ' PHE . . . -92.67 160.95 14.76 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.855 0.836 . . . . 0.0 112.243 -178.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.8 mt -130.79 -146.42 0.3 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -174.4 32.16 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.717 -1.24 . . . . 0.0 110.968 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.485 HG12 ' HB2' ' A' ' 58' ' ' ARG . 1.1 pt -62.8 -158.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.143 -0.973 . . . . 0.0 109.897 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.33 148.55 48.06 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.275 -0.891 . . . . 0.0 110.773 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.792 ' HD3' ' HB2' ' A' ' 57' ' ' ALA . 41.8 Cg_endo -68.21 82.81 0.48 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 124.081 1.569 . . . . 0.0 110.494 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.505 ' HA ' ' CE1' ' B' ' 94' ' ' TYR . 18.9 p -169.47 160.21 9.02 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.544 -0.722 . . . . 0.0 109.445 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.703 ' HA ' ' HA ' ' A' ' 54' ' ' ALA . 0.5 OUTLIER -52.58 168.63 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.06 -1.025 . . . . 0.0 109.003 179.836 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.894 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -118.51 99.52 0.79 Allowed Glycine 0 N--CA 1.486 2.014 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 1.138 HG22 HG21 ' A' ' 36' ' ' VAL . 1.4 t -58.53 86.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-O 122.09 0.948 . . . . 0.0 108.82 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 76' ' ' GLY . 0.2 OUTLIER -79.58 -152.77 0.07 Allowed 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 121.726 0.774 . . . . 0.0 110.272 -179.129 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.816 HG23 HD13 ' A' ' 50' ' ' ILE . 5.4 p 179.98 178.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.872 ' CB ' ' HD3' ' A' ' 81' ' ' PRO . 16.3 mttt -148.45 -70.19 0.02 OUTLIER Pre-proline 0 C--N 1.302 -1.462 0 C-N-CA 117.856 -1.537 . . . . 0.0 112.464 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.872 ' HD3' ' CB ' ' A' ' 80' ' ' LYS . 57.0 Cg_endo -102.23 -172.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.297 -2.16 0 C-N-CA 121.375 1.383 . . . . 0.0 112.834 -177.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.875 ' HA2' HD22 ' A' ' 48' ' ' LEU . . . 177.31 24.08 0.03 OUTLIER Glycine 0 C--N 1.29 -2.024 0 N-CA-C 107.23 -2.348 . . . . 0.0 107.23 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.898 ' O ' ' N ' ' A' ' 85' ' ' LEU . 44.3 tt0 32.6 48.38 0.12 Allowed 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 -176.091 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . 1.325 ' O ' ' N ' ' A' ' 86' ' ' LYS . 0.2 OUTLIER 13.21 41.21 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.334 0 CA-C-N 114.007 -1.452 . . . . 0.0 109.686 -176.685 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 1.069 ' C ' ' O ' ' A' ' 84' ' ' SER . 4.7 mt 20.23 32.43 0.0 OUTLIER 'General case' 0 C--O 1.198 -1.642 0 N-CA-C 102.236 -3.246 . . . . 0.0 102.236 -173.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 1.325 ' N ' ' O ' ' A' ' 84' ' ' SER 0.349 3.2 tttt -57.77 -41.59 82.32 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 103.288 -2.856 . . . . 0.0 103.288 176.496 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.304 11.8 tttp -70.35 -32.77 70.61 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 111.44 -2.618 . . . . 0.0 105.438 174.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.838 ' HB1' ' HB ' ' B' ' 36' ' ' VAL . . . -77.41 -16.33 58.89 Favored 'General case' 0 C--O 1.2 -1.508 0 CA-C-O 122.201 1.001 . . . . 0.0 109.172 178.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.787 ' CB ' HG12 ' B' ' 75' ' ' VAL . . . -89.96 -24.12 21.36 Favored 'General case' 0 C--N 1.282 -2.337 0 O-C-N 120.443 -1.41 . . . . 0.0 108.787 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -71.85 -34.64 69.43 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.873 ' HA3' ' HB1' ' B' ' 37' ' ' ALA . . . -77.34 -32.44 47.63 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 178.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.889 ' CD1' HG21 ' B' ' 75' ' ' VAL 0.26 2.5 mt -51.33 -7.83 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.104 -1.233 . . . . 0.0 112.021 179.573 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' A' ' 96' ' ' ASP . 0.2 OUTLIER 62.56 36.7 13.67 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 -175.313 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.501 ' CD1' ' N ' ' B' ' 75' ' ' VAL . 63.9 t80 -34.18 -45.08 0.2 Allowed 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.697 -178.086 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -54.56 -41.34 69.69 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.272 -0.893 . . . . 0.0 109.737 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.45 ' N ' ' O ' ' A' ' 93' ' ' LYS . 6.9 t0 -63.76 -33.86 76.61 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.721 ' HB3' ' HB2' ' B' ' 54' ' ' ALA . 0.1 OUTLIER -81.75 -17.9 46.1 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.82 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.5 -32.85 54.42 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.506 -0.746 . . . . 0.0 110.25 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 118.043 -0.98 . . . . 0.0 110.211 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.523 ' CE ' HD23 ' B' ' 6' ' ' LEU . 2.1 mtp . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 120.886 0.374 . . . . 0.0 110.113 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 2' ' ' ASN . . . . . 0.446 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 41.7 t30 -177.82 178.06 1.02 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.299 -0.876 . . . . 0.0 110.693 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.515 ' HE3' ' CB ' ' B' ' 29' ' ' GLU . 0.0 OUTLIER -49.45 -19.62 0.57 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.437 -0.789 . . . . 0.0 110.096 179.553 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.554 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 81.4 m -103.64 -41.43 5.95 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.158 -0.964 . . . . 0.0 108.941 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.445 ' CB ' ' HA ' ' B' ' 1' ' ' MET . 0.0 OUTLIER -65.22 -49.93 67.82 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.692 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.903 HD11 HG13 ' A' ' 42' ' ' VAL . 9.4 mt -60.54 -33.48 72.73 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 7' ' ' ILE . . . . . 0.941 HG23 ' HB ' ' B' ' 21' ' ' VAL . 0.6 OUTLIER -53.24 -55.71 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.333 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 8' ' ' LYS . . . . . 0.953 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.0 OUTLIER -58.15 -31.62 67.41 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.13 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 9' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' B' ' 6' ' ' LEU . . . -56.1 -37.16 69.0 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.173 -0.954 . . . . 0.0 109.021 178.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.82 HG23 ' HB3' ' A' ' 24' ' ' MET . 1.5 mp -92.86 -33.38 5.36 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.953 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -67.46 -13.94 62.48 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.488 ' N ' ' O ' ' B' ' 8' ' ' LYS . 3.9 tp-100 -108.47 -43.33 4.34 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.44 -21.74 66.69 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 177.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.934 HG21 ' HB2' ' A' ' 20' ' ' SER . 0.2 OUTLIER -121.96 -80.82 0.63 Allowed 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.97 179.786 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 15' ' ' GLY . . . . . 0.505 ' O ' ' C ' ' B' ' 16' ' ' LEU . . . 70.43 -18.8 0.71 Allowed Glycine 0 N--CA 1.498 2.778 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 16' ' ' LEU . . . . . 1.056 ' CD1' HG23 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -27.83 -64.65 0.08 Allowed 'General case' 0 N--CA 1.515 2.805 0 CA-C-O 122.078 0.942 . . . . 0.0 111.068 -179.722 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 17' ' ' THR . . . . . 0.712 HG21 HG21 ' A' ' 17' ' ' THR . 0.4 OUTLIER -130.11 -0.56 4.65 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.597 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 18' ' ' GLN . . . . . 0.641 ' O ' ' C ' ' B' ' 19' ' ' VAL . 2.4 mt-30 58.09 29.55 17.99 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 -176.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 1.076 HG23 ' CD1' ' A' ' 16' ' ' LEU . 0.4 OUTLIER 5.33 -99.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.616 -179.221 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 20' ' ' SER . . . . . 1.002 ' HB3' HD21 ' A' ' 16' ' ' LEU . 1.7 p -136.07 23.17 3.28 Favored 'General case' 0 C--N 1.273 -2.721 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 177.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.941 ' HB ' HG23 ' B' ' 7' ' ' ILE . 35.1 m -5.0 -42.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-O 122.406 1.098 . . . . 0.0 111.037 -177.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.997 ' N ' ' O ' ' B' ' 20' ' ' SER . 14.0 p -76.74 -37.58 55.7 Favored 'General case' 0 C--N 1.28 -2.423 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.741 179.045 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 23' ' ' LYS . . . . . 0.868 ' N ' ' O ' ' B' ' 20' ' ' SER . 1.6 mtmt -88.78 -31.07 18.56 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.358 -0.839 . . . . 0.0 111.329 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 24' ' ' MET . . . . . 0.617 ' SD ' ' HA ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -72.09 -36.98 69.66 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.234 -1.541 . . . . 0.0 108.754 179.773 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.716 HD12 HG13 ' B' ' 7' ' ' ILE . 0.3 OUTLIER -80.06 -35.89 36.43 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 118.168 -1.413 . . . . 0.0 108.149 177.742 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 26' ' ' ALA . . . . . 0.502 ' HB2' ' O ' ' B' ' 22' ' ' SER . . . -66.07 -34.37 77.92 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 176.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 27' ' ' SER . . . . . 0.572 ' O ' ' N ' ' B' ' 31' ' ' ILE . 83.7 p -81.97 -27.38 33.24 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.007 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 28' ' ' PHE . . . . . 0.863 ' O ' HG13 ' B' ' 31' ' ' ILE . 0.5 OUTLIER -59.04 -50.73 72.96 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 178.26 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 29' ' ' GLU . . . . . 0.614 ' HG3' ' CD1' ' A' ' 47' ' ' PHE . 1.2 tt0 -65.21 -31.49 72.69 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 176.173 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 1.271 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 9.3 ttmt -69.88 -22.48 63.24 Favored 'General case' 0 C--O 1.186 -2.278 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.865 HD13 ' CB ' ' A' ' 9' ' ' ALA . 0.9 OUTLIER -100.76 -29.37 3.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 O-C-N 119.945 -1.722 . . . . 0.0 108.055 177.824 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.787 HG21 ' CE2' ' A' ' 47' ' ' PHE . 1.4 mm -65.3 -60.93 2.0 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 176.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 33' ' ' THR . . . . . 0.647 ' O ' ' CB ' ' A' ' 88' ' ' ALA . 0.4 OUTLIER -76.56 -27.76 56.0 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 119.279 -0.968 . . . . 0.0 108.95 179.587 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 1.271 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 79.1 mm-40 -80.19 -27.37 38.9 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.101 -1.624 . . . . 0.0 110.204 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 35' ' ' THR . . . . . 0.645 HG23 ' HB2' ' B' ' 40' ' ' ASP . 3.7 m -72.15 -48.76 41.14 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.656 -1.277 . . . . 0.0 108.575 178.3 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.852 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 4.5 t -51.1 -48.54 30.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 C-N-CA 116.867 -1.933 . . . . 0.0 106.047 177.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 0.873 ' HB1' ' HA3' ' A' ' 91' ' ' GLY . . . -70.24 5.96 1.5 Allowed 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 121.58 0.705 . . . . 0.0 111.044 177.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 38' ' ' LYS . . . . . 0.492 ' HB2' ' O ' ' B' ' 34' ' ' GLU . 0.0 OUTLIER -108.57 -35.1 6.54 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 177.438 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 39' ' ' GLY . . . . . 0.418 ' HA2' HD21 ' A' ' 92' ' ' LEU . . . 121.17 32.24 1.08 Allowed Glycine 0 C--N 1.302 -1.326 0 C-N-CA 119.727 -1.225 . . . . 0.0 111.487 177.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 40' ' ' ASP . . . . . 0.645 ' HB2' HG23 ' B' ' 35' ' ' THR . 0.3 OUTLIER -125.26 146.63 49.45 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.798 -1.413 . . . . 0.0 110.371 179.123 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 2.8 mtmm -88.6 91.6 8.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.512 -0.743 . . . . 0.0 110.179 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.516 HG13 HD11 ' A' ' 6' ' ' LEU . 78.2 t -64.35 153.3 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.564 -0.71 . . . . 0.0 110.367 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 43' ' ' GLN . . . . . 0.782 ' O ' HD23 ' B' ' 44' ' ' LEU . 0.2 OUTLIER -165.83 164.14 18.69 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.44 -0.787 . . . . 0.0 110.043 179.821 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.841 HD22 ' HE2' ' A' ' 28' ' ' PHE . 15.4 mt -125.46 117.92 24.7 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.394 -0.816 . . . . 0.0 109.718 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 45' ' ' THR . . . . . 0.536 HG21 ' HB3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 30.34 -93.28 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.875 -0.516 . . . . 0.0 111.124 -179.812 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.549 ' O ' ' HA3' ' B' ' 82' ' ' GLY . . . -144.54 24.34 2.0 Favored Glycine 0 N--CA 1.483 1.775 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 47' ' ' PHE . . . . . 0.715 ' CE1' HD12 ' B' ' 44' ' ' LEU . 8.8 p90 -120.7 -22.09 6.45 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.111 -1.229 . . . . 0.0 111.4 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.551 ' HB2' ' HB2' ' B' ' 44' ' ' LEU . 0.9 OUTLIER -128.22 115.45 18.37 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.388 -1.445 . . . . 0.0 110.624 177.828 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 49' ' ' ASN . . . . . 0.632 ' O ' ' HA ' ' B' ' 79' ' ' VAL . 1.2 m120 -113.78 94.75 4.98 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.717 -0.614 . . . . 0.0 111.408 -178.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 50' ' ' ILE . . . . . 0.508 ' CD1' HG23 ' B' ' 79' ' ' VAL . 1.3 mp -93.45 141.48 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 O-C-N 121.246 -0.909 . . . . 0.0 109.839 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 51' ' ' LYS . . . . . 0.426 ' HG3' ' CB ' ' B' ' 78' ' ' SER . 0.0 OUTLIER -161.29 113.42 1.26 Allowed Pre-proline 0 N--CA 1.5 2.025 0 C-N-CA 118.769 -1.172 . . . . 0.0 111.318 179.723 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.688 ' HB3' HG13 ' B' ' 36' ' ' VAL . 55.7 Cg_endo -83.06 141.91 10.7 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 O-C-N 123.571 1.301 . . . . 0.0 111.724 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.618 ' O ' ' N ' ' B' ' 76' ' ' GLY . 33.4 m -149.24 114.73 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.581 0.705 . . . . 0.0 110.718 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.721 ' HB2' ' HB3' ' A' ' 97' ' ' PHE . . . -57.36 134.05 55.68 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.448 -0.783 . . . . 0.0 111.46 -178.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 55' ' ' ARG . . . . . 0.436 ' C ' ' HG2' ' B' ' 56' ' ' GLN . 0.0 OUTLIER 170.45 81.5 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.382 -0.824 . . . . 0.0 110.206 179.596 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 56' ' ' GLN . . . . . 0.52 ' HG3' ' O ' ' B' ' 74' ' ' SER . 28.3 mm100 -148.98 -144.34 0.15 Allowed 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.436 -0.906 . . . . 0.0 111.004 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.837 ' HB1' ' HB ' ' B' ' 71' ' ' ILE . . . -56.4 -165.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 122.336 1.065 . . . . 0.0 112.729 -178.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 58' ' ' ARG . . . . . 0.836 ' O ' HD11 ' B' ' 71' ' ' ILE . 12.4 mpt_? -90.08 -142.33 0.16 Allowed 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.701 -178.155 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 59' ' ' LYS . . . . . 0.673 ' CB ' ' O ' ' B' ' 58' ' ' ARG . 0.3 OUTLIER 137.0 54.95 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.655 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.597 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -110.44 -100.55 2.6 Favored Glycine 0 N--CA 1.491 2.305 0 C-N-CA 120.032 -1.08 . . . . 0.0 110.964 -178.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 61' ' ' PHE . . . . . 0.95 ' CD1' ' O ' ' B' ' 67' ' ' GLU . 0.4 OUTLIER -173.48 111.9 0.2 Allowed 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.338 -1.095 . . . . 0.0 109.774 -178.256 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 62' ' ' ASN . . . . . 0.986 ' C ' ' HA ' ' B' ' 67' ' ' GLU . 5.2 m-20 -113.66 -75.34 0.02 OUTLIER Pre-proline 0 N--CA 1.511 2.595 0 O-C-N 121.103 -0.998 . . . . 0.0 112.181 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.702 ' O ' ' N ' ' B' ' 67' ' ' GLU . 56.0 Cg_endo -79.69 -90.33 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 120.569 0.846 . . . . 0.0 112.131 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 64' ' ' GLN . . . . . 1.08 ' HB2' ' HB2' ' B' ' 68' ' ' ALA . 5.6 tp60 37.85 24.78 0.01 OUTLIER 'General case' 0 N--CA 1.518 2.962 0 O-C-N 121.182 -0.949 . . . . 0.0 112.835 -178.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.438 ' N ' ' O ' ' B' ' 63' ' ' PRO . 1.1 p 48.52 24.26 0.73 Allowed 'General case' 0 N--CA 1.505 2.295 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 -176.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 66' ' ' GLN . . . . . 0.762 ' O ' ' HB2' ' B' ' 67' ' ' GLU . 0.0 OUTLIER -170.77 -36.31 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 114.036 -1.438 . . . . 0.0 107.484 -177.206 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 67' ' ' GLU . . . . . 0.986 ' HA ' ' C ' ' B' ' 62' ' ' ASN . 12.2 mt-10 138.02 129.9 0.0 OUTLIER 'General case' 0 C--O 1.194 -1.832 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 68' ' ' ALA . . . . . 1.08 ' HB2' ' HB2' ' B' ' 64' ' ' GLN . . . -149.86 91.24 1.77 Allowed 'General case' 0 N--CA 1.51 2.545 0 O-C-N 120.286 -1.509 . . . . 0.0 111.055 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.78 HD21 ' ND2' ' B' ' 62' ' ' ASN . 22.8 mt -94.41 153.38 17.99 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.916 -1.115 . . . . 0.0 110.58 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 70' ' ' GLU . . . . . 0.751 ' O ' HG23 ' B' ' 71' ' ' ILE . 0.4 OUTLIER -159.55 142.06 13.74 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.551 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.837 ' HB ' ' HB1' ' B' ' 57' ' ' ALA 0.253 0.7 OUTLIER -164.55 -148.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.645 -0.659 . . . . 0.0 109.295 -176.57 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -107.11 81.94 1.05 Allowed Pre-proline 0 C--N 1.296 -1.751 0 O-C-N 121.371 -0.831 . . . . 0.0 111.179 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 73' ' ' PRO . . . . . 0.531 ' HD3' ' O ' ' B' ' 71' ' ' ILE . 54.3 Cg_endo -77.18 123.76 6.85 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.697 1.367 . . . . 0.0 110.338 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 74' ' ' SER . . . . . 0.52 ' O ' ' HG3' ' B' ' 56' ' ' GLN . 48.0 t -156.95 135.08 11.14 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.863 -1.148 . . . . 0.0 109.96 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 75' ' ' VAL . . . . . 0.889 HG21 ' CD1' ' A' ' 92' ' ' LEU . 1.4 p -60.09 -173.75 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.703 -1.248 . . . . 0.0 109.081 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 76' ' ' GLY . . . . . 0.626 ' O ' ' N ' ' B' ' 78' ' ' SER . . . -113.14 50.22 0.79 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.856 -1.698 . . . . 0.0 108.856 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.736 HG23 HD12 ' A' ' 85' ' ' LEU . 7.1 p -45.69 81.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-O 121.695 0.76 . . . . 0.0 111.534 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 78' ' ' SER . . . . . 0.626 ' N ' ' O ' ' B' ' 76' ' ' GLY . 0.6 OUTLIER -77.48 178.81 6.92 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 119.28 -0.968 . . . . 0.0 108.737 178.408 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.632 ' HA ' ' O ' ' B' ' 49' ' ' ASN . 0.2 OUTLIER 179.48 172.8 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.517 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 80' ' ' LYS . . . . . 0.521 ' N ' ' CG2' ' B' ' 79' ' ' VAL . 0.2 OUTLIER 176.46 172.56 0.33 Allowed Pre-proline 0 N--CA 1.487 1.417 0 O-C-N 121.149 -0.97 . . . . 0.0 110.892 178.404 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 81' ' ' PRO . . . . . 0.707 ' HA ' ' O ' ' B' ' 47' ' ' PHE . 54.6 Cg_endo -88.95 165.78 5.83 Favored 'Trans proline' 0 C--N 1.298 -2.079 0 O-C-N 124.617 1.851 . . . . 0.0 107.475 174.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 82' ' ' GLY . . . . . 0.549 ' HA3' ' O ' ' B' ' 46' ' ' GLY . . . -126.79 -99.33 1.08 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 107.711 -2.156 . . . . 0.0 107.711 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 83' ' ' GLU . . . . . 0.911 ' O ' ' N ' ' B' ' 85' ' ' LEU . 0.4 OUTLIER -79.43 45.24 0.65 Allowed 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.121 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 84' ' ' SER . . . . . 1.334 ' O ' ' N ' ' B' ' 86' ' ' LYS . 0.1 OUTLIER 8.45 43.16 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 122.148 0.975 . . . . 0.0 111.164 179.165 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 1.004 ' C ' ' O ' ' B' ' 84' ' ' SER . 0.4 OUTLIER 20.55 30.05 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 102.786 -3.042 . . . . 0.0 102.786 -172.647 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 86' ' ' LYS . . . . . 1.334 ' N ' ' O ' ' B' ' 84' ' ' SER 0.336 7.7 tttt -56.38 -37.17 69.73 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 103.82 -2.659 . . . . 0.0 103.82 177.08 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . 0.29 0.0 OUTLIER -70.59 -34.79 72.56 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 111.905 -2.407 . . . . 0.0 105.796 175.377 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.648 ' HB3' ' CB ' ' B' ' 85' ' ' LEU . . . -75.3 -27.77 59.45 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 118.586 -1.246 . . . . 0.0 107.859 178.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.905 ' HA ' HD23 ' B' ' 92' ' ' LEU . . . -62.42 -48.33 80.16 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -57.24 -28.98 63.41 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 176.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -69.68 -33.94 72.07 Favored Glycine 0 N--CA 1.489 2.184 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.189 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 92' ' ' LEU . . . . . 0.905 HD23 ' HA ' ' B' ' 89' ' ' ALA . 0.7 OUTLIER -85.75 16.95 3.62 Favored 'General case' 0 N--CA 1.506 2.335 0 CA-C-N 119.689 1.745 . . . . 0.0 111.556 -179.155 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 93' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' B' ' 92' ' ' LEU . 8.7 mmtp 54.92 40.22 31.9 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -178.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 94' ' ' TYR . . . . . 0.505 ' CE1' ' HA ' ' A' ' 74' ' ' SER . 2.6 p90 -41.77 -30.7 0.26 Allowed 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.651 -178.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 95' ' ' GLU . . . . . 0.426 ' O ' ' HB3' ' B' ' 98' ' ' ALA . 8.8 pt-20 -58.22 -42.51 86.44 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.246 -0.909 . . . . 0.0 108.871 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.72 -33.68 76.19 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 177.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -76.52 -22.73 54.03 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 98' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' B' ' 95' ' ' GLU . . . -68.74 -41.18 79.33 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.554 -0.716 . . . . 0.0 110.036 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 4.6 mtmp? . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.224 179.977 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.503 ' HG2' ' HB3' ' A' ' 5' ' ' GLU . 4.0 mtp . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 120.932 0.396 . . . . 0.0 110.134 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.83 ' C ' HD12 ' A' ' 6' ' ' LEU . 4.0 t30 -176.08 -174.79 0.66 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.18 -0.95 . . . . 0.0 111.052 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.542 ' O ' ' CG2' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -51.84 -15.3 0.48 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.453 -0.779 . . . . 0.0 110.275 179.619 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.652 ' O ' HG13 ' A' ' 7' ' ' ILE . 38.7 m -106.89 -58.48 1.93 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 122.004 0.907 . . . . 0.0 109.161 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.503 ' HB3' ' HG2' ' A' ' 1' ' ' MET . 2.6 mt-10 -50.46 -45.05 55.81 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.056 -1.028 . . . . 0.0 108.571 179.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.83 HD12 ' C ' ' A' ' 2' ' ' ASN . 2.4 mt -58.26 -36.31 73.06 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.364 -0.934 . . . . 0.0 109.954 178.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.652 HG13 ' O ' ' A' ' 4' ' ' THR . 0.9 OUTLIER -55.8 -42.81 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.295 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.869 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -64.64 -33.76 76.69 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 177.863 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.672 ' HB3' ' O ' ' A' ' 6' ' ' LEU . . . -56.23 -38.11 70.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.473 -0.767 . . . . 0.0 109.019 178.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.722 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.4 mp -91.52 -32.41 5.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 178.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.869 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -65.3 -14.11 60.0 Favored 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 118.689 -1.205 . . . . 0.0 108.227 178.008 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.402 ' N ' ' O ' ' A' ' 8' ' ' LYS . 6.4 tp-100 -110.75 -46.07 3.41 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.441 ' OD2' HG23 ' B' ' 31' ' ' ILE . 1.6 m-20 -66.63 -27.78 67.96 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 177.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.794 ' CG2' ' HB2' ' B' ' 20' ' ' SER . 0.2 OUTLIER -111.55 -82.26 0.58 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 178.848 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.516 ' O ' ' C ' ' A' ' 16' ' ' LEU . . . 69.0 -21.35 0.37 Allowed Glycine 0 N--CA 1.498 2.831 0 O-C-N 121.004 -1.06 . . . . 0.0 110.825 178.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.113 ' CD1' HG23 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -30.2 -63.77 0.13 Allowed 'General case' 0 N--CA 1.518 2.925 0 CA-C-O 122.052 0.929 . . . . 0.0 110.497 -179.57 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.683 HG22 ' H ' ' A' ' 19' ' ' VAL . 0.5 OUTLIER -129.31 -4.89 4.87 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.774 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.626 ' O ' ' C ' ' A' ' 19' ' ' VAL . 22.1 mt-30 56.41 31.78 19.41 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -177.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 1.024 HG11 HG11 ' B' ' 19' ' ' VAL . 1.6 p -6.46 -98.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.538 -178.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.92 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -133.48 23.28 4.03 Favored 'General case' 0 C--N 1.279 -2.493 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 177.15 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.625 HG12 HG22 ' A' ' 10' ' ' ILE . 30.4 m -20.6 -37.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-O 122.254 1.026 . . . . 0.0 109.858 -178.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.825 ' N ' ' O ' ' A' ' 20' ' ' SER . 11.2 t -75.46 -42.76 52.41 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.931 177.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.92 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -93.8 -22.91 18.38 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.52 -0.738 . . . . 0.0 109.888 178.739 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.79 ' N ' ' OG ' ' A' ' 20' ' ' SER 0.26 2.0 tmm? -68.02 -33.01 73.79 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 179.201 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.597 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 7.3 mt -84.41 -41.55 16.56 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 176.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.539 ' HB3' ' HA ' ' A' ' 23' ' ' LYS . . . -59.19 -34.1 71.74 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 177.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.487 ' O ' HG13 ' A' ' 31' ' ' ILE . 10.2 t -80.17 -36.32 35.23 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 178.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.645 ' CE1' HD22 ' B' ' 44' ' ' LEU . 0.2 OUTLIER -52.1 -44.87 64.63 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.694 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.662 ' HG3' ' CD2' ' B' ' 47' ' ' PHE . 0.9 OUTLIER -69.53 -36.72 76.66 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.247 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 1.129 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 16.5 ttpt -62.53 -23.82 67.17 Favored 'General case' 0 C--O 1.191 -1.981 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.734 HD12 HD23 ' B' ' 6' ' ' LEU . 0.5 OUTLIER -104.15 -27.96 3.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 O-C-N 120.499 -1.376 . . . . 0.0 109.379 178.225 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.623 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.3 mm -73.81 -57.55 6.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 177.26 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.565 ' HB ' ' O ' ' A' ' 29' ' ' GLU . 0.6 OUTLIER -68.35 -36.33 79.08 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.568 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 1.129 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 68.2 mm-40 -75.55 -37.79 59.75 Favored 'General case' 0 N--CA 1.483 1.185 0 O-C-N 121.17 -0.956 . . . . 0.0 111.702 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.584 HG23 ' HB2' ' A' ' 40' ' ' ASP . 14.0 m -62.18 -53.97 47.63 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 120.281 -1.512 . . . . 0.0 109.499 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.817 HG22 ' HD3' ' A' ' 52' ' ' PRO . 2.1 t -54.76 -32.89 26.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 177.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.843 ' HB1' ' O ' ' B' ' 88' ' ' ALA . . . -90.38 10.5 24.79 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.333 177.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.675 ' HB2' ' O ' ' A' ' 34' ' ' GLU . 1.9 ttmt -114.23 -35.35 5.03 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 178.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 127.95 38.58 0.38 Allowed Glycine 0 C--N 1.301 -1.404 0 C-N-CA 119.732 -1.223 . . . . 0.0 110.835 178.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.584 ' HB2' HG23 ' A' ' 35' ' ' THR . 0.3 OUTLIER -145.92 135.8 23.49 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.083 -1.245 . . . . 0.0 110.281 179.431 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.02 76.49 2.21 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.391 -0.818 . . . . 0.0 110.459 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.884 HG23 HD11 ' B' ' 6' ' ' LEU . 11.0 p -60.56 136.46 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.412 -0.805 . . . . 0.0 110.056 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' B' ' 1' ' ' MET . 6.9 pt20 -144.75 175.15 10.39 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.239 -0.913 . . . . 0.0 110.737 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.03 HD12 ' CB ' ' A' ' 48' ' ' LEU . 27.6 mt -125.26 115.01 19.7 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.665 -0.647 . . . . 0.0 109.276 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.537 HG21 ' HG3' ' B' ' 29' ' ' GLU . 0.0 OUTLIER 32.26 -93.88 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.859 -0.526 . . . . 0.0 111.552 -179.767 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.432 ' H ' HG23 ' A' ' 45' ' ' THR . . . -145.05 21.87 1.94 Allowed Glycine 0 N--CA 1.489 2.188 0 C-N-CA 119.504 -1.331 . . . . 0.0 111.013 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.684 ' CD2' ' HG3' ' B' ' 29' ' ' GLU . 8.5 p90 -119.76 -22.15 6.96 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.768 -1.431 . . . . 0.0 111.216 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.03 ' CB ' HD12 ' A' ' 44' ' ' LEU . 6.8 mt -128.72 108.47 10.51 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.453 -1.404 . . . . 0.0 110.653 178.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.607 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 1.1 t-20 -109.68 91.13 3.52 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.673 -0.642 . . . . 0.0 111.095 -179.037 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.762 HG22 HG21 ' A' ' 36' ' ' VAL . 11.1 mm -93.52 138.11 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.29 -0.881 . . . . 0.0 110.138 179.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 21.0 ptmt -160.93 128.39 2.7 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 120.804 -1.185 . . . . 0.0 111.295 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.817 ' HD3' HG22 ' A' ' 36' ' ' VAL . 55.7 Cg_endo -78.69 141.91 17.66 Favored 'Trans proline' 0 C--N 1.314 -1.274 0 O-C-N 123.513 1.27 . . . . 0.0 110.631 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.753 HG22 ' O ' ' A' ' 76' ' ' GLY . 34.5 m -145.66 113.04 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 C-N-CA 119.465 -0.894 . . . . 0.0 111.928 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.922 ' HB1' ' HB3' ' B' ' 96' ' ' ASP . . . -59.54 125.34 23.26 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 119.259 -0.976 . . . . 0.0 109.379 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.912 ' H ' ' N ' ' A' ' 75' ' ' VAL . 31.5 ttt-85 -179.03 84.1 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 121.593 0.711 . . . . 0.0 110.272 -178.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.81 ' C ' ' O ' ' A' ' 73' ' ' PRO . 27.1 mt-30 -159.61 28.88 0.19 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.601 ' HA ' ' HG2' ' A' ' 73' ' ' PRO . . . -100.3 146.56 26.79 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 -174.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.719 ' HB2' HG12 ' A' ' 71' ' ' ILE 0.28 2.7 ttt85 -84.5 17.67 2.58 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 113.957 -1.474 . . . . 0.0 110.593 178.12 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.443 ' N ' HD11 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -51.52 95.69 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.199 -0.938 . . . . 0.0 110.076 -179.153 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 58' ' ' ARG . . . -118.96 -104.84 2.16 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.646 ' CE1' ' CB ' ' A' ' 64' ' ' GLN . 34.4 p90 -175.43 -169.09 0.35 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.32 -1.106 . . . . 0.0 111.348 -179.252 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 1.0 ' CB ' ' HB2' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -139.19 -45.26 0.02 OUTLIER Pre-proline 0 N--CA 1.486 1.369 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.214 178.235 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.925 ' HD2' ' H ' ' A' ' 62' ' ' ASN . 39.5 Cg_endo -67.56 65.9 0.79 Allowed 'Trans proline' 0 N--CA 1.487 1.142 0 O-C-N 122.692 0.838 . . . . 0.0 111.258 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.646 ' CB ' ' CE1' ' A' ' 61' ' ' PHE . 0.3 OUTLIER -173.73 -104.17 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 179.041 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.534 ' O ' ' HB2' ' A' ' 66' ' ' GLN . 31.1 p -74.24 -6.93 50.79 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.236 -1.54 . . . . 0.0 108.925 177.192 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.534 ' HB2' ' O ' ' A' ' 65' ' ' THR . 42.7 mm-40 73.05 94.26 0.08 Allowed 'General case' 0 N--CA 1.503 2.22 0 CA-C-O 121.534 0.683 . . . . 0.0 112.141 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.647 ' H ' ' HA ' ' A' ' 62' ' ' ASN . 5.2 tt0 172.96 60.85 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 1.0 ' HB2' ' CB ' ' A' ' 62' ' ' ASN . . . -61.24 143.5 55.51 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.26 -0.9 . . . . 0.0 110.441 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.587 ' HG ' ' C ' ' A' ' 68' ' ' ALA . 0.4 OUTLIER -137.59 157.99 45.34 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.324 -178.349 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -153.67 19.13 0.53 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.45 -0.781 . . . . 0.0 110.069 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.719 HG12 ' HB2' ' A' ' 58' ' ' ARG . 0.1 OUTLIER -47.88 175.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.882 -0.511 . . . . 0.0 110.85 179.043 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.785 ' N ' ' HD3' ' A' ' 73' ' ' PRO . . . -137.18 44.58 0.97 Allowed Pre-proline 0 N--CA 1.497 1.918 0 O-C-N 120.81 -1.182 . . . . 0.0 112.425 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.81 ' O ' ' C ' ' A' ' 56' ' ' GLN . 42.1 Cg_endo -94.76 114.3 0.18 Allowed 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 121.229 1.286 . . . . 0.0 111.532 178.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.803 ' O ' ' HB3' ' B' ' 96' ' ' ASP . 0.4 OUTLIER -165.9 128.87 2.06 Favored 'General case' 0 CA--C 1.565 1.526 0 O-C-N 120.807 -1.183 . . . . 0.0 113.197 178.32 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.997 ' HB ' ' CD2' ' B' ' 94' ' ' TYR . 1.1 t 164.36 127.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.796 0 CA-C-O 122.236 1.017 . . . . 0.0 108.761 175.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.753 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -138.28 99.22 0.27 Allowed Glycine 0 C--N 1.289 -2.068 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -178.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.701 ' CG2' HD13 ' B' ' 85' ' ' LEU . 1.5 p -59.93 82.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.838 -0.801 . . . . 0.0 109.368 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.632 ' C ' HG12 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -62.67 177.1 0.57 Allowed 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.554 -0.858 . . . . 0.0 110.535 -179.462 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.632 HG12 ' C ' ' A' ' 78' ' ' SER . 0.2 OUTLIER 177.42 174.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.761 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.86 ' O ' HD23 ' A' ' 48' ' ' LEU . 0.5 OUTLIER 177.71 170.26 0.45 Allowed Pre-proline 0 N--CA 1.485 1.323 0 O-C-N 120.822 -1.174 . . . . 0.0 110.997 177.227 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.502 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 56.1 Cg_endo -103.83 136.06 0.1 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 123.359 2.706 . . . . 0.0 109.223 176.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.558 ' HA3' ' HA ' ' A' ' 47' ' ' PHE . . . -97.46 161.25 21.33 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 108.295 -1.922 . . . . 0.0 108.295 178.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.451 ' HA ' ' HB2' ' A' ' 86' ' ' LYS . 0.5 OUTLIER -57.71 -23.95 54.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.015 -1.285 . . . . 0.0 110.584 -179.429 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.5 t -51.82 -31.18 26.39 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.117 -0.989 . . . . 0.0 108.654 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.89 HD13 ' CG1' ' B' ' 77' ' ' VAL . 0.5 OUTLIER -82.96 -31.22 27.72 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.597 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.718 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 5.0 mttt -81.27 -31.8 33.53 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.581 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.421 ' O ' ' HG3' ' A' ' 90' ' ' GLU . 1.1 tmtt? -69.63 -40.2 76.68 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 178.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.759 ' O ' ' HB1' ' B' ' 37' ' ' ALA . . . -62.0 -38.4 88.49 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 176.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.79 ' HA ' HD23 ' A' ' 92' ' ' LEU . . . -53.57 -43.04 68.17 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 120.0 -0.68 . . . . 0.0 109.5 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.502 ' HG3' ' N ' ' A' ' 91' ' ' GLY . 0.3 OUTLIER -54.16 -30.96 51.25 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 177.517 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.502 ' N ' ' HG3' ' A' ' 90' ' ' GLU . . . -64.1 -43.3 97.44 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 178.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.923 HD21 HG21 ' B' ' 75' ' ' VAL . 0.4 OUTLIER -71.59 8.91 0.96 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.745 -1.444 . . . . 0.0 110.831 179.804 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 17.2 mmtm 65.69 50.34 1.61 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 -177.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.584 ' CD1' ' N ' ' B' ' 75' ' ' VAL . 0.0 OUTLIER -34.64 -38.57 0.08 Allowed 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.063 -179.005 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.581 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 24.8 mt-10 -65.93 -46.42 78.27 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.333 -0.855 . . . . 0.0 109.828 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.433 ' N ' ' O ' ' A' ' 93' ' ' LYS . 1.2 m-20 -52.2 -35.31 48.79 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.49 -0.756 . . . . 0.0 108.962 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -76.68 -28.89 56.11 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 95' ' ' GLU . . . -57.98 -37.42 74.17 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.696 -0.628 . . . . 0.0 109.99 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.102 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.462 ' HA ' ' CB ' ' B' ' 5' ' ' GLU . 5.3 mtp . . . . . 0 N--CA 1.493 1.687 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 2' ' ' ASN . . . . . 0.434 ' N ' HD12 ' B' ' 6' ' ' LEU . 22.6 p30 -176.73 -172.7 0.45 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.249 -0.907 . . . . 0.0 111.099 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.496 ' O ' HG13 ' B' ' 7' ' ' ILE . 0.0 OUTLIER -51.5 -11.15 0.12 Allowed 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.381 -0.825 . . . . 0.0 111.244 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.629 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 45.7 m -114.48 -43.28 3.19 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.812 -1.18 . . . . 0.0 108.995 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.501 ' HA ' ' HE2' ' B' ' 8' ' ' LYS . 0.0 OUTLIER -64.19 -50.41 68.22 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.708 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.884 HD11 HG23 ' A' ' 42' ' ' VAL . 0.7 OUTLIER -62.08 -28.93 69.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.375 -0.828 . . . . 0.0 108.898 178.176 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 7' ' ' ILE . . . . . 1.006 HG13 HD12 ' B' ' 25' ' ' LEU . 0.5 OUTLIER -55.52 -59.32 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.144 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 8' ' ' LYS . . . . . 0.895 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.1 OUTLIER -57.86 -30.3 65.7 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.375 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 9' ' ' ALA . . . . . 0.675 ' HB3' ' O ' ' B' ' 6' ' ' LEU . . . -58.98 -36.57 75.1 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.466 -0.894 . . . . 0.0 108.97 178.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.914 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.1 mp -89.03 -35.16 7.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 177.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.895 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -65.57 -9.46 26.78 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 118.839 -1.144 . . . . 0.0 108.42 177.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.491 ' HB3' ' O ' ' B' ' 8' ' ' LYS . 0.4 OUTLIER -118.46 -43.15 2.72 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.547 -0.721 . . . . 0.0 109.448 178.846 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.442 ' HB3' ' OG ' ' A' ' 27' ' ' SER . 1.7 m-20 -66.1 -38.32 87.93 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 177.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 14' ' ' THR . . . . . 1.057 HG22 ' CD1' ' B' ' 16' ' ' LEU 0.251 0.1 OUTLIER -89.13 -77.95 0.36 Allowed 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 177.549 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.84 6.52 78.49 Favored Glycine 0 N--CA 1.5 2.936 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 177.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 16' ' ' LEU . . . . . 1.057 ' CD1' HG22 ' B' ' 14' ' ' THR . 5.2 mp -55.48 -71.4 0.09 Allowed 'General case' 0 C--N 1.294 -1.817 0 O-C-N 121.63 -0.924 . . . . 0.0 110.569 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 17' ' ' THR . . . . . 0.683 ' CG2' HG21 ' A' ' 17' ' ' THR . 0.5 OUTLIER -139.57 8.37 2.39 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.581 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 18' ' ' GLN . . . . . 0.613 ' O ' ' C ' ' B' ' 19' ' ' VAL . 11.2 mt-30 58.69 23.86 11.53 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 -175.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 1.113 HG23 ' CD1' ' A' ' 16' ' ' LEU . 0.2 OUTLIER 5.49 -94.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.125 -179.194 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.978 ' O ' ' N ' ' B' ' 23' ' ' LYS . 0.4 OUTLIER -135.72 23.19 3.37 Favored 'General case' 0 C--N 1.275 -2.654 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 178.153 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.977 ' HB ' HG23 ' B' ' 7' ' ' ILE . 18.3 m -15.0 -40.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-O 122.245 1.022 . . . . 0.0 109.885 -177.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.914 ' N ' ' O ' ' B' ' 20' ' ' SER . 7.7 t -74.93 -42.21 58.16 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.173 177.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 23' ' ' LYS . . . . . 0.978 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.2 OUTLIER -92.89 -25.9 17.86 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.661 -0.649 . . . . 0.0 109.827 178.599 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 24' ' ' MET . . . . . 0.583 ' HE2' ' HA ' ' B' ' 21' ' ' VAL . 2.2 tmm? -64.12 -41.06 97.39 Favored 'General case' 0 C--N 1.316 -0.85 0 O-C-N 120.779 -1.201 . . . . 0.0 108.321 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 1.006 HD12 HG13 ' B' ' 7' ' ' ILE . 2.5 mt -81.28 -42.63 20.34 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 118.952 -1.099 . . . . 0.0 108.547 177.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 26' ' ' ALA . . . . . 0.553 ' HB3' ' HA ' ' B' ' 23' ' ' LYS . . . -58.01 -34.02 69.58 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 27' ' ' SER . . . . . 0.566 ' O ' HG13 ' B' ' 31' ' ' ILE . 73.8 m -82.02 -37.12 27.0 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 177.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 28' ' ' PHE . . . . . 0.954 ' CE1' HD22 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -52.81 -48.3 67.03 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.318 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 29' ' ' GLU . . . . . 0.684 ' HG3' ' CD2' ' A' ' 47' ' ' PHE . 1.7 tt0 -67.16 -34.93 78.59 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 1.241 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 13.8 ttpt -65.41 -20.84 66.55 Favored 'General case' 0 C--O 1.193 -1.92 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.662 HD11 ' HA ' ' B' ' 28' ' ' PHE . 0.7 OUTLIER -106.47 -25.33 3.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 O-C-N 120.057 -1.652 . . . . 0.0 108.968 177.929 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.634 HD11 ' CE2' ' B' ' 28' ' ' PHE . 1.2 mm -76.53 -58.96 3.61 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 176.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 33' ' ' THR . . . . . 0.492 ' OG1' ' HG ' ' A' ' 85' ' ' LEU . 0.6 OUTLIER -70.35 -34.19 72.35 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.257 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 1.241 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 77.9 mm-40 -78.83 -37.29 40.91 Favored 'General case' 0 C--O 1.208 -1.093 0 O-C-N 121.126 -0.984 . . . . 0.0 111.614 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 35' ' ' THR . . . . . 0.512 ' CB ' ' O ' ' B' ' 31' ' ' ILE . 26.1 m -61.55 -47.15 86.86 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 120.073 -1.642 . . . . 0.0 108.459 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.917 HG22 ' HD3' ' B' ' 52' ' ' PRO . 1.7 t -52.66 -44.46 46.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 177.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 0.759 ' HB1' ' O ' ' A' ' 88' ' ' ALA . . . -84.85 -1.28 56.29 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.815 178.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 38' ' ' LYS . . . . . 0.661 ' HB2' ' O ' ' B' ' 34' ' ' GLU . 3.0 ttmt -94.16 -29.84 14.93 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 177.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.1 31.88 0.56 Allowed Glycine 0 C--N 1.303 -1.254 0 C-N-CA 119.665 -1.255 . . . . 0.0 111.395 177.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 40' ' ' ASP . . . . . 0.464 ' CB ' ' CG2' ' B' ' 35' ' ' THR . 0.2 OUTLIER -146.84 146.38 30.19 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.758 -1.436 . . . . 0.0 110.934 179.453 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.39 96.75 9.72 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.609 0.719 . . . . 0.0 109.341 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.554 HG13 HD11 ' A' ' 6' ' ' LEU . 74.5 t -58.35 129.95 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.567 -0.708 . . . . 0.0 110.124 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 43' ' ' GLN . . . . . 0.431 ' HA ' ' HA ' ' B' ' 49' ' ' ASN . 0.0 OUTLIER -123.69 109.05 13.23 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.517 -0.74 . . . . 0.0 109.955 -179.726 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.894 HD12 ' HB3' ' B' ' 48' ' ' LEU . 23.4 mt -77.06 106.32 8.69 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.214 -0.929 . . . . 0.0 109.93 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 45' ' ' THR . . . . . 0.609 HG21 ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 32.42 -93.25 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.246 0 O-C-N 122.018 -0.426 . . . . 0.0 111.425 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -148.28 29.39 1.35 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 47' ' ' PHE . . . . . 0.733 ' HD1' HD12 ' B' ' 85' ' ' LEU . 3.2 p90 -130.18 -24.66 2.57 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.075 -1.25 . . . . 0.0 111.152 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.894 ' HB3' HD12 ' B' ' 44' ' ' LEU . 6.5 mt -134.49 94.09 3.15 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.727 -1.233 . . . . 0.0 110.196 178.093 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 49' ' ' ASN . . . . . 0.431 ' HA ' ' HA ' ' B' ' 43' ' ' GLN . 0.1 OUTLIER -98.03 72.43 2.19 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.386 -0.821 . . . . 0.0 111.365 -179.371 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 50' ' ' ILE . . . . . 0.842 HD13 ' HB ' ' B' ' 79' ' ' VAL . 2.8 mm -61.06 125.28 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.146 -0.971 . . . . 0.0 108.752 178.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 51' ' ' LYS . . . . . 0.415 ' HG3' ' CB ' ' B' ' 78' ' ' SER . 2.2 ptmt -145.5 113.68 4.74 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 120.821 -1.175 . . . . 0.0 110.489 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.917 ' HD3' HG22 ' B' ' 36' ' ' VAL . 55.8 Cg_endo -79.87 138.37 13.14 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.742 1.39 . . . . 0.0 110.759 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.87 ' O ' HG22 ' B' ' 75' ' ' VAL . 17.0 m -122.08 -156.75 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.5 ' HA ' ' HA ' ' B' ' 75' ' ' VAL . . . -151.48 141.23 21.84 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 121.01 -1.056 . . . . 0.0 111.964 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.73 141.07 0.1 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 56' ' ' GLN . . . . . 0.824 ' O ' ' HB2' ' B' ' 57' ' ' ALA . 18.3 mt-30 -80.38 18.12 0.96 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.845 -1.159 . . . . 0.0 110.961 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.824 ' HB2' ' O ' ' B' ' 56' ' ' GLN . . . 148.95 175.12 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.198 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 58' ' ' ARG . . . . . 0.629 ' HB3' ' CG1' ' B' ' 71' ' ' ILE . 0.2 OUTLIER -161.78 159.99 27.76 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.114 -0.991 . . . . 0.0 109.788 -179.085 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 59' ' ' LYS . . . . . 0.468 ' N ' ' HG3' ' B' ' 58' ' ' ARG . 1.3 ttmm -175.65 117.83 0.15 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.227 -0.921 . . . . 0.0 110.514 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 60' ' ' GLY . . . . . 0.445 ' HA2' ' HB1' ' B' ' 68' ' ' ALA . . . 83.1 53.91 3.34 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 61' ' ' PHE . . . . . 0.791 ' O ' ' CB ' ' B' ' 62' ' ' ASN . 18.0 t80 -83.49 171.72 13.12 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.277 -1.131 . . . . 0.0 110.924 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 62' ' ' ASN . . . . . 0.791 ' CB ' ' O ' ' B' ' 61' ' ' PHE . 0.7 OUTLIER 143.07 -36.91 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.07 0 O-C-N 121.597 -0.69 . . . . 0.0 111.235 179.313 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.699 ' HD2' ' N ' ' B' ' 62' ' ' ASN . 40.2 Cg_endo -68.61 -4.92 14.07 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 N-CA-C 109.387 -1.043 . . . . 0.0 109.387 178.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 64' ' ' GLN . . . . . 0.613 ' HB2' ' CE2' ' B' ' 61' ' ' PHE . 1.3 mm-40 -105.56 -42.69 5.14 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.455 -0.778 . . . . 0.0 110.28 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.632 HG22 ' O ' ' B' ' 65' ' ' THR . 88.2 m -147.86 18.1 1.13 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.453 -0.78 . . . . 0.0 110.195 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 66' ' ' GLN . . . . . 0.554 ' O ' ' CB ' ' B' ' 67' ' ' GLU . 1.7 mp0 54.57 95.47 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.364 -0.835 . . . . 0.0 111.816 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 67' ' ' GLU . . . . . 0.554 ' CB ' ' O ' ' B' ' 66' ' ' GLN . 1.8 pt-20 151.79 74.92 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 68' ' ' ALA . . . . . 0.747 ' HA ' ' CA ' ' B' ' 61' ' ' PHE . . . -48.1 143.79 4.18 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.248 -0.907 . . . . 0.0 111.737 -178.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.723 ' HG ' ' HB3' ' B' ' 61' ' ' PHE . 0.2 OUTLIER -135.05 -156.15 0.7 Allowed 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.131 -177.594 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 70' ' ' GLU . . . . . 0.448 ' HA ' ' HG2' ' B' ' 58' ' ' ARG . 0.0 OUTLIER -175.77 59.36 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.283 -0.886 . . . . 0.0 110.369 -179.739 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.772 HD12 ' O ' ' B' ' 72' ' ' ALA . 1.0 OUTLIER -66.09 -156.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.213 -0.929 . . . . 0.0 110.26 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 72' ' ' ALA . . . . . 1.003 ' HB1' ' HD2' ' B' ' 73' ' ' PRO . . . -134.41 -174.78 0.42 Allowed Pre-proline 0 C--N 1.301 -1.513 0 O-C-N 121.54 -0.725 . . . . 0.0 109.684 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 73' ' ' PRO . . . . . 1.003 ' HD2' ' HB1' ' B' ' 72' ' ' ALA . 38.0 Cg_endo -65.77 86.28 0.23 Allowed 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 123.638 1.336 . . . . 0.0 110.276 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 74' ' ' SER . . . . . 0.518 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 5.3 p -179.08 165.76 1.52 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.733 -0.605 . . . . 0.0 109.696 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 75' ' ' VAL . . . . . 0.923 HG21 HD21 ' A' ' 92' ' ' LEU . 0.9 OUTLIER -53.86 167.47 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.186 -0.946 . . . . 0.0 108.558 179.63 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 76' ' ' GLY . . . . . 0.675 ' CA ' HG22 ' B' ' 53' ' ' VAL . . . -117.59 90.25 0.5 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.89 ' CG1' HD13 ' A' ' 85' ' ' LEU . 65.2 t -66.35 78.79 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 O-C-N 121.628 -0.925 . . . . 0.0 110.027 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 78' ' ' SER . . . . . 0.472 ' O ' ' HB ' ' B' ' 79' ' ' VAL . 0.4 OUTLIER -75.73 174.37 9.9 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 118.75 -1.18 . . . . 0.0 110.368 -179.831 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.842 ' HB ' HD13 ' B' ' 50' ' ' ILE . 7.2 p 175.09 177.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 80' ' ' LYS . . . . . 0.652 ' O ' HD23 ' B' ' 48' ' ' LEU . 0.3 OUTLIER -177.5 172.5 0.77 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 120.743 -1.223 . . . . 0.0 110.933 177.207 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 81' ' ' PRO . . . . . 0.419 ' HD2' ' HB2' ' B' ' 80' ' ' LYS . 56.7 Cg_endo -96.44 100.33 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.559 2.173 . . . . 0.0 110.352 178.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 82' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' B' ' 46' ' ' GLY . . . -61.81 172.93 7.95 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 108.623 -1.791 . . . . 0.0 108.623 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -68.1 -26.45 65.82 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.978 -1.307 . . . . 0.0 110.558 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -50.14 -33.83 20.26 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.21 -0.931 . . . . 0.0 108.658 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.765 HD22 HG11 ' A' ' 36' ' ' VAL . 0.5 OUTLIER -82.57 -31.78 28.83 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 178.522 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 86' ' ' LYS . . . . . 0.754 ' O ' ' HB3' ' B' ' 89' ' ' ALA . 1.2 tttt -76.15 -39.24 55.43 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.586 -0.696 . . . . 0.0 109.695 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 31.7 tttt -65.61 -39.95 92.08 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 178.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.843 ' O ' ' HB1' ' A' ' 37' ' ' ALA . . . -64.06 -35.45 80.79 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 176.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.782 ' HA ' HD23 ' B' ' 92' ' ' LEU . . . -53.65 -41.87 67.22 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.478 ' HA ' ' HB2' ' B' ' 94' ' ' TYR . 0.9 OUTLIER -55.19 -33.39 62.99 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 176.868 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 91' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' B' ' 88' ' ' ALA . . . -70.06 -25.51 75.51 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 178.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 92' ' ' LEU . . . . . 0.89 ' O ' HD12 ' B' ' 92' ' ' LEU . 0.4 OUTLIER -73.76 20.18 0.1 Allowed 'General case' 0 N--CA 1.502 2.157 0 O-C-N 120.671 -1.488 . . . . 0.0 110.6 179.788 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 93' ' ' LYS . . . . . 0.731 ' O ' ' C ' ' B' ' 94' ' ' TYR . 0.0 OUTLIER 72.0 29.93 2.29 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 -177.437 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 94' ' ' TYR . . . . . 0.997 ' CD2' ' HB ' ' A' ' 75' ' ' VAL . 15.0 t80 -22.2 -66.5 0.03 OUTLIER 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 95' ' ' GLU . . . . . 0.964 ' O ' ' N ' ' B' ' 98' ' ' ALA . 8.2 mt-10 4.85 36.47 0.0 OUTLIER 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 101.563 -3.495 . . . . 0.0 101.563 177.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 96' ' ' ASP . . . . . 1.196 ' O ' ' N ' ' B' ' 98' ' ' ALA . 0.0 OUTLIER 17.87 40.61 0.0 OUTLIER 'General case' 0 CA--C 1.476 -1.881 0 CA-C-N 112.689 -2.051 . . . . 0.0 107.531 -173.741 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 97' ' ' PHE . . . . . 0.973 ' C ' ' O ' ' B' ' 96' ' ' ASP . 42.2 p90 25.66 27.91 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.793 1 N-CA-C 99.96 -4.089 . . . . 0.0 99.96 -167.871 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 98' ' ' ALA . . . . . 1.196 ' N ' ' O ' ' B' ' 96' ' ' ASP 0.297 . . -52.28 -30.11 26.43 Favored 'General case' 0 C--O 1.215 -0.728 0 CA-C-N 108.855 -3.793 . . . . 0.0 108.482 179.059 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.096 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.708 ' HE1' HD13 ' B' ' 31' ' ' ILE . 6.5 mtp . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 120.89 0.376 . . . . 0.0 110.109 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.872 ' C ' HD12 ' A' ' 6' ' ' LEU . 26.5 p30 -177.85 -173.02 0.37 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.219 -0.926 . . . . 0.0 110.995 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.575 ' HE2' ' HA ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -48.57 -15.36 0.08 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.533 -0.729 . . . . 0.0 110.923 -179.724 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.646 ' O ' HG13 ' A' ' 7' ' ' ILE . 60.7 m -107.07 -60.47 1.67 Allowed 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 122.059 0.933 . . . . 0.0 109.461 179.039 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.546 ' HB3' ' HG2' ' A' ' 1' ' ' MET . 8.9 mt-10 -50.57 -44.21 56.67 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.014 -1.054 . . . . 0.0 108.469 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.872 HD12 ' C ' ' A' ' 2' ' ' ASN . 4.7 mt -56.64 -34.37 67.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.365 -0.834 . . . . 0.0 109.955 178.01 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.646 HG13 ' O ' ' A' ' 4' ' ' THR . 0.9 OUTLIER -60.12 -41.52 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 179.301 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.789 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -70.63 -29.92 66.43 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 177.571 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 6' ' ' LEU . . . -61.48 -37.52 83.95 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.517 -0.74 . . . . 0.0 109.159 178.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.686 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.1 mp -93.64 -30.04 4.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 178.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.789 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -62.69 -13.88 37.43 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 118.473 -1.291 . . . . 0.0 108.335 178.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -116.21 -46.56 2.79 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 121.631 -0.668 . . . . 0.0 109.865 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.17 -29.97 71.05 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 177.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . 1.06 HG22 ' CD1' ' A' ' 16' ' ' LEU 0.271 0.2 OUTLIER -105.09 -74.43 0.65 Allowed 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 179.016 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 57.48 11.51 7.41 Favored Glycine 0 N--CA 1.497 2.747 0 O-C-N 121.402 -0.811 . . . . 0.0 111.811 177.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.06 ' CD1' HG22 ' A' ' 14' ' ' THR . 2.4 mp -54.37 -62.3 1.74 Allowed 'General case' 0 N--CA 1.505 2.296 0 O-C-N 121.011 -1.288 . . . . 0.0 109.334 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.559 HG21 ' CG2' ' B' ' 17' ' ' THR . 0.6 OUTLIER -135.89 4.61 3.03 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.384 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.597 ' O ' ' C ' ' A' ' 19' ' ' VAL . 24.5 mt-30 56.97 28.89 15.43 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 -176.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 1.084 HG11 HG11 ' B' ' 19' ' ' VAL . 1.5 p -10.7 -97.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.979 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.921 ' O ' ' N ' ' A' ' 22' ' ' SER . 0.3 OUTLIER -133.55 24.76 4.07 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 177.977 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.65 ' HA ' ' SD ' ' A' ' 24' ' ' MET . 32.5 m -16.01 -38.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 CA-C-O 122.551 1.167 . . . . 0.0 110.117 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.921 ' N ' ' O ' ' A' ' 20' ' ' SER . 98.0 p -79.22 -38.08 36.56 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.392 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.914 ' N ' ' O ' ' A' ' 20' ' ' SER . 14.1 ttpt -92.08 -25.24 18.85 Favored 'General case' 0 C--N 1.308 -1.225 0 O-C-N 121.226 -0.921 . . . . 0.0 110.897 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.65 ' SD ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -74.91 -35.67 62.2 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 117.399 -1.72 . . . . 0.0 107.418 178.541 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.663 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 8.2 mt -77.48 -37.87 50.4 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 118.68 -1.208 . . . . 0.0 108.494 177.237 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.575 ' HA ' ' HE2' ' A' ' 3' ' ' LYS . . . -64.48 -35.53 81.23 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 177.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.523 ' O ' HG13 ' A' ' 31' ' ' ILE . 82.7 p -80.93 -28.82 35.62 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.69 ' CE2' HD11 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -54.78 -41.41 70.51 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.686 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.653 ' HG3' ' CD1' ' B' ' 47' ' ' PHE . 0.7 OUTLIER -72.39 -36.44 68.69 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 176.201 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 1.12 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 22.9 ttpt -60.71 -23.59 65.01 Favored 'General case' 0 C--O 1.191 -2.02 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.647 HD11 ' HA ' ' A' ' 28' ' ' PHE . 0.7 OUTLIER -104.17 -27.23 3.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 120.682 -1.261 . . . . 0.0 109.404 178.127 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.69 HD11 ' CE2' ' A' ' 28' ' ' PHE . 1.2 mm -70.89 -58.5 5.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 177.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.819 ' OG1' HD12 ' B' ' 85' ' ' LEU . 0.5 OUTLIER -67.71 -42.84 81.36 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.342 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 1.12 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 34.0 mm-40 -69.09 -34.62 75.38 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.24 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.9 HG23 ' CB ' ' A' ' 40' ' ' ASP . 1.2 m -57.88 -50.35 73.62 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.44 -1.413 . . . . 0.0 107.812 178.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.684 HG11 ' HB2' ' B' ' 85' ' ' LEU . 2.1 t -53.1 -40.52 38.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 C-N-CA 118.607 -1.237 . . . . 0.0 107.853 178.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.801 ' HB2' ' HB1' ' B' ' 88' ' ' ALA . . . -77.71 -9.34 58.94 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.481 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -102.1 2.19 37.19 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 177.495 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.464 ' HA2' ' HG2' ' A' ' 52' ' ' PRO . . . 66.26 50.92 47.66 Favored Glycine 0 C--N 1.302 -1.359 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.9 ' CB ' HG23 ' A' ' 35' ' ' THR . 0.2 OUTLIER -127.9 157.78 39.58 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.284 -1.127 . . . . 0.0 110.081 179.591 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.412 ' CG ' ' HB2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -107.05 92.93 4.29 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.45 -0.781 . . . . 0.0 111.001 -178.969 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 1.011 HG13 HD11 ' B' ' 6' ' ' LEU . 2.3 t -87.4 92.17 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.557 -0.714 . . . . 0.0 109.303 179.023 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.471 ' O ' HD23 ' A' ' 44' ' ' LEU . 0.6 OUTLIER -89.19 148.37 23.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.137 -0.977 . . . . 0.0 110.617 -179.313 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.658 ' HB2' ' HB2' ' A' ' 48' ' ' LEU . 19.2 mt -118.45 117.31 28.68 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.543 -0.723 . . . . 0.0 109.725 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.518 HG23 ' CD2' ' A' ' 47' ' ' PHE . 0.1 OUTLIER 29.91 -88.59 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.429 0 O-C-N 121.82 -0.55 . . . . 0.0 111.137 179.506 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -152.38 21.28 0.84 Allowed Glycine 0 N--CA 1.486 2.009 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.688 ' CE1' HG21 ' B' ' 32' ' ' ILE . 8.8 p90 -118.54 -23.54 7.1 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.916 -1.343 . . . . 0.0 111.25 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.658 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -129.27 94.11 3.72 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.8 -1.188 . . . . 0.0 110.792 178.543 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.651 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 0.6 OUTLIER -96.02 83.37 3.64 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.64 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.948 HG22 ' CG2' ' A' ' 79' ' ' VAL . 0.7 OUTLIER -94.26 144.72 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.022 -1.048 . . . . 0.0 113.093 -177.629 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.584 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 9.7 ptmt -177.01 112.43 0.24 Allowed Pre-proline 0 N--CA 1.494 1.746 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 177.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.665 ' CB ' HG21 ' A' ' 75' ' ' VAL . 55.5 Cg_endo -69.58 132.06 22.8 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 O-C-N 123.313 1.165 . . . . 0.0 113.379 -175.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.89 ' O ' HG23 ' A' ' 75' ' ' VAL . 19.1 m -125.37 -141.16 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.272 177.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.739 ' HB2' ' HB3' ' B' ' 97' ' ' PHE . . . -149.78 124.9 10.04 Favored 'General case' 0 C--N 1.292 -1.896 0 O-C-N 120.576 -1.328 . . . . 0.0 111.189 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.0 tpp180 -173.0 109.54 0.18 Allowed 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.404 ' HG2' ' OH ' ' B' ' 94' ' ' TYR . 3.6 mt-30 -64.1 -150.2 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.239 -0.913 . . . . 0.0 109.947 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.859 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -167.26 177.92 5.86 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.245 -0.909 . . . . 0.0 110.879 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 1.11 ' O ' HD11 ' A' ' 71' ' ' ILE . 0.8 OUTLIER -84.4 -153.55 0.15 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.499 -0.75 . . . . 0.0 112.16 -178.485 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.695 ' CB ' ' O ' ' A' ' 58' ' ' ARG . 25.1 ttpp 139.24 118.11 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.601 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.524 ' O ' ' HB3' ' A' ' 61' ' ' PHE . . . -166.02 -104.22 0.18 Allowed Glycine 0 N--CA 1.489 2.184 0 C-N-CA 119.243 -1.456 . . . . 0.0 111.181 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.664 ' HD1' ' N ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER 173.88 155.07 0.12 Allowed 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.678 -0.895 . . . . 0.0 110.319 -178.81 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.793 ' HB2' ' H ' ' A' ' 68' ' ' ALA . 0.3 OUTLIER -107.08 -55.53 0.07 OUTLIER Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 121.152 -0.968 . . . . 0.0 111.885 -179.151 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.704 ' HD2' ' H ' ' A' ' 62' ' ' ASN . 39.1 Cg_endo -66.46 67.49 0.49 Allowed 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 123.49 1.258 . . . . 0.0 109.897 -178.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.64 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 0.8 OUTLIER -177.6 40.04 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -179.311 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.544 HG23 ' C ' ' A' ' 64' ' ' GLN . 1.4 p 62.39 27.36 16.3 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -178.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.497 ' CB ' ' CE1' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -142.78 -149.45 0.27 Allowed 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.393 -0.817 . . . . 0.0 110.098 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.763 ' O ' HD11 ' A' ' 69' ' ' LEU . 13.6 pt-20 -142.05 122.73 14.26 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.793 ' H ' ' HB2' ' A' ' 62' ' ' ASN . . . -79.99 138.55 37.08 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.71 0.767 . . . . 0.0 109.696 -178.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.763 HD11 ' O ' ' A' ' 67' ' ' GLU . 0.2 OUTLIER -137.7 -156.9 0.73 Allowed 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.097 -177.319 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.565 ' HB2' ' O ' ' A' ' 69' ' ' LEU . 11.2 tt0 167.51 125.38 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.505 -0.747 . . . . 0.0 110.33 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 1.11 HD11 ' O ' ' A' ' 58' ' ' ARG . 1.0 OUTLIER -158.45 -154.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 -179.712 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.889 ' HB1' ' HD2' ' B' ' 86' ' ' LYS . . . -141.59 93.35 7.77 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.101 -0.999 . . . . 0.0 111.789 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 72' ' ' ALA . 36.8 Cg_endo -63.42 111.67 1.53 Allowed 'Trans proline' 0 N--CA 1.488 1.204 0 O-C-N 123.476 1.25 . . . . 0.0 109.637 177.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.61 ' HA ' ' CE2' ' B' ' 94' ' ' TYR . 6.6 p 176.25 -165.6 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -179.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.89 HG23 ' O ' ' A' ' 53' ' ' VAL . 8.7 p -46.46 160.34 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.556 ' HA3' ' CG2' ' A' ' 53' ' ' VAL . . . -91.6 55.85 3.07 Favored Glycine 0 N--CA 1.484 1.84 0 N-CA-C 107.449 -2.261 . . . . 0.0 107.449 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.895 HG21 ' HA ' ' B' ' 84' ' ' SER . 19.2 t -26.0 93.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-O 122.932 1.348 . . . . 0.0 110.986 -178.162 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.569 ' CB ' ' HG3' ' A' ' 51' ' ' LYS . 45.7 t -57.31 -41.63 80.28 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 114.199 -1.364 . . . . 0.0 113.329 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.948 ' CG2' HG22 ' A' ' 50' ' ' ILE 0.255 7.5 p -44.38 167.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 CA-C-O 122.423 1.106 . . . . 0.0 113.568 -172.238 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.632 ' O ' HD23 ' A' ' 48' ' ' LEU . 0.5 OUTLIER 174.61 176.07 0.21 Allowed Pre-proline 0 N--CA 1.485 1.301 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.382 -179.518 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -78.96 130.76 9.65 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 123.751 1.395 . . . . 0.0 109.344 176.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.458 ' CA ' ' HA ' ' A' ' 47' ' ' PHE . . . -104.39 -174.93 25.15 Favored Glycine 0 N--CA 1.498 2.821 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.43 ' HA ' ' HB2' ' A' ' 86' ' ' LYS . 2.2 pm0 -80.93 -24.27 38.29 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.32 -1.106 . . . . 0.0 110.707 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.423 ' HB2' ' HA3' ' A' ' 46' ' ' GLY . 22.0 t -51.07 -32.13 21.05 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.15 -0.969 . . . . 0.0 108.518 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.974 HD11 ' CG1' ' B' ' 36' ' ' VAL . 0.6 OUTLIER -84.22 -35.1 23.71 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.592 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.753 ' HG3' HG23 ' B' ' 77' ' ' VAL . 0.6 OUTLIER -71.34 -31.12 67.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.244 -0.91 . . . . 0.0 109.182 178.809 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.45 -37.18 65.9 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.913 ' C ' ' HB1' ' B' ' 37' ' ' ALA . . . -65.24 -33.77 76.78 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 176.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 1.002 ' CB ' HG11 ' B' ' 75' ' ' VAL . . . -62.38 -35.07 78.01 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.1 -26.37 66.16 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 175.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.519 ' C ' ' H ' ' A' ' 93' ' ' LYS . . . -59.83 -50.18 70.48 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 178.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.747 HD23 ' C ' ' B' ' 37' ' ' ALA . 1.3 pp -74.91 27.76 0.09 Allowed 'General case' 0 N--CA 1.505 2.311 0 O-C-N 120.454 -1.615 . . . . 0.0 109.473 178.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.613 ' HB3' ' O ' ' A' ' 92' ' ' LEU . 4.1 ttpt 68.99 93.39 0.08 Allowed 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -177.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.834 ' O ' ' N ' ' A' ' 97' ' ' PHE . 24.8 t80 -58.95 -60.74 3.38 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 115.301 -2.56 . . . . 0.0 106.181 177.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.939 ' O ' ' N ' ' A' ' 98' ' ' ALA . 38.5 mm-40 10.81 41.44 0.0 OUTLIER 'General case' 0 CA--C 1.484 -1.596 0 N-CA-C 101.366 -3.568 . . . . 0.0 101.366 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 1.044 ' O ' ' N ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER 19.55 44.11 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 112.968 -1.924 . . . . 0.0 108.054 -172.87 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.851 ' CE2' ' HB2' ' B' ' 54' ' ' ALA . 0.0 OUTLIER 26.26 29.67 0.0 OUTLIER 'General case' 0 C--N 1.366 1.31 0 N-CA-C 102.401 -3.185 . . . . 0.0 102.401 -170.536 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 1.044 ' N ' ' O ' ' A' ' 96' ' ' ASP 0.278 . . -73.73 -30.0 62.57 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 109.867 -3.333 . . . . 0.0 109.843 -178.404 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 29.8 mtmt . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.173 179.919 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.595 ' HA ' ' HB2' ' B' ' 5' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 120.823 0.344 . . . . 0.0 110.246 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 2' ' ' ASN . . . . . 0.48 ' C ' ' H ' ' B' ' 4' ' ' THR . 40.7 p-10 -176.37 -135.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.131 -1.027 . . . . 0.0 111.374 178.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.83 ' HD3' HD11 ' B' ' 25' ' ' LEU . 4.9 mttp -61.5 9.16 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.006 -1.058 . . . . 0.0 111.289 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.48 ' H ' ' C ' ' B' ' 2' ' ' ASN . 52.9 m -127.8 -66.39 0.87 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.518 -1.364 . . . . 0.0 110.591 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.595 ' HB2' ' HA ' ' B' ' 1' ' ' MET . 19.7 mp0 -53.59 -42.44 67.64 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.955 -1.09 . . . . 0.0 109.797 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 1.011 HD11 HG13 ' A' ' 42' ' ' VAL . 18.0 mt -57.59 -33.08 67.82 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 118.804 -1.158 . . . . 0.0 109.636 179.039 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 7' ' ' ILE . . . . . 0.731 HG22 HD22 ' B' ' 25' ' ' LEU . 0.8 OUTLIER -61.83 -41.47 90.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 178.111 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 8' ' ' LYS . . . . . 0.839 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.0 OUTLIER -70.39 -29.86 66.61 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 177.875 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 9' ' ' ALA . . . . . 0.553 ' HB3' ' O ' ' B' ' 6' ' ' LEU . . . -59.17 -39.46 82.56 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.508 -0.745 . . . . 0.0 109.257 178.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.87 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.1 mp -92.64 -29.81 4.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 178.154 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.839 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -62.87 -15.59 55.42 Favored 'General case' 0 C--N 1.294 -1.809 0 C-N-CA 118.403 -1.319 . . . . 0.0 108.42 178.116 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.444 ' HB3' ' O ' ' B' ' 8' ' ' LYS . 15.3 tp60 -114.74 -45.31 3.0 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.567 -0.708 . . . . 0.0 109.4 178.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' B' ' 9' ' ' ALA . 3.0 m-20 -62.63 -27.75 69.43 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 177.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 14' ' ' THR . . . . . 1.1 HG22 ' CD1' ' B' ' 16' ' ' LEU 0.258 0.2 OUTLIER -106.66 -82.52 0.54 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 178.412 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.95 4.17 82.35 Favored Glycine 0 N--CA 1.5 2.931 0 O-C-N 121.038 -1.039 . . . . 0.0 110.681 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 16' ' ' LEU . . . . . 1.1 ' CD1' HG22 ' B' ' 14' ' ' THR . 5.4 mp -50.95 -71.02 0.07 Allowed 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.632 -0.923 . . . . 0.0 110.838 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 17' ' ' THR . . . . . 0.559 ' CG2' HG21 ' A' ' 17' ' ' THR . 0.6 OUTLIER -136.96 7.82 2.96 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -179.638 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 18' ' ' GLN . . . . . 0.614 ' O ' ' C ' ' B' ' 19' ' ' VAL . 30.6 mt-30 58.34 26.78 14.43 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 -175.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 1.084 HG11 HG11 ' A' ' 19' ' ' VAL . 1.4 p -6.44 -92.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.857 -179.182 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.937 ' O ' ' N ' ' B' ' 23' ' ' LYS . 0.5 OUTLIER -134.51 25.11 3.76 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 177.531 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.696 ' HA ' ' CE ' ' B' ' 24' ' ' MET . 35.3 m -15.56 -41.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 122.66 1.219 . . . . 0.0 109.26 -177.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.925 ' N ' ' O ' ' B' ' 20' ' ' SER . 48.0 t -79.74 -41.68 26.14 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 114.537 -1.21 . . . . 0.0 110.288 177.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 23' ' ' LYS . . . . . 0.937 ' N ' ' O ' ' B' ' 20' ' ' SER . 1.5 mtpt -85.04 -34.95 22.19 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 121.461 -0.774 . . . . 0.0 111.662 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 24' ' ' MET . . . . . 0.696 ' CE ' ' HA ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -69.23 -30.64 68.83 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 117.667 -1.613 . . . . 0.0 108.058 179.261 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.842 ' HG ' ' N ' ' B' ' 26' ' ' ALA . 0.3 OUTLIER -72.84 -43.23 62.9 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 118.403 -1.319 . . . . 0.0 108.043 177.488 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 26' ' ' ALA . . . . . 0.842 ' N ' ' HG ' ' B' ' 25' ' ' LEU . . . -63.98 -26.69 68.69 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 27' ' ' SER . . . . . 0.606 ' O ' HG23 ' B' ' 31' ' ' ILE . 1.4 t -83.4 -35.83 24.75 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 177.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 28' ' ' PHE . . . . . 0.711 ' HA ' ' CG1' ' B' ' 31' ' ' ILE . 0.6 OUTLIER -64.85 -48.48 74.18 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.467 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 29' ' ' GLU . . . . . 0.605 ' HG3' ' CD2' ' B' ' 28' ' ' PHE . 6.4 mt-10 -72.35 -30.21 64.51 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 120.492 -1.38 . . . . 0.0 107.536 178.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 1.147 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 14.3 tttt -73.19 -25.32 60.73 Favored 'General case' 0 C--O 1.187 -2.203 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 177.117 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.711 ' CG1' ' HA ' ' B' ' 28' ' ' PHE . 1.9 pp -100.28 -29.89 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.266 -1.521 . . . . 0.0 109.465 178.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.688 HG21 ' CE1' ' A' ' 47' ' ' PHE . 1.5 mm -65.79 -64.59 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 177.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 33' ' ' THR . . . . . 0.757 ' O ' HD13 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -62.72 -38.5 90.73 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.034 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 1.147 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 76.7 mm-40 -74.38 -42.74 58.78 Favored 'General case' 0 C--O 1.202 -1.404 0 O-C-N 121.036 -1.04 . . . . 0.0 112.111 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 35' ' ' THR . . . . . 0.518 ' HA ' ' HB3' ' B' ' 38' ' ' LYS . 67.5 m -57.19 -56.55 20.29 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 120.222 -1.548 . . . . 0.0 110.494 -178.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 1.013 HG23 HG12 ' B' ' 42' ' ' VAL . 1.3 t -51.63 -44.39 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 117.667 -1.613 . . . . 0.0 106.974 178.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 0.913 ' HB1' ' C ' ' A' ' 88' ' ' ALA . . . -85.97 6.08 30.29 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.705 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 38' ' ' LYS . . . . . 0.785 ' N ' ' O ' ' B' ' 34' ' ' GLU . 0.1 OUTLIER -105.64 -36.43 7.09 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 178.156 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 142.68 37.57 0.08 OUTLIER Glycine 0 C--N 1.301 -1.388 0 C-N-CA 119.252 -1.451 . . . . 0.0 111.4 178.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 40' ' ' ASP . . . . . 0.456 ' HB2' HG23 ' B' ' 35' ' ' THR . 0.4 OUTLIER -155.53 145.0 21.07 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.821 -1.4 . . . . 0.0 110.988 179.461 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.15 92.79 5.72 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.557 0.694 . . . . 0.0 109.519 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 1.013 HG12 HG23 ' B' ' 36' ' ' VAL . 11.3 p -68.25 154.81 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.668 -0.645 . . . . 0.0 110.447 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 43' ' ' GLN . . . . . 0.841 ' O ' HD23 ' B' ' 44' ' ' LEU . 0.4 OUTLIER -164.1 176.3 9.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.189 -0.945 . . . . 0.0 111.386 179.937 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.841 HD23 ' O ' ' B' ' 43' ' ' GLN . 18.1 mt -134.28 118.8 17.96 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 45' ' ' THR . . . . . 0.577 HG21 ' CG ' ' A' ' 29' ' ' GLU . 0.1 OUTLIER 27.21 -95.11 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.416 0 O-C-N 121.826 -0.546 . . . . 0.0 112.374 -179.812 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.529 ' H ' HG23 ' B' ' 45' ' ' THR . . . -137.66 14.97 3.62 Favored Glycine 0 N--CA 1.49 2.247 0 C-N-CA 119.322 -1.418 . . . . 0.0 111.686 -178.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 47' ' ' PHE . . . . . 0.909 ' CD2' HD23 ' B' ' 48' ' ' LEU . 20.4 p90 -110.9 -33.48 6.5 Favored 'General case' 0 C--O 1.195 -1.803 0 CA-C-N 119.447 1.623 . . . . 0.0 109.342 178.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.909 HD23 ' CD2' ' B' ' 47' ' ' PHE . 1.2 mm? -127.37 128.57 46.08 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 119.931 -1.731 . . . . 0.0 115.095 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 49' ' ' ASN . . . . . 0.715 ' N ' ' HG2' ' B' ' 81' ' ' PRO . 0.5 OUTLIER -143.93 91.86 2.27 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.621 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 50' ' ' ILE . . . . . 0.577 ' CD1' HG12 ' B' ' 79' ' ' VAL . 24.9 mm -83.79 148.07 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.457 -0.777 . . . . 0.0 110.688 -178.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 51' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' B' ' 78' ' ' SER . 0.0 OUTLIER -149.9 129.88 6.68 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.177 -0.952 . . . . 0.0 109.399 179.149 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.628 ' HG3' ' O ' ' B' ' 36' ' ' VAL . 54.9 Cg_endo -81.77 151.64 16.84 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 O-C-N 123.388 1.204 . . . . 0.0 111.387 -178.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.747 HG22 ' O ' ' B' ' 76' ' ' GLY . 20.1 m -138.8 117.48 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-O 122.364 1.078 . . . . 0.0 111.134 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.969 ' HB1' ' CB ' ' A' ' 96' ' ' ASP . . . -79.46 115.17 18.93 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.598 -0.689 . . . . 0.0 110.991 -179.094 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 55' ' ' ARG . . . . . 0.538 ' HB3' ' O ' ' B' ' 54' ' ' ALA . 0.0 OUTLIER 163.87 76.88 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.632 -0.668 . . . . 0.0 109.728 179.466 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 56' ' ' GLN . . . . . 0.502 ' O ' ' O ' ' B' ' 72' ' ' ALA . 12.8 mt-30 -155.82 19.47 0.38 Allowed 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.095 -1.042 . . . . 0.0 111.76 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.856 ' HB2' ' CA ' ' B' ' 73' ' ' PRO . . . -119.07 57.08 0.89 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.796 -1.19 . . . . 0.0 111.464 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 58' ' ' ARG . . . . . 0.768 ' N ' HD11 ' B' ' 71' ' ' ILE . 2.4 mtt-85 -51.62 176.21 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.512 -0.743 . . . . 0.0 109.841 178.143 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 59' ' ' LYS . . . . . 0.505 ' HB3' ' O ' ' B' ' 58' ' ' ARG . 1.5 pttt 173.83 56.18 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.43 -0.794 . . . . 0.0 109.223 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -134.25 -86.57 0.26 Allowed Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 61' ' ' PHE . . . . . 0.761 ' CD2' ' HB2' ' B' ' 68' ' ' ALA . 2.2 t80 -178.1 145.35 0.36 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.345 -1.091 . . . . 0.0 111.178 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 62' ' ' ASN . . . . . 0.845 ' OD1' HD11 ' B' ' 69' ' ' LEU . 1.4 t30 -66.63 -170.0 0.06 OUTLIER Pre-proline 0 C--N 1.303 -1.448 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 177.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.467 ' HD2' ' CB ' ' B' ' 62' ' ' ASN . 44.4 Cg_endo -76.75 51.54 3.39 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 N-CA-C 109.368 -1.051 . . . . 0.0 109.368 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 64' ' ' GLN . . . . . 0.418 ' HB2' ' HG3' ' B' ' 67' ' ' GLU . 32.2 mm-40 -147.12 -159.63 1.05 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 122.198 0.999 . . . . 0.0 110.158 -179.104 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.452 ' C ' ' CZ ' ' B' ' 61' ' ' PHE . 11.4 p -139.5 -2.42 1.59 Allowed 'General case' 0 C--N 1.286 -2.177 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.348 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 66' ' ' GLN . . . . . 0.479 ' N ' ' HZ ' ' B' ' 61' ' ' PHE . 5.2 mt-30 -129.65 -7.69 4.59 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.016 -1.052 . . . . 0.0 111.166 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 67' ' ' GLU . . . . . 0.418 ' HG3' ' HB2' ' B' ' 64' ' ' GLN . 0.2 OUTLIER -127.47 79.14 1.87 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.971 -1.081 . . . . 0.0 109.633 179.031 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 68' ' ' ALA . . . . . 0.761 ' HB2' ' CD2' ' B' ' 61' ' ' PHE . . . -78.78 175.2 10.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.529 -0.732 . . . . 0.0 110.82 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.845 HD11 ' OD1' ' B' ' 62' ' ' ASN . 82.3 mt -106.15 -177.59 3.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.554 -0.716 . . . . 0.0 110.041 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 70' ' ' GLU . . . . . 0.559 ' O ' ' O ' ' B' ' 71' ' ' ILE . 0.9 OUTLIER -177.44 36.8 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.415 -0.803 . . . . 0.0 110.181 179.804 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.768 HD11 ' N ' ' B' ' 58' ' ' ARG . 0.3 OUTLIER -51.13 -157.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 O-C-N 121.718 -0.614 . . . . 0.0 110.919 179.317 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 72' ' ' ALA . . . . . 0.502 ' O ' ' O ' ' B' ' 56' ' ' GLN . . . -137.84 146.64 53.51 Favored Pre-proline 0 N--CA 1.487 1.393 0 O-C-N 120.723 -1.235 . . . . 0.0 111.923 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 73' ' ' PRO . . . . . 0.856 ' CA ' ' HB2' ' B' ' 57' ' ' ALA . 36.6 Cg_endo -62.09 122.01 10.3 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.566 1.824 . . . . 0.0 110.844 178.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 74' ' ' SER . . . . . 0.516 ' N ' ' CE2' ' A' ' 94' ' ' TYR . 21.5 t -160.64 117.08 2.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.588 -0.695 . . . . 0.0 109.868 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 75' ' ' VAL . . . . . 1.002 HG11 ' CB ' ' A' ' 89' ' ' ALA . 9.4 p -52.16 162.46 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.234 -0.917 . . . . 0.0 109.923 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 76' ' ' GLY . . . . . 0.747 ' O ' HG22 ' B' ' 53' ' ' VAL . . . -114.79 98.96 0.89 Allowed Glycine 0 N--CA 1.484 1.847 0 C-N-CA 118.938 -1.601 . . . . 0.0 109.24 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.753 HG23 ' HG3' ' A' ' 86' ' ' LYS . 67.9 t -68.84 66.07 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.701 -0.882 . . . . 0.0 109.078 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 78' ' ' SER . . . . . 0.487 ' C ' HG13 ' B' ' 79' ' ' VAL . 37.6 t -65.89 -176.19 0.36 Allowed 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.603 0.716 . . . . 0.0 109.648 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.577 HG12 ' CD1' ' B' ' 50' ' ' ILE . 17.7 m -152.68 -153.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 80' ' ' LYS . . . . . 0.719 ' HB3' ' HD3' ' B' ' 81' ' ' PRO . 13.0 ttmt -164.99 -57.58 0.01 OUTLIER Pre-proline 0 C--N 1.294 -1.808 0 O-C-N 121.452 -0.78 . . . . 0.0 109.985 178.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 81' ' ' PRO . . . . . 0.719 ' HD3' ' HB3' ' B' ' 80' ' ' LYS . 44.3 Cg_endo -95.95 164.84 1.33 Allowed 'Trans proline' 0 C--N 1.296 -2.213 0 C-N-CA 121.825 1.683 . . . . 0.0 112.842 -179.047 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 82' ' ' GLY . . . . . 0.711 ' N ' ' O ' ' B' ' 47' ' ' PHE . . . 177.05 -25.39 0.06 OUTLIER Glycine 0 C--N 1.287 -2.141 0 N-CA-C 105.774 -2.93 . . . . 0.0 105.774 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 83' ' ' GLU . . . . . 0.908 ' O ' ' N ' ' B' ' 85' ' ' LEU . 22.5 tt0 30.76 49.84 0.09 Allowed 'General case' 0 C--O 1.205 -1.268 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 84' ' ' SER . . . . . 1.3 ' O ' ' N ' ' B' ' 86' ' ' LYS . 1.2 m 12.67 43.93 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.941 1.353 . . . . 0.0 109.093 -178.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 1.116 ' O ' ' N ' ' B' ' 88' ' ' ALA . 0.3 OUTLIER 23.05 26.4 0.0 OUTLIER 'General case' 0 C--O 1.187 -2.225 0 N-CA-C 102.785 -3.043 . . . . 0.0 102.785 -170.182 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 86' ' ' LYS . . . . . 1.3 ' N ' ' O ' ' B' ' 84' ' ' SER 0.324 21.8 tttt -37.33 -40.83 0.37 Allowed 'General case' 0 CA--C 1.486 -1.497 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 176.624 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 87' ' ' LYS . . . . . 0.426 ' N ' ' C ' ' B' ' 85' ' ' LEU 0.307 0.0 OUTLIER -61.06 -39.71 90.9 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-N 111.865 -2.425 . . . . 0.0 106.711 175.355 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 1.116 ' N ' ' O ' ' B' ' 85' ' ' LEU . . . -90.03 -21.62 22.27 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.433 -0.907 . . . . 0.0 108.966 178.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.711 ' N ' ' O ' ' B' ' 85' ' ' LEU . . . -71.83 -36.74 70.3 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 178.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -66.51 -31.93 72.97 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 174.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -60.88 -42.18 99.53 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 92' ' ' LEU . . . . . 0.862 ' O ' HD12 ' B' ' 92' ' ' LEU . 1.2 pp -85.34 21.17 1.8 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 120.443 -1.622 . . . . 0.0 110.581 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 93' ' ' LYS . . . . . 0.453 ' O ' ' N ' ' B' ' 96' ' ' ASP . 0.8 OUTLIER 55.66 45.22 25.11 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 -178.071 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 94' ' ' TYR . . . . . 0.61 ' CE2' ' HA ' ' A' ' 74' ' ' SER . 0.0 OUTLIER -37.29 -43.69 0.55 Allowed 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.661 -178.862 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 95' ' ' GLU . . . . . 0.528 ' O ' ' HB3' ' B' ' 98' ' ' ALA . 8.7 pt-20 -54.42 -41.84 69.79 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.297 -0.877 . . . . 0.0 109.535 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 96' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' B' ' 93' ' ' LYS . 0.7 OUTLIER -59.76 -34.29 72.79 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.193 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 97' ' ' PHE . . . . . 0.739 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -69.74 -27.48 64.99 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.272 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 98' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' B' ' 95' ' ' GLU . . . -67.04 -53.01 35.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.588 -0.695 . . . . 0.0 110.215 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.234 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.5 ' HG2' ' HB3' ' A' ' 5' ' ' GLU . 11.2 mtp . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 120.852 0.358 . . . . 0.0 110.093 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.486 ' C ' HD12 ' A' ' 6' ' ' LEU . 7.8 t-20 -179.17 -179.86 0.6 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.261 -0.9 . . . . 0.0 110.304 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.529 ' O ' HG13 ' A' ' 7' ' ' ILE . 0.6 OUTLIER -52.63 -20.08 2.8 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.12 -0.988 . . . . 0.0 109.931 179.668 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.464 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 16.6 m -97.69 -46.68 5.9 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.545 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -62.55 -47.04 85.6 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 178.657 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.743 HD11 HG13 ' B' ' 42' ' ' VAL . 2.4 mt -65.69 -29.68 70.26 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.193 178.05 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.831 HG23 ' HB ' ' A' ' 21' ' ' VAL . 0.3 OUTLIER -56.34 -58.76 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 178.428 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.973 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 0.2 OUTLIER -62.64 -27.47 69.24 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.506 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 6' ' ' LEU . . . -61.22 -32.19 71.97 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.202 -0.937 . . . . 0.0 108.708 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.852 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.2 tp -96.29 -37.59 7.44 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.549 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 178.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.973 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -59.38 -24.19 63.2 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.428 ' HB3' ' O ' ' A' ' 8' ' ' LYS . 39.3 tp60 -92.5 -45.15 8.27 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.434 ' HB3' ' CB ' ' B' ' 27' ' ' SER . 3.3 m-20 -63.81 -32.12 73.52 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 177.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.948 HG22 ' OG ' ' B' ' 20' ' ' SER . 27.7 p -82.5 -74.01 0.37 Allowed 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 58.87 14.79 24.99 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.936 HD22 ' O ' ' B' ' 19' ' ' VAL . 2.9 mp -77.0 -47.31 21.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.542 -0.976 . . . . 0.0 108.615 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.664 ' HB ' HG21 ' B' ' 17' ' ' THR . 0.5 OUTLIER -160.69 5.57 0.07 Allowed 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 120.0 -0.68 . . . . 0.0 111.055 -179.158 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.552 ' O ' ' C ' ' A' ' 19' ' ' VAL . 13.7 mt-30 58.97 25.52 13.89 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 -176.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.982 HG11 HG11 ' B' ' 19' ' ' VAL . 1.9 p -5.03 -93.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.942 -178.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.965 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -130.32 25.05 5.18 Favored 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 179.695 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.831 ' HB ' HG23 ' A' ' 7' ' ' ILE . 12.5 m -19.26 -40.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 CA-C-O 122.553 1.168 . . . . 0.0 109.548 -178.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.826 ' N ' ' O ' ' A' ' 20' ' ' SER . 29.2 t -80.06 -35.75 36.62 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.999 178.217 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.965 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.3 OUTLIER -90.8 -36.21 14.38 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.479 -0.763 . . . . 0.0 110.891 179.561 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.755 ' O ' HD11 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -67.61 -38.64 84.23 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 117.626 -1.63 . . . . 0.0 108.994 179.462 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.763 HD12 HG13 ' A' ' 7' ' ' ILE . 0.2 OUTLIER -78.29 -48.04 16.53 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 117.858 -1.537 . . . . 0.0 109.112 178.455 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.478 ' HA ' ' HE3' ' A' ' 3' ' ' LYS . . . -54.97 -37.24 66.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.747 -1.221 . . . . 0.0 107.831 177.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.588 ' O ' HG13 ' A' ' 31' ' ' ILE . 8.4 t -83.18 -28.82 29.06 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.13 178.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.667 ' CE1' HD22 ' B' ' 44' ' ' LEU . 2.8 t80 -51.91 -49.26 63.4 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.847 ' HG3' ' CD1' ' B' ' 47' ' ' PHE . 3.3 tt0 -67.17 -35.52 79.83 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 176.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 1.285 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 32.6 tttt -66.11 -17.88 64.99 Favored 'General case' 0 C--O 1.193 -1.913 0 C-N-CA 119.527 -0.869 . . . . 0.0 108.951 178.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.61 HG13 ' O ' ' A' ' 28' ' ' PHE . 1.3 pp -109.24 -26.21 3.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 119.786 -1.821 . . . . 0.0 109.344 178.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.658 ' O ' HG22 ' A' ' 36' ' ' VAL . 1.2 mm -76.5 -54.7 12.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 177.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.77 ' HA ' ' HG ' ' B' ' 85' ' ' LEU . 0.6 OUTLIER -79.35 -29.39 42.19 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.876 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 1.285 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 41.5 mm-40 -78.5 -29.88 46.89 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 118.851 -1.14 . . . . 0.0 110.232 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.537 ' HA ' ' HB2' ' A' ' 38' ' ' LYS . 7.2 m -73.73 -58.73 3.1 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 117.718 -1.593 . . . . 0.0 107.916 178.035 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.658 HG22 ' O ' ' A' ' 32' ' ' ILE . 24.7 m -43.22 -40.7 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.734 ' O ' ' HB2' ' B' ' 92' ' ' LEU . . . -79.01 -32.56 45.16 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.787 ' N ' HD12 ' B' ' 92' ' ' LEU . 0.0 OUTLIER -60.44 -27.66 67.68 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 105.129 -2.175 . . . . 0.0 105.129 176.664 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.484 ' CA ' ' CZ ' ' B' ' 97' ' ' PHE . . . 116.74 26.98 2.91 Favored Glycine 0 C--N 1.297 -1.628 0 CA-C-N 114.363 -1.29 . . . . 0.0 111.025 176.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.508 ' HB2' HG23 ' A' ' 35' ' ' THR . 0.2 OUTLIER -122.0 137.34 54.84 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.251 -1.146 . . . . 0.0 110.072 179.213 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.9 mttm -82.02 87.73 6.44 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.535 -0.728 . . . . 0.0 110.704 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.466 HG22 ' CG1' ' A' ' 36' ' ' VAL . 33.2 m -65.09 140.18 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.446 -0.784 . . . . 0.0 109.718 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.5 ' O ' ' HA ' ' B' ' 2' ' ' ASN . 9.0 mt-30 -135.29 172.22 13.32 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.168 -0.958 . . . . 0.0 110.251 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.948 HD22 ' CE1' ' B' ' 28' ' ' PHE . 11.7 mt -131.65 115.99 16.77 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.214 -0.929 . . . . 0.0 110.332 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.571 HG23 ' HD2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER 26.82 -93.41 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.891 -0.506 . . . . 0.0 111.853 178.892 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.428 ' N ' ' OG1' ' A' ' 45' ' ' THR . . . -153.27 33.87 0.78 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.811 ' CD2' ' HG3' ' B' ' 29' ' ' GLU . 3.2 p90 -131.44 -15.3 3.2 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.265 -1.138 . . . . 0.0 111.154 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.89 HD12 ' O ' ' A' ' 80' ' ' LYS . 47.6 tp -161.05 121.61 2.79 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 118.261 -1.375 . . . . 0.0 111.085 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.477 ' HA ' ' HA ' ' A' ' 43' ' ' GLN . 16.2 m-20 -131.59 118.16 19.71 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.46 0.648 . . . . 0.0 111.163 -178.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.665 HD13 HG23 ' A' ' 79' ' ' VAL . 5.0 mm -94.61 151.51 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.677 -0.639 . . . . 0.0 109.564 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.458 ' O ' ' N ' ' A' ' 78' ' ' SER . 11.5 ptmt -165.52 115.1 0.83 Allowed Pre-proline 0 N--CA 1.5 2.051 0 O-C-N 120.68 -1.263 . . . . 0.0 110.851 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.645 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 43.9 Cg_endo -82.69 155.78 15.83 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 O-C-N 123.515 1.271 . . . . 0.0 112.024 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.726 HG22 ' O ' ' A' ' 76' ' ' GLY . 33.0 m -147.62 118.42 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 CA-C-O 121.669 0.747 . . . . 0.0 110.701 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.574 ' HA ' ' CE1' ' B' ' 94' ' ' TYR . . . -77.47 117.99 19.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.635 -0.666 . . . . 0.0 111.428 -179.003 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.441 ' HB3' ' O ' ' A' ' 54' ' ' ALA . 2.7 ptp180 171.71 63.56 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.773 -0.579 . . . . 0.0 109.463 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.459 ' O ' ' HA ' ' A' ' 73' ' ' PRO . 45.7 mt-30 -150.92 72.16 1.06 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.116 -0.99 . . . . 0.0 111.751 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.956 ' HA ' HG12 ' A' ' 71' ' ' ILE . . . -145.44 65.66 1.24 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.077 -1.014 . . . . 0.0 110.339 179.014 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.895 ' CA ' HG23 ' A' ' 71' ' ' ILE 0.253 0.8 OUTLIER -179.48 123.45 0.08 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.286 -0.884 . . . . 0.0 112.301 -178.566 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.778 ' HB2' HG21 ' A' ' 71' ' ' ILE . 5.5 ttmt 169.1 19.57 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.163 -0.961 . . . . 0.0 110.257 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.549 ' HA3' ' HG ' ' A' ' 69' ' ' LEU . . . -86.46 5.15 85.26 Favored Glycine 0 N--CA 1.484 1.885 0 C-N-CA 119.68 -1.248 . . . . 0.0 110.107 -179.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.939 ' CZ ' ' HB2' ' A' ' 68' ' ' ALA . 1.7 m-85 -50.53 -177.75 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.08 -1.247 . . . . 0.0 109.802 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.717 ' HB3' ' CD ' ' A' ' 63' ' ' PRO . 2.4 t-20 -127.8 -82.96 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.636 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.026 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.717 ' CD ' ' HB3' ' A' ' 62' ' ' ASN . 44.2 Cg_endo -77.66 -5.26 15.31 Favored 'Trans proline' 0 C--N 1.322 -0.838 0 N-CA-C 107.103 -1.922 . . . . 0.0 107.103 174.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.594 ' CB ' ' O ' ' A' ' 63' ' ' PRO . 11.5 tt0 88.63 60.56 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.33 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 178.012 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . 1.086 HG23 ' NE2' ' A' ' 66' ' ' GLN . 0.0 OUTLIER 172.15 23.59 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.404 0 O-C-N 121.379 -0.826 . . . . 0.0 111.954 177.791 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 1.086 ' NE2' HG23 ' A' ' 65' ' ' THR . 26.3 mp0 -146.21 -112.37 0.09 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.547 -1.345 . . . . 0.0 111.406 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.423 ' O ' HD23 ' A' ' 69' ' ' LEU . 0.9 OUTLIER -64.45 82.48 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.947 -1.096 . . . . 0.0 110.526 -179.044 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.939 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . . . -76.25 64.88 2.11 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.577 -0.702 . . . . 0.0 110.359 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.845 ' O ' ' O ' ' A' ' 70' ' ' GLU . 0.4 OUTLIER -65.7 66.9 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.488 -0.758 . . . . 0.0 110.374 179.79 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.845 ' O ' ' O ' ' A' ' 69' ' ' LEU . 39.2 mt-10 -19.2 -164.71 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 115.972 1.842 . . . . 0.0 115.972 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.956 HG12 ' HA ' ' A' ' 57' ' ' ALA 0.298 0.1 OUTLIER -134.02 -163.6 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-N 114.071 -1.422 . . . . 0.0 109.729 -175.044 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.657 ' N ' HG13 ' A' ' 71' ' ' ILE . . . -88.88 120.18 70.0 Favored Pre-proline 0 C--N 1.286 -2.152 0 O-C-N 121.888 -0.507 . . . . 0.0 111.712 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.752 ' CA ' ' HB2' ' A' ' 57' ' ' ALA . 37.1 Cg_endo -62.55 124.46 14.24 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 123.876 1.461 . . . . 0.0 109.752 178.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.485 ' C ' ' CE1' ' B' ' 94' ' ' TYR . 5.3 m -148.49 140.14 23.64 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.479 -0.763 . . . . 0.0 110.132 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.91 HG11 ' HB3' ' B' ' 89' ' ' ALA . 7.5 p -50.09 161.47 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.46 -0.775 . . . . 0.0 111.413 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.726 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -116.9 68.75 0.3 Allowed Glycine 0 N--CA 1.487 2.088 0 N-CA-C 108.749 -1.741 . . . . 0.0 108.749 179.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.894 ' CG2' HD22 ' B' ' 85' ' ' LEU . 6.4 p -47.08 80.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.963 -0.728 . . . . 0.0 111.622 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.642 ' C ' HG12 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -77.15 176.66 8.51 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 177.757 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.665 HG23 HD13 ' A' ' 50' ' ' ILE . 0.2 OUTLIER 177.49 174.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -179.745 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.89 ' O ' HD12 ' A' ' 48' ' ' LEU . 6.5 ptpt -178.15 170.21 0.87 Allowed Pre-proline 0 C--N 1.299 -1.599 0 O-C-N 121.538 -0.726 . . . . 0.0 109.557 176.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.573 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 56.0 Cg_endo -100.69 176.28 0.27 Allowed 'Trans proline' 0 C--N 1.292 -2.447 0 C-N-CA 122.6 2.2 . . . . 0.0 110.943 178.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 47' ' ' PHE . . . -126.27 163.2 20.29 Favored Glycine 0 N--CA 1.485 1.958 0 N-CA-C 107.084 -2.407 . . . . 0.0 107.084 177.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -58.06 -22.5 50.58 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.751 -1.441 . . . . 0.0 110.905 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.436 ' CB ' ' HB3' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -53.54 -35.29 60.56 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.0 -1.063 . . . . 0.0 108.894 179.198 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.966 HD13 ' CG1' ' B' ' 77' ' ' VAL . 0.5 OUTLIER -82.31 -25.65 33.77 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.742 -0.599 . . . . 0.0 109.386 178.711 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.572 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 20.4 mttt -84.86 -30.67 24.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.345 -0.847 . . . . 0.0 109.956 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -73.5 -38.43 65.37 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.831 ' O ' ' HB1' ' B' ' 37' ' ' ALA . . . -63.65 -37.28 86.73 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 176.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 1.002 ' HB1' ' CG1' ' B' ' 75' ' ' VAL . . . -54.92 -44.46 74.26 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 120.106 -0.638 . . . . 0.0 109.362 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.46 ' HA ' ' CB ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -54.47 -29.37 49.72 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.247 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 88' ' ' ALA . . . -67.9 -40.86 89.07 Favored Glycine 0 N--CA 1.488 2.122 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.31 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.89 HD11 ' CZ ' ' A' ' 97' ' ' PHE . 0.3 OUTLIER -70.39 -47.63 59.96 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 119.895 1.847 . . . . 0.0 110.533 -178.948 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.645 ' O ' ' CG ' ' A' ' 93' ' ' LYS . 0.1 OUTLIER 160.35 57.0 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.175 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.931 ' CD2' ' HB2' ' B' ' 74' ' ' SER . 17.4 t80 -53.18 -65.47 0.55 Allowed 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 178.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 1.048 ' O ' ' N ' ' A' ' 98' ' ' ALA . 1.0 OUTLIER 5.41 41.97 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 103.208 -2.886 . . . . 0.0 103.208 175.833 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 1.228 ' CA ' ' HB3' ' B' ' 74' ' ' SER . 0.0 OUTLIER 17.11 42.47 0.0 OUTLIER 'General case' 0 CA--C 1.461 -2.455 0 CA-C-N 113.176 -1.829 . . . . 0.0 109.515 -172.327 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 1.06 ' C ' ' O ' ' A' ' 96' ' ' ASP 0.327 69.5 m-85 30.52 25.1 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.744 1 N-CA-C 97.542 -4.985 . . . . 0.0 97.542 -168.671 . . . . . . . . 4 3 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 1.169 ' HB2' ' CG ' ' A' ' 96' ' ' ASP 0.258 . . -50.87 -26.1 5.38 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 110.012 -3.267 . . . . 0.0 108.596 -178.565 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.829 0 CA-C-N 114.351 -1.295 . . . . 0.0 110.494 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.478 ' HA ' ' HB2' ' B' ' 5' ' ' GLU . 5.5 mtp . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 120.881 0.372 . . . . 0.0 110.259 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 2' ' ' ASN . . . . . 0.667 ' O ' HD12 ' B' ' 6' ' ' LEU . 16.4 m-80 -147.45 -155.99 0.68 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.076 -1.015 . . . . 0.0 111.083 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.526 ' O ' ' CG2' ' B' ' 7' ' ' ILE . 1.0 OUTLIER -60.92 2.17 0.12 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.342 -0.849 . . . . 0.0 110.446 179.765 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.686 ' O ' HG13 ' B' ' 7' ' ' ILE . 4.5 m -116.3 -63.25 1.48 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 122.147 0.975 . . . . 0.0 108.904 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.478 ' HB2' ' HA ' ' B' ' 1' ' ' MET . 5.5 mm-40 -52.03 -48.05 64.71 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.214 -0.929 . . . . 0.0 108.515 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.667 HD12 ' O ' ' B' ' 2' ' ' ASN . 7.5 mt -56.72 -32.8 65.87 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 119.122 -1.031 . . . . 0.0 110.256 178.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 7' ' ' ILE . . . . . 0.686 HG13 ' O ' ' B' ' 4' ' ' THR . 1.1 pp -60.72 -42.42 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.54 -1.35 . . . . 0.0 107.91 179.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 8' ' ' LYS . . . . . 0.822 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.0 OUTLIER -71.93 -27.2 62.65 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.29 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 9' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' B' ' 6' ' ' LEU . . . -62.54 -36.35 82.35 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.958 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.0 OUTLIER -95.46 -35.24 5.79 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.382 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.787 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.822 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -56.32 -25.25 48.15 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -92.49 -46.82 7.45 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.522 ' OD2' HG21 ' A' ' 31' ' ' ILE . 87.0 m-20 -61.64 -24.97 67.08 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 177.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.958 ' OG1' ' O ' ' B' ' 10' ' ' ILE . 17.2 p -93.77 -77.93 0.44 Allowed 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 177.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 61.46 9.23 16.46 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 16' ' ' LEU . . . . . 0.944 HD22 ' O ' ' A' ' 19' ' ' VAL . 3.2 mp -72.75 -60.25 2.32 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.377 -1.072 . . . . 0.0 108.343 179.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 17' ' ' THR . . . . . 0.664 HG21 ' HB ' ' A' ' 17' ' ' THR . 0.5 OUTLIER -143.5 3.44 1.31 Allowed 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.598 179.659 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 18' ' ' GLN . . . . . 0.639 ' O ' ' C ' ' B' ' 19' ' ' VAL . 4.9 mt-30 59.1 25.33 13.79 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 106.565 -1.642 . . . . 0.0 106.565 -176.424 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.982 HG11 HG11 ' A' ' 19' ' ' VAL . 2.2 p 2.54 -97.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.481 -179.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.95 ' O ' ' N ' ' B' ' 23' ' ' LYS . 0.3 OUTLIER -131.55 21.77 4.7 Favored 'General case' 0 C--N 1.278 -2.525 0 N-CA-C 105.655 -1.98 . . . . 0.0 105.655 175.891 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.959 ' HA ' ' HE2' ' B' ' 24' ' ' MET . 21.2 m -15.31 -39.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-O 122.426 1.108 . . . . 0.0 109.444 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.936 ' N ' ' O ' ' B' ' 20' ' ' SER . 16.5 m -77.41 -45.01 27.2 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.983 177.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 23' ' ' LYS . . . . . 0.95 ' N ' ' O ' ' B' ' 20' ' ' SER . 6.6 mtmt -96.76 -14.36 22.03 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 121.482 -0.761 . . . . 0.0 109.719 178.322 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 24' ' ' MET . . . . . 0.959 ' HE2' ' HA ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -71.78 -36.06 70.23 Favored 'General case' 0 C--O 1.216 -0.71 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 177.708 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.556 ' HA ' ' HB3' ' B' ' 28' ' ' PHE . 3.4 mt -84.51 -36.16 22.41 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 176.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 26' ' ' ALA . . . . . 0.734 ' HB3' ' HA ' ' B' ' 23' ' ' LYS . . . -61.48 -34.21 75.09 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 27' ' ' SER . . . . . 0.483 ' O ' HG13 ' B' ' 31' ' ' ILE . 11.1 m -77.45 -34.76 54.41 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 28' ' ' PHE . . . . . 0.948 ' CE1' HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -52.36 -45.53 65.77 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.745 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 29' ' ' GLU . . . . . 0.811 ' HG3' ' CD2' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -68.72 -35.96 77.82 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 118.455 -1.298 . . . . 0.0 107.577 177.08 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 1.158 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 23.5 ttmt -63.92 -22.58 66.99 Favored 'General case' 0 C--O 1.191 -1.978 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.64 HD11 ' HA ' ' B' ' 28' ' ' PHE . 0.4 OUTLIER -105.08 -27.99 3.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 O-C-N 120.24 -1.537 . . . . 0.0 108.935 177.963 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.654 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.1 mm -72.46 -58.75 4.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 177.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 33' ' ' THR . . . . . 0.664 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 0.5 OUTLIER -69.05 -36.13 77.36 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.49 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 1.158 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 22.3 mm-40 -75.19 -39.03 60.52 Favored 'General case' 0 C--O 1.206 -1.185 0 C-N-CA 119.156 -1.018 . . . . 0.0 111.832 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 35' ' ' THR . . . . . 0.516 ' HA ' ' CB ' ' B' ' 38' ' ' LYS . 55.4 m -62.77 -51.59 66.51 Favored 'General case' 0 N--CA 1.504 2.229 0 CA-C-N 120.546 1.521 . . . . 0.0 109.826 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.692 ' HB ' HD21 ' A' ' 85' ' ' LEU . 2.4 t -53.85 -36.77 31.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 178.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 0.831 ' HB1' ' O ' ' A' ' 88' ' ' ALA . . . -94.66 11.65 30.47 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.581 0.705 . . . . 0.0 109.424 177.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 38' ' ' LYS . . . . . 0.741 ' HB2' ' O ' ' B' ' 34' ' ' GLU . 0.1 OUTLIER -106.76 -33.62 7.53 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 176.933 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 131.07 38.46 0.28 Allowed Glycine 0 C--N 1.303 -1.264 0 C-N-CA 119.837 -1.173 . . . . 0.0 111.033 177.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 40' ' ' ASP . . . . . 0.493 ' HB2' HG23 ' B' ' 35' ' ' THR . 0.2 OUTLIER -147.82 147.31 29.68 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.771 -1.429 . . . . 0.0 111.235 179.634 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -91.4 95.96 10.26 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.743 HG13 HD11 ' A' ' 6' ' ' LEU . 61.8 t -59.27 124.65 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.655 -0.653 . . . . 0.0 110.924 -178.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 43' ' ' GLN . . . . . 0.426 ' CG ' ' O ' ' A' ' 1' ' ' MET . 11.1 pt20 -120.68 96.79 5.26 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.454 -0.779 . . . . 0.0 109.235 178.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.736 HD12 ' HB3' ' B' ' 48' ' ' LEU . 10.6 mt -65.53 113.2 4.0 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.497 -0.752 . . . . 0.0 110.406 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 45' ' ' THR . . . . . 0.632 HG23 ' HD1' ' B' ' 47' ' ' PHE . 0.0 OUTLIER 29.4 -91.97 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.99 -0.444 . . . . 0.0 111.39 179.351 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -149.85 29.51 1.14 Allowed Glycine 0 N--CA 1.484 1.884 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 47' ' ' PHE . . . . . 0.847 ' CD1' ' HG3' ' A' ' 29' ' ' GLU . 3.9 p90 -132.66 -23.97 2.01 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.044 -1.268 . . . . 0.0 111.743 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.736 ' HB3' HD12 ' B' ' 44' ' ' LEU . 7.3 mt -132.59 105.62 7.32 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.382 -1.449 . . . . 0.0 111.876 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 49' ' ' ASN . . . . . 0.431 ' O ' ' HA ' ' B' ' 79' ' ' VAL . 0.1 OUTLIER -110.38 88.63 2.81 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.283 -0.886 . . . . 0.0 110.603 179.561 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 50' ' ' ILE . . . . . 0.609 HD11 ' CD2' ' A' ' 48' ' ' LEU . 1.1 mm -76.83 148.91 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.413 -0.804 . . . . 0.0 110.303 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 51' ' ' LYS . . . . . 0.418 ' HG3' ' CB ' ' B' ' 78' ' ' SER . 0.0 OUTLIER -161.17 126.75 2.27 Favored Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 120.918 -1.114 . . . . 0.0 110.182 179.096 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.49 ' HB3' HG13 ' B' ' 36' ' ' VAL . 50.1 Cg_endo -75.74 146.82 30.53 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.493 1.26 . . . . 0.0 111.334 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.523 ' O ' HG23 ' B' ' 53' ' ' VAL . 33.3 m -146.38 123.74 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.68 -0.637 . . . . 0.0 110.56 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 1.073 ' HA ' ' C ' ' B' ' 74' ' ' SER . . . -65.93 112.91 4.04 Favored 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 118.857 -1.137 . . . . 0.0 111.713 -178.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 55' ' ' ARG . . . . . 0.417 ' HB3' ' O ' ' B' ' 54' ' ' ALA . 0.6 OUTLIER 170.56 66.19 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.134 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.581 -179.857 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 56' ' ' GLN . . . . . 0.478 ' H ' ' N ' ' B' ' 74' ' ' SER . 3.9 mt-30 -138.49 89.06 2.35 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.281 -0.887 . . . . 0.0 111.248 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.653 ' HB2' ' CD ' ' B' ' 73' ' ' PRO . . . -138.05 -152.57 0.44 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.109 -0.994 . . . . 0.0 111.086 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 58' ' ' ARG . . . . . 0.736 ' O ' ' O ' ' B' ' 59' ' ' LYS . 10.2 ptt180 -155.49 -142.04 0.1 Allowed 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.333 -0.947 . . . . 0.0 112.285 -177.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 59' ' ' LYS . . . . . 0.736 ' O ' ' O ' ' B' ' 58' ' ' ARG . 0.0 OUTLIER -40.63 -137.36 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 CA-C-O 121.065 0.46 . . . . 0.0 111.749 179.789 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 60' ' ' GLY . . . . . 0.482 ' O ' ' CB ' ' B' ' 61' ' ' PHE . . . 66.27 -159.0 47.91 Favored Glycine 0 N--CA 1.485 1.904 0 O-C-N 120.865 -1.147 . . . . 0.0 110.415 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 61' ' ' PHE . . . . . 0.482 ' CB ' ' O ' ' B' ' 60' ' ' GLY . 19.2 t80 163.05 115.45 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 62' ' ' ASN . . . . . 0.449 ' O ' ' N ' ' B' ' 64' ' ' GLN . 0.9 OUTLIER -61.39 170.61 1.63 Allowed Pre-proline 0 C--N 1.301 -1.539 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.256 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -70.25 63.46 2.07 Favored 'Trans proline' 0 C--N 1.302 -1.888 0 N-CA-C 108.236 -1.486 . . . . 0.0 108.236 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 64' ' ' GLN . . . . . 0.703 ' O ' HG23 ' B' ' 65' ' ' THR . 22.3 mt-30 -128.45 -110.53 0.28 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.692 -0.803 . . . . 0.0 112.115 -178.028 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.703 HG23 ' O ' ' B' ' 64' ' ' GLN . 0.8 OUTLIER -162.35 -31.04 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.203 -0.936 . . . . 0.0 109.866 -179.747 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -137.95 9.92 2.82 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.487 -0.758 . . . . 0.0 111.021 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 67' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' B' ' 61' ' ' PHE . 3.6 tt0 -94.28 87.9 5.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.941 -1.099 . . . . 0.0 109.835 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -84.61 137.92 33.0 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.629 -0.669 . . . . 0.0 110.913 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.585 ' N ' ' O ' ' B' ' 59' ' ' LYS . 0.8 OUTLIER -177.18 100.23 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.464 -0.773 . . . . 0.0 110.529 179.742 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 70' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' B' ' 59' ' ' LYS . 0.0 OUTLIER -84.61 14.08 4.99 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.71 -1.244 . . . . 0.0 108.937 178.799 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.721 HG22 ' HG2' ' B' ' 58' ' ' ARG 0.255 0.2 OUTLIER -159.29 176.6 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -179.329 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' B' B ' 72' ' ' ALA . . . . . 0.753 ' O ' ' OH ' ' A' ' 94' ' ' TYR 0.25 . . -91.85 98.53 1.96 Allowed Pre-proline 0 C--N 1.291 -1.955 0 O-C-N 121.519 -0.738 . . . . 0.0 110.344 179.04 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 73' ' ' PRO . . . . . 0.653 ' CD ' ' HB2' ' B' ' 57' ' ' ALA . 37.2 Cg_endo -67.1 135.9 38.97 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 123.555 1.292 . . . . 0.0 112.006 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 74' ' ' SER . . . . . 1.228 ' HB3' ' CA ' ' A' ' 96' ' ' ASP . 0.8 OUTLIER -159.8 -159.58 0.74 Allowed 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 179.868 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 75' ' ' VAL . . . . . 1.002 ' CG1' ' HB1' ' A' ' 89' ' ' ALA . 74.1 t -20.31 113.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-O 122.696 1.236 . . . . 0.0 112.036 -176.142 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 76' ' ' GLY . . . . . 0.543 ' C ' HG23 ' B' ' 77' ' ' VAL . . . -109.2 -142.96 9.94 Favored Glycine 0 C--N 1.283 -2.399 0 N-CA-C 106.764 -2.534 . . . . 0.0 106.764 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.966 ' CG1' HD13 ' A' ' 85' ' ' LEU . 99.2 t -155.18 77.57 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 O-C-N 121.279 -1.13 . . . . 0.0 110.138 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 78' ' ' SER . . . . . 0.438 ' O ' ' HB ' ' B' ' 79' ' ' VAL . 0.6 OUTLIER -74.74 175.95 7.47 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 118.788 -1.165 . . . . 0.0 110.147 179.745 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.614 HG22 ' N ' ' B' ' 80' ' ' LYS . 5.9 p 176.25 177.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 80' ' ' LYS . . . . . 0.632 ' O ' HD23 ' B' ' 48' ' ' LEU . 0.1 OUTLIER -177.35 174.3 0.65 Allowed Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 120.878 -1.138 . . . . 0.0 110.604 178.053 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 81' ' ' PRO . . . . . 0.574 ' HA ' ' O ' ' B' ' 47' ' ' PHE . 51.5 Cg_endo -90.86 144.36 3.55 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.245 1.964 . . . . 0.0 110.137 178.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 82' ' ' GLY . . . . . 0.51 ' H ' ' HA ' ' B' ' 47' ' ' PHE . . . -106.24 41.45 2.17 Favored Glycine 0 N--CA 1.496 2.663 0 C-N-CA 120.002 -1.094 . . . . 0.0 110.608 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 83' ' ' GLU . . . . . 0.458 ' O ' ' N ' ' B' ' 87' ' ' LYS . 0.3 OUTLIER 66.46 -48.59 0.44 Allowed 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.419 -1.048 . . . . 0.0 111.604 179.669 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 84' ' ' SER . . . . . 0.418 ' N ' ' O ' ' B' ' 82' ' ' GLY . 4.9 t -46.1 -31.93 2.62 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.192 -0.942 . . . . 0.0 109.488 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.894 HD22 ' CG2' ' A' ' 77' ' ' VAL . 4.0 tt -86.16 -32.76 21.1 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.425 0.631 . . . . 0.0 109.436 178.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 86' ' ' LYS . . . . . 0.649 ' HG3' HG12 ' A' ' 77' ' ' VAL . 14.8 tttt -81.95 -22.01 36.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.456 -0.777 . . . . 0.0 110.329 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 87' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' B' ' 83' ' ' GLU . 0.0 OUTLIER -90.81 -29.74 17.4 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.642 ' O ' ' HG ' ' B' ' 92' ' ' LEU . . . -70.56 -36.23 73.51 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 177.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.91 ' HB3' HG11 ' A' ' 75' ' ' VAL . . . -73.51 -40.42 64.06 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 119.891 -0.724 . . . . 0.0 109.466 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.447 ' CG ' ' HA ' ' A' ' 74' ' ' SER . 0.1 OUTLIER -57.4 -22.28 41.97 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.488 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -101.44 -12.7 34.94 Favored Glycine 0 N--CA 1.485 1.926 0 C-N-CA 120.069 -1.062 . . . . 0.0 113.181 -178.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 92' ' ' LEU . . . . . 0.787 HD12 ' N ' ' A' ' 38' ' ' LYS . 3.4 mt -94.35 -69.4 0.75 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 121.751 2.775 . . . . 0.0 111.281 -179.035 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 93' ' ' LYS . . . . . 0.455 ' HB3' ' CE1' ' B' ' 97' ' ' PHE . 0.6 OUTLIER -148.4 49.31 1.03 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.0 -1.063 . . . . 0.0 111.23 -179.576 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 94' ' ' TYR . . . . . 0.584 ' CE2' ' HB2' ' A' ' 73' ' ' PRO . 55.3 t80 -53.85 -48.74 69.68 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.151 -0.968 . . . . 0.0 109.866 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -64.25 -38.82 92.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.455 -0.778 . . . . 0.0 109.858 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.37 -27.78 57.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.526 -0.734 . . . . 0.0 109.547 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 97' ' ' PHE . . . . . 0.484 ' CZ ' ' CA ' ' A' ' 39' ' ' GLY . 2.9 m-85 -89.62 -28.11 19.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.493 -0.754 . . . . 0.0 109.615 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.76 -31.71 72.71 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.432 -0.793 . . . . 0.0 110.049 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.175 179.935 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.575 ' CB ' HG12 ' B' ' 42' ' ' VAL . 1.5 mtp . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.505 ' HA ' ' O ' ' B' ' 43' ' ' GLN . 29.4 p-10 -170.25 -151.11 0.08 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.14 -1.024 . . . . 0.0 111.743 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.457 ' NZ ' ' HB ' ' B' ' 45' ' ' THR . 3.6 mttp -53.7 -3.83 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.286 -0.884 . . . . 0.0 111.407 -179.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.687 ' O ' HG13 ' A' ' 7' ' ' ILE . 72.9 m -118.25 -63.93 1.35 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.017 -1.052 . . . . 0.0 110.241 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.532 ' HB2' ' HA ' ' A' ' 1' ' ' MET . 3.9 mt-10 -50.6 -42.93 56.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.907 -1.121 . . . . 0.0 109.375 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.636 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 28.0 mt -61.16 -32.76 72.49 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.201 -1.0 . . . . 0.0 109.726 178.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.687 HG13 ' O ' ' A' ' 4' ' ' THR . 1.0 OUTLIER -60.03 -42.11 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 178.769 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.863 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -68.38 -31.22 70.44 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 177.478 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.636 ' HB3' ' O ' ' A' ' 6' ' ' LEU . . . -56.91 -38.73 73.26 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.497 -0.752 . . . . 0.0 109.008 178.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.724 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.4 mp -93.38 -30.38 4.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 178.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.863 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -63.19 -13.13 33.83 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 118.455 -1.298 . . . . 0.0 108.58 178.227 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -116.9 -45.19 2.78 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.513 -0.742 . . . . 0.0 110.155 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 9' ' ' ALA . 1.0 OUTLIER -67.22 -23.98 65.78 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 177.723 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . 1.138 HG22 ' CD1' ' A' ' 16' ' ' LEU 0.278 0.2 OUTLIER -111.27 -71.96 0.74 Allowed 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 179.25 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 57.31 19.22 31.85 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.421 -0.8 . . . . 0.0 111.228 177.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.138 ' CD1' HG22 ' A' ' 14' ' ' THR . 4.7 mp -60.92 -66.45 0.53 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.414 -1.051 . . . . 0.0 110.015 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.555 HG21 HG21 ' B' ' 17' ' ' THR . 0.6 OUTLIER -135.14 8.59 3.46 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -179.807 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.587 ' O ' ' C ' ' A' ' 19' ' ' VAL . 22.3 mt-30 58.03 27.37 14.75 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 -175.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 1.105 HG23 ' CD1' ' B' ' 16' ' ' LEU . 0.5 OUTLIER -11.32 -95.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.626 -179.222 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.951 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -135.59 24.69 3.43 Favored 'General case' 0 C--N 1.279 -2.488 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 178.471 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.637 ' C ' ' O ' ' A' ' 20' ' ' SER . 26.8 m -18.48 -39.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-O 122.478 1.132 . . . . 0.0 109.71 -177.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.861 ' N ' ' O ' ' A' ' 20' ' ' SER . 4.9 p -84.88 -37.66 20.36 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.808 178.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.951 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.1 OUTLIER -85.56 -33.25 21.77 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.609 -0.682 . . . . 0.0 110.939 179.468 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.525 ' CE ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -74.39 -41.68 60.53 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 118.207 -1.397 . . . . 0.0 108.949 179.493 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.601 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 3.1 mt -69.49 -43.76 72.49 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 118.029 -1.469 . . . . 0.0 108.045 177.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.428 ' HA ' ' HD3' ' A' ' 3' ' ' LYS . . . -61.18 -32.33 72.07 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 177.355 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.547 ' O ' ' N ' ' A' ' 31' ' ' ILE . 7.2 t -75.86 -38.09 58.31 Favored 'General case' 0 C--O 1.207 -1.158 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 177.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.719 ' HA ' ' CG1' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -57.3 -38.08 73.45 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.315 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.872 ' HG2' HG22 ' B' ' 45' ' ' THR . 1.4 mt-10 -77.18 -36.67 54.87 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 1.052 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 15.9 ttpt -69.14 -20.21 64.03 Favored 'General case' 0 C--O 1.19 -2.049 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 177.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.821 HD13 ' HB1' ' B' ' 9' ' ' ALA . 1.1 pp -105.93 -30.69 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 120.603 -1.311 . . . . 0.0 109.342 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.718 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.1 mm -67.43 -54.22 25.6 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 176.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.743 ' HA ' HD12 ' B' ' 85' ' ' LEU . 0.3 OUTLIER -68.73 -40.2 80.0 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.955 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 1.052 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 61.3 mm-40 -73.26 -35.29 66.18 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.329 -0.857 . . . . 0.0 111.49 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.702 HG23 ' HB2' ' A' ' 40' ' ' ASP . 3.4 m -59.3 -50.66 73.12 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.598 -1.314 . . . . 0.0 108.078 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.725 HG22 ' HD3' ' A' ' 52' ' ' PRO . 1.1 t -54.22 -36.94 34.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 177.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.926 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -80.75 -5.04 56.58 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.639 0.733 . . . . 0.0 109.714 177.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -101.05 -24.21 14.35 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.36 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 105.86 40.68 1.96 Allowed Glycine 0 C--N 1.3 -1.433 0 C-N-CA 120.136 -1.031 . . . . 0.0 110.641 178.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.702 ' HB2' HG23 ' A' ' 35' ' ' THR . 0.1 OUTLIER -134.18 123.43 24.33 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.21 -1.171 . . . . 0.0 110.03 179.284 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.422 ' HB2' ' HB3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -79.87 68.48 5.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.438 -0.789 . . . . 0.0 110.629 -179.43 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 1.002 HG13 ' HB ' ' A' ' 50' ' ' ILE . 2.6 p -59.61 145.97 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.168 -0.958 . . . . 0.0 109.405 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -137.8 120.65 16.44 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.238 -0.914 . . . . 0.0 111.03 -178.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.736 HD12 ' CE1' ' A' ' 47' ' ' PHE . 10.1 mt -64.5 -178.81 0.42 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.28 -0.887 . . . . 0.0 109.326 178.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.791 HG22 ' HG2' ' B' ' 29' ' ' GLU . 1.4 t -36.32 -34.16 0.06 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.77 -0.581 . . . . 0.0 111.467 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 166.39 -23.37 0.13 Allowed Glycine 0 N--CA 1.488 2.155 0 C-N-CA 119.686 -1.245 . . . . 0.0 110.398 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.82 ' CG ' HD23 ' A' ' 85' ' ' LEU . 20.2 p90 -81.65 -18.83 43.22 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.885 -1.362 . . . . 0.0 111.395 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.707 ' HB2' HD12 ' A' ' 44' ' ' LEU . 2.7 mt -125.94 100.32 6.32 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 118.553 -1.259 . . . . 0.0 111.611 178.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.639 ' C ' HG23 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -91.81 64.48 4.79 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.056 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 1.011 HD11 HD11 ' B' ' 48' ' ' LEU . 27.2 mm -57.29 116.42 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 O-C-N 121.335 -0.853 . . . . 0.0 112.767 -177.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.552 ' HG2' ' O ' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -172.71 135.7 0.77 Allowed Pre-proline 0 N--CA 1.494 1.734 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.038 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.725 ' HD3' HG22 ' A' ' 36' ' ' VAL . 51.2 Cg_endo -90.63 156.08 4.27 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.473 1.249 . . . . 0.0 113.147 -177.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.61 ' O ' ' N ' ' A' ' 76' ' ' GLY . 27.1 m -132.14 111.94 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 CA-C-O 121.717 0.77 . . . . 0.0 110.195 177.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.746 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . -48.7 142.31 6.29 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 122.07 0.938 . . . . 0.0 112.473 -178.26 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.11 86.57 0.48 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.71 ' O ' HD11 ' A' ' 71' ' ' ILE . 0.6 OUTLIER -55.22 -171.21 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.976 0.893 . . . . 0.0 112.354 -177.916 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.731 ' HB2' ' HB3' ' A' ' 73' ' ' PRO . . . -73.7 -168.08 0.54 Allowed 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.843 0.83 . . . . 0.0 111.962 -178.046 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.793 ' HD3' ' N ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -177.78 -150.92 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -177.563 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.57 ' N ' ' HG2' ' A' ' 58' ' ' ARG . 0.5 OUTLIER 171.01 81.84 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.462 -0.774 . . . . 0.0 110.514 177.691 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.734 ' N ' ' O ' ' A' ' 69' ' ' LEU . . . 38.45 48.73 2.28 Favored Glycine 0 N--CA 1.495 2.616 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.886 ' CE2' HD12 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -94.73 145.44 24.86 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.93 -1.335 . . . . 0.0 113.481 -178.611 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.874 ' H ' ' CD ' ' A' ' 63' ' ' PRO . 15.0 p30 -145.58 -9.48 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 178.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.874 ' CD ' ' H ' ' A' ' 62' ' ' ASN . 46.8 Cg_endo -74.78 -10.62 21.69 Favored 'Trans proline' 0 N--CA 1.481 0.767 0 N-CA-C 108.898 -1.231 . . . . 0.0 108.898 178.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.576 ' CB ' ' CE1' ' A' ' 61' ' ' PHE . 1.0 OUTLIER -87.76 -103.57 0.08 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.661 -0.65 . . . . 0.0 109.356 179.567 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.44 ' O ' ' CB ' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -80.54 -0.31 37.1 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.485 -1.384 . . . . 0.0 109.827 178.87 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.629 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 0.6 OUTLIER 75.29 110.45 0.07 Allowed 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.749 0.785 . . . . 0.0 112.428 178.807 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.605 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 7.9 mt-10 138.58 89.96 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.317 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.716 ' HA ' ' C ' ' A' ' 61' ' ' PHE . . . -41.8 102.6 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.371 0 O-C-N 120.792 -1.192 . . . . 0.0 110.422 -178.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.886 HD12 ' CE2' ' A' ' 61' ' ' PHE . 22.0 mt -96.84 137.26 36.2 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.474 -0.766 . . . . 0.0 110.987 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.682 ' HA ' ' HG2' ' A' ' 58' ' ' ARG . 1.0 OUTLIER -135.99 23.01 3.3 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.694 -0.628 . . . . 0.0 110.463 -179.645 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.78 HD12 ' N ' ' A' ' 72' ' ' ALA . 2.1 pp -58.37 -146.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 O-C-N 121.249 -0.907 . . . . 0.0 110.896 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.78 ' N ' HD12 ' A' ' 71' ' ' ILE . . . -136.82 156.58 75.92 Favored Pre-proline 0 C--N 1.302 -1.492 0 O-C-N 120.852 -1.155 . . . . 0.0 111.458 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.731 ' HB3' ' HB2' ' A' ' 57' ' ' ALA . 45.7 Cg_endo -72.9 94.3 0.8 Allowed 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 121.968 1.779 . . . . 0.0 110.226 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.545 ' HA ' ' CE1' ' B' ' 94' ' ' TYR . 0.5 OUTLIER 178.22 156.06 0.4 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.571 -0.706 . . . . 0.0 109.966 -179.729 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.823 ' CG1' ' HB1' ' B' ' 89' ' ' ALA . 0.4 OUTLIER -56.35 176.24 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.03 -1.044 . . . . 0.0 108.613 179.114 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.61 ' N ' ' O ' ' A' ' 53' ' ' VAL . . . -113.32 -149.14 10.34 Favored Glycine 0 C--N 1.299 -1.487 0 N-CA-C 108.337 -1.905 . . . . 0.0 108.337 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.992 HG11 ' HB3' ' B' ' 81' ' ' PRO . 4.3 t -144.99 86.85 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 CA-C-O 122.021 0.915 . . . . 0.0 108.783 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.514 ' CB ' ' HG3' ' A' ' 51' ' ' LYS . 0.5 OUTLIER -56.37 -44.54 80.25 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.812 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.808 HG12 HG12 ' A' ' 77' ' ' VAL 0.267 13.2 p -47.53 173.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 CA-C-O 122.082 0.944 . . . . 0.0 113.057 -175.226 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.671 ' HB2' ' HD2' ' A' ' 81' ' ' PRO . 0.1 OUTLIER 177.94 176.4 0.3 Allowed Pre-proline 0 N--CA 1.484 1.229 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -178.954 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.671 ' HD2' ' HB2' ' A' ' 80' ' ' LYS . 50.7 Cg_endo -78.07 112.51 3.26 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.612 1.322 . . . . 0.0 109.693 177.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -81.04 -172.53 46.37 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.449 ' HA ' ' HB2' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -77.04 -23.66 52.07 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.363 -1.081 . . . . 0.0 110.62 -179.888 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.26 -37.51 23.83 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.199 -0.938 . . . . 0.0 108.814 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.896 ' CG ' HG21 ' B' ' 77' ' ' VAL . 0.1 OUTLIER -79.63 -35.11 39.94 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.555 0.693 . . . . 0.0 109.152 178.486 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.449 ' HB2' ' HA ' ' A' ' 83' ' ' GLU . 0.1 OUTLIER -73.38 -31.38 63.87 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 120.036 -0.666 . . . . 0.0 110.039 -179.778 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -70.77 -40.27 72.74 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 178.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.654 ' HB2' HG23 ' B' ' 33' ' ' THR . . . -66.22 -35.31 80.09 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 176.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.859 ' HB1' ' CG1' ' B' ' 75' ' ' VAL . . . -58.46 -43.53 88.91 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.255 178.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.572 ' HA ' ' HB2' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -58.28 -24.36 59.19 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 177.29 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -74.71 -38.27 43.3 Favored Glycine 0 N--CA 1.488 2.126 0 CA-C-O 119.399 -0.667 . . . . 0.0 112.792 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 1.094 HD21 HG21 ' B' ' 75' ' ' VAL . 2.0 pp -57.26 -49.37 76.28 Favored 'General case' 0 N--CA 1.505 2.299 0 CA-C-N 120.774 2.287 . . . . 0.0 111.326 -178.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.602 ' H ' ' HG ' ' A' ' 92' ' ' LEU . 0.4 OUTLIER 159.05 45.95 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -179.447 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.734 ' CD2' ' OG ' ' B' ' 74' ' ' SER . 2.4 t80 -32.48 -71.75 0.05 Allowed 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.331 0.586 . . . . 0.0 112.41 -178.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -46.6 -35.57 6.03 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.397 -0.815 . . . . 0.0 110.465 -178.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.438 ' CB ' ' HB3' ' A' ' 93' ' ' LYS . 0.5 OUTLIER -69.81 -30.44 67.96 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.801 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.513 ' HB3' ' HB2' ' B' ' 54' ' ' ALA . 0.5 OUTLIER -93.6 -3.49 52.52 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.325 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.886 ' HB2' ' OG ' ' B' ' 74' ' ' SER . . . -87.26 -36.07 18.13 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 121.36 0.6 . . . . 0.0 110.172 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.8 mttm . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 118.112 -0.947 . . . . 0.0 110.238 179.953 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.686 ' HB3' HG23 ' A' ' 42' ' ' VAL . 5.9 mtp . . . . . 0 N--CA 1.493 1.692 0 N-CA-C 110.081 -0.341 . . . . 0.0 110.081 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -171.57 -158.51 0.13 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.941 -1.099 . . . . 0.0 112.063 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.545 ' HE2' ' HA ' ' B' ' 26' ' ' ALA . 0.1 OUTLIER -49.72 -12.38 0.07 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.556 -0.715 . . . . 0.0 111.038 -179.536 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.681 ' O ' HG13 ' B' ' 7' ' ' ILE . 19.7 m -114.04 -58.68 2.12 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.007 -1.058 . . . . 0.0 110.197 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.725 ' HA ' ' HE2' ' B' ' 8' ' ' LYS . 0.3 OUTLIER -49.34 -46.64 47.21 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.07 -1.019 . . . . 0.0 109.23 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.827 HD11 ' CG2' ' A' ' 42' ' ' VAL . 10.7 mt -58.79 -31.36 68.33 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.289 -0.964 . . . . 0.0 109.815 178.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 7' ' ' ILE . . . . . 0.683 HD13 ' CG2' ' B' ' 21' ' ' VAL . 0.9 OUTLIER -58.82 -41.77 83.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.517 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 8' ' ' LYS . . . . . 0.867 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 35.6 mtmt -63.55 -35.31 80.07 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 9' ' ' ALA . . . . . 0.821 ' HB1' HD13 ' A' ' 31' ' ' ILE . . . -53.63 -39.75 65.22 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.944 -0.702 . . . . 0.0 109.199 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.678 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.5 mp -90.56 -32.23 5.37 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 178.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.867 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -64.21 -15.87 60.82 Favored 'General case' 0 C--N 1.293 -1.871 0 O-C-N 120.805 -1.185 . . . . 0.0 108.58 178.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 -111.54 -43.41 3.67 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.514 -0.741 . . . . 0.0 109.587 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -69.66 -24.55 63.63 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.766 ' CG2' ' HB2' ' A' ' 20' ' ' SER . 0.2 OUTLIER -115.2 -82.65 0.62 Allowed 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 179.258 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 15' ' ' GLY . . . . . 0.515 ' O ' ' C ' ' B' ' 16' ' ' LEU . . . 67.22 -21.92 0.21 Allowed Glycine 0 N--CA 1.5 2.924 0 O-C-N 120.993 -1.067 . . . . 0.0 110.469 178.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 16' ' ' LEU . . . . . 1.105 ' CD1' HG23 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -27.44 -54.73 0.09 Allowed 'General case' 0 N--CA 1.514 2.736 0 CA-C-O 121.942 0.877 . . . . 0.0 110.76 -179.758 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 17' ' ' THR . . . . . 0.555 HG21 HG21 ' A' ' 17' ' ' THR . 0.5 OUTLIER -138.78 -3.28 1.66 Allowed 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.975 -179.433 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 18' ' ' GLN . . . . . 0.538 ' O ' ' C ' ' B' ' 19' ' ' VAL . 11.9 mt-30 56.78 34.94 25.51 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 -176.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 1.085 HG11 HG11 ' A' ' 19' ' ' VAL . 1.8 p -20.43 -95.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.521 -178.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.916 ' O ' ' N ' ' B' ' 23' ' ' LYS . 0.5 OUTLIER -133.44 24.11 4.08 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 178.495 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.683 ' CG2' HD13 ' B' ' 7' ' ' ILE . 30.0 m -19.0 -39.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-O 122.382 1.087 . . . . 0.0 109.585 -178.054 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.841 ' N ' ' O ' ' B' ' 20' ' ' SER . 28.0 t -84.34 -38.71 20.0 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.009 178.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 23' ' ' LYS . . . . . 0.916 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.3 OUTLIER -84.91 -32.06 23.34 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.406 -0.809 . . . . 0.0 111.276 179.831 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 24' ' ' MET . . . . . 0.637 ' HB3' HG21 ' A' ' 14' ' ' THR . 0.0 OUTLIER -74.9 -41.07 60.44 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 118.073 -1.451 . . . . 0.0 108.462 178.812 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.674 ' HA ' ' HB3' ' B' ' 28' ' ' PHE . 11.1 mt -69.01 -44.34 72.96 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 118.319 -1.353 . . . . 0.0 108.008 177.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 26' ' ' ALA . . . . . 0.545 ' HA ' ' HE2' ' B' ' 3' ' ' LYS . . . -57.29 -34.5 68.75 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 27' ' ' SER . . . . . 0.627 ' HA ' ' HB3' ' B' ' 30' ' ' LYS . 54.0 p -84.09 -26.61 28.85 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 28' ' ' PHE . . . . . 0.744 ' O ' HG13 ' B' ' 31' ' ' ILE . 0.4 OUTLIER -62.54 -44.51 96.17 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.0 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 29' ' ' GLU . . . . . 0.791 ' HG2' HG22 ' A' ' 45' ' ' THR . 0.7 OUTLIER -74.49 -32.37 62.52 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 177.918 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 0.808 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 17.5 ttpp -69.17 -27.17 65.28 Favored 'General case' 0 C--O 1.192 -1.933 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 176.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.744 HG13 ' O ' ' B' ' 28' ' ' PHE . 2.0 pp -97.33 -30.6 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.113 -0.992 . . . . 0.0 109.246 178.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.737 HG22 HD21 ' A' ' 85' ' ' LEU . 1.9 mm -64.58 -53.82 37.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 177.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 33' ' ' THR . . . . . 0.654 HG23 ' HB2' ' A' ' 88' ' ' ALA . 0.4 OUTLIER -68.57 -40.38 80.6 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.129 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.808 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 52.7 mm-40 -70.03 -36.11 74.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.523 -0.735 . . . . 0.0 111.058 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 35' ' ' THR . . . . . 0.949 HG21 HG13 ' B' ' 42' ' ' VAL . 3.2 m -59.02 -52.78 64.27 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.799 -1.188 . . . . 0.0 108.651 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.844 HG13 ' HB3' ' B' ' 52' ' ' PRO . 13.6 t -54.25 -36.85 34.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 177.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 0.629 ' HB2' ' C ' ' A' ' 88' ' ' ALA . . . -79.14 -3.84 47.46 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 38' ' ' LYS . . . . . 0.485 ' N ' ' O ' ' B' ' 35' ' ' THR . 0.0 OUTLIER -102.43 -29.43 11.62 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 177.823 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 39' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' B' ' 35' ' ' THR . . . 112.66 38.55 1.29 Allowed Glycine 0 C--N 1.302 -1.355 0 C-N-CA 120.001 -1.095 . . . . 0.0 111.03 177.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 40' ' ' ASP . . . . . 0.634 ' CB ' HG23 ' B' ' 35' ' ' THR . 0.1 OUTLIER -130.29 133.63 46.62 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.043 -1.269 . . . . 0.0 110.745 179.364 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.441 ' HG3' ' HD2' ' B' ' 52' ' ' PRO . 0.1 OUTLIER -82.98 88.4 6.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.581 -0.7 . . . . 0.0 109.664 179.683 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.949 HG13 HG21 ' B' ' 35' ' ' THR . 25.4 m -73.39 144.91 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.507 -0.745 . . . . 0.0 110.443 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 43' ' ' GLN . . . . . 0.505 ' O ' ' HA ' ' A' ' 2' ' ' ASN . 19.6 mt-30 -138.9 171.53 14.19 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.469 -0.769 . . . . 0.0 110.24 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 1.001 HD12 ' CB ' ' B' ' 48' ' ' LEU . 91.5 mt -136.06 -179.16 5.49 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.276 -0.89 . . . . 0.0 110.608 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 45' ' ' THR . . . . . 0.872 HG22 ' HG2' ' A' ' 29' ' ' GLU . 4.1 t -45.62 72.19 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.674 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . 42.74 29.03 0.72 Allowed Glycine 0 N--CA 1.494 2.562 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 47' ' ' PHE . . . . . 0.73 ' CE2' ' HG ' ' B' ' 48' ' ' LEU . 0.7 OUTLIER -129.12 -32.83 2.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.054 -1.262 . . . . 0.0 110.476 179.606 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 1.011 HD11 HD11 ' A' ' 50' ' ' ILE . 8.0 mt -128.29 117.99 22.46 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.685 -1.259 . . . . 0.0 110.46 178.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -118.04 69.19 0.78 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.607 -0.683 . . . . 0.0 110.856 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 50' ' ' ILE . . . . . 0.919 HD13 ' HB ' ' B' ' 79' ' ' VAL . 11.2 mm -59.86 113.46 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.164 -0.96 . . . . 0.0 109.637 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 51' ' ' LYS . . . . . 0.444 ' O ' ' HG3' ' B' ' 51' ' ' LYS . 1.3 ptmt -138.34 121.92 11.32 Favored Pre-proline 0 N--CA 1.498 1.952 0 O-C-N 121.017 -1.052 . . . . 0.0 110.246 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.844 ' HB3' HG13 ' B' ' 36' ' ' VAL . 50.2 Cg_endo -76.61 135.46 16.23 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 123.482 1.254 . . . . 0.0 112.237 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.599 ' O ' ' N ' ' B' ' 76' ' ' GLY . 33.6 m -139.41 116.8 10.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.772 ' HB1' ' HA ' ' B' ' 74' ' ' SER . . . -76.23 141.2 41.82 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -176.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 55' ' ' ARG . . . . . 0.619 ' HB2' ' O ' ' B' ' 54' ' ' ALA . 0.2 OUTLIER 146.79 68.37 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.604 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.225 179.746 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 56' ' ' GLN . . . . . 0.57 ' O ' ' HA ' ' B' ' 73' ' ' PRO . 10.2 mt-30 -154.95 103.63 2.42 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.899 -1.125 . . . . 0.0 111.835 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.618 ' HB1' HG13 ' B' ' 71' ' ' ILE . . . -142.41 179.97 6.63 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.076 -1.015 . . . . 0.0 111.485 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 58' ' ' ARG . . . . . 0.569 ' HB2' HG23 ' B' ' 71' ' ' ILE . 2.0 mpt_? -84.64 165.4 17.96 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 121.212 0.53 . . . . 0.0 110.184 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 59' ' ' LYS . . . . . 0.414 ' HB3' ' O ' ' B' ' 58' ' ' ARG . 7.8 pttt -178.99 48.69 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.504 -0.747 . . . . 0.0 109.642 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -104.97 -105.2 3.0 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 61' ' ' PHE . . . . . 0.787 ' O ' ' N ' ' B' ' 67' ' ' GLU . 0.4 OUTLIER -173.83 177.18 2.49 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.371 -1.076 . . . . 0.0 110.011 -179.828 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 62' ' ' ASN . . . . . 0.935 ' N ' ' HB2' ' B' ' 68' ' ' ALA . 1.1 t-20 -102.5 -58.62 0.09 OUTLIER Pre-proline 0 N--CA 1.499 1.999 0 O-C-N 120.99 -1.069 . . . . 0.0 111.654 -178.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.6 ' HD2' ' H ' ' B' ' 62' ' ' ASN . 42.3 Cg_endo -69.32 62.15 1.51 Allowed 'Trans proline' 0 C--N 1.315 -1.234 0 O-C-N 123.345 1.181 . . . . 0.0 109.864 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 64' ' ' GLN . . . . . 0.78 ' HB3' ' CE1' ' B' ' 61' ' ' PHE . 1.3 mt-30 -175.9 30.36 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 4.1 p 50.81 44.88 27.86 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.603 -0.686 . . . . 0.0 110.752 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 66' ' ' GLN . . . . . 0.661 ' HB2' ' CE1' ' B' ' 61' ' ' PHE . 1.4 tp60 -130.65 -88.37 0.49 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.25 -0.906 . . . . 0.0 110.94 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 67' ' ' GLU . . . . . 0.787 ' N ' ' O ' ' B' ' 61' ' ' PHE . 2.0 mt-10 156.54 90.92 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 68' ' ' ALA . . . . . 0.935 ' HB2' ' N ' ' B' ' 62' ' ' ASN . . . -70.76 104.24 2.82 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.162 -0.961 . . . . 0.0 110.204 -178.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.733 HD23 ' O ' ' B' ' 68' ' ' ALA . 0.2 OUTLIER 174.66 -169.12 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.899 -179.374 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -156.51 91.32 1.23 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.437 -0.789 . . . . 0.0 109.554 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.618 HG13 ' HB1' ' B' ' 57' ' ' ALA . 1.0 OUTLIER -56.74 -172.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.361 -0.837 . . . . 0.0 110.189 -179.642 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -90.27 108.92 29.83 Favored Pre-proline 0 C--N 1.296 -1.722 0 O-C-N 121.681 -0.637 . . . . 0.0 110.75 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 73' ' ' PRO . . . . . 0.61 ' CB ' ' HB2' ' B' ' 57' ' ' ALA . 45.7 Cg_endo -79.36 123.15 5.39 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 O-C-N 123.698 1.367 . . . . 0.0 111.088 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 74' ' ' SER . . . . . 0.886 ' OG ' ' HB2' ' A' ' 98' ' ' ALA . 0.3 OUTLIER -150.21 -151.03 0.37 Allowed 'General case' 0 C--N 1.292 -1.922 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.988 179.264 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 75' ' ' VAL . . . . . 1.094 HG21 HD21 ' A' ' 92' ' ' LEU . 45.2 t -17.34 139.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.719 0 CA-C-O 122.706 1.241 . . . . 0.0 114.002 -175.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 76' ' ' GLY . . . . . 0.599 ' N ' ' O ' ' B' ' 53' ' ' VAL . . . -142.56 68.12 0.45 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.896 HG21 ' CG ' ' A' ' 85' ' ' LEU . 5.3 p -36.48 95.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.827 -0.807 . . . . 0.0 112.139 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 78' ' ' SER . . . . . 0.49 ' O ' ' HB ' ' B' ' 79' ' ' VAL . 15.5 t -94.07 176.0 6.49 Favored 'General case' 0 C--N 1.293 -1.872 0 C-N-CA 119.547 -0.861 . . . . 0.0 108.846 177.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.919 ' HB ' HD13 ' B' ' 50' ' ' ILE . 14.5 p 176.24 178.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 80' ' ' LYS . . . . . 0.587 ' N ' HG22 ' B' ' 79' ' ' VAL . 0.2 OUTLIER -178.0 173.35 0.66 Allowed Pre-proline 0 C--N 1.305 -1.352 0 O-C-N 121.024 -1.047 . . . . 0.0 110.424 178.097 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 81' ' ' PRO . . . . . 0.992 ' HB3' HG11 ' A' ' 77' ' ' VAL . 51.0 Cg_endo -88.01 103.74 0.49 Allowed 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 121.834 1.689 . . . . 0.0 109.853 178.16 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 82' ' ' GLY . . . . . 0.48 ' O ' ' HB3' ' B' ' 83' ' ' GLU . . . -71.46 37.43 0.57 Allowed Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 83' ' ' GLU . . . . . 0.48 ' HB3' ' O ' ' B' ' 82' ' ' GLY . 1.2 tp10 64.22 -27.93 0.09 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.303 -1.116 . . . . 0.0 112.613 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 84' ' ' SER . . . . . 0.446 ' HB3' ' CB ' ' B' ' 47' ' ' PHE . 1.0 OUTLIER -52.13 -36.43 51.28 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.435 -1.415 . . . . 0.0 108.945 179.602 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.743 HD12 ' HA ' ' A' ' 33' ' ' THR . 1.2 tt -85.79 -36.42 20.1 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 86' ' ' LYS . . . . . 0.66 ' O ' ' HB3' ' B' ' 89' ' ' ALA . 0.2 OUTLIER -70.52 -35.39 73.15 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.094 179.323 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 87' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' B' ' 83' ' ' GLU . 0.2 OUTLIER -70.25 -38.87 75.25 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 178.487 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.573 ' C ' ' HB2' ' A' ' 37' ' ' ALA . . . -63.92 -37.49 87.61 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 176.204 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.823 ' HB1' ' CG1' ' A' ' 75' ' ' VAL . . . -55.95 -42.33 76.04 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.255 178.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.66 -31.67 58.03 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 177.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -71.74 -27.76 70.3 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 179.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 92' ' ' LEU . . . . . 0.926 ' HB3' ' HA ' ' A' ' 37' ' ' ALA . 0.5 OUTLIER -71.58 9.47 0.84 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.761 -1.435 . . . . 0.0 111.675 -179.654 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 93' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' B' ' 92' ' ' LEU . 29.9 mmtp 60.76 40.35 16.22 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 -177.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 94' ' ' TYR . . . . . 0.629 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 1.8 p90 -41.95 -29.94 0.24 Allowed 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.768 -178.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 95' ' ' GLU . . . . . 0.672 ' O ' ' HB3' ' B' ' 98' ' ' ALA . 3.8 mp0 -59.53 -47.85 83.92 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.87 -35.52 66.58 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 177.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.44 -30.18 64.36 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 178.004 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 98' ' ' ALA . . . . . 0.672 ' HB3' ' O ' ' B' ' 95' ' ' GLU . . . -58.18 -39.19 78.28 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.332 0.587 . . . . 0.0 110.182 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.15 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.543 ' CE ' HD23 ' A' ' 6' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.496 1.826 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.419 ' O ' ' HB2' ' A' ' 6' ' ' LEU . 2.8 t-20 -174.1 -169.2 0.45 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.945 -1.097 . . . . 0.0 111.635 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.623 ' O ' HG13 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -57.74 -4.87 0.32 Allowed 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.473 -0.767 . . . . 0.0 110.702 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.924 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 99.2 m -125.29 -40.31 2.13 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.323 -0.86 . . . . 0.0 108.974 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.489 ' CB ' ' HA ' ' A' ' 1' ' ' MET . 0.1 OUTLIER -61.66 -50.59 71.9 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.274 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.827 HD11 ' CG1' ' B' ' 42' ' ' VAL . 9.1 mt -57.8 -31.25 66.39 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 1.062 HG23 ' HB ' ' A' ' 21' ' ' VAL . 3.5 mt -52.55 -51.65 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 178.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.971 ' CE ' HG22 ' A' ' 7' ' ' ILE . 3.1 mmpt? -60.53 -34.24 73.82 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.004 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.884 ' HB1' HD13 ' B' ' 31' ' ' ILE . . . -55.26 -37.18 66.91 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.535 -0.866 . . . . 0.0 109.504 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.836 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.0 OUTLIER -97.12 -30.27 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.291 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.823 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -68.14 -13.62 62.36 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 118.829 -1.148 . . . . 0.0 108.542 178.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.426 ' CG ' ' N ' ' A' ' 13' ' ' ASP . 6.5 pt20 -111.14 -39.61 4.7 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.522 -0.736 . . . . 0.0 109.432 178.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.426 ' N ' ' CG ' ' A' ' 12' ' ' GLN . 0.9 OUTLIER -66.89 -36.07 81.45 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 177.408 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.861 HG22 HD21 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -97.31 -67.46 0.85 Allowed 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.376 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 46.17 29.98 3.8 Favored Glycine 0 N--CA 1.497 2.759 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 178.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.069 ' CD1' HG23 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -89.65 -26.85 20.52 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.621 -0.929 . . . . 0.0 109.687 179.333 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.704 HG22 ' H ' ' A' ' 19' ' ' VAL . 0.4 OUTLIER -162.15 -3.03 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.683 -178.6 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.536 ' O ' ' C ' ' A' ' 19' ' ' VAL . 9.7 mt-30 54.27 30.45 12.45 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 -177.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.969 HG11 HG11 ' B' ' 19' ' ' VAL . 2.3 p -12.25 -93.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.526 -178.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.945 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.5 OUTLIER -128.5 23.37 5.9 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 178.688 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 1.062 ' HB ' HG23 ' A' ' 7' ' ' ILE . 15.3 m -24.59 -37.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 CA-C-O 122.233 1.016 . . . . 0.0 109.4 -178.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.735 ' N ' ' O ' ' A' ' 20' ' ' SER . 48.5 t -82.28 -36.55 26.94 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.253 177.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.945 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.3 OUTLIER -86.82 -32.43 20.3 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.637 -0.665 . . . . 0.0 111.744 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.787 ' HG2' HG22 ' B' ' 14' ' ' THR . 0.0 OUTLIER -78.4 -36.67 45.44 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.433 -1.417 . . . . 0.0 109.873 179.631 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.789 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 0.4 OUTLIER -80.5 -45.04 18.15 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 118.535 -1.266 . . . . 0.0 109.345 178.904 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.603 ' HA ' ' HG2' ' A' ' 3' ' ' LYS . . . -57.24 -33.37 67.49 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 177.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.81 ' O ' HG23 ' A' ' 31' ' ' ILE . 49.4 m -87.46 -31.15 20.16 Favored 'General case' 0 C--O 1.199 -1.586 0 C-N-CA 119.687 -0.805 . . . . 0.0 109.238 178.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.969 ' HB2' HD11 ' B' ' 10' ' ' ILE . 0.1 OUTLIER -58.21 -49.71 76.1 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.04 -1.037 . . . . 0.0 109.931 179.45 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.759 ' HG2' HG22 ' B' ' 45' ' ' THR . 1.1 mt-10 -73.12 -37.4 66.68 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 1.244 ' O ' ' HB3' ' A' ' 34' ' ' GLU . 16.8 ttpt -69.06 -16.37 63.68 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 177.177 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 1.044 ' HA ' ' CG ' ' A' ' 34' ' ' GLU . 1.8 pp -107.39 -29.38 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.14 -0.975 . . . . 0.0 110.241 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.613 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.2 mm -63.39 -45.77 97.15 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 178.141 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.853 ' O ' ' HB1' ' B' ' 88' ' ' ALA . 0.5 OUTLIER -79.03 -41.32 29.15 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 177.704 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 1.244 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -59.39 -35.51 74.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.134 -0.979 . . . . 0.0 109.124 177.842 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.764 HG23 ' HB2' ' A' ' 40' ' ' ASP . 15.8 m -63.73 -48.93 75.04 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 177.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.736 HG21 HD22 ' B' ' 85' ' ' LEU . 24.5 t -55.69 -35.58 39.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 177.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.878 ' HB2' ' O ' ' B' ' 88' ' ' ALA . . . -83.14 -1.24 52.39 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 177.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -106.27 -11.69 15.94 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 177.198 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 35' ' ' THR . . . 85.88 46.28 5.44 Favored Glycine 0 C--N 1.303 -1.255 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.243 177.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.764 ' HB2' HG23 ' A' ' 35' ' ' THR . 0.2 OUTLIER -124.6 143.15 50.87 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.031 -1.276 . . . . 0.0 109.975 178.951 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.419 ' CG ' ' HB2' ' A' ' 51' ' ' LYS . 0.3 OUTLIER -105.35 97.58 7.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.549 -0.72 . . . . 0.0 110.185 -179.317 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 1.006 HG22 ' HB2' ' B' ' 1' ' ' MET . 3.2 t -84.83 172.62 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.472 -0.768 . . . . 0.0 110.134 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 43' ' ' GLN . 4.5 pt20 -157.32 107.21 2.21 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.602 -0.686 . . . . 0.0 109.207 179.06 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.808 HD12 ' HB2' ' A' ' 48' ' ' LEU . 16.1 mt -70.72 179.93 2.43 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.228 -0.92 . . . . 0.0 111.14 -178.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.836 HG22 ' HG2' ' B' ' 29' ' ' GLU . 1.8 t -31.63 -43.43 0.06 Allowed 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 121.053 0.454 . . . . 0.0 111.433 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.444 ' N ' HG23 ' A' ' 45' ' ' THR . . . 172.61 24.44 0.02 OUTLIER Glycine 0 N--CA 1.487 2.071 0 C-N-CA 119.347 -1.406 . . . . 0.0 111.127 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.669 ' CZ ' HG21 ' B' ' 32' ' ' ILE . 49.3 p90 -127.82 -49.33 1.36 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.696 -1.473 . . . . 0.0 111.502 178.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.035 ' CD1' HD11 ' B' ' 48' ' ' LEU . 0.3 OUTLIER -96.53 110.75 23.08 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.697 -1.252 . . . . 0.0 112.513 -179.238 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.709 ' O ' ' HB ' ' A' ' 79' ' ' VAL . 1.7 t-20 -105.82 63.33 0.67 Allowed 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.684 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.909 HD11 HG23 ' A' ' 42' ' ' VAL . 1.1 pp -57.46 130.27 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.69 0 O-C-N 121.117 -0.989 . . . . 0.0 112.67 -177.172 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.597 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -175.5 112.23 0.27 Allowed Pre-proline 0 N--CA 1.492 1.671 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.171 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.664 ' HG3' HG13 ' A' ' 36' ' ' VAL . 55.9 Cg_endo -90.77 156.89 4.15 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 120.882 1.055 . . . . 0.0 111.434 -178.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.915 HG22 ' O ' ' A' ' 76' ' ' GLY . 32.4 m -139.81 114.92 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 121.913 0.863 . . . . 0.0 111.114 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.619 ' HA ' ' HE1' ' B' ' 94' ' ' TYR . . . -56.41 106.45 0.29 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.691 -0.631 . . . . 0.0 112.137 -178.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.462 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 7.9 ptm180 166.64 136.14 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.783 -0.573 . . . . 0.0 109.556 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.849 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -168.6 16.96 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 118.699 -1.2 . . . . 0.0 113.809 -179.882 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.849 ' HB2' ' O ' ' A' ' 56' ' ' GLN . . . 146.19 -167.8 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.928 0 CA-C-N 119.425 1.011 . . . . 0.0 110.758 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.812 ' HA ' ' HA ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -130.2 149.42 51.91 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.717 0.77 . . . . 0.0 111.72 178.935 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 70' ' ' GLU . 4.1 tttt -150.14 19.65 0.87 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.834 -0.541 . . . . 0.0 110.157 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.708 ' HA3' ' N ' ' A' ' 69' ' ' LEU . . . -106.03 -120.44 4.68 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.876 ' CE1' HD11 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -138.67 -149.9 0.31 Allowed 'General case' 0 C--O 1.206 -1.195 0 O-C-N 120.853 -1.381 . . . . 0.0 114.402 -179.583 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.75 ' H ' ' HD2' ' A' ' 63' ' ' PRO . 0.1 OUTLIER 164.02 -33.67 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 121.31 -0.869 . . . . 0.0 112.559 -179.752 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.75 ' HD2' ' H ' ' A' ' 62' ' ' ASN . 37.2 Cg_endo -62.98 -6.23 9.1 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 N-CA-C 110.381 -0.661 . . . . 0.0 110.381 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.55 ' CB ' ' CE2' ' A' ' 61' ' ' PHE . 0.2 OUTLIER -99.01 -72.29 0.66 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.185 -0.947 . . . . 0.0 109.491 178.486 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.429 ' HG1' ' HZ ' ' A' ' 61' ' ' PHE . 10.1 p -109.41 5.79 23.72 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.441 -0.787 . . . . 0.0 109.998 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.525 ' O ' ' CB ' ' A' ' 67' ' ' GLU . 66.8 mm-40 63.58 92.7 0.06 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.468 -0.77 . . . . 0.0 111.482 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.56 ' H ' ' HA ' ' A' ' 62' ' ' ASN . 2.4 mt-10 155.93 95.76 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.74 ' HA ' ' N ' ' A' ' 61' ' ' PHE . . . -51.08 125.26 13.34 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.836 -1.165 . . . . 0.0 108.82 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.876 HD11 ' CE1' ' A' ' 61' ' ' PHE . 8.2 mt -95.84 54.25 1.49 Allowed 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.401 0.619 . . . . 0.0 111.688 -177.088 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.464 ' HB2' ' CA ' ' A' ' 60' ' ' GLY . 1.5 mt-10 174.87 50.07 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.812 ' HA ' ' HA ' ' A' ' 58' ' ' ARG . 0.6 OUTLIER -103.17 118.69 50.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-O 122.395 1.093 . . . . 0.0 113.219 -177.549 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.803 ' HB2' ' O ' ' A' ' 71' ' ' ILE . . . 136.57 80.83 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.027 0 CA-C-N 113.979 -1.464 . . . . 0.0 112.419 177.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.69 ' HD2' ' CB ' ' A' ' 56' ' ' GLN . 46.9 Cg_endo -91.18 16.86 1.49 Allowed 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.297 1.156 . . . . 0.0 113.742 178.092 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.785 ' N ' ' CE2' ' B' ' 94' ' ' TYR . 0.0 OUTLIER -174.23 144.28 0.94 Allowed 'General case' 0 C--N 1.288 -2.067 0 O-C-N 121.354 -0.841 . . . . 0.0 110.049 177.345 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.54 ' N ' ' CE1' ' B' ' 94' ' ' TYR . 0.4 OUTLIER -69.29 174.08 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.439 -1.413 . . . . 0.0 107.465 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.915 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -118.95 97.99 0.72 Allowed Glycine 0 N--CA 1.488 2.165 0 C-N-CA 118.837 -1.649 . . . . 0.0 109.631 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.703 HG21 HD12 ' B' ' 85' ' ' LEU . 6.1 p -63.09 84.21 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-O 122.504 1.145 . . . . 0.0 108.667 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 76' ' ' GLY . 0.3 OUTLIER -56.7 -44.15 81.24 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.374 -179.397 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.787 ' CB ' ' HA ' ' A' ' 50' ' ' ILE 0.286 1.9 p -45.98 172.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-O 122.758 1.266 . . . . 0.0 113.971 -174.392 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.601 ' N ' ' CG2' ' A' ' 79' ' ' VAL . 0.0 OUTLIER 178.62 174.22 0.39 Allowed Pre-proline 0 C--N 1.309 -1.188 0 CA-C-N 114.403 -1.272 . . . . 0.0 108.204 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.66 ' HG3' HG12 ' B' ' 79' ' ' VAL . 39.0 Cg_endo -66.77 153.77 76.81 Favored 'Trans proline' 0 C--N 1.298 -2.095 0 O-C-N 123.464 1.244 . . . . 0.0 109.166 176.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.487 ' H ' ' HA ' ' A' ' 47' ' ' PHE . . . -120.0 -83.73 0.81 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 108.239 -1.945 . . . . 0.0 108.239 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.941 ' O ' ' N ' ' A' ' 85' ' ' LEU . 17.5 tt0 -76.54 43.56 0.32 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.428 -1.042 . . . . 0.0 108.791 177.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . 1.343 ' O ' ' N ' ' A' ' 86' ' ' LYS . 0.5 OUTLIER 7.21 44.69 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 122.212 1.005 . . . . 0.0 110.203 178.567 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 1.023 HD12 HG21 ' B' ' 36' ' ' VAL . 0.2 OUTLIER 20.07 28.65 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 104.538 -2.393 . . . . 0.0 104.538 -171.326 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 1.343 ' N ' ' O ' ' A' ' 84' ' ' SER 0.354 7.7 tttt -62.28 -42.07 99.04 Favored 'General case' 0 CA--C 1.483 -1.616 0 N-CA-C 103.496 -2.779 . . . . 0.0 103.496 176.383 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.257 24.0 tptt -67.4 -35.48 79.37 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 111.834 -2.439 . . . . 0.0 104.857 175.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.703 ' HB3' ' O ' ' A' ' 85' ' ' LEU . . . -71.59 -27.87 63.43 Favored 'General case' 0 C--O 1.211 -0.927 0 C-N-CA 118.326 -1.35 . . . . 0.0 108.36 178.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.954 ' HA ' HD23 ' A' ' 92' ' ' LEU . . . -59.16 -49.92 76.03 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.977 -1.077 . . . . 0.0 109.363 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.471 ' HG2' ' N ' ' A' ' 91' ' ' GLY . 2.2 pt-20 -56.95 -27.96 61.66 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.903 -1.518 . . . . 0.0 106.903 177.256 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.471 ' N ' ' HG2' ' A' ' 90' ' ' GLU . . . -68.39 -32.46 75.57 Favored Glycine 0 N--CA 1.488 2.155 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.186 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.954 HD23 ' HA ' ' A' ' 89' ' ' ALA . 0.8 OUTLIER -84.85 22.12 1.43 Allowed 'General case' 0 N--CA 1.504 2.263 0 O-C-N 120.213 -1.757 . . . . 0.0 110.975 -179.657 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.489 ' O ' ' N ' ' A' ' 96' ' ' ASP . 2.6 mmtt 55.29 38.19 30.01 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 -177.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.625 ' CD1' ' N ' ' B' ' 75' ' ' VAL . 1.5 t80 -33.66 -41.03 0.08 Allowed 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.81 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -54.98 -43.0 73.13 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.333 -0.854 . . . . 0.0 109.629 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 93' ' ' LYS . 11.8 m-20 -62.22 -33.58 74.84 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.152 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -77.98 -21.76 50.42 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.452 0.644 . . . . 0.0 109.306 178.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.406 ' HA ' ' HB1' ' B' ' 54' ' ' ALA . . . -72.21 -34.46 68.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.515 -0.74 . . . . 0.0 110.218 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 24.8 mttt . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 117.918 -1.039 . . . . 0.0 110.221 -179.972 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' MET . . . . . 1.006 ' HB2' HG22 ' A' ' 42' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 2' ' ' ASN . . . . . 0.447 ' N ' ' HB2' ' B' ' 5' ' ' GLU . 0.7 OUTLIER 177.67 176.64 0.4 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.016 -1.053 . . . . 0.0 111.324 -179.811 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.95 ' O ' HD22 ' B' ' 25' ' ' LEU . 0.9 OUTLIER -47.63 -29.05 2.67 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.174 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.548 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 16.1 m -95.71 -45.39 7.03 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.661 0.743 . . . . 0.0 109.733 179.04 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.662 ' HA ' ' HE2' ' B' ' 8' ' ' LYS . 0.0 OUTLIER -56.04 -49.87 72.53 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 120.945 -1.097 . . . . 0.0 108.054 179.207 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.802 ' CD1' HG11 ' A' ' 42' ' ' VAL . 7.6 mt -55.8 -35.01 65.85 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.213 -0.995 . . . . 0.0 108.662 177.155 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 7' ' ' ILE . . . . . 0.823 ' CD1' HD23 ' B' ' 25' ' ' LEU . 0.3 OUTLIER -50.87 -48.86 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 178.166 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 8' ' ' LYS . . . . . 0.802 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 39.7 mtmt -61.99 -37.75 86.0 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 9' ' ' ALA . . . . . 0.925 ' HB1' HD13 ' A' ' 31' ' ' ILE . . . -52.58 -34.39 50.33 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 119.695 -0.802 . . . . 0.0 108.911 178.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.969 HD11 ' HB2' ' A' ' 28' ' ' PHE . 0.8 OUTLIER -99.41 -36.74 5.56 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.627 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.47 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.802 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -63.21 -25.89 68.55 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -93.41 -39.21 11.04 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 177.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.472 ' OD2' ' HB3' ' A' ' 27' ' ' SER . 23.9 m-20 -68.21 -20.16 64.82 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 176.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.859 HG22 ' HB2' ' A' ' 20' ' ' SER . 31.0 p -93.77 -77.84 0.44 Allowed 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 177.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 61.97 11.45 31.47 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 16' ' ' LEU . . . . . 0.892 HD11 ' OG ' ' A' ' 20' ' ' SER . 3.4 mp -83.18 -65.14 1.05 Allowed 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 122.27 1.034 . . . . 0.0 109.151 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 17' ' ' THR . . . . . 0.62 HG22 ' H ' ' B' ' 19' ' ' VAL . 0.5 OUTLIER -140.55 6.73 2.09 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 115.386 -0.824 . . . . 0.0 108.878 -179.724 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 18' ' ' GLN . . . . . 0.582 ' O ' ' C ' ' B' ' 19' ' ' VAL . 6.8 mt-30 57.38 24.5 10.17 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 -176.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 1.069 HG23 ' CD1' ' A' ' 16' ' ' LEU . 0.1 OUTLIER 17.14 -96.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.36 -178.833 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 20' ' ' SER . . . . . 1.024 ' O ' ' N ' ' B' ' 22' ' ' SER . 1.4 p -136.25 23.19 3.23 Favored 'General case' 0 C--N 1.272 -2.776 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 176.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.733 ' HA ' ' CE ' ' B' ' 24' ' ' MET . 17.8 m -5.35 -42.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.397 1.094 . . . . 0.0 110.452 -177.273 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 22' ' ' SER . . . . . 1.024 ' N ' ' O ' ' B' ' 20' ' ' SER . 27.3 t -73.33 -40.34 64.54 Favored 'General case' 0 C--N 1.281 -2.371 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.498 178.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 23' ' ' LYS . . . . . 0.873 ' N ' ' O ' ' B' ' 20' ' ' SER . 13.5 ttpt -93.26 -27.42 16.84 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.254 -0.904 . . . . 0.0 111.239 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 24' ' ' MET . . . . . 0.733 ' CE ' ' HA ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -73.63 -25.74 60.45 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 119.905 -1.747 . . . . 0.0 108.281 179.115 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.95 HD22 ' O ' ' B' ' 3' ' ' LYS . 0.2 OUTLIER -81.99 -46.27 14.21 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 176.946 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 26' ' ' ALA . . . . . 0.697 ' N ' ' HG ' ' B' ' 25' ' ' LEU . . . -64.27 -27.73 69.24 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 178.219 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 27' ' ' SER . . . . . 0.68 ' HA ' ' HB3' ' B' ' 30' ' ' LYS . 30.6 t -83.67 -40.07 19.41 Favored 'General case' 0 C--O 1.2 -1.549 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.135 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 28' ' ' PHE . . . . . 0.772 ' O ' HG13 ' B' ' 31' ' ' ILE . 0.5 OUTLIER -51.51 -46.4 63.24 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.52 0.676 . . . . 0.0 109.379 179.548 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 29' ' ' GLU . . . . . 0.836 ' HG2' HG22 ' A' ' 45' ' ' THR . 0.6 OUTLIER -75.31 -31.58 60.69 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 177.855 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 1.295 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 18.0 ttpt -71.41 -18.54 62.33 Favored 'General case' 0 C--O 1.191 -2.016 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 176.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.884 HD13 ' HB1' ' A' ' 9' ' ' ALA . 1.0 OUTLIER -105.82 -32.01 2.68 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.491 0 O-C-N 119.879 -1.763 . . . . 0.0 108.673 178.368 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.669 HG21 ' CZ ' ' A' ' 47' ' ' PHE . 1.5 mm -67.37 -63.42 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 176.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 33' ' ' THR . . . . . 0.852 ' OG1' HD22 ' A' ' 85' ' ' LEU . 0.5 OUTLIER -64.3 -45.11 89.4 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.74 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 1.295 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 15.6 mm-40 -68.79 -27.72 66.13 Favored 'General case' 0 C--N 1.31 -1.116 0 O-C-N 121.339 -0.851 . . . . 0.0 111.165 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 35' ' ' THR . . . . . 0.719 HG23 ' CB ' ' B' ' 40' ' ' ASP . 1.1 m -57.85 -51.14 70.84 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 177.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 1.023 HG21 HD12 ' A' ' 85' ' ' LEU . 4.3 t -54.07 -36.25 31.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 117.249 -1.78 . . . . 0.0 107.068 177.197 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 0.843 ' HA ' ' HB3' ' A' ' 92' ' ' LEU . . . -81.4 1.09 34.55 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.212 177.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 38' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' B' ' 34' ' ' GLU . 0.0 OUTLIER -108.72 -25.69 10.71 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.703 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.22 40.7 1.48 Allowed Glycine 0 C--N 1.303 -1.289 0 C-N-CA 119.946 -1.121 . . . . 0.0 110.748 178.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 40' ' ' ASP . . . . . 0.719 ' CB ' HG23 ' B' ' 35' ' ' THR . 0.3 OUTLIER -136.77 135.83 38.39 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.086 -1.244 . . . . 0.0 110.553 179.594 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.9 93.12 9.29 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.48 -0.762 . . . . 0.0 109.006 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.827 ' CG1' HD11 ' A' ' 6' ' ' LEU . 14.1 t -59.3 135.17 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.499 -0.75 . . . . 0.0 110.008 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 43' ' ' GLN . . . . . 0.445 ' HA ' ' HA ' ' B' ' 49' ' ' ASN . 11.2 mt-30 -132.0 91.95 3.04 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.501 -0.749 . . . . 0.0 109.757 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.667 ' HB3' ' CE2' ' B' ' 47' ' ' PHE . 7.6 mt -67.65 -179.28 1.07 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.284 -0.885 . . . . 0.0 110.979 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 45' ' ' THR . . . . . 0.759 HG22 ' HG2' ' A' ' 29' ' ' GLU . 3.2 t -52.53 73.38 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 O-C-N 122.109 -0.369 . . . . 0.0 111.687 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . 40.09 62.12 1.57 Allowed Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 47' ' ' PHE . . . . . 0.674 ' CE1' ' HG ' ' B' ' 48' ' ' LEU . 0.2 OUTLIER -163.45 -45.16 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.445 -1.032 . . . . 0.0 108.775 -179.867 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 1.035 HD11 ' CD1' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -125.02 102.17 7.39 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.785 -0.572 . . . . 0.0 109.958 178.843 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 49' ' ' ASN . . . . . 0.929 ' O ' ' O ' ' B' ' 79' ' ' VAL . 0.7 OUTLIER -120.24 100.58 7.26 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.11 -0.994 . . . . 0.0 110.568 -179.635 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 50' ' ' ILE . . . . . 0.693 HG13 HD11 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -90.84 140.8 15.36 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 O-C-N 121.252 -0.905 . . . . 0.0 110.921 -179.177 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 51' ' ' LYS . . . . . 0.499 ' HD3' ' O ' ' B' ' 51' ' ' LYS . 0.0 OUTLIER -157.3 119.37 2.11 Favored Pre-proline 0 N--CA 1.496 1.825 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.663 179.205 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.754 ' HB3' HG13 ' B' ' 36' ' ' VAL . 57.2 Cg_endo -87.9 136.55 3.68 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.62 1.326 . . . . 0.0 110.778 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.581 ' O ' HG23 ' B' ' 53' ' ' VAL . 30.6 m -128.41 111.7 24.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-O 122.016 0.913 . . . . 0.0 110.642 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.59 ' HA ' ' HE1' ' A' ' 94' ' ' TYR . . . -61.78 127.42 31.33 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.879 -0.513 . . . . 0.0 111.534 -178.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 55' ' ' ARG . . . . . 0.451 ' CB ' ' O ' ' B' ' 54' ' ' ALA . 3.1 mtt180 168.86 55.81 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.371 -0.83 . . . . 0.0 110.355 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 56' ' ' GLN . . . . . 0.791 ' O ' ' HA ' ' B' ' 73' ' ' PRO . 29.8 mt-30 -155.18 110.95 3.11 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.965 -1.084 . . . . 0.0 111.42 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.54 ' HB2' ' O ' ' B' ' 56' ' ' GLN . . . 176.5 121.66 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.233 -0.917 . . . . 0.0 110.002 178.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 58' ' ' ARG . . . . . 0.504 ' NH1' HG21 ' B' ' 71' ' ' ILE . 0.1 OUTLIER -166.98 158.72 12.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.285 -0.884 . . . . 0.0 110.583 -179.502 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 59' ' ' LYS . . . . . 0.425 ' CG ' ' HA ' ' B' ' 70' ' ' GLU . 1.6 mtmt -172.34 125.0 0.51 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.525 -0.734 . . . . 0.0 109.549 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 60' ' ' GLY . . . . . 0.727 ' HA3' HD12 ' B' ' 69' ' ' LEU . . . -155.23 -112.12 0.41 Allowed Glycine 0 N--CA 1.49 2.28 0 C-N-CA 119.603 -1.284 . . . . 0.0 110.405 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 61' ' ' PHE . . . . . 0.622 ' C ' ' CD1' ' B' ' 61' ' ' PHE . 19.3 p90 -171.1 -179.77 2.82 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.5 -1.0 . . . . 0.0 110.042 -179.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 62' ' ' ASN . . . . . 0.967 ' CB ' ' HB2' ' B' ' 68' ' ' ALA . 0.0 OUTLIER -135.66 -44.68 0.02 OUTLIER Pre-proline 0 C--N 1.297 -1.684 0 C-N-CA 119.667 -0.813 . . . . 0.0 112.388 178.347 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.908 ' HD2' ' H ' ' B' ' 62' ' ' ASN . 41.3 Cg_endo -69.31 63.46 1.53 Allowed 'Trans proline' 0 N--CA 1.488 1.154 0 O-C-N 122.768 0.878 . . . . 0.0 110.88 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 64' ' ' GLN . . . . . 0.566 ' CB ' ' CE1' ' B' ' 61' ' ' PHE . 2.8 mt-30 -167.57 -106.87 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.522 HG22 ' CZ ' ' B' ' 61' ' ' PHE . 0.6 OUTLIER -75.63 -4.14 38.47 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.347 -1.471 . . . . 0.0 109.122 177.345 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 66' ' ' GLN . . . . . 0.494 ' O ' ' HB3' ' B' ' 67' ' ' GLU . 0.9 OUTLIER 75.57 102.22 0.07 Allowed 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 121.455 0.645 . . . . 0.0 112.048 179.141 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 67' ' ' GLU . . . . . 0.542 ' H ' ' HA ' ' B' ' 62' ' ' ASN . 1.5 pt-20 160.09 69.34 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 68' ' ' ALA . . . . . 0.967 ' HB2' ' CB ' ' B' ' 62' ' ' ASN . . . -66.33 135.95 55.11 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.869 0.842 . . . . 0.0 111.121 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.727 HD12 ' HA3' ' B' ' 60' ' ' GLY . 0.2 OUTLIER -141.95 142.46 33.0 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -178.68 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 70' ' ' GLU . . . . . 0.425 ' HA ' ' CG ' ' B' ' 59' ' ' LYS . 16.4 pt-20 -172.36 19.83 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.049 -1.032 . . . . 0.0 111.864 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.504 HG21 ' NH1' ' B' ' 58' ' ' ARG . 1.1 pt -64.8 -155.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 120.826 -1.171 . . . . 0.0 108.876 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 72' ' ' ALA . . . . . 0.788 ' HB1' ' HD2' ' B' ' 73' ' ' PRO . . . -156.66 169.96 9.69 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 120.825 -1.172 . . . . 0.0 112.601 -179.121 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 73' ' ' PRO . . . . . 0.791 ' HA ' ' O ' ' B' ' 56' ' ' GLN . 42.0 Cg_endo -68.32 117.87 5.25 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 125.07 2.09 . . . . 0.0 111.401 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 74' ' ' SER . . . . . 0.511 ' N ' ' CE2' ' A' ' 94' ' ' TYR . 1.3 m -165.55 126.96 1.95 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.57 -0.706 . . . . 0.0 109.112 179.265 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 75' ' ' VAL . . . . . 0.7 ' CG1' HG23 ' B' ' 77' ' ' VAL . 0.3 OUTLIER -54.07 175.5 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.816 -1.177 . . . . 0.0 109.376 -179.293 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 76' ' ' GLY . . . . . 0.611 ' O ' ' N ' ' B' ' 78' ' ' SER . . . -107.57 57.27 0.45 Allowed Glycine 0 N--CA 1.484 1.842 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.85 HG11 ' C ' ' A' ' 84' ' ' SER . 73.5 t -45.17 87.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 122.117 -0.637 . . . . 0.0 109.944 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 78' ' ' SER . . . . . 0.611 ' N ' ' O ' ' B' ' 76' ' ' GLY . 5.7 m -57.54 -129.03 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.929 ' O ' ' O ' ' B' ' 49' ' ' ASN . 1.9 m -144.34 179.74 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 119.702 -1.874 . . . . 0.0 113.2 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 80' ' ' LYS . . . . . 0.893 ' CB ' HD13 ' B' ' 48' ' ' LEU . 3.6 mmtt -101.81 -54.8 0.13 Allowed Pre-proline 0 C--N 1.296 -1.731 0 CA-C-N 113.962 -1.472 . . . . 0.0 112.526 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 81' ' ' PRO . . . . . 0.804 ' HD2' ' H ' ' B' ' 80' ' ' LYS . 28.6 Cg_endo -53.35 114.78 1.9 Allowed 'Trans proline' 0 C--N 1.298 -2.083 0 O-C-N 123.317 1.167 . . . . 0.0 110.339 -177.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -130.85 -57.9 0.09 OUTLIER Glycine 0 N--CA 1.478 1.436 0 N-CA-C 107.072 -2.411 . . . . 0.0 107.072 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 83' ' ' GLU . . . . . 0.833 ' O ' ' N ' ' B' ' 85' ' ' LEU . 25.7 tt0 -82.78 56.21 3.32 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 177.014 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 84' ' ' SER . . . . . 1.304 ' O ' ' N ' ' B' ' 86' ' ' LYS . 1.3 m 8.9 45.2 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.983 0.897 . . . . 0.0 111.561 178.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.999 ' C ' ' O ' ' B' ' 84' ' ' SER . 1.2 mt 22.08 29.36 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 103.745 -2.687 . . . . 0.0 103.745 -171.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 86' ' ' LYS . . . . . 1.304 ' N ' ' O ' ' B' ' 84' ' ' SER 0.337 8.3 tttt -59.26 -40.71 86.84 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 104.074 -2.565 . . . . 0.0 104.074 177.119 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 87' ' ' LYS . . . . . 0.406 ' O ' ' HG2' ' B' ' 90' ' ' GLU 0.278 6.7 tttp -63.62 -37.67 88.19 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 112.248 -2.251 . . . . 0.0 105.749 175.23 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.878 ' O ' ' HB2' ' A' ' 37' ' ' ALA . . . -78.14 -24.57 47.3 Favored 'General case' 0 C--O 1.207 -1.145 0 C-N-CA 119.023 -1.071 . . . . 0.0 108.185 178.148 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.716 ' N ' ' O ' ' B' ' 85' ' ' LEU . . . -76.03 -37.75 58.02 Favored 'General case' 0 C--N 1.291 -1.959 0 O-C-N 120.962 -1.086 . . . . 0.0 109.036 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' B' ' 87' ' ' LYS . 3.7 pt-20 -66.98 -23.54 65.95 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 176.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 91' ' ' GLY . . . . . 0.417 ' C ' ' HB1' ' A' ' 37' ' ' ALA . . . -72.39 -38.92 57.99 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 92' ' ' LEU . . . . . 0.79 ' HB3' ' HA ' ' A' ' 37' ' ' ALA . 2.2 pp -76.5 22.25 0.18 Allowed 'General case' 0 N--CA 1.503 2.218 0 CA-C-N 120.177 1.988 . . . . 0.0 110.618 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 93' ' ' LYS . . . . . 0.49 ' O ' ' N ' ' B' ' 96' ' ' ASP . 0.1 OUTLIER 54.77 49.39 18.03 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 106.457 -1.682 . . . . 0.0 106.457 -177.927 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 94' ' ' TYR . . . . . 0.785 ' CE2' ' N ' ' A' ' 74' ' ' SER . 28.3 t80 -27.56 -46.22 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.919 -178.06 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -57.35 -48.13 79.8 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.302 -0.874 . . . . 0.0 109.79 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 96' ' ' ASP . . . . . 0.49 ' N ' ' O ' ' B' ' 93' ' ' LYS . 7.8 m-20 -54.24 -33.54 58.67 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.414 -0.804 . . . . 0.0 109.008 178.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 97' ' ' PHE . . . . . 0.541 ' CD2' ' HB2' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -86.93 -22.18 25.81 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.816 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 98' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' B' ' 94' ' ' TYR . . . -66.04 -31.69 72.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.638 -0.664 . . . . 0.0 110.203 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 117.948 -1.025 . . . . 0.0 110.205 -179.753 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.487 ' HA ' ' CB ' ' A' ' 5' ' ' GLU . 5.8 mtp . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 120.972 0.415 . . . . 0.0 110.075 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.644 ' O ' HD12 ' A' ' 6' ' ' LEU . 5.2 t-20 -172.62 -173.34 1.0 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.055 -1.028 . . . . 0.0 111.059 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.555 ' HE3' ' CB ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -51.53 -15.7 0.48 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.219 -0.926 . . . . 0.0 110.034 179.419 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.652 ' O ' HG13 ' A' ' 7' ' ' ILE . 18.5 m -107.82 -55.42 2.36 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 122.094 0.95 . . . . 0.0 109.261 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.71 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 0.4 OUTLIER -50.83 -47.69 60.1 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.104 -0.997 . . . . 0.0 108.832 179.37 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.644 HD12 ' O ' ' A' ' 2' ' ' ASN . 1.0 OUTLIER -58.38 -30.6 66.92 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.542 -0.863 . . . . 0.0 110.146 178.563 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.652 HG13 ' O ' ' A' ' 4' ' ' THR . 1.0 OUTLIER -60.47 -41.14 86.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.829 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.824 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 33.4 mtmt -65.47 -36.42 83.84 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 177.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.926 ' CB ' HD13 ' B' ' 31' ' ' ILE . . . -55.88 -38.18 69.82 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.6 -0.688 . . . . 0.0 109.176 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.729 HG22 HG12 ' A' ' 21' ' ' VAL . 1.4 mp -90.05 -32.09 5.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 178.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.824 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -66.41 -11.14 50.06 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 119.055 -1.058 . . . . 0.0 108.345 178.133 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.5 tp-100 -116.36 -43.77 2.92 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.513 ' OD2' HG23 ' B' ' 31' ' ' ILE . 2.1 m-20 -65.13 -38.4 90.51 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 177.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.717 HG22 HD21 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -98.37 -70.95 0.71 Allowed 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 178.036 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.416 ' CA ' ' O ' ' A' ' 11' ' ' ALA . . . 45.06 27.42 1.54 Allowed Glycine 0 N--CA 1.5 2.952 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 178.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.082 ' CD1' HG23 ' B' ' 19' ' ' VAL . 0.1 OUTLIER -84.46 -20.3 31.97 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.678 -0.895 . . . . 0.0 109.255 179.139 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.756 HG21 ' CG2' ' B' ' 17' ' ' THR . 0.4 OUTLIER -162.96 -7.75 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.819 -0.551 . . . . 0.0 110.573 -178.914 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.478 ' O ' ' C ' ' A' ' 19' ' ' VAL . 4.6 mt-30 59.73 33.83 21.91 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 -176.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 1.006 HG11 HG11 ' B' ' 19' ' ' VAL . 2.8 p -23.88 -98.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.228 -178.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.941 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -129.71 22.7 5.43 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 178.625 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.729 HG12 HG22 ' A' ' 10' ' ' ILE . 28.1 m -25.42 -39.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 CA-C-O 122.31 1.053 . . . . 0.0 109.05 -178.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.695 ' N ' ' O ' ' A' ' 20' ' ' SER . 23.0 t -83.45 -34.57 25.4 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 114.922 -1.036 . . . . 0.0 109.326 177.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.941 ' N ' ' O ' ' A' ' 20' ' ' SER . 2.4 mtmt -87.35 -31.76 19.97 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.676 -0.64 . . . . 0.0 111.481 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.664 ' HG2' HG22 ' B' ' 14' ' ' THR . 0.0 OUTLIER -77.47 -35.71 53.5 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.45 -1.407 . . . . 0.0 108.869 179.186 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.635 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 13.4 mt -76.34 -41.42 48.4 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 118.462 -1.295 . . . . 0.0 108.737 178.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.458 ' HA ' ' HE2' ' A' ' 3' ' ' LYS . . . -62.59 -35.26 78.96 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 177.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.555 ' HA ' ' CB ' ' A' ' 30' ' ' LYS . 60.2 p -83.67 -29.02 27.95 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.295 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.635 ' HB3' ' HA ' ' A' ' 25' ' ' LEU . 0.6 OUTLIER -51.55 -40.28 59.41 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.742 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.674 ' HG3' HG21 ' B' ' 45' ' ' THR . 0.2 OUTLIER -73.49 -41.55 62.97 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 175.816 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.896 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 12.5 tttt -56.63 -22.78 36.65 Favored 'General case' 0 C--O 1.192 -1.967 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 177.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.851 HD13 ' HB1' ' B' ' 9' ' ' ALA . 0.5 OUTLIER -106.28 -30.72 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 120.521 -1.362 . . . . 0.0 109.307 178.168 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.671 HG21 ' CE2' ' B' ' 47' ' ' PHE . 1.5 mm -71.43 -53.41 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 176.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.653 ' HA ' HD23 ' B' ' 85' ' ' LEU 0.26 3.6 m -61.78 -53.86 50.19 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.73 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.896 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 62.0 mm-40 -62.14 -34.53 76.55 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.711 -0.618 . . . . 0.0 110.822 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.945 HG23 ' CB ' ' A' ' 40' ' ' ASP . 1.0 OUTLIER -55.03 -53.26 58.14 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 120.839 -1.163 . . . . 0.0 108.428 179.026 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.814 HG21 HD22 ' B' ' 85' ' ' LEU . 4.0 t -51.95 -42.35 33.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 C-N-CA 118.656 -1.217 . . . . 0.0 107.924 178.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.917 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -78.23 -1.93 35.33 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.341 177.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 35' ' ' THR . 0.0 OUTLIER -108.49 -8.01 15.64 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.73 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.28 49.7 4.59 Favored Glycine 0 C--N 1.305 -1.192 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.945 ' CB ' HG23 ' A' ' 35' ' ' THR . 0.1 OUTLIER -131.22 134.8 46.81 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.1 -1.236 . . . . 0.0 110.783 179.51 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.418 ' CD ' ' HB3' ' A' ' 51' ' ' LYS . 0.8 OUTLIER -98.57 110.21 22.84 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.35 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.787 HG22 ' HB2' ' B' ' 1' ' ' MET . 39.4 t -89.9 120.92 39.48 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 C-N-CA 119.116 -1.034 . . . . 0.0 111.031 -178.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -108.88 91.02 3.47 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.741 HD12 ' HB3' ' A' ' 48' ' ' LEU . 9.8 mt -60.88 104.53 0.37 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.547 -0.721 . . . . 0.0 110.783 -178.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.592 HG21 ' HG3' ' B' ' 29' ' ' GLU . 0.1 OUTLIER 32.91 -91.43 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 120.892 0.377 . . . . 0.0 111.402 179.498 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.494 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -149.12 29.81 1.22 Allowed Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.664 ' CE2' ' HG3' ' B' ' 29' ' ' GLU . 1.8 p90 -131.33 -22.69 2.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.286 -1.126 . . . . 0.0 111.585 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.798 HD23 ' O ' ' A' ' 80' ' ' LYS . 5.3 mt -133.86 119.52 19.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.235 -1.541 . . . . 0.0 110.712 178.071 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.655 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 0.6 OUTLIER -119.97 84.18 2.17 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.432 -0.793 . . . . 0.0 111.586 -178.656 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.764 HG22 ' CG2' ' A' ' 79' ' ' VAL . 1.1 pt -83.3 147.66 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.042 -1.036 . . . . 0.0 110.425 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.428 ' HG3' ' HB2' ' A' ' 78' ' ' SER . 0.4 OUTLIER -165.94 113.99 0.78 Allowed Pre-proline 0 N--CA 1.495 1.778 0 C-N-CA 119.011 -1.076 . . . . 0.0 110.72 179.427 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.535 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 47.4 Cg_endo -71.31 143.92 44.71 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 O-C-N 123.51 1.269 . . . . 0.0 111.26 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.73 HG22 ' O ' ' A' ' 76' ' ' GLY . 25.8 m -138.23 114.88 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.726 0.774 . . . . 0.0 110.526 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.82 ' HB2' ' HB3' ' B' ' 97' ' ' PHE . . . -44.49 116.42 1.04 Allowed 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.735 0.778 . . . . 0.0 112.482 -178.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.409 ' HG3' HG23 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -143.15 136.66 28.43 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.907 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.564 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 14.3 mp0 -95.86 -175.36 3.39 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.073 -1.017 . . . . 0.0 111.249 -179.036 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.912 ' HB3' ' C ' ' A' ' 72' ' ' ALA . . . -173.74 -153.58 0.06 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.449 -0.782 . . . . 0.0 111.187 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.779 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -113.41 -148.43 0.43 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.59 -0.694 . . . . 0.0 111.381 -178.382 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.806 ' O ' ' N ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -144.09 -148.79 0.25 Allowed 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.754 -1.216 . . . . 0.0 108.576 178.521 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.623 ' HA2' ' C ' ' A' ' 69' ' ' LEU . . . -146.79 96.08 0.17 Allowed Glycine 0 N--CA 1.483 1.814 0 C-N-CA 118.95 -1.595 . . . . 0.0 111.423 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.848 ' CE2' ' HB2' ' A' ' 66' ' ' GLN . 6.9 p90 -167.42 159.49 12.46 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.281 -1.129 . . . . 0.0 111.349 178.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.826 ' H ' ' CD ' ' A' ' 63' ' ' PRO . 0.4 OUTLIER -139.98 -27.27 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.731 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -179.141 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.826 ' CD ' ' H ' ' A' ' 62' ' ' ASN . 42.6 Cg_endo -73.18 -11.31 25.03 Favored 'Trans proline' 0 N--CA 1.485 0.975 0 CA-C-N 118.896 0.641 . . . . 0.0 110.533 -178.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.621 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 0.9 OUTLIER -91.62 49.39 1.57 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.372 -0.83 . . . . 0.0 109.341 178.967 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.406 HG23 ' C ' ' A' ' 64' ' ' GLN . 2.7 p 56.29 48.85 16.35 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.849 -0.532 . . . . 0.0 110.371 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.848 ' HB2' ' CE2' ' A' ' 61' ' ' PHE . 0.9 OUTLIER -153.82 -152.53 0.42 Allowed 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.371 -0.831 . . . . 0.0 110.619 -179.495 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.638 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 9.7 mp0 -131.42 130.2 42.23 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 178.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.886 ' O ' HD23 ' A' ' 69' ' ' LEU . . . -58.53 133.15 55.57 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-O 122.017 0.913 . . . . 0.0 111.289 -178.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.886 HD23 ' O ' ' A' ' 68' ' ' ALA . 1.3 mt -142.02 -137.49 0.11 Allowed 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.832 ' O ' ' O ' ' A' ' 71' ' ' ILE . 3.2 tt0 -166.48 -128.2 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.538 -1.352 . . . . 0.0 112.551 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.832 ' O ' ' O ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -10.77 153.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -176.501 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 1.012 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -137.47 -171.86 0.29 Allowed Pre-proline 0 C--N 1.298 -1.657 0 CA-C-N 114.878 -1.055 . . . . 0.0 112.686 -177.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 1.012 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 38.3 Cg_endo -66.06 117.76 4.94 Favored 'Trans proline' 0 C--N 1.318 -1.069 0 O-C-N 124.236 1.65 . . . . 0.0 110.963 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.525 ' HA ' ' CD2' ' B' ' 94' ' ' TYR . 0.8 OUTLIER -157.86 149.12 21.37 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.768 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.81 HG12 ' HB2' ' B' ' 89' ' ' ALA . 0.4 OUTLIER -48.53 166.99 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.103 -0.998 . . . . 0.0 109.961 -179.364 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.73 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -108.15 85.72 0.42 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.18 -1.968 . . . . 0.0 108.18 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 1.109 HG11 HD13 ' B' ' 85' ' ' LEU . 73.4 t -60.19 80.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.781 -0.835 . . . . 0.0 110.557 -179.052 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.468 ' N ' ' O ' ' A' ' 76' ' ' GLY . 0.3 OUTLIER -75.43 178.48 5.88 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.27 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.764 ' CG2' HG22 ' A' ' 50' ' ' ILE . 6.6 p 178.64 177.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.798 ' O ' HD23 ' A' ' 48' ' ' LEU . 1.4 mttt -175.83 173.67 0.88 Allowed Pre-proline 0 N--CA 1.487 1.396 0 O-C-N 120.799 -1.188 . . . . 0.0 111.069 178.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.485 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 56.5 Cg_endo -94.96 142.69 1.32 Allowed 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 122.586 2.191 . . . . 0.0 109.407 177.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.515 ' CA ' ' HA ' ' A' ' 47' ' ' PHE . . . -106.26 163.97 13.65 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.273 -1.931 . . . . 0.0 108.273 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.34 -24.79 57.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.071 -1.252 . . . . 0.0 110.624 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.457 ' HB2' ' HB3' ' A' ' 47' ' ' PHE . 3.5 m -55.29 -36.64 66.37 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.037 -1.039 . . . . 0.0 108.652 178.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.892 HD13 HG21 ' B' ' 77' ' ' VAL . 0.5 OUTLIER -80.69 -30.78 36.38 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.757 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.815 ' HG3' HG12 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -77.32 -41.9 38.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.639 -0.663 . . . . 0.0 109.947 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.3 ttmt -64.15 -38.97 92.98 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.896 ' O ' ' HB1' ' B' ' 37' ' ' ALA . . . -66.18 -35.99 81.9 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 176.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.908 ' HB1' ' CG1' ' B' ' 75' ' ' VAL . . . -56.65 -39.39 73.62 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.774 -0.77 . . . . 0.0 108.932 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.39 -33.05 65.39 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 176.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.446 ' C ' ' H ' ' A' ' 93' ' ' LYS . . . -60.21 -42.33 98.61 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 178.098 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.883 ' O ' HD12 ' A' ' 92' ' ' LEU . 0.5 OUTLIER -65.2 6.01 0.31 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.729 -1.454 . . . . 0.0 110.822 179.649 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.614 ' HB3' ' HB2' ' A' ' 96' ' ' ASP . 3.1 mmtt 80.07 52.95 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 CA-C-O 122.052 0.929 . . . . 0.0 108.783 -179.008 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.944 ' CD1' ' HB2' ' B' ' 74' ' ' SER . 4.5 t80 -42.28 -61.87 1.08 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.535 ' HA ' ' CB ' ' B' ' 74' ' ' SER . 15.2 mt-10 -51.18 -33.83 28.9 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.878 -1.139 . . . . 0.0 110.305 179.011 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.614 ' HB2' ' HB3' ' A' ' 93' ' ' LYS . 9.2 t0 -62.41 -26.12 68.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.277 -0.89 . . . . 0.0 109.133 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.533 ' HB3' ' HB2' ' B' ' 54' ' ' ALA . 0.5 OUTLIER -84.52 -20.81 31.0 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.232 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.995 ' HB2' ' CB ' ' B' ' 74' ' ' SER . . . -69.43 -36.6 76.81 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.633 -0.667 . . . . 0.0 109.804 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 14.8 mttm . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 118.005 -0.997 . . . . 0.0 110.221 -179.889 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.787 ' HB2' HG22 ' A' ' 42' ' ' VAL . 9.6 mtp . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 120.869 0.366 . . . . 0.0 110.08 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 2' ' ' ASN . . . . . 0.44 ' O ' ' HB2' ' B' ' 6' ' ' LEU . 0.7 OUTLIER -172.44 -169.59 0.62 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.126 -0.984 . . . . 0.0 111.017 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.584 ' HD2' ' HB ' ' A' ' 45' ' ' THR . 0.0 OUTLIER -56.53 -10.85 1.06 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.308 -0.87 . . . . 0.0 110.098 179.61 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.688 ' O ' HG13 ' B' ' 7' ' ' ILE . 37.1 m -109.86 -56.68 2.29 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 122.162 0.982 . . . . 0.0 108.761 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.628 ' HA ' ' HE2' ' B' ' 8' ' ' LYS . 0.1 OUTLIER -49.4 -46.11 47.01 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.057 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.735 HD11 ' CG1' ' A' ' 42' ' ' VAL . 5.3 mt -64.45 -27.01 68.7 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.154 -1.019 . . . . 0.0 110.557 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 7' ' ' ILE . . . . . 0.688 HG13 ' O ' ' B' ' 4' ' ' THR . 1.2 pp -59.36 -41.68 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 120.37 -1.456 . . . . 0.0 107.306 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 8' ' ' LYS . . . . . 0.767 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 18.6 mtmt -67.36 -44.09 79.84 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 177.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 9' ' ' ALA . . . . . 0.851 ' HB1' HD13 ' A' ' 31' ' ' ILE . . . -53.69 -32.11 50.52 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.646 -0.659 . . . . 0.0 109.863 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.734 ' O ' ' OG1' ' B' ' 14' ' ' THR . 0.8 OUTLIER -94.4 -29.85 4.21 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.478 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 178.162 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.767 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -63.08 -28.53 70.14 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 177.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.425 ' HG3' ' O ' ' B' ' 8' ' ' LYS . 58.5 mt-30 -87.96 -43.85 11.45 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.447 ' HB3' ' OG ' ' A' ' 27' ' ' SER . 94.1 m-20 -64.16 -26.1 68.38 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 177.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.827 HG22 ' HB2' ' A' ' 20' ' ' SER . 20.6 p -87.74 -76.74 0.37 Allowed 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 177.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 61.32 10.99 25.1 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 16' ' ' LEU . . . . . 0.879 HD22 ' O ' ' A' ' 19' ' ' VAL . 3.1 mp -82.33 -67.16 0.81 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.525 -0.985 . . . . 0.0 109.204 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 17' ' ' THR . . . . . 0.756 ' CG2' HG21 ' A' ' 17' ' ' THR . 0.5 OUTLIER -137.52 6.39 2.74 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.787 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 18' ' ' GLN . . . . . 0.639 ' O ' ' C ' ' B' ' 19' ' ' VAL . 15.4 mt-30 57.97 25.88 12.75 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 -176.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 1.082 HG23 ' CD1' ' A' ' 16' ' ' LEU . 0.4 OUTLIER 4.17 -102.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.642 -179.099 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.967 ' O ' ' N ' ' B' ' 22' ' ' SER . 0.2 OUTLIER -135.2 24.09 3.52 Favored 'General case' 0 C--N 1.27 -2.853 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 177.33 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.601 ' C ' ' O ' ' B' ' 20' ' ' SER . 35.2 m -12.4 -38.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-O 122.394 1.092 . . . . 0.0 110.469 -177.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.967 ' N ' ' O ' ' B' ' 20' ' ' SER . 12.1 t -80.14 -46.87 15.65 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.34 177.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 23' ' ' LYS . . . . . 0.939 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.1 OUTLIER -85.44 -24.1 27.59 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.855 -0.528 . . . . 0.0 110.085 178.624 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 24' ' ' MET . . . . . 0.599 ' CE ' HG21 ' B' ' 10' ' ' ILE . 3.5 tmm? -68.37 -45.1 73.71 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.701 ' HA ' ' HB3' ' B' ' 28' ' ' PHE . 11.6 mt -71.0 -34.79 71.69 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 176.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 26' ' ' ALA . . . . . 0.585 ' HB3' ' HA ' ' B' ' 23' ' ' LYS . . . -62.29 -34.72 77.12 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 177.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 27' ' ' SER . . . . . 0.466 ' HA ' ' HB3' ' B' ' 30' ' ' LYS . 0.1 OUTLIER -76.38 -40.71 50.28 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 177.636 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 28' ' ' PHE . . . . . 0.701 ' HB3' ' HA ' ' B' ' 25' ' ' LEU . 0.1 OUTLIER -52.84 -45.94 67.57 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.163 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 29' ' ' GLU . . . . . 0.664 ' HG3' ' CE2' ' A' ' 47' ' ' PHE . 1.2 tt0 -68.58 -36.38 78.66 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 177.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 1.246 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 13.4 ttmt -64.71 -22.74 67.05 Favored 'General case' 0 C--O 1.191 -1.989 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.926 HD13 ' CB ' ' A' ' 9' ' ' ALA . 0.6 OUTLIER -105.83 -27.61 3.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 O-C-N 120.282 -1.511 . . . . 0.0 109.335 178.237 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.645 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.2 mm -73.18 -60.42 2.43 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 177.044 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 33' ' ' THR . . . . . 0.598 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 0.6 OUTLIER -68.75 -35.21 76.81 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.553 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 1.246 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 31.1 mm-40 -78.54 -37.78 42.06 Favored 'General case' 0 C--O 1.207 -1.184 0 O-C-N 121.115 -0.99 . . . . 0.0 111.952 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 35' ' ' THR . . . . . 0.514 ' CB ' ' O ' ' B' ' 31' ' ' ILE . 37.2 m -61.95 -49.99 73.92 Favored 'General case' 0 N--CA 1.504 2.246 0 CA-C-N 120.714 1.597 . . . . 0.0 109.201 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.734 HG11 HD22 ' A' ' 85' ' ' LEU . 2.1 t -52.83 -43.53 45.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 178.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 0.896 ' HB1' ' O ' ' A' ' 88' ' ' ALA . . . -85.99 0.82 52.31 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.834 178.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 38' ' ' LYS . . . . . 0.747 ' HB2' ' O ' ' B' ' 34' ' ' GLU . 7.6 tppt? -96.05 -33.46 12.1 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 177.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 134.01 33.44 0.33 Allowed Glycine 0 C--N 1.303 -1.263 0 C-N-CA 119.581 -1.295 . . . . 0.0 111.482 177.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 40' ' ' ASP . . . . . 0.453 ' CB ' ' CG2' ' B' ' 35' ' ' THR . 0.1 OUTLIER -144.85 157.55 44.12 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.752 -1.44 . . . . 0.0 110.66 179.356 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.401 ' HG3' ' HD2' ' B' ' 52' ' ' PRO . 4.5 mptp? -103.96 99.81 9.57 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.518 -0.739 . . . . 0.0 109.61 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.511 HG13 HD11 ' A' ' 6' ' ' LEU . 59.7 t -59.07 136.28 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.584 -0.698 . . . . 0.0 110.085 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -127.96 97.25 4.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.342 -0.849 . . . . 0.0 109.403 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.714 HD12 ' HB3' ' B' ' 48' ' ' LEU . 11.0 mt -69.1 101.6 1.47 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.249 -0.907 . . . . 0.0 110.442 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 45' ' ' THR . . . . . 0.674 HG21 ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 32.34 -95.1 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.036 0 O-C-N 122.052 -0.405 . . . . 0.0 111.451 179.277 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -144.41 30.71 1.85 Allowed Glycine 0 N--CA 1.487 2.037 0 C-N-CA 119.668 -1.253 . . . . 0.0 110.448 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 47' ' ' PHE . . . . . 0.702 ' O ' ' HA ' ' B' ' 81' ' ' PRO . 3.9 p90 -133.65 -18.6 2.15 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.893 -1.357 . . . . 0.0 111.686 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.714 ' HB3' HD12 ' B' ' 44' ' ' LEU . 4.6 mt -135.47 120.25 18.43 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.337 -1.477 . . . . 0.0 111.196 178.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 49' ' ' ASN . . . . . 0.53 ' O ' ' HA ' ' B' ' 79' ' ' VAL . 2.6 m120 -116.95 94.56 4.64 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.506 -0.747 . . . . 0.0 111.208 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 50' ' ' ILE . . . . . 0.647 HG22 HG21 ' B' ' 36' ' ' VAL . 33.8 mm -90.19 141.91 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.305 -0.872 . . . . 0.0 109.739 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 51' ' ' LYS . . . . . 0.432 ' O ' ' N ' ' B' ' 78' ' ' SER . 2.3 pttt -162.44 128.63 2.35 Favored Pre-proline 0 N--CA 1.498 1.951 0 O-C-N 120.582 -1.324 . . . . 0.0 111.439 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.566 ' O ' HG13 ' B' ' 53' ' ' VAL . 52.5 Cg_endo -77.12 145.15 24.27 Favored 'Trans proline' 0 C--N 1.314 -1.24 0 O-C-N 123.531 1.28 . . . . 0.0 110.72 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.659 HG22 ' O ' ' B' ' 76' ' ' GLY . 15.3 m -156.57 121.28 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-O 121.257 0.551 . . . . 0.0 109.962 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.832 ' HA ' ' N ' ' B' ' 75' ' ' VAL . . . -68.04 125.02 25.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.12 -0.988 . . . . 0.0 111.561 -178.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 55' ' ' ARG . . . . . 0.578 ' HB2' ' O ' ' B' ' 54' ' ' ALA . 0.1 OUTLIER 172.23 39.63 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.831 -179.671 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 56' ' ' GLN . . . . . 0.495 ' O ' ' OH ' ' A' ' 94' ' ' TYR . 8.3 mm-40 -122.56 96.88 5.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.235 -0.916 . . . . 0.0 110.04 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.673 ' HB2' ' CD ' ' B' ' 73' ' ' PRO . . . -137.36 166.75 23.06 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.237 -0.985 . . . . 0.0 111.318 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 58' ' ' ARG . . . . . 0.598 ' N ' ' HD3' ' B' ' 58' ' ' ARG . 0.0 OUTLIER -98.3 157.33 16.24 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.752 -0.592 . . . . 0.0 110.949 -178.901 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 59' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' B' ' 58' ' ' ARG . 0.7 OUTLIER -178.88 40.06 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.586 -0.696 . . . . 0.0 109.484 179.278 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -106.78 -108.43 3.3 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 61' ' ' PHE . . . . . 0.804 ' O ' ' N ' ' B' ' 67' ' ' GLU . 5.9 p90 -179.34 172.45 1.2 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.291 -1.123 . . . . 0.0 110.238 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 62' ' ' ASN . . . . . 0.853 ' N ' ' HB2' ' B' ' 68' ' ' ALA . 1.8 t30 -106.85 -60.07 0.05 OUTLIER Pre-proline 0 N--CA 1.499 1.986 0 O-C-N 120.95 -1.094 . . . . 0.0 112.184 -178.056 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.629 ' HD2' ' H ' ' B' ' 62' ' ' ASN . 41.6 Cg_endo -67.89 62.82 0.94 Allowed 'Trans proline' 0 C--N 1.315 -1.2 0 O-C-N 123.322 1.17 . . . . 0.0 110.285 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 64' ' ' GLN . . . . . 0.799 ' HB3' ' CE1' ' B' ' 61' ' ' PHE . 0.0 OUTLIER -177.18 33.44 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.545 0.688 . . . . 0.0 109.295 -179.735 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.408 HG23 ' C ' ' B' ' 64' ' ' GLN . 2.8 p 55.83 53.22 9.63 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.709 -0.62 . . . . 0.0 111.097 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 66' ' ' GLN . . . . . 0.737 ' HB2' ' CE1' ' B' ' 61' ' ' PHE . 0.0 OUTLIER -150.09 -100.36 0.07 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.002 -1.061 . . . . 0.0 110.935 179.858 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 67' ' ' GLU . . . . . 0.804 ' N ' ' O ' ' B' ' 61' ' ' PHE . 2.7 pt-20 170.39 96.41 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.137 -0.977 . . . . 0.0 108.803 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 68' ' ' ALA . . . . . 0.951 ' O ' HD23 ' B' ' 69' ' ' LEU . . . -71.1 94.91 1.16 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.189 -0.945 . . . . 0.0 110.1 -178.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.951 HD23 ' O ' ' B' ' 68' ' ' ALA . 5.9 mt -142.61 155.87 45.02 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.747 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -144.15 50.78 1.31 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.387 -0.821 . . . . 0.0 110.059 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.473 HG12 ' HD3' ' B' ' 58' ' ' ARG . 3.2 pt -61.14 -153.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.441 -0.787 . . . . 0.0 110.17 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -133.84 139.99 35.13 Favored Pre-proline 0 C--N 1.301 -1.515 0 O-C-N 121.227 -0.92 . . . . 0.0 111.316 -179.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 73' ' ' PRO . . . . . 0.673 ' CD ' ' HB2' ' B' ' 57' ' ' ALA . 47.1 Cg_endo -80.88 132.42 8.58 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 124.046 1.551 . . . . 0.0 108.911 178.137 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 74' ' ' SER . . . . . 0.995 ' CB ' ' HB2' ' A' ' 98' ' ' ALA . 0.7 OUTLIER -153.48 19.21 0.55 Allowed 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 119.19 -1.004 . . . . 0.0 113.143 -178.945 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 75' ' ' VAL . . . . . 0.908 ' CG1' ' HB1' ' A' ' 89' ' ' ALA . 0.9 OUTLIER 163.18 144.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.517 2.894 0 CA-C-O 121.908 0.861 . . . . 0.0 109.288 175.954 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 76' ' ' GLY . . . . . 0.659 ' O ' HG22 ' B' ' 53' ' ' VAL . . . -157.17 110.63 0.45 Allowed Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.892 HG21 HD13 ' A' ' 85' ' ' LEU . 2.7 p -67.93 89.42 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.395 -1.062 . . . . 0.0 111.31 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 78' ' ' SER . . . . . 0.617 ' C ' HG12 ' B' ' 79' ' ' VAL . 0.3 OUTLIER -74.52 -176.38 2.72 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 177.343 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.617 HG12 ' C ' ' B' ' 78' ' ' SER . 0.2 OUTLIER 179.84 174.66 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.298 -0.876 . . . . 0.0 109.028 179.676 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 80' ' ' LYS . . . . . 0.555 ' O ' HD23 ' B' ' 48' ' ' LEU . 4.7 mttt 179.25 174.25 0.42 Allowed Pre-proline 0 C--N 1.307 -1.243 0 O-C-N 121.492 -0.755 . . . . 0.0 109.379 178.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 81' ' ' PRO . . . . . 0.702 ' HA ' ' O ' ' B' ' 47' ' ' PHE . 52.3 Cg_endo -95.68 171.57 1.22 Allowed 'Trans proline' 0 C--N 1.296 -2.206 0 C-N-CA 121.856 1.704 . . . . 0.0 109.567 177.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 82' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' B' ' 47' ' ' PHE . . . -120.5 -92.63 1.31 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 106.177 -2.769 . . . . 0.0 106.177 177.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 83' ' ' GLU . . . . . 0.877 ' O ' ' N ' ' B' ' 85' ' ' LEU . 29.2 tt0 -80.13 51.61 1.41 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 175.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 84' ' ' SER . . . . . 0.671 ' O ' HG21 ' A' ' 77' ' ' VAL . 0.1 OUTLIER 8.27 44.15 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.007 179.586 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 1.109 HD13 HG11 ' A' ' 77' ' ' VAL . 3.6 mp 20.18 28.93 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 103.104 -2.924 . . . . 0.0 103.104 -172.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 86' ' ' LYS . . . . . 0.59 ' HD2' ' HB2' ' B' ' 84' ' ' SER 0.349 4.0 tttp -57.94 -42.59 85.23 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 104.418 -2.438 . . . . 0.0 104.418 177.397 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 87' ' ' LYS . . . . . 0.419 ' O ' ' HG2' ' B' ' 90' ' ' GLU 0.282 15.8 tttt -69.2 -31.17 69.59 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 111.789 -2.459 . . . . 0.0 105.976 175.654 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.768 ' HB3' ' HB3' ' B' ' 85' ' ' LEU . . . -78.02 -27.04 48.8 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 118.19 -1.404 . . . . 0.0 107.917 178.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 1.008 ' HA ' HD23 ' B' ' 92' ' ' LEU . . . -64.96 -48.7 73.1 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.294 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.423 ' HG2' ' N ' ' B' ' 91' ' ' GLY . 4.0 pt-20 -59.24 -28.08 66.37 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 177.282 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 91' ' ' GLY . . . . . 0.423 ' N ' ' HG2' ' B' ' 90' ' ' GLU . . . -75.51 -24.49 70.34 Favored Glycine 0 N--CA 1.49 2.255 0 C-N-CA 120.462 -0.875 . . . . 0.0 111.137 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 92' ' ' LEU . . . . . 1.008 HD23 ' HA ' ' B' ' 89' ' ' ALA . 0.3 OUTLIER -88.05 23.92 1.96 Allowed 'General case' 0 N--CA 1.503 2.216 0 O-C-N 120.322 -1.693 . . . . 0.0 110.544 -179.738 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 93' ' ' LYS . . . . . 0.406 ' O ' ' N ' ' B' ' 96' ' ' ASP . 1.2 mmmm 55.11 35.86 25.7 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 -177.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 94' ' ' TYR . . . . . 0.538 ' CD1' ' N ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -41.71 -43.62 2.92 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.794 -178.701 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 95' ' ' GLU . . . . . 0.434 ' HG2' ' N ' ' B' ' 96' ' ' ASP . 4.9 pm0 -53.81 -36.11 62.12 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.264 -0.897 . . . . 0.0 109.289 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 96' ' ' ASP . . . . . 0.434 ' N ' ' HG2' ' B' ' 95' ' ' GLU . 20.1 t70 -64.97 -34.35 78.23 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 177.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 97' ' ' PHE . . . . . 0.82 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -73.91 -25.33 59.94 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.267 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.03 -30.86 65.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.591 -0.693 . . . . 0.0 110.17 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.22 179.965 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.839 ' HB3' HG22 ' B' ' 42' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.446 ' HA ' ' O ' ' B' ' 43' ' ' GLN . 52.2 p-10 -171.66 -149.25 0.06 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.988 -1.07 . . . . 0.0 112.044 178.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.895 ' HA ' HD11 ' A' ' 25' ' ' LEU . 3.8 tttm -51.32 -6.94 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.44 -0.788 . . . . 0.0 111.622 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.645 ' O ' HG13 ' A' ' 7' ' ' ILE . 48.7 m -118.13 -62.49 1.54 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.849 -1.157 . . . . 0.0 110.586 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.542 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 4.9 mt-10 -49.22 -42.02 39.08 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.071 -1.018 . . . . 0.0 109.167 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.696 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 21.0 mt -62.26 -32.51 73.22 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.111 -1.035 . . . . 0.0 109.556 178.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.828 HG22 HD23 ' A' ' 25' ' ' LEU . 1.0 OUTLIER -57.18 -43.95 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 178.292 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.901 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 2.6 mtpt -63.56 -34.75 78.49 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.862 ' HB1' HD13 ' B' ' 31' ' ' ILE . . . -52.56 -40.12 62.21 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.807 -0.757 . . . . 0.0 109.155 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.776 HG22 HG12 ' A' ' 21' ' ' VAL . 1.5 mp -91.15 -32.1 5.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 178.085 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.901 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -66.79 -13.06 61.05 Favored 'General case' 0 C--N 1.292 -1.918 0 O-C-N 120.756 -1.215 . . . . 0.0 108.923 178.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.444 ' N ' ' O ' ' A' ' 8' ' ' LYS . 11.5 pt20 -114.58 -39.98 3.68 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.45 -0.781 . . . . 0.0 109.656 179.046 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.426 ' HB3' ' OG ' ' B' ' 27' ' ' SER . 1.0 OUTLIER -73.95 -20.29 60.41 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 176.887 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . 1.017 HG22 HD11 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -119.14 -83.99 0.65 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 179.232 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.539 ' O ' ' C ' ' A' ' 16' ' ' LEU . . . 68.6 -21.17 0.34 Allowed Glycine 0 N--CA 1.495 2.588 0 O-C-N 120.957 -1.09 . . . . 0.0 110.843 178.349 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.017 HD11 HG22 ' A' ' 14' ' ' THR . 0.0 OUTLIER -28.77 -59.68 0.13 Allowed 'General case' 0 N--CA 1.518 2.973 0 CA-C-O 122.004 0.906 . . . . 0.0 110.266 -179.166 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.589 HG21 ' CG2' ' B' ' 17' ' ' THR . 0.6 OUTLIER -130.23 -7.28 4.3 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.564 -179.932 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.566 ' O ' ' C ' ' A' ' 19' ' ' VAL . 23.6 mt-30 57.25 36.86 27.88 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -177.188 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 1.062 HG11 HG11 ' B' ' 19' ' ' VAL . 1.0 OUTLIER -19.62 -93.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.872 -178.974 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.935 ' O ' ' N ' ' A' ' 22' ' ' SER . 0.4 OUTLIER -134.39 25.03 3.8 Favored 'General case' 0 C--N 1.278 -2.506 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 177.946 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.776 HG12 HG22 ' A' ' 10' ' ' ILE . 27.3 m -16.34 -38.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 122.684 1.23 . . . . 0.0 109.466 -178.006 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.935 ' N ' ' O ' ' A' ' 20' ' ' SER . 32.2 p -84.55 -39.31 18.93 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 114.66 -1.154 . . . . 0.0 110.38 178.24 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.926 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.3 OUTLIER -89.69 -25.38 21.25 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 121.245 -0.91 . . . . 0.0 110.613 179.593 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.963 ' HB3' HG21 ' B' ' 14' ' ' THR . 0.0 OUTLIER -81.01 -35.02 32.47 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.25 -1.531 . . . . 0.0 109.361 178.9 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.895 HD11 ' HA ' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -80.75 -40.99 24.27 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 117.875 -1.53 . . . . 0.0 107.141 177.819 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.502 ' CB ' ' O ' ' A' ' 22' ' ' SER . . . -60.55 -25.74 66.38 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 176.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.494 ' HA ' ' HB3' ' A' ' 30' ' ' LYS . 7.0 t -83.42 -37.9 22.62 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.238 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.756 ' HA ' ' CG1' ' A' ' 31' ' ' ILE . 0.1 OUTLIER -60.11 -33.04 71.56 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.486 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.663 ' HG3' ' CD1' ' A' ' 28' ' ' PHE . 29.6 mt-10 -80.06 -33.89 38.61 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 177.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.85 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 6.6 tttm -69.46 -28.0 65.72 Favored 'General case' 0 C--O 1.195 -1.799 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 177.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.935 HD13 ' HB1' ' B' ' 9' ' ' ALA . 1.1 pp -96.98 -30.3 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.217 -0.927 . . . . 0.0 109.728 179.106 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.747 HG21 ' CE1' ' B' ' 47' ' ' PHE . 1.6 mm -65.09 -53.98 34.68 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 177.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.629 HG23 ' HB2' ' B' ' 88' ' ' ALA . 0.4 OUTLIER -69.09 -37.3 78.35 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.162 -1.015 . . . . 0.0 108.464 179.591 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.85 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 15.5 mm-40 -73.17 -38.41 66.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.431 -0.793 . . . . 0.0 111.25 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.539 ' N ' ' O ' ' A' ' 31' ' ' ILE . 19.4 m -58.13 -48.49 80.08 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.697 -1.252 . . . . 0.0 108.097 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.776 HG13 ' HB3' ' A' ' 52' ' ' PRO . 2.8 t -55.84 -36.79 44.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 106.652 -1.611 . . . . 0.0 106.652 177.115 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.768 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -80.29 -4.01 51.63 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.505 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -101.81 -32.58 10.19 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.583 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.72 34.57 0.79 Allowed Glycine 0 C--N 1.302 -1.33 0 C-N-CA 119.682 -1.247 . . . . 0.0 111.472 177.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.53 ' HB2' HG23 ' A' ' 35' ' ' THR . 0.4 OUTLIER -135.8 144.0 45.5 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.856 -1.379 . . . . 0.0 110.552 179.262 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.454 ' HG2' ' HB2' ' A' ' 51' ' ' LYS . 49.0 mtmt -91.67 92.4 8.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.517 -0.739 . . . . 0.0 109.978 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.608 HG23 ' HB ' ' A' ' 50' ' ' ILE . 35.4 m -63.05 147.29 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.533 -0.73 . . . . 0.0 110.413 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.882 ' O ' HD23 ' A' ' 44' ' ' LEU . 31.9 mt-30 -142.74 171.41 14.08 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.308 -0.87 . . . . 0.0 110.49 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.882 HD23 ' O ' ' A' ' 43' ' ' GLN . 21.3 mt -131.47 -177.99 4.66 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.512 -0.743 . . . . 0.0 109.781 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.829 HG22 ' HG2' ' B' ' 29' ' ' GLU . 2.8 t -43.25 66.23 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.88 -0.512 . . . . 0.0 112.098 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.78 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . 46.98 23.03 1.39 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.802 ' HA ' ' HA2' ' A' ' 82' ' ' GLY . 0.7 OUTLIER -117.61 -37.83 3.4 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 121.014 -1.286 . . . . 0.0 109.522 179.39 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.832 ' HB2' HD12 ' A' ' 44' ' ' LEU . 6.9 mt -120.6 118.86 31.25 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.442 -1.411 . . . . 0.0 111.095 177.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.672 ' H ' ' HB2' ' A' ' 80' ' ' LYS . 32.6 t-20 -116.9 85.64 2.36 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.766 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.64 HD13 ' HA ' ' A' ' 79' ' ' VAL . 40.1 mm -86.12 126.07 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.444 -0.785 . . . . 0.0 110.473 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.598 ' HD2' HG13 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -147.48 130.69 8.09 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.353 -0.842 . . . . 0.0 109.441 179.307 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.776 ' HB3' HG13 ' A' ' 36' ' ' VAL . 53.7 Cg_endo -78.18 142.09 18.97 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 123.57 1.3 . . . . 0.0 112.467 -178.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.7 HG22 ' O ' ' A' ' 76' ' ' GLY . 33.7 m -134.72 109.64 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 CA-C-O 121.696 0.76 . . . . 0.0 110.92 178.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.731 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . -62.37 119.09 8.42 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.43 -0.794 . . . . 0.0 111.471 -179.114 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.469 ' O ' ' HB3' ' A' ' 56' ' ' GLN . 0.9 OUTLIER -173.83 16.44 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 118.888 -1.125 . . . . 0.0 113.696 179.098 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.707 ' N ' ' HA ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -176.34 141.73 0.43 Allowed 'General case' 0 N--CA 1.506 2.344 0 O-C-N 120.077 -1.64 . . . . 0.0 115.197 178.654 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.879 ' N ' ' O ' ' A' ' 72' ' ' ALA . . . 161.16 -177.75 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.652 ' HA ' ' HA ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -177.62 123.85 0.12 Allowed 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 122.248 1.023 . . . . 0.0 112.336 177.233 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.912 ' HB2' ' HB2' ' A' ' 70' ' ' GLU . 3.4 mmtm -62.81 -129.0 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.153 -0.93 . . . . 0.0 108.952 177.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.496 ' O ' ' O ' ' A' ' 61' ' ' PHE . . . -147.9 130.79 3.61 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 118.927 -1.606 . . . . 0.0 111.347 -178.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.829 ' HB3' ' N ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -53.23 -161.5 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.929 -0.748 . . . . 0.0 109.588 179.129 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.757 ' N ' ' CG ' ' A' ' 61' ' ' PHE 0.272 1.0 OUTLIER -45.07 179.72 0.01 OUTLIER Pre-proline 0 C--N 1.299 -1.589 0 O-C-N 121.242 -0.912 . . . . 0.0 110.724 177.509 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.435 ' HD2' ' CG ' ' A' ' 62' ' ' ASN . 45.8 Cg_endo -74.48 3.57 5.21 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 O-C-N 123.221 1.116 . . . . 0.0 109.944 178.42 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.532 ' CB ' ' CE1' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -78.67 -103.87 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.315 -0.866 . . . . 0.0 110.191 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.471 ' H ' ' HB3' ' A' ' 64' ' ' GLN . 77.1 p -68.03 -8.33 36.73 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.701 -1.25 . . . . 0.0 109.872 179.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 54.56 51.27 14.32 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.35 -0.844 . . . . 0.0 110.528 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.758 ' C ' ' HB3' ' A' ' 61' ' ' PHE . 0.1 OUTLIER 177.78 87.2 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.601 0 O-C-N 121.197 -0.94 . . . . 0.0 111.443 179.499 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.829 ' N ' ' HB3' ' A' ' 61' ' ' PHE . . . 173.78 18.66 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.719 ' O ' HD12 ' A' ' 69' ' ' LEU . 0.8 OUTLIER -171.99 45.04 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.226 0 O-C-N 119.827 -1.796 . . . . 0.0 110.977 177.954 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.912 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -175.65 48.19 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.188 -0.945 . . . . 0.0 109.72 -179.836 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.964 HD12 ' N ' ' A' ' 72' ' ' ALA . 0.7 OUTLIER -63.36 -176.86 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.241 -0.912 . . . . 0.0 111.154 -178.731 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.964 ' N ' HD12 ' A' ' 71' ' ' ILE . . . -165.31 143.64 5.16 Favored Pre-proline 0 C--O 1.198 -1.619 0 O-C-N 121.73 -0.606 . . . . 0.0 109.495 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.707 ' HA ' ' N ' ' A' ' 56' ' ' GLN . 54.9 Cg_endo -98.45 62.04 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 121.781 1.654 . . . . 0.0 111.726 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.781 ' HB2' ' HB2' ' A' ' 57' ' ' ALA . 10.4 t -52.8 158.58 1.32 Allowed 'General case' 0 N--CA 1.505 2.309 0 O-C-N 120.83 -1.169 . . . . 0.0 112.644 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.731 ' HA ' ' HA ' ' A' ' 54' ' ' ALA . 0.8 OUTLIER -68.16 150.12 11.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-O 122.043 0.925 . . . . 0.0 109.733 179.877 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.7 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -114.24 86.22 0.41 Allowed Glycine 0 C--N 1.289 -2.067 0 N-CA-C 108.886 -1.685 . . . . 0.0 108.886 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.84 HG21 HD13 ' B' ' 85' ' ' LEU . 3.8 p -45.21 87.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 CA-C-O 121.766 0.793 . . . . 0.0 110.792 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.544 ' N ' ' O ' ' A' ' 76' ' ' GLY . 0.1 OUTLIER -59.37 -162.35 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.122 179.8 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.712 HG11 ' HD3' ' B' ' 81' ' ' PRO . 5.4 p 179.93 178.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.672 ' HB2' ' H ' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -139.76 177.69 1.92 Allowed Pre-proline 0 C--N 1.305 -1.331 0 O-C-N 120.896 -1.127 . . . . 0.0 110.455 179.051 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.435 ' HD3' ' CG ' ' A' ' 80' ' ' LYS . 56.4 Cg_endo -106.69 84.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.298 -2.095 0 C-N-CA 124.074 3.183 . . . . 0.0 108.592 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.802 ' HA2' ' HA ' ' A' ' 47' ' ' PHE . . . -55.73 100.72 0.1 Allowed Glycine 0 N--CA 1.483 1.779 0 C-N-CA 118.698 -1.715 . . . . 0.0 110.955 -177.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.414 ' HA ' ' HB2' ' A' ' 86' ' ' LYS . 6.2 pt-20 -57.35 -29.01 63.64 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.451 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 0.3 OUTLIER -61.88 -32.76 73.15 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 177.3 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.819 HD21 HG21 ' B' ' 36' ' ' VAL . 1.9 tt -81.69 -39.45 24.28 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 177.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.698 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 0.3 OUTLIER -69.78 -45.93 66.9 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.614 0.721 . . . . 0.0 109.53 179.301 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.69 -37.55 87.78 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.489 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.662 ' C ' ' HB2' ' B' ' 37' ' ' ALA . . . -66.28 -36.89 84.13 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 176.254 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 1.045 ' HB1' HG21 ' B' ' 75' ' ' VAL . . . -57.77 -31.6 66.68 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.654 ' HA ' ' CD1' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -65.2 -31.33 72.45 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 177.096 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.473 ' N ' ' HG3' ' A' ' 90' ' ' GLU . . . -66.01 -31.85 80.73 Favored Glycine 0 N--CA 1.484 1.869 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 178.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.877 HD12 ' HB2' ' A' ' 93' ' ' LYS . 1.0 OUTLIER -58.19 -43.39 87.52 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 120.723 -1.457 . . . . 0.0 111.386 -179.253 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.877 ' HB2' HD12 ' A' ' 92' ' ' LEU . 0.0 OUTLIER 164.82 46.11 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -179.651 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.776 ' CE1' ' C ' ' B' ' 74' ' ' SER . 2.2 t80 -40.29 -73.29 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -178.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.494 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 5.7 mt-10 -51.4 -41.86 61.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.197 -0.939 . . . . 0.0 110.256 -178.408 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -61.28 -32.22 72.05 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.684 ' HD2' HD11 ' A' ' 92' ' ' LEU . 0.1 OUTLIER -86.59 -20.61 27.66 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.467 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.923 ' HB2' ' HB2' ' B' ' 74' ' ' SER . . . -76.8 -34.94 57.92 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.776 -0.577 . . . . 0.0 110.386 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.182 -179.957 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.713 ' CE ' HD23 ' B' ' 6' ' ' LEU . 10.0 mtp . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 2' ' ' ASN . . . . . 0.498 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 10.2 p30 -170.86 -156.63 0.12 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.971 -1.081 . . . . 0.0 112.191 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.517 ' HE3' ' HB ' ' A' ' 45' ' ' THR . 0.3 OUTLIER -57.07 -4.69 0.2 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.61 -0.681 . . . . 0.0 111.26 -179.282 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.656 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 93.9 m -124.08 -42.15 2.16 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.935 -1.103 . . . . 0.0 109.743 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.58 ' CB ' ' HA ' ' B' ' 1' ' ' MET . 0.0 OUTLIER -63.68 -53.49 50.54 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.134 -0.979 . . . . 0.0 108.709 179.087 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.764 ' O ' ' HB3' ' B' ' 9' ' ' ALA . 14.8 mt -60.0 -29.78 68.7 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.335 -0.946 . . . . 0.0 108.964 178.315 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 7' ' ' ILE . . . . . 1.042 HG23 ' HB ' ' B' ' 21' ' ' VAL . 1.1 mt -54.65 -55.73 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.29 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 8' ' ' LYS . . . . . 0.913 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 14.6 mtmt -56.57 -34.24 66.94 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 177.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 9' ' ' ALA . . . . . 0.935 ' HB1' HD13 ' A' ' 31' ' ' ILE . . . -53.22 -38.63 63.08 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.585 -0.846 . . . . 0.0 109.259 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.793 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.4 mp -92.7 -31.15 4.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 177.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.913 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -68.92 -6.48 27.71 Favored 'General case' 0 C--N 1.29 -2.0 0 C-N-CA 118.38 -1.328 . . . . 0.0 108.645 178.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.42 ' CG ' ' N ' ' B' ' 13' ' ' ASP . 12.7 pt20 -122.45 -40.13 2.5 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.324 -0.86 . . . . 0.0 110.13 179.071 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.433 ' HB2' ' O ' ' B' ' 9' ' ' ALA . 1.0 OUTLIER -70.76 -30.04 66.43 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 177.22 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 14' ' ' THR . . . . . 1.149 HG22 ' CD1' ' B' ' 16' ' ' LEU 0.271 0.2 OUTLIER -101.62 -75.59 0.59 Allowed 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.286 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.91 14.37 51.93 Favored Glycine 0 N--CA 1.499 2.868 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 177.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 16' ' ' LEU . . . . . 1.149 ' CD1' HG22 ' B' ' 14' ' ' THR . 4.7 mp -53.02 -64.99 0.64 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.557 -0.966 . . . . 0.0 110.005 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 17' ' ' THR . . . . . 0.589 ' CG2' HG21 ' A' ' 17' ' ' THR . 0.5 OUTLIER -141.92 9.47 1.94 Allowed 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.696 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 18' ' ' GLN . . . . . 0.638 ' O ' ' C ' ' B' ' 19' ' ' VAL . 14.6 mt-30 57.95 27.48 14.79 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -175.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 1.062 HG11 HG11 ' A' ' 19' ' ' VAL . 1.2 p -2.13 -96.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.988 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.971 ' O ' ' N ' ' B' ' 22' ' ' SER . 0.8 OUTLIER -134.09 23.74 3.86 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 177.496 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 1.042 ' HB ' HG23 ' B' ' 7' ' ' ILE . 28.6 m -9.93 -40.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 CA-C-O 122.415 1.102 . . . . 0.0 110.857 -178.177 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.971 ' N ' ' O ' ' B' ' 20' ' ' SER . 7.1 m -77.92 -39.68 42.1 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.264 178.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 23' ' ' LYS . . . . . 0.91 ' N ' ' O ' ' B' ' 20' ' ' SER . 1.3 mtmt -89.47 -25.71 21.32 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.478 -0.764 . . . . 0.0 111.113 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 24' ' ' MET . . . . . 0.67 ' SD ' ' HA ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -74.79 -40.59 61.05 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 117.529 -1.668 . . . . 0.0 108.795 179.225 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.781 HD12 HG13 ' B' ' 7' ' ' ILE . 0.5 OUTLIER -74.15 -40.47 62.58 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 117.708 -1.597 . . . . 0.0 107.291 176.804 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 26' ' ' ALA . . . . . 0.515 ' HA ' ' HE2' ' B' ' 3' ' ' LYS . . . -60.15 -33.38 72.09 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 177.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 27' ' ' SER . . . . . 0.676 ' HA ' ' HB3' ' B' ' 30' ' ' LYS . 18.6 m -78.63 -34.1 46.81 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.205 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 28' ' ' PHE . . . . . 0.864 ' O ' HG13 ' B' ' 31' ' ' ILE . 0.3 OUTLIER -60.72 -49.17 78.6 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.768 -0.582 . . . . 0.0 109.689 179.413 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 29' ' ' GLU . . . . . 0.829 ' HG2' HG22 ' A' ' 45' ' ' THR . 0.6 OUTLIER -71.89 -33.49 68.38 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 178.043 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 0.92 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 10.8 ttpp -68.59 -21.02 64.53 Favored 'General case' 0 C--O 1.189 -2.085 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 176.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.864 HG13 ' O ' ' B' ' 28' ' ' PHE . 1.2 pp -105.15 -28.8 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 120.557 -1.339 . . . . 0.0 109.198 178.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.645 HG21 ' HZ ' ' A' ' 47' ' ' PHE . 1.6 mm -69.64 -50.97 45.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 176.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 33' ' ' THR . . . . . 0.733 ' HB ' ' O ' ' B' ' 29' ' ' GLU . 0.3 OUTLIER -70.33 -40.21 74.29 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.46 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.92 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 39.4 mm-40 -73.91 -33.03 63.83 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.419 -0.801 . . . . 0.0 111.163 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 35' ' ' THR . . . . . 0.994 HG21 HG23 ' B' ' 42' ' ' VAL . 1.6 m -59.27 -48.75 80.45 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 120.53 -1.356 . . . . 0.0 107.531 178.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.863 ' CG1' ' HB2' ' A' ' 89' ' ' ALA . 1.2 t -56.12 -35.1 40.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 177.053 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 0.662 ' HB2' ' C ' ' A' ' 88' ' ' ALA . . . -77.59 -1.35 30.32 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.534 0.683 . . . . 0.0 109.216 176.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 38' ' ' LYS . . . . . 0.427 ' H ' ' C ' ' B' ' 35' ' ' THR . 0.4 OUTLIER -115.68 -5.4 12.14 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.737 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.44 48.14 8.35 Favored Glycine 0 C--N 1.301 -1.378 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 40' ' ' ASP . . . . . 0.842 ' CB ' HG23 ' B' ' 35' ' ' THR . 0.1 OUTLIER -128.05 117.79 22.32 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.173 -1.192 . . . . 0.0 110.07 179.273 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 12.9 mtmt -70.51 80.82 0.57 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.492 -0.755 . . . . 0.0 109.954 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.994 HG23 HG21 ' B' ' 35' ' ' THR . 2.7 t -68.29 147.4 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.314 -0.866 . . . . 0.0 109.257 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 43' ' ' GLN . . . . . 0.446 ' O ' ' HA ' ' A' ' 2' ' ' ASN . 31.0 mt-30 -143.4 113.51 7.25 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.067 -1.021 . . . . 0.0 110.705 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.804 HD12 ' CB ' ' B' ' 48' ' ' LEU . 45.9 mt -73.98 120.11 19.11 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.271 -0.893 . . . . 0.0 109.939 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 45' ' ' THR . . . . . 0.547 ' HB ' ' HD2' ' A' ' 3' ' ' LYS . 0.0 OUTLIER 31.68 -96.19 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.757 -0.589 . . . . 0.0 110.583 179.793 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.455 ' H ' HG23 ' B' ' 45' ' ' THR . . . -138.79 7.54 3.29 Favored Glycine 0 N--CA 1.482 1.732 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 47' ' ' PHE . . . . . 0.747 ' CE1' HG21 ' A' ' 32' ' ' ILE . 37.4 p90 -105.46 -54.99 2.39 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.588 -1.536 . . . . 0.0 111.76 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.804 ' CB ' HD12 ' B' ' 44' ' ' LEU . 0.2 OUTLIER -92.12 148.03 22.49 Favored 'General case' 0 C--N 1.292 -1.903 0 O-C-N 120.047 -1.658 . . . . 0.0 113.241 -178.849 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 49' ' ' ASN . . . . . 0.535 ' O ' ' HB ' ' B' ' 79' ' ' VAL . 1.4 m-20 -132.82 146.22 51.64 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 178.127 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 50' ' ' ILE . . . . . 0.917 ' HA ' HG21 ' B' ' 79' ' ' VAL . 26.8 mm -137.21 98.76 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 O-C-N 120.97 -1.081 . . . . 0.0 111.601 -178.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 51' ' ' LYS . . . . . 0.534 ' N ' ' CG1' ' B' ' 79' ' ' VAL . 2.5 pttt -145.56 126.29 7.34 Favored Pre-proline 0 N--CA 1.487 1.415 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.765 ' CD ' HG22 ' B' ' 36' ' ' VAL . 55.6 Cg_endo -88.08 151.21 6.96 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.239 1.126 . . . . 0.0 111.849 -178.18 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.566 HG11 ' HB2' ' B' ' 78' ' ' SER . 14.0 m -133.14 118.64 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-O 121.506 0.67 . . . . 0.0 109.838 178.287 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.881 ' HA ' ' HA ' ' B' ' 75' ' ' VAL . . . -67.06 147.78 52.73 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 122.694 1.235 . . . . 0.0 112.899 -177.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 55' ' ' ARG . . . . . 0.542 ' O ' ' HA ' ' B' ' 74' ' ' SER . 6.3 ttt180 -157.36 -138.84 0.06 Allowed 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 56' ' ' GLN . . . . . 0.734 ' HA ' ' CA ' ' B' ' 73' ' ' PRO . 0.0 OUTLIER -142.4 -165.66 2.08 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 118.032 -1.467 . . . . 0.0 111.595 178.224 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.779 ' HB1' ' CG1' ' B' ' 71' ' ' ILE . . . -163.07 -154.2 0.28 Allowed 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.506 -0.746 . . . . 0.0 110.884 -177.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 58' ' ' ARG . . . . . 0.518 ' HG3' ' N ' ' B' ' 59' ' ' LYS . 0.1 OUTLIER -57.35 157.27 6.69 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.681 -0.637 . . . . 0.0 110.235 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 59' ' ' LYS . . . . . 0.518 ' N ' ' HG3' ' B' ' 58' ' ' ARG . 1.9 tpmt? -163.11 136.86 5.94 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.558 -0.714 . . . . 0.0 109.851 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 60' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' B' ' 69' ' ' LEU . . . -167.34 -131.16 1.24 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 61' ' ' PHE . . . . . 0.871 ' CE2' ' HB2' ' B' ' 66' ' ' GLN . 30.3 p90 -172.83 -174.85 1.17 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.238 -1.154 . . . . 0.0 111.344 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 62' ' ' ASN . . . . . 0.916 ' HB3' ' HB2' ' B' ' 68' ' ' ALA . 0.3 OUTLIER -150.68 -28.71 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.719 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 -179.696 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.88 ' HD2' ' H ' ' B' ' 62' ' ' ASN . 42.5 Cg_endo -71.47 -9.79 25.78 Favored 'Trans proline' 0 N--CA 1.486 1.067 0 CA-C-N 118.903 0.644 . . . . 0.0 111.0 -178.013 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 64' ' ' GLN . . . . . 0.566 ' CB ' ' CE2' ' B' ' 61' ' ' PHE . 0.0 OUTLIER -96.92 46.4 1.04 Allowed 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.228 -0.92 . . . . 0.0 109.115 178.704 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.477 HG23 ' C ' ' B' ' 64' ' ' GLN . 1.7 p 60.51 48.72 7.31 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 121.046 0.45 . . . . 0.0 110.706 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 66' ' ' GLN . . . . . 0.871 ' HB2' ' CE2' ' B' ' 61' ' ' PHE . 1.2 mp0 -146.56 -155.94 0.67 Allowed 'General case' 0 N--CA 1.484 1.243 0 O-C-N 121.235 -0.916 . . . . 0.0 110.411 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 67' ' ' GLU . . . . . 0.56 ' O ' ' CD1' ' B' ' 69' ' ' LEU . 3.9 mm-40 -130.1 117.15 19.53 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 178.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 68' ' ' ALA . . . . . 0.916 ' HB2' ' HB3' ' B' ' 62' ' ' ASN . . . -57.28 132.3 52.61 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 122.022 0.915 . . . . 0.0 111.809 -177.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.56 ' CD1' ' O ' ' B' ' 67' ' ' GLU . 0.2 OUTLIER -134.38 117.71 16.63 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.796 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 70' ' ' GLU . . . . . 0.475 ' CA ' ' HG2' ' B' ' 58' ' ' ARG . 1.9 pt-20 -173.66 83.96 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.169 -0.957 . . . . 0.0 110.713 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.779 ' CG1' ' HB1' ' B' ' 57' ' ' ALA . 25.3 pt -64.0 -143.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.427 -0.796 . . . . 0.0 109.44 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 72' ' ' ALA . . . . . 0.541 ' O ' ' OH ' ' A' ' 94' ' ' TYR . . . -99.09 107.61 45.12 Favored Pre-proline 0 C--N 1.287 -2.12 0 C-N-CA 119.823 -0.751 . . . . 0.0 112.902 -177.357 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 73' ' ' PRO . . . . . 0.734 ' CA ' ' HA ' ' B' ' 56' ' ' GLN . 55.7 Cg_endo -101.56 88.45 0.04 OUTLIER 'Trans proline' 0 CA--C 1.556 1.597 0 C-N-CA 122.434 2.089 . . . . 0.0 113.549 178.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 74' ' ' SER . . . . . 0.923 ' HB2' ' HB2' ' A' ' 98' ' ' ALA . 0.4 OUTLIER 162.85 33.65 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.15 0 O-C-N 120.138 -1.601 . . . . 0.0 114.828 177.397 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 75' ' ' VAL . . . . . 1.045 HG21 ' HB1' ' A' ' 89' ' ' ALA . 0.3 OUTLIER 176.02 142.84 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.519 2.989 0 O-C-N 120.302 -1.499 . . . . 0.0 111.248 176.275 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 76' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' B' ' 53' ' ' VAL . . . -140.64 -144.9 4.53 Favored Glycine 0 N--CA 1.483 1.772 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.467 HG23 ' HD2' ' A' ' 86' ' ' LYS . 7.6 t -140.9 85.64 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 78' ' ' SER . . . . . 0.566 ' HB2' HG11 ' B' ' 53' ' ' VAL . 0.3 OUTLIER -57.93 -50.58 72.88 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.53 0.681 . . . . 0.0 111.279 -179.139 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.917 HG21 ' HA ' ' B' ' 50' ' ' ILE . 17.7 m -51.54 -176.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -176.029 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 80' ' ' LYS . . . . . 0.739 ' HB2' ' HD2' ' B' ' 81' ' ' PRO . 0.0 OUTLIER 178.87 177.26 0.3 Allowed Pre-proline 0 N--CA 1.484 1.251 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.033 -178.727 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 81' ' ' PRO . . . . . 0.739 ' HD2' ' HB2' ' B' ' 80' ' ' LYS . 45.1 Cg_endo -72.54 137.61 28.12 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 123.508 1.268 . . . . 0.0 110.926 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 82' ' ' GLY . . . . . 0.576 ' N ' ' O ' ' B' ' 47' ' ' PHE . . . -94.92 -154.6 31.02 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 83' ' ' GLU . . . . . 0.51 ' HA ' ' HB2' ' B' ' 86' ' ' LYS . 16.4 pt-20 -88.05 -16.73 32.81 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.369 -1.077 . . . . 0.0 110.739 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 84' ' ' SER . . . . . 0.475 ' HB2' ' HB3' ' B' ' 47' ' ' PHE . 3.4 m -53.6 -37.14 62.72 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.067 -1.021 . . . . 0.0 109.51 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.84 HD13 HG21 ' A' ' 77' ' ' VAL . 0.5 OUTLIER -81.67 -33.26 31.37 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.717 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 86' ' ' LYS . . . . . 0.51 ' HB2' ' HA ' ' B' ' 83' ' ' GLU . 7.5 mttt -74.43 -27.46 60.62 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.382 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 1.3 ttmm -74.7 -39.16 62.11 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 177.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.686 ' HB1' ' HB2' ' A' ' 37' ' ' ALA . . . -64.8 -35.19 80.3 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 176.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.953 ' HA ' HD23 ' B' ' 92' ' ' LEU . . . -54.48 -45.43 73.21 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.454 -0.898 . . . . 0.0 109.19 178.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.9 -31.85 51.36 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 177.079 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 91' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' B' ' 88' ' ' ALA . . . -63.38 -38.65 96.73 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 178.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 92' ' ' LEU . . . . . 0.953 HD23 ' HA ' ' B' ' 89' ' ' ALA . 0.7 OUTLIER -75.46 15.17 0.49 Allowed 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.523 -1.575 . . . . 0.0 110.957 -179.823 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 93' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' B' ' 92' ' ' LEU . 22.3 mmtm 57.82 44.57 19.97 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 -177.241 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 94' ' ' TYR . . . . . 0.895 ' OH ' ' HB1' ' A' ' 72' ' ' ALA . 0.1 OUTLIER -36.91 -36.37 0.12 Allowed 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.314 -178.829 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 95' ' ' GLU . . . . . 0.519 ' N ' ' CD1' ' B' ' 94' ' ' TYR . 8.8 pt-20 -57.25 -43.52 83.05 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.327 -0.858 . . . . 0.0 109.42 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 96' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' B' ' 93' ' ' LYS . 0.9 OUTLIER -61.81 -31.58 71.83 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 177.971 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -80.74 -24.87 38.42 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.78 -30.52 69.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.577 -0.702 . . . . 0.0 110.037 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.378 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.672 ' SD ' HG21 ' B' ' 35' ' ' THR . 3.5 ptm . . . . . 0 N--CA 1.496 1.857 0 CA-C-O 121.282 0.563 . . . . 0.0 110.732 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.568 ' C ' HD12 ' A' ' 6' ' ' LEU . 16.7 p-10 -177.17 -153.99 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 119.727 -0.789 . . . . 0.0 111.248 178.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.56 ' HE2' ' HA ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -52.41 -7.98 0.07 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.401 -0.812 . . . . 0.0 111.143 -179.812 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.606 ' O ' HG13 ' A' ' 7' ' ' ILE . 87.4 m -114.54 -64.26 1.34 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.17 -0.956 . . . . 0.0 109.903 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.577 ' HA ' ' CE ' ' A' ' 8' ' ' LYS . 0.4 OUTLIER -49.11 -41.01 34.43 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.915 -1.115 . . . . 0.0 109.096 179.577 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.649 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 28.2 mt -61.52 -35.05 76.62 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.335 -0.946 . . . . 0.0 109.621 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.652 ' N ' HD12 ' A' ' 25' ' ' LEU . 1.1 pp -57.2 -38.74 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 178.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.834 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 1.3 mtmp? -65.79 -40.11 91.6 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 177.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.857 ' CB ' HD13 ' B' ' 31' ' ' ILE . . . -51.61 -37.34 49.59 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.768 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.3 mp -91.98 -30.85 4.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 178.114 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.834 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -66.25 -9.57 33.72 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 118.575 -1.25 . . . . 0.0 108.497 178.101 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.435 ' CG ' ' N ' ' A' ' 13' ' ' ASP . 17.2 pt20 -119.59 -42.22 2.65 Favored 'General case' 0 N--CA 1.483 1.185 0 O-C-N 121.413 -0.805 . . . . 0.0 110.41 179.41 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 9' ' ' ALA . 6.6 m-20 -69.53 -33.73 73.21 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 177.458 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . 1.15 HG22 ' CD1' ' A' ' 16' ' ' LEU 0.273 0.2 OUTLIER -95.14 -71.41 0.67 Allowed 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.479 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 57.37 18.52 29.54 Favored Glycine 0 N--CA 1.5 2.91 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 177.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.15 ' CD1' HG22 ' A' ' 14' ' ' THR . 4.4 mp -63.82 -68.17 0.37 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.425 -1.044 . . . . 0.0 109.815 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.637 ' CG2' HG21 ' B' ' 17' ' ' THR . 0.6 OUTLIER -135.07 7.48 3.42 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.592 ' O ' ' C ' ' A' ' 19' ' ' VAL . 15.0 mt-30 57.88 26.92 13.89 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 -176.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 1.125 HG23 ' CD1' ' B' ' 16' ' ' LEU . 0.3 OUTLIER -5.92 -97.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.184 -179.128 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.98 ' O ' ' N ' ' A' ' 23' ' ' LYS . 1.7 p -135.63 25.01 3.42 Favored 'General case' 0 C--N 1.275 -2.653 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 178.211 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.571 ' C ' ' O ' ' A' ' 20' ' ' SER . 27.4 m -19.15 -38.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 CA-C-O 122.284 1.04 . . . . 0.0 110.435 -178.256 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.803 ' N ' ' O ' ' A' ' 20' ' ' SER . 25.4 p -79.3 -36.26 39.92 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.16 178.252 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.98 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.2 OUTLIER -91.82 -32.65 15.27 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.779 -0.576 . . . . 0.0 111.642 179.811 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.635 ' N ' ' OG ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -72.8 -30.31 63.97 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 117.764 -1.574 . . . . 0.0 108.061 179.385 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.652 HD12 ' N ' ' A' ' 7' ' ' ILE . 2.2 mt -82.01 -37.58 26.36 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 118.741 -1.184 . . . . 0.0 107.895 177.141 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.56 ' HA ' ' HE2' ' A' ' 3' ' ' LYS . . . -67.6 -34.04 76.21 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 177.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 31' ' ' ILE . 61.1 p -82.56 -30.51 29.62 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.19 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.66 ' O ' HG13 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -52.48 -45.61 66.22 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.335 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.747 ' HG3' ' CD1' ' B' ' 47' ' ' PHE . 0.5 OUTLIER -69.62 -36.58 76.27 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 176.856 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 1.116 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 13.1 tttt -62.26 -23.42 66.68 Favored 'General case' 0 C--O 1.19 -2.058 0 C-N-CA 119.275 -0.97 . . . . 0.0 108.434 178.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.939 HD13 ' HB1' ' B' ' 9' ' ' ALA . 0.5 OUTLIER -103.61 -28.39 3.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 120.589 -1.319 . . . . 0.0 109.202 178.141 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.636 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.2 mm -72.56 -56.15 10.79 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 177.225 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.894 ' HA ' HD23 ' B' ' 85' ' ' LEU . 0.4 OUTLIER -69.67 -36.45 76.03 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.4 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 1.116 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 44.5 mm-40 -74.31 -35.46 63.68 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.084 -1.01 . . . . 0.0 110.696 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.652 HG23 ' CB ' ' A' ' 40' ' ' ASP . 2.2 m -58.58 -51.51 69.57 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.63 -1.294 . . . . 0.0 108.248 178.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.681 HG22 ' HD3' ' A' ' 52' ' ' PRO . 0.9 OUTLIER -54.11 -35.71 29.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 177.792 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.73 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -82.23 -4.2 56.63 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.629 0.728 . . . . 0.0 109.416 178.008 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -101.07 -26.39 13.71 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.087 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.84 39.23 1.6 Allowed Glycine 0 C--N 1.301 -1.4 0 C-N-CA 120.092 -1.052 . . . . 0.0 110.906 177.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.652 ' CB ' HG23 ' A' ' 35' ' ' THR . 0.1 OUTLIER -132.47 134.23 44.8 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.067 -1.255 . . . . 0.0 110.274 179.384 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.87 92.24 6.09 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.584 -0.697 . . . . 0.0 109.887 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.532 HG13 HD11 ' B' ' 6' ' ' LEU . 58.2 t -59.29 132.97 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.589 -0.694 . . . . 0.0 109.868 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -129.7 89.21 2.79 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.335 -0.853 . . . . 0.0 110.178 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.773 HD12 ' HB3' ' A' ' 48' ' ' LEU . 10.7 mt -59.92 107.6 0.64 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.295 -0.878 . . . . 0.0 109.516 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.457 ' CG2' ' C ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER 34.11 -90.67 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.308 0 O-C-N 122.0 -0.438 . . . . 0.0 110.953 -179.457 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -151.01 28.32 1.01 Allowed Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.997 ' CE1' HG21 ' B' ' 32' ' ' ILE . 1.6 p90 -129.98 -26.3 2.42 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.17 -1.194 . . . . 0.0 111.922 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.773 ' HB3' HD12 ' A' ' 44' ' ' LEU . 4.6 mt -128.95 96.02 4.24 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.568 -1.332 . . . . 0.0 110.867 178.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -102.05 86.35 2.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.66 -0.65 . . . . 0.0 110.576 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.567 HD13 HG23 ' A' ' 79' ' ' VAL . 6.9 mm -73.22 131.9 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.409 ' HG3' ' CB ' ' A' ' 78' ' ' SER . 1.7 ptmt -145.52 113.99 4.76 Favored Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 120.613 -1.304 . . . . 0.0 111.129 -179.39 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.681 ' HD3' HG22 ' A' ' 36' ' ' VAL . 54.7 Cg_endo -78.48 143.81 19.63 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 O-C-N 123.638 1.336 . . . . 0.0 111.135 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.655 HG22 ' O ' ' A' ' 76' ' ' GLY . 24.2 m -142.33 116.86 4.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-O 121.582 0.706 . . . . 0.0 110.395 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.519 ' HB1' ' HB2' ' B' ' 98' ' ' ALA . . . -37.31 124.28 0.97 Allowed 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 121.917 0.865 . . . . 0.0 112.404 -178.283 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.569 ' O ' ' O ' ' A' ' 74' ' ' SER . 5.7 ttt85 -170.06 123.01 0.7 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.453 ' HB2' HD12 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -61.17 -140.07 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.968 -1.082 . . . . 0.0 110.811 -178.65 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.969 ' CB ' ' HB3' ' A' ' 72' ' ' ALA . . . -167.1 132.25 2.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.693 -1.254 . . . . 0.0 110.615 -177.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.856 ' HB2' ' C ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -170.52 164.42 8.48 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 120.666 -1.272 . . . . 0.0 109.964 179.51 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -169.62 19.83 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.308 -0.957 . . . . 0.0 111.952 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.604 ' HA3' HD13 ' A' ' 69' ' ' LEU . . . -173.28 -133.67 1.71 Allowed Glycine 0 N--CA 1.49 2.262 0 C-N-CA 118.667 -1.73 . . . . 0.0 111.586 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.805 ' CE2' ' HB2' ' A' ' 66' ' ' GLN . 50.4 p90 177.61 -163.52 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.924 -0.75 . . . . 0.0 110.153 -178.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.911 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 9.7 p-10 -158.33 -16.07 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.588 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 178.361 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.892 ' CD ' ' H ' ' A' ' 62' ' ' ASN . 40.5 Cg_endo -69.02 -13.85 37.33 Favored 'Trans proline' 0 N--CA 1.483 0.867 0 N-CA-C 108.778 -1.278 . . . . 0.0 108.778 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.59 ' CB ' ' CE2' ' A' ' 61' ' ' PHE . 0.2 OUTLIER -102.02 39.73 1.43 Allowed 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.388 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' A' ' 64' ' ' GLN . 3.1 p 59.23 62.92 1.7 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.858 -0.526 . . . . 0.0 110.641 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.805 ' HB2' ' CE2' ' A' ' 61' ' ' PHE . 0.9 OUTLIER -157.21 119.47 3.86 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.227 -0.92 . . . . 0.0 111.001 -179.689 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.718 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 0.4 OUTLIER -45.38 97.37 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.947 -1.096 . . . . 0.0 109.264 178.96 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.911 ' HB2' ' HB3' ' A' ' 62' ' ' ASN . . . -41.23 134.19 2.2 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 122.695 1.236 . . . . 0.0 113.201 -177.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.723 ' N ' HD12 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -142.62 51.31 1.44 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 179.5 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.856 ' C ' ' HB2' ' A' ' 58' ' ' ARG . 2.0 mp0 -105.56 -138.49 0.36 Allowed 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 120.144 -0.623 . . . . 0.0 112.287 -176.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.822 ' N ' ' HB2' ' A' ' 58' ' ' ARG . 3.0 tp -26.52 145.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 123.51 1.624 . . . . 0.0 114.287 -176.206 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.969 ' HB3' ' CB ' ' A' ' 57' ' ' ALA . . . -171.83 152.27 2.99 Favored Pre-proline 0 C--N 1.286 -2.163 0 CA-C-N 113.049 -1.887 . . . . 0.0 108.415 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 72' ' ' ALA . 55.1 Cg_endo -91.47 121.01 0.63 Allowed 'Trans proline' 0 C--N 1.291 -2.455 0 C-N-CA 121.712 1.608 . . . . 0.0 111.388 -178.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.569 ' O ' ' O ' ' A' ' 55' ' ' ARG . 26.3 p -176.89 109.13 0.08 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.02 -1.05 . . . . 0.0 110.3 179.054 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.634 ' HB ' ' HB2' ' B' ' 94' ' ' TYR . 0.3 OUTLIER -48.66 172.48 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.052 -1.03 . . . . 0.0 110.059 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.655 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -101.85 77.83 0.36 Allowed Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.889 HG21 ' CB ' ' B' ' 85' ' ' LEU . 4.4 p -59.54 74.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.576 -0.955 . . . . 0.0 110.3 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.565 ' N ' ' O ' ' A' ' 76' ' ' GLY . 0.6 OUTLIER -67.68 177.34 2.07 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.524 -0.87 . . . . 0.0 109.824 179.585 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.567 HG23 HD13 ' A' ' 50' ' ' ILE . 0.8 OUTLIER 176.62 175.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -179.82 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.689 ' O ' HD23 ' A' ' 48' ' ' LEU . 2.3 ptpt -177.18 172.23 0.83 Allowed Pre-proline 0 N--CA 1.486 1.362 0 O-C-N 121.161 -0.962 . . . . 0.0 110.176 177.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.501 ' HB2' HG13 ' B' ' 77' ' ' VAL . 55.2 Cg_endo -98.77 133.38 0.25 Allowed 'Trans proline' 0 C--N 1.302 -1.901 0 C-N-CA 122.542 2.161 . . . . 0.0 110.489 178.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.546 ' HA3' ' HA ' ' A' ' 47' ' ' PHE . . . -92.09 177.78 40.0 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 108.382 -1.887 . . . . 0.0 108.382 178.618 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.415 ' HA ' ' HB2' ' A' ' 86' ' ' LYS . 0.1 OUTLIER -67.89 -18.25 64.73 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.115 -1.226 . . . . 0.0 110.676 -179.788 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.46 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -51.92 -39.89 59.87 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.119 -0.988 . . . . 0.0 109.401 179.8 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.902 HD21 ' CD1' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -75.66 -34.32 60.48 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.744 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.632 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 0.8 OUTLIER -72.94 -43.82 61.9 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.961 -179.257 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -61.46 -40.82 95.89 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 178.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.779 ' O ' ' HB1' ' B' ' 37' ' ' ALA . . . -66.68 -36.24 82.05 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 176.22 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 1.061 ' CB ' HG11 ' B' ' 75' ' ' VAL . . . -58.56 -34.36 70.96 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.406 ' HB2' ' CG ' ' B' ' 59' ' ' LYS . 0.4 OUTLIER -55.98 -34.54 65.84 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 176.252 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.423 ' C ' ' H ' ' A' ' 93' ' ' LYS . . . -61.54 -44.54 97.85 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 178.032 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.824 ' O ' HD12 ' A' ' 92' ' ' LEU . 0.6 OUTLIER -58.07 -2.59 0.18 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.707 -1.467 . . . . 0.0 111.212 179.699 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.512 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 6.7 mmmt 68.1 58.97 0.45 Allowed 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -177.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.714 ' CD1' ' C ' ' B' ' 74' ' ' SER . 23.5 t80 -37.41 -33.97 0.08 Allowed 'General case' 0 N--CA 1.494 1.775 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.21 -179.066 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.68 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 6.1 mt-10 -60.77 -48.0 83.76 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.155 -0.966 . . . . 0.0 109.083 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.82 -40.82 76.71 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.339 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.799 ' HB3' ' HB2' ' B' ' 54' ' ' ALA . 0.1 OUTLIER -69.87 -27.83 65.15 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.192 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.68 ' HB3' ' O ' ' A' ' 95' ' ' GLU . . . -62.3 -46.73 87.45 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.407 0.622 . . . . 0.0 110.155 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.1 mtmt . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.222 -179.888 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.633 ' HG2' ' HB3' ' B' ' 5' ' ' GLU . 24.2 mtp . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 2' ' ' ASN . . . . . 0.554 ' O ' ' HB2' ' B' ' 6' ' ' LEU . 19.5 p-10 -175.4 -162.63 0.11 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.167 -0.958 . . . . 0.0 111.299 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.515 ' O ' ' CG2' ' B' ' 7' ' ' ILE . 0.0 OUTLIER -57.1 -3.52 0.14 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.423 -0.798 . . . . 0.0 110.885 -179.888 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.678 ' O ' HG13 ' B' ' 7' ' ' ILE . 96.8 m -117.93 -60.71 1.77 Allowed 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 122.167 0.984 . . . . 0.0 109.101 179.068 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.633 ' HB3' ' HG2' ' B' ' 1' ' ' MET . 0.4 OUTLIER -52.04 -44.74 64.37 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.098 -1.001 . . . . 0.0 109.013 179.27 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.661 ' O ' ' HB3' ' B' ' 9' ' ' ALA . 1.9 mt -61.18 -32.1 71.84 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.191 -1.004 . . . . 0.0 109.966 178.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 7' ' ' ILE . . . . . 0.74 HG22 HD12 ' B' ' 25' ' ' LEU . 0.9 OUTLIER -57.7 -40.79 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 179.1 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 8' ' ' LYS . . . . . 0.852 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 1.0 OUTLIER -64.87 -37.79 88.81 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 177.484 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 9' ' ' ALA . . . . . 0.939 ' HB1' HD13 ' A' ' 31' ' ' ILE . . . -52.33 -38.3 58.22 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 120.15 -0.62 . . . . 0.0 109.618 179.359 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.736 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.3 mp -93.73 -29.19 4.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 178.209 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.852 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -66.8 -16.25 64.14 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.815 -1.178 . . . . 0.0 108.329 178.048 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.431 ' CG ' ' N ' ' B' ' 13' ' ' ASP . 17.7 pt20 -108.62 -41.91 4.67 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.515 -0.741 . . . . 0.0 109.098 178.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.431 ' N ' ' CG ' ' B' ' 12' ' ' GLN . 1.1 m-20 -68.78 -22.55 64.27 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 176.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.736 ' OG1' ' O ' ' B' ' 10' ' ' ILE . 0.2 OUTLIER -120.32 -83.14 0.65 Allowed 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.363 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 15' ' ' GLY . . . . . 0.511 ' O ' ' C ' ' B' ' 16' ' ' LEU . . . 69.36 -21.01 0.42 Allowed Glycine 0 N--CA 1.498 2.779 0 O-C-N 120.924 -1.11 . . . . 0.0 110.65 178.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 16' ' ' LEU . . . . . 1.125 ' CD1' HG23 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -29.21 -59.45 0.14 Allowed 'General case' 0 N--CA 1.517 2.876 0 CA-C-O 122.008 0.908 . . . . 0.0 110.712 -179.608 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 17' ' ' THR . . . . . 0.662 HG22 ' H ' ' B' ' 19' ' ' VAL . 0.5 OUTLIER -132.7 -2.75 3.32 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -179.927 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 18' ' ' GLN . . . . . 0.618 ' O ' ' C ' ' B' ' 19' ' ' VAL . 8.2 mt-30 56.56 30.97 18.21 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -176.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 1.109 HG11 HG11 ' A' ' 19' ' ' VAL . 2.0 p -8.74 -97.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.802 -179.059 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.92 ' O ' ' N ' ' B' ' 23' ' ' LYS . 0.4 OUTLIER -132.94 22.08 4.17 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 177.449 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.669 HG12 HG22 ' B' ' 10' ' ' ILE . 27.9 m -18.51 -38.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-O 122.401 1.096 . . . . 0.0 109.255 -178.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.91 ' N ' ' O ' ' B' ' 20' ' ' SER . 26.5 t -79.16 -44.92 20.98 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.19 177.497 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 23' ' ' LYS . . . . . 0.92 ' N ' ' O ' ' B' ' 20' ' ' SER . 5.9 mtmt -89.69 -21.56 22.68 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.431 -0.793 . . . . 0.0 109.889 178.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 24' ' ' MET . . . . . 0.621 ' HE2' ' HA ' ' B' ' 21' ' ' VAL 0.263 2.2 tmm? -68.89 -38.93 79.95 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 178.653 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.74 HD12 HG22 ' B' ' 7' ' ' ILE . 8.3 mt -73.97 -41.38 62.03 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 176.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 26' ' ' ALA . . . . . 0.553 ' HB3' ' HA ' ' B' ' 23' ' ' LYS . . . -58.03 -34.51 70.13 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 177.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 27' ' ' SER . . . . . 0.485 ' O ' ' HB3' ' B' ' 30' ' ' LYS . 6.2 m -79.59 -33.49 41.58 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.136 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 28' ' ' PHE . . . . . 0.673 ' O ' HG13 ' B' ' 31' ' ' ILE . 2.8 t80 -60.74 -57.46 12.58 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 178.427 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 29' ' ' GLU . . . . . 0.744 ' HG3' ' CD2' ' A' ' 47' ' ' PHE . 2.3 tt0 -58.04 -31.85 67.41 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 118.216 -1.394 . . . . 0.0 107.637 177.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 1.174 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 24.1 ttmm -67.42 -26.79 66.6 Favored 'General case' 0 C--O 1.191 -1.988 0 C-N-CA 119.344 -0.942 . . . . 0.0 108.487 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.857 HD13 ' CB ' ' A' ' 9' ' ' ALA . 0.3 OUTLIER -98.57 -30.21 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 120.344 -1.473 . . . . 0.0 109.598 178.169 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.997 HG21 ' CE1' ' A' ' 47' ' ' PHE . 1.8 mp -67.85 -66.37 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.14 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 33' ' ' THR . . . . . 0.895 ' HA ' HD23 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -60.78 -37.64 82.6 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.254 -179.082 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 1.174 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 62.3 mm-40 -73.13 -40.07 65.2 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 119.366 -0.934 . . . . 0.0 111.048 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 35' ' ' THR . . . . . 0.672 HG21 ' SD ' ' A' ' 1' ' ' MET . 23.6 m -61.7 -49.46 76.4 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 118.316 -1.354 . . . . 0.0 109.423 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.803 HG21 HG23 ' B' ' 77' ' ' VAL . 0.6 OUTLIER -50.82 -43.26 24.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 C-N-CA 118.918 -1.113 . . . . 0.0 108.027 179.195 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 0.779 ' HB1' ' O ' ' A' ' 88' ' ' ALA . . . -88.22 -4.01 58.78 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.69 0.757 . . . . 0.0 109.773 178.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 38' ' ' LYS . . . . . 0.712 ' HB2' ' O ' ' B' ' 34' ' ' GLU . 0.0 OUTLIER -88.56 -26.16 22.13 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 176.958 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 117.14 39.69 0.79 Allowed Glycine 0 C--N 1.302 -1.323 0 C-N-CA 120.194 -1.003 . . . . 0.0 110.968 177.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 40' ' ' ASP . . . . . 0.636 ' HB2' HG23 ' B' ' 35' ' ' THR . 0.3 OUTLIER -145.44 161.27 40.11 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.902 -1.351 . . . . 0.0 110.718 179.475 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.409 ' HG3' ' HD2' ' B' ' 52' ' ' PRO . 3.5 mppt? -107.04 96.76 6.66 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.561 -0.712 . . . . 0.0 110.045 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.607 HG13 HD11 ' A' ' 6' ' ' LEU . 91.4 t -60.22 120.0 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.498 -0.751 . . . . 0.0 109.813 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 43' ' ' GLN . . . . . 0.421 ' O ' ' HA ' ' A' ' 2' ' ' ASN . 0.7 OUTLIER -108.96 103.02 11.98 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.277 -0.889 . . . . 0.0 110.117 -179.431 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.741 HD12 ' CB ' ' B' ' 48' ' ' LEU . 12.6 mt -75.75 100.26 4.65 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.001 -1.062 . . . . 0.0 109.286 179.298 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 45' ' ' THR . . . . . 0.552 HG21 ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 35.07 -93.88 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.913 -0.492 . . . . 0.0 111.224 -179.61 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -147.65 28.47 1.46 Allowed Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.715 -1.231 . . . . 0.0 110.17 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 47' ' ' PHE . . . . . 0.747 ' CD1' ' HG3' ' A' ' 29' ' ' GLU . 4.2 p90 -129.2 -23.58 2.97 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.969 -1.313 . . . . 0.0 111.594 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.917 HD23 ' O ' ' B' ' 80' ' ' LYS . 7.7 mt -128.73 106.03 8.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.482 -1.386 . . . . 0.0 110.711 178.154 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 49' ' ' ASN . . . . . 0.534 ' O ' ' HA ' ' B' ' 79' ' ' VAL . 0.6 OUTLIER -101.21 86.56 3.04 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.725 -0.609 . . . . 0.0 110.56 -179.385 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 50' ' ' ILE . . . . . 0.861 HG23 HG12 ' B' ' 79' ' ' VAL . 12.3 mm -84.33 128.43 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.383 -0.823 . . . . 0.0 109.836 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 51' ' ' LYS . . . . . 0.418 ' O ' ' HG3' ' B' ' 51' ' ' LYS . 0.0 OUTLIER -152.25 123.98 3.81 Favored Pre-proline 0 N--CA 1.501 2.078 0 O-C-N 120.87 -1.144 . . . . 0.0 110.972 -179.878 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.62 ' HG3' ' HA ' ' B' ' 36' ' ' VAL . 57.1 Cg_endo -84.93 141.8 8.58 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 123.406 1.214 . . . . 0.0 111.454 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.622 HG22 ' O ' ' B' ' 76' ' ' GLY . 30.0 m -143.79 112.31 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-O 121.9 0.857 . . . . 0.0 110.673 178.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.81 ' HA ' ' HA ' ' B' ' 75' ' ' VAL . . . -54.37 118.15 3.88 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.727 -0.608 . . . . 0.0 110.952 -179.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 55' ' ' ARG . . . . . 0.495 ' O ' ' HG2' ' B' ' 56' ' ' GLN . 0.0 OUTLIER -174.88 40.95 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 118.585 -1.246 . . . . 0.0 110.372 179.568 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 56' ' ' GLN . . . . . 1.024 ' HB3' ' HG2' ' B' ' 73' ' ' PRO . 10.0 mt-30 -140.19 -157.35 0.76 Allowed 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.285 -0.966 . . . . 0.0 111.458 -179.091 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.71 ' CB ' ' HB3' ' B' ' 72' ' ' ALA . . . -69.84 -178.53 1.56 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.893 0.854 . . . . 0.0 111.866 -178.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 58' ' ' ARG . . . . . 0.679 ' HB2' HG21 ' B' ' 71' ' ' ILE . 9.9 mpt_? -73.01 -168.95 0.53 Allowed 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 122.139 0.971 . . . . 0.0 111.775 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 59' ' ' LYS . . . . . 0.406 ' CG ' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -140.26 25.02 2.28 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.126 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 60' ' ' GLY . . . . . 0.6 ' HA2' ' N ' ' B' ' 69' ' ' LEU . . . 169.98 74.0 0.04 OUTLIER Glycine 0 N--CA 1.488 2.11 0 C-N-CA 119.476 -1.345 . . . . 0.0 111.651 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 61' ' ' PHE . . . . . 0.889 ' CE1' ' HB2' ' B' ' 66' ' ' GLN . 1.1 p90 -152.33 142.08 21.94 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-N 119.493 1.646 . . . . 0.0 113.015 178.039 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 62' ' ' ASN . . . . . 0.905 ' H ' ' HD2' ' B' ' 63' ' ' PRO . 0.0 OUTLIER -120.48 -50.4 0.04 OUTLIER Pre-proline 0 N--CA 1.507 2.404 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -178.013 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.905 ' HD2' ' H ' ' B' ' 62' ' ' ASN . 35.7 Cg_endo -59.07 -10.01 9.25 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 O-C-N 123.043 1.023 . . . . 0.0 112.049 -176.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 64' ' ' GLN . . . . . 0.713 ' HB3' ' CE1' ' B' ' 61' ' ' PHE . 1.8 mt-30 -95.45 37.66 1.18 Allowed 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.163 -0.961 . . . . 0.0 108.568 177.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.613 HG23 ' C ' ' B' ' 64' ' ' GLN . 1.9 p 68.97 42.45 1.29 Allowed 'General case' 0 N--CA 1.504 2.232 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.332 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 66' ' ' GLN . . . . . 0.889 ' HB2' ' CE1' ' B' ' 61' ' ' PHE . 0.0 OUTLIER -155.61 -142.9 0.11 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.038 -1.038 . . . . 0.0 110.723 179.696 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 67' ' ' GLU . . . . . 0.522 ' C ' ' O ' ' B' ' 61' ' ' PHE . 6.5 mt-10 -129.0 116.56 19.52 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.028 -1.045 . . . . 0.0 109.246 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 68' ' ' ALA . . . . . 0.842 ' HB2' ' HB3' ' B' ' 62' ' ' ASN . . . -64.59 84.82 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.697 -0.627 . . . . 0.0 110.182 -179.012 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.849 ' O ' ' HB2' ' B' ' 70' ' ' GLU . 0.3 OUTLIER 171.72 15.08 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 179.853 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 70' ' ' GLU . . . . . 0.849 ' HB2' ' O ' ' B' ' 69' ' ' LEU . 2.4 mt-10 137.56 44.94 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.41 0 CA-C-N 122.004 2.184 . . . . 0.0 112.079 178.009 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.838 ' O ' ' O ' ' B' ' 72' ' ' ALA . 0.0 OUTLIER -53.28 176.89 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 120.432 -1.417 . . . . 0.0 110.855 179.187 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 72' ' ' ALA . . . . . 1.034 ' HB1' ' CD ' ' B' ' 73' ' ' PRO 0.254 . . -18.13 -139.56 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.954 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 73' ' ' PRO . . . . . 1.034 ' CD ' ' HB1' ' B' ' 72' ' ' ALA . 31.3 Cg_endo -68.88 -154.15 0.03 OUTLIER 'Trans proline' 0 C--N 1.325 -0.701 0 O-C-N 122.323 0.644 . . . . 0.0 113.618 -178.481 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 74' ' ' SER . . . . . 0.775 ' O ' ' HB ' ' B' ' 75' ' ' VAL . 0.4 OUTLIER 155.43 60.29 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 -176.341 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 75' ' ' VAL . . . . . 1.061 HG11 ' CB ' ' A' ' 89' ' ' ALA . 12.2 p 139.74 162.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.468 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -179.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 76' ' ' GLY . . . . . 0.622 ' O ' HG22 ' B' ' 53' ' ' VAL . . . -125.9 73.62 0.43 Allowed Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.24 -1.457 . . . . 0.0 109.792 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.893 HG21 ' CB ' ' A' ' 85' ' ' LEU . 3.7 p -61.69 72.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.544 -0.974 . . . . 0.0 109.326 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 78' ' ' SER . . . . . 0.84 ' O ' HG13 ' B' ' 79' ' ' VAL . 0.1 OUTLIER -64.3 176.26 1.1 Allowed 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.454 -0.898 . . . . 0.0 109.986 -179.709 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.861 HG12 HG23 ' B' ' 50' ' ' ILE . 16.9 m -172.37 179.0 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 80' ' ' LYS . . . . . 0.917 ' O ' HD23 ' B' ' 48' ' ' LEU . 0.1 OUTLIER 179.3 170.58 0.55 Allowed Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 120.833 -1.167 . . . . 0.0 111.12 176.8 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 81' ' ' PRO . . . . . 0.617 ' HB2' HG13 ' A' ' 77' ' ' VAL . 56.2 Cg_endo -102.27 133.37 0.13 Allowed 'Trans proline' 0 C--N 1.303 -1.832 0 C-N-CA 123.076 2.517 . . . . 0.0 110.252 177.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 82' ' ' GLY . . . . . 0.514 ' HA3' ' HA ' ' B' ' 47' ' ' PHE . . . -96.96 171.09 26.84 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 107.955 -2.058 . . . . 0.0 107.955 178.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 83' ' ' GLU . . . . . 0.515 ' HA ' ' HB2' ' B' ' 86' ' ' LYS . 3.5 pm0 -59.75 -19.15 48.41 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.99 -1.3 . . . . 0.0 110.674 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 84' ' ' SER . . . . . 0.498 ' CB ' ' HB3' ' B' ' 47' ' ' PHE . 0.4 OUTLIER -52.08 -38.03 55.9 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.101 -0.999 . . . . 0.0 109.552 179.6 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.894 HD23 ' HA ' ' A' ' 33' ' ' THR . 1.0 OUTLIER -78.46 -33.07 48.63 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.471 -0.768 . . . . 0.0 108.951 178.617 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 86' ' ' LYS . . . . . 0.615 ' O ' ' HB3' ' B' ' 89' ' ' ALA . 0.6 OUTLIER -73.71 -42.42 61.23 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.493 -179.274 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 7.3 tttp -64.5 -39.77 94.4 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 177.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.65 ' HB1' ' HB2' ' A' ' 37' ' ' ALA . . . -66.91 -34.48 77.87 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 176.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.997 ' HA ' HD23 ' B' ' 92' ' ' LEU . . . -57.18 -44.6 83.7 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.471 -0.768 . . . . 0.0 109.222 179.182 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.41 ' HG2' ' N ' ' B' ' 91' ' ' GLY . 1.4 pt-20 -53.88 -31.82 51.16 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 177.386 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 91' ' ' GLY . . . . . 0.41 ' N ' ' HG2' ' B' ' 90' ' ' GLU . . . -67.14 -33.8 84.3 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 178.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 92' ' ' LEU . . . . . 0.997 HD23 ' HA ' ' B' ' 89' ' ' ALA . 0.4 OUTLIER -77.51 13.07 1.34 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.648 -1.501 . . . . 0.0 111.438 -179.553 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 93' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' B' ' 92' ' ' LEU . 34.9 mmtt 58.53 39.53 24.8 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -177.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 94' ' ' TYR . . . . . 0.634 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -42.07 -33.58 0.6 Allowed 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.449 -179.14 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 95' ' ' GLU . . . . . 0.481 ' N ' ' CD1' ' B' ' 94' ' ' TYR . 2.5 pp20? -61.62 -39.92 93.0 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.383 -0.823 . . . . 0.0 109.467 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.66 -34.82 76.38 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 177.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 97' ' ' PHE . . . . . 0.459 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 0.1 OUTLIER -72.05 -26.33 62.14 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 178.307 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 98' ' ' ALA . . . . . 0.519 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -77.67 -76.79 0.17 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.584 -0.698 . . . . 0.0 110.325 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 33.4 mtmt . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.209 -179.913 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.555 ' HG2' ' HB3' ' A' ' 5' ' ' GLU . 2.7 mtp . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 120.892 0.377 . . . . 0.0 110.184 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.481 ' N ' HG23 ' B' ' 42' ' ' VAL . 39.2 p-10 179.56 -167.57 0.09 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.184 -0.947 . . . . 0.0 111.21 179.373 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.871 ' HG2' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -55.47 -11.68 0.91 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.568 -0.708 . . . . 0.0 110.326 179.794 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.713 ' O ' HG12 ' A' ' 7' ' ' ILE . 53.7 m -104.02 -55.25 2.4 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 122.113 0.959 . . . . 0.0 109.286 179.15 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.693 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 0.2 OUTLIER -57.13 -49.6 75.42 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.068 -1.02 . . . . 0.0 109.14 179.427 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.918 HD11 HG21 ' B' ' 42' ' ' VAL . 15.7 mt -49.93 -40.81 44.7 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 119.322 -0.951 . . . . 0.0 110.396 178.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.713 HG12 ' O ' ' A' ' 4' ' ' THR . 0.7 OUTLIER -57.47 -45.33 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.238 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.87 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 28.6 mtmt -56.36 -37.17 69.67 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 177.172 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.878 ' CB ' HD13 ' B' ' 31' ' ' ILE . . . -54.9 -37.56 66.49 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.736 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.5 mp -88.26 -33.81 6.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 178.316 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.87 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -65.85 -13.05 58.86 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 119.158 -1.017 . . . . 0.0 108.818 178.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -117.08 -39.65 3.2 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 121.449 -0.782 . . . . 0.0 109.652 178.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.45 ' HB3' ' HB2' ' B' ' 27' ' ' SER . 1.5 m-20 -66.97 -30.15 70.19 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 177.02 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.784 HG22 HD11 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -104.66 -75.31 0.63 Allowed 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 114.339 -1.3 . . . . 0.0 108.19 178.983 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 51.14 15.79 1.73 Allowed Glycine 0 N--CA 1.494 2.522 0 C-N-CA 120.306 -0.95 . . . . 0.0 110.883 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.073 ' CD1' HG23 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -73.06 -27.66 61.87 Favored 'General case' 0 N--CA 1.508 2.432 0 O-C-N 121.073 -1.251 . . . . 0.0 107.963 178.812 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.759 HG21 HG21 ' B' ' 17' ' ' THR . 0.4 OUTLIER -159.6 -12.39 0.06 Allowed 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.552 -179.861 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.706 ' O ' ' C ' ' A' ' 19' ' ' VAL . 21.1 mt-30 58.24 34.37 24.04 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 -177.08 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.924 ' CG2' HD13 ' B' ' 16' ' ' LEU . 0.2 OUTLIER 0.69 -94.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -178.875 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . 1.106 ' O ' ' N ' ' A' ' 22' ' ' SER . 18.7 p -135.06 21.74 3.49 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 175.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.594 ' C ' ' O ' ' A' ' 20' ' ' SER . 33.9 m -4.44 -38.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 122.451 1.119 . . . . 0.0 111.061 -178.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . 1.106 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.5 OUTLIER -75.24 -41.61 57.1 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-N 115.008 -0.997 . . . . 0.0 108.622 177.629 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.885 ' N ' ' O ' ' A' ' 20' ' ' SER . 2.5 mtpt -90.7 -30.8 16.88 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.549 -0.72 . . . . 0.0 109.502 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.581 ' HE2' ' HA ' ' A' ' 21' ' ' VAL . 2.0 tmm? -61.63 -29.73 70.25 Favored 'General case' 0 C--O 1.215 -0.717 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.871 HD13 ' HG2' ' A' ' 3' ' ' LYS . 1.2 pp -81.97 -44.39 16.78 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.642 ' N ' HD12 ' A' ' 25' ' ' LEU . . . -63.61 -23.73 67.5 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 178.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.507 ' O ' ' CG1' ' A' ' 31' ' ' ILE . 7.9 m -85.14 -40.98 16.11 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.136 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.687 ' CE1' HD22 ' B' ' 44' ' ' LEU . 0.0 OUTLIER -58.97 -45.52 90.36 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.853 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.6 ' HG3' ' CE2' ' B' ' 47' ' ' PHE . 0.8 OUTLIER -69.02 -37.37 78.6 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.046 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 1.256 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 20.2 tttt -62.37 -22.02 65.79 Favored 'General case' 0 C--O 1.193 -1.883 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.049 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.634 HG13 ' O ' ' A' ' 28' ' ' PHE . 0.6 OUTLIER -106.81 -27.72 2.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 120.144 -1.597 . . . . 0.0 109.482 178.013 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.623 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.3 mm -74.02 -59.47 3.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 177.076 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.685 ' HA ' HD23 ' B' ' 85' ' ' LEU . 0.7 OUTLIER -70.51 -32.59 70.12 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.393 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 1.256 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 71.7 mm-40 -81.75 -27.31 33.9 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 121.125 -0.984 . . . . 0.0 111.676 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.605 ' HA ' ' HB2' ' A' ' 38' ' ' LYS . 3.1 m -70.57 -55.39 8.97 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 117.496 -1.682 . . . . 0.0 108.437 178.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.953 HG11 HG23 ' A' ' 77' ' ' VAL . 87.1 t -55.2 -40.96 58.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.782 ' HB1' ' C ' ' B' ' 88' ' ' ALA . . . -68.93 -22.2 64.16 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.651 ' N ' HD12 ' B' ' 92' ' ' LEU . 13.4 mtmt -82.32 -25.48 33.88 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 177.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 35' ' ' THR . . . 104.06 30.79 4.97 Favored Glycine 0 C--N 1.295 -1.722 0 C-N-CA 120.133 -1.032 . . . . 0.0 110.653 177.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.567 ' CB ' HG23 ' A' ' 35' ' ' THR . 0.3 OUTLIER -117.25 138.22 51.87 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.225 -1.162 . . . . 0.0 110.018 179.545 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -72.18 82.55 1.0 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.461 -0.774 . . . . 0.0 110.638 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.624 ' CG2' HD11 ' B' ' 6' ' ' LEU . 14.8 p -73.36 140.96 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.47 -0.769 . . . . 0.0 109.654 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.417 ' HG3' ' OD1' ' B' ' 2' ' ' ASN . 1.6 pt20 -149.1 163.18 38.31 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.009 -1.057 . . . . 0.0 111.462 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.641 HD12 ' HB2' ' A' ' 48' ' ' LEU . 23.4 mt -106.94 109.28 21.14 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.53 HG21 ' HG3' ' B' ' 29' ' ' GLU . 0.0 OUTLIER 35.8 -95.11 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.743 -0.598 . . . . 0.0 111.378 -178.854 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -139.47 10.49 3.22 Favored Glycine 0 N--CA 1.488 2.105 0 C-N-CA 119.52 -1.324 . . . . 0.0 111.034 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.898 ' HD1' HD11 ' A' ' 85' ' ' LEU . 23.6 p90 -105.11 -20.31 13.56 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.604 -1.527 . . . . 0.0 110.695 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.641 ' HB2' HD12 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -132.81 147.67 52.31 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.13 -0.981 . . . . 0.0 111.666 178.505 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -154.08 116.28 4.31 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.773 -0.58 . . . . 0.0 109.718 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.613 HG21 HG21 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -109.54 155.1 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.212 -0.93 . . . . 0.0 110.522 -179.657 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 9.0 ptmt -162.19 126.78 2.04 Favored Pre-proline 0 N--CA 1.498 1.939 0 C-N-CA 118.803 -1.159 . . . . 0.0 110.96 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.717 ' HG3' ' O ' ' A' ' 36' ' ' VAL . 53.9 Cg_endo -87.05 144.29 7.09 Favored 'Trans proline' 0 C--N 1.316 -1.17 0 O-C-N 123.405 1.213 . . . . 0.0 110.888 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.637 HG22 ' O ' ' A' ' 76' ' ' GLY . 25.8 m -143.85 116.59 3.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-O 121.599 0.714 . . . . 0.0 110.278 179.415 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.538 ' HB2' ' HB3' ' B' ' 97' ' ' PHE . . . -30.87 124.38 0.2 Allowed 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.62 0.724 . . . . 0.0 112.318 -178.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.68 -148.73 0.12 Allowed 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.677 ' CB ' ' HB1' ' A' ' 72' ' ' ALA . 0.1 OUTLIER -174.97 -165.46 0.19 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.713 -1.242 . . . . 0.0 111.922 179.122 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.488 ' O ' ' HB3' ' A' ' 58' ' ' ARG 0.273 . . -172.26 138.59 0.97 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.672 -0.642 . . . . 0.0 109.659 -177.948 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.883 ' HB3' HD13 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -179.21 -163.34 0.06 Allowed 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 117.992 -1.483 . . . . 0.0 114.663 -179.58 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.451 ' CB ' ' O ' ' A' ' 58' ' ' ARG . 4.5 mtmt 159.73 28.62 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 113.741 -1.572 . . . . 0.0 108.597 178.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.776 ' O ' ' N ' ' A' ' 69' ' ' LEU . . . -156.2 -113.31 0.42 Allowed Glycine 0 N--CA 1.493 2.441 0 C-N-CA 120.014 -1.089 . . . . 0.0 110.595 -179.03 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.511 ' O ' HG22 ' A' ' 71' ' ' ILE . 0.3 OUTLIER -50.04 179.1 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.197 0 O-C-N 120.932 -1.334 . . . . 0.0 111.75 -178.737 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.694 ' CB ' ' CD ' ' A' ' 63' ' ' PRO . 2.2 m120 -147.93 -78.24 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.337 -0.852 . . . . 0.0 108.877 179.243 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.694 ' CD ' ' CB ' ' A' ' 62' ' ' ASN . 54.2 Cg_endo -74.42 -12.21 22.76 Favored 'Trans proline' 0 C--N 1.318 -1.048 0 N-CA-C 108.454 -1.402 . . . . 0.0 108.454 177.452 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.67 ' O ' HG23 ' A' ' 65' ' ' THR . 3.1 tt0 68.77 70.85 0.28 Allowed 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.665 0.745 . . . . 0.0 110.735 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.67 HG23 ' O ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -179.4 -22.98 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.739 -0.601 . . . . 0.0 110.787 179.28 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.478 ' NE2' ' HB ' ' A' ' 65' ' ' THR . 0.7 OUTLIER -174.6 -12.45 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.075 0 O-C-N 120.869 -1.144 . . . . 0.0 113.071 -179.77 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.689 ' O ' ' HB2' ' A' ' 68' ' ' ALA . 1.4 tt0 -85.64 -158.51 0.39 Allowed 'General case' 0 N--CA 1.483 1.181 0 O-C-N 120.365 -1.46 . . . . 0.0 109.653 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.689 ' HB2' ' O ' ' A' ' 67' ' ' GLU . . . 167.83 72.12 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.861 -0.524 . . . . 0.0 111.53 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.776 ' N ' ' O ' ' A' ' 60' ' ' GLY . 3.6 pp -150.56 15.65 0.78 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.924 -1.11 . . . . 0.0 111.982 178.256 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.688 ' CB ' ' O ' ' A' ' 69' ' ' LEU . 0.6 OUTLIER 136.71 97.23 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.9 0 CA-C-N 118.473 0.578 . . . . 0.0 110.601 178.288 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.883 HD13 ' HB3' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -82.41 -165.41 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 177.531 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.731 ' HB2' ' O ' ' A' ' 71' ' ' ILE . . . 173.82 60.87 0.04 OUTLIER Pre-proline 0 N--CA 1.515 2.784 0 O-C-N 119.035 -2.29 . . . . 0.0 114.295 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.649 ' HD3' ' CD1' ' A' ' 71' ' ' ILE . 57.1 Cg_endo -108.09 84.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.302 -1.887 0 C-N-CA 121.541 1.494 . . . . 0.0 110.991 178.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.67 111.96 0.91 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.149 -1.594 . . . . 0.0 111.573 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.565 HG11 ' HB1' ' B' ' 89' ' ' ALA . 0.3 OUTLIER -55.9 -178.43 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.21 -0.931 . . . . 0.0 109.034 178.821 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.637 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -110.74 64.02 0.27 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.953 HG23 HG11 ' A' ' 36' ' ' VAL . 7.5 p -54.86 75.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.531 -0.982 . . . . 0.0 110.75 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.626 ' N ' ' O ' ' A' ' 76' ' ' GLY . 29.9 t -79.78 178.72 7.98 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.294 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.593 HG12 ' C ' ' A' ' 78' ' ' SER . 0.2 OUTLIER 179.27 172.96 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.463 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.56 ' N ' ' CG2' ' A' ' 79' ' ' VAL . 0.1 OUTLIER 177.28 173.8 0.33 Allowed Pre-proline 0 C--N 1.299 -1.616 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 177.814 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.668 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 52.5 Cg_endo -85.87 174.59 6.41 Favored 'Trans proline' 0 C--N 1.294 -2.294 0 O-C-N 123.648 1.341 . . . . 0.0 110.106 177.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -115.84 -68.58 0.43 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 105.289 -3.124 . . . . 0.0 105.289 177.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.863 ' O ' ' N ' ' A' ' 85' ' ' LEU . 37.8 tt0 -87.33 53.13 2.7 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 174.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . 1.312 ' O ' ' N ' ' A' ' 86' ' ' LYS . 1.9 m 9.62 44.31 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 122.386 1.089 . . . . 0.0 110.854 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 1.067 HD13 HG21 ' B' ' 77' ' ' VAL . 3.6 mp 21.6 29.58 0.0 OUTLIER 'General case' 0 C--O 1.195 -1.802 0 N-CA-C 103.685 -2.709 . . . . 0.0 103.685 -172.411 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 1.312 ' N ' ' O ' ' A' ' 84' ' ' SER 0.339 9.7 tttt -55.59 -36.66 67.14 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 104.261 -2.496 . . . . 0.0 104.261 176.732 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.292 14.0 tttt -75.99 -31.59 59.03 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 111.625 -2.534 . . . . 0.0 106.5 176.462 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 1.001 ' HB3' ' HB3' ' A' ' 85' ' ' LEU . . . -82.21 -20.48 37.67 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 118.53 -1.268 . . . . 0.0 108.755 179.132 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 1.021 ' HA ' HD23 ' A' ' 92' ' ' LEU . . . -80.99 -43.94 18.87 Favored 'General case' 0 C--N 1.293 -1.888 0 O-C-N 120.941 -1.099 . . . . 0.0 108.587 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.7 -30.46 67.43 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 177.226 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.789 ' HA3' ' HB1' ' B' ' 37' ' ' ALA . . . -71.63 -33.83 63.37 Favored Glycine 0 N--CA 1.489 2.18 0 C-N-CA 120.279 -0.962 . . . . 0.0 110.837 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 1.021 HD23 ' HA ' ' A' ' 89' ' ' ALA . 0.4 OUTLIER -81.07 20.84 0.76 Allowed 'General case' 0 N--CA 1.504 2.241 0 O-C-N 120.371 -1.664 . . . . 0.0 110.764 -179.807 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.403 ' O ' ' N ' ' A' ' 96' ' ' ASP . 0.0 OUTLIER 57.2 37.46 28.38 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -178.397 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.522 ' HB2' ' HB ' ' B' ' 75' ' ' VAL . 0.0 OUTLIER -39.18 -33.94 0.16 Allowed 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.61 -179.21 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.56 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 46.1 mt-10 -63.33 -45.9 89.14 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.439 -0.788 . . . . 0.0 109.305 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 93' ' ' LYS . 60.3 m-20 -54.37 -39.68 67.42 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 178.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.754 ' HB3' ' HB2' ' B' ' 54' ' ' ALA . 0.1 OUTLIER -71.55 -29.12 64.38 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.292 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 95' ' ' GLU . . . -66.21 -61.9 1.77 Allowed 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.456 0.646 . . . . 0.0 110.172 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 25.8 mtmt . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.22 -179.848 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.544 ' HE2' ' HG ' ' B' ' 6' ' ' LEU . 5.2 mtp . . . . . 0 N--CA 1.493 1.69 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 2' ' ' ASN . . . . . 0.443 ' N ' ' HB2' ' B' ' 5' ' ' GLU . 12.2 t30 -177.22 178.01 1.15 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.207 -0.933 . . . . 0.0 110.816 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.545 ' NZ ' ' O ' ' B' ' 25' ' ' LEU . 1.7 mttm -44.53 -23.29 0.11 Allowed 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.49 -0.756 . . . . 0.0 110.58 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.506 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 13.4 m -102.94 -43.9 5.39 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.165 -0.96 . . . . 0.0 109.309 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.482 ' O ' ' CG ' ' B' ' 8' ' ' LYS . 0.1 OUTLIER -62.06 -46.51 88.82 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.153 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.679 ' O ' ' HB3' ' B' ' 9' ' ' ALA . 1.6 mt -66.13 -29.23 69.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.944 -1.098 . . . . 0.0 109.154 178.122 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 7' ' ' ILE . . . . . 0.875 HG23 ' HB ' ' B' ' 21' ' ' VAL . 0.3 OUTLIER -56.79 -59.77 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.638 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 8' ' ' LYS . . . . . 0.953 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 19.9 pttt -61.13 -25.87 67.29 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.512 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 9' ' ' ALA . . . . . 0.679 ' HB3' ' O ' ' B' ' 6' ' ' LEU . . . -58.56 -38.29 77.53 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.018 -1.051 . . . . 0.0 108.744 178.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.862 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.1 mp -90.62 -35.99 7.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 177.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.953 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -62.42 -12.82 23.89 Favored 'General case' 0 C--N 1.293 -1.851 0 C-N-CA 118.783 -1.167 . . . . 0.0 108.689 177.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.465 ' HB3' ' O ' ' B' ' 8' ' ' LYS . 6.9 tp-100 -113.79 -44.26 3.2 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.501 -0.749 . . . . 0.0 109.284 178.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.547 ' OD2' HG23 ' A' ' 31' ' ' ILE . 1.7 m-20 -64.29 -33.26 75.42 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 14' ' ' THR . . . . . 1.07 HG22 HD11 ' B' ' 16' ' ' LEU 0.253 0.2 OUTLIER -98.77 -69.53 0.76 Allowed 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 178.348 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 57.86 22.2 46.96 Favored Glycine 0 N--CA 1.501 2.98 0 O-C-N 121.398 -0.814 . . . . 0.0 111.585 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 16' ' ' LEU . . . . . 1.07 HD11 HG22 ' B' ' 14' ' ' THR . 4.9 mp -65.66 -66.17 0.58 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.348 -1.09 . . . . 0.0 109.64 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 17' ' ' THR . . . . . 0.759 HG21 HG21 ' A' ' 17' ' ' THR . 0.5 OUTLIER -135.54 6.73 3.26 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -179.57 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 18' ' ' GLN . . . . . 0.652 ' O ' ' C ' ' B' ' 19' ' ' VAL . 25.1 mt-30 58.69 24.98 12.78 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 -175.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 1.073 HG23 ' CD1' ' A' ' 16' ' ' LEU . 0.2 OUTLIER 7.69 -95.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 CA-C-N 115.211 -0.904 . . . . 0.0 108.958 -179.185 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 20' ' ' SER . . . . . 1.026 ' O ' ' N ' ' B' ' 22' ' ' SER . 1.2 p -137.42 23.47 2.95 Favored 'General case' 0 C--N 1.273 -2.729 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 177.172 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.875 ' HB ' HG23 ' B' ' 7' ' ' ILE . 9.4 m -4.02 -43.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 122.441 1.115 . . . . 0.0 111.006 -177.436 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 22' ' ' SER . . . . . 1.026 ' N ' ' O ' ' B' ' 20' ' ' SER . 5.9 m -75.35 -38.06 60.34 Favored 'General case' 0 C--N 1.278 -2.506 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.559 178.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 23' ' ' LYS . . . . . 0.868 ' N ' ' O ' ' B' ' 20' ' ' SER . 6.1 mtmt -92.94 -26.99 17.33 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.36 -0.837 . . . . 0.0 111.154 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 24' ' ' MET . . . . . 0.672 ' HB3' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -70.9 -37.52 72.96 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 117.157 -1.817 . . . . 0.0 108.264 179.177 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.731 HD12 HG13 ' B' ' 7' ' ' ILE . 0.4 OUTLIER -80.44 -51.45 8.8 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 117.956 -1.498 . . . . 0.0 108.241 177.52 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 26' ' ' ALA . . . . . 0.491 ' O ' ' HB2' ' B' ' 30' ' ' LYS . . . -49.95 -34.11 19.75 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.374 -0.829 . . . . 0.0 108.859 178.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 27' ' ' SER . . . . . 0.507 ' HA ' ' HB3' ' B' ' 30' ' ' LYS . 83.1 p -81.92 -33.88 30.17 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.284 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 28' ' ' PHE . . . . . 0.811 ' O ' HG13 ' B' ' 31' ' ' ILE . 0.3 OUTLIER -56.02 -52.44 64.22 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.812 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 29' ' ' GLU . . . . . 0.791 ' O ' ' OG1' ' B' ' 33' ' ' THR . 0.2 OUTLIER -63.42 -39.01 93.34 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 176.401 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 0.992 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 17.5 ttpt -59.96 -23.79 63.87 Favored 'General case' 0 C--O 1.189 -2.115 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.878 HD13 ' CB ' ' A' ' 9' ' ' ALA . 0.6 OUTLIER -102.83 -27.16 3.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 O-C-N 120.615 -1.303 . . . . 0.0 108.582 178.047 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.715 HD11 ' CE2' ' B' ' 28' ' ' PHE . 1.2 mm -68.88 -54.33 21.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 177.308 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 33' ' ' THR . . . . . 0.811 ' HA ' HD23 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -70.73 -49.07 50.86 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.107 -1.037 . . . . 0.0 108.669 178.576 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.992 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 19.2 mm-40 -58.09 -35.68 71.77 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.551 -0.86 . . . . 0.0 109.95 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 35' ' ' THR . . . . . 0.831 HG22 ' CB ' ' B' ' 40' ' ' ASP . 31.1 m -69.72 -42.34 74.13 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 118.302 -1.359 . . . . 0.0 107.697 177.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.976 HG21 HD22 ' A' ' 85' ' ' LEU . 55.5 t -56.95 -43.03 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 177.111 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 0.804 ' HA ' ' HB3' ' A' ' 92' ' ' LEU . . . -76.89 2.92 13.25 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.398 -0.921 . . . . 0.0 109.69 177.255 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 38' ' ' LYS . . . . . 0.546 ' HB2' ' O ' ' B' ' 34' ' ' GLU . 0.1 OUTLIER -119.91 4.6 10.95 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.107 -0.996 . . . . 0.0 109.311 178.001 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.73 34.46 4.07 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 40' ' ' ASP . . . . . 0.831 ' CB ' HG22 ' B' ' 35' ' ' THR . 14.2 t0 -49.17 162.91 0.11 Allowed 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 123.086 1.422 . . . . 0.0 113.019 -179.01 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -179.83 56.99 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 104.381 -2.451 . . . . 0.0 104.381 178.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.918 HG21 HD11 ' A' ' 6' ' ' LEU . 7.4 p -90.67 148.74 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.941 -176.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -132.26 95.9 3.76 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.903 HD12 ' HB3' ' B' ' 48' ' ' LEU . 19.2 mt -59.65 101.59 0.12 Allowed 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.245 -0.909 . . . . 0.0 109.792 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 45' ' ' THR . . . . . 0.534 HG22 ' HD3' ' A' ' 3' ' ' LYS . 0.0 OUTLIER 35.53 -93.55 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 120.921 0.391 . . . . 0.0 110.877 -179.648 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -147.17 35.4 1.25 Allowed Glycine 0 N--CA 1.485 1.95 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 47' ' ' PHE . . . . . 0.73 ' O ' HD11 ' B' ' 85' ' ' LEU . 1.1 p90 -135.75 -25.53 1.26 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.246 -1.149 . . . . 0.0 111.773 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.903 ' HB3' HD12 ' B' ' 44' ' ' LEU . 4.8 mt -136.36 113.58 10.64 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.214 -1.554 . . . . 0.0 111.374 178.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -113.69 95.95 5.6 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.414 -0.804 . . . . 0.0 110.291 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 50' ' ' ILE . . . . . 0.783 ' CG1' HG22 ' B' ' 79' ' ' VAL . 0.3 OUTLIER -87.5 139.42 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.37 -0.831 . . . . 0.0 109.271 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 51' ' ' LYS . . . . . 0.408 ' O ' ' HB3' ' B' ' 78' ' ' SER . 1.7 ptmt -158.83 111.4 1.61 Allowed Pre-proline 0 N--CA 1.5 2.042 0 C-N-CA 118.603 -1.239 . . . . 0.0 111.233 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.577 ' HB3' HG13 ' B' ' 36' ' ' VAL . 44.9 Cg_endo -69.38 144.66 56.78 Favored 'Trans proline' 0 C--N 1.314 -1.251 0 O-C-N 123.47 1.248 . . . . 0.0 111.681 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.703 HG22 ' O ' ' B' ' 76' ' ' GLY . 29.7 m -143.07 116.86 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 121.491 0.663 . . . . 0.0 110.841 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.754 ' HB2' ' HB3' ' A' ' 97' ' ' PHE . . . -46.01 145.14 1.62 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 121.806 0.812 . . . . 0.0 112.105 -178.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.27 96.33 0.19 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 56' ' ' GLN . . . . . 0.745 ' O ' HD13 ' B' ' 71' ' ' ILE . 13.5 mt-30 -59.07 -165.03 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.261 -0.899 . . . . 0.0 111.052 -178.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.635 ' HB2' ' HD3' ' B' ' 73' ' ' PRO . . . -91.53 166.39 12.87 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.662 -0.649 . . . . 0.0 110.977 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 58' ' ' ARG . . . . . 0.69 ' HG3' HD11 ' B' ' 71' ' ' ILE . 47.8 mtt85 -157.25 142.14 16.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.815 -0.553 . . . . 0.0 109.535 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 2.5 pttt -170.24 66.46 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.201 -0.937 . . . . 0.0 110.457 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 154.43 -32.72 0.7 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 61' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -171.8 -164.66 0.32 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.325 -1.103 . . . . 0.0 110.349 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 62' ' ' ASN . . . . . 0.72 ' HB3' ' CD ' ' B' ' 63' ' ' PRO . 2.6 t-20 -170.21 -79.4 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.455 -0.778 . . . . 0.0 109.807 179.424 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.72 ' CD ' ' HB3' ' B' ' 62' ' ' ASN . 57.0 Cg_endo -80.22 1.77 9.0 Favored 'Trans proline' 0 C--N 1.321 -0.889 0 N-CA-C 109.496 -1.002 . . . . 0.0 109.496 178.256 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 62.21 20.05 11.42 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.337 -0.852 . . . . 0.0 109.253 -178.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.53 HG23 ' O ' ' B' ' 63' ' ' PRO . 65.1 p -124.15 44.36 2.75 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.583 -0.698 . . . . 0.0 109.17 179.405 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 66' ' ' GLN . . . . . 0.431 ' HB2' ' O ' ' B' ' 65' ' ' THR . 33.6 mm-40 66.59 56.06 0.76 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.796 -0.565 . . . . 0.0 111.133 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 67' ' ' GLU . . . . . 0.406 ' HB2' ' HG2' ' B' ' 63' ' ' PRO . 0.2 OUTLIER -140.6 64.7 1.43 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.09 -1.006 . . . . 0.0 109.474 179.002 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.82 126.0 25.79 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.705 -0.622 . . . . 0.0 110.684 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.407 ' HA ' HD23 ' B' ' 69' ' ' LEU . 80.2 mt -116.76 176.44 5.12 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.404 -0.81 . . . . 0.0 110.301 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -154.45 73.63 0.92 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.367 -0.833 . . . . 0.0 110.522 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.745 HD13 ' O ' ' B' ' 56' ' ' GLN . 1.5 pp -117.69 -160.17 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.349 -0.844 . . . . 0.0 109.561 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -126.14 156.78 71.59 Favored Pre-proline 0 C--N 1.304 -1.412 0 O-C-N 121.187 -0.946 . . . . 0.0 111.098 -179.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 73' ' ' PRO . . . . . 0.635 ' HD3' ' HB2' ' B' ' 57' ' ' ALA . 45.0 Cg_endo -73.38 82.17 1.67 Allowed 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 124.325 1.697 . . . . 0.0 110.379 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 74' ' ' SER . . . . . 0.48 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 9.2 p -176.42 154.58 1.32 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.45 -0.781 . . . . 0.0 109.628 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 75' ' ' VAL . . . . . 0.897 ' HB ' ' HB1' ' A' ' 89' ' ' ALA . 1.2 t -52.85 169.83 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.132 -0.98 . . . . 0.0 109.364 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 76' ' ' GLY . . . . . 0.703 ' O ' HG22 ' B' ' 53' ' ' VAL . . . -115.32 86.9 0.42 Allowed Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.136 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 1.067 HG21 HD13 ' A' ' 85' ' ' LEU . 3.6 p -60.53 78.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.767 -0.843 . . . . 0.0 109.827 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 78' ' ' SER . . . . . 0.941 ' O ' HG23 ' B' ' 79' ' ' VAL . 2.2 t -68.05 177.66 2.12 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.551 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.941 HG23 ' O ' ' B' ' 78' ' ' SER . 14.6 t -172.33 175.27 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 80' ' ' LYS . . . . . 0.865 ' O ' HD23 ' B' ' 48' ' ' LEU . 0.0 OUTLIER 179.28 172.17 0.49 Allowed Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 120.87 -1.144 . . . . 0.0 110.178 177.186 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 81' ' ' PRO . . . . . 0.504 ' HA ' ' O ' ' B' ' 47' ' ' PHE . 54.0 Cg_endo -95.17 143.45 1.31 Allowed 'Trans proline' 0 C--N 1.303 -1.855 0 C-N-CA 122.35 2.033 . . . . 0.0 110.739 178.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 82' ' ' GLY . . . . . 0.557 ' O ' ' HB3' ' B' ' 83' ' ' GLU . . . -107.6 42.37 1.95 Allowed Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.215 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 83' ' ' GLU . . . . . 0.557 ' HB3' ' O ' ' B' ' 82' ' ' GLY . 1.0 OUTLIER 69.02 -40.18 0.44 Allowed 'General case' 0 N--CA 1.506 2.34 0 O-C-N 121.448 -1.031 . . . . 0.0 111.93 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 84' ' ' SER . . . . . 0.472 ' CB ' ' HB3' ' B' ' 47' ' ' PHE . 0.1 OUTLIER -48.85 -33.34 10.39 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.949 -1.094 . . . . 0.0 110.165 -179.177 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.817 ' HB2' HG21 ' A' ' 77' ' ' VAL . 0.8 OUTLIER -82.61 -29.98 29.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.412 -0.805 . . . . 0.0 108.877 178.703 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 86' ' ' LYS . . . . . 0.576 ' CD ' HG12 ' A' ' 77' ' ' VAL . 0.3 OUTLIER -82.49 -39.5 22.37 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.53 0.681 . . . . 0.0 109.607 179.812 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 87' ' ' LYS . . . . . 0.465 ' O ' ' CG ' ' B' ' 90' ' ' GLU . 1.2 ttmp? -68.69 -37.05 79.26 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 178.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.782 ' C ' ' HB1' ' A' ' 37' ' ' ALA . . . -71.62 -30.66 66.02 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 177.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.674 ' HA ' ' HA ' ' A' ' 37' ' ' ALA . . . -69.94 -52.79 21.55 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.623 -0.673 . . . . 0.0 110.368 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.64 ' HA ' ' CB ' ' B' ' 94' ' ' TYR . 8.2 pt-20 -52.2 -23.25 5.28 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 177.455 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 91' ' ' GLY . . . . . 0.859 ' C ' HD23 ' B' ' 92' ' ' LEU . . . -81.17 -29.66 40.41 Favored Glycine 0 CA--C 1.546 2.03 0 CA-C-O 118.604 -1.109 . . . . 0.0 112.81 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 92' ' ' LEU . . . . . 0.859 HD23 ' C ' ' B' ' 91' ' ' GLY . 0.2 OUTLIER -111.64 -73.55 0.67 Allowed 'General case' 0 N--CA 1.507 2.391 0 CA-C-N 122.065 2.933 . . . . 0.0 113.54 -177.687 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -120.31 42.7 2.9 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.771 -1.205 . . . . 0.0 112.628 -177.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 94' ' ' TYR . . . . . 0.64 ' CB ' ' HA ' ' B' ' 90' ' ' GLU . 0.8 OUTLIER -77.19 -43.51 33.46 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.124 -0.985 . . . . 0.0 108.967 178.507 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 95' ' ' GLU . . . . . 0.408 ' O ' ' HB3' ' B' ' 98' ' ' ALA . 1.2 mp0 -75.04 -35.73 61.89 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.07 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.19 -40.13 76.77 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 97' ' ' PHE . . . . . 0.538 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -75.25 -26.67 59.04 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.497 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 98' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' B' ' 95' ' ' GLU . . . -67.71 -37.35 82.12 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.614 -0.679 . . . . 0.0 110.179 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 36.2 mttm . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.18 -179.89 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.507 ' HA ' ' CB ' ' A' ' 5' ' ' GLU . 2.8 mtp . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.466 ' H ' ' HB2' ' A' ' 5' ' ' GLU . 0.6 OUTLIER -177.12 -162.54 0.08 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.023 -1.048 . . . . 0.0 111.728 179.855 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.519 ' HE2' ' HA ' ' A' ' 26' ' ' ALA . 0.9 OUTLIER -52.22 -11.77 0.2 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.657 -0.652 . . . . 0.0 110.396 179.778 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.611 ' O ' HG13 ' A' ' 7' ' ' ILE . 73.7 m -114.38 -58.95 2.08 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.104 -0.997 . . . . 0.0 110.731 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.507 ' CB ' ' HA ' ' A' ' 1' ' ' MET . 1.6 mm-40 -49.74 -48.4 50.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.822 -1.174 . . . . 0.0 108.945 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.824 HD11 ' CG1' ' B' ' 42' ' ' VAL . 16.2 mt -55.65 -32.93 63.61 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.151 -1.02 . . . . 0.0 110.105 178.455 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.794 ' HA ' HD12 ' A' ' 25' ' ' LEU . 1.0 OUTLIER -60.5 -40.94 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 120.599 -1.313 . . . . 0.0 107.563 178.743 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.858 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -66.75 -31.14 71.6 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 177.343 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.659 ' HB3' ' O ' ' A' ' 6' ' ' LEU . . . -58.45 -39.01 78.69 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.815 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.4 mp -91.01 -30.61 4.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 178.03 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.858 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -66.08 -10.6 41.94 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 118.456 -1.298 . . . . 0.0 108.493 178.218 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.443 ' CG ' ' N ' ' A' ' 13' ' ' ASP . 6.4 pt20 -118.53 -42.52 2.75 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.48 -0.762 . . . . 0.0 110.405 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.73 ' OD2' HG21 ' B' ' 31' ' ' ILE . 16.8 m-20 -69.85 -25.82 63.91 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 177.525 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . 1.139 HG22 ' CD1' ' A' ' 16' ' ' LEU 0.277 0.2 OUTLIER -106.53 -72.89 0.7 Allowed 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 179.025 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.65 15.68 54.3 Favored Glycine 0 N--CA 1.501 2.974 0 O-C-N 121.328 -0.857 . . . . 0.0 111.039 177.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.139 ' CD1' HG22 ' A' ' 14' ' ' THR . 4.4 mp -59.36 -68.87 0.23 Allowed 'General case' 0 C--N 1.294 -1.835 0 O-C-N 121.524 -0.986 . . . . 0.0 110.628 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.532 ' O ' HG23 ' A' ' 17' ' ' THR . 0.6 OUTLIER -138.11 9.64 2.77 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.302 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.558 ' O ' ' C ' ' A' ' 19' ' ' VAL . 7.7 mt-30 57.84 25.71 12.34 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -176.152 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 1.026 HG11 HG11 ' B' ' 19' ' ' VAL . 2.4 p -11.45 -95.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.089 -179.045 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.976 ' HB2' HG22 ' B' ' 14' ' ' THR . 0.6 OUTLIER -130.74 22.86 5.02 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 177.957 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.652 ' HA ' ' CE ' ' A' ' 24' ' ' MET . 30.5 m -25.19 -38.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-O 122.479 1.133 . . . . 0.0 109.182 -178.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.71 ' N ' ' O ' ' A' ' 20' ' ' SER . 4.9 m -84.49 -35.36 23.01 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.135 177.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.942 ' N ' ' O ' ' A' ' 20' ' ' SER . 1.2 mtmt -85.69 -34.07 21.37 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.652 -0.655 . . . . 0.0 111.543 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.781 ' HB3' HG23 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -76.1 -40.24 53.41 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.44 -1.412 . . . . 0.0 109.349 179.466 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.794 HD12 ' HA ' ' A' ' 7' ' ' ILE . 11.6 mt -74.56 -38.29 62.74 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 117.894 -1.523 . . . . 0.0 108.724 178.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.519 ' HA ' ' HE2' ' A' ' 3' ' ' LYS . . . -64.08 -33.22 75.26 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 177.252 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.551 ' O ' ' N ' ' A' ' 31' ' ' ILE . 58.3 m -84.25 -30.52 25.61 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 178.231 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.865 ' HB2' HD11 ' B' ' 10' ' ' ILE . 0.1 OUTLIER -59.24 -35.91 74.53 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.608 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.753 ' O ' ' HB ' ' A' ' 33' ' ' THR . 2.1 mt-10 -79.99 -32.92 39.76 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 177.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.739 ' O ' ' CG ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -68.6 -27.31 65.93 Favored 'General case' 0 C--O 1.194 -1.821 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 176.758 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.738 ' CG1' ' HA ' ' A' ' 28' ' ' PHE . 1.7 pp -97.11 -31.69 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.299 -0.875 . . . . 0.0 109.445 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.637 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 3.3 mm -65.42 -51.62 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 177.142 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.753 ' HB ' ' O ' ' A' ' 29' ' ' GLU . 0.3 OUTLIER -65.51 -43.27 90.62 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.867 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.739 ' CG ' ' O ' ' A' ' 30' ' ' LYS . 44.5 mm-40 -69.02 -36.08 77.36 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.614 -0.679 . . . . 0.0 111.451 179.347 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.971 HG21 HG23 ' A' ' 42' ' ' VAL . 2.3 m -57.59 -56.12 26.05 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.736 -1.228 . . . . 0.0 108.689 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.019 HG21 HG23 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -55.51 -29.51 24.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 106.303 -1.739 . . . . 0.0 106.303 177.414 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 1.065 ' HB2' ' HB1' ' B' ' 88' ' ' ALA . . . -75.73 -4.1 38.53 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 177.164 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 35' ' ' THR . 0.0 OUTLIER -115.26 -32.07 5.77 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.634 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.18 42.58 0.76 Allowed Glycine 0 C--N 1.301 -1.391 0 C-N-CA 119.804 -1.189 . . . . 0.0 110.558 178.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.773 ' CB ' HG23 ' A' ' 35' ' ' THR . 0.1 OUTLIER -125.86 117.44 23.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.218 -1.166 . . . . 0.0 110.33 179.349 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.6 mtmt -67.13 89.41 0.18 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.57 0.7 . . . . 0.0 109.626 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.971 HG23 HG21 ' A' ' 35' ' ' THR . 42.5 t -66.23 131.94 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.682 -0.637 . . . . 0.0 110.374 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.503 ' O ' HD23 ' A' ' 44' ' ' LEU . 1.5 pt20 -128.04 154.8 45.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.517 -0.739 . . . . 0.0 109.59 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.983 HD12 ' CB ' ' A' ' 48' ' ' LEU . 73.1 mt -128.13 112.19 14.28 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.287 -0.883 . . . . 0.0 109.686 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.59 HG22 ' HG2' ' B' ' 29' ' ' GLU . 0.1 OUTLIER 32.45 -90.89 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.427 0 O-C-N 121.937 -0.477 . . . . 0.0 111.007 -179.371 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -149.94 28.99 1.14 Allowed Glycine 0 N--CA 1.482 1.752 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.646 ' O ' ' HA ' ' A' ' 81' ' ' PRO . 5.8 p90 -129.06 -24.09 2.94 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.096 -1.238 . . . . 0.0 112.046 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.983 ' CB ' HD12 ' A' ' 44' ' ' LEU . 1.0 OUTLIER -131.47 107.63 9.03 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.38 -1.45 . . . . 0.0 111.524 179.143 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -111.46 95.51 5.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.608 -0.683 . . . . 0.0 109.741 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.801 HD12 HG22 ' A' ' 79' ' ' VAL . 0.3 OUTLIER -83.44 142.42 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.369 -0.832 . . . . 0.0 109.969 -179.351 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 13.0 ptmt -157.48 128.09 3.54 Favored Pre-proline 0 N--CA 1.494 1.743 0 C-N-CA 118.564 -1.255 . . . . 0.0 110.51 178.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.675 ' HB3' HG22 ' A' ' 36' ' ' VAL . 54.8 Cg_endo -85.28 143.74 9.01 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.475 1.25 . . . . 0.0 111.891 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.859 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 32.6 m -133.13 -149.37 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.257 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.938 ' HA ' ' CA ' ' A' ' 75' ' ' VAL . . . -167.18 143.01 4.21 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 118.542 -1.263 . . . . 0.0 113.238 177.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 54' ' ' ALA . 0.1 OUTLIER 168.38 101.61 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.729 -178.842 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.586 ' HB2' ' HA ' ' A' ' 74' ' ' SER . 2.9 mt-30 -161.43 32.91 0.13 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.375 -0.828 . . . . 0.0 110.531 -179.349 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 1.002 ' CB ' ' HB3' ' A' ' 72' ' ' ALA . . . -130.47 163.02 27.89 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-O 123.039 1.399 . . . . 0.0 113.721 -178.034 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.543 ' NH1' HD11 ' A' ' 71' ' ' ILE . 52.4 mtt180 -43.58 165.69 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 113.782 -1.554 . . . . 0.0 111.22 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.89 37.57 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.565 -0.709 . . . . 0.0 109.527 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 141.74 -20.69 2.54 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.487 ' HA ' ' O ' ' A' ' 67' ' ' GLU . 0.4 OUTLIER -162.49 174.27 12.9 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.38 -1.071 . . . . 0.0 110.032 179.891 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.683 ' HB3' ' CD ' ' A' ' 63' ' ' PRO . 12.5 t30 -145.93 -76.93 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.345 -0.847 . . . . 0.0 109.147 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.683 ' CD ' ' HB3' ' A' ' 62' ' ' ASN . 54.4 Cg_endo -75.25 -12.39 21.03 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 N-CA-C 107.991 -1.58 . . . . 0.0 107.991 177.181 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.702 ' O ' HG23 ' A' ' 65' ' ' THR . 2.3 tp60 70.86 71.85 0.19 Allowed 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.66 0.743 . . . . 0.0 110.946 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.702 HG23 ' O ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER 177.63 -24.82 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.928 -0.482 . . . . 0.0 110.364 179.134 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.516 ' NE2' ' HB ' ' A' ' 65' ' ' THR . 0.9 OUTLIER -178.59 16.14 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.113 -0.992 . . . . 0.0 112.446 -179.485 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.487 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 0.5 OUTLIER -128.5 100.27 5.71 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.431 -1.418 . . . . 0.0 110.636 -179.699 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.43 99.07 8.61 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.462 -0.774 . . . . 0.0 110.522 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.479 ' HB2' ' CD ' ' A' ' 58' ' ' ARG . 1.1 mp -123.53 -152.12 0.5 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.361 -0.837 . . . . 0.0 110.062 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.468 ' CA ' ' HB2' ' A' ' 58' ' ' ARG . 9.0 tt0 -164.42 43.61 0.09 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.112 -0.992 . . . . 0.0 110.881 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.957 ' O ' HD12 ' A' ' 71' ' ' ILE . 2.8 pp -130.54 145.86 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 O-C-N 121.052 -1.03 . . . . 0.0 111.715 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 1.051 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . 158.17 -166.14 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 122.067 -0.395 . . . . 0.0 110.116 179.386 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 1.051 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 43.4 Cg_endo -78.14 168.36 21.97 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 124.119 1.589 . . . . 0.0 111.433 178.022 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.866 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 0.1 OUTLIER -171.94 111.92 0.3 Allowed 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.385 179.301 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.938 ' CA ' ' HA ' ' A' ' 54' ' ' ALA . 0.9 OUTLIER -173.21 141.36 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.704 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 176.859 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.846 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -145.11 111.18 0.58 Allowed Glycine 0 N--CA 1.491 2.321 0 C-N-CA 119.1 -1.524 . . . . 0.0 110.805 -178.142 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 1.019 HG23 HG21 ' A' ' 36' ' ' VAL . 4.9 p -76.96 81.69 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 O-C-N 121.603 -0.939 . . . . 0.0 110.08 179.248 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . 1.008 ' O ' HG23 ' A' ' 79' ' ' VAL . 2.7 t -67.05 178.14 1.52 Allowed 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.347 -0.941 . . . . 0.0 109.607 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 1.008 HG23 ' O ' ' A' ' 78' ' ' SER . 3.4 t -176.41 174.96 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.607 ' O ' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER 179.32 170.59 0.55 Allowed Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 120.993 -1.067 . . . . 0.0 110.558 176.357 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.646 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 54.7 Cg_endo -95.09 144.53 1.41 Allowed 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 122.637 2.225 . . . . 0.0 110.551 178.018 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.503 ' H ' ' HA ' ' A' ' 47' ' ' PHE . . . -106.07 -171.68 23.32 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.79 -26.21 54.21 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.959 -1.318 . . . . 0.0 110.401 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.413 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 1.7 t -53.64 -27.56 27.91 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.873 HD22 HG11 ' B' ' 36' ' ' VAL . 1.3 mt -84.97 -29.07 25.38 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 178.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.506 ' HG3' HG13 ' B' ' 75' ' ' VAL . 0.4 OUTLIER -84.25 -29.2 26.67 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.306 -0.871 . . . . 0.0 109.706 179.823 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.83 -38.06 58.44 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 178.175 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.886 ' C ' ' HB1' ' B' ' 37' ' ' ALA . . . -65.61 -33.31 75.61 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 177.191 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 1.243 ' N ' ' HB1' ' B' ' 37' ' ' ALA . . . -72.63 -26.86 61.82 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.77 -34.57 62.79 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 175.217 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -63.6 -50.08 64.47 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 107.864 -2.094 . . . . 0.0 107.864 176.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.714 HD12 ' HA ' ' B' ' 37' ' ' ALA . 3.4 mt -49.67 -12.56 0.07 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.073 -1.251 . . . . 0.0 111.484 178.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.524 ' CB ' ' O ' ' A' ' 92' ' ' LEU . 0.0 OUTLIER 73.54 61.14 0.09 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -177.589 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.659 ' CE2' ' HA ' ' B' ' 73' ' ' PRO . 50.8 t80 -37.46 -39.99 0.34 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.189 -178.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.447 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 10.0 pt-20 -55.11 -43.16 73.8 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.293 -0.879 . . . . 0.0 109.697 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -62.05 -35.87 79.9 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.558 ' HB3' ' HB2' ' B' ' 54' ' ' ALA . 0.1 OUTLIER -72.82 -28.01 62.3 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.499 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.576 ' HA ' ' HB1' ' B' ' 54' ' ' ALA . . . -64.47 -63.98 0.99 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.578 -0.702 . . . . 0.0 110.206 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.147 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.504 ' HB3' ' HG ' ' B' ' 6' ' ' LEU . 1.5 mtp . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.059 0.457 . . . . 0.0 110.329 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 2' ' ' ASN . . . . . 0.514 ' O ' ' HB2' ' B' ' 6' ' ' LEU . 12.4 t-20 -173.54 -161.06 0.13 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.306 -0.871 . . . . 0.0 110.892 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.511 ' HE2' ' HB2' ' B' ' 29' ' ' GLU . 0.7 OUTLIER -55.77 -2.21 0.05 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.335 -0.853 . . . . 0.0 110.895 179.903 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.635 ' O ' ' CG1' ' B' ' 7' ' ' ILE . 54.4 m -122.77 -60.14 1.55 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.966 -1.084 . . . . 0.0 109.969 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.486 ' HB2' ' CA ' ' B' ' 1' ' ' MET . 5.4 mt-10 -51.74 -47.62 63.99 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.822 -1.174 . . . . 0.0 109.108 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.724 HD11 HG13 ' A' ' 42' ' ' VAL . 5.2 mt -60.43 -33.3 72.33 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.265 178.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 7' ' ' ILE . . . . . 0.747 ' N ' HD12 ' B' ' 25' ' ' LEU . 0.9 OUTLIER -58.4 -42.65 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 120.582 -1.324 . . . . 0.0 108.397 179.812 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 8' ' ' LYS . . . . . 0.77 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.1 OUTLIER -67.14 -32.2 73.15 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.213 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 9' ' ' ALA . . . . . 0.626 ' HB3' ' O ' ' B' ' 6' ' ' LEU . . . -62.33 -30.78 71.4 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 178.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.865 HD11 ' HB2' ' A' ' 28' ' ' PHE . 1.2 mp -96.65 -32.59 4.25 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.5 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 178.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.77 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -63.79 -29.58 70.77 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.154 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.412 ' HG3' ' N ' ' B' ' 13' ' ' ASP . 6.5 pt20 -89.56 -38.16 14.17 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.116 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.481 ' HB2' ' HA ' ' B' ' 10' ' ' ILE . 66.0 m-20 -67.96 -23.03 65.01 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 176.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.976 HG22 ' HB2' ' A' ' 20' ' ' SER . 18.4 p -92.31 -76.46 0.46 Allowed 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 61.05 12.37 29.62 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 16' ' ' LEU . . . . . 0.867 HD22 ' O ' ' A' ' 19' ' ' VAL . 3.3 mp -79.78 -61.66 1.92 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.481 -1.011 . . . . 0.0 109.016 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 17' ' ' THR . . . . . 0.505 HG22 ' H ' ' B' ' 19' ' ' VAL . 0.6 OUTLIER -141.55 5.93 1.84 Allowed 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.889 -179.794 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 18' ' ' GLN . . . . . 0.575 ' O ' ' C ' ' B' ' 19' ' ' VAL . 6.7 mt-30 54.53 29.69 11.74 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 -176.55 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 1.026 HG11 HG11 ' A' ' 19' ' ' VAL . 1.4 p -12.07 -95.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.743 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.945 ' O ' ' N ' ' B' ' 23' ' ' LYS . 0.5 OUTLIER -132.97 24.39 4.25 Favored 'General case' 0 C--N 1.283 -2.311 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 178.601 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.696 HG11 ' CB ' ' B' ' 11' ' ' ALA . 17.1 m -19.28 -39.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 CA-C-O 122.398 1.094 . . . . 0.0 109.433 -177.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.848 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.6 OUTLIER -82.43 -37.54 25.31 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.875 178.221 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 23' ' ' LYS . . . . . 0.945 ' N ' ' O ' ' B' ' 20' ' ' SER . 1.9 mtmt -89.63 -28.75 19.29 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.46 -0.775 . . . . 0.0 111.377 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 24' ' ' MET . . . . . 0.744 ' HB3' HG21 ' A' ' 14' ' ' THR . 0.0 OUTLIER -77.81 -36.36 50.33 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 118.002 -1.479 . . . . 0.0 108.549 179.078 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.747 HD12 ' N ' ' B' ' 7' ' ' ILE . 0.8 OUTLIER -75.18 -42.63 55.39 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 177.281 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 26' ' ' ALA . . . . . 0.468 ' HA ' ' HE2' ' B' ' 3' ' ' LYS . . . -60.3 -32.48 71.25 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 177.151 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 27' ' ' SER . . . . . 0.562 ' HA ' ' HB3' ' B' ' 30' ' ' LYS . 12.1 m -79.88 -35.66 37.73 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 28' ' ' PHE . . . . . 0.739 ' HE1' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -59.25 -40.08 84.84 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 178.849 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 29' ' ' GLU . . . . . 0.717 ' HG3' ' CE1' ' B' ' 28' ' ' PHE . 1.3 mt-10 -76.03 -34.05 59.66 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 0.751 ' O ' ' CG ' ' B' ' 34' ' ' GLU . 30.0 tttp -70.08 -29.89 66.99 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 177.324 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.739 ' CG1' ' HA ' ' B' ' 28' ' ' PHE . 2.0 pp -93.02 -35.23 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.311 -0.868 . . . . 0.0 109.232 179.119 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.68 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.3 mm -60.52 -60.05 3.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 33' ' ' THR . . . . . 0.678 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 0.4 OUTLIER -58.29 -39.53 79.55 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.116 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.842 ' O ' ' N ' ' B' ' 38' ' ' LYS . 7.0 mm-40 -68.66 -54.7 14.76 Favored 'General case' 0 C--O 1.199 -1.586 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.109 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 35' ' ' THR . . . . . 0.556 ' HA ' ' HB2' ' B' ' 38' ' ' LYS . 50.2 m -47.02 -63.85 0.93 Allowed 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.87 -1.144 . . . . 0.0 112.124 -178.445 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 1.026 HG23 HD12 ' B' ' 50' ' ' ILE . 0.9 OUTLIER -49.61 -44.02 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 C-N-CA 118.058 -1.457 . . . . 0.0 107.841 179.126 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 1.243 ' HB1' ' N ' ' A' ' 89' ' ' ALA . . . -93.63 15.27 16.63 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.793 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 38' ' ' LYS . . . . . 0.842 ' N ' ' O ' ' B' ' 34' ' ' GLU . 4.7 mmtt -121.95 -28.08 4.5 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 144.16 41.11 0.06 OUTLIER Glycine 0 N--CA 1.477 1.384 0 C-N-CA 119.026 -1.559 . . . . 0.0 112.06 178.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 40' ' ' ASP . . . . . 0.492 ' O ' ' HA ' ' B' ' 36' ' ' VAL . 0.4 OUTLIER -172.92 147.3 1.65 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.59 -1.535 . . . . 0.0 111.421 179.069 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.409 ' CG ' ' HD2' ' B' ' 52' ' ' PRO . 2.2 mttt -102.81 114.7 29.18 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.001 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.824 ' CG1' HD11 ' A' ' 6' ' ' LEU . 7.5 t -87.92 154.95 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 C-N-CA 119.858 -0.737 . . . . 0.0 111.107 -178.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 43' ' ' GLN . . . . . 0.408 ' HA ' ' O ' ' B' ' 48' ' ' LEU . 14.6 mt-30 -142.04 121.12 12.92 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.552 -0.717 . . . . 0.0 109.89 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.712 HD13 ' CZ ' ' A' ' 28' ' ' PHE . 20.5 mt -87.09 102.56 14.54 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.199 -0.938 . . . . 0.0 109.934 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 45' ' ' THR . . . . . 0.619 HG22 ' HG2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 37.56 28.09 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.435 0 O-C-N 121.819 -0.55 . . . . 0.0 111.753 -179.659 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . 90.64 -11.5 71.44 Favored Glycine 0 N--CA 1.486 2.028 0 C-N-CA 119.903 -1.142 . . . . 0.0 111.902 178.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 47' ' ' PHE . . . . . 0.627 ' CE2' ' HG2' ' A' ' 29' ' ' GLU . 0.8 OUTLIER -87.76 -35.3 17.96 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 120.028 1.914 . . . . 0.0 111.776 -179.561 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.612 ' HB2' HD12 ' B' ' 44' ' ' LEU . 0.4 OUTLIER -120.18 85.59 2.41 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.63 -1.294 . . . . 0.0 110.516 178.539 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -90.84 80.41 5.83 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.847 -0.533 . . . . 0.0 110.444 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 50' ' ' ILE . . . . . 1.026 HD12 HG23 ' B' ' 36' ' ' VAL . 2.9 pt -73.07 147.86 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.227 -0.921 . . . . 0.0 110.344 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 51' ' ' LYS . . . . . 0.564 ' O ' ' N ' ' B' ' 78' ' ' SER . 0.0 OUTLIER -165.14 132.52 2.35 Favored Pre-proline 0 N--CA 1.498 1.935 0 C-N-CA 119.285 -0.966 . . . . 0.0 110.549 179.456 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.827 ' HG3' ' O ' ' B' ' 36' ' ' VAL . 54.4 Cg_endo -85.47 149.19 10.16 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 O-C-N 123.398 1.209 . . . . 0.0 111.174 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.602 HG22 ' HA3' ' B' ' 76' ' ' GLY . 11.8 m -144.93 120.15 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 CA-C-O 122.296 1.046 . . . . 0.0 111.619 178.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.576 ' HB1' ' HA ' ' A' ' 98' ' ' ALA . . . -70.95 108.19 4.42 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.875 -179.297 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 55' ' ' ARG . . . . . 0.463 ' HB3' ' O ' ' B' ' 54' ' ' ALA . 0.0 OUTLIER 166.0 86.39 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 179.906 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 56' ' ' GLN . . . . . 0.546 ' CG ' ' O ' ' B' ' 74' ' ' SER . 1.2 mt-30 -159.79 -158.73 0.67 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.053 -1.059 . . . . 0.0 112.34 -177.213 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 1.024 ' HA ' ' HA ' ' B' ' 72' ' ' ALA . . . -172.73 148.06 1.84 Allowed 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 122.692 1.235 . . . . 0.0 113.451 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 58' ' ' ARG . . . . . 0.847 ' CD ' HG22 ' B' ' 71' ' ' ILE . 1.0 OUTLIER -66.23 -173.33 0.19 Allowed 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.186 179.624 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 4.2 ttmt -165.81 23.7 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.403 -0.811 . . . . 0.0 110.819 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 60' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' B' ' 69' ' ' LEU . . . 128.45 58.75 0.11 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.916 -1.273 . . . . 0.0 109.916 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 61' ' ' PHE . . . . . 0.906 ' CE2' HD12 ' B' ' 69' ' ' LEU . 0.1 OUTLIER -97.97 144.28 27.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.991 -1.299 . . . . 0.0 112.994 -179.38 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 62' ' ' ASN . . . . . 0.839 ' H ' ' CD ' ' B' ' 63' ' ' PRO . 9.7 p30 -144.47 -10.78 0.01 OUTLIER Pre-proline 0 C--N 1.302 -1.49 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.839 ' CD ' ' H ' ' B' ' 62' ' ' ASN . 46.5 Cg_endo -74.51 -7.52 19.62 Favored 'Trans proline' 0 N--CA 1.482 0.817 0 N-CA-C 109.042 -1.176 . . . . 0.0 109.042 178.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 64' ' ' GLN . . . . . 0.584 ' CB ' ' CE1' ' B' ' 61' ' ' PHE . 0.0 OUTLIER -94.27 -106.25 0.13 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.63 -0.669 . . . . 0.0 109.42 179.864 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.537 ' O ' ' HB2' ' B' ' 66' ' ' GLN . 19.5 p -71.33 -6.35 39.35 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.396 -1.44 . . . . 0.0 110.065 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 66' ' ' GLN . . . . . 0.654 ' HA ' ' O ' ' B' ' 62' ' ' ASN . 9.3 mm100 77.71 106.6 0.08 Allowed 'General case' 0 N--CA 1.504 2.252 0 CA-C-O 121.602 0.715 . . . . 0.0 111.968 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 67' ' ' GLU . . . . . 0.599 ' O ' ' HG ' ' B' ' 69' ' ' LEU . 10.9 mt-10 138.95 93.27 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 68' ' ' ALA . . . . . 0.719 ' HA ' ' C ' ' B' ' 61' ' ' PHE . . . -41.56 102.03 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.404 0 O-C-N 120.659 -1.275 . . . . 0.0 110.229 -179.007 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.906 HD12 ' CE2' ' B' ' 61' ' ' PHE . 22.0 mt -94.54 -141.87 0.24 Allowed 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.607 -0.683 . . . . 0.0 111.003 -178.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 70' ' ' GLU . . . . . 0.548 ' HA ' ' HB3' ' B' ' 58' ' ' ARG . 2.4 tm-20 177.57 34.78 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.05 -1.031 . . . . 0.0 109.957 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 1.052 HG23 ' HD3' ' B' ' 73' ' ' PRO . 0.0 OUTLIER -66.11 -143.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 O-C-N 120.894 -1.128 . . . . 0.0 112.269 -178.335 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 72' ' ' ALA . . . . . 1.024 ' HA ' ' HA ' ' B' ' 57' ' ' ALA . . . -132.36 28.84 0.16 Allowed Pre-proline 0 N--CA 1.506 2.339 0 N-CA-C 117.138 2.273 . . . . 0.0 117.138 -174.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 73' ' ' PRO . . . . . 1.052 ' HD3' HG23 ' B' ' 71' ' ' ILE . 58.3 Cg_endo -110.32 99.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.303 -1.849 0 C-N-CA 120.635 0.89 . . . . 0.0 114.41 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 74' ' ' SER . . . . . 0.546 ' O ' ' CG ' ' B' ' 56' ' ' GLN . 0.3 OUTLIER -150.33 90.29 1.65 Allowed 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 119.495 -0.882 . . . . 0.0 109.339 176.201 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 75' ' ' VAL . . . . . 1.092 HG11 ' HB3' ' A' ' 89' ' ' ALA . 7.6 p -30.68 145.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.496 0 O-C-N 121.278 -0.889 . . . . 0.0 111.09 -179.259 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 76' ' ' GLY . . . . . 0.602 ' HA3' HG22 ' B' ' 53' ' ' VAL . . . -101.25 78.81 0.4 Allowed Glycine 0 N--CA 1.478 1.495 0 C-N-CA 118.693 -1.718 . . . . 0.0 109.248 -179.309 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.867 HG21 ' HB3' ' A' ' 85' ' ' LEU . 2.4 p -66.74 69.19 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 O-C-N 121.672 -0.899 . . . . 0.0 109.384 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 78' ' ' SER . . . . . 0.564 ' N ' ' O ' ' B' ' 51' ' ' LYS . 0.6 OUTLIER -64.37 174.12 1.79 Allowed 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 118.927 -1.109 . . . . 0.0 110.136 -179.944 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.77 ' CG2' HG22 ' B' ' 50' ' ' ILE . 3.7 p 174.06 176.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 80' ' ' LYS . . . . . 0.614 ' N ' HG22 ' B' ' 79' ' ' VAL . 0.0 OUTLIER 179.68 171.26 0.56 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 120.865 -1.147 . . . . 0.0 110.663 176.91 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 81' ' ' PRO . . . . . 0.575 ' HA ' ' O ' ' B' ' 47' ' ' PHE . 54.8 Cg_endo -94.9 138.84 0.97 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.493 2.128 . . . . 0.0 110.227 177.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 82' ' ' GLY . . . . . 0.516 ' HA3' ' HA ' ' B' ' 47' ' ' PHE . . . -92.64 -164.71 38.17 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 108.248 -1.941 . . . . 0.0 108.248 178.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 83' ' ' GLU . . . . . 0.503 ' O ' ' N ' ' B' ' 87' ' ' LYS . 0.0 OUTLIER -94.46 -18.17 21.75 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.138 -1.213 . . . . 0.0 110.36 179.517 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 14.5 t -61.22 -34.83 75.74 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 177.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.859 ' CG ' HG21 ' A' ' 77' ' ' VAL . 0.9 OUTLIER -86.74 -26.87 23.99 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.283 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 86' ' ' LYS . . . . . 0.813 ' O ' ' HB3' ' B' ' 89' ' ' ALA . 4.4 tttp -79.32 -34.32 42.4 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 177.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 87' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' B' ' 83' ' ' GLU . 15.7 tttt -67.14 -39.56 86.59 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 178.09 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 1.065 ' HB1' ' HB2' ' A' ' 37' ' ' ALA . . . -60.45 -38.0 82.75 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 175.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.847 ' CA ' HD23 ' B' ' 92' ' ' LEU . . . -55.78 -34.99 65.76 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 177.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.687 ' HA ' ' HB2' ' B' ' 94' ' ' TYR . 0.0 OUTLIER -56.91 -32.53 66.03 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 177.346 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.24 -13.27 77.23 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 92' ' ' LEU . . . . . 0.9 ' O ' HD12 ' B' ' 92' ' ' LEU . 0.3 OUTLIER -78.69 16.75 0.8 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.689 -1.477 . . . . 0.0 111.267 -179.883 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 93' ' ' LYS . . . . . 0.594 ' CG ' ' O ' ' B' ' 92' ' ' LEU . 0.1 OUTLIER 86.75 34.55 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -178.324 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 94' ' ' TYR . . . . . 0.775 ' CD2' ' HB ' ' A' ' 75' ' ' VAL . 3.6 t80 -42.09 -62.38 0.94 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.413 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 95' ' ' GLU . . . . . 0.709 ' HA ' ' HB3' ' B' ' 98' ' ' ALA . 26.4 mt-10 -58.39 -32.62 68.77 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.53 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 96' ' ' ASP . . . . . 0.476 ' HB3' ' HG3' ' B' ' 93' ' ' LYS . 0.5 OUTLIER -64.52 -34.77 79.0 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.711 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -83.17 -12.74 56.64 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 177.372 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 98' ' ' ALA . . . . . 0.72 ' HB2' ' N ' ' A' ' 74' ' ' SER . . . -92.79 -16.3 25.53 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.484 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 3.0 mttp . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.203 179.979 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.557 ' SD ' HG21 ' B' ' 35' ' ' THR . 1.4 mtp . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.01 0.433 . . . . 0.0 110.041 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.583 ' H ' ' HB2' ' A' ' 5' ' ' GLU . 47.0 p-10 -177.03 -169.68 0.26 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.295 -0.878 . . . . 0.0 110.44 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.795 ' O ' HD12 ' A' ' 25' ' ' LEU . 2.5 tptm -52.0 -17.38 1.0 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.4 -0.812 . . . . 0.0 110.158 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.435 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 24.4 m -95.49 -54.58 3.33 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.128 -0.983 . . . . 0.0 109.292 178.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.583 ' HB2' ' H ' ' A' ' 2' ' ' ASN . 2.8 mt-10 -62.85 -42.24 99.67 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.446 -0.901 . . . . 0.0 108.631 179.263 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.008 HD11 HG13 ' B' ' 42' ' ' VAL . 23.2 mt -65.35 -31.26 72.28 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 118.899 -1.12 . . . . 0.0 108.585 177.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.887 HG13 HD12 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -57.91 -57.23 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 178.341 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.976 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 18.4 pttt -65.83 -24.33 66.88 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 6' ' ' LEU . . . -60.25 -38.46 83.56 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.089 -1.007 . . . . 0.0 108.451 178.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.818 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.2 mp -88.48 -37.83 10.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 177.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.976 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -61.13 -15.76 36.92 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 119.047 -1.061 . . . . 0.0 108.631 177.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.451 ' HB3' ' O ' ' A' ' 8' ' ' LYS . 53.2 tp60 -111.13 -43.74 3.69 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.605 -0.684 . . . . 0.0 109.237 178.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.603 ' OD2' HG21 ' B' ' 31' ' ' ILE . 35.5 m-20 -62.33 -30.63 71.3 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 177.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.818 ' OG1' ' O ' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -105.03 -70.59 0.77 Allowed 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.122 179.053 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 49.08 26.7 6.32 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.065 ' CD1' HG23 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -87.41 -27.46 22.74 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.48 -1.012 . . . . 0.0 109.042 178.851 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.768 HG21 ' CG2' ' B' ' 17' ' ' THR . 0.4 OUTLIER -159.34 -7.61 0.07 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.982 -0.449 . . . . 0.0 110.169 -179.448 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.62 ' O ' ' C ' ' A' ' 19' ' ' VAL . 5.4 mt-30 58.0 31.2 20.31 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 -176.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.911 HG11 HG11 ' B' ' 19' ' ' VAL . 1.6 p -5.05 -91.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.502 -178.494 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.97 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -132.43 22.99 4.38 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.101 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.701 ' HA ' ' HE2' ' A' ' 24' ' ' MET . 16.0 m -19.41 -38.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 122.331 1.062 . . . . 0.0 109.389 -178.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.862 ' N ' ' O ' ' A' ' 20' ' ' SER . 5.6 t -78.88 -39.24 35.59 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.409 177.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.97 ' N ' ' O ' ' A' ' 20' ' ' SER . 3.1 mtmt -94.85 -28.36 15.27 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.603 -0.686 . . . . 0.0 109.543 178.445 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.701 ' HE2' ' HA ' ' A' ' 21' ' ' VAL 0.261 0.0 OUTLIER -63.09 -42.26 99.56 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.896 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.887 HD12 HG13 ' A' ' 7' ' ' ILE . 0.4 OUTLIER -86.1 -49.16 7.99 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 118.822 -1.151 . . . . 0.0 109.63 177.743 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' A' ' 22' ' ' SER . . . -46.77 -39.66 12.15 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.543 -1.348 . . . . 0.0 108.148 178.126 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.872 ' O ' HG23 ' A' ' 31' ' ' ILE . 55.6 m -78.31 -30.26 48.18 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.934 ' O ' HG13 ' A' ' 31' ' ' ILE . 7.7 t80 -54.79 -47.35 74.08 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.572 -0.705 . . . . 0.0 109.455 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.68 ' HB2' ' HE3' ' A' ' 3' ' ' LYS . 21.4 tt0 -68.78 -34.28 75.3 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 117.577 -1.649 . . . . 0.0 107.177 177.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.953 ' O ' ' HB3' ' A' ' 34' ' ' GLU . 7.8 tttp -69.22 -22.5 63.87 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.375 -0.93 . . . . 0.0 108.821 178.436 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.934 HG13 ' O ' ' A' ' 28' ' ' PHE . 2.3 pp -95.42 -40.43 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 119.364 -0.934 . . . . 0.0 109.66 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 1.054 HG21 ' CE1' ' B' ' 47' ' ' PHE . 6.2 mm -50.31 -50.28 21.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 177.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.694 HG22 ' HG ' ' B' ' 85' ' ' LEU . 7.5 p -69.38 -39.7 77.87 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.046 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.953 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -56.76 -32.86 66.02 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.692 -179.121 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.841 HG21 HG13 ' A' ' 42' ' ' VAL . 2.2 m -85.28 -56.23 3.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.021 -1.072 . . . . 0.0 110.272 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.754 HG13 ' HB3' ' A' ' 52' ' ' PRO . 94.2 t -53.92 -39.56 40.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 118.308 -1.357 . . . . 0.0 108.101 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.733 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -77.69 -3.45 41.16 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.101 -1.04 . . . . 0.0 109.012 177.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.619 ' HB2' ' O ' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -103.04 -26.76 12.95 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.253 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.49 43.29 1.37 Allowed Glycine 0 C--N 1.3 -1.418 0 C-N-CA 120.058 -1.068 . . . . 0.0 110.507 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.838 ' CB ' HG23 ' A' ' 35' ' ' THR . 0.1 OUTLIER -129.01 140.94 51.41 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.179 -1.189 . . . . 0.0 109.979 179.241 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.453 ' O ' ' N ' ' A' ' 43' ' ' GLN . 51.3 mtpt -88.08 89.32 7.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.552 -0.717 . . . . 0.0 110.53 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.841 HG13 HG21 ' A' ' 35' ' ' THR . 27.8 m -61.63 80.31 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.608 -0.683 . . . . 0.0 109.939 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.464 ' O ' ' HA ' ' B' ' 2' ' ' ASN . 1.9 tt0 -84.04 107.24 16.27 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.469 -0.769 . . . . 0.0 109.318 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.953 HD12 ' CB ' ' A' ' 48' ' ' LEU . 65.1 mt -61.89 114.67 3.48 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.138 -0.976 . . . . 0.0 109.179 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.588 HG23 ' HD1' ' A' ' 47' ' ' PHE . 0.0 OUTLIER 33.02 -97.5 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.853 -0.529 . . . . 0.0 111.256 -179.614 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.413 ' H ' HG23 ' A' ' 45' ' ' THR . . . -144.44 28.32 1.93 Allowed Glycine 0 N--CA 1.489 2.201 0 C-N-CA 119.726 -1.226 . . . . 0.0 110.39 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.713 ' CD1' ' HG3' ' B' ' 29' ' ' GLU . 3.6 p90 -126.03 -29.54 3.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.903 -1.351 . . . . 0.0 110.517 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.953 ' CB ' HD12 ' A' ' 44' ' ' LEU . 11.9 mt -123.63 93.12 3.84 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.23 -1.544 . . . . 0.0 110.53 177.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -86.86 86.0 7.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.911 -0.493 . . . . 0.0 110.055 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.854 ' CD1' HG23 ' A' ' 79' ' ' VAL . 1.5 mp -82.97 137.81 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.425 -0.797 . . . . 0.0 110.069 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 13.5 ptmt -153.43 127.94 4.66 Favored Pre-proline 0 N--CA 1.494 1.732 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.472 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.754 ' HB3' HG13 ' A' ' 36' ' ' VAL . 41.1 Cg_endo -65.47 141.33 67.05 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 123.539 1.284 . . . . 0.0 111.894 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.732 HG22 ' O ' ' A' ' 76' ' ' GLY . 33.4 m -147.66 117.69 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 CA-C-O 121.326 0.584 . . . . 0.0 111.244 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.799 ' HB1' ' O ' ' A' ' 73' ' ' PRO . . . -62.12 131.25 48.91 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.309 -0.869 . . . . 0.0 112.278 -178.484 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.528 ' H ' ' C ' ' A' ' 74' ' ' SER . 0.6 OUTLIER -176.16 106.75 0.08 Allowed 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.631 0.729 . . . . 0.0 110.358 179.548 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.657 ' CB ' ' H ' ' A' ' 74' ' ' SER . 0.9 OUTLIER -172.18 19.11 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.561 -0.712 . . . . 0.0 110.018 179.227 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.586 ' HB3' HG23 ' A' ' 71' ' ' ILE . . . -172.07 169.16 5.67 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.181 -0.95 . . . . 0.0 110.355 -177.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.935 ' N ' HG21 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -144.66 174.68 10.76 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.33 -0.857 . . . . 0.0 110.26 178.21 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.769 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . 1.1 tttm -169.06 -139.14 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.127 -0.983 . . . . 0.0 111.006 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.09 98.94 0.24 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.551 ' HA ' ' O ' ' A' ' 67' ' ' GLU . 48.0 p90 -53.3 170.95 0.08 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.435 -1.038 . . . . 0.0 110.91 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.535 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 0.3 OUTLIER -59.12 -165.32 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.937 0 O-C-N 121.622 -0.674 . . . . 0.0 109.361 179.817 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.535 ' HD2' ' HB3' ' A' ' 62' ' ' ASN . 44.5 Cg_endo -75.99 60.23 6.08 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 N-CA-C 109.133 -1.141 . . . . 0.0 109.133 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.435 ' C ' ' CE1' ' A' ' 61' ' ' PHE . 24.1 mt-30 -139.8 -109.48 0.16 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.509 -0.744 . . . . 0.0 110.534 -179.177 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.46 ' HA ' ' CZ ' ' A' ' 61' ' ' PHE . 6.7 t -175.34 29.08 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.895 -1.128 . . . . 0.0 110.829 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -174.18 -26.8 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.025 -1.047 . . . . 0.0 111.918 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.714 ' O ' HD23 ' A' ' 69' ' ' LEU . 9.8 mt-10 -72.29 65.02 0.59 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.905 -1.122 . . . . 0.0 110.227 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.502 ' CB ' ' HB2' ' A' ' 58' ' ' ARG . . . -64.63 133.06 51.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.697 -0.627 . . . . 0.0 110.941 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.778 ' O ' HD12 ' A' ' 69' ' ' LEU . 1.5 pp -174.71 56.41 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.252 -0.905 . . . . 0.0 111.053 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.586 ' CB ' ' HB3' ' A' ' 59' ' ' LYS . 1.6 tt0 -131.29 19.21 4.86 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.765 -1.21 . . . . 0.0 110.697 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.935 HG21 ' N ' ' A' ' 58' ' ' ARG 0.301 16.6 tt -111.99 -138.76 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.516 -0.74 . . . . 0.0 110.647 -178.832 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.709 ' H ' HG12 ' A' ' 71' ' ' ILE . . . -117.9 81.43 15.66 Favored Pre-proline 0 C--N 1.3 -1.557 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -176.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.956 ' HD2' ' HB1' ' B' ' 98' ' ' ALA . 45.0 Cg_endo -70.45 122.64 9.12 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 O-C-N 123.896 1.471 . . . . 0.0 111.285 177.239 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.885 ' HA ' ' CD1' ' B' ' 94' ' ' TYR . 14.7 t -76.6 129.51 36.51 Favored 'General case' 0 N--CA 1.51 2.571 0 CA-C-O 121.644 0.735 . . . . 0.0 112.807 -178.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 1.029 ' HB ' ' HB1' ' B' ' 89' ' ' ALA . 38.2 t -54.19 138.48 13.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-O 122.162 0.982 . . . . 0.0 109.975 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.732 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -126.57 105.62 0.79 Allowed Glycine 0 C--N 1.29 -1.998 0 N-CA-C 108.015 -2.034 . . . . 0.0 108.015 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.771 HG13 ' O ' ' A' ' 77' ' ' VAL . 13.2 p -51.02 89.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.678 -0.895 . . . . 0.0 110.476 -178.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.504 ' N ' ' O ' ' A' ' 76' ' ' GLY . 0.5 OUTLIER -58.58 -171.92 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.281 -0.887 . . . . 0.0 110.729 -179.14 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.854 HG23 ' CD1' ' A' ' 50' ' ' ILE . 3.3 p -167.48 -164.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.693 ' H ' HG22 ' A' ' 79' ' ' VAL . 2.0 mttm -160.08 178.59 1.61 Allowed Pre-proline 0 C--N 1.308 -1.211 0 O-C-N 120.914 -1.116 . . . . 0.0 111.335 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.447 ' CD ' ' CB ' ' A' ' 80' ' ' LYS . 55.5 Cg_endo -103.64 83.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 123.977 3.118 . . . . 0.0 108.862 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.651 ' CA ' ' O ' ' A' ' 47' ' ' PHE . . . -57.0 121.63 25.94 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.591 -1.29 . . . . 0.0 111.183 -178.089 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -62.19 -35.74 79.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.53 -0.982 . . . . 0.0 109.043 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.596 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 0.3 OUTLIER -53.94 -30.85 48.35 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.586 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.987 HD21 HG11 ' B' ' 36' ' ' VAL . 8.8 tt -85.26 -34.23 21.99 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.742 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 0.3 OUTLIER -75.35 -44.75 43.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.542 -0.724 . . . . 0.0 109.446 179.606 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 41.4 tptt -64.98 -38.26 90.38 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 177.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.828 ' O ' ' HB1' ' B' ' 37' ' ' ALA . . . -61.65 -36.63 81.35 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 176.358 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.742 ' HB3' ' O ' ' A' ' 86' ' ' LYS . . . -56.42 -39.68 73.46 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.492 ' HA ' ' CB ' ' A' ' 94' ' ' TYR . 6.4 mm-40 -55.9 -28.89 58.81 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 176.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 88' ' ' ALA . . . -65.72 -50.84 51.56 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 178.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.718 HD11 ' CE1' ' A' ' 97' ' ' PHE . 0.4 OUTLIER -59.85 -37.2 78.61 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.417 -1.637 . . . . 0.0 109.64 -179.745 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.596 ' CB ' ' O ' ' A' ' 92' ' ' LEU . 1.1 ttmt 143.82 65.23 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 1.345 ' O ' ' N ' ' A' ' 96' ' ' ASP . 7.7 t80 -49.11 -60.74 2.53 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 116.328 -2.149 . . . . 0.0 106.45 178.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 1.095 ' C ' ' O ' ' A' ' 94' ' ' TYR . 3.8 mm-40 10.96 41.9 0.0 OUTLIER 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 102.291 -3.226 . . . . 0.0 102.291 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 1.345 ' N ' ' O ' ' A' ' 94' ' ' TYR . 0.3 OUTLIER 21.13 43.18 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 113.533 -1.667 . . . . 0.0 107.626 -172.916 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.849 ' N ' ' O ' ' A' ' 94' ' ' TYR 0.254 1.0 OUTLIER 27.83 28.44 0.0 OUTLIER 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 101.677 -3.453 . . . . 0.0 101.677 -170.35 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 1.061 ' N ' ' O ' ' A' ' 96' ' ' ASP . . . -68.52 -30.93 69.85 Favored 'General case' 0 C--O 1.215 -0.733 0 CA-C-N 110.292 -3.14 . . . . 0.0 109.559 -178.382 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 26.2 mttm . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.196 179.993 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.659 ' HG2' HG12 ' A' ' 42' ' ' VAL . 1.6 tpt . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 120.855 0.36 . . . . 0.0 110.401 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 2' ' ' ASN . . . . . 0.475 ' HB3' ' O ' ' B' ' 1' ' ' MET . 25.9 p30 179.6 -160.49 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.343 -0.943 . . . . 0.0 111.41 178.05 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.559 ' HE3' ' CG2' ' A' ' 45' ' ' THR . 0.1 OUTLIER -52.56 -10.45 0.15 Allowed 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.419 -0.801 . . . . 0.0 110.814 -179.705 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.502 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 4.4 m -106.43 -51.5 2.94 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.861 -1.149 . . . . 0.0 109.495 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.607 ' CB ' ' HA ' ' B' ' 1' ' ' MET . 1.3 mt-10 -65.46 -37.84 88.05 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.217 -0.927 . . . . 0.0 108.637 179.348 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.81 HD11 ' HB ' ' A' ' 42' ' ' VAL . 24.6 mt -71.88 -27.95 63.2 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 118.892 -1.123 . . . . 0.0 108.214 177.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 7' ' ' ILE . . . . . 0.786 HG23 ' HB ' ' B' ' 21' ' ' VAL . 0.2 OUTLIER -57.31 -60.78 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 177.542 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 8' ' ' LYS . . . . . 0.941 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.0 OUTLIER -62.8 -24.1 67.57 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.581 178.443 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 9' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' B' ' 6' ' ' LEU . . . -60.83 -36.28 78.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.04 -1.038 . . . . 0.0 108.674 178.226 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.915 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.0 OUTLIER -96.56 -35.19 5.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 178.535 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.941 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -60.34 -25.12 65.58 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -91.27 -43.25 9.92 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 178.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.482 ' HB3' ' CB ' ' A' ' 27' ' ' SER . 1.1 m-20 -64.33 -26.11 68.33 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 177.149 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.915 ' OG1' ' O ' ' B' ' 10' ' ' ILE . 10.7 p -91.78 -75.1 0.49 Allowed 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 177.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 15' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' B' ' 11' ' ' ALA . . . 57.75 17.78 29.24 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 178.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 16' ' ' LEU . . . . . 0.896 HD22 ' O ' ' A' ' 19' ' ' VAL . 3.8 mp -77.54 -57.13 3.98 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 122.317 1.056 . . . . 0.0 108.532 178.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 17' ' ' THR . . . . . 0.768 ' CG2' HG21 ' A' ' 17' ' ' THR . 0.5 OUTLIER -142.67 5.54 1.59 Allowed 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 115.162 -0.927 . . . . 0.0 109.18 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 18' ' ' GLN . . . . . 0.622 ' O ' ' C ' ' B' ' 19' ' ' VAL . 3.9 mt-30 58.26 25.24 12.43 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 -176.134 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 1.065 HG23 ' CD1' ' A' ' 16' ' ' LEU . 0.2 OUTLIER 9.43 -98.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.437 -178.954 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 20' ' ' SER . . . . . 1.051 ' O ' ' N ' ' B' ' 22' ' ' SER . 1.9 p -136.6 24.14 3.15 Favored 'General case' 0 C--N 1.273 -2.733 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 177.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.786 ' HB ' HG23 ' B' ' 7' ' ' ILE . 21.9 m -4.35 -42.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 CA-C-O 122.528 1.156 . . . . 0.0 110.763 -177.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 22' ' ' SER . . . . . 1.051 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.5 OUTLIER -76.62 -38.09 55.31 Favored 'General case' 0 C--N 1.281 -2.407 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.2 178.724 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 23' ' ' LYS . . . . . 0.882 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.0 OUTLIER -89.19 -32.79 17.28 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.437 -0.79 . . . . 0.0 111.302 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 24' ' ' MET . . . . . 0.594 ' HG2' HG22 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -68.83 -37.7 79.35 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 117.322 -1.751 . . . . 0.0 108.736 179.683 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.698 ' HA ' ' HB3' ' B' ' 28' ' ' PHE . 0.3 OUTLIER -82.91 -44.39 15.43 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 118.21 -1.396 . . . . 0.0 109.669 178.234 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 26' ' ' ALA . . . . . 0.541 ' HA ' ' CE ' ' B' ' 3' ' ' LYS . . . -58.4 -35.36 71.9 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.957 -1.089 . . . . 0.0 108.2 178.152 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 27' ' ' SER . . . . . 0.554 ' O ' HG13 ' B' ' 31' ' ' ILE . 20.0 t -81.68 -30.99 32.43 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.468 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 28' ' ' PHE . . . . . 0.738 ' CZ ' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -54.51 -45.09 73.23 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 178.793 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 29' ' ' GLU . . . . . 0.713 ' HG3' ' CD1' ' A' ' 47' ' ' PHE . 1.5 tt0 -69.93 -34.83 73.97 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 176.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 1.128 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 7.2 tttp -63.95 -18.27 64.08 Favored 'General case' 0 C--O 1.189 -2.112 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 177.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.69 ' CG1' ' HA ' ' B' ' 28' ' ' PHE . 1.2 pp -108.53 -26.08 3.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 120.32 -1.487 . . . . 0.0 108.617 177.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.624 HD11 ' CE2' ' B' ' 28' ' ' PHE . 1.1 mm -73.42 -57.02 7.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 176.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 33' ' ' THR . . . . . 0.561 ' OG1' ' HB2' ' A' ' 85' ' ' LEU . 0.5 OUTLIER -67.19 -40.88 86.59 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.335 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 1.128 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 76.9 mm-40 -74.72 -40.69 61.15 Favored 'General case' 0 C--O 1.207 -1.138 0 O-C-N 121.4 -0.813 . . . . 0.0 112.513 -179.08 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 35' ' ' THR . . . . . 0.557 HG21 ' SD ' ' A' ' 1' ' ' MET . 53.3 m -59.51 -49.11 79.05 Favored 'General case' 0 N--CA 1.505 2.284 0 CA-C-N 120.797 1.635 . . . . 0.0 109.469 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.987 HG11 HD21 ' A' ' 85' ' ' LEU . 1.4 t -53.0 -41.77 42.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 C-N-CA 118.266 -1.374 . . . . 0.0 107.345 178.386 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 0.828 ' HB1' ' O ' ' A' ' 88' ' ' ALA . . . -92.7 11.57 26.33 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.717 -0.793 . . . . 0.0 109.745 178.209 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 38' ' ' LYS . . . . . 0.704 ' HB2' ' O ' ' B' ' 34' ' ' GLU . 1.4 tppt? -104.76 -29.26 10.67 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 177.112 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.82 34.56 0.43 Allowed Glycine 0 C--N 1.305 -1.183 0 C-N-CA 119.835 -1.174 . . . . 0.0 111.042 177.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 40' ' ' ASP . . . . . 0.49 ' HB2' HG23 ' B' ' 35' ' ' THR . 0.1 OUTLIER -150.94 179.82 7.92 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.869 -1.371 . . . . 0.0 110.785 179.638 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.409 ' O ' ' HG3' ' B' ' 43' ' ' GLN . 5.0 mtmp? -133.2 113.6 12.86 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 1.008 HG13 HD11 ' A' ' 6' ' ' LEU . 59.2 t -61.24 140.52 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.441 -0.787 . . . . 0.0 110.499 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 43' ' ' GLN . . . . . 0.5 ' HA ' ' HA ' ' B' ' 49' ' ' ASN . 43.6 mt-30 -140.53 82.91 1.87 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.524 -0.735 . . . . 0.0 109.826 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.749 HD12 ' HB3' ' B' ' 48' ' ' LEU . 5.6 mt -59.79 117.5 5.07 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.274 -0.891 . . . . 0.0 110.704 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 45' ' ' THR . . . . . 0.594 HG23 ' CD2' ' B' ' 47' ' ' PHE . 0.0 OUTLIER 24.38 -92.73 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.243 0 O-C-N 122.16 -0.337 . . . . 0.0 111.436 179.062 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.488 ' H ' HG23 ' B' ' 45' ' ' THR . . . -146.54 48.3 0.67 Allowed Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 47' ' ' PHE . . . . . 1.054 ' CE1' HG21 ' A' ' 32' ' ' ILE . 16.5 p90 -151.27 -40.09 0.12 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.963 -1.316 . . . . 0.0 111.671 179.11 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.863 HD13 ' CB ' ' B' ' 80' ' ' LYS . 0.0 OUTLIER -116.86 107.94 15.22 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.703 -1.248 . . . . 0.0 110.378 179.401 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 49' ' ' ASN . . . . . 0.945 ' O ' ' O ' ' B' ' 79' ' ' VAL . 0.8 OUTLIER -124.54 97.49 5.32 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.997 -1.064 . . . . 0.0 110.606 -179.495 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 50' ' ' ILE . . . . . 0.508 ' H ' ' HD3' ' B' ' 80' ' ' LYS . 0.5 OUTLIER -88.56 143.89 10.27 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 O-C-N 121.496 -0.753 . . . . 0.0 110.883 -179.211 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 51' ' ' LYS . . . . . 0.55 ' HG3' ' HB2' ' B' ' 78' ' ' SER . 0.0 OUTLIER -159.88 136.69 6.66 Favored Pre-proline 0 N--CA 1.495 1.792 0 C-N-CA 119.416 -0.914 . . . . 0.0 110.023 179.6 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.736 ' HB3' HG13 ' B' ' 36' ' ' VAL . 56.6 Cg_endo -89.28 144.86 4.98 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.752 1.396 . . . . 0.0 112.58 -178.305 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.59 HG22 ' O ' ' B' ' 76' ' ' GLY . 33.3 m -144.23 113.16 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-O 121.655 0.741 . . . . 0.0 109.709 177.226 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.788 ' HB2' ' CD2' ' A' ' 97' ' ' PHE . . . -45.02 120.22 2.29 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 122.0 0.905 . . . . 0.0 112.462 -178.063 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 55' ' ' ARG . . . . . 0.437 ' N ' ' OD1' ' A' ' 96' ' ' ASP . 0.4 OUTLIER -141.79 93.75 2.59 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.895 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 56' ' ' GLN . . . . . 0.651 ' O ' HD11 ' B' ' 71' ' ' ILE . 0.0 OUTLIER -52.81 -176.14 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.404 -0.81 . . . . 0.0 111.543 -178.513 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.868 ' HB2' ' HD3' ' B' ' 73' ' ' PRO . . . -73.63 -158.91 0.06 Allowed 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.57 0.7 . . . . 0.0 110.872 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 58' ' ' ARG . . . . . 0.445 ' HB2' HG12 ' B' ' 71' ' ' ILE . 0.0 OUTLIER -158.38 175.16 14.07 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.772 -0.58 . . . . 0.0 109.92 -179.629 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 2.9 tptt -176.82 93.35 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.232 -0.918 . . . . 0.0 110.433 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 60' ' ' GLY . . . . . 0.596 ' HA2' ' HB1' ' B' ' 68' ' ' ALA . . . 97.13 52.72 1.45 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 61' ' ' PHE . . . . . 0.781 ' O ' ' CB ' ' B' ' 62' ' ' ASN . 21.3 t80 -76.62 164.37 25.97 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.266 -1.138 . . . . 0.0 111.305 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 62' ' ' ASN . . . . . 0.781 ' CB ' ' O ' ' B' ' 61' ' ' PHE . 2.7 t30 138.83 -36.58 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.035 0 O-C-N 121.721 -0.612 . . . . 0.0 110.45 178.215 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.753 ' HD2' ' N ' ' B' ' 62' ' ' ASN . 38.4 Cg_endo -66.49 -17.25 53.12 Favored 'Trans proline' 0 C--N 1.316 -1.167 0 N-CA-C 108.069 -1.551 . . . . 0.0 108.069 177.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 64' ' ' GLN . . . . . 0.704 ' O ' HG23 ' B' ' 65' ' ' THR . 0.9 OUTLIER -74.56 -72.87 0.26 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.704 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.704 HG23 ' O ' ' B' ' 64' ' ' GLN . 0.0 OUTLIER -176.24 20.05 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.854 -0.529 . . . . 0.0 110.317 178.753 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 66' ' ' GLN . . . . . 0.713 ' HB2' ' CE1' ' B' ' 61' ' ' PHE . 0.1 OUTLIER -138.93 -141.66 0.15 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.073 -1.017 . . . . 0.0 109.696 179.864 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 67' ' ' GLU . . . . . 0.599 ' O ' ' HD1' ' B' ' 61' ' ' PHE . 25.5 mt-10 -105.74 -157.27 0.61 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 177.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 68' ' ' ALA . . . . . 0.859 ' C ' HD23 ' B' ' 69' ' ' LEU . . . -108.03 133.76 51.88 Favored 'General case' 0 C--N 1.287 -2.129 0 C-N-CA 118.406 -1.318 . . . . 0.0 110.948 179.163 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.859 HD23 ' C ' ' B' ' 68' ' ' ALA . 0.0 OUTLIER -140.0 144.58 37.04 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.786 -178.571 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -114.85 68.02 0.7 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.412 -0.805 . . . . 0.0 110.344 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.651 HD11 ' O ' ' B' ' 56' ' ' GLN . 1.5 pt -60.38 -159.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.89 . . . . 0.0 110.344 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.71 154.09 66.85 Favored Pre-proline 0 C--N 1.302 -1.466 0 O-C-N 121.375 -0.828 . . . . 0.0 110.97 -178.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 73' ' ' PRO . . . . . 0.868 ' HD3' ' HB2' ' B' ' 57' ' ' ALA . 44.0 Cg_endo -71.25 116.73 4.81 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.225 1.645 . . . . 0.0 110.322 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 74' ' ' SER . . . . . 0.492 ' HA ' ' CD1' ' A' ' 94' ' ' TYR . 4.5 p -179.27 171.4 1.31 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.33 -0.856 . . . . 0.0 109.676 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 75' ' ' VAL . . . . . 0.715 HG11 ' CB ' ' A' ' 89' ' ' ALA . 6.1 p -52.64 175.24 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.252 -0.905 . . . . 0.0 109.416 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 76' ' ' GLY . . . . . 0.59 ' O ' HG22 ' B' ' 53' ' ' VAL . . . -118.26 45.14 1.3 Allowed Glycine 0 N--CA 1.488 2.16 0 C-N-CA 118.898 -1.62 . . . . 0.0 109.825 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.877 ' CG2' HD22 ' A' ' 85' ' ' LEU . 6.5 p -28.13 91.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 122.061 -0.67 . . . . 0.0 110.828 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 78' ' ' SER . . . . . 0.55 ' HB2' ' HG3' ' B' ' 51' ' ' LYS . 57.7 m -57.91 -122.12 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 119.864 -0.734 . . . . 0.0 109.102 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.945 ' O ' ' O ' ' B' ' 49' ' ' ASN . 4.5 m -148.41 -168.88 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 119.859 -1.776 . . . . 0.0 112.868 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 80' ' ' LYS . . . . . 0.888 ' H ' ' HD2' ' B' ' 81' ' ' PRO . 0.0 OUTLIER -114.58 -52.92 0.04 OUTLIER Pre-proline 0 C--N 1.301 -1.531 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -178.403 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 81' ' ' PRO . . . . . 0.888 ' HD2' ' H ' ' B' ' 80' ' ' LYS . 26.7 Cg_endo -49.49 130.59 25.99 Favored 'Trans proline' 0 C--N 1.298 -2.106 0 C-N-CA 120.869 1.046 . . . . 0.0 112.551 -175.164 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -128.04 -62.8 0.13 Allowed Glycine 0 N--CA 1.486 1.981 0 N-CA-C 105.856 -2.897 . . . . 0.0 105.856 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 83' ' ' GLU . . . . . 0.885 ' O ' ' N ' ' B' ' 85' ' ' LEU . 26.3 tt0 -91.03 47.6 1.42 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.514 -1.662 . . . . 0.0 106.514 175.322 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 84' ' ' SER . . . . . 1.286 ' O ' ' N ' ' B' ' 86' ' ' LYS . 4.5 m 8.45 43.79 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.506 1.146 . . . . 0.0 110.875 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 1.026 ' C ' ' O ' ' B' ' 84' ' ' SER . 4.3 mp 22.01 29.66 0.0 OUTLIER 'General case' 0 C--O 1.194 -1.831 0 N-CA-C 103.599 -2.741 . . . . 0.0 103.599 -171.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 86' ' ' LYS . . . . . 1.286 ' N ' ' O ' ' B' ' 84' ' ' SER 0.319 6.5 tttm -51.85 -34.78 42.13 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 103.459 -2.793 . . . . 0.0 103.459 175.997 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 87' ' ' LYS . . . . . 0.456 ' O ' ' CG ' ' B' ' 90' ' ' GLU 0.286 16.8 tptp -68.01 -36.2 79.58 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 111.773 -2.467 . . . . 0.0 106.609 175.565 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.919 ' HB3' ' HB3' ' B' ' 85' ' ' LEU . . . -80.38 -26.2 38.7 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 118.349 -1.34 . . . . 0.0 107.764 177.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 1.029 ' HB1' ' HB ' ' A' ' 75' ' ' VAL . . . -67.27 -50.11 61.74 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.53 -0.731 . . . . 0.0 109.051 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.456 ' CG ' ' O ' ' B' ' 87' ' ' LYS . 6.5 pt-20 -57.03 -27.83 61.98 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 176.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 91' ' ' GLY . . . . . 0.44 ' N ' ' HG3' ' B' ' 90' ' ' GLU . . . -63.32 -38.25 96.13 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 178.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 92' ' ' LEU . . . . . 0.843 HD23 ' HA ' ' B' ' 89' ' ' ALA . 0.9 OUTLIER -85.37 23.48 1.31 Allowed 'General case' 0 N--CA 1.503 2.222 0 O-C-N 120.493 -1.592 . . . . 0.0 110.5 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 93' ' ' LYS . . . . . 0.458 ' O ' ' N ' ' B' ' 96' ' ' ASP . 0.4 OUTLIER 58.58 48.17 12.24 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 -177.659 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 94' ' ' TYR . . . . . 0.885 ' CD1' ' HA ' ' A' ' 74' ' ' SER . 0.0 OUTLIER -42.98 -37.11 1.77 Allowed 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.762 -178.51 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 95' ' ' GLU . . . . . 0.469 ' N ' ' CD1' ' B' ' 94' ' ' TYR . 8.8 pt-20 -53.85 -39.48 65.65 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.258 -0.901 . . . . 0.0 109.097 178.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 96' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' B' ' 93' ' ' LYS . 0.2 OUTLIER -65.96 -28.5 68.95 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.308 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -97.65 2.62 50.0 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.549 -0.719 . . . . 0.0 109.185 178.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 98' ' ' ALA . . . . . 0.956 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -94.58 -33.88 12.85 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.59 -0.694 . . . . 0.0 110.278 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 19.8 mttt . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.261 179.937 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.575 ' CE ' HD23 ' A' ' 6' ' ' LEU . 3.8 mtp . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 120.908 0.385 . . . . 0.0 110.064 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.805 ' C ' HD12 ' A' ' 6' ' ' LEU . 27.3 p30 -177.82 -167.75 0.16 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.215 -0.928 . . . . 0.0 111.28 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.607 ' HG2' HD13 ' A' ' 25' ' ' LEU . 12.7 tttt -51.31 -16.63 0.56 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.555 -0.716 . . . . 0.0 110.252 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.609 ' O ' HG12 ' A' ' 7' ' ' ILE . 41.0 m -104.69 -58.95 1.81 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.263 -0.898 . . . . 0.0 110.271 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.455 ' HB2' ' H ' ' A' ' 2' ' ' ASN . 3.5 mm-40 -54.88 -45.54 74.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.125 -0.985 . . . . 0.0 109.762 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.805 HD12 ' C ' ' A' ' 2' ' ' ASN . 12.0 mt -52.04 -45.85 64.81 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.389 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.72 HG21 HD22 ' A' ' 25' ' ' LEU . 0.6 OUTLIER -56.36 -45.99 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 178.271 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.866 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 0.9 OUTLIER -56.67 -39.94 74.65 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 176.828 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.913 ' CB ' HD13 ' B' ' 31' ' ' ILE . . . -54.85 -35.71 64.3 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 178.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.768 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.5 mp -88.33 -32.45 5.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 177.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.866 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -67.89 -10.84 56.5 Favored 'General case' 0 C--N 1.287 -2.12 0 C-N-CA 118.999 -1.08 . . . . 0.0 108.969 178.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.449 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -120.6 -34.73 3.53 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.356 -0.84 . . . . 0.0 110.333 179.157 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.479 ' HB3' ' HB2' ' B' ' 27' ' ' SER . 0.9 OUTLIER -74.94 -36.88 62.11 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 176.823 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . 1.113 HG22 ' CD1' ' A' ' 16' ' ' LEU 0.268 0.2 OUTLIER -91.96 -70.28 0.7 Allowed 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 177.95 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 54.45 21.49 20.56 Favored Glycine 0 N--CA 1.5 2.908 0 O-C-N 121.534 -0.729 . . . . 0.0 111.445 177.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.113 ' CD1' HG22 ' A' ' 14' ' ' THR . 5.0 mp -64.7 -62.87 1.31 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.362 -1.081 . . . . 0.0 109.01 178.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.675 HG21 HG21 ' B' ' 17' ' ' THR . 0.5 OUTLIER -138.82 6.45 2.44 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.866 -179.815 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.594 ' O ' ' C ' ' A' ' 19' ' ' VAL . 6.3 mt-30 57.53 26.92 13.32 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 -176.107 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 1.057 HG11 HG11 ' B' ' 19' ' ' VAL . 1.2 p -0.83 -95.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.802 -178.132 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.96 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -133.2 25.79 4.19 Favored 'General case' 0 C--N 1.277 -2.575 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 179.005 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.66 ' HA ' ' CE ' ' A' ' 24' ' ' MET . 31.0 m -19.1 -39.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 CA-C-O 122.483 1.135 . . . . 0.0 109.505 -178.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.854 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.6 OUTLIER -77.7 -40.47 41.25 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.362 177.522 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.96 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -85.6 -38.94 17.88 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 121.543 -0.723 . . . . 0.0 111.577 179.891 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.66 ' CE ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -66.22 -27.21 67.8 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 117.315 -1.754 . . . . 0.0 108.176 179.368 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.72 HD22 HG21 ' A' ' 7' ' ' ILE . 0.4 OUTLIER -74.64 -45.1 47.07 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 118.827 -1.149 . . . . 0.0 108.838 177.933 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.672 ' N ' ' HG ' ' A' ' 25' ' ' LEU . . . -63.99 -25.27 68.05 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 178.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.568 ' HA ' ' HB3' ' A' ' 30' ' ' LYS . 19.1 p -85.3 -41.03 15.9 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.424 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.692 ' CE1' HD22 ' B' ' 44' ' ' LEU . 0.0 OUTLIER -57.33 -48.23 79.52 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.087 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.587 ' HG3' ' CE2' ' B' ' 47' ' ' PHE . 0.7 OUTLIER -68.6 -35.14 76.94 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.034 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 1.248 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 13.8 ttmt -64.85 -22.13 66.93 Favored 'General case' 0 C--O 1.191 -2.023 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 177.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.881 HD13 ' CB ' ' B' ' 9' ' ' ALA . 0.6 OUTLIER -105.08 -28.44 2.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 120.068 -1.645 . . . . 0.0 109.17 178.076 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.651 HG21 ' CE1' ' B' ' 47' ' ' PHE . 1.2 mm -72.24 -61.15 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 176.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.819 ' HA ' HD23 ' B' ' 85' ' ' LEU . 0.5 OUTLIER -67.8 -35.27 78.34 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.282 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 1.248 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 27.4 mm-40 -77.8 -32.31 52.32 Favored 'General case' 0 N--CA 1.482 1.138 0 O-C-N 120.958 -1.089 . . . . 0.0 111.214 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.748 HG23 ' CB ' ' A' ' 40' ' ' ASP . 1.8 m -59.3 -50.93 72.11 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.32 -1.488 . . . . 0.0 107.457 178.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.05 HG21 HG23 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -53.89 -36.49 30.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 C-N-CA 117.918 -1.513 . . . . 0.0 107.006 177.868 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.606 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -80.43 -7.86 59.31 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.677 0.751 . . . . 0.0 109.632 177.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.555 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -100.26 -8.21 23.73 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 177.566 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 80.47 47.49 6.82 Favored Glycine 0 C--N 1.302 -1.316 0 N-CA-C 110.201 -1.159 . . . . 0.0 110.201 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.748 ' CB ' HG23 ' A' ' 35' ' ' THR . 0.3 OUTLIER -130.28 119.51 22.97 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.295 -1.121 . . . . 0.0 110.314 179.594 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -76.09 81.9 2.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.479 -0.763 . . . . 0.0 109.519 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.86 ' CG2' HD11 ' B' ' 6' ' ' LEU . 5.9 p -63.6 144.91 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.439 -0.788 . . . . 0.0 110.253 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -128.01 98.87 5.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.502 -0.749 . . . . 0.0 109.876 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.75 HD12 ' HB3' ' A' ' 48' ' ' LEU . 8.7 mt -61.62 108.22 0.94 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.256 -0.902 . . . . 0.0 109.495 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.55 HG21 ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER 31.12 -91.77 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.315 0 O-C-N 122.003 -0.436 . . . . 0.0 111.189 -179.669 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -149.48 32.36 1.12 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.738 ' CD1' HD21 ' A' ' 85' ' ' LEU . 2.1 p90 -134.92 -23.04 1.57 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.031 -1.276 . . . . 0.0 111.936 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.872 HD23 ' O ' ' A' ' 80' ' ' LYS . 5.0 mt -130.82 118.23 20.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.259 -1.525 . . . . 0.0 111.166 178.171 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.447 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 2.1 m-20 -115.92 93.57 4.31 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.544 -0.723 . . . . 0.0 110.513 -179.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.866 HG23 HG22 ' A' ' 79' ' ' VAL . 9.5 mm -87.63 132.94 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.313 -0.867 . . . . 0.0 109.282 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.501 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 0.5 OUTLIER -149.85 126.06 5.16 Favored Pre-proline 0 N--CA 1.497 1.895 0 C-N-CA 118.57 -1.252 . . . . 0.0 111.038 179.959 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.881 ' HB3' HG22 ' A' ' 36' ' ' VAL . 56.1 Cg_endo -81.48 138.95 11.16 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.439 1.231 . . . . 0.0 110.51 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.706 HG22 ' O ' ' A' ' 76' ' ' GLY . 28.6 m -140.84 115.61 6.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-O 121.546 0.689 . . . . 0.0 110.377 179.268 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.491 ' HB2' ' HB3' ' B' ' 97' ' ' PHE . . . -41.99 129.21 3.58 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.824 0.821 . . . . 0.0 112.139 -178.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -153.72 151.61 29.82 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -123.57 -171.97 2.42 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.12 -0.987 . . . . 0.0 110.957 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.721 ' HB3' ' N ' ' A' ' 72' ' ' ALA . . . -165.5 156.02 13.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.525 -0.734 . . . . 0.0 109.61 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.754 ' HA ' ' HB ' ' A' ' 71' ' ' ILE . 78.1 mmt-85 -152.3 157.96 42.1 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.131 -0.98 . . . . 0.0 111.687 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.884 ' N ' HG22 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -117.48 168.63 10.21 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.385 -0.822 . . . . 0.0 110.053 179.145 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.636 ' CA ' ' HB1' ' A' ' 68' ' ' ALA . . . 60.61 15.45 40.38 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.131 -1.587 . . . . 0.0 109.131 -179.201 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.89 ' HB3' ' HG ' ' A' ' 69' ' ' LEU . 8.7 t80 -57.99 172.03 0.46 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.316 -1.108 . . . . 0.0 111.317 -179.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.769 ' CB ' ' O ' ' A' ' 61' ' ' PHE . 1.9 t-20 145.56 -37.72 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.088 0 O-C-N 121.633 -0.667 . . . . 0.0 110.984 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.688 ' HD2' ' N ' ' A' ' 62' ' ' ASN . 40.9 Cg_endo -68.85 -5.71 16.24 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 O-C-N 122.963 0.98 . . . . 0.0 109.639 178.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.589 ' HB2' ' CE2' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -103.33 -43.53 5.41 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.28 -0.888 . . . . 0.0 110.087 179.282 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.635 HG22 ' O ' ' A' ' 65' ' ' THR . 100.0 m -147.65 18.82 1.16 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.508 -0.745 . . . . 0.0 109.941 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.677 ' O ' ' CB ' ' A' ' 67' ' ' GLU . 0.1 OUTLIER 55.17 103.62 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.419 -0.801 . . . . 0.0 111.728 179.439 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.677 ' CB ' ' O ' ' A' ' 66' ' ' GLN . 3.0 tt0 139.89 80.88 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.736 ' HA ' ' CA ' ' A' ' 61' ' ' PHE . . . -48.08 148.75 1.64 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.086 -1.008 . . . . 0.0 110.397 -179.037 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.89 ' HG ' ' HB3' ' A' ' 61' ' ' PHE . 6.2 mt -123.53 -135.25 0.29 Allowed 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 119.689 -0.804 . . . . 0.0 112.217 -175.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 58' ' ' ARG . 0.9 OUTLIER -144.63 159.49 42.73 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 -179.369 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.884 HG22 ' N ' ' A' ' 59' ' ' LYS . 0.4 OUTLIER -121.49 170.17 11.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 C-N-CA 118.371 -1.332 . . . . 0.0 113.059 -176.59 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.721 ' N ' ' HB3' ' A' ' 57' ' ' ALA . . . 159.82 72.99 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.628 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.292 -179.346 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.716 ' HD3' HD12 ' A' ' 71' ' ' ILE . 37.3 Cg_endo -60.72 118.56 5.44 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.684 1.36 . . . . 0.0 111.502 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.51 ' HA ' ' CD2' ' B' ' 94' ' ' TYR . 41.9 p -173.73 152.13 1.98 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.683 HG12 ' CB ' ' B' ' 89' ' ' ALA . 0.4 OUTLIER -54.79 177.47 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.822 -1.174 . . . . 0.0 109.67 -179.831 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.706 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -113.49 70.69 0.23 Allowed Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 1.05 HG23 HG21 ' A' ' 36' ' ' VAL . 2.6 p -51.07 79.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.821 -0.811 . . . . 0.0 110.18 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.774 ' O ' HG23 ' A' ' 79' ' ' VAL . 0.7 OUTLIER -73.53 178.16 4.85 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.227 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.866 HG22 HG23 ' A' ' 50' ' ' ILE . 41.8 t -166.5 175.99 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.872 ' O ' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -175.33 169.15 1.56 Allowed Pre-proline 0 C--N 1.308 -1.225 0 O-C-N 120.982 -1.074 . . . . 0.0 110.045 176.662 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.587 ' HB2' HG13 ' B' ' 77' ' ' VAL . 55.8 Cg_endo -103.32 137.84 0.12 Allowed 'Trans proline' 0 C--N 1.3 -1.991 0 C-N-CA 122.962 2.442 . . . . 0.0 110.727 178.217 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.503 ' HA3' ' HA ' ' A' ' 47' ' ' PHE . . . -89.83 -148.11 18.59 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 107.437 -2.265 . . . . 0.0 107.437 177.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.403 ' HA ' ' HB2' ' A' ' 86' ' ' LYS . 2.0 pm0 -101.28 -13.96 17.85 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.064 -1.256 . . . . 0.0 109.803 178.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.458 ' CB ' ' HB3' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -56.5 -32.97 65.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.3 -0.875 . . . . 0.0 108.953 179.161 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.893 HD23 ' HA ' ' B' ' 33' ' ' THR . 0.5 OUTLIER -82.48 -31.73 29.19 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.961 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.456 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 0.1 OUTLIER -75.53 -39.98 57.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.485 -0.759 . . . . 0.0 110.173 -179.399 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.1 ttmt -70.22 -37.61 75.06 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.641 ' O ' ' HB1' ' B' ' 37' ' ' ALA . . . -69.18 -34.03 74.29 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 176.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.967 ' HA ' HD23 ' A' ' 92' ' ' LEU . . . -59.89 -43.52 94.75 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.089 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.46 -32.91 52.11 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.25 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -66.11 -35.78 90.99 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 178.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.967 HD23 ' HA ' ' A' ' 89' ' ' ALA . 0.5 OUTLIER -72.69 7.21 2.03 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.722 -1.457 . . . . 0.0 111.438 -179.715 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.414 ' CB ' ' O ' ' A' ' 92' ' ' LEU . 0.1 OUTLIER 63.75 38.42 9.23 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -177.862 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.652 ' HB2' ' HB ' ' B' ' 75' ' ' VAL . 0.4 OUTLIER -43.69 -35.75 1.94 Allowed 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.506 -179.238 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.458 ' N ' ' CG ' ' A' ' 94' ' ' TYR . 15.2 pt-20 -57.35 -42.06 81.27 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.4 -0.812 . . . . 0.0 109.157 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.13 -35.29 76.66 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 177.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.85 -27.25 62.75 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.282 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.633 ' HB2' ' HB1' ' B' ' 54' ' ' ALA . . . -75.5 -81.11 0.08 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.729 -0.607 . . . . 0.0 110.37 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 9.5 pttt . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.274 -179.903 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.661 ' HG3' HG23 ' A' ' 42' ' ' VAL . 4.0 ptp . . . . . 0 N--CA 1.495 1.807 0 CA-C-O 121.605 0.717 . . . . 0.0 110.577 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 2' ' ' ASN . . . . . 0.444 ' HB3' ' O ' ' B' ' 1' ' ' MET . 14.1 p-10 179.72 -157.93 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.542 178.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.55 ' HE2' HG21 ' A' ' 45' ' ' THR . 9.7 mttm -53.92 -11.53 0.44 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.253 -0.904 . . . . 0.0 110.761 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.438 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 15.4 m -101.04 -55.03 2.66 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.039 -1.038 . . . . 0.0 110.008 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.489 ' CB ' ' CB ' ' B' ' 1' ' ' MET . 2.5 mp0 -64.09 -50.16 69.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.195 -0.94 . . . . 0.0 109.24 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.86 HD11 ' CG2' ' A' ' 42' ' ' VAL . 32.5 mt -53.94 -43.28 69.69 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.151 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 7' ' ' ILE . . . . . 0.851 HG23 ' HB ' ' B' ' 21' ' ' VAL . 0.3 OUTLIER -50.24 -52.4 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 177.163 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 8' ' ' LYS . . . . . 0.936 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.0 OUTLIER -56.26 -39.73 73.06 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.056 177.22 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 9' ' ' ALA . . . . . 0.881 ' CB ' HD13 ' A' ' 31' ' ' ILE . . . -49.61 -38.1 30.55 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.195 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.714 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.4 mp -93.63 -32.0 4.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 178.009 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.936 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -68.23 -8.49 39.55 Favored 'General case' 0 C--N 1.291 -1.973 0 C-N-CA 118.377 -1.329 . . . . 0.0 109.012 178.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.515 ' HB3' ' O ' ' B' ' 8' ' ' LYS . 0.9 OUTLIER -119.9 -41.84 2.64 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.364 -0.835 . . . . 0.0 109.674 179.294 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.491 ' CB ' ' HB2' ' A' ' 27' ' ' SER . 1.5 m-20 -70.28 -35.4 73.71 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 177.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.901 HG22 ' CD2' ' B' ' 16' ' ' LEU 0.262 0.2 OUTLIER -96.72 -79.27 0.45 Allowed 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 177.592 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 52.47 5.01 0.17 Allowed Glycine 0 N--CA 1.502 3.04 0 O-C-N 121.226 -0.921 . . . . 0.0 111.793 177.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 16' ' ' LEU . . . . . 0.901 ' CD2' HG22 ' B' ' 14' ' ' THR . 0.7 OUTLIER -61.43 -23.7 66.01 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.127 -1.219 . . . . 0.0 110.052 179.524 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 17' ' ' THR . . . . . 0.675 HG21 HG21 ' A' ' 17' ' ' THR . 0.5 OUTLIER -159.82 -9.98 0.06 Allowed 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.707 -0.621 . . . . 0.0 110.482 -179.783 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 18' ' ' GLN . . . . . 0.645 ' O ' ' C ' ' B' ' 19' ' ' VAL . 7.3 mt-30 54.94 35.94 25.64 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 -177.431 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 1.057 HG11 HG11 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -10.53 -92.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.165 -179.329 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 20' ' ' SER . . . . . 1.063 ' O ' ' N ' ' B' ' 22' ' ' SER . 4.5 p -134.96 24.9 3.61 Favored 'General case' 0 C--N 1.282 -2.368 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 176.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.851 ' HB ' HG23 ' B' ' 7' ' ' ILE . 30.7 m -4.48 -41.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 CA-C-O 122.561 1.172 . . . . 0.0 110.976 -177.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 22' ' ' SER . . . . . 1.063 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.6 OUTLIER -76.74 -37.3 56.21 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.766 179.13 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 23' ' ' LYS . . . . . 0.837 ' N ' ' O ' ' B' ' 20' ' ' SER . 1.5 mtmt -89.6 -31.47 17.55 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.318 -0.864 . . . . 0.0 110.811 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 24' ' ' MET . . . . . 0.696 ' HB3' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -68.65 -39.69 80.59 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 117.191 -1.804 . . . . 0.0 108.759 179.285 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.704 HD12 HG13 ' B' ' 7' ' ' ILE . 0.3 OUTLIER -77.02 -45.09 28.45 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 118.132 -1.427 . . . . 0.0 108.431 177.574 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 26' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' B' ' 22' ' ' SER . . . -55.26 -34.46 64.06 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 27' ' ' SER . . . . . 0.484 ' O ' HG13 ' B' ' 31' ' ' ILE . 90.8 p -81.49 -35.44 30.46 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.332 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 28' ' ' PHE . . . . . 0.668 ' O ' HG13 ' B' ' 31' ' ' ILE . 0.7 OUTLIER -53.41 -49.17 67.83 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.633 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 29' ' ' GLU . . . . . 0.728 ' HG3' ' CD2' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -67.55 -34.88 77.97 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 177.184 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 1.183 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 53.1 tttm -64.51 -21.55 66.71 Favored 'General case' 0 C--O 1.19 -2.064 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.056 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.913 HD13 ' CB ' ' A' ' 9' ' ' ALA . 0.6 OUTLIER -105.61 -26.69 3.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 O-C-N 120.163 -1.586 . . . . 0.0 109.062 177.924 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.631 HD11 ' CE2' ' B' ' 28' ' ' PHE . 1.2 mm -74.87 -58.14 5.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 176.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 33' ' ' THR . . . . . 0.893 ' HA ' HD23 ' A' ' 85' ' ' LEU . 0.6 OUTLIER -70.15 -35.5 74.08 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.263 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 1.183 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 50.9 mm-40 -76.69 -32.84 58.15 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 119.314 -0.954 . . . . 0.0 111.033 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 35' ' ' THR . . . . . 0.671 HG21 ' CG2' ' B' ' 42' ' ' VAL . 2.2 m -61.68 -50.79 71.07 Favored 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 118.015 -1.474 . . . . 0.0 107.942 178.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.735 HG21 HG23 ' B' ' 77' ' ' VAL . 1.2 t -54.12 -36.0 30.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 177.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 0.641 ' HB1' ' O ' ' A' ' 88' ' ' ALA . . . -81.5 -5.44 57.96 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-O 121.655 0.74 . . . . 0.0 109.346 177.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 38' ' ' LYS . . . . . 0.511 ' N ' ' O ' ' B' ' 34' ' ' GLU . 0.9 OUTLIER -99.08 -25.08 14.66 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 177.833 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.32 39.5 2.09 Favored Glycine 0 C--N 1.303 -1.292 0 C-N-CA 120.183 -1.008 . . . . 0.0 110.795 177.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 40' ' ' ASP . . . . . 0.613 ' CB ' HG23 ' B' ' 35' ' ' THR . 0.1 OUTLIER -131.02 133.35 45.67 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.984 -1.304 . . . . 0.0 110.567 179.528 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.51 89.45 6.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.546 -0.721 . . . . 0.0 109.879 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.671 ' CG2' HG21 ' B' ' 35' ' ' THR . 58.6 t -60.02 127.3 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.59 -0.694 . . . . 0.0 110.449 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 43' ' ' GLN . . . . . 0.458 ' HA ' ' HA ' ' B' ' 49' ' ' ASN . 1.9 tt0 -119.32 99.63 6.81 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 121.391 -0.818 . . . . 0.0 109.548 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.897 HD12 ' HB3' ' B' ' 48' ' ' LEU . 12.6 mt -71.98 87.72 1.05 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.156 -0.965 . . . . 0.0 110.386 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 45' ' ' THR . . . . . 0.508 ' HB ' ' HD2' ' A' ' 3' ' ' LYS . 1.8 t 36.2 29.58 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . 93.31 -26.02 17.56 Favored Glycine 0 N--CA 1.491 2.347 0 C-N-CA 119.883 -1.151 . . . . 0.0 112.453 177.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 47' ' ' PHE . . . . . 0.95 ' CD1' HD21 ' B' ' 85' ' ' LEU . 0.4 OUTLIER -81.72 -29.76 32.81 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 119.738 1.769 . . . . 0.0 111.415 -178.776 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.897 ' HB3' HD12 ' B' ' 44' ' ' LEU . 4.6 mt -133.65 95.21 3.43 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.475 -1.391 . . . . 0.0 110.367 177.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 49' ' ' ASN . . . . . 0.468 ' O ' ' HA ' ' B' ' 79' ' ' VAL . 17.3 t-20 -103.22 90.23 3.66 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.222 -0.924 . . . . 0.0 111.368 -179.326 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 50' ' ' ILE . . . . . 0.6 HD11 HD11 ' A' ' 48' ' ' LEU . 1.2 mm -73.44 141.84 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.495 -0.753 . . . . 0.0 109.468 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 51' ' ' LYS . . . . . 0.419 ' O ' ' HG3' ' B' ' 51' ' ' LYS . 9.6 ptmt -152.52 115.57 2.88 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 120.889 -1.132 . . . . 0.0 110.656 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.545 ' HA ' ' HA ' ' B' ' 77' ' ' VAL . 52.7 Cg_endo -77.14 142.89 22.1 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 O-C-N 123.528 1.278 . . . . 0.0 111.194 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.733 HG22 ' O ' ' B' ' 76' ' ' GLY . 33.2 m -143.15 116.35 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-O 121.416 0.627 . . . . 0.0 110.528 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.633 ' HB1' ' HB2' ' A' ' 98' ' ' ALA . . . -42.47 140.92 1.1 Allowed 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.782 0.801 . . . . 0.0 112.213 -178.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.97 83.73 0.19 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 56' ' ' GLN . . . . . 0.472 ' HA ' ' HA ' ' B' ' 73' ' ' PRO . 19.4 mt-30 -56.81 -170.48 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.381 -0.824 . . . . 0.0 111.376 -178.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.594 ' HA ' HD11 ' B' ' 71' ' ' ILE . . . -80.53 165.49 22.07 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.733 -0.605 . . . . 0.0 110.816 -179.4 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 58' ' ' ARG . . . . . 0.766 ' HB2' HD12 ' B' ' 71' ' ' ILE . 21.6 mtt85 -139.13 19.02 2.61 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.565 -0.71 . . . . 0.0 110.53 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 2.9 ptmt -59.43 78.15 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.487 0.66 . . . . 0.0 110.156 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 60' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' B' ' 58' ' ' ARG . . . -148.49 -95.53 0.15 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.359 -1.497 . . . . 0.0 109.359 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 61' ' ' PHE . . . . . 0.839 ' O ' ' N ' ' B' ' 67' ' ' GLU . 4.0 p90 176.18 -178.67 0.15 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.262 -1.14 . . . . 0.0 110.244 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 62' ' ' ASN . . . . . 0.764 ' N ' ' HB2' ' B' ' 68' ' ' ALA . 0.6 OUTLIER -111.32 -60.57 0.04 OUTLIER Pre-proline 0 N--CA 1.5 2.047 0 O-C-N 120.997 -1.064 . . . . 0.0 112.287 -178.328 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.643 ' HD2' ' H ' ' B' ' 62' ' ' ASN . 41.3 Cg_endo -67.68 64.99 0.85 Allowed 'Trans proline' 0 C--N 1.316 -1.174 0 O-C-N 123.379 1.2 . . . . 0.0 110.479 -178.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 64' ' ' GLN . . . . . 0.783 ' HB3' ' CE1' ' B' ' 61' ' ' PHE . 0.0 OUTLIER 179.85 38.42 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.784 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 3.9 p 54.63 51.89 13.17 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.69 -0.631 . . . . 0.0 110.204 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 66' ' ' GLN . . . . . 0.714 ' HB2' ' CE1' ' B' ' 61' ' ' PHE . 0.0 OUTLIER -149.66 -120.51 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.26 -0.9 . . . . 0.0 110.498 -179.641 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 67' ' ' GLU . . . . . 0.839 ' N ' ' O ' ' B' ' 61' ' ' PHE . 0.9 OUTLIER -175.48 93.8 0.06 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.845 -1.159 . . . . 0.0 108.629 179.756 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 68' ' ' ALA . . . . . 0.819 ' O ' HD23 ' B' ' 69' ' ' LEU . . . -66.13 92.48 0.18 Allowed 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.969 0.89 . . . . 0.0 109.663 -178.378 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.819 HD23 ' O ' ' B' ' 68' ' ' ALA . 13.7 mt -142.67 -155.83 0.63 Allowed 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.994 -179.053 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -166.49 26.7 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.218 -0.926 . . . . 0.0 110.966 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.766 HD12 ' HB2' ' B' ' 58' ' ' ARG . 0.0 OUTLIER -61.79 -160.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.15 -0.969 . . . . 0.0 109.393 179.611 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 72' ' ' ALA . . . . . 0.524 ' N ' HG12 ' B' ' 71' ' ' ILE . . . -127.5 145.77 55.9 Favored Pre-proline 0 C--N 1.3 -1.553 0 O-C-N 121.141 -0.974 . . . . 0.0 111.095 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 73' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' B' ' 56' ' ' GLN . 40.8 Cg_endo -68.57 83.99 0.5 Allowed 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 124.048 1.552 . . . . 0.0 110.422 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 74' ' ' SER . . . . . 0.48 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 8.9 t -176.94 166.16 2.46 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.623 -0.673 . . . . 0.0 109.437 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 75' ' ' VAL . . . . . 0.652 ' HB ' ' HB2' ' A' ' 94' ' ' TYR . 0.4 OUTLIER -56.37 172.48 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.948 -1.095 . . . . 0.0 109.445 -179.994 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 76' ' ' GLY . . . . . 0.733 ' O ' HG22 ' B' ' 53' ' ' VAL . . . -114.25 75.63 0.24 Allowed Glycine 0 N--CA 1.486 1.99 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.878 HG21 ' CB ' ' A' ' 85' ' ' LEU . 2.8 p -51.54 82.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.79 -0.829 . . . . 0.0 110.365 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 78' ' ' SER . . . . . 0.584 ' N ' ' O ' ' B' ' 76' ' ' GLY . 0.5 OUTLIER -80.81 177.91 8.73 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.819 -0.753 . . . . 0.0 110.034 179.762 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.615 HG22 ' N ' ' B' ' 80' ' ' LYS . 7.4 p 177.97 177.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 80' ' ' LYS . . . . . 0.672 ' O ' HD23 ' B' ' 48' ' ' LEU . 2.7 ptpt -171.85 173.26 1.69 Allowed Pre-proline 0 C--N 1.307 -1.265 0 O-C-N 120.845 -1.159 . . . . 0.0 110.539 178.025 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 81' ' ' PRO . . . . . 0.508 ' HA ' ' O ' ' B' ' 47' ' ' PHE . 55.5 Cg_endo -98.9 128.6 0.19 Allowed 'Trans proline' 0 C--N 1.3 -1.989 0 C-N-CA 122.689 2.259 . . . . 0.0 110.549 178.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 82' ' ' GLY . . . . . 0.475 ' H ' ' HA ' ' B' ' 47' ' ' PHE . . . -81.8 -155.33 14.68 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 107.941 -2.064 . . . . 0.0 107.941 178.31 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 83' ' ' GLU . . . . . 0.446 ' HA ' ' HB2' ' B' ' 86' ' ' LYS . 3.4 pm0 -93.84 -15.35 25.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.097 -1.237 . . . . 0.0 109.977 179.07 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.38 -36.93 66.9 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.247 -0.908 . . . . 0.0 109.144 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.95 HD21 ' CD1' ' B' ' 47' ' ' PHE . 0.3 OUTLIER -82.29 -32.26 29.64 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.487 -0.758 . . . . 0.0 109.017 179.116 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 86' ' ' LYS . . . . . 0.478 ' O ' ' HB3' ' B' ' 89' ' ' ALA . 2.2 mttp -73.39 -37.43 65.98 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.496 -0.752 . . . . 0.0 109.922 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 28.5 tptt -69.66 -37.99 76.93 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 178.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.591 ' CB ' ' HB2' ' A' ' 37' ' ' ALA . . . -67.85 -34.43 76.69 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 176.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.985 ' HA ' HD23 ' B' ' 92' ' ' LEU . . . -59.67 -44.6 93.54 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.073 179.082 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -53.52 -31.83 47.93 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 177.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -68.43 -32.68 75.72 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 178.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 92' ' ' LEU . . . . . 0.985 HD23 ' HA ' ' B' ' 89' ' ' ALA . 0.5 OUTLIER -73.33 8.97 1.45 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.748 -1.443 . . . . 0.0 111.426 -179.728 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 61.55 38.43 15.61 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 -177.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 94' ' ' TYR . . . . . 0.629 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 0.2 OUTLIER -45.43 -37.7 5.36 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.609 -178.998 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 95' ' ' GLU . . . . . 0.448 ' N ' ' CG ' ' B' ' 94' ' ' TYR . 2.6 pp20? -57.28 -38.01 73.28 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.324 -0.86 . . . . 0.0 109.162 179.267 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.06 -34.84 78.43 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 177.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 97' ' ' PHE . . . . . 0.491 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -70.17 -27.49 64.57 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.312 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 98' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' B' ' 95' ' ' GLU . . . -72.53 -30.63 64.63 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.645 -0.659 . . . . 0.0 110.241 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 15.4 mttt . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.211 -179.948 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.605 ' CG ' ' HB3' ' A' ' 5' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 121.096 0.474 . . . . 0.0 110.25 . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.565 ' N ' ' HB2' ' A' ' 5' ' ' GLU . 2.0 t-20 -177.24 -178.84 0.82 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.187 -0.946 . . . . 0.0 110.931 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.818 ' O ' HD22 ' A' ' 25' ' ' LEU . 8.4 mttt -46.67 -25.13 0.66 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.64 -0.663 . . . . 0.0 109.852 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.458 ' O ' HG22 ' A' ' 7' ' ' ILE . 8.3 m -101.63 -52.4 3.22 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.396 -0.815 . . . . 0.0 110.111 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.605 ' HB3' ' CG ' ' A' ' 1' ' ' MET . 6.7 mt-10 -53.7 -47.61 70.33 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.107 -0.996 . . . . 0.0 108.573 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.641 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 4.1 mt -55.37 -37.67 67.83 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 119.177 -1.009 . . . . 0.0 108.814 177.261 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.763 ' CD1' HD23 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -50.77 -44.86 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.081 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.751 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -68.18 -32.4 72.61 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.745 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.641 ' HB3' ' O ' ' A' ' 6' ' ' LEU . . . -53.23 -38.52 63.01 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.369 -0.832 . . . . 0.0 109.033 179.061 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.765 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.3 mp -102.32 -29.7 3.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.413 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.751 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -69.11 -11.32 60.69 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 118.554 -1.259 . . . . 0.0 108.577 178.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.418 ' CG ' ' O ' ' A' ' 8' ' ' LYS . 54.0 mm-40 -113.74 -42.49 3.42 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.484 -0.76 . . . . 0.0 109.053 178.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.425 ' HB2' ' O ' ' A' ' 9' ' ' ALA . 1.5 m-20 -65.54 -36.17 83.0 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 177.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.765 ' OG1' ' O ' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -99.69 -73.04 0.64 Allowed 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 178.144 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 46.32 22.55 0.99 Allowed Glycine 0 N--CA 1.5 2.919 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 178.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.079 ' CD1' HG23 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -75.05 -26.25 59.27 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 121.507 -0.996 . . . . 0.0 108.8 179.323 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.729 HG22 ' H ' ' A' ' 19' ' ' VAL . 0.4 OUTLIER -162.05 -2.91 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.932 -179.191 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.575 ' O ' ' C ' ' A' ' 19' ' ' VAL . 21.9 mt-30 57.92 28.16 15.73 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -176.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 1.002 ' O ' HD22 ' B' ' 16' ' ' LEU . 1.6 p -1.76 -90.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.235 -178.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.958 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.4 OUTLIER -129.98 25.6 5.26 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 178.918 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.791 ' HA ' ' CE ' ' A' ' 24' ' ' MET . 13.5 m -22.91 -41.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 CA-C-O 122.576 1.179 . . . . 0.0 108.777 -178.397 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.747 ' N ' ' O ' ' A' ' 20' ' ' SER . 6.6 m -76.36 -37.74 56.83 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.731 177.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.958 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.9 OUTLIER -89.01 -38.73 14.19 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.493 -0.755 . . . . 0.0 111.717 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.791 ' CE ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -66.88 -27.75 67.77 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.075 -1.64 . . . . 0.0 109.178 179.648 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.818 HD22 ' O ' ' A' ' 3' ' ' LYS . 0.2 OUTLIER -82.94 -45.47 14.11 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 118.865 -1.134 . . . . 0.0 108.982 178.618 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.651 ' N ' ' HG ' ' A' ' 25' ' ' LEU . . . -66.4 -27.64 68.01 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.56 ' O ' ' N ' ' A' ' 31' ' ' ILE . 52.9 p -87.76 -31.24 19.73 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.426 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.829 ' O ' HG13 ' A' ' 31' ' ' ILE . 0.1 OUTLIER -55.66 -48.17 75.47 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.562 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.576 ' HG3' ' CE2' ' B' ' 47' ' ' PHE . 1.0 OUTLIER -69.89 -36.37 75.37 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 177.01 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 1.201 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 35.7 tttp -65.22 -17.8 64.78 Favored 'General case' 0 C--O 1.19 -2.043 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.066 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.829 HG13 ' O ' ' A' ' 28' ' ' PHE . 1.2 pp -108.56 -30.07 2.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 120.195 -1.566 . . . . 0.0 108.916 178.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.598 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.1 mm -71.41 -58.06 6.05 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 176.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.982 ' HA ' HD23 ' B' ' 85' ' ' LEU . 0.6 OUTLIER -69.95 -42.26 73.45 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.915 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 1.201 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 55.1 mm-40 -68.39 -34.39 75.95 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 120.728 -1.232 . . . . 0.0 111.178 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.867 HG21 HG23 ' A' ' 42' ' ' VAL . 1.8 m -57.85 -49.1 77.83 Favored 'General case' 0 N--CA 1.5 2.037 0 C-N-CA 118.071 -1.451 . . . . 0.0 107.446 178.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.912 HG13 ' HB3' ' A' ' 52' ' ' PRO . 36.4 t -55.13 -35.81 36.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 C-N-CA 117.85 -1.54 . . . . 0.0 107.362 177.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.789 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -84.86 2.77 41.0 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 121.626 0.727 . . . . 0.0 109.094 177.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.513 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -110.13 -15.82 13.92 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.798 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.93 46.89 3.27 Favored Glycine 0 C--N 1.304 -1.243 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 178.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.778 ' CB ' HG23 ' A' ' 35' ' ' THR . 0.3 OUTLIER -137.25 136.68 38.31 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.052 -1.264 . . . . 0.0 110.861 179.521 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.5 mtmm -80.06 91.96 5.56 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.572 -0.705 . . . . 0.0 109.45 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.867 HG23 HG21 ' A' ' 35' ' ' THR . 41.1 t -59.97 124.34 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.615 -0.678 . . . . 0.0 110.163 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.46 ' O ' ' HA ' ' B' ' 2' ' ' ASN . 19.1 mt-30 -125.5 165.17 18.95 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.341 -0.849 . . . . 0.0 109.832 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.045 HD12 ' CB ' ' A' ' 48' ' ' LEU . 72.1 mt -134.43 108.09 7.95 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.416 -0.803 . . . . 0.0 109.084 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.534 HG23 ' HD1' ' A' ' 47' ' ' PHE . 0.0 OUTLIER 35.22 -96.05 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.871 -0.518 . . . . 0.0 111.475 -179.037 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.417 ' H ' HG23 ' A' ' 45' ' ' THR . . . -138.91 22.55 2.96 Favored Glycine 0 N--CA 1.488 2.12 0 C-N-CA 119.385 -1.388 . . . . 0.0 110.911 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.936 ' CD2' HD23 ' A' ' 48' ' ' LEU . 17.6 p90 -118.13 -56.82 2.14 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.728 -1.454 . . . . 0.0 111.101 179.028 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.045 ' CB ' HD12 ' A' ' 44' ' ' LEU . 0.9 OUTLIER -103.89 128.89 51.36 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.057 -1.652 . . . . 0.0 115.281 -178.162 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.547 ' CB ' ' CG ' ' A' ' 81' ' ' PRO . 19.2 t-20 -129.72 99.9 5.3 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.564 177.003 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.881 HD11 HD11 ' B' ' 48' ' ' LEU . 1.0 OUTLIER -86.82 158.07 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.162 -0.961 . . . . 0.0 110.21 -179.93 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.6 ptmt -166.49 123.39 0.99 Allowed Pre-proline 0 N--CA 1.496 1.833 0 C-N-CA 118.681 -1.208 . . . . 0.0 111.213 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.912 ' HB3' HG13 ' A' ' 36' ' ' VAL . 54.0 Cg_endo -79.96 144.31 16.88 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.609 1.32 . . . . 0.0 110.985 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.577 ' O ' HG23 ' A' ' 53' ' ' VAL . 28.4 m -137.06 113.81 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 CA-C-O 121.849 0.833 . . . . 0.0 111.459 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . -71.8 133.46 45.54 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.62 -0.675 . . . . 0.0 111.006 -179.064 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.4 ' O ' ' CG ' ' A' ' 56' ' ' GLN . 0.8 OUTLIER 174.77 47.32 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.413 -0.804 . . . . 0.0 110.691 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.68 ' O ' ' HA ' ' A' ' 73' ' ' PRO . 27.8 mt-30 -157.0 118.63 3.77 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.943 -1.098 . . . . 0.0 111.544 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.487 ' H ' HD11 ' A' ' 71' ' ' ILE . . . -177.08 72.61 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.252 -0.905 . . . . 0.0 109.591 178.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.87 ' NE ' HD13 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -133.15 156.07 48.12 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.476 -0.765 . . . . 0.0 110.075 -179.123 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.498 ' N ' ' HG3' ' A' ' 58' ' ' ARG . 13.8 mttt -154.98 102.72 2.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.567 -0.708 . . . . 0.0 109.749 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 119.2 -147.95 18.27 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.665 ' CG ' ' N ' ' A' ' 62' ' ' ASN . 66.4 t80 -127.76 175.01 8.64 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.103 -1.234 . . . . 0.0 110.941 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.665 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 2.3 t30 -63.33 -170.89 0.04 OUTLIER Pre-proline 0 N--CA 1.48 1.064 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 177.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.419 ' CD ' ' CB ' ' A' ' 62' ' ' ASN . 48.1 Cg_endo -79.57 51.71 3.99 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.093 1.049 . . . . 0.0 109.818 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.59 ' CB ' ' HE2' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -157.44 -117.07 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.139 0 O-C-N 121.209 -0.932 . . . . 0.0 110.084 -179.224 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.531 ' N ' ' CE2' ' A' ' 61' ' ' PHE . 4.7 t 177.64 69.53 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.117 -0.989 . . . . 0.0 109.156 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -130.56 -70.76 0.61 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.306 -0.871 . . . . 0.0 110.67 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -115.66 78.13 1.15 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.311 -0.868 . . . . 0.0 110.382 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.416 ' HA ' ' HB2' ' A' ' 61' ' ' PHE . . . -59.53 139.15 57.39 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.412 -0.805 . . . . 0.0 110.94 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.87 HD13 ' NE ' ' A' ' 58' ' ' ARG . 1.8 mp -112.42 -159.11 0.67 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.582 -0.699 . . . . 0.0 109.934 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.443 ' CB ' ' O ' ' A' ' 69' ' ' LEU . 2.3 mt-10 169.55 30.39 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.418 -0.801 . . . . 0.0 110.405 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.487 HD11 ' H ' ' A' ' 57' ' ' ALA . 1.0 OUTLIER -75.75 -159.95 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.11 -0.994 . . . . 0.0 110.01 -179.864 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 1.012 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -163.97 -175.5 0.47 Allowed Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.101 -1.0 . . . . 0.0 111.018 -178.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 1.012 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 41.3 Cg_endo -69.17 112.88 3.1 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 O-C-N 124.014 1.534 . . . . 0.0 111.37 -179.278 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.7 p -164.9 105.46 0.8 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.659 -0.65 . . . . 0.0 109.349 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.835 HG12 ' HB2' ' B' ' 89' ' ' ALA . 0.3 OUTLIER -51.13 170.45 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.372 -0.83 . . . . 0.0 109.919 -179.284 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.574 ' O ' ' N ' ' A' ' 78' ' ' SER . . . -105.99 77.16 0.24 Allowed Glycine 0 N--CA 1.484 1.874 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.903 HG11 ' HB2' ' B' ' 85' ' ' LEU . 15.5 t -59.87 77.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.492 -1.005 . . . . 0.0 109.232 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.574 ' N ' ' O ' ' A' ' 76' ' ' GLY . 0.3 OUTLIER -97.31 -165.18 1.23 Allowed 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 122.461 1.124 . . . . 0.0 111.733 -178.671 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.611 HG12 ' CG1' ' A' ' 50' ' ' ILE . 29.9 m -152.82 -157.08 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.65 ' HB3' ' HD3' ' A' ' 81' ' ' PRO . 0.1 OUTLIER -172.06 -58.12 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.69 0 C-N-CA 118.345 -1.342 . . . . 0.0 112.824 179.421 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.65 ' HD3' ' HB3' ' A' ' 80' ' ' LYS . 55.8 Cg_endo -89.62 171.82 4.13 Favored 'Trans proline' 0 C--N 1.297 -2.151 0 O-C-N 123.595 1.313 . . . . 0.0 112.963 -176.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.65 ' O ' ' C ' ' A' ' 83' ' ' GLU . . . 176.2 -1.57 0.03 OUTLIER Glycine 0 C--N 1.301 -1.405 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 179.093 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.905 ' O ' ' N ' ' A' ' 85' ' ' LEU . 11.8 pt-20 31.8 45.78 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 -176.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.873 ' C ' HD22 ' A' ' 85' ' ' LEU . 1.2 t 12.4 41.71 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.335 0 CA-C-O 122.873 1.321 . . . . 0.0 109.608 -177.021 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 1.005 HD23 HG11 ' B' ' 36' ' ' VAL . 0.0 OUTLIER 18.31 27.05 0.0 OUTLIER 'General case' 0 C--O 1.189 -2.117 0 N-CA-C 101.381 -3.563 . . . . 0.0 101.381 -173.293 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.76 ' HB2' ' HB3' ' A' ' 84' ' ' SER 0.351 4.5 tttt -51.91 -44.25 63.72 Favored 'General case' 0 CA--C 1.469 -2.145 0 CA-C-N 111.808 -2.451 . . . . 0.0 105.631 178.589 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.277 23.6 tttt -62.23 -38.02 87.62 Favored 'General case' 0 C--N 1.268 -2.971 0 CA-C-N 111.409 -2.632 . . . . 0.0 106.625 177.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.826 ' O ' ' HB1' ' B' ' 37' ' ' ALA . . . -86.99 -22.34 25.6 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 118.232 -1.387 . . . . 0.0 109.39 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.793 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . -76.32 -47.13 24.66 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.474 ' HA ' ' CB ' ' A' ' 94' ' ' TYR . 4.0 mm-40 -56.86 -27.24 60.11 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 175.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.972 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -76.95 -32.52 49.15 Favored Glycine 0 CA--C 1.548 2.147 0 CA-C-O 118.496 -1.169 . . . . 0.0 113.169 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.972 HD23 ' C ' ' A' ' 91' ' ' GLY . 0.1 OUTLIER -115.21 -74.2 0.62 Allowed 'General case' 0 N--CA 1.505 2.312 0 CA-C-N 122.31 3.055 . . . . 0.0 113.44 -177.301 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -120.39 42.0 3.09 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.827 -1.171 . . . . 0.0 112.713 -177.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.495 ' HA ' HG23 ' B' ' 75' ' ' VAL . 0.0 OUTLIER -74.37 -55.5 5.93 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.102 -0.999 . . . . 0.0 108.923 178.371 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.432 ' N ' ' CG ' ' A' ' 94' ' ' TYR . 12.0 pt-20 -69.22 -37.28 77.95 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.604 -0.685 . . . . 0.0 109.547 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -57.74 -34.87 69.98 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.518 ' CB ' ' HB2' ' B' ' 54' ' ' ALA . 3.9 m-85 -78.23 -26.5 47.37 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 120.091 -0.644 . . . . 0.0 109.584 178.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.612 ' HB2' ' HB1' ' B' ' 54' ' ' ALA . . . -71.9 -56.33 5.9 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.402 -0.811 . . . . 0.0 110.304 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.4 mttp . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.156 -179.914 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.453 ' CB ' ' HB3' ' B' ' 5' ' ' GLU . 9.0 mtp . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 120.867 0.365 . . . . 0.0 110.063 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 2' ' ' ASN . . . . . 0.46 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 0.1 OUTLIER -176.48 -172.97 0.49 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.237 -0.914 . . . . 0.0 110.801 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.549 ' O ' HG13 ' B' ' 7' ' ' ILE . 0.0 OUTLIER -54.24 -15.07 1.35 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.234 -0.916 . . . . 0.0 110.335 179.785 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.552 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 19.1 m -105.64 -46.65 4.11 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.106 -0.996 . . . . 0.0 108.69 178.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.486 ' HA ' ' HE2' ' B' ' 8' ' ' LYS . 0.8 OUTLIER -62.01 -50.6 71.39 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.927 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.707 HD11 HG13 ' A' ' 42' ' ' VAL . 2.0 mt -64.51 -26.51 68.46 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.488 -0.885 . . . . 0.0 109.013 178.217 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 7' ' ' ILE . . . . . 0.735 HG12 ' O ' ' B' ' 21' ' ' VAL . 0.3 OUTLIER -56.84 -58.97 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.408 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 8' ' ' LYS . . . . . 0.893 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.1 OUTLIER -62.43 -26.99 68.79 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.137 178.758 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 9' ' ' ALA . . . . . 0.598 ' HB3' ' O ' ' B' ' 6' ' ' LEU . . . -59.85 -34.67 73.42 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 119.441 -0.904 . . . . 0.0 108.699 178.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.861 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.0 OUTLIER -97.47 -36.82 6.3 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.498 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 178.522 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.893 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -59.04 -28.3 66.3 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.437 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -90.8 -42.01 10.9 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.496 ' OD2' HG21 ' A' ' 31' ' ' ILE . 82.6 m-20 -64.98 -23.13 67.13 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 106.932 -1.506 . . . . 0.0 106.932 176.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.951 HG22 ' HB2' ' A' ' 20' ' ' SER . 17.8 p -93.41 -75.57 0.49 Allowed 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.08 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 58.35 17.72 33.15 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 16' ' ' LEU . . . . . 1.002 HD22 ' O ' ' A' ' 19' ' ' VAL . 2.7 mp -84.32 -59.28 2.44 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.324 -1.103 . . . . 0.0 108.411 178.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 17' ' ' THR . . . . . 0.716 ' CG2' HG21 ' A' ' 17' ' ' THR . 0.5 OUTLIER -140.87 3.44 1.83 Allowed 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.357 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 18' ' ' GLN . . . . . 0.594 ' O ' ' C ' ' B' ' 19' ' ' VAL . 16.6 mt-30 57.14 24.71 10.03 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 106.762 -1.569 . . . . 0.0 106.762 -176.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 1.079 HG23 ' CD1' ' A' ' 16' ' ' LEU . 0.1 OUTLIER 10.61 -94.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.917 -179.167 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 20' ' ' SER . . . . . 1.025 ' O ' ' N ' ' B' ' 22' ' ' SER . 0.3 OUTLIER -137.17 23.46 3.01 Favored 'General case' 0 C--N 1.276 -2.619 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 178.193 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.735 ' O ' HG12 ' B' ' 7' ' ' ILE . 15.3 m -5.24 -44.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 122.503 1.144 . . . . 0.0 110.537 -177.505 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 22' ' ' SER . . . . . 1.025 ' N ' ' O ' ' B' ' 20' ' ' SER . 5.8 m -79.54 -38.59 33.87 Favored 'General case' 0 C--N 1.281 -2.393 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.355 178.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 23' ' ' LYS . . . . . 0.932 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.5 OUTLIER -91.12 -24.61 19.93 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.418 -0.801 . . . . 0.0 110.875 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 24' ' ' MET . . . . . 0.653 ' HG2' HG22 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -77.07 -38.76 51.86 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 117.444 -1.703 . . . . 0.0 108.558 178.349 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.675 ' HA ' ' HB3' ' B' ' 28' ' ' PHE . 0.3 OUTLIER -78.0 -36.17 49.13 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 118.234 -1.387 . . . . 0.0 108.438 177.711 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 26' ' ' ALA . . . . . 0.49 ' HB2' ' O ' ' B' ' 22' ' ' SER . . . -64.45 -34.61 78.6 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 176.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 27' ' ' SER . . . . . 0.622 ' O ' HG13 ' B' ' 31' ' ' ILE . 29.2 t -80.42 -32.09 37.45 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 28' ' ' PHE . . . . . 0.862 ' CE1' HD22 ' A' ' 44' ' ' LEU . 0.4 OUTLIER -52.74 -47.11 67.62 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.828 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 29' ' ' GLU . . . . . 0.651 ' HG3' ' CD1' ' A' ' 47' ' ' PHE . 1.7 tt0 -68.47 -35.61 77.81 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 176.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 1.185 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 2.0 tttt -63.8 -19.39 64.97 Favored 'General case' 0 C--O 1.189 -2.096 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.095 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.638 ' CG1' ' HA ' ' B' ' 28' ' ' PHE . 1.4 pp -107.43 -28.24 2.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 120.29 -1.506 . . . . 0.0 108.714 178.037 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.674 HD11 ' CE2' ' B' ' 28' ' ' PHE . 1.2 mm -72.66 -58.18 5.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 176.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 33' ' ' THR . . . . . 0.982 ' OG1' HD12 ' A' ' 85' ' ' LEU . 0.6 OUTLIER -68.52 -38.07 80.57 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.771 179.169 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 1.185 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 78.7 mm-40 -76.95 -27.57 54.87 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 121.172 -0.955 . . . . 0.0 111.963 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 35' ' ' THR . . . . . 0.558 ' O ' ' N ' ' B' ' 38' ' ' LYS . 2.7 m -70.63 -59.75 2.65 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 117.706 -1.597 . . . . 0.0 109.462 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 1.005 HG11 HD23 ' A' ' 85' ' ' LEU . 0.9 OUTLIER -51.02 -43.86 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 178.94 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 0.826 ' HB1' ' O ' ' A' ' 88' ' ' ALA . . . -60.91 -27.83 68.48 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.829 177.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 38' ' ' LYS . . . . . 0.795 ' N ' HD12 ' A' ' 92' ' ' LEU . 0.6 OUTLIER -76.64 -32.3 57.91 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 177.574 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.5 23.7 4.99 Favored Glycine 0 C--N 1.295 -1.695 0 C-N-CA 120.087 -1.054 . . . . 0.0 110.944 177.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 40' ' ' ASP . . . . . 0.481 ' HB3' ' CG2' ' B' ' 35' ' ' THR . 0.4 OUTLIER -100.48 158.34 15.98 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.103 -1.234 . . . . 0.0 109.749 179.38 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -95.28 90.77 5.97 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.388 -0.82 . . . . 0.0 110.436 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 73.3 t -59.83 118.43 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.423 -0.798 . . . . 0.0 109.712 179.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -123.71 93.22 3.87 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.309 -0.869 . . . . 0.0 110.068 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 1.004 HD12 ' CB ' ' B' ' 48' ' ' LEU . 75.3 mt -62.33 101.18 0.21 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.173 -0.954 . . . . 0.0 109.549 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 45' ' ' THR . . . . . 0.556 HG21 ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 34.99 -94.78 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.928 -0.482 . . . . 0.0 111.31 -179.557 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.427 ' H ' HG23 ' B' ' 45' ' ' THR . . . -141.0 20.45 2.68 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 119.493 -1.337 . . . . 0.0 110.908 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 47' ' ' PHE . . . . . 0.576 ' CE2' ' HG3' ' A' ' 29' ' ' GLU . 8.8 p90 -119.84 -22.71 6.69 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.702 -1.47 . . . . 0.0 111.446 179.402 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 1.004 ' CB ' HD12 ' B' ' 44' ' ' LEU . 0.2 OUTLIER -133.48 139.21 46.54 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.614 -1.304 . . . . 0.0 111.472 178.242 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 49' ' ' ASN . . . . . 0.417 ' C ' HD13 ' B' ' 50' ' ' ILE . 1.3 t30 -143.31 116.69 9.07 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.738 -0.601 . . . . 0.0 109.952 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 50' ' ' ILE . . . . . 0.797 HG23 ' HB ' ' B' ' 79' ' ' VAL . 6.4 mm -116.79 147.05 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 O-C-N 121.314 -0.866 . . . . 0.0 110.592 -179.359 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 51' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' B' ' 78' ' ' SER . 14.4 ptmt -156.81 124.85 2.83 Favored Pre-proline 0 N--CA 1.502 2.164 0 O-C-N 120.877 -1.139 . . . . 0.0 110.631 179.12 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.578 ' HA ' ' HA ' ' B' ' 77' ' ' VAL . 53.6 Cg_endo -84.96 150.75 11.01 Favored 'Trans proline' 0 C--N 1.317 -1.12 0 O-C-N 123.239 1.126 . . . . 0.0 111.748 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.852 HG22 ' O ' ' B' ' 76' ' ' GLY . 33.0 m -140.54 115.69 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 CA-C-O 121.966 0.889 . . . . 0.0 110.391 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.612 ' HB1' ' HB2' ' A' ' 98' ' ' ALA . . . -50.04 160.27 0.36 Allowed 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 122.073 0.94 . . . . 0.0 112.237 -178.422 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -175.26 59.56 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 56' ' ' GLN . . . . . 0.943 ' O ' HD11 ' B' ' 71' ' ' ILE . 3.4 pt20 -47.38 174.07 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 122.144 0.973 . . . . 0.0 112.717 -177.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.614 ' HB2' ' HB3' ' B' ' 73' ' ' PRO . . . -62.79 -172.44 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 122.263 1.03 . . . . 0.0 112.392 -178.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 58' ' ' ARG . . . . . 0.78 ' HD3' ' N ' ' B' ' 71' ' ' ILE . 0.0 OUTLIER 175.94 -152.86 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -179.008 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 59' ' ' LYS . . . . . 0.58 ' N ' ' HD2' ' B' ' 58' ' ' ARG . 3.9 pttt 173.59 90.11 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.236 -0.915 . . . . 0.0 110.653 177.389 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 60' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' B' ' 69' ' ' LEU . . . 47.11 49.63 17.99 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.944 -1.263 . . . . 0.0 109.944 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 61' ' ' PHE . . . . . 0.78 ' CE1' ' HB2' ' B' ' 66' ' ' GLN . 0.0 OUTLIER -97.36 131.31 44.16 Favored 'General case' 0 N--CA 1.483 1.217 0 O-C-N 121.157 -1.202 . . . . 0.0 112.972 -178.977 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 62' ' ' ASN . . . . . 0.77 ' H ' ' CD ' ' B' ' 63' ' ' PRO . 0.1 OUTLIER -132.98 -29.19 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.6 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -179.477 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.77 ' CD ' ' H ' ' B' ' 62' ' ' ASN . 43.4 Cg_endo -73.86 -12.72 24.12 Favored 'Trans proline' 0 N--CA 1.483 0.885 0 O-C-N 122.289 0.626 . . . . 0.0 110.525 -178.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 64' ' ' GLN . . . . . 0.653 ' HB3' ' CE1' ' B' ' 61' ' ' PHE . 0.1 OUTLIER -84.76 53.65 2.78 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.301 -0.874 . . . . 0.0 109.271 178.831 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 3.1 p 55.61 42.2 29.8 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.914 -0.491 . . . . 0.0 110.342 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 66' ' ' GLN . . . . . 0.78 ' HB2' ' CE1' ' B' ' 61' ' ' PHE . 0.1 OUTLIER -158.5 -156.85 0.58 Allowed 'General case' 0 C--N 1.309 -1.195 0 O-C-N 121.386 -0.821 . . . . 0.0 110.569 -179.616 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 67' ' ' GLU . . . . . 0.617 ' O ' ' HG ' ' B' ' 69' ' ' LEU . 18.5 tt0 -126.99 139.2 53.21 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 178.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 68' ' ' ALA . . . . . 0.667 ' HA ' ' C ' ' B' ' 61' ' ' PHE . . . -45.03 123.47 3.89 Favored 'General case' 0 C--N 1.289 -2.043 0 O-C-N 121.621 -0.675 . . . . 0.0 110.981 -178.279 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' B' ' 67' ' ' GLU . 1.3 mp -118.42 -145.87 0.38 Allowed 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.529 -0.732 . . . . 0.0 112.337 -178.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 70' ' ' GLU . . . . . 0.488 ' C ' ' HD3' ' B' ' 58' ' ' ARG . 2.1 pt-20 172.08 21.89 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.357 0 O-C-N 121.416 -0.803 . . . . 0.0 109.75 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.943 HD11 ' O ' ' B' ' 56' ' ' GLN . 0.9 OUTLIER -59.02 -151.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.399 -0.813 . . . . 0.0 111.188 -179.727 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 72' ' ' ALA . . . . . 0.697 ' O ' HD12 ' B' ' 71' ' ' ILE . . . -139.95 153.14 69.27 Favored Pre-proline 0 N--CA 1.488 1.425 0 O-C-N 121.406 -0.809 . . . . 0.0 110.495 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 73' ' ' PRO . . . . . 0.614 ' HB3' ' HB2' ' B' ' 57' ' ' ALA . 42.9 Cg_endo -70.51 113.37 3.47 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 121.693 1.595 . . . . 0.0 110.845 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 74' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' B' ' 73' ' ' PRO . 0.4 OUTLIER 171.89 -168.88 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.568 -0.708 . . . . 0.0 110.197 179.762 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 75' ' ' VAL . . . . . 0.495 HG23 ' HA ' ' A' ' 94' ' ' TYR . 0.7 OUTLIER -109.01 172.84 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.309 -0.87 . . . . 0.0 109.272 179.46 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 76' ' ' GLY . . . . . 0.852 ' O ' HG22 ' B' ' 53' ' ' VAL . . . -121.86 96.42 0.58 Allowed Glycine 0 N--CA 1.494 2.536 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.832 HG13 ' O ' ' B' ' 77' ' ' VAL . 8.1 p -67.63 74.54 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.644 -0.915 . . . . 0.0 111.5 -178.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 78' ' ' SER . . . . . 0.797 ' C ' HG12 ' B' ' 79' ' ' VAL . 0.1 OUTLIER -61.45 172.76 1.07 Allowed 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 117.368 -1.733 . . . . 0.0 107.463 178.209 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.797 ' HB ' HG23 ' B' ' 50' ' ' ILE . 0.2 OUTLIER 176.41 173.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.041 -1.037 . . . . 0.0 110.137 179.397 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 80' ' ' LYS . . . . . 0.595 ' N ' ' CG2' ' B' ' 79' ' ' VAL . 0.1 OUTLIER 176.08 171.14 0.34 Allowed Pre-proline 0 C--N 1.299 -1.61 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 175.955 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 81' ' ' PRO . . . . . 0.638 ' HA ' HD23 ' B' ' 48' ' ' LEU . 54.0 Cg_endo -89.89 -169.43 0.36 Allowed 'Trans proline' 0 C--N 1.293 -2.361 0 O-C-N 123.712 1.375 . . . . 0.0 109.791 176.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -128.83 -90.96 0.65 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 106.293 -2.723 . . . . 0.0 106.293 178.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 83' ' ' GLU . . . . . 0.949 ' O ' ' N ' ' B' ' 85' ' ' LEU . 1.6 tt0 -77.99 56.65 1.63 Allowed 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 175.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 84' ' ' SER . . . . . 1.302 ' O ' ' N ' ' B' ' 86' ' ' LYS . 0.3 OUTLIER 8.43 43.84 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 122.396 1.093 . . . . 0.0 110.274 -179.79 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.982 HD23 ' HA ' ' A' ' 33' ' ' THR . 3.7 mp 20.92 29.69 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 103.616 -2.735 . . . . 0.0 103.616 -172.387 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 86' ' ' LYS . . . . . 1.302 ' N ' ' O ' ' B' ' 84' ' ' SER 0.346 15.6 tttt -57.79 -42.45 84.18 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 104.161 -2.533 . . . . 0.0 104.161 177.043 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 87' ' ' LYS . . . . . 0.42 ' O ' ' CG ' ' B' ' 90' ' ' GLU 0.286 34.8 tttp -65.14 -34.41 78.34 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 112.055 -2.339 . . . . 0.0 105.846 175.342 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.889 ' HB1' ' O ' ' A' ' 33' ' ' THR . . . -78.84 -25.24 44.08 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 118.419 -1.313 . . . . 0.0 108.051 178.217 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 1.069 ' HA ' HD23 ' B' ' 92' ' ' LEU . . . -68.42 -49.76 57.69 Favored 'General case' 0 C--N 1.294 -1.843 0 O-C-N 121.141 -0.975 . . . . 0.0 109.291 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.425 ' HG3' ' N ' ' B' ' 91' ' ' GLY . 7.0 pt-20 -58.52 -27.18 64.27 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 177.375 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 91' ' ' GLY . . . . . 0.425 ' N ' ' HG3' ' B' ' 90' ' ' GLU . . . -75.97 -23.07 72.88 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 179.03 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 92' ' ' LEU . . . . . 1.069 HD23 ' HA ' ' B' ' 89' ' ' ALA . 0.4 OUTLIER -80.79 21.65 0.66 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.575 -1.544 . . . . 0.0 110.38 179.625 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 93' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' B' ' 92' ' ' LEU . 0.9 OUTLIER 58.18 37.85 26.28 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 -177.067 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 94' ' ' TYR . . . . . 0.537 ' CD1' ' N ' ' A' ' 75' ' ' VAL . 52.3 t80 -33.89 -45.94 0.21 Allowed 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 114.926 -1.033 . . . . 0.0 111.602 -178.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 95' ' ' GLU . . . . . 0.466 ' O ' ' HB3' ' B' ' 98' ' ' ALA . 17.0 mm-40 -56.92 -44.67 82.68 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.156 -0.965 . . . . 0.0 109.599 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 96' ' ' ASP . . . . . 0.436 ' N ' ' O ' ' B' ' 93' ' ' LYS . 0.2 OUTLIER -57.07 -33.43 67.27 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.777 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -85.67 -22.89 27.67 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 98' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' B' ' 95' ' ' GLU . . . -59.08 -47.26 85.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.623 -0.673 . . . . 0.0 110.172 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.177 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.502 ' HB3' ' HG ' ' A' ' 6' ' ' LEU . 9.6 mtp . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.445 ' HA ' ' O ' ' B' ' 43' ' ' GLN . 0.6 OUTLIER -173.13 -168.76 0.49 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.99 -1.069 . . . . 0.0 112.043 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.465 ' O ' ' CG2' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -51.92 -16.5 0.73 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.604 -0.685 . . . . 0.0 109.856 179.697 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.75 ' O ' HG13 ' A' ' 7' ' ' ILE . 1.4 m -112.86 -53.92 2.67 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.822 0.82 . . . . 0.0 109.906 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.627 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 0.1 OUTLIER -48.41 -48.26 37.19 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.154 -0.966 . . . . 0.0 109.068 -179.955 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.839 HD11 HG13 ' B' ' 42' ' ' VAL . 1.2 mt -61.01 -29.79 69.92 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.363 -0.935 . . . . 0.0 110.44 178.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.75 HG13 ' O ' ' A' ' 4' ' ' THR . 1.0 OUTLIER -60.82 -44.18 97.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 120.621 -1.299 . . . . 0.0 107.868 179.381 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.877 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -64.6 -33.35 75.71 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 177.658 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' A' ' 6' ' ' LEU . . . -56.19 -38.82 71.48 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 119.921 -0.712 . . . . 0.0 109.165 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.823 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.1 mp -90.98 -33.18 5.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 178.139 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.877 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -62.93 -13.43 34.37 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 118.574 -1.251 . . . . 0.0 108.655 178.38 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.45 ' CG ' ' N ' ' A' ' 13' ' ' ASP . 15.9 pt20 -115.53 -42.24 3.16 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.486 -0.759 . . . . 0.0 110.177 179.31 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.45 ' N ' ' CG ' ' A' ' 12' ' ' GLN . 65.6 m-20 -69.76 -31.29 69.17 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 177.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . 1.068 HG22 ' CD1' ' A' ' 16' ' ' LEU 0.265 0.2 OUTLIER -99.27 -67.95 0.83 Allowed 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 178.666 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 53.06 23.82 18.05 Favored Glycine 0 N--CA 1.501 3.022 0 O-C-N 121.439 -0.788 . . . . 0.0 111.417 177.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.068 ' CD1' HG22 ' A' ' 14' ' ' THR . 4.7 mp -67.85 -69.15 0.34 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.536 -0.979 . . . . 0.0 110.028 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.54 HG21 HG21 ' B' ' 17' ' ' THR . 0.6 OUTLIER -130.17 6.03 4.92 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.843 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.597 ' O ' ' C ' ' A' ' 19' ' ' VAL . 22.8 mt-30 56.94 28.01 14.03 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 -176.235 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 1.075 HG23 ' CD1' ' B' ' 16' ' ' LEU . 0.4 OUTLIER -9.24 -97.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.306 -179.412 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.97 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.9 OUTLIER -136.37 25.1 3.21 Favored 'General case' 0 C--N 1.278 -2.516 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 177.779 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.707 HG23 HD13 ' A' ' 7' ' ' ILE . 27.2 m -18.23 -39.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 CA-C-O 122.24 1.019 . . . . 0.0 110.343 -177.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.806 ' N ' ' O ' ' A' ' 20' ' ' SER . 5.2 m -80.02 -37.55 33.89 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 115.032 -0.986 . . . . 0.0 108.998 178.359 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.97 ' N ' ' O ' ' A' ' 20' ' ' SER . 2.6 mtpt -88.0 -30.45 19.97 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.867 -0.521 . . . . 0.0 111.24 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.786 ' HB3' HG23 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -74.48 -36.76 63.3 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 117.982 -1.487 . . . . 0.0 109.14 -179.671 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.576 HD12 ' CA ' ' A' ' 7' ' ' ILE . 12.8 mt -77.27 -47.33 20.37 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 118.11 -1.436 . . . . 0.0 107.851 177.223 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 22' ' ' SER . . . -54.82 -33.57 61.78 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 177.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.674 ' O ' HG23 ' A' ' 31' ' ' ILE . 89.6 p -78.38 -34.03 48.47 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.735 ' HA ' ' CG1' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -66.31 -31.15 71.77 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.381 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.71 ' O ' ' HB ' ' A' ' 33' ' ' THR . 1.6 mt-10 -86.21 -33.13 20.85 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 177.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.741 ' O ' ' CG ' ' A' ' 34' ' ' GLU . 17.6 tttm -69.26 -30.63 68.79 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 176.119 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.735 ' CG1' ' HA ' ' A' ' 28' ' ' PHE . 1.8 pp -91.33 -36.18 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.35 -0.844 . . . . 0.0 109.379 178.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.823 HG21 ' CE1' ' B' ' 47' ' ' PHE . 3.4 mm -58.42 -55.23 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 177.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.834 ' OG1' HD12 ' B' ' 85' ' ' LEU . 0.3 OUTLIER -63.01 -36.88 85.04 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.559 179.862 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.741 ' CG ' ' O ' ' A' ' 30' ' ' LYS . 5.2 mm-40 -72.68 -47.05 50.53 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.758 -0.588 . . . . 0.0 111.845 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.647 HG21 ' SD ' ' B' ' 1' ' ' MET . 66.5 m -56.02 -50.78 69.96 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.536 -1.352 . . . . 0.0 109.722 -179.492 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.981 HG11 HD23 ' B' ' 85' ' ' LEU . 2.1 t -50.08 -44.54 22.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.951 ' HB1' ' O ' ' B' ' 88' ' ' ALA . . . -84.26 -4.87 59.12 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 121.746 0.784 . . . . 0.0 110.024 178.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.635 ' N ' ' O ' ' A' ' 34' ' ' GLU . 3.1 ttmt -90.66 -26.21 19.72 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 177.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.05 37.04 0.9 Allowed Glycine 0 C--N 1.302 -1.319 0 C-N-CA 120.071 -1.062 . . . . 0.0 111.185 177.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.447 ' HB3' ' CG2' ' A' ' 35' ' ' THR . 0.3 OUTLIER -145.53 140.89 27.8 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.906 -1.35 . . . . 0.0 110.713 179.356 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -92.07 93.73 8.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.666 -0.646 . . . . 0.0 109.374 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.821 HG12 ' CG ' ' B' ' 1' ' ' MET . 31.6 m -60.19 137.39 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.544 -0.723 . . . . 0.0 110.382 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.457 ' O ' ' CB ' ' B' ' 2' ' ' ASN . 3.9 mt-30 -125.7 107.92 11.02 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.413 -0.805 . . . . 0.0 110.008 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.926 HD12 ' HB3' ' A' ' 48' ' ' LEU . 24.1 mt -72.38 103.49 3.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.182 -0.949 . . . . 0.0 109.892 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.452 ' CG2' ' C ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER 33.55 -96.65 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.915 -0.491 . . . . 0.0 111.193 -179.748 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.7 28.98 2.01 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.776 ' CD1' HD21 ' A' ' 85' ' ' LEU . 1.5 p90 -129.43 -25.34 2.67 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.097 -1.237 . . . . 0.0 111.275 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.926 ' HB3' HD12 ' A' ' 44' ' ' LEU . 5.0 mt -134.79 95.85 3.42 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.45 -1.406 . . . . 0.0 110.6 178.058 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.437 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 4.5 m-20 -103.98 89.6 3.34 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.178 -0.951 . . . . 0.0 110.888 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.614 HG12 HG23 ' A' ' 79' ' ' VAL . 0.9 OUTLIER -80.31 153.46 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.393 -0.817 . . . . 0.0 110.301 179.645 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.535 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 16.0 ptmt -165.58 115.25 0.82 Allowed Pre-proline 0 N--CA 1.495 1.811 0 C-N-CA 118.969 -1.092 . . . . 0.0 110.43 178.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.943 ' HB3' HG13 ' A' ' 36' ' ' VAL . 55.3 Cg_endo -78.13 141.51 18.62 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.451 1.238 . . . . 0.0 111.089 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.666 HG22 ' O ' ' A' ' 76' ' ' GLY . 23.8 m -146.39 115.32 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-O 121.57 0.7 . . . . 0.0 110.393 179.414 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.671 ' HB2' ' HB3' ' B' ' 97' ' ' PHE . . . -31.66 106.81 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 121.086 0.47 . . . . 0.0 111.938 -178.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.03 128.31 3.15 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.261 -0.899 . . . . 0.0 109.468 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -55.53 -175.83 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.214 -0.929 . . . . 0.0 110.165 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.692 ' HA ' ' HB3' ' A' ' 72' ' ' ALA . . . -67.05 168.71 9.6 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.843 0.83 . . . . 0.0 111.462 -179.254 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.606 ' HB2' ' H ' ' A' ' 71' ' ' ILE . 1.9 mtp85 -47.31 170.43 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.259 0.552 . . . . 0.0 110.819 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.427 ' HB3' ' O ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -178.56 93.17 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.435 -0.791 . . . . 0.0 110.004 179.644 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.633 ' N ' ' HB3' ' A' ' 68' ' ' ALA . . . 172.21 -86.22 0.08 OUTLIER Glycine 0 N--CA 1.5 2.926 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.882 ' N ' ' HB2' ' A' ' 68' ' ' ALA . 0.2 OUTLIER -171.09 152.19 3.41 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.203 -1.174 . . . . 0.0 111.618 178.036 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.734 ' CB ' ' HD3' ' A' ' 63' ' ' PRO . 0.4 OUTLIER -152.95 -60.43 0.02 OUTLIER Pre-proline 0 C--N 1.307 -1.252 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.763 178.833 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.734 ' HD3' ' CB ' ' A' ' 62' ' ' ASN . 55.8 Cg_endo -102.27 -4.11 0.33 Allowed 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 121.534 1.489 . . . . 0.0 112.821 -178.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.656 ' O ' ' N ' ' A' ' 66' ' ' GLN . 5.4 mt-30 -139.57 52.67 1.72 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 120.533 -1.354 . . . . 0.0 112.397 -177.191 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.642 ' N ' ' CE1' ' A' ' 61' ' ' PHE . 8.8 t 33.06 18.38 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.656 ' N ' ' O ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER 177.68 29.55 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.533 -1.354 . . . . 0.0 112.314 179.671 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.805 ' C ' ' HA ' ' A' ' 61' ' ' PHE . 3.0 mt-10 -156.49 89.88 1.14 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.246 -1.534 . . . . 0.0 110.208 179.417 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.882 ' HB2' ' N ' ' A' ' 61' ' ' PHE . . . -75.94 72.62 2.81 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.83 HD12 HG12 ' A' ' 71' ' ' ILE . 0.3 OUTLIER -13.78 92.97 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.323 0 CA-C-O 121.725 0.774 . . . . 0.0 110.279 -178.125 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 68' ' ' ALA . 5.9 mt-10 -44.65 102.06 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.599 -177.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 1.071 ' O ' HD12 ' A' ' 71' ' ' ILE . 2.5 pp -145.5 113.81 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 O-C-N 121.288 -0.882 . . . . 0.0 111.975 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.902 ' H ' ' HD3' ' A' ' 73' ' ' PRO . . . 136.43 49.79 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.329 0 CA-C-N 115.043 -0.981 . . . . 0.0 112.312 178.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.902 ' HD3' ' H ' ' A' ' 72' ' ' ALA . 55.6 Cg_endo -85.78 77.11 2.68 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 O-C-N 122.683 0.833 . . . . 0.0 110.683 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.923 ' O ' ' HB ' ' A' ' 75' ' ' VAL . 86.2 p -178.65 19.17 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.756 -1.215 . . . . 0.0 111.221 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.923 ' HB ' ' O ' ' A' ' 74' ' ' SER . 4.4 p 136.86 -173.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.736 ' H ' HG22 ' A' ' 75' ' ' VAL . . . -123.6 61.41 0.58 Allowed Glycine 0 N--CA 1.487 2.094 0 N-CA-C 108.935 -1.666 . . . . 0.0 108.935 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.798 HG11 ' CB ' ' B' ' 84' ' ' SER . 3.4 p -47.73 82.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.803 -0.821 . . . . 0.0 110.803 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.599 ' N ' ' O ' ' A' ' 76' ' ' GLY . 0.4 OUTLIER -83.73 174.84 10.13 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 118.597 -1.241 . . . . 0.0 110.093 179.952 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.614 HG23 HG12 ' A' ' 50' ' ' ILE . 2.6 p 175.15 176.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.707 ' O ' HD23 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -177.14 173.0 0.76 Allowed Pre-proline 0 N--CA 1.485 1.324 0 O-C-N 120.934 -1.103 . . . . 0.0 110.195 177.377 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.564 ' HB2' HG13 ' B' ' 77' ' ' VAL . 55.0 Cg_endo -98.6 135.45 0.3 Allowed 'Trans proline' 0 C--N 1.302 -1.904 0 C-N-CA 122.505 2.137 . . . . 0.0 110.622 178.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.426 ' HA3' ' HA ' ' A' ' 47' ' ' PHE . . . -89.73 -158.28 34.17 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 107.956 -2.058 . . . . 0.0 107.956 178.3 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.445 ' HA ' ' HB2' ' A' ' 86' ' ' LYS . 3.4 pm0 -90.17 -16.12 30.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.029 -1.277 . . . . 0.0 110.217 179.397 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.412 ' CB ' ' HB3' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -53.42 -36.61 61.71 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.269 -0.895 . . . . 0.0 109.267 179.412 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.95 ' CB ' HG21 ' B' ' 77' ' ' VAL . 0.5 OUTLIER -82.3 -33.21 29.12 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.915 -0.714 . . . . 0.0 109.158 179.07 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.736 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 2.2 mttt -70.97 -43.83 67.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.458 -0.776 . . . . 0.0 109.755 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.4 tptt -64.71 -39.06 93.0 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 177.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.688 ' O ' ' HB1' ' B' ' 37' ' ' ALA . . . -64.55 -34.9 79.31 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 176.34 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.964 ' HA ' HD23 ' A' ' 92' ' ' LEU . . . -54.43 -46.3 73.21 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 120.036 -0.666 . . . . 0.0 109.211 179.242 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -52.65 -32.58 42.85 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 177.262 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 88' ' ' ALA . . . -64.65 -38.42 95.64 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 178.323 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.964 HD23 ' HA ' ' A' ' 89' ' ' ALA . 0.5 OUTLIER -72.45 10.37 0.83 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.537 -1.567 . . . . 0.0 111.13 -179.85 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 22.1 mmtt 61.41 41.69 12.54 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -177.403 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.544 ' CD1' ' N ' ' B' ' 75' ' ' VAL . 0.0 OUTLIER -38.0 -40.27 0.46 Allowed 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.005 -178.962 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -60.84 -39.25 88.35 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.37 -0.831 . . . . 0.0 109.769 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 93' ' ' LYS . 0.6 OUTLIER -61.02 -35.5 77.03 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.394 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.625 ' HB3' ' HB2' ' B' ' 54' ' ' ALA . 0.2 OUTLIER -73.83 -23.98 59.72 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.708 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.85 -43.53 58.34 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.502 -0.749 . . . . 0.0 110.28 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 30.2 mttt . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.17 -179.965 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.821 ' CG ' HG12 ' A' ' 42' ' ' VAL . 1.3 ptm . . . . . 0 N--CA 1.496 1.842 0 CA-C-O 121.479 0.657 . . . . 0.0 110.871 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 2' ' ' ASN . . . . . 0.457 ' CB ' ' O ' ' A' ' 43' ' ' GLN . 17.8 p30 -178.3 -152.32 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 120.106 -0.637 . . . . 0.0 110.516 178.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.484 ' HD3' HD11 ' B' ' 25' ' ' LEU . 1.0 OUTLIER -59.14 -3.22 0.35 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.147 -0.971 . . . . 0.0 110.207 179.612 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.688 ' O ' HG23 ' B' ' 7' ' ' ILE . 25.1 m -109.01 -53.26 2.67 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.003 -1.061 . . . . 0.0 109.969 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.487 ' HB3' ' CB ' ' B' ' 1' ' ' MET . 1.8 mt-10 -65.88 -46.84 76.9 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.199 -0.938 . . . . 0.0 109.532 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.688 ' O ' ' HB3' ' B' ' 9' ' ' ALA . 29.9 mt -49.05 -51.7 29.69 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.213 -0.929 . . . . 0.0 109.643 179.151 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 7' ' ' ILE . . . . . 0.929 HG21 HD22 ' B' ' 25' ' ' LEU . 0.1 OUTLIER -50.22 -51.05 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 177.414 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 8' ' ' LYS . . . . . 0.883 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.1 OUTLIER -56.15 -37.38 69.42 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.489 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 9' ' ' ALA . . . . . 0.688 ' HB3' ' O ' ' B' ' 6' ' ' LEU . . . -55.34 -36.2 66.03 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.372 -0.83 . . . . 0.0 108.825 179.063 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.786 HG23 ' HB3' ' A' ' 24' ' ' MET . 1.6 mp -89.22 -34.22 6.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 178.335 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.883 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -67.22 -12.48 60.18 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.069 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.476 ' N ' ' O ' ' B' ' 8' ' ' LYS . 8.9 tp-100 -112.61 -44.19 3.37 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' B' ' 9' ' ' ALA . 2.2 m-20 -68.89 -22.41 64.19 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 176.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.771 HG22 HD21 ' B' ' 16' ' ' LEU . 0.2 OUTLIER -120.04 -83.54 0.65 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.297 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 15' ' ' GLY . . . . . 0.546 ' O ' ' C ' ' B' ' 16' ' ' LEU . . . 68.32 -21.84 0.3 Allowed Glycine 0 N--CA 1.497 2.713 0 O-C-N 120.906 -1.121 . . . . 0.0 110.346 178.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 16' ' ' LEU . . . . . 1.075 ' CD1' HG23 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -25.57 -58.3 0.07 Allowed 'General case' 0 N--CA 1.514 2.735 0 CA-C-O 122.202 1.001 . . . . 0.0 110.794 -179.819 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 17' ' ' THR . . . . . 0.646 HG22 ' H ' ' B' ' 19' ' ' VAL . 0.5 OUTLIER -136.25 -0.89 2.42 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.419 -179.38 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 18' ' ' GLN . . . . . 0.655 ' O ' ' C ' ' B' ' 19' ' ' VAL . 4.7 mt-30 55.24 31.15 15.95 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 -176.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 1.041 HG11 HG11 ' A' ' 19' ' ' VAL . 1.2 p -4.09 -92.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.856 -178.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.934 ' O ' ' N ' ' B' ' 22' ' ' SER . 0.6 OUTLIER -133.37 25.83 4.14 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 177.803 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.692 ' O ' HD23 ' B' ' 25' ' ' LEU . 30.0 m -17.26 -37.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-O 122.426 1.107 . . . . 0.0 109.374 -178.309 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.934 ' N ' ' O ' ' B' ' 20' ' ' SER . 12.2 t -80.14 -41.24 25.79 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.904 177.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 23' ' ' LYS . . . . . 0.911 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.0 OUTLIER -87.33 -36.17 17.99 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.438 -0.789 . . . . 0.0 111.483 179.963 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 24' ' ' MET . . . . . 0.769 ' HB3' HG21 ' A' ' 14' ' ' THR . 0.0 OUTLIER -71.42 -30.09 65.67 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 118.023 -1.471 . . . . 0.0 108.512 179.367 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.929 HD22 HG21 ' B' ' 7' ' ' ILE . 0.3 OUTLIER -75.31 -41.85 55.93 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 118.662 -1.215 . . . . 0.0 107.843 177.368 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 26' ' ' ALA . . . . . 0.659 ' N ' ' HG ' ' B' ' 25' ' ' LEU . . . -68.42 -24.43 64.74 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.119 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 27' ' ' SER . . . . . 0.505 ' O ' ' HB3' ' B' ' 30' ' ' LYS . 4.5 t -84.55 -36.83 21.87 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 28' ' ' PHE . . . . . 0.764 ' CE1' HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -51.89 -53.45 40.7 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.441 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 29' ' ' GLU . . . . . 0.614 ' N ' ' CD1' ' B' ' 28' ' ' PHE . 0.1 OUTLIER -63.87 -39.04 93.27 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 177.742 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 1.269 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 19.3 tttm -56.08 -29.51 60.68 Favored 'General case' 0 C--O 1.191 -2.015 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.314 178.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.645 HD12 ' HA ' ' B' ' 28' ' ' PHE . 0.2 OUTLIER -104.46 -23.88 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 119.645 -1.909 . . . . 0.0 108.382 177.516 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.56 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.3 mm -73.1 -61.53 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 177.367 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 33' ' ' THR . . . . . 0.798 ' HA ' HD23 ' A' ' 85' ' ' LEU . 0.7 OUTLIER -67.38 -36.29 81.04 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.916 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 1.269 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 18.4 mm-40 -78.3 -35.24 48.07 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 121.07 -1.019 . . . . 0.0 111.658 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 35' ' ' THR . . . . . 0.639 HG23 ' CB ' ' B' ' 40' ' ' ASP . 3.0 m -56.39 -47.94 77.92 Favored 'General case' 0 N--CA 1.504 2.257 0 CA-C-N 120.49 1.496 . . . . 0.0 107.211 178.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.817 HG13 ' HB3' ' B' ' 52' ' ' PRO . 23.5 t -53.58 -42.32 49.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 177.359 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 0.688 ' HB1' ' O ' ' A' ' 88' ' ' ALA . . . -82.89 -1.19 51.44 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.735 178.239 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 38' ' ' LYS . . . . . 0.663 ' N ' ' O ' ' B' ' 34' ' ' GLU . 0.0 OUTLIER -100.37 -18.85 16.56 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 177.905 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.99 42.43 2.26 Favored Glycine 0 C--N 1.302 -1.321 0 C-N-CA 120.272 -0.966 . . . . 0.0 110.74 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 40' ' ' ASP . . . . . 0.639 ' CB ' HG23 ' B' ' 35' ' ' THR . 0.4 OUTLIER -144.88 150.96 37.97 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.13 -1.218 . . . . 0.0 110.159 179.276 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 63.9 mttt -97.34 92.18 5.85 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.549 -0.719 . . . . 0.0 110.238 -179.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.839 HG13 HD11 ' A' ' 6' ' ' LEU . 66.9 t -59.38 129.62 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.536 -0.728 . . . . 0.0 109.399 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 43' ' ' GLN . . . . . 0.504 ' HA ' ' O ' ' B' ' 48' ' ' LEU . 0.8 OUTLIER -125.02 103.91 8.27 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.092 -1.005 . . . . 0.0 111.123 -179.021 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.662 HD12 ' CE1' ' B' ' 47' ' ' PHE . 19.9 mt -62.96 113.97 3.4 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.225 -0.922 . . . . 0.0 109.111 178.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 45' ' ' THR . . . . . 0.562 HG22 ' HG2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 33.12 -89.87 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.499 0 O-C-N 121.832 -0.543 . . . . 0.0 110.93 -179.252 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -146.06 15.79 1.72 Allowed Glycine 0 N--CA 1.484 1.856 0 C-N-CA 119.732 -1.223 . . . . 0.0 110.338 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 47' ' ' PHE . . . . . 0.823 ' CE1' HG21 ' A' ' 32' ' ' ILE . 17.1 p90 -111.14 -37.79 5.23 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.762 -1.434 . . . . 0.0 112.113 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.642 ' HB2' HD12 ' B' ' 44' ' ' LEU . 0.0 OUTLIER -114.32 117.8 32.11 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.3 -1.5 . . . . 0.0 111.272 179.703 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -113.19 74.17 0.85 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.699 -0.626 . . . . 0.0 110.569 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 50' ' ' ILE . . . . . 0.924 HD13 ' HB ' ' B' ' 79' ' ' VAL . 3.1 mm -59.87 134.95 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.422 -0.799 . . . . 0.0 110.144 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 51' ' ' LYS . . . . . 0.602 ' HD3' HG13 ' B' ' 53' ' ' VAL . 0.0 OUTLIER -154.05 126.15 3.85 Favored Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 120.872 -1.142 . . . . 0.0 110.959 179.338 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.817 ' HB3' HG13 ' B' ' 36' ' ' VAL . 55.7 Cg_endo -83.79 142.17 10.02 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 O-C-N 123.439 1.231 . . . . 0.0 110.655 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.756 HG22 ' O ' ' B' ' 76' ' ' GLY . 27.6 m -137.88 114.78 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-O 121.762 0.791 . . . . 0.0 111.058 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.625 ' HB2' ' HB3' ' A' ' 97' ' ' PHE . . . -56.15 104.93 0.16 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.561 -0.712 . . . . 0.0 110.504 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 -130.1 82.59 2.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.613 -0.679 . . . . 0.0 109.332 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.68 -154.29 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.409 -0.807 . . . . 0.0 109.987 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 1.041 ' HB3' HD13 ' B' ' 71' ' ' ILE . . . -154.7 177.46 11.22 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.015 -1.053 . . . . 0.0 111.57 -179.345 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 58' ' ' ARG . . . . . 0.685 ' N ' HG12 ' B' ' 71' ' ' ILE . 4.8 mpt_? -57.51 -161.24 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.7 -179.594 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 59' ' ' LYS . . . . . 0.518 ' CB ' ' O ' ' B' ' 58' ' ' ARG . 0.0 OUTLIER 159.47 52.68 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.201 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 60' ' ' GLY . . . . . 0.437 ' O ' HD23 ' B' ' 69' ' ' LEU . . . -128.31 -101.47 1.06 Allowed Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.973 -1.108 . . . . 0.0 110.499 -179.254 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 61' ' ' PHE . . . . . 0.709 ' CZ ' ' HD2' ' B' ' 63' ' ' PRO . 0.0 OUTLIER -139.76 178.53 7.18 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.202 -1.175 . . . . 0.0 111.14 -178.864 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 62' ' ' ASN . . . . . 0.77 ' N ' ' HA ' ' B' ' 68' ' ' ALA . 44.5 m-80 -51.6 -114.34 0.0 OUTLIER Pre-proline 0 C--N 1.305 -1.336 0 CA-C-O 117.548 -1.215 . . . . 0.0 109.993 -178.137 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.709 ' HD2' ' CZ ' ' B' ' 61' ' ' PHE . 37.4 Cg_endo -61.08 -128.65 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.48 0 CA-C-N 121.255 1.484 . . . . 0.0 109.303 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 64' ' ' GLN . . . . . 0.648 ' HB2' ' CE1' ' B' ' 61' ' ' PHE . 4.6 tt0 61.99 -66.23 0.08 Allowed 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.286 -1.509 . . . . 0.0 108.505 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.679 ' N ' ' O ' ' B' ' 63' ' ' PRO . 7.2 p -140.0 19.62 2.46 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 177.292 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 66' ' ' GLN . . . . . 0.683 ' HA ' ' O ' ' B' ' 62' ' ' ASN . 8.5 mp0 41.69 99.18 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 122.222 1.01 . . . . 0.0 111.477 -179.022 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 67' ' ' GLU . . . . . 0.634 ' O ' ' N ' ' B' ' 69' ' ' LEU . 5.7 pt-20 168.58 71.49 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 105.118 -2.178 . . . . 0.0 105.118 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 68' ' ' ALA . . . . . 0.954 ' O ' HD12 ' B' ' 69' ' ' LEU . . . -46.66 14.82 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 116.822 2.156 . . . . 0.0 116.822 -174.003 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.954 HD12 ' O ' ' B' ' 68' ' ' ALA . 4.4 mt 122.16 17.12 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.629 0 CA-C-N 120.775 1.625 . . . . 0.0 112.372 174.083 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 70' ' ' GLU . . . . . 0.695 ' O ' HG23 ' B' ' 71' ' ' ILE . 21.7 tt0 166.68 162.39 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.397 -0.815 . . . . 0.0 110.065 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 1.041 HD13 ' HB3' ' B' ' 57' ' ' ALA . 1.0 OUTLIER -161.64 -154.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 O-C-N 121.592 -0.692 . . . . 0.0 109.366 -179.414 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -115.31 85.37 12.83 Favored Pre-proline 0 C--N 1.301 -1.503 0 O-C-N 121.229 -0.919 . . . . 0.0 112.289 -178.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 73' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -79.68 120.92 4.46 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.779 1.41 . . . . 0.0 109.827 178.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 74' ' ' SER . . . . . 0.528 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 7.5 p -177.5 158.25 1.37 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.076 -1.015 . . . . 0.0 109.849 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 75' ' ' VAL . . . . . 0.554 HG21 HD21 ' A' ' 92' ' ' LEU . 1.1 t -60.06 170.0 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.101 -0.999 . . . . 0.0 108.884 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 76' ' ' GLY . . . . . 0.756 ' O ' HG22 ' B' ' 53' ' ' VAL . . . -120.03 86.35 0.4 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.95 HG21 ' CB ' ' A' ' 85' ' ' LEU . 3.2 p -61.22 76.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.648 -0.913 . . . . 0.0 109.485 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 78' ' ' SER . . . . . 0.534 ' N ' ' O ' ' B' ' 76' ' ' GLY . 0.1 OUTLIER -77.3 177.78 7.65 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.872 0.844 . . . . 0.0 110.37 -179.884 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.924 ' HB ' HD13 ' B' ' 50' ' ' ILE . 7.0 p 177.73 174.76 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 80' ' ' LYS . . . . . 0.614 ' HB2' ' HD2' ' B' ' 81' ' ' PRO . 0.0 OUTLIER 177.17 171.75 0.39 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 120.821 -1.174 . . . . 0.0 111.14 177.493 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 81' ' ' PRO . . . . . 0.666 ' HA ' ' O ' ' B' ' 47' ' ' PHE . 51.1 Cg_endo -74.64 141.45 27.81 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.374 1.723 . . . . 0.0 110.475 176.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 82' ' ' GLY . . . . . 0.52 ' H ' ' HA ' ' B' ' 47' ' ' PHE . . . -110.31 -75.67 0.83 Allowed Glycine 0 N--CA 1.492 2.433 0 N-CA-C 106.501 -2.64 . . . . 0.0 106.501 178.079 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 83' ' ' GLU . . . . . 0.885 ' O ' ' N ' ' B' ' 85' ' ' LEU . 2.1 pt-20 -91.22 40.62 1.03 Allowed 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 176.307 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 84' ' ' SER . . . . . 1.034 ' C ' HD22 ' B' ' 85' ' ' LEU . 1.9 t 10.52 43.83 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.665 1.222 . . . . 0.0 110.302 178.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 1.034 HD22 ' C ' ' B' ' 84' ' ' SER . 0.0 OUTLIER 18.76 26.21 0.0 OUTLIER 'General case' 0 C--O 1.186 -2.287 0 N-CA-C 102.898 -3.001 . . . . 0.0 102.898 -170.669 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 86' ' ' LYS . . . . . 0.583 ' HB2' ' HB3' ' B' ' 84' ' ' SER 0.325 2.9 tttm -48.71 -38.59 21.9 Favored 'General case' 0 CA--C 1.473 -2.018 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 177.708 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . 0.27 2.9 tttt -62.54 -40.92 98.33 Favored 'General case' 0 C--N 1.275 -2.652 0 CA-C-N 111.886 -2.415 . . . . 0.0 106.137 177.276 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.951 ' O ' ' HB1' ' A' ' 37' ' ' ALA . . . -78.65 -33.57 47.08 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 118.29 -1.364 . . . . 0.0 107.989 177.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.926 ' HA ' HD23 ' B' ' 92' ' ' LEU . . . -64.73 -30.63 71.65 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.258 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -64.46 -33.92 77.01 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 175.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -64.23 -45.36 93.81 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 178.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 92' ' ' LEU . . . . . 0.926 HD23 ' HA ' ' B' ' 89' ' ' ALA . 0.5 OUTLIER -65.49 2.32 0.94 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.499 -1.589 . . . . 0.0 111.403 -179.617 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 93' ' ' LYS . . . . . 0.508 ' CB ' ' O ' ' B' ' 92' ' ' LEU . 7.0 tptt 72.9 53.91 0.14 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -177.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 94' ' ' TYR . . . . . 0.707 ' CD2' ' HA ' ' A' ' 74' ' ' SER . 6.1 t80 -38.97 -43.62 0.99 Allowed 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.008 -179.108 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -57.16 -41.19 78.75 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.304 -0.873 . . . . 0.0 109.656 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 96' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' B' ' 93' ' ' LYS . 4.1 t70 -60.89 -31.95 71.42 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 97' ' ' PHE . . . . . 0.671 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 0.1 OUTLIER -82.69 -24.75 33.52 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.924 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 98' ' ' ALA . . . . . 0.62 ' HA ' ' HB1' ' A' ' 54' ' ' ALA . . . -67.45 -31.76 72.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.448 -0.783 . . . . 0.0 109.939 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.22 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.83 ' HB3' HG22 ' B' ' 42' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 120.897 0.379 . . . . 0.0 110.291 . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.481 ' H ' ' HB2' ' A' ' 5' ' ' GLU . 16.1 p-10 -173.29 -161.62 0.14 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.398 -0.921 . . . . 0.0 111.459 178.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.586 ' HD2' ' HB ' ' B' ' 45' ' ' THR . 6.8 tttt -45.88 -21.75 0.15 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.956 -0.465 . . . . 0.0 110.116 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.656 ' O ' HG13 ' A' ' 7' ' ' ILE . 88.3 m -94.29 -66.36 0.92 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.501 -0.749 . . . . 0.0 110.662 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.501 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 4.2 mt-10 -48.98 -41.11 33.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.888 -1.133 . . . . 0.0 109.123 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.725 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 22.5 mt -53.25 -41.88 65.92 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.763 178.194 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.775 HG21 ' CD2' ' A' ' 25' ' ' LEU . 1.2 pp -59.05 -40.34 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 178.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.848 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 17.7 mtmt -62.31 -37.52 85.9 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 176.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.864 ' CB ' HD13 ' B' ' 31' ' ' ILE . . . -53.87 -36.87 63.11 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.848 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.6 mp -90.91 -31.95 5.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 178.166 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.848 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -67.45 -8.0 29.84 Favored 'General case' 0 C--N 1.284 -2.26 0 O-C-N 120.777 -1.202 . . . . 0.0 109.128 179.017 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.436 ' HB3' ' O ' ' A' ' 8' ' ' LYS . 1.5 tt0 -124.07 -38.73 2.43 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.374 -0.829 . . . . 0.0 109.961 179.008 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 9' ' ' ALA . 1.0 OUTLIER -73.18 -19.22 61.15 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 177.482 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . 1.146 HG22 ' CD1' ' A' ' 16' ' ' LEU 0.28 0.2 OUTLIER -112.1 -71.59 0.75 Allowed 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 179.516 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 57.4 18.64 30.2 Favored Glycine 0 N--CA 1.498 2.769 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 177.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.146 ' CD1' HG22 ' A' ' 14' ' ' THR . 4.9 mp -58.73 -62.75 1.63 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.419 -1.048 . . . . 0.0 109.384 179.161 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.551 ' O ' HG23 ' A' ' 17' ' ' THR . 0.5 OUTLIER -143.27 8.88 1.62 Allowed 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.242 -179.771 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.611 ' O ' ' C ' ' A' ' 19' ' ' VAL . 2.7 mt-30 58.24 26.7 14.18 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 -176.017 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 1.037 HG11 HG11 ' B' ' 19' ' ' VAL . 0.6 OUTLIER -2.26 -98.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.453 -179.306 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . 1.045 ' HB3' HD21 ' B' ' 16' ' ' LEU . 1.1 p -134.4 25.57 3.79 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 178.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.697 ' HA ' ' CE ' ' A' ' 24' ' ' MET . 28.3 m -19.36 -39.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 CA-C-O 122.55 1.166 . . . . 0.0 109.872 -178.195 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.809 ' N ' ' O ' ' A' ' 20' ' ' SER . 36.7 t -76.64 -41.85 44.28 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.118 177.492 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.967 ' N ' ' O ' ' A' ' 20' ' ' SER . 1.2 mtpt -82.78 -37.72 24.18 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.664 -0.648 . . . . 0.0 111.999 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.697 ' CE ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -69.27 -24.52 63.99 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 117.47 -1.692 . . . . 0.0 108.437 179.914 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.775 ' CD2' HG21 ' A' ' 7' ' ' ILE . 0.3 OUTLIER -75.66 -47.32 26.86 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.134 -1.027 . . . . 0.0 109.241 178.609 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.701 ' N ' ' HG ' ' A' ' 25' ' ' LEU . . . -64.0 -27.93 69.46 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 178.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.605 ' O ' HG13 ' A' ' 31' ' ' ILE . 7.2 p -85.96 -34.99 20.72 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 178.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.684 ' HE1' HD22 ' B' ' 44' ' ' LEU . 0.1 OUTLIER -58.31 -46.65 85.73 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 179.146 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.549 ' HG3' ' CE2' ' B' ' 47' ' ' PHE . 2.4 tt0 -70.95 -34.35 71.38 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 177.494 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 1.293 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 60.6 tttt -64.37 -19.1 65.27 Favored 'General case' 0 C--O 1.193 -1.888 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 177.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.642 HD12 HG12 ' A' ' 32' ' ' ILE . 1.7 pp -108.91 -29.2 2.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 120.116 -1.615 . . . . 0.0 109.062 178.107 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.642 HG12 HD12 ' A' ' 31' ' ' ILE . 1.1 mm -72.0 -55.05 14.68 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.62 HG23 ' HB2' ' B' ' 88' ' ' ALA . 0.7 OUTLIER -78.0 -32.2 51.08 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.791 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 1.293 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 73.2 mm-40 -78.75 -37.13 41.96 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 120.933 -1.104 . . . . 0.0 110.606 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.833 HG22 ' CB ' ' A' ' 40' ' ' ASP . 73.1 m -64.96 -37.45 87.68 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 177.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.037 HG21 HD22 ' B' ' 85' ' ' LEU . 1.4 t -56.75 -35.94 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 175.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.678 ' CB ' ' O ' ' B' ' 88' ' ' ALA . . . -89.46 12.67 15.8 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 176.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 34' ' ' GLU . 3.1 ttmt -130.17 17.1 5.56 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.069 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.32 40.49 10.05 Favored Glycine 0 N--CA 1.48 1.598 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.833 ' CB ' HG22 ' A' ' 35' ' ' THR . 4.8 t70 -60.68 163.23 5.7 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 122.578 1.18 . . . . 0.0 112.8 -178.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.467 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 16.8 mtmt -157.52 57.58 0.5 Allowed 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 105.9 -1.889 . . . . 0.0 105.9 176.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.771 ' CG1' HD11 ' B' ' 6' ' ' LEU . 2.2 t -95.68 150.15 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-O 121.533 0.683 . . . . 0.0 111.05 -177.547 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.469 ' O ' ' CG ' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -137.53 99.94 4.08 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.299 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.614 HD12 ' HB2' ' A' ' 48' ' ' LEU . 11.9 mt -66.78 113.3 4.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.095 -1.003 . . . . 0.0 110.17 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.562 HG23 ' CD2' ' A' ' 47' ' ' PHE . 0.1 OUTLIER 29.99 -88.93 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.21 0 O-C-N 122.038 -0.414 . . . . 0.0 111.411 179.299 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -147.6 19.49 1.48 Allowed Glycine 0 N--CA 1.484 1.884 0 C-N-CA 119.729 -1.224 . . . . 0.0 110.274 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.592 ' CE1' HG21 ' B' ' 32' ' ' ILE . 32.1 p90 -116.91 -39.2 3.29 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.759 -1.436 . . . . 0.0 111.831 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.963 HD11 HD11 ' B' ' 48' ' ' LEU . 0.1 OUTLIER -115.78 108.92 16.95 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.758 -1.214 . . . . 0.0 112.238 -179.885 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.721 ' O ' ' HB ' ' A' ' 79' ' ' VAL . 0.1 OUTLIER -92.81 68.13 4.53 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.711 -0.618 . . . . 0.0 109.675 179.002 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.836 HD13 HG21 ' A' ' 79' ' ' VAL . 48.0 mm -53.07 114.3 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.49 0 O-C-N 121.186 -0.946 . . . . 0.0 112.398 -176.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.504 ' O ' ' N ' ' A' ' 78' ' ' SER . 0.6 OUTLIER -157.39 109.65 1.86 Allowed Pre-proline 0 N--CA 1.478 0.967 0 O-C-N 121.846 -0.534 . . . . 0.0 110.293 179.973 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.569 ' HB2' HG11 ' A' ' 75' ' ' VAL . 50.2 Cg_endo -76.8 149.85 30.03 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 O-C-N 123.132 1.069 . . . . 0.0 109.86 178.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 1.046 ' O ' HG22 ' A' ' 75' ' ' VAL . 1.9 t -110.95 -142.91 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.487 -0.758 . . . . 0.0 110.17 -179.38 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.637 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . 174.06 103.64 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.377 -0.827 . . . . 0.0 109.703 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.532 ' HB3' ' O ' ' A' ' 54' ' ' ALA . 0.1 OUTLIER 162.35 72.54 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.467 0 O-C-N 121.483 -0.76 . . . . 0.0 109.85 -179.897 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.739 ' O ' ' HA ' ' A' ' 73' ' ' PRO . 7.8 mt-30 -158.57 143.68 16.31 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.098 -1.001 . . . . 0.0 110.633 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.803 ' O ' ' O ' ' A' ' 58' ' ' ARG . . . 168.58 143.81 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 122.051 0.929 . . . . 0.0 111.619 178.279 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.874 ' O ' ' N ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -22.1 -141.78 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 178.751 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.541 ' C ' ' O ' ' A' ' 58' ' ' ARG . 0.5 OUTLIER -18.07 66.78 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 122.079 0.942 . . . . 0.0 111.483 -179.003 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.874 ' N ' ' O ' ' A' ' 58' ' ' ARG . . . -167.1 -76.86 0.03 OUTLIER Glycine 0 N--CA 1.485 1.949 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.549 ' CB ' ' O ' ' A' ' 60' ' ' GLY . 2.6 t80 163.84 134.09 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.65 -0.912 . . . . 0.0 110.643 179.583 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.591 ' OD1' HD21 ' A' ' 69' ' ' LEU . 1.0 OUTLIER -71.84 179.18 1.05 Allowed Pre-proline 0 N--CA 1.489 1.477 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.608 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.42 ' HD2' ' HB3' ' A' ' 62' ' ' ASN . 47.8 Cg_endo -74.68 53.43 3.19 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.272 1.143 . . . . 0.0 109.279 178.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -121.41 -113.8 0.32 Allowed 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.339 -0.851 . . . . 0.0 111.984 -178.503 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.547 ' N ' ' HE1' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -155.78 -28.44 0.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.345 -0.847 . . . . 0.0 109.855 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.462 ' NE2' ' HB ' ' A' ' 65' ' ' THR . 0.5 OUTLIER -155.67 32.15 0.36 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.258 -0.901 . . . . 0.0 110.169 -179.838 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -119.74 99.01 6.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.267 -0.895 . . . . 0.0 110.262 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -106.36 138.61 42.23 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.398 -0.814 . . . . 0.0 110.428 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.656 ' CD1' HG22 ' A' ' 71' ' ' ILE . 0.3 OUTLIER -151.43 -169.93 3.51 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.348 -0.845 . . . . 0.0 110.199 179.912 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.518 ' HA ' ' CB ' ' A' ' 58' ' ' ARG . 0.4 OUTLIER -102.89 77.11 1.54 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.192 -0.942 . . . . 0.0 110.639 -179.62 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.849 ' H ' ' HA ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -97.39 -162.42 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-O 122.135 0.969 . . . . 0.0 110.753 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.813 ' N ' ' CG1' ' A' ' 71' ' ' ILE 0.254 . . -120.08 171.8 5.26 Favored Pre-proline 0 C--N 1.303 -1.44 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.187 178.173 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.739 ' HA ' ' O ' ' A' ' 56' ' ' GLN . 51.0 Cg_endo -85.04 132.83 4.68 Favored 'Trans proline' 0 C--N 1.3 -1.986 0 O-C-N 124.214 1.639 . . . . 0.0 110.105 178.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.624 ' N ' ' CE2' ' B' ' 94' ' ' TYR . 28.7 t -161.43 135.81 7.05 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.332 -0.855 . . . . 0.0 109.722 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 1.046 HG22 ' O ' ' A' ' 53' ' ' VAL . 0.9 OUTLIER -52.69 173.61 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.221 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.458 ' N ' ' CG1' ' A' ' 75' ' ' VAL . . . -111.94 -157.38 13.84 Favored Glycine 0 N--CA 1.475 1.283 0 C-N-CA 118.659 -1.734 . . . . 0.0 109.561 -179.287 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.79 HG12 ' CG1' ' A' ' 79' ' ' VAL . 3.5 t -139.02 85.62 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.172 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.504 ' N ' ' O ' ' A' ' 51' ' ' LYS . 0.2 OUTLIER -55.09 -45.7 75.46 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.453 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.836 HG21 HD13 ' A' ' 50' ' ' ILE 0.273 5.8 p -50.37 170.84 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-O 122.347 1.07 . . . . 0.0 112.264 -177.165 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.661 ' HB2' ' HD2' ' A' ' 81' ' ' PRO . 5.6 ptmt 174.79 177.46 0.2 Allowed Pre-proline 0 C--N 1.302 -1.499 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.661 ' HD2' ' HB2' ' A' ' 80' ' ' LYS . 36.8 Cg_endo -63.15 143.59 90.42 Favored 'Trans proline' 0 C--N 1.295 -2.249 0 N-CA-C 106.973 -1.972 . . . . 0.0 106.973 175.139 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.49 ' C ' ' H ' ' A' ' 84' ' ' SER . . . -120.77 -102.97 1.88 Allowed Glycine 0 N--CA 1.498 2.797 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -178.127 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.96 ' O ' ' N ' ' A' ' 85' ' ' LEU . 32.6 tt0 -72.38 50.51 0.23 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.117 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.653 ' HB3' ' HB2' ' A' ' 86' ' ' LYS . 2.7 t 7.86 43.54 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 122.491 1.139 . . . . 0.0 109.785 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 1.114 HD11 HG12 ' B' ' 36' ' ' VAL . 3.0 pp 18.48 27.98 0.0 OUTLIER 'General case' 0 C--O 1.196 -1.713 0 N-CA-C 103.33 -2.841 . . . . 0.0 103.33 -171.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.685 ' HA ' ' HB3' ' A' ' 89' ' ' ALA 0.335 1.6 tttt -55.71 -39.85 71.62 Favored 'General case' 0 CA--C 1.473 -2.004 0 N-CA-C 104.473 -2.418 . . . . 0.0 104.473 177.134 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.255 28.7 tttt -59.11 -41.34 87.91 Favored 'General case' 0 C--N 1.28 -2.43 0 CA-C-N 112.188 -2.278 . . . . 0.0 105.79 177.167 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.896 ' O ' ' HB1' ' B' ' 37' ' ' ALA . . . -77.76 -32.08 52.42 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 117.65 -1.62 . . . . 0.0 107.061 177.336 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.869 ' HA ' HD23 ' A' ' 92' ' ' LEU . . . -61.5 -34.32 75.29 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.21 -1.034 . . . . 0.0 108.21 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.412 ' HA ' ' CB ' ' A' ' 94' ' ' TYR . 3.9 mt-10 -60.23 -35.91 76.52 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 175.58 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -62.51 -32.88 84.7 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 178.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 1.009 HD11 ' CE1' ' A' ' 97' ' ' PHE . 0.3 OUTLIER -78.73 17.37 0.71 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.481 -1.599 . . . . 0.0 110.667 -179.81 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.745 ' O ' ' C ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER 80.12 32.47 0.19 Allowed 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -178.068 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.848 ' O ' ' N ' ' A' ' 97' ' ' PHE . 9.5 t80 -25.53 -68.22 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 117.755 -1.578 . . . . 0.0 108.25 -177.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.968 ' O ' ' N ' ' A' ' 98' ' ' ALA . 62.6 mm-40 9.72 41.07 0.0 OUTLIER 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 101.391 -3.559 . . . . 0.0 101.391 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 1.076 ' O ' ' N ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER 18.5 43.3 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 112.708 -2.042 . . . . 0.0 107.713 -172.198 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 1.009 ' CE1' HD11 ' A' ' 92' ' ' LEU . 0.0 OUTLIER 26.27 28.76 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 101.859 -3.386 . . . . 0.0 101.859 -169.465 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 1.076 ' N ' ' O ' ' A' ' 96' ' ' ASP 0.275 . . -66.1 -28.48 68.85 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 109.831 -3.349 . . . . 0.0 109.073 -179.362 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 118.039 -0.982 . . . . 0.0 110.265 179.77 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.595 ' SD ' HG21 ' A' ' 35' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 120.721 0.296 . . . . 0.0 110.309 . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 2' ' ' ASN . . . . . 0.543 ' HB3' ' O ' ' B' ' 1' ' ' MET . 25.4 p30 178.89 -143.94 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.577 178.079 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.782 ' HA ' HD11 ' B' ' 25' ' ' LEU . 3.1 mttp -55.05 -3.13 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.215 -0.928 . . . . 0.0 111.192 -179.388 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.677 ' O ' HG13 ' B' ' 7' ' ' ILE . 16.3 m -114.51 -65.03 1.23 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.898 -1.126 . . . . 0.0 110.573 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.539 ' HB2' ' HA ' ' B' ' 1' ' ' MET . 9.2 mp0 -49.02 -44.72 41.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.84 -1.163 . . . . 0.0 108.909 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.771 HD11 ' CG1' ' A' ' 42' ' ' VAL . 20.1 mt -57.01 -34.47 68.2 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.125 -1.03 . . . . 0.0 109.648 178.327 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 7' ' ' ILE . . . . . 0.825 HG22 HD23 ' B' ' 25' ' ' LEU . 1.1 pp -57.63 -43.43 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 178.215 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 8' ' ' LYS . . . . . 0.912 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.0 OUTLIER -63.7 -32.55 74.08 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 177.926 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 9' ' ' ALA . . . . . 0.696 ' HB3' ' O ' ' B' ' 6' ' ' LEU . . . -55.18 -40.94 71.26 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.439 -0.788 . . . . 0.0 109.162 178.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.816 HG22 HG12 ' B' ' 21' ' ' VAL . 1.1 mp -91.44 -29.79 4.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 178.22 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.912 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -65.99 -15.42 62.99 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.268 -0.973 . . . . 0.0 108.399 178.02 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.471 ' HB3' ' O ' ' B' ' 8' ' ' LYS . 1.8 tp60 -112.31 -42.99 3.59 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.583 ' OD2' HG21 ' A' ' 31' ' ' ILE . 18.8 m-20 -59.83 -39.97 86.92 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 177.118 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.785 HG21 ' CG2' ' A' ' 19' ' ' VAL . 0.2 OUTLIER -98.83 -71.69 0.68 Allowed 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 113.858 -1.519 . . . . 0.0 108.504 179.387 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 47.26 27.39 3.85 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 16' ' ' LEU . . . . . 1.045 HD21 ' HB3' ' A' ' 20' ' ' SER . 0.4 OUTLIER -91.6 -28.56 17.44 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.543 -0.975 . . . . 0.0 108.814 178.89 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 17' ' ' THR . . . . . 0.805 ' N ' HD12 ' B' ' 16' ' ' LEU . 0.7 OUTLIER -147.39 -13.94 0.4 Allowed 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.893 -0.504 . . . . 0.0 110.342 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 18' ' ' GLN . . . . . 0.446 ' O ' ' O ' ' B' ' 19' ' ' VAL . 3.1 mt-30 57.36 43.71 22.86 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -177.313 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 1.037 HG11 HG11 ' A' ' 19' ' ' VAL . 1.4 p -34.5 -94.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.96 -178.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.918 ' O ' ' N ' ' B' ' 23' ' ' LYS . 0.4 OUTLIER -134.16 25.19 3.88 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 178.845 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.816 HG12 HG22 ' B' ' 10' ' ' ILE . 31.1 m -17.28 -39.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-O 122.642 1.211 . . . . 0.0 109.574 -178.149 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.896 ' N ' ' O ' ' B' ' 20' ' ' SER . 38.2 p -85.67 -38.43 18.36 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.071 178.334 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 23' ' ' LYS . . . . . 0.918 ' N ' ' O ' ' B' ' 20' ' ' SER . 1.8 mtpt -86.1 -29.91 22.98 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.463 -0.773 . . . . 0.0 111.092 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 24' ' ' MET . . . . . 0.917 ' HB3' HG21 ' A' ' 14' ' ' THR . 0.0 OUTLIER -80.66 -35.08 34.28 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.588 -1.32 . . . . 0.0 110.093 179.856 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.893 ' C ' HD12 ' B' ' 25' ' ' LEU . 0.1 OUTLIER -79.81 -43.06 23.11 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 118.099 -1.441 . . . . 0.0 107.368 177.955 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 26' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' B' ' 22' ' ' SER . . . -59.75 -25.25 64.71 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 176.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 27' ' ' SER . . . . . 0.565 ' HA ' ' HB3' ' B' ' 30' ' ' LYS . 4.3 t -81.24 -36.81 29.52 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.154 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 28' ' ' PHE . . . . . 0.758 ' HA ' ' CG1' ' B' ' 31' ' ' ILE . 0.0 OUTLIER -60.96 -36.43 79.37 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.769 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 29' ' ' GLU . . . . . 0.674 ' O ' ' HB ' ' B' ' 33' ' ' THR . 9.2 mt-10 -77.55 -34.5 53.81 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 177.184 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 1.012 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 64.0 tttt -68.42 -25.4 65.01 Favored 'General case' 0 C--O 1.192 -1.97 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 177.332 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.864 HD13 ' CB ' ' A' ' 9' ' ' ALA . 1.1 pp -100.81 -29.85 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 120.983 -1.073 . . . . 0.0 109.518 178.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.703 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.1 mm -66.02 -57.32 11.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 176.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 33' ' ' THR . . . . . 0.98 ' O ' HD13 ' A' ' 85' ' ' LEU . 0.5 OUTLIER -65.26 -38.48 90.46 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.474 179.172 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 1.012 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 23.9 mm-40 -75.21 -38.9 60.5 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.37 -0.831 . . . . 0.0 112.067 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 35' ' ' THR . . . . . 0.512 ' N ' ' O ' ' B' ' 31' ' ' ILE . 44.1 m -59.57 -54.59 44.79 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.334 -1.479 . . . . 0.0 109.425 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 1.114 HG12 HD11 ' A' ' 85' ' ' LEU . 2.6 t -54.32 -36.23 32.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 177.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 0.896 ' HB1' ' O ' ' A' ' 88' ' ' ALA . . . -88.49 4.8 45.31 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.686 0.755 . . . . 0.0 109.823 177.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 38' ' ' LYS . . . . . 0.73 ' N ' ' O ' ' B' ' 34' ' ' GLU . 1.2 tppp? -105.26 -32.9 8.41 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 178.263 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.21 35.03 0.44 Allowed Glycine 0 C--N 1.301 -1.397 0 C-N-CA 119.661 -1.256 . . . . 0.0 111.092 177.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 40' ' ' ASP . . . . . 0.44 ' HB3' ' CG2' ' B' ' 35' ' ' THR . 0.2 OUTLIER -147.14 173.05 12.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.011 -1.288 . . . . 0.0 110.543 179.523 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.424 ' HB3' ' HB2' ' B' ' 51' ' ' LYS . 0.0 OUTLIER -127.65 114.53 17.47 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.651 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.83 HG22 ' HB3' ' A' ' 1' ' ' MET . 38.4 t -98.96 131.02 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.572 -178.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 43' ' ' GLN . . . . . 0.454 ' HG3' ' CB ' ' A' ' 2' ' ' ASN . 0.0 OUTLIER -111.51 123.61 50.58 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.259 -0.9 . . . . 0.0 110.547 180.0 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.871 HD12 ' HB3' ' B' ' 48' ' ' LEU . 16.4 mt -84.04 102.69 12.68 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.267 -0.896 . . . . 0.0 109.705 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 45' ' ' THR . . . . . 0.586 ' HB ' ' HD2' ' A' ' 3' ' ' LYS . 0.1 OUTLIER 34.98 -91.97 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.975 -0.453 . . . . 0.0 111.125 -179.777 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -148.85 20.1 1.26 Allowed Glycine 0 N--CA 1.487 2.095 0 N-CA-C 110.089 -1.205 . . . . 0.0 110.089 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 47' ' ' PHE . . . . . 0.584 ' CZ ' HD13 ' B' ' 44' ' ' LEU . 3.8 p90 -116.61 -33.6 4.81 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.056 -1.261 . . . . 0.0 111.079 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.963 HD11 HD11 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -119.58 178.9 4.39 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.626 -1.296 . . . . 0.0 111.797 179.227 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 49' ' ' ASN . . . . . 0.675 ' O ' ' HB ' ' B' ' 79' ' ' VAL . 2.0 m-80 -165.98 145.05 6.04 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 50' ' ' ILE . . . . . 1.071 ' HA ' HG21 ' B' ' 79' ' ' VAL . 1.6 pp -146.59 101.61 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-O 122.131 0.967 . . . . 0.0 110.636 178.394 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 51' ' ' LYS . . . . . 0.535 ' N ' HG11 ' B' ' 79' ' ' VAL . 0.1 OUTLIER -147.94 133.14 9.17 Favored Pre-proline 0 N--CA 1.495 1.782 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.919 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.836 ' CG ' HG13 ' B' ' 36' ' ' VAL . 58.0 Cg_endo -95.71 153.18 1.5 Allowed 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.305 1.16 . . . . 0.0 112.49 -178.361 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 1.003 HG22 ' O ' ' B' ' 76' ' ' GLY . 27.9 m -134.57 112.92 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 CA-C-O 122.017 0.913 . . . . 0.0 109.965 176.551 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.93 ' HB1' ' CB ' ' A' ' 96' ' ' ASP . . . -51.67 118.89 3.68 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.687 -0.633 . . . . 0.0 111.662 -178.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 5.3 ttm-85 -163.91 126.96 2.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.445 -0.784 . . . . 0.0 109.372 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -59.45 -161.29 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.285 -0.884 . . . . 0.0 110.026 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.989 ' HB1' HD11 ' B' ' 71' ' ' ILE . . . -168.24 -162.14 0.4 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.017 -1.052 . . . . 0.0 111.743 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 58' ' ' ARG . . . . . 0.668 ' O ' ' HB3' ' B' ' 59' ' ' LYS . 0.0 OUTLIER -69.04 143.17 54.36 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.9 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 59' ' ' LYS . . . . . 0.668 ' HB3' ' O ' ' B' ' 58' ' ' ARG . 1.6 ttpp 139.39 126.84 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.601 0 C-N-CA 123.878 0.871 . . . . 0.0 109.371 177.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 60' ' ' GLY . . . . . 0.523 ' O ' ' C ' ' B' ' 61' ' ' PHE . . . 96.49 70.98 1.06 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 61' ' ' PHE . . . . . 0.665 ' CB ' ' HA ' ' B' ' 68' ' ' ALA . 0.1 OUTLIER -19.94 140.55 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.339 0 CA-C-O 121.443 0.639 . . . . 0.0 112.311 -179.501 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 62' ' ' ASN . . . . . 0.43 ' O ' ' N ' ' B' ' 64' ' ' GLN . 1.0 OUTLIER -49.96 169.0 0.2 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.283 -0.886 . . . . 0.0 109.064 179.478 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -69.3 62.62 1.52 Allowed 'Trans proline' 0 C--N 1.303 -1.826 0 O-C-N 123.442 1.233 . . . . 0.0 109.286 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 64' ' ' GLN . . . . . 0.463 ' C ' HG23 ' B' ' 65' ' ' THR . 36.0 tp60 -127.05 -122.45 0.24 Allowed 'General case' 0 C--N 1.312 -1.044 0 O-C-N 121.327 -0.858 . . . . 0.0 110.574 -179.161 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.463 HG23 ' C ' ' B' ' 64' ' ' GLN . 82.2 p -149.01 10.84 0.81 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.233 -0.917 . . . . 0.0 110.329 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 66' ' ' GLN . . . . . 0.497 ' NE2' ' N ' ' B' ' 67' ' ' GLU . 1.6 pm0 -174.94 -18.42 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.1 -1.0 . . . . 0.0 112.367 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 67' ' ' GLU . . . . . 0.497 ' N ' ' NE2' ' B' ' 66' ' ' GLN . 11.0 tt0 -66.89 76.49 0.12 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.656 -1.278 . . . . 0.0 110.203 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 68' ' ' ALA . . . . . 0.665 ' HA ' ' CB ' ' B' ' 61' ' ' PHE . . . -69.95 167.87 16.54 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.633 -0.667 . . . . 0.0 111.31 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.589 ' HB3' ' HG3' ' B' ' 58' ' ' ARG . 95.3 mt -125.23 -139.85 0.28 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.653 -0.654 . . . . 0.0 110.359 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 70' ' ' GLU . . . . . 0.907 ' O ' ' O ' ' B' ' 71' ' ' ILE . 4.1 tt0 -166.8 -129.22 0.02 OUTLIER 'General case' 0 C--O 1.204 -1.311 0 O-C-N 120.771 -1.206 . . . . 0.0 111.085 -177.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.989 HD11 ' HB1' ' B' ' 57' ' ' ALA . 0.5 OUTLIER -8.65 -150.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -177.132 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 72' ' ' ALA . . . . . 0.741 ' O ' ' HB3' ' B' ' 57' ' ' ALA . . . -154.62 165.67 17.61 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 120.121 -1.612 . . . . 0.0 112.862 -177.196 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 73' ' ' PRO . . . . . 0.608 ' HD2' ' HB1' ' B' ' 72' ' ' ALA . 42.9 Cg_endo -69.87 128.1 15.44 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 124.844 1.97 . . . . 0.0 109.817 178.496 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 74' ' ' SER . . . . . 0.53 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 69.0 m -166.18 161.95 17.27 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 75' ' ' VAL . . . . . 0.597 ' HB ' ' HB1' ' A' ' 89' ' ' ALA . 0.4 OUTLIER -51.53 168.77 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.874 -1.141 . . . . 0.0 108.911 -179.563 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 76' ' ' GLY . . . . . 1.003 ' O ' HG22 ' B' ' 53' ' ' VAL . . . -118.02 99.3 0.8 Allowed Glycine 0 N--CA 1.486 1.968 0 C-N-CA 119.217 -1.468 . . . . 0.0 109.642 -179.21 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.648 ' O ' HG12 ' B' ' 77' ' ' VAL . 2.1 t -60.71 88.08 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 179.135 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 78' ' ' SER . . . . . 0.621 ' OG ' HG13 ' B' ' 53' ' ' VAL . 0.8 OUTLIER -58.06 -48.25 80.7 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.564 -178.057 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 1.071 HG21 ' HA ' ' B' ' 50' ' ' ILE . 27.2 m -49.46 177.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 115.224 1.564 . . . . 0.0 115.224 -174.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 80' ' ' LYS . . . . . 0.658 ' HB2' ' HD2' ' B' ' 81' ' ' PRO . 0.0 OUTLIER 179.56 178.97 0.28 Allowed Pre-proline 0 N--CA 1.481 1.087 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.161 -179.051 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 81' ' ' PRO . . . . . 0.678 ' HB2' HG11 ' A' ' 77' ' ' VAL . 41.8 Cg_endo -70.21 130.99 19.7 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.372 1.196 . . . . 0.0 110.78 179.092 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -82.18 -157.99 22.03 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 83' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' B' ' 87' ' ' LYS . 11.1 pt-20 -83.73 -21.25 32.34 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.574 -0.956 . . . . 0.0 110.842 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 84' ' ' SER . . . . . 0.513 ' HB3' ' HB3' ' B' ' 47' ' ' PHE . 0.4 OUTLIER -56.28 -45.39 80.16 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.032 -1.042 . . . . 0.0 109.282 -179.682 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 1.037 HD22 HG21 ' A' ' 36' ' ' VAL . 12.8 mt -61.6 -32.53 72.65 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.246 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 86' ' ' LYS . . . . . 0.564 ' O ' ' HB3' ' B' ' 89' ' ' ALA . 1.7 tttp -82.7 -31.32 28.62 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.642 0.734 . . . . 0.0 109.799 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 87' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' B' ' 83' ' ' GLU . 9.8 tmtt? -73.56 -38.97 65.04 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.678 ' O ' ' CB ' ' A' ' 37' ' ' ALA . . . -66.71 -34.73 78.49 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 176.665 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.914 ' HB1' ' CG1' ' A' ' 75' ' ' VAL . . . -53.39 -46.16 69.58 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.406 -0.809 . . . . 0.0 109.448 178.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.408 ' HG2' ' N ' ' B' ' 91' ' ' GLY . 1.5 pt-20 -56.5 -29.71 62.13 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 176.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 91' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' B' ' 88' ' ' ALA . . . -64.72 -34.21 89.28 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 178.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 92' ' ' LEU . . . . . 1.031 HD21 HG21 ' A' ' 75' ' ' VAL . 1.5 pp -71.06 20.8 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 CA-C-N 119.928 1.864 . . . . 0.0 110.947 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 93' ' ' LYS . . . . . 0.461 ' H ' ' C ' ' B' ' 91' ' ' GLY . 0.2 OUTLIER 59.42 44.33 15.21 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 106.044 -1.835 . . . . 0.0 106.044 -177.656 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 94' ' ' TYR . . . . . 0.732 ' CD1' HG23 ' A' ' 75' ' ' VAL . 0.3 OUTLIER -35.53 -42.24 0.22 Allowed 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.044 -178.233 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -52.85 -41.39 64.23 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.206 -0.934 . . . . 0.0 109.5 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 96' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' B' ' 93' ' ' LYS . 0.4 OUTLIER -65.14 -30.4 71.32 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.141 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 97' ' ' PHE . . . . . 0.458 ' HB2' HD11 ' B' ' 92' ' ' LEU . 0.1 OUTLIER -85.18 -16.41 40.46 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.625 -0.672 . . . . 0.0 109.371 178.609 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 98' ' ' ALA . . . . . 0.444 ' HB2' ' CE1' ' B' ' 94' ' ' TYR . . . -74.14 -39.47 63.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.521 -0.737 . . . . 0.0 110.057 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.201 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.479 ' HG2' ' HB3' ' A' ' 5' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.139 0.495 . . . . 0.0 110.132 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.443 ' N ' ' HB2' ' A' ' 5' ' ' GLU . 4.4 p30 173.05 173.26 0.12 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.489 -0.757 . . . . 0.0 110.337 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.747 ' HD2' HD13 ' A' ' 25' ' ' LEU . 2.2 mmmp? -43.19 -26.16 0.15 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.627 -0.671 . . . . 0.0 110.555 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.54 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 5.7 m -85.83 -55.46 3.96 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.247 -0.908 . . . . 0.0 109.027 178.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.481 ' HA ' ' CE ' ' A' ' 8' ' ' LYS . 1.0 OUTLIER -60.2 -48.76 80.36 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.697 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.795 HD11 ' CG2' ' B' ' 42' ' ' VAL . 9.5 mt -57.56 -33.24 67.94 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.575 -0.85 . . . . 0.0 108.718 177.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 1.015 ' CD1' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -54.79 -54.09 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 178.373 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.927 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -68.74 -27.86 66.3 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.65 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 6' ' ' LEU . . . -59.49 -33.86 71.86 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.289 -0.882 . . . . 0.0 108.795 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.927 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.8 OUTLIER -95.75 -37.02 7.05 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.528 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 178.429 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.927 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -60.18 -26.93 66.72 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.316 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.418 ' CG ' ' O ' ' A' ' 8' ' ' LYS . 1.4 pp0? -92.91 -37.56 12.18 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.536 ' HB3' ' CB ' ' B' ' 27' ' ' SER . 21.8 m-20 -69.08 -29.59 67.72 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 176.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . 1.016 HG22 ' HB2' ' B' ' 20' ' ' SER . 16.6 p -85.82 -75.77 0.36 Allowed 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 177.506 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 55.26 15.25 7.27 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.774 HD11 ' OG ' ' B' ' 20' ' ' SER . 0.7 OUTLIER -80.92 -51.53 8.47 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.251 -1.146 . . . . 0.0 107.989 178.702 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.685 HG22 ' H ' ' A' ' 19' ' ' VAL . 0.5 OUTLIER -144.8 -2.21 0.84 Allowed 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.897 -179.847 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.671 ' O ' ' C ' ' A' ' 19' ' ' VAL . 6.7 mt-30 56.23 30.07 15.96 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 -176.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.978 HG23 HD13 ' B' ' 16' ' ' LEU . 0.4 OUTLIER 3.78 -97.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.868 -179.399 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . 1.022 ' O ' ' N ' ' A' ' 22' ' ' SER . 6.1 p -134.98 24.14 3.58 Favored 'General case' 0 C--N 1.28 -2.456 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 176.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.771 ' HA ' ' CE ' ' A' ' 24' ' ' MET . 18.1 m -5.14 -44.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-O 122.447 1.118 . . . . 0.0 110.719 -177.639 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . 1.022 ' N ' ' O ' ' A' ' 20' ' ' SER . 33.3 m -71.22 -41.79 69.74 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.88 178.242 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.89 ' N ' ' O ' ' A' ' 20' ' ' SER . 5.0 mtpt -85.87 -32.61 21.6 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.459 -0.776 . . . . 0.0 111.486 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.771 ' CE ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -65.82 -26.83 67.86 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 116.938 -1.905 . . . . 0.0 108.158 179.277 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 1.015 HD23 ' CD1' ' A' ' 7' ' ' ILE . 0.1 OUTLIER -77.88 -49.68 13.74 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 177.727 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.563 ' N ' HD12 ' A' ' 25' ' ' LEU . . . -57.79 -29.72 65.09 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.191 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.525 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 1.6 t -83.39 -38.92 21.33 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.118 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.65 ' CZ ' HD13 ' B' ' 44' ' ' LEU . 19.7 t80 -53.32 -48.09 68.73 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.212 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.638 ' HG3' HG21 ' B' ' 45' ' ' THR . 0.1 OUTLIER -66.86 -38.76 86.95 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 176.332 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 1.273 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 42.2 tttt -60.79 -19.56 59.74 Favored 'General case' 0 C--O 1.194 -1.836 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.479 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.717 HD13 ' HB1' ' B' ' 9' ' ' ALA . 0.9 OUTLIER -112.74 -23.46 4.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 O-C-N 119.996 -1.69 . . . . 0.0 109.904 178.641 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.649 HG21 ' CE1' ' B' ' 47' ' ' PHE . 1.3 mm -82.46 -49.68 16.88 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 176.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.494 ' OG1' ' O ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -77.48 -38.88 48.27 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.564 178.677 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 1.273 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 64.2 mm-40 -74.16 -28.5 61.34 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.946 -1.096 . . . . 0.0 111.157 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.731 HG22 ' CA ' ' A' ' 40' ' ' ASP . 87.8 m -78.09 -42.29 32.53 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 118.19 -1.404 . . . . 0.0 109.425 179.22 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.715 HG13 ' HB1' ' B' ' 88' ' ' ALA . 3.4 p -54.42 -41.22 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 177.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.698 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -78.85 -2.71 41.04 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.806 -0.758 . . . . 0.0 110.115 178.363 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -113.66 1.25 14.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.925 -1.109 . . . . 0.0 108.982 177.697 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.33 35.77 2.82 Favored Glycine 0 N--CA 1.484 1.887 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.731 ' CA ' HG22 ' A' ' 35' ' ' THR . 12.4 t70 -47.15 165.22 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 122.619 1.2 . . . . 0.0 112.912 -179.156 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.422 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 8.2 mttt -174.21 58.39 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 178.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.844 HG12 ' CB ' ' B' ' 1' ' ' MET . 12.0 m -93.39 132.63 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 CA-C-O 121.606 0.717 . . . . 0.0 111.324 -177.621 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.443 ' O ' ' CG ' ' A' ' 43' ' ' GLN . 1.1 tt0 -118.35 102.29 8.84 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.954 HD12 ' HB3' ' A' ' 48' ' ' LEU . 72.1 mt -70.52 104.45 2.78 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.093 -1.005 . . . . 0.0 110.166 -179.034 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.457 ' CG2' ' C ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER 33.36 -92.48 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.141 0 O-C-N 122.09 -0.381 . . . . 0.0 111.064 179.965 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -149.49 34.7 1.06 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.802 ' CD1' HD21 ' A' ' 85' ' ' LEU . 1.5 p90 -133.69 -26.1 1.61 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.111 -1.229 . . . . 0.0 111.617 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.954 ' HB3' HD12 ' A' ' 44' ' ' LEU . 5.7 mt -139.72 104.9 5.01 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.603 -1.311 . . . . 0.0 110.605 178.324 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.802 ' C ' HG23 ' A' ' 79' ' ' VAL . 1.5 t30 -106.12 76.79 1.18 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.165 -0.959 . . . . 0.0 110.716 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.888 HD13 ' HB ' ' A' ' 79' ' ' VAL . 1.4 mm -64.29 109.98 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.187 -0.946 . . . . 0.0 109.849 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.51 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -131.06 119.59 17.92 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.053 -1.029 . . . . 0.0 109.84 -179.913 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.568 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 54.0 Cg_endo -79.42 139.28 14.45 Favored 'Trans proline' 0 C--N 1.316 -1.146 0 O-C-N 123.39 1.205 . . . . 0.0 111.832 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.723 HG22 ' O ' ' A' ' 76' ' ' GLY . 33.9 m -144.24 117.7 3.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.359 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.687 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . -42.33 120.23 1.59 Allowed 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 121.626 0.727 . . . . 0.0 111.96 -178.667 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.41 78.24 1.32 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.26 -159.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.591 0.71 . . . . 0.0 111.121 -178.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.909 ' HB3' HD13 ' A' ' 71' ' ' ILE . . . -155.11 170.2 22.36 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.49 -0.756 . . . . 0.0 110.03 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.73 ' O ' HG13 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -84.34 107.48 16.65 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.553 -0.717 . . . . 0.0 112.072 -179.397 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.404 ' O ' ' O ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -54.32 -178.05 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.22 -0.925 . . . . 0.0 109.596 178.686 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.513 ' HA3' ' O ' ' A' ' 69' ' ' LEU . . . -109.6 121.95 6.26 Favored Glycine 0 N--CA 1.484 1.836 0 C-N-CA 119.181 -1.485 . . . . 0.0 111.707 -178.395 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.881 ' CE1' ' HB3' ' A' ' 64' ' ' GLN . 1.3 p90 -162.37 157.63 22.89 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 121.462 -1.022 . . . . 0.0 111.694 178.148 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.861 ' H ' ' CD ' ' A' ' 63' ' ' PRO . 5.1 p-10 -142.59 -11.37 0.01 OUTLIER Pre-proline 0 C--N 1.299 -1.612 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 178.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.861 ' CD ' ' H ' ' A' ' 62' ' ' ASN . 49.9 Cg_endo -78.18 -10.77 16.37 Favored 'Trans proline' 0 N--CA 1.483 0.864 0 N-CA-C 109.798 -0.885 . . . . 0.0 109.798 178.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.881 ' HB3' ' CE1' ' A' ' 61' ' ' PHE . 41.9 tp60 -90.25 -106.4 0.09 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.325 -0.859 . . . . 0.0 109.837 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.469 ' O ' ' CB ' ' A' ' 66' ' ' GLN . 15.5 p -73.96 -1.02 18.02 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.576 -1.327 . . . . 0.0 110.091 179.129 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.599 ' O ' ' HB3' ' A' ' 67' ' ' GLU . 0.4 OUTLIER 75.31 104.29 0.07 Allowed 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.589 -0.694 . . . . 0.0 111.416 179.663 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.631 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 4.1 pt-20 153.29 77.65 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.847 ' O ' HD23 ' A' ' 69' ' ' LEU . . . -59.72 136.67 58.07 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.158 -0.964 . . . . 0.0 109.712 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.847 HD23 ' O ' ' A' ' 68' ' ' ALA . 2.1 mt -142.11 -138.81 0.11 Allowed 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.582 -0.698 . . . . 0.0 110.615 -178.394 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.691 ' O ' HG23 ' A' ' 71' ' ' ILE . 2.1 tt0 143.87 139.4 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.775 0 CA-C-O 121.344 0.592 . . . . 0.0 109.871 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.909 HD13 ' HB3' ' A' ' 57' ' ' ALA . 0.8 OUTLIER -164.38 -155.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -179.512 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.43 ' HA ' ' HD2' ' A' ' 73' ' ' PRO . . . -129.91 87.11 52.87 Favored Pre-proline 0 C--N 1.303 -1.434 0 O-C-N 121.262 -0.899 . . . . 0.0 111.566 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.553 ' HD3' HD13 ' A' ' 71' ' ' ILE . 38.0 Cg_endo -62.85 119.5 6.61 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 O-C-N 123.61 1.321 . . . . 0.0 110.739 178.435 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.51 ' HA ' ' CD1' ' B' ' 94' ' ' TYR . 1.0 OUTLIER -171.07 166.06 7.39 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.317 -0.864 . . . . 0.0 109.818 179.856 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.774 HG12 ' CB ' ' B' ' 89' ' ' ALA . 0.4 OUTLIER -54.97 -179.66 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.047 -1.033 . . . . 0.0 109.584 179.766 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.723 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -123.76 86.45 0.38 Allowed Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.927 HG21 ' CD1' ' B' ' 85' ' ' LEU . 4.7 p -64.77 68.9 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.549 -0.971 . . . . 0.0 108.697 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.563 ' O ' ' HB ' ' A' ' 79' ' ' VAL . 1.0 OUTLIER -65.42 174.49 2.14 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.903 0.859 . . . . 0.0 110.983 -178.517 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.888 ' HB ' HD13 ' A' ' 50' ' ' ILE . 4.9 p 174.79 -168.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.846 ' O ' HD23 ' A' ' 48' ' ' LEU . 7.6 pttt -172.98 172.26 1.63 Allowed Pre-proline 0 N--CA 1.485 1.279 0 O-C-N 120.678 -1.264 . . . . 0.0 111.235 177.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.806 ' HB3' HG12 ' B' ' 77' ' ' VAL . 55.3 Cg_endo -93.3 87.3 0.16 Allowed 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 122.635 2.223 . . . . 0.0 109.472 178.254 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.747 ' O ' HD12 ' A' ' 85' ' ' LEU . . . -58.73 158.05 19.98 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 87' ' ' LYS . 13.7 pt-20 -55.21 -17.27 4.15 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.219 -1.165 . . . . 0.0 111.07 -179.229 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.507 ' CB ' ' HB3' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -55.8 -35.89 66.82 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.85 -1.156 . . . . 0.0 109.317 179.426 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.802 HD21 ' CD1' ' A' ' 47' ' ' PHE . 0.7 OUTLIER -81.74 -37.8 26.71 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.894 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.449 ' N ' HG21 ' B' ' 77' ' ' VAL . 0.6 OUTLIER -75.0 -30.95 61.29 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.448 0.642 . . . . 0.0 110.368 -179.429 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.431 ' HA ' ' HG2' ' A' ' 90' ' ' GLU . 16.2 ttpt -78.1 -34.66 49.97 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.659 ' O ' ' HG ' ' A' ' 92' ' ' LEU . . . -71.59 -32.18 67.77 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 177.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.702 ' HA ' ' HA ' ' B' ' 37' ' ' ALA . . . -73.02 -54.12 9.39 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.538 -0.726 . . . . 0.0 110.484 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.588 ' HA ' ' HB3' ' A' ' 94' ' ' TYR . 19.1 pt-20 -53.86 -21.42 7.59 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 177.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.706 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -83.66 -28.87 34.06 Favored Glycine 0 CA--C 1.54 1.629 0 CA-C-O 119.093 -0.837 . . . . 0.0 112.335 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.725 HD12 ' C ' ' B' ' 37' ' ' ALA . 2.3 mt -97.88 -74.1 0.59 Allowed 'General case' 0 N--CA 1.5 2.026 0 CA-C-N 121.425 2.613 . . . . 0.0 111.816 -178.332 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -146.87 42.61 1.14 Allowed 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 119.244 -0.982 . . . . 0.0 111.385 -178.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.588 ' HB3' ' HA ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -60.63 -48.41 81.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.279 -0.888 . . . . 0.0 108.824 178.857 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -66.07 -36.45 83.23 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.554 -0.716 . . . . 0.0 109.301 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.0 -30.47 61.88 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.534 ' CB ' ' HB2' ' B' ' 54' ' ' ALA . 6.5 m-85 -79.07 -33.74 44.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.618 -0.676 . . . . 0.0 109.274 178.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.49 ' HB2' ' HB1' ' B' ' 54' ' ' ALA . . . -64.08 -28.42 69.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.615 -0.678 . . . . 0.0 110.148 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 18.6 mtmt . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.195 179.931 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.844 ' CB ' HG12 ' A' ' 42' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.126 0.489 . . . . 0.0 110.223 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 2' ' ' ASN . . . . . 0.532 ' H ' ' HB2' ' B' ' 5' ' ' GLU . 0.6 OUTLIER 178.3 178.21 0.4 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.39 -0.819 . . . . 0.0 109.834 -179.426 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.663 ' O ' HD22 ' B' ' 25' ' ' LEU . 0.1 OUTLIER -51.34 -23.86 4.09 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.764 -0.774 . . . . 0.0 108.975 178.915 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.512 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 30.4 m -90.22 -53.58 4.4 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.664 0.745 . . . . 0.0 109.51 178.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.532 ' HB2' ' H ' ' B' ' 2' ' ' ASN . 8.6 mm-40 -59.19 -49.23 78.64 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.701 ' O ' ' HB3' ' B' ' 9' ' ' ALA . 17.6 mt -54.42 -37.23 64.86 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.227 -0.989 . . . . 0.0 108.506 177.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 7' ' ' ILE . . . . . 0.999 ' CD1' HD23 ' B' ' 25' ' ' LEU . 0.1 OUTLIER -51.7 -51.27 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 177.604 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 8' ' ' LYS . . . . . 0.962 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.0 OUTLIER -64.79 -29.67 70.64 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.539 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 9' ' ' ALA . . . . . 0.717 ' HB1' HD13 ' A' ' 31' ' ' ILE . . . -53.57 -38.19 63.64 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.294 -0.879 . . . . 0.0 108.64 178.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.761 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.1 mp -97.41 -33.72 4.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.056 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.962 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -66.23 -12.3 55.33 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 118.579 -1.248 . . . . 0.0 109.197 178.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.453 ' N ' ' O ' ' B' ' 8' ' ' LYS . 23.3 mm100 -113.22 -41.67 3.66 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.345 -0.847 . . . . 0.0 109.525 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.457 ' CB ' ' OG ' ' A' ' 27' ' ' SER . 1.1 m-20 -70.67 -31.12 67.91 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 177.133 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 14' ' ' THR . . . . . 1.049 HG22 ' CD1' ' B' ' 16' ' ' LEU . 0.1 OUTLIER -106.63 -84.04 0.52 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 177.752 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 15' ' ' GLY . . . . . 0.592 ' O ' ' C ' ' B' ' 16' ' ' LEU . . . 72.63 -19.49 1.15 Allowed Glycine 0 N--CA 1.5 2.921 0 O-C-N 121.038 -1.039 . . . . 0.0 111.18 177.239 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 16' ' ' LEU . . . . . 1.049 ' CD1' HG22 ' B' ' 14' ' ' THR . 4.9 mp -18.86 -61.44 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.511 0 CA-C-O 122.031 0.919 . . . . 0.0 111.575 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 17' ' ' THR . . . . . 0.649 ' CG2' HG21 ' A' ' 17' ' ' THR . 0.5 OUTLIER -142.59 7.47 1.7 Allowed 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.543 -179.464 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 18' ' ' GLN . . . . . 0.584 ' O ' ' C ' ' B' ' 19' ' ' VAL . 29.7 mt-30 60.01 23.1 12.25 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 -175.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.939 HG11 HG11 ' A' ' 19' ' ' VAL . 1.4 p 5.04 -91.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.951 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 20' ' ' SER . . . . . 1.016 ' HB2' HG22 ' A' ' 14' ' ' THR . 0.5 OUTLIER -132.44 24.64 4.45 Favored 'General case' 0 C--N 1.277 -2.578 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 179.236 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.719 ' HA ' ' CE ' ' B' ' 24' ' ' MET . 16.7 m -22.69 -43.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 CA-C-O 122.541 1.162 . . . . 0.0 108.578 -178.019 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.717 ' N ' ' O ' ' B' ' 20' ' ' SER . 13.7 t -74.91 -39.06 61.65 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.614 177.527 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 23' ' ' LYS . . . . . 0.972 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.3 OUTLIER -86.25 -40.94 15.03 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.592 -0.692 . . . . 0.0 111.792 179.869 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 24' ' ' MET . . . . . 0.719 ' CE ' ' HA ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -61.84 -28.19 69.31 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 117.203 -1.799 . . . . 0.0 108.814 179.383 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.999 HD23 ' CD1' ' B' ' 7' ' ' ILE . 0.1 OUTLIER -80.57 -48.82 12.15 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 118.476 -1.29 . . . . 0.0 108.766 178.122 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 26' ' ' ALA . . . . . 0.568 ' N ' HD12 ' B' ' 25' ' ' LEU . . . -61.07 -29.25 69.63 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 27' ' ' SER . . . . . 0.551 ' HA ' ' HB3' ' B' ' 30' ' ' LYS . 75.3 m -83.64 -33.12 25.34 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 28' ' ' PHE . . . . . 0.794 ' CE1' HD22 ' A' ' 44' ' ' LEU . 0.7 OUTLIER -55.43 -50.78 68.91 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.913 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 29' ' ' GLU . . . . . 0.632 ' HG3' ' CE2' ' A' ' 47' ' ' PHE . 3.0 tt0 -65.73 -34.66 78.71 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 176.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 1.333 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 23.2 ttpp -66.89 -20.85 65.99 Favored 'General case' 0 C--O 1.193 -1.905 0 C-N-CA 119.414 -0.914 . . . . 0.0 108.93 178.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.673 HG13 ' O ' ' B' ' 28' ' ' PHE . 0.9 OUTLIER -108.04 -25.35 3.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 O-C-N 119.728 -1.858 . . . . 0.0 109.604 178.569 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.622 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.1 mm -76.62 -58.29 4.66 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 177.169 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 33' ' ' THR . . . . . 0.527 ' HA ' HD23 ' A' ' 85' ' ' LEU . 0.7 OUTLIER -75.54 -29.12 59.3 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.328 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 1.333 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 74.3 mm-40 -81.58 -27.59 34.21 Favored 'General case' 0 C--N 1.315 -0.915 0 O-C-N 120.898 -1.126 . . . . 0.0 110.416 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 35' ' ' THR . . . . . 0.594 HG23 ' CB ' ' B' ' 40' ' ' ASP . 1.8 m -69.73 -57.08 5.56 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 117.715 -1.594 . . . . 0.0 107.485 177.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.74 ' O ' ' HG3' ' B' ' 52' ' ' PRO . 7.1 p -48.43 -40.25 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.485 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 0.725 ' C ' HD12 ' A' ' 92' ' ' LEU . . . -71.34 -32.83 69.01 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.14 178.24 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 38' ' ' LYS . . . . . 0.645 ' N ' HD12 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -68.86 -21.49 64.26 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 176.653 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 39' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' B' ' 35' ' ' THR . . . 99.25 30.88 6.41 Favored Glycine 0 C--N 1.298 -1.557 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 177.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 40' ' ' ASP . . . . . 0.594 ' CB ' HG23 ' B' ' 35' ' ' THR . 0.3 OUTLIER -118.03 151.82 36.74 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.395 -1.062 . . . . 0.0 109.905 179.528 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.416 ' CG ' ' CB ' ' B' ' 51' ' ' LYS . 0.0 OUTLIER -95.59 90.54 5.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.428 -0.795 . . . . 0.0 110.558 -179.299 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.863 HG12 HG22 ' B' ' 50' ' ' ILE . 10.5 p -75.06 152.89 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.41 -0.806 . . . . 0.0 109.392 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 43' ' ' GLN . . . . . 0.607 ' O ' HD23 ' B' ' 44' ' ' LEU . 18.5 pt20 -157.16 175.94 13.38 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.148 -0.97 . . . . 0.0 111.14 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.686 HD12 ' HB2' ' B' ' 48' ' ' LEU . 24.1 mt -128.51 117.49 21.4 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.625 -0.672 . . . . 0.0 109.356 179.151 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 45' ' ' THR . . . . . 0.638 HG21 ' HG3' ' A' ' 29' ' ' GLU . 0.6 OUTLIER 28.54 -103.37 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.815 -0.553 . . . . 0.0 111.313 179.893 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.488 ' H ' HG23 ' B' ' 45' ' ' THR . . . -133.96 57.97 0.7 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 47' ' ' PHE . . . . . 0.731 ' CD1' HD21 ' B' ' 85' ' ' LEU . 8.0 p90 -157.67 -25.39 0.09 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.081 -1.247 . . . . 0.0 110.987 178.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.949 HD13 ' HG2' ' B' ' 80' ' ' LYS . 0.5 OUTLIER -130.78 145.65 52.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.842 -1.161 . . . . 0.0 109.965 178.003 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 49' ' ' ASN . . . . . 0.85 ' O ' ' O ' ' B' ' 79' ' ' VAL 0.265 0.4 OUTLIER -162.18 90.61 0.75 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.333 -0.854 . . . . 0.0 110.874 -177.247 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' B' B ' 50' ' ' ILE . . . . . 0.863 HG22 HG12 ' B' ' 42' ' ' VAL . 0.3 OUTLIER -83.53 146.14 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.884 -1.135 . . . . 0.0 109.809 -179.428 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 51' ' ' LYS . . . . . 0.448 ' HG3' ' HB3' ' B' ' 78' ' ' SER . 1.5 ptmt -167.3 122.79 0.87 Allowed Pre-proline 0 N--CA 1.495 1.807 0 C-N-CA 119.124 -1.03 . . . . 0.0 110.689 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.74 ' HG3' ' O ' ' B' ' 36' ' ' VAL . 55.4 Cg_endo -88.45 146.92 6.19 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.611 1.321 . . . . 0.0 110.841 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.572 ' O ' HG23 ' B' ' 53' ' ' VAL . 26.7 m -132.22 114.39 23.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-O 121.909 0.861 . . . . 0.0 110.065 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.534 ' HB2' ' CB ' ' A' ' 97' ' ' PHE . . . -44.26 112.9 0.46 Allowed 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.484 0.659 . . . . 0.0 111.58 -178.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 -145.79 84.35 1.67 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.33 -153.39 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.493 -0.755 . . . . 0.0 110.27 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 1.071 ' HB3' HD13 ' B' ' 71' ' ' ILE . . . -158.37 175.01 14.26 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.04 -1.037 . . . . 0.0 111.004 -179.331 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 58' ' ' ARG . . . . . 0.837 ' O ' HD11 ' B' ' 71' ' ' ILE . 0.0 OUTLIER -46.62 148.4 1.01 Allowed 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.902 0.858 . . . . 0.0 112.081 -179.53 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 59' ' ' LYS . . . . . 0.465 ' HB3' ' O ' ' B' ' 58' ' ' ARG . 0.7 OUTLIER 177.54 76.26 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.037 -1.039 . . . . 0.0 109.302 178.385 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 60' ' ' GLY . . . . . 0.42 ' C ' ' CD2' ' B' ' 61' ' ' PHE . . . -127.16 -101.52 1.15 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 61' ' ' PHE . . . . . 0.812 ' O ' ' N ' ' B' ' 67' ' ' GLU . 4.2 p90 174.97 177.75 0.15 Allowed 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.412 -1.052 . . . . 0.0 110.09 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 62' ' ' ASN . . . . . 0.844 ' N ' ' HB2' ' B' ' 68' ' ' ALA . 0.8 OUTLIER -108.69 -61.13 0.04 OUTLIER Pre-proline 0 N--CA 1.502 2.136 0 O-C-N 120.967 -1.083 . . . . 0.0 112.219 -178.392 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.613 ' HD2' ' H ' ' B' ' 62' ' ' ASN . 41.2 Cg_endo -67.54 64.23 0.81 Allowed 'Trans proline' 0 N--CA 1.489 1.213 0 O-C-N 123.402 1.211 . . . . 0.0 110.41 -178.506 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 64' ' ' GLN . . . . . 0.798 ' HB3' ' CE1' ' B' ' 61' ' ' PHE . 0.7 OUTLIER -178.74 36.77 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.766 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 6.1 p 53.58 55.13 8.99 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.795 -0.566 . . . . 0.0 110.607 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 66' ' ' GLN . . . . . 0.73 ' HB2' ' CE1' ' B' ' 61' ' ' PHE . 0.0 OUTLIER -151.73 -109.53 0.05 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.188 -0.945 . . . . 0.0 110.622 -179.939 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 67' ' ' GLU . . . . . 0.812 ' N ' ' O ' ' B' ' 61' ' ' PHE . 5.6 pt-20 176.78 97.76 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.996 -1.065 . . . . 0.0 108.434 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 68' ' ' ALA . . . . . 0.967 ' O ' HD23 ' B' ' 69' ' ' LEU . . . -73.09 100.36 3.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.283 -0.885 . . . . 0.0 109.604 -178.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.967 HD23 ' O ' ' B' ' 68' ' ' ALA . 12.6 mt -136.24 -141.68 0.17 Allowed 'General case' 0 C--N 1.291 -1.949 0 C-N-CA 120.146 -0.622 . . . . 0.0 109.563 -179.165 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 70' ' ' GLU . . . . . 0.764 ' O ' HG23 ' B' ' 71' ' ' ILE . 1.1 pt-20 179.06 161.82 0.75 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.012 -1.055 . . . . 0.0 109.628 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 1.071 HD13 ' HB3' ' B' ' 57' ' ' ALA . 1.1 pp -162.89 -151.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.515 -0.741 . . . . 0.0 109.364 -178.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 72' ' ' ALA . . . . . 0.409 ' H ' ' HB ' ' B' ' 71' ' ' ILE . . . -126.23 90.45 50.04 Favored Pre-proline 0 C--N 1.303 -1.438 0 O-C-N 121.281 -0.887 . . . . 0.0 112.165 -179.309 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 73' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.55 122.63 8.42 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.826 1.435 . . . . 0.0 109.512 178.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 74' ' ' SER . . . . . 0.507 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 1.4 m -173.62 171.41 3.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.127 -0.983 . . . . 0.0 109.547 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 75' ' ' VAL . . . . . 0.743 HG12 HG23 ' B' ' 77' ' ' VAL . 0.5 OUTLIER -54.63 173.11 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.122 -0.986 . . . . 0.0 109.226 179.908 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 76' ' ' GLY . . . . . 0.57 ' O ' HG22 ' B' ' 53' ' ' VAL . . . -114.8 54.48 0.57 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.806 HG12 ' HB3' ' A' ' 81' ' ' PRO . 69.9 t -37.75 87.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 122.052 -0.675 . . . . 0.0 111.59 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 78' ' ' SER . . . . . 0.552 ' N ' ' O ' ' B' ' 76' ' ' GLY . 1.8 t -59.45 -129.51 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.85 ' O ' ' O ' ' B' ' 49' ' ' ASN . 17.7 m -140.15 -170.01 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 119.76 -1.838 . . . . 0.0 112.815 178.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 80' ' ' LYS . . . . . 0.949 ' HG2' HD13 ' B' ' 48' ' ' LEU . 0.0 OUTLIER -101.28 -54.26 0.15 Allowed Pre-proline 0 C--N 1.29 -2.004 0 CA-C-N 113.49 -1.686 . . . . 0.0 113.261 -178.489 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 81' ' ' PRO . . . . . 0.78 ' HD2' ' H ' ' B' ' 80' ' ' LYS . 30.5 Cg_endo -52.43 138.88 56.53 Favored 'Trans proline' 0 C--N 1.298 -2.115 0 C-N-CA 121.219 1.279 . . . . 0.0 113.372 -174.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -135.2 -64.41 0.06 OUTLIER Glycine 0 N--CA 1.485 1.95 0 N-CA-C 106.091 -2.803 . . . . 0.0 106.091 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 83' ' ' GLU . . . . . 0.924 ' O ' ' N ' ' B' ' 85' ' ' LEU . 4.0 tt0 -97.19 46.18 1.04 Allowed 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 175.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 84' ' ' SER . . . . . 1.33 ' O ' ' N ' ' B' ' 86' ' ' LYS . 0.1 OUTLIER 8.18 43.26 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 122.551 1.167 . . . . 0.0 110.489 179.393 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 1.047 ' C ' ' O ' ' B' ' 84' ' ' SER . 0.5 OUTLIER 21.29 28.85 0.0 OUTLIER 'General case' 0 C--O 1.191 -2.004 0 N-CA-C 103.203 -2.888 . . . . 0.0 103.203 -171.161 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 86' ' ' LYS . . . . . 1.33 ' N ' ' O ' ' B' ' 84' ' ' SER 0.309 1.2 tttm -49.8 -35.99 24.78 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 176.938 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 87' ' ' LYS . . . . . 0.411 ' O ' ' HG2' ' B' ' 90' ' ' GLU 0.298 0.0 OUTLIER -66.49 -38.78 88.02 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 111.97 -2.377 . . . . 0.0 106.569 175.64 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.793 ' N ' ' O ' ' B' ' 85' ' ' LEU . . . -79.35 -26.33 42.11 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 118.725 -1.19 . . . . 0.0 108.285 178.407 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.932 ' HA ' HD23 ' B' ' 92' ' ' LEU . . . -68.48 -45.01 73.54 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.448 -0.782 . . . . 0.0 108.924 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.48 ' HG2' ' N ' ' B' ' 91' ' ' GLY . 3.6 pt-20 -58.58 -28.37 65.49 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 176.507 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 91' ' ' GLY . . . . . 0.48 ' N ' ' HG2' ' B' ' 90' ' ' GLU . . . -62.48 -38.84 96.99 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 110.646 -0.981 . . . . 0.0 110.646 178.587 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 92' ' ' LEU . . . . . 0.932 HD23 ' HA ' ' B' ' 89' ' ' ALA . 0.9 OUTLIER -78.82 18.99 0.54 Allowed 'General case' 0 N--CA 1.505 2.28 0 O-C-N 120.392 -1.652 . . . . 0.0 111.481 -179.557 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 93' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' B' ' 92' ' ' LEU . 6.7 mptt 54.51 39.53 31.16 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -178.253 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 94' ' ' TYR . . . . . 0.583 ' HB2' ' CB ' ' A' ' 75' ' ' VAL . 1.2 p90 -42.01 -30.42 0.28 Allowed 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.746 -178.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 95' ' ' GLU . . . . . 0.607 ' O ' ' HB3' ' B' ' 98' ' ' ALA . 22.7 mt-10 -59.08 -47.37 85.51 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.188 -0.945 . . . . 0.0 108.501 178.518 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.97 -36.44 67.83 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -74.06 -28.25 61.31 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.217 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 98' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' B' ' 95' ' ' GLU . . . -61.31 -35.04 76.28 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.733 -0.604 . . . . 0.0 110.259 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 23.7 mttt . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.299 -179.877 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.535 ' HA ' ' CB ' ' A' ' 5' ' ' GLU . 5.9 mtp . . . . . 0 N--CA 1.496 1.842 0 CA-C-O 120.743 0.306 . . . . 0.0 110.238 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -173.97 -164.24 0.19 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.049 -1.032 . . . . 0.0 111.795 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.585 ' HE3' HG21 ' B' ' 45' ' ' THR . 12.9 mttt -62.52 -3.22 1.34 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.444 -0.785 . . . . 0.0 110.321 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.678 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 87.2 m -124.36 -39.61 2.31 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.201 -0.937 . . . . 0.0 108.871 179.061 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.579 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -63.11 -55.52 24.61 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 178.343 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.762 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 0.8 OUTLIER -58.71 -29.58 66.78 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.499 -0.881 . . . . 0.0 109.201 178.198 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.958 HG23 ' HB ' ' A' ' 21' ' ' VAL . 1.7 mt -54.25 -56.09 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.49 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.916 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 12.7 mtmt -58.69 -33.28 69.97 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.23 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.87 ' HB1' HD13 ' B' ' 31' ' ' ILE . . . -52.34 -37.97 57.45 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.574 -0.851 . . . . 0.0 109.202 179.106 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.862 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.0 OUTLIER -96.07 -35.1 5.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 178.546 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.916 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -61.49 -13.14 18.49 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 118.616 -1.234 . . . . 0.0 108.687 178.467 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -114.75 -43.66 3.12 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.474 -0.766 . . . . 0.0 109.377 178.431 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 9' ' ' ALA . 1.1 m-20 -63.99 -39.55 94.37 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 177.501 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' THR . . . . . 1.062 HG22 ' CD1' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -89.45 -78.0 0.37 Allowed 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 177.375 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.9 7.8 67.05 Favored Glycine 0 N--CA 1.5 2.924 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 177.528 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.062 ' CD1' HG22 ' A' ' 14' ' ' THR . 5.1 mp -54.75 -68.1 0.21 Allowed 'General case' 0 C--N 1.293 -1.858 0 O-C-N 121.671 -0.899 . . . . 0.0 110.676 179.821 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.584 HG22 ' H ' ' A' ' 19' ' ' VAL . 0.5 OUTLIER -142.94 7.98 1.65 Allowed 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.715 -179.25 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.664 ' O ' HG22 ' A' ' 21' ' ' VAL . 11.6 mt-30 59.4 24.61 13.23 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 -176.031 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 1.058 HG11 HG11 ' B' ' 19' ' ' VAL . 1.6 p -2.72 -91.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.932 -179.064 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.987 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.5 OUTLIER -131.01 24.8 4.96 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 178.21 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.958 ' HB ' HG23 ' A' ' 7' ' ' ILE . 1.4 m -20.93 -40.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-O 122.265 1.031 . . . . 0.0 109.409 -178.248 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.77 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.2 OUTLIER -80.42 -34.68 35.99 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.603 177.863 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.987 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -90.13 -38.11 13.75 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.563 -0.71 . . . . 0.0 111.193 179.544 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.656 ' CE ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -66.54 -37.33 84.77 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 117.686 -1.605 . . . . 0.0 108.774 179.455 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.8 HD12 HG13 ' A' ' 7' ' ' ILE . 0.4 OUTLIER -79.89 -37.99 33.58 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 118.054 -1.458 . . . . 0.0 109.425 178.699 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.468 ' HA ' ' CE ' ' A' ' 3' ' ' LYS . . . -66.06 -34.78 78.86 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 177.447 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.64 ' O ' HG13 ' A' ' 31' ' ' ILE . 62.1 m -83.16 -30.46 27.8 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.205 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.651 ' CE1' HD22 ' B' ' 44' ' ' LEU . 1.4 t80 -52.49 -49.53 64.53 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.552 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.73 ' HG3' ' CD2' ' B' ' 47' ' ' PHE . 0.2 OUTLIER -67.15 -35.99 80.87 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 177.172 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 1.16 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 9.7 ttmm -64.22 -20.79 66.27 Favored 'General case' 0 C--O 1.19 -2.061 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.413 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.672 HD12 HG12 ' A' ' 32' ' ' ILE . 1.3 pp -105.04 -27.99 3.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 O-C-N 120.297 -1.502 . . . . 0.0 108.951 178.222 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.678 HG21 ' CE1' ' B' ' 47' ' ' PHE . 1.2 mm -73.48 -58.69 4.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 177.078 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.931 ' HA ' HD23 ' B' ' 85' ' ' LEU . 0.4 OUTLIER -69.43 -33.42 72.94 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.305 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 1.16 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 27.2 mm-40 -76.96 -39.42 50.67 Favored 'General case' 0 N--CA 1.483 1.211 0 O-C-N 121.056 -1.027 . . . . 0.0 111.094 179.104 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.779 HG21 ' SD ' ' B' ' 1' ' ' MET . 21.9 m -57.94 -52.76 64.15 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.074 -1.641 . . . . 0.0 108.488 179.295 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.83 HG13 ' HB3' ' A' ' 52' ' ' PRO . 2.4 t -54.35 -36.56 34.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 177.918 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.752 ' HB1' ' O ' ' B' ' 88' ' ' ALA . . . -87.24 -0.23 56.4 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.432 0.634 . . . . 0.0 109.724 178.668 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.697 ' HB2' ' HA ' ' A' ' 35' ' ' THR . 1.5 mmpt? -102.6 -30.6 10.85 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 177.85 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.11 41.51 0.47 Allowed Glycine 0 C--N 1.303 -1.282 0 C-N-CA 119.945 -1.121 . . . . 0.0 110.842 177.936 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.737 ' O ' HG22 ' A' ' 35' ' ' THR . 0.4 OUTLIER -147.0 120.27 8.93 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.074 -1.25 . . . . 0.0 110.624 179.526 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.2 mtpt -63.95 86.62 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.53 -0.731 . . . . 0.0 109.608 179.723 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.664 HG23 HD21 ' B' ' 6' ' ' LEU . 11.3 p -68.1 146.75 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.656 -0.653 . . . . 0.0 110.391 -179.479 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.626 ' O ' HD23 ' A' ' 44' ' ' LEU . 22.9 mt-30 -144.68 176.48 9.39 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.341 -0.849 . . . . 0.0 110.257 -179.805 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.7 HD12 ' HB2' ' A' ' 48' ' ' LEU . 32.4 mt -125.52 113.9 18.07 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.594 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.548 HG22 ' HG2' ' B' ' 29' ' ' GLU . 0.1 OUTLIER 36.05 -87.53 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.85 -0.531 . . . . 0.0 110.621 -179.229 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -151.59 27.09 0.95 Allowed Glycine 0 N--CA 1.484 1.87 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.34 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.823 ' CE1' HG21 ' B' ' 32' ' ' ILE . 4.6 p90 -125.38 -29.92 3.19 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.96 -1.318 . . . . 0.0 112.66 179.84 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.7 ' HB2' HD12 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -122.04 85.71 2.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.445 -1.409 . . . . 0.0 110.692 179.132 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -89.47 85.6 6.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.811 -0.556 . . . . 0.0 109.88 179.605 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.871 HD12 HG22 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -75.68 139.37 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.404 -0.81 . . . . 0.0 109.656 -179.57 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.499 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 2.2 ptmt -153.9 125.51 3.7 Favored Pre-proline 0 N--CA 1.496 1.861 0 C-N-CA 118.752 -1.179 . . . . 0.0 110.785 179.674 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.83 ' HB3' HG13 ' A' ' 36' ' ' VAL . 52.9 Cg_endo -80.97 144.18 14.87 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 O-C-N 123.518 1.272 . . . . 0.0 111.248 -179.768 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.768 HG22 ' O ' ' A' ' 76' ' ' GLY . 31.6 m -137.98 114.82 11.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-O 121.772 0.796 . . . . 0.0 110.259 179.043 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.547 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . -50.05 137.77 16.82 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.924 0.869 . . . . 0.0 111.898 -178.513 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -162.28 107.46 1.21 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.415 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.833 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 2.8 pt20 -84.32 18.5 2.18 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.143 -0.973 . . . . 0.0 112.264 -178.063 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.833 ' HB2' ' O ' ' A' ' 56' ' ' GLN . . . 150.62 161.7 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.618 -0.677 . . . . 0.0 110.593 178.348 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.637 ' HG3' HD11 ' A' ' 71' ' ' ILE . 5.6 mtt-85 -161.22 141.96 11.24 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.756 -0.59 . . . . 0.0 110.25 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.0 ptpt -163.69 28.31 0.08 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.387 -0.821 . . . . 0.0 110.174 179.724 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -109.93 -91.98 2.15 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 179.681 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.674 ' CD1' ' N ' ' A' ' 62' ' ' ASN . 32.9 t80 -175.08 161.39 2.89 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.391 -1.064 . . . . 0.0 110.584 179.405 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.674 ' N ' ' CD1' ' A' ' 61' ' ' PHE . 1.8 t30 -68.11 -165.2 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.639 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.678 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.512 ' CD ' ' CB ' ' A' ' 62' ' ' ASN . 49.8 Cg_endo -84.1 50.08 2.98 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 N-CA-C 109.524 -0.991 . . . . 0.0 109.524 178.743 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 -151.62 -116.23 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.128 -0.983 . . . . 0.0 110.894 -178.991 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.622 ' N ' ' CE1' ' A' ' 61' ' ' PHE . 5.1 t -172.86 -16.99 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.977 -1.077 . . . . 0.0 111.43 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.509 ' HG3' HG23 ' A' ' 65' ' ' THR . 1.2 mt-30 -104.47 -48.5 3.8 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.809 -1.182 . . . . 0.0 111.148 -179.809 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.5 86.33 6.35 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.153 -0.967 . . . . 0.0 110.214 -179.803 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.491 ' HB2' ' CD2' ' A' ' 61' ' ' PHE . . . -89.03 169.94 11.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.555 -0.716 . . . . 0.0 110.668 -179.769 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -162.68 -175.41 4.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.46 -0.775 . . . . 0.0 110.304 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -173.81 58.26 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.279 -0.888 . . . . 0.0 110.392 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.637 HD11 ' HG3' ' A' ' 58' ' ' ARG . 2.8 pp -54.45 -178.93 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.063 -1.023 . . . . 0.0 110.699 -179.946 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 1.098 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -109.39 -172.09 0.23 Allowed Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.418 -0.801 . . . . 0.0 110.893 -178.254 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 1.098 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 39.1 Cg_endo -66.74 107.35 1.26 Allowed 'Trans proline' 0 C--N 1.315 -1.186 0 O-C-N 123.544 1.286 . . . . 0.0 111.184 -179.42 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.446 ' HA ' ' CE2' ' B' ' 94' ' ' TYR . 0.4 OUTLIER 172.27 157.84 0.1 Allowed 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.8 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.67 ' HB ' ' HB2' ' B' ' 94' ' ' TYR . 1.0 OUTLIER -58.64 169.63 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.97 -1.081 . . . . 0.0 109.14 179.735 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.768 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -117.74 86.92 0.42 Allowed Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.141 -1.583 . . . . 0.0 109.141 -179.86 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.908 HG21 ' CB ' ' B' ' 85' ' ' LEU . 5.0 p -60.75 77.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.676 -0.896 . . . . 0.0 109.834 179.868 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' SER . . . . . 1.027 ' O ' HG23 ' A' ' 79' ' ' VAL . 0.8 OUTLIER -62.69 178.02 0.48 Allowed 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.502 -0.879 . . . . 0.0 109.565 179.775 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 1.027 HG23 ' O ' ' A' ' 78' ' ' SER . 2.7 t -176.78 173.56 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.709 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.664 ' O ' HD23 ' A' ' 48' ' ' LEU . 10.9 pttp 177.53 169.33 0.47 Allowed Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.081 -1.012 . . . . 0.0 110.027 176.503 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.571 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 55.1 Cg_endo -97.47 141.83 0.61 Allowed 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 122.505 2.136 . . . . 0.0 110.753 177.757 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.603 ' H ' HD11 ' A' ' 85' ' ' LEU . . . -97.63 -155.09 29.87 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 108.432 -1.867 . . . . 0.0 108.432 178.424 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.626 ' HA ' ' HB2' ' A' ' 86' ' ' LYS . 4.7 pm0 -93.77 -15.37 25.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.126 -1.22 . . . . 0.0 110.347 179.358 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.35 -34.18 56.53 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.309 -0.87 . . . . 0.0 109.574 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.782 ' CB ' HG21 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -88.17 -25.36 22.98 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 119.68 -0.808 . . . . 0.0 108.855 179.005 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.626 ' HB2' ' HA ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -76.19 -35.71 58.98 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.554 -0.858 . . . . 0.0 109.184 179.647 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.7 tttp -72.82 -39.83 66.31 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 177.166 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.834 ' O ' ' HB1' ' B' ' 37' ' ' ALA . . . -65.08 -37.0 86.11 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 176.243 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.692 ' HA ' HD23 ' A' ' 92' ' ' LEU . . . -56.71 -38.04 71.77 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.758 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.15 -33.06 62.6 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 176.391 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.483 ' C ' ' H ' ' A' ' 93' ' ' LYS . . . -59.82 -44.44 97.04 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 177.805 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.962 ' O ' HD12 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -69.42 15.44 0.07 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.71 -1.465 . . . . 0.0 110.422 179.397 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.602 ' HB3' ' O ' ' A' ' 92' ' ' LEU . 0.8 OUTLIER 65.37 73.77 0.39 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 -177.086 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.78 ' O ' ' N ' ' A' ' 97' ' ' PHE . 47.7 t80 -47.39 -58.19 4.44 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 116.481 -2.088 . . . . 0.0 106.538 179.817 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.928 ' O ' ' N ' ' A' ' 98' ' ' ALA . 56.2 mm-40 8.48 39.36 0.0 OUTLIER 'General case' 0 CA--C 1.484 -1.588 0 N-CA-C 102.3 -3.222 . . . . 0.0 102.3 179.295 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 1.166 ' O ' ' N ' ' A' ' 98' ' ' ALA 0.287 0.1 OUTLIER 19.95 42.17 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 113.222 -1.808 . . . . 0.0 106.741 -174.193 . . . . . . . . 4 4 . 1 . 021 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.823 ' C ' ' O ' ' A' ' 96' ' ' ASP . 5.2 p90 23.44 27.63 0.0 OUTLIER 'General case' 0 CA--C 1.487 -1.447 0 N-CA-C 102.127 -3.286 . . . . 0.0 102.127 -168.824 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 1.166 ' N ' ' O ' ' A' ' 96' ' ' ASP 0.281 . . -61.3 -26.88 68.08 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 109.427 -3.533 . . . . 0.0 108.629 179.982 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.127 179.855 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.779 ' SD ' HG21 ' A' ' 35' ' ' THR . 4.2 ptm . . . . . 0 N--CA 1.496 1.832 0 CA-C-O 121.307 0.575 . . . . 0.0 110.833 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 2' ' ' ASN . . . . . 0.557 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 16.4 p-10 -176.15 -140.81 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.706 -0.797 . . . . 0.0 111.238 178.044 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.451 ' HE3' ' HB3' ' B' ' 29' ' ' GLU . 0.1 OUTLIER -57.56 -0.36 0.07 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.003 -1.061 . . . . 0.0 110.916 -179.62 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.777 ' O ' HG13 ' B' ' 7' ' ' ILE . 4.2 m -120.16 -69.47 0.84 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.957 -1.089 . . . . 0.0 110.376 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.594 ' O ' ' HG3' ' B' ' 8' ' ' LYS . 1.7 mm-40 -48.82 -36.17 16.17 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.062 -1.024 . . . . 0.0 109.331 -179.865 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.664 HD21 HG23 ' A' ' 42' ' ' VAL . 87.0 mt -69.36 -28.96 66.66 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 118.869 -1.133 . . . . 0.0 109.988 178.608 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 7' ' ' ILE . . . . . 0.874 ' HA ' HD12 ' B' ' 25' ' ' LEU . 1.5 pp -63.76 -45.91 95.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.521 -1.362 . . . . 0.0 107.972 178.929 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 8' ' ' LYS . . . . . 0.829 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.0 OUTLIER -74.23 -20.44 60.17 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.39 -0.924 . . . . 0.0 108.562 177.522 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 9' ' ' ALA . . . . . 0.536 ' HB3' ' HA ' ' B' ' 6' ' ' LEU . . . -69.15 -33.57 73.63 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.149 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.861 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.0 OUTLIER -94.37 -34.5 5.63 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.4 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 178.3 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.829 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -56.91 -25.49 57.4 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.285 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 11.6 mm-40 -92.52 -45.03 8.32 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.441 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.424 ' HB2' ' HA ' ' B' ' 10' ' ' ILE . 4.6 m-20 -62.34 -25.26 67.8 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 177.061 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.882 HG22 ' HB2' ' A' ' 20' ' ' SER . 14.8 p -91.42 -74.39 0.51 Allowed 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.119 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 59.15 17.24 36.9 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.575 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 16' ' ' LEU . . . . . 0.964 HD22 ' O ' ' A' ' 19' ' ' VAL . 3.4 mp -83.44 -61.53 1.82 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.358 -1.084 . . . . 0.0 108.878 179.053 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 17' ' ' THR . . . . . 0.561 HG22 ' H ' ' B' ' 19' ' ' VAL . 0.6 OUTLIER -139.84 2.84 2.0 Allowed 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.732 179.909 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 18' ' ' GLN . . . . . 0.623 ' O ' ' C ' ' B' ' 19' ' ' VAL . 17.6 mt-30 56.64 28.14 13.61 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 -176.836 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 1.058 HG11 HG11 ' A' ' 19' ' ' VAL . 1.7 p -6.16 -100.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.765 -179.377 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.899 ' O ' ' N ' ' B' ' 23' ' ' LYS . 0.5 OUTLIER -133.92 24.12 3.93 Favored 'General case' 0 C--N 1.28 -2.445 0 N-CA-C 105.434 -2.062 . . . . 0.0 105.434 177.154 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.635 ' HA ' ' HE2' ' B' ' 24' ' ' MET . 16.6 m -18.43 -37.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 CA-C-O 122.212 1.006 . . . . 0.0 110.513 -177.922 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.844 ' N ' ' O ' ' B' ' 20' ' ' SER . 5.2 t -77.49 -43.13 33.25 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.146 -0.934 . . . . 0.0 108.893 178.496 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 23' ' ' LYS . . . . . 0.899 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.0 OUTLIER -92.3 -19.21 22.39 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.724 -0.61 . . . . 0.0 109.566 178.474 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 24' ' ' MET . . . . . 0.728 ' N ' ' OG ' ' B' ' 20' ' ' SER 0.258 3.1 tmm? -68.57 -44.86 73.54 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.3 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.874 HD12 ' HA ' ' B' ' 7' ' ' ILE . 8.4 mt -76.83 -44.14 33.55 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 177.005 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 26' ' ' ALA . . . . . 0.604 ' HB3' ' HA ' ' B' ' 23' ' ' LYS . . . -54.74 -33.48 61.21 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 177.567 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 27' ' ' SER . . . . . 0.538 ' O ' HG23 ' B' ' 31' ' ' ILE . 10.4 m -75.27 -40.97 58.24 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.465 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 28' ' ' PHE . . . . . 0.759 ' HA ' ' CG1' ' B' ' 31' ' ' ILE . 0.0 OUTLIER -64.39 -31.38 72.57 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.548 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 29' ' ' GLU . . . . . 0.604 ' HG3' ' CE2' ' B' ' 28' ' ' PHE . 1.5 mt-10 -84.4 -32.3 24.22 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 178.221 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 0.747 ' O ' ' CG ' ' B' ' 34' ' ' GLU . 24.8 tttt -71.4 -29.02 64.43 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 176.332 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.87 HD13 ' HB1' ' A' ' 9' ' ' ALA . 1.3 pp -93.89 -31.29 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.224 -0.922 . . . . 0.0 109.749 178.955 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.823 HG21 ' CE1' ' A' ' 47' ' ' PHE . 3.4 mm -61.65 -55.22 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 177.447 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 33' ' ' THR . . . . . 0.451 ' HB ' ' O ' ' B' ' 29' ' ' GLU . 0.4 OUTLIER -64.52 -40.32 95.4 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.429 179.46 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.793 ' O ' ' N ' ' B' ' 38' ' ' LYS . 17.8 mm-40 -68.92 -44.14 73.73 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.77 -0.581 . . . . 0.0 110.959 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 35' ' ' THR . . . . . 0.483 ' HA ' ' CB ' ' B' ' 38' ' ' LYS . 93.0 m -54.0 -52.12 61.76 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.798 -1.189 . . . . 0.0 108.998 179.876 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.992 HG21 HG23 ' B' ' 77' ' ' VAL . 0.4 OUTLIER -50.9 -37.26 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.145 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 0.834 ' HB1' ' O ' ' A' ' 88' ' ' ALA . . . -96.32 0.77 51.21 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.774 0.797 . . . . 0.0 110.108 179.043 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 38' ' ' LYS . . . . . 0.793 ' N ' ' O ' ' B' ' 34' ' ' GLU . 0.0 OUTLIER -95.8 -22.84 17.24 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 176.906 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.49 44.87 0.69 Allowed Glycine 0 C--N 1.304 -1.22 0 C-N-CA 120.35 -0.928 . . . . 0.0 110.961 177.631 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 40' ' ' ASP . . . . . 0.415 ' HB2' HG23 ' B' ' 35' ' ' THR . 0.4 OUTLIER -155.41 166.14 34.47 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.005 -1.291 . . . . 0.0 111.399 179.6 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.47 ' HG2' ' HD2' ' B' ' 52' ' ' PRO . 11.0 mttt -121.48 112.86 19.04 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.273 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.87 HG22 ' CG1' ' B' ' 50' ' ' ILE . 0.8 OUTLIER -79.47 147.15 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 C-N-CA 118.664 -1.214 . . . . 0.0 110.064 -178.602 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 43' ' ' GLN . . . . . 0.424 ' HA ' ' HA ' ' B' ' 49' ' ' ASN . 1.6 mt-30 -123.66 85.85 2.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.485 -0.759 . . . . 0.0 109.259 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.813 HD12 ' HB3' ' B' ' 48' ' ' LEU . 12.6 mt -58.96 90.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.473 -0.767 . . . . 0.0 110.727 -179.219 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 45' ' ' THR . . . . . 0.585 HG21 ' HE3' ' A' ' 3' ' ' LYS . 2.2 t 35.93 26.98 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 179.34 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . 97.91 -25.39 27.71 Favored Glycine 0 N--CA 1.494 2.563 0 C-N-CA 119.841 -1.171 . . . . 0.0 112.859 177.44 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 47' ' ' PHE . . . . . 0.931 ' CD1' HD21 ' B' ' 85' ' ' LEU . 1.4 p90 -86.44 -28.43 23.51 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 119.873 1.836 . . . . 0.0 112.031 -178.577 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.813 ' HB3' HD12 ' B' ' 44' ' ' LEU . 5.5 mt -129.78 94.06 3.65 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.6 -1.313 . . . . 0.0 110.382 177.786 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 49' ' ' ASN . . . . . 0.512 ' O ' ' HA ' ' B' ' 79' ' ' VAL . 0.6 OUTLIER -105.0 95.26 5.73 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.533 -0.729 . . . . 0.0 110.156 -179.695 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 50' ' ' ILE . . . . . 0.87 ' CG1' HG22 ' B' ' 42' ' ' VAL . 2.0 pp -86.83 146.63 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.483 -0.761 . . . . 0.0 110.684 -179.765 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 51' ' ' LYS . . . . . 0.451 ' O ' ' HG3' ' B' ' 51' ' ' LYS . 2.6 ptmt -155.11 128.79 4.5 Favored Pre-proline 0 N--CA 1.496 1.848 0 C-N-CA 119.092 -1.043 . . . . 0.0 110.434 179.044 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.694 ' HB3' HG22 ' B' ' 36' ' ' VAL . 57.1 Cg_endo -84.72 140.99 8.41 Favored 'Trans proline' 0 C--N 1.315 -1.205 0 O-C-N 123.352 1.185 . . . . 0.0 110.955 -179.404 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.655 HG22 ' O ' ' B' ' 76' ' ' GLY . 24.8 m -144.61 116.25 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-O 121.767 0.794 . . . . 0.0 111.281 179.18 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.8 ' HB1' ' CG ' ' A' ' 96' ' ' ASP . . . -64.68 117.69 7.82 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.807 -0.558 . . . . 0.0 111.332 -179.231 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 55' ' ' ARG . . . . . 0.559 ' NH1' HG21 ' B' ' 53' ' ' VAL . 0.7 OUTLIER 166.3 85.49 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.356 0 O-C-N 121.58 -0.7 . . . . 0.0 110.214 178.955 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 56' ' ' GLN . . . . . 0.717 ' O ' ' HB3' ' B' ' 73' ' ' PRO . 6.5 mt-30 -157.59 178.31 10.42 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.076 -1.015 . . . . 0.0 111.863 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.665 ' HB2' ' O ' ' B' ' 56' ' ' GLN . . . 139.18 126.78 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.599 0 C-N-CA 123.484 0.713 . . . . 0.0 109.16 179.252 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 58' ' ' ARG . . . . . 0.659 ' HB2' ' CG1' ' B' ' 71' ' ' ILE . 0.0 OUTLIER -97.89 -166.58 1.4 Allowed 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 122.002 0.906 . . . . 0.0 111.933 -178.47 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 59' ' ' LYS . . . . . 0.453 ' C ' ' HA ' ' B' ' 69' ' ' LEU . 6.3 ttpt 177.68 74.04 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.48 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 60' ' ' GLY . . . . . 0.647 ' N ' ' HA ' ' B' ' 69' ' ' LEU . . . -133.19 -99.57 0.7 Allowed Glycine 0 N--CA 1.496 2.635 0 C-N-CA 120.381 -0.914 . . . . 0.0 111.192 -178.977 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 61' ' ' PHE . . . . . 0.805 ' C ' ' HA ' ' B' ' 68' ' ' ALA . 24.7 p90 -149.15 161.05 42.76 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.022 -1.281 . . . . 0.0 112.683 -178.097 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 62' ' ' ASN . . . . . 0.704 ' H ' ' CD ' ' B' ' 63' ' ' PRO . 11.3 p30 -124.73 -23.41 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.577 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.704 ' CD ' ' H ' ' B' ' 62' ' ' ASN . 41.5 Cg_endo -71.11 -31.17 15.14 Favored 'Trans proline' 0 N--CA 1.482 0.819 0 N-CA-C 107.603 -1.73 . . . . 0.0 107.603 179.256 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 64' ' ' GLN . . . . . 0.721 ' HB3' ' CE1' ' B' ' 61' ' ' PHE . 0.0 OUTLIER -80.17 -9.1 59.7 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.032 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.459 HG23 ' C ' ' B' ' 64' ' ' GLN . 1.8 p 59.16 85.28 0.1 Allowed 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 178.575 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 66' ' ' GLN . . . . . 0.637 ' HB2' ' CE1' ' B' ' 61' ' ' PHE . 0.0 OUTLIER 179.78 -16.06 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.871 -1.143 . . . . 0.0 113.276 177.682 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 67' ' ' GLU . . . . . 0.652 ' O ' ' N ' ' B' ' 61' ' ' PHE . 1.6 pt-20 170.75 65.2 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.419 0 O-C-N 120.532 -1.355 . . . . 0.0 110.297 179.887 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 68' ' ' ALA . . . . . 0.805 ' HA ' ' C ' ' B' ' 61' ' ' PHE . . . -39.51 158.83 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 121.816 0.817 . . . . 0.0 113.038 -178.632 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.926 HD13 ' H ' ' B' ' 69' ' ' LEU . 0.0 OUTLIER -73.55 22.47 0.08 Allowed 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.637 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 70' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' B' ' 69' ' ' LEU . 1.9 tp10 -178.1 33.4 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.607 -1.308 . . . . 0.0 111.937 179.376 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.749 HD12 ' O ' ' B' ' 72' ' ' ALA . 1.2 pp -62.19 -161.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.794 -1.191 . . . . 0.0 108.546 178.637 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 72' ' ' ALA . . . . . 0.785 ' HB1' ' HD2' ' B' ' 73' ' ' PRO . . . -112.44 170.05 5.7 Favored Pre-proline 0 C--N 1.295 -1.77 0 C-N-CA 118.897 -1.121 . . . . 0.0 112.345 -178.731 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 73' ' ' PRO . . . . . 0.785 ' HD2' ' HB1' ' B' ' 72' ' ' ALA . 53.5 Cg_endo -74.72 -153.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.292 -2.406 0 O-C-N 125.178 2.146 . . . . 0.0 109.61 178.916 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 74' ' ' SER . . . . . 0.458 ' CB ' ' O ' ' B' ' 73' ' ' PRO . 5.4 t 162.79 144.44 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 75' ' ' VAL . . . . . 0.758 HG21 HD21 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -53.26 173.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 120.682 -1.261 . . . . 0.0 109.714 -179.452 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 76' ' ' GLY . . . . . 0.655 ' O ' HG22 ' B' ' 53' ' ' VAL . . . -114.42 68.8 0.25 Allowed Glycine 0 N--CA 1.487 2.098 0 C-N-CA 119.403 -1.38 . . . . 0.0 109.656 -179.382 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.992 HG23 HG21 ' B' ' 36' ' ' VAL . 2.5 p -58.09 76.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.453 -1.027 . . . . 0.0 109.428 179.521 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 78' ' ' SER . . . . . 0.624 ' N ' ' O ' ' B' ' 76' ' ' GLY . 6.5 t -76.95 177.17 7.95 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.897 0.856 . . . . 0.0 110.789 -179.446 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.859 ' CG2' HG22 ' B' ' 50' ' ' ILE . 4.8 p 177.23 177.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 80' ' ' LYS . . . . . 0.699 ' O ' HD23 ' B' ' 48' ' ' LEU . 0.1 OUTLIER -172.48 173.51 1.48 Allowed Pre-proline 0 N--CA 1.485 1.303 0 O-C-N 120.64 -1.288 . . . . 0.0 110.642 178.131 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 81' ' ' PRO . . . . . 0.603 ' HB2' HG13 ' A' ' 77' ' ' VAL . 53.4 Cg_endo -97.72 133.1 0.32 Allowed 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 122.503 2.136 . . . . 0.0 110.504 178.801 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 82' ' ' GLY . . . . . 0.518 ' HA3' ' HA ' ' B' ' 47' ' ' PHE . . . -89.76 -164.37 39.98 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 108.41 -1.876 . . . . 0.0 108.41 178.669 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -83.87 -18.25 38.14 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.039 -1.271 . . . . 0.0 110.385 179.805 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 84' ' ' SER . . . . . 0.414 ' HB2' ' HB3' ' B' ' 47' ' ' PHE . 1.1 m -52.44 -38.18 58.59 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.23 -0.918 . . . . 0.0 109.434 179.656 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.931 HD23 ' HA ' ' A' ' 33' ' ' THR . 0.4 OUTLIER -78.71 -33.03 47.11 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.17 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 86' ' ' LYS . . . . . 0.672 ' O ' ' HB3' ' B' ' 89' ' ' ALA . 0.1 OUTLIER -73.04 -45.57 56.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.66 -0.65 . . . . 0.0 110.563 -179.32 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.74 -39.31 93.69 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 178.443 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.752 ' O ' ' HB1' ' A' ' 37' ' ' ALA . . . -66.83 -33.68 76.15 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 176.822 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.946 ' HA ' HD23 ' B' ' 92' ' ' LEU . . . -56.44 -44.83 80.84 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.019 179.17 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -53.81 -32.86 54.18 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 177.114 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -64.71 -35.82 92.38 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 178.447 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 92' ' ' LEU . . . . . 0.946 HD23 ' HA ' ' B' ' 89' ' ' ALA . 0.4 OUTLIER -75.58 12.01 1.14 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.689 -1.477 . . . . 0.0 111.111 -179.768 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 93' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' B' ' 92' ' ' LEU . 0.0 OUTLIER 61.01 40.04 15.72 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -177.639 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 94' ' ' TYR . . . . . 0.67 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 0.1 OUTLIER -37.79 -38.49 0.29 Allowed 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.167 -179.055 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 95' ' ' GLU . . . . . 0.507 ' O ' ' HB3' ' B' ' 98' ' ' ALA . 14.6 pt-20 -61.74 -42.93 99.61 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.31 -0.869 . . . . 0.0 109.885 179.77 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -58.96 -33.71 70.96 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.57 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.88 -26.81 62.49 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.463 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 98' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' B' ' 95' ' ' GLU . . . -65.75 -63.46 1.08 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.588 -0.695 . . . . 0.0 110.194 179.834 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 3.5 mtmp? . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 118.024 -0.988 . . . . 0.0 110.196 179.924 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.775 ' HG3' HG23 ' B' ' 42' ' ' VAL . 1.5 ptm . . . . . 0 N--CA 1.496 1.841 0 CA-C-O 121.297 0.57 . . . . 0.0 110.739 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.411 ' HB3' ' O ' ' A' ' 1' ' ' MET . 34.5 p-10 -175.38 -148.08 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 119.714 -0.795 . . . . 0.0 111.359 178.648 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.418 ' O ' ' CG2' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -53.83 -6.88 0.1 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.178 -0.952 . . . . 0.0 111.091 -179.521 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.627 ' O ' ' CG1' ' A' ' 7' ' ' ILE . 32.9 m -118.49 -64.1 1.33 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.953 -1.092 . . . . 0.0 110.613 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.703 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 5.0 mt-10 -48.79 -40.32 28.58 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.846 -1.159 . . . . 0.0 109.314 -179.706 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.682 HD11 ' CG2' ' B' ' 42' ' ' VAL . 74.0 mt -62.66 -33.88 75.95 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.456 178.19 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.807 ' HA ' HD12 ' A' ' 25' ' ' LEU . 0.9 OUTLIER -58.78 -38.03 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 178.771 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.841 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 31.4 mtmt -68.95 -34.29 75.1 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.17 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.67 ' HB1' HD13 ' B' ' 31' ' ' ILE . . . -54.37 -40.4 68.09 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.286 179.163 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.852 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.4 mp -92.24 -29.23 4.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 178.247 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.841 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -68.07 -9.14 43.86 Favored 'General case' 0 C--N 1.289 -2.033 0 O-C-N 120.579 -1.326 . . . . 0.0 108.723 178.596 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -121.51 -41.46 2.49 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.376 -0.828 . . . . 0.0 110.102 179.202 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.664 ' OD2' HG21 ' B' ' 31' ' ' ILE . 62.8 m-20 -68.62 -24.5 64.57 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 177.471 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' THR . . . . . 1.094 HG22 ' CD1' ' A' ' 16' ' ' LEU 0.274 0.2 OUTLIER -106.96 -81.85 0.55 Allowed 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 178.752 . . . . . . . . 4 4 . 1 . 022 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.51 6.43 66.07 Favored Glycine 0 N--CA 1.501 3.02 0 O-C-N 121.07 -1.019 . . . . 0.0 110.61 177.679 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.094 ' CD1' HG22 ' A' ' 14' ' ' THR . 5.0 mp -51.81 -70.17 0.09 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.67 -0.9 . . . . 0.0 110.514 179.812 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.536 ' CG2' HG21 ' B' ' 17' ' ' THR . 0.6 OUTLIER -132.82 8.57 4.14 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.825 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.588 ' O ' ' C ' ' A' ' 19' ' ' VAL . 2.3 mt-30 57.04 26.98 12.62 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 -176.179 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 1.104 HG23 ' CD1' ' B' ' 16' ' ' LEU . 0.6 OUTLIER -10.17 -94.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.626 -179.034 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.931 ' O ' ' N ' ' A' ' 23' ' ' LYS . 2.4 m -134.57 23.29 3.69 Favored 'General case' 0 C--N 1.28 -2.425 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 178.181 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.669 ' C ' ' O ' ' A' ' 20' ' ' SER . 31.5 m -18.16 -40.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 CA-C-O 122.418 1.104 . . . . 0.0 109.279 -177.376 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.867 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.4 OUTLIER -86.43 -38.03 17.75 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.088 178.142 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.931 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.9 OUTLIER -85.21 -31.52 23.13 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.535 -0.728 . . . . 0.0 110.895 179.448 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.803 ' HB3' HG23 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -76.46 -43.77 38.5 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 118.217 -1.393 . . . . 0.0 109.315 179.249 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.807 HD12 ' HA ' ' A' ' 7' ' ' ILE . 7.0 mt -68.5 -48.54 64.14 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 117.743 -1.583 . . . . 0.0 108.293 177.888 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.435 ' CB ' ' O ' ' A' ' 22' ' ' SER . . . -55.76 -33.14 64.05 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 177.558 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.532 ' O ' ' CG1' ' A' ' 31' ' ' ILE . 7.5 t -73.34 -36.81 66.24 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 177.488 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.744 ' HA ' ' CG1' ' A' ' 31' ' ' ILE . 0.1 OUTLIER -64.19 -33.74 76.49 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.535 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.567 ' HG3' ' CD2' ' A' ' 28' ' ' PHE . 2.1 mt-10 -83.1 -31.44 27.27 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.175 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.762 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 6.7 tttm -72.12 -27.62 62.74 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 176.588 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.744 ' CG1' ' HA ' ' A' ' 28' ' ' PHE . 1.8 pp -95.99 -31.71 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.35 -0.844 . . . . 0.0 109.751 179.009 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.762 HG21 ' CE1' ' B' ' 47' ' ' PHE . 2.6 mm -63.28 -52.89 52.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.829 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.583 HG23 ' HB2' ' B' ' 88' ' ' ALA . 0.4 OUTLIER -68.34 -38.82 81.85 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.556 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.762 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 34.0 mm-40 -71.94 -34.3 68.91 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.413 -0.805 . . . . 0.0 110.832 179.169 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.737 HG21 HG13 ' A' ' 42' ' ' VAL . 3.2 m -59.98 -54.16 49.31 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.997 -1.064 . . . . 0.0 108.563 179.894 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.635 HG11 HD22 ' B' ' 85' ' ' LEU . 1.0 OUTLIER -54.04 -35.04 27.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 177.755 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.737 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -78.51 -7.15 57.18 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.736 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.489 ' N ' ' O ' ' A' ' 35' ' ' THR . 1.3 ttmt -102.21 -25.28 13.75 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 178.122 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 35' ' ' THR . . . 104.8 41.83 1.92 Allowed Glycine 0 C--N 1.3 -1.417 0 C-N-CA 120.218 -0.991 . . . . 0.0 110.699 178.067 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.704 ' CB ' HG23 ' A' ' 35' ' ' THR . 0.3 OUTLIER -128.67 154.27 46.45 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.116 -1.226 . . . . 0.0 110.429 179.449 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.421 ' HE3' ' CB ' ' A' ' 51' ' ' LYS . 43.1 tttt -109.01 98.38 7.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.382 -0.824 . . . . 0.0 110.0 -179.738 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.762 HG12 ' HB2' ' B' ' 1' ' ' MET . 19.3 m -84.93 147.41 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.451 -0.781 . . . . 0.0 110.414 -179.602 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.436 ' O ' ' HA ' ' B' ' 2' ' ' ASN . 1.7 tt0 -136.57 107.91 6.86 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 121.296 -0.878 . . . . 0.0 110.134 -179.131 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.712 HD22 ' HE2' ' B' ' 28' ' ' PHE . 20.3 mt -66.64 99.13 0.57 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.039 -1.038 . . . . 0.0 109.875 179.51 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.637 HG21 ' HB3' ' B' ' 29' ' ' GLU . 1.7 t 37.17 26.67 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.782 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . 94.44 -0.24 65.58 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 120.06 -1.067 . . . . 0.0 112.487 177.664 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.881 ' CE1' HG21 ' B' ' 32' ' ' ILE . 0.8 OUTLIER -104.23 -31.38 9.62 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 120.002 1.901 . . . . 0.0 111.96 -179.919 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.832 HD13 HD13 ' B' ' 48' ' ' LEU . 1.0 OUTLIER -123.04 93.82 4.07 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.706 -1.246 . . . . 0.0 109.779 178.115 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -96.08 75.14 3.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.702 -0.624 . . . . 0.0 111.371 -179.114 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.863 HD13 ' HB ' ' A' ' 79' ' ' VAL . 2.6 mm -63.19 129.71 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.202 -0.936 . . . . 0.0 109.031 178.798 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 78' ' ' SER . 0.0 OUTLIER -144.05 127.26 8.81 Favored Pre-proline 0 N--CA 1.492 1.656 0 C-N-CA 118.712 -1.195 . . . . 0.0 109.704 179.491 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.623 ' HB3' HG13 ' A' ' 36' ' ' VAL . 54.3 Cg_endo -76.71 142.13 22.56 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.384 1.202 . . . . 0.0 111.162 -179.277 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 1.055 ' O ' HG22 ' A' ' 75' ' ' VAL . 1.7 t -122.08 -142.84 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.588 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.532 ' HB2' ' O ' ' A' ' 53' ' ' VAL . . . 177.42 118.36 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.291 -0.88 . . . . 0.0 110.158 179.693 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.49 88.86 0.23 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.433 -0.792 . . . . 0.0 109.764 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.562 ' CD ' ' HB1' ' B' ' 98' ' ' ALA . 1.3 mt-30 -58.68 128.07 35.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.402 -0.811 . . . . 0.0 110.247 -179.752 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.882 ' C ' HD13 ' A' ' 71' ' ' ILE . . . -56.73 -169.4 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.807 0.813 . . . . 0.0 110.269 179.645 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.739 ' C ' HG21 ' A' ' 71' ' ' ILE 0.251 4.2 mpt_? -57.12 -135.62 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.891 0 CA-C-O 122.576 1.179 . . . . 0.0 111.471 179.701 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.745 ' HA ' ' H ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER 170.4 61.05 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 177.622 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -45.05 115.4 1.44 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 -179.108 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.791 ' O ' ' HB2' ' A' ' 62' ' ' ASN 0.26 0.6 OUTLIER -78.06 6.1 8.61 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 118.231 -1.387 . . . . 0.0 112.075 -178.208 . . . . . . . . 4 4 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.791 ' HB2' ' O ' ' A' ' 61' ' ' PHE . 6.9 t30 161.21 -156.65 0.0 OUTLIER Pre-proline 0 C--N 1.28 -2.446 0 N-CA-C 104.764 -2.31 . . . . 0.0 104.764 -177.326 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.555 ' HD2' ' HB3' ' A' ' 62' ' ' ASN . 45.0 Cg_endo -78.12 35.91 0.55 Allowed 'Trans proline' 0 C--N 1.305 -1.715 0 N-CA-C 108.644 -1.329 . . . . 0.0 108.644 177.247 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.783 ' O ' HG23 ' A' ' 65' ' ' THR . 0.1 OUTLIER -158.79 -118.29 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 O-C-N 121.259 -0.9 . . . . 0.0 110.928 -178.582 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.783 HG23 ' O ' ' A' ' 64' ' ' GLN . 0.2 OUTLIER -174.27 101.7 0.1 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.001 -1.062 . . . . 0.0 110.0 -179.458 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.516 ' HB2' ' CE2' ' A' ' 61' ' ' PHE . 0.8 OUTLIER -151.19 -69.67 0.17 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.439 -0.788 . . . . 0.0 109.247 179.831 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.899 ' O ' HD23 ' A' ' 69' ' ' LEU . 7.7 mt-10 -101.39 37.34 1.81 Allowed 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 177.777 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.709 ' HB1' ' HG3' ' A' ' 59' ' ' LYS . . . -19.77 137.8 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -177.199 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.899 HD23 ' O ' ' A' ' 67' ' ' GLU . 1.1 pp -174.5 44.28 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.935 ' O ' HG23 ' A' ' 71' ' ' ILE . 2.4 tm-20 -169.75 112.15 0.47 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 119.461 -2.024 . . . . 0.0 113.105 178.953 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.935 HG23 ' O ' ' A' ' 70' ' ' GLU 0.25 0.5 OUTLIER -168.49 -157.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-O 121.686 0.755 . . . . 0.0 111.191 -179.247 . . . . . . . . 4 4 . 1 . 022 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -113.51 74.9 2.33 Favored Pre-proline 0 C--N 1.31 -1.14 0 O-C-N 121.756 -0.59 . . . . 0.0 111.327 -179.605 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.53 121.75 8.26 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.741 1.39 . . . . 0.0 109.972 178.962 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.541 ' HA ' ' CE2' ' B' ' 94' ' ' TYR . 11.0 p -166.41 147.07 6.24 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.2 -0.938 . . . . 0.0 109.942 -179.879 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 1.055 HG22 ' O ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -53.87 175.18 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.143 -0.973 . . . . 0.0 108.38 179.738 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.618 ' O ' ' N ' ' A' ' 78' ' ' SER . . . -110.91 38.67 3.19 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 118.569 -1.777 . . . . 0.0 110.226 -178.765 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.734 ' CG2' HD22 ' B' ' 85' ' ' LEU . 3.0 p -27.78 87.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 CA-C-O 121.924 0.868 . . . . 0.0 110.58 179.781 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.618 ' N ' ' O ' ' A' ' 76' ' ' GLY . 0.1 OUTLIER -87.81 175.52 7.8 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.963 -179.168 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.863 ' HB ' HD13 ' A' ' 50' ' ' ILE . 7.2 p 175.57 177.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.845 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.671 ' O ' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -177.15 171.71 0.89 Allowed Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.001 -1.062 . . . . 0.0 110.185 176.948 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.603 ' HB2' HG13 ' B' ' 77' ' ' VAL . 54.7 Cg_endo -96.91 128.8 0.3 Allowed 'Trans proline' 0 C--N 1.302 -1.894 0 C-N-CA 122.414 2.076 . . . . 0.0 110.691 178.639 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.494 ' HA3' ' HA ' ' A' ' 47' ' ' PHE . . . -87.75 173.18 43.28 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 178.749 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -62.19 -17.92 59.52 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.086 -1.244 . . . . 0.0 110.591 -179.846 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.526 ' HB2' ' HB3' ' A' ' 47' ' ' PHE . 0.8 OUTLIER -53.74 -41.15 66.77 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.177 -0.952 . . . . 0.0 109.506 179.802 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.924 ' CB ' HG21 ' B' ' 77' ' ' VAL . 1.0 OUTLIER -76.76 -26.79 54.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.448 -0.783 . . . . 0.0 109.116 179.111 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.669 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 0.7 OUTLIER -81.03 -41.27 22.93 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.665 -0.647 . . . . 0.0 110.63 -179.522 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.67 -40.92 98.02 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 178.985 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.736 ' O ' ' HB1' ' B' ' 37' ' ' ALA . . . -65.29 -37.39 87.02 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 176.3 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 1.091 ' HB1' HG11 ' B' ' 75' ' ' VAL . . . -56.66 -40.33 75.31 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.467 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.412 ' HG2' ' N ' ' A' ' 91' ' ' GLY . 1.1 pt-20 -55.5 -31.75 62.3 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 177.096 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.412 ' N ' ' HG2' ' A' ' 90' ' ' GLU . . . -68.56 -34.04 77.97 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 178.643 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.835 ' O ' HD12 ' A' ' 92' ' ' LEU . 0.6 OUTLIER -66.27 5.84 0.49 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.648 -1.501 . . . . 0.0 111.305 -179.806 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.423 ' CB ' ' O ' ' A' ' 92' ' ' LEU . 0.4 OUTLIER 65.36 39.49 5.23 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 -177.388 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.525 ' HA ' HD11 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -43.54 -31.49 0.74 Allowed 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.154 -179.079 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -57.91 -41.68 83.15 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.279 -0.888 . . . . 0.0 108.944 179.151 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -63.58 -36.0 82.37 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 177.515 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.593 ' HB3' ' HB2' ' B' ' 54' ' ' ALA . 0.1 OUTLIER -71.05 -25.47 62.65 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.139 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.642 ' HB1' ' HB3' ' B' ' 56' ' ' GLN . . . -76.14 -70.39 0.44 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.662 -0.649 . . . . 0.0 110.136 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 18.1 mtmt . . . . . 0 N--CA 1.494 1.76 0 CA-C-O 118.053 -0.975 . . . . 0.0 110.31 -179.979 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.762 ' HB2' HG12 ' A' ' 42' ' ' VAL . 2.5 mtp . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 2' ' ' ASN . . . . . 0.44 ' H ' ' HB2' ' B' ' 5' ' ' GLU . 17.5 p30 -173.43 -153.91 0.06 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.002 -1.061 . . . . 0.0 111.693 179.705 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.465 ' HG3' ' HB ' ' A' ' 45' ' ' THR . 0.1 OUTLIER -56.52 -0.55 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.515 -0.741 . . . . 0.0 111.562 -179.229 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.72 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 61.3 m -125.52 -45.68 1.78 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.779 -1.201 . . . . 0.0 110.363 179.738 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.54 ' CB ' ' HA ' ' B' ' 1' ' ' MET . 3.3 mt-10 -65.99 -51.45 58.23 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.051 -1.031 . . . . 0.0 108.682 179.673 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.778 ' O ' ' HB3' ' B' ' 9' ' ' ALA . 17.9 mt -58.02 -32.62 68.12 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.161 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 7' ' ' ILE . . . . . 0.845 HG23 ' HB ' ' B' ' 21' ' ' VAL . 1.3 mt -53.63 -55.35 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 177.591 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 8' ' ' LYS . . . . . 0.965 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.6 OUTLIER -57.11 -31.98 65.84 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 177.829 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 9' ' ' ALA . . . . . 0.778 ' HB3' ' O ' ' B' ' 6' ' ' LEU . . . -54.52 -38.42 66.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.271 -0.893 . . . . 0.0 108.971 178.677 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.803 HG23 ' HB3' ' A' ' 24' ' ' MET . 1.6 mp -90.83 -34.34 6.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 178.121 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.965 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -67.28 -12.62 60.6 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 119.139 -1.024 . . . . 0.0 109.011 178.686 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.491 ' N ' ' O ' ' B' ' 8' ' ' LYS . 1.1 pp0? -113.7 -36.0 5.0 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.339 -0.851 . . . . 0.0 109.416 178.496 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.435 ' OD2' HG21 ' A' ' 31' ' ' ILE . 56.0 m-20 -72.15 -21.54 61.44 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 176.784 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.837 HG21 ' HB2' ' A' ' 20' ' ' SER . 0.2 OUTLIER -117.24 -77.94 0.57 Allowed 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.462 179.648 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 15' ' ' GLY . . . . . 0.46 ' O ' ' C ' ' B' ' 16' ' ' LEU . . . 64.99 -13.1 0.21 Allowed Glycine 0 N--CA 1.5 2.908 0 N-CA-C 110.499 -1.041 . . . . 0.0 110.499 179.065 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 16' ' ' LEU . . . . . 1.104 ' CD1' HG23 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -35.05 -59.43 0.5 Allowed 'General case' 0 N--CA 1.513 2.677 0 CA-C-O 122.06 0.934 . . . . 0.0 110.678 -179.695 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 17' ' ' THR . . . . . 0.641 HG22 ' H ' ' B' ' 19' ' ' VAL . 0.5 OUTLIER -136.38 -1.17 2.36 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.543 -179.291 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 18' ' ' GLN . . . . . 0.627 ' O ' ' C ' ' B' ' 19' ' ' VAL . 5.1 mt-30 54.83 31.79 16.37 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 -176.815 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 1.005 HG11 HG11 ' A' ' 19' ' ' VAL . 0.9 OUTLIER -6.79 -93.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.01 -178.835 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 20' ' ' SER . . . . . 1.06 ' O ' ' N ' ' B' ' 22' ' ' SER . 0.3 OUTLIER -133.16 24.77 4.2 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 178.116 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.918 HG11 ' HB2' ' B' ' 11' ' ' ALA . 0.0 OUTLIER -8.85 -39.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-O 122.362 1.077 . . . . 0.0 110.288 -178.252 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 22' ' ' SER . . . . . 1.06 ' N ' ' O ' ' B' ' 20' ' ' SER . 5.9 m -85.05 -43.09 14.23 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.483 178.244 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 23' ' ' LYS . . . . . 0.885 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.2 OUTLIER -81.94 -25.3 35.0 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.286 -0.884 . . . . 0.0 111.004 179.927 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 24' ' ' MET . . . . . 0.695 ' HB3' HG21 ' A' ' 14' ' ' THR . 0.0 OUTLIER -82.94 -45.92 13.57 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 118.357 -1.337 . . . . 0.0 110.063 179.399 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.644 HD23 ' HE3' ' B' ' 24' ' ' MET . 0.4 OUTLIER -69.05 -48.22 63.4 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 117.53 -1.668 . . . . 0.0 108.104 178.272 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 26' ' ' ALA . . . . . 0.46 ' HA ' ' HE2' ' B' ' 3' ' ' LYS . . . -54.84 -34.09 62.48 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 177.698 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 27' ' ' SER . . . . . 0.737 ' O ' HG23 ' B' ' 31' ' ' ILE . 3.7 t -72.55 -39.45 67.47 Favored 'General case' 0 C--O 1.204 -1.311 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.681 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 28' ' ' PHE . . . . . 0.732 ' HA ' ' CG1' ' B' ' 31' ' ' ILE . 0.1 OUTLIER -62.96 -37.68 88.05 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.688 0.756 . . . . 0.0 109.287 179.357 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 29' ' ' GLU . . . . . 0.637 ' HB3' HG21 ' A' ' 45' ' ' THR . 0.9 OUTLIER -81.9 -31.18 31.56 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 178.656 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 0.815 ' O ' ' CG ' ' B' ' 34' ' ' GLU . 9.7 ttmt -71.99 -30.19 64.99 Favored 'General case' 0 C--O 1.19 -2.03 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 176.277 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.737 HG23 ' O ' ' B' ' 27' ' ' SER . 1.3 pp -91.19 -30.28 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.21 -0.931 . . . . 0.0 109.606 179.167 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.881 HG21 ' CE1' ' A' ' 47' ' ' PHE . 5.2 mm -62.57 -51.68 69.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 177.495 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 33' ' ' THR . . . . . 0.834 ' HA ' HD23 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -75.69 -25.66 56.9 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 114.904 -1.043 . . . . 0.0 108.966 179.74 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.815 ' CG ' ' O ' ' B' ' 30' ' ' LYS . 5.6 mm-40 -81.84 -35.75 29.04 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.078 -1.014 . . . . 0.0 109.394 178.674 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 35' ' ' THR . . . . . 0.613 HG23 ' HB2' ' B' ' 40' ' ' ASP . 52.0 m -62.55 -54.34 41.18 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 178.232 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.805 HG22 ' O ' ' B' ' 32' ' ' ILE . 2.2 m -50.17 -34.39 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 177.146 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 0.736 ' HB1' ' O ' ' A' ' 88' ' ' ALA . . . -90.58 -4.13 57.08 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 121.57 0.7 . . . . 0.0 110.352 178.318 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 38' ' ' LYS . . . . . 0.658 ' N ' ' O ' ' B' ' 34' ' ' GLU . 0.0 OUTLIER -97.93 -24.5 15.36 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 177.731 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 111.81 43.87 0.92 Allowed Glycine 0 C--N 1.301 -1.383 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 178.089 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 40' ' ' ASP . . . . . 0.613 ' HB2' HG23 ' B' ' 35' ' ' THR . 0.1 OUTLIER -145.82 136.64 24.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.202 -1.175 . . . . 0.0 110.565 179.684 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 10.9 mtmt -89.68 88.28 7.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.477 -0.764 . . . . 0.0 109.901 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.775 HG23 ' HG3' ' A' ' 1' ' ' MET . 7.6 p -62.1 142.19 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.486 -0.759 . . . . 0.0 110.128 -179.808 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 43' ' ' GLN . . . . . 0.438 ' HA ' ' O ' ' B' ' 48' ' ' LEU . 6.2 mt-30 -134.31 110.92 9.81 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.448 -0.782 . . . . 0.0 110.548 -179.361 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.65 HD22 ' HE2' ' A' ' 28' ' ' PHE . 17.0 mt -66.64 118.63 10.48 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.253 -0.904 . . . . 0.0 109.533 179.323 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 45' ' ' THR . . . . . 0.547 HG21 ' HB3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 29.06 -89.34 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.823 -0.548 . . . . 0.0 111.228 -179.975 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -149.58 26.85 1.2 Allowed Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 179.623 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 47' ' ' PHE . . . . . 0.762 ' CE1' HG21 ' A' ' 32' ' ' ILE . 7.7 p90 -125.45 -24.44 3.91 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.951 -1.323 . . . . 0.0 112.011 179.736 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.832 HD13 HD13 ' A' ' 48' ' ' LEU . 1.6 mt -128.07 108.47 10.68 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.404 -1.435 . . . . 0.0 110.82 178.814 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -106.19 69.83 0.82 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.574 -0.704 . . . . 0.0 110.989 -179.643 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 50' ' ' ILE . . . . . 0.912 HD13 ' HB ' ' B' ' 79' ' ' VAL . 1.9 mm -60.1 125.6 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.302 -0.874 . . . . 0.0 109.281 179.142 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 51' ' ' LYS . . . . . 0.461 ' HG3' ' HB2' ' B' ' 78' ' ' SER . 9.1 ptmt -149.71 122.63 4.37 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 120.665 -1.272 . . . . 0.0 111.252 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.613 ' HA ' ' HA ' ' B' ' 77' ' ' VAL . 55.4 Cg_endo -79.8 144.49 17.32 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 O-C-N 123.61 1.321 . . . . 0.0 110.964 179.78 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.705 HG22 ' O ' ' B' ' 76' ' ' GLY . 32.6 m -138.92 114.3 8.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-O 121.833 0.825 . . . . 0.0 110.753 179.282 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.593 ' HB2' ' HB3' ' A' ' 97' ' ' PHE . . . -56.74 94.29 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.581 -0.699 . . . . 0.0 111.173 -179.022 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 8.7 ttt-85 -108.01 69.39 0.73 Allowed 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.623 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 56' ' ' GLN . . . . . 0.642 ' HB3' ' HB1' ' A' ' 98' ' ' ALA . 7.3 pt20 -51.85 -175.48 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.889 0.852 . . . . 0.0 111.647 -178.496 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.75 -168.59 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.306 0.574 . . . . 0.0 111.173 -179.074 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 58' ' ' ARG . . . . . 0.766 ' HD2' ' N ' ' B' ' 71' ' ' ILE . 0.0 OUTLIER -175.4 -157.15 0.06 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.445 -0.784 . . . . 0.0 110.204 -177.83 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 59' ' ' LYS . . . . . 0.645 ' HB3' ' O ' ' B' ' 58' ' ' ARG . 0.0 OUTLIER 150.68 88.59 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.238 0 CA-C-O 121.36 0.6 . . . . 0.0 109.51 177.921 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 60' ' ' GLY . . . . . 0.83 ' HA3' HD12 ' B' ' 69' ' ' LEU . . . -118.0 -112.83 2.58 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 -179.685 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 61' ' ' PHE . . . . . 0.634 ' C ' ' CD1' ' B' ' 61' ' ' PHE . 11.9 p90 179.37 175.77 0.67 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.479 -1.012 . . . . 0.0 110.282 -179.517 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 62' ' ' ASN . . . . . 0.973 ' CB ' ' HB2' ' B' ' 68' ' ' ALA . 0.0 OUTLIER -135.4 -44.08 0.02 OUTLIER Pre-proline 0 C--N 1.298 -1.672 0 C-N-CA 119.719 -0.792 . . . . 0.0 112.353 178.322 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.933 ' HD2' ' H ' ' B' ' 62' ' ' ASN . 41.1 Cg_endo -69.67 64.17 1.75 Allowed 'Trans proline' 0 N--CA 1.486 1.055 0 O-C-N 122.62 0.8 . . . . 0.0 110.957 -179.651 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 64' ' ' GLN . . . . . 0.576 ' CB ' ' CE1' ' B' ' 61' ' ' PHE . 0.0 OUTLIER -168.47 -106.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 179.119 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.443 ' O ' ' CB ' ' B' ' 66' ' ' GLN . 0.5 OUTLIER -75.45 -1.9 26.24 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.358 -1.464 . . . . 0.0 109.005 177.247 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 66' ' ' GLN . . . . . 0.458 ' O ' ' CB ' ' B' ' 67' ' ' GLU . 0.9 OUTLIER 73.53 98.63 0.07 Allowed 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 121.533 0.682 . . . . 0.0 111.817 179.221 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 67' ' ' GLU . . . . . 0.632 ' H ' ' HA ' ' B' ' 62' ' ' ASN . 0.3 OUTLIER 164.48 67.81 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.922 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 68' ' ' ALA . . . . . 0.973 ' HB2' ' CB ' ' B' ' 62' ' ' ASN . . . -64.81 138.95 58.69 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.451 -0.781 . . . . 0.0 110.554 -179.659 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.83 HD12 ' HA3' ' B' ' 60' ' ' GLY . 1.4 mt -138.12 125.09 21.3 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.813 -0.554 . . . . 0.0 109.54 -178.507 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 70' ' ' GLU . . . . . 0.499 ' C ' ' HD2' ' B' ' 58' ' ' ARG . 3.3 tt0 -166.15 27.64 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.3 -0.875 . . . . 0.0 110.508 -179.318 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.812 HD12 ' N ' ' B' ' 72' ' ' ALA . 2.4 pp -61.92 -150.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.296 -0.878 . . . . 0.0 110.033 178.98 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 72' ' ' ALA . . . . . 0.812 ' N ' HD12 ' B' ' 71' ' ' ILE . . . -135.67 163.23 52.06 Favored Pre-proline 0 C--N 1.301 -1.512 0 O-C-N 121.044 -1.035 . . . . 0.0 110.986 -179.31 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 73' ' ' PRO . . . . . 0.473 ' HD2' ' HB1' ' B' ' 72' ' ' ALA . 44.1 Cg_endo -70.72 114.98 4.03 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 124.238 1.652 . . . . 0.0 110.278 179.887 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 74' ' ' SER . . . . . 0.471 ' N ' ' OH ' ' A' ' 94' ' ' TYR . 2.0 t 166.89 138.41 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.726 -0.609 . . . . 0.0 109.766 179.995 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 75' ' ' VAL . . . . . 1.091 HG11 ' HB1' ' A' ' 89' ' ' ALA . 8.6 p -59.02 166.34 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.175 -0.953 . . . . 0.0 109.132 179.183 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 76' ' ' GLY . . . . . 0.705 ' O ' HG22 ' B' ' 53' ' ' VAL . . . -120.24 96.72 0.63 Allowed Glycine 0 N--CA 1.49 2.244 0 C-N-CA 119.295 -1.431 . . . . 0.0 110.239 -179.143 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.924 HG21 ' CB ' ' A' ' 85' ' ' LEU . 6.4 p -69.39 68.61 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.575 -0.956 . . . . 0.0 109.075 179.04 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 78' ' ' SER . . . . . 0.461 ' HB2' ' HG3' ' B' ' 51' ' ' LYS . 1.6 m -65.65 177.18 1.28 Allowed 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.894 0.854 . . . . 0.0 110.732 -179.178 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.912 ' HB ' HD13 ' B' ' 50' ' ' ILE . 7.3 p 177.24 177.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -179.84 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 80' ' ' LYS . . . . . 0.68 ' O ' HD23 ' B' ' 48' ' ' LEU . 0.6 OUTLIER -177.47 172.62 0.76 Allowed Pre-proline 0 N--CA 1.487 1.423 0 O-C-N 120.852 -1.155 . . . . 0.0 110.769 177.651 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 81' ' ' PRO . . . . . 0.524 ' HA ' ' O ' ' B' ' 47' ' ' PHE . 53.4 Cg_endo -92.76 128.25 0.79 Allowed 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.441 2.094 . . . . 0.0 110.61 178.527 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 82' ' ' GLY . . . . . 0.473 ' H ' ' HA ' ' B' ' 47' ' ' PHE . . . -91.67 178.93 41.37 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 108.634 -1.787 . . . . 0.0 108.634 179.152 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 83' ' ' GLU . . . . . 0.469 ' HA ' ' HB2' ' B' ' 86' ' ' LYS . 4.0 pt-20 -69.61 -28.31 65.82 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.115 -1.227 . . . . 0.0 110.498 -179.828 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -48.71 -32.17 8.03 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.841 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.734 HD22 ' CG2' ' A' ' 77' ' ' VAL . 0.5 OUTLIER -83.4 -38.23 22.22 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.211 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 86' ' ' LYS . . . . . 0.758 ' O ' ' HB3' ' B' ' 89' ' ' ALA . 0.1 OUTLIER -70.12 -36.39 74.79 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.447 -0.783 . . . . 0.0 109.125 179.575 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 13.0 ttpt -64.97 -42.03 94.94 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 178.029 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.591 ' HB1' ' HB2' ' A' ' 37' ' ' ALA . . . -63.72 -34.86 78.82 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 176.233 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.982 ' HA ' HD23 ' B' ' 92' ' ' LEU . . . -54.47 -43.99 72.21 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.616 -0.834 . . . . 0.0 109.275 178.743 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -53.35 -32.7 50.47 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 177.104 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 91' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' B' ' 88' ' ' ALA . . . -60.88 -42.3 99.57 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 178.138 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 92' ' ' LEU . . . . . 0.982 HD23 ' HA ' ' B' ' 89' ' ' ALA . 0.4 OUTLIER -75.39 17.79 0.25 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.665 -1.491 . . . . 0.0 110.502 179.682 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 93' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' B' ' 92' ' ' LEU . 0.0 OUTLIER 58.17 44.74 18.56 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -177.539 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 94' ' ' TYR . . . . . 0.693 ' HD1' HG23 ' A' ' 75' ' ' VAL . 0.1 OUTLIER -36.71 -35.62 0.09 Allowed 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.68 -179.16 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 95' ' ' GLU . . . . . 0.425 ' HG3' ' N ' ' B' ' 96' ' ' ASP . 0.0 OUTLIER -64.77 -44.0 91.42 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.382 -0.824 . . . . 0.0 109.382 179.887 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 96' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' B' ' 93' ' ' LYS . 25.8 m-20 -56.39 -34.52 66.78 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.572 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -82.51 -25.09 33.76 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.81 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 98' ' ' ALA . . . . . 0.562 ' HB1' ' CD ' ' A' ' 56' ' ' GLN . . . -68.28 -49.11 62.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.691 -0.631 . . . . 0.0 110.32 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.258 -179.922 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.645 ' HB2' HG12 ' B' ' 42' ' ' VAL . 11.1 mtp . . . . . 0 N--CA 1.493 1.706 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.499 ' HA ' ' O ' ' B' ' 43' ' ' GLN . 43.7 p-10 -168.5 -159.03 0.25 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.83 -1.169 . . . . 0.0 112.36 -179.891 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.507 ' HE2' ' HB2' ' A' ' 29' ' ' GLU . 5.6 tttm -50.92 -10.09 0.06 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.547 -0.721 . . . . 0.0 111.305 -179.388 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.692 ' O ' HG13 ' A' ' 7' ' ' ILE . 1.3 m -120.12 -57.88 1.91 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.978 -1.076 . . . . 0.0 109.558 179.208 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.564 ' CB ' ' HA ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -48.11 -40.86 24.77 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.402 -0.811 . . . . 0.0 109.154 179.576 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.581 ' HG ' ' HB3' ' A' ' 1' ' ' MET . 5.6 mt -68.83 -29.65 68.02 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.301 -0.96 . . . . 0.0 110.169 178.583 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.729 ' HA ' HD12 ' A' ' 25' ' ' LEU . 1.2 pp -59.99 -46.8 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.667 -1.271 . . . . 0.0 108.263 179.73 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.94 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 18.4 pttt -72.43 -24.8 61.28 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.2 -1.0 . . . . 0.0 108.678 177.514 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 6' ' ' LEU . . . -58.45 -39.26 79.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.264 -0.898 . . . . 0.0 109.04 178.774 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.802 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.9 OUTLIER -92.28 -32.79 5.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 177.863 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.94 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -60.61 -14.29 19.39 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 118.856 -1.138 . . . . 0.0 108.966 178.129 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 10.0 mm-40 -112.87 -44.01 3.35 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.271 -0.893 . . . . 0.0 109.656 179.071 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.43 ' HB3' ' HB2' ' B' ' 27' ' ' SER . 0.7 OUTLIER -65.79 -39.03 90.54 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.569 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 14' ' ' THR . . . . . 1.14 HG22 ' CD1' ' A' ' 16' ' ' LEU 0.251 0.2 OUTLIER -91.87 -70.07 0.71 Allowed 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 177.693 . . . . . . . . 4 4 . 1 . 023 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.467 ' HA2' ' O ' ' A' ' 11' ' ' ALA . . . 58.23 18.9 37.11 Favored Glycine 0 N--CA 1.499 2.853 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 177.236 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.14 ' CD1' HG22 ' A' ' 14' ' ' THR . 3.3 mp -62.74 -63.83 1.1 Allowed 'General case' 0 C--N 1.293 -1.853 0 O-C-N 121.48 -1.012 . . . . 0.0 109.937 179.308 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.6 HG21 ' CG2' ' B' ' 17' ' ' THR . 0.6 OUTLIER -138.13 7.63 2.67 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.445 -179.681 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.54 ' O ' ' C ' ' A' ' 19' ' ' VAL . 28.4 mt-30 58.14 26.5 13.79 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 -176.219 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.976 HG11 HG11 ' B' ' 19' ' ' VAL . 2.7 p -13.88 -96.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.121 -178.708 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.959 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -129.72 23.38 5.41 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 105.966 -1.865 . . . . 0.0 105.966 178.402 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.739 HG12 HG22 ' A' ' 10' ' ' ILE . 30.0 m -24.6 -39.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 CA-C-O 122.481 1.134 . . . . 0.0 109.156 -178.868 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.706 ' N ' ' O ' ' A' ' 20' ' ' SER . 48.2 t -82.66 -35.27 27.04 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.246 177.92 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.959 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.6 OUTLIER -86.84 -36.56 18.41 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.684 -0.635 . . . . 0.0 111.347 179.521 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.654 ' CE ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -70.06 -39.4 75.7 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.28 -1.513 . . . . 0.0 109.039 179.433 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.729 HD12 ' HA ' ' A' ' 7' ' ' ILE . 9.0 mt -77.82 -44.54 27.11 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 118.167 -1.413 . . . . 0.0 109.413 178.638 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.48 ' CB ' ' O ' ' A' ' 22' ' ' SER . . . -58.01 -32.8 68.27 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.955 -1.09 . . . . 0.0 108.121 178.025 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.58 ' O ' ' N ' ' A' ' 31' ' ' ILE . 25.8 p -85.27 -31.42 23.11 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.378 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.894 ' HB2' HD11 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -56.13 -34.67 66.3 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.572 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.781 ' HG2' HG22 ' B' ' 45' ' ' THR . 0.8 OUTLIER -79.74 -39.31 31.38 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.378 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.81 ' O ' ' CG ' ' A' ' 34' ' ' GLU . 39.7 ttmt -65.92 -28.08 68.66 Favored 'General case' 0 C--O 1.192 -1.965 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.478 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.749 ' CD1' HD23 ' B' ' 6' ' ' LEU . 2.1 pp -93.2 -37.97 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.911 . . . . 0.0 108.939 179.103 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.749 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.1 mm -58.71 -53.52 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 177.651 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.716 ' OG1' ' HB2' ' B' ' 85' ' ' LEU . 0.3 OUTLIER -69.92 -27.35 64.71 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.654 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.81 ' CG ' ' O ' ' A' ' 30' ' ' LYS . 16.9 mm-40 -76.67 -45.03 31.4 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.0 -1.062 . . . . 0.0 110.685 178.973 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.477 ' C ' ' H ' ' A' ' 38' ' ' LYS . 96.4 m -61.58 -53.43 56.36 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 120.651 -1.281 . . . . 0.0 108.859 179.445 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.952 ' CG2' HD13 ' B' ' 85' ' ' LEU . 15.7 m -50.11 -35.34 11.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 177.25 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.755 ' HB1' ' O ' ' B' ' 88' ' ' ALA . . . -92.01 1.18 57.36 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-O 121.582 0.706 . . . . 0.0 110.32 178.484 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.595 ' N ' ' O ' ' A' ' 34' ' ' GLU . 8.8 ttmt -101.53 -32.93 10.14 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 177.784 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 132.98 35.87 0.29 Allowed Glycine 0 C--N 1.305 -1.173 0 C-N-CA 119.637 -1.268 . . . . 0.0 111.565 177.738 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.467 ' CB ' ' CG2' ' A' ' 35' ' ' THR . 0.2 OUTLIER -145.97 -174.02 4.32 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.824 -1.398 . . . . 0.0 111.39 179.467 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.4 ' HG2' ' CB ' ' A' ' 51' ' ' LYS . 0.5 OUTLIER -134.57 127.67 31.73 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.831 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.693 HG22 HD11 ' B' ' 6' ' ' LEU . 1.1 t -85.96 115.38 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.201 -0.937 . . . . 0.0 110.713 -178.794 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.442 ' O ' ' HA ' ' B' ' 2' ' ' ASN . 4.8 mt-30 -105.54 100.43 10.0 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.951 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.918 HD22 ' HD2' ' B' ' 3' ' ' LYS . 47.8 mt -71.9 115.44 11.12 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.219 -0.926 . . . . 0.0 110.704 -178.933 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.536 ' C ' ' O ' ' A' ' 44' ' ' LEU . 2.1 t 28.43 -117.17 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.717 -0.615 . . . . 0.0 110.516 178.981 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -127.08 32.32 3.63 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 109.071 -1.611 . . . . 0.0 109.071 179.024 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.709 ' HE1' ' HB3' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -131.08 -28.0 1.98 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.14 -1.212 . . . . 0.0 111.921 -179.836 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.927 HD21 HD11 ' B' ' 50' ' ' ILE . 6.3 mt -128.03 128.9 45.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 119.852 -1.78 . . . . 0.0 110.602 176.796 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.514 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 7.4 m-80 -129.81 111.47 12.64 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.533 -0.729 . . . . 0.0 110.399 -178.876 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.837 HG22 HG12 ' A' ' 79' ' ' VAL . 1.2 pp -111.9 149.18 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.581 -0.699 . . . . 0.0 110.348 179.947 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.402 ' HG3' ' HB3' ' A' ' 78' ' ' SER . 0.0 OUTLIER -165.58 117.68 0.87 Allowed Pre-proline 0 N--CA 1.497 1.918 0 O-C-N 120.696 -1.253 . . . . 0.0 110.933 -179.78 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.545 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 53.0 Cg_endo -82.33 149.59 15.07 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 O-C-N 123.667 1.351 . . . . 0.0 111.212 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.772 ' O ' HG23 ' A' ' 75' ' ' VAL . 10.8 m -132.48 -149.95 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 O-C-N 121.521 -0.737 . . . . 0.0 110.345 179.542 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.805 ' HB2' ' HB3' ' B' ' 97' ' ' PHE . . . -148.68 106.26 3.66 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.1 -1.0 . . . . 0.0 111.266 -179.132 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.593 ' HB2' ' O ' ' A' ' 54' ' ' ALA . 2.9 ttt-85 168.34 89.87 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.669 -0.645 . . . . 0.0 109.535 179.519 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.717 ' HB2' ' H ' ' A' ' 74' ' ' SER . 6.8 mt-30 -153.77 19.4 0.53 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 118.585 -1.246 . . . . 0.0 112.319 179.903 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.936 ' HB2' ' CA ' ' A' ' 73' ' ' PRO . . . -131.88 -163.4 1.33 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.748 -1.22 . . . . 0.0 110.491 178.897 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.547 ' O ' ' N ' ' A' ' 60' ' ' GLY . 2.1 mtt85 -159.61 19.93 0.17 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.295 -0.878 . . . . 0.0 111.43 -178.512 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.497 ' C ' ' O ' ' A' ' 58' ' ' ARG . 2.3 ttpm? -24.23 85.05 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.304 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.619 ' N ' ' HA ' ' A' ' 69' ' ' LEU . . . -160.32 -61.19 0.01 OUTLIER Glycine 0 N--CA 1.493 2.471 0 C-N-CA 120.108 -1.044 . . . . 0.0 110.758 179.756 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 1.021 ' CE2' ' HB2' ' A' ' 66' ' ' GLN . 53.2 p90 177.53 175.2 0.46 Allowed 'General case' 0 N--CA 1.508 2.463 0 O-C-N 121.344 -1.092 . . . . 0.0 109.991 -178.656 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.711 ' H ' ' HD2' ' A' ' 63' ' ' PRO . 1.5 t-20 -117.08 -58.8 0.04 OUTLIER Pre-proline 0 C--N 1.304 -1.385 0 C-N-CA 119.441 -0.903 . . . . 0.0 112.719 -178.9 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.711 ' HD2' ' H ' ' A' ' 62' ' ' ASN . 39.5 Cg_endo -66.89 69.58 0.52 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.177 1.093 . . . . 0.0 110.668 -178.869 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.712 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 0.1 OUTLIER -179.69 43.57 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.611 -0.681 . . . . 0.0 109.82 179.82 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.588 HG23 ' C ' ' A' ' 64' ' ' GLN . 2.5 p 71.14 8.49 6.45 Favored 'General case' 0 N--CA 1.507 2.42 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 179.076 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 1.021 ' HB2' ' CE2' ' A' ' 61' ' ' PHE . 1.9 mp0 -113.74 -142.37 0.38 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.838 -1.164 . . . . 0.0 108.185 178.349 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.777 ' O ' ' CB ' ' A' ' 68' ' ' ALA . 18.9 mt-10 -144.73 12.75 1.48 Allowed 'General case' 0 N--CA 1.486 1.33 0 O-C-N 120.553 -1.342 . . . . 0.0 111.153 178.002 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.777 ' CB ' ' O ' ' A' ' 67' ' ' GLU . . . 133.86 -176.3 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.612 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 175.524 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.857 ' HG ' ' HA ' ' A' ' 61' ' ' PHE . 3.1 mp -95.24 18.97 11.34 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 114.23 -1.35 . . . . 0.0 111.114 -179.816 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.442 ' CB ' ' O ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER 172.39 56.43 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.952 -1.093 . . . . 0.0 111.655 -179.81 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.57 HD11 ' C ' ' A' ' 57' ' ' ALA . 24.1 pt -65.81 -146.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 120.636 -1.29 . . . . 0.0 109.169 178.466 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.432 ' HA ' ' HD2' ' A' ' 73' ' ' PRO . . . -106.36 101.67 36.5 Favored Pre-proline 0 C--N 1.29 -2.022 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -176.702 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.936 ' CA ' ' HB2' ' A' ' 57' ' ' ALA . 48.0 Cg_endo -73.81 132.9 17.72 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 O-C-N 124.113 1.586 . . . . 0.0 108.472 176.755 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.717 ' H ' ' HB2' ' A' ' 56' ' ' GLN . 0.4 OUTLIER -156.55 137.92 13.88 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.243 -0.91 . . . . 0.0 110.994 179.963 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 1.038 HG11 ' CB ' ' B' ' 89' ' ' ALA . 14.6 p -45.22 162.26 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 121.368 -0.833 . . . . 0.0 110.125 179.28 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.698 ' HA3' HG22 ' A' ' 53' ' ' VAL . . . -110.13 87.02 0.46 Allowed Glycine 0 N--CA 1.487 2.037 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 179.356 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.737 HG21 ' HG ' ' B' ' 85' ' ' LEU . 84.1 t -65.2 75.49 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 O-C-N 121.918 -0.754 . . . . 0.0 110.753 -179.247 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.856 ' O ' HG13 ' A' ' 79' ' ' VAL . 0.5 OUTLIER -65.83 178.77 0.99 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.323 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.856 HG13 ' O ' ' A' ' 78' ' ' SER . 0.0 OUTLIER 179.7 178.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.924 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.511 ' O ' HD23 ' A' ' 48' ' ' LEU . 11.1 mttt 179.14 169.79 0.57 Allowed Pre-proline 0 C--N 1.307 -1.28 0 O-C-N 121.384 -0.822 . . . . 0.0 110.46 177.13 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.591 ' HB2' HG13 ' B' ' 77' ' ' VAL . 57.4 Cg_endo -109.39 161.15 0.08 OUTLIER 'Trans proline' 0 C--N 1.301 -1.959 0 C-N-CA 123.413 2.742 . . . . 0.0 110.605 177.798 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 47' ' ' PHE . . . -105.57 -150.79 19.55 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 107.604 -2.198 . . . . 0.0 107.604 177.093 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -100.46 -13.1 18.84 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.88 -1.365 . . . . 0.0 110.125 178.885 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.411 ' HB3' ' HB2' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -58.02 -38.09 75.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.335 -0.853 . . . . 0.0 109.075 179.664 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.923 ' CB ' HG21 ' B' ' 77' ' ' VAL . 0.5 OUTLIER -77.42 -38.16 50.23 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.692 -0.63 . . . . 0.0 109.539 179.239 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.527 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -69.14 -41.5 77.22 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.799 -0.761 . . . . 0.0 110.779 -178.923 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -64.93 -40.24 94.74 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 178.942 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.661 ' O ' ' HB1' ' B' ' 37' ' ' ALA . . . -72.79 -30.78 64.37 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 177.02 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.878 ' HA ' HD23 ' A' ' 92' ' ' LEU . . . -64.68 -39.08 93.05 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.304 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -56.98 -33.15 66.8 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 176.935 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -74.07 -20.79 79.66 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 178.745 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.929 ' O ' HD12 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -76.82 16.07 0.57 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.681 -1.482 . . . . 0.0 111.268 -179.757 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.419 ' CB ' ' O ' ' A' ' 92' ' ' LEU . 0.0 OUTLIER 65.19 34.94 8.15 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -177.728 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.545 ' CD1' ' HB ' ' B' ' 75' ' ' VAL . 0.0 OUTLIER -49.31 -27.75 4.18 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.486 -179.578 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.584 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 11.0 pt-20 -57.57 -40.59 79.31 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.362 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -61.57 -36.84 81.79 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 176.953 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.652 ' HB3' ' HB2' ' B' ' 54' ' ' ALA . 0.2 OUTLIER -63.22 -31.2 72.29 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.737 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.584 ' HB3' ' O ' ' A' ' 95' ' ' GLU . . . -69.31 -29.84 67.77 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.322 0.582 . . . . 0.0 110.074 179.671 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.354 180.0 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.489 ' HG2' ' HB3' ' B' ' 5' ' ' GLU . 3.0 mtp . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.193 0.52 . . . . 0.0 110.211 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 2' ' ' ASN . . . . . 0.81 ' C ' HD12 ' B' ' 6' ' ' LEU . 23.3 t-20 -173.06 165.99 4.98 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.374 -0.829 . . . . 0.0 109.783 -179.816 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.918 ' HD2' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -47.36 -26.15 1.21 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.983 -1.073 . . . . 0.0 109.202 179.307 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.655 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 16.7 m -79.28 -56.19 4.53 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 177.342 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.489 ' HB3' ' HG2' ' B' ' 1' ' ' MET . 0.5 OUTLIER -57.95 -50.46 73.29 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 177.42 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.81 HD12 ' C ' ' B' ' 2' ' ' ASN . 1.8 mt -61.15 -28.05 68.83 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 177.302 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 7' ' ' ILE . . . . . 1.025 ' CD1' HD23 ' B' ' 25' ' ' LEU . 0.1 OUTLIER -53.68 -54.28 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.278 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 8' ' ' LYS . . . . . 0.831 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.1 OUTLIER -62.97 -32.91 74.34 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.234 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 9' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' B' ' 6' ' ' LEU . . . -62.68 -29.38 70.61 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.375 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.894 HD11 ' HB2' ' A' ' 28' ' ' PHE . 0.6 OUTLIER -93.19 -35.58 6.7 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.627 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 178.109 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.831 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -63.75 -29.11 70.36 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.849 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.469 ' N ' ' O ' ' B' ' 8' ' ' LYS . 1.1 tt0 -89.85 -39.06 13.31 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.027 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.451 ' HB2' ' HA ' ' B' ' 10' ' ' ILE . 43.2 m-20 -67.41 -25.51 65.97 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 176.755 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.915 HG22 ' HB2' ' A' ' 20' ' ' SER . 24.7 p -88.73 -76.35 0.4 Allowed 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.756 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 60.45 12.53 26.08 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.604 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 16' ' ' LEU . . . . . 0.914 HD22 ' O ' ' A' ' 19' ' ' VAL . 3.4 mp -82.98 -60.66 2.09 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.43 -1.041 . . . . 0.0 108.708 179.092 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 17' ' ' THR . . . . . 0.615 HG22 ' H ' ' B' ' 19' ' ' VAL . 0.5 OUTLIER -146.14 3.9 0.93 Allowed 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.816 -179.665 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 18' ' ' GLN . . . . . 0.677 ' O ' ' C ' ' B' ' 19' ' ' VAL . 8.3 mt-30 57.09 28.03 14.3 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 -176.367 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.976 HG11 HG11 ' A' ' 19' ' ' VAL . 1.0 OUTLIER 5.73 -97.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.917 -179.516 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 20' ' ' SER . . . . . 1.033 ' O ' ' N ' ' B' ' 22' ' ' SER . 96.4 p -133.47 23.85 4.06 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 175.833 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.662 ' O ' HD11 ' B' ' 7' ' ' ILE . 30.8 m -9.1 -41.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 CA-C-O 122.289 1.042 . . . . 0.0 109.885 -177.593 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 22' ' ' SER . . . . . 1.033 ' N ' ' O ' ' B' ' 20' ' ' SER . 15.3 p -67.81 -46.46 71.81 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.944 177.285 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 23' ' ' LYS . . . . . 0.902 ' N ' ' O ' ' B' ' 20' ' ' SER . 32.6 mtmt -91.72 -23.85 19.65 Favored 'General case' 0 C--N 1.307 -1.258 0 O-C-N 121.543 -0.723 . . . . 0.0 109.338 178.498 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 24' ' ' MET . . . . . 0.609 ' HE2' ' HA ' ' B' ' 21' ' ' VAL . 2.1 tmm? -63.46 -24.75 67.96 Favored 'General case' 0 C--O 1.216 -0.701 0 O-C-N 120.459 -1.401 . . . . 0.0 107.625 178.207 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 1.025 HD23 ' CD1' ' B' ' 7' ' ' ILE . 0.1 OUTLIER -89.27 -46.4 8.79 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 176.61 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 26' ' ' ALA . . . . . 0.531 ' HB3' ' HA ' ' B' ' 23' ' ' LYS . . . -58.96 -28.19 66.06 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.25 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 27' ' ' SER . . . . . 0.774 ' O ' HG23 ' B' ' 31' ' ' ILE . 23.8 p -86.61 -31.82 20.94 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.082 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 28' ' ' PHE . . . . . 0.897 ' O ' HG13 ' B' ' 31' ' ' ILE . 0.7 OUTLIER -57.69 -42.27 83.35 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.08 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 29' ' ' GLU . . . . . 0.7 ' O ' ' HB ' ' B' ' 33' ' ' THR . 2.3 tt0 -70.78 -43.27 69.07 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 177.35 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 1.296 ' O ' ' HB3' ' B' ' 34' ' ' GLU . 25.5 ttpt -60.57 -21.34 62.49 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.873 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.919 ' HA ' ' HG2' ' B' ' 34' ' ' GLU . 1.3 pp -102.71 -33.7 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 119.361 -0.936 . . . . 0.0 110.209 179.58 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.681 HG13 ' CD1' ' B' ' 28' ' ' PHE . 1.0 OUTLIER -71.88 -43.76 68.33 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 176.791 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 33' ' ' THR . . . . . 0.7 ' HB ' ' O ' ' B' ' 29' ' ' GLU . 0.3 OUTLIER -77.02 -26.22 53.52 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 177.277 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 1.296 ' HB3' ' O ' ' B' ' 30' ' ' LYS . 0.0 OUTLIER -64.54 -43.94 92.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.097 -1.002 . . . . 0.0 109.961 178.3 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 35' ' ' THR . . . . . 0.778 HG21 HG13 ' B' ' 42' ' ' VAL . 47.9 m -67.33 -56.08 11.23 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 118.911 -1.115 . . . . 0.0 109.255 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.672 ' CG2' ' HA ' ' B' ' 33' ' ' THR . 19.6 m -50.22 -33.92 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 118.164 -1.414 . . . . 0.0 108.217 178.978 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 0.661 ' HB1' ' O ' ' A' ' 88' ' ' ALA . . . -93.3 0.5 57.0 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.242 0.544 . . . . 0.0 110.492 178.84 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 38' ' ' LYS . . . . . 0.745 ' HB2' ' O ' ' B' ' 34' ' ' GLU . 9.7 tppt? -103.89 -16.74 15.28 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 106.673 -1.602 . . . . 0.0 106.673 177.132 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.89 50.07 1.3 Allowed Glycine 0 C--N 1.304 -1.216 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 178.21 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 40' ' ' ASP . . . . . 0.664 ' O ' HG22 ' B' ' 35' ' ' THR . 0.3 OUTLIER -148.94 141.01 23.86 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.057 -1.26 . . . . 0.0 110.775 179.43 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -90.57 92.89 9.05 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.621 -0.674 . . . . 0.0 109.24 179.866 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.824 HG22 HG22 ' B' ' 50' ' ' ILE . 24.1 m -59.28 137.95 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 C-N-CA 119.814 -0.755 . . . . 0.0 110.001 -179.608 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 43' ' ' GLN . . . . . 0.499 ' O ' ' HA ' ' A' ' 2' ' ' ASN . 1.6 mt-30 -118.51 173.43 6.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.345 -0.847 . . . . 0.0 110.149 -179.318 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.76 HD22 ' HE2' ' A' ' 28' ' ' PHE . 36.1 mt -141.31 -177.67 5.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.383 -0.823 . . . . 0.0 110.794 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 45' ' ' THR . . . . . 0.781 HG22 ' HG2' ' A' ' 29' ' ' GLU . 2.4 t -51.58 69.02 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 120.878 0.371 . . . . 0.0 111.765 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.656 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . 41.57 29.63 0.48 Allowed Glycine 0 N--CA 1.5 2.914 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 179.352 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 47' ' ' PHE . . . . . 0.708 ' CE1' HD13 ' B' ' 44' ' ' LEU . 0.5 OUTLIER -123.72 -27.79 3.94 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.166 -1.197 . . . . 0.0 110.656 -179.755 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.716 HD12 ' H ' ' B' ' 49' ' ' ASN . 11.1 tp -168.73 150.0 4.7 Favored 'General case' 0 C--N 1.293 -1.854 0 C-N-CA 118.069 -1.452 . . . . 0.0 111.322 -179.839 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 49' ' ' ASN . . . . . 0.716 ' H ' HD12 ' B' ' 48' ' ' LEU . 17.2 m-80 -148.35 -178.95 6.6 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.96 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 50' ' ' ILE . . . . . 0.927 HD11 HD21 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -142.8 167.17 14.7 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 O-C-N 121.411 -0.806 . . . . 0.0 110.382 179.716 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 51' ' ' LYS . . . . . 0.462 ' HD3' ' O ' ' B' ' 51' ' ' LYS . 0.0 OUTLIER -170.88 130.13 0.79 Allowed Pre-proline 0 N--CA 1.494 1.771 0 C-N-CA 119.259 -0.977 . . . . 0.0 110.605 179.333 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.576 ' HA ' ' HA ' ' B' ' 77' ' ' VAL . 57.7 Cg_endo -90.39 143.22 3.73 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.67 1.353 . . . . 0.0 110.741 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.65 HG22 ' CA ' ' B' ' 76' ' ' GLY . 16.5 m -126.6 -152.54 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 C-N-CA 119.841 -0.744 . . . . 0.0 110.229 178.945 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.652 ' HB2' ' HB3' ' A' ' 97' ' ' PHE . . . -134.88 116.23 14.53 Favored 'General case' 0 C--N 1.291 -1.969 0 O-C-N 121.292 -0.88 . . . . 0.0 110.506 -179.298 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 5.4 mtp180 -148.57 93.43 2.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.552 -0.718 . . . . 0.0 109.477 179.858 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.17 134.95 13.8 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.607 -0.683 . . . . 0.0 111.556 -179.168 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.934 ' HB3' ' CB ' ' B' ' 72' ' ' ALA . . . -74.24 65.63 1.2 Allowed 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 122.03 0.919 . . . . 0.0 109.146 178.762 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 58' ' ' ARG . . . . . 0.659 ' HG2' ' C ' ' B' ' 71' ' ' ILE . 46.3 mtm180 -138.53 124.23 19.75 Favored 'General case' 0 C--N 1.285 -2.223 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.111 -178.452 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 59' ' ' LYS . . . . . 0.45 ' CA ' ' HG3' ' B' ' 70' ' ' GLU . 0.5 OUTLIER -160.88 19.75 0.13 Allowed 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.506 -178.763 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 60' ' ' GLY . . . . . 0.506 ' HA2' ' N ' ' B' ' 69' ' ' LEU . . . 91.89 66.56 1.13 Allowed Glycine 0 N--CA 1.485 1.966 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.718 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 61' ' ' PHE . . . . . 0.889 ' C ' ' HA ' ' B' ' 68' ' ' ALA . 0.0 OUTLIER -75.46 130.87 39.63 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.905 -1.35 . . . . 0.0 113.573 -178.967 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 62' ' ' ASN . . . . . 0.814 ' H ' ' CD ' ' B' ' 63' ' ' PRO . 3.7 p-10 -136.84 -19.77 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.477 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 178.803 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.814 ' CD ' ' H ' ' B' ' 62' ' ' ASN . 47.4 Cg_endo -75.69 -6.62 17.79 Favored 'Trans proline' 0 N--CA 1.484 0.924 0 CA-C-N 119.466 0.845 . . . . 0.0 110.347 179.94 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 64' ' ' GLN . . . . . 0.602 ' HB3' ' CE1' ' B' ' 61' ' ' PHE . 0.0 OUTLIER -88.6 -105.45 0.08 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.317 -0.864 . . . . 0.0 109.223 179.526 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.405 ' H ' ' HB3' ' B' ' 64' ' ' GLN . 0.0 OUTLIER -81.5 12.14 3.99 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.536 -1.353 . . . . 0.0 110.097 178.797 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 66' ' ' GLN . . . . . 0.6 ' O ' ' CB ' ' B' ' 67' ' ' GLU . 0.0 OUTLIER 69.75 109.87 0.05 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.395 -0.816 . . . . 0.0 111.887 179.125 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 67' ' ' GLU . . . . . 0.918 ' O ' ' HG ' ' B' ' 69' ' ' LEU . 4.2 pt-20 140.75 87.08 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.389 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.769 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 68' ' ' ALA . . . . . 0.889 ' HA ' ' C ' ' B' ' 61' ' ' PHE . . . -56.14 101.77 0.06 Allowed 'General case' 0 N--CA 1.504 2.23 0 O-C-N 120.902 -1.124 . . . . 0.0 112.137 -178.332 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.918 ' HG ' ' O ' ' B' ' 67' ' ' GLU . 1.0 OUTLIER -131.09 147.91 52.67 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.55 -0.718 . . . . 0.0 109.738 178.099 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 70' ' ' GLU . . . . . 0.649 ' O ' HG23 ' B' ' 71' ' ' ILE . 2.3 mt-10 -80.08 108.75 13.91 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.022 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.812 ' O ' ' HB2' ' B' ' 72' ' ' ALA . 0.8 OUTLIER -155.95 119.71 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.647 -1.283 . . . . 0.0 113.516 -178.231 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 72' ' ' ALA . . . . . 0.934 ' CB ' ' HB3' ' B' ' 57' ' ' ALA . . . 138.78 138.5 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.962 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.06 178.355 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 73' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' B' ' 72' ' ' ALA . 53.3 Cg_endo -94.26 127.97 0.54 Allowed 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.22 1.947 . . . . 0.0 109.687 178.817 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 74' ' ' SER . . . . . 0.503 ' HB2' ' HB2' ' B' ' 57' ' ' ALA . 0.3 OUTLIER -153.65 141.27 19.91 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.881 -1.137 . . . . 0.0 111.427 -179.989 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 75' ' ' VAL . . . . . 0.581 HG11 ' HB1' ' A' ' 89' ' ' ALA . 0.3 OUTLIER -100.83 172.63 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.55 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 76' ' ' GLY . . . . . 0.65 ' CA ' HG22 ' B' ' 53' ' ' VAL . . . -114.89 88.2 0.47 Allowed Glycine 0 N--CA 1.491 2.303 0 C-N-CA 118.539 -1.791 . . . . 0.0 110.494 -179.178 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.923 HG21 ' CB ' ' A' ' 85' ' ' LEU . 5.0 p -69.62 68.58 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.354 -1.086 . . . . 0.0 108.308 178.349 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 78' ' ' SER . . . . . 0.479 ' N ' ' O ' ' B' ' 76' ' ' GLY . 0.3 OUTLIER -59.93 -153.8 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 121.895 0.855 . . . . 0.0 110.953 -179.073 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.764 ' HA ' ' HA ' ' B' ' 50' ' ' ILE . 3.1 p -157.19 -169.49 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 179.805 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 80' ' ' LYS . . . . . 0.512 ' H ' HG22 ' B' ' 79' ' ' VAL . 0.9 OUTLIER -140.38 175.29 3.24 Favored Pre-proline 0 C--N 1.307 -1.25 0 C-N-CA 117.651 -1.62 . . . . 0.0 113.126 -179.692 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 81' ' ' PRO . . . . . 0.43 ' CD ' ' CB ' ' B' ' 80' ' ' LYS . 58.9 Cg_endo -111.52 119.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 124.78 3.653 . . . . 0.0 111.185 -179.075 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 82' ' ' GLY . . . . . 0.667 ' HA3' ' C ' ' B' ' 47' ' ' PHE . . . -123.78 144.6 15.6 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 177.934 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 83' ' ' GLU . . . . . 0.454 ' HA ' ' HB2' ' B' ' 86' ' ' LYS . 8.0 pm0 -85.3 -23.62 28.04 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.156 -1.203 . . . . 0.0 111.59 -178.882 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 84' ' ' SER . . . . . 0.408 ' CB ' ' O ' ' B' ' 45' ' ' THR . 5.4 t -51.16 -30.96 18.29 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.051 -1.031 . . . . 0.0 108.42 179.283 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.952 HD13 ' CG2' ' A' ' 36' ' ' VAL . 0.1 OUTLIER -87.2 -40.52 14.5 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.172 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 86' ' ' LYS . . . . . 0.454 ' HB2' ' HA ' ' B' ' 83' ' ' GLU . 3.1 mtpp -64.24 -26.39 68.48 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.059 -1.057 . . . . 0.0 109.129 178.68 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -81.37 -36.01 30.13 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 178.343 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.755 ' O ' ' HB1' ' A' ' 37' ' ' ALA . . . -66.37 -37.98 86.52 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 176.737 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 1.038 ' CB ' HG11 ' A' ' 75' ' ' VAL . . . -61.43 -35.06 76.51 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.414 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.401 ' HG2' ' N ' ' B' ' 91' ' ' GLY . 0.7 OUTLIER -56.2 -32.87 64.79 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 176.751 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 91' ' ' GLY . . . . . 0.401 ' N ' ' HG2' ' B' ' 90' ' ' GLU . . . -66.42 -36.94 92.28 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 178.288 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 92' ' ' LEU . . . . . 0.858 ' O ' HD12 ' B' ' 92' ' ' LEU . 0.4 OUTLIER -69.65 7.1 0.93 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.902 -1.352 . . . . 0.0 110.658 179.553 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 93' ' ' LYS . . . . . 0.516 ' CB ' ' O ' ' B' ' 92' ' ' LEU . 6.5 tptm 72.99 43.41 0.41 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -177.76 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 94' ' ' TYR . . . . . 0.517 ' CZ ' ' N ' ' A' ' 74' ' ' SER . 0.2 OUTLIER -41.31 -33.47 0.39 Allowed 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.422 -179.542 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 95' ' ' GLU . . . . . 0.603 ' O ' ' HB3' ' B' ' 98' ' ' ALA . 10.1 pt-20 -61.51 -43.19 99.3 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.193 -0.942 . . . . 0.0 109.323 179.299 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.3 -36.81 76.27 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 177.77 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 97' ' ' PHE . . . . . 0.805 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 0.1 OUTLIER -63.77 -28.51 69.92 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.967 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 98' ' ' ALA . . . . . 0.603 ' HB3' ' O ' ' B' ' 95' ' ' GLU . . . -70.35 -52.17 24.62 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.372 0.606 . . . . 0.0 110.237 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 28.9 mtmt . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.255 -179.939 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.662 ' CB ' HG22 ' B' ' 42' ' ' VAL . 1.2 mtp . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.404 ' HA ' ' O ' ' B' ' 43' ' ' GLN . 3.2 t-20 -174.12 -167.55 0.35 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.884 -1.135 . . . . 0.0 111.736 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.435 ' NZ ' ' HA ' ' A' ' 26' ' ' ALA . 0.4 OUTLIER -53.02 -11.56 0.25 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.574 -0.704 . . . . 0.0 110.847 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.707 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 19.6 m -116.47 -42.48 3.0 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.026 -1.046 . . . . 0.0 109.538 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.588 ' CB ' ' HA ' ' A' ' 1' ' ' MET . 0.4 OUTLIER -62.13 -54.31 42.95 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.164 -0.96 . . . . 0.0 108.612 179.073 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.876 HD11 ' CG1' ' B' ' 42' ' ' VAL . 9.9 mt -57.93 -29.32 65.04 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.318 -0.864 . . . . 0.0 108.974 177.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.867 HG23 ' HB ' ' A' ' 21' ' ' VAL . 0.6 OUTLIER -55.17 -58.62 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.85 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.929 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -61.06 -28.19 68.89 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.625 -0.83 . . . . 0.0 108.761 178.235 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.669 ' HB3' ' O ' ' A' ' 6' ' ' LEU . . . -61.16 -32.59 72.32 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.361 -0.837 . . . . 0.0 109.064 179.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.814 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.7 OUTLIER -97.52 -34.84 4.97 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.446 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 178.465 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.929 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -61.22 -26.89 68.04 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 177.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.413 ' CG ' ' N ' ' A' ' 13' ' ' ASP . 11.0 pt20 -91.56 -39.85 11.68 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.446 ' HB2' ' HA ' ' A' ' 10' ' ' ILE . 43.8 m-20 -66.21 -22.89 66.36 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 176.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.948 HG22 ' HB2' ' B' ' 20' ' ' SER . 16.8 p -93.0 -76.12 0.48 Allowed 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 58.63 14.52 22.06 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.903 HD12 ' HB ' ' A' ' 14' ' ' THR . 1.7 mp -80.79 -50.89 9.26 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.365 -1.079 . . . . 0.0 108.465 179.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.6 HG22 ' H ' ' A' ' 19' ' ' VAL . 0.5 OUTLIER -150.7 0.74 0.42 Allowed 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 120.266 -0.573 . . . . 0.0 110.619 -179.655 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.593 ' O ' ' C ' ' A' ' 19' ' ' VAL . 9.1 mt-30 55.64 29.66 14.03 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 -176.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 1.056 HG11 HG11 ' B' ' 19' ' ' VAL . 0.7 OUTLIER -4.98 -95.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.714 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 1.092 ' O ' ' N ' ' A' ' 22' ' ' SER . 0.1 OUTLIER -132.45 24.42 4.43 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 178.292 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.867 ' HB ' HG23 ' A' ' 7' ' ' ILE . 13.4 m -4.29 -40.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 CA-C-O 122.417 1.104 . . . . 0.0 110.898 -178.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 1.092 ' N ' ' O ' ' A' ' 20' ' ' SER . 8.6 t -79.92 -40.77 27.45 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.335 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.862 ' N ' ' O ' ' A' ' 20' ' ' SER . 1.7 ttpt -84.73 -27.71 26.79 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.412 -0.805 . . . . 0.0 111.366 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.547 ' CE ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -78.45 -40.39 35.78 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 117.895 -1.522 . . . . 0.0 109.751 179.627 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.727 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 0.2 OUTLIER -78.8 -49.21 13.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.585 -1.322 . . . . 0.0 109.837 178.842 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 22' ' ' SER . . . -55.04 -34.23 63.34 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.63 ' HA ' ' HB3' ' A' ' 30' ' ' LYS . 20.7 t -85.16 -29.64 24.59 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.744 -0.783 . . . . 0.0 108.99 178.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.732 ' HA ' ' CG1' ' A' ' 31' ' ' ILE . 0.2 OUTLIER -59.81 -39.27 84.45 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.442 -0.786 . . . . 0.0 109.101 179.165 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.553 ' HB3' HG21 ' B' ' 45' ' ' THR . 4.5 mt-10 -79.21 -31.96 43.86 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.974 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 24.7 tttm -69.74 -25.86 64.04 Favored 'General case' 0 C--O 1.188 -2.179 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 176.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.732 ' CG1' ' HA ' ' A' ' 28' ' ' PHE . 1.9 pp -97.59 -31.33 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.957 -1.09 . . . . 0.0 109.157 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.666 HG21 ' CE1' ' B' ' 47' ' ' PHE . 2.0 mm -63.68 -56.16 18.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 177.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.49 ' HA ' ' HB3' ' B' ' 85' ' ' LEU . 0.4 OUTLIER -68.82 -36.98 78.89 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.39 -0.823 . . . . 0.0 108.882 179.313 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.974 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 59.4 mm-40 -74.98 -32.84 61.78 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.554 -0.716 . . . . 0.0 111.652 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.552 ' N ' ' O ' ' A' ' 31' ' ' ILE . 24.2 m -67.66 -58.14 5.18 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 118.221 -1.391 . . . . 0.0 108.988 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.788 ' O ' ' HG3' ' A' ' 52' ' ' PRO . 0.7 OUTLIER -51.29 -35.65 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 178.447 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.788 ' HB1' ' C ' ' B' ' 88' ' ' ALA . . . -73.32 -27.9 61.78 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.082 178.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.606 ' N ' HD12 ' B' ' 92' ' ' LEU . 0.0 OUTLIER -75.78 -25.77 56.71 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 177.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.413 ' HA3' ' CE ' ' B' ' 93' ' ' LYS . . . 108.97 27.58 4.8 Favored Glycine 0 C--N 1.295 -1.706 0 C-N-CA 120.075 -1.059 . . . . 0.0 111.403 177.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.527 ' HB2' HG23 ' A' ' 35' ' ' THR . 0.2 OUTLIER -108.46 151.65 25.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.123 -1.222 . . . . 0.0 109.651 179.011 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -76.69 81.61 3.32 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.374 -0.829 . . . . 0.0 110.421 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.491 ' CG2' ' CG2' ' A' ' 35' ' ' THR . 60.7 t -68.29 140.63 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.448 -0.782 . . . . 0.0 109.8 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.487 ' HG2' ' HA ' ' B' ' 2' ' ' ASN . 4.2 pt20 -158.85 174.17 15.4 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.372 -0.83 . . . . 0.0 109.76 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.929 HD22 ' CE1' ' B' ' 28' ' ' PHE . 27.9 mt -127.5 115.22 18.53 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.441 -0.787 . . . . 0.0 109.244 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.566 HG23 ' HD1' ' A' ' 47' ' ' PHE . 0.0 OUTLIER 33.2 -95.54 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.89 -0.507 . . . . 0.0 111.566 -179.599 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.468 ' H ' HG23 ' A' ' 45' ' ' THR . . . -139.73 25.06 2.72 Favored Glycine 0 N--CA 1.487 2.083 0 C-N-CA 119.417 -1.373 . . . . 0.0 111.089 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.779 ' CD1' ' HG3' ' B' ' 29' ' ' GLU . 13.3 p90 -122.07 -31.83 3.81 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.616 -1.52 . . . . 0.0 110.538 178.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.898 ' HB2' HD12 ' A' ' 44' ' ' LEU . 8.3 mt -122.09 148.97 44.21 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 119.886 -1.759 . . . . 0.0 111.548 177.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.488 ' N ' ' HB2' ' A' ' 80' ' ' LYS . 1.0 OUTLIER -149.25 77.12 1.35 Allowed 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.289 0.566 . . . . 0.0 110.483 -179.815 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.771 HG22 HG21 ' A' ' 36' ' ' VAL . 43.5 mm -69.63 126.28 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.394 -0.816 . . . . 0.0 109.962 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -140.67 126.33 11.38 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.335 -0.853 . . . . 0.0 108.766 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.788 ' HG3' ' O ' ' A' ' 36' ' ' VAL . 55.2 Cg_endo -86.83 140.37 5.9 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.317 1.167 . . . . 0.0 110.885 -178.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.595 HG22 ' O ' ' A' ' 76' ' ' GLY . 18.4 m -137.28 117.07 15.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-O 122.204 1.002 . . . . 0.0 110.837 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.691 ' HB2' ' CB ' ' B' ' 97' ' ' PHE . . . . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.72 0.771 . . . . 0.0 111.765 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.961 HG11 ' HB3' ' B' ' 89' ' ' ALA . 8.0 p . . . . . 0 N--CA 1.498 1.974 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.595 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -117.93 82.92 0.34 Allowed Glycine 0 N--CA 1.493 2.445 0 C-N-CA 118.556 -1.783 . . . . 0.0 110.285 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.667 HG11 HD13 ' B' ' 85' ' ' LEU . 97.3 t -70.69 74.45 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.146 -1.208 . . . . 0.0 109.165 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.461 ' N ' ' O ' ' A' ' 51' ' ' LYS . 0.4 OUTLIER -58.87 -166.41 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.445 0.641 . . . . 0.0 110.587 -179.68 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.728 HG11 ' HD3' ' B' ' 81' ' ' PRO . 7.9 p -172.21 178.74 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.541 -0.724 . . . . 0.0 109.061 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.592 ' N ' HG22 ' A' ' 79' ' ' VAL . 0.4 OUTLIER -122.04 177.96 1.4 Allowed Pre-proline 0 C--N 1.309 -1.192 0 O-C-N 120.905 -1.122 . . . . 0.0 110.619 179.425 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.419 ' CD ' ' CB ' ' A' ' 80' ' ' LYS . 56.4 Cg_endo -106.32 74.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.302 -1.919 0 C-N-CA 123.739 2.96 . . . . 0.0 109.874 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.718 ' CA ' ' O ' ' A' ' 47' ' ' PHE . . . -56.53 93.83 0.03 OUTLIER Glycine 0 N--CA 1.486 2.032 0 C-N-CA 119.198 -1.477 . . . . 0.0 110.71 -178.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' A' ' 81' ' ' PRO . 2.9 pt-20 -62.2 -28.14 69.47 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.668 -0.901 . . . . 0.0 108.995 178.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.442 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 71.1 m -53.24 -27.66 23.38 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.644 ' CD2' HG22 ' B' ' 77' ' ' VAL . 4.4 tt -85.74 -30.91 22.72 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.673 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 3.0 tttt -79.9 -40.31 28.53 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.629 0.728 . . . . 0.0 109.139 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -67.73 -37.08 81.71 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 178.256 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.628 ' O ' ' HB1' ' B' ' 37' ' ' ALA . . . -64.12 -36.71 84.94 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 176.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.818 ' HB1' ' CG1' ' B' ' 75' ' ' VAL . . . -57.49 -39.34 76.23 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.594 ' HA ' ' HB2' ' A' ' 94' ' ' TYR . 6.3 mm-40 -56.44 -29.07 61.19 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 176.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -70.42 -42.44 64.68 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.795 HD12 ' HB2' ' A' ' 93' ' ' LYS . 0.4 OUTLIER -61.36 -48.94 79.0 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.27 -1.723 . . . . 0.0 110.791 -178.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.795 ' HB2' HD12 ' A' ' 92' ' ' LEU . 0.0 OUTLIER 157.06 44.02 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.42 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.577 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.622 ' CD1' ' O ' ' B' ' 75' ' ' VAL . 87.5 t80 -42.48 -54.55 3.83 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.717 -0.615 . . . . 0.0 111.053 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 . . . . . 0 N--CA 1.496 1.854 0 O-C-N 121.087 -1.008 . . . . 0.0 110.557 179.881 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.521 ' HA ' ' CB ' ' B' ' 5' ' ' GLU . 5.3 mtp . . . . . 0 N--CA 1.492 1.653 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 2' ' ' ASN . . . . . 0.861 ' C ' HD12 ' B' ' 6' ' ' LEU . 23.2 p30 -176.47 -174.02 0.56 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.237 -0.914 . . . . 0.0 111.225 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.512 ' HE3' ' CG2' ' A' ' 45' ' ' THR . 0.0 OUTLIER -49.53 -16.37 0.21 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.493 -0.754 . . . . 0.0 110.728 -179.641 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . 0.58 ' O ' HG13 ' B' ' 7' ' ' ILE . 3.2 m -105.87 -57.53 2.03 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 122.113 0.958 . . . . 0.0 108.716 178.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.521 ' CB ' ' HA ' ' B' ' 1' ' ' MET . 0.4 OUTLIER -50.35 -46.01 55.48 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.838 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.861 HD12 ' C ' ' B' ' 2' ' ' ASN . 6.2 mt -58.02 -31.6 67.14 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.795 -0.762 . . . . 0.0 109.914 178.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' ILE . . . . . 0.606 HG22 ' CD1' ' B' ' 25' ' ' LEU . 0.8 OUTLIER -60.9 -40.39 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 178.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . 0.852 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.0 OUTLIER -70.43 -31.45 68.64 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 177.865 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . 0.557 ' HB1' HD13 ' A' ' 31' ' ' ILE . . . -58.53 -37.95 76.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.6 -0.687 . . . . 0.0 109.152 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.736 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.3 mp -92.89 -30.41 4.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.852 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -67.6 -12.97 61.63 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 118.576 -1.25 . . . . 0.0 108.455 178.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.444 ' CG ' ' N ' ' B' ' 13' ' ' ASP . 17.0 pt20 -112.93 -42.0 3.65 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.432 -0.793 . . . . 0.0 109.338 178.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.444 ' N ' ' CG ' ' B' ' 12' ' ' GLN . 0.9 OUTLIER -70.9 -27.43 63.79 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 176.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.98 HG22 ' CD1' ' B' ' 16' ' ' LEU . 0.1 OUTLIER -113.54 -85.76 0.58 Allowed 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 178.143 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . 0.571 ' O ' ' C ' ' B' ' 16' ' ' LEU . . . 80.19 -28.26 2.64 Favored Glycine 0 N--CA 1.499 2.885 0 O-C-N 121.031 -1.043 . . . . 0.0 111.062 177.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' LEU . . . . . 0.98 ' CD1' HG22 ' B' ' 14' ' ' THR . 5.1 mp -13.93 -66.0 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.519 0 CA-C-O 121.918 0.866 . . . . 0.0 112.062 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . 0.584 ' CG2' HG21 ' A' ' 17' ' ' THR . 0.6 OUTLIER -139.64 7.62 2.33 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.549 -179.579 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . 0.618 ' O ' ' C ' ' B' ' 19' ' ' VAL . 11.4 mt-30 58.95 25.83 14.23 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 -175.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 1.056 HG11 HG11 ' A' ' 19' ' ' VAL . 2.4 p -4.94 -96.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.393 -179.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 0.961 ' O ' ' N ' ' B' ' 23' ' ' LYS . 0.6 OUTLIER -132.01 23.07 4.54 Favored 'General case' 0 C--N 1.279 -2.462 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 178.045 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.616 ' C ' ' O ' ' B' ' 20' ' ' SER . 30.4 m -24.42 -40.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 122.449 1.119 . . . . 0.0 109.054 -178.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.693 ' N ' ' O ' ' B' ' 20' ' ' SER . 3.2 m -81.95 -36.24 28.19 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.088 177.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . 0.961 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.8 OUTLIER -85.19 -37.92 19.58 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.675 -0.641 . . . . 0.0 111.44 179.656 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' MET . . . . . 0.575 ' HG3' ' O ' ' B' ' 20' ' ' SER . 0.0 OUTLIER -68.14 -38.11 81.82 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 117.637 -1.625 . . . . 0.0 108.374 179.156 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.606 ' CD1' HG22 ' B' ' 7' ' ' ILE . 8.8 mt -71.68 -35.5 70.31 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 118.47 -1.292 . . . . 0.0 108.976 178.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . 0.475 ' HA ' ' CE ' ' B' ' 3' ' ' LYS . . . -62.96 -37.15 85.95 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 177.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' SER . . . . . 0.53 ' O ' ' N ' ' B' ' 31' ' ' ILE . 1.2 p -80.86 -26.59 36.86 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . 0.929 ' CE1' HD22 ' A' ' 44' ' ' LEU . 1.8 t80 -55.36 -48.84 73.63 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . 0.779 ' HG3' ' CD1' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -69.16 -33.91 74.15 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.869 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 1.228 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 24.1 tttp -64.88 -22.61 67.02 Favored 'General case' 0 C--O 1.191 -1.99 0 C-N-CA 119.012 -1.075 . . . . 0.0 108.374 178.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.662 HG13 ' O ' ' B' ' 28' ' ' PHE . 0.7 OUTLIER -104.53 -27.04 3.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 120.271 -1.518 . . . . 0.0 109.345 178.265 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.657 HD11 ' CE2' ' B' ' 28' ' ' PHE . 1.2 mm -70.99 -61.88 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 177.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' THR . . . . . 0.428 ' OG1' ' N ' ' A' ' 85' ' ' LEU . 0.6 OUTLIER -66.73 -37.79 85.37 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.408 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 1.228 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 18.2 mm-40 -76.25 -35.0 59.17 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 121.065 -1.022 . . . . 0.0 111.901 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' THR . . . . . 0.964 HG21 HG23 ' B' ' 42' ' ' VAL . 4.5 m -61.82 -52.8 62.71 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 120.339 -1.476 . . . . 0.0 108.912 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.571 HG22 ' CD ' ' B' ' 52' ' ' PRO . 1.0 OUTLIER -53.35 -38.32 31.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 C-N-CA 118.194 -1.402 . . . . 0.0 107.259 178.71 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . 0.628 ' HB1' ' O ' ' A' ' 88' ' ' ALA . . . -83.37 -2.36 55.59 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.832 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.576 ' HB2' ' O ' ' B' ' 34' ' ' GLU . 0.0 OUTLIER -100.95 -23.83 14.46 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 177.546 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.05 43.97 1.45 Allowed Glycine 0 C--N 1.301 -1.375 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . 0.709 ' CB ' HG23 ' B' ' 35' ' ' THR . 0.1 OUTLIER -138.16 137.92 38.1 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.105 -1.232 . . . . 0.0 110.103 179.366 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 5.7 mttp -90.79 84.17 5.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.461 -0.775 . . . . 0.0 110.916 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.964 HG23 HG21 ' B' ' 35' ' ' THR . 3.5 t -63.54 146.39 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.399 -0.813 . . . . 0.0 109.278 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' GLN . . . . . 0.404 ' O ' ' HA ' ' A' ' 2' ' ' ASN . 1.3 tt0 -138.61 114.1 9.68 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 120.88 -1.138 . . . . 0.0 110.501 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.685 HD22 ' HE2' ' A' ' 28' ' ' PHE . 17.1 mt -85.75 110.99 19.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.187 -0.946 . . . . 0.0 108.784 178.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . 0.553 HG21 ' HB3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 33.07 -89.83 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.407 0 O-C-N 121.739 -0.601 . . . . 0.0 110.997 -179.441 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -148.31 22.01 1.38 Allowed Glycine 0 N--CA 1.485 1.917 0 C-N-CA 119.818 -1.182 . . . . 0.0 110.176 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . 0.666 ' CE1' HG21 ' A' ' 32' ' ' ILE . 14.4 p90 -118.14 -34.91 3.97 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.832 -1.393 . . . . 0.0 112.111 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.633 ' HB2' HD12 ' B' ' 44' ' ' LEU . 0.0 OUTLIER -115.76 92.06 3.79 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.805 -1.185 . . . . 0.0 110.692 179.428 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' ASN . . . . . 0.659 ' O ' ' HB ' ' B' ' 79' ' ' VAL . 1.1 t-20 -79.96 60.82 3.65 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.88 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' ILE . . . . . 0.811 HD13 HG21 ' B' ' 79' ' ' VAL . 32.2 mm -56.34 116.92 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.314 -0.867 . . . . 0.0 111.62 -177.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . 0.552 ' O ' ' HG3' ' B' ' 51' ' ' LYS . 6.9 ptmt -169.97 126.17 0.73 Allowed Pre-proline 0 N--CA 1.488 1.435 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' PRO . . . . . 0.571 ' CD ' HG22 ' B' ' 36' ' ' VAL . 54.8 Cg_endo -79.32 144.76 18.42 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.433 1.228 . . . . 0.0 112.158 -177.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.5 ' O ' HG23 ' B' ' 53' ' ' VAL . 30.0 m -150.31 122.17 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . 0.508 ' HB2' ' N ' ' B' ' 75' ' ' VAL . . . . . . . . 0 C--N 1.299 -1.61 0 C-N-CA 118.96 -1.096 . . . . 0.0 111.535 -177.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . 0.818 ' CG1' ' HB1' ' A' ' 89' ' ' ALA . 84.3 t . . . . . 0 N--CA 1.526 3.335 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -143.57 -142.65 3.98 Favored Glycine 0 N--CA 1.491 2.305 0 O-C-N 120.285 -1.509 . . . . 0.0 110.559 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.644 HG22 ' CD2' ' A' ' 85' ' ' LEU . 11.3 t -141.57 83.55 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-O 121.982 0.896 . . . . 0.0 109.734 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 78' ' ' SER . . . . . 0.49 ' HB3' ' HG3' ' B' ' 51' ' ' LYS . 0.1 OUTLIER -58.44 -45.04 89.31 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.586 0.707 . . . . 0.0 110.947 179.343 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.811 HG21 HD13 ' B' ' 50' ' ' ILE 0.284 7.5 p -46.9 172.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-O 122.438 1.113 . . . . 0.0 113.791 -174.52 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 80' ' ' LYS . . . . . 0.64 ' HB2' ' HD2' ' B' ' 81' ' ' PRO . 0.3 OUTLIER 178.15 175.74 0.32 Allowed Pre-proline 0 N--CA 1.48 1.03 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -179.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 81' ' ' PRO . . . . . 0.728 ' HD3' HG11 ' A' ' 79' ' ' VAL . 47.1 Cg_endo -72.84 137.99 27.97 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.374 1.197 . . . . 0.0 109.583 177.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . 0.546 ' O ' HD12 ' B' ' 85' ' ' LEU . . . -101.67 -161.02 26.87 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . 0.473 ' HA ' ' HB2' ' B' ' 86' ' ' LYS . 0.4 OUTLIER -91.11 -10.64 41.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.418 -1.048 . . . . 0.0 110.417 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -54.93 -36.69 65.52 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.252 -0.905 . . . . 0.0 109.977 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.667 HD13 HG11 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -85.4 -33.42 21.97 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 119.629 -0.828 . . . . 0.0 108.852 179.198 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 86' ' ' LYS . . . . . 0.612 ' HG2' HG13 ' A' ' 75' ' ' VAL . 8.6 mttt -69.38 -34.09 74.01 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.653 -0.819 . . . . 0.0 109.264 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . 0.526 ' O ' ' HG3' ' B' ' 90' ' ' GLU . 35.8 tptt -73.15 -38.17 66.32 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 177.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.788 ' C ' ' HB1' ' A' ' 37' ' ' ALA . . . -67.71 -34.23 76.46 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 177.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.961 ' HB3' HG11 ' A' ' 75' ' ' VAL . . . -72.16 -45.21 61.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.79 -0.569 . . . . 0.0 110.45 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . 0.526 ' HG3' ' O ' ' B' ' 87' ' ' LYS . 0.6 OUTLIER -56.82 -19.31 16.63 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.622 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . 0.853 ' C ' HD23 ' B' ' 92' ' ' LEU . . . -93.93 -24.58 19.68 Favored Glycine 0 CA--C 1.547 2.089 0 CA-C-O 118.467 -1.185 . . . . 0.0 113.57 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 92' ' ' LEU . . . . . 0.853 HD23 ' C ' ' B' ' 91' ' ' GLY . 0.1 OUTLIER -113.03 -71.67 0.74 Allowed 'General case' 0 N--CA 1.507 2.381 0 CA-C-N 122.27 3.035 . . . . 0.0 113.171 -177.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 93' ' ' LYS . . . . . 0.459 ' O ' ' CD2' ' B' ' 97' ' ' PHE . 0.0 OUTLIER -113.0 36.58 3.44 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.803 -1.186 . . . . 0.0 112.459 -177.462 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . 0.512 ' HB2' ' HA ' ' B' ' 90' ' ' GLU . 6.2 t80 -71.24 -53.63 13.72 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 119.241 -0.984 . . . . 0.0 109.371 178.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -71.72 -31.53 66.81 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.41 -34.84 69.32 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 97' ' ' PHE . . . . . 0.691 ' CB ' ' HB2' ' A' ' 54' ' ' ALA . 7.4 m-85 . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.759 ' SD ' HG21 ' B' ' 35' ' ' THR . 2.3 mtp . . . . . 0 N--CA 1.494 1.768 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.465 ' HA ' ' O ' ' B' ' 43' ' ' GLN . 49.9 p-10 -166.93 -158.3 0.29 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.005 -1.059 . . . . 0.0 111.794 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.426 ' CD ' ' HA ' ' A' ' 26' ' ' ALA . 2.1 mmtp -56.02 -8.04 0.41 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.472 -0.768 . . . . 0.0 111.352 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.758 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 33.8 m -123.82 -41.95 2.21 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 120.854 -1.154 . . . . 0.0 109.885 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.522 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -61.9 -54.94 34.96 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.015 -1.053 . . . . 0.0 108.2 179.0 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.88 HD11 ' CG1' ' B' ' 42' ' ' VAL . 6.9 mt -56.38 -29.24 61.2 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.592 -0.843 . . . . 0.0 109.179 177.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.919 HG23 ' HB ' ' A' ' 21' ' ' VAL . 0.8 OUTLIER -55.94 -59.73 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.47 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.892 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 0.1 OUTLIER -60.96 -28.56 69.07 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.224 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.65 ' HB3' ' O ' ' A' ' 6' ' ' LEU . . . -59.61 -33.96 72.16 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.554 -0.858 . . . . 0.0 108.991 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.772 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.6 OUTLIER -95.44 -36.14 6.48 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.422 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 178.318 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.892 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -57.98 -23.98 56.19 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.719 -0.793 . . . . 0.0 108.89 178.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -93.13 -44.2 8.49 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.48 ' OD2' HG21 ' B' ' 31' ' ' ILE . 96.5 m-20 -62.46 -31.39 72.11 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 177.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.772 ' OG1' ' O ' ' A' ' 10' ' ' ILE . 28.2 p -83.25 -75.44 0.32 Allowed 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 177.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 59.02 18.8 42.32 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.001 -1.239 . . . . 0.0 110.001 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.975 HD22 ' O ' ' B' ' 19' ' ' VAL . 3.5 mp -87.41 -53.66 4.7 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.326 -1.102 . . . . 0.0 109.112 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.579 HG22 ' H ' ' A' ' 19' ' ' VAL . 0.5 OUTLIER -149.89 4.99 0.57 Allowed 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 120.021 -0.671 . . . . 0.0 110.596 -178.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.556 ' O ' ' C ' ' A' ' 19' ' ' VAL . 16.8 mt-30 56.48 26.68 11.16 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 -176.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 1.157 HG11 HG11 ' B' ' 19' ' ' VAL . 1.7 p -3.24 -94.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.9 -179.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.947 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -131.69 25.13 4.72 Favored 'General case' 0 C--N 1.28 -2.453 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 179.729 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.919 ' HB ' HG23 ' A' ' 7' ' ' ILE . 5.6 m -17.27 -39.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-O 122.464 1.125 . . . . 0.0 110.12 -178.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.871 ' N ' ' O ' ' A' ' 20' ' ' SER . 16.3 p -80.85 -37.27 30.25 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.038 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.947 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.5 OUTLIER -88.7 -28.83 20.3 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.442 -0.786 . . . . 0.0 111.186 179.878 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.847 ' HB3' HG23 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -76.83 -38.55 53.61 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 117.875 -1.53 . . . . 0.0 109.288 179.744 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.745 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 0.3 OUTLIER -80.21 -48.35 13.25 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 118.172 -1.411 . . . . 0.0 109.365 178.827 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 22' ' ' SER . . . -54.55 -34.33 61.66 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 119.054 -1.058 . . . . 0.0 108.217 178.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.615 ' O ' ' N ' ' A' ' 31' ' ' ILE . 25.1 p -87.21 -31.02 20.55 Favored 'General case' 0 C--O 1.203 -1.364 0 C-N-CA 119.696 -0.802 . . . . 0.0 109.381 178.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.769 ' HB2' HD11 ' B' ' 10' ' ' ILE . 0.1 OUTLIER -56.57 -38.23 71.67 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.2 -0.938 . . . . 0.0 108.927 179.079 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.634 ' HB3' HG21 ' B' ' 45' ' ' THR . 1.0 OUTLIER -82.15 -33.93 29.35 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 178.146 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.987 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 20.1 tttt -68.45 -21.47 64.64 Favored 'General case' 0 C--O 1.189 -2.097 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 176.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 1.07 HD13 ' HB1' ' B' ' 9' ' ' ALA . 1.3 pp -102.31 -30.49 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.878 -1.139 . . . . 0.0 109.448 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.719 HG21 ' CZ ' ' B' ' 47' ' ' PHE . 2.1 mm -65.87 -56.4 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 177.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.707 HG23 ' HB2' ' B' ' 88' ' ' ALA . 0.4 OUTLIER -64.95 -49.43 70.37 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 178.559 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.987 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 15.4 mm-40 -62.52 -32.04 72.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.46 -0.775 . . . . 0.0 111.044 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.83 HG23 ' CB ' ' A' ' 40' ' ' ASP . 1.2 m -56.25 -53.11 61.09 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 178.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.069 HG21 HD12 ' B' ' 85' ' ' LEU . 13.4 t -54.89 -34.38 30.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 C-N-CA 117.91 -1.516 . . . . 0.0 106.975 177.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.727 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -79.29 -3.58 46.7 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -108.53 -18.51 13.71 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.34 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 35' ' ' THR . . . 95.77 43.85 3.26 Favored Glycine 0 C--N 1.303 -1.266 0 C-N-CA 120.209 -0.996 . . . . 0.0 110.657 178.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.83 ' CB ' HG23 ' A' ' 35' ' ' THR . 0.2 OUTLIER -125.71 127.05 45.62 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.125 -1.22 . . . . 0.0 110.222 179.236 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.1 mtmt -77.64 87.66 3.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.566 -0.708 . . . . 0.0 110.065 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 1.129 HG13 HD11 ' B' ' 6' ' ' LEU . 93.0 t -60.04 123.29 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.571 -0.706 . . . . 0.0 110.238 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -121.86 94.8 4.42 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.517 -0.739 . . . . 0.0 109.357 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.702 HD12 ' CB ' ' A' ' 48' ' ' LEU . 12.1 mt -72.52 104.28 3.79 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.336 -0.852 . . . . 0.0 110.411 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.499 HG21 ' HG3' ' B' ' 29' ' ' GLU . 0.1 OUTLIER 31.24 -90.28 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 O-C-N 122.108 -0.37 . . . . 0.0 111.508 179.504 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -148.74 19.67 1.28 Allowed Glycine 0 N--CA 1.486 2.022 0 C-N-CA 119.746 -1.216 . . . . 0.0 110.272 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.704 ' CD1' ' HG3' ' B' ' 29' ' ' GLU . 6.1 p90 -120.7 -22.03 6.47 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.879 -1.365 . . . . 0.0 111.853 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.702 ' CB ' HD12 ' A' ' 44' ' ' LEU . 4.6 mt -129.08 102.71 6.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.229 -1.545 . . . . 0.0 110.632 177.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.77 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 1.3 m120 -99.67 89.71 4.22 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.853 -0.53 . . . . 0.0 111.696 -178.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.63 ' HA ' ' HA ' ' A' ' 79' ' ' VAL . 0.9 OUTLIER -90.19 148.17 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.242 0 O-C-N 121.39 -0.818 . . . . 0.0 110.777 179.376 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.407 ' CE ' ' HB3' ' A' ' 78' ' ' SER . 0.2 OUTLIER -164.64 110.22 0.86 Allowed Pre-proline 0 N--CA 1.504 2.262 0 O-C-N 120.881 -1.137 . . . . 0.0 111.367 179.265 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.94 ' HB3' HG13 ' A' ' 36' ' ' VAL . 55.8 Cg_endo -78.53 141.43 17.66 Favored 'Trans proline' 0 N--CA 1.489 1.253 0 O-C-N 123.635 1.334 . . . . 0.0 112.264 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.702 ' O ' ' N ' ' A' ' 76' ' ' GLY . 33.9 m -151.39 115.66 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 CA-C-O 121.355 0.597 . . . . 0.0 110.38 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.559 ' HB2' ' HB3' ' B' ' 97' ' ' PHE . . . . . . . . 0 N--CA 1.504 2.255 0 CA-C-O 121.599 0.714 . . . . 0.0 112.513 -178.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.666 ' N ' ' HB1' ' B' ' 89' ' ' ALA . 0.4 OUTLIER . . . . . 0 N--CA 1.498 1.926 0 CA-C-O 121.269 0.557 . . . . 0.0 110.061 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.768 ' O ' ' N ' ' A' ' 78' ' ' SER . . . -99.31 53.93 1.01 Allowed Glycine 0 N--CA 1.484 1.862 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 1.052 HG11 ' O ' ' B' ' 84' ' ' SER . 4.5 p -50.91 69.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.922 -0.752 . . . . 0.0 109.971 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.768 ' N ' ' O ' ' A' ' 76' ' ' GLY . 1.0 OUTLIER -70.39 175.78 4.47 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 118.815 -1.154 . . . . 0.0 109.329 -179.771 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.77 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 0.7 OUTLIER 176.46 175.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 179.644 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.65 ' O ' HD23 ' A' ' 48' ' ' LEU . 0.4 OUTLIER -176.1 174.5 0.76 Allowed Pre-proline 0 C--N 1.299 -1.622 0 O-C-N 121.159 -0.963 . . . . 0.0 109.865 178.521 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.819 ' HB2' HG11 ' B' ' 77' ' ' VAL . 54.2 Cg_endo -88.11 169.56 6.25 Favored 'Trans proline' 0 C--N 1.293 -2.368 0 O-C-N 124.529 1.805 . . . . 0.0 108.255 176.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.613 ' CA ' ' HA ' ' A' ' 47' ' ' PHE . . . -150.15 133.64 4.46 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 107.307 -2.317 . . . . 0.0 107.307 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.879 ' O ' ' N ' ' A' ' 85' ' ' LEU . 8.6 tt0 51.09 32.63 7.99 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.142 -1.211 . . . . 0.0 107.901 -177.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.904 ' C ' HD22 ' A' ' 85' ' ' LEU . 1.6 t 8.94 45.83 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 122.45 1.119 . . . . 0.0 110.204 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 1.015 HD12 ' OG1' ' B' ' 33' ' ' THR . 0.0 OUTLIER 19.2 27.6 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 104.026 -2.583 . . . . 0.0 104.026 -171.353 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.582 ' HB2' ' CB ' ' A' ' 84' ' ' SER 0.339 7.9 tttt -66.16 -45.71 79.96 Favored 'General case' 0 CA--C 1.475 -1.914 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 178.497 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.03 -34.42 76.19 Favored 'General case' 0 C--N 1.281 -2.403 0 CA-C-N 112.445 -2.161 . . . . 0.0 106.118 177.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 1.07 ' C ' ' HB1' ' B' ' 37' ' ' ALA . . . -81.59 -30.02 33.12 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 117.764 -1.574 . . . . 0.0 107.585 178.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.696 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . -73.25 -27.66 61.7 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.497 ' N ' ' O ' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -67.07 -30.02 69.96 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 174.468 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -56.99 -50.05 66.98 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 177.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.873 ' O ' HD12 ' A' ' 92' ' ' LEU . 0.6 OUTLIER -80.52 17.72 1.05 Allowed 'General case' 0 N--CA 1.502 2.154 0 O-C-N 120.62 -1.518 . . . . 0.0 110.506 179.317 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.477 ' CB ' ' O ' ' A' ' 92' ' ' LEU . 0.0 OUTLIER 71.72 67.09 0.15 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.305 -0.872 . . . . 0.0 109.387 -179.393 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.497 ' CD1' ' N ' ' B' ' 75' ' ' VAL . 0.0 OUTLIER -45.64 -36.26 4.68 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.706 -0.621 . . . . 0.0 109.923 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 . . . . . 0 N--CA 1.492 1.645 0 O-C-N 121.47 -0.769 . . . . 0.0 109.764 179.748 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.55 ' HA ' ' CB ' ' B' ' 5' ' ' GLU . 11.6 mtp . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 120.879 0.371 . . . . 0.0 110.169 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -174.83 -166.71 0.25 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.086 -1.009 . . . . 0.0 111.303 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.459 ' CE ' ' HB2' ' B' ' 29' ' ' GLU . 0.0 OUTLIER -52.04 -11.48 0.17 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.408 -0.807 . . . . 0.0 111.471 -179.267 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . 0.564 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 59.6 m -115.59 -44.01 2.99 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.93 -1.106 . . . . 0.0 109.376 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.583 ' HA ' ' HE2' ' B' ' 8' ' ' LYS . 0.0 OUTLIER -62.07 -51.47 67.8 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 1.129 HD11 HG13 ' A' ' 42' ' ' VAL . 6.2 mt -62.99 -30.76 71.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.374 -0.829 . . . . 0.0 108.869 178.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' ILE . . . . . 0.821 HG23 ' HB ' ' B' ' 21' ' ' VAL . 0.6 OUTLIER -53.17 -54.38 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.369 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . 0.906 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 14.1 mtmt -59.44 -36.5 76.04 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.714 -0.846 . . . . 0.0 108.714 178.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . 1.07 ' HB1' HD13 ' A' ' 31' ' ' ILE . . . -52.71 -34.63 53.19 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.819 -0.753 . . . . 0.0 109.243 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.847 HG23 ' HB3' ' A' ' 24' ' ' MET . 1.2 mp -97.15 -35.74 5.66 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.425 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.906 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -60.09 -25.91 65.78 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.71 -0.796 . . . . 0.0 108.878 178.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.441 ' CG ' ' N ' ' B' ' 13' ' ' ASP . 16.6 pt20 -92.77 -41.2 10.25 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.448 ' OD2' HG21 ' A' ' 31' ' ' ILE . 1.3 m-20 -65.13 -22.49 66.94 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 176.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.846 ' OG1' ' O ' ' B' ' 10' ' ' ILE . 24.5 p -96.33 -78.38 0.47 Allowed 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 61.87 12.42 35.47 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' LEU . . . . . 0.883 HD22 ' O ' ' A' ' 19' ' ' VAL . 3.7 mp -78.19 -54.57 6.1 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.433 -1.039 . . . . 0.0 108.652 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . 0.586 HG22 ' H ' ' B' ' 19' ' ' VAL . 0.5 OUTLIER -151.01 6.21 0.5 Allowed 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.3 -179.13 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . 0.555 ' O ' ' C ' ' B' ' 19' ' ' VAL . 16.4 mt-30 56.92 25.8 10.97 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 -176.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 1.157 HG11 HG11 ' A' ' 19' ' ' VAL . 2.3 p -0.28 -94.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.118 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 0.94 ' O ' ' N ' ' B' ' 23' ' ' LYS . 0.0 OUTLIER -130.17 24.12 5.23 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.821 ' HB ' HG23 ' B' ' 7' ' ' ILE . 15.5 m -22.7 -40.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-O 122.446 1.117 . . . . 0.0 109.259 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.76 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.3 OUTLIER -76.32 -36.57 58.22 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.092 178.167 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . 0.94 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.0 OUTLIER -95.1 -28.29 15.15 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 118.786 -1.166 . . . . 0.0 111.13 179.125 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' MET . . . . . 0.755 ' N ' ' OG ' ' B' ' 20' ' ' SER . 0.0 OUTLIER -70.41 -35.14 73.25 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 116.761 -1.976 . . . . 0.0 108.241 179.123 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.666 HD12 HG13 ' B' ' 7' ' ' ILE . 0.3 OUTLIER -83.12 -41.75 18.17 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 118.2 -1.4 . . . . 0.0 109.24 178.315 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . 0.408 ' CB ' ' O ' ' B' ' 22' ' ' SER . . . -64.3 -34.88 79.16 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 177.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' SER . . . . . 0.599 ' CB ' ' O ' ' B' ' 23' ' ' LYS . 7.3 t -84.7 -28.24 26.48 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 119.447 -0.901 . . . . 0.0 108.575 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . 0.722 ' HB2' HD11 ' A' ' 10' ' ' ILE . 0.7 OUTLIER -51.05 -44.44 61.11 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . 0.745 ' O ' ' HB ' ' B' ' 33' ' ' THR . 1.4 tt0 -70.79 -38.63 73.39 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 176.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 1.251 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 6.9 ttpt -60.96 -19.9 61.55 Favored 'General case' 0 C--O 1.192 -1.931 0 C-N-CA 119.302 -0.959 . . . . 0.0 108.636 178.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.637 HG13 ' O ' ' B' ' 28' ' ' PHE . 0.8 OUTLIER -108.48 -28.67 2.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 120.111 -1.618 . . . . 0.0 109.366 178.276 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.624 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.2 mm -73.53 -59.78 3.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 176.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' THR . . . . . 1.015 ' OG1' HD12 ' A' ' 85' ' ' LEU . 0.9 OUTLIER -66.67 -38.98 87.94 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 114.748 -1.114 . . . . 0.0 108.658 179.159 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 1.251 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 75.6 mm-40 -77.52 -39.54 45.82 Favored 'General case' 0 C--O 1.205 -1.262 0 O-C-N 121.029 -1.044 . . . . 0.0 112.788 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' THR . . . . . 0.759 HG21 ' SD ' ' A' ' 1' ' ' MET . 98.1 m -63.13 -51.19 67.48 Favored 'General case' 0 N--CA 1.504 2.268 0 CA-C-N 121.206 1.821 . . . . 0.0 110.13 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.927 ' CG2' HG22 ' B' ' 50' ' ' ILE . 0.9 OUTLIER -53.97 -41.46 49.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 178.042 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . 1.07 ' HB1' ' C ' ' A' ' 88' ' ' ALA . . . -86.38 3.14 44.91 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.291 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.761 ' HB2' ' O ' ' B' ' 34' ' ' GLU . 0.0 OUTLIER -102.71 -36.33 8.34 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.468 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 141.16 33.2 0.13 Allowed Glycine 0 C--N 1.302 -1.36 0 C-N-CA 119.056 -1.545 . . . . 0.0 111.56 178.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . 0.459 ' HB3' ' CG2' ' B' ' 35' ' ' THR . 0.2 OUTLIER -146.93 158.87 44.04 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.79 -1.418 . . . . 0.0 110.605 179.271 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 33.3 mtpt -101.34 91.46 4.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.455 -0.778 . . . . 0.0 110.007 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.88 ' CG1' HD11 ' A' ' 6' ' ' LEU . 91.5 t -70.78 148.97 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.471 -0.768 . . . . 0.0 110.471 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' GLN . . . . . 0.625 ' O ' HD23 ' B' ' 44' ' ' LEU . 20.5 mt-30 -146.73 165.41 29.72 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.13 -0.981 . . . . 0.0 110.39 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.739 HD22 ' HE2' ' A' ' 28' ' ' PHE . 19.0 mt -122.81 117.42 25.61 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.388 -0.82 . . . . 0.0 109.58 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . 0.634 HG21 ' HB3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 29.04 -92.47 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.809 -0.557 . . . . 0.0 111.136 179.817 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -148.61 23.11 1.34 Allowed Glycine 0 N--CA 1.485 1.966 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . 0.719 ' CZ ' HG21 ' A' ' 32' ' ' ILE . 0.9 OUTLIER -116.57 -32.83 5.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.135 -1.215 . . . . 0.0 111.252 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.595 ' CB ' HD12 ' B' ' 44' ' ' LEU . 0.1 OUTLIER -118.24 162.85 17.58 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.692 -1.255 . . . . 0.0 112.768 179.856 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' ASN . . . . . 0.74 ' O ' HD13 ' B' ' 50' ' ' ILE . 0.2 OUTLIER -142.1 142.22 32.78 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 178.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' ILE . . . . . 0.927 HG22 ' CG2' ' B' ' 36' ' ' VAL . 33.6 mm -138.06 101.91 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.227 -0.921 . . . . 0.0 110.431 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . 0.675 ' HA ' HG22 ' B' ' 36' ' ' VAL . 0.0 OUTLIER -157.43 133.5 6.07 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.065 -1.022 . . . . 0.0 109.064 -179.798 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' PRO . . . . . 0.76 ' CG ' HG13 ' B' ' 36' ' ' VAL . 57.9 Cg_endo -93.96 159.61 2.21 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.153 1.081 . . . . 0.0 112.009 -178.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 1.007 HG22 ' O ' ' B' ' 76' ' ' GLY . 28.0 m -137.95 116.83 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-O 121.935 0.874 . . . . 0.0 110.441 177.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . 0.497 ' HA ' ' HA ' ' B' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.495 1.789 0 CA-C-O 121.55 0.69 . . . . 0.0 111.991 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . 0.599 HG11 ' CB ' ' A' ' 89' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.496 1.839 0 CA-C-O 121.191 0.519 . . . . 0.0 109.829 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 76' ' ' GLY . . . . . 1.007 ' O ' HG22 ' B' ' 53' ' ' VAL . . . -129.67 107.28 0.78 Allowed Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.819 HG11 ' HB2' ' A' ' 81' ' ' PRO . 8.6 p -58.41 86.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.194 -1.18 . . . . 0.0 108.875 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 78' ' ' SER . . . . . 0.547 ' OG ' HG11 ' B' ' 53' ' ' VAL . 0.5 OUTLIER -58.16 -47.32 83.74 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 -178.258 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.91 HG21 ' HA ' ' B' ' 50' ' ' ILE . 17.7 m -48.08 178.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 -173.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 80' ' ' LYS . . . . . 0.811 ' HB2' ' HD2' ' B' ' 81' ' ' PRO . 0.0 OUTLIER 179.4 -179.7 0.24 Allowed Pre-proline 0 C--N 1.308 -1.228 0 CA-C-N 113.64 -1.618 . . . . 0.0 107.162 -177.391 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 81' ' ' PRO . . . . . 0.811 ' HD2' ' HB2' ' B' ' 80' ' ' LYS . 39.2 Cg_endo -63.64 153.16 76.82 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 122.989 0.994 . . . . 0.0 111.691 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . 0.521 ' C ' ' H ' ' B' ' 84' ' ' SER . . . -117.16 -79.53 0.73 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 107.351 -2.3 . . . . 0.0 107.351 178.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . 0.918 ' O ' ' N ' ' B' ' 85' ' ' LEU . 16.9 tt0 -75.71 41.32 0.2 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.523 -0.986 . . . . 0.0 108.707 177.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 84' ' ' SER . . . . . 1.052 ' O ' HG11 ' A' ' 77' ' ' VAL . 0.3 OUTLIER 7.8 44.72 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 122.741 1.258 . . . . 0.0 110.453 178.209 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 1.069 HD12 HG21 ' A' ' 36' ' ' VAL . 0.2 OUTLIER 19.08 28.61 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 104.08 -2.563 . . . . 0.0 104.08 -171.577 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 86' ' ' LYS . . . . . 0.475 ' HB2' ' CB ' ' B' ' 84' ' ' SER 0.355 2.7 tttt -58.05 -41.8 84.08 Favored 'General case' 0 CA--C 1.482 -1.658 0 N-CA-C 103.794 -2.669 . . . . 0.0 103.794 176.765 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . 0.407 ' O ' ' HG2' ' B' ' 90' ' ' GLU 0.264 0.0 OUTLIER -66.05 -35.92 81.83 Favored 'General case' 0 C--N 1.285 -2.228 0 CA-C-N 111.588 -2.551 . . . . 0.0 105.532 176.236 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.707 ' HB2' HG23 ' A' ' 33' ' ' THR . . . -74.52 -27.3 60.48 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 118.54 -1.264 . . . . 0.0 108.409 178.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.749 ' HA ' HD23 ' B' ' 92' ' ' LEU . . . -62.01 -50.0 73.81 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.114 -0.991 . . . . 0.0 109.264 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . 0.445 ' HG2' ' N ' ' B' ' 91' ' ' GLY . 2.7 pt-20 -57.62 -26.69 61.93 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 176.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . 0.445 ' N ' ' HG2' ' B' ' 90' ' ' GLU . . . -65.66 -37.53 93.64 Favored Glycine 0 N--CA 1.487 2.055 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.286 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 92' ' ' LEU . . . . . 0.749 HD23 ' HA ' ' B' ' 89' ' ' ALA . 1.1 pp -85.4 22.11 1.6 Allowed 'General case' 0 N--CA 1.504 2.258 0 CA-C-N 119.931 1.865 . . . . 0.0 111.239 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 93' ' ' LYS . . . . . 0.447 ' O ' ' N ' ' B' ' 96' ' ' ASP . 4.0 mmtt 53.65 39.02 29.63 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 -177.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . 0.583 ' HA ' HD11 ' B' ' 92' ' ' LEU . 0.0 OUTLIER -36.16 -36.81 0.1 Allowed 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.943 -178.643 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . 0.51 ' N ' ' CD1' ' B' ' 94' ' ' TYR . 7.0 pt-20 -60.01 -42.3 94.01 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.332 -0.855 . . . . 0.0 109.609 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 96' ' ' ASP . . . . . 0.447 ' N ' ' O ' ' B' ' 93' ' ' LYS . 0.3 OUTLIER -61.09 -35.08 76.02 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.085 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 97' ' ' PHE . . . . . 0.559 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.505 ' CE ' HD23 ' A' ' 6' ' ' LEU . 6.3 mtp . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 120.837 0.351 . . . . 0.0 110.069 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.689 ' C ' HD12 ' A' ' 6' ' ' LEU . 1.6 t-20 -176.93 -165.31 0.12 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.946 -1.096 . . . . 0.0 111.626 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.552 ' CD ' ' HB ' ' B' ' 45' ' ' THR . 0.4 OUTLIER -51.07 -12.93 0.13 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.511 -0.743 . . . . 0.0 110.802 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.644 ' O ' HG13 ' A' ' 7' ' ' ILE . 74.8 m -112.61 -60.6 1.85 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.172 -0.955 . . . . 0.0 109.938 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.545 ' HA ' ' CE ' ' A' ' 8' ' ' LYS . 4.6 mt-10 -50.17 -41.6 49.61 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.98 -1.075 . . . . 0.0 108.879 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.689 HD12 ' C ' ' A' ' 2' ' ' ASN . 10.1 mt -60.62 -34.51 74.36 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.303 -0.959 . . . . 0.0 109.772 177.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.644 HG13 ' O ' ' A' ' 4' ' ' THR . 1.0 OUTLIER -57.59 -39.74 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 179.089 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.818 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 1.0 OUTLIER -66.97 -36.66 82.69 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.397 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.691 ' HB1' HD13 ' B' ' 31' ' ' ILE . . . -52.39 -39.0 60.33 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 120.214 -0.594 . . . . 0.0 109.447 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.708 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.3 mp -93.93 -29.99 4.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.818 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -63.92 -15.15 58.43 Favored 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 118.496 -1.282 . . . . 0.0 108.858 178.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -115.16 -42.78 3.14 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.405 -0.81 . . . . 0.0 109.352 178.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 9' ' ' ALA . 1.0 OUTLIER -67.12 -26.15 66.54 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 177.071 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 1.104 HG22 ' CD1' ' A' ' 16' ' ' LEU 0.257 0.2 OUTLIER -112.54 -82.8 0.59 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 178.891 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 16' ' ' LEU . . . 71.15 -11.17 2.89 Favored Glycine 0 N--CA 1.501 2.967 0 O-C-N 121.0 -1.063 . . . . 0.0 111.739 177.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 1.104 ' CD1' HG22 ' A' ' 14' ' ' THR . 4.4 mp -35.73 -64.11 0.32 Allowed 'General case' 0 N--CA 1.511 2.59 0 O-C-N 121.518 -0.989 . . . . 0.0 110.532 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.571 HG22 ' H ' ' A' ' 19' ' ' VAL . 0.5 OUTLIER -135.22 3.64 3.14 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.167 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.613 ' O ' ' C ' ' A' ' 19' ' ' VAL . 28.2 mt-30 56.44 29.04 14.57 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 -176.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 1.007 HG11 HG11 ' B' ' 19' ' ' VAL . 1.5 p -9.68 -94.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.904 -178.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.968 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -133.9 25.13 3.97 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 177.627 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.703 HG12 HG22 ' A' ' 10' ' ' ILE . 27.0 m -19.17 -39.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 122.474 1.13 . . . . 0.0 109.347 -178.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.852 ' N ' ' O ' ' A' ' 20' ' ' SER . 3.1 m -81.5 -38.7 25.89 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.661 177.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.968 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.1 OUTLIER -86.45 -35.79 19.45 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.547 -0.72 . . . . 0.0 111.186 179.492 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.578 ' HB3' HG21 ' B' ' 14' ' ' THR . 0.0 OUTLIER -68.17 -38.21 81.81 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 117.567 -1.653 . . . . 0.0 108.15 178.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.645 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 8.4 mt -72.42 -47.27 50.49 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 118.404 -1.319 . . . . 0.0 107.832 176.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.507 ' HA ' ' HE2' ' A' ' 3' ' ' LYS . . . -55.31 -34.0 63.78 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 177.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.634 ' HA ' ' HB3' ' A' ' 30' ' ' LYS . 54.9 p -83.16 -32.25 26.72 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.833 ' O ' HG13 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -56.57 -47.13 80.17 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.013 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.684 ' O ' ' HB ' ' A' ' 33' ' ' THR . 0.3 OUTLIER -71.02 -35.68 72.11 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 177.733 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.873 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 70.9 tttt -65.04 -21.44 66.83 Favored 'General case' 0 C--O 1.192 -1.962 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.833 HG13 ' O ' ' A' ' 28' ' ' PHE . 1.3 pp -105.06 -29.48 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.761 -1.212 . . . . 0.0 109.062 178.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.616 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.2 mm -71.43 -49.34 47.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 176.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.684 ' HB ' ' O ' ' A' ' 29' ' ' GLU . 0.3 OUTLIER -69.07 -43.37 74.71 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 177.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.873 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 57.7 mm-40 -68.31 -41.62 80.59 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 121.616 -0.677 . . . . 0.0 110.905 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.612 HG21 HG23 ' A' ' 42' ' ' VAL . 3.8 m -52.58 -50.37 63.14 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.588 -1.32 . . . . 0.0 108.537 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.932 HG21 HG23 ' A' ' 77' ' ' VAL . 1.1 t -54.01 -36.89 32.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 177.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.678 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -81.33 -6.24 58.68 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.537 0.684 . . . . 0.0 109.7 178.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.606 ' HG2' ' O ' ' A' ' 34' ' ' GLU . 2.4 mmpt? -97.58 -25.05 15.27 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 177.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.79 41.07 1.76 Allowed Glycine 0 C--N 1.303 -1.295 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 178.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.562 ' CB ' HG23 ' A' ' 35' ' ' THR . 0.2 OUTLIER -136.76 147.64 46.8 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.176 -1.191 . . . . 0.0 110.593 179.707 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.5 mtmt -100.51 102.94 14.25 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 1.12 HG13 HD11 ' B' ' 6' ' ' LEU . 2.0 t -74.77 152.42 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 C-N-CA 119.622 -0.831 . . . . 0.0 110.019 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.464 ' HA ' ' O ' ' A' ' 48' ' ' LEU . 6.1 mt-30 -140.26 94.16 2.71 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.403 -0.81 . . . . 0.0 110.221 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.642 HD12 ' CE1' ' A' ' 47' ' ' PHE . 22.1 mt -58.84 112.77 1.77 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.954 -1.091 . . . . 0.0 109.078 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.572 HG22 ' HG2' ' B' ' 29' ' ' GLU . 0.1 OUTLIER 35.99 -88.48 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.869 -0.519 . . . . 0.0 110.606 -179.157 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -149.52 29.12 1.19 Allowed Glycine 0 N--CA 1.484 1.898 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.77 ' CE1' HG21 ' B' ' 32' ' ' ILE . 3.9 p90 -128.03 -28.64 2.62 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.991 -1.3 . . . . 0.0 112.717 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.796 HD11 HD11 ' B' ' 50' ' ' ILE . 0.6 OUTLIER -123.78 100.84 6.97 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.36 -1.462 . . . . 0.0 111.297 179.28 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.431 ' HA ' ' HA ' ' A' ' 43' ' ' GLN . 44.6 t-20 -109.45 87.35 2.48 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.863 -0.523 . . . . 0.0 110.623 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.803 HG22 ' CG2' ' A' ' 79' ' ' VAL . 1.1 pt -79.39 147.62 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.159 -0.963 . . . . 0.0 110.505 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.422 ' HG3' ' HB3' ' A' ' 78' ' ' SER . 8.4 ptmt -157.15 122.71 2.42 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.053 -1.029 . . . . 0.0 110.079 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.506 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 55.3 Cg_endo -80.65 140.87 13.42 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 O-C-N 123.459 1.241 . . . . 0.0 112.025 -178.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.706 ' O ' ' N ' ' A' ' 76' ' ' GLY . 31.5 m -142.21 114.75 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 121.441 0.639 . . . . 0.0 109.64 178.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 1.012 ' HB2' HG23 ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.497 1.914 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -177.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 1.012 HG23 ' HB2' ' A' ' 54' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.281 0.562 . . . . 0.0 109.888 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.706 ' N ' ' O ' ' A' ' 53' ' ' VAL . . . -115.37 61.2 0.38 Allowed Glycine 0 N--CA 1.484 1.873 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.95 HG21 ' CB ' ' B' ' 85' ' ' LEU . 2.3 p -43.47 83.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.998 -0.707 . . . . 0.0 110.787 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.617 ' N ' ' O ' ' A' ' 76' ' ' GLY . 1.3 t -81.68 175.97 10.02 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.985 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.803 ' CG2' HG22 ' A' ' 50' ' ' ILE . 3.3 p 176.25 176.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.606 ' N ' HG22 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -176.09 171.43 1.1 Allowed Pre-proline 0 N--CA 1.485 1.286 0 O-C-N 120.799 -1.188 . . . . 0.0 110.868 177.3 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.581 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 55.6 Cg_endo -97.03 136.51 0.44 Allowed 'Trans proline' 0 C--N 1.302 -1.878 0 C-N-CA 122.843 2.362 . . . . 0.0 110.706 178.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.657 ' O ' HD12 ' A' ' 85' ' ' LEU . . . -91.64 -158.74 34.85 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 178.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -89.33 -16.53 30.87 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.117 -1.226 . . . . 0.0 110.394 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.436 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -53.59 -33.42 54.81 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.304 -0.872 . . . . 0.0 109.975 -179.857 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.825 ' CB ' HG21 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -86.0 -30.94 22.32 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.326 -0.859 . . . . 0.0 108.77 178.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.439 ' HA ' ' CG1' ' B' ' 75' ' ' VAL . 0.6 OUTLIER -72.94 -33.12 65.72 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.415 -0.803 . . . . 0.0 109.838 -179.88 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -78.63 -34.92 46.22 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 1.035 ' C ' ' HB1' ' B' ' 37' ' ' ALA . . . -68.53 -31.26 70.37 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 177.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 1.051 ' N ' ' HB1' ' B' ' 37' ' ' ALA . . . -69.94 -35.73 74.74 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -178.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -59.55 -24.79 64.01 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 174.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -64.43 -54.41 29.53 Favored Glycine 0 N--CA 1.483 1.797 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 178.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.879 HD23 ' C ' ' B' ' 37' ' ' ALA . 2.1 pp -67.11 -42.19 84.96 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 119.76 1.78 . . . . 0.0 109.502 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.8 ' HB3' HD12 ' A' ' 92' ' ' LEU . 2.6 tttp 156.8 80.88 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 1.059 ' O ' ' C ' ' A' ' 95' ' ' GLU . 9.1 t80 -61.79 -62.85 1.51 Allowed 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 115.297 -2.561 . . . . 0.0 105.96 177.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 1.059 ' C ' ' O ' ' A' ' 94' ' ' TYR . 2.3 mp0 . . . . . 0 CA--C 1.486 -1.501 0 N-CA-C 101.561 -3.496 . . . . 0.0 101.561 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.757 ' HB2' HG22 ' A' ' 42' ' ' VAL . 5.9 mtp . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 120.863 0.363 . . . . 0.0 110.133 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 2' ' ' ASN . . . . . 0.551 ' H ' ' HB2' ' B' ' 5' ' ' GLU . 2.0 t-20 -172.53 -159.42 0.13 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.055 -1.028 . . . . 0.0 111.396 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.494 ' HG2' ' OE1' ' B' ' 29' ' ' GLU . 1.4 mttt -58.36 -7.56 0.92 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.407 -0.808 . . . . 0.0 110.291 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . 0.671 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 90.0 m -116.82 -48.3 2.67 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.042 -1.036 . . . . 0.0 110.304 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.59 ' HA ' ' HE2' ' B' ' 8' ' ' LYS . 3.0 mt-10 -61.64 -52.89 62.49 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.117 -0.989 . . . . 0.0 108.904 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 1.12 HD11 HG13 ' A' ' 42' ' ' VAL . 0.9 OUTLIER -60.23 -27.79 67.49 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.196 -1.002 . . . . 0.0 108.928 178.355 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' ILE . . . . . 0.808 HG23 ' HB ' ' B' ' 21' ' ' VAL . 0.4 OUTLIER -56.26 -58.01 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 178.158 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . 0.91 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.1 OUTLIER -55.35 -31.85 62.08 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . 0.768 ' HB3' ' O ' ' B' ' 6' ' ' LEU . . . -57.57 -37.22 72.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.27 -0.894 . . . . 0.0 108.958 178.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.934 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.2 mp -92.57 -25.96 4.95 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.209 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 177.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.91 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -75.99 -2.23 29.51 Favored 'General case' 0 C--N 1.287 -2.121 0 O-C-N 120.703 -1.248 . . . . 0.0 108.152 177.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.418 ' HB3' ' O ' ' B' ' 8' ' ' LYS . 55.7 tp60 -125.3 -41.62 2.04 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.531 -0.731 . . . . 0.0 109.898 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' B' ' 9' ' ' ALA . 1.0 OUTLIER -72.18 -23.78 61.32 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 177.838 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 1.092 HG22 ' CD1' ' B' ' 16' ' ' LEU 0.284 0.2 OUTLIER -103.8 -62.13 1.34 Allowed 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 179.609 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 52.12 24.07 14.01 Favored Glycine 0 N--CA 1.5 2.912 0 O-C-N 121.369 -0.832 . . . . 0.0 111.569 177.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' LEU . . . . . 1.092 ' CD1' HG22 ' B' ' 14' ' ' THR . 4.5 mp -69.76 -69.97 0.31 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.343 -1.092 . . . . 0.0 109.904 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . 0.586 HG22 ' H ' ' B' ' 19' ' ' VAL . 0.6 OUTLIER -137.81 5.74 2.64 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.736 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . 0.669 ' O ' ' C ' ' B' ' 19' ' ' VAL . 33.2 mt-30 57.42 27.53 14.04 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 -176.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 1.007 HG11 HG11 ' A' ' 19' ' ' VAL . 1.5 p -0.41 -96.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.947 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 1.091 ' O ' ' N ' ' B' ' 22' ' ' SER . 14.9 p -133.53 23.08 4.01 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 175.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.808 ' HB ' HG23 ' B' ' 7' ' ' ILE . 28.1 m -3.87 -39.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-O 122.302 1.048 . . . . 0.0 110.981 -177.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 1.091 ' N ' ' O ' ' B' ' 20' ' ' SER . 2.4 t -73.0 -44.01 61.5 Favored 'General case' 0 C--N 1.281 -2.387 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.93 177.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . 0.813 ' N ' ' O ' ' B' ' 20' ' ' SER . 5.1 mtpt -88.37 -29.32 20.37 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.659 -0.651 . . . . 0.0 109.693 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' MET . . . . . 0.715 ' HE2' ' HA ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -62.77 -41.44 99.24 Favored 'General case' 0 C--N 1.314 -0.958 0 O-C-N 120.899 -1.126 . . . . 0.0 109.443 179.796 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.716 HD12 HG13 ' B' ' 7' ' ' ILE . 1.2 mt -84.51 -45.38 12.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.891 -1.13 . . . . 0.0 108.406 177.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . 0.499 ' O ' ' CB ' ' B' ' 30' ' ' LYS . . . -53.31 -34.68 58.38 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 178.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' SER . . . . . 0.611 ' O ' HG23 ' B' ' 31' ' ' ILE . 58.4 m -78.55 -40.28 35.34 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 177.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . 0.728 ' HA ' ' CG1' ' B' ' 31' ' ' ILE . 0.1 OUTLIER -63.82 -36.63 84.53 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.636 -0.665 . . . . 0.0 109.394 179.42 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . 0.587 ' HG3' ' CE2' ' B' ' 28' ' ' PHE . 0.9 OUTLIER -82.07 -31.97 30.57 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 178.721 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 0.82 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 16.6 tttp -72.22 -28.42 63.16 Favored 'General case' 0 C--O 1.191 -1.989 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 176.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.728 ' CG1' ' HA ' ' B' ' 28' ' ' PHE . 1.6 pp -94.67 -30.48 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.03 -1.044 . . . . 0.0 109.884 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.979 HD13 HG21 ' B' ' 42' ' ' VAL . 3.6 mm -62.91 -61.88 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 177.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' THR . . . . . 0.557 ' OG1' ' HG ' ' A' ' 85' ' ' LEU . 0.4 OUTLIER -58.42 -40.18 81.79 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.813 179.213 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.84 ' O ' ' N ' ' B' ' 38' ' ' LYS . 40.9 mm-40 -73.29 -48.42 34.74 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.855 -0.528 . . . . 0.0 112.296 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' THR . . . . . 0.667 HG22 ' O ' ' B' ' 40' ' ' ASP . 92.9 m -52.16 -59.16 4.7 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.477 -1.389 . . . . 0.0 110.504 -178.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.998 HG23 HG12 ' B' ' 42' ' ' VAL . 0.9 OUTLIER -51.38 -45.32 33.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 178.408 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . 1.051 ' HB1' ' N ' ' A' ' 89' ' ' ALA . . . -83.52 1.88 39.71 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.993 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.84 ' N ' ' O ' ' B' ' 34' ' ' GLU . 0.5 OUTLIER -107.53 -37.85 6.07 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.188 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 145.28 41.92 0.05 OUTLIER Glycine 0 C--N 1.301 -1.405 0 C-N-CA 119.008 -1.568 . . . . 0.0 111.273 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . 0.667 ' O ' HG22 ' B' ' 35' ' ' THR . 0.6 OUTLIER -161.75 127.11 3.54 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.93 -1.335 . . . . 0.0 110.604 179.236 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.83 86.53 0.23 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.675 -0.641 . . . . 0.0 109.421 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.998 HG12 HG23 ' B' ' 36' ' ' VAL . 9.4 p -61.8 125.93 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 C-N-CA 119.919 -0.712 . . . . 0.0 109.66 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' GLN . . . . . 0.55 ' O ' ' HA ' ' A' ' 2' ' ' ASN . 5.4 mt-30 -131.11 172.25 12.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.899 . . . . 0.0 110.29 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.97 HD12 ' CB ' ' B' ' 48' ' ' LEU . 29.3 mt -136.48 120.21 17.31 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.503 -0.748 . . . . 0.0 109.625 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . 0.552 ' HB ' ' CD ' ' A' ' 3' ' ' LYS . 0.1 OUTLIER 34.43 -92.72 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.375 0 O-C-N 121.646 -0.659 . . . . 0.0 110.821 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -159.24 30.37 0.42 Allowed Glycine 0 N--CA 1.486 2.032 0 N-CA-C 108.256 -1.937 . . . . 0.0 108.256 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . 0.673 ' CE1' ' HG2' ' A' ' 29' ' ' GLU . 0.1 OUTLIER -124.65 -26.76 3.78 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.546 -0.973 . . . . 0.0 110.981 -179.447 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.97 ' CB ' HD12 ' B' ' 44' ' ' LEU . 9.7 mt -130.56 90.29 2.9 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.835 -1.165 . . . . 0.0 110.415 177.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' ASN . . . . . 0.414 ' O ' ' HA ' ' B' ' 79' ' ' VAL . 0.7 OUTLIER -98.26 88.83 4.28 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.705 -0.622 . . . . 0.0 110.481 -179.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' ILE . . . . . 0.947 HG22 HG21 ' B' ' 36' ' ' VAL . 0.8 OUTLIER -81.73 147.32 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.383 -0.823 . . . . 0.0 110.906 -179.835 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' B' ' 78' ' ' SER . 3.3 ptmt -164.31 131.04 2.34 Favored Pre-proline 0 N--CA 1.502 2.154 0 O-C-N 121.258 -0.901 . . . . 0.0 110.391 179.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' PRO . . . . . 0.897 ' HD3' HG22 ' B' ' 36' ' ' VAL . 50.8 Cg_endo -84.28 146.86 11.27 Favored 'Trans proline' 0 C--N 1.318 -1.039 0 O-C-N 123.195 1.103 . . . . 0.0 112.241 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.669 HG22 ' O ' ' B' ' 76' ' ' GLY . 23.1 m -146.4 117.39 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-O 121.765 0.793 . . . . 0.0 110.284 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 121.755 0.788 . . . . 0.0 111.783 -178.69 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . 1.038 HG11 ' CB ' ' A' ' 89' ' ' ALA . 11.9 p . . . . . 0 N--CA 1.497 1.889 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 76' ' ' GLY . . . . . 0.669 ' O ' HG22 ' B' ' 53' ' ' VAL . . . -119.23 71.31 0.32 Allowed Glycine 0 N--CA 1.488 2.161 0 C-N-CA 119.005 -1.569 . . . . 0.0 109.826 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.894 HG23 HG11 ' B' ' 36' ' ' VAL . 3.1 p -59.07 77.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.377 -1.072 . . . . 0.0 109.726 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 78' ' ' SER . . . . . 0.56 ' N ' ' O ' ' B' ' 76' ' ' GLY . 0.2 OUTLIER -71.11 177.35 3.83 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 122.174 0.988 . . . . 0.0 111.286 -179.298 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.574 HG22 ' N ' ' B' ' 80' ' ' LYS . 1.6 p 176.56 176.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 80' ' ' LYS . . . . . 0.691 ' O ' HD23 ' B' ' 48' ' ' LEU . 16.1 ptmt -176.33 174.05 0.78 Allowed Pre-proline 0 N--CA 1.486 1.326 0 O-C-N 120.764 -1.21 . . . . 0.0 110.349 178.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 81' ' ' PRO . . . . . 0.471 ' HA ' ' O ' ' B' ' 47' ' ' PHE . 52.8 Cg_endo -96.01 136.56 0.6 Allowed 'Trans proline' 0 C--N 1.302 -1.877 0 C-N-CA 122.294 1.996 . . . . 0.0 109.842 178.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . 0.461 ' HA3' ' HA ' ' B' ' 47' ' ' PHE . . . -97.35 -168.3 32.86 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 107.793 -2.123 . . . . 0.0 107.793 178.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . 0.63 ' HA ' ' HB2' ' B' ' 86' ' ' LYS . 0.9 OUTLIER -76.97 -18.28 58.33 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.886 -1.361 . . . . 0.0 110.283 179.776 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 84' ' ' SER . . . . . 0.487 ' CB ' ' HB3' ' B' ' 47' ' ' PHE . 0.2 OUTLIER -50.94 -42.19 59.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.167 -0.958 . . . . 0.0 108.815 179.368 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.95 ' CB ' HG21 ' A' ' 77' ' ' VAL . 1.0 OUTLIER -73.72 -31.41 63.37 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 177.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 86' ' ' LYS . . . . . 0.63 ' HB2' ' HA ' ' B' ' 83' ' ' GLU . 29.4 mtmm -73.29 -38.24 65.97 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.392 0.615 . . . . 0.0 110.196 -179.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 13.8 ttpt -74.54 -37.12 63.12 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 177.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.642 ' O ' ' HB1' ' A' ' 37' ' ' ALA . . . -68.92 -34.73 75.86 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 176.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.948 ' HA ' HD23 ' B' ' 92' ' ' LEU . . . -55.95 -44.36 78.36 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -54.07 -33.51 57.67 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 176.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' B' ' 88' ' ' ALA . . . -61.79 -38.47 96.0 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 178.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 92' ' ' LEU . . . . . 0.948 HD23 ' HA ' ' B' ' 89' ' ' ALA . 0.4 OUTLIER -72.27 13.8 0.29 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.69 -1.477 . . . . 0.0 110.762 179.697 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 93' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' B' ' 92' ' ' LEU . 72.8 mmtt 62.17 39.84 12.37 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 -177.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . 0.511 ' HD1' ' HB1' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -38.09 -37.23 0.25 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.565 -179.214 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -60.12 -42.53 94.97 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.46 -0.775 . . . . 0.0 109.811 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 96' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' B' ' 93' ' ' LYS . 3.4 m-20 -60.57 -36.68 79.08 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 97' ' ' PHE . . . . . 0.504 ' HB3' ' HB3' ' A' ' 54' ' ' ALA . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.458 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.583 ' HE3' ' HG ' ' A' ' 6' ' ' LEU . 7.3 mtp . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.519 ' CA ' HD12 ' A' ' 6' ' ' LEU . 50.4 p-10 -171.16 -162.78 0.26 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.798 -1.189 . . . . 0.0 112.43 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.555 ' HE2' ' HA ' ' A' ' 26' ' ' ALA . 9.8 tttm -46.79 -15.34 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.776 -0.578 . . . . 0.0 111.068 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.632 ' O ' ' CG1' ' A' ' 7' ' ' ILE . 58.6 m -117.26 -58.06 2.09 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.126 -0.984 . . . . 0.0 110.304 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.599 ' HA ' ' HE3' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -46.64 -44.86 18.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.115 -0.991 . . . . 0.0 109.489 179.698 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.715 HD23 ' CD1' ' B' ' 31' ' ' ILE . 1.3 mt -63.74 -33.28 75.3 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.15 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.75 ' N ' HD12 ' A' ' 25' ' ' LEU . 0.9 OUTLIER -56.68 -42.61 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.764 -1.21 . . . . 0.0 108.097 179.699 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.908 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 6.7 mtmt -66.56 -34.14 77.23 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 177.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.865 ' CB ' HD13 ' B' ' 31' ' ' ILE . . . -53.71 -39.51 65.26 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.546 -0.862 . . . . 0.0 109.362 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.776 HG22 HG12 ' A' ' 21' ' ' VAL . 1.3 mp -91.01 -31.58 5.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 178.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.908 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -65.3 -13.47 58.53 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 118.956 -1.098 . . . . 0.0 108.364 177.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.445 ' HB3' ' O ' ' A' ' 8' ' ' LYS . 1.1 tp60 -113.44 -45.12 3.15 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.487 ' HB3' ' HB2' ' B' ' 27' ' ' SER . 1.8 m-20 -62.34 -33.8 75.41 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 177.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.723 ' OG1' ' O ' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -102.16 -71.14 0.73 Allowed 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 178.494 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 46.37 27.37 2.8 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 1.076 ' CD1' HG23 ' B' ' 19' ' ' VAL . 0.1 OUTLIER -87.28 -25.83 23.75 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.449 -1.03 . . . . 0.0 108.946 178.868 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.712 HG21 HG21 ' B' ' 17' ' ' THR . 0.5 OUTLIER -153.8 -8.32 0.16 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.907 -0.496 . . . . 0.0 110.228 -179.449 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.515 ' O ' ' C ' ' A' ' 19' ' ' VAL . 4.5 mt-30 57.06 36.82 28.19 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 -177.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 1.056 HG23 ' CD1' ' B' ' 16' ' ' LEU . 0.6 OUTLIER -23.93 -93.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.614 -178.712 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.945 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -135.18 22.92 3.49 Favored 'General case' 0 C--N 1.281 -2.39 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 178.709 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.776 HG12 HG22 ' A' ' 10' ' ' ILE . 31.3 m -21.7 -40.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-O 122.385 1.088 . . . . 0.0 108.697 -177.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.811 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.2 OUTLIER -82.16 -39.04 23.8 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 114.891 -1.049 . . . . 0.0 109.601 177.614 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.945 ' N ' ' O ' ' A' ' 20' ' ' SER . 1.2 mtpt -85.33 -32.76 22.29 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.576 -0.703 . . . . 0.0 111.836 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.82 ' HB3' HG23 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -77.01 -34.95 57.37 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.252 -1.53 . . . . 0.0 108.976 179.715 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.75 HD12 ' N ' ' A' ' 7' ' ' ILE . 2.2 mt -77.74 -43.57 30.49 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 118.551 -1.26 . . . . 0.0 107.863 177.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.555 ' HA ' ' HE2' ' A' ' 3' ' ' LYS . . . -59.3 -34.08 71.88 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 177.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.611 ' O ' HG23 ' A' ' 31' ' ' ILE . 85.6 p -81.75 -26.64 34.33 Favored 'General case' 0 C--O 1.204 -1.294 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.841 ' HE2' HD22 ' B' ' 44' ' ' LEU . 0.3 OUTLIER -64.86 -30.23 71.22 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.67 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.748 ' O ' ' HB ' ' A' ' 33' ' ' THR . 4.5 mt-10 -90.64 -21.55 21.62 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 177.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.785 ' O ' ' CG ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -83.36 -19.06 36.81 Favored 'General case' 0 C--O 1.192 -1.944 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 175.52 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.756 ' CG1' ' HA ' ' A' ' 28' ' ' PHE . 2.1 pp -104.67 -33.34 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.059 -1.025 . . . . 0.0 109.048 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 1.027 HD13 HG11 ' A' ' 42' ' ' VAL . 2.6 mm -64.14 -46.46 93.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 176.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.833 ' HA ' HD13 ' B' ' 85' ' ' LEU 0.324 16.4 m -67.56 -54.26 21.42 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 113.762 -1.563 . . . . 0.0 108.197 178.504 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.785 ' CG ' ' O ' ' A' ' 30' ' ' LYS . 57.2 mm-40 -63.2 -32.43 73.82 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.054 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.832 HG21 ' CG2' ' A' ' 42' ' ' VAL . 1.5 m -58.26 -51.79 68.29 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.026 -1.046 . . . . 0.0 108.417 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.138 HG21 HG22 ' A' ' 77' ' ' VAL . 0.9 OUTLIER -52.39 -41.61 35.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 C-N-CA 117.982 -1.487 . . . . 0.0 107.218 177.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.888 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -72.51 -7.99 52.84 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.463 -0.895 . . . . 0.0 109.343 177.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.521 ' N ' ' O ' ' A' ' 35' ' ' THR . 0.0 OUTLIER -101.52 -23.69 14.26 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.301 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 35' ' ' THR . . . 102.61 41.48 2.33 Favored Glycine 0 C--N 1.301 -1.383 0 C-N-CA 119.967 -1.111 . . . . 0.0 110.648 178.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.791 ' CB ' HG23 ' A' ' 35' ' ' THR . 0.1 OUTLIER -128.86 133.97 48.14 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.011 -1.288 . . . . 0.0 110.809 179.648 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -85.27 91.83 8.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.56 -0.713 . . . . 0.0 109.55 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 1.027 HG11 HD13 ' A' ' 32' ' ' ILE . 82.0 t -67.43 149.63 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-O 121.437 0.637 . . . . 0.0 111.153 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.446 ' O ' ' HA ' ' B' ' 2' ' ' ASN . 4.2 pt20 -158.2 147.62 19.56 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.566 -0.709 . . . . 0.0 109.885 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.808 HD22 ' CE1' ' B' ' 28' ' ' PHE . 35.7 mt -99.47 118.7 36.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.3 -0.875 . . . . 0.0 109.736 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.524 HG21 ' CG ' ' B' ' 29' ' ' GLU . 0.0 OUTLIER 27.36 -95.18 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.953 -0.467 . . . . 0.0 112.235 -179.627 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.501 ' H ' HG23 ' A' ' 45' ' ' THR . . . -129.82 4.45 6.11 Favored Glycine 0 N--CA 1.486 1.976 0 C-N-CA 119.556 -1.307 . . . . 0.0 111.241 -178.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.787 ' CE2' HG21 ' B' ' 32' ' ' ILE . 26.8 p90 -100.24 -64.67 1.02 Allowed 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 119.554 1.677 . . . . 0.0 110.765 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.875 HD22 ' HA2' ' A' ' 82' ' ' GLY . 0.8 OUTLIER -88.17 142.31 27.86 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.241 -1.537 . . . . 0.0 114.673 -178.843 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.661 ' HB2' ' HG2' ' A' ' 81' ' ' PRO . 0.1 OUTLIER -145.25 92.31 2.24 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.567 177.021 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.816 HD13 HG23 ' A' ' 79' ' ' VAL . 46.6 mm -85.71 160.17 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.172 -0.955 . . . . 0.0 110.655 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.413 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 5.0 ptmt -167.32 128.04 1.18 Allowed Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 120.976 -1.077 . . . . 0.0 110.478 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.501 ' HB2' HG11 ' A' ' 75' ' ' VAL . 52.4 Cg_endo -77.62 148.65 26.14 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 O-C-N 123.55 1.289 . . . . 0.0 111.216 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.894 HG22 ' O ' ' A' ' 76' ' ' GLY . 32.9 m -140.59 114.86 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-O 121.717 0.77 . . . . 0.0 111.085 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.703 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.498 1.927 0 CA-C-O 122.0 0.905 . . . . 0.0 111.861 -178.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.703 ' HA ' ' HA ' ' A' ' 54' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.495 1.791 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.894 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -118.51 99.52 0.79 Allowed Glycine 0 N--CA 1.486 2.014 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 1.138 HG22 HG21 ' A' ' 36' ' ' VAL . 1.4 t -58.53 86.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-O 122.09 0.948 . . . . 0.0 108.82 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 76' ' ' GLY . 0.2 OUTLIER -79.58 -152.77 0.07 Allowed 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 121.726 0.774 . . . . 0.0 110.272 -179.129 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.816 HG23 HD13 ' A' ' 50' ' ' ILE . 5.4 p 179.98 178.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.872 ' CB ' ' HD3' ' A' ' 81' ' ' PRO . 16.3 mttt -148.45 -70.19 0.02 OUTLIER Pre-proline 0 C--N 1.302 -1.462 0 C-N-CA 117.856 -1.537 . . . . 0.0 112.464 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.872 ' HD3' ' CB ' ' A' ' 80' ' ' LYS . 57.0 Cg_endo -102.23 -172.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.297 -2.16 0 C-N-CA 121.375 1.383 . . . . 0.0 112.834 -177.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.875 ' HA2' HD22 ' A' ' 48' ' ' LEU . . . 177.31 24.08 0.03 OUTLIER Glycine 0 C--N 1.29 -2.024 0 N-CA-C 107.23 -2.348 . . . . 0.0 107.23 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.898 ' O ' ' N ' ' A' ' 85' ' ' LEU . 44.3 tt0 32.6 48.38 0.12 Allowed 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 -176.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 1.325 ' O ' ' N ' ' A' ' 86' ' ' LYS . 0.2 OUTLIER 13.21 41.21 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.334 0 CA-C-N 114.007 -1.452 . . . . 0.0 109.686 -176.685 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 1.069 ' C ' ' O ' ' A' ' 84' ' ' SER . 4.7 mt 20.23 32.43 0.0 OUTLIER 'General case' 0 C--O 1.198 -1.642 0 N-CA-C 102.236 -3.246 . . . . 0.0 102.236 -173.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 1.325 ' N ' ' O ' ' A' ' 84' ' ' SER 0.349 3.2 tttt -57.77 -41.59 82.32 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 103.288 -2.856 . . . . 0.0 103.288 176.496 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.304 11.8 tttp -70.35 -32.77 70.61 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 111.44 -2.618 . . . . 0.0 105.438 174.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.838 ' HB1' ' HB ' ' B' ' 36' ' ' VAL . . . -77.41 -16.33 58.89 Favored 'General case' 0 C--O 1.2 -1.508 0 CA-C-O 122.201 1.001 . . . . 0.0 109.172 178.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.787 ' CB ' HG12 ' B' ' 75' ' ' VAL . . . -89.96 -24.12 21.36 Favored 'General case' 0 C--N 1.282 -2.337 0 O-C-N 120.443 -1.41 . . . . 0.0 108.787 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -71.85 -34.64 69.43 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.873 ' HA3' ' HB1' ' B' ' 37' ' ' ALA . . . -77.34 -32.44 47.63 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 178.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.889 ' CD1' HG21 ' B' ' 75' ' ' VAL 0.26 2.5 mt -51.33 -7.83 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.104 -1.233 . . . . 0.0 112.021 179.573 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.431 ' H ' ' C ' ' A' ' 91' ' ' GLY . 0.2 OUTLIER 62.56 36.7 13.67 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 -175.313 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.501 ' CD1' ' N ' ' B' ' 75' ' ' VAL . 63.9 t80 -34.18 -45.08 0.2 Allowed 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.697 -178.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 . . . . . 0 N--CA 1.494 1.752 0 O-C-N 121.272 -0.893 . . . . 0.0 109.737 179.857 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.523 ' CE ' HD23 ' B' ' 6' ' ' LEU . 2.1 mtp . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 120.886 0.374 . . . . 0.0 110.113 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 2' ' ' ASN . . . . . 0.446 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 41.7 t30 -177.82 178.06 1.02 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.299 -0.876 . . . . 0.0 110.693 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.515 ' HE3' ' CB ' ' B' ' 29' ' ' GLU . 0.0 OUTLIER -49.45 -19.62 0.57 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.437 -0.789 . . . . 0.0 110.096 179.553 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . 0.554 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 81.4 m -103.64 -41.43 5.95 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.158 -0.964 . . . . 0.0 108.941 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.445 ' CB ' ' HA ' ' B' ' 1' ' ' MET . 0.0 OUTLIER -65.22 -49.93 67.82 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.692 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.903 HD11 HG13 ' A' ' 42' ' ' VAL . 9.4 mt -60.54 -33.48 72.73 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' ILE . . . . . 0.941 HG23 ' HB ' ' B' ' 21' ' ' VAL . 0.6 OUTLIER -53.24 -55.71 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.333 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . 0.953 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.0 OUTLIER -58.15 -31.62 67.41 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.13 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' B' ' 6' ' ' LEU . . . -56.1 -37.16 69.0 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.173 -0.954 . . . . 0.0 109.021 178.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.82 HG23 ' HB3' ' A' ' 24' ' ' MET . 1.5 mp -92.86 -33.38 5.36 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.953 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -67.46 -13.94 62.48 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.488 ' N ' ' O ' ' B' ' 8' ' ' LYS . 3.9 tp-100 -108.47 -43.33 4.34 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.44 -21.74 66.69 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 177.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.934 HG21 ' HB2' ' A' ' 20' ' ' SER . 0.2 OUTLIER -121.96 -80.82 0.63 Allowed 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.97 179.786 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . 0.505 ' O ' ' C ' ' B' ' 16' ' ' LEU . . . 70.43 -18.8 0.71 Allowed Glycine 0 N--CA 1.498 2.778 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' LEU . . . . . 1.056 ' CD1' HG23 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -27.83 -64.65 0.08 Allowed 'General case' 0 N--CA 1.515 2.805 0 CA-C-O 122.078 0.942 . . . . 0.0 111.068 -179.722 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . 0.712 HG21 HG21 ' A' ' 17' ' ' THR . 0.4 OUTLIER -130.11 -0.56 4.65 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.597 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . 0.641 ' O ' ' C ' ' B' ' 19' ' ' VAL . 2.4 mt-30 58.09 29.55 17.99 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 -176.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 1.076 HG23 ' CD1' ' A' ' 16' ' ' LEU . 0.4 OUTLIER 5.33 -99.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.616 -179.221 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 1.002 ' HB3' HD21 ' A' ' 16' ' ' LEU . 1.7 p -136.07 23.17 3.28 Favored 'General case' 0 C--N 1.273 -2.721 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 177.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.941 ' HB ' HG23 ' B' ' 7' ' ' ILE . 35.1 m -5.0 -42.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-O 122.406 1.098 . . . . 0.0 111.037 -177.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.997 ' N ' ' O ' ' B' ' 20' ' ' SER . 14.0 p -76.74 -37.58 55.7 Favored 'General case' 0 C--N 1.28 -2.423 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.741 179.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . 0.868 ' N ' ' O ' ' B' ' 20' ' ' SER . 1.6 mtmt -88.78 -31.07 18.56 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.358 -0.839 . . . . 0.0 111.329 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' MET . . . . . 0.617 ' SD ' ' HA ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -72.09 -36.98 69.66 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.234 -1.541 . . . . 0.0 108.754 179.773 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.716 HD12 HG13 ' B' ' 7' ' ' ILE . 0.3 OUTLIER -80.06 -35.89 36.43 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 118.168 -1.413 . . . . 0.0 108.149 177.742 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . 0.502 ' HB2' ' O ' ' B' ' 22' ' ' SER . . . -66.07 -34.37 77.92 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 176.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' SER . . . . . 0.572 ' O ' ' N ' ' B' ' 31' ' ' ILE . 83.7 p -81.97 -27.38 33.24 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . 0.863 ' O ' HG13 ' B' ' 31' ' ' ILE . 0.5 OUTLIER -59.04 -50.73 72.96 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 178.26 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . 0.614 ' HG3' ' CD1' ' A' ' 47' ' ' PHE . 1.2 tt0 -65.21 -31.49 72.69 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 176.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 1.271 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 9.3 ttmt -69.88 -22.48 63.24 Favored 'General case' 0 C--O 1.186 -2.278 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.865 HD13 ' CB ' ' A' ' 9' ' ' ALA . 0.9 OUTLIER -100.76 -29.37 3.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 O-C-N 119.945 -1.722 . . . . 0.0 108.055 177.824 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.787 HG21 ' CE2' ' A' ' 47' ' ' PHE . 1.4 mm -65.3 -60.93 2.0 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 176.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' THR . . . . . 0.647 ' O ' ' CB ' ' A' ' 88' ' ' ALA . 0.4 OUTLIER -76.56 -27.76 56.0 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 119.279 -0.968 . . . . 0.0 108.95 179.587 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 1.271 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 79.1 mm-40 -80.19 -27.37 38.9 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.101 -1.624 . . . . 0.0 110.204 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' THR . . . . . 0.645 HG23 ' HB2' ' B' ' 40' ' ' ASP . 3.7 m -72.15 -48.76 41.14 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.656 -1.277 . . . . 0.0 108.575 178.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.852 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 4.5 t -51.1 -48.54 30.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 C-N-CA 116.867 -1.933 . . . . 0.0 106.047 177.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . 0.873 ' HB1' ' HA3' ' A' ' 91' ' ' GLY . . . -70.24 5.96 1.5 Allowed 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 121.58 0.705 . . . . 0.0 111.044 177.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.492 ' HB2' ' O ' ' B' ' 34' ' ' GLU . 0.0 OUTLIER -108.57 -35.1 6.54 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 177.438 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . 0.418 ' HA2' HD21 ' A' ' 92' ' ' LEU . . . 121.17 32.24 1.08 Allowed Glycine 0 C--N 1.302 -1.326 0 C-N-CA 119.727 -1.225 . . . . 0.0 111.487 177.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . 0.645 ' HB2' HG23 ' B' ' 35' ' ' THR . 0.3 OUTLIER -125.26 146.63 49.45 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.798 -1.413 . . . . 0.0 110.371 179.123 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 2.8 mtmm -88.6 91.6 8.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.512 -0.743 . . . . 0.0 110.179 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.516 HG13 HD11 ' A' ' 6' ' ' LEU . 78.2 t -64.35 153.3 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.564 -0.71 . . . . 0.0 110.367 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' GLN . . . . . 0.782 ' O ' HD23 ' B' ' 44' ' ' LEU . 0.2 OUTLIER -165.83 164.14 18.69 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.44 -0.787 . . . . 0.0 110.043 179.821 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.841 HD22 ' HE2' ' A' ' 28' ' ' PHE . 15.4 mt -125.46 117.92 24.7 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.394 -0.816 . . . . 0.0 109.718 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . 0.536 HG21 ' HB3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 30.34 -93.28 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.875 -0.516 . . . . 0.0 111.124 -179.812 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . 0.549 ' O ' ' HA3' ' B' ' 82' ' ' GLY . . . -144.54 24.34 2.0 Favored Glycine 0 N--CA 1.483 1.775 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . 0.715 ' CE1' HD12 ' B' ' 44' ' ' LEU . 8.8 p90 -120.7 -22.09 6.45 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.111 -1.229 . . . . 0.0 111.4 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.551 ' HB2' ' HB2' ' B' ' 44' ' ' LEU . 0.9 OUTLIER -128.22 115.45 18.37 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.388 -1.445 . . . . 0.0 110.624 177.828 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' ASN . . . . . 0.632 ' O ' ' HA ' ' B' ' 79' ' ' VAL . 1.2 m120 -113.78 94.75 4.98 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.717 -0.614 . . . . 0.0 111.408 -178.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' ILE . . . . . 0.508 ' CD1' HG23 ' B' ' 79' ' ' VAL . 1.3 mp -93.45 141.48 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 O-C-N 121.246 -0.909 . . . . 0.0 109.839 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . 0.426 ' HG3' ' CB ' ' B' ' 78' ' ' SER . 0.0 OUTLIER -161.29 113.42 1.26 Allowed Pre-proline 0 N--CA 1.5 2.025 0 C-N-CA 118.769 -1.172 . . . . 0.0 111.318 179.723 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' PRO . . . . . 0.688 ' HB3' HG13 ' B' ' 36' ' ' VAL . 55.7 Cg_endo -83.06 141.91 10.7 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 O-C-N 123.571 1.301 . . . . 0.0 111.724 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.618 ' O ' ' N ' ' B' ' 76' ' ' GLY . 33.4 m -149.24 114.73 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.581 0.705 . . . . 0.0 110.718 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . 0.655 ' HA ' ' HA ' ' B' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.501 2.09 0 O-C-N 121.448 -0.783 . . . . 0.0 111.46 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . 0.889 HG21 ' CD1' ' A' ' 92' ' ' LEU . 1.4 p . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 76' ' ' GLY . . . . . 0.626 ' O ' ' N ' ' B' ' 78' ' ' SER . . . -113.14 50.22 0.79 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.856 -1.698 . . . . 0.0 108.856 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.736 HG23 HD12 ' A' ' 85' ' ' LEU . 7.1 p -45.69 81.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-O 121.695 0.76 . . . . 0.0 111.534 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 78' ' ' SER . . . . . 0.626 ' N ' ' O ' ' B' ' 76' ' ' GLY . 0.6 OUTLIER -77.48 178.81 6.92 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 119.28 -0.968 . . . . 0.0 108.737 178.408 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.632 ' HA ' ' O ' ' B' ' 49' ' ' ASN . 0.2 OUTLIER 179.48 172.8 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.517 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 80' ' ' LYS . . . . . 0.521 ' N ' ' CG2' ' B' ' 79' ' ' VAL . 0.2 OUTLIER 176.46 172.56 0.33 Allowed Pre-proline 0 N--CA 1.487 1.417 0 O-C-N 121.149 -0.97 . . . . 0.0 110.892 178.404 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 81' ' ' PRO . . . . . 0.707 ' HA ' ' O ' ' B' ' 47' ' ' PHE . 54.6 Cg_endo -88.95 165.78 5.83 Favored 'Trans proline' 0 C--N 1.298 -2.079 0 O-C-N 124.617 1.851 . . . . 0.0 107.475 174.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . 0.549 ' HA3' ' O ' ' B' ' 46' ' ' GLY . . . -126.79 -99.33 1.08 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 107.711 -2.156 . . . . 0.0 107.711 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . 0.911 ' O ' ' N ' ' B' ' 85' ' ' LEU . 0.4 OUTLIER -79.43 45.24 0.65 Allowed 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.121 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 84' ' ' SER . . . . . 1.334 ' O ' ' N ' ' B' ' 86' ' ' LYS . 0.1 OUTLIER 8.45 43.16 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 122.148 0.975 . . . . 0.0 111.164 179.165 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 1.004 ' C ' ' O ' ' B' ' 84' ' ' SER . 0.4 OUTLIER 20.55 30.05 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 102.786 -3.042 . . . . 0.0 102.786 -172.647 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 86' ' ' LYS . . . . . 1.334 ' N ' ' O ' ' B' ' 84' ' ' SER 0.336 7.7 tttt -56.38 -37.17 69.73 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 103.82 -2.659 . . . . 0.0 103.82 177.08 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . 0.29 0.0 OUTLIER -70.59 -34.79 72.56 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 111.905 -2.407 . . . . 0.0 105.796 175.377 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.648 ' HB3' ' CB ' ' B' ' 85' ' ' LEU . . . -75.3 -27.77 59.45 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 118.586 -1.246 . . . . 0.0 107.859 178.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.905 ' HA ' HD23 ' B' ' 92' ' ' LEU . . . -62.42 -48.33 80.16 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -57.24 -28.98 63.41 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 176.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -69.68 -33.94 72.07 Favored Glycine 0 N--CA 1.489 2.184 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.189 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 92' ' ' LEU . . . . . 0.905 HD23 ' HA ' ' B' ' 89' ' ' ALA . 0.7 OUTLIER -85.75 16.95 3.62 Favored 'General case' 0 N--CA 1.506 2.335 0 CA-C-N 119.689 1.745 . . . . 0.0 111.556 -179.155 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 93' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' B' ' 92' ' ' LEU . 8.7 mmtp 54.92 40.22 31.9 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -178.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . 0.501 ' HA ' HD11 ' B' ' 92' ' ' LEU . 2.6 p90 -41.77 -30.7 0.26 Allowed 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.651 -178.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -58.22 -42.51 86.44 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.246 -0.909 . . . . 0.0 108.871 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.72 -33.68 76.19 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 177.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.488 1.428 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.503 ' HG2' ' HB3' ' A' ' 5' ' ' GLU . 4.0 mtp . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 120.932 0.396 . . . . 0.0 110.134 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.83 ' C ' HD12 ' A' ' 6' ' ' LEU . 4.0 t30 -176.08 -174.79 0.66 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.18 -0.95 . . . . 0.0 111.052 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.542 ' O ' ' CG2' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -51.84 -15.3 0.48 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.453 -0.779 . . . . 0.0 110.275 179.619 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.652 ' O ' HG13 ' A' ' 7' ' ' ILE . 38.7 m -106.89 -58.48 1.93 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 122.004 0.907 . . . . 0.0 109.161 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.503 ' HB3' ' HG2' ' A' ' 1' ' ' MET . 2.6 mt-10 -50.46 -45.05 55.81 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.056 -1.028 . . . . 0.0 108.571 179.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.83 HD12 ' C ' ' A' ' 2' ' ' ASN . 2.4 mt -58.26 -36.31 73.06 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.364 -0.934 . . . . 0.0 109.954 178.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.652 HG13 ' O ' ' A' ' 4' ' ' THR . 0.9 OUTLIER -55.8 -42.81 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.295 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.869 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -64.64 -33.76 76.69 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 177.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.672 ' HB3' ' O ' ' A' ' 6' ' ' LEU . . . -56.23 -38.11 70.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.473 -0.767 . . . . 0.0 109.019 178.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.722 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.4 mp -91.52 -32.41 5.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 178.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.869 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -65.3 -14.11 60.0 Favored 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 118.689 -1.205 . . . . 0.0 108.227 178.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.402 ' N ' ' O ' ' A' ' 8' ' ' LYS . 6.4 tp-100 -110.75 -46.07 3.41 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.441 ' OD2' HG23 ' B' ' 31' ' ' ILE . 1.6 m-20 -66.63 -27.78 67.96 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 177.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.794 ' CG2' ' HB2' ' B' ' 20' ' ' SER . 0.2 OUTLIER -111.55 -82.26 0.58 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 178.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.516 ' O ' ' C ' ' A' ' 16' ' ' LEU . . . 69.0 -21.35 0.37 Allowed Glycine 0 N--CA 1.498 2.831 0 O-C-N 121.004 -1.06 . . . . 0.0 110.825 178.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 1.113 ' CD1' HG23 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -30.2 -63.77 0.13 Allowed 'General case' 0 N--CA 1.518 2.925 0 CA-C-O 122.052 0.929 . . . . 0.0 110.497 -179.57 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.683 HG22 ' H ' ' A' ' 19' ' ' VAL . 0.5 OUTLIER -129.31 -4.89 4.87 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.774 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.626 ' O ' ' C ' ' A' ' 19' ' ' VAL . 22.1 mt-30 56.41 31.78 19.41 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -177.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 1.024 HG11 HG11 ' B' ' 19' ' ' VAL . 1.6 p -6.46 -98.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.538 -178.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.92 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -133.48 23.28 4.03 Favored 'General case' 0 C--N 1.279 -2.493 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 177.15 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.625 HG12 HG22 ' A' ' 10' ' ' ILE . 30.4 m -20.6 -37.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-O 122.254 1.026 . . . . 0.0 109.858 -178.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.825 ' N ' ' O ' ' A' ' 20' ' ' SER . 11.2 t -75.46 -42.76 52.41 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.931 177.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.92 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -93.8 -22.91 18.38 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.52 -0.738 . . . . 0.0 109.888 178.739 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.79 ' N ' ' OG ' ' A' ' 20' ' ' SER 0.26 2.0 tmm? -68.02 -33.01 73.79 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 179.201 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.597 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 7.3 mt -84.41 -41.55 16.56 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 176.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.539 ' HB3' ' HA ' ' A' ' 23' ' ' LYS . . . -59.19 -34.1 71.74 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 177.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.487 ' O ' HG13 ' A' ' 31' ' ' ILE . 10.2 t -80.17 -36.32 35.23 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 178.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.645 ' CE1' HD22 ' B' ' 44' ' ' LEU . 0.2 OUTLIER -52.1 -44.87 64.63 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.694 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.662 ' HG3' ' CD2' ' B' ' 47' ' ' PHE . 0.9 OUTLIER -69.53 -36.72 76.66 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.247 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 1.129 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 16.5 ttpt -62.53 -23.82 67.17 Favored 'General case' 0 C--O 1.191 -1.981 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.734 HD12 HD23 ' B' ' 6' ' ' LEU . 0.5 OUTLIER -104.15 -27.96 3.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 O-C-N 120.499 -1.376 . . . . 0.0 109.379 178.225 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.623 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.3 mm -73.81 -57.55 6.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 177.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.565 ' HB ' ' O ' ' A' ' 29' ' ' GLU . 0.6 OUTLIER -68.35 -36.33 79.08 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.568 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 1.129 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 68.2 mm-40 -75.55 -37.79 59.75 Favored 'General case' 0 N--CA 1.483 1.185 0 O-C-N 121.17 -0.956 . . . . 0.0 111.702 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.584 HG23 ' HB2' ' A' ' 40' ' ' ASP . 14.0 m -62.18 -53.97 47.63 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 120.281 -1.512 . . . . 0.0 109.499 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.817 HG22 ' HD3' ' A' ' 52' ' ' PRO . 2.1 t -54.76 -32.89 26.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 177.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.843 ' HB1' ' O ' ' B' ' 88' ' ' ALA . . . -90.38 10.5 24.79 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.333 177.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.675 ' HB2' ' O ' ' A' ' 34' ' ' GLU . 1.9 ttmt -114.23 -35.35 5.03 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 178.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 127.95 38.58 0.38 Allowed Glycine 0 C--N 1.301 -1.404 0 C-N-CA 119.732 -1.223 . . . . 0.0 110.835 178.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.584 ' HB2' HG23 ' A' ' 35' ' ' THR . 0.3 OUTLIER -145.92 135.8 23.49 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.083 -1.245 . . . . 0.0 110.281 179.431 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.02 76.49 2.21 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.391 -0.818 . . . . 0.0 110.459 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.884 HG23 HD11 ' B' ' 6' ' ' LEU . 11.0 p -60.56 136.46 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.412 -0.805 . . . . 0.0 110.056 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' B' ' 1' ' ' MET . 6.9 pt20 -144.75 175.15 10.39 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.239 -0.913 . . . . 0.0 110.737 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 1.03 HD12 ' CB ' ' A' ' 48' ' ' LEU . 27.6 mt -125.26 115.01 19.7 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.665 -0.647 . . . . 0.0 109.276 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.537 HG21 ' HG3' ' B' ' 29' ' ' GLU . 0.0 OUTLIER 32.26 -93.88 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.859 -0.526 . . . . 0.0 111.552 -179.767 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.432 ' H ' HG23 ' A' ' 45' ' ' THR . . . -145.05 21.87 1.94 Allowed Glycine 0 N--CA 1.489 2.188 0 C-N-CA 119.504 -1.331 . . . . 0.0 111.013 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.684 ' CD2' ' HG3' ' B' ' 29' ' ' GLU . 8.5 p90 -119.76 -22.15 6.96 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.768 -1.431 . . . . 0.0 111.216 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.03 ' CB ' HD12 ' A' ' 44' ' ' LEU . 6.8 mt -128.72 108.47 10.51 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.453 -1.404 . . . . 0.0 110.653 178.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.607 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 1.1 t-20 -109.68 91.13 3.52 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.673 -0.642 . . . . 0.0 111.095 -179.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.762 HG22 HG21 ' A' ' 36' ' ' VAL . 11.1 mm -93.52 138.11 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.29 -0.881 . . . . 0.0 110.138 179.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 21.0 ptmt -160.93 128.39 2.7 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 120.804 -1.185 . . . . 0.0 111.295 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.817 ' HD3' HG22 ' A' ' 36' ' ' VAL . 55.7 Cg_endo -78.69 141.91 17.66 Favored 'Trans proline' 0 C--N 1.314 -1.274 0 O-C-N 123.513 1.27 . . . . 0.0 110.631 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.753 HG22 ' O ' ' A' ' 76' ' ' GLY . 34.5 m -145.66 113.04 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 C-N-CA 119.465 -0.894 . . . . 0.0 111.928 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.922 ' HB1' ' HB3' ' B' ' 96' ' ' ASP . . . . . . . . 0 N--CA 1.495 1.798 0 C-N-CA 119.259 -0.976 . . . . 0.0 109.379 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.997 ' HB ' ' CD2' ' B' ' 94' ' ' TYR . 1.1 t . . . . . 0 N--CA 1.515 2.796 0 CA-C-O 122.236 1.017 . . . . 0.0 108.761 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.753 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -138.28 99.22 0.27 Allowed Glycine 0 C--N 1.289 -2.068 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -178.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.701 ' CG2' HD13 ' B' ' 85' ' ' LEU . 1.5 p -59.93 82.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.838 -0.801 . . . . 0.0 109.368 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.632 ' C ' HG12 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -62.67 177.1 0.57 Allowed 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.554 -0.858 . . . . 0.0 110.535 -179.462 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.632 HG12 ' C ' ' A' ' 78' ' ' SER . 0.2 OUTLIER 177.42 174.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.761 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.86 ' O ' HD23 ' A' ' 48' ' ' LEU . 0.5 OUTLIER 177.71 170.26 0.45 Allowed Pre-proline 0 N--CA 1.485 1.323 0 O-C-N 120.822 -1.174 . . . . 0.0 110.997 177.227 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.502 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 56.1 Cg_endo -103.83 136.06 0.1 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 123.359 2.706 . . . . 0.0 109.223 176.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.558 ' HA3' ' HA ' ' A' ' 47' ' ' PHE . . . -97.46 161.25 21.33 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 108.295 -1.922 . . . . 0.0 108.295 178.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.451 ' HA ' ' HB2' ' A' ' 86' ' ' LYS . 0.5 OUTLIER -57.71 -23.95 54.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.015 -1.285 . . . . 0.0 110.584 -179.429 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.5 t -51.82 -31.18 26.39 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.117 -0.989 . . . . 0.0 108.654 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.89 HD13 ' CG1' ' B' ' 77' ' ' VAL . 0.5 OUTLIER -82.96 -31.22 27.72 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.597 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.718 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 5.0 mttt -81.27 -31.8 33.53 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.581 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.421 ' O ' ' HG3' ' A' ' 90' ' ' GLU . 1.1 tmtt? -69.63 -40.2 76.68 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 178.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.759 ' O ' ' HB1' ' B' ' 37' ' ' ALA . . . -62.0 -38.4 88.49 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 176.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.79 ' HA ' HD23 ' A' ' 92' ' ' LEU . . . -53.57 -43.04 68.17 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 120.0 -0.68 . . . . 0.0 109.5 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.502 ' HG3' ' N ' ' A' ' 91' ' ' GLY . 0.3 OUTLIER -54.16 -30.96 51.25 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 177.517 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.502 ' N ' ' HG3' ' A' ' 90' ' ' GLU . . . -64.1 -43.3 97.44 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 178.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.923 HD21 HG21 ' B' ' 75' ' ' VAL . 0.4 OUTLIER -71.59 8.91 0.96 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.745 -1.444 . . . . 0.0 110.831 179.804 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 17.2 mmtm 65.69 50.34 1.61 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 -177.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.584 ' CD1' ' N ' ' B' ' 75' ' ' VAL . 0.0 OUTLIER -34.64 -38.57 0.08 Allowed 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.063 -179.005 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.446 ' HG2' ' CE2' ' A' ' 94' ' ' TYR . 24.8 mt-10 . . . . . 0 N--CA 1.495 1.777 0 O-C-N 121.333 -0.855 . . . . 0.0 109.828 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.462 ' HA ' ' CB ' ' B' ' 5' ' ' GLU . 5.3 mtp . . . . . 0 N--CA 1.493 1.687 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 2' ' ' ASN . . . . . 0.434 ' N ' HD12 ' B' ' 6' ' ' LEU . 22.6 p30 -176.73 -172.7 0.45 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.249 -0.907 . . . . 0.0 111.099 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.496 ' O ' HG13 ' B' ' 7' ' ' ILE . 0.0 OUTLIER -51.5 -11.15 0.12 Allowed 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.381 -0.825 . . . . 0.0 111.244 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . 0.629 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 45.7 m -114.48 -43.28 3.19 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.812 -1.18 . . . . 0.0 108.995 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.501 ' HA ' ' HE2' ' B' ' 8' ' ' LYS . 0.0 OUTLIER -64.19 -50.41 68.22 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.708 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.884 HD11 HG23 ' A' ' 42' ' ' VAL . 0.7 OUTLIER -62.08 -28.93 69.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.375 -0.828 . . . . 0.0 108.898 178.176 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' ILE . . . . . 1.006 HG13 HD12 ' B' ' 25' ' ' LEU . 0.5 OUTLIER -55.52 -59.32 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.144 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . 0.895 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.1 OUTLIER -57.86 -30.3 65.7 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.375 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . 0.675 ' HB3' ' O ' ' B' ' 6' ' ' LEU . . . -58.98 -36.57 75.1 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.466 -0.894 . . . . 0.0 108.97 178.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.914 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.1 mp -89.03 -35.16 7.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 177.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.895 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -65.57 -9.46 26.78 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 118.839 -1.144 . . . . 0.0 108.42 177.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.491 ' HB3' ' O ' ' B' ' 8' ' ' LYS . 0.4 OUTLIER -118.46 -43.15 2.72 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.547 -0.721 . . . . 0.0 109.448 178.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.442 ' HB3' ' OG ' ' A' ' 27' ' ' SER . 1.7 m-20 -66.1 -38.32 87.93 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 177.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 1.057 HG22 ' CD1' ' B' ' 16' ' ' LEU 0.251 0.1 OUTLIER -89.13 -77.95 0.36 Allowed 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 177.549 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.84 6.52 78.49 Favored Glycine 0 N--CA 1.5 2.936 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 177.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' LEU . . . . . 1.057 ' CD1' HG22 ' B' ' 14' ' ' THR . 5.2 mp -55.48 -71.4 0.09 Allowed 'General case' 0 C--N 1.294 -1.817 0 O-C-N 121.63 -0.924 . . . . 0.0 110.569 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . 0.683 ' CG2' HG21 ' A' ' 17' ' ' THR . 0.5 OUTLIER -139.57 8.37 2.39 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.581 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . 0.613 ' O ' ' C ' ' B' ' 19' ' ' VAL . 11.2 mt-30 58.69 23.86 11.53 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 -175.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 1.113 HG23 ' CD1' ' A' ' 16' ' ' LEU . 0.2 OUTLIER 5.49 -94.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.125 -179.194 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 0.978 ' O ' ' N ' ' B' ' 23' ' ' LYS . 0.4 OUTLIER -135.72 23.19 3.37 Favored 'General case' 0 C--N 1.275 -2.654 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 178.153 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.977 ' HB ' HG23 ' B' ' 7' ' ' ILE . 18.3 m -15.0 -40.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-O 122.245 1.022 . . . . 0.0 109.885 -177.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.914 ' N ' ' O ' ' B' ' 20' ' ' SER . 7.7 t -74.93 -42.21 58.16 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.173 177.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . 0.978 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.2 OUTLIER -92.89 -25.9 17.86 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.661 -0.649 . . . . 0.0 109.827 178.599 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' MET . . . . . 0.583 ' HE2' ' HA ' ' B' ' 21' ' ' VAL . 2.2 tmm? -64.12 -41.06 97.39 Favored 'General case' 0 C--N 1.316 -0.85 0 O-C-N 120.779 -1.201 . . . . 0.0 108.321 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 1.006 HD12 HG13 ' B' ' 7' ' ' ILE . 2.5 mt -81.28 -42.63 20.34 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 118.952 -1.099 . . . . 0.0 108.547 177.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . 0.553 ' HB3' ' HA ' ' B' ' 23' ' ' LYS . . . -58.01 -34.02 69.58 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' SER . . . . . 0.566 ' O ' HG13 ' B' ' 31' ' ' ILE . 73.8 m -82.02 -37.12 27.0 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 177.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . 0.954 ' CE1' HD22 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -52.81 -48.3 67.03 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.318 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . 0.684 ' HG3' ' CD2' ' A' ' 47' ' ' PHE . 1.7 tt0 -67.16 -34.93 78.59 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 1.241 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 13.8 ttpt -65.41 -20.84 66.55 Favored 'General case' 0 C--O 1.193 -1.92 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.662 HD11 ' HA ' ' B' ' 28' ' ' PHE . 0.7 OUTLIER -106.47 -25.33 3.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 O-C-N 120.057 -1.652 . . . . 0.0 108.968 177.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.634 HD11 ' CE2' ' B' ' 28' ' ' PHE . 1.2 mm -76.53 -58.96 3.61 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 176.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' THR . . . . . 0.492 ' OG1' ' HG ' ' A' ' 85' ' ' LEU . 0.6 OUTLIER -70.35 -34.19 72.35 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.257 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 1.241 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 77.9 mm-40 -78.83 -37.29 40.91 Favored 'General case' 0 C--O 1.208 -1.093 0 O-C-N 121.126 -0.984 . . . . 0.0 111.614 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' THR . . . . . 0.512 ' CB ' ' O ' ' B' ' 31' ' ' ILE . 26.1 m -61.55 -47.15 86.86 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 120.073 -1.642 . . . . 0.0 108.459 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.917 HG22 ' HD3' ' B' ' 52' ' ' PRO . 1.7 t -52.66 -44.46 46.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 177.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . 0.759 ' HB1' ' O ' ' A' ' 88' ' ' ALA . . . -84.85 -1.28 56.29 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.815 178.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.661 ' HB2' ' O ' ' B' ' 34' ' ' GLU . 3.0 ttmt -94.16 -29.84 14.93 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 177.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.1 31.88 0.56 Allowed Glycine 0 C--N 1.303 -1.254 0 C-N-CA 119.665 -1.255 . . . . 0.0 111.395 177.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . 0.464 ' CB ' ' CG2' ' B' ' 35' ' ' THR . 0.2 OUTLIER -146.84 146.38 30.19 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.758 -1.436 . . . . 0.0 110.934 179.453 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.39 96.75 9.72 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.609 0.719 . . . . 0.0 109.341 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.554 HG13 HD11 ' A' ' 6' ' ' LEU . 74.5 t -58.35 129.95 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.567 -0.708 . . . . 0.0 110.124 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' GLN . . . . . 0.431 ' HA ' ' HA ' ' B' ' 49' ' ' ASN . 0.0 OUTLIER -123.69 109.05 13.23 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.517 -0.74 . . . . 0.0 109.955 -179.726 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.894 HD12 ' HB3' ' B' ' 48' ' ' LEU . 23.4 mt -77.06 106.32 8.69 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.214 -0.929 . . . . 0.0 109.93 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . 0.609 HG21 ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 32.42 -93.25 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.246 0 O-C-N 122.018 -0.426 . . . . 0.0 111.425 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -148.28 29.39 1.35 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . 0.733 ' HD1' HD12 ' B' ' 85' ' ' LEU . 3.2 p90 -130.18 -24.66 2.57 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.075 -1.25 . . . . 0.0 111.152 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.894 ' HB3' HD12 ' B' ' 44' ' ' LEU . 6.5 mt -134.49 94.09 3.15 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.727 -1.233 . . . . 0.0 110.196 178.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' ASN . . . . . 0.431 ' HA ' ' HA ' ' B' ' 43' ' ' GLN . 21.5 t-20 -98.03 72.43 2.19 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.386 -0.821 . . . . 0.0 111.365 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' ILE . . . . . 0.842 HD13 ' HB ' ' B' ' 79' ' ' VAL . 2.8 mm -61.06 125.28 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.146 -0.971 . . . . 0.0 108.752 178.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . 0.415 ' HG3' ' CB ' ' B' ' 78' ' ' SER . 2.2 ptmt -145.5 113.68 4.74 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 120.821 -1.175 . . . . 0.0 110.489 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' PRO . . . . . 0.917 ' HD3' HG22 ' B' ' 36' ' ' VAL . 55.8 Cg_endo -79.87 138.37 13.14 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.742 1.39 . . . . 0.0 110.759 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.87 ' O ' HG22 ' B' ' 75' ' ' VAL . 17.0 m -122.08 -156.75 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . 0.5 ' HA ' ' HA ' ' B' ' 75' ' ' VAL . . . . . . . . 0 C--N 1.293 -1.857 0 O-C-N 121.01 -1.056 . . . . 0.0 111.964 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . 0.923 HG21 HD21 ' A' ' 92' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.779 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 76' ' ' GLY . . . . . 0.675 ' CA ' HG22 ' B' ' 53' ' ' VAL . . . -117.59 90.25 0.5 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.89 ' CG1' HD13 ' A' ' 85' ' ' LEU . 65.2 t -66.35 78.79 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 O-C-N 121.628 -0.925 . . . . 0.0 110.027 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 78' ' ' SER . . . . . 0.472 ' O ' ' HB ' ' B' ' 79' ' ' VAL . 0.4 OUTLIER -75.73 174.37 9.9 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 118.75 -1.18 . . . . 0.0 110.368 -179.831 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.842 ' HB ' HD13 ' B' ' 50' ' ' ILE . 7.2 p 175.09 177.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 80' ' ' LYS . . . . . 0.652 ' O ' HD23 ' B' ' 48' ' ' LEU . 0.3 OUTLIER -177.5 172.5 0.77 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 120.743 -1.223 . . . . 0.0 110.933 177.207 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 81' ' ' PRO . . . . . 0.419 ' HD2' ' HB2' ' B' ' 80' ' ' LYS . 56.7 Cg_endo -96.44 100.33 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.559 2.173 . . . . 0.0 110.352 178.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' B' ' 46' ' ' GLY . . . -61.81 172.93 7.95 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 108.623 -1.791 . . . . 0.0 108.623 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -68.1 -26.45 65.82 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.978 -1.307 . . . . 0.0 110.558 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -50.14 -33.83 20.26 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.21 -0.931 . . . . 0.0 108.658 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.765 HD22 HG11 ' A' ' 36' ' ' VAL . 0.5 OUTLIER -82.57 -31.78 28.83 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 178.522 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 86' ' ' LYS . . . . . 0.754 ' O ' ' HB3' ' B' ' 89' ' ' ALA . 1.2 tttt -76.15 -39.24 55.43 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.586 -0.696 . . . . 0.0 109.695 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 31.7 tttt -65.61 -39.95 92.08 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 178.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.843 ' O ' ' HB1' ' A' ' 37' ' ' ALA . . . -64.06 -35.45 80.79 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 176.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.782 ' HA ' HD23 ' B' ' 92' ' ' LEU . . . -53.65 -41.87 67.22 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . 0.478 ' HA ' ' HB2' ' B' ' 94' ' ' TYR . 0.9 OUTLIER -55.19 -33.39 62.99 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 176.868 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' B' ' 88' ' ' ALA . . . -70.06 -25.51 75.51 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 178.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 92' ' ' LEU . . . . . 0.89 ' O ' HD12 ' B' ' 92' ' ' LEU . 0.4 OUTLIER -73.76 20.18 0.1 Allowed 'General case' 0 N--CA 1.502 2.157 0 O-C-N 120.671 -1.488 . . . . 0.0 110.6 179.788 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 93' ' ' LYS . . . . . 0.731 ' O ' ' C ' ' B' ' 94' ' ' TYR . 0.0 OUTLIER 72.0 29.93 2.29 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 -177.437 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . 0.997 ' CD2' ' HB ' ' A' ' 75' ' ' VAL . 15.0 t80 -22.2 -66.5 0.03 OUTLIER 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . 0.747 ' O ' ' N ' ' B' ' 97' ' ' PHE . 8.2 mt-10 4.85 36.47 0.0 OUTLIER 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 101.563 -3.495 . . . . 0.0 101.563 177.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 96' ' ' ASP . . . . . 0.973 ' O ' ' C ' ' B' ' 97' ' ' PHE . 0.0 OUTLIER 17.87 40.61 0.0 OUTLIER 'General case' 0 CA--C 1.476 -1.881 0 CA-C-N 112.689 -2.051 . . . . 0.0 107.531 -173.741 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 97' ' ' PHE . . . . . 0.973 ' C ' ' O ' ' B' ' 96' ' ' ASP . 42.2 p90 . . . . . 0 CA--C 1.504 -0.793 1 N-CA-C 99.96 -4.089 . . . . 0.0 99.96 -167.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.708 ' HE1' HD13 ' B' ' 31' ' ' ILE . 6.5 mtp . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 120.89 0.376 . . . . 0.0 110.109 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.872 ' C ' HD12 ' A' ' 6' ' ' LEU . 26.5 p30 -177.85 -173.02 0.37 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.219 -0.926 . . . . 0.0 110.995 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.575 ' HE2' ' HA ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -48.57 -15.36 0.08 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.533 -0.729 . . . . 0.0 110.923 -179.724 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.646 ' O ' HG13 ' A' ' 7' ' ' ILE . 60.7 m -107.07 -60.47 1.67 Allowed 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 122.059 0.933 . . . . 0.0 109.461 179.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.546 ' HB3' ' HG2' ' A' ' 1' ' ' MET . 8.9 mt-10 -50.57 -44.21 56.67 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.014 -1.054 . . . . 0.0 108.469 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.872 HD12 ' C ' ' A' ' 2' ' ' ASN . 4.7 mt -56.64 -34.37 67.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.365 -0.834 . . . . 0.0 109.955 178.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.646 HG13 ' O ' ' A' ' 4' ' ' THR . 0.9 OUTLIER -60.12 -41.52 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 179.301 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.789 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -70.63 -29.92 66.43 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 177.571 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 6' ' ' LEU . . . -61.48 -37.52 83.95 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.517 -0.74 . . . . 0.0 109.159 178.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.686 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.1 mp -93.64 -30.04 4.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 178.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.789 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -62.69 -13.88 37.43 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 118.473 -1.291 . . . . 0.0 108.335 178.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -116.21 -46.56 2.79 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 121.631 -0.668 . . . . 0.0 109.865 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.17 -29.97 71.05 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 177.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 1.06 HG22 ' CD1' ' A' ' 16' ' ' LEU 0.271 0.2 OUTLIER -105.09 -74.43 0.65 Allowed 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 179.016 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 57.48 11.51 7.41 Favored Glycine 0 N--CA 1.497 2.747 0 O-C-N 121.402 -0.811 . . . . 0.0 111.811 177.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 1.06 ' CD1' HG22 ' A' ' 14' ' ' THR . 2.4 mp -54.37 -62.3 1.74 Allowed 'General case' 0 N--CA 1.505 2.296 0 O-C-N 121.011 -1.288 . . . . 0.0 109.334 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.559 HG21 ' CG2' ' B' ' 17' ' ' THR . 0.6 OUTLIER -135.89 4.61 3.03 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.384 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.597 ' O ' ' C ' ' A' ' 19' ' ' VAL . 24.5 mt-30 56.97 28.89 15.43 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 -176.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 1.084 HG11 HG11 ' B' ' 19' ' ' VAL . 1.5 p -10.7 -97.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.979 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.921 ' O ' ' N ' ' A' ' 22' ' ' SER . 0.3 OUTLIER -133.55 24.76 4.07 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 177.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.65 ' HA ' ' SD ' ' A' ' 24' ' ' MET . 32.5 m -16.01 -38.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 CA-C-O 122.551 1.167 . . . . 0.0 110.117 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.921 ' N ' ' O ' ' A' ' 20' ' ' SER . 98.0 p -79.22 -38.08 36.56 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.392 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.914 ' N ' ' O ' ' A' ' 20' ' ' SER . 14.1 ttpt -92.08 -25.24 18.85 Favored 'General case' 0 C--N 1.308 -1.225 0 O-C-N 121.226 -0.921 . . . . 0.0 110.897 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.65 ' SD ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -74.91 -35.67 62.2 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 117.399 -1.72 . . . . 0.0 107.418 178.541 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.663 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 8.2 mt -77.48 -37.87 50.4 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 118.68 -1.208 . . . . 0.0 108.494 177.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.575 ' HA ' ' HE2' ' A' ' 3' ' ' LYS . . . -64.48 -35.53 81.23 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 177.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.523 ' O ' HG13 ' A' ' 31' ' ' ILE . 82.7 p -80.93 -28.82 35.62 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.69 ' CE2' HD11 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -54.78 -41.41 70.51 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.686 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.653 ' HG3' ' CD1' ' B' ' 47' ' ' PHE . 0.7 OUTLIER -72.39 -36.44 68.69 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 176.201 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 1.12 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 22.9 ttpt -60.71 -23.59 65.01 Favored 'General case' 0 C--O 1.191 -2.02 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.647 HD11 ' HA ' ' A' ' 28' ' ' PHE . 0.7 OUTLIER -104.17 -27.23 3.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 120.682 -1.261 . . . . 0.0 109.404 178.127 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.69 HD11 ' CE2' ' A' ' 28' ' ' PHE . 1.2 mm -70.89 -58.5 5.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 177.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.819 ' OG1' HD12 ' B' ' 85' ' ' LEU . 0.5 OUTLIER -67.71 -42.84 81.36 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.342 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 1.12 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 34.0 mm-40 -69.09 -34.62 75.38 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.24 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.9 HG23 ' CB ' ' A' ' 40' ' ' ASP . 1.2 m -57.88 -50.35 73.62 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.44 -1.413 . . . . 0.0 107.812 178.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.684 HG11 ' HB2' ' B' ' 85' ' ' LEU . 2.1 t -53.1 -40.52 38.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 C-N-CA 118.607 -1.237 . . . . 0.0 107.853 178.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.801 ' HB2' ' HB1' ' B' ' 88' ' ' ALA . . . -77.71 -9.34 58.94 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.481 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -102.1 2.19 37.19 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 177.495 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.464 ' HA2' ' HG2' ' A' ' 52' ' ' PRO . . . 66.26 50.92 47.66 Favored Glycine 0 C--N 1.302 -1.359 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.9 ' CB ' HG23 ' A' ' 35' ' ' THR . 0.2 OUTLIER -127.9 157.78 39.58 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.284 -1.127 . . . . 0.0 110.081 179.591 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.412 ' CG ' ' HB2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -107.05 92.93 4.29 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.45 -0.781 . . . . 0.0 111.001 -178.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 1.011 HG13 HD11 ' B' ' 6' ' ' LEU . 2.3 t -87.4 92.17 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.557 -0.714 . . . . 0.0 109.303 179.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.471 ' O ' HD23 ' A' ' 44' ' ' LEU . 0.6 OUTLIER -89.19 148.37 23.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.137 -0.977 . . . . 0.0 110.617 -179.313 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.658 ' HB2' ' HB2' ' A' ' 48' ' ' LEU . 19.2 mt -118.45 117.31 28.68 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.543 -0.723 . . . . 0.0 109.725 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.518 HG23 ' CD2' ' A' ' 47' ' ' PHE . 0.1 OUTLIER 29.91 -88.59 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.429 0 O-C-N 121.82 -0.55 . . . . 0.0 111.137 179.506 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -152.38 21.28 0.84 Allowed Glycine 0 N--CA 1.486 2.009 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.688 ' CE1' HG21 ' B' ' 32' ' ' ILE . 8.8 p90 -118.54 -23.54 7.1 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.916 -1.343 . . . . 0.0 111.25 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.658 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -129.27 94.11 3.72 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.8 -1.188 . . . . 0.0 110.792 178.543 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.651 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 0.6 OUTLIER -96.02 83.37 3.64 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.64 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.948 HG22 ' CG2' ' A' ' 79' ' ' VAL . 0.7 OUTLIER -94.26 144.72 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.022 -1.048 . . . . 0.0 113.093 -177.629 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.584 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 9.7 ptmt -177.01 112.43 0.24 Allowed Pre-proline 0 N--CA 1.494 1.746 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 177.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.665 ' CB ' HG21 ' A' ' 75' ' ' VAL . 55.5 Cg_endo -69.58 132.06 22.8 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 O-C-N 123.313 1.165 . . . . 0.0 113.379 -175.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.89 ' O ' HG23 ' A' ' 75' ' ' VAL . 19.1 m -125.37 -141.16 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.272 177.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.739 ' HB2' ' HB3' ' B' ' 97' ' ' PHE . . . . . . . . 0 C--N 1.292 -1.896 0 O-C-N 120.576 -1.328 . . . . 0.0 111.189 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.89 HG23 ' O ' ' A' ' 53' ' ' VAL . 8.7 p . . . . . 0 N--CA 1.494 1.742 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.556 ' HA3' ' CG2' ' A' ' 53' ' ' VAL . . . -91.6 55.85 3.07 Favored Glycine 0 N--CA 1.484 1.84 0 N-CA-C 107.449 -2.261 . . . . 0.0 107.449 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.895 HG21 ' HA ' ' B' ' 84' ' ' SER . 19.2 t -26.0 93.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-O 122.932 1.348 . . . . 0.0 110.986 -178.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.569 ' CB ' ' HG3' ' A' ' 51' ' ' LYS . 45.7 t -57.31 -41.63 80.28 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 114.199 -1.364 . . . . 0.0 113.329 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.948 ' CG2' HG22 ' A' ' 50' ' ' ILE 0.255 7.5 p -44.38 167.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 CA-C-O 122.423 1.106 . . . . 0.0 113.568 -172.238 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.632 ' O ' HD23 ' A' ' 48' ' ' LEU . 0.5 OUTLIER 174.61 176.07 0.21 Allowed Pre-proline 0 N--CA 1.485 1.301 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.382 -179.518 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -78.96 130.76 9.65 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 123.751 1.395 . . . . 0.0 109.344 176.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.458 ' CA ' ' HA ' ' A' ' 47' ' ' PHE . . . -104.39 -174.93 25.15 Favored Glycine 0 N--CA 1.498 2.821 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.43 ' HA ' ' HB2' ' A' ' 86' ' ' LYS . 2.2 pm0 -80.93 -24.27 38.29 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.32 -1.106 . . . . 0.0 110.707 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.423 ' HB2' ' HA3' ' A' ' 46' ' ' GLY . 22.0 t -51.07 -32.13 21.05 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.15 -0.969 . . . . 0.0 108.518 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.974 HD11 ' CG1' ' B' ' 36' ' ' VAL . 0.6 OUTLIER -84.22 -35.1 23.71 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.592 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.753 ' HG3' HG23 ' B' ' 77' ' ' VAL . 0.6 OUTLIER -71.34 -31.12 67.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.244 -0.91 . . . . 0.0 109.182 178.809 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.45 -37.18 65.9 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.913 ' C ' ' HB1' ' B' ' 37' ' ' ALA . . . -65.24 -33.77 76.78 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 176.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 1.002 ' CB ' HG11 ' B' ' 75' ' ' VAL . . . -62.38 -35.07 78.01 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.1 -26.37 66.16 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 175.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.519 ' C ' ' H ' ' A' ' 93' ' ' LYS . . . -59.83 -50.18 70.48 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 178.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.747 HD23 ' C ' ' B' ' 37' ' ' ALA . 1.3 pp -74.91 27.76 0.09 Allowed 'General case' 0 N--CA 1.505 2.311 0 O-C-N 120.454 -1.615 . . . . 0.0 109.473 178.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.613 ' HB3' ' O ' ' A' ' 92' ' ' LEU . 4.1 ttpt 68.99 93.39 0.08 Allowed 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -177.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 1.126 ' O ' ' C ' ' A' ' 95' ' ' GLU . 24.8 t80 -58.95 -60.74 3.38 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 115.301 -2.56 . . . . 0.0 106.181 177.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 1.126 ' C ' ' O ' ' A' ' 94' ' ' TYR . 38.5 mm-40 . . . . . 0 CA--C 1.484 -1.596 0 N-CA-C 101.366 -3.568 . . . . 0.0 101.366 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.595 ' HA ' ' HB2' ' B' ' 5' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 120.823 0.344 . . . . 0.0 110.246 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 2' ' ' ASN . . . . . 0.48 ' C ' ' H ' ' B' ' 4' ' ' THR . 40.7 p-10 -176.37 -135.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.131 -1.027 . . . . 0.0 111.374 178.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.83 ' HD3' HD11 ' B' ' 25' ' ' LEU . 4.9 mttp -61.5 9.16 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.006 -1.058 . . . . 0.0 111.289 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . 0.48 ' H ' ' C ' ' B' ' 2' ' ' ASN . 52.9 m -127.8 -66.39 0.87 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.518 -1.364 . . . . 0.0 110.591 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.595 ' HB2' ' HA ' ' B' ' 1' ' ' MET . 19.7 mp0 -53.59 -42.44 67.64 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.955 -1.09 . . . . 0.0 109.797 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 1.011 HD11 HG13 ' A' ' 42' ' ' VAL . 18.0 mt -57.59 -33.08 67.82 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 118.804 -1.158 . . . . 0.0 109.636 179.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' ILE . . . . . 0.731 HG22 HD22 ' B' ' 25' ' ' LEU . 0.8 OUTLIER -61.83 -41.47 90.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 178.111 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . 0.839 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.0 OUTLIER -70.39 -29.86 66.61 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 177.875 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . 0.553 ' HB3' ' O ' ' B' ' 6' ' ' LEU . . . -59.17 -39.46 82.56 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.508 -0.745 . . . . 0.0 109.257 178.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.87 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.1 mp -92.64 -29.81 4.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 178.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.839 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -62.87 -15.59 55.42 Favored 'General case' 0 C--N 1.294 -1.809 0 C-N-CA 118.403 -1.319 . . . . 0.0 108.42 178.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.444 ' HB3' ' O ' ' B' ' 8' ' ' LYS . 15.3 tp60 -114.74 -45.31 3.0 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.567 -0.708 . . . . 0.0 109.4 178.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' B' ' 9' ' ' ALA . 3.0 m-20 -62.63 -27.75 69.43 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 177.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 1.1 HG22 ' CD1' ' B' ' 16' ' ' LEU 0.258 0.2 OUTLIER -106.66 -82.52 0.54 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 178.412 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.95 4.17 82.35 Favored Glycine 0 N--CA 1.5 2.931 0 O-C-N 121.038 -1.039 . . . . 0.0 110.681 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' LEU . . . . . 1.1 ' CD1' HG22 ' B' ' 14' ' ' THR . 5.4 mp -50.95 -71.02 0.07 Allowed 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.632 -0.923 . . . . 0.0 110.838 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . 0.559 ' CG2' HG21 ' A' ' 17' ' ' THR . 0.6 OUTLIER -136.96 7.82 2.96 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -179.638 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . 0.614 ' O ' ' C ' ' B' ' 19' ' ' VAL . 30.6 mt-30 58.34 26.78 14.43 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 -175.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 1.084 HG11 HG11 ' A' ' 19' ' ' VAL . 1.4 p -6.44 -92.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.857 -179.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 0.937 ' O ' ' N ' ' B' ' 23' ' ' LYS . 0.5 OUTLIER -134.51 25.11 3.76 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 177.531 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.696 ' HA ' ' CE ' ' B' ' 24' ' ' MET . 35.3 m -15.56 -41.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 122.66 1.219 . . . . 0.0 109.26 -177.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.925 ' N ' ' O ' ' B' ' 20' ' ' SER . 48.0 t -79.74 -41.68 26.14 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 114.537 -1.21 . . . . 0.0 110.288 177.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . 0.937 ' N ' ' O ' ' B' ' 20' ' ' SER . 1.5 mtpt -85.04 -34.95 22.19 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 121.461 -0.774 . . . . 0.0 111.662 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' MET . . . . . 0.696 ' CE ' ' HA ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -69.23 -30.64 68.83 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 117.667 -1.613 . . . . 0.0 108.058 179.261 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.842 ' HG ' ' N ' ' B' ' 26' ' ' ALA . 0.3 OUTLIER -72.84 -43.23 62.9 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 118.403 -1.319 . . . . 0.0 108.043 177.488 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . 0.842 ' N ' ' HG ' ' B' ' 25' ' ' LEU . . . -63.98 -26.69 68.69 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' SER . . . . . 0.606 ' O ' HG23 ' B' ' 31' ' ' ILE . 1.4 t -83.4 -35.83 24.75 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 177.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . 0.711 ' HA ' ' CG1' ' B' ' 31' ' ' ILE . 0.6 OUTLIER -64.85 -48.48 74.18 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.467 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . 0.605 ' HG3' ' CD2' ' B' ' 28' ' ' PHE . 6.4 mt-10 -72.35 -30.21 64.51 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 120.492 -1.38 . . . . 0.0 107.536 178.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 1.147 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 14.3 tttt -73.19 -25.32 60.73 Favored 'General case' 0 C--O 1.187 -2.203 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 177.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.711 ' CG1' ' HA ' ' B' ' 28' ' ' PHE . 1.9 pp -100.28 -29.89 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.266 -1.521 . . . . 0.0 109.465 178.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.688 HG21 ' CE1' ' A' ' 47' ' ' PHE . 1.5 mm -65.79 -64.59 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 177.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' THR . . . . . 0.757 ' O ' HD13 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -62.72 -38.5 90.73 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.034 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 1.147 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 76.7 mm-40 -74.38 -42.74 58.78 Favored 'General case' 0 C--O 1.202 -1.404 0 O-C-N 121.036 -1.04 . . . . 0.0 112.111 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' THR . . . . . 0.518 ' HA ' ' HB3' ' B' ' 38' ' ' LYS . 67.5 m -57.19 -56.55 20.29 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 120.222 -1.548 . . . . 0.0 110.494 -178.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 1.013 HG23 HG12 ' B' ' 42' ' ' VAL . 1.3 t -51.63 -44.39 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 117.667 -1.613 . . . . 0.0 106.974 178.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . 0.913 ' HB1' ' C ' ' A' ' 88' ' ' ALA . . . -85.97 6.08 30.29 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.705 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.785 ' N ' ' O ' ' B' ' 34' ' ' GLU . 0.1 OUTLIER -105.64 -36.43 7.09 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 178.156 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 142.68 37.57 0.08 OUTLIER Glycine 0 C--N 1.301 -1.388 0 C-N-CA 119.252 -1.451 . . . . 0.0 111.4 178.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . 0.456 ' HB2' HG23 ' B' ' 35' ' ' THR . 0.4 OUTLIER -155.53 145.0 21.07 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.821 -1.4 . . . . 0.0 110.988 179.461 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.15 92.79 5.72 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.557 0.694 . . . . 0.0 109.519 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 1.013 HG12 HG23 ' B' ' 36' ' ' VAL . 11.3 p -68.25 154.81 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.668 -0.645 . . . . 0.0 110.447 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' GLN . . . . . 0.841 ' O ' HD23 ' B' ' 44' ' ' LEU . 0.4 OUTLIER -164.1 176.3 9.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.189 -0.945 . . . . 0.0 111.386 179.937 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.841 HD23 ' O ' ' B' ' 43' ' ' GLN . 18.1 mt -134.28 118.8 17.96 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . 0.577 HG21 ' CG ' ' A' ' 29' ' ' GLU . 0.1 OUTLIER 27.21 -95.11 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.416 0 O-C-N 121.826 -0.546 . . . . 0.0 112.374 -179.812 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . 0.529 ' H ' HG23 ' B' ' 45' ' ' THR . . . -137.66 14.97 3.62 Favored Glycine 0 N--CA 1.49 2.247 0 C-N-CA 119.322 -1.418 . . . . 0.0 111.686 -178.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . 0.909 ' CD2' HD23 ' B' ' 48' ' ' LEU . 20.4 p90 -110.9 -33.48 6.5 Favored 'General case' 0 C--O 1.195 -1.803 0 CA-C-N 119.447 1.623 . . . . 0.0 109.342 178.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.909 HD23 ' CD2' ' B' ' 47' ' ' PHE . 1.2 mm? -127.37 128.57 46.08 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 119.931 -1.731 . . . . 0.0 115.095 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' ASN . . . . . 0.715 ' N ' ' HG2' ' B' ' 81' ' ' PRO . 0.5 OUTLIER -143.93 91.86 2.27 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.621 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' ILE . . . . . 0.577 ' CD1' HG12 ' B' ' 79' ' ' VAL . 24.9 mm -83.79 148.07 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.457 -0.777 . . . . 0.0 110.688 -178.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' B' ' 78' ' ' SER . 0.0 OUTLIER -149.9 129.88 6.68 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.177 -0.952 . . . . 0.0 109.399 179.149 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' PRO . . . . . 0.628 ' HG3' ' O ' ' B' ' 36' ' ' VAL . 54.9 Cg_endo -81.77 151.64 16.84 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 O-C-N 123.388 1.204 . . . . 0.0 111.387 -178.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.747 HG22 ' O ' ' B' ' 76' ' ' GLY . 20.1 m -138.8 117.48 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-O 122.364 1.078 . . . . 0.0 111.134 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . 0.477 ' HA ' ' HE1' ' A' ' 94' ' ' TYR . . . . . . . . 0 N--CA 1.493 1.697 0 O-C-N 121.598 -0.689 . . . . 0.0 110.991 -179.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . 1.002 HG11 ' CB ' ' A' ' 89' ' ' ALA . 9.4 p . . . . . 0 N--CA 1.496 1.862 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 76' ' ' GLY . . . . . 0.747 ' O ' HG22 ' B' ' 53' ' ' VAL . . . -114.79 98.96 0.89 Allowed Glycine 0 N--CA 1.484 1.847 0 C-N-CA 118.938 -1.601 . . . . 0.0 109.24 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.753 HG23 ' HG3' ' A' ' 86' ' ' LYS . 67.9 t -68.84 66.07 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.701 -0.882 . . . . 0.0 109.078 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 78' ' ' SER . . . . . 0.487 ' C ' HG13 ' B' ' 79' ' ' VAL . 37.6 t -65.89 -176.19 0.36 Allowed 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.603 0.716 . . . . 0.0 109.648 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.577 HG12 ' CD1' ' B' ' 50' ' ' ILE . 17.7 m -152.68 -153.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 80' ' ' LYS . . . . . 0.719 ' HB3' ' HD3' ' B' ' 81' ' ' PRO . 13.0 ttmt -164.99 -57.58 0.01 OUTLIER Pre-proline 0 C--N 1.294 -1.808 0 O-C-N 121.452 -0.78 . . . . 0.0 109.985 178.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 81' ' ' PRO . . . . . 0.719 ' HD3' ' HB3' ' B' ' 80' ' ' LYS . 44.3 Cg_endo -95.95 164.84 1.33 Allowed 'Trans proline' 0 C--N 1.296 -2.213 0 C-N-CA 121.825 1.683 . . . . 0.0 112.842 -179.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . 0.711 ' N ' ' O ' ' B' ' 47' ' ' PHE . . . 177.05 -25.39 0.06 OUTLIER Glycine 0 C--N 1.287 -2.141 0 N-CA-C 105.774 -2.93 . . . . 0.0 105.774 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . 0.908 ' O ' ' N ' ' B' ' 85' ' ' LEU . 22.5 tt0 30.76 49.84 0.09 Allowed 'General case' 0 C--O 1.205 -1.268 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 84' ' ' SER . . . . . 1.3 ' O ' ' N ' ' B' ' 86' ' ' LYS . 1.2 m 12.67 43.93 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.941 1.353 . . . . 0.0 109.093 -178.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 1.116 ' O ' ' N ' ' B' ' 88' ' ' ALA . 0.3 OUTLIER 23.05 26.4 0.0 OUTLIER 'General case' 0 C--O 1.187 -2.225 0 N-CA-C 102.785 -3.043 . . . . 0.0 102.785 -170.182 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 86' ' ' LYS . . . . . 1.3 ' N ' ' O ' ' B' ' 84' ' ' SER 0.324 21.8 tttt -37.33 -40.83 0.37 Allowed 'General case' 0 CA--C 1.486 -1.497 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 176.624 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . 0.426 ' N ' ' C ' ' B' ' 85' ' ' LEU 0.307 0.0 OUTLIER -61.06 -39.71 90.9 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-N 111.865 -2.425 . . . . 0.0 106.711 175.355 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 1.116 ' N ' ' O ' ' B' ' 85' ' ' LEU . . . -90.03 -21.62 22.27 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.433 -0.907 . . . . 0.0 108.966 178.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.711 ' N ' ' O ' ' B' ' 85' ' ' LEU . . . -71.83 -36.74 70.3 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 178.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -66.51 -31.93 72.97 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 174.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -60.88 -42.18 99.53 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 92' ' ' LEU . . . . . 0.862 ' O ' HD12 ' B' ' 92' ' ' LEU . 1.2 pp -85.34 21.17 1.8 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 120.443 -1.622 . . . . 0.0 110.581 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 93' ' ' LYS . . . . . 0.453 ' O ' ' N ' ' B' ' 96' ' ' ASP . 0.8 OUTLIER 55.66 45.22 25.11 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 -178.071 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . 0.486 ' CD1' ' N ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -37.29 -43.69 0.55 Allowed 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.661 -178.862 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -54.42 -41.84 69.79 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.297 -0.877 . . . . 0.0 109.535 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 96' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' B' ' 93' ' ' LYS . 0.7 OUTLIER -59.76 -34.29 72.79 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.193 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 97' ' ' PHE . . . . . 0.739 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.5 ' HG2' ' HB3' ' A' ' 5' ' ' GLU . 11.2 mtp . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 120.852 0.358 . . . . 0.0 110.093 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.486 ' C ' HD12 ' A' ' 6' ' ' LEU . 7.8 t-20 -179.17 -179.86 0.6 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.261 -0.9 . . . . 0.0 110.304 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.529 ' O ' HG13 ' A' ' 7' ' ' ILE . 0.6 OUTLIER -52.63 -20.08 2.8 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.12 -0.988 . . . . 0.0 109.931 179.668 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.464 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 16.6 m -97.69 -46.68 5.9 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.545 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -62.55 -47.04 85.6 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 178.657 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.743 HD11 HG13 ' B' ' 42' ' ' VAL . 2.4 mt -65.69 -29.68 70.26 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.193 178.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.831 HG23 ' HB ' ' A' ' 21' ' ' VAL . 0.3 OUTLIER -56.34 -58.76 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 178.428 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.973 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 0.2 OUTLIER -62.64 -27.47 69.24 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.506 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 6' ' ' LEU . . . -61.22 -32.19 71.97 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.202 -0.937 . . . . 0.0 108.708 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.852 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.2 tp -96.29 -37.59 7.44 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.549 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 178.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.973 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -59.38 -24.19 63.2 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.428 ' HB3' ' O ' ' A' ' 8' ' ' LYS . 39.3 tp60 -92.5 -45.15 8.27 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.434 ' HB3' ' CB ' ' B' ' 27' ' ' SER . 3.3 m-20 -63.81 -32.12 73.52 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 177.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.948 HG22 ' OG ' ' B' ' 20' ' ' SER . 27.7 p -82.5 -74.01 0.37 Allowed 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 58.87 14.79 24.99 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.936 HD22 ' O ' ' B' ' 19' ' ' VAL . 2.9 mp -77.0 -47.31 21.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.542 -0.976 . . . . 0.0 108.615 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.664 ' HB ' HG21 ' B' ' 17' ' ' THR . 0.5 OUTLIER -160.69 5.57 0.07 Allowed 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 120.0 -0.68 . . . . 0.0 111.055 -179.158 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.552 ' O ' ' C ' ' A' ' 19' ' ' VAL . 13.7 mt-30 58.97 25.52 13.89 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 -176.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.982 HG11 HG11 ' B' ' 19' ' ' VAL . 1.9 p -5.03 -93.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.942 -178.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.965 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -130.32 25.05 5.18 Favored 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 179.695 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.831 ' HB ' HG23 ' A' ' 7' ' ' ILE . 12.5 m -19.26 -40.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 CA-C-O 122.553 1.168 . . . . 0.0 109.548 -178.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.826 ' N ' ' O ' ' A' ' 20' ' ' SER . 29.2 t -80.06 -35.75 36.62 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.999 178.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.965 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.3 OUTLIER -90.8 -36.21 14.38 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.479 -0.763 . . . . 0.0 110.891 179.561 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.755 ' O ' HD11 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -67.61 -38.64 84.23 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 117.626 -1.63 . . . . 0.0 108.994 179.462 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.763 HD12 HG13 ' A' ' 7' ' ' ILE . 0.2 OUTLIER -78.29 -48.04 16.53 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 117.858 -1.537 . . . . 0.0 109.112 178.455 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.478 ' HA ' ' HE3' ' A' ' 3' ' ' LYS . . . -54.97 -37.24 66.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.747 -1.221 . . . . 0.0 107.831 177.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.588 ' O ' HG13 ' A' ' 31' ' ' ILE . 8.4 t -83.18 -28.82 29.06 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.13 178.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.667 ' CE1' HD22 ' B' ' 44' ' ' LEU . 2.8 t80 -51.91 -49.26 63.4 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.847 ' HG3' ' CD1' ' B' ' 47' ' ' PHE . 3.3 tt0 -67.17 -35.52 79.83 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 176.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 1.285 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 32.6 tttt -66.11 -17.88 64.99 Favored 'General case' 0 C--O 1.193 -1.913 0 C-N-CA 119.527 -0.869 . . . . 0.0 108.951 178.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.61 HG13 ' O ' ' A' ' 28' ' ' PHE . 1.3 pp -109.24 -26.21 3.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 119.786 -1.821 . . . . 0.0 109.344 178.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.658 ' O ' HG22 ' A' ' 36' ' ' VAL . 1.2 mm -76.5 -54.7 12.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 177.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.77 ' HA ' ' HG ' ' B' ' 85' ' ' LEU . 0.6 OUTLIER -79.35 -29.39 42.19 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.876 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 1.285 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 41.5 mm-40 -78.5 -29.88 46.89 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 118.851 -1.14 . . . . 0.0 110.232 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.537 ' HA ' ' HB2' ' A' ' 38' ' ' LYS . 7.2 m -73.73 -58.73 3.1 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 117.718 -1.593 . . . . 0.0 107.916 178.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.658 HG22 ' O ' ' A' ' 32' ' ' ILE . 24.7 m -43.22 -40.7 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.734 ' O ' ' HB2' ' B' ' 92' ' ' LEU . . . -79.01 -32.56 45.16 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.787 ' N ' HD12 ' B' ' 92' ' ' LEU . 0.0 OUTLIER -60.44 -27.66 67.68 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 105.129 -2.175 . . . . 0.0 105.129 176.664 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.484 ' CA ' ' CZ ' ' B' ' 97' ' ' PHE . . . 116.74 26.98 2.91 Favored Glycine 0 C--N 1.297 -1.628 0 CA-C-N 114.363 -1.29 . . . . 0.0 111.025 176.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.508 ' HB2' HG23 ' A' ' 35' ' ' THR . 0.2 OUTLIER -122.0 137.34 54.84 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.251 -1.146 . . . . 0.0 110.072 179.213 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.9 mttm -82.02 87.73 6.44 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.535 -0.728 . . . . 0.0 110.704 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.466 HG22 ' CG1' ' A' ' 36' ' ' VAL . 33.2 m -65.09 140.18 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.446 -0.784 . . . . 0.0 109.718 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.5 ' O ' ' HA ' ' B' ' 2' ' ' ASN . 9.0 mt-30 -135.29 172.22 13.32 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.168 -0.958 . . . . 0.0 110.251 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.948 HD22 ' CE1' ' B' ' 28' ' ' PHE . 11.7 mt -131.65 115.99 16.77 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.214 -0.929 . . . . 0.0 110.332 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.571 HG23 ' HD2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER 26.82 -93.41 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.891 -0.506 . . . . 0.0 111.853 178.892 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.428 ' N ' ' OG1' ' A' ' 45' ' ' THR . . . -153.27 33.87 0.78 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.811 ' CD2' ' HG3' ' B' ' 29' ' ' GLU . 3.2 p90 -131.44 -15.3 3.2 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.265 -1.138 . . . . 0.0 111.154 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.89 HD12 ' O ' ' A' ' 80' ' ' LYS . 47.6 tp -161.05 121.61 2.79 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 118.261 -1.375 . . . . 0.0 111.085 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.477 ' HA ' ' HA ' ' A' ' 43' ' ' GLN . 16.2 m-20 -131.59 118.16 19.71 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.46 0.648 . . . . 0.0 111.163 -178.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.665 HD13 HG23 ' A' ' 79' ' ' VAL . 5.0 mm -94.61 151.51 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.677 -0.639 . . . . 0.0 109.564 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.458 ' O ' ' N ' ' A' ' 78' ' ' SER . 11.5 ptmt -165.52 115.1 0.83 Allowed Pre-proline 0 N--CA 1.5 2.051 0 O-C-N 120.68 -1.263 . . . . 0.0 110.851 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.645 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 43.9 Cg_endo -82.69 155.78 15.83 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 O-C-N 123.515 1.271 . . . . 0.0 112.024 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.726 HG22 ' O ' ' A' ' 76' ' ' GLY . 33.0 m -147.62 118.42 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 CA-C-O 121.669 0.747 . . . . 0.0 110.701 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.574 ' HA ' ' CE1' ' B' ' 94' ' ' TYR . . . . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.635 -0.666 . . . . 0.0 111.428 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.91 HG11 ' HB3' ' B' ' 89' ' ' ALA . 7.5 p . . . . . 0 N--CA 1.496 1.859 0 CA-C-O 121.412 0.625 . . . . 0.0 111.413 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.726 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -116.9 68.75 0.3 Allowed Glycine 0 N--CA 1.487 2.088 0 N-CA-C 108.749 -1.741 . . . . 0.0 108.749 179.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.894 ' CG2' HD22 ' B' ' 85' ' ' LEU . 6.4 p -47.08 80.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.963 -0.728 . . . . 0.0 111.622 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.642 ' C ' HG12 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -77.15 176.66 8.51 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 177.757 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.665 HG23 HD13 ' A' ' 50' ' ' ILE . 0.2 OUTLIER 177.49 174.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -179.745 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.89 ' O ' HD12 ' A' ' 48' ' ' LEU . 6.5 ptpt -178.15 170.21 0.87 Allowed Pre-proline 0 C--N 1.299 -1.599 0 O-C-N 121.538 -0.726 . . . . 0.0 109.557 176.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.573 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 56.0 Cg_endo -100.69 176.28 0.27 Allowed 'Trans proline' 0 C--N 1.292 -2.447 0 C-N-CA 122.6 2.2 . . . . 0.0 110.943 178.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 47' ' ' PHE . . . -126.27 163.2 20.29 Favored Glycine 0 N--CA 1.485 1.958 0 N-CA-C 107.084 -2.407 . . . . 0.0 107.084 177.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -58.06 -22.5 50.58 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.751 -1.441 . . . . 0.0 110.905 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.436 ' CB ' ' HB3' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -53.54 -35.29 60.56 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.0 -1.063 . . . . 0.0 108.894 179.198 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.966 HD13 ' CG1' ' B' ' 77' ' ' VAL . 0.5 OUTLIER -82.31 -25.65 33.77 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.742 -0.599 . . . . 0.0 109.386 178.711 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.572 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 20.4 mttt -84.86 -30.67 24.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.345 -0.847 . . . . 0.0 109.956 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -73.5 -38.43 65.37 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.831 ' O ' ' HB1' ' B' ' 37' ' ' ALA . . . -63.65 -37.28 86.73 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 176.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 1.002 ' HB1' ' CG1' ' B' ' 75' ' ' VAL . . . -54.92 -44.46 74.26 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 120.106 -0.638 . . . . 0.0 109.362 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.46 ' HA ' ' CB ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -54.47 -29.37 49.72 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.247 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 88' ' ' ALA . . . -67.9 -40.86 89.07 Favored Glycine 0 N--CA 1.488 2.122 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.31 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.615 ' HG ' ' N ' ' A' ' 93' ' ' LYS . 0.3 OUTLIER -70.39 -47.63 59.96 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 119.895 1.847 . . . . 0.0 110.533 -178.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.645 ' O ' ' CG ' ' A' ' 93' ' ' LYS . 0.1 OUTLIER 160.35 57.0 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.175 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 1.029 ' O ' ' C ' ' A' ' 95' ' ' GLU . 17.4 t80 -53.18 -65.47 0.55 Allowed 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 178.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 1.029 ' C ' ' O ' ' A' ' 94' ' ' TYR . 1.0 OUTLIER . . . . . 0 N--CA 1.483 1.216 0 N-CA-C 103.208 -2.886 . . . . 0.0 103.208 175.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.478 ' HA ' ' HB2' ' B' ' 5' ' ' GLU . 5.5 mtp . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 120.881 0.372 . . . . 0.0 110.259 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 2' ' ' ASN . . . . . 0.667 ' O ' HD12 ' B' ' 6' ' ' LEU . 16.4 m-80 -147.45 -155.99 0.68 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.076 -1.015 . . . . 0.0 111.083 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.526 ' O ' ' CG2' ' B' ' 7' ' ' ILE . 1.0 OUTLIER -60.92 2.17 0.12 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.342 -0.849 . . . . 0.0 110.446 179.765 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . 0.686 ' O ' HG13 ' B' ' 7' ' ' ILE . 4.5 m -116.3 -63.25 1.48 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 122.147 0.975 . . . . 0.0 108.904 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.478 ' HB2' ' HA ' ' B' ' 1' ' ' MET . 5.5 mm-40 -52.03 -48.05 64.71 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.214 -0.929 . . . . 0.0 108.515 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.667 HD12 ' O ' ' B' ' 2' ' ' ASN . 7.5 mt -56.72 -32.8 65.87 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 119.122 -1.031 . . . . 0.0 110.256 178.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' ILE . . . . . 0.686 HG13 ' O ' ' B' ' 4' ' ' THR . 1.1 pp -60.72 -42.42 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.54 -1.35 . . . . 0.0 107.91 179.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . 0.822 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.0 OUTLIER -71.93 -27.2 62.65 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.29 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' B' ' 6' ' ' LEU . . . -62.54 -36.35 82.35 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.958 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.0 OUTLIER -95.46 -35.24 5.79 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.382 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.787 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.822 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -56.32 -25.25 48.15 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -92.49 -46.82 7.45 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.522 ' OD2' HG21 ' A' ' 31' ' ' ILE . 87.0 m-20 -61.64 -24.97 67.08 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 177.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.958 ' OG1' ' O ' ' B' ' 10' ' ' ILE . 17.2 p -93.77 -77.93 0.44 Allowed 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 177.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 61.46 9.23 16.46 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' LEU . . . . . 0.944 HD22 ' O ' ' A' ' 19' ' ' VAL . 3.2 mp -72.75 -60.25 2.32 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.377 -1.072 . . . . 0.0 108.343 179.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . 0.664 HG21 ' HB ' ' A' ' 17' ' ' THR . 0.5 OUTLIER -143.5 3.44 1.31 Allowed 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.598 179.659 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . 0.639 ' O ' ' C ' ' B' ' 19' ' ' VAL . 4.9 mt-30 59.1 25.33 13.79 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 106.565 -1.642 . . . . 0.0 106.565 -176.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.982 HG11 HG11 ' A' ' 19' ' ' VAL . 2.2 p 2.54 -97.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.481 -179.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 0.95 ' O ' ' N ' ' B' ' 23' ' ' LYS . 0.3 OUTLIER -131.55 21.77 4.7 Favored 'General case' 0 C--N 1.278 -2.525 0 N-CA-C 105.655 -1.98 . . . . 0.0 105.655 175.891 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.959 ' HA ' ' HE2' ' B' ' 24' ' ' MET . 21.2 m -15.31 -39.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-O 122.426 1.108 . . . . 0.0 109.444 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.936 ' N ' ' O ' ' B' ' 20' ' ' SER . 16.5 m -77.41 -45.01 27.2 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.983 177.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . 0.95 ' N ' ' O ' ' B' ' 20' ' ' SER . 6.6 mtmt -96.76 -14.36 22.03 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 121.482 -0.761 . . . . 0.0 109.719 178.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' MET . . . . . 0.959 ' HE2' ' HA ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -71.78 -36.06 70.23 Favored 'General case' 0 C--O 1.216 -0.71 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 177.708 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.556 ' HA ' ' HB3' ' B' ' 28' ' ' PHE . 3.4 mt -84.51 -36.16 22.41 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 176.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . 0.734 ' HB3' ' HA ' ' B' ' 23' ' ' LYS . . . -61.48 -34.21 75.09 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' SER . . . . . 0.483 ' O ' HG13 ' B' ' 31' ' ' ILE . 11.1 m -77.45 -34.76 54.41 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . 0.948 ' CE1' HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -52.36 -45.53 65.77 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.745 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . 0.811 ' HG3' ' CD2' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -68.72 -35.96 77.82 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 118.455 -1.298 . . . . 0.0 107.577 177.08 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 1.158 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 23.5 ttmt -63.92 -22.58 66.99 Favored 'General case' 0 C--O 1.191 -1.978 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.64 HD11 ' HA ' ' B' ' 28' ' ' PHE . 0.4 OUTLIER -105.08 -27.99 3.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 O-C-N 120.24 -1.537 . . . . 0.0 108.935 177.963 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.654 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.1 mm -72.46 -58.75 4.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 177.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' THR . . . . . 0.664 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 0.5 OUTLIER -69.05 -36.13 77.36 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.49 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 1.158 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 22.3 mm-40 -75.19 -39.03 60.52 Favored 'General case' 0 C--O 1.206 -1.185 0 C-N-CA 119.156 -1.018 . . . . 0.0 111.832 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' THR . . . . . 0.516 ' HA ' ' CB ' ' B' ' 38' ' ' LYS . 55.4 m -62.77 -51.59 66.51 Favored 'General case' 0 N--CA 1.504 2.229 0 CA-C-N 120.546 1.521 . . . . 0.0 109.826 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.692 ' HB ' HD21 ' A' ' 85' ' ' LEU . 2.4 t -53.85 -36.77 31.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 178.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . 0.831 ' HB1' ' O ' ' A' ' 88' ' ' ALA . . . -94.66 11.65 30.47 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.581 0.705 . . . . 0.0 109.424 177.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.741 ' HB2' ' O ' ' B' ' 34' ' ' GLU . 0.1 OUTLIER -106.76 -33.62 7.53 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 176.933 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 131.07 38.46 0.28 Allowed Glycine 0 C--N 1.303 -1.264 0 C-N-CA 119.837 -1.173 . . . . 0.0 111.033 177.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . 0.493 ' HB2' HG23 ' B' ' 35' ' ' THR . 0.2 OUTLIER -147.82 147.31 29.68 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.771 -1.429 . . . . 0.0 111.235 179.634 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -91.4 95.96 10.26 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.743 HG13 HD11 ' A' ' 6' ' ' LEU . 61.8 t -59.27 124.65 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.655 -0.653 . . . . 0.0 110.924 -178.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' GLN . . . . . 0.426 ' CG ' ' O ' ' A' ' 1' ' ' MET . 11.1 pt20 -120.68 96.79 5.26 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.454 -0.779 . . . . 0.0 109.235 178.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.736 HD12 ' HB3' ' B' ' 48' ' ' LEU . 10.6 mt -65.53 113.2 4.0 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.497 -0.752 . . . . 0.0 110.406 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . 0.632 HG23 ' HD1' ' B' ' 47' ' ' PHE . 0.0 OUTLIER 29.4 -91.97 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.99 -0.444 . . . . 0.0 111.39 179.351 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -149.85 29.51 1.14 Allowed Glycine 0 N--CA 1.484 1.884 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . 0.847 ' CD1' ' HG3' ' A' ' 29' ' ' GLU . 3.9 p90 -132.66 -23.97 2.01 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.044 -1.268 . . . . 0.0 111.743 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.736 ' HB3' HD12 ' B' ' 44' ' ' LEU . 7.3 mt -132.59 105.62 7.32 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.382 -1.449 . . . . 0.0 111.876 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' ASN . . . . . 0.431 ' O ' ' HA ' ' B' ' 79' ' ' VAL . 0.1 OUTLIER -110.38 88.63 2.81 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.283 -0.886 . . . . 0.0 110.603 179.561 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' ILE . . . . . 0.609 HD11 ' CD2' ' A' ' 48' ' ' LEU . 1.1 mm -76.83 148.91 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.413 -0.804 . . . . 0.0 110.303 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . 0.418 ' HG3' ' CB ' ' B' ' 78' ' ' SER . 0.0 OUTLIER -161.17 126.75 2.27 Favored Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 120.918 -1.114 . . . . 0.0 110.182 179.096 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' PRO . . . . . 0.49 ' HB3' HG13 ' B' ' 36' ' ' VAL . 50.1 Cg_endo -75.74 146.82 30.53 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.493 1.26 . . . . 0.0 111.334 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.523 ' O ' HG23 ' B' ' 53' ' ' VAL . 33.3 m -146.38 123.74 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.68 -0.637 . . . . 0.0 110.56 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . 0.947 ' HA ' ' N ' ' B' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.498 1.96 0 C-N-CA 118.857 -1.137 . . . . 0.0 111.713 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . 1.002 ' CG1' ' HB1' ' A' ' 89' ' ' ALA . 74.1 t . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 122.696 1.236 . . . . 0.0 112.036 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 76' ' ' GLY . . . . . 0.543 ' C ' HG23 ' B' ' 77' ' ' VAL . . . -109.2 -142.96 9.94 Favored Glycine 0 C--N 1.283 -2.399 0 N-CA-C 106.764 -2.534 . . . . 0.0 106.764 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.966 ' CG1' HD13 ' A' ' 85' ' ' LEU . 99.2 t -155.18 77.57 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 O-C-N 121.279 -1.13 . . . . 0.0 110.138 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 78' ' ' SER . . . . . 0.438 ' O ' ' HB ' ' B' ' 79' ' ' VAL . 0.6 OUTLIER -74.74 175.95 7.47 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 118.788 -1.165 . . . . 0.0 110.147 179.745 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.614 HG22 ' N ' ' B' ' 80' ' ' LYS . 5.9 p 176.25 177.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 80' ' ' LYS . . . . . 0.632 ' O ' HD23 ' B' ' 48' ' ' LEU . 0.1 OUTLIER -177.35 174.3 0.65 Allowed Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 120.878 -1.138 . . . . 0.0 110.604 178.053 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 81' ' ' PRO . . . . . 0.574 ' HA ' ' O ' ' B' ' 47' ' ' PHE . 51.5 Cg_endo -90.86 144.36 3.55 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.245 1.964 . . . . 0.0 110.137 178.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . 0.51 ' H ' ' HA ' ' B' ' 47' ' ' PHE . . . -106.24 41.45 2.17 Favored Glycine 0 N--CA 1.496 2.663 0 C-N-CA 120.002 -1.094 . . . . 0.0 110.608 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . 0.458 ' O ' ' N ' ' B' ' 87' ' ' LYS . 0.3 OUTLIER 66.46 -48.59 0.44 Allowed 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.419 -1.048 . . . . 0.0 111.604 179.669 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 84' ' ' SER . . . . . 0.418 ' N ' ' O ' ' B' ' 82' ' ' GLY . 4.9 t -46.1 -31.93 2.62 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.192 -0.942 . . . . 0.0 109.488 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.894 HD22 ' CG2' ' A' ' 77' ' ' VAL . 4.0 tt -86.16 -32.76 21.1 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.425 0.631 . . . . 0.0 109.436 178.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 86' ' ' LYS . . . . . 0.649 ' HG3' HG12 ' A' ' 77' ' ' VAL . 14.8 tttt -81.95 -22.01 36.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.456 -0.777 . . . . 0.0 110.329 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' B' ' 83' ' ' GLU . 0.0 OUTLIER -90.81 -29.74 17.4 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.642 ' O ' ' HG ' ' B' ' 92' ' ' LEU . . . -70.56 -36.23 73.51 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 177.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.91 ' HB3' HG11 ' A' ' 75' ' ' VAL . . . -73.51 -40.42 64.06 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 119.891 -0.724 . . . . 0.0 109.466 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.4 -22.28 41.97 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -101.44 -12.7 34.94 Favored Glycine 0 N--CA 1.485 1.926 0 C-N-CA 120.069 -1.062 . . . . 0.0 113.181 -178.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 92' ' ' LEU . . . . . 0.787 HD12 ' N ' ' A' ' 38' ' ' LYS . 3.4 mt -94.35 -69.4 0.75 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 121.751 2.775 . . . . 0.0 111.281 -179.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 93' ' ' LYS . . . . . 0.455 ' HB3' ' CE1' ' B' ' 97' ' ' PHE . 0.6 OUTLIER -148.4 49.31 1.03 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.0 -1.063 . . . . 0.0 111.23 -179.576 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . 0.574 ' CE1' ' HA ' ' A' ' 54' ' ' ALA . 55.3 t80 -53.85 -48.74 69.68 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.151 -0.968 . . . . 0.0 109.866 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -64.25 -38.82 92.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.455 -0.778 . . . . 0.0 109.858 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.37 -27.78 57.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.526 -0.734 . . . . 0.0 109.547 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 97' ' ' PHE . . . . . 0.484 ' CZ ' ' CA ' ' A' ' 39' ' ' GLY . 2.9 m-85 . . . . . 0 N--CA 1.493 1.684 0 O-C-N 121.493 -0.754 . . . . 0.0 109.615 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.575 ' CB ' HG12 ' B' ' 42' ' ' VAL . 1.5 mtp . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.505 ' HA ' ' O ' ' B' ' 43' ' ' GLN . 29.4 p-10 -170.25 -151.11 0.08 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.14 -1.024 . . . . 0.0 111.743 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.457 ' NZ ' ' HB ' ' B' ' 45' ' ' THR . 3.6 mttp -53.7 -3.83 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.286 -0.884 . . . . 0.0 111.407 -179.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.687 ' O ' HG13 ' A' ' 7' ' ' ILE . 72.9 m -118.25 -63.93 1.35 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.017 -1.052 . . . . 0.0 110.241 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.532 ' HB2' ' HA ' ' A' ' 1' ' ' MET . 3.9 mt-10 -50.6 -42.93 56.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.907 -1.121 . . . . 0.0 109.375 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.636 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 28.0 mt -61.16 -32.76 72.49 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.201 -1.0 . . . . 0.0 109.726 178.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.687 HG13 ' O ' ' A' ' 4' ' ' THR . 1.0 OUTLIER -60.03 -42.11 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 178.769 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.863 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -68.38 -31.22 70.44 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 177.478 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.636 ' HB3' ' O ' ' A' ' 6' ' ' LEU . . . -56.91 -38.73 73.26 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.497 -0.752 . . . . 0.0 109.008 178.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.724 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.4 mp -93.38 -30.38 4.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 178.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.863 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -63.19 -13.13 33.83 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 118.455 -1.298 . . . . 0.0 108.58 178.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -116.9 -45.19 2.78 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.513 -0.742 . . . . 0.0 110.155 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 9' ' ' ALA . 1.0 OUTLIER -67.22 -23.98 65.78 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 177.723 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 1.138 HG22 ' CD1' ' A' ' 16' ' ' LEU 0.278 0.2 OUTLIER -111.27 -71.96 0.74 Allowed 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 179.25 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 57.31 19.22 31.85 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.421 -0.8 . . . . 0.0 111.228 177.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 1.138 ' CD1' HG22 ' A' ' 14' ' ' THR . 4.7 mp -60.92 -66.45 0.53 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.414 -1.051 . . . . 0.0 110.015 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.555 HG21 HG21 ' B' ' 17' ' ' THR . 0.6 OUTLIER -135.14 8.59 3.46 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -179.807 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.587 ' O ' ' C ' ' A' ' 19' ' ' VAL . 22.3 mt-30 58.03 27.37 14.75 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 -175.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 1.105 HG23 ' CD1' ' B' ' 16' ' ' LEU . 0.5 OUTLIER -11.32 -95.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.626 -179.222 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.951 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -135.59 24.69 3.43 Favored 'General case' 0 C--N 1.279 -2.488 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 178.471 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.637 ' C ' ' O ' ' A' ' 20' ' ' SER . 26.8 m -18.48 -39.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-O 122.478 1.132 . . . . 0.0 109.71 -177.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.861 ' N ' ' O ' ' A' ' 20' ' ' SER . 4.9 p -84.88 -37.66 20.36 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.808 178.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.951 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.1 OUTLIER -85.56 -33.25 21.77 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.609 -0.682 . . . . 0.0 110.939 179.468 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.525 ' CE ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -74.39 -41.68 60.53 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 118.207 -1.397 . . . . 0.0 108.949 179.493 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.601 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 3.1 mt -69.49 -43.76 72.49 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 118.029 -1.469 . . . . 0.0 108.045 177.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.428 ' HA ' ' HD3' ' A' ' 3' ' ' LYS . . . -61.18 -32.33 72.07 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 177.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.547 ' O ' ' N ' ' A' ' 31' ' ' ILE . 7.2 t -75.86 -38.09 58.31 Favored 'General case' 0 C--O 1.207 -1.158 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 177.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.719 ' HA ' ' CG1' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -57.3 -38.08 73.45 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.315 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.872 ' HG2' HG22 ' B' ' 45' ' ' THR . 1.4 mt-10 -77.18 -36.67 54.87 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 1.052 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 15.9 ttpt -69.14 -20.21 64.03 Favored 'General case' 0 C--O 1.19 -2.049 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 177.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.821 HD13 ' HB1' ' B' ' 9' ' ' ALA . 1.1 pp -105.93 -30.69 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 120.603 -1.311 . . . . 0.0 109.342 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.718 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.1 mm -67.43 -54.22 25.6 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 176.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.743 ' HA ' HD12 ' B' ' 85' ' ' LEU . 0.3 OUTLIER -68.73 -40.2 80.0 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 1.052 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 61.3 mm-40 -73.26 -35.29 66.18 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.329 -0.857 . . . . 0.0 111.49 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.702 HG23 ' HB2' ' A' ' 40' ' ' ASP . 3.4 m -59.3 -50.66 73.12 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.598 -1.314 . . . . 0.0 108.078 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.725 HG22 ' HD3' ' A' ' 52' ' ' PRO . 1.1 t -54.22 -36.94 34.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 177.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.926 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -80.75 -5.04 56.58 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.639 0.733 . . . . 0.0 109.714 177.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -101.05 -24.21 14.35 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.36 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 105.86 40.68 1.96 Allowed Glycine 0 C--N 1.3 -1.433 0 C-N-CA 120.136 -1.031 . . . . 0.0 110.641 178.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.702 ' HB2' HG23 ' A' ' 35' ' ' THR . 0.1 OUTLIER -134.18 123.43 24.33 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.21 -1.171 . . . . 0.0 110.03 179.284 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.422 ' HB2' ' HB3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -79.87 68.48 5.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.438 -0.789 . . . . 0.0 110.629 -179.43 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 1.002 HG13 ' HB ' ' A' ' 50' ' ' ILE . 2.6 p -59.61 145.97 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.168 -0.958 . . . . 0.0 109.405 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -137.8 120.65 16.44 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.238 -0.914 . . . . 0.0 111.03 -178.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.736 HD12 ' CE1' ' A' ' 47' ' ' PHE . 10.1 mt -64.5 -178.81 0.42 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.28 -0.887 . . . . 0.0 109.326 178.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.791 HG22 ' HG2' ' B' ' 29' ' ' GLU . 1.4 t -36.32 -34.16 0.06 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.77 -0.581 . . . . 0.0 111.467 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 166.39 -23.37 0.13 Allowed Glycine 0 N--CA 1.488 2.155 0 C-N-CA 119.686 -1.245 . . . . 0.0 110.398 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.82 ' CG ' HD23 ' A' ' 85' ' ' LEU . 20.2 p90 -81.65 -18.83 43.22 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.885 -1.362 . . . . 0.0 111.395 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.707 ' HB2' HD12 ' A' ' 44' ' ' LEU . 2.7 mt -125.94 100.32 6.32 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 118.553 -1.259 . . . . 0.0 111.611 178.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.639 ' C ' HG23 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -91.81 64.48 4.79 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.056 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 1.011 HD11 HD11 ' B' ' 48' ' ' LEU . 27.2 mm -57.29 116.42 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 O-C-N 121.335 -0.853 . . . . 0.0 112.767 -177.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.552 ' HG2' ' O ' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -172.71 135.7 0.77 Allowed Pre-proline 0 N--CA 1.494 1.734 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.038 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.725 ' HD3' HG22 ' A' ' 36' ' ' VAL . 51.2 Cg_endo -90.63 156.08 4.27 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.473 1.249 . . . . 0.0 113.147 -177.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.61 ' O ' ' N ' ' A' ' 76' ' ' GLY . 27.1 m -132.14 111.94 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 CA-C-O 121.717 0.77 . . . . 0.0 110.195 177.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.746 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.498 1.973 0 CA-C-O 122.07 0.938 . . . . 0.0 112.473 -178.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.823 ' CG1' ' HB1' ' B' ' 89' ' ' ALA . 0.4 OUTLIER . . . . . 0 N--CA 1.494 1.728 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.61 ' N ' ' O ' ' A' ' 53' ' ' VAL . . . -113.32 -149.14 10.34 Favored Glycine 0 C--N 1.299 -1.487 0 N-CA-C 108.337 -1.905 . . . . 0.0 108.337 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.992 HG11 ' HB3' ' B' ' 81' ' ' PRO . 4.3 t -144.99 86.85 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 CA-C-O 122.021 0.915 . . . . 0.0 108.783 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.514 ' CB ' ' HG3' ' A' ' 51' ' ' LYS . 0.5 OUTLIER -56.37 -44.54 80.25 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.812 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.808 HG12 HG12 ' A' ' 77' ' ' VAL 0.267 13.2 p -47.53 173.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 CA-C-O 122.082 0.944 . . . . 0.0 113.057 -175.226 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.671 ' HB2' ' HD2' ' A' ' 81' ' ' PRO . 0.1 OUTLIER 177.94 176.4 0.3 Allowed Pre-proline 0 N--CA 1.484 1.229 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -178.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.671 ' HD2' ' HB2' ' A' ' 80' ' ' LYS . 50.7 Cg_endo -78.07 112.51 3.26 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.612 1.322 . . . . 0.0 109.693 177.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -81.04 -172.53 46.37 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.449 ' HA ' ' HB2' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -77.04 -23.66 52.07 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.363 -1.081 . . . . 0.0 110.62 -179.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.26 -37.51 23.83 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.199 -0.938 . . . . 0.0 108.814 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.896 ' CG ' HG21 ' B' ' 77' ' ' VAL . 0.1 OUTLIER -79.63 -35.11 39.94 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.555 0.693 . . . . 0.0 109.152 178.486 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.449 ' HB2' ' HA ' ' A' ' 83' ' ' GLU . 0.1 OUTLIER -73.38 -31.38 63.87 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 120.036 -0.666 . . . . 0.0 110.039 -179.778 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -70.77 -40.27 72.74 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 178.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.654 ' HB2' HG23 ' B' ' 33' ' ' THR . . . -66.22 -35.31 80.09 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 176.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.859 ' HB1' ' CG1' ' B' ' 75' ' ' VAL . . . -58.46 -43.53 88.91 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.255 178.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.572 ' HA ' ' HB2' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -58.28 -24.36 59.19 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 177.29 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -74.71 -38.27 43.3 Favored Glycine 0 N--CA 1.488 2.126 0 CA-C-O 119.399 -0.667 . . . . 0.0 112.792 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 1.094 HD21 HG21 ' B' ' 75' ' ' VAL . 2.0 pp -57.26 -49.37 76.28 Favored 'General case' 0 N--CA 1.505 2.299 0 CA-C-N 120.774 2.287 . . . . 0.0 111.326 -178.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.602 ' H ' ' HG ' ' A' ' 92' ' ' LEU . 0.4 OUTLIER 159.05 45.95 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -179.447 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.617 ' HE1' ' O ' ' B' ' 75' ' ' VAL . 2.4 t80 -32.48 -71.75 0.05 Allowed 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.331 0.586 . . . . 0.0 112.41 -178.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 . . . . . 0 C--N 1.301 -1.539 0 O-C-N 121.397 -0.815 . . . . 0.0 110.465 -178.354 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.686 ' HB3' HG23 ' A' ' 42' ' ' VAL . 5.9 mtp . . . . . 0 N--CA 1.493 1.692 0 N-CA-C 110.081 -0.341 . . . . 0.0 110.081 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -171.57 -158.51 0.13 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.941 -1.099 . . . . 0.0 112.063 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.545 ' HE2' ' HA ' ' B' ' 26' ' ' ALA . 0.1 OUTLIER -49.72 -12.38 0.07 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.556 -0.715 . . . . 0.0 111.038 -179.536 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . 0.681 ' O ' HG13 ' B' ' 7' ' ' ILE . 19.7 m -114.04 -58.68 2.12 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.007 -1.058 . . . . 0.0 110.197 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.725 ' HA ' ' HE2' ' B' ' 8' ' ' LYS . 0.3 OUTLIER -49.34 -46.64 47.21 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.07 -1.019 . . . . 0.0 109.23 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.827 HD11 ' CG2' ' A' ' 42' ' ' VAL . 10.7 mt -58.79 -31.36 68.33 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.289 -0.964 . . . . 0.0 109.815 178.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' ILE . . . . . 0.683 HD13 ' CG2' ' B' ' 21' ' ' VAL . 0.9 OUTLIER -58.82 -41.77 83.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.517 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . 0.867 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 35.6 mtmt -63.55 -35.31 80.07 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . 0.821 ' HB1' HD13 ' A' ' 31' ' ' ILE . . . -53.63 -39.75 65.22 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.944 -0.702 . . . . 0.0 109.199 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.678 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.5 mp -90.56 -32.23 5.37 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 178.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.867 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -64.21 -15.87 60.82 Favored 'General case' 0 C--N 1.293 -1.871 0 O-C-N 120.805 -1.185 . . . . 0.0 108.58 178.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 -111.54 -43.41 3.67 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.514 -0.741 . . . . 0.0 109.587 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -69.66 -24.55 63.63 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.766 ' CG2' ' HB2' ' A' ' 20' ' ' SER . 0.2 OUTLIER -115.2 -82.65 0.62 Allowed 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 179.258 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . 0.515 ' O ' ' C ' ' B' ' 16' ' ' LEU . . . 67.22 -21.92 0.21 Allowed Glycine 0 N--CA 1.5 2.924 0 O-C-N 120.993 -1.067 . . . . 0.0 110.469 178.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' LEU . . . . . 1.105 ' CD1' HG23 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -27.44 -54.73 0.09 Allowed 'General case' 0 N--CA 1.514 2.736 0 CA-C-O 121.942 0.877 . . . . 0.0 110.76 -179.758 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . 0.555 HG21 HG21 ' A' ' 17' ' ' THR . 0.5 OUTLIER -138.78 -3.28 1.66 Allowed 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.975 -179.433 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . 0.538 ' O ' ' C ' ' B' ' 19' ' ' VAL . 11.9 mt-30 56.78 34.94 25.51 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 -176.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 1.085 HG11 HG11 ' A' ' 19' ' ' VAL . 1.8 p -20.43 -95.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.521 -178.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 0.916 ' O ' ' N ' ' B' ' 23' ' ' LYS . 0.5 OUTLIER -133.44 24.11 4.08 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 178.495 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.683 ' CG2' HD13 ' B' ' 7' ' ' ILE . 30.0 m -19.0 -39.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-O 122.382 1.087 . . . . 0.0 109.585 -178.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.841 ' N ' ' O ' ' B' ' 20' ' ' SER . 28.0 t -84.34 -38.71 20.0 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.009 178.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . 0.916 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.3 OUTLIER -84.91 -32.06 23.34 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.406 -0.809 . . . . 0.0 111.276 179.831 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' MET . . . . . 0.637 ' HB3' HG21 ' A' ' 14' ' ' THR . 0.0 OUTLIER -74.9 -41.07 60.44 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 118.073 -1.451 . . . . 0.0 108.462 178.812 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.674 ' HA ' ' HB3' ' B' ' 28' ' ' PHE . 11.1 mt -69.01 -44.34 72.96 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 118.319 -1.353 . . . . 0.0 108.008 177.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . 0.545 ' HA ' ' HE2' ' B' ' 3' ' ' LYS . . . -57.29 -34.5 68.75 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' SER . . . . . 0.627 ' HA ' ' HB3' ' B' ' 30' ' ' LYS . 54.0 p -84.09 -26.61 28.85 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . 0.744 ' O ' HG13 ' B' ' 31' ' ' ILE . 0.4 OUTLIER -62.54 -44.51 96.17 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.0 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . 0.791 ' HG2' HG22 ' A' ' 45' ' ' THR . 0.7 OUTLIER -74.49 -32.37 62.52 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 177.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 0.808 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 17.5 ttpp -69.17 -27.17 65.28 Favored 'General case' 0 C--O 1.192 -1.933 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 176.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.744 HG13 ' O ' ' B' ' 28' ' ' PHE . 2.0 pp -97.33 -30.6 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.113 -0.992 . . . . 0.0 109.246 178.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.737 HG22 HD21 ' A' ' 85' ' ' LEU . 1.9 mm -64.58 -53.82 37.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 177.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' THR . . . . . 0.654 HG23 ' HB2' ' A' ' 88' ' ' ALA . 0.4 OUTLIER -68.57 -40.38 80.6 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.129 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.808 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 52.7 mm-40 -70.03 -36.11 74.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.523 -0.735 . . . . 0.0 111.058 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' THR . . . . . 0.949 HG21 HG13 ' B' ' 42' ' ' VAL . 3.2 m -59.02 -52.78 64.27 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.799 -1.188 . . . . 0.0 108.651 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.844 HG13 ' HB3' ' B' ' 52' ' ' PRO . 13.6 t -54.25 -36.85 34.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 177.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . 0.629 ' HB2' ' C ' ' A' ' 88' ' ' ALA . . . -79.14 -3.84 47.46 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.485 ' N ' ' O ' ' B' ' 35' ' ' THR . 0.0 OUTLIER -102.43 -29.43 11.62 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 177.823 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' B' ' 35' ' ' THR . . . 112.66 38.55 1.29 Allowed Glycine 0 C--N 1.302 -1.355 0 C-N-CA 120.001 -1.095 . . . . 0.0 111.03 177.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . 0.634 ' CB ' HG23 ' B' ' 35' ' ' THR . 0.1 OUTLIER -130.29 133.63 46.62 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.043 -1.269 . . . . 0.0 110.745 179.364 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.441 ' HG3' ' HD2' ' B' ' 52' ' ' PRO . 0.1 OUTLIER -82.98 88.4 6.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.581 -0.7 . . . . 0.0 109.664 179.683 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.949 HG13 HG21 ' B' ' 35' ' ' THR . 25.4 m -73.39 144.91 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.507 -0.745 . . . . 0.0 110.443 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' GLN . . . . . 0.505 ' O ' ' HA ' ' A' ' 2' ' ' ASN . 19.6 mt-30 -138.9 171.53 14.19 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.469 -0.769 . . . . 0.0 110.24 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 1.001 HD12 ' CB ' ' B' ' 48' ' ' LEU . 91.5 mt -136.06 -179.16 5.49 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.276 -0.89 . . . . 0.0 110.608 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . 0.872 HG22 ' HG2' ' A' ' 29' ' ' GLU . 4.1 t -45.62 72.19 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . 0.674 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . 42.74 29.03 0.72 Allowed Glycine 0 N--CA 1.494 2.562 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . 0.73 ' CE2' ' HG ' ' B' ' 48' ' ' LEU . 0.7 OUTLIER -129.12 -32.83 2.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.054 -1.262 . . . . 0.0 110.476 179.606 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 1.011 HD11 HD11 ' A' ' 50' ' ' ILE . 8.0 mt -128.29 117.99 22.46 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.685 -1.259 . . . . 0.0 110.46 178.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -118.04 69.19 0.78 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.607 -0.683 . . . . 0.0 110.856 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' ILE . . . . . 0.919 HD13 ' HB ' ' B' ' 79' ' ' VAL . 11.2 mm -59.86 113.46 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.164 -0.96 . . . . 0.0 109.637 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . 0.444 ' O ' ' HG3' ' B' ' 51' ' ' LYS . 1.3 ptmt -138.34 121.92 11.32 Favored Pre-proline 0 N--CA 1.498 1.952 0 O-C-N 121.017 -1.052 . . . . 0.0 110.246 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' PRO . . . . . 0.844 ' HB3' HG13 ' B' ' 36' ' ' VAL . 50.2 Cg_endo -76.61 135.46 16.23 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 123.482 1.254 . . . . 0.0 112.237 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.599 ' O ' ' N ' ' B' ' 76' ' ' GLY . 33.6 m -139.41 116.8 10.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . 0.514 ' HA ' ' N ' ' B' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.492 1.653 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -176.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . 1.094 HG21 HD21 ' A' ' 92' ' ' LEU . 45.2 t . . . . . 0 N--CA 1.513 2.719 0 CA-C-O 122.706 1.241 . . . . 0.0 114.002 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 76' ' ' GLY . . . . . 0.599 ' N ' ' O ' ' B' ' 53' ' ' VAL . . . -142.56 68.12 0.45 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.896 HG21 ' CG ' ' A' ' 85' ' ' LEU . 5.3 p -36.48 95.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.827 -0.807 . . . . 0.0 112.139 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 78' ' ' SER . . . . . 0.49 ' O ' ' HB ' ' B' ' 79' ' ' VAL . 15.5 t -94.07 176.0 6.49 Favored 'General case' 0 C--N 1.293 -1.872 0 C-N-CA 119.547 -0.861 . . . . 0.0 108.846 177.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.919 ' HB ' HD13 ' B' ' 50' ' ' ILE . 14.5 p 176.24 178.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 80' ' ' LYS . . . . . 0.587 ' N ' HG22 ' B' ' 79' ' ' VAL . 0.2 OUTLIER -178.0 173.35 0.66 Allowed Pre-proline 0 C--N 1.305 -1.352 0 O-C-N 121.024 -1.047 . . . . 0.0 110.424 178.097 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 81' ' ' PRO . . . . . 0.992 ' HB3' HG11 ' A' ' 77' ' ' VAL . 51.0 Cg_endo -88.01 103.74 0.49 Allowed 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 121.834 1.689 . . . . 0.0 109.853 178.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . 0.48 ' O ' ' HB3' ' B' ' 83' ' ' GLU . . . -71.46 37.43 0.57 Allowed Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . 0.48 ' HB3' ' O ' ' B' ' 82' ' ' GLY . 1.2 tp10 64.22 -27.93 0.09 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.303 -1.116 . . . . 0.0 112.613 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 84' ' ' SER . . . . . 0.446 ' HB3' ' CB ' ' B' ' 47' ' ' PHE . 1.0 OUTLIER -52.13 -36.43 51.28 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.435 -1.415 . . . . 0.0 108.945 179.602 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.743 HD12 ' HA ' ' A' ' 33' ' ' THR . 1.2 tt -85.79 -36.42 20.1 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 86' ' ' LYS . . . . . 0.66 ' O ' ' HB3' ' B' ' 89' ' ' ALA . 0.2 OUTLIER -70.52 -35.39 73.15 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.094 179.323 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' B' ' 83' ' ' GLU . 0.2 OUTLIER -70.25 -38.87 75.25 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 178.487 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.573 ' C ' ' HB2' ' A' ' 37' ' ' ALA . . . -63.92 -37.49 87.61 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 176.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.823 ' HB1' ' CG1' ' A' ' 75' ' ' VAL . . . -55.95 -42.33 76.04 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.255 178.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.66 -31.67 58.03 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 177.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -71.74 -27.76 70.3 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 179.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 92' ' ' LEU . . . . . 0.926 ' HB3' ' HA ' ' A' ' 37' ' ' ALA . 0.5 OUTLIER -71.58 9.47 0.84 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.761 -1.435 . . . . 0.0 111.675 -179.654 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 93' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' B' ' 92' ' ' LEU . 29.9 mmtp 60.76 40.35 16.22 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 -177.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . 0.629 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 1.8 p90 -41.95 -29.94 0.24 Allowed 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.768 -178.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . 0.469 ' HG3' ' CE1' ' B' ' 94' ' ' TYR . 3.8 mp0 -59.53 -47.85 83.92 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.87 -35.52 66.58 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 177.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 178.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.543 ' CE ' HD23 ' A' ' 6' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.496 1.826 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.419 ' O ' ' HB2' ' A' ' 6' ' ' LEU . 2.8 t-20 -174.1 -169.2 0.45 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.945 -1.097 . . . . 0.0 111.635 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.623 ' O ' HG13 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -57.74 -4.87 0.32 Allowed 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.473 -0.767 . . . . 0.0 110.702 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.924 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 99.2 m -125.29 -40.31 2.13 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.323 -0.86 . . . . 0.0 108.974 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.489 ' CB ' ' HA ' ' A' ' 1' ' ' MET . 0.1 OUTLIER -61.66 -50.59 71.9 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.274 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.827 HD11 ' CG1' ' B' ' 42' ' ' VAL . 9.1 mt -57.8 -31.25 66.39 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 1.062 HG23 ' HB ' ' A' ' 21' ' ' VAL . 3.5 mt -52.55 -51.65 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 178.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.971 ' CE ' HG22 ' A' ' 7' ' ' ILE . 3.1 mmpt? -60.53 -34.24 73.82 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.884 ' HB1' HD13 ' B' ' 31' ' ' ILE . . . -55.26 -37.18 66.91 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.535 -0.866 . . . . 0.0 109.504 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.836 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.0 OUTLIER -97.12 -30.27 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.291 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.823 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -68.14 -13.62 62.36 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 118.829 -1.148 . . . . 0.0 108.542 178.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.426 ' CG ' ' N ' ' A' ' 13' ' ' ASP . 6.5 pt20 -111.14 -39.61 4.7 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.522 -0.736 . . . . 0.0 109.432 178.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.426 ' N ' ' CG ' ' A' ' 12' ' ' GLN . 0.9 OUTLIER -66.89 -36.07 81.45 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 177.408 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.861 HG22 HD21 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -97.31 -67.46 0.85 Allowed 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.376 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 46.17 29.98 3.8 Favored Glycine 0 N--CA 1.497 2.759 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 178.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 1.069 ' CD1' HG23 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -89.65 -26.85 20.52 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.621 -0.929 . . . . 0.0 109.687 179.333 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.704 HG22 ' H ' ' A' ' 19' ' ' VAL . 0.4 OUTLIER -162.15 -3.03 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.683 -178.6 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.536 ' O ' ' C ' ' A' ' 19' ' ' VAL . 9.7 mt-30 54.27 30.45 12.45 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 -177.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.969 HG11 HG11 ' B' ' 19' ' ' VAL . 2.3 p -12.25 -93.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.526 -178.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.945 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.5 OUTLIER -128.5 23.37 5.9 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 178.688 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 1.062 ' HB ' HG23 ' A' ' 7' ' ' ILE . 15.3 m -24.59 -37.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 CA-C-O 122.233 1.016 . . . . 0.0 109.4 -178.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.735 ' N ' ' O ' ' A' ' 20' ' ' SER . 48.5 t -82.28 -36.55 26.94 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.253 177.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.945 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.3 OUTLIER -86.82 -32.43 20.3 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.637 -0.665 . . . . 0.0 111.744 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.787 ' HG2' HG22 ' B' ' 14' ' ' THR . 0.0 OUTLIER -78.4 -36.67 45.44 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.433 -1.417 . . . . 0.0 109.873 179.631 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.789 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 0.4 OUTLIER -80.5 -45.04 18.15 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 118.535 -1.266 . . . . 0.0 109.345 178.904 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.603 ' HA ' ' HG2' ' A' ' 3' ' ' LYS . . . -57.24 -33.37 67.49 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 177.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.81 ' O ' HG23 ' A' ' 31' ' ' ILE . 49.4 m -87.46 -31.15 20.16 Favored 'General case' 0 C--O 1.199 -1.586 0 C-N-CA 119.687 -0.805 . . . . 0.0 109.238 178.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.969 ' HB2' HD11 ' B' ' 10' ' ' ILE . 0.1 OUTLIER -58.21 -49.71 76.1 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.04 -1.037 . . . . 0.0 109.931 179.45 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.759 ' HG2' HG22 ' B' ' 45' ' ' THR . 1.1 mt-10 -73.12 -37.4 66.68 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 1.244 ' O ' ' HB3' ' A' ' 34' ' ' GLU . 16.8 ttpt -69.06 -16.37 63.68 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 177.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 1.044 ' HA ' ' CG ' ' A' ' 34' ' ' GLU . 1.8 pp -107.39 -29.38 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.14 -0.975 . . . . 0.0 110.241 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.613 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.2 mm -63.39 -45.77 97.15 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 178.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.853 ' O ' ' HB1' ' B' ' 88' ' ' ALA . 0.5 OUTLIER -79.03 -41.32 29.15 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 177.704 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 1.244 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -59.39 -35.51 74.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.134 -0.979 . . . . 0.0 109.124 177.842 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.764 HG23 ' HB2' ' A' ' 40' ' ' ASP . 15.8 m -63.73 -48.93 75.04 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 177.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.736 HG21 HD22 ' B' ' 85' ' ' LEU . 24.5 t -55.69 -35.58 39.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 177.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.878 ' HB2' ' O ' ' B' ' 88' ' ' ALA . . . -83.14 -1.24 52.39 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 177.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -106.27 -11.69 15.94 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 177.198 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 35' ' ' THR . . . 85.88 46.28 5.44 Favored Glycine 0 C--N 1.303 -1.255 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.243 177.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.764 ' HB2' HG23 ' A' ' 35' ' ' THR . 0.2 OUTLIER -124.6 143.15 50.87 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.031 -1.276 . . . . 0.0 109.975 178.951 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.419 ' CG ' ' HB2' ' A' ' 51' ' ' LYS . 0.3 OUTLIER -105.35 97.58 7.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.549 -0.72 . . . . 0.0 110.185 -179.317 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 1.006 HG22 ' HB2' ' B' ' 1' ' ' MET . 3.2 t -84.83 172.62 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.472 -0.768 . . . . 0.0 110.134 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 43' ' ' GLN . 4.5 pt20 -157.32 107.21 2.21 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.602 -0.686 . . . . 0.0 109.207 179.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.808 HD12 ' HB2' ' A' ' 48' ' ' LEU . 16.1 mt -70.72 179.93 2.43 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.228 -0.92 . . . . 0.0 111.14 -178.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.836 HG22 ' HG2' ' B' ' 29' ' ' GLU . 1.8 t -31.63 -43.43 0.06 Allowed 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 121.053 0.454 . . . . 0.0 111.433 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.444 ' N ' HG23 ' A' ' 45' ' ' THR . . . 172.61 24.44 0.02 OUTLIER Glycine 0 N--CA 1.487 2.071 0 C-N-CA 119.347 -1.406 . . . . 0.0 111.127 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.669 ' CZ ' HG21 ' B' ' 32' ' ' ILE . 49.3 p90 -127.82 -49.33 1.36 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.696 -1.473 . . . . 0.0 111.502 178.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.035 ' CD1' HD11 ' B' ' 48' ' ' LEU . 0.3 OUTLIER -96.53 110.75 23.08 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.697 -1.252 . . . . 0.0 112.513 -179.238 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.709 ' O ' ' HB ' ' A' ' 79' ' ' VAL . 1.7 t-20 -105.82 63.33 0.67 Allowed 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.684 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.909 HD11 HG23 ' A' ' 42' ' ' VAL . 1.1 pp -57.46 130.27 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.69 0 O-C-N 121.117 -0.989 . . . . 0.0 112.67 -177.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.597 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -175.5 112.23 0.27 Allowed Pre-proline 0 N--CA 1.492 1.671 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.171 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.664 ' HG3' HG13 ' A' ' 36' ' ' VAL . 55.9 Cg_endo -90.77 156.89 4.15 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 120.882 1.055 . . . . 0.0 111.434 -178.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.915 HG22 ' O ' ' A' ' 76' ' ' GLY . 32.4 m -139.81 114.92 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 121.913 0.863 . . . . 0.0 111.114 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.619 ' HA ' ' HE1' ' B' ' 94' ' ' TYR . . . . . . . . 0 N--CA 1.499 1.989 0 O-C-N 121.691 -0.631 . . . . 0.0 112.137 -178.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.54 ' N ' ' CE1' ' B' ' 94' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.915 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -118.95 97.99 0.72 Allowed Glycine 0 N--CA 1.488 2.165 0 C-N-CA 118.837 -1.649 . . . . 0.0 109.631 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.703 HG21 HD12 ' B' ' 85' ' ' LEU . 6.1 p -63.09 84.21 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-O 122.504 1.145 . . . . 0.0 108.667 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 76' ' ' GLY . 0.3 OUTLIER -56.7 -44.15 81.24 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.374 -179.397 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.787 ' CB ' ' HA ' ' A' ' 50' ' ' ILE 0.286 1.9 p -45.98 172.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-O 122.758 1.266 . . . . 0.0 113.971 -174.392 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.601 ' N ' ' CG2' ' A' ' 79' ' ' VAL . 0.0 OUTLIER 178.62 174.22 0.39 Allowed Pre-proline 0 C--N 1.309 -1.188 0 CA-C-N 114.403 -1.272 . . . . 0.0 108.204 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.66 ' HG3' HG12 ' B' ' 79' ' ' VAL . 39.0 Cg_endo -66.77 153.77 76.81 Favored 'Trans proline' 0 C--N 1.298 -2.095 0 O-C-N 123.464 1.244 . . . . 0.0 109.166 176.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.487 ' H ' ' HA ' ' A' ' 47' ' ' PHE . . . -120.0 -83.73 0.81 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 108.239 -1.945 . . . . 0.0 108.239 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.941 ' O ' ' N ' ' A' ' 85' ' ' LEU . 17.5 tt0 -76.54 43.56 0.32 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.428 -1.042 . . . . 0.0 108.791 177.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 1.343 ' O ' ' N ' ' A' ' 86' ' ' LYS . 0.5 OUTLIER 7.21 44.69 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 122.212 1.005 . . . . 0.0 110.203 178.567 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 1.023 HD12 HG21 ' B' ' 36' ' ' VAL . 0.2 OUTLIER 20.07 28.65 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 104.538 -2.393 . . . . 0.0 104.538 -171.326 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 1.343 ' N ' ' O ' ' A' ' 84' ' ' SER 0.354 7.7 tttt -62.28 -42.07 99.04 Favored 'General case' 0 CA--C 1.483 -1.616 0 N-CA-C 103.496 -2.779 . . . . 0.0 103.496 176.383 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.257 24.0 tptt -67.4 -35.48 79.37 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 111.834 -2.439 . . . . 0.0 104.857 175.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.703 ' HB3' ' O ' ' A' ' 85' ' ' LEU . . . -71.59 -27.87 63.43 Favored 'General case' 0 C--O 1.211 -0.927 0 C-N-CA 118.326 -1.35 . . . . 0.0 108.36 178.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.954 ' HA ' HD23 ' A' ' 92' ' ' LEU . . . -59.16 -49.92 76.03 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.977 -1.077 . . . . 0.0 109.363 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.471 ' HG2' ' N ' ' A' ' 91' ' ' GLY . 2.2 pt-20 -56.95 -27.96 61.66 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.903 -1.518 . . . . 0.0 106.903 177.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.471 ' N ' ' HG2' ' A' ' 90' ' ' GLU . . . -68.39 -32.46 75.57 Favored Glycine 0 N--CA 1.488 2.155 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.186 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.954 HD23 ' HA ' ' A' ' 89' ' ' ALA . 0.8 OUTLIER -84.85 22.12 1.43 Allowed 'General case' 0 N--CA 1.504 2.263 0 O-C-N 120.213 -1.757 . . . . 0.0 110.975 -179.657 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.45 ' O ' ' C ' ' A' ' 94' ' ' TYR . 2.6 mmtt 55.29 38.19 30.01 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 -177.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.625 ' CD1' ' N ' ' B' ' 75' ' ' VAL . 1.5 t80 -33.66 -41.03 0.08 Allowed 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.81 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 . . . . . 0 N--CA 1.494 1.746 0 O-C-N 121.333 -0.854 . . . . 0.0 109.629 179.727 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 1.006 ' HB2' HG22 ' A' ' 42' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 2' ' ' ASN . . . . . 0.447 ' N ' ' HB2' ' B' ' 5' ' ' GLU . 0.7 OUTLIER 177.67 176.64 0.4 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.016 -1.053 . . . . 0.0 111.324 -179.811 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.95 ' O ' HD22 ' B' ' 25' ' ' LEU . 0.9 OUTLIER -47.63 -29.05 2.67 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.174 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . 0.548 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 16.1 m -95.71 -45.39 7.03 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.661 0.743 . . . . 0.0 109.733 179.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.662 ' HA ' ' HE2' ' B' ' 8' ' ' LYS . 0.0 OUTLIER -56.04 -49.87 72.53 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 120.945 -1.097 . . . . 0.0 108.054 179.207 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.802 ' CD1' HG11 ' A' ' 42' ' ' VAL . 7.6 mt -55.8 -35.01 65.85 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.213 -0.995 . . . . 0.0 108.662 177.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' ILE . . . . . 0.823 ' CD1' HD23 ' B' ' 25' ' ' LEU . 0.3 OUTLIER -50.87 -48.86 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 178.166 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . 0.802 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 39.7 mtmt -61.99 -37.75 86.0 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . 0.925 ' HB1' HD13 ' A' ' 31' ' ' ILE . . . -52.58 -34.39 50.33 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 119.695 -0.802 . . . . 0.0 108.911 178.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.969 HD11 ' HB2' ' A' ' 28' ' ' PHE . 0.8 OUTLIER -99.41 -36.74 5.56 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.627 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.47 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.802 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -63.21 -25.89 68.55 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -93.41 -39.21 11.04 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 177.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.472 ' OD2' ' HB3' ' A' ' 27' ' ' SER . 23.9 m-20 -68.21 -20.16 64.82 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 176.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.859 HG22 ' HB2' ' A' ' 20' ' ' SER . 31.0 p -93.77 -77.84 0.44 Allowed 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 177.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 61.97 11.45 31.47 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' LEU . . . . . 0.892 HD11 ' OG ' ' A' ' 20' ' ' SER . 3.4 mp -83.18 -65.14 1.05 Allowed 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 122.27 1.034 . . . . 0.0 109.151 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . 0.62 HG22 ' H ' ' B' ' 19' ' ' VAL . 0.5 OUTLIER -140.55 6.73 2.09 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 115.386 -0.824 . . . . 0.0 108.878 -179.724 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . 0.582 ' O ' ' C ' ' B' ' 19' ' ' VAL . 6.8 mt-30 57.38 24.5 10.17 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 -176.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 1.069 HG23 ' CD1' ' A' ' 16' ' ' LEU . 0.1 OUTLIER 17.14 -96.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.36 -178.833 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 1.024 ' O ' ' N ' ' B' ' 22' ' ' SER . 1.4 p -136.25 23.19 3.23 Favored 'General case' 0 C--N 1.272 -2.776 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 176.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.733 ' HA ' ' CE ' ' B' ' 24' ' ' MET . 17.8 m -5.35 -42.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.397 1.094 . . . . 0.0 110.452 -177.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 1.024 ' N ' ' O ' ' B' ' 20' ' ' SER . 27.3 t -73.33 -40.34 64.54 Favored 'General case' 0 C--N 1.281 -2.371 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.498 178.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . 0.873 ' N ' ' O ' ' B' ' 20' ' ' SER . 13.5 ttpt -93.26 -27.42 16.84 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.254 -0.904 . . . . 0.0 111.239 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' MET . . . . . 0.733 ' CE ' ' HA ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -73.63 -25.74 60.45 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 119.905 -1.747 . . . . 0.0 108.281 179.115 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.95 HD22 ' O ' ' B' ' 3' ' ' LYS . 0.2 OUTLIER -81.99 -46.27 14.21 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 176.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . 0.697 ' N ' ' HG ' ' B' ' 25' ' ' LEU . . . -64.27 -27.73 69.24 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 178.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' SER . . . . . 0.68 ' HA ' ' HB3' ' B' ' 30' ' ' LYS . 30.6 t -83.67 -40.07 19.41 Favored 'General case' 0 C--O 1.2 -1.549 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . 0.772 ' O ' HG13 ' B' ' 31' ' ' ILE . 0.5 OUTLIER -51.51 -46.4 63.24 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.52 0.676 . . . . 0.0 109.379 179.548 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . 0.836 ' HG2' HG22 ' A' ' 45' ' ' THR . 0.6 OUTLIER -75.31 -31.58 60.69 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 177.855 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 1.295 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 18.0 ttpt -71.41 -18.54 62.33 Favored 'General case' 0 C--O 1.191 -2.016 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 176.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.884 HD13 ' HB1' ' A' ' 9' ' ' ALA . 1.0 OUTLIER -105.82 -32.01 2.68 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.491 0 O-C-N 119.879 -1.763 . . . . 0.0 108.673 178.368 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.669 HG21 ' CZ ' ' A' ' 47' ' ' PHE . 1.5 mm -67.37 -63.42 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 176.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' THR . . . . . 0.852 ' OG1' HD22 ' A' ' 85' ' ' LEU . 0.5 OUTLIER -64.3 -45.11 89.4 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.74 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 1.295 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 15.6 mm-40 -68.79 -27.72 66.13 Favored 'General case' 0 C--N 1.31 -1.116 0 O-C-N 121.339 -0.851 . . . . 0.0 111.165 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' THR . . . . . 0.719 HG23 ' CB ' ' B' ' 40' ' ' ASP . 1.1 m -57.85 -51.14 70.84 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 177.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 1.023 HG21 HD12 ' A' ' 85' ' ' LEU . 4.3 t -54.07 -36.25 31.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 117.249 -1.78 . . . . 0.0 107.068 177.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . 0.843 ' HA ' ' HB3' ' A' ' 92' ' ' LEU . . . -81.4 1.09 34.55 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.212 177.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' B' ' 34' ' ' GLU . 0.0 OUTLIER -108.72 -25.69 10.71 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.703 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.22 40.7 1.48 Allowed Glycine 0 C--N 1.303 -1.289 0 C-N-CA 119.946 -1.121 . . . . 0.0 110.748 178.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . 0.719 ' CB ' HG23 ' B' ' 35' ' ' THR . 0.3 OUTLIER -136.77 135.83 38.39 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.086 -1.244 . . . . 0.0 110.553 179.594 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.9 93.12 9.29 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.48 -0.762 . . . . 0.0 109.006 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.827 ' CG1' HD11 ' A' ' 6' ' ' LEU . 14.1 t -59.3 135.17 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.499 -0.75 . . . . 0.0 110.008 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' GLN . . . . . 0.445 ' HA ' ' HA ' ' B' ' 49' ' ' ASN . 11.2 mt-30 -132.0 91.95 3.04 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.501 -0.749 . . . . 0.0 109.757 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.667 ' HB3' ' CE2' ' B' ' 47' ' ' PHE . 7.6 mt -67.65 -179.28 1.07 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.284 -0.885 . . . . 0.0 110.979 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . 0.759 HG22 ' HG2' ' A' ' 29' ' ' GLU . 3.2 t -52.53 73.38 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 O-C-N 122.109 -0.369 . . . . 0.0 111.687 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . 40.09 62.12 1.57 Allowed Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . 0.674 ' CE1' ' HG ' ' B' ' 48' ' ' LEU . 0.2 OUTLIER -163.45 -45.16 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.445 -1.032 . . . . 0.0 108.775 -179.867 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 1.035 HD11 ' CD1' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -125.02 102.17 7.39 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.785 -0.572 . . . . 0.0 109.958 178.843 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' ASN . . . . . 0.929 ' O ' ' O ' ' B' ' 79' ' ' VAL . 0.7 OUTLIER -120.24 100.58 7.26 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.11 -0.994 . . . . 0.0 110.568 -179.635 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' ILE . . . . . 0.693 HG13 HD11 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -90.84 140.8 15.36 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 O-C-N 121.252 -0.905 . . . . 0.0 110.921 -179.177 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . 0.499 ' HD3' ' O ' ' B' ' 51' ' ' LYS . 0.0 OUTLIER -157.3 119.37 2.11 Favored Pre-proline 0 N--CA 1.496 1.825 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.663 179.205 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' PRO . . . . . 0.754 ' HB3' HG13 ' B' ' 36' ' ' VAL . 57.2 Cg_endo -87.9 136.55 3.68 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.62 1.326 . . . . 0.0 110.778 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.581 ' O ' HG23 ' B' ' 53' ' ' VAL . 30.6 m -128.41 111.7 24.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-O 122.016 0.913 . . . . 0.0 110.642 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . 0.59 ' HA ' ' HE1' ' A' ' 94' ' ' TYR . . . . . . . . 0 N--CA 1.498 1.964 0 O-C-N 121.879 -0.513 . . . . 0.0 111.534 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . 0.7 ' CG1' HG23 ' B' ' 77' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.711 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 76' ' ' GLY . . . . . 0.611 ' O ' ' N ' ' B' ' 78' ' ' SER . . . -107.57 57.27 0.45 Allowed Glycine 0 N--CA 1.484 1.842 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.85 HG11 ' C ' ' A' ' 84' ' ' SER . 73.5 t -45.17 87.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 122.117 -0.637 . . . . 0.0 109.944 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 78' ' ' SER . . . . . 0.611 ' N ' ' O ' ' B' ' 76' ' ' GLY . 5.7 m -57.54 -129.03 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.929 ' O ' ' O ' ' B' ' 49' ' ' ASN . 1.9 m -144.34 179.74 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 119.702 -1.874 . . . . 0.0 113.2 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 80' ' ' LYS . . . . . 0.893 ' CB ' HD13 ' B' ' 48' ' ' LEU . 3.6 mmtt -101.81 -54.8 0.13 Allowed Pre-proline 0 C--N 1.296 -1.731 0 CA-C-N 113.962 -1.472 . . . . 0.0 112.526 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 81' ' ' PRO . . . . . 0.804 ' HD2' ' H ' ' B' ' 80' ' ' LYS . 28.6 Cg_endo -53.35 114.78 1.9 Allowed 'Trans proline' 0 C--N 1.298 -2.083 0 O-C-N 123.317 1.167 . . . . 0.0 110.339 -177.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -130.85 -57.9 0.09 OUTLIER Glycine 0 N--CA 1.478 1.436 0 N-CA-C 107.072 -2.411 . . . . 0.0 107.072 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . 0.833 ' O ' ' N ' ' B' ' 85' ' ' LEU . 25.7 tt0 -82.78 56.21 3.32 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 177.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 84' ' ' SER . . . . . 1.304 ' O ' ' N ' ' B' ' 86' ' ' LYS . 1.3 m 8.9 45.2 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.983 0.897 . . . . 0.0 111.561 178.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.999 ' C ' ' O ' ' B' ' 84' ' ' SER . 1.2 mt 22.08 29.36 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 103.745 -2.687 . . . . 0.0 103.745 -171.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 86' ' ' LYS . . . . . 1.304 ' N ' ' O ' ' B' ' 84' ' ' SER 0.337 8.3 tttt -59.26 -40.71 86.84 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 104.074 -2.565 . . . . 0.0 104.074 177.119 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . 0.406 ' O ' ' HG2' ' B' ' 90' ' ' GLU 0.278 6.7 tttp -63.62 -37.67 88.19 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 112.248 -2.251 . . . . 0.0 105.749 175.23 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.878 ' O ' ' HB2' ' A' ' 37' ' ' ALA . . . -78.14 -24.57 47.3 Favored 'General case' 0 C--O 1.207 -1.145 0 C-N-CA 119.023 -1.071 . . . . 0.0 108.185 178.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.716 ' N ' ' O ' ' B' ' 85' ' ' LEU . . . -76.03 -37.75 58.02 Favored 'General case' 0 C--N 1.291 -1.959 0 O-C-N 120.962 -1.086 . . . . 0.0 109.036 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' B' ' 87' ' ' LYS . 3.7 pt-20 -66.98 -23.54 65.95 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 176.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . 0.417 ' C ' ' HB1' ' A' ' 37' ' ' ALA . . . -72.39 -38.92 57.99 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 92' ' ' LEU . . . . . 0.79 ' HB3' ' HA ' ' A' ' 37' ' ' ALA . 2.2 pp -76.5 22.25 0.18 Allowed 'General case' 0 N--CA 1.503 2.218 0 CA-C-N 120.177 1.988 . . . . 0.0 110.618 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 93' ' ' LYS . . . . . 0.49 ' O ' ' N ' ' B' ' 96' ' ' ASP . 0.1 OUTLIER 54.77 49.39 18.03 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 106.457 -1.682 . . . . 0.0 106.457 -177.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . 0.638 ' HA ' HD11 ' B' ' 92' ' ' LEU . 28.3 t80 -27.56 -46.22 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.919 -178.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -57.35 -48.13 79.8 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.302 -0.874 . . . . 0.0 109.79 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 96' ' ' ASP . . . . . 0.49 ' N ' ' O ' ' B' ' 93' ' ' LYS . 7.8 m-20 -54.24 -33.54 58.67 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.414 -0.804 . . . . 0.0 109.008 178.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 97' ' ' PHE . . . . . 0.541 ' CD2' ' HB2' ' A' ' 54' ' ' ALA . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.487 ' HA ' ' CB ' ' A' ' 5' ' ' GLU . 5.8 mtp . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 120.972 0.415 . . . . 0.0 110.075 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.644 ' O ' HD12 ' A' ' 6' ' ' LEU . 5.2 t-20 -172.62 -173.34 1.0 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.055 -1.028 . . . . 0.0 111.059 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.555 ' HE3' ' CB ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -51.53 -15.7 0.48 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.219 -0.926 . . . . 0.0 110.034 179.419 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.652 ' O ' HG13 ' A' ' 7' ' ' ILE . 18.5 m -107.82 -55.42 2.36 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 122.094 0.95 . . . . 0.0 109.261 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.71 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 0.4 OUTLIER -50.83 -47.69 60.1 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.104 -0.997 . . . . 0.0 108.832 179.37 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.644 HD12 ' O ' ' A' ' 2' ' ' ASN . 1.0 OUTLIER -58.38 -30.6 66.92 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.542 -0.863 . . . . 0.0 110.146 178.563 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.652 HG13 ' O ' ' A' ' 4' ' ' THR . 1.0 OUTLIER -60.47 -41.14 86.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.829 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.824 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 33.4 mtmt -65.47 -36.42 83.84 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 177.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.926 ' CB ' HD13 ' B' ' 31' ' ' ILE . . . -55.88 -38.18 69.82 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.6 -0.688 . . . . 0.0 109.176 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.729 HG22 HG12 ' A' ' 21' ' ' VAL . 1.4 mp -90.05 -32.09 5.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 178.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.824 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -66.41 -11.14 50.06 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 119.055 -1.058 . . . . 0.0 108.345 178.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.5 tp-100 -116.36 -43.77 2.92 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.513 ' OD2' HG23 ' B' ' 31' ' ' ILE . 2.1 m-20 -65.13 -38.4 90.51 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 177.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.717 HG22 HD21 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -98.37 -70.95 0.71 Allowed 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 178.036 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.416 ' CA ' ' O ' ' A' ' 11' ' ' ALA . . . 45.06 27.42 1.54 Allowed Glycine 0 N--CA 1.5 2.952 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 178.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 1.082 ' CD1' HG23 ' B' ' 19' ' ' VAL . 0.1 OUTLIER -84.46 -20.3 31.97 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.678 -0.895 . . . . 0.0 109.255 179.139 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.756 HG21 ' CG2' ' B' ' 17' ' ' THR . 0.4 OUTLIER -162.96 -7.75 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.819 -0.551 . . . . 0.0 110.573 -178.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.478 ' O ' ' C ' ' A' ' 19' ' ' VAL . 4.6 mt-30 59.73 33.83 21.91 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 -176.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 1.006 HG11 HG11 ' B' ' 19' ' ' VAL . 2.8 p -23.88 -98.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.228 -178.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.941 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -129.71 22.7 5.43 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 178.625 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.729 HG12 HG22 ' A' ' 10' ' ' ILE . 28.1 m -25.42 -39.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 CA-C-O 122.31 1.053 . . . . 0.0 109.05 -178.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.695 ' N ' ' O ' ' A' ' 20' ' ' SER . 23.0 t -83.45 -34.57 25.4 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 114.922 -1.036 . . . . 0.0 109.326 177.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.941 ' N ' ' O ' ' A' ' 20' ' ' SER . 2.4 mtmt -87.35 -31.76 19.97 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.676 -0.64 . . . . 0.0 111.481 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.664 ' HG2' HG22 ' B' ' 14' ' ' THR . 0.0 OUTLIER -77.47 -35.71 53.5 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.45 -1.407 . . . . 0.0 108.869 179.186 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.635 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 13.4 mt -76.34 -41.42 48.4 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 118.462 -1.295 . . . . 0.0 108.737 178.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.458 ' HA ' ' HE2' ' A' ' 3' ' ' LYS . . . -62.59 -35.26 78.96 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 177.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.555 ' HA ' ' CB ' ' A' ' 30' ' ' LYS . 60.2 p -83.67 -29.02 27.95 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.635 ' HB3' ' HA ' ' A' ' 25' ' ' LEU . 0.6 OUTLIER -51.55 -40.28 59.41 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.742 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.674 ' HG3' HG21 ' B' ' 45' ' ' THR . 0.2 OUTLIER -73.49 -41.55 62.97 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 175.816 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.896 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 12.5 tttt -56.63 -22.78 36.65 Favored 'General case' 0 C--O 1.192 -1.967 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 177.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.851 HD13 ' HB1' ' B' ' 9' ' ' ALA . 0.5 OUTLIER -106.28 -30.72 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 120.521 -1.362 . . . . 0.0 109.307 178.168 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.671 HG21 ' CE2' ' B' ' 47' ' ' PHE . 1.5 mm -71.43 -53.41 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 176.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.653 ' HA ' HD23 ' B' ' 85' ' ' LEU 0.26 3.6 m -61.78 -53.86 50.19 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.73 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.896 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 62.0 mm-40 -62.14 -34.53 76.55 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.711 -0.618 . . . . 0.0 110.822 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.945 HG23 ' CB ' ' A' ' 40' ' ' ASP . 1.0 OUTLIER -55.03 -53.26 58.14 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 120.839 -1.163 . . . . 0.0 108.428 179.026 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.814 HG21 HD22 ' B' ' 85' ' ' LEU . 4.0 t -51.95 -42.35 33.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 C-N-CA 118.656 -1.217 . . . . 0.0 107.924 178.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.917 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -78.23 -1.93 35.33 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.341 177.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 35' ' ' THR . 0.0 OUTLIER -108.49 -8.01 15.64 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.73 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.28 49.7 4.59 Favored Glycine 0 C--N 1.305 -1.192 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.945 ' CB ' HG23 ' A' ' 35' ' ' THR . 0.1 OUTLIER -131.22 134.8 46.81 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.1 -1.236 . . . . 0.0 110.783 179.51 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.418 ' CD ' ' HB3' ' A' ' 51' ' ' LYS . 0.8 OUTLIER -98.57 110.21 22.84 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.35 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.787 HG22 ' HB2' ' B' ' 1' ' ' MET . 39.4 t -89.9 120.92 39.48 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 C-N-CA 119.116 -1.034 . . . . 0.0 111.031 -178.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -108.88 91.02 3.47 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.741 HD12 ' HB3' ' A' ' 48' ' ' LEU . 9.8 mt -60.88 104.53 0.37 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.547 -0.721 . . . . 0.0 110.783 -178.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.592 HG21 ' HG3' ' B' ' 29' ' ' GLU . 0.1 OUTLIER 32.91 -91.43 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 120.892 0.377 . . . . 0.0 111.402 179.498 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.494 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -149.12 29.81 1.22 Allowed Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.664 ' CE2' ' HG3' ' B' ' 29' ' ' GLU . 1.8 p90 -131.33 -22.69 2.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.286 -1.126 . . . . 0.0 111.585 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.798 HD23 ' O ' ' A' ' 80' ' ' LYS . 5.3 mt -133.86 119.52 19.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.235 -1.541 . . . . 0.0 110.712 178.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.655 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 0.6 OUTLIER -119.97 84.18 2.17 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.432 -0.793 . . . . 0.0 111.586 -178.656 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.764 HG22 ' CG2' ' A' ' 79' ' ' VAL . 1.1 pt -83.3 147.66 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.042 -1.036 . . . . 0.0 110.425 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.428 ' HG3' ' HB2' ' A' ' 78' ' ' SER . 0.4 OUTLIER -165.94 113.99 0.78 Allowed Pre-proline 0 N--CA 1.495 1.778 0 C-N-CA 119.011 -1.076 . . . . 0.0 110.72 179.427 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.535 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 47.4 Cg_endo -71.31 143.92 44.71 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 O-C-N 123.51 1.269 . . . . 0.0 111.26 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.73 HG22 ' O ' ' A' ' 76' ' ' GLY . 25.8 m -138.23 114.88 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.726 0.774 . . . . 0.0 110.526 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.82 ' HB2' ' HB3' ' B' ' 97' ' ' PHE . . . . . . . . 0 N--CA 1.499 1.997 0 CA-C-O 121.735 0.778 . . . . 0.0 112.482 -178.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.81 HG12 ' HB2' ' B' ' 89' ' ' ALA . 0.4 OUTLIER . . . . . 0 N--CA 1.496 1.833 0 CA-C-O 121.308 0.575 . . . . 0.0 109.961 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.73 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -108.15 85.72 0.42 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.18 -1.968 . . . . 0.0 108.18 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 1.109 HG11 HD13 ' B' ' 85' ' ' LEU . 73.4 t -60.19 80.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.781 -0.835 . . . . 0.0 110.557 -179.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.468 ' N ' ' O ' ' A' ' 76' ' ' GLY . 0.3 OUTLIER -75.43 178.48 5.88 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.27 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.764 ' CG2' HG22 ' A' ' 50' ' ' ILE . 6.6 p 178.64 177.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.798 ' O ' HD23 ' A' ' 48' ' ' LEU . 1.4 mttt -175.83 173.67 0.88 Allowed Pre-proline 0 N--CA 1.487 1.396 0 O-C-N 120.799 -1.188 . . . . 0.0 111.069 178.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.485 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 56.5 Cg_endo -94.96 142.69 1.32 Allowed 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 122.586 2.191 . . . . 0.0 109.407 177.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.515 ' CA ' ' HA ' ' A' ' 47' ' ' PHE . . . -106.26 163.97 13.65 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.273 -1.931 . . . . 0.0 108.273 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.34 -24.79 57.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.071 -1.252 . . . . 0.0 110.624 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.457 ' HB2' ' HB3' ' A' ' 47' ' ' PHE . 3.5 m -55.29 -36.64 66.37 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.037 -1.039 . . . . 0.0 108.652 178.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.892 HD13 HG21 ' B' ' 77' ' ' VAL . 0.5 OUTLIER -80.69 -30.78 36.38 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.757 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.815 ' HG3' HG12 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -77.32 -41.9 38.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.639 -0.663 . . . . 0.0 109.947 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.3 ttmt -64.15 -38.97 92.98 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.896 ' O ' ' HB1' ' B' ' 37' ' ' ALA . . . -66.18 -35.99 81.9 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 176.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.908 ' HB1' ' CG1' ' B' ' 75' ' ' VAL . . . -56.65 -39.39 73.62 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.774 -0.77 . . . . 0.0 108.932 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.39 -33.05 65.39 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 176.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.446 ' C ' ' H ' ' A' ' 93' ' ' LYS . . . -60.21 -42.33 98.61 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 178.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.883 ' O ' HD12 ' A' ' 92' ' ' LEU . 0.5 OUTLIER -65.2 6.01 0.31 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.729 -1.454 . . . . 0.0 110.822 179.649 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.542 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 3.1 mmtt 80.07 52.95 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 CA-C-O 122.052 0.929 . . . . 0.0 108.783 -179.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.688 ' CD2' ' HB ' ' B' ' 75' ' ' VAL . 4.5 t80 -42.28 -61.87 1.08 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 . . . . . 0 N--CA 1.499 2.016 0 O-C-N 120.878 -1.139 . . . . 0.0 110.305 179.011 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.787 ' HB2' HG22 ' A' ' 42' ' ' VAL . 9.6 mtp . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 120.869 0.366 . . . . 0.0 110.08 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 2' ' ' ASN . . . . . 0.44 ' O ' ' HB2' ' B' ' 6' ' ' LEU . 0.7 OUTLIER -172.44 -169.59 0.62 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.126 -0.984 . . . . 0.0 111.017 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.584 ' HD2' ' HB ' ' A' ' 45' ' ' THR . 0.0 OUTLIER -56.53 -10.85 1.06 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.308 -0.87 . . . . 0.0 110.098 179.61 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . 0.688 ' O ' HG13 ' B' ' 7' ' ' ILE . 37.1 m -109.86 -56.68 2.29 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 122.162 0.982 . . . . 0.0 108.761 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.628 ' HA ' ' HE2' ' B' ' 8' ' ' LYS . 0.1 OUTLIER -49.4 -46.11 47.01 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.057 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.735 HD11 ' CG1' ' A' ' 42' ' ' VAL . 5.3 mt -64.45 -27.01 68.7 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.154 -1.019 . . . . 0.0 110.557 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' ILE . . . . . 0.688 HG13 ' O ' ' B' ' 4' ' ' THR . 1.2 pp -59.36 -41.68 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 120.37 -1.456 . . . . 0.0 107.306 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . 0.767 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 18.6 mtmt -67.36 -44.09 79.84 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 177.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . 0.851 ' HB1' HD13 ' A' ' 31' ' ' ILE . . . -53.69 -32.11 50.52 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.646 -0.659 . . . . 0.0 109.863 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.734 ' O ' ' OG1' ' B' ' 14' ' ' THR . 0.8 OUTLIER -94.4 -29.85 4.21 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.478 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 178.162 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.767 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -63.08 -28.53 70.14 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 177.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.425 ' HG3' ' O ' ' B' ' 8' ' ' LYS . 58.5 mt-30 -87.96 -43.85 11.45 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.447 ' HB3' ' OG ' ' A' ' 27' ' ' SER . 94.1 m-20 -64.16 -26.1 68.38 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 177.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.827 HG22 ' HB2' ' A' ' 20' ' ' SER . 20.6 p -87.74 -76.74 0.37 Allowed 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 177.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 61.32 10.99 25.1 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' LEU . . . . . 0.879 HD22 ' O ' ' A' ' 19' ' ' VAL . 3.1 mp -82.33 -67.16 0.81 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.525 -0.985 . . . . 0.0 109.204 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . 0.756 ' CG2' HG21 ' A' ' 17' ' ' THR . 0.5 OUTLIER -137.52 6.39 2.74 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.787 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . 0.639 ' O ' ' C ' ' B' ' 19' ' ' VAL . 15.4 mt-30 57.97 25.88 12.75 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 -176.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 1.082 HG23 ' CD1' ' A' ' 16' ' ' LEU . 0.4 OUTLIER 4.17 -102.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.642 -179.099 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 0.967 ' O ' ' N ' ' B' ' 22' ' ' SER . 0.2 OUTLIER -135.2 24.09 3.52 Favored 'General case' 0 C--N 1.27 -2.853 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 177.33 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.601 ' C ' ' O ' ' B' ' 20' ' ' SER . 35.2 m -12.4 -38.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-O 122.394 1.092 . . . . 0.0 110.469 -177.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.967 ' N ' ' O ' ' B' ' 20' ' ' SER . 12.1 t -80.14 -46.87 15.65 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.34 177.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . 0.939 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.1 OUTLIER -85.44 -24.1 27.59 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.855 -0.528 . . . . 0.0 110.085 178.624 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' MET . . . . . 0.599 ' CE ' HG21 ' B' ' 10' ' ' ILE . 3.5 tmm? -68.37 -45.1 73.71 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.701 ' HA ' ' HB3' ' B' ' 28' ' ' PHE . 11.6 mt -71.0 -34.79 71.69 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 176.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . 0.585 ' HB3' ' HA ' ' B' ' 23' ' ' LYS . . . -62.29 -34.72 77.12 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 177.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' SER . . . . . 0.466 ' HA ' ' HB3' ' B' ' 30' ' ' LYS . 0.1 OUTLIER -76.38 -40.71 50.28 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 177.636 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . 0.701 ' HB3' ' HA ' ' B' ' 25' ' ' LEU . 0.1 OUTLIER -52.84 -45.94 67.57 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.163 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . 0.664 ' HG3' ' CE2' ' A' ' 47' ' ' PHE . 1.2 tt0 -68.58 -36.38 78.66 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 177.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 1.246 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 13.4 ttmt -64.71 -22.74 67.05 Favored 'General case' 0 C--O 1.191 -1.989 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.926 HD13 ' CB ' ' A' ' 9' ' ' ALA . 0.6 OUTLIER -105.83 -27.61 3.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 O-C-N 120.282 -1.511 . . . . 0.0 109.335 178.237 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.645 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.2 mm -73.18 -60.42 2.43 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 177.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' THR . . . . . 0.598 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 0.6 OUTLIER -68.75 -35.21 76.81 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.553 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 1.246 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 31.1 mm-40 -78.54 -37.78 42.06 Favored 'General case' 0 C--O 1.207 -1.184 0 O-C-N 121.115 -0.99 . . . . 0.0 111.952 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' THR . . . . . 0.514 ' CB ' ' O ' ' B' ' 31' ' ' ILE . 37.2 m -61.95 -49.99 73.92 Favored 'General case' 0 N--CA 1.504 2.246 0 CA-C-N 120.714 1.597 . . . . 0.0 109.201 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.734 HG11 HD22 ' A' ' 85' ' ' LEU . 2.1 t -52.83 -43.53 45.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 178.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . 0.896 ' HB1' ' O ' ' A' ' 88' ' ' ALA . . . -85.99 0.82 52.31 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.834 178.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.747 ' HB2' ' O ' ' B' ' 34' ' ' GLU . 7.6 tppt? -96.05 -33.46 12.1 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 177.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 134.01 33.44 0.33 Allowed Glycine 0 C--N 1.303 -1.263 0 C-N-CA 119.581 -1.295 . . . . 0.0 111.482 177.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . 0.453 ' CB ' ' CG2' ' B' ' 35' ' ' THR . 0.1 OUTLIER -144.85 157.55 44.12 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.752 -1.44 . . . . 0.0 110.66 179.356 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.401 ' HG3' ' HD2' ' B' ' 52' ' ' PRO . 4.5 mptp? -103.96 99.81 9.57 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.518 -0.739 . . . . 0.0 109.61 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.511 HG13 HD11 ' A' ' 6' ' ' LEU . 59.7 t -59.07 136.28 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.584 -0.698 . . . . 0.0 110.085 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -127.96 97.25 4.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.342 -0.849 . . . . 0.0 109.403 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.714 HD12 ' HB3' ' B' ' 48' ' ' LEU . 11.0 mt -69.1 101.6 1.47 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.249 -0.907 . . . . 0.0 110.442 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . 0.674 HG21 ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 32.34 -95.1 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.036 0 O-C-N 122.052 -0.405 . . . . 0.0 111.451 179.277 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -144.41 30.71 1.85 Allowed Glycine 0 N--CA 1.487 2.037 0 C-N-CA 119.668 -1.253 . . . . 0.0 110.448 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . 0.702 ' O ' ' HA ' ' B' ' 81' ' ' PRO . 3.9 p90 -133.65 -18.6 2.15 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.893 -1.357 . . . . 0.0 111.686 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.714 ' HB3' HD12 ' B' ' 44' ' ' LEU . 4.6 mt -135.47 120.25 18.43 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.337 -1.477 . . . . 0.0 111.196 178.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' ASN . . . . . 0.53 ' O ' ' HA ' ' B' ' 79' ' ' VAL . 2.6 m120 -116.95 94.56 4.64 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.506 -0.747 . . . . 0.0 111.208 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' ILE . . . . . 0.647 HG22 HG21 ' B' ' 36' ' ' VAL . 33.8 mm -90.19 141.91 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.305 -0.872 . . . . 0.0 109.739 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . 0.432 ' O ' ' N ' ' B' ' 78' ' ' SER . 2.3 pttt -162.44 128.63 2.35 Favored Pre-proline 0 N--CA 1.498 1.951 0 O-C-N 120.582 -1.324 . . . . 0.0 111.439 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' PRO . . . . . 0.566 ' O ' HG13 ' B' ' 53' ' ' VAL . 52.5 Cg_endo -77.12 145.15 24.27 Favored 'Trans proline' 0 C--N 1.314 -1.24 0 O-C-N 123.531 1.28 . . . . 0.0 110.72 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.659 HG22 ' O ' ' B' ' 76' ' ' GLY . 15.3 m -156.57 121.28 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-O 121.257 0.551 . . . . 0.0 109.962 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . 0.832 ' HA ' ' N ' ' B' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.12 -0.988 . . . . 0.0 111.561 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . 0.908 ' CG1' ' HB1' ' A' ' 89' ' ' ALA . 0.9 OUTLIER . . . . . 0 N--CA 1.517 2.894 0 CA-C-O 121.908 0.861 . . . . 0.0 109.288 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 76' ' ' GLY . . . . . 0.659 ' O ' HG22 ' B' ' 53' ' ' VAL . . . -157.17 110.63 0.45 Allowed Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.892 HG21 HD13 ' A' ' 85' ' ' LEU . 2.7 p -67.93 89.42 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.395 -1.062 . . . . 0.0 111.31 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 78' ' ' SER . . . . . 0.617 ' C ' HG12 ' B' ' 79' ' ' VAL . 0.3 OUTLIER -74.52 -176.38 2.72 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 177.343 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.617 HG12 ' C ' ' B' ' 78' ' ' SER . 0.2 OUTLIER 179.84 174.66 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.298 -0.876 . . . . 0.0 109.028 179.676 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 80' ' ' LYS . . . . . 0.555 ' O ' HD23 ' B' ' 48' ' ' LEU . 4.7 mttt 179.25 174.25 0.42 Allowed Pre-proline 0 C--N 1.307 -1.243 0 O-C-N 121.492 -0.755 . . . . 0.0 109.379 178.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 81' ' ' PRO . . . . . 0.702 ' HA ' ' O ' ' B' ' 47' ' ' PHE . 52.3 Cg_endo -95.68 171.57 1.22 Allowed 'Trans proline' 0 C--N 1.296 -2.206 0 C-N-CA 121.856 1.704 . . . . 0.0 109.567 177.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' B' ' 47' ' ' PHE . . . -120.5 -92.63 1.31 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 106.177 -2.769 . . . . 0.0 106.177 177.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . 0.877 ' O ' ' N ' ' B' ' 85' ' ' LEU . 29.2 tt0 -80.13 51.61 1.41 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 175.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 84' ' ' SER . . . . . 0.671 ' O ' HG21 ' A' ' 77' ' ' VAL . 0.1 OUTLIER 8.27 44.15 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.007 179.586 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 1.109 HD13 HG11 ' A' ' 77' ' ' VAL . 3.6 mp 20.18 28.93 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 103.104 -2.924 . . . . 0.0 103.104 -172.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 86' ' ' LYS . . . . . 0.59 ' HD2' ' HB2' ' B' ' 84' ' ' SER 0.349 4.0 tttp -57.94 -42.59 85.23 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 104.418 -2.438 . . . . 0.0 104.418 177.397 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . 0.419 ' O ' ' HG2' ' B' ' 90' ' ' GLU 0.282 15.8 tttt -69.2 -31.17 69.59 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 111.789 -2.459 . . . . 0.0 105.976 175.654 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.768 ' HB3' ' HB3' ' B' ' 85' ' ' LEU . . . -78.02 -27.04 48.8 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 118.19 -1.404 . . . . 0.0 107.917 178.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 1.008 ' HA ' HD23 ' B' ' 92' ' ' LEU . . . -64.96 -48.7 73.1 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.294 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . 0.423 ' HG2' ' N ' ' B' ' 91' ' ' GLY . 4.0 pt-20 -59.24 -28.08 66.37 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 177.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . 0.423 ' N ' ' HG2' ' B' ' 90' ' ' GLU . . . -75.51 -24.49 70.34 Favored Glycine 0 N--CA 1.49 2.255 0 C-N-CA 120.462 -0.875 . . . . 0.0 111.137 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 92' ' ' LEU . . . . . 1.008 HD23 ' HA ' ' B' ' 89' ' ' ALA . 0.3 OUTLIER -88.05 23.92 1.96 Allowed 'General case' 0 N--CA 1.503 2.216 0 O-C-N 120.322 -1.693 . . . . 0.0 110.544 -179.738 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 93' ' ' LYS . . . . . 0.406 ' O ' ' N ' ' B' ' 96' ' ' ASP . 1.2 mmmm 55.11 35.86 25.7 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 -177.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . 0.538 ' CD1' ' N ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -41.71 -43.62 2.92 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.794 -178.701 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . 0.434 ' HG2' ' N ' ' B' ' 96' ' ' ASP . 4.9 pm0 -53.81 -36.11 62.12 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.264 -0.897 . . . . 0.0 109.289 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 96' ' ' ASP . . . . . 0.434 ' N ' ' HG2' ' B' ' 95' ' ' GLU . 20.1 t70 -64.97 -34.35 78.23 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 177.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 97' ' ' PHE . . . . . 0.82 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.839 ' HB3' HG22 ' B' ' 42' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.446 ' HA ' ' O ' ' B' ' 43' ' ' GLN . 52.2 p-10 -171.66 -149.25 0.06 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.988 -1.07 . . . . 0.0 112.044 178.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.895 ' HA ' HD11 ' A' ' 25' ' ' LEU . 3.8 tttm -51.32 -6.94 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.44 -0.788 . . . . 0.0 111.622 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.645 ' O ' HG13 ' A' ' 7' ' ' ILE . 48.7 m -118.13 -62.49 1.54 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.849 -1.157 . . . . 0.0 110.586 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.542 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 4.9 mt-10 -49.22 -42.02 39.08 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.071 -1.018 . . . . 0.0 109.167 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.696 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 21.0 mt -62.26 -32.51 73.22 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.111 -1.035 . . . . 0.0 109.556 178.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.828 HG22 HD23 ' A' ' 25' ' ' LEU . 1.0 OUTLIER -57.18 -43.95 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 178.292 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.901 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 2.6 mtpt -63.56 -34.75 78.49 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.862 ' HB1' HD13 ' B' ' 31' ' ' ILE . . . -52.56 -40.12 62.21 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.807 -0.757 . . . . 0.0 109.155 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.776 HG22 HG12 ' A' ' 21' ' ' VAL . 1.5 mp -91.15 -32.1 5.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 178.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.901 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -66.79 -13.06 61.05 Favored 'General case' 0 C--N 1.292 -1.918 0 O-C-N 120.756 -1.215 . . . . 0.0 108.923 178.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.444 ' N ' ' O ' ' A' ' 8' ' ' LYS . 11.5 pt20 -114.58 -39.98 3.68 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.45 -0.781 . . . . 0.0 109.656 179.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.426 ' HB3' ' OG ' ' B' ' 27' ' ' SER . 1.0 OUTLIER -73.95 -20.29 60.41 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 176.887 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 1.017 HG22 HD11 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -119.14 -83.99 0.65 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 179.232 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.539 ' O ' ' C ' ' A' ' 16' ' ' LEU . . . 68.6 -21.17 0.34 Allowed Glycine 0 N--CA 1.495 2.588 0 O-C-N 120.957 -1.09 . . . . 0.0 110.843 178.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 1.017 HD11 HG22 ' A' ' 14' ' ' THR . 0.0 OUTLIER -28.77 -59.68 0.13 Allowed 'General case' 0 N--CA 1.518 2.973 0 CA-C-O 122.004 0.906 . . . . 0.0 110.266 -179.166 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.589 HG21 ' CG2' ' B' ' 17' ' ' THR . 0.6 OUTLIER -130.23 -7.28 4.3 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.564 -179.932 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.566 ' O ' ' C ' ' A' ' 19' ' ' VAL . 23.6 mt-30 57.25 36.86 27.88 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -177.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 1.062 HG11 HG11 ' B' ' 19' ' ' VAL . 1.0 OUTLIER -19.62 -93.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.872 -178.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.935 ' O ' ' N ' ' A' ' 22' ' ' SER . 0.4 OUTLIER -134.39 25.03 3.8 Favored 'General case' 0 C--N 1.278 -2.506 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 177.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.776 HG12 HG22 ' A' ' 10' ' ' ILE . 27.3 m -16.34 -38.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 122.684 1.23 . . . . 0.0 109.466 -178.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.935 ' N ' ' O ' ' A' ' 20' ' ' SER . 32.2 p -84.55 -39.31 18.93 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 114.66 -1.154 . . . . 0.0 110.38 178.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.926 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.3 OUTLIER -89.69 -25.38 21.25 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 121.245 -0.91 . . . . 0.0 110.613 179.593 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.963 ' HB3' HG21 ' B' ' 14' ' ' THR . 0.0 OUTLIER -81.01 -35.02 32.47 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.25 -1.531 . . . . 0.0 109.361 178.9 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.895 HD11 ' HA ' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -80.75 -40.99 24.27 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 117.875 -1.53 . . . . 0.0 107.141 177.819 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.502 ' CB ' ' O ' ' A' ' 22' ' ' SER . . . -60.55 -25.74 66.38 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 176.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.494 ' HA ' ' HB3' ' A' ' 30' ' ' LYS . 7.0 t -83.42 -37.9 22.62 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.756 ' HA ' ' CG1' ' A' ' 31' ' ' ILE . 0.1 OUTLIER -60.11 -33.04 71.56 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.486 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.663 ' HG3' ' CD1' ' A' ' 28' ' ' PHE . 29.6 mt-10 -80.06 -33.89 38.61 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 177.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.85 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 6.6 tttm -69.46 -28.0 65.72 Favored 'General case' 0 C--O 1.195 -1.799 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 177.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.935 HD13 ' HB1' ' B' ' 9' ' ' ALA . 1.1 pp -96.98 -30.3 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.217 -0.927 . . . . 0.0 109.728 179.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.747 HG21 ' CE1' ' B' ' 47' ' ' PHE . 1.6 mm -65.09 -53.98 34.68 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 177.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.629 HG23 ' HB2' ' B' ' 88' ' ' ALA . 0.4 OUTLIER -69.09 -37.3 78.35 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.162 -1.015 . . . . 0.0 108.464 179.591 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.85 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 15.5 mm-40 -73.17 -38.41 66.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.431 -0.793 . . . . 0.0 111.25 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.539 ' N ' ' O ' ' A' ' 31' ' ' ILE . 19.4 m -58.13 -48.49 80.08 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.697 -1.252 . . . . 0.0 108.097 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.776 HG13 ' HB3' ' A' ' 52' ' ' PRO . 2.8 t -55.84 -36.79 44.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 106.652 -1.611 . . . . 0.0 106.652 177.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.768 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -80.29 -4.01 51.63 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -101.81 -32.58 10.19 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.583 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.72 34.57 0.79 Allowed Glycine 0 C--N 1.302 -1.33 0 C-N-CA 119.682 -1.247 . . . . 0.0 111.472 177.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.53 ' HB2' HG23 ' A' ' 35' ' ' THR . 0.4 OUTLIER -135.8 144.0 45.5 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.856 -1.379 . . . . 0.0 110.552 179.262 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.454 ' HG2' ' HB2' ' A' ' 51' ' ' LYS . 49.0 mtmt -91.67 92.4 8.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.517 -0.739 . . . . 0.0 109.978 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.608 HG23 ' HB ' ' A' ' 50' ' ' ILE . 35.4 m -63.05 147.29 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.533 -0.73 . . . . 0.0 110.413 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.882 ' O ' HD23 ' A' ' 44' ' ' LEU . 31.9 mt-30 -142.74 171.41 14.08 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.308 -0.87 . . . . 0.0 110.49 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.882 HD23 ' O ' ' A' ' 43' ' ' GLN . 21.3 mt -131.47 -177.99 4.66 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.512 -0.743 . . . . 0.0 109.781 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.829 HG22 ' HG2' ' B' ' 29' ' ' GLU . 2.8 t -43.25 66.23 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.88 -0.512 . . . . 0.0 112.098 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.78 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . 46.98 23.03 1.39 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.802 ' HA ' ' HA2' ' A' ' 82' ' ' GLY . 0.7 OUTLIER -117.61 -37.83 3.4 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 121.014 -1.286 . . . . 0.0 109.522 179.39 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.832 ' HB2' HD12 ' A' ' 44' ' ' LEU . 6.9 mt -120.6 118.86 31.25 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.442 -1.411 . . . . 0.0 111.095 177.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.672 ' H ' ' HB2' ' A' ' 80' ' ' LYS . 32.6 t-20 -116.9 85.64 2.36 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.766 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.64 HD13 ' HA ' ' A' ' 79' ' ' VAL . 40.1 mm -86.12 126.07 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.444 -0.785 . . . . 0.0 110.473 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.598 ' HD2' HG13 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -147.48 130.69 8.09 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.353 -0.842 . . . . 0.0 109.441 179.307 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.776 ' HB3' HG13 ' A' ' 36' ' ' VAL . 53.7 Cg_endo -78.18 142.09 18.97 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 123.57 1.3 . . . . 0.0 112.467 -178.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.7 HG22 ' O ' ' A' ' 76' ' ' GLY . 33.7 m -134.72 109.64 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 CA-C-O 121.696 0.76 . . . . 0.0 110.92 178.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.731 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.504 2.232 0 O-C-N 121.43 -0.794 . . . . 0.0 111.471 -179.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.731 ' HA ' ' HA ' ' A' ' 54' ' ' ALA . 0.8 OUTLIER . . . . . 0 N--CA 1.477 0.898 0 CA-C-O 122.043 0.925 . . . . 0.0 109.733 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.7 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -114.24 86.22 0.41 Allowed Glycine 0 C--N 1.289 -2.067 0 N-CA-C 108.886 -1.685 . . . . 0.0 108.886 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.84 HG21 HD13 ' B' ' 85' ' ' LEU . 3.8 p -45.21 87.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 CA-C-O 121.766 0.793 . . . . 0.0 110.792 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.544 ' N ' ' O ' ' A' ' 76' ' ' GLY . 0.1 OUTLIER -59.37 -162.35 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.122 179.8 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.712 HG11 ' HD3' ' B' ' 81' ' ' PRO . 5.4 p 179.93 178.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.672 ' HB2' ' H ' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -139.76 177.69 1.92 Allowed Pre-proline 0 C--N 1.305 -1.331 0 O-C-N 120.896 -1.127 . . . . 0.0 110.455 179.051 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.435 ' HD3' ' CG ' ' A' ' 80' ' ' LYS . 56.4 Cg_endo -106.69 84.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.298 -2.095 0 C-N-CA 124.074 3.183 . . . . 0.0 108.592 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.802 ' HA2' ' HA ' ' A' ' 47' ' ' PHE . . . -55.73 100.72 0.1 Allowed Glycine 0 N--CA 1.483 1.779 0 C-N-CA 118.698 -1.715 . . . . 0.0 110.955 -177.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.414 ' HA ' ' HB2' ' A' ' 86' ' ' LYS . 6.2 pt-20 -57.35 -29.01 63.64 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.451 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 0.3 OUTLIER -61.88 -32.76 73.15 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 177.3 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.819 HD21 HG21 ' B' ' 36' ' ' VAL . 1.9 tt -81.69 -39.45 24.28 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 177.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.698 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 0.3 OUTLIER -69.78 -45.93 66.9 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.614 0.721 . . . . 0.0 109.53 179.301 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.69 -37.55 87.78 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.662 ' C ' ' HB2' ' B' ' 37' ' ' ALA . . . -66.28 -36.89 84.13 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 176.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 1.045 ' HB1' HG21 ' B' ' 75' ' ' VAL . . . -57.77 -31.6 66.68 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.654 ' HA ' ' CD1' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -65.2 -31.33 72.45 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 177.096 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.473 ' N ' ' HG3' ' A' ' 90' ' ' GLU . . . -66.01 -31.85 80.73 Favored Glycine 0 N--CA 1.484 1.869 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 178.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.877 HD12 ' HB2' ' A' ' 93' ' ' LYS . 1.0 OUTLIER -58.19 -43.39 87.52 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 120.723 -1.457 . . . . 0.0 111.386 -179.253 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.877 ' HB2' HD12 ' A' ' 92' ' ' LEU . 0.0 OUTLIER 164.82 46.11 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -179.651 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.654 ' CD1' ' HA ' ' A' ' 90' ' ' GLU . 2.2 t80 -40.29 -73.29 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -178.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.197 -0.939 . . . . 0.0 110.256 -178.408 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.713 ' CE ' HD23 ' B' ' 6' ' ' LEU . 10.0 mtp . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 2' ' ' ASN . . . . . 0.498 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 10.2 p30 -170.86 -156.63 0.12 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.971 -1.081 . . . . 0.0 112.191 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.517 ' HE3' ' HB ' ' A' ' 45' ' ' THR . 0.3 OUTLIER -57.07 -4.69 0.2 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.61 -0.681 . . . . 0.0 111.26 -179.282 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . 0.656 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 93.9 m -124.08 -42.15 2.16 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.935 -1.103 . . . . 0.0 109.743 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.58 ' CB ' ' HA ' ' B' ' 1' ' ' MET . 0.0 OUTLIER -63.68 -53.49 50.54 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.134 -0.979 . . . . 0.0 108.709 179.087 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.764 ' O ' ' HB3' ' B' ' 9' ' ' ALA . 14.8 mt -60.0 -29.78 68.7 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.335 -0.946 . . . . 0.0 108.964 178.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 7' ' ' ILE . . . . . 1.042 HG23 ' HB ' ' B' ' 21' ' ' VAL . 1.1 mt -54.65 -55.73 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . 0.913 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 14.6 mtmt -56.57 -34.24 66.94 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 177.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . 0.935 ' HB1' HD13 ' A' ' 31' ' ' ILE . . . -53.22 -38.63 63.08 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.585 -0.846 . . . . 0.0 109.259 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.793 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.4 mp -92.7 -31.15 4.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 177.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.913 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -68.92 -6.48 27.71 Favored 'General case' 0 C--N 1.29 -2.0 0 C-N-CA 118.38 -1.328 . . . . 0.0 108.645 178.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.42 ' CG ' ' N ' ' B' ' 13' ' ' ASP . 12.7 pt20 -122.45 -40.13 2.5 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.324 -0.86 . . . . 0.0 110.13 179.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.433 ' HB2' ' O ' ' B' ' 9' ' ' ALA . 1.0 OUTLIER -70.76 -30.04 66.43 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 177.22 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 1.149 HG22 ' CD1' ' B' ' 16' ' ' LEU 0.271 0.2 OUTLIER -101.62 -75.59 0.59 Allowed 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.286 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.91 14.37 51.93 Favored Glycine 0 N--CA 1.499 2.868 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 177.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 16' ' ' LEU . . . . . 1.149 ' CD1' HG22 ' B' ' 14' ' ' THR . 4.7 mp -53.02 -64.99 0.64 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.557 -0.966 . . . . 0.0 110.005 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . 0.589 ' CG2' HG21 ' A' ' 17' ' ' THR . 0.5 OUTLIER -141.92 9.47 1.94 Allowed 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.696 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . 0.638 ' O ' ' C ' ' B' ' 19' ' ' VAL . 14.6 mt-30 57.95 27.48 14.79 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -175.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 1.062 HG11 HG11 ' A' ' 19' ' ' VAL . 1.2 p -2.13 -96.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.988 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 0.971 ' O ' ' N ' ' B' ' 22' ' ' SER . 0.8 OUTLIER -134.09 23.74 3.86 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 177.496 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 1.042 ' HB ' HG23 ' B' ' 7' ' ' ILE . 28.6 m -9.93 -40.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 CA-C-O 122.415 1.102 . . . . 0.0 110.857 -178.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.971 ' N ' ' O ' ' B' ' 20' ' ' SER . 7.1 m -77.92 -39.68 42.1 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.264 178.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . 0.91 ' N ' ' O ' ' B' ' 20' ' ' SER . 1.3 mtmt -89.47 -25.71 21.32 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.478 -0.764 . . . . 0.0 111.113 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' MET . . . . . 0.67 ' SD ' ' HA ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -74.79 -40.59 61.05 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 117.529 -1.668 . . . . 0.0 108.795 179.225 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.781 HD12 HG13 ' B' ' 7' ' ' ILE . 0.5 OUTLIER -74.15 -40.47 62.58 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 117.708 -1.597 . . . . 0.0 107.291 176.804 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . 0.515 ' HA ' ' HE2' ' B' ' 3' ' ' LYS . . . -60.15 -33.38 72.09 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 177.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' SER . . . . . 0.676 ' HA ' ' HB3' ' B' ' 30' ' ' LYS . 18.6 m -78.63 -34.1 46.81 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . 0.864 ' O ' HG13 ' B' ' 31' ' ' ILE . 0.3 OUTLIER -60.72 -49.17 78.6 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.768 -0.582 . . . . 0.0 109.689 179.413 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . 0.829 ' HG2' HG22 ' A' ' 45' ' ' THR . 0.6 OUTLIER -71.89 -33.49 68.38 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 178.043 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 0.92 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 10.8 ttpp -68.59 -21.02 64.53 Favored 'General case' 0 C--O 1.189 -2.085 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 176.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.864 HG13 ' O ' ' B' ' 28' ' ' PHE . 1.2 pp -105.15 -28.8 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 120.557 -1.339 . . . . 0.0 109.198 178.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.645 HG21 ' HZ ' ' A' ' 47' ' ' PHE . 1.6 mm -69.64 -50.97 45.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 176.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' THR . . . . . 0.733 ' HB ' ' O ' ' B' ' 29' ' ' GLU . 0.3 OUTLIER -70.33 -40.21 74.29 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.46 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.92 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 39.4 mm-40 -73.91 -33.03 63.83 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.419 -0.801 . . . . 0.0 111.163 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 35' ' ' THR . . . . . 0.994 HG21 HG23 ' B' ' 42' ' ' VAL . 1.6 m -59.27 -48.75 80.45 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 120.53 -1.356 . . . . 0.0 107.531 178.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.863 ' CG1' ' HB2' ' A' ' 89' ' ' ALA . 1.2 t -56.12 -35.1 40.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 177.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . 0.662 ' HB2' ' C ' ' A' ' 88' ' ' ALA . . . -77.59 -1.35 30.32 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.534 0.683 . . . . 0.0 109.216 176.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.427 ' H ' ' C ' ' B' ' 35' ' ' THR . 0.4 OUTLIER -115.68 -5.4 12.14 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.737 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.44 48.14 8.35 Favored Glycine 0 C--N 1.301 -1.378 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . 0.842 ' CB ' HG23 ' B' ' 35' ' ' THR . 0.1 OUTLIER -128.05 117.79 22.32 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.173 -1.192 . . . . 0.0 110.07 179.273 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 12.9 mtmt -70.51 80.82 0.57 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.492 -0.755 . . . . 0.0 109.954 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.994 HG23 HG21 ' B' ' 35' ' ' THR . 2.7 t -68.29 147.4 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.314 -0.866 . . . . 0.0 109.257 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 43' ' ' GLN . . . . . 0.446 ' O ' ' HA ' ' A' ' 2' ' ' ASN . 31.0 mt-30 -143.4 113.51 7.25 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.067 -1.021 . . . . 0.0 110.705 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.804 HD12 ' CB ' ' B' ' 48' ' ' LEU . 45.9 mt -73.98 120.11 19.11 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.271 -0.893 . . . . 0.0 109.939 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . 0.547 ' HB ' ' HD2' ' A' ' 3' ' ' LYS . 0.0 OUTLIER 31.68 -96.19 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.757 -0.589 . . . . 0.0 110.583 179.793 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . 0.455 ' H ' HG23 ' B' ' 45' ' ' THR . . . -138.79 7.54 3.29 Favored Glycine 0 N--CA 1.482 1.732 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . 0.747 ' CE1' HG21 ' A' ' 32' ' ' ILE . 37.4 p90 -105.46 -54.99 2.39 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.588 -1.536 . . . . 0.0 111.76 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.804 ' CB ' HD12 ' B' ' 44' ' ' LEU . 0.2 OUTLIER -92.12 148.03 22.49 Favored 'General case' 0 C--N 1.292 -1.903 0 O-C-N 120.047 -1.658 . . . . 0.0 113.241 -178.849 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 49' ' ' ASN . . . . . 0.535 ' O ' ' HB ' ' B' ' 79' ' ' VAL . 1.4 m-20 -132.82 146.22 51.64 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 178.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 50' ' ' ILE . . . . . 0.917 ' HA ' HG21 ' B' ' 79' ' ' VAL . 26.8 mm -137.21 98.76 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 O-C-N 120.97 -1.081 . . . . 0.0 111.601 -178.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . 0.534 ' N ' ' CG1' ' B' ' 79' ' ' VAL . 2.5 pttt -145.56 126.29 7.34 Favored Pre-proline 0 N--CA 1.487 1.415 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 52' ' ' PRO . . . . . 0.765 ' CD ' HG22 ' B' ' 36' ' ' VAL . 55.6 Cg_endo -88.08 151.21 6.96 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.239 1.126 . . . . 0.0 111.849 -178.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.566 HG11 ' HB2' ' B' ' 78' ' ' SER . 14.0 m -133.14 118.64 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-O 121.506 0.67 . . . . 0.0 109.838 178.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . 0.881 ' HA ' ' HA ' ' B' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 122.694 1.235 . . . . 0.0 112.899 -177.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . 1.045 HG21 ' HB1' ' A' ' 89' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.519 2.989 0 CA-C-O 122.064 0.935 . . . . 0.0 111.248 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 76' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' B' ' 53' ' ' VAL . . . -140.64 -144.9 4.53 Favored Glycine 0 N--CA 1.483 1.772 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.467 HG23 ' HD2' ' A' ' 86' ' ' LYS . 7.6 t -140.9 85.64 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 78' ' ' SER . . . . . 0.566 ' HB2' HG11 ' B' ' 53' ' ' VAL . 0.3 OUTLIER -57.93 -50.58 72.88 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.53 0.681 . . . . 0.0 111.279 -179.139 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.917 HG21 ' HA ' ' B' ' 50' ' ' ILE . 17.7 m -51.54 -176.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -176.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 80' ' ' LYS . . . . . 0.739 ' HB2' ' HD2' ' B' ' 81' ' ' PRO . 0.0 OUTLIER 178.87 177.26 0.3 Allowed Pre-proline 0 N--CA 1.484 1.251 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.033 -178.727 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 81' ' ' PRO . . . . . 0.739 ' HD2' ' HB2' ' B' ' 80' ' ' LYS . 45.1 Cg_endo -72.54 137.61 28.12 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 123.508 1.268 . . . . 0.0 110.926 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . 0.576 ' N ' ' O ' ' B' ' 47' ' ' PHE . . . -94.92 -154.6 31.02 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . 0.51 ' HA ' ' HB2' ' B' ' 86' ' ' LYS . 16.4 pt-20 -88.05 -16.73 32.81 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.369 -1.077 . . . . 0.0 110.739 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 84' ' ' SER . . . . . 0.475 ' HB2' ' HB3' ' B' ' 47' ' ' PHE . 3.4 m -53.6 -37.14 62.72 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.067 -1.021 . . . . 0.0 109.51 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.84 HD13 HG21 ' A' ' 77' ' ' VAL . 0.5 OUTLIER -81.67 -33.26 31.37 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.717 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 86' ' ' LYS . . . . . 0.51 ' HB2' ' HA ' ' B' ' 83' ' ' GLU . 7.5 mttt -74.43 -27.46 60.62 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.382 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 1.3 ttmm -74.7 -39.16 62.11 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 177.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.686 ' HB1' ' HB2' ' A' ' 37' ' ' ALA . . . -64.8 -35.19 80.3 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 176.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.953 ' HA ' HD23 ' B' ' 92' ' ' LEU . . . -54.48 -45.43 73.21 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.454 -0.898 . . . . 0.0 109.19 178.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.9 -31.85 51.36 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 177.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' B' ' 88' ' ' ALA . . . -63.38 -38.65 96.73 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 178.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 92' ' ' LEU . . . . . 0.953 HD23 ' HA ' ' B' ' 89' ' ' ALA . 0.7 OUTLIER -75.46 15.17 0.49 Allowed 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.523 -1.575 . . . . 0.0 110.957 -179.823 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 93' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' B' ' 92' ' ' LEU . 22.3 mmtm 57.82 44.57 19.97 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 -177.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . 0.713 ' C ' ' CD1' ' B' ' 94' ' ' TYR . 0.1 OUTLIER -36.91 -36.37 0.12 Allowed 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.314 -178.829 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . 0.519 ' N ' ' CD1' ' B' ' 94' ' ' TYR . 8.8 pt-20 -57.25 -43.52 83.05 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.327 -0.858 . . . . 0.0 109.42 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 96' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' B' ' 93' ' ' LYS . 0.9 OUTLIER -61.81 -31.58 71.83 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 177.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.672 ' SD ' HG21 ' B' ' 35' ' ' THR . 3.5 ptm . . . . . 0 N--CA 1.496 1.857 0 CA-C-O 121.282 0.563 . . . . 0.0 110.732 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.568 ' C ' HD12 ' A' ' 6' ' ' LEU . 16.7 p-10 -177.17 -153.99 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 119.727 -0.789 . . . . 0.0 111.248 178.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.56 ' HE2' ' HA ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -52.41 -7.98 0.07 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.401 -0.812 . . . . 0.0 111.143 -179.812 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.606 ' O ' HG13 ' A' ' 7' ' ' ILE . 87.4 m -114.54 -64.26 1.34 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.17 -0.956 . . . . 0.0 109.903 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.577 ' HA ' ' CE ' ' A' ' 8' ' ' LYS . 0.4 OUTLIER -49.11 -41.01 34.43 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.915 -1.115 . . . . 0.0 109.096 179.577 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.649 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 28.2 mt -61.52 -35.05 76.62 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.335 -0.946 . . . . 0.0 109.621 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.652 ' N ' HD12 ' A' ' 25' ' ' LEU . 1.1 pp -57.2 -38.74 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 178.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.834 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 1.3 mtmp? -65.79 -40.11 91.6 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 177.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.857 ' CB ' HD13 ' B' ' 31' ' ' ILE . . . -51.61 -37.34 49.59 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.768 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.3 mp -91.98 -30.85 4.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 178.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.834 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -66.25 -9.57 33.72 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 118.575 -1.25 . . . . 0.0 108.497 178.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.435 ' CG ' ' N ' ' A' ' 13' ' ' ASP . 17.2 pt20 -119.59 -42.22 2.65 Favored 'General case' 0 N--CA 1.483 1.185 0 O-C-N 121.413 -0.805 . . . . 0.0 110.41 179.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 9' ' ' ALA . 6.6 m-20 -69.53 -33.73 73.21 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 177.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 1.15 HG22 ' CD1' ' A' ' 16' ' ' LEU 0.273 0.2 OUTLIER -95.14 -71.41 0.67 Allowed 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.479 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 57.37 18.52 29.54 Favored Glycine 0 N--CA 1.5 2.91 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 177.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 1.15 ' CD1' HG22 ' A' ' 14' ' ' THR . 4.4 mp -63.82 -68.17 0.37 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.425 -1.044 . . . . 0.0 109.815 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.637 ' CG2' HG21 ' B' ' 17' ' ' THR . 0.6 OUTLIER -135.07 7.48 3.42 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.592 ' O ' ' C ' ' A' ' 19' ' ' VAL . 15.0 mt-30 57.88 26.92 13.89 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 -176.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 1.125 HG23 ' CD1' ' B' ' 16' ' ' LEU . 0.3 OUTLIER -5.92 -97.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.184 -179.128 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.98 ' O ' ' N ' ' A' ' 23' ' ' LYS . 1.7 p -135.63 25.01 3.42 Favored 'General case' 0 C--N 1.275 -2.653 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 178.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.571 ' C ' ' O ' ' A' ' 20' ' ' SER . 27.4 m -19.15 -38.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 CA-C-O 122.284 1.04 . . . . 0.0 110.435 -178.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.803 ' N ' ' O ' ' A' ' 20' ' ' SER . 25.4 p -79.3 -36.26 39.92 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.16 178.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.98 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.2 OUTLIER -91.82 -32.65 15.27 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.779 -0.576 . . . . 0.0 111.642 179.811 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.635 ' N ' ' OG ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -72.8 -30.31 63.97 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 117.764 -1.574 . . . . 0.0 108.061 179.385 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.652 HD12 ' N ' ' A' ' 7' ' ' ILE . 2.2 mt -82.01 -37.58 26.36 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 118.741 -1.184 . . . . 0.0 107.895 177.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.56 ' HA ' ' HE2' ' A' ' 3' ' ' LYS . . . -67.6 -34.04 76.21 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 177.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 31' ' ' ILE . 61.1 p -82.56 -30.51 29.62 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.66 ' O ' HG13 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -52.48 -45.61 66.22 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.335 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.747 ' HG3' ' CD1' ' B' ' 47' ' ' PHE . 0.5 OUTLIER -69.62 -36.58 76.27 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 176.856 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 1.116 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 13.1 tttt -62.26 -23.42 66.68 Favored 'General case' 0 C--O 1.19 -2.058 0 C-N-CA 119.275 -0.97 . . . . 0.0 108.434 178.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.939 HD13 ' HB1' ' B' ' 9' ' ' ALA . 0.5 OUTLIER -103.61 -28.39 3.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 120.589 -1.319 . . . . 0.0 109.202 178.141 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.636 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.2 mm -72.56 -56.15 10.79 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 177.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.894 ' HA ' HD23 ' B' ' 85' ' ' LEU . 0.4 OUTLIER -69.67 -36.45 76.03 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.4 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 1.116 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 44.5 mm-40 -74.31 -35.46 63.68 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.084 -1.01 . . . . 0.0 110.696 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.652 HG23 ' CB ' ' A' ' 40' ' ' ASP . 2.2 m -58.58 -51.51 69.57 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.63 -1.294 . . . . 0.0 108.248 178.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.681 HG22 ' HD3' ' A' ' 52' ' ' PRO . 0.9 OUTLIER -54.11 -35.71 29.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 177.792 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.73 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -82.23 -4.2 56.63 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.629 0.728 . . . . 0.0 109.416 178.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -101.07 -26.39 13.71 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.087 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.84 39.23 1.6 Allowed Glycine 0 C--N 1.301 -1.4 0 C-N-CA 120.092 -1.052 . . . . 0.0 110.906 177.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.652 ' CB ' HG23 ' A' ' 35' ' ' THR . 0.1 OUTLIER -132.47 134.23 44.8 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.067 -1.255 . . . . 0.0 110.274 179.384 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.87 92.24 6.09 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.584 -0.697 . . . . 0.0 109.887 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.532 HG13 HD11 ' B' ' 6' ' ' LEU . 58.2 t -59.29 132.97 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.589 -0.694 . . . . 0.0 109.868 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -129.7 89.21 2.79 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.335 -0.853 . . . . 0.0 110.178 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.773 HD12 ' HB3' ' A' ' 48' ' ' LEU . 10.7 mt -59.92 107.6 0.64 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.295 -0.878 . . . . 0.0 109.516 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.457 ' CG2' ' C ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER 34.11 -90.67 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.308 0 O-C-N 122.0 -0.438 . . . . 0.0 110.953 -179.457 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -151.01 28.32 1.01 Allowed Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.997 ' CE1' HG21 ' B' ' 32' ' ' ILE . 1.6 p90 -129.98 -26.3 2.42 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.17 -1.194 . . . . 0.0 111.922 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.773 ' HB3' HD12 ' A' ' 44' ' ' LEU . 4.6 mt -128.95 96.02 4.24 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.568 -1.332 . . . . 0.0 110.867 178.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -102.05 86.35 2.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.66 -0.65 . . . . 0.0 110.576 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.567 HD13 HG23 ' A' ' 79' ' ' VAL . 6.9 mm -73.22 131.9 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.409 ' HG3' ' CB ' ' A' ' 78' ' ' SER . 1.7 ptmt -145.52 113.99 4.76 Favored Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 120.613 -1.304 . . . . 0.0 111.129 -179.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.681 ' HD3' HG22 ' A' ' 36' ' ' VAL . 54.7 Cg_endo -78.48 143.81 19.63 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 O-C-N 123.638 1.336 . . . . 0.0 111.135 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.655 HG22 ' O ' ' A' ' 76' ' ' GLY . 24.2 m -142.33 116.86 4.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-O 121.582 0.706 . . . . 0.0 110.395 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.459 ' HB2' ' HB3' ' B' ' 97' ' ' PHE . . . . . . . . 0 N--CA 1.499 1.995 0 CA-C-O 121.917 0.865 . . . . 0.0 112.404 -178.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.634 ' HB ' ' HB2' ' B' ' 94' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.501 2.097 0 CA-C-O 121.202 0.525 . . . . 0.0 110.059 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.655 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -101.85 77.83 0.36 Allowed Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.889 HG21 ' CB ' ' B' ' 85' ' ' LEU . 4.4 p -59.54 74.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.576 -0.955 . . . . 0.0 110.3 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.565 ' N ' ' O ' ' A' ' 76' ' ' GLY . 0.6 OUTLIER -67.68 177.34 2.07 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.524 -0.87 . . . . 0.0 109.824 179.585 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.567 HG23 HD13 ' A' ' 50' ' ' ILE . 0.8 OUTLIER 176.62 175.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -179.82 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.689 ' O ' HD23 ' A' ' 48' ' ' LEU . 2.3 ptpt -177.18 172.23 0.83 Allowed Pre-proline 0 N--CA 1.486 1.362 0 O-C-N 121.161 -0.962 . . . . 0.0 110.176 177.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.501 ' HB2' HG13 ' B' ' 77' ' ' VAL . 55.2 Cg_endo -98.77 133.38 0.25 Allowed 'Trans proline' 0 C--N 1.302 -1.901 0 C-N-CA 122.542 2.161 . . . . 0.0 110.489 178.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.546 ' HA3' ' HA ' ' A' ' 47' ' ' PHE . . . -92.09 177.78 40.0 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 108.382 -1.887 . . . . 0.0 108.382 178.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.415 ' HA ' ' HB2' ' A' ' 86' ' ' LYS . 0.1 OUTLIER -67.89 -18.25 64.73 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.115 -1.226 . . . . 0.0 110.676 -179.788 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.46 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -51.92 -39.89 59.87 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.119 -0.988 . . . . 0.0 109.401 179.8 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.902 HD21 ' CD1' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -75.66 -34.32 60.48 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.744 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.632 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 0.8 OUTLIER -72.94 -43.82 61.9 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.961 -179.257 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -61.46 -40.82 95.89 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 178.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.779 ' O ' ' HB1' ' B' ' 37' ' ' ALA . . . -66.68 -36.24 82.05 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 176.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 1.061 ' CB ' HG11 ' B' ' 75' ' ' VAL . . . -58.56 -34.36 70.96 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -55.98 -34.54 65.84 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 176.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.423 ' C ' ' H ' ' A' ' 93' ' ' LYS . . . -61.54 -44.54 97.85 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 178.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.824 ' O ' HD12 ' A' ' 92' ' ' LEU . 0.6 OUTLIER -58.07 -2.59 0.18 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.707 -1.467 . . . . 0.0 111.212 179.699 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.512 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 6.7 mmmt 68.1 58.97 0.45 Allowed 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -177.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.401 ' C ' ' O ' ' A' ' 93' ' ' LYS . 23.5 t80 -37.41 -33.97 0.08 Allowed 'General case' 0 N--CA 1.494 1.775 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.21 -179.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 . . . . . 0 N--CA 1.494 1.748 0 O-C-N 121.155 -0.966 . . . . 0.0 109.083 179.208 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.633 ' HG2' ' HB3' ' B' ' 5' ' ' GLU . 24.2 mtp . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 2' ' ' ASN . . . . . 0.554 ' O ' ' HB2' ' B' ' 6' ' ' LEU . 19.5 p-10 -175.4 -162.63 0.11 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.167 -0.958 . . . . 0.0 111.299 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.515 ' O ' ' CG2' ' B' ' 7' ' ' ILE . 0.0 OUTLIER -57.1 -3.52 0.14 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.423 -0.798 . . . . 0.0 110.885 -179.888 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . 0.678 ' O ' HG13 ' B' ' 7' ' ' ILE . 96.8 m -117.93 -60.71 1.77 Allowed 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 122.167 0.984 . . . . 0.0 109.101 179.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.633 ' HB3' ' HG2' ' B' ' 1' ' ' MET . 0.4 OUTLIER -52.04 -44.74 64.37 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.098 -1.001 . . . . 0.0 109.013 179.27 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.661 ' O ' ' HB3' ' B' ' 9' ' ' ALA . 1.9 mt -61.18 -32.1 71.84 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.191 -1.004 . . . . 0.0 109.966 178.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 7' ' ' ILE . . . . . 0.74 HG22 HD12 ' B' ' 25' ' ' LEU . 0.9 OUTLIER -57.7 -40.79 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 179.1 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . 0.852 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 1.0 OUTLIER -64.87 -37.79 88.81 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 177.484 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . 0.939 ' HB1' HD13 ' A' ' 31' ' ' ILE . . . -52.33 -38.3 58.22 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 120.15 -0.62 . . . . 0.0 109.618 179.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.736 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.3 mp -93.73 -29.19 4.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 178.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.852 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -66.8 -16.25 64.14 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.815 -1.178 . . . . 0.0 108.329 178.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.431 ' CG ' ' N ' ' B' ' 13' ' ' ASP . 17.7 pt20 -108.62 -41.91 4.67 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.515 -0.741 . . . . 0.0 109.098 178.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.431 ' N ' ' CG ' ' B' ' 12' ' ' GLN . 1.1 m-20 -68.78 -22.55 64.27 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 176.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.736 ' OG1' ' O ' ' B' ' 10' ' ' ILE . 0.2 OUTLIER -120.32 -83.14 0.65 Allowed 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.363 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . 0.511 ' O ' ' C ' ' B' ' 16' ' ' LEU . . . 69.36 -21.01 0.42 Allowed Glycine 0 N--CA 1.498 2.779 0 O-C-N 120.924 -1.11 . . . . 0.0 110.65 178.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 16' ' ' LEU . . . . . 1.125 ' CD1' HG23 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -29.21 -59.45 0.14 Allowed 'General case' 0 N--CA 1.517 2.876 0 CA-C-O 122.008 0.908 . . . . 0.0 110.712 -179.608 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . 0.662 HG22 ' H ' ' B' ' 19' ' ' VAL . 0.5 OUTLIER -132.7 -2.75 3.32 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -179.927 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . 0.618 ' O ' ' C ' ' B' ' 19' ' ' VAL . 8.2 mt-30 56.56 30.97 18.21 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -176.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 1.109 HG11 HG11 ' A' ' 19' ' ' VAL . 2.0 p -8.74 -97.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.802 -179.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 0.92 ' O ' ' N ' ' B' ' 23' ' ' LYS . 0.4 OUTLIER -132.94 22.08 4.17 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 177.449 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.669 HG12 HG22 ' B' ' 10' ' ' ILE . 27.9 m -18.51 -38.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-O 122.401 1.096 . . . . 0.0 109.255 -178.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.91 ' N ' ' O ' ' B' ' 20' ' ' SER . 26.5 t -79.16 -44.92 20.98 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.19 177.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . 0.92 ' N ' ' O ' ' B' ' 20' ' ' SER . 5.9 mtmt -89.69 -21.56 22.68 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.431 -0.793 . . . . 0.0 109.889 178.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' MET . . . . . 0.621 ' HE2' ' HA ' ' B' ' 21' ' ' VAL 0.263 2.2 tmm? -68.89 -38.93 79.95 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 178.653 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.74 HD12 HG22 ' B' ' 7' ' ' ILE . 8.3 mt -73.97 -41.38 62.03 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 176.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . 0.553 ' HB3' ' HA ' ' B' ' 23' ' ' LYS . . . -58.03 -34.51 70.13 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 177.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' SER . . . . . 0.485 ' O ' ' HB3' ' B' ' 30' ' ' LYS . 6.2 m -79.59 -33.49 41.58 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . 0.673 ' O ' HG13 ' B' ' 31' ' ' ILE . 2.8 t80 -60.74 -57.46 12.58 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 178.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . 0.744 ' HG3' ' CD2' ' A' ' 47' ' ' PHE . 2.3 tt0 -58.04 -31.85 67.41 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 118.216 -1.394 . . . . 0.0 107.637 177.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 1.174 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 24.1 ttmm -67.42 -26.79 66.6 Favored 'General case' 0 C--O 1.191 -1.988 0 C-N-CA 119.344 -0.942 . . . . 0.0 108.487 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.857 HD13 ' CB ' ' A' ' 9' ' ' ALA . 0.3 OUTLIER -98.57 -30.21 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 120.344 -1.473 . . . . 0.0 109.598 178.169 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.997 HG21 ' CE1' ' A' ' 47' ' ' PHE . 1.8 mp -67.85 -66.37 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' THR . . . . . 0.895 ' HA ' HD23 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -60.78 -37.64 82.6 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.254 -179.082 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 1.174 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 62.3 mm-40 -73.13 -40.07 65.2 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 119.366 -0.934 . . . . 0.0 111.048 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 35' ' ' THR . . . . . 0.672 HG21 ' SD ' ' A' ' 1' ' ' MET . 23.6 m -61.7 -49.46 76.4 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 118.316 -1.354 . . . . 0.0 109.423 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.803 HG21 HG23 ' B' ' 77' ' ' VAL . 0.6 OUTLIER -50.82 -43.26 24.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 C-N-CA 118.918 -1.113 . . . . 0.0 108.027 179.195 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . 0.779 ' HB1' ' O ' ' A' ' 88' ' ' ALA . . . -88.22 -4.01 58.78 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.69 0.757 . . . . 0.0 109.773 178.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.712 ' HB2' ' O ' ' B' ' 34' ' ' GLU . 0.0 OUTLIER -88.56 -26.16 22.13 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 176.958 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 117.14 39.69 0.79 Allowed Glycine 0 C--N 1.302 -1.323 0 C-N-CA 120.194 -1.003 . . . . 0.0 110.968 177.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . 0.636 ' HB2' HG23 ' B' ' 35' ' ' THR . 0.3 OUTLIER -145.44 161.27 40.11 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.902 -1.351 . . . . 0.0 110.718 179.475 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.409 ' HG3' ' HD2' ' B' ' 52' ' ' PRO . 3.5 mppt? -107.04 96.76 6.66 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.561 -0.712 . . . . 0.0 110.045 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.607 HG13 HD11 ' A' ' 6' ' ' LEU . 91.4 t -60.22 120.0 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.498 -0.751 . . . . 0.0 109.813 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 43' ' ' GLN . . . . . 0.421 ' O ' ' HA ' ' A' ' 2' ' ' ASN . 0.7 OUTLIER -108.96 103.02 11.98 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.277 -0.889 . . . . 0.0 110.117 -179.431 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.741 HD12 ' CB ' ' B' ' 48' ' ' LEU . 12.6 mt -75.75 100.26 4.65 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.001 -1.062 . . . . 0.0 109.286 179.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . 0.552 HG21 ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 35.07 -93.88 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.913 -0.492 . . . . 0.0 111.224 -179.61 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -147.65 28.47 1.46 Allowed Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.715 -1.231 . . . . 0.0 110.17 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . 0.747 ' CD1' ' HG3' ' A' ' 29' ' ' GLU . 4.2 p90 -129.2 -23.58 2.97 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.969 -1.313 . . . . 0.0 111.594 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.917 HD23 ' O ' ' B' ' 80' ' ' LYS . 7.7 mt -128.73 106.03 8.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.482 -1.386 . . . . 0.0 110.711 178.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 49' ' ' ASN . . . . . 0.534 ' O ' ' HA ' ' B' ' 79' ' ' VAL . 0.6 OUTLIER -101.21 86.56 3.04 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.725 -0.609 . . . . 0.0 110.56 -179.385 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 50' ' ' ILE . . . . . 0.861 HG23 HG12 ' B' ' 79' ' ' VAL . 12.3 mm -84.33 128.43 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.383 -0.823 . . . . 0.0 109.836 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . 0.418 ' O ' ' HG3' ' B' ' 51' ' ' LYS . 0.0 OUTLIER -152.25 123.98 3.81 Favored Pre-proline 0 N--CA 1.501 2.078 0 O-C-N 120.87 -1.144 . . . . 0.0 110.972 -179.878 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 52' ' ' PRO . . . . . 0.62 ' HG3' ' HA ' ' B' ' 36' ' ' VAL . 57.1 Cg_endo -84.93 141.8 8.58 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 123.406 1.214 . . . . 0.0 111.454 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.622 HG22 ' O ' ' B' ' 76' ' ' GLY . 30.0 m -143.79 112.31 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-O 121.9 0.857 . . . . 0.0 110.673 178.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . 0.81 ' HA ' ' HA ' ' B' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.495 1.81 0 O-C-N 121.727 -0.608 . . . . 0.0 110.952 -179.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . 1.061 HG11 ' CB ' ' A' ' 89' ' ' ALA . 12.2 p . . . . . 0 N--CA 1.508 2.468 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 76' ' ' GLY . . . . . 0.622 ' O ' HG22 ' B' ' 53' ' ' VAL . . . -125.9 73.62 0.43 Allowed Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.24 -1.457 . . . . 0.0 109.792 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.893 HG21 ' CB ' ' A' ' 85' ' ' LEU . 3.7 p -61.69 72.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.544 -0.974 . . . . 0.0 109.326 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 78' ' ' SER . . . . . 0.84 ' O ' HG13 ' B' ' 79' ' ' VAL . 0.1 OUTLIER -64.3 176.26 1.1 Allowed 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.454 -0.898 . . . . 0.0 109.986 -179.709 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.861 HG12 HG23 ' B' ' 50' ' ' ILE . 16.9 m -172.37 179.0 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 80' ' ' LYS . . . . . 0.917 ' O ' HD23 ' B' ' 48' ' ' LEU . 0.1 OUTLIER 179.3 170.58 0.55 Allowed Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 120.833 -1.167 . . . . 0.0 111.12 176.8 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 81' ' ' PRO . . . . . 0.617 ' HB2' HG13 ' A' ' 77' ' ' VAL . 56.2 Cg_endo -102.27 133.37 0.13 Allowed 'Trans proline' 0 C--N 1.303 -1.832 0 C-N-CA 123.076 2.517 . . . . 0.0 110.252 177.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . 0.514 ' HA3' ' HA ' ' B' ' 47' ' ' PHE . . . -96.96 171.09 26.84 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 107.955 -2.058 . . . . 0.0 107.955 178.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . 0.515 ' HA ' ' HB2' ' B' ' 86' ' ' LYS . 3.5 pm0 -59.75 -19.15 48.41 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.99 -1.3 . . . . 0.0 110.674 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 84' ' ' SER . . . . . 0.498 ' CB ' ' HB3' ' B' ' 47' ' ' PHE . 0.4 OUTLIER -52.08 -38.03 55.9 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.101 -0.999 . . . . 0.0 109.552 179.6 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.894 HD23 ' HA ' ' A' ' 33' ' ' THR . 1.0 OUTLIER -78.46 -33.07 48.63 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.471 -0.768 . . . . 0.0 108.951 178.617 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 86' ' ' LYS . . . . . 0.615 ' O ' ' HB3' ' B' ' 89' ' ' ALA . 0.6 OUTLIER -73.71 -42.42 61.23 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.493 -179.274 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 7.3 tttp -64.5 -39.77 94.4 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 177.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.65 ' HB1' ' HB2' ' A' ' 37' ' ' ALA . . . -66.91 -34.48 77.87 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 176.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.997 ' HA ' HD23 ' B' ' 92' ' ' LEU . . . -57.18 -44.6 83.7 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.471 -0.768 . . . . 0.0 109.222 179.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . 0.41 ' HG2' ' N ' ' B' ' 91' ' ' GLY . 1.4 pt-20 -53.88 -31.82 51.16 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 177.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . 0.41 ' N ' ' HG2' ' B' ' 90' ' ' GLU . . . -67.14 -33.8 84.3 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 178.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 92' ' ' LEU . . . . . 0.997 HD23 ' HA ' ' B' ' 89' ' ' ALA . 0.4 OUTLIER -77.51 13.07 1.34 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.648 -1.501 . . . . 0.0 111.438 -179.553 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 93' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' B' ' 92' ' ' LEU . 34.9 mmtt 58.53 39.53 24.8 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -177.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . 0.634 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -42.07 -33.58 0.6 Allowed 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.449 -179.14 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . 0.481 ' N ' ' CD1' ' B' ' 94' ' ' TYR . 2.5 pp20? -61.62 -39.92 93.0 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.383 -0.823 . . . . 0.0 109.467 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.66 -34.82 76.38 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 177.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 97' ' ' PHE . . . . . 0.459 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.459 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 178.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.555 ' HG2' ' HB3' ' A' ' 5' ' ' GLU . 2.7 mtp . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 120.892 0.377 . . . . 0.0 110.184 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.481 ' N ' HG23 ' B' ' 42' ' ' VAL . 39.2 p-10 179.56 -167.57 0.09 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.184 -0.947 . . . . 0.0 111.21 179.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.871 ' HG2' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -55.47 -11.68 0.91 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.568 -0.708 . . . . 0.0 110.326 179.794 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.713 ' O ' HG12 ' A' ' 7' ' ' ILE . 53.7 m -104.02 -55.25 2.4 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 122.113 0.959 . . . . 0.0 109.286 179.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.693 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 0.2 OUTLIER -57.13 -49.6 75.42 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.068 -1.02 . . . . 0.0 109.14 179.427 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.918 HD11 HG21 ' B' ' 42' ' ' VAL . 15.7 mt -49.93 -40.81 44.7 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 119.322 -0.951 . . . . 0.0 110.396 178.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.713 HG12 ' O ' ' A' ' 4' ' ' THR . 0.7 OUTLIER -57.47 -45.33 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.238 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.87 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 28.6 mtmt -56.36 -37.17 69.67 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 177.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.878 ' CB ' HD13 ' B' ' 31' ' ' ILE . . . -54.9 -37.56 66.49 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.736 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.5 mp -88.26 -33.81 6.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 178.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.87 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -65.85 -13.05 58.86 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 119.158 -1.017 . . . . 0.0 108.818 178.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -117.08 -39.65 3.2 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 121.449 -0.782 . . . . 0.0 109.652 178.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.45 ' HB3' ' HB2' ' B' ' 27' ' ' SER . 1.5 m-20 -66.97 -30.15 70.19 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 177.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.784 HG22 HD11 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -104.66 -75.31 0.63 Allowed 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 114.339 -1.3 . . . . 0.0 108.19 178.983 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 51.14 15.79 1.73 Allowed Glycine 0 N--CA 1.494 2.522 0 C-N-CA 120.306 -0.95 . . . . 0.0 110.883 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 1.073 ' CD1' HG23 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -73.06 -27.66 61.87 Favored 'General case' 0 N--CA 1.508 2.432 0 O-C-N 121.073 -1.251 . . . . 0.0 107.963 178.812 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.759 HG21 HG21 ' B' ' 17' ' ' THR . 0.4 OUTLIER -159.6 -12.39 0.06 Allowed 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.552 -179.861 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.706 ' O ' ' C ' ' A' ' 19' ' ' VAL . 21.1 mt-30 58.24 34.37 24.04 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 -177.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.924 ' CG2' HD13 ' B' ' 16' ' ' LEU . 0.2 OUTLIER 0.69 -94.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -178.875 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 1.106 ' O ' ' N ' ' A' ' 22' ' ' SER . 18.7 p -135.06 21.74 3.49 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 175.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.594 ' C ' ' O ' ' A' ' 20' ' ' SER . 33.9 m -4.44 -38.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 122.451 1.119 . . . . 0.0 111.061 -178.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 1.106 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.5 OUTLIER -75.24 -41.61 57.1 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-N 115.008 -0.997 . . . . 0.0 108.622 177.629 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.885 ' N ' ' O ' ' A' ' 20' ' ' SER . 2.5 mtpt -90.7 -30.8 16.88 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.549 -0.72 . . . . 0.0 109.502 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.581 ' HE2' ' HA ' ' A' ' 21' ' ' VAL . 2.0 tmm? -61.63 -29.73 70.25 Favored 'General case' 0 C--O 1.215 -0.717 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.871 HD13 ' HG2' ' A' ' 3' ' ' LYS . 1.2 pp -81.97 -44.39 16.78 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.642 ' N ' HD12 ' A' ' 25' ' ' LEU . . . -63.61 -23.73 67.5 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 178.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.507 ' O ' ' CG1' ' A' ' 31' ' ' ILE . 7.9 m -85.14 -40.98 16.11 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.687 ' CE1' HD22 ' B' ' 44' ' ' LEU . 0.0 OUTLIER -58.97 -45.52 90.36 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.853 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.6 ' HG3' ' CE2' ' B' ' 47' ' ' PHE . 0.8 OUTLIER -69.02 -37.37 78.6 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.046 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 1.256 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 20.2 tttt -62.37 -22.02 65.79 Favored 'General case' 0 C--O 1.193 -1.883 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.634 HG13 ' O ' ' A' ' 28' ' ' PHE . 0.6 OUTLIER -106.81 -27.72 2.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 120.144 -1.597 . . . . 0.0 109.482 178.013 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.623 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.3 mm -74.02 -59.47 3.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 177.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.685 ' HA ' HD23 ' B' ' 85' ' ' LEU . 0.7 OUTLIER -70.51 -32.59 70.12 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.393 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 1.256 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 71.7 mm-40 -81.75 -27.31 33.9 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 121.125 -0.984 . . . . 0.0 111.676 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.605 ' HA ' ' HB2' ' A' ' 38' ' ' LYS . 3.1 m -70.57 -55.39 8.97 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 117.496 -1.682 . . . . 0.0 108.437 178.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.953 HG11 HG23 ' A' ' 77' ' ' VAL . 87.1 t -55.2 -40.96 58.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.782 ' HB1' ' C ' ' B' ' 88' ' ' ALA . . . -68.93 -22.2 64.16 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.651 ' N ' HD12 ' B' ' 92' ' ' LEU . 13.4 mtmt -82.32 -25.48 33.88 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 177.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 35' ' ' THR . . . 104.06 30.79 4.97 Favored Glycine 0 C--N 1.295 -1.722 0 C-N-CA 120.133 -1.032 . . . . 0.0 110.653 177.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.567 ' CB ' HG23 ' A' ' 35' ' ' THR . 0.3 OUTLIER -117.25 138.22 51.87 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.225 -1.162 . . . . 0.0 110.018 179.545 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -72.18 82.55 1.0 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.461 -0.774 . . . . 0.0 110.638 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.624 ' CG2' HD11 ' B' ' 6' ' ' LEU . 14.8 p -73.36 140.96 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.47 -0.769 . . . . 0.0 109.654 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.417 ' HG3' ' OD1' ' B' ' 2' ' ' ASN . 1.6 pt20 -149.1 163.18 38.31 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.009 -1.057 . . . . 0.0 111.462 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.641 HD12 ' HB2' ' A' ' 48' ' ' LEU . 23.4 mt -106.94 109.28 21.14 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.53 HG21 ' HG3' ' B' ' 29' ' ' GLU . 0.0 OUTLIER 35.8 -95.11 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.743 -0.598 . . . . 0.0 111.378 -178.854 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -139.47 10.49 3.22 Favored Glycine 0 N--CA 1.488 2.105 0 C-N-CA 119.52 -1.324 . . . . 0.0 111.034 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.898 ' HD1' HD11 ' A' ' 85' ' ' LEU . 23.6 p90 -105.11 -20.31 13.56 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.604 -1.527 . . . . 0.0 110.695 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.641 ' HB2' HD12 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -132.81 147.67 52.31 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.13 -0.981 . . . . 0.0 111.666 178.505 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -154.08 116.28 4.31 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.773 -0.58 . . . . 0.0 109.718 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.613 HG21 HG21 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -109.54 155.1 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.212 -0.93 . . . . 0.0 110.522 -179.657 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 9.0 ptmt -162.19 126.78 2.04 Favored Pre-proline 0 N--CA 1.498 1.939 0 C-N-CA 118.803 -1.159 . . . . 0.0 110.96 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.717 ' HG3' ' O ' ' A' ' 36' ' ' VAL . 53.9 Cg_endo -87.05 144.29 7.09 Favored 'Trans proline' 0 C--N 1.316 -1.17 0 O-C-N 123.405 1.213 . . . . 0.0 110.888 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.637 HG22 ' O ' ' A' ' 76' ' ' GLY . 25.8 m -143.85 116.59 3.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-O 121.599 0.714 . . . . 0.0 110.278 179.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.538 ' HB2' ' HB3' ' B' ' 97' ' ' PHE . . . . . . . . 0 N--CA 1.5 2.035 0 CA-C-O 121.62 0.724 . . . . 0.0 112.318 -178.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.565 HG11 ' HB1' ' B' ' 89' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.783 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.637 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -110.74 64.02 0.27 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.953 HG23 HG11 ' A' ' 36' ' ' VAL . 7.5 p -54.86 75.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.531 -0.982 . . . . 0.0 110.75 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.626 ' N ' ' O ' ' A' ' 76' ' ' GLY . 29.9 t -79.78 178.72 7.98 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.294 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.593 HG12 ' C ' ' A' ' 78' ' ' SER . 0.2 OUTLIER 179.27 172.96 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.463 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.56 ' N ' ' CG2' ' A' ' 79' ' ' VAL . 0.1 OUTLIER 177.28 173.8 0.33 Allowed Pre-proline 0 C--N 1.299 -1.616 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 177.814 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.668 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 52.5 Cg_endo -85.87 174.59 6.41 Favored 'Trans proline' 0 C--N 1.294 -2.294 0 O-C-N 123.648 1.341 . . . . 0.0 110.106 177.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -115.84 -68.58 0.43 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 105.289 -3.124 . . . . 0.0 105.289 177.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.863 ' O ' ' N ' ' A' ' 85' ' ' LEU . 37.8 tt0 -87.33 53.13 2.7 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 174.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 1.312 ' O ' ' N ' ' A' ' 86' ' ' LYS . 1.9 m 9.62 44.31 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 122.386 1.089 . . . . 0.0 110.854 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 1.067 HD13 HG21 ' B' ' 77' ' ' VAL . 3.6 mp 21.6 29.58 0.0 OUTLIER 'General case' 0 C--O 1.195 -1.802 0 N-CA-C 103.685 -2.709 . . . . 0.0 103.685 -172.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 1.312 ' N ' ' O ' ' A' ' 84' ' ' SER 0.339 9.7 tttt -55.59 -36.66 67.14 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 104.261 -2.496 . . . . 0.0 104.261 176.732 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.292 14.0 tttt -75.99 -31.59 59.03 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 111.625 -2.534 . . . . 0.0 106.5 176.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 1.001 ' HB3' ' HB3' ' A' ' 85' ' ' LEU . . . -82.21 -20.48 37.67 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 118.53 -1.268 . . . . 0.0 108.755 179.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 1.021 ' HA ' HD23 ' A' ' 92' ' ' LEU . . . -80.99 -43.94 18.87 Favored 'General case' 0 C--N 1.293 -1.888 0 O-C-N 120.941 -1.099 . . . . 0.0 108.587 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.7 -30.46 67.43 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 177.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.789 ' HA3' ' HB1' ' B' ' 37' ' ' ALA . . . -71.63 -33.83 63.37 Favored Glycine 0 N--CA 1.489 2.18 0 C-N-CA 120.279 -0.962 . . . . 0.0 110.837 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 1.021 HD23 ' HA ' ' A' ' 89' ' ' ALA . 0.4 OUTLIER -81.07 20.84 0.76 Allowed 'General case' 0 N--CA 1.504 2.241 0 O-C-N 120.371 -1.664 . . . . 0.0 110.764 -179.807 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.2 37.46 28.38 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -178.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.522 ' HB2' ' HB ' ' B' ' 75' ' ' VAL . 0.0 OUTLIER -39.18 -33.94 0.16 Allowed 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.61 -179.21 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.44 ' HG2' ' CE2' ' A' ' 94' ' ' TYR . 46.1 mt-10 . . . . . 0 N--CA 1.493 1.701 0 O-C-N 121.439 -0.788 . . . . 0.0 109.305 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.544 ' HE2' ' HG ' ' B' ' 6' ' ' LEU . 5.2 mtp . . . . . 0 N--CA 1.493 1.69 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 2' ' ' ASN . . . . . 0.443 ' N ' ' HB2' ' B' ' 5' ' ' GLU . 12.2 t30 -177.22 178.01 1.15 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.207 -0.933 . . . . 0.0 110.816 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.545 ' NZ ' ' O ' ' B' ' 25' ' ' LEU . 1.7 mttm -44.53 -23.29 0.11 Allowed 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.49 -0.756 . . . . 0.0 110.58 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . 0.506 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 13.4 m -102.94 -43.9 5.39 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.165 -0.96 . . . . 0.0 109.309 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.482 ' O ' ' CG ' ' B' ' 8' ' ' LYS . 0.1 OUTLIER -62.06 -46.51 88.82 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.153 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.679 ' O ' ' HB3' ' B' ' 9' ' ' ALA . 1.6 mt -66.13 -29.23 69.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.944 -1.098 . . . . 0.0 109.154 178.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 7' ' ' ILE . . . . . 0.875 HG23 ' HB ' ' B' ' 21' ' ' VAL . 0.3 OUTLIER -56.79 -59.77 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.638 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . 0.953 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 19.9 pttt -61.13 -25.87 67.29 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . 0.679 ' HB3' ' O ' ' B' ' 6' ' ' LEU . . . -58.56 -38.29 77.53 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.018 -1.051 . . . . 0.0 108.744 178.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.862 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.1 mp -90.62 -35.99 7.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 177.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.953 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -62.42 -12.82 23.89 Favored 'General case' 0 C--N 1.293 -1.851 0 C-N-CA 118.783 -1.167 . . . . 0.0 108.689 177.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.465 ' HB3' ' O ' ' B' ' 8' ' ' LYS . 6.9 tp-100 -113.79 -44.26 3.2 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.501 -0.749 . . . . 0.0 109.284 178.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.547 ' OD2' HG23 ' A' ' 31' ' ' ILE . 1.7 m-20 -64.29 -33.26 75.42 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 1.07 HG22 HD11 ' B' ' 16' ' ' LEU 0.253 0.2 OUTLIER -98.77 -69.53 0.76 Allowed 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 178.348 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 57.86 22.2 46.96 Favored Glycine 0 N--CA 1.501 2.98 0 O-C-N 121.398 -0.814 . . . . 0.0 111.585 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 16' ' ' LEU . . . . . 1.07 HD11 HG22 ' B' ' 14' ' ' THR . 4.9 mp -65.66 -66.17 0.58 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.348 -1.09 . . . . 0.0 109.64 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . 0.759 HG21 HG21 ' A' ' 17' ' ' THR . 0.5 OUTLIER -135.54 6.73 3.26 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -179.57 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . 0.652 ' O ' ' C ' ' B' ' 19' ' ' VAL . 25.1 mt-30 58.69 24.98 12.78 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 -175.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 1.073 HG23 ' CD1' ' A' ' 16' ' ' LEU . 0.2 OUTLIER 7.69 -95.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 CA-C-N 115.211 -0.904 . . . . 0.0 108.958 -179.185 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 1.026 ' O ' ' N ' ' B' ' 22' ' ' SER . 1.2 p -137.42 23.47 2.95 Favored 'General case' 0 C--N 1.273 -2.729 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 177.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.875 ' HB ' HG23 ' B' ' 7' ' ' ILE . 9.4 m -4.02 -43.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 122.441 1.115 . . . . 0.0 111.006 -177.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 1.026 ' N ' ' O ' ' B' ' 20' ' ' SER . 5.9 m -75.35 -38.06 60.34 Favored 'General case' 0 C--N 1.278 -2.506 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.559 178.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . 0.868 ' N ' ' O ' ' B' ' 20' ' ' SER . 6.1 mtmt -92.94 -26.99 17.33 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.36 -0.837 . . . . 0.0 111.154 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' MET . . . . . 0.672 ' HB3' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -70.9 -37.52 72.96 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 117.157 -1.817 . . . . 0.0 108.264 179.177 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.731 HD12 HG13 ' B' ' 7' ' ' ILE . 0.4 OUTLIER -80.44 -51.45 8.8 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 117.956 -1.498 . . . . 0.0 108.241 177.52 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . 0.491 ' O ' ' HB2' ' B' ' 30' ' ' LYS . . . -49.95 -34.11 19.75 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.374 -0.829 . . . . 0.0 108.859 178.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' SER . . . . . 0.507 ' HA ' ' HB3' ' B' ' 30' ' ' LYS . 83.1 p -81.92 -33.88 30.17 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . 0.811 ' O ' HG13 ' B' ' 31' ' ' ILE . 0.3 OUTLIER -56.02 -52.44 64.22 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.812 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . 0.791 ' O ' ' OG1' ' B' ' 33' ' ' THR . 0.2 OUTLIER -63.42 -39.01 93.34 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 176.401 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 0.992 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 17.5 ttpt -59.96 -23.79 63.87 Favored 'General case' 0 C--O 1.189 -2.115 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.878 HD13 ' CB ' ' A' ' 9' ' ' ALA . 0.6 OUTLIER -102.83 -27.16 3.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 O-C-N 120.615 -1.303 . . . . 0.0 108.582 178.047 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.715 HD11 ' CE2' ' B' ' 28' ' ' PHE . 1.2 mm -68.88 -54.33 21.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 177.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' THR . . . . . 0.811 ' HA ' HD23 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -70.73 -49.07 50.86 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.107 -1.037 . . . . 0.0 108.669 178.576 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.992 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 19.2 mm-40 -58.09 -35.68 71.77 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.551 -0.86 . . . . 0.0 109.95 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 35' ' ' THR . . . . . 0.831 HG22 ' CB ' ' B' ' 40' ' ' ASP . 31.1 m -69.72 -42.34 74.13 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 118.302 -1.359 . . . . 0.0 107.697 177.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.976 HG21 HD22 ' A' ' 85' ' ' LEU . 55.5 t -56.95 -43.03 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 177.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . 0.804 ' HA ' ' HB3' ' A' ' 92' ' ' LEU . . . -76.89 2.92 13.25 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.398 -0.921 . . . . 0.0 109.69 177.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.546 ' HB2' ' O ' ' B' ' 34' ' ' GLU . 0.1 OUTLIER -119.91 4.6 10.95 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.107 -0.996 . . . . 0.0 109.311 178.001 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.73 34.46 4.07 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . 0.831 ' CB ' HG22 ' B' ' 35' ' ' THR . 14.2 t0 -49.17 162.91 0.11 Allowed 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 123.086 1.422 . . . . 0.0 113.019 -179.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -179.83 56.99 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 104.381 -2.451 . . . . 0.0 104.381 178.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.918 HG21 HD11 ' A' ' 6' ' ' LEU . 7.4 p -90.67 148.74 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.941 -176.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -132.26 95.9 3.76 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.903 HD12 ' HB3' ' B' ' 48' ' ' LEU . 19.2 mt -59.65 101.59 0.12 Allowed 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.245 -0.909 . . . . 0.0 109.792 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . 0.534 HG22 ' HD3' ' A' ' 3' ' ' LYS . 0.0 OUTLIER 35.53 -93.55 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 120.921 0.391 . . . . 0.0 110.877 -179.648 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -147.17 35.4 1.25 Allowed Glycine 0 N--CA 1.485 1.95 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . 0.73 ' O ' HD11 ' B' ' 85' ' ' LEU . 1.1 p90 -135.75 -25.53 1.26 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.246 -1.149 . . . . 0.0 111.773 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.903 ' HB3' HD12 ' B' ' 44' ' ' LEU . 4.8 mt -136.36 113.58 10.64 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.214 -1.554 . . . . 0.0 111.374 178.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -113.69 95.95 5.6 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.414 -0.804 . . . . 0.0 110.291 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 50' ' ' ILE . . . . . 0.783 ' CG1' HG22 ' B' ' 79' ' ' VAL . 0.3 OUTLIER -87.5 139.42 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.37 -0.831 . . . . 0.0 109.271 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . 0.408 ' O ' ' HB3' ' B' ' 78' ' ' SER . 1.7 ptmt -158.83 111.4 1.61 Allowed Pre-proline 0 N--CA 1.5 2.042 0 C-N-CA 118.603 -1.239 . . . . 0.0 111.233 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 52' ' ' PRO . . . . . 0.577 ' HB3' HG13 ' B' ' 36' ' ' VAL . 44.9 Cg_endo -69.38 144.66 56.78 Favored 'Trans proline' 0 C--N 1.314 -1.251 0 O-C-N 123.47 1.248 . . . . 0.0 111.681 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.703 HG22 ' O ' ' B' ' 76' ' ' GLY . 29.7 m -143.07 116.86 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 121.491 0.663 . . . . 0.0 110.841 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . 0.684 ' HA ' ' HA ' ' B' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.5 2.067 0 CA-C-O 121.806 0.812 . . . . 0.0 112.105 -178.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . 0.897 ' HB ' ' HB1' ' A' ' 89' ' ' ALA . 1.2 t . . . . . 0 N--CA 1.493 1.711 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 76' ' ' GLY . . . . . 0.703 ' O ' HG22 ' B' ' 53' ' ' VAL . . . -115.32 86.9 0.42 Allowed Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 1.067 HG21 HD13 ' A' ' 85' ' ' LEU . 3.6 p -60.53 78.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.767 -0.843 . . . . 0.0 109.827 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 78' ' ' SER . . . . . 0.941 ' O ' HG23 ' B' ' 79' ' ' VAL . 2.2 t -68.05 177.66 2.12 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.551 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.941 HG23 ' O ' ' B' ' 78' ' ' SER . 14.6 t -172.33 175.27 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 80' ' ' LYS . . . . . 0.865 ' O ' HD23 ' B' ' 48' ' ' LEU . 0.0 OUTLIER 179.28 172.17 0.49 Allowed Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 120.87 -1.144 . . . . 0.0 110.178 177.186 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 81' ' ' PRO . . . . . 0.504 ' HA ' ' O ' ' B' ' 47' ' ' PHE . 54.0 Cg_endo -95.17 143.45 1.31 Allowed 'Trans proline' 0 C--N 1.303 -1.855 0 C-N-CA 122.35 2.033 . . . . 0.0 110.739 178.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . 0.557 ' O ' ' HB3' ' B' ' 83' ' ' GLU . . . -107.6 42.37 1.95 Allowed Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . 0.557 ' HB3' ' O ' ' B' ' 82' ' ' GLY . 1.0 OUTLIER 69.02 -40.18 0.44 Allowed 'General case' 0 N--CA 1.506 2.34 0 O-C-N 121.448 -1.031 . . . . 0.0 111.93 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 84' ' ' SER . . . . . 0.472 ' CB ' ' HB3' ' B' ' 47' ' ' PHE . 0.1 OUTLIER -48.85 -33.34 10.39 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.949 -1.094 . . . . 0.0 110.165 -179.177 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.817 ' HB2' HG21 ' A' ' 77' ' ' VAL . 0.8 OUTLIER -82.61 -29.98 29.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.412 -0.805 . . . . 0.0 108.877 178.703 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 86' ' ' LYS . . . . . 0.576 ' CD ' HG12 ' A' ' 77' ' ' VAL . 0.3 OUTLIER -82.49 -39.5 22.37 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.53 0.681 . . . . 0.0 109.607 179.812 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . 0.465 ' O ' ' CG ' ' B' ' 90' ' ' GLU . 1.2 ttmp? -68.69 -37.05 79.26 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 178.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.782 ' C ' ' HB1' ' A' ' 37' ' ' ALA . . . -71.62 -30.66 66.02 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 177.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.674 ' HA ' ' HA ' ' A' ' 37' ' ' ALA . . . -69.94 -52.79 21.55 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.623 -0.673 . . . . 0.0 110.368 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . 0.64 ' HA ' ' CB ' ' B' ' 94' ' ' TYR . 8.2 pt-20 -52.2 -23.25 5.28 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 177.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . 0.859 ' C ' HD23 ' B' ' 92' ' ' LEU . . . -81.17 -29.66 40.41 Favored Glycine 0 CA--C 1.546 2.03 0 CA-C-O 118.604 -1.109 . . . . 0.0 112.81 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 92' ' ' LEU . . . . . 0.859 HD23 ' C ' ' B' ' 91' ' ' GLY . 0.2 OUTLIER -111.64 -73.55 0.67 Allowed 'General case' 0 N--CA 1.507 2.391 0 CA-C-N 122.065 2.933 . . . . 0.0 113.54 -177.687 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -120.31 42.7 2.9 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.771 -1.205 . . . . 0.0 112.628 -177.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . 0.64 ' CB ' ' HA ' ' B' ' 90' ' ' GLU . 0.8 OUTLIER -77.19 -43.51 33.46 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.124 -0.985 . . . . 0.0 108.967 178.507 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -75.04 -35.73 61.89 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.19 -40.13 76.77 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 97' ' ' PHE . . . . . 0.538 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.507 ' HA ' ' CB ' ' A' ' 5' ' ' GLU . 2.8 mtp . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.466 ' H ' ' HB2' ' A' ' 5' ' ' GLU . 0.6 OUTLIER -177.12 -162.54 0.08 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.023 -1.048 . . . . 0.0 111.728 179.855 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.519 ' HE2' ' HA ' ' A' ' 26' ' ' ALA . 0.9 OUTLIER -52.22 -11.77 0.2 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.657 -0.652 . . . . 0.0 110.396 179.778 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.611 ' O ' HG13 ' A' ' 7' ' ' ILE . 73.7 m -114.38 -58.95 2.08 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.104 -0.997 . . . . 0.0 110.731 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.507 ' CB ' ' HA ' ' A' ' 1' ' ' MET . 1.6 mm-40 -49.74 -48.4 50.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.822 -1.174 . . . . 0.0 108.945 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.824 HD11 ' CG1' ' B' ' 42' ' ' VAL . 16.2 mt -55.65 -32.93 63.61 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.151 -1.02 . . . . 0.0 110.105 178.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.794 ' HA ' HD12 ' A' ' 25' ' ' LEU . 1.0 OUTLIER -60.5 -40.94 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 120.599 -1.313 . . . . 0.0 107.563 178.743 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.858 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -66.75 -31.14 71.6 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 177.343 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.659 ' HB3' ' O ' ' A' ' 6' ' ' LEU . . . -58.45 -39.01 78.69 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.815 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.4 mp -91.01 -30.61 4.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 178.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.858 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -66.08 -10.6 41.94 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 118.456 -1.298 . . . . 0.0 108.493 178.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.443 ' CG ' ' N ' ' A' ' 13' ' ' ASP . 6.4 pt20 -118.53 -42.52 2.75 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.48 -0.762 . . . . 0.0 110.405 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.73 ' OD2' HG21 ' B' ' 31' ' ' ILE . 16.8 m-20 -69.85 -25.82 63.91 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 177.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 1.139 HG22 ' CD1' ' A' ' 16' ' ' LEU 0.277 0.2 OUTLIER -106.53 -72.89 0.7 Allowed 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 179.025 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.65 15.68 54.3 Favored Glycine 0 N--CA 1.501 2.974 0 O-C-N 121.328 -0.857 . . . . 0.0 111.039 177.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 1.139 ' CD1' HG22 ' A' ' 14' ' ' THR . 4.4 mp -59.36 -68.87 0.23 Allowed 'General case' 0 C--N 1.294 -1.835 0 O-C-N 121.524 -0.986 . . . . 0.0 110.628 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.532 ' O ' HG23 ' A' ' 17' ' ' THR . 0.6 OUTLIER -138.11 9.64 2.77 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.302 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.558 ' O ' ' C ' ' A' ' 19' ' ' VAL . 7.7 mt-30 57.84 25.71 12.34 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -176.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 1.026 HG11 HG11 ' B' ' 19' ' ' VAL . 2.4 p -11.45 -95.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.089 -179.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.976 ' HB2' HG22 ' B' ' 14' ' ' THR . 0.6 OUTLIER -130.74 22.86 5.02 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 177.957 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.652 ' HA ' ' CE ' ' A' ' 24' ' ' MET . 30.5 m -25.19 -38.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-O 122.479 1.133 . . . . 0.0 109.182 -178.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.71 ' N ' ' O ' ' A' ' 20' ' ' SER . 4.9 m -84.49 -35.36 23.01 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.135 177.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.942 ' N ' ' O ' ' A' ' 20' ' ' SER . 1.2 mtmt -85.69 -34.07 21.37 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.652 -0.655 . . . . 0.0 111.543 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.781 ' HB3' HG23 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -76.1 -40.24 53.41 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.44 -1.412 . . . . 0.0 109.349 179.466 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.794 HD12 ' HA ' ' A' ' 7' ' ' ILE . 11.6 mt -74.56 -38.29 62.74 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 117.894 -1.523 . . . . 0.0 108.724 178.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.519 ' HA ' ' HE2' ' A' ' 3' ' ' LYS . . . -64.08 -33.22 75.26 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 177.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.551 ' O ' ' N ' ' A' ' 31' ' ' ILE . 58.3 m -84.25 -30.52 25.61 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 178.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.865 ' HB2' HD11 ' B' ' 10' ' ' ILE . 0.1 OUTLIER -59.24 -35.91 74.53 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.608 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.753 ' O ' ' HB ' ' A' ' 33' ' ' THR . 2.1 mt-10 -79.99 -32.92 39.76 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 177.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.739 ' O ' ' CG ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -68.6 -27.31 65.93 Favored 'General case' 0 C--O 1.194 -1.821 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 176.758 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.738 ' CG1' ' HA ' ' A' ' 28' ' ' PHE . 1.7 pp -97.11 -31.69 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.299 -0.875 . . . . 0.0 109.445 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.637 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 3.3 mm -65.42 -51.62 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 177.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.753 ' HB ' ' O ' ' A' ' 29' ' ' GLU . 0.3 OUTLIER -65.51 -43.27 90.62 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.867 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.739 ' CG ' ' O ' ' A' ' 30' ' ' LYS . 44.5 mm-40 -69.02 -36.08 77.36 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.614 -0.679 . . . . 0.0 111.451 179.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.971 HG21 HG23 ' A' ' 42' ' ' VAL . 2.3 m -57.59 -56.12 26.05 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.736 -1.228 . . . . 0.0 108.689 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.019 HG21 HG23 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -55.51 -29.51 24.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 106.303 -1.739 . . . . 0.0 106.303 177.414 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 1.065 ' HB2' ' HB1' ' B' ' 88' ' ' ALA . . . -75.73 -4.1 38.53 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 177.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 35' ' ' THR . 0.0 OUTLIER -115.26 -32.07 5.77 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.634 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.18 42.58 0.76 Allowed Glycine 0 C--N 1.301 -1.391 0 C-N-CA 119.804 -1.189 . . . . 0.0 110.558 178.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.773 ' CB ' HG23 ' A' ' 35' ' ' THR . 0.1 OUTLIER -125.86 117.44 23.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.218 -1.166 . . . . 0.0 110.33 179.349 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.6 mtmt -67.13 89.41 0.18 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.57 0.7 . . . . 0.0 109.626 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.971 HG23 HG21 ' A' ' 35' ' ' THR . 42.5 t -66.23 131.94 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.682 -0.637 . . . . 0.0 110.374 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.503 ' O ' HD23 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -128.04 154.8 45.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.517 -0.739 . . . . 0.0 109.59 179.454 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.983 HD12 ' CB ' ' A' ' 48' ' ' LEU . 73.1 mt -128.13 112.19 14.28 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.287 -0.883 . . . . 0.0 109.686 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.59 HG22 ' HG2' ' B' ' 29' ' ' GLU . 0.1 OUTLIER 32.45 -90.89 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.427 0 O-C-N 121.937 -0.477 . . . . 0.0 111.007 -179.371 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -149.94 28.99 1.14 Allowed Glycine 0 N--CA 1.482 1.752 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.646 ' O ' ' HA ' ' A' ' 81' ' ' PRO . 5.8 p90 -129.06 -24.09 2.94 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.096 -1.238 . . . . 0.0 112.046 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.983 ' CB ' HD12 ' A' ' 44' ' ' LEU . 1.0 OUTLIER -131.47 107.63 9.03 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.38 -1.45 . . . . 0.0 111.524 179.143 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -111.46 95.51 5.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.608 -0.683 . . . . 0.0 109.741 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.801 HD12 HG22 ' A' ' 79' ' ' VAL . 0.3 OUTLIER -83.44 142.42 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.369 -0.832 . . . . 0.0 109.969 -179.351 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 13.0 ptmt -157.48 128.09 3.54 Favored Pre-proline 0 N--CA 1.494 1.743 0 C-N-CA 118.564 -1.255 . . . . 0.0 110.51 178.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.675 ' HB3' HG22 ' A' ' 36' ' ' VAL . 54.8 Cg_endo -85.28 143.74 9.01 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.475 1.25 . . . . 0.0 111.891 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.859 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 32.6 m -133.13 -149.37 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.938 ' HA ' ' CA ' ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.496 1.849 0 C-N-CA 118.542 -1.263 . . . . 0.0 113.238 177.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.938 ' CA ' ' HA ' ' A' ' 54' ' ' ALA . 0.9 OUTLIER . . . . . 0 N--CA 1.513 2.704 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.846 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -145.11 111.18 0.58 Allowed Glycine 0 N--CA 1.491 2.321 0 C-N-CA 119.1 -1.524 . . . . 0.0 110.805 -178.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 1.019 HG23 HG21 ' A' ' 36' ' ' VAL . 4.9 p -76.96 81.69 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 O-C-N 121.603 -0.939 . . . . 0.0 110.08 179.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 1.008 ' O ' HG23 ' A' ' 79' ' ' VAL . 2.7 t -67.05 178.14 1.52 Allowed 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.347 -0.941 . . . . 0.0 109.607 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 1.008 HG23 ' O ' ' A' ' 78' ' ' SER . 3.4 t -176.41 174.96 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.607 ' O ' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER 179.32 170.59 0.55 Allowed Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 120.993 -1.067 . . . . 0.0 110.558 176.357 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.646 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 54.7 Cg_endo -95.09 144.53 1.41 Allowed 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 122.637 2.225 . . . . 0.0 110.551 178.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.503 ' H ' ' HA ' ' A' ' 47' ' ' PHE . . . -106.07 -171.68 23.32 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.79 -26.21 54.21 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.959 -1.318 . . . . 0.0 110.401 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.413 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 1.7 t -53.64 -27.56 27.91 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.873 HD22 HG11 ' B' ' 36' ' ' VAL . 1.3 mt -84.97 -29.07 25.38 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 178.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.506 ' HG3' HG13 ' B' ' 75' ' ' VAL . 0.4 OUTLIER -84.25 -29.2 26.67 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.306 -0.871 . . . . 0.0 109.706 179.823 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.83 -38.06 58.44 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 178.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.886 ' C ' ' HB1' ' B' ' 37' ' ' ALA . . . -65.61 -33.31 75.61 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 177.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 1.243 ' N ' ' HB1' ' B' ' 37' ' ' ALA . . . -72.63 -26.86 61.82 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.77 -34.57 62.79 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 175.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -63.6 -50.08 64.47 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 107.864 -2.094 . . . . 0.0 107.864 176.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.714 HD12 ' HA ' ' B' ' 37' ' ' ALA . 3.4 mt -49.67 -12.56 0.07 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.073 -1.251 . . . . 0.0 111.484 178.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.524 ' CB ' ' O ' ' A' ' 92' ' ' LEU . 0.0 OUTLIER 73.54 61.14 0.09 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -177.589 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.528 ' CD1' ' N ' ' B' ' 75' ' ' VAL . 50.8 t80 -37.46 -39.99 0.34 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.189 -178.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 . . . . . 0 N--CA 1.495 1.791 0 O-C-N 121.293 -0.879 . . . . 0.0 109.697 179.83 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.504 ' HB3' ' HG ' ' B' ' 6' ' ' LEU . 1.5 mtp . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.059 0.457 . . . . 0.0 110.329 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 2' ' ' ASN . . . . . 0.514 ' O ' ' HB2' ' B' ' 6' ' ' LEU . 12.4 t-20 -173.54 -161.06 0.13 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.306 -0.871 . . . . 0.0 110.892 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.511 ' HE2' ' HB2' ' B' ' 29' ' ' GLU . 0.7 OUTLIER -55.77 -2.21 0.05 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.335 -0.853 . . . . 0.0 110.895 179.903 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . 0.635 ' O ' ' CG1' ' B' ' 7' ' ' ILE . 54.4 m -122.77 -60.14 1.55 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.966 -1.084 . . . . 0.0 109.969 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.486 ' HB2' ' CA ' ' B' ' 1' ' ' MET . 5.4 mt-10 -51.74 -47.62 63.99 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.822 -1.174 . . . . 0.0 109.108 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.724 HD11 HG13 ' A' ' 42' ' ' VAL . 5.2 mt -60.43 -33.3 72.33 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.265 178.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 7' ' ' ILE . . . . . 0.747 ' N ' HD12 ' B' ' 25' ' ' LEU . 0.9 OUTLIER -58.4 -42.65 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 120.582 -1.324 . . . . 0.0 108.397 179.812 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . 0.77 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.1 OUTLIER -67.14 -32.2 73.15 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.213 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . 0.626 ' HB3' ' O ' ' B' ' 6' ' ' LEU . . . -62.33 -30.78 71.4 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 178.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.865 HD11 ' HB2' ' A' ' 28' ' ' PHE . 1.2 mp -96.65 -32.59 4.25 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.5 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 178.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.77 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -63.79 -29.58 70.77 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.412 ' HG3' ' N ' ' B' ' 13' ' ' ASP . 6.5 pt20 -89.56 -38.16 14.17 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.481 ' HB2' ' HA ' ' B' ' 10' ' ' ILE . 66.0 m-20 -67.96 -23.03 65.01 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 176.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.976 HG22 ' HB2' ' A' ' 20' ' ' SER . 18.4 p -92.31 -76.46 0.46 Allowed 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 61.05 12.37 29.62 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 16' ' ' LEU . . . . . 0.867 HD22 ' O ' ' A' ' 19' ' ' VAL . 3.3 mp -79.78 -61.66 1.92 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.481 -1.011 . . . . 0.0 109.016 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . 0.505 HG22 ' H ' ' B' ' 19' ' ' VAL . 0.6 OUTLIER -141.55 5.93 1.84 Allowed 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.889 -179.794 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . 0.575 ' O ' ' C ' ' B' ' 19' ' ' VAL . 6.7 mt-30 54.53 29.69 11.74 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 -176.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 1.026 HG11 HG11 ' A' ' 19' ' ' VAL . 1.4 p -12.07 -95.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.743 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 0.945 ' O ' ' N ' ' B' ' 23' ' ' LYS . 0.5 OUTLIER -132.97 24.39 4.25 Favored 'General case' 0 C--N 1.283 -2.311 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 178.601 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.696 HG11 ' CB ' ' B' ' 11' ' ' ALA . 17.1 m -19.28 -39.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 CA-C-O 122.398 1.094 . . . . 0.0 109.433 -177.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.848 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.6 OUTLIER -82.43 -37.54 25.31 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.875 178.221 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . 0.945 ' N ' ' O ' ' B' ' 20' ' ' SER . 1.9 mtmt -89.63 -28.75 19.29 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.46 -0.775 . . . . 0.0 111.377 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' MET . . . . . 0.744 ' HB3' HG21 ' A' ' 14' ' ' THR . 0.0 OUTLIER -77.81 -36.36 50.33 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 118.002 -1.479 . . . . 0.0 108.549 179.078 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.747 HD12 ' N ' ' B' ' 7' ' ' ILE . 0.8 OUTLIER -75.18 -42.63 55.39 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 177.281 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . 0.468 ' HA ' ' HE2' ' B' ' 3' ' ' LYS . . . -60.3 -32.48 71.25 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 177.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' SER . . . . . 0.562 ' HA ' ' HB3' ' B' ' 30' ' ' LYS . 12.1 m -79.88 -35.66 37.73 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . 0.739 ' HE1' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -59.25 -40.08 84.84 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 178.849 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . 0.717 ' HG3' ' CE1' ' B' ' 28' ' ' PHE . 1.3 mt-10 -76.03 -34.05 59.66 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 0.751 ' O ' ' CG ' ' B' ' 34' ' ' GLU . 30.0 tttp -70.08 -29.89 66.99 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 177.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.739 ' CG1' ' HA ' ' B' ' 28' ' ' PHE . 2.0 pp -93.02 -35.23 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.311 -0.868 . . . . 0.0 109.232 179.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.68 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.3 mm -60.52 -60.05 3.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 33' ' ' THR . . . . . 0.678 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 0.4 OUTLIER -58.29 -39.53 79.55 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.116 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.842 ' O ' ' N ' ' B' ' 38' ' ' LYS . 7.0 mm-40 -68.66 -54.7 14.76 Favored 'General case' 0 C--O 1.199 -1.586 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.109 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 35' ' ' THR . . . . . 0.556 ' HA ' ' HB2' ' B' ' 38' ' ' LYS . 50.2 m -47.02 -63.85 0.93 Allowed 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.87 -1.144 . . . . 0.0 112.124 -178.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 1.026 HG23 HD12 ' B' ' 50' ' ' ILE . 0.9 OUTLIER -49.61 -44.02 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 C-N-CA 118.058 -1.457 . . . . 0.0 107.841 179.126 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . 1.243 ' HB1' ' N ' ' A' ' 89' ' ' ALA . . . -93.63 15.27 16.63 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.793 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.842 ' N ' ' O ' ' B' ' 34' ' ' GLU . 4.7 mmtt -121.95 -28.08 4.5 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 144.16 41.11 0.06 OUTLIER Glycine 0 N--CA 1.477 1.384 0 C-N-CA 119.026 -1.559 . . . . 0.0 112.06 178.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . 0.492 ' O ' ' HA ' ' B' ' 36' ' ' VAL . 0.4 OUTLIER -172.92 147.3 1.65 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.59 -1.535 . . . . 0.0 111.421 179.069 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.409 ' CG ' ' HD2' ' B' ' 52' ' ' PRO . 2.2 mttt -102.81 114.7 29.18 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.824 ' CG1' HD11 ' A' ' 6' ' ' LEU . 7.5 t -87.92 154.95 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 C-N-CA 119.858 -0.737 . . . . 0.0 111.107 -178.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 43' ' ' GLN . . . . . 0.408 ' HA ' ' O ' ' B' ' 48' ' ' LEU . 14.6 mt-30 -142.04 121.12 12.92 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.552 -0.717 . . . . 0.0 109.89 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.712 HD13 ' CZ ' ' A' ' 28' ' ' PHE . 20.5 mt -87.09 102.56 14.54 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.199 -0.938 . . . . 0.0 109.934 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . 0.619 HG22 ' HG2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 37.56 28.09 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.435 0 O-C-N 121.819 -0.55 . . . . 0.0 111.753 -179.659 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . 90.64 -11.5 71.44 Favored Glycine 0 N--CA 1.486 2.028 0 C-N-CA 119.903 -1.142 . . . . 0.0 111.902 178.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . 0.627 ' CE2' ' HG2' ' A' ' 29' ' ' GLU . 0.8 OUTLIER -87.76 -35.3 17.96 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 120.028 1.914 . . . . 0.0 111.776 -179.561 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.612 ' HB2' HD12 ' B' ' 44' ' ' LEU . 0.4 OUTLIER -120.18 85.59 2.41 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.63 -1.294 . . . . 0.0 110.516 178.539 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -90.84 80.41 5.83 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.847 -0.533 . . . . 0.0 110.444 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 50' ' ' ILE . . . . . 1.026 HD12 HG23 ' B' ' 36' ' ' VAL . 2.9 pt -73.07 147.86 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.227 -0.921 . . . . 0.0 110.344 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . 0.564 ' O ' ' N ' ' B' ' 78' ' ' SER . 0.0 OUTLIER -165.14 132.52 2.35 Favored Pre-proline 0 N--CA 1.498 1.935 0 C-N-CA 119.285 -0.966 . . . . 0.0 110.549 179.456 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 52' ' ' PRO . . . . . 0.827 ' HG3' ' O ' ' B' ' 36' ' ' VAL . 54.4 Cg_endo -85.47 149.19 10.16 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 O-C-N 123.398 1.209 . . . . 0.0 111.174 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.602 HG22 ' HA3' ' B' ' 76' ' ' GLY . 11.8 m -144.93 120.15 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 CA-C-O 122.296 1.046 . . . . 0.0 111.619 178.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . 0.493 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . . . . . . . . 0 N--CA 1.495 1.778 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.875 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . 1.092 HG11 ' HB3' ' A' ' 89' ' ' ALA . 7.6 p . . . . . 0 N--CA 1.509 2.496 0 CA-C-O 121.065 0.459 . . . . 0.0 111.09 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 76' ' ' GLY . . . . . 0.602 ' HA3' HG22 ' B' ' 53' ' ' VAL . . . -101.25 78.81 0.4 Allowed Glycine 0 N--CA 1.478 1.495 0 C-N-CA 118.693 -1.718 . . . . 0.0 109.248 -179.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.867 HG21 ' HB3' ' A' ' 85' ' ' LEU . 2.4 p -66.74 69.19 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 O-C-N 121.672 -0.899 . . . . 0.0 109.384 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 78' ' ' SER . . . . . 0.564 ' N ' ' O ' ' B' ' 51' ' ' LYS . 0.6 OUTLIER -64.37 174.12 1.79 Allowed 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 118.927 -1.109 . . . . 0.0 110.136 -179.944 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.77 ' CG2' HG22 ' B' ' 50' ' ' ILE . 3.7 p 174.06 176.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 80' ' ' LYS . . . . . 0.614 ' N ' HG22 ' B' ' 79' ' ' VAL . 0.0 OUTLIER 179.68 171.26 0.56 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 120.865 -1.147 . . . . 0.0 110.663 176.91 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 81' ' ' PRO . . . . . 0.575 ' HA ' ' O ' ' B' ' 47' ' ' PHE . 54.8 Cg_endo -94.9 138.84 0.97 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.493 2.128 . . . . 0.0 110.227 177.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . 0.516 ' HA3' ' HA ' ' B' ' 47' ' ' PHE . . . -92.64 -164.71 38.17 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 108.248 -1.941 . . . . 0.0 108.248 178.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . 0.503 ' O ' ' N ' ' B' ' 87' ' ' LYS . 0.0 OUTLIER -94.46 -18.17 21.75 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.138 -1.213 . . . . 0.0 110.36 179.517 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 14.5 t -61.22 -34.83 75.74 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 177.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.859 ' CG ' HG21 ' A' ' 77' ' ' VAL . 0.9 OUTLIER -86.74 -26.87 23.99 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.283 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 86' ' ' LYS . . . . . 0.813 ' O ' ' HB3' ' B' ' 89' ' ' ALA . 4.4 tttp -79.32 -34.32 42.4 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 177.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' B' ' 83' ' ' GLU . 15.7 tttt -67.14 -39.56 86.59 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 178.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 1.065 ' HB1' ' HB2' ' A' ' 37' ' ' ALA . . . -60.45 -38.0 82.75 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 175.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.847 ' CA ' HD23 ' B' ' 92' ' ' LEU . . . -55.78 -34.99 65.76 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 177.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . 0.687 ' HA ' ' HB2' ' B' ' 94' ' ' TYR . 0.0 OUTLIER -56.91 -32.53 66.03 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 177.346 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.24 -13.27 77.23 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 92' ' ' LEU . . . . . 0.9 ' O ' HD12 ' B' ' 92' ' ' LEU . 0.3 OUTLIER -78.69 16.75 0.8 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.689 -1.477 . . . . 0.0 111.267 -179.883 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 93' ' ' LYS . . . . . 0.594 ' CG ' ' O ' ' B' ' 92' ' ' LEU . 0.1 OUTLIER 86.75 34.55 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -178.324 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . 0.775 ' CD2' ' HB ' ' A' ' 75' ' ' VAL . 3.6 t80 -42.09 -62.38 0.94 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.413 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -58.39 -32.62 68.77 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.53 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 96' ' ' ASP . . . . . 0.476 ' HB3' ' HG3' ' B' ' 93' ' ' LYS . 0.5 OUTLIER -64.52 -34.77 79.0 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.711 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.439 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 177.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.557 ' SD ' HG21 ' B' ' 35' ' ' THR . 1.4 mtp . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.01 0.433 . . . . 0.0 110.041 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.583 ' H ' ' HB2' ' A' ' 5' ' ' GLU . 47.0 p-10 -177.03 -169.68 0.26 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.295 -0.878 . . . . 0.0 110.44 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.795 ' O ' HD12 ' A' ' 25' ' ' LEU . 2.5 tptm -52.0 -17.38 1.0 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.4 -0.812 . . . . 0.0 110.158 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.435 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 24.4 m -95.49 -54.58 3.33 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.128 -0.983 . . . . 0.0 109.292 178.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.583 ' HB2' ' H ' ' A' ' 2' ' ' ASN . 2.8 mt-10 -62.85 -42.24 99.67 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.446 -0.901 . . . . 0.0 108.631 179.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.008 HD11 HG13 ' B' ' 42' ' ' VAL . 23.2 mt -65.35 -31.26 72.28 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 118.899 -1.12 . . . . 0.0 108.585 177.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.887 HG13 HD12 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -57.91 -57.23 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 178.341 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.976 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 18.4 pttt -65.83 -24.33 66.88 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 6' ' ' LEU . . . -60.25 -38.46 83.56 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.089 -1.007 . . . . 0.0 108.451 178.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.818 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.2 mp -88.48 -37.83 10.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 177.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.976 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -61.13 -15.76 36.92 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 119.047 -1.061 . . . . 0.0 108.631 177.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.451 ' HB3' ' O ' ' A' ' 8' ' ' LYS . 53.2 tp60 -111.13 -43.74 3.69 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.605 -0.684 . . . . 0.0 109.237 178.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.603 ' OD2' HG21 ' B' ' 31' ' ' ILE . 35.5 m-20 -62.33 -30.63 71.3 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 177.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.818 ' OG1' ' O ' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -105.03 -70.59 0.77 Allowed 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.122 179.053 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 49.08 26.7 6.32 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 1.065 ' CD1' HG23 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -87.41 -27.46 22.74 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.48 -1.012 . . . . 0.0 109.042 178.851 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.768 HG21 ' CG2' ' B' ' 17' ' ' THR . 0.4 OUTLIER -159.34 -7.61 0.07 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.982 -0.449 . . . . 0.0 110.169 -179.448 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.62 ' O ' ' C ' ' A' ' 19' ' ' VAL . 5.4 mt-30 58.0 31.2 20.31 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 -176.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.911 HG11 HG11 ' B' ' 19' ' ' VAL . 1.6 p -5.05 -91.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.502 -178.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.97 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -132.43 22.99 4.38 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.101 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.701 ' HA ' ' HE2' ' A' ' 24' ' ' MET . 16.0 m -19.41 -38.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 122.331 1.062 . . . . 0.0 109.389 -178.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.862 ' N ' ' O ' ' A' ' 20' ' ' SER . 5.6 t -78.88 -39.24 35.59 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.409 177.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.97 ' N ' ' O ' ' A' ' 20' ' ' SER . 3.1 mtmt -94.85 -28.36 15.27 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.603 -0.686 . . . . 0.0 109.543 178.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.701 ' HE2' ' HA ' ' A' ' 21' ' ' VAL 0.261 0.0 OUTLIER -63.09 -42.26 99.56 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.896 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.887 HD12 HG13 ' A' ' 7' ' ' ILE . 0.4 OUTLIER -86.1 -49.16 7.99 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 118.822 -1.151 . . . . 0.0 109.63 177.743 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' A' ' 22' ' ' SER . . . -46.77 -39.66 12.15 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.543 -1.348 . . . . 0.0 108.148 178.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.872 ' O ' HG23 ' A' ' 31' ' ' ILE . 55.6 m -78.31 -30.26 48.18 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.934 ' O ' HG13 ' A' ' 31' ' ' ILE . 7.7 t80 -54.79 -47.35 74.08 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.572 -0.705 . . . . 0.0 109.455 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.68 ' HB2' ' HE3' ' A' ' 3' ' ' LYS . 21.4 tt0 -68.78 -34.28 75.3 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 117.577 -1.649 . . . . 0.0 107.177 177.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.953 ' O ' ' HB3' ' A' ' 34' ' ' GLU . 7.8 tttp -69.22 -22.5 63.87 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.375 -0.93 . . . . 0.0 108.821 178.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.934 HG13 ' O ' ' A' ' 28' ' ' PHE . 2.3 pp -95.42 -40.43 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 119.364 -0.934 . . . . 0.0 109.66 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 1.054 HG21 ' CE1' ' B' ' 47' ' ' PHE . 6.2 mm -50.31 -50.28 21.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 177.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.694 HG22 ' HG ' ' B' ' 85' ' ' LEU . 7.5 p -69.38 -39.7 77.87 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.953 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -56.76 -32.86 66.02 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.692 -179.121 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.841 HG21 HG13 ' A' ' 42' ' ' VAL . 2.2 m -85.28 -56.23 3.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.021 -1.072 . . . . 0.0 110.272 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.754 HG13 ' HB3' ' A' ' 52' ' ' PRO . 94.2 t -53.92 -39.56 40.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 118.308 -1.357 . . . . 0.0 108.101 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.733 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -77.69 -3.45 41.16 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.101 -1.04 . . . . 0.0 109.012 177.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.619 ' HB2' ' O ' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -103.04 -26.76 12.95 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.253 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.49 43.29 1.37 Allowed Glycine 0 C--N 1.3 -1.418 0 C-N-CA 120.058 -1.068 . . . . 0.0 110.507 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.838 ' CB ' HG23 ' A' ' 35' ' ' THR . 0.1 OUTLIER -129.01 140.94 51.41 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.179 -1.189 . . . . 0.0 109.979 179.241 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.453 ' O ' ' N ' ' A' ' 43' ' ' GLN . 51.3 mtpt -88.08 89.32 7.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.552 -0.717 . . . . 0.0 110.53 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.841 HG13 HG21 ' A' ' 35' ' ' THR . 27.8 m -61.63 80.31 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.608 -0.683 . . . . 0.0 109.939 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.464 ' O ' ' HA ' ' B' ' 2' ' ' ASN . 1.9 tt0 -84.04 107.24 16.27 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.469 -0.769 . . . . 0.0 109.318 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.953 HD12 ' CB ' ' A' ' 48' ' ' LEU . 65.1 mt -61.89 114.67 3.48 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.138 -0.976 . . . . 0.0 109.179 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.588 HG23 ' HD1' ' A' ' 47' ' ' PHE . 0.0 OUTLIER 33.02 -97.5 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.853 -0.529 . . . . 0.0 111.256 -179.614 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.413 ' H ' HG23 ' A' ' 45' ' ' THR . . . -144.44 28.32 1.93 Allowed Glycine 0 N--CA 1.489 2.201 0 C-N-CA 119.726 -1.226 . . . . 0.0 110.39 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.713 ' CD1' ' HG3' ' B' ' 29' ' ' GLU . 3.6 p90 -126.03 -29.54 3.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.903 -1.351 . . . . 0.0 110.517 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.953 ' CB ' HD12 ' A' ' 44' ' ' LEU . 11.9 mt -123.63 93.12 3.84 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.23 -1.544 . . . . 0.0 110.53 177.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -86.86 86.0 7.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.911 -0.493 . . . . 0.0 110.055 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.854 ' CD1' HG23 ' A' ' 79' ' ' VAL . 1.5 mp -82.97 137.81 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.425 -0.797 . . . . 0.0 110.069 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 13.5 ptmt -153.43 127.94 4.66 Favored Pre-proline 0 N--CA 1.494 1.732 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.472 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.754 ' HB3' HG13 ' A' ' 36' ' ' VAL . 41.1 Cg_endo -65.47 141.33 67.05 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 123.539 1.284 . . . . 0.0 111.894 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.732 HG22 ' O ' ' A' ' 76' ' ' GLY . 33.4 m -147.66 117.69 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 CA-C-O 121.326 0.584 . . . . 0.0 111.244 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.582 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.504 2.262 0 O-C-N 121.309 -0.869 . . . . 0.0 112.278 -178.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 1.029 ' HB ' ' HB1' ' B' ' 89' ' ' ALA . 38.2 t . . . . . 0 N--CA 1.48 1.055 0 CA-C-O 122.162 0.982 . . . . 0.0 109.975 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.732 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -126.57 105.62 0.79 Allowed Glycine 0 C--N 1.29 -1.998 0 N-CA-C 108.015 -2.034 . . . . 0.0 108.015 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.771 HG13 ' O ' ' A' ' 77' ' ' VAL . 13.2 p -51.02 89.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.678 -0.895 . . . . 0.0 110.476 -178.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.504 ' N ' ' O ' ' A' ' 76' ' ' GLY . 0.5 OUTLIER -58.58 -171.92 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.281 -0.887 . . . . 0.0 110.729 -179.14 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.854 HG23 ' CD1' ' A' ' 50' ' ' ILE . 3.3 p -167.48 -164.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.693 ' H ' HG22 ' A' ' 79' ' ' VAL . 2.0 mttm -160.08 178.59 1.61 Allowed Pre-proline 0 C--N 1.308 -1.211 0 O-C-N 120.914 -1.116 . . . . 0.0 111.335 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.447 ' CD ' ' CB ' ' A' ' 80' ' ' LYS . 55.5 Cg_endo -103.64 83.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 123.977 3.118 . . . . 0.0 108.862 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.651 ' CA ' ' O ' ' A' ' 47' ' ' PHE . . . -57.0 121.63 25.94 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.591 -1.29 . . . . 0.0 111.183 -178.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -62.19 -35.74 79.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.53 -0.982 . . . . 0.0 109.043 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.596 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 0.3 OUTLIER -53.94 -30.85 48.35 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.586 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.987 HD21 HG11 ' B' ' 36' ' ' VAL . 8.8 tt -85.26 -34.23 21.99 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.742 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 0.3 OUTLIER -75.35 -44.75 43.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.542 -0.724 . . . . 0.0 109.446 179.606 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 41.4 tptt -64.98 -38.26 90.38 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 177.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.828 ' O ' ' HB1' ' B' ' 37' ' ' ALA . . . -61.65 -36.63 81.35 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 176.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.742 ' HB3' ' O ' ' A' ' 86' ' ' LYS . . . -56.42 -39.68 73.46 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.492 ' HA ' ' CB ' ' A' ' 94' ' ' TYR . 6.4 mm-40 -55.9 -28.89 58.81 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 176.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 88' ' ' ALA . . . -65.72 -50.84 51.56 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 178.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.624 ' HB3' ' O ' ' B' ' 37' ' ' ALA . 0.4 OUTLIER -59.85 -37.2 78.61 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.417 -1.637 . . . . 0.0 109.64 -179.745 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.596 ' CB ' ' O ' ' A' ' 92' ' ' LEU . 1.1 ttmt 143.82 65.23 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 1.095 ' O ' ' C ' ' A' ' 95' ' ' GLU . 7.7 t80 -49.11 -60.74 2.53 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 116.328 -2.149 . . . . 0.0 106.45 178.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 1.095 ' C ' ' O ' ' A' ' 94' ' ' TYR . 3.8 mm-40 . . . . . 0 CA--C 1.488 -1.417 0 N-CA-C 102.291 -3.226 . . . . 0.0 102.291 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.659 ' HG2' HG12 ' A' ' 42' ' ' VAL . 1.6 tpt . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 120.855 0.36 . . . . 0.0 110.401 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 2' ' ' ASN . . . . . 0.475 ' HB3' ' O ' ' B' ' 1' ' ' MET . 25.9 p30 179.6 -160.49 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.343 -0.943 . . . . 0.0 111.41 178.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.559 ' HE3' ' CG2' ' A' ' 45' ' ' THR . 0.1 OUTLIER -52.56 -10.45 0.15 Allowed 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.419 -0.801 . . . . 0.0 110.814 -179.705 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . 0.502 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 4.4 m -106.43 -51.5 2.94 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.861 -1.149 . . . . 0.0 109.495 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.607 ' CB ' ' HA ' ' B' ' 1' ' ' MET . 1.3 mt-10 -65.46 -37.84 88.05 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.217 -0.927 . . . . 0.0 108.637 179.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.81 HD11 ' HB ' ' A' ' 42' ' ' VAL . 24.6 mt -71.88 -27.95 63.2 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 118.892 -1.123 . . . . 0.0 108.214 177.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 7' ' ' ILE . . . . . 0.786 HG23 ' HB ' ' B' ' 21' ' ' VAL . 0.2 OUTLIER -57.31 -60.78 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 177.542 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . 0.941 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.0 OUTLIER -62.8 -24.1 67.57 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.581 178.443 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' B' ' 6' ' ' LEU . . . -60.83 -36.28 78.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.04 -1.038 . . . . 0.0 108.674 178.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.915 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.0 OUTLIER -96.56 -35.19 5.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 178.535 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.941 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -60.34 -25.12 65.58 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -91.27 -43.25 9.92 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 178.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.482 ' HB3' ' CB ' ' A' ' 27' ' ' SER . 1.1 m-20 -64.33 -26.11 68.33 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 177.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.915 ' OG1' ' O ' ' B' ' 10' ' ' ILE . 10.7 p -91.78 -75.1 0.49 Allowed 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 177.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' B' ' 11' ' ' ALA . . . 57.75 17.78 29.24 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 178.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 16' ' ' LEU . . . . . 0.896 HD22 ' O ' ' A' ' 19' ' ' VAL . 3.8 mp -77.54 -57.13 3.98 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 122.317 1.056 . . . . 0.0 108.532 178.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . 0.768 ' CG2' HG21 ' A' ' 17' ' ' THR . 0.5 OUTLIER -142.67 5.54 1.59 Allowed 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 115.162 -0.927 . . . . 0.0 109.18 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . 0.622 ' O ' ' C ' ' B' ' 19' ' ' VAL . 3.9 mt-30 58.26 25.24 12.43 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 -176.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 1.065 HG23 ' CD1' ' A' ' 16' ' ' LEU . 0.2 OUTLIER 9.43 -98.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.437 -178.954 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 1.051 ' O ' ' N ' ' B' ' 22' ' ' SER . 1.9 p -136.6 24.14 3.15 Favored 'General case' 0 C--N 1.273 -2.733 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 177.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.786 ' HB ' HG23 ' B' ' 7' ' ' ILE . 21.9 m -4.35 -42.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 CA-C-O 122.528 1.156 . . . . 0.0 110.763 -177.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 1.051 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.5 OUTLIER -76.62 -38.09 55.31 Favored 'General case' 0 C--N 1.281 -2.407 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.2 178.724 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . 0.882 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.0 OUTLIER -89.19 -32.79 17.28 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.437 -0.79 . . . . 0.0 111.302 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' MET . . . . . 0.594 ' HG2' HG22 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -68.83 -37.7 79.35 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 117.322 -1.751 . . . . 0.0 108.736 179.683 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.698 ' HA ' ' HB3' ' B' ' 28' ' ' PHE . 0.3 OUTLIER -82.91 -44.39 15.43 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 118.21 -1.396 . . . . 0.0 109.669 178.234 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . 0.541 ' HA ' ' CE ' ' B' ' 3' ' ' LYS . . . -58.4 -35.36 71.9 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.957 -1.089 . . . . 0.0 108.2 178.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' SER . . . . . 0.554 ' O ' HG13 ' B' ' 31' ' ' ILE . 20.0 t -81.68 -30.99 32.43 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . 0.738 ' CZ ' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -54.51 -45.09 73.23 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 178.793 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . 0.713 ' HG3' ' CD1' ' A' ' 47' ' ' PHE . 1.5 tt0 -69.93 -34.83 73.97 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 176.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 1.128 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 7.2 tttp -63.95 -18.27 64.08 Favored 'General case' 0 C--O 1.189 -2.112 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 177.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.69 ' CG1' ' HA ' ' B' ' 28' ' ' PHE . 1.2 pp -108.53 -26.08 3.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 120.32 -1.487 . . . . 0.0 108.617 177.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.624 HD11 ' CE2' ' B' ' 28' ' ' PHE . 1.1 mm -73.42 -57.02 7.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 176.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 33' ' ' THR . . . . . 0.561 ' OG1' ' HB2' ' A' ' 85' ' ' LEU . 0.5 OUTLIER -67.19 -40.88 86.59 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.335 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 1.128 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 76.9 mm-40 -74.72 -40.69 61.15 Favored 'General case' 0 C--O 1.207 -1.138 0 O-C-N 121.4 -0.813 . . . . 0.0 112.513 -179.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 35' ' ' THR . . . . . 0.557 HG21 ' SD ' ' A' ' 1' ' ' MET . 53.3 m -59.51 -49.11 79.05 Favored 'General case' 0 N--CA 1.505 2.284 0 CA-C-N 120.797 1.635 . . . . 0.0 109.469 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.987 HG11 HD21 ' A' ' 85' ' ' LEU . 1.4 t -53.0 -41.77 42.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 C-N-CA 118.266 -1.374 . . . . 0.0 107.345 178.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . 0.828 ' HB1' ' O ' ' A' ' 88' ' ' ALA . . . -92.7 11.57 26.33 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.717 -0.793 . . . . 0.0 109.745 178.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.704 ' HB2' ' O ' ' B' ' 34' ' ' GLU . 1.4 tppt? -104.76 -29.26 10.67 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 177.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.82 34.56 0.43 Allowed Glycine 0 C--N 1.305 -1.183 0 C-N-CA 119.835 -1.174 . . . . 0.0 111.042 177.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . 0.49 ' HB2' HG23 ' B' ' 35' ' ' THR . 0.1 OUTLIER -150.94 179.82 7.92 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.869 -1.371 . . . . 0.0 110.785 179.638 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.409 ' O ' ' HG3' ' B' ' 43' ' ' GLN . 5.0 mtmp? -133.2 113.6 12.86 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 1.008 HG13 HD11 ' A' ' 6' ' ' LEU . 59.2 t -61.24 140.52 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.441 -0.787 . . . . 0.0 110.499 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 43' ' ' GLN . . . . . 0.5 ' HA ' ' HA ' ' B' ' 49' ' ' ASN . 12.4 mt-30 -140.53 82.91 1.87 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.524 -0.735 . . . . 0.0 109.826 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.749 HD12 ' HB3' ' B' ' 48' ' ' LEU . 5.6 mt -59.79 117.5 5.07 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.274 -0.891 . . . . 0.0 110.704 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . 0.594 HG23 ' CD2' ' B' ' 47' ' ' PHE . 0.0 OUTLIER 24.38 -92.73 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.243 0 O-C-N 122.16 -0.337 . . . . 0.0 111.436 179.062 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . 0.488 ' H ' HG23 ' B' ' 45' ' ' THR . . . -146.54 48.3 0.67 Allowed Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . 1.054 ' CE1' HG21 ' A' ' 32' ' ' ILE . 16.5 p90 -151.27 -40.09 0.12 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.963 -1.316 . . . . 0.0 111.671 179.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.863 HD13 ' CB ' ' B' ' 80' ' ' LYS . 0.0 OUTLIER -116.86 107.94 15.22 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.703 -1.248 . . . . 0.0 110.378 179.401 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 49' ' ' ASN . . . . . 0.945 ' O ' ' O ' ' B' ' 79' ' ' VAL . 0.5 OUTLIER -124.54 97.49 5.32 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.997 -1.064 . . . . 0.0 110.606 -179.495 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 50' ' ' ILE . . . . . 0.508 ' H ' ' HD3' ' B' ' 80' ' ' LYS . 0.5 OUTLIER -88.56 143.89 10.27 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 O-C-N 121.496 -0.753 . . . . 0.0 110.883 -179.211 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . 0.55 ' HG3' ' HB2' ' B' ' 78' ' ' SER . 0.0 OUTLIER -159.88 136.69 6.66 Favored Pre-proline 0 N--CA 1.495 1.792 0 C-N-CA 119.416 -0.914 . . . . 0.0 110.023 179.6 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 52' ' ' PRO . . . . . 0.736 ' HB3' HG13 ' B' ' 36' ' ' VAL . 56.6 Cg_endo -89.28 144.86 4.98 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.752 1.396 . . . . 0.0 112.58 -178.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.59 HG22 ' O ' ' B' ' 76' ' ' GLY . 33.3 m -144.23 113.16 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-O 121.655 0.741 . . . . 0.0 109.709 177.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' B' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.495 1.822 0 CA-C-O 122.0 0.905 . . . . 0.0 112.462 -178.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . 0.715 HG11 ' CB ' ' A' ' 89' ' ' ALA . 6.1 p . . . . . 0 N--CA 1.495 1.789 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 76' ' ' GLY . . . . . 0.59 ' O ' HG22 ' B' ' 53' ' ' VAL . . . -118.26 45.14 1.3 Allowed Glycine 0 N--CA 1.488 2.16 0 C-N-CA 118.898 -1.62 . . . . 0.0 109.825 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.877 ' CG2' HD22 ' A' ' 85' ' ' LEU . 6.5 p -28.13 91.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 122.061 -0.67 . . . . 0.0 110.828 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 78' ' ' SER . . . . . 0.55 ' HB2' ' HG3' ' B' ' 51' ' ' LYS . 57.7 m -57.91 -122.12 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 119.864 -0.734 . . . . 0.0 109.102 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.945 ' O ' ' O ' ' B' ' 49' ' ' ASN . 4.5 m -148.41 -168.88 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 119.859 -1.776 . . . . 0.0 112.868 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 80' ' ' LYS . . . . . 0.888 ' H ' ' HD2' ' B' ' 81' ' ' PRO . 0.0 OUTLIER -114.58 -52.92 0.04 OUTLIER Pre-proline 0 C--N 1.301 -1.531 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -178.403 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 81' ' ' PRO . . . . . 0.888 ' HD2' ' H ' ' B' ' 80' ' ' LYS . 26.7 Cg_endo -49.49 130.59 25.99 Favored 'Trans proline' 0 C--N 1.298 -2.106 0 C-N-CA 120.869 1.046 . . . . 0.0 112.551 -175.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -128.04 -62.8 0.13 Allowed Glycine 0 N--CA 1.486 1.981 0 N-CA-C 105.856 -2.897 . . . . 0.0 105.856 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . 0.885 ' O ' ' N ' ' B' ' 85' ' ' LEU . 26.3 tt0 -91.03 47.6 1.42 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.514 -1.662 . . . . 0.0 106.514 175.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 84' ' ' SER . . . . . 1.286 ' O ' ' N ' ' B' ' 86' ' ' LYS . 4.5 m 8.45 43.79 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.506 1.146 . . . . 0.0 110.875 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 1.026 ' C ' ' O ' ' B' ' 84' ' ' SER . 4.3 mp 22.01 29.66 0.0 OUTLIER 'General case' 0 C--O 1.194 -1.831 0 N-CA-C 103.599 -2.741 . . . . 0.0 103.599 -171.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 86' ' ' LYS . . . . . 1.286 ' N ' ' O ' ' B' ' 84' ' ' SER 0.319 6.5 tttm -51.85 -34.78 42.13 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 103.459 -2.793 . . . . 0.0 103.459 175.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . 0.456 ' O ' ' CG ' ' B' ' 90' ' ' GLU 0.286 16.8 tptp -68.01 -36.2 79.58 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 111.773 -2.467 . . . . 0.0 106.609 175.565 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.919 ' HB3' ' HB3' ' B' ' 85' ' ' LEU . . . -80.38 -26.2 38.7 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 118.349 -1.34 . . . . 0.0 107.764 177.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 1.029 ' HB1' ' HB ' ' A' ' 75' ' ' VAL . . . -67.27 -50.11 61.74 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.53 -0.731 . . . . 0.0 109.051 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . 0.456 ' CG ' ' O ' ' B' ' 87' ' ' LYS . 6.5 pt-20 -57.03 -27.83 61.98 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 176.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . 0.44 ' N ' ' HG3' ' B' ' 90' ' ' GLU . . . -63.32 -38.25 96.13 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 178.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 92' ' ' LEU . . . . . 0.843 HD23 ' HA ' ' B' ' 89' ' ' ALA . 0.9 OUTLIER -85.37 23.48 1.31 Allowed 'General case' 0 N--CA 1.503 2.222 0 O-C-N 120.493 -1.592 . . . . 0.0 110.5 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 93' ' ' LYS . . . . . 0.458 ' O ' ' N ' ' B' ' 96' ' ' ASP . 0.4 OUTLIER 58.58 48.17 12.24 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 -177.659 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . 0.721 ' C ' ' CD1' ' B' ' 94' ' ' TYR . 0.0 OUTLIER -42.98 -37.11 1.77 Allowed 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.762 -178.51 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . 0.469 ' N ' ' CD1' ' B' ' 94' ' ' TYR . 8.8 pt-20 -53.85 -39.48 65.65 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.258 -0.901 . . . . 0.0 109.097 178.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 96' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' B' ' 93' ' ' LYS . 0.2 OUTLIER -65.96 -28.5 68.95 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.308 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.412 0 O-C-N 121.549 -0.719 . . . . 0.0 109.185 178.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.575 ' CE ' HD23 ' A' ' 6' ' ' LEU . 3.8 mtp . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 120.908 0.385 . . . . 0.0 110.064 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.805 ' C ' HD12 ' A' ' 6' ' ' LEU . 27.3 p30 -177.82 -167.75 0.16 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.215 -0.928 . . . . 0.0 111.28 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.607 ' HG2' HD13 ' A' ' 25' ' ' LEU . 12.7 tttt -51.31 -16.63 0.56 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.555 -0.716 . . . . 0.0 110.252 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.609 ' O ' HG12 ' A' ' 7' ' ' ILE . 41.0 m -104.69 -58.95 1.81 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.263 -0.898 . . . . 0.0 110.271 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.455 ' HB2' ' H ' ' A' ' 2' ' ' ASN . 3.5 mm-40 -54.88 -45.54 74.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.125 -0.985 . . . . 0.0 109.762 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.805 HD12 ' C ' ' A' ' 2' ' ' ASN . 12.0 mt -52.04 -45.85 64.81 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.389 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.72 HG21 HD22 ' A' ' 25' ' ' LEU . 0.6 OUTLIER -56.36 -45.99 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 178.271 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.866 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 0.9 OUTLIER -56.67 -39.94 74.65 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 176.828 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.913 ' CB ' HD13 ' B' ' 31' ' ' ILE . . . -54.85 -35.71 64.3 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 178.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.768 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.5 mp -88.33 -32.45 5.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 177.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.866 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -67.89 -10.84 56.5 Favored 'General case' 0 C--N 1.287 -2.12 0 C-N-CA 118.999 -1.08 . . . . 0.0 108.969 178.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.449 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -120.6 -34.73 3.53 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.356 -0.84 . . . . 0.0 110.333 179.157 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.479 ' HB3' ' HB2' ' B' ' 27' ' ' SER . 0.9 OUTLIER -74.94 -36.88 62.11 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 176.823 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 1.113 HG22 ' CD1' ' A' ' 16' ' ' LEU 0.268 0.2 OUTLIER -91.96 -70.28 0.7 Allowed 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 177.95 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 54.45 21.49 20.56 Favored Glycine 0 N--CA 1.5 2.908 0 O-C-N 121.534 -0.729 . . . . 0.0 111.445 177.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 1.113 ' CD1' HG22 ' A' ' 14' ' ' THR . 5.0 mp -64.7 -62.87 1.31 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.362 -1.081 . . . . 0.0 109.01 178.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.675 HG21 HG21 ' B' ' 17' ' ' THR . 0.5 OUTLIER -138.82 6.45 2.44 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.866 -179.815 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.594 ' O ' ' C ' ' A' ' 19' ' ' VAL . 6.3 mt-30 57.53 26.92 13.32 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 -176.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 1.057 HG11 HG11 ' B' ' 19' ' ' VAL . 1.2 p -0.83 -95.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.802 -178.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.96 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -133.2 25.79 4.19 Favored 'General case' 0 C--N 1.277 -2.575 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 179.005 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.66 ' HA ' ' CE ' ' A' ' 24' ' ' MET . 31.0 m -19.1 -39.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 CA-C-O 122.483 1.135 . . . . 0.0 109.505 -178.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.854 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.6 OUTLIER -77.7 -40.47 41.25 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.362 177.522 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.96 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -85.6 -38.94 17.88 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 121.543 -0.723 . . . . 0.0 111.577 179.891 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.66 ' CE ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -66.22 -27.21 67.8 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 117.315 -1.754 . . . . 0.0 108.176 179.368 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.72 HD22 HG21 ' A' ' 7' ' ' ILE . 0.4 OUTLIER -74.64 -45.1 47.07 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 118.827 -1.149 . . . . 0.0 108.838 177.933 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.672 ' N ' ' HG ' ' A' ' 25' ' ' LEU . . . -63.99 -25.27 68.05 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 178.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.568 ' HA ' ' HB3' ' A' ' 30' ' ' LYS . 19.1 p -85.3 -41.03 15.9 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.692 ' CE1' HD22 ' B' ' 44' ' ' LEU . 0.0 OUTLIER -57.33 -48.23 79.52 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.087 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.587 ' HG3' ' CE2' ' B' ' 47' ' ' PHE . 0.7 OUTLIER -68.6 -35.14 76.94 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.034 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 1.248 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 13.8 ttmt -64.85 -22.13 66.93 Favored 'General case' 0 C--O 1.191 -2.023 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 177.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.881 HD13 ' CB ' ' B' ' 9' ' ' ALA . 0.6 OUTLIER -105.08 -28.44 2.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 120.068 -1.645 . . . . 0.0 109.17 178.076 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.651 HG21 ' CE1' ' B' ' 47' ' ' PHE . 1.2 mm -72.24 -61.15 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 176.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.819 ' HA ' HD23 ' B' ' 85' ' ' LEU . 0.5 OUTLIER -67.8 -35.27 78.34 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.282 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 1.248 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 27.4 mm-40 -77.8 -32.31 52.32 Favored 'General case' 0 N--CA 1.482 1.138 0 O-C-N 120.958 -1.089 . . . . 0.0 111.214 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.748 HG23 ' CB ' ' A' ' 40' ' ' ASP . 1.8 m -59.3 -50.93 72.11 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.32 -1.488 . . . . 0.0 107.457 178.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.05 HG21 HG23 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -53.89 -36.49 30.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 C-N-CA 117.918 -1.513 . . . . 0.0 107.006 177.868 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.606 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -80.43 -7.86 59.31 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.677 0.751 . . . . 0.0 109.632 177.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.555 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -100.26 -8.21 23.73 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 177.566 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 80.47 47.49 6.82 Favored Glycine 0 C--N 1.302 -1.316 0 N-CA-C 110.201 -1.159 . . . . 0.0 110.201 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.748 ' CB ' HG23 ' A' ' 35' ' ' THR . 0.3 OUTLIER -130.28 119.51 22.97 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.295 -1.121 . . . . 0.0 110.314 179.594 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -76.09 81.9 2.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.479 -0.763 . . . . 0.0 109.519 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.86 ' CG2' HD11 ' B' ' 6' ' ' LEU . 5.9 p -63.6 144.91 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.439 -0.788 . . . . 0.0 110.253 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -128.01 98.87 5.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.502 -0.749 . . . . 0.0 109.876 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.75 HD12 ' HB3' ' A' ' 48' ' ' LEU . 8.7 mt -61.62 108.22 0.94 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.256 -0.902 . . . . 0.0 109.495 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.55 HG21 ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER 31.12 -91.77 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.315 0 O-C-N 122.003 -0.436 . . . . 0.0 111.189 -179.669 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -149.48 32.36 1.12 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.738 ' CD1' HD21 ' A' ' 85' ' ' LEU . 2.1 p90 -134.92 -23.04 1.57 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.031 -1.276 . . . . 0.0 111.936 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.872 HD23 ' O ' ' A' ' 80' ' ' LYS . 5.0 mt -130.82 118.23 20.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.259 -1.525 . . . . 0.0 111.166 178.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.447 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 2.1 m-20 -115.92 93.57 4.31 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.544 -0.723 . . . . 0.0 110.513 -179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.866 HG23 HG22 ' A' ' 79' ' ' VAL . 9.5 mm -87.63 132.94 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.313 -0.867 . . . . 0.0 109.282 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.501 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 0.5 OUTLIER -149.85 126.06 5.16 Favored Pre-proline 0 N--CA 1.497 1.895 0 C-N-CA 118.57 -1.252 . . . . 0.0 111.038 179.959 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.881 ' HB3' HG22 ' A' ' 36' ' ' VAL . 56.1 Cg_endo -81.48 138.95 11.16 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.439 1.231 . . . . 0.0 110.51 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.706 HG22 ' O ' ' A' ' 76' ' ' GLY . 28.6 m -140.84 115.61 6.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-O 121.546 0.689 . . . . 0.0 110.377 179.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.491 ' HB2' ' HB3' ' B' ' 97' ' ' PHE . . . . . . . . 0 N--CA 1.498 1.962 0 CA-C-O 121.824 0.821 . . . . 0.0 112.139 -178.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.683 HG12 ' CB ' ' B' ' 89' ' ' ALA . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.804 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.706 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -113.49 70.69 0.23 Allowed Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 1.05 HG23 HG21 ' A' ' 36' ' ' VAL . 2.6 p -51.07 79.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.821 -0.811 . . . . 0.0 110.18 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.774 ' O ' HG23 ' A' ' 79' ' ' VAL . 0.7 OUTLIER -73.53 178.16 4.85 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.227 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.866 HG22 HG23 ' A' ' 50' ' ' ILE . 41.8 t -166.5 175.99 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.872 ' O ' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -175.33 169.15 1.56 Allowed Pre-proline 0 C--N 1.308 -1.225 0 O-C-N 120.982 -1.074 . . . . 0.0 110.045 176.662 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.587 ' HB2' HG13 ' B' ' 77' ' ' VAL . 55.8 Cg_endo -103.32 137.84 0.12 Allowed 'Trans proline' 0 C--N 1.3 -1.991 0 C-N-CA 122.962 2.442 . . . . 0.0 110.727 178.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.503 ' HA3' ' HA ' ' A' ' 47' ' ' PHE . . . -89.83 -148.11 18.59 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 107.437 -2.265 . . . . 0.0 107.437 177.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.403 ' HA ' ' HB2' ' A' ' 86' ' ' LYS . 2.0 pm0 -101.28 -13.96 17.85 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.064 -1.256 . . . . 0.0 109.803 178.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.458 ' CB ' ' HB3' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -56.5 -32.97 65.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.3 -0.875 . . . . 0.0 108.953 179.161 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.893 HD23 ' HA ' ' B' ' 33' ' ' THR . 0.5 OUTLIER -82.48 -31.73 29.19 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.456 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 0.1 OUTLIER -75.53 -39.98 57.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.485 -0.759 . . . . 0.0 110.173 -179.399 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.1 ttmt -70.22 -37.61 75.06 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.641 ' O ' ' HB1' ' B' ' 37' ' ' ALA . . . -69.18 -34.03 74.29 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 176.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.967 ' HA ' HD23 ' A' ' 92' ' ' LEU . . . -59.89 -43.52 94.75 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.46 -32.91 52.11 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -66.11 -35.78 90.99 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 178.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.967 HD23 ' HA ' ' A' ' 89' ' ' ALA . 0.5 OUTLIER -72.69 7.21 2.03 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.722 -1.457 . . . . 0.0 111.438 -179.715 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.414 ' CB ' ' O ' ' A' ' 92' ' ' LEU . 0.1 OUTLIER 63.75 38.42 9.23 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -177.862 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.652 ' HB2' ' HB ' ' B' ' 75' ' ' VAL . 0.4 OUTLIER -43.69 -35.75 1.94 Allowed 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.506 -179.238 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.458 ' N ' ' CG ' ' A' ' 94' ' ' TYR . 15.2 pt-20 . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.4 -0.812 . . . . 0.0 109.157 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.661 ' HG3' HG23 ' A' ' 42' ' ' VAL . 4.0 ptp . . . . . 0 N--CA 1.495 1.807 0 CA-C-O 121.605 0.717 . . . . 0.0 110.577 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 2' ' ' ASN . . . . . 0.444 ' HB3' ' O ' ' B' ' 1' ' ' MET . 14.1 p-10 179.72 -157.93 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.542 178.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.55 ' HE2' HG21 ' A' ' 45' ' ' THR . 9.7 mttm -53.92 -11.53 0.44 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.253 -0.904 . . . . 0.0 110.761 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . 0.438 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 15.4 m -101.04 -55.03 2.66 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.039 -1.038 . . . . 0.0 110.008 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.489 ' CB ' ' CB ' ' B' ' 1' ' ' MET . 2.5 mp0 -64.09 -50.16 69.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.195 -0.94 . . . . 0.0 109.24 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.86 HD11 ' CG2' ' A' ' 42' ' ' VAL . 32.5 mt -53.94 -43.28 69.69 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 7' ' ' ILE . . . . . 0.851 HG23 ' HB ' ' B' ' 21' ' ' VAL . 0.3 OUTLIER -50.24 -52.4 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 177.163 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . 0.936 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.0 OUTLIER -56.26 -39.73 73.06 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.056 177.22 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . 0.881 ' CB ' HD13 ' A' ' 31' ' ' ILE . . . -49.61 -38.1 30.55 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.195 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.714 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.4 mp -93.63 -32.0 4.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 178.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.936 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -68.23 -8.49 39.55 Favored 'General case' 0 C--N 1.291 -1.973 0 C-N-CA 118.377 -1.329 . . . . 0.0 109.012 178.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.515 ' HB3' ' O ' ' B' ' 8' ' ' LYS . 0.9 OUTLIER -119.9 -41.84 2.64 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.364 -0.835 . . . . 0.0 109.674 179.294 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.491 ' CB ' ' HB2' ' A' ' 27' ' ' SER . 1.5 m-20 -70.28 -35.4 73.71 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 177.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.901 HG22 ' CD2' ' B' ' 16' ' ' LEU 0.262 0.2 OUTLIER -96.72 -79.27 0.45 Allowed 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 177.592 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 52.47 5.01 0.17 Allowed Glycine 0 N--CA 1.502 3.04 0 O-C-N 121.226 -0.921 . . . . 0.0 111.793 177.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 16' ' ' LEU . . . . . 0.901 ' CD2' HG22 ' B' ' 14' ' ' THR . 0.7 OUTLIER -61.43 -23.7 66.01 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.127 -1.219 . . . . 0.0 110.052 179.524 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . 0.675 HG21 HG21 ' A' ' 17' ' ' THR . 0.5 OUTLIER -159.82 -9.98 0.06 Allowed 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.707 -0.621 . . . . 0.0 110.482 -179.783 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . 0.645 ' O ' ' C ' ' B' ' 19' ' ' VAL . 7.3 mt-30 54.94 35.94 25.64 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 -177.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 1.057 HG11 HG11 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -10.53 -92.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.165 -179.329 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 1.063 ' O ' ' N ' ' B' ' 22' ' ' SER . 4.5 p -134.96 24.9 3.61 Favored 'General case' 0 C--N 1.282 -2.368 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 176.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.851 ' HB ' HG23 ' B' ' 7' ' ' ILE . 30.7 m -4.48 -41.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 CA-C-O 122.561 1.172 . . . . 0.0 110.976 -177.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 1.063 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.6 OUTLIER -76.74 -37.3 56.21 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.766 179.13 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . 0.837 ' N ' ' O ' ' B' ' 20' ' ' SER . 1.5 mtmt -89.6 -31.47 17.55 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.318 -0.864 . . . . 0.0 110.811 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 24' ' ' MET . . . . . 0.696 ' HB3' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -68.65 -39.69 80.59 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 117.191 -1.804 . . . . 0.0 108.759 179.285 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.704 HD12 HG13 ' B' ' 7' ' ' ILE . 0.3 OUTLIER -77.02 -45.09 28.45 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 118.132 -1.427 . . . . 0.0 108.431 177.574 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' B' ' 22' ' ' SER . . . -55.26 -34.46 64.06 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 27' ' ' SER . . . . . 0.484 ' O ' HG13 ' B' ' 31' ' ' ILE . 90.8 p -81.49 -35.44 30.46 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . 0.668 ' O ' HG13 ' B' ' 31' ' ' ILE . 0.7 OUTLIER -53.41 -49.17 67.83 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.633 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . 0.728 ' HG3' ' CD2' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -67.55 -34.88 77.97 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 177.184 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 1.183 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 53.1 tttm -64.51 -21.55 66.71 Favored 'General case' 0 C--O 1.19 -2.064 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.913 HD13 ' CB ' ' A' ' 9' ' ' ALA . 0.6 OUTLIER -105.61 -26.69 3.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 O-C-N 120.163 -1.586 . . . . 0.0 109.062 177.924 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.631 HD11 ' CE2' ' B' ' 28' ' ' PHE . 1.2 mm -74.87 -58.14 5.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 176.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 33' ' ' THR . . . . . 0.893 ' HA ' HD23 ' A' ' 85' ' ' LEU . 0.6 OUTLIER -70.15 -35.5 74.08 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.263 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 1.183 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 50.9 mm-40 -76.69 -32.84 58.15 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 119.314 -0.954 . . . . 0.0 111.033 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 35' ' ' THR . . . . . 0.671 HG21 ' CG2' ' B' ' 42' ' ' VAL . 2.2 m -61.68 -50.79 71.07 Favored 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 118.015 -1.474 . . . . 0.0 107.942 178.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.735 HG21 HG23 ' B' ' 77' ' ' VAL . 1.2 t -54.12 -36.0 30.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 177.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . 0.641 ' HB1' ' O ' ' A' ' 88' ' ' ALA . . . -81.5 -5.44 57.96 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-O 121.655 0.74 . . . . 0.0 109.346 177.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.511 ' N ' ' O ' ' B' ' 34' ' ' GLU . 0.9 OUTLIER -99.08 -25.08 14.66 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 177.833 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.32 39.5 2.09 Favored Glycine 0 C--N 1.303 -1.292 0 C-N-CA 120.183 -1.008 . . . . 0.0 110.795 177.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . 0.613 ' CB ' HG23 ' B' ' 35' ' ' THR . 0.1 OUTLIER -131.02 133.35 45.67 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.984 -1.304 . . . . 0.0 110.567 179.528 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.51 89.45 6.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.546 -0.721 . . . . 0.0 109.879 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.671 ' CG2' HG21 ' B' ' 35' ' ' THR . 58.6 t -60.02 127.3 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.59 -0.694 . . . . 0.0 110.449 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 43' ' ' GLN . . . . . 0.458 ' HA ' ' HA ' ' B' ' 49' ' ' ASN . 1.9 tt0 -119.32 99.63 6.81 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 121.391 -0.818 . . . . 0.0 109.548 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.897 HD12 ' HB3' ' B' ' 48' ' ' LEU . 12.6 mt -71.98 87.72 1.05 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.156 -0.965 . . . . 0.0 110.386 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . 0.508 ' HB ' ' HD2' ' A' ' 3' ' ' LYS . 1.8 t 36.2 29.58 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . 93.31 -26.02 17.56 Favored Glycine 0 N--CA 1.491 2.347 0 C-N-CA 119.883 -1.151 . . . . 0.0 112.453 177.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . 0.95 ' CD1' HD21 ' B' ' 85' ' ' LEU . 0.4 OUTLIER -81.72 -29.76 32.81 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 119.738 1.769 . . . . 0.0 111.415 -178.776 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.897 ' HB3' HD12 ' B' ' 44' ' ' LEU . 4.6 mt -133.65 95.21 3.43 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.475 -1.391 . . . . 0.0 110.367 177.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 49' ' ' ASN . . . . . 0.468 ' O ' ' HA ' ' B' ' 79' ' ' VAL . 17.3 t-20 -103.22 90.23 3.66 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.222 -0.924 . . . . 0.0 111.368 -179.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 50' ' ' ILE . . . . . 0.6 HD11 HD11 ' A' ' 48' ' ' LEU . 1.2 mm -73.44 141.84 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.495 -0.753 . . . . 0.0 109.468 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . 0.419 ' O ' ' HG3' ' B' ' 51' ' ' LYS . 9.6 ptmt -152.52 115.57 2.88 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 120.889 -1.132 . . . . 0.0 110.656 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 52' ' ' PRO . . . . . 0.545 ' HA ' ' HA ' ' B' ' 77' ' ' VAL . 52.7 Cg_endo -77.14 142.89 22.1 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 O-C-N 123.528 1.278 . . . . 0.0 111.194 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.733 HG22 ' O ' ' B' ' 76' ' ' GLY . 33.2 m -143.15 116.35 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-O 121.416 0.627 . . . . 0.0 110.528 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . 0.583 ' HA ' ' HA ' ' B' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.5 2.042 0 CA-C-O 121.782 0.801 . . . . 0.0 112.213 -178.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . 0.652 ' HB ' ' HB2' ' A' ' 94' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.696 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 76' ' ' GLY . . . . . 0.733 ' O ' HG22 ' B' ' 53' ' ' VAL . . . -114.25 75.63 0.24 Allowed Glycine 0 N--CA 1.486 1.99 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.878 HG21 ' CB ' ' A' ' 85' ' ' LEU . 2.8 p -51.54 82.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.79 -0.829 . . . . 0.0 110.365 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 78' ' ' SER . . . . . 0.584 ' N ' ' O ' ' B' ' 76' ' ' GLY . 0.5 OUTLIER -80.81 177.91 8.73 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.819 -0.753 . . . . 0.0 110.034 179.762 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.615 HG22 ' N ' ' B' ' 80' ' ' LYS . 7.4 p 177.97 177.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 80' ' ' LYS . . . . . 0.672 ' O ' HD23 ' B' ' 48' ' ' LEU . 2.7 ptpt -171.85 173.26 1.69 Allowed Pre-proline 0 C--N 1.307 -1.265 0 O-C-N 120.845 -1.159 . . . . 0.0 110.539 178.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 81' ' ' PRO . . . . . 0.508 ' HA ' ' O ' ' B' ' 47' ' ' PHE . 55.5 Cg_endo -98.9 128.6 0.19 Allowed 'Trans proline' 0 C--N 1.3 -1.989 0 C-N-CA 122.689 2.259 . . . . 0.0 110.549 178.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . 0.475 ' H ' ' HA ' ' B' ' 47' ' ' PHE . . . -81.8 -155.33 14.68 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 107.941 -2.064 . . . . 0.0 107.941 178.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . 0.446 ' HA ' ' HB2' ' B' ' 86' ' ' LYS . 3.4 pm0 -93.84 -15.35 25.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.097 -1.237 . . . . 0.0 109.977 179.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.38 -36.93 66.9 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.247 -0.908 . . . . 0.0 109.144 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.95 HD21 ' CD1' ' B' ' 47' ' ' PHE . 0.3 OUTLIER -82.29 -32.26 29.64 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.487 -0.758 . . . . 0.0 109.017 179.116 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 86' ' ' LYS . . . . . 0.478 ' O ' ' HB3' ' B' ' 89' ' ' ALA . 2.2 mttp -73.39 -37.43 65.98 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.496 -0.752 . . . . 0.0 109.922 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 28.5 tptt -69.66 -37.99 76.93 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 178.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.591 ' CB ' ' HB2' ' A' ' 37' ' ' ALA . . . -67.85 -34.43 76.69 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 176.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.985 ' HA ' HD23 ' B' ' 92' ' ' LEU . . . -59.67 -44.6 93.54 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.073 179.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -53.52 -31.83 47.93 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 177.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -68.43 -32.68 75.72 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 178.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 92' ' ' LEU . . . . . 0.985 HD23 ' HA ' ' B' ' 89' ' ' ALA . 0.5 OUTLIER -73.33 8.97 1.45 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.748 -1.443 . . . . 0.0 111.426 -179.728 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 61.55 38.43 15.61 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 -177.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . 0.629 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 0.2 OUTLIER -45.43 -37.7 5.36 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.609 -178.998 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . 0.448 ' N ' ' CG ' ' B' ' 94' ' ' TYR . 2.6 pp20? -57.28 -38.01 73.28 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.324 -0.86 . . . . 0.0 109.162 179.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.06 -34.84 78.43 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 177.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 97' ' ' PHE . . . . . 0.491 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.481 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.605 ' CG ' ' HB3' ' A' ' 5' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 121.096 0.474 . . . . 0.0 110.25 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.565 ' N ' ' HB2' ' A' ' 5' ' ' GLU . 2.0 t-20 -177.24 -178.84 0.82 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.187 -0.946 . . . . 0.0 110.931 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.818 ' O ' HD22 ' A' ' 25' ' ' LEU . 8.4 mttt -46.67 -25.13 0.66 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.64 -0.663 . . . . 0.0 109.852 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.458 ' O ' HG22 ' A' ' 7' ' ' ILE . 8.3 m -101.63 -52.4 3.22 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.396 -0.815 . . . . 0.0 110.111 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.605 ' HB3' ' CG ' ' A' ' 1' ' ' MET . 6.7 mt-10 -53.7 -47.61 70.33 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.107 -0.996 . . . . 0.0 108.573 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.641 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 4.1 mt -55.37 -37.67 67.83 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 119.177 -1.009 . . . . 0.0 108.814 177.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.763 ' CD1' HD23 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -50.77 -44.86 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.081 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.751 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -68.18 -32.4 72.61 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.745 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.641 ' HB3' ' O ' ' A' ' 6' ' ' LEU . . . -53.23 -38.52 63.01 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.369 -0.832 . . . . 0.0 109.033 179.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.765 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.3 mp -102.32 -29.7 3.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.751 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -69.11 -11.32 60.69 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 118.554 -1.259 . . . . 0.0 108.577 178.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.418 ' CG ' ' O ' ' A' ' 8' ' ' LYS . 54.0 mm-40 -113.74 -42.49 3.42 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.484 -0.76 . . . . 0.0 109.053 178.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.425 ' HB2' ' O ' ' A' ' 9' ' ' ALA . 1.5 m-20 -65.54 -36.17 83.0 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 177.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.765 ' OG1' ' O ' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -99.69 -73.04 0.64 Allowed 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 178.144 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 46.32 22.55 0.99 Allowed Glycine 0 N--CA 1.5 2.919 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 178.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 1.079 ' CD1' HG23 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -75.05 -26.25 59.27 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 121.507 -0.996 . . . . 0.0 108.8 179.323 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.729 HG22 ' H ' ' A' ' 19' ' ' VAL . 0.4 OUTLIER -162.05 -2.91 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.932 -179.191 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.575 ' O ' ' C ' ' A' ' 19' ' ' VAL . 21.9 mt-30 57.92 28.16 15.73 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -176.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 1.002 ' O ' HD22 ' B' ' 16' ' ' LEU . 1.6 p -1.76 -90.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.235 -178.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.958 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.4 OUTLIER -129.98 25.6 5.26 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 178.918 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.791 ' HA ' ' CE ' ' A' ' 24' ' ' MET . 13.5 m -22.91 -41.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 CA-C-O 122.576 1.179 . . . . 0.0 108.777 -178.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.747 ' N ' ' O ' ' A' ' 20' ' ' SER . 6.6 m -76.36 -37.74 56.83 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.731 177.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.958 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.9 OUTLIER -89.01 -38.73 14.19 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.493 -0.755 . . . . 0.0 111.717 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.791 ' CE ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -66.88 -27.75 67.77 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.075 -1.64 . . . . 0.0 109.178 179.648 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.818 HD22 ' O ' ' A' ' 3' ' ' LYS . 0.2 OUTLIER -82.94 -45.47 14.11 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 118.865 -1.134 . . . . 0.0 108.982 178.618 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.651 ' N ' ' HG ' ' A' ' 25' ' ' LEU . . . -66.4 -27.64 68.01 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.56 ' O ' ' N ' ' A' ' 31' ' ' ILE . 52.9 p -87.76 -31.24 19.73 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.829 ' O ' HG13 ' A' ' 31' ' ' ILE . 0.1 OUTLIER -55.66 -48.17 75.47 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.562 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.576 ' HG3' ' CE2' ' B' ' 47' ' ' PHE . 1.0 OUTLIER -69.89 -36.37 75.37 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 177.01 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 1.201 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 35.7 tttp -65.22 -17.8 64.78 Favored 'General case' 0 C--O 1.19 -2.043 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.829 HG13 ' O ' ' A' ' 28' ' ' PHE . 1.2 pp -108.56 -30.07 2.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 120.195 -1.566 . . . . 0.0 108.916 178.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.598 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.1 mm -71.41 -58.06 6.05 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 176.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.982 ' HA ' HD23 ' B' ' 85' ' ' LEU . 0.6 OUTLIER -69.95 -42.26 73.45 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.915 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 1.201 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 55.1 mm-40 -68.39 -34.39 75.95 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 120.728 -1.232 . . . . 0.0 111.178 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.867 HG21 HG23 ' A' ' 42' ' ' VAL . 1.8 m -57.85 -49.1 77.83 Favored 'General case' 0 N--CA 1.5 2.037 0 C-N-CA 118.071 -1.451 . . . . 0.0 107.446 178.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.912 HG13 ' HB3' ' A' ' 52' ' ' PRO . 36.4 t -55.13 -35.81 36.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 C-N-CA 117.85 -1.54 . . . . 0.0 107.362 177.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.789 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -84.86 2.77 41.0 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 121.626 0.727 . . . . 0.0 109.094 177.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.513 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -110.13 -15.82 13.92 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.798 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.93 46.89 3.27 Favored Glycine 0 C--N 1.304 -1.243 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 178.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.778 ' CB ' HG23 ' A' ' 35' ' ' THR . 0.3 OUTLIER -137.25 136.68 38.31 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.052 -1.264 . . . . 0.0 110.861 179.521 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.5 mtmm -80.06 91.96 5.56 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.572 -0.705 . . . . 0.0 109.45 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.867 HG23 HG21 ' A' ' 35' ' ' THR . 41.1 t -59.97 124.34 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.615 -0.678 . . . . 0.0 110.163 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.46 ' O ' ' HA ' ' B' ' 2' ' ' ASN . 19.1 mt-30 -125.5 165.17 18.95 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.341 -0.849 . . . . 0.0 109.832 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 1.045 HD12 ' CB ' ' A' ' 48' ' ' LEU . 72.1 mt -134.43 108.09 7.95 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.416 -0.803 . . . . 0.0 109.084 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.534 HG23 ' HD1' ' A' ' 47' ' ' PHE . 0.0 OUTLIER 35.22 -96.05 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.871 -0.518 . . . . 0.0 111.475 -179.037 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.417 ' H ' HG23 ' A' ' 45' ' ' THR . . . -138.91 22.55 2.96 Favored Glycine 0 N--CA 1.488 2.12 0 C-N-CA 119.385 -1.388 . . . . 0.0 110.911 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.936 ' CD2' HD23 ' A' ' 48' ' ' LEU . 17.6 p90 -118.13 -56.82 2.14 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.728 -1.454 . . . . 0.0 111.101 179.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.045 ' CB ' HD12 ' A' ' 44' ' ' LEU . 0.9 OUTLIER -103.89 128.89 51.36 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.057 -1.652 . . . . 0.0 115.281 -178.162 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.547 ' CB ' ' CG ' ' A' ' 81' ' ' PRO . 19.2 t-20 -129.72 99.9 5.3 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.564 177.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.881 HD11 HD11 ' B' ' 48' ' ' LEU . 1.0 OUTLIER -86.82 158.07 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.162 -0.961 . . . . 0.0 110.21 -179.93 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.6 ptmt -166.49 123.39 0.99 Allowed Pre-proline 0 N--CA 1.496 1.833 0 C-N-CA 118.681 -1.208 . . . . 0.0 111.213 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.912 ' HB3' HG13 ' A' ' 36' ' ' VAL . 54.0 Cg_endo -79.96 144.31 16.88 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.609 1.32 . . . . 0.0 110.985 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.577 ' O ' HG23 ' A' ' 53' ' ' VAL . 28.4 m -137.06 113.81 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 CA-C-O 121.849 0.833 . . . . 0.0 111.459 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.499 1.989 0 O-C-N 121.62 -0.675 . . . . 0.0 111.006 -179.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.835 HG12 ' HB2' ' B' ' 89' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 121.18 0.514 . . . . 0.0 109.919 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.574 ' O ' ' N ' ' A' ' 78' ' ' SER . . . -105.99 77.16 0.24 Allowed Glycine 0 N--CA 1.484 1.874 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.903 HG11 ' HB2' ' B' ' 85' ' ' LEU . 15.5 t -59.87 77.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.492 -1.005 . . . . 0.0 109.232 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.574 ' N ' ' O ' ' A' ' 76' ' ' GLY . 0.3 OUTLIER -97.31 -165.18 1.23 Allowed 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 122.461 1.124 . . . . 0.0 111.733 -178.671 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.611 HG12 ' CG1' ' A' ' 50' ' ' ILE . 29.9 m -152.82 -157.08 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.65 ' HB3' ' HD3' ' A' ' 81' ' ' PRO . 0.1 OUTLIER -172.06 -58.12 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.69 0 C-N-CA 118.345 -1.342 . . . . 0.0 112.824 179.421 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.65 ' HD3' ' HB3' ' A' ' 80' ' ' LYS . 55.8 Cg_endo -89.62 171.82 4.13 Favored 'Trans proline' 0 C--N 1.297 -2.151 0 O-C-N 123.595 1.313 . . . . 0.0 112.963 -176.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.65 ' O ' ' C ' ' A' ' 83' ' ' GLU . . . 176.2 -1.57 0.03 OUTLIER Glycine 0 C--N 1.301 -1.405 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 179.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.905 ' O ' ' N ' ' A' ' 85' ' ' LEU . 11.8 pt-20 31.8 45.78 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 -176.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.873 ' C ' HD22 ' A' ' 85' ' ' LEU . 1.2 t 12.4 41.71 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.335 0 CA-C-O 122.873 1.321 . . . . 0.0 109.608 -177.021 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 1.005 HD23 HG11 ' B' ' 36' ' ' VAL . 0.0 OUTLIER 18.31 27.05 0.0 OUTLIER 'General case' 0 C--O 1.189 -2.117 0 N-CA-C 101.381 -3.563 . . . . 0.0 101.381 -173.293 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.76 ' HB2' ' HB3' ' A' ' 84' ' ' SER 0.351 4.5 tttt -51.91 -44.25 63.72 Favored 'General case' 0 CA--C 1.469 -2.145 0 CA-C-N 111.808 -2.451 . . . . 0.0 105.631 178.589 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.277 23.6 tttt -62.23 -38.02 87.62 Favored 'General case' 0 C--N 1.268 -2.971 0 CA-C-N 111.409 -2.632 . . . . 0.0 106.625 177.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.826 ' O ' ' HB1' ' B' ' 37' ' ' ALA . . . -86.99 -22.34 25.6 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 118.232 -1.387 . . . . 0.0 109.39 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.793 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . -76.32 -47.13 24.66 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.474 ' HA ' ' CB ' ' A' ' 94' ' ' TYR . 4.0 mm-40 -56.86 -27.24 60.11 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 175.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.972 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -76.95 -32.52 49.15 Favored Glycine 0 CA--C 1.548 2.147 0 CA-C-O 118.496 -1.169 . . . . 0.0 113.169 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.972 HD23 ' C ' ' A' ' 91' ' ' GLY . 0.1 OUTLIER -115.21 -74.2 0.62 Allowed 'General case' 0 N--CA 1.505 2.312 0 CA-C-N 122.31 3.055 . . . . 0.0 113.44 -177.301 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -120.39 42.0 3.09 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.827 -1.171 . . . . 0.0 112.713 -177.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.495 ' HA ' HG23 ' B' ' 75' ' ' VAL . 0.0 OUTLIER -74.37 -55.5 5.93 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.102 -0.999 . . . . 0.0 108.923 178.371 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.432 ' N ' ' CG ' ' A' ' 94' ' ' TYR . 12.0 pt-20 . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.604 -0.685 . . . . 0.0 109.547 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.453 ' CB ' ' HB3' ' B' ' 5' ' ' GLU . 9.0 mtp . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 120.867 0.365 . . . . 0.0 110.063 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 2' ' ' ASN . . . . . 0.46 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 1.0 OUTLIER -176.48 -172.97 0.49 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.237 -0.914 . . . . 0.0 110.801 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.549 ' O ' HG13 ' B' ' 7' ' ' ILE . 0.0 OUTLIER -54.24 -15.07 1.35 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.234 -0.916 . . . . 0.0 110.335 179.785 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . 0.552 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 19.1 m -105.64 -46.65 4.11 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.106 -0.996 . . . . 0.0 108.69 178.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.486 ' HA ' ' HE2' ' B' ' 8' ' ' LYS . 0.8 OUTLIER -62.01 -50.6 71.39 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.927 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.707 HD11 HG13 ' A' ' 42' ' ' VAL . 2.0 mt -64.51 -26.51 68.46 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.488 -0.885 . . . . 0.0 109.013 178.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 7' ' ' ILE . . . . . 0.735 HG12 ' O ' ' B' ' 21' ' ' VAL . 0.3 OUTLIER -56.84 -58.97 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.408 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . 0.893 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.1 OUTLIER -62.43 -26.99 68.79 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.137 178.758 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . 0.598 ' HB3' ' O ' ' B' ' 6' ' ' LEU . . . -59.85 -34.67 73.42 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 119.441 -0.904 . . . . 0.0 108.699 178.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.861 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.0 OUTLIER -97.47 -36.82 6.3 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.498 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 178.522 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.893 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -59.04 -28.3 66.3 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -90.8 -42.01 10.9 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.496 ' OD2' HG21 ' A' ' 31' ' ' ILE . 82.6 m-20 -64.98 -23.13 67.13 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 106.932 -1.506 . . . . 0.0 106.932 176.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.951 HG22 ' HB2' ' A' ' 20' ' ' SER . 17.8 p -93.41 -75.57 0.49 Allowed 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 58.35 17.72 33.15 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 16' ' ' LEU . . . . . 1.002 HD22 ' O ' ' A' ' 19' ' ' VAL . 2.7 mp -84.32 -59.28 2.44 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.324 -1.103 . . . . 0.0 108.411 178.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . 0.716 ' CG2' HG21 ' A' ' 17' ' ' THR . 0.5 OUTLIER -140.87 3.44 1.83 Allowed 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.357 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . 0.594 ' O ' ' C ' ' B' ' 19' ' ' VAL . 16.6 mt-30 57.14 24.71 10.03 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 106.762 -1.569 . . . . 0.0 106.762 -176.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 1.079 HG23 ' CD1' ' A' ' 16' ' ' LEU . 0.1 OUTLIER 10.61 -94.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.917 -179.167 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 1.025 ' O ' ' N ' ' B' ' 22' ' ' SER . 0.3 OUTLIER -137.17 23.46 3.01 Favored 'General case' 0 C--N 1.276 -2.619 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 178.193 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.735 ' O ' HG12 ' B' ' 7' ' ' ILE . 15.3 m -5.24 -44.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 122.503 1.144 . . . . 0.0 110.537 -177.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 1.025 ' N ' ' O ' ' B' ' 20' ' ' SER . 5.8 m -79.54 -38.59 33.87 Favored 'General case' 0 C--N 1.281 -2.393 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.355 178.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . 0.932 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.5 OUTLIER -91.12 -24.61 19.93 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.418 -0.801 . . . . 0.0 110.875 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 24' ' ' MET . . . . . 0.653 ' HG2' HG22 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -77.07 -38.76 51.86 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 117.444 -1.703 . . . . 0.0 108.558 178.349 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.675 ' HA ' ' HB3' ' B' ' 28' ' ' PHE . 0.3 OUTLIER -78.0 -36.17 49.13 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 118.234 -1.387 . . . . 0.0 108.438 177.711 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . 0.49 ' HB2' ' O ' ' B' ' 22' ' ' SER . . . -64.45 -34.61 78.6 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 176.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 27' ' ' SER . . . . . 0.622 ' O ' HG13 ' B' ' 31' ' ' ILE . 29.2 t -80.42 -32.09 37.45 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . 0.862 ' CE1' HD22 ' A' ' 44' ' ' LEU . 0.4 OUTLIER -52.74 -47.11 67.62 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.828 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . 0.651 ' HG3' ' CD1' ' A' ' 47' ' ' PHE . 1.7 tt0 -68.47 -35.61 77.81 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 176.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 1.185 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 2.0 tttt -63.8 -19.39 64.97 Favored 'General case' 0 C--O 1.189 -2.096 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.095 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.638 ' CG1' ' HA ' ' B' ' 28' ' ' PHE . 1.4 pp -107.43 -28.24 2.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 120.29 -1.506 . . . . 0.0 108.714 178.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.674 HD11 ' CE2' ' B' ' 28' ' ' PHE . 1.2 mm -72.66 -58.18 5.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 176.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 33' ' ' THR . . . . . 0.982 ' OG1' HD12 ' A' ' 85' ' ' LEU . 0.6 OUTLIER -68.52 -38.07 80.57 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.771 179.169 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 1.185 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 78.7 mm-40 -76.95 -27.57 54.87 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 121.172 -0.955 . . . . 0.0 111.963 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 35' ' ' THR . . . . . 0.558 ' O ' ' N ' ' B' ' 38' ' ' LYS . 2.7 m -70.63 -59.75 2.65 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 117.706 -1.597 . . . . 0.0 109.462 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 1.005 HG11 HD23 ' A' ' 85' ' ' LEU . 0.9 OUTLIER -51.02 -43.86 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 178.94 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . 0.826 ' HB1' ' O ' ' A' ' 88' ' ' ALA . . . -60.91 -27.83 68.48 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.829 177.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.795 ' N ' HD12 ' A' ' 92' ' ' LEU . 0.6 OUTLIER -76.64 -32.3 57.91 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 177.574 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.5 23.7 4.99 Favored Glycine 0 C--N 1.295 -1.695 0 C-N-CA 120.087 -1.054 . . . . 0.0 110.944 177.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . 0.481 ' HB3' ' CG2' ' B' ' 35' ' ' THR . 0.4 OUTLIER -100.48 158.34 15.98 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.103 -1.234 . . . . 0.0 109.749 179.38 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -95.28 90.77 5.97 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.388 -0.82 . . . . 0.0 110.436 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 73.3 t -59.83 118.43 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.423 -0.798 . . . . 0.0 109.712 179.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -123.71 93.22 3.87 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.309 -0.869 . . . . 0.0 110.068 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 1.004 HD12 ' CB ' ' B' ' 48' ' ' LEU . 75.3 mt -62.33 101.18 0.21 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.173 -0.954 . . . . 0.0 109.549 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . 0.556 HG21 ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 34.99 -94.78 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.928 -0.482 . . . . 0.0 111.31 -179.557 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . 0.427 ' H ' HG23 ' B' ' 45' ' ' THR . . . -141.0 20.45 2.68 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 119.493 -1.337 . . . . 0.0 110.908 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . 0.576 ' CE2' ' HG3' ' A' ' 29' ' ' GLU . 8.8 p90 -119.84 -22.71 6.69 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.702 -1.47 . . . . 0.0 111.446 179.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 1.004 ' CB ' HD12 ' B' ' 44' ' ' LEU . 0.2 OUTLIER -133.48 139.21 46.54 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.614 -1.304 . . . . 0.0 111.472 178.242 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 49' ' ' ASN . . . . . 0.417 ' C ' HD13 ' B' ' 50' ' ' ILE . 1.3 t30 -143.31 116.69 9.07 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.738 -0.601 . . . . 0.0 109.952 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 50' ' ' ILE . . . . . 0.797 HG23 ' HB ' ' B' ' 79' ' ' VAL . 6.4 mm -116.79 147.05 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 O-C-N 121.314 -0.866 . . . . 0.0 110.592 -179.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' B' ' 78' ' ' SER . 14.4 ptmt -156.81 124.85 2.83 Favored Pre-proline 0 N--CA 1.502 2.164 0 O-C-N 120.877 -1.139 . . . . 0.0 110.631 179.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 52' ' ' PRO . . . . . 0.578 ' HA ' ' HA ' ' B' ' 77' ' ' VAL . 53.6 Cg_endo -84.96 150.75 11.01 Favored 'Trans proline' 0 C--N 1.317 -1.12 0 O-C-N 123.239 1.126 . . . . 0.0 111.748 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.852 HG22 ' O ' ' B' ' 76' ' ' GLY . 33.0 m -140.54 115.69 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 CA-C-O 121.966 0.889 . . . . 0.0 110.391 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . 0.422 ' HA ' ' HA ' ' B' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 122.073 0.94 . . . . 0.0 112.237 -178.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . 0.495 HG23 ' HA ' ' A' ' 94' ' ' TYR . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 76' ' ' GLY . . . . . 0.852 ' O ' HG22 ' B' ' 53' ' ' VAL . . . -121.86 96.42 0.58 Allowed Glycine 0 N--CA 1.494 2.536 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.832 HG13 ' O ' ' B' ' 77' ' ' VAL . 8.1 p -67.63 74.54 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.644 -0.915 . . . . 0.0 111.5 -178.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 78' ' ' SER . . . . . 0.797 ' C ' HG12 ' B' ' 79' ' ' VAL . 0.1 OUTLIER -61.45 172.76 1.07 Allowed 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 117.368 -1.733 . . . . 0.0 107.463 178.209 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.797 ' HB ' HG23 ' B' ' 50' ' ' ILE . 0.2 OUTLIER 176.41 173.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.041 -1.037 . . . . 0.0 110.137 179.397 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 80' ' ' LYS . . . . . 0.595 ' N ' ' CG2' ' B' ' 79' ' ' VAL . 0.1 OUTLIER 176.08 171.14 0.34 Allowed Pre-proline 0 C--N 1.299 -1.61 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 175.955 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 81' ' ' PRO . . . . . 0.638 ' HA ' HD23 ' B' ' 48' ' ' LEU . 54.0 Cg_endo -89.89 -169.43 0.36 Allowed 'Trans proline' 0 C--N 1.293 -2.361 0 O-C-N 123.712 1.375 . . . . 0.0 109.791 176.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -128.83 -90.96 0.65 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 106.293 -2.723 . . . . 0.0 106.293 178.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . 0.949 ' O ' ' N ' ' B' ' 85' ' ' LEU . 1.6 tt0 -77.99 56.65 1.63 Allowed 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 175.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 84' ' ' SER . . . . . 1.302 ' O ' ' N ' ' B' ' 86' ' ' LYS . 0.3 OUTLIER 8.43 43.84 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 122.396 1.093 . . . . 0.0 110.274 -179.79 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.982 HD23 ' HA ' ' A' ' 33' ' ' THR . 3.7 mp 20.92 29.69 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 103.616 -2.735 . . . . 0.0 103.616 -172.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 86' ' ' LYS . . . . . 1.302 ' N ' ' O ' ' B' ' 84' ' ' SER 0.346 15.6 tttt -57.79 -42.45 84.18 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 104.161 -2.533 . . . . 0.0 104.161 177.043 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . 0.42 ' O ' ' CG ' ' B' ' 90' ' ' GLU 0.286 34.8 tttp -65.14 -34.41 78.34 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 112.055 -2.339 . . . . 0.0 105.846 175.342 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.889 ' HB1' ' O ' ' A' ' 33' ' ' THR . . . -78.84 -25.24 44.08 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 118.419 -1.313 . . . . 0.0 108.051 178.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 1.069 ' HA ' HD23 ' B' ' 92' ' ' LEU . . . -68.42 -49.76 57.69 Favored 'General case' 0 C--N 1.294 -1.843 0 O-C-N 121.141 -0.975 . . . . 0.0 109.291 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . 0.425 ' HG3' ' N ' ' B' ' 91' ' ' GLY . 7.0 pt-20 -58.52 -27.18 64.27 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 177.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . 0.425 ' N ' ' HG3' ' B' ' 90' ' ' GLU . . . -75.97 -23.07 72.88 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 179.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 92' ' ' LEU . . . . . 1.069 HD23 ' HA ' ' B' ' 89' ' ' ALA . 0.4 OUTLIER -80.79 21.65 0.66 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.575 -1.544 . . . . 0.0 110.38 179.625 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 93' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' B' ' 92' ' ' LEU . 0.9 OUTLIER 58.18 37.85 26.28 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 -177.067 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . 0.537 ' CD1' ' N ' ' A' ' 75' ' ' VAL . 52.3 t80 -33.89 -45.94 0.21 Allowed 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 114.926 -1.033 . . . . 0.0 111.602 -178.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -56.92 -44.67 82.68 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.156 -0.965 . . . . 0.0 109.599 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 96' ' ' ASP . . . . . 0.436 ' N ' ' O ' ' B' ' 93' ' ' LYS . 0.2 OUTLIER -57.07 -33.43 67.27 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.777 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.502 ' HB3' ' HG ' ' A' ' 6' ' ' LEU . 9.6 mtp . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.445 ' HA ' ' O ' ' B' ' 43' ' ' GLN . 0.6 OUTLIER -173.13 -168.76 0.49 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.99 -1.069 . . . . 0.0 112.043 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.465 ' O ' ' CG2' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -51.92 -16.5 0.73 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.604 -0.685 . . . . 0.0 109.856 179.697 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.75 ' O ' HG13 ' A' ' 7' ' ' ILE . 1.4 m -112.86 -53.92 2.67 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.822 0.82 . . . . 0.0 109.906 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.627 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 0.1 OUTLIER -48.41 -48.26 37.19 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.154 -0.966 . . . . 0.0 109.068 -179.955 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.839 HD11 HG13 ' B' ' 42' ' ' VAL . 1.2 mt -61.01 -29.79 69.92 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.363 -0.935 . . . . 0.0 110.44 178.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.75 HG13 ' O ' ' A' ' 4' ' ' THR . 1.0 OUTLIER -60.82 -44.18 97.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 120.621 -1.299 . . . . 0.0 107.868 179.381 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.877 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -64.6 -33.35 75.71 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 177.658 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' A' ' 6' ' ' LEU . . . -56.19 -38.82 71.48 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 119.921 -0.712 . . . . 0.0 109.165 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.823 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.1 mp -90.98 -33.18 5.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 178.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.877 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -62.93 -13.43 34.37 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 118.574 -1.251 . . . . 0.0 108.655 178.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.45 ' CG ' ' N ' ' A' ' 13' ' ' ASP . 8.0 pt20 -115.53 -42.24 3.16 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.486 -0.759 . . . . 0.0 110.177 179.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.45 ' N ' ' CG ' ' A' ' 12' ' ' GLN . 65.6 m-20 -69.76 -31.29 69.17 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 177.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 1.068 HG22 ' CD1' ' A' ' 16' ' ' LEU 0.265 0.2 OUTLIER -99.27 -67.95 0.83 Allowed 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 178.666 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 53.06 23.82 18.05 Favored Glycine 0 N--CA 1.501 3.022 0 O-C-N 121.439 -0.788 . . . . 0.0 111.417 177.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 1.068 ' CD1' HG22 ' A' ' 14' ' ' THR . 4.7 mp -67.85 -69.15 0.34 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.536 -0.979 . . . . 0.0 110.028 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.54 HG21 HG21 ' B' ' 17' ' ' THR . 0.6 OUTLIER -130.17 6.03 4.92 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.843 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.597 ' O ' ' C ' ' A' ' 19' ' ' VAL . 22.8 mt-30 56.94 28.01 14.03 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 -176.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 1.075 HG23 ' CD1' ' B' ' 16' ' ' LEU . 0.4 OUTLIER -9.24 -97.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.306 -179.412 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.97 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.9 OUTLIER -136.37 25.1 3.21 Favored 'General case' 0 C--N 1.278 -2.516 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 177.779 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.707 HG23 HD13 ' A' ' 7' ' ' ILE . 27.2 m -18.23 -39.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 CA-C-O 122.24 1.019 . . . . 0.0 110.343 -177.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.806 ' N ' ' O ' ' A' ' 20' ' ' SER . 5.2 m -80.02 -37.55 33.89 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 115.032 -0.986 . . . . 0.0 108.998 178.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.97 ' N ' ' O ' ' A' ' 20' ' ' SER . 2.6 mtpt -88.0 -30.45 19.97 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.867 -0.521 . . . . 0.0 111.24 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.786 ' HB3' HG23 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -74.48 -36.76 63.3 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 117.982 -1.487 . . . . 0.0 109.14 -179.671 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.576 HD12 ' CA ' ' A' ' 7' ' ' ILE . 12.8 mt -77.27 -47.33 20.37 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 118.11 -1.436 . . . . 0.0 107.851 177.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 22' ' ' SER . . . -54.82 -33.57 61.78 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 177.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.674 ' O ' HG23 ' A' ' 31' ' ' ILE . 89.6 p -78.38 -34.03 48.47 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.735 ' HA ' ' CG1' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -66.31 -31.15 71.77 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.381 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.71 ' O ' ' HB ' ' A' ' 33' ' ' THR . 1.6 mt-10 -86.21 -33.13 20.85 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 177.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.741 ' O ' ' CG ' ' A' ' 34' ' ' GLU . 17.6 tttm -69.26 -30.63 68.79 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 176.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.735 ' CG1' ' HA ' ' A' ' 28' ' ' PHE . 1.8 pp -91.33 -36.18 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.35 -0.844 . . . . 0.0 109.379 178.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.823 HG21 ' CE1' ' B' ' 47' ' ' PHE . 3.4 mm -58.42 -55.23 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 177.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.834 ' OG1' HD12 ' B' ' 85' ' ' LEU . 0.3 OUTLIER -63.01 -36.88 85.04 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.559 179.862 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.741 ' CG ' ' O ' ' A' ' 30' ' ' LYS . 5.2 mm-40 -72.68 -47.05 50.53 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.758 -0.588 . . . . 0.0 111.845 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.647 HG21 ' SD ' ' B' ' 1' ' ' MET . 66.5 m -56.02 -50.78 69.96 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.536 -1.352 . . . . 0.0 109.722 -179.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.981 HG11 HD23 ' B' ' 85' ' ' LEU . 2.1 t -50.08 -44.54 22.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.951 ' HB1' ' O ' ' B' ' 88' ' ' ALA . . . -84.26 -4.87 59.12 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 121.746 0.784 . . . . 0.0 110.024 178.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.635 ' N ' ' O ' ' A' ' 34' ' ' GLU . 3.1 ttmt -90.66 -26.21 19.72 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 177.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.05 37.04 0.9 Allowed Glycine 0 C--N 1.302 -1.319 0 C-N-CA 120.071 -1.062 . . . . 0.0 111.185 177.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.447 ' HB3' ' CG2' ' A' ' 35' ' ' THR . 0.3 OUTLIER -145.53 140.89 27.8 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.906 -1.35 . . . . 0.0 110.713 179.356 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -92.07 93.73 8.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.666 -0.646 . . . . 0.0 109.374 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.821 HG12 ' CG ' ' B' ' 1' ' ' MET . 31.6 m -60.19 137.39 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.544 -0.723 . . . . 0.0 110.382 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.457 ' O ' ' CB ' ' B' ' 2' ' ' ASN . 3.9 mt-30 -125.7 107.92 11.02 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.413 -0.805 . . . . 0.0 110.008 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.926 HD12 ' HB3' ' A' ' 48' ' ' LEU . 24.1 mt -72.38 103.49 3.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.182 -0.949 . . . . 0.0 109.892 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.452 ' CG2' ' C ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER 33.55 -96.65 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.915 -0.491 . . . . 0.0 111.193 -179.748 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.7 28.98 2.01 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.776 ' CD1' HD21 ' A' ' 85' ' ' LEU . 1.5 p90 -129.43 -25.34 2.67 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.097 -1.237 . . . . 0.0 111.275 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.926 ' HB3' HD12 ' A' ' 44' ' ' LEU . 5.0 mt -134.79 95.85 3.42 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.45 -1.406 . . . . 0.0 110.6 178.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.437 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 4.5 m-20 -103.98 89.6 3.34 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.178 -0.951 . . . . 0.0 110.888 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.614 HG12 HG23 ' A' ' 79' ' ' VAL . 0.9 OUTLIER -80.31 153.46 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.393 -0.817 . . . . 0.0 110.301 179.645 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.535 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 16.0 ptmt -165.58 115.25 0.82 Allowed Pre-proline 0 N--CA 1.495 1.811 0 C-N-CA 118.969 -1.092 . . . . 0.0 110.43 178.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.943 ' HB3' HG13 ' A' ' 36' ' ' VAL . 55.3 Cg_endo -78.13 141.51 18.62 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.451 1.238 . . . . 0.0 111.089 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.666 HG22 ' O ' ' A' ' 76' ' ' GLY . 23.8 m -146.39 115.32 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-O 121.57 0.7 . . . . 0.0 110.393 179.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.671 ' HB2' ' HB3' ' B' ' 97' ' ' PHE . . . . . . . . 0 N--CA 1.503 2.181 0 CA-C-O 121.086 0.47 . . . . 0.0 111.938 -178.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.736 HG22 ' H ' ' A' ' 76' ' ' GLY . 4.4 p . . . . . 0 N--CA 1.506 2.359 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.736 ' H ' HG22 ' A' ' 75' ' ' VAL . . . -123.6 61.41 0.58 Allowed Glycine 0 N--CA 1.487 2.094 0 N-CA-C 108.935 -1.666 . . . . 0.0 108.935 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.798 HG11 ' CB ' ' B' ' 84' ' ' SER . 3.4 p -47.73 82.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.803 -0.821 . . . . 0.0 110.803 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.599 ' N ' ' O ' ' A' ' 76' ' ' GLY . 0.4 OUTLIER -83.73 174.84 10.13 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 118.597 -1.241 . . . . 0.0 110.093 179.952 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.614 HG23 HG12 ' A' ' 50' ' ' ILE . 2.6 p 175.15 176.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.707 ' O ' HD23 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -177.14 173.0 0.76 Allowed Pre-proline 0 N--CA 1.485 1.324 0 O-C-N 120.934 -1.103 . . . . 0.0 110.195 177.377 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.564 ' HB2' HG13 ' B' ' 77' ' ' VAL . 55.0 Cg_endo -98.6 135.45 0.3 Allowed 'Trans proline' 0 C--N 1.302 -1.904 0 C-N-CA 122.505 2.137 . . . . 0.0 110.622 178.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.426 ' HA3' ' HA ' ' A' ' 47' ' ' PHE . . . -89.73 -158.28 34.17 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 107.956 -2.058 . . . . 0.0 107.956 178.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.445 ' HA ' ' HB2' ' A' ' 86' ' ' LYS . 3.4 pm0 -90.17 -16.12 30.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.029 -1.277 . . . . 0.0 110.217 179.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.412 ' CB ' ' HB3' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -53.42 -36.61 61.71 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.269 -0.895 . . . . 0.0 109.267 179.412 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.95 ' CB ' HG21 ' B' ' 77' ' ' VAL . 0.5 OUTLIER -82.3 -33.21 29.12 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.915 -0.714 . . . . 0.0 109.158 179.07 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.736 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 2.2 mttt -70.97 -43.83 67.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.458 -0.776 . . . . 0.0 109.755 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.4 tptt -64.71 -39.06 93.0 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 177.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.688 ' O ' ' HB1' ' B' ' 37' ' ' ALA . . . -64.55 -34.9 79.31 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 176.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.964 ' HA ' HD23 ' A' ' 92' ' ' LEU . . . -54.43 -46.3 73.21 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 120.036 -0.666 . . . . 0.0 109.211 179.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -52.65 -32.58 42.85 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 177.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 88' ' ' ALA . . . -64.65 -38.42 95.64 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 178.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.964 HD23 ' HA ' ' A' ' 89' ' ' ALA . 0.5 OUTLIER -72.45 10.37 0.83 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.537 -1.567 . . . . 0.0 111.13 -179.85 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 22.1 mmtt 61.41 41.69 12.54 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -177.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.544 ' CD1' ' N ' ' B' ' 75' ' ' VAL . 0.0 OUTLIER -38.0 -40.27 0.46 Allowed 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.005 -178.962 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? . . . . . 0 N--CA 1.494 1.75 0 O-C-N 121.37 -0.831 . . . . 0.0 109.769 179.698 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.821 ' CG ' HG12 ' A' ' 42' ' ' VAL . 1.3 ptm . . . . . 0 N--CA 1.496 1.842 0 CA-C-O 121.479 0.657 . . . . 0.0 110.871 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 2' ' ' ASN . . . . . 0.457 ' CB ' ' O ' ' A' ' 43' ' ' GLN . 17.8 p30 -178.3 -152.32 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 120.106 -0.637 . . . . 0.0 110.516 178.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.484 ' HD3' HD11 ' B' ' 25' ' ' LEU . 1.0 OUTLIER -59.14 -3.22 0.35 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.147 -0.971 . . . . 0.0 110.207 179.612 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . 0.688 ' O ' HG23 ' B' ' 7' ' ' ILE . 25.1 m -109.01 -53.26 2.67 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.003 -1.061 . . . . 0.0 109.969 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.487 ' HB3' ' CB ' ' B' ' 1' ' ' MET . 1.8 mt-10 -65.88 -46.84 76.9 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.199 -0.938 . . . . 0.0 109.532 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.688 ' O ' ' HB3' ' B' ' 9' ' ' ALA . 29.9 mt -49.05 -51.7 29.69 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.213 -0.929 . . . . 0.0 109.643 179.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 7' ' ' ILE . . . . . 0.929 HG21 HD22 ' B' ' 25' ' ' LEU . 0.1 OUTLIER -50.22 -51.05 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 177.414 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . 0.883 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.1 OUTLIER -56.15 -37.38 69.42 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.489 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . 0.688 ' HB3' ' O ' ' B' ' 6' ' ' LEU . . . -55.34 -36.2 66.03 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.372 -0.83 . . . . 0.0 108.825 179.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.786 HG23 ' HB3' ' A' ' 24' ' ' MET . 1.6 mp -89.22 -34.22 6.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 178.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.883 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -67.22 -12.48 60.18 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.476 ' N ' ' O ' ' B' ' 8' ' ' LYS . 8.9 tp-100 -112.61 -44.19 3.37 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' B' ' 9' ' ' ALA . 2.2 m-20 -68.89 -22.41 64.19 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 176.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.771 HG22 HD21 ' B' ' 16' ' ' LEU . 0.2 OUTLIER -120.04 -83.54 0.65 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.297 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . 0.546 ' O ' ' C ' ' B' ' 16' ' ' LEU . . . 68.32 -21.84 0.3 Allowed Glycine 0 N--CA 1.497 2.713 0 O-C-N 120.906 -1.121 . . . . 0.0 110.346 178.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 16' ' ' LEU . . . . . 1.075 ' CD1' HG23 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -25.57 -58.3 0.07 Allowed 'General case' 0 N--CA 1.514 2.735 0 CA-C-O 122.202 1.001 . . . . 0.0 110.794 -179.819 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . 0.646 HG22 ' H ' ' B' ' 19' ' ' VAL . 0.5 OUTLIER -136.25 -0.89 2.42 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.419 -179.38 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . 0.655 ' O ' ' C ' ' B' ' 19' ' ' VAL . 4.7 mt-30 55.24 31.15 15.95 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 -176.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 1.041 HG11 HG11 ' A' ' 19' ' ' VAL . 1.2 p -4.09 -92.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.856 -178.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 0.934 ' O ' ' N ' ' B' ' 22' ' ' SER . 0.6 OUTLIER -133.37 25.83 4.14 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 177.803 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.692 ' O ' HD23 ' B' ' 25' ' ' LEU . 30.0 m -17.26 -37.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-O 122.426 1.107 . . . . 0.0 109.374 -178.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.934 ' N ' ' O ' ' B' ' 20' ' ' SER . 12.2 t -80.14 -41.24 25.79 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.904 177.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . 0.911 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.0 OUTLIER -87.33 -36.17 17.99 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.438 -0.789 . . . . 0.0 111.483 179.963 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 24' ' ' MET . . . . . 0.769 ' HB3' HG21 ' A' ' 14' ' ' THR . 0.0 OUTLIER -71.42 -30.09 65.67 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 118.023 -1.471 . . . . 0.0 108.512 179.367 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.929 HD22 HG21 ' B' ' 7' ' ' ILE . 0.3 OUTLIER -75.31 -41.85 55.93 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 118.662 -1.215 . . . . 0.0 107.843 177.368 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . 0.659 ' N ' ' HG ' ' B' ' 25' ' ' LEU . . . -68.42 -24.43 64.74 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 27' ' ' SER . . . . . 0.505 ' O ' ' HB3' ' B' ' 30' ' ' LYS . 4.5 t -84.55 -36.83 21.87 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . 0.764 ' CE1' HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -51.89 -53.45 40.7 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.441 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . 0.614 ' N ' ' CD1' ' B' ' 28' ' ' PHE . 0.1 OUTLIER -63.87 -39.04 93.27 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 177.742 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 1.269 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 19.3 tttm -56.08 -29.51 60.68 Favored 'General case' 0 C--O 1.191 -2.015 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.314 178.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.645 HD12 ' HA ' ' B' ' 28' ' ' PHE . 0.2 OUTLIER -104.46 -23.88 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 119.645 -1.909 . . . . 0.0 108.382 177.516 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.56 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.3 mm -73.1 -61.53 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 177.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 33' ' ' THR . . . . . 0.798 ' HA ' HD23 ' A' ' 85' ' ' LEU . 0.7 OUTLIER -67.38 -36.29 81.04 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.916 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 1.269 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 18.4 mm-40 -78.3 -35.24 48.07 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 121.07 -1.019 . . . . 0.0 111.658 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 35' ' ' THR . . . . . 0.639 HG23 ' CB ' ' B' ' 40' ' ' ASP . 3.0 m -56.39 -47.94 77.92 Favored 'General case' 0 N--CA 1.504 2.257 0 CA-C-N 120.49 1.496 . . . . 0.0 107.211 178.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.817 HG13 ' HB3' ' B' ' 52' ' ' PRO . 23.5 t -53.58 -42.32 49.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 177.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . 0.688 ' HB1' ' O ' ' A' ' 88' ' ' ALA . . . -82.89 -1.19 51.44 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.735 178.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.663 ' N ' ' O ' ' B' ' 34' ' ' GLU . 0.0 OUTLIER -100.37 -18.85 16.56 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 177.905 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.99 42.43 2.26 Favored Glycine 0 C--N 1.302 -1.321 0 C-N-CA 120.272 -0.966 . . . . 0.0 110.74 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . 0.639 ' CB ' HG23 ' B' ' 35' ' ' THR . 0.4 OUTLIER -144.88 150.96 37.97 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.13 -1.218 . . . . 0.0 110.159 179.276 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 63.9 mttt -97.34 92.18 5.85 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.549 -0.719 . . . . 0.0 110.238 -179.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.839 HG13 HD11 ' A' ' 6' ' ' LEU . 66.9 t -59.38 129.62 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.536 -0.728 . . . . 0.0 109.399 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 43' ' ' GLN . . . . . 0.504 ' HA ' ' O ' ' B' ' 48' ' ' LEU . 0.8 OUTLIER -125.02 103.91 8.27 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.092 -1.005 . . . . 0.0 111.123 -179.021 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.662 HD12 ' CE1' ' B' ' 47' ' ' PHE . 19.9 mt -62.96 113.97 3.4 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.225 -0.922 . . . . 0.0 109.111 178.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . 0.562 HG22 ' HG2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 33.12 -89.87 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.499 0 O-C-N 121.832 -0.543 . . . . 0.0 110.93 -179.252 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -146.06 15.79 1.72 Allowed Glycine 0 N--CA 1.484 1.856 0 C-N-CA 119.732 -1.223 . . . . 0.0 110.338 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . 0.823 ' CE1' HG21 ' A' ' 32' ' ' ILE . 17.1 p90 -111.14 -37.79 5.23 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.762 -1.434 . . . . 0.0 112.113 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.642 ' HB2' HD12 ' B' ' 44' ' ' LEU . 0.0 OUTLIER -114.32 117.8 32.11 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.3 -1.5 . . . . 0.0 111.272 179.703 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -113.19 74.17 0.85 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.699 -0.626 . . . . 0.0 110.569 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 50' ' ' ILE . . . . . 0.924 HD13 ' HB ' ' B' ' 79' ' ' VAL . 3.1 mm -59.87 134.95 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.422 -0.799 . . . . 0.0 110.144 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . 0.602 ' HD3' HG13 ' B' ' 53' ' ' VAL . 0.0 OUTLIER -154.05 126.15 3.85 Favored Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 120.872 -1.142 . . . . 0.0 110.959 179.338 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 52' ' ' PRO . . . . . 0.817 ' HB3' HG13 ' B' ' 36' ' ' VAL . 55.7 Cg_endo -83.79 142.17 10.02 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 O-C-N 123.439 1.231 . . . . 0.0 110.655 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.756 HG22 ' O ' ' B' ' 76' ' ' GLY . 27.6 m -137.88 114.78 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-O 121.762 0.791 . . . . 0.0 111.058 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . 0.523 ' HA ' ' HA ' ' B' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.494 1.753 0 O-C-N 121.561 -0.712 . . . . 0.0 110.504 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . 0.554 HG21 HD21 ' A' ' 92' ' ' LEU . 1.1 t . . . . . 0 N--CA 1.493 1.675 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 76' ' ' GLY . . . . . 0.756 ' O ' HG22 ' B' ' 53' ' ' VAL . . . -120.03 86.35 0.4 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.95 HG21 ' CB ' ' A' ' 85' ' ' LEU . 3.2 p -61.22 76.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.648 -0.913 . . . . 0.0 109.485 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 78' ' ' SER . . . . . 0.534 ' N ' ' O ' ' B' ' 76' ' ' GLY . 0.1 OUTLIER -77.3 177.78 7.65 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.872 0.844 . . . . 0.0 110.37 -179.884 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.924 ' HB ' HD13 ' B' ' 50' ' ' ILE . 7.0 p 177.73 174.76 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 80' ' ' LYS . . . . . 0.614 ' HB2' ' HD2' ' B' ' 81' ' ' PRO . 0.0 OUTLIER 177.17 171.75 0.39 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 120.821 -1.174 . . . . 0.0 111.14 177.493 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 81' ' ' PRO . . . . . 0.666 ' HA ' ' O ' ' B' ' 47' ' ' PHE . 51.1 Cg_endo -74.64 141.45 27.81 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.374 1.723 . . . . 0.0 110.475 176.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . 0.52 ' H ' ' HA ' ' B' ' 47' ' ' PHE . . . -110.31 -75.67 0.83 Allowed Glycine 0 N--CA 1.492 2.433 0 N-CA-C 106.501 -2.64 . . . . 0.0 106.501 178.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . 0.885 ' O ' ' N ' ' B' ' 85' ' ' LEU . 2.1 pt-20 -91.22 40.62 1.03 Allowed 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 176.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 84' ' ' SER . . . . . 1.034 ' C ' HD22 ' B' ' 85' ' ' LEU . 1.9 t 10.52 43.83 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.665 1.222 . . . . 0.0 110.302 178.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 1.034 HD22 ' C ' ' B' ' 84' ' ' SER . 0.0 OUTLIER 18.76 26.21 0.0 OUTLIER 'General case' 0 C--O 1.186 -2.287 0 N-CA-C 102.898 -3.001 . . . . 0.0 102.898 -170.669 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 86' ' ' LYS . . . . . 0.583 ' HB2' ' HB3' ' B' ' 84' ' ' SER 0.325 2.9 tttm -48.71 -38.59 21.9 Favored 'General case' 0 CA--C 1.473 -2.018 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 177.708 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . 0.27 2.9 tttt -62.54 -40.92 98.33 Favored 'General case' 0 C--N 1.275 -2.652 0 CA-C-N 111.886 -2.415 . . . . 0.0 106.137 177.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.951 ' O ' ' HB1' ' A' ' 37' ' ' ALA . . . -78.65 -33.57 47.08 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 118.29 -1.364 . . . . 0.0 107.989 177.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.926 ' HA ' HD23 ' B' ' 92' ' ' LEU . . . -64.73 -30.63 71.65 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -64.46 -33.92 77.01 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 175.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -64.23 -45.36 93.81 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 178.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 92' ' ' LEU . . . . . 0.926 HD23 ' HA ' ' B' ' 89' ' ' ALA . 0.5 OUTLIER -65.49 2.32 0.94 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.499 -1.589 . . . . 0.0 111.403 -179.617 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 93' ' ' LYS . . . . . 0.508 ' CB ' ' O ' ' B' ' 92' ' ' LEU . 7.0 tptt 72.9 53.91 0.14 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -177.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . 0.416 ' CD1' ' N ' ' A' ' 75' ' ' VAL . 6.1 t80 -38.97 -43.62 0.99 Allowed 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.008 -179.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -57.16 -41.19 78.75 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.304 -0.873 . . . . 0.0 109.656 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 96' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' B' ' 93' ' ' LYS . 4.1 t70 -60.89 -31.95 71.42 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 97' ' ' PHE . . . . . 0.671 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.83 ' HB3' HG22 ' B' ' 42' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 120.897 0.379 . . . . 0.0 110.291 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.481 ' H ' ' HB2' ' A' ' 5' ' ' GLU . 16.1 p-10 -173.29 -161.62 0.14 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.398 -0.921 . . . . 0.0 111.459 178.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.586 ' HD2' ' HB ' ' B' ' 45' ' ' THR . 6.8 tttt -45.88 -21.75 0.15 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.956 -0.465 . . . . 0.0 110.116 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.656 ' O ' HG13 ' A' ' 7' ' ' ILE . 88.3 m -94.29 -66.36 0.92 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.501 -0.749 . . . . 0.0 110.662 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.501 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 4.2 mt-10 -48.98 -41.11 33.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.888 -1.133 . . . . 0.0 109.123 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.725 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 22.5 mt -53.25 -41.88 65.92 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.763 178.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.775 HG21 ' CD2' ' A' ' 25' ' ' LEU . 1.2 pp -59.05 -40.34 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 178.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.848 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 17.7 mtmt -62.31 -37.52 85.9 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 176.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.864 ' CB ' HD13 ' B' ' 31' ' ' ILE . . . -53.87 -36.87 63.11 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.848 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.6 mp -90.91 -31.95 5.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 178.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.848 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -67.45 -8.0 29.84 Favored 'General case' 0 C--N 1.284 -2.26 0 O-C-N 120.777 -1.202 . . . . 0.0 109.128 179.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.436 ' HB3' ' O ' ' A' ' 8' ' ' LYS . 1.5 tt0 -124.07 -38.73 2.43 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.374 -0.829 . . . . 0.0 109.961 179.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 9' ' ' ALA . 1.0 OUTLIER -73.18 -19.22 61.15 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 177.482 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 1.146 HG22 ' CD1' ' A' ' 16' ' ' LEU 0.28 0.2 OUTLIER -112.1 -71.59 0.75 Allowed 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 179.516 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 57.4 18.64 30.2 Favored Glycine 0 N--CA 1.498 2.769 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 177.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 1.146 ' CD1' HG22 ' A' ' 14' ' ' THR . 4.9 mp -58.73 -62.75 1.63 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.419 -1.048 . . . . 0.0 109.384 179.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.551 ' O ' HG23 ' A' ' 17' ' ' THR . 0.5 OUTLIER -143.27 8.88 1.62 Allowed 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.242 -179.771 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.611 ' O ' ' C ' ' A' ' 19' ' ' VAL . 2.7 mt-30 58.24 26.7 14.18 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 -176.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 1.037 HG11 HG11 ' B' ' 19' ' ' VAL . 0.6 OUTLIER -2.26 -98.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.453 -179.306 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 1.045 ' HB3' HD21 ' B' ' 16' ' ' LEU . 1.1 p -134.4 25.57 3.79 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 178.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.697 ' HA ' ' CE ' ' A' ' 24' ' ' MET . 28.3 m -19.36 -39.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 CA-C-O 122.55 1.166 . . . . 0.0 109.872 -178.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.809 ' N ' ' O ' ' A' ' 20' ' ' SER . 36.7 t -76.64 -41.85 44.28 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.118 177.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.967 ' N ' ' O ' ' A' ' 20' ' ' SER . 1.2 mtpt -82.78 -37.72 24.18 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.664 -0.648 . . . . 0.0 111.999 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.697 ' CE ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -69.27 -24.52 63.99 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 117.47 -1.692 . . . . 0.0 108.437 179.914 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.775 ' CD2' HG21 ' A' ' 7' ' ' ILE . 0.3 OUTLIER -75.66 -47.32 26.86 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.134 -1.027 . . . . 0.0 109.241 178.609 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.701 ' N ' ' HG ' ' A' ' 25' ' ' LEU . . . -64.0 -27.93 69.46 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 178.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.605 ' O ' HG13 ' A' ' 31' ' ' ILE . 7.2 p -85.96 -34.99 20.72 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 178.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.684 ' HE1' HD22 ' B' ' 44' ' ' LEU . 0.1 OUTLIER -58.31 -46.65 85.73 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 179.146 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.549 ' HG3' ' CE2' ' B' ' 47' ' ' PHE . 2.4 tt0 -70.95 -34.35 71.38 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 177.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 1.293 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 60.6 tttt -64.37 -19.1 65.27 Favored 'General case' 0 C--O 1.193 -1.888 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 177.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.642 HD12 HG12 ' A' ' 32' ' ' ILE . 1.7 pp -108.91 -29.2 2.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 120.116 -1.615 . . . . 0.0 109.062 178.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.642 HG12 HD12 ' A' ' 31' ' ' ILE . 1.1 mm -72.0 -55.05 14.68 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.62 HG23 ' HB2' ' B' ' 88' ' ' ALA . 0.7 OUTLIER -78.0 -32.2 51.08 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.791 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 1.293 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 73.2 mm-40 -78.75 -37.13 41.96 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 120.933 -1.104 . . . . 0.0 110.606 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.833 HG22 ' CB ' ' A' ' 40' ' ' ASP . 73.1 m -64.96 -37.45 87.68 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 177.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.037 HG21 HD22 ' B' ' 85' ' ' LEU . 1.4 t -56.75 -35.94 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 175.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.678 ' CB ' ' O ' ' B' ' 88' ' ' ALA . . . -89.46 12.67 15.8 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 176.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 34' ' ' GLU . 3.1 ttmt -130.17 17.1 5.56 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.32 40.49 10.05 Favored Glycine 0 N--CA 1.48 1.598 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.833 ' CB ' HG22 ' A' ' 35' ' ' THR . 4.8 t70 -60.68 163.23 5.7 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 122.578 1.18 . . . . 0.0 112.8 -178.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.467 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 16.8 mtmt -157.52 57.58 0.5 Allowed 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 105.9 -1.889 . . . . 0.0 105.9 176.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.771 ' CG1' HD11 ' B' ' 6' ' ' LEU . 2.2 t -95.68 150.15 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-O 121.533 0.683 . . . . 0.0 111.05 -177.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.469 ' O ' ' CG ' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -137.53 99.94 4.08 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.299 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.614 HD12 ' HB2' ' A' ' 48' ' ' LEU . 11.9 mt -66.78 113.3 4.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.095 -1.003 . . . . 0.0 110.17 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.562 HG23 ' CD2' ' A' ' 47' ' ' PHE . 0.1 OUTLIER 29.99 -88.93 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.21 0 O-C-N 122.038 -0.414 . . . . 0.0 111.411 179.299 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -147.6 19.49 1.48 Allowed Glycine 0 N--CA 1.484 1.884 0 C-N-CA 119.729 -1.224 . . . . 0.0 110.274 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.592 ' CE1' HG21 ' B' ' 32' ' ' ILE . 32.1 p90 -116.91 -39.2 3.29 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.759 -1.436 . . . . 0.0 111.831 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.963 HD11 HD11 ' B' ' 48' ' ' LEU . 0.1 OUTLIER -115.78 108.92 16.95 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.758 -1.214 . . . . 0.0 112.238 -179.885 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.721 ' O ' ' HB ' ' A' ' 79' ' ' VAL . 0.1 OUTLIER -92.81 68.13 4.53 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.711 -0.618 . . . . 0.0 109.675 179.002 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.836 HD13 HG21 ' A' ' 79' ' ' VAL . 48.0 mm -53.07 114.3 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.49 0 O-C-N 121.186 -0.946 . . . . 0.0 112.398 -176.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.504 ' O ' ' N ' ' A' ' 78' ' ' SER . 0.6 OUTLIER -157.39 109.65 1.86 Allowed Pre-proline 0 N--CA 1.478 0.967 0 O-C-N 121.846 -0.534 . . . . 0.0 110.293 179.973 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.569 ' HB2' HG11 ' A' ' 75' ' ' VAL . 50.2 Cg_endo -76.8 149.85 30.03 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 O-C-N 123.132 1.069 . . . . 0.0 109.86 178.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 1.046 ' O ' HG22 ' A' ' 75' ' ' VAL . 1.9 t -110.95 -142.91 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.487 -0.758 . . . . 0.0 110.17 -179.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.637 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.501 2.087 0 O-C-N 121.377 -0.827 . . . . 0.0 109.703 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 1.046 HG22 ' O ' ' A' ' 53' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.496 1.852 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.458 ' N ' ' CG1' ' A' ' 75' ' ' VAL . . . -111.94 -157.38 13.84 Favored Glycine 0 N--CA 1.475 1.283 0 C-N-CA 118.659 -1.734 . . . . 0.0 109.561 -179.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.79 HG12 ' CG1' ' A' ' 79' ' ' VAL . 3.5 t -139.02 85.62 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.172 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.504 ' N ' ' O ' ' A' ' 51' ' ' LYS . 0.2 OUTLIER -55.09 -45.7 75.46 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.453 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.836 HG21 HD13 ' A' ' 50' ' ' ILE 0.273 5.8 p -50.37 170.84 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-O 122.347 1.07 . . . . 0.0 112.264 -177.165 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.661 ' HB2' ' HD2' ' A' ' 81' ' ' PRO . 5.6 ptmt 174.79 177.46 0.2 Allowed Pre-proline 0 C--N 1.302 -1.499 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.661 ' HD2' ' HB2' ' A' ' 80' ' ' LYS . 36.8 Cg_endo -63.15 143.59 90.42 Favored 'Trans proline' 0 C--N 1.295 -2.249 0 N-CA-C 106.973 -1.972 . . . . 0.0 106.973 175.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.49 ' C ' ' H ' ' A' ' 84' ' ' SER . . . -120.77 -102.97 1.88 Allowed Glycine 0 N--CA 1.498 2.797 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -178.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.96 ' O ' ' N ' ' A' ' 85' ' ' LEU . 32.6 tt0 -72.38 50.51 0.23 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.653 ' HB3' ' HB2' ' A' ' 86' ' ' LYS . 2.7 t 7.86 43.54 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 122.491 1.139 . . . . 0.0 109.785 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 1.114 HD11 HG12 ' B' ' 36' ' ' VAL . 3.0 pp 18.48 27.98 0.0 OUTLIER 'General case' 0 C--O 1.196 -1.713 0 N-CA-C 103.33 -2.841 . . . . 0.0 103.33 -171.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.685 ' HA ' ' HB3' ' A' ' 89' ' ' ALA 0.335 1.6 tttt -55.71 -39.85 71.62 Favored 'General case' 0 CA--C 1.473 -2.004 0 N-CA-C 104.473 -2.418 . . . . 0.0 104.473 177.134 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.255 28.7 tttt -59.11 -41.34 87.91 Favored 'General case' 0 C--N 1.28 -2.43 0 CA-C-N 112.188 -2.278 . . . . 0.0 105.79 177.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.896 ' O ' ' HB1' ' B' ' 37' ' ' ALA . . . -77.76 -32.08 52.42 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 117.65 -1.62 . . . . 0.0 107.061 177.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.869 ' HA ' HD23 ' A' ' 92' ' ' LEU . . . -61.5 -34.32 75.29 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.21 -1.034 . . . . 0.0 108.21 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.412 ' HA ' ' CB ' ' A' ' 94' ' ' TYR . 3.9 mt-10 -60.23 -35.91 76.52 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 175.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -62.51 -32.88 84.7 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 178.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.869 HD23 ' HA ' ' A' ' 89' ' ' ALA . 0.3 OUTLIER -78.73 17.37 0.71 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.481 -1.599 . . . . 0.0 110.667 -179.81 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.745 ' O ' ' C ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER 80.12 32.47 0.19 Allowed 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -178.068 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 1.11 ' O ' ' C ' ' A' ' 95' ' ' GLU . 9.5 t80 -25.53 -68.22 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 117.755 -1.578 . . . . 0.0 108.25 -177.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 1.11 ' C ' ' O ' ' A' ' 94' ' ' TYR . 62.6 mm-40 . . . . . 0 CA--C 1.489 -1.403 0 N-CA-C 101.391 -3.559 . . . . 0.0 101.391 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.595 ' SD ' HG21 ' A' ' 35' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 120.721 0.296 . . . . 0.0 110.309 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 2' ' ' ASN . . . . . 0.543 ' HB3' ' O ' ' B' ' 1' ' ' MET . 25.4 p30 178.89 -143.94 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.577 178.079 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.782 ' HA ' HD11 ' B' ' 25' ' ' LEU . 3.1 mttp -55.05 -3.13 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.215 -0.928 . . . . 0.0 111.192 -179.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . 0.677 ' O ' HG13 ' B' ' 7' ' ' ILE . 16.3 m -114.51 -65.03 1.23 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.898 -1.126 . . . . 0.0 110.573 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.539 ' HB2' ' HA ' ' B' ' 1' ' ' MET . 9.2 mp0 -49.02 -44.72 41.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.84 -1.163 . . . . 0.0 108.909 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.771 HD11 ' CG1' ' A' ' 42' ' ' VAL . 20.1 mt -57.01 -34.47 68.2 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.125 -1.03 . . . . 0.0 109.648 178.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 7' ' ' ILE . . . . . 0.825 HG22 HD23 ' B' ' 25' ' ' LEU . 1.1 pp -57.63 -43.43 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 178.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . 0.912 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.0 OUTLIER -63.7 -32.55 74.08 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 177.926 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . 0.696 ' HB3' ' O ' ' B' ' 6' ' ' LEU . . . -55.18 -40.94 71.26 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.439 -0.788 . . . . 0.0 109.162 178.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.816 HG22 HG12 ' B' ' 21' ' ' VAL . 1.1 mp -91.44 -29.79 4.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 178.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.912 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -65.99 -15.42 62.99 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.268 -0.973 . . . . 0.0 108.399 178.02 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.471 ' HB3' ' O ' ' B' ' 8' ' ' LYS . 1.8 tp60 -112.31 -42.99 3.59 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.583 ' OD2' HG21 ' A' ' 31' ' ' ILE . 18.8 m-20 -59.83 -39.97 86.92 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 177.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.785 HG21 ' CG2' ' A' ' 19' ' ' VAL . 0.2 OUTLIER -98.83 -71.69 0.68 Allowed 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 113.858 -1.519 . . . . 0.0 108.504 179.387 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 47.26 27.39 3.85 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 16' ' ' LEU . . . . . 1.045 HD21 ' HB3' ' A' ' 20' ' ' SER . 0.4 OUTLIER -91.6 -28.56 17.44 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.543 -0.975 . . . . 0.0 108.814 178.89 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . 0.805 ' N ' HD12 ' B' ' 16' ' ' LEU . 0.7 OUTLIER -147.39 -13.94 0.4 Allowed 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.893 -0.504 . . . . 0.0 110.342 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . 0.446 ' O ' ' O ' ' B' ' 19' ' ' VAL . 3.1 mt-30 57.36 43.71 22.86 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -177.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 1.037 HG11 HG11 ' A' ' 19' ' ' VAL . 1.4 p -34.5 -94.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.96 -178.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 0.918 ' O ' ' N ' ' B' ' 23' ' ' LYS . 0.4 OUTLIER -134.16 25.19 3.88 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 178.845 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.816 HG12 HG22 ' B' ' 10' ' ' ILE . 31.1 m -17.28 -39.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-O 122.642 1.211 . . . . 0.0 109.574 -178.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.896 ' N ' ' O ' ' B' ' 20' ' ' SER . 38.2 p -85.67 -38.43 18.36 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.071 178.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . 0.918 ' N ' ' O ' ' B' ' 20' ' ' SER . 1.8 mtpt -86.1 -29.91 22.98 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.463 -0.773 . . . . 0.0 111.092 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 24' ' ' MET . . . . . 0.917 ' HB3' HG21 ' A' ' 14' ' ' THR . 0.0 OUTLIER -80.66 -35.08 34.28 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.588 -1.32 . . . . 0.0 110.093 179.856 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.893 ' C ' HD12 ' B' ' 25' ' ' LEU . 0.1 OUTLIER -79.81 -43.06 23.11 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 118.099 -1.441 . . . . 0.0 107.368 177.955 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' B' ' 22' ' ' SER . . . -59.75 -25.25 64.71 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 176.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 27' ' ' SER . . . . . 0.565 ' HA ' ' HB3' ' B' ' 30' ' ' LYS . 4.3 t -81.24 -36.81 29.52 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . 0.758 ' HA ' ' CG1' ' B' ' 31' ' ' ILE . 0.0 OUTLIER -60.96 -36.43 79.37 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.769 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . 0.674 ' O ' ' HB ' ' B' ' 33' ' ' THR . 9.2 mt-10 -77.55 -34.5 53.81 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 177.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 1.012 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 64.0 tttt -68.42 -25.4 65.01 Favored 'General case' 0 C--O 1.192 -1.97 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 177.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.864 HD13 ' CB ' ' A' ' 9' ' ' ALA . 1.1 pp -100.81 -29.85 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 120.983 -1.073 . . . . 0.0 109.518 178.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.703 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.1 mm -66.02 -57.32 11.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 176.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 33' ' ' THR . . . . . 0.98 ' O ' HD13 ' A' ' 85' ' ' LEU . 0.5 OUTLIER -65.26 -38.48 90.46 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.474 179.172 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 1.012 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 23.9 mm-40 -75.21 -38.9 60.5 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.37 -0.831 . . . . 0.0 112.067 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 35' ' ' THR . . . . . 0.512 ' N ' ' O ' ' B' ' 31' ' ' ILE . 44.1 m -59.57 -54.59 44.79 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.334 -1.479 . . . . 0.0 109.425 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 1.114 HG12 HD11 ' A' ' 85' ' ' LEU . 2.6 t -54.32 -36.23 32.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 177.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . 0.896 ' HB1' ' O ' ' A' ' 88' ' ' ALA . . . -88.49 4.8 45.31 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.686 0.755 . . . . 0.0 109.823 177.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.73 ' N ' ' O ' ' B' ' 34' ' ' GLU . 1.2 tppp? -105.26 -32.9 8.41 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 178.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.21 35.03 0.44 Allowed Glycine 0 C--N 1.301 -1.397 0 C-N-CA 119.661 -1.256 . . . . 0.0 111.092 177.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . 0.44 ' HB3' ' CG2' ' B' ' 35' ' ' THR . 0.2 OUTLIER -147.14 173.05 12.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.011 -1.288 . . . . 0.0 110.543 179.523 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.424 ' HB3' ' HB2' ' B' ' 51' ' ' LYS . 0.0 OUTLIER -127.65 114.53 17.47 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.651 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.83 HG22 ' HB3' ' A' ' 1' ' ' MET . 38.4 t -98.96 131.02 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.572 -178.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 43' ' ' GLN . . . . . 0.454 ' HG3' ' CB ' ' A' ' 2' ' ' ASN . 0.0 OUTLIER -111.51 123.61 50.58 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.259 -0.9 . . . . 0.0 110.547 180.0 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.871 HD12 ' HB3' ' B' ' 48' ' ' LEU . 16.4 mt -84.04 102.69 12.68 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.267 -0.896 . . . . 0.0 109.705 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . 0.586 ' HB ' ' HD2' ' A' ' 3' ' ' LYS . 0.1 OUTLIER 34.98 -91.97 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.975 -0.453 . . . . 0.0 111.125 -179.777 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -148.85 20.1 1.26 Allowed Glycine 0 N--CA 1.487 2.095 0 N-CA-C 110.089 -1.205 . . . . 0.0 110.089 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . 0.584 ' CZ ' HD13 ' B' ' 44' ' ' LEU . 3.8 p90 -116.61 -33.6 4.81 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.056 -1.261 . . . . 0.0 111.079 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.963 HD11 HD11 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -119.58 178.9 4.39 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.626 -1.296 . . . . 0.0 111.797 179.227 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 49' ' ' ASN . . . . . 0.675 ' O ' ' HB ' ' B' ' 79' ' ' VAL . 2.0 m-80 -165.98 145.05 6.04 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 50' ' ' ILE . . . . . 1.071 ' HA ' HG21 ' B' ' 79' ' ' VAL . 1.6 pp -146.59 101.61 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-O 122.131 0.967 . . . . 0.0 110.636 178.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . 0.535 ' N ' HG11 ' B' ' 79' ' ' VAL . 0.1 OUTLIER -147.94 133.14 9.17 Favored Pre-proline 0 N--CA 1.495 1.782 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.919 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 52' ' ' PRO . . . . . 0.836 ' CG ' HG13 ' B' ' 36' ' ' VAL . 58.0 Cg_endo -95.71 153.18 1.5 Allowed 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.305 1.16 . . . . 0.0 112.49 -178.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 1.003 HG22 ' O ' ' B' ' 76' ' ' GLY . 27.9 m -134.57 112.92 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 CA-C-O 122.017 0.913 . . . . 0.0 109.965 176.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.865 0 O-C-N 121.687 -0.633 . . . . 0.0 111.662 -178.608 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . 0.597 ' HB ' ' HB1' ' A' ' 89' ' ' ALA . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 76' ' ' GLY . . . . . 1.003 ' O ' HG22 ' B' ' 53' ' ' VAL . . . -118.02 99.3 0.8 Allowed Glycine 0 N--CA 1.486 1.968 0 C-N-CA 119.217 -1.468 . . . . 0.0 109.642 -179.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.648 ' O ' HG12 ' B' ' 77' ' ' VAL . 2.1 t -60.71 88.08 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 179.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 78' ' ' SER . . . . . 0.621 ' OG ' HG13 ' B' ' 53' ' ' VAL . 0.8 OUTLIER -58.06 -48.25 80.7 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.564 -178.057 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 1.071 HG21 ' HA ' ' B' ' 50' ' ' ILE . 27.2 m -49.46 177.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 115.224 1.564 . . . . 0.0 115.224 -174.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 80' ' ' LYS . . . . . 0.658 ' HB2' ' HD2' ' B' ' 81' ' ' PRO . 0.0 OUTLIER 179.56 178.97 0.28 Allowed Pre-proline 0 N--CA 1.481 1.087 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.161 -179.051 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 81' ' ' PRO . . . . . 0.678 ' HB2' HG11 ' A' ' 77' ' ' VAL . 41.8 Cg_endo -70.21 130.99 19.7 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.372 1.196 . . . . 0.0 110.78 179.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -82.18 -157.99 22.03 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' B' ' 87' ' ' LYS . 11.1 pt-20 -83.73 -21.25 32.34 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.574 -0.956 . . . . 0.0 110.842 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 84' ' ' SER . . . . . 0.513 ' HB3' ' HB3' ' B' ' 47' ' ' PHE . 0.4 OUTLIER -56.28 -45.39 80.16 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.032 -1.042 . . . . 0.0 109.282 -179.682 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 1.037 HD22 HG21 ' A' ' 36' ' ' VAL . 12.8 mt -61.6 -32.53 72.65 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 86' ' ' LYS . . . . . 0.564 ' O ' ' HB3' ' B' ' 89' ' ' ALA . 1.7 tttp -82.7 -31.32 28.62 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.642 0.734 . . . . 0.0 109.799 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' B' ' 83' ' ' GLU . 9.8 tmtt? -73.56 -38.97 65.04 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.678 ' O ' ' CB ' ' A' ' 37' ' ' ALA . . . -66.71 -34.73 78.49 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 176.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.914 ' HB1' ' CG1' ' A' ' 75' ' ' VAL . . . -53.39 -46.16 69.58 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.406 -0.809 . . . . 0.0 109.448 178.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . 0.408 ' HG2' ' N ' ' B' ' 91' ' ' GLY . 1.5 pt-20 -56.5 -29.71 62.13 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 176.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' B' ' 88' ' ' ALA . . . -64.72 -34.21 89.28 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 178.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 92' ' ' LEU . . . . . 1.031 HD21 HG21 ' A' ' 75' ' ' VAL . 1.5 pp -71.06 20.8 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 CA-C-N 119.928 1.864 . . . . 0.0 110.947 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 93' ' ' LYS . . . . . 0.461 ' H ' ' C ' ' B' ' 91' ' ' GLY . 0.2 OUTLIER 59.42 44.33 15.21 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 106.044 -1.835 . . . . 0.0 106.044 -177.656 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . 0.732 ' CD1' HG23 ' A' ' 75' ' ' VAL . 0.3 OUTLIER -35.53 -42.24 0.22 Allowed 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.044 -178.233 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -52.85 -41.39 64.23 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.206 -0.934 . . . . 0.0 109.5 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 96' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' B' ' 93' ' ' LYS . 0.4 OUTLIER -65.14 -30.4 71.32 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.141 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 97' ' ' PHE . . . . . 0.458 ' HB2' HD11 ' B' ' 92' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.625 -0.672 . . . . 0.0 109.371 178.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.479 ' HG2' ' HB3' ' A' ' 5' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.139 0.495 . . . . 0.0 110.132 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.443 ' N ' ' HB2' ' A' ' 5' ' ' GLU . 4.4 p30 173.05 173.26 0.12 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.489 -0.757 . . . . 0.0 110.337 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.747 ' HD2' HD13 ' A' ' 25' ' ' LEU . 2.2 mmmp? -43.19 -26.16 0.15 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.627 -0.671 . . . . 0.0 110.555 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.54 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 5.7 m -85.83 -55.46 3.96 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.247 -0.908 . . . . 0.0 109.027 178.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.481 ' HA ' ' CE ' ' A' ' 8' ' ' LYS . 1.0 OUTLIER -60.2 -48.76 80.36 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.697 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.795 HD11 ' CG2' ' B' ' 42' ' ' VAL . 9.5 mt -57.56 -33.24 67.94 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.575 -0.85 . . . . 0.0 108.718 177.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 1.015 ' CD1' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -54.79 -54.09 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 178.373 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.927 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -68.74 -27.86 66.3 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.65 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 6' ' ' LEU . . . -59.49 -33.86 71.86 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.289 -0.882 . . . . 0.0 108.795 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.927 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.8 OUTLIER -95.75 -37.02 7.05 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.528 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 178.429 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.927 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -60.18 -26.93 66.72 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.418 ' CG ' ' O ' ' A' ' 8' ' ' LYS . 1.4 pp0? -92.91 -37.56 12.18 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.536 ' HB3' ' CB ' ' B' ' 27' ' ' SER . 21.8 m-20 -69.08 -29.59 67.72 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 176.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 1.016 HG22 ' HB2' ' B' ' 20' ' ' SER . 16.6 p -85.82 -75.77 0.36 Allowed 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 177.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 55.26 15.25 7.27 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.774 HD11 ' OG ' ' B' ' 20' ' ' SER . 0.7 OUTLIER -80.92 -51.53 8.47 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.251 -1.146 . . . . 0.0 107.989 178.702 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.685 HG22 ' H ' ' A' ' 19' ' ' VAL . 0.5 OUTLIER -144.8 -2.21 0.84 Allowed 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.897 -179.847 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.671 ' O ' ' C ' ' A' ' 19' ' ' VAL . 6.7 mt-30 56.23 30.07 15.96 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 -176.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.978 HG23 HD13 ' B' ' 16' ' ' LEU . 0.4 OUTLIER 3.78 -97.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.868 -179.399 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 1.022 ' O ' ' N ' ' A' ' 22' ' ' SER . 6.1 p -134.98 24.14 3.58 Favored 'General case' 0 C--N 1.28 -2.456 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 176.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.771 ' HA ' ' CE ' ' A' ' 24' ' ' MET . 18.1 m -5.14 -44.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-O 122.447 1.118 . . . . 0.0 110.719 -177.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 1.022 ' N ' ' O ' ' A' ' 20' ' ' SER . 33.3 m -71.22 -41.79 69.74 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.88 178.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.89 ' N ' ' O ' ' A' ' 20' ' ' SER . 5.0 mtpt -85.87 -32.61 21.6 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.459 -0.776 . . . . 0.0 111.486 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.771 ' CE ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -65.82 -26.83 67.86 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 116.938 -1.905 . . . . 0.0 108.158 179.277 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 1.015 HD23 ' CD1' ' A' ' 7' ' ' ILE . 0.1 OUTLIER -77.88 -49.68 13.74 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 177.727 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.563 ' N ' HD12 ' A' ' 25' ' ' LEU . . . -57.79 -29.72 65.09 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.525 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 1.6 t -83.39 -38.92 21.33 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.65 ' CZ ' HD13 ' B' ' 44' ' ' LEU . 19.7 t80 -53.32 -48.09 68.73 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.638 ' HG3' HG21 ' B' ' 45' ' ' THR . 0.1 OUTLIER -66.86 -38.76 86.95 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 176.332 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 1.273 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 42.2 tttt -60.79 -19.56 59.74 Favored 'General case' 0 C--O 1.194 -1.836 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.717 HD13 ' HB1' ' B' ' 9' ' ' ALA . 0.9 OUTLIER -112.74 -23.46 4.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 O-C-N 119.996 -1.69 . . . . 0.0 109.904 178.641 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.649 HG21 ' CE1' ' B' ' 47' ' ' PHE . 1.3 mm -82.46 -49.68 16.88 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 176.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.494 ' OG1' ' O ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -77.48 -38.88 48.27 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.564 178.677 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 1.273 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 64.2 mm-40 -74.16 -28.5 61.34 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.946 -1.096 . . . . 0.0 111.157 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.731 HG22 ' CA ' ' A' ' 40' ' ' ASP . 87.8 m -78.09 -42.29 32.53 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 118.19 -1.404 . . . . 0.0 109.425 179.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.715 HG13 ' HB1' ' B' ' 88' ' ' ALA . 3.4 p -54.42 -41.22 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 177.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.698 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -78.85 -2.71 41.04 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.806 -0.758 . . . . 0.0 110.115 178.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -113.66 1.25 14.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.925 -1.109 . . . . 0.0 108.982 177.697 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.33 35.77 2.82 Favored Glycine 0 N--CA 1.484 1.887 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.731 ' CA ' HG22 ' A' ' 35' ' ' THR . 12.4 t70 -47.15 165.22 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 122.619 1.2 . . . . 0.0 112.912 -179.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.422 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 8.2 mttt -174.21 58.39 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 178.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.844 HG12 ' CB ' ' B' ' 1' ' ' MET . 12.0 m -93.39 132.63 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 CA-C-O 121.606 0.717 . . . . 0.0 111.324 -177.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.443 ' O ' ' CG ' ' A' ' 43' ' ' GLN . 1.1 tt0 -118.35 102.29 8.84 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.954 HD12 ' HB3' ' A' ' 48' ' ' LEU . 72.1 mt -70.52 104.45 2.78 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.093 -1.005 . . . . 0.0 110.166 -179.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.457 ' CG2' ' C ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER 33.36 -92.48 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.141 0 O-C-N 122.09 -0.381 . . . . 0.0 111.064 179.965 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -149.49 34.7 1.06 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.802 ' CD1' HD21 ' A' ' 85' ' ' LEU . 1.5 p90 -133.69 -26.1 1.61 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.111 -1.229 . . . . 0.0 111.617 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.954 ' HB3' HD12 ' A' ' 44' ' ' LEU . 5.7 mt -139.72 104.9 5.01 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.603 -1.311 . . . . 0.0 110.605 178.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.802 ' C ' HG23 ' A' ' 79' ' ' VAL . 1.5 t30 -106.12 76.79 1.18 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.165 -0.959 . . . . 0.0 110.716 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.888 HD13 ' HB ' ' A' ' 79' ' ' VAL . 1.4 mm -64.29 109.98 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.187 -0.946 . . . . 0.0 109.849 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.51 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -131.06 119.59 17.92 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.053 -1.029 . . . . 0.0 109.84 -179.913 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.568 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 54.0 Cg_endo -79.42 139.28 14.45 Favored 'Trans proline' 0 C--N 1.316 -1.146 0 O-C-N 123.39 1.205 . . . . 0.0 111.832 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.723 HG22 ' O ' ' A' ' 76' ' ' GLY . 33.9 m -144.24 117.7 3.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.359 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.687 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.499 2.012 0 CA-C-O 121.626 0.727 . . . . 0.0 111.96 -178.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.774 HG12 ' CB ' ' B' ' 89' ' ' ALA . 0.4 OUTLIER . . . . . 0 N--CA 1.496 1.849 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.723 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -123.76 86.45 0.38 Allowed Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.927 HG21 ' CD1' ' B' ' 85' ' ' LEU . 4.7 p -64.77 68.9 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.549 -0.971 . . . . 0.0 108.697 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.563 ' O ' ' HB ' ' A' ' 79' ' ' VAL . 1.0 OUTLIER -65.42 174.49 2.14 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.903 0.859 . . . . 0.0 110.983 -178.517 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.888 ' HB ' HD13 ' A' ' 50' ' ' ILE . 4.9 p 174.79 -168.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.846 ' O ' HD23 ' A' ' 48' ' ' LEU . 7.6 pttt -172.98 172.26 1.63 Allowed Pre-proline 0 N--CA 1.485 1.279 0 O-C-N 120.678 -1.264 . . . . 0.0 111.235 177.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.806 ' HB3' HG12 ' B' ' 77' ' ' VAL . 55.3 Cg_endo -93.3 87.3 0.16 Allowed 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 122.635 2.223 . . . . 0.0 109.472 178.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.747 ' O ' HD12 ' A' ' 85' ' ' LEU . . . -58.73 158.05 19.98 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 87' ' ' LYS . 13.7 pt-20 -55.21 -17.27 4.15 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.219 -1.165 . . . . 0.0 111.07 -179.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.507 ' CB ' ' HB3' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -55.8 -35.89 66.82 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.85 -1.156 . . . . 0.0 109.317 179.426 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.802 HD21 ' CD1' ' A' ' 47' ' ' PHE . 0.7 OUTLIER -81.74 -37.8 26.71 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.894 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.449 ' N ' HG21 ' B' ' 77' ' ' VAL . 0.6 OUTLIER -75.0 -30.95 61.29 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.448 0.642 . . . . 0.0 110.368 -179.429 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.431 ' HA ' ' HG2' ' A' ' 90' ' ' GLU . 16.2 ttpt -78.1 -34.66 49.97 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.659 ' O ' ' HG ' ' A' ' 92' ' ' LEU . . . -71.59 -32.18 67.77 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 177.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.702 ' HA ' ' HA ' ' B' ' 37' ' ' ALA . . . -73.02 -54.12 9.39 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.538 -0.726 . . . . 0.0 110.484 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.588 ' HA ' ' HB3' ' A' ' 94' ' ' TYR . 19.1 pt-20 -53.86 -21.42 7.59 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 177.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.706 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -83.66 -28.87 34.06 Favored Glycine 0 CA--C 1.54 1.629 0 CA-C-O 119.093 -0.837 . . . . 0.0 112.335 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.725 HD12 ' C ' ' B' ' 37' ' ' ALA . 2.3 mt -97.88 -74.1 0.59 Allowed 'General case' 0 N--CA 1.5 2.026 0 CA-C-N 121.425 2.613 . . . . 0.0 111.816 -178.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -146.87 42.61 1.14 Allowed 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 119.244 -0.982 . . . . 0.0 111.385 -178.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.588 ' HB3' ' HA ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -60.63 -48.41 81.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.279 -0.888 . . . . 0.0 108.824 178.857 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.554 -0.716 . . . . 0.0 109.301 179.32 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.844 ' CB ' HG12 ' A' ' 42' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.126 0.489 . . . . 0.0 110.223 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 2' ' ' ASN . . . . . 0.532 ' H ' ' HB2' ' B' ' 5' ' ' GLU . 0.6 OUTLIER 178.3 178.21 0.4 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.39 -0.819 . . . . 0.0 109.834 -179.426 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.663 ' O ' HD22 ' B' ' 25' ' ' LEU . 0.1 OUTLIER -51.34 -23.86 4.09 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.764 -0.774 . . . . 0.0 108.975 178.915 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . 0.512 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 30.4 m -90.22 -53.58 4.4 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.664 0.745 . . . . 0.0 109.51 178.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.532 ' HB2' ' H ' ' B' ' 2' ' ' ASN . 8.6 mm-40 -59.19 -49.23 78.64 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.701 ' O ' ' HB3' ' B' ' 9' ' ' ALA . 17.6 mt -54.42 -37.23 64.86 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.227 -0.989 . . . . 0.0 108.506 177.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 7' ' ' ILE . . . . . 0.999 ' CD1' HD23 ' B' ' 25' ' ' LEU . 0.1 OUTLIER -51.7 -51.27 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 177.604 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . 0.962 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.0 OUTLIER -64.79 -29.67 70.64 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.539 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . 0.717 ' HB1' HD13 ' A' ' 31' ' ' ILE . . . -53.57 -38.19 63.64 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.294 -0.879 . . . . 0.0 108.64 178.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.761 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.1 mp -97.41 -33.72 4.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.056 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.962 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -66.23 -12.3 55.33 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 118.579 -1.248 . . . . 0.0 109.197 178.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.453 ' N ' ' O ' ' B' ' 8' ' ' LYS . 23.3 mm100 -113.22 -41.67 3.66 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.345 -0.847 . . . . 0.0 109.525 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.457 ' CB ' ' OG ' ' A' ' 27' ' ' SER . 1.1 m-20 -70.67 -31.12 67.91 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 177.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 1.049 HG22 ' CD1' ' B' ' 16' ' ' LEU . 0.1 OUTLIER -106.63 -84.04 0.52 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 177.752 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . 0.592 ' O ' ' C ' ' B' ' 16' ' ' LEU . . . 72.63 -19.49 1.15 Allowed Glycine 0 N--CA 1.5 2.921 0 O-C-N 121.038 -1.039 . . . . 0.0 111.18 177.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 16' ' ' LEU . . . . . 1.049 ' CD1' HG22 ' B' ' 14' ' ' THR . 4.9 mp -18.86 -61.44 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.511 0 CA-C-O 122.031 0.919 . . . . 0.0 111.575 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . 0.649 ' CG2' HG21 ' A' ' 17' ' ' THR . 0.5 OUTLIER -142.59 7.47 1.7 Allowed 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.543 -179.464 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . 0.584 ' O ' ' C ' ' B' ' 19' ' ' VAL . 29.7 mt-30 60.01 23.1 12.25 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 -175.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.939 HG11 HG11 ' A' ' 19' ' ' VAL . 1.4 p 5.04 -91.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.951 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 1.016 ' HB2' HG22 ' A' ' 14' ' ' THR . 0.5 OUTLIER -132.44 24.64 4.45 Favored 'General case' 0 C--N 1.277 -2.578 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 179.236 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.719 ' HA ' ' CE ' ' B' ' 24' ' ' MET . 16.7 m -22.69 -43.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 CA-C-O 122.541 1.162 . . . . 0.0 108.578 -178.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.717 ' N ' ' O ' ' B' ' 20' ' ' SER . 13.7 t -74.91 -39.06 61.65 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.614 177.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . 0.972 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.3 OUTLIER -86.25 -40.94 15.03 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.592 -0.692 . . . . 0.0 111.792 179.869 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 24' ' ' MET . . . . . 0.719 ' CE ' ' HA ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -61.84 -28.19 69.31 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 117.203 -1.799 . . . . 0.0 108.814 179.383 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.999 HD23 ' CD1' ' B' ' 7' ' ' ILE . 0.1 OUTLIER -80.57 -48.82 12.15 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 118.476 -1.29 . . . . 0.0 108.766 178.122 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . 0.568 ' N ' HD12 ' B' ' 25' ' ' LEU . . . -61.07 -29.25 69.63 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 27' ' ' SER . . . . . 0.551 ' HA ' ' HB3' ' B' ' 30' ' ' LYS . 75.3 m -83.64 -33.12 25.34 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . 0.794 ' CE1' HD22 ' A' ' 44' ' ' LEU . 0.7 OUTLIER -55.43 -50.78 68.91 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.913 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . 0.632 ' HG3' ' CE2' ' A' ' 47' ' ' PHE . 3.0 tt0 -65.73 -34.66 78.71 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 176.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 1.333 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 23.2 ttpp -66.89 -20.85 65.99 Favored 'General case' 0 C--O 1.193 -1.905 0 C-N-CA 119.414 -0.914 . . . . 0.0 108.93 178.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.673 HG13 ' O ' ' B' ' 28' ' ' PHE . 0.9 OUTLIER -108.04 -25.35 3.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 O-C-N 119.728 -1.858 . . . . 0.0 109.604 178.569 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.622 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.1 mm -76.62 -58.29 4.66 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 177.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 33' ' ' THR . . . . . 0.527 ' HA ' HD23 ' A' ' 85' ' ' LEU . 0.7 OUTLIER -75.54 -29.12 59.3 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.328 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 1.333 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 74.3 mm-40 -81.58 -27.59 34.21 Favored 'General case' 0 C--N 1.315 -0.915 0 O-C-N 120.898 -1.126 . . . . 0.0 110.416 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 35' ' ' THR . . . . . 0.594 HG23 ' CB ' ' B' ' 40' ' ' ASP . 1.8 m -69.73 -57.08 5.56 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 117.715 -1.594 . . . . 0.0 107.485 177.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.74 ' O ' ' HG3' ' B' ' 52' ' ' PRO . 7.1 p -48.43 -40.25 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . 0.725 ' C ' HD12 ' A' ' 92' ' ' LEU . . . -71.34 -32.83 69.01 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.14 178.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.645 ' N ' HD12 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -68.86 -21.49 64.26 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 176.653 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' B' ' 35' ' ' THR . . . 99.25 30.88 6.41 Favored Glycine 0 C--N 1.298 -1.557 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 177.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . 0.594 ' CB ' HG23 ' B' ' 35' ' ' THR . 0.3 OUTLIER -118.03 151.82 36.74 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.395 -1.062 . . . . 0.0 109.905 179.528 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.416 ' CG ' ' CB ' ' B' ' 51' ' ' LYS . 0.0 OUTLIER -95.59 90.54 5.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.428 -0.795 . . . . 0.0 110.558 -179.299 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.863 HG12 HG22 ' B' ' 50' ' ' ILE . 10.5 p -75.06 152.89 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.41 -0.806 . . . . 0.0 109.392 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 43' ' ' GLN . . . . . 0.607 ' O ' HD23 ' B' ' 44' ' ' LEU . 18.5 pt20 -157.16 175.94 13.38 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.148 -0.97 . . . . 0.0 111.14 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.686 HD12 ' HB2' ' B' ' 48' ' ' LEU . 24.1 mt -128.51 117.49 21.4 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.625 -0.672 . . . . 0.0 109.356 179.151 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . 0.638 HG21 ' HG3' ' A' ' 29' ' ' GLU . 0.6 OUTLIER 28.54 -103.37 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.815 -0.553 . . . . 0.0 111.313 179.893 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . 0.488 ' H ' HG23 ' B' ' 45' ' ' THR . . . -133.96 57.97 0.7 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . 0.731 ' CD1' HD21 ' B' ' 85' ' ' LEU . 8.0 p90 -157.67 -25.39 0.09 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.081 -1.247 . . . . 0.0 110.987 178.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.949 HD13 ' HG2' ' B' ' 80' ' ' LYS . 0.5 OUTLIER -130.78 145.65 52.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.842 -1.161 . . . . 0.0 109.965 178.003 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 49' ' ' ASN . . . . . 0.85 ' O ' ' O ' ' B' ' 79' ' ' VAL 0.265 0.4 OUTLIER -162.18 90.61 0.75 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.333 -0.854 . . . . 0.0 110.874 -177.247 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' B' B ' 50' ' ' ILE . . . . . 0.863 HG22 HG12 ' B' ' 42' ' ' VAL . 0.3 OUTLIER -83.53 146.14 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.884 -1.135 . . . . 0.0 109.809 -179.428 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . 0.448 ' HG3' ' HB3' ' B' ' 78' ' ' SER . 1.5 ptmt -167.3 122.79 0.87 Allowed Pre-proline 0 N--CA 1.495 1.807 0 C-N-CA 119.124 -1.03 . . . . 0.0 110.689 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 52' ' ' PRO . . . . . 0.74 ' HG3' ' O ' ' B' ' 36' ' ' VAL . 55.4 Cg_endo -88.45 146.92 6.19 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.611 1.321 . . . . 0.0 110.841 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.572 ' O ' HG23 ' B' ' 53' ' ' VAL . 26.7 m -132.22 114.39 23.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-O 121.909 0.861 . . . . 0.0 110.065 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.806 0 CA-C-O 121.484 0.659 . . . . 0.0 111.58 -178.855 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . 0.743 HG12 HG23 ' B' ' 77' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 76' ' ' GLY . . . . . 0.57 ' O ' HG22 ' B' ' 53' ' ' VAL . . . -114.8 54.48 0.57 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.806 HG12 ' HB3' ' A' ' 81' ' ' PRO . 69.9 t -37.75 87.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 122.052 -0.675 . . . . 0.0 111.59 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 78' ' ' SER . . . . . 0.552 ' N ' ' O ' ' B' ' 76' ' ' GLY . 1.8 t -59.45 -129.51 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.85 ' O ' ' O ' ' B' ' 49' ' ' ASN . 17.7 m -140.15 -170.01 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 119.76 -1.838 . . . . 0.0 112.815 178.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 80' ' ' LYS . . . . . 0.949 ' HG2' HD13 ' B' ' 48' ' ' LEU . 0.0 OUTLIER -101.28 -54.26 0.15 Allowed Pre-proline 0 C--N 1.29 -2.004 0 CA-C-N 113.49 -1.686 . . . . 0.0 113.261 -178.489 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 81' ' ' PRO . . . . . 0.78 ' HD2' ' H ' ' B' ' 80' ' ' LYS . 30.5 Cg_endo -52.43 138.88 56.53 Favored 'Trans proline' 0 C--N 1.298 -2.115 0 C-N-CA 121.219 1.279 . . . . 0.0 113.372 -174.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -135.2 -64.41 0.06 OUTLIER Glycine 0 N--CA 1.485 1.95 0 N-CA-C 106.091 -2.803 . . . . 0.0 106.091 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . 0.924 ' O ' ' N ' ' B' ' 85' ' ' LEU . 4.0 tt0 -97.19 46.18 1.04 Allowed 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 175.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 84' ' ' SER . . . . . 1.33 ' O ' ' N ' ' B' ' 86' ' ' LYS . 0.1 OUTLIER 8.18 43.26 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 122.551 1.167 . . . . 0.0 110.489 179.393 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 1.047 ' C ' ' O ' ' B' ' 84' ' ' SER . 0.5 OUTLIER 21.29 28.85 0.0 OUTLIER 'General case' 0 C--O 1.191 -2.004 0 N-CA-C 103.203 -2.888 . . . . 0.0 103.203 -171.161 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 86' ' ' LYS . . . . . 1.33 ' N ' ' O ' ' B' ' 84' ' ' SER 0.309 1.2 tttm -49.8 -35.99 24.78 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 176.938 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . 0.411 ' O ' ' HG2' ' B' ' 90' ' ' GLU 0.298 0.0 OUTLIER -66.49 -38.78 88.02 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 111.97 -2.377 . . . . 0.0 106.569 175.64 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.793 ' N ' ' O ' ' B' ' 85' ' ' LEU . . . -79.35 -26.33 42.11 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 118.725 -1.19 . . . . 0.0 108.285 178.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.932 ' HA ' HD23 ' B' ' 92' ' ' LEU . . . -68.48 -45.01 73.54 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.448 -0.782 . . . . 0.0 108.924 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . 0.48 ' HG2' ' N ' ' B' ' 91' ' ' GLY . 3.6 pt-20 -58.58 -28.37 65.49 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 176.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . 0.48 ' N ' ' HG2' ' B' ' 90' ' ' GLU . . . -62.48 -38.84 96.99 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 110.646 -0.981 . . . . 0.0 110.646 178.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 92' ' ' LEU . . . . . 0.932 HD23 ' HA ' ' B' ' 89' ' ' ALA . 0.9 OUTLIER -78.82 18.99 0.54 Allowed 'General case' 0 N--CA 1.505 2.28 0 O-C-N 120.392 -1.652 . . . . 0.0 111.481 -179.557 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 93' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' B' ' 92' ' ' LEU . 6.7 mptt 54.51 39.53 31.16 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -178.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . 0.583 ' HB2' ' CB ' ' A' ' 75' ' ' VAL . 1.2 p90 -42.01 -30.42 0.28 Allowed 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.746 -178.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . 0.506 ' CG ' ' CE1' ' B' ' 94' ' ' TYR . 22.7 mt-10 -59.08 -47.37 85.51 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.188 -0.945 . . . . 0.0 108.501 178.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.97 -36.44 67.83 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.217 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.535 ' HA ' ' CB ' ' A' ' 5' ' ' GLU . 5.9 mtp . . . . . 0 N--CA 1.496 1.842 0 CA-C-O 120.743 0.306 . . . . 0.0 110.238 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -173.97 -164.24 0.19 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.049 -1.032 . . . . 0.0 111.795 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.585 ' HE3' HG21 ' B' ' 45' ' ' THR . 12.9 mttt -62.52 -3.22 1.34 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.444 -0.785 . . . . 0.0 110.321 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.678 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 87.2 m -124.36 -39.61 2.31 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.201 -0.937 . . . . 0.0 108.871 179.061 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.579 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -63.11 -55.52 24.61 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 178.343 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.762 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 0.8 OUTLIER -58.71 -29.58 66.78 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.499 -0.881 . . . . 0.0 109.201 178.198 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.958 HG23 ' HB ' ' A' ' 21' ' ' VAL . 1.7 mt -54.25 -56.09 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.49 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.916 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 12.7 mtmt -58.69 -33.28 69.97 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.23 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.87 ' HB1' HD13 ' B' ' 31' ' ' ILE . . . -52.34 -37.97 57.45 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.574 -0.851 . . . . 0.0 109.202 179.106 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.862 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.0 OUTLIER -96.07 -35.1 5.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 178.546 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.916 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -61.49 -13.14 18.49 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 118.616 -1.234 . . . . 0.0 108.687 178.467 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -114.75 -43.66 3.12 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.474 -0.766 . . . . 0.0 109.377 178.431 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 9' ' ' ALA . 1.1 m-20 -63.99 -39.55 94.37 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 177.501 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 1.062 HG22 ' CD1' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -89.45 -78.0 0.37 Allowed 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 177.375 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.9 7.8 67.05 Favored Glycine 0 N--CA 1.5 2.924 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 177.528 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 1.062 ' CD1' HG22 ' A' ' 14' ' ' THR . 5.1 mp -54.75 -68.1 0.21 Allowed 'General case' 0 C--N 1.293 -1.858 0 O-C-N 121.671 -0.899 . . . . 0.0 110.676 179.821 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.584 HG22 ' H ' ' A' ' 19' ' ' VAL . 0.5 OUTLIER -142.94 7.98 1.65 Allowed 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.715 -179.25 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.664 ' O ' HG22 ' A' ' 21' ' ' VAL . 11.6 mt-30 59.4 24.61 13.23 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 -176.031 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 1.058 HG11 HG11 ' B' ' 19' ' ' VAL . 1.6 p -2.72 -91.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.932 -179.064 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.987 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.5 OUTLIER -131.01 24.8 4.96 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 178.21 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.958 ' HB ' HG23 ' A' ' 7' ' ' ILE . 1.4 m -20.93 -40.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-O 122.265 1.031 . . . . 0.0 109.409 -178.248 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.77 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.2 OUTLIER -80.42 -34.68 35.99 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.603 177.863 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.987 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -90.13 -38.11 13.75 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.563 -0.71 . . . . 0.0 111.193 179.544 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.656 ' CE ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -66.54 -37.33 84.77 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 117.686 -1.605 . . . . 0.0 108.774 179.455 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.8 HD12 HG13 ' A' ' 7' ' ' ILE . 0.4 OUTLIER -79.89 -37.99 33.58 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 118.054 -1.458 . . . . 0.0 109.425 178.699 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.468 ' HA ' ' CE ' ' A' ' 3' ' ' LYS . . . -66.06 -34.78 78.86 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 177.447 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.64 ' O ' HG13 ' A' ' 31' ' ' ILE . 62.1 m -83.16 -30.46 27.8 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.205 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.651 ' CE1' HD22 ' B' ' 44' ' ' LEU . 1.4 t80 -52.49 -49.53 64.53 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.552 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.73 ' HG3' ' CD2' ' B' ' 47' ' ' PHE . 0.2 OUTLIER -67.15 -35.99 80.87 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 177.172 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 1.16 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 9.7 ttmm -64.22 -20.79 66.27 Favored 'General case' 0 C--O 1.19 -2.061 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.413 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.672 HD12 HG12 ' A' ' 32' ' ' ILE . 1.3 pp -105.04 -27.99 3.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 O-C-N 120.297 -1.502 . . . . 0.0 108.951 178.222 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.678 HG21 ' CE1' ' B' ' 47' ' ' PHE . 1.2 mm -73.48 -58.69 4.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 177.078 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.931 ' HA ' HD23 ' B' ' 85' ' ' LEU . 0.4 OUTLIER -69.43 -33.42 72.94 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.305 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 1.16 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 27.2 mm-40 -76.96 -39.42 50.67 Favored 'General case' 0 N--CA 1.483 1.211 0 O-C-N 121.056 -1.027 . . . . 0.0 111.094 179.104 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.779 HG21 ' SD ' ' B' ' 1' ' ' MET . 21.9 m -57.94 -52.76 64.15 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.074 -1.641 . . . . 0.0 108.488 179.295 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.83 HG13 ' HB3' ' A' ' 52' ' ' PRO . 2.4 t -54.35 -36.56 34.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 177.918 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.752 ' HB1' ' O ' ' B' ' 88' ' ' ALA . . . -87.24 -0.23 56.4 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.432 0.634 . . . . 0.0 109.724 178.668 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.697 ' HB2' ' HA ' ' A' ' 35' ' ' THR . 1.5 mmpt? -102.6 -30.6 10.85 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 177.85 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.11 41.51 0.47 Allowed Glycine 0 C--N 1.303 -1.282 0 C-N-CA 119.945 -1.121 . . . . 0.0 110.842 177.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.737 ' O ' HG22 ' A' ' 35' ' ' THR . 0.4 OUTLIER -147.0 120.27 8.93 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.074 -1.25 . . . . 0.0 110.624 179.526 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.2 mtpt -63.95 86.62 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.53 -0.731 . . . . 0.0 109.608 179.723 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.664 HG23 HD21 ' B' ' 6' ' ' LEU . 11.3 p -68.1 146.75 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.656 -0.653 . . . . 0.0 110.391 -179.479 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.626 ' O ' HD23 ' A' ' 44' ' ' LEU . 22.9 mt-30 -144.68 176.48 9.39 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.341 -0.849 . . . . 0.0 110.257 -179.805 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.7 HD12 ' HB2' ' A' ' 48' ' ' LEU . 32.4 mt -125.52 113.9 18.07 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.594 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.548 HG22 ' HG2' ' B' ' 29' ' ' GLU . 0.1 OUTLIER 36.05 -87.53 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.85 -0.531 . . . . 0.0 110.621 -179.229 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -151.59 27.09 0.95 Allowed Glycine 0 N--CA 1.484 1.87 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.34 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.823 ' CE1' HG21 ' B' ' 32' ' ' ILE . 4.6 p90 -125.38 -29.92 3.19 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.96 -1.318 . . . . 0.0 112.66 179.84 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.7 ' HB2' HD12 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -122.04 85.71 2.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.445 -1.409 . . . . 0.0 110.692 179.132 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -89.47 85.6 6.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.811 -0.556 . . . . 0.0 109.88 179.605 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.871 HD12 HG22 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -75.68 139.37 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.404 -0.81 . . . . 0.0 109.656 -179.57 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.499 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 2.2 ptmt -153.9 125.51 3.7 Favored Pre-proline 0 N--CA 1.496 1.861 0 C-N-CA 118.752 -1.179 . . . . 0.0 110.785 179.674 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.83 ' HB3' HG13 ' A' ' 36' ' ' VAL . 52.9 Cg_endo -80.97 144.18 14.87 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 O-C-N 123.518 1.272 . . . . 0.0 111.248 -179.768 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.768 HG22 ' O ' ' A' ' 76' ' ' GLY . 31.6 m -137.98 114.82 11.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-O 121.772 0.796 . . . . 0.0 110.259 179.043 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.547 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.496 1.835 0 CA-C-O 121.924 0.869 . . . . 0.0 111.898 -178.513 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.67 ' HB ' ' HB2' ' B' ' 94' ' ' TYR . 1.0 OUTLIER . . . . . 0 N--CA 1.496 1.831 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.768 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -117.74 86.92 0.42 Allowed Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.141 -1.583 . . . . 0.0 109.141 -179.86 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.908 HG21 ' CB ' ' B' ' 85' ' ' LEU . 5.0 p -60.75 77.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.676 -0.896 . . . . 0.0 109.834 179.868 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 1.027 ' O ' HG23 ' A' ' 79' ' ' VAL . 0.8 OUTLIER -62.69 178.02 0.48 Allowed 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.502 -0.879 . . . . 0.0 109.565 179.775 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 1.027 HG23 ' O ' ' A' ' 78' ' ' SER . 2.7 t -176.78 173.56 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.709 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.664 ' O ' HD23 ' A' ' 48' ' ' LEU . 10.9 pttp 177.53 169.33 0.47 Allowed Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.081 -1.012 . . . . 0.0 110.027 176.503 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.571 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 55.1 Cg_endo -97.47 141.83 0.61 Allowed 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 122.505 2.136 . . . . 0.0 110.753 177.757 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.603 ' H ' HD11 ' A' ' 85' ' ' LEU . . . -97.63 -155.09 29.87 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 108.432 -1.867 . . . . 0.0 108.432 178.424 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.626 ' HA ' ' HB2' ' A' ' 86' ' ' LYS . 4.7 pm0 -93.77 -15.37 25.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.126 -1.22 . . . . 0.0 110.347 179.358 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.35 -34.18 56.53 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.309 -0.87 . . . . 0.0 109.574 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.782 ' CB ' HG21 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -88.17 -25.36 22.98 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 119.68 -0.808 . . . . 0.0 108.855 179.005 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.626 ' HB2' ' HA ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -76.19 -35.71 58.98 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.554 -0.858 . . . . 0.0 109.184 179.647 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.7 tttp -72.82 -39.83 66.31 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 177.166 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.834 ' O ' ' HB1' ' B' ' 37' ' ' ALA . . . -65.08 -37.0 86.11 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 176.243 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.692 ' HA ' HD23 ' A' ' 92' ' ' LEU . . . -56.71 -38.04 71.77 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.758 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.15 -33.06 62.6 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 176.391 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.483 ' C ' ' H ' ' A' ' 93' ' ' LYS . . . -59.82 -44.44 97.04 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 177.805 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.962 ' O ' HD12 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -69.42 15.44 0.07 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.71 -1.465 . . . . 0.0 110.422 179.397 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.602 ' HB3' ' O ' ' A' ' 92' ' ' LEU . 0.8 OUTLIER 65.37 73.77 0.39 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 -177.086 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 1.055 ' O ' ' C ' ' A' ' 95' ' ' GLU . 47.7 t80 -47.39 -58.19 4.44 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 116.481 -2.088 . . . . 0.0 106.538 179.817 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 1.055 ' C ' ' O ' ' A' ' 94' ' ' TYR . 56.2 mm-40 . . . . . 0 CA--C 1.484 -1.588 0 N-CA-C 102.3 -3.222 . . . . 0.0 102.3 179.295 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.779 ' SD ' HG21 ' A' ' 35' ' ' THR . 4.2 ptm . . . . . 0 N--CA 1.496 1.832 0 CA-C-O 121.307 0.575 . . . . 0.0 110.833 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 2' ' ' ASN . . . . . 0.557 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 16.4 p-10 -176.15 -140.81 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.706 -0.797 . . . . 0.0 111.238 178.044 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.451 ' HE3' ' HB3' ' B' ' 29' ' ' GLU . 0.1 OUTLIER -57.56 -0.36 0.07 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.003 -1.061 . . . . 0.0 110.916 -179.62 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . 0.777 ' O ' HG13 ' B' ' 7' ' ' ILE . 4.2 m -120.16 -69.47 0.84 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.957 -1.089 . . . . 0.0 110.376 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.594 ' O ' ' HG3' ' B' ' 8' ' ' LYS . 1.7 mm-40 -48.82 -36.17 16.17 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.062 -1.024 . . . . 0.0 109.331 -179.865 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.664 HD21 HG23 ' A' ' 42' ' ' VAL . 87.0 mt -69.36 -28.96 66.66 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 118.869 -1.133 . . . . 0.0 109.988 178.608 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 7' ' ' ILE . . . . . 0.874 ' HA ' HD12 ' B' ' 25' ' ' LEU . 1.5 pp -63.76 -45.91 95.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.521 -1.362 . . . . 0.0 107.972 178.929 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . 0.829 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.0 OUTLIER -74.23 -20.44 60.17 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.39 -0.924 . . . . 0.0 108.562 177.522 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . 0.536 ' HB3' ' HA ' ' B' ' 6' ' ' LEU . . . -69.15 -33.57 73.63 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.149 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.861 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.0 OUTLIER -94.37 -34.5 5.63 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.4 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 178.3 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.829 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -56.91 -25.49 57.4 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.285 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 11.6 mm-40 -92.52 -45.03 8.32 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.441 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.424 ' HB2' ' HA ' ' B' ' 10' ' ' ILE . 4.6 m-20 -62.34 -25.26 67.8 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 177.061 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.882 HG22 ' HB2' ' A' ' 20' ' ' SER . 14.8 p -91.42 -74.39 0.51 Allowed 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.119 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 59.15 17.24 36.9 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.575 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 16' ' ' LEU . . . . . 0.964 HD22 ' O ' ' A' ' 19' ' ' VAL . 3.4 mp -83.44 -61.53 1.82 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.358 -1.084 . . . . 0.0 108.878 179.053 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . 0.561 HG22 ' H ' ' B' ' 19' ' ' VAL . 0.6 OUTLIER -139.84 2.84 2.0 Allowed 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.732 179.909 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . 0.623 ' O ' ' C ' ' B' ' 19' ' ' VAL . 17.6 mt-30 56.64 28.14 13.61 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 -176.836 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 1.058 HG11 HG11 ' A' ' 19' ' ' VAL . 1.7 p -6.16 -100.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.765 -179.377 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 0.899 ' O ' ' N ' ' B' ' 23' ' ' LYS . 0.5 OUTLIER -133.92 24.12 3.93 Favored 'General case' 0 C--N 1.28 -2.445 0 N-CA-C 105.434 -2.062 . . . . 0.0 105.434 177.154 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.635 ' HA ' ' HE2' ' B' ' 24' ' ' MET . 16.6 m -18.43 -37.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 CA-C-O 122.212 1.006 . . . . 0.0 110.513 -177.922 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.844 ' N ' ' O ' ' B' ' 20' ' ' SER . 5.2 t -77.49 -43.13 33.25 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.146 -0.934 . . . . 0.0 108.893 178.496 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . 0.899 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.0 OUTLIER -92.3 -19.21 22.39 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.724 -0.61 . . . . 0.0 109.566 178.474 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 24' ' ' MET . . . . . 0.728 ' N ' ' OG ' ' B' ' 20' ' ' SER 0.258 3.1 tmm? -68.57 -44.86 73.54 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.3 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.874 HD12 ' HA ' ' B' ' 7' ' ' ILE . 8.4 mt -76.83 -44.14 33.55 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 177.005 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . 0.604 ' HB3' ' HA ' ' B' ' 23' ' ' LYS . . . -54.74 -33.48 61.21 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 177.567 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 27' ' ' SER . . . . . 0.538 ' O ' HG23 ' B' ' 31' ' ' ILE . 10.4 m -75.27 -40.97 58.24 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.465 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . 0.759 ' HA ' ' CG1' ' B' ' 31' ' ' ILE . 0.0 OUTLIER -64.39 -31.38 72.57 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.548 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . 0.604 ' HG3' ' CE2' ' B' ' 28' ' ' PHE . 1.5 mt-10 -84.4 -32.3 24.22 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 178.221 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 0.747 ' O ' ' CG ' ' B' ' 34' ' ' GLU . 24.8 tttt -71.4 -29.02 64.43 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 176.332 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.87 HD13 ' HB1' ' A' ' 9' ' ' ALA . 1.3 pp -93.89 -31.29 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.224 -0.922 . . . . 0.0 109.749 178.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.823 HG21 ' CE1' ' A' ' 47' ' ' PHE . 3.4 mm -61.65 -55.22 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 177.447 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 33' ' ' THR . . . . . 0.451 ' HB ' ' O ' ' B' ' 29' ' ' GLU . 0.4 OUTLIER -64.52 -40.32 95.4 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.429 179.46 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.793 ' O ' ' N ' ' B' ' 38' ' ' LYS . 17.8 mm-40 -68.92 -44.14 73.73 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.77 -0.581 . . . . 0.0 110.959 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 35' ' ' THR . . . . . 0.483 ' HA ' ' CB ' ' B' ' 38' ' ' LYS . 93.0 m -54.0 -52.12 61.76 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.798 -1.189 . . . . 0.0 108.998 179.876 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.992 HG21 HG23 ' B' ' 77' ' ' VAL . 0.4 OUTLIER -50.9 -37.26 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.145 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . 0.834 ' HB1' ' O ' ' A' ' 88' ' ' ALA . . . -96.32 0.77 51.21 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.774 0.797 . . . . 0.0 110.108 179.043 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.793 ' N ' ' O ' ' B' ' 34' ' ' GLU . 0.0 OUTLIER -95.8 -22.84 17.24 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 176.906 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.49 44.87 0.69 Allowed Glycine 0 C--N 1.304 -1.22 0 C-N-CA 120.35 -0.928 . . . . 0.0 110.961 177.631 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . 0.415 ' HB2' HG23 ' B' ' 35' ' ' THR . 0.4 OUTLIER -155.41 166.14 34.47 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.005 -1.291 . . . . 0.0 111.399 179.6 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.47 ' HG2' ' HD2' ' B' ' 52' ' ' PRO . 11.0 mttt -121.48 112.86 19.04 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.273 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.87 HG22 ' CG1' ' B' ' 50' ' ' ILE . 0.8 OUTLIER -79.47 147.15 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 C-N-CA 118.664 -1.214 . . . . 0.0 110.064 -178.602 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 43' ' ' GLN . . . . . 0.424 ' HA ' ' HA ' ' B' ' 49' ' ' ASN . 1.6 mt-30 -123.66 85.85 2.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.485 -0.759 . . . . 0.0 109.259 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.813 HD12 ' HB3' ' B' ' 48' ' ' LEU . 12.6 mt -58.96 90.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.473 -0.767 . . . . 0.0 110.727 -179.219 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . 0.585 HG21 ' HE3' ' A' ' 3' ' ' LYS . 2.2 t 35.93 26.98 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 179.34 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . 97.91 -25.39 27.71 Favored Glycine 0 N--CA 1.494 2.563 0 C-N-CA 119.841 -1.171 . . . . 0.0 112.859 177.44 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . 0.931 ' CD1' HD21 ' B' ' 85' ' ' LEU . 1.4 p90 -86.44 -28.43 23.51 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 119.873 1.836 . . . . 0.0 112.031 -178.577 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.813 ' HB3' HD12 ' B' ' 44' ' ' LEU . 5.5 mt -129.78 94.06 3.65 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.6 -1.313 . . . . 0.0 110.382 177.786 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 49' ' ' ASN . . . . . 0.512 ' O ' ' HA ' ' B' ' 79' ' ' VAL . 0.6 OUTLIER -105.0 95.26 5.73 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.533 -0.729 . . . . 0.0 110.156 -179.695 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 50' ' ' ILE . . . . . 0.87 ' CG1' HG22 ' B' ' 42' ' ' VAL . 2.0 pp -86.83 146.63 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.483 -0.761 . . . . 0.0 110.684 -179.765 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . 0.451 ' O ' ' HG3' ' B' ' 51' ' ' LYS . 2.6 ptmt -155.11 128.79 4.5 Favored Pre-proline 0 N--CA 1.496 1.848 0 C-N-CA 119.092 -1.043 . . . . 0.0 110.434 179.044 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 52' ' ' PRO . . . . . 0.694 ' HB3' HG22 ' B' ' 36' ' ' VAL . 57.1 Cg_endo -84.72 140.99 8.41 Favored 'Trans proline' 0 C--N 1.315 -1.205 0 O-C-N 123.352 1.185 . . . . 0.0 110.955 -179.404 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.655 HG22 ' O ' ' B' ' 76' ' ' GLY . 24.8 m -144.61 116.25 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-O 121.767 0.794 . . . . 0.0 111.281 179.18 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . 0.415 ' HA ' ' HA ' ' B' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.496 1.87 0 O-C-N 121.807 -0.558 . . . . 0.0 111.332 -179.231 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . 0.758 HG21 HD21 ' A' ' 92' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.811 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 76' ' ' GLY . . . . . 0.655 ' O ' HG22 ' B' ' 53' ' ' VAL . . . -114.42 68.8 0.25 Allowed Glycine 0 N--CA 1.487 2.098 0 C-N-CA 119.403 -1.38 . . . . 0.0 109.656 -179.382 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.992 HG23 HG21 ' B' ' 36' ' ' VAL . 2.5 p -58.09 76.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.453 -1.027 . . . . 0.0 109.428 179.521 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 78' ' ' SER . . . . . 0.624 ' N ' ' O ' ' B' ' 76' ' ' GLY . 6.5 t -76.95 177.17 7.95 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.897 0.856 . . . . 0.0 110.789 -179.446 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.859 ' CG2' HG22 ' B' ' 50' ' ' ILE . 4.8 p 177.23 177.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 80' ' ' LYS . . . . . 0.699 ' O ' HD23 ' B' ' 48' ' ' LEU . 0.1 OUTLIER -172.48 173.51 1.48 Allowed Pre-proline 0 N--CA 1.485 1.303 0 O-C-N 120.64 -1.288 . . . . 0.0 110.642 178.131 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 81' ' ' PRO . . . . . 0.603 ' HB2' HG13 ' A' ' 77' ' ' VAL . 53.4 Cg_endo -97.72 133.1 0.32 Allowed 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 122.503 2.136 . . . . 0.0 110.504 178.801 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . 0.518 ' HA3' ' HA ' ' B' ' 47' ' ' PHE . . . -89.76 -164.37 39.98 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 108.41 -1.876 . . . . 0.0 108.41 178.669 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -83.87 -18.25 38.14 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.039 -1.271 . . . . 0.0 110.385 179.805 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 84' ' ' SER . . . . . 0.414 ' HB2' ' HB3' ' B' ' 47' ' ' PHE . 1.1 m -52.44 -38.18 58.59 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.23 -0.918 . . . . 0.0 109.434 179.656 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.931 HD23 ' HA ' ' A' ' 33' ' ' THR . 0.4 OUTLIER -78.71 -33.03 47.11 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.17 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 86' ' ' LYS . . . . . 0.672 ' O ' ' HB3' ' B' ' 89' ' ' ALA . 0.1 OUTLIER -73.04 -45.57 56.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.66 -0.65 . . . . 0.0 110.563 -179.32 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.74 -39.31 93.69 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 178.443 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.752 ' O ' ' HB1' ' A' ' 37' ' ' ALA . . . -66.83 -33.68 76.15 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 176.822 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.946 ' HA ' HD23 ' B' ' 92' ' ' LEU . . . -56.44 -44.83 80.84 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.019 179.17 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -53.81 -32.86 54.18 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 177.114 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -64.71 -35.82 92.38 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 178.447 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 92' ' ' LEU . . . . . 0.946 HD23 ' HA ' ' B' ' 89' ' ' ALA . 0.4 OUTLIER -75.58 12.01 1.14 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.689 -1.477 . . . . 0.0 111.111 -179.768 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 93' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' B' ' 92' ' ' LEU . 0.0 OUTLIER 61.01 40.04 15.72 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -177.639 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . 0.67 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 0.1 OUTLIER -37.79 -38.49 0.29 Allowed 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.167 -179.055 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . 0.413 ' N ' ' CG ' ' B' ' 94' ' ' TYR . 14.6 pt-20 -61.74 -42.93 99.61 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.31 -0.869 . . . . 0.0 109.885 179.77 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -58.96 -33.71 70.96 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.57 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.463 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.775 ' HG3' HG23 ' B' ' 42' ' ' VAL . 1.5 ptm . . . . . 0 N--CA 1.496 1.841 0 CA-C-O 121.297 0.57 . . . . 0.0 110.739 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.411 ' HB3' ' O ' ' A' ' 1' ' ' MET . 34.5 p-10 -175.38 -148.08 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 119.714 -0.795 . . . . 0.0 111.359 178.648 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.418 ' O ' ' CG2' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -53.83 -6.88 0.1 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.178 -0.952 . . . . 0.0 111.091 -179.521 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.627 ' O ' ' CG1' ' A' ' 7' ' ' ILE . 32.9 m -118.49 -64.1 1.33 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.953 -1.092 . . . . 0.0 110.613 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.703 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 5.0 mt-10 -48.79 -40.32 28.58 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.846 -1.159 . . . . 0.0 109.314 -179.706 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.682 HD11 ' CG2' ' B' ' 42' ' ' VAL . 74.0 mt -62.66 -33.88 75.95 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.456 178.19 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.807 ' HA ' HD12 ' A' ' 25' ' ' LEU . 0.9 OUTLIER -58.78 -38.03 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 178.771 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.841 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 31.4 mtmt -68.95 -34.29 75.1 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.17 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.67 ' HB1' HD13 ' B' ' 31' ' ' ILE . . . -54.37 -40.4 68.09 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.286 179.163 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.852 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.4 mp -92.24 -29.23 4.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 178.247 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.841 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -68.07 -9.14 43.86 Favored 'General case' 0 C--N 1.289 -2.033 0 O-C-N 120.579 -1.326 . . . . 0.0 108.723 178.596 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -121.51 -41.46 2.49 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.376 -0.828 . . . . 0.0 110.102 179.202 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.664 ' OD2' HG21 ' B' ' 31' ' ' ILE . 62.8 m-20 -68.62 -24.5 64.57 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 177.471 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 1.094 HG22 ' CD1' ' A' ' 16' ' ' LEU 0.274 0.2 OUTLIER -106.96 -81.85 0.55 Allowed 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 178.752 . . . . . . . . 4 4 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.51 6.43 66.07 Favored Glycine 0 N--CA 1.501 3.02 0 O-C-N 121.07 -1.019 . . . . 0.0 110.61 177.679 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 1.094 ' CD1' HG22 ' A' ' 14' ' ' THR . 5.0 mp -51.81 -70.17 0.09 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.67 -0.9 . . . . 0.0 110.514 179.812 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.536 ' CG2' HG21 ' B' ' 17' ' ' THR . 0.6 OUTLIER -132.82 8.57 4.14 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.825 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.588 ' O ' ' C ' ' A' ' 19' ' ' VAL . 2.3 mt-30 57.04 26.98 12.62 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 -176.179 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 1.104 HG23 ' CD1' ' B' ' 16' ' ' LEU . 0.6 OUTLIER -10.17 -94.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.626 -179.034 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.931 ' O ' ' N ' ' A' ' 23' ' ' LYS . 2.4 m -134.57 23.29 3.69 Favored 'General case' 0 C--N 1.28 -2.425 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 178.181 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.669 ' C ' ' O ' ' A' ' 20' ' ' SER . 31.5 m -18.16 -40.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 CA-C-O 122.418 1.104 . . . . 0.0 109.279 -177.376 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.867 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.4 OUTLIER -86.43 -38.03 17.75 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.088 178.142 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.931 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.9 OUTLIER -85.21 -31.52 23.13 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.535 -0.728 . . . . 0.0 110.895 179.448 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.803 ' HB3' HG23 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -76.46 -43.77 38.5 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 118.217 -1.393 . . . . 0.0 109.315 179.249 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.807 HD12 ' HA ' ' A' ' 7' ' ' ILE . 7.0 mt -68.5 -48.54 64.14 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 117.743 -1.583 . . . . 0.0 108.293 177.888 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.435 ' CB ' ' O ' ' A' ' 22' ' ' SER . . . -55.76 -33.14 64.05 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 177.558 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.532 ' O ' ' CG1' ' A' ' 31' ' ' ILE . 7.5 t -73.34 -36.81 66.24 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 177.488 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.744 ' HA ' ' CG1' ' A' ' 31' ' ' ILE . 0.1 OUTLIER -64.19 -33.74 76.49 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.535 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.567 ' HG3' ' CD2' ' A' ' 28' ' ' PHE . 2.1 mt-10 -83.1 -31.44 27.27 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.175 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.762 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 6.7 tttm -72.12 -27.62 62.74 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 176.588 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.744 ' CG1' ' HA ' ' A' ' 28' ' ' PHE . 1.8 pp -95.99 -31.71 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.35 -0.844 . . . . 0.0 109.751 179.009 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.762 HG21 ' CE1' ' B' ' 47' ' ' PHE . 2.6 mm -63.28 -52.89 52.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.829 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.583 HG23 ' HB2' ' B' ' 88' ' ' ALA . 0.4 OUTLIER -68.34 -38.82 81.85 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.556 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.762 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 34.0 mm-40 -71.94 -34.3 68.91 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.413 -0.805 . . . . 0.0 110.832 179.169 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.737 HG21 HG13 ' A' ' 42' ' ' VAL . 3.2 m -59.98 -54.16 49.31 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.997 -1.064 . . . . 0.0 108.563 179.894 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.635 HG11 HD22 ' B' ' 85' ' ' LEU . 1.0 OUTLIER -54.04 -35.04 27.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 177.755 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.737 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -78.51 -7.15 57.18 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.736 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.489 ' N ' ' O ' ' A' ' 35' ' ' THR . 1.3 ttmt -102.21 -25.28 13.75 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 178.122 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 35' ' ' THR . . . 104.8 41.83 1.92 Allowed Glycine 0 C--N 1.3 -1.417 0 C-N-CA 120.218 -0.991 . . . . 0.0 110.699 178.067 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.704 ' CB ' HG23 ' A' ' 35' ' ' THR . 0.3 OUTLIER -128.67 154.27 46.45 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.116 -1.226 . . . . 0.0 110.429 179.449 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.421 ' HE3' ' CB ' ' A' ' 51' ' ' LYS . 43.1 tttt -109.01 98.38 7.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.382 -0.824 . . . . 0.0 110.0 -179.738 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.762 HG12 ' HB2' ' B' ' 1' ' ' MET . 19.3 m -84.93 147.41 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.451 -0.781 . . . . 0.0 110.414 -179.602 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.436 ' O ' ' HA ' ' B' ' 2' ' ' ASN . 1.7 tt0 -136.57 107.91 6.86 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 121.296 -0.878 . . . . 0.0 110.134 -179.131 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.712 HD22 ' HE2' ' B' ' 28' ' ' PHE . 20.3 mt -66.64 99.13 0.57 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.039 -1.038 . . . . 0.0 109.875 179.51 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.637 HG21 ' HB3' ' B' ' 29' ' ' GLU . 1.7 t 37.17 26.67 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.782 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . 94.44 -0.24 65.58 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 120.06 -1.067 . . . . 0.0 112.487 177.664 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.881 ' CE1' HG21 ' B' ' 32' ' ' ILE . 0.8 OUTLIER -104.23 -31.38 9.62 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 120.002 1.901 . . . . 0.0 111.96 -179.919 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.832 HD13 HD13 ' B' ' 48' ' ' LEU . 1.0 OUTLIER -123.04 93.82 4.07 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.706 -1.246 . . . . 0.0 109.779 178.115 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -96.08 75.14 3.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.702 -0.624 . . . . 0.0 111.371 -179.114 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.863 HD13 ' HB ' ' A' ' 79' ' ' VAL . 2.6 mm -63.19 129.71 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.202 -0.936 . . . . 0.0 109.031 178.798 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 78' ' ' SER . 0.0 OUTLIER -144.05 127.26 8.81 Favored Pre-proline 0 N--CA 1.492 1.656 0 C-N-CA 118.712 -1.195 . . . . 0.0 109.704 179.491 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.623 ' HB3' HG13 ' A' ' 36' ' ' VAL . 54.3 Cg_endo -76.71 142.13 22.56 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.384 1.202 . . . . 0.0 111.162 -179.277 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 1.055 ' O ' HG22 ' A' ' 75' ' ' VAL . 1.7 t -122.08 -142.84 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.588 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.532 ' HB2' ' O ' ' A' ' 53' ' ' VAL . . . . . . . . 0 N--CA 1.5 2.037 0 O-C-N 121.291 -0.88 . . . . 0.0 110.158 179.693 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 1.055 HG22 ' O ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.497 1.923 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 . . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.618 ' O ' ' N ' ' A' ' 78' ' ' SER . . . -110.91 38.67 3.19 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 118.569 -1.777 . . . . 0.0 110.226 -178.765 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.734 ' CG2' HD22 ' B' ' 85' ' ' LEU . 3.0 p -27.78 87.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 CA-C-O 121.924 0.868 . . . . 0.0 110.58 179.781 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.618 ' N ' ' O ' ' A' ' 76' ' ' GLY . 0.1 OUTLIER -87.81 175.52 7.8 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.963 -179.168 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.863 ' HB ' HD13 ' A' ' 50' ' ' ILE . 7.2 p 175.57 177.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.845 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.671 ' O ' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -177.15 171.71 0.89 Allowed Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.001 -1.062 . . . . 0.0 110.185 176.948 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.603 ' HB2' HG13 ' B' ' 77' ' ' VAL . 54.7 Cg_endo -96.91 128.8 0.3 Allowed 'Trans proline' 0 C--N 1.302 -1.894 0 C-N-CA 122.414 2.076 . . . . 0.0 110.691 178.639 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.494 ' HA3' ' HA ' ' A' ' 47' ' ' PHE . . . -87.75 173.18 43.28 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 178.749 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -62.19 -17.92 59.52 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.086 -1.244 . . . . 0.0 110.591 -179.846 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.526 ' HB2' ' HB3' ' A' ' 47' ' ' PHE . 0.8 OUTLIER -53.74 -41.15 66.77 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.177 -0.952 . . . . 0.0 109.506 179.802 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.924 ' CB ' HG21 ' B' ' 77' ' ' VAL . 1.0 OUTLIER -76.76 -26.79 54.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.448 -0.783 . . . . 0.0 109.116 179.111 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.669 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 0.7 OUTLIER -81.03 -41.27 22.93 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.665 -0.647 . . . . 0.0 110.63 -179.522 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.67 -40.92 98.02 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 178.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.736 ' O ' ' HB1' ' B' ' 37' ' ' ALA . . . -65.29 -37.39 87.02 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 176.3 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 1.091 ' HB1' HG11 ' B' ' 75' ' ' VAL . . . -56.66 -40.33 75.31 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.467 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.412 ' HG2' ' N ' ' A' ' 91' ' ' GLY . 1.1 pt-20 -55.5 -31.75 62.3 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 177.096 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.412 ' N ' ' HG2' ' A' ' 90' ' ' GLU . . . -68.56 -34.04 77.97 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 178.643 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.835 ' O ' HD12 ' A' ' 92' ' ' LEU . 0.6 OUTLIER -66.27 5.84 0.49 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.648 -1.501 . . . . 0.0 111.305 -179.806 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.423 ' CB ' ' O ' ' A' ' 92' ' ' LEU . 0.4 OUTLIER 65.36 39.49 5.23 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 -177.388 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.525 ' HA ' HD11 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -43.54 -31.49 0.74 Allowed 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.154 -179.079 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 . . . . . 0 N--CA 1.494 1.741 0 O-C-N 121.279 -0.888 . . . . 0.0 108.944 179.151 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.762 ' HB2' HG12 ' A' ' 42' ' ' VAL . 2.5 mtp . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 2' ' ' ASN . . . . . 0.44 ' H ' ' HB2' ' B' ' 5' ' ' GLU . 17.5 p30 -173.43 -153.91 0.06 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.002 -1.061 . . . . 0.0 111.693 179.705 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.465 ' HG3' ' HB ' ' A' ' 45' ' ' THR . 0.1 OUTLIER -56.52 -0.55 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.515 -0.741 . . . . 0.0 111.562 -179.229 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . 0.72 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 61.3 m -125.52 -45.68 1.78 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.779 -1.201 . . . . 0.0 110.363 179.738 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.54 ' CB ' ' HA ' ' B' ' 1' ' ' MET . 3.3 mt-10 -65.99 -51.45 58.23 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.051 -1.031 . . . . 0.0 108.682 179.673 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.778 ' O ' ' HB3' ' B' ' 9' ' ' ALA . 17.9 mt -58.02 -32.62 68.12 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.161 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 7' ' ' ILE . . . . . 0.845 HG23 ' HB ' ' B' ' 21' ' ' VAL . 1.3 mt -53.63 -55.35 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 177.591 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . 0.965 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.6 OUTLIER -57.11 -31.98 65.84 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 177.829 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . 0.778 ' HB3' ' O ' ' B' ' 6' ' ' LEU . . . -54.52 -38.42 66.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.271 -0.893 . . . . 0.0 108.971 178.677 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.803 HG23 ' HB3' ' A' ' 24' ' ' MET . 1.6 mp -90.83 -34.34 6.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 178.121 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.965 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -67.28 -12.62 60.6 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 119.139 -1.024 . . . . 0.0 109.011 178.686 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.491 ' N ' ' O ' ' B' ' 8' ' ' LYS . 1.1 pp0? -113.7 -36.0 5.0 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.339 -0.851 . . . . 0.0 109.416 178.496 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.435 ' OD2' HG21 ' A' ' 31' ' ' ILE . 56.0 m-20 -72.15 -21.54 61.44 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 176.784 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.837 HG21 ' HB2' ' A' ' 20' ' ' SER . 0.2 OUTLIER -117.24 -77.94 0.57 Allowed 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.462 179.648 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . 0.46 ' O ' ' C ' ' B' ' 16' ' ' LEU . . . 64.99 -13.1 0.21 Allowed Glycine 0 N--CA 1.5 2.908 0 N-CA-C 110.499 -1.041 . . . . 0.0 110.499 179.065 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 16' ' ' LEU . . . . . 1.104 ' CD1' HG23 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -35.05 -59.43 0.5 Allowed 'General case' 0 N--CA 1.513 2.677 0 CA-C-O 122.06 0.934 . . . . 0.0 110.678 -179.695 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . 0.641 HG22 ' H ' ' B' ' 19' ' ' VAL . 0.5 OUTLIER -136.38 -1.17 2.36 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.543 -179.291 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . 0.627 ' O ' ' C ' ' B' ' 19' ' ' VAL . 5.1 mt-30 54.83 31.79 16.37 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 -176.815 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 1.005 HG11 HG11 ' A' ' 19' ' ' VAL . 0.9 OUTLIER -6.79 -93.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.01 -178.835 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 1.06 ' O ' ' N ' ' B' ' 22' ' ' SER . 0.3 OUTLIER -133.16 24.77 4.2 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 178.116 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.918 HG11 ' HB2' ' B' ' 11' ' ' ALA . 0.0 OUTLIER -8.85 -39.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-O 122.362 1.077 . . . . 0.0 110.288 -178.252 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 1.06 ' N ' ' O ' ' B' ' 20' ' ' SER . 5.9 m -85.05 -43.09 14.23 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.483 178.244 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . 0.885 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.2 OUTLIER -81.94 -25.3 35.0 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.286 -0.884 . . . . 0.0 111.004 179.927 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 24' ' ' MET . . . . . 0.695 ' HB3' HG21 ' A' ' 14' ' ' THR . 0.0 OUTLIER -82.94 -45.92 13.57 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 118.357 -1.337 . . . . 0.0 110.063 179.399 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.644 HD23 ' HE3' ' B' ' 24' ' ' MET . 0.4 OUTLIER -69.05 -48.22 63.4 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 117.53 -1.668 . . . . 0.0 108.104 178.272 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . 0.46 ' HA ' ' HE2' ' B' ' 3' ' ' LYS . . . -54.84 -34.09 62.48 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 177.698 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 27' ' ' SER . . . . . 0.737 ' O ' HG23 ' B' ' 31' ' ' ILE . 3.7 t -72.55 -39.45 67.47 Favored 'General case' 0 C--O 1.204 -1.311 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.681 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . 0.732 ' HA ' ' CG1' ' B' ' 31' ' ' ILE . 0.1 OUTLIER -62.96 -37.68 88.05 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.688 0.756 . . . . 0.0 109.287 179.357 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . 0.637 ' HB3' HG21 ' A' ' 45' ' ' THR . 0.9 OUTLIER -81.9 -31.18 31.56 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 178.656 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 0.815 ' O ' ' CG ' ' B' ' 34' ' ' GLU . 9.7 ttmt -71.99 -30.19 64.99 Favored 'General case' 0 C--O 1.19 -2.03 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 176.277 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.737 HG23 ' O ' ' B' ' 27' ' ' SER . 1.3 pp -91.19 -30.28 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.21 -0.931 . . . . 0.0 109.606 179.167 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.881 HG21 ' CE1' ' A' ' 47' ' ' PHE . 5.2 mm -62.57 -51.68 69.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 177.495 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 33' ' ' THR . . . . . 0.834 ' HA ' HD23 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -75.69 -25.66 56.9 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 114.904 -1.043 . . . . 0.0 108.966 179.74 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.815 ' CG ' ' O ' ' B' ' 30' ' ' LYS . 5.6 mm-40 -81.84 -35.75 29.04 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.078 -1.014 . . . . 0.0 109.394 178.674 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 35' ' ' THR . . . . . 0.613 HG23 ' HB2' ' B' ' 40' ' ' ASP . 52.0 m -62.55 -54.34 41.18 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 178.232 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.805 HG22 ' O ' ' B' ' 32' ' ' ILE . 2.2 m -50.17 -34.39 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 177.146 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . 0.736 ' HB1' ' O ' ' A' ' 88' ' ' ALA . . . -90.58 -4.13 57.08 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 121.57 0.7 . . . . 0.0 110.352 178.318 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.658 ' N ' ' O ' ' B' ' 34' ' ' GLU . 0.0 OUTLIER -97.93 -24.5 15.36 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 177.731 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 111.81 43.87 0.92 Allowed Glycine 0 C--N 1.301 -1.383 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 178.089 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . 0.613 ' HB2' HG23 ' B' ' 35' ' ' THR . 0.1 OUTLIER -145.82 136.64 24.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.202 -1.175 . . . . 0.0 110.565 179.684 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 10.9 mtmt -89.68 88.28 7.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.477 -0.764 . . . . 0.0 109.901 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.775 HG23 ' HG3' ' A' ' 1' ' ' MET . 7.6 p -62.1 142.19 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.486 -0.759 . . . . 0.0 110.128 -179.808 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 43' ' ' GLN . . . . . 0.438 ' HA ' ' O ' ' B' ' 48' ' ' LEU . 6.2 mt-30 -134.31 110.92 9.81 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.448 -0.782 . . . . 0.0 110.548 -179.361 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.65 HD22 ' HE2' ' A' ' 28' ' ' PHE . 17.0 mt -66.64 118.63 10.48 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.253 -0.904 . . . . 0.0 109.533 179.323 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . 0.547 HG21 ' HB3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 29.06 -89.34 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.823 -0.548 . . . . 0.0 111.228 -179.975 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -149.58 26.85 1.2 Allowed Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 179.623 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . 0.762 ' CE1' HG21 ' A' ' 32' ' ' ILE . 7.7 p90 -125.45 -24.44 3.91 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.951 -1.323 . . . . 0.0 112.011 179.736 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.832 HD13 HD13 ' A' ' 48' ' ' LEU . 1.6 mt -128.07 108.47 10.68 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.404 -1.435 . . . . 0.0 110.82 178.814 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -106.19 69.83 0.82 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.574 -0.704 . . . . 0.0 110.989 -179.643 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 50' ' ' ILE . . . . . 0.912 HD13 ' HB ' ' B' ' 79' ' ' VAL . 1.9 mm -60.1 125.6 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.302 -0.874 . . . . 0.0 109.281 179.142 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . 0.461 ' HG3' ' HB2' ' B' ' 78' ' ' SER . 9.1 ptmt -149.71 122.63 4.37 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 120.665 -1.272 . . . . 0.0 111.252 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 52' ' ' PRO . . . . . 0.613 ' HA ' ' HA ' ' B' ' 77' ' ' VAL . 55.4 Cg_endo -79.8 144.49 17.32 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 O-C-N 123.61 1.321 . . . . 0.0 110.964 179.78 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.705 HG22 ' O ' ' B' ' 76' ' ' GLY . 32.6 m -138.92 114.3 8.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-O 121.833 0.825 . . . . 0.0 110.753 179.282 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . 0.563 ' HA ' ' HA ' ' B' ' 75' ' ' VAL . . . . . . . . 0 N--CA 1.493 1.701 0 O-C-N 121.581 -0.699 . . . . 0.0 111.173 -179.022 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . 1.091 HG11 ' HB1' ' A' ' 89' ' ' ALA . 8.6 p . . . . . 0 N--CA 1.493 1.716 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 76' ' ' GLY . . . . . 0.705 ' O ' HG22 ' B' ' 53' ' ' VAL . . . -120.24 96.72 0.63 Allowed Glycine 0 N--CA 1.49 2.244 0 C-N-CA 119.295 -1.431 . . . . 0.0 110.239 -179.143 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.924 HG21 ' CB ' ' A' ' 85' ' ' LEU . 6.4 p -69.39 68.61 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.575 -0.956 . . . . 0.0 109.075 179.04 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 78' ' ' SER . . . . . 0.461 ' HB2' ' HG3' ' B' ' 51' ' ' LYS . 1.6 m -65.65 177.18 1.28 Allowed 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.894 0.854 . . . . 0.0 110.732 -179.178 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.912 ' HB ' HD13 ' B' ' 50' ' ' ILE . 7.3 p 177.24 177.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -179.84 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 80' ' ' LYS . . . . . 0.68 ' O ' HD23 ' B' ' 48' ' ' LEU . 0.6 OUTLIER -177.47 172.62 0.76 Allowed Pre-proline 0 N--CA 1.487 1.423 0 O-C-N 120.852 -1.155 . . . . 0.0 110.769 177.651 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 81' ' ' PRO . . . . . 0.524 ' HA ' ' O ' ' B' ' 47' ' ' PHE . 53.4 Cg_endo -92.76 128.25 0.79 Allowed 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.441 2.094 . . . . 0.0 110.61 178.527 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . 0.473 ' H ' ' HA ' ' B' ' 47' ' ' PHE . . . -91.67 178.93 41.37 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 108.634 -1.787 . . . . 0.0 108.634 179.152 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . 0.469 ' HA ' ' HB2' ' B' ' 86' ' ' LYS . 4.0 pt-20 -69.61 -28.31 65.82 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.115 -1.227 . . . . 0.0 110.498 -179.828 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -48.71 -32.17 8.03 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.841 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.734 HD22 ' CG2' ' A' ' 77' ' ' VAL . 0.5 OUTLIER -83.4 -38.23 22.22 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.211 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 86' ' ' LYS . . . . . 0.758 ' O ' ' HB3' ' B' ' 89' ' ' ALA . 0.1 OUTLIER -70.12 -36.39 74.79 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.447 -0.783 . . . . 0.0 109.125 179.575 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 13.0 ttpt -64.97 -42.03 94.94 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 178.029 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.591 ' HB1' ' HB2' ' A' ' 37' ' ' ALA . . . -63.72 -34.86 78.82 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 176.233 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.982 ' HA ' HD23 ' B' ' 92' ' ' LEU . . . -54.47 -43.99 72.21 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.616 -0.834 . . . . 0.0 109.275 178.743 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -53.35 -32.7 50.47 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 177.104 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' B' ' 88' ' ' ALA . . . -60.88 -42.3 99.57 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 178.138 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 92' ' ' LEU . . . . . 0.982 HD23 ' HA ' ' B' ' 89' ' ' ALA . 0.4 OUTLIER -75.39 17.79 0.25 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.665 -1.491 . . . . 0.0 110.502 179.682 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 93' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' B' ' 92' ' ' LEU . 0.0 OUTLIER 58.17 44.74 18.56 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -177.539 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . 0.693 ' HD1' HG23 ' A' ' 75' ' ' VAL . 0.1 OUTLIER -36.71 -35.62 0.09 Allowed 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.68 -179.16 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . 0.425 ' HG3' ' N ' ' B' ' 96' ' ' ASP . 0.0 OUTLIER -64.77 -44.0 91.42 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.382 -0.824 . . . . 0.0 109.382 179.887 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 96' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' B' ' 93' ' ' LYS . 25.8 m-20 -56.39 -34.52 66.78 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.572 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.439 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.81 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.645 ' HB2' HG12 ' B' ' 42' ' ' VAL . 11.1 mtp . . . . . 0 N--CA 1.493 1.706 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.499 ' HA ' ' O ' ' B' ' 43' ' ' GLN . 43.7 p-10 -168.5 -159.03 0.25 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.83 -1.169 . . . . 0.0 112.36 -179.891 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.507 ' HE2' ' HB2' ' A' ' 29' ' ' GLU . 5.6 tttm -50.92 -10.09 0.06 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.547 -0.721 . . . . 0.0 111.305 -179.388 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.692 ' O ' HG13 ' A' ' 7' ' ' ILE . 1.3 m -120.12 -57.88 1.91 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.978 -1.076 . . . . 0.0 109.558 179.208 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.564 ' CB ' ' HA ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -48.11 -40.86 24.77 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.402 -0.811 . . . . 0.0 109.154 179.576 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.581 ' HG ' ' HB3' ' A' ' 1' ' ' MET . 5.6 mt -68.83 -29.65 68.02 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.301 -0.96 . . . . 0.0 110.169 178.583 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.729 ' HA ' HD12 ' A' ' 25' ' ' LEU . 1.2 pp -59.99 -46.8 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.667 -1.271 . . . . 0.0 108.263 179.73 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.94 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 18.4 pttt -72.43 -24.8 61.28 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.2 -1.0 . . . . 0.0 108.678 177.514 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 6' ' ' LEU . . . -58.45 -39.26 79.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.264 -0.898 . . . . 0.0 109.04 178.774 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.802 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.9 OUTLIER -92.28 -32.79 5.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 177.863 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.94 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -60.61 -14.29 19.39 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 118.856 -1.138 . . . . 0.0 108.966 178.129 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -112.87 -44.01 3.35 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.271 -0.893 . . . . 0.0 109.656 179.071 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.43 ' HB3' ' HB2' ' B' ' 27' ' ' SER . 0.7 OUTLIER -65.79 -39.03 90.54 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.569 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 1.14 HG22 ' CD1' ' A' ' 16' ' ' LEU 0.251 0.2 OUTLIER -91.87 -70.07 0.71 Allowed 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 177.693 . . . . . . . . 4 4 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.467 ' HA2' ' O ' ' A' ' 11' ' ' ALA . . . 58.23 18.9 37.11 Favored Glycine 0 N--CA 1.499 2.853 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 177.236 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 1.14 ' CD1' HG22 ' A' ' 14' ' ' THR . 3.3 mp -62.74 -63.83 1.1 Allowed 'General case' 0 C--N 1.293 -1.853 0 O-C-N 121.48 -1.012 . . . . 0.0 109.937 179.308 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.6 HG21 ' CG2' ' B' ' 17' ' ' THR . 0.6 OUTLIER -138.13 7.63 2.67 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.445 -179.681 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.54 ' O ' ' C ' ' A' ' 19' ' ' VAL . 28.4 mt-30 58.14 26.5 13.79 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 -176.219 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.976 HG11 HG11 ' B' ' 19' ' ' VAL . 2.7 p -13.88 -96.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.121 -178.708 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.959 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -129.72 23.38 5.41 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 105.966 -1.865 . . . . 0.0 105.966 178.402 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.739 HG12 HG22 ' A' ' 10' ' ' ILE . 30.0 m -24.6 -39.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 CA-C-O 122.481 1.134 . . . . 0.0 109.156 -178.868 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.706 ' N ' ' O ' ' A' ' 20' ' ' SER . 48.2 t -82.66 -35.27 27.04 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.246 177.92 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.959 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.6 OUTLIER -86.84 -36.56 18.41 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.684 -0.635 . . . . 0.0 111.347 179.521 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.654 ' CE ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -70.06 -39.4 75.7 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.28 -1.513 . . . . 0.0 109.039 179.433 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.729 HD12 ' HA ' ' A' ' 7' ' ' ILE . 9.0 mt -77.82 -44.54 27.11 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 118.167 -1.413 . . . . 0.0 109.413 178.638 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.48 ' CB ' ' O ' ' A' ' 22' ' ' SER . . . -58.01 -32.8 68.27 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.955 -1.09 . . . . 0.0 108.121 178.025 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.58 ' O ' ' N ' ' A' ' 31' ' ' ILE . 25.8 p -85.27 -31.42 23.11 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.378 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.894 ' HB2' HD11 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -56.13 -34.67 66.3 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.572 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.781 ' HG2' HG22 ' B' ' 45' ' ' THR . 0.8 OUTLIER -79.74 -39.31 31.38 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.378 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.81 ' O ' ' CG ' ' A' ' 34' ' ' GLU . 39.7 ttmt -65.92 -28.08 68.66 Favored 'General case' 0 C--O 1.192 -1.965 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.478 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.749 ' CD1' HD23 ' B' ' 6' ' ' LEU . 2.1 pp -93.2 -37.97 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.911 . . . . 0.0 108.939 179.103 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.749 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.1 mm -58.71 -53.52 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 177.651 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.716 ' OG1' ' HB2' ' B' ' 85' ' ' LEU . 0.3 OUTLIER -69.92 -27.35 64.71 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.654 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.81 ' CG ' ' O ' ' A' ' 30' ' ' LYS . 16.9 mm-40 -76.67 -45.03 31.4 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.0 -1.062 . . . . 0.0 110.685 178.973 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.477 ' C ' ' H ' ' A' ' 38' ' ' LYS . 96.4 m -61.58 -53.43 56.36 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 120.651 -1.281 . . . . 0.0 108.859 179.445 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.952 ' CG2' HD13 ' B' ' 85' ' ' LEU . 15.7 m -50.11 -35.34 11.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 177.25 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.755 ' HB1' ' O ' ' B' ' 88' ' ' ALA . . . -92.01 1.18 57.36 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-O 121.582 0.706 . . . . 0.0 110.32 178.484 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.595 ' N ' ' O ' ' A' ' 34' ' ' GLU . 8.8 ttmt -101.53 -32.93 10.14 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 177.784 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 132.98 35.87 0.29 Allowed Glycine 0 C--N 1.305 -1.173 0 C-N-CA 119.637 -1.268 . . . . 0.0 111.565 177.738 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.467 ' CB ' ' CG2' ' A' ' 35' ' ' THR . 0.2 OUTLIER -145.97 -174.02 4.32 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.824 -1.398 . . . . 0.0 111.39 179.467 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.4 ' HG2' ' CB ' ' A' ' 51' ' ' LYS . 0.5 OUTLIER -134.57 127.67 31.73 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.831 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.693 HG22 HD11 ' B' ' 6' ' ' LEU . 1.1 t -85.96 115.38 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.201 -0.937 . . . . 0.0 110.713 -178.794 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.442 ' O ' ' HA ' ' B' ' 2' ' ' ASN . 4.8 mt-30 -105.54 100.43 10.0 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.951 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.918 HD22 ' HD2' ' B' ' 3' ' ' LYS . 47.8 mt -71.9 115.44 11.12 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.219 -0.926 . . . . 0.0 110.704 -178.933 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.536 ' C ' ' O ' ' A' ' 44' ' ' LEU . 2.1 t 28.43 -117.17 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.717 -0.615 . . . . 0.0 110.516 178.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -127.08 32.32 3.63 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 109.071 -1.611 . . . . 0.0 109.071 179.024 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.709 ' HE1' ' HB3' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -131.08 -28.0 1.98 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.14 -1.212 . . . . 0.0 111.921 -179.836 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.927 HD21 HD11 ' B' ' 50' ' ' ILE . 6.3 mt -128.03 128.9 45.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 119.852 -1.78 . . . . 0.0 110.602 176.796 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.514 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 7.4 m-80 -129.81 111.47 12.64 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.533 -0.729 . . . . 0.0 110.399 -178.876 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.837 HG22 HG12 ' A' ' 79' ' ' VAL . 1.2 pp -111.9 149.18 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.581 -0.699 . . . . 0.0 110.348 179.947 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.402 ' HG3' ' HB3' ' A' ' 78' ' ' SER . 0.0 OUTLIER -165.58 117.68 0.87 Allowed Pre-proline 0 N--CA 1.497 1.918 0 O-C-N 120.696 -1.253 . . . . 0.0 110.933 -179.78 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.545 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 53.0 Cg_endo -82.33 149.59 15.07 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 O-C-N 123.667 1.351 . . . . 0.0 111.212 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.772 ' O ' HG23 ' A' ' 75' ' ' VAL . 10.8 m -132.48 -149.95 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 O-C-N 121.521 -0.737 . . . . 0.0 110.345 179.542 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.805 ' HB2' ' HB3' ' B' ' 97' ' ' PHE . . . . . . . . 0 C--N 1.296 -1.758 0 O-C-N 121.1 -1.0 . . . . 0.0 111.266 -179.132 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 1.038 HG11 ' CB ' ' B' ' 89' ' ' ALA . 14.6 p . . . . . 0 N--CA 1.501 2.081 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.698 ' HA3' HG22 ' A' ' 53' ' ' VAL . . . -110.13 87.02 0.46 Allowed Glycine 0 N--CA 1.487 2.037 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 179.356 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.737 HG21 ' HG ' ' B' ' 85' ' ' LEU . 84.1 t -65.2 75.49 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 O-C-N 121.918 -0.754 . . . . 0.0 110.753 -179.247 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.856 ' O ' HG13 ' A' ' 79' ' ' VAL . 0.5 OUTLIER -65.83 178.77 0.99 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.323 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.856 HG13 ' O ' ' A' ' 78' ' ' SER . 0.0 OUTLIER 179.7 178.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.924 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.511 ' O ' HD23 ' A' ' 48' ' ' LEU . 11.1 mttt 179.14 169.79 0.57 Allowed Pre-proline 0 C--N 1.307 -1.28 0 O-C-N 121.384 -0.822 . . . . 0.0 110.46 177.13 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.591 ' HB2' HG13 ' B' ' 77' ' ' VAL . 57.4 Cg_endo -109.39 161.15 0.08 OUTLIER 'Trans proline' 0 C--N 1.301 -1.959 0 C-N-CA 123.413 2.742 . . . . 0.0 110.605 177.798 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 47' ' ' PHE . . . -105.57 -150.79 19.55 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 107.604 -2.198 . . . . 0.0 107.604 177.093 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -100.46 -13.1 18.84 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.88 -1.365 . . . . 0.0 110.125 178.885 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.411 ' HB3' ' HB2' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -58.02 -38.09 75.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.335 -0.853 . . . . 0.0 109.075 179.664 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.923 ' CB ' HG21 ' B' ' 77' ' ' VAL . 0.5 OUTLIER -77.42 -38.16 50.23 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.692 -0.63 . . . . 0.0 109.539 179.239 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.527 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -69.14 -41.5 77.22 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.799 -0.761 . . . . 0.0 110.779 -178.923 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -64.93 -40.24 94.74 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 178.942 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.661 ' O ' ' HB1' ' B' ' 37' ' ' ALA . . . -72.79 -30.78 64.37 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 177.02 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.878 ' HA ' HD23 ' A' ' 92' ' ' LEU . . . -64.68 -39.08 93.05 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.304 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -56.98 -33.15 66.8 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 176.935 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -74.07 -20.79 79.66 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 178.745 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.929 ' O ' HD12 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -76.82 16.07 0.57 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.681 -1.482 . . . . 0.0 111.268 -179.757 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.419 ' CB ' ' O ' ' A' ' 92' ' ' LEU . 0.0 OUTLIER 65.19 34.94 8.15 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -177.728 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.545 ' CD1' ' HB ' ' B' ' 75' ' ' VAL . 0.0 OUTLIER -49.31 -27.75 4.18 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.486 -179.578 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.362 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.489 ' HG2' ' HB3' ' B' ' 5' ' ' GLU . 3.0 mtp . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.193 0.52 . . . . 0.0 110.211 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 2' ' ' ASN . . . . . 0.81 ' C ' HD12 ' B' ' 6' ' ' LEU . 23.3 t-20 -173.06 165.99 4.98 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.374 -0.829 . . . . 0.0 109.783 -179.816 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.918 ' HD2' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -47.36 -26.15 1.21 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.983 -1.073 . . . . 0.0 109.202 179.307 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . 0.655 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 16.7 m -79.28 -56.19 4.53 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 177.342 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.489 ' HB3' ' HG2' ' B' ' 1' ' ' MET . 0.5 OUTLIER -57.95 -50.46 73.29 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 177.42 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.81 HD12 ' C ' ' B' ' 2' ' ' ASN . 1.8 mt -61.15 -28.05 68.83 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 177.302 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 7' ' ' ILE . . . . . 1.025 ' CD1' HD23 ' B' ' 25' ' ' LEU . 0.1 OUTLIER -53.68 -54.28 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.278 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . 0.831 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.1 OUTLIER -62.97 -32.91 74.34 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.234 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' B' ' 6' ' ' LEU . . . -62.68 -29.38 70.61 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.375 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.894 HD11 ' HB2' ' A' ' 28' ' ' PHE . 0.6 OUTLIER -93.19 -35.58 6.7 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.627 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 178.109 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.831 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -63.75 -29.11 70.36 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.849 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.469 ' N ' ' O ' ' B' ' 8' ' ' LYS . 1.1 tt0 -89.85 -39.06 13.31 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.027 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.451 ' HB2' ' HA ' ' B' ' 10' ' ' ILE . 43.2 m-20 -67.41 -25.51 65.97 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 176.755 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.915 HG22 ' HB2' ' A' ' 20' ' ' SER . 24.7 p -88.73 -76.35 0.4 Allowed 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.756 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 60.45 12.53 26.08 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.604 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 16' ' ' LEU . . . . . 0.914 HD22 ' O ' ' A' ' 19' ' ' VAL . 3.4 mp -82.98 -60.66 2.09 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.43 -1.041 . . . . 0.0 108.708 179.092 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . 0.615 HG22 ' H ' ' B' ' 19' ' ' VAL . 0.5 OUTLIER -146.14 3.9 0.93 Allowed 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.816 -179.665 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 18' ' ' GLN . . . . . 0.677 ' O ' ' C ' ' B' ' 19' ' ' VAL . 8.3 mt-30 57.09 28.03 14.3 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 -176.367 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.976 HG11 HG11 ' A' ' 19' ' ' VAL . 1.0 OUTLIER 5.73 -97.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.917 -179.516 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 1.033 ' O ' ' N ' ' B' ' 22' ' ' SER . 96.4 p -133.47 23.85 4.06 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 175.833 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.662 ' O ' HD11 ' B' ' 7' ' ' ILE . 30.8 m -9.1 -41.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 CA-C-O 122.289 1.042 . . . . 0.0 109.885 -177.593 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 1.033 ' N ' ' O ' ' B' ' 20' ' ' SER . 15.3 p -67.81 -46.46 71.81 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.944 177.285 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . 0.902 ' N ' ' O ' ' B' ' 20' ' ' SER . 32.6 mtmt -91.72 -23.85 19.65 Favored 'General case' 0 C--N 1.307 -1.258 0 O-C-N 121.543 -0.723 . . . . 0.0 109.338 178.498 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 24' ' ' MET . . . . . 0.609 ' HE2' ' HA ' ' B' ' 21' ' ' VAL . 2.1 tmm? -63.46 -24.75 67.96 Favored 'General case' 0 C--O 1.216 -0.701 0 O-C-N 120.459 -1.401 . . . . 0.0 107.625 178.207 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 1.025 HD23 ' CD1' ' B' ' 7' ' ' ILE . 0.1 OUTLIER -89.27 -46.4 8.79 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 176.61 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . 0.531 ' HB3' ' HA ' ' B' ' 23' ' ' LYS . . . -58.96 -28.19 66.06 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.25 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 27' ' ' SER . . . . . 0.774 ' O ' HG23 ' B' ' 31' ' ' ILE . 23.8 p -86.61 -31.82 20.94 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.082 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 28' ' ' PHE . . . . . 0.897 ' O ' HG13 ' B' ' 31' ' ' ILE . 0.7 OUTLIER -57.69 -42.27 83.35 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.08 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 29' ' ' GLU . . . . . 0.7 ' O ' ' HB ' ' B' ' 33' ' ' THR . 2.3 tt0 -70.78 -43.27 69.07 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 177.35 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 1.296 ' O ' ' HB3' ' B' ' 34' ' ' GLU . 25.5 ttpt -60.57 -21.34 62.49 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.873 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.919 ' HA ' ' HG2' ' B' ' 34' ' ' GLU . 1.3 pp -102.71 -33.7 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 119.361 -0.936 . . . . 0.0 110.209 179.58 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.681 HG13 ' CD1' ' B' ' 28' ' ' PHE . 1.0 OUTLIER -71.88 -43.76 68.33 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 176.791 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 33' ' ' THR . . . . . 0.7 ' HB ' ' O ' ' B' ' 29' ' ' GLU . 0.3 OUTLIER -77.02 -26.22 53.52 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 177.277 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 1.296 ' HB3' ' O ' ' B' ' 30' ' ' LYS . 0.0 OUTLIER -64.54 -43.94 92.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.097 -1.002 . . . . 0.0 109.961 178.3 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 35' ' ' THR . . . . . 0.778 HG21 HG13 ' B' ' 42' ' ' VAL . 47.9 m -67.33 -56.08 11.23 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 118.911 -1.115 . . . . 0.0 109.255 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.672 ' CG2' ' HA ' ' B' ' 33' ' ' THR . 19.6 m -50.22 -33.92 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 118.164 -1.414 . . . . 0.0 108.217 178.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . 0.661 ' HB1' ' O ' ' A' ' 88' ' ' ALA . . . -93.3 0.5 57.0 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.242 0.544 . . . . 0.0 110.492 178.84 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.745 ' HB2' ' O ' ' B' ' 34' ' ' GLU . 9.7 tppt? -103.89 -16.74 15.28 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 106.673 -1.602 . . . . 0.0 106.673 177.132 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.89 50.07 1.3 Allowed Glycine 0 C--N 1.304 -1.216 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 178.21 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . 0.664 ' O ' HG22 ' B' ' 35' ' ' THR . 0.3 OUTLIER -148.94 141.01 23.86 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.057 -1.26 . . . . 0.0 110.775 179.43 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -90.57 92.89 9.05 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.621 -0.674 . . . . 0.0 109.24 179.866 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.824 HG22 HG22 ' B' ' 50' ' ' ILE . 24.1 m -59.28 137.95 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 C-N-CA 119.814 -0.755 . . . . 0.0 110.001 -179.608 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 43' ' ' GLN . . . . . 0.499 ' O ' ' HA ' ' A' ' 2' ' ' ASN . 1.6 mt-30 -118.51 173.43 6.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.345 -0.847 . . . . 0.0 110.149 -179.318 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.76 HD22 ' HE2' ' A' ' 28' ' ' PHE . 36.1 mt -141.31 -177.67 5.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.383 -0.823 . . . . 0.0 110.794 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . 0.781 HG22 ' HG2' ' A' ' 29' ' ' GLU . 2.4 t -51.58 69.02 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 120.878 0.371 . . . . 0.0 111.765 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . 0.656 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . 41.57 29.63 0.48 Allowed Glycine 0 N--CA 1.5 2.914 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 179.352 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . 0.708 ' CE1' HD13 ' B' ' 44' ' ' LEU . 0.5 OUTLIER -123.72 -27.79 3.94 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.166 -1.197 . . . . 0.0 110.656 -179.755 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.716 HD12 ' H ' ' B' ' 49' ' ' ASN . 11.1 tp -168.73 150.0 4.7 Favored 'General case' 0 C--N 1.293 -1.854 0 C-N-CA 118.069 -1.452 . . . . 0.0 111.322 -179.839 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 49' ' ' ASN . . . . . 0.716 ' H ' HD12 ' B' ' 48' ' ' LEU . 17.2 m-80 -148.35 -178.95 6.6 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.96 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 50' ' ' ILE . . . . . 0.927 HD11 HD21 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -142.8 167.17 14.7 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 O-C-N 121.411 -0.806 . . . . 0.0 110.382 179.716 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 51' ' ' LYS . . . . . 0.462 ' HD3' ' O ' ' B' ' 51' ' ' LYS . 0.0 OUTLIER -170.88 130.13 0.79 Allowed Pre-proline 0 N--CA 1.494 1.771 0 C-N-CA 119.259 -0.977 . . . . 0.0 110.605 179.333 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 52' ' ' PRO . . . . . 0.576 ' HA ' ' HA ' ' B' ' 77' ' ' VAL . 57.7 Cg_endo -90.39 143.22 3.73 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.67 1.353 . . . . 0.0 110.741 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.65 HG22 ' CA ' ' B' ' 76' ' ' GLY . 16.5 m -126.6 -152.54 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 C-N-CA 119.841 -0.744 . . . . 0.0 110.229 178.945 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' B' ' 75' ' ' VAL . . . . . . . . 0 C--N 1.291 -1.969 0 O-C-N 121.292 -0.88 . . . . 0.0 110.506 -179.298 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . 0.581 HG11 ' HB1' ' A' ' 89' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.502 2.128 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 . . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 76' ' ' GLY . . . . . 0.65 ' CA ' HG22 ' B' ' 53' ' ' VAL . . . -114.89 88.2 0.47 Allowed Glycine 0 N--CA 1.491 2.303 0 C-N-CA 118.539 -1.791 . . . . 0.0 110.494 -179.178 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.923 HG21 ' CB ' ' A' ' 85' ' ' LEU . 5.0 p -69.62 68.58 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.354 -1.086 . . . . 0.0 108.308 178.349 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 78' ' ' SER . . . . . 0.479 ' N ' ' O ' ' B' ' 76' ' ' GLY . 0.3 OUTLIER -59.93 -153.8 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 121.895 0.855 . . . . 0.0 110.953 -179.073 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.764 ' HA ' ' HA ' ' B' ' 50' ' ' ILE . 3.1 p -157.19 -169.49 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 179.805 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 80' ' ' LYS . . . . . 0.512 ' H ' HG22 ' B' ' 79' ' ' VAL . 0.9 OUTLIER -140.38 175.29 3.24 Favored Pre-proline 0 C--N 1.307 -1.25 0 C-N-CA 117.651 -1.62 . . . . 0.0 113.126 -179.692 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 81' ' ' PRO . . . . . 0.43 ' CD ' ' CB ' ' B' ' 80' ' ' LYS . 58.9 Cg_endo -111.52 119.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 124.78 3.653 . . . . 0.0 111.185 -179.075 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . 0.667 ' HA3' ' C ' ' B' ' 47' ' ' PHE . . . -123.78 144.6 15.6 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 177.934 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . 0.454 ' HA ' ' HB2' ' B' ' 86' ' ' LYS . 8.0 pm0 -85.3 -23.62 28.04 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.156 -1.203 . . . . 0.0 111.59 -178.882 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 84' ' ' SER . . . . . 0.408 ' CB ' ' O ' ' B' ' 45' ' ' THR . 5.4 t -51.16 -30.96 18.29 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.051 -1.031 . . . . 0.0 108.42 179.283 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.952 HD13 ' CG2' ' A' ' 36' ' ' VAL . 0.1 OUTLIER -87.2 -40.52 14.5 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.172 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 86' ' ' LYS . . . . . 0.454 ' HB2' ' HA ' ' B' ' 83' ' ' GLU . 3.1 mtpp -64.24 -26.39 68.48 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.059 -1.057 . . . . 0.0 109.129 178.68 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -81.37 -36.01 30.13 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 178.343 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.755 ' O ' ' HB1' ' A' ' 37' ' ' ALA . . . -66.37 -37.98 86.52 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 176.737 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 1.038 ' CB ' HG11 ' A' ' 75' ' ' VAL . . . -61.43 -35.06 76.51 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.414 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . 0.401 ' HG2' ' N ' ' B' ' 91' ' ' GLY . 0.7 OUTLIER -56.2 -32.87 64.79 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 176.751 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . 0.401 ' N ' ' HG2' ' B' ' 90' ' ' GLU . . . -66.42 -36.94 92.28 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 178.288 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 92' ' ' LEU . . . . . 0.858 ' O ' HD12 ' B' ' 92' ' ' LEU . 0.4 OUTLIER -69.65 7.1 0.93 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.902 -1.352 . . . . 0.0 110.658 179.553 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 93' ' ' LYS . . . . . 0.516 ' CB ' ' O ' ' B' ' 92' ' ' LEU . 6.5 tptm 72.99 43.41 0.41 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -177.76 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . 0.516 ' CD1' ' CA ' ' A' ' 75' ' ' VAL . 0.2 OUTLIER -41.31 -33.47 0.39 Allowed 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.422 -179.542 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -61.51 -43.19 99.3 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.193 -0.942 . . . . 0.0 109.323 179.299 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.3 -36.81 76.27 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 177.77 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 97' ' ' PHE . . . . . 0.805 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.451 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.662 ' CB ' HG22 ' B' ' 42' ' ' VAL . 1.2 mtp . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.404 ' HA ' ' O ' ' B' ' 43' ' ' GLN . 3.2 t-20 -174.12 -167.55 0.35 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.884 -1.135 . . . . 0.0 111.736 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.435 ' NZ ' ' HA ' ' A' ' 26' ' ' ALA . 0.4 OUTLIER -53.02 -11.56 0.25 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.574 -0.704 . . . . 0.0 110.847 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.707 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 19.6 m -116.47 -42.48 3.0 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.026 -1.046 . . . . 0.0 109.538 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.588 ' CB ' ' HA ' ' A' ' 1' ' ' MET . 0.4 OUTLIER -62.13 -54.31 42.95 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.164 -0.96 . . . . 0.0 108.612 179.073 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.876 HD11 ' CG1' ' B' ' 42' ' ' VAL . 9.9 mt -57.93 -29.32 65.04 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.318 -0.864 . . . . 0.0 108.974 177.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.867 HG23 ' HB ' ' A' ' 21' ' ' VAL . 0.6 OUTLIER -55.17 -58.62 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.85 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.929 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -61.06 -28.19 68.89 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.625 -0.83 . . . . 0.0 108.761 178.235 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.669 ' HB3' ' O ' ' A' ' 6' ' ' LEU . . . -61.16 -32.59 72.32 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.361 -0.837 . . . . 0.0 109.064 179.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.814 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.7 OUTLIER -97.52 -34.84 4.97 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.446 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 178.465 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.929 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -61.22 -26.89 68.04 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 177.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.413 ' CG ' ' N ' ' A' ' 13' ' ' ASP . 11.0 pt20 -91.56 -39.85 11.68 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.446 ' HB2' ' HA ' ' A' ' 10' ' ' ILE . 43.8 m-20 -66.21 -22.89 66.36 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 176.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.948 HG22 ' HB2' ' B' ' 20' ' ' SER . 16.8 p -93.0 -76.12 0.48 Allowed 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 58.63 14.52 22.06 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.903 HD12 ' HB ' ' A' ' 14' ' ' THR . 1.7 mp -80.79 -50.89 9.26 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.365 -1.079 . . . . 0.0 108.465 179.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.6 HG22 ' H ' ' A' ' 19' ' ' VAL . 0.5 OUTLIER -150.7 0.74 0.42 Allowed 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 120.266 -0.573 . . . . 0.0 110.619 -179.655 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.593 ' O ' ' C ' ' A' ' 19' ' ' VAL . 9.1 mt-30 55.64 29.66 14.03 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 -176.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 1.056 HG11 HG11 ' B' ' 19' ' ' VAL . 0.7 OUTLIER -4.98 -95.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.714 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 1.092 ' O ' ' N ' ' A' ' 22' ' ' SER . 0.1 OUTLIER -132.45 24.42 4.43 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 178.292 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.867 ' HB ' HG23 ' A' ' 7' ' ' ILE . 13.4 m -4.29 -40.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 CA-C-O 122.417 1.104 . . . . 0.0 110.898 -178.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 1.092 ' N ' ' O ' ' A' ' 20' ' ' SER . 8.6 t -79.92 -40.77 27.45 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.335 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.862 ' N ' ' O ' ' A' ' 20' ' ' SER . 1.7 ttpt -84.73 -27.71 26.79 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.412 -0.805 . . . . 0.0 111.366 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.547 ' CE ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -78.45 -40.39 35.78 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 117.895 -1.522 . . . . 0.0 109.751 179.627 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.727 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 0.2 OUTLIER -78.8 -49.21 13.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.585 -1.322 . . . . 0.0 109.837 178.842 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 22' ' ' SER . . . -55.04 -34.23 63.34 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.63 ' HA ' ' HB3' ' A' ' 30' ' ' LYS . 20.7 t -85.16 -29.64 24.59 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.744 -0.783 . . . . 0.0 108.99 178.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.732 ' HA ' ' CG1' ' A' ' 31' ' ' ILE . 0.2 OUTLIER -59.81 -39.27 84.45 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.442 -0.786 . . . . 0.0 109.101 179.165 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.553 ' HB3' HG21 ' B' ' 45' ' ' THR . 4.5 mt-10 -79.21 -31.96 43.86 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.974 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 24.7 tttm -69.74 -25.86 64.04 Favored 'General case' 0 C--O 1.188 -2.179 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 176.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.732 ' CG1' ' HA ' ' A' ' 28' ' ' PHE . 1.9 pp -97.59 -31.33 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.957 -1.09 . . . . 0.0 109.157 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.666 HG21 ' CE1' ' B' ' 47' ' ' PHE . 2.0 mm -63.68 -56.16 18.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 177.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.49 ' HA ' ' HB3' ' B' ' 85' ' ' LEU . 0.4 OUTLIER -68.82 -36.98 78.89 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.39 -0.823 . . . . 0.0 108.882 179.313 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.974 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 59.4 mm-40 -74.98 -32.84 61.78 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.554 -0.716 . . . . 0.0 111.652 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.552 ' N ' ' O ' ' A' ' 31' ' ' ILE . 24.2 m -67.66 -58.14 5.18 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 118.221 -1.391 . . . . 0.0 108.988 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.788 ' O ' ' HG3' ' A' ' 52' ' ' PRO . 0.7 OUTLIER -51.29 -35.65 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 178.447 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.788 ' HB1' ' C ' ' B' ' 88' ' ' ALA . . . -73.32 -27.9 61.78 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.082 178.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.606 ' N ' HD12 ' B' ' 92' ' ' LEU . 0.0 OUTLIER -75.78 -25.77 56.71 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 177.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.413 ' HA3' ' CE ' ' B' ' 93' ' ' LYS . . . 108.97 27.58 4.8 Favored Glycine 0 C--N 1.295 -1.706 0 C-N-CA 120.075 -1.059 . . . . 0.0 111.403 177.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.527 ' HB2' HG23 ' A' ' 35' ' ' THR . 0.2 OUTLIER -108.46 151.65 25.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.123 -1.222 . . . . 0.0 109.651 179.011 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -76.69 81.61 3.32 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.374 -0.829 . . . . 0.0 110.421 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.491 ' CG2' ' CG2' ' A' ' 35' ' ' THR . 60.7 t -68.29 140.63 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.448 -0.782 . . . . 0.0 109.8 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.487 ' HG2' ' HA ' ' B' ' 2' ' ' ASN . 4.2 pt20 -158.85 174.17 15.4 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.372 -0.83 . . . . 0.0 109.76 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.929 HD22 ' CE1' ' B' ' 28' ' ' PHE . 27.9 mt -127.5 115.22 18.53 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.441 -0.787 . . . . 0.0 109.244 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.566 HG23 ' HD1' ' A' ' 47' ' ' PHE . 0.0 OUTLIER 33.2 -95.54 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.89 -0.507 . . . . 0.0 111.566 -179.599 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.468 ' H ' HG23 ' A' ' 45' ' ' THR . . . -139.73 25.06 2.72 Favored Glycine 0 N--CA 1.487 2.083 0 C-N-CA 119.417 -1.373 . . . . 0.0 111.089 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.779 ' CD1' ' HG3' ' B' ' 29' ' ' GLU . 13.3 p90 -122.07 -31.83 3.81 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.616 -1.52 . . . . 0.0 110.538 178.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.898 ' HB2' HD12 ' A' ' 44' ' ' LEU . 8.3 mt -122.09 148.97 44.21 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 119.886 -1.759 . . . . 0.0 111.548 177.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.488 ' N ' ' HB2' ' A' ' 80' ' ' LYS . 1.0 OUTLIER -149.25 77.12 1.35 Allowed 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.289 0.566 . . . . 0.0 110.483 -179.815 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.771 HG22 HG21 ' A' ' 36' ' ' VAL . 43.5 mm -69.63 126.28 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.394 -0.816 . . . . 0.0 109.962 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -140.67 126.33 11.38 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.335 -0.853 . . . . 0.0 108.766 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.788 ' HG3' ' O ' ' A' ' 36' ' ' VAL . 55.2 Cg_endo -86.83 140.37 5.9 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.317 1.167 . . . . 0.0 110.885 -178.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.595 HG22 ' O ' ' A' ' 76' ' ' GLY . 18.4 m -137.28 117.07 15.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-O 122.204 1.002 . . . . 0.0 110.837 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.691 ' HB2' ' CB ' ' B' ' 97' ' ' PHE . . . -43.34 115.66 0.81 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.72 0.771 . . . . 0.0 111.765 -178.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.7 ttt-85 -141.21 -151.18 0.35 Allowed 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.672 ' HB2' ' HB1' ' A' ' 72' ' ' ALA . 4.1 pt20 -177.43 -175.33 0.54 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.898 -1.126 . . . . 0.0 111.552 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.503 ' H ' ' HA ' ' A' ' 72' ' ' ALA . . . -172.9 148.98 1.86 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.847 -0.533 . . . . 0.0 109.772 -178.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 1.006 ' HB2' HD12 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -176.17 147.3 0.71 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.741 -1.224 . . . . 0.0 112.724 -179.892 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.747 ' HB3' ' O ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER 135.26 39.16 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.225 0 C-N-CA 123.659 0.784 . . . . 0.0 109.917 176.038 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 1.082 ' O ' ' O ' ' A' ' 61' ' ' PHE . . . -146.93 72.22 0.32 Allowed Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 1.152 ' N ' ' H ' ' A' ' 68' ' ' ALA . 0.3 OUTLIER -11.71 -155.7 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.201 0 C-N-CA 123.728 0.811 . . . . 0.0 111.646 -177.435 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.551 ' CB ' ' O ' ' A' ' 61' ' ' PHE . 1.2 t30 170.57 -56.94 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 120.186 -1.572 . . . . 0.0 112.21 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' A' ' 62' ' ' ASN . 38.8 Cg_endo -65.02 -13.35 39.28 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.392 1.206 . . . . 0.0 111.661 -178.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.526 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 4.7 tt0 -116.22 -111.55 0.35 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.022 -1.048 . . . . 0.0 109.376 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.424 ' O ' ' O ' ' A' ' 66' ' ' GLN . 6.7 t -96.29 7.86 45.39 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.888 -1.132 . . . . 0.0 109.955 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.721 ' O ' ' CB ' ' A' ' 67' ' ' GLU . 3.1 mp0 58.23 118.8 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.578 -0.701 . . . . 0.0 110.294 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.776 ' O ' ' HB2' ' A' ' 68' ' ' ALA . 7.0 tt0 137.17 41.81 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.308 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 1.152 ' H ' ' N ' ' A' ' 61' ' ' PHE . . . 163.06 96.67 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.694 HD13 HG13 ' A' ' 71' ' ' ILE . 2.8 pp -152.18 -148.76 0.27 Allowed 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 174.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.83 ' HA ' ' HG3' ' A' ' 58' ' ' ARG . 0.3 OUTLIER -177.19 67.75 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.459 -1.401 . . . . 0.0 110.617 179.729 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 1.006 HD12 ' HB2' ' A' ' 58' ' ' ARG . 0.9 OUTLIER -115.41 -152.38 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.291 0 O-C-N 120.933 -1.104 . . . . 0.0 109.721 179.125 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.672 ' HB1' ' HB2' ' A' ' 56' ' ' GLN . . . -179.94 56.33 0.07 OUTLIER Pre-proline 0 N--CA 1.5 2.031 0 O-C-N 119.894 -1.754 . . . . 0.0 112.086 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.577 ' HD3' ' N ' ' A' ' 72' ' ' ALA . 55.7 Cg_endo -103.79 96.88 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 121.133 1.222 . . . . 0.0 111.212 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.434 ' CB ' ' HA ' ' A' ' 56' ' ' GLN . 1.2 t -161.89 95.87 0.99 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.561 -1.337 . . . . 0.0 111.925 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.961 HG11 ' HB3' ' B' ' 89' ' ' ALA . 8.0 p -62.47 170.91 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.04 -1.037 . . . . 0.0 108.287 178.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.595 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -117.93 82.92 0.34 Allowed Glycine 0 N--CA 1.493 2.445 0 C-N-CA 118.556 -1.783 . . . . 0.0 110.285 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.667 HG11 HD13 ' B' ' 85' ' ' LEU . 97.3 t -70.69 74.45 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.146 -1.208 . . . . 0.0 109.165 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.461 ' N ' ' O ' ' A' ' 51' ' ' LYS . 0.4 OUTLIER -58.87 -166.41 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.445 0.641 . . . . 0.0 110.587 -179.68 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.728 HG11 ' HD3' ' B' ' 81' ' ' PRO . 7.9 p -172.21 178.74 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.541 -0.724 . . . . 0.0 109.061 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.592 ' N ' HG22 ' A' ' 79' ' ' VAL . 0.4 OUTLIER -122.04 177.96 1.4 Allowed Pre-proline 0 C--N 1.309 -1.192 0 O-C-N 120.905 -1.122 . . . . 0.0 110.619 179.425 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.419 ' CD ' ' CB ' ' A' ' 80' ' ' LYS . 56.4 Cg_endo -106.32 74.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.302 -1.919 0 C-N-CA 123.739 2.96 . . . . 0.0 109.874 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.718 ' CA ' ' O ' ' A' ' 47' ' ' PHE . . . -56.53 93.83 0.03 OUTLIER Glycine 0 N--CA 1.486 2.032 0 C-N-CA 119.198 -1.477 . . . . 0.0 110.71 -178.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' A' ' 81' ' ' PRO . 2.9 pt-20 -62.2 -28.14 69.47 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.668 -0.901 . . . . 0.0 108.995 178.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.442 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 71.1 m -53.24 -27.66 23.38 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.644 ' CD2' HG22 ' B' ' 77' ' ' VAL . 4.4 tt -85.74 -30.91 22.72 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.673 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 3.0 tttt -79.9 -40.31 28.53 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.629 0.728 . . . . 0.0 109.139 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -67.73 -37.08 81.71 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 178.256 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.628 ' O ' ' HB1' ' B' ' 37' ' ' ALA . . . -64.12 -36.71 84.94 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 176.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.818 ' HB1' ' CG1' ' B' ' 75' ' ' VAL . . . -57.49 -39.34 76.23 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.594 ' HA ' ' HB2' ' A' ' 94' ' ' TYR . 6.3 mm-40 -56.44 -29.07 61.19 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 176.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -70.42 -42.44 64.68 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.795 HD12 ' HB2' ' A' ' 93' ' ' LYS . 0.4 OUTLIER -61.36 -48.94 79.0 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.27 -1.723 . . . . 0.0 110.791 -178.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.795 ' HB2' HD12 ' A' ' 92' ' ' LEU . 0.0 OUTLIER 157.06 44.02 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.42 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.577 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 1.049 ' CG ' ' HB3' ' B' ' 74' ' ' SER . 87.5 t80 -42.48 -54.55 3.83 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.717 -0.615 . . . . 0.0 111.053 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.636 ' HA ' ' OG ' ' B' ' 74' ' ' SER . 5.3 mp0 -61.98 -39.5 92.37 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.087 -1.008 . . . . 0.0 110.557 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.528 ' HB2' ' CD ' ' A' ' 93' ' ' LYS . 0.6 OUTLIER -53.37 -31.1 43.14 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.279 -0.888 . . . . 0.0 109.68 179.81 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.437 ' HB3' ' HB2' ' B' ' 54' ' ' ALA . 9.2 m-85 -80.75 -29.84 36.2 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.538 -0.865 . . . . 0.0 108.756 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.946 ' HB2' ' OG ' ' B' ' 74' ' ' SER . . . -69.69 -21.0 63.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.782 -0.574 . . . . 0.0 110.427 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 11.4 mtmt . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.215 179.929 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.521 ' HA ' ' CB ' ' B' ' 5' ' ' GLU . 5.3 mtp . . . . . 0 N--CA 1.492 1.653 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . 0.861 ' C ' HD12 ' B' ' 6' ' ' LEU . 23.2 p30 -176.47 -174.02 0.56 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.237 -0.914 . . . . 0.0 111.225 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.512 ' HE3' ' CG2' ' A' ' 45' ' ' THR . 0.0 OUTLIER -49.53 -16.37 0.21 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.493 -0.754 . . . . 0.0 110.728 -179.641 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.58 ' O ' HG13 ' B' ' 7' ' ' ILE . 3.2 m -105.87 -57.53 2.03 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 122.113 0.958 . . . . 0.0 108.716 178.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.521 ' CB ' ' HA ' ' B' ' 1' ' ' MET . 0.4 OUTLIER -50.35 -46.01 55.48 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.838 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.861 HD12 ' C ' ' B' ' 2' ' ' ASN . 6.2 mt -58.02 -31.6 67.14 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.795 -0.762 . . . . 0.0 109.914 178.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' ILE . . . . . 0.606 HG22 ' CD1' ' B' ' 25' ' ' LEU . 0.8 OUTLIER -60.9 -40.39 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 178.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . 0.852 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.0 OUTLIER -70.43 -31.45 68.64 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 177.865 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . 0.557 ' HB1' HD13 ' A' ' 31' ' ' ILE . . . -58.53 -37.95 76.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.6 -0.687 . . . . 0.0 109.152 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.736 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.3 mp -92.89 -30.41 4.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.852 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -67.6 -12.97 61.63 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 118.576 -1.25 . . . . 0.0 108.455 178.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.444 ' CG ' ' N ' ' B' ' 13' ' ' ASP . 17.0 pt20 -112.93 -42.0 3.65 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.432 -0.793 . . . . 0.0 109.338 178.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.444 ' N ' ' CG ' ' B' ' 12' ' ' GLN . 0.9 OUTLIER -70.9 -27.43 63.79 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 176.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.98 HG22 ' CD1' ' B' ' 16' ' ' LEU . 0.1 OUTLIER -113.54 -85.76 0.58 Allowed 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 178.143 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . 0.571 ' O ' ' C ' ' B' ' 16' ' ' LEU . . . 80.19 -28.26 2.64 Favored Glycine 0 N--CA 1.499 2.885 0 O-C-N 121.031 -1.043 . . . . 0.0 111.062 177.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' LEU . . . . . 0.98 ' CD1' HG22 ' B' ' 14' ' ' THR . 5.1 mp -13.93 -66.0 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.519 0 CA-C-O 121.918 0.866 . . . . 0.0 112.062 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . 0.584 ' CG2' HG21 ' A' ' 17' ' ' THR . 0.6 OUTLIER -139.64 7.62 2.33 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.549 -179.579 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . 0.618 ' O ' ' C ' ' B' ' 19' ' ' VAL . 11.4 mt-30 58.95 25.83 14.23 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 -175.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 1.056 HG11 HG11 ' A' ' 19' ' ' VAL . 2.4 p -4.94 -96.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.393 -179.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.961 ' O ' ' N ' ' B' ' 23' ' ' LYS . 0.6 OUTLIER -132.01 23.07 4.54 Favored 'General case' 0 C--N 1.279 -2.462 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 178.045 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.616 ' C ' ' O ' ' B' ' 20' ' ' SER . 30.4 m -24.42 -40.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 122.449 1.119 . . . . 0.0 109.054 -178.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.693 ' N ' ' O ' ' B' ' 20' ' ' SER . 3.2 m -81.95 -36.24 28.19 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.088 177.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . 0.961 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.8 OUTLIER -85.19 -37.92 19.58 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.675 -0.641 . . . . 0.0 111.44 179.656 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' MET . . . . . 0.575 ' HG3' ' O ' ' B' ' 20' ' ' SER . 0.0 OUTLIER -68.14 -38.11 81.82 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 117.637 -1.625 . . . . 0.0 108.374 179.156 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.606 ' CD1' HG22 ' B' ' 7' ' ' ILE . 8.8 mt -71.68 -35.5 70.31 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 118.47 -1.292 . . . . 0.0 108.976 178.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . 0.475 ' HA ' ' CE ' ' B' ' 3' ' ' LYS . . . -62.96 -37.15 85.95 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 177.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . 0.53 ' O ' ' N ' ' B' ' 31' ' ' ILE . 1.2 p -80.86 -26.59 36.86 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . 0.929 ' CE1' HD22 ' A' ' 44' ' ' LEU . 1.8 t80 -55.36 -48.84 73.63 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . 0.779 ' HG3' ' CD1' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -69.16 -33.91 74.15 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.869 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 1.228 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 24.1 tttp -64.88 -22.61 67.02 Favored 'General case' 0 C--O 1.191 -1.99 0 C-N-CA 119.012 -1.075 . . . . 0.0 108.374 178.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.662 HG13 ' O ' ' B' ' 28' ' ' PHE . 0.7 OUTLIER -104.53 -27.04 3.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 120.271 -1.518 . . . . 0.0 109.345 178.265 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.657 HD11 ' CE2' ' B' ' 28' ' ' PHE . 1.2 mm -70.99 -61.88 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 177.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' THR . . . . . 0.428 ' OG1' ' N ' ' A' ' 85' ' ' LEU . 0.6 OUTLIER -66.73 -37.79 85.37 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.408 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 1.228 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 18.2 mm-40 -76.25 -35.0 59.17 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 121.065 -1.022 . . . . 0.0 111.901 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' THR . . . . . 0.964 HG21 HG23 ' B' ' 42' ' ' VAL . 4.5 m -61.82 -52.8 62.71 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 120.339 -1.476 . . . . 0.0 108.912 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.571 HG22 ' CD ' ' B' ' 52' ' ' PRO . 1.0 OUTLIER -53.35 -38.32 31.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 C-N-CA 118.194 -1.402 . . . . 0.0 107.259 178.71 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 0.628 ' HB1' ' O ' ' A' ' 88' ' ' ALA . . . -83.37 -2.36 55.59 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.832 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.576 ' HB2' ' O ' ' B' ' 34' ' ' GLU . 0.0 OUTLIER -100.95 -23.83 14.46 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 177.546 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.05 43.97 1.45 Allowed Glycine 0 C--N 1.301 -1.375 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . 0.709 ' CB ' HG23 ' B' ' 35' ' ' THR . 0.1 OUTLIER -138.16 137.92 38.1 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.105 -1.232 . . . . 0.0 110.103 179.366 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 5.7 mttp -90.79 84.17 5.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.461 -0.775 . . . . 0.0 110.916 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.964 HG23 HG21 ' B' ' 35' ' ' THR . 3.5 t -63.54 146.39 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.399 -0.813 . . . . 0.0 109.278 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' GLN . . . . . 0.404 ' O ' ' HA ' ' A' ' 2' ' ' ASN . 1.3 tt0 -138.61 114.1 9.68 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 120.88 -1.138 . . . . 0.0 110.501 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.685 HD22 ' HE2' ' A' ' 28' ' ' PHE . 17.1 mt -85.75 110.99 19.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.187 -0.946 . . . . 0.0 108.784 178.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . 0.553 HG21 ' HB3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 33.07 -89.83 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.407 0 O-C-N 121.739 -0.601 . . . . 0.0 110.997 -179.441 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -148.31 22.01 1.38 Allowed Glycine 0 N--CA 1.485 1.917 0 C-N-CA 119.818 -1.182 . . . . 0.0 110.176 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . 0.666 ' CE1' HG21 ' A' ' 32' ' ' ILE . 14.4 p90 -118.14 -34.91 3.97 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.832 -1.393 . . . . 0.0 112.111 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.633 ' HB2' HD12 ' B' ' 44' ' ' LEU . 0.0 OUTLIER -115.76 92.06 3.79 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.805 -1.185 . . . . 0.0 110.692 179.428 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' ASN . . . . . 0.659 ' O ' ' HB ' ' B' ' 79' ' ' VAL . 1.1 t-20 -79.96 60.82 3.65 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.88 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' ILE . . . . . 0.811 HD13 HG21 ' B' ' 79' ' ' VAL . 32.2 mm -56.34 116.92 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.314 -0.867 . . . . 0.0 111.62 -177.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . 0.552 ' O ' ' HG3' ' B' ' 51' ' ' LYS . 6.9 ptmt -169.97 126.17 0.73 Allowed Pre-proline 0 N--CA 1.488 1.435 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.571 ' CD ' HG22 ' B' ' 36' ' ' VAL . 54.8 Cg_endo -79.32 144.76 18.42 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.433 1.228 . . . . 0.0 112.158 -177.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.5 ' O ' HG23 ' B' ' 53' ' ' VAL . 30.0 m -150.31 122.17 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.75 ' HA ' ' O ' ' B' ' 74' ' ' SER . . . -64.26 148.13 50.88 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 118.96 -1.096 . . . . 0.0 111.535 -177.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . 0.494 ' O ' ' CG ' ' B' ' 56' ' ' GLN . 3.8 tpt180 -158.57 17.62 0.21 Allowed 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 119.421 -0.912 . . . . 0.0 111.681 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . 0.773 ' N ' ' HA ' ' B' ' 73' ' ' PRO . 0.0 OUTLIER -173.5 147.02 1.41 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.181 -0.949 . . . . 0.0 111.491 179.14 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.763 ' HB3' ' O ' ' B' ' 72' ' ' ALA . . . -165.81 21.8 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.259 -0.901 . . . . 0.0 110.7 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' ARG . . . . . 0.63 ' HG3' ' N ' ' B' ' 59' ' ' LYS . 0.0 OUTLIER -166.87 152.36 7.84 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.236 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . 0.63 ' N ' ' HG3' ' B' ' 58' ' ' ARG . 2.8 ptpt -174.57 36.62 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.309 -0.869 . . . . 0.0 111.07 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -102.57 104.0 2.52 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 108.421 -1.872 . . . . 0.0 108.421 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' PHE . . . . . 0.621 ' CD2' ' O ' ' B' ' 62' ' ' ASN . 42.3 p90 -52.19 158.21 1.19 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.283 -1.128 . . . . 0.0 111.277 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . 0.621 ' O ' ' CD2' ' B' ' 61' ' ' PHE . 1.2 t-20 -56.22 -171.19 0.02 OUTLIER Pre-proline 0 N--CA 1.495 1.776 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.516 ' HD2' ' CB ' ' B' ' 62' ' ' ASN . 43.5 Cg_endo -72.78 60.91 3.66 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 N-CA-C 109.145 -1.137 . . . . 0.0 109.145 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . 0.702 ' O ' HG23 ' B' ' 65' ' ' THR . 10.8 mt-30 -135.47 -94.05 0.27 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.427 -0.796 . . . . 0.0 111.178 -179.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.702 HG23 ' O ' ' B' ' 64' ' ' GLN . 0.0 OUTLIER -174.92 -30.88 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.977 -1.077 . . . . 0.0 110.974 -179.85 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -139.66 15.04 2.53 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.073 -1.017 . . . . 0.0 111.988 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . 0.44 ' O ' ' HA ' ' B' ' 61' ' ' PHE . 5.7 tt0 -89.37 47.39 1.48 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.73 -1.231 . . . . 0.0 109.54 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . 0.432 ' HA ' ' CA ' ' B' ' 61' ' ' PHE . . . -47.92 152.77 0.72 Allowed 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.508 0.671 . . . . 0.0 111.506 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.485 ' O ' ' HB3' ' B' ' 70' ' ' GLU . 17.4 mt -127.48 -162.83 1.2 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.596 -0.69 . . . . 0.0 109.485 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . 0.485 ' HB3' ' O ' ' B' ' 69' ' ' LEU . 1.9 pt-20 173.96 79.87 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.422 -0.798 . . . . 0.0 109.421 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.78 ' O ' ' HB2' ' B' ' 72' ' ' ALA . 1.2 pp -111.27 88.9 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.682 -1.261 . . . . 0.0 112.484 -179.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . 0.78 ' HB2' ' O ' ' B' ' 71' ' ' ILE . . . 135.78 124.09 0.0 OUTLIER Pre-proline 0 C--N 1.283 -2.292 0 CA-C-N 114.144 -1.389 . . . . 0.0 108.522 178.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' PRO . . . . . 0.773 ' HA ' ' N ' ' B' ' 56' ' ' GLN . 48.1 Cg_endo -103.11 131.4 0.1 Allowed 'Trans proline' 0 C--N 1.296 -2.197 0 O-C-N 122.99 0.995 . . . . 0.0 111.897 179.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . 1.049 ' HB3' ' CG ' ' A' ' 94' ' ' TYR . 2.7 m -111.18 155.47 22.87 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 176.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . 0.818 ' CG1' ' HB1' ' A' ' 89' ' ' ALA . 84.3 t -19.41 145.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -176.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -143.57 -142.65 3.98 Favored Glycine 0 N--CA 1.491 2.305 0 O-C-N 120.285 -1.509 . . . . 0.0 110.559 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.644 HG22 ' CD2' ' A' ' 85' ' ' LEU . 11.3 t -141.57 83.55 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-O 121.982 0.896 . . . . 0.0 109.734 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . 0.49 ' HB3' ' HG3' ' B' ' 51' ' ' LYS . 0.1 OUTLIER -58.44 -45.04 89.31 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.586 0.707 . . . . 0.0 110.947 179.343 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.811 HG21 HD13 ' B' ' 50' ' ' ILE 0.284 7.5 p -46.9 172.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-O 122.438 1.113 . . . . 0.0 113.791 -174.52 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . 0.64 ' HB2' ' HD2' ' B' ' 81' ' ' PRO . 0.3 OUTLIER 178.15 175.74 0.32 Allowed Pre-proline 0 N--CA 1.48 1.03 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -179.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' PRO . . . . . 0.728 ' HD3' HG11 ' A' ' 79' ' ' VAL . 47.1 Cg_endo -72.84 137.99 27.97 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.374 1.197 . . . . 0.0 109.583 177.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . 0.546 ' O ' HD12 ' B' ' 85' ' ' LEU . . . -101.67 -161.02 26.87 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . 0.473 ' HA ' ' HB2' ' B' ' 86' ' ' LYS . 0.4 OUTLIER -91.11 -10.64 41.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.418 -1.048 . . . . 0.0 110.417 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -54.93 -36.69 65.52 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.252 -0.905 . . . . 0.0 109.977 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.667 HD13 HG11 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -85.4 -33.42 21.97 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 119.629 -0.828 . . . . 0.0 108.852 179.198 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . 0.612 ' HG2' HG13 ' A' ' 75' ' ' VAL . 8.6 mttt -69.38 -34.09 74.01 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.653 -0.819 . . . . 0.0 109.264 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . 0.526 ' O ' ' HG3' ' B' ' 90' ' ' GLU . 35.8 tptt -73.15 -38.17 66.32 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 177.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.788 ' C ' ' HB1' ' A' ' 37' ' ' ALA . . . -67.71 -34.23 76.46 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 177.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.961 ' HB3' HG11 ' A' ' 75' ' ' VAL . . . -72.16 -45.21 61.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.79 -0.569 . . . . 0.0 110.45 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.526 ' HG3' ' O ' ' B' ' 87' ' ' LYS . 0.6 OUTLIER -56.82 -19.31 16.63 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.622 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . 0.853 ' C ' HD23 ' B' ' 92' ' ' LEU . . . -93.93 -24.58 19.68 Favored Glycine 0 CA--C 1.547 2.089 0 CA-C-O 118.467 -1.185 . . . . 0.0 113.57 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . 0.853 HD23 ' C ' ' B' ' 91' ' ' GLY . 0.1 OUTLIER -113.03 -71.67 0.74 Allowed 'General case' 0 N--CA 1.507 2.381 0 CA-C-N 122.27 3.035 . . . . 0.0 113.171 -177.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . 0.459 ' O ' ' CD2' ' B' ' 97' ' ' PHE . 0.0 OUTLIER -113.0 36.58 3.44 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.803 -1.186 . . . . 0.0 112.459 -177.462 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . 0.512 ' HB2' ' HA ' ' B' ' 90' ' ' GLU . 6.2 t80 -71.24 -53.63 13.72 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 119.241 -0.984 . . . . 0.0 109.371 178.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -71.72 -31.53 66.81 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.41 -34.84 69.32 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' PHE . . . . . 0.691 ' CB ' ' HB2' ' A' ' 54' ' ' ALA . 7.4 m-85 -76.99 -34.84 57.51 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.48 -45.15 92.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.669 -0.644 . . . . 0.0 110.274 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 3.9 pttt . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.294 -179.931 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.759 ' SD ' HG21 ' B' ' 35' ' ' THR . 2.3 mtp . . . . . 0 N--CA 1.494 1.768 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.465 ' HA ' ' O ' ' B' ' 43' ' ' GLN . 49.9 p-10 -166.93 -158.3 0.29 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.005 -1.059 . . . . 0.0 111.794 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.426 ' CD ' ' HA ' ' A' ' 26' ' ' ALA . 2.1 mmtp -56.02 -8.04 0.41 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.472 -0.768 . . . . 0.0 111.352 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.758 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 33.8 m -123.82 -41.95 2.21 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 120.854 -1.154 . . . . 0.0 109.885 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.522 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -61.9 -54.94 34.96 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.015 -1.053 . . . . 0.0 108.2 179.0 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.88 HD11 ' CG1' ' B' ' 42' ' ' VAL . 6.9 mt -56.38 -29.24 61.2 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.592 -0.843 . . . . 0.0 109.179 177.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.919 HG23 ' HB ' ' A' ' 21' ' ' VAL . 0.8 OUTLIER -55.94 -59.73 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.47 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.892 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 0.1 OUTLIER -60.96 -28.56 69.07 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.224 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.65 ' HB3' ' O ' ' A' ' 6' ' ' LEU . . . -59.61 -33.96 72.16 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.554 -0.858 . . . . 0.0 108.991 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.772 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.6 OUTLIER -95.44 -36.14 6.48 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.422 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 178.318 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.892 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -57.98 -23.98 56.19 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.719 -0.793 . . . . 0.0 108.89 178.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -93.13 -44.2 8.49 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.48 ' OD2' HG21 ' B' ' 31' ' ' ILE . 96.5 m-20 -62.46 -31.39 72.11 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 177.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.772 ' OG1' ' O ' ' A' ' 10' ' ' ILE . 28.2 p -83.25 -75.44 0.32 Allowed 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 177.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 59.02 18.8 42.32 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.001 -1.239 . . . . 0.0 110.001 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.975 HD22 ' O ' ' B' ' 19' ' ' VAL . 3.5 mp -87.41 -53.66 4.7 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.326 -1.102 . . . . 0.0 109.112 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.579 HG22 ' H ' ' A' ' 19' ' ' VAL . 0.5 OUTLIER -149.89 4.99 0.57 Allowed 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 120.021 -0.671 . . . . 0.0 110.596 -178.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.556 ' O ' ' C ' ' A' ' 19' ' ' VAL . 16.8 mt-30 56.48 26.68 11.16 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 -176.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 1.157 HG11 HG11 ' B' ' 19' ' ' VAL . 1.7 p -3.24 -94.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.9 -179.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.947 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -131.69 25.13 4.72 Favored 'General case' 0 C--N 1.28 -2.453 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 179.729 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.919 ' HB ' HG23 ' A' ' 7' ' ' ILE . 5.6 m -17.27 -39.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-O 122.464 1.125 . . . . 0.0 110.12 -178.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.871 ' N ' ' O ' ' A' ' 20' ' ' SER . 16.3 p -80.85 -37.27 30.25 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.038 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.947 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.5 OUTLIER -88.7 -28.83 20.3 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.442 -0.786 . . . . 0.0 111.186 179.878 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.847 ' HB3' HG23 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -76.83 -38.55 53.61 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 117.875 -1.53 . . . . 0.0 109.288 179.744 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.745 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 0.3 OUTLIER -80.21 -48.35 13.25 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 118.172 -1.411 . . . . 0.0 109.365 178.827 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 22' ' ' SER . . . -54.55 -34.33 61.66 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 119.054 -1.058 . . . . 0.0 108.217 178.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.615 ' O ' ' N ' ' A' ' 31' ' ' ILE . 25.1 p -87.21 -31.02 20.55 Favored 'General case' 0 C--O 1.203 -1.364 0 C-N-CA 119.696 -0.802 . . . . 0.0 109.381 178.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.769 ' HB2' HD11 ' B' ' 10' ' ' ILE . 0.1 OUTLIER -56.57 -38.23 71.67 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.2 -0.938 . . . . 0.0 108.927 179.079 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.634 ' HB3' HG21 ' B' ' 45' ' ' THR . 1.0 OUTLIER -82.15 -33.93 29.35 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 178.146 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.987 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 20.1 tttt -68.45 -21.47 64.64 Favored 'General case' 0 C--O 1.189 -2.097 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 176.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 1.07 HD13 ' HB1' ' B' ' 9' ' ' ALA . 1.3 pp -102.31 -30.49 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.878 -1.139 . . . . 0.0 109.448 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.719 HG21 ' CZ ' ' B' ' 47' ' ' PHE . 2.1 mm -65.87 -56.4 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 177.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.707 HG23 ' HB2' ' B' ' 88' ' ' ALA . 0.4 OUTLIER -64.95 -49.43 70.37 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 178.559 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.987 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 15.4 mm-40 -62.52 -32.04 72.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.46 -0.775 . . . . 0.0 111.044 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.83 HG23 ' CB ' ' A' ' 40' ' ' ASP . 1.2 m -56.25 -53.11 61.09 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 178.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.069 HG21 HD12 ' B' ' 85' ' ' LEU . 13.4 t -54.89 -34.38 30.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 C-N-CA 117.91 -1.516 . . . . 0.0 106.975 177.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.727 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -79.29 -3.58 46.7 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -108.53 -18.51 13.71 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.34 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 35' ' ' THR . . . 95.77 43.85 3.26 Favored Glycine 0 C--N 1.303 -1.266 0 C-N-CA 120.209 -0.996 . . . . 0.0 110.657 178.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.83 ' CB ' HG23 ' A' ' 35' ' ' THR . 0.2 OUTLIER -125.71 127.05 45.62 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.125 -1.22 . . . . 0.0 110.222 179.236 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.1 mtmt -77.64 87.66 3.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.566 -0.708 . . . . 0.0 110.065 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 1.129 HG13 HD11 ' B' ' 6' ' ' LEU . 93.0 t -60.04 123.29 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.571 -0.706 . . . . 0.0 110.238 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -121.86 94.8 4.42 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.517 -0.739 . . . . 0.0 109.357 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.702 HD12 ' CB ' ' A' ' 48' ' ' LEU . 12.1 mt -72.52 104.28 3.79 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.336 -0.852 . . . . 0.0 110.411 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.499 HG21 ' HG3' ' B' ' 29' ' ' GLU . 0.1 OUTLIER 31.24 -90.28 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 O-C-N 122.108 -0.37 . . . . 0.0 111.508 179.504 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -148.74 19.67 1.28 Allowed Glycine 0 N--CA 1.486 2.022 0 C-N-CA 119.746 -1.216 . . . . 0.0 110.272 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.704 ' CD1' ' HG3' ' B' ' 29' ' ' GLU . 6.1 p90 -120.7 -22.03 6.47 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.879 -1.365 . . . . 0.0 111.853 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.702 ' CB ' HD12 ' A' ' 44' ' ' LEU . 4.6 mt -129.08 102.71 6.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.229 -1.545 . . . . 0.0 110.632 177.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.77 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 1.3 m120 -99.67 89.71 4.22 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.853 -0.53 . . . . 0.0 111.696 -178.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.63 ' HA ' ' HA ' ' A' ' 79' ' ' VAL . 0.9 OUTLIER -90.19 148.17 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.242 0 O-C-N 121.39 -0.818 . . . . 0.0 110.777 179.376 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.407 ' CE ' ' HB3' ' A' ' 78' ' ' SER . 0.2 OUTLIER -164.64 110.22 0.86 Allowed Pre-proline 0 N--CA 1.504 2.262 0 O-C-N 120.881 -1.137 . . . . 0.0 111.367 179.265 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.94 ' HB3' HG13 ' A' ' 36' ' ' VAL . 55.8 Cg_endo -78.53 141.43 17.66 Favored 'Trans proline' 0 N--CA 1.489 1.253 0 O-C-N 123.635 1.334 . . . . 0.0 112.264 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.702 ' O ' ' N ' ' A' ' 76' ' ' GLY . 33.9 m -151.39 115.66 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 CA-C-O 121.355 0.597 . . . . 0.0 110.38 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.559 ' HB2' ' HB3' ' B' ' 97' ' ' PHE . . . -37.09 133.35 0.64 Allowed 'General case' 0 N--CA 1.504 2.255 0 CA-C-O 121.599 0.714 . . . . 0.0 112.513 -178.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.56 ' O ' ' O ' ' A' ' 74' ' ' SER . 13.0 ttp85 -174.15 107.41 0.12 Allowed 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.482 ' O ' ' O ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -55.53 -158.21 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.144 -0.972 . . . . 0.0 111.569 -178.399 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 1.01 ' HB3' ' HB3' ' A' ' 72' ' ' ALA 0.262 . . -158.36 146.34 18.38 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.139 -0.976 . . . . 0.0 110.587 -177.41 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.927 ' HB2' ' C ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -179.45 169.58 1.4 Allowed 'General case' 0 N--CA 1.483 1.223 0 O-C-N 120.587 -1.32 . . . . 0.0 111.534 179.166 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.432 ' H ' ' HA ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -169.1 24.76 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.858 -179.781 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.582 ' O ' ' O ' ' A' ' 61' ' ' PHE . . . 47.52 -164.47 0.19 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.861 ' HB2' ' C ' ' A' ' 67' ' ' GLU . 1.1 t80 -57.67 -139.19 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.424 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 178.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.484 ' CB ' ' CD ' ' A' ' 63' ' ' PRO . 0.8 OUTLIER 177.54 -62.56 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 120.75 -1.219 . . . . 0.0 112.048 178.1 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.615 ' HD2' ' CD1' ' A' ' 61' ' ' PHE . 46.7 Cg_endo -70.91 7.25 1.38 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.207 1.109 . . . . 0.0 112.628 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.467 ' HB2' ' CE2' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -156.38 90.22 1.17 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.493 -1.379 . . . . 0.0 111.088 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.517 ' O ' ' O ' ' A' ' 66' ' ' GLN . 25.6 p 50.37 11.37 0.07 Allowed 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.732 -0.605 . . . . 0.0 112.011 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.62 ' O ' ' HB3' ' A' ' 67' ' ' GLU . 10.2 mp0 54.41 131.64 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.286 -0.884 . . . . 0.0 111.745 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.861 ' C ' ' HB2' ' A' ' 61' ' ' PHE . 0.0 OUTLIER 139.07 76.42 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.22 0 C-N-CA 124.473 1.109 . . . . 0.0 110.317 179.843 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.757 ' HB3' ' CG ' ' A' ' 61' ' ' PHE . . . -176.06 18.37 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.731 -1.23 . . . . 0.0 112.178 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.556 HD23 ' O ' ' A' ' 68' ' ' ALA . 0.5 OUTLIER 166.31 101.8 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 179.283 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.927 ' C ' ' HB2' ' A' ' 58' ' ' ARG . 1.5 pt-20 -135.81 56.07 1.84 Allowed 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.236 -0.986 . . . . 0.0 111.351 -177.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.939 HD12 ' H ' ' A' ' 72' ' ' ALA . 0.3 OUTLIER -162.47 151.39 3.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-O 122.515 1.15 . . . . 0.0 110.318 177.839 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 1.01 ' HB3' ' HB3' ' A' ' 57' ' ' ALA . . . -176.61 143.85 0.61 Allowed Pre-proline 0 C--N 1.288 -2.094 0 CA-C-N 114.944 -1.026 . . . . 0.0 108.706 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 72' ' ' ALA . 55.2 Cg_endo -96.51 125.16 0.27 Allowed 'Trans proline' 0 C--N 1.299 -2.059 0 C-N-CA 121.55 1.5 . . . . 0.0 110.726 -179.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.56 ' O ' ' O ' ' A' ' 55' ' ' ARG . 0.4 OUTLIER -173.55 108.27 0.15 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.937 -1.102 . . . . 0.0 110.502 179.405 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.793 ' H ' ' HB1' ' B' ' 89' ' ' ALA . 0.4 OUTLIER -49.31 177.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.269 -0.894 . . . . 0.0 110.061 179.613 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.768 ' O ' ' N ' ' A' ' 78' ' ' SER . . . -99.31 53.93 1.01 Allowed Glycine 0 N--CA 1.484 1.862 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 1.052 HG11 ' O ' ' B' ' 84' ' ' SER . 4.5 p -50.91 69.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.922 -0.752 . . . . 0.0 109.971 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.768 ' N ' ' O ' ' A' ' 76' ' ' GLY . 1.0 OUTLIER -70.39 175.78 4.47 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 118.815 -1.154 . . . . 0.0 109.329 -179.771 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.77 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 0.7 OUTLIER 176.46 175.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 179.644 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.65 ' O ' HD23 ' A' ' 48' ' ' LEU . 0.4 OUTLIER -176.1 174.5 0.76 Allowed Pre-proline 0 C--N 1.299 -1.622 0 O-C-N 121.159 -0.963 . . . . 0.0 109.865 178.521 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.819 ' HB2' HG11 ' B' ' 77' ' ' VAL . 54.2 Cg_endo -88.11 169.56 6.25 Favored 'Trans proline' 0 C--N 1.293 -2.368 0 O-C-N 124.529 1.805 . . . . 0.0 108.255 176.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.613 ' CA ' ' HA ' ' A' ' 47' ' ' PHE . . . -150.15 133.64 4.46 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 107.307 -2.317 . . . . 0.0 107.307 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.879 ' O ' ' N ' ' A' ' 85' ' ' LEU . 8.6 tt0 51.09 32.63 7.99 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.142 -1.211 . . . . 0.0 107.901 -177.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.904 ' C ' HD22 ' A' ' 85' ' ' LEU . 1.6 t 8.94 45.83 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 122.45 1.119 . . . . 0.0 110.204 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 1.015 HD12 ' OG1' ' B' ' 33' ' ' THR . 0.0 OUTLIER 19.2 27.6 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 104.026 -2.583 . . . . 0.0 104.026 -171.353 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.582 ' HB2' ' CB ' ' A' ' 84' ' ' SER 0.339 7.9 tttt -66.16 -45.71 79.96 Favored 'General case' 0 CA--C 1.475 -1.914 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 178.497 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.03 -34.42 76.19 Favored 'General case' 0 C--N 1.281 -2.403 0 CA-C-N 112.445 -2.161 . . . . 0.0 106.118 177.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 1.07 ' C ' ' HB1' ' B' ' 37' ' ' ALA . . . -81.59 -30.02 33.12 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 117.764 -1.574 . . . . 0.0 107.585 178.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.696 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . -73.25 -27.66 61.7 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.497 ' N ' ' O ' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -67.07 -30.02 69.96 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 174.468 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -56.99 -50.05 66.98 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 177.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.873 ' O ' HD12 ' A' ' 92' ' ' LEU . 0.6 OUTLIER -80.52 17.72 1.05 Allowed 'General case' 0 N--CA 1.502 2.154 0 O-C-N 120.62 -1.518 . . . . 0.0 110.506 179.317 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.477 ' CB ' ' O ' ' A' ' 92' ' ' LEU . 0.0 OUTLIER 71.72 67.09 0.15 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.305 -0.872 . . . . 0.0 109.387 -179.393 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.544 ' CD2' ' HA ' ' B' ' 74' ' ' SER . 0.0 OUTLIER -45.64 -36.26 4.68 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.706 -0.621 . . . . 0.0 109.923 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.421 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 8.1 pt-20 -62.2 -41.11 98.06 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.47 -0.769 . . . . 0.0 109.764 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.402 ' HB2' ' HB3' ' A' ' 93' ' ' LYS . 4.4 m-20 -57.69 -34.41 69.4 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.673 ' HD2' HD11 ' A' ' 92' ' ' LEU . 0.1 OUTLIER -72.48 -25.72 61.53 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.971 -0.692 . . . . 0.0 109.196 178.785 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.594 ' HB2' ' HB1' ' B' ' 54' ' ' ALA . . . -72.19 -29.22 63.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.682 -0.636 . . . . 0.0 110.107 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 6.4 mttm . . . . . 0 N--CA 1.494 1.758 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.157 -179.988 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.55 ' HA ' ' CB ' ' B' ' 5' ' ' GLU . 11.6 mtp . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 120.879 0.371 . . . . 0.0 110.169 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -174.83 -166.71 0.25 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.086 -1.009 . . . . 0.0 111.303 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.459 ' CE ' ' HB2' ' B' ' 29' ' ' GLU . 0.0 OUTLIER -52.04 -11.48 0.17 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.408 -0.807 . . . . 0.0 111.471 -179.267 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.564 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 59.6 m -115.59 -44.01 2.99 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.93 -1.106 . . . . 0.0 109.376 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.583 ' HA ' ' HE2' ' B' ' 8' ' ' LYS . 0.0 OUTLIER -62.07 -51.47 67.8 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 1.129 HD11 HG13 ' A' ' 42' ' ' VAL . 6.2 mt -62.99 -30.76 71.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.374 -0.829 . . . . 0.0 108.869 178.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' ILE . . . . . 0.821 HG23 ' HB ' ' B' ' 21' ' ' VAL . 0.6 OUTLIER -53.17 -54.38 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.369 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . 0.906 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 14.1 mtmt -59.44 -36.5 76.04 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.714 -0.846 . . . . 0.0 108.714 178.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . 1.07 ' HB1' HD13 ' A' ' 31' ' ' ILE . . . -52.71 -34.63 53.19 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.819 -0.753 . . . . 0.0 109.243 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.847 HG23 ' HB3' ' A' ' 24' ' ' MET . 1.2 mp -97.15 -35.74 5.66 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.425 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.906 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -60.09 -25.91 65.78 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.71 -0.796 . . . . 0.0 108.878 178.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.441 ' CG ' ' N ' ' B' ' 13' ' ' ASP . 16.6 pt20 -92.77 -41.2 10.25 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.448 ' OD2' HG21 ' A' ' 31' ' ' ILE . 1.3 m-20 -65.13 -22.49 66.94 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 176.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.846 ' OG1' ' O ' ' B' ' 10' ' ' ILE . 24.5 p -96.33 -78.38 0.47 Allowed 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 61.87 12.42 35.47 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' LEU . . . . . 0.883 HD22 ' O ' ' A' ' 19' ' ' VAL . 3.7 mp -78.19 -54.57 6.1 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.433 -1.039 . . . . 0.0 108.652 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . 0.586 HG22 ' H ' ' B' ' 19' ' ' VAL . 0.5 OUTLIER -151.01 6.21 0.5 Allowed 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.3 -179.13 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . 0.555 ' O ' ' C ' ' B' ' 19' ' ' VAL . 16.4 mt-30 56.92 25.8 10.97 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 -176.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 1.157 HG11 HG11 ' A' ' 19' ' ' VAL . 2.3 p -0.28 -94.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.118 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.94 ' O ' ' N ' ' B' ' 23' ' ' LYS . 0.0 OUTLIER -130.17 24.12 5.23 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.821 ' HB ' HG23 ' B' ' 7' ' ' ILE . 15.5 m -22.7 -40.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-O 122.446 1.117 . . . . 0.0 109.259 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.76 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.3 OUTLIER -76.32 -36.57 58.22 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.092 178.167 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . 0.94 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.0 OUTLIER -95.1 -28.29 15.15 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 118.786 -1.166 . . . . 0.0 111.13 179.125 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' MET . . . . . 0.755 ' N ' ' OG ' ' B' ' 20' ' ' SER . 0.0 OUTLIER -70.41 -35.14 73.25 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 116.761 -1.976 . . . . 0.0 108.241 179.123 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.666 HD12 HG13 ' B' ' 7' ' ' ILE . 0.3 OUTLIER -83.12 -41.75 18.17 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 118.2 -1.4 . . . . 0.0 109.24 178.315 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . 0.408 ' CB ' ' O ' ' B' ' 22' ' ' SER . . . -64.3 -34.88 79.16 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 177.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . 0.599 ' CB ' ' O ' ' B' ' 23' ' ' LYS . 7.3 t -84.7 -28.24 26.48 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 119.447 -0.901 . . . . 0.0 108.575 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . 0.722 ' HB2' HD11 ' A' ' 10' ' ' ILE . 0.7 OUTLIER -51.05 -44.44 61.11 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . 0.745 ' O ' ' HB ' ' B' ' 33' ' ' THR . 1.4 tt0 -70.79 -38.63 73.39 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 176.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 1.251 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 6.9 ttpt -60.96 -19.9 61.55 Favored 'General case' 0 C--O 1.192 -1.931 0 C-N-CA 119.302 -0.959 . . . . 0.0 108.636 178.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.637 HG13 ' O ' ' B' ' 28' ' ' PHE . 0.8 OUTLIER -108.48 -28.67 2.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 120.111 -1.618 . . . . 0.0 109.366 178.276 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.624 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.2 mm -73.53 -59.78 3.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 176.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' THR . . . . . 1.015 ' OG1' HD12 ' A' ' 85' ' ' LEU . 0.9 OUTLIER -66.67 -38.98 87.94 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 114.748 -1.114 . . . . 0.0 108.658 179.159 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 1.251 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 75.6 mm-40 -77.52 -39.54 45.82 Favored 'General case' 0 C--O 1.205 -1.262 0 O-C-N 121.029 -1.044 . . . . 0.0 112.788 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' THR . . . . . 0.759 HG21 ' SD ' ' A' ' 1' ' ' MET . 98.1 m -63.13 -51.19 67.48 Favored 'General case' 0 N--CA 1.504 2.268 0 CA-C-N 121.206 1.821 . . . . 0.0 110.13 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.927 ' CG2' HG22 ' B' ' 50' ' ' ILE . 0.9 OUTLIER -53.97 -41.46 49.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 178.042 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 1.07 ' HB1' ' C ' ' A' ' 88' ' ' ALA . . . -86.38 3.14 44.91 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.291 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.761 ' HB2' ' O ' ' B' ' 34' ' ' GLU . 0.0 OUTLIER -102.71 -36.33 8.34 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.468 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 141.16 33.2 0.13 Allowed Glycine 0 C--N 1.302 -1.36 0 C-N-CA 119.056 -1.545 . . . . 0.0 111.56 178.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . 0.459 ' HB3' ' CG2' ' B' ' 35' ' ' THR . 0.2 OUTLIER -146.93 158.87 44.04 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.79 -1.418 . . . . 0.0 110.605 179.271 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 33.3 mtpt -101.34 91.46 4.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.455 -0.778 . . . . 0.0 110.007 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.88 ' CG1' HD11 ' A' ' 6' ' ' LEU . 91.5 t -70.78 148.97 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.471 -0.768 . . . . 0.0 110.471 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' GLN . . . . . 0.625 ' O ' HD23 ' B' ' 44' ' ' LEU . 20.5 mt-30 -146.73 165.41 29.72 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.13 -0.981 . . . . 0.0 110.39 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.739 HD22 ' HE2' ' A' ' 28' ' ' PHE . 19.0 mt -122.81 117.42 25.61 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.388 -0.82 . . . . 0.0 109.58 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . 0.634 HG21 ' HB3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 29.04 -92.47 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.809 -0.557 . . . . 0.0 111.136 179.817 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -148.61 23.11 1.34 Allowed Glycine 0 N--CA 1.485 1.966 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . 0.719 ' CZ ' HG21 ' A' ' 32' ' ' ILE . 0.9 OUTLIER -116.57 -32.83 5.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.135 -1.215 . . . . 0.0 111.252 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.595 ' CB ' HD12 ' B' ' 44' ' ' LEU . 0.1 OUTLIER -118.24 162.85 17.58 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.692 -1.255 . . . . 0.0 112.768 179.856 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' ASN . . . . . 0.74 ' O ' HD13 ' B' ' 50' ' ' ILE . 0.2 OUTLIER -142.1 142.22 32.78 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 178.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' ILE . . . . . 0.927 HG22 ' CG2' ' B' ' 36' ' ' VAL . 33.6 mm -138.06 101.91 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.227 -0.921 . . . . 0.0 110.431 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . 0.675 ' HA ' HG22 ' B' ' 36' ' ' VAL . 0.0 OUTLIER -157.43 133.5 6.07 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.065 -1.022 . . . . 0.0 109.064 -179.798 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.76 ' CG ' HG13 ' B' ' 36' ' ' VAL . 57.9 Cg_endo -93.96 159.61 2.21 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.153 1.081 . . . . 0.0 112.009 -178.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 1.007 HG22 ' O ' ' B' ' 76' ' ' GLY . 28.0 m -137.95 116.83 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-O 121.935 0.874 . . . . 0.0 110.441 177.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.594 ' HB1' ' HB2' ' A' ' 98' ' ' ALA . . . -46.55 112.6 0.52 Allowed 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.55 0.69 . . . . 0.0 111.991 -178.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 2.3 ttp180 -137.54 157.66 46.05 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . 0.487 ' HA ' ' HA ' ' B' ' 73' ' ' PRO . 44.9 mt-30 -87.07 -157.57 0.39 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.906 -1.121 . . . . 0.0 110.285 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.808 ' HB3' ' O ' ' B' ' 72' ' ' ALA . . . -176.46 145.82 0.59 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.164 -0.96 . . . . 0.0 111.226 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' ARG . . . . . 0.535 ' CB ' ' O ' ' B' ' 70' ' ' GLU . 0.7 OUTLIER 170.73 139.64 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.531 0.682 . . . . 0.0 110.858 178.744 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . 0.742 ' N ' ' HB2' ' B' ' 70' ' ' GLU . 0.0 OUTLIER -140.64 88.08 2.17 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.679 -0.638 . . . . 0.0 110.672 -179.852 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . 0.584 ' N ' ' HB3' ' B' ' 70' ' ' GLU . . . 140.42 70.17 0.04 OUTLIER Glycine 0 N--CA 1.498 2.771 0 C-N-CA 119.609 -1.281 . . . . 0.0 111.014 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' PHE . . . . . 0.826 ' CE1' ' HB2' ' B' ' 66' ' ' GLN . 39.6 p90 -69.22 -159.15 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.348 0 O-C-N 121.563 -0.963 . . . . 0.0 111.202 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . 0.892 ' HB3' ' HB2' ' B' ' 68' ' ' ALA . 0.3 OUTLIER -134.57 -58.7 0.02 OUTLIER Pre-proline 0 N--CA 1.504 2.241 0 O-C-N 121.539 -0.726 . . . . 0.0 111.816 179.238 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.792 ' HD2' ' H ' ' B' ' 62' ' ' ASN . 37.9 Cg_endo -62.78 70.5 0.13 Allowed 'Trans proline' 0 N--CA 1.492 1.422 0 O-C-N 123.613 1.323 . . . . 0.0 111.548 -178.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . 0.724 ' CB ' ' CE1' ' B' ' 61' ' ' PHE . 0.0 OUTLIER 169.94 61.08 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.199 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.555 HG22 ' O ' ' B' ' 64' ' ' GLN . 9.0 t 42.08 53.39 4.29 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.536 0.684 . . . . 0.0 110.705 -178.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . 0.826 ' HB2' ' CE1' ' B' ' 61' ' ' PHE . 0.0 OUTLIER -148.48 -146.41 0.2 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.441 -0.787 . . . . 0.0 110.467 -179.472 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . 0.764 ' HG3' HD11 ' B' ' 69' ' ' LEU . 11.5 pt-20 -152.43 116.91 5.0 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . 0.892 ' HB2' ' HB3' ' B' ' 62' ' ' ASN . . . -73.24 119.41 17.43 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 122.479 1.133 . . . . 0.0 111.792 -176.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.764 HD11 ' HG3' ' B' ' 67' ' ' GLU . 0.0 OUTLIER -168.79 46.56 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 -179.699 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . 0.742 ' HB2' ' N ' ' B' ' 59' ' ' LYS . 1.1 pt-20 -125.02 107.87 11.26 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.954 -176.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 1.047 HD12 ' N ' ' B' ' 72' ' ' ALA . 0.1 OUTLIER -163.22 153.04 3.01 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 O-C-N 120.854 -1.154 . . . . 0.0 110.469 179.601 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . 1.047 ' N ' HD12 ' B' ' 71' ' ' ILE . . . 160.95 58.14 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.523 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.89 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' PRO . . . . . 0.555 ' CD ' HD12 ' B' ' 71' ' ' ILE . 38.0 Cg_endo -62.57 122.69 11.15 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.06 1.032 . . . . 0.0 111.387 -178.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . 0.544 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 2.3 m -148.28 159.01 44.42 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . 0.599 HG11 ' CB ' ' A' ' 89' ' ' ALA . 0.5 OUTLIER -53.48 171.9 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 120.877 -1.139 . . . . 0.0 109.829 -179.631 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . 1.007 ' O ' HG22 ' B' ' 53' ' ' VAL . . . -129.67 107.28 0.78 Allowed Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.819 HG11 ' HB2' ' A' ' 81' ' ' PRO . 8.6 p -58.41 86.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.194 -1.18 . . . . 0.0 108.875 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . 0.547 ' OG ' HG11 ' B' ' 53' ' ' VAL . 0.5 OUTLIER -58.16 -47.32 83.74 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 -178.258 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.91 HG21 ' HA ' ' B' ' 50' ' ' ILE . 17.7 m -48.08 178.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 -173.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . 0.811 ' HB2' ' HD2' ' B' ' 81' ' ' PRO . 0.0 OUTLIER 179.4 -179.7 0.24 Allowed Pre-proline 0 C--N 1.308 -1.228 0 CA-C-N 113.64 -1.618 . . . . 0.0 107.162 -177.391 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' PRO . . . . . 0.811 ' HD2' ' HB2' ' B' ' 80' ' ' LYS . 39.2 Cg_endo -63.64 153.16 76.82 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 122.989 0.994 . . . . 0.0 111.691 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . 0.521 ' C ' ' H ' ' B' ' 84' ' ' SER . . . -117.16 -79.53 0.73 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 107.351 -2.3 . . . . 0.0 107.351 178.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . 0.918 ' O ' ' N ' ' B' ' 85' ' ' LEU . 16.9 tt0 -75.71 41.32 0.2 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.523 -0.986 . . . . 0.0 108.707 177.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' SER . . . . . 1.052 ' O ' HG11 ' A' ' 77' ' ' VAL . 0.3 OUTLIER 7.8 44.72 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 122.741 1.258 . . . . 0.0 110.453 178.209 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 1.069 HD12 HG21 ' A' ' 36' ' ' VAL . 0.2 OUTLIER 19.08 28.61 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 104.08 -2.563 . . . . 0.0 104.08 -171.577 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . 0.475 ' HB2' ' CB ' ' B' ' 84' ' ' SER 0.355 2.7 tttt -58.05 -41.8 84.08 Favored 'General case' 0 CA--C 1.482 -1.658 0 N-CA-C 103.794 -2.669 . . . . 0.0 103.794 176.765 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . 0.407 ' O ' ' HG2' ' B' ' 90' ' ' GLU 0.264 0.0 OUTLIER -66.05 -35.92 81.83 Favored 'General case' 0 C--N 1.285 -2.228 0 CA-C-N 111.588 -2.551 . . . . 0.0 105.532 176.236 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.707 ' HB2' HG23 ' A' ' 33' ' ' THR . . . -74.52 -27.3 60.48 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 118.54 -1.264 . . . . 0.0 108.409 178.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.793 ' HB1' ' H ' ' A' ' 75' ' ' VAL . . . -62.01 -50.0 73.81 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.114 -0.991 . . . . 0.0 109.264 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.445 ' HG2' ' N ' ' B' ' 91' ' ' GLY . 2.7 pt-20 -57.62 -26.69 61.93 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 176.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . 0.445 ' N ' ' HG2' ' B' ' 90' ' ' GLU . . . -65.66 -37.53 93.64 Favored Glycine 0 N--CA 1.487 2.055 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.286 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . 0.749 HD23 ' HA ' ' B' ' 89' ' ' ALA . 1.1 pp -85.4 22.11 1.6 Allowed 'General case' 0 N--CA 1.504 2.258 0 CA-C-N 119.931 1.865 . . . . 0.0 111.239 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . 0.447 ' O ' ' N ' ' B' ' 96' ' ' ASP . 4.0 mmtt 53.65 39.02 29.63 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 -177.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . 0.583 ' HA ' HD11 ' B' ' 92' ' ' LEU . 0.0 OUTLIER -36.16 -36.81 0.1 Allowed 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.943 -178.643 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . 0.51 ' N ' ' CD1' ' B' ' 94' ' ' TYR . 7.0 pt-20 -60.01 -42.3 94.01 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.332 -0.855 . . . . 0.0 109.609 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 96' ' ' ASP . . . . . 0.447 ' N ' ' O ' ' B' ' 93' ' ' LYS . 0.3 OUTLIER -61.09 -35.08 76.02 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.085 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 97' ' ' PHE . . . . . 0.559 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 0.1 OUTLIER -74.44 -26.27 59.95 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.635 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.83 -63.72 1.07 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.585 -0.697 . . . . 0.0 110.229 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.174 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.505 ' CE ' HD23 ' A' ' 6' ' ' LEU . 6.3 mtp . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 120.837 0.351 . . . . 0.0 110.069 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.689 ' C ' HD12 ' A' ' 6' ' ' LEU . 1.6 t-20 -176.93 -165.31 0.12 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.946 -1.096 . . . . 0.0 111.626 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.552 ' CD ' ' HB ' ' B' ' 45' ' ' THR . 0.4 OUTLIER -51.07 -12.93 0.13 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.511 -0.743 . . . . 0.0 110.802 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.644 ' O ' HG13 ' A' ' 7' ' ' ILE . 74.8 m -112.61 -60.6 1.85 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.172 -0.955 . . . . 0.0 109.938 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.545 ' HA ' ' CE ' ' A' ' 8' ' ' LYS . 4.6 mt-10 -50.17 -41.6 49.61 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.98 -1.075 . . . . 0.0 108.879 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.689 HD12 ' C ' ' A' ' 2' ' ' ASN . 10.1 mt -60.62 -34.51 74.36 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.303 -0.959 . . . . 0.0 109.772 177.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.644 HG13 ' O ' ' A' ' 4' ' ' THR . 1.0 OUTLIER -57.59 -39.74 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 179.089 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.818 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 1.0 OUTLIER -66.97 -36.66 82.69 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.397 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.691 ' HB1' HD13 ' B' ' 31' ' ' ILE . . . -52.39 -39.0 60.33 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 120.214 -0.594 . . . . 0.0 109.447 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.708 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.3 mp -93.93 -29.99 4.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.818 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -63.92 -15.15 58.43 Favored 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 118.496 -1.282 . . . . 0.0 108.858 178.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -115.16 -42.78 3.14 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.405 -0.81 . . . . 0.0 109.352 178.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 9' ' ' ALA . 1.0 OUTLIER -67.12 -26.15 66.54 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 177.071 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 1.104 HG22 ' CD1' ' A' ' 16' ' ' LEU 0.257 0.2 OUTLIER -112.54 -82.8 0.59 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 178.891 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 16' ' ' LEU . . . 71.15 -11.17 2.89 Favored Glycine 0 N--CA 1.501 2.967 0 O-C-N 121.0 -1.063 . . . . 0.0 111.739 177.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.104 ' CD1' HG22 ' A' ' 14' ' ' THR . 4.4 mp -35.73 -64.11 0.32 Allowed 'General case' 0 N--CA 1.511 2.59 0 O-C-N 121.518 -0.989 . . . . 0.0 110.532 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.571 HG22 ' H ' ' A' ' 19' ' ' VAL . 0.5 OUTLIER -135.22 3.64 3.14 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.167 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.613 ' O ' ' C ' ' A' ' 19' ' ' VAL . 28.2 mt-30 56.44 29.04 14.57 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 -176.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 1.007 HG11 HG11 ' B' ' 19' ' ' VAL . 1.5 p -9.68 -94.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.904 -178.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.968 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -133.9 25.13 3.97 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 177.627 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.703 HG12 HG22 ' A' ' 10' ' ' ILE . 27.0 m -19.17 -39.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 122.474 1.13 . . . . 0.0 109.347 -178.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.852 ' N ' ' O ' ' A' ' 20' ' ' SER . 3.1 m -81.5 -38.7 25.89 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.661 177.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.968 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.1 OUTLIER -86.45 -35.79 19.45 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.547 -0.72 . . . . 0.0 111.186 179.492 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.578 ' HB3' HG21 ' B' ' 14' ' ' THR . 0.0 OUTLIER -68.17 -38.21 81.81 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 117.567 -1.653 . . . . 0.0 108.15 178.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.645 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 8.4 mt -72.42 -47.27 50.49 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 118.404 -1.319 . . . . 0.0 107.832 176.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.507 ' HA ' ' HE2' ' A' ' 3' ' ' LYS . . . -55.31 -34.0 63.78 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 177.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.634 ' HA ' ' HB3' ' A' ' 30' ' ' LYS . 54.9 p -83.16 -32.25 26.72 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.833 ' O ' HG13 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -56.57 -47.13 80.17 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.013 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.684 ' O ' ' HB ' ' A' ' 33' ' ' THR . 0.3 OUTLIER -71.02 -35.68 72.11 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 177.733 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.873 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 70.9 tttt -65.04 -21.44 66.83 Favored 'General case' 0 C--O 1.192 -1.962 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.833 HG13 ' O ' ' A' ' 28' ' ' PHE . 1.3 pp -105.06 -29.48 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.761 -1.212 . . . . 0.0 109.062 178.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.616 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.2 mm -71.43 -49.34 47.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 176.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.684 ' HB ' ' O ' ' A' ' 29' ' ' GLU . 0.3 OUTLIER -69.07 -43.37 74.71 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 177.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.873 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 57.7 mm-40 -68.31 -41.62 80.59 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 121.616 -0.677 . . . . 0.0 110.905 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.612 HG21 HG23 ' A' ' 42' ' ' VAL . 3.8 m -52.58 -50.37 63.14 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.588 -1.32 . . . . 0.0 108.537 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.932 HG21 HG23 ' A' ' 77' ' ' VAL . 1.1 t -54.01 -36.89 32.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 177.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.678 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -81.33 -6.24 58.68 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.537 0.684 . . . . 0.0 109.7 178.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.606 ' HG2' ' O ' ' A' ' 34' ' ' GLU . 2.4 mmpt? -97.58 -25.05 15.27 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 177.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.79 41.07 1.76 Allowed Glycine 0 C--N 1.303 -1.295 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 178.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.562 ' CB ' HG23 ' A' ' 35' ' ' THR . 0.2 OUTLIER -136.76 147.64 46.8 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.176 -1.191 . . . . 0.0 110.593 179.707 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.5 mtmt -100.51 102.94 14.25 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 1.12 HG13 HD11 ' B' ' 6' ' ' LEU . 2.0 t -74.77 152.42 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 C-N-CA 119.622 -0.831 . . . . 0.0 110.019 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.464 ' HA ' ' O ' ' A' ' 48' ' ' LEU . 6.1 mt-30 -140.26 94.16 2.71 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.403 -0.81 . . . . 0.0 110.221 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.642 HD12 ' CE1' ' A' ' 47' ' ' PHE . 22.1 mt -58.84 112.77 1.77 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.954 -1.091 . . . . 0.0 109.078 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.572 HG22 ' HG2' ' B' ' 29' ' ' GLU . 0.1 OUTLIER 35.99 -88.48 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.869 -0.519 . . . . 0.0 110.606 -179.157 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -149.52 29.12 1.19 Allowed Glycine 0 N--CA 1.484 1.898 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.77 ' CE1' HG21 ' B' ' 32' ' ' ILE . 3.9 p90 -128.03 -28.64 2.62 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.991 -1.3 . . . . 0.0 112.717 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.796 HD11 HD11 ' B' ' 50' ' ' ILE . 0.6 OUTLIER -123.78 100.84 6.97 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.36 -1.462 . . . . 0.0 111.297 179.28 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.431 ' HA ' ' HA ' ' A' ' 43' ' ' GLN . 44.6 t-20 -109.45 87.35 2.48 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.863 -0.523 . . . . 0.0 110.623 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.803 HG22 ' CG2' ' A' ' 79' ' ' VAL . 1.1 pt -79.39 147.62 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.159 -0.963 . . . . 0.0 110.505 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.422 ' HG3' ' HB3' ' A' ' 78' ' ' SER . 8.4 ptmt -157.15 122.71 2.42 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.053 -1.029 . . . . 0.0 110.079 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.506 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 55.3 Cg_endo -80.65 140.87 13.42 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 O-C-N 123.459 1.241 . . . . 0.0 112.025 -178.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.706 ' O ' ' N ' ' A' ' 76' ' ' GLY . 31.5 m -142.21 114.75 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 121.441 0.639 . . . . 0.0 109.64 178.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 1.012 ' HB2' HG23 ' A' ' 75' ' ' VAL . . . -117.0 145.06 43.9 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -177.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.612 ' O ' ' CB ' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -162.5 7.87 0.06 Allowed 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.986 175.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.843 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 0.0 OUTLIER 130.72 14.55 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.436 0 C-N-CA 124.547 1.139 . . . . 0.0 110.19 176.868 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.893 ' HB1' ' O ' ' A' ' 71' ' ' ILE . . . 152.9 179.95 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 122.27 1.033 . . . . 0.0 111.624 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.708 ' HB3' HG23 ' A' ' 71' ' ' ILE 0.261 0.0 OUTLIER -91.68 -143.85 0.19 Allowed 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.438 -179.868 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.477 ' HA ' ' C ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -160.98 48.58 0.22 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.341 -0.849 . . . . 0.0 109.802 179.571 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -163.41 33.93 0.3 Allowed Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.601 -1.285 . . . . 0.0 110.978 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.824 ' CD1' ' O ' ' A' ' 61' ' ' PHE . 0.1 OUTLIER -90.33 116.88 28.63 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.816 -1.402 . . . . 0.0 112.824 -179.692 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.673 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 0.9 OUTLIER -117.67 -26.23 0.09 OUTLIER Pre-proline 0 N--CA 1.497 1.903 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 -178.75 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.611 ' CD ' ' H ' ' A' ' 62' ' ' ASN . 45.2 Cg_endo -75.38 -4.63 15.58 Favored 'Trans proline' 0 N--CA 1.485 1.008 0 N-CA-C 110.027 -0.797 . . . . 0.0 110.027 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.813 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -90.14 46.3 1.34 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.511 -0.743 . . . . 0.0 110.133 179.527 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.1 p 50.97 23.76 1.59 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.293 -0.88 . . . . 0.0 109.591 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.661 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -155.21 111.05 3.12 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.648 -0.658 . . . . 0.0 109.909 -179.778 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.557 ' O ' ' CD2' ' A' ' 69' ' ' LEU . 5.6 mt-10 -29.74 152.38 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 122.335 1.064 . . . . 0.0 111.851 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.813 ' HA ' ' C ' ' A' ' 61' ' ' PHE . . . -57.88 118.69 5.61 Favored 'General case' 0 C--N 1.281 -2.395 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.118 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.599 ' H ' ' N ' ' A' ' 61' ' ' PHE . 0.4 OUTLIER 175.71 19.46 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.594 -0.692 . . . . 0.0 112.355 179.549 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.7 ' H ' ' H ' ' A' ' 61' ' ' PHE . 3.2 mt-10 162.41 85.99 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.308 0 O-C-N 121.075 -1.016 . . . . 0.0 110.598 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.893 ' O ' ' HB1' ' A' ' 57' ' ' ALA . 0.7 OUTLIER -80.14 -174.38 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.828 -1.17 . . . . 0.0 109.017 178.909 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.832 ' N ' HD12 ' A' ' 71' ' ' ILE . . . -48.09 170.74 0.1 Allowed Pre-proline 0 C--N 1.283 -2.299 0 O-C-N 121.952 -0.468 . . . . 0.0 112.178 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.769 ' HA ' ' O ' ' A' ' 56' ' ' GLN . 36.7 Cg_endo -61.96 117.3 4.13 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 122.878 2.385 . . . . 0.0 110.015 178.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.563 ' N ' ' CZ ' ' B' ' 94' ' ' TYR . 0.5 OUTLIER 176.37 165.6 0.44 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.339 -0.851 . . . . 0.0 109.113 -179.548 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 1.012 HG23 ' HB2' ' A' ' 54' ' ' ALA . 0.3 OUTLIER -61.58 171.78 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.058 -1.026 . . . . 0.0 109.888 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.706 ' N ' ' O ' ' A' ' 53' ' ' VAL . . . -115.37 61.2 0.38 Allowed Glycine 0 N--CA 1.484 1.873 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.95 HG21 ' CB ' ' B' ' 85' ' ' LEU . 2.3 p -43.47 83.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.998 -0.707 . . . . 0.0 110.787 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.617 ' N ' ' O ' ' A' ' 76' ' ' GLY . 1.3 t -81.68 175.97 10.02 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.985 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.803 ' CG2' HG22 ' A' ' 50' ' ' ILE . 3.3 p 176.25 176.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.606 ' N ' HG22 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -176.09 171.43 1.1 Allowed Pre-proline 0 N--CA 1.485 1.286 0 O-C-N 120.799 -1.188 . . . . 0.0 110.868 177.3 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.581 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 55.6 Cg_endo -97.03 136.51 0.44 Allowed 'Trans proline' 0 C--N 1.302 -1.878 0 C-N-CA 122.843 2.362 . . . . 0.0 110.706 178.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.657 ' O ' HD12 ' A' ' 85' ' ' LEU . . . -91.64 -158.74 34.85 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 178.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -89.33 -16.53 30.87 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.117 -1.226 . . . . 0.0 110.394 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.436 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -53.59 -33.42 54.81 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.304 -0.872 . . . . 0.0 109.975 -179.857 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.825 ' CB ' HG21 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -86.0 -30.94 22.32 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.326 -0.859 . . . . 0.0 108.77 178.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.439 ' HA ' ' CG1' ' B' ' 75' ' ' VAL . 0.6 OUTLIER -72.94 -33.12 65.72 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.415 -0.803 . . . . 0.0 109.838 -179.88 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -78.63 -34.92 46.22 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 1.035 ' C ' ' HB1' ' B' ' 37' ' ' ALA . . . -68.53 -31.26 70.37 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 177.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 1.051 ' N ' ' HB1' ' B' ' 37' ' ' ALA . . . -69.94 -35.73 74.74 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -178.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -59.55 -24.79 64.01 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 174.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -64.43 -54.41 29.53 Favored Glycine 0 N--CA 1.483 1.797 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 178.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.879 HD23 ' C ' ' B' ' 37' ' ' ALA . 2.1 pp -67.11 -42.19 84.96 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 119.76 1.78 . . . . 0.0 109.502 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.8 ' HB3' HD12 ' A' ' 92' ' ' LEU . 2.6 tttp 156.8 80.88 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.8 ' O ' ' N ' ' A' ' 97' ' ' PHE . 9.1 t80 -61.79 -62.85 1.51 Allowed 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 115.297 -2.561 . . . . 0.0 105.96 177.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.975 ' O ' ' N ' ' A' ' 98' ' ' ALA . 2.3 mp0 10.35 41.28 0.0 OUTLIER 'General case' 0 CA--C 1.486 -1.501 0 N-CA-C 101.561 -3.496 . . . . 0.0 101.561 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 1.045 ' O ' ' N ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER 19.39 44.52 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 113.027 -1.897 . . . . 0.0 108.103 -173.029 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.812 ' C ' ' O ' ' A' ' 96' ' ' ASP . 0.1 OUTLIER 27.16 28.8 0.0 OUTLIER 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 101.888 -3.375 . . . . 0.0 101.888 -170.495 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 1.045 ' N ' ' O ' ' A' ' 96' ' ' ASP 0.263 . . -70.01 -31.68 69.46 Favored 'General case' 0 C--O 1.215 -0.711 0 CA-C-N 110.186 -3.188 . . . . 0.0 109.614 -178.356 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.199 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.757 ' HB2' HG22 ' A' ' 42' ' ' VAL . 5.9 mtp . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 120.863 0.363 . . . . 0.0 110.133 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . 0.551 ' H ' ' HB2' ' B' ' 5' ' ' GLU . 2.0 t-20 -172.53 -159.42 0.13 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.055 -1.028 . . . . 0.0 111.396 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.494 ' HG2' ' OE1' ' B' ' 29' ' ' GLU . 1.4 mttt -58.36 -7.56 0.92 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.407 -0.808 . . . . 0.0 110.291 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.671 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 90.0 m -116.82 -48.3 2.67 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.042 -1.036 . . . . 0.0 110.304 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.59 ' HA ' ' HE2' ' B' ' 8' ' ' LYS . 3.0 mt-10 -61.64 -52.89 62.49 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.117 -0.989 . . . . 0.0 108.904 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 1.12 HD11 HG13 ' A' ' 42' ' ' VAL . 0.9 OUTLIER -60.23 -27.79 67.49 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.196 -1.002 . . . . 0.0 108.928 178.355 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' ILE . . . . . 0.808 HG23 ' HB ' ' B' ' 21' ' ' VAL . 0.4 OUTLIER -56.26 -58.01 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 178.158 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . 0.91 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.1 OUTLIER -55.35 -31.85 62.08 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . 0.768 ' HB3' ' O ' ' B' ' 6' ' ' LEU . . . -57.57 -37.22 72.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.27 -0.894 . . . . 0.0 108.958 178.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.934 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.2 mp -92.57 -25.96 4.95 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.209 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 177.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.91 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -75.99 -2.23 29.51 Favored 'General case' 0 C--N 1.287 -2.121 0 O-C-N 120.703 -1.248 . . . . 0.0 108.152 177.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.418 ' HB3' ' O ' ' B' ' 8' ' ' LYS . 55.7 tp60 -125.3 -41.62 2.04 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.531 -0.731 . . . . 0.0 109.898 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' B' ' 9' ' ' ALA . 1.0 OUTLIER -72.18 -23.78 61.32 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 177.838 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 1.092 HG22 ' CD1' ' B' ' 16' ' ' LEU 0.284 0.2 OUTLIER -103.8 -62.13 1.34 Allowed 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 179.609 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 52.12 24.07 14.01 Favored Glycine 0 N--CA 1.5 2.912 0 O-C-N 121.369 -0.832 . . . . 0.0 111.569 177.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' LEU . . . . . 1.092 ' CD1' HG22 ' B' ' 14' ' ' THR . 4.5 mp -69.76 -69.97 0.31 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.343 -1.092 . . . . 0.0 109.904 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . 0.586 HG22 ' H ' ' B' ' 19' ' ' VAL . 0.6 OUTLIER -137.81 5.74 2.64 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.736 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . 0.669 ' O ' ' C ' ' B' ' 19' ' ' VAL . 33.2 mt-30 57.42 27.53 14.04 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 -176.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 1.007 HG11 HG11 ' A' ' 19' ' ' VAL . 1.5 p -0.41 -96.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.947 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 1.091 ' O ' ' N ' ' B' ' 22' ' ' SER . 14.9 p -133.53 23.08 4.01 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 175.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.808 ' HB ' HG23 ' B' ' 7' ' ' ILE . 28.1 m -3.87 -39.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-O 122.302 1.048 . . . . 0.0 110.981 -177.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 1.091 ' N ' ' O ' ' B' ' 20' ' ' SER . 2.4 t -73.0 -44.01 61.5 Favored 'General case' 0 C--N 1.281 -2.387 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.93 177.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . 0.813 ' N ' ' O ' ' B' ' 20' ' ' SER . 5.1 mtpt -88.37 -29.32 20.37 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.659 -0.651 . . . . 0.0 109.693 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' MET . . . . . 0.715 ' HE2' ' HA ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -62.77 -41.44 99.24 Favored 'General case' 0 C--N 1.314 -0.958 0 O-C-N 120.899 -1.126 . . . . 0.0 109.443 179.796 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.716 HD12 HG13 ' B' ' 7' ' ' ILE . 1.2 mt -84.51 -45.38 12.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.891 -1.13 . . . . 0.0 108.406 177.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . 0.499 ' O ' ' CB ' ' B' ' 30' ' ' LYS . . . -53.31 -34.68 58.38 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 178.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . 0.611 ' O ' HG23 ' B' ' 31' ' ' ILE . 58.4 m -78.55 -40.28 35.34 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 177.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . 0.728 ' HA ' ' CG1' ' B' ' 31' ' ' ILE . 0.1 OUTLIER -63.82 -36.63 84.53 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.636 -0.665 . . . . 0.0 109.394 179.42 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . 0.587 ' HG3' ' CE2' ' B' ' 28' ' ' PHE . 0.9 OUTLIER -82.07 -31.97 30.57 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 178.721 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 0.82 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 16.6 tttp -72.22 -28.42 63.16 Favored 'General case' 0 C--O 1.191 -1.989 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 176.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.728 ' CG1' ' HA ' ' B' ' 28' ' ' PHE . 1.6 pp -94.67 -30.48 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.03 -1.044 . . . . 0.0 109.884 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.979 HD13 HG21 ' B' ' 42' ' ' VAL . 3.6 mm -62.91 -61.88 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 177.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' THR . . . . . 0.557 ' OG1' ' HG ' ' A' ' 85' ' ' LEU . 0.4 OUTLIER -58.42 -40.18 81.79 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.813 179.213 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.84 ' O ' ' N ' ' B' ' 38' ' ' LYS . 40.9 mm-40 -73.29 -48.42 34.74 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.855 -0.528 . . . . 0.0 112.296 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' THR . . . . . 0.667 HG22 ' O ' ' B' ' 40' ' ' ASP . 92.9 m -52.16 -59.16 4.7 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.477 -1.389 . . . . 0.0 110.504 -178.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.998 HG23 HG12 ' B' ' 42' ' ' VAL . 0.9 OUTLIER -51.38 -45.32 33.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 178.408 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 1.051 ' HB1' ' N ' ' A' ' 89' ' ' ALA . . . -83.52 1.88 39.71 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.993 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.84 ' N ' ' O ' ' B' ' 34' ' ' GLU . 0.5 OUTLIER -107.53 -37.85 6.07 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.188 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 145.28 41.92 0.05 OUTLIER Glycine 0 C--N 1.301 -1.405 0 C-N-CA 119.008 -1.568 . . . . 0.0 111.273 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . 0.667 ' O ' HG22 ' B' ' 35' ' ' THR . 0.6 OUTLIER -161.75 127.11 3.54 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.93 -1.335 . . . . 0.0 110.604 179.236 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.83 86.53 0.23 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.675 -0.641 . . . . 0.0 109.421 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.998 HG12 HG23 ' B' ' 36' ' ' VAL . 9.4 p -61.8 125.93 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 C-N-CA 119.919 -0.712 . . . . 0.0 109.66 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' GLN . . . . . 0.55 ' O ' ' HA ' ' A' ' 2' ' ' ASN . 5.4 mt-30 -131.11 172.25 12.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.899 . . . . 0.0 110.29 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.97 HD12 ' CB ' ' B' ' 48' ' ' LEU . 29.3 mt -136.48 120.21 17.31 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.503 -0.748 . . . . 0.0 109.625 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . 0.552 ' HB ' ' CD ' ' A' ' 3' ' ' LYS . 0.1 OUTLIER 34.43 -92.72 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.375 0 O-C-N 121.646 -0.659 . . . . 0.0 110.821 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -159.24 30.37 0.42 Allowed Glycine 0 N--CA 1.486 2.032 0 N-CA-C 108.256 -1.937 . . . . 0.0 108.256 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . 0.673 ' CE1' ' HG2' ' A' ' 29' ' ' GLU . 0.1 OUTLIER -124.65 -26.76 3.78 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.546 -0.973 . . . . 0.0 110.981 -179.447 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.97 ' CB ' HD12 ' B' ' 44' ' ' LEU . 9.7 mt -130.56 90.29 2.9 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.835 -1.165 . . . . 0.0 110.415 177.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' ASN . . . . . 0.414 ' O ' ' HA ' ' B' ' 79' ' ' VAL . 0.7 OUTLIER -98.26 88.83 4.28 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.705 -0.622 . . . . 0.0 110.481 -179.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' ILE . . . . . 0.947 HG22 HG21 ' B' ' 36' ' ' VAL . 0.8 OUTLIER -81.73 147.32 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.383 -0.823 . . . . 0.0 110.906 -179.835 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' B' ' 78' ' ' SER . 3.3 ptmt -164.31 131.04 2.34 Favored Pre-proline 0 N--CA 1.502 2.154 0 O-C-N 121.258 -0.901 . . . . 0.0 110.391 179.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.897 ' HD3' HG22 ' B' ' 36' ' ' VAL . 50.8 Cg_endo -84.28 146.86 11.27 Favored 'Trans proline' 0 C--N 1.318 -1.039 0 O-C-N 123.195 1.103 . . . . 0.0 112.241 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.669 HG22 ' O ' ' B' ' 76' ' ' GLY . 23.1 m -146.4 117.39 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-O 121.765 0.793 . . . . 0.0 110.284 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.88 ' HB1' ' CB ' ' A' ' 96' ' ' ASP . . . -51.66 130.69 28.88 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.755 0.788 . . . . 0.0 111.783 -178.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.89 96.11 1.7 Allowed 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . 0.437 ' HA ' ' HA ' ' B' ' 73' ' ' PRO . 61.6 mt-30 -60.71 -171.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.29 -0.881 . . . . 0.0 111.566 -178.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.901 ' HB2' ' HD3' ' B' ' 73' ' ' PRO . . . -80.7 -157.39 0.16 Allowed 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.502 0.667 . . . . 0.0 110.382 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' ARG . . . . . 0.565 ' HB3' HG12 ' B' ' 71' ' ' ILE . 0.0 OUTLIER -166.33 148.85 6.91 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.637 -0.665 . . . . 0.0 109.555 -179.806 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -164.91 165.67 20.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.329 -0.857 . . . . 0.0 110.372 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . 0.501 ' O ' ' HB3' ' B' ' 61' ' ' PHE . . . 166.46 -101.78 0.18 Allowed Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' PHE . . . . . 0.672 ' CD1' ' N ' ' B' ' 61' ' ' PHE . 0.0 OUTLIER 170.49 152.48 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.68 -0.894 . . . . 0.0 110.879 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . 0.649 ' H ' ' HD2' ' B' ' 63' ' ' PRO . 0.0 OUTLIER -105.88 -44.91 0.14 Allowed Pre-proline 0 N--CA 1.502 2.161 0 O-C-N 120.836 -1.165 . . . . 0.0 113.404 -178.656 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.649 ' HD2' ' H ' ' B' ' 62' ' ' ASN . 39.9 Cg_endo -67.54 -11.85 33.59 Favored 'Trans proline' 0 N--CA 1.488 1.177 0 O-C-N 122.843 0.918 . . . . 0.0 111.223 -177.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . 0.558 ' CB ' ' CD2' ' B' ' 61' ' ' PHE . 0.9 OUTLIER -90.84 50.4 1.8 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.333 -0.854 . . . . 0.0 109.222 178.738 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 3.2 p 53.33 28.42 7.32 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.454 -0.779 . . . . 0.0 109.701 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . 0.558 ' CB ' ' CE1' ' B' ' 61' ' ' PHE . 0.0 OUTLIER -139.91 -145.67 0.19 Allowed 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.47 -0.768 . . . . 0.0 110.126 -179.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . 0.69 ' HB3' HD21 ' B' ' 69' ' ' LEU . 2.8 mt-10 -140.34 117.11 10.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.13 -0.981 . . . . 0.0 108.49 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . 0.897 ' O ' HD23 ' B' ' 69' ' ' LEU . . . -73.61 133.15 43.42 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.358 -0.839 . . . . 0.0 109.944 -178.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.897 HD23 ' O ' ' B' ' 68' ' ' ALA . 1.4 mt -138.67 177.93 7.52 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 120.029 -0.669 . . . . 0.0 110.38 -177.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' B' ' 58' ' ' ARG . 0.6 OUTLIER 173.59 37.89 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.356 -0.84 . . . . 0.0 110.964 -179.653 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.565 HG12 ' HB3' ' B' ' 58' ' ' ARG . 2.6 pt -65.15 -153.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.957 -1.09 . . . . 0.0 110.181 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -131.39 143.45 49.32 Favored Pre-proline 0 C--N 1.303 -1.427 0 O-C-N 121.291 -0.881 . . . . 0.0 111.943 -178.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' PRO . . . . . 0.901 ' HD3' ' HB2' ' B' ' 57' ' ' ALA . 48.6 Cg_endo -74.95 123.08 7.64 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.65 1.566 . . . . 0.0 109.804 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . 0.428 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 4.9 p -178.57 152.28 0.63 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.214 -0.929 . . . . 0.0 110.168 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . 1.038 HG11 ' CB ' ' A' ' 89' ' ' ALA . 11.9 p -50.99 170.03 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.419 -0.801 . . . . 0.0 109.994 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . 0.669 ' O ' HG22 ' B' ' 53' ' ' VAL . . . -119.23 71.31 0.32 Allowed Glycine 0 N--CA 1.488 2.161 0 C-N-CA 119.005 -1.569 . . . . 0.0 109.826 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.894 HG23 HG11 ' B' ' 36' ' ' VAL . 3.1 p -59.07 77.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.377 -1.072 . . . . 0.0 109.726 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . 0.56 ' N ' ' O ' ' B' ' 76' ' ' GLY . 0.2 OUTLIER -71.11 177.35 3.83 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 122.174 0.988 . . . . 0.0 111.286 -179.298 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.574 HG22 ' N ' ' B' ' 80' ' ' LYS . 1.6 p 176.56 176.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . 0.691 ' O ' HD23 ' B' ' 48' ' ' LEU . 16.1 ptmt -176.33 174.05 0.78 Allowed Pre-proline 0 N--CA 1.486 1.326 0 O-C-N 120.764 -1.21 . . . . 0.0 110.349 178.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' PRO . . . . . 0.471 ' HA ' ' O ' ' B' ' 47' ' ' PHE . 52.8 Cg_endo -96.01 136.56 0.6 Allowed 'Trans proline' 0 C--N 1.302 -1.877 0 C-N-CA 122.294 1.996 . . . . 0.0 109.842 178.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . 0.461 ' HA3' ' HA ' ' B' ' 47' ' ' PHE . . . -97.35 -168.3 32.86 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 107.793 -2.123 . . . . 0.0 107.793 178.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . 0.63 ' HA ' ' HB2' ' B' ' 86' ' ' LYS . 0.9 OUTLIER -76.97 -18.28 58.33 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.886 -1.361 . . . . 0.0 110.283 179.776 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' SER . . . . . 0.487 ' CB ' ' HB3' ' B' ' 47' ' ' PHE . 0.2 OUTLIER -50.94 -42.19 59.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.167 -0.958 . . . . 0.0 108.815 179.368 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.95 ' CB ' HG21 ' A' ' 77' ' ' VAL . 1.0 OUTLIER -73.72 -31.41 63.37 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 177.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . 0.63 ' HB2' ' HA ' ' B' ' 83' ' ' GLU . 29.4 mtmm -73.29 -38.24 65.97 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.392 0.615 . . . . 0.0 110.196 -179.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 13.8 ttpt -74.54 -37.12 63.12 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 177.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.642 ' O ' ' HB1' ' A' ' 37' ' ' ALA . . . -68.92 -34.73 75.86 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 176.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.948 ' HA ' HD23 ' B' ' 92' ' ' LEU . . . -55.95 -44.36 78.36 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -54.07 -33.51 57.67 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 176.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' B' ' 88' ' ' ALA . . . -61.79 -38.47 96.0 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 178.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . 0.948 HD23 ' HA ' ' B' ' 89' ' ' ALA . 0.4 OUTLIER -72.27 13.8 0.29 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.69 -1.477 . . . . 0.0 110.762 179.697 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' B' ' 92' ' ' LEU . 72.8 mmtt 62.17 39.84 12.37 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 -177.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . 0.563 ' CZ ' ' N ' ' A' ' 74' ' ' SER . 0.0 OUTLIER -38.09 -37.23 0.25 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.565 -179.214 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -60.12 -42.53 94.97 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.46 -0.775 . . . . 0.0 109.811 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 96' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' B' ' 93' ' ' LYS . 3.4 m-20 -60.57 -36.68 79.08 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 97' ' ' PHE . . . . . 0.504 ' HB3' ' HB3' ' A' ' 54' ' ' ALA . 0.7 OUTLIER -75.43 -26.34 58.24 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.709 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 98' ' ' ALA . . . . . 0.407 ' HA ' ' HA ' ' A' ' 55' ' ' ARG . . . -76.1 -57.1 4.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.605 -0.684 . . . . 0.0 110.191 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 35.8 mttt . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 117.917 -1.04 . . . . 0.0 110.191 -179.995 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.583 ' HE3' ' HG ' ' A' ' 6' ' ' LEU . 7.3 mtp . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.519 ' CA ' HD12 ' A' ' 6' ' ' LEU . 50.4 p-10 -171.16 -162.78 0.26 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.798 -1.189 . . . . 0.0 112.43 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.555 ' HE2' ' HA ' ' A' ' 26' ' ' ALA . 9.8 tttm -46.79 -15.34 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.776 -0.578 . . . . 0.0 111.068 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.632 ' O ' ' CG1' ' A' ' 7' ' ' ILE . 58.6 m -117.26 -58.06 2.09 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.126 -0.984 . . . . 0.0 110.304 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.599 ' HA ' ' HE3' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -46.64 -44.86 18.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.115 -0.991 . . . . 0.0 109.489 179.698 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.715 HD23 ' CD1' ' B' ' 31' ' ' ILE . 1.3 mt -63.74 -33.28 75.3 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.15 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.75 ' N ' HD12 ' A' ' 25' ' ' LEU . 0.9 OUTLIER -56.68 -42.61 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.764 -1.21 . . . . 0.0 108.097 179.699 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.908 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 6.7 mtmt -66.56 -34.14 77.23 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 177.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.865 ' CB ' HD13 ' B' ' 31' ' ' ILE . . . -53.71 -39.51 65.26 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.546 -0.862 . . . . 0.0 109.362 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.776 HG22 HG12 ' A' ' 21' ' ' VAL . 1.3 mp -91.01 -31.58 5.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 178.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.908 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -65.3 -13.47 58.53 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 118.956 -1.098 . . . . 0.0 108.364 177.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.445 ' HB3' ' O ' ' A' ' 8' ' ' LYS . 1.1 tp60 -113.44 -45.12 3.15 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.487 ' HB3' ' HB2' ' B' ' 27' ' ' SER . 1.8 m-20 -62.34 -33.8 75.41 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 177.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.723 ' OG1' ' O ' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -102.16 -71.14 0.73 Allowed 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 178.494 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 46.37 27.37 2.8 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.076 ' CD1' HG23 ' B' ' 19' ' ' VAL . 0.1 OUTLIER -87.28 -25.83 23.75 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.449 -1.03 . . . . 0.0 108.946 178.868 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.712 HG21 HG21 ' B' ' 17' ' ' THR . 0.5 OUTLIER -153.8 -8.32 0.16 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.907 -0.496 . . . . 0.0 110.228 -179.449 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.515 ' O ' ' C ' ' A' ' 19' ' ' VAL . 4.5 mt-30 57.06 36.82 28.19 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 -177.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 1.056 HG23 ' CD1' ' B' ' 16' ' ' LEU . 0.6 OUTLIER -23.93 -93.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.614 -178.712 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.945 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -135.18 22.92 3.49 Favored 'General case' 0 C--N 1.281 -2.39 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 178.709 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.776 HG12 HG22 ' A' ' 10' ' ' ILE . 31.3 m -21.7 -40.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-O 122.385 1.088 . . . . 0.0 108.697 -177.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.811 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.2 OUTLIER -82.16 -39.04 23.8 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 114.891 -1.049 . . . . 0.0 109.601 177.614 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.945 ' N ' ' O ' ' A' ' 20' ' ' SER . 1.2 mtpt -85.33 -32.76 22.29 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.576 -0.703 . . . . 0.0 111.836 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.82 ' HB3' HG23 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -77.01 -34.95 57.37 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.252 -1.53 . . . . 0.0 108.976 179.715 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.75 HD12 ' N ' ' A' ' 7' ' ' ILE . 2.2 mt -77.74 -43.57 30.49 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 118.551 -1.26 . . . . 0.0 107.863 177.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.555 ' HA ' ' HE2' ' A' ' 3' ' ' LYS . . . -59.3 -34.08 71.88 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 177.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.611 ' O ' HG23 ' A' ' 31' ' ' ILE . 85.6 p -81.75 -26.64 34.33 Favored 'General case' 0 C--O 1.204 -1.294 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.841 ' HE2' HD22 ' B' ' 44' ' ' LEU . 0.3 OUTLIER -64.86 -30.23 71.22 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.67 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.748 ' O ' ' HB ' ' A' ' 33' ' ' THR . 4.5 mt-10 -90.64 -21.55 21.62 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 177.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.785 ' O ' ' CG ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -83.36 -19.06 36.81 Favored 'General case' 0 C--O 1.192 -1.944 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 175.52 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.756 ' CG1' ' HA ' ' A' ' 28' ' ' PHE . 2.1 pp -104.67 -33.34 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.059 -1.025 . . . . 0.0 109.048 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 1.027 HD13 HG11 ' A' ' 42' ' ' VAL . 2.6 mm -64.14 -46.46 93.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 176.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.833 ' HA ' HD13 ' B' ' 85' ' ' LEU 0.324 16.4 m -67.56 -54.26 21.42 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 113.762 -1.563 . . . . 0.0 108.197 178.504 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.785 ' CG ' ' O ' ' A' ' 30' ' ' LYS . 57.2 mm-40 -63.2 -32.43 73.82 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.054 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.832 HG21 ' CG2' ' A' ' 42' ' ' VAL . 1.5 m -58.26 -51.79 68.29 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.026 -1.046 . . . . 0.0 108.417 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.138 HG21 HG22 ' A' ' 77' ' ' VAL . 0.9 OUTLIER -52.39 -41.61 35.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 C-N-CA 117.982 -1.487 . . . . 0.0 107.218 177.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.888 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -72.51 -7.99 52.84 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.463 -0.895 . . . . 0.0 109.343 177.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.521 ' N ' ' O ' ' A' ' 35' ' ' THR . 0.0 OUTLIER -101.52 -23.69 14.26 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.301 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 35' ' ' THR . . . 102.61 41.48 2.33 Favored Glycine 0 C--N 1.301 -1.383 0 C-N-CA 119.967 -1.111 . . . . 0.0 110.648 178.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.791 ' CB ' HG23 ' A' ' 35' ' ' THR . 0.1 OUTLIER -128.86 133.97 48.14 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.011 -1.288 . . . . 0.0 110.809 179.648 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -85.27 91.83 8.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.56 -0.713 . . . . 0.0 109.55 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 1.027 HG11 HD13 ' A' ' 32' ' ' ILE . 82.0 t -67.43 149.63 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-O 121.437 0.637 . . . . 0.0 111.153 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.446 ' O ' ' HA ' ' B' ' 2' ' ' ASN . 4.2 pt20 -158.2 147.62 19.56 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.566 -0.709 . . . . 0.0 109.885 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.808 HD22 ' CE1' ' B' ' 28' ' ' PHE . 35.7 mt -99.47 118.7 36.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.3 -0.875 . . . . 0.0 109.736 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.524 HG21 ' CG ' ' B' ' 29' ' ' GLU . 0.0 OUTLIER 27.36 -95.18 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.953 -0.467 . . . . 0.0 112.235 -179.627 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.501 ' H ' HG23 ' A' ' 45' ' ' THR . . . -129.82 4.45 6.11 Favored Glycine 0 N--CA 1.486 1.976 0 C-N-CA 119.556 -1.307 . . . . 0.0 111.241 -178.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.787 ' CE2' HG21 ' B' ' 32' ' ' ILE . 26.8 p90 -100.24 -64.67 1.02 Allowed 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 119.554 1.677 . . . . 0.0 110.765 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.875 HD22 ' HA2' ' A' ' 82' ' ' GLY . 0.8 OUTLIER -88.17 142.31 27.86 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.241 -1.537 . . . . 0.0 114.673 -178.843 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.661 ' HB2' ' HG2' ' A' ' 81' ' ' PRO . 0.1 OUTLIER -145.25 92.31 2.24 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.567 177.021 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.816 HD13 HG23 ' A' ' 79' ' ' VAL . 46.6 mm -85.71 160.17 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.172 -0.955 . . . . 0.0 110.655 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.413 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 5.0 ptmt -167.32 128.04 1.18 Allowed Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 120.976 -1.077 . . . . 0.0 110.478 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.501 ' HB2' HG11 ' A' ' 75' ' ' VAL . 52.4 Cg_endo -77.62 148.65 26.14 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 O-C-N 123.55 1.289 . . . . 0.0 111.216 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.894 HG22 ' O ' ' A' ' 76' ' ' GLY . 32.9 m -140.59 114.86 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-O 121.717 0.77 . . . . 0.0 111.085 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.703 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . -54.48 141.53 30.63 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 122.0 0.905 . . . . 0.0 111.861 -178.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.06 94.13 0.09 Allowed 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.498 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 7.7 mt-30 -51.99 -178.07 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.451 -0.781 . . . . 0.0 111.661 -178.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.792 ' HB2' ' HD3' ' A' ' 73' ' ' PRO . . . -67.14 179.78 1.12 Allowed 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.456 0.646 . . . . 0.0 110.878 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.485 ' HB2' HG12 ' A' ' 71' ' ' ILE . 52.9 mtp85 -153.89 19.6 0.52 Allowed 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.655 -0.653 . . . . 0.0 110.593 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.59 97.98 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.868 0.842 . . . . 0.0 110.779 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.442 ' O ' ' HB3' ' A' ' 61' ' ' PHE . . . 168.47 -103.51 0.2 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 107.758 -2.137 . . . . 0.0 107.758 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.588 ' CD1' ' O ' ' A' ' 62' ' ' ASN . 51.3 p90 -178.4 162.87 1.53 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.407 -1.055 . . . . 0.0 110.443 178.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.588 ' O ' ' CD1' ' A' ' 61' ' ' PHE . 1.3 t-20 -56.59 -170.38 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.62 -0.675 . . . . 0.0 109.56 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.522 ' HD2' ' CB ' ' A' ' 62' ' ' ASN . 43.1 Cg_endo -73.2 61.63 4.1 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 N-CA-C 108.884 -1.237 . . . . 0.0 108.884 178.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.743 ' O ' HG23 ' A' ' 65' ' ' THR . 32.8 mt-30 -140.0 -110.07 0.15 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.505 -0.747 . . . . 0.0 110.66 -178.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.743 HG23 ' O ' ' A' ' 64' ' ' GLN . 0.1 OUTLIER -171.95 21.44 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.977 -1.077 . . . . 0.0 110.743 179.754 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.438 ' HG2' ' N ' ' A' ' 67' ' ' GLU . 2.2 pm0 -173.72 -27.45 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.953 -1.092 . . . . 0.0 111.887 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.528 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 3.5 tp10 -64.93 82.25 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.927 -1.108 . . . . 0.0 109.329 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' A' ' 61' ' ' PHE . . . -92.67 160.95 14.76 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.855 0.836 . . . . 0.0 112.243 -178.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.8 mt -130.79 -146.42 0.3 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -174.4 32.16 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.717 -1.24 . . . . 0.0 110.968 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.485 HG12 ' HB2' ' A' ' 58' ' ' ARG . 1.1 pt -62.8 -158.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.143 -0.973 . . . . 0.0 109.897 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.33 148.55 48.06 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.275 -0.891 . . . . 0.0 110.773 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.792 ' HD3' ' HB2' ' A' ' 57' ' ' ALA . 41.8 Cg_endo -68.21 82.81 0.48 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 124.081 1.569 . . . . 0.0 110.494 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.505 ' HA ' ' CE1' ' B' ' 94' ' ' TYR . 18.9 p -169.47 160.21 9.02 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.544 -0.722 . . . . 0.0 109.445 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.703 ' HA ' ' HA ' ' A' ' 54' ' ' ALA . 0.5 OUTLIER -52.58 168.63 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.06 -1.025 . . . . 0.0 109.003 179.836 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.894 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -118.51 99.52 0.79 Allowed Glycine 0 N--CA 1.486 2.014 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 1.138 HG22 HG21 ' A' ' 36' ' ' VAL . 1.4 t -58.53 86.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-O 122.09 0.948 . . . . 0.0 108.82 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 76' ' ' GLY . 0.2 OUTLIER -79.58 -152.77 0.07 Allowed 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 121.726 0.774 . . . . 0.0 110.272 -179.129 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.816 HG23 HD13 ' A' ' 50' ' ' ILE . 5.4 p 179.98 178.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.872 ' CB ' ' HD3' ' A' ' 81' ' ' PRO . 16.3 mttt -148.45 -70.19 0.02 OUTLIER Pre-proline 0 C--N 1.302 -1.462 0 C-N-CA 117.856 -1.537 . . . . 0.0 112.464 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.872 ' HD3' ' CB ' ' A' ' 80' ' ' LYS . 57.0 Cg_endo -102.23 -172.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.297 -2.16 0 C-N-CA 121.375 1.383 . . . . 0.0 112.834 -177.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.875 ' HA2' HD22 ' A' ' 48' ' ' LEU . . . 177.31 24.08 0.03 OUTLIER Glycine 0 C--N 1.29 -2.024 0 N-CA-C 107.23 -2.348 . . . . 0.0 107.23 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.898 ' O ' ' N ' ' A' ' 85' ' ' LEU . 44.3 tt0 32.6 48.38 0.12 Allowed 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 -176.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 1.325 ' O ' ' N ' ' A' ' 86' ' ' LYS . 0.2 OUTLIER 13.21 41.21 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.334 0 CA-C-N 114.007 -1.452 . . . . 0.0 109.686 -176.685 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 1.069 ' C ' ' O ' ' A' ' 84' ' ' SER . 4.7 mt 20.23 32.43 0.0 OUTLIER 'General case' 0 C--O 1.198 -1.642 0 N-CA-C 102.236 -3.246 . . . . 0.0 102.236 -173.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 1.325 ' N ' ' O ' ' A' ' 84' ' ' SER 0.349 3.2 tttt -57.77 -41.59 82.32 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 103.288 -2.856 . . . . 0.0 103.288 176.496 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.304 11.8 tttp -70.35 -32.77 70.61 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 111.44 -2.618 . . . . 0.0 105.438 174.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.838 ' HB1' ' HB ' ' B' ' 36' ' ' VAL . . . -77.41 -16.33 58.89 Favored 'General case' 0 C--O 1.2 -1.508 0 CA-C-O 122.201 1.001 . . . . 0.0 109.172 178.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.787 ' CB ' HG12 ' B' ' 75' ' ' VAL . . . -89.96 -24.12 21.36 Favored 'General case' 0 C--N 1.282 -2.337 0 O-C-N 120.443 -1.41 . . . . 0.0 108.787 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -71.85 -34.64 69.43 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.873 ' HA3' ' HB1' ' B' ' 37' ' ' ALA . . . -77.34 -32.44 47.63 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 178.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.889 ' CD1' HG21 ' B' ' 75' ' ' VAL 0.26 2.5 mt -51.33 -7.83 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.104 -1.233 . . . . 0.0 112.021 179.573 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' A' ' 96' ' ' ASP . 0.2 OUTLIER 62.56 36.7 13.67 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 -175.313 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.501 ' CD1' ' N ' ' B' ' 75' ' ' VAL . 63.9 t80 -34.18 -45.08 0.2 Allowed 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.697 -178.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -54.56 -41.34 69.69 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.272 -0.893 . . . . 0.0 109.737 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.45 ' N ' ' O ' ' A' ' 93' ' ' LYS . 6.9 t0 -63.76 -33.86 76.61 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.721 ' HB3' ' HB2' ' B' ' 54' ' ' ALA . 0.1 OUTLIER -81.75 -17.9 46.1 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.82 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.5 -32.85 54.42 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.506 -0.746 . . . . 0.0 110.25 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 118.043 -0.98 . . . . 0.0 110.211 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.523 ' CE ' HD23 ' B' ' 6' ' ' LEU . 2.1 mtp . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 120.886 0.374 . . . . 0.0 110.113 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . 0.446 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 41.7 t30 -177.82 178.06 1.02 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.299 -0.876 . . . . 0.0 110.693 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.515 ' HE3' ' CB ' ' B' ' 29' ' ' GLU . 0.0 OUTLIER -49.45 -19.62 0.57 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.437 -0.789 . . . . 0.0 110.096 179.553 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.554 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 81.4 m -103.64 -41.43 5.95 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.158 -0.964 . . . . 0.0 108.941 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.445 ' CB ' ' HA ' ' B' ' 1' ' ' MET . 0.0 OUTLIER -65.22 -49.93 67.82 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.692 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.903 HD11 HG13 ' A' ' 42' ' ' VAL . 9.4 mt -60.54 -33.48 72.73 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' ILE . . . . . 0.941 HG23 ' HB ' ' B' ' 21' ' ' VAL . 0.6 OUTLIER -53.24 -55.71 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.333 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . 0.953 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.0 OUTLIER -58.15 -31.62 67.41 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.13 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' B' ' 6' ' ' LEU . . . -56.1 -37.16 69.0 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.173 -0.954 . . . . 0.0 109.021 178.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.82 HG23 ' HB3' ' A' ' 24' ' ' MET . 1.5 mp -92.86 -33.38 5.36 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.953 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -67.46 -13.94 62.48 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.488 ' N ' ' O ' ' B' ' 8' ' ' LYS . 3.9 tp-100 -108.47 -43.33 4.34 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.44 -21.74 66.69 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 177.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.934 HG21 ' HB2' ' A' ' 20' ' ' SER . 0.2 OUTLIER -121.96 -80.82 0.63 Allowed 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.97 179.786 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . 0.505 ' O ' ' C ' ' B' ' 16' ' ' LEU . . . 70.43 -18.8 0.71 Allowed Glycine 0 N--CA 1.498 2.778 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' LEU . . . . . 1.056 ' CD1' HG23 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -27.83 -64.65 0.08 Allowed 'General case' 0 N--CA 1.515 2.805 0 CA-C-O 122.078 0.942 . . . . 0.0 111.068 -179.722 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . 0.712 HG21 HG21 ' A' ' 17' ' ' THR . 0.4 OUTLIER -130.11 -0.56 4.65 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.597 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . 0.641 ' O ' ' C ' ' B' ' 19' ' ' VAL . 2.4 mt-30 58.09 29.55 17.99 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 -176.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 1.076 HG23 ' CD1' ' A' ' 16' ' ' LEU . 0.4 OUTLIER 5.33 -99.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.616 -179.221 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 1.002 ' HB3' HD21 ' A' ' 16' ' ' LEU . 1.7 p -136.07 23.17 3.28 Favored 'General case' 0 C--N 1.273 -2.721 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 177.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.941 ' HB ' HG23 ' B' ' 7' ' ' ILE . 35.1 m -5.0 -42.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-O 122.406 1.098 . . . . 0.0 111.037 -177.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.997 ' N ' ' O ' ' B' ' 20' ' ' SER . 14.0 p -76.74 -37.58 55.7 Favored 'General case' 0 C--N 1.28 -2.423 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.741 179.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . 0.868 ' N ' ' O ' ' B' ' 20' ' ' SER . 1.6 mtmt -88.78 -31.07 18.56 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.358 -0.839 . . . . 0.0 111.329 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' MET . . . . . 0.617 ' SD ' ' HA ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -72.09 -36.98 69.66 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.234 -1.541 . . . . 0.0 108.754 179.773 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.716 HD12 HG13 ' B' ' 7' ' ' ILE . 0.3 OUTLIER -80.06 -35.89 36.43 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 118.168 -1.413 . . . . 0.0 108.149 177.742 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . 0.502 ' HB2' ' O ' ' B' ' 22' ' ' SER . . . -66.07 -34.37 77.92 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 176.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . 0.572 ' O ' ' N ' ' B' ' 31' ' ' ILE . 83.7 p -81.97 -27.38 33.24 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . 0.863 ' O ' HG13 ' B' ' 31' ' ' ILE . 0.5 OUTLIER -59.04 -50.73 72.96 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 178.26 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . 0.614 ' HG3' ' CD1' ' A' ' 47' ' ' PHE . 1.2 tt0 -65.21 -31.49 72.69 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 176.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 1.271 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 9.3 ttmt -69.88 -22.48 63.24 Favored 'General case' 0 C--O 1.186 -2.278 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.865 HD13 ' CB ' ' A' ' 9' ' ' ALA . 0.9 OUTLIER -100.76 -29.37 3.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 O-C-N 119.945 -1.722 . . . . 0.0 108.055 177.824 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.787 HG21 ' CE2' ' A' ' 47' ' ' PHE . 1.4 mm -65.3 -60.93 2.0 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 176.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' THR . . . . . 0.647 ' O ' ' CB ' ' A' ' 88' ' ' ALA . 0.4 OUTLIER -76.56 -27.76 56.0 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 119.279 -0.968 . . . . 0.0 108.95 179.587 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 1.271 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 79.1 mm-40 -80.19 -27.37 38.9 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.101 -1.624 . . . . 0.0 110.204 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' THR . . . . . 0.645 HG23 ' HB2' ' B' ' 40' ' ' ASP . 3.7 m -72.15 -48.76 41.14 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.656 -1.277 . . . . 0.0 108.575 178.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.852 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 4.5 t -51.1 -48.54 30.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 C-N-CA 116.867 -1.933 . . . . 0.0 106.047 177.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 0.873 ' HB1' ' HA3' ' A' ' 91' ' ' GLY . . . -70.24 5.96 1.5 Allowed 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 121.58 0.705 . . . . 0.0 111.044 177.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.492 ' HB2' ' O ' ' B' ' 34' ' ' GLU . 0.0 OUTLIER -108.57 -35.1 6.54 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 177.438 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . 0.418 ' HA2' HD21 ' A' ' 92' ' ' LEU . . . 121.17 32.24 1.08 Allowed Glycine 0 C--N 1.302 -1.326 0 C-N-CA 119.727 -1.225 . . . . 0.0 111.487 177.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . 0.645 ' HB2' HG23 ' B' ' 35' ' ' THR . 0.3 OUTLIER -125.26 146.63 49.45 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.798 -1.413 . . . . 0.0 110.371 179.123 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 2.8 mtmm -88.6 91.6 8.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.512 -0.743 . . . . 0.0 110.179 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.516 HG13 HD11 ' A' ' 6' ' ' LEU . 78.2 t -64.35 153.3 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.564 -0.71 . . . . 0.0 110.367 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' GLN . . . . . 0.782 ' O ' HD23 ' B' ' 44' ' ' LEU . 0.2 OUTLIER -165.83 164.14 18.69 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.44 -0.787 . . . . 0.0 110.043 179.821 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.841 HD22 ' HE2' ' A' ' 28' ' ' PHE . 15.4 mt -125.46 117.92 24.7 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.394 -0.816 . . . . 0.0 109.718 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . 0.536 HG21 ' HB3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 30.34 -93.28 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.875 -0.516 . . . . 0.0 111.124 -179.812 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.549 ' O ' ' HA3' ' B' ' 82' ' ' GLY . . . -144.54 24.34 2.0 Favored Glycine 0 N--CA 1.483 1.775 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . 0.715 ' CE1' HD12 ' B' ' 44' ' ' LEU . 8.8 p90 -120.7 -22.09 6.45 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.111 -1.229 . . . . 0.0 111.4 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.551 ' HB2' ' HB2' ' B' ' 44' ' ' LEU . 0.9 OUTLIER -128.22 115.45 18.37 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.388 -1.445 . . . . 0.0 110.624 177.828 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' ASN . . . . . 0.632 ' O ' ' HA ' ' B' ' 79' ' ' VAL . 1.2 m120 -113.78 94.75 4.98 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.717 -0.614 . . . . 0.0 111.408 -178.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' ILE . . . . . 0.508 ' CD1' HG23 ' B' ' 79' ' ' VAL . 1.3 mp -93.45 141.48 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 O-C-N 121.246 -0.909 . . . . 0.0 109.839 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . 0.426 ' HG3' ' CB ' ' B' ' 78' ' ' SER . 0.0 OUTLIER -161.29 113.42 1.26 Allowed Pre-proline 0 N--CA 1.5 2.025 0 C-N-CA 118.769 -1.172 . . . . 0.0 111.318 179.723 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.688 ' HB3' HG13 ' B' ' 36' ' ' VAL . 55.7 Cg_endo -83.06 141.91 10.7 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 O-C-N 123.571 1.301 . . . . 0.0 111.724 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.618 ' O ' ' N ' ' B' ' 76' ' ' GLY . 33.4 m -149.24 114.73 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.581 0.705 . . . . 0.0 110.718 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.721 ' HB2' ' HB3' ' A' ' 97' ' ' PHE . . . -57.36 134.05 55.68 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.448 -0.783 . . . . 0.0 111.46 -178.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . 0.436 ' C ' ' HG2' ' B' ' 56' ' ' GLN . 0.0 OUTLIER 170.45 81.5 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.382 -0.824 . . . . 0.0 110.206 179.596 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . 0.52 ' HG3' ' O ' ' B' ' 74' ' ' SER . 28.3 mm100 -148.98 -144.34 0.15 Allowed 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.436 -0.906 . . . . 0.0 111.004 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.837 ' HB1' ' HB ' ' B' ' 71' ' ' ILE . . . -56.4 -165.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 122.336 1.065 . . . . 0.0 112.729 -178.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' ARG . . . . . 0.836 ' O ' HD11 ' B' ' 71' ' ' ILE . 12.4 mpt_? -90.08 -142.33 0.16 Allowed 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.701 -178.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . 0.673 ' CB ' ' O ' ' B' ' 58' ' ' ARG . 0.3 OUTLIER 137.0 54.95 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.655 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.597 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -110.44 -100.55 2.6 Favored Glycine 0 N--CA 1.491 2.305 0 C-N-CA 120.032 -1.08 . . . . 0.0 110.964 -178.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' PHE . . . . . 0.95 ' CD1' ' O ' ' B' ' 67' ' ' GLU . 0.4 OUTLIER -173.48 111.9 0.2 Allowed 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.338 -1.095 . . . . 0.0 109.774 -178.256 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . 0.986 ' C ' ' HA ' ' B' ' 67' ' ' GLU . 5.2 m-20 -113.66 -75.34 0.02 OUTLIER Pre-proline 0 N--CA 1.511 2.595 0 O-C-N 121.103 -0.998 . . . . 0.0 112.181 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.702 ' O ' ' N ' ' B' ' 67' ' ' GLU . 56.0 Cg_endo -79.69 -90.33 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 120.569 0.846 . . . . 0.0 112.131 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . 1.08 ' HB2' ' HB2' ' B' ' 68' ' ' ALA . 5.6 tp60 37.85 24.78 0.01 OUTLIER 'General case' 0 N--CA 1.518 2.962 0 O-C-N 121.182 -0.949 . . . . 0.0 112.835 -178.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.438 ' N ' ' O ' ' B' ' 63' ' ' PRO . 1.1 p 48.52 24.26 0.73 Allowed 'General case' 0 N--CA 1.505 2.295 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 -176.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . 0.762 ' O ' ' HB2' ' B' ' 67' ' ' GLU . 0.0 OUTLIER -170.77 -36.31 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 114.036 -1.438 . . . . 0.0 107.484 -177.206 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . 0.986 ' HA ' ' C ' ' B' ' 62' ' ' ASN . 12.2 mt-10 138.02 129.9 0.0 OUTLIER 'General case' 0 C--O 1.194 -1.832 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . 1.08 ' HB2' ' HB2' ' B' ' 64' ' ' GLN . . . -149.86 91.24 1.77 Allowed 'General case' 0 N--CA 1.51 2.545 0 O-C-N 120.286 -1.509 . . . . 0.0 111.055 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.78 HD21 ' ND2' ' B' ' 62' ' ' ASN . 22.8 mt -94.41 153.38 17.99 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.916 -1.115 . . . . 0.0 110.58 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . 0.751 ' O ' HG23 ' B' ' 71' ' ' ILE . 0.4 OUTLIER -159.55 142.06 13.74 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.551 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.837 ' HB ' ' HB1' ' B' ' 57' ' ' ALA 0.253 0.7 OUTLIER -164.55 -148.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.645 -0.659 . . . . 0.0 109.295 -176.57 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -107.11 81.94 1.05 Allowed Pre-proline 0 C--N 1.296 -1.751 0 O-C-N 121.371 -0.831 . . . . 0.0 111.179 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' PRO . . . . . 0.531 ' HD3' ' O ' ' B' ' 71' ' ' ILE . 54.3 Cg_endo -77.18 123.76 6.85 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.697 1.367 . . . . 0.0 110.338 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . 0.52 ' O ' ' HG3' ' B' ' 56' ' ' GLN . 48.0 t -156.95 135.08 11.14 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.863 -1.148 . . . . 0.0 109.96 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . 0.889 HG21 ' CD1' ' A' ' 92' ' ' LEU . 1.4 p -60.09 -173.75 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.703 -1.248 . . . . 0.0 109.081 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . 0.626 ' O ' ' N ' ' B' ' 78' ' ' SER . . . -113.14 50.22 0.79 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.856 -1.698 . . . . 0.0 108.856 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.736 HG23 HD12 ' A' ' 85' ' ' LEU . 7.1 p -45.69 81.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-O 121.695 0.76 . . . . 0.0 111.534 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . 0.626 ' N ' ' O ' ' B' ' 76' ' ' GLY . 0.6 OUTLIER -77.48 178.81 6.92 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 119.28 -0.968 . . . . 0.0 108.737 178.408 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.632 ' HA ' ' O ' ' B' ' 49' ' ' ASN . 0.2 OUTLIER 179.48 172.8 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.517 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . 0.521 ' N ' ' CG2' ' B' ' 79' ' ' VAL . 0.2 OUTLIER 176.46 172.56 0.33 Allowed Pre-proline 0 N--CA 1.487 1.417 0 O-C-N 121.149 -0.97 . . . . 0.0 110.892 178.404 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' PRO . . . . . 0.707 ' HA ' ' O ' ' B' ' 47' ' ' PHE . 54.6 Cg_endo -88.95 165.78 5.83 Favored 'Trans proline' 0 C--N 1.298 -2.079 0 O-C-N 124.617 1.851 . . . . 0.0 107.475 174.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . 0.549 ' HA3' ' O ' ' B' ' 46' ' ' GLY . . . -126.79 -99.33 1.08 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 107.711 -2.156 . . . . 0.0 107.711 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . 0.911 ' O ' ' N ' ' B' ' 85' ' ' LEU . 0.4 OUTLIER -79.43 45.24 0.65 Allowed 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.121 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' SER . . . . . 1.334 ' O ' ' N ' ' B' ' 86' ' ' LYS . 0.1 OUTLIER 8.45 43.16 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 122.148 0.975 . . . . 0.0 111.164 179.165 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 1.004 ' C ' ' O ' ' B' ' 84' ' ' SER . 0.4 OUTLIER 20.55 30.05 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 102.786 -3.042 . . . . 0.0 102.786 -172.647 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . 1.334 ' N ' ' O ' ' B' ' 84' ' ' SER 0.336 7.7 tttt -56.38 -37.17 69.73 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 103.82 -2.659 . . . . 0.0 103.82 177.08 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . 0.29 0.0 OUTLIER -70.59 -34.79 72.56 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 111.905 -2.407 . . . . 0.0 105.796 175.377 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.648 ' HB3' ' CB ' ' B' ' 85' ' ' LEU . . . -75.3 -27.77 59.45 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 118.586 -1.246 . . . . 0.0 107.859 178.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.905 ' HA ' HD23 ' B' ' 92' ' ' LEU . . . -62.42 -48.33 80.16 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -57.24 -28.98 63.41 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 176.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -69.68 -33.94 72.07 Favored Glycine 0 N--CA 1.489 2.184 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.189 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . 0.905 HD23 ' HA ' ' B' ' 89' ' ' ALA . 0.7 OUTLIER -85.75 16.95 3.62 Favored 'General case' 0 N--CA 1.506 2.335 0 CA-C-N 119.689 1.745 . . . . 0.0 111.556 -179.155 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' B' ' 92' ' ' LEU . 8.7 mmtp 54.92 40.22 31.9 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -178.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . 0.505 ' CE1' ' HA ' ' A' ' 74' ' ' SER . 2.6 p90 -41.77 -30.7 0.26 Allowed 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.651 -178.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . 0.426 ' O ' ' HB3' ' B' ' 98' ' ' ALA . 8.8 pt-20 -58.22 -42.51 86.44 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.246 -0.909 . . . . 0.0 108.871 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.72 -33.68 76.19 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 177.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -76.52 -22.73 54.03 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 98' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' B' ' 95' ' ' GLU . . . -68.74 -41.18 79.33 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.554 -0.716 . . . . 0.0 110.036 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 4.6 mtmp? . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.224 179.977 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.503 ' HG2' ' HB3' ' A' ' 5' ' ' GLU . 4.0 mtp . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 120.932 0.396 . . . . 0.0 110.134 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.83 ' C ' HD12 ' A' ' 6' ' ' LEU . 4.0 t30 -176.08 -174.79 0.66 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.18 -0.95 . . . . 0.0 111.052 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.542 ' O ' ' CG2' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -51.84 -15.3 0.48 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.453 -0.779 . . . . 0.0 110.275 179.619 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.652 ' O ' HG13 ' A' ' 7' ' ' ILE . 38.7 m -106.89 -58.48 1.93 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 122.004 0.907 . . . . 0.0 109.161 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.503 ' HB3' ' HG2' ' A' ' 1' ' ' MET . 2.6 mt-10 -50.46 -45.05 55.81 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.056 -1.028 . . . . 0.0 108.571 179.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.83 HD12 ' C ' ' A' ' 2' ' ' ASN . 2.4 mt -58.26 -36.31 73.06 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.364 -0.934 . . . . 0.0 109.954 178.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.652 HG13 ' O ' ' A' ' 4' ' ' THR . 0.9 OUTLIER -55.8 -42.81 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.295 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.869 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -64.64 -33.76 76.69 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 177.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.672 ' HB3' ' O ' ' A' ' 6' ' ' LEU . . . -56.23 -38.11 70.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.473 -0.767 . . . . 0.0 109.019 178.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.722 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.4 mp -91.52 -32.41 5.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 178.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.869 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -65.3 -14.11 60.0 Favored 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 118.689 -1.205 . . . . 0.0 108.227 178.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.402 ' N ' ' O ' ' A' ' 8' ' ' LYS . 6.4 tp-100 -110.75 -46.07 3.41 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.441 ' OD2' HG23 ' B' ' 31' ' ' ILE . 1.6 m-20 -66.63 -27.78 67.96 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 177.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.794 ' CG2' ' HB2' ' B' ' 20' ' ' SER . 0.2 OUTLIER -111.55 -82.26 0.58 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 178.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.516 ' O ' ' C ' ' A' ' 16' ' ' LEU . . . 69.0 -21.35 0.37 Allowed Glycine 0 N--CA 1.498 2.831 0 O-C-N 121.004 -1.06 . . . . 0.0 110.825 178.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.113 ' CD1' HG23 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -30.2 -63.77 0.13 Allowed 'General case' 0 N--CA 1.518 2.925 0 CA-C-O 122.052 0.929 . . . . 0.0 110.497 -179.57 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.683 HG22 ' H ' ' A' ' 19' ' ' VAL . 0.5 OUTLIER -129.31 -4.89 4.87 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.774 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.626 ' O ' ' C ' ' A' ' 19' ' ' VAL . 22.1 mt-30 56.41 31.78 19.41 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -177.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 1.024 HG11 HG11 ' B' ' 19' ' ' VAL . 1.6 p -6.46 -98.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.538 -178.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.92 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -133.48 23.28 4.03 Favored 'General case' 0 C--N 1.279 -2.493 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 177.15 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.625 HG12 HG22 ' A' ' 10' ' ' ILE . 30.4 m -20.6 -37.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-O 122.254 1.026 . . . . 0.0 109.858 -178.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.825 ' N ' ' O ' ' A' ' 20' ' ' SER . 11.2 t -75.46 -42.76 52.41 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.931 177.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.92 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -93.8 -22.91 18.38 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.52 -0.738 . . . . 0.0 109.888 178.739 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.79 ' N ' ' OG ' ' A' ' 20' ' ' SER 0.26 2.0 tmm? -68.02 -33.01 73.79 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 179.201 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.597 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 7.3 mt -84.41 -41.55 16.56 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 176.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.539 ' HB3' ' HA ' ' A' ' 23' ' ' LYS . . . -59.19 -34.1 71.74 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 177.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.487 ' O ' HG13 ' A' ' 31' ' ' ILE . 10.2 t -80.17 -36.32 35.23 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 178.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.645 ' CE1' HD22 ' B' ' 44' ' ' LEU . 0.2 OUTLIER -52.1 -44.87 64.63 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.694 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.662 ' HG3' ' CD2' ' B' ' 47' ' ' PHE . 0.9 OUTLIER -69.53 -36.72 76.66 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.247 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 1.129 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 16.5 ttpt -62.53 -23.82 67.17 Favored 'General case' 0 C--O 1.191 -1.981 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.734 HD12 HD23 ' B' ' 6' ' ' LEU . 0.5 OUTLIER -104.15 -27.96 3.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 O-C-N 120.499 -1.376 . . . . 0.0 109.379 178.225 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.623 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.3 mm -73.81 -57.55 6.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 177.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.565 ' HB ' ' O ' ' A' ' 29' ' ' GLU . 0.6 OUTLIER -68.35 -36.33 79.08 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.568 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 1.129 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 68.2 mm-40 -75.55 -37.79 59.75 Favored 'General case' 0 N--CA 1.483 1.185 0 O-C-N 121.17 -0.956 . . . . 0.0 111.702 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.584 HG23 ' HB2' ' A' ' 40' ' ' ASP . 14.0 m -62.18 -53.97 47.63 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 120.281 -1.512 . . . . 0.0 109.499 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.817 HG22 ' HD3' ' A' ' 52' ' ' PRO . 2.1 t -54.76 -32.89 26.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 177.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.843 ' HB1' ' O ' ' B' ' 88' ' ' ALA . . . -90.38 10.5 24.79 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.333 177.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.675 ' HB2' ' O ' ' A' ' 34' ' ' GLU . 1.9 ttmt -114.23 -35.35 5.03 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 178.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 127.95 38.58 0.38 Allowed Glycine 0 C--N 1.301 -1.404 0 C-N-CA 119.732 -1.223 . . . . 0.0 110.835 178.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.584 ' HB2' HG23 ' A' ' 35' ' ' THR . 0.3 OUTLIER -145.92 135.8 23.49 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.083 -1.245 . . . . 0.0 110.281 179.431 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.02 76.49 2.21 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.391 -0.818 . . . . 0.0 110.459 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.884 HG23 HD11 ' B' ' 6' ' ' LEU . 11.0 p -60.56 136.46 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.412 -0.805 . . . . 0.0 110.056 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' B' ' 1' ' ' MET . 6.9 pt20 -144.75 175.15 10.39 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.239 -0.913 . . . . 0.0 110.737 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.03 HD12 ' CB ' ' A' ' 48' ' ' LEU . 27.6 mt -125.26 115.01 19.7 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.665 -0.647 . . . . 0.0 109.276 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.537 HG21 ' HG3' ' B' ' 29' ' ' GLU . 0.0 OUTLIER 32.26 -93.88 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.859 -0.526 . . . . 0.0 111.552 -179.767 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.432 ' H ' HG23 ' A' ' 45' ' ' THR . . . -145.05 21.87 1.94 Allowed Glycine 0 N--CA 1.489 2.188 0 C-N-CA 119.504 -1.331 . . . . 0.0 111.013 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.684 ' CD2' ' HG3' ' B' ' 29' ' ' GLU . 8.5 p90 -119.76 -22.15 6.96 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.768 -1.431 . . . . 0.0 111.216 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.03 ' CB ' HD12 ' A' ' 44' ' ' LEU . 6.8 mt -128.72 108.47 10.51 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.453 -1.404 . . . . 0.0 110.653 178.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.607 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 1.1 t-20 -109.68 91.13 3.52 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.673 -0.642 . . . . 0.0 111.095 -179.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.762 HG22 HG21 ' A' ' 36' ' ' VAL . 11.1 mm -93.52 138.11 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.29 -0.881 . . . . 0.0 110.138 179.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 21.0 ptmt -160.93 128.39 2.7 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 120.804 -1.185 . . . . 0.0 111.295 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.817 ' HD3' HG22 ' A' ' 36' ' ' VAL . 55.7 Cg_endo -78.69 141.91 17.66 Favored 'Trans proline' 0 C--N 1.314 -1.274 0 O-C-N 123.513 1.27 . . . . 0.0 110.631 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.753 HG22 ' O ' ' A' ' 76' ' ' GLY . 34.5 m -145.66 113.04 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 C-N-CA 119.465 -0.894 . . . . 0.0 111.928 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.922 ' HB1' ' HB3' ' B' ' 96' ' ' ASP . . . -59.54 125.34 23.26 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 119.259 -0.976 . . . . 0.0 109.379 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.912 ' H ' ' N ' ' A' ' 75' ' ' VAL . 31.5 ttt-85 -179.03 84.1 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 121.593 0.711 . . . . 0.0 110.272 -178.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.81 ' C ' ' O ' ' A' ' 73' ' ' PRO . 27.1 mt-30 -159.61 28.88 0.19 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.601 ' HA ' ' HG2' ' A' ' 73' ' ' PRO . . . -100.3 146.56 26.79 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 -174.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.719 ' HB2' HG12 ' A' ' 71' ' ' ILE 0.28 2.7 ttt85 -84.5 17.67 2.58 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 113.957 -1.474 . . . . 0.0 110.593 178.12 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.443 ' N ' HD11 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -51.52 95.69 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.199 -0.938 . . . . 0.0 110.076 -179.153 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 58' ' ' ARG . . . -118.96 -104.84 2.16 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.646 ' CE1' ' CB ' ' A' ' 64' ' ' GLN . 34.4 p90 -175.43 -169.09 0.35 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.32 -1.106 . . . . 0.0 111.348 -179.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 1.0 ' CB ' ' HB2' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -139.19 -45.26 0.02 OUTLIER Pre-proline 0 N--CA 1.486 1.369 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.214 178.235 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.925 ' HD2' ' H ' ' A' ' 62' ' ' ASN . 39.5 Cg_endo -67.56 65.9 0.79 Allowed 'Trans proline' 0 N--CA 1.487 1.142 0 O-C-N 122.692 0.838 . . . . 0.0 111.258 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.646 ' CB ' ' CE1' ' A' ' 61' ' ' PHE . 0.3 OUTLIER -173.73 -104.17 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 179.041 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.534 ' O ' ' HB2' ' A' ' 66' ' ' GLN . 31.1 p -74.24 -6.93 50.79 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.236 -1.54 . . . . 0.0 108.925 177.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.534 ' HB2' ' O ' ' A' ' 65' ' ' THR . 42.7 mm-40 73.05 94.26 0.08 Allowed 'General case' 0 N--CA 1.503 2.22 0 CA-C-O 121.534 0.683 . . . . 0.0 112.141 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.647 ' H ' ' HA ' ' A' ' 62' ' ' ASN . 5.2 tt0 172.96 60.85 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 1.0 ' HB2' ' CB ' ' A' ' 62' ' ' ASN . . . -61.24 143.5 55.51 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.26 -0.9 . . . . 0.0 110.441 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.587 ' HG ' ' C ' ' A' ' 68' ' ' ALA . 0.4 OUTLIER -137.59 157.99 45.34 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.324 -178.349 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -153.67 19.13 0.53 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.45 -0.781 . . . . 0.0 110.069 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.719 HG12 ' HB2' ' A' ' 58' ' ' ARG . 0.1 OUTLIER -47.88 175.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.882 -0.511 . . . . 0.0 110.85 179.043 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.785 ' N ' ' HD3' ' A' ' 73' ' ' PRO . . . -137.18 44.58 0.97 Allowed Pre-proline 0 N--CA 1.497 1.918 0 O-C-N 120.81 -1.182 . . . . 0.0 112.425 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.81 ' O ' ' C ' ' A' ' 56' ' ' GLN . 42.1 Cg_endo -94.76 114.3 0.18 Allowed 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 121.229 1.286 . . . . 0.0 111.532 178.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.803 ' O ' ' HB3' ' B' ' 96' ' ' ASP . 0.4 OUTLIER -165.9 128.87 2.06 Favored 'General case' 0 CA--C 1.565 1.526 0 O-C-N 120.807 -1.183 . . . . 0.0 113.197 178.32 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.997 ' HB ' ' CD2' ' B' ' 94' ' ' TYR . 1.1 t 164.36 127.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.796 0 CA-C-O 122.236 1.017 . . . . 0.0 108.761 175.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.753 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -138.28 99.22 0.27 Allowed Glycine 0 C--N 1.289 -2.068 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -178.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.701 ' CG2' HD13 ' B' ' 85' ' ' LEU . 1.5 p -59.93 82.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.838 -0.801 . . . . 0.0 109.368 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.632 ' C ' HG12 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -62.67 177.1 0.57 Allowed 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.554 -0.858 . . . . 0.0 110.535 -179.462 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.632 HG12 ' C ' ' A' ' 78' ' ' SER . 0.2 OUTLIER 177.42 174.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.761 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.86 ' O ' HD23 ' A' ' 48' ' ' LEU . 0.5 OUTLIER 177.71 170.26 0.45 Allowed Pre-proline 0 N--CA 1.485 1.323 0 O-C-N 120.822 -1.174 . . . . 0.0 110.997 177.227 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.502 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 56.1 Cg_endo -103.83 136.06 0.1 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 123.359 2.706 . . . . 0.0 109.223 176.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.558 ' HA3' ' HA ' ' A' ' 47' ' ' PHE . . . -97.46 161.25 21.33 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 108.295 -1.922 . . . . 0.0 108.295 178.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.451 ' HA ' ' HB2' ' A' ' 86' ' ' LYS . 0.5 OUTLIER -57.71 -23.95 54.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.015 -1.285 . . . . 0.0 110.584 -179.429 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.5 t -51.82 -31.18 26.39 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.117 -0.989 . . . . 0.0 108.654 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.89 HD13 ' CG1' ' B' ' 77' ' ' VAL . 0.5 OUTLIER -82.96 -31.22 27.72 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.597 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.718 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 5.0 mttt -81.27 -31.8 33.53 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.581 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.421 ' O ' ' HG3' ' A' ' 90' ' ' GLU . 1.1 tmtt? -69.63 -40.2 76.68 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 178.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.759 ' O ' ' HB1' ' B' ' 37' ' ' ALA . . . -62.0 -38.4 88.49 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 176.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.79 ' HA ' HD23 ' A' ' 92' ' ' LEU . . . -53.57 -43.04 68.17 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 120.0 -0.68 . . . . 0.0 109.5 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.502 ' HG3' ' N ' ' A' ' 91' ' ' GLY . 0.3 OUTLIER -54.16 -30.96 51.25 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 177.517 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.502 ' N ' ' HG3' ' A' ' 90' ' ' GLU . . . -64.1 -43.3 97.44 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 178.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.923 HD21 HG21 ' B' ' 75' ' ' VAL . 0.4 OUTLIER -71.59 8.91 0.96 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.745 -1.444 . . . . 0.0 110.831 179.804 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 17.2 mmtm 65.69 50.34 1.61 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 -177.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.584 ' CD1' ' N ' ' B' ' 75' ' ' VAL . 0.0 OUTLIER -34.64 -38.57 0.08 Allowed 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.063 -179.005 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.581 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 24.8 mt-10 -65.93 -46.42 78.27 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.333 -0.855 . . . . 0.0 109.828 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.433 ' N ' ' O ' ' A' ' 93' ' ' LYS . 1.2 m-20 -52.2 -35.31 48.79 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.49 -0.756 . . . . 0.0 108.962 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -76.68 -28.89 56.11 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 95' ' ' GLU . . . -57.98 -37.42 74.17 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.696 -0.628 . . . . 0.0 109.99 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.102 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.462 ' HA ' ' CB ' ' B' ' 5' ' ' GLU . 5.3 mtp . . . . . 0 N--CA 1.493 1.687 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . 0.434 ' N ' HD12 ' B' ' 6' ' ' LEU . 22.6 p30 -176.73 -172.7 0.45 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.249 -0.907 . . . . 0.0 111.099 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.496 ' O ' HG13 ' B' ' 7' ' ' ILE . 0.0 OUTLIER -51.5 -11.15 0.12 Allowed 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.381 -0.825 . . . . 0.0 111.244 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.629 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 45.7 m -114.48 -43.28 3.19 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.812 -1.18 . . . . 0.0 108.995 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.501 ' HA ' ' HE2' ' B' ' 8' ' ' LYS . 0.0 OUTLIER -64.19 -50.41 68.22 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.708 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.884 HD11 HG23 ' A' ' 42' ' ' VAL . 0.7 OUTLIER -62.08 -28.93 69.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.375 -0.828 . . . . 0.0 108.898 178.176 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' ILE . . . . . 1.006 HG13 HD12 ' B' ' 25' ' ' LEU . 0.5 OUTLIER -55.52 -59.32 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.144 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . 0.895 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.1 OUTLIER -57.86 -30.3 65.7 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.375 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . 0.675 ' HB3' ' O ' ' B' ' 6' ' ' LEU . . . -58.98 -36.57 75.1 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.466 -0.894 . . . . 0.0 108.97 178.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.914 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.1 mp -89.03 -35.16 7.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 177.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.895 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -65.57 -9.46 26.78 Favored 'General case' 0 C--N 1.291 -1.955 0 C-N-CA 118.839 -1.144 . . . . 0.0 108.42 177.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.491 ' HB3' ' O ' ' B' ' 8' ' ' LYS . 0.4 OUTLIER -118.46 -43.15 2.72 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.547 -0.721 . . . . 0.0 109.448 178.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.442 ' HB3' ' OG ' ' A' ' 27' ' ' SER . 1.7 m-20 -66.1 -38.32 87.93 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 177.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 1.057 HG22 ' CD1' ' B' ' 16' ' ' LEU 0.251 0.1 OUTLIER -89.13 -77.95 0.36 Allowed 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 177.549 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.84 6.52 78.49 Favored Glycine 0 N--CA 1.5 2.936 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 177.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' LEU . . . . . 1.057 ' CD1' HG22 ' B' ' 14' ' ' THR . 5.2 mp -55.48 -71.4 0.09 Allowed 'General case' 0 C--N 1.294 -1.817 0 O-C-N 121.63 -0.924 . . . . 0.0 110.569 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . 0.683 ' CG2' HG21 ' A' ' 17' ' ' THR . 0.5 OUTLIER -139.57 8.37 2.39 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.581 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . 0.613 ' O ' ' C ' ' B' ' 19' ' ' VAL . 11.2 mt-30 58.69 23.86 11.53 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 -175.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 1.113 HG23 ' CD1' ' A' ' 16' ' ' LEU . 0.2 OUTLIER 5.49 -94.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.125 -179.194 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.978 ' O ' ' N ' ' B' ' 23' ' ' LYS . 0.4 OUTLIER -135.72 23.19 3.37 Favored 'General case' 0 C--N 1.275 -2.654 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 178.153 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.977 ' HB ' HG23 ' B' ' 7' ' ' ILE . 18.3 m -15.0 -40.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-O 122.245 1.022 . . . . 0.0 109.885 -177.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.914 ' N ' ' O ' ' B' ' 20' ' ' SER . 7.7 t -74.93 -42.21 58.16 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.173 177.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . 0.978 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.2 OUTLIER -92.89 -25.9 17.86 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.661 -0.649 . . . . 0.0 109.827 178.599 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' MET . . . . . 0.583 ' HE2' ' HA ' ' B' ' 21' ' ' VAL . 2.2 tmm? -64.12 -41.06 97.39 Favored 'General case' 0 C--N 1.316 -0.85 0 O-C-N 120.779 -1.201 . . . . 0.0 108.321 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 1.006 HD12 HG13 ' B' ' 7' ' ' ILE . 2.5 mt -81.28 -42.63 20.34 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 118.952 -1.099 . . . . 0.0 108.547 177.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . 0.553 ' HB3' ' HA ' ' B' ' 23' ' ' LYS . . . -58.01 -34.02 69.58 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . 0.566 ' O ' HG13 ' B' ' 31' ' ' ILE . 73.8 m -82.02 -37.12 27.0 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 177.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . 0.954 ' CE1' HD22 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -52.81 -48.3 67.03 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.318 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . 0.684 ' HG3' ' CD2' ' A' ' 47' ' ' PHE . 1.7 tt0 -67.16 -34.93 78.59 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 1.241 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 13.8 ttpt -65.41 -20.84 66.55 Favored 'General case' 0 C--O 1.193 -1.92 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.662 HD11 ' HA ' ' B' ' 28' ' ' PHE . 0.7 OUTLIER -106.47 -25.33 3.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 O-C-N 120.057 -1.652 . . . . 0.0 108.968 177.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.634 HD11 ' CE2' ' B' ' 28' ' ' PHE . 1.2 mm -76.53 -58.96 3.61 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 176.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' THR . . . . . 0.492 ' OG1' ' HG ' ' A' ' 85' ' ' LEU . 0.6 OUTLIER -70.35 -34.19 72.35 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 179.257 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 1.241 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 77.9 mm-40 -78.83 -37.29 40.91 Favored 'General case' 0 C--O 1.208 -1.093 0 O-C-N 121.126 -0.984 . . . . 0.0 111.614 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' THR . . . . . 0.512 ' CB ' ' O ' ' B' ' 31' ' ' ILE . 26.1 m -61.55 -47.15 86.86 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 120.073 -1.642 . . . . 0.0 108.459 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.917 HG22 ' HD3' ' B' ' 52' ' ' PRO . 1.7 t -52.66 -44.46 46.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 177.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 0.759 ' HB1' ' O ' ' A' ' 88' ' ' ALA . . . -84.85 -1.28 56.29 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.815 178.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.661 ' HB2' ' O ' ' B' ' 34' ' ' GLU . 3.0 ttmt -94.16 -29.84 14.93 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 177.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.1 31.88 0.56 Allowed Glycine 0 C--N 1.303 -1.254 0 C-N-CA 119.665 -1.255 . . . . 0.0 111.395 177.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . 0.464 ' CB ' ' CG2' ' B' ' 35' ' ' THR . 0.2 OUTLIER -146.84 146.38 30.19 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.758 -1.436 . . . . 0.0 110.934 179.453 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.39 96.75 9.72 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.609 0.719 . . . . 0.0 109.341 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.554 HG13 HD11 ' A' ' 6' ' ' LEU . 74.5 t -58.35 129.95 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.567 -0.708 . . . . 0.0 110.124 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' GLN . . . . . 0.431 ' HA ' ' HA ' ' B' ' 49' ' ' ASN . 0.0 OUTLIER -123.69 109.05 13.23 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.517 -0.74 . . . . 0.0 109.955 -179.726 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.894 HD12 ' HB3' ' B' ' 48' ' ' LEU . 23.4 mt -77.06 106.32 8.69 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.214 -0.929 . . . . 0.0 109.93 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . 0.609 HG21 ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 32.42 -93.25 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.246 0 O-C-N 122.018 -0.426 . . . . 0.0 111.425 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -148.28 29.39 1.35 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . 0.733 ' HD1' HD12 ' B' ' 85' ' ' LEU . 3.2 p90 -130.18 -24.66 2.57 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.075 -1.25 . . . . 0.0 111.152 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.894 ' HB3' HD12 ' B' ' 44' ' ' LEU . 6.5 mt -134.49 94.09 3.15 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.727 -1.233 . . . . 0.0 110.196 178.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' ASN . . . . . 0.431 ' HA ' ' HA ' ' B' ' 43' ' ' GLN . 21.5 t-20 -98.03 72.43 2.19 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.386 -0.821 . . . . 0.0 111.365 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' ILE . . . . . 0.842 HD13 ' HB ' ' B' ' 79' ' ' VAL . 2.8 mm -61.06 125.28 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.146 -0.971 . . . . 0.0 108.752 178.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . 0.415 ' HG3' ' CB ' ' B' ' 78' ' ' SER . 2.2 ptmt -145.5 113.68 4.74 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 120.821 -1.175 . . . . 0.0 110.489 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.917 ' HD3' HG22 ' B' ' 36' ' ' VAL . 55.8 Cg_endo -79.87 138.37 13.14 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.742 1.39 . . . . 0.0 110.759 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.87 ' O ' HG22 ' B' ' 75' ' ' VAL . 17.0 m -122.08 -156.75 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.5 ' HA ' ' HA ' ' B' ' 75' ' ' VAL . . . -151.48 141.23 21.84 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 121.01 -1.056 . . . . 0.0 111.964 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.73 141.07 0.1 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . 0.824 ' O ' ' HB2' ' B' ' 57' ' ' ALA . 18.3 mt-30 -80.38 18.12 0.96 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.845 -1.159 . . . . 0.0 110.961 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.824 ' HB2' ' O ' ' B' ' 56' ' ' GLN . . . 148.95 175.12 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.198 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' ARG . . . . . 0.629 ' HB3' ' CG1' ' B' ' 71' ' ' ILE . 0.2 OUTLIER -161.78 159.99 27.76 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.114 -0.991 . . . . 0.0 109.788 -179.085 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . 0.468 ' N ' ' HG3' ' B' ' 58' ' ' ARG . 1.3 ttmm -175.65 117.83 0.15 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.227 -0.921 . . . . 0.0 110.514 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . 0.445 ' HA2' ' HB1' ' B' ' 68' ' ' ALA . . . 83.1 53.91 3.34 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' PHE . . . . . 0.791 ' O ' ' CB ' ' B' ' 62' ' ' ASN . 18.0 t80 -83.49 171.72 13.12 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.277 -1.131 . . . . 0.0 110.924 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . 0.791 ' CB ' ' O ' ' B' ' 61' ' ' PHE . 0.7 OUTLIER 143.07 -36.91 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.07 0 O-C-N 121.597 -0.69 . . . . 0.0 111.235 179.313 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.699 ' HD2' ' N ' ' B' ' 62' ' ' ASN . 40.2 Cg_endo -68.61 -4.92 14.07 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 N-CA-C 109.387 -1.043 . . . . 0.0 109.387 178.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . 0.613 ' HB2' ' CE2' ' B' ' 61' ' ' PHE . 1.3 mm-40 -105.56 -42.69 5.14 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.455 -0.778 . . . . 0.0 110.28 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.632 HG22 ' O ' ' B' ' 65' ' ' THR . 88.2 m -147.86 18.1 1.13 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.453 -0.78 . . . . 0.0 110.195 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . 0.554 ' O ' ' CB ' ' B' ' 67' ' ' GLU . 1.7 mp0 54.57 95.47 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.364 -0.835 . . . . 0.0 111.816 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . 0.554 ' CB ' ' O ' ' B' ' 66' ' ' GLN . 1.8 pt-20 151.79 74.92 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . 0.747 ' HA ' ' CA ' ' B' ' 61' ' ' PHE . . . -48.1 143.79 4.18 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.248 -0.907 . . . . 0.0 111.737 -178.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.723 ' HG ' ' HB3' ' B' ' 61' ' ' PHE . 0.2 OUTLIER -135.05 -156.15 0.7 Allowed 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.131 -177.594 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . 0.448 ' HA ' ' HG2' ' B' ' 58' ' ' ARG . 0.0 OUTLIER -175.77 59.36 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.283 -0.886 . . . . 0.0 110.369 -179.739 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.772 HD12 ' O ' ' B' ' 72' ' ' ALA . 1.0 OUTLIER -66.09 -156.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.213 -0.929 . . . . 0.0 110.26 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . 1.003 ' HB1' ' HD2' ' B' ' 73' ' ' PRO . . . -134.41 -174.78 0.42 Allowed Pre-proline 0 C--N 1.301 -1.513 0 O-C-N 121.54 -0.725 . . . . 0.0 109.684 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' PRO . . . . . 1.003 ' HD2' ' HB1' ' B' ' 72' ' ' ALA . 38.0 Cg_endo -65.77 86.28 0.23 Allowed 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 123.638 1.336 . . . . 0.0 110.276 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . 0.518 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 5.3 p -179.08 165.76 1.52 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.733 -0.605 . . . . 0.0 109.696 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . 0.923 HG21 HD21 ' A' ' 92' ' ' LEU . 0.9 OUTLIER -53.86 167.47 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.186 -0.946 . . . . 0.0 108.558 179.63 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . 0.675 ' CA ' HG22 ' B' ' 53' ' ' VAL . . . -117.59 90.25 0.5 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.89 ' CG1' HD13 ' A' ' 85' ' ' LEU . 65.2 t -66.35 78.79 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 O-C-N 121.628 -0.925 . . . . 0.0 110.027 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . 0.472 ' O ' ' HB ' ' B' ' 79' ' ' VAL . 0.4 OUTLIER -75.73 174.37 9.9 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 118.75 -1.18 . . . . 0.0 110.368 -179.831 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.842 ' HB ' HD13 ' B' ' 50' ' ' ILE . 7.2 p 175.09 177.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . 0.652 ' O ' HD23 ' B' ' 48' ' ' LEU . 0.3 OUTLIER -177.5 172.5 0.77 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 120.743 -1.223 . . . . 0.0 110.933 177.207 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' PRO . . . . . 0.419 ' HD2' ' HB2' ' B' ' 80' ' ' LYS . 56.7 Cg_endo -96.44 100.33 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.559 2.173 . . . . 0.0 110.352 178.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' B' ' 46' ' ' GLY . . . -61.81 172.93 7.95 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 108.623 -1.791 . . . . 0.0 108.623 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -68.1 -26.45 65.82 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.978 -1.307 . . . . 0.0 110.558 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -50.14 -33.83 20.26 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.21 -0.931 . . . . 0.0 108.658 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.765 HD22 HG11 ' A' ' 36' ' ' VAL . 0.5 OUTLIER -82.57 -31.78 28.83 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 178.522 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . 0.754 ' O ' ' HB3' ' B' ' 89' ' ' ALA . 1.2 tttt -76.15 -39.24 55.43 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.586 -0.696 . . . . 0.0 109.695 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 31.7 tttt -65.61 -39.95 92.08 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 178.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.843 ' O ' ' HB1' ' A' ' 37' ' ' ALA . . . -64.06 -35.45 80.79 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 176.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.782 ' HA ' HD23 ' B' ' 92' ' ' LEU . . . -53.65 -41.87 67.22 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.478 ' HA ' ' HB2' ' B' ' 94' ' ' TYR . 0.9 OUTLIER -55.19 -33.39 62.99 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 176.868 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' B' ' 88' ' ' ALA . . . -70.06 -25.51 75.51 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 178.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . 0.89 ' O ' HD12 ' B' ' 92' ' ' LEU . 0.4 OUTLIER -73.76 20.18 0.1 Allowed 'General case' 0 N--CA 1.502 2.157 0 O-C-N 120.671 -1.488 . . . . 0.0 110.6 179.788 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . 0.731 ' O ' ' C ' ' B' ' 94' ' ' TYR . 0.0 OUTLIER 72.0 29.93 2.29 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 -177.437 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . 0.997 ' CD2' ' HB ' ' A' ' 75' ' ' VAL . 15.0 t80 -22.2 -66.5 0.03 OUTLIER 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . 0.964 ' O ' ' N ' ' B' ' 98' ' ' ALA . 8.2 mt-10 4.85 36.47 0.0 OUTLIER 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 101.563 -3.495 . . . . 0.0 101.563 177.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 96' ' ' ASP . . . . . 1.196 ' O ' ' N ' ' B' ' 98' ' ' ALA . 0.0 OUTLIER 17.87 40.61 0.0 OUTLIER 'General case' 0 CA--C 1.476 -1.881 0 CA-C-N 112.689 -2.051 . . . . 0.0 107.531 -173.741 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 97' ' ' PHE . . . . . 0.973 ' C ' ' O ' ' B' ' 96' ' ' ASP . 42.2 p90 25.66 27.91 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.793 1 N-CA-C 99.96 -4.089 . . . . 0.0 99.96 -167.871 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 98' ' ' ALA . . . . . 1.196 ' N ' ' O ' ' B' ' 96' ' ' ASP 0.297 . . -52.28 -30.11 26.43 Favored 'General case' 0 C--O 1.215 -0.728 0 CA-C-N 108.855 -3.793 . . . . 0.0 108.482 179.059 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.096 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.708 ' HE1' HD13 ' B' ' 31' ' ' ILE . 6.5 mtp . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 120.89 0.376 . . . . 0.0 110.109 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.872 ' C ' HD12 ' A' ' 6' ' ' LEU . 26.5 p30 -177.85 -173.02 0.37 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.219 -0.926 . . . . 0.0 110.995 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.575 ' HE2' ' HA ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -48.57 -15.36 0.08 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.533 -0.729 . . . . 0.0 110.923 -179.724 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.646 ' O ' HG13 ' A' ' 7' ' ' ILE . 60.7 m -107.07 -60.47 1.67 Allowed 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 122.059 0.933 . . . . 0.0 109.461 179.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.546 ' HB3' ' HG2' ' A' ' 1' ' ' MET . 8.9 mt-10 -50.57 -44.21 56.67 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.014 -1.054 . . . . 0.0 108.469 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.872 HD12 ' C ' ' A' ' 2' ' ' ASN . 4.7 mt -56.64 -34.37 67.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.365 -0.834 . . . . 0.0 109.955 178.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.646 HG13 ' O ' ' A' ' 4' ' ' THR . 0.9 OUTLIER -60.12 -41.52 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 179.301 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.789 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -70.63 -29.92 66.43 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 177.571 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 6' ' ' LEU . . . -61.48 -37.52 83.95 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.517 -0.74 . . . . 0.0 109.159 178.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.686 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.1 mp -93.64 -30.04 4.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 178.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.789 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -62.69 -13.88 37.43 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 118.473 -1.291 . . . . 0.0 108.335 178.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -116.21 -46.56 2.79 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 121.631 -0.668 . . . . 0.0 109.865 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.17 -29.97 71.05 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 177.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 1.06 HG22 ' CD1' ' A' ' 16' ' ' LEU 0.271 0.2 OUTLIER -105.09 -74.43 0.65 Allowed 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 179.016 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 57.48 11.51 7.41 Favored Glycine 0 N--CA 1.497 2.747 0 O-C-N 121.402 -0.811 . . . . 0.0 111.811 177.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.06 ' CD1' HG22 ' A' ' 14' ' ' THR . 2.4 mp -54.37 -62.3 1.74 Allowed 'General case' 0 N--CA 1.505 2.296 0 O-C-N 121.011 -1.288 . . . . 0.0 109.334 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.559 HG21 ' CG2' ' B' ' 17' ' ' THR . 0.6 OUTLIER -135.89 4.61 3.03 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.384 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.597 ' O ' ' C ' ' A' ' 19' ' ' VAL . 24.5 mt-30 56.97 28.89 15.43 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 -176.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 1.084 HG11 HG11 ' B' ' 19' ' ' VAL . 1.5 p -10.7 -97.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.979 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.921 ' O ' ' N ' ' A' ' 22' ' ' SER . 0.3 OUTLIER -133.55 24.76 4.07 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 177.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.65 ' HA ' ' SD ' ' A' ' 24' ' ' MET . 32.5 m -16.01 -38.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 CA-C-O 122.551 1.167 . . . . 0.0 110.117 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.921 ' N ' ' O ' ' A' ' 20' ' ' SER . 98.0 p -79.22 -38.08 36.56 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.392 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.914 ' N ' ' O ' ' A' ' 20' ' ' SER . 14.1 ttpt -92.08 -25.24 18.85 Favored 'General case' 0 C--N 1.308 -1.225 0 O-C-N 121.226 -0.921 . . . . 0.0 110.897 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.65 ' SD ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -74.91 -35.67 62.2 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 117.399 -1.72 . . . . 0.0 107.418 178.541 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.663 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 8.2 mt -77.48 -37.87 50.4 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 118.68 -1.208 . . . . 0.0 108.494 177.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.575 ' HA ' ' HE2' ' A' ' 3' ' ' LYS . . . -64.48 -35.53 81.23 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 177.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.523 ' O ' HG13 ' A' ' 31' ' ' ILE . 82.7 p -80.93 -28.82 35.62 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.69 ' CE2' HD11 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -54.78 -41.41 70.51 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.686 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.653 ' HG3' ' CD1' ' B' ' 47' ' ' PHE . 0.7 OUTLIER -72.39 -36.44 68.69 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 176.201 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 1.12 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 22.9 ttpt -60.71 -23.59 65.01 Favored 'General case' 0 C--O 1.191 -2.02 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.647 HD11 ' HA ' ' A' ' 28' ' ' PHE . 0.7 OUTLIER -104.17 -27.23 3.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 120.682 -1.261 . . . . 0.0 109.404 178.127 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.69 HD11 ' CE2' ' A' ' 28' ' ' PHE . 1.2 mm -70.89 -58.5 5.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 177.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.819 ' OG1' HD12 ' B' ' 85' ' ' LEU . 0.5 OUTLIER -67.71 -42.84 81.36 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.342 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 1.12 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 34.0 mm-40 -69.09 -34.62 75.38 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.24 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.9 HG23 ' CB ' ' A' ' 40' ' ' ASP . 1.2 m -57.88 -50.35 73.62 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.44 -1.413 . . . . 0.0 107.812 178.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.684 HG11 ' HB2' ' B' ' 85' ' ' LEU . 2.1 t -53.1 -40.52 38.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 C-N-CA 118.607 -1.237 . . . . 0.0 107.853 178.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.801 ' HB2' ' HB1' ' B' ' 88' ' ' ALA . . . -77.71 -9.34 58.94 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.481 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -102.1 2.19 37.19 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 177.495 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.464 ' HA2' ' HG2' ' A' ' 52' ' ' PRO . . . 66.26 50.92 47.66 Favored Glycine 0 C--N 1.302 -1.359 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.9 ' CB ' HG23 ' A' ' 35' ' ' THR . 0.2 OUTLIER -127.9 157.78 39.58 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.284 -1.127 . . . . 0.0 110.081 179.591 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.412 ' CG ' ' HB2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -107.05 92.93 4.29 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.45 -0.781 . . . . 0.0 111.001 -178.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 1.011 HG13 HD11 ' B' ' 6' ' ' LEU . 2.3 t -87.4 92.17 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.557 -0.714 . . . . 0.0 109.303 179.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.471 ' O ' HD23 ' A' ' 44' ' ' LEU . 0.6 OUTLIER -89.19 148.37 23.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.137 -0.977 . . . . 0.0 110.617 -179.313 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.658 ' HB2' ' HB2' ' A' ' 48' ' ' LEU . 19.2 mt -118.45 117.31 28.68 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.543 -0.723 . . . . 0.0 109.725 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.518 HG23 ' CD2' ' A' ' 47' ' ' PHE . 0.1 OUTLIER 29.91 -88.59 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.429 0 O-C-N 121.82 -0.55 . . . . 0.0 111.137 179.506 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -152.38 21.28 0.84 Allowed Glycine 0 N--CA 1.486 2.009 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.688 ' CE1' HG21 ' B' ' 32' ' ' ILE . 8.8 p90 -118.54 -23.54 7.1 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.916 -1.343 . . . . 0.0 111.25 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.658 ' HB2' ' HB2' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -129.27 94.11 3.72 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.8 -1.188 . . . . 0.0 110.792 178.543 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.651 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 0.6 OUTLIER -96.02 83.37 3.64 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.64 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.948 HG22 ' CG2' ' A' ' 79' ' ' VAL . 0.7 OUTLIER -94.26 144.72 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.022 -1.048 . . . . 0.0 113.093 -177.629 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.584 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 9.7 ptmt -177.01 112.43 0.24 Allowed Pre-proline 0 N--CA 1.494 1.746 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 177.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.665 ' CB ' HG21 ' A' ' 75' ' ' VAL . 55.5 Cg_endo -69.58 132.06 22.8 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 O-C-N 123.313 1.165 . . . . 0.0 113.379 -175.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.89 ' O ' HG23 ' A' ' 75' ' ' VAL . 19.1 m -125.37 -141.16 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.272 177.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.739 ' HB2' ' HB3' ' B' ' 97' ' ' PHE . . . -149.78 124.9 10.04 Favored 'General case' 0 C--N 1.292 -1.896 0 O-C-N 120.576 -1.328 . . . . 0.0 111.189 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.0 tpp180 -173.0 109.54 0.18 Allowed 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.404 ' HG2' ' OH ' ' B' ' 94' ' ' TYR . 3.6 mt-30 -64.1 -150.2 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.239 -0.913 . . . . 0.0 109.947 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.859 ' CB ' HD13 ' A' ' 71' ' ' ILE . . . -167.26 177.92 5.86 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.245 -0.909 . . . . 0.0 110.879 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 1.11 ' O ' HD11 ' A' ' 71' ' ' ILE . 0.8 OUTLIER -84.4 -153.55 0.15 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.499 -0.75 . . . . 0.0 112.16 -178.485 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.695 ' CB ' ' O ' ' A' ' 58' ' ' ARG . 25.1 ttpp 139.24 118.11 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.601 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.524 ' O ' ' HB3' ' A' ' 61' ' ' PHE . . . -166.02 -104.22 0.18 Allowed Glycine 0 N--CA 1.489 2.184 0 C-N-CA 119.243 -1.456 . . . . 0.0 111.181 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.664 ' HD1' ' N ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER 173.88 155.07 0.12 Allowed 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.678 -0.895 . . . . 0.0 110.319 -178.81 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.793 ' HB2' ' H ' ' A' ' 68' ' ' ALA . 0.3 OUTLIER -107.08 -55.53 0.07 OUTLIER Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 121.152 -0.968 . . . . 0.0 111.885 -179.151 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.704 ' HD2' ' H ' ' A' ' 62' ' ' ASN . 39.1 Cg_endo -66.46 67.49 0.49 Allowed 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 123.49 1.258 . . . . 0.0 109.897 -178.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.64 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 0.8 OUTLIER -177.6 40.04 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -179.311 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.544 HG23 ' C ' ' A' ' 64' ' ' GLN . 1.4 p 62.39 27.36 16.3 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -178.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.497 ' CB ' ' CE1' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -142.78 -149.45 0.27 Allowed 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.393 -0.817 . . . . 0.0 110.098 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.763 ' O ' HD11 ' A' ' 69' ' ' LEU . 13.6 pt-20 -142.05 122.73 14.26 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.793 ' H ' ' HB2' ' A' ' 62' ' ' ASN . . . -79.99 138.55 37.08 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.71 0.767 . . . . 0.0 109.696 -178.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.763 HD11 ' O ' ' A' ' 67' ' ' GLU . 0.2 OUTLIER -137.7 -156.9 0.73 Allowed 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.097 -177.319 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.565 ' HB2' ' O ' ' A' ' 69' ' ' LEU . 11.2 tt0 167.51 125.38 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.505 -0.747 . . . . 0.0 110.33 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 1.11 HD11 ' O ' ' A' ' 58' ' ' ARG . 1.0 OUTLIER -158.45 -154.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 -179.712 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.889 ' HB1' ' HD2' ' B' ' 86' ' ' LYS . . . -141.59 93.35 7.77 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.101 -0.999 . . . . 0.0 111.789 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 72' ' ' ALA . 36.8 Cg_endo -63.42 111.67 1.53 Allowed 'Trans proline' 0 N--CA 1.488 1.204 0 O-C-N 123.476 1.25 . . . . 0.0 109.637 177.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.61 ' HA ' ' CE2' ' B' ' 94' ' ' TYR . 6.6 p 176.25 -165.6 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -179.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.89 HG23 ' O ' ' A' ' 53' ' ' VAL . 8.7 p -46.46 160.34 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.556 ' HA3' ' CG2' ' A' ' 53' ' ' VAL . . . -91.6 55.85 3.07 Favored Glycine 0 N--CA 1.484 1.84 0 N-CA-C 107.449 -2.261 . . . . 0.0 107.449 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.895 HG21 ' HA ' ' B' ' 84' ' ' SER . 19.2 t -26.0 93.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-O 122.932 1.348 . . . . 0.0 110.986 -178.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.569 ' CB ' ' HG3' ' A' ' 51' ' ' LYS . 45.7 t -57.31 -41.63 80.28 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 114.199 -1.364 . . . . 0.0 113.329 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.948 ' CG2' HG22 ' A' ' 50' ' ' ILE 0.255 7.5 p -44.38 167.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 CA-C-O 122.423 1.106 . . . . 0.0 113.568 -172.238 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.632 ' O ' HD23 ' A' ' 48' ' ' LEU . 0.5 OUTLIER 174.61 176.07 0.21 Allowed Pre-proline 0 N--CA 1.485 1.301 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.382 -179.518 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -78.96 130.76 9.65 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 123.751 1.395 . . . . 0.0 109.344 176.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.458 ' CA ' ' HA ' ' A' ' 47' ' ' PHE . . . -104.39 -174.93 25.15 Favored Glycine 0 N--CA 1.498 2.821 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.43 ' HA ' ' HB2' ' A' ' 86' ' ' LYS . 2.2 pm0 -80.93 -24.27 38.29 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.32 -1.106 . . . . 0.0 110.707 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.423 ' HB2' ' HA3' ' A' ' 46' ' ' GLY . 22.0 t -51.07 -32.13 21.05 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.15 -0.969 . . . . 0.0 108.518 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.974 HD11 ' CG1' ' B' ' 36' ' ' VAL . 0.6 OUTLIER -84.22 -35.1 23.71 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.592 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.753 ' HG3' HG23 ' B' ' 77' ' ' VAL . 0.6 OUTLIER -71.34 -31.12 67.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.244 -0.91 . . . . 0.0 109.182 178.809 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.45 -37.18 65.9 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.913 ' C ' ' HB1' ' B' ' 37' ' ' ALA . . . -65.24 -33.77 76.78 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 176.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 1.002 ' CB ' HG11 ' B' ' 75' ' ' VAL . . . -62.38 -35.07 78.01 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.1 -26.37 66.16 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 175.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.519 ' C ' ' H ' ' A' ' 93' ' ' LYS . . . -59.83 -50.18 70.48 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 178.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.747 HD23 ' C ' ' B' ' 37' ' ' ALA . 1.3 pp -74.91 27.76 0.09 Allowed 'General case' 0 N--CA 1.505 2.311 0 O-C-N 120.454 -1.615 . . . . 0.0 109.473 178.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.613 ' HB3' ' O ' ' A' ' 92' ' ' LEU . 4.1 ttpt 68.99 93.39 0.08 Allowed 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -177.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.834 ' O ' ' N ' ' A' ' 97' ' ' PHE . 24.8 t80 -58.95 -60.74 3.38 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 115.301 -2.56 . . . . 0.0 106.181 177.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.939 ' O ' ' N ' ' A' ' 98' ' ' ALA . 38.5 mm-40 10.81 41.44 0.0 OUTLIER 'General case' 0 CA--C 1.484 -1.596 0 N-CA-C 101.366 -3.568 . . . . 0.0 101.366 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 1.044 ' O ' ' N ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER 19.55 44.11 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 112.968 -1.924 . . . . 0.0 108.054 -172.87 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.851 ' CE2' ' HB2' ' B' ' 54' ' ' ALA . 0.0 OUTLIER 26.26 29.67 0.0 OUTLIER 'General case' 0 C--N 1.366 1.31 0 N-CA-C 102.401 -3.185 . . . . 0.0 102.401 -170.536 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 1.044 ' N ' ' O ' ' A' ' 96' ' ' ASP 0.278 . . -73.73 -30.0 62.57 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 109.867 -3.333 . . . . 0.0 109.843 -178.404 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 29.8 mtmt . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.173 179.919 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.595 ' HA ' ' HB2' ' B' ' 5' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 120.823 0.344 . . . . 0.0 110.246 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . 0.48 ' C ' ' H ' ' B' ' 4' ' ' THR . 40.7 p-10 -176.37 -135.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.131 -1.027 . . . . 0.0 111.374 178.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.83 ' HD3' HD11 ' B' ' 25' ' ' LEU . 4.9 mttp -61.5 9.16 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.006 -1.058 . . . . 0.0 111.289 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.48 ' H ' ' C ' ' B' ' 2' ' ' ASN . 52.9 m -127.8 -66.39 0.87 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.518 -1.364 . . . . 0.0 110.591 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.595 ' HB2' ' HA ' ' B' ' 1' ' ' MET . 19.7 mp0 -53.59 -42.44 67.64 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.955 -1.09 . . . . 0.0 109.797 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 1.011 HD11 HG13 ' A' ' 42' ' ' VAL . 18.0 mt -57.59 -33.08 67.82 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 118.804 -1.158 . . . . 0.0 109.636 179.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' ILE . . . . . 0.731 HG22 HD22 ' B' ' 25' ' ' LEU . 0.8 OUTLIER -61.83 -41.47 90.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 178.111 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . 0.839 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.0 OUTLIER -70.39 -29.86 66.61 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 177.875 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . 0.553 ' HB3' ' O ' ' B' ' 6' ' ' LEU . . . -59.17 -39.46 82.56 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.508 -0.745 . . . . 0.0 109.257 178.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.87 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.1 mp -92.64 -29.81 4.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 178.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.839 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -62.87 -15.59 55.42 Favored 'General case' 0 C--N 1.294 -1.809 0 C-N-CA 118.403 -1.319 . . . . 0.0 108.42 178.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.444 ' HB3' ' O ' ' B' ' 8' ' ' LYS . 15.3 tp60 -114.74 -45.31 3.0 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.567 -0.708 . . . . 0.0 109.4 178.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' B' ' 9' ' ' ALA . 3.0 m-20 -62.63 -27.75 69.43 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 177.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 1.1 HG22 ' CD1' ' B' ' 16' ' ' LEU 0.258 0.2 OUTLIER -106.66 -82.52 0.54 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 178.412 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.95 4.17 82.35 Favored Glycine 0 N--CA 1.5 2.931 0 O-C-N 121.038 -1.039 . . . . 0.0 110.681 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' LEU . . . . . 1.1 ' CD1' HG22 ' B' ' 14' ' ' THR . 5.4 mp -50.95 -71.02 0.07 Allowed 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.632 -0.923 . . . . 0.0 110.838 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . 0.559 ' CG2' HG21 ' A' ' 17' ' ' THR . 0.6 OUTLIER -136.96 7.82 2.96 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -179.638 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . 0.614 ' O ' ' C ' ' B' ' 19' ' ' VAL . 30.6 mt-30 58.34 26.78 14.43 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 -175.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 1.084 HG11 HG11 ' A' ' 19' ' ' VAL . 1.4 p -6.44 -92.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.857 -179.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.937 ' O ' ' N ' ' B' ' 23' ' ' LYS . 0.5 OUTLIER -134.51 25.11 3.76 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 177.531 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.696 ' HA ' ' CE ' ' B' ' 24' ' ' MET . 35.3 m -15.56 -41.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 122.66 1.219 . . . . 0.0 109.26 -177.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.925 ' N ' ' O ' ' B' ' 20' ' ' SER . 48.0 t -79.74 -41.68 26.14 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 114.537 -1.21 . . . . 0.0 110.288 177.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . 0.937 ' N ' ' O ' ' B' ' 20' ' ' SER . 1.5 mtpt -85.04 -34.95 22.19 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 121.461 -0.774 . . . . 0.0 111.662 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' MET . . . . . 0.696 ' CE ' ' HA ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -69.23 -30.64 68.83 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 117.667 -1.613 . . . . 0.0 108.058 179.261 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.842 ' HG ' ' N ' ' B' ' 26' ' ' ALA . 0.3 OUTLIER -72.84 -43.23 62.9 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 118.403 -1.319 . . . . 0.0 108.043 177.488 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . 0.842 ' N ' ' HG ' ' B' ' 25' ' ' LEU . . . -63.98 -26.69 68.69 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . 0.606 ' O ' HG23 ' B' ' 31' ' ' ILE . 1.4 t -83.4 -35.83 24.75 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 177.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . 0.711 ' HA ' ' CG1' ' B' ' 31' ' ' ILE . 0.6 OUTLIER -64.85 -48.48 74.18 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.467 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . 0.605 ' HG3' ' CD2' ' B' ' 28' ' ' PHE . 6.4 mt-10 -72.35 -30.21 64.51 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 120.492 -1.38 . . . . 0.0 107.536 178.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 1.147 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 14.3 tttt -73.19 -25.32 60.73 Favored 'General case' 0 C--O 1.187 -2.203 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 177.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.711 ' CG1' ' HA ' ' B' ' 28' ' ' PHE . 1.9 pp -100.28 -29.89 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.266 -1.521 . . . . 0.0 109.465 178.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.688 HG21 ' CE1' ' A' ' 47' ' ' PHE . 1.5 mm -65.79 -64.59 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 177.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' THR . . . . . 0.757 ' O ' HD13 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -62.72 -38.5 90.73 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.034 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 1.147 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 76.7 mm-40 -74.38 -42.74 58.78 Favored 'General case' 0 C--O 1.202 -1.404 0 O-C-N 121.036 -1.04 . . . . 0.0 112.111 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' THR . . . . . 0.518 ' HA ' ' HB3' ' B' ' 38' ' ' LYS . 67.5 m -57.19 -56.55 20.29 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 120.222 -1.548 . . . . 0.0 110.494 -178.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 1.013 HG23 HG12 ' B' ' 42' ' ' VAL . 1.3 t -51.63 -44.39 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 117.667 -1.613 . . . . 0.0 106.974 178.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 0.913 ' HB1' ' C ' ' A' ' 88' ' ' ALA . . . -85.97 6.08 30.29 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.705 179.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.785 ' N ' ' O ' ' B' ' 34' ' ' GLU . 0.1 OUTLIER -105.64 -36.43 7.09 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 178.156 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 142.68 37.57 0.08 OUTLIER Glycine 0 C--N 1.301 -1.388 0 C-N-CA 119.252 -1.451 . . . . 0.0 111.4 178.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . 0.456 ' HB2' HG23 ' B' ' 35' ' ' THR . 0.4 OUTLIER -155.53 145.0 21.07 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.821 -1.4 . . . . 0.0 110.988 179.461 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.15 92.79 5.72 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.557 0.694 . . . . 0.0 109.519 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 1.013 HG12 HG23 ' B' ' 36' ' ' VAL . 11.3 p -68.25 154.81 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.668 -0.645 . . . . 0.0 110.447 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' GLN . . . . . 0.841 ' O ' HD23 ' B' ' 44' ' ' LEU . 0.4 OUTLIER -164.1 176.3 9.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.189 -0.945 . . . . 0.0 111.386 179.937 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.841 HD23 ' O ' ' B' ' 43' ' ' GLN . 18.1 mt -134.28 118.8 17.96 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . 0.577 HG21 ' CG ' ' A' ' 29' ' ' GLU . 0.1 OUTLIER 27.21 -95.11 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.416 0 O-C-N 121.826 -0.546 . . . . 0.0 112.374 -179.812 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.529 ' H ' HG23 ' B' ' 45' ' ' THR . . . -137.66 14.97 3.62 Favored Glycine 0 N--CA 1.49 2.247 0 C-N-CA 119.322 -1.418 . . . . 0.0 111.686 -178.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . 0.909 ' CD2' HD23 ' B' ' 48' ' ' LEU . 20.4 p90 -110.9 -33.48 6.5 Favored 'General case' 0 C--O 1.195 -1.803 0 CA-C-N 119.447 1.623 . . . . 0.0 109.342 178.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.909 HD23 ' CD2' ' B' ' 47' ' ' PHE . 1.2 mm? -127.37 128.57 46.08 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 119.931 -1.731 . . . . 0.0 115.095 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' ASN . . . . . 0.715 ' N ' ' HG2' ' B' ' 81' ' ' PRO . 0.5 OUTLIER -143.93 91.86 2.27 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.621 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' ILE . . . . . 0.577 ' CD1' HG12 ' B' ' 79' ' ' VAL . 24.9 mm -83.79 148.07 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.457 -0.777 . . . . 0.0 110.688 -178.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' B' ' 78' ' ' SER . 0.0 OUTLIER -149.9 129.88 6.68 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.177 -0.952 . . . . 0.0 109.399 179.149 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.628 ' HG3' ' O ' ' B' ' 36' ' ' VAL . 54.9 Cg_endo -81.77 151.64 16.84 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 O-C-N 123.388 1.204 . . . . 0.0 111.387 -178.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.747 HG22 ' O ' ' B' ' 76' ' ' GLY . 20.1 m -138.8 117.48 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-O 122.364 1.078 . . . . 0.0 111.134 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.969 ' HB1' ' CB ' ' A' ' 96' ' ' ASP . . . -79.46 115.17 18.93 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.598 -0.689 . . . . 0.0 110.991 -179.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . 0.538 ' HB3' ' O ' ' B' ' 54' ' ' ALA . 0.0 OUTLIER 163.87 76.88 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.632 -0.668 . . . . 0.0 109.728 179.466 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . 0.502 ' O ' ' O ' ' B' ' 72' ' ' ALA . 12.8 mt-30 -155.82 19.47 0.38 Allowed 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.095 -1.042 . . . . 0.0 111.76 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.856 ' HB2' ' CA ' ' B' ' 73' ' ' PRO . . . -119.07 57.08 0.89 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.796 -1.19 . . . . 0.0 111.464 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' ARG . . . . . 0.768 ' N ' HD11 ' B' ' 71' ' ' ILE . 2.4 mtt-85 -51.62 176.21 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.512 -0.743 . . . . 0.0 109.841 178.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . 0.505 ' HB3' ' O ' ' B' ' 58' ' ' ARG . 1.5 pttt 173.83 56.18 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.43 -0.794 . . . . 0.0 109.223 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -134.25 -86.57 0.26 Allowed Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' PHE . . . . . 0.761 ' CD2' ' HB2' ' B' ' 68' ' ' ALA . 2.2 t80 -178.1 145.35 0.36 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.345 -1.091 . . . . 0.0 111.178 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . 0.845 ' OD1' HD11 ' B' ' 69' ' ' LEU . 1.4 t30 -66.63 -170.0 0.06 OUTLIER Pre-proline 0 C--N 1.303 -1.448 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 177.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.467 ' HD2' ' CB ' ' B' ' 62' ' ' ASN . 44.4 Cg_endo -76.75 51.54 3.39 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 N-CA-C 109.368 -1.051 . . . . 0.0 109.368 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . 0.418 ' HB2' ' HG3' ' B' ' 67' ' ' GLU . 32.2 mm-40 -147.12 -159.63 1.05 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 122.198 0.999 . . . . 0.0 110.158 -179.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.452 ' C ' ' CZ ' ' B' ' 61' ' ' PHE . 11.4 p -139.5 -2.42 1.59 Allowed 'General case' 0 C--N 1.286 -2.177 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.348 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . 0.479 ' N ' ' HZ ' ' B' ' 61' ' ' PHE . 0.1 OUTLIER -129.65 -7.69 4.59 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.016 -1.052 . . . . 0.0 111.166 179.271 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . 0.418 ' HG3' ' HB2' ' B' ' 64' ' ' GLN . 0.2 OUTLIER -127.47 79.14 1.87 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.971 -1.081 . . . . 0.0 109.633 179.031 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . 0.761 ' HB2' ' CD2' ' B' ' 61' ' ' PHE . . . -78.78 175.2 10.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.529 -0.732 . . . . 0.0 110.82 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.845 HD11 ' OD1' ' B' ' 62' ' ' ASN . 82.3 mt -106.15 -177.59 3.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.554 -0.716 . . . . 0.0 110.041 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . 0.559 ' O ' ' O ' ' B' ' 71' ' ' ILE . 0.9 OUTLIER -177.44 36.8 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.415 -0.803 . . . . 0.0 110.181 179.804 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.768 HD11 ' N ' ' B' ' 58' ' ' ARG . 0.3 OUTLIER -51.13 -157.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 O-C-N 121.718 -0.614 . . . . 0.0 110.919 179.317 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . 0.502 ' O ' ' O ' ' B' ' 56' ' ' GLN . . . -137.84 146.64 53.51 Favored Pre-proline 0 N--CA 1.487 1.393 0 O-C-N 120.723 -1.235 . . . . 0.0 111.923 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' PRO . . . . . 0.856 ' CA ' ' HB2' ' B' ' 57' ' ' ALA . 36.6 Cg_endo -62.09 122.01 10.3 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.566 1.824 . . . . 0.0 110.844 178.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . 0.516 ' N ' ' CE2' ' A' ' 94' ' ' TYR . 21.5 t -160.64 117.08 2.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.588 -0.695 . . . . 0.0 109.868 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . 1.002 HG11 ' CB ' ' A' ' 89' ' ' ALA . 9.4 p -52.16 162.46 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.234 -0.917 . . . . 0.0 109.923 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . 0.747 ' O ' HG22 ' B' ' 53' ' ' VAL . . . -114.79 98.96 0.89 Allowed Glycine 0 N--CA 1.484 1.847 0 C-N-CA 118.938 -1.601 . . . . 0.0 109.24 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.753 HG23 ' HG3' ' A' ' 86' ' ' LYS . 67.9 t -68.84 66.07 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.701 -0.882 . . . . 0.0 109.078 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . 0.487 ' C ' HG13 ' B' ' 79' ' ' VAL . 37.6 t -65.89 -176.19 0.36 Allowed 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.603 0.716 . . . . 0.0 109.648 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.577 HG12 ' CD1' ' B' ' 50' ' ' ILE . 17.7 m -152.68 -153.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . 0.719 ' HB3' ' HD3' ' B' ' 81' ' ' PRO . 13.0 ttmt -164.99 -57.58 0.01 OUTLIER Pre-proline 0 C--N 1.294 -1.808 0 O-C-N 121.452 -0.78 . . . . 0.0 109.985 178.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' PRO . . . . . 0.719 ' HD3' ' HB3' ' B' ' 80' ' ' LYS . 44.3 Cg_endo -95.95 164.84 1.33 Allowed 'Trans proline' 0 C--N 1.296 -2.213 0 C-N-CA 121.825 1.683 . . . . 0.0 112.842 -179.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . 0.711 ' N ' ' O ' ' B' ' 47' ' ' PHE . . . 177.05 -25.39 0.06 OUTLIER Glycine 0 C--N 1.287 -2.141 0 N-CA-C 105.774 -2.93 . . . . 0.0 105.774 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . 0.908 ' O ' ' N ' ' B' ' 85' ' ' LEU . 22.5 tt0 30.76 49.84 0.09 Allowed 'General case' 0 C--O 1.205 -1.268 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' SER . . . . . 1.3 ' O ' ' N ' ' B' ' 86' ' ' LYS . 1.2 m 12.67 43.93 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.941 1.353 . . . . 0.0 109.093 -178.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 1.116 ' O ' ' N ' ' B' ' 88' ' ' ALA . 0.3 OUTLIER 23.05 26.4 0.0 OUTLIER 'General case' 0 C--O 1.187 -2.225 0 N-CA-C 102.785 -3.043 . . . . 0.0 102.785 -170.182 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . 1.3 ' N ' ' O ' ' B' ' 84' ' ' SER 0.324 21.8 tttt -37.33 -40.83 0.37 Allowed 'General case' 0 CA--C 1.486 -1.497 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 176.624 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . 0.426 ' N ' ' C ' ' B' ' 85' ' ' LEU 0.307 0.0 OUTLIER -61.06 -39.71 90.9 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-N 111.865 -2.425 . . . . 0.0 106.711 175.355 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 1.116 ' N ' ' O ' ' B' ' 85' ' ' LEU . . . -90.03 -21.62 22.27 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.433 -0.907 . . . . 0.0 108.966 178.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.711 ' N ' ' O ' ' B' ' 85' ' ' LEU . . . -71.83 -36.74 70.3 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 178.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -66.51 -31.93 72.97 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 174.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -60.88 -42.18 99.53 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . 0.862 ' O ' HD12 ' B' ' 92' ' ' LEU . 1.2 pp -85.34 21.17 1.8 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 120.443 -1.622 . . . . 0.0 110.581 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . 0.453 ' O ' ' N ' ' B' ' 96' ' ' ASP . 0.8 OUTLIER 55.66 45.22 25.11 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 -178.071 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . 0.61 ' CE2' ' HA ' ' A' ' 74' ' ' SER . 0.0 OUTLIER -37.29 -43.69 0.55 Allowed 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.661 -178.862 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . 0.528 ' O ' ' HB3' ' B' ' 98' ' ' ALA . 8.7 pt-20 -54.42 -41.84 69.79 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.297 -0.877 . . . . 0.0 109.535 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 96' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' B' ' 93' ' ' LYS . 0.7 OUTLIER -59.76 -34.29 72.79 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.193 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 97' ' ' PHE . . . . . 0.739 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -69.74 -27.48 64.99 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.272 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 98' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' B' ' 95' ' ' GLU . . . -67.04 -53.01 35.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.588 -0.695 . . . . 0.0 110.215 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.234 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.5 ' HG2' ' HB3' ' A' ' 5' ' ' GLU . 11.2 mtp . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 120.852 0.358 . . . . 0.0 110.093 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.486 ' C ' HD12 ' A' ' 6' ' ' LEU . 7.8 t-20 -179.17 -179.86 0.6 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.261 -0.9 . . . . 0.0 110.304 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.529 ' O ' HG13 ' A' ' 7' ' ' ILE . 0.6 OUTLIER -52.63 -20.08 2.8 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.12 -0.988 . . . . 0.0 109.931 179.668 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.464 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 16.6 m -97.69 -46.68 5.9 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.545 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -62.55 -47.04 85.6 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 178.657 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.743 HD11 HG13 ' B' ' 42' ' ' VAL . 2.4 mt -65.69 -29.68 70.26 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.754 -0.779 . . . . 0.0 109.193 178.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.831 HG23 ' HB ' ' A' ' 21' ' ' VAL . 0.3 OUTLIER -56.34 -58.76 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 178.428 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.973 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 0.2 OUTLIER -62.64 -27.47 69.24 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.506 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 6' ' ' LEU . . . -61.22 -32.19 71.97 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.202 -0.937 . . . . 0.0 108.708 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.852 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.2 tp -96.29 -37.59 7.44 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.549 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 178.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.973 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -59.38 -24.19 63.2 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.428 ' HB3' ' O ' ' A' ' 8' ' ' LYS . 39.3 tp60 -92.5 -45.15 8.27 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.434 ' HB3' ' CB ' ' B' ' 27' ' ' SER . 3.3 m-20 -63.81 -32.12 73.52 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 177.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.948 HG22 ' OG ' ' B' ' 20' ' ' SER . 27.7 p -82.5 -74.01 0.37 Allowed 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 58.87 14.79 24.99 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.936 HD22 ' O ' ' B' ' 19' ' ' VAL . 2.9 mp -77.0 -47.31 21.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.542 -0.976 . . . . 0.0 108.615 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.664 ' HB ' HG21 ' B' ' 17' ' ' THR . 0.5 OUTLIER -160.69 5.57 0.07 Allowed 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 120.0 -0.68 . . . . 0.0 111.055 -179.158 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.552 ' O ' ' C ' ' A' ' 19' ' ' VAL . 13.7 mt-30 58.97 25.52 13.89 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 -176.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.982 HG11 HG11 ' B' ' 19' ' ' VAL . 1.9 p -5.03 -93.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.942 -178.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.965 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -130.32 25.05 5.18 Favored 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 179.695 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.831 ' HB ' HG23 ' A' ' 7' ' ' ILE . 12.5 m -19.26 -40.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 CA-C-O 122.553 1.168 . . . . 0.0 109.548 -178.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.826 ' N ' ' O ' ' A' ' 20' ' ' SER . 29.2 t -80.06 -35.75 36.62 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.999 178.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.965 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.3 OUTLIER -90.8 -36.21 14.38 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.479 -0.763 . . . . 0.0 110.891 179.561 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.755 ' O ' HD11 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -67.61 -38.64 84.23 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 117.626 -1.63 . . . . 0.0 108.994 179.462 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.763 HD12 HG13 ' A' ' 7' ' ' ILE . 0.2 OUTLIER -78.29 -48.04 16.53 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 117.858 -1.537 . . . . 0.0 109.112 178.455 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.478 ' HA ' ' HE3' ' A' ' 3' ' ' LYS . . . -54.97 -37.24 66.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.747 -1.221 . . . . 0.0 107.831 177.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.588 ' O ' HG13 ' A' ' 31' ' ' ILE . 8.4 t -83.18 -28.82 29.06 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.13 178.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.667 ' CE1' HD22 ' B' ' 44' ' ' LEU . 2.8 t80 -51.91 -49.26 63.4 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.847 ' HG3' ' CD1' ' B' ' 47' ' ' PHE . 3.3 tt0 -67.17 -35.52 79.83 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 176.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 1.285 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 32.6 tttt -66.11 -17.88 64.99 Favored 'General case' 0 C--O 1.193 -1.913 0 C-N-CA 119.527 -0.869 . . . . 0.0 108.951 178.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.61 HG13 ' O ' ' A' ' 28' ' ' PHE . 1.3 pp -109.24 -26.21 3.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 119.786 -1.821 . . . . 0.0 109.344 178.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.658 ' O ' HG22 ' A' ' 36' ' ' VAL . 1.2 mm -76.5 -54.7 12.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 177.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.77 ' HA ' ' HG ' ' B' ' 85' ' ' LEU . 0.6 OUTLIER -79.35 -29.39 42.19 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.876 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 1.285 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 41.5 mm-40 -78.5 -29.88 46.89 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 118.851 -1.14 . . . . 0.0 110.232 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.537 ' HA ' ' HB2' ' A' ' 38' ' ' LYS . 7.2 m -73.73 -58.73 3.1 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 117.718 -1.593 . . . . 0.0 107.916 178.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.658 HG22 ' O ' ' A' ' 32' ' ' ILE . 24.7 m -43.22 -40.7 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.734 ' O ' ' HB2' ' B' ' 92' ' ' LEU . . . -79.01 -32.56 45.16 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.787 ' N ' HD12 ' B' ' 92' ' ' LEU . 0.0 OUTLIER -60.44 -27.66 67.68 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 105.129 -2.175 . . . . 0.0 105.129 176.664 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.484 ' CA ' ' CZ ' ' B' ' 97' ' ' PHE . . . 116.74 26.98 2.91 Favored Glycine 0 C--N 1.297 -1.628 0 CA-C-N 114.363 -1.29 . . . . 0.0 111.025 176.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.508 ' HB2' HG23 ' A' ' 35' ' ' THR . 0.2 OUTLIER -122.0 137.34 54.84 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.251 -1.146 . . . . 0.0 110.072 179.213 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.9 mttm -82.02 87.73 6.44 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.535 -0.728 . . . . 0.0 110.704 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.466 HG22 ' CG1' ' A' ' 36' ' ' VAL . 33.2 m -65.09 140.18 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.446 -0.784 . . . . 0.0 109.718 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.5 ' O ' ' HA ' ' B' ' 2' ' ' ASN . 9.0 mt-30 -135.29 172.22 13.32 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.168 -0.958 . . . . 0.0 110.251 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.948 HD22 ' CE1' ' B' ' 28' ' ' PHE . 11.7 mt -131.65 115.99 16.77 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.214 -0.929 . . . . 0.0 110.332 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.571 HG23 ' HD2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER 26.82 -93.41 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.891 -0.506 . . . . 0.0 111.853 178.892 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.428 ' N ' ' OG1' ' A' ' 45' ' ' THR . . . -153.27 33.87 0.78 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.811 ' CD2' ' HG3' ' B' ' 29' ' ' GLU . 3.2 p90 -131.44 -15.3 3.2 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.265 -1.138 . . . . 0.0 111.154 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.89 HD12 ' O ' ' A' ' 80' ' ' LYS . 47.6 tp -161.05 121.61 2.79 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 118.261 -1.375 . . . . 0.0 111.085 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.477 ' HA ' ' HA ' ' A' ' 43' ' ' GLN . 16.2 m-20 -131.59 118.16 19.71 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.46 0.648 . . . . 0.0 111.163 -178.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.665 HD13 HG23 ' A' ' 79' ' ' VAL . 5.0 mm -94.61 151.51 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.677 -0.639 . . . . 0.0 109.564 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.458 ' O ' ' N ' ' A' ' 78' ' ' SER . 11.5 ptmt -165.52 115.1 0.83 Allowed Pre-proline 0 N--CA 1.5 2.051 0 O-C-N 120.68 -1.263 . . . . 0.0 110.851 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.645 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 43.9 Cg_endo -82.69 155.78 15.83 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 O-C-N 123.515 1.271 . . . . 0.0 112.024 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.726 HG22 ' O ' ' A' ' 76' ' ' GLY . 33.0 m -147.62 118.42 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 CA-C-O 121.669 0.747 . . . . 0.0 110.701 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.574 ' HA ' ' CE1' ' B' ' 94' ' ' TYR . . . -77.47 117.99 19.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.635 -0.666 . . . . 0.0 111.428 -179.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.441 ' HB3' ' O ' ' A' ' 54' ' ' ALA . 2.7 ptp180 171.71 63.56 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.773 -0.579 . . . . 0.0 109.463 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.459 ' O ' ' HA ' ' A' ' 73' ' ' PRO . 41.3 mt-30 -150.92 72.16 1.06 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.116 -0.99 . . . . 0.0 111.751 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.956 ' HA ' HG12 ' A' ' 71' ' ' ILE . . . -145.44 65.66 1.24 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.077 -1.014 . . . . 0.0 110.339 179.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.895 ' CA ' HG23 ' A' ' 71' ' ' ILE 0.253 0.8 OUTLIER -179.48 123.45 0.08 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.286 -0.884 . . . . 0.0 112.301 -178.566 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.778 ' HB2' HG21 ' A' ' 71' ' ' ILE . 5.5 ttmt 169.1 19.57 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.163 -0.961 . . . . 0.0 110.257 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.549 ' HA3' ' HG ' ' A' ' 69' ' ' LEU . . . -86.46 5.15 85.26 Favored Glycine 0 N--CA 1.484 1.885 0 C-N-CA 119.68 -1.248 . . . . 0.0 110.107 -179.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.939 ' CZ ' ' HB2' ' A' ' 68' ' ' ALA . 1.7 m-85 -50.53 -177.75 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.08 -1.247 . . . . 0.0 109.802 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.717 ' HB3' ' CD ' ' A' ' 63' ' ' PRO . 2.4 t-20 -127.8 -82.96 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.636 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.717 ' CD ' ' HB3' ' A' ' 62' ' ' ASN . 44.2 Cg_endo -77.66 -5.26 15.31 Favored 'Trans proline' 0 C--N 1.322 -0.838 0 N-CA-C 107.103 -1.922 . . . . 0.0 107.103 174.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.594 ' CB ' ' O ' ' A' ' 63' ' ' PRO . 11.5 tt0 88.63 60.56 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.33 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 178.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.936 HG23 ' OE1' ' A' ' 66' ' ' GLN . 0.0 OUTLIER 172.15 23.59 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.404 0 O-C-N 121.379 -0.826 . . . . 0.0 111.954 177.791 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.936 ' OE1' HG23 ' A' ' 65' ' ' THR . 0.0 OUTLIER -146.21 -112.37 0.09 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.547 -1.345 . . . . 0.0 111.406 179.111 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.423 ' O ' HD23 ' A' ' 69' ' ' LEU . 0.9 OUTLIER -64.45 82.48 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.947 -1.096 . . . . 0.0 110.526 -179.044 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.939 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . . . -76.25 64.88 2.11 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.577 -0.702 . . . . 0.0 110.359 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.845 ' O ' ' O ' ' A' ' 70' ' ' GLU . 0.4 OUTLIER -65.7 66.9 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.488 -0.758 . . . . 0.0 110.374 179.79 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.845 ' O ' ' O ' ' A' ' 69' ' ' LEU . 39.2 mt-10 -19.2 -164.71 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 115.972 1.842 . . . . 0.0 115.972 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.956 HG12 ' HA ' ' A' ' 57' ' ' ALA 0.298 0.1 OUTLIER -134.02 -163.6 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-N 114.071 -1.422 . . . . 0.0 109.729 -175.044 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.657 ' N ' HG13 ' A' ' 71' ' ' ILE . . . -88.88 120.18 70.0 Favored Pre-proline 0 C--N 1.286 -2.152 0 O-C-N 121.888 -0.507 . . . . 0.0 111.712 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.752 ' CA ' ' HB2' ' A' ' 57' ' ' ALA . 37.1 Cg_endo -62.55 124.46 14.24 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 123.876 1.461 . . . . 0.0 109.752 178.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.485 ' C ' ' CE1' ' B' ' 94' ' ' TYR . 5.3 m -148.49 140.14 23.64 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.479 -0.763 . . . . 0.0 110.132 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.91 HG11 ' HB3' ' B' ' 89' ' ' ALA . 7.5 p -50.09 161.47 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.46 -0.775 . . . . 0.0 111.413 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.726 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -116.9 68.75 0.3 Allowed Glycine 0 N--CA 1.487 2.088 0 N-CA-C 108.749 -1.741 . . . . 0.0 108.749 179.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.894 ' CG2' HD22 ' B' ' 85' ' ' LEU . 6.4 p -47.08 80.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.963 -0.728 . . . . 0.0 111.622 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.642 ' C ' HG12 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -77.15 176.66 8.51 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 177.757 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.665 HG23 HD13 ' A' ' 50' ' ' ILE . 0.2 OUTLIER 177.49 174.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -179.745 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.89 ' O ' HD12 ' A' ' 48' ' ' LEU . 6.5 ptpt -178.15 170.21 0.87 Allowed Pre-proline 0 C--N 1.299 -1.599 0 O-C-N 121.538 -0.726 . . . . 0.0 109.557 176.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.573 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 56.0 Cg_endo -100.69 176.28 0.27 Allowed 'Trans proline' 0 C--N 1.292 -2.447 0 C-N-CA 122.6 2.2 . . . . 0.0 110.943 178.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 47' ' ' PHE . . . -126.27 163.2 20.29 Favored Glycine 0 N--CA 1.485 1.958 0 N-CA-C 107.084 -2.407 . . . . 0.0 107.084 177.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -58.06 -22.5 50.58 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.751 -1.441 . . . . 0.0 110.905 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.436 ' CB ' ' HB3' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -53.54 -35.29 60.56 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.0 -1.063 . . . . 0.0 108.894 179.198 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.966 HD13 ' CG1' ' B' ' 77' ' ' VAL . 0.5 OUTLIER -82.31 -25.65 33.77 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.742 -0.599 . . . . 0.0 109.386 178.711 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.572 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 20.4 mttt -84.86 -30.67 24.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.345 -0.847 . . . . 0.0 109.956 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -73.5 -38.43 65.37 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.831 ' O ' ' HB1' ' B' ' 37' ' ' ALA . . . -63.65 -37.28 86.73 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 176.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 1.002 ' HB1' ' CG1' ' B' ' 75' ' ' VAL . . . -54.92 -44.46 74.26 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 120.106 -0.638 . . . . 0.0 109.362 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.46 ' HA ' ' CB ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -54.47 -29.37 49.72 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.247 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 88' ' ' ALA . . . -67.9 -40.86 89.07 Favored Glycine 0 N--CA 1.488 2.122 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.31 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.89 HD11 ' CZ ' ' A' ' 97' ' ' PHE . 0.3 OUTLIER -70.39 -47.63 59.96 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 119.895 1.847 . . . . 0.0 110.533 -178.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.645 ' O ' ' CG ' ' A' ' 93' ' ' LYS . 0.1 OUTLIER 160.35 57.0 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.175 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.931 ' CD2' ' HB2' ' B' ' 74' ' ' SER . 17.4 t80 -53.18 -65.47 0.55 Allowed 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 178.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 1.048 ' O ' ' N ' ' A' ' 98' ' ' ALA . 1.0 OUTLIER 5.41 41.97 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 103.208 -2.886 . . . . 0.0 103.208 175.833 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 1.228 ' CA ' ' HB3' ' B' ' 74' ' ' SER . 0.0 OUTLIER 17.11 42.47 0.0 OUTLIER 'General case' 0 CA--C 1.461 -2.455 0 CA-C-N 113.176 -1.829 . . . . 0.0 109.515 -172.327 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 1.06 ' C ' ' O ' ' A' ' 96' ' ' ASP 0.327 69.5 m-85 30.52 25.1 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.744 1 N-CA-C 97.542 -4.985 . . . . 0.0 97.542 -168.671 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 1.169 ' HB2' ' CG ' ' A' ' 96' ' ' ASP 0.258 . . -50.87 -26.1 5.38 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 110.012 -3.267 . . . . 0.0 108.596 -178.565 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.829 0 CA-C-N 114.351 -1.295 . . . . 0.0 110.494 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.478 ' HA ' ' HB2' ' B' ' 5' ' ' GLU . 5.5 mtp . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 120.881 0.372 . . . . 0.0 110.259 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . 0.667 ' O ' HD12 ' B' ' 6' ' ' LEU . 16.4 m-80 -147.45 -155.99 0.68 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.076 -1.015 . . . . 0.0 111.083 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.526 ' O ' ' CG2' ' B' ' 7' ' ' ILE . 1.0 OUTLIER -60.92 2.17 0.12 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.342 -0.849 . . . . 0.0 110.446 179.765 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.686 ' O ' HG13 ' B' ' 7' ' ' ILE . 4.5 m -116.3 -63.25 1.48 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 122.147 0.975 . . . . 0.0 108.904 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.478 ' HB2' ' HA ' ' B' ' 1' ' ' MET . 5.5 mm-40 -52.03 -48.05 64.71 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.214 -0.929 . . . . 0.0 108.515 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.667 HD12 ' O ' ' B' ' 2' ' ' ASN . 7.5 mt -56.72 -32.8 65.87 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 119.122 -1.031 . . . . 0.0 110.256 178.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' ILE . . . . . 0.686 HG13 ' O ' ' B' ' 4' ' ' THR . 1.1 pp -60.72 -42.42 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.54 -1.35 . . . . 0.0 107.91 179.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . 0.822 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.0 OUTLIER -71.93 -27.2 62.65 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.29 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' B' ' 6' ' ' LEU . . . -62.54 -36.35 82.35 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.958 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.0 OUTLIER -95.46 -35.24 5.79 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.382 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.787 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.822 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -56.32 -25.25 48.15 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -92.49 -46.82 7.45 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.522 ' OD2' HG21 ' A' ' 31' ' ' ILE . 87.0 m-20 -61.64 -24.97 67.08 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 177.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.958 ' OG1' ' O ' ' B' ' 10' ' ' ILE . 17.2 p -93.77 -77.93 0.44 Allowed 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 177.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 61.46 9.23 16.46 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' LEU . . . . . 0.944 HD22 ' O ' ' A' ' 19' ' ' VAL . 3.2 mp -72.75 -60.25 2.32 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.377 -1.072 . . . . 0.0 108.343 179.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . 0.664 HG21 ' HB ' ' A' ' 17' ' ' THR . 0.5 OUTLIER -143.5 3.44 1.31 Allowed 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.598 179.659 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . 0.639 ' O ' ' C ' ' B' ' 19' ' ' VAL . 4.9 mt-30 59.1 25.33 13.79 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 106.565 -1.642 . . . . 0.0 106.565 -176.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.982 HG11 HG11 ' A' ' 19' ' ' VAL . 2.2 p 2.54 -97.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.481 -179.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.95 ' O ' ' N ' ' B' ' 23' ' ' LYS . 0.3 OUTLIER -131.55 21.77 4.7 Favored 'General case' 0 C--N 1.278 -2.525 0 N-CA-C 105.655 -1.98 . . . . 0.0 105.655 175.891 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.959 ' HA ' ' HE2' ' B' ' 24' ' ' MET . 21.2 m -15.31 -39.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-O 122.426 1.108 . . . . 0.0 109.444 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.936 ' N ' ' O ' ' B' ' 20' ' ' SER . 16.5 m -77.41 -45.01 27.2 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.983 177.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . 0.95 ' N ' ' O ' ' B' ' 20' ' ' SER . 6.6 mtmt -96.76 -14.36 22.03 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 121.482 -0.761 . . . . 0.0 109.719 178.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' MET . . . . . 0.959 ' HE2' ' HA ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -71.78 -36.06 70.23 Favored 'General case' 0 C--O 1.216 -0.71 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 177.708 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.556 ' HA ' ' HB3' ' B' ' 28' ' ' PHE . 3.4 mt -84.51 -36.16 22.41 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 176.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . 0.734 ' HB3' ' HA ' ' B' ' 23' ' ' LYS . . . -61.48 -34.21 75.09 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . 0.483 ' O ' HG13 ' B' ' 31' ' ' ILE . 11.1 m -77.45 -34.76 54.41 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . 0.948 ' CE1' HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -52.36 -45.53 65.77 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.745 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . 0.811 ' HG3' ' CD2' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -68.72 -35.96 77.82 Favored 'General case' 0 C--N 1.292 -1.899 0 C-N-CA 118.455 -1.298 . . . . 0.0 107.577 177.08 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 1.158 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 23.5 ttmt -63.92 -22.58 66.99 Favored 'General case' 0 C--O 1.191 -1.978 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.64 HD11 ' HA ' ' B' ' 28' ' ' PHE . 0.4 OUTLIER -105.08 -27.99 3.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 O-C-N 120.24 -1.537 . . . . 0.0 108.935 177.963 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.654 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.1 mm -72.46 -58.75 4.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 177.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' THR . . . . . 0.664 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 0.5 OUTLIER -69.05 -36.13 77.36 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.49 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 1.158 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 22.3 mm-40 -75.19 -39.03 60.52 Favored 'General case' 0 C--O 1.206 -1.185 0 C-N-CA 119.156 -1.018 . . . . 0.0 111.832 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' THR . . . . . 0.516 ' HA ' ' CB ' ' B' ' 38' ' ' LYS . 55.4 m -62.77 -51.59 66.51 Favored 'General case' 0 N--CA 1.504 2.229 0 CA-C-N 120.546 1.521 . . . . 0.0 109.826 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.692 ' HB ' HD21 ' A' ' 85' ' ' LEU . 2.4 t -53.85 -36.77 31.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 178.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 0.831 ' HB1' ' O ' ' A' ' 88' ' ' ALA . . . -94.66 11.65 30.47 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.581 0.705 . . . . 0.0 109.424 177.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.741 ' HB2' ' O ' ' B' ' 34' ' ' GLU . 0.1 OUTLIER -106.76 -33.62 7.53 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 176.933 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 131.07 38.46 0.28 Allowed Glycine 0 C--N 1.303 -1.264 0 C-N-CA 119.837 -1.173 . . . . 0.0 111.033 177.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . 0.493 ' HB2' HG23 ' B' ' 35' ' ' THR . 0.2 OUTLIER -147.82 147.31 29.68 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.771 -1.429 . . . . 0.0 111.235 179.634 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -91.4 95.96 10.26 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.743 HG13 HD11 ' A' ' 6' ' ' LEU . 61.8 t -59.27 124.65 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.655 -0.653 . . . . 0.0 110.924 -178.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' GLN . . . . . 0.426 ' CG ' ' O ' ' A' ' 1' ' ' MET . 11.1 pt20 -120.68 96.79 5.26 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.454 -0.779 . . . . 0.0 109.235 178.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.736 HD12 ' HB3' ' B' ' 48' ' ' LEU . 10.6 mt -65.53 113.2 4.0 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.497 -0.752 . . . . 0.0 110.406 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . 0.632 HG23 ' HD1' ' B' ' 47' ' ' PHE . 0.0 OUTLIER 29.4 -91.97 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.99 -0.444 . . . . 0.0 111.39 179.351 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -149.85 29.51 1.14 Allowed Glycine 0 N--CA 1.484 1.884 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . 0.847 ' CD1' ' HG3' ' A' ' 29' ' ' GLU . 3.9 p90 -132.66 -23.97 2.01 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.044 -1.268 . . . . 0.0 111.743 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.736 ' HB3' HD12 ' B' ' 44' ' ' LEU . 7.3 mt -132.59 105.62 7.32 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.382 -1.449 . . . . 0.0 111.876 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' ASN . . . . . 0.431 ' O ' ' HA ' ' B' ' 79' ' ' VAL . 0.1 OUTLIER -110.38 88.63 2.81 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.283 -0.886 . . . . 0.0 110.603 179.561 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' ILE . . . . . 0.609 HD11 ' CD2' ' A' ' 48' ' ' LEU . 1.1 mm -76.83 148.91 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.413 -0.804 . . . . 0.0 110.303 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . 0.418 ' HG3' ' CB ' ' B' ' 78' ' ' SER . 0.0 OUTLIER -161.17 126.75 2.27 Favored Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 120.918 -1.114 . . . . 0.0 110.182 179.096 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.49 ' HB3' HG13 ' B' ' 36' ' ' VAL . 50.1 Cg_endo -75.74 146.82 30.53 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.493 1.26 . . . . 0.0 111.334 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.523 ' O ' HG23 ' B' ' 53' ' ' VAL . 33.3 m -146.38 123.74 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.68 -0.637 . . . . 0.0 110.56 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 1.073 ' HA ' ' C ' ' B' ' 74' ' ' SER . . . -65.93 112.91 4.04 Favored 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 118.857 -1.137 . . . . 0.0 111.713 -178.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . 0.417 ' HB3' ' O ' ' B' ' 54' ' ' ALA . 0.6 OUTLIER 170.56 66.19 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.134 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.581 -179.857 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . 0.478 ' H ' ' N ' ' B' ' 74' ' ' SER . 3.9 mt-30 -138.49 89.06 2.35 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.281 -0.887 . . . . 0.0 111.248 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.653 ' HB2' ' CD ' ' B' ' 73' ' ' PRO . . . -138.05 -152.57 0.44 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.109 -0.994 . . . . 0.0 111.086 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' ARG . . . . . 0.736 ' O ' ' O ' ' B' ' 59' ' ' LYS . 10.2 ptt180 -155.49 -142.04 0.1 Allowed 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.333 -0.947 . . . . 0.0 112.285 -177.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . 0.736 ' O ' ' O ' ' B' ' 58' ' ' ARG . 0.0 OUTLIER -40.63 -137.36 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 CA-C-O 121.065 0.46 . . . . 0.0 111.749 179.789 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . 0.482 ' O ' ' CB ' ' B' ' 61' ' ' PHE . . . 66.27 -159.0 47.91 Favored Glycine 0 N--CA 1.485 1.904 0 O-C-N 120.865 -1.147 . . . . 0.0 110.415 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' PHE . . . . . 0.482 ' CB ' ' O ' ' B' ' 60' ' ' GLY . 19.2 t80 163.05 115.45 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . 0.449 ' O ' ' N ' ' B' ' 64' ' ' GLN . 0.9 OUTLIER -61.39 170.61 1.63 Allowed Pre-proline 0 C--N 1.301 -1.539 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.256 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -70.25 63.46 2.07 Favored 'Trans proline' 0 C--N 1.302 -1.888 0 N-CA-C 108.236 -1.486 . . . . 0.0 108.236 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . 0.703 ' O ' HG23 ' B' ' 65' ' ' THR . 22.3 mt-30 -128.45 -110.53 0.28 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.692 -0.803 . . . . 0.0 112.115 -178.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.703 HG23 ' O ' ' B' ' 64' ' ' GLN . 0.8 OUTLIER -162.35 -31.04 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.203 -0.936 . . . . 0.0 109.866 -179.747 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -137.95 9.92 2.82 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.487 -0.758 . . . . 0.0 111.021 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' B' ' 61' ' ' PHE . 3.6 tt0 -94.28 87.9 5.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.941 -1.099 . . . . 0.0 109.835 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -84.61 137.92 33.0 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.629 -0.669 . . . . 0.0 110.913 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.585 ' N ' ' O ' ' B' ' 59' ' ' LYS . 0.8 OUTLIER -177.18 100.23 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.464 -0.773 . . . . 0.0 110.529 179.742 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' B' ' 59' ' ' LYS . 0.0 OUTLIER -84.61 14.08 4.99 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.71 -1.244 . . . . 0.0 108.937 178.799 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.721 HG22 ' HG2' ' B' ' 58' ' ' ARG 0.255 0.2 OUTLIER -159.29 176.6 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -179.329 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . 0.753 ' O ' ' OH ' ' A' ' 94' ' ' TYR 0.25 . . -91.85 98.53 1.96 Allowed Pre-proline 0 C--N 1.291 -1.955 0 O-C-N 121.519 -0.738 . . . . 0.0 110.344 179.04 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' PRO . . . . . 0.653 ' CD ' ' HB2' ' B' ' 57' ' ' ALA . 37.2 Cg_endo -67.1 135.9 38.97 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 123.555 1.292 . . . . 0.0 112.006 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . 1.228 ' HB3' ' CA ' ' A' ' 96' ' ' ASP . 0.8 OUTLIER -159.8 -159.58 0.74 Allowed 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 179.868 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . 1.002 ' CG1' ' HB1' ' A' ' 89' ' ' ALA . 74.1 t -20.31 113.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-O 122.696 1.236 . . . . 0.0 112.036 -176.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . 0.543 ' C ' HG23 ' B' ' 77' ' ' VAL . . . -109.2 -142.96 9.94 Favored Glycine 0 C--N 1.283 -2.399 0 N-CA-C 106.764 -2.534 . . . . 0.0 106.764 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.966 ' CG1' HD13 ' A' ' 85' ' ' LEU . 99.2 t -155.18 77.57 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 O-C-N 121.279 -1.13 . . . . 0.0 110.138 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . 0.438 ' O ' ' HB ' ' B' ' 79' ' ' VAL . 0.6 OUTLIER -74.74 175.95 7.47 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 118.788 -1.165 . . . . 0.0 110.147 179.745 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.614 HG22 ' N ' ' B' ' 80' ' ' LYS . 5.9 p 176.25 177.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . 0.632 ' O ' HD23 ' B' ' 48' ' ' LEU . 0.1 OUTLIER -177.35 174.3 0.65 Allowed Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 120.878 -1.138 . . . . 0.0 110.604 178.053 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' PRO . . . . . 0.574 ' HA ' ' O ' ' B' ' 47' ' ' PHE . 51.5 Cg_endo -90.86 144.36 3.55 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.245 1.964 . . . . 0.0 110.137 178.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . 0.51 ' H ' ' HA ' ' B' ' 47' ' ' PHE . . . -106.24 41.45 2.17 Favored Glycine 0 N--CA 1.496 2.663 0 C-N-CA 120.002 -1.094 . . . . 0.0 110.608 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . 0.458 ' O ' ' N ' ' B' ' 87' ' ' LYS . 0.3 OUTLIER 66.46 -48.59 0.44 Allowed 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.419 -1.048 . . . . 0.0 111.604 179.669 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' SER . . . . . 0.418 ' N ' ' O ' ' B' ' 82' ' ' GLY . 4.9 t -46.1 -31.93 2.62 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.192 -0.942 . . . . 0.0 109.488 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.894 HD22 ' CG2' ' A' ' 77' ' ' VAL . 4.0 tt -86.16 -32.76 21.1 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.425 0.631 . . . . 0.0 109.436 178.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . 0.649 ' HG3' HG12 ' A' ' 77' ' ' VAL . 14.8 tttt -81.95 -22.01 36.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.456 -0.777 . . . . 0.0 110.329 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' B' ' 83' ' ' GLU . 0.0 OUTLIER -90.81 -29.74 17.4 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.642 ' O ' ' HG ' ' B' ' 92' ' ' LEU . . . -70.56 -36.23 73.51 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 177.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.91 ' HB3' HG11 ' A' ' 75' ' ' VAL . . . -73.51 -40.42 64.06 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 119.891 -0.724 . . . . 0.0 109.466 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.447 ' CG ' ' HA ' ' A' ' 74' ' ' SER . 0.1 OUTLIER -57.4 -22.28 41.97 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.488 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -101.44 -12.7 34.94 Favored Glycine 0 N--CA 1.485 1.926 0 C-N-CA 120.069 -1.062 . . . . 0.0 113.181 -178.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . 0.787 HD12 ' N ' ' A' ' 38' ' ' LYS . 3.4 mt -94.35 -69.4 0.75 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 121.751 2.775 . . . . 0.0 111.281 -179.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . 0.455 ' HB3' ' CE1' ' B' ' 97' ' ' PHE . 0.6 OUTLIER -148.4 49.31 1.03 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.0 -1.063 . . . . 0.0 111.23 -179.576 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . 0.584 ' CE2' ' HB2' ' A' ' 73' ' ' PRO . 55.3 t80 -53.85 -48.74 69.68 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.151 -0.968 . . . . 0.0 109.866 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -64.25 -38.82 92.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.455 -0.778 . . . . 0.0 109.858 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.37 -27.78 57.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.526 -0.734 . . . . 0.0 109.547 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 97' ' ' PHE . . . . . 0.484 ' CZ ' ' CA ' ' A' ' 39' ' ' GLY . 2.9 m-85 -89.62 -28.11 19.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.493 -0.754 . . . . 0.0 109.615 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.76 -31.71 72.71 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.432 -0.793 . . . . 0.0 110.049 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.175 179.935 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.575 ' CB ' HG12 ' B' ' 42' ' ' VAL . 1.5 mtp . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.505 ' HA ' ' O ' ' B' ' 43' ' ' GLN . 29.4 p-10 -170.25 -151.11 0.08 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.14 -1.024 . . . . 0.0 111.743 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.457 ' NZ ' ' HB ' ' B' ' 45' ' ' THR . 3.6 mttp -53.7 -3.83 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.286 -0.884 . . . . 0.0 111.407 -179.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.687 ' O ' HG13 ' A' ' 7' ' ' ILE . 72.9 m -118.25 -63.93 1.35 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.017 -1.052 . . . . 0.0 110.241 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.532 ' HB2' ' HA ' ' A' ' 1' ' ' MET . 3.9 mt-10 -50.6 -42.93 56.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.907 -1.121 . . . . 0.0 109.375 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.636 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 28.0 mt -61.16 -32.76 72.49 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.201 -1.0 . . . . 0.0 109.726 178.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.687 HG13 ' O ' ' A' ' 4' ' ' THR . 1.0 OUTLIER -60.03 -42.11 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 178.769 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.863 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -68.38 -31.22 70.44 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 177.478 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.636 ' HB3' ' O ' ' A' ' 6' ' ' LEU . . . -56.91 -38.73 73.26 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.497 -0.752 . . . . 0.0 109.008 178.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.724 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.4 mp -93.38 -30.38 4.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 178.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.863 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -63.19 -13.13 33.83 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 118.455 -1.298 . . . . 0.0 108.58 178.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -116.9 -45.19 2.78 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.513 -0.742 . . . . 0.0 110.155 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 9' ' ' ALA . 1.0 OUTLIER -67.22 -23.98 65.78 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 177.723 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 1.138 HG22 ' CD1' ' A' ' 16' ' ' LEU 0.278 0.2 OUTLIER -111.27 -71.96 0.74 Allowed 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 179.25 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 57.31 19.22 31.85 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 121.421 -0.8 . . . . 0.0 111.228 177.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.138 ' CD1' HG22 ' A' ' 14' ' ' THR . 4.7 mp -60.92 -66.45 0.53 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.414 -1.051 . . . . 0.0 110.015 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.555 HG21 HG21 ' B' ' 17' ' ' THR . 0.6 OUTLIER -135.14 8.59 3.46 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -179.807 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.587 ' O ' ' C ' ' A' ' 19' ' ' VAL . 22.3 mt-30 58.03 27.37 14.75 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 -175.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 1.105 HG23 ' CD1' ' B' ' 16' ' ' LEU . 0.5 OUTLIER -11.32 -95.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.626 -179.222 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.951 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -135.59 24.69 3.43 Favored 'General case' 0 C--N 1.279 -2.488 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 178.471 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.637 ' C ' ' O ' ' A' ' 20' ' ' SER . 26.8 m -18.48 -39.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-O 122.478 1.132 . . . . 0.0 109.71 -177.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.861 ' N ' ' O ' ' A' ' 20' ' ' SER . 4.9 p -84.88 -37.66 20.36 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.808 178.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.951 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.1 OUTLIER -85.56 -33.25 21.77 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.609 -0.682 . . . . 0.0 110.939 179.468 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.525 ' CE ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -74.39 -41.68 60.53 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 118.207 -1.397 . . . . 0.0 108.949 179.493 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.601 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 3.1 mt -69.49 -43.76 72.49 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 118.029 -1.469 . . . . 0.0 108.045 177.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.428 ' HA ' ' HD3' ' A' ' 3' ' ' LYS . . . -61.18 -32.33 72.07 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 177.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.547 ' O ' ' N ' ' A' ' 31' ' ' ILE . 7.2 t -75.86 -38.09 58.31 Favored 'General case' 0 C--O 1.207 -1.158 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 177.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.719 ' HA ' ' CG1' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -57.3 -38.08 73.45 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.315 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.872 ' HG2' HG22 ' B' ' 45' ' ' THR . 1.4 mt-10 -77.18 -36.67 54.87 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 1.052 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 15.9 ttpt -69.14 -20.21 64.03 Favored 'General case' 0 C--O 1.19 -2.049 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 177.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.821 HD13 ' HB1' ' B' ' 9' ' ' ALA . 1.1 pp -105.93 -30.69 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 120.603 -1.311 . . . . 0.0 109.342 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.718 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.1 mm -67.43 -54.22 25.6 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 176.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.743 ' HA ' HD12 ' B' ' 85' ' ' LEU . 0.3 OUTLIER -68.73 -40.2 80.0 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 1.052 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 61.3 mm-40 -73.26 -35.29 66.18 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.329 -0.857 . . . . 0.0 111.49 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.702 HG23 ' HB2' ' A' ' 40' ' ' ASP . 3.4 m -59.3 -50.66 73.12 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.598 -1.314 . . . . 0.0 108.078 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.725 HG22 ' HD3' ' A' ' 52' ' ' PRO . 1.1 t -54.22 -36.94 34.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 177.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.926 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -80.75 -5.04 56.58 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.639 0.733 . . . . 0.0 109.714 177.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -101.05 -24.21 14.35 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.36 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 105.86 40.68 1.96 Allowed Glycine 0 C--N 1.3 -1.433 0 C-N-CA 120.136 -1.031 . . . . 0.0 110.641 178.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.702 ' HB2' HG23 ' A' ' 35' ' ' THR . 0.1 OUTLIER -134.18 123.43 24.33 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.21 -1.171 . . . . 0.0 110.03 179.284 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.422 ' HB2' ' HB3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -79.87 68.48 5.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.438 -0.789 . . . . 0.0 110.629 -179.43 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 1.002 HG13 ' HB ' ' A' ' 50' ' ' ILE . 2.6 p -59.61 145.97 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.168 -0.958 . . . . 0.0 109.405 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -137.8 120.65 16.44 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.238 -0.914 . . . . 0.0 111.03 -178.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.736 HD12 ' CE1' ' A' ' 47' ' ' PHE . 10.1 mt -64.5 -178.81 0.42 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.28 -0.887 . . . . 0.0 109.326 178.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.791 HG22 ' HG2' ' B' ' 29' ' ' GLU . 1.4 t -36.32 -34.16 0.06 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.77 -0.581 . . . . 0.0 111.467 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 166.39 -23.37 0.13 Allowed Glycine 0 N--CA 1.488 2.155 0 C-N-CA 119.686 -1.245 . . . . 0.0 110.398 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.82 ' CG ' HD23 ' A' ' 85' ' ' LEU . 20.2 p90 -81.65 -18.83 43.22 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.885 -1.362 . . . . 0.0 111.395 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.707 ' HB2' HD12 ' A' ' 44' ' ' LEU . 2.7 mt -125.94 100.32 6.32 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 118.553 -1.259 . . . . 0.0 111.611 178.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.639 ' C ' HG23 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -91.81 64.48 4.79 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.056 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 1.011 HD11 HD11 ' B' ' 48' ' ' LEU . 27.2 mm -57.29 116.42 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 O-C-N 121.335 -0.853 . . . . 0.0 112.767 -177.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.552 ' HG2' ' O ' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -172.71 135.7 0.77 Allowed Pre-proline 0 N--CA 1.494 1.734 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.038 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.725 ' HD3' HG22 ' A' ' 36' ' ' VAL . 51.2 Cg_endo -90.63 156.08 4.27 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.473 1.249 . . . . 0.0 113.147 -177.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.61 ' O ' ' N ' ' A' ' 76' ' ' GLY . 27.1 m -132.14 111.94 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 CA-C-O 121.717 0.77 . . . . 0.0 110.195 177.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.746 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . -48.7 142.31 6.29 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 122.07 0.938 . . . . 0.0 112.473 -178.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.11 86.57 0.48 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.71 ' O ' HD11 ' A' ' 71' ' ' ILE . 0.6 OUTLIER -55.22 -171.21 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.976 0.893 . . . . 0.0 112.354 -177.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.731 ' HB2' ' HB3' ' A' ' 73' ' ' PRO . . . -73.7 -168.08 0.54 Allowed 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.843 0.83 . . . . 0.0 111.962 -178.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.793 ' HD3' ' N ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -177.78 -150.92 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -177.563 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.57 ' N ' ' HG2' ' A' ' 58' ' ' ARG . 0.5 OUTLIER 171.01 81.84 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.462 -0.774 . . . . 0.0 110.514 177.691 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.734 ' N ' ' O ' ' A' ' 69' ' ' LEU . . . 38.45 48.73 2.28 Favored Glycine 0 N--CA 1.495 2.616 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.886 ' CE2' HD12 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -94.73 145.44 24.86 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.93 -1.335 . . . . 0.0 113.481 -178.611 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.874 ' H ' ' CD ' ' A' ' 63' ' ' PRO . 15.0 p30 -145.58 -9.48 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 178.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.874 ' CD ' ' H ' ' A' ' 62' ' ' ASN . 46.8 Cg_endo -74.78 -10.62 21.69 Favored 'Trans proline' 0 N--CA 1.481 0.767 0 N-CA-C 108.898 -1.231 . . . . 0.0 108.898 178.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.576 ' CB ' ' CE1' ' A' ' 61' ' ' PHE . 1.0 OUTLIER -87.76 -103.57 0.08 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.661 -0.65 . . . . 0.0 109.356 179.567 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.44 ' O ' ' CB ' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -80.54 -0.31 37.1 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.485 -1.384 . . . . 0.0 109.827 178.87 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.629 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER 75.29 110.45 0.07 Allowed 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.749 0.785 . . . . 0.0 112.428 178.807 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.605 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 7.9 mt-10 138.58 89.96 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.317 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.716 ' HA ' ' C ' ' A' ' 61' ' ' PHE . . . -41.8 102.6 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.371 0 O-C-N 120.792 -1.192 . . . . 0.0 110.422 -178.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.886 HD12 ' CE2' ' A' ' 61' ' ' PHE . 22.0 mt -96.84 137.26 36.2 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.474 -0.766 . . . . 0.0 110.987 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.682 ' HA ' ' HG2' ' A' ' 58' ' ' ARG . 1.0 OUTLIER -135.99 23.01 3.3 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.694 -0.628 . . . . 0.0 110.463 -179.645 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.78 HD12 ' N ' ' A' ' 72' ' ' ALA . 2.1 pp -58.37 -146.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 O-C-N 121.249 -0.907 . . . . 0.0 110.896 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.78 ' N ' HD12 ' A' ' 71' ' ' ILE . . . -136.82 156.58 75.92 Favored Pre-proline 0 C--N 1.302 -1.492 0 O-C-N 120.852 -1.155 . . . . 0.0 111.458 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.731 ' HB3' ' HB2' ' A' ' 57' ' ' ALA . 45.7 Cg_endo -72.9 94.3 0.8 Allowed 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 121.968 1.779 . . . . 0.0 110.226 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.545 ' HA ' ' CE1' ' B' ' 94' ' ' TYR . 0.5 OUTLIER 178.22 156.06 0.4 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.571 -0.706 . . . . 0.0 109.966 -179.729 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.823 ' CG1' ' HB1' ' B' ' 89' ' ' ALA . 0.4 OUTLIER -56.35 176.24 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.03 -1.044 . . . . 0.0 108.613 179.114 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.61 ' N ' ' O ' ' A' ' 53' ' ' VAL . . . -113.32 -149.14 10.34 Favored Glycine 0 C--N 1.299 -1.487 0 N-CA-C 108.337 -1.905 . . . . 0.0 108.337 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.992 HG11 ' HB3' ' B' ' 81' ' ' PRO . 4.3 t -144.99 86.85 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 CA-C-O 122.021 0.915 . . . . 0.0 108.783 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.514 ' CB ' ' HG3' ' A' ' 51' ' ' LYS . 0.5 OUTLIER -56.37 -44.54 80.25 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.812 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.808 HG12 HG12 ' A' ' 77' ' ' VAL 0.267 13.2 p -47.53 173.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 CA-C-O 122.082 0.944 . . . . 0.0 113.057 -175.226 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.671 ' HB2' ' HD2' ' A' ' 81' ' ' PRO . 0.1 OUTLIER 177.94 176.4 0.3 Allowed Pre-proline 0 N--CA 1.484 1.229 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -178.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.671 ' HD2' ' HB2' ' A' ' 80' ' ' LYS . 50.7 Cg_endo -78.07 112.51 3.26 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.612 1.322 . . . . 0.0 109.693 177.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -81.04 -172.53 46.37 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.449 ' HA ' ' HB2' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -77.04 -23.66 52.07 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.363 -1.081 . . . . 0.0 110.62 -179.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.26 -37.51 23.83 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.199 -0.938 . . . . 0.0 108.814 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.896 ' CG ' HG21 ' B' ' 77' ' ' VAL . 0.1 OUTLIER -79.63 -35.11 39.94 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.555 0.693 . . . . 0.0 109.152 178.486 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.449 ' HB2' ' HA ' ' A' ' 83' ' ' GLU . 0.1 OUTLIER -73.38 -31.38 63.87 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 120.036 -0.666 . . . . 0.0 110.039 -179.778 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -70.77 -40.27 72.74 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 178.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.654 ' HB2' HG23 ' B' ' 33' ' ' THR . . . -66.22 -35.31 80.09 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 176.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.859 ' HB1' ' CG1' ' B' ' 75' ' ' VAL . . . -58.46 -43.53 88.91 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.255 178.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.572 ' HA ' ' HB2' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -58.28 -24.36 59.19 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 177.29 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -74.71 -38.27 43.3 Favored Glycine 0 N--CA 1.488 2.126 0 CA-C-O 119.399 -0.667 . . . . 0.0 112.792 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 1.094 HD21 HG21 ' B' ' 75' ' ' VAL . 2.0 pp -57.26 -49.37 76.28 Favored 'General case' 0 N--CA 1.505 2.299 0 CA-C-N 120.774 2.287 . . . . 0.0 111.326 -178.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.602 ' H ' ' HG ' ' A' ' 92' ' ' LEU . 0.4 OUTLIER 159.05 45.95 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -179.447 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.734 ' CD2' ' OG ' ' B' ' 74' ' ' SER . 2.4 t80 -32.48 -71.75 0.05 Allowed 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.331 0.586 . . . . 0.0 112.41 -178.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -46.6 -35.57 6.03 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.397 -0.815 . . . . 0.0 110.465 -178.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.438 ' CB ' ' HB3' ' A' ' 93' ' ' LYS . 0.5 OUTLIER -69.81 -30.44 67.96 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.801 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.513 ' HB3' ' HB2' ' B' ' 54' ' ' ALA . 0.5 OUTLIER -93.6 -3.49 52.52 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.325 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.886 ' HB2' ' OG ' ' B' ' 74' ' ' SER . . . -87.26 -36.07 18.13 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-O 121.36 0.6 . . . . 0.0 110.172 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.8 mttm . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 118.112 -0.947 . . . . 0.0 110.238 179.953 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.686 ' HB3' HG23 ' A' ' 42' ' ' VAL . 5.9 mtp . . . . . 0 N--CA 1.493 1.692 0 N-CA-C 110.081 -0.341 . . . . 0.0 110.081 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -171.57 -158.51 0.13 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.941 -1.099 . . . . 0.0 112.063 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.545 ' HE2' ' HA ' ' B' ' 26' ' ' ALA . 0.1 OUTLIER -49.72 -12.38 0.07 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.556 -0.715 . . . . 0.0 111.038 -179.536 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.681 ' O ' HG13 ' B' ' 7' ' ' ILE . 19.7 m -114.04 -58.68 2.12 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.007 -1.058 . . . . 0.0 110.197 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.725 ' HA ' ' HE2' ' B' ' 8' ' ' LYS . 0.3 OUTLIER -49.34 -46.64 47.21 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.07 -1.019 . . . . 0.0 109.23 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.827 HD11 ' CG2' ' A' ' 42' ' ' VAL . 10.7 mt -58.79 -31.36 68.33 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.289 -0.964 . . . . 0.0 109.815 178.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' ILE . . . . . 0.683 HD13 ' CG2' ' B' ' 21' ' ' VAL . 0.9 OUTLIER -58.82 -41.77 83.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.517 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . 0.867 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 35.6 mtmt -63.55 -35.31 80.07 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . 0.821 ' HB1' HD13 ' A' ' 31' ' ' ILE . . . -53.63 -39.75 65.22 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.944 -0.702 . . . . 0.0 109.199 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.678 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.5 mp -90.56 -32.23 5.37 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 178.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.867 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -64.21 -15.87 60.82 Favored 'General case' 0 C--N 1.293 -1.871 0 O-C-N 120.805 -1.185 . . . . 0.0 108.58 178.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 -111.54 -43.41 3.67 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.514 -0.741 . . . . 0.0 109.587 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -69.66 -24.55 63.63 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.766 ' CG2' ' HB2' ' A' ' 20' ' ' SER . 0.2 OUTLIER -115.2 -82.65 0.62 Allowed 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 179.258 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . 0.515 ' O ' ' C ' ' B' ' 16' ' ' LEU . . . 67.22 -21.92 0.21 Allowed Glycine 0 N--CA 1.5 2.924 0 O-C-N 120.993 -1.067 . . . . 0.0 110.469 178.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' LEU . . . . . 1.105 ' CD1' HG23 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -27.44 -54.73 0.09 Allowed 'General case' 0 N--CA 1.514 2.736 0 CA-C-O 121.942 0.877 . . . . 0.0 110.76 -179.758 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . 0.555 HG21 HG21 ' A' ' 17' ' ' THR . 0.5 OUTLIER -138.78 -3.28 1.66 Allowed 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.975 -179.433 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . 0.538 ' O ' ' C ' ' B' ' 19' ' ' VAL . 11.9 mt-30 56.78 34.94 25.51 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 -176.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 1.085 HG11 HG11 ' A' ' 19' ' ' VAL . 1.8 p -20.43 -95.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.521 -178.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.916 ' O ' ' N ' ' B' ' 23' ' ' LYS . 0.5 OUTLIER -133.44 24.11 4.08 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 178.495 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.683 ' CG2' HD13 ' B' ' 7' ' ' ILE . 30.0 m -19.0 -39.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-O 122.382 1.087 . . . . 0.0 109.585 -178.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.841 ' N ' ' O ' ' B' ' 20' ' ' SER . 28.0 t -84.34 -38.71 20.0 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.009 178.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . 0.916 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.3 OUTLIER -84.91 -32.06 23.34 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.406 -0.809 . . . . 0.0 111.276 179.831 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' MET . . . . . 0.637 ' HB3' HG21 ' A' ' 14' ' ' THR . 0.0 OUTLIER -74.9 -41.07 60.44 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 118.073 -1.451 . . . . 0.0 108.462 178.812 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.674 ' HA ' ' HB3' ' B' ' 28' ' ' PHE . 11.1 mt -69.01 -44.34 72.96 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 118.319 -1.353 . . . . 0.0 108.008 177.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . 0.545 ' HA ' ' HE2' ' B' ' 3' ' ' LYS . . . -57.29 -34.5 68.75 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . 0.627 ' HA ' ' HB3' ' B' ' 30' ' ' LYS . 54.0 p -84.09 -26.61 28.85 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . 0.744 ' O ' HG13 ' B' ' 31' ' ' ILE . 0.4 OUTLIER -62.54 -44.51 96.17 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.0 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . 0.791 ' HG2' HG22 ' A' ' 45' ' ' THR . 0.7 OUTLIER -74.49 -32.37 62.52 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 177.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 0.808 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 17.5 ttpp -69.17 -27.17 65.28 Favored 'General case' 0 C--O 1.192 -1.933 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 176.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.744 HG13 ' O ' ' B' ' 28' ' ' PHE . 2.0 pp -97.33 -30.6 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.113 -0.992 . . . . 0.0 109.246 178.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.737 HG22 HD21 ' A' ' 85' ' ' LEU . 1.9 mm -64.58 -53.82 37.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 177.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' THR . . . . . 0.654 HG23 ' HB2' ' A' ' 88' ' ' ALA . 0.4 OUTLIER -68.57 -40.38 80.6 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.129 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.808 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 52.7 mm-40 -70.03 -36.11 74.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.523 -0.735 . . . . 0.0 111.058 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' THR . . . . . 0.949 HG21 HG13 ' B' ' 42' ' ' VAL . 3.2 m -59.02 -52.78 64.27 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.799 -1.188 . . . . 0.0 108.651 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.844 HG13 ' HB3' ' B' ' 52' ' ' PRO . 13.6 t -54.25 -36.85 34.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 177.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 0.629 ' HB2' ' C ' ' A' ' 88' ' ' ALA . . . -79.14 -3.84 47.46 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.485 ' N ' ' O ' ' B' ' 35' ' ' THR . 0.0 OUTLIER -102.43 -29.43 11.62 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 177.823 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' B' ' 35' ' ' THR . . . 112.66 38.55 1.29 Allowed Glycine 0 C--N 1.302 -1.355 0 C-N-CA 120.001 -1.095 . . . . 0.0 111.03 177.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . 0.634 ' CB ' HG23 ' B' ' 35' ' ' THR . 0.1 OUTLIER -130.29 133.63 46.62 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.043 -1.269 . . . . 0.0 110.745 179.364 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.441 ' HG3' ' HD2' ' B' ' 52' ' ' PRO . 0.1 OUTLIER -82.98 88.4 6.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.581 -0.7 . . . . 0.0 109.664 179.683 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.949 HG13 HG21 ' B' ' 35' ' ' THR . 25.4 m -73.39 144.91 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.507 -0.745 . . . . 0.0 110.443 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' GLN . . . . . 0.505 ' O ' ' HA ' ' A' ' 2' ' ' ASN . 19.6 mt-30 -138.9 171.53 14.19 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.469 -0.769 . . . . 0.0 110.24 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 1.001 HD12 ' CB ' ' B' ' 48' ' ' LEU . 91.5 mt -136.06 -179.16 5.49 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.276 -0.89 . . . . 0.0 110.608 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . 0.872 HG22 ' HG2' ' A' ' 29' ' ' GLU . 4.1 t -45.62 72.19 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.674 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . 42.74 29.03 0.72 Allowed Glycine 0 N--CA 1.494 2.562 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . 0.73 ' CE2' ' HG ' ' B' ' 48' ' ' LEU . 0.7 OUTLIER -129.12 -32.83 2.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.054 -1.262 . . . . 0.0 110.476 179.606 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 1.011 HD11 HD11 ' A' ' 50' ' ' ILE . 8.0 mt -128.29 117.99 22.46 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.685 -1.259 . . . . 0.0 110.46 178.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -118.04 69.19 0.78 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.607 -0.683 . . . . 0.0 110.856 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' ILE . . . . . 0.919 HD13 ' HB ' ' B' ' 79' ' ' VAL . 11.2 mm -59.86 113.46 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.164 -0.96 . . . . 0.0 109.637 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . 0.444 ' O ' ' HG3' ' B' ' 51' ' ' LYS . 1.3 ptmt -138.34 121.92 11.32 Favored Pre-proline 0 N--CA 1.498 1.952 0 O-C-N 121.017 -1.052 . . . . 0.0 110.246 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.844 ' HB3' HG13 ' B' ' 36' ' ' VAL . 50.2 Cg_endo -76.61 135.46 16.23 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 123.482 1.254 . . . . 0.0 112.237 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.599 ' O ' ' N ' ' B' ' 76' ' ' GLY . 33.6 m -139.41 116.8 10.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.772 ' HB1' ' HA ' ' B' ' 74' ' ' SER . . . -76.23 141.2 41.82 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -176.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . 0.619 ' HB2' ' O ' ' B' ' 54' ' ' ALA . 0.2 OUTLIER 146.79 68.37 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.604 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.225 179.746 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . 0.57 ' O ' ' HA ' ' B' ' 73' ' ' PRO . 10.2 mt-30 -154.95 103.63 2.42 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.899 -1.125 . . . . 0.0 111.835 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.618 ' HB1' HG13 ' B' ' 71' ' ' ILE . . . -142.41 179.97 6.63 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.076 -1.015 . . . . 0.0 111.485 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' ARG . . . . . 0.569 ' HB2' HG23 ' B' ' 71' ' ' ILE . 2.0 mpt_? -84.64 165.4 17.96 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 121.212 0.53 . . . . 0.0 110.184 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . 0.414 ' HB3' ' O ' ' B' ' 58' ' ' ARG . 7.8 pttt -178.99 48.69 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.504 -0.747 . . . . 0.0 109.642 179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -104.97 -105.2 3.0 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' PHE . . . . . 0.787 ' O ' ' N ' ' B' ' 67' ' ' GLU . 0.4 OUTLIER -173.83 177.18 2.49 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.371 -1.076 . . . . 0.0 110.011 -179.828 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . 0.935 ' N ' ' HB2' ' B' ' 68' ' ' ALA . 1.1 t-20 -102.5 -58.62 0.09 OUTLIER Pre-proline 0 N--CA 1.499 1.999 0 O-C-N 120.99 -1.069 . . . . 0.0 111.654 -178.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.6 ' HD2' ' H ' ' B' ' 62' ' ' ASN . 42.3 Cg_endo -69.32 62.15 1.51 Allowed 'Trans proline' 0 C--N 1.315 -1.234 0 O-C-N 123.345 1.181 . . . . 0.0 109.864 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . 0.78 ' HB3' ' CE1' ' B' ' 61' ' ' PHE . 0.4 OUTLIER -175.9 30.36 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -179.36 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.429 ' O ' ' NE2' ' B' ' 66' ' ' GLN . 4.1 p 50.81 44.88 27.86 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.603 -0.686 . . . . 0.0 110.752 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . 0.661 ' HB2' ' CE1' ' B' ' 61' ' ' PHE . 0.1 OUTLIER -130.65 -88.37 0.49 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.25 -0.906 . . . . 0.0 110.94 -179.707 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . 0.787 ' N ' ' O ' ' B' ' 61' ' ' PHE . 2.0 mt-10 156.54 90.92 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . 0.935 ' HB2' ' N ' ' B' ' 62' ' ' ASN . . . -70.76 104.24 2.82 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.162 -0.961 . . . . 0.0 110.204 -178.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.733 HD23 ' O ' ' B' ' 68' ' ' ALA . 0.2 OUTLIER 174.66 -169.12 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.899 -179.374 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -156.51 91.32 1.23 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.437 -0.789 . . . . 0.0 109.554 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.618 HG13 ' HB1' ' B' ' 57' ' ' ALA . 1.0 OUTLIER -56.74 -172.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.361 -0.837 . . . . 0.0 110.189 -179.642 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -90.27 108.92 29.83 Favored Pre-proline 0 C--N 1.296 -1.722 0 O-C-N 121.681 -0.637 . . . . 0.0 110.75 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' PRO . . . . . 0.61 ' CB ' ' HB2' ' B' ' 57' ' ' ALA . 45.7 Cg_endo -79.36 123.15 5.39 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 O-C-N 123.698 1.367 . . . . 0.0 111.088 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . 0.886 ' OG ' ' HB2' ' A' ' 98' ' ' ALA . 0.3 OUTLIER -150.21 -151.03 0.37 Allowed 'General case' 0 C--N 1.292 -1.922 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.988 179.264 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . 1.094 HG21 HD21 ' A' ' 92' ' ' LEU . 45.2 t -17.34 139.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.719 0 CA-C-O 122.706 1.241 . . . . 0.0 114.002 -175.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . 0.599 ' N ' ' O ' ' B' ' 53' ' ' VAL . . . -142.56 68.12 0.45 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.896 HG21 ' CG ' ' A' ' 85' ' ' LEU . 5.3 p -36.48 95.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.827 -0.807 . . . . 0.0 112.139 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . 0.49 ' O ' ' HB ' ' B' ' 79' ' ' VAL . 15.5 t -94.07 176.0 6.49 Favored 'General case' 0 C--N 1.293 -1.872 0 C-N-CA 119.547 -0.861 . . . . 0.0 108.846 177.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.919 ' HB ' HD13 ' B' ' 50' ' ' ILE . 14.5 p 176.24 178.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . 0.587 ' N ' HG22 ' B' ' 79' ' ' VAL . 0.2 OUTLIER -178.0 173.35 0.66 Allowed Pre-proline 0 C--N 1.305 -1.352 0 O-C-N 121.024 -1.047 . . . . 0.0 110.424 178.097 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' PRO . . . . . 0.992 ' HB3' HG11 ' A' ' 77' ' ' VAL . 51.0 Cg_endo -88.01 103.74 0.49 Allowed 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 121.834 1.689 . . . . 0.0 109.853 178.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . 0.48 ' O ' ' HB3' ' B' ' 83' ' ' GLU . . . -71.46 37.43 0.57 Allowed Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . 0.48 ' HB3' ' O ' ' B' ' 82' ' ' GLY . 1.2 tp10 64.22 -27.93 0.09 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.303 -1.116 . . . . 0.0 112.613 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' SER . . . . . 0.446 ' HB3' ' CB ' ' B' ' 47' ' ' PHE . 1.0 OUTLIER -52.13 -36.43 51.28 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.435 -1.415 . . . . 0.0 108.945 179.602 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.743 HD12 ' HA ' ' A' ' 33' ' ' THR . 1.2 tt -85.79 -36.42 20.1 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . 0.66 ' O ' ' HB3' ' B' ' 89' ' ' ALA . 0.2 OUTLIER -70.52 -35.39 73.15 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.094 179.323 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' B' ' 83' ' ' GLU . 0.2 OUTLIER -70.25 -38.87 75.25 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 178.487 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.573 ' C ' ' HB2' ' A' ' 37' ' ' ALA . . . -63.92 -37.49 87.61 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 176.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.823 ' HB1' ' CG1' ' A' ' 75' ' ' VAL . . . -55.95 -42.33 76.04 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.255 178.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.66 -31.67 58.03 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 177.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -71.74 -27.76 70.3 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 179.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . 0.926 ' HB3' ' HA ' ' A' ' 37' ' ' ALA . 0.5 OUTLIER -71.58 9.47 0.84 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.761 -1.435 . . . . 0.0 111.675 -179.654 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' B' ' 92' ' ' LEU . 29.9 mmtp 60.76 40.35 16.22 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 -177.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . 0.629 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 1.8 p90 -41.95 -29.94 0.24 Allowed 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.768 -178.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . 0.672 ' O ' ' HB3' ' B' ' 98' ' ' ALA . 3.8 mp0 -59.53 -47.85 83.92 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.87 -35.52 66.58 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 177.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.44 -30.18 64.36 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 178.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 98' ' ' ALA . . . . . 0.672 ' HB3' ' O ' ' B' ' 95' ' ' GLU . . . -58.18 -39.19 78.28 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.332 0.587 . . . . 0.0 110.182 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.15 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.543 ' CE ' HD23 ' A' ' 6' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.496 1.826 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.419 ' O ' ' HB2' ' A' ' 6' ' ' LEU . 2.8 t-20 -174.1 -169.2 0.45 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.945 -1.097 . . . . 0.0 111.635 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.623 ' O ' HG13 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -57.74 -4.87 0.32 Allowed 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.473 -0.767 . . . . 0.0 110.702 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.924 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 99.2 m -125.29 -40.31 2.13 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.323 -0.86 . . . . 0.0 108.974 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.489 ' CB ' ' HA ' ' A' ' 1' ' ' MET . 0.1 OUTLIER -61.66 -50.59 71.9 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.274 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.827 HD11 ' CG1' ' B' ' 42' ' ' VAL . 9.1 mt -57.8 -31.25 66.39 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 1.062 HG23 ' HB ' ' A' ' 21' ' ' VAL . 3.5 mt -52.55 -51.65 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 178.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.971 ' CE ' HG22 ' A' ' 7' ' ' ILE . 3.1 mmpt? -60.53 -34.24 73.82 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.884 ' HB1' HD13 ' B' ' 31' ' ' ILE . . . -55.26 -37.18 66.91 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.535 -0.866 . . . . 0.0 109.504 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.836 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.0 OUTLIER -97.12 -30.27 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.291 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.823 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -68.14 -13.62 62.36 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 118.829 -1.148 . . . . 0.0 108.542 178.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.426 ' CG ' ' N ' ' A' ' 13' ' ' ASP . 6.5 pt20 -111.14 -39.61 4.7 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.522 -0.736 . . . . 0.0 109.432 178.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.426 ' N ' ' CG ' ' A' ' 12' ' ' GLN . 0.9 OUTLIER -66.89 -36.07 81.45 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 177.408 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.861 HG22 HD21 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -97.31 -67.46 0.85 Allowed 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 178.376 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 46.17 29.98 3.8 Favored Glycine 0 N--CA 1.497 2.759 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 178.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.069 ' CD1' HG23 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -89.65 -26.85 20.52 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.621 -0.929 . . . . 0.0 109.687 179.333 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.704 HG22 ' H ' ' A' ' 19' ' ' VAL . 0.4 OUTLIER -162.15 -3.03 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 120.231 -0.588 . . . . 0.0 110.683 -178.6 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.536 ' O ' ' C ' ' A' ' 19' ' ' VAL . 9.7 mt-30 54.27 30.45 12.45 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 -177.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.969 HG11 HG11 ' B' ' 19' ' ' VAL . 2.3 p -12.25 -93.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.526 -178.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.945 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.5 OUTLIER -128.5 23.37 5.9 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 178.688 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 1.062 ' HB ' HG23 ' A' ' 7' ' ' ILE . 15.3 m -24.59 -37.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 CA-C-O 122.233 1.016 . . . . 0.0 109.4 -178.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.735 ' N ' ' O ' ' A' ' 20' ' ' SER . 48.5 t -82.28 -36.55 26.94 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.253 177.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.945 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.3 OUTLIER -86.82 -32.43 20.3 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.637 -0.665 . . . . 0.0 111.744 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.787 ' HG2' HG22 ' B' ' 14' ' ' THR . 0.0 OUTLIER -78.4 -36.67 45.44 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.433 -1.417 . . . . 0.0 109.873 179.631 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.789 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 0.4 OUTLIER -80.5 -45.04 18.15 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 118.535 -1.266 . . . . 0.0 109.345 178.904 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.603 ' HA ' ' HG2' ' A' ' 3' ' ' LYS . . . -57.24 -33.37 67.49 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 177.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.81 ' O ' HG23 ' A' ' 31' ' ' ILE . 49.4 m -87.46 -31.15 20.16 Favored 'General case' 0 C--O 1.199 -1.586 0 C-N-CA 119.687 -0.805 . . . . 0.0 109.238 178.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.969 ' HB2' HD11 ' B' ' 10' ' ' ILE . 0.1 OUTLIER -58.21 -49.71 76.1 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.04 -1.037 . . . . 0.0 109.931 179.45 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.759 ' HG2' HG22 ' B' ' 45' ' ' THR . 1.1 mt-10 -73.12 -37.4 66.68 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 1.244 ' O ' ' HB3' ' A' ' 34' ' ' GLU . 16.8 ttpt -69.06 -16.37 63.68 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 177.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 1.044 ' HA ' ' CG ' ' A' ' 34' ' ' GLU . 1.8 pp -107.39 -29.38 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.14 -0.975 . . . . 0.0 110.241 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.613 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.2 mm -63.39 -45.77 97.15 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 178.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.853 ' O ' ' HB1' ' B' ' 88' ' ' ALA . 0.5 OUTLIER -79.03 -41.32 29.15 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 177.704 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 1.244 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -59.39 -35.51 74.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.134 -0.979 . . . . 0.0 109.124 177.842 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.764 HG23 ' HB2' ' A' ' 40' ' ' ASP . 15.8 m -63.73 -48.93 75.04 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 177.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.736 HG21 HD22 ' B' ' 85' ' ' LEU . 24.5 t -55.69 -35.58 39.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 177.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.878 ' HB2' ' O ' ' B' ' 88' ' ' ALA . . . -83.14 -1.24 52.39 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 177.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -106.27 -11.69 15.94 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 177.198 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 35' ' ' THR . . . 85.88 46.28 5.44 Favored Glycine 0 C--N 1.303 -1.255 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.243 177.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.764 ' HB2' HG23 ' A' ' 35' ' ' THR . 0.2 OUTLIER -124.6 143.15 50.87 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.031 -1.276 . . . . 0.0 109.975 178.951 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.419 ' CG ' ' HB2' ' A' ' 51' ' ' LYS . 0.3 OUTLIER -105.35 97.58 7.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.549 -0.72 . . . . 0.0 110.185 -179.317 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 1.006 HG22 ' HB2' ' B' ' 1' ' ' MET . 3.2 t -84.83 172.62 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.472 -0.768 . . . . 0.0 110.134 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 43' ' ' GLN . 4.5 pt20 -157.32 107.21 2.21 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.602 -0.686 . . . . 0.0 109.207 179.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.808 HD12 ' HB2' ' A' ' 48' ' ' LEU . 16.1 mt -70.72 179.93 2.43 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.228 -0.92 . . . . 0.0 111.14 -178.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.836 HG22 ' HG2' ' B' ' 29' ' ' GLU . 1.8 t -31.63 -43.43 0.06 Allowed 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 121.053 0.454 . . . . 0.0 111.433 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.444 ' N ' HG23 ' A' ' 45' ' ' THR . . . 172.61 24.44 0.02 OUTLIER Glycine 0 N--CA 1.487 2.071 0 C-N-CA 119.347 -1.406 . . . . 0.0 111.127 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.669 ' CZ ' HG21 ' B' ' 32' ' ' ILE . 49.3 p90 -127.82 -49.33 1.36 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.696 -1.473 . . . . 0.0 111.502 178.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.035 ' CD1' HD11 ' B' ' 48' ' ' LEU . 0.3 OUTLIER -96.53 110.75 23.08 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.697 -1.252 . . . . 0.0 112.513 -179.238 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.709 ' O ' ' HB ' ' A' ' 79' ' ' VAL . 1.7 t-20 -105.82 63.33 0.67 Allowed 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.684 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.909 HD11 HG23 ' A' ' 42' ' ' VAL . 1.1 pp -57.46 130.27 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.69 0 O-C-N 121.117 -0.989 . . . . 0.0 112.67 -177.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.597 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -175.5 112.23 0.27 Allowed Pre-proline 0 N--CA 1.492 1.671 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.171 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.664 ' HG3' HG13 ' A' ' 36' ' ' VAL . 55.9 Cg_endo -90.77 156.89 4.15 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 120.882 1.055 . . . . 0.0 111.434 -178.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.915 HG22 ' O ' ' A' ' 76' ' ' GLY . 32.4 m -139.81 114.92 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 121.913 0.863 . . . . 0.0 111.114 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.619 ' HA ' ' HE1' ' B' ' 94' ' ' TYR . . . -56.41 106.45 0.29 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.691 -0.631 . . . . 0.0 112.137 -178.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.462 ' O ' ' HG2' ' A' ' 56' ' ' GLN . 7.9 ptm180 166.64 136.14 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.783 -0.573 . . . . 0.0 109.556 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.849 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 0.7 OUTLIER -168.6 16.96 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 118.699 -1.2 . . . . 0.0 113.809 -179.882 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.849 ' HB2' ' O ' ' A' ' 56' ' ' GLN . . . 146.19 -167.8 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.928 0 CA-C-N 119.425 1.011 . . . . 0.0 110.758 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.812 ' HA ' ' HA ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -130.2 149.42 51.91 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.717 0.77 . . . . 0.0 111.72 178.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 70' ' ' GLU . 4.1 tttt -150.14 19.65 0.87 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.834 -0.541 . . . . 0.0 110.157 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.708 ' HA3' ' N ' ' A' ' 69' ' ' LEU . . . -106.03 -120.44 4.68 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.876 ' CE1' HD11 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -138.67 -149.9 0.31 Allowed 'General case' 0 C--O 1.206 -1.195 0 O-C-N 120.853 -1.381 . . . . 0.0 114.402 -179.583 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.75 ' H ' ' HD2' ' A' ' 63' ' ' PRO . 0.1 OUTLIER 164.02 -33.67 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 121.31 -0.869 . . . . 0.0 112.559 -179.752 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.75 ' HD2' ' H ' ' A' ' 62' ' ' ASN . 37.2 Cg_endo -62.98 -6.23 9.1 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 N-CA-C 110.381 -0.661 . . . . 0.0 110.381 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.55 ' CB ' ' CE2' ' A' ' 61' ' ' PHE . 0.2 OUTLIER -99.01 -72.29 0.66 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.185 -0.947 . . . . 0.0 109.491 178.486 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.429 ' HG1' ' HZ ' ' A' ' 61' ' ' PHE . 10.1 p -109.41 5.79 23.72 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.441 -0.787 . . . . 0.0 109.998 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.525 ' O ' ' CB ' ' A' ' 67' ' ' GLU . 66.8 mm-40 63.58 92.7 0.06 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.468 -0.77 . . . . 0.0 111.482 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.56 ' H ' ' HA ' ' A' ' 62' ' ' ASN . 2.4 mt-10 155.93 95.76 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.74 ' HA ' ' N ' ' A' ' 61' ' ' PHE . . . -51.08 125.26 13.34 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.836 -1.165 . . . . 0.0 108.82 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.876 HD11 ' CE1' ' A' ' 61' ' ' PHE . 8.2 mt -95.84 54.25 1.49 Allowed 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.401 0.619 . . . . 0.0 111.688 -177.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.464 ' HB2' ' CA ' ' A' ' 60' ' ' GLY . 1.5 mt-10 174.87 50.07 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.812 ' HA ' ' HA ' ' A' ' 58' ' ' ARG . 0.6 OUTLIER -103.17 118.69 50.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-O 122.395 1.093 . . . . 0.0 113.219 -177.549 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.803 ' HB2' ' O ' ' A' ' 71' ' ' ILE . . . 136.57 80.83 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.027 0 CA-C-N 113.979 -1.464 . . . . 0.0 112.419 177.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.69 ' HD2' ' CB ' ' A' ' 56' ' ' GLN . 46.9 Cg_endo -91.18 16.86 1.49 Allowed 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.297 1.156 . . . . 0.0 113.742 178.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.785 ' N ' ' CE2' ' B' ' 94' ' ' TYR . 0.0 OUTLIER -174.23 144.28 0.94 Allowed 'General case' 0 C--N 1.288 -2.067 0 O-C-N 121.354 -0.841 . . . . 0.0 110.049 177.345 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.54 ' N ' ' CE1' ' B' ' 94' ' ' TYR . 0.4 OUTLIER -69.29 174.08 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.439 -1.413 . . . . 0.0 107.465 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.915 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -118.95 97.99 0.72 Allowed Glycine 0 N--CA 1.488 2.165 0 C-N-CA 118.837 -1.649 . . . . 0.0 109.631 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.703 HG21 HD12 ' B' ' 85' ' ' LEU . 6.1 p -63.09 84.21 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-O 122.504 1.145 . . . . 0.0 108.667 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 76' ' ' GLY . 0.3 OUTLIER -56.7 -44.15 81.24 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.374 -179.397 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.787 ' CB ' ' HA ' ' A' ' 50' ' ' ILE 0.286 1.9 p -45.98 172.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-O 122.758 1.266 . . . . 0.0 113.971 -174.392 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.601 ' N ' ' CG2' ' A' ' 79' ' ' VAL . 0.0 OUTLIER 178.62 174.22 0.39 Allowed Pre-proline 0 C--N 1.309 -1.188 0 CA-C-N 114.403 -1.272 . . . . 0.0 108.204 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.66 ' HG3' HG12 ' B' ' 79' ' ' VAL . 39.0 Cg_endo -66.77 153.77 76.81 Favored 'Trans proline' 0 C--N 1.298 -2.095 0 O-C-N 123.464 1.244 . . . . 0.0 109.166 176.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.487 ' H ' ' HA ' ' A' ' 47' ' ' PHE . . . -120.0 -83.73 0.81 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 108.239 -1.945 . . . . 0.0 108.239 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.941 ' O ' ' N ' ' A' ' 85' ' ' LEU . 17.5 tt0 -76.54 43.56 0.32 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.428 -1.042 . . . . 0.0 108.791 177.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 1.343 ' O ' ' N ' ' A' ' 86' ' ' LYS . 0.5 OUTLIER 7.21 44.69 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 122.212 1.005 . . . . 0.0 110.203 178.567 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 1.023 HD12 HG21 ' B' ' 36' ' ' VAL . 0.2 OUTLIER 20.07 28.65 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 104.538 -2.393 . . . . 0.0 104.538 -171.326 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 1.343 ' N ' ' O ' ' A' ' 84' ' ' SER 0.354 7.7 tttt -62.28 -42.07 99.04 Favored 'General case' 0 CA--C 1.483 -1.616 0 N-CA-C 103.496 -2.779 . . . . 0.0 103.496 176.383 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.257 24.0 tptt -67.4 -35.48 79.37 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 111.834 -2.439 . . . . 0.0 104.857 175.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.703 ' HB3' ' O ' ' A' ' 85' ' ' LEU . . . -71.59 -27.87 63.43 Favored 'General case' 0 C--O 1.211 -0.927 0 C-N-CA 118.326 -1.35 . . . . 0.0 108.36 178.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.954 ' HA ' HD23 ' A' ' 92' ' ' LEU . . . -59.16 -49.92 76.03 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.977 -1.077 . . . . 0.0 109.363 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.471 ' HG2' ' N ' ' A' ' 91' ' ' GLY . 2.2 pt-20 -56.95 -27.96 61.66 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.903 -1.518 . . . . 0.0 106.903 177.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.471 ' N ' ' HG2' ' A' ' 90' ' ' GLU . . . -68.39 -32.46 75.57 Favored Glycine 0 N--CA 1.488 2.155 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.186 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.954 HD23 ' HA ' ' A' ' 89' ' ' ALA . 0.8 OUTLIER -84.85 22.12 1.43 Allowed 'General case' 0 N--CA 1.504 2.263 0 O-C-N 120.213 -1.757 . . . . 0.0 110.975 -179.657 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.489 ' O ' ' N ' ' A' ' 96' ' ' ASP . 2.6 mmtt 55.29 38.19 30.01 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 -177.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.625 ' CD1' ' N ' ' B' ' 75' ' ' VAL . 1.5 t80 -33.66 -41.03 0.08 Allowed 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.81 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -54.98 -43.0 73.13 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.333 -0.854 . . . . 0.0 109.629 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 93' ' ' LYS . 11.8 m-20 -62.22 -33.58 74.84 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -77.98 -21.76 50.42 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.452 0.644 . . . . 0.0 109.306 178.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.406 ' HA ' ' HB1' ' B' ' 54' ' ' ALA . . . -72.21 -34.46 68.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.515 -0.74 . . . . 0.0 110.218 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 24.8 mttt . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 117.918 -1.039 . . . . 0.0 110.221 -179.972 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 1.006 ' HB2' HG22 ' A' ' 42' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . 0.447 ' N ' ' HB2' ' B' ' 5' ' ' GLU . 0.7 OUTLIER 177.67 176.64 0.4 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.016 -1.053 . . . . 0.0 111.324 -179.811 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.95 ' O ' HD22 ' B' ' 25' ' ' LEU . 0.9 OUTLIER -47.63 -29.05 2.67 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.174 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.548 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 16.1 m -95.71 -45.39 7.03 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.661 0.743 . . . . 0.0 109.733 179.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.662 ' HA ' ' HE2' ' B' ' 8' ' ' LYS . 0.0 OUTLIER -56.04 -49.87 72.53 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 120.945 -1.097 . . . . 0.0 108.054 179.207 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.802 ' CD1' HG11 ' A' ' 42' ' ' VAL . 7.6 mt -55.8 -35.01 65.85 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.213 -0.995 . . . . 0.0 108.662 177.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' ILE . . . . . 0.823 ' CD1' HD23 ' B' ' 25' ' ' LEU . 0.3 OUTLIER -50.87 -48.86 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 178.166 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . 0.802 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 39.7 mtmt -61.99 -37.75 86.0 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . 0.925 ' HB1' HD13 ' A' ' 31' ' ' ILE . . . -52.58 -34.39 50.33 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 119.695 -0.802 . . . . 0.0 108.911 178.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.969 HD11 ' HB2' ' A' ' 28' ' ' PHE . 0.8 OUTLIER -99.41 -36.74 5.56 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.627 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.47 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.802 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -63.21 -25.89 68.55 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -93.41 -39.21 11.04 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 177.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.472 ' OD2' ' HB3' ' A' ' 27' ' ' SER . 23.9 m-20 -68.21 -20.16 64.82 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 176.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.859 HG22 ' HB2' ' A' ' 20' ' ' SER . 31.0 p -93.77 -77.84 0.44 Allowed 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 177.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 61.97 11.45 31.47 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' LEU . . . . . 0.892 HD11 ' OG ' ' A' ' 20' ' ' SER . 3.4 mp -83.18 -65.14 1.05 Allowed 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 122.27 1.034 . . . . 0.0 109.151 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . 0.62 HG22 ' H ' ' B' ' 19' ' ' VAL . 0.5 OUTLIER -140.55 6.73 2.09 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 115.386 -0.824 . . . . 0.0 108.878 -179.724 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . 0.582 ' O ' ' C ' ' B' ' 19' ' ' VAL . 6.8 mt-30 57.38 24.5 10.17 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 -176.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 1.069 HG23 ' CD1' ' A' ' 16' ' ' LEU . 0.1 OUTLIER 17.14 -96.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.36 -178.833 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 1.024 ' O ' ' N ' ' B' ' 22' ' ' SER . 1.4 p -136.25 23.19 3.23 Favored 'General case' 0 C--N 1.272 -2.776 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 176.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.733 ' HA ' ' CE ' ' B' ' 24' ' ' MET . 17.8 m -5.35 -42.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.397 1.094 . . . . 0.0 110.452 -177.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 1.024 ' N ' ' O ' ' B' ' 20' ' ' SER . 27.3 t -73.33 -40.34 64.54 Favored 'General case' 0 C--N 1.281 -2.371 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.498 178.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . 0.873 ' N ' ' O ' ' B' ' 20' ' ' SER . 13.5 ttpt -93.26 -27.42 16.84 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.254 -0.904 . . . . 0.0 111.239 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' MET . . . . . 0.733 ' CE ' ' HA ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -73.63 -25.74 60.45 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 119.905 -1.747 . . . . 0.0 108.281 179.115 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.95 HD22 ' O ' ' B' ' 3' ' ' LYS . 0.2 OUTLIER -81.99 -46.27 14.21 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 176.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . 0.697 ' N ' ' HG ' ' B' ' 25' ' ' LEU . . . -64.27 -27.73 69.24 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 178.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . 0.68 ' HA ' ' HB3' ' B' ' 30' ' ' LYS . 30.6 t -83.67 -40.07 19.41 Favored 'General case' 0 C--O 1.2 -1.549 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . 0.772 ' O ' HG13 ' B' ' 31' ' ' ILE . 0.5 OUTLIER -51.51 -46.4 63.24 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.52 0.676 . . . . 0.0 109.379 179.548 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . 0.836 ' HG2' HG22 ' A' ' 45' ' ' THR . 0.6 OUTLIER -75.31 -31.58 60.69 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 177.855 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 1.295 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 18.0 ttpt -71.41 -18.54 62.33 Favored 'General case' 0 C--O 1.191 -2.016 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 176.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.884 HD13 ' HB1' ' A' ' 9' ' ' ALA . 1.0 OUTLIER -105.82 -32.01 2.68 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.491 0 O-C-N 119.879 -1.763 . . . . 0.0 108.673 178.368 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.669 HG21 ' CZ ' ' A' ' 47' ' ' PHE . 1.5 mm -67.37 -63.42 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 176.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' THR . . . . . 0.852 ' OG1' HD22 ' A' ' 85' ' ' LEU . 0.5 OUTLIER -64.3 -45.11 89.4 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.74 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 1.295 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 15.6 mm-40 -68.79 -27.72 66.13 Favored 'General case' 0 C--N 1.31 -1.116 0 O-C-N 121.339 -0.851 . . . . 0.0 111.165 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' THR . . . . . 0.719 HG23 ' CB ' ' B' ' 40' ' ' ASP . 1.1 m -57.85 -51.14 70.84 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 177.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 1.023 HG21 HD12 ' A' ' 85' ' ' LEU . 4.3 t -54.07 -36.25 31.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 117.249 -1.78 . . . . 0.0 107.068 177.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 0.843 ' HA ' ' HB3' ' A' ' 92' ' ' LEU . . . -81.4 1.09 34.55 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.212 177.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' B' ' 34' ' ' GLU . 0.0 OUTLIER -108.72 -25.69 10.71 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.703 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.22 40.7 1.48 Allowed Glycine 0 C--N 1.303 -1.289 0 C-N-CA 119.946 -1.121 . . . . 0.0 110.748 178.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . 0.719 ' CB ' HG23 ' B' ' 35' ' ' THR . 0.3 OUTLIER -136.77 135.83 38.39 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.086 -1.244 . . . . 0.0 110.553 179.594 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.9 93.12 9.29 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.48 -0.762 . . . . 0.0 109.006 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.827 ' CG1' HD11 ' A' ' 6' ' ' LEU . 14.1 t -59.3 135.17 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.499 -0.75 . . . . 0.0 110.008 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' GLN . . . . . 0.445 ' HA ' ' HA ' ' B' ' 49' ' ' ASN . 11.2 mt-30 -132.0 91.95 3.04 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.501 -0.749 . . . . 0.0 109.757 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.667 ' HB3' ' CE2' ' B' ' 47' ' ' PHE . 7.6 mt -67.65 -179.28 1.07 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.284 -0.885 . . . . 0.0 110.979 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . 0.759 HG22 ' HG2' ' A' ' 29' ' ' GLU . 3.2 t -52.53 73.38 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 O-C-N 122.109 -0.369 . . . . 0.0 111.687 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . 40.09 62.12 1.57 Allowed Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . 0.674 ' CE1' ' HG ' ' B' ' 48' ' ' LEU . 0.2 OUTLIER -163.45 -45.16 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.445 -1.032 . . . . 0.0 108.775 -179.867 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 1.035 HD11 ' CD1' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -125.02 102.17 7.39 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.785 -0.572 . . . . 0.0 109.958 178.843 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' ASN . . . . . 0.929 ' O ' ' O ' ' B' ' 79' ' ' VAL . 0.7 OUTLIER -120.24 100.58 7.26 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.11 -0.994 . . . . 0.0 110.568 -179.635 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' ILE . . . . . 0.693 HG13 HD11 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -90.84 140.8 15.36 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 O-C-N 121.252 -0.905 . . . . 0.0 110.921 -179.177 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . 0.499 ' HD3' ' O ' ' B' ' 51' ' ' LYS . 0.0 OUTLIER -157.3 119.37 2.11 Favored Pre-proline 0 N--CA 1.496 1.825 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.663 179.205 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.754 ' HB3' HG13 ' B' ' 36' ' ' VAL . 57.2 Cg_endo -87.9 136.55 3.68 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.62 1.326 . . . . 0.0 110.778 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.581 ' O ' HG23 ' B' ' 53' ' ' VAL . 30.6 m -128.41 111.7 24.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-O 122.016 0.913 . . . . 0.0 110.642 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.59 ' HA ' ' HE1' ' A' ' 94' ' ' TYR . . . -61.78 127.42 31.33 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.879 -0.513 . . . . 0.0 111.534 -178.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . 0.451 ' CB ' ' O ' ' B' ' 54' ' ' ALA . 3.1 mtt180 168.86 55.81 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.371 -0.83 . . . . 0.0 110.355 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . 0.791 ' O ' ' HA ' ' B' ' 73' ' ' PRO . 29.8 mt-30 -155.18 110.95 3.11 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.965 -1.084 . . . . 0.0 111.42 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.54 ' HB2' ' O ' ' B' ' 56' ' ' GLN . . . 176.5 121.66 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.233 -0.917 . . . . 0.0 110.002 178.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' ARG . . . . . 0.504 ' NH1' HG21 ' B' ' 71' ' ' ILE . 0.1 OUTLIER -166.98 158.72 12.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.285 -0.884 . . . . 0.0 110.583 -179.502 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . 0.425 ' CG ' ' HA ' ' B' ' 70' ' ' GLU . 1.6 mtmt -172.34 125.0 0.51 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.525 -0.734 . . . . 0.0 109.549 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . 0.727 ' HA3' HD12 ' B' ' 69' ' ' LEU . . . -155.23 -112.12 0.41 Allowed Glycine 0 N--CA 1.49 2.28 0 C-N-CA 119.603 -1.284 . . . . 0.0 110.405 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' PHE . . . . . 0.622 ' C ' ' CD1' ' B' ' 61' ' ' PHE . 19.3 p90 -171.1 -179.77 2.82 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.5 -1.0 . . . . 0.0 110.042 -179.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . 0.967 ' CB ' ' HB2' ' B' ' 68' ' ' ALA . 0.0 OUTLIER -135.66 -44.68 0.02 OUTLIER Pre-proline 0 C--N 1.297 -1.684 0 C-N-CA 119.667 -0.813 . . . . 0.0 112.388 178.347 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.908 ' HD2' ' H ' ' B' ' 62' ' ' ASN . 41.3 Cg_endo -69.31 63.46 1.53 Allowed 'Trans proline' 0 N--CA 1.488 1.154 0 O-C-N 122.768 0.878 . . . . 0.0 110.88 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . 0.566 ' CB ' ' CE1' ' B' ' 61' ' ' PHE . 2.8 mt-30 -167.57 -106.87 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.522 HG22 ' CZ ' ' B' ' 61' ' ' PHE . 0.6 OUTLIER -75.63 -4.14 38.47 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.347 -1.471 . . . . 0.0 109.122 177.345 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . 0.494 ' O ' ' HB3' ' B' ' 67' ' ' GLU . 0.9 OUTLIER 75.57 102.22 0.07 Allowed 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 121.455 0.645 . . . . 0.0 112.048 179.141 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . 0.542 ' H ' ' HA ' ' B' ' 62' ' ' ASN . 1.5 pt-20 160.09 69.34 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . 0.967 ' HB2' ' CB ' ' B' ' 62' ' ' ASN . . . -66.33 135.95 55.11 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.869 0.842 . . . . 0.0 111.121 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.727 HD12 ' HA3' ' B' ' 60' ' ' GLY . 0.2 OUTLIER -141.95 142.46 33.0 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -178.68 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . 0.425 ' HA ' ' CG ' ' B' ' 59' ' ' LYS . 16.4 pt-20 -172.36 19.83 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.049 -1.032 . . . . 0.0 111.864 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.504 HG21 ' NH1' ' B' ' 58' ' ' ARG . 1.1 pt -64.8 -155.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 120.826 -1.171 . . . . 0.0 108.876 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . 0.788 ' HB1' ' HD2' ' B' ' 73' ' ' PRO . . . -156.66 169.96 9.69 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 120.825 -1.172 . . . . 0.0 112.601 -179.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' PRO . . . . . 0.791 ' HA ' ' O ' ' B' ' 56' ' ' GLN . 42.0 Cg_endo -68.32 117.87 5.25 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 125.07 2.09 . . . . 0.0 111.401 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . 0.511 ' N ' ' CE2' ' A' ' 94' ' ' TYR . 1.3 m -165.55 126.96 1.95 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.57 -0.706 . . . . 0.0 109.112 179.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . 0.7 ' CG1' HG23 ' B' ' 77' ' ' VAL . 0.3 OUTLIER -54.07 175.5 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.816 -1.177 . . . . 0.0 109.376 -179.293 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . 0.611 ' O ' ' N ' ' B' ' 78' ' ' SER . . . -107.57 57.27 0.45 Allowed Glycine 0 N--CA 1.484 1.842 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.85 HG11 ' C ' ' A' ' 84' ' ' SER . 73.5 t -45.17 87.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 122.117 -0.637 . . . . 0.0 109.944 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . 0.611 ' N ' ' O ' ' B' ' 76' ' ' GLY . 5.7 m -57.54 -129.03 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.929 ' O ' ' O ' ' B' ' 49' ' ' ASN . 1.9 m -144.34 179.74 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 119.702 -1.874 . . . . 0.0 113.2 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . 0.893 ' CB ' HD13 ' B' ' 48' ' ' LEU . 3.6 mmtt -101.81 -54.8 0.13 Allowed Pre-proline 0 C--N 1.296 -1.731 0 CA-C-N 113.962 -1.472 . . . . 0.0 112.526 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' PRO . . . . . 0.804 ' HD2' ' H ' ' B' ' 80' ' ' LYS . 28.6 Cg_endo -53.35 114.78 1.9 Allowed 'Trans proline' 0 C--N 1.298 -2.083 0 O-C-N 123.317 1.167 . . . . 0.0 110.339 -177.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -130.85 -57.9 0.09 OUTLIER Glycine 0 N--CA 1.478 1.436 0 N-CA-C 107.072 -2.411 . . . . 0.0 107.072 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . 0.833 ' O ' ' N ' ' B' ' 85' ' ' LEU . 25.7 tt0 -82.78 56.21 3.32 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 177.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' SER . . . . . 1.304 ' O ' ' N ' ' B' ' 86' ' ' LYS . 1.3 m 8.9 45.2 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.983 0.897 . . . . 0.0 111.561 178.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.999 ' C ' ' O ' ' B' ' 84' ' ' SER . 1.2 mt 22.08 29.36 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 103.745 -2.687 . . . . 0.0 103.745 -171.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . 1.304 ' N ' ' O ' ' B' ' 84' ' ' SER 0.337 8.3 tttt -59.26 -40.71 86.84 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 104.074 -2.565 . . . . 0.0 104.074 177.119 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . 0.406 ' O ' ' HG2' ' B' ' 90' ' ' GLU 0.278 6.7 tttp -63.62 -37.67 88.19 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 112.248 -2.251 . . . . 0.0 105.749 175.23 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.878 ' O ' ' HB2' ' A' ' 37' ' ' ALA . . . -78.14 -24.57 47.3 Favored 'General case' 0 C--O 1.207 -1.145 0 C-N-CA 119.023 -1.071 . . . . 0.0 108.185 178.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.716 ' N ' ' O ' ' B' ' 85' ' ' LEU . . . -76.03 -37.75 58.02 Favored 'General case' 0 C--N 1.291 -1.959 0 O-C-N 120.962 -1.086 . . . . 0.0 109.036 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' B' ' 87' ' ' LYS . 3.7 pt-20 -66.98 -23.54 65.95 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 176.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . 0.417 ' C ' ' HB1' ' A' ' 37' ' ' ALA . . . -72.39 -38.92 57.99 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . 0.79 ' HB3' ' HA ' ' A' ' 37' ' ' ALA . 2.2 pp -76.5 22.25 0.18 Allowed 'General case' 0 N--CA 1.503 2.218 0 CA-C-N 120.177 1.988 . . . . 0.0 110.618 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . 0.49 ' O ' ' N ' ' B' ' 96' ' ' ASP . 0.1 OUTLIER 54.77 49.39 18.03 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 106.457 -1.682 . . . . 0.0 106.457 -177.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . 0.785 ' CE2' ' N ' ' A' ' 74' ' ' SER . 28.3 t80 -27.56 -46.22 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.919 -178.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -57.35 -48.13 79.8 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.302 -0.874 . . . . 0.0 109.79 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 96' ' ' ASP . . . . . 0.49 ' N ' ' O ' ' B' ' 93' ' ' LYS . 7.8 m-20 -54.24 -33.54 58.67 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.414 -0.804 . . . . 0.0 109.008 178.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 97' ' ' PHE . . . . . 0.541 ' CD2' ' HB2' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -86.93 -22.18 25.81 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.816 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 98' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' B' ' 94' ' ' TYR . . . -66.04 -31.69 72.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.638 -0.664 . . . . 0.0 110.203 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 117.948 -1.025 . . . . 0.0 110.205 -179.753 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.487 ' HA ' ' CB ' ' A' ' 5' ' ' GLU . 5.8 mtp . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 120.972 0.415 . . . . 0.0 110.075 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.644 ' O ' HD12 ' A' ' 6' ' ' LEU . 5.2 t-20 -172.62 -173.34 1.0 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.055 -1.028 . . . . 0.0 111.059 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.555 ' HE3' ' CB ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -51.53 -15.7 0.48 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.219 -0.926 . . . . 0.0 110.034 179.419 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.652 ' O ' HG13 ' A' ' 7' ' ' ILE . 18.5 m -107.82 -55.42 2.36 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 122.094 0.95 . . . . 0.0 109.261 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.71 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 0.4 OUTLIER -50.83 -47.69 60.1 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.104 -0.997 . . . . 0.0 108.832 179.37 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.644 HD12 ' O ' ' A' ' 2' ' ' ASN . 1.0 OUTLIER -58.38 -30.6 66.92 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.542 -0.863 . . . . 0.0 110.146 178.563 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.652 HG13 ' O ' ' A' ' 4' ' ' THR . 1.0 OUTLIER -60.47 -41.14 86.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.829 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.824 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 33.4 mtmt -65.47 -36.42 83.84 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 177.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.926 ' CB ' HD13 ' B' ' 31' ' ' ILE . . . -55.88 -38.18 69.82 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.6 -0.688 . . . . 0.0 109.176 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.729 HG22 HG12 ' A' ' 21' ' ' VAL . 1.4 mp -90.05 -32.09 5.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 178.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.824 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -66.41 -11.14 50.06 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 119.055 -1.058 . . . . 0.0 108.345 178.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.5 tp-100 -116.36 -43.77 2.92 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.513 ' OD2' HG23 ' B' ' 31' ' ' ILE . 2.1 m-20 -65.13 -38.4 90.51 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 177.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.717 HG22 HD21 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -98.37 -70.95 0.71 Allowed 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 178.036 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.416 ' CA ' ' O ' ' A' ' 11' ' ' ALA . . . 45.06 27.42 1.54 Allowed Glycine 0 N--CA 1.5 2.952 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 178.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.082 ' CD1' HG23 ' B' ' 19' ' ' VAL . 0.1 OUTLIER -84.46 -20.3 31.97 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.678 -0.895 . . . . 0.0 109.255 179.139 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.756 HG21 ' CG2' ' B' ' 17' ' ' THR . 0.4 OUTLIER -162.96 -7.75 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.819 -0.551 . . . . 0.0 110.573 -178.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.478 ' O ' ' C ' ' A' ' 19' ' ' VAL . 4.6 mt-30 59.73 33.83 21.91 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 -176.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 1.006 HG11 HG11 ' B' ' 19' ' ' VAL . 2.8 p -23.88 -98.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.228 -178.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.941 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -129.71 22.7 5.43 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 178.625 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.729 HG12 HG22 ' A' ' 10' ' ' ILE . 28.1 m -25.42 -39.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 CA-C-O 122.31 1.053 . . . . 0.0 109.05 -178.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.695 ' N ' ' O ' ' A' ' 20' ' ' SER . 23.0 t -83.45 -34.57 25.4 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 114.922 -1.036 . . . . 0.0 109.326 177.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.941 ' N ' ' O ' ' A' ' 20' ' ' SER . 2.4 mtmt -87.35 -31.76 19.97 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.676 -0.64 . . . . 0.0 111.481 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.664 ' HG2' HG22 ' B' ' 14' ' ' THR . 0.0 OUTLIER -77.47 -35.71 53.5 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.45 -1.407 . . . . 0.0 108.869 179.186 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.635 ' HA ' ' HB3' ' A' ' 28' ' ' PHE . 13.4 mt -76.34 -41.42 48.4 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 118.462 -1.295 . . . . 0.0 108.737 178.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.458 ' HA ' ' HE2' ' A' ' 3' ' ' LYS . . . -62.59 -35.26 78.96 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 177.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.555 ' HA ' ' CB ' ' A' ' 30' ' ' LYS . 60.2 p -83.67 -29.02 27.95 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.635 ' HB3' ' HA ' ' A' ' 25' ' ' LEU . 0.6 OUTLIER -51.55 -40.28 59.41 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.742 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.674 ' HG3' HG21 ' B' ' 45' ' ' THR . 0.2 OUTLIER -73.49 -41.55 62.97 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 175.816 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.896 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 12.5 tttt -56.63 -22.78 36.65 Favored 'General case' 0 C--O 1.192 -1.967 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 177.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.851 HD13 ' HB1' ' B' ' 9' ' ' ALA . 0.5 OUTLIER -106.28 -30.72 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 120.521 -1.362 . . . . 0.0 109.307 178.168 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.671 HG21 ' CE2' ' B' ' 47' ' ' PHE . 1.5 mm -71.43 -53.41 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 176.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.653 ' HA ' HD23 ' B' ' 85' ' ' LEU 0.26 3.6 m -61.78 -53.86 50.19 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.73 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.896 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 62.0 mm-40 -62.14 -34.53 76.55 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.711 -0.618 . . . . 0.0 110.822 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.945 HG23 ' CB ' ' A' ' 40' ' ' ASP . 1.0 OUTLIER -55.03 -53.26 58.14 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 120.839 -1.163 . . . . 0.0 108.428 179.026 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.814 HG21 HD22 ' B' ' 85' ' ' LEU . 4.0 t -51.95 -42.35 33.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 C-N-CA 118.656 -1.217 . . . . 0.0 107.924 178.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.917 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -78.23 -1.93 35.33 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.341 177.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 35' ' ' THR . 0.0 OUTLIER -108.49 -8.01 15.64 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.73 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.28 49.7 4.59 Favored Glycine 0 C--N 1.305 -1.192 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.945 ' CB ' HG23 ' A' ' 35' ' ' THR . 0.1 OUTLIER -131.22 134.8 46.81 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.1 -1.236 . . . . 0.0 110.783 179.51 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.418 ' CD ' ' HB3' ' A' ' 51' ' ' LYS . 0.8 OUTLIER -98.57 110.21 22.84 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.35 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.787 HG22 ' HB2' ' B' ' 1' ' ' MET . 39.4 t -89.9 120.92 39.48 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 C-N-CA 119.116 -1.034 . . . . 0.0 111.031 -178.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -108.88 91.02 3.47 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.741 HD12 ' HB3' ' A' ' 48' ' ' LEU . 9.8 mt -60.88 104.53 0.37 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.547 -0.721 . . . . 0.0 110.783 -178.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.592 HG21 ' HG3' ' B' ' 29' ' ' GLU . 0.1 OUTLIER 32.91 -91.43 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 120.892 0.377 . . . . 0.0 111.402 179.498 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.494 ' O ' ' HA3' ' A' ' 82' ' ' GLY . . . -149.12 29.81 1.22 Allowed Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.664 ' CE2' ' HG3' ' B' ' 29' ' ' GLU . 1.8 p90 -131.33 -22.69 2.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.286 -1.126 . . . . 0.0 111.585 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.798 HD23 ' O ' ' A' ' 80' ' ' LYS . 5.3 mt -133.86 119.52 19.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.235 -1.541 . . . . 0.0 110.712 178.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.655 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 0.6 OUTLIER -119.97 84.18 2.17 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.432 -0.793 . . . . 0.0 111.586 -178.656 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.764 HG22 ' CG2' ' A' ' 79' ' ' VAL . 1.1 pt -83.3 147.66 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.042 -1.036 . . . . 0.0 110.425 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.428 ' HG3' ' HB2' ' A' ' 78' ' ' SER . 0.4 OUTLIER -165.94 113.99 0.78 Allowed Pre-proline 0 N--CA 1.495 1.778 0 C-N-CA 119.011 -1.076 . . . . 0.0 110.72 179.427 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.535 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 47.4 Cg_endo -71.31 143.92 44.71 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 O-C-N 123.51 1.269 . . . . 0.0 111.26 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.73 HG22 ' O ' ' A' ' 76' ' ' GLY . 25.8 m -138.23 114.88 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.726 0.774 . . . . 0.0 110.526 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.82 ' HB2' ' HB3' ' B' ' 97' ' ' PHE . . . -44.49 116.42 1.04 Allowed 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.735 0.778 . . . . 0.0 112.482 -178.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.409 ' HG3' HG23 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -143.15 136.66 28.43 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.564 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 14.3 mp0 -95.86 -175.36 3.39 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.073 -1.017 . . . . 0.0 111.249 -179.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.912 ' HB3' ' C ' ' A' ' 72' ' ' ALA . . . -173.74 -153.58 0.06 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.449 -0.782 . . . . 0.0 111.187 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.779 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -113.41 -148.43 0.43 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.59 -0.694 . . . . 0.0 111.381 -178.382 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.806 ' O ' ' N ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -144.09 -148.79 0.25 Allowed 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.754 -1.216 . . . . 0.0 108.576 178.521 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.623 ' HA2' ' C ' ' A' ' 69' ' ' LEU . . . -146.79 96.08 0.17 Allowed Glycine 0 N--CA 1.483 1.814 0 C-N-CA 118.95 -1.595 . . . . 0.0 111.423 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.848 ' CE2' ' HB2' ' A' ' 66' ' ' GLN . 6.9 p90 -167.42 159.49 12.46 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.281 -1.129 . . . . 0.0 111.349 178.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.826 ' H ' ' CD ' ' A' ' 63' ' ' PRO . 0.4 OUTLIER -139.98 -27.27 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.731 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -179.141 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.826 ' CD ' ' H ' ' A' ' 62' ' ' ASN . 42.6 Cg_endo -73.18 -11.31 25.03 Favored 'Trans proline' 0 N--CA 1.485 0.975 0 CA-C-N 118.896 0.641 . . . . 0.0 110.533 -178.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.621 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 0.9 OUTLIER -91.62 49.39 1.57 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.372 -0.83 . . . . 0.0 109.341 178.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.406 HG23 ' C ' ' A' ' 64' ' ' GLN . 2.7 p 56.29 48.85 16.35 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.849 -0.532 . . . . 0.0 110.371 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.848 ' HB2' ' CE2' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -153.82 -152.53 0.42 Allowed 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.371 -0.831 . . . . 0.0 110.619 -179.495 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.638 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 9.7 mp0 -131.42 130.2 42.23 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 178.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.886 ' O ' HD23 ' A' ' 69' ' ' LEU . . . -58.53 133.15 55.57 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-O 122.017 0.913 . . . . 0.0 111.289 -178.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.886 HD23 ' O ' ' A' ' 68' ' ' ALA . 1.3 mt -142.02 -137.49 0.11 Allowed 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.832 ' O ' ' O ' ' A' ' 71' ' ' ILE . 3.2 tt0 -166.48 -128.2 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.538 -1.352 . . . . 0.0 112.551 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.832 ' O ' ' O ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -10.77 153.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -176.501 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 1.012 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -137.47 -171.86 0.29 Allowed Pre-proline 0 C--N 1.298 -1.657 0 CA-C-N 114.878 -1.055 . . . . 0.0 112.686 -177.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 1.012 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 38.3 Cg_endo -66.06 117.76 4.94 Favored 'Trans proline' 0 C--N 1.318 -1.069 0 O-C-N 124.236 1.65 . . . . 0.0 110.963 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.525 ' HA ' ' CD2' ' B' ' 94' ' ' TYR . 0.8 OUTLIER -157.86 149.12 21.37 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.768 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.81 HG12 ' HB2' ' B' ' 89' ' ' ALA . 0.4 OUTLIER -48.53 166.99 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.103 -0.998 . . . . 0.0 109.961 -179.364 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.73 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -108.15 85.72 0.42 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.18 -1.968 . . . . 0.0 108.18 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 1.109 HG11 HD13 ' B' ' 85' ' ' LEU . 73.4 t -60.19 80.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.781 -0.835 . . . . 0.0 110.557 -179.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.468 ' N ' ' O ' ' A' ' 76' ' ' GLY . 0.3 OUTLIER -75.43 178.48 5.88 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.27 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.764 ' CG2' HG22 ' A' ' 50' ' ' ILE . 6.6 p 178.64 177.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.798 ' O ' HD23 ' A' ' 48' ' ' LEU . 1.4 mttt -175.83 173.67 0.88 Allowed Pre-proline 0 N--CA 1.487 1.396 0 O-C-N 120.799 -1.188 . . . . 0.0 111.069 178.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.485 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 56.5 Cg_endo -94.96 142.69 1.32 Allowed 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 122.586 2.191 . . . . 0.0 109.407 177.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.515 ' CA ' ' HA ' ' A' ' 47' ' ' PHE . . . -106.26 163.97 13.65 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.273 -1.931 . . . . 0.0 108.273 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.34 -24.79 57.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.071 -1.252 . . . . 0.0 110.624 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.457 ' HB2' ' HB3' ' A' ' 47' ' ' PHE . 3.5 m -55.29 -36.64 66.37 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.037 -1.039 . . . . 0.0 108.652 178.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.892 HD13 HG21 ' B' ' 77' ' ' VAL . 0.5 OUTLIER -80.69 -30.78 36.38 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.757 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.815 ' HG3' HG12 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -77.32 -41.9 38.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.639 -0.663 . . . . 0.0 109.947 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.3 ttmt -64.15 -38.97 92.98 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.896 ' O ' ' HB1' ' B' ' 37' ' ' ALA . . . -66.18 -35.99 81.9 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 176.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.908 ' HB1' ' CG1' ' B' ' 75' ' ' VAL . . . -56.65 -39.39 73.62 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.774 -0.77 . . . . 0.0 108.932 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.39 -33.05 65.39 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 176.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.446 ' C ' ' H ' ' A' ' 93' ' ' LYS . . . -60.21 -42.33 98.61 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 178.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.883 ' O ' HD12 ' A' ' 92' ' ' LEU . 0.5 OUTLIER -65.2 6.01 0.31 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.729 -1.454 . . . . 0.0 110.822 179.649 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.614 ' HB3' ' HB2' ' A' ' 96' ' ' ASP . 3.1 mmtt 80.07 52.95 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 CA-C-O 122.052 0.929 . . . . 0.0 108.783 -179.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.944 ' CD1' ' HB2' ' B' ' 74' ' ' SER . 4.5 t80 -42.28 -61.87 1.08 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.535 ' HA ' ' CB ' ' B' ' 74' ' ' SER . 15.2 mt-10 -51.18 -33.83 28.9 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.878 -1.139 . . . . 0.0 110.305 179.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.614 ' HB2' ' HB3' ' A' ' 93' ' ' LYS . 9.2 t0 -62.41 -26.12 68.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.277 -0.89 . . . . 0.0 109.133 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.533 ' HB3' ' HB2' ' B' ' 54' ' ' ALA . 0.5 OUTLIER -84.52 -20.81 31.0 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.232 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.995 ' HB2' ' CB ' ' B' ' 74' ' ' SER . . . -69.43 -36.6 76.81 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.633 -0.667 . . . . 0.0 109.804 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 14.8 mttm . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 118.005 -0.997 . . . . 0.0 110.221 -179.889 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.787 ' HB2' HG22 ' A' ' 42' ' ' VAL . 9.6 mtp . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 120.869 0.366 . . . . 0.0 110.08 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . 0.44 ' O ' ' HB2' ' B' ' 6' ' ' LEU . 0.7 OUTLIER -172.44 -169.59 0.62 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.126 -0.984 . . . . 0.0 111.017 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.584 ' HD2' ' HB ' ' A' ' 45' ' ' THR . 0.0 OUTLIER -56.53 -10.85 1.06 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.308 -0.87 . . . . 0.0 110.098 179.61 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.688 ' O ' HG13 ' B' ' 7' ' ' ILE . 37.1 m -109.86 -56.68 2.29 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 122.162 0.982 . . . . 0.0 108.761 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.628 ' HA ' ' HE2' ' B' ' 8' ' ' LYS . 0.1 OUTLIER -49.4 -46.11 47.01 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.057 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.735 HD11 ' CG1' ' A' ' 42' ' ' VAL . 5.3 mt -64.45 -27.01 68.7 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.154 -1.019 . . . . 0.0 110.557 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' ILE . . . . . 0.688 HG13 ' O ' ' B' ' 4' ' ' THR . 1.2 pp -59.36 -41.68 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 120.37 -1.456 . . . . 0.0 107.306 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . 0.767 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 18.6 mtmt -67.36 -44.09 79.84 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 177.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . 0.851 ' HB1' HD13 ' A' ' 31' ' ' ILE . . . -53.69 -32.11 50.52 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.646 -0.659 . . . . 0.0 109.863 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.734 ' O ' ' OG1' ' B' ' 14' ' ' THR . 0.8 OUTLIER -94.4 -29.85 4.21 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.478 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 178.162 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.767 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -63.08 -28.53 70.14 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 177.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.425 ' HG3' ' O ' ' B' ' 8' ' ' LYS . 58.5 mt-30 -87.96 -43.85 11.45 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.447 ' HB3' ' OG ' ' A' ' 27' ' ' SER . 94.1 m-20 -64.16 -26.1 68.38 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 177.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.827 HG22 ' HB2' ' A' ' 20' ' ' SER . 20.6 p -87.74 -76.74 0.37 Allowed 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 177.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 61.32 10.99 25.1 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' LEU . . . . . 0.879 HD22 ' O ' ' A' ' 19' ' ' VAL . 3.1 mp -82.33 -67.16 0.81 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.525 -0.985 . . . . 0.0 109.204 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . 0.756 ' CG2' HG21 ' A' ' 17' ' ' THR . 0.5 OUTLIER -137.52 6.39 2.74 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.787 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . 0.639 ' O ' ' C ' ' B' ' 19' ' ' VAL . 15.4 mt-30 57.97 25.88 12.75 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 -176.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 1.082 HG23 ' CD1' ' A' ' 16' ' ' LEU . 0.4 OUTLIER 4.17 -102.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.642 -179.099 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.967 ' O ' ' N ' ' B' ' 22' ' ' SER . 0.2 OUTLIER -135.2 24.09 3.52 Favored 'General case' 0 C--N 1.27 -2.853 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 177.33 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.601 ' C ' ' O ' ' B' ' 20' ' ' SER . 35.2 m -12.4 -38.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-O 122.394 1.092 . . . . 0.0 110.469 -177.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.967 ' N ' ' O ' ' B' ' 20' ' ' SER . 12.1 t -80.14 -46.87 15.65 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.34 177.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . 0.939 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.1 OUTLIER -85.44 -24.1 27.59 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.855 -0.528 . . . . 0.0 110.085 178.624 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' MET . . . . . 0.599 ' CE ' HG21 ' B' ' 10' ' ' ILE . 3.5 tmm? -68.37 -45.1 73.71 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.701 ' HA ' ' HB3' ' B' ' 28' ' ' PHE . 11.6 mt -71.0 -34.79 71.69 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 176.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . 0.585 ' HB3' ' HA ' ' B' ' 23' ' ' LYS . . . -62.29 -34.72 77.12 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 177.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . 0.466 ' HA ' ' HB3' ' B' ' 30' ' ' LYS . 0.1 OUTLIER -76.38 -40.71 50.28 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 177.636 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . 0.701 ' HB3' ' HA ' ' B' ' 25' ' ' LEU . 0.1 OUTLIER -52.84 -45.94 67.57 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.163 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . 0.664 ' HG3' ' CE2' ' A' ' 47' ' ' PHE . 1.2 tt0 -68.58 -36.38 78.66 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 177.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 1.246 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 13.4 ttmt -64.71 -22.74 67.05 Favored 'General case' 0 C--O 1.191 -1.989 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.926 HD13 ' CB ' ' A' ' 9' ' ' ALA . 0.6 OUTLIER -105.83 -27.61 3.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 O-C-N 120.282 -1.511 . . . . 0.0 109.335 178.237 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.645 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.2 mm -73.18 -60.42 2.43 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 177.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' THR . . . . . 0.598 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 0.6 OUTLIER -68.75 -35.21 76.81 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.553 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 1.246 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 31.1 mm-40 -78.54 -37.78 42.06 Favored 'General case' 0 C--O 1.207 -1.184 0 O-C-N 121.115 -0.99 . . . . 0.0 111.952 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' THR . . . . . 0.514 ' CB ' ' O ' ' B' ' 31' ' ' ILE . 37.2 m -61.95 -49.99 73.92 Favored 'General case' 0 N--CA 1.504 2.246 0 CA-C-N 120.714 1.597 . . . . 0.0 109.201 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.734 HG11 HD22 ' A' ' 85' ' ' LEU . 2.1 t -52.83 -43.53 45.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 178.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 0.896 ' HB1' ' O ' ' A' ' 88' ' ' ALA . . . -85.99 0.82 52.31 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.834 178.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.747 ' HB2' ' O ' ' B' ' 34' ' ' GLU . 7.6 tppt? -96.05 -33.46 12.1 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 177.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 134.01 33.44 0.33 Allowed Glycine 0 C--N 1.303 -1.263 0 C-N-CA 119.581 -1.295 . . . . 0.0 111.482 177.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . 0.453 ' CB ' ' CG2' ' B' ' 35' ' ' THR . 0.1 OUTLIER -144.85 157.55 44.12 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.752 -1.44 . . . . 0.0 110.66 179.356 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.401 ' HG3' ' HD2' ' B' ' 52' ' ' PRO . 4.5 mptp? -103.96 99.81 9.57 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.518 -0.739 . . . . 0.0 109.61 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.511 HG13 HD11 ' A' ' 6' ' ' LEU . 59.7 t -59.07 136.28 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.584 -0.698 . . . . 0.0 110.085 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -127.96 97.25 4.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.342 -0.849 . . . . 0.0 109.403 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.714 HD12 ' HB3' ' B' ' 48' ' ' LEU . 11.0 mt -69.1 101.6 1.47 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.249 -0.907 . . . . 0.0 110.442 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . 0.674 HG21 ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 32.34 -95.1 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.036 0 O-C-N 122.052 -0.405 . . . . 0.0 111.451 179.277 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -144.41 30.71 1.85 Allowed Glycine 0 N--CA 1.487 2.037 0 C-N-CA 119.668 -1.253 . . . . 0.0 110.448 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . 0.702 ' O ' ' HA ' ' B' ' 81' ' ' PRO . 3.9 p90 -133.65 -18.6 2.15 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.893 -1.357 . . . . 0.0 111.686 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.714 ' HB3' HD12 ' B' ' 44' ' ' LEU . 4.6 mt -135.47 120.25 18.43 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.337 -1.477 . . . . 0.0 111.196 178.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' ASN . . . . . 0.53 ' O ' ' HA ' ' B' ' 79' ' ' VAL . 2.6 m120 -116.95 94.56 4.64 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.506 -0.747 . . . . 0.0 111.208 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' ILE . . . . . 0.647 HG22 HG21 ' B' ' 36' ' ' VAL . 33.8 mm -90.19 141.91 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.305 -0.872 . . . . 0.0 109.739 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . 0.432 ' O ' ' N ' ' B' ' 78' ' ' SER . 2.3 pttt -162.44 128.63 2.35 Favored Pre-proline 0 N--CA 1.498 1.951 0 O-C-N 120.582 -1.324 . . . . 0.0 111.439 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.566 ' O ' HG13 ' B' ' 53' ' ' VAL . 52.5 Cg_endo -77.12 145.15 24.27 Favored 'Trans proline' 0 C--N 1.314 -1.24 0 O-C-N 123.531 1.28 . . . . 0.0 110.72 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.659 HG22 ' O ' ' B' ' 76' ' ' GLY . 15.3 m -156.57 121.28 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-O 121.257 0.551 . . . . 0.0 109.962 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.832 ' HA ' ' N ' ' B' ' 75' ' ' VAL . . . -68.04 125.02 25.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.12 -0.988 . . . . 0.0 111.561 -178.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . 0.578 ' HB2' ' O ' ' B' ' 54' ' ' ALA . 0.1 OUTLIER 172.23 39.63 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.831 -179.671 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . 0.495 ' O ' ' OH ' ' A' ' 94' ' ' TYR . 0.8 OUTLIER -122.56 96.88 5.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.235 -0.916 . . . . 0.0 110.04 -179.533 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.673 ' HB2' ' CD ' ' B' ' 73' ' ' PRO . . . -137.36 166.75 23.06 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.237 -0.985 . . . . 0.0 111.318 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' ARG . . . . . 0.598 ' N ' ' HD3' ' B' ' 58' ' ' ARG . 0.0 OUTLIER -98.3 157.33 16.24 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.752 -0.592 . . . . 0.0 110.949 -178.901 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' B' ' 58' ' ' ARG . 0.7 OUTLIER -178.88 40.06 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.586 -0.696 . . . . 0.0 109.484 179.278 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -106.78 -108.43 3.3 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' PHE . . . . . 0.804 ' O ' ' N ' ' B' ' 67' ' ' GLU . 5.9 p90 -179.34 172.45 1.2 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.291 -1.123 . . . . 0.0 110.238 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . 0.853 ' N ' ' HB2' ' B' ' 68' ' ' ALA . 1.8 t30 -106.85 -60.07 0.05 OUTLIER Pre-proline 0 N--CA 1.499 1.986 0 O-C-N 120.95 -1.094 . . . . 0.0 112.184 -178.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.629 ' HD2' ' H ' ' B' ' 62' ' ' ASN . 41.6 Cg_endo -67.89 62.82 0.94 Allowed 'Trans proline' 0 C--N 1.315 -1.2 0 O-C-N 123.322 1.17 . . . . 0.0 110.285 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . 0.799 ' HB3' ' CE1' ' B' ' 61' ' ' PHE . 0.0 OUTLIER -177.18 33.44 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.545 0.688 . . . . 0.0 109.295 -179.735 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.408 HG23 ' C ' ' B' ' 64' ' ' GLN . 2.8 p 55.83 53.22 9.63 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.709 -0.62 . . . . 0.0 111.097 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . 0.737 ' HB2' ' CE1' ' B' ' 61' ' ' PHE . 0.0 OUTLIER -150.09 -100.36 0.07 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.002 -1.061 . . . . 0.0 110.935 179.858 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . 0.804 ' N ' ' O ' ' B' ' 61' ' ' PHE . 2.7 pt-20 170.39 96.41 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.137 -0.977 . . . . 0.0 108.803 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . 0.951 ' O ' HD23 ' B' ' 69' ' ' LEU . . . -71.1 94.91 1.16 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.189 -0.945 . . . . 0.0 110.1 -178.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.951 HD23 ' O ' ' B' ' 68' ' ' ALA . 5.9 mt -142.61 155.87 45.02 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.747 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -144.15 50.78 1.31 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.387 -0.821 . . . . 0.0 110.059 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.473 HG12 ' HD3' ' B' ' 58' ' ' ARG . 3.2 pt -61.14 -153.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.441 -0.787 . . . . 0.0 110.17 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -133.84 139.99 35.13 Favored Pre-proline 0 C--N 1.301 -1.515 0 O-C-N 121.227 -0.92 . . . . 0.0 111.316 -179.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' PRO . . . . . 0.673 ' CD ' ' HB2' ' B' ' 57' ' ' ALA . 47.1 Cg_endo -80.88 132.42 8.58 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 124.046 1.551 . . . . 0.0 108.911 178.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . 0.995 ' CB ' ' HB2' ' A' ' 98' ' ' ALA . 0.7 OUTLIER -153.48 19.21 0.55 Allowed 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 119.19 -1.004 . . . . 0.0 113.143 -178.945 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . 0.908 ' CG1' ' HB1' ' A' ' 89' ' ' ALA . 0.9 OUTLIER 163.18 144.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.517 2.894 0 CA-C-O 121.908 0.861 . . . . 0.0 109.288 175.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . 0.659 ' O ' HG22 ' B' ' 53' ' ' VAL . . . -157.17 110.63 0.45 Allowed Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.892 HG21 HD13 ' A' ' 85' ' ' LEU . 2.7 p -67.93 89.42 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.395 -1.062 . . . . 0.0 111.31 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . 0.617 ' C ' HG12 ' B' ' 79' ' ' VAL . 0.3 OUTLIER -74.52 -176.38 2.72 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 177.343 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.617 HG12 ' C ' ' B' ' 78' ' ' SER . 0.2 OUTLIER 179.84 174.66 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.298 -0.876 . . . . 0.0 109.028 179.676 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . 0.555 ' O ' HD23 ' B' ' 48' ' ' LEU . 4.7 mttt 179.25 174.25 0.42 Allowed Pre-proline 0 C--N 1.307 -1.243 0 O-C-N 121.492 -0.755 . . . . 0.0 109.379 178.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' PRO . . . . . 0.702 ' HA ' ' O ' ' B' ' 47' ' ' PHE . 52.3 Cg_endo -95.68 171.57 1.22 Allowed 'Trans proline' 0 C--N 1.296 -2.206 0 C-N-CA 121.856 1.704 . . . . 0.0 109.567 177.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' B' ' 47' ' ' PHE . . . -120.5 -92.63 1.31 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 106.177 -2.769 . . . . 0.0 106.177 177.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . 0.877 ' O ' ' N ' ' B' ' 85' ' ' LEU . 29.2 tt0 -80.13 51.61 1.41 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 175.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' SER . . . . . 0.671 ' O ' HG21 ' A' ' 77' ' ' VAL . 0.1 OUTLIER 8.27 44.15 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.007 179.586 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 1.109 HD13 HG11 ' A' ' 77' ' ' VAL . 3.6 mp 20.18 28.93 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 103.104 -2.924 . . . . 0.0 103.104 -172.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . 0.59 ' HD2' ' HB2' ' B' ' 84' ' ' SER 0.349 4.0 tttp -57.94 -42.59 85.23 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 104.418 -2.438 . . . . 0.0 104.418 177.397 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . 0.419 ' O ' ' HG2' ' B' ' 90' ' ' GLU 0.282 15.8 tttt -69.2 -31.17 69.59 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 111.789 -2.459 . . . . 0.0 105.976 175.654 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.768 ' HB3' ' HB3' ' B' ' 85' ' ' LEU . . . -78.02 -27.04 48.8 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 118.19 -1.404 . . . . 0.0 107.917 178.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 1.008 ' HA ' HD23 ' B' ' 92' ' ' LEU . . . -64.96 -48.7 73.1 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.294 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.423 ' HG2' ' N ' ' B' ' 91' ' ' GLY . 4.0 pt-20 -59.24 -28.08 66.37 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 177.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . 0.423 ' N ' ' HG2' ' B' ' 90' ' ' GLU . . . -75.51 -24.49 70.34 Favored Glycine 0 N--CA 1.49 2.255 0 C-N-CA 120.462 -0.875 . . . . 0.0 111.137 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . 1.008 HD23 ' HA ' ' B' ' 89' ' ' ALA . 0.3 OUTLIER -88.05 23.92 1.96 Allowed 'General case' 0 N--CA 1.503 2.216 0 O-C-N 120.322 -1.693 . . . . 0.0 110.544 -179.738 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . 0.406 ' O ' ' N ' ' B' ' 96' ' ' ASP . 1.2 mmmm 55.11 35.86 25.7 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 -177.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . 0.538 ' CD1' ' N ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -41.71 -43.62 2.92 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.794 -178.701 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . 0.434 ' HG2' ' N ' ' B' ' 96' ' ' ASP . 4.9 pm0 -53.81 -36.11 62.12 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.264 -0.897 . . . . 0.0 109.289 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 96' ' ' ASP . . . . . 0.434 ' N ' ' HG2' ' B' ' 95' ' ' GLU . 20.1 t70 -64.97 -34.35 78.23 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 177.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 97' ' ' PHE . . . . . 0.82 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -73.91 -25.33 59.94 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.267 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.03 -30.86 65.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.591 -0.693 . . . . 0.0 110.17 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.22 179.965 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.839 ' HB3' HG22 ' B' ' 42' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.446 ' HA ' ' O ' ' B' ' 43' ' ' GLN . 52.2 p-10 -171.66 -149.25 0.06 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.988 -1.07 . . . . 0.0 112.044 178.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.895 ' HA ' HD11 ' A' ' 25' ' ' LEU . 3.8 tttm -51.32 -6.94 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.44 -0.788 . . . . 0.0 111.622 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.645 ' O ' HG13 ' A' ' 7' ' ' ILE . 48.7 m -118.13 -62.49 1.54 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.849 -1.157 . . . . 0.0 110.586 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.542 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 4.9 mt-10 -49.22 -42.02 39.08 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.071 -1.018 . . . . 0.0 109.167 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.696 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 21.0 mt -62.26 -32.51 73.22 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.111 -1.035 . . . . 0.0 109.556 178.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.828 HG22 HD23 ' A' ' 25' ' ' LEU . 1.0 OUTLIER -57.18 -43.95 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 178.292 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.901 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 2.6 mtpt -63.56 -34.75 78.49 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.862 ' HB1' HD13 ' B' ' 31' ' ' ILE . . . -52.56 -40.12 62.21 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.807 -0.757 . . . . 0.0 109.155 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.776 HG22 HG12 ' A' ' 21' ' ' VAL . 1.5 mp -91.15 -32.1 5.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 178.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.901 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -66.79 -13.06 61.05 Favored 'General case' 0 C--N 1.292 -1.918 0 O-C-N 120.756 -1.215 . . . . 0.0 108.923 178.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.444 ' N ' ' O ' ' A' ' 8' ' ' LYS . 11.5 pt20 -114.58 -39.98 3.68 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.45 -0.781 . . . . 0.0 109.656 179.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.426 ' HB3' ' OG ' ' B' ' 27' ' ' SER . 1.0 OUTLIER -73.95 -20.29 60.41 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 176.887 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 1.017 HG22 HD11 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -119.14 -83.99 0.65 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 179.232 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.539 ' O ' ' C ' ' A' ' 16' ' ' LEU . . . 68.6 -21.17 0.34 Allowed Glycine 0 N--CA 1.495 2.588 0 O-C-N 120.957 -1.09 . . . . 0.0 110.843 178.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.017 HD11 HG22 ' A' ' 14' ' ' THR . 0.0 OUTLIER -28.77 -59.68 0.13 Allowed 'General case' 0 N--CA 1.518 2.973 0 CA-C-O 122.004 0.906 . . . . 0.0 110.266 -179.166 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.589 HG21 ' CG2' ' B' ' 17' ' ' THR . 0.6 OUTLIER -130.23 -7.28 4.3 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.564 -179.932 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.566 ' O ' ' C ' ' A' ' 19' ' ' VAL . 23.6 mt-30 57.25 36.86 27.88 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -177.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 1.062 HG11 HG11 ' B' ' 19' ' ' VAL . 1.0 OUTLIER -19.62 -93.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.872 -178.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.935 ' O ' ' N ' ' A' ' 22' ' ' SER . 0.4 OUTLIER -134.39 25.03 3.8 Favored 'General case' 0 C--N 1.278 -2.506 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 177.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.776 HG12 HG22 ' A' ' 10' ' ' ILE . 27.3 m -16.34 -38.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 122.684 1.23 . . . . 0.0 109.466 -178.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.935 ' N ' ' O ' ' A' ' 20' ' ' SER . 32.2 p -84.55 -39.31 18.93 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 114.66 -1.154 . . . . 0.0 110.38 178.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.926 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.3 OUTLIER -89.69 -25.38 21.25 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 121.245 -0.91 . . . . 0.0 110.613 179.593 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.963 ' HB3' HG21 ' B' ' 14' ' ' THR . 0.0 OUTLIER -81.01 -35.02 32.47 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.25 -1.531 . . . . 0.0 109.361 178.9 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.895 HD11 ' HA ' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -80.75 -40.99 24.27 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 117.875 -1.53 . . . . 0.0 107.141 177.819 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.502 ' CB ' ' O ' ' A' ' 22' ' ' SER . . . -60.55 -25.74 66.38 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 176.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.494 ' HA ' ' HB3' ' A' ' 30' ' ' LYS . 7.0 t -83.42 -37.9 22.62 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.756 ' HA ' ' CG1' ' A' ' 31' ' ' ILE . 0.1 OUTLIER -60.11 -33.04 71.56 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.486 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.663 ' HG3' ' CD1' ' A' ' 28' ' ' PHE . 29.6 mt-10 -80.06 -33.89 38.61 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 177.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.85 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 6.6 tttm -69.46 -28.0 65.72 Favored 'General case' 0 C--O 1.195 -1.799 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 177.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.935 HD13 ' HB1' ' B' ' 9' ' ' ALA . 1.1 pp -96.98 -30.3 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.217 -0.927 . . . . 0.0 109.728 179.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.747 HG21 ' CE1' ' B' ' 47' ' ' PHE . 1.6 mm -65.09 -53.98 34.68 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 177.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.629 HG23 ' HB2' ' B' ' 88' ' ' ALA . 0.4 OUTLIER -69.09 -37.3 78.35 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.162 -1.015 . . . . 0.0 108.464 179.591 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.85 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 15.5 mm-40 -73.17 -38.41 66.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.431 -0.793 . . . . 0.0 111.25 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.539 ' N ' ' O ' ' A' ' 31' ' ' ILE . 19.4 m -58.13 -48.49 80.08 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.697 -1.252 . . . . 0.0 108.097 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.776 HG13 ' HB3' ' A' ' 52' ' ' PRO . 2.8 t -55.84 -36.79 44.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 106.652 -1.611 . . . . 0.0 106.652 177.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.768 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -80.29 -4.01 51.63 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -101.81 -32.58 10.19 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.583 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.72 34.57 0.79 Allowed Glycine 0 C--N 1.302 -1.33 0 C-N-CA 119.682 -1.247 . . . . 0.0 111.472 177.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.53 ' HB2' HG23 ' A' ' 35' ' ' THR . 0.4 OUTLIER -135.8 144.0 45.5 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.856 -1.379 . . . . 0.0 110.552 179.262 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.454 ' HG2' ' HB2' ' A' ' 51' ' ' LYS . 49.0 mtmt -91.67 92.4 8.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.517 -0.739 . . . . 0.0 109.978 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.608 HG23 ' HB ' ' A' ' 50' ' ' ILE . 35.4 m -63.05 147.29 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.533 -0.73 . . . . 0.0 110.413 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.882 ' O ' HD23 ' A' ' 44' ' ' LEU . 31.9 mt-30 -142.74 171.41 14.08 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.308 -0.87 . . . . 0.0 110.49 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.882 HD23 ' O ' ' A' ' 43' ' ' GLN . 21.3 mt -131.47 -177.99 4.66 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.512 -0.743 . . . . 0.0 109.781 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.829 HG22 ' HG2' ' B' ' 29' ' ' GLU . 2.8 t -43.25 66.23 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.88 -0.512 . . . . 0.0 112.098 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.78 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . 46.98 23.03 1.39 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.802 ' HA ' ' HA2' ' A' ' 82' ' ' GLY . 0.7 OUTLIER -117.61 -37.83 3.4 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 121.014 -1.286 . . . . 0.0 109.522 179.39 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.832 ' HB2' HD12 ' A' ' 44' ' ' LEU . 6.9 mt -120.6 118.86 31.25 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.442 -1.411 . . . . 0.0 111.095 177.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.672 ' H ' ' HB2' ' A' ' 80' ' ' LYS . 32.6 t-20 -116.9 85.64 2.36 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.766 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.64 HD13 ' HA ' ' A' ' 79' ' ' VAL . 40.1 mm -86.12 126.07 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.444 -0.785 . . . . 0.0 110.473 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.598 ' HD2' HG13 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -147.48 130.69 8.09 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.353 -0.842 . . . . 0.0 109.441 179.307 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.776 ' HB3' HG13 ' A' ' 36' ' ' VAL . 53.7 Cg_endo -78.18 142.09 18.97 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 123.57 1.3 . . . . 0.0 112.467 -178.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.7 HG22 ' O ' ' A' ' 76' ' ' GLY . 33.7 m -134.72 109.64 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 CA-C-O 121.696 0.76 . . . . 0.0 110.92 178.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.731 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . -62.37 119.09 8.42 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.43 -0.794 . . . . 0.0 111.471 -179.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.469 ' O ' ' HB3' ' A' ' 56' ' ' GLN . 0.9 OUTLIER -173.83 16.44 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 118.888 -1.125 . . . . 0.0 113.696 179.098 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.707 ' N ' ' HA ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -176.34 141.73 0.43 Allowed 'General case' 0 N--CA 1.506 2.344 0 O-C-N 120.077 -1.64 . . . . 0.0 115.197 178.654 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.879 ' N ' ' O ' ' A' ' 72' ' ' ALA . . . 161.16 -177.75 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.652 ' HA ' ' HA ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -177.62 123.85 0.12 Allowed 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 122.248 1.023 . . . . 0.0 112.336 177.233 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.912 ' HB2' ' HB2' ' A' ' 70' ' ' GLU . 3.4 mmtm -62.81 -129.0 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.153 -0.93 . . . . 0.0 108.952 177.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.496 ' O ' ' O ' ' A' ' 61' ' ' PHE . . . -147.9 130.79 3.61 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 118.927 -1.606 . . . . 0.0 111.347 -178.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.829 ' HB3' ' N ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -53.23 -161.5 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.929 -0.748 . . . . 0.0 109.588 179.129 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.757 ' N ' ' CG ' ' A' ' 61' ' ' PHE 0.272 1.0 OUTLIER -45.07 179.72 0.01 OUTLIER Pre-proline 0 C--N 1.299 -1.589 0 O-C-N 121.242 -0.912 . . . . 0.0 110.724 177.509 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.435 ' HD2' ' CG ' ' A' ' 62' ' ' ASN . 45.8 Cg_endo -74.48 3.57 5.21 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 O-C-N 123.221 1.116 . . . . 0.0 109.944 178.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.532 ' CB ' ' CE1' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -78.67 -103.87 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.315 -0.866 . . . . 0.0 110.191 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.471 ' H ' ' HB3' ' A' ' 64' ' ' GLN . 77.1 p -68.03 -8.33 36.73 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.701 -1.25 . . . . 0.0 109.872 179.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 54.56 51.27 14.32 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.35 -0.844 . . . . 0.0 110.528 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.758 ' C ' ' HB3' ' A' ' 61' ' ' PHE . 0.1 OUTLIER 177.78 87.2 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.601 0 O-C-N 121.197 -0.94 . . . . 0.0 111.443 179.499 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.829 ' N ' ' HB3' ' A' ' 61' ' ' PHE . . . 173.78 18.66 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.719 ' O ' HD12 ' A' ' 69' ' ' LEU . 0.8 OUTLIER -171.99 45.04 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.226 0 O-C-N 119.827 -1.796 . . . . 0.0 110.977 177.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.912 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -175.65 48.19 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.188 -0.945 . . . . 0.0 109.72 -179.836 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.964 HD12 ' N ' ' A' ' 72' ' ' ALA . 0.7 OUTLIER -63.36 -176.86 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.241 -0.912 . . . . 0.0 111.154 -178.731 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.964 ' N ' HD12 ' A' ' 71' ' ' ILE . . . -165.31 143.64 5.16 Favored Pre-proline 0 C--O 1.198 -1.619 0 O-C-N 121.73 -0.606 . . . . 0.0 109.495 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.707 ' HA ' ' N ' ' A' ' 56' ' ' GLN . 54.9 Cg_endo -98.45 62.04 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 121.781 1.654 . . . . 0.0 111.726 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.781 ' HB2' ' HB2' ' A' ' 57' ' ' ALA . 10.4 t -52.8 158.58 1.32 Allowed 'General case' 0 N--CA 1.505 2.309 0 O-C-N 120.83 -1.169 . . . . 0.0 112.644 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.731 ' HA ' ' HA ' ' A' ' 54' ' ' ALA . 0.8 OUTLIER -68.16 150.12 11.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-O 122.043 0.925 . . . . 0.0 109.733 179.877 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.7 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -114.24 86.22 0.41 Allowed Glycine 0 C--N 1.289 -2.067 0 N-CA-C 108.886 -1.685 . . . . 0.0 108.886 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.84 HG21 HD13 ' B' ' 85' ' ' LEU . 3.8 p -45.21 87.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 CA-C-O 121.766 0.793 . . . . 0.0 110.792 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.544 ' N ' ' O ' ' A' ' 76' ' ' GLY . 0.1 OUTLIER -59.37 -162.35 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.122 179.8 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.712 HG11 ' HD3' ' B' ' 81' ' ' PRO . 5.4 p 179.93 178.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.672 ' HB2' ' H ' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -139.76 177.69 1.92 Allowed Pre-proline 0 C--N 1.305 -1.331 0 O-C-N 120.896 -1.127 . . . . 0.0 110.455 179.051 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.435 ' HD3' ' CG ' ' A' ' 80' ' ' LYS . 56.4 Cg_endo -106.69 84.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.298 -2.095 0 C-N-CA 124.074 3.183 . . . . 0.0 108.592 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.802 ' HA2' ' HA ' ' A' ' 47' ' ' PHE . . . -55.73 100.72 0.1 Allowed Glycine 0 N--CA 1.483 1.779 0 C-N-CA 118.698 -1.715 . . . . 0.0 110.955 -177.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.414 ' HA ' ' HB2' ' A' ' 86' ' ' LYS . 6.2 pt-20 -57.35 -29.01 63.64 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.451 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 0.3 OUTLIER -61.88 -32.76 73.15 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 177.3 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.819 HD21 HG21 ' B' ' 36' ' ' VAL . 1.9 tt -81.69 -39.45 24.28 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 177.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.698 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 0.3 OUTLIER -69.78 -45.93 66.9 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.614 0.721 . . . . 0.0 109.53 179.301 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.69 -37.55 87.78 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.662 ' C ' ' HB2' ' B' ' 37' ' ' ALA . . . -66.28 -36.89 84.13 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 176.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 1.045 ' HB1' HG21 ' B' ' 75' ' ' VAL . . . -57.77 -31.6 66.68 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.654 ' HA ' ' CD1' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -65.2 -31.33 72.45 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 177.096 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.473 ' N ' ' HG3' ' A' ' 90' ' ' GLU . . . -66.01 -31.85 80.73 Favored Glycine 0 N--CA 1.484 1.869 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 178.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.877 HD12 ' HB2' ' A' ' 93' ' ' LYS . 1.0 OUTLIER -58.19 -43.39 87.52 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 120.723 -1.457 . . . . 0.0 111.386 -179.253 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.877 ' HB2' HD12 ' A' ' 92' ' ' LEU . 0.0 OUTLIER 164.82 46.11 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -179.651 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.776 ' CE1' ' C ' ' B' ' 74' ' ' SER . 2.2 t80 -40.29 -73.29 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -178.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.494 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 5.7 mt-10 -51.4 -41.86 61.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.197 -0.939 . . . . 0.0 110.256 -178.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -61.28 -32.22 72.05 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.684 ' HD2' HD11 ' A' ' 92' ' ' LEU . 0.1 OUTLIER -86.59 -20.61 27.66 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.467 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.923 ' HB2' ' HB2' ' B' ' 74' ' ' SER . . . -76.8 -34.94 57.92 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.776 -0.577 . . . . 0.0 110.386 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.182 -179.957 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.713 ' CE ' HD23 ' B' ' 6' ' ' LEU . 10.0 mtp . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . 0.498 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 10.2 p30 -170.86 -156.63 0.12 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.971 -1.081 . . . . 0.0 112.191 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.517 ' HE3' ' HB ' ' A' ' 45' ' ' THR . 0.3 OUTLIER -57.07 -4.69 0.2 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.61 -0.681 . . . . 0.0 111.26 -179.282 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.656 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 93.9 m -124.08 -42.15 2.16 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.935 -1.103 . . . . 0.0 109.743 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.58 ' CB ' ' HA ' ' B' ' 1' ' ' MET . 0.0 OUTLIER -63.68 -53.49 50.54 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.134 -0.979 . . . . 0.0 108.709 179.087 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.764 ' O ' ' HB3' ' B' ' 9' ' ' ALA . 14.8 mt -60.0 -29.78 68.7 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.335 -0.946 . . . . 0.0 108.964 178.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' ILE . . . . . 1.042 HG23 ' HB ' ' B' ' 21' ' ' VAL . 1.1 mt -54.65 -55.73 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . 0.913 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 14.6 mtmt -56.57 -34.24 66.94 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 177.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . 0.935 ' HB1' HD13 ' A' ' 31' ' ' ILE . . . -53.22 -38.63 63.08 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.585 -0.846 . . . . 0.0 109.259 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.793 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.4 mp -92.7 -31.15 4.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 177.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.913 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -68.92 -6.48 27.71 Favored 'General case' 0 C--N 1.29 -2.0 0 C-N-CA 118.38 -1.328 . . . . 0.0 108.645 178.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.42 ' CG ' ' N ' ' B' ' 13' ' ' ASP . 12.7 pt20 -122.45 -40.13 2.5 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.324 -0.86 . . . . 0.0 110.13 179.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.433 ' HB2' ' O ' ' B' ' 9' ' ' ALA . 1.0 OUTLIER -70.76 -30.04 66.43 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 177.22 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 1.149 HG22 ' CD1' ' B' ' 16' ' ' LEU 0.271 0.2 OUTLIER -101.62 -75.59 0.59 Allowed 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.286 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.91 14.37 51.93 Favored Glycine 0 N--CA 1.499 2.868 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 177.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' LEU . . . . . 1.149 ' CD1' HG22 ' B' ' 14' ' ' THR . 4.7 mp -53.02 -64.99 0.64 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.557 -0.966 . . . . 0.0 110.005 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . 0.589 ' CG2' HG21 ' A' ' 17' ' ' THR . 0.5 OUTLIER -141.92 9.47 1.94 Allowed 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.696 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . 0.638 ' O ' ' C ' ' B' ' 19' ' ' VAL . 14.6 mt-30 57.95 27.48 14.79 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -175.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 1.062 HG11 HG11 ' A' ' 19' ' ' VAL . 1.2 p -2.13 -96.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.988 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.971 ' O ' ' N ' ' B' ' 22' ' ' SER . 0.8 OUTLIER -134.09 23.74 3.86 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 177.496 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 1.042 ' HB ' HG23 ' B' ' 7' ' ' ILE . 28.6 m -9.93 -40.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 CA-C-O 122.415 1.102 . . . . 0.0 110.857 -178.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.971 ' N ' ' O ' ' B' ' 20' ' ' SER . 7.1 m -77.92 -39.68 42.1 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.264 178.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . 0.91 ' N ' ' O ' ' B' ' 20' ' ' SER . 1.3 mtmt -89.47 -25.71 21.32 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.478 -0.764 . . . . 0.0 111.113 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' MET . . . . . 0.67 ' SD ' ' HA ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -74.79 -40.59 61.05 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 117.529 -1.668 . . . . 0.0 108.795 179.225 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.781 HD12 HG13 ' B' ' 7' ' ' ILE . 0.5 OUTLIER -74.15 -40.47 62.58 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 117.708 -1.597 . . . . 0.0 107.291 176.804 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . 0.515 ' HA ' ' HE2' ' B' ' 3' ' ' LYS . . . -60.15 -33.38 72.09 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 177.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . 0.676 ' HA ' ' HB3' ' B' ' 30' ' ' LYS . 18.6 m -78.63 -34.1 46.81 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . 0.864 ' O ' HG13 ' B' ' 31' ' ' ILE . 0.3 OUTLIER -60.72 -49.17 78.6 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.768 -0.582 . . . . 0.0 109.689 179.413 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . 0.829 ' HG2' HG22 ' A' ' 45' ' ' THR . 0.6 OUTLIER -71.89 -33.49 68.38 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 178.043 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 0.92 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 10.8 ttpp -68.59 -21.02 64.53 Favored 'General case' 0 C--O 1.189 -2.085 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 176.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.864 HG13 ' O ' ' B' ' 28' ' ' PHE . 1.2 pp -105.15 -28.8 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 120.557 -1.339 . . . . 0.0 109.198 178.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.645 HG21 ' HZ ' ' A' ' 47' ' ' PHE . 1.6 mm -69.64 -50.97 45.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 176.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' THR . . . . . 0.733 ' HB ' ' O ' ' B' ' 29' ' ' GLU . 0.3 OUTLIER -70.33 -40.21 74.29 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.46 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.92 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 39.4 mm-40 -73.91 -33.03 63.83 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.419 -0.801 . . . . 0.0 111.163 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' THR . . . . . 0.994 HG21 HG23 ' B' ' 42' ' ' VAL . 1.6 m -59.27 -48.75 80.45 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 120.53 -1.356 . . . . 0.0 107.531 178.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.863 ' CG1' ' HB2' ' A' ' 89' ' ' ALA . 1.2 t -56.12 -35.1 40.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 177.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 0.662 ' HB2' ' C ' ' A' ' 88' ' ' ALA . . . -77.59 -1.35 30.32 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.534 0.683 . . . . 0.0 109.216 176.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.427 ' H ' ' C ' ' B' ' 35' ' ' THR . 0.4 OUTLIER -115.68 -5.4 12.14 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.737 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.44 48.14 8.35 Favored Glycine 0 C--N 1.301 -1.378 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . 0.842 ' CB ' HG23 ' B' ' 35' ' ' THR . 0.1 OUTLIER -128.05 117.79 22.32 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.173 -1.192 . . . . 0.0 110.07 179.273 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 12.9 mtmt -70.51 80.82 0.57 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.492 -0.755 . . . . 0.0 109.954 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.994 HG23 HG21 ' B' ' 35' ' ' THR . 2.7 t -68.29 147.4 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.314 -0.866 . . . . 0.0 109.257 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' GLN . . . . . 0.446 ' O ' ' HA ' ' A' ' 2' ' ' ASN . 31.0 mt-30 -143.4 113.51 7.25 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.067 -1.021 . . . . 0.0 110.705 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.804 HD12 ' CB ' ' B' ' 48' ' ' LEU . 45.9 mt -73.98 120.11 19.11 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.271 -0.893 . . . . 0.0 109.939 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . 0.547 ' HB ' ' HD2' ' A' ' 3' ' ' LYS . 0.0 OUTLIER 31.68 -96.19 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.757 -0.589 . . . . 0.0 110.583 179.793 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.455 ' H ' HG23 ' B' ' 45' ' ' THR . . . -138.79 7.54 3.29 Favored Glycine 0 N--CA 1.482 1.732 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . 0.747 ' CE1' HG21 ' A' ' 32' ' ' ILE . 37.4 p90 -105.46 -54.99 2.39 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.588 -1.536 . . . . 0.0 111.76 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.804 ' CB ' HD12 ' B' ' 44' ' ' LEU . 0.2 OUTLIER -92.12 148.03 22.49 Favored 'General case' 0 C--N 1.292 -1.903 0 O-C-N 120.047 -1.658 . . . . 0.0 113.241 -178.849 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' ASN . . . . . 0.535 ' O ' ' HB ' ' B' ' 79' ' ' VAL . 1.4 m-20 -132.82 146.22 51.64 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 178.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' ILE . . . . . 0.917 ' HA ' HG21 ' B' ' 79' ' ' VAL . 26.8 mm -137.21 98.76 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 O-C-N 120.97 -1.081 . . . . 0.0 111.601 -178.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . 0.534 ' N ' ' CG1' ' B' ' 79' ' ' VAL . 2.5 pttt -145.56 126.29 7.34 Favored Pre-proline 0 N--CA 1.487 1.415 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.765 ' CD ' HG22 ' B' ' 36' ' ' VAL . 55.6 Cg_endo -88.08 151.21 6.96 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.239 1.126 . . . . 0.0 111.849 -178.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.566 HG11 ' HB2' ' B' ' 78' ' ' SER . 14.0 m -133.14 118.64 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-O 121.506 0.67 . . . . 0.0 109.838 178.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.881 ' HA ' ' HA ' ' B' ' 75' ' ' VAL . . . -67.06 147.78 52.73 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 122.694 1.235 . . . . 0.0 112.899 -177.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . 0.542 ' O ' ' HA ' ' B' ' 74' ' ' SER . 6.3 ttt180 -157.36 -138.84 0.06 Allowed 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . 0.734 ' HA ' ' CA ' ' B' ' 73' ' ' PRO . 1.4 mm-40 -142.4 -165.66 2.08 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 118.032 -1.467 . . . . 0.0 111.595 178.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.779 ' HB1' ' CG1' ' B' ' 71' ' ' ILE . . . -163.07 -154.2 0.28 Allowed 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.506 -0.746 . . . . 0.0 110.884 -177.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 58' ' ' ARG . . . . . 0.518 ' HG3' ' N ' ' B' ' 59' ' ' LYS . 0.1 OUTLIER -57.35 157.27 6.69 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.681 -0.637 . . . . 0.0 110.235 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . 0.518 ' N ' ' HG3' ' B' ' 58' ' ' ARG . 1.9 tpmt? -163.11 136.86 5.94 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.558 -0.714 . . . . 0.0 109.851 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' B' ' 69' ' ' LEU . . . -167.34 -131.16 1.24 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 61' ' ' PHE . . . . . 0.871 ' CE2' ' HB2' ' B' ' 66' ' ' GLN . 30.3 p90 -172.83 -174.85 1.17 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.238 -1.154 . . . . 0.0 111.344 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . 0.916 ' HB3' ' HB2' ' B' ' 68' ' ' ALA . 0.3 OUTLIER -150.68 -28.71 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.719 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 -179.696 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.88 ' HD2' ' H ' ' B' ' 62' ' ' ASN . 42.5 Cg_endo -71.47 -9.79 25.78 Favored 'Trans proline' 0 N--CA 1.486 1.067 0 CA-C-N 118.903 0.644 . . . . 0.0 111.0 -178.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . 0.566 ' CB ' ' CE2' ' B' ' 61' ' ' PHE . 0.0 OUTLIER -96.92 46.4 1.04 Allowed 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.228 -0.92 . . . . 0.0 109.115 178.704 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.477 HG23 ' C ' ' B' ' 64' ' ' GLN . 1.7 p 60.51 48.72 7.31 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 121.046 0.45 . . . . 0.0 110.706 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . 0.871 ' HB2' ' CE2' ' B' ' 61' ' ' PHE . 0.0 OUTLIER -146.56 -155.94 0.67 Allowed 'General case' 0 N--CA 1.484 1.243 0 O-C-N 121.235 -0.916 . . . . 0.0 110.411 -179.911 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . 0.56 ' O ' ' CD1' ' B' ' 69' ' ' LEU . 3.9 mm-40 -130.1 117.15 19.53 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 178.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . 0.916 ' HB2' ' HB3' ' B' ' 62' ' ' ASN . . . -57.28 132.3 52.61 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 122.022 0.915 . . . . 0.0 111.809 -177.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.56 ' CD1' ' O ' ' B' ' 67' ' ' GLU . 0.2 OUTLIER -134.38 117.71 16.63 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.796 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . 0.475 ' CA ' ' HG2' ' B' ' 58' ' ' ARG . 1.9 pt-20 -173.66 83.96 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.169 -0.957 . . . . 0.0 110.713 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.779 ' CG1' ' HB1' ' B' ' 57' ' ' ALA . 25.3 pt -64.0 -143.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.427 -0.796 . . . . 0.0 109.44 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . 0.541 ' O ' ' OH ' ' A' ' 94' ' ' TYR . . . -99.09 107.61 45.12 Favored Pre-proline 0 C--N 1.287 -2.12 0 C-N-CA 119.823 -0.751 . . . . 0.0 112.902 -177.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 73' ' ' PRO . . . . . 0.734 ' CA ' ' HA ' ' B' ' 56' ' ' GLN . 55.7 Cg_endo -101.56 88.45 0.04 OUTLIER 'Trans proline' 0 CA--C 1.556 1.597 0 C-N-CA 122.434 2.089 . . . . 0.0 113.549 178.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . 0.923 ' HB2' ' HB2' ' A' ' 98' ' ' ALA . 0.4 OUTLIER 162.85 33.65 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.15 0 O-C-N 120.138 -1.601 . . . . 0.0 114.828 177.397 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . 1.045 HG21 ' HB1' ' A' ' 89' ' ' ALA . 0.3 OUTLIER 176.02 142.84 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.519 2.989 0 O-C-N 120.302 -1.499 . . . . 0.0 111.248 176.275 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' B' ' 53' ' ' VAL . . . -140.64 -144.9 4.53 Favored Glycine 0 N--CA 1.483 1.772 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.467 HG23 ' HD2' ' A' ' 86' ' ' LYS . 7.6 t -140.9 85.64 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . 0.566 ' HB2' HG11 ' B' ' 53' ' ' VAL . 0.3 OUTLIER -57.93 -50.58 72.88 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.53 0.681 . . . . 0.0 111.279 -179.139 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.917 HG21 ' HA ' ' B' ' 50' ' ' ILE . 17.7 m -51.54 -176.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -176.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . 0.739 ' HB2' ' HD2' ' B' ' 81' ' ' PRO . 0.0 OUTLIER 178.87 177.26 0.3 Allowed Pre-proline 0 N--CA 1.484 1.251 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.033 -178.727 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 81' ' ' PRO . . . . . 0.739 ' HD2' ' HB2' ' B' ' 80' ' ' LYS . 45.1 Cg_endo -72.54 137.61 28.12 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 123.508 1.268 . . . . 0.0 110.926 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . 0.576 ' N ' ' O ' ' B' ' 47' ' ' PHE . . . -94.92 -154.6 31.02 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . 0.51 ' HA ' ' HB2' ' B' ' 86' ' ' LYS . 16.4 pt-20 -88.05 -16.73 32.81 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.369 -1.077 . . . . 0.0 110.739 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 84' ' ' SER . . . . . 0.475 ' HB2' ' HB3' ' B' ' 47' ' ' PHE . 3.4 m -53.6 -37.14 62.72 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.067 -1.021 . . . . 0.0 109.51 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.84 HD13 HG21 ' A' ' 77' ' ' VAL . 0.5 OUTLIER -81.67 -33.26 31.37 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.717 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . 0.51 ' HB2' ' HA ' ' B' ' 83' ' ' GLU . 7.5 mttt -74.43 -27.46 60.62 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.382 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 1.3 ttmm -74.7 -39.16 62.11 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 177.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.686 ' HB1' ' HB2' ' A' ' 37' ' ' ALA . . . -64.8 -35.19 80.3 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 176.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.953 ' HA ' HD23 ' B' ' 92' ' ' LEU . . . -54.48 -45.43 73.21 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.454 -0.898 . . . . 0.0 109.19 178.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.9 -31.85 51.36 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 177.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' B' ' 88' ' ' ALA . . . -63.38 -38.65 96.73 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 178.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . 0.953 HD23 ' HA ' ' B' ' 89' ' ' ALA . 0.7 OUTLIER -75.46 15.17 0.49 Allowed 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.523 -1.575 . . . . 0.0 110.957 -179.823 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' B' ' 92' ' ' LEU . 22.3 mmtm 57.82 44.57 19.97 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 -177.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . 0.895 ' OH ' ' HB1' ' A' ' 72' ' ' ALA . 0.1 OUTLIER -36.91 -36.37 0.12 Allowed 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.314 -178.829 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . 0.519 ' N ' ' CD1' ' B' ' 94' ' ' TYR . 8.8 pt-20 -57.25 -43.52 83.05 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.327 -0.858 . . . . 0.0 109.42 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 96' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' B' ' 93' ' ' LYS . 0.9 OUTLIER -61.81 -31.58 71.83 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 177.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -80.74 -24.87 38.42 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.78 -30.52 69.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.577 -0.702 . . . . 0.0 110.037 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.378 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.672 ' SD ' HG21 ' B' ' 35' ' ' THR . 3.5 ptm . . . . . 0 N--CA 1.496 1.857 0 CA-C-O 121.282 0.563 . . . . 0.0 110.732 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.568 ' C ' HD12 ' A' ' 6' ' ' LEU . 16.7 p-10 -177.17 -153.99 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 119.727 -0.789 . . . . 0.0 111.248 178.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.56 ' HE2' ' HA ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -52.41 -7.98 0.07 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.401 -0.812 . . . . 0.0 111.143 -179.812 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.606 ' O ' HG13 ' A' ' 7' ' ' ILE . 87.4 m -114.54 -64.26 1.34 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.17 -0.956 . . . . 0.0 109.903 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.577 ' HA ' ' CE ' ' A' ' 8' ' ' LYS . 0.4 OUTLIER -49.11 -41.01 34.43 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.915 -1.115 . . . . 0.0 109.096 179.577 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.649 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 28.2 mt -61.52 -35.05 76.62 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.335 -0.946 . . . . 0.0 109.621 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.652 ' N ' HD12 ' A' ' 25' ' ' LEU . 1.1 pp -57.2 -38.74 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 178.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.834 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 1.3 mtmp? -65.79 -40.11 91.6 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 177.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.857 ' CB ' HD13 ' B' ' 31' ' ' ILE . . . -51.61 -37.34 49.59 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.768 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.3 mp -91.98 -30.85 4.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 178.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.834 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -66.25 -9.57 33.72 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 118.575 -1.25 . . . . 0.0 108.497 178.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.435 ' CG ' ' N ' ' A' ' 13' ' ' ASP . 17.2 pt20 -119.59 -42.22 2.65 Favored 'General case' 0 N--CA 1.483 1.185 0 O-C-N 121.413 -0.805 . . . . 0.0 110.41 179.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 9' ' ' ALA . 6.6 m-20 -69.53 -33.73 73.21 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 177.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 1.15 HG22 ' CD1' ' A' ' 16' ' ' LEU 0.273 0.2 OUTLIER -95.14 -71.41 0.67 Allowed 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.479 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 57.37 18.52 29.54 Favored Glycine 0 N--CA 1.5 2.91 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 177.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.15 ' CD1' HG22 ' A' ' 14' ' ' THR . 4.4 mp -63.82 -68.17 0.37 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.425 -1.044 . . . . 0.0 109.815 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.637 ' CG2' HG21 ' B' ' 17' ' ' THR . 0.6 OUTLIER -135.07 7.48 3.42 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.592 ' O ' ' C ' ' A' ' 19' ' ' VAL . 15.0 mt-30 57.88 26.92 13.89 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 -176.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 1.125 HG23 ' CD1' ' B' ' 16' ' ' LEU . 0.3 OUTLIER -5.92 -97.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.184 -179.128 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.98 ' O ' ' N ' ' A' ' 23' ' ' LYS . 1.7 p -135.63 25.01 3.42 Favored 'General case' 0 C--N 1.275 -2.653 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 178.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.571 ' C ' ' O ' ' A' ' 20' ' ' SER . 27.4 m -19.15 -38.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 CA-C-O 122.284 1.04 . . . . 0.0 110.435 -178.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.803 ' N ' ' O ' ' A' ' 20' ' ' SER . 25.4 p -79.3 -36.26 39.92 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.16 178.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.98 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.2 OUTLIER -91.82 -32.65 15.27 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.779 -0.576 . . . . 0.0 111.642 179.811 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.635 ' N ' ' OG ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -72.8 -30.31 63.97 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 117.764 -1.574 . . . . 0.0 108.061 179.385 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.652 HD12 ' N ' ' A' ' 7' ' ' ILE . 2.2 mt -82.01 -37.58 26.36 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 118.741 -1.184 . . . . 0.0 107.895 177.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.56 ' HA ' ' HE2' ' A' ' 3' ' ' LYS . . . -67.6 -34.04 76.21 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 177.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 31' ' ' ILE . 61.1 p -82.56 -30.51 29.62 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.66 ' O ' HG13 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -52.48 -45.61 66.22 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.335 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.747 ' HG3' ' CD1' ' B' ' 47' ' ' PHE . 0.5 OUTLIER -69.62 -36.58 76.27 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 176.856 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 1.116 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 13.1 tttt -62.26 -23.42 66.68 Favored 'General case' 0 C--O 1.19 -2.058 0 C-N-CA 119.275 -0.97 . . . . 0.0 108.434 178.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.939 HD13 ' HB1' ' B' ' 9' ' ' ALA . 0.5 OUTLIER -103.61 -28.39 3.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 120.589 -1.319 . . . . 0.0 109.202 178.141 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.636 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.2 mm -72.56 -56.15 10.79 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 177.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.894 ' HA ' HD23 ' B' ' 85' ' ' LEU . 0.4 OUTLIER -69.67 -36.45 76.03 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.4 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 1.116 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 44.5 mm-40 -74.31 -35.46 63.68 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.084 -1.01 . . . . 0.0 110.696 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.652 HG23 ' CB ' ' A' ' 40' ' ' ASP . 2.2 m -58.58 -51.51 69.57 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.63 -1.294 . . . . 0.0 108.248 178.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.681 HG22 ' HD3' ' A' ' 52' ' ' PRO . 0.9 OUTLIER -54.11 -35.71 29.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 177.792 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.73 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -82.23 -4.2 56.63 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.629 0.728 . . . . 0.0 109.416 178.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -101.07 -26.39 13.71 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.087 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.84 39.23 1.6 Allowed Glycine 0 C--N 1.301 -1.4 0 C-N-CA 120.092 -1.052 . . . . 0.0 110.906 177.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.652 ' CB ' HG23 ' A' ' 35' ' ' THR . 0.1 OUTLIER -132.47 134.23 44.8 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.067 -1.255 . . . . 0.0 110.274 179.384 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.87 92.24 6.09 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.584 -0.697 . . . . 0.0 109.887 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.532 HG13 HD11 ' B' ' 6' ' ' LEU . 58.2 t -59.29 132.97 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.589 -0.694 . . . . 0.0 109.868 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -129.7 89.21 2.79 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.335 -0.853 . . . . 0.0 110.178 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.773 HD12 ' HB3' ' A' ' 48' ' ' LEU . 10.7 mt -59.92 107.6 0.64 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.295 -0.878 . . . . 0.0 109.516 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.457 ' CG2' ' C ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER 34.11 -90.67 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.308 0 O-C-N 122.0 -0.438 . . . . 0.0 110.953 -179.457 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -151.01 28.32 1.01 Allowed Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.997 ' CE1' HG21 ' B' ' 32' ' ' ILE . 1.6 p90 -129.98 -26.3 2.42 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.17 -1.194 . . . . 0.0 111.922 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.773 ' HB3' HD12 ' A' ' 44' ' ' LEU . 4.6 mt -128.95 96.02 4.24 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.568 -1.332 . . . . 0.0 110.867 178.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -102.05 86.35 2.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.66 -0.65 . . . . 0.0 110.576 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.567 HD13 HG23 ' A' ' 79' ' ' VAL . 6.9 mm -73.22 131.9 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.409 ' HG3' ' CB ' ' A' ' 78' ' ' SER . 1.7 ptmt -145.52 113.99 4.76 Favored Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 120.613 -1.304 . . . . 0.0 111.129 -179.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.681 ' HD3' HG22 ' A' ' 36' ' ' VAL . 54.7 Cg_endo -78.48 143.81 19.63 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 O-C-N 123.638 1.336 . . . . 0.0 111.135 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.655 HG22 ' O ' ' A' ' 76' ' ' GLY . 24.2 m -142.33 116.86 4.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-O 121.582 0.706 . . . . 0.0 110.395 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.519 ' HB1' ' HB2' ' B' ' 98' ' ' ALA . . . -37.31 124.28 0.97 Allowed 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 121.917 0.865 . . . . 0.0 112.404 -178.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.569 ' O ' ' O ' ' A' ' 74' ' ' SER . 5.7 ttt85 -170.06 123.01 0.7 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.453 ' HB2' HD12 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -61.17 -140.07 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.968 -1.082 . . . . 0.0 110.811 -178.65 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.969 ' CB ' ' HB3' ' A' ' 72' ' ' ALA . . . -167.1 132.25 2.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.693 -1.254 . . . . 0.0 110.615 -177.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.856 ' HB2' ' C ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -170.52 164.42 8.48 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 120.666 -1.272 . . . . 0.0 109.964 179.51 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -169.62 19.83 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.308 -0.957 . . . . 0.0 111.952 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.604 ' HA3' HD13 ' A' ' 69' ' ' LEU . . . -173.28 -133.67 1.71 Allowed Glycine 0 N--CA 1.49 2.262 0 C-N-CA 118.667 -1.73 . . . . 0.0 111.586 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.805 ' CE2' ' HB2' ' A' ' 66' ' ' GLN . 50.4 p90 177.61 -163.52 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.924 -0.75 . . . . 0.0 110.153 -178.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.911 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 1.6 p30 -158.33 -16.07 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.588 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 178.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.892 ' CD ' ' H ' ' A' ' 62' ' ' ASN . 40.5 Cg_endo -69.02 -13.85 37.33 Favored 'Trans proline' 0 N--CA 1.483 0.867 0 N-CA-C 108.778 -1.278 . . . . 0.0 108.778 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.59 ' CB ' ' CE2' ' A' ' 61' ' ' PHE . 0.2 OUTLIER -102.02 39.73 1.43 Allowed 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.388 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' A' ' 64' ' ' GLN . 3.1 p 59.23 62.92 1.7 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.858 -0.526 . . . . 0.0 110.641 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.805 ' HB2' ' CE2' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -157.21 119.47 3.86 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.227 -0.92 . . . . 0.0 111.001 -179.689 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.718 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 0.4 OUTLIER -45.38 97.37 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.947 -1.096 . . . . 0.0 109.264 178.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.911 ' HB2' ' HB3' ' A' ' 62' ' ' ASN . . . -41.23 134.19 2.2 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 122.695 1.236 . . . . 0.0 113.201 -177.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.723 ' N ' HD12 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -142.62 51.31 1.44 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 179.5 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.856 ' C ' ' HB2' ' A' ' 58' ' ' ARG . 2.0 mp0 -105.56 -138.49 0.36 Allowed 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 120.144 -0.623 . . . . 0.0 112.287 -176.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.822 ' N ' ' HB2' ' A' ' 58' ' ' ARG . 3.0 tp -26.52 145.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 123.51 1.624 . . . . 0.0 114.287 -176.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.969 ' HB3' ' CB ' ' A' ' 57' ' ' ALA . . . -171.83 152.27 2.99 Favored Pre-proline 0 C--N 1.286 -2.163 0 CA-C-N 113.049 -1.887 . . . . 0.0 108.415 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 72' ' ' ALA . 55.1 Cg_endo -91.47 121.01 0.63 Allowed 'Trans proline' 0 C--N 1.291 -2.455 0 C-N-CA 121.712 1.608 . . . . 0.0 111.388 -178.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.569 ' O ' ' O ' ' A' ' 55' ' ' ARG . 26.3 p -176.89 109.13 0.08 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.02 -1.05 . . . . 0.0 110.3 179.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.634 ' HB ' ' HB2' ' B' ' 94' ' ' TYR . 0.3 OUTLIER -48.66 172.48 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.052 -1.03 . . . . 0.0 110.059 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.655 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -101.85 77.83 0.36 Allowed Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.889 HG21 ' CB ' ' B' ' 85' ' ' LEU . 4.4 p -59.54 74.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.576 -0.955 . . . . 0.0 110.3 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.565 ' N ' ' O ' ' A' ' 76' ' ' GLY . 0.6 OUTLIER -67.68 177.34 2.07 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.524 -0.87 . . . . 0.0 109.824 179.585 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.567 HG23 HD13 ' A' ' 50' ' ' ILE . 0.8 OUTLIER 176.62 175.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -179.82 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.689 ' O ' HD23 ' A' ' 48' ' ' LEU . 2.3 ptpt -177.18 172.23 0.83 Allowed Pre-proline 0 N--CA 1.486 1.362 0 O-C-N 121.161 -0.962 . . . . 0.0 110.176 177.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.501 ' HB2' HG13 ' B' ' 77' ' ' VAL . 55.2 Cg_endo -98.77 133.38 0.25 Allowed 'Trans proline' 0 C--N 1.302 -1.901 0 C-N-CA 122.542 2.161 . . . . 0.0 110.489 178.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.546 ' HA3' ' HA ' ' A' ' 47' ' ' PHE . . . -92.09 177.78 40.0 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 108.382 -1.887 . . . . 0.0 108.382 178.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.415 ' HA ' ' HB2' ' A' ' 86' ' ' LYS . 0.1 OUTLIER -67.89 -18.25 64.73 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.115 -1.226 . . . . 0.0 110.676 -179.788 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.46 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -51.92 -39.89 59.87 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.119 -0.988 . . . . 0.0 109.401 179.8 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.902 HD21 ' CD1' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -75.66 -34.32 60.48 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.744 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.632 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 0.8 OUTLIER -72.94 -43.82 61.9 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.961 -179.257 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -61.46 -40.82 95.89 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 178.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.779 ' O ' ' HB1' ' B' ' 37' ' ' ALA . . . -66.68 -36.24 82.05 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 176.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 1.061 ' CB ' HG11 ' B' ' 75' ' ' VAL . . . -58.56 -34.36 70.96 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.406 ' HB2' ' CG ' ' B' ' 59' ' ' LYS . 0.4 OUTLIER -55.98 -34.54 65.84 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 176.252 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.423 ' C ' ' H ' ' A' ' 93' ' ' LYS . . . -61.54 -44.54 97.85 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 178.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.824 ' O ' HD12 ' A' ' 92' ' ' LEU . 0.6 OUTLIER -58.07 -2.59 0.18 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.707 -1.467 . . . . 0.0 111.212 179.699 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.512 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 6.7 mmmt 68.1 58.97 0.45 Allowed 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -177.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.714 ' CD1' ' C ' ' B' ' 74' ' ' SER . 23.5 t80 -37.41 -33.97 0.08 Allowed 'General case' 0 N--CA 1.494 1.775 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.21 -179.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.68 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 6.1 mt-10 -60.77 -48.0 83.76 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.155 -0.966 . . . . 0.0 109.083 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.82 -40.82 76.71 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.799 ' HB3' ' HB2' ' B' ' 54' ' ' ALA . 0.1 OUTLIER -69.87 -27.83 65.15 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.192 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.68 ' HB3' ' O ' ' A' ' 95' ' ' GLU . . . -62.3 -46.73 87.45 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.407 0.622 . . . . 0.0 110.155 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.1 mtmt . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.222 -179.888 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.633 ' HG2' ' HB3' ' B' ' 5' ' ' GLU . 24.2 mtp . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . 0.554 ' O ' ' HB2' ' B' ' 6' ' ' LEU . 19.5 p-10 -175.4 -162.63 0.11 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.167 -0.958 . . . . 0.0 111.299 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.515 ' O ' ' CG2' ' B' ' 7' ' ' ILE . 0.0 OUTLIER -57.1 -3.52 0.14 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.423 -0.798 . . . . 0.0 110.885 -179.888 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.678 ' O ' HG13 ' B' ' 7' ' ' ILE . 96.8 m -117.93 -60.71 1.77 Allowed 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 122.167 0.984 . . . . 0.0 109.101 179.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.633 ' HB3' ' HG2' ' B' ' 1' ' ' MET . 0.4 OUTLIER -52.04 -44.74 64.37 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.098 -1.001 . . . . 0.0 109.013 179.27 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.661 ' O ' ' HB3' ' B' ' 9' ' ' ALA . 1.9 mt -61.18 -32.1 71.84 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.191 -1.004 . . . . 0.0 109.966 178.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' ILE . . . . . 0.74 HG22 HD12 ' B' ' 25' ' ' LEU . 0.9 OUTLIER -57.7 -40.79 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 179.1 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . 0.852 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 1.0 OUTLIER -64.87 -37.79 88.81 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 177.484 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . 0.939 ' HB1' HD13 ' A' ' 31' ' ' ILE . . . -52.33 -38.3 58.22 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 120.15 -0.62 . . . . 0.0 109.618 179.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.736 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.3 mp -93.73 -29.19 4.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 178.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.852 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -66.8 -16.25 64.14 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.815 -1.178 . . . . 0.0 108.329 178.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.431 ' CG ' ' N ' ' B' ' 13' ' ' ASP . 17.7 pt20 -108.62 -41.91 4.67 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.515 -0.741 . . . . 0.0 109.098 178.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.431 ' N ' ' CG ' ' B' ' 12' ' ' GLN . 1.1 m-20 -68.78 -22.55 64.27 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 176.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.736 ' OG1' ' O ' ' B' ' 10' ' ' ILE . 0.2 OUTLIER -120.32 -83.14 0.65 Allowed 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.363 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . 0.511 ' O ' ' C ' ' B' ' 16' ' ' LEU . . . 69.36 -21.01 0.42 Allowed Glycine 0 N--CA 1.498 2.779 0 O-C-N 120.924 -1.11 . . . . 0.0 110.65 178.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' LEU . . . . . 1.125 ' CD1' HG23 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -29.21 -59.45 0.14 Allowed 'General case' 0 N--CA 1.517 2.876 0 CA-C-O 122.008 0.908 . . . . 0.0 110.712 -179.608 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . 0.662 HG22 ' H ' ' B' ' 19' ' ' VAL . 0.5 OUTLIER -132.7 -2.75 3.32 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -179.927 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . 0.618 ' O ' ' C ' ' B' ' 19' ' ' VAL . 8.2 mt-30 56.56 30.97 18.21 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -176.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 1.109 HG11 HG11 ' A' ' 19' ' ' VAL . 2.0 p -8.74 -97.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.802 -179.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.92 ' O ' ' N ' ' B' ' 23' ' ' LYS . 0.4 OUTLIER -132.94 22.08 4.17 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 177.449 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.669 HG12 HG22 ' B' ' 10' ' ' ILE . 27.9 m -18.51 -38.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-O 122.401 1.096 . . . . 0.0 109.255 -178.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.91 ' N ' ' O ' ' B' ' 20' ' ' SER . 26.5 t -79.16 -44.92 20.98 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.19 177.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . 0.92 ' N ' ' O ' ' B' ' 20' ' ' SER . 5.9 mtmt -89.69 -21.56 22.68 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.431 -0.793 . . . . 0.0 109.889 178.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' MET . . . . . 0.621 ' HE2' ' HA ' ' B' ' 21' ' ' VAL 0.263 2.2 tmm? -68.89 -38.93 79.95 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 178.653 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.74 HD12 HG22 ' B' ' 7' ' ' ILE . 8.3 mt -73.97 -41.38 62.03 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 176.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . 0.553 ' HB3' ' HA ' ' B' ' 23' ' ' LYS . . . -58.03 -34.51 70.13 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 177.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . 0.485 ' O ' ' HB3' ' B' ' 30' ' ' LYS . 6.2 m -79.59 -33.49 41.58 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . 0.673 ' O ' HG13 ' B' ' 31' ' ' ILE . 2.8 t80 -60.74 -57.46 12.58 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 178.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . 0.744 ' HG3' ' CD2' ' A' ' 47' ' ' PHE . 2.3 tt0 -58.04 -31.85 67.41 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 118.216 -1.394 . . . . 0.0 107.637 177.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 1.174 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 24.1 ttmm -67.42 -26.79 66.6 Favored 'General case' 0 C--O 1.191 -1.988 0 C-N-CA 119.344 -0.942 . . . . 0.0 108.487 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.857 HD13 ' CB ' ' A' ' 9' ' ' ALA . 0.3 OUTLIER -98.57 -30.21 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 120.344 -1.473 . . . . 0.0 109.598 178.169 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.997 HG21 ' CE1' ' A' ' 47' ' ' PHE . 1.8 mp -67.85 -66.37 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' THR . . . . . 0.895 ' HA ' HD23 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -60.78 -37.64 82.6 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.254 -179.082 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 1.174 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 62.3 mm-40 -73.13 -40.07 65.2 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 119.366 -0.934 . . . . 0.0 111.048 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' THR . . . . . 0.672 HG21 ' SD ' ' A' ' 1' ' ' MET . 23.6 m -61.7 -49.46 76.4 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 118.316 -1.354 . . . . 0.0 109.423 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.803 HG21 HG23 ' B' ' 77' ' ' VAL . 0.6 OUTLIER -50.82 -43.26 24.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 C-N-CA 118.918 -1.113 . . . . 0.0 108.027 179.195 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 0.779 ' HB1' ' O ' ' A' ' 88' ' ' ALA . . . -88.22 -4.01 58.78 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.69 0.757 . . . . 0.0 109.773 178.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.712 ' HB2' ' O ' ' B' ' 34' ' ' GLU . 0.0 OUTLIER -88.56 -26.16 22.13 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 176.958 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 117.14 39.69 0.79 Allowed Glycine 0 C--N 1.302 -1.323 0 C-N-CA 120.194 -1.003 . . . . 0.0 110.968 177.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . 0.636 ' HB2' HG23 ' B' ' 35' ' ' THR . 0.3 OUTLIER -145.44 161.27 40.11 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.902 -1.351 . . . . 0.0 110.718 179.475 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.409 ' HG3' ' HD2' ' B' ' 52' ' ' PRO . 3.5 mppt? -107.04 96.76 6.66 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.561 -0.712 . . . . 0.0 110.045 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.607 HG13 HD11 ' A' ' 6' ' ' LEU . 91.4 t -60.22 120.0 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.498 -0.751 . . . . 0.0 109.813 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' GLN . . . . . 0.421 ' O ' ' HA ' ' A' ' 2' ' ' ASN . 0.7 OUTLIER -108.96 103.02 11.98 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.277 -0.889 . . . . 0.0 110.117 -179.431 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.741 HD12 ' CB ' ' B' ' 48' ' ' LEU . 12.6 mt -75.75 100.26 4.65 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.001 -1.062 . . . . 0.0 109.286 179.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . 0.552 HG21 ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 35.07 -93.88 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.913 -0.492 . . . . 0.0 111.224 -179.61 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -147.65 28.47 1.46 Allowed Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.715 -1.231 . . . . 0.0 110.17 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . 0.747 ' CD1' ' HG3' ' A' ' 29' ' ' GLU . 4.2 p90 -129.2 -23.58 2.97 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.969 -1.313 . . . . 0.0 111.594 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.917 HD23 ' O ' ' B' ' 80' ' ' LYS . 7.7 mt -128.73 106.03 8.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.482 -1.386 . . . . 0.0 110.711 178.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' ASN . . . . . 0.534 ' O ' ' HA ' ' B' ' 79' ' ' VAL . 0.6 OUTLIER -101.21 86.56 3.04 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.725 -0.609 . . . . 0.0 110.56 -179.385 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' ILE . . . . . 0.861 HG23 HG12 ' B' ' 79' ' ' VAL . 12.3 mm -84.33 128.43 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.383 -0.823 . . . . 0.0 109.836 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . 0.418 ' O ' ' HG3' ' B' ' 51' ' ' LYS . 0.0 OUTLIER -152.25 123.98 3.81 Favored Pre-proline 0 N--CA 1.501 2.078 0 O-C-N 120.87 -1.144 . . . . 0.0 110.972 -179.878 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.62 ' HG3' ' HA ' ' B' ' 36' ' ' VAL . 57.1 Cg_endo -84.93 141.8 8.58 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 123.406 1.214 . . . . 0.0 111.454 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.622 HG22 ' O ' ' B' ' 76' ' ' GLY . 30.0 m -143.79 112.31 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-O 121.9 0.857 . . . . 0.0 110.673 178.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.81 ' HA ' ' HA ' ' B' ' 75' ' ' VAL . . . -54.37 118.15 3.88 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.727 -0.608 . . . . 0.0 110.952 -179.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . 0.495 ' O ' ' HG2' ' B' ' 56' ' ' GLN . 0.0 OUTLIER -174.88 40.95 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 118.585 -1.246 . . . . 0.0 110.372 179.568 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . 1.024 ' HB3' ' HG2' ' B' ' 73' ' ' PRO . 10.0 mt-30 -140.19 -157.35 0.76 Allowed 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.285 -0.966 . . . . 0.0 111.458 -179.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.71 ' CB ' ' HB3' ' B' ' 72' ' ' ALA . . . -69.84 -178.53 1.56 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.893 0.854 . . . . 0.0 111.866 -178.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 58' ' ' ARG . . . . . 0.679 ' HB2' HG21 ' B' ' 71' ' ' ILE . 9.9 mpt_? -73.01 -168.95 0.53 Allowed 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 122.139 0.971 . . . . 0.0 111.775 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . 0.406 ' CG ' ' HB2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -140.26 25.02 2.28 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.126 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . 0.6 ' HA2' ' N ' ' B' ' 69' ' ' LEU . . . 169.98 74.0 0.04 OUTLIER Glycine 0 N--CA 1.488 2.11 0 C-N-CA 119.476 -1.345 . . . . 0.0 111.651 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 61' ' ' PHE . . . . . 0.889 ' CE1' ' HB2' ' B' ' 66' ' ' GLN . 1.1 p90 -152.33 142.08 21.94 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-N 119.493 1.646 . . . . 0.0 113.015 178.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . 0.905 ' H ' ' HD2' ' B' ' 63' ' ' PRO . 0.0 OUTLIER -120.48 -50.4 0.04 OUTLIER Pre-proline 0 N--CA 1.507 2.404 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -178.013 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.905 ' HD2' ' H ' ' B' ' 62' ' ' ASN . 35.7 Cg_endo -59.07 -10.01 9.25 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 O-C-N 123.043 1.023 . . . . 0.0 112.049 -176.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . 0.713 ' HB3' ' CE1' ' B' ' 61' ' ' PHE . 1.8 mt-30 -95.45 37.66 1.18 Allowed 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.163 -0.961 . . . . 0.0 108.568 177.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.613 HG23 ' C ' ' B' ' 64' ' ' GLN . 1.9 p 68.97 42.45 1.29 Allowed 'General case' 0 N--CA 1.504 2.232 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.332 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . 0.889 ' HB2' ' CE1' ' B' ' 61' ' ' PHE . 0.0 OUTLIER -155.61 -142.9 0.11 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.038 -1.038 . . . . 0.0 110.723 179.696 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . 0.522 ' C ' ' O ' ' B' ' 61' ' ' PHE . 6.5 mt-10 -129.0 116.56 19.52 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.028 -1.045 . . . . 0.0 109.246 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . 0.842 ' HB2' ' HB3' ' B' ' 62' ' ' ASN . . . -64.59 84.82 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.697 -0.627 . . . . 0.0 110.182 -179.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.849 ' O ' ' HB2' ' B' ' 70' ' ' GLU . 0.3 OUTLIER 171.72 15.08 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 179.853 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . 0.849 ' HB2' ' O ' ' B' ' 69' ' ' LEU . 2.4 mt-10 137.56 44.94 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.41 0 CA-C-N 122.004 2.184 . . . . 0.0 112.079 178.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.838 ' O ' ' O ' ' B' ' 72' ' ' ALA . 0.0 OUTLIER -53.28 176.89 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 120.432 -1.417 . . . . 0.0 110.855 179.187 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . 1.034 ' HB1' ' CD ' ' B' ' 73' ' ' PRO 0.254 . . -18.13 -139.56 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.954 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 73' ' ' PRO . . . . . 1.034 ' CD ' ' HB1' ' B' ' 72' ' ' ALA . 31.3 Cg_endo -68.88 -154.15 0.03 OUTLIER 'Trans proline' 0 C--N 1.325 -0.701 0 O-C-N 122.323 0.644 . . . . 0.0 113.618 -178.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . 0.775 ' O ' ' HB ' ' B' ' 75' ' ' VAL . 0.4 OUTLIER 155.43 60.29 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 -176.341 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . 1.061 HG11 ' CB ' ' A' ' 89' ' ' ALA . 12.2 p 139.74 162.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.468 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -179.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . 0.622 ' O ' HG22 ' B' ' 53' ' ' VAL . . . -125.9 73.62 0.43 Allowed Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.24 -1.457 . . . . 0.0 109.792 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.893 HG21 ' CB ' ' A' ' 85' ' ' LEU . 3.7 p -61.69 72.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.544 -0.974 . . . . 0.0 109.326 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . 0.84 ' O ' HG13 ' B' ' 79' ' ' VAL . 0.1 OUTLIER -64.3 176.26 1.1 Allowed 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.454 -0.898 . . . . 0.0 109.986 -179.709 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.861 HG12 HG23 ' B' ' 50' ' ' ILE . 16.9 m -172.37 179.0 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . 0.917 ' O ' HD23 ' B' ' 48' ' ' LEU . 0.1 OUTLIER 179.3 170.58 0.55 Allowed Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 120.833 -1.167 . . . . 0.0 111.12 176.8 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 81' ' ' PRO . . . . . 0.617 ' HB2' HG13 ' A' ' 77' ' ' VAL . 56.2 Cg_endo -102.27 133.37 0.13 Allowed 'Trans proline' 0 C--N 1.303 -1.832 0 C-N-CA 123.076 2.517 . . . . 0.0 110.252 177.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . 0.514 ' HA3' ' HA ' ' B' ' 47' ' ' PHE . . . -96.96 171.09 26.84 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 107.955 -2.058 . . . . 0.0 107.955 178.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . 0.515 ' HA ' ' HB2' ' B' ' 86' ' ' LYS . 3.5 pm0 -59.75 -19.15 48.41 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.99 -1.3 . . . . 0.0 110.674 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 84' ' ' SER . . . . . 0.498 ' CB ' ' HB3' ' B' ' 47' ' ' PHE . 0.4 OUTLIER -52.08 -38.03 55.9 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.101 -0.999 . . . . 0.0 109.552 179.6 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.894 HD23 ' HA ' ' A' ' 33' ' ' THR . 1.0 OUTLIER -78.46 -33.07 48.63 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.471 -0.768 . . . . 0.0 108.951 178.617 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . 0.615 ' O ' ' HB3' ' B' ' 89' ' ' ALA . 0.6 OUTLIER -73.71 -42.42 61.23 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.493 -179.274 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 7.3 tttp -64.5 -39.77 94.4 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 177.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.65 ' HB1' ' HB2' ' A' ' 37' ' ' ALA . . . -66.91 -34.48 77.87 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 176.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.997 ' HA ' HD23 ' B' ' 92' ' ' LEU . . . -57.18 -44.6 83.7 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.471 -0.768 . . . . 0.0 109.222 179.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.41 ' HG2' ' N ' ' B' ' 91' ' ' GLY . 1.4 pt-20 -53.88 -31.82 51.16 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 177.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . 0.41 ' N ' ' HG2' ' B' ' 90' ' ' GLU . . . -67.14 -33.8 84.3 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 178.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . 0.997 HD23 ' HA ' ' B' ' 89' ' ' ALA . 0.4 OUTLIER -77.51 13.07 1.34 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.648 -1.501 . . . . 0.0 111.438 -179.553 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' B' ' 92' ' ' LEU . 34.9 mmtt 58.53 39.53 24.8 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -177.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . 0.634 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -42.07 -33.58 0.6 Allowed 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.449 -179.14 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . 0.481 ' N ' ' CD1' ' B' ' 94' ' ' TYR . 2.5 pp20? -61.62 -39.92 93.0 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.383 -0.823 . . . . 0.0 109.467 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.66 -34.82 76.38 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 177.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 97' ' ' PHE . . . . . 0.459 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 0.1 OUTLIER -72.05 -26.33 62.14 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 178.307 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 98' ' ' ALA . . . . . 0.519 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -77.67 -76.79 0.17 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.584 -0.698 . . . . 0.0 110.325 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 33.4 mtmt . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.209 -179.913 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.555 ' HG2' ' HB3' ' A' ' 5' ' ' GLU . 2.7 mtp . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 120.892 0.377 . . . . 0.0 110.184 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.481 ' N ' HG23 ' B' ' 42' ' ' VAL . 39.2 p-10 179.56 -167.57 0.09 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.184 -0.947 . . . . 0.0 111.21 179.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.871 ' HG2' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -55.47 -11.68 0.91 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.568 -0.708 . . . . 0.0 110.326 179.794 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.713 ' O ' HG12 ' A' ' 7' ' ' ILE . 53.7 m -104.02 -55.25 2.4 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 122.113 0.959 . . . . 0.0 109.286 179.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.693 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 0.2 OUTLIER -57.13 -49.6 75.42 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.068 -1.02 . . . . 0.0 109.14 179.427 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.918 HD11 HG21 ' B' ' 42' ' ' VAL . 15.7 mt -49.93 -40.81 44.7 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 119.322 -0.951 . . . . 0.0 110.396 178.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.713 HG12 ' O ' ' A' ' 4' ' ' THR . 0.7 OUTLIER -57.47 -45.33 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.238 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.87 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 28.6 mtmt -56.36 -37.17 69.67 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 177.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.878 ' CB ' HD13 ' B' ' 31' ' ' ILE . . . -54.9 -37.56 66.49 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.736 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.5 mp -88.26 -33.81 6.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 178.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.87 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -65.85 -13.05 58.86 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 119.158 -1.017 . . . . 0.0 108.818 178.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -117.08 -39.65 3.2 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 121.449 -0.782 . . . . 0.0 109.652 178.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.45 ' HB3' ' HB2' ' B' ' 27' ' ' SER . 1.5 m-20 -66.97 -30.15 70.19 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 177.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.784 HG22 HD11 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -104.66 -75.31 0.63 Allowed 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 114.339 -1.3 . . . . 0.0 108.19 178.983 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 51.14 15.79 1.73 Allowed Glycine 0 N--CA 1.494 2.522 0 C-N-CA 120.306 -0.95 . . . . 0.0 110.883 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.073 ' CD1' HG23 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -73.06 -27.66 61.87 Favored 'General case' 0 N--CA 1.508 2.432 0 O-C-N 121.073 -1.251 . . . . 0.0 107.963 178.812 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.759 HG21 HG21 ' B' ' 17' ' ' THR . 0.4 OUTLIER -159.6 -12.39 0.06 Allowed 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.552 -179.861 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.706 ' O ' ' C ' ' A' ' 19' ' ' VAL . 21.1 mt-30 58.24 34.37 24.04 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 -177.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.924 ' CG2' HD13 ' B' ' 16' ' ' LEU . 0.2 OUTLIER 0.69 -94.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -178.875 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 1.106 ' O ' ' N ' ' A' ' 22' ' ' SER . 18.7 p -135.06 21.74 3.49 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 175.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.594 ' C ' ' O ' ' A' ' 20' ' ' SER . 33.9 m -4.44 -38.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 122.451 1.119 . . . . 0.0 111.061 -178.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 1.106 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.5 OUTLIER -75.24 -41.61 57.1 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-N 115.008 -0.997 . . . . 0.0 108.622 177.629 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.885 ' N ' ' O ' ' A' ' 20' ' ' SER . 2.5 mtpt -90.7 -30.8 16.88 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.549 -0.72 . . . . 0.0 109.502 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.581 ' HE2' ' HA ' ' A' ' 21' ' ' VAL . 2.0 tmm? -61.63 -29.73 70.25 Favored 'General case' 0 C--O 1.215 -0.717 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.871 HD13 ' HG2' ' A' ' 3' ' ' LYS . 1.2 pp -81.97 -44.39 16.78 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.642 ' N ' HD12 ' A' ' 25' ' ' LEU . . . -63.61 -23.73 67.5 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 178.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.507 ' O ' ' CG1' ' A' ' 31' ' ' ILE . 7.9 m -85.14 -40.98 16.11 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.687 ' CE1' HD22 ' B' ' 44' ' ' LEU . 0.0 OUTLIER -58.97 -45.52 90.36 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.853 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.6 ' HG3' ' CE2' ' B' ' 47' ' ' PHE . 0.8 OUTLIER -69.02 -37.37 78.6 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.046 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 1.256 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 20.2 tttt -62.37 -22.02 65.79 Favored 'General case' 0 C--O 1.193 -1.883 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.634 HG13 ' O ' ' A' ' 28' ' ' PHE . 0.6 OUTLIER -106.81 -27.72 2.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 120.144 -1.597 . . . . 0.0 109.482 178.013 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.623 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.3 mm -74.02 -59.47 3.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 177.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.685 ' HA ' HD23 ' B' ' 85' ' ' LEU . 0.7 OUTLIER -70.51 -32.59 70.12 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.393 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 1.256 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 71.7 mm-40 -81.75 -27.31 33.9 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 121.125 -0.984 . . . . 0.0 111.676 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.605 ' HA ' ' HB2' ' A' ' 38' ' ' LYS . 3.1 m -70.57 -55.39 8.97 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 117.496 -1.682 . . . . 0.0 108.437 178.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.953 HG11 HG23 ' A' ' 77' ' ' VAL . 87.1 t -55.2 -40.96 58.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.782 ' HB1' ' C ' ' B' ' 88' ' ' ALA . . . -68.93 -22.2 64.16 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 177.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.651 ' N ' HD12 ' B' ' 92' ' ' LEU . 13.4 mtmt -82.32 -25.48 33.88 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 177.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 35' ' ' THR . . . 104.06 30.79 4.97 Favored Glycine 0 C--N 1.295 -1.722 0 C-N-CA 120.133 -1.032 . . . . 0.0 110.653 177.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.567 ' CB ' HG23 ' A' ' 35' ' ' THR . 0.3 OUTLIER -117.25 138.22 51.87 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.225 -1.162 . . . . 0.0 110.018 179.545 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -72.18 82.55 1.0 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.461 -0.774 . . . . 0.0 110.638 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.624 ' CG2' HD11 ' B' ' 6' ' ' LEU . 14.8 p -73.36 140.96 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.47 -0.769 . . . . 0.0 109.654 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.417 ' HG3' ' OD1' ' B' ' 2' ' ' ASN . 1.6 pt20 -149.1 163.18 38.31 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.009 -1.057 . . . . 0.0 111.462 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.641 HD12 ' HB2' ' A' ' 48' ' ' LEU . 23.4 mt -106.94 109.28 21.14 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.53 HG21 ' HG3' ' B' ' 29' ' ' GLU . 0.0 OUTLIER 35.8 -95.11 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.743 -0.598 . . . . 0.0 111.378 -178.854 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -139.47 10.49 3.22 Favored Glycine 0 N--CA 1.488 2.105 0 C-N-CA 119.52 -1.324 . . . . 0.0 111.034 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.898 ' HD1' HD11 ' A' ' 85' ' ' LEU . 23.6 p90 -105.11 -20.31 13.56 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.604 -1.527 . . . . 0.0 110.695 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.641 ' HB2' HD12 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -132.81 147.67 52.31 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.13 -0.981 . . . . 0.0 111.666 178.505 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -154.08 116.28 4.31 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.773 -0.58 . . . . 0.0 109.718 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.613 HG21 HG21 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -109.54 155.1 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.212 -0.93 . . . . 0.0 110.522 -179.657 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 9.0 ptmt -162.19 126.78 2.04 Favored Pre-proline 0 N--CA 1.498 1.939 0 C-N-CA 118.803 -1.159 . . . . 0.0 110.96 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.717 ' HG3' ' O ' ' A' ' 36' ' ' VAL . 53.9 Cg_endo -87.05 144.29 7.09 Favored 'Trans proline' 0 C--N 1.316 -1.17 0 O-C-N 123.405 1.213 . . . . 0.0 110.888 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.637 HG22 ' O ' ' A' ' 76' ' ' GLY . 25.8 m -143.85 116.59 3.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-O 121.599 0.714 . . . . 0.0 110.278 179.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.538 ' HB2' ' HB3' ' B' ' 97' ' ' PHE . . . -30.87 124.38 0.2 Allowed 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.62 0.724 . . . . 0.0 112.318 -178.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.68 -148.73 0.12 Allowed 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.677 ' CB ' ' HB1' ' A' ' 72' ' ' ALA . 0.1 OUTLIER -174.97 -165.46 0.19 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.713 -1.242 . . . . 0.0 111.922 179.122 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.488 ' O ' ' HB3' ' A' ' 58' ' ' ARG 0.273 . . -172.26 138.59 0.97 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.672 -0.642 . . . . 0.0 109.659 -177.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.883 ' HB3' HD13 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -179.21 -163.34 0.06 Allowed 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 117.992 -1.483 . . . . 0.0 114.663 -179.58 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.451 ' CB ' ' O ' ' A' ' 58' ' ' ARG . 4.5 mtmt 159.73 28.62 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 113.741 -1.572 . . . . 0.0 108.597 178.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.776 ' O ' ' N ' ' A' ' 69' ' ' LEU . . . -156.2 -113.31 0.42 Allowed Glycine 0 N--CA 1.493 2.441 0 C-N-CA 120.014 -1.089 . . . . 0.0 110.595 -179.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.511 ' O ' HG22 ' A' ' 71' ' ' ILE . 0.3 OUTLIER -50.04 179.1 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.197 0 O-C-N 120.932 -1.334 . . . . 0.0 111.75 -178.737 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.694 ' CB ' ' CD ' ' A' ' 63' ' ' PRO . 2.2 m120 -147.93 -78.24 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.337 -0.852 . . . . 0.0 108.877 179.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.694 ' CD ' ' CB ' ' A' ' 62' ' ' ASN . 54.2 Cg_endo -74.42 -12.21 22.76 Favored 'Trans proline' 0 C--N 1.318 -1.048 0 N-CA-C 108.454 -1.402 . . . . 0.0 108.454 177.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.67 ' O ' HG23 ' A' ' 65' ' ' THR . 3.1 tt0 68.77 70.85 0.28 Allowed 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.665 0.745 . . . . 0.0 110.735 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.67 HG23 ' O ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -179.4 -22.98 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.739 -0.601 . . . . 0.0 110.787 179.28 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.509 ' NE2' ' HG2' ' A' ' 63' ' ' PRO . 0.9 OUTLIER -174.6 -12.45 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.075 0 O-C-N 120.869 -1.144 . . . . 0.0 113.071 -179.77 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.689 ' O ' ' HB2' ' A' ' 68' ' ' ALA . 1.4 tt0 -85.64 -158.51 0.39 Allowed 'General case' 0 N--CA 1.483 1.181 0 O-C-N 120.365 -1.46 . . . . 0.0 109.653 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.689 ' HB2' ' O ' ' A' ' 67' ' ' GLU . . . 167.83 72.12 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.861 -0.524 . . . . 0.0 111.53 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.776 ' N ' ' O ' ' A' ' 60' ' ' GLY . 3.6 pp -150.56 15.65 0.78 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.924 -1.11 . . . . 0.0 111.982 178.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.688 ' CB ' ' O ' ' A' ' 69' ' ' LEU . 0.6 OUTLIER 136.71 97.23 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.9 0 CA-C-N 118.473 0.578 . . . . 0.0 110.601 178.288 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.883 HD13 ' HB3' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -82.41 -165.41 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 177.531 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.731 ' HB2' ' O ' ' A' ' 71' ' ' ILE . . . 173.82 60.87 0.04 OUTLIER Pre-proline 0 N--CA 1.515 2.784 0 O-C-N 119.035 -2.29 . . . . 0.0 114.295 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.649 ' HD3' ' CD1' ' A' ' 71' ' ' ILE . 57.1 Cg_endo -108.09 84.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.302 -1.887 0 C-N-CA 121.541 1.494 . . . . 0.0 110.991 178.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.67 111.96 0.91 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.149 -1.594 . . . . 0.0 111.573 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.565 HG11 ' HB1' ' B' ' 89' ' ' ALA . 0.3 OUTLIER -55.9 -178.43 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.21 -0.931 . . . . 0.0 109.034 178.821 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.637 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -110.74 64.02 0.27 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.953 HG23 HG11 ' A' ' 36' ' ' VAL . 7.5 p -54.86 75.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.531 -0.982 . . . . 0.0 110.75 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.626 ' N ' ' O ' ' A' ' 76' ' ' GLY . 29.9 t -79.78 178.72 7.98 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.294 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.593 HG12 ' C ' ' A' ' 78' ' ' SER . 0.2 OUTLIER 179.27 172.96 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.463 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.56 ' N ' ' CG2' ' A' ' 79' ' ' VAL . 0.1 OUTLIER 177.28 173.8 0.33 Allowed Pre-proline 0 C--N 1.299 -1.616 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 177.814 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.668 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 52.5 Cg_endo -85.87 174.59 6.41 Favored 'Trans proline' 0 C--N 1.294 -2.294 0 O-C-N 123.648 1.341 . . . . 0.0 110.106 177.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -115.84 -68.58 0.43 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 105.289 -3.124 . . . . 0.0 105.289 177.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.863 ' O ' ' N ' ' A' ' 85' ' ' LEU . 37.8 tt0 -87.33 53.13 2.7 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 174.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 1.312 ' O ' ' N ' ' A' ' 86' ' ' LYS . 1.9 m 9.62 44.31 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 122.386 1.089 . . . . 0.0 110.854 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 1.067 HD13 HG21 ' B' ' 77' ' ' VAL . 3.6 mp 21.6 29.58 0.0 OUTLIER 'General case' 0 C--O 1.195 -1.802 0 N-CA-C 103.685 -2.709 . . . . 0.0 103.685 -172.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 1.312 ' N ' ' O ' ' A' ' 84' ' ' SER 0.339 9.7 tttt -55.59 -36.66 67.14 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 104.261 -2.496 . . . . 0.0 104.261 176.732 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.292 14.0 tttt -75.99 -31.59 59.03 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 111.625 -2.534 . . . . 0.0 106.5 176.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 1.001 ' HB3' ' HB3' ' A' ' 85' ' ' LEU . . . -82.21 -20.48 37.67 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 118.53 -1.268 . . . . 0.0 108.755 179.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 1.021 ' HA ' HD23 ' A' ' 92' ' ' LEU . . . -80.99 -43.94 18.87 Favored 'General case' 0 C--N 1.293 -1.888 0 O-C-N 120.941 -1.099 . . . . 0.0 108.587 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.7 -30.46 67.43 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 177.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.789 ' HA3' ' HB1' ' B' ' 37' ' ' ALA . . . -71.63 -33.83 63.37 Favored Glycine 0 N--CA 1.489 2.18 0 C-N-CA 120.279 -0.962 . . . . 0.0 110.837 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 1.021 HD23 ' HA ' ' A' ' 89' ' ' ALA . 0.4 OUTLIER -81.07 20.84 0.76 Allowed 'General case' 0 N--CA 1.504 2.241 0 O-C-N 120.371 -1.664 . . . . 0.0 110.764 -179.807 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.403 ' O ' ' N ' ' A' ' 96' ' ' ASP . 0.0 OUTLIER 57.2 37.46 28.38 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -178.397 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.522 ' HB2' ' HB ' ' B' ' 75' ' ' VAL . 0.0 OUTLIER -39.18 -33.94 0.16 Allowed 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.61 -179.21 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.56 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 46.1 mt-10 -63.33 -45.9 89.14 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.439 -0.788 . . . . 0.0 109.305 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 93' ' ' LYS . 60.3 m-20 -54.37 -39.68 67.42 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 178.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.754 ' HB3' ' HB2' ' B' ' 54' ' ' ALA . 0.1 OUTLIER -71.55 -29.12 64.38 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.292 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 95' ' ' GLU . . . -66.21 -61.9 1.77 Allowed 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.456 0.646 . . . . 0.0 110.172 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 25.8 mtmt . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.22 -179.848 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.544 ' HE2' ' HG ' ' B' ' 6' ' ' LEU . 5.2 mtp . . . . . 0 N--CA 1.493 1.69 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . 0.443 ' N ' ' HB2' ' B' ' 5' ' ' GLU . 12.2 t30 -177.22 178.01 1.15 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.207 -0.933 . . . . 0.0 110.816 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.545 ' NZ ' ' O ' ' B' ' 25' ' ' LEU . 1.7 mttm -44.53 -23.29 0.11 Allowed 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.49 -0.756 . . . . 0.0 110.58 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.506 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 13.4 m -102.94 -43.9 5.39 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.165 -0.96 . . . . 0.0 109.309 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.482 ' O ' ' CG ' ' B' ' 8' ' ' LYS . 0.1 OUTLIER -62.06 -46.51 88.82 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.153 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.679 ' O ' ' HB3' ' B' ' 9' ' ' ALA . 1.6 mt -66.13 -29.23 69.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.944 -1.098 . . . . 0.0 109.154 178.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' ILE . . . . . 0.875 HG23 ' HB ' ' B' ' 21' ' ' VAL . 0.3 OUTLIER -56.79 -59.77 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.638 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . 0.953 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 19.9 pttt -61.13 -25.87 67.29 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . 0.679 ' HB3' ' O ' ' B' ' 6' ' ' LEU . . . -58.56 -38.29 77.53 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.018 -1.051 . . . . 0.0 108.744 178.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.862 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.1 mp -90.62 -35.99 7.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 177.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.953 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -62.42 -12.82 23.89 Favored 'General case' 0 C--N 1.293 -1.851 0 C-N-CA 118.783 -1.167 . . . . 0.0 108.689 177.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.465 ' HB3' ' O ' ' B' ' 8' ' ' LYS . 6.9 tp-100 -113.79 -44.26 3.2 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.501 -0.749 . . . . 0.0 109.284 178.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.547 ' OD2' HG23 ' A' ' 31' ' ' ILE . 1.7 m-20 -64.29 -33.26 75.42 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 1.07 HG22 HD11 ' B' ' 16' ' ' LEU 0.253 0.2 OUTLIER -98.77 -69.53 0.76 Allowed 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 178.348 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 57.86 22.2 46.96 Favored Glycine 0 N--CA 1.501 2.98 0 O-C-N 121.398 -0.814 . . . . 0.0 111.585 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' LEU . . . . . 1.07 HD11 HG22 ' B' ' 14' ' ' THR . 4.9 mp -65.66 -66.17 0.58 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.348 -1.09 . . . . 0.0 109.64 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . 0.759 HG21 HG21 ' A' ' 17' ' ' THR . 0.5 OUTLIER -135.54 6.73 3.26 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -179.57 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . 0.652 ' O ' ' C ' ' B' ' 19' ' ' VAL . 25.1 mt-30 58.69 24.98 12.78 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 -175.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 1.073 HG23 ' CD1' ' A' ' 16' ' ' LEU . 0.2 OUTLIER 7.69 -95.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 CA-C-N 115.211 -0.904 . . . . 0.0 108.958 -179.185 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 1.026 ' O ' ' N ' ' B' ' 22' ' ' SER . 1.2 p -137.42 23.47 2.95 Favored 'General case' 0 C--N 1.273 -2.729 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 177.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.875 ' HB ' HG23 ' B' ' 7' ' ' ILE . 9.4 m -4.02 -43.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 122.441 1.115 . . . . 0.0 111.006 -177.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 1.026 ' N ' ' O ' ' B' ' 20' ' ' SER . 5.9 m -75.35 -38.06 60.34 Favored 'General case' 0 C--N 1.278 -2.506 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.559 178.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . 0.868 ' N ' ' O ' ' B' ' 20' ' ' SER . 6.1 mtmt -92.94 -26.99 17.33 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.36 -0.837 . . . . 0.0 111.154 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' MET . . . . . 0.672 ' HB3' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -70.9 -37.52 72.96 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 117.157 -1.817 . . . . 0.0 108.264 179.177 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.731 HD12 HG13 ' B' ' 7' ' ' ILE . 0.4 OUTLIER -80.44 -51.45 8.8 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 117.956 -1.498 . . . . 0.0 108.241 177.52 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . 0.491 ' O ' ' HB2' ' B' ' 30' ' ' LYS . . . -49.95 -34.11 19.75 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.374 -0.829 . . . . 0.0 108.859 178.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . 0.507 ' HA ' ' HB3' ' B' ' 30' ' ' LYS . 83.1 p -81.92 -33.88 30.17 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . 0.811 ' O ' HG13 ' B' ' 31' ' ' ILE . 0.3 OUTLIER -56.02 -52.44 64.22 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.812 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . 0.791 ' O ' ' OG1' ' B' ' 33' ' ' THR . 0.2 OUTLIER -63.42 -39.01 93.34 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 176.401 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 0.992 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 17.5 ttpt -59.96 -23.79 63.87 Favored 'General case' 0 C--O 1.189 -2.115 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.878 HD13 ' CB ' ' A' ' 9' ' ' ALA . 0.6 OUTLIER -102.83 -27.16 3.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 O-C-N 120.615 -1.303 . . . . 0.0 108.582 178.047 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.715 HD11 ' CE2' ' B' ' 28' ' ' PHE . 1.2 mm -68.88 -54.33 21.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 177.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' THR . . . . . 0.811 ' HA ' HD23 ' A' ' 85' ' ' LEU . 0.3 OUTLIER -70.73 -49.07 50.86 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.107 -1.037 . . . . 0.0 108.669 178.576 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.992 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 19.2 mm-40 -58.09 -35.68 71.77 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.551 -0.86 . . . . 0.0 109.95 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' THR . . . . . 0.831 HG22 ' CB ' ' B' ' 40' ' ' ASP . 31.1 m -69.72 -42.34 74.13 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 118.302 -1.359 . . . . 0.0 107.697 177.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.976 HG21 HD22 ' A' ' 85' ' ' LEU . 55.5 t -56.95 -43.03 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 177.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 0.804 ' HA ' ' HB3' ' A' ' 92' ' ' LEU . . . -76.89 2.92 13.25 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.398 -0.921 . . . . 0.0 109.69 177.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.546 ' HB2' ' O ' ' B' ' 34' ' ' GLU . 0.1 OUTLIER -119.91 4.6 10.95 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.107 -0.996 . . . . 0.0 109.311 178.001 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.73 34.46 4.07 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . 0.831 ' CB ' HG22 ' B' ' 35' ' ' THR . 14.2 t0 -49.17 162.91 0.11 Allowed 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 123.086 1.422 . . . . 0.0 113.019 -179.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -179.83 56.99 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 104.381 -2.451 . . . . 0.0 104.381 178.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.918 HG21 HD11 ' A' ' 6' ' ' LEU . 7.4 p -90.67 148.74 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.941 -176.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -132.26 95.9 3.76 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.903 HD12 ' HB3' ' B' ' 48' ' ' LEU . 19.2 mt -59.65 101.59 0.12 Allowed 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.245 -0.909 . . . . 0.0 109.792 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . 0.534 HG22 ' HD3' ' A' ' 3' ' ' LYS . 0.0 OUTLIER 35.53 -93.55 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 120.921 0.391 . . . . 0.0 110.877 -179.648 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -147.17 35.4 1.25 Allowed Glycine 0 N--CA 1.485 1.95 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . 0.73 ' O ' HD11 ' B' ' 85' ' ' LEU . 1.1 p90 -135.75 -25.53 1.26 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.246 -1.149 . . . . 0.0 111.773 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.903 ' HB3' HD12 ' B' ' 44' ' ' LEU . 4.8 mt -136.36 113.58 10.64 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.214 -1.554 . . . . 0.0 111.374 178.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -113.69 95.95 5.6 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.414 -0.804 . . . . 0.0 110.291 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' ILE . . . . . 0.783 ' CG1' HG22 ' B' ' 79' ' ' VAL . 0.3 OUTLIER -87.5 139.42 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.37 -0.831 . . . . 0.0 109.271 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . 0.408 ' O ' ' HB3' ' B' ' 78' ' ' SER . 1.7 ptmt -158.83 111.4 1.61 Allowed Pre-proline 0 N--CA 1.5 2.042 0 C-N-CA 118.603 -1.239 . . . . 0.0 111.233 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.577 ' HB3' HG13 ' B' ' 36' ' ' VAL . 44.9 Cg_endo -69.38 144.66 56.78 Favored 'Trans proline' 0 C--N 1.314 -1.251 0 O-C-N 123.47 1.248 . . . . 0.0 111.681 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.703 HG22 ' O ' ' B' ' 76' ' ' GLY . 29.7 m -143.07 116.86 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 121.491 0.663 . . . . 0.0 110.841 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.754 ' HB2' ' HB3' ' A' ' 97' ' ' PHE . . . -46.01 145.14 1.62 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 121.806 0.812 . . . . 0.0 112.105 -178.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.27 96.33 0.19 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . 0.745 ' O ' HD13 ' B' ' 71' ' ' ILE . 13.5 mt-30 -59.07 -165.03 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.261 -0.899 . . . . 0.0 111.052 -178.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.635 ' HB2' ' HD3' ' B' ' 73' ' ' PRO . . . -91.53 166.39 12.87 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.662 -0.649 . . . . 0.0 110.977 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 58' ' ' ARG . . . . . 0.69 ' HG3' HD11 ' B' ' 71' ' ' ILE . 47.8 mtt85 -157.25 142.14 16.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.815 -0.553 . . . . 0.0 109.535 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 2.5 pttt -170.24 66.46 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.201 -0.937 . . . . 0.0 110.457 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 154.43 -32.72 0.7 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 61' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -171.8 -164.66 0.32 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.325 -1.103 . . . . 0.0 110.349 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . 0.72 ' HB3' ' CD ' ' B' ' 63' ' ' PRO . 2.6 t-20 -170.21 -79.4 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.455 -0.778 . . . . 0.0 109.807 179.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.72 ' CD ' ' HB3' ' B' ' 62' ' ' ASN . 57.0 Cg_endo -80.22 1.77 9.0 Favored 'Trans proline' 0 C--N 1.321 -0.889 0 N-CA-C 109.496 -1.002 . . . . 0.0 109.496 178.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 62.21 20.05 11.42 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.337 -0.852 . . . . 0.0 109.253 -178.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.53 HG23 ' O ' ' B' ' 63' ' ' PRO . 65.1 p -124.15 44.36 2.75 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.583 -0.698 . . . . 0.0 109.17 179.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . 0.431 ' HB2' ' O ' ' B' ' 65' ' ' THR . 33.6 mm-40 66.59 56.06 0.76 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.796 -0.565 . . . . 0.0 111.133 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . 0.406 ' HB2' ' HG2' ' B' ' 63' ' ' PRO . 0.2 OUTLIER -140.6 64.7 1.43 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.09 -1.006 . . . . 0.0 109.474 179.002 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.82 126.0 25.79 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.705 -0.622 . . . . 0.0 110.684 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.407 ' HA ' HD23 ' B' ' 69' ' ' LEU . 80.2 mt -116.76 176.44 5.12 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.404 -0.81 . . . . 0.0 110.301 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -154.45 73.63 0.92 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.367 -0.833 . . . . 0.0 110.522 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.745 HD13 ' O ' ' B' ' 56' ' ' GLN . 1.5 pp -117.69 -160.17 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.349 -0.844 . . . . 0.0 109.561 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -126.14 156.78 71.59 Favored Pre-proline 0 C--N 1.304 -1.412 0 O-C-N 121.187 -0.946 . . . . 0.0 111.098 -179.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 73' ' ' PRO . . . . . 0.635 ' HD3' ' HB2' ' B' ' 57' ' ' ALA . 45.0 Cg_endo -73.38 82.17 1.67 Allowed 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 124.325 1.697 . . . . 0.0 110.379 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . 0.48 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 9.2 p -176.42 154.58 1.32 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.45 -0.781 . . . . 0.0 109.628 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . 0.897 ' HB ' ' HB1' ' A' ' 89' ' ' ALA . 1.2 t -52.85 169.83 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.132 -0.98 . . . . 0.0 109.364 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . 0.703 ' O ' HG22 ' B' ' 53' ' ' VAL . . . -115.32 86.9 0.42 Allowed Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 1.067 HG21 HD13 ' A' ' 85' ' ' LEU . 3.6 p -60.53 78.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.767 -0.843 . . . . 0.0 109.827 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . 0.941 ' O ' HG23 ' B' ' 79' ' ' VAL . 2.2 t -68.05 177.66 2.12 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.551 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.941 HG23 ' O ' ' B' ' 78' ' ' SER . 14.6 t -172.33 175.27 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . 0.865 ' O ' HD23 ' B' ' 48' ' ' LEU . 0.0 OUTLIER 179.28 172.17 0.49 Allowed Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 120.87 -1.144 . . . . 0.0 110.178 177.186 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 81' ' ' PRO . . . . . 0.504 ' HA ' ' O ' ' B' ' 47' ' ' PHE . 54.0 Cg_endo -95.17 143.45 1.31 Allowed 'Trans proline' 0 C--N 1.303 -1.855 0 C-N-CA 122.35 2.033 . . . . 0.0 110.739 178.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . 0.557 ' O ' ' HB3' ' B' ' 83' ' ' GLU . . . -107.6 42.37 1.95 Allowed Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . 0.557 ' HB3' ' O ' ' B' ' 82' ' ' GLY . 1.0 OUTLIER 69.02 -40.18 0.44 Allowed 'General case' 0 N--CA 1.506 2.34 0 O-C-N 121.448 -1.031 . . . . 0.0 111.93 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 84' ' ' SER . . . . . 0.472 ' CB ' ' HB3' ' B' ' 47' ' ' PHE . 0.1 OUTLIER -48.85 -33.34 10.39 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.949 -1.094 . . . . 0.0 110.165 -179.177 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.817 ' HB2' HG21 ' A' ' 77' ' ' VAL . 0.8 OUTLIER -82.61 -29.98 29.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.412 -0.805 . . . . 0.0 108.877 178.703 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . 0.576 ' CD ' HG12 ' A' ' 77' ' ' VAL . 0.3 OUTLIER -82.49 -39.5 22.37 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.53 0.681 . . . . 0.0 109.607 179.812 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . 0.465 ' O ' ' CG ' ' B' ' 90' ' ' GLU . 1.2 ttmp? -68.69 -37.05 79.26 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 178.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.782 ' C ' ' HB1' ' A' ' 37' ' ' ALA . . . -71.62 -30.66 66.02 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 177.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.674 ' HA ' ' HA ' ' A' ' 37' ' ' ALA . . . -69.94 -52.79 21.55 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.623 -0.673 . . . . 0.0 110.368 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.64 ' HA ' ' CB ' ' B' ' 94' ' ' TYR . 8.2 pt-20 -52.2 -23.25 5.28 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 177.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . 0.859 ' C ' HD23 ' B' ' 92' ' ' LEU . . . -81.17 -29.66 40.41 Favored Glycine 0 CA--C 1.546 2.03 0 CA-C-O 118.604 -1.109 . . . . 0.0 112.81 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . 0.859 HD23 ' C ' ' B' ' 91' ' ' GLY . 0.2 OUTLIER -111.64 -73.55 0.67 Allowed 'General case' 0 N--CA 1.507 2.391 0 CA-C-N 122.065 2.933 . . . . 0.0 113.54 -177.687 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -120.31 42.7 2.9 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.771 -1.205 . . . . 0.0 112.628 -177.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . 0.64 ' CB ' ' HA ' ' B' ' 90' ' ' GLU . 0.8 OUTLIER -77.19 -43.51 33.46 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.124 -0.985 . . . . 0.0 108.967 178.507 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . 0.408 ' O ' ' HB3' ' B' ' 98' ' ' ALA . 1.2 mp0 -75.04 -35.73 61.89 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.19 -40.13 76.77 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 97' ' ' PHE . . . . . 0.538 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -75.25 -26.67 59.04 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.497 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 98' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' B' ' 95' ' ' GLU . . . -67.71 -37.35 82.12 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.614 -0.679 . . . . 0.0 110.179 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 36.2 mttm . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.18 -179.89 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.507 ' HA ' ' CB ' ' A' ' 5' ' ' GLU . 2.8 mtp . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.466 ' H ' ' HB2' ' A' ' 5' ' ' GLU . 0.6 OUTLIER -177.12 -162.54 0.08 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.023 -1.048 . . . . 0.0 111.728 179.855 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.519 ' HE2' ' HA ' ' A' ' 26' ' ' ALA . 0.9 OUTLIER -52.22 -11.77 0.2 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.657 -0.652 . . . . 0.0 110.396 179.778 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.611 ' O ' HG13 ' A' ' 7' ' ' ILE . 73.7 m -114.38 -58.95 2.08 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.104 -0.997 . . . . 0.0 110.731 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.507 ' CB ' ' HA ' ' A' ' 1' ' ' MET . 1.6 mm-40 -49.74 -48.4 50.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.822 -1.174 . . . . 0.0 108.945 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.824 HD11 ' CG1' ' B' ' 42' ' ' VAL . 16.2 mt -55.65 -32.93 63.61 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.151 -1.02 . . . . 0.0 110.105 178.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.794 ' HA ' HD12 ' A' ' 25' ' ' LEU . 1.0 OUTLIER -60.5 -40.94 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 120.599 -1.313 . . . . 0.0 107.563 178.743 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.858 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -66.75 -31.14 71.6 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 177.343 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.659 ' HB3' ' O ' ' A' ' 6' ' ' LEU . . . -58.45 -39.01 78.69 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.815 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.4 mp -91.01 -30.61 4.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 178.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.858 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -66.08 -10.6 41.94 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 118.456 -1.298 . . . . 0.0 108.493 178.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.443 ' CG ' ' N ' ' A' ' 13' ' ' ASP . 6.4 pt20 -118.53 -42.52 2.75 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.48 -0.762 . . . . 0.0 110.405 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.73 ' OD2' HG21 ' B' ' 31' ' ' ILE . 16.8 m-20 -69.85 -25.82 63.91 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 177.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 1.139 HG22 ' CD1' ' A' ' 16' ' ' LEU 0.277 0.2 OUTLIER -106.53 -72.89 0.7 Allowed 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 179.025 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.65 15.68 54.3 Favored Glycine 0 N--CA 1.501 2.974 0 O-C-N 121.328 -0.857 . . . . 0.0 111.039 177.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.139 ' CD1' HG22 ' A' ' 14' ' ' THR . 4.4 mp -59.36 -68.87 0.23 Allowed 'General case' 0 C--N 1.294 -1.835 0 O-C-N 121.524 -0.986 . . . . 0.0 110.628 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.532 ' O ' HG23 ' A' ' 17' ' ' THR . 0.6 OUTLIER -138.11 9.64 2.77 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.302 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.558 ' O ' ' C ' ' A' ' 19' ' ' VAL . 7.7 mt-30 57.84 25.71 12.34 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -176.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 1.026 HG11 HG11 ' B' ' 19' ' ' VAL . 2.4 p -11.45 -95.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.089 -179.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.976 ' HB2' HG22 ' B' ' 14' ' ' THR . 0.6 OUTLIER -130.74 22.86 5.02 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 177.957 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.652 ' HA ' ' CE ' ' A' ' 24' ' ' MET . 30.5 m -25.19 -38.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-O 122.479 1.133 . . . . 0.0 109.182 -178.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.71 ' N ' ' O ' ' A' ' 20' ' ' SER . 4.9 m -84.49 -35.36 23.01 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.135 177.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.942 ' N ' ' O ' ' A' ' 20' ' ' SER . 1.2 mtmt -85.69 -34.07 21.37 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.652 -0.655 . . . . 0.0 111.543 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.781 ' HB3' HG23 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -76.1 -40.24 53.41 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.44 -1.412 . . . . 0.0 109.349 179.466 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.794 HD12 ' HA ' ' A' ' 7' ' ' ILE . 11.6 mt -74.56 -38.29 62.74 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 117.894 -1.523 . . . . 0.0 108.724 178.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.519 ' HA ' ' HE2' ' A' ' 3' ' ' LYS . . . -64.08 -33.22 75.26 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 177.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.551 ' O ' ' N ' ' A' ' 31' ' ' ILE . 58.3 m -84.25 -30.52 25.61 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 178.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.865 ' HB2' HD11 ' B' ' 10' ' ' ILE . 0.1 OUTLIER -59.24 -35.91 74.53 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.608 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.753 ' O ' ' HB ' ' A' ' 33' ' ' THR . 2.1 mt-10 -79.99 -32.92 39.76 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 177.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.739 ' O ' ' CG ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -68.6 -27.31 65.93 Favored 'General case' 0 C--O 1.194 -1.821 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 176.758 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.738 ' CG1' ' HA ' ' A' ' 28' ' ' PHE . 1.7 pp -97.11 -31.69 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.299 -0.875 . . . . 0.0 109.445 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.637 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 3.3 mm -65.42 -51.62 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 177.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.753 ' HB ' ' O ' ' A' ' 29' ' ' GLU . 0.3 OUTLIER -65.51 -43.27 90.62 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.867 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.739 ' CG ' ' O ' ' A' ' 30' ' ' LYS . 44.5 mm-40 -69.02 -36.08 77.36 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.614 -0.679 . . . . 0.0 111.451 179.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.971 HG21 HG23 ' A' ' 42' ' ' VAL . 2.3 m -57.59 -56.12 26.05 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.736 -1.228 . . . . 0.0 108.689 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.019 HG21 HG23 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -55.51 -29.51 24.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 106.303 -1.739 . . . . 0.0 106.303 177.414 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 1.065 ' HB2' ' HB1' ' B' ' 88' ' ' ALA . . . -75.73 -4.1 38.53 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 177.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 35' ' ' THR . 0.0 OUTLIER -115.26 -32.07 5.77 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.634 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.18 42.58 0.76 Allowed Glycine 0 C--N 1.301 -1.391 0 C-N-CA 119.804 -1.189 . . . . 0.0 110.558 178.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.773 ' CB ' HG23 ' A' ' 35' ' ' THR . 0.1 OUTLIER -125.86 117.44 23.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.218 -1.166 . . . . 0.0 110.33 179.349 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.6 mtmt -67.13 89.41 0.18 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.57 0.7 . . . . 0.0 109.626 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.971 HG23 HG21 ' A' ' 35' ' ' THR . 42.5 t -66.23 131.94 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.682 -0.637 . . . . 0.0 110.374 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.503 ' O ' HD23 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -128.04 154.8 45.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.517 -0.739 . . . . 0.0 109.59 179.454 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.983 HD12 ' CB ' ' A' ' 48' ' ' LEU . 73.1 mt -128.13 112.19 14.28 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.287 -0.883 . . . . 0.0 109.686 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.59 HG22 ' HG2' ' B' ' 29' ' ' GLU . 0.1 OUTLIER 32.45 -90.89 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.427 0 O-C-N 121.937 -0.477 . . . . 0.0 111.007 -179.371 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -149.94 28.99 1.14 Allowed Glycine 0 N--CA 1.482 1.752 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.646 ' O ' ' HA ' ' A' ' 81' ' ' PRO . 5.8 p90 -129.06 -24.09 2.94 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.096 -1.238 . . . . 0.0 112.046 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.983 ' CB ' HD12 ' A' ' 44' ' ' LEU . 1.0 OUTLIER -131.47 107.63 9.03 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.38 -1.45 . . . . 0.0 111.524 179.143 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -111.46 95.51 5.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.608 -0.683 . . . . 0.0 109.741 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.801 HD12 HG22 ' A' ' 79' ' ' VAL . 0.3 OUTLIER -83.44 142.42 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.369 -0.832 . . . . 0.0 109.969 -179.351 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 13.0 ptmt -157.48 128.09 3.54 Favored Pre-proline 0 N--CA 1.494 1.743 0 C-N-CA 118.564 -1.255 . . . . 0.0 110.51 178.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.675 ' HB3' HG22 ' A' ' 36' ' ' VAL . 54.8 Cg_endo -85.28 143.74 9.01 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.475 1.25 . . . . 0.0 111.891 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.859 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 32.6 m -133.13 -149.37 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.938 ' HA ' ' CA ' ' A' ' 75' ' ' VAL . . . -167.18 143.01 4.21 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 118.542 -1.263 . . . . 0.0 113.238 177.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 54' ' ' ALA . 0.1 OUTLIER 168.38 101.61 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.729 -178.842 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.586 ' HB2' ' HA ' ' A' ' 74' ' ' SER . 0.2 OUTLIER -161.43 32.91 0.13 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.375 -0.828 . . . . 0.0 110.531 -179.349 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 1.002 ' CB ' ' HB3' ' A' ' 72' ' ' ALA . . . -130.47 163.02 27.89 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-O 123.039 1.399 . . . . 0.0 113.721 -178.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.543 ' NH1' HD11 ' A' ' 71' ' ' ILE . 52.4 mtt180 -43.58 165.69 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 113.782 -1.554 . . . . 0.0 111.22 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.89 37.57 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.565 -0.709 . . . . 0.0 109.527 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 141.74 -20.69 2.54 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.487 ' HA ' ' O ' ' A' ' 67' ' ' GLU . 0.4 OUTLIER -162.49 174.27 12.9 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.38 -1.071 . . . . 0.0 110.032 179.891 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.683 ' HB3' ' CD ' ' A' ' 63' ' ' PRO . 2.2 t-20 -145.93 -76.93 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.345 -0.847 . . . . 0.0 109.147 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.683 ' CD ' ' HB3' ' A' ' 62' ' ' ASN . 54.4 Cg_endo -75.25 -12.39 21.03 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 N-CA-C 107.991 -1.58 . . . . 0.0 107.991 177.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.702 ' O ' HG23 ' A' ' 65' ' ' THR . 2.3 tp60 70.86 71.85 0.19 Allowed 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.66 0.743 . . . . 0.0 110.946 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.702 HG23 ' O ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER 177.63 -24.82 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.928 -0.482 . . . . 0.0 110.364 179.134 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.545 ' NE2' ' N ' ' A' ' 66' ' ' GLN . 0.4 OUTLIER -178.59 16.14 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.113 -0.992 . . . . 0.0 112.446 -179.485 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.487 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 0.5 OUTLIER -128.5 100.27 5.71 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.431 -1.418 . . . . 0.0 110.636 -179.699 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.43 99.07 8.61 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.462 -0.774 . . . . 0.0 110.522 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.479 ' HB2' ' CD ' ' A' ' 58' ' ' ARG . 1.1 mp -123.53 -152.12 0.5 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.361 -0.837 . . . . 0.0 110.062 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.468 ' CA ' ' HB2' ' A' ' 58' ' ' ARG . 9.0 tt0 -164.42 43.61 0.09 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.112 -0.992 . . . . 0.0 110.881 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.957 ' O ' HD12 ' A' ' 71' ' ' ILE . 2.8 pp -130.54 145.86 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 O-C-N 121.052 -1.03 . . . . 0.0 111.715 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 1.051 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . 158.17 -166.14 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 122.067 -0.395 . . . . 0.0 110.116 179.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 1.051 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 43.4 Cg_endo -78.14 168.36 21.97 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 124.119 1.589 . . . . 0.0 111.433 178.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.866 ' O ' ' HB1' ' A' ' 54' ' ' ALA . 0.1 OUTLIER -171.94 111.92 0.3 Allowed 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.385 179.301 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.938 ' CA ' ' HA ' ' A' ' 54' ' ' ALA . 0.9 OUTLIER -173.21 141.36 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.704 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 176.859 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.846 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -145.11 111.18 0.58 Allowed Glycine 0 N--CA 1.491 2.321 0 C-N-CA 119.1 -1.524 . . . . 0.0 110.805 -178.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 1.019 HG23 HG21 ' A' ' 36' ' ' VAL . 4.9 p -76.96 81.69 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 O-C-N 121.603 -0.939 . . . . 0.0 110.08 179.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 1.008 ' O ' HG23 ' A' ' 79' ' ' VAL . 2.7 t -67.05 178.14 1.52 Allowed 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.347 -0.941 . . . . 0.0 109.607 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 1.008 HG23 ' O ' ' A' ' 78' ' ' SER . 3.4 t -176.41 174.96 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.607 ' O ' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER 179.32 170.59 0.55 Allowed Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 120.993 -1.067 . . . . 0.0 110.558 176.357 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.646 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 54.7 Cg_endo -95.09 144.53 1.41 Allowed 'Trans proline' 0 C--N 1.303 -1.865 0 C-N-CA 122.637 2.225 . . . . 0.0 110.551 178.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.503 ' H ' ' HA ' ' A' ' 47' ' ' PHE . . . -106.07 -171.68 23.32 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.79 -26.21 54.21 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.959 -1.318 . . . . 0.0 110.401 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.413 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 1.7 t -53.64 -27.56 27.91 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.873 HD22 HG11 ' B' ' 36' ' ' VAL . 1.3 mt -84.97 -29.07 25.38 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 178.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.506 ' HG3' HG13 ' B' ' 75' ' ' VAL . 0.4 OUTLIER -84.25 -29.2 26.67 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.306 -0.871 . . . . 0.0 109.706 179.823 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.83 -38.06 58.44 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 178.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.886 ' C ' ' HB1' ' B' ' 37' ' ' ALA . . . -65.61 -33.31 75.61 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 177.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 1.243 ' N ' ' HB1' ' B' ' 37' ' ' ALA . . . -72.63 -26.86 61.82 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.77 -34.57 62.79 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 175.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -63.6 -50.08 64.47 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 107.864 -2.094 . . . . 0.0 107.864 176.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.714 HD12 ' HA ' ' B' ' 37' ' ' ALA . 3.4 mt -49.67 -12.56 0.07 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.073 -1.251 . . . . 0.0 111.484 178.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.524 ' CB ' ' O ' ' A' ' 92' ' ' LEU . 0.0 OUTLIER 73.54 61.14 0.09 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -177.589 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.659 ' CE2' ' HA ' ' B' ' 73' ' ' PRO . 50.8 t80 -37.46 -39.99 0.34 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.189 -178.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.447 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 10.0 pt-20 -55.11 -43.16 73.8 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.293 -0.879 . . . . 0.0 109.697 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -62.05 -35.87 79.9 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.558 ' HB3' ' HB2' ' B' ' 54' ' ' ALA . 0.1 OUTLIER -72.82 -28.01 62.3 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.499 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.576 ' HA ' ' HB1' ' B' ' 54' ' ' ALA . . . -64.47 -63.98 0.99 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.578 -0.702 . . . . 0.0 110.206 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.147 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.504 ' HB3' ' HG ' ' B' ' 6' ' ' LEU . 1.5 mtp . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.059 0.457 . . . . 0.0 110.329 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . 0.514 ' O ' ' HB2' ' B' ' 6' ' ' LEU . 12.4 t-20 -173.54 -161.06 0.13 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.306 -0.871 . . . . 0.0 110.892 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.511 ' HE2' ' HB2' ' B' ' 29' ' ' GLU . 0.7 OUTLIER -55.77 -2.21 0.05 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.335 -0.853 . . . . 0.0 110.895 179.903 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.635 ' O ' ' CG1' ' B' ' 7' ' ' ILE . 54.4 m -122.77 -60.14 1.55 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.966 -1.084 . . . . 0.0 109.969 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.486 ' HB2' ' CA ' ' B' ' 1' ' ' MET . 5.4 mt-10 -51.74 -47.62 63.99 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.822 -1.174 . . . . 0.0 109.108 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.724 HD11 HG13 ' A' ' 42' ' ' VAL . 5.2 mt -60.43 -33.3 72.33 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.265 178.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' ILE . . . . . 0.747 ' N ' HD12 ' B' ' 25' ' ' LEU . 0.9 OUTLIER -58.4 -42.65 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 120.582 -1.324 . . . . 0.0 108.397 179.812 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . 0.77 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.1 OUTLIER -67.14 -32.2 73.15 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.213 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . 0.626 ' HB3' ' O ' ' B' ' 6' ' ' LEU . . . -62.33 -30.78 71.4 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 178.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.865 HD11 ' HB2' ' A' ' 28' ' ' PHE . 1.2 mp -96.65 -32.59 4.25 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.5 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 178.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.77 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -63.79 -29.58 70.77 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.412 ' HG3' ' N ' ' B' ' 13' ' ' ASP . 6.5 pt20 -89.56 -38.16 14.17 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.481 ' HB2' ' HA ' ' B' ' 10' ' ' ILE . 66.0 m-20 -67.96 -23.03 65.01 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 176.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.976 HG22 ' HB2' ' A' ' 20' ' ' SER . 18.4 p -92.31 -76.46 0.46 Allowed 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 61.05 12.37 29.62 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' LEU . . . . . 0.867 HD22 ' O ' ' A' ' 19' ' ' VAL . 3.3 mp -79.78 -61.66 1.92 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.481 -1.011 . . . . 0.0 109.016 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . 0.505 HG22 ' H ' ' B' ' 19' ' ' VAL . 0.6 OUTLIER -141.55 5.93 1.84 Allowed 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.889 -179.794 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . 0.575 ' O ' ' C ' ' B' ' 19' ' ' VAL . 6.7 mt-30 54.53 29.69 11.74 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 -176.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 1.026 HG11 HG11 ' A' ' 19' ' ' VAL . 1.4 p -12.07 -95.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.743 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.945 ' O ' ' N ' ' B' ' 23' ' ' LYS . 0.5 OUTLIER -132.97 24.39 4.25 Favored 'General case' 0 C--N 1.283 -2.311 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 178.601 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.696 HG11 ' CB ' ' B' ' 11' ' ' ALA . 17.1 m -19.28 -39.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 CA-C-O 122.398 1.094 . . . . 0.0 109.433 -177.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.848 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.6 OUTLIER -82.43 -37.54 25.31 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.875 178.221 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . 0.945 ' N ' ' O ' ' B' ' 20' ' ' SER . 1.9 mtmt -89.63 -28.75 19.29 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.46 -0.775 . . . . 0.0 111.377 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' MET . . . . . 0.744 ' HB3' HG21 ' A' ' 14' ' ' THR . 0.0 OUTLIER -77.81 -36.36 50.33 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 118.002 -1.479 . . . . 0.0 108.549 179.078 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.747 HD12 ' N ' ' B' ' 7' ' ' ILE . 0.8 OUTLIER -75.18 -42.63 55.39 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 177.281 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . 0.468 ' HA ' ' HE2' ' B' ' 3' ' ' LYS . . . -60.3 -32.48 71.25 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 177.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . 0.562 ' HA ' ' HB3' ' B' ' 30' ' ' LYS . 12.1 m -79.88 -35.66 37.73 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . 0.739 ' HE1' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -59.25 -40.08 84.84 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 178.849 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . 0.717 ' HG3' ' CE1' ' B' ' 28' ' ' PHE . 1.3 mt-10 -76.03 -34.05 59.66 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 0.751 ' O ' ' CG ' ' B' ' 34' ' ' GLU . 30.0 tttp -70.08 -29.89 66.99 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 177.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.739 ' CG1' ' HA ' ' B' ' 28' ' ' PHE . 2.0 pp -93.02 -35.23 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.311 -0.868 . . . . 0.0 109.232 179.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.68 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.3 mm -60.52 -60.05 3.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' THR . . . . . 0.678 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 0.4 OUTLIER -58.29 -39.53 79.55 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.116 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.842 ' O ' ' N ' ' B' ' 38' ' ' LYS . 7.0 mm-40 -68.66 -54.7 14.76 Favored 'General case' 0 C--O 1.199 -1.586 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.109 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' THR . . . . . 0.556 ' HA ' ' HB2' ' B' ' 38' ' ' LYS . 50.2 m -47.02 -63.85 0.93 Allowed 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.87 -1.144 . . . . 0.0 112.124 -178.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 1.026 HG23 HD12 ' B' ' 50' ' ' ILE . 0.9 OUTLIER -49.61 -44.02 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 C-N-CA 118.058 -1.457 . . . . 0.0 107.841 179.126 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 1.243 ' HB1' ' N ' ' A' ' 89' ' ' ALA . . . -93.63 15.27 16.63 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.793 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.842 ' N ' ' O ' ' B' ' 34' ' ' GLU . 4.7 mmtt -121.95 -28.08 4.5 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 144.16 41.11 0.06 OUTLIER Glycine 0 N--CA 1.477 1.384 0 C-N-CA 119.026 -1.559 . . . . 0.0 112.06 178.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . 0.492 ' O ' ' HA ' ' B' ' 36' ' ' VAL . 0.4 OUTLIER -172.92 147.3 1.65 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.59 -1.535 . . . . 0.0 111.421 179.069 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.409 ' CG ' ' HD2' ' B' ' 52' ' ' PRO . 2.2 mttt -102.81 114.7 29.18 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.824 ' CG1' HD11 ' A' ' 6' ' ' LEU . 7.5 t -87.92 154.95 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 C-N-CA 119.858 -0.737 . . . . 0.0 111.107 -178.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' GLN . . . . . 0.408 ' HA ' ' O ' ' B' ' 48' ' ' LEU . 14.6 mt-30 -142.04 121.12 12.92 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.552 -0.717 . . . . 0.0 109.89 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.712 HD13 ' CZ ' ' A' ' 28' ' ' PHE . 20.5 mt -87.09 102.56 14.54 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.199 -0.938 . . . . 0.0 109.934 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . 0.619 HG22 ' HG2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 37.56 28.09 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.435 0 O-C-N 121.819 -0.55 . . . . 0.0 111.753 -179.659 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . 90.64 -11.5 71.44 Favored Glycine 0 N--CA 1.486 2.028 0 C-N-CA 119.903 -1.142 . . . . 0.0 111.902 178.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . 0.627 ' CE2' ' HG2' ' A' ' 29' ' ' GLU . 0.8 OUTLIER -87.76 -35.3 17.96 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 120.028 1.914 . . . . 0.0 111.776 -179.561 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.612 ' HB2' HD12 ' B' ' 44' ' ' LEU . 0.4 OUTLIER -120.18 85.59 2.41 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.63 -1.294 . . . . 0.0 110.516 178.539 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -90.84 80.41 5.83 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.847 -0.533 . . . . 0.0 110.444 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 50' ' ' ILE . . . . . 1.026 HD12 HG23 ' B' ' 36' ' ' VAL . 2.9 pt -73.07 147.86 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.227 -0.921 . . . . 0.0 110.344 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . 0.564 ' O ' ' N ' ' B' ' 78' ' ' SER . 0.0 OUTLIER -165.14 132.52 2.35 Favored Pre-proline 0 N--CA 1.498 1.935 0 C-N-CA 119.285 -0.966 . . . . 0.0 110.549 179.456 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.827 ' HG3' ' O ' ' B' ' 36' ' ' VAL . 54.4 Cg_endo -85.47 149.19 10.16 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 O-C-N 123.398 1.209 . . . . 0.0 111.174 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.602 HG22 ' HA3' ' B' ' 76' ' ' GLY . 11.8 m -144.93 120.15 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 CA-C-O 122.296 1.046 . . . . 0.0 111.619 178.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.576 ' HB1' ' HA ' ' A' ' 98' ' ' ALA . . . -70.95 108.19 4.42 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.875 -179.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . 0.463 ' HB3' ' O ' ' B' ' 54' ' ' ALA . 0.0 OUTLIER 166.0 86.39 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 179.906 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . 0.546 ' CG ' ' O ' ' B' ' 74' ' ' SER . 1.2 mt-30 -159.79 -158.73 0.67 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.053 -1.059 . . . . 0.0 112.34 -177.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 1.024 ' HA ' ' HA ' ' B' ' 72' ' ' ALA . . . -172.73 148.06 1.84 Allowed 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 122.692 1.235 . . . . 0.0 113.451 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 58' ' ' ARG . . . . . 0.847 ' CD ' HG22 ' B' ' 71' ' ' ILE . 1.0 OUTLIER -66.23 -173.33 0.19 Allowed 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.186 179.624 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 4.2 ttmt -165.81 23.7 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.403 -0.811 . . . . 0.0 110.819 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' B' ' 69' ' ' LEU . . . 128.45 58.75 0.11 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.916 -1.273 . . . . 0.0 109.916 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 61' ' ' PHE . . . . . 0.906 ' CE2' HD12 ' B' ' 69' ' ' LEU . 0.1 OUTLIER -97.97 144.28 27.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.991 -1.299 . . . . 0.0 112.994 -179.38 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . 0.839 ' H ' ' CD ' ' B' ' 63' ' ' PRO . 9.7 p30 -144.47 -10.78 0.01 OUTLIER Pre-proline 0 C--N 1.302 -1.49 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.839 ' CD ' ' H ' ' B' ' 62' ' ' ASN . 46.5 Cg_endo -74.51 -7.52 19.62 Favored 'Trans proline' 0 N--CA 1.482 0.817 0 N-CA-C 109.042 -1.176 . . . . 0.0 109.042 178.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . 0.584 ' CB ' ' CE1' ' B' ' 61' ' ' PHE . 0.0 OUTLIER -94.27 -106.25 0.13 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.63 -0.669 . . . . 0.0 109.42 179.864 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.537 ' O ' ' HB2' ' B' ' 66' ' ' GLN . 19.5 p -71.33 -6.35 39.35 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.396 -1.44 . . . . 0.0 110.065 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . 0.654 ' HA ' ' O ' ' B' ' 62' ' ' ASN . 41.7 mm-40 77.71 106.6 0.08 Allowed 'General case' 0 N--CA 1.504 2.252 0 CA-C-O 121.602 0.715 . . . . 0.0 111.968 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . 0.599 ' O ' ' HG ' ' B' ' 69' ' ' LEU . 10.9 mt-10 138.95 93.27 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . 0.719 ' HA ' ' C ' ' B' ' 61' ' ' PHE . . . -41.56 102.03 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.404 0 O-C-N 120.659 -1.275 . . . . 0.0 110.229 -179.007 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.906 HD12 ' CE2' ' B' ' 61' ' ' PHE . 22.0 mt -94.54 -141.87 0.24 Allowed 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.607 -0.683 . . . . 0.0 111.003 -178.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . 0.548 ' HA ' ' HB3' ' B' ' 58' ' ' ARG . 2.4 tm-20 177.57 34.78 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.05 -1.031 . . . . 0.0 109.957 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 1.052 HG23 ' HD3' ' B' ' 73' ' ' PRO . 0.0 OUTLIER -66.11 -143.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 O-C-N 120.894 -1.128 . . . . 0.0 112.269 -178.335 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . 1.024 ' HA ' ' HA ' ' B' ' 57' ' ' ALA . . . -132.36 28.84 0.16 Allowed Pre-proline 0 N--CA 1.506 2.339 0 N-CA-C 117.138 2.273 . . . . 0.0 117.138 -174.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 73' ' ' PRO . . . . . 1.052 ' HD3' HG23 ' B' ' 71' ' ' ILE . 58.3 Cg_endo -110.32 99.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.303 -1.849 0 C-N-CA 120.635 0.89 . . . . 0.0 114.41 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . 0.546 ' O ' ' CG ' ' B' ' 56' ' ' GLN . 0.3 OUTLIER -150.33 90.29 1.65 Allowed 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 119.495 -0.882 . . . . 0.0 109.339 176.201 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . 1.092 HG11 ' HB3' ' A' ' 89' ' ' ALA . 7.6 p -30.68 145.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.496 0 O-C-N 121.278 -0.889 . . . . 0.0 111.09 -179.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . 0.602 ' HA3' HG22 ' B' ' 53' ' ' VAL . . . -101.25 78.81 0.4 Allowed Glycine 0 N--CA 1.478 1.495 0 C-N-CA 118.693 -1.718 . . . . 0.0 109.248 -179.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.867 HG21 ' HB3' ' A' ' 85' ' ' LEU . 2.4 p -66.74 69.19 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 O-C-N 121.672 -0.899 . . . . 0.0 109.384 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . 0.564 ' N ' ' O ' ' B' ' 51' ' ' LYS . 0.6 OUTLIER -64.37 174.12 1.79 Allowed 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 118.927 -1.109 . . . . 0.0 110.136 -179.944 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.77 ' CG2' HG22 ' B' ' 50' ' ' ILE . 3.7 p 174.06 176.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . 0.614 ' N ' HG22 ' B' ' 79' ' ' VAL . 0.0 OUTLIER 179.68 171.26 0.56 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 120.865 -1.147 . . . . 0.0 110.663 176.91 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 81' ' ' PRO . . . . . 0.575 ' HA ' ' O ' ' B' ' 47' ' ' PHE . 54.8 Cg_endo -94.9 138.84 0.97 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.493 2.128 . . . . 0.0 110.227 177.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . 0.516 ' HA3' ' HA ' ' B' ' 47' ' ' PHE . . . -92.64 -164.71 38.17 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 108.248 -1.941 . . . . 0.0 108.248 178.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . 0.503 ' O ' ' N ' ' B' ' 87' ' ' LYS . 0.0 OUTLIER -94.46 -18.17 21.75 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.138 -1.213 . . . . 0.0 110.36 179.517 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 14.5 t -61.22 -34.83 75.74 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 177.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.859 ' CG ' HG21 ' A' ' 77' ' ' VAL . 0.9 OUTLIER -86.74 -26.87 23.99 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.283 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . 0.813 ' O ' ' HB3' ' B' ' 89' ' ' ALA . 4.4 tttp -79.32 -34.32 42.4 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 177.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' B' ' 83' ' ' GLU . 15.7 tttt -67.14 -39.56 86.59 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 178.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 1.065 ' HB1' ' HB2' ' A' ' 37' ' ' ALA . . . -60.45 -38.0 82.75 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 175.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.847 ' CA ' HD23 ' B' ' 92' ' ' LEU . . . -55.78 -34.99 65.76 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 177.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.687 ' HA ' ' HB2' ' B' ' 94' ' ' TYR . 0.0 OUTLIER -56.91 -32.53 66.03 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 177.346 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.24 -13.27 77.23 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . 0.9 ' O ' HD12 ' B' ' 92' ' ' LEU . 0.3 OUTLIER -78.69 16.75 0.8 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.689 -1.477 . . . . 0.0 111.267 -179.883 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . 0.594 ' CG ' ' O ' ' B' ' 92' ' ' LEU . 0.1 OUTLIER 86.75 34.55 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -178.324 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . 0.775 ' CD2' ' HB ' ' A' ' 75' ' ' VAL . 3.6 t80 -42.09 -62.38 0.94 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.413 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . 0.709 ' HA ' ' HB3' ' B' ' 98' ' ' ALA . 26.4 mt-10 -58.39 -32.62 68.77 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.53 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 96' ' ' ASP . . . . . 0.476 ' HB3' ' HG3' ' B' ' 93' ' ' LYS . 0.5 OUTLIER -64.52 -34.77 79.0 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.711 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -83.17 -12.74 56.64 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 177.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 98' ' ' ALA . . . . . 0.72 ' HB2' ' N ' ' A' ' 74' ' ' SER . . . -92.79 -16.3 25.53 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.484 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 3.0 mttp . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.203 179.979 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.557 ' SD ' HG21 ' B' ' 35' ' ' THR . 1.4 mtp . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.01 0.433 . . . . 0.0 110.041 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.583 ' H ' ' HB2' ' A' ' 5' ' ' GLU . 47.0 p-10 -177.03 -169.68 0.26 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.295 -0.878 . . . . 0.0 110.44 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.795 ' O ' HD12 ' A' ' 25' ' ' LEU . 2.5 tptm -52.0 -17.38 1.0 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.4 -0.812 . . . . 0.0 110.158 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.435 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 24.4 m -95.49 -54.58 3.33 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.128 -0.983 . . . . 0.0 109.292 178.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.583 ' HB2' ' H ' ' A' ' 2' ' ' ASN . 2.8 mt-10 -62.85 -42.24 99.67 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.446 -0.901 . . . . 0.0 108.631 179.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.008 HD11 HG13 ' B' ' 42' ' ' VAL . 23.2 mt -65.35 -31.26 72.28 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 118.899 -1.12 . . . . 0.0 108.585 177.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.887 HG13 HD12 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -57.91 -57.23 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 178.341 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.976 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 18.4 pttt -65.83 -24.33 66.88 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 6' ' ' LEU . . . -60.25 -38.46 83.56 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.089 -1.007 . . . . 0.0 108.451 178.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.818 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.2 mp -88.48 -37.83 10.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 177.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.976 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -61.13 -15.76 36.92 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 119.047 -1.061 . . . . 0.0 108.631 177.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.451 ' HB3' ' O ' ' A' ' 8' ' ' LYS . 53.2 tp60 -111.13 -43.74 3.69 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.605 -0.684 . . . . 0.0 109.237 178.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.603 ' OD2' HG21 ' B' ' 31' ' ' ILE . 35.5 m-20 -62.33 -30.63 71.3 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 177.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.818 ' OG1' ' O ' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -105.03 -70.59 0.77 Allowed 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.122 179.053 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 49.08 26.7 6.32 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.065 ' CD1' HG23 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -87.41 -27.46 22.74 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.48 -1.012 . . . . 0.0 109.042 178.851 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.768 HG21 ' CG2' ' B' ' 17' ' ' THR . 0.4 OUTLIER -159.34 -7.61 0.07 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.982 -0.449 . . . . 0.0 110.169 -179.448 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.62 ' O ' ' C ' ' A' ' 19' ' ' VAL . 5.4 mt-30 58.0 31.2 20.31 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 -176.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.911 HG11 HG11 ' B' ' 19' ' ' VAL . 1.6 p -5.05 -91.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.502 -178.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.97 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -132.43 22.99 4.38 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.101 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.701 ' HA ' ' HE2' ' A' ' 24' ' ' MET . 16.0 m -19.41 -38.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 122.331 1.062 . . . . 0.0 109.389 -178.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.862 ' N ' ' O ' ' A' ' 20' ' ' SER . 5.6 t -78.88 -39.24 35.59 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.409 177.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.97 ' N ' ' O ' ' A' ' 20' ' ' SER . 3.1 mtmt -94.85 -28.36 15.27 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.603 -0.686 . . . . 0.0 109.543 178.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.701 ' HE2' ' HA ' ' A' ' 21' ' ' VAL 0.261 0.0 OUTLIER -63.09 -42.26 99.56 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.896 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.887 HD12 HG13 ' A' ' 7' ' ' ILE . 0.4 OUTLIER -86.1 -49.16 7.99 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 118.822 -1.151 . . . . 0.0 109.63 177.743 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' A' ' 22' ' ' SER . . . -46.77 -39.66 12.15 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.543 -1.348 . . . . 0.0 108.148 178.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.872 ' O ' HG23 ' A' ' 31' ' ' ILE . 55.6 m -78.31 -30.26 48.18 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.934 ' O ' HG13 ' A' ' 31' ' ' ILE . 7.7 t80 -54.79 -47.35 74.08 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.572 -0.705 . . . . 0.0 109.455 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.68 ' HB2' ' HE3' ' A' ' 3' ' ' LYS . 21.4 tt0 -68.78 -34.28 75.3 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 117.577 -1.649 . . . . 0.0 107.177 177.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.953 ' O ' ' HB3' ' A' ' 34' ' ' GLU . 7.8 tttp -69.22 -22.5 63.87 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.375 -0.93 . . . . 0.0 108.821 178.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.934 HG13 ' O ' ' A' ' 28' ' ' PHE . 2.3 pp -95.42 -40.43 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 119.364 -0.934 . . . . 0.0 109.66 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 1.054 HG21 ' CE1' ' B' ' 47' ' ' PHE . 6.2 mm -50.31 -50.28 21.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 177.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.694 HG22 ' HG ' ' B' ' 85' ' ' LEU . 7.5 p -69.38 -39.7 77.87 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.953 ' HB3' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -56.76 -32.86 66.02 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.692 -179.121 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.841 HG21 HG13 ' A' ' 42' ' ' VAL . 2.2 m -85.28 -56.23 3.64 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.021 -1.072 . . . . 0.0 110.272 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.754 HG13 ' HB3' ' A' ' 52' ' ' PRO . 94.2 t -53.92 -39.56 40.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 118.308 -1.357 . . . . 0.0 108.101 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.733 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -77.69 -3.45 41.16 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.101 -1.04 . . . . 0.0 109.012 177.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.619 ' HB2' ' O ' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -103.04 -26.76 12.95 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.253 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.49 43.29 1.37 Allowed Glycine 0 C--N 1.3 -1.418 0 C-N-CA 120.058 -1.068 . . . . 0.0 110.507 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.838 ' CB ' HG23 ' A' ' 35' ' ' THR . 0.1 OUTLIER -129.01 140.94 51.41 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.179 -1.189 . . . . 0.0 109.979 179.241 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.453 ' O ' ' N ' ' A' ' 43' ' ' GLN . 51.3 mtpt -88.08 89.32 7.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.552 -0.717 . . . . 0.0 110.53 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.841 HG13 HG21 ' A' ' 35' ' ' THR . 27.8 m -61.63 80.31 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.608 -0.683 . . . . 0.0 109.939 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.464 ' O ' ' HA ' ' B' ' 2' ' ' ASN . 1.9 tt0 -84.04 107.24 16.27 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.469 -0.769 . . . . 0.0 109.318 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.953 HD12 ' CB ' ' A' ' 48' ' ' LEU . 65.1 mt -61.89 114.67 3.48 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.138 -0.976 . . . . 0.0 109.179 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.588 HG23 ' HD1' ' A' ' 47' ' ' PHE . 0.0 OUTLIER 33.02 -97.5 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.853 -0.529 . . . . 0.0 111.256 -179.614 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.413 ' H ' HG23 ' A' ' 45' ' ' THR . . . -144.44 28.32 1.93 Allowed Glycine 0 N--CA 1.489 2.201 0 C-N-CA 119.726 -1.226 . . . . 0.0 110.39 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.713 ' CD1' ' HG3' ' B' ' 29' ' ' GLU . 3.6 p90 -126.03 -29.54 3.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.903 -1.351 . . . . 0.0 110.517 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.953 ' CB ' HD12 ' A' ' 44' ' ' LEU . 11.9 mt -123.63 93.12 3.84 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.23 -1.544 . . . . 0.0 110.53 177.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -86.86 86.0 7.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.911 -0.493 . . . . 0.0 110.055 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.854 ' CD1' HG23 ' A' ' 79' ' ' VAL . 1.5 mp -82.97 137.81 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.425 -0.797 . . . . 0.0 110.069 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 13.5 ptmt -153.43 127.94 4.66 Favored Pre-proline 0 N--CA 1.494 1.732 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.472 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.754 ' HB3' HG13 ' A' ' 36' ' ' VAL . 41.1 Cg_endo -65.47 141.33 67.05 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 123.539 1.284 . . . . 0.0 111.894 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.732 HG22 ' O ' ' A' ' 76' ' ' GLY . 33.4 m -147.66 117.69 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 CA-C-O 121.326 0.584 . . . . 0.0 111.244 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.799 ' HB1' ' O ' ' A' ' 73' ' ' PRO . . . -62.12 131.25 48.91 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.309 -0.869 . . . . 0.0 112.278 -178.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.528 ' H ' ' C ' ' A' ' 74' ' ' SER . 0.6 OUTLIER -176.16 106.75 0.08 Allowed 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.631 0.729 . . . . 0.0 110.358 179.548 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.657 ' CB ' ' H ' ' A' ' 74' ' ' SER . 0.9 OUTLIER -172.18 19.11 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.561 -0.712 . . . . 0.0 110.018 179.227 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.586 ' HB3' HG23 ' A' ' 71' ' ' ILE . . . -172.07 169.16 5.67 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.181 -0.95 . . . . 0.0 110.355 -177.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.935 ' N ' HG21 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -144.66 174.68 10.76 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.33 -0.857 . . . . 0.0 110.26 178.21 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.769 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . 1.1 tttm -169.06 -139.14 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.127 -0.983 . . . . 0.0 111.006 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.09 98.94 0.24 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.551 ' HA ' ' O ' ' A' ' 67' ' ' GLU . 48.0 p90 -53.3 170.95 0.08 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.435 -1.038 . . . . 0.0 110.91 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.535 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 0.3 OUTLIER -59.12 -165.32 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.937 0 O-C-N 121.622 -0.674 . . . . 0.0 109.361 179.817 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.535 ' HD2' ' HB3' ' A' ' 62' ' ' ASN . 44.5 Cg_endo -75.99 60.23 6.08 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 N-CA-C 109.133 -1.141 . . . . 0.0 109.133 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.435 ' C ' ' CE1' ' A' ' 61' ' ' PHE . 24.1 mt-30 -139.8 -109.48 0.16 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.509 -0.744 . . . . 0.0 110.534 -179.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.46 ' HA ' ' CZ ' ' A' ' 61' ' ' PHE . 6.7 t -175.34 29.08 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.895 -1.128 . . . . 0.0 110.829 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -174.18 -26.8 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.025 -1.047 . . . . 0.0 111.918 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.714 ' O ' HD23 ' A' ' 69' ' ' LEU . 9.8 mt-10 -72.29 65.02 0.59 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.905 -1.122 . . . . 0.0 110.227 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.502 ' CB ' ' HB2' ' A' ' 58' ' ' ARG . . . -64.63 133.06 51.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.697 -0.627 . . . . 0.0 110.941 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.778 ' O ' HD12 ' A' ' 69' ' ' LEU . 1.5 pp -174.71 56.41 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.252 -0.905 . . . . 0.0 111.053 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.586 ' CB ' ' HB3' ' A' ' 59' ' ' LYS . 1.6 tt0 -131.29 19.21 4.86 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.765 -1.21 . . . . 0.0 110.697 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.935 HG21 ' N ' ' A' ' 58' ' ' ARG 0.301 16.6 tt -111.99 -138.76 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.516 -0.74 . . . . 0.0 110.647 -178.832 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.709 ' H ' HG12 ' A' ' 71' ' ' ILE . . . -117.9 81.43 15.66 Favored Pre-proline 0 C--N 1.3 -1.557 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -176.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.956 ' HD2' ' HB1' ' B' ' 98' ' ' ALA . 45.0 Cg_endo -70.45 122.64 9.12 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 O-C-N 123.896 1.471 . . . . 0.0 111.285 177.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.885 ' HA ' ' CD1' ' B' ' 94' ' ' TYR . 14.7 t -76.6 129.51 36.51 Favored 'General case' 0 N--CA 1.51 2.571 0 CA-C-O 121.644 0.735 . . . . 0.0 112.807 -178.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 1.029 ' HB ' ' HB1' ' B' ' 89' ' ' ALA . 38.2 t -54.19 138.48 13.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-O 122.162 0.982 . . . . 0.0 109.975 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.732 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -126.57 105.62 0.79 Allowed Glycine 0 C--N 1.29 -1.998 0 N-CA-C 108.015 -2.034 . . . . 0.0 108.015 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.771 HG13 ' O ' ' A' ' 77' ' ' VAL . 13.2 p -51.02 89.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.678 -0.895 . . . . 0.0 110.476 -178.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.504 ' N ' ' O ' ' A' ' 76' ' ' GLY . 0.5 OUTLIER -58.58 -171.92 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.281 -0.887 . . . . 0.0 110.729 -179.14 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.854 HG23 ' CD1' ' A' ' 50' ' ' ILE . 3.3 p -167.48 -164.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.693 ' H ' HG22 ' A' ' 79' ' ' VAL . 2.0 mttm -160.08 178.59 1.61 Allowed Pre-proline 0 C--N 1.308 -1.211 0 O-C-N 120.914 -1.116 . . . . 0.0 111.335 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.447 ' CD ' ' CB ' ' A' ' 80' ' ' LYS . 55.5 Cg_endo -103.64 83.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 123.977 3.118 . . . . 0.0 108.862 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.651 ' CA ' ' O ' ' A' ' 47' ' ' PHE . . . -57.0 121.63 25.94 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.591 -1.29 . . . . 0.0 111.183 -178.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -62.19 -35.74 79.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.53 -0.982 . . . . 0.0 109.043 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.596 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 0.3 OUTLIER -53.94 -30.85 48.35 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.586 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.987 HD21 HG11 ' B' ' 36' ' ' VAL . 8.8 tt -85.26 -34.23 21.99 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.742 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 0.3 OUTLIER -75.35 -44.75 43.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.542 -0.724 . . . . 0.0 109.446 179.606 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 41.4 tptt -64.98 -38.26 90.38 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 177.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.828 ' O ' ' HB1' ' B' ' 37' ' ' ALA . . . -61.65 -36.63 81.35 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 176.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.742 ' HB3' ' O ' ' A' ' 86' ' ' LYS . . . -56.42 -39.68 73.46 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.492 ' HA ' ' CB ' ' A' ' 94' ' ' TYR . 6.4 mm-40 -55.9 -28.89 58.81 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 176.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 88' ' ' ALA . . . -65.72 -50.84 51.56 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 178.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.718 HD11 ' CE1' ' A' ' 97' ' ' PHE . 0.4 OUTLIER -59.85 -37.2 78.61 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.417 -1.637 . . . . 0.0 109.64 -179.745 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.596 ' CB ' ' O ' ' A' ' 92' ' ' LEU . 1.1 ttmt 143.82 65.23 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 1.345 ' O ' ' N ' ' A' ' 96' ' ' ASP . 7.7 t80 -49.11 -60.74 2.53 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 116.328 -2.149 . . . . 0.0 106.45 178.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 1.095 ' C ' ' O ' ' A' ' 94' ' ' TYR . 3.8 mm-40 10.96 41.9 0.0 OUTLIER 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 102.291 -3.226 . . . . 0.0 102.291 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 1.345 ' N ' ' O ' ' A' ' 94' ' ' TYR . 0.3 OUTLIER 21.13 43.18 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 113.533 -1.667 . . . . 0.0 107.626 -172.916 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.849 ' N ' ' O ' ' A' ' 94' ' ' TYR 0.254 1.0 OUTLIER 27.83 28.44 0.0 OUTLIER 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 101.677 -3.453 . . . . 0.0 101.677 -170.35 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 1.061 ' N ' ' O ' ' A' ' 96' ' ' ASP . . . -68.52 -30.93 69.85 Favored 'General case' 0 C--O 1.215 -0.733 0 CA-C-N 110.292 -3.14 . . . . 0.0 109.559 -178.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 26.2 mttm . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.196 179.993 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.659 ' HG2' HG12 ' A' ' 42' ' ' VAL . 1.6 tpt . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 120.855 0.36 . . . . 0.0 110.401 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . 0.475 ' HB3' ' O ' ' B' ' 1' ' ' MET . 25.9 p30 179.6 -160.49 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.343 -0.943 . . . . 0.0 111.41 178.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.559 ' HE3' ' CG2' ' A' ' 45' ' ' THR . 0.1 OUTLIER -52.56 -10.45 0.15 Allowed 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.419 -0.801 . . . . 0.0 110.814 -179.705 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.502 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 4.4 m -106.43 -51.5 2.94 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.861 -1.149 . . . . 0.0 109.495 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.607 ' CB ' ' HA ' ' B' ' 1' ' ' MET . 1.3 mt-10 -65.46 -37.84 88.05 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.217 -0.927 . . . . 0.0 108.637 179.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.81 HD11 ' HB ' ' A' ' 42' ' ' VAL . 24.6 mt -71.88 -27.95 63.2 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 118.892 -1.123 . . . . 0.0 108.214 177.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' ILE . . . . . 0.786 HG23 ' HB ' ' B' ' 21' ' ' VAL . 0.2 OUTLIER -57.31 -60.78 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 177.542 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . 0.941 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.0 OUTLIER -62.8 -24.1 67.57 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.581 178.443 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' B' ' 6' ' ' LEU . . . -60.83 -36.28 78.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.04 -1.038 . . . . 0.0 108.674 178.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.915 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.0 OUTLIER -96.56 -35.19 5.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 178.535 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.941 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -60.34 -25.12 65.58 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -91.27 -43.25 9.92 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 178.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.482 ' HB3' ' CB ' ' A' ' 27' ' ' SER . 1.1 m-20 -64.33 -26.11 68.33 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 177.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.915 ' OG1' ' O ' ' B' ' 10' ' ' ILE . 10.7 p -91.78 -75.1 0.49 Allowed 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 177.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' B' ' 11' ' ' ALA . . . 57.75 17.78 29.24 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 178.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' LEU . . . . . 0.896 HD22 ' O ' ' A' ' 19' ' ' VAL . 3.8 mp -77.54 -57.13 3.98 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 122.317 1.056 . . . . 0.0 108.532 178.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . 0.768 ' CG2' HG21 ' A' ' 17' ' ' THR . 0.5 OUTLIER -142.67 5.54 1.59 Allowed 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 115.162 -0.927 . . . . 0.0 109.18 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . 0.622 ' O ' ' C ' ' B' ' 19' ' ' VAL . 3.9 mt-30 58.26 25.24 12.43 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 -176.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 1.065 HG23 ' CD1' ' A' ' 16' ' ' LEU . 0.2 OUTLIER 9.43 -98.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.437 -178.954 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 1.051 ' O ' ' N ' ' B' ' 22' ' ' SER . 1.9 p -136.6 24.14 3.15 Favored 'General case' 0 C--N 1.273 -2.733 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 177.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.786 ' HB ' HG23 ' B' ' 7' ' ' ILE . 21.9 m -4.35 -42.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 CA-C-O 122.528 1.156 . . . . 0.0 110.763 -177.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 1.051 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.5 OUTLIER -76.62 -38.09 55.31 Favored 'General case' 0 C--N 1.281 -2.407 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.2 178.724 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . 0.882 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.0 OUTLIER -89.19 -32.79 17.28 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.437 -0.79 . . . . 0.0 111.302 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' MET . . . . . 0.594 ' HG2' HG22 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -68.83 -37.7 79.35 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 117.322 -1.751 . . . . 0.0 108.736 179.683 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.698 ' HA ' ' HB3' ' B' ' 28' ' ' PHE . 0.3 OUTLIER -82.91 -44.39 15.43 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 118.21 -1.396 . . . . 0.0 109.669 178.234 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . 0.541 ' HA ' ' CE ' ' B' ' 3' ' ' LYS . . . -58.4 -35.36 71.9 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.957 -1.089 . . . . 0.0 108.2 178.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . 0.554 ' O ' HG13 ' B' ' 31' ' ' ILE . 20.0 t -81.68 -30.99 32.43 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . 0.738 ' CZ ' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -54.51 -45.09 73.23 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 178.793 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . 0.713 ' HG3' ' CD1' ' A' ' 47' ' ' PHE . 1.5 tt0 -69.93 -34.83 73.97 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 176.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 1.128 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 7.2 tttp -63.95 -18.27 64.08 Favored 'General case' 0 C--O 1.189 -2.112 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 177.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.69 ' CG1' ' HA ' ' B' ' 28' ' ' PHE . 1.2 pp -108.53 -26.08 3.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 120.32 -1.487 . . . . 0.0 108.617 177.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.624 HD11 ' CE2' ' B' ' 28' ' ' PHE . 1.1 mm -73.42 -57.02 7.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 176.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' THR . . . . . 0.561 ' OG1' ' HB2' ' A' ' 85' ' ' LEU . 0.5 OUTLIER -67.19 -40.88 86.59 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.335 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 1.128 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 76.9 mm-40 -74.72 -40.69 61.15 Favored 'General case' 0 C--O 1.207 -1.138 0 O-C-N 121.4 -0.813 . . . . 0.0 112.513 -179.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' THR . . . . . 0.557 HG21 ' SD ' ' A' ' 1' ' ' MET . 53.3 m -59.51 -49.11 79.05 Favored 'General case' 0 N--CA 1.505 2.284 0 CA-C-N 120.797 1.635 . . . . 0.0 109.469 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.987 HG11 HD21 ' A' ' 85' ' ' LEU . 1.4 t -53.0 -41.77 42.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 C-N-CA 118.266 -1.374 . . . . 0.0 107.345 178.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 0.828 ' HB1' ' O ' ' A' ' 88' ' ' ALA . . . -92.7 11.57 26.33 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.717 -0.793 . . . . 0.0 109.745 178.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.704 ' HB2' ' O ' ' B' ' 34' ' ' GLU . 1.4 tppt? -104.76 -29.26 10.67 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 177.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.82 34.56 0.43 Allowed Glycine 0 C--N 1.305 -1.183 0 C-N-CA 119.835 -1.174 . . . . 0.0 111.042 177.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . 0.49 ' HB2' HG23 ' B' ' 35' ' ' THR . 0.1 OUTLIER -150.94 179.82 7.92 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.869 -1.371 . . . . 0.0 110.785 179.638 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.409 ' O ' ' HG3' ' B' ' 43' ' ' GLN . 5.0 mtmp? -133.2 113.6 12.86 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 1.008 HG13 HD11 ' A' ' 6' ' ' LEU . 59.2 t -61.24 140.52 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.441 -0.787 . . . . 0.0 110.499 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' GLN . . . . . 0.5 ' HA ' ' HA ' ' B' ' 49' ' ' ASN . 12.4 mt-30 -140.53 82.91 1.87 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.524 -0.735 . . . . 0.0 109.826 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.749 HD12 ' HB3' ' B' ' 48' ' ' LEU . 5.6 mt -59.79 117.5 5.07 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.274 -0.891 . . . . 0.0 110.704 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . 0.594 HG23 ' CD2' ' B' ' 47' ' ' PHE . 0.0 OUTLIER 24.38 -92.73 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.243 0 O-C-N 122.16 -0.337 . . . . 0.0 111.436 179.062 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.488 ' H ' HG23 ' B' ' 45' ' ' THR . . . -146.54 48.3 0.67 Allowed Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . 1.054 ' CE1' HG21 ' A' ' 32' ' ' ILE . 16.5 p90 -151.27 -40.09 0.12 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.963 -1.316 . . . . 0.0 111.671 179.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.863 HD13 ' CB ' ' B' ' 80' ' ' LYS . 0.0 OUTLIER -116.86 107.94 15.22 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.703 -1.248 . . . . 0.0 110.378 179.401 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' ASN . . . . . 0.945 ' O ' ' O ' ' B' ' 79' ' ' VAL . 0.5 OUTLIER -124.54 97.49 5.32 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.997 -1.064 . . . . 0.0 110.606 -179.495 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 50' ' ' ILE . . . . . 0.508 ' H ' ' HD3' ' B' ' 80' ' ' LYS . 0.5 OUTLIER -88.56 143.89 10.27 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 O-C-N 121.496 -0.753 . . . . 0.0 110.883 -179.211 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . 0.55 ' HG3' ' HB2' ' B' ' 78' ' ' SER . 0.0 OUTLIER -159.88 136.69 6.66 Favored Pre-proline 0 N--CA 1.495 1.792 0 C-N-CA 119.416 -0.914 . . . . 0.0 110.023 179.6 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.736 ' HB3' HG13 ' B' ' 36' ' ' VAL . 56.6 Cg_endo -89.28 144.86 4.98 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.752 1.396 . . . . 0.0 112.58 -178.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.59 HG22 ' O ' ' B' ' 76' ' ' GLY . 33.3 m -144.23 113.16 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-O 121.655 0.741 . . . . 0.0 109.709 177.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.788 ' HB2' ' CD2' ' A' ' 97' ' ' PHE . . . -45.02 120.22 2.29 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 122.0 0.905 . . . . 0.0 112.462 -178.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . 0.437 ' N ' ' OD1' ' A' ' 96' ' ' ASP . 0.4 OUTLIER -141.79 93.75 2.59 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.895 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . 0.651 ' O ' HD11 ' B' ' 71' ' ' ILE . 0.0 OUTLIER -52.81 -176.14 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.404 -0.81 . . . . 0.0 111.543 -178.513 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.868 ' HB2' ' HD3' ' B' ' 73' ' ' PRO . . . -73.63 -158.91 0.06 Allowed 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.57 0.7 . . . . 0.0 110.872 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 58' ' ' ARG . . . . . 0.445 ' HB2' HG12 ' B' ' 71' ' ' ILE . 0.0 OUTLIER -158.38 175.16 14.07 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.772 -0.58 . . . . 0.0 109.92 -179.629 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 2.9 tptt -176.82 93.35 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.232 -0.918 . . . . 0.0 110.433 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . 0.596 ' HA2' ' HB1' ' B' ' 68' ' ' ALA . . . 97.13 52.72 1.45 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 61' ' ' PHE . . . . . 0.781 ' O ' ' CB ' ' B' ' 62' ' ' ASN . 21.3 t80 -76.62 164.37 25.97 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.266 -1.138 . . . . 0.0 111.305 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . 0.781 ' CB ' ' O ' ' B' ' 61' ' ' PHE . 2.7 t30 138.83 -36.58 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.035 0 O-C-N 121.721 -0.612 . . . . 0.0 110.45 178.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.753 ' HD2' ' N ' ' B' ' 62' ' ' ASN . 38.4 Cg_endo -66.49 -17.25 53.12 Favored 'Trans proline' 0 C--N 1.316 -1.167 0 N-CA-C 108.069 -1.551 . . . . 0.0 108.069 177.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . 0.704 ' O ' HG23 ' B' ' 65' ' ' THR . 0.9 OUTLIER -74.56 -72.87 0.26 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.704 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.704 HG23 ' O ' ' B' ' 64' ' ' GLN . 0.0 OUTLIER -176.24 20.05 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.854 -0.529 . . . . 0.0 110.317 178.753 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . 0.713 ' HB2' ' CE1' ' B' ' 61' ' ' PHE . 0.7 OUTLIER -138.93 -141.66 0.15 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.073 -1.017 . . . . 0.0 109.696 179.864 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . 0.599 ' O ' ' HD1' ' B' ' 61' ' ' PHE . 25.5 mt-10 -105.74 -157.27 0.61 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 177.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . 0.859 ' C ' HD23 ' B' ' 69' ' ' LEU . . . -108.03 133.76 51.88 Favored 'General case' 0 C--N 1.287 -2.129 0 C-N-CA 118.406 -1.318 . . . . 0.0 110.948 179.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.859 HD23 ' C ' ' B' ' 68' ' ' ALA . 0.0 OUTLIER -140.0 144.58 37.04 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.786 -178.571 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -114.85 68.02 0.7 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.412 -0.805 . . . . 0.0 110.344 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.651 HD11 ' O ' ' B' ' 56' ' ' GLN . 1.5 pt -60.38 -159.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.89 . . . . 0.0 110.344 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.71 154.09 66.85 Favored Pre-proline 0 C--N 1.302 -1.466 0 O-C-N 121.375 -0.828 . . . . 0.0 110.97 -178.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 73' ' ' PRO . . . . . 0.868 ' HD3' ' HB2' ' B' ' 57' ' ' ALA . 44.0 Cg_endo -71.25 116.73 4.81 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.225 1.645 . . . . 0.0 110.322 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . 0.492 ' HA ' ' CD1' ' A' ' 94' ' ' TYR . 4.5 p -179.27 171.4 1.31 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.33 -0.856 . . . . 0.0 109.676 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . 0.715 HG11 ' CB ' ' A' ' 89' ' ' ALA . 6.1 p -52.64 175.24 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.252 -0.905 . . . . 0.0 109.416 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . 0.59 ' O ' HG22 ' B' ' 53' ' ' VAL . . . -118.26 45.14 1.3 Allowed Glycine 0 N--CA 1.488 2.16 0 C-N-CA 118.898 -1.62 . . . . 0.0 109.825 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.877 ' CG2' HD22 ' A' ' 85' ' ' LEU . 6.5 p -28.13 91.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 122.061 -0.67 . . . . 0.0 110.828 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . 0.55 ' HB2' ' HG3' ' B' ' 51' ' ' LYS . 57.7 m -57.91 -122.12 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 119.864 -0.734 . . . . 0.0 109.102 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.945 ' O ' ' O ' ' B' ' 49' ' ' ASN . 4.5 m -148.41 -168.88 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 119.859 -1.776 . . . . 0.0 112.868 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . 0.888 ' H ' ' HD2' ' B' ' 81' ' ' PRO . 0.0 OUTLIER -114.58 -52.92 0.04 OUTLIER Pre-proline 0 C--N 1.301 -1.531 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -178.403 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 81' ' ' PRO . . . . . 0.888 ' HD2' ' H ' ' B' ' 80' ' ' LYS . 26.7 Cg_endo -49.49 130.59 25.99 Favored 'Trans proline' 0 C--N 1.298 -2.106 0 C-N-CA 120.869 1.046 . . . . 0.0 112.551 -175.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -128.04 -62.8 0.13 Allowed Glycine 0 N--CA 1.486 1.981 0 N-CA-C 105.856 -2.897 . . . . 0.0 105.856 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . 0.885 ' O ' ' N ' ' B' ' 85' ' ' LEU . 26.3 tt0 -91.03 47.6 1.42 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.514 -1.662 . . . . 0.0 106.514 175.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 84' ' ' SER . . . . . 1.286 ' O ' ' N ' ' B' ' 86' ' ' LYS . 4.5 m 8.45 43.79 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.506 1.146 . . . . 0.0 110.875 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 1.026 ' C ' ' O ' ' B' ' 84' ' ' SER . 4.3 mp 22.01 29.66 0.0 OUTLIER 'General case' 0 C--O 1.194 -1.831 0 N-CA-C 103.599 -2.741 . . . . 0.0 103.599 -171.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . 1.286 ' N ' ' O ' ' B' ' 84' ' ' SER 0.319 6.5 tttm -51.85 -34.78 42.13 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 103.459 -2.793 . . . . 0.0 103.459 175.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . 0.456 ' O ' ' CG ' ' B' ' 90' ' ' GLU 0.286 16.8 tptp -68.01 -36.2 79.58 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 111.773 -2.467 . . . . 0.0 106.609 175.565 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.919 ' HB3' ' HB3' ' B' ' 85' ' ' LEU . . . -80.38 -26.2 38.7 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 118.349 -1.34 . . . . 0.0 107.764 177.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 1.029 ' HB1' ' HB ' ' A' ' 75' ' ' VAL . . . -67.27 -50.11 61.74 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.53 -0.731 . . . . 0.0 109.051 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.456 ' CG ' ' O ' ' B' ' 87' ' ' LYS . 6.5 pt-20 -57.03 -27.83 61.98 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 176.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . 0.44 ' N ' ' HG3' ' B' ' 90' ' ' GLU . . . -63.32 -38.25 96.13 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 178.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . 0.843 HD23 ' HA ' ' B' ' 89' ' ' ALA . 0.9 OUTLIER -85.37 23.48 1.31 Allowed 'General case' 0 N--CA 1.503 2.222 0 O-C-N 120.493 -1.592 . . . . 0.0 110.5 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . 0.458 ' O ' ' N ' ' B' ' 96' ' ' ASP . 0.4 OUTLIER 58.58 48.17 12.24 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 -177.659 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . 0.885 ' CD1' ' HA ' ' A' ' 74' ' ' SER . 0.0 OUTLIER -42.98 -37.11 1.77 Allowed 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.762 -178.51 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . 0.469 ' N ' ' CD1' ' B' ' 94' ' ' TYR . 8.8 pt-20 -53.85 -39.48 65.65 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.258 -0.901 . . . . 0.0 109.097 178.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 96' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' B' ' 93' ' ' LYS . 0.2 OUTLIER -65.96 -28.5 68.95 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.308 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -97.65 2.62 50.0 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.549 -0.719 . . . . 0.0 109.185 178.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 98' ' ' ALA . . . . . 0.956 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -94.58 -33.88 12.85 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.59 -0.694 . . . . 0.0 110.278 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 19.8 mttt . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.261 179.937 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.575 ' CE ' HD23 ' A' ' 6' ' ' LEU . 3.8 mtp . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 120.908 0.385 . . . . 0.0 110.064 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.805 ' C ' HD12 ' A' ' 6' ' ' LEU . 27.3 p30 -177.82 -167.75 0.16 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.215 -0.928 . . . . 0.0 111.28 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.607 ' HG2' HD13 ' A' ' 25' ' ' LEU . 12.7 tttt -51.31 -16.63 0.56 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.555 -0.716 . . . . 0.0 110.252 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.609 ' O ' HG12 ' A' ' 7' ' ' ILE . 41.0 m -104.69 -58.95 1.81 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.263 -0.898 . . . . 0.0 110.271 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.455 ' HB2' ' H ' ' A' ' 2' ' ' ASN . 3.5 mm-40 -54.88 -45.54 74.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.125 -0.985 . . . . 0.0 109.762 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.805 HD12 ' C ' ' A' ' 2' ' ' ASN . 12.0 mt -52.04 -45.85 64.81 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.389 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.72 HG21 HD22 ' A' ' 25' ' ' LEU . 0.6 OUTLIER -56.36 -45.99 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 178.271 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.866 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 0.9 OUTLIER -56.67 -39.94 74.65 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 176.828 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.913 ' CB ' HD13 ' B' ' 31' ' ' ILE . . . -54.85 -35.71 64.3 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 178.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.768 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.5 mp -88.33 -32.45 5.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 177.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.866 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -67.89 -10.84 56.5 Favored 'General case' 0 C--N 1.287 -2.12 0 C-N-CA 118.999 -1.08 . . . . 0.0 108.969 178.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.449 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -120.6 -34.73 3.53 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.356 -0.84 . . . . 0.0 110.333 179.157 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.479 ' HB3' ' HB2' ' B' ' 27' ' ' SER . 0.9 OUTLIER -74.94 -36.88 62.11 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 176.823 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 1.113 HG22 ' CD1' ' A' ' 16' ' ' LEU 0.268 0.2 OUTLIER -91.96 -70.28 0.7 Allowed 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 177.95 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 54.45 21.49 20.56 Favored Glycine 0 N--CA 1.5 2.908 0 O-C-N 121.534 -0.729 . . . . 0.0 111.445 177.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.113 ' CD1' HG22 ' A' ' 14' ' ' THR . 5.0 mp -64.7 -62.87 1.31 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.362 -1.081 . . . . 0.0 109.01 178.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.675 HG21 HG21 ' B' ' 17' ' ' THR . 0.5 OUTLIER -138.82 6.45 2.44 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.866 -179.815 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.594 ' O ' ' C ' ' A' ' 19' ' ' VAL . 6.3 mt-30 57.53 26.92 13.32 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 -176.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 1.057 HG11 HG11 ' B' ' 19' ' ' VAL . 1.2 p -0.83 -95.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.802 -178.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.96 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -133.2 25.79 4.19 Favored 'General case' 0 C--N 1.277 -2.575 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 179.005 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.66 ' HA ' ' CE ' ' A' ' 24' ' ' MET . 31.0 m -19.1 -39.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 CA-C-O 122.483 1.135 . . . . 0.0 109.505 -178.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.854 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.6 OUTLIER -77.7 -40.47 41.25 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.362 177.522 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.96 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -85.6 -38.94 17.88 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 121.543 -0.723 . . . . 0.0 111.577 179.891 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.66 ' CE ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -66.22 -27.21 67.8 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 117.315 -1.754 . . . . 0.0 108.176 179.368 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.72 HD22 HG21 ' A' ' 7' ' ' ILE . 0.4 OUTLIER -74.64 -45.1 47.07 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 118.827 -1.149 . . . . 0.0 108.838 177.933 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.672 ' N ' ' HG ' ' A' ' 25' ' ' LEU . . . -63.99 -25.27 68.05 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 178.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.568 ' HA ' ' HB3' ' A' ' 30' ' ' LYS . 19.1 p -85.3 -41.03 15.9 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.692 ' CE1' HD22 ' B' ' 44' ' ' LEU . 0.0 OUTLIER -57.33 -48.23 79.52 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.087 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.587 ' HG3' ' CE2' ' B' ' 47' ' ' PHE . 0.7 OUTLIER -68.6 -35.14 76.94 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.034 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 1.248 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 13.8 ttmt -64.85 -22.13 66.93 Favored 'General case' 0 C--O 1.191 -2.023 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 177.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.881 HD13 ' CB ' ' B' ' 9' ' ' ALA . 0.6 OUTLIER -105.08 -28.44 2.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 120.068 -1.645 . . . . 0.0 109.17 178.076 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.651 HG21 ' CE1' ' B' ' 47' ' ' PHE . 1.2 mm -72.24 -61.15 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 176.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.819 ' HA ' HD23 ' B' ' 85' ' ' LEU . 0.5 OUTLIER -67.8 -35.27 78.34 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.282 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 1.248 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 27.4 mm-40 -77.8 -32.31 52.32 Favored 'General case' 0 N--CA 1.482 1.138 0 O-C-N 120.958 -1.089 . . . . 0.0 111.214 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.748 HG23 ' CB ' ' A' ' 40' ' ' ASP . 1.8 m -59.3 -50.93 72.11 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.32 -1.488 . . . . 0.0 107.457 178.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.05 HG21 HG23 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -53.89 -36.49 30.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 C-N-CA 117.918 -1.513 . . . . 0.0 107.006 177.868 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.606 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -80.43 -7.86 59.31 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.677 0.751 . . . . 0.0 109.632 177.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.555 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -100.26 -8.21 23.73 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 177.566 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 80.47 47.49 6.82 Favored Glycine 0 C--N 1.302 -1.316 0 N-CA-C 110.201 -1.159 . . . . 0.0 110.201 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.748 ' CB ' HG23 ' A' ' 35' ' ' THR . 0.3 OUTLIER -130.28 119.51 22.97 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.295 -1.121 . . . . 0.0 110.314 179.594 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -76.09 81.9 2.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.479 -0.763 . . . . 0.0 109.519 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.86 ' CG2' HD11 ' B' ' 6' ' ' LEU . 5.9 p -63.6 144.91 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.439 -0.788 . . . . 0.0 110.253 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -128.01 98.87 5.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.502 -0.749 . . . . 0.0 109.876 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.75 HD12 ' HB3' ' A' ' 48' ' ' LEU . 8.7 mt -61.62 108.22 0.94 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.256 -0.902 . . . . 0.0 109.495 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.55 HG21 ' HE2' ' B' ' 3' ' ' LYS . 0.0 OUTLIER 31.12 -91.77 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.315 0 O-C-N 122.003 -0.436 . . . . 0.0 111.189 -179.669 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -149.48 32.36 1.12 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.738 ' CD1' HD21 ' A' ' 85' ' ' LEU . 2.1 p90 -134.92 -23.04 1.57 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.031 -1.276 . . . . 0.0 111.936 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.872 HD23 ' O ' ' A' ' 80' ' ' LYS . 5.0 mt -130.82 118.23 20.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.259 -1.525 . . . . 0.0 111.166 178.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.447 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 2.1 m-20 -115.92 93.57 4.31 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.544 -0.723 . . . . 0.0 110.513 -179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.866 HG23 HG22 ' A' ' 79' ' ' VAL . 9.5 mm -87.63 132.94 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.313 -0.867 . . . . 0.0 109.282 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.501 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 0.5 OUTLIER -149.85 126.06 5.16 Favored Pre-proline 0 N--CA 1.497 1.895 0 C-N-CA 118.57 -1.252 . . . . 0.0 111.038 179.959 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.881 ' HB3' HG22 ' A' ' 36' ' ' VAL . 56.1 Cg_endo -81.48 138.95 11.16 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.439 1.231 . . . . 0.0 110.51 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.706 HG22 ' O ' ' A' ' 76' ' ' GLY . 28.6 m -140.84 115.61 6.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-O 121.546 0.689 . . . . 0.0 110.377 179.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.491 ' HB2' ' HB3' ' B' ' 97' ' ' PHE . . . -41.99 129.21 3.58 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.824 0.821 . . . . 0.0 112.139 -178.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -153.72 151.61 29.82 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -123.57 -171.97 2.42 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.12 -0.987 . . . . 0.0 110.957 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.721 ' HB3' ' N ' ' A' ' 72' ' ' ALA . . . -165.5 156.02 13.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.525 -0.734 . . . . 0.0 109.61 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.754 ' HA ' ' HB ' ' A' ' 71' ' ' ILE . 78.1 mmt-85 -152.3 157.96 42.1 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.131 -0.98 . . . . 0.0 111.687 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.884 ' N ' HG22 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -117.48 168.63 10.21 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.385 -0.822 . . . . 0.0 110.053 179.145 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.636 ' CA ' ' HB1' ' A' ' 68' ' ' ALA . . . 60.61 15.45 40.38 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.131 -1.587 . . . . 0.0 109.131 -179.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.89 ' HB3' ' HG ' ' A' ' 69' ' ' LEU . 8.7 t80 -57.99 172.03 0.46 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.316 -1.108 . . . . 0.0 111.317 -179.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.769 ' CB ' ' O ' ' A' ' 61' ' ' PHE . 1.9 t-20 145.56 -37.72 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.088 0 O-C-N 121.633 -0.667 . . . . 0.0 110.984 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.688 ' HD2' ' N ' ' A' ' 62' ' ' ASN . 40.9 Cg_endo -68.85 -5.71 16.24 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 O-C-N 122.963 0.98 . . . . 0.0 109.639 178.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.589 ' HB2' ' CE2' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -103.33 -43.53 5.41 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.28 -0.888 . . . . 0.0 110.087 179.282 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.635 HG22 ' O ' ' A' ' 65' ' ' THR . 100.0 m -147.65 18.82 1.16 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.508 -0.745 . . . . 0.0 109.941 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.677 ' O ' ' CB ' ' A' ' 67' ' ' GLU . 0.9 OUTLIER 55.17 103.62 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.419 -0.801 . . . . 0.0 111.728 179.439 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.677 ' CB ' ' O ' ' A' ' 66' ' ' GLN . 3.0 tt0 139.89 80.88 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.736 ' HA ' ' CA ' ' A' ' 61' ' ' PHE . . . -48.08 148.75 1.64 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.086 -1.008 . . . . 0.0 110.397 -179.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.89 ' HG ' ' HB3' ' A' ' 61' ' ' PHE . 6.2 mt -123.53 -135.25 0.29 Allowed 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 119.689 -0.804 . . . . 0.0 112.217 -175.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 58' ' ' ARG . 0.9 OUTLIER -144.63 159.49 42.73 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 -179.369 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.884 HG22 ' N ' ' A' ' 59' ' ' LYS . 0.4 OUTLIER -121.49 170.17 11.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 C-N-CA 118.371 -1.332 . . . . 0.0 113.059 -176.59 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.721 ' N ' ' HB3' ' A' ' 57' ' ' ALA . . . 159.82 72.99 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.628 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.292 -179.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.716 ' HD3' HD12 ' A' ' 71' ' ' ILE . 37.3 Cg_endo -60.72 118.56 5.44 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.684 1.36 . . . . 0.0 111.502 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.51 ' HA ' ' CD2' ' B' ' 94' ' ' TYR . 41.9 p -173.73 152.13 1.98 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.683 HG12 ' CB ' ' B' ' 89' ' ' ALA . 0.4 OUTLIER -54.79 177.47 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.822 -1.174 . . . . 0.0 109.67 -179.831 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.706 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -113.49 70.69 0.23 Allowed Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 1.05 HG23 HG21 ' A' ' 36' ' ' VAL . 2.6 p -51.07 79.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.821 -0.811 . . . . 0.0 110.18 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.774 ' O ' HG23 ' A' ' 79' ' ' VAL . 0.7 OUTLIER -73.53 178.16 4.85 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.227 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.866 HG22 HG23 ' A' ' 50' ' ' ILE . 41.8 t -166.5 175.99 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.872 ' O ' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -175.33 169.15 1.56 Allowed Pre-proline 0 C--N 1.308 -1.225 0 O-C-N 120.982 -1.074 . . . . 0.0 110.045 176.662 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.587 ' HB2' HG13 ' B' ' 77' ' ' VAL . 55.8 Cg_endo -103.32 137.84 0.12 Allowed 'Trans proline' 0 C--N 1.3 -1.991 0 C-N-CA 122.962 2.442 . . . . 0.0 110.727 178.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.503 ' HA3' ' HA ' ' A' ' 47' ' ' PHE . . . -89.83 -148.11 18.59 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 107.437 -2.265 . . . . 0.0 107.437 177.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.403 ' HA ' ' HB2' ' A' ' 86' ' ' LYS . 2.0 pm0 -101.28 -13.96 17.85 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.064 -1.256 . . . . 0.0 109.803 178.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.458 ' CB ' ' HB3' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -56.5 -32.97 65.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.3 -0.875 . . . . 0.0 108.953 179.161 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.893 HD23 ' HA ' ' B' ' 33' ' ' THR . 0.5 OUTLIER -82.48 -31.73 29.19 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.456 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 0.1 OUTLIER -75.53 -39.98 57.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.485 -0.759 . . . . 0.0 110.173 -179.399 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.1 ttmt -70.22 -37.61 75.06 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.641 ' O ' ' HB1' ' B' ' 37' ' ' ALA . . . -69.18 -34.03 74.29 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 176.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.967 ' HA ' HD23 ' A' ' 92' ' ' LEU . . . -59.89 -43.52 94.75 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.46 -32.91 52.11 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -66.11 -35.78 90.99 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 178.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.967 HD23 ' HA ' ' A' ' 89' ' ' ALA . 0.5 OUTLIER -72.69 7.21 2.03 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.722 -1.457 . . . . 0.0 111.438 -179.715 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.414 ' CB ' ' O ' ' A' ' 92' ' ' LEU . 0.1 OUTLIER 63.75 38.42 9.23 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -177.862 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.652 ' HB2' ' HB ' ' B' ' 75' ' ' VAL . 0.4 OUTLIER -43.69 -35.75 1.94 Allowed 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.506 -179.238 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.458 ' N ' ' CG ' ' A' ' 94' ' ' TYR . 15.2 pt-20 -57.35 -42.06 81.27 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.4 -0.812 . . . . 0.0 109.157 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.13 -35.29 76.66 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 177.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.85 -27.25 62.75 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.633 ' HB2' ' HB1' ' B' ' 54' ' ' ALA . . . -75.5 -81.11 0.08 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.729 -0.607 . . . . 0.0 110.37 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 9.5 pttt . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.274 -179.903 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.661 ' HG3' HG23 ' A' ' 42' ' ' VAL . 4.0 ptp . . . . . 0 N--CA 1.495 1.807 0 CA-C-O 121.605 0.717 . . . . 0.0 110.577 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . 0.444 ' HB3' ' O ' ' B' ' 1' ' ' MET . 14.1 p-10 179.72 -157.93 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.542 178.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.55 ' HE2' HG21 ' A' ' 45' ' ' THR . 9.7 mttm -53.92 -11.53 0.44 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.253 -0.904 . . . . 0.0 110.761 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.438 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 15.4 m -101.04 -55.03 2.66 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.039 -1.038 . . . . 0.0 110.008 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.489 ' CB ' ' CB ' ' B' ' 1' ' ' MET . 2.5 mp0 -64.09 -50.16 69.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.195 -0.94 . . . . 0.0 109.24 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.86 HD11 ' CG2' ' A' ' 42' ' ' VAL . 32.5 mt -53.94 -43.28 69.69 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' ILE . . . . . 0.851 HG23 ' HB ' ' B' ' 21' ' ' VAL . 0.3 OUTLIER -50.24 -52.4 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 177.163 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . 0.936 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.0 OUTLIER -56.26 -39.73 73.06 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.056 177.22 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . 0.881 ' CB ' HD13 ' A' ' 31' ' ' ILE . . . -49.61 -38.1 30.55 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.195 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.714 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.4 mp -93.63 -32.0 4.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 178.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.936 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -68.23 -8.49 39.55 Favored 'General case' 0 C--N 1.291 -1.973 0 C-N-CA 118.377 -1.329 . . . . 0.0 109.012 178.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.515 ' HB3' ' O ' ' B' ' 8' ' ' LYS . 0.9 OUTLIER -119.9 -41.84 2.64 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.364 -0.835 . . . . 0.0 109.674 179.294 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.491 ' CB ' ' HB2' ' A' ' 27' ' ' SER . 1.5 m-20 -70.28 -35.4 73.71 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 177.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.901 HG22 ' CD2' ' B' ' 16' ' ' LEU 0.262 0.2 OUTLIER -96.72 -79.27 0.45 Allowed 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 177.592 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 52.47 5.01 0.17 Allowed Glycine 0 N--CA 1.502 3.04 0 O-C-N 121.226 -0.921 . . . . 0.0 111.793 177.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 16' ' ' LEU . . . . . 0.901 ' CD2' HG22 ' B' ' 14' ' ' THR . 0.7 OUTLIER -61.43 -23.7 66.01 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.127 -1.219 . . . . 0.0 110.052 179.524 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . 0.675 HG21 HG21 ' A' ' 17' ' ' THR . 0.5 OUTLIER -159.82 -9.98 0.06 Allowed 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.707 -0.621 . . . . 0.0 110.482 -179.783 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . 0.645 ' O ' ' C ' ' B' ' 19' ' ' VAL . 7.3 mt-30 54.94 35.94 25.64 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 -177.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 1.057 HG11 HG11 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -10.53 -92.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.165 -179.329 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 1.063 ' O ' ' N ' ' B' ' 22' ' ' SER . 4.5 p -134.96 24.9 3.61 Favored 'General case' 0 C--N 1.282 -2.368 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 176.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.851 ' HB ' HG23 ' B' ' 7' ' ' ILE . 30.7 m -4.48 -41.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 CA-C-O 122.561 1.172 . . . . 0.0 110.976 -177.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 1.063 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.6 OUTLIER -76.74 -37.3 56.21 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.766 179.13 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . 0.837 ' N ' ' O ' ' B' ' 20' ' ' SER . 1.5 mtmt -89.6 -31.47 17.55 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.318 -0.864 . . . . 0.0 110.811 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' MET . . . . . 0.696 ' HB3' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -68.65 -39.69 80.59 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 117.191 -1.804 . . . . 0.0 108.759 179.285 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.704 HD12 HG13 ' B' ' 7' ' ' ILE . 0.3 OUTLIER -77.02 -45.09 28.45 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 118.132 -1.427 . . . . 0.0 108.431 177.574 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' B' ' 22' ' ' SER . . . -55.26 -34.46 64.06 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . 0.484 ' O ' HG13 ' B' ' 31' ' ' ILE . 90.8 p -81.49 -35.44 30.46 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . 0.668 ' O ' HG13 ' B' ' 31' ' ' ILE . 0.7 OUTLIER -53.41 -49.17 67.83 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.633 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . 0.728 ' HG3' ' CD2' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -67.55 -34.88 77.97 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 177.184 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 1.183 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 53.1 tttm -64.51 -21.55 66.71 Favored 'General case' 0 C--O 1.19 -2.064 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.913 HD13 ' CB ' ' A' ' 9' ' ' ALA . 0.6 OUTLIER -105.61 -26.69 3.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 O-C-N 120.163 -1.586 . . . . 0.0 109.062 177.924 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.631 HD11 ' CE2' ' B' ' 28' ' ' PHE . 1.2 mm -74.87 -58.14 5.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 176.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 33' ' ' THR . . . . . 0.893 ' HA ' HD23 ' A' ' 85' ' ' LEU . 0.6 OUTLIER -70.15 -35.5 74.08 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.263 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 1.183 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 50.9 mm-40 -76.69 -32.84 58.15 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 119.314 -0.954 . . . . 0.0 111.033 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 35' ' ' THR . . . . . 0.671 HG21 ' CG2' ' B' ' 42' ' ' VAL . 2.2 m -61.68 -50.79 71.07 Favored 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 118.015 -1.474 . . . . 0.0 107.942 178.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.735 HG21 HG23 ' B' ' 77' ' ' VAL . 1.2 t -54.12 -36.0 30.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 177.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 0.641 ' HB1' ' O ' ' A' ' 88' ' ' ALA . . . -81.5 -5.44 57.96 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-O 121.655 0.74 . . . . 0.0 109.346 177.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.511 ' N ' ' O ' ' B' ' 34' ' ' GLU . 0.9 OUTLIER -99.08 -25.08 14.66 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 177.833 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.32 39.5 2.09 Favored Glycine 0 C--N 1.303 -1.292 0 C-N-CA 120.183 -1.008 . . . . 0.0 110.795 177.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . 0.613 ' CB ' HG23 ' B' ' 35' ' ' THR . 0.1 OUTLIER -131.02 133.35 45.67 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.984 -1.304 . . . . 0.0 110.567 179.528 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.51 89.45 6.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.546 -0.721 . . . . 0.0 109.879 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.671 ' CG2' HG21 ' B' ' 35' ' ' THR . 58.6 t -60.02 127.3 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.59 -0.694 . . . . 0.0 110.449 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 43' ' ' GLN . . . . . 0.458 ' HA ' ' HA ' ' B' ' 49' ' ' ASN . 1.9 tt0 -119.32 99.63 6.81 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 121.391 -0.818 . . . . 0.0 109.548 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.897 HD12 ' HB3' ' B' ' 48' ' ' LEU . 12.6 mt -71.98 87.72 1.05 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.156 -0.965 . . . . 0.0 110.386 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . 0.508 ' HB ' ' HD2' ' A' ' 3' ' ' LYS . 1.8 t 36.2 29.58 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . 93.31 -26.02 17.56 Favored Glycine 0 N--CA 1.491 2.347 0 C-N-CA 119.883 -1.151 . . . . 0.0 112.453 177.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . 0.95 ' CD1' HD21 ' B' ' 85' ' ' LEU . 0.4 OUTLIER -81.72 -29.76 32.81 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 119.738 1.769 . . . . 0.0 111.415 -178.776 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.897 ' HB3' HD12 ' B' ' 44' ' ' LEU . 4.6 mt -133.65 95.21 3.43 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.475 -1.391 . . . . 0.0 110.367 177.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 49' ' ' ASN . . . . . 0.468 ' O ' ' HA ' ' B' ' 79' ' ' VAL . 17.3 t-20 -103.22 90.23 3.66 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.222 -0.924 . . . . 0.0 111.368 -179.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 50' ' ' ILE . . . . . 0.6 HD11 HD11 ' A' ' 48' ' ' LEU . 1.2 mm -73.44 141.84 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.495 -0.753 . . . . 0.0 109.468 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . 0.419 ' O ' ' HG3' ' B' ' 51' ' ' LYS . 9.6 ptmt -152.52 115.57 2.88 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 120.889 -1.132 . . . . 0.0 110.656 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.545 ' HA ' ' HA ' ' B' ' 77' ' ' VAL . 52.7 Cg_endo -77.14 142.89 22.1 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 O-C-N 123.528 1.278 . . . . 0.0 111.194 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.733 HG22 ' O ' ' B' ' 76' ' ' GLY . 33.2 m -143.15 116.35 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-O 121.416 0.627 . . . . 0.0 110.528 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.633 ' HB1' ' HB2' ' A' ' 98' ' ' ALA . . . -42.47 140.92 1.1 Allowed 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.782 0.801 . . . . 0.0 112.213 -178.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.97 83.73 0.19 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . 0.472 ' HA ' ' HA ' ' B' ' 73' ' ' PRO . 19.4 mt-30 -56.81 -170.48 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.381 -0.824 . . . . 0.0 111.376 -178.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.594 ' HA ' HD11 ' B' ' 71' ' ' ILE . . . -80.53 165.49 22.07 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.733 -0.605 . . . . 0.0 110.816 -179.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 58' ' ' ARG . . . . . 0.766 ' HB2' HD12 ' B' ' 71' ' ' ILE . 21.6 mtt85 -139.13 19.02 2.61 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.565 -0.71 . . . . 0.0 110.53 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . . . . . . . . . 2.9 ptmt -59.43 78.15 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.487 0.66 . . . . 0.0 110.156 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' B' ' 58' ' ' ARG . . . -148.49 -95.53 0.15 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.359 -1.497 . . . . 0.0 109.359 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 61' ' ' PHE . . . . . 0.839 ' O ' ' N ' ' B' ' 67' ' ' GLU . 4.0 p90 176.18 -178.67 0.15 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.262 -1.14 . . . . 0.0 110.244 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . 0.764 ' N ' ' HB2' ' B' ' 68' ' ' ALA . 0.6 OUTLIER -111.32 -60.57 0.04 OUTLIER Pre-proline 0 N--CA 1.5 2.047 0 O-C-N 120.997 -1.064 . . . . 0.0 112.287 -178.328 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.643 ' HD2' ' H ' ' B' ' 62' ' ' ASN . 41.3 Cg_endo -67.68 64.99 0.85 Allowed 'Trans proline' 0 C--N 1.316 -1.174 0 O-C-N 123.379 1.2 . . . . 0.0 110.479 -178.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . 0.783 ' HB3' ' CE1' ' B' ' 61' ' ' PHE . 0.0 OUTLIER 179.85 38.42 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.784 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 3.9 p 54.63 51.89 13.17 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.69 -0.631 . . . . 0.0 110.204 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . 0.714 ' HB2' ' CE1' ' B' ' 61' ' ' PHE . 0.0 OUTLIER -149.66 -120.51 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.26 -0.9 . . . . 0.0 110.498 -179.641 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . 0.839 ' N ' ' O ' ' B' ' 61' ' ' PHE . 0.9 OUTLIER -175.48 93.8 0.06 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.845 -1.159 . . . . 0.0 108.629 179.756 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . 0.819 ' O ' HD23 ' B' ' 69' ' ' LEU . . . -66.13 92.48 0.18 Allowed 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.969 0.89 . . . . 0.0 109.663 -178.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.819 HD23 ' O ' ' B' ' 68' ' ' ALA . 13.7 mt -142.67 -155.83 0.63 Allowed 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.994 -179.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -166.49 26.7 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.218 -0.926 . . . . 0.0 110.966 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.766 HD12 ' HB2' ' B' ' 58' ' ' ARG . 0.0 OUTLIER -61.79 -160.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.15 -0.969 . . . . 0.0 109.393 179.611 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . 0.524 ' N ' HG12 ' B' ' 71' ' ' ILE . . . -127.5 145.77 55.9 Favored Pre-proline 0 C--N 1.3 -1.553 0 O-C-N 121.141 -0.974 . . . . 0.0 111.095 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 73' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' B' ' 56' ' ' GLN . 40.8 Cg_endo -68.57 83.99 0.5 Allowed 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 124.048 1.552 . . . . 0.0 110.422 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . 0.48 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 8.9 t -176.94 166.16 2.46 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.623 -0.673 . . . . 0.0 109.437 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . 0.652 ' HB ' ' HB2' ' A' ' 94' ' ' TYR . 0.4 OUTLIER -56.37 172.48 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.948 -1.095 . . . . 0.0 109.445 -179.994 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . 0.733 ' O ' HG22 ' B' ' 53' ' ' VAL . . . -114.25 75.63 0.24 Allowed Glycine 0 N--CA 1.486 1.99 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.878 HG21 ' CB ' ' A' ' 85' ' ' LEU . 2.8 p -51.54 82.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.79 -0.829 . . . . 0.0 110.365 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . 0.584 ' N ' ' O ' ' B' ' 76' ' ' GLY . 0.5 OUTLIER -80.81 177.91 8.73 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.819 -0.753 . . . . 0.0 110.034 179.762 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.615 HG22 ' N ' ' B' ' 80' ' ' LYS . 7.4 p 177.97 177.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . 0.672 ' O ' HD23 ' B' ' 48' ' ' LEU . 2.7 ptpt -171.85 173.26 1.69 Allowed Pre-proline 0 C--N 1.307 -1.265 0 O-C-N 120.845 -1.159 . . . . 0.0 110.539 178.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 81' ' ' PRO . . . . . 0.508 ' HA ' ' O ' ' B' ' 47' ' ' PHE . 55.5 Cg_endo -98.9 128.6 0.19 Allowed 'Trans proline' 0 C--N 1.3 -1.989 0 C-N-CA 122.689 2.259 . . . . 0.0 110.549 178.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . 0.475 ' H ' ' HA ' ' B' ' 47' ' ' PHE . . . -81.8 -155.33 14.68 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 107.941 -2.064 . . . . 0.0 107.941 178.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . 0.446 ' HA ' ' HB2' ' B' ' 86' ' ' LYS . 3.4 pm0 -93.84 -15.35 25.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.097 -1.237 . . . . 0.0 109.977 179.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.38 -36.93 66.9 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.247 -0.908 . . . . 0.0 109.144 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.95 HD21 ' CD1' ' B' ' 47' ' ' PHE . 0.3 OUTLIER -82.29 -32.26 29.64 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.487 -0.758 . . . . 0.0 109.017 179.116 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . 0.478 ' O ' ' HB3' ' B' ' 89' ' ' ALA . 2.2 mttp -73.39 -37.43 65.98 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.496 -0.752 . . . . 0.0 109.922 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 28.5 tptt -69.66 -37.99 76.93 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 178.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.591 ' CB ' ' HB2' ' A' ' 37' ' ' ALA . . . -67.85 -34.43 76.69 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 176.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.985 ' HA ' HD23 ' B' ' 92' ' ' LEU . . . -59.67 -44.6 93.54 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.073 179.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -53.52 -31.83 47.93 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 177.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -68.43 -32.68 75.72 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 178.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . 0.985 HD23 ' HA ' ' B' ' 89' ' ' ALA . 0.5 OUTLIER -73.33 8.97 1.45 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.748 -1.443 . . . . 0.0 111.426 -179.728 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 61.55 38.43 15.61 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 -177.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . 0.629 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 0.2 OUTLIER -45.43 -37.7 5.36 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.609 -178.998 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . 0.448 ' N ' ' CG ' ' B' ' 94' ' ' TYR . 2.6 pp20? -57.28 -38.01 73.28 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.324 -0.86 . . . . 0.0 109.162 179.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.06 -34.84 78.43 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 177.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 97' ' ' PHE . . . . . 0.491 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -70.17 -27.49 64.57 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.312 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 98' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' B' ' 95' ' ' GLU . . . -72.53 -30.63 64.63 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.645 -0.659 . . . . 0.0 110.241 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 15.4 mttt . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.211 -179.948 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.605 ' CG ' ' HB3' ' A' ' 5' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 121.096 0.474 . . . . 0.0 110.25 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.565 ' N ' ' HB2' ' A' ' 5' ' ' GLU . 2.0 t-20 -177.24 -178.84 0.82 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.187 -0.946 . . . . 0.0 110.931 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.818 ' O ' HD22 ' A' ' 25' ' ' LEU . 8.4 mttt -46.67 -25.13 0.66 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.64 -0.663 . . . . 0.0 109.852 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.458 ' O ' HG22 ' A' ' 7' ' ' ILE . 8.3 m -101.63 -52.4 3.22 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.396 -0.815 . . . . 0.0 110.111 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.605 ' HB3' ' CG ' ' A' ' 1' ' ' MET . 6.7 mt-10 -53.7 -47.61 70.33 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.107 -0.996 . . . . 0.0 108.573 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.641 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 4.1 mt -55.37 -37.67 67.83 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 119.177 -1.009 . . . . 0.0 108.814 177.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.763 ' CD1' HD23 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -50.77 -44.86 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.081 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.751 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -68.18 -32.4 72.61 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.745 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.641 ' HB3' ' O ' ' A' ' 6' ' ' LEU . . . -53.23 -38.52 63.01 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.369 -0.832 . . . . 0.0 109.033 179.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.765 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.3 mp -102.32 -29.7 3.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.751 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -69.11 -11.32 60.69 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 118.554 -1.259 . . . . 0.0 108.577 178.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.418 ' CG ' ' O ' ' A' ' 8' ' ' LYS . 54.0 mm-40 -113.74 -42.49 3.42 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.484 -0.76 . . . . 0.0 109.053 178.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.425 ' HB2' ' O ' ' A' ' 9' ' ' ALA . 1.5 m-20 -65.54 -36.17 83.0 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 177.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.765 ' OG1' ' O ' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -99.69 -73.04 0.64 Allowed 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 178.144 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 46.32 22.55 0.99 Allowed Glycine 0 N--CA 1.5 2.919 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 178.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.079 ' CD1' HG23 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -75.05 -26.25 59.27 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 121.507 -0.996 . . . . 0.0 108.8 179.323 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.729 HG22 ' H ' ' A' ' 19' ' ' VAL . 0.4 OUTLIER -162.05 -2.91 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.932 -179.191 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.575 ' O ' ' C ' ' A' ' 19' ' ' VAL . 21.9 mt-30 57.92 28.16 15.73 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -176.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 1.002 ' O ' HD22 ' B' ' 16' ' ' LEU . 1.6 p -1.76 -90.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.235 -178.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.958 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.4 OUTLIER -129.98 25.6 5.26 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 178.918 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.791 ' HA ' ' CE ' ' A' ' 24' ' ' MET . 13.5 m -22.91 -41.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 CA-C-O 122.576 1.179 . . . . 0.0 108.777 -178.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.747 ' N ' ' O ' ' A' ' 20' ' ' SER . 6.6 m -76.36 -37.74 56.83 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.731 177.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.958 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.9 OUTLIER -89.01 -38.73 14.19 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.493 -0.755 . . . . 0.0 111.717 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.791 ' CE ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -66.88 -27.75 67.77 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.075 -1.64 . . . . 0.0 109.178 179.648 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.818 HD22 ' O ' ' A' ' 3' ' ' LYS . 0.2 OUTLIER -82.94 -45.47 14.11 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 118.865 -1.134 . . . . 0.0 108.982 178.618 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.651 ' N ' ' HG ' ' A' ' 25' ' ' LEU . . . -66.4 -27.64 68.01 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.56 ' O ' ' N ' ' A' ' 31' ' ' ILE . 52.9 p -87.76 -31.24 19.73 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.829 ' O ' HG13 ' A' ' 31' ' ' ILE . 0.1 OUTLIER -55.66 -48.17 75.47 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.562 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.576 ' HG3' ' CE2' ' B' ' 47' ' ' PHE . 1.0 OUTLIER -69.89 -36.37 75.37 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 177.01 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 1.201 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 35.7 tttp -65.22 -17.8 64.78 Favored 'General case' 0 C--O 1.19 -2.043 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.829 HG13 ' O ' ' A' ' 28' ' ' PHE . 1.2 pp -108.56 -30.07 2.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 120.195 -1.566 . . . . 0.0 108.916 178.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.598 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.1 mm -71.41 -58.06 6.05 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 176.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.982 ' HA ' HD23 ' B' ' 85' ' ' LEU . 0.6 OUTLIER -69.95 -42.26 73.45 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.915 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 1.201 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 55.1 mm-40 -68.39 -34.39 75.95 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 120.728 -1.232 . . . . 0.0 111.178 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.867 HG21 HG23 ' A' ' 42' ' ' VAL . 1.8 m -57.85 -49.1 77.83 Favored 'General case' 0 N--CA 1.5 2.037 0 C-N-CA 118.071 -1.451 . . . . 0.0 107.446 178.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.912 HG13 ' HB3' ' A' ' 52' ' ' PRO . 36.4 t -55.13 -35.81 36.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 C-N-CA 117.85 -1.54 . . . . 0.0 107.362 177.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.789 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -84.86 2.77 41.0 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 121.626 0.727 . . . . 0.0 109.094 177.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.513 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -110.13 -15.82 13.92 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.798 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.93 46.89 3.27 Favored Glycine 0 C--N 1.304 -1.243 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 178.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.778 ' CB ' HG23 ' A' ' 35' ' ' THR . 0.3 OUTLIER -137.25 136.68 38.31 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.052 -1.264 . . . . 0.0 110.861 179.521 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.5 mtmm -80.06 91.96 5.56 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.572 -0.705 . . . . 0.0 109.45 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.867 HG23 HG21 ' A' ' 35' ' ' THR . 41.1 t -59.97 124.34 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.615 -0.678 . . . . 0.0 110.163 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.46 ' O ' ' HA ' ' B' ' 2' ' ' ASN . 19.1 mt-30 -125.5 165.17 18.95 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.341 -0.849 . . . . 0.0 109.832 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.045 HD12 ' CB ' ' A' ' 48' ' ' LEU . 72.1 mt -134.43 108.09 7.95 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.416 -0.803 . . . . 0.0 109.084 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.534 HG23 ' HD1' ' A' ' 47' ' ' PHE . 0.0 OUTLIER 35.22 -96.05 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.871 -0.518 . . . . 0.0 111.475 -179.037 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.417 ' H ' HG23 ' A' ' 45' ' ' THR . . . -138.91 22.55 2.96 Favored Glycine 0 N--CA 1.488 2.12 0 C-N-CA 119.385 -1.388 . . . . 0.0 110.911 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.936 ' CD2' HD23 ' A' ' 48' ' ' LEU . 17.6 p90 -118.13 -56.82 2.14 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.728 -1.454 . . . . 0.0 111.101 179.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.045 ' CB ' HD12 ' A' ' 44' ' ' LEU . 0.9 OUTLIER -103.89 128.89 51.36 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.057 -1.652 . . . . 0.0 115.281 -178.162 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.547 ' CB ' ' CG ' ' A' ' 81' ' ' PRO . 19.2 t-20 -129.72 99.9 5.3 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.564 177.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.881 HD11 HD11 ' B' ' 48' ' ' LEU . 1.0 OUTLIER -86.82 158.07 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.162 -0.961 . . . . 0.0 110.21 -179.93 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.6 ptmt -166.49 123.39 0.99 Allowed Pre-proline 0 N--CA 1.496 1.833 0 C-N-CA 118.681 -1.208 . . . . 0.0 111.213 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.912 ' HB3' HG13 ' A' ' 36' ' ' VAL . 54.0 Cg_endo -79.96 144.31 16.88 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.609 1.32 . . . . 0.0 110.985 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.577 ' O ' HG23 ' A' ' 53' ' ' VAL . 28.4 m -137.06 113.81 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 CA-C-O 121.849 0.833 . . . . 0.0 111.459 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . -71.8 133.46 45.54 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.62 -0.675 . . . . 0.0 111.006 -179.064 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.4 ' O ' ' CG ' ' A' ' 56' ' ' GLN . 0.8 OUTLIER 174.77 47.32 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.413 -0.804 . . . . 0.0 110.691 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.68 ' O ' ' HA ' ' A' ' 73' ' ' PRO . 10.3 mt-30 -157.0 118.63 3.77 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.943 -1.098 . . . . 0.0 111.544 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.487 ' H ' HD11 ' A' ' 71' ' ' ILE . . . -177.08 72.61 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.252 -0.905 . . . . 0.0 109.591 178.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.87 ' NE ' HD13 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -133.15 156.07 48.12 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.476 -0.765 . . . . 0.0 110.075 -179.123 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.498 ' N ' ' HG3' ' A' ' 58' ' ' ARG . 13.8 mttt -154.98 102.72 2.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.567 -0.708 . . . . 0.0 109.749 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 119.2 -147.95 18.27 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.665 ' CG ' ' N ' ' A' ' 62' ' ' ASN . 66.4 t80 -127.76 175.01 8.64 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.103 -1.234 . . . . 0.0 110.941 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.665 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 2.3 t30 -63.33 -170.89 0.04 OUTLIER Pre-proline 0 N--CA 1.48 1.064 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 177.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.419 ' CD ' ' CB ' ' A' ' 62' ' ' ASN . 48.1 Cg_endo -79.57 51.71 3.99 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.093 1.049 . . . . 0.0 109.818 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.59 ' CB ' ' HE2' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -157.44 -117.07 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.139 0 O-C-N 121.209 -0.932 . . . . 0.0 110.084 -179.224 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.531 ' N ' ' CE2' ' A' ' 61' ' ' PHE . 4.7 t 177.64 69.53 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.117 -0.989 . . . . 0.0 109.156 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -130.56 -70.76 0.61 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.306 -0.871 . . . . 0.0 110.67 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -115.66 78.13 1.15 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.311 -0.868 . . . . 0.0 110.382 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.416 ' HA ' ' HB2' ' A' ' 61' ' ' PHE . . . -59.53 139.15 57.39 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.412 -0.805 . . . . 0.0 110.94 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.87 HD13 ' NE ' ' A' ' 58' ' ' ARG . 1.8 mp -112.42 -159.11 0.67 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.582 -0.699 . . . . 0.0 109.934 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.443 ' CB ' ' O ' ' A' ' 69' ' ' LEU . 2.3 mt-10 169.55 30.39 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.418 -0.801 . . . . 0.0 110.405 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.487 HD11 ' H ' ' A' ' 57' ' ' ALA . 1.0 OUTLIER -75.75 -159.95 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.11 -0.994 . . . . 0.0 110.01 -179.864 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 1.012 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -163.97 -175.5 0.47 Allowed Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.101 -1.0 . . . . 0.0 111.018 -178.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 1.012 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 41.3 Cg_endo -69.17 112.88 3.1 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 O-C-N 124.014 1.534 . . . . 0.0 111.37 -179.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 17.7 p -164.9 105.46 0.8 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.659 -0.65 . . . . 0.0 109.349 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.835 HG12 ' HB2' ' B' ' 89' ' ' ALA . 0.3 OUTLIER -51.13 170.45 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.372 -0.83 . . . . 0.0 109.919 -179.284 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.574 ' O ' ' N ' ' A' ' 78' ' ' SER . . . -105.99 77.16 0.24 Allowed Glycine 0 N--CA 1.484 1.874 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.903 HG11 ' HB2' ' B' ' 85' ' ' LEU . 15.5 t -59.87 77.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.492 -1.005 . . . . 0.0 109.232 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.574 ' N ' ' O ' ' A' ' 76' ' ' GLY . 0.3 OUTLIER -97.31 -165.18 1.23 Allowed 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 122.461 1.124 . . . . 0.0 111.733 -178.671 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.611 HG12 ' CG1' ' A' ' 50' ' ' ILE . 29.9 m -152.82 -157.08 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.65 ' HB3' ' HD3' ' A' ' 81' ' ' PRO . 0.1 OUTLIER -172.06 -58.12 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.69 0 C-N-CA 118.345 -1.342 . . . . 0.0 112.824 179.421 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.65 ' HD3' ' HB3' ' A' ' 80' ' ' LYS . 55.8 Cg_endo -89.62 171.82 4.13 Favored 'Trans proline' 0 C--N 1.297 -2.151 0 O-C-N 123.595 1.313 . . . . 0.0 112.963 -176.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.65 ' O ' ' C ' ' A' ' 83' ' ' GLU . . . 176.2 -1.57 0.03 OUTLIER Glycine 0 C--N 1.301 -1.405 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 179.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.905 ' O ' ' N ' ' A' ' 85' ' ' LEU . 11.8 pt-20 31.8 45.78 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 -176.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.873 ' C ' HD22 ' A' ' 85' ' ' LEU . 1.2 t 12.4 41.71 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.335 0 CA-C-O 122.873 1.321 . . . . 0.0 109.608 -177.021 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 1.005 HD23 HG11 ' B' ' 36' ' ' VAL . 0.0 OUTLIER 18.31 27.05 0.0 OUTLIER 'General case' 0 C--O 1.189 -2.117 0 N-CA-C 101.381 -3.563 . . . . 0.0 101.381 -173.293 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.76 ' HB2' ' HB3' ' A' ' 84' ' ' SER 0.351 4.5 tttt -51.91 -44.25 63.72 Favored 'General case' 0 CA--C 1.469 -2.145 0 CA-C-N 111.808 -2.451 . . . . 0.0 105.631 178.589 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.277 23.6 tttt -62.23 -38.02 87.62 Favored 'General case' 0 C--N 1.268 -2.971 0 CA-C-N 111.409 -2.632 . . . . 0.0 106.625 177.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.826 ' O ' ' HB1' ' B' ' 37' ' ' ALA . . . -86.99 -22.34 25.6 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 118.232 -1.387 . . . . 0.0 109.39 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.793 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . -76.32 -47.13 24.66 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.474 ' HA ' ' CB ' ' A' ' 94' ' ' TYR . 4.0 mm-40 -56.86 -27.24 60.11 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 175.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.972 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -76.95 -32.52 49.15 Favored Glycine 0 CA--C 1.548 2.147 0 CA-C-O 118.496 -1.169 . . . . 0.0 113.169 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.972 HD23 ' C ' ' A' ' 91' ' ' GLY . 0.1 OUTLIER -115.21 -74.2 0.62 Allowed 'General case' 0 N--CA 1.505 2.312 0 CA-C-N 122.31 3.055 . . . . 0.0 113.44 -177.301 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -120.39 42.0 3.09 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.827 -1.171 . . . . 0.0 112.713 -177.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.495 ' HA ' HG23 ' B' ' 75' ' ' VAL . 0.0 OUTLIER -74.37 -55.5 5.93 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.102 -0.999 . . . . 0.0 108.923 178.371 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.432 ' N ' ' CG ' ' A' ' 94' ' ' TYR . 12.0 pt-20 -69.22 -37.28 77.95 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.604 -0.685 . . . . 0.0 109.547 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -57.74 -34.87 69.98 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.518 ' CB ' ' HB2' ' B' ' 54' ' ' ALA . 3.9 m-85 -78.23 -26.5 47.37 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 120.091 -0.644 . . . . 0.0 109.584 178.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.612 ' HB2' ' HB1' ' B' ' 54' ' ' ALA . . . -71.9 -56.33 5.9 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.402 -0.811 . . . . 0.0 110.304 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.4 mttp . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.156 -179.914 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.453 ' CB ' ' HB3' ' B' ' 5' ' ' GLU . 9.0 mtp . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 120.867 0.365 . . . . 0.0 110.063 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . 0.46 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 1.0 OUTLIER -176.48 -172.97 0.49 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.237 -0.914 . . . . 0.0 110.801 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.549 ' O ' HG13 ' B' ' 7' ' ' ILE . 0.0 OUTLIER -54.24 -15.07 1.35 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.234 -0.916 . . . . 0.0 110.335 179.785 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.552 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 19.1 m -105.64 -46.65 4.11 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.106 -0.996 . . . . 0.0 108.69 178.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.486 ' HA ' ' HE2' ' B' ' 8' ' ' LYS . 0.8 OUTLIER -62.01 -50.6 71.39 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.927 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.707 HD11 HG13 ' A' ' 42' ' ' VAL . 2.0 mt -64.51 -26.51 68.46 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.488 -0.885 . . . . 0.0 109.013 178.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' ILE . . . . . 0.735 HG12 ' O ' ' B' ' 21' ' ' VAL . 0.3 OUTLIER -56.84 -58.97 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.408 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . 0.893 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.1 OUTLIER -62.43 -26.99 68.79 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.137 178.758 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . 0.598 ' HB3' ' O ' ' B' ' 6' ' ' LEU . . . -59.85 -34.67 73.42 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 119.441 -0.904 . . . . 0.0 108.699 178.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.861 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.0 OUTLIER -97.47 -36.82 6.3 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.498 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 178.522 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.893 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -59.04 -28.3 66.3 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -90.8 -42.01 10.9 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.496 ' OD2' HG21 ' A' ' 31' ' ' ILE . 82.6 m-20 -64.98 -23.13 67.13 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 106.932 -1.506 . . . . 0.0 106.932 176.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.951 HG22 ' HB2' ' A' ' 20' ' ' SER . 17.8 p -93.41 -75.57 0.49 Allowed 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 58.35 17.72 33.15 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 16' ' ' LEU . . . . . 1.002 HD22 ' O ' ' A' ' 19' ' ' VAL . 2.7 mp -84.32 -59.28 2.44 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.324 -1.103 . . . . 0.0 108.411 178.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . 0.716 ' CG2' HG21 ' A' ' 17' ' ' THR . 0.5 OUTLIER -140.87 3.44 1.83 Allowed 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.357 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . 0.594 ' O ' ' C ' ' B' ' 19' ' ' VAL . 16.6 mt-30 57.14 24.71 10.03 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 106.762 -1.569 . . . . 0.0 106.762 -176.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 1.079 HG23 ' CD1' ' A' ' 16' ' ' LEU . 0.1 OUTLIER 10.61 -94.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.917 -179.167 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 1.025 ' O ' ' N ' ' B' ' 22' ' ' SER . 0.3 OUTLIER -137.17 23.46 3.01 Favored 'General case' 0 C--N 1.276 -2.619 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 178.193 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.735 ' O ' HG12 ' B' ' 7' ' ' ILE . 15.3 m -5.24 -44.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 122.503 1.144 . . . . 0.0 110.537 -177.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 1.025 ' N ' ' O ' ' B' ' 20' ' ' SER . 5.8 m -79.54 -38.59 33.87 Favored 'General case' 0 C--N 1.281 -2.393 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.355 178.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . 0.932 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.5 OUTLIER -91.12 -24.61 19.93 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.418 -0.801 . . . . 0.0 110.875 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' MET . . . . . 0.653 ' HG2' HG22 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -77.07 -38.76 51.86 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 117.444 -1.703 . . . . 0.0 108.558 178.349 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.675 ' HA ' ' HB3' ' B' ' 28' ' ' PHE . 0.3 OUTLIER -78.0 -36.17 49.13 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 118.234 -1.387 . . . . 0.0 108.438 177.711 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . 0.49 ' HB2' ' O ' ' B' ' 22' ' ' SER . . . -64.45 -34.61 78.6 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 176.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . 0.622 ' O ' HG13 ' B' ' 31' ' ' ILE . 29.2 t -80.42 -32.09 37.45 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . 0.862 ' CE1' HD22 ' A' ' 44' ' ' LEU . 0.4 OUTLIER -52.74 -47.11 67.62 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.828 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . 0.651 ' HG3' ' CD1' ' A' ' 47' ' ' PHE . 1.7 tt0 -68.47 -35.61 77.81 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 176.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 1.185 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 2.0 tttt -63.8 -19.39 64.97 Favored 'General case' 0 C--O 1.189 -2.096 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.095 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.638 ' CG1' ' HA ' ' B' ' 28' ' ' PHE . 1.4 pp -107.43 -28.24 2.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 120.29 -1.506 . . . . 0.0 108.714 178.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.674 HD11 ' CE2' ' B' ' 28' ' ' PHE . 1.2 mm -72.66 -58.18 5.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 176.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 33' ' ' THR . . . . . 0.982 ' OG1' HD12 ' A' ' 85' ' ' LEU . 0.6 OUTLIER -68.52 -38.07 80.57 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.771 179.169 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 1.185 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 78.7 mm-40 -76.95 -27.57 54.87 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 121.172 -0.955 . . . . 0.0 111.963 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 35' ' ' THR . . . . . 0.558 ' O ' ' N ' ' B' ' 38' ' ' LYS . 2.7 m -70.63 -59.75 2.65 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 117.706 -1.597 . . . . 0.0 109.462 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 1.005 HG11 HD23 ' A' ' 85' ' ' LEU . 0.9 OUTLIER -51.02 -43.86 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 178.94 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 0.826 ' HB1' ' O ' ' A' ' 88' ' ' ALA . . . -60.91 -27.83 68.48 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.829 177.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.795 ' N ' HD12 ' A' ' 92' ' ' LEU . 0.6 OUTLIER -76.64 -32.3 57.91 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 177.574 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.5 23.7 4.99 Favored Glycine 0 C--N 1.295 -1.695 0 C-N-CA 120.087 -1.054 . . . . 0.0 110.944 177.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . 0.481 ' HB3' ' CG2' ' B' ' 35' ' ' THR . 0.4 OUTLIER -100.48 158.34 15.98 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.103 -1.234 . . . . 0.0 109.749 179.38 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -95.28 90.77 5.97 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.388 -0.82 . . . . 0.0 110.436 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 73.3 t -59.83 118.43 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.423 -0.798 . . . . 0.0 109.712 179.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 43' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -123.71 93.22 3.87 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.309 -0.869 . . . . 0.0 110.068 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 1.004 HD12 ' CB ' ' B' ' 48' ' ' LEU . 75.3 mt -62.33 101.18 0.21 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.173 -0.954 . . . . 0.0 109.549 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . 0.556 HG21 ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 34.99 -94.78 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.928 -0.482 . . . . 0.0 111.31 -179.557 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.427 ' H ' HG23 ' B' ' 45' ' ' THR . . . -141.0 20.45 2.68 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 119.493 -1.337 . . . . 0.0 110.908 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . 0.576 ' CE2' ' HG3' ' A' ' 29' ' ' GLU . 8.8 p90 -119.84 -22.71 6.69 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.702 -1.47 . . . . 0.0 111.446 179.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 1.004 ' CB ' HD12 ' B' ' 44' ' ' LEU . 0.2 OUTLIER -133.48 139.21 46.54 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.614 -1.304 . . . . 0.0 111.472 178.242 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 49' ' ' ASN . . . . . 0.417 ' C ' HD13 ' B' ' 50' ' ' ILE . 1.3 t30 -143.31 116.69 9.07 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.738 -0.601 . . . . 0.0 109.952 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 50' ' ' ILE . . . . . 0.797 HG23 ' HB ' ' B' ' 79' ' ' VAL . 6.4 mm -116.79 147.05 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 O-C-N 121.314 -0.866 . . . . 0.0 110.592 -179.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' B' ' 78' ' ' SER . 14.4 ptmt -156.81 124.85 2.83 Favored Pre-proline 0 N--CA 1.502 2.164 0 O-C-N 120.877 -1.139 . . . . 0.0 110.631 179.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.578 ' HA ' ' HA ' ' B' ' 77' ' ' VAL . 53.6 Cg_endo -84.96 150.75 11.01 Favored 'Trans proline' 0 C--N 1.317 -1.12 0 O-C-N 123.239 1.126 . . . . 0.0 111.748 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.852 HG22 ' O ' ' B' ' 76' ' ' GLY . 33.0 m -140.54 115.69 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 CA-C-O 121.966 0.889 . . . . 0.0 110.391 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.612 ' HB1' ' HB2' ' A' ' 98' ' ' ALA . . . -50.04 160.27 0.36 Allowed 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 122.073 0.94 . . . . 0.0 112.237 -178.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -175.26 59.56 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . 0.943 ' O ' HD11 ' B' ' 71' ' ' ILE . 3.4 pt20 -47.38 174.07 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 122.144 0.973 . . . . 0.0 112.717 -177.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.614 ' HB2' ' HB3' ' B' ' 73' ' ' PRO . . . -62.79 -172.44 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 122.263 1.03 . . . . 0.0 112.392 -178.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 58' ' ' ARG . . . . . 0.78 ' HD3' ' N ' ' B' ' 71' ' ' ILE . 0.0 OUTLIER 175.94 -152.86 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -179.008 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . 0.58 ' N ' ' HD2' ' B' ' 58' ' ' ARG . 3.9 pttt 173.59 90.11 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.236 -0.915 . . . . 0.0 110.653 177.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' B' ' 69' ' ' LEU . . . 47.11 49.63 17.99 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.944 -1.263 . . . . 0.0 109.944 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 61' ' ' PHE . . . . . 0.78 ' CE1' ' HB2' ' B' ' 66' ' ' GLN . 0.0 OUTLIER -97.36 131.31 44.16 Favored 'General case' 0 N--CA 1.483 1.217 0 O-C-N 121.157 -1.202 . . . . 0.0 112.972 -178.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . 0.77 ' H ' ' CD ' ' B' ' 63' ' ' PRO . 0.1 OUTLIER -132.98 -29.19 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.6 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -179.477 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.77 ' CD ' ' H ' ' B' ' 62' ' ' ASN . 43.4 Cg_endo -73.86 -12.72 24.12 Favored 'Trans proline' 0 N--CA 1.483 0.885 0 O-C-N 122.289 0.626 . . . . 0.0 110.525 -178.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . 0.653 ' HB3' ' CE1' ' B' ' 61' ' ' PHE . 0.1 OUTLIER -84.76 53.65 2.78 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.301 -0.874 . . . . 0.0 109.271 178.831 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 3.1 p 55.61 42.2 29.8 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.914 -0.491 . . . . 0.0 110.342 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . 0.78 ' HB2' ' CE1' ' B' ' 61' ' ' PHE . 0.0 OUTLIER -158.5 -156.85 0.58 Allowed 'General case' 0 C--N 1.309 -1.195 0 O-C-N 121.386 -0.821 . . . . 0.0 110.569 -179.616 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . 0.617 ' O ' ' HG ' ' B' ' 69' ' ' LEU . 18.5 tt0 -126.99 139.2 53.21 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 178.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . 0.667 ' HA ' ' C ' ' B' ' 61' ' ' PHE . . . -45.03 123.47 3.89 Favored 'General case' 0 C--N 1.289 -2.043 0 O-C-N 121.621 -0.675 . . . . 0.0 110.981 -178.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' B' ' 67' ' ' GLU . 1.3 mp -118.42 -145.87 0.38 Allowed 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.529 -0.732 . . . . 0.0 112.337 -178.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . 0.488 ' C ' ' HD3' ' B' ' 58' ' ' ARG . 2.1 pt-20 172.08 21.89 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.357 0 O-C-N 121.416 -0.803 . . . . 0.0 109.75 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.943 HD11 ' O ' ' B' ' 56' ' ' GLN . 0.9 OUTLIER -59.02 -151.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.399 -0.813 . . . . 0.0 111.188 -179.727 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . 0.697 ' O ' HD12 ' B' ' 71' ' ' ILE . . . -139.95 153.14 69.27 Favored Pre-proline 0 N--CA 1.488 1.425 0 O-C-N 121.406 -0.809 . . . . 0.0 110.495 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 73' ' ' PRO . . . . . 0.614 ' HB3' ' HB2' ' B' ' 57' ' ' ALA . 42.9 Cg_endo -70.51 113.37 3.47 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 121.693 1.595 . . . . 0.0 110.845 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' B' ' 73' ' ' PRO . 0.4 OUTLIER 171.89 -168.88 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.568 -0.708 . . . . 0.0 110.197 179.762 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . 0.495 HG23 ' HA ' ' A' ' 94' ' ' TYR . 0.7 OUTLIER -109.01 172.84 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.309 -0.87 . . . . 0.0 109.272 179.46 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . 0.852 ' O ' HG22 ' B' ' 53' ' ' VAL . . . -121.86 96.42 0.58 Allowed Glycine 0 N--CA 1.494 2.536 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.832 HG13 ' O ' ' B' ' 77' ' ' VAL . 8.1 p -67.63 74.54 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.644 -0.915 . . . . 0.0 111.5 -178.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . 0.797 ' C ' HG12 ' B' ' 79' ' ' VAL . 0.1 OUTLIER -61.45 172.76 1.07 Allowed 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 117.368 -1.733 . . . . 0.0 107.463 178.209 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.797 ' HB ' HG23 ' B' ' 50' ' ' ILE . 0.2 OUTLIER 176.41 173.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.041 -1.037 . . . . 0.0 110.137 179.397 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . 0.595 ' N ' ' CG2' ' B' ' 79' ' ' VAL . 0.1 OUTLIER 176.08 171.14 0.34 Allowed Pre-proline 0 C--N 1.299 -1.61 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 175.955 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 81' ' ' PRO . . . . . 0.638 ' HA ' HD23 ' B' ' 48' ' ' LEU . 54.0 Cg_endo -89.89 -169.43 0.36 Allowed 'Trans proline' 0 C--N 1.293 -2.361 0 O-C-N 123.712 1.375 . . . . 0.0 109.791 176.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -128.83 -90.96 0.65 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 106.293 -2.723 . . . . 0.0 106.293 178.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . 0.949 ' O ' ' N ' ' B' ' 85' ' ' LEU . 1.6 tt0 -77.99 56.65 1.63 Allowed 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 175.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 84' ' ' SER . . . . . 1.302 ' O ' ' N ' ' B' ' 86' ' ' LYS . 0.3 OUTLIER 8.43 43.84 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 122.396 1.093 . . . . 0.0 110.274 -179.79 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.982 HD23 ' HA ' ' A' ' 33' ' ' THR . 3.7 mp 20.92 29.69 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 103.616 -2.735 . . . . 0.0 103.616 -172.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . 1.302 ' N ' ' O ' ' B' ' 84' ' ' SER 0.346 15.6 tttt -57.79 -42.45 84.18 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 104.161 -2.533 . . . . 0.0 104.161 177.043 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . 0.42 ' O ' ' CG ' ' B' ' 90' ' ' GLU 0.286 34.8 tttp -65.14 -34.41 78.34 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 112.055 -2.339 . . . . 0.0 105.846 175.342 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.889 ' HB1' ' O ' ' A' ' 33' ' ' THR . . . -78.84 -25.24 44.08 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 118.419 -1.313 . . . . 0.0 108.051 178.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 1.069 ' HA ' HD23 ' B' ' 92' ' ' LEU . . . -68.42 -49.76 57.69 Favored 'General case' 0 C--N 1.294 -1.843 0 O-C-N 121.141 -0.975 . . . . 0.0 109.291 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.425 ' HG3' ' N ' ' B' ' 91' ' ' GLY . 7.0 pt-20 -58.52 -27.18 64.27 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 177.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . 0.425 ' N ' ' HG3' ' B' ' 90' ' ' GLU . . . -75.97 -23.07 72.88 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 179.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . 1.069 HD23 ' HA ' ' B' ' 89' ' ' ALA . 0.4 OUTLIER -80.79 21.65 0.66 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.575 -1.544 . . . . 0.0 110.38 179.625 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' B' ' 92' ' ' LEU . 0.9 OUTLIER 58.18 37.85 26.28 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 -177.067 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . 0.537 ' CD1' ' N ' ' A' ' 75' ' ' VAL . 52.3 t80 -33.89 -45.94 0.21 Allowed 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 114.926 -1.033 . . . . 0.0 111.602 -178.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . 0.466 ' O ' ' HB3' ' B' ' 98' ' ' ALA . 17.0 mm-40 -56.92 -44.67 82.68 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.156 -0.965 . . . . 0.0 109.599 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 96' ' ' ASP . . . . . 0.436 ' N ' ' O ' ' B' ' 93' ' ' LYS . 0.2 OUTLIER -57.07 -33.43 67.27 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.777 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -85.67 -22.89 27.67 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 98' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' B' ' 95' ' ' GLU . . . -59.08 -47.26 85.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.623 -0.673 . . . . 0.0 110.172 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.177 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.502 ' HB3' ' HG ' ' A' ' 6' ' ' LEU . 9.6 mtp . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.445 ' HA ' ' O ' ' B' ' 43' ' ' GLN . 0.6 OUTLIER -173.13 -168.76 0.49 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.99 -1.069 . . . . 0.0 112.043 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.465 ' O ' ' CG2' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -51.92 -16.5 0.73 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.604 -0.685 . . . . 0.0 109.856 179.697 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.75 ' O ' HG13 ' A' ' 7' ' ' ILE . 1.4 m -112.86 -53.92 2.67 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.822 0.82 . . . . 0.0 109.906 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.627 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 0.1 OUTLIER -48.41 -48.26 37.19 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.154 -0.966 . . . . 0.0 109.068 -179.955 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.839 HD11 HG13 ' B' ' 42' ' ' VAL . 1.2 mt -61.01 -29.79 69.92 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.363 -0.935 . . . . 0.0 110.44 178.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.75 HG13 ' O ' ' A' ' 4' ' ' THR . 1.0 OUTLIER -60.82 -44.18 97.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 120.621 -1.299 . . . . 0.0 107.868 179.381 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.877 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -64.6 -33.35 75.71 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 177.658 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' A' ' 6' ' ' LEU . . . -56.19 -38.82 71.48 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 119.921 -0.712 . . . . 0.0 109.165 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.823 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.1 mp -90.98 -33.18 5.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 178.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.877 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -62.93 -13.43 34.37 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 118.574 -1.251 . . . . 0.0 108.655 178.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.45 ' CG ' ' N ' ' A' ' 13' ' ' ASP . 8.0 pt20 -115.53 -42.24 3.16 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.486 -0.759 . . . . 0.0 110.177 179.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.45 ' N ' ' CG ' ' A' ' 12' ' ' GLN . 65.6 m-20 -69.76 -31.29 69.17 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 177.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 1.068 HG22 ' CD1' ' A' ' 16' ' ' LEU 0.265 0.2 OUTLIER -99.27 -67.95 0.83 Allowed 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 178.666 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 53.06 23.82 18.05 Favored Glycine 0 N--CA 1.501 3.022 0 O-C-N 121.439 -0.788 . . . . 0.0 111.417 177.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.068 ' CD1' HG22 ' A' ' 14' ' ' THR . 4.7 mp -67.85 -69.15 0.34 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.536 -0.979 . . . . 0.0 110.028 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.54 HG21 HG21 ' B' ' 17' ' ' THR . 0.6 OUTLIER -130.17 6.03 4.92 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.843 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.597 ' O ' ' C ' ' A' ' 19' ' ' VAL . 22.8 mt-30 56.94 28.01 14.03 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 -176.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 1.075 HG23 ' CD1' ' B' ' 16' ' ' LEU . 0.4 OUTLIER -9.24 -97.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.306 -179.412 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.97 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.9 OUTLIER -136.37 25.1 3.21 Favored 'General case' 0 C--N 1.278 -2.516 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 177.779 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.707 HG23 HD13 ' A' ' 7' ' ' ILE . 27.2 m -18.23 -39.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 CA-C-O 122.24 1.019 . . . . 0.0 110.343 -177.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.806 ' N ' ' O ' ' A' ' 20' ' ' SER . 5.2 m -80.02 -37.55 33.89 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 115.032 -0.986 . . . . 0.0 108.998 178.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.97 ' N ' ' O ' ' A' ' 20' ' ' SER . 2.6 mtpt -88.0 -30.45 19.97 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.867 -0.521 . . . . 0.0 111.24 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.786 ' HB3' HG23 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -74.48 -36.76 63.3 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 117.982 -1.487 . . . . 0.0 109.14 -179.671 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.576 HD12 ' CA ' ' A' ' 7' ' ' ILE . 12.8 mt -77.27 -47.33 20.37 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 118.11 -1.436 . . . . 0.0 107.851 177.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 22' ' ' SER . . . -54.82 -33.57 61.78 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 177.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.674 ' O ' HG23 ' A' ' 31' ' ' ILE . 89.6 p -78.38 -34.03 48.47 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.735 ' HA ' ' CG1' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -66.31 -31.15 71.77 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.381 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.71 ' O ' ' HB ' ' A' ' 33' ' ' THR . 1.6 mt-10 -86.21 -33.13 20.85 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 177.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.741 ' O ' ' CG ' ' A' ' 34' ' ' GLU . 17.6 tttm -69.26 -30.63 68.79 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 176.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.735 ' CG1' ' HA ' ' A' ' 28' ' ' PHE . 1.8 pp -91.33 -36.18 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.35 -0.844 . . . . 0.0 109.379 178.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.823 HG21 ' CE1' ' B' ' 47' ' ' PHE . 3.4 mm -58.42 -55.23 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 177.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.834 ' OG1' HD12 ' B' ' 85' ' ' LEU . 0.3 OUTLIER -63.01 -36.88 85.04 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.559 179.862 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.741 ' CG ' ' O ' ' A' ' 30' ' ' LYS . 5.2 mm-40 -72.68 -47.05 50.53 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.758 -0.588 . . . . 0.0 111.845 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.647 HG21 ' SD ' ' B' ' 1' ' ' MET . 66.5 m -56.02 -50.78 69.96 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.536 -1.352 . . . . 0.0 109.722 -179.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.981 HG11 HD23 ' B' ' 85' ' ' LEU . 2.1 t -50.08 -44.54 22.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.951 ' HB1' ' O ' ' B' ' 88' ' ' ALA . . . -84.26 -4.87 59.12 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 121.746 0.784 . . . . 0.0 110.024 178.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.635 ' N ' ' O ' ' A' ' 34' ' ' GLU . 3.1 ttmt -90.66 -26.21 19.72 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 177.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.05 37.04 0.9 Allowed Glycine 0 C--N 1.302 -1.319 0 C-N-CA 120.071 -1.062 . . . . 0.0 111.185 177.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.447 ' HB3' ' CG2' ' A' ' 35' ' ' THR . 0.3 OUTLIER -145.53 140.89 27.8 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.906 -1.35 . . . . 0.0 110.713 179.356 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -92.07 93.73 8.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.666 -0.646 . . . . 0.0 109.374 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.821 HG12 ' CG ' ' B' ' 1' ' ' MET . 31.6 m -60.19 137.39 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.544 -0.723 . . . . 0.0 110.382 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.457 ' O ' ' CB ' ' B' ' 2' ' ' ASN . 3.9 mt-30 -125.7 107.92 11.02 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.413 -0.805 . . . . 0.0 110.008 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.926 HD12 ' HB3' ' A' ' 48' ' ' LEU . 24.1 mt -72.38 103.49 3.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.182 -0.949 . . . . 0.0 109.892 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.452 ' CG2' ' C ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER 33.55 -96.65 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.915 -0.491 . . . . 0.0 111.193 -179.748 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.7 28.98 2.01 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.776 ' CD1' HD21 ' A' ' 85' ' ' LEU . 1.5 p90 -129.43 -25.34 2.67 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.097 -1.237 . . . . 0.0 111.275 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.926 ' HB3' HD12 ' A' ' 44' ' ' LEU . 5.0 mt -134.79 95.85 3.42 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.45 -1.406 . . . . 0.0 110.6 178.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.437 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 4.5 m-20 -103.98 89.6 3.34 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.178 -0.951 . . . . 0.0 110.888 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.614 HG12 HG23 ' A' ' 79' ' ' VAL . 0.9 OUTLIER -80.31 153.46 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.393 -0.817 . . . . 0.0 110.301 179.645 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.535 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 16.0 ptmt -165.58 115.25 0.82 Allowed Pre-proline 0 N--CA 1.495 1.811 0 C-N-CA 118.969 -1.092 . . . . 0.0 110.43 178.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.943 ' HB3' HG13 ' A' ' 36' ' ' VAL . 55.3 Cg_endo -78.13 141.51 18.62 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.451 1.238 . . . . 0.0 111.089 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.666 HG22 ' O ' ' A' ' 76' ' ' GLY . 23.8 m -146.39 115.32 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-O 121.57 0.7 . . . . 0.0 110.393 179.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.671 ' HB2' ' HB3' ' B' ' 97' ' ' PHE . . . -31.66 106.81 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 121.086 0.47 . . . . 0.0 111.938 -178.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.03 128.31 3.15 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.261 -0.899 . . . . 0.0 109.468 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -55.53 -175.83 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.214 -0.929 . . . . 0.0 110.165 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.692 ' HA ' ' HB3' ' A' ' 72' ' ' ALA . . . -67.05 168.71 9.6 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.843 0.83 . . . . 0.0 111.462 -179.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.606 ' HB2' ' H ' ' A' ' 71' ' ' ILE . 1.9 mtp85 -47.31 170.43 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.259 0.552 . . . . 0.0 110.819 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.427 ' HB3' ' O ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -178.56 93.17 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.435 -0.791 . . . . 0.0 110.004 179.644 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.633 ' N ' ' HB3' ' A' ' 68' ' ' ALA . . . 172.21 -86.22 0.08 OUTLIER Glycine 0 N--CA 1.5 2.926 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.882 ' N ' ' HB2' ' A' ' 68' ' ' ALA . 0.2 OUTLIER -171.09 152.19 3.41 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.203 -1.174 . . . . 0.0 111.618 178.036 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.734 ' CB ' ' HD3' ' A' ' 63' ' ' PRO . 0.4 OUTLIER -152.95 -60.43 0.02 OUTLIER Pre-proline 0 C--N 1.307 -1.252 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.763 178.833 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.734 ' HD3' ' CB ' ' A' ' 62' ' ' ASN . 55.8 Cg_endo -102.27 -4.11 0.33 Allowed 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 121.534 1.489 . . . . 0.0 112.821 -178.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.656 ' O ' ' N ' ' A' ' 66' ' ' GLN . 5.4 mt-30 -139.57 52.67 1.72 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 120.533 -1.354 . . . . 0.0 112.397 -177.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.642 ' N ' ' CE1' ' A' ' 61' ' ' PHE . 8.8 t 33.06 18.38 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.656 ' N ' ' O ' ' A' ' 64' ' ' GLN . 0.9 OUTLIER 177.68 29.55 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.533 -1.354 . . . . 0.0 112.314 179.671 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.805 ' C ' ' HA ' ' A' ' 61' ' ' PHE . 3.0 mt-10 -156.49 89.88 1.14 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.246 -1.534 . . . . 0.0 110.208 179.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.882 ' HB2' ' N ' ' A' ' 61' ' ' PHE . . . -75.94 72.62 2.81 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.83 HD12 HG12 ' A' ' 71' ' ' ILE . 0.3 OUTLIER -13.78 92.97 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.323 0 CA-C-O 121.725 0.774 . . . . 0.0 110.279 -178.125 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 68' ' ' ALA . 5.9 mt-10 -44.65 102.06 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.599 -177.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 1.071 ' O ' HD12 ' A' ' 71' ' ' ILE . 2.5 pp -145.5 113.81 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 O-C-N 121.288 -0.882 . . . . 0.0 111.975 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.902 ' H ' ' HD3' ' A' ' 73' ' ' PRO . . . 136.43 49.79 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.329 0 CA-C-N 115.043 -0.981 . . . . 0.0 112.312 178.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.902 ' HD3' ' H ' ' A' ' 72' ' ' ALA . 55.6 Cg_endo -85.78 77.11 2.68 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 O-C-N 122.683 0.833 . . . . 0.0 110.683 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.923 ' O ' ' HB ' ' A' ' 75' ' ' VAL . 86.2 p -178.65 19.17 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.756 -1.215 . . . . 0.0 111.221 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.923 ' HB ' ' O ' ' A' ' 74' ' ' SER . 4.4 p 136.86 -173.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.736 ' H ' HG22 ' A' ' 75' ' ' VAL . . . -123.6 61.41 0.58 Allowed Glycine 0 N--CA 1.487 2.094 0 N-CA-C 108.935 -1.666 . . . . 0.0 108.935 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.798 HG11 ' CB ' ' B' ' 84' ' ' SER . 3.4 p -47.73 82.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.803 -0.821 . . . . 0.0 110.803 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.599 ' N ' ' O ' ' A' ' 76' ' ' GLY . 0.4 OUTLIER -83.73 174.84 10.13 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 118.597 -1.241 . . . . 0.0 110.093 179.952 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.614 HG23 HG12 ' A' ' 50' ' ' ILE . 2.6 p 175.15 176.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.707 ' O ' HD23 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -177.14 173.0 0.76 Allowed Pre-proline 0 N--CA 1.485 1.324 0 O-C-N 120.934 -1.103 . . . . 0.0 110.195 177.377 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.564 ' HB2' HG13 ' B' ' 77' ' ' VAL . 55.0 Cg_endo -98.6 135.45 0.3 Allowed 'Trans proline' 0 C--N 1.302 -1.904 0 C-N-CA 122.505 2.137 . . . . 0.0 110.622 178.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.426 ' HA3' ' HA ' ' A' ' 47' ' ' PHE . . . -89.73 -158.28 34.17 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 107.956 -2.058 . . . . 0.0 107.956 178.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.445 ' HA ' ' HB2' ' A' ' 86' ' ' LYS . 3.4 pm0 -90.17 -16.12 30.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.029 -1.277 . . . . 0.0 110.217 179.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.412 ' CB ' ' HB3' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -53.42 -36.61 61.71 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.269 -0.895 . . . . 0.0 109.267 179.412 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.95 ' CB ' HG21 ' B' ' 77' ' ' VAL . 0.5 OUTLIER -82.3 -33.21 29.12 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.915 -0.714 . . . . 0.0 109.158 179.07 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.736 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 2.2 mttt -70.97 -43.83 67.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.458 -0.776 . . . . 0.0 109.755 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.4 tptt -64.71 -39.06 93.0 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 177.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.688 ' O ' ' HB1' ' B' ' 37' ' ' ALA . . . -64.55 -34.9 79.31 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 176.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.964 ' HA ' HD23 ' A' ' 92' ' ' LEU . . . -54.43 -46.3 73.21 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 120.036 -0.666 . . . . 0.0 109.211 179.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -52.65 -32.58 42.85 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 177.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 88' ' ' ALA . . . -64.65 -38.42 95.64 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 178.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.964 HD23 ' HA ' ' A' ' 89' ' ' ALA . 0.5 OUTLIER -72.45 10.37 0.83 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.537 -1.567 . . . . 0.0 111.13 -179.85 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 22.1 mmtt 61.41 41.69 12.54 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -177.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.544 ' CD1' ' N ' ' B' ' 75' ' ' VAL . 0.0 OUTLIER -38.0 -40.27 0.46 Allowed 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.005 -178.962 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -60.84 -39.25 88.35 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.37 -0.831 . . . . 0.0 109.769 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 93' ' ' LYS . 0.6 OUTLIER -61.02 -35.5 77.03 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.394 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.625 ' HB3' ' HB2' ' B' ' 54' ' ' ALA . 0.2 OUTLIER -73.83 -23.98 59.72 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.708 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.85 -43.53 58.34 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.502 -0.749 . . . . 0.0 110.28 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 30.2 mttt . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.17 -179.965 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.821 ' CG ' HG12 ' A' ' 42' ' ' VAL . 1.3 ptm . . . . . 0 N--CA 1.496 1.842 0 CA-C-O 121.479 0.657 . . . . 0.0 110.871 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . 0.457 ' CB ' ' O ' ' A' ' 43' ' ' GLN . 17.8 p30 -178.3 -152.32 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 120.106 -0.637 . . . . 0.0 110.516 178.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.484 ' HD3' HD11 ' B' ' 25' ' ' LEU . 1.0 OUTLIER -59.14 -3.22 0.35 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.147 -0.971 . . . . 0.0 110.207 179.612 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.688 ' O ' HG23 ' B' ' 7' ' ' ILE . 25.1 m -109.01 -53.26 2.67 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.003 -1.061 . . . . 0.0 109.969 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.487 ' HB3' ' CB ' ' B' ' 1' ' ' MET . 1.8 mt-10 -65.88 -46.84 76.9 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.199 -0.938 . . . . 0.0 109.532 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.688 ' O ' ' HB3' ' B' ' 9' ' ' ALA . 29.9 mt -49.05 -51.7 29.69 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.213 -0.929 . . . . 0.0 109.643 179.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' ILE . . . . . 0.929 HG21 HD22 ' B' ' 25' ' ' LEU . 0.1 OUTLIER -50.22 -51.05 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 177.414 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . 0.883 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.1 OUTLIER -56.15 -37.38 69.42 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.489 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . 0.688 ' HB3' ' O ' ' B' ' 6' ' ' LEU . . . -55.34 -36.2 66.03 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.372 -0.83 . . . . 0.0 108.825 179.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.786 HG23 ' HB3' ' A' ' 24' ' ' MET . 1.6 mp -89.22 -34.22 6.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 178.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.883 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -67.22 -12.48 60.18 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.476 ' N ' ' O ' ' B' ' 8' ' ' LYS . 8.9 tp-100 -112.61 -44.19 3.37 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' B' ' 9' ' ' ALA . 2.2 m-20 -68.89 -22.41 64.19 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 176.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.771 HG22 HD21 ' B' ' 16' ' ' LEU . 0.2 OUTLIER -120.04 -83.54 0.65 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.297 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . 0.546 ' O ' ' C ' ' B' ' 16' ' ' LEU . . . 68.32 -21.84 0.3 Allowed Glycine 0 N--CA 1.497 2.713 0 O-C-N 120.906 -1.121 . . . . 0.0 110.346 178.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 16' ' ' LEU . . . . . 1.075 ' CD1' HG23 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -25.57 -58.3 0.07 Allowed 'General case' 0 N--CA 1.514 2.735 0 CA-C-O 122.202 1.001 . . . . 0.0 110.794 -179.819 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . 0.646 HG22 ' H ' ' B' ' 19' ' ' VAL . 0.5 OUTLIER -136.25 -0.89 2.42 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.419 -179.38 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . 0.655 ' O ' ' C ' ' B' ' 19' ' ' VAL . 4.7 mt-30 55.24 31.15 15.95 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 -176.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 1.041 HG11 HG11 ' A' ' 19' ' ' VAL . 1.2 p -4.09 -92.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.856 -178.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.934 ' O ' ' N ' ' B' ' 22' ' ' SER . 0.6 OUTLIER -133.37 25.83 4.14 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 177.803 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.692 ' O ' HD23 ' B' ' 25' ' ' LEU . 30.0 m -17.26 -37.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-O 122.426 1.107 . . . . 0.0 109.374 -178.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.934 ' N ' ' O ' ' B' ' 20' ' ' SER . 12.2 t -80.14 -41.24 25.79 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.904 177.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . 0.911 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.0 OUTLIER -87.33 -36.17 17.99 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.438 -0.789 . . . . 0.0 111.483 179.963 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' MET . . . . . 0.769 ' HB3' HG21 ' A' ' 14' ' ' THR . 0.0 OUTLIER -71.42 -30.09 65.67 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 118.023 -1.471 . . . . 0.0 108.512 179.367 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.929 HD22 HG21 ' B' ' 7' ' ' ILE . 0.3 OUTLIER -75.31 -41.85 55.93 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 118.662 -1.215 . . . . 0.0 107.843 177.368 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . 0.659 ' N ' ' HG ' ' B' ' 25' ' ' LEU . . . -68.42 -24.43 64.74 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . 0.505 ' O ' ' HB3' ' B' ' 30' ' ' LYS . 4.5 t -84.55 -36.83 21.87 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . 0.764 ' CE1' HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -51.89 -53.45 40.7 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.441 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . 0.614 ' N ' ' CD1' ' B' ' 28' ' ' PHE . 0.1 OUTLIER -63.87 -39.04 93.27 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 177.742 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 1.269 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 19.3 tttm -56.08 -29.51 60.68 Favored 'General case' 0 C--O 1.191 -2.015 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.314 178.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.645 HD12 ' HA ' ' B' ' 28' ' ' PHE . 0.2 OUTLIER -104.46 -23.88 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 119.645 -1.909 . . . . 0.0 108.382 177.516 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.56 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.3 mm -73.1 -61.53 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 177.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 33' ' ' THR . . . . . 0.798 ' HA ' HD23 ' A' ' 85' ' ' LEU . 0.7 OUTLIER -67.38 -36.29 81.04 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.916 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 1.269 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 18.4 mm-40 -78.3 -35.24 48.07 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 121.07 -1.019 . . . . 0.0 111.658 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 35' ' ' THR . . . . . 0.639 HG23 ' CB ' ' B' ' 40' ' ' ASP . 3.0 m -56.39 -47.94 77.92 Favored 'General case' 0 N--CA 1.504 2.257 0 CA-C-N 120.49 1.496 . . . . 0.0 107.211 178.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.817 HG13 ' HB3' ' B' ' 52' ' ' PRO . 23.5 t -53.58 -42.32 49.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 177.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 0.688 ' HB1' ' O ' ' A' ' 88' ' ' ALA . . . -82.89 -1.19 51.44 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.735 178.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.663 ' N ' ' O ' ' B' ' 34' ' ' GLU . 0.0 OUTLIER -100.37 -18.85 16.56 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 177.905 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.99 42.43 2.26 Favored Glycine 0 C--N 1.302 -1.321 0 C-N-CA 120.272 -0.966 . . . . 0.0 110.74 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . 0.639 ' CB ' HG23 ' B' ' 35' ' ' THR . 0.4 OUTLIER -144.88 150.96 37.97 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.13 -1.218 . . . . 0.0 110.159 179.276 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 63.9 mttt -97.34 92.18 5.85 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.549 -0.719 . . . . 0.0 110.238 -179.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.839 HG13 HD11 ' A' ' 6' ' ' LEU . 66.9 t -59.38 129.62 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.536 -0.728 . . . . 0.0 109.399 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 43' ' ' GLN . . . . . 0.504 ' HA ' ' O ' ' B' ' 48' ' ' LEU . 0.8 OUTLIER -125.02 103.91 8.27 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.092 -1.005 . . . . 0.0 111.123 -179.021 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.662 HD12 ' CE1' ' B' ' 47' ' ' PHE . 19.9 mt -62.96 113.97 3.4 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.225 -0.922 . . . . 0.0 109.111 178.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . 0.562 HG22 ' HG2' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 33.12 -89.87 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.499 0 O-C-N 121.832 -0.543 . . . . 0.0 110.93 -179.252 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -146.06 15.79 1.72 Allowed Glycine 0 N--CA 1.484 1.856 0 C-N-CA 119.732 -1.223 . . . . 0.0 110.338 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . 0.823 ' CE1' HG21 ' A' ' 32' ' ' ILE . 17.1 p90 -111.14 -37.79 5.23 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.762 -1.434 . . . . 0.0 112.113 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.642 ' HB2' HD12 ' B' ' 44' ' ' LEU . 0.0 OUTLIER -114.32 117.8 32.11 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.3 -1.5 . . . . 0.0 111.272 179.703 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -113.19 74.17 0.85 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.699 -0.626 . . . . 0.0 110.569 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 50' ' ' ILE . . . . . 0.924 HD13 ' HB ' ' B' ' 79' ' ' VAL . 3.1 mm -59.87 134.95 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.422 -0.799 . . . . 0.0 110.144 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . 0.602 ' HD3' HG13 ' B' ' 53' ' ' VAL . 0.0 OUTLIER -154.05 126.15 3.85 Favored Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 120.872 -1.142 . . . . 0.0 110.959 179.338 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.817 ' HB3' HG13 ' B' ' 36' ' ' VAL . 55.7 Cg_endo -83.79 142.17 10.02 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 O-C-N 123.439 1.231 . . . . 0.0 110.655 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.756 HG22 ' O ' ' B' ' 76' ' ' GLY . 27.6 m -137.88 114.78 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-O 121.762 0.791 . . . . 0.0 111.058 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.625 ' HB2' ' HB3' ' A' ' 97' ' ' PHE . . . -56.15 104.93 0.16 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.561 -0.712 . . . . 0.0 110.504 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 -130.1 82.59 2.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.613 -0.679 . . . . 0.0 109.332 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.68 -154.29 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.409 -0.807 . . . . 0.0 109.987 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 1.041 ' HB3' HD13 ' B' ' 71' ' ' ILE . . . -154.7 177.46 11.22 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.015 -1.053 . . . . 0.0 111.57 -179.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 58' ' ' ARG . . . . . 0.685 ' N ' HG12 ' B' ' 71' ' ' ILE . 4.8 mpt_? -57.51 -161.24 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.7 -179.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . 0.518 ' CB ' ' O ' ' B' ' 58' ' ' ARG . 0.0 OUTLIER 159.47 52.68 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.201 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . 0.437 ' O ' HD23 ' B' ' 69' ' ' LEU . . . -128.31 -101.47 1.06 Allowed Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.973 -1.108 . . . . 0.0 110.499 -179.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 61' ' ' PHE . . . . . 0.709 ' CZ ' ' HD2' ' B' ' 63' ' ' PRO . 0.0 OUTLIER -139.76 178.53 7.18 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.202 -1.175 . . . . 0.0 111.14 -178.864 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . 0.77 ' N ' ' HA ' ' B' ' 68' ' ' ALA . 44.5 m-80 -51.6 -114.34 0.0 OUTLIER Pre-proline 0 C--N 1.305 -1.336 0 CA-C-O 117.548 -1.215 . . . . 0.0 109.993 -178.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.709 ' HD2' ' CZ ' ' B' ' 61' ' ' PHE . 37.4 Cg_endo -61.08 -128.65 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.48 0 CA-C-N 121.255 1.484 . . . . 0.0 109.303 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . 0.648 ' HB2' ' CE1' ' B' ' 61' ' ' PHE . 4.6 tt0 61.99 -66.23 0.08 Allowed 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.286 -1.509 . . . . 0.0 108.505 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.679 ' N ' ' O ' ' B' ' 63' ' ' PRO . 7.2 p -140.0 19.62 2.46 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 177.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . 0.683 ' HA ' ' O ' ' B' ' 62' ' ' ASN . 8.5 mp0 41.69 99.18 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 122.222 1.01 . . . . 0.0 111.477 -179.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . 0.634 ' O ' ' N ' ' B' ' 69' ' ' LEU . 5.7 pt-20 168.58 71.49 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 105.118 -2.178 . . . . 0.0 105.118 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . 0.954 ' O ' HD12 ' B' ' 69' ' ' LEU . . . -46.66 14.82 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 116.822 2.156 . . . . 0.0 116.822 -174.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.954 HD12 ' O ' ' B' ' 68' ' ' ALA . 4.4 mt 122.16 17.12 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.629 0 CA-C-N 120.775 1.625 . . . . 0.0 112.372 174.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . 0.695 ' O ' HG23 ' B' ' 71' ' ' ILE . 21.7 tt0 166.68 162.39 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.397 -0.815 . . . . 0.0 110.065 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 1.041 HD13 ' HB3' ' B' ' 57' ' ' ALA . 1.0 OUTLIER -161.64 -154.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 O-C-N 121.592 -0.692 . . . . 0.0 109.366 -179.414 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -115.31 85.37 12.83 Favored Pre-proline 0 C--N 1.301 -1.503 0 O-C-N 121.229 -0.919 . . . . 0.0 112.289 -178.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 73' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -79.68 120.92 4.46 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.779 1.41 . . . . 0.0 109.827 178.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . 0.528 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 7.5 p -177.5 158.25 1.37 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.076 -1.015 . . . . 0.0 109.849 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . 0.554 HG21 HD21 ' A' ' 92' ' ' LEU . 1.1 t -60.06 170.0 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.101 -0.999 . . . . 0.0 108.884 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . 0.756 ' O ' HG22 ' B' ' 53' ' ' VAL . . . -120.03 86.35 0.4 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.95 HG21 ' CB ' ' A' ' 85' ' ' LEU . 3.2 p -61.22 76.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.648 -0.913 . . . . 0.0 109.485 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . 0.534 ' N ' ' O ' ' B' ' 76' ' ' GLY . 0.1 OUTLIER -77.3 177.78 7.65 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.872 0.844 . . . . 0.0 110.37 -179.884 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.924 ' HB ' HD13 ' B' ' 50' ' ' ILE . 7.0 p 177.73 174.76 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . 0.614 ' HB2' ' HD2' ' B' ' 81' ' ' PRO . 0.0 OUTLIER 177.17 171.75 0.39 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 120.821 -1.174 . . . . 0.0 111.14 177.493 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 81' ' ' PRO . . . . . 0.666 ' HA ' ' O ' ' B' ' 47' ' ' PHE . 51.1 Cg_endo -74.64 141.45 27.81 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.374 1.723 . . . . 0.0 110.475 176.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . 0.52 ' H ' ' HA ' ' B' ' 47' ' ' PHE . . . -110.31 -75.67 0.83 Allowed Glycine 0 N--CA 1.492 2.433 0 N-CA-C 106.501 -2.64 . . . . 0.0 106.501 178.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . 0.885 ' O ' ' N ' ' B' ' 85' ' ' LEU . 2.1 pt-20 -91.22 40.62 1.03 Allowed 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 176.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 84' ' ' SER . . . . . 1.034 ' C ' HD22 ' B' ' 85' ' ' LEU . 1.9 t 10.52 43.83 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.665 1.222 . . . . 0.0 110.302 178.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 1.034 HD22 ' C ' ' B' ' 84' ' ' SER . 0.0 OUTLIER 18.76 26.21 0.0 OUTLIER 'General case' 0 C--O 1.186 -2.287 0 N-CA-C 102.898 -3.001 . . . . 0.0 102.898 -170.669 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . 0.583 ' HB2' ' HB3' ' B' ' 84' ' ' SER 0.325 2.9 tttm -48.71 -38.59 21.9 Favored 'General case' 0 CA--C 1.473 -2.018 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 177.708 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . 0.27 2.9 tttt -62.54 -40.92 98.33 Favored 'General case' 0 C--N 1.275 -2.652 0 CA-C-N 111.886 -2.415 . . . . 0.0 106.137 177.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.951 ' O ' ' HB1' ' A' ' 37' ' ' ALA . . . -78.65 -33.57 47.08 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 118.29 -1.364 . . . . 0.0 107.989 177.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.926 ' HA ' HD23 ' B' ' 92' ' ' LEU . . . -64.73 -30.63 71.65 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -64.46 -33.92 77.01 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 175.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -64.23 -45.36 93.81 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 178.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . 0.926 HD23 ' HA ' ' B' ' 89' ' ' ALA . 0.5 OUTLIER -65.49 2.32 0.94 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.499 -1.589 . . . . 0.0 111.403 -179.617 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . 0.508 ' CB ' ' O ' ' B' ' 92' ' ' LEU . 7.0 tptt 72.9 53.91 0.14 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -177.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . 0.707 ' CD2' ' HA ' ' A' ' 74' ' ' SER . 6.1 t80 -38.97 -43.62 0.99 Allowed 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.008 -179.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -57.16 -41.19 78.75 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.304 -0.873 . . . . 0.0 109.656 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 96' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' B' ' 93' ' ' LYS . 4.1 t70 -60.89 -31.95 71.42 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 97' ' ' PHE . . . . . 0.671 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 0.1 OUTLIER -82.69 -24.75 33.52 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.924 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 98' ' ' ALA . . . . . 0.62 ' HA ' ' HB1' ' A' ' 54' ' ' ALA . . . -67.45 -31.76 72.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.448 -0.783 . . . . 0.0 109.939 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.22 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.83 ' HB3' HG22 ' B' ' 42' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 120.897 0.379 . . . . 0.0 110.291 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.481 ' H ' ' HB2' ' A' ' 5' ' ' GLU . 16.1 p-10 -173.29 -161.62 0.14 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.398 -0.921 . . . . 0.0 111.459 178.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.586 ' HD2' ' HB ' ' B' ' 45' ' ' THR . 6.8 tttt -45.88 -21.75 0.15 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.956 -0.465 . . . . 0.0 110.116 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.656 ' O ' HG13 ' A' ' 7' ' ' ILE . 88.3 m -94.29 -66.36 0.92 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.501 -0.749 . . . . 0.0 110.662 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.501 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 4.2 mt-10 -48.98 -41.11 33.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.888 -1.133 . . . . 0.0 109.123 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.725 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 22.5 mt -53.25 -41.88 65.92 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.763 178.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.775 HG21 ' CD2' ' A' ' 25' ' ' LEU . 1.2 pp -59.05 -40.34 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 178.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.848 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 17.7 mtmt -62.31 -37.52 85.9 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 176.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.864 ' CB ' HD13 ' B' ' 31' ' ' ILE . . . -53.87 -36.87 63.11 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.848 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.6 mp -90.91 -31.95 5.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 178.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.848 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -67.45 -8.0 29.84 Favored 'General case' 0 C--N 1.284 -2.26 0 O-C-N 120.777 -1.202 . . . . 0.0 109.128 179.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.436 ' HB3' ' O ' ' A' ' 8' ' ' LYS . 1.5 tt0 -124.07 -38.73 2.43 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.374 -0.829 . . . . 0.0 109.961 179.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 9' ' ' ALA . 1.0 OUTLIER -73.18 -19.22 61.15 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 177.482 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 1.146 HG22 ' CD1' ' A' ' 16' ' ' LEU 0.28 0.2 OUTLIER -112.1 -71.59 0.75 Allowed 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 179.516 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 57.4 18.64 30.2 Favored Glycine 0 N--CA 1.498 2.769 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 177.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.146 ' CD1' HG22 ' A' ' 14' ' ' THR . 4.9 mp -58.73 -62.75 1.63 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.419 -1.048 . . . . 0.0 109.384 179.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.551 ' O ' HG23 ' A' ' 17' ' ' THR . 0.5 OUTLIER -143.27 8.88 1.62 Allowed 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.242 -179.771 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.611 ' O ' ' C ' ' A' ' 19' ' ' VAL . 2.7 mt-30 58.24 26.7 14.18 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 -176.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 1.037 HG11 HG11 ' B' ' 19' ' ' VAL . 0.6 OUTLIER -2.26 -98.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.453 -179.306 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 1.045 ' HB3' HD21 ' B' ' 16' ' ' LEU . 1.1 p -134.4 25.57 3.79 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 178.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.697 ' HA ' ' CE ' ' A' ' 24' ' ' MET . 28.3 m -19.36 -39.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 CA-C-O 122.55 1.166 . . . . 0.0 109.872 -178.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.809 ' N ' ' O ' ' A' ' 20' ' ' SER . 36.7 t -76.64 -41.85 44.28 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.118 177.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.967 ' N ' ' O ' ' A' ' 20' ' ' SER . 1.2 mtpt -82.78 -37.72 24.18 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.664 -0.648 . . . . 0.0 111.999 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.697 ' CE ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -69.27 -24.52 63.99 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 117.47 -1.692 . . . . 0.0 108.437 179.914 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.775 ' CD2' HG21 ' A' ' 7' ' ' ILE . 0.3 OUTLIER -75.66 -47.32 26.86 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.134 -1.027 . . . . 0.0 109.241 178.609 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.701 ' N ' ' HG ' ' A' ' 25' ' ' LEU . . . -64.0 -27.93 69.46 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 178.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.605 ' O ' HG13 ' A' ' 31' ' ' ILE . 7.2 p -85.96 -34.99 20.72 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 178.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.684 ' HE1' HD22 ' B' ' 44' ' ' LEU . 0.1 OUTLIER -58.31 -46.65 85.73 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 179.146 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.549 ' HG3' ' CE2' ' B' ' 47' ' ' PHE . 2.4 tt0 -70.95 -34.35 71.38 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 177.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 1.293 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 60.6 tttt -64.37 -19.1 65.27 Favored 'General case' 0 C--O 1.193 -1.888 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 177.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.642 HD12 HG12 ' A' ' 32' ' ' ILE . 1.7 pp -108.91 -29.2 2.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 120.116 -1.615 . . . . 0.0 109.062 178.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.642 HG12 HD12 ' A' ' 31' ' ' ILE . 1.1 mm -72.0 -55.05 14.68 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.62 HG23 ' HB2' ' B' ' 88' ' ' ALA . 0.7 OUTLIER -78.0 -32.2 51.08 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.791 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 1.293 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 73.2 mm-40 -78.75 -37.13 41.96 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 120.933 -1.104 . . . . 0.0 110.606 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.833 HG22 ' CB ' ' A' ' 40' ' ' ASP . 73.1 m -64.96 -37.45 87.68 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 177.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.037 HG21 HD22 ' B' ' 85' ' ' LEU . 1.4 t -56.75 -35.94 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 175.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.678 ' CB ' ' O ' ' B' ' 88' ' ' ALA . . . -89.46 12.67 15.8 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 176.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 34' ' ' GLU . 3.1 ttmt -130.17 17.1 5.56 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 178.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.32 40.49 10.05 Favored Glycine 0 N--CA 1.48 1.598 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.833 ' CB ' HG22 ' A' ' 35' ' ' THR . 4.8 t70 -60.68 163.23 5.7 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 122.578 1.18 . . . . 0.0 112.8 -178.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.467 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 16.8 mtmt -157.52 57.58 0.5 Allowed 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 105.9 -1.889 . . . . 0.0 105.9 176.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.771 ' CG1' HD11 ' B' ' 6' ' ' LEU . 2.2 t -95.68 150.15 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-O 121.533 0.683 . . . . 0.0 111.05 -177.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.469 ' O ' ' CG ' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -137.53 99.94 4.08 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.299 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.614 HD12 ' HB2' ' A' ' 48' ' ' LEU . 11.9 mt -66.78 113.3 4.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.095 -1.003 . . . . 0.0 110.17 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.562 HG23 ' CD2' ' A' ' 47' ' ' PHE . 0.1 OUTLIER 29.99 -88.93 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.21 0 O-C-N 122.038 -0.414 . . . . 0.0 111.411 179.299 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -147.6 19.49 1.48 Allowed Glycine 0 N--CA 1.484 1.884 0 C-N-CA 119.729 -1.224 . . . . 0.0 110.274 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.592 ' CE1' HG21 ' B' ' 32' ' ' ILE . 32.1 p90 -116.91 -39.2 3.29 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.759 -1.436 . . . . 0.0 111.831 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.963 HD11 HD11 ' B' ' 48' ' ' LEU . 0.1 OUTLIER -115.78 108.92 16.95 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.758 -1.214 . . . . 0.0 112.238 -179.885 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.721 ' O ' ' HB ' ' A' ' 79' ' ' VAL . 0.1 OUTLIER -92.81 68.13 4.53 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.711 -0.618 . . . . 0.0 109.675 179.002 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.836 HD13 HG21 ' A' ' 79' ' ' VAL . 48.0 mm -53.07 114.3 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.49 0 O-C-N 121.186 -0.946 . . . . 0.0 112.398 -176.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.504 ' O ' ' N ' ' A' ' 78' ' ' SER . 0.6 OUTLIER -157.39 109.65 1.86 Allowed Pre-proline 0 N--CA 1.478 0.967 0 O-C-N 121.846 -0.534 . . . . 0.0 110.293 179.973 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.569 ' HB2' HG11 ' A' ' 75' ' ' VAL . 50.2 Cg_endo -76.8 149.85 30.03 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 O-C-N 123.132 1.069 . . . . 0.0 109.86 178.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 1.046 ' O ' HG22 ' A' ' 75' ' ' VAL . 1.9 t -110.95 -142.91 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.487 -0.758 . . . . 0.0 110.17 -179.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.637 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . 174.06 103.64 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.377 -0.827 . . . . 0.0 109.703 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.532 ' HB3' ' O ' ' A' ' 54' ' ' ALA . 0.1 OUTLIER 162.35 72.54 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.467 0 O-C-N 121.483 -0.76 . . . . 0.0 109.85 -179.897 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.739 ' O ' ' HA ' ' A' ' 73' ' ' PRO . 7.8 mt-30 -158.57 143.68 16.31 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.098 -1.001 . . . . 0.0 110.633 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.803 ' O ' ' O ' ' A' ' 58' ' ' ARG . . . 168.58 143.81 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 122.051 0.929 . . . . 0.0 111.619 178.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.874 ' O ' ' N ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -22.1 -141.78 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 178.751 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.541 ' C ' ' O ' ' A' ' 58' ' ' ARG . 0.5 OUTLIER -18.07 66.78 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 122.079 0.942 . . . . 0.0 111.483 -179.003 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.874 ' N ' ' O ' ' A' ' 58' ' ' ARG . . . -167.1 -76.86 0.03 OUTLIER Glycine 0 N--CA 1.485 1.949 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.549 ' CB ' ' O ' ' A' ' 60' ' ' GLY . 2.6 t80 163.84 134.09 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.65 -0.912 . . . . 0.0 110.643 179.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.591 ' OD1' HD21 ' A' ' 69' ' ' LEU . 1.0 OUTLIER -71.84 179.18 1.05 Allowed Pre-proline 0 N--CA 1.489 1.477 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.608 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.42 ' HD2' ' HB3' ' A' ' 62' ' ' ASN . 47.8 Cg_endo -74.68 53.43 3.19 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.272 1.143 . . . . 0.0 109.279 178.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -121.41 -113.8 0.32 Allowed 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.339 -0.851 . . . . 0.0 111.984 -178.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.547 ' N ' ' HE1' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -155.78 -28.44 0.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.345 -0.847 . . . . 0.0 109.855 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -155.67 32.15 0.36 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.258 -0.901 . . . . 0.0 110.169 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -119.74 99.01 6.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.267 -0.895 . . . . 0.0 110.262 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -106.36 138.61 42.23 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.398 -0.814 . . . . 0.0 110.428 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.656 ' CD1' HG22 ' A' ' 71' ' ' ILE . 0.3 OUTLIER -151.43 -169.93 3.51 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.348 -0.845 . . . . 0.0 110.199 179.912 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.518 ' HA ' ' CB ' ' A' ' 58' ' ' ARG . 0.4 OUTLIER -102.89 77.11 1.54 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.192 -0.942 . . . . 0.0 110.639 -179.62 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.849 ' H ' ' HA ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -97.39 -162.42 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-O 122.135 0.969 . . . . 0.0 110.753 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.813 ' N ' ' CG1' ' A' ' 71' ' ' ILE 0.254 . . -120.08 171.8 5.26 Favored Pre-proline 0 C--N 1.303 -1.44 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.187 178.173 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.739 ' HA ' ' O ' ' A' ' 56' ' ' GLN . 51.0 Cg_endo -85.04 132.83 4.68 Favored 'Trans proline' 0 C--N 1.3 -1.986 0 O-C-N 124.214 1.639 . . . . 0.0 110.105 178.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.624 ' N ' ' CE2' ' B' ' 94' ' ' TYR . 28.7 t -161.43 135.81 7.05 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.332 -0.855 . . . . 0.0 109.722 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 1.046 HG22 ' O ' ' A' ' 53' ' ' VAL . 0.9 OUTLIER -52.69 173.61 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.221 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.458 ' N ' ' CG1' ' A' ' 75' ' ' VAL . . . -111.94 -157.38 13.84 Favored Glycine 0 N--CA 1.475 1.283 0 C-N-CA 118.659 -1.734 . . . . 0.0 109.561 -179.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.79 HG12 ' CG1' ' A' ' 79' ' ' VAL . 3.5 t -139.02 85.62 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.172 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.504 ' N ' ' O ' ' A' ' 51' ' ' LYS . 0.2 OUTLIER -55.09 -45.7 75.46 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.453 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.836 HG21 HD13 ' A' ' 50' ' ' ILE 0.273 5.8 p -50.37 170.84 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-O 122.347 1.07 . . . . 0.0 112.264 -177.165 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.661 ' HB2' ' HD2' ' A' ' 81' ' ' PRO . 5.6 ptmt 174.79 177.46 0.2 Allowed Pre-proline 0 C--N 1.302 -1.499 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.661 ' HD2' ' HB2' ' A' ' 80' ' ' LYS . 36.8 Cg_endo -63.15 143.59 90.42 Favored 'Trans proline' 0 C--N 1.295 -2.249 0 N-CA-C 106.973 -1.972 . . . . 0.0 106.973 175.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.49 ' C ' ' H ' ' A' ' 84' ' ' SER . . . -120.77 -102.97 1.88 Allowed Glycine 0 N--CA 1.498 2.797 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -178.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.96 ' O ' ' N ' ' A' ' 85' ' ' LEU . 32.6 tt0 -72.38 50.51 0.23 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.653 ' HB3' ' HB2' ' A' ' 86' ' ' LYS . 2.7 t 7.86 43.54 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 122.491 1.139 . . . . 0.0 109.785 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 1.114 HD11 HG12 ' B' ' 36' ' ' VAL . 3.0 pp 18.48 27.98 0.0 OUTLIER 'General case' 0 C--O 1.196 -1.713 0 N-CA-C 103.33 -2.841 . . . . 0.0 103.33 -171.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.685 ' HA ' ' HB3' ' A' ' 89' ' ' ALA 0.335 1.6 tttt -55.71 -39.85 71.62 Favored 'General case' 0 CA--C 1.473 -2.004 0 N-CA-C 104.473 -2.418 . . . . 0.0 104.473 177.134 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.255 28.7 tttt -59.11 -41.34 87.91 Favored 'General case' 0 C--N 1.28 -2.43 0 CA-C-N 112.188 -2.278 . . . . 0.0 105.79 177.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.896 ' O ' ' HB1' ' B' ' 37' ' ' ALA . . . -77.76 -32.08 52.42 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 117.65 -1.62 . . . . 0.0 107.061 177.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.869 ' HA ' HD23 ' A' ' 92' ' ' LEU . . . -61.5 -34.32 75.29 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.21 -1.034 . . . . 0.0 108.21 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.412 ' HA ' ' CB ' ' A' ' 94' ' ' TYR . 3.9 mt-10 -60.23 -35.91 76.52 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 175.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -62.51 -32.88 84.7 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 178.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 1.009 HD11 ' CE1' ' A' ' 97' ' ' PHE . 0.3 OUTLIER -78.73 17.37 0.71 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.481 -1.599 . . . . 0.0 110.667 -179.81 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.745 ' O ' ' C ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER 80.12 32.47 0.19 Allowed 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -178.068 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.848 ' O ' ' N ' ' A' ' 97' ' ' PHE . 9.5 t80 -25.53 -68.22 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 117.755 -1.578 . . . . 0.0 108.25 -177.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.968 ' O ' ' N ' ' A' ' 98' ' ' ALA . 62.6 mm-40 9.72 41.07 0.0 OUTLIER 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 101.391 -3.559 . . . . 0.0 101.391 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 1.076 ' O ' ' N ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER 18.5 43.3 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 112.708 -2.042 . . . . 0.0 107.713 -172.198 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 1.009 ' CE1' HD11 ' A' ' 92' ' ' LEU . 0.0 OUTLIER 26.27 28.76 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 101.859 -3.386 . . . . 0.0 101.859 -169.465 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 1.076 ' N ' ' O ' ' A' ' 96' ' ' ASP 0.275 . . -66.1 -28.48 68.85 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 109.831 -3.349 . . . . 0.0 109.073 -179.362 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 118.039 -0.982 . . . . 0.0 110.265 179.77 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.595 ' SD ' HG21 ' A' ' 35' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 120.721 0.296 . . . . 0.0 110.309 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . 0.543 ' HB3' ' O ' ' B' ' 1' ' ' MET . 25.4 p30 178.89 -143.94 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.577 178.079 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.782 ' HA ' HD11 ' B' ' 25' ' ' LEU . 3.1 mttp -55.05 -3.13 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.215 -0.928 . . . . 0.0 111.192 -179.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.677 ' O ' HG13 ' B' ' 7' ' ' ILE . 16.3 m -114.51 -65.03 1.23 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.898 -1.126 . . . . 0.0 110.573 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.539 ' HB2' ' HA ' ' B' ' 1' ' ' MET . 9.2 mp0 -49.02 -44.72 41.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.84 -1.163 . . . . 0.0 108.909 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.771 HD11 ' CG1' ' A' ' 42' ' ' VAL . 20.1 mt -57.01 -34.47 68.2 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.125 -1.03 . . . . 0.0 109.648 178.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' ILE . . . . . 0.825 HG22 HD23 ' B' ' 25' ' ' LEU . 1.1 pp -57.63 -43.43 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 178.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . 0.912 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.0 OUTLIER -63.7 -32.55 74.08 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 177.926 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . 0.696 ' HB3' ' O ' ' B' ' 6' ' ' LEU . . . -55.18 -40.94 71.26 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.439 -0.788 . . . . 0.0 109.162 178.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.816 HG22 HG12 ' B' ' 21' ' ' VAL . 1.1 mp -91.44 -29.79 4.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 178.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.912 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -65.99 -15.42 62.99 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.268 -0.973 . . . . 0.0 108.399 178.02 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.471 ' HB3' ' O ' ' B' ' 8' ' ' LYS . 1.8 tp60 -112.31 -42.99 3.59 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.583 ' OD2' HG21 ' A' ' 31' ' ' ILE . 18.8 m-20 -59.83 -39.97 86.92 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 177.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.785 HG21 ' CG2' ' A' ' 19' ' ' VAL . 0.2 OUTLIER -98.83 -71.69 0.68 Allowed 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 113.858 -1.519 . . . . 0.0 108.504 179.387 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 47.26 27.39 3.85 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 16' ' ' LEU . . . . . 1.045 HD21 ' HB3' ' A' ' 20' ' ' SER . 0.4 OUTLIER -91.6 -28.56 17.44 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.543 -0.975 . . . . 0.0 108.814 178.89 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . 0.805 ' N ' HD12 ' B' ' 16' ' ' LEU . 0.7 OUTLIER -147.39 -13.94 0.4 Allowed 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.893 -0.504 . . . . 0.0 110.342 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . 0.446 ' O ' ' O ' ' B' ' 19' ' ' VAL . 3.1 mt-30 57.36 43.71 22.86 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -177.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 1.037 HG11 HG11 ' A' ' 19' ' ' VAL . 1.4 p -34.5 -94.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.96 -178.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.918 ' O ' ' N ' ' B' ' 23' ' ' LYS . 0.4 OUTLIER -134.16 25.19 3.88 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 178.845 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.816 HG12 HG22 ' B' ' 10' ' ' ILE . 31.1 m -17.28 -39.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-O 122.642 1.211 . . . . 0.0 109.574 -178.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.896 ' N ' ' O ' ' B' ' 20' ' ' SER . 38.2 p -85.67 -38.43 18.36 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.071 178.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . 0.918 ' N ' ' O ' ' B' ' 20' ' ' SER . 1.8 mtpt -86.1 -29.91 22.98 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.463 -0.773 . . . . 0.0 111.092 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' MET . . . . . 0.917 ' HB3' HG21 ' A' ' 14' ' ' THR . 0.0 OUTLIER -80.66 -35.08 34.28 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.588 -1.32 . . . . 0.0 110.093 179.856 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.893 ' C ' HD12 ' B' ' 25' ' ' LEU . 0.1 OUTLIER -79.81 -43.06 23.11 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 118.099 -1.441 . . . . 0.0 107.368 177.955 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' B' ' 22' ' ' SER . . . -59.75 -25.25 64.71 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 176.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . 0.565 ' HA ' ' HB3' ' B' ' 30' ' ' LYS . 4.3 t -81.24 -36.81 29.52 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . 0.758 ' HA ' ' CG1' ' B' ' 31' ' ' ILE . 0.0 OUTLIER -60.96 -36.43 79.37 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.769 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . 0.674 ' O ' ' HB ' ' B' ' 33' ' ' THR . 9.2 mt-10 -77.55 -34.5 53.81 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 177.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 1.012 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 64.0 tttt -68.42 -25.4 65.01 Favored 'General case' 0 C--O 1.192 -1.97 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 177.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.864 HD13 ' CB ' ' A' ' 9' ' ' ALA . 1.1 pp -100.81 -29.85 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 120.983 -1.073 . . . . 0.0 109.518 178.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.703 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.1 mm -66.02 -57.32 11.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 176.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 33' ' ' THR . . . . . 0.98 ' O ' HD13 ' A' ' 85' ' ' LEU . 0.5 OUTLIER -65.26 -38.48 90.46 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.474 179.172 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 1.012 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 23.9 mm-40 -75.21 -38.9 60.5 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.37 -0.831 . . . . 0.0 112.067 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 35' ' ' THR . . . . . 0.512 ' N ' ' O ' ' B' ' 31' ' ' ILE . 44.1 m -59.57 -54.59 44.79 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.334 -1.479 . . . . 0.0 109.425 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 1.114 HG12 HD11 ' A' ' 85' ' ' LEU . 2.6 t -54.32 -36.23 32.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 177.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 0.896 ' HB1' ' O ' ' A' ' 88' ' ' ALA . . . -88.49 4.8 45.31 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.686 0.755 . . . . 0.0 109.823 177.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.73 ' N ' ' O ' ' B' ' 34' ' ' GLU . 1.2 tppp? -105.26 -32.9 8.41 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 178.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 130.21 35.03 0.44 Allowed Glycine 0 C--N 1.301 -1.397 0 C-N-CA 119.661 -1.256 . . . . 0.0 111.092 177.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . 0.44 ' HB3' ' CG2' ' B' ' 35' ' ' THR . 0.2 OUTLIER -147.14 173.05 12.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.011 -1.288 . . . . 0.0 110.543 179.523 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.424 ' HB3' ' HB2' ' B' ' 51' ' ' LYS . 0.0 OUTLIER -127.65 114.53 17.47 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.651 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.83 HG22 ' HB3' ' A' ' 1' ' ' MET . 38.4 t -98.96 131.02 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.572 -178.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 43' ' ' GLN . . . . . 0.454 ' HG3' ' CB ' ' A' ' 2' ' ' ASN . 0.0 OUTLIER -111.51 123.61 50.58 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.259 -0.9 . . . . 0.0 110.547 180.0 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.871 HD12 ' HB3' ' B' ' 48' ' ' LEU . 16.4 mt -84.04 102.69 12.68 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.267 -0.896 . . . . 0.0 109.705 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . 0.586 ' HB ' ' HD2' ' A' ' 3' ' ' LYS . 0.1 OUTLIER 34.98 -91.97 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.975 -0.453 . . . . 0.0 111.125 -179.777 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -148.85 20.1 1.26 Allowed Glycine 0 N--CA 1.487 2.095 0 N-CA-C 110.089 -1.205 . . . . 0.0 110.089 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . 0.584 ' CZ ' HD13 ' B' ' 44' ' ' LEU . 3.8 p90 -116.61 -33.6 4.81 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.056 -1.261 . . . . 0.0 111.079 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.963 HD11 HD11 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -119.58 178.9 4.39 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.626 -1.296 . . . . 0.0 111.797 179.227 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 49' ' ' ASN . . . . . 0.675 ' O ' ' HB ' ' B' ' 79' ' ' VAL . 2.0 m-80 -165.98 145.05 6.04 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 50' ' ' ILE . . . . . 1.071 ' HA ' HG21 ' B' ' 79' ' ' VAL . 1.6 pp -146.59 101.61 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-O 122.131 0.967 . . . . 0.0 110.636 178.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . 0.535 ' N ' HG11 ' B' ' 79' ' ' VAL . 0.1 OUTLIER -147.94 133.14 9.17 Favored Pre-proline 0 N--CA 1.495 1.782 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.919 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.836 ' CG ' HG13 ' B' ' 36' ' ' VAL . 58.0 Cg_endo -95.71 153.18 1.5 Allowed 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.305 1.16 . . . . 0.0 112.49 -178.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 1.003 HG22 ' O ' ' B' ' 76' ' ' GLY . 27.9 m -134.57 112.92 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 CA-C-O 122.017 0.913 . . . . 0.0 109.965 176.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.93 ' HB1' ' CB ' ' A' ' 96' ' ' ASP . . . -51.67 118.89 3.68 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.687 -0.633 . . . . 0.0 111.662 -178.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 5.3 ttm-85 -163.91 126.96 2.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.445 -0.784 . . . . 0.0 109.372 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -59.45 -161.29 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.285 -0.884 . . . . 0.0 110.026 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.989 ' HB1' HD11 ' B' ' 71' ' ' ILE . . . -168.24 -162.14 0.4 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.017 -1.052 . . . . 0.0 111.743 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 58' ' ' ARG . . . . . 0.668 ' O ' ' HB3' ' B' ' 59' ' ' LYS . 0.0 OUTLIER -69.04 143.17 54.36 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.9 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . 0.668 ' HB3' ' O ' ' B' ' 58' ' ' ARG . 1.6 ttpp 139.39 126.84 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.601 0 C-N-CA 123.878 0.871 . . . . 0.0 109.371 177.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . 0.523 ' O ' ' C ' ' B' ' 61' ' ' PHE . . . 96.49 70.98 1.06 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 61' ' ' PHE . . . . . 0.665 ' CB ' ' HA ' ' B' ' 68' ' ' ALA . 0.1 OUTLIER -19.94 140.55 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.339 0 CA-C-O 121.443 0.639 . . . . 0.0 112.311 -179.501 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . 0.43 ' O ' ' N ' ' B' ' 64' ' ' GLN . 1.0 OUTLIER -49.96 169.0 0.2 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.283 -0.886 . . . . 0.0 109.064 179.478 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -69.3 62.62 1.52 Allowed 'Trans proline' 0 C--N 1.303 -1.826 0 O-C-N 123.442 1.233 . . . . 0.0 109.286 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . 0.463 ' C ' HG23 ' B' ' 65' ' ' THR . 36.0 tp60 -127.05 -122.45 0.24 Allowed 'General case' 0 C--N 1.312 -1.044 0 O-C-N 121.327 -0.858 . . . . 0.0 110.574 -179.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.463 HG23 ' C ' ' B' ' 64' ' ' GLN . 82.2 p -149.01 10.84 0.81 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.233 -0.917 . . . . 0.0 110.329 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . 0.455 ' N ' ' NE2' ' B' ' 66' ' ' GLN . 0.0 OUTLIER -174.94 -18.42 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.1 -1.0 . . . . 0.0 112.367 -179.918 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' B' ' 61' ' ' PHE . 11.0 tt0 -66.89 76.49 0.12 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.656 -1.278 . . . . 0.0 110.203 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . 0.665 ' HA ' ' CB ' ' B' ' 61' ' ' PHE . . . -69.95 167.87 16.54 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.633 -0.667 . . . . 0.0 111.31 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.589 ' HB3' ' HG3' ' B' ' 58' ' ' ARG . 95.3 mt -125.23 -139.85 0.28 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.653 -0.654 . . . . 0.0 110.359 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . 0.907 ' O ' ' O ' ' B' ' 71' ' ' ILE . 4.1 tt0 -166.8 -129.22 0.02 OUTLIER 'General case' 0 C--O 1.204 -1.311 0 O-C-N 120.771 -1.206 . . . . 0.0 111.085 -177.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.989 HD11 ' HB1' ' B' ' 57' ' ' ALA . 0.5 OUTLIER -8.65 -150.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -177.132 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . 0.741 ' O ' ' HB3' ' B' ' 57' ' ' ALA . . . -154.62 165.67 17.61 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 120.121 -1.612 . . . . 0.0 112.862 -177.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 73' ' ' PRO . . . . . 0.608 ' HD2' ' HB1' ' B' ' 72' ' ' ALA . 42.9 Cg_endo -69.87 128.1 15.44 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 124.844 1.97 . . . . 0.0 109.817 178.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . 0.53 ' HA ' ' CD2' ' A' ' 94' ' ' TYR . 69.0 m -166.18 161.95 17.27 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . 0.597 ' HB ' ' HB1' ' A' ' 89' ' ' ALA . 0.4 OUTLIER -51.53 168.77 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.874 -1.141 . . . . 0.0 108.911 -179.563 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . 1.003 ' O ' HG22 ' B' ' 53' ' ' VAL . . . -118.02 99.3 0.8 Allowed Glycine 0 N--CA 1.486 1.968 0 C-N-CA 119.217 -1.468 . . . . 0.0 109.642 -179.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.648 ' O ' HG12 ' B' ' 77' ' ' VAL . 2.1 t -60.71 88.08 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 179.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . 0.621 ' OG ' HG13 ' B' ' 53' ' ' VAL . 0.8 OUTLIER -58.06 -48.25 80.7 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.564 -178.057 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 1.071 HG21 ' HA ' ' B' ' 50' ' ' ILE . 27.2 m -49.46 177.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 115.224 1.564 . . . . 0.0 115.224 -174.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . 0.658 ' HB2' ' HD2' ' B' ' 81' ' ' PRO . 0.0 OUTLIER 179.56 178.97 0.28 Allowed Pre-proline 0 N--CA 1.481 1.087 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.161 -179.051 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 81' ' ' PRO . . . . . 0.678 ' HB2' HG11 ' A' ' 77' ' ' VAL . 41.8 Cg_endo -70.21 130.99 19.7 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.372 1.196 . . . . 0.0 110.78 179.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -82.18 -157.99 22.03 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' B' ' 87' ' ' LYS . 11.1 pt-20 -83.73 -21.25 32.34 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.574 -0.956 . . . . 0.0 110.842 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 84' ' ' SER . . . . . 0.513 ' HB3' ' HB3' ' B' ' 47' ' ' PHE . 0.4 OUTLIER -56.28 -45.39 80.16 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.032 -1.042 . . . . 0.0 109.282 -179.682 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 1.037 HD22 HG21 ' A' ' 36' ' ' VAL . 12.8 mt -61.6 -32.53 72.65 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . 0.564 ' O ' ' HB3' ' B' ' 89' ' ' ALA . 1.7 tttp -82.7 -31.32 28.62 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.642 0.734 . . . . 0.0 109.799 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' B' ' 83' ' ' GLU . 9.8 tmtt? -73.56 -38.97 65.04 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.678 ' O ' ' CB ' ' A' ' 37' ' ' ALA . . . -66.71 -34.73 78.49 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 176.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.914 ' HB1' ' CG1' ' A' ' 75' ' ' VAL . . . -53.39 -46.16 69.58 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.406 -0.809 . . . . 0.0 109.448 178.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.408 ' HG2' ' N ' ' B' ' 91' ' ' GLY . 1.5 pt-20 -56.5 -29.71 62.13 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 176.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' B' ' 88' ' ' ALA . . . -64.72 -34.21 89.28 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 178.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . 1.031 HD21 HG21 ' A' ' 75' ' ' VAL . 1.5 pp -71.06 20.8 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 CA-C-N 119.928 1.864 . . . . 0.0 110.947 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . 0.461 ' H ' ' C ' ' B' ' 91' ' ' GLY . 0.2 OUTLIER 59.42 44.33 15.21 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 106.044 -1.835 . . . . 0.0 106.044 -177.656 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . 0.732 ' CD1' HG23 ' A' ' 75' ' ' VAL . 0.3 OUTLIER -35.53 -42.24 0.22 Allowed 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.044 -178.233 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -52.85 -41.39 64.23 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.206 -0.934 . . . . 0.0 109.5 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 96' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' B' ' 93' ' ' LYS . 0.4 OUTLIER -65.14 -30.4 71.32 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.141 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 97' ' ' PHE . . . . . 0.458 ' HB2' HD11 ' B' ' 92' ' ' LEU . 0.1 OUTLIER -85.18 -16.41 40.46 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.625 -0.672 . . . . 0.0 109.371 178.609 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 98' ' ' ALA . . . . . 0.444 ' HB2' ' CE1' ' B' ' 94' ' ' TYR . . . -74.14 -39.47 63.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.521 -0.737 . . . . 0.0 110.057 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.201 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.479 ' HG2' ' HB3' ' A' ' 5' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.139 0.495 . . . . 0.0 110.132 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.443 ' N ' ' HB2' ' A' ' 5' ' ' GLU . 4.4 p30 173.05 173.26 0.12 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.489 -0.757 . . . . 0.0 110.337 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.747 ' HD2' HD13 ' A' ' 25' ' ' LEU . 2.2 mmmp? -43.19 -26.16 0.15 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.627 -0.671 . . . . 0.0 110.555 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.54 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 5.7 m -85.83 -55.46 3.96 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.247 -0.908 . . . . 0.0 109.027 178.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.481 ' HA ' ' CE ' ' A' ' 8' ' ' LYS . 1.0 OUTLIER -60.2 -48.76 80.36 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.697 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.795 HD11 ' CG2' ' B' ' 42' ' ' VAL . 9.5 mt -57.56 -33.24 67.94 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.575 -0.85 . . . . 0.0 108.718 177.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 1.015 ' CD1' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -54.79 -54.09 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 178.373 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.927 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -68.74 -27.86 66.3 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.65 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 6' ' ' LEU . . . -59.49 -33.86 71.86 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.289 -0.882 . . . . 0.0 108.795 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.927 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.8 OUTLIER -95.75 -37.02 7.05 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.528 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 178.429 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.927 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -60.18 -26.93 66.72 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.418 ' CG ' ' O ' ' A' ' 8' ' ' LYS . 1.4 pp0? -92.91 -37.56 12.18 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.536 ' HB3' ' CB ' ' B' ' 27' ' ' SER . 21.8 m-20 -69.08 -29.59 67.72 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 176.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 1.016 HG22 ' HB2' ' B' ' 20' ' ' SER . 16.6 p -85.82 -75.77 0.36 Allowed 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 177.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 55.26 15.25 7.27 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.774 HD11 ' OG ' ' B' ' 20' ' ' SER . 0.7 OUTLIER -80.92 -51.53 8.47 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.251 -1.146 . . . . 0.0 107.989 178.702 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.685 HG22 ' H ' ' A' ' 19' ' ' VAL . 0.5 OUTLIER -144.8 -2.21 0.84 Allowed 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.897 -179.847 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.671 ' O ' ' C ' ' A' ' 19' ' ' VAL . 6.7 mt-30 56.23 30.07 15.96 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 -176.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.978 HG23 HD13 ' B' ' 16' ' ' LEU . 0.4 OUTLIER 3.78 -97.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.868 -179.399 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 1.022 ' O ' ' N ' ' A' ' 22' ' ' SER . 6.1 p -134.98 24.14 3.58 Favored 'General case' 0 C--N 1.28 -2.456 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 176.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.771 ' HA ' ' CE ' ' A' ' 24' ' ' MET . 18.1 m -5.14 -44.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-O 122.447 1.118 . . . . 0.0 110.719 -177.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 1.022 ' N ' ' O ' ' A' ' 20' ' ' SER . 33.3 m -71.22 -41.79 69.74 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.88 178.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.89 ' N ' ' O ' ' A' ' 20' ' ' SER . 5.0 mtpt -85.87 -32.61 21.6 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.459 -0.776 . . . . 0.0 111.486 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.771 ' CE ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -65.82 -26.83 67.86 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 116.938 -1.905 . . . . 0.0 108.158 179.277 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 1.015 HD23 ' CD1' ' A' ' 7' ' ' ILE . 0.1 OUTLIER -77.88 -49.68 13.74 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 177.727 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.563 ' N ' HD12 ' A' ' 25' ' ' LEU . . . -57.79 -29.72 65.09 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.525 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 1.6 t -83.39 -38.92 21.33 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.65 ' CZ ' HD13 ' B' ' 44' ' ' LEU . 19.7 t80 -53.32 -48.09 68.73 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.638 ' HG3' HG21 ' B' ' 45' ' ' THR . 0.1 OUTLIER -66.86 -38.76 86.95 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 176.332 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 1.273 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 42.2 tttt -60.79 -19.56 59.74 Favored 'General case' 0 C--O 1.194 -1.836 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.717 HD13 ' HB1' ' B' ' 9' ' ' ALA . 0.9 OUTLIER -112.74 -23.46 4.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 O-C-N 119.996 -1.69 . . . . 0.0 109.904 178.641 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.649 HG21 ' CE1' ' B' ' 47' ' ' PHE . 1.3 mm -82.46 -49.68 16.88 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 176.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.494 ' OG1' ' O ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -77.48 -38.88 48.27 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.564 178.677 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 1.273 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 64.2 mm-40 -74.16 -28.5 61.34 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.946 -1.096 . . . . 0.0 111.157 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.731 HG22 ' CA ' ' A' ' 40' ' ' ASP . 87.8 m -78.09 -42.29 32.53 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 118.19 -1.404 . . . . 0.0 109.425 179.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.715 HG13 ' HB1' ' B' ' 88' ' ' ALA . 3.4 p -54.42 -41.22 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 177.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.698 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -78.85 -2.71 41.04 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.806 -0.758 . . . . 0.0 110.115 178.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -113.66 1.25 14.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.925 -1.109 . . . . 0.0 108.982 177.697 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.33 35.77 2.82 Favored Glycine 0 N--CA 1.484 1.887 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.731 ' CA ' HG22 ' A' ' 35' ' ' THR . 12.4 t70 -47.15 165.22 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 122.619 1.2 . . . . 0.0 112.912 -179.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.422 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 8.2 mttt -174.21 58.39 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 178.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.844 HG12 ' CB ' ' B' ' 1' ' ' MET . 12.0 m -93.39 132.63 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 CA-C-O 121.606 0.717 . . . . 0.0 111.324 -177.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.443 ' O ' ' CG ' ' A' ' 43' ' ' GLN . 1.1 tt0 -118.35 102.29 8.84 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.954 HD12 ' HB3' ' A' ' 48' ' ' LEU . 72.1 mt -70.52 104.45 2.78 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.093 -1.005 . . . . 0.0 110.166 -179.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.457 ' CG2' ' C ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER 33.36 -92.48 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.141 0 O-C-N 122.09 -0.381 . . . . 0.0 111.064 179.965 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -149.49 34.7 1.06 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.802 ' CD1' HD21 ' A' ' 85' ' ' LEU . 1.5 p90 -133.69 -26.1 1.61 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.111 -1.229 . . . . 0.0 111.617 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.954 ' HB3' HD12 ' A' ' 44' ' ' LEU . 5.7 mt -139.72 104.9 5.01 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.603 -1.311 . . . . 0.0 110.605 178.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.802 ' C ' HG23 ' A' ' 79' ' ' VAL . 1.5 t30 -106.12 76.79 1.18 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.165 -0.959 . . . . 0.0 110.716 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.888 HD13 ' HB ' ' A' ' 79' ' ' VAL . 1.4 mm -64.29 109.98 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.187 -0.946 . . . . 0.0 109.849 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.51 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -131.06 119.59 17.92 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.053 -1.029 . . . . 0.0 109.84 -179.913 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.568 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 54.0 Cg_endo -79.42 139.28 14.45 Favored 'Trans proline' 0 C--N 1.316 -1.146 0 O-C-N 123.39 1.205 . . . . 0.0 111.832 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.723 HG22 ' O ' ' A' ' 76' ' ' GLY . 33.9 m -144.24 117.7 3.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.359 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.687 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . -42.33 120.23 1.59 Allowed 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 121.626 0.727 . . . . 0.0 111.96 -178.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.41 78.24 1.32 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.26 -159.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.591 0.71 . . . . 0.0 111.121 -178.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.909 ' HB3' HD13 ' A' ' 71' ' ' ILE . . . -155.11 170.2 22.36 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.49 -0.756 . . . . 0.0 110.03 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.73 ' O ' HG13 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -84.34 107.48 16.65 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.553 -0.717 . . . . 0.0 112.072 -179.397 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.404 ' O ' ' O ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -54.32 -178.05 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.22 -0.925 . . . . 0.0 109.596 178.686 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.513 ' HA3' ' O ' ' A' ' 69' ' ' LEU . . . -109.6 121.95 6.26 Favored Glycine 0 N--CA 1.484 1.836 0 C-N-CA 119.181 -1.485 . . . . 0.0 111.707 -178.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.881 ' CE1' ' HB3' ' A' ' 64' ' ' GLN . 1.3 p90 -162.37 157.63 22.89 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 121.462 -1.022 . . . . 0.0 111.694 178.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.861 ' H ' ' CD ' ' A' ' 63' ' ' PRO . 3.0 p30 -142.59 -11.37 0.01 OUTLIER Pre-proline 0 C--N 1.299 -1.612 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 178.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.861 ' CD ' ' H ' ' A' ' 62' ' ' ASN . 49.9 Cg_endo -78.18 -10.77 16.37 Favored 'Trans proline' 0 N--CA 1.483 0.864 0 N-CA-C 109.798 -0.885 . . . . 0.0 109.798 178.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.881 ' HB3' ' CE1' ' A' ' 61' ' ' PHE . 41.9 tp60 -90.25 -106.4 0.09 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.325 -0.859 . . . . 0.0 109.837 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.469 ' O ' ' CB ' ' A' ' 66' ' ' GLN . 15.5 p -73.96 -1.02 18.02 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.576 -1.327 . . . . 0.0 110.091 179.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.599 ' O ' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER 75.31 104.29 0.07 Allowed 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.589 -0.694 . . . . 0.0 111.416 179.663 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.631 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 4.1 pt-20 153.29 77.65 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.847 ' O ' HD23 ' A' ' 69' ' ' LEU . . . -59.72 136.67 58.07 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.158 -0.964 . . . . 0.0 109.712 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.847 HD23 ' O ' ' A' ' 68' ' ' ALA . 2.1 mt -142.11 -138.81 0.11 Allowed 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.582 -0.698 . . . . 0.0 110.615 -178.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.691 ' O ' HG23 ' A' ' 71' ' ' ILE . 2.1 tt0 143.87 139.4 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.775 0 CA-C-O 121.344 0.592 . . . . 0.0 109.871 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.909 HD13 ' HB3' ' A' ' 57' ' ' ALA . 0.8 OUTLIER -164.38 -155.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -179.512 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.43 ' HA ' ' HD2' ' A' ' 73' ' ' PRO . . . -129.91 87.11 52.87 Favored Pre-proline 0 C--N 1.303 -1.434 0 O-C-N 121.262 -0.899 . . . . 0.0 111.566 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.553 ' HD3' HD13 ' A' ' 71' ' ' ILE . 38.0 Cg_endo -62.85 119.5 6.61 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 O-C-N 123.61 1.321 . . . . 0.0 110.739 178.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.51 ' HA ' ' CD1' ' B' ' 94' ' ' TYR . 1.0 OUTLIER -171.07 166.06 7.39 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.317 -0.864 . . . . 0.0 109.818 179.856 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.774 HG12 ' CB ' ' B' ' 89' ' ' ALA . 0.4 OUTLIER -54.97 -179.66 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.047 -1.033 . . . . 0.0 109.584 179.766 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.723 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -123.76 86.45 0.38 Allowed Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.927 HG21 ' CD1' ' B' ' 85' ' ' LEU . 4.7 p -64.77 68.9 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.549 -0.971 . . . . 0.0 108.697 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.563 ' O ' ' HB ' ' A' ' 79' ' ' VAL . 1.0 OUTLIER -65.42 174.49 2.14 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.903 0.859 . . . . 0.0 110.983 -178.517 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.888 ' HB ' HD13 ' A' ' 50' ' ' ILE . 4.9 p 174.79 -168.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.846 ' O ' HD23 ' A' ' 48' ' ' LEU . 7.6 pttt -172.98 172.26 1.63 Allowed Pre-proline 0 N--CA 1.485 1.279 0 O-C-N 120.678 -1.264 . . . . 0.0 111.235 177.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.806 ' HB3' HG12 ' B' ' 77' ' ' VAL . 55.3 Cg_endo -93.3 87.3 0.16 Allowed 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 122.635 2.223 . . . . 0.0 109.472 178.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.747 ' O ' HD12 ' A' ' 85' ' ' LEU . . . -58.73 158.05 19.98 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 87' ' ' LYS . 13.7 pt-20 -55.21 -17.27 4.15 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.219 -1.165 . . . . 0.0 111.07 -179.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.507 ' CB ' ' HB3' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -55.8 -35.89 66.82 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.85 -1.156 . . . . 0.0 109.317 179.426 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.802 HD21 ' CD1' ' A' ' 47' ' ' PHE . 0.7 OUTLIER -81.74 -37.8 26.71 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.894 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.449 ' N ' HG21 ' B' ' 77' ' ' VAL . 0.6 OUTLIER -75.0 -30.95 61.29 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.448 0.642 . . . . 0.0 110.368 -179.429 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.431 ' HA ' ' HG2' ' A' ' 90' ' ' GLU . 16.2 ttpt -78.1 -34.66 49.97 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.659 ' O ' ' HG ' ' A' ' 92' ' ' LEU . . . -71.59 -32.18 67.77 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 177.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.702 ' HA ' ' HA ' ' B' ' 37' ' ' ALA . . . -73.02 -54.12 9.39 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.538 -0.726 . . . . 0.0 110.484 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.588 ' HA ' ' HB3' ' A' ' 94' ' ' TYR . 19.1 pt-20 -53.86 -21.42 7.59 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 177.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.706 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -83.66 -28.87 34.06 Favored Glycine 0 CA--C 1.54 1.629 0 CA-C-O 119.093 -0.837 . . . . 0.0 112.335 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.725 HD12 ' C ' ' B' ' 37' ' ' ALA . 2.3 mt -97.88 -74.1 0.59 Allowed 'General case' 0 N--CA 1.5 2.026 0 CA-C-N 121.425 2.613 . . . . 0.0 111.816 -178.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -146.87 42.61 1.14 Allowed 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 119.244 -0.982 . . . . 0.0 111.385 -178.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.588 ' HB3' ' HA ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -60.63 -48.41 81.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.279 -0.888 . . . . 0.0 108.824 178.857 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -66.07 -36.45 83.23 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.554 -0.716 . . . . 0.0 109.301 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.0 -30.47 61.88 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.534 ' CB ' ' HB2' ' B' ' 54' ' ' ALA . 6.5 m-85 -79.07 -33.74 44.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.618 -0.676 . . . . 0.0 109.274 178.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.49 ' HB2' ' HB1' ' B' ' 54' ' ' ALA . . . -64.08 -28.42 69.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.615 -0.678 . . . . 0.0 110.148 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 18.6 mtmt . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.195 179.931 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.844 ' CB ' HG12 ' A' ' 42' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.126 0.489 . . . . 0.0 110.223 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . 0.532 ' H ' ' HB2' ' B' ' 5' ' ' GLU . 0.6 OUTLIER 178.3 178.21 0.4 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.39 -0.819 . . . . 0.0 109.834 -179.426 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.663 ' O ' HD22 ' B' ' 25' ' ' LEU . 0.1 OUTLIER -51.34 -23.86 4.09 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.764 -0.774 . . . . 0.0 108.975 178.915 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.512 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 30.4 m -90.22 -53.58 4.4 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.664 0.745 . . . . 0.0 109.51 178.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.532 ' HB2' ' H ' ' B' ' 2' ' ' ASN . 8.6 mm-40 -59.19 -49.23 78.64 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.701 ' O ' ' HB3' ' B' ' 9' ' ' ALA . 17.6 mt -54.42 -37.23 64.86 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.227 -0.989 . . . . 0.0 108.506 177.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' ILE . . . . . 0.999 ' CD1' HD23 ' B' ' 25' ' ' LEU . 0.1 OUTLIER -51.7 -51.27 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 177.604 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . 0.962 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.0 OUTLIER -64.79 -29.67 70.64 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.539 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . 0.717 ' HB1' HD13 ' A' ' 31' ' ' ILE . . . -53.57 -38.19 63.64 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.294 -0.879 . . . . 0.0 108.64 178.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.761 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.1 mp -97.41 -33.72 4.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.056 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.962 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -66.23 -12.3 55.33 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 118.579 -1.248 . . . . 0.0 109.197 178.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.453 ' N ' ' O ' ' B' ' 8' ' ' LYS . 23.3 mm100 -113.22 -41.67 3.66 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.345 -0.847 . . . . 0.0 109.525 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.457 ' CB ' ' OG ' ' A' ' 27' ' ' SER . 1.1 m-20 -70.67 -31.12 67.91 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 177.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 1.049 HG22 ' CD1' ' B' ' 16' ' ' LEU . 0.1 OUTLIER -106.63 -84.04 0.52 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 177.752 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . 0.592 ' O ' ' C ' ' B' ' 16' ' ' LEU . . . 72.63 -19.49 1.15 Allowed Glycine 0 N--CA 1.5 2.921 0 O-C-N 121.038 -1.039 . . . . 0.0 111.18 177.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 16' ' ' LEU . . . . . 1.049 ' CD1' HG22 ' B' ' 14' ' ' THR . 4.9 mp -18.86 -61.44 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.511 0 CA-C-O 122.031 0.919 . . . . 0.0 111.575 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . 0.649 ' CG2' HG21 ' A' ' 17' ' ' THR . 0.5 OUTLIER -142.59 7.47 1.7 Allowed 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.543 -179.464 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . 0.584 ' O ' ' C ' ' B' ' 19' ' ' VAL . 29.7 mt-30 60.01 23.1 12.25 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 -175.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.939 HG11 HG11 ' A' ' 19' ' ' VAL . 1.4 p 5.04 -91.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.951 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 1.016 ' HB2' HG22 ' A' ' 14' ' ' THR . 0.5 OUTLIER -132.44 24.64 4.45 Favored 'General case' 0 C--N 1.277 -2.578 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 179.236 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.719 ' HA ' ' CE ' ' B' ' 24' ' ' MET . 16.7 m -22.69 -43.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 CA-C-O 122.541 1.162 . . . . 0.0 108.578 -178.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.717 ' N ' ' O ' ' B' ' 20' ' ' SER . 13.7 t -74.91 -39.06 61.65 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.614 177.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . 0.972 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.3 OUTLIER -86.25 -40.94 15.03 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.592 -0.692 . . . . 0.0 111.792 179.869 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' MET . . . . . 0.719 ' CE ' ' HA ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -61.84 -28.19 69.31 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 117.203 -1.799 . . . . 0.0 108.814 179.383 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.999 HD23 ' CD1' ' B' ' 7' ' ' ILE . 0.1 OUTLIER -80.57 -48.82 12.15 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 118.476 -1.29 . . . . 0.0 108.766 178.122 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . 0.568 ' N ' HD12 ' B' ' 25' ' ' LEU . . . -61.07 -29.25 69.63 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . 0.551 ' HA ' ' HB3' ' B' ' 30' ' ' LYS . 75.3 m -83.64 -33.12 25.34 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . 0.794 ' CE1' HD22 ' A' ' 44' ' ' LEU . 0.7 OUTLIER -55.43 -50.78 68.91 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.913 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . 0.632 ' HG3' ' CE2' ' A' ' 47' ' ' PHE . 3.0 tt0 -65.73 -34.66 78.71 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 176.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 1.333 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 23.2 ttpp -66.89 -20.85 65.99 Favored 'General case' 0 C--O 1.193 -1.905 0 C-N-CA 119.414 -0.914 . . . . 0.0 108.93 178.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.673 HG13 ' O ' ' B' ' 28' ' ' PHE . 0.9 OUTLIER -108.04 -25.35 3.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 O-C-N 119.728 -1.858 . . . . 0.0 109.604 178.569 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.622 ' CG1' ' O ' ' B' ' 28' ' ' PHE . 1.1 mm -76.62 -58.29 4.66 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 177.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 33' ' ' THR . . . . . 0.527 ' HA ' HD23 ' A' ' 85' ' ' LEU . 0.7 OUTLIER -75.54 -29.12 59.3 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.328 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 1.333 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 74.3 mm-40 -81.58 -27.59 34.21 Favored 'General case' 0 C--N 1.315 -0.915 0 O-C-N 120.898 -1.126 . . . . 0.0 110.416 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 35' ' ' THR . . . . . 0.594 HG23 ' CB ' ' B' ' 40' ' ' ASP . 1.8 m -69.73 -57.08 5.56 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 117.715 -1.594 . . . . 0.0 107.485 177.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.74 ' O ' ' HG3' ' B' ' 52' ' ' PRO . 7.1 p -48.43 -40.25 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 0.725 ' C ' HD12 ' A' ' 92' ' ' LEU . . . -71.34 -32.83 69.01 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.14 178.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.645 ' N ' HD12 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -68.86 -21.49 64.26 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 176.653 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' B' ' 35' ' ' THR . . . 99.25 30.88 6.41 Favored Glycine 0 C--N 1.298 -1.557 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 177.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . 0.594 ' CB ' HG23 ' B' ' 35' ' ' THR . 0.3 OUTLIER -118.03 151.82 36.74 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.395 -1.062 . . . . 0.0 109.905 179.528 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.416 ' CG ' ' CB ' ' B' ' 51' ' ' LYS . 0.0 OUTLIER -95.59 90.54 5.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.428 -0.795 . . . . 0.0 110.558 -179.299 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.863 HG12 HG22 ' B' ' 50' ' ' ILE . 10.5 p -75.06 152.89 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.41 -0.806 . . . . 0.0 109.392 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 43' ' ' GLN . . . . . 0.607 ' O ' HD23 ' B' ' 44' ' ' LEU . 18.5 pt20 -157.16 175.94 13.38 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.148 -0.97 . . . . 0.0 111.14 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.686 HD12 ' HB2' ' B' ' 48' ' ' LEU . 24.1 mt -128.51 117.49 21.4 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.625 -0.672 . . . . 0.0 109.356 179.151 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . 0.638 HG21 ' HG3' ' A' ' 29' ' ' GLU . 0.6 OUTLIER 28.54 -103.37 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.815 -0.553 . . . . 0.0 111.313 179.893 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.488 ' H ' HG23 ' B' ' 45' ' ' THR . . . -133.96 57.97 0.7 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . 0.731 ' CD1' HD21 ' B' ' 85' ' ' LEU . 8.0 p90 -157.67 -25.39 0.09 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.081 -1.247 . . . . 0.0 110.987 178.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.949 HD13 ' HG2' ' B' ' 80' ' ' LYS . 0.5 OUTLIER -130.78 145.65 52.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.842 -1.161 . . . . 0.0 109.965 178.003 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 49' ' ' ASN . . . . . 0.85 ' O ' ' O ' ' B' ' 79' ' ' VAL 0.265 0.4 OUTLIER -162.18 90.61 0.75 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.333 -0.854 . . . . 0.0 110.874 -177.247 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' B' B ' 50' ' ' ILE . . . . . 0.863 HG22 HG12 ' B' ' 42' ' ' VAL . 0.3 OUTLIER -83.53 146.14 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.884 -1.135 . . . . 0.0 109.809 -179.428 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . 0.448 ' HG3' ' HB3' ' B' ' 78' ' ' SER . 1.5 ptmt -167.3 122.79 0.87 Allowed Pre-proline 0 N--CA 1.495 1.807 0 C-N-CA 119.124 -1.03 . . . . 0.0 110.689 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.74 ' HG3' ' O ' ' B' ' 36' ' ' VAL . 55.4 Cg_endo -88.45 146.92 6.19 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.611 1.321 . . . . 0.0 110.841 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.572 ' O ' HG23 ' B' ' 53' ' ' VAL . 26.7 m -132.22 114.39 23.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-O 121.909 0.861 . . . . 0.0 110.065 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.534 ' HB2' ' CB ' ' A' ' 97' ' ' PHE . . . -44.26 112.9 0.46 Allowed 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.484 0.659 . . . . 0.0 111.58 -178.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 -145.79 84.35 1.67 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.33 -153.39 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.493 -0.755 . . . . 0.0 110.27 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 1.071 ' HB3' HD13 ' B' ' 71' ' ' ILE . . . -158.37 175.01 14.26 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.04 -1.037 . . . . 0.0 111.004 -179.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 58' ' ' ARG . . . . . 0.837 ' O ' HD11 ' B' ' 71' ' ' ILE . 0.0 OUTLIER -46.62 148.4 1.01 Allowed 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.902 0.858 . . . . 0.0 112.081 -179.53 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . 0.465 ' HB3' ' O ' ' B' ' 58' ' ' ARG . 0.7 OUTLIER 177.54 76.26 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.037 -1.039 . . . . 0.0 109.302 178.385 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . 0.42 ' C ' ' CD2' ' B' ' 61' ' ' PHE . . . -127.16 -101.52 1.15 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 61' ' ' PHE . . . . . 0.812 ' O ' ' N ' ' B' ' 67' ' ' GLU . 4.2 p90 174.97 177.75 0.15 Allowed 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.412 -1.052 . . . . 0.0 110.09 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . 0.844 ' N ' ' HB2' ' B' ' 68' ' ' ALA . 0.8 OUTLIER -108.69 -61.13 0.04 OUTLIER Pre-proline 0 N--CA 1.502 2.136 0 O-C-N 120.967 -1.083 . . . . 0.0 112.219 -178.392 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.613 ' HD2' ' H ' ' B' ' 62' ' ' ASN . 41.2 Cg_endo -67.54 64.23 0.81 Allowed 'Trans proline' 0 N--CA 1.489 1.213 0 O-C-N 123.402 1.211 . . . . 0.0 110.41 -178.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . 0.798 ' HB3' ' CE1' ' B' ' 61' ' ' PHE . 0.7 OUTLIER -178.74 36.77 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.766 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 6.1 p 53.58 55.13 8.99 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.795 -0.566 . . . . 0.0 110.607 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . 0.73 ' HB2' ' CE1' ' B' ' 61' ' ' PHE . 0.0 OUTLIER -151.73 -109.53 0.05 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.188 -0.945 . . . . 0.0 110.622 -179.939 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . 0.812 ' N ' ' O ' ' B' ' 61' ' ' PHE . 5.6 pt-20 176.78 97.76 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.996 -1.065 . . . . 0.0 108.434 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . 0.967 ' O ' HD23 ' B' ' 69' ' ' LEU . . . -73.09 100.36 3.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.283 -0.885 . . . . 0.0 109.604 -178.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.967 HD23 ' O ' ' B' ' 68' ' ' ALA . 12.6 mt -136.24 -141.68 0.17 Allowed 'General case' 0 C--N 1.291 -1.949 0 C-N-CA 120.146 -0.622 . . . . 0.0 109.563 -179.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . 0.764 ' O ' HG23 ' B' ' 71' ' ' ILE . 1.1 pt-20 179.06 161.82 0.75 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.012 -1.055 . . . . 0.0 109.628 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 1.071 HD13 ' HB3' ' B' ' 57' ' ' ALA . 1.1 pp -162.89 -151.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.515 -0.741 . . . . 0.0 109.364 -178.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . 0.409 ' H ' ' HB ' ' B' ' 71' ' ' ILE . . . -126.23 90.45 50.04 Favored Pre-proline 0 C--N 1.303 -1.438 0 O-C-N 121.281 -0.887 . . . . 0.0 112.165 -179.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 73' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.55 122.63 8.42 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.826 1.435 . . . . 0.0 109.512 178.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . 0.507 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 1.4 m -173.62 171.41 3.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.127 -0.983 . . . . 0.0 109.547 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . 0.743 HG12 HG23 ' B' ' 77' ' ' VAL . 0.5 OUTLIER -54.63 173.11 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.122 -0.986 . . . . 0.0 109.226 179.908 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . 0.57 ' O ' HG22 ' B' ' 53' ' ' VAL . . . -114.8 54.48 0.57 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.806 HG12 ' HB3' ' A' ' 81' ' ' PRO . 69.9 t -37.75 87.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 122.052 -0.675 . . . . 0.0 111.59 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . 0.552 ' N ' ' O ' ' B' ' 76' ' ' GLY . 1.8 t -59.45 -129.51 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.85 ' O ' ' O ' ' B' ' 49' ' ' ASN . 17.7 m -140.15 -170.01 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 119.76 -1.838 . . . . 0.0 112.815 178.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . 0.949 ' HG2' HD13 ' B' ' 48' ' ' LEU . 0.0 OUTLIER -101.28 -54.26 0.15 Allowed Pre-proline 0 C--N 1.29 -2.004 0 CA-C-N 113.49 -1.686 . . . . 0.0 113.261 -178.489 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 81' ' ' PRO . . . . . 0.78 ' HD2' ' H ' ' B' ' 80' ' ' LYS . 30.5 Cg_endo -52.43 138.88 56.53 Favored 'Trans proline' 0 C--N 1.298 -2.115 0 C-N-CA 121.219 1.279 . . . . 0.0 113.372 -174.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -135.2 -64.41 0.06 OUTLIER Glycine 0 N--CA 1.485 1.95 0 N-CA-C 106.091 -2.803 . . . . 0.0 106.091 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . 0.924 ' O ' ' N ' ' B' ' 85' ' ' LEU . 4.0 tt0 -97.19 46.18 1.04 Allowed 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 175.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 84' ' ' SER . . . . . 1.33 ' O ' ' N ' ' B' ' 86' ' ' LYS . 0.1 OUTLIER 8.18 43.26 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 122.551 1.167 . . . . 0.0 110.489 179.393 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 1.047 ' C ' ' O ' ' B' ' 84' ' ' SER . 0.5 OUTLIER 21.29 28.85 0.0 OUTLIER 'General case' 0 C--O 1.191 -2.004 0 N-CA-C 103.203 -2.888 . . . . 0.0 103.203 -171.161 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . 1.33 ' N ' ' O ' ' B' ' 84' ' ' SER 0.309 1.2 tttm -49.8 -35.99 24.78 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 176.938 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . 0.411 ' O ' ' HG2' ' B' ' 90' ' ' GLU 0.298 0.0 OUTLIER -66.49 -38.78 88.02 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 111.97 -2.377 . . . . 0.0 106.569 175.64 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.793 ' N ' ' O ' ' B' ' 85' ' ' LEU . . . -79.35 -26.33 42.11 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 118.725 -1.19 . . . . 0.0 108.285 178.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.932 ' HA ' HD23 ' B' ' 92' ' ' LEU . . . -68.48 -45.01 73.54 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.448 -0.782 . . . . 0.0 108.924 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.48 ' HG2' ' N ' ' B' ' 91' ' ' GLY . 3.6 pt-20 -58.58 -28.37 65.49 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 176.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . 0.48 ' N ' ' HG2' ' B' ' 90' ' ' GLU . . . -62.48 -38.84 96.99 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 110.646 -0.981 . . . . 0.0 110.646 178.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . 0.932 HD23 ' HA ' ' B' ' 89' ' ' ALA . 0.9 OUTLIER -78.82 18.99 0.54 Allowed 'General case' 0 N--CA 1.505 2.28 0 O-C-N 120.392 -1.652 . . . . 0.0 111.481 -179.557 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' B' ' 92' ' ' LEU . 6.7 mptt 54.51 39.53 31.16 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -178.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . 0.583 ' HB2' ' CB ' ' A' ' 75' ' ' VAL . 1.2 p90 -42.01 -30.42 0.28 Allowed 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.746 -178.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . 0.607 ' O ' ' HB3' ' B' ' 98' ' ' ALA . 22.7 mt-10 -59.08 -47.37 85.51 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.188 -0.945 . . . . 0.0 108.501 178.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.97 -36.44 67.83 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -74.06 -28.25 61.31 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 98' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' B' ' 95' ' ' GLU . . . -61.31 -35.04 76.28 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.733 -0.604 . . . . 0.0 110.259 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 23.7 mttt . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.299 -179.877 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.535 ' HA ' ' CB ' ' A' ' 5' ' ' GLU . 5.9 mtp . . . . . 0 N--CA 1.496 1.842 0 CA-C-O 120.743 0.306 . . . . 0.0 110.238 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -173.97 -164.24 0.19 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.049 -1.032 . . . . 0.0 111.795 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.585 ' HE3' HG21 ' B' ' 45' ' ' THR . 12.9 mttt -62.52 -3.22 1.34 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.444 -0.785 . . . . 0.0 110.321 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.678 ' O ' ' HB ' ' A' ' 7' ' ' ILE . 87.2 m -124.36 -39.61 2.31 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.201 -0.937 . . . . 0.0 108.871 179.061 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.579 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -63.11 -55.52 24.61 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 178.343 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.762 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 0.8 OUTLIER -58.71 -29.58 66.78 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.499 -0.881 . . . . 0.0 109.201 178.198 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.958 HG23 ' HB ' ' A' ' 21' ' ' VAL . 1.7 mt -54.25 -56.09 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.49 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.916 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 12.7 mtmt -58.69 -33.28 69.97 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.23 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.87 ' HB1' HD13 ' B' ' 31' ' ' ILE . . . -52.34 -37.97 57.45 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.574 -0.851 . . . . 0.0 109.202 179.106 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.862 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.0 OUTLIER -96.07 -35.1 5.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 178.546 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.916 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -61.49 -13.14 18.49 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 118.616 -1.234 . . . . 0.0 108.687 178.467 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -114.75 -43.66 3.12 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.474 -0.766 . . . . 0.0 109.377 178.431 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 9' ' ' ALA . 1.1 m-20 -63.99 -39.55 94.37 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 177.501 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 1.062 HG22 ' CD1' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -89.45 -78.0 0.37 Allowed 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 177.375 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.9 7.8 67.05 Favored Glycine 0 N--CA 1.5 2.924 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 177.528 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.062 ' CD1' HG22 ' A' ' 14' ' ' THR . 5.1 mp -54.75 -68.1 0.21 Allowed 'General case' 0 C--N 1.293 -1.858 0 O-C-N 121.671 -0.899 . . . . 0.0 110.676 179.821 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.584 HG22 ' H ' ' A' ' 19' ' ' VAL . 0.5 OUTLIER -142.94 7.98 1.65 Allowed 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.715 -179.25 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.664 ' O ' HG22 ' A' ' 21' ' ' VAL . 11.6 mt-30 59.4 24.61 13.23 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 -176.031 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 1.058 HG11 HG11 ' B' ' 19' ' ' VAL . 1.6 p -2.72 -91.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.932 -179.064 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.987 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.5 OUTLIER -131.01 24.8 4.96 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 178.21 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.958 ' HB ' HG23 ' A' ' 7' ' ' ILE . 1.4 m -20.93 -40.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-O 122.265 1.031 . . . . 0.0 109.409 -178.248 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.77 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.2 OUTLIER -80.42 -34.68 35.99 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.603 177.863 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.987 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -90.13 -38.11 13.75 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.563 -0.71 . . . . 0.0 111.193 179.544 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.656 ' CE ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -66.54 -37.33 84.77 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 117.686 -1.605 . . . . 0.0 108.774 179.455 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.8 HD12 HG13 ' A' ' 7' ' ' ILE . 0.4 OUTLIER -79.89 -37.99 33.58 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 118.054 -1.458 . . . . 0.0 109.425 178.699 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.468 ' HA ' ' CE ' ' A' ' 3' ' ' LYS . . . -66.06 -34.78 78.86 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 177.447 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.64 ' O ' HG13 ' A' ' 31' ' ' ILE . 62.1 m -83.16 -30.46 27.8 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.205 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.651 ' CE1' HD22 ' B' ' 44' ' ' LEU . 1.4 t80 -52.49 -49.53 64.53 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.552 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.73 ' HG3' ' CD2' ' B' ' 47' ' ' PHE . 0.2 OUTLIER -67.15 -35.99 80.87 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 177.172 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 1.16 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 9.7 ttmm -64.22 -20.79 66.27 Favored 'General case' 0 C--O 1.19 -2.061 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.413 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.672 HD12 HG12 ' A' ' 32' ' ' ILE . 1.3 pp -105.04 -27.99 3.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 O-C-N 120.297 -1.502 . . . . 0.0 108.951 178.222 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.678 HG21 ' CE1' ' B' ' 47' ' ' PHE . 1.2 mm -73.48 -58.69 4.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 177.078 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.931 ' HA ' HD23 ' B' ' 85' ' ' LEU . 0.4 OUTLIER -69.43 -33.42 72.94 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.305 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 1.16 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 27.2 mm-40 -76.96 -39.42 50.67 Favored 'General case' 0 N--CA 1.483 1.211 0 O-C-N 121.056 -1.027 . . . . 0.0 111.094 179.104 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.779 HG21 ' SD ' ' B' ' 1' ' ' MET . 21.9 m -57.94 -52.76 64.15 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.074 -1.641 . . . . 0.0 108.488 179.295 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.83 HG13 ' HB3' ' A' ' 52' ' ' PRO . 2.4 t -54.35 -36.56 34.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 177.918 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.752 ' HB1' ' O ' ' B' ' 88' ' ' ALA . . . -87.24 -0.23 56.4 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.432 0.634 . . . . 0.0 109.724 178.668 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.697 ' HB2' ' HA ' ' A' ' 35' ' ' THR . 1.5 mmpt? -102.6 -30.6 10.85 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 177.85 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.11 41.51 0.47 Allowed Glycine 0 C--N 1.303 -1.282 0 C-N-CA 119.945 -1.121 . . . . 0.0 110.842 177.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.737 ' O ' HG22 ' A' ' 35' ' ' THR . 0.4 OUTLIER -147.0 120.27 8.93 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.074 -1.25 . . . . 0.0 110.624 179.526 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.2 mtpt -63.95 86.62 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.53 -0.731 . . . . 0.0 109.608 179.723 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.664 HG23 HD21 ' B' ' 6' ' ' LEU . 11.3 p -68.1 146.75 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.656 -0.653 . . . . 0.0 110.391 -179.479 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.626 ' O ' HD23 ' A' ' 44' ' ' LEU . 22.9 mt-30 -144.68 176.48 9.39 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.341 -0.849 . . . . 0.0 110.257 -179.805 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.7 HD12 ' HB2' ' A' ' 48' ' ' LEU . 32.4 mt -125.52 113.9 18.07 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.594 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.548 HG22 ' HG2' ' B' ' 29' ' ' GLU . 0.1 OUTLIER 36.05 -87.53 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.85 -0.531 . . . . 0.0 110.621 -179.229 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -151.59 27.09 0.95 Allowed Glycine 0 N--CA 1.484 1.87 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.34 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.823 ' CE1' HG21 ' B' ' 32' ' ' ILE . 4.6 p90 -125.38 -29.92 3.19 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.96 -1.318 . . . . 0.0 112.66 179.84 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.7 ' HB2' HD12 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -122.04 85.71 2.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.445 -1.409 . . . . 0.0 110.692 179.132 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -89.47 85.6 6.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.811 -0.556 . . . . 0.0 109.88 179.605 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.871 HD12 HG22 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -75.68 139.37 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.404 -0.81 . . . . 0.0 109.656 -179.57 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.499 ' HG3' ' O ' ' A' ' 51' ' ' LYS . 2.2 ptmt -153.9 125.51 3.7 Favored Pre-proline 0 N--CA 1.496 1.861 0 C-N-CA 118.752 -1.179 . . . . 0.0 110.785 179.674 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.83 ' HB3' HG13 ' A' ' 36' ' ' VAL . 52.9 Cg_endo -80.97 144.18 14.87 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 O-C-N 123.518 1.272 . . . . 0.0 111.248 -179.768 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.768 HG22 ' O ' ' A' ' 76' ' ' GLY . 31.6 m -137.98 114.82 11.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-O 121.772 0.796 . . . . 0.0 110.259 179.043 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.547 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . -50.05 137.77 16.82 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.924 0.869 . . . . 0.0 111.898 -178.513 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -162.28 107.46 1.21 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.415 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.833 ' O ' ' HB2' ' A' ' 57' ' ' ALA . 2.8 pt20 -84.32 18.5 2.18 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.143 -0.973 . . . . 0.0 112.264 -178.063 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.833 ' HB2' ' O ' ' A' ' 56' ' ' GLN . . . 150.62 161.7 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.618 -0.677 . . . . 0.0 110.593 178.348 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.637 ' HG3' HD11 ' A' ' 71' ' ' ILE . 5.6 mtt-85 -161.22 141.96 11.24 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.756 -0.59 . . . . 0.0 110.25 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.0 ptpt -163.69 28.31 0.08 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.387 -0.821 . . . . 0.0 110.174 179.724 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -109.93 -91.98 2.15 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 179.681 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.674 ' CD1' ' N ' ' A' ' 62' ' ' ASN . 32.9 t80 -175.08 161.39 2.89 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.391 -1.064 . . . . 0.0 110.584 179.405 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.674 ' N ' ' CD1' ' A' ' 61' ' ' PHE . 0.3 OUTLIER -68.11 -165.2 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.639 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.678 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.512 ' CD ' ' CB ' ' A' ' 62' ' ' ASN . 49.8 Cg_endo -84.1 50.08 2.98 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 N-CA-C 109.524 -0.991 . . . . 0.0 109.524 178.743 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 -151.62 -116.23 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.128 -0.983 . . . . 0.0 110.894 -178.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.622 ' N ' ' CE1' ' A' ' 61' ' ' PHE . 5.1 t -172.86 -16.99 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.977 -1.077 . . . . 0.0 111.43 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.509 ' HG3' HG23 ' A' ' 65' ' ' THR . 1.2 mt-30 -104.47 -48.5 3.8 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.809 -1.182 . . . . 0.0 111.148 -179.809 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.5 86.33 6.35 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.153 -0.967 . . . . 0.0 110.214 -179.803 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.491 ' HB2' ' CD2' ' A' ' 61' ' ' PHE . . . -89.03 169.94 11.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.555 -0.716 . . . . 0.0 110.668 -179.769 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.463 HD21 HD22 ' A' ' 62' ' ' ASN . 0.6 OUTLIER -162.68 -175.41 4.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.46 -0.775 . . . . 0.0 110.304 179.88 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -173.81 58.26 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.279 -0.888 . . . . 0.0 110.392 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.637 HD11 ' HG3' ' A' ' 58' ' ' ARG . 2.8 pp -54.45 -178.93 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.063 -1.023 . . . . 0.0 110.699 -179.946 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 1.098 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -109.39 -172.09 0.23 Allowed Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.418 -0.801 . . . . 0.0 110.893 -178.254 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 1.098 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 39.1 Cg_endo -66.74 107.35 1.26 Allowed 'Trans proline' 0 C--N 1.315 -1.186 0 O-C-N 123.544 1.286 . . . . 0.0 111.184 -179.42 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.446 ' HA ' ' CE2' ' B' ' 94' ' ' TYR . 0.4 OUTLIER 172.27 157.84 0.1 Allowed 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.8 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.67 ' HB ' ' HB2' ' B' ' 94' ' ' TYR . 1.0 OUTLIER -58.64 169.63 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.97 -1.081 . . . . 0.0 109.14 179.735 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.768 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -117.74 86.92 0.42 Allowed Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.141 -1.583 . . . . 0.0 109.141 -179.86 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.908 HG21 ' CB ' ' B' ' 85' ' ' LEU . 5.0 p -60.75 77.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.676 -0.896 . . . . 0.0 109.834 179.868 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 1.027 ' O ' HG23 ' A' ' 79' ' ' VAL . 0.8 OUTLIER -62.69 178.02 0.48 Allowed 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.502 -0.879 . . . . 0.0 109.565 179.775 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 1.027 HG23 ' O ' ' A' ' 78' ' ' SER . 2.7 t -176.78 173.56 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.709 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.664 ' O ' HD23 ' A' ' 48' ' ' LEU . 10.9 pttp 177.53 169.33 0.47 Allowed Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.081 -1.012 . . . . 0.0 110.027 176.503 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.571 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 55.1 Cg_endo -97.47 141.83 0.61 Allowed 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 122.505 2.136 . . . . 0.0 110.753 177.757 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.603 ' H ' HD11 ' A' ' 85' ' ' LEU . . . -97.63 -155.09 29.87 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 108.432 -1.867 . . . . 0.0 108.432 178.424 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.626 ' HA ' ' HB2' ' A' ' 86' ' ' LYS . 4.7 pm0 -93.77 -15.37 25.23 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.126 -1.22 . . . . 0.0 110.347 179.358 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.35 -34.18 56.53 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.309 -0.87 . . . . 0.0 109.574 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.782 ' CB ' HG21 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -88.17 -25.36 22.98 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 119.68 -0.808 . . . . 0.0 108.855 179.005 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.626 ' HB2' ' HA ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -76.19 -35.71 58.98 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.554 -0.858 . . . . 0.0 109.184 179.647 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.7 tttp -72.82 -39.83 66.31 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 177.166 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.834 ' O ' ' HB1' ' B' ' 37' ' ' ALA . . . -65.08 -37.0 86.11 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 176.243 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.692 ' HA ' HD23 ' A' ' 92' ' ' LEU . . . -56.71 -38.04 71.77 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.758 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.15 -33.06 62.6 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 176.391 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.483 ' C ' ' H ' ' A' ' 93' ' ' LYS . . . -59.82 -44.44 97.04 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 177.805 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.962 ' O ' HD12 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -69.42 15.44 0.07 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.71 -1.465 . . . . 0.0 110.422 179.397 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.602 ' HB3' ' O ' ' A' ' 92' ' ' LEU . 0.8 OUTLIER 65.37 73.77 0.39 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 -177.086 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.78 ' O ' ' N ' ' A' ' 97' ' ' PHE . 47.7 t80 -47.39 -58.19 4.44 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 116.481 -2.088 . . . . 0.0 106.538 179.817 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.928 ' O ' ' N ' ' A' ' 98' ' ' ALA . 56.2 mm-40 8.48 39.36 0.0 OUTLIER 'General case' 0 CA--C 1.484 -1.588 0 N-CA-C 102.3 -3.222 . . . . 0.0 102.3 179.295 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 1.166 ' O ' ' N ' ' A' ' 98' ' ' ALA 0.287 0.1 OUTLIER 19.95 42.17 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 113.222 -1.808 . . . . 0.0 106.741 -174.193 . . . . . . . . 4 4 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.823 ' C ' ' O ' ' A' ' 96' ' ' ASP . 5.2 p90 23.44 27.63 0.0 OUTLIER 'General case' 0 CA--C 1.487 -1.447 0 N-CA-C 102.127 -3.286 . . . . 0.0 102.127 -168.824 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 1.166 ' N ' ' O ' ' A' ' 96' ' ' ASP 0.281 . . -61.3 -26.88 68.08 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 109.427 -3.533 . . . . 0.0 108.629 179.982 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.127 179.855 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.779 ' SD ' HG21 ' A' ' 35' ' ' THR . 4.2 ptm . . . . . 0 N--CA 1.496 1.832 0 CA-C-O 121.307 0.575 . . . . 0.0 110.833 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . 0.557 ' HA ' ' O ' ' A' ' 43' ' ' GLN . 16.4 p-10 -176.15 -140.81 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.706 -0.797 . . . . 0.0 111.238 178.044 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.451 ' HE3' ' HB3' ' B' ' 29' ' ' GLU . 0.1 OUTLIER -57.56 -0.36 0.07 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.003 -1.061 . . . . 0.0 110.916 -179.62 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.777 ' O ' HG13 ' B' ' 7' ' ' ILE . 4.2 m -120.16 -69.47 0.84 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.957 -1.089 . . . . 0.0 110.376 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.594 ' O ' ' HG3' ' B' ' 8' ' ' LYS . 1.7 mm-40 -48.82 -36.17 16.17 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.062 -1.024 . . . . 0.0 109.331 -179.865 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.664 HD21 HG23 ' A' ' 42' ' ' VAL . 87.0 mt -69.36 -28.96 66.66 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 118.869 -1.133 . . . . 0.0 109.988 178.608 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 7' ' ' ILE . . . . . 0.874 ' HA ' HD12 ' B' ' 25' ' ' LEU . 1.5 pp -63.76 -45.91 95.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.521 -1.362 . . . . 0.0 107.972 178.929 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . 0.829 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.0 OUTLIER -74.23 -20.44 60.17 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.39 -0.924 . . . . 0.0 108.562 177.522 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . 0.536 ' HB3' ' HA ' ' B' ' 6' ' ' LEU . . . -69.15 -33.57 73.63 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.149 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.861 ' O ' ' OG1' ' B' ' 14' ' ' THR . 1.0 OUTLIER -94.37 -34.5 5.63 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.4 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 178.3 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.829 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -56.91 -25.49 57.4 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.285 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 11.6 mm-40 -92.52 -45.03 8.32 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.441 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.424 ' HB2' ' HA ' ' B' ' 10' ' ' ILE . 4.6 m-20 -62.34 -25.26 67.8 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 177.061 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.882 HG22 ' HB2' ' A' ' 20' ' ' SER . 14.8 p -91.42 -74.39 0.51 Allowed 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.119 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 59.15 17.24 36.9 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.575 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 16' ' ' LEU . . . . . 0.964 HD22 ' O ' ' A' ' 19' ' ' VAL . 3.4 mp -83.44 -61.53 1.82 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.358 -1.084 . . . . 0.0 108.878 179.053 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . 0.561 HG22 ' H ' ' B' ' 19' ' ' VAL . 0.6 OUTLIER -139.84 2.84 2.0 Allowed 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.732 179.909 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . 0.623 ' O ' ' C ' ' B' ' 19' ' ' VAL . 17.6 mt-30 56.64 28.14 13.61 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 -176.836 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 1.058 HG11 HG11 ' A' ' 19' ' ' VAL . 1.7 p -6.16 -100.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.765 -179.377 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.899 ' O ' ' N ' ' B' ' 23' ' ' LYS . 0.5 OUTLIER -133.92 24.12 3.93 Favored 'General case' 0 C--N 1.28 -2.445 0 N-CA-C 105.434 -2.062 . . . . 0.0 105.434 177.154 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.635 ' HA ' ' HE2' ' B' ' 24' ' ' MET . 16.6 m -18.43 -37.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 CA-C-O 122.212 1.006 . . . . 0.0 110.513 -177.922 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.844 ' N ' ' O ' ' B' ' 20' ' ' SER . 5.2 t -77.49 -43.13 33.25 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.146 -0.934 . . . . 0.0 108.893 178.496 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . 0.899 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.0 OUTLIER -92.3 -19.21 22.39 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.724 -0.61 . . . . 0.0 109.566 178.474 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 24' ' ' MET . . . . . 0.728 ' N ' ' OG ' ' B' ' 20' ' ' SER 0.258 3.1 tmm? -68.57 -44.86 73.54 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.3 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.874 HD12 ' HA ' ' B' ' 7' ' ' ILE . 8.4 mt -76.83 -44.14 33.55 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 177.005 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . 0.604 ' HB3' ' HA ' ' B' ' 23' ' ' LYS . . . -54.74 -33.48 61.21 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 177.567 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . 0.538 ' O ' HG23 ' B' ' 31' ' ' ILE . 10.4 m -75.27 -40.97 58.24 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.465 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . 0.759 ' HA ' ' CG1' ' B' ' 31' ' ' ILE . 0.0 OUTLIER -64.39 -31.38 72.57 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.548 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . 0.604 ' HG3' ' CE2' ' B' ' 28' ' ' PHE . 1.5 mt-10 -84.4 -32.3 24.22 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 178.221 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 0.747 ' O ' ' CG ' ' B' ' 34' ' ' GLU . 24.8 tttt -71.4 -29.02 64.43 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 176.332 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.87 HD13 ' HB1' ' A' ' 9' ' ' ALA . 1.3 pp -93.89 -31.29 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.224 -0.922 . . . . 0.0 109.749 178.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.823 HG21 ' CE1' ' A' ' 47' ' ' PHE . 3.4 mm -61.65 -55.22 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 177.447 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 33' ' ' THR . . . . . 0.451 ' HB ' ' O ' ' B' ' 29' ' ' GLU . 0.4 OUTLIER -64.52 -40.32 95.4 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.429 179.46 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.793 ' O ' ' N ' ' B' ' 38' ' ' LYS . 17.8 mm-40 -68.92 -44.14 73.73 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.77 -0.581 . . . . 0.0 110.959 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 35' ' ' THR . . . . . 0.483 ' HA ' ' CB ' ' B' ' 38' ' ' LYS . 93.0 m -54.0 -52.12 61.76 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.798 -1.189 . . . . 0.0 108.998 179.876 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.992 HG21 HG23 ' B' ' 77' ' ' VAL . 0.4 OUTLIER -50.9 -37.26 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.145 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 0.834 ' HB1' ' O ' ' A' ' 88' ' ' ALA . . . -96.32 0.77 51.21 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.774 0.797 . . . . 0.0 110.108 179.043 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.793 ' N ' ' O ' ' B' ' 34' ' ' GLU . 0.0 OUTLIER -95.8 -22.84 17.24 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 176.906 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.49 44.87 0.69 Allowed Glycine 0 C--N 1.304 -1.22 0 C-N-CA 120.35 -0.928 . . . . 0.0 110.961 177.631 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . 0.415 ' HB2' HG23 ' B' ' 35' ' ' THR . 0.4 OUTLIER -155.41 166.14 34.47 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.005 -1.291 . . . . 0.0 111.399 179.6 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.47 ' HG2' ' HD2' ' B' ' 52' ' ' PRO . 11.0 mttt -121.48 112.86 19.04 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.273 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.87 HG22 ' CG1' ' B' ' 50' ' ' ILE . 0.8 OUTLIER -79.47 147.15 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 C-N-CA 118.664 -1.214 . . . . 0.0 110.064 -178.602 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 43' ' ' GLN . . . . . 0.424 ' HA ' ' HA ' ' B' ' 49' ' ' ASN . 1.6 mt-30 -123.66 85.85 2.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.485 -0.759 . . . . 0.0 109.259 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.813 HD12 ' HB3' ' B' ' 48' ' ' LEU . 12.6 mt -58.96 90.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.473 -0.767 . . . . 0.0 110.727 -179.219 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . 0.585 HG21 ' HE3' ' A' ' 3' ' ' LYS . 2.2 t 35.93 26.98 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 179.34 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . 97.91 -25.39 27.71 Favored Glycine 0 N--CA 1.494 2.563 0 C-N-CA 119.841 -1.171 . . . . 0.0 112.859 177.44 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . 0.931 ' CD1' HD21 ' B' ' 85' ' ' LEU . 1.4 p90 -86.44 -28.43 23.51 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 119.873 1.836 . . . . 0.0 112.031 -178.577 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.813 ' HB3' HD12 ' B' ' 44' ' ' LEU . 5.5 mt -129.78 94.06 3.65 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.6 -1.313 . . . . 0.0 110.382 177.786 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 49' ' ' ASN . . . . . 0.512 ' O ' ' HA ' ' B' ' 79' ' ' VAL . 0.6 OUTLIER -105.0 95.26 5.73 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.533 -0.729 . . . . 0.0 110.156 -179.695 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 50' ' ' ILE . . . . . 0.87 ' CG1' HG22 ' B' ' 42' ' ' VAL . 2.0 pp -86.83 146.63 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.483 -0.761 . . . . 0.0 110.684 -179.765 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . 0.451 ' O ' ' HG3' ' B' ' 51' ' ' LYS . 2.6 ptmt -155.11 128.79 4.5 Favored Pre-proline 0 N--CA 1.496 1.848 0 C-N-CA 119.092 -1.043 . . . . 0.0 110.434 179.044 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.694 ' HB3' HG22 ' B' ' 36' ' ' VAL . 57.1 Cg_endo -84.72 140.99 8.41 Favored 'Trans proline' 0 C--N 1.315 -1.205 0 O-C-N 123.352 1.185 . . . . 0.0 110.955 -179.404 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.655 HG22 ' O ' ' B' ' 76' ' ' GLY . 24.8 m -144.61 116.25 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-O 121.767 0.794 . . . . 0.0 111.281 179.18 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.8 ' HB1' ' CG ' ' A' ' 96' ' ' ASP . . . -64.68 117.69 7.82 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.807 -0.558 . . . . 0.0 111.332 -179.231 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . 0.559 ' NH1' HG21 ' B' ' 53' ' ' VAL . 0.7 OUTLIER 166.3 85.49 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.356 0 O-C-N 121.58 -0.7 . . . . 0.0 110.214 178.955 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . 0.717 ' O ' ' HB3' ' B' ' 73' ' ' PRO . 6.5 mt-30 -157.59 178.31 10.42 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.076 -1.015 . . . . 0.0 111.863 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.665 ' HB2' ' O ' ' B' ' 56' ' ' GLN . . . 139.18 126.78 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.599 0 C-N-CA 123.484 0.713 . . . . 0.0 109.16 179.252 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 58' ' ' ARG . . . . . 0.659 ' HB2' ' CG1' ' B' ' 71' ' ' ILE . 0.0 OUTLIER -97.89 -166.58 1.4 Allowed 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 122.002 0.906 . . . . 0.0 111.933 -178.47 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . 0.453 ' C ' ' HA ' ' B' ' 69' ' ' LEU . 6.3 ttpt 177.68 74.04 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.48 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . 0.647 ' N ' ' HA ' ' B' ' 69' ' ' LEU . . . -133.19 -99.57 0.7 Allowed Glycine 0 N--CA 1.496 2.635 0 C-N-CA 120.381 -0.914 . . . . 0.0 111.192 -178.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 61' ' ' PHE . . . . . 0.805 ' C ' ' HA ' ' B' ' 68' ' ' ALA . 24.7 p90 -149.15 161.05 42.76 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.022 -1.281 . . . . 0.0 112.683 -178.097 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . 0.704 ' H ' ' CD ' ' B' ' 63' ' ' PRO . 11.3 p30 -124.73 -23.41 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.577 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.704 ' CD ' ' H ' ' B' ' 62' ' ' ASN . 41.5 Cg_endo -71.11 -31.17 15.14 Favored 'Trans proline' 0 N--CA 1.482 0.819 0 N-CA-C 107.603 -1.73 . . . . 0.0 107.603 179.256 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . 0.721 ' HB3' ' CE1' ' B' ' 61' ' ' PHE . 0.0 OUTLIER -80.17 -9.1 59.7 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.032 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.459 HG23 ' C ' ' B' ' 64' ' ' GLN . 1.8 p 59.16 85.28 0.1 Allowed 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 178.575 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . 0.637 ' HB2' ' CE1' ' B' ' 61' ' ' PHE . 0.0 OUTLIER 179.78 -16.06 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.871 -1.143 . . . . 0.0 113.276 177.682 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . 0.652 ' O ' ' N ' ' B' ' 61' ' ' PHE . 1.6 pt-20 170.75 65.2 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.419 0 O-C-N 120.532 -1.355 . . . . 0.0 110.297 179.887 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . 0.805 ' HA ' ' C ' ' B' ' 61' ' ' PHE . . . -39.51 158.83 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 121.816 0.817 . . . . 0.0 113.038 -178.632 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.926 HD13 ' H ' ' B' ' 69' ' ' LEU . 0.0 OUTLIER -73.55 22.47 0.08 Allowed 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.637 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' B' ' 69' ' ' LEU . 1.9 tp10 -178.1 33.4 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.607 -1.308 . . . . 0.0 111.937 179.376 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.749 HD12 ' O ' ' B' ' 72' ' ' ALA . 1.2 pp -62.19 -161.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.794 -1.191 . . . . 0.0 108.546 178.637 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . 0.785 ' HB1' ' HD2' ' B' ' 73' ' ' PRO . . . -112.44 170.05 5.7 Favored Pre-proline 0 C--N 1.295 -1.77 0 C-N-CA 118.897 -1.121 . . . . 0.0 112.345 -178.731 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 73' ' ' PRO . . . . . 0.785 ' HD2' ' HB1' ' B' ' 72' ' ' ALA . 53.5 Cg_endo -74.72 -153.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.292 -2.406 0 O-C-N 125.178 2.146 . . . . 0.0 109.61 178.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . 0.458 ' CB ' ' O ' ' B' ' 73' ' ' PRO . 5.4 t 162.79 144.44 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . 0.758 HG21 HD21 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -53.26 173.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 120.682 -1.261 . . . . 0.0 109.714 -179.452 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . 0.655 ' O ' HG22 ' B' ' 53' ' ' VAL . . . -114.42 68.8 0.25 Allowed Glycine 0 N--CA 1.487 2.098 0 C-N-CA 119.403 -1.38 . . . . 0.0 109.656 -179.382 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.992 HG23 HG21 ' B' ' 36' ' ' VAL . 2.5 p -58.09 76.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.453 -1.027 . . . . 0.0 109.428 179.521 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . 0.624 ' N ' ' O ' ' B' ' 76' ' ' GLY . 6.5 t -76.95 177.17 7.95 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.897 0.856 . . . . 0.0 110.789 -179.446 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.859 ' CG2' HG22 ' B' ' 50' ' ' ILE . 4.8 p 177.23 177.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . 0.699 ' O ' HD23 ' B' ' 48' ' ' LEU . 0.1 OUTLIER -172.48 173.51 1.48 Allowed Pre-proline 0 N--CA 1.485 1.303 0 O-C-N 120.64 -1.288 . . . . 0.0 110.642 178.131 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 81' ' ' PRO . . . . . 0.603 ' HB2' HG13 ' A' ' 77' ' ' VAL . 53.4 Cg_endo -97.72 133.1 0.32 Allowed 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 122.503 2.136 . . . . 0.0 110.504 178.801 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . 0.518 ' HA3' ' HA ' ' B' ' 47' ' ' PHE . . . -89.76 -164.37 39.98 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 108.41 -1.876 . . . . 0.0 108.41 178.669 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -83.87 -18.25 38.14 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.039 -1.271 . . . . 0.0 110.385 179.805 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 84' ' ' SER . . . . . 0.414 ' HB2' ' HB3' ' B' ' 47' ' ' PHE . 1.1 m -52.44 -38.18 58.59 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.23 -0.918 . . . . 0.0 109.434 179.656 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.931 HD23 ' HA ' ' A' ' 33' ' ' THR . 0.4 OUTLIER -78.71 -33.03 47.11 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.17 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . 0.672 ' O ' ' HB3' ' B' ' 89' ' ' ALA . 0.1 OUTLIER -73.04 -45.57 56.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.66 -0.65 . . . . 0.0 110.563 -179.32 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.74 -39.31 93.69 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 178.443 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.752 ' O ' ' HB1' ' A' ' 37' ' ' ALA . . . -66.83 -33.68 76.15 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 176.822 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.946 ' HA ' HD23 ' B' ' 92' ' ' LEU . . . -56.44 -44.83 80.84 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.019 179.17 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -53.81 -32.86 54.18 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 177.114 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -64.71 -35.82 92.38 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 178.447 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . 0.946 HD23 ' HA ' ' B' ' 89' ' ' ALA . 0.4 OUTLIER -75.58 12.01 1.14 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.689 -1.477 . . . . 0.0 111.111 -179.768 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' B' ' 92' ' ' LEU . 0.0 OUTLIER 61.01 40.04 15.72 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -177.639 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . 0.67 ' HB2' ' HB ' ' A' ' 75' ' ' VAL . 0.1 OUTLIER -37.79 -38.49 0.29 Allowed 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.167 -179.055 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . 0.507 ' O ' ' HB3' ' B' ' 98' ' ' ALA . 14.6 pt-20 -61.74 -42.93 99.61 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.31 -0.869 . . . . 0.0 109.885 179.77 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -58.96 -33.71 70.96 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.57 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.88 -26.81 62.49 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.463 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 98' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' B' ' 95' ' ' GLU . . . -65.75 -63.46 1.08 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.588 -0.695 . . . . 0.0 110.194 179.834 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 3.5 mtmp? . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 118.024 -0.988 . . . . 0.0 110.196 179.924 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.775 ' HG3' HG23 ' B' ' 42' ' ' VAL . 1.5 ptm . . . . . 0 N--CA 1.496 1.841 0 CA-C-O 121.297 0.57 . . . . 0.0 110.739 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.411 ' HB3' ' O ' ' A' ' 1' ' ' MET . 34.5 p-10 -175.38 -148.08 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 119.714 -0.795 . . . . 0.0 111.359 178.648 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.418 ' O ' ' CG2' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -53.83 -6.88 0.1 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.178 -0.952 . . . . 0.0 111.091 -179.521 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.627 ' O ' ' CG1' ' A' ' 7' ' ' ILE . 32.9 m -118.49 -64.1 1.33 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.953 -1.092 . . . . 0.0 110.613 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.703 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 5.0 mt-10 -48.79 -40.32 28.58 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.846 -1.159 . . . . 0.0 109.314 -179.706 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.682 HD11 ' CG2' ' B' ' 42' ' ' VAL . 74.0 mt -62.66 -33.88 75.95 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.456 178.19 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.807 ' HA ' HD12 ' A' ' 25' ' ' LEU . 0.9 OUTLIER -58.78 -38.03 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 178.771 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.841 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 31.4 mtmt -68.95 -34.29 75.1 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.17 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.67 ' HB1' HD13 ' B' ' 31' ' ' ILE . . . -54.37 -40.4 68.09 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.286 179.163 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.852 ' O ' ' OG1' ' A' ' 14' ' ' THR . 1.4 mp -92.24 -29.23 4.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 178.247 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.841 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -68.07 -9.14 43.86 Favored 'General case' 0 C--N 1.289 -2.033 0 O-C-N 120.579 -1.326 . . . . 0.0 108.723 178.596 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -121.51 -41.46 2.49 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.376 -0.828 . . . . 0.0 110.102 179.202 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.664 ' OD2' HG21 ' B' ' 31' ' ' ILE . 62.8 m-20 -68.62 -24.5 64.57 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 177.471 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 1.094 HG22 ' CD1' ' A' ' 16' ' ' LEU 0.274 0.2 OUTLIER -106.96 -81.85 0.55 Allowed 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 178.752 . . . . . . . . 4 4 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.51 6.43 66.07 Favored Glycine 0 N--CA 1.501 3.02 0 O-C-N 121.07 -1.019 . . . . 0.0 110.61 177.679 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.094 ' CD1' HG22 ' A' ' 14' ' ' THR . 5.0 mp -51.81 -70.17 0.09 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.67 -0.9 . . . . 0.0 110.514 179.812 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.536 ' CG2' HG21 ' B' ' 17' ' ' THR . 0.6 OUTLIER -132.82 8.57 4.14 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.825 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.588 ' O ' ' C ' ' A' ' 19' ' ' VAL . 2.3 mt-30 57.04 26.98 12.62 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 -176.179 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 1.104 HG23 ' CD1' ' B' ' 16' ' ' LEU . 0.6 OUTLIER -10.17 -94.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.626 -179.034 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.931 ' O ' ' N ' ' A' ' 23' ' ' LYS . 2.4 m -134.57 23.29 3.69 Favored 'General case' 0 C--N 1.28 -2.425 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 178.181 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.669 ' C ' ' O ' ' A' ' 20' ' ' SER . 31.5 m -18.16 -40.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 CA-C-O 122.418 1.104 . . . . 0.0 109.279 -177.376 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.867 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.4 OUTLIER -86.43 -38.03 17.75 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.088 178.142 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.931 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.9 OUTLIER -85.21 -31.52 23.13 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.535 -0.728 . . . . 0.0 110.895 179.448 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.803 ' HB3' HG23 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -76.46 -43.77 38.5 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 118.217 -1.393 . . . . 0.0 109.315 179.249 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.807 HD12 ' HA ' ' A' ' 7' ' ' ILE . 7.0 mt -68.5 -48.54 64.14 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 117.743 -1.583 . . . . 0.0 108.293 177.888 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.435 ' CB ' ' O ' ' A' ' 22' ' ' SER . . . -55.76 -33.14 64.05 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 177.558 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.532 ' O ' ' CG1' ' A' ' 31' ' ' ILE . 7.5 t -73.34 -36.81 66.24 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 177.488 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.744 ' HA ' ' CG1' ' A' ' 31' ' ' ILE . 0.1 OUTLIER -64.19 -33.74 76.49 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.535 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.567 ' HG3' ' CD2' ' A' ' 28' ' ' PHE . 2.1 mt-10 -83.1 -31.44 27.27 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.175 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.762 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 6.7 tttm -72.12 -27.62 62.74 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 176.588 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.744 ' CG1' ' HA ' ' A' ' 28' ' ' PHE . 1.8 pp -95.99 -31.71 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.35 -0.844 . . . . 0.0 109.751 179.009 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.762 HG21 ' CE1' ' B' ' 47' ' ' PHE . 2.6 mm -63.28 -52.89 52.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.829 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.583 HG23 ' HB2' ' B' ' 88' ' ' ALA . 0.4 OUTLIER -68.34 -38.82 81.85 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.556 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.762 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 34.0 mm-40 -71.94 -34.3 68.91 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.413 -0.805 . . . . 0.0 110.832 179.169 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.737 HG21 HG13 ' A' ' 42' ' ' VAL . 3.2 m -59.98 -54.16 49.31 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.997 -1.064 . . . . 0.0 108.563 179.894 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.635 HG11 HD22 ' B' ' 85' ' ' LEU . 1.0 OUTLIER -54.04 -35.04 27.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 177.755 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.737 ' HA ' ' HB3' ' B' ' 92' ' ' LEU . . . -78.51 -7.15 57.18 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.736 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.489 ' N ' ' O ' ' A' ' 35' ' ' THR . 1.3 ttmt -102.21 -25.28 13.75 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 178.122 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 35' ' ' THR . . . 104.8 41.83 1.92 Allowed Glycine 0 C--N 1.3 -1.417 0 C-N-CA 120.218 -0.991 . . . . 0.0 110.699 178.067 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.704 ' CB ' HG23 ' A' ' 35' ' ' THR . 0.3 OUTLIER -128.67 154.27 46.45 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.116 -1.226 . . . . 0.0 110.429 179.449 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.421 ' HE3' ' CB ' ' A' ' 51' ' ' LYS . 43.1 tttt -109.01 98.38 7.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.382 -0.824 . . . . 0.0 110.0 -179.738 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.762 HG12 ' HB2' ' B' ' 1' ' ' MET . 19.3 m -84.93 147.41 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.451 -0.781 . . . . 0.0 110.414 -179.602 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.436 ' O ' ' HA ' ' B' ' 2' ' ' ASN . 1.7 tt0 -136.57 107.91 6.86 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 121.296 -0.878 . . . . 0.0 110.134 -179.131 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.712 HD22 ' HE2' ' B' ' 28' ' ' PHE . 20.3 mt -66.64 99.13 0.57 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.039 -1.038 . . . . 0.0 109.875 179.51 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.637 HG21 ' HB3' ' B' ' 29' ' ' GLU . 1.7 t 37.17 26.67 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.782 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . 94.44 -0.24 65.58 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 120.06 -1.067 . . . . 0.0 112.487 177.664 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.881 ' CE1' HG21 ' B' ' 32' ' ' ILE . 0.8 OUTLIER -104.23 -31.38 9.62 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 120.002 1.901 . . . . 0.0 111.96 -179.919 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.832 HD13 HD13 ' B' ' 48' ' ' LEU . 1.0 OUTLIER -123.04 93.82 4.07 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.706 -1.246 . . . . 0.0 109.779 178.115 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -96.08 75.14 3.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.702 -0.624 . . . . 0.0 111.371 -179.114 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.863 HD13 ' HB ' ' A' ' 79' ' ' VAL . 2.6 mm -63.19 129.71 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.202 -0.936 . . . . 0.0 109.031 178.798 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 78' ' ' SER . 0.0 OUTLIER -144.05 127.26 8.81 Favored Pre-proline 0 N--CA 1.492 1.656 0 C-N-CA 118.712 -1.195 . . . . 0.0 109.704 179.491 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.623 ' HB3' HG13 ' A' ' 36' ' ' VAL . 54.3 Cg_endo -76.71 142.13 22.56 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.384 1.202 . . . . 0.0 111.162 -179.277 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 1.055 ' O ' HG22 ' A' ' 75' ' ' VAL . 1.7 t -122.08 -142.84 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.588 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.532 ' HB2' ' O ' ' A' ' 53' ' ' VAL . . . 177.42 118.36 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.291 -0.88 . . . . 0.0 110.158 179.693 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.49 88.86 0.23 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.433 -0.792 . . . . 0.0 109.764 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.562 ' CD ' ' HB1' ' B' ' 98' ' ' ALA . 1.3 mt-30 -58.68 128.07 35.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.402 -0.811 . . . . 0.0 110.247 -179.752 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.882 ' C ' HD13 ' A' ' 71' ' ' ILE . . . -56.73 -169.4 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.807 0.813 . . . . 0.0 110.269 179.645 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.739 ' C ' HG21 ' A' ' 71' ' ' ILE 0.251 4.2 mpt_? -57.12 -135.62 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.891 0 CA-C-O 122.576 1.179 . . . . 0.0 111.471 179.701 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.745 ' HA ' ' H ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER 170.4 61.05 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 177.622 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -45.05 115.4 1.44 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 -179.108 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.791 ' O ' ' HB2' ' A' ' 62' ' ' ASN 0.26 0.6 OUTLIER -78.06 6.1 8.61 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 118.231 -1.387 . . . . 0.0 112.075 -178.208 . . . . . . . . 4 4 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.791 ' HB2' ' O ' ' A' ' 61' ' ' PHE . 6.9 t30 161.21 -156.65 0.0 OUTLIER Pre-proline 0 C--N 1.28 -2.446 0 N-CA-C 104.764 -2.31 . . . . 0.0 104.764 -177.326 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.555 ' HD2' ' HB3' ' A' ' 62' ' ' ASN . 45.0 Cg_endo -78.12 35.91 0.55 Allowed 'Trans proline' 0 C--N 1.305 -1.715 0 N-CA-C 108.644 -1.329 . . . . 0.0 108.644 177.247 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.783 ' O ' HG23 ' A' ' 65' ' ' THR . 0.1 OUTLIER -158.79 -118.29 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 O-C-N 121.259 -0.9 . . . . 0.0 110.928 -178.582 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.783 HG23 ' O ' ' A' ' 64' ' ' GLN . 0.2 OUTLIER -174.27 101.7 0.1 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.001 -1.062 . . . . 0.0 110.0 -179.458 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.516 ' HB2' ' CE2' ' A' ' 61' ' ' PHE . 0.8 OUTLIER -151.19 -69.67 0.17 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.439 -0.788 . . . . 0.0 109.247 179.831 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.899 ' O ' HD23 ' A' ' 69' ' ' LEU . 7.7 mt-10 -101.39 37.34 1.81 Allowed 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 177.777 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.709 ' HB1' ' HG3' ' A' ' 59' ' ' LYS . . . -19.77 137.8 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -177.199 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.899 HD23 ' O ' ' A' ' 67' ' ' GLU . 1.1 pp -174.5 44.28 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.935 ' O ' HG23 ' A' ' 71' ' ' ILE . 2.4 tm-20 -169.75 112.15 0.47 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 119.461 -2.024 . . . . 0.0 113.105 178.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.935 HG23 ' O ' ' A' ' 70' ' ' GLU 0.25 0.5 OUTLIER -168.49 -157.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-O 121.686 0.755 . . . . 0.0 111.191 -179.247 . . . . . . . . 4 4 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -113.51 74.9 2.33 Favored Pre-proline 0 C--N 1.31 -1.14 0 O-C-N 121.756 -0.59 . . . . 0.0 111.327 -179.605 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.53 121.75 8.26 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.741 1.39 . . . . 0.0 109.972 178.962 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.541 ' HA ' ' CE2' ' B' ' 94' ' ' TYR . 11.0 p -166.41 147.07 6.24 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.2 -0.938 . . . . 0.0 109.942 -179.879 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 1.055 HG22 ' O ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -53.87 175.18 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.143 -0.973 . . . . 0.0 108.38 179.738 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.618 ' O ' ' N ' ' A' ' 78' ' ' SER . . . -110.91 38.67 3.19 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 118.569 -1.777 . . . . 0.0 110.226 -178.765 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.734 ' CG2' HD22 ' B' ' 85' ' ' LEU . 3.0 p -27.78 87.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 CA-C-O 121.924 0.868 . . . . 0.0 110.58 179.781 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.618 ' N ' ' O ' ' A' ' 76' ' ' GLY . 0.1 OUTLIER -87.81 175.52 7.8 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.963 -179.168 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.863 ' HB ' HD13 ' A' ' 50' ' ' ILE . 7.2 p 175.57 177.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.845 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.671 ' O ' HD23 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -177.15 171.71 0.89 Allowed Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.001 -1.062 . . . . 0.0 110.185 176.948 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.603 ' HB2' HG13 ' B' ' 77' ' ' VAL . 54.7 Cg_endo -96.91 128.8 0.3 Allowed 'Trans proline' 0 C--N 1.302 -1.894 0 C-N-CA 122.414 2.076 . . . . 0.0 110.691 178.639 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.494 ' HA3' ' HA ' ' A' ' 47' ' ' PHE . . . -87.75 173.18 43.28 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 178.749 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -62.19 -17.92 59.52 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.086 -1.244 . . . . 0.0 110.591 -179.846 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.526 ' HB2' ' HB3' ' A' ' 47' ' ' PHE . 0.8 OUTLIER -53.74 -41.15 66.77 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.177 -0.952 . . . . 0.0 109.506 179.802 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.924 ' CB ' HG21 ' B' ' 77' ' ' VAL . 1.0 OUTLIER -76.76 -26.79 54.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.448 -0.783 . . . . 0.0 109.116 179.111 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.669 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 0.7 OUTLIER -81.03 -41.27 22.93 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.665 -0.647 . . . . 0.0 110.63 -179.522 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.67 -40.92 98.02 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 178.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.736 ' O ' ' HB1' ' B' ' 37' ' ' ALA . . . -65.29 -37.39 87.02 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 176.3 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 1.091 ' HB1' HG11 ' B' ' 75' ' ' VAL . . . -56.66 -40.33 75.31 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.467 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.412 ' HG2' ' N ' ' A' ' 91' ' ' GLY . 1.1 pt-20 -55.5 -31.75 62.3 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 177.096 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.412 ' N ' ' HG2' ' A' ' 90' ' ' GLU . . . -68.56 -34.04 77.97 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 178.643 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.835 ' O ' HD12 ' A' ' 92' ' ' LEU . 0.6 OUTLIER -66.27 5.84 0.49 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.648 -1.501 . . . . 0.0 111.305 -179.806 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.423 ' CB ' ' O ' ' A' ' 92' ' ' LEU . 0.4 OUTLIER 65.36 39.49 5.23 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 -177.388 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.525 ' HA ' HD11 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -43.54 -31.49 0.74 Allowed 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.154 -179.079 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -57.91 -41.68 83.15 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.279 -0.888 . . . . 0.0 108.944 179.151 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -63.58 -36.0 82.37 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 177.515 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.593 ' HB3' ' HB2' ' B' ' 54' ' ' ALA . 0.1 OUTLIER -71.05 -25.47 62.65 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.139 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.642 ' HB1' ' HB3' ' B' ' 56' ' ' GLN . . . -76.14 -70.39 0.44 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.662 -0.649 . . . . 0.0 110.136 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 18.1 mtmt . . . . . 0 N--CA 1.494 1.76 0 CA-C-O 118.053 -0.975 . . . . 0.0 110.31 -179.979 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.762 ' HB2' HG12 ' A' ' 42' ' ' VAL . 2.5 mtp . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . 0.44 ' H ' ' HB2' ' B' ' 5' ' ' GLU . 17.5 p30 -173.43 -153.91 0.06 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.002 -1.061 . . . . 0.0 111.693 179.705 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.465 ' HG3' ' HB ' ' A' ' 45' ' ' THR . 0.1 OUTLIER -56.52 -0.55 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.515 -0.741 . . . . 0.0 111.562 -179.229 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.72 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 61.3 m -125.52 -45.68 1.78 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.779 -1.201 . . . . 0.0 110.363 179.738 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.54 ' CB ' ' HA ' ' B' ' 1' ' ' MET . 3.3 mt-10 -65.99 -51.45 58.23 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.051 -1.031 . . . . 0.0 108.682 179.673 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.778 ' O ' ' HB3' ' B' ' 9' ' ' ALA . 17.9 mt -58.02 -32.62 68.12 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.161 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 7' ' ' ILE . . . . . 0.845 HG23 ' HB ' ' B' ' 21' ' ' VAL . 1.3 mt -53.63 -55.35 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 177.591 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . 0.965 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.6 OUTLIER -57.11 -31.98 65.84 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 177.829 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . 0.778 ' HB3' ' O ' ' B' ' 6' ' ' LEU . . . -54.52 -38.42 66.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.271 -0.893 . . . . 0.0 108.971 178.677 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.803 HG23 ' HB3' ' A' ' 24' ' ' MET . 1.6 mp -90.83 -34.34 6.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 178.121 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.965 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -67.28 -12.62 60.6 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 119.139 -1.024 . . . . 0.0 109.011 178.686 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.491 ' N ' ' O ' ' B' ' 8' ' ' LYS . 1.1 pp0? -113.7 -36.0 5.0 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.339 -0.851 . . . . 0.0 109.416 178.496 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.435 ' OD2' HG21 ' A' ' 31' ' ' ILE . 56.0 m-20 -72.15 -21.54 61.44 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 176.784 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.837 HG21 ' HB2' ' A' ' 20' ' ' SER . 0.2 OUTLIER -117.24 -77.94 0.57 Allowed 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.462 179.648 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . 0.46 ' O ' ' C ' ' B' ' 16' ' ' LEU . . . 64.99 -13.1 0.21 Allowed Glycine 0 N--CA 1.5 2.908 0 N-CA-C 110.499 -1.041 . . . . 0.0 110.499 179.065 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 16' ' ' LEU . . . . . 1.104 ' CD1' HG23 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -35.05 -59.43 0.5 Allowed 'General case' 0 N--CA 1.513 2.677 0 CA-C-O 122.06 0.934 . . . . 0.0 110.678 -179.695 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . 0.641 HG22 ' H ' ' B' ' 19' ' ' VAL . 0.5 OUTLIER -136.38 -1.17 2.36 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.543 -179.291 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . 0.627 ' O ' ' C ' ' B' ' 19' ' ' VAL . 5.1 mt-30 54.83 31.79 16.37 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 -176.815 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 1.005 HG11 HG11 ' A' ' 19' ' ' VAL . 0.9 OUTLIER -6.79 -93.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.01 -178.835 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 1.06 ' O ' ' N ' ' B' ' 22' ' ' SER . 0.3 OUTLIER -133.16 24.77 4.2 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 178.116 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.918 HG11 ' HB2' ' B' ' 11' ' ' ALA . 0.0 OUTLIER -8.85 -39.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-O 122.362 1.077 . . . . 0.0 110.288 -178.252 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 1.06 ' N ' ' O ' ' B' ' 20' ' ' SER . 5.9 m -85.05 -43.09 14.23 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.483 178.244 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . 0.885 ' N ' ' O ' ' B' ' 20' ' ' SER . 0.2 OUTLIER -81.94 -25.3 35.0 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.286 -0.884 . . . . 0.0 111.004 179.927 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 24' ' ' MET . . . . . 0.695 ' HB3' HG21 ' A' ' 14' ' ' THR . 0.0 OUTLIER -82.94 -45.92 13.57 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 118.357 -1.337 . . . . 0.0 110.063 179.399 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.644 HD23 ' HE3' ' B' ' 24' ' ' MET . 0.4 OUTLIER -69.05 -48.22 63.4 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 117.53 -1.668 . . . . 0.0 108.104 178.272 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . 0.46 ' HA ' ' HE2' ' B' ' 3' ' ' LYS . . . -54.84 -34.09 62.48 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 177.698 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . 0.737 ' O ' HG23 ' B' ' 31' ' ' ILE . 3.7 t -72.55 -39.45 67.47 Favored 'General case' 0 C--O 1.204 -1.311 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.681 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . 0.732 ' HA ' ' CG1' ' B' ' 31' ' ' ILE . 0.1 OUTLIER -62.96 -37.68 88.05 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.688 0.756 . . . . 0.0 109.287 179.357 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . 0.637 ' HB3' HG21 ' A' ' 45' ' ' THR . 0.9 OUTLIER -81.9 -31.18 31.56 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 178.656 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 0.815 ' O ' ' CG ' ' B' ' 34' ' ' GLU . 9.7 ttmt -71.99 -30.19 64.99 Favored 'General case' 0 C--O 1.19 -2.03 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 176.277 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.737 HG23 ' O ' ' B' ' 27' ' ' SER . 1.3 pp -91.19 -30.28 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.21 -0.931 . . . . 0.0 109.606 179.167 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.881 HG21 ' CE1' ' A' ' 47' ' ' PHE . 5.2 mm -62.57 -51.68 69.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 177.495 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 33' ' ' THR . . . . . 0.834 ' HA ' HD23 ' A' ' 85' ' ' LEU . 0.4 OUTLIER -75.69 -25.66 56.9 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 114.904 -1.043 . . . . 0.0 108.966 179.74 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.815 ' CG ' ' O ' ' B' ' 30' ' ' LYS . 5.6 mm-40 -81.84 -35.75 29.04 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.078 -1.014 . . . . 0.0 109.394 178.674 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 35' ' ' THR . . . . . 0.613 HG23 ' HB2' ' B' ' 40' ' ' ASP . 52.0 m -62.55 -54.34 41.18 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 178.232 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.805 HG22 ' O ' ' B' ' 32' ' ' ILE . 2.2 m -50.17 -34.39 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 177.146 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 0.736 ' HB1' ' O ' ' A' ' 88' ' ' ALA . . . -90.58 -4.13 57.08 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 121.57 0.7 . . . . 0.0 110.352 178.318 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.658 ' N ' ' O ' ' B' ' 34' ' ' GLU . 0.0 OUTLIER -97.93 -24.5 15.36 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 177.731 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 111.81 43.87 0.92 Allowed Glycine 0 C--N 1.301 -1.383 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 178.089 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . 0.613 ' HB2' HG23 ' B' ' 35' ' ' THR . 0.1 OUTLIER -145.82 136.64 24.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.202 -1.175 . . . . 0.0 110.565 179.684 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 10.9 mtmt -89.68 88.28 7.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.477 -0.764 . . . . 0.0 109.901 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.775 HG23 ' HG3' ' A' ' 1' ' ' MET . 7.6 p -62.1 142.19 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.486 -0.759 . . . . 0.0 110.128 -179.808 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 43' ' ' GLN . . . . . 0.438 ' HA ' ' O ' ' B' ' 48' ' ' LEU . 6.2 mt-30 -134.31 110.92 9.81 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.448 -0.782 . . . . 0.0 110.548 -179.361 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.65 HD22 ' HE2' ' A' ' 28' ' ' PHE . 17.0 mt -66.64 118.63 10.48 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.253 -0.904 . . . . 0.0 109.533 179.323 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . 0.547 HG21 ' HB3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 29.06 -89.34 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.823 -0.548 . . . . 0.0 111.228 -179.975 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . -149.58 26.85 1.2 Allowed Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 179.623 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . 0.762 ' CE1' HG21 ' A' ' 32' ' ' ILE . 7.7 p90 -125.45 -24.44 3.91 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.951 -1.323 . . . . 0.0 112.011 179.736 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.832 HD13 HD13 ' A' ' 48' ' ' LEU . 1.6 mt -128.07 108.47 10.68 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.404 -1.435 . . . . 0.0 110.82 178.814 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -106.19 69.83 0.82 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.574 -0.704 . . . . 0.0 110.989 -179.643 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 50' ' ' ILE . . . . . 0.912 HD13 ' HB ' ' B' ' 79' ' ' VAL . 1.9 mm -60.1 125.6 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.302 -0.874 . . . . 0.0 109.281 179.142 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . 0.461 ' HG3' ' HB2' ' B' ' 78' ' ' SER . 9.1 ptmt -149.71 122.63 4.37 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 120.665 -1.272 . . . . 0.0 111.252 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.613 ' HA ' ' HA ' ' B' ' 77' ' ' VAL . 55.4 Cg_endo -79.8 144.49 17.32 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 O-C-N 123.61 1.321 . . . . 0.0 110.964 179.78 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.705 HG22 ' O ' ' B' ' 76' ' ' GLY . 32.6 m -138.92 114.3 8.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-O 121.833 0.825 . . . . 0.0 110.753 179.282 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.593 ' HB2' ' HB3' ' A' ' 97' ' ' PHE . . . -56.74 94.29 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.581 -0.699 . . . . 0.0 111.173 -179.022 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 8.7 ttt-85 -108.01 69.39 0.73 Allowed 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.623 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . 0.642 ' HB3' ' HB1' ' A' ' 98' ' ' ALA . 7.3 pt20 -51.85 -175.48 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.889 0.852 . . . . 0.0 111.647 -178.496 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.75 -168.59 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.306 0.574 . . . . 0.0 111.173 -179.074 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 58' ' ' ARG . . . . . 0.766 ' HD2' ' N ' ' B' ' 71' ' ' ILE . 0.0 OUTLIER -175.4 -157.15 0.06 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.445 -0.784 . . . . 0.0 110.204 -177.83 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . 0.645 ' HB3' ' O ' ' B' ' 58' ' ' ARG . 0.0 OUTLIER 150.68 88.59 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.238 0 CA-C-O 121.36 0.6 . . . . 0.0 109.51 177.921 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . 0.83 ' HA3' HD12 ' B' ' 69' ' ' LEU . . . -118.0 -112.83 2.58 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 -179.685 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 61' ' ' PHE . . . . . 0.634 ' C ' ' CD1' ' B' ' 61' ' ' PHE . 11.9 p90 179.37 175.77 0.67 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.479 -1.012 . . . . 0.0 110.282 -179.517 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . 0.973 ' CB ' ' HB2' ' B' ' 68' ' ' ALA . 0.0 OUTLIER -135.4 -44.08 0.02 OUTLIER Pre-proline 0 C--N 1.298 -1.672 0 C-N-CA 119.719 -0.792 . . . . 0.0 112.353 178.322 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.933 ' HD2' ' H ' ' B' ' 62' ' ' ASN . 41.1 Cg_endo -69.67 64.17 1.75 Allowed 'Trans proline' 0 N--CA 1.486 1.055 0 O-C-N 122.62 0.8 . . . . 0.0 110.957 -179.651 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . 0.576 ' CB ' ' CE1' ' B' ' 61' ' ' PHE . 0.0 OUTLIER -168.47 -106.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 179.119 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.443 ' O ' ' CB ' ' B' ' 66' ' ' GLN . 0.5 OUTLIER -75.45 -1.9 26.24 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.358 -1.464 . . . . 0.0 109.005 177.247 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . 0.458 ' O ' ' CB ' ' B' ' 67' ' ' GLU . 0.9 OUTLIER 73.53 98.63 0.07 Allowed 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 121.533 0.682 . . . . 0.0 111.817 179.221 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . 0.632 ' H ' ' HA ' ' B' ' 62' ' ' ASN . 0.3 OUTLIER 164.48 67.81 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.922 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . 0.973 ' HB2' ' CB ' ' B' ' 62' ' ' ASN . . . -64.81 138.95 58.69 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.451 -0.781 . . . . 0.0 110.554 -179.659 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.83 HD12 ' HA3' ' B' ' 60' ' ' GLY . 1.4 mt -138.12 125.09 21.3 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.813 -0.554 . . . . 0.0 109.54 -178.507 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . 0.499 ' C ' ' HD2' ' B' ' 58' ' ' ARG . 3.3 tt0 -166.15 27.64 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.3 -0.875 . . . . 0.0 110.508 -179.318 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.812 HD12 ' N ' ' B' ' 72' ' ' ALA . 2.4 pp -61.92 -150.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.296 -0.878 . . . . 0.0 110.033 178.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . 0.812 ' N ' HD12 ' B' ' 71' ' ' ILE . . . -135.67 163.23 52.06 Favored Pre-proline 0 C--N 1.301 -1.512 0 O-C-N 121.044 -1.035 . . . . 0.0 110.986 -179.31 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 73' ' ' PRO . . . . . 0.473 ' HD2' ' HB1' ' B' ' 72' ' ' ALA . 44.1 Cg_endo -70.72 114.98 4.03 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 124.238 1.652 . . . . 0.0 110.278 179.887 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . 0.471 ' N ' ' OH ' ' A' ' 94' ' ' TYR . 2.0 t 166.89 138.41 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.726 -0.609 . . . . 0.0 109.766 179.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . 1.091 HG11 ' HB1' ' A' ' 89' ' ' ALA . 8.6 p -59.02 166.34 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.175 -0.953 . . . . 0.0 109.132 179.183 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . 0.705 ' O ' HG22 ' B' ' 53' ' ' VAL . . . -120.24 96.72 0.63 Allowed Glycine 0 N--CA 1.49 2.244 0 C-N-CA 119.295 -1.431 . . . . 0.0 110.239 -179.143 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.924 HG21 ' CB ' ' A' ' 85' ' ' LEU . 6.4 p -69.39 68.61 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.575 -0.956 . . . . 0.0 109.075 179.04 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . 0.461 ' HB2' ' HG3' ' B' ' 51' ' ' LYS . 1.6 m -65.65 177.18 1.28 Allowed 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.894 0.854 . . . . 0.0 110.732 -179.178 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.912 ' HB ' HD13 ' B' ' 50' ' ' ILE . 7.3 p 177.24 177.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -179.84 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . 0.68 ' O ' HD23 ' B' ' 48' ' ' LEU . 0.6 OUTLIER -177.47 172.62 0.76 Allowed Pre-proline 0 N--CA 1.487 1.423 0 O-C-N 120.852 -1.155 . . . . 0.0 110.769 177.651 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 81' ' ' PRO . . . . . 0.524 ' HA ' ' O ' ' B' ' 47' ' ' PHE . 53.4 Cg_endo -92.76 128.25 0.79 Allowed 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.441 2.094 . . . . 0.0 110.61 178.527 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . 0.473 ' H ' ' HA ' ' B' ' 47' ' ' PHE . . . -91.67 178.93 41.37 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 108.634 -1.787 . . . . 0.0 108.634 179.152 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . 0.469 ' HA ' ' HB2' ' B' ' 86' ' ' LYS . 4.0 pt-20 -69.61 -28.31 65.82 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.115 -1.227 . . . . 0.0 110.498 -179.828 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -48.71 -32.17 8.03 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.841 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.734 HD22 ' CG2' ' A' ' 77' ' ' VAL . 0.5 OUTLIER -83.4 -38.23 22.22 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.211 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . 0.758 ' O ' ' HB3' ' B' ' 89' ' ' ALA . 0.1 OUTLIER -70.12 -36.39 74.79 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.447 -0.783 . . . . 0.0 109.125 179.575 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 13.0 ttpt -64.97 -42.03 94.94 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 178.029 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.591 ' HB1' ' HB2' ' A' ' 37' ' ' ALA . . . -63.72 -34.86 78.82 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 176.233 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.982 ' HA ' HD23 ' B' ' 92' ' ' LEU . . . -54.47 -43.99 72.21 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.616 -0.834 . . . . 0.0 109.275 178.743 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -53.35 -32.7 50.47 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 177.104 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' B' ' 88' ' ' ALA . . . -60.88 -42.3 99.57 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 178.138 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . 0.982 HD23 ' HA ' ' B' ' 89' ' ' ALA . 0.4 OUTLIER -75.39 17.79 0.25 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.665 -1.491 . . . . 0.0 110.502 179.682 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' B' ' 92' ' ' LEU . 0.0 OUTLIER 58.17 44.74 18.56 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -177.539 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . 0.693 ' HD1' HG23 ' A' ' 75' ' ' VAL . 0.1 OUTLIER -36.71 -35.62 0.09 Allowed 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.68 -179.16 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . 0.425 ' HG3' ' N ' ' B' ' 96' ' ' ASP . 0.0 OUTLIER -64.77 -44.0 91.42 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.382 -0.824 . . . . 0.0 109.382 179.887 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 96' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' B' ' 93' ' ' LYS . 25.8 m-20 -56.39 -34.52 66.78 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.572 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 97' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -82.51 -25.09 33.76 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.81 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 98' ' ' ALA . . . . . 0.562 ' HB1' ' CD ' ' A' ' 56' ' ' GLN . . . -68.28 -49.11 62.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.691 -0.631 . . . . 0.0 110.32 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.258 -179.922 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.645 ' HB2' HG12 ' B' ' 42' ' ' VAL . 11.1 mtp . . . . . 0 N--CA 1.493 1.706 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.499 ' HA ' ' O ' ' B' ' 43' ' ' GLN . 43.7 p-10 -168.5 -159.03 0.25 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.83 -1.169 . . . . 0.0 112.36 -179.891 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.507 ' HE2' ' HB2' ' A' ' 29' ' ' GLU . 5.6 tttm -50.92 -10.09 0.06 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.547 -0.721 . . . . 0.0 111.305 -179.388 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.692 ' O ' HG13 ' A' ' 7' ' ' ILE . 1.3 m -120.12 -57.88 1.91 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.978 -1.076 . . . . 0.0 109.558 179.208 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.564 ' CB ' ' HA ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -48.11 -40.86 24.77 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.402 -0.811 . . . . 0.0 109.154 179.576 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.581 ' HG ' ' HB3' ' A' ' 1' ' ' MET . 5.6 mt -68.83 -29.65 68.02 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.301 -0.96 . . . . 0.0 110.169 178.583 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.729 ' HA ' HD12 ' A' ' 25' ' ' LEU . 1.2 pp -59.99 -46.8 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.667 -1.271 . . . . 0.0 108.263 179.73 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.94 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 18.4 pttt -72.43 -24.8 61.28 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.2 -1.0 . . . . 0.0 108.678 177.514 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 6' ' ' LEU . . . -58.45 -39.26 79.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.264 -0.898 . . . . 0.0 109.04 178.774 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.802 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.9 OUTLIER -92.28 -32.79 5.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 177.863 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.94 ' HB3' ' HA ' ' A' ' 8' ' ' LYS . . . -60.61 -14.29 19.39 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 118.856 -1.138 . . . . 0.0 108.966 178.129 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -112.87 -44.01 3.35 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.271 -0.893 . . . . 0.0 109.656 179.071 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.43 ' HB3' ' HB2' ' B' ' 27' ' ' SER . 0.7 OUTLIER -65.79 -39.03 90.54 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.569 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 1.14 HG22 ' CD1' ' A' ' 16' ' ' LEU 0.251 0.2 OUTLIER -91.87 -70.07 0.71 Allowed 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 177.693 . . . . . . . . 4 4 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.467 ' HA2' ' O ' ' A' ' 11' ' ' ALA . . . 58.23 18.9 37.11 Favored Glycine 0 N--CA 1.499 2.853 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 177.236 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.14 ' CD1' HG22 ' A' ' 14' ' ' THR . 3.3 mp -62.74 -63.83 1.1 Allowed 'General case' 0 C--N 1.293 -1.853 0 O-C-N 121.48 -1.012 . . . . 0.0 109.937 179.308 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.6 HG21 ' CG2' ' B' ' 17' ' ' THR . 0.6 OUTLIER -138.13 7.63 2.67 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.445 -179.681 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.54 ' O ' ' C ' ' A' ' 19' ' ' VAL . 28.4 mt-30 58.14 26.5 13.79 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 -176.219 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.976 HG11 HG11 ' B' ' 19' ' ' VAL . 2.7 p -13.88 -96.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.121 -178.708 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.959 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -129.72 23.38 5.41 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 105.966 -1.865 . . . . 0.0 105.966 178.402 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.739 HG12 HG22 ' A' ' 10' ' ' ILE . 30.0 m -24.6 -39.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 CA-C-O 122.481 1.134 . . . . 0.0 109.156 -178.868 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.706 ' N ' ' O ' ' A' ' 20' ' ' SER . 48.2 t -82.66 -35.27 27.04 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.246 177.92 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.959 ' N ' ' O ' ' A' ' 20' ' ' SER . 0.6 OUTLIER -86.84 -36.56 18.41 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.684 -0.635 . . . . 0.0 111.347 179.521 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.654 ' CE ' ' HA ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -70.06 -39.4 75.7 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.28 -1.513 . . . . 0.0 109.039 179.433 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.729 HD12 ' HA ' ' A' ' 7' ' ' ILE . 9.0 mt -77.82 -44.54 27.11 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 118.167 -1.413 . . . . 0.0 109.413 178.638 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.48 ' CB ' ' O ' ' A' ' 22' ' ' SER . . . -58.01 -32.8 68.27 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.955 -1.09 . . . . 0.0 108.121 178.025 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.58 ' O ' ' N ' ' A' ' 31' ' ' ILE . 25.8 p -85.27 -31.42 23.11 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.378 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.894 ' HB2' HD11 ' B' ' 10' ' ' ILE . 0.0 OUTLIER -56.13 -34.67 66.3 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.572 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.781 ' HG2' HG22 ' B' ' 45' ' ' THR . 0.8 OUTLIER -79.74 -39.31 31.38 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.378 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.81 ' O ' ' CG ' ' A' ' 34' ' ' GLU . 39.7 ttmt -65.92 -28.08 68.66 Favored 'General case' 0 C--O 1.192 -1.965 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.478 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.749 ' CD1' HD23 ' B' ' 6' ' ' LEU . 2.1 pp -93.2 -37.97 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.911 . . . . 0.0 108.939 179.103 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.749 ' CG1' ' O ' ' A' ' 28' ' ' PHE . 1.1 mm -58.71 -53.52 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 177.651 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.716 ' OG1' ' HB2' ' B' ' 85' ' ' LEU . 0.3 OUTLIER -69.92 -27.35 64.71 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.654 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.81 ' CG ' ' O ' ' A' ' 30' ' ' LYS . 16.9 mm-40 -76.67 -45.03 31.4 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.0 -1.062 . . . . 0.0 110.685 178.973 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.477 ' C ' ' H ' ' A' ' 38' ' ' LYS . 96.4 m -61.58 -53.43 56.36 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 120.651 -1.281 . . . . 0.0 108.859 179.445 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.952 ' CG2' HD13 ' B' ' 85' ' ' LEU . 15.7 m -50.11 -35.34 11.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 177.25 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.755 ' HB1' ' O ' ' B' ' 88' ' ' ALA . . . -92.01 1.18 57.36 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-O 121.582 0.706 . . . . 0.0 110.32 178.484 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.595 ' N ' ' O ' ' A' ' 34' ' ' GLU . 8.8 ttmt -101.53 -32.93 10.14 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 177.784 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 132.98 35.87 0.29 Allowed Glycine 0 C--N 1.305 -1.173 0 C-N-CA 119.637 -1.268 . . . . 0.0 111.565 177.738 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.467 ' CB ' ' CG2' ' A' ' 35' ' ' THR . 0.2 OUTLIER -145.97 -174.02 4.32 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.824 -1.398 . . . . 0.0 111.39 179.467 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.4 ' HG2' ' CB ' ' A' ' 51' ' ' LYS . 0.5 OUTLIER -134.57 127.67 31.73 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.831 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.693 HG22 HD11 ' B' ' 6' ' ' LEU . 1.1 t -85.96 115.38 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.201 -0.937 . . . . 0.0 110.713 -178.794 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.442 ' O ' ' HA ' ' B' ' 2' ' ' ASN . 4.8 mt-30 -105.54 100.43 10.0 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.951 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.918 HD22 ' HD2' ' B' ' 3' ' ' LYS . 47.8 mt -71.9 115.44 11.12 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.219 -0.926 . . . . 0.0 110.704 -178.933 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.536 ' C ' ' O ' ' A' ' 44' ' ' LEU . 2.1 t 28.43 -117.17 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.717 -0.615 . . . . 0.0 110.516 178.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -127.08 32.32 3.63 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 109.071 -1.611 . . . . 0.0 109.071 179.024 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.709 ' HE1' ' HB3' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -131.08 -28.0 1.98 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.14 -1.212 . . . . 0.0 111.921 -179.836 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.927 HD21 HD11 ' B' ' 50' ' ' ILE . 6.3 mt -128.03 128.9 45.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 119.852 -1.78 . . . . 0.0 110.602 176.796 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.514 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 7.4 m-80 -129.81 111.47 12.64 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.533 -0.729 . . . . 0.0 110.399 -178.876 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.837 HG22 HG12 ' A' ' 79' ' ' VAL . 1.2 pp -111.9 149.18 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.581 -0.699 . . . . 0.0 110.348 179.947 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.402 ' HG3' ' HB3' ' A' ' 78' ' ' SER . 0.0 OUTLIER -165.58 117.68 0.87 Allowed Pre-proline 0 N--CA 1.497 1.918 0 O-C-N 120.696 -1.253 . . . . 0.0 110.933 -179.78 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.545 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 53.0 Cg_endo -82.33 149.59 15.07 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 O-C-N 123.667 1.351 . . . . 0.0 111.212 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.772 ' O ' HG23 ' A' ' 75' ' ' VAL . 10.8 m -132.48 -149.95 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 O-C-N 121.521 -0.737 . . . . 0.0 110.345 179.542 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.805 ' HB2' ' HB3' ' B' ' 97' ' ' PHE . . . -148.68 106.26 3.66 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.1 -1.0 . . . . 0.0 111.266 -179.132 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.593 ' HB2' ' O ' ' A' ' 54' ' ' ALA . 2.9 ttt-85 168.34 89.87 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.669 -0.645 . . . . 0.0 109.535 179.519 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.717 ' HB2' ' H ' ' A' ' 74' ' ' SER . 6.8 mt-30 -153.77 19.4 0.53 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 118.585 -1.246 . . . . 0.0 112.319 179.903 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.936 ' HB2' ' CA ' ' A' ' 73' ' ' PRO . . . -131.88 -163.4 1.33 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.748 -1.22 . . . . 0.0 110.491 178.897 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.547 ' O ' ' N ' ' A' ' 60' ' ' GLY . 2.1 mtt85 -159.61 19.93 0.17 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.295 -0.878 . . . . 0.0 111.43 -178.512 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.497 ' C ' ' O ' ' A' ' 58' ' ' ARG . 2.3 ttpm? -24.23 85.05 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.304 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.619 ' N ' ' HA ' ' A' ' 69' ' ' LEU . . . -160.32 -61.19 0.01 OUTLIER Glycine 0 N--CA 1.493 2.471 0 C-N-CA 120.108 -1.044 . . . . 0.0 110.758 179.756 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 1.021 ' CE2' ' HB2' ' A' ' 66' ' ' GLN . 53.2 p90 177.53 175.2 0.46 Allowed 'General case' 0 N--CA 1.508 2.463 0 O-C-N 121.344 -1.092 . . . . 0.0 109.991 -178.656 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.711 ' H ' ' HD2' ' A' ' 63' ' ' PRO . 1.5 t-20 -117.08 -58.8 0.04 OUTLIER Pre-proline 0 C--N 1.304 -1.385 0 C-N-CA 119.441 -0.903 . . . . 0.0 112.719 -178.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.711 ' HD2' ' H ' ' A' ' 62' ' ' ASN . 39.5 Cg_endo -66.89 69.58 0.52 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.177 1.093 . . . . 0.0 110.668 -178.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.712 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 0.1 OUTLIER -179.69 43.57 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.611 -0.681 . . . . 0.0 109.82 179.82 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.588 HG23 ' C ' ' A' ' 64' ' ' GLN . 2.5 p 71.14 8.49 6.45 Favored 'General case' 0 N--CA 1.507 2.42 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 179.076 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 1.021 ' HB2' ' CE2' ' A' ' 61' ' ' PHE . 0.1 OUTLIER -113.74 -142.37 0.38 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.838 -1.164 . . . . 0.0 108.185 178.349 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.777 ' O ' ' CB ' ' A' ' 68' ' ' ALA . 18.9 mt-10 -144.73 12.75 1.48 Allowed 'General case' 0 N--CA 1.486 1.33 0 O-C-N 120.553 -1.342 . . . . 0.0 111.153 178.002 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.777 ' CB ' ' O ' ' A' ' 67' ' ' GLU . . . 133.86 -176.3 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.612 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 175.524 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.857 ' HG ' ' HA ' ' A' ' 61' ' ' PHE . 3.1 mp -95.24 18.97 11.34 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 114.23 -1.35 . . . . 0.0 111.114 -179.816 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.442 ' CB ' ' O ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER 172.39 56.43 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.952 -1.093 . . . . 0.0 111.655 -179.81 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.57 HD11 ' C ' ' A' ' 57' ' ' ALA . 24.1 pt -65.81 -146.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 120.636 -1.29 . . . . 0.0 109.169 178.466 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.432 ' HA ' ' HD2' ' A' ' 73' ' ' PRO . . . -106.36 101.67 36.5 Favored Pre-proline 0 C--N 1.29 -2.022 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -176.702 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.936 ' CA ' ' HB2' ' A' ' 57' ' ' ALA . 48.0 Cg_endo -73.81 132.9 17.72 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 O-C-N 124.113 1.586 . . . . 0.0 108.472 176.755 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.717 ' H ' ' HB2' ' A' ' 56' ' ' GLN . 0.4 OUTLIER -156.55 137.92 13.88 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.243 -0.91 . . . . 0.0 110.994 179.963 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 1.038 HG11 ' CB ' ' B' ' 89' ' ' ALA . 14.6 p -45.22 162.26 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 121.368 -0.833 . . . . 0.0 110.125 179.28 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.698 ' HA3' HG22 ' A' ' 53' ' ' VAL . . . -110.13 87.02 0.46 Allowed Glycine 0 N--CA 1.487 2.037 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 179.356 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.737 HG21 ' HG ' ' B' ' 85' ' ' LEU . 84.1 t -65.2 75.49 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 O-C-N 121.918 -0.754 . . . . 0.0 110.753 -179.247 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.856 ' O ' HG13 ' A' ' 79' ' ' VAL . 0.5 OUTLIER -65.83 178.77 0.99 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.323 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.856 HG13 ' O ' ' A' ' 78' ' ' SER . 0.0 OUTLIER 179.7 178.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.924 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.511 ' O ' HD23 ' A' ' 48' ' ' LEU . 11.1 mttt 179.14 169.79 0.57 Allowed Pre-proline 0 C--N 1.307 -1.28 0 O-C-N 121.384 -0.822 . . . . 0.0 110.46 177.13 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.591 ' HB2' HG13 ' B' ' 77' ' ' VAL . 57.4 Cg_endo -109.39 161.15 0.08 OUTLIER 'Trans proline' 0 C--N 1.301 -1.959 0 C-N-CA 123.413 2.742 . . . . 0.0 110.605 177.798 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 47' ' ' PHE . . . -105.57 -150.79 19.55 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 107.604 -2.198 . . . . 0.0 107.604 177.093 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -100.46 -13.1 18.84 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.88 -1.365 . . . . 0.0 110.125 178.885 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.411 ' HB3' ' HB2' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -58.02 -38.09 75.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.335 -0.853 . . . . 0.0 109.075 179.664 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.923 ' CB ' HG21 ' B' ' 77' ' ' VAL . 0.5 OUTLIER -77.42 -38.16 50.23 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.692 -0.63 . . . . 0.0 109.539 179.239 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.527 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -69.14 -41.5 77.22 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.799 -0.761 . . . . 0.0 110.779 -178.923 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -64.93 -40.24 94.74 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 178.942 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.661 ' O ' ' HB1' ' B' ' 37' ' ' ALA . . . -72.79 -30.78 64.37 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 177.02 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.878 ' HA ' HD23 ' A' ' 92' ' ' LEU . . . -64.68 -39.08 93.05 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.304 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -56.98 -33.15 66.8 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 176.935 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -74.07 -20.79 79.66 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 178.745 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.929 ' O ' HD12 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -76.82 16.07 0.57 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.681 -1.482 . . . . 0.0 111.268 -179.757 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.419 ' CB ' ' O ' ' A' ' 92' ' ' LEU . 0.0 OUTLIER 65.19 34.94 8.15 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -177.728 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.545 ' CD1' ' HB ' ' B' ' 75' ' ' VAL . 0.0 OUTLIER -49.31 -27.75 4.18 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.486 -179.578 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.584 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 11.0 pt-20 -57.57 -40.59 79.31 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.362 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -61.57 -36.84 81.79 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 176.953 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.652 ' HB3' ' HB2' ' B' ' 54' ' ' ALA . 0.2 OUTLIER -63.22 -31.2 72.29 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.737 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.584 ' HB3' ' O ' ' A' ' 95' ' ' GLU . . . -69.31 -29.84 67.77 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.322 0.582 . . . . 0.0 110.074 179.671 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.354 180.0 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.489 ' HG2' ' HB3' ' B' ' 5' ' ' GLU . 3.0 mtp . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.193 0.52 . . . . 0.0 110.211 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . 0.81 ' C ' HD12 ' B' ' 6' ' ' LEU . 23.3 t-20 -173.06 165.99 4.98 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.374 -0.829 . . . . 0.0 109.783 -179.816 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.918 ' HD2' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -47.36 -26.15 1.21 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.983 -1.073 . . . . 0.0 109.202 179.307 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.655 ' O ' ' HB ' ' B' ' 7' ' ' ILE . 16.7 m -79.28 -56.19 4.53 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 177.342 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.489 ' HB3' ' HG2' ' B' ' 1' ' ' MET . 0.5 OUTLIER -57.95 -50.46 73.29 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 177.42 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.81 HD12 ' C ' ' B' ' 2' ' ' ASN . 1.8 mt -61.15 -28.05 68.83 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 177.302 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 7' ' ' ILE . . . . . 1.025 ' CD1' HD23 ' B' ' 25' ' ' LEU . 0.1 OUTLIER -53.68 -54.28 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.278 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . 0.831 ' HA ' ' HB3' ' B' ' 11' ' ' ALA . 0.1 OUTLIER -62.97 -32.91 74.34 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.234 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' B' ' 6' ' ' LEU . . . -62.68 -29.38 70.61 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.375 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.894 HD11 ' HB2' ' A' ' 28' ' ' PHE . 0.6 OUTLIER -93.19 -35.58 6.7 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.627 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 178.109 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.831 ' HB3' ' HA ' ' B' ' 8' ' ' LYS . . . -63.75 -29.11 70.36 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.849 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.469 ' N ' ' O ' ' B' ' 8' ' ' LYS . 1.1 tt0 -89.85 -39.06 13.31 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.027 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.451 ' HB2' ' HA ' ' B' ' 10' ' ' ILE . 43.2 m-20 -67.41 -25.51 65.97 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 176.755 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.915 HG22 ' HB2' ' A' ' 20' ' ' SER . 24.7 p -88.73 -76.35 0.4 Allowed 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.756 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 60.45 12.53 26.08 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.604 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 16' ' ' LEU . . . . . 0.914 HD22 ' O ' ' A' ' 19' ' ' VAL . 3.4 mp -82.98 -60.66 2.09 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.43 -1.041 . . . . 0.0 108.708 179.092 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . 0.615 HG22 ' H ' ' B' ' 19' ' ' VAL . 0.5 OUTLIER -146.14 3.9 0.93 Allowed 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.816 -179.665 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . 0.677 ' O ' ' C ' ' B' ' 19' ' ' VAL . 8.3 mt-30 57.09 28.03 14.3 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 -176.367 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.976 HG11 HG11 ' A' ' 19' ' ' VAL . 1.0 OUTLIER 5.73 -97.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.917 -179.516 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 1.033 ' O ' ' N ' ' B' ' 22' ' ' SER . 96.4 p -133.47 23.85 4.06 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 175.833 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.662 ' O ' HD11 ' B' ' 7' ' ' ILE . 30.8 m -9.1 -41.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 CA-C-O 122.289 1.042 . . . . 0.0 109.885 -177.593 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 1.033 ' N ' ' O ' ' B' ' 20' ' ' SER . 15.3 p -67.81 -46.46 71.81 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.944 177.285 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . 0.902 ' N ' ' O ' ' B' ' 20' ' ' SER . 32.6 mtmt -91.72 -23.85 19.65 Favored 'General case' 0 C--N 1.307 -1.258 0 O-C-N 121.543 -0.723 . . . . 0.0 109.338 178.498 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 24' ' ' MET . . . . . 0.609 ' HE2' ' HA ' ' B' ' 21' ' ' VAL . 2.1 tmm? -63.46 -24.75 67.96 Favored 'General case' 0 C--O 1.216 -0.701 0 O-C-N 120.459 -1.401 . . . . 0.0 107.625 178.207 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 1.025 HD23 ' CD1' ' B' ' 7' ' ' ILE . 0.1 OUTLIER -89.27 -46.4 8.79 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 176.61 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . 0.531 ' HB3' ' HA ' ' B' ' 23' ' ' LYS . . . -58.96 -28.19 66.06 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.25 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . 0.774 ' O ' HG23 ' B' ' 31' ' ' ILE . 23.8 p -86.61 -31.82 20.94 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.082 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 28' ' ' PHE . . . . . 0.897 ' O ' HG13 ' B' ' 31' ' ' ILE . 0.7 OUTLIER -57.69 -42.27 83.35 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.08 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . 0.7 ' O ' ' HB ' ' B' ' 33' ' ' THR . 2.3 tt0 -70.78 -43.27 69.07 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 177.35 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 1.296 ' O ' ' HB3' ' B' ' 34' ' ' GLU . 25.5 ttpt -60.57 -21.34 62.49 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.873 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.919 ' HA ' ' HG2' ' B' ' 34' ' ' GLU . 1.3 pp -102.71 -33.7 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 119.361 -0.936 . . . . 0.0 110.209 179.58 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.681 HG13 ' CD1' ' B' ' 28' ' ' PHE . 1.0 OUTLIER -71.88 -43.76 68.33 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 176.791 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 33' ' ' THR . . . . . 0.7 ' HB ' ' O ' ' B' ' 29' ' ' GLU . 0.3 OUTLIER -77.02 -26.22 53.52 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 177.277 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 1.296 ' HB3' ' O ' ' B' ' 30' ' ' LYS . 0.0 OUTLIER -64.54 -43.94 92.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.097 -1.002 . . . . 0.0 109.961 178.3 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 35' ' ' THR . . . . . 0.778 HG21 HG13 ' B' ' 42' ' ' VAL . 47.9 m -67.33 -56.08 11.23 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 118.911 -1.115 . . . . 0.0 109.255 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.672 ' CG2' ' HA ' ' B' ' 33' ' ' THR . 19.6 m -50.22 -33.92 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 118.164 -1.414 . . . . 0.0 108.217 178.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 0.661 ' HB1' ' O ' ' A' ' 88' ' ' ALA . . . -93.3 0.5 57.0 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.242 0.544 . . . . 0.0 110.492 178.84 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.745 ' HB2' ' O ' ' B' ' 34' ' ' GLU . 9.7 tppt? -103.89 -16.74 15.28 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 106.673 -1.602 . . . . 0.0 106.673 177.132 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.89 50.07 1.3 Allowed Glycine 0 C--N 1.304 -1.216 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 178.21 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . 0.664 ' O ' HG22 ' B' ' 35' ' ' THR . 0.3 OUTLIER -148.94 141.01 23.86 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.057 -1.26 . . . . 0.0 110.775 179.43 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -90.57 92.89 9.05 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.621 -0.674 . . . . 0.0 109.24 179.866 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.824 HG22 HG22 ' B' ' 50' ' ' ILE . 24.1 m -59.28 137.95 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 C-N-CA 119.814 -0.755 . . . . 0.0 110.001 -179.608 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 43' ' ' GLN . . . . . 0.499 ' O ' ' HA ' ' A' ' 2' ' ' ASN . 1.6 mt-30 -118.51 173.43 6.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.345 -0.847 . . . . 0.0 110.149 -179.318 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.76 HD22 ' HE2' ' A' ' 28' ' ' PHE . 36.1 mt -141.31 -177.67 5.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.383 -0.823 . . . . 0.0 110.794 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . 0.781 HG22 ' HG2' ' A' ' 29' ' ' GLU . 2.4 t -51.58 69.02 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 120.878 0.371 . . . . 0.0 111.765 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.656 ' N ' ' O ' ' B' ' 44' ' ' LEU . . . 41.57 29.63 0.48 Allowed Glycine 0 N--CA 1.5 2.914 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 179.352 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . 0.708 ' CE1' HD13 ' B' ' 44' ' ' LEU . 0.5 OUTLIER -123.72 -27.79 3.94 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.166 -1.197 . . . . 0.0 110.656 -179.755 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.716 HD12 ' H ' ' B' ' 49' ' ' ASN . 11.1 tp -168.73 150.0 4.7 Favored 'General case' 0 C--N 1.293 -1.854 0 C-N-CA 118.069 -1.452 . . . . 0.0 111.322 -179.839 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 49' ' ' ASN . . . . . 0.716 ' H ' HD12 ' B' ' 48' ' ' LEU . 17.2 m-80 -148.35 -178.95 6.6 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.96 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 50' ' ' ILE . . . . . 0.927 HD11 HD21 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -142.8 167.17 14.7 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 O-C-N 121.411 -0.806 . . . . 0.0 110.382 179.716 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . 0.462 ' HD3' ' O ' ' B' ' 51' ' ' LYS . 0.0 OUTLIER -170.88 130.13 0.79 Allowed Pre-proline 0 N--CA 1.494 1.771 0 C-N-CA 119.259 -0.977 . . . . 0.0 110.605 179.333 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.576 ' HA ' ' HA ' ' B' ' 77' ' ' VAL . 57.7 Cg_endo -90.39 143.22 3.73 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.67 1.353 . . . . 0.0 110.741 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.65 HG22 ' CA ' ' B' ' 76' ' ' GLY . 16.5 m -126.6 -152.54 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 C-N-CA 119.841 -0.744 . . . . 0.0 110.229 178.945 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.652 ' HB2' ' HB3' ' A' ' 97' ' ' PHE . . . -134.88 116.23 14.53 Favored 'General case' 0 C--N 1.291 -1.969 0 O-C-N 121.292 -0.88 . . . . 0.0 110.506 -179.298 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 55' ' ' ARG . . . . . . . . . . . . . 5.4 mtp180 -148.57 93.43 2.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.552 -0.718 . . . . 0.0 109.477 179.858 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.17 134.95 13.8 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.607 -0.683 . . . . 0.0 111.556 -179.168 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.934 ' HB3' ' CB ' ' B' ' 72' ' ' ALA . . . -74.24 65.63 1.2 Allowed 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 122.03 0.919 . . . . 0.0 109.146 178.762 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 58' ' ' ARG . . . . . 0.659 ' HG2' ' C ' ' B' ' 71' ' ' ILE . 46.3 mtm180 -138.53 124.23 19.75 Favored 'General case' 0 C--N 1.285 -2.223 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.111 -178.452 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 59' ' ' LYS . . . . . 0.45 ' CA ' ' HG3' ' B' ' 70' ' ' GLU . 0.5 OUTLIER -160.88 19.75 0.13 Allowed 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.506 -178.763 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . 0.506 ' HA2' ' N ' ' B' ' 69' ' ' LEU . . . 91.89 66.56 1.13 Allowed Glycine 0 N--CA 1.485 1.966 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.718 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 61' ' ' PHE . . . . . 0.889 ' C ' ' HA ' ' B' ' 68' ' ' ALA . 0.0 OUTLIER -75.46 130.87 39.63 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.905 -1.35 . . . . 0.0 113.573 -178.967 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . 0.814 ' H ' ' CD ' ' B' ' 63' ' ' PRO . 7.5 p30 -136.84 -19.77 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.477 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 178.803 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.814 ' CD ' ' H ' ' B' ' 62' ' ' ASN . 47.4 Cg_endo -75.69 -6.62 17.79 Favored 'Trans proline' 0 N--CA 1.484 0.924 0 CA-C-N 119.466 0.845 . . . . 0.0 110.347 179.94 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . 0.602 ' HB3' ' CE1' ' B' ' 61' ' ' PHE . 0.0 OUTLIER -88.6 -105.45 0.08 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.317 -0.864 . . . . 0.0 109.223 179.526 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.405 ' H ' ' HB3' ' B' ' 64' ' ' GLN . 0.0 OUTLIER -81.5 12.14 3.99 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.536 -1.353 . . . . 0.0 110.097 178.797 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . 0.6 ' O ' ' CB ' ' B' ' 67' ' ' GLU . 0.0 OUTLIER 69.75 109.87 0.05 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.395 -0.816 . . . . 0.0 111.887 179.125 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 67' ' ' GLU . . . . . 0.918 ' O ' ' HG ' ' B' ' 69' ' ' LEU . 4.2 pt-20 140.75 87.08 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.389 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.769 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . 0.889 ' HA ' ' C ' ' B' ' 61' ' ' PHE . . . -56.14 101.77 0.06 Allowed 'General case' 0 N--CA 1.504 2.23 0 O-C-N 120.902 -1.124 . . . . 0.0 112.137 -178.332 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.918 ' HG ' ' O ' ' B' ' 67' ' ' GLU . 1.0 OUTLIER -131.09 147.91 52.67 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.55 -0.718 . . . . 0.0 109.738 178.099 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . 0.649 ' O ' HG23 ' B' ' 71' ' ' ILE . 2.3 mt-10 -80.08 108.75 13.91 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.022 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.812 ' O ' ' HB2' ' B' ' 72' ' ' ALA . 0.8 OUTLIER -155.95 119.71 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.647 -1.283 . . . . 0.0 113.516 -178.231 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . 0.934 ' CB ' ' HB3' ' B' ' 57' ' ' ALA . . . 138.78 138.5 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.962 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.06 178.355 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 73' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' B' ' 72' ' ' ALA . 53.3 Cg_endo -94.26 127.97 0.54 Allowed 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.22 1.947 . . . . 0.0 109.687 178.817 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . 0.503 ' HB2' ' HB2' ' B' ' 57' ' ' ALA . 0.3 OUTLIER -153.65 141.27 19.91 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.881 -1.137 . . . . 0.0 111.427 -179.989 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . 0.581 HG11 ' HB1' ' A' ' 89' ' ' ALA . 0.3 OUTLIER -100.83 172.63 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.55 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . 0.65 ' CA ' HG22 ' B' ' 53' ' ' VAL . . . -114.89 88.2 0.47 Allowed Glycine 0 N--CA 1.491 2.303 0 C-N-CA 118.539 -1.791 . . . . 0.0 110.494 -179.178 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.923 HG21 ' CB ' ' A' ' 85' ' ' LEU . 5.0 p -69.62 68.58 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.354 -1.086 . . . . 0.0 108.308 178.349 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . 0.479 ' N ' ' O ' ' B' ' 76' ' ' GLY . 0.3 OUTLIER -59.93 -153.8 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 121.895 0.855 . . . . 0.0 110.953 -179.073 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.764 ' HA ' ' HA ' ' B' ' 50' ' ' ILE . 3.1 p -157.19 -169.49 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 179.805 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 80' ' ' LYS . . . . . 0.512 ' H ' HG22 ' B' ' 79' ' ' VAL . 0.9 OUTLIER -140.38 175.29 3.24 Favored Pre-proline 0 C--N 1.307 -1.25 0 C-N-CA 117.651 -1.62 . . . . 0.0 113.126 -179.692 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 81' ' ' PRO . . . . . 0.43 ' CD ' ' CB ' ' B' ' 80' ' ' LYS . 58.9 Cg_endo -111.52 119.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 124.78 3.653 . . . . 0.0 111.185 -179.075 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . 0.667 ' HA3' ' C ' ' B' ' 47' ' ' PHE . . . -123.78 144.6 15.6 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 177.934 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . 0.454 ' HA ' ' HB2' ' B' ' 86' ' ' LYS . 8.0 pm0 -85.3 -23.62 28.04 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.156 -1.203 . . . . 0.0 111.59 -178.882 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 84' ' ' SER . . . . . 0.408 ' CB ' ' O ' ' B' ' 45' ' ' THR . 5.4 t -51.16 -30.96 18.29 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.051 -1.031 . . . . 0.0 108.42 179.283 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.952 HD13 ' CG2' ' A' ' 36' ' ' VAL . 0.1 OUTLIER -87.2 -40.52 14.5 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.172 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 86' ' ' LYS . . . . . 0.454 ' HB2' ' HA ' ' B' ' 83' ' ' GLU . 3.1 mtpp -64.24 -26.39 68.48 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.059 -1.057 . . . . 0.0 109.129 178.68 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -81.37 -36.01 30.13 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 178.343 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.755 ' O ' ' HB1' ' A' ' 37' ' ' ALA . . . -66.37 -37.98 86.52 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 176.737 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 1.038 ' CB ' HG11 ' A' ' 75' ' ' VAL . . . -61.43 -35.06 76.51 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.414 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.401 ' HG2' ' N ' ' B' ' 91' ' ' GLY . 0.7 OUTLIER -56.2 -32.87 64.79 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 176.751 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . 0.401 ' N ' ' HG2' ' B' ' 90' ' ' GLU . . . -66.42 -36.94 92.28 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 178.288 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . 0.858 ' O ' HD12 ' B' ' 92' ' ' LEU . 0.4 OUTLIER -69.65 7.1 0.93 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.902 -1.352 . . . . 0.0 110.658 179.553 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . 0.516 ' CB ' ' O ' ' B' ' 92' ' ' LEU . 6.5 tptm 72.99 43.41 0.41 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -177.76 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . 0.517 ' CZ ' ' N ' ' A' ' 74' ' ' SER . 0.2 OUTLIER -41.31 -33.47 0.39 Allowed 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.422 -179.542 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . 0.603 ' O ' ' HB3' ' B' ' 98' ' ' ALA . 10.1 pt-20 -61.51 -43.19 99.3 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.193 -0.942 . . . . 0.0 109.323 179.299 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 96' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.3 -36.81 76.27 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 177.77 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 97' ' ' PHE . . . . . 0.805 ' HB3' ' HB2' ' A' ' 54' ' ' ALA . 0.1 OUTLIER -63.77 -28.51 69.92 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.967 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 98' ' ' ALA . . . . . 0.603 ' HB3' ' O ' ' B' ' 95' ' ' GLU . . . -70.35 -52.17 24.62 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.372 0.606 . . . . 0.0 110.237 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 99' ' ' LYS . . . . . . . . . . . . . 28.9 mtmt . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.255 -179.939 . . . . . . . . 0 0 . 1 stop_ save_